PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Obeid, S; Welte, W; Diederichs, K; Marx, A				Obeid, Samra; Welte, Wolfram; Diederichs, Kay; Marx, Andreas			Amino Acid Templating Mechanisms in Selection of Nucleotides Opposite Abasic Sites by a Family A DNA Polymerase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APURINIC APYRIMIDINIC SITES; DIFFERENT SEQUENCE CONTEXTS; STRUCTURAL BASIS; TRANSLESION SYNTHESIS; A-RULE; REPLICATION FIDELITY; CRYSTAL-STRUCTURES; ACTIVE-SITE; MUTATIONAL SPECIFICITY; KLENOW FRAGMENT	Cleavage of the N-glycosidic bond that connects the nucleobase to the backbone in DNA leads to abasic sites, the most frequent lesion under physiological conditions. Several DNA polymerases preferentially incorporate an A opposite this lesion, a phenomenon termed "A-rule." Accordingly, KlenTaq, the large fragment of Thermus aquaticus DNA polymerase I, incorporates a nucleotide opposite an abasic site with efficiencies of A > G > T > C. Here we provide structural insights into constraints of the active site during nucleotide selection opposite an abasic site. It appears that these confines govern the nucleotide selection mainly by interaction of the incoming nucleotide with Tyr-671. Depending on the nucleobase, the nucleotides are differently positioned opposite Tyr-671 resulting in different alignments of the functional groups that are required for bond formation. The distances between the alpha-phosphate and the 3'-primer terminus increases in the order A < G < T, which follows the order of incorporation efficiency. Additionally, a binary KlenTaq structure bound to DNA containing an abasic site indicates that binding of the nucleotide triggers a remarkable rearrangement of enzyme and DNA template. The ability to resolve the stacking arrangement might be dependent on the intrinsic properties of the respective nucleotide contributing to nucleotide selection. Furthermore, we studied the incorporation of a non-natural nucleotide opposite an abasic site. The nucleotide was often used in studying stacking effects in DNA polymerization. Here, no interaction with Tyr-761 as found for the natural nucleotides is observed, indicating a different reaction path for this non-natural nucleotide.	[Obeid, Samra; Marx, Andreas] Univ Konstanz, Dept Chem, D-78457 Constance, Germany; [Welte, Wolfram; Diederichs, Kay] Univ Konstanz, Dept Biol, D-78457 Constance, Germany; [Obeid, Samra; Welte, Wolfram; Diederichs, Kay; Marx, Andreas] Univ Konstanz, Konstanz Res Sch Chem Biol, D-78457 Constance, Germany	University of Konstanz; University of Konstanz; University of Konstanz	Marx, A (corresponding author), Univ Konstanz, Dept Chem, Univ Str 10, D-78457 Constance, Germany.	andreas.marx@uni-konstanz.de			Deutsche Forschungsgemeinschaft [SPP 1170]; Zukunftskolleg, University of Konstanz	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Zukunftskolleg, University of Konstanz	This work was supported by the Deutsche Forschungsgemeinschaft through a grant in SPP 1170.; Supported by funding from the Zukunftskolleg, University of Konstanz.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Avkin S, 2002, P NATL ACAD SCI USA, V99, P3764, DOI 10.1073/pnas.062038699; Batra VK, 2008, MOL CELL, V30, P315, DOI 10.1016/j.molcel.2008.02.025; Bell JB, 1997, J BIOL CHEM, V272, P7345, DOI 10.1074/jbc.272.11.7345; Betz K, 2010, ANGEW CHEM INT EDIT, V49, P5181, DOI 10.1002/anie.200905724; Choi JY, 2010, J MOL BIOL, V404, P34, DOI 10.1016/j.jmb.2010.09.015; Copeland WC, 2003, ACTA BIOCHIM POL, V50, P155; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; DELARUE M, 1990, PROTEIN ENG, V3, P461, DOI 10.1093/protein/3.6.461; Di Pasquale F, 2008, J AM CHEM SOC, V130, P10748, DOI 10.1021/ja8028284; Efrati E, 1997, J BIOL CHEM, V272, P2559; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fiala KA, 2007, J BIOL CHEM, V282, P8188, DOI 10.1074/jbc.M610718200; Florian J, 2005, P NATL ACAD SCI USA, V102, P6819, DOI 10.1073/pnas.0408173102; Freisinger E, 2004, EMBO J, V23, P1494, DOI 10.1038/sj.emboj.7600158; GOODMAN MF, 1994, ANN NY ACAD SCI, V726, P132, DOI 10.1111/j.1749-6632.1994.tb52804.x; Goodman MF, 1997, P NATL ACAD SCI USA, V94, P10493, DOI 10.1073/pnas.94.20.10493; Graziewicz MA, 2004, NAT STRUCT MOL BIOL, V11, P770, DOI 10.1038/nsmb805; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Hogg M, 2004, EMBO J, V23, P1483, DOI 10.1038/sj.emboj.7600150; Hubscher U, 2002, ANNU REV BIOCHEM, V71, P133, DOI 10.1146/annurev.biochem.71.090501.150041; Hwang HS, 2004, BIOCHEMISTRY-US, V43, P14612, DOI 10.1021/bi0489558; Johnson KA, 2010, BBA-PROTEINS PROTEOM, V1804, P1041, DOI 10.1016/j.bbapap.2010.01.006; Joyce CM, 2010, BBA-PROTEINS PROTEOM, V1804, P1032, DOI 10.1016/j.bbapap.2009.07.021; Joyce CM, 2004, BIOCHEMISTRY-US, V43, P14317, DOI 10.1021/bi048422z; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kool ET, 2002, ANNU REV BIOCHEM, V71, P191, DOI 10.1146/annurev.biochem.71.110601.135453; KOROLEV S, 1995, P NATL ACAD SCI USA, V92, P9264, DOI 10.1073/pnas.92.20.9264; Li Y, 1999, P NATL ACAD SCI USA, V96, P9491, DOI 10.1073/pnas.96.17.9491; Li Y, 1998, EMBO J, V17, P7514, DOI 10.1093/emboj/17.24.7514; Li Y, 2001, PROTEIN SCI, V10, P1225, DOI 10.1110/ps.250101; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Ling H, 2004, MOL CELL, V13, P751, DOI 10.1016/S1097-2765(04)00101-7; LOAKES D, 1994, NUCLEIC ACIDS RES, V22, P4039, DOI 10.1093/nar/22.20.4039; Loakes D, 2001, NUCLEIC ACIDS RES, V29, P2437, DOI 10.1093/nar/29.12.2437; LOEB LA, 1986, ANNU REV GENET, V20, P201, DOI 10.1146/annurev.ge.20.120186.001221; Masuda K, 2007, J BIOL CHEM, V282, P17387, DOI 10.1074/jbc.M611849200; Matray TJ, 1999, NATURE, V399, P704, DOI 10.1038/21453; Minnick DT, 1999, J BIOL CHEM, V274, P3067, DOI 10.1074/jbc.274.5.3067; Motea EA, 2011, NUCLEIC ACIDS RES, V39, P1623, DOI 10.1093/nar/gkq925; Nair DT, 2011, J MOL BIOL, V406, P18, DOI 10.1016/j.jmb.2010.12.016; Nair DT, 2009, STRUCTURE, V17, P530, DOI 10.1016/j.str.2009.02.015; Obeid S, 2011, CHEMBIOCHEM, V12, P1574, DOI 10.1002/cbic.201000783; Obeid S, 2010, P NATL ACAD SCI USA, V107, P21327, DOI 10.1073/pnas.1013804107; Obeid S, 2010, EMBO J, V29, P1738, DOI 10.1038/emboj.2010.64; Pages V, 2008, P NATL ACAD SCI USA, V105, P1170, DOI 10.1073/pnas.0711227105; RANDALL SK, 1987, J BIOL CHEM, V262, P6864; Reineks EZ, 2004, BIOCHEMISTRY-US, V43, P393, DOI 10.1021/bi034948s; SAGHER D, 1983, BIOCHEMISTRY-US, V22, P4518, DOI 10.1021/bi00288a026; Santoso Y, 2010, P NATL ACAD SCI USA, V107, P715, DOI 10.1073/pnas.0910909107; SCHAAPER RM, 1983, P NATL ACAD SCI-BIOL, V80, P487, DOI 10.1073/pnas.80.2.487; Seki M, 2004, EMBO J, V23, P4484, DOI 10.1038/sj.emboj.7600424; Sheriff A, 2008, BIOCHEMISTRY-US, V47, P8527, DOI 10.1021/bi800324r; Sherrer SM, 2011, NUCLEIC ACIDS RES, V39, P609, DOI 10.1093/nar/gkq719; Shibutani S, 1997, J BIOL CHEM, V272, P13916, DOI 10.1074/jbc.272.21.13916; Smith CL, 1998, NUCLEOS NUCLEOT, V17, P541, DOI 10.1080/07328319808005197; Strauss BS, 2002, DNA REPAIR, V1, P125, DOI 10.1016/S1568-7864(01)00014-3; Suzuki M, 1996, P NATL ACAD SCI USA, V93, P9670, DOI 10.1073/pnas.93.18.9670; Taylor JS, 2002, MUTAT RES-FUND MOL M, V510, P55, DOI 10.1016/S0027-5107(02)00252-X; Vineyard D, 2007, ORG BIOMOL CHEM, V5, P3623, DOI 10.1039/b712480e; Wintjens R, 2000, J MOL BIOL, V302, P395, DOI 10.1006/jmbi.2000.4040; Wu EY, 2011, J BIOL CHEM, V286, P19758, DOI 10.1074/jbc.M110.191130; Yang W, 2007, P NATL ACAD SCI USA, V104, P15591, DOI 10.1073/pnas.0704219104; Zahn KE, 2007, BIOCHEMISTRY-US, V46, P10551, DOI 10.1021/bi7008807; Zahn KE, 2011, CURR OPIN STRUC BIOL, V21, P358, DOI 10.1016/j.sbi.2011.03.008	66	19	20	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					14099	14108		10.1074/jbc.M111.334904	http://dx.doi.org/10.1074/jbc.M111.334904			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22318723	Green Submitted, hybrid, Green Published			2022-12-25	WOS:000303996300063
J	Bustard, DE; Menolfi, D; Jeppsson, K; Ball, LG; Dewey, SC; Shirahige, K; Sjogren, C; Branzei, D; Cobb, JA				Bustard, Denise E.; Menolfi, Demis; Jeppsson, Kristian; Ball, Lindsay G.; Dewey, Sidney Carter; Shirahige, Katsuhiko; Sjogren, Camilla; Branzei, Dana; Cobb, Jennifer A.			During Replication Stress, Non-Smc Element 5 (Nse5) Is Required for Smc5/6 Protein Complex Functionality at Stalled Forks	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-REPAIR; SUMO LIGASE; SMC5-SMC6 COMPLEX; CHECKPOINT; HELICASE; MUTANTS; ROLES; CONJUGATION; COMPONENT; SUBUNIT	The Smc5/6 complex belongs to the SMC (structural maintenance of chromosomes) family, which also includes cohesin and condensin. In Saccharomyces cerevisiae, the Smc5/6 complex contains six essential non-Smcelements, Nse1-6. Very little is known about how these additional elements contribute to complex function except for Nse2/Mms21, which is an E3 small ubiquitin-like modifier (SUMO) ligase important for Smc5 sumoylation. Characterization of two temperature-sensitive mutants, nse5-ts1 and nse5-ts2, demonstrated the importance of Nse5 within the Smc5/6 complex for its stability and functionality at forks during hydroxyurea-induced replication stress. Both NSE5 alleles showed a marked reduction in Smc5 sumoylation to levels lower than those observed with mms2111, a mutant of Mms21 that is deficient in SUMO ligase activity. However, a phenotypic comparison of nse5-ts1 and nse5-ts2 revealed a separation of importance between Smc5 sumoylation and the function of the Smc5/6 complex during replication. Only cells carrying the nse5-ts1 allele exhibited defects such as dissociation of the replisome from stalled forks, formation of fork-associated homologous recombination intermediates, and hydroxyurea sensitivity that is additive with mms21-11. These defects are attributed to a failure in Smc5/6 localization to forks in nse5-ts1 cells. Overall, these data support the premise that Nse5 is important for vital interactions between components within the Smc5/6 complex, and for its functionality during replication stress.	[Bustard, Denise E.; Ball, Lindsay G.; Cobb, Jennifer A.] Univ Calgary, So Alberta Canc Res Inst, Dept Biochem & Mol Biol, Calgary, AB T2N 4N1, Canada; [Menolfi, Demis; Branzei, Dana] Ist FIRC Oncol Mol IFOM, I-20139 Milan, Italy; [Menolfi, Demis] Univ Milan, I-20122 Milan, Italy; [Jeppsson, Kristian; Dewey, Sidney Carter; Sjogren, Camilla] Karolinska Inst, Dept Cell & Mol Biol, S-17177 Stockholm, Sweden; [Shirahige, Katsuhiko] Univ Tokyo, Inst Mol & Cellular Biosci, Lab Genome Struct & Funct, Ctr Epigenet Dis,Bunkyo Ku, Tokyo 1130032, Japan	University of Calgary; IFOM - FIRC Institute of Molecular Oncology; University of Milan; Karolinska Institutet; University of Tokyo	Cobb, JA (corresponding author), Univ Calgary, So Alberta Canc Res Inst, Dept Biochem & Mol Biol, 3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.	jcobb@ucalgary.ca	Branzei, Dana/A-2806-2015; Branzei, Dana/GOG-9093-2022; Menolfi, Demis/GSM-8062-2022	Branzei, Dana/0000-0002-0544-4888; Branzei, Dana/0000-0002-0544-4888; Bjorkegren, Camilla/0000-0001-7354-9270; Menolfi, Demis/0000-0002-3824-9931	Alberta Heritage Foundation for Medical Research (AHFMR), Alberta Cancer Board [23575]; Canadian Institutes of Health Research [MOP-82736]; Associazione Italiana per la Ricerca sul Cancro (AIRC) [IG 10637]; European Research Council (ERC) [REPSUBREP242928]; European Research Council; Swedish Research Council; Swedish Cancer Society; Vinnova; Swedish Foundation for Strategic Research (SSF)	Alberta Heritage Foundation for Medical Research (AHFMR), Alberta Cancer Board; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); European Research Council (ERC)(European Research Council (ERC)European Commission); European Research Council(European Research Council (ERC)European Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Vinnova(Vinnova); Swedish Foundation for Strategic Research (SSF)(Swedish Foundation for Strategic Research)	This work was supported by grants from the Alberta Heritage Foundation for Medical Research (AHFMR), Alberta Cancer Board Grant 23575, and Canadian Institutes of Health Research Grant MOP-82736 (to J. A. C.); Associazione Italiana per la Ricerca sul Cancro (AIRC) Grant IG 10637 and European Research Council (ERC) Grant REPSUBREP242928 (to D. B.); and the European Research Council, the Swedish Research Council, the Swedish Cancer Society, Vinnova, and the Swedish Foundation for Strategic Research (SSF) (to C. S.).	Ampatzidou E, 2006, MOL CELL BIOL, V26, P9387, DOI 10.1128/MCB.01335-06; Andrews EA, 2005, MOL CELL BIOL, V25, P185, DOI 10.1128/MCB.25.1.185-196.2005; Aushubel F. M., 1994, CURRENT PROTOCOLS MO; Ben-Aroya S, 2008, MOL CELL, V30, P248, DOI 10.1016/j.molcel.2008.02.021; Bjergbaek L, 2005, EMBO J, V24, P405, DOI 10.1038/sj.emboj.7600511; Branzei D, 2006, CELL, V127, P509, DOI 10.1016/j.cell.2006.08.050; Chavez A, 2011, J BIOL CHEM, V286, P5119, DOI 10.1074/jbc.M110.201608; Chen YH, 2009, P NATL ACAD SCI USA, V106, P21252, DOI 10.1073/pnas.0908258106; Choi KY, 2010, MOL BIOL CELL, V21, P2306, DOI 10.1091/mbc.E10-01-0050; Cobb JA, 2003, EMBO J, V22, P4325, DOI 10.1093/emboj/cdg391; Cobb JA, 2005, GENE DEV, V19, P3055, DOI 10.1101/gad.361805; Cost GJ, 2006, GENETICS, V172, P2185, DOI 10.1534/genetics.105.053876; De Piccoli G, 2009, CHROMOSOME RES, V17, P251, DOI 10.1007/s10577-008-9016-8; Duan XY, 2009, MOL CELL, V35, P657, DOI 10.1016/j.molcel.2009.06.032; Duan XY, 2009, J BIOL CHEM, V284, P8507, DOI 10.1074/jbc.M809139200; Hazbun TR, 2003, MOL CELL, V12, P1353, DOI 10.1016/S1097-2765(03)00476-3; Hu B, 2005, MOL MICROBIOL, V55, P1735, DOI 10.1111/j.1365-2958.2005.04531.x; Hwang JY, 2008, DNA REPAIR, V7, P1426, DOI 10.1016/j.dnarep.2008.05.006; Irmisch A, 2009, EMBO J, V28, P144, DOI 10.1038/emboj.2008.273; Johnson ES, 2001, CELL, V106, P735, DOI 10.1016/S0092-8674(01)00491-3; Johnson ES, 1997, J BIOL CHEM, V272, P26799, DOI 10.1074/jbc.272.43.26799; Katou Y, 2006, METHOD ENZYMOL, V409, P389, DOI 10.1016/S0076-6879(05)09023-3; Kegel A, 2011, NATURE, V471, P392, DOI 10.1038/nature09791; Liberi G, 2005, GENE DEV, V19, P339, DOI 10.1101/gad.322605; Lindroos HB, 2006, MOL CELL, V22, P755, DOI 10.1016/j.molcel.2006.05.014; Miyabe I, 2006, MOL CELL BIOL, V26, P343, DOI 10.1128/MCB.26.1.343-353.2006; Murray JM, 2008, NAT REV MOL CELL BIO, V9, P177, DOI 10.1038/nrm2309; Pebernard S, 2006, MOL CELL BIOL, V26, P1617, DOI 10.1128/MCB.26.5.1617-1630.2006; Pebernard S, 2004, MOL BIOL CELL, V15, P4866, DOI 10.1091/mbc.E04-05-0436; Pebernard S, 2008, EMBO J, V27, P3011, DOI 10.1038/emboj.2008.220; Potts PR, 2009, DNA REPAIR, V8, P499, DOI 10.1016/j.dnarep.2009.01.009; Potts PR, 2005, MOL CELL BIOL, V25, P7021, DOI 10.1128/MCB.25.16.7021-7032.2005; Sollier J, 2009, MOL BIOL CELL, V20, P1671, DOI 10.1091/mbc.E08-08-0875; Takahashi Y, 2001, GENE, V275, P223, DOI 10.1016/S0378-1119(01)00662-X; Tittel-Elmer M, 2009, EMBO J, V28, P1142, DOI 10.1038/emboj.2009.60; Torres-Rosell J, 2005, NAT CELL BIOL, V7, P412, DOI 10.1038/ncb1239; Vanoli F, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001205; Wohlschlegel JA, 2006, J PROTEOME RES, V5, P761, DOI 10.1021/pr050451o; Zhao XL, 2005, P NATL ACAD SCI USA, V102, P4777, DOI 10.1073/pnas.0500537102	39	40	41	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					11374	11383		10.1074/jbc.M111.336263	http://dx.doi.org/10.1074/jbc.M111.336263			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22303010	Green Published, hybrid			2022-12-25	WOS:000302780100067
J	Havens, CG; Shobnam, N; Guarino, E; Centore, RC; Zou, L; Kearsey, SE; Walter, JC				Havens, Courtney G.; Shobnam, Nadia; Guarino, Estrella; Centore, Richard C.; Zou, Lee; Kearsey, Stephen E.; Walter, Johannes C.			Direct Role for Proliferating Cell Nuclear Antigen in Substrate Recognition by the E3 Ubiquitin Ligase CRL4(Cdt2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT KINASE INHIBITOR; XENOPUS EGG EXTRACTS; DNA-POLYMERASE ALPHA; S-PHASE; STRUCTURAL BASIS; CDT1 PROTEOLYSIS; FISSION YEAST; HISTONE H3; PIP BOX; CHROMATIN ASSOCIATION	The E3 ubiquitin ligase Cullin-ring ligase 4-Cdt2 (CRL4(Cdt2)) is emerging as an important cell cycle regulator that targets numerous proteins for destruction in S phase and after DNA damage, including Cdt1, p21, and Set8. CRL4(Cdt2) substrates contain a "PIP degron," which consists of a canonical proliferating cell nuclear antigen (PCNA) interaction motif (PIP box) and an adjacent basic amino acid. Substrates use their PIP box to form a binary complex with PCNA on chromatin and the basic residue to recruit CRL4(Cdt2) for substrate ubiquitylation. Using Xenopus egg extracts, we identify an acidic residue in PCNA that is essential to support destruction of all CRL4(Cdt2) substrates. This PCNA residue, which adjoins the basic amino acid of the bound PIP degron, is dispensable for substrate binding to PCNA but essential for CRL4(Cdt2) recruitment to chromatin. Our data show that the interaction of CRL4(Cdt2) with substrates requires molecular determinants not only in the substrate degron but also on PCNA. The results illustrate a potentially general mechanism by which E3 ligases can couple ubiquitylation to the formation of protein-protein interactions.	[Havens, Courtney G.; Shobnam, Nadia; Walter, Johannes C.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Guarino, Estrella; Kearsey, Stephen E.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Centore, Richard C.; Zou, Lee] Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA	Harvard University; Harvard Medical School; University of Oxford; Harvard University; Massachusetts General Hospital	Walter, JC (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, 240 Longwood Ave,Bldg C2-226A, Boston, MA 02115 USA.	johannes_walter@hms.harvard.edu		Walter, Johannes/0000-0002-4186-7570	National Institutes of Health [GM80676, GM082014, GM089150]; Cancer Research UK [C814/A9035]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080676, F32GM089150, F32GM082014] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research UK(Cancer Research UK); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM80676 (to J. C. W.), GM082014 (to C. G. H.), and GM089150 (to R. C. C.). This work was also supported by Cancer Research UK Grant C814/A9035 (to S. E. K.).	Abbas T, 2008, GENE DEV, V22, P2496, DOI 10.1101/gad.1676108; Abbas T, 2011, CELL CYCLE, V10, P241, DOI 10.4161/cc.10.2.14530; Abbas T, 2010, MOL CELL, V40, P9, DOI 10.1016/j.molcel.2010.09.014; Angers S, 2006, NATURE, V443, P590, DOI 10.1038/nature05175; Arias EE, 2006, NAT CELL BIOL, V8, P84, DOI 10.1038/ncb1346; Arias EE, 2005, GENE DEV, V19, P114, DOI 10.1101/gad.1255805; Centore RC, 2010, MOL CELL, V40, P22, DOI 10.1016/j.molcel.2010.09.015; Chuang LC, 2005, J BIOL CHEM, V280, P35299, DOI 10.1074/jbc.M506429200; Chuang LC, 2005, J BIOL CHEM, V280, P35290, DOI 10.1074/jbc.M506430200; Couture JF, 2006, NAT STRUCT MOL BIOL, V13, P698, DOI 10.1038/nsmb1116; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Eissenberg JC, 1997, MOL CELL BIOL, V17, P6367, DOI 10.1128/MCB.17.11.6367; Gomes XV, 2000, EMBO J, V19, P3811, DOI 10.1093/emboj/19.14.3811; Gregan J, 2003, MOL BIOL CELL, V14, P3876, DOI 10.1091/mbc.E03-02-0090; Guarino E, 2011, NUCLEIC ACIDS RES, V39, P5978, DOI 10.1093/nar/gkr222; Gulbis JM, 1996, CELL, V87, P297, DOI 10.1016/S0092-8674(00)81347-1; Han ZF, 2006, MOL CELL, V22, P137, DOI 10.1016/j.molcel.2006.03.018; Hao B, 2005, MOL CELL, V20, P9, DOI 10.1016/j.molcel.2005.09.003; Hao B, 2007, MOL CELL, V26, P131, DOI 10.1016/j.molcel.2007.02.022; Havens CG, 2011, GENE DEV, V25, P1568, DOI 10.1101/gad.2068611; Havens CG, 2009, MOL CELL, V35, P93, DOI 10.1016/j.molcel.2009.05.012; Higa LA, 2006, CELL CYCLE, V5, P1675, DOI 10.4161/cc.5.15.3149; Jin JP, 2006, MOL CELL, V23, P709, DOI 10.1016/j.molcel.2006.08.010; Jin LY, 2008, CELL, V133, P653, DOI 10.1016/j.cell.2008.04.012; Jorgensen S, 2011, J CELL BIOL, V192, P43, DOI 10.1083/jcb.201009076; Kim DH, 2010, MOL CELL BIOL, V30, P4120, DOI 10.1128/MCB.01135-09; Kim SH, 2008, MOL CELL, V32, P757, DOI 10.1016/j.molcel.2008.11.016; Kim Y, 2008, GENE DEV, V22, P2507, DOI 10.1101/gad.1703708; Kochaniak AB, 2009, J BIOL CHEM, V284, P17700, DOI 10.1074/jbc.M109.008706; Lebofsky Ronald, 2009, V521, P229, DOI [10.1007/978-1-60327-817-5_13, 10.1007/978-1-60327-815-7_13]; Li T, 2006, CELL, V124, P105, DOI 10.1016/j.cell.2005.10.033; Lindner K, 2002, MOL BIOL CELL, V13, P435, DOI 10.1091/mbc.01-11-0537; Liu C, 2005, EMBO J, V24, P3940, DOI 10.1038/sj.emboj.7600854; Michishita M, 2011, GENES CELLS, V16, P12, DOI 10.1111/j.1365-2443.2010.01464.x; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Montagnoli A, 1999, GENE DEV, V13, P1181, DOI 10.1101/gad.13.9.1181; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Nguyen H, 1999, MOL CELL BIOL, V19, P1190; Nishitani H, 2008, J BIOL CHEM, V283, P29045, DOI 10.1074/jbc.M806045200; Oda H, 2010, MOL CELL, V40, P364, DOI 10.1016/j.molcel.2010.10.011; Ralph E, 2006, EMBO REP, V7, P1134, DOI 10.1038/sj.embor.7400827; Rodrigo-Brenni MC, 2010, MOL CELL, V39, P548, DOI 10.1016/j.molcel.2010.07.027; Saha A, 2011, MOL CELL, V42, P75, DOI 10.1016/j.molcel.2011.03.016; Sansam CL, 2006, GENE DEV, V20, P3117, DOI 10.1101/gad.1482106; Schuetz A, 2006, EMBO J, V25, P4245, DOI 10.1038/sj.emboj.7601316; Scrima A, 2011, FEBS LETT, V585, P2818, DOI 10.1016/j.febslet.2011.04.064; Scrima A, 2008, CELL, V135, P1213, DOI 10.1016/j.cell.2008.10.045; Senga T, 2006, J BIOL CHEM, V281, P6246, DOI 10.1074/jbc.M512705200; Shibata E, 2011, MOL CELL BIOL, V31, P3136, DOI 10.1128/MCB.05496-11; Shibutani ST, 2008, DEV CELL, V15, P890, DOI 10.1016/j.devcel.2008.10.003; Sitry D, 2002, J BIOL CHEM, V277, P42233, DOI 10.1074/jbc.M205254200; Stokes MP, 2003, J CELL BIOL, V163, P245, DOI 10.1083/jcb.200306006; Tan X, 2007, NATURE, V446, P640, DOI 10.1038/nature05731; Tardat M, 2010, NAT CELL BIOL, V12, P1086, DOI 10.1038/ncb2113; Walter J, 2000, MOL CELL, V5, P617, DOI 10.1016/S1097-2765(00)80241-5; Walter J, 1998, MOL CELL, V1, P519, DOI 10.1016/S1097-2765(00)80052-0; Wickliffe KE, 2011, CELL, V144, P769, DOI 10.1016/j.cell.2011.01.035; Wu G, 2003, MOL CELL, V11, P1445, DOI 10.1016/S1097-2765(03)00234-X; Xu SC, 2007, J BIOL CHEM, V282, P15462, DOI 10.1074/jbc.M610758200; Yang XW, 2005, BMC MOL BIOL, V6, DOI 10.1186/1471-2199-6-13; Ye YH, 2009, NAT REV MOL CELL BIO, V10, P755, DOI 10.1038/nrm2780; You ZS, 2002, GENE DEV, V16, P1182, DOI 10.1101/gad.985302; Yu H, 2007, MOL CELL, V27, P3, DOI 10.1016/j.molcel.2007.06.009; Zhang P, 1998, J BIOL CHEM, V273, P713, DOI 10.1074/jbc.273.2.713; Zielke N, 2011, NATURE, V480, P123, DOI 10.1038/nature10579	65	33	34	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					11410	11421		10.1074/jbc.M111.337683	http://dx.doi.org/10.1074/jbc.M111.337683			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22303007	Green Published, hybrid			2022-12-25	WOS:000302780100070
J	Yuyama, K; Sun, H; Mitsutake, S; Igarashi, Y				Yuyama, Kohei; Sun, Hui; Mitsutake, Susumu; Igarashi, Yasuyuki			Sphingolipid-modulated Exosome Secretion Promotes Clearance of Amyloid-beta by Microglia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; GM1 GANGLIOSIDE; SPHINGOMYELIN SYNTHASE; FIBRIL FORMATION; PROTEIN; CELLS; ENDOCYTOSIS; ASSOCIATION; ACTIVATION; CERAMIDE	Background: Exosome is a membrane vesicle released from several types of cells, including neurons. Results: Neuronal exosomes accelerate A beta fibril formation, and the exosome-associated A beta is taken into microglia to degrade it. Conclusion: Exosomes promote A beta clearance. Significance: These findings provide a new function of exosome in the brain and also suggest its involvement in the development of Alzheimer disease.	[Yuyama, Kohei; Sun, Hui; Mitsutake, Susumu; Igarashi, Yasuyuki] Hokkaido Univ, Fac Adv Life Sci, Dept Biomembrane & Biofunct Chem, Sapporo, Hokkaido 0010021, Japan	Hokkaido University	Igarashi, Y (corresponding author), Hokkaido Univ, Fac Adv Life Sci, Dept Biomembrane & Biofunct Chem, Sapporo, Hokkaido 0010021, Japan.	yigarash@pharm.hokudai.ac.jp	Mitsutake, Susumu/A-4082-2012; Yuyama, Kohei/A-7454-2012					Alvarez-Erviti L, 2011, NAT BIOTECHNOL, V29, P341, DOI 10.1038/nbt.1807; Ariga T, 2008, J LIPID RES, V49, P1157, DOI 10.1194/jlr.R800007-JLR200; Randall JB, 2006, NAT MED, V12, P856, DOI 10.1038/nm1438; Cameron B, 2010, NEUROBIOL DIS, V37, P503, DOI 10.1016/j.nbd.2009.10.006; de Gassart A, 2003, BLOOD, V102, P4336, DOI 10.1182/blood-2003-03-0871; El Khoury J, 2007, NAT MED, V13, P432, DOI 10.1038/nm1555; Emmanouilidou E, 2010, J NEUROSCI, V30, P6838, DOI 10.1523/JNEUROSCI.5699-09.2010; Faure J, 2006, MOL CELL NEUROSCI, V31, P642, DOI 10.1016/j.mcn.2005.12.003; Fevrier B, 2004, P NATL ACAD SCI USA, V101, P9683, DOI 10.1073/pnas.0308413101; Fevrier B, 2004, CURR OPIN CELL BIOL, V16, P415, DOI 10.1016/j.ceb.2004.06.003; Fitzner D, 2011, J CELL SCI, V124, P447, DOI 10.1242/jcs.074088; Goldsbury C, 2005, J MOL BIOL, V352, P282, DOI 10.1016/j.jmb.2005.07.029; Gulbins E, 2003, ONCOGENE, V22, P7070, DOI 10.1038/sj.onc.1207146; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; Haughey NJ, 2010, BBA-MOL CELL BIOL L, V1801, P878, DOI 10.1016/j.bbalip.2010.05.003; Hayashi H, 2004, J NEUROSCI, V24, P4894, DOI 10.1523/JNEUROSCI.0861-04.2004; Huitema K, 2004, EMBO J, V23, P33, DOI 10.1038/sj.emboj.7600034; Karakashian AA, 2004, FASEB J, V18, P968, DOI 10.1096/fj.03-0875fje; Keller S, 2007, KIDNEY INT, V72, P1095, DOI 10.1038/sj.ki.5002486; Kimura N, 2007, NEUROREPORT, V18, P1669, DOI 10.1097/WNR.0b013e3282f0d2ab; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Levi G., 1989, DISSECTION TISSUE CU, P154; Liu B, 1998, J BIOL CHEM, V273, P34472, DOI 10.1074/jbc.273.51.34472; Luberto C, 1998, J BIOL CHEM, V273, P14550, DOI 10.1074/jbc.273.23.14550; Magnus T, 2001, J IMMUNOL, V167, P5004, DOI 10.4049/jimmunol.167.9.5004; Majumdar A, 2007, MOL BIOL CELL, V18, P1490, DOI 10.1091/mbc.E06-10-0975; Mawuenyega KG, 2010, SCIENCE, V330, P1774, DOI 10.1126/science.1197623; Mitsutake S, 2011, J BIOL CHEM, V286, P28544, DOI 10.1074/jbc.M111.255646; Miyanishi M, 2007, NATURE, V450, P435, DOI 10.1038/nature06307; Morelli AE, 2004, BLOOD, V104, P3257, DOI 10.1182/blood-2004-03-0824; Naiki H, 1999, METHOD ENZYMOL, V309, P305; Napoli I, 2009, NEUROSCIENCE, V158, P1030, DOI 10.1016/j.neuroscience.2008.06.046; Okada T, 2008, J MOL BIOL, V382, P1066, DOI 10.1016/j.jmb.2008.07.072; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Rajendran L, 2006, P NATL ACAD SCI USA, V103, P11172, DOI 10.1073/pnas.0603838103; Ransohoff RM, 2007, NAT NEUROSCI, V10, P1507, DOI 10.1038/nn1207-1507; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Selkoe DJ, 1997, SCIENCE, V275, P630, DOI 10.1126/science.275.5300.630; Sharples RA, 2008, FASEB J, V22, P1469, DOI 10.1096/fj.07-9357com; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; Tafesse FG, 2006, J BIOL CHEM, V281, P29421, DOI 10.1074/jbc.R600021200; Takahashi RH, 2002, AM J PATHOL, V161, P1869, DOI 10.1016/S0002-9440(10)64463-X; Tam C, 2010, J CELL BIOL, V189, P1027, DOI 10.1083/jcb.201003053; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; Vella LJ, 2007, J PATHOL, V211, P582, DOI 10.1002/path.2145; Yamamoto N, 2008, BBA-BIOMEMBRANES, V1778, P2717, DOI 10.1016/j.bbamem.2008.07.028; YANAGISAWA K, 1995, NAT MED, V1, P1062, DOI 10.1038/nm1095-1062; Yuyama K, 2008, J NEUROCHEM, V105, P217, DOI 10.1111/j.1471-4159.2007.05128.x; Zha XH, 1998, J CELL BIOL, V140, P39, DOI 10.1083/jcb.140.1.39	54	370	391	5	68	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					10977	10989		10.1074/jbc.M111.324616	http://dx.doi.org/10.1074/jbc.M111.324616			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22303002	Green Published, hybrid			2022-12-25	WOS:000302780100026
J	Frankel, MB; Schneewind, O				Frankel, Matthew B.; Schneewind, Olaf			Determinants of Murein Hydrolase Targeting to Cross-wall of Staphylococcus aureus Peptidoglycan	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							L-ALANINE AMIDASE; BETA-N-ACETYLGLUCOSAMINIDASE; GRAM-POSITIVE BACTERIA; RIBITOL TEICHOIC-ACIDS; BACILLUS-SUBTILIS W23; CELL-WALL; LYSM DOMAINS; LINKAGE UNIT; METHICILLIN RESISTANCE; NUCLEOTIDE-SEQUENCE	Cells of eukaryotic or prokaryotic origin express proteins with LysM domains that associate with the cell wall envelope of bacteria. The molecular properties that enable LysM domains to interact with microbial cell walls are not yet established. Staphylococcus aureus, a spherical microbe, secretes two murein hydrolases with LysM domains, Sle1 and LytN. We show here that the LysM domains of Sle1 and LytN direct murein hydrolases to the staphylococcal envelope in the vicinity of the crosswall, the mid-cell compartment for peptidoglycan synthesis. LysM domains associate with the repeating disaccharide beta-N-acetylmuramic acid, (1 -> 4)-beta-N-acetylglucosamine of staphylococcal peptidoglycan. Modification of N-acetylmuramic acid with wall teichoic acid, a ribitol-phosphate polymer tethered to murein linkage units, prevents the LysM domain from binding to peptidoglycan. The localization of LytN and Sle1 to the crosswall is abolished in staphylococcal tagO mutants, which are defective for wall teichoic acid synthesis. We propose a model whereby the LysM domain ensures septal localization of LytN and Sle1 followed by processive cleavage of peptidoglycan, thereby exposing new LysM binding sites in the cross-wall and separating bacterial cells.	[Frankel, Matthew B.; Schneewind, Olaf] Univ Chicago, Dept Microbiol, Chicago, IL 60637 USA	University of Chicago	Schneewind, O (corresponding author), Univ Chicago, Dept Microbiol, 920 E 58th St, Chicago, IL 60637 USA.	oschnee@bsd.uchicago.edu			National Institutes of Health, NIAID, Infectious Disease Branch [AI038897]; NIAID, National Institutes of Health [AI085709]; Region V "Great Lakes" Regional Center of Excellence in Biodefense and Emerging Infectious Diseases Consortium (GLRCE, National Institutes of Health, NIAID) [1-U54-AI-057153]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057153, F32AI085709, R01AI038897] Funding Source: NIH RePORTER	National Institutes of Health, NIAID, Infectious Disease Branch; NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Region V "Great Lakes" Regional Center of Excellence in Biodefense and Emerging Infectious Diseases Consortium (GLRCE, National Institutes of Health, NIAID); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health, NIAID, Infectious Disease Branch, Grant AI038897 (to O. S.).; Supported by NIAID, National Institutes of Health, Postdoctoral Fellowship Award AI085709.; Member of and supported by the Region V "Great Lakes" Regional Center of Excellence in Biodefense and Emerging Infectious Diseases Consortium (GLRCE, National Institutes of Health, NIAID, Grant 1-U54-AI-057153). To whom correspondence should be addressed: Dept. of Microbiology, University of Chicago, 920 E. 58th St., Chicago, IL. Tel.: 773-834-9060; Fax: 773-834-8150; E-mail: oschnee@bsd.uchicago.edu.	ANDERSON JS, 1965, P NATL ACAD SCI USA, V53, P881, DOI 10.1073/pnas.53.4.881; ARCHIBALD A, 1961, NATURE, V191, P570, DOI 10.1038/191570a0; Atilano ML, 2010, P NATL ACAD SCI USA, V107, P18991, DOI 10.1073/pnas.1004304107; Baba T, 1998, EMBO J, V17, P4639, DOI 10.1093/emboj/17.16.4639; Baba T, 2008, J BACTERIOL, V190, P300, DOI 10.1128/JB.01000-07; Bae T, 2004, P NATL ACAD SCI USA, V101, P12312, DOI 10.1073/pnas.0404728101; Bateman A, 2000, J MOL BIOL, V299, P1113, DOI 10.1006/jmbi.2000.3778; BLUMBERG PM, 1972, P NATL ACAD SCI USA, V69, P3751, DOI 10.1073/pnas.69.12.3751; BUIST G, 1995, J BACTERIOL, V177, P1554, DOI 10.1128/jb.177.6.1554-1563.1995; Buist G, 2008, MOL MICROBIOL, V68, P838, DOI 10.1111/j.1365-2958.2008.06211.x; Carroll SA, 2003, J BACTERIOL, V185, P6801, DOI 10.1128/JB.185.23.6801-6808.2003; Chambers HF, 2009, NAT REV MICROBIOL, V7, P629, DOI 10.1038/nrmicro2200; Chen WQ, 2010, PROTEIN CELL, V1, P1093, DOI 10.1007/s13238-010-0127-6; COLEY J, 1976, FEBS LETT, V61, P240, DOI 10.1016/0014-5793(76)81047-2; D'Elia MA, 2006, J BACTERIOL, V188, P4183, DOI 10.1128/JB.00197-06; D'Elia MA, 2009, J BACTERIOL, V191, P4030, DOI 10.1128/JB.00611-08; DeDent A, 2008, EMBO J, V27, P2656, DOI 10.1038/emboj.2008.185; DEJONGE BLM, 1992, J BIOL CHEM, V267, P11248; Frankel MB, 2011, J BIOL CHEM, V286, P32593, DOI 10.1074/jbc.M111.258863; GARVEY KJ, 1986, NUCLEIC ACIDS RES, V14, P10001, DOI 10.1093/nar/14.24.10001; GHUYSEN JM, 1963, BIOCHEMISTRY-US, V2, P1119, DOI 10.1021/bi00905a036; GHUYSEN JM, 1968, BACTERIOL REV, V32, P425, DOI 10.1128/MMBR.32.4_Pt_2.425-464.1968; Giesbrecht P, 1998, MICROBIOL MOL BIOL R, V62, P1371, DOI 10.1128/MMBR.62.4.1371-1414.1998; GIESBRECHT P, 1976, INT REV CYTOL, V44, P225, DOI 10.1016/S0074-7696(08)61651-4; Grundling A, 2006, J BACTERIOL, V188, P2463, DOI 10.1128/JB.188.7.2463-2472.2006; Grundling A, 2007, P NATL ACAD SCI USA, V104, P8478, DOI 10.1073/pnas.0701821104; Grundling A, 2006, J BACTERIOL, V188, P6286, DOI 10.1128/JB.00457-06; HANCOCK IC, 1976, FEBS LETT, V69, P75, DOI 10.1016/0014-5793(76)80657-6; HARRINGTON CR, 1985, EUR J BIOCHEM, V153, P639, DOI 10.1111/j.1432-1033.1985.tb09348.x; HENZE U, 1993, J BACTERIOL, V175, P1612, DOI 10.1128/JB.175.6.1612-1620.1993; HIGASHI Y, 1970, J BIOL CHEM, V245, P3697; HIGASHI Y, 1967, P NATL ACAD SCI USA, V57, P1878, DOI 10.1073/pnas.57.6.1878; Kajimura J, 2005, MOL MICROBIOL, V58, P1087, DOI 10.1111/j.1365-2958.2005.04881.x; Kawai Y, 2011, EMBO J, V30, P4931, DOI 10.1038/emboj.2011.358; Kern J, 2010, J MOL BIOL, V401, P757, DOI 10.1016/j.jmb.2010.06.059; KOJIMA N, 1985, J BACTERIOL, V161, P299, DOI 10.1128/JB.161.1.299-306.1985; Komatsuzawa H, 1997, MICROBIOL IMMUNOL, V41, P469, DOI 10.1111/j.1348-0421.1997.tb01880.x; KREISWIRTH BN, 1983, NATURE, V305, P709, DOI 10.1038/305709a0; LAZAREVIC V, 1995, MOL MICROBIOL, V16, P345, DOI 10.1111/j.1365-2958.1995.tb02306.x; LEROUGE P, 1990, NATURE, V344, P781, DOI 10.1038/344781a0; LIU TY, 1967, J BIOL CHEM, V242, P471; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; LUTKENHAUS J, 1993, MOL MICROBIOL, V9, P403, DOI 10.1111/j.1365-2958.1993.tb01701.x; MAIDHOF H, 1991, J BACTERIOL, V173, P3507, DOI 10.1128/jb.173.11.3507-3513.1991; MATSUHASHI M, 1965, P NATL ACAD SCI USA, V54, P587, DOI 10.1073/pnas.54.2.587; MAUEL C, 1989, MOL GEN GENET, V215, P388, DOI 10.1007/BF00427034; MCARTHUR HAI, 1978, FEBS LETT, V86, P193, DOI 10.1016/0014-5793(78)80561-4; Mesnage S, 2008, J BIOL CHEM, V283, P19845, DOI 10.1074/jbc.M802323200; Ohnuma T, 2008, J BIOL CHEM, V283, P5178, DOI 10.1074/jbc.M707156200; OSHIDA T, 1995, P NATL ACAD SCI USA, V92, P285, DOI 10.1073/pnas.92.1.285; PARK JT, 1952, J BIOL CHEM, V194, P897; PARK JT, 1957, SCIENCE, V125, P99, DOI 10.1126/science.125.3238.99; POXTON IR, 1978, BIOCHEM J, V175, P1033, DOI 10.1042/bj1751033; Projan SJ, 2006, CURR OPIN PHARMACOL, V6, P473, DOI 10.1016/j.coph.2006.04.005; Radutoiu S, 2003, NATURE, V425, P585, DOI 10.1038/nature02039; Radutoiu S, 2007, EMBO J, V26, P3923, DOI 10.1038/sj.emboj.7601826; REEDER WJ, 1971, J IMMUNOL, V106, P334; Rigden DJ, 2003, TRENDS BIOCHEM SCI, V28, P230, DOI 10.1016/S0968-0004(03)00062-8; ROBERTS RJ, 1974, J BIOL CHEM, V249, P4787; Rohrer S, 1999, P NATL ACAD SCI USA, V96, P9351, DOI 10.1073/pnas.96.16.9351; SALTON MRJ, 1952, NATURE, V170, P746, DOI 10.1038/170746a0; SCHINDLER CA, 1964, P NATL ACAD SCI USA, V51, P414, DOI 10.1073/pnas.51.3.414; Schlag M, 2010, MOL MICROBIOL, V75, P864, DOI 10.1111/j.1365-2958.2009.07007.x; SCHNEEWIND O, 1995, SCIENCE, V268, P103, DOI 10.1126/science.7701329; Soldo B, 2002, MICROBIOL-SGM, V148, P2079, DOI 10.1099/00221287-148-7-2079; Steen A, 2005, FEBS J, V272, P2854, DOI 10.1111/j.1742-4658.2005.04706.x; STROMINGER JL, 1967, FED PROC, V26, P9; SUGAI M, 1995, J BACTERIOL, V177, P1491, DOI 10.1128/jb.177.6.1491-1496.1995; TIPPER DJ, 1965, P NATL ACAD SCI USA, V54, P1133, DOI 10.1073/pnas.54.4.1133; TZAGOLOFF H, 1977, J BACTERIOL, V129, P343, DOI 10.1128/JB.129.1.343-350.1977; WALSH CT, 1993, SCIENCE, V261, P308, DOI 10.1126/science.8392747; Weidenmaier C, 2004, NAT MED, V10, P243, DOI 10.1038/nm991; YOKOGAWA K, 1974, ANTIMICROB AGENTS CH, V6, P156, DOI 10.1128/AAC.6.2.156; YOKOYAMA K, 1986, EUR J BIOCHEM, V161, P479, DOI 10.1111/j.1432-1033.1986.tb10469.x; Zapun A, 2008, FEMS MICROBIOL REV, V32, P345, DOI 10.1111/j.1574-6976.2007.00098.x; Zoll S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000807	76	61	61	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					10460	10471		10.1074/jbc.M111.336404	http://dx.doi.org/10.1074/jbc.M111.336404			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22303016	hybrid, Green Published			2022-12-25	WOS:000302167200073
J	Spertini, C; Baisse, B; Spertini, O				Spertini, Caroline; Baisse, Benedicte; Spertini, Olivier			Ezrin-Radixin-Moesin-binding Sequence of PSGL-1 Glycoprotein Regulates Leukocyte Rolling on Selectins and Activation of Extracellular Signal-regulated Kinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P-SELECTIN; ERM PROTEINS; IN-VIVO; INTEGRIN ACTIVATION; CYTOPLASMIC DOMAIN; TYROSINE KINASE; FLOW CONDITIONS; ADHESION; LIGAND-1; CELLS	P-selectin glycoprotein ligand-1 (PSGL-1) mediates the capture (tethering) of free-flowing leukocytes and subsequent rolling on selectins. PSGL-1 interactions with endothelial selectins activate Src kinases and spleen tyrosine kinase (Syk), leading to alpha(L)beta(2) integrin-dependent leukocyte slow rolling, which promotes leukocyte recruitment into tissues. In addition, but through a distinct pathway, PSGL-1 engagement activates ERK. Because ezrin, radixin and moesin proteins (ERMs) link PSGL-1 to actin cytoskeleton and because they serve as adaptor molecules between PSGL-1 and Syk, we examined the role of PSGL-1 ERM-binding sequence (EBS) on cell capture, rolling, and signaling through Syk and MAPK pathways. We carried out mutational analysis and observed that deletion of EBS severely reduced 32D leukocyte tethering and rolling on L-, P-, and E-selectin and slightly increased rolling velocity. Alanine substitution of Arg-337 and Lys-338 showed that these residues play a key role in supporting leukocyte tethering and rolling on selectins. Importantly, EBS deletion or Arg-337 and Lys-338 mutations abrogated PSGL-1-induced ERK activation, whereas they did not prevent Syk phosphorylation or E-selectin-induced leukocyte slow rolling. These studies demonstrate that PSGL-1 EBS plays a critical role in recruiting leukocytes on selectins and in activating the MAPK pathway, whereas it is dispensable to phosphorylate Syk and to lead to alpha(L)beta(2)-dependent leukocyte slow rolling.	[Spertini, Olivier] Univ Lausanne Hosp, Serv Hematol, CH-1011 Lausanne, Switzerland; Univ Lausanne Hosp, Cent Hematol Lab, CH-1011 Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Spertini, O (corresponding author), Univ Lausanne Hosp, Serv Hematol, Rue Bugnon 46, CH-1011 Lausanne, Switzerland.	Olivier.Spertini@chuv.ch			Swiss National Foundation for Scientific Research [310030_127368]	Swiss National Foundation for Scientific Research(Swiss National Science Foundation (SNSF))	This work was supported by Swiss National Foundation for Scientific Research Grant 310030_127368 (to O. S.).	Abbal C, 2006, BLOOD, V108, P3352, DOI 10.1182/blood-2006-04-013912; Alonso-Lebrero JL, 2000, BLOOD, V95, P2413, DOI 10.1182/blood.V95.7.2413.007k17_2413_2419; Azab AK, 2012, BLOOD, V119, P1468, DOI 10.1182/blood-2011-07-368050; Baisse B, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-166; Bernimoulin MP, 2003, J BIOL CHEM, V278, P37, DOI 10.1074/jbc.M204360200; Buscher K, 2010, J BIOL CHEM, V285, P13490, DOI 10.1074/jbc.M110.102640; Chen SQ, 1999, J CELL BIOL, V144, P185, DOI 10.1083/jcb.144.1.185; Fehon RG, 2010, NAT REV MOL CELL BIO, V11, P276, DOI 10.1038/nrm2866; Gal I, 2003, J BIOL CHEM, V278, P11150, DOI 10.1074/jbc.M210661200; Hermiston ML, 2009, IMMUNOL REV, V228, P288, DOI 10.1111/j.1600-065X.2008.00752.x; Hidalgo A, 2007, IMMUNITY, V26, P477, DOI 10.1016/j.immuni.2007.03.011; Hidari KIPJ, 1997, J BIOL CHEM, V272, P28750, DOI 10.1074/jbc.272.45.28750; Ivetic A, 2004, J BIOL CHEM, V279, P33263, DOI 10.1074/jbc.M312212200; Krasik EF, 2004, BIOPHYS J, V87, P2919, DOI 10.1529/biophysj.104.039693; LEY K, 1995, J EXP MED, V181, P669, DOI 10.1084/jem.181.2.669; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Martinez M, 2005, J BIOL CHEM, V280, P5378, DOI 10.1074/jbc.M410899200; Miner JJ, 2008, BLOOD, V112, P2035, DOI 10.1182/blood-2008-04-149468; Mocsai A, 2010, NAT REV IMMUNOL, V10, P387, DOI 10.1038/nri2765; Mueller H, 2010, BLOOD, V115, P3118, DOI 10.1182/blood-2009-11-254185; Park EYH, 2002, BIOPHYS J, V82, P1835, DOI 10.1016/S0006-3495(02)75534-3; Pospieszalska MK, 2009, CELL MOL BIOENG, V2, P207, DOI 10.1007/s12195-009-0063-9; Python JL, 2010, BIOCHEM BIOPH RES CO, V397, P621, DOI 10.1016/j.bbrc.2010.06.012; SAKO D, 1993, CELL, V75, P1179, DOI 10.1016/0092-8674(93)90327-M; Serrador JM, 1998, BLOOD, V91, P4632, DOI 10.1182/blood.V91.12.4632.412k17_4632_4644; Serrador JM, 2002, EUR J IMMUNOL, V32, P1560, DOI 10.1002/1521-4141(200206)32:6<1560::AID-IMMU1560>3.0.CO;2-U; Shao JY, 1998, P NATL ACAD SCI USA, V95, P6797, DOI 10.1073/pnas.95.12.6797; Snapp KR, 2002, BLOOD, V99, P4494, DOI 10.1182/blood.V99.12.4494; Sperandio M, 2001, J IMMUNOL, V167, P2268, DOI 10.4049/jimmunol.167.4.2268; Spertini O, 1996, J CELL BIOL, V135, P523, DOI 10.1083/jcb.135.2.523; Stadtmann A, 2011, EUR J IMMUNOL, V41, P2074, DOI 10.1002/eji.201041196; Stein JV, 1999, J EXP MED, V189, P37, DOI 10.1084/jem.189.1.37; Takai Y, 2007, GENES CELLS, V12, P1329, DOI 10.1111/j.1365-2443.2007.01137.x; Tauxe C, 2008, J BIOL CHEM, V283, P28536, DOI 10.1074/jbc.M802865200; Urzainqui A, 2002, IMMUNITY, V17, P401, DOI 10.1016/S1074-7613(02)00420-X; Walcheck B, 1996, J CLIN INVEST, V98, P1081, DOI 10.1172/JCI118888; Wang HB, 2007, NAT IMMUNOL, V8, P882, DOI 10.1038/ni1491; Xie X, 2000, J BIOL CHEM, V275, P34818, DOI 10.1074/jbc.M001257200; Yago T, 2010, BLOOD, V116, P485, DOI 10.1182/blood-2009-12-259556; Zarbock A, 2008, J EXP MED, V205, P2339, DOI 10.1084/jem.20072660; Zarbock A, 2011, BLOOD, V118, P6743, DOI 10.1182/blood-2011-07-343566; Zarbock A, 2011, ARCH BIOCHEM BIOPHYS, V510, P112, DOI 10.1016/j.abb.2011.02.009	42	27	27	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					10693	10702		10.1074/jbc.M111.318022	http://dx.doi.org/10.1074/jbc.M111.318022			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22311979	hybrid, Green Published			2022-12-25	WOS:000302167200094
J	Dhatwalia, R; Singh, H; Oppenheimer, M; Karr, DB; Nix, JC; Sobrado, P; Tanner, JJ				Dhatwalia, Richa; Singh, Harkewal; Oppenheimer, Michelle; Karr, Dale B.; Nix, Jay C.; Sobrado, Pablo; Tanner, John J.			Crystal Structures and Small-angle X-ray Scattering Analysis of UDP-galactopyranose Mutase from the Pathogenic Fungus Aspergillus fumigatus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDIZED STATE; GALACTOFURANOSE; PROTEINS; SYSTEM; PHENIX	UDP-galactopyranose mutase (UGM) is a flavoenzyme that catalyzes the conversion of UDP-galactopyranose to UDP-galactofuranose, which is a central reaction in galactofuranose biosynthesis. Galactofuranose has never been found in humans but is an essential building block of the cell wall and extracellular matrix of many bacteria, fungi, and protozoa. The importance of UGM for the viability of many pathogens and its absence in humans make UGM a potential drug target. Here we report the first crystal structures and small-angle x-ray scattering data for UGM from the fungus Aspergillus fumigatus, the causative agent of aspergillosis. The structures reveal that Aspergillus UGM has several extra secondary and tertiary structural elements that are not found in bacterial UGMs yet are important for substrate recognition and oligomerization. Small-angle x-ray scattering data show that Aspergillus UGM forms a tetramer in solution, which is unprecedented for UGMs. The binding of UDP or the substrate induces profound conformational changes in the enzyme. Two loops on opposite sides of the active site move toward each other by over 10 angstrom to cover the substrate and create a closed active site. The degree of substrate-induced conformational change exceeds that of bacterial UGMs and is a direct consequence of the unique quaternary structure of Aspergillus UGM. Galactopyranose binds at the re face of the FAD isoalloxazine with the anomeric carbon atom poised for nucleophilic attack by the FAD N5 atom. The structural data provide new insight into substrate recognition and the catalytic mechanism and thus will aid inhibitor design.	[Dhatwalia, Richa; Singh, Harkewal; Karr, Dale B.; Tanner, John J.] Univ Missouri, Dept Chem, Columbia, MO 65211 USA; [Tanner, John J.] Univ Missouri, Dept Biochem, Columbia, MO 65211 USA; [Oppenheimer, Michelle; Sobrado, Pablo] Virginia Polytech Inst & State Univ, Dept Biochem, Blacksburg, VA 24061 USA; [Nix, Jay C.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Mol Biol Consortium, Berkeley, CA 94720 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; Virginia Polytechnic Institute & State University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Tanner, JJ (corresponding author), Univ Missouri, Dept Chem, Columbia, MO 65211 USA.	tannerjj@missouri.edu		Tanner, John/0000-0001-8314-113X	National Institutes of Health [R01GM094469]; National Center for Research Resources at the National Institutes of Health [RR-15301]; United States Department of Energy, Office of Basic Energy Sciences [W-31-109-ENG-38]; Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy [DE-AC02-05CH11231]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094469] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); United States Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM094469 (to P. S. and J. J. T.).; We thank Dr. Norma Duke, Dr. Greg Hura, and Dr. Jonathan Schuermann for help with x-ray data collection and processing. Part of this work is based upon research conducted at the Northeastern Collaborative Access Team beamlines of the Advanced Photon Source, supported by Award RR-15301 from the National Center for Research Resources at the National Institutes of Health. Use of the Advanced Photon Source is supported by the United States Department of Energy, Office of Basic Energy Sciences, under Contract W-31-109-ENG-38. The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy under Contract DE-AC02-05CH11231.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Beis K, 2005, J MOL BIOL, V348, P971, DOI 10.1016/j.jmb.2005.02.057; Chong S, 2006, EUR J RADIOL, V59, P371, DOI 10.1016/j.ejrad.2006.04.017; Corradi HR, 2006, J BIOL CHEM, V281, P38625, DOI 10.1074/jbc.M606640200; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ENGH RA, 1991, ACTA CRYSTALLOGR A, V47, P392, DOI 10.1107/S0108767391001071; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fullerton SWB, 2003, BIOCHEMISTRY-US, V42, P2104, DOI 10.1021/bi027077f; Gruber TD, 2009, BIOCHEMISTRY-US, V48, P9171, DOI 10.1021/bi901437v; Huang ZH, 2003, BIOORG CHEM, V31, P494, DOI 10.1016/j.bioorg.2003.08.002; Hura GL, 2009, NAT METHODS, V6, P606, DOI 10.1038/nmeth.1353; Kleczka B, 2007, J BIOL CHEM, V282, P10498, DOI 10.1074/jbc.M700023200; Knutsen AP, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/843763; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Kradin RL, 2008, ARCH PATHOL LAB MED, V132, P606, DOI 10.1043/1543-2165(2008)132[606:TPOPDD]2.0.CO;2; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lamarre C, 2009, CELL MICROBIOL, V11, P1612, DOI 10.1111/j.1462-5822.2009.01352.x; Latge JP, 2009, MED MYCOL, V47, pS104, DOI 10.1080/13693780802258832; Lin SJ, 2001, CLIN INFECT DIS, V32, P358, DOI 10.1086/318483; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; McMahon SA, 1999, ACTA CRYSTALLOGR D, V55, P399, DOI 10.1107/S0907444998010877; Oppenheimer M, 2010, ARCH BIOCHEM BIOPHYS, V502, P31, DOI 10.1016/j.abb.2010.06.035; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pan F, 2001, J BACTERIOL, V183, P3991, DOI 10.1128/JB.183.13.3991-3998.2001; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Partha SK, 2009, J MOL BIOL, V394, P864, DOI 10.1016/j.jmb.2009.10.013; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Richards MR, 2009, CHEMBIOCHEM, V10, P1920, DOI 10.1002/cbic.200900208; Samarakoon P, 2008, Chron Respir Dis, V5, P19, DOI 10.1177/1479972307085637; Sanders DAR, 2001, NAT STRUCT BIOL, V8, P858, DOI 10.1038/nsb1001-858; Schmalhorst PS, 2008, EUKARYOT CELL, V7, P1268, DOI 10.1128/EC.00109-08; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Sheldrick GM, 2002, Z KRISTALLOGR, V217, P644, DOI 10.1524/zkri.217.12.644.20662; Soltero-Higgin M, 2004, NAT STRUCT MOL BIOL, V11, P539, DOI 10.1038/nsmb772; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Tefsen B., 2011, GLYCOBIOLOG IN PRESS; Virnig C, 2007, CURR OPIN PULM MED, V13, P67, DOI 10.1097/MCP.0b013e328010c812; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wriggers Willy, 2010, Biophys Rev, V2, P21, DOI 10.1007/s12551-009-0026-3	46	31	32	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					9041	9051		10.1074/jbc.M111.327536	http://dx.doi.org/10.1074/jbc.M111.327536			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22294687	Green Published, hybrid			2022-12-25	WOS:000301797800034
J	Banerjee, S; Chakraborty, P; Saha, P; Bandyopadhyay, SA; Banerjee, S; Kabir, SN				Banerjee, Sayani; Chakraborty, Pratip; Saha, Piyali; Bandyopadhyay, Soma Aditya; Banerjee, Sutapa; Kabir, Syed N.			Ovotoxic Effects of Galactose Involve Attenuation of Follicle-Stimulating Hormone Bioactivity and Up-Regulation of Granulosa Cell p53 Expression	PLOS ONE			English	Article							PREMATURE OVARIAN FAILURE; DEFECTIVE GALACTOSYLATION; HYPERGONADOTROPIC HYPOGONADISM; SERUM TRANSFERRIN; GONADAL-FUNCTION; MENSTRUAL-CYCLE; FEMALE-PATIENTS; RAT; FSH; DIFFERENTIATION	Clinical evidence suggests an association between galactosaemia and premature ovarian insufficiency (POI); however, the mechanism still remains unresolved. Experimental galactose toxicity in rats produces an array of ovarian dysfunction including ovarian development with deficient follicular reserve and follicular resistance to gonadotrophins that characterize the basic tenets of human POI. The present investigation explores if galactose toxicity in rats attenuates the bioactivity of gonadotrophins or interferes with their receptor competency, and accelerates the rate of follicular atresia. Pregnant rats were fed isocaloric food-pellets supplemented with or without 35% D-galactose from day-3 of gestation and continuing through weaning of the litters. The 35-day old female litters were autopsied. Serum galactose-binding capacity, galactosyltransferase (GalTase) activity, and bioactivity of FSH and LH together with their receptor competency were assessed. Ovarian follicular atresia was evaluated in situ by TUNEL. The in vitro effects of galactose were studied in isolated whole follicles in respect of generation of reactive oxygen species (ROS) and expression of caspase 3, and in isolated granulosa cells in respect of mitochondrial membrane potential, expression of p53, and apoptosis. The rats prenatally exposed to galactose exhibited significantly decreased serum GalTase activity and greater degree of galactose-incorporation capacity of sera proteins. LH biopotency and LH-FSH receptor competency were comparable between the control and study population, but the latter group showed significantly attenuated FSH bioactivity and increased rate of follicular atresia. In culture, galactose increased follicular generation of ROS and expression of caspase 3. In isolated granulosa cells, galactose disrupted mitochondrial membrane potential, stimulated p53 expression, and induced apoptosis in vitro; however co-treatment with either FSH or estradiol significantly prevented galactose-induced granulosa cell p53 expression. We conclude that the ovotoxic effects of galactose involves attenuation of FSH bioactivity that renders the ovary resistant to gonadotrophins leading to increased granulosa cell expression of p53 and follicular atresia.	[Banerjee, Sayani; Saha, Piyali; Bandyopadhyay, Soma Aditya; Banerjee, Sutapa; Kabir, Syed N.] CSIR Indian Inst Chem Biol, Kolkata, W Bengal, India; [Chakraborty, Pratip] Inst Reprod Med, Dept Infertil, Kolkata, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Banerjee, S (corresponding author), CSIR Indian Inst Chem Biol, Kolkata, W Bengal, India.	snkabir@iicb.res.in			Department of Science and Technology, New Delhi, India [SP/SO/B31/97]	Department of Science and Technology, New Delhi, India(Department of Science & Technology (India))	This study was supported by grants from Department of Science and Technology (SP/SO/B31/97), New Delhi, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anasti JN, 1998, FERTIL STERIL, V70, P1, DOI 10.1016/S0015-0282(98)00099-5; ANDREE HAM, 1990, J BIOL CHEM, V265, P4923; Anobile CJ, 1998, MOL HUM REPROD, V4, P631, DOI 10.1093/molehr/4.7.631; Bandyopadhyay S, 2003, HUM REPROD, V18, P276, DOI 10.1093/humrep/deg058; Bandyopadhyay S, 2003, HUM REPROD, V18, P2031, DOI 10.1093/humrep/deg414; BRETSCHER MS, 1972, NATURE-NEW BIOL, V236, P11, DOI 10.1038/newbio236011a0; Campbell BK, 2010, REPRODUCTION, V140, P721, DOI 10.1530/REP-10-0185; Campbell BK, 2010, REPRODUCTION, V140, P541, DOI 10.1530/REP-10-0146; Charlwood J, 1998, GLYCOBIOLOGY, V8, P351, DOI 10.1093/glycob/8.4.351; CHEN YT, 1984, PEDIATR RES, V18, P345, DOI 10.1203/00006450-198404000-00008; COSSARIZZA A, 1993, BIOCHEM BIOPH RES CO, V197, P40, DOI 10.1006/bbrc.1993.2438; CRAMER DW, 1989, FERTIL STERIL, V51, P609; Creus S, 1996, CLIN ENDOCRINOL, V44, P181, DOI 10.1046/j.1365-2265.1996.646467.x; DAHL KD, 1987, J CLIN ENDOCR METAB, V64, P486, DOI 10.1210/jcem-64-3-486; DOBBIE JA, 1990, ANN CLIN BIOCHEM, V27, P274, DOI 10.1177/000456329002700317; Forges T, 2006, HUM REPROD UPDATE, V12, P573, DOI 10.1093/humupd/dml031; FRASER I S, 1986, Clinical Reproduction and Fertility, V4, P133; FREILICH LS, 1977, J CELL BIOL, V72, P655, DOI 10.1083/jcb.72.3.655; Fridovich-Keil JL, 2011, J INHERIT METAB DIS, V34, P357, DOI 10.1007/s10545-010-9221-4; GIBSON JB, 1995, EUR J PEDIATR, V154, pS14, DOI 10.1007/BF02143797; Gilchrist RB, 2008, HUM REPROD UPDATE, V14, P159, DOI 10.1093/humupd/dmm040; GITZELMANN R, 1984, ENZYME, V32, P37, DOI 10.1159/000469448; Gubbels CS, 2011, J INHERIT METAB DIS, V34, P387, DOI 10.1007/s10545-010-9180-9; Guerrero NV, 2000, J PEDIATR-US, V137, P833, DOI 10.1067/mpd.2000.109148; HABERLAN.C, 1971, J NEUROPATH EXP NEUR, V30, P431, DOI 10.1097/00005072-197107000-00009; Hussein MR, 2005, HUM REPROD UPDATE, V11, P162, DOI 10.1093/humupd/dmi001; JAEKEN J, 1992, LANCET, V340, P1472, DOI 10.1016/0140-6736(92)92664-2; JIA XC, 1986, ENDOCRINOLOGY, V119, P1570, DOI 10.1210/endo-119-4-1570; KAUFMAN FR, 1981, NEW ENGL J MED, V304, P994, DOI 10.1056/NEJM198104233041702; KAUFMAN FR, 1988, J PEDIATR-US, V112, P754, DOI 10.1016/S0022-3476(88)80697-8; KESSEL B, 1988, J CLIN ENDOCR METAB, V66, P361, DOI 10.1210/jcem-66-2-361; KIM YS, 1972, J CLIN INVEST, V51, P2033, DOI 10.1172/JCI107009; Kishi H, 1998, FEBS LETT, V422, P274, DOI 10.1016/S0014-5793(98)00023-4; Lai KW, 2003, CELL TISSUE RES, V311, P417, DOI 10.1007/s00441-002-0689-6; Liu GT, 2006, REPROD TOXICOL, V21, P26, DOI 10.1016/j.reprotox.2005.07.001; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MAGOFFIN DA, 1982, J BIOL CHEM, V257, P4507; MAGOFFIN DA, 1988, ENDOCRINOLOGY, V122, P2345, DOI 10.1210/endo-122-5-2345; Mazerbourg S, 2003, MOL CELL ENDOCRINOL, V202, P31, DOI 10.1016/S0303-7207(03)00058-3; McGee EA, 2001, BIOL REPROD, V64, P293, DOI 10.1095/biolreprod64.1.293; Menezo YJR, 2004, J ASSIST REPROD GEN, V21, P89, DOI 10.1023/B:JARG.0000027020.28592.7b; NG WG, 1989, J INHERIT METAB DIS, V12, P257, DOI 10.1007/BF01799215; O'Shaughnessy PJ, 2010, REPRODUCTION, V139, P177, DOI 10.1530/REP-09-0377; ORNSTEIN KS, 1992, PEDIATR RES, V31, P508, DOI 10.1203/00006450-199205000-00020; PETRY K, 1991, BIOCHEM MED METAB B, V46, P93, DOI 10.1016/0885-4505(91)90054-O; Prestoz LLC, 1997, EUR J PEDIATR, V156, P116, DOI 10.1007/s004310050568; Quirk S M, 2004, J Anim Sci, V82 E-Suppl, pE40; REDDI K, 1990, CLIN ENDOCRINOL, V33, P547, DOI 10.1111/j.1365-2265.1990.tb03892.x; Rubio-Gozalbo ME, 2010, HUM REPROD UPDATE, V16, P177, DOI 10.1093/humupd/dmp038; SAIRAM MR, 1989, FASEB J, V3, P1915, DOI 10.1096/fasebj.3.8.2542111; Sanders RD, 2009, FERTIL STERIL, V92, P344, DOI 10.1016/j.fertnstert.2008.04.060; SEGAL S, 1995, EUR J PEDIATR, V154, pS82, DOI 10.1007/BF02143810; SEGAL S, 1995, EUR J PEDIATR, V154, pS65, DOI 10.1007/BF02143806; Sharma RK, 2009, J MICROSC-OXFORD, V236, P236, DOI 10.1111/j.1365-2818.2009.03281.x; Sturiale L, 2005, GLYCOBIOLOGY, V15, P1268, DOI 10.1093/glycob/cwj021; SWARTZ WJ, 1988, FERTIL STERIL, V49, P522; TEDESCO TA, 1979, SCIENCE, V205, P1395, DOI 10.1126/science.472754; Tsai-Turton M, 2006, ENDOCRINOLOGY, V147, P1224, DOI 10.1210/en.2005-1281; van Engeland M, 1998, CYTOMETRY, V31, P1, DOI 10.1002/(SICI)1097-0320(19980101)31:1<1::AID-CYTO1>3.0.CO;2-R; WAGGONER DD, 1990, J INHERIT METAB DIS, V13, P802, DOI 10.1007/BF01800204; Xu MF, 2001, AM J PHYSIOL-HEART C, V281, pH1295, DOI 10.1152/ajpheart.2001.281.3.H1295	61	27	27	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2012	7	2							e30709	10.1371/journal.pone.0030709	http://dx.doi.org/10.1371/journal.pone.0030709			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UV	22319579	Green Submitted, gold, Green Published			2022-12-25	WOS:000301979000011
J	Sandell, LL; Lynn, ML; Inman, KE; McDowell, W; Trainor, PA				Sandell, Lisa L.; Lynn, Megan L.; Inman, Kimberly E.; McDowell, William; Trainor, Paul A.			RDH10 Oxidation of Vitamin A Is a Critical Control Step in Synthesis of Retinoic Acid during Mouse Embryogenesis	PLOS ONE			English	Article							NULL MUTANT MICE; ALCOHOL-DEHYDROGENASE ADH1; ALL-TRANS-RETINOL; NERVOUS-SYSTEM; EXPRESSION; METABOLISM; MECHANISM; TOXICITY; GENES; ORGANOGENESIS	Retinoic Acid (RA) is a small lipophilic signaling molecule essential for embryonic development and adult tissue maintenance. Both an excess of RA and a deficiency of RA can cause pathogenic anomalies, hence it is critical to understand the mechanisms controlling the spatial and temporal distribution of RA. However, our current understanding of these processes remains incomplete. Vitamin A is metabolized to RA via two sequential enzymatic reactions. The first requires retinol dehydrogenase (RDH) activity to oxidize Vitamin A (retinol) to retinal, and the second requires retinaldehyde activity (RALDH) to oxidize retinal into RA. The first reaction has previously been attributed to the alcohol dehydrogenase (ADH) family, whose genes are ubiquitously or redundantly expressed. Consequently, the specificity of RA synthesis was thought to reside exclusively at the level of the second reaction. To better understand the metabolism of Vitamin A into RA during embryogenesis, we generated new mouse models that disrupt this process. Here we describe a new targeted knockout of Rdh10 in which RA synthesis is severely impaired, particularly at critical early embryonic stages. We also introduce a new mutant allele of Aldh1a2. Both mutations produce similar developmental defects resulting in lethality around embryonic day 10.5 (E10.5). The severity of the Rdh10 null phenotype demonstrates that embryonic oxidation of retinol is carried out primarily by RDH10 and that neither ADHs nor other enzymes contribute significantly to this reaction. We also show that reduced RA production results in upregulation of Rdh10. These data demonstrate that RDH10 plays a critical role in mediating the rate limiting RDH step of Vitamin A metabolism and functions as a nodal point in feedback regulation of RA synthesis. Moreover, RDH10-mediated oxidation of retinol plays as important a role in the control and regulation of RA production during embryogenesis as does the subsequent RALDH-mediated reaction.	[Sandell, Lisa L.; Lynn, Megan L.; Inman, Kimberly E.; McDowell, William; Trainor, Paul A.] Stowers Inst Med Res, Kansas City, MO USA; [Sandell, Lisa L.] Univ Louisville, Dept Mol Cellular & Craniofacial Biol, Louisville, KY 40292 USA; [Trainor, Paul A.] Univ Kansas, Med Ctr, Dept Anat & Cell Biol, Kansas City, KS 66103 USA	Stowers Institute for Medical Research; University of Louisville; University of Kansas; University of Kansas Medical Center	Sandell, LL (corresponding author), Stowers Inst Med Res, Kansas City, MO USA.	lisa.sandell@louisville.edu; pat@stowers.org	Sandell, Lisa L/M-4238-2013	Sandell, Lisa L/0000-0002-1735-8223; Trainor, Paul/0000-0003-2774-3624	Stowers Institute for Medical Research; National Institute of Dental and Craniofacial Research [R01 DE 016082]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE016082] Funding Source: NIH RePORTER	Stowers Institute for Medical Research; National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	Research in the Trainor laboratory is supported by the Stowers Institute for Medical Research and the National Institute of Dental and Craniofacial Research (R01 DE 016082). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang HL, 1996, J BIOL CHEM, V271, P9526, DOI 10.1074/jbc.271.16.9526; Cammas L, 2007, DEV DYNAM, V236, P2899, DOI 10.1002/dvdy.21312; CHEN H, 1995, BIOCHEM PHARMACOL, V50, P1257, DOI 10.1016/0006-2952(95)02005-W; Clagett-Dame M, 2011, NUTRIENTS, V3, P385, DOI 10.3390/nu3040385; Cunningham TJ, 2011, DEV DYNAM, V240, P1142, DOI 10.1002/dvdy.22583; de Vries WN, 2000, GENESIS, V26, P110, DOI 10.1002/(SICI)1526-968X(200002)26:2<110::AID-GENE2>3.0.CO;2-8; Deltour L, 1999, DEV GENET, V25, P1, DOI 10.1002/(SICI)1520-6408(1999)25:1<1::AID-DVG1>3.0.CO;2-W; Deltour L, 1999, J BIOL CHEM, V274, P16796, DOI 10.1074/jbc.274.24.16796; Dowling JE, 1961, ROLE VITAMIN A ACID, P515; Duester G, 2003, CHEM-BIOL INTERACT, V143, P201, DOI 10.1016/S0009-2797(02)00204-1; Duester G, 1998, J NUTR, V128, p459S, DOI 10.1093/jn/128.2.459S; Duester G, 2008, CELL, V134, P921, DOI 10.1016/j.cell.2008.09.002; Dupe V, 2003, P NATL ACAD SCI USA, V100, P14036, DOI 10.1073/pnas.2336223100; Fan XH, 2003, MOL CELL BIOL, V23, P4637, DOI 10.1128/MCB.23.13.4637-4648.2003; Farjo KM, 2011, DEV BIOL, V357, P347, DOI 10.1016/j.ydbio.2011.07.011; Farley FW, 2000, GENESIS, V28, P106, DOI 10.1002/1526-968X(200011/12)28:3/4<106::AID-GENE30>3.0.CO;2-T; Feng L, 2010, DEV BIOL, V338, P1, DOI 10.1016/j.ydbio.2009.10.029; Hall JA, 2011, IMMUNITY, V35, P13, DOI 10.1016/j.immuni.2011.07.002; Kane MA, 2010, FASEB J, V24, P823, DOI 10.1096/fj.09-141572; Kumar S, 2011, BIOCH BIOPHYSICA ACT; Lewandoski M, 1997, CURR BIOL, V7, P148, DOI 10.1016/S0960-9822(06)00059-5; Maden M, 2007, NAT REV NEUROSCI, V8, P755, DOI 10.1038/nrn2212; Mark Manuel, 2009, Nucl Recept Signal, V7, pe002, DOI 10.1621/nrs.07002; Matt N, 2005, DEVELOPMENT, V132, P4789, DOI 10.1242/dev.02031; Mic FA, 2002, DEVELOPMENT, V129, P2271; Molotkov A, 2005, DEV DYNAM, V232, P950, DOI 10.1002/dvdy.20256; Molotkov A, 2002, EUR J BIOCHEM, V269, P2607, DOI 10.1046/j.1432-1033.2002.02935.x; Molotkov A, 2002, J BIOL CHEM, V277, P13804, DOI 10.1074/jbc.M112039200; Niederreither K, 1999, NAT GENET, V21, P444, DOI 10.1038/7788; Niederreither K, 2008, NAT REV GENET, V9, P541, DOI 10.1038/nrg2340; Pares X, 2008, CELL MOL LIFE SCI, V65, P3936, DOI 10.1007/s00018-008-8591-3; Reijntjes S, 2010, INT J DEV BIOL, V54, P1267, DOI 10.1387/ijdb.093009sr; Rhinn M, 2011, P NATL ACAD SCI USA, V108, P16687, DOI 10.1073/pnas.1103877108; ROSSANT J, 1991, GENE DEV, V5, P1333, DOI 10.1101/gad.5.8.1333; Sandell LL, 2007, GENE DEV, V21, P1113, DOI 10.1101/gad.1533407; Sandell LL, 2011, GENESIS, V49, P342, DOI 10.1002/dvg.20727; See AWM, 2008, DEV BIOL, V316, P171, DOI 10.1016/j.ydbio.2007.10.018; Strate I, 2009, DEVELOPMENT, V136, P461, DOI 10.1242/dev.024901; Takahashi Y, 2009, BIOCHEM J, V419, P113, DOI 10.1042/BJ20080812; Villarroya F, 2004, CURR MED CHEM, V11, P795, DOI 10.2174/0929867043455747; WARKANY J, 1946, ARCH OPHTHALMOL-CHIC, V35, P150, DOI 10.1001/archopht.1946.00890200155008; WILSON JG, 1949, AM J ANAT, V85, P113, DOI 10.1002/aja.1000850106; WILSON JG, 1948, AM J ANAT, V83, P357, DOI 10.1002/aja.1000830303; Wu BX, 2004, INVEST OPHTH VIS SCI, V45, P3857, DOI 10.1167/iovs.03-1302; ZACHMAN RD, 1961, J BIOL CHEM, V236, P2309	45	73	73	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2012	7	2							e30698	10.1371/journal.pone.0030698	http://dx.doi.org/10.1371/journal.pone.0030698			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UV	22319578	gold, Green Published, Green Submitted			2022-12-25	WOS:000301979000010
J	Tegze, B; Szallasi, Z; Haltrich, I; Penzvalto, Z; Toth, Z; Liko, I; Gyorffy, B				Tegze, Balint; Szallasi, Zoltan; Haltrich, Iren; Penzvalto, Zsofia; Toth, Zsuzsa; Liko, Istvan; Gyoerffy, Balazs			Parallel Evolution under Chemotherapy Pressure in 29 Breast Cancer Cell Lines Results in Dissimilar Mechanisms of Resistance	PLOS ONE			English	Article							TOPOISOMERASE-II ACTIVITY; MULTIDRUG-RESISTANCE; LUNG-CANCER; PACLITAXEL RESISTANCE; PREDICTS RESISTANCE; ACQUIRED-RESISTANCE; EXPRESSION; PROTEIN; AMPLIFICATION; DOXORUBICIN	Background: Developing chemotherapy resistant cell lines can help to identify markers of resistance. Instead of using a panel of highly heterogeneous cell lines, we assumed that truly robust and convergent pattern of resistance can be identified in multiple parallel engineered derivatives of only a few parental cell lines. Methods: Parallel cell populations were initiated for two breast cancer cell lines (MDA-MB-231 and MCF-7) and these were treated independently for 18 months with doxorubicin or paclitaxel. IC50 values against 4 chemotherapy agents were determined to measure cross-resistance. Chromosomal instability and karyotypic changes were determined by cytogenetics. TaqMan RT-PCR measurements were performed for resistance-candidate genes. Pgp activity was measured by FACS. Results: All together 16 doxorubicin-and 13 paclitaxel-treated cell lines were developed showing 2-46 fold and 3-28 fold increase in resistance, respectively. The RT-PCR and FACS analyses confirmed changes in tubulin isofom composition, TOP2A and MVP expression and activity of transport pumps (ABCB1, ABCG2). Cytogenetics showed less chromosomes but more structural aberrations in the resistant cells. Conclusion: We surpassed previous studies by parallel developing a massive number of cell lines to investigate chemoresistance. While the heterogeneity caused evolution of multiple resistant clones with different resistance characteristics, the activation of only a few mechanisms were sufficient in one cell line to achieve resistance.	[Tegze, Balint; Penzvalto, Zsofia] Semmelweis Univ, Dept Pediat 1, Budapest, Hungary; [Szallasi, Zoltan] Childrens Hosp, Boston, MA 02115 USA; [Szallasi, Zoltan] Tech Univ Denmark, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark; [Haltrich, Iren; Toth, Zsuzsa] Semmelweis Univ, Dept Pediat 2, Budapest, Hungary; [Liko, Istvan] Gedeon Richter Plc, Budapest, Hungary; [Gyoerffy, Balazs] Charite, Lab Funct Genom, D-13353 Berlin, Germany; [Gyoerffy, Balazs] Hungarian Acad Sci, Res Lab Pediat & Nephrol, Budapest, Hungary	Semmelweis University; Harvard University; Boston Children's Hospital; Technical University of Denmark; Semmelweis University; Gedeon Richter Chemistry Works; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Hungarian Academy of Sciences	Tegze, B (corresponding author), Semmelweis Univ, Dept Pediat 1, Budapest, Hungary.	balint@tegze.net	Haltrich, Irén/K-2890-2017; Gyorffy, Balazs/AAA-9135-2021	Haltrich, Irén/0000-0003-0094-5285; Gyorffy, Balazs/0000-0002-5772-3766; Szallasi, Zoltan/0000-0001-5395-7509; Liko, Istvan/0000-0001-7668-4726	Hungarian Scientific Research Fund [OTKA PD 83154]; Medical Research Council [ETT 029/2009]; National Development Agency, Hungary [TAMOP-4.2.1/B 09/1/KMR-2010-0001]; Economic Competitiveness Operational Programme [GVOP-3.2.1 - 2004 - 04 -0124/3.0]; Alexander von Humboldt-Foundation; Breast Cancer Research Foundation	Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Development Agency, Hungary; Economic Competitiveness Operational Programme; Alexander von Humboldt-Foundation(Alexander von Humboldt Foundation); Breast Cancer Research Foundation	The study was supported by the Hungarian Scientific Research Fund (OTKA PD 83154), by the Medical Research Council (ETT 029/2009), by the Social Renewal Operational Programme (National Development Agency, Hungary)(TAMOP-4.2.1/B 09/1/KMR-2010-0001) and by the Economic Competitiveness Operational Programme (GVOP-3.2.1 - 2004 - 04 -0124/3.0) grants, by the Alexander von Humboldt-Foundation and by the Breast Cancer Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre F, 2010, CURR OPIN ONCOL, V22, P547, DOI 10.1097/CCO.0b013e32833fb384; Bean J, 2007, P NATL ACAD SCI USA, V104, P20932, DOI 10.1073/pnas.0710370104; Borst P, 2000, JNCI-J NATL CANCER I, V92, P1295, DOI 10.1093/jnci/92.16.1295; Dalton WS, 1999, J NATL CANCER I, V91, P1604, DOI 10.1093/jnci/91.19.1604; Desmedt C, 2011, J CLIN ONCOL; DOROSHOW JH, 1986, BIOCHEM BIOPH RES CO, V135, P330, DOI 10.1016/0006-291X(86)90981-2; EIJDEMS EWHM, 1995, BRIT J CANCER, V71, P40, DOI 10.1038/bjc.1995.9; Ein-Dor L, 2006, P NATL ACAD SCI USA, V103, P5923, DOI 10.1073/pnas.0601231103; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Farmer P, 2009, NAT MED, V15, P68, DOI 10.1038/nm.1908; Gerlinger M, 2010, BRIT J CANCER, V103, P1139, DOI 10.1038/sj.bjc.6605912; Gyorffy B, 2005, ONCOGENE, V24, P7542, DOI 10.1038/sj.onc.1208908; Gyorffy B, 2006, INT J CANCER, V118, P1699, DOI 10.1002/ijc.21570; Gyorffy Balazs, 2005, Orv Hetil, V146, P559; KARTNER N, 1983, SCIENCE, V221, P1285, DOI 10.1126/science.6137059; Kavallaris M, 1997, J CLIN INVEST, V100, P1282, DOI 10.1172/JCI119642; Lage H, 2000, BRIT J CANCER, V82, P488, DOI 10.1054/bjoc.1999.0947; Lehne G, 2000, INT J CLIN PHARM TH, V38, P187; Li Y, 2010, NAT MED, V16, P214, DOI 10.1038/nm.2090; Liedtke C, 2010, BREAST CANCER RES TR, V121, P301, DOI 10.1007/s10549-009-0445-7; Maley CC, 2006, NAT GENET, V38, P468, DOI 10.1038/ng1768; Marusyk A, 2010, BBA-REV CANCER, V1805, P105, DOI 10.1016/j.bbcan.2009.11.002; Mechetner E, 1998, CLIN CANCER RES, V4, P389; Monzo M, 1999, J CLIN ONCOL, V17, P1786, DOI 10.1200/JCO.1999.17.6.1786; Mozzetti S, 2005, CLIN CANCER RES, V11, P298; Munkacsy G, 2010, BRIT J CANCER, V102, P361, DOI 10.1038/sj.bjc.6605478; Penson RT, 2004, GYNECOL ONCOL, V93, P98, DOI 10.1016/j.ygyno.2003.11.053; Potti A, 2006, NAT MED, V12, P1294, DOI 10.1038/nm1491; Potti A, 2011, NAT MED, V17, P135, DOI 10.1038/nm0111-135; Qi J, 2011, CANCER RES, V71, P1081, DOI 10.1158/0008-5472.CAN-10-1623; Renes J, 2000, DRUG RESIST UPDATE, V3, P289, DOI 10.1054/drup.2000.0156; Rouzier R, 2005, P NATL ACAD SCI USA, V102, P8315, DOI 10.1073/pnas.0408974102; Saad ED, 2010, J CLIN ONCOL, V28, P1958, DOI 10.1200/JCO.2009.25.5414; Shannon CE, 1997, M D COMPUT, V14, P306; Silver DP, 2010, J CLIN ONCOL, V28, P1145, DOI 10.1200/JCO.2009.22.4725; Wang HM, 2001, J BIOL CHEM, V276, P15990, DOI 10.1074/jbc.M011143200	36	35	38	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2012	7	2							e30804	10.1371/journal.pone.0030804	http://dx.doi.org/10.1371/journal.pone.0030804			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UV	22319589	Green Submitted, Green Published, gold			2022-12-25	WOS:000301979000015
J	Tyagi, M; Thangudu, RR; Zhang, DC; Bryant, SH; Madej, T; Panchenko, AR				Tyagi, Manoj; Thangudu, Ratna R.; Zhang, Dachuan; Bryant, Stephen H.; Madej, Thomas; Panchenko, Anna R.			Homology Inference of Protein-Protein Interactions via Conserved Binding Sites	PLOS ONE			English	Article							PREDICTION; SEQUENCE; ANNOTATION; DIVERGENCE; COMPLEXES	The coverage and reliability of protein-protein interactions determined by high-throughput experiments still needs to be improved, especially for higher organisms, therefore the question persists, how interactions can be verified and predicted by computational approaches using available data on protein structural complexes. Recently we developed an approach called IBIS (Inferred Biomolecular Interaction Server) to predict and annotate protein-protein binding sites and interaction partners, which is based on the assumption that the structural location and sequence patterns of protein-protein binding sites are conserved between close homologs. In this study first we confirmed high accuracy of our method and found that its accuracy depends critically on the usage of all available data on structures of homologous complexes, compared to the approaches where only a non-redundant set of complexes is employed. Second we showed that there exists a trade-off between specificity and sensitivity if we employ in the prediction only evolutionarily conserved binding site clusters or clusters supported by only one observation (singletons). Finally we addressed the question of identifying the biologically relevant interactions using the homology inference approach and demonstrated that a large majority of crystal packing interactions can be correctly identified and filtered by our algorithm. At the same time, about half of biological interfaces that are not present in the protein crystallographic asymmetric unit can be reconstructed by IBIS from homologous complexes without the prior knowledge of crystal parameters of the query protein.	[Tyagi, Manoj; Thangudu, Ratna R.; Zhang, Dachuan; Bryant, Stephen H.; Madej, Thomas; Panchenko, Anna R.] NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM)	Tyagi, M (corresponding author), NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bldg 10, Bethesda, MD 20892 USA.	madej@ncbi.nlm.nih.gov; panch@ncbi.nlm.nih.gov	Tyagi, Manoj/K-8438-2014		National Institutes of Health/Department of Health and Human Services of the National Library of Medicine; NATIONAL LIBRARY OF MEDICINE [ZIALM100604, ZIALM000046] Funding Source: NIH RePORTER	National Institutes of Health/Department of Health and Human Services of the National Library of Medicine; NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by the National Institutes of Health/Department of Health and Human Services Intramural Research program of the National Library of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloy P, 2003, J MOL BIOL, V332, P989, DOI 10.1016/j.jmb.2003.07.006; Altschul SF, 2001, NUCLEIC ACIDS RES, V29, P351, DOI 10.1093/nar/29.2.351; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Burgess B, 2002, NITROGEN FIXATION MO, P13; Chen HL, 2005, PROTEINS, V61, P21, DOI 10.1002/prot.20514; Chen J, 2003, NUCLEIC ACIDS RES, V31, P474, DOI 10.1093/nar/gkg086; Dayhoff JE, 2010, J MOL BIOL, V395, P860, DOI 10.1016/j.jmb.2009.10.052; Dessailly BH, 2010, STRUCTURE, V18, P1522, DOI 10.1016/j.str.2010.08.017; Fariselli P, 2002, EUR J BIOCHEM, V269, P1356, DOI 10.1046/j.1432-1033.2002.02767.x; Gibrat JF, 1996, CURR OPIN STRUC BIOL, V6, P377, DOI 10.1016/S0959-440X(96)80058-3; GRIBSKOV M, 1987, P NATL ACAD SCI USA, V84, P4355, DOI 10.1073/pnas.84.13.4355; Hashimoto K, 2010, P NATL ACAD SCI USA, V107, P20352, DOI 10.1073/pnas.1012999107; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Henrick K, 1998, TRENDS BIOCHEM SCI, V23, P358, DOI 10.1016/S0968-0004(98)01253-5; Holm RH, SUBSITE SPECIFIC STR, P1; Ispolatov I, 2005, NUCLEIC ACIDS RES, V33, P3629, DOI 10.1093/nar/gki678; Jefferson ER, 2006, J MOL BIOL, V364, P1118, DOI 10.1016/j.jmb.2006.09.042; Kemmer D, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-r106; KIM J, 1993, BIOCHEMISTRY-US, V32, P7104, DOI 10.1021/bi00079a006; KIM JS, 1992, NATURE, V360, P553, DOI 10.1038/360553a0; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Levy ED, 2007, STRUCTURE, V15, P1364, DOI 10.1016/j.str.2007.09.019; Liang SD, 2006, NUCLEIC ACIDS RES, V34, P3698, DOI 10.1093/nar/gkl454; Ma BG, 2010, STRUCTURE, V18, P819, DOI 10.1016/j.str.2010.04.004; Marchler-Bauer A, 2005, NUCLEIC ACIDS RES, V33, pD192, DOI 10.1093/nar/gki069; Marchler-Bauer A, 2004, NUCLEIC ACIDS RES, V32, pW327, DOI 10.1093/nar/gkh454; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Matthews LR, 2001, GENOME RES, V11, P2120, DOI 10.1101/gr.205301; Mika S, 2006, PLOS COMPUT BIOL, V2, P698, DOI 10.1371/journal.pcbi.0020079; Mintz S, 2005, PROTEINS, V61, P6, DOI 10.1002/prot.20580; Neuvirth H, 2004, J MOL BIOL, V338, P181, DOI 10.1016/j.jmb.2004.02.040; Newton WE, 1992, BIOL NITROGEN FIXATI, P877; Persico M, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S4-S21; Reguly Teresa, 2006, J Biol, V5, P11, DOI 10.1186/jbiol36; Shoemaker BA, 2006, PROTEIN SCI, V15, P352, DOI 10.1110/ps.051760806; Shoemaker BA, 2007, PLOS COMPUT BIOL, V3, P595, DOI 10.1371/journal.pcbi.0030043; Shoemaker BA, 2010, NUCLEIC ACIDS RES, V38, pD518, DOI 10.1093/nar/gkp842; Shulman-Peleg A, 2004, LECT NOTES COMPUT SC, V3240, P194; Slonim N, 2005, P NATL ACAD SCI USA, V102, P18297, DOI 10.1073/pnas.0507432102; Stumpf MPH, 2008, P NATL ACAD SCI USA, V105, P6959, DOI 10.1073/pnas.0708078105; Thangudu RR, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-365; Walhout AJM, 2000, SCIENCE, V287, P116, DOI 10.1126/science.287.5450.116; Xu QF, 2008, J MOL BIOL, V381, P487, DOI 10.1016/j.jmb.2008.06.002; Xue LC, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-244; Yu HY, 2004, GENOME RES, V14, P1107, DOI 10.1101/gr.1774904; Zhang QC, 2010, P NATL ACAD SCI USA, V107, P10896, DOI 10.1073/pnas.1005894107; Zhu HB, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-27	47	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2012	7	1							e28896	10.1371/journal.pone.0028896	http://dx.doi.org/10.1371/journal.pone.0028896			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	912BY	22303436	Green Published, gold, Green Submitted			2022-12-25	WOS:000301770700003
J	Pesnel, S; Pillon, A; Creancier, L; Lerondel, S; Le Pape, A; Recher, C; Demur, C; Guilbaud, N; Kruczynski, A				Pesnel, Sabrina; Pillon, Arnaud; Creancier, Laurent; Lerondel, Stephanie; Le Pape, Alain; Recher, Christian; Demur, Cecile; Guilbaud, Nicolas; Kruczynski, Anna			Optical Imaging of Disseminated Leukemia Models in Mice with Near-Infrared Probe Conjugated to a Monoclonal Antibody	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; CD44	Background: The assessment of anticancer agents to treat leukemia needs to have animal models closer to the human pathology such as implantation in immunodeficient mice of leukemic cells from patient samples. A sensitive and early detection of tumor cells in these orthotopic models is a prerequisite for monitoring engraftment of leukemic cells and their dissemination in mice. Therefore, we developed a fluorescent antibody based strategy to detect leukemic foci in mice bearing patient-derived leukemic cells using fluorescence reflectance imaging (FRI) to determine when to start treatments with novel antitumor agents. Methods: Two mAbs against the CD44 human myeloid marker or the CD45 human leukocyte marker were labeled with Alexa Fluor 750 and administered to leukemia-bearing mice after having verified the immunoreactivity in vitro. Bioluminescent leukemic cells (HL60-Luc) were used to compare the colocalization of the fluorescent mAb with these cells. The impact of the labeled antibodies on disease progression was further determined. Finally, the fluorescent hCD45 mAb was tested in mice engrafted with human leukemic cells. Results: The probe labeling did not modify the immunoreactivity of the mAbs. There was a satisfactory correlation between bioluminescence imaging (BLI) and FRI and low doses of mAb were sufficient to detect leukemic foci. However, anti-hCD44 mAb had a strong impact on the tumor proliferation contrary to anti-hCD45 mAb. The use of anti-hCD45 mAb allowed the detection of leukemic patient cells engrafted onto NOD/SCID mice. Conclusions: A mAb labeled with a near infrared fluorochrome is useful to detect leukemic foci in disseminated models provided that its potential impact on tumor proliferation has been thoroughly documented.	[Pesnel, Sabrina; Pillon, Arnaud; Creancier, Laurent; Guilbaud, Nicolas; Kruczynski, Anna] Ctr Rech Oncol Expt, Inst Rech Pierre Fabre, Toulouse, France; [Pesnel, Sabrina; Lerondel, Stephanie; Le Pape, Alain] CNRS, UPS TAAM CIPA 44, F-45071 Orleans, France; [Le Pape, Alain] INSERM, U618, Tours, France; [Recher, Christian; Demur, Cecile] CHU Toulouse, Hop Purpan, Serv Hematol, Toulouse, France; [Recher, Christian; Demur, Cecile] CHU Purpan, Ctr Physiopathol, INSERM, U563, Toulouse, France	Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de Toulouse; CHU de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm)	Pesnel, S (corresponding author), Ctr Rech Oncol Expt, Inst Rech Pierre Fabre, Toulouse, France.	spesnel@cnrs-orleans.fr		Pesnel, Sabrina/0000-0001-7839-4394				Adonai N, 2002, P NATL ACAD SCI USA, V99, P3030, DOI 10.1073/pnas.052709599; Burke John M, 2002, Cancer Control, V9, P106; Creancier L, 2010, P AM ASS CANC RES 10; Dayde D, 2009, BLOOD, V113, P3765, DOI 10.1182/blood-2008-08-175125; Ghoroghchian PP, 2009, WIRES NANOMED NANOBI, V1, P156, DOI 10.1002/wnan.7; Goodison S, 1999, J CLIN PATHOL-MOL PA, V52, P189; Green DJ, 2009, BLOOD, V114, P1226, DOI 10.1182/blood-2009-03-210344; Isaza MP, 2008, LUMINESCENCE, V23, P17, DOI 10.1002/bio.1010; Kalchenko V, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2364903; Kotzerke J, 2005, BONE MARROW TRANSPL, V36, P1021, DOI 10.1038/sj.bmt.1705182; Krause DS, 2010, ARCH PATHOL LAB MED, V134, P1033, DOI 10.1043/2009-0347-OA.1; Kuenzle Katherina, 2002, Mol Imaging Biol, V4, P179, DOI 10.1016/S1095-0397(01)00056-5; Leblond F, 2010, J PHOTOCH PHOTOBIO B, V98, P77, DOI 10.1016/j.jphotobiol.2009.11.007; LENERS N, 1991, NUCL MED BIOL, V18, P727; Liu JN, 2006, CELL MOL IMMUNOL, V3, P359; McCormack E, 2007, MOL IMAGING, V6, P193, DOI 10.2310/7290.2007.00016; Morris JC, 2009, EXPERT REV MOL MED, V30, P11; Olafsen T, 2010, SEMIN NUCL MED, V40, P167, DOI 10.1053/j.semnuclmed.2009.12.005; OMARY MB, 1980, J EXP MED, V152, P842, DOI 10.1084/jem.152.4.842; Paroo Z, 2004, MOL IMAGING, V3, P117, DOI 10.1162/1535350041464865; PRESS OW, 1989, CANCER RES, V49, P4906; Sanchez PV, 2009, LEUKEMIA, V23, P2109, DOI 10.1038/leu.2009.143; Tomimaru Y, 2010, ONCOL REP, V24, P613, DOI 10.3892/or_00000899; Vosjan MJWD, 2010, NAT PROTOC, V5, P739, DOI 10.1038/nprot.2010.13	24	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2012	7	1							e30690	10.1371/journal.pone.0030690	http://dx.doi.org/10.1371/journal.pone.0030690			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911GB	22303450	Green Published, gold, Green Submitted			2022-12-25	WOS:000301704200029
J	Plantard, O; Bouju-Albert, A; Malard, MA; Hermouet, A; Capron, G; Verheyden, H				Plantard, Olivier; Bouju-Albert, Agnes; Malard, Marie-Astrid; Hermouet, Axelle; Capron, Gilles; Verheyden, Helene			Detection of Wolbachia in the Tick Ixodes ricinus is Due to the Presence of the Hymenoptera Endoparasitoid Ixodiphagus hookeri	PLOS ONE			English	Article							MIDICHLORIA-MITOCHONDRII; REPRODUCTIVE PARASITES; MICROBIAL COMMUNITIES; SCAPULARIS ACARI; ENDOSYMBIONT; WIDESPREAD; SYMBIONT; DIVERSITY; BACTERIA; IXODIDAE	The identification of micro-organisms carried by ticks is an important issue for human and animal health. In addition to their role as pathogen vectors, ticks are also the hosts for symbiotic bacteria whose impact on tick biology is poorly known. Among these, the bacterium Wolbachia pipientis has already been reported associated with Ixodes ricinus and other tick species. However, the origins of Wolbachia in ticks and their consequences on tick biology (known to be very diverse in invertebrates, ranging from nutritional symbionts in nematodes to reproductive manipulators in insects) are unknown. Here we report that the endoparasitoid wasp Ixodiphagus hookeri (Hymenoptera, Chalcidoidea, Encyrtidae) - strictly associated with ticks for their development - is infested at almost 100% prevalence by a W. pipientis strain belonging to a Wolbachia supergroup that has already been reported as associated with other hymenopteran parasitoids. In a natural population of I. ricinus that suffers high parasitism rates due to I. hookeri, we used specific PCR primers for both hymenopteran and W. pipientis gene fragments to show that all unfed tick nymphs parasitized by I. hookeri also harbored Wolbachia, while unparasitized ticks were Wolbachia-free. We demonstrated experimentally that unfed nymphs obtained from larvae exposed to I. hookeri while gorging on their vertebrate host also harbor Wolbachia. We hypothesize that previous studies that have reported W. pipientis in ticks are due to the cryptic presence of the endoparasitoid wasp I. hookeri. This association has remained hidden until now because parasitoids within ticks cannot be detected until engorgement of the nymphs brings the wasp eggs out of diapause. Finally, we discuss the consequences of this finding for our understanding of the tick microbiome, and their possible role in horizontal gene transfer among pathogenic and symbiotic bacteria.	[Plantard, Olivier; Bouju-Albert, Agnes; Malard, Marie-Astrid; Hermouet, Axelle] INRA, UMR 1300, BioEpAR, F-44026 Nantes, France; [Plantard, Olivier; Bouju-Albert, Agnes; Malard, Marie-Astrid; Hermouet, Axelle] LUNAM Univ, Oniris, Nantes, France; [Capron, Gilles] DIR Poitou Charentes Limousin, ONCFS, Paris, France; [Verheyden, Helene] INRA, UR 035, F-31326 Castanet Tolosan, France	Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; INRAE; Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; INRAE	Plantard, O (corresponding author), INRA, UMR 1300, BioEpAR, F-44026 Nantes, France.	olivier.plantard@oniris-nantes.fr		DURAND, Axelle/0000-0002-4291-2281; Plantard, Olivier/0000-0001-6473-4271	Jeune Equipe INRA Varibabix	Jeune Equipe INRA Varibabix	This work was supported by "Jeune Equipe INRA Varibabix". Action Incitative Programme du Centre International pour la Recherche Agronomique et le Developpement (CIRAD) et de l'Institut National de la Recherche Agronomique (INRA) "Dynamique et diversite genetique des tiques et pathogenes transmis" INRA, Animal Health Division. http://www.inra.fr/sante_animale/ The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreotti R, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-6; Baldo L, 2006, MOL BIOL EVOL, V23, P437, DOI 10.1093/molbev/msj049; Benson MJ, 2004, APPL ENVIRON MICROB, V70, P616, DOI 10.1128/AEM.70.1.616-620.2004; Bian GW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000833; Bonnet S, 2007, PARASITOLOGY, V134, P197, DOI 10.1017/S0031182006001545; Braig HR, 1998, J BACTERIOL, V180, P2373, DOI 10.1128/JB.180.9.2373-2378.1998; BREEUWER JAJ, 1993, GENETICS, V135, P565; Brumpi E, 1930, CR HEBD ACAD SCI, V191, P1085; Brumpt E., 1913, PRESSE MED PARIS, V36, P359; Carpi G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025604; Casiraghi M, 2004, INT J PARASITOL, V34, P191, DOI 10.1016/j.ijpara.2003.10.004; Cirimotich CM, 2011, SCIENCE, V332, P855, DOI 10.1126/science.1201618; Clay K, 2008, MOL ECOL, V17, P4371, DOI 10.1111/j.1365-294X.2008.03914.x; Collatz J, 2011, J APPL ENTOMOL, V135, P351, DOI 10.1111/j.1439-0418.2010.01560.x; Cooley RA, 1919, SCIENCE, V68, P656; Dib L, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040007; Duron O, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-27; EGGLETON P, 1992, PHILOS T R SOC B, V337, P1, DOI 10.1098/rstb.1992.0079; Engelstadter J, 2007, GENETICS, V175, P245, DOI 10.1534/genetics.106.060921; Epis S, 2008, PARASITOLOGY, V135, P485, DOI 10.1017/S0031182007004052; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Haine ER, 2008, P ROY SOC B-BIOL SCI, V275, P353, DOI 10.1098/rspb.2007.1211; Hartelt K, 2004, INT J MED MICROBIOL, V293, P86, DOI 10.1016/S1433-1128(04)80013-5; Heath ACG, 2010, NEW ZEAL J ZOOL, V37, P147, DOI 10.1080/03014223.2010.482973; Hedges LM, 2008, SCIENCE, V322, P702, DOI 10.1126/science.1162418; Hosokawa T, 2010, P NATL ACAD SCI USA, V107, P769, DOI 10.1073/pnas.0911476107; Hotopp JCD, 2007, SCIENCE, V317, P1753, DOI 10.1126/science.1142490; Hu R, 1998, SYSTEMATIC APPL ACAR, V3, P1362; Hu RJ, 1998, J MED ENTOMOL, V35, P1050, DOI 10.1093/jmedent/35.6.1050; Inokuma H, 2000, J CLIN MICROBIOL, V38, P4219, DOI 10.1128/JCM.38.11.4219-4221.2000; Ishmael N, 2009, MICROBIOL-SGM, V155, P2211, DOI 10.1099/mic.0.027581-0; Jongejan F, 2004, PARASITOLOGY, V129, pS3, DOI 10.1017/S0031182004005967; Kirkness EF, 2010, P NATL ACAD SCI USA, V107, P12168, DOI 10.1073/pnas.1003379107; Lo N, 2006, ENVIRON MICROBIOL, V8, P1280, DOI 10.1111/j.1462-2920.2006.01024.x; MATHER TN, 1987, MED VET ENTOMOL, V1, P3, DOI 10.1111/j.1365-2915.1987.tb00317.x; Mediannikov O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011478; Moreno CX, 2006, ENVIRON MICROBIOL, V8, P761, DOI 10.1111/j.1462-2920.2005.00955.x; Mousson L, 2010, MOL ECOL, V19, P1953, DOI 10.1111/j.1365-294X.2010.04606.x; Niebylski ML, 1997, APPL ENVIRON MICROB, V63, P3933, DOI 10.1128/AEM.63.10.3933-3940.1997; Noda H, 1997, APPL ENVIRON MICROB, V63, P3926, DOI 10.1128/AEM.63.10.3926-3932.1997; Parola P, 2005, CLIN MICROBIOL REV, V18, P719, DOI 10.1128/CMR.18.4.719-756.2005; Parola P, 2001, CLIN INFECT DIS, V32, P897, DOI 10.1086/319347; QUARAISHI M. S., 1958, AMER MIDLAND NAT, V59, P489, DOI 10.2307/2422494; Randolph SE, 2004, PARASITOLOGY, V129, pS37, DOI 10.1017/S0031182004004925; Raychoudhury R, 2010, HEREDITY, V104, P318, DOI 10.1038/hdy.2009.160; Reis C, 2011, VECTOR-BORNE ZOONOT, V11, P907, DOI 10.1089/vbz.2010.0103; Sacchi L, 2004, TISSUE CELL, V36, P43, DOI 10.1016/j.tice.2003.08.004; Sarih MH, 2005, J CLIN MICROBIOL, V43, P1127, DOI 10.1128/JCM.43.3.1127-1132.2005; Sassera D, 2011, MOL BIOL EVOLUTION; Sassera D, 2006, INT J SYST EVOL MICR, V56, P2535, DOI 10.1099/ijs.0.64386-0; Scheffer SJ, 2003, MOL ECOL, V12, P415, DOI 10.1046/j.1365-294X.2003.01725.x; Sonenshine DE., 1991, BIOL TICKS; Stafford KC, 2003, J MED ENTOMOL, V40, P642, DOI 10.1603/0022-2585-40.5.642; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2011, MOL BIOL EVOLUTION; Telfer S, 2010, SCIENCE, V330, P243, DOI 10.1126/science.1190333; van Overbeek L, 2008, FEMS MICROBIOL ECOL, V66, P72, DOI 10.1111/j.1574-6941.2008.00468.x; Weinert LA, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-6; Werren JH, 1997, ANNU REV ENTOMOL, V42, P587, DOI 10.1146/annurev.ento.42.1.587; WERREN JH, 1995, P ROY SOC B-BIOL SCI, V261, P55, DOI 10.1098/rspb.1995.0117; Wood HP, 1911, J ECON ENTOMOL, V4, P425, DOI 10.1093/jee/4.5.425; Zhong JM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000405	62	64	64	0	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2012	7	1							e30692	10.1371/journal.pone.0030692	http://dx.doi.org/10.1371/journal.pone.0030692			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911FX	22292021	Green Published, gold, Green Submitted			2022-12-25	WOS:000301703800026
J	Wang, JF; Chou, KC				Wang, Jing-Fang; Chou, Kuo-Chen			Insights into the Mutation-Induced HHH Syndrome from Modeling Human Mitochondrial Ornithine Transporter-1	PLOS ONE			English	Article							HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME; PROTEIN-STRUCTURE PREDICTION; PERSONALIZED DRUG DESIGN; SUBSTRATE-BINDING SITE; M2 PROTON CHANNEL; MOLECULAR-DYNAMICS; SEQUENCE-PROFILE; SYNDROME HYPERORNITHINEMIA; STRUCTURE INFORMATION; FOLD RECOGNITION	Human mitochondrial ornithine transporter-1 is reported in coupling with the hyperornithinemia-hyperammonemia-homocitrullinuria (HHH) syndrome, which is a rare autosomal recessive disorder. For in-depth understanding of the molecular mechanism of the disease, it is crucially important to acquire the 3D structure of human mitochondrial ornithine transporter-1. Since no such structure is available in the current protein structure database, we have developed it via computational approaches based on the recent NMR structure of human mitochondrial uncoupling protein (Berardi MJ, Chou JJ, et al. Nature 2011, 476: 109-113). Subsequently, we docked the ligand L-ornithine into the computational structure to search for the favorable binding mode. It was observed that the binding interaction for the most favorable binding mode is featured by six remarkable hydrogen bonds between the receptor and ligand, and that the most favorable binding mode shared the same ligand-binding site with most of the homologous mitochondrial carriers from different organisms, implying that the ligand-binding sites are quite conservative in the mitochondrial carriers family although their sequences similarity is very low with 20% or so. Moreover, according to our structural analysis, the relationship between the disease-causing mutations of human mitochondrial ornithine transporter-1 and the HHH syndrome can be classified into the following three categories: (i) the mutation occurs in the pseudo-repeat regions so as to change the region of the protein closer to the mitochondrial matrix; (ii) the mutation is directly affecting the substrate binding pocket so as to reduce the substrate binding affinity; (iii) the mutation is located in the structural region closer to the intermembrane space that can significantly break the salt bridge networks of the protein. These findings may provide useful insights for in-depth understanding of the molecular mechanism of the HHH syndrome and developing effective drugs against the disease.	[Wang, Jing-Fang] Shanghai Jiao Tong Univ, Minist Educ, Key Lab Syst Biomed, Shanghai 200030, Peoples R China; [Wang, Jing-Fang] Shanghai Ctr Bioinformat & Technol, Shanghai, Peoples R China; [Chou, Kuo-Chen] Gordon Life Sci Inst, San Diego, CA USA	Shanghai Jiao Tong University; Chinese Academy of Sciences	Wang, JF (corresponding author), Shanghai Jiao Tong Univ, Minist Educ, Key Lab Syst Biomed, Shanghai 200030, Peoples R China.	jfwang8113@sjtu.edu.cn	Wang, Jingfang/Q-2597-2018; Chou, Kuo-Chen/A-8340-2009	Wang, Jingfang/0000-0002-1355-5481; 				Benkert P, 2008, PROTEINS, V71, P261, DOI 10.1002/prot.21715; Berardi MJ, 2011, NATURE, V476, P109, DOI 10.1038/nature10257; BLUNDELL TL, 1987, NATURE, V326, P347, DOI 10.1038/326347a0; Camacho JA, 1999, NAT GENET, V22, P151, DOI 10.1038/9658; Chen Q, 2011, CURR DRUG METAB, V12, P436, DOI 10.2174/138920011795495259; Fecarotta S, 2006, J INHERIT METAB DIS, V29, P186, DOI 10.1007/s10545-006-0120-7; Fiermonte G, 2003, J BIOL CHEM, V278, P32778, DOI 10.1074/jbc.M302317200; Gonzalez-Diaz H, 2011, MOL BIOSYST, V7, P1938, DOI 10.1039/c1mb05069a; Gonzalez-Diaz H, 2011, J PROTEOME RES, V10, P1698, DOI 10.1021/pr101009e; Gonzalez-Diaz H, 2011, J THEOR BIOL, V276, P229, DOI 10.1016/j.jtbi.2011.01.010; Gu H, 2010, CHINESE SCI BULL, V55, P2677, DOI 10.1007/s11434-010-3257-6; HOMMES FA, 1982, J INHERIT METAB DIS, V5, P41, DOI 10.1007/BF01799753; HOMMES FA, 1986, NEUROPEDIATRICS, V17, P48, DOI 10.1055/s-2008-1052499; Juretic D, 2002, J CHEM INF COMP SCI, V42, P620, DOI 10.1021/ci010263s; Karplus K, 2005, PROTEINS, V61, P135, DOI 10.1002/prot.20730; Kunji ERS, 2006, BBA-BIOENERGETICS, V1757, P1237, DOI 10.1016/j.bbabio.2006.03.021; Kunji ERS, 2004, FEBS LETT, V564, P239, DOI 10.1016/S0014-5793(04)00242-X; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Laurie ATR, 2005, BIOINFORMATICS, V21, P1908, DOI 10.1093/bioinformatics/bti315; Li J, 2011, J CHEM INF MODEL, V51, P3217, DOI 10.1021/ci2004016; Lian P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018587; Magdziarz T, 2009, J MOL MODEL, V15, P41, DOI 10.1007/s00894-008-0373-1; Margelevicius M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-89; Melo F, 1998, J MOL BIOL, V277, P1141, DOI 10.1006/jmbi.1998.1665; Miyamoto T, 2002, PEDIATR NEUROL, V26, P65, DOI 10.1016/S0887-8994(01)00335-6; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Noguchi R, 1988, Masui, V37, P86; Nury H, 2005, FEBS LETT, V579, P6031, DOI 10.1016/j.febslet.2005.09.061; Palmieri F, 2004, PFLUG ARCH EUR J PHY, V447, P689, DOI 10.1007/s00424-003-1099-7; Palmieri F, 2006, BBA-BIOENERGETICS, V1757, P1249, DOI 10.1016/j.bbabio.2006.05.023; Pebay-Peyroula E, 2003, NATURE, V426, P39, DOI 10.1038/nature02056; Robinson AJ, 2006, P NATL ACAD SCI USA, V103, P2617, DOI 10.1073/pnas.0509994103; Robinson AJ, 2008, P NATL ACAD SCI USA, V105, P17766, DOI 10.1073/pnas.0809580105; Salvi S, 2001, Hum Mutat, V18, P460, DOI 10.1002/humu.1221; Salvi S, 2001, NEUROLOGY, V57, P911, DOI 10.1212/WNL.57.5.911; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; Shigeto H, 1992, Rinsho Shinkeigaku, V32, P729; SHIMIZU H, 1990, BRAIN DEV-JPN, V12, P533, DOI 10.1016/S0387-7604(12)80222-1; SMITH L, 1992, J PEDIATR GASTR NUTR, V15, P431, DOI 10.1097/00005176-199211000-00011; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Tessa A, 2009, HUM MUTAT, V30, P741, DOI 10.1002/humu.20930; Tsujino S, 2000, ANN NEUROL, V47, P625, DOI 10.1002/1531-8249(200005)47:5<625::AID-ANA10>3.3.CO;2-H; Valle D., 2001, METABOLIC MOL BASES, P1857; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Wang JF, 2011, J MOL MODEL, DOI [10.1007/s00894-011-1295x, DOI 10.1007/S00894-011-1295X]; Wang JF, 2008, PROTEIN PEPTIDE LETT, V15, P27; Wang JF, 2007, BIOCHEM BIOPH RES CO, V359, P323, DOI 10.1016/j.bbrc.2007.05.101; Wang JF, 2007, BIOCHEM BIOPH RES CO, V355, P513, DOI 10.1016/j.bbrc.2007.01.185; Wang JF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018414; Wang JF, 2010, PROTEIN ENG DES SEL, V23, P663, DOI 10.1093/protein/gzq040; Wang JF, 2010, CURR DRUG METAB, V11, P342, DOI 10.2174/138920010791514180; Wang JF, 2009, BIOCHEM BIOPH RES CO, V388, P413, DOI 10.1016/j.bbrc.2009.08.026; Wang JF, 2009, BIOCHEM BIOPH RES CO, V390, P608, DOI 10.1016/j.bbrc.2009.10.014; Wang JF, 2009, PROTEIN ENG DES SEL, V22, P349, DOI 10.1093/protein/gzp012; Wang JF, 2010, CHINESE SCI BULL, V55, P1877, DOI 10.1007/s11434-009-3697-z; Wang Y, 2010, J CHEM INF MODEL, V50, P875, DOI 10.1021/ci900458u; Wu ST, 2008, PROTEINS, V72, P547, DOI 10.1002/prot.21945; Wu ST, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-17; Wu ST, 2007, NUCLEIC ACIDS RES, V35, P3375, DOI 10.1093/nar/gkm251; Xu Y, 2000, PROTEINS, V40, P343, DOI 10.1002/1097-0134(20000815)40:3<343::AID-PROT10>3.0.CO;2-S; Zhou HY, 2005, PROTEINS, V58, P321, DOI 10.1002/prot.20308; Zhou HY, 2004, PROTEINS, V55, P1005, DOI 10.1002/prot.20007; Zhou HY, 2002, PROTEIN SCI, V11, P2714, DOI 10.1110/ps.0217002	64	46	46	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2012	7	1							e31048	10.1371/journal.pone.0031048	http://dx.doi.org/10.1371/journal.pone.0031048			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911FX	22292090	Green Published, gold, Green Submitted			2022-12-25	WOS:000301703800040
J	Oleinikov, AV; Voronkova, VV; Frye, IT; Amos, E; Morrison, R; Fried, M; Duffy, PE				Oleinikov, Andrew V.; Voronkova, Valentina V.; Frye, Isaac Tyler; Amos, Emily; Morrison, Robert; Fried, Michal; Duffy, Patrick E.			A Plasma Survey Using 38 PfEMP1 Domains Reveals Frequent Recognition of the Plasmodium falciparum Antigen VAR2CSA among Young Tanzanian Children	PLOS ONE			English	Article							ERYTHROCYTE-MEMBRANE PROTEIN-1; INTERCELLULAR-ADHESION MOLECULE-1; INFECTED ERYTHROCYTES; IMMUNOGLOBULIN-G; SEVERE MALARIA; VAR GENES; DIFFERENTIAL EXPRESSION; HUMAN PLACENTA; ANTIBODIES; CYTOADHERENCE	PfEMP1 proteins comprise a family of variant antigens that appear on the surface of P. falciparum-infected erythrocytes and bind to multiple host receptors. Using a mammalian expression system and BioPlex technology, we developed an array of 24 protein constructs representing 38 PfEMP1 domains for high throughput analyses of receptor binding as well as total and functional antibody responses. We analyzed the reactivity of 561 plasma samples from 378 young Tanzanian children followed up to maximum 192 weeks of life in a longitudinal birth cohort. Surprisingly, reactivity to the DBL5 domain of VAR2CSA, a pregnancy malaria vaccine candidate, was most common, and the prevalence of reactivity was stable throughout early childhood. Reactivity to all other PfEMP1 constructs increased with age. Antibodies to the DBL2 beta C2(PF11_0521) domain, measured as plasma reactivity or plasma inhibition of ICAM1 binding, predicted reduced risk of hospitalization for severe or moderately severe malaria. These data suggest a role for VAR2CSA in childhood malaria and implicate DBL2 beta C2(PF11_0521) in protective immunity.	[Oleinikov, Andrew V.; Voronkova, Valentina V.; Frye, Isaac Tyler; Amos, Emily; Morrison, Robert; Fried, Michal; Duffy, Patrick E.] Seattle Biomed Res Inst, Seattle, WA 98109 USA; [Fried, Michal; Duffy, Patrick E.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Fried, Michal; Duffy, Patrick E.] NIAID, Lab Malaria Immunol & Vaccinol, NIH, Rockville, MD USA	Center for Infectious Disease Research; University of Washington; University of Washington Seattle; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Oleinikov, AV (corresponding author), Seattle Biomed Res Inst, 4 Nickerson St, Seattle, WA 98109 USA.	andrew.oleinikov@seattlebiomed.org			National Institutes of Health [1R21AI064503, 1R01AI092120, RO1AI52059]; Foundation of the National Institutes of Health through the Grand Challenges in Global Health initiative [29202]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052059, ZIAAI001178, ZIAAI001056, R01AI092120, R21AI064503, ZIAAI001134] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation of the National Institutes of Health through the Grand Challenges in Global Health initiative; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was supported by National Institutes of Health (http://www.nih.gov) grants 1R21AI064503 and 1R01AI092120 to AVO, RO1AI52059 to PED, and funded in part by the Foundation of the National Institutes of Health through the Grand Challenges in Global Health initiative (http://www.grandchallenges.org/Pages/default.aspx) Grant No. 29202 to PED. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARNWELL JW, 1989, J CLIN INVEST, V84, P765, DOI 10.1172/JCI114234; Barragan A, 1999, BIOCHEM SOC T, V27, P487, DOI 10.1042/bst0270487; Beeson JG, 2007, AM J TROP MED HYG, V77, P22, DOI 10.4269/ajtmh.2007.77.22; BERENDT AR, 1989, NATURE, V341, P57, DOI 10.1038/341057a0; Bull PC, 2005, PLOS PATHOG, V1, P202, DOI 10.1371/journal.ppat.0010026; Cham GKK, 2009, J IMMUNOL, V183, P3356, DOI 10.4049/jimmunol.0901331; DAVID PH, 1988, AM J TROP MED HYG, V38, P289, DOI 10.4269/ajtmh.1988.38.289; Dondorp AM, 2008, TRANSFUS CLIN BIOL, V15, P56, DOI 10.1016/j.tracli.2008.04.013; Fried M, 1998, J IMMUNOL, V160, P2523; Fried M, 1996, SCIENCE, V272, P1502, DOI 10.1126/science.272.5267.1502; Fried M, 1998, NATURE, V395, P851, DOI 10.1038/27570; Fried M, 2007, MOL BIOCHEM PARASIT, V155, P57, DOI 10.1016/j.molbiopara.2007.05.010; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Greenwood B, 2002, NATURE, V415, P670, DOI 10.1038/415670a; Gupta S, 1999, NAT MED, V5, P340, DOI 10.1038/6560; HANDUNNETTI SM, 1989, AM J TROP MED HYG, V40, P115, DOI 10.4269/ajtmh.1989.40.115; Hogh B, 1996, SCAND J INFECT DIS, P9; Hviid L, 2010, HUMAN VACCINES, P6; Jensen ATR, 2004, J EXP MED, V199, P1179, DOI 10.1084/jem.20040274; Joergensen L, 2006, INFECT IMMUN, V74, P6778, DOI 10.1128/IAI.01187-06; Kaestli M, 2006, J INFECT DIS, V193, P1567, DOI 10.1086/503776; Kriek N, 2003, MOL MICROBIOL, V50, P1215, DOI 10.1046/j.1365-2958.2003.03784.x; Kurtis JD, 1999, INFECT IMMUN, V67, P3424, DOI 10.1128/IAI.67.7.3424-3429.1999; Kyriacou HM, 2006, MOL BIOCHEM PARASIT, V150, P211, DOI 10.1016/j.molbiopara.2006.08.005; Lavstsen T, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-27; Lusingu JPA, 2006, INFECT IMMUN, V74, P2867, DOI 10.1128/IAI.74.5.2867-2875.2006; Magistrado PA, 2007, INFECT IMMUN, V75, P2415, DOI 10.1128/IAI.00951-06; MARSH K, 1989, T ROY SOC TROP MED H, V83, P293, DOI 10.1016/0035-9203(89)90478-1; MILLER LH, 1994, SCIENCE, V264, P1878, DOI 10.1126/science.8009217; Mutabingwa TK, 2005, PLOS MED, V2, P1260, DOI 10.1371/journal.pmed.0020407; Ndam NGT, 2006, J INFECT DIS, V193, P713, DOI 10.1086/500146; Newbold C, 1997, AM J TROP MED HYG, V57, P389, DOI 10.4269/ajtmh.1997.57.389; Okiro EA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-4; Oleinikov AV, 2008, J INFECT DIS, V197, P1119, DOI 10.1086/529526; Oleinikov AV, 2007, J INFECT DIS, V196, P155, DOI 10.1086/518513; Oleinikov AV, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000386; Pasvol G, 2005, BRIT MED BULL, V75-76, P29, DOI 10.1093/bmb/ldh059; Rasti N, 2006, P NATL ACAD SCI USA, V103, P13795, DOI 10.1073/pnas.0601519103; Robinson BA, 2003, MOL MICROBIOL, V47, P1265, DOI 10.1046/j.1365-2958.2003.03378.x; Rottmann M, 2006, INFECT IMMUN, V74, P3904, DOI 10.1128/IAI.02073-05; Salanti A, 2004, J EXP MED, V200, P1197, DOI 10.1084/jem.20041579; SMITH JD, 1995, CELL, V82, P101, DOI 10.1016/0092-8674(95)90056-X; SU XZ, 1995, CELL, V82, P89, DOI 10.1016/0092-8674(95)90055-1; TURNER GDH, 1994, AM J PATHOL, V145, P1057; Warimwe GM, 2009, P NATL ACAD SCI USA, V106, P21801, DOI 10.1073/pnas.0907590106	45	32	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e31011	10.1371/journal.pone.0031011	http://dx.doi.org/10.1371/journal.pone.0031011			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910ME	22295123	gold, Green Published, Green Submitted			2022-12-25	WOS:000301640600068
J	Qin, C; Cao, Q; Li, P; Ju, XB; Wang, ML; Chen, JW; Wu, YL; Meng, XX; Zhu, J; Zhang, ZD; Lu, Q; Yin, CJ				Qin, Chao; Cao, Qiang; Li, Pu; Ju, Xiaobing; Wang, Meilin; Chen, Jiawei; Wu, Yilong; Meng, Xiaoxin; Zhu, Jian; Zhang, Zhengdong; Lu, Qiang; Yin, Changjun			Functional Promoter-31G > C Variant in Survivin Gene Is Associated with Risk and Progression of Renal Cell Cancer in a Chinese Population	PLOS ONE			English	Article							EXPRESSION; POLYMORPHISMS; CARCINOMA; BIOMARKERS	Background: Survivin is an inhibitor of apoptosis protein and is involved in the occurrence and progression of human malignancies. Recently, a functional polymorphism (-31G>C, rs9904341) in the promoter of survivin has been shown to influence its expression and confer susceptibility to different types of cancer. The present study was aimed to investigate whether the polymorphism also influences susceptibility and progression of renal cell cancer (RCC) in a Chinese population. Methods: We genotyped this polymorphism using the TaqMan assay in a case-control study comprised of 710 RCC patients and 760 controls. The logistic regression was used to assess the genetic association with occurrence and progression of RCC. Results: Compared with the genotypes containing G allele (GG and GC), we found a statistically significant increased occurrence of RCC associated with the CC genotype [P = 0.006, adjusted odds ratio (OR) = 1.38, 95% confidence interval (CI) = 1.08-1.76]. The polymorphism was associated with risk of developing advanced stage (OR = 2.02, 95% CI = 1.34-3.07) and moderately differentiated (OR = 1.75; 95% CI = 1.20-2.54) RCC. Furthermore, the patients carrying the CC genotype had a significantly greater prevalence of high clinical stage disease (P-trend = 0.003). Similar results were also observed when we restricted the analysis to clear cell RCC, a major histological type of RCC. Conclusions: Our results suggest that the functional -31G>C polymorphism in the promoter of survivin may influence the susceptibility and progression of RCC in the Chinese population. Large population-based prospective studies are required to validate our findings.	[Qin, Chao; Cao, Qiang; Li, Pu; Ju, Xiaobing; Chen, Jiawei; Wu, Yilong; Meng, Xiaoxin; Zhu, Jian; Lu, Qiang; Yin, Changjun] Nanjing Med Univ, Affiliated Hosp 1, Dept Urol, Nanjing, Jiangsu, Peoples R China; [Wang, Meilin; Zhang, Zhengdong] Nanjing Med Univ, Sch Publ Hlth, Dept Mol & Genet Toxicol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University	Qin, C (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Urol, Nanjing, Jiangsu, Peoples R China.	doctorlvqiang@sina.com; drcjyin@gmail.com	zhang, zheng/HCH-9684-2022; Cao, Qiang/K-2349-2019	Lu, Qiang/0000-0003-3589-2507	Innovative Research Team in the First Affiliated Hospital of Nanjing Medical University; Provincial Initiative Program for Excellency Disciplines, Jiangsu Province; Natural Science Foundation of Jiangsu Province [BK2008473]	Innovative Research Team in the First Affiliated Hospital of Nanjing Medical University; Provincial Initiative Program for Excellency Disciplines, Jiangsu Province; Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	The work was supported by the Program for Development of Innovative Research Team in the First Affiliated Hospital of Nanjing Medical University, Provincial Initiative Program for Excellency Disciplines, Jiangsu Province and the Natural Science Foundation of Jiangsu Province [BK2008473]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altieri DC, 2008, NAT REV CANCER, V8, P61, DOI 10.1038/nrc2293; Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917; Baytekin F, 2009, UROL ONCOL; Borbely AA, 2007, J CLIN PATHOL, V60, P303, DOI 10.1136/jcp.2006.037804; Chen WC, 2004, WORLD J GASTROENTERO, V10, P2886; Chow WH, 2010, NAT REV UROL, V7, P245, DOI 10.1038/nrurol.2010.46; Falleni M, 2003, J PATHOL, V200, P620, DOI 10.1002/path.1388; Fields AC, 2004, MODERN PATHOL, V17, P1378, DOI 10.1038/modpathol.3800203; Gossage L, 2010, NAT REV CLIN ONCOL, V7, P277, DOI 10.1038/nrclinonc.2010.42; Jang JS, 2008, LUNG CANCER, V60, P31, DOI 10.1016/j.lungcan.2007.09.008; Kawata N, 2011, INT J CANC; Kleinrath T, 2007, J CLIN ONCOL, V25, P845, DOI 10.1200/JCO.2006.07.8154; Kosari F, 2005, CLIN CANCER RES, V11, P5128, DOI 10.1158/1078-0432.CCR-05-0073; Lei Y, 2010, MOL CELL BIOCHEM, V344, P23, DOI 10.1007/s11010-010-0525-3; Li FZ, 2003, J CELL PHYSIOL, V197, P8, DOI 10.1002/jcp.10327; Lin J, 2010, CARCINOGENESIS, V31, P1805, DOI 10.1093/carcin/bgq168; Liu BB, 2011, WORLD J CLIN ONCOL, V2, P164, DOI 10.5306/wjco.v2.i3.164; Ljungberg B, 2011, EUR UROL; McGuire BB, 2009, CURR OPIN UROL, V19, P441, DOI 10.1097/MOU.0b013e32832f0c68; Melet A, 2008, ADV EXP MED BIOL, V615, P47, DOI 10.1007/978-1-4020-6554-5_4; Mityaev M, 2008, BIOCHEMISTRY-MOSCOW+, V73, P1183, DOI 10.1134/S0006297908110035; Nakamura E, 2002, CLIN CANCER RES, V8, P2620; Okamura K, 2009, CANCER EPIDEMIOL, V33, P137, DOI 10.1016/j.canep.2009.06.005; Purdue MP, 2011, NAT GENET, V43, P60, DOI 10.1038/ng.723; Qin C, 2011, ANN ONCOL; Reed JC, 2001, J CLIN INVEST, V108, P965, DOI 10.1172/JCI14123; Semenza JC, 2001, AM J EPIDEMIOL, V153, P851, DOI 10.1093/aje/153.9.851; Srivastava K, 2011, MOL BIOL REP; Wang WJ, 2006, J SURG ONCOL, V93, P578, DOI 10.1002/jso.20507; Wang YH, 2009, UROLOGY, V73, P670, DOI 10.1016/j.urology.2008.09.048; Wu X, 2011, HUM MOL GENET; Wu YH, 2008, ACTA BIOCHIM POL, V55, P673; Xu Y, 2004, DNA CELL BIOL, V23, P527, DOI 10.1089/dna.2004.23.527; Zamparese R, 2008, CANCER INVEST, V26, P929, DOI 10.1080/07357900802017553; Zhen HN, 2007, INT J ONCOL, V31, P1111	35	26	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e28829	10.1371/journal.pone.0028829	http://dx.doi.org/10.1371/journal.pone.0028829			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910ME	22295057	Green Submitted, Green Published, gold			2022-12-25	WOS:000301640600002
J	Chan, HS; Chang, SJ; Wang, TY; Ko, HJ; Lin, YC; Lin, KT; Chang, KM; Chuang, YJ				Chan, Hau-Shien; Chang, Shing-Jyh; Wang, Tao-Yeuan; Ko, Hung-Ju; Lin, Yu-Chih; Lin, Kuan-Ting; Chang, Kuo-Ming; Chuang, Yung-Jen			Serine Protease PRSS23 Is Upregulated by Estrogen Receptor alpha and Associated with Proliferation of Breast Cancer Cells	PLOS ONE			English	Article							SIGNALING PATHWAYS; GENE-EXPRESSION; CATHEPSIN-D; ER-ALPHA; ACTIVATION; GROWTH; BETA; TRANSACTIVATION; LOCALIZATION; PROGRESSION	Serine protease PRSS23 is a newly discovered protein that has been associated with tumor progression in various types of cancers. Interestingly, PRSS23 is coexpressed with estrogen receptor alpha (ER alpha), which is a prominent biomarker and therapeutic target for human breast cancer. Estrogen signaling through ER alpha is also known to affect cell proliferation, apoptosis, and survival, which promotes tumorigenesis by regulating the production of numerous downstream effector proteins. In the present study, we aimed to clarify the correlation between and functional implication of ER alpha and PRSS23 in breast cancer. Analysis of published breast cancer microarray datasets revealed that the gene expression correlation between ER alpha and PRSS23 is highly significant among all ER alpha-associated proteases in breast cancer. We then assessed PRSS23 expression in 56 primary breast cancer biopsies and 8 cancer cell lines. The results further confirmed the coexpression of PRSS23 and ER alpha and provided clinicopathological significance. In vitro assays in MCF-7 breast cancer cells demonstrated that PRSS23 expression is induced by 17 beta-estradiol-activated ER alpha through an interaction with an upstream promoter region of PRSS23 gene. In addition, PRSS23 knockdown may suppress estrogen-driven cell proliferation of MCF-7 cells. Our findings imply that PRSS23 might be a critical component of estrogen-mediated cell proliferation of ER alpha-positive breast cancer cells. In conclusion, the present study highlights the potential for PRSS23 to be a novel therapeutic target in breast cancer research.	[Chan, Hau-Shien; Ko, Hung-Ju; Lin, Yu-Chih; Chuang, Yung-Jen] Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Dept Med Sci, Hsinchu, Taiwan; [Chang, Shing-Jyh] Natl Tsing Hua Univ, Inst Mol & Cellular Biol, Hsinchu, Taiwan; [Chang, Shing-Jyh] Hsinchu Mackay Mem Hosp, Dept Obstet & Gynecol, Hsinchu, Taiwan; [Wang, Tao-Yeuan] Mackay Mem Hosp, Dept Pathol, Taipei, Taiwan; [Wang, Tao-Yeuan] Mackay Med Coll, Taipei, Taiwan; [Wang, Tao-Yeuan] Mackay Med Nursing & Management Coll, Taipei, Taiwan; [Lin, Kuan-Ting] Natl Tsing Hua Univ, Dept Life Sci, Hsinchu, Taiwan; [Chang, Kuo-Ming] Hsinchu Mackay Mem Hosp, Dept Pathol, Hsinchu, Taiwan	National Tsing Hua University; National Tsing Hua University; Mackay Memorial Hospital; Mackay Memorial Hospital; Mackay Medical College; Mackay Junior College of Medicine, Nursing & Management; National Tsing Hua University; Mackay Memorial Hospital	Chan, HS (corresponding author), Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Dept Med Sci, Hsinchu, Taiwan.	yjchuang@life.nthu.edu.tw	Chuang, Yung-Jen/D-2362-2013	Chuang, Yung-Jen/0000-0002-6022-0107	National Science Council of Taiwan [95-2752-B-007-002-PAE]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by the Program for Promoting Academic Excellence of Universities (grant number 95-2752-B-007-002-PAE), National Science Council of Taiwan. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allred DC, 1998, MODERN PATHOL, V11, P155; Berchem G, 2002, ONCOGENE, V21, P5951, DOI 10.1038/sj.onc.1205745; BLOOM HJG, 1957, BRIT J CANCER, V11, P359, DOI 10.1038/bjc.1957.43; Chang CY, 1999, MOL CELL BIOL, V19, P8226; Chen LM, 2001, J BIOL CHEM, V276, P21434, DOI 10.1074/jbc.M011423200; Cho SD, 2010, MOL PHARMACOL, V77, P396, DOI 10.1124/mol.109.061143; Coser KR, 2003, P NATL ACAD SCI USA, V100, P13994, DOI 10.1073/pnas.2235866100; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Ellis CM, 2005, J CLIN PATHOL, V58, P710, DOI 10.1136/jcp.2004.023424; Eng FCS, 1997, MOL CELL BIOL, V17, P4644, DOI 10.1128/MCB.17.8.4644; Fan MY, 2004, MOL ENDOCRINOL, V18, P2603, DOI 10.1210/me.2004-0164; Fritz WA, 2002, MOL CELL ENDOCRINOL, V186, P89, DOI 10.1016/S0303-7207(01)00663-3; Fujita N, 2003, CELL, V113, P207, DOI 10.1016/S0092-8674(03)00234-4; Grisouard J, 2007, MOL ENDOCRINOL, V21, P2427, DOI 10.1210/me.2007-0129; Hall JM, 2001, J BIOL CHEM, V276, P36869, DOI 10.1074/jbc.R100029200; Heldring N, 2007, PHYSIOL REV, V87, P905, DOI 10.1152/physrev.00026.2006; Ifon ET, 2005, CANCER CELL INT, V5, DOI 10.1186/1475-2867-5-19; Jarzab B, 2005, CANCER RES, V65, P1587, DOI 10.1158/0008-5472.CAN-04-3078; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Katzenellenbogen BS, 1996, BIOL REPROD, V54, P287, DOI 10.1095/biolreprod54.2.287; Kazi AA, 2007, ENDOCRINOLOGY, V148, P2363, DOI 10.1210/en.2006-1394; Khaleque MA, 2007, HEAT SHOCK FACTOR 1; KING WJ, 1984, NATURE, V307, P745, DOI 10.1038/307745a0; KRISHNAN V, 1994, J BIOL CHEM, V269, P15912; Kuiper GGJM, 1997, ENDOCRINOLOGY, V138, P863, DOI 10.1210/en.138.3.863; Latil A, 2001, CANCER RES, V61, P1919; Lecomte J, 2008, BREAST CANCER RES TR, V112, P437, DOI 10.1007/s10549-007-9886-z; Li SJ, 2010, J HISTOCHEM CYTOCHEM, V58, P509, DOI 10.1369/jhc.2009.954644; Lippman Marc E, 2008, Trans Am Clin Climatol Assoc, V119, P77; Lonard DM, 2000, MOL CELL, V5, P939, DOI 10.1016/S1097-2765(00)80259-2; Matthews Jason, 2003, Mol Interv, V3, P281, DOI 10.1124/mi.3.5.281; Miyakoshi K, 2006, BIOL REPROD, V75, P823, DOI 10.1095/biolreprod.106.052290; Moggs JG, 2005, J MOL ENDOCRINOL, V34, P535, DOI 10.1677/jme.1.01677; Onn I, 2007, EMBO J, V26, P1024, DOI 10.1038/sj.emboj.7601562; Pentecost BT, 2005, MOL CELL ENDOCRINOL, V238, P9, DOI 10.1016/j.mce.2005.04.005; Rich RL, 2002, P NATL ACAD SCI USA, V99, P8562, DOI 10.1073/pnas.142288199; Safe S, 2008, J MOL ENDOCRINOL, V41, P263, DOI 10.1677/JME-08-0103; Schulltz-Norton JR, 2011, TRENDS ENDOCRIN MET, V22, P124, DOI 10.1016/j.tem.2010.11.005; Simpson JC, 2000, EMBO REP, V1, P287, DOI 10.1093/embo-reports/kvd058; Sommer S, 2001, SEMIN CANCER BIOL, V11, P339, DOI 10.1006/scbi.2001.0389; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; TANDON AK, 1990, NEW ENGL J MED, V322, P297, DOI 10.1056/NEJM199002013220504; Toillon RA, 2007, INT J RADIAT ONCOL, V67, P1187, DOI 10.1016/j.ijrobp.2006.11.040; TSAI MJ, 1994, ANNU REV BIOCHEM, V63, P451, DOI 10.1146/annurev.biochem.63.1.451; Tsunoda N, 2009, CANCER SCI, V100, P111, DOI 10.1111/j.1349-7006.2008.01007.x; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wahlberg P, 2008, ENDOCRINOLOGY, V149, P5070, DOI 10.1210/en.2007-1736; Wood JL, 2008, J BIOL CHEM, V283, P29586, DOI 10.1074/jbc.M804080200	49	28	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30397	10.1371/journal.pone.0030397	http://dx.doi.org/10.1371/journal.pone.0030397			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22291950	Green Published, gold, Green Submitted			2022-12-25	WOS:000301570600040
J	Ulrich, DL; Lynch, J; Wang, Y; Fukuda, Y; Nachagari, D; Du, GQ; Sun, DX; Fan, YP; Tsurkan, L; Potter, PM; Rehg, JE; Schuetz, JD				Ulrich, Dagny L.; Lynch, John; Wang, Yao; Fukuda, Yu; Nachagari, Deepa; Du, Guoqing; Sun, Daxi; Fan, Yiping; Tsurkan, Lyudmila; Potter, Philip M.; Rehg, Jerold E.; Schuetz, John D.			ATP-dependent Mitochondrial Porphyrin Importer ABCB6 Protects against Phenylhydrazine Toxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING CASSETTE TRANSPORTER; KRUPPEL-LIKE FACTOR; HEME OXYGENASE-1; ERYTHROPOIETIC PROTOPORPHYRIA; PROMOTER REGION; CELL-SURVIVAL; FERROCHELATASE; MICE; IDENTIFICATION; MITOFERRIN-1	Abcb6 is a mammalian mitochondrial ATP-binding cassette (ABC) transporter that regulates de novo porphyrin synthesis. In previous studies, haploinsufficient (Abcb6(+/-)) embryonic stem cells showed impaired porphyrin synthesis. Unexpectedly, Abcb6(-/-) mice derived from these stem cells appeared phenotypically normal. We hypothesized that other ATP-dependent and/or -independent mechanisms conserve porphyrins. Here, we demonstrate that Abcb6(-/-) mice lack mitochondrial ATP-driven import of coproporphyrin III. Gene expression analysis revealed that loss of Abcb6 results in up-regulation of compensatory porphyrin and iron pathways, associated with elevated protoporphyrin IX (PPIX). Phenylhydrazine-induced stress caused higher mortality in Abcb6(-/-) mice, possibly because of sustained elevation of PPIX and an inability to convert PPIX to heme despite elevated ferrochelatase levels. Therefore, Abcb6 is the sole ATP-dependent porphyrin importer, and loss of Abcb6 produces up-regulation of heme and iron pathways necessary for normal development. However, under extreme demand for porphyrins (e.g. phenylhydrazine stress), these adaptations appear inadequate, which suggests that under these conditions Abcb6 is important for optimal survival.	[Ulrich, Dagny L.; Lynch, John; Wang, Yao; Fukuda, Yu; Nachagari, Deepa; Du, Guoqing; Sun, Daxi; Schuetz, John D.] St Jude Childrens Res Hosp, Dept Pharmaceut Sci, Memphis, TN 38105 USA; [Fan, Yiping] St Jude Childrens Res Hosp, Dept Res Informat, Memphis, TN 38105 USA; [Tsurkan, Lyudmila; Potter, Philip M.] St Jude Childrens Res Hosp, Dept Chem Biol & Therapeut, Memphis, TN 38105 USA; [Rehg, Jerold E.] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA	St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital	Schuetz, JD (corresponding author), St Jude Childrens Res Hosp, Dept Pharmaceut Sci, MS 313,262 Danny Thomas Pl, Memphis, TN 38105 USA.	John.Schuetz@stjude.org	Fukuda, Yu/GLT-1434-2022; Rehg, Jerold E/N-8111-2018; Potter, Philip/J-4515-2013	Potter, Philip/0000-0001-8922-8535; Fukuda, Yu/0000-0001-6182-540X	National Institutes of Health [ES058571, P30 CA21745, CA21865]; American Lebanese Syrian Associated Charities	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC))	This work was supported, in whole or in part, by National Institutes of Health Grants ES058571, P30 CA21745, and CA21865. This work was also supported by American Lebanese Syrian Associated Charities.	Azuma M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003070; BIEKER JJ, 1995, MOL CELL BIOL, V15, P852; Camaschella C, 2007, BLOOD, V110, P1353, DOI 10.1182/blood-2007-02-072520; Chen GG, 2004, J CELL BIOCHEM, V92, P1246, DOI 10.1002/jcb.20157; Chen W, 2010, BLOOD, V116, P628, DOI 10.1182/blood-2009-12-259614; Chen W, 2009, P NATL ACAD SCI USA, V106, P16263, DOI 10.1073/pnas.0904519106; Cooperman SS, 2005, BLOOD, V106, P1084, DOI 10.1182/blood-2004-12-4703; Crooks DR, 2010, BLOOD, V115, P860, DOI 10.1182/blood-2009-09-243105; Drissen R, 2005, MOL CELL BIOL, V25, P5205, DOI 10.1128/MCB.25.12.5205-5214.2005; Emadi-Konjin HP, 2002, BBA-GENE STRUCT EXPR, V1574, P117, DOI 10.1016/S0167-4781(01)00340-2; FENG WC, 1994, J BIOL CHEM, V269, P1493; FRAMPTON J, 1990, MOL CELL BIOL, V10, P3838, DOI 10.1128/MCB.10.7.3838; Goerz G, 1996, BRIT J DERMATOL, V134, P880; Hyde B. B., 2012, CELL DEATH DIFFER, V19, P1; Jonker JW, 2002, P NATL ACAD SCI USA, V99, P15649, DOI 10.1073/pnas.202607599; Kabe Y, 2006, J BIOL CHEM, V281, P31729, DOI 10.1074/jbc.M604729200; KOLLER ME, 1980, BIOCHEM J, V188, P329, DOI 10.1042/bj1880329; Kramer MF, 2000, GENE, V247, P153, DOI 10.1016/S0378-1119(00)00103-7; Krishnamurthy P, 2004, J BIOL CHEM, V279, P24218, DOI 10.1074/jbc.M313599200; Krishnamurthy P, 2006, ANNU REV PHARMACOL, V46, P381, DOI 10.1146/annurev.pharmtox.46.120604.141238; Krishnamurthy PC, 2006, NATURE, V443, P586, DOI 10.1038/nature05125; Labbe RF, 1999, CLIN CHEM, V45, P2060; LAVROVSKY Y, 1994, P NATL ACAD SCI USA, V91, P5987, DOI 10.1073/pnas.91.13.5987; Li F M, 1987, Biomed Chromatogr, V2, P164, DOI 10.1002/bmc.1130020408; Liu ZM, 2004, ONCOGENE, V23, P503, DOI 10.1038/sj.onc.1207173; Lynch J, 2009, CANCER RES, V69, P5560, DOI 10.1158/0008-5472.CAN-09-0078; Magness ST, 2002, BLOOD, V100, P1470, DOI 10.1182/blood-2001-12-0283; Medlock AE, 2000, BIOCHEMISTRY-US, V39, P7461, DOI 10.1021/bi000134p; Nilsson R, 2009, CELL METAB, V10, P119, DOI 10.1016/j.cmet.2009.06.012; O'Callaghan KM, 2010, J BIOL CHEM, V285, P381, DOI 10.1074/jbc.M109.063248; Pilon AM, 2011, BLOOD, V118, pE139, DOI 10.1182/blood-2011-05-355107; Pondarre C, 2006, HUM MOL GENET, V15, P953, DOI 10.1093/hmg/ddl012; Rajagopal A, 2008, NATURE, V453, P1127, DOI 10.1038/nature06934; Rampon C, 2009, FASEB J, V23, P4181, DOI 10.1096/fj.09-129262; Rebeiz N, 1996, ARCH BIOCHEM BIOPHYS, V333, P475, DOI 10.1006/abbi.1996.0417; Rettmer RL, 1999, PEDIATRICS, V104, DOI 10.1542/peds.104.3.e37; Socolovsky M, 2001, BLOOD, V98, P3261, DOI 10.1182/blood.V98.12.3261; Thomas-Chollier M, 2008, NUCLEIC ACIDS RES, V36, pW119, DOI 10.1093/nar/gkn304; TUGORES A, 1994, J BIOL CHEM, V269, P30789; Vanhee C, 2011, PLANT CELL, V23, P785, DOI 10.1105/tpc.110.081570; Wendler G, 2003, BIOCHEM BIOPH RES CO, V311, P847, DOI 10.1016/j.bbrc.2003.10.070; Wingert RA, 2005, NATURE, V436, P1035, DOI 10.1038/nature03887; Winzerling JJ, 2001, J PEDIATR-US, V139, P134, DOI 10.1067/mpd.2001.115574; Zhang J, 2003, BLOOD, V102, P3938, DOI 10.1182/blood-2003-05-1479	44	47	49	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					12679	12690		10.1074/jbc.M111.336180	http://dx.doi.org/10.1074/jbc.M111.336180			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22294697	hybrid, Green Published			2022-12-25	WOS:000302903700008
J	Hur, JY; Teranishi, Y; Kihara, T; Yamamoto, NG; Inoue, M; Hosia, W; Hashimoto, M; Winblad, B; Frykman, S; Tjernberg, LO				Hur, Ji-Yeun; Teranishi, Yasuhiro; Kihara, Takahiro; Yamamoto, Natsuko Goto; Inoue, Mitsuhiro; Hosia, Waltteri; Hashimoto, Masakazu; Winblad, Bengt; Frykman, Susanne; Tjernberg, Lars O.			Identification of Novel gamma-Secretase-associated Proteins in Detergent-resistant Membranes from Brain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; ATP SYNTHASE COMPLEX; LIPID RAFT PROTEINS; ALZHEIMERS-DISEASE; A-BETA; VESICULAR TRAFFICKING; ENRICHED MICRODOMAINS; PRESENILIN MUTATIONS; CELL-MEMBRANES; TALKING POINT	In Alzheimer disease, oligomeric amyloid beta-peptide (A beta) species lead to synapse loss and neuronal death. gamma-Secretase, the transmembrane protease complex that mediates the final catalytic step that liberates A beta from its precursor protein (APP), has a multitude of substrates, and therapeutics aimed at reducing A beta production should ideally be specific for APP cleavage. It has been shown that APP can be processed in lipid rafts, and gamma-secretase-associated proteins can affect A beta production. Here, we use a biotinylated inhibitor for affinity purification of gamma-secretase and associated proteins and mass spectrometry for identification of the purified proteins, and we identify novel gamma-secretase-associated proteins in detergent-resistant membranes from brain. Furthermore, we show by small interfering RNA-mediated knockdown of gene expression that a subset of the gamma-secretase-associated proteins, in particular voltage-dependent anion channel 1 (VDAC1) and contactin-associated protein 1 (CNTNAP1), reduced A beta production (A beta 40 and A beta 42) by around 70%, whereas knockdown of presenilin 1, one of the essential gamma-secretase complex components, reduced A beta production by 50%. Importantly, these proteins had a less pronounced effect on Notch processing. We conclude that VDAC1 and CNTNAP1 associate with gamma-secretase in detergent-resistant membranes and affect APP processing and suggest that molecules that interfere with	[Hur, Ji-Yeun; Teranishi, Yasuhiro; Kihara, Takahiro; Yamamoto, Natsuko Goto; Inoue, Mitsuhiro; Hosia, Waltteri; Hashimoto, Masakazu; Winblad, Bengt; Frykman, Susanne; Tjernberg, Lars O.] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Kl Alzheimer Dis Res Ctr, Dainippon Sumitomo Pharma Alzheimer Ctr, SE-14157 Huddinge, Sweden	Karolinska Institutet	Hur, JY (corresponding author), Blickagangen 6D, S-14157 Huddinge, Sweden.	hurj@mskcc.org		Hur, Ji Yeun/0000-0002-9895-3090	Gamla Tjanarinnor; Knut and Alice Wallenberg Foundation; Dainippon Sumitomo Pharma	Gamla Tjanarinnor; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Dainippon Sumitomo Pharma(Dainippon Sumitomo Pharma Co., Ltd.)	This work was supported by Gamla Tjanarinnor (to J.-Y.H.), Knut and Alice Wallenberg Foundation, and Dainippon Sumitomo Pharma.	Abad-Rodriguez J, 2004, J CELL BIOL, V167, P953, DOI 10.1083/jcb.200404149; Adam RM, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-30; Aoki M, 2008, NEUROREPORT, V19, P1085, DOI 10.1097/WNR.0b013e328302c858; Bae TJ, 2004, PROTEOMICS, V4, P3536, DOI 10.1002/pmic.200400952; Bai Y, 2008, MOL CELL PROTEOMICS, V7, P15, DOI 10.1074/mcp.M700077-MCP200; Berntenis N., 2007, World Intellectual Property Organization Patent, Patent No. [WO/2007/140971, 2007140971]; Bhat MA, 2001, NEURON, V30, P369, DOI 10.1016/S0896-6273(01)00294-X; Blonder J, 2005, J PROTEOME RES, V4, P523, DOI 10.1021/pr049790s; Blum R, 1996, J BIOL CHEM, V271, P17183, DOI 10.1074/jbc.271.29.17183; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Browman DT, 2006, J CELL SCI, V119, P3149, DOI 10.1242/jcs.03060; Buckholtz NS, 2011, NATURE, V475, pS8, DOI 10.1038/475S8a; Chen FS, 2006, NATURE, V440, P1208, DOI 10.1038/nature04667; Compton AG, 2008, AM J HUM GENET, V83, P714, DOI 10.1016/j.ajhg.2008.10.022; De Strooper B, 2007, EMBO REP, V8, P141, DOI 10.1038/sj.embor.7400897; Devanathan V, 2010, J NEUROSCI, V30, P9292, DOI 10.1523/JNEUROSCI.5657-09.2010; Dickerson BC, 2011, NEUROLOGY, V76, P1395, DOI 10.1212/WNL.0b013e3182166e96; Edbauer D, 2003, NAT CELL BIOL, V5, P486, DOI 10.1038/ncb960; Ehehalt R, 2003, J CELL BIOL, V160, P113, DOI 10.1083/jcb.200207113; Farmery MR, 2003, J BIOL CHEM, V278, P24277, DOI 10.1074/jbc.M211992200; Ferrer I, 2009, J BIOENERG BIOMEMBR, V41, P425, DOI 10.1007/s10863-009-9243-5; Foster LJ, 2003, P NATL ACAD SCI USA, V100, P5813, DOI 10.1073/pnas.0631608100; Gollan L, 2003, J CELL BIOL, V163, P1213, DOI 10.1083/jcb.200309147; Hansson CA, 2004, J BIOL CHEM, V279, P51654, DOI 10.1074/jbc.M404500200; Hattori C, 2006, J NEUROSCI RES, V84, P912, DOI 10.1002/jnr.20981; He G, 2010, NATURE, V467, P95, DOI 10.1038/nature09325; Hur JY, 2008, FEBS J, V275, P1174, DOI 10.1111/j.1742-4658.2008.06278.x; Imbimbo BP, 2011, EXPERT OPIN INV DRUG, V20, P325, DOI 10.1517/13543784.2011.550572; Jan A, 2008, J BIOL CHEM, V283, P28176, DOI 10.1074/jbc.M803159200; JARRETT JT, 1993, BIOCHEMISTRY-US, V32, P4693, DOI 10.1021/bi00069a001; Jenne N, 2002, J BIOL CHEM, V277, P46504, DOI 10.1074/jbc.M206989200; Kim KB, 2006, PROTEOMICS, V6, P2444, DOI 10.1002/pmic.200500574; Kimberly WT, 2003, J NEUROSCI RES, V74, P353, DOI 10.1002/jnr.10736; Lee K. H., 2006, World Intellectual Property Organization Patent, Patent No. [WO/2006/110621, 2006110621]; Lee SJ, 1998, NAT MED, V4, P730, DOI 10.1038/nm0698-730; Li N, 2004, PROTEOMICS, V4, P3156, DOI 10.1002/pmic.200400832; Li N, 2003, PROTEOMICS, V3, P536, DOI 10.1002/pmic.200390067; Luider T. M., 2008, World Intellectual Property Organization Patent, Patent No. [WO/2008/085035, 2008085035]; Man P, 2005, PROTEOMICS, V5, P113, DOI 10.1002/pmic.200400887; Martosella J, 2006, J PROTEOME RES, V5, P1301, DOI 10.1021/pr060051g; Matsuda S, 2008, J NEUROSCI, V28, P8668, DOI 10.1523/JNEUROSCI.2094-08.2008; Pardossi-Piquard R, 2009, J BIOL CHEM, V284, P28634, DOI 10.1074/jbc.M109.059345; Pavlov PF, 2009, J CELL MOL MED, V13, P4137, DOI 10.1111/j.1582-4934.2009.00892.x; Peles E, 1997, EMBO J, V16, P978, DOI 10.1093/emboj/16.5.978; Perreau VM, 2010, PROTEOMICS, V10, P2377, DOI 10.1002/pmic.200900773; Raimondo F, 2005, EXPERT REV PROTEOMIC, V2, P793, DOI 10.1586/14789450.2.5.793; Ramirez CM, 2009, MOL CELL NEUROSCI, V42, P172, DOI 10.1016/j.mcn.2009.07.001; Rees R. C., 2009, World Intellectual Property Organization Patent, Patent No. [WO/2009/156747, 2009156747]; Rios JC, 2000, J NEUROSCI, V20, P8354, DOI 10.1523/JNEUROSCI.20-22-08354.2000; Rogaeva E, 2007, NAT GENET, V39, P168, DOI 10.1038/ng1943; Schuck S, 2003, P NATL ACAD SCI USA, V100, P5795, DOI 10.1073/pnas.0631579100; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Selkoe DJ, 2001, P NATL ACAD SCI USA, V98, P11039, DOI 10.1073/pnas.211352598; Siemers ER, 2006, NEUROLOGY, V66, P602, DOI 10.1212/01.WNL.0000198762.41312.E1; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Smith SKF, 2000, MOL BRAIN RES, V78, P100, DOI 10.1016/S0169-328X(00)00079-6; Sultana R, 2006, NEUROBIOL DIS, V22, P76, DOI 10.1016/j.nbd.2005.10.004; Teranishi Y, 2010, J CELL MOL MED, V14, P2675, DOI 10.1111/j.1582-4934.2009.00907.x; Urano Y, 2005, J LIPID RES, V46, P904, DOI 10.1194/jlr.M400333-JLR200; Vetrivel KS, 2005, J BIOL CHEM, V280, P25892, DOI 10.1074/jbc.M503570200; Vetrivel KS, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-4; Wahrle S, 2002, NEUROBIOL DIS, V9, P11, DOI 10.1006/nbdi.2001.0470; Wakabayashi T, 2009, NAT CELL BIOL, V11, P1340, DOI 10.1038/ncb1978; Welander H, 2009, J NEUROCHEM, V110, P697, DOI 10.1111/j.1471-4159.2009.06170.x; Williamson R, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-120; Winkler E, 2009, BIOCHEMISTRY-US, V48, P1183, DOI 10.1021/bi801204g; Wolfe MS, 2007, EMBO REP, V8, P136, DOI 10.1038/sj.embor.7400896; Zhou SX, 2005, P NATL ACAD SCI USA, V102, P7499, DOI 10.1073/pnas.0502768102	68	43	44	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					11991	12005		10.1074/jbc.M111.246074	http://dx.doi.org/10.1074/jbc.M111.246074			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22315232	Green Published, hybrid			2022-12-25	WOS:000302782200037
J	Lo, D; Dai, MS; Sun, XX; Zeng, SX; Lu, H				Lo, Dorothy; Dai, Mu-Shui; Sun, Xiao-Xin; Zeng, Shelya X.; Lu, Hua			Ubiquitin- and MDM2 E3 Ligase-independent Proteasomal Turnover of Nucleostemin in Response to GTP Depletion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYCOPHENOLIC-ACID; ACTIVATES P53; INHIBITION; PROMOTES; UBIQUITYLATION; PROLIFERATION; DEGRADATION; NUCLEOLUS; PROTEINS; CELLS	Nucleostemin (NS) is a nucleolar GTP-binding protein essential for ribosomal biogenesis, proliferation, and animal embryogenesis. It remains largely unclear how this protein is regulated. While working on its role in suppression of MDM2 and activation of p53, we observed that NS protein (but not mRNA) levels decreased drastically in response to GTP depletion. When trying to further elucidate the molecular mechanism(s) underlying this unusual phenomenon, we found that NS was degraded independently of ubiquitin and MDM2 upon GTP depletion. First, depletion of GTP by treating cells with mycophenolic acid decreased the level of NS without apparently affecting the levels of other nucleolar proteins. Second, mutant NS defective in GTP binding and exported to the nucleoplasm was much less stable than wild-type NS. Although NS was ubiquitinated in cells, its polyubiquitination was independent of Lys-48 or Lys-63 in the ubiquitin molecule. Inactivation of E1 in E1 temperature-sensitive mouse embryonic fibroblast (MEF) cells failed to prevent the proteasomal degradation of NS. The proteasomal turnover of NS was also MDM2-independent, as its half-life in p53/MDM2 double knock-out MEF cells was the same as that in wild-type MEF cells. Moreover, NS ubiquitination was MDM2-independent. Mycophenolic acid or doxorubicin induced NS degradation in various human cancerous cells regardless of the status of MDM2. Hence, these results indicate that NS undergoes a ubiquitin-and MDM2-independent proteasomal degradation when intracellular GTP levels are markedly reduced and also suggest that ubiquitination of NS may be involved in regulation of its function rather than stability.	[Lo, Dorothy; Zeng, Shelya X.; Lu, Hua] Tulane Univ, Sch Med, Dept Biochem & Mol Biol, New Orleans, LA 70112 USA; [Lo, Dorothy; Zeng, Shelya X.; Lu, Hua] Tulane Univ, Sch Med, Tulane Canc Ctr, New Orleans, LA 70112 USA; [Dai, Mu-Shui; Sun, Xiao-Xin] Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97239 USA	Tulane University; Tulane University; Oregon Health & Science University	Lu, H (corresponding author), Tulane Univ, Sch Med, Dept Biochem & Mol Biol, 1430 Tulane Ave, New Orleans, LA 70112 USA.	hlu2@tulane.edu			National Institutes of Health from NCI [CA095441, CA079721, CA129828]; NATIONAL CANCER INSTITUTE [R01CA129828, R01CA079721, R01CA095441] Funding Source: NIH RePORTER	National Institutes of Health from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA095441, CA079721, and CA129828 from NCI (to H. L.).	Beekman C, 2006, MOL CELL BIOL, V26, P9291, DOI 10.1128/MCB.01183-06; Boulon S, 2010, MOL CELL, V40, P216, DOI 10.1016/j.molcel.2010.09.024; CHOWDARY DR, 1994, MOL CELL BIOL, V14, P1997, DOI 10.1128/MCB.14.3.1997; Dai MS, 2004, MOL CELL BIOL, V24, P7654, DOI 10.1128/MCB.24.17.7654-7668.2004; Dai MS, 2008, MOL CELL BIOL, V28, P4365, DOI 10.1128/MCB.01662-07; Haglund K, 2005, EMBO J, V24, P3353, DOI 10.1038/sj.emboj.7600808; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Huang M, 2008, LEUKEMIA RES, V32, P131, DOI 10.1016/j.leukres.2007.03.025; Huang M, 2009, CANCER RES, V69, P3004, DOI 10.1158/0008-5472.CAN-08-3413; Jin YT, 2003, EMBO J, V22, P6365, DOI 10.1093/emboj/cdg600; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Lo D, 2010, CELL CYCLE, V9, P3227, DOI 10.4161/cc.9.16.12605; LOWE JK, 1977, CANCER RES, V37, P736; Meng LJ, 2007, MOL CELL BIOL, V27, P8670, DOI 10.1128/MCB.00635-07; Meng LJ, 2006, J CELL SCI, V119, P5124, DOI 10.1242/jcs.03292; Meng LJ, 2008, J CELL SCI, V121, P4037, DOI 10.1242/jcs.037952; Raver-Shapira N, 2007, MOL CELL, V26, P731, DOI 10.1016/j.molcel.2007.05.017; Romanova L, 2009, J BIOL CHEM, V284, P4968, DOI 10.1074/jbc.M804594200; Salghetti SE, 1999, EMBO J, V18, P717, DOI 10.1093/emboj/18.3.717; Siddiqi S, 2008, CIRC RES, V103, P89, DOI 10.1161/CIRCRESAHA.107.169334; Stewart DP, 2010, MOL CELL BIOL, V30, P3099, DOI 10.1128/MCB.01266-09; Sun XX, 2008, J BIOL CHEM, V283, P12387, DOI 10.1074/jbc.M801387200; Tsai RYL, 2002, GENE DEV, V16, P2991, DOI 10.1101/gad.55671; Tsai RYL, 2005, J CELL BIOL, V168, P179, DOI 10.1083/jcb.200409053; Yang WL, 2010, ONCOGENE, V29, P4493, DOI 10.1038/onc.2010.190; Zwolinska AK, 2012, ONCOGENE, V31, P3311, DOI 10.1038/onc.2011.507	28	16	17	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					10013	10020		10.1074/jbc.M111.335141	http://dx.doi.org/10.1074/jbc.M111.335141			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22318725	Green Published, hybrid			2022-12-25	WOS:000302167200033
J	Mor-Cohen, R; Rosenberg, N; Einav, Y; Zelzion, E; Landau, M; Mansour, W; Averbukh, Y; Seligsohn, U				Mor-Cohen, Ronit; Rosenberg, Nurit; Einav, Yulia; Zelzion, Ehud; Landau, Meytal; Mansour, Wissam; Averbukh, Yulia; Seligsohn, Uri			Unique Disulfide Bonds in Epidermal Growth Factor (EGF) Domains of beta 3 Affect Structure and Function of alpha IIb beta 3 and alpha v beta 3 Integrins in Different Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLANZMANN THROMBASTHENIA; AFFINITY MODULATION; MOLECULAR-DYNAMICS; BETA(3) SUBUNIT; BINDING SITE; OUTSIDE-IN; ACTIVATION; ALPHA(V)BETA(3); LIGAND; ALPHA(IIB)BETA(3)	The beta 3 subunit of alpha IIb beta 3 and alpha v beta 3 integrins contains four epidermal growth factor (EGF)-like domains. Each domain harbors four disulfide bonds of which one is unique for integrins. We previously discerned a regulatory role of the EGF-4 Cys-560-Cys-583 unique bond for alpha IIb beta 3 activation. In this study we further investigated the role of all four integrin unique bonds in both alpha IIb beta 3 and alpha v beta 3. We created beta 3 mutants harboring serine substitutions of each or both cysteines that disrupt the four unique bonds (Cys-437-Cys-457 in EGF-1, Cys-473-Cys-503 in EGF-2, Cys-523-Cys-544 in EGF-3, and Cys-560-Cys-583 in EGF-4) and transfected them into baby hamster kidney cells together with normal alpha v or alpha IIb. Flow cytometry was used to measure surface expression of alpha IIb beta 3 and alpha v beta 3 and their activity state by soluble fibrinogen binding. Most cysteine substitutions caused similarly reduced surface expression of both receptors. Disrupting all four unique disulfide bonds by single cysteine substitutions resulted in variable constitutive activation of alpha IIb beta 3 and alpha v beta 3. In contrast, whereas double C437S/C457S and C473S/C503S mutations yielded constitutively active alpha IIb beta 3 and alpha v beta 3, the C560S/C583S mutation did not, and the C523S/C544S mutation only yielded constitutively active alpha IIb beta 3. Activation of C523S/C544S alpha v beta 3 mutant by activating antibody and dithiothreitol was also impaired. Molecular dynamics of C523S/C544S beta 3 in alpha IIb beta 3 but not in alpha v beta 3 displayed an altered stable conformation. Our findings indicate that unique disulfide bonds in beta 3 differently affect the function of alpha IIb beta 3 and alpha v beta 3 and suggest a free sulfhydryl-dependent regulatory role for Cys-560-Cys-583 in both alpha IIb beta 3 and alpha v beta 3 and for Cys-523-Cys-544 only in alpha v beta 3.	[Mor-Cohen, Ronit; Rosenberg, Nurit; Landau, Meytal; Mansour, Wissam; Averbukh, Yulia; Seligsohn, Uri] Chaim Sheba Med Ctr, Amalia Biron Res Inst Thrombosis & Hemostasis, IL-52621 Tel Hashomer, Israel; [Mor-Cohen, Ronit; Rosenberg, Nurit; Landau, Meytal; Mansour, Wissam; Averbukh, Yulia; Seligsohn, Uri] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel; [Einav, Yulia; Zelzion, Ehud] Holon Inst Technol, Fac Sci, Math Biol Unit, IL-58102 Holon, Israel	Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine	Mor-Cohen, R (corresponding author), Chaim Sheba Med Ctr, Amalia Biron Res Inst Thrombosis & Hemostasis, IL-52621 Tel Hashomer, Israel.	ronit.cohen@sheba.health.gov.il	Mor-Cohen, Ronit/AAB-8657-2020; Landau, Meytal/J-3075-2012; Landau, Meytal/AAF-3479-2021	Landau, Meytal/0000-0002-1743-3430; Landau, Meytal/0000-0002-1743-3430				Adair BD, 2005, J CELL BIOL, V168, P1109, DOI 10.1083/jcb.200410068; Beglova N, 2002, NAT STRUCT BIOL, V9, P282, DOI 10.1038/nsb779; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berendsen HJC, 1981, INTERMOLECULAR FORCE, P331, DOI [DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658-1_21]; Berndt C, 2008, BBA-MOL CELL RES, V1783, P641, DOI 10.1016/j.bbamcr.2008.02.003; BROOKS PC, 1994, SCIENCE, V264, P569, DOI 10.1126/science.7512751; Brooks PC, 1996, CELL, V85, P683, DOI 10.1016/S0092-8674(00)81235-0; Byzova TV, 1998, J CELL BIOL, V143, P2081, DOI 10.1083/jcb.143.7.2081; Calvete JJ, 1999, P SOC EXP BIOL MED, V222, P29, DOI 10.1111/j.1525-1373.1999.09993.x; Cao LS, 2006, INFECT IMMUN, V74, P4990, DOI 10.1128/IAI.00697-06; COLLER BS, 1991, BLOOD, V77, P75; Donald JE, 2010, J BIOL CHEM, V285, P38658, DOI 10.1074/jbc.M110.170670; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Faccio R, 2002, J CELL SCI, V115, P2919; Felding-Habermann B, 2001, P NATL ACAD SCI USA, V98, P1853, DOI 10.1073/pnas.98.4.1853; FRELINGER AL, 1991, J BIOL CHEM, V266, P17106; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Habermann BF, 1993, CURR OPIN CELL BIOL, V5, P864, DOI 10.1016/0955-0674(93)90036-P; Hato T, 2008, J BIOL CHEM, V283, P5662, DOI 10.1074/jbc.M707246200; Hauschner H, 2010, BLOOD, V115, P4542, DOI 10.1182/blood-2009-10-251066; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hogg PJ, 2009, J THROMB HAEMOST, V7, P13, DOI 10.1111/j.1538-7836.2009.03364.x; Hogg PJ, 2003, TRENDS BIOCHEM SCI, V28, P210, DOI 10.1016/S0968-0004(03)00057-4; HU DD, 1995, J BIOL CHEM, V270, P9917, DOI 10.1074/jbc.270.17.9917; Hughes PE, 1996, J BIOL CHEM, V271, P6571, DOI 10.1074/jbc.271.12.6571; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kamata T, 2004, BIOCHEM J, V378, P1079, DOI 10.1042/BJ20031701; Kashiwagi H, 1999, BLOOD, V93, P2559, DOI 10.1182/blood.V93.8.2559.408k12_2559_2568; Lahav J, 2000, FEBS LETT, V475, P89, DOI 10.1016/S0014-5793(00)01630-6; Lahav J, 2002, BLOOD, V100, P2472, DOI 10.1182/blood-2001-12-0339; Legler DF, 2001, J CELL SCI, V114, P1545; Lorger M, 2009, P NATL ACAD SCI USA, V106, P10666, DOI 10.1073/pnas.0903035106; Luo BH, 2003, P NATL ACAD SCI USA, V100, P2403, DOI 10.1073/pnas.0438060100; Mahabeleshwar GH, 2008, CELL CYCLE, V7, P335, DOI 10.4161/cc.7.3.5234; Mor-Cohen R, 2007, THROMB HAEMOSTASIS, V98, P1257, DOI 10.1160/TH07-04-0248; Mor-Cohen R, 2008, J BIOL CHEM, V283, P19235, DOI 10.1074/jbc.M802399200; Morel-Kopp MC, 2001, THROMB HAEMOSTASIS, V86, P1425; O'Neill S, 2000, J BIOL CHEM, V275, P36984, DOI 10.1074/jbc.M003279200; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; Oxvig C, 1999, P NATL ACAD SCI USA, V96, P2215, DOI 10.1073/pnas.96.5.2215; Pampori N, 1999, J BIOL CHEM, V274, P21609, DOI 10.1074/jbc.274.31.21609; Pelletier AJ, 1996, J BIOL CHEM, V271, P1364, DOI 10.1074/jbc.271.3.1364; PHILLIPS DR, 1991, CELL, V65, P359, DOI 10.1016/0092-8674(91)90451-4; Schmidt B, 2006, BIOCHEMISTRY-US, V45, P7429, DOI 10.1021/bi0603064; Schwartz SM, 1997, J CLIN INVEST, V99, P2814, DOI 10.1172/JCI119472; SHATTIL SJ, 1995, THROMB HAEMOSTASIS, V74, P149; Shattil SJ, 1998, BLOOD, V91, P2645, DOI 10.1182/blood.V91.8.2645.2645_2645_2657; Smagghe BJ, 2010, J BIOL CHEM, V285, P32954, DOI 10.1074/jbc.M110.145177; Tadokoro S, 2002, BLOOD, V99, P931, DOI 10.1182/blood.V99.3.931; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; Takagi J, 2001, P NATL ACAD SCI USA, V98, P11175, DOI 10.1073/pnas.201420198; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; WICKHAM TJ, 1993, CELL, V73, P309, DOI 10.1016/0092-8674(93)90231-E; Wouters MA, 2007, CURR PROTEIN PEPT SC, V8, P484, DOI 10.2174/138920307782411464; Wouters MA, 2010, ANTIOXID REDOX SIGN, V12, P53, DOI [10.1089/ars.2009.2510, 10.1089/ARS.2009.2510]; Xiao T, 2004, NATURE, V432, P59, DOI 10.1038/nature02976; Xiong JP, 2009, J CELL BIOL, V186, P589, DOI 10.1083/jcb.200905085; Xiong JP, 2003, BLOOD, V102, P1155, DOI 10.1182/blood-2003-01-0334; Yan BX, 2001, BIOCHEMISTRY-US, V40, P8861, DOI 10.1021/bi002902i; Yan BX, 2000, J BIOL CHEM, V275, P39964, DOI 10.1074/jbc.M007041200; Ye F, 2008, J MOL BIOL, V378, P976, DOI 10.1016/j.jmb.2008.03.014; Zhu JH, 2008, MOL CELL, V32, P849, DOI 10.1016/j.molcel.2008.11.018; Zhu JQ, 2007, J BIOL CHEM, V282, P11914, DOI 10.1074/jbc.M700249200	64	53	54	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					8879	8891		10.1074/jbc.M111.311043	http://dx.doi.org/10.1074/jbc.M111.311043			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22308022	hybrid, Green Published			2022-12-25	WOS:000301797800019
J	Lu, LN; Zhou, L; Chen, EZ; Sun, K; Jiang, PY; Wang, LJ; Su, XX; Sun, H; Wang, HT				Lu, Leina; Zhou, Liang; Chen, Eric Z.; Sun, Kun; Jiang, Peiyong; Wang, Lijun; Su, Xiaoxi; Sun, Hao; Wang, Huating			A Novel YY1-miR-1 Regulatory Circuit in Skeletal Myogenesis Revealed by Genome-Wide Prediction of YY1-miRNA Network	PLOS ONE			English	Article							MUSCLE-SPECIFIC MICRORNA; GENE-EXPRESSION; CELL-CYCLE; DIFFERENTIATION; PROLIFERATION; TRANSCRIPTION; MECHANISM; TARGETS; MIR-1	microRNAs (miRNAs) are non-coding RNAs that regulate gene expression post-transcriptionally, and mounting evidence supports the prevalence and functional significance of their interplay with transcription factors (TFs). Here we describe the identification of a regulatory circuit between muscle miRNAs (miR-1, miR-133 and miR-206) and Yin Yang 1 (YY1), an epigenetic repressor of skeletal myogenesis in mouse. Genome-wide identification of potential down-stream targets of YY1 by combining computational prediction with expression profiling data reveals a large number of putative miRNA targets of YY1 during skeletal myoblasts differentiation into myotubes with muscle miRs ranking on top of the list. The subsequent experimental results demonstrate that YY1 indeed represses muscle miRs expression in myoblasts and the repression is mediated through multiple enhancers and recruitment of Polycomb complex to several YY1 binding sites. YY1 regulating miR-1 is functionally important for both C2C12 myogenic differentiation and injury-induced muscle regeneration. Furthermore, we demonstrate that miR-1 in turn targets YY1, thus forming a negative feedback loop. Together, these results identify a novel regulatory circuit required for skeletal myogenesis and reinforce the idea that regulatory circuitries involving miRNAs and TFs are prevalent mechanisms.	[Lu, Leina; Chen, Eric Z.; Sun, Kun; Jiang, Peiyong; Su, Xiaoxi; Sun, Hao] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Dept Chem Pathol, Hong Kong, Hong Kong, Peoples R China; [Zhou, Liang; Wang, Lijun; Wang, Huating] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Dept Obstet & Gynaecol, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong	Lu, LN (corresponding author), Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Dept Chem Pathol, Hong Kong, Hong Kong, Peoples R China.	haosun@cuhk.edu.hk; huating.wang@cuhk.edu.hk	Sun, Kun/Q-6479-2018; JIANG, Peiyong/AAZ-9898-2020; sun, hao/GRS-7732-2022; c, c/I-5855-2016; Sun, Hao/J-9964-2013; Zhou, Liang/P-4174-2015; Wang, Huating/C-6719-2014; Sun, Hao/T-5576-2019	Sun, Kun/0000-0002-9883-1616; Sun, Hao/0000-0002-5547-9501; Zhou, Liang/0000-0001-5973-7873; Wang, Huating/0000-0001-5474-2905; Sun, Hao/0000-0002-5547-9501; Jiang, Peiyong/0000-0003-4523-3476	Research Grants Council (RGC) of the Hong Kong Special Administrative Region, China [2140655, 2140701, 473211]; CUHK [2041474, 2041492]	Research Grants Council (RGC) of the Hong Kong Special Administrative Region, China(Hong Kong Research Grants Council); CUHK(Chinese University of Hong Kong)	The work described in this paper was substantially supported by three General Research Funds (GRF) to H. W. and H. S. from the Research Grants Council (RGC) of the Hong Kong Special Administrative Region, China (Project Code: 2140655, 2140701 and 473211), a CUHK Direct Grant to H. W. (2041474) and a CUHK Direct Grant to H. S. (2041492). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeel T, 2008, GENOME RES, V18, P310, DOI 10.1101/gr.6991408; Anderson C, 2006, NUCLEIC ACIDS RES, V34, P5863, DOI 10.1093/nar/gkl743; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Buckingham M, 2006, CURR OPIN GENET DEV, V16, P525, DOI 10.1016/j.gde.2006.08.008; Caretti G, 2004, GENE DEV, V18, P2627, DOI 10.1101/gad.1241904; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Chen JF, 2010, J CELL BIOL, V190, P867, DOI 10.1083/jcb.200911036; Cordes KR, 2010, PEDIATR CARDIOL, V31, P349, DOI 10.1007/s00246-010-9639-3; Fabbri M, 2010, ADV GENET, V70, P87, DOI [10.1016/S0065-2660(10)70004-3, 10.1016/B978-0-12-380866-0.60004-6]; Fei T, 2010, GENOME RES, V20, P36, DOI 10.1101/gr.092114.109; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Guller I, 2010, J PHYSIOL-LONDON, V588, P4075, DOI 10.1113/jphysiol.2010.194175; HYDEDERUYSCHER RP, 1995, NUCLEIC ACIDS RES, V23, P4457, DOI 10.1093/nar/23.21.4457; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Ivey KN, 2010, CELL STEM CELL, V7, P36, DOI 10.1016/j.stem.2010.06.012; Juan AH, 2010, CELL CYCLE, V9, P1445, DOI 10.4161/cc.9.8.11472; Kim HK, 2006, J CELL BIOL, V174, P677, DOI 10.1083/jcb.200603008; Liu CG, 2008, NAT PROTOC, V3, P563, DOI 10.1038/nprot.2008.14; Liu N, 2007, P NATL ACAD SCI USA, V104, P20844, DOI 10.1073/pnas.0710558105; Liu N, 2010, DEV CELL, V18, P510, DOI 10.1016/j.devcel.2010.03.010; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Martinez NJ, 2009, BIOESSAYS, V31, P435, DOI 10.1002/bies.200800212; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Nakasa T, 2010, J CELL MOL MED, V14, P2495, DOI 10.1111/j.1582-4934.2009.00898.x; Olguin HC, 2004, DEV BIOL, V275, P375, DOI 10.1016/j.ydbio.2004.08.015; Rao PK, 2006, P NATL ACAD SCI USA, V103, P8721, DOI 10.1073/pnas.0602831103; Rao PK, 2010, FASEB J, V24, P3427, DOI 10.1096/fj.09-150698; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Rosenberg MI, 2006, J CELL BIOL, V175, P77, DOI 10.1083/jcb.200603039; Sabourin LA, 2000, CLIN GENET, V57, P16, DOI 10.1034/j.1399-0004.2000.570103.x; Saccone V, 2010, ORGANOGENESIS, V6, P48, DOI 10.4161/org.6.1.11293; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Schones DE, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-19; Shalgi R, 2007, PLOS COMPUT BIOL, V3, P1291, DOI 10.1371/journal.pcbi.0030131; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Townley-Tilson WHD, 2010, INT J BIOCHEM CELL B, V42, P1252, DOI 10.1016/j.biocel.2009.03.002; Wang H, 2008, CANCER CELL, V14, P369, DOI 10.1016/j.ccr.2008.10.006; Wang HT, 2007, MOL CELL BIOL, V27, P4374, DOI 10.1128/MCB.02020-06; Wong CF, 2008, J BIOL CHEM, V283, P9836, DOI 10.1074/jbc.M709614200; Xu CQ, 2007, J CELL SCI, V120, P3045, DOI 10.1242/jcs.010728; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817; Zhao Y, 2007, CELL, V129, P303, DOI 10.1016/j.cell.2007.03.030	43	129	133	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2012	7	2							e27596	10.1371/journal.pone.0027596	http://dx.doi.org/10.1371/journal.pone.0027596			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UG	22319554	Green Published, Green Submitted, gold			2022-12-25	WOS:000301977500001
J	Ogata, Y; Chikayama, E; Morioka, Y; Everroad, RC; Shino, A; Matsushima, A; Haruna, H; Moriya, S; Toyoda, T; Kikuchi, J				Ogata, Yoshiyuki; Chikayama, Eisuke; Morioka, Yusuke; Everroad, R. Craig; Shino, Amiu; Matsushima, Akihiro; Haruna, Hideaki; Moriya, Shigeharu; Toyoda, Tetsuro; Kikuchi, Jun			ECOMICS: A Web-Based Toolkit for Investigating the Biomolecular Web in Ecosystems Using a Trans-omics Approach	PLOS ONE			English	Article							NUCLEAR-MAGNETIC-RESONANCE; NMR-BASED METABOLOMICS; C-13 MAS NMR; ARABIDOPSIS-THALIANA; COMPLEX SOLUTIONS; ORGANIC-CARBON; HIGHER-PLANTS; LIGNIN; SPECTROSCOPY; METABOLITES	Ecosystems can be conceptually thought of as interconnected environmental and metabolic systems, in which small molecules to macro-molecules interact through diverse networks. State-of-the-art technologies in post-genomic science offer ways to inspect and analyze this biomolecular web using omics-based approaches. Exploring useful genes and enzymes, as well as biomass resources responsible for anabolism and catabolism within ecosystems will contribute to a better understanding of environmental functions and their application to biotechnology. Here we present ECOMICS, a suite of web-based tools for ECosystem trans-OMICS investigation that target metagenomic, metatranscriptomic, and metametabolomic systems, including biomacromolecular mixtures derived from biomass. ECOMICS is made of four integrated webtools. E-class allows for the sequence-based taxonomic classification of eukaryotic and prokaryotic ribosomal data and the functional classification of selected enzymes. FT2B allows for the digital processing of NMR spectra for downstream metabolic or chemical phenotyping. Bm-Char allows for statistical assignment of specific compounds found in lignocellulose-based biomass, and HetMap is a data matrix generator and correlation calculator that can be applied to trans-omics datasets as analyzed by these and other web tools. This web suite is unique in that it allows for the monitoring of biomass metabolism in a particular environment, i.e., from macromolecular complexes (FT2DB and Bm-Char) to microbial composition and degradation (E-class), and makes possible the understanding of relationships between molecular and microbial elements (HetMap). This website is available to the public domain at: https://database.riken.jp/ecomics/.	[Ogata, Yoshiyuki; Chikayama, Eisuke; Shino, Amiu; Kikuchi, Jun] RIKEN, Plant Sci Ctr, Yokohama, Kanagawa, Japan; [Chikayama, Eisuke; Morioka, Yusuke; Haruna, Hideaki; Moriya, Shigeharu; Kikuchi, Jun] Yokohama City Univ, Grad Sch Nanobiosci, Yokohama, Kanagawa 232, Japan; [Everroad, R. Craig; Moriya, Shigeharu] RIKEN, Adv Sci Inst, Wako, Saitama, Japan; [Toyoda, Tetsuro] RIKEN, Bioinformat & Syst Engn Div, Yokohama, Kanagawa, Japan; [Toyoda, Tetsuro; Kikuchi, Jun] RIKEN Cluster Innovat, Biomass Engn Program, Wako, Saitama, Japan; [Kikuchi, Jun] Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan	RIKEN; Yokohama City University; RIKEN; RIKEN; RIKEN; Nagoya University	Ogata, Y (corresponding author), RIKEN, Plant Sci Ctr, Yokohama, Kanagawa, Japan.	kikuchi@psc.riken.jp	Kikuchi, Jun/M-5512-2015; Kikuchi, Jun/O-4725-2019; Moriya, Shigeharu/AGY-8351-2022; Moriya, Shigeharu/H-1656-2011; Moriya, Shigeharu/F-4604-2014	Kikuchi, Jun/0000-0002-6809-394X; Kikuchi, Jun/0000-0002-6809-394X; Moriya, Shigeharu/0000-0002-2519-5874; Moriya, Shigeharu/0000-0002-2519-5874; Moriya, Shigeharu/0000-0002-2519-5874	Ministry of Education, Culture, Sports, Science, and Technology, Japan; Bio-oriented Technology Research Advancement Institution (BRAIN); New Energy and Industrial Technology Development Organization (NEDO); Grants-in-Aid for Scientific Research [21247010] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Bio-oriented Technology Research Advancement Institution (BRAIN); New Energy and Industrial Technology Development Organization (NEDO)(New Energy and Industrial Technology Development Organization (NEDO)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported in part by Grants-in-Aid for Scientific Research for challenging exploratory research (Dr. Kikuchi), and Scientific Research (A) (Dr. Kikuchi) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan. This work was also supported, in part, by grants from Research and Development Program for New Bio-industry Initiatives of the Bio-oriented Technology Research Advancement Institution (BRAIN to Dr. Kikuchi), and the New Energy and Industrial Technology Development Organization (NEDO to Dr. Kikuchi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama Kenji, 2008, In Silico Biology, V8, P339; Azam F, 1998, SCIENCE, V280, P694, DOI 10.1126/science.280.5364.694; Betson TR, 2006, ANAL CHEM, V78, P8406, DOI 10.1021/ac061050a; Chen FF, 2011, J PROTEOME RES, V10, P2273, DOI 10.1021/pr101095t; Chikayama E, 2010, ANAL CHEM, V82, P1653, DOI 10.1021/ac9022023; Chikayama E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003805; Cloarec O, 2005, ANAL CHEM, V77, P1282, DOI 10.1021/ac048630x; Covert JS, 2001, AQUAT MICROB ECOL, V25, P127, DOI 10.3354/ame025127; Cui Q, 2008, NAT BIOTECHNOL, V26, P162, DOI 10.1038/nbt0208-162; Dam P, 2011, NUCLEIC ACIDS RES, V39, P3240, DOI 10.1093/nar/gkq1281; Date Y, 2010, J BIOSCI BIOENG, V110, P87, DOI 10.1016/j.jbiosc.2010.01.004; del Rio JC, 2008, J AGR FOOD CHEM, V56, P9525, DOI 10.1021/jf800806h; del Rio JC, 2009, J AGR FOOD CHEM, V57, P10271, DOI 10.1021/jf900815x; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Demain AL, 2009, J IND MICROBIOL BIOT, V36, P319, DOI 10.1007/s10295-008-0521-8; Dick-Perez M, 2011, BIOCHEMISTRY-US, V50, P989, DOI 10.1021/bi101795q; Dudukovic MP, 2009, SCIENCE, V325, P698, DOI 10.1126/science.1174274; Elser JJ, 2009, SCIENCE, V326, P835, DOI 10.1126/science.1176199; Fort D. A., 2006, HOLZFORSCHUNG, V9, P63; Frimmersdorf E, 2010, ENVIRON MICROBIOL, V12, P1734, DOI 10.1111/j.1462-2920.2010.02253.x; Fu CX, 2011, P NATL ACAD SCI USA, V108, P3803, DOI 10.1073/pnas.1100310108; Fukuda S, 2011, NATURE; Fukuda S, 2011, NATURE, V469, P543, DOI 10.1038/nature09646; Fukuda S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004893; Gao DH, 2011, BIOTECHNOL BIOFUELS, V4, DOI 10.1186/1754-6834-4-5; Gilbert A, 2009, ANAL CHEM, V81, P8978, DOI 10.1021/ac901441g; Groger C, 2009, PROG NUCL MAG RES SP, V54, P54, DOI 10.1016/j.pnmrs.2008.02.003; Haquin Sabrina, 2008, V426, P49, DOI 10.1007/978-1-60327-058-8_4; Hassan KA, 2010, ENVIRON MICROBIOL, V12, P899, DOI 10.1111/j.1462-2920.2009.02134.x; Hedenstrom M, 2009, MOL PLANT, V2, P933, DOI 10.1093/mp/ssp047; Holmes E, 2007, ANAL CHEM, V79, P2629, DOI 10.1021/ac062305n; Jorgensen H, 2007, BIOTECHNOL BIOENG, V96, P862, DOI 10.1002/bit.21115; Keiluweit M, 2010, ENVIRON SCI TECHNOL, V44, P1247, DOI 10.1021/es9031419; Kikuchi J, 2004, PLANT CELL PHYSIOL, V45, P1099, DOI 10.1093/pcp/pch117; KIKUCHI J., 2011, J ECOSYSTEM ECOGRA S, VS2, P1, DOI DOI 10.4172/2157-7625.S2-001; Kikuchi Jun, 2007, V358, P273, DOI 10.1007/978-1-59745-244-1_15; Kim H, 2010, ORG BIOMOL CHEM, V8, P576, DOI 10.1039/b916070a; Lehtio J, 2003, P NATL ACAD SCI USA, V100, P484, DOI 10.1073/pnas.212651999; Lewis IA, 2007, ANAL CHEM, V79, P9385, DOI 10.1021/ac071583z; Lewis IA, 2010, ANAL CHEM, V82, P4558, DOI 10.1021/ac100565b; Lewis IA, 2009, MAGN RESON CHEM, V47, pS123, DOI 10.1002/mrc.2526; Liu CX, 2010, J PROTEOME RES, V9, P6774, DOI 10.1021/pr100970q; Markley JL, 2008, J BIOMOL NMR, V40, P153, DOI 10.1007/s10858-008-9221-y; Martinez AT, 2011, ENVIRON MICROBIOL, V13, P96, DOI 10.1111/j.1462-2920.2010.02312.x; Martinez AT, 2008, PHYTOCHEMISTRY, V69, P2831, DOI 10.1016/j.phytochem.2008.09.005; McCarthy M, 1997, NATURE, V390, P150, DOI 10.1038/36535; Mochida K, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-568; Morreel K, 2010, ANAL CHEM, V82, P8095, DOI 10.1021/ac100968g; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Nakamura I, 2005, MACROMOL BIOSCI, V5, P623, DOI 10.1002/mabi.200500044; Nakanishi Y, 2011, J PROTEOME RES, V10, P824, DOI 10.1021/pr100989c; O'Sullivan LA, 2004, FEMS MICROBIOL ECOL, V47, P359, DOI 10.1016/S0168-6496(03)00300-3; Ogata Y, 2009, PLANT CELL PHYSIOL, V50, P173, DOI 10.1093/pcp/pcn179; Ogata Y, 2010, BIOINFORMATICS, V26, P1267, DOI 10.1093/bioinformatics/btq121; Ogata Yoshiyuki, 2009, Genome Inform, V23, P117; Ragauskas AJ, 2006, SCIENCE, V311, P484, DOI 10.1126/science.1114736; Rappe MS, 2003, ANNU REV MICROBIOL, V57, P369, DOI 10.1146/annurev.micro.57.030502.090759; Rencoret J, 2011, PLANT PHYSIOL, V155, P667, DOI 10.1104/pp.110.167254; Rubin EM, 2008, NATURE, V454, P841, DOI 10.1038/nature07190; Sannigrahi P, 2006, ENVIRON SCI TECHNOL, V40, P666, DOI 10.1021/es051150i; Santos EM, 2010, ENVIRON SCI TECHNOL, V44, P820, DOI 10.1021/es902558k; Scheller HV, 2010, ANNU REV PLANT BIOL, V61, P263, DOI 10.1146/annurev-arplant-042809-112315; Sekiyama Y, 2007, PHYTOCHEMISTRY, V68, P2320, DOI 10.1016/j.phytochem.2007.04.011; Sekiyama Y, 2011, ANAL CHEM, V83, P719, DOI 10.1021/ac102097u; Sekiyama Y, 2010, ANAL CHEM, V82, P1643, DOI 10.1021/ac9019076; Shi DL, 2010, SCIENCE, V327, P676, DOI 10.1126/science.1183517; Sinha G, 2005, SCIENCE, V310, P965, DOI 10.1126/science.310.5750.965; Somerville C, 2010, SCIENCE, V329, P790, DOI 10.1126/science.1189268; Spraul M, 2009, MAGN RESON CHEM, V47, pS130, DOI 10.1002/mrc.2528; Sturcova A, 2004, BIOMACROMOLECULES, V5, P1333, DOI 10.1021/bm034517p; Sudesh K., 2001, RIKEN REV, V42, P75; Sun RC, 1998, J AGR FOOD CHEM, V46, P718, DOI 10.1021/jf9705532; Tang HR, 2003, BIOMACROMOLECULES, V4, P1269, DOI 10.1021/bm0340772; Tang HR, 1999, J AGR FOOD CHEM, V47, P510, DOI 10.1021/jf980553h; Taylor PG, 2010, NATURE, V464, P1178, DOI 10.1038/nature08985; Tian C, 2007, J BIOL CHEM, V282, P18532, DOI 10.1074/jbc.M700549200; Tiirola MA, 2002, APPL ENVIRON MICROB, V68, P173, DOI 10.1128/AEM.68.1.173-180.2002; Vanholme R, 2008, CURR OPIN PLANT BIOL, V11, P278, DOI 10.1016/j.pbi.2008.03.005; Viant MR, 2009, ENVIRON SCI TECHNOL, V43, P219, DOI 10.1021/es802198z; Ward JL, 2010, METABOLOMICS, V6, P263, DOI 10.1007/s11306-010-0200-4; Waszkielewicz A, 2004, POL J PHARMACOL, V56, P43; Zhang JT, 2011, J PROTEOME RES, V10, P1904, DOI 10.1021/pr101140n; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	83	28	28	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2012	7	2							e30263	10.1371/journal.pone.0030263	http://dx.doi.org/10.1371/journal.pone.0030263			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UG	22319563	Green Published, Green Submitted, gold			2022-12-25	WOS:000301977500006
J	Grover, A; Singh, R; Shandilya, A; Priyandoko, D; Agrawal, V; Bisaria, VS; Wadhwa, R; Kaul, SC; Sundar, D				Grover, Abhinav; Singh, Rumani; Shandilya, Ashutosh; Priyandoko, Didik; Agrawal, Vibhuti; Bisaria, Virendra S.; Wadhwa, Renu; Kaul, Sunil C.; Sundar, Durai			Ashwagandha Derived Withanone Targets TPX2-Aurora A Complex: Computational and Experimental Evidence to its Anticancer Activity	PLOS ONE			English	Article							HERBAL DRUG WITHAFERIN; KINASE AURORA-A; CANCER-CELLS; CHROMOSOMAL INSTABILITY; INHIBITOR INTERACTIONS; PANCREATIC-CANCER; AUTOMATED DOCKING; MITOTIC SPINDLE; PROSTATE-CANCER; POTENTIAL ROLE	Cancer is largely marked by genetic instability. Specific inhibition of individual proteins or signalling pathways that regulate genetic stability during cell division thus hold a great potential for cancer therapy. The Aurora A kinase is a Ser/Thr kinase that plays a critical role during mitosis and cytokinesis and is found upregulated in several cancer types. It is functionally regulated by its interactions with TPX2, a candidate oncogene. Aurora A inhibitors have been proposed as anticancer drugs that work by blocking its ATP binding site. This site is common to other kinases and hence these inhibitors lack specificity for Aurora A inhibition in particular, thus advocating the need of some alternative inhibition route. Previously, we identified TPX2 as a cellular target for withanone that selectively kill cancer cells. By computational approach, we found here that withanone binds to TPX2-Aurora A complex. In experiment, withanone treatment to cancer cells indeed resulted in dissociation of TPX2-Aurora A complex and disruption of mitotic spindle apparatus proposing this as a mechanism of the anticancer activity of withanone. From docking analysis, non-formation/disruption of the active TPX2-Aurora A association complex could be discerned. Our MD simulation results suggesting the thermodynamic and structural stability of TPX2-Aurora A in complex with withanone further substantiates the binding. We report a computational rationale of the ability of naturally occurring withanone to alter the kinase signalling pathway in an ATP-independent manner and experimental evidence in which withanone cause inactivation of the TPX2-Aurora A complex. The study demonstrated that TPX2-Aurora A complex is a target of withanone, a potential natural anticancer drug.	[Grover, Abhinav; Agrawal, Vibhuti; Bisaria, Virendra S.; Sundar, Durai] Indian Inst Technol IIT Delhi, Dept Biochem Engn & Biotechnol, New Delhi, India; [Singh, Rumani; Priyandoko, Didik; Wadhwa, Renu; Kaul, Sunil C.] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki, Japan; [Singh, Rumani; Priyandoko, Didik] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 305, Japan; [Shandilya, Ashutosh] Indian Inst Technol IIT Delhi, Supercomp Facil Bioinformat & Computat Biol, New Delhi, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi; National Institute of Advanced Industrial Science & Technology (AIST); University of Tsukuba; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi	Grover, A (corresponding author), Indian Inst Technol IIT Delhi, Dept Biochem Engn & Biotechnol, Hauz Khas, New Delhi, India.	s-kaul@aist.go.jp; sundar@dbeb.iitd.ac.in	Kaul, Sunil C/L-8671-2018; Wadhwa, Renu/L-8898-2018; Sundar, Durai/F-7671-2012; Shandilya, Ashutosh/G-9995-2012; Priyandoko, Didik/GNP-1593-2022	Kaul, Sunil C/0000-0002-0046-3916; Wadhwa, Renu/0000-0001-8248-5192; Priyandoko, Didik/0000-0001-8601-9818; Sundar, Durai/0000-0002-6549-6663	National Institute of Advanced Industrial Science & Technology (AIST), Japan; Ministry of Education, Culture, Sports, Science & Technology (MEXT), Japan; Indonesian Government; Supercomputing Facility for Bioinformatics and Computational Biology (SCFBio) at Indian Institute of Technology Delhi	National Institute of Advanced Industrial Science & Technology (AIST), Japan; Ministry of Education, Culture, Sports, Science & Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Indonesian Government(Ministry of Research and Technology of the Republic of Indonesia (RISTEK)); Supercomputing Facility for Bioinformatics and Computational Biology (SCFBio) at Indian Institute of Technology Delhi	The work was supported by grants from National Institute of Advanced Industrial Science & Technology (AIST), Japan. R. Singh is supported by the Ministry of Education, Culture, Sports, Science & Technology (MEXT) Scholarship, Japan. D. Priyandoko is a recipient of Indonesian Government Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Prof. B. Jayaram, Coordinator of Supercomputing Facility for Bioinformatics and Computational Biology (SCFBio) at Indian Institute of Technology Delhi for his support and encouragement.	Agnese V, 2007, ANN ONCOL, V18, P47, DOI 10.1093/annonc/mdm224; Anderson K, 2007, BIOCHEMISTRY-US, V46, P10287, DOI 10.1021/bi7011355; Andrews PD, 2003, CURR OPIN CELL BIOL, V15, P672, DOI 10.1016/j.ceb.2003.10.013; Andrews PD, 2005, ONCOGENE, V24, P5005, DOI 10.1038/sj.onc.1208752; Asteriti IA, 2010, BBA-REV CANCER, V1806, P230, DOI 10.1016/j.bbcan.2010.08.001; Bar-Shira A, 2002, CANCER RES, V62, P6803; Bayliss R, 2003, MOL CELL, V12, P851, DOI 10.1016/S1097-2765(03)00392-7; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bischoff JR, 1998, EMBO J, V17, P3052, DOI 10.1093/emboj/17.11.3052; Bischoff JR, 1999, TRENDS CELL BIOL, V9, P454, DOI 10.1016/S0962-8924(99)01658-X; Buschhorn HM, 2005, PROSTATE, V64, P341, DOI 10.1002/pros.20247; Carmena M, 2003, NAT REV MOL CELL BIO, V4, P842, DOI 10.1038/nrm1245; Case D.A., 2022, AMBER 2020; Cornell WD, 1996, J AM CHEM SOC, V118, P2309, DOI 10.1021/ja955032e; CORNELL WD, 1993, J AM CHEM SOC, V115, P9620, DOI 10.1021/ja00074a030; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Ditchfield C, 2003, J CELL BIOL, V161, P267, DOI 10.1083/jcb.200208091; Dym O, 2002, MOL PHARMACOL, V61, P20, DOI 10.1124/mol.61.1.20; Eyers PA, 2003, CURR BIOL, V13, P691, DOI 10.1016/S0960-9822(03)00166-0; Fraizer GC, 2004, INT J ONCOL, V25, P1631; Goodsell DS, 1996, J MOL RECOGNIT, V9, P1, DOI 10.1002/(SICI)1099-1352(199601)9:1<1::AID-JMR241>3.0.CO;2-6; Gritsko TM, 2003, CLIN CANCER RES, V9, P1420; Grover A, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S1-S30; Grover A, 2011, BIOCHEM BIOPH RES CO, V404, P498, DOI 10.1016/j.bbrc.2010.12.010; Grover A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S4-S25; Grover A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S4-S15; Gruss OJ, 2004, J CELL BIOL, V166, P949, DOI 10.1083/jcb.200312112; Gupta A, 2007, PROTEIN PEPTIDE LETT, V14, P632; Harrington EA, 2004, NAT MED, V10, P262, DOI 10.1038/nm1003; Hauf S, 2003, J CELL BIOL, V161, P281, DOI 10.1083/jcb.200208092; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kamada K, 2004, ONCOL REP, V12, P593; Karsenti E, 2001, SCIENCE, V294, P543, DOI 10.1126/science.1063488; Kleywegt GJ, 1996, STRUCTURE, V4, P1395, DOI 10.1016/S0969-2126(96)00147-5; Knuutila S, 1998, AM J PATHOL, V152, P1107; Li DH, 2003, CLIN CANCER RES, V9, P991; Li YH, 2005, CANCER INVEST, V23, P660, DOI 10.1080/07357900500359836; Morgan-Lappe SE, 2007, CANCER RES, V67, P4390, DOI 10.1158/0008-5472.CAN-06-4132; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; Rao MS, 1999, PROTEINS, V34, P173, DOI 10.1002/(SICI)1097-0134(19990201)34:2<173::AID-PROT3>3.0.CO;2-F; Scotto L, 2008, GENE CHROMOSOME CANC, V47, P755, DOI 10.1002/gcc.20577; Tanaka T, 1999, CANCER RES, V59, P2041; Tonon G, 2005, P NATL ACAD SCI USA, V102, P9625, DOI 10.1073/pnas.0504126102; Tsai MY, 2003, NAT CELL BIOL, V5, P242, DOI 10.1038/ncb936; Wang Y, 2002, J IMMUNOL, V169, P1102, DOI 10.4049/jimmunol.169.2.1102; Warner SL, 2009, CLIN CANCER RES, V15, P6519, DOI 10.1158/1078-0432.CCR-09-0077; Widodo N, 2008, CANCER LETT, V262, P37, DOI 10.1016/j.canlet.2007.11.037; Widodo N, 2007, CLIN CANCER RES, V13, P2298, DOI 10.1158/1078-0432.CCR-06-0948; Widodo N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013536; Wittmann T, 1998, J CELL BIOL, V143, P673, DOI 10.1083/jcb.143.3.673; Zhang LJ, 2008, TOXICOLOGY, V252, P49, DOI 10.1016/j.tox.2008.07.059; Zhao BG, 2008, PROTEIN SCI, V17, P1791, DOI 10.1110/ps.036590.108	55	31	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2012	7	1							e30890	10.1371/journal.pone.0030890	http://dx.doi.org/10.1371/journal.pone.0030890			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911GB	22303466	Green Published, gold, Green Submitted			2022-12-25	WOS:000301704200042
J	Hendaoui, I; Lavergne, E; Lee, HS; Hong, SH; Kim, HZ; Parent, C; Heuze-Vourc'h, N; Clement, B; Musso, O				Hendaoui, Ismail; Lavergne, Elise; Lee, Heun-Sik; Hong, Seong Hyun; Kim, Hak-Zoo; Parent, Christelle; Heuze-Vourc'h, Nathalie; Clement, Bruno; Musso, Orlando			Inhibition of Wnt/beta-Catenin Signaling by a Soluble Collagen-Derived Frizzled Domain Interacting with Wnt3a and the Receptors Frizzled 1 and 8	PLOS ONE			English	Article							BETA-CATENIN; IN-VIVO; CELLS; BINDING; PROTEIN; DROSOPHILA; MODULE; LIGAND; GROWTH; XVIII	The Wnt/beta-catenin pathway controls cell proliferation, death and differentiation. Several families of extracellular proteins can antagonize Wnt/beta-catenin signaling, including the decoy receptors known as secreted frizzled related proteins (SFRPs), which have a cysteine-rich domain (CRD) structurally similar to the extracellular Wnt-binding domain of the frizzled receptors. SFRPs inhibit Wnt signaling by sequestering Wnts through the CRD or by forming inactive complexes with the frizzled receptors. Other endogenous molecules carrying frizzled CRDs inhibit Wnt signaling, such as V3Nter, which is proteolytically derived from the cell surface component collagen XVIII and contains a biologically active frizzled domain (FZC18) inhibiting in vivo cell proliferation and tumor growth in mice. We recently showed that FZC18 expressing cells deliver short-range signals to neighboring cells, decreasing their proliferation in vitro and in vivo through the Wnt/beta-catenin signaling pathway. Here, using low concentrations of soluble FZC18 and Wnt3a, we show that they physically interact in a cell-free system. In addition, soluble FZC18 binds the frizzled 1 and 8 receptors' CRDs, reducing cell sensitivity to Wnt3a. Conversely, inhibition of Wnt/beta-catenin signaling was partially rescued by the expression of full-length frizzled 1 and 8 receptors, but enhanced by the expression of a chimeric cell-membrane-tethered frizzled 8 CRD. Moreover, soluble, partially purified recombinant FZC18_CRD inhibited Wnt3a-induced beta-catenin activation. Taken together, the data indicate that collagen XVIII-derived frizzled CRD shifts Wnt sensitivity of normal cells to a lower pitch and controls their growth.	[Hendaoui, Ismail; Lavergne, Elise; Lee, Heun-Sik; Clement, Bruno; Musso, Orlando] INSERM, U991, Rennes, France; [Hendaoui, Ismail; Lavergne, Elise; Lee, Heun-Sik; Clement, Bruno; Musso, Orlando] Univ Rennes 1, Rennes, France; [Parent, Christelle; Heuze-Vourc'h, Nathalie] INSERM, U618, Tours, France; [Hong, Seong Hyun; Kim, Hak-Zoo] Gyeonggi Bioctr, Gyeonggi Inst Sci & Technol Promot, Suwon, South Korea	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; Institut National de la Sante et de la Recherche Medicale (Inserm)	Hendaoui, I (corresponding author), INSERM, U991, Rennes, France.	orlando.musso@inserm.fr	HEUZE-VOURC'H, Nathalie/P-8081-2016; Musso, Orlando/N-5756-2017; Clement, Bruno/E-5546-2016	Clement, Bruno/0000-0001-8827-146X; Parent, Christelle/0000-0001-8086-4690; Heuze-Vourc'h, Nathalie/0000-0003-4929-5068; Musso, Orlando/0000-0001-8881-6925	Institut National de la Sante et de la Recherche Medicale, Institut National du Cancer, Agence Nationale de la Recherche, Universite de Rennes 1, Region Bretagne	Institut National de la Sante et de la Recherche Medicale, Institut National du Cancer, Agence Nationale de la Recherche, Universite de Rennes 1, Region Bretagne(French National Research Agency (ANR))	Institut National de la Sante et de la Recherche Medicale, Institut National du Cancer, Agence Nationale de la Recherche (Emergence-BIO Program 2008), Universite de Rennes 1, Region Bretagne. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bovolenta P, 2008, J CELL SCI, V121, P737, DOI 10.1242/jcs.026096; Cadigan KM, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002881; Carmon KS, 2008, BIOCHEM BIOPH RES CO, V368, P285, DOI 10.1016/j.bbrc.2008.01.088; Carmon KS, 2010, ANAL BIOCHEM, V401, P288, DOI 10.1016/j.ab.2010.03.009; Dann CE, 2001, NATURE, V412, P86, DOI 10.1038/35083601; DeAlmeida VI, 2007, CANCER RES, V67, P5371, DOI 10.1158/0008-5472.CAN-07-0266; Elamaa H, 2003, MATRIX BIOL, V22, P427, DOI 10.1016/S0945-053X(03)00073-8; Goentoro L, 2009, MOL CELL, V36, P872, DOI 10.1016/j.molcel.2009.11.017; Hsieh JC, 1999, P NATL ACAD SCI USA, V96, P3546, DOI 10.1073/pnas.96.7.3546; Kohfeldt E, 1997, FEBS LETT, V414, P557, DOI 10.1016/S0014-5793(97)01070-3; Lavergne E, 2011, ONCOGENE, V30, P423, DOI 10.1038/onc.2010.432; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Mikels AJ, 2006, ONCOGENE, V25, P7461, DOI 10.1038/sj.onc.1210053; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Mukai A, 2010, EMBO J, V29, P2114, DOI 10.1038/emboj.2010.100; Musso O, 2001, HEPATOLOGY, V33, P868, DOI 10.1053/jhep.2001.23189; Quelard D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001878; Roman-Roman S, 2004, J BIOL CHEM, V279, P5725, DOI 10.1074/jbc.M309233200; Sato A, 1999, DEVELOPMENT, V126, P4421; Semenov MV, 2001, CURR BIOL, V11, P951, DOI 10.1016/S0960-9822(01)00290-1; VALLET V, 1995, MOL CELL BIOL, V15, P5453; Vermeulen L, 2010, NAT CELL BIOL, V12, P468, DOI 10.1038/ncb2048; Wawrzak D, 2007, BIOCHEM BIOPH RES CO, V357, P1119, DOI 10.1016/j.bbrc.2007.04.069; Wu CH, 2002, J BIOL CHEM, V277, P41762, DOI 10.1074/jbc.M207850200	24	17	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2012	7	1							e30601	10.1371/journal.pone.0030601	http://dx.doi.org/10.1371/journal.pone.0030601			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911GB	22303445	Green Published, gold			2022-12-25	WOS:000301704200025
J	Jono, H; Lim, JH; Xu, HD; Li, JD				Jono, Hirofumi; Lim, Jae Hyang; Xu, Haidong; Li, Jian-Dong			PKC theta Synergizes with TLR-Dependent TRAF6 Signaling Pathway to Upregulate MUC5AC Mucin via CARMA1	PLOS ONE			English	Article							NF-KAPPA-B; PROTEIN-KINASE-C; NONTYPABLE HAEMOPHILUS-INFLUENZAE; NECROSIS-FACTOR-ALPHA; BRONCHIAL EPITHELIAL-CELLS; OBSTRUCTIVE PULMONARY-DISEASE; NEGATIVE CROSS-TALK; TOLL-LIKE RECEPTORS; STREPTOCOCCUS-PNEUMONIAE; NEUTROPHIL ELASTASE	CARD-containing MAGUK protein 1 (CARMA1) plays a crucial role in regulating adaptive immune responses upon T-cell receptor (TCR) activation in T cells. Its role in regulating host mucosal innate immune response such as upregulation of mucin remains unknown. Here we show that CARMA1 acts as a key signaling mediator for synergistic upregulation of MUC5AC mucin by bacterium nontypeable Haemophilus influenzae (NTHi) and phorbol ester PMA in respiratory epithelial cells. NTHi-induced TLR-dependent TRAF6-MKK3-p38 MAPK signaling pathway synergizes with PKC theta-MEK-ERK signaling pathway. CARMA1 plays a crucial role in mediating this synergistic effect via TRAF6, thereby resulting in synergistic upregulation of MUC5AC mucin. Thus our study unveils a novel role for CARMA1 in mediating host mucosal innate immune response.	[Jono, Hirofumi; Lim, Jae Hyang; Xu, Haidong; Li, Jian-Dong] Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Rochester, NY 14642 USA; [Lim, Jae Hyang; Xu, Haidong; Li, Jian-Dong] Georgia State Univ, Dept Biol, Atlanta, GA USA; [Lim, Jae Hyang; Xu, Haidong; Li, Jian-Dong] Georgia State Univ, Ctr Inflammat Immun & Infect, Atlanta, GA 30303 USA	University of Rochester; University System of Georgia; Georgia State University; University System of Georgia; Georgia State University	Jono, H (corresponding author), Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Rochester, NY 14642 USA.	jdli@gsu.edu		Lim, Jae Hyang/0000-0003-0972-9271; Li, Jian-Dong/0000-0002-5593-050X	National Institutes of Health [DC005843, DC005843-S1, DC004562, AI073374]; American Heart Association [10SDG2630077]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073374] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005843, R01DC004562] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [23790091] Funding Source: KAKEN	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from National Institutes of Health DC005843, DC005843-S1, DC004562 and AI073374 (to J.-D.L.) and by American Heart Association 10SDG2630077 (to J.H.L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah LH, 1997, AM J PHYSIOL-LUNG C, V273, pL201, DOI 10.1152/ajplung.1997.273.1.L201; Abdullah LH, 2007, AM J PHYSIOL-LUNG C, V293, pL591, DOI 10.1152/ajplung.00150.2007; Akira S, 2004, CR BIOL, V327, P581, DOI 10.1016/j.crvi.2004.04.002; Allen-Gipson DS, 2005, J PHARMACOL EXP THER, V314, P476, DOI 10.1124/jpet.104.079822; Barnes PJ, 2003, ANNU REV MED, V54, P113, DOI 10.1146/annurev.med.54.101601.152209; Barnes PJ, 2003, EUR RESPIR J, V22, P672, DOI 10.1183/09031936.03.00040703; Basbaum C, 1999, AM J RESP CRIT CARE, V160, pS44, DOI 10.1164/ajrccm.160.supplement_1.12; Bertin J, 2001, J BIOL CHEM, V276, P11877, DOI 10.1074/jbc.M010512200; Beutler B, 2004, NATURE, V430, P257, DOI 10.1038/nature02761; Blonska M, 2007, IMMUNITY, V26, P55, DOI 10.1016/j.immuni.2006.11.008; BOBEK LA, 1993, J BIOL CHEM, V268, P20563; CARRIE S, 1992, ACTA OTO-LARYNGOL, V112, P504, DOI 10.3109/00016489209137432; Che TJ, 2004, J BIOL CHEM, V279, P15870, DOI 10.1074/jbc.M310599200; Chen R, 2004, BIOCHEM BIOPH RES CO, V324, P1087, DOI 10.1016/j.bbrc.2004.09.157; Chen Y, 2004, AM J RESP CELL MOL, V30, P155, DOI 10.1165/rcmb.2003-0103OC; Chun YM, 2002, ANN OTO RHINOL LARYN, V111, P507, DOI 10.1177/000348940211100606; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Dunne Aisling, 2003, Sci STKE, V2003, pre3, DOI 10.1126/stke.2003.171.re3; Fischer BM, 1999, AM J RESP CELL MOL, V20, P413, DOI 10.1165/ajrcmb.20.3.3393; FORSTNER G, 1993, AM J PHYSIOL, V264, pG1096, DOI 10.1152/ajpgi.1993.264.6.G1096; Gaide O, 2002, NAT IMMUNOL, V3, P836, DOI 10.1038/ni830; GENDLER SJ, 1995, ANNU REV PHYSIOL, V57, P607, DOI 10.1146/annurev.ph.57.030195.003135; Gum JR, 2002, BIOCHEM BIOPH RES CO, V291, P466, DOI 10.1006/bbrc.2002.6475; Ha UH, 2008, J BIOL CHEM, V283, P30624, DOI 10.1074/jbc.M802519200; Ha U, 2007, J IMMUNOL, V178, P1736, DOI 10.4049/jimmunol.178.3.1736; Hara H, 2004, J EXP MED, V200, P1167, DOI 10.1084/jem.20032246; Hara H, 2003, IMMUNITY, V18, P763, DOI 10.1016/S1074-7613(03)00148-1; Hewson CA, 2004, J MOL BIOL, V344, P683, DOI 10.1016/j.jmb.2004.09.059; Higuchi T, 2004, J BIOL CHEM, V279, P1968, DOI 10.1074/jbc.M304558200; Hong DH, 1999, AM J PHYSIOL-GASTR L, V277, pG1041, DOI 10.1152/ajpgi.1999.277.5.G1041; Hovenberg HW, 1996, BIOCHEM J, V318, P319, DOI 10.1042/bj3180319; Huang YX, 2007, BIOCHEM BIOPH RES CO, V359, P691, DOI 10.1016/j.bbrc.2007.05.170; Ishiguro K, 2006, MOL CELL BIOL, V26, P5497, DOI 10.1128/MCB.02469-05; Ishinaga H, 2007, EMBO J, V26, P1150, DOI 10.1038/sj.emboj.7601546; Jaimes EA, 2007, AM J PHYSIOL-HEART C, V292, pH76, DOI 10.1152/ajpheart.00693.2006; Jaken S, 1996, CURR OPIN CELL BIOL, V8, P168, DOI 10.1016/S0955-0674(96)80062-7; Jono H, 2003, J BIOL CHEM, V278, P27811, DOI 10.1074/jbc.M301773200; Jono H, 2002, J BIOL CHEM, V277, P45547, DOI 10.1074/jbc.M206883200; KELLER K, 1992, ARCHIVES OF MEDICAL RESEARCH, VOL 23, NO 2, P217; Kerschner JE, 2007, LARYNGOSCOPE, V117, P1666, DOI 10.1097/MLG.0b013e31806db531; Kim WD, 1997, EUR RESPIR J, V10, P1914, DOI 10.1183/09031936.97.10081914; Kim YD, 2002, J KOREAN MED SCI, V17, P765, DOI 10.3346/jkms.2002.17.6.765; KIM YS, 1995, GASTROENTEROLOGY, V109, P999, DOI 10.1016/0016-5085(95)90412-3; Knowles MR, 2002, J CLIN INVEST, V109, P571, DOI 10.1172/JCI200215217; Koo JS, 2002, EXP LUNG RES, V28, P315, DOI 10.1080/01902140252964393; Kopp E, 2003, CURR OPIN IMMUNOL, V15, P396, DOI 10.1016/S0952-7915(03)00080-3; Lapensee L, 1997, FERTIL STERIL, V68, P702, DOI 10.1016/S0015-0282(97)00317-8; LARIVEE P, 1994, AM J RESP CELL MOL, V11, P199, DOI 10.1165/ajrcmb.11.2.8049080; Latz E, 2002, J BIOL CHEM, V277, P47834, DOI 10.1074/jbc.M207873200; Lee HW, 2002, J BIOL CHEM, V277, P32624, DOI 10.1074/jbc.M200353200; Lee KY, 2005, SCIENCE, V308, P114, DOI 10.1126/science.1107107; Lee SD, 2001, AM J PHYSIOL-LUNG C, V281, pL403, DOI 10.1152/ajplung.2001.281.2.L403; Li JD, 2003, J PHARMACOL SCI, V91, P1, DOI 10.1254/jphs.91.1; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Lim JH, 2008, CELL MICROBIOL, V10, P2247, DOI 10.1111/j.1462-5822.2008.01204.x; Lim JH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001032; Lim JH, 2007, IMMUNITY, V27, P349, DOI 10.1016/j.immuni.2007.07.011; Lim JH, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-40; Lin X, 2004, SEMIN IMMUNOL, V16, P429, DOI 10.1016/j.smim.2004.08.022; Longphre M, 1999, J CLIN INVEST, V104, P1375, DOI 10.1172/JCI6097; Matsumoto R, 2005, IMMUNITY, V23, P575, DOI 10.1016/j.immuni.2005.10.007; McCully RR, 2008, MOL CELL BIOL, V28, P5668, DOI 10.1128/MCB.00418-08; Medeiros RB, 2007, SCIENCE, V316, P754, DOI 10.1126/science.1137895; Mikami F, 2005, J BIOL CHEM, V280, P36185, DOI 10.1074/jbc.M503941200; Mikami F, 2006, J BIOL CHEM, V281, P22397, DOI 10.1074/jbc.M602124200; Misra RS, 2007, J BIOL CHEM, V282, P19365, DOI 10.1074/jbc.M610610200; Murphy TF, 2006, INFECT IMMUN, V74, P5169, DOI 10.1128/IAI.00692-06; Pallesen LT, 2002, EUR J BIOCHEM, V269, P2755, DOI 10.1046/j.1432-1033.2002.02949.x; Parekh R, 2000, IEEE T NEURAL NETWOR, V11, P436, DOI 10.1109/72.839013; Park JA, 2005, AM J PATHOL, V167, P651, DOI 10.1016/S0002-9440(10)62040-8; Park JA, 2007, AM J PATHOL, V171, P1822, DOI 10.2353/ajpath.2007.070318; Park SG, 2009, NAT IMMUNOL, V10, P158, DOI 10.1038/ni.1687; Rogers DF, 2006, ANN MED, V38, P116, DOI 10.1080/07853890600585795; Ron D, 1999, FASEB J, V13, P1658, DOI 10.1096/fasebj.13.13.1658; Rose MC, 2006, PHYSIOL REV, V86, P245, DOI 10.1152/physrev.00010.2005; Rose MC, 2001, AM J RESP CELL MOL, V25, P533, DOI 10.1165/ajrcmb.25.5.f218; Sakai A, 2007, FEBS J, V274, P3655, DOI 10.1111/j.1742-4658.2007.05899.x; Schmitz ML, 2003, FASEB J, V17, P2187, DOI 10.1096/fj.02-1100rev; Schulze-Luehrmann J, 2006, IMMUNITY, V25, P701, DOI 10.1016/j.immuni.2006.10.010; SERS C, 1993, P NATL ACAD SCI USA, V90, P8514, DOI 10.1073/pnas.90.18.8514; Shambharkar PB, 2007, EMBO J, V26, P1794, DOI 10.1038/sj.emboj.7601622; SHANKAR V, 1994, BIOCHEM J, V300, P295, DOI 10.1042/bj3000295; Shao MXG, 2005, J IMMUNOL, V175, P4009, DOI 10.4049/jimmunol.175.6.4009; Shao ZH, 2003, PHARMACOL RES, V47, P463, DOI 10.1016/S1043-6618(03)00041-0; Sharma P, 1998, AM J RESP CELL MOL, V19, P30, DOI 10.1165/ajrcmb.19.1.3054; Shinohara H, 2005, J EXP MED, V202, P1423, DOI 10.1084/jem.20051591; Smirnova MG, 2001, EUR CYTOKINE NETW, V12, P119; Sommer K, 2005, IMMUNITY, V23, P561, DOI 10.1016/j.immuni.2005.09.014; Stilo R, 2004, J BIOL CHEM, V279, P34323, DOI 10.1074/jbc.M402244200; Takeuchi O, 2000, J IMMUNOL, V165, P5392, DOI 10.4049/jimmunol.165.10.5392; Thome M, 2007, TRENDS IMMUNOL, V28, P281, DOI 10.1016/j.it.2007.04.004; Thornton David J, 2004, Proc Am Thorac Soc, V1, P54, DOI 10.1513/pats.2306016; TORIBARA NW, 1993, J BIOL CHEM, V268, P5879; Wang BN, 2002, J BIOL CHEM, V277, P949, DOI 10.1074/jbc.M107484200; Wang DH, 2004, MOL CELL BIOL, V24, P164, DOI 10.1128/MCB.24.1.164-171.2003; Wang DH, 2002, NAT IMMUNOL, V3, P830, DOI 10.1038/ni824; Watanabe T, 2004, P NATL ACAD SCI USA, V101, P3563, DOI 10.1073/pnas.0400557101; Way KJ, 2000, TRENDS PHARMACOL SCI, V21, P181, DOI 10.1016/S0165-6147(00)01468-1; Williams SJ, 1999, CANCER RES, V59, P4083; Williams SJ, 2001, J BIOL CHEM, V276, P18327, DOI 10.1074/jbc.M008850200; Yin BWT, 2001, J BIOL CHEM, V276, P27371, DOI 10.1074/jbc.M103554200; Yoshida H, 2005, J BIOL CHEM, V280, P41111, DOI 10.1074/jbc.M509526200	102	7	9	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2012	7	1							e31049	10.1371/journal.pone.0031049	http://dx.doi.org/10.1371/journal.pone.0031049			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911GB	22303480	Green Published, Green Submitted, gold			2022-12-25	WOS:000301704200057
J	Negi, S; Jetha, A; Aikin, R; Hasilo, C; Sladek, R; Paraskevas, S				Negi, Sarita; Jetha, Arif; Aikin, Reid; Hasilo, Craig; Sladek, Rob; Paraskevas, Steven			Analysis of Beta-Cell Gene Expression Reveals Inflammatory Signaling and Evidence of Dedifferentiation following Human Islet Isolation and Culture	PLOS ONE			English	Article							HUMAN PANCREATIC-ISLETS; NF-KAPPA-B; STIMULATED INSULIN-SECRETION; ADULT HUMAN; IN-VITRO; ENDOCRINE PANCREAS; GRAFT FUNCTION; MESENCHYMAL TRANSITION; PROGENITOR CELLS; PRECURSOR CELLS	The stresses encountered during islet isolation and culture may have deleterious effects on beta-cell physiology. However, the biological response of human islet cells to isolation remains poorly characterized. A better understanding of the network of signaling pathways induced by islet isolation and culturing may lead to strategies aimed at improving islet graft survival and function. Laser capture microdissection (LCM) was used to extract beta-cell RNA from 1) intact pancreatic islets, 2) freshly isolated islets, 3) islets cultured for 3 days, and changes in gene expression were examined by microarray analysis. We identified a strong inflammatory response induced by islet isolation that continues during in-vitro culture manifested by upregulation of several cytokines and cytokine-receptors. The most highly upregulated gene, interleukin-8 (IL-8), was induced by 3.6-fold following islet isolation and 56-fold after 3 days in culture. Immunofluorescence studies showed that the majority of IL-8 was produced by beta-cells themselves. We also observed that several pancreas-specific transcription factors were down-regulated in cultured islets. Concordantly, several pancreatic progenitor cell-specific transcription factors like SOX4, SOX9, and ID2 were upregulated in cultured islets, suggesting progressive transformation of mature beta-cell phenotype toward an immature endocrine cell phenotype. Our findings suggest islet isolation and culture induces an inflammatory response and loss of the mature endocrine cell phenotype. A better understanding of the signals required to maintain a mature beta-cell phenotype may help improve the efficacy of islet transplantation.	[Negi, Sarita; Jetha, Arif; Aikin, Reid; Hasilo, Craig; Paraskevas, Steven] McGill Univ, Ctr Hlth, Human Islet Transplantat Lab, Montreal, PQ, Canada; [Negi, Sarita; Jetha, Arif; Aikin, Reid; Hasilo, Craig; Paraskevas, Steven] McGill Univ, Dept Surg, Montreal, PQ H3A 2T5, Canada; [Sladek, Rob] Genome Quebec Innovat Ctr, Montreal, PQ, Canada	McGill University; McGill University	Negi, S (corresponding author), McGill Univ, Ctr Hlth, Human Islet Transplantat Lab, Montreal, PQ, Canada.	steven.paraskevas@mcgill.ca	Sladek, Robert/R-2391-2019	Sladek, Robert/0000-0002-2730-1204	Diabetes-Quebec	Diabetes-Quebec	This work was supported by a grant from Diabetes-Quebec. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 2008, FEBS J, V275, P318, DOI 10.1111/j.1742-4658.2007.06202.x; Artner I, 2007, P NATL ACAD SCI USA, V104, P3853, DOI 10.1073/pnas.0700013104; Artner I, 2010, DIABETES, V59, P2530, DOI 10.2337/db10-0190; Bar Y, 2008, DIABETES, V57, P2413, DOI 10.2337/db07-1323; BEATTIE GM, 1991, J CLIN ENDOCR METAB, V73, P93, DOI 10.1210/jcem-73-1-93; Bedke J, 2010, MOL IMMUNOL, V47, P1047, DOI 10.1016/j.molimm.2009.11.012; Bennet W, 2000, UPSALA J MED SCI, V105, P125, DOI 10.1517/03009734000000059; Bertuzzi F, 2004, J CLIN ENDOCR METAB, V89, P5724, DOI 10.1210/jc.2004-0659; Boni-Schnetzler M, 2008, J CLIN ENDOCR METAB, V93, P4065, DOI 10.1210/jc.2008-0396; Cabrera O, 2006, P NATL ACAD SCI USA, V103, P2334, DOI 10.1073/pnas.0510790103; Chao CS, 2007, DEV BIOL, V312, P523, DOI 10.1016/j.ydbio.2007.09.057; Chen C, 2011, AM J TRANSPLANT; Collombat P, 2003, GENE DEV, V17, P2591, DOI 10.1101/gad.269003; De Perrot M, 2002, AM J RESP CRIT CARE, V165, P211, DOI 10.1164/ajrccm.165.2.2011151; Driessler F, 2004, CLIN EXP IMMUNOL, V135, P64, DOI 10.1111/j.1365-2249.2004.02342.x; Dror V, 2007, DIABETOLOGIA, V50, P2504, DOI 10.1007/s00125-007-0835-5; Ehses JA, 2007, DIABETES, V56, P2356, DOI 10.2337/db06-1650; Eich T, 2007, NEW ENGL J MED, V356, P2754, DOI 10.1056/NEJMc070201; Gershengorn MC, 2004, SCIENCE, V306, P2261, DOI 10.1126/science.1101968; Giuliani M, 2005, CELL TRANSPLANT, V14, P67, DOI 10.3727/000000005783983287; Gu CY, 2010, CELL METAB, V11, P298, DOI 10.1016/j.cmet.2010.03.006; GUILLEMOT F, 1995, NAT GENET, V9, P235, DOI 10.1038/ng0395-235; Hardikar AA, 2003, P NATL ACAD SCI USA, V100, P7117, DOI 10.1073/pnas.1232230100; Hochachka PW, 1996, P NATL ACAD SCI USA, V93, P9493, DOI 10.1073/pnas.93.18.9493; Hua H, 2006, J BIOL CHEM, V281, P13574, DOI 10.1074/jbc.M600526200; Iguchi H, 2005, J BIOL CHEM, V280, P37669, DOI 10.1074/jbc.M505392200; Ilmakunnas M, 2010, CLIN TRANSPLANT, V24, P29, DOI 10.1111/j.1399-0012.2009.00975.x; Kalousova A, 2010, DEV BIOL, V348, P143, DOI 10.1016/j.ydbio.2010.09.007; Kim SK, 2002, NAT GENET, V30, P430, DOI 10.1038/ng860; Kwon O, 2003, AM J KIDNEY DIS, V41, P1074, DOI 10.1016/S0272-6386(03)00206-3; Lakey JRT, 2001, TRANSPLANTATION, V72, P565; Linn T, 2003, FASEB J, V17, P881, DOI 10.1096/fj.02-0615fje; Lynn FC, 2007, P NATL ACAD SCI USA, V104, P10500, DOI 10.1073/pnas.0704054104; Marselli L, 2008, J CLIN ENDOCR METAB, V93, P1046, DOI 10.1210/jc.2007-0931; Marzorati S, 2006, AM J TRANSPLANT, V6, P2791, DOI 10.1111/j.1600-6143.2006.01512.x; Matsuda T, 2005, AM J TRANSPLANT, V5, P484, DOI 10.1046/j.1600-6143.2004.00716.x; McDonald E, 2009, STEM CELLS DEV, V18, P1379, DOI 10.1089/scd.2009.0240; Mita A, 2010, CELL TRANSPLANT, V19, P1537, DOI 10.3727/096368910X516600; Miyatsuka T, 2009, DIABETES, V58, P1863, DOI 10.2337/db09-0390; Movahedi B, 2008, DIABETES, V57, P2128, DOI 10.2337/db07-1705; Nakhai H, 2008, DEVELOPMENT, V135, P2757, DOI 10.1242/dev.013722; Nishimura W, 2008, DEV BIOL, V314, P443, DOI 10.1016/j.ydbio.2007.12.009; Paraskevas S, 1999, FEBS LETT, V455, P203, DOI 10.1016/S0014-5793(99)00882-0; Paraskevas S, 2000, PANCREAS, V20, P270, DOI 10.1097/00006676-200004000-00008; Piemonti L, 2002, DIABETES, V51, P55, DOI 10.2337/diabetes.51.1.55; Rao JN, 2003, EUR J CARDIO-THORAC, V23, P497, DOI 10.1016/S1010-7940(02)00842-4; Rehman KK, 2003, J BIOL CHEM, V278, P9862, DOI 10.1074/jbc.M207700200; RICORDI C, 1988, DIABETES, V37, P413, DOI 10.2337/diabetes.37.4.413; Rukstalis JM, 2007, GENE EXPR PATTERNS, V7, P471, DOI 10.1016/j.modgep.2006.11.001; Russ HA, 2008, DIABETES, V57, P1575, DOI 10.2337/db07-1283; Russ HA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006417; Sarkar SA, 2009, DIABETOLOGIA, V52, P1092, DOI 10.1007/s00125-009-1331-x; Schmitz ML, 2004, CHEMBIOCHEM, V5, P1348, DOI 10.1002/cbic.200400144; Seymour PA, 2007, P NATL ACAD SCI USA, V104, P1865, DOI 10.1073/pnas.0609217104; Shapiro AMJ, 2006, NEW ENGL J MED, V355, P1318, DOI 10.1056/NEJMoa061267; Szabat M, 2011, ISLETS, V3, P175, DOI 10.4161/isl.3.4.15881; Thackaberry EA, 2003, TOXICOL SCI, V76, P407, DOI 10.1093/toxsci/kfg229; Uno S, 2010, ENDOCR J, V57, P991, DOI 10.1507/endocrj.K10E-076; Ushita M, 2009, OSTEOARTHR CARTILAGE, V17, P1065, DOI 10.1016/j.joca.2009.02.003; Vanhorenbeeck V, 2007, DEV BIOL, V305, P685, DOI 10.1016/j.ydbio.2007.02.027; Wang S, 2007, MECH DEVELOP, V124, P898, DOI 10.1016/j.mod.2007.08.004; Weinberg N, 2007, DIABETES, V56, P1299, DOI 10.2337/db06-1654; Wilson ME, 2005, DIABETES, V54, P3402, DOI 10.2337/diabetes.54.12.3402; Wu YX, 2010, LAB INVEST, V90, P1373, DOI 10.1038/labinvest.2010.106; Ylipaa Antti, 2011, Chin J Cancer, V30, P27; Zhang C, 2005, MOL CELL BIOL, V25, P4969, DOI 10.1128/MCB.25.12.4969-4976.2005	66	94	95	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2012	7	1							e30415	10.1371/journal.pone.0030415	http://dx.doi.org/10.1371/journal.pone.0030415			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911GB	22299040	Green Published, gold, Green Submitted			2022-12-25	WOS:000301704200017
J	Ning, XX; Sun, SR; Zhang, K; Liang, J; Chuai, YC; Li, Y; Wang, XM				Ning, Xiaoxuan; Sun, Shiren; Zhang, Kun; Liang, Jie; Chuai, Yucai; Li, Yuan; Wang, Xiaoming			S100A6 Protein Negatively Regulates CacyBP/SIP-Mediated Inhibition of Gastric Cancer Cell Proliferation and Tumorigenesis	PLOS ONE			English	Article							CALCIUM-BINDING PROTEINS; CALCYCLIN; PATHWAY; DEGRADATION; EXPRESSION; TUBULIN; SIP; INVASION; COMPLEX; SIAH-1	Calcyclin-binding protein (CacyBP/SIP), identified on the basis of its ability to interact with S100 proteins in a calcium-dependent manner, was previously found to inhibit the proliferation and tumorigenesis of gastric cancer cells in our laboratory. Importantly, the effects of S100 proteins on the biological behavior of CacyBP/SIP in gastric cancer remain unclear. Herein, we report the construction of eukaryotic expression vectors for wild-type CacyBP/SIP and a truncated mutant lacking the S100 protein binding domain (CacyBP/SIPDS100). The expressions of the wild-type and truncated recombinant proteins were demonstrated by transfection of MKN45 gastric cancer cells. Co-immunoprecipitation assays demonstrated interaction between S100A6 and wild-type CacyBP/SIP in MKN45 cells. Removal of the S100 protein binding domain dramatically reduced the affinity of CacyBP/SIP for S100 proteins as indicated by reduced co-immunoprecipitation of S100A6 by CacyBP/SIPDS100. The MTT assay, FACS assay, clonogenic assay and tumor xenograft experiment were performed to assess the effect of CacyBP/SIP on cell growth and tumorigenesis in vitro and in vivo. Overexpression of CacyBP/SIP inhibited the proliferation and tumorigenesis of MKN45 gastric cancer cells; the proliferation and tumorigenesis rates were even further reduced by the expression of CacyBP/SIPDS100. We also showed that S100 proteins negatively regulate CacyBP/SIP-mediated inhibition of gastric cancer cell proliferation, through an effect on beta-catenin protein expression and transcriptional activation of Tcf/LEF. Although the underlying mechanism of action requires further investigation, this study provides new insight into the interaction between S100 proteins and CacyBP/SIP, which might enrich our knowledge of S100 proteins and be helpful for our understanding of the development of gastric cancer.	[Ning, Xiaoxuan; Chuai, Yucai; Li, Yuan; Wang, Xiaoming] Fourth Mil Med Univ, Xijing Hosp, Dept Geriatr, Xian 710032, Shaanxi, Peoples R China; [Sun, Shiren] Fourth Mil Med Univ, Xijing Hosp, Dept Nephrol, Xian 710032, Shaanxi, Peoples R China; [Liang, Jie] Fourth Mil Med Univ, Xijing Hosp, State Key Lab Canc Biol, Xian 710032, Shaanxi, Peoples R China; [Liang, Jie] Fourth Mil Med Univ, Xijing Hosp, Inst Digest Dis, Xian 710032, Shaanxi, Peoples R China; [Zhang, Kun] Shaanxi Normal Univ, Coll Life Sci, Xian, Shaanxi, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Shaanxi Normal University	Ning, XX (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Geriatr, Xian 710032, Shaanxi, Peoples R China.	ningxx01@sohu.com; ggcgxl@fmmu.edu.cn; xmwang@fmmu.edu.cn			National Nature Science Foundation of China [30872964, 30772461]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from National Nature Science Foundation of China (No. 30872964, No. 30772461). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhattacharya S, 2005, BIOCHEMISTRY-US, V44, P9462, DOI 10.1021/bi0502689; Cho YG, 2003, APMIS, V111, P539, DOI 10.1034/j.1600-0463.2003.1110502.x; Donato R, 1999, BBA-MOL CELL RES, V1450, P191, DOI 10.1016/S0167-4889(99)00058-0; Filipek A, 2006, CHEMOTHERAPY, V52, P32, DOI 10.1159/000090240; Filipek A, 1998, J NEUROCHEM, V70, P1793, DOI 10.1046/j.1471-4159.1998.70051793.x; Filipek A, 2002, J BIOL CHEM, V277, P28848, DOI 10.1074/jbc.M203602200; Filipek A, 2008, J NEURAL TRANSM, V115, P1257, DOI 10.1007/s00702-008-0062-3; Filipek A, 2008, ADV ENZYME REGUL, V48, P225, DOI 10.1016/j.advenzreg.2007.11.001; Fukushima T, 2006, IMMUNITY, V24, P29, DOI 10.1016/j.immuni.2005.12.002; Heizmann CW, 2002, FRONT BIOSCI-LANDMRK, V7, pD1356, DOI 10.2741/heizmann; Kilanczyk E, 2009, BIOCHEM BIOPH RES CO, V380, P54, DOI 10.1016/j.bbrc.2009.01.026; Kolligs FT, 2002, DIGESTION, V66, P131, DOI 10.1159/000066755; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Lai RH, 2010, CANCER LETT, V288, P75, DOI 10.1016/j.canlet.2009.06.025; Lee YT, 2008, BIOCHEMISTRY-US, V47, P10921, DOI 10.1021/bi801233z; Lesniak W, 2009, BIOCHEM BIOPH RES CO, V390, P1087, DOI 10.1016/j.bbrc.2009.10.150; Lustig B, 2003, J CANCER RES CLIN, V129, P199, DOI 10.1007/s00432-003-0431-0; Martensson A, 2007, ONCOL REP, V17, P447; Matsuzawa S, 2001, MOL CELL, V7, P915, DOI 10.1016/S1097-2765(01)00242-8; Meng FP, 2009, CANCER BIOL THER, V8, P174, DOI 10.4161/cbt.8.2.7208; Mori M, 2004, ONCOL REP, V11, P1287; Ning XX, 2007, MOL CANCER RES, V5, P1254, DOI 10.1158/1541-7786.MCR-06-0426; Nowotny M, 2003, J BIOL CHEM, V278, P26923, DOI 10.1074/jbc.M211518200; Ohuchida K, 2005, CLIN CANCER RES, V11, P7785, DOI 10.1158/1078-0432.CCR-05-0714; Saadeddin A, 2009, MOL CANCER RES, V7, P1189, DOI 10.1158/1541-7786.MCR-09-0027; Saleem M, 2006, P NATL ACAD SCI USA, V103, P14825, DOI 10.1073/pnas.0606747103; Santamaria-Kisiel L, 2006, BIOCHEM J, V396, P201, DOI 10.1042/BJ20060195; Santelli E, 2005, J BIOL CHEM, V280, P34278, DOI 10.1074/jbc.M506707200; Schafer BW, 1996, TRENDS BIOCHEM SCI, V21, P134, DOI 10.1016/S0968-0004(96)80167-8; SCHAFER BW, 1995, GENOMICS, V25, P638, DOI 10.1016/0888-7543(95)80005-7; Schneider G, 2007, BBA-MOL CELL RES, V1773, P1628, DOI 10.1016/j.bbamcr.2007.07.013; Schneider G, 2010, BBA-MOL CELL RES, V1803, P1308, DOI 10.1016/j.bbamcr.2010.07.003; Schneider G, 2011, AMINO ACIDS, V41, P773, DOI 10.1007/s00726-010-0498-2; Shimamoto S, 2010, FEBS LETT, V584, P1119, DOI 10.1016/j.febslet.2010.02.055; Shyu RY, 2003, J BIOMED SCI, V10, P313, DOI 10.1159/000070096; Sun SR, 2007, BIOCHEM BIOPH RES CO, V356, P864, DOI 10.1016/j.bbrc.2007.03.080; van Dieck J, 2010, ONCOGENE, V29, P2024, DOI 10.1038/onc.2009.490; Ye YW, 2011, CANCER LETT, V307, P124, DOI 10.1016/j.canlet.2011.03.024; Zhai HH, 2006, HYBRIDOMA, V25, P91, DOI 10.1089/hyb.2006.25.91; Zhao YQ, 2002, CANCER LETT, V185, P211, DOI 10.1016/S0304-3835(02)00264-1	40	24	29	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e30185	10.1371/journal.pone.0030185	http://dx.doi.org/10.1371/journal.pone.0030185			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910ME	22295074	gold, Green Published, Green Submitted			2022-12-25	WOS:000301640600019
J	Segovia, J; Sabbah, A; Mgbemena, V; Tsai, SY; Chang, TH; Berton, MT; Morris, IR; Allen, IC; Ting, JPY; Bose, S				Segovia, Jesus; Sabbah, Ahmed; Mgbemena, Victoria; Tsai, Su-Yu; Chang, Te-Hung; Berton, Michael T.; Morris, Ian R.; Allen, Irving C.; Ting, Jenny P. -Y.; Bose, Santanu			TLR2/MyD88/NF-kappa B Pathway, Reactive Oxygen Species, Potassium Efflux Activates NLRP3/ASC Inflammasome during Respiratory Syncytial Virus Infection	PLOS ONE			English	Article							INNATE ANTIVIRAL RESPONSE; NUCLEOTIDE-BINDING DOMAIN; ANTHRAX LETHAL TOXIN; LEUCINE-RICH REPEAT; TOLL-LIKE RECEPTORS; CUTTING EDGE; CASPASE-1 ACTIVATION; NALP3 INFLAMMASOME; VIRAL-INFECTION; GENE-EXPRESSION	Human respiratory syncytial virus (RSV) constitute highly pathogenic virus that cause severe respiratory diseases in newborn, children, elderly and immuno-compromised individuals. Airway inflammation is a critical regulator of disease outcome in RSV infected hosts. Although "controlled'' inflammation is required for virus clearance, aberrant and exaggerated inflammation during RSV infection results in development of inflammatory diseases like pneumonia and bronchiolitis. Interleukin-1 beta (IL-1 beta) plays an important role in inflammation by orchestrating the pro-inflammatory response. IL-1b is synthesized as an immature pro-IL-1 beta form. It is cleaved by activated caspase-1 to yield mature IL-1 beta that is secreted extracellularly. Activation of caspase-1 is mediated by a multi-protein complex known as the inflammasome. Although RSV infection results in IL-1 beta release, the mechanism is unknown. Here in, we have characterized the mechanism of IL-1 beta secretion following RSV infection. Our study revealed that NLRP3/ASC inflammasome activation is crucial for IL-1 beta production during RSV infection. Further studies illustrated that prior to inflammasome formation; the "first signal'' constitutes activation of toll-like receptor-2 (TLR2)/MyD88/NF-kappa B pathway. TLR2/MyD88/NF-kappa B signaling is required for pro-IL-1 beta and NLRP3 gene expression during RSV infection. Following expression of these genes, two "second signals'' are essential for triggering inflammasome activation. Intracellular reactive oxygen species (ROS) and potassium (K+) efflux due to stimulation of ATP-sensitive ion channel promote inflammasome activation following RSV infection. Thus, our studies have underscored the requirement of TLR2/MyD88/NF-kappa B pathway (first signal) and ROS/potassium efflux (second signal) for NLRP3/ASC inflammasome formation, leading to caspase-1 activation and subsequent IL-1 beta release during RSV infection.	[Segovia, Jesus; Sabbah, Ahmed; Mgbemena, Victoria; Tsai, Su-Yu; Chang, Te-Hung; Berton, Michael T.; Morris, Ian R.; Bose, Santanu] Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol & Immunol, San Antonio, TX 78229 USA; [Allen, Irving C.; Ting, Jenny P. -Y.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Microbiol Immunol, Chapel Hill, NC 27599 USA	University of Texas System; University of Texas Health San Antonio; University of North Carolina; University of North Carolina Chapel Hill	Segovia, J (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol & Immunol, San Antonio, TX 78229 USA.	bose@uthscsa.edu			National Institutes of Health (NIH) [AI083387, AI057986, U19 AI077437, U54 AI057157, T32AI007271]; Center for Innovation in Prevention and Treatment of Airway Diseases (CIPTAD); NIH National Institute of Dental and Craniofacial Research (NIDCR) [DE14318]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI057986, U54AI057157, R01AI083387, U19AI077437, T32AI007271] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T32DE014318] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Innovation in Prevention and Treatment of Airway Diseases (CIPTAD); NIH National Institute of Dental and Craniofacial Research (NIDCR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by the National Institutes of Health (NIH) grants AI083387 (SB), AI057986 (MTB), U19 AI077437 (JPYT), U54 AI057157 (JPYT) and a grant from Center for Innovation in Prevention and Treatment of Airway Diseases (CIPTAD) (SB). AS and VM were supported by NIH National Institute of Dental and Craniofacial Research (NIDCR) grant DE14318 for the COSTAR program. IRM was supported by NIH training grant T32AI007271. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Sater AA, 2009, J BIOL CHEM, V284, P26789, DOI 10.1074/jbc.M109.026823; Allam R, 2011, J IMMUNOL, V186, P2714, DOI 10.4049/jimmunol.1002657; Allen IC, 2009, IMMUNITY, V30, P556, DOI 10.1016/j.immuni.2009.02.005; Babelova A, 2009, J BIOL CHEM, V284, P24035, DOI 10.1074/jbc.M109.014266; Barlan AU, 2011, J VIROL, V85, P146, DOI 10.1128/JVI.01265-10; Bauernfeind F, 2011, J IMMUNOL, V187, P613, DOI 10.4049/jimmunol.1100613; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Becker CE, 2009, J BIOL CHEM, V284, P34531, DOI 10.1074/jbc.M109.046102; Bermejo-Martin JF, 2007, EUR CYTOKINE NETW, V18, P162; Blanco JCG, 2002, J INFECT DIS, V185, P1780, DOI 10.1086/340823; Bose S, 2003, J INTERF CYTOK RES, V23, P401, DOI 10.1089/107999003322277810; Bose S, 2003, P NATL ACAD SCI USA, V100, P10890, DOI 10.1073/pnas.1832775100; Bryant C, 2009, TRENDS CELL BIOL, V19, P455, DOI 10.1016/j.tcb.2009.06.002; Cassel SL, 2008, P NATL ACAD SCI USA, V105, P9035, DOI 10.1073/pnas.0803933105; Castro SM, 2006, AM J RESP CRIT CARE, V174, P1361, DOI 10.1164/rccm.200603-319OC; Chen WZ, 2000, EXP LUNG RES, V26, P13, DOI 10.1080/019021400269934; Chu J, 2009, J LEUKOCYTE BIOL, V86, P1227, DOI 10.1189/jlb.0309164; COLLINS PL, 2001, FIELDS VIROLOGY, P1443; Davis BK, 2011, ANNU REV IMMUNOL, V29, P707, DOI 10.1146/annurev-immunol-031210-101405; Davis IC, 2006, AM J RESP CRIT CARE, V173, P673, DOI 10.1164/rccm.200508-1200OC; Delaloye J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000480; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Dostert C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006510; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Duncan JA, 2009, J IMMUNOL, V182, P6460, DOI 10.4049/jimmunol.0802696; Echchgadda I, 2009, CANCER GENE THER, V16, P923, DOI 10.1038/cgt.2009.34; Fink SL, 2008, P NATL ACAD SCI USA, V105, P4312, DOI 10.1073/pnas.0707370105; Franchi L, 2007, J BIOL CHEM, V282, P18810, DOI 10.1074/jbc.M610762200; Franchi L, 2010, EUR J IMMUNOL, V40, P611, DOI 10.1002/eji.200940180; Franchi L, 2009, J IMMUNOL, V183, P792, DOI 10.4049/jimmunol.0900173; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; Franchi L, 2009, IMMUNOL REV, V227, P106, DOI 10.1111/j.1600-065X.2008.00734.x; Gross O, 2009, NATURE, V459, P433, DOI 10.1038/nature07965; Guerrero-Plata A, 2005, J VIROL, V79, P14992, DOI 10.1128/JVI.79.23.14992-14997.2005; Gurcel L, 2006, CELL, V126, P1135, DOI 10.1016/j.cell.2006.07.033; Hall CB, 2001, NEW ENGL J MED, V344, P1917, DOI 10.1056/NEJM200106213442507; Harder J, 2009, J IMMUNOL, V183, P5823, DOI 10.4049/jimmunol.0900444; Haynes LM, 2001, J VIROL, V75, P10730, DOI 10.1128/JVI.75.22.10730-10737.2001; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Ichinohe T, 2010, NAT IMMUNOL, V11, P404, DOI 10.1038/ni.1861; Ichinohe T, 2009, J EXP MED, V206, P79, DOI 10.1084/jem.20081667; Jha S, 2009, J IMMUNOL, V183, P7623, DOI 10.4049/jimmunol.0902425; Jin CC, 2010, J CLIN IMMUNOL, V30, P628, DOI 10.1007/s10875-010-9440-3; Kankkunen P, 2010, J IMMUNOL, V184, P6335, DOI 10.4049/jimmunol.0903019; Kanneganti TD, 2006, J BIOL CHEM, V281, P36560, DOI 10.1074/jbc.M607594200; Kanneganti TD, 2010, NAT REV IMMUNOL, V10, P688, DOI 10.1038/nri2851; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Kota S, 2008, J BIOL CHEM, V283, P22417, DOI 10.1074/jbc.M710415200; Kurt-Jones EA, 2000, NAT IMMUNOL, V1, P398, DOI 10.1038/80833; Lamkanfi M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000510; Lamkanfi M, 2009, J BIOL CHEM, V284, P20574, DOI 10.1074/jbc.M109.023689; Lindgren C, 1996, ACTA PAEDIATR, V85, P798, DOI 10.1111/j.1651-2227.1996.tb14154.x; Liu TS, 2004, J BIOL CHEM, V279, P2461, DOI 10.1074/jbc.M307251200; Maitra R, 2009, MOL IMMUNOL, V47, P175, DOI 10.1016/j.molimm.2009.09.023; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Masters SL, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001902; Masters SL, 2010, NAT IMMUNOL, V11, P897, DOI 10.1038/ni.1935; Mastronarde JG, 1996, J INFECT DIS, V174, P262, DOI 10.1093/infdis/174.2.262; Meissner F, 2008, NAT IMMUNOL, V9, P866, DOI 10.1038/ni.1633; Murawski MR, 2009, J VIROL, V83, P1492, DOI 10.1128/JVI.00671-08; Naik E, 2011, J EXP MED, V208, P417, DOI 10.1084/jem.20110367; Netea MG, 2009, BLOOD, V113, P2324, DOI 10.1182/blood-2008-03-146720; O'Connor W, 2003, J IMMUNOL, V171, P6329, DOI 10.4049/jimmunol.171.12.6329; O'Neill LAJ, 2006, CURR OPIN IMMUNOL, V18, P3, DOI 10.1016/j.coi.2005.11.012; O'Neill LAJ, 2010, CURR BIOL, V20, pR328, DOI 10.1016/j.cub.2010.01.044; Okada SF, 2011, AM J RESP CELL MOL, V45, P253, DOI 10.1165/rcmb.2010-0253OC; Pazdrak K, 2002, AM J PHYSIOL-LUNG C, V283, pL364, DOI 10.1152/ajplung.00331.2001; Poeck H, 2010, NAT IMMUNOL, V11, P63, DOI 10.1038/ni.1824; Qu Y, 2007, J IMMUNOL, V179, P1913, DOI 10.4049/jimmunol.179.3.1913; RACOOSIN EL, 1989, J EXP MED, V170, P1635, DOI 10.1084/jem.170.5.1635; Rajamaki K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011765; Rathinam VAK, 2010, J CLIN IMMUNOL, V30, P632, DOI 10.1007/s10875-010-9431-4; Rathinam VAK, 2010, NAT IMMUNOL, V11, P395, DOI 10.1038/ni.1864; Ruuskanen O, 2011, LANCET, V377, P1264, DOI 10.1016/S0140-6736(10)61459-6; Sabbah A, 2009, NAT IMMUNOL, V10, P1073, DOI 10.1038/ni.1782; Said-Sadier N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010008; Schmitz N, 2005, J VIROL, V79, P6441, DOI 10.1128/JVI.79.10.6441-6448.2005; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Schroder K, 2010, SCIENCE, V327, P296, DOI 10.1126/science.1184003; Tannahill GM, 2011, FEBS LETT, V585, P1568, DOI 10.1016/j.febslet.2011.05.008; Thomas PG, 2009, IMMUNITY, V30, P566, DOI 10.1016/j.immuni.2009.02.006; Tian B, 2002, J VIROL, V76, P6800, DOI 10.1128/JVI.76.13.6800-6814.2002; Toma C, 2010, J IMMUNOL, V184, P5287, DOI 10.4049/jimmunol.0903536; UEBA O, 1978, ACTA MED OKAYAMA, V32, P265; van de Veerdonk FL, 2009, J INFECT DIS, V199, P1087, DOI 10.1086/597274; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Wen HT, 2011, NAT IMMUNOL, V12, P408, DOI 10.1038/ni.2022; Wickliffe KE, 2008, CELL MICROBIOL, V10, P332, DOI 10.1111/j.1462-5822.2007.01044.x; Ye ZM, 2008, CURR OPIN IMMUNOL, V20, P3, DOI 10.1016/j.coi.2008.01.003; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831	92	176	186	3	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e29695	10.1371/journal.pone.0029695	http://dx.doi.org/10.1371/journal.pone.0029695			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910ME	22295065	gold, Green Published, Green Submitted			2022-12-25	WOS:000301640600010
J	van der Horst, PH; Wang, YY; Vandenput, I; Kuhne, LC; Ewing, PC; van IJcken, WFJ; van der Zee, M; Amant, F; Burger, CW; Blok, LJ				van der Horst, Paul H.; Wang, Yongyi; Vandenput, Ingrid; Kuhne, Liesbeth C.; Ewing, Patricia C.; van IJcken, Wilfred F. J.; van der Zee, Marten; Amant, Frederic; Burger, Curt W.; Blok, Leen J.			Progesterone Inhibits Epithelial-to-Mesenchymal Transition in Endometrial Cancer	PLOS ONE			English	Article							BETA-CATENIN; TUMOR MICROENVIRONMENT; COLORECTAL-CANCER; IMMUNE CELLS; TGF-BETA; B-CELLS; RECEPTOR; EXPRESSION; CARCINOMA; INVASION	Background: Every year approximately 74,000 women die of endometrial cancer, mainly due to recurrent or metastatic disease. The presence of tumor infiltrating lymphocytes (TILs) as well as progesterone receptor (PR) positivity has been correlated with improved prognosis. This study describes two mechanisms by which progesterone inhibits metastatic spread of endometrial cancer: by stimulating T-cell infiltration and by inhibiting epithelial-to-mesenchymal cell transition (EMT). Methodology and Principal Findings: Paraffin sections from patients with (n = 9) or without (n = 9) progressive endometrial cancer (recurrent or metastatic disease) were assessed for the presence of CD4+ (helper), CD8+ (cytotoxic) and Foxp3+ (regulatory) T-lymphocytes and PR expression. Progressive disease was observed to be associated with significant loss of TILs and loss of PR expression. Frozen tumor samples, used for genome-wide expression analysis, showed significant regulation of pathways involved in immunesurveillance, EMT and metastasis. For a number of genes, such as CXCL14, DKK1, DKK4, PEG10 and WIF1, quantitive RT-PCR was performed to verify up- or downregulation in progressive disease. To corroborate the role of progesterone in regulating invasion, Ishikawa(IK) endometrial cancer cell lines stably transfected with PRA (IKPRA), PRB(IKPRB) and PRA+PRB (IKPRAB) were cultured in presence/absence of progesterone (MPA) and used for genome-wide expression analysis, Boyden- and wound healing migration assays, and IHC for known EMT markers. IKPRB and IKPRAB cell lines showed MPA induced inhibition of migration and loss of the mesenchymal marker vimentin at the invasive front of the wound healing assay. Furthermore, pathway analysis of significantly MPA regulated genes showed significant down regulation of important pathways involved in EMT, immunesuppression and metastasis: such as IL6-, TGF-beta and Wnt/beta-catenin signaling. Conclusion: Intact progesterone signaling in non-progressive endometrial cancer seems to be an important factor stimulating immunosurveilance and inhibiting transition from an epithelial to a more mesenchymal, more invasive phenotype.	[van der Horst, Paul H.; Wang, Yongyi; Kuhne, Liesbeth C.; van der Zee, Marten; Burger, Curt W.; Blok, Leen J.] Erasmus MC, Dept Obstet & Gynaecol, Rotterdam, Netherlands; [Vandenput, Ingrid; Amant, Frederic] Catholic Univ Louvain, Univ Hosp Gasthuisberg, Div Gynecol Oncol, B-3000 Louvain, Belgium; [Ewing, Patricia C.] Erasmus MC, Dept Pathol, Rotterdam, Netherlands; [van IJcken, Wilfred F. J.] Erasmus MC, Dept Biom, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; KU Leuven; University Hospital Leuven; Universite Catholique Louvain; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	van der Horst, PH (corresponding author), Erasmus MC, Dept Obstet & Gynaecol, Rotterdam, Netherlands.	p.vanderhorst@erasmusmc.nl	van ijcken, willem/N-9805-2018; Amant, Frédéric/W-7436-2019	van ijcken, willem/0000-0002-0421-8301; Amant, Frédéric/0000-0002-5452-4905	Dutch Cancer Society [EMCR 2008-4056]	Dutch Cancer Society(KWF Kankerbestrijding)	The work of LJB and MvdZ is supported by a grant from the Dutch Cancer Society (EMCR 2008-4056). The funders had no role in study design, data collection and analyses, decision to publish or preparation of the manuscript.	Ace Christopher I, 2004, Reprod Biol Endocrinol, V2, P54, DOI 10.1186/1477-7827-2-54; Allavena P, 2011, EXPT CELL R IN PRESS; Amant F, 2005, LANCET, V366, P491, DOI 10.1016/S0140-6736(05)67063-8; Avila DM, 2001, J STEROID BIOCHEM, V76, P135, DOI 10.1016/S0960-0760(00)00158-8; Berry KK, 2001, INT J GYNECOL CANCER, V11, P54, DOI 10.1046/j.1525-1438.2001.011001054.x; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brabletz T, 1998, PATHOL RES PRACT, V194, P701, DOI 10.1016/S0344-0338(98)80129-5; Bruner-Tran KL, 2002, J CLIN ENDOCR METAB, V87, P4782, DOI 10.1210/jc.2002-020418; Clark CE, 2007, CANCER RES, V67, P9518, DOI 10.1158/0008-5472.CAN-07-0175; Clemente CG, 1996, CANCER, V77, P1303, DOI 10.1002/(SICI)1097-0142(19960401)77:7<1303::AID-CNCR12>3.3.CO;2-0; Cohn DE, 2002, GYNECOL ONCOL, V87, P243, DOI 10.1006/gyno.2002.6825; de Jong RA, 2009, GYNECOL ONCOL, V114, P105, DOI 10.1016/j.ygyno.2009.03.022; EHRLICH CE, 1988, AM J OBSTET GYNECOL, V158, P796, DOI 10.1016/0002-9378(88)90075-0; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Gavert N, 2005, J CELL BIOL, V168, P633, DOI 10.1083/jcb.200408051; Giangrande PH, 1999, RECENT PROG HORM RES, V54, P291; Giangrande PH, 2000, MOL CELL BIOL, V20, P3102, DOI 10.1128/MCB.20.9.3102-3115.2000; Giangrande PH, 1997, J BIOL CHEM, V272, P32889, DOI 10.1074/jbc.272.52.32889; Hanekamp EE, 2003, CLIN CANCER RES, V9, P4190; Hanekamp EE, 2005, J SOC GYNECOL INVEST, V12, P278, DOI 10.1016/j.jsgi.2005.01.030; Hanekamp EE, 2002, EUR J CANCER, V38, pS71; Hiraoka N, 2010, INT J CLIN ONCOL, P1; Hu CS, 2004, CELL MOL IMMUNOL, V1, P280; Ip WK, 2007, CANCER LETT, V250, P284, DOI 10.1016/j.canlet.2006.10.012; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jeon YT, 2006, CANCER LETT, V239, P198, DOI 10.1016/j.canlet.2005.08.001; Jie X, 2007, ONCOGENE, V26, P5741, DOI 10.1038/sj.onc.1210362; Jolly S, 2006, GYNECOL ONCOL, V103, P87, DOI 10.1016/j.ygyno.2006.01.038; KELLY RW, 1994, HUM REPROD, V9, P253, DOI 10.1093/oxfordjournals.humrep.a138491; Kilic A, 2009, J SURG RES; Kim JJ, 2010, SEMIN REPROD MED, V28, P81, DOI 10.1055/s-0029-1242998; Kim YB, 1997, CANCER, V79, P320, DOI 10.1002/(SICI)1097-0142(19970115)79:2<320::AID-CNCR15>3.0.CO;2-2; Kondratiev S, 2004, CLIN CANCER RES, V10, P4450, DOI 10.1158/1078-0432.CCR-0732-3; KOSARY CL, 1994, SEMIN SURG ONCOL, V10, P31, DOI 10.1002/ssu.2980100107; Ladle BH, 2010, INT J CANC, pn/a; Leffers N, 2010, BRIT J CANCER, V103, P685, DOI 10.1038/sj.bjc.6605820; Lindauer J, 2003, GYNECOL ONCOL, V91, P547, DOI 10.1016/j.ygyno.2003.08.003; Liu Damon Shing-Min, 2011, Proceedings of the 2011 Workshop on Digital Media and Digital Content Management (DMDCM 2011), P1, DOI 10.1109/DMDCM.2011.24; Mokhtar NM, 2010, MOL HUM REPROD, V16, P170, DOI 10.1093/molehr/gap100; Naishiro Y, 2001, CANCER RES, V61, P2751; Nicholson RI, 2003, BREAST CANCER RES TR, V80, pS29; Pecorelli S, 2009, INT J GYNECOL OBSTET, V105, P103, DOI 10.1016/j.ijgo.2009.02.012; Pfeifer M, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-64; Scholten AN, 2003, J PATHOL, V201, P460, DOI 10.1002/path.1402; Smid-Koopman E, 2005, J SOC GYNECOL INVEST, V12, P285, DOI 10.1016/j.jsgi.2005.01.003; Talbi S, 2006, ENDOCRINOLOGY, V147, P1097, DOI 10.1210/en.2005-1076; Tavassoli FA, 2003, WHO TUMOURS BREAST F; Tetel MJ, 1999, MOL ENDOCRINOL, V13, P910, DOI 10.1210/me.13.6.910; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thigpen JT, 1999, J CLIN ONCOL, V17, P1736, DOI 10.1200/JCO.1999.17.6.1736; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van Steenwijk PJD, 2010, CANCER RES, V70, P2707, DOI 10.1158/0008-5472.CAN-09-4299; Wang XB, 2007, J IMMUNOL, V179, P2880, DOI 10.4049/jimmunol.179.5.2880; Wang YY, 2009, CLIN CANCER RES, V15, P5784, DOI 10.1158/1078-0432.CCR-09-0814; Ward EC, 2008, ENDOCRINOLOGY, V149, P1942, DOI 10.1210/en.2007-0756; Yahata T, 2006, HUM REPROD, V21, P1070, DOI 10.1093/humrep/dei434; Yang L, 2010, CURR MOL MED, V10, P374, DOI 10.2174/156652410791317039; Yang L, 2010, TRENDS IMMUNOL, V31, P220, DOI 10.1016/j.it.2010.04.002; Yee DS, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-162; Zhang L, 2003, NEW ENGL J MED, V348, P203, DOI 10.1056/NEJMoa020177	61	53	56	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e30840	10.1371/journal.pone.0030840	http://dx.doi.org/10.1371/journal.pone.0030840			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910ME	22295114	Green Published, gold, Green Submitted			2022-12-25	WOS:000301640600059
J	Sapra, S; Beavin, LE; Zak, PJ				Sapra, Steve; Beavin, Laura E.; Zak, Paul J.			A Combination of Dopamine Genes Predicts Success by Professional Wall Street Traders	PLOS ONE			English	Article							FINANCIAL RISK-TAKING; TANDEM DUPLICATION POLYMORPHISM; METHYLTRANSFERASE VAL(158)MET GENOTYPE; IMPULSE CONTROL DISORDERS; RECEPTOR GENE; DRD4 GENE; PARKINSON-DISEASE; DECISION-MAKING; ASSOCIATION; BEHAVIOR	What determines success on Wall Street? This study examined if genes affecting dopamine levels of professional traders were associated with their career tenure. Sixty professional Wall Street traders were genotyped and compared to a control group who did not trade stocks. We found that distinct alleles of the dopamine receptor 4 promoter (DRD4P) and catecholamine-O-methyltransferase (COMT) that affect synaptic dopamine were predominant in traders. These alleles are associated with moderate, rather than very high or very low, levels of synaptic dopamine. The activity of these alleles correlated positively with years spent trading stocks on Wall Street. Differences in personality and trading behavior were also correlated with allelic variants. This evidence suggests there may be a genetic basis for the traits that make one a successful trader.	[Sapra, Steve; Beavin, Laura E.; Zak, Paul J.] Claremont Grad Univ, Ctr Neuroecon Studies, Claremont, CA 91711 USA; [Zak, Paul J.] Claremont Grad Univ, Dept Econ, Claremont, CA USA; [Zak, Paul J.] Loma Linda Univ, Med Ctr, Dept Neurol, Loma Linda, CA USA	Claremont Colleges; Claremont Graduate School; Claremont Colleges; Claremont Graduate School; Loma Linda University	Zak, PJ (corresponding author), Claremont Grad Univ, Ctr Neuroecon Studies, Claremont, CA 91711 USA.	paul.zak@cgu.edu						Apicella CL, 2008, EVOL HUM BEHAV, V29, P384, DOI 10.1016/j.evolhumbehav.2008.07.001; ASGHARI V, 1995, J NEUROCHEM, V65, P1157, DOI 10.1046/j.1471-4159.1995.65031157.x; Bajtelsmit VL., 1999, FINANCIAL SERVICES R, V8, P1, DOI [DOI 10.1016/S1057-0810(99)00030-X, 10.1016/S1057-0810(99)00030-X]; Balding DJ, 2006, NAT REV GENET, V7, P781, DOI 10.1038/nrg1916; Barber BM, 2001, Q J ECON, V116, P261, DOI 10.1162/003355301556400; Barnea A, 2010, J FINANC ECON, V98, P583, DOI 10.1016/j.jfineco.2010.08.001; Bilder RM, 2004, NEUROPSYCHOPHARMACOL, V29, P1943, DOI 10.1038/sj.npp.1300542; Blasi G, 2005, J NEUROSCI, V25, P5038, DOI 10.1523/JNEUROSCI.0476-05.2005; Briggs-Myers Isabel, 1995, GIFTS DIFFERING UNDE; Carver CS, 2011, PSYCHOL SCI, V22, P589, DOI 10.1177/0956797611404085; Cesarini D, 2010, J FINANC, V65, P1725, DOI 10.1111/j.1540-6261.2010.01592.x; Coates JM, 2008, P NATL ACAD SCI USA, V105, P6167, DOI 10.1073/pnas.0704025105; Coates JM, 2009, P NATL ACAD SCI USA, V106, P623, DOI 10.1073/pnas.0810907106; Cools R, 2008, NEUROSCIENTIST, V14, P381, DOI 10.1177/1073858408317009; Coval JD, 2005, J FINANC, V60, P1, DOI 10.1111/j.1540-6261.2005.00723.x; Crisan LG, 2009, SOC COGN AFFECT NEUR, V4, P399, DOI 10.1093/scan/nsp019; D'Souza UM, 2004, BIOL PSYCHIAT, V56, P691, DOI 10.1016/j.biopsych.2004.08.008; de Frias CM, 2005, J COGNITIVE NEUROSCI, V17, P1018, DOI 10.1162/0898929054475136; Dreber A, 2009, EVOL HUM BEHAV, V30, P85, DOI 10.1016/j.evolhumbehav.2008.11.001; Durand RB, 2008, J BEHAV FINANC, V9, P193, DOI 10.1080/15427560802341020; Efremidze L, 2011, INTERRUPTIN IN PRESS; Ellis CD, 2002, WINNING LOSERS GAME, P142; Fossella J, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-14; Frydman C, 2011, P ROY SOC B-BIOL SCI, V278, P2053, DOI 10.1098/rspb.2010.2304; Gabaix X, 2006, Q J ECON, V121, P461, DOI 10.1162/qjec.2006.121.2.461; Gjedde A, 2010, P NATL ACAD SCI USA, V107, P3870, DOI 10.1073/pnas.0912319107; Glaser M, 2007, GENEVA RISK INS REV, V32, P1, DOI 10.1007/s10713-007-0003-3; Goldman-Rakic PS, 2000, BRAIN RES REV, V31, P295, DOI 10.1016/S0165-0173(99)00045-4; Golimbet V E, 2007, Neurosci Behav Physiol, V37, P601, DOI 10.1007/s11055-007-0058-8; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Haber SN, 2010, NEUROPSYCHOPHARMACOL, V35, P4, DOI 10.1038/npp.2009.129; Haigh MS, 2005, J FINANC, V60, P523, DOI 10.1111/j.1540-6261.2005.00737.x; Hariri AR, 2005, ARCH GEN PSYCHIAT, V62, P146, DOI 10.1001/archpsyc.62.2.146; He QH, 2010, NEUROPHARMACOLOGY, V59, P518, DOI 10.1016/j.neuropharm.2010.07.008; Jianakoplos NA, 1998, ECON INQ, V36, P620, DOI 10.1111/j.1465-7295.1998.tb01740.x; Knutson B, 2008, NEUROREPORT, V19, P509, DOI 10.1097/WNR.0b013e3282f85c01; Knutson B, 2007, J NEUROSCI, V27, P8174, DOI 10.1523/JNEUROSCI.1564-07.2007; Kuhnen CM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004362; Kuhnen CM, 2005, NEURON, V47, P763, DOI 10.1016/j.neuron.2005.08.008; Lachman HM, 1996, PHARMACOGENETICS, V6, P243, DOI 10.1097/00008571-199606000-00007; Laviola G, 2003, NEUROSCI BIOBEHAV R, V27, P19, DOI 10.1016/S0149-7634(03)00006-X; Lei Feng, 2005, Review of Finance, V9, P305, DOI 10.1007/s10679-005-2262-0; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; Levinson DF, 2006, BIOL PSYCHIAT, V60, P84, DOI 10.1016/j.biopsych.2005.08.024; Lo AW, 2005, AM ECON REV, V95, P352, DOI 10.1257/000282805774670095; Lo AW, 2002, J COGNITIVE NEUROSCI, V14, P323, DOI 10.1162/089892902317361877; McCracken JT, 2000, MOL PSYCHIATR, V5, P531, DOI 10.1038/sj.mp.4000770; MCCRAE RR, 1989, J PERS, V57, P17, DOI 10.1111/j.1467-6494.1989.tb00759.x; Mehra R, 2002, J ECON DYN CONTROL, V26, P869, DOI 10.1016/S0165-1889(01)00035-5; Myers I. B., 1998, MBTI MANUAL GUIDE DE, DOI DOI 10.1080/03075079.2014.977859; Nolan KA, 2004, AM J PSYCHIAT, V161, P359, DOI 10.1176/appi.ajp.161.2.359; Owens M J, 1998, Depress Anxiety, V8 Suppl 1, P5, DOI 10.1002/(SICI)1520-6394(1998)8:1+<5::AID-DA2>3.0.CO;2-I; Paterson AD, 1999, NEUROPSYCHOPHARMACOL, V21, P3, DOI 10.1016/S0893-133X(98)00115-8; Philibert RA, 2008, AM J MED GENET B, V147B, P565, DOI 10.1002/ajmg.b.30778; Pontone G, 2006, NEUROLOGY, V67, P1258, DOI 10.1212/01.wnl.0000238401.76928.45; Riba J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002479; Rivera M, 2009, AM J MED GENET B, V150B, P395, DOI 10.1002/ajmg.b.30829; Rogers G, 2004, AM J MED GENET B, V126B, P95, DOI 10.1002/ajmg.b.20133; Roohi J, 2009, J AUTISM DEV DISORD, V39, P67, DOI 10.1007/s10803-008-0600-8; Ruiz-Sanz JI, 2007, MOL CELL PROBE, V21, P202, DOI 10.1016/j.mcp.2006.12.001; Sapienza P, 2009, P NATL ACAD SCI USA, V106, P15268, DOI 10.1073/pnas.0907352106; Schmack K, 2008, NEUROIMAGE, V42, P1631, DOI 10.1016/j.neuroimage.2008.06.019; Schwager JS, 2008, STOCK MARKET WIZARDS; Schwartz RA, 2009, J TRADING, V4, P46, DOI 10.3905/jot.2009.4.2.046; Seaman MI, 1999, AM J MED GENET, V88, P705, DOI 10.1002/(SICI)1096-8628(19991215)88:6<705::AID-AJMG22>3.0.CO;2-F; Shiller RJ, 2003, J ECON PERSPECT, V17, P83, DOI 10.1257/089533003321164967; SHILLER RJ, 1981, AM ECON REV, V71, P421; STAMFORD JA, 1989, J NEUROCHEM, V52, P1582, DOI 10.1111/j.1471-4159.1989.tb09212.x; Stein MB, 2005, NEUROPSYCHOPHARMACOL, V30, P2092, DOI 10.1038/sj.npp.1300787; Steinberg L, 2010, DEV PSYCHOBIOL, V52, P216, DOI 10.1002/dev.20445; Tadic A, 2003, AM J MED GENET B, V117B, P1, DOI 10.1002/ajmg.b.10013; Taylor WD, 2007, PSYCHIAT RES-NEUROIM, V155, P173, DOI 10.1016/j.pscychresns.2007.01.005; Vandenbergh DJ, 2000, AM J MED GENET, V96, P678, DOI 10.1002/1096-8628(20001009)96:5<678::AID-AJMG15>3.0.CO;2-8; Wahlstrom D, 2010, BRAIN COGNITION, V72, P146, DOI 10.1016/j.bandc.2009.10.013; Weintraub D, 2006, ARCH NEUROL-CHICAGO, V63, P969, DOI 10.1001/archneur.63.7.969; Wyart M, 2007, J ECON BEHAV ORGAN, V63, P1, DOI 10.1016/j.jebo.2004.11.016; Zak PJ, 2004, PHILOS T R SOC B, V359, P1737, DOI 10.1098/rstb.2004.1544; Zhong SF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008516	78	18	18	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2012	7	1							e30844	10.1371/journal.pone.0030844	http://dx.doi.org/10.1371/journal.pone.0030844			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910LV	22292056	Green Submitted, gold, Green Published			2022-12-25	WOS:000301639600060
J	Bilichak, A; Ilnystkyy, Y; Hollunder, J; Kovalchuk, I				Bilichak, Andriy; Ilnystkyy, Yaroslav; Hollunder, Jens; Kovalchuk, Igor			The Progeny of Arabidopsis thaliana Plants Exposed to Salt Exhibit Changes in DNA Methylation, Histone Modifications and Gene Expression	PLOS ONE			English	Article							TRANSCRIPTIONAL ACTIVATION; BINDING PROTEINS; GENOME STABILITY; H3 LYSINE-9; STRESS; RECOMBINATION; DEMETHYLATION; ADAPTATION; MEMORY; VIRUS	Plants are able to acclimate to new growth conditions on a relatively short time-scale. Recently, we showed that the progeny of plants exposed to various abiotic stresses exhibited changes in genome stability, methylation patterns and stress tolerance. Here, we performed a more detailed analysis of methylation patterns in the progeny of Arabidopsis thaliana (Arabidopsis) plants exposed to 25 and 75 mM sodium chloride. We found that the majority of gene promoters exhibiting changes in methylation were hypermethylated, and this group was overrepresented by regulators of the chromatin structure. The analysis of DNA methylation at gene bodies showed that hypermethylation in the progeny of stressed plants was primarily due to changes in the 5' and 3' ends as well as in exons rather than introns. All but one hypermethylated gene tested had lower gene expression. The analysis of histone modifications in the promoters and coding sequences showed that hypermethylation and lower gene expression correlated with the enrichment of H3K9me2 and depletion of H3K9ac histones. Thus, our work demonstrated a high degree of correlation between changes in DNA methylation, histone modifications and gene expression in the progeny of salt-stressed plants.	[Bilichak, Andriy; Ilnystkyy, Yaroslav; Kovalchuk, Igor] Univ Lethbridge, Dept Biol Sci, Lethbridge, AB T1K 3M4, Canada; [Hollunder, Jens] Univ Ghent VIB, Dept Plant Syst Biol, Ghent, Belgium; [Hollunder, Jens] Univ Ghent, Dept Mol Genet, B-9000 Ghent, Belgium	University of Lethbridge; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University	Bilichak, A (corresponding author), Univ Lethbridge, Dept Biol Sci, Lethbridge, AB T1K 3M4, Canada.	igor.kovalchuk@uleth.ca	Hollunder, Jens/G-6588-2016	Hollunder, Jens/0000-0003-3234-6762; Berger, Frederic/0000-0002-3609-8260	Natural Sciences and Engineering Research Council (NSERC) of Canada; Human Frontiers Science Program; Alberta Agriculture Research Institute	Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Human Frontiers Science Program(Human Frontier Science Program); Alberta Agriculture Research Institute	This work was supported by a Discovery grant from the Natural Sciences and Engineering Research Council (NSERC) of Canada and by grants from the Human Frontiers Science Program and Alberta Agriculture Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agius F, 2006, P NATL ACAD SCI USA, V103, P11796, DOI 10.1073/pnas.0603563103; Boyko A, 2011, CURR OPIN PLANT BIOL, V14, P260, DOI 10.1016/j.pbi.2011.03.003; Boyko A, 2010, PLANT SIGNAL BEHAV, V5, P995, DOI [10.4161/psb.5.8.12227, 10.1371/journal.pone.0009514]; Boyko A, 2010, PLANT CELL PHYSIOL, V51, P1066, DOI 10.1093/pcp/pcq048; Boyko A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009514; Boyko A, 2007, NUCLEIC ACIDS RES, V35, P1714, DOI 10.1093/nar/gkm029; Casati P, 2008, PLANT CELL, V20, P827, DOI 10.1105/tpc.107.056457; Chinnusamy V, 2009, CURR OPIN PLANT BIOL, V12, P133, DOI 10.1016/j.pbi.2008.12.006; Choi CS, 2007, MOL GENET GENOMICS, V277, P589, DOI 10.1007/s00438-007-0209-1; Cloix C, 2008, MOL PLANT, V1, P118, DOI 10.1093/mp/ssm012; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Curtin SJ, 2008, FEBS LETT, V582, P2753, DOI 10.1016/j.febslet.2008.07.004; Doyle MR, 2009, PLANT PHYSIOL, V151, P1688, DOI 10.1104/pp.109.145581; Dyachenko OV, 2006, BIOCHEMISTRY-MOSCOW+, V71, P461, DOI 10.1134/S000629790604016X; Ebbs ML, 2006, PLANT CELL, V18, P1166, DOI 10.1105/tpc.106.041400; Feng SH, 2011, CURR OPIN PLANT BIOL, V14, P179, DOI 10.1016/j.pbi.2010.12.002; Feng SH, 2010, P NATL ACAD SCI USA, V107, P8689, DOI 10.1073/pnas.1002720107; Gendrel AV, 2002, SCIENCE, V297, P1871, DOI 10.1126/science.1074950; Iizuka M, 2003, CURR OPIN GENET DEV, V13, P154, DOI 10.1016/S0959-437X(03)00020-0; Ilnytskyy Y, 2004, MUTAT RES-GEN TOX EN, V559, P189, DOI 10.1016/j.mrgentox.2004.02.001; Ponferrada-Marin MI, 2010, J BIOL CHEM, V285, P23030, DOI 10.1074/jbc.M110.124578; Ito H, 2011, NATURE, V472, P115, DOI 10.1038/nature09861; Jackson JP, 2004, CHROMOSOMA, V112, P308, DOI 10.1007/s00412-004-0275-7; Johnson LM, 2002, CURR BIOL, V12, P1360, DOI 10.1016/S0960-9822(02)00976-4; Kathiria P, 2010, PLANT PHYSIOL, V153, P1859, DOI 10.1104/pp.110.157263; Kim JM, 2008, PLANT CELL PHYSIOL, V49, P1580, DOI 10.1093/pcp/pcn133; Kovalchuk I, 2004, PLANT PHYSIOL, V135, P357, DOI 10.1104/pp.104.040477; Kovalchuk O, 2003, MUTAT RES-FUND MOL M, V529, P13, DOI 10.1016/S0027-5107(03)00103-9; Lang-Mladek C, 2010, MOL PLANT, V3, P594, DOI 10.1093/mp/ssq014; Lario LD, 2011, J EXP BOT, V62, P2925, DOI 10.1093/jxb/err001; LARSEN F, 1992, GENOMICS, V13, P1095, DOI 10.1016/0888-7543(92)90024-M; Laurent L, 2010, GENOME RES, V20, P320, DOI 10.1101/gr.101907.109; Lippman Z, 2003, PLOS BIOL, V1, P420, DOI 10.1371/journal.pbio.0000067; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Mason G, 2008, J VIROL METHODS, V147, P282, DOI 10.1016/j.jviromet.2007.09.015; Mathieu O, 2007, CELL, V130, P851, DOI 10.1016/j.cell.2007.07.007; Mirouze M, 2011, CURR OPIN PLANT BIOL, V14, P267, DOI 10.1016/j.pbi.2011.03.004; Molinier J, 2006, NATURE, V442, P1046, DOI 10.1038/nature05022; Naumann K, 2005, EMBO J, V24, P1418, DOI 10.1038/sj.emboj.7600604; Numa H, 2010, EMBO J, V29, P352, DOI 10.1038/emboj.2009.374; Panella M, 2004, ENVIRON POLLUT, V128, P303, DOI 10.1016/j.envpol.2003.09.003; Paszkowski J, 2011, CURR OPIN PLANT BIOL, V14, P195, DOI 10.1016/j.pbi.2011.01.002; Pavet V, 2006, MOL PLANT MICROBE IN, V19, P577, DOI 10.1094/MPMI-19-0577; Pecinka A, 2010, PLANT CELL, V22, P3118, DOI 10.1105/tpc.110.078493; Pecinka A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005202; Saleh A, 2008, NAT PROTOC, V3, P1018, DOI 10.1038/nprot.2008.66; Saze H, 2008, SEMIN CELL DEV BIOL, V19, P527, DOI 10.1016/j.semcdb.2008.07.017; Sha AH, 2005, MOL GENET GENOMICS, V273, P484, DOI 10.1007/s00438-005-1148-3; Sridhar VV, 2007, NATURE, V447, P735, DOI 10.1038/nature05864; Steward N, 2002, J BIOL CHEM, V277, P37741, DOI 10.1074/jbc.M204050200; SWOBODA P, 1994, EMBO J, V13, P484, DOI 10.1002/j.1460-2075.1994.tb06283.x; Tam PPC, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-44; Tamaru H, 2001, NATURE, V414, P277, DOI 10.1038/35104508; Tariq M, 2004, TRENDS GENET, V20, P244, DOI 10.1016/j.tig.2004.04.005; Teixeira FK, 2009, SCIENCE, V323, P1600, DOI 10.1126/science.1165313; Toedling J, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-221; Urano K, 2010, CURR OPIN PLANT BIOL, V13, P132, DOI 10.1016/j.pbi.2009.12.006; Vaillant I, 2007, CURR OPIN PLANT BIOL, V10, P528, DOI 10.1016/j.pbi.2007.06.008; Vaughn MW, 2007, PLOS BIOL, V5, P1617, DOI 10.1371/journal.pbio.0050174; Verhoeven KJF, 2010, NEW PHYTOL, V185, P1108, DOI 10.1111/j.1469-8137.2009.03121.x; Wada Y, 2003, J BIOL CHEM, V278, P42386, DOI 10.1074/jbc.M303892200; Yao YL, 2011, MUTAT RES-FUND MOL M, V707, P61, DOI 10.1016/j.mrfmmm.2010.12.013; Zaratiegui M, 2007, CELL, V128, P763, DOI 10.1016/j.cell.2007.02.016; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003; Zhou JL, 2010, PLANT MOL BIOL, V72, P585, DOI 10.1007/s11103-009-9594-7; Zilberman D, 2007, NAT GENET, V39, P61, DOI 10.1038/ng1929	66	125	132	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30515	10.1371/journal.pone.0030515	http://dx.doi.org/10.1371/journal.pone.0030515			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22291972	Green Published, gold			2022-12-25	WOS:000301570600051
J	Moiroux, N; Boussari, O; Djenontin, A; Damien, G; Cottrell, G; Henry, MC; Guis, H; Corbel, V				Moiroux, Nicolas; Boussari, Olayide; Djenontin, Armel; Damien, Georgia; Cottrell, Gilles; Henry, Marie-Claire; Guis, Helene; Corbel, Vincent			Dry Season Determinants of Malaria Disease and Net Use in Benin, West Africa	PLOS ONE			English	Article							ANOPHELES-FUNESTUS DIPTERA; TRANSMISSION; CULICIDAE; AREA; RESISTANCE; DYNAMICS; GAMBIAE; BIONOMICS; COVERAGE; CHILDREN	Background: To achieve malaria eradication, control efforts have to be sustained even when the incidence of malaria cases becomes low during the dry season. In this work, malaria incidence and its determinants including bed net use were investigated in children of under 5 years of age in 28 villages in southern Benin during the dry season. Methods and Findings: Mean malaria clinical incidence was measured in children aged 0-5 years by active case detection in 28 villages of the Ouidah-Kpomasse-Tori Bossito sanitary district between November 2007 and March 2008. Using Poisson mixed-effect models, malaria incidence was assessed according to the level of transmission by different vector species, and Long-Lasting Insecticide-treated mosquito Nets (LLIN) use and ownership. Then, a Binomial mixed-effect model was developed to assess whether nighttime temperature (derived from MODIS remote sensing data), biting nuisance and LLIN ownership are good predictors of LLIN use >60%. Results suggested that Anopheles funestus (Incidence Rates Ratio (IRR) = 3.38 [IC95 1.91-6]) rather than An. gambiae s.s. is responsible for malaria transmission. A rate of LLIN use >60% was associated with a lower risk of malaria (IRR = 0.6 [IC95 0.37-0.99]). Low nocturnal temperature and high biting nuisance were good predictors of LLIN use >60%. Conclusions: As recommended by the Malaria Eradication (MalERA) Consultative Group on Modelling, there is a need to understand better the effects of seasonality on malaria morbidity. This study highlights the need to take into account the specificity of malaria epidemiology during the dry-hot season and get a better understanding of the factors that influence malaria incidence and net use. These findings should help National Malaria Control Programmes to implement more effective and sustainable malaria control strategies in Africa.	[Moiroux, Nicolas; Djenontin, Armel; Damien, Georgia; Corbel, Vincent] IRD, MIVEGEC IRD CNRS UM1 224 5290, Cotonou, Benin; [Moiroux, Nicolas; Boussari, Olayide; Djenontin, Armel; Henry, Marie-Claire; Corbel, Vincent] Minist Sante, CREC, Cotonou, Benin; [Cottrell, Gilles] IRD, Mere & Enfant Face Infect Trop UMR216, Cotonou, Benin; [Cottrell, Gilles] Univ Abomey Calavi, ISBA, Cotonou, Benin; [Henry, Marie-Claire] Ambassade France, SCAC, Cotonou, Benin; [Guis, Helene] CIRAD, UMR CMAEE, Montpellier, France	Institut de Recherche pour le Developpement (IRD); Entomological Research Center of Cotonou (CREC); Institut de Recherche pour le Developpement (IRD); University of Abomey Calavi; CIRAD	Moiroux, N (corresponding author), IRD, MIVEGEC IRD CNRS UM1 224 5290, Cotonou, Benin.	vincent.corbel@ird.fr	Corbel, VIncent/G-9576-2016; Moiroux, Nicolas/AFT-2925-2022	Moiroux, Nicolas/0000-0001-6755-6167; Cottrell, Gilles/0000-0002-7964-8963; corbel, vincent/0000-0003-0995-3257; Guis, Helene/0000-0002-0355-0898	French Ministry of Foreign Affairs; Institut de Recherche pour le Developpement (IRD) [2006-22]	French Ministry of Foreign Affairs; Institut de Recherche pour le Developpement (IRD)	This work was supported by the French Ministry of Foreign Affairs and the Institut de Recherche pour le Developpement (IRD)[FSP project REFS No2006-22]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adja AM, 2011, ANN TROP MED PARASIT, V105, P13, DOI 10.1179/136485910X12851868780388; Ahorlu CK, 1997, TROP MED INT HEALTH, V2, P488, DOI 10.1046/j.1365-3156.1997.d01-298.x; [Anonymous], 2010, R LANG ENV STAT COMP; [Anonymous], 2004, COCHRANE DB SYST REV; Appawu M, 2004, TROP MED INT HEALTH, V9, P164, DOI 10.1046/j.1365-3156.2003.01162.x; Awolola TS, 2002, ANN TROP MED PARASIT, V96, P75, DOI 10.1179/000349802125000538; Bangana ASB, 2009, 5 MIM PAN AFR MAL C; Bates D., 2009, IME4 LINEAR MIXED EF; Binka FN, 1997, TROP MED INT HEALTH, V2, P499, DOI 10.1046/j.1365-3156.1997.d01-299.x; Coetzee M., 2006, Bulletin de la Societe de Pathologie Exotique, V99, P400; Cohuet A, 2004, J MED ENTOMOL, V41, P901, DOI 10.1603/0022-2585-41.5.901; Dabire KR, 2007, J MED ENTOMOL, V44, P990, DOI 10.1603/0022-2585(2007)44[990:AFDCIA]2.0.CO;2; Damien GB, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-380; Depinay JMO, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-29; Djenontin A, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-83; Doannio J.M.C., 2006, Bulletin de la Societe de Pathologie Exotique, V99, P204; Fontenille D, 1997, T ROY SOC TROP MED H, V91, P647, DOI 10.1016/S0035-9203(97)90506-X; Fontenille D, 1997, AM J TROP MED HYG, V56, P247, DOI 10.4269/ajtmh.1997.56.247; Frey C, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-70; GILLIES M. T., 1968, The Anophelinae of Africa south of the Sahara (Ethiopian Zoogeographical Region).; Hay SI, 1998, PARASITOL TODAY, V14, P306, DOI 10.1016/S0169-4758(98)01285-X; Kelly-Hope LA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-268; Kelly-Hope LA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-19; Korenromp EL, 2003, TROP MED INT HEALTH, V8, P693, DOI 10.1046/j.1365-3156.2003.01084.x; Kweka EJ, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-59; *MALERA CONS GROUP, 2011, PLOS MED, V0008; *MALERA CONS GROUP, 2011, PLOS MED, V0008; Najera JA, 1998, 981084 WHOMAL, P1; Okoye PN, 2008, T ROY SOC TROP MED H, V102, P591, DOI 10.1016/j.trstmh.2008.02.022; Patz JA, 1998, TROP MED INT HEALTH, V3, P818, DOI 10.1046/j.1365-3156.1998.00309.x; Ranson H, 2011, TRENDS PARASITOL, V27, P91, DOI 10.1016/j.pt.2010.08.004; Roberts L, 2007, SCIENCE, V318, P1544, DOI 10.1126/science.318.5856.1544; THOMSON MC, 1994, T ROY SOC TROP MED H, V88, P638, DOI 10.1016/0035-9203(94)90204-6; Toe LP, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-175; United Nations, 2010, MILL DEV GOALS REP 2; Vancutsem C, 2010, REMOTE SENS ENVIRON, V114, P449, DOI 10.1016/j.rse.2009.10.002; WHO, 2010, WORLD MALARIA REPORT 2010, P1; WHO RBM, 2000, WHOCDSRBM200346	38	27	27	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30558	10.1371/journal.pone.0030558	http://dx.doi.org/10.1371/journal.pone.0030558			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22291987	Green Submitted, Green Published, gold			2022-12-25	WOS:000301570600058
J	Yan, W; Zhang, W; You, G; Bao, ZS; Wang, YZ; Liu, YW; Kang, CS; You, YP; Wang, L; Jiang, T				Yan, Wei; Zhang, Wei; You, Gan; Bao, Zhaoshi; Wang, Yongzhi; Liu, Yanwei; Kang, Chunsheng; You, Yongping; Wang, Lei; Jiang, Tao			Correlation of IDH1 Mutation with Clinicopathologic Factors and Prognosis in Primary Glioblastoma: A Report of 118 Patients from China	PLOS ONE			English	Article							GLIOMAS; THERAPY; MGMT; TEMOZOLOMIDE; CANCER; PROLIFERATION; METHYLATION; MULTIFORME; INDEX	It has been reported that IDH1 (IDH1R132) mutation was a frequent genomic alteration in grade II and grade III glial tumors but rare in primary glioblastoma (pGBM). To elucidate the frequency of IDH1 mutation and its clinical significance in Chinese patients with pGBM, one hundred eighteen pGBMs were assessed by pyro-sequencing for IDH1 mutation status, and the results were correlated with clinical characteristics and molecular pathological factors. IDH1 mutations were detected in 19/118 pGBM cases (16.1%). Younger age, methylated MGMT promoter, high expression of mutant P53 protein, low expression of Ki-67 or EGFR protein were significantly correlated with IDH1 mutation status. Most notably, we identified pGBM cases with IDH1 mutation were mainly involved in the frontal lobe when compared with those with wild-type IDH1. In addition, Kaplan-Meier survival analysis revealed a highly significant association between IDH1 mutation and a better clinical outcome (p = 0.026 for progression-free survival; p = 0.029 for overall survival). However, in our further multivariable regression analysis, the independent prognostic effect of IDH1 mutation is limited when considering age, preoperative KPS score, extent of resection, TMZ chemotherapy, and Ki-67 protein expression levels, which might narrow its prognostic power in Chinese population in the future.	[Yan, Wei; Zhang, Wei; You, Gan; Bao, Zhaoshi; Wang, Yongzhi; Liu, Yanwei; Wang, Lei; Jiang, Tao] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurosurg, Beijing, Peoples R China; [You, Yongping] Nanjing Med Univ, Dept Neurosurg, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China; [Kang, Chunsheng] Tianjin Neurol Inst, Lab Neurooncol, Tianjin, Peoples R China	Capital Medical University; Nanjing Medical University	Yan, W (corresponding author), Capital Med Univ, Beijing Tiantan Hosp, Dept Neurosurg, Beijing, Peoples R China.	wangleitiantan@126.com; taojiang1964@yahoo.com.cn	Kang, Chunsheng/AAM-5979-2021; jiang, tao/GWC-7108-2022; Jiang, Tao/N-8142-2014	Kang, Chunsheng/0000-0002-3255-3369; 	National Key Project of Science and Technology Supporting Programs of China [2007BAI05B08]; National Natural Science Foundation of China [30772238, 30730035]	National Key Project of Science and Technology Supporting Programs of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was Supported by grants from National Key Project of Science and Technology Supporting Programs of China (No. 2007BAI05B08) and National Natural Science Foundation of China (No. 30772238 and 30730035, http://www.nsfc.gov.cn/Portal0/default152.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burcombe R, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1508; Christensen BC, 2011, JNCI-J NATL CANCER I, V103, DOI 10.1093/jnci/djq497; Ciardiello F, 2008, NEW ENGL J MED, V358, P1160, DOI 10.1056/NEJMra0707704; Fukushima T, 2009, ANTICANCER RES, V29, P4845; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Herbst RS, 2004, INT J RADIAT ONCOL, V59, P21, DOI 10.1016/j.ijrobp.2003.11.041; Houillier C, 2010, NEUROLOGY, V75, P1560, DOI 10.1212/WNL.0b013e3181f96282; Ichimura K, 2009, NEURO-ONCOLOGY, V11, P341, DOI 10.1215/15228517-2009-025; Jin Q, 2011, CHIN MED J, V17, P2584; Kanu OO, 2009, EXPERT OPIN THER TAR, V13, P701, DOI [10.1517/14728220902942348 , 10.1517/14728220902942348]; Labussiere M, 2010, ONCOLOGIST, V15, P196, DOI 10.1634/theoncologist.2009-0218; Muller PAJ, 2009, CELL, V139, P1327, DOI 10.1016/j.cell.2009.11.026; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Quick A, 2010, REV RECENT CLIN TRIA, V5, P14, DOI 10.2174/157488710790820544; Sanson M, 2009, J CLIN ONCOL, V27, P4150, DOI 10.1200/JCO.2009.21.9832; SCHERER H. J., 1940, AMER JOUR CANCER, V40, P159; van den Bent MJ, 2010, CLIN CANCER RES, V16, P1597, DOI 10.1158/1078-0432.CCR-09-2902; von Deimling A, 2011, BRAIN PATHOL, V21, P74, DOI 10.1111/j.1750-3639.2010.00454.x; Wang WG, 2003, CANCER BIOL THER, V2, pS55; Weller M, 2010, NAT REV NEUROL, V6, P39, DOI 10.1038/nrneurol.2009.197; Weller M, 2009, J CLIN ONCOL, V27, P5743, DOI 10.1200/JCO.2009.23.0805; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Yan W, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-58; Zhang W, 2009, CHINESE MED J-PEKING, V122, P1250, DOI 10.3760/cma.j.issn.0366-6999.2009.11.003	26	98	106	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30339	10.1371/journal.pone.0030339	http://dx.doi.org/10.1371/journal.pone.0030339			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22291938	Green Submitted, gold, Green Published			2022-12-25	WOS:000301570600034
J	Formosa, A; Lena, AM; Markert, EK; Cortelli, S; Miano, R; Mauriello, A; Croce, N; Vandesompele, J; Mestdagh, P; Finazzi-Agro, E; Levine, AJ; Melino, G; Bernardini, S; Candi, E				Formosa, A.; Lena, A. M.; Markert, E. K.; Cortelli, S.; Miano, R.; Mauriello, A.; Croce, N.; Vandesompele, J.; Mestdagh, P.; Finazzi-Agro, E.; Levine, A. J.; Melino, G.; Bernardini, S.; Candi, E.			DNA methylation silences miR-132 in prostate cancer	ONCOGENE			English	Article						prostate cancer; miRNAs; miR-132; methylation; methylation-specific PCR; anoikis	MICRORNA EXPRESSION; TUMOR-SUPPRESSOR; CELL-ADHESION; GROWTH-FACTOR; EPIGENETICS; METASTASIS; HYPERMETHYLATION; CARCINOMA; APOPTOSIS; PROMOTES	Silencing of microRNAs (miRNAs) by promoter CpG island methylation may be an important mechanism in prostate carcinogenesis. To screen for epigenetically silenced miRNAs in prostate cancer (PCa), we treated prostate normal epithelial and carcinoma cells with 5-aza-2'-deoxycytidine (AZA) and subsequently examined expression changes of 650 miRNAs by megaplex stemloop reverse transcription-quantitative PCR. After applying a selection strategy, we analyzed the methylation status of CpG islands upstream to a subset of miRNAs by methylation-specific PCR. The CpG islands of miR-18b, miR-132, miR-34b/c, miR-148a, miR-450a and miR-542-3p showed methylation patterns congruent with their expression modulations in response to AZA. Methylation analysis of these CpG islands in a panel of 50 human prostate carcinoma specimens and 24 normal controls revealed miR-132 to be methylated in 42% of human cancer cases in a manner positively correlated to total Gleason score and tumor stage. Expression analysis of miR-132 in our tissue panel confirmed its downregulation in methylated tumors. Re-expression of miR-132 in PC3 cells induced cell detachment followed by cell death (anoikis). Two pro-survival proteins-heparin-binding epidermal growth factor and TALIN2-were confirmed as direct targets of miR-132. The results of this study point to miR-132 as a methylation-silenced miRNA with an antimetastatic role in PCa controlling cellular adhesion. Oncogene (2013) 32, 127-134; doi:10.1038/onc.2012.14; published online 6 February 2012	[Formosa, A.; Cortelli, S.; Croce, N.; Bernardini, S.] Univ Roma Tor Vergata, Dept Internal Med, Rome, Italy; [Lena, A. M.; Melino, G.; Candi, E.] Univ Roma Tor Vergata, Dept Expt Med & Biochem Sci, Rome, Italy; [Lena, A. M.; Melino, G.; Candi, E.] Univ Roma Tor Vergata, Biochem Lab IDI IRCCS, Rome, Italy; [Markert, E. K.] Inst Adv Study, Simons Ctr Syst Biol, Princeton, NJ 08540 USA; [Miano, R.; Finazzi-Agro, E.] Univ Roma Tor Vergata, Policlin Tor Vergata, Div Urol, Dept Surg, Rome, Italy; [Mauriello, A.] Univ Roma Tor Vergata, Dept Biopathol & Image Diagnost, Rome, Italy; [Vandesompele, J.; Mestdagh, P.] Ghent Univ Hosp, Ctr Med Genet Ghent, Ghent, Belgium; [Vandesompele, J.] Biogazelle, Zwijnaarde, Belgium; [Levine, A. J.] Canc Inst New Jersey, New Brunswick, NJ USA	University of Rome Tor Vergata; University of Rome Tor Vergata; University of Rome Tor Vergata; Institute for Advanced Study - USA; University of Rome Tor Vergata; Policlin Tor Vergata; University of Rome Tor Vergata; Ghent University; Ghent University Hospital; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey	Bernardini, S (corresponding author), Univ Rome, Dept Internal Med, I-00133 Rome, Italy.	bernards@uniroma2.it; candi@uniroma2.it	Agrò, Enrico Finazzi/N-7969-2018; MAURIELLO, ALESSANDRO/K-4705-2016; Lena, Anna Maria/AAI-5042-2020; Vandesompele, Jo/W-3411-2018	Agrò, Enrico Finazzi/0000-0002-0308-8824; MAURIELLO, ALESSANDRO/0000-0002-7351-5676; Vandesompele, Jo/0000-0001-6274-0184; Mestdagh, Pieter/0000-0001-7821-9684; Miano, Roberto/0000-0003-2445-1204	MIUR-PRIN; Min Sal onc_ord [26/07]; ISS e Min Sal [ACC12]; RF07 [55, 57]; MRC [MC_U132670600] Funding Source: UKRI; Medical Research Council [MC_U132670600] Funding Source: researchfish	MIUR-PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Min Sal onc_ord; ISS e Min Sal; RF07; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by grants from MIUR-PRIN08, Min Sal onc_ord 26/07, RF07#55 to GM, and ISS e Min Sal ACC12 and RF07#57 to GM and EC.	Adam RM, 2002, ENDOCRINOLOGY, V143, P4599, DOI 10.1210/en.2002-220561; Ambs S, 2008, CANCER RES, V68, P6162, DOI 10.1158/0008-5472.CAN-08-0144; Anand S, 2010, NAT MED, V16, P909, DOI 10.1038/nm.2186; Bartkowiak D, 1999, CYTOMETRY, V37, P191, DOI 10.1002/(SICI)1097-0320(19991101)37:3<191::AID-CYTO5>3.0.CO;2-U; Boissier S, 1997, CANCER RES, V57, P3890; Brandes JC, 2007, ONCOGENE, V26, P6229, DOI 10.1038/sj.onc.1210433; Chu K, 2008, MOL CANCER RES, V6, P1259, DOI 10.1158/1541-7786.MCR-08-0077; Cooper CS, 2009, BRIT J CANCER, V100, P240, DOI 10.1038/sj.bjc.6604771; Cooper CR, 2000, PROSTATE CANCER P D, V3, P6, DOI 10.1038/sj.pcan.4500387; Coppola V, 2010, ENDOCR-RELAT CANCER, V17, pF1, DOI 10.1677/ERC-09-0172; Fabbri M, 2010, ADV GENET, V70, P87, DOI [10.1016/S0065-2660(10)70004-3, 10.1016/B978-0-12-380866-0.60004-6]; Galluzzi L, 2009, CELL DEATH DIFFER, V16, P1093, DOI 10.1038/cdd.2009.44; Gougelet A, 2011, INT J CANCER, V129, P680, DOI 10.1002/ijc.25715; Kalimutho M, 2011, BRIT J CANCER, V104, P1770, DOI 10.1038/bjc.2011.82; Kozaki KI, 2008, CANCER RES, V68, P2094, DOI 10.1158/0008-5472.CAN-07-5194; Lages E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020600; Lena AM, 2008, CELL DEATH DIFFER, V15, P1187, DOI 10.1038/cdd.2008.69; Lujambio A, 2008, P NATL ACAD SCI USA, V105, P13556, DOI 10.1073/pnas.0803055105; Lujambio A, 2007, CELL CYCLE, V6, P1455; Matsunaga S, 2007, ANTICANCER RES, V27, P927; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Mestdagh P, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn725; Miyamoto S, 2007, ANTICANCER RES, V27, P3713; Monkley SJ, 2001, BIOCHEM BIOPH RES CO, V286, P880, DOI 10.1006/bbrc.2001.5497; Nelson WG, 2009, ENDOCRINOLOGY, V150, P3991, DOI 10.1210/en.2009-0573; Ozen M, 2008, ONCOGENE, V27, P1788, DOI 10.1038/sj.onc.1210809; Papadopoulos GL, 2009, BIOINFORMATICS, V25, P1991, DOI 10.1093/bioinformatics/btp299; Park JY, 2010, CANCER CONTROL, V17, P245, DOI 10.1177/107327481001700405; Pavicic W, 2011, MOL MED, V17, P726, DOI 10.2119/molmed.2010.00239; Rauhala HE, 2010, INT J CANCER, V127, P1363, DOI 10.1002/ijc.25162; Rodriguez-Paredes M, 2011, NAT MED, V17, P330, DOI 10.1038/nm.2305; Sakamoto S, 2010, CANCER RES, V70, P1885, DOI 10.1158/0008-5472.CAN-09-2833; Sharma S, 2010, CARCINOGENESIS, V31, P27, DOI 10.1093/carcin/bgp220; Suh SO, 2011, CARCINOGENESIS, V32, P772, DOI 10.1093/carcin/bgr036; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Torring N, 2000, ANTICANCER RES, V20, P91; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Viticchie G, 2011, CELL CYCLE, V10, P1121, DOI 10.4161/cc.10.7.15180; Wong TS, 2008, INT J CANCER, V123, P251, DOI 10.1002/ijc.23583; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Yoon S, 2010, FEBS LETT, V584, P4048, DOI 10.1016/j.febslet.2010.08.025; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028; Zhang SY, 2011, CARCINOGENESIS, V32, P1183, DOI 10.1093/carcin/bgr105; Zhang X, 2008, NAT CELL BIOL, V10, P1062, DOI 10.1038/ncb1765	44	117	128	0	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2013	32	1					127	134		10.1038/onc.2012.14	http://dx.doi.org/10.1038/onc.2012.14			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	063VG	22310291				2022-12-25	WOS:000313029500013
J	Bosmann, M; Grailer, JJ; Zhu, KT; Matthay, MA; Sarma, JV; Zetoune, FS; Ward, PA				Bosmann, Markus; Grailer, Jamison J.; Zhu, Ketong; Matthay, Michael A.; Sarma, J. Vidya; Zetoune, Firas S.; Ward, Peter A.			Anti-inflammatory effects of beta(2) adrenergic receptor agonists in experimental acute lung injury	FASEB JOURNAL			English	Article						albuterol; formoterol; macrophages; neutrophils; JNK	BRONCHIAL EPITHELIAL-CELLS; RESPIRATORY-DISTRESS-SYNDROME; CONTROLLED CLINICAL-TRIAL; ALVEOLAR FLUID CLEARANCE; PULMONARY-EDEMA; COMPLEMENT ACTIVATION; ENDOTHELIAL-CELLS; CYTOKINE RELEASE; RAT LUNGS; SALMETEROL	These studies were undertaken to extend emerging evidence that beta(2) adrenergic receptor (beta(2)AR) agonists, in addition to their bronchorelaxing effects, may have broad anti-inflammatory effects in the lung following onset of experimental acute lung injury (ALI). Young male C57BL/6 mice (25 g) developed ALI following airway deposition of bacterial LPS or IgG immune complexes in the absence or presence of appropriate stereoisomers (enantiomers) of beta(2)AR agonists, albuterol or formoterol. Endpoints included albumin leak into lung and buildup of polymorphonuclear neutrophils and cytokines/chemokines in bronchoalveolar fluids. Both beta(2)AR agonists suppressed lung inflammatory parameters (IC50=10(-7) M). Similar effects of beta(2)AR agonists on mediator release were found when mouse macrophages were stimulated in vitro with LPS. The protective effects were associated with reduced activation (phosphorylation) of JNK but not of other signaling proteins. Collectively, these data suggest that beta(2)AR agonists have broad anti-inflammatory effects in the setting of ALI. While beta(2)AR agonists suppress JNK activation, the extent to which this can explain the blunted lung inflammatory responses in the ALI models remains to be determined.-Bosmann, M., Grailer, J. J., Zhu, K., Matthay, M A., Vidya Sarma, J., Zetoune, F. S., Ward, P. A. Anti-inflammatory effects of beta(2) adrenergic receptor agonists in experimental acute lung injury. FASEB J. 26, 2137-2144 (2012). www.fasebj.org	[Bosmann, Markus; Grailer, Jamison J.; Zhu, Ketong; Sarma, J. Vidya; Zetoune, Firas S.; Ward, Peter A.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [Matthay, Michael A.] Univ Calif San Francisco, Dept Med & Anesthesia, San Francisco, CA 94143 USA	University of Michigan System; University of Michigan; University of California System; University of California San Francisco	Ward, PA (corresponding author), Univ Michigan, Sch Med, Dept Pathol, 1301 Catherine Rd,Box 5602, Ann Arbor, MI 48109 USA.	pward@umich.edu		Bosmann, Markus/0000-0003-2773-1033	U.S. National Institutes of Health [GM-29507, GM-61656, NHLBI-T32-HL007517-29, HL-51856, HL-51854]; Deutsche Forschungsgemeinschaft [571701, BO 3482/1-1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL051856, T32HL007517, R01HL051854, R01HL051856] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061656, R01GM029507, R37GM029507] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by U.S. National Institutes of Health grants to P.A.W. (GM-29507, GM-61656), J.J.G. (NHLBI-T32-HL007517-29), and M.A.M. (HL-51856, HL-51854) and by a Deutsche Forschungsgemeinschaft grant to M.B. (project 571701, BO 3482/1-1). The authors declare no conflicts of interest. The authors acknowledge the excellent staff support of Beverly Schumann, Sue Scott, and Robin Kunkel.	Atabai K, 2002, INTENS CARE MED, V28, P705, DOI 10.1007/s00134-002-1282-x; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Bloemen PGM, 1997, AM J PHYSIOL-LUNG C, V272, pL580, DOI 10.1152/ajplung.1997.272.4.L580; Bosmann M, 2011, FASEB J, V25, P4222, DOI 10.1096/fj.11-191205; Bosmann M, 2011, SHOCK, V36, P396, DOI 10.1097/SHK.0b013e3182295f5f; Chen FS, 2006, ANN THORAC SURG, V82, P465, DOI 10.1016/j.athoracsur.2006.01.010; Cobelens PM, 2002, J IMMUNOL, V169, P5028, DOI 10.4049/jimmunol.169.9.5028; Dhingra VK, 2001, ANESTHESIOLOGY, V95, P947, DOI 10.1097/00000542-200110000-00025; Donnelly LE, 2010, EUR RESPIR J, V36, P178, DOI 10.1183/09031936.00158008; Dutta EJ, 2002, MED CLIN N AM, V86, P991, DOI 10.1016/S0025-7125(02)00031-7; FIORENTINO DF, 1991, J IMMUNOL, V147, P3815; Flierl MA, 2007, NATURE, V449, P721, DOI 10.1038/nature06185; Gao HW, 2006, ANNU REV PATHOL-MECH, V1, P215, DOI 10.1146/annurev.pathol.1.110304.100155; Goss CH, 2003, CRIT CARE MED, V31, P1607, DOI 10.1097/01.CCM.0000063475.65751.1D; Huber-Lang M, 2006, NAT MED, V12, P682, DOI 10.1038/nm1419; Johnson M, 1998, AM J RESP CRIT CARE, V158, pS146, DOI 10.1164/ajrccm.158.supplement_2.13tac110; Levitt JE, 2009, CHEST, V135, P936, DOI 10.1378/chest.08-2346; Manocha S, 2006, CRIT CARE, V10, DOI 10.1186/cc3971; Maris NA, 2005, AM J RESP CRIT CARE, V172, P878, DOI 10.1164/rccm.200503-451OC; Matthay MA, 2006, AM J RESP CRIT CARE, V173, P254, DOI 10.1164/rccm.rccm2511003; Matthay MA, 2005, AM J RESP CELL MOL, V33, P319, DOI 10.1165/rcmb.F305; Matthay MA, 2011, AM J RESP CRIT CARE, V184, P561, DOI 10.1164/rccm.201012-2090OC; McAuley DF, 2004, CRIT CARE MED, V32, P1470, DOI 10.1097/01.CCM.0000129489.34416.0E; Mutlu GM, 2005, AM J PHYSIOL-LUNG C, V289, pL685, DOI 10.1152/ajplung.00247.2005; Mutlu GM, 2008, AM J RESP CELL MOL, V38, P127, DOI 10.1165/rcmb.2007-0198TR; Oddera S, 1998, J ASTHMA, V35, P401, DOI 10.3109/02770909809048948; Perkins GD, 2004, CRIT CARE, V8, P25, DOI 10.1186/cc2417; Perkins GD, 2006, AM J RESP CRIT CARE, V173, P281, DOI 10.1164/rccm.200508-1302OC; Queen LR, 2006, J PHYSIOL-LONDON, V576, P585, DOI 10.1113/jphysiol.2006.115998; Rittirsch D, 2008, J IMMUNOL, V180, P7664, DOI 10.4049/jimmunol.180.11.7664; Roux FJ, 1996, AM J RESP CRIT CARE, V153, P1489, DOI 10.1164/ajrccm.153.5.8630591; Sabatini F, 2003, RESP MED, V97, P1052, DOI 10.1016/S0954-6111(03)00137-9; Sakuma T, 1997, AM J RESP CRIT CARE, V155, P506, DOI 10.1164/ajrccm.155.2.9032186; SAKUMA T, 1994, AM J RESP CRIT CARE, V150, P305, DOI 10.1164/ajrccm.150.2.8049807; Sartori C, 2002, NEW ENGL J MED, V346, P1631, DOI 10.1056/NEJMoa013183; Scola AM, 2009, BRIT J PHARMACOL, V158, P267, DOI 10.1111/j.1476-5381.2009.00178.x; Shanley TP, 1997, J IMMUNOL, V158, P3439; Spoelstra FM, 2002, THORAX, V57, P237, DOI 10.1136/thorax.57.3.237; Tracey KJ, 2009, NAT REV IMMUNOL, V9, P418, DOI 10.1038/nri2566; WARREN JS, 1989, J CLIN INVEST, V84, P1873, DOI 10.1172/JCI114374; WHELAN CJ, 1993, BRIT J PHARMACOL, V110, P613, DOI 10.1111/j.1476-5381.1993.tb13855.x; ZINK S, 1995, AM J PHYSIOL-CELL PH, V269, pC1209, DOI 10.1152/ajpcell.1995.269.5.C1209	42	71	76	1	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	MAY	2012	26	5					2137	2144		10.1096/fj.11-201640	http://dx.doi.org/10.1096/fj.11-201640			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	937TD	22318967	Green Published, Green Submitted			2022-12-25	WOS:000303680800039
J	Liu, SP; Ammirati, MJ; Song, X; Knafels, JD; Zhang, J; Greasley, SE; Pfefferkorn, JA; Qiu, XY				Liu, Shenping; Ammirati, Mark J.; Song, Xi; Knafels, John D.; Zhang, Jeff; Greasley, Samantha E.; Pfefferkorn, Jeffrey A.; Qiu, Xiayang			Insights into Mechanism of Glucokinase Activation OBSERVATION OF MULTIPLE DISTINCT PROTEIN CONFORMATIONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN PANCREATIC GLUCOKINASE; DEPENDENT DIABETES-MELLITUS; X-RAY SOLUTION; ALLOSTERIC ACTIVATORS; REGULATORY PROTEIN; MACROMOLECULAR STRUCTURES; KINETIC COOPERATIVITY; CLINICAL CANDIDATE; LIVER GLUCOKINASE; CRYSTAL-STRUCTURE	Human glucokinase (GK) is a principal regulating sensor of plasma glucose levels. Mutations that inactivate GK are linked to diabetes, and mutations that activate it are associated with hypoglycemia. Unique kinetic properties equip GK for its regulatory role: although it has weak basal affinity for glucose, positive cooperativity in its binding of glucose causes a rapid increase in catalytic activity when plasma glucose concentrations rise above euglycemic levels. In clinical trials, small molecule GK activators (GKAs) have been efficacious in lowering plasma glucose and enhancing glucose-stimulated insulin secretion, but they carry a risk of overly activating GK and causing hypoglycemia. The theoretical models proposed to date attribute the positive cooperativity of GK to the existence of distinct protein conformations that interconvert slowly and exhibit different affinities for glucose. Here we report the respective crystal structures of the catalytic complex of GK and of a GK-glucose complex in a wide open conformation. To assess conformations of GK in solution, we also carried out small angle x-ray scattering experiments. The results showed that glucose dose-dependently converts GK from an apo conformation to an active open conformation. Compared with wild type GK, activating mutants required notably lower concentrations of glucose to be converted to the active open conformation. GKAs decreased the level of glucose required for GK activation, and different compounds demonstrated distinct activation profiles. These results lead us to propose a modified mnemonic model to explain cooperativity in GK. Our findings may offer new approaches for designing GKAs with reduced hypoglycemic risk.	[Liu, Shenping; Ammirati, Mark J.; Song, Xi; Knafels, John D.; Zhang, Jeff; Pfefferkorn, Jeffrey A.; Qiu, Xiayang] Pfizer Groton Labs, Groton, CT 06340 USA; [Greasley, Samantha E.] Pfizer La Jolla Labs, San Diego, CA 92121 USA	Pfizer; Pfizer	Liu, SP (corresponding author), Pfizer Groton Labs, Eastern Point Rd, Groton, CT 06340 USA.	shenping.liu@pfizer.com						AINSLIE GR, 1972, J BIOL CHEM, V247, P7088; Aleshin AE, 1998, J MOL BIOL, V282, P345, DOI 10.1006/jmbi.1998.2017; Antoine M, 2009, BIOCHEMISTRY-US, V48, P5466, DOI 10.1021/bi900374c; Bebernitz GR, 2009, J MED CHEM, V52, P6142, DOI 10.1021/jm900839k; Bricogne G., 2010, BUSTER VERSION 2 9; BUC J, 1977, EUR J BIOCHEM, V80, P593, DOI 10.1111/j.1432-1033.1977.tb11916.x; Cuesta-Munoz AL, 2004, DIABETES, V53, P2164, DOI 10.2337/diabetes.53.8.2164; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dunten P, 2004, FRONT DIABETES, V16, P145; Efanov AM, 2005, ENDOCRINOLOGY, V146, P3696, DOI 10.1210/en.2005-0377; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Feigin L.A., 1987, STRUCTURE ANAL SMALL; Filipski K. J., 2010, 240 ACS NAT M BOST A; FROGUEL P, 1992, NATURE, V356, P162, DOI 10.1038/356162a0; Futamura M, 2006, J BIOL CHEM, V281, P37668, DOI 10.1074/jbc.M605186200; Glaser B, 1998, NEW ENGL J MED, V338, P226, DOI 10.1056/NEJM199801223380404; Gloyn AL, 2003, DIABETES, V52, P2433, DOI 10.2337/diabetes.52.9.2433; Grimsby J, 2003, SCIENCE, V301, P370, DOI 10.1126/science.1084073; HATTERSLEY AT, 1992, LANCET, V339, P1307, DOI 10.1016/0140-6736(92)91958-B; Henquin JC, 2003, EUR J CLIN INVEST, V33, P742, DOI 10.1046/j.1365-2362.2003.01207.x; Heredia VV, 2006, BIOCHEMISTRY-US, V45, P7553, DOI 10.1021/bi060253q; Heredia VV, 2006, J BIOL CHEM, V281, P40201, DOI 10.1074/jbc.M607987200; IYNEDJIAN PB, 1988, J BIOL CHEM, V263, P740; Jacques DA, 2010, PROTEIN SCI, V19, P642, DOI 10.1002/pro.351; JETTON TL, 1994, J BIOL CHEM, V269, P3641; Kamata K, 2004, STRUCTURE, V12, P429, DOI 10.1016/j.str.2004.02.005; Kester R. F., 2009, 238 ACS NAT M WASH D; Kleywegt GJ, 1997, METHOD ENZYMOL, V277, P525, DOI 10.1016/S0076-6879(97)77029-0; Krukenberg KA, 2008, STRUCTURE, V16, P755, DOI 10.1016/j.str.2008.01.021; Larion M, 2010, BIOCHEMISTRY-US, V49, P8902, DOI 10.1021/bi1008672; Larion M, 2010, BIOCHEMISTRY-US, V49, P7969, DOI 10.1021/bi101098f; LIN SX, 1990, J BIOL CHEM, V265, P9670; Magnuson MA, 2004, FRONT DIABETES, V16, P1; Mahalingam B, 1999, DIABETES, V48, P1698, DOI 10.2337/diabetes.48.9.1698; Matschinsky Franz M, 2005, Curr Diab Rep, V5, P171, DOI 10.1007/s11892-005-0005-4; Molnes J, 2011, FEBS J, V278, P2372, DOI 10.1111/j.1742-4658.2011.08160.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z., 2001, INT TABLES CRYSTALLO, VF, P226; Petit P, 2011, ACTA CRYSTALLOGR D, V67, P929, DOI 10.1107/S0907444911036729; Pfefferkorn JA, 2012, J MED CHEM, V55, P1318, DOI 10.1021/jm2014887; Pfefferkorn JA, 2011, MEDCHEMCOMM, V2, P828, DOI 10.1039/c1md00116g; Putnam CD, 2007, Q REV BIOPHYS, V40, P191, DOI 10.1017/S0033583507004635; RICARD J, 1974, EUR J BIOCHEM, V49, P195, DOI 10.1111/j.1432-1033.1974.tb03825.x; Segal I. H, 1993, ENZYME KINETICS BEHA, P189; STEITZ TA, 1981, PHILOS T ROY SOC B, V293, P43, DOI 10.1098/rstb.1981.0058; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; VANSCHAFTINGEN E, 1994, FASEB J, V8, P414, DOI 10.1096/fasebj.8.6.8168691; VIONNET N, 1992, NATURE, V356, P721, DOI 10.1038/356721a0; Vonrhein C, 2011, ACTA CRYSTALLOGR D, V67, P293, DOI 10.1107/S0907444911007773; Yang L., 2010, SAXS WAXS DATA COLLE; Zorn JA, 2010, NAT CHEM BIOL, V6, P179, DOI 10.1038/NCHEMBIO.318	51	46	46	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					13598	13610		10.1074/jbc.M111.274126	http://dx.doi.org/10.1074/jbc.M111.274126			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22298776	Green Published, hybrid			2022-12-25	WOS:000303996300016
J	Kitajima, T; Jigami, Y; Chiba, Y				Kitajima, Toshihiko; Jigami, Yoshifumi; Chiba, Yasunori			Cytotoxic Mechanism of Selenomethionine in Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AFFINITY METHIONINE PERMEASE; IONIZATION MASS-SPECTROMETRY; SACCHAROMYCES-CEREVISIAE; TRANSFER-RNA; SELENOCYSTEINE; SELENIUM; METABOLISM; TOXICITY; SULFUR; GENE	Although selenium is an essential element, its excessive uptake is detrimental to living organisms. The significance of selenium for living organisms has been exploited for various purposes. However, the molecular basis of selenium toxicity is not completely understood. Here, we applied a capillary electrophoresis time-of-flight mass spectrometry-based metabolomics approach to analysis of yeast cells treated with selenomethionine. The data indicated that intracellular thiol compounds are significantly decreased, and diselenide and selenosulfide compounds are increased in selenomethionine-treated cells. The growth defect induced by selenomethionine was recovered by extracellular addition of cysteine and by genetic modification of yeast cells that have an additional de novo synthetic pathway for cysteine. Because cysteine is an intermediate of thiol compounds, these results suggested that the loss of a reduced form of thiol compounds due to selenomethionine causes a growth defect of yeast cells.	[Kitajima, Toshihiko; Jigami, Yoshifumi; Chiba, Yasunori] Natl Inst Adv Ind Sci & Technol, Res Ctr Med Glycosci, Tsukuba, Ibaraki 3058566, Japan	National Institute of Advanced Industrial Science & Technology (AIST)	Chiba, Y (corresponding author), Natl Inst Adv Ind Sci & Technol, Res Ctr Med Glycosci, Cent 6,1-1-1 Higashi, Tsukuba, Ibaraki 3058566, Japan.	y-chiba@aist.go.jp	Kitajima, Toshihiko/K-2894-2013; Kitajima, Toshihiko/D-2463-2016; Chiba, Yasunori/L-7993-2018	Kitajima, Toshihiko/0000-0002-0202-5282; Kitajima, Toshihiko/0000-0001-9677-5086; Chiba, Yasunori/0000-0002-6401-5071				Abe H, 2003, GLYCOBIOLOGY, V13, P87, DOI 10.1093/glycob/cwg014; Bockhorn J, 2008, P NATL ACAD SCI USA, V105, P17682, DOI 10.1073/pnas.0805642105; Carlson BA, 2004, P NATL ACAD SCI USA, V101, P12848, DOI 10.1073/pnas.0402636101; CHAMBERS I, 1986, EMBO J, V5, P1221, DOI 10.1002/j.1460-2075.1986.tb04350.x; CHEREST H, 1969, J BACTERIOL, V97, P328, DOI 10.1128/JB.97.1.328-336.1969; EUSTICE DC, 1981, PLANT PHYSIOL, V67, P1054, DOI 10.1104/pp.67.5.1054; HATFIELD D, 1982, P NATL ACAD SCI-BIOL, V79, P6215, DOI 10.1073/pnas.79.20.6215; HENDRICKSON WA, 1990, EMBO J, V9, P1665, DOI 10.1002/j.1460-2075.1990.tb08287.x; HUBER RE, 1967, ARCH BIOCHEM BIOPHYS, V122, P164, DOI 10.1016/0003-9861(67)90136-1; Kaiser JT, 2005, BIOCHEMISTRY-US, V44, P13315, DOI 10.1021/bi051110r; Kim HY, 2006, BIOCHEMISTRY-US, V45, P13697, DOI 10.1021/bi0611614; Kitajima T, 2010, APPL ENVIRON MICROB, V76, P6351, DOI 10.1128/AEM.01026-10; Kosugi A, 2001, BIOSCI BIOTECH BIOCH, V65, P728, DOI 10.1271/bbb.65.728; LEINFELDER W, 1990, P NATL ACAD SCI USA, V87, P543, DOI 10.1073/pnas.87.2.543; LEINFELDER W, 1988, NATURE, V331, P723, DOI 10.1038/331723a0; Letavayova L, 2008, MUTAT RES-FUND MOL M, V638, P1, DOI 10.1016/j.mrfmmm.2007.08.009; Malkowski MG, 2007, P NATL ACAD SCI USA, V104, P6678, DOI 10.1073/pnas.0610337104; Nakamuro K, 2000, J HEALTH SCI, V46, P418; Nauser T, 2012, AMINO ACIDS, V42, P39, DOI 10.1007/s00726-010-0602-7; Palace VP, 2004, ECOTOX ENVIRON SAFE, V58, P17, DOI 10.1016/j.ecoenv.2003.08.019; Pappas AC, 2008, COMP BIOCHEM PHYS B, V151, P361, DOI 10.1016/j.cbpb.2008.08.009; PLEASANTS JC, 1989, J AM CHEM SOC, V111, P6553, DOI 10.1021/ja00199a012; Rao YL, 2010, ANAL CHEM, V82, P8121, DOI 10.1021/ac1011798; Rice LM, 2000, ACTA CRYSTALLOGR D, V56, P1413, DOI 10.1107/S0907444900010039; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Soga T, 2002, ANAL CHEM, V74, P2233, DOI 10.1021/ac020064n; Soga T, 2003, J PROTEOME RES, V2, P488, DOI 10.1021/pr034020m; Soga T, 2000, ANAL CHEM, V72, P1236, DOI 10.1021/ac990976y; Sors TG, 2005, PHOTOSYNTH RES, V86, P373, DOI 10.1007/s11120-005-5222-9; Terry N, 2000, ANNU REV PLANT PHYS, V51, P401, DOI 10.1146/annurev.arplant.51.1.401; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Thomas D, 1997, MICROBIOL MOL BIOL R, V61, P503, DOI 10.1128/.61.4.503-532.1997; Wessjohann LA, 2007, BIOL CHEM, V388, P997, DOI 10.1515/BC.2007.138; Xu XM, 2007, PLOS BIOL, V5, P96, DOI 10.1371/journal.pbio.0050004; YAMAGATA S, 1974, J BIOCHEM, V75, P1221, DOI 10.1093/oxfordjournals.jbchem.a130505; Yuan J, 2006, P NATL ACAD SCI USA, V103, P18923, DOI 10.1073/pnas.0609703104; ZINONI F, 1986, P NATL ACAD SCI USA, V83, P4650, DOI 10.1073/pnas.83.13.4650	37	16	17	2	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					10032	10038		10.1074/jbc.M111.324244	http://dx.doi.org/10.1074/jbc.M111.324244			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22311978	hybrid, Green Published			2022-12-25	WOS:000302167200035
J	Pickering, AM; Linder, RA; Zhang, HQ; Forman, HJ; Davies, KJA				Pickering, Andrew M.; Linder, Robert A.; Zhang, Hongqiao; Forman, Henry J.; Davies, Kelvin J. A.			Nrf2-dependent Induction of Proteasome and Pa28 alpha beta Regulator Are Required for Adaptation to Oxidative Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR NRF2; PROTEIN OXIDATION; OXIDIZED PROTEINS; LON PROTEASE; NITRIC-OXIDE; MITOCHONDRIAL ACONITASE; ENDOTHELIAL-CELLS; GENE-EXPRESSION; UP-REGULATION; DEGRADATION	The ability to adapt to acute oxidative stress (e.g. H2O2, peroxynitrite, menadione, and paraquat) through transient alterations in gene expression is an important component of cellular defense mechanisms. We show that such adaptation includes Nrf2-dependent increases in cellular capacity to degrade oxidized proteins that are attributable to increased expression of the 20 S proteasome and the Pa28 alpha beta (11 S) proteasome regulator. Increased cellular levels of Nrf2, translocation of Nrf2 from the cytoplasm to the nucleus, and increased binding of Nrf2 to antioxidant response elements (AREs) or electrophile response elements (EpREs) in the 5'-untranslated region of the proteasome beta 5 subunit gene (demonstrated by chromatin immuno-precipitation (or ChIP) assay) are shown to be necessary requirements for increased proteasome/Pa28 alpha beta levels, and for maximal increases in proteolytic capacity and stress resistance; Nrf2 siRNA and the Nrf2 inhibitor retinoic acid both block these adaptive changes and the Nrf2 inducers DL-sulforaphane, lipoic acid, and curcumin all replicate them without oxidant exposure. The immunoproteasome is also induced during oxidative stress adaptation, contributing to overall capacity to degrade oxidized proteins and stress resistance. Two of the three immunoproteasome subunit genes, however, contain no ARE/EpRE elements, and Nrf2 inducers, inhibitors, and siRNA all have minimal effects on immunoproteasome expression during adaptation to oxidative stress. Thus, immunoproteasome appears to be (at most) minimally regulated by the Nrf2 signal transduction pathway.	[Pickering, Andrew M.; Linder, Robert A.; Zhang, Hongqiao; Forman, Henry J.; Davies, Kelvin J. A.] Univ So Calif, Ethel Percy Andrus Gerontol Ctr, Davis Sch Gerontol, Los Angeles, CA 90089 USA; [Pickering, Andrew M.; Linder, Robert A.; Davies, Kelvin J. A.] Univ So Calif, Div Mol & Computat Biol, Dept Biol Sci, Dornsife Coll Letters Arts & Sci, Los Angeles, CA 90089 USA; [Zhang, Hongqiao; Forman, Henry J.] Univ Calif Merced, Merced, CA 95343 USA	University of Southern California; University of Southern California; University of California System; University of California Merced	Davies, KJA (corresponding author), Univ So Calif, Ethel Percy Andrus Gerontol Ctr, Davis Sch Gerontol, 3715 McClintock Ave, Los Angeles, CA 90089 USA.	kelvin@usc.edu		Davies, Kelvin/0000-0001-7790-3003; Forman, Henry Jay/0000-0001-5838-2791	National Institutes of Health [RO1-ES003598]; ARRA from the NIEHS [3RO1-ES003598-22S2]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES003598] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ARRA from the NIEHS; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1-ES003598 and ARRA Supplement 3RO1-ES003598-22S2 from the NIEHS (to K. J. A. D.).	Ahn K, 1996, J BIOL CHEM, V271, P18237, DOI 10.1074/jbc.271.30.18237; Bota DA, 2002, NAT CELL BIOL, V4, P674, DOI 10.1038/ncb836; Bota DA, 2005, FREE RADICAL BIO MED, V38, P665, DOI 10.1016/j.freeradbiomed.2004.11.017; Bulteau AL, 2005, P NATL ACAD SCI USA, V102, P5987, DOI 10.1073/pnas.0501519102; Bulteau AL, 2006, EXP GERONTOL, V41, P653, DOI 10.1016/j.exger.2006.03.013; Chondrogianni N, 2003, J BIOL CHEM, V278, P28026, DOI 10.1074/jbc.M301048200; Conconi M, 1996, ARCH BIOCHEM BIOPHYS, V331, P232, DOI 10.1006/abbi.1996.0303; DAVIES K J A, 1986, Journal of Free Radicals in Biology and Medicine, V2, P155, DOI 10.1016/S0748-5514(86)80066-6; Davies KJA, 1999, IUBMB LIFE, V48, P41, DOI 10.1080/152165499307404; DAVIES KJA, 1993, BIOCHEM SOC T, V21, P346, DOI 10.1042/bst0210346; Davies KJA, 2000, IUBMB LIFE, V50, P279, DOI 10.1080/15216540051081010; Davies KJA, 2001, BIOCHIMIE, V83, P301, DOI 10.1016/S0300-9084(01)01250-0; DAVIES KJA, 1987, J BIOL CHEM, V262, P8227; Ding QX, 2004, J NEUROCHEM, V91, P1211, DOI 10.1111/j.1471-4159.2004.02802.x; Enomoto A, 2001, TOXICOL SCI, V59, P169, DOI 10.1093/toxsci/59.1.169; Ermak G, 2002, FASEB J, V16, DOI 10.1096/fj.01-0846com; Ferrington DA, 2005, FASEB J, V19, P664, DOI 10.1096/fj.04-2578fje; Ferrington DA, 2008, J NEUROCHEM, V106, P158, DOI 10.1111/j.1471-4159.2008.05345.x; Foss GS, 1999, J BIOL CHEM, V274, P35196, DOI 10.1074/jbc.274.49.35196; FUCCI L, 1983, P NATL ACAD SCI-BIOL, V80, P1521, DOI 10.1073/pnas.80.6.1521; Gan NQ, 2010, TOXICOL APPL PHARM, V247, P129, DOI 10.1016/j.taap.2010.06.005; Grune T, 1996, J BIOL CHEM, V271, P15504, DOI 10.1074/jbc.271.26.15504; Husom AD, 2004, ARCH BIOCHEM BIOPHYS, V421, P67, DOI 10.1016/j.abb.2003.10.010; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Itoh K, 2003, GENES CELLS, V8, P379, DOI 10.1046/j.1365-2443.2003.00640.x; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; JENTOFT N, 1979, J BIOL CHEM, V254, P4359; KAMANNA VS, 1991, AM J PHYSIOL, V261, pF163, DOI 10.1152/ajprenal.1991.261.1.F163; Keller JN, 2005, NEUROLOGY, V64, P1152, DOI 10.1212/01.WNL.0000156156.13641.BA; Kotamraju S, 2006, FREE RADICAL BIO MED, V40, P1034, DOI 10.1016/j.freeradbiomed.2005.10.052; Kotamraju S, 2003, P NATL ACAD SCI USA, V100, P10653, DOI 10.1073/pnas.1933581100; Kraft DC, 2006, ANN NY ACAD SCI, V1067, P420, DOI 10.1196/annals.1354.060; Kwak MK, 2003, MOL CELL BIOL, V23, P8786, DOI 10.1128/MCB.23.23.8786-8794.2003; Lii CK, 2010, J NUTR, V140, P885, DOI 10.3945/jn.110.121418; Mandal MNA, 2009, FREE RADICAL BIO MED, V46, P672, DOI 10.1016/j.freeradbiomed.2008.12.006; McMahon M, 2001, CANCER RES, V61, P3299; McMahon M, 2003, J BIOL CHEM, V278, P21592, DOI 10.1074/jbc.M300931200; MOI P, 1994, P NATL ACAD SCI USA, V91, P9926, DOI 10.1073/pnas.91.21.9926; Nair S, 2010, ACTA PHARMACOL SIN, V31, P1223, DOI 10.1038/aps.2010.147; Namiki S, 2005, FEBS LETT, V579, P2781, DOI 10.1016/j.febslet.2005.04.012; Ngo JK, 2009, FREE RADICAL BIO MED, V46, P1042, DOI 10.1016/j.freeradbiomed.2008.12.024; Nguyen T, 2003, ANNU REV PHARMACOL, V43, P233, DOI 10.1146/annurev.pharmtox.43.100901.140229; PACIFICI RE, 1993, J BIOL CHEM, V268, P15405; PACIFICI RE, 1991, GERONTOLOGY, V37, P166; Pickering AM, 2010, BIOCHEM J, V432, P585, DOI 10.1042/BJ20100878; Ramos-Gomez M, 2001, P NATL ACAD SCI USA, V98, P3410, DOI 10.1073/pnas.051618798; Reinheckel T, 2000, METH MOL B, V99, P49; RUSHMORE TH, 1991, J BIOL CHEM, V266, P11632; Seifert U, 2010, CELL, V142, P613, DOI 10.1016/j.cell.2010.07.036; SHANG F, 1995, BIOCHEM J, V307, P297, DOI 10.1042/bj3070297; Shay KP, 2009, BBA-GEN SUBJECTS, V1790, P1149, DOI 10.1016/j.bbagen.2009.07.026; Shenvi SV, 2009, PHARMACOL RES, V60, P229, DOI 10.1016/j.phrs.2009.06.003; Shringarpure R, 2003, J BIOL CHEM, V278, P311, DOI 10.1074/jbc.M206279200; STADTMAN ER, 1986, TRENDS BIOCHEM SCI, V11, P11, DOI 10.1016/0968-0004(86)90221-5; STARKEREED PE, 1989, ARCH BIOCHEM BIOPHYS, V275, P559, DOI 10.1016/0003-9861(89)90402-5; Suh JH, 2004, P NATL ACAD SCI USA, V101, P3381, DOI 10.1073/pnas.0400282101; TAYLOR A, 1987, FREE RADICAL BIO MED, V3, P371, DOI 10.1016/0891-5849(87)90015-3; Teoh CY, 2004, ARCH BIOCHEM BIOPHYS, V423, P88, DOI 10.1016/j.abb.2003.12.001; Thomas S, 2007, FREE RADICAL BIO MED, V42, P1049, DOI 10.1016/j.freeradbiomed.2007.01.005; Ullrich O, 1999, P NATL ACAD SCI USA, V96, P6223, DOI 10.1073/pnas.96.11.6223; Venugopal R, 1996, P NATL ACAD SCI USA, V93, P14960, DOI 10.1073/pnas.93.25.14960; Wang XJ, 2007, P NATL ACAD SCI USA, V104, P19589, DOI 10.1073/pnas.0709483104; Whittier JE, 2004, J BIOL CHEM, V279, P46135, DOI 10.1074/jbc.M406048200; WIESE AG, 1995, ARCH BIOCHEM BIOPHYS, V318, P231, DOI 10.1006/abbi.1995.1225; WOLFF SP, 1986, BIOCHEM J, V234, P399, DOI 10.1042/bj2340399; Yamano T, 2002, J EXP MED, V196, P185, DOI 10.1084/jem.20011922; Yang CH, 2009, BRAIN RES, V1282, P133, DOI 10.1016/j.brainres.2009.05.009; Zhang H, 2008, AM J RESP CELL MOL, V38, P483, DOI 10.1165/rcmb.2007-0260OC; Zhao HD, 2010, WORLD J GASTROENTERO, V16, P3002, DOI 10.3748/wjg.v16.i24.3002	69	214	220	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					10021	10031		10.1074/jbc.M111.277145	http://dx.doi.org/10.1074/jbc.M111.277145			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22308036	hybrid, Green Published			2022-12-25	WOS:000302167200034
J	Telezhkin, V; Reilly, JM; Thomas, AM; Tinker, A; Brown, DA				Telezhkin, Vsevolod; Reilly, Joanne M.; Thomas, Alison M.; Tinker, Andrew; Brown, David A.			Structural Requirements of Membrane Phospholipids for M-type Potassium Channel Activation and Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; PHOSPHOINOSITIDE BINDING; KCNQ CHANNELS; HIGH-AFFINITY; PIP2; PHOSPHATIDYLSERINE; ORGANIZATION; MODULATION; PROTEINS; SUBUNITS	M-channels are voltage-gated potassium channels that regulate cell excitability. They are heterotetrameric assemblies of Kv7.2 and Kv7.3 subunits. Their opening requires the presence of the membrane phospholipid phosphatidylinositol 4,5-bisphosphate (PI(4,5)P-2). However, the specificity of PI(4,5)P-2 as a binding and activating ligand is unknown. Here, we tested the ability of different phosphoinositides and lipid phosphates to activate or bind to M-channel proteins. Activation of functional channels was measured in membrane patches isolated from cells coexpressing Kv7.2 and Kv7.3 subunits. Channels were activated to similar extents (maximum open probability of similar to 0.8 at 0 mV) by 0.1-300 mu M dioctanoyl homologs of the three endogenous phosphoinositides, PI(4)P, PI(4,5)P-2, and PI(3,4,5)P-3, with sensitivity increasing with increasing numbers of phosphates. Non-acylated inositol phosphates had no effect up to 100 mu M. Channels were also activated with increasing efficacy by 1-300 mu M concentrations of the monoacyl monophosphates fingolimod phosphate, sphingosine 1-phosphate, and lysophosphatidic acid but not by phosphate-free fingolimod or sphingosine or by phosphate-masked phosphatidylcholine or phosphatidyl-glycerol. An overlay assay confirmed that a fusion protein containing the full-length C terminus of Kv7.2 could bind to a broad range of phosphoinositides and phospholipids. A mutated Kv7.2 C-terminal construct with reduced sensitivity to PI(4,5)P showed significantly less binding to most polyphosphoinositides. We concluded that M-channels bind to, and are activated by, a wide range of lipid phosphates, with a minimum requirement for an acyl chain and a phosphate headgroup. In this, they more closely resemble inwardly rectifying Kir6.2 potassium channels than the more PI(4,5)P-2-specific Kir2 channels. Notwithstanding, the data also support the view that the main endogenous activator of M-channels is PI(4,5)P-2.	[Telezhkin, Vsevolod; Reilly, Joanne M.; Brown, David A.] UCL, Dept Neurosci Physiol & Pharmacol, London WC1E 6BT, England; [Thomas, Alison M.; Tinker, Andrew] Barts & London Queen Marys Sch Med & Dent, William Harvey Heart Ctr, London EC1M 6BQ, England	University of London; University College London; University of London; Queen Mary University London	Brown, DA (corresponding author), UCL, Dept Neurosci Physiol & Pharmacol, Gower St, London WC1E 6BT, England.	d.a.brown@ucl.ac.uk	Brown, David A/J-9019-2012	Telezhkin, Vsevolod/0000-0002-5054-8774	Wellcome Trust [085419]; British Heart Foundation [RG/10/10/28447]	Wellcome Trust(Wellcome TrustEuropean Commission); British Heart Foundation(British Heart Foundation)	This work was supported by Grant 085419 from the Wellcome Trust and Grant RG/10/10/28447 from the British Heart Foundation.	ALLAN D, 1983, BIOCHEM J, V213, P555, DOI 10.1042/bj2130555; Brown DA, 2009, BRIT J PHARMACOL, V156, P1185, DOI 10.1111/j.1476-5381.2009.00111.x; Colquhoun D, 1998, BRIT J PHARMACOL, V125, P924; Delmas P, 2005, NAT REV NEUROSCI, V6, P850, DOI 10.1038/nrn1785; Gamper N, 2007, NAT REV NEUROSCI, V8, P921, DOI 10.1038/nrn2257; Garcia P, 1995, BIOCHEMISTRY-US, V34, P16228, DOI 10.1021/bi00049a039; Hansen SB, 2011, NATURE, V477, P495, DOI 10.1038/nature10370; Hernandez CC, 2008, J GEN PHYSIOL, V132, P361, DOI 10.1085/jgp.200810007; Hilgemann D W, 2001, Sci STKE, V2001, pre19, DOI 10.1126/stke.2001.111.re19; Ishii I, 2004, ANNU REV BIOCHEM, V73, P321, DOI 10.1146/annurev.biochem.73.011303.073731; Ju M, 2010, J PHYSIOL-LONDON, V588, P1419, DOI 10.1113/jphysiol.2009.185256; LEMMON MA, 1995, P NATL ACAD SCI USA, V92, P10472, DOI 10.1073/pnas.92.23.10472; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Li Y, 2005, J NEUROSCI, V25, P9825, DOI 10.1523/JNEUROSCI.2597-05.2005; Logothetis DE, 2007, PFLUG ARCH EUR J PHY, V455, P83, DOI 10.1007/s00424-007-0276-5; Main MJ, 2000, MOL PHARMACOL, V58, P253, DOI 10.1124/mol.58.2.253; Manna D, 2008, J BIOL CHEM, V283, P26047, DOI 10.1074/jbc.M802617200; McLaughlin S, 2005, NATURE, V438, P605, DOI 10.1038/nature04398; McLaughlin S, 2002, ANNU REV BIOPH BIOM, V31, P151, DOI 10.1146/annurev.biophys.31.082901.134259; Osborne SL, 2001, NEURON, V32, P9, DOI 10.1016/S0896-6273(01)00455-X; Rohacs T, 2003, P NATL ACAD SCI USA, V100, P745, DOI 10.1073/pnas.0236364100; Rohacs T, 1999, J BIOL CHEM, V274, P36065, DOI 10.1074/jbc.274.51.36065; Santagata S, 2001, SCIENCE, V292, P2041, DOI 10.1126/science.1061233; Selyanko AA, 2001, J PHYSIOL-LONDON, V534, P15, DOI 10.1111/j.1469-7793.2001.00015.x; Stansfeld PJ, 2009, BIOCHEMISTRY-US, V48, P10926, DOI 10.1021/bi9013193; Stephens L, 2000, FR MOLEC B, V27, P32; STEPHENS LR, 1991, NATURE, V351, P33, DOI 10.1038/351033a0; Suh BC, 2002, NEURON, V35, P507, DOI 10.1016/S0896-6273(02)00790-0; Suh BC, 2008, ANNU REV BIOPHYS, V37, P175, DOI 10.1146/annurev.biophys.37.032807.125859; Suh BC, 2007, J PHYSIOL-LONDON, V582, P911, DOI 10.1113/jphysiol.2007.132647; Suh BC, 2006, SCIENCE, V314, P1454, DOI 10.1126/science.1131163; Telezhkin V., 2010, F20 2010 NEUR M PLAN; Thomas AM, 2006, J MEMBRANE BIOL, V211, P43, DOI 10.1007/s00232-006-0014-5; Thomas AM, 2011, J BIOL CHEM, V286, P2088, DOI 10.1074/jbc.M110.153551; Thomas Alison M., 2008, V491, P103, DOI 10.1007/978-1-59745-526-8_8; Tucker SJ, 2008, J GEN PHYSIOL, V131, P431, DOI 10.1085/jgp.200709936; Wang HS, 1998, SCIENCE, V282, P1890, DOI 10.1126/science.282.5395.1890; Willars GB, 1998, J BIOL CHEM, V273, P5037, DOI 10.1074/jbc.273.9.5037; Xu C, 2003, J CELL BIOL, V161, P779, DOI 10.1083/jcb.200301070; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066; Zhang HL, 2003, NEURON, V37, P963, DOI 10.1016/S0896-6273(03)00125-9	41	33	34	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					10001	10012		10.1074/jbc.M111.322552	http://dx.doi.org/10.1074/jbc.M111.322552			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22303005	Green Published, hybrid			2022-12-25	WOS:000302167200032
J	Zhang, Y; Chan, NC; Ngo, HB; Gristick, H; Chan, DC				Zhang, Yan; Chan, Nickie C.; Ngo, Huu B.; Gristick, Harry; Chan, David C.			Crystal Structure of Mitochondrial Fission Complex Reveals Scaffolding Function for Mitochondrial Division 1 (Mdv1) Coiled Coil	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DYNAMIN-RELATED GTPASE; WD REPEAT PROTEIN; MAMMALIAN-CELLS; PEROXISOMAL FISSION; FIS1; DNM1P; FUSION; DRP1; RECRUITMENT; MITOPHAGY	The mitochondrial fission machinery is best understood in the yeast Saccharomyces cerevisiae, where Fis1, Mdv1, and Dnm1 are essential components. Fis1 is a mitochondrial outer membrane protein that recruits the dynamin-related GTPase Dnm1 during the fission process. This recruitment occurs via Mdv1, which binds both Fis1 and Dnm1 and therefore functions as a molecular adaptor linking the two molecules. Mdv1 has a modular structure, consisting of an N-terminal extension that binds Fis1, a central coiled coil for dimerization, and a C-terminal WD40 repeat region that binds Dnm1. We have solved the crystal structure of a dimeric Mdv1-Fis1 complex that contains both the N-terminal extension and coiled-coil regions of Mdv1. Consistent with previous studies, Mdv1 binds Fis1 through a U-shaped helix-loop-helix motif, and dimerization of the Mdv1-Fis1 complex is mediated by the antiparallel coiled coil of Mdv1. However, the complex is surprisingly compact and rigid due to two additional contacts mediated by the surface of the Mdv1 coiled coil. The coiled coil packs against both Fis1 and the second helix of the Mdv1 helix-loop-helix motif. Mutational analyses showed that these contacts are important for mitochondrial fission activity. These results indicate that, in addition to dimerization, the unusually long Mdv1 coiled coil serves a scaffolding function to stabilize the Mdv1-Fis1 complex.	[Chan, Nickie C.; Chan, David C.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; [Zhang, Yan; Chan, Nickie C.; Ngo, Huu B.; Gristick, Harry; Chan, David C.] CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology; Howard Hughes Medical Institute; California Institute of Technology	Chan, DC (corresponding author), CALTECH, Howard Hughes Med Inst, 1200 E Calif Blvd,MC114-96, Pasadena, CA 91125 USA.	dchan@caltech.edu		Zhang, Yan/0000-0001-8376-3190	National Institutes of Health [GM083121, GM062967]; American Heart Association; Gordon and Betty Moore Foundation; Sanofi-Aventis; Department of Energy Office of Biological and Environmental Research; National Institutes of Health National Center for Research Resources [P41RR001209]; NIGMS; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083121, R01GM062967] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Sanofi-Aventis(Sanofi-Aventis); Department of Energy Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM083121 and GM062967.; Supported in part by a postdoctoral fellowship from the American Heart Association.; We thank Janet Shaw for yeast strains, constructs, and helpful discussions. Some of the initial screening was done at the Molecular Observatory at California Institute of Technology, which is supported by the Gordon and Betty Moore Foundation and the Sanofi-Aventis Bioengineering Research Program. Portions of this work were carried out at the Stanford Synchrotron Radiation Lightsource, a Directorate of the SLAC National Accelerator Laboratory and an Office of Science User Facility operated for the United States Department of Energy Office of Science by Stanford University. The Stanford Synchrotron Radiation Lightsource Structural Molecular Biology Program is supported by the Department of Energy Office of Biological and Environmental Research and by National Institutes of Health National Center for Research Resources Bio-medical Technology Program Grant P41RR001209 and NIGMS.	Bleazard W, 1999, NAT CELL BIOL, V1, P298, DOI 10.1038/13014; Cerveny KL, 2003, MOL BIOL CELL, V14, P4126, DOI 10.1091/mbc.E03-02-0092; Chen HC, 2009, HUM MOL GENET, V18, pR169, DOI 10.1093/hmg/ddp326; Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275; Dohm JA, 2004, PROTEINS, V54, P153, DOI 10.1002/prot.10524; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fekkes P, 2000, J CELL BIOL, V151, P333, DOI 10.1083/jcb.151.2.333; Gandre-Babbe S, 2008, MOL BIOL CELL, V19, P2402, DOI 10.1091/mbc.E07-12-1287; Goldschmidt L, 2007, PROTEIN SCI, V16, P1569, DOI 10.1110/ps.072914007; Griffin EE, 2005, J CELL BIOL, V170, P237, DOI 10.1083/jcb.200503148; Ishihara N, 2009, NAT CELL BIOL, V11, P958, DOI 10.1038/ncb1907; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Koch A, 2005, MOL BIOL CELL, V16, P5077, DOI 10.1091/mbc.E05-02-0159; Koirala S, 2010, J CELL BIOL, V191, P1127, DOI 10.1083/jcb.201005046; Lackner LL, 2009, SCIENCE, V325, P874, DOI 10.1126/science.1176921; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mozdy AD, 2000, J CELL BIOL, V151, P367, DOI 10.1083/jcb.151.2.367; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otera H, 2010, J CELL BIOL, V191, P1141, DOI 10.1083/jcb.201007152; Sesaki H, 1999, J CELL BIOL, V147, P699, DOI 10.1083/jcb.147.4.699; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; Stojanovski D, 2004, J CELL SCI, V117, P1201, DOI 10.1242/jcs.01058; Suen DF, 2008, GENE DEV, V22, P1577, DOI 10.1101/gad.1658508; Suzuki M, 2005, J BIOL CHEM, V280, P21444, DOI 10.1074/jbc.M414092200; Suzuki M, 2003, J MOL BIOL, V334, P445, DOI 10.1016/j.jmb.2003.09.064; Tanaka A, 2010, J CELL BIOL, V191, P1367, DOI 10.1083/jcb.201007013; Tieu Q, 2000, J CELL BIOL, V151, P353, DOI 10.1083/jcb.151.2.353; Tieu Q, 2002, J CELL BIOL, V158, P445, DOI 10.1083/jcb.200205031; Tooley JE, 2011, ACTA CRYSTALLOGR F, V67, P1310, DOI 10.1107/S1744309111029368; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Wakabayashi J, 2009, J CELL BIOL, V186, P805, DOI 10.1083/jcb.200903065; Waterham HR, 2007, NEW ENGL J MED, V356, P1736, DOI 10.1056/NEJMoa064436; Westermann B, 2010, NAT REV MOL CELL BIO, V11, P872, DOI 10.1038/nrm3013; Yoon Y, 2003, MOL CELL BIOL, V23, P5409, DOI 10.1128/MCB.23.15.5409-5420.2003; Yu TZ, 2005, J CELL SCI, V118, P4141, DOI 10.1242/jcs.02537; Zhang Y, 2007, P NATL ACAD SCI USA, V104, P18526, DOI 10.1073/pnas.0706441104	37	21	22	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					9855	9861		10.1074/jbc.M111.329359	http://dx.doi.org/10.1074/jbc.M111.329359			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22303011	Green Published, Green Accepted, hybrid, Green Submitted			2022-12-25	WOS:000302167200018
J	Berrout, J; Jin, M; Mamenko, M; Zaika, O; Pochynyuk, O; O'Neil, RG				Berrout, Jonathan; Jin, Min; Mamenko, Mykola; Zaika, Oleg; Pochynyuk, Oleh; O'Neil, Roger G.			Function of Transient Receptor Potential Cation Channel Subfamily V Member 4 (TRPV4) as a Mechanical Transducer in Flow-sensitive Segments of Renal Collecting Duct System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL NA+ CHANNEL; CONNECTING TUBULE; PRIMARY CILIUM; ACTIVATION; POLYCYSTIN-2; SECRETION; TRANSPORT; SENSATION; PATHWAYS; CALCIUM	The TRPV4 Ca2+-permeable channel is sensitive to mechanical stimuli. In the current study we have employed immunocytochemical staining in kidney slices and functional assessments (Ca2+ imaging) in isolated, split-opened, tubule segments to define TRPV4 sites of expression and flow-dependent function in the collecting duct system. Staining patterns revealed strong expression of TRPV4 along the entire collecting duct system with highest levels at the apical (luminal)/subapical region of the principal cells (PCs), the dominant cell type, with more diffuse staining in intercalated cells (ICs). Using fluorescence Ca2+ imaging and the selective TRPV4 agonist, GSK1016790A, we demonstrated functional TRPV4 channels in PCs and ICs of split-opened cortical collecting ducts and connecting tubules. The agonist was ineffective in inducing a rise in [Ca2+](i) in the absence of extracellular Ca2+ or in tubules from TRPV4-deficient animals. Most importantly, a 10-fold elevation in luminal (apical) fluid flow induced a rapid and sustained influx of Ca2+ that was abolished by the TRPV channel inhibitor, ruthenium red, or in tubules isolated from TRPV4 deficient animals. We concluded that TRPV4 is highly expressed along the entire collecting duct system where it appears to function as a sensor/transducer of flow-induce mechanical stresses.	[Berrout, Jonathan; Jin, Min; Mamenko, Mykola; Zaika, Oleg; Pochynyuk, Oleh; O'Neil, Roger G.] Univ Texas Hlth Sci Ctr, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston	O'Neil, RG (corresponding author), Univ Texas Hlth Sci Ctr, Dept Integrat Biol & Pharmacol, 6431 Fannin St,Rm MSB 4-132, Houston, TX 77030 USA.	roger.g.oneil@uth.tmc.edu	Mamenko, Mykola/I-6061-2015	Mamenko, Mykola/0000-0001-8683-0715	National Institutes of Health [R01 DK070950, R21 DE018522]; American Heart Association [SDG2230391]; American Society of Nephrology; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R21DE018522] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070950] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); American Society of Nephrology; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The study was supported, in whole or in part, by National Institutes of Health Grants R01 DK070950 (to R. G. O.) and R21 DE018522 (to R. G. O.). This work was also supported by American Heart Association Grant SDG2230391 (to O. P.) and the Carl W. Gottschalk Research Scholar Grant from the American Society of Nephrology (to O. P.).	AbouAlaiwi WA, 2009, CIRC RES, V104, P860, DOI 10.1161/CIRCRESAHA.108.192765; Cai ZQ, 2000, AM J PHYSIOL-RENAL, V279, pF270, DOI 10.1152/ajprenal.2000.279.2.F270; Cuajungco MP, 2006, J BIOL CHEM, V281, P18753, DOI 10.1074/jbc.M602452200; Fan HC, 2009, J BIOL CHEM, V284, P27884, DOI 10.1074/jbc.M109.028803; Gao X, 2003, J BIOL CHEM, V278, P27129, DOI 10.1074/jbc.M302517200; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Guler AD, 2002, J NEUROSCI, V22, P6408; Hartmannsgruber V, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000827; Jin M., 2012, CELL CALCIU IN PRESS; Jin M, 2011, TRP CHANNELS, P353; Jin M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016713; Kotttgen M, 2008, J CELL BIOL, V182, P437, DOI 10.1083/jcb.200805124; LATTA H, 1961, J BIOPHYS BIOCHEM CY, V11, P248, DOI 10.1083/jcb.11.1.248; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Liu W, 2003, AM J PHYSIOL-RENAL, V285, pF998, DOI 10.1152/ajprenal.00067.2003; Liu W, 2007, AM J PHYSIOL-RENAL, V293, pF227, DOI 10.1152/ajprenal.00057.2007; Loffing J, 2004, J AM SOC NEPHROL, V15, P2276, DOI 10.1097/01.ASN.0000138234.18569.63; Loffing J, 2001, AM J PHYSIOL-RENAL, V281, pF1021, DOI 10.1152/ajprenal.0085.2001; Loot AE, 2008, CARDIOVASC RES, V80, P445, DOI 10.1093/cvr/cvn207; Ma X, 2010, ARTERIOSCL THROM VAS, V30, P851, DOI 10.1161/ATVBAHA.109.196584; Mamenko M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022824; Mendoza SA, 2010, AM J PHYSIOL-HEART C, V298, pH466, DOI 10.1152/ajpheart.00854.2009; Mizuno A, 2003, AM J PHYSIOL-CELL PH, V285, pC96, DOI 10.1152/ajpcell.00559.2002; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Pluznick JL, 2005, AM J PHYSIOL-RENAL, V288, pF846, DOI 10.1152/ajprenal.00340.2004; Pochynyuk O, 2008, J BIOL CHEM, V283, P36599, DOI 10.1074/jbc.M807129200; Rieg T, 2007, KIDNEY INT, V72, P566, DOI 10.1038/sj.ki.5002369; Schwartz EA, 1997, AM J PHYSIOL-RENAL, V272, pF132, DOI 10.1152/ajprenal.1997.272.1.F132; Stewart AP, 2010, BIOPHYS J, V99, P790, DOI 10.1016/j.bpj.2010.05.012; Strotmann R, 2000, NAT CELL BIOL, V2, P695, DOI 10.1038/35036318; Suzuki M, 2003, J BIOL CHEM, V278, P22664, DOI 10.1074/jbc.M302561200; TANIGUCHI J, 1994, J MEMBRANE BIOL, V140, P123; Taniguchi J, 2007, AM J PHYSIOL-RENAL, V292, pF667, DOI 10.1152/ajprenal.00458.2005; Thorneloe KS, 2008, J PHARMACOL EXP THER, V326, P432, DOI 10.1124/jpet.108.139295; Tian W, 2004, AM J PHYSIOL-RENAL, V287, pF17, DOI 10.1152/ajprenal.00397.2003; Vriens J, 2005, CIRC RES, V97, P908, DOI 10.1161/01.RES.0000187474.47805.30; Vriens J, 2004, P NATL ACAD SCI USA, V101, P396, DOI 10.1073/pnas.0303329101; Wu L, 2007, AM J PHYSIOL-RENAL, V293, pF1699, DOI 10.1152/ajprenal.00462.2006; Xu F, 2003, BRIT J PHARMACOL, V140, P413, DOI 10.1038/sj.bjp.0705443; Xu XP, 2009, CHANNELS, V3, P156, DOI 10.4161/chan.3.3.8555; Zaika O, 2011, AM J PHYSIOL-RENAL, V300, pF1105, DOI 10.1152/ajprenal.00606.2010	41	72	72	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					8782	8791		10.1074/jbc.M111.308411	http://dx.doi.org/10.1074/jbc.M111.308411			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22298783	Green Published, hybrid			2022-12-25	WOS:000301797800011
J	Huang, D; Chen, CY; Zhang, MH; Qiu, LY; Shen, Y; Du, G; Zhou, KY; Wang, R; Chen, ZW				Huang, Dan; Chen, Crystal Y.; Zhang, Meihong; Qiu, Liyou; Shen, Yun; Du, George; Zhou, Keyuan; Wang, Richard; Chen, Zheng W.			Clonal Immune Responses of Mycobacterium-Specific gamma delta T Cells in Tuberculous and Non-Tuberculous Tissues during M. tuberculosis Infection	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS-INFECTION; (E)-4-HYDROXY-3-METHYL-BUT-2-ENYL PYROPHOSPHATE; V-GAMMA-2V-DELTA-2 TCR; EFFECTOR-CELLS; DRUG-USERS; COINFECTION; REPERTOIRE; MACAQUES; RECOGNITION; PULMONARY	Background: We previously demonstrated that unvaccinated macaques infected with large-dose M. tuberculosis(Mtb) exhibited delays for pulmonary trafficking of Ag-specific alpha beta and gamma delta T effector cells, and developed severe lung tuberculosis(TB) and "secondary" Mtb infection in remote organs such as liver and kidney. Despite delays in lungs, local immunity in remote organs may accumulate since progressive immune activation after pulmonary Mtb infection may allow IFN gamma-producing gamma delta T cells to adequately develop and traffic to lately-infected remote organs. As initial efforts to test this hypothesis, we comparatively examined TCR repertoire/clonality, tissue trafficking and effector function of V gamma 2V delta 2 T cells in lung with severe TB and in liver/kidney without apparent TB. Methodology/Principal Findings: We utilized conventional infection-immunity approaches in macaque TB model, and employed our decades-long expertise for TCR repertoire analyses. TCR repertoires in V gamma 2V delta 2 T-cell subpopulation were broad during primary Mtb infection as most TCR clones found in lymphoid system, lung, kidney and liver were distinct. Polyclonally-expanded V gamma 2V delta 2 T-cell clones from lymphoid tissues appeared to distribute and localize in lung TB granuloms at the endpoint after Mtb infection by aerosol. Interestingly, some TCR clones appeared to be more predominant than others in lymphocytes from liver or kidney without apparent TB lesions. TCR CDR3 spetratyping revealed such clonal dominance, and the clonal dominance of expanded V gamma 2V delta 2 T cells in kidney/liver tissues was associated with undetectable or low-level TB burdens. Furthermore, V gamma 2V delta 2 T cells from tissue compartments could mount effector function for producing anti-mycobacterium cytokine. Conclusion: We were the first to demonstrate clonal immune responses of mycobacterium-specific V gamma 2V delta 2 T cells in the lymphoid system, heavily-infected lungs and lately subtly-infected kidneys or livers during primary Mtb infection. While clonally-expanded V gamma 2V delta 2 T cells accumulated in lately-infected kidneys/livers without apparent TB lesions, TB burdens or lesions appeared to impact TCR repertoires and tissue trafficking patterns of activated V gamma 2V delta 2 T cells.	[Huang, Dan; Chen, Crystal Y.; Shen, Yun; Du, George; Wang, Richard; Chen, Zheng W.] Univ Illinois, Coll Med, Dept Microbiol & Immunol, Ctr Primate Biomed Res, Chicago, IL 60612 USA; [Zhang, Meihong; Zhou, Keyuan] Wuhan Univ, Zhongnan Hosp, Ctr Gene Diag, Wuhan 430072, Peoples R China; [Zhang, Meihong; Zhou, Keyuan] Guangdong Med Coll, Key Lab Med Mol Act Res, Dongguan, Peoples R China; [Qiu, Liyou] Henan Agr Univ, Coll Life Sci, Zhengzhou, Peoples R China	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Wuhan University; Guangdong Medical University; Henan Agricultural University	Huang, D (corresponding author), Univ Illinois, Coll Med, Dept Microbiol & Immunol, Ctr Primate Biomed Res, Chicago, IL 60612 USA.	pres@gdmc.edu.cn; zchen@uic.edu			National Institutes of Health [HL64560, RR13601]; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR013601] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064560] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R01OD015092] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health R01 grants; HL64560 (to Dr. Chen) and RR13601 (to Dr. Chen). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abanmi A, 2005, J BIOCHEM MOL BIOL, V38, P350; Ali Z, 2007, J IMMUNOL, V179, P8287, DOI 10.4049/jimmunol.179.12.8287; BUKOWSKI JF, 1995, J IMMUNOL, V154, P998; Chen CY, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000392; Chen Y, 2008, BLOOD, V111, P4220, DOI 10.1182/blood-2007-07-101691; Chen ZW, 2005, CLIN IMMUNOL, V116, P202, DOI 10.1016/j.clim.2005.04.005; Cooper AM, 2009, ANNU REV IMMUNOL, V27, P393, DOI 10.1146/annurev.immunol.021908.132703; Du G, 2006, J IMMUNOL METHODS, V308, P19, DOI 10.1016/j.jim.2005.09.009; Du G, 2010, J IMMUNOL, V185, P3940, DOI 10.4049/jimmunol.1001222; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; Holtmeier W, 2002, J IMMUNOL, V169, P1993, DOI 10.4049/jimmunol.169.4.1993; Huang D, 2008, INFECT IMMUN, V76, P426, DOI 10.1128/IAI.01008-07; Huang D, 2009, P NATL ACAD SCI USA, V106, P7553, DOI 10.1073/pnas.0811250106; Kaufmann SHE, 2010, IMMUNITY, V33, P567, DOI 10.1016/j.immuni.2010.09.015; Kuusisto KM, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2832; Lai X, 2003, CLIN EXP IMMUNOL, V133, P182, DOI 10.1046/j.1365-2249.2003.02209.x; Lawn S, 2011, LANCET, V2011; Qiu LY, 2008, J INFECT DIS, V198, P1514, DOI 10.1086/592448; Roth SJ, 1998, EUR J IMMUNOL, V28, P104, DOI 10.1002/(SICI)1521-4141(199801)28:01<104::AID-IMMU104>3.0.CO;2-F; SELWYN PA, 1989, NEW ENGL J MED, V320, P545, DOI 10.1056/NEJM198903023200901; SELWYN PA, 1992, NEW ENGL J MED, V327, P1697, DOI 10.1056/NEJM199212103272401; Shen L, 2004, J INFECT DIS, V190, P1438, DOI 10.1086/423939; Shen Y, 2004, J VIROL, V78, P14023, DOI 10.1128/JVI.78.24.14023-14032.2004; Shen Y, 2002, INFECT IMMUN, V70, P869, DOI 10.1128/IAI.70.2.869-877.2002; Shen Y, 2002, SCIENCE, V295, P2255, DOI 10.1126/science.1068819; Wang H, 2003, J IMMUNOL, V170, P3696, DOI 10.4049/jimmunol.170.7.3696; Wei HY, 2008, J IMMUNOL, V181, P4798, DOI 10.4049/jimmunol.181.7.4798; Wells CD, 2007, J INFECT DIS, V196, pS86, DOI 10.1086/518665; Wu HL, 2001, KIDNEY INT, V60, P1324, DOI 10.1046/j.1523-1755.2001.00937.x; Zhou DJ, 2003, J VIROL, V77, P2998, DOI 10.1128/JVI.77.5.2998-3006.2003	30	16	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2012	7	2							e30631	10.1371/journal.pone.0030631	http://dx.doi.org/10.1371/journal.pone.0030631			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UG	22319574	Green Published, Green Submitted, gold			2022-12-25	WOS:000301977500014
J	Gomulski, LM; Dimopoulos, G; Xi, ZY; Scolari, F; Gabrieli, P; Siciliano, P; Clarke, AR; Malacrida, AR; Gasperi, G				Gomulski, Ludvik M.; Dimopoulos, George; Xi, Zhiyong; Scolari, Francesca; Gabrieli, Paolo; Siciliano, Paolo; Clarke, Anthony R.; Malacrida, Anna R.; Gasperi, Giuliano			Transcriptome Profiling of Sexual Maturation and Mating in the Mediterranean Fruit Fly, Ceratitis capitata	PLOS ONE			English	Article							GENOME-WIDE ANALYSIS; OLFACTORY-MEDIATED BEHAVIOR; BINDING-PROTEIN GENES; DROSOPHILA-MELANOGASTER; IMMUNE-RESPONSE; FLIES DIPTERA; MOLECULAR CHARACTERISTICS; EXPRESSION PATTERNS; KINASE-ACTIVITY; HONEY-BEE	Sexual maturation and mating in insects are generally accompanied by major physiological and behavioural changes. Many of these changes are related to the need to locate a mate and subsequently, in the case of females, to switch from mate searching to oviposition behaviour. The prodigious reproductive capacity of the Mediterranean fruit fly, Ceratitis capitata, is one of the factors that has led to its success as an invasive pest species. To identify the molecular changes related to maturation and mating status in male and female medfly, a microarray-based gene expression approach was used to compare the head transcriptomes of sexually immature, mature virgin, and mated individuals. Attention was focused on the changes in abundance of transcripts related to reproduction, behaviour, sensory perception of chemical stimulus, and immune system processes. Broad transcriptional changes were recorded during female maturation, while post-mating transcriptional changes in females were, by contrast, modest. In male medfly, transcriptional changes were consistent both during maturation and as a consequence of mating. Of particular note was the lack of the mating-induced immune responses that have been recorded for Drosophila melanogaster, that may be due to the different reproductive strategies of these species. This study, in addition to increasing our understanding of the molecular machinery behind maturation and mating in the medfly, has identified important gene targets that might be useful in the future management of this pest.	[Gomulski, Ludvik M.; Scolari, Francesca; Gabrieli, Paolo; Siciliano, Paolo; Malacrida, Anna R.; Gasperi, Giuliano] Univ Pavia, Dept Anim Biol, I-27100 Pavia, Italy; [Dimopoulos, George; Xi, Zhiyong] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD USA; [Clarke, Anthony R.] Queensland Univ Technol, Discipline Biogeosci, Brisbane, Qld 4001, Australia	University of Pavia; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Queensland University of Technology (QUT)	Gomulski, LM (corresponding author), Univ Pavia, Dept Anim Biol, Via Palestro 3, I-27100 Pavia, Italy.	gasperi@unipv.it	Gomulski, Ludvik/AAG-2709-2022; Scolari, Francesca/ABC-2285-2020; Gomulski, Ludvik/AFK-3930-2022; Gasperi, Giuliano/Y-1894-2019; Xi, Zhiyong/AAD-7936-2022; Gabrieli, Paolo/A-3206-2016; Clarke, Anthony R/B-5143-2011	Scolari, Francesca/0000-0003-3085-9038; Gasperi, Giuliano/0000-0001-6972-8591; Xi, Zhiyong/0000-0001-7786-012X; Gabrieli, Paolo/0000-0002-4996-2468; Clarke, Anthony R/0000-0002-8165-3032; GOMULSKI, LUDVIK/0000-0002-1506-7051; Dimopoulos, George/0000-0001-6755-8111; malacrida, anna/0000-0003-4566-8795	Italian Ministry of Universities and Research PRIN [2004053427, 20077RCHRW]; JHMRI	Italian Ministry of Universities and Research PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); JHMRI	The study was partially funded by Italian Ministry of Universities and Research PRIN grants 2004053427 and 20077RCHRW (LMG, ARM, GG). ZX was supported by a JHMRI Postdoctoral Fellowship. The work was also carried out within the IAEA CRP programme "Development and evaluation of improved strains of insect pests for SIT'' (GG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anholt RRH, 2003, NAT GENET, V35, P180, DOI 10.1038/ng1240; Arya GH, 2010, GENETICS, V186, P1475, DOI 10.1534/genetics.110.123166; Ayme-Southgate A, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-17; Bebas P, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-64; Bohbot J, 2005, INSECT BIOCHEM MOLEC, V35, P961, DOI 10.1016/j.ibmb.2005.03.010; Bonizzoni M, 2006, J ECON ENTOMOL, V99, P1420, DOI 10.1603/0022-0493-99.4.1420; CANT K, 1994, J CELL BIOL, V125, P369, DOI 10.1083/jcb.125.2.369; Carbon S, 2009, BIOINFORMATICS, V25, P288, DOI 10.1093/bioinformatics/btn615; Chapman T, 2003, P NATL ACAD SCI USA, V100, P9923, DOI 10.1073/pnas.1631635100; Chapman T, 1998, P ROY SOC B-BIOL SCI, V265, P1879, DOI 10.1098/rspb.1998.0516; CHAPMAN T, 1995, NATURE, V373, P241, DOI 10.1038/373241a0; Christophides GK, 2000, INSECT MOL BIOL, V9, P185, DOI 10.1046/j.1365-2583.2000.00176.x; Christophides GK, 2000, GENETICS, V156, P173; Comas D, 2004, NATURE, V430, P460, DOI 10.1038/nature02726; Dalton JE, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-541; Das Suchismita, 2008, BMC Physiology, V8, P23, DOI 10.1186/1472-6793-8-23; De Gregorio E, 2001, P NATL ACAD SCI USA, V98, P12590, DOI 10.1073/pnas.221458698; Deddouche S, 2008, NAT IMMUNOL, V9, P1425, DOI 10.1038/ni.1664; Diamantidis AD, 2008, ENTOMOL EXP APPL, V128, P389, DOI 10.1111/j.1570-7458.2008.00730.x; Diaz-Fleischer F, 2000, FRUIT FLIES (TEPHRITIDAE): PHYLOGENY AND EVOLUTION OF BEHAVIOR, P811; Dickson BJ, 2008, SCIENCE, V322, P904, DOI 10.1126/science.1159276; Dong YM, 2006, PLOS PATHOG, V2, P513, DOI 10.1371/journal.ppat.0020052; Drew RAI, 2000, FRUIT FLIES (TEPHRITIDAE): PHYLOGENY AND EVOLUTION OF BEHAVIOR, P731; Dubnau J, 2003, CURR BIOL, V13, P286, DOI 10.1016/S0960-9822(03)00064-2; Edwards Alexis C, 2009, BMC Biol, V7, P29, DOI 10.1186/1741-7007-7-29; Ellis LL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-558; Fan YJ, 2010, GENETICS, V184, P141, DOI 10.1534/genetics.109.109553; Fayyazuddin A, 2006, PLOS BIOL, V4, P420, DOI 10.1371/journal.pbio.0040063; FERVEUR JF, 1995, SCIENCE, V267, P902, DOI 10.1126/science.7846534; FLETCHER BS, 1989, FRUIT FLIES THEIR B, V3, P209; Fujii S, 2002, EMBO J, V21, P5353, DOI 10.1093/emboj/cdf556; Galindo K, 2001, GENETICS, V159, P1059; Gasperi G, 2002, GENETICA, V116, P125, DOI 10.1023/A:1020971911612; Gillott C, 2003, ANNU REV ENTOMOL, V48, P163, DOI 10.1146/annurev.ento.48.091801.112657; Goldman TD, 2007, PLOS GENET, V3, P2278, DOI 10.1371/journal.pgen.0030216; HALL JC, 1994, SCIENCE, V264, P1702, DOI 10.1126/science.8209251; Harvey Kieran F., 2010, Journal of Biology (London), V9, P8, DOI 10.1186/jbiol219; Hedengren M, 1999, MOL CELL, V4, P827, DOI 10.1016/S1097-2765(00)80392-5; Heifetz Y, 2004, P NATL ACAD SCI USA, V101, P6261, DOI 10.1073/pnas.0401337101; HENDRICHS J, 1991, OECOLOGIA, V86, P223, DOI 10.1007/BF00317534; Innocenti P, 2009, J EVOLUTION BIOL, V22, P964, DOI 10.1111/j.1420-9101.2009.01708.x; Jang EB, 2002, FLA ENTOMOL, V85, P89, DOI 10.1653/0015-4040(2002)085[0089:POMBIM]2.0.CO;2; Jang EB, 1998, ANN ENTOMOL SOC AM, V91, P139, DOI 10.1093/aesa/91.1.139; JANG EB, 1995, J INSECT PHYSIOL, V41, P705, DOI 10.1016/0022-1910(95)00015-M; Kankare Maaria, 2010, BMC Ecology, V10, P3, DOI 10.1186/1472-6785-10-3; Kapelnikov A, 2008, P NATL ACAD SCI USA, V105, P13912, DOI 10.1073/pnas.0710997105; Kaspi R, 2002, PHYSIOL ENTOMOL, V27, P29, DOI 10.1046/j.1365-3032.2001.00264.x; Kocher SD, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-232; Kraaijeveld K, 2004, P ROY SOC B-BIOL SCI, V271, pS209, DOI 10.1098/rsbl.2003.0116; Krafsur ES, 1998, J AGR ENTOMOL, V15, P303; Lawniczak MKN, 2004, GENOME, V47, P900, DOI 10.1139/G04-050; Leclerc V, 2004, IMMUNOL REV, V198, P59, DOI 10.1111/j.0105-2896.2004.0130.x; Lee G, 2000, J NEUROBIOL, V43, P404, DOI 10.1002/1097-4695(20000615)43:4<404::AID-NEU8>3.0.CO;2-D; Leulier F, 2000, EMBO REP, V1, P353, DOI 10.1093/embo-reports/kvd073; Liebl FLW, 2008, DEV NEUROBIOL, V68, P152, DOI 10.1002/dneu.20562; Lochhead PA, 2003, BIOCHEM J, V374, P381, DOI 10.1042/BJ20030500; Lyne R, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r129; Mackay TFC, 2005, P NATL ACAD SCI USA, V102, P6622, DOI 10.1073/pnas.0501986102; Malacrida AR, 2007, GENETICA, V131, P1, DOI 10.1007/s10709-006-9117-2; MARCHINI D, 1995, J BIOL CHEM, V270, P6199, DOI 10.1074/jbc.270.11.6199; Marchini D, 2003, ARTHROPOD STRUCT DEV, V31, P313, DOI 10.1016/S1467-8039(03)00003-3; Marcillac F, 2005, GENETICS, V171, P1617, DOI 10.1534/genetics.104.033159; Mateos J, 2006, J MUSCLE RES CELL M, V27, P189, DOI 10.1007/s10974-005-9044-3; McGraw LA, 2004, CURR BIOL, V14, P1509, DOI 10.1016/j.cub.2004.08.028; McGraw LA, 2008, GENETICS, V179, P1395, DOI 10.1534/genetics.108.086934; Meunier N, 2007, J EXP BIOL, V210, P1424, DOI 10.1242/jeb.02755; Miyatake T, 1999, J INSECT PHYSIOL, V45, P1021, DOI 10.1016/S0022-1910(99)00083-9; Montaner D, 2006, NUCLEIC ACIDS RES, V34, pW486, DOI 10.1093/nar/gkl197; Moshitzky P, 1996, ARCH INSECT BIOCHEM, V32, P363, DOI 10.1002/(SICI)1520-6327(1996)32:3/4&lt;363::AID-ARCH9&gt;3.0.CO;2-T; Mossinson S, 2003, J INSECT PHYSIOL, V49, P561, DOI 10.1016/S0022-1910(03)00027-1; Muda M, 2002, BIOCHEM J, V366, P73, DOI 10.1042/BJ20020298; Nijhout H. F., 1998, INSECT HORMONES, P267; Ottiger M, 2000, J NEUROBIOL, V44, P57; Papadopoulos NT, 2010, J INSECT PHYSIOL, V56, P283, DOI 10.1016/j.jinsphys.2009.10.014; Papadopoulos NT, 1998, ENTOMOL EXP APPL, V89, P175, DOI 10.1023/A:1003580814122; Peng J, 2005, CURR BIOL, V15, P1690, DOI 10.1016/j.cub.2005.08.048; Piulachs MD, 2003, INSECT BIOCHEM MOLEC, V33, P459, DOI 10.1016/S0965-1748(03)00021-3; Radhakrishnan P, 2008, PHYSIOL ENTOMOL, V33, P302, DOI 10.1111/j.1365-3032.2008.00631.x; Ram KR, 2007, PLOS GENET, V3, P2428, DOI 10.1371/journal.pgen.0030238; Rogers DW, 2008, P NATL ACAD SCI USA, V105, P19390, DOI 10.1073/pnas.0809723105; Rollmann SM, 2005, J NEUROBIOL, V63, P146, DOI 10.1002/neu.20123; ROSETTO M, 1993, GENE, V134, P241, DOI 10.1016/0378-1119(93)90100-H; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; SAMAKOVLIS C, 1990, EMBO J, V9, P2969, DOI 10.1002/j.1460-2075.1990.tb07489.x; Sappington TW, 1998, INSECT BIOCHEM MOLEC, V28, P277, DOI 10.1016/S0965-1748(97)00110-0; Sarov-Blat L, 2000, CELL, V101, P647, DOI 10.1016/S0092-8674(00)80876-4; SAUL SH, 1982, ANN ENTOMOL SOC AM, V75, P480, DOI 10.1093/aesa/75.4.480; Sem KP, 2002, MOL CELL BIOL, V22, P3685, DOI 10.1128/MCB.22.11.3685-3697.2002; Sivinski J, 2000, FRUIT FLIES (TEPHRITIDAE): PHYLOGENY AND EVOLUTION OF BEHAVIOR, P751; So WV, 2000, MOL CELL BIOL, V20, P6935, DOI 10.1128/MCB.20.18.6935-6944.2000; Soller M, 1999, DEV BIOL, V208, P337, DOI 10.1006/dbio.1999.9210; Stanewsky R, 2002, CELL TISSUE RES, V309, P11, DOI 10.1007/s00441-002-0569-0; Swarup S, 2011, GENES BRAIN BEHAV, V10, P648, DOI 10.1111/j.1601-183X.2011.00704.x; Taylor PW, 1999, ANIM BEHAV, V58, P247, DOI 10.1006/anbe.1999.1137; Townsend JP, 2002, GENOME BIOL, V3; Tram U, 1998, P NATL ACAD SCI USA, V95, P4051, DOI 10.1073/pnas.95.7.4051; Tufail M, 2008, J INSECT PHYSIOL, V54, P1447, DOI 10.1016/j.jinsphys.2008.08.007; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; White I.M., 1992, FRUIT FLIES EC SIGNI; Whitfield CW, 2006, P NATL ACAD SCI USA, V103, P16068, DOI 10.1073/pnas.0606909103; WHITTIER TS, 1992, ANN ENTOMOL SOC AM, V85, P214, DOI 10.1093/aesa/85.2.214; Wijnen H, 2006, PLOS GENET, V2, P326, DOI 10.1371/journal.pgen.0020039; Williamson D.L., 1989, World Crop Pests, V3A, P141; Wong R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006063; Yun B, 2000, GENETICS, V156, P749; Yuval B, 2000, FRUIT FLIES (TEPHRITIDAE): PHYLOGENY AND EVOLUTION OF BEHAVIOR, P429; Zheng Q, 2008, NUCLEIC ACIDS RES, V36, pW358, DOI 10.1093/nar/gkn276; Zhou SS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000681	110	54	56	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2012	7	1							e30857	10.1371/journal.pone.0030857	http://dx.doi.org/10.1371/journal.pone.0030857			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911GB	22303464	gold, Green Published, Green Submitted			2022-12-25	WOS:000301704200040
J	Phan, V; Thai, S; Choun, K; Lynen, L; van Griensven, J				Phan, Vichet; Thai, Sopheak; Choun, Kimcheng; Lynen, Lutgarde; van Griensven, Johan			Incidence of Treatment-Limiting Toxicity with Stavudine-Based Antiretroviral Therapy in Cambodia: A Retrospective Cohort Study	PLOS ONE			English	Article							HIV-INFECTED PERSONS; QUALITY-OF-LIFE; BODY CHANGES; LIPODYSTROPHY; PREVALENCE; ADULTS; RISK; SUBSTITUTION; ADHERENCE; SYMPTOMS	Background: Although stavudine (D4T) remains frequently used in low-income countries in Asia, associated long-term toxicity data are scarce. The aim of this study was to determine the long-term incidence of severe D4T-toxicity (requiring drug substitution) and associated risk factors in HIV-infected Cambodians up to six years on antiretroviral treatment (ART). Methodology/Principal Findings: This is a retrospective analysis of an observational cohort, using data from an ART program with systematic monitoring for D4T-toxicity. Probabilities of time to D4T substitution due to suspected D4T toxicity (treatment-limiting D4T toxicity) were calculated, a risk factor analysis was performed using multivariate Cox regression modelling. Out of 2581 adults initiating a D4T-containing regimen, D4T was replaced in 276 (10.7%) patients for neuropathy, 14 (0.5%) for lactic acidosis and 957 (37.1%) for lipoatrophy. The main early side effect was peripheral neuropathy (7.0% by 1 year). After the first year, lipoatrophy became predominant, with a cumulative incidence of 56.1% and 72.4% by 3 and 6 years respectively. Older age (aHR 1.8; 95%CI: 1.4-2.3) and lower baseline haemoglobin (aHR 1.7; 95%CI: 1.4-2.2) were associated with the occurrence of neuropathy. Being female (aHR 3.8; 95%CI: 1.1-12.5), a higher baseline BMI (aHR 12.6; 95%CI: 3.7-43.1), and TB treatment at ART initiation (aHR 8.6; 95%CI: 2.7-27.5) increased the likelihood of lactic acidosis. Lipoatrophy was positively associated with female gender (aHR 2.3; 95%CI: 2.0-2.6), an older age (aHR 1.3; 95%CI: 1.1-1.4), and a CD4 count <200 cells/mu L (aHR 1.3; 95%CI: 1.1-1.5). Conclusions: Stavudine-based treatment regimens in low-income countries are associated with significant long-term toxicities, predominantly lipoatrophy. Close clinical monitoring for toxicity with timely D4T substitution is recommended. Phasing-out of stavudine should be implemented, as costs allows.	[Phan, Vichet; Thai, Sopheak; Choun, Kimcheng; van Griensven, Johan] Sihanouk Hosp Ctr HOPE, Phnom Penh, Cambodia; [Lynen, Lutgarde; van Griensven, Johan] Inst Trop Med, B-2000 Antwerp, Belgium	Institute of Tropical Medicine (ITM)	Phan, V (corresponding author), Sihanouk Hosp Ctr HOPE, Phnom Penh, Cambodia.	phanvichet@yahoo.com	Lynen, Lutgarde/AAT-9180-2020; Lynen, Lutgarde/A-1212-2014	Lynen, Lutgarde/0000-0001-7183-4895; Lynen, Lutgarde/0000-0001-7183-4895	Belgian Directorate General of Development Cooperation; Institute of Tropical Medicine, Antwerp; Global Fund; InBev-Baillet Latour Fund	Belgian Directorate General of Development Cooperation; Institute of Tropical Medicine, Antwerp; Global Fund; InBev-Baillet Latour Fund	The HIV program was supported by the Belgian Directorate General of Development Cooperation through the framework agreement with the Institute of Tropical Medicine, Antwerp, the Global Fund to fight AIDS, Tuberculosis and Malaria, and Hope World Wide. JvG is supported by the InBev-Baillet Latour Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boulle A, 2007, ANTIVIR THER, V12, P753; Burgoyne R, 2005, QUAL LIFE RES, V14, P981, DOI 10.1007/s11136-004-2580-2; Clucas C, 2011, HIV MED, V12, P87, DOI 10.1111/j.1468-1293.2010.00851.x; Cooper V, 2009, AIDS CARE, V21, P520, DOI 10.1080/09540120802301824; Gallant JE, 2004, JAMA-J AM MED ASSOC, V292, P191, DOI 10.1001/jama.292.2.191; Glass TR, 2010, JAIDS-J ACQ IMM DEF, V54, P197, DOI 10.1097/QAI.0b013e3181ca48bf; Guaraldi G, 2008, AIDS REV, V10, P152; Hawkins C, 2007, JAIDS-J ACQ IMM DEF, V45, P304; Imhof A, 2005, CLIN INFECT DIS, V41, P721, DOI 10.1086/432471; Isaakidis P, 2008, JAIDS-J ACQ IMM DEF, V49, P48, DOI 10.1097/QAI.0b013e31817bec19; Justice AC, 2001, MED CARE, V39, P397, DOI 10.1097/00005650-200104000-00010; Kowalska JD, 2007, AIDS RES HUM RETROV, V23, P1183, DOI 10.1089/aid.2006.0292; Lampe FC, 2010, JAIDS-J ACQ IMM DEF, V54, P500, DOI 10.1097/QAI.0b013e3181ce6afe; Lynen L, 2009, JAIDS-J ACQ IMM DEF, V52, P40, DOI 10.1097/QAI.0b013e3181af6705; Mercier S, 2009, JAIDS-J ACQ IMM DEF, V51, P224, DOI 10.1097/QAI.0b013e31819c16f4; Mutimura E, 2007, JAIDS-J ACQ IMM DEF, V46, P451, DOI 10.1097/QAI.0b013e318158c0a6; Nachega Jean B, 2009, Curr HIV/AIDS Rep, V6, P121, DOI 10.1007/s11904-009-0017-9; Santos CP, 2005, AIDS, V19, pS14, DOI 10.1097/01.aids.0000191485.92285.c7; Thai S, 2009, TROP MED INT HEALTH, V14, P1048, DOI 10.1111/j.1365-3156.2009.02334.x; van Griensven J, 2007, T ROY SOC TROP MED H, V101, P793, DOI 10.1016/j.trstmh.2007.02.020; van Griensven J, 2010, T ROY SOC TROP MED H, V104, P148, DOI 10.1016/j.trstmh.2009.07.009; Westreich DJ, 2009, CLIN INFECT DIS, V48, P1617, DOI 10.1086/598977; [WHO UNAIDS UNICEF], 2009, UN ACC SCAL PRIOR HI; WHO, 2010, ANT THER HIV INF AD; WHO, 2004, SCAL ANT THER RES LI; Womack J, 2009, AIDS READ, V19, P131; World Health Organization, 2006, ANT THER HIV INF AD	27	30	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2012	7	1							e30647	10.1371/journal.pone.0030647	http://dx.doi.org/10.1371/journal.pone.0030647			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911GB	22303447	gold, Green Submitted, Green Published			2022-12-25	WOS:000301704200026
J	Lorenz, M; Fechner, M; Kalkowski, J; Frohlich, K; Trautmann, A; Bohm, V; Liebisch, G; Lehneis, S; Schmitz, G; Ludwig, A; Baumann, G; Stangl, K; Stangl, V				Lorenz, Mario; Fechner, Mandy; Kalkowski, Janine; Froehlich, Kati; Trautmann, Anne; Boehm, Volker; Liebisch, Gerhard; Lehneis, Stefan; Schmitz, Gerd; Ludwig, Antje; Baumann, Gert; Stangl, Karl; Stangl, Verena			Effects of Lycopene on the Initial State of Atherosclerosis in New Zealand White (NZW) Rabbits	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; HUMAN-PLASMA; CAROTID ATHEROSCLEROSIS; MEDIA THICKNESS; SERUM LYCOPENE; ANIMAL-MODEL; CAROTENOIDS; RISK; ANTIOXIDANTS; ASSOCIATION	Background: Lycopene is the main carotenoid in tomatoes, where it is found in high concentrations. Strong epidemiological evidence suggests that lycopene may provide protection against cardiovascular diseases. We therefore studied the effects of lycopene on diet-induced increase in serum lipid levels and the initiation of atherosclerosis in New Zealand White (NZW) rabbits. Methodology/Principal Findings: The animals, divided into four groups of 9 animals each, were fed either a standard diet, a high-cholesterol diet containing 0.5% cholesterol, a high-cholesterol diet containing placebo beadlets, or a high-cholesterol diet plus 5 mg/kg body weight/day of lycopene ( in the form of lycopene beadlets), for a period of 4 weeks. We found significantly elevated lycopene plasma levels in the animal group treated with lycopene beadlets. Compared to the high-cholesterol and the placebo group, this was associated with a significant reduction of 50% in total cholesterol and LDL cholesterol serum levels in the lycopene group. The amount of cholesteryl ester in the aorta was significantly decreased by lycopene. However, we did not observe a significant decrease in the extent of aortic surface lipid accumulation in the lycopene group. In addition, no differences in the intima-media thickness among groups were observed. Endothelial-dependent and endothelial-independent vasodilation in isolated rabbit aortic and carotid rings did not differ among any of the animal groups. Conclusions: Lycopene supplementation for 4 weeks increased lycopene plasma levels in the animals. Although we found strongly reduced total and LDL cholesterol serum levels as well as significantly lower amounts of cholesteryl ester in the aortae in the lycopene-treated group, no significant differences in initial lesions in the aortae were detected.	[Lorenz, Mario; Fechner, Mandy; Kalkowski, Janine; Ludwig, Antje; Baumann, Gert; Stangl, Karl; Stangl, Verena] Charite, Campus Mitte, Med Klin Kardiol & Angiol, D-13353 Berlin, Germany; [Froehlich, Kati; Trautmann, Anne; Boehm, Volker] Univ Jena, Inst Nutr, Jena, Germany; [Froehlich, Kati] Food GmbH Jena Analyt Consulting Jena, Jena, Germany; [Liebisch, Gerhard; Lehneis, Stefan; Schmitz, Gerd] Univ Klinikum Regensburg, Inst Klin Chem & Lab Med, Regensburg, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Friedrich Schiller University of Jena; University of Regensburg	Lorenz, M (corresponding author), Charite, Campus Mitte, Med Klin Kardiol & Angiol, D-13353 Berlin, Germany.	verena.stangl@charite.de	, Antje Ludwig/ABF-6556-2021; Liebisch, Gerhard/G-6130-2010	Liebisch, Gerhard/0000-0003-4886-0811; Lorenz, Mario/0000-0001-5267-4101; Ludwig, Antje/0000-0002-8369-7020	European Community [IP 016213]	European Community(European Commission)	This work was supported by the European Community Sixth Framework Programme (IP 016213). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BIERI JG, 1985, J LIQ CHROMATOGR, V8, P473, DOI 10.1080/01483918508067094; Blum Arnon, 2005, Eur J Intern Med, V16, P402, DOI 10.1016/j.ejim.2005.02.017; Delahoy PJ, 2009, CLIN THER, V31, P236, DOI 10.1016/j.clinthera.2009.02.017; Engelhard YN, 2006, AM HEART J, V151, DOI 10.1016/j.ahj.2005.05.008; Frederiksen H, 2007, BRIT J NUTR, V97, P6, DOI 10.1017/S0007114507210153; Frohlich K, 2006, BRIT J NUTR, V95, P734, DOI 10.1079/BJN20051657; Gianetti J, 2002, AM HEART J, V143, P467, DOI 10.1067/mhj.2002.120776; Hu MY, 2008, NUTRITION, V24, P1030, DOI 10.1016/j.nut.2008.05.006; Karppi J, 2011, J INTERN MED, V270, P478, DOI 10.1111/j.1365-2796.2011.02401.x; Kelkel M, 2011, FREE RADICAL RES, V45, P925, DOI 10.3109/10715762.2011.564168; Kim OY, 2010, ATHEROSCLEROSIS, V208, P581, DOI 10.1016/j.atherosclerosis.2009.08.009; Klipstein-Grobusch K, 2000, ATHEROSCLEROSIS, V148, P49, DOI 10.1016/S0021-9150(99)00221-X; Liebisch G, 2006, BBA-MOL CELL BIOL L, V1761, P121, DOI 10.1016/j.bbalip.2005.12.007; Matsumoto I, 2011, CIRC J, V75, P905, DOI 10.1253/circj.CJ-10-0258; Misra R, 2006, J OBSTET GYNAECOL RE, V32, P299, DOI 10.1111/j.1447-0756.2006.00410.x; Mordente A, 2011, CURR MED CHEM, V18, P1146, DOI 10.2174/092986711795029717; Palozza P, 2011, J NUTR BIOCHEM, V22, P971, DOI 10.1016/j.jnutbio.2010.08.010; Palozza P, 2010, ARCH BIOCHEM BIOPHYS, V504, P26, DOI 10.1016/j.abb.2010.06.031; Preiss D, 2009, CLIN ENDOCRINOL, V70, P815, DOI 10.1111/j.1365-2265.2008.03490.x; Riccioni G, 2010, J BIOL REG HOMEOS AG, V24, P447; Riccioni G, 2010, INT J IMMUNOPATH PH, V23, P327, DOI 10.1177/039463201002300131; Ried K, 2011, MATURITAS, V68, P299, DOI 10.1016/j.maturitas.2010.11.018; Rissanen T, 2002, EXP BIOL MED, V227, P900, DOI 10.1177/153537020222701010; Rissanen TH, 2003, AM J CLIN NUTR, V77, P133, DOI 10.1093/ajcn/77.1.133; ROMANCHIK JE, 1995, J NUTR, V125, P2610; Sun YP, 2000, P SOC EXP BIOL MED, V224, P166, DOI 10.1046/j.1525-1373.2000.22416.x; TANZAWA K, 1980, FEBS LETT, V118, P81, DOI 10.1016/0014-5793(80)81223-3; Verghese M., 2008, Journal of Biological Sciences, V8, P268; WONG SHY, 1987, CLIN CHEM, V33, P214; Yanni AE, 2004, LAB ANIM-UK, V38, P246, DOI 10.1258/002367704323133628; Yeo HY, 2011, METABOLISM, V60, P537, DOI 10.1016/j.metabol.2010.05.003	31	31	33	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e30808	10.1371/journal.pone.0030808	http://dx.doi.org/10.1371/journal.pone.0030808			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910ME	22295112	Green Submitted, Green Published, gold			2022-12-25	WOS:000301640600057
J	Yamakawa, N; Kaneda, K; Saito, Y; Ichihara, E; Morishita, K				Yamakawa, Norio; Kaneda, Kazuko; Saito, Yusuke; Ichihara, Emi; Morishita, Kazuhiro			The Increased Expression of Integrin alpha 6 (ITGA6) Enhances Drug Resistance in EVI1(high) Leukemia	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; BONE-MARROW; HEMATOPOIETIC PROGENITORS; GENE; EVI1; IDENTIFICATION; ACTIVATION; TRANSCRIPTION; FIBRONECTIN; SURVIVAL	Ecotropic viral integration site-1 (EVI1) is one of the candidate oncogenes for human acute myeloid leukemia (AML) with chromosomal alterations at 3q26. High EVI1 expression (EVI1(high)) is a risk factor for AML with poor outcome. Using DNA microarray analysis, we previously identified that integrin alpha 6 (ITGA6) was upregulated over 10-fold in EVI1(high) leukemia cells. In this study, we determined whether the increased expression of ITGA6 is associated with drug-resistance and increased cell adhesion, resulting in poor prognosis. To this end, we first confirmed the expression pattern of a series of integrin genes using semi-quantitative PCR and fluorescence-activated cell sorter (FACS) analysis and determined the cell adhesion ability in EVI1(high) leukemia cells. We found that the adhesion ability of EVI1(high) leukemia cells to laminin increased with the increased expression of ITGA6 and integrin beta 4 (ITGB4). The introduction of small-hairpin RNA against EVI1 (shEVI1) into EVI1(high) leukemia cells reduced the cell adhesion ability and downregulated the expression of ITGA6 and ITGB4. In addition, the overexpression of EVI1 in EVI1(low) leukemia cells enhanced their cell adhesion ability and increased the expression of ITGA6 and ITGB4. In a subsequent experiment, the introduction of shRNA against ITGA6 or ITGB4 into EVI1(high) AML cells downregulated their cell adhesion ability; however, the EVI1(high) AML cells transfected with shRNA against ITGA6 could not be maintained in culture. Moreover, treating EVI1(high) leukemia cells with neutralizing antibodies against ITGA6 or ITGB4 resulted in an enhanced responsiveness to anti-cancer drugs and a reduction of their cell adhesion ability. The expression of ITGA6 is significantly elevated in cells from relapsed and EVI1(high) AML cases; therefore, ITGA6 might represent an important therapeutic target for both refractory and EVI1(high) AML.	[Yamakawa, Norio; Kaneda, Kazuko; Saito, Yusuke; Ichihara, Emi; Morishita, Kazuhiro] Miyazaki Univ, Fac Med, Dept Med Sci, Div Tumor & Cellular Biochem, Miyazaki, Japan	University of Miyazaki	Yamakawa, N (corresponding author), Miyazaki Univ, Fac Med, Dept Med Sci, Div Tumor & Cellular Biochem, Miyazaki, Japan.	kmorishi@medmiyazaki-u.ac.jp		Kaneda-Nakashima, Kazuko/0000-0001-6657-5059	Ministry of Education, Culture, Sports, Science and Technology in Japan	Ministry of Education, Culture, Sports, Science and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-Aid for Scientific Research in Priority Areas from the Ministry of Education, Culture, Sports, Science and Technology in Japan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barjesteh van Waalwijk van Doorn-Khosrovani S, 2001, BLOOD, V101, P837; Becker PS, 2009, BLOOD, V113, P866, DOI 10.1182/blood-2007-12-124818; Bei L, 2007, J BIOL CHEM, V282, P16846, DOI 10.1074/jbc.M609744200; Bergamini C, 2007, HEPATOLOGY, V46, P1801, DOI 10.1002/hep.21936; Chan JYH, 2001, BRIT J HAEMATOL, V112, P541, DOI 10.1046/j.1365-2141.2001.02439.x; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Evsikov AV, 2003, SCIENCE, V302; Goyama S, 2010, INT J HEMATOL, V91, P753, DOI 10.1007/s12185-010-0618-5; Kurokawa M, 1998, NATURE, V394, P92, DOI 10.1038/27945; Levesque JP, 2010, LEUKEMIA, V24, P1979, DOI 10.1038/leu.2010.214; Lin KT, 2005, J BIOMED SCI, V12, P803, DOI 10.1007/s11373-005-9005-2; Liu Y, 2006, ONCOGENE, V25, P3565, DOI 10.1038/sj.onc.1209403; Lugthart S, 2008, BLOOD, V111, P4329, DOI 10.1182/blood-2007-10-119230; Matsunaga T, 2008, LEUKEMIA, V22, P353, DOI 10.1038/sj.leu.2405017; Matsunaga T, 2003, NAT MED, V9, P1158, DOI 10.1038/nm909; MORISHITA K, 1990, ONCOGENE RES, V5, P221; MORISHITA K, 1988, CELL, V54, P831, DOI 10.1016/S0092-8674(88)91175-0; Morishita K, 2007, INT J HEMATOL, V85, P279, DOI 10.1532/IJH97.06174; MUCENSKI ML, 1988, MOL CELL BIOL, V8, P301, DOI 10.1128/MCB.8.1.301; Nitta E, 2005, ONCOGENE, V24, P6165, DOI 10.1038/sj.onc.1208754; Palmer S, 2001, J BIOL CHEM, V276, P25834, DOI 10.1074/jbc.M102343200; PAPAYANNOPOULOU T, 1993, P NATL ACAD SCI USA, V90, P9374, DOI 10.1073/pnas.90.20.9374; PAPAYANNOPOULOU T, 1995, P NATL ACAD SCI USA, V92, P9647, DOI 10.1073/pnas.92.21.9647; Papayannopoulou T, 2001, BLOOD, V98, P2403, DOI 10.1182/blood.V98.8.2403; Saito Y, 2011, LEUKEMIA, V25, P921, DOI 10.1038/leu.2011.36; Scott LM, 2003, MOL CELL BIOL, V23, P9349, DOI 10.1128/MCB.23.24.9349-9360.2003; Shimahara A, 2010, J BIOL CHEM, V285, P16967, DOI 10.1074/jbc.M110.102046; Verhaak RGW, 2009, HAEMATOL-HEMATOL J, V94, P131, DOI 10.3324/haematol.13299; Wu JY, 2009, J BONE MINER RES, V24, P759, DOI [10.1359/JBMR.090225, 10.1359/jbmr.090225]; Yagi T, 2003, BLOOD, V102, P1849, DOI 10.1182/blood-2003-02-0578; Yuasa H, 2005, EMBO J, V24, P1976, DOI 10.1038/sj.emboj.7600679; Zaidel-Bar R, 2010, J CELL SCI, V123, P1385, DOI 10.1242/jcs.066183; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	33	49	55	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e30706	10.1371/journal.pone.0030706	http://dx.doi.org/10.1371/journal.pone.0030706			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910ME	22295105	Green Published, gold, Green Submitted			2022-12-25	WOS:000301640600050
J	Yang, JH; Lee, YM; Bae, SG; Jacobs, DR; Lee, DH				Yang, Jin-Hoon; Lee, Yu-Mi; Bae, Sang-Geun; Jacobs, David R., Jr.; Lee, Duk-Hee			Associations between Organochlorine Pesticides and Vitamin D Deficiency in the US Population	PLOS ONE			English	Article							PERSISTENT ORGANIC POLLUTANTS; SERUM CONCENTRATIONS; NATIONAL-HEALTH; D METABOLISM; DDT	Background: Recently low dose organochlorine (OC) pesticides have been strongly linked to various chronic diseases including diabetes and cardiovascular diseases. Both field and animal studies have suggested a possibility that persistent lipophilic chemicals like OC pesticides can cause vitamin D deficiency, but there have been no human studies of exposure to any chemical as a possible cause of vitamin D deficiency. This study was performed to examine if serum concentrations of OC pesticides were associated with serum concentrations of 25-hydroxyvitamin D (25(OH) D) in the U. S. general population. Methodology/Principal Findings: Cross-sectional associations of serum OC pesticides with serum 25(OH) D were investigated in 1,275 subjects aged >= 20 in the National Health and Nutrition Examination Survey(NHANES), 2003-2004. We selected 7 OC pesticides detectable in >= 80% of participants. Among the 7 OC pesticides, p,p'-DDT (beta = -0.022, P<0.01), p,p'-DDE (beta = -0.018, P = 0.04), and beta-hexachlorocyclohexane (beta = -0.022, P = 0.02) showed significant inverse associations with serum 25(OH) D levels. When study subjects were stratified by age, race, and the presence of various chronic diseases, p,p'-DDT showed consistent inverse associations in all subgroups, although stronger associations tended to be observed among subjects with old age, white race, or chronic diseases. Conclusion/Significance: The current study suggests that the background exposure to some OC pesticides leads to vitamin D deficiency in human. Considering the importance of vitamin D deficiency in the development of chronic diseases, chemical exposure as a possible cause of vitamin D deficiency should be evaluated in prospective and experimental studies.	[Yang, Jin-Hoon; Lee, Yu-Mi; Bae, Sang-Geun; Lee, Duk-Hee] Kyungpook Natl Univ, Sch Med, Dept Preventat Med, Taegu, South Korea; [Yang, Jin-Hoon] CHA Univ, CHA Gumi Med Ctr, Dept Occupat Med, Gumi, South Korea; [Jacobs, David R., Jr.] Univ Minnesota, Sch Publ Hlth, Div Epidemiol, Minneapolis, MN 55455 USA; [Jacobs, David R., Jr.] Univ Oslo, Dept Nutr, Oslo, Norway	Kyungpook National University; Pochon Cha University; University of Minnesota System; University of Minnesota Twin Cities; University of Oslo	Yang, JH (corresponding author), Kyungpook Natl Univ, Sch Med, Dept Preventat Med, Taegu, South Korea.	lee_dh@knu.ac.kr		Jacobs, David/0000-0002-7232-0543; Bae, Sang-geun/0000-0001-7603-7676	Korea Food & Drug Administration [11162KFDA702]; National Research Foundation of Korea (NRF); Korea government (MEST) [2011-0004692]	Korea Food & Drug Administration(Ministry of Food & Drug Safety (MFDS), Republic of Korea); National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This research was partly supported by a grant (11162KFDA702) from Korea Food & Drug Administration in 2011 and National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST) (No. 2011-0004692). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Lloret P, 2009, TOXICOL LETT, V187, P63, DOI 10.1016/j.toxlet.2009.01.030; ATSDR, 2010, TOX PROF HEX; Bettinetti R, 2006, ENVIRON SCI POLLUT R, V13, P59, DOI 10.1065/espr2006.01.010; Bordelon P, 2009, AM FAM PHYSICIAN, V80, P841; Breivik K, 1999, SCI TOTAL ENVIRON, V239, P151, DOI 10.1016/S0048-9697(99)00291-0; ELLIOTT JE, 1988, ENVIRON POLLUT, V52, P81, DOI 10.1016/0269-7491(88)90083-8; Ginde AA, 2009, ARCH INTERN MED, V169, P626, DOI 10.1001/archinternmed.2008.604; Graubard BL, 1999, JNCI-J NATL CANCER I, V91, P1005, DOI 10.1093/jnci/91.12.1005; Ha MH, 2007, ENVIRON HEALTH PERSP, V115, P1204, DOI 10.1289/ehp.10184; Holick MF, 2008, AM J CLIN NUTR, V87, p1080S; KORN EL, 1991, AM J PUBLIC HEALTH, V81, P1166, DOI 10.2105/AJPH.81.9.1166; Laden F, 1999, ENVIRON HEALTH PERSP, V107, P75, DOI 10.2307/3434292; Lee D, 2011, PLOS ONE; Lee DH, 2006, DIABETES CARE, V29, P1638, DOI 10.2337/dc06-0543; Lee DH, 2010, ENVIRON HEALTH PERSP, V118, P1235, DOI 10.1289/ehp.0901480; Lilienthal H, 2000, TOXICOL SCI, V57, P292, DOI 10.1093/toxsci/57.2.292; Mithal A, 2009, OSTEOPOROSIS INT, V20, P1807, DOI 10.1007/s00198-009-0954-6; NOWICKI HG, 1972, J AGR FOOD CHEM, V20, P376, DOI 10.1021/jf60180a058; PEAKALL DB, 1969, NATURE, V224, P1219, DOI 10.1038/2241219a0; Reichrath J, 2009, BRIT J DERMATOL, V161, P54, DOI 10.1111/j.1365-2133.2009.09450.x; Rogan WJ, 2005, LANCET, V366, P763, DOI 10.1016/S0140-6736(05)67182-6; Routti H, 2008, ENVIRON TOXICOL CHEM, V27, P873, DOI 10.1897/07-139.1; SILVER J, 1979, CHEM-BIOL INTERACT, V24, P133, DOI 10.1016/0009-2797(79)90002-4; van den Berg H, 2009, ENVIRON HEALTH PERSP, V117, P1656, DOI 10.1289/ehp.0900785; Vijgen J, 2011, ENVIRON SCI POLLUT R, V18, P152, DOI 10.1007/s11356-010-0417-9; Welshons WV, 2003, ENVIRON HEALTH PERSP, V111, P994, DOI 10.1289/ehp.5494; Windham GC, 2010, ENVIRON RES, V110, P251, DOI 10.1016/j.envres.2010.01.004; Yetley EA, 2008, AM J CLIN NUTR, V88, p558S, DOI 10.1093/ajcn/88.2.558S	28	38	39	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e30093	10.1371/journal.pone.0030093	http://dx.doi.org/10.1371/journal.pone.0030093			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910ME	22295072	Green Published, gold, Green Submitted			2022-12-25	WOS:000301640600017
J	Li, LY; Huang, YS; Zhang, LZ; Lin, ZB; Wang, GF				Li, Lingyun; Huang, Yisheng; Zhang, Lizhen; Lin, Zhoubin; Wang, Guofu			Growth, Mechanical, Thermal and Spectral Properties of Cr3+:MgMoO4 Crystal	PLOS ONE			English	Article							ENERGY-LEVELS; SYNCHROTRON-RADIATION; LASER PERFORMANCE; STATE; MGMOO4; LUMINESCENCE; CR-3; CR3+	This paper reports the growth, mechanical, thermal and spectral properties of Cr3+:MgMoO4 crystals. The Cr3+:MgMoO4 crystals with dimensions up to 30 mmx18 mmx14 mm were obtained by TSSG method. The absorption cross-sections of (4)A(2)-> T-4(1) and (4)A(2)-> T-4(2) transitions are 12.94x10(-20) cm(2) at 493 nm and 7.89x10(-20) cm(2) at 705 nm for E//N-g, respectively. The Cr3+: MgMoO4 crystal shows broad band emission extending from 750 nm to 1300 nm with peak at about 705 nm. The emission cross-section with FWHM of 188 nm is 119.88x10(-20) cm(2) at 963 nm for E//N-g. The investigated results showed that the Cr3+:MgMoO4 crystal may be regarded as a potential tunable laser gain medium.	[Li, Lingyun; Huang, Yisheng; Zhang, Lizhen; Lin, Zhoubin; Wang, Guofu] Chinese Acad Sci, Fujian Inst Res Struct Matter, State Key Lab Optoelect Mat Chem & Phys, Fuzhou 350002, Fujian, Peoples R China; [Li, Lingyun] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Fujian Institute of Research on the Structure of Matter, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Li, LY (corresponding author), Chinese Acad Sci, Fujian Inst Res Struct Matter, State Key Lab Optoelect Mat Chem & Phys, Fuzhou 350002, Fujian, Peoples R China.	wgf@ms.fjirsm.ac.cn			National Natural Science Foundation of China [61008060]; National Natural Science Foundation of Fujian Province [2011J01376]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of Fujian Province(Natural Science Foundation of Fujian Province)	This work is supported by the National Natural Science Foundation of China ( No. 61008060) and the National Natural Science Foundation of Fujian Province (No. 2011J01376), respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKAKIN VV, 1982, KRISTALLOGRAFIYA+, V27, P38; Cavalli E, 2008, J PHYS CHEM SOLIDS, V69, P29, DOI 10.1016/j.jpcs.2007.07.101; FANO U, 1961, PHYS REV, V124, P1866, DOI 10.1103/PhysRev.124.1866; FANO U, 1965, PHYS REV, V137, P1364, DOI 10.1103/PhysRev.137.A1364; HUBER G, 1975, J APPL PHYS, V46, P3580, DOI 10.1063/1.322269; KENYON PT, 1982, IEEE J QUANTUM ELECT, V18, P1189, DOI 10.1109/JQE.1982.1071692; KISLIUK P, 1967, PHYS REV, V160, P307, DOI 10.1103/PhysRev.160.307; Kuck S, 2001, APPL PHYS B-LASERS O, V72, P515, DOI 10.1007/s003400100540; LAI ST, 1986, IEEE J QUANTUM ELECT, V22, P1931; Long XF, 2004, CHEM PHYS LETT, V392, P192, DOI 10.1016/j.cplett.2004.05.067; Mikhailik VB, 2006, NUCL INSTRUM METH A, V562, P513, DOI 10.1016/j.nima.2006.03.005; Mikhailik VB, 2005, PHYS STATUS SOLIDI B, V242, pR17, DOI 10.1002/pssb.200409087; PAYNE SA, 1988, IEEE J QUANTUM ELECT, V24, P2243, DOI 10.1109/3.8567; PAYNE SA, 1989, J APPL PHYS, V66, P1051, DOI 10.1063/1.343491; Preifer E, 1990, CRYST RES TECHNOL, V25, P3; Samtleben TA, 2005, OPT LASER ENG, V43, P251, DOI 10.1016/j.optlaseng.2004.02.010; Spasskii DA, 2009, OPT SPECTROSC+, V106, P556, DOI 10.1134/S0030400X09040171; STRUVE B, 1983, APPL PHYS B-PHOTO, V30, P117, DOI 10.1007/BF00695465; Sugano S, MULTIPLETS TRANSITIO; Wang GJ, 2011, MATER RES INNOV, V15, P167, DOI 10.1179/143307511X12998222919191; WANG GF, 1990, J CRYST GROWTH, V100, P447, DOI 10.1016/0022-0248(90)90243-E; Wang GJ, 2008, J LUMIN, V128, P1556, DOI 10.1016/j.jlumin.2008.03.004; Wang GJ, 2010, J ALLOY COMPD, V489, P293, DOI 10.1016/j.jallcom.2009.09.076; Wang GJ, 2009, J LUMIN, V129, P1398, DOI 10.1016/j.jlumin.2009.07.012	24	10	10	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2012	7	1							e30327	10.1371/journal.pone.0030327	http://dx.doi.org/10.1371/journal.pone.0030327			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910LV	22291935	Green Published, gold, Green Submitted			2022-12-25	WOS:000301639600014
J	Kang, JM; Park, S; Kim, SJ; Hong, HY; Jeong, J; Kim, HS; Kim, SJ				Kang, J. M.; Park, S.; Kim, S. J.; Hong, H. Y.; Jeong, J.; Kim, H-S; Kim, S-J			CBL enhances breast tumor formation by inhibiting tumor suppressive activity of TGF-beta signaling	ONCOGENE			English	Article						TGF-beta; smad; CBL; breast cancer; tumorigenesis	GROWTH-FACTOR-BETA; ACQUIRED UNIPARENTAL DISOMY; II RECEPTOR; C-CBL; CANCER CELLS; TYROSINE KINASES; NUCLEAR IMPORT; SMAD3; MUTATIONS; TRANSCRIPTION	Casitas B-lineage lymphoma (CBL) protein family functions as multifunctional adaptor proteins and E3 ubiquitin ligases that are implicated as regulators of signaling in various cell types. Recent discovery revealed mutations of proto-oncogenic CBL in the linker region and RING finger domain in human acute myeloid neoplasm, and these transforming mutations induced carcinogenesis. However, the adaptor function of CBL mediated signaling pathway during tumorigenesis has not been well characterized. Here, we show that CBL is highly expressed in breast cancer cells and significantly inhibits transforming growth factor-beta (TGF-beta) tumor suppressive activity. Knockdown of CBL expression resulted in the increased expression of TGF-beta target genes, PAI-I and CDK inhibitors such as p15(INK4b) and p21(Cip1). Furthermore, we demonstrate that CBL is frequently overexpressed in human breast cancer tissues, and the loss of CBL decreases the tumorigenic activity of breast cancer cells in vivo. CBL directly binds to Smad3 through its proline-rich motif, thereby preventing Smad3 from interacting with Smad4 and blocking nuclear translocation of Smad3. CBL-b, one of CBL protein family, also interacted with Smad3 and knockdown of both CBL and CBL-b further enhanced TGF-beta transcriptional activity. Our findings provide evidence for a previously undescribed mechanism by which oncogenic CBL can block TGF-beta tumor suppressor activity. Oncogene (2012) 31, 5123-5131; doi:10.1038/onc.2012.18; published online 6 February 2012	[Kang, J. M.; Park, S.; Kim, S. J.; Kim, S-J] CHA Univ, Dept Biomed Sci, Seoul 135081, South Korea; [Hong, H. Y.; Kim, S-J] Gachon Univ Med & Sci, Lee Gil Ya Canc & Diabet Inst, Lab Cell Regulat & Carcinogenesis, Inchon, South Korea; [Jeong, J.] Yonsei Univ, Coll Med, Gangnam Severance Hosp, Dept Surg, Seoul, South Korea; [Kim, H-S; Kim, S-J] Case Western Reserve Univ, Rainbow Babies & Childrens Hosp, Dept Pediat, Cleveland, OH 44106 USA	Pochon Cha University; Gachon University; Yonsei University; Yonsei University Health System; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Rainbow Babies & Children's Hospital	Kim, SJ (corresponding author), CHA Univ, Dept Biomed Sci, 605 Yeoksam 1 Dong, Seoul 135081, South Korea.	kimsj@cha.ac.kr		Kim, Staci J./0000-0001-9932-255X; Kang, Jin Muk/0000-0002-7949-9160	National Research Foundation grant of Korea [20090081756, 2011-0014281]; Korea government	National Research Foundation grant of Korea(National Research Foundation of Korea); Korea government(Korean Government)	This work was supported by a National Research Foundation grant of Korea (20090081756 and 2011-0014281) funded by the Korea government. We thank H Kim, W Joo, Y Kim and J Park for their technical supporting.	Bisogna M, 2001, CANCER GENET CYTOGEN, V125, P131, DOI 10.1016/S0165-4608(00)00367-8; Chacko BM, 2004, MOL CELL, V15, P813, DOI 10.1016/j.molcel.2004.07.016; Chipuk JE, 2002, J BIOL CHEM, V277, P1240, DOI 10.1074/jbc.M108855200; Dunbar AJ, 2008, CANCER RES, V68, P10349, DOI 10.1158/0008-5472.CAN-08-2754; Falanga V, 2004, WOUND REPAIR REGEN, V12, P320, DOI 10.1111/j.1067-1927.2004.012316.x; Grand FH, 2009, BLOOD, V113, P6182, DOI 10.1182/blood-2008-12-194548; Hansson MD, 2008, ANAL BIOCHEM, V375, P373, DOI 10.1016/j.ab.2007.12.005; Inoue Y, 2009, J CELL BIOCHEM, V108, P285, DOI 10.1002/jcb.22252; Jin W, 2005, P NATL ACAD SCI USA, V102, P16239, DOI 10.1073/pnas.0503137102; Jin W, 2007, CANCER RES, V67, P9869, DOI 10.1158/0008-5472.CAN-07-0436; Jin W, 2010, CARCINOGENESIS, V31, P1939, DOI 10.1093/carcin/bgq180; Knight JF, 2008, BRIT J CANCER, V99, P1849, DOI 10.1038/sj.bjc.6604774; Komuro A, 2004, ONCOGENE, V23, P6914, DOI 10.1038/sj.onc.1207885; Lahn M, 2006, SMAD SIGNAL TRANSDUC, P415; Lee BI, 2001, CANCER RES, V61, P931; Lee DK, 2002, J BIOL CHEM, V277, P38557, DOI 10.1074/jbc.M206786200; Li LY, 2004, MOL CELL BIOL, V24, P856, DOI 10.1128/MCB.24.2.856-864.2004; Loh ML, 2009, BLOOD, V114, P1859, DOI 10.1182/blood-2009-01-198416; Markowitz Sanford D., 1996, Cytokine and Growth Factor Reviews, V7, P93, DOI 10.1016/1359-6101(96)00001-9; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; PARK KC, 1994, P NATL ACAD SCI USA, V91, P8772, DOI 10.1073/pnas.91.19.8772; Pennock S, 2008, MOL CELL BIOL, V28, P3020, DOI 10.1128/MCB.01809-07; Sanada M, 2009, NATURE, V460, P904, DOI 10.1038/nature08240; Schmidt MHH, 2005, NAT REV MOL CELL BIO, V6, P907, DOI 10.1038/nrm1762; Tan YHC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008972; Thien CBF, 2001, NAT REV MOL CELL BIO, V2, P294, DOI 10.1038/35067100; Wan M, 2005, AM J PATHOL, V166, P1379, DOI 10.1016/S0002-9440(10)62356-5; Xu L, 2002, MOL CELL, V10, P271, DOI 10.1016/S1097-2765(02)00586-5; Xu L, 2000, NAT CELL BIOL, V2, P559, DOI 10.1038/35019649; Xu L, 2003, J BIOL CHEM, V278, P42569, DOI 10.1074/jbc.M307601200	32	31	34	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	DEC	2012	31	50					5123	5131		10.1038/onc.2012.18	http://dx.doi.org/10.1038/onc.2012.18			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	055WY	22310290				2022-12-25	WOS:000312449800001
J	Haldar, S; Chattopadhyay, K				Haldar, Shubhasis; Chattopadhyay, Krishnananda			Interconnection of Salt-induced Hydrophobic Compaction and Secondary Structure Formation Depends on Solution Conditions REVISITING EARLY EVENTS OF PROTEIN FOLDING AT SINGLE MOLECULE RESOLUTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLUORESCENCE CORRELATION SPECTROSCOPY; HYDROGEN-BOND FORMATION; X-RAY-SCATTERING; CYTOCHROME-C; UNFOLDED STATES; COLLAPSE; UREA; KINETICS; DENATURATION; FLUCTUATIONS	What happens in the early stage of protein folding remains an interesting unsolved problem. Rapid kinetics measurements with cytochrome c using submillisecond continuous flow mixing devices suggest simultaneous formation of a compact collapsed state and secondary structure. These data seem to indicate that collapse formation is guided by specific short and long range interactions (heteropolymer collapse). A contrasting interpretation also has been proposed, which suggests that the collapse formation is rapid, nonspecific, and a trivial solvent related compaction, which could as well be observed by a homopolymer (homopolymer collapse). We address this controversy using fluorescence correlation spectroscopy (FCS), which enables us to monitor the salt-induced compaction accompanying collapse formation and the associated time constant directly at single molecule resolution. In addition, we follow the formation of secondary structure using far UV CD. The data presented here suggest that both these models (homopolymer and heteropolymer) could be applicable depending on the solution conditions. For example, the formation of secondary structure and compact state is not simultaneous in aqueous buffer. In aqueous buffer, formation of the compact state occurs through a two-state co-operative transition following heteropolymer formalism, whereas secondary structure formation takes place gradually. In contrast, in the presence of urea, a compaction of the protein radius occurs gradually over an extended range of salt concentration following homopolymer formalism. The salt-induced compaction and the formation of secondary structure take place simultaneously in the presence of urea.	[Haldar, Shubhasis; Chattopadhyay, Krishnananda] Indian Inst Chem Biol, Prot Folding & Dynam Lab, Struct Biol & Bioinformat Div, Council Sci & Ind Res, Kolkata 700032, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Chattopadhyay, K (corresponding author), Indian Inst Chem Biol, Prot Folding & Dynam Lab, Struct Biol & Bioinformat Div, Council Sci & Ind Res, 4 Raja SC Mullick Rd, Kolkata 700032, India.	krish@iicb.res.in		Haldar, Shubhasis/0000-0002-4304-5570; Chattopadhyay, Krishnananda/0000-0002-1449-8909	Council for Scientific and Industrial Research Empower Project [OLP004]; Indian Institute of Chemical Biology	Council for Scientific and Industrial Research Empower Project; Indian Institute of Chemical Biology(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by Council for Scientific and Industrial Research Empower Project Grant OLP004.; We thank Professor S. Maiti of the Tata Institute of Fundamental Research for the Maximum Entropy Method analysis software. We also thank Professors Elliot Elson and Carl Frieden of the Washington University School of Medicine for critical comments on this work. Professor S. Roy of the Indian Institute of Chemical Biology is acknowledged for help and support.	Akiyama S, 2000, NAT STRUCT BIOL, V7, P514; Baldwin RL, 1999, TRENDS BIOCHEM SCI, V24, P77, DOI 10.1016/S0968-0004(98)01345-0; Bennion BJ, 2003, P NATL ACAD SCI USA, V100, P5142, DOI 10.1073/pnas.0930122100; Caflisch A, 1999, STRUCT FOLD DES, V7, P477, DOI 10.1016/S0969-2126(99)80064-1; Chattopadhyay K, 2005, P NATL ACAD SCI USA, V102, P2385, DOI 10.1073/pnas.0500127102; Chattopadhyay K, 2002, BIOCHEMISTRY-US, V41, P4040, DOI 10.1021/bi012042l; Chen EF, 2004, J AM CHEM SOC, V126, P11175, DOI 10.1021/ja0400077; Chen HM, 2007, P NATL ACAD SCI USA, V104, P10459, DOI 10.1073/pnas.0704073104; CHU B, 1995, MACROMOLECULES, V28, P180, DOI 10.1021/ma00105a024; Eaton WA, 1996, STRUCTURE, V4, P1133, DOI 10.1016/S0969-2126(96)00121-9; Elson EL, 2004, J BIOMED OPT, V9, P857, DOI 10.1117/1.1779234; Gast K, 1997, FEBS LETT, V403, P245, DOI 10.1016/S0014-5793(97)00058-6; Ghosh R, 2009, BIOCHEMISTRY-US, V48, P1135, DOI 10.1021/bi802065j; Goldbeck RA, 2009, INT J MOL SCI, V10, P1476, DOI 10.3390/ijms10041476; Hagen SJ, 2000, J MOL BIOL, V301, P1019, DOI 10.1006/jmbi.2000.3969; Hagen SJ, 1996, P NATL ACAD SCI USA, V93, P11615, DOI 10.1073/pnas.93.21.11615; Haldar S, 2011, LANGMUIR, V27, P5842, DOI 10.1021/la200580z; Haldar S, 2010, J BIOL CHEM, V285, P25314, DOI 10.1074/jbc.M110.116673; Haupts U, 1998, P NATL ACAD SCI USA, V95, P13573, DOI 10.1073/pnas.95.23.13573; Hess ST, 2002, BIOPHYS J, V83, P2300, DOI 10.1016/S0006-3495(02)73990-8; Hess ST, 2002, BIOCHEMISTRY-US, V41, P697, DOI 10.1021/bi0118512; Hoffmann A, 2007, P NATL ACAD SCI USA, V104, P105, DOI 10.1073/pnas.0604353104; KATAOKA M, 1993, J MOL BIOL, V229, P591, DOI 10.1006/jmbi.1993.1064; Kimura T, 2005, P NATL ACAD SCI USA, V102, P2748, DOI 10.1073/pnas.0407982102; Kristjansdottir S, 2005, J MOL BIOL, V347, P1053, DOI 10.1016/j.jmb.2005.01.009; Lim WK, 2009, P NATL ACAD SCI USA, V106, P2595, DOI 10.1073/pnas.0812588106; Meng WL, 2011, PROTEINS, V79, P3500, DOI 10.1002/prot.23145; Moglich A, 2006, P NATL ACAD SCI USA, V103, P12394, DOI 10.1073/pnas.0604748103; Muller-Spath S, 2010, P NATL ACAD SCI USA, V107, P14609, DOI 10.1073/pnas.1001743107; Mukrasch MD, 2007, J AM CHEM SOC, V129, P5235, DOI 10.1021/ja0690159; Nettels D, 2009, P NATL ACAD SCI USA, V106, P20740, DOI 10.1073/pnas.0900622106; O'Brien EP, 2007, J AM CHEM SOC, V129, P7346, DOI 10.1021/ja069232+; Oostenbrink C, 2005, PHYS CHEM CHEM PHYS, V7, P53, DOI 10.1039/b413167c; Pascher T, 1996, SCIENCE, V271, P1558, DOI 10.1126/science.271.5255.1558; Pletneva EV, 2005, J MOL BIOL, V345, P855, DOI 10.1016/j.jmb.2004.10.085; Sadqi M, 2003, P NATL ACAD SCI USA, V100, P12117, DOI 10.1073/pnas.2033863100; Segel DJ, 1998, BIOCHEMISTRY-US, V37, P12443, DOI 10.1021/bi980535t; Sengupta P, 2003, BIOPHYS J, V84, P1977, DOI 10.1016/S0006-3495(03)75006-1; Shastry MCR, 1998, NAT STRUCT BIOL, V5, P385, DOI 10.1038/nsb0598-385; Sinha KK, 2007, J MOL BIOL, V370, P385, DOI 10.1016/j.jmb.2007.04.061; Sosnick TR, 1997, P NATL ACAD SCI USA, V94, P8545, DOI 10.1073/pnas.94.16.8545; Sosnick TR, 1996, PROTEINS, V24, P413; Srinivasan R, 1999, P NATL ACAD SCI USA, V96, P14258, DOI 10.1073/pnas.96.25.14258; Stumpe MC, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000221; Takahashi S, 1997, NAT STRUCT BIOL, V4, P44, DOI 10.1038/nsb0197-44; Uversky VN, 2002, FEBS LETT, V515, P79, DOI 10.1016/S0014-5793(02)02441-9; Werner JH, 2006, P NATL ACAD SCI USA, V103, P11130, DOI 10.1073/pnas.0604712103; Wilkins DK, 1999, BIOCHEMISTRY-US, V38, P16424, DOI 10.1021/bi991765q; Zhang OW, 1997, BIOCHEMISTRY-US, V36, P3959, DOI 10.1021/bi9627626; Zhu PW, 1997, J CHEM PHYS, V106, P6492, DOI 10.1063/1.474098; Ziv G, 2009, PHYS CHEM CHEM PHYS, V11, P83, DOI 10.1039/b813961j; Ziv G, 2009, J AM CHEM SOC, V131, P2942, DOI 10.1021/ja808305u; Zou Q, 1998, PROTEINS, V31, P107, DOI 10.1002/(SICI)1097-0134(19980501)31:2<107::AID-PROT1>3.0.CO;2-J	53	23	23	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					11546	11555		10.1074/jbc.M111.315648	http://dx.doi.org/10.1074/jbc.M111.315648			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22303014	hybrid, Green Published			2022-12-25	WOS:000302780100082
J	Kim, SD; Pahuja, KB; Ravazzola, M; Yoon, J; Boyadjiev, SA; Hammamoto, S; Schekman, R; Orci, L; Kim, J				Kim, Sun-Don; Pahuja, Kanika Bajaj; Ravazzola, Mariella; Yoon, Joonsik; Boyadjiev, Simeon A.; Hammamoto, Susan; Schekman, Randy; Orci, Lelio; Kim, Jinoh			SEC23-SEC31 the Interface Plays Critical Role for Export of Procollagen from the Endoplasmic Reticulum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LENTICULO-SUTURAL DYSPLASIA; TO-GOLGI TRANSPORT; COPII COAT; COLLAGEN SECRETION; INTERMEDIATE COMPARTMENT; VESICLE FORMATION; STRUCTURAL BASIS; LIVING CELLS; ER; PROTEIN	COPII proteins are essential for exporting most cargo molecules from the endoplasmic reticulum. The membrane-facing surface of the COPII proteins (especially SEC23-SEC24) interacts directly or indirectly with the cargo molecules destined for exit. As we characterized the SEC23A mutations at the SEC31 binding site identified from patients with cranio-lenticulo-sutural dysplasia, we discovered that the SEC23-SEC31 interface can also influence cargo selection. Remarkably, M702V SEC23A does not compromise COPII assembly, vesicle size, and packaging of cargo molecules into COPII vesicles that we have tested but induces accumulation of procollagen in the endoplasmic reticulum when expressed in normal fibroblasts. We observed that M702V SEC23A activates SAR1B GTPase more than wildtype SEC23A when SEC13-SEC31 is present, indicating that M702V SEC23A causes premature dissociation of COPII from the membrane. Our results indicate that a longer stay of COPII proteins on the membrane is required to cargo procollagen than other molecules and suggest that the SEC23-SEC31 interface plays a critical role in capturing various cargo molecules.	[Kim, Sun-Don; Yoon, Joonsik; Boyadjiev, Simeon A.; Kim, Jinoh] Univ Calif Davis, Med Ctr, Genet Sect, Dept Pediat, Sacramento, CA 95817 USA; [Pahuja, Kanika Bajaj; Hammamoto, Susan; Schekman, Randy] Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Ravazzola, Mariella; Orci, Lelio] Univ Geneva, Med Ctr, Dept Cell Physiol & Metab, CH-1211 Geneva, Switzerland	University of California System; University of California Davis; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of Geneva	Kim, J (corresponding author), Univ Calif Davis, Med Ctr, Genet Sect, Dept Pediat, 2805 50th St,MIND Inst Wet Lab 1421, Sacramento, CA 95817 USA.	jinoh.kim@ucdmc.ucdavis.edu	Kim, Jinoh/AAF-9178-2020	Kim, Jinoh/0000-0003-2841-147X; Bajaj Pahuja, Kanika/0000-0001-8977-9812	MOEHRD [KRF-2007-357-E00005]; Children's Miracle Network; NIDCR, National Institutes of Health [DE016886]; Howard Hughes Medical Institute; Swiss National Science Foundation; Academic Senate Faculty; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE016886] Funding Source: NIH RePORTER	MOEHRD(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea); Children's Miracle Network; NIDCR, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Academic Senate Faculty; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	Supported in part by the Korean Research Fellowship (Foundation Fellowship (MOEHRD: KRF-2007-357-E00005).; Supported in part by an Endowed Chair from the Children's Miracle Network and by Grant DE016886 from NIDCR, National Institutes of Health.; Supported in part by the Howard Hughes Medical Institute.; Supported by the Swiss National Science Foundation.; Supported by an Academic Senate Faculty Research Award. To whom correspondence should be addressed: Sect. of Genetics, Dept. of Pediatrics, University of California Davis Medical Center, 2805 50th St., The M.I.N.D. Institute Wet Laboratory 1421, Sacramento, CA 95817. Tel.: 916-703-0451; Fax: 916-703-0370; E-mail: jinoh.kim@ucdmc.ucdavis.edu.	Antonny B, 2001, NAT CELL BIOL, V3, P531, DOI 10.1038/35078500; Appenzeller-Herzog C, 2006, J CELL SCI, V119, P2173, DOI 10.1242/jcs.03019; Aridor M, 2001, J CELL BIOL, V152, P213, DOI 10.1083/jcb.152.1.213; BACHINGER HP, 1993, AM J MED GENET, V45, P152, DOI 10.1002/ajmg.1320450204; BARLOWE C, 1994, CELL, V77, P895, DOI 10.1016/0092-8674(94)90138-4; Bi XP, 2007, DEV CELL, V13, P635, DOI 10.1016/j.devcel.2007.10.006; Bonfanti L, 1998, CELL, V95, P993, DOI 10.1016/S0092-8674(00)81723-7; Boyadjiev SA, 2011, CLIN GENET, V80, P169, DOI 10.1111/j.1399-0004.2010.01550.x; Boyadjiev SA, 2006, NAT GENET, V38, P1192, DOI 10.1038/ng1876; Fath S, 2007, CELL, V129, P1325, DOI 10.1016/j.cell.2007.05.036; Fisher L. W., 1989, CONNECT TISSUE RES, V21, P43; Fisher L. W., 1989, CONNECT TISSUE RES, V21, P49; FRIEND DS, 1967, J CELL BIOL, V35, P357, DOI 10.1083/jcb.35.2.357; Fromme JC, 2008, TRENDS CELL BIOL, V18, P330, DOI 10.1016/j.tcb.2008.04.006; Fromme JC, 2007, DEV CELL, V13, P623, DOI 10.1016/j.devcel.2007.10.005; GEDDIS AE, 1993, MATRIX, V13, P399, DOI 10.1016/S0934-8832(11)80045-4; Gusarova V, 2003, J BIOL CHEM, V278, P48051, DOI 10.1074/jbc.M306898200; HAMMOND C, 1994, J CELL BIOL, V126, P41, DOI 10.1083/jcb.126.1.41; Kaykas A, 2004, NAT CELL BIOL, V6, P52, DOI 10.1038/ncb1081; Kim J, 2005, J BIOL CHEM, V280, P7758, DOI 10.1074/jbc.M411091200; Kim J, 2007, J CELL BIOL, V179, P951, DOI 10.1083/jcb.200709012; Kim J, 2007, CELL HOST MICROBE, V2, P160, DOI 10.1016/j.chom.2007.07.010; Lang MR, 2006, NAT GENET, V38, P1198, DOI 10.1038/ng1880; Lee MCS, 2005, CELL, V122, P605, DOI 10.1016/j.cell.2005.07.025; Lee MCS, 2004, ANNU REV CELL DEV BI, V20, P87, DOI 10.1146/annurev.cellbio.20.010403.105307; Long KR, 2010, J CELL BIOL, V190, P115, DOI 10.1083/jcb.201004132; Mancias JD, 2008, EMBO J, V27, P2918, DOI 10.1038/emboj.2008.208; Matsuoka K, 1998, CELL, V93, P263, DOI 10.1016/S0092-8674(00)81577-9; Milenkovic L, 2009, J CELL BIOL, V187, P365, DOI 10.1083/jcb.200907126; Miller EA, 2003, CELL, V114, P497, DOI 10.1016/S0092-8674(03)00609-3; Mironov AA, 2003, DEV CELL, V5, P583, DOI 10.1016/S1534-5807(03)00294-6; Mossessova E, 2003, CELL, V114, P483, DOI 10.1016/S0092-8674(03)00608-1; NOVICK P, 1980, CELL, V21, P205, DOI 10.1016/0092-8674(80)90128-2; Ohisa S, 2010, DEV BIOL, V342, P85, DOI 10.1016/j.ydbio.2010.03.016; Presley JF, 1997, NATURE, V389, P81, DOI 10.1038/38001; Roberts B, 2003, MOL BIOL CELL, V14, P4414, DOI 10.1091/mbc.E03-03-0162; Saito A, 2009, NAT CELL BIOL, V11, P1197, DOI 10.1038/ncb1962; Saito K, 2009, CELL, V136, P891, DOI 10.1016/j.cell.2008.12.025; Sarmah S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010367; Sato K, 2004, J BIOL CHEM, V279, P1330, DOI 10.1074/jbc.C300457200; Scales SJ, 1997, CELL, V90, P1137, DOI 10.1016/S0092-8674(00)80379-7; Stagg SM, 2008, CELL, V134, P474, DOI 10.1016/j.cell.2008.06.024; Stagg SM, 2006, NATURE, V439, P234, DOI 10.1038/nature04339; TANDLER B, 1990, J ELECTRON MICR TECH, V16, P81, DOI 10.1002/jemt.1060160110; Tang BL, 1999, BIOCHEM BIOPH RES CO, V258, P679, DOI 10.1006/bbrc.1999.0574; Townley AK, 2008, J CELL SCI, V121, P3025, DOI 10.1242/jcs.031070; Weibel E R, 1969, Int Rev Cytol, V26, P235, DOI 10.1016/S0074-7696(08)61637-X; Wilson DG, 2011, J CELL BIOL, V193, P935, DOI 10.1083/jcb.201007162; YOSHIHISA T, 1993, SCIENCE, V259, P1466, DOI 10.1126/science.8451644; ZAREMBA S, 1983, J CELL BIOL, V97, P1339, DOI 10.1083/jcb.97.5.1339	50	32	33	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					10134	10144		10.1074/jbc.M111.283382	http://dx.doi.org/10.1074/jbc.M111.283382			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22298774	Green Published, hybrid			2022-12-25	WOS:000302167200045
J	Yang, ZQ; Gu, P; Shao, XY; Li, ZQ; Zhou, Y; Lu, LM; Chou, KY				Yang, Zhiqiang; Gu, Peng; Shao, Xiaoyi; Li, Zuoqing; Zhou, Yun; Lu, Liming; Chou, Kuang-Yen			Mutated Major Histocompatibility Complex Class II Transactivator Up-regulates Interleukin-33-dependent Differentiation of Th2 Subset through Nod2 Binding for NLR (NOD-like Receptor) Signaling Initiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INNATE IMMUNE-RESPONSE; NF-KAPPA-B; T-CELLS; CONSTRUCTS LACKING; TERMINAL DOMAIN; CUTTING EDGE; IL-1 FAMILY; EXPRESSION; MHC; EFFECTOR	Dominant-negative mutants of class II transactivator (mCIITAs) with N-terminal depletion have been used to repress the transcription of class II genes in xenotransplantation. Here, we report that mCIITA overexpressing myeloid cell line Ana-1 (Ana-1-mCIITA) derived from a C57BL/6 mouse was able to down-regulate the MHC class II expression and reverse immune responses from Th1 (IL-2(+)IFN-gamma(+)STAT4(+)) to Th2 (IL-4(+)IL-5(+)IL-10(+)IL-13(+)STAT6(+)) when cocultured with T cells. Mechanism analysis indicated that the mCIITA protein is able to initiate a NOD-like receptor-related signaling pathway via binding of the cytoplasmic Nod2 protein, which was followed by activating RIP2, caspase 1, and IKK-alpha/beta. This ensures the expression of the genes encoding the cytokines IL-33, IL-1 beta, and TNF-alpha; however, only the highly expressed IL-33 is responsible for inducing the type 2 response, with a skewed Th2 cytokine secretion (IL-4(+)IL-5(+)IL-10(+)IL-13(+)IL-2(-)IFN-gamma(-)), which was completely prevented by the deactivation of the Nod2 gene with siRNA or by the blockage of the IL-33-related signaling using the mAb ST2L against the IL-33 receptor. mCIITA-mediated Th2 conversion was also successfully induced in vivo in a mCIITA-transgenic C57BL/6 mouse model. These results indicate that the Th1/Th2 balance could be regulated by an Nterminus-depleted CIITA molecule via NOD-like receptor-related signaling, a property valuable for disease control, especially for inducing transplantation tolerance via the repression of class II expression and the attenuation of a Th1-dominant response.	[Gu, Peng; Shao, Xiaoyi; Li, Zuoqing; Zhou, Yun; Lu, Liming] Shanghai Jiao Tong Univ, Sch Med, Shanghai Inst Immunol, Shanghai 200030, Peoples R China; [Yang, Zhiqiang; Chou, Kuang-Yen] Shanghai Jiao Tong Univ, Sch Med, Dept Immunol, Shanghai 200030, Peoples R China	Chinese Academy of Sciences; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Lu, LM (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Inst Immunol, Shanghai 200030, Peoples R China.	lulunew2003@163.com; kychouimm@sjtu.edu.cn	Gu, Peng/GPW-7040-2022		Natural Science Foundation of China [30530690, 30772018, 30700766]; Foundation of Shanghai Sci-Tech Council [07JC14033]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation of Shanghai Sci-Tech Council	This study was supported by the Natural Science Foundation of China Grants 30530690, 30772018, and 30700766 and the Foundation of Shanghai Sci-Tech Council 07JC14033.	Aggarwal S, 2003, J BIOL CHEM, V278, P1910, DOI 10.1074/jbc.M207577200; Amsen D, 2004, CELL, V117, P515, DOI 10.1016/S0092-8674(04)00451-9; Bafica A, 2005, J EXP MED, V202, P1715, DOI 10.1084/jem.20051782; Cherry WB, 2008, J ALLERGY CLIN IMMUN, V121, P1484, DOI 10.1016/j.jaci.2008.04.005; Dardalhon V, 2008, NAT IMMUNOL, V9, P1347, DOI 10.1038/ni.1677; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; Haraldsen G, 2009, TRENDS IMMUNOL, V30, P227, DOI 10.1016/j.it.2009.03.003; Hasegawa M, 2008, EMBO J, V27, P373, DOI 10.1038/sj.emboj.7601962; Hatada EN, 2000, CURR OPIN IMMUNOL, V12, P52, DOI 10.1016/S0952-7915(99)00050-3; Imanishi T, 2007, J IMMUNOL, V178, P6715, DOI 10.4049/jimmunol.178.11.6715; Inohara N, 2003, NAT REV IMMUNOL, V3, P371, DOI 10.1038/nri1086; Kanneganti TD, 2007, IMMUNITY, V27, P549, DOI 10.1016/j.immuni.2007.10.002; Kanneganti TD, 2010, NAT REV IMMUNOL, V10, P688, DOI 10.1038/nri2851; LeibundGut-Landmann S, 2004, EUR J IMMUNOL, V34, P1513, DOI 10.1002/eji.200424964; Li K, 2009, CIRC RES, V105, P353, DOI 10.1161/CIRCRESAHA.109.195230; Liew FY, 2010, NAT REV IMMUNOL, V10, P103, DOI 10.1038/nri2692; Lohr J, 2009, MICROBES INFECT, V11, P589, DOI 10.1016/j.micinf.2009.04.012; Magalhaes JG, 2008, J IMMUNOL, V181, P7925, DOI 10.4049/jimmunol.181.11.7925; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; Netea MG, 2005, ANTIMICROB AGENTS CH, V49, P3991, DOI 10.1128/AAC.49.10.3991-3996.2005; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; Ou QS, 2004, J CLIN IMMUNOL, V24, P97, DOI 10.1023/B:JOCI.0000018068.37899.6d; Park JH, 2007, J IMMUNOL, V178, P2380, DOI 10.4049/jimmunol.178.4.2380; Paul WE, 2010, NAT REV IMMUNOL, V10, P225, DOI 10.1038/nri2735; Reith W, 2001, ANNU REV IMMUNOL, V19, P331, DOI 10.1146/annurev.immunol.19.1.331; Rietdijk ST, 2008, CURR OPIN PHARMACOL, V8, P261, DOI 10.1016/j.coph.2008.04.003; Salomon B, 1998, J IMMUNOL, V161, P5138; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; So T, 2006, P NATL ACAD SCI USA, V103, P3740, DOI 10.1073/pnas.0600205103; Soroosh P, 2009, IMMUNOLOGY, V127, P450, DOI 10.1111/j.1365-2567.2009.03114.x; Ting JPY, 2008, IMMUNITY, V28, P285, DOI 10.1016/j.immuni.2008.02.005; Ting JPY, 2002, CELL, V109, pS21, DOI 10.1016/S0092-8674(02)00696-7; Veldhoen M, 2008, NAT IMMUNOL, V9, P1341, DOI 10.1038/ni.1659; Watanabe H, 2004, SHOCK, V22, P460, DOI 10.1097/01.shk.0000142249.08135.e9; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; Xu D, 1998, J EXP MED, V187, P787, DOI 10.1084/jem.187.5.787; Yun S, 1998, TRANSPLANTATION, V66, P103, DOI 10.1097/00007890-199807150-00016; Yun S, 1997, INT IMMUNOL, V9, P1545, DOI 10.1093/intimm/9.10.1545; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001; Zhu JF, 2008, BLOOD, V112, P1557, DOI 10.1182/blood-2008-05-078154	41	5	6	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					9972	9981		10.1074/jbc.M111.288498	http://dx.doi.org/10.1074/jbc.M111.288498			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22294690	Green Published, hybrid			2022-12-25	WOS:000302167200029
J	Covaleda, G; del Rivero, MA; Chavez, MA; Aviles, FX; Reverter, D				Covaleda, Giovanni; Alonso del Rivero, Maday; Chavez, Maria A.; Aviles, Francesc X.; Reverter, David			Crystal Structure of Novel Metallocarboxypeptidase Inhibitor from Marine Mollusk Nerita versicolor in Complex with Human Carboxypeptidase A4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING; PROTEIN; CRYSTALLOGRAPHY; SEQUENCE; CLONING	NvCI is a novel exogenous proteinaceous inhibitor of metallocarboxypeptidases from the marine snail Nerita versicolor. The complex between human carboxypeptidase A4 and NvCI has been crystallized and determined at 1.7 angstrom resolution. The NvCI structure defines a distinctive protein fold basically composed of a two-stranded antiparallel beta-sheet connected by three loops and the inhibitory C-terminal tail and stabilized by three disulfide bridges. NvCI is a tight-binding inhibitor that interacts with the active site of the enzyme in a substrate-like manner. NvCI displays an extended and novel interface with human carboxypeptidase A4, responsible for inhibitory constants in the picomolar range for some members of the M14A subfamily of carboxypeptidases. This makes NvCI the strongest inhibitor reported so far for this family. The structural homology displayed by the C-terminal tails of different carboxypeptidase inhibitors represents a relevant example of convergent evolution.	[Covaleda, Giovanni; Aviles, Francesc X.; Reverter, David] Univ Autonoma Barcelona, Inst Biotecnol & Biomed, Bellaterra 08193, Barcelona, Spain; [Covaleda, Giovanni; Aviles, Francesc X.; Reverter, David] Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, Bellaterra 08193, Barcelona, Spain; [Alonso del Rivero, Maday; Chavez, Maria A.] Univ Habana, Fac Biol, Ctr Estudio Prot, Havana, Cuba	Autonomous University of Barcelona; Autonomous University of Barcelona; Universidad de la Habana	Aviles, FX (corresponding author), Univ Autonoma Barcelona, Inst Biotecnol & Biomed, Bellaterra 08193, Barcelona, Spain.	francescxavier.aviles@uab.es; david.reverter@uab.cat	Reverter, David/H-5360-2015; Aviles, Francesc Xavier/F-3482-2019; Cortes, Giovanni Covaleda/D-1575-2018; Avilés, Francesc Xavier/A-2664-2015	Reverter, David/0000-0002-5347-0992; Aviles, Francesc Xavier/0000-0002-1399-6789; Cortes, Giovanni Covaleda/0000-0002-7621-852X; Avilés, Francesc Xavier/0000-0002-1399-6789; Alonso del Rivero Antigua, Maday/0000-0003-1988-6852	Ministerio de Ciencia e Innovacion of Spain [BFU2008-0364, BIO2010-22321-C02]; European Community [MIRG-CT-2007-200346, LIVIMODE 241919]; Universitat Autonoma de Barcelona [FI-UAB-2007]	Ministerio de Ciencia e Innovacion of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Community(European Commission); Universitat Autonoma de Barcelona	This work was in part supported by Grants BFU2008-0364 and BIO2010-22321-C02 from the Ministerio de Ciencia e Innovacion of Spain and by Grants MIRG-CT-2007-200346 and LIVIMODE 241919 (FP7-Health-2009) from the European Community.; Supported by Universitat Autonoma de Barcelona Scholarship FI-UAB-2007.; Supported by the Ramon y Cajal Program of the Ministerio de Ciencia e Innovacion of Spain. To whom correspondence may be addressed. Tel.: 93-586-8955; Fax: 93-581-2011; E-mail: david. reverter@uab.cat.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Arolas JL, 2005, J MOL BIOL, V350, P489, DOI 10.1016/j.jmb.2005.05.015; Arolas JL, 2005, J BIOL CHEM, V280, P3441, DOI 10.1074/jbc.M411086200; Arolas JL, 2007, CURR PHARM DESIGN, V13, P349, DOI 10.2174/138161207780162980; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; de la Vega MR, 2007, FASEB J, V21, P851, DOI 10.1096/fj.06-7330com; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Delfin J, 1996, TOXICON, V34, P1367, DOI 10.1016/S0041-0101(96)00114-6; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fernandez D, 2010, CHEM BIOL DRUG DES, V75, P29, DOI 10.1111/j.1747-0285.2009.00907.x; Gonzalez Y, 2007, BIOL CHEM, V388, P1183, DOI 10.1515/BC.2007.129; HASS GM, 1975, BIOCHEMISTRY-US, V14, P1334, DOI 10.1021/bi00677a036; Huang HJ, 1999, CANCER RES, V59, P2981; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kalinina E, 2007, FASEB J, V21, P836, DOI 10.1096/fj.06-7329com; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Lenarcic B, 1997, J BIOL CHEM, V272, P13899; Marino-Buslje C, 2000, EUR J BIOCHEM, V267, P1502, DOI 10.1046/j.1432-1327.2000.01150.x; Mock WL, 1996, ANAL BIOCHEM, V239, P218, DOI 10.1006/abio.1996.0318; MORRISON JF, 1982, TRENDS BIOCHEM SCI, V7, P102, DOI 10.1016/0968-0004(82)90157-8; Pallares I, 2005, P NATL ACAD SCI USA, V102, P3978, DOI 10.1073/pnas.0500678102; Pallares I, 2008, ACTA CRYSTALLOGR D, V64, P784, DOI 10.1107/S0907444908013474; REES DC, 1982, J MOL BIOL, V160, P475, DOI 10.1016/0022-2836(82)90309-6; Reverter D, 1998, J BIOL CHEM, V273, P32927, DOI 10.1074/jbc.273.49.32927; Reverter D, 1998, J BIOL CHEM, V273, P3535, DOI 10.1074/jbc.273.6.3535; Reverter D, 2000, NAT STRUCT BIOL, V7, P322, DOI 10.1038/74092; REYNOLDS DS, 1989, P NATL ACAD SCI USA, V86, P9480, DOI 10.1073/pnas.86.23.9480; Sanglas L, 2009, P NATL ACAD SCI USA, V106, P1743, DOI 10.1073/pnas.0812623106; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Tanco S, 2010, J BIOL CHEM, V285, P18385, DOI 10.1074/jbc.M109.060350; Vendrell J., 2004, HDB METALLOPROTEINS, V3, P176; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	32	20	22	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					9250	9258		10.1074/jbc.M111.330100	http://dx.doi.org/10.1074/jbc.M111.330100			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22294694	hybrid, Green Published			2022-12-25	WOS:000301797800053
J	Schmid-Siegert, E; Loscos, J; Farmer, EE				Schmid-Siegert, Emanuel; Loscos, Jorge; Farmer, Edward E.			Inducible Malondialdehyde Pools in Zones of Cell Proliferation and Developing Tissues in Arabidopsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMATOGRAPHY MASS-SPECTROMETRY; LIPID-PEROXIDATION; LIQUID-CHROMATOGRAPHY; THIOBARBITURIC ACID; LINOLENIC ACID; JASMONIC ACID; DNA-DAMAGE; ALDEHYDES; MUTANT; PROTEINS	Malondialdehyde (MDA) is a natural and widespread genotoxin. Given its potentially deleterious effects, it is of interest to establish the identities of the cell types containing this aldehyde. We used in situ chemical trapping with 2-thiobarbituric acid and mass spectrometry with a deuterated standard to characterize MDA pools in the vegetative phase in Arabidopsis thaliana. In leaves, MDA occurred predominantly in the intracellular compartment of mesophyll cells and was enriched in chloroplasts where it was derived primarily from triunsaturated fatty acids (TFAs). High levels of MDA (most of which was unbound) were found within dividing cells in the root tip cell proliferation zone. The bulk of this MDA did not originate from TFAs. We confirmed the localization of MDA in transversal root sections. In addition to MDA in proliferating cells near the root tip we found evidence for the presence of MDA in pericyle cells. Remodeling of non-TFA-derived MDA pools occurred when seedlings were infected with the fungus Botrytis cinerea. Treatment of uninfected seedlings with mediators of plant stress responses (jasmonic acid or salicylic acid) increased seedling MDA levels over 20-fold. In summary, major pools of MDA are associated with cell division foci containing stem cells. The aldehyde is pathogen-inducible in these regions and its levels are increased by cellular mediators that impact defense and growth.	[Schmid-Siegert, Emanuel; Loscos, Jorge; Farmer, Edward E.] Univ Lausanne, Dept Plant Mol Biol, CH-1015 Lausanne, Switzerland	University of Lausanne	Farmer, EE (corresponding author), Univ Lausanne, Dept Plant Mol Biol, CH-1015 Lausanne, Switzerland.	edward.farmer@unil.ch	Schmid-Siegert, Emanuel/N-8657-2019; Schmid-Siegert, Emanuel/G-5067-2012; Loscos, Jorge/F-3082-2013; Farmer, Edward E/H-1635-2011; Loscos, Jorge/A-7827-2008	Schmid-Siegert, Emanuel/0000-0003-1339-5120; Loscos, Jorge/0000-0003-1435-1779; Loscos, Jorge/0000-0003-1435-1779	Swiss National Science Foundation NCCR; SNSF [3100A0-122441]; Marie Curie Postdoctoral Fellowship	Swiss National Science Foundation NCCR(Swiss National Science Foundation (SNSF)); SNSF(Swiss National Science Foundation (SNSF)); Marie Curie Postdoctoral Fellowship(European Commission)	This work was supported in part by Swiss National Science Foundation NCCR Plant Survival Grant and by SNSF Grant 3100A0-122441.; Supported by a Marie Curie Postdoctoral Fellowship.	CAO H, 1994, PLANT CELL, V6, P1583, DOI 10.1105/tpc.6.11.1583; Chou MY, 2009, J CLIN INVEST, V119, P1335, DOI 10.1172/JCI36800; Clausen C, 2004, PLANTA, V220, P30, DOI 10.1007/s00425-004-1325-3; Dubrovsky JG, 2000, PLANT PHYSIOL, V124, P1648, DOI 10.1104/pp.124.4.1648; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Farmer EE, 2007, CURR OPIN PLANT BIOL, V10, P380, DOI 10.1016/j.pbi.2007.04.019; Gindro K, 2001, FEMS MICROBIOL LETT, V204, P101, DOI 10.1111/j.1574-6968.2001.tb10870.x; Glauser G, 2009, J BIOL CHEM, V284, P34506, DOI 10.1074/jbc.M109.061432; JANERO DR, 1990, FREE RADICAL BIO MED, V9, P515, DOI 10.1016/0891-5849(90)90131-2; Jauh GY, 1999, PLANT CELL, V11, P1867, DOI 10.1105/tpc.11.10.1867; Kruft V, 2001, PLANT PHYSIOL, V127, P1694, DOI 10.1104/pp.010474; Liu JK, 1997, ANAL BIOCHEM, V245, P161, DOI 10.1006/abio.1996.9990; Long JG, 2009, NEUROCHEM RES, V34, P786, DOI 10.1007/s11064-008-9882-7; Mano J, 2009, PLANTA, V230, P639, DOI 10.1007/s00425-009-0964-9; Mano S, 2002, PLANT CELL PHYSIOL, V43, P331, DOI 10.1093/pcp/pcf037; Marnett LJ, 2002, TOXICOLOGY, V181, P219, DOI 10.1016/S0300-483X(02)00448-1; Mauch F, 2001, PLANT J, V25, P67, DOI 10.1046/j.1365-313x.2001.00940.x; McConn M, 1996, PLANT CELL, V8, P403, DOI 10.1105/tpc.8.3.403; Mene-Saffrane L, 2009, J BIOL CHEM, V284, P1702, DOI 10.1074/jbc.M807114200; Mene-Saffrane L, 2007, J BIOL CHEM, V282, P35749, DOI 10.1074/jbc.M706838200; Niedernhofer LJ, 2003, J BIOL CHEM, V278, P31426, DOI 10.1074/jbc.M212549200; Pan XQ, 2008, PHYTOCHEMISTRY, V69, P1773, DOI 10.1016/j.phytochem.2008.02.008; Porra RJ, 2002, PHOTOSYNTH RES, V73, P149, DOI 10.1023/A:1020470224740; Refsgaard HHF, 2000, P NATL ACAD SCI USA, V97, P611, DOI 10.1073/pnas.97.2.611; Rodriguez VM, 2010, PLANT PHYSIOL, V152, P1335, DOI 10.1104/pp.109.150474; Schalk M, 1998, PLANT PHYSIOL, V118, P209, DOI 10.1104/pp.118.1.209; Slatter DA, 2000, DIABETOLOGIA, V43, P550, DOI 10.1007/s001250051342; Staswick PE, 2004, PLANT CELL, V16, P2117, DOI 10.1105/tpc.104.023549; STASWICK PE, 1992, P NATL ACAD SCI USA, V89, P6837, DOI 10.1073/pnas.89.15.6837; TATUM VL, 1990, LIPIDS, V25, P226, DOI 10.1007/BF02535752; Voulgaridou GP, 2011, MUTAT RES-FUND MOL M, V711, P13, DOI 10.1016/j.mrfmmm.2011.03.006; Weber H, 2004, PLANT J, V37, P877, DOI 10.1111/j.1365-313X.2003.02013.x; Yamauchi Y, 2008, PLANT PHYSIOL BIOCH, V46, P786, DOI 10.1016/j.plaphy.2008.04.018; Yamauchi Y, 2010, PLANTA, V231, P1077, DOI 10.1007/s00425-010-1112-2; YEO HC, 1994, ANAL BIOCHEM, V220, P391, DOI 10.1006/abio.1994.1355	35	19	20	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					8954	8962		10.1074/jbc.M111.322842	http://dx.doi.org/10.1074/jbc.M111.322842			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22298768	Green Published, hybrid			2022-12-25	WOS:000301797800026
J	Dimitroff, B; Howe, K; Watson, A; Campion, B; Lee, HG; Zhao, N; O'Connor, MB; Neufeld, TP; Selleck, SB				Dimitroff, Brian; Howe, Katie; Watson, Adrienne; Campion, Bridget; Lee, Hyun-Gwan; Zhao, Na; O'Connor, Michael B.; Neufeld, Thomas P.; Selleck, Scott B.			Diet and Energy-Sensing Inputs Affect TorC1-Mediated Axon Misrouting but Not TorC2-Directed Synapse Growth in a Drosophila Model of Tuberous Sclerosis	PLOS ONE			English	Article							CELL-GROWTH; SIGNALING PATHWAY; RAG GTPASES; COMPLEX; MTOR; TOR; SURVIVAL; KINASE; TARGET; RAPTOR	The Target of Rapamycin (TOR) growth regulatory system is influenced by a number of different inputs, including growth factor signaling, nutrient availability, and cellular energy levels. While the effects of TOR on cell and organismal growth have been well characterized, this pathway also has profound effects on neural development and behavior. Hyperactivation of the TOR pathway by mutations in the upstream TOR inhibitors TSC1 (tuberous sclerosis complex 1) or TSC2 promotes benign tumors and neurological and behavioral deficits, a syndrome known as tuberous sclerosis (TS). In Drosophila, neuron-specific overexpression of Rheb, the direct downstream target inhibited by Tsc1/Tsc2, produced significant synapse overgrowth, axon misrouting, and phototaxis deficits. To understand how misregulation of Tor signaling affects neural and behavioral development, we examined the influence of growth factor, nutrient, and energy sensing inputs on these neurodevelopmental phenotypes. Neural expression of Pi3K, a principal mediator of growth factor inputs to Tor, caused synapse overgrowth similar to Rheb, but did not disrupt axon guidance or phototaxis. Dietary restriction rescued Rheb-mediated behavioral and axon guidance deficits, as did overexpression of AMPK, a component of the cellular energy sensing pathway, but neither was able to rescue synapse overgrowth. While axon guidance and behavioral phenotypes were affected by altering the function of a Tor complex 1 (TorC1) component, Raptor, or a TORC1 downstream element (S6k), synapse overgrowth was only suppressed by reducing the function of Tor complex 2 (TorC2) components (Rictor, Sin1). These findings demonstrate that different inputs to Tor signaling have distinct activities in nervous system development, and that Tor provides an important connection between nutrient-energy sensing systems and patterning of the nervous system.	[Dimitroff, Brian; Watson, Adrienne; O'Connor, Michael B.; Neufeld, Thomas P.; Selleck, Scott B.] Univ Minnesota, Dept Genet Cell Biol & Dev, Ctr Dev Biol, Minneapolis, MN 55455 USA; [Howe, Katie; Campion, Bridget; Selleck, Scott B.] Univ Minnesota, Grad Program Neurosci, Minneapolis, MN 55455 USA; [Dimitroff, Brian; Lee, Hyun-Gwan; Zhao, Na; Selleck, Scott B.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Dimitroff, B (corresponding author), Univ Minnesota, Dept Genet Cell Biol & Dev, Ctr Dev Biol, Minneapolis, MN 55455 USA.	sbs24@psu.edu	Watson, Adrienne L/GRO-1978-2022; O'Connor, Michael B/C-9977-2014	Watson, Adrienne L/0000-0002-9752-3689; O'Connor, Michael B/0000-0002-3067-5506; Neufeld, Thomas/0000-0001-5659-4811	Department of Defense Congressionally; Harrison Endowment fund; University of Minnesota Autism Initiative; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062509] Funding Source: NIH RePORTER	Department of Defense Congressionally; Harrison Endowment fund; University of Minnesota Autism Initiative; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was funded by the Department of Defense Congressionally Directed Medical Research Program for Tubersous Sclerosis, the Harrison Endowment fund to SBS, and the University of Minnesota Autism Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avruch J, 2009, AM J PHYSIOL-ENDOC M, V296, pE592, DOI 10.1152/ajpendo.90645.2008; Avruch J, 2009, BIOCHEM SOC T, V37, P223, DOI 10.1042/BST0370223; BENZER S, 1967, P NATL ACAD SCI USA, V58, P1112, DOI 10.1073/pnas.58.3.1112; Binda M, 2009, MOL CELL, V35, P563, DOI 10.1016/j.molcel.2009.06.033; Blair SS, 2000, DROSOPHILA PROTOCOLS, P159; Carvalho GB, 2005, NAT METHODS, V2, P813, DOI 10.1038/NMETH798; Chalhoub N, 2009, GENE DEV, V23, P1619, DOI 10.1101/gad.1799609; Choe KM, 2005, CURR TOP DEV BIOL, V69, P187, DOI 10.1016/S0070-2153(05)69007-2; Choi YJ, 2008, GENE DEV, V22, P2485, DOI 10.1101/gad.1685008; Cummings AM, 2004, CRIT REV TOXICOL, V34, P461, DOI 10.1080/10408440490519786; Curatolo P, 2008, LANCET, V372, P657, DOI 10.1016/S0140-6736(08)61279-9; DiAntonio A, 2001, NATURE, V412, P449, DOI 10.1038/35086595; Fayyazuddin A, 2006, PLOS BIOL, V4, P420, DOI 10.1371/journal.pbio.0040063; Gibbs SM, 2001, J NEUROSCI, V21, P7705, DOI 10.1523/JNEUROSCI.21-19-07705.2001; Hartman AL, 2007, EPILEPSIA, V48, P31, DOI 10.1111/j.1528-1167.2007.00914.x; Inoki K, 2005, NAT GENET, V37, P19, DOI 10.1038/ng1494; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; Knox S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000375; Kockel L, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000990; Koike-Kumagai M, 2009, EMBO J, V28, P3879, DOI 10.1038/emboj.2009.312; Kwon CH, 2006, NEURON, V50, P377, DOI 10.1016/j.neuron.2006.03.023; Lee JH, 2007, NATURE, V447, P1017, DOI 10.1038/nature05828; Leevers SJ, 1996, EMBO J, V15, P6584, DOI 10.1002/j.1460-2075.1996.tb01049.x; Li H, 2002, NEUROSCIENCE, V115, P505, DOI 10.1016/S0306-4522(02)00380-9; Long X, 2005, CURR BIOL, V15, P702, DOI 10.1016/j.cub.2005.02.053; Mair W, 2005, PLOS BIOL, V3, P1305, DOI 10.1371/journal.pbio.0030223; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; McGuire SE, 2004, TRENDS GENET, V20, P384, DOI 10.1016/j.tig.2004.06.012; Meikle L, 2008, J NEUROSCI, V28, P5422, DOI 10.1523/JNEUROSCI.0955-08.2008; Meikle L, 2007, J NEUROSCI, V27, P5546, DOI 10.1523/JNEUROSCI.5540-06.2007; Neufeld T P, 2004, Curr Top Microbiol Immunol, V279, P139; Newsome TP, 2000, DEVELOPMENT, V127, P851; PARSONS PA, 1975, BEHAV GENET, V5, P17, DOI 10.1007/BF01067578; Potter CJ, 2001, CELL, V105, P357, DOI 10.1016/S0092-8674(01)00333-6; Richardson CJ, 2004, SEMIN CELL DEV BIOL, V15, P147, DOI 10.1016/j.semcdb.2003.12.023; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Scanga SE, 2000, ONCOGENE, V19, P3971, DOI 10.1038/sj.onc.1203739; Shen W, 2009, J CELL BIOL, V187, P71, DOI 10.1083/jcb.200907109; Spasic MR, 2008, J NEUROSCI, V28, P6419, DOI 10.1523/JNEUROSCI.1646-08.2008; STEWART BA, 1994, J COMP PHYSIOL A, V175, P179, DOI 10.1007/BF00215114; Swiech L, 2008, BBA-PROTEINS PROTEOM, V1784, P116, DOI 10.1016/j.bbapap.2007.08.015; Tapon N, 2001, CELL, V105, P345, DOI 10.1016/S0092-8674(01)00332-4; Tavazoie SF, 2005, NAT NEUROSCI, V8, P1727, DOI 10.1038/nn1566; van Spronsen FJ, 2010, NAT REV ENDOCRINOL, V6, P509, DOI 10.1038/nrendo.2010.125; von der Brelie C, 2006, EUR J NEUROSCI, V23, P686, DOI 10.1111/j.1460-9568.2006.04594.x; Wan HI, 2000, NEURON, V26, P313, DOI 10.1016/S0896-6273(00)81166-6; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yang Q, 2006, P NATL ACAD SCI USA, V103, P6811, DOI 10.1073/pnas.0602282103; Yang Q, 2007, CELL RES, V17, P666, DOI 10.1038/cr.2007.64; Zhang HB, 2000, GENE DEV, V14, P2712, DOI 10.1101/gad.835000	53	14	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2012	7	2							e30722	10.1371/journal.pone.0030722	http://dx.doi.org/10.1371/journal.pone.0030722			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LO	22319582	gold, Green Submitted, Green Published			2022-12-25	WOS:000302178400013
J	Yates, AM; Neumann, FH; Hancox, PJ				Yates, Adam M.; Neumann, Frank H.; Hancox, P. John			The Earliest Post-Paleozoic Freshwater Bivalves Preserved in Coprolites from the Karoo Basin, South Africa	PLOS ONE			English	Article							PERMIAN MASS EXTINCTION; BEAUFORT-GROUP; TRIASSIC RECOVERY; MOLLUSCA; BEHAVIOR	Background: Several clades of bivalve molluscs have invaded freshwaters at various times throughout Phanerozoic history. The most successful freshwater clade in the modern world is the Unionoida. Unionoids arose in the Triassic Period, sometime after the major extinction event at the End-Permian boundary and are now widely distributed across all continents except Antarctica. Until now, no freshwater bivalves of any kind were known to exist in the Early Triassic. Principal Findings: Here we report on a faunule of two small freshwater bivalve species preserved in vertebrate coprolites from the Olenekian (Lower Triassic) of the Burgersdorp Formation of the Karoo Basin, South Africa. Positive identification of these bivalves is not possible due to the limited material. Nevertheless they do show similarities with Unionoida although they fall below the size range of extant unionoids. Phylogenetic analysis is not possible with such limited material and consequently the assignment remains somewhat speculative. Conclusions: Bivalve molluscs re-invaded freshwaters soon after the End-Permian extinction event, during the earliest part of the recovery phase during the Olenekian Stage of the Early Triassic. If the specimens do represent unionoids then these Early Triassic examples may be an example of the Lilliput effect. Since the oldest incontrovertible freshwater unionoids are also from sub-Saharan Africa, it is possible that this subcontinent hosted the initial freshwater radiation of the Unionoida. This find also demonstrates the importance of coprolites as microenvironments of exceptional preservation that contain fossils of organisms that would otherwise have left no trace.	[Yates, Adam M.; Neumann, Frank H.; Hancox, P. John] Univ Witwatersrand, Bernard Price Inst Palaeontol Res, Johannesburg, South Africa; [Yates, Adam M.] Museum Cent Australia, Alice Springs, NT, Australia; [Neumann, Frank H.] Univ Munster, Forsch Stelle Palaobot, Munster, Germany	University of Witwatersrand; University of Munster	Yates, AM (corresponding author), Univ Witwatersrand, Bernard Price Inst Palaeontol Res, Johannesburg, South Africa.	yatesam@gmail.com			Lower Triassic of Driefontein, Free State, South Africa, from the Palaeontological Scientific Trust (PAST)	Lower Triassic of Driefontein, Free State, South Africa, from the Palaeontological Scientific Trust (PAST)	The work was supported by a grant to the project "A multidisciplinary study of a rich assemblage of coprolites from the Lower Triassic of Driefontein, Free State, South Africa.'' from the Palaeontological Scientific Trust (PAST) www.past.org.za. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdala F, 2006, ZOOL J LINN SOC-LOND, V147, P383, DOI 10.1111/j.1096-3642.2006.00224.x; Bender PA, 2004, GONDWANA RES, V7, P185, DOI 10.1016/S1342-937X(05)70317-8; Bowring SA, 1998, SCIENCE, V280, P1039, DOI 10.1126/science.280.5366.1039; Brayard A, 2010, GEOLOGY, V38, P147, DOI 10.1130/G30553.1; Cox L.R., 1932, J GEOLOGICAL SOC LON, V88, P623, DOI 10.1144/gsl.jgs; COX LR, 1969, TREATISE INVERTEBR N, V1, pN2; CURREY JD, 1974, J ZOOL, V173, P395; Damiani RJ, 2003, J VERTEBR PALEONTOL, V23, P54, DOI 10.1671/0272-4634(2003)23[54:NMTFTC]2.0.CO;2; Dixey F., 1937, Q J GEOL SOC, V93, P52, DOI [DOI 10.1144/GSL.JGS.1937.093.01-04.05, 10.1144/GSL.JGS.1937.093.01-04.05]; Erwin D. H., 2006, EXTINCTION LIFE EART; Giribet G, 2002, INVERTEBR BIOL, V121, P271; Good S.C., 1989, P233; Graf DL, 2007, J MOLLUS STUD, V73, P291, DOI 10.1093/mollus/eym029; Haas F., 1969, TREATISE INVERTEBR N, V1, pN411; Hancox PJ, 2001, J AFR EARTH SCI, V33, P563, DOI 10.1016/S0899-5362(01)00081-1; HANCOX PJ, 1995, S AFR J SCI, V91, P143; Hautmann M, 2005, PALAEONTOLOGY, V48, P1131, DOI 10.1111/j.1475-4983.2005.00505.x; Hoeh WR, 1998, MALACOLOGIA, V40, P267; Irmis R, 2008, J VERTEBR PALEONTOL, V28, p95A; Jin YG, 2000, SCIENCE, V289, P432, DOI 10.1126/science.289.5478.432; JOHNSON MR, 1976, THESIS RHODES U GRAH; Kent L.E., 1990, HDB OGF GEOLOGICAL S, V8, P535; Kondo Y, 2009, PALEONTOL RES, V13, P39, DOI 10.2517/1342-8144-13.1.039; Neveling J., 2004, B COUNCIL GEOSCIENCE, V137, P1; NEWELL N D, 1975, Bulletin of the American Museum of Natural History, V154, P53; Payne JL, 2005, PALEOBIOLOGY, V31, P269, DOI 10.1666/0094-8373(2005)031[0269:EDOGSA]2.0.CO;2; RETALLACK GJ, 1995, SCIENCE, V267, P77, DOI 10.1126/science.267.5194.77; Retallack GJ, 1996, GEOL SOC AM BULL, V108, P195, DOI 10.1130/0016-7606(1996)108<0195:GCGBPT>2.3.CO;2; Rodland DL, 2001, PALAIOS, V16, P95, DOI 10.2307/3515554; Rubidge B.S., 1995, GEOLOGICAL SURVEY S, V1, P1; Shishkin M. A., 1994, Palaeontologia Africana, V31, P39; Stanley GD, 2003, EARTH-SCI REV, V60, P195, DOI 10.1016/S0012-8252(02)00104-6; Twitchett RJ, 2007, PALAEOGEOGR PALAEOCL, V252, P132, DOI 10.1016/j.palaeo.2006.11.038; Urbanek Adam, 1993, Historical Biology, V7, P29; Weir, 1969, TREATISE INVERTEBR N, V6, pN402; Weir J., 1969, TREATISE INVERTEBR N, pN401	36	12	12	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2012	7	2							e30228	10.1371/journal.pone.0030228	http://dx.doi.org/10.1371/journal.pone.0030228			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UV	22319562	Green Published, gold, Green Submitted			2022-12-25	WOS:000301979000003
J	Hahn, S; Hoye, BJ; Korthals, H; Klaassen, M				Hahn, Steffen; Hoye, Bethany J.; Korthals, Harry; Klaassen, Marcel			From Food to Offspring Down: Tissue-Specific Discrimination and Turn-Over of Stable Isotopes in Herbivorous Waterbirds and Other Avian Foraging Guilds	PLOS ONE			English	Article							BODY CONDITION; NITROGEN; CARBON; DIET; FRACTIONATION; FEATHERS; HABITAT; DELTA-N-15; DELTA-C-13; SIGNATURES	Isotopic discrimination and turn-over are fundamental to the application of stable isotope ecology in animals. However, detailed information for specific tissues and species are widely lacking, notably for herbivorous species. We provide details on tissue-specific carbon and nitrogen discrimination and turn-over times from food to blood, feathers, claws, egg tissues and offspring down feathers in four species of herbivorous waterbirds. Source-to-tissue discrimination factors for carbon (delta C-13) and nitrogen stable isotope ratios (delta N-15) showed little variation across species but varied between tissues. Apparent discrimination factors ranged between -0.5 to 2.5 parts per thousand for delta C-13 and 2.8 to 5.2 parts per thousand for delta N-15, and were more similar between blood components than between keratinous tissues or egg tissue. Comparing these results with published data from other species we found no effect of foraging guild on discrimination factors for carbon but a significant foraging-guild effect for nitrogen discrimination factors. Turn-over of delta C-13 in tissues was most rapid in blood plasma, with a half-life of 4.3 d, whereas delta C-13 in blood cells had a half-life of approximately 32 d. Turn-over times for albumen and yolk in laying females were similar to those of blood plasma, at 3.2 and 6.0 d respectively. Within yolk, we found decreasing half-life times of delta C-13 from inner yolk (13.3 d) to outer yolk (3.1 d), related to the temporal pattern of tissue formation. We found similarities in tissue-specific turn-over times across all avian species studied to date. Yet, while generalities regarding discrimination factors and tissue turn-over times can be made, a large amount of variation remains unexplained.	[Hahn, Steffen] Swiss Ornithol Inst, Sempach, Switzerland; [Hahn, Steffen; Hoye, Bethany J.; Klaassen, Marcel] Netherlands Inst Ecol NIOO KNAW, Dept Anim Ecol, Wageningen, Netherlands; [Korthals, Harry] Netherlands Inst Ecol NIOO KNAW, Dept Aquat Ecol, Wageningen, Netherlands; [Klaassen, Marcel] Deakin Univ, Ctr Integrated Ecol, Geelong, Vic 3217, Australia	Swiss Ornithological Institute; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Deakin University	Hahn, S (corresponding author), Swiss Ornithol Inst, Sempach, Switzerland.	steffen.hahn@vogelwarte.ch	Klaassen, Marcel/B-4325-2008; Hoye, Bethany J/A-4486-2010; KNAW, NIOO-KNAW/A-4320-2012	Klaassen, Marcel/0000-0003-3907-9599; Hoye, Bethany J/0000-0001-9502-5582; Hahn, Steffen/0000-0002-4924-495X; KNAW, NIOO-KNAW/0000-0002-3835-159X	Research Council for Earth and Life Sciences (ALW) Netherlands Organization for Scientific Research (NWO) [851.30.003, 851.40.073]; German Research Council (DFG) [HA4437/1-1]	Research Council for Earth and Life Sciences (ALW) Netherlands Organization for Scientific Research (NWO); German Research Council (DFG)(German Research Foundation (DFG))	This study was supported by the Research Council for Earth and Life Sciences (ALW) with financial aid from the Netherlands Organization for Scientific Research (NWO; grants 851.30.003 and 851.40.073) and the German Research Council (DFG grant HA4437/1-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alisauskas Ray T., 1992, P30; Bauchinger U, 2009, PHYSIOL BIOCHEM ZOOL, V82, P787, DOI 10.1086/605548; Bearhop S, 2004, P ROY SOC B-BIOL SCI, V271, pS215, DOI 10.1098/rsbl.2003.0129; Bearhop S, 2003, FUNCT ECOL, V17, P270, DOI 10.1046/j.1365-2435.2003.00725.x; Bearhop S, 2002, PHYSIOL BIOCHEM ZOOL, V75, P451, DOI 10.1086/342800; Bocher P, 2000, MAR ECOL PROG SER, V208, P249, DOI 10.3354/meps208249; Bugoni L, 2008, RAPID COMMUN MASS SP, V22, P2457, DOI 10.1002/rcm.3633; Carleton SA, 2005, OECOLOGIA, V144, P226, DOI 10.1007/s00442-005-0066-8; Caut S, 2009, J APPL ECOL, V46, P443, DOI 10.1111/j.1365-2664.2009.01620.x; Cherel Y, 2005, ECOLOGY, V86, P2881, DOI 10.1890/05-0562; Dalerum F, 2005, OECOLOGIA, V144, P647, DOI 10.1007/s00442-005-0118-0; del Rio CM, 2009, BIOL REV, V84, P91, DOI 10.1111/j.1469-185X.2008.00064.x; Fox AD, 2009, J AVIAN BIOL, V40, P108, DOI 10.1111/j.1600-048X.2009.04720.x; Fry B., 2006, STABLE ISOTOPE ECOLO; Gannes LZ, 1998, COMP BIOCHEM PHYS A, V119, P725, DOI 10.1016/S1095-6433(98)01016-2; GROSSMAN EL, 1986, CHEM GEOL, V59, P59, DOI 10.1016/0168-9622(86)90057-6; Hahn S, 2011, J AVIAN BIOL, V42, P159, DOI 10.1111/j.1600-048X.2010.05189.x; HOBSON KA, 1992, CONDOR, V94, P181, DOI 10.2307/1368807; HOBSON KA, 1992, CONDOR, V94, P189, DOI 10.2307/1368808; Hobson KA, 2008, TERR ECOL SER, V2, P45, DOI 10.1016/S1936-7961(07)00003-6; Inger R, 2008, J AVIAN BIOL, V39, P704, DOI 10.1111/j.1600-048X.2008.04332.x; Karasov WH, 1990, STUDIES AVIAN BIOL, P391; Kear J., 1961, WILDFOWL, V14, P72; Klaassen M, 2010, FUNCT ECOL, V24, P796, DOI 10.1111/j.1365-2435.2010.01689.x; McCutchan JH, 2003, OIKOS, V102, P378, DOI 10.1034/j.1600-0706.2003.12098.x; MIZUTANI H, 1991, ISOTOPENPRAXIS, V27, P166, DOI 10.1080/10256019108622500; OWEN M, 1975, J WILDLIFE MANAGE, V39, P271, DOI 10.2307/3799903; Pearson SF, 2003, OECOLOGIA, V135, P516, DOI 10.1007/s00442-003-1221-8; Perga ME, 2010, J APPL ECOL, V47, P942, DOI 10.1111/j.1365-2664.2009.01730.x; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; Robbins CT, 2010, OECOLOGIA, V162, P571, DOI 10.1007/s00442-009-1485-8; Robbins CT, 2005, OECOLOGIA, V144, P534, DOI 10.1007/s00442-005-0021-8; ROUDYBUSH TE, 1979, CONDOR, V81, P293, DOI 10.2307/1367636; Sjogersten S, 2010, POLAR BIOL, V33, P1195, DOI 10.1007/s00300-010-0809-9; Smith AD, 2005, CONDOR, V107, P547, DOI 10.1650/0010-5422(2005)107[0547:VITSIC]2.0.CO;2; TIESZEN LL, 1983, OECOLOGIA, V57, P32, DOI 10.1007/BF00379558; Vanderklift MA, 2003, OECOLOGIA, V136, P169, DOI 10.1007/s00442-003-1270-z; Williams CT, 2007, OECOLOGIA, V153, P11, DOI 10.1007/s00442-007-0717-z	38	30	32	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2012	7	2							e30242	10.1371/journal.pone.0030242	http://dx.doi.org/10.1371/journal.pone.0030242			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UG	22312422	gold, Green Published, Green Submitted			2022-12-25	WOS:000301977500005
J	Incardona, JP; Vines, CA; Linbo, TL; Myers, MS; Sloan, CA; Anulacion, BF; Boyd, D; Collier, TK; Morgan, S; Cherr, GN; Scholz, NL				Incardona, John P.; Vines, Carol A.; Linbo, Tiffany L.; Myers, Mark S.; Sloan, Catherine A.; Anulacion, Bernadita F.; Boyd, Daryle; Collier, Tracy K.; Morgan, Steven; Cherr, Gary N.; Scholz, Nathaniel L.			Potent Phototoxicity of Marine Bunker Oil to Translucent Herring Embryos after Prolonged Weathering	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; PRINCE-WILLIAM-SOUND; EXXON-VALDEZ OIL; CRUDE-OIL; PHOTOINDUCED TOXICITY; ULTRAVIOLET-RADIATION; FATHEAD MINNOW; DAPHNIA-MAGNA; FISH EMBRYOS; CELL-LINE	Pacific herring embryos (Clupea pallasi) spawned three months following the Cosco Busan bunker oil spill in San Francisco Bay showed high rates of late embryonic mortality in the intertidal zone at oiled sites. Dead embryos developed to the hatching stage (e. g. fully pigmented eyes) before suffering extensive tissue deterioration. In contrast, embryos incubated subtidally at oiled sites showed evidence of sublethal oil exposure (petroleum-induced cardiac toxicity) with very low rates of mortality. These field findings suggested an enhancement of oil toxicity through an interaction between oil and another environmental stressor in the intertidal zone, such as higher levels of sunlight-derived ultraviolet (UV) radiation. We tested this hypothesis by exposing herring embryos to both trace levels of weathered Cosco Busan bunker oil and sunlight, with and without protection from UV radiation. Cosco Busan oil and UV co-exposure were both necessary and sufficient to induce an acutely lethal necrotic syndrome in hatching stage embryos that closely mimicked the condition of dead embryos sampled from oiled sites. Tissue levels of known phototoxic polycyclic aromatic compounds were too low to explain the observed degree of phototoxicity, indicating the presence of other unidentified or unmeasured phototoxic compounds derived from bunker oil. These findings provide a parsimonious explanation for the unexpectedly high losses of intertidal herring spawn following the Cosco Busan spill. The chemical composition and associated toxicity of bunker oils should be more thoroughly evaluated to better understand and anticipate the ecological impacts of vessel-derived spills associated with an expanding global transportation network.	[Incardona, John P.; Linbo, Tiffany L.; Myers, Mark S.; Sloan, Catherine A.; Anulacion, Bernadita F.; Boyd, Daryle; Collier, Tracy K.; Scholz, Nathaniel L.] NOAA, NW Fisheries Sci Ctr, Environm Conservat Div, Seattle, WA USA; [Vines, Carol A.; Morgan, Steven; Cherr, Gary N.] Univ Calif Davis, Bodega Marine Lab, Bodega Bay, CA 94923 USA; [Cherr, Gary N.] Univ Calif Davis, Dept Environm Toxicol, Davis, CA 95616 USA; [Cherr, Gary N.] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA	National Oceanic Atmospheric Admin (NOAA) - USA; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Incardona, JP (corresponding author), NOAA, NW Fisheries Sci Ctr, Environm Conservat Div, Seattle, WA USA.	john.incardona@noaa.gov	Scholz, Nathaniel L/L-1642-2013; Morgan, Steven G/GXG-5459-2022	Scholz, Nathaniel L/0000-0001-6207-0272; 	Natural Resource Damage Assessment process; Cosco Busan oil spill Responsible Party by Federal and California State	Natural Resource Damage Assessment process; Cosco Busan oil spill Responsible Party by Federal and California State	All funding for this work was provided by the Natural Resource Damage Assessment process, obtained from the Cosco Busan oil spill Responsible Party by Federal and California State co-Trustees under the authority of the US Clean Water and Oil Pollution Acts. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arfsten DP, 1996, ECOTOX ENVIRON SAFE, V33, P1, DOI 10.1006/eesa.1996.0001; Barron MG, 2003, ENVIRON TOXICOL CHEM, V22, P650, DOI 10.1002/etc.5620220326; Carls MG, 1999, ENVIRON TOXICOL CHEM, V18, P481, DOI 10.1002/etc.5620180317; Carls MG, 2003, MAR ECOL PROG SER, V248, P245, DOI 10.3354/meps248245; Diamond SA, 2003, COMP SER PHOTOCHEM, V1, P219; Diamond SA, 2006, ENVIRON TOXICOL CHEM, V25, P3015, DOI 10.1897/06-038R.1; Dinnel P, 2008, DEV LARVAL PACIFIC H; Fathalla EM, 2011, ENVIRON TOXICOL CHEM, V30, P2004, DOI 10.1002/etc.607; Frysinger GS, 2003, ENVIRON SCI TECHNOL, V37, P1653, DOI 10.1021/es020742n; Griffin FJ, 1998, BIOL BULL, V194, P25, DOI 10.2307/1542510; Grove AD, 2000, TOXICOL APPL PHARM, V162, P34, DOI 10.1006/taap.1999.8815; HALL AT, 1991, AQUAT TOXICOL, V19, P249; Hatlen K, 2010, AQUAT TOXICOL, V99, P56, DOI 10.1016/j.aquatox.2010.04.002; Hicken CE, 2011, P NATL ACAD SCI USA, V108, P7086, DOI 10.1073/pnas.1019031108; Incardona JP, 2009, ENVIRON SCI TECHNOL, V43, P201, DOI 10.1021/es802270t; Incardona JP, 2005, ENVIRON HEALTH PERSP, V113, P1755, DOI 10.1289/ehp.8230; Incardona JP, 2004, TOXICOL APPL PHARM, V196, P191, DOI 10.1016/j.taap.2003.11.026; Incardona JP, 2011, P NATL ACAD IN PRESS; KAGAN J, 1987, CHEMOSPHERE, V16, P2417, DOI 10.1016/0045-6535(87)90300-6; Lampi MA, 2006, ENVIRON TOXICOL CHEM, V25, P1079, DOI 10.1897/05-276R.1; Linbo T. L., 2009, NMFSNWFSC100 NOAA US; Mallakin A, 2000, CHEMOSPHERE, V40, P1435, DOI 10.1016/S0045-6535(99)00331-8; Marty GD, 1997, CAN J FISH AQUAT SCI, V54, P1846, DOI 10.1139/cjfas-54-8-1846; Marty GD, 1997, CAN J ZOOL, V75, P989, DOI 10.1139/z97-120; Matsunaga T, 2010, TOXICOLOGY, V268, P191, DOI 10.1016/j.tox.2009.12.015; MCCLOSKEY JT, 1993, AQUAT TOXICOL, V24, P207, DOI 10.1016/0166-445X(93)90072-9; MEKENYAN OG, 1994, CHEMOSPHERE, V28, P567, DOI 10.1016/0045-6535(94)90299-2; NEWSTED JL, 1987, ENVIRON TOXICOL CHEM, V6, P445; ORIS JT, 1987, CHEMOSPHERE, V16, P1395, DOI 10.1016/0045-6535(87)90079-8; Peters ZJ, 2007, REPROD TOXICOL, V23, P513, DOI 10.1016/j.reprotox.2007.01.008; Rowland SJ, 2011, RAPID COMMUN MASS SP, V25, P1741, DOI 10.1002/rcm.5040; Schirmer K, 1998, TOXICOLOGY, V127, P143, DOI 10.1016/S0300-483X(98)00031-6; Short JW, 1997, ENVIRON SCI TECHNOL, V31, P2375, DOI 10.1021/es960985d; Sloan CA., 2005, TECHNIQUES AQUATIC T, P631, DOI 10.1201/9780203501597.CH35; Weinstein JE, 1997, AQUAT TOXICOL, V39, P1, DOI 10.1016/S0166-445X(97)00018-0; Yu HT, 2002, J ENVIRON SCI HEAL C, V20, P149, DOI 10.1081/GNC-120016203	36	39	39	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2012	7	2							e30116	10.1371/journal.pone.0030116	http://dx.doi.org/10.1371/journal.pone.0030116			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UG	22312421	Green Published, gold, Green Submitted			2022-12-25	WOS:000301977500004
J	Al-Hashmi, S; Boels, PJM; Zadjali, F; Sadeghi, B; Sallstrom, J; Hultenby, K; Hassan, Z; Arner, A; Hassan, M				Al-Hashmi, Sulaiman; Boels, Piet J. M.; Zadjali, Fahad; Sadeghi, Behnam; Sallstrom, Johan; Hultenby, Kjell; Hassan, Zuzana; Arner, Anders; Hassan, Moustapha			Busulphan-Cyclophosphamide Cause Endothelial Injury, Remodeling of Resistance Arteries and Enhanced Expression of Endothelial Nitric Oxide Synthase	PLOS ONE			English	Article							STEM-CELL TRANSPLANTATION; BONE-MARROW-TRANSPLANTATION; INDUCED HEMORRHAGIC CYSTITIS; TOTAL-BODY IRRADIATION; OF-THE-ART; CARDIAC TOXICITY; CARDIOVASCULAR-DISEASE; CANCER-THERAPY; HEART-FAILURE; COMPLICATIONS	Stem cell transplantation (SCT) is a curative treatment for malignant and non malignant diseases. However, transplantation-related complications including cardiovascular disease deteriorate the clinical outcome and quality of life. We have investigated the acute effects of conditioning regimen on the pharmacology, physiology and structure of large elastic arteries and small resistance-sized arteries in a SCT mouse model. Mesenteric resistance arteries and aorta were dissected from Balb/c mice conditioned with busulphan (Bu) and cyclophosphamide (Cy). In vitro isometric force development and pharmacology, in combination with RT-PCR, Western blotting and electron microscopy were used to study vascular properties. Compared with controls, mesenteric resistance arteries from the Bu-Cy group had larger internal circumference, showed enhanced endothelium mediated relaxation and increased expression of endothelial nitric oxide synthase (eNOS). Bu-Cy treated animals had lower mean blood pressure and signs of endothelial injury. Aortas of treated animals had a higher reactivity to noradrenaline. We conclude that short-term consequences of Bu-Cy treatment divergently affect large and small arteries of the cardiovascular system. The increased noradrenaline reactivity of large elastic arteries was not associated with increased blood pressure at rest. Instead, Bu-Cy treatment lowered blood pressure via augmented microvascular endothelial dependent relaxation, increased expression of vascular eNOS and remodeling toward a larger lumen. The changes in the properties of resistance arteries can be associated with direct effects of the compounds on vascular wall or possibly indirectly induced via altered translational activity associated with the reduced hematocrit and shear stress. This study contributes to understanding the mechanisms that underlie the early effects of conditioning regimen on resistance arteries and may help in designing further investigations to understand the late effects on vascular system.	[Al-Hashmi, Sulaiman; Hultenby, Kjell] Karolinska Inst, Dept Lab Med, EMIL, Stockholm, Sweden; [Boels, Piet J. M.; Sallstrom, Johan; Arner, Anders] 3Ph S Biomed, Stockholm, Sweden; [Boels, Piet J. M.] Karolinska Inst, Dept Physiol & Pharmacol, Div Genet Physiol, Stockholm, Sweden; [Zadjali, Fahad] Karolinska Inst, CMM, Dept Mol Med & Surg MMK, Stockholm, Sweden; [Hassan, Zuzana; Hassan, Moustapha] Karolinska Univ Hosp Huddinge, Clinincal Res Ctr, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Al-Hashmi, S (corresponding author), Karolinska Inst, Dept Lab Med, EMIL, Stockholm, Sweden.	moustapha.hassan@ki.se	Hassan, Moustapha/H-9260-2015; Sadeghi, Behnam/AAH-1221-2019; ZADJALI, FAHAD/B-5091-2019	Hassan, Moustapha/0000-0003-1927-5859; Sadeghi, Behnam/0000-0002-8721-0400; ZADJALI, FAHAD/0000-0001-5891-4700	Swedish Cancer Foundation; Swedish Children Cancer Society; Swedish Research Council; Swedish Heart-Lung Foundation; The Karolinska Institutet	Swedish Cancer Foundation; Swedish Children Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); The Karolinska Institutet(Karolinska Institutet)	This work was supported by the Swedish Cancer Foundation, Swedish Children Cancer Society, Swedish Research Council, and Swedish Heart-Lung Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The study was designed in an academic institution without infleuces of any commercial source. The grants were handed to The Karolinska Institutet and were used in buying materials, animals and antibodies. 3Ph_S Biomedical, Sweden is the new address of Dr. Boels, however, the whole study was conducted at the Department of Physiology and Pharmacology at the Karolinska Institutet, where Dr. Boels is employed. 3Ph_S Biomedical, Sweden is an academic consulting orgnization without any economic interest.	Agabiti-Rosei E, 2007, HYPERTENSION, V50, P154, DOI 10.1161/HYPERTENSIONAHA.107.090068; Al-Hashmi S, 2011, INT J CLIN EXP PATHO, V4, P596; Albini A, 2010, JNCI-J NATL CANCER I, V102, P14, DOI 10.1093/jnci/djp440; Antoniades C, 2011, CIRCULATION, V124, P1860, DOI 10.1161/CIRCULATIONAHA.111.029272; Armenian SH, 2008, HAEMATOL-HEMATOL J, V93, P1132, DOI 10.3324/haematol.13514; Armenian SH, 2008, J CLIN ONCOL, V26, P5537, DOI 10.1200/JCO.2008.17.7428; AYASH LJ, 1992, J CLIN ONCOL, V10, P995, DOI 10.1200/JCO.1992.10.6.995; BEARMAN SI, 1990, BONE MARROW TRANSPL, V5, P173; BERTHOU C, 1991, BRIT J HAEMATOL, V79, P335, DOI 10.1111/j.1365-2141.1991.tb04543.x; BOELS PJ, 1994, PFLUG ARCH EUR J PHY, V426, P506, DOI 10.1007/BF00378528; Bunin N, 2003, BONE MARROW TRANSPL, V32, P543, DOI 10.1038/sj.bmt.1704198; Busse D, 1998, Pharm Unserer Zeit, V27, P216, DOI 10.1002/pauz.19980270507; CAZIN B, 1986, CANCER, V57, P2061, DOI 10.1002/1097-0142(19860515)57:10<2061::AID-CNCR2820571031>3.0.CO;2-H; Cho Kun Hyun, 2010, Int Neurourol J, V14, P149, DOI 10.5213/inj.2010.14.3.149; Clapp BR, 2005, CIRCULATION, V111, P1530, DOI 10.1161/01.CIR.0000159336.31613.31; DOLL DC, 1992, SEMIN ONCOL, V19, P580; Doll Donald C., 1994, Current Opinion in Oncology, V6, P345, DOI 10.1097/00001622-199407000-00004; Ferry C, 2003, EXP HEMATOL, V31, P1182, DOI 10.1016/j.exphem.2003.09.008; Ghobrial IM, 2004, MAYO CLIN PROC, V79, P403, DOI 10.4065/79.3.403; GOLDBERG MA, 1986, BLOOD, V68, P1114; Gupta T, 2011, Hematol Oncol Stem Cell Ther, V4, P17; Gyurkocza B, 2010, EXPERT REV HEMATOL, V3, P285, DOI 10.1586/EHM.10.21; Hassan M, 1996, LEUKEMIA LYMPHOMA, V22, P395, DOI 10.3109/10428199609054777; Jenq RR, 2010, NAT REV CANCER, V10, P213, DOI 10.1038/nrc2804; Kanagy NL, 2003, J CARDIOVASC PHARM, V42, P527, DOI 10.1097/00005344-200310000-00011; Kaul DK, 2000, AM J PHYSIOL-HEART C, V278, pH1799, DOI 10.1152/ajpheart.2000.278.6.H1799; Korkmaz A, 2007, CELL BIOL TOXICOL, V23, P303, DOI 10.1007/s10565-006-0078-0; Limsuwan A, 2006, CARDIOLOGY, V105, P188, DOI 10.1159/000091638; Luznik L, 2010, BLOOD; Luznik L, 2010, IMMUNOL RES; Majhail NS, 2009, BIOL BLOOD MARROW TR, V15, P1100, DOI 10.1016/j.bbmt.2009.05.010; Molyneux G, 2011, CELL BIOL TOXICOL, V27, P13, DOI 10.1007/s10565-010-9167-1; MOREAU P, 1995, STROKE, V26, P1922, DOI 10.1161/01.STR.26.10.1922; Mulvany MJ, 2008, MED BIOL ENG COMPUT, V46, P461, DOI 10.1007/s11517-008-0305-3; Mulvany MJ, 2002, NEWS PHYSIOL SCI, V17, P105, DOI 10.1152/nips.01366.2001; Murdych T, 2001, BONE MARROW TRANSPL, V28, P283, DOI 10.1038/sj.bmt.1703133; Naik S, 2011, BONE MARROW TRANSPL, V46, P192, DOI 10.1038/bmt.2010.114; Oter S, 2004, UROL RES, V32, P185, DOI 10.1007/s00240-003-0398-y; Park CB, 2007, CELL, V130, P273, DOI 10.1016/j.cell.2007.05.046; PATEL JM, 1993, TOXICOL APPL PHARM, V122, P46, DOI 10.1006/taap.1993.1170; Perry TE, 2009, CARDIOVASC RES, V84, P317, DOI 10.1093/cvr/cvp215; Peterson L, 1966, PHYS FACTORS WHICH I; Pries AR, 1996, CARDIOVASC RES, V32, P654, DOI 10.1016/S0008-6363(96)00065-X; Ringden O, 2005, APMIS, V113, P813, DOI 10.1111/j.1600-0463.2005.apm_336.x; Rosei EA, 2005, CURR HYPERTENS REP, V7, P79, DOI 10.1007/s11906-005-0077-1; Sadeghi B, 2008, BONE MARROW TRANSPL, V42, P807, DOI 10.1038/bmt.2008.261; Sadeghi B, 2010, CLIN DEV IMMUNOL, DOI 10.1155/2010/142943; SANTOS GW, 1989, BONE MARROW TRANSPL, V4, P236; SANTOS GW, 1971, TRANSPLANT P, V3, P400; Senkus E, 2011, CANCER TREAT REV, V37, P300, DOI 10.1016/j.ctrv.2010.11.001; Shesely EG, 1996, P NATL ACAD SCI USA, V93, P13176, DOI 10.1073/pnas.93.23.13176; Sohn SK, 2003, BRIT J HAEMATOL, V121, P469, DOI 10.1046/j.1365-2141.2003.04288.x; Spiers A, 2005, METH MOLEC MED, V108, P91; STORB R, 1970, CANCER RES, V30, P2195; STUMPE KO, 1995, AM J CARDIOL, V76, pE50, DOI 10.1016/S0002-9149(99)80505-0; Takatsuka H, 2000, BONE MARROW TRANSPL, V26, P419, DOI 10.1038/sj.bmt.1702517; TERPSTRA W, 1989, NETH J MED, V35, P249; Tichelli A, 2008, BRIT J HAEMATOL, V142, P11, DOI 10.1111/j.1365-2141.2008.07165.x; Tichelli A, 2008, HAEMATOL-HEMATOL J, V93, P1203, DOI 10.3324/haematol.12949; Tichelli A, 2007, BLOOD, V110, P3463, DOI 10.1182/blood-2006-10-054080; Uderzo C, 2009, PEDIATR TRANSPLANT, V13, P719, DOI 10.1111/j.1399-3046.2008.01055.x; Wang XQ, 1999, HYPERTENSION, V33, P894, DOI 10.1161/01.HYP.33.3.894; Wang XF, 2009, EUR J HEART FAIL, V11, P154, DOI 10.1093/eurjhf/hfn012; Yeh ETH, 2004, CIRCULATION, V109, P3122, DOI 10.1161/01.CIR.0000133187.74800.B9; Zeng L, 2008, TRANSPL P, V40, P2670, DOI 10.1016/j.transproceed.2008.06.038; Zeng L, 2010, TRANSPL P, V42, P2720, DOI 10.1016/j.transproceed.2010.04.024; Zver S, 2007, INT J HEMATOL, V85, P408, DOI 10.1532/IJH97.E0620	67	19	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2012	7	1							e30897	10.1371/journal.pone.0030897	http://dx.doi.org/10.1371/journal.pone.0030897			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911GB	22303468	gold, Green Submitted, Green Published			2022-12-25	WOS:000301704200044
J	Liu, Y; Semina, EV				Liu, Yi; Semina, Elena V.			pitx2 Deficiency Results in Abnormal Ocular and Craniofacial Development in Zebrafish	PLOS ONE			English	Article							AXENFELD-RIEGER-SYNDROME; LEFT-RIGHT ASYMMETRY; FETAL VASCULATURE PFV; NEURAL CREST SURVIVAL; HOMEOBOX GENE PITX2; RETINAL VASCULATURE; HYALOID VASCULATURE; TOOTH MORPHOGENESIS; CELL-DEATH; EXPRESSION	Human PITX2 mutations are associated with Axenfeld-Rieger syndrome, an autosomal-dominant developmental disorder that involves ocular anterior segment defects, dental hypoplasia, craniofacial dysmorphism and umbilical abnormalities. Characterization of the PITX2 pathway and identification of the mechanisms underlying the anomalies associated with PITX2 deficiency is important for better understanding of normal development and disease; studies of pitx2 function in animal models can facilitate these analyses. A knockdown of pitx2 in zebrafish was generated using a morpholino that targeted all known alternative transcripts of the pitx2 gene; morphant embryos generated with the pitx2(ex4/5) splicing-blocking oligomer produced abnormal transcripts predicted to encode truncated pitx2 proteins lacking the third (recognition) helix of the DNA-binding homeodomain. The morphological phenotype of pitx2(ex4/5) morphants included small head and eyes, jaw abnormalities and pericardial edema; lethality was observed at similar to 6-8-dpf. Cartilage staining revealed a reduction in size and an abnormal shape/position of the elements of the mandibular and hyoid pharyngeal arches; the ceratobranchial arches were also decreased in size. Histological and marker analyses of the misshapen eyes of the pitx2(ex4/5) morphants identified anterior segment dysgenesis and disordered hyaloid vasculature. In summary, we demonstrate that pitx2 is essential for proper eye and craniofacial development in zebrafish and, therefore, that PITX2/pitx2 function is conserved in vertebrates.	[Liu, Yi; Semina, Elena V.] Med Coll Wisconsin, Dept Pediat, Milwaukee, WI 53226 USA; [Liu, Yi; Semina, Elena V.] Med Coll Wisconsin, Childrens Res Inst, Milwaukee, WI 53226 USA; [Liu, Yi; Semina, Elena V.] Childrens Hosp Wisconsin, Milwaukee, WI 53201 USA; [Semina, Elena V.] Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA	Medical College of Wisconsin; Medical College of Wisconsin; Children's Hospital of Wisconsin; Medical College of Wisconsin	Liu, Y (corresponding author), Shandong Acad Med Sci, Shandong Med Biotechnol Ctr, Jinan, Peoples R China.	esemina@mcw.edu			National Institutes of Health [EY015518]; NATIONAL EYE INSTITUTE [R01EY015518] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the National Institutes of Health award EY015518 (EVS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez Y, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-114; Arikawa A, 2010, EYE, V24, P391, DOI 10.1038/eye.2009.114; Bamforth SD, 2004, NAT GENET, V36, P1189, DOI 10.1038/ng1446; Barrallo-Gimeno A, 2004, DEVELOPMENT, V131, P1463, DOI 10.1242/dev.01033; Bisgrove BW, 2000, DEVELOPMENT, V127, P3567; Bredrup C, 2008, AM J OPHTHALMOL, V146, P602, DOI 10.1016/j.ajo.2008.05.039; Campione M, 1999, DEVELOPMENT, V126, P1225; Campione M, 2001, DEV BIOL, V231, P252, DOI 10.1006/dbio.2000.0133; Chang B, 2001, BMC GENET, V2, DOI 10.1186/1471-2156-2-18; Chen JY, 2001, BIOCHEM BIOPH RES CO, V285, P105, DOI 10.1006/bbrc.2001.5099; Chen Y, 2008, DEVELOPMENT, V135, P2939, DOI 10.1242/dev.021097; Christiaen L, 2005, DEV BIOL, V277, P557, DOI 10.1016/j.ydbio.2004.10.008; Cox CJ, 2002, J BIOL CHEM, V277, P25001, DOI 10.1074/jbc.M201737200; Dahlman JM, 2005, MOL VIS, V11, P88; Dhingra S, 2006, BRIT J OPHTHALMOL, V90, P1324, DOI 10.1136/bjo.2005.088625; Edwards MM, 2010, J BIOL CHEM, V285, P7697, DOI 10.1074/jbc.M109.069575; Ekker SC, 2008, ZEBRAFISH, V5, P121, DOI 10.1089/zeb.2008.9988; Espinoza HM, 2002, HUM MOL GENET, V11, P743, DOI 10.1093/hmg/11.7.743; Essner JJ, 2000, DEVELOPMENT, V127, P1081; Evans AL, 2005, HUM MOL GENET, V14, P3347, DOI 10.1093/hmg/ddi365; Gage PJ, 2008, DEV BIOL, V317, P310, DOI 10.1016/j.ydbio.2008.02.030; Gage PJ, 1999, DEVELOPMENT, V126, P4643; Goldberg MF, 1997, AM J OPHTHALMOL, V124, P587, DOI 10.1016/S0002-9394(14)70899-2; HADDAD R, 1978, SURV OPHTHALMOL, V23, P123, DOI 10.1016/0039-6257(78)90091-7; Hjalt Tord A., 2005, Expert Reviews in Molecular Medicine, V7, P1, DOI 10.1017/S1462399405010082; Ishimaru Y, 2008, DEVELOPMENT, V135, P677, DOI 10.1242/dev.012856; Ito M, 1999, ANAT EMBRYOL, V200, P403, DOI 10.1007/s004290050289; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kitamura K, 1999, DEVELOPMENT, V126, P5749; Kleinjan DA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040029; Kraus P, 2006, AM J MED GENET A, V140A, P1366, DOI 10.1002/ajmg.a.31252; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Lieschke GJ, 2007, NAT REV GENET, V8, P353, DOI 10.1038/nrg2091; Lin CR, 1999, NATURE, V401, P279, DOI 10.1038/45803; Lister JA, 2006, DEV BIOL, V290, P92, DOI 10.1016/j.ydbio.2005.11.014; Liu CQ, 2008, DEVELOPMENT, V135, P3567, DOI 10.1242/dev.028076; Liu W, 2003, DEVELOPMENT, V130, P6375, DOI 10.1242/dev.00849; Lobov IB, 2005, NATURE, V437, P417, DOI 10.1038/nature03928; Lu MF, 1999, NATURE, V401, P276, DOI 10.1038/45797; Martin DM, 2004, DEV BIOL, V267, P93, DOI 10.1016/j.ydbio.2003.10.035; Nelms BL, 2010, TRANSCRIPTIONAL CONT, P227; Piotrowski T, 1996, DEVELOPMENT, V123, P345; Richter M, 1998, INVEST OPHTH VIS SCI, V39, P2450; Robitaille JM, 2009, OPHTHALMIC GENET, V30, P23, DOI 10.1080/13816810802464312; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Rutland CS, 2007, MOL VIS, V13, P47; Ryan AK, 1998, NATURE, V394, P545, DOI 10.1038/29004; Schweickert A, 2000, MECH DEVELOP, V90, P41, DOI 10.1016/S0925-4773(99)00227-0; Semina EV, 2006, DEV BIOL, V299, P63, DOI 10.1016/j.ydbio.2006.07.005; Semina EV, 1996, NAT GENET, V14, P392, DOI 10.1038/ng1296-392; Shi XH, 2005, MECH DEVELOP, V122, P513, DOI 10.1016/j.mod.2004.11.012; Silbert, 2000, Clin Eye Vis Care, V12, P131, DOI 10.1016/S0953-4431(00)00054-0; Sperber SM, 2008, DEV BIOL, V314, P59, DOI 10.1016/j.ydbio.2007.11.005; Toro R, 2004, J BIOL CHEM, V279, P52087, DOI 10.1074/jbc.M404802200; Tumer Z, 2009, EUR J HUM GENET, V17, P1527, DOI 10.1038/ejhg.2009.93; Volkmann BA, 2011, INVEST OPHTH VIS SCI, V52, P1450, DOI 10.1167/iovs.10-6060; Yoshikawa S, 2007, DEV DYNAM, V236, P1929, DOI 10.1002/dvdy.21197; Yu XY, 2001, DEVELOPMENT, V128, P1005; Zhang JM, 2008, INVEST OPHTH VIS SCI, V49, P5561, DOI 10.1167/iovs.08-2226; Zhao XPC, 2006, INVEST OPHTH VIS SCI, V47, P4341, DOI 10.1167/iovs.05-1611; Zhu MD, 2000, EXP EYE RES, V70, P767, DOI 10.1006/exer.2000.0844; Zilinski CA, 2005, GENESIS, V41, P33, DOI 10.1002/gene.20094	62	29	31	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2012	7	1							e30896	10.1371/journal.pone.0030896	http://dx.doi.org/10.1371/journal.pone.0030896			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911GB	22303467	Green Submitted, Green Published, gold			2022-12-25	WOS:000301704200043
J	Makarevitch, I; Thompson, A; Muehlbauer, GJ; Springer, NM				Makarevitch, Irina; Thompson, Addie; Muehlbauer, Gary J.; Springer, Nathan M.			Brd1 Gene in Maize Encodes a Brassinosteroid C-6 Oxidase	PLOS ONE			English	Article							RICE DWARF MUTANT; FUNCTIONAL-ANALYSIS; PLANT DEVELOPMENT; BIOSYNTHESIS; ARABIDOPSIS; CYTOCHROME-P450; MODULATORS; HOMOLOG; ENZYME	The role of brassinosteroids in plant growth and development has been well-characterized in a number of plant species. However, very little is known about the role of brassinosteroids in maize. Map-based cloning of a severe dwarf mutant in maize revealed a nonsense mutation in an ortholog of a brassinosteroid C-6 oxidase, termed brd1, the gene encoding the enzyme that catalyzes the final steps of brassinosteroid synthesis. Homozygous brd1-m1 maize plants have essentially no internode elongation and exhibit no etiolation response when germinated in the dark. These phenotypes could be rescued by exogenous application of brassinolide, confirming the molecular defect in the maize brd1-m1 mutant. The brd1-m1 mutant plants also display alterations in leaf and floral morphology. The meristem is not altered in size but there is evidence for differences in the cellular structure of several tissues. The isolation of a maize mutant defective in brassinosteroid synthesis will provide opportunities for the analysis of the role of brassinosteroids in this important crop system.	[Makarevitch, Irina] Hamline Univ, Dept Biol, St Paul, MN 55104 USA; [Thompson, Addie; Muehlbauer, Gary J.] Univ Minnesota, Dept Agron & Plant Genet, St Paul, MN USA; [Springer, Nathan M.] Univ Minnesota, Microbial & Plant Genom Inst, St Paul, MN 55108 USA; [Springer, Nathan M.] Univ Minnesota, Dept Plant Biol, St Paul, MN USA	Mitchell Hamline School of Law; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Makarevitch, I (corresponding author), Hamline Univ, Dept Biol, St Paul, MN 55104 USA.	imakarevitch01@hamline.edu	Springer, Nathan/F-2680-2013	Springer, Nathan/0000-0002-7301-4759; Thompson, Addie/0000-0002-4442-6578	National Science Foundation [IOS-0922095, DBI-0820610]; National Science Foundation (MRI) [0957312]; Hamline Biology Department	National Science Foundation(National Science Foundation (NSF)); National Science Foundation (MRI)(National Science Foundation (NSF)); Hamline Biology Department	This research was supported by a grant from the National Science Foundation to NMS and IM (IOS-0922095), a grant from the National Science Foundation to GJM (DBI-0820610), a grant from the National Science Foundation to IM (MRI #0957312), and the Lund Fund from Hamline Biology Department. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENSEN RJ, 1995, PLANT CELL, V7, P75, DOI 10.1105/tpc.7.1.75; Bishop GJ, 1999, P NATL ACAD SCI USA, V96, P1761, DOI 10.1073/pnas.96.4.1761; Clouse SD, 2011, PLANT CELL, V23, P1219, DOI 10.1105/tpc.111.084475; Fernandez MGS, 2009, TRENDS PLANT SCI, V14, P454, DOI 10.1016/j.tplants.2009.06.005; Fu Y, 2006, GENETICS, V174, P1671, DOI 10.1534/genetics.106.060376; Fujioka S, 2003, ANNU REV PLANT BIOL, V54, P137, DOI 10.1146/annurev.arplant.54.031902.134921; Gendron JM, 2007, CURR OPIN PLANT BIOL, V10, P436, DOI 10.1016/j.pbi.2007.08.015; Hartwig T, 2011, P NATL ACAD SCI USA, V108, P19814, DOI 10.1073/pnas.1108359108; Hong Z, 2005, PLANT CELL, V17, P2243, DOI 10.1105/tpc.105.030973; Hong Z, 2003, PLANT CELL, V15, P2900, DOI 10.1105/tpc.014712; Hong Z, 2002, PLANT J, V32, P495, DOI 10.1046/j.1365-313X.2002.01438.x; Jager CE, 2007, PLANT PHYSIOL, V143, P1894, DOI 10.1104/pp.106.093088; Kim YS, 2005, PHYTOCHEMISTRY, V66, P1000, DOI 10.1016/j.phytochem.2005.03.007; Lawit SJ, 2010, PLANT CELL PHYSIOL, V51, P1854, DOI 10.1093/pcp/pcq153; Li JM, 2007, TRENDS PLANT SCI, V12, P37, DOI 10.1016/j.tplants.2006.11.002; Liu SZ, 2010, GENETICS, V184, P19, DOI 10.1534/genetics.109.107557; Liu TS, 2007, PLANT CELL REP, V26, P2091, DOI 10.1007/s00299-007-0418-4; Mori M, 2002, PLANT PHYSIOL, V130, P1152, DOI 10.1104/pp.007179; Nelson DR, 1996, PHARMACOGENETICS, V6, P1, DOI 10.1097/00008571-199602000-00002; Neuffer MG, 1997, MUTANTS MAIZE; Peng JR, 1999, NATURE, V400, P256, DOI 10.1038/22307; Rozen S, 2000, Methods Mol Biol, V132, P365; Ruzin S.E., 1999, PLANT MICROTECHNIQUE; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Schultz L, 2001, PLANT MOL BIOL, V47, P491, DOI 10.1023/A:1011894812794; Sekhon RS, 2011, PLANT J, V66, P553, DOI 10.1111/j.1365-313X.2011.04527.x; Shimada Y, 2001, PLANT PHYSIOL, V126, P770, DOI 10.1104/pp.126.2.770; Tanabe S, 2005, PLANT CELL, V17, P776, DOI 10.1105/tpc.104.024950; Tao YZ, 2004, PLANT SCI, V167, P743, DOI 10.1016/j.plantsci.2004.05.012; Till Bradley J., 2004, BMC Plant Biology, V4, P12, DOI 10.1186/1471-2229-4-12; WINKLER RG, 1995, PLANT CELL, V7, P1307, DOI 10.1105/tpc.7.8.1307	31	92	105	7	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2012	7	1							e30798	10.1371/journal.pone.0030798	http://dx.doi.org/10.1371/journal.pone.0030798			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911FX	22292043	Green Published, gold, Green Submitted			2022-12-25	WOS:000301703800031
J	Songok, EM; Luo, M; Liang, B; Mclaren, P; Kaefer, N; Apidi, W; Boucher, G; Kimani, J; Wachihi, C; Sekaly, R; Fowke, K; Ball, BT; Plummer, FA				Songok, Elijah M.; Luo, Ma; Liang, Ben; Mclaren, Paul; Kaefer, Nadine; Apidi, Winnie; Boucher, Genevieve; Kimani, Joshua; Wachihi, Charles; Sekaly, Rafick; Fowke, Keith; Ball, Blake T.; Plummer, Francis A.			Microarray Analysis of HIV Resistant Female Sex Workers Reveal a Gene Expression Signature Pattern Reminiscent of a Lowered Immune Activation State	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; DIPEPTIDYL-PEPTIDASE-IV; PERIPHERAL T-CELLS; IN-VITRO; HIV-1-INFECTED INDIVIDUALS; INFECTION; LYMPHOCYTES; MUCOSAL; CD26; CD4	To identify novel biomarkers for HIV-1 resistance, including pathways that may be critical in anti-HIV-1 vaccine design, we carried out a gene expression analysis on blood samples obtained from HIV-1 highly exposed seronegatives (HESN) from a commercial sex worker cohort in Nairobi and compared their profiles to HIV-1 negative controls. Whole blood samples were collected from 43 HIV-1 resistant sex workers and a similar number of controls. Total RNA was extracted and hybridized to the Affymetrix HUG 133 Plus 2.0 micro arrays (Affymetrix, Santa Clara CA). Output data was analysed through ArrayAssist software (Agilent, San Jose CA). More than 2,274 probe sets were differentially expressed in the HESN as compared to the control group (fold change >= 1.3; p value <= 0.0001, FDR <0.05). Unsupervised hierarchical clustering of the differentially expressed genes readily distinguished HESNs from controls. Pathway analysis through the KEGG signaling database revealed a majority of the impacted pathways (13 of 15, 87%) had genes that were significantly down regulated. The most down expressed pathways were glycolysis/gluconeogenesis, pentose phosphate, phosphatidyl inositol, natural killer cell cytotoxicity and T-cell receptor signaling. Ribosomal protein synthesis and tight junction genes were up regulated. We infer that the hallmark of HIV-1 resistance is down regulation of genes in key signaling pathways that HIV-1 depends on for infection.	[Songok, Elijah M.] Kenya Govt Med Res Ctr, Nairobi, Kenya; [Songok, Elijah M.; Luo, Ma; Mclaren, Paul; Kaefer, Nadine; Apidi, Winnie; Kimani, Joshua; Fowke, Keith; Ball, Blake T.; Plummer, Francis A.] Kenya Govt Med Res Ctr, Nairobi, Kenya; [Boucher, Genevieve; Sekaly, Rafick] Univ Montreal, Montreal, PQ, Canada; [Luo, Ma; Liang, Ben; Ball, Blake T.; Plummer, Francis A.] Publ Hlth Agcy Canada, Winnipeg, MB, Canada; [Kimani, Joshua; Wachihi, Charles] Univ Nairobi, Nairobi, Kenya	Kenya Medical Research Institute; Kenya Medical Research Institute; Universite de Montreal; Public Health Agency of Canada; University of Nairobi	Songok, EM (corresponding author), Kenya Govt Med Res Ctr, Nairobi, Kenya.	Esongok@kemri.org	Liang, Binhua/ABN-9806-2022	Songok, Elijah/0000-0001-7790-7063; Fowke, Keith/0000-0001-8227-6649; McLaren, Paul/0000-0001-6019-7018; Boucher, Genevieve/0000-0001-6389-9007; liang, binhua/0000-0002-1108-6407	Bill and Melinda Gates Foundation under Grand Challenges in Global Health (GCGH) initiative; Canada Institutes of Health Research (CIHR)	Bill and Melinda Gates Foundation under Grand Challenges in Global Health (GCGH) initiative; Canada Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This study was funded by Bill and Melinda Gates Foundation under Grand Challenges in Global Health (GCGH) initiative and the Canada Institutes of Health Research (CIHR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALCAMI J, 1995, EMBO J, V14, P1552, DOI 10.1002/j.1460-2075.1995.tb07141.x; An P, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030019; Arthos J, 2008, NAT IMMUNOL, V9, P301, DOI 10.1038/ni1566; Ball TB, 2007, AIDS, V21, P1091, DOI 10.1097/QAD.0b013e3280ef6ae1; Begaud E, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-35; BENTWICH Z, 1995, IMMUNOL TODAY, V16, P187, DOI 10.1016/0167-5699(95)80119-7; Beyrer C, 1999, J INFECT DIS, V179, P59, DOI 10.1086/314556; Biasin M, 2000, J INFECT DIS, V182, P1365, DOI 10.1086/315873; BLAZQUEZ MV, 1992, J IMMUNOL, V149, P3073; Boonacker E, 2003, EUR J CELL BIOL, V82, P53, DOI 10.1078/0171-9335-00302; Boyton RJ, 2007, CLIN EXP IMMUNOL, V149, P1, DOI 10.1111/j.1365-2249.2007.03424.x; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Brown BK, 2007, J VIROL, V81, P2087, DOI 10.1128/JVI.02011-06; Burgener A, 2008, J PROTEOME RES, V7, P4446, DOI 10.1021/pr800406r; Carthagena L, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-59; Chang TL, 2005, J CLIN INVEST, V115, P765, DOI 10.1172/JCI200521948; Chugh P, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-11; CLERICI M, 1993, AIDS, V7, P1427, DOI 10.1097/00002030-199311000-00004; de Witte L, 2007, NAT MED, V13, P367, DOI 10.1038/nm1541; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Drucker DJ, 1997, NAT BIOTECHNOL, V15, P673, DOI 10.1038/nbt0797-673; Dudoit S, 2003, BIOTECHNIQUES, P45; Finberg RW, 2007, REV MED VIROL, V17, P35, DOI 10.1002/rmv.525; Fowke KR, 1996, LANCET, V348, P1347, DOI 10.1016/S0140-6736(95)12269-2; Francois F, 2003, J VIROL, V77, P2539, DOI 10.1128/JVI.77.4.2539-2549.2003; Gonzalez E, 2005, SCIENCE, V174, P5655; Havre PA, 2008, FRONT BIOSCI-LANDMRK, V13, P1634, DOI 10.2741/2787; Hildebrandt M, 2001, SCAND J GASTROENTERO, V36, P1067, DOI 10.1080/003655201750422675; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Isotani S, 1999, J BIOL CHEM, V274, P34493, DOI 10.1074/jbc.274.48.34493; Jennes W, 2006, CLIN EXP IMMUNOL, V143, P435, DOI 10.1111/j.1365-2249.2006.03017.x; Jennes W, 2006, J IMMUNOL, V177, P6588, DOI 10.4049/jimmunol.177.10.6588; Joint United Nations Programme on HIV/AIDS UNAIDS, 2008, REP GLOB AIDS EPID; Jones RG, 2007, IMMUNITY, V27, P173, DOI 10.1016/j.immuni.2007.07.008; Kallings LO, 2008, J INTERN MED, V263, P218, DOI 10.1111/j.1365-2796.2007.01910.x; Kaul R, 2001, AIDS, V15, P431, DOI 10.1097/00002030-200102160-00026; Kawata H, 2003, BIOCHEM J, V373, P747, DOI 10.1042/BJ20030171; KELKER HC, 1992, AIDS RES HUM RETROV, V8, P1355, DOI 10.1089/aid.1992.8.1355; Koblavi-Deme S, 2003, AIDS, V17, pS17, DOI 10.1097/00002030-200317003-00003; Krauss S, 2001, IMMUNITY, V15, P497, DOI 10.1016/S1074-7613(01)00205-9; Lama J, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-52; Lester RT, 2008, AIDS, V22, P685, DOI 10.1097/QAD.0b013e3282f4de35; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; MacDonald KS, 2000, J INFECT DIS, V181, P1581, DOI 10.1086/315472; Martin MP, 2004, J VIROL, V78, P14053, DOI 10.1128/JVI.78.24.14053-14056.2004; McLaren PJ, 2010, J INFECT DIS, V202, pS339, DOI 10.1086/655968; MENTLEIN R, 1993, EUR J BIOCHEM, V214, P829, DOI 10.1111/j.1432-1033.1993.tb17986.x; Modiano JF, 2008, IMMUNOL RES, V41, P137, DOI 10.1007/s12026-008-8017-1; MORIMOTO C, 1994, P NATL ACAD SCI USA, V91, P9960, DOI 10.1073/pnas.91.21.9960; Plummer FA, 1999, IMMUNOL LETT, V66, P27, DOI 10.1016/S0165-2478(98)00182-5; Pratley RE, 2007, CURR MED RES OPIN, V23, P919, DOI 10.1185/030079906X162746; Proost P, 1998, J BIOL CHEM, V273, P7222, DOI 10.1074/jbc.273.13.7222; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Rits MAN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003975; ROOS D, 1973, EXP CELL RES, V77, P127, DOI 10.1016/0014-4827(73)90561-2; ROWLANDJONES S, 1995, NAT MED, V1, P59, DOI 10.1038/nm0195-59; ROWLANDJONES SL, 1993, LANCET, V341, P860, DOI 10.1016/0140-6736(93)93063-7; Saez-Cirion A, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-81; SCHUITEMAKER H, 1994, RES IMMUNOL, V145, P588, DOI 10.1016/S0923-2494(05)80038-0; Schweneker M, 2004, BIOCHEM BIOPH RES CO, V325, P751, DOI 10.1016/j.bbrc.2004.10.096; Songok EM, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-343; Stover J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003729; Suy A, 2007, J INFECT DIS, V196, P1191, DOI 10.1086/521193; Tran HK, 2006, AIDS RES HUM RETROV, V22, P255, DOI 10.1089/aid.2006.22.255; Ueno M, 2005, DIABETOLOGIA, V48, P506, DOI 10.1007/s00125-004-1662-6; Valcke HS, 2006, AIDS, V20, P1984, DOI 10.1097/01.aids.0000247124.35129.e1; Vanham G, 1993, J ACQ IMMUN DEF SYND, P749; Wainberg MA, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-31; Winkler C, 1998, SCIENCE, V279, P389, DOI 10.1126/science.279.5349.389; Wutz A, 2007, CURR OPIN GENET DEV, V17, P387, DOI 10.1016/j.gde.2007.08.001; Xie Z, 2008, P NATL ACAD SCI USA, V105, P10859, DOI 10.1073/pnas.0800647105	72	44	45	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2012	7	1							e30048	10.1371/journal.pone.0030048	http://dx.doi.org/10.1371/journal.pone.0030048			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911FX	22291902	gold, Green Published, Green Submitted			2022-12-25	WOS:000301703800007
J	Bhogal, RH; Weston, CJ; Curbishley, SM; Adams, DH; Afford, SC				Bhogal, Ricky H.; Weston, Christopher J.; Curbishley, Stuart M.; Adams, David H.; Afford, Simon C.			Activation of CD40 with Platelet Derived CD154 Promotes Reactive Oxygen Species Dependent Death of Human Hepatocytes during Hypoxia and Reoxygenation	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; FAS LIGAND EXPRESSION; LIVER ISCHEMIA; CELL-DEATH; RAT-LIVER; ISCHEMIA/REPERFUSION INJURY; ALLOGRAFT-REJECTION; OXIDATIVE STRESS; P38 MAPK; APOPTOSIS	Background: Hypoxia and hypoxia-reoxygenation (H-R) are pathogenic factors in many liver diseases that lead to hepatocyte death as a result of reactive oxygen species (ROS) accumulation. The tumor necrosis factor super-family member CD154 can also induce hepatocyte apoptosis via activation of its receptor CD40 and induction of autocrine/paracrine Fas Ligand/CD178 but the relationship between CD40 activation, ROS generation and apoptosis is poorly understood. We hypothesised that CD40 activation and ROS accumulation act synergistically to drive human hepatocyte apoptosis. Methods: Human hepatocytes were isolated from liver tissue and exposed to an in vitro model of hypoxia and H-R in the presence or absence of CD154 and/or various inhibitors. Hepatocyte ROS production, apoptosis and necrosis were determined by labelling cells with 2',7'-dichlorofluorescin, Annexin-V and 7-AAD respectively in a three-colour reporter flow cytometry assay. Results: Exposure of human hepatocytes to recombinant CD154 or platelet-derived soluble CD154 augments ROS accumulation during H-R resulting in NADPH oxidase-dependent apoptosis and necrosis. The inhibition of c-Jun N-terminal Kinase and p38 attenuated CD154-mediated apoptosis but not necrosis. Conclusions: CD154-mediated apoptosis of hepatocytes involves ROS generation that is amplified during hypoxia-reoxygenation. This finding provides a molecular mechanism to explain the role of platelets in hepatocyte death during ischemia-reperfusion injury.	[Bhogal, Ricky H.; Weston, Christopher J.; Curbishley, Stuart M.; Adams, David H.; Afford, Simon C.] Univ Birmingham, Sch Med, Liver Res Ctr, Sch Infect & Immun,Inst Biomed Res, Birmingham, W Midlands, England	University of Birmingham	Bhogal, RH (corresponding author), Univ Birmingham, Sch Med, Liver Res Ctr, Sch Infect & Immun,Inst Biomed Res, Birmingham, W Midlands, England.	balsin@hotmail.com	Adams, David H/C-9092-2009	Adams, David H/0000-0001-6776-0336; Weston, Chris/0000-0002-9651-1264	Wellcome Trust Fellowship [DDDP.RCXH14183]; Birmingham Biomedical Research Unit (BRU); National Institute Health Research (NIHR); Medical Research Council [G9818340B] Funding Source: researchfish	Wellcome Trust Fellowship(Wellcome Trust); Birmingham Biomedical Research Unit (BRU); National Institute Health Research (NIHR)(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Mr. RH Bhogal's work has been funded by a Wellcome Trust Fellowship (DDDP.RCXH14183). The authors would also like to thank the Birmingham Biomedical Research Unit (BRU) and the National Institute Health Research (NIHR) for continued funding and help with research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afford SC, 1999, J EXP MED, V189, P441, DOI 10.1084/jem.189.2.441; Afford SC, 2001, FASEB J, V15, P2345, DOI 10.1096/fj.01-0088com; Ahmed-Choudhury J, 2006, CELL SIGNAL, V18, P456, DOI 10.1016/j.cellsig.2005.05.015; Alabraba EB, 2008, HEPATOLOGY, V47, P552, DOI 10.1002/hep.22011; Andre P, 2002, NAT MED, V8, P247, DOI 10.1038/nm0302-247; Bhogal RH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018222; Bhogal RH, 2010, LIVER TRANSPLANT, V16, P1303, DOI 10.1002/lt.22157; Broughan TA, 2008, J SURG RES, V145, P150, DOI 10.1016/j.jss.2007.04.014; Bu SZ, 2006, APOPTOSIS, V11, P413, DOI 10.1007/s10495-006-4064-z; Bumpus NN, 2011, TOXICOL APPL PHARM, V257, P227, DOI 10.1016/j.taap.2011.09.008; Chai J, 2011, HEPATOLOGY; Chang LF, 2006, CELL, V124, P601, DOI 10.1016/j.cell.2006.01.021; Chaparro M, 2007, ANN HEPATOL, V6, P208, DOI 10.1016/S1665-2681(19)31900-3; Choudhury JA, 2003, MOL BIOL CELL, V14, P1334, DOI 10.1091/mbc.E02-07-0378; Conti A, 2007, LIVER TRANSPLANT, V13, P99, DOI 10.1002/lt.20960; Cursio R, 2005, J SURG RES, V125, P30, DOI 10.1016/j.jss.2004.11.026; Ding WX, 2004, HEPATOLOGY, V40, P403, DOI 10.1002/hep.20310; Garcia-Ruiz C, 2007, J GASTROEN HEPATOL, V22, pS38, DOI 10.1111/j.1440-1746.2006.04644.x; Gardmo C, 2005, BIOCHEM PHARMACOL, V69, P1805, DOI 10.1016/j.bcp.2005.03.028; Ha YJ, 2004, J IMMUNOL, V172, P231, DOI 10.4049/jimmunol.172.1.231; Ha YJ, 2011, EXP MOL MED, V43, P101, DOI 10.3858/emm.2011.43.2.012; Hong SW, 2010, ARCH PHARM RES, V33, P601, DOI 10.1007/s12272-010-0415-y; Humphreys EH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014037; Jaeschke H, 2003, GASTROENTEROLOGY, V125, P1246, DOI 10.1016/S0016-5085(03)01209-5; Ke B, 2005, TRANSPLANTATION, V79, P1078, DOI 10.1097/01.TP.0000161248.43481.A2; Khandoga A, 2003, MICROVASC RES, V65, P71, DOI 10.1016/S0026-2862(02)00018-3; King LA, 2009, J HEPATO-BILIARY-PAN, V16, P763, DOI 10.1007/s00534-009-0155-x; Kobayashi M, 2002, SURGERY, V131, P344, DOI 10.1067/msy.2002.121097; Kohrmann M, 1999, J NEUROSCI RES, V58, P831; LALOR P, 1995, BRIT J HAEMATOL, V89, P725; Lee YJ, 2007, EUR J PHARMACOL, V573, P29, DOI 10.1016/j.ejphar.2007.06.049; Lei K, 2003, P NATL ACAD SCI USA, V100, P2432, DOI 10.1073/pnas.0438011100; Lisman T, 2010, SEMIN THROMB HEMOST, V36, P170, DOI 10.1055/s-0030-1251501; Massip-Salcedo M, 2007, LIVER INT, V27, P6, DOI 10.1111/j.1478-3231.2006.01390.x; Mebratu Y, 2009, CELL CYCLE, V8, P1168, DOI 10.4161/cc.8.8.8147; Nakajima H, 2008, APOPTOSIS, V13, P1013, DOI 10.1007/s10495-008-0234-5; Ohtaki Y, 2009, INT IMMUNOPHARMACOL, V9, P1071, DOI 10.1016/j.intimp.2009.04.016; Park Jae-Seung, 2011, BMC Res Notes, V4, P8, DOI 10.1186/1756-0500-4-8; Shen XD, 2009, HEPATOLOGY, V50, P1537, DOI 10.1002/hep.23153; Smith MK, 2007, J BIOMED MATER RES A, V80A, P520, DOI 10.1002/jbm.a.30930; Sullivan BP, 2010, TOXICOL SCI, V115, P286, DOI 10.1093/toxsci/kfq042; Taniai H, 2004, HEPATOLOGY, V39, P1544, DOI 10.1002/hep.20217; Uehara T, 2004, TRANSPLANTATION, V78, P324, DOI 10.1097/01.TP.0000128859.42696.28; Ueno T, 2009, MED SCI MONITOR, V15, pCR341; Vardanian AJ, 2008, MOL MED, V14, P337, DOI 10.2119/2007-00134.Vardanian; Xia M, 2010, J THROMB HAEMOST, V8, P397, DOI 10.1111/j.1538-7836.2009.03683.x; Xu H, 2006, J CLIN INVEST, V116, P769, DOI 10.1172/JCI27155; Xu H, 2003, J IMMUNOL, V170, P2776, DOI 10.4049/jimmunol.170.5.2776	48	17	19	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e30867	10.1371/journal.pone.0030867	http://dx.doi.org/10.1371/journal.pone.0030867			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910ME	22295117	Green Submitted, Green Published, gold			2022-12-25	WOS:000301640600062
J	Lee, JD; Kwon, TJ; Kim, UK; Lee, WS				Lee, Jong Dae; Kwon, Tae Jun; Kim, Un-Kyung; Lee, Won-Sang			Genetic and Epigenetic Alterations of the NF2 Gene in Sporadic Vestibular Schwannomas	PLOS ONE			English	Article							NEUROFIBROMATOSIS TYPE-2 GENE; TUMOR-SUPPRESSOR; METHYLATION; MUTATION; RETINOBLASTOMA; GROWTH	Background: Mutations in the neurofibromatosis type 2 (NF2) tumor-suppressor gene have been identified in not only NF2-related tumors but also sporadic vestibular schwannomas (VS). This study investigated the genetic and epigenetic alterations in tumors and blood from 30 Korean patients with sporadic VS and correlated these alterations with tumor behavior. Methodology/Principal Findings: NF2 gene mutations were detected using PCR and direct DNA sequencing and three highly polymorphic microsatellite DNA markers were used to assess the loss of heterozygosity (LOH) from chromosome 22. Aberrant hypermethylation of the CpG island of the NF2 gene was also analyzed. The tumor size, the clinical growth index, and the proliferative activity assessed using the Ki-67 labeling index were evaluated. We found 18 mutations in 16 cases of 30 schwannomas (53%). The mutations included eight frameshift mutations, seven nonsense mutations, one in-frame deletion, one splicing donor site, and one missense mutation. Nine patients (30%) showed allelic loss. No patient had aberrant hypermethylation of the NF2 gene and correlation between NF2 genetic alterations and tumor behavior was not observed in this study. Conclusions/Significance: The molecular genetic changes in sporadic VS identified here included mutations and allelic loss, but no aberrant hypermethylation of the NF2 gene was detected. In addition, no clear genotype/phenotype correlation was identified. Therefore, it is likely that other factors contribute to tumor formation and growth.	[Lee, Jong Dae] Soonchunhyang Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Puchon, South Korea; [Kwon, Tae Jun; Kim, Un-Kyung] Kyungpook Natl Univ, Coll Nat Sci, Dept Biol, Taegu, South Korea; [Lee, Won-Sang] Yonsei Univ, Coll Med, Dept Otorhinolaryngol, Seoul, South Korea	Soonchunhyang University; Kyungpook National University; Yonsei University; Yonsei University Health System	Lee, JD (corresponding author), Soonchunhyang Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Puchon, South Korea.	kimuk@knu.ac.kr			Ministry of Health and Welfare, Republic of Korea [A100367]	Ministry of Health and Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This study was supported by a grant from the Korea Healthcare technology R&D Project, Ministry of Health and Welfare, Republic of Korea (A100367). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antinheimo J, 2000, ACTA NEUROCHIR, V142, P1099, DOI 10.1007/s007010070036; Baser ME, 2006, HUM MUTAT, V27, P297, DOI 10.1002/humu.20317; Bian LG, 2005, J NEURO-ONCOL, V73, P253, DOI 10.1007/s11060-004-5176-3; Caye-Thomasen P, 2010, OTOL NEUROTOL, V31, P256, DOI 10.1097/MAO.0b013e3181be6478; Evans DGR, 2005, J MED GENET, V42, P630, DOI 10.1136/jmg.2004.027953; GREGER V, 1989, HUM GENET, V83, P155, DOI 10.1007/BF00286709; Hadfield KD, 2010, ONCOGENE, V29, P6216, DOI 10.1038/onc.2010.363; Irving RM, 1997, AM J OTOL, V18, P754; JACOBY LB, 1994, HUM MOL GENET, V3, P413, DOI 10.1093/hmg/3.3.413; Kino T, 2001, GENES CELLS, V6, P441, DOI 10.1046/j.1365-2443.2001.00432.x; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Kullar PJ, 2010, NEUROPATH APPL NEURO, V36, P505, DOI 10.1111/j.1365-2990.2010.01090.x; Lassaletta L, 2006, OTOL NEUROTOL, V27, P1180, DOI 10.1097/01.mao.0000226291.42165.22; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Lomas J, 2005, GENE CHROMOSOME CANC, V42, P314, DOI 10.1002/gcc.20141; MERLO A, 1995, NAT MED, V1, P686, DOI 10.1038/nm0795-686; Mohyuddin A, 2003, CLIN OTOLARYNGOL, V28, P85, DOI 10.1046/j.1365-2273.2003.00670.x; Neff BA, 2006, OTOL NEUROTOL, V27, P197, DOI 10.1097/01.mao.0000180484.24242.54; Patel NP, 2004, OTOL NEUROTOL, V25, P636, DOI 10.1097/00129492-200407000-00038; ROULEAU GA, 1993, NATURE, V363, P515, DOI 10.1038/363515a0; TROFATTER JA, 1993, CELL, V72, P791, DOI 10.1016/0092-8674(93)90406-G; Welling DB, 2002, OTOL NEUROTOL, V23, P736, DOI 10.1097/00129492-200209000-00022; Welling DB, 1996, HUM GENET, V98, P189, DOI 10.1007/s004390050188	23	25	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e30418	10.1371/journal.pone.0030418	http://dx.doi.org/10.1371/journal.pone.0030418			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910ME	22295085	Green Submitted, Green Published, gold			2022-12-25	WOS:000301640600030
J	Costechareyre, D; Balmand, S; Condemine, G; Rahbe, Y				Costechareyre, Denis; Balmand, Severine; Condemine, Guy; Rahbe, Yvan			Dickeya dadantii, a Plant Pathogenic Bacterium Producing Cyt-Like Entomotoxins, Causes Septicemia in the Pea Aphid Acyrthosiphon pisum	PLOS ONE			English	Article							ERWINIA APHIDICOLA; EXPRESSION REVEALS; INSECT; POTATO; LOCUS; HOST	Dickeya dadantii (syn. Erwinia chrysanthemi) is a plant pathogenic bacteria that harbours a cluster of four horizontally-transferred, insect-specific toxin genes. It was recently shown to be capable of causing an acute infection in the pea aphid Acyrthosiphon pisum (Insecta: Hemiptera). The infection route of the pathogen, and the role and in vivo expression pattern of these toxins, remain unknown. Using bacterial numeration and immunolocalization, we investigated the kinetics and the pattern of infection of this phytopathogenic bacterium within its insect host. We compared infection by the wild-type strain and by the Cyt toxin-deficient mutant. D. dadantii was found to form dense clusters in many luminal parts of the aphid intestinal tract, including the stomach, from which it invaded internal tissues as early as day 1 post-infection. Septicemia occurred soon after, with the fat body being the main infected tissue, together with numerous early infections of the embryonic chains showing embryonic gut and fat body as the target organs. Generalized septicemia led to insect death when the bacterial load reached about 10(8) cfu. Some individual aphids regularly escaped infection, indicating an effective partial immune response to this bacteria. Cyt-defective mutants killed insects more slowly but were capable of localisation in any type of tissue. Cyt toxin expression appeared to be restricted to the digestive tract where it probably assisted in crossing over the first cell barrier and, thus, accelerating bacterial diffusion into the aphid haemocel. Finally, the presence of bacteria on the surface of leaves hosting infected aphids indicated that the insects could be vectors of the bacteria.	[Costechareyre, Denis; Balmand, Severine; Rahbe, Yvan] INSA Lyon, INRA, UMR203 BF2I, Villeurbanne, France; [Costechareyre, Denis; Condemine, Guy] Univ Lyon 1, UCBL Dept Biol, F-69622 Villeurbanne, France; [Costechareyre, Denis; Balmand, Severine; Condemine, Guy; Rahbe, Yvan] Univ Lyon, Lyon, France; [Costechareyre, Denis; Condemine, Guy] CNRS, MAP UMR5240, Villeurbanne, France	INRAE; Institut National des Sciences Appliquees de Lyon - INSA Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National des Sciences Appliquees de Lyon - INSA Lyon	Costechareyre, D (corresponding author), INSA Lyon, INRA, UMR203 BF2I, Villeurbanne, France.	yvan.rahbe@lyon.inra.fr	Rahbe, Yvan/B-9389-2009	Rahbe, Yvan/0000-0002-0074-4443; COSTECHAREYRE, Denis/0000-0002-9258-7421; Condemine, Guy/0000-0002-3256-3815	ANR-Genoplante;  [ANR07GPLA002-Aphicibles]	ANR-Genoplante(French National Research Agency (ANR)); 	This study was funded by an ANR-Genoplante grant to GC, including a post-doctoral fellowship to DC, coordinated by YR (ANR07GPLA002-Aphicibles). The funders had no role in the study design, data collection and analysis, or preparation of the manuscript.	Altincicek B, 2011, DEV COMP IMMUNOL, V35, P1089, DOI 10.1016/j.dci.2011.03.017; Blot N, 2002, J BIOL CHEM, V277, P7936, DOI 10.1074/jbc.M109193200; Broderick NA, 2006, P NATL ACAD SCI USA, V103, P15196, DOI 10.1073/pnas.0604865103; Costechareyre D, 2010, ENVIRON MICROBIOL, V12, P3290, DOI 10.1111/j.1462-2920.2010.02305.x; Delangle A, 2007, J BACTERIOL, V189, P7053, DOI 10.1128/JB.00845-07; Duarte X, 2000, FEMS MICROBIOL LETT, V190, P81, DOI 10.1016/S0378-1097(00)00325-6; Gerardo NM, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r21; Glasner JD, 2011, J BACTERIOL, V193, P2076, DOI 10.1128/JB.01513-10; Graf J, 2011, MBIO, V2, DOI 10.1128/mBio.00161-11; Grenier AM, 2006, APPL ENVIRON MICROB, V72, P1956, DOI 10.1128/AEM.72.3.1956-1965.2006; Hansen AK, 2011, P NATL ACAD SCI USA, V108, P2849, DOI 10.1073/pnas.1013465108; Harada H, 1997, J GEN APPL MICROBIOL, V43, P349, DOI 10.2323/jgam.43.349; Harada H, 1997, J GEN APPL MICROBIOL, V43, P363, DOI 10.2323/jgam.43.363; Helias V, 2008, CAH AGRIC, V17, P349, DOI 10.1684/agr.2008.0216; HugouvieuxCottePattat N, 1996, ANNU REV MICROBIOL, V50, P213, DOI 10.1146/annurev.micro.50.1.213; KLOEPPER JW, 1981, AM POTATO J, V58, P165, DOI 10.1007/BF02854416; Laughton AM, 2011, J INSECT PHYSIOL, V57, P830, DOI 10.1016/j.jinsphys.2011.03.015; Mason KL, 2011, MBIO, V2, DOI 10.1128/mBio.00065-11; Nadarasah G, 2011, FEMS MICROBIOL REV, V35, P555, DOI 10.1111/j.1574-6976.2011.00264.x; Nakabachi A, 2005, P NATL ACAD SCI USA; Oliver KM, 2010, ANNU REV ENTOMOL, V55, P247, DOI 10.1146/annurev-ento-112408-085305; RAHBE Y, 1993, ENTOMOL EXP APPL, V67, P149, DOI 10.1007/BF02386520; Shirasu-Hiza MM, 2007, CELL MICROBIOL, V9, P2775, DOI 10.1111/j.1462-5822.2007.01042.x; Stavrinides J, 2010, ENVIRON MICROBIOL, V12, P147, DOI 10.1111/j.1462-2920.2009.02056.x; Stavrinides J, 2009, APPL ENVIRON MICROB, V75, P2230, DOI 10.1128/AEM.02860-08	25	29	30	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2012	7	1							e30702	10.1371/journal.pone.0030702	http://dx.doi.org/10.1371/journal.pone.0030702			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910LV	22292023	gold, Green Published, Green Submitted			2022-12-25	WOS:000301639600048
J	Coupe, B; Grit, I; Hulin, P; Randuineau, G; Parnet, P				Coupe, Berengere; Grit, Isabelle; Hulin, Philippe; Randuineau, Gwenaelle; Parnet, Patricia			Postnatal Growth after Intrauterine Growth Restriction Alters Central Leptin Signal and Energy Homeostasis	PLOS ONE			English	Article							CATCH-UP GROWTH; DIET-INDUCED OBESITY; DEVELOPMENTAL ORIGINS; HYPOTHALAMIC NEURONS; PROTEIN RESTRICTION; ADIPOSE-TISSUE; EXPRESSION; TRANSCRIPTION-3; TRANSDUCER; MECHANISMS	Intrauterine growth restriction (IUGR) is closely linked with metabolic diseases, appetite disorders and obesity at adulthood. Leptin, a major adipokine secreted by adipose tissue, circulates in direct proportion to body fat stores, enters the brain and regulates food intake and energy expenditure. Deficient leptin neuronal signalling favours weight gain by affecting central homeostatic circuitry. The aim of this study was to determine if leptin resistance was programmed by perinatal nutritional environment and to decipher potential cellular mechanisms underneath. We clearly demonstrated that 5 months old IUGR rats develop a decrease of leptin sentivity, characterized by no significant reduction of food intake following an intraperitoneal injection of leptin. Apart from the resistance to leptin injection, results obtained from IUGR rats submitted to rapid catch-up growth differed from those of IUGR rats with no catch-up since we observed, for the first group only, fat accumulation, increased appetite for food rich in fat and increased leptin synthesis. Centrally, the leptin resistant state of both groups was associated with a complex and not always similar changes in leptin receptor signalling steps. Leptin resistance in IUGR rats submitted to rapid catch-up was associated with alteration in AKT and mTOR pathways. Alternatively, in IUGR rats with no catch-up, leptin resistance was associated with low hypothalamic expression of LepRa and LepRb. This study reveals leptin resistance as an early marker of metabolic disorders that appears before any evidence of body weight increase in IUGR rats but whose mechanisms could depend of nutritional environment of the perinatal period.	[Coupe, Berengere; Grit, Isabelle; Randuineau, Gwenaelle; Parnet, Patricia] Univ Nantes Atlantique, UMR Physiol Adaptat Nutr 1280, Nantes, France; [Coupe, Berengere; Grit, Isabelle; Randuineau, Gwenaelle; Parnet, Patricia] Res Ctr Human Nutr Nantes, Nantes, France; [Hulin, Philippe] Univ Nantes, Plate Forme MicroPICell IFR26 Inst Rech Therapeut, Nantes, France	Nantes Universite; Nantes Universite	Coupe, B (corresponding author), Univ Nantes Atlantique, UMR Physiol Adaptat Nutr 1280, Nantes, France.	patricia.parnet@univ-nantes.fr	Parnet, Patricia/AAW-5064-2021; Parnet, Patricia/GOH-1209-2022		INRA; Region Pays de la Loire; La Fondation Louis Bonduelle (France); Agence Nationale de la Recherche (ANR) [PNRA 2005-009]	INRA; Region Pays de la Loire(Region Pays de la Loire); La Fondation Louis Bonduelle (France); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR))	BC was sponsored by a doctoral fellowship from INRA and Region Pays de la Loire and by a grant from La Fondation Louis Bonduelle (France). This study was supported by a grant from the Agence Nationale de la Recherche (ANR PNRA 2005-009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahima RS, 2000, ANNU REV PHYSIOL, V62, P413, DOI 10.1146/annurev.physiol.62.1.413; Alexandre-Gouabau MC, 2011, J PROTEOME RES, V10, P3292, DOI 10.1021/pr2003193; Bjorbaek C, 1998, MOL CELL, V1, P619, DOI 10.1016/S1097-2765(00)80062-3; Bol VV, 2009, AM J PHYSIOL-REG I, V297, pR291, DOI 10.1152/ajpregu.90497.2008; Bouret SG, 2004, SCIENCE, V304, P108, DOI 10.1126/science.1095004; Considine RV, 1996, NEW ENGL J MED, V334, P292, DOI 10.1056/NEJM199602013340503; Cota D, 2006, SCIENCE, V312, P927, DOI 10.1126/science.1124147; Cota D, 2008, J NEUROSCI, V28, P7202, DOI 10.1523/JNEUROSCI.1389-08.2008; Coupe B, 2010, ENDOCRINOLOGY, V151, P702, DOI 10.1210/en.2009-0893; Coupe B, 2009, AM J PHYSIOL-REG I, V297, pR813, DOI 10.1152/ajpregu.00201.2009; Desai M, 2007, REPROD SCI, V14, P329, DOI 10.1177/1933719107303983; Elmquist JK, 1997, ENDOCRINOLOGY, V138, P839, DOI 10.1210/en.138.2.839; Elmquist JK, 1998, J COMP NEUROL, V395, P535; Elmquist JK, 1998, P NATL ACAD SCI USA, V95, P741, DOI 10.1073/pnas.95.2.741; Gluckman PD, 2005, MATERN CHILD NUTR, V1, P130, DOI 10.1111/j.1740-8709.2005.00020.x; Gong L, 2008, ENDOCRINOLOGY, V149, P3346, DOI 10.1210/en.2007-0945; Grove KL, 2003, PHYSIOL BEHAV, V79, P47, DOI 10.1016/S0031-9384(03)00104-5; Hales CN, 2001, BRIT MED BULL, V60, P5, DOI 10.1093/bmb/60.1.5; HAMILTON BS, 1995, NAT MED, V1, P953, DOI 10.1038/nm0995-953; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martin TL, 2006, J BIOL CHEM, V281, P18933, DOI 10.1074/jbc.M512831200; McMillen IC, 2005, PHYSIOL REV, V85, P571, DOI 10.1152/physrev.00053.2003; Metlakunta AS, 2008, ENDOCRINOLOGY, V149, P1121, DOI 10.1210/en.2007-1307; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; Mori H, 2009, CELL METAB, V9, P362, DOI 10.1016/j.cmet.2009.03.005; Morris D, 2009, AM J PHYSL ENDOCRINO; Myers MG, 2008, ANNU REV PHYSIOL, V70, P537, DOI 10.1146/annurev.physiol.70.113006.100707; Myers MG, 2010, TRENDS ENDOCRIN MET, V21, P643, DOI 10.1016/j.tem.2010.08.002; Myers MG, 2004, RECENT PROG HORM RES, V59, P287, DOI 10.1210/rp.59.1.287; Ong KKL, 2000, BRIT MED J, V320, P967, DOI 10.1136/bmj.320.7240.967; Orozco-Solis R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013537; Paxinos G, 2005, RAT BRAIN STREREOTAX; Ravelli ACJ, 1999, AM J CLIN NUTR, V70, P811; Sahu A, 2011, NEUROENDOCRINOLOGY, V93, P201, DOI 10.1159/000326785; Smith SR, 2001, METABOLISM, V50, P425, DOI 10.1053/meta.2001.21693; Xu AW, 2007, ENDOCRINOLOGY, V148, P72, DOI 10.1210/en.2006-1119; Zhang EE, 2004, P NATL ACAD SCI USA, V101, P16064, DOI 10.1073/pnas.0405041101	37	42	45	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30616	10.1371/journal.pone.0030616	http://dx.doi.org/10.1371/journal.pone.0030616			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22291999	gold, Green Published, Green Submitted			2022-12-25	WOS:000301570600064
J	Kalt, I; Levy, A; Borodianskiy-Shteinberg, T; Sarid, R				Kalt, Inna; Levy, Ayelet; Borodianskiy-Shteinberg, Tatyana; Sarid, Ronit			Nucleolar Localization of GLTSCR2/PICT-1 Is Mediated by Multiple Unique Nucleolar Localization Sequences	PLOS ONE			English	Article							TUMOR-SUPPRESSOR CANDIDATE; NUCLEAR EXPORT; PROTEIN; SIGNALS; NOP53P; PREDICTION	The human glioma tumor suppressor candidate region 2 gene product, GLTSCR2, also called 'protein interacting with carboxyl terminus 1' (PICT-1), has been implicated in the regulation of two major tumor suppressor proteins, PTEN and p53, and reported to bind the membrane-cytoskeleton regulator of cell signaling, Merlin. PICT-1 is a nucleolar protein, conserved among eukaryotes, and its yeast homolog has been functionally associated with ribosomal RNA processing. By means of confocal microscopy of EGFP and myc-tagged PICT-1 fusion proteins, we delineate that the nucleolar localization of PICT-1 is mediated by two independent nucleolar localization sequences (NoLS). Unlike most NoLSs, these NoLSs are relatively long with flexible boundaries and contain arginine and leucine clusters. In addition, we show that PICT-1 exhibits a nucleolar distribution similar to proteins involved in ribosomal RNA processing, yet does not colocalize precisely with either UBF1 or Fibrillarin under normal or stressed conditions. Identification of the precise location of PICT-1 and the signals that mediate its nucleolar localization is an important step towards advancing our understanding of the demonstrated influence of this protein on cell fate and tumorigenesis.	[Kalt, Inna; Levy, Ayelet; Borodianskiy-Shteinberg, Tatyana; Sarid, Ronit] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel	Bar Ilan University	Kalt, I (corresponding author), Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel.	saridr@mail.biu.ac.il			Israel Cancer Association; Chief Scientist's Office of the Ministry of Health Israel; Israel Science Foundation [709/10]; NICHD	Israel Cancer Association; Chief Scientist's Office of the Ministry of Health Israel; Israel Science Foundation(Israel Science Foundation); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by grants from the Israel Cancer Association (http://www.cancer.org.il/), the Chief Scientist's Office of the Ministry of Health Israel (http://www.health.gov.il/pages/default.asp?PageId = 873&catld=45&maincat=14), and the Israel Science Foundation (Grant No. 709/10)(http://www.isf.org.il/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Yaron Shav-Tal for helpful discussion and Noa Kinor for technical support and advice. Portions of this work will be submitted to Bar Ilan Univeristy, Ramat Gan, Israel, by T. Borodianskiy-Shteinberg in partial fulfillment of the degree of Doctor of Philosophy. The anti-myc developed by Prof. Bishop, J.M. was obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the NICHD and maintained by The University of Iowa, Department of Biology, Iowa City, IA 52242.	Ahmad Y, 2009, NUCLEIC ACIDS RES, V37, pD181, DOI 10.1093/nar/gkn804; Andersen JS, 2005, NATURE, V433, P77, DOI 10.1038/nature03207; Boisvert FM, 2007, NAT REV MOL CELL BIO, V8, P574, DOI 10.1038/nrm2184; Boyne JR, 2006, P NATL ACAD SCI USA, V103, P15190, DOI 10.1073/pnas.0604890103; Bruni R, 1999, J VIROL, V73, P3810, DOI 10.1128/JVI.73.5.3810-3817.1999; Chen HB, 2011, INT J BIOCHEM CELL B, V43, P545, DOI 10.1016/j.biocel.2010.12.011; Corredor AG, 2009, J VIROL, V83, P12842, DOI 10.1128/JVI.01613-09; Emmott E, 2009, EMBO REP, V10, P231, DOI 10.1038/embor.2009.14; Granato DC, 2008, FEBS J, V275, P4164, DOI 10.1111/j.1742-4658.2008.06565.x; Hahn MA, 2007, FEBS LETT, V581, P5070, DOI 10.1016/j.febslet.2007.09.050; Hsu SC, 2007, J BIOL CHEM, V282, P10432, DOI 10.1074/jbc.M610014200; Huang HS, 2005, ARCH BIOCHEM BIOPHYS, V443, P33, DOI 10.1016/j.abb.2005.08.021; Kakuk A, 2008, EXP CELL RES, V314, P2376, DOI 10.1016/j.yexcr.2008.05.006; Kalt I, 2010, J VIROL, V84, P2935, DOI 10.1128/JVI.00757-09; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kim JY, 2011, AM J PATHOL, V179, P1257, DOI 10.1016/j.ajpath.2011.05.041; Kim YJ, 2008, J PATHOL, V216, P218, DOI 10.1002/path.2401; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Luo M, 2004, TRAFFIC, V5, P847, DOI 10.1111/j.1600-0854.2004.00227.x; Nemeth A, 2011, TRENDS GENET, V27, P149, DOI 10.1016/j.tig.2011.01.002; Okahara F, 2004, J BIOL CHEM, V279, P45300, DOI 10.1074/jbc.C400377200; Okahara F, 2006, MOL BIOL CELL, V17, P4888, DOI 10.1091/mbc.E06-04-0301; Pederson T, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a000521; Raska I, 2006, CURR OPIN CELL BIOL, V18, P325, DOI 10.1016/j.ceb.2006.04.008; Sasaki M, 2011, NAT MED, V17, P944, DOI 10.1038/nm.2392; Scherl A, 2002, MOL BIOL CELL, V13, P4100, DOI 10.1091/mbc.E02-05-0271; Scott MS, 2010, NUCLEIC ACIDS RES, V38, P7388, DOI 10.1093/nar/gkq653; Shav-Tal Y, 2005, MOL BIOL CELL, V16, P2395, DOI 10.1091/mbc.E04-11-0992; Simmer F, 2003, PLOS BIOL, V1, P77, DOI 10.1371/journal.pbio.0000012; Sirri V, 2008, HISTOCHEM CELL BIOL, V129, P13, DOI 10.1007/s00418-007-0359-6; Slabinski L, 2007, BIOINFORMATICS, V23, P3403, DOI 10.1093/bioinformatics/btm477; Smith JS, 2000, GENOMICS, V64, P44, DOI 10.1006/geno.1999.6101; Sydorskyy Y, 2005, BIOCHEM J, V388, P819, DOI 10.1042/BJ20041297; Thomson E, 2005, RNA, V11, P1215, DOI 10.1261/rna.2720205; Wang AH, 2001, MOL CELL BIOL, V21, P5992, DOI 10.1128/MCB.21.17.5992-6005.2001; Yim JH, 2007, CELL DEATH DIFFER, V14, P1872, DOI 10.1038/sj.cdd.4402204; Yu B, 2005, EXP CELL RES, V311, P218, DOI 10.1016/j.yexcr.2005.08.012; Zhang HY, 2010, BIOCHEM BIOPH RES CO, V391, P651, DOI 10.1016/j.bbrc.2009.11.114	38	22	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30825	10.1371/journal.pone.0030825	http://dx.doi.org/10.1371/journal.pone.0030825			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22292050	Green Published, gold, Green Submitted			2022-12-25	WOS:000301570600084
J	Nogueira-Silva, C; Piairo, P; Carvalho-Dias, E; Peixoto, FO; Moura, RS; Correia-Pinto, J				Nogueira-Silva, Cristina; Piairo, Paulina; Carvalho-Dias, Emanuel; Peixoto, Francisca O.; Moura, Rute S.; Correia-Pinto, Jorge			Leukemia Inhibitory Factor in Rat Fetal Lung Development: Expression and Functional Studies	PLOS ONE			English	Article							FACTOR LIF; DIFFERENTIATION; RECEPTOR; GROWTH; MORPHOGENESIS; CYTOKINE; IL-6; ANGIOTENSIN; MECHANISMS; SURFACTANT	Background: Leukemia inhibitory factor (LIF) and interleukin-6 (IL-6) are members of the family of the glycoprotein 130 (gp130)-type cytokines. These cytokines share gp130 as a common signal transducer, which explains why they show some functional redundancy. Recently, it was demonstrated that IL-6 promotes fetal lung branching. Additionally, LIF has been implicated in developmental processes of some branching organs. Thus, in this study LIF expression pattern and its effects on fetal rat lung morphogenesis were assessed. Methodology/Principal Findings: LIF and its subunit receptor LIFR alpha expression levels were evaluated by immunohistochemistry and western blot in fetal rat lungs of different gestational ages, ranging from 13.5 to 21.5 days post-conception. Throughout all gestational ages studied, LIF was constitutively expressed in pulmonary epithelium, whereas LIFR alpha was first mainly expressed in the mesenchyme, but after pseudoglandular stage it was also observed in epithelial cells. These results point to a LIF epithelium-mesenchyme cross-talk, which is known to be important for lung branching process. Regarding functional studies, fetal lung explants were cultured with increasing doses of LIF or LIF neutralizing antibodies during 4 days. MAPK, AKT, and STAT3 phosphorylation in the treated lung explants was analyzed. LIF supplementation significantly inhibited lung growth in spite of an increase in p44/42 phosphorylation. On the other hand, LIF inhibition significantly stimulated lung growth via p38 and Akt pathways. Conclusions/Significance: The present study describes that LIF and its subunit receptor LIFR alpha are constitutively expressed during fetal lung development and that they have an inhibitory physiological role on fetal lung branching.	[Nogueira-Silva, Cristina; Piairo, Paulina; Carvalho-Dias, Emanuel; Peixoto, Francisca O.; Moura, Rute S.; Correia-Pinto, Jorge] Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst ICVS, Braga, Portugal; [Nogueira-Silva, Cristina; Piairo, Paulina; Carvalho-Dias, Emanuel; Peixoto, Francisca O.; Moura, Rute S.; Correia-Pinto, Jorge] ICVS 3Bs PT Govt Associate Lab, Braga, Portugal; [Nogueira-Silva, Cristina] Hosp Braga, Dept Obstet & Gynecol, Braga, Portugal; [Carvalho-Dias, Emanuel] Hosp Sao Joao, Dept Urol, Oporto, Portugal; [Correia-Pinto, Jorge] Hosp Braga, Dept Pediat Surg, Braga, Portugal	Universidade do Minho; Hospital de Braga; Sao Joao Hospital; Hospital de Braga	Nogueira-Silva, C (corresponding author), Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst ICVS, Braga, Portugal.	jcp@ecsaude.uminho.pt	Correia-Pinto, Jorge/B-3344-2012; Moura, Rute S/B-4208-2011; Moura, Rute/GYV-3259-2022; Nogueira-Silva, Cristina/T-6998-2018	Correia-Pinto, Jorge/0000-0002-9265-6896; Moura, Rute S/0000-0003-1763-9014; Nogueira-Silva, Cristina/0000-0001-7273-2911; Piairo, Paulina/0000-0003-1905-671X	Fundacao para a Ciencia e a Tecnologia [PTDC/SAU-OBD/108051/2008, SFRH/BPD/15408/2005, UMINHO/BII/172/2009]; Seccao de Neonatologia da Sociedade Portuguesa de Pediatria; Fundação para a Ciência e a Tecnologia [PTDC/SAU-OBD/108051/2008] Funding Source: FCT	Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Seccao de Neonatologia da Sociedade Portuguesa de Pediatria; Fundação para a Ciência e a Tecnologia	This project was funded by Fundacao para a Ciencia e a Tecnologia (PTDC/SAU-OBD/108051/2008) and by Seccao de Neonatologia da Sociedade Portuguesa de Pediatria (Grant ZERU 2008). RSM was supported by Fundacao para a Ciencia e a Tecnologia (reference SFRH/BPD/15408/2005). FOP was supported by Fundacao para a Ciencia e a Tecnologia (reference UMINHO/BII/172/2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE E, 1986, P NATL ACAD SCI USA, V83, P5958, DOI 10.1073/pnas.83.16.5958; Acosta JM, 2001, AM J PHYSIOL-LUNG C, V281, pL250, DOI 10.1152/ajplung.2001.281.1.L250; Andrew DJ, 2010, DEV BIOL, V341, P34, DOI 10.1016/j.ydbio.2009.09.024; Auernhammer CJ, 2000, ENDOCR REV, V21, P313, DOI 10.1210/er.21.3.313; BARD JBL, 1991, DEVELOPMENT, V113, P193; Bellusci S, 1997, DEVELOPMENT, V124, P4867; Betz UAK, 1998, J EXP MED, V188, P1955, DOI 10.1084/jem.188.10.1955; Carbia-Nagashima A, 2004, IUBMB LIFE, V56, P83, DOI 10.1080/15216540410001668064; De Breuck S, 2006, DIABETOLOGIA, V49, P108, DOI 10.1007/s00125-005-0079-1; ESTROV Z, 1995, J INTERF CYTOK RES, V15, P905, DOI 10.1089/jir.1995.15.905; Grant SL, 2001, GROWTH FACTORS, V19, P153, DOI 10.3109/08977190109001083; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Ikegami T, 2000, EUR J OBSTET GYN R B, V93, P97, DOI 10.1016/S0301-2115(00)00247-5; Ikezono T, 1997, BBA-MOL CELL RES, V1355, P121, DOI 10.1016/S0167-4889(96)00122-X; Jorens PG, 1996, CYTOKINE, V8, P873, DOI 10.1006/cyto.1996.9999; Kling DE, 2002, AM J PHYSIOL-LUNG C, V282, pL370, DOI 10.1152/ajplung.00200.2001; Knight D, 1997, BRIT J PHARMACOL, V120, P883, DOI 10.1038/sj.bjp.0700965; Knight D, 2001, PULM PHARMACOL THER, V14, P169, DOI 10.1006/pupt.2001.0282; Knight DA, 1999, AM J RESP CELL MOL, V20, P834, DOI 10.1165/ajrcmb.20.4.3429; Koblar SA, 1998, P NATL ACAD SCI USA, V95, P3178, DOI 10.1073/pnas.95.6.3178; Kritikou EA, 2003, DEVELOPMENT, V130, P3459, DOI 10.1242/dev.00578; Kurdi M, 2005, MOL CELL BIOCHEM, V269, P95, DOI 10.1007/s11010-005-3085-1; LI M, 1995, NATURE, V378, P724, DOI 10.1038/378724a0; McColm JR, 2006, EXP EYE RES, V83, P438, DOI 10.1016/j.exer.2006.01.027; Megeney LA, 1996, DEV GENET, V19, P139, DOI 10.1002/(SICI)1520-6408(1996)19:2<139::AID-DVG5>3.0.CO;2-A; Metcalf D, 2003, STEM CELLS, V21, P5, DOI 10.1634/stemcells.21-1-5; Moreno-Barriuso N, 2006, DEV DYNAM, V235, P2040, DOI 10.1002/dvdy.20842; Moss TJM, 2002, AM J RESP CRIT CARE, V165, P805, DOI 10.1164/ajrccm.165.6.2108053; Nogueira-Silva C, 2006, PEDIATR RES, V60, P530, DOI 10.1203/01.pdr.0000242300.09427.3b; Nogueira-Silva C, 2012, MOL MED, V18, P231, DOI 10.2119/molmed.2011.00210; Park JI, 2005, CYTOKINE, V29, P125, DOI 10.1016/j.cyto.2004.10.005; Park JI, 2003, MOL CELL BIOL, V23, P543, DOI 10.1128/MCB.23.2.543-554.2003; PATTERSON PH, 1992, CIBA F SYMP, V167, P125; Piairo P, 2011, PEPTIDES, V32, P2474, DOI 10.1016/j.peptides.2011.10.010; Pichel JG, 2003, MECH DEVELOP, V120, P349, DOI 10.1016/S0925-4773(02)00449-5; Plisov SY, 2001, DEVELOPMENT, V128, P1045; ROBERTSON M, 1993, DEV GENET, V14, P165, DOI 10.1002/dvg.1020140303; Sariola H, 2002, NEPHROL DIAL TRANSPL, V17, P88, DOI 10.1093/ndt/17.suppl_9.88; Shimoya K, 2000, HUM REPROD, V15, P2234, DOI 10.1093/humrep/15.10.2234; STEWART CL, 1992, NATURE, V359, P76, DOI 10.1038/359076a0; Stoll M, 2001, REGUL PEPTIDES, V99, P175, DOI 10.1016/S0167-0115(01)00246-4; Wang JM, 2003, J BIOL CHEM, V278, P31226, DOI 10.1074/jbc.M301820200; Warburton D, 2005, PEDIATR RES, V57, p26R, DOI 10.1203/01.PDR.0000159570.01327.ED; WARE CB, 1995, DEVELOPMENT, V121, P1283; WILLIAMS RL, 1988, NATURE, V336, P684, DOI 10.1038/336684a0; Xiong WN, 2007, J HUAZHONG U SCI-MED, V27, P372, DOI 10.1007/s11596-007-0406-5; YAMAMORI T, 1989, SCIENCE, V246, P1412, DOI 10.1126/science.2512641	47	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30517	10.1371/journal.pone.0030517	http://dx.doi.org/10.1371/journal.pone.0030517			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22291973	Green Published, gold			2022-12-25	WOS:000301570600052
J	Kan, CY; Wen, VW; Pasquier, E; Jankowski, K; Chang, M; Richards, LA; Kavallaris, M; MacKenzie, KL				Kan, C-Y; Wen, V. W.; Pasquier, E.; Jankowski, K.; Chang, M.; Richards, L. A.; Kavallaris, M.; MacKenzie, K. L.			Endothelial cell dysfunction and cytoskeletal changes associated with repression of p16(INK4a) during immortalization	ONCOGENE			English	Article						endothelial cell; p16(INK4a); TERT; immortalization; cytoskeleton; morphogenesis	MOLECULAR-WEIGHT TROPOMYOSINS; MAMMARY EPITHELIAL-CELLS; MALIGNANT-TRANSFORMATION; REPLICATIVE SENESCENCE; ACTIN CYTOSKELETON; CYCLE PROGRESSION; 4 ANGIOSARCOMAS; TELOMERE; VIMENTIN; EXPRESSION	The immortalization process is a fundamental step in the development of most (if not all) human cancers, including the aggressive endothelial cell (EC)-derived malignancy angiosarcoma. Inactivation of the tumor suppressor p16(INK4a) and the development of multiple chromosomal abnormalities are features of angiosarcoma that are recapitulated during telomerase-mediated immortalization of human ECs in vitro. The present study used a panel of telomerase-immortalized bone marrow EC (BMEC) lines to define the consequences of inactivation of p16(INK4a) on EC function and to identify molecular changes associated with repression of p16(INK4a). In a comparison of two immortalized BMEC mass cultures and six clones, the cell lines that repressed p16(INK4a) showed a higher rate of proliferation and an impaired ability to undergo morphogenic differentiation and form vessel-like structures in vitro. Proteomic comparison of a p16(INK4a)-negative and a p16(INK4a)-positive BMEC mass culture at early-and late-passage time points following transduction with telomerase reverse transcriptase (hTERT) revealed altered expression of cytoskeletal proteins, including vimentin and a-tropomyosin (alpha Tm), in the immortal cells. Immunoblot analyses of a panel of 11 immortal clones showed that cells that lacked p16(INK4a) expression tended to accumulate more dramatic changes in these cytoskeletal proteins than cells that retained p16(INK4a) expression. This corresponded with aberrant cytoskeletal architectures among p16(INK4a)-negative clones, which featured thicker actin stress fibers and less fluid membrane ruffles than p16(INK4a)-positive cells. A direct link between p16(INK4a) repression and defective EC function was confirmed by analysis of normal cells transfected with small interfering RNA (siRNA) targeting p16(INK4a). siRNA-mediated repression of p16(INK4a) significantly impaired random motility and vessel formation in vitro. This report is the first to demonstrate that ECs that repress the expression of p16(INK4a) are prone to defects in motility, morphogenesis and cytoskeletal organization. These defects are likely to reflect alterations that occur during the development of EC-derived malignancies.	[Kan, C-Y; Wen, V. W.; Jankowski, K.; Richards, L. A.; MacKenzie, K. L.] Univ New S Wales, Lowy Canc Res Ctr, Childrens Canc Inst Australia, Canc Cell Dev Grp, Randwick, NSW 2031, Australia; [Pasquier, E.; Chang, M.; Kavallaris, M.] Univ New S Wales, Lowy Canc Res Ctr, Childrens Canc Inst Australia, Tumour Biol & Targeting Program, Randwick, NSW 2031, Australia; [Kavallaris, M.] Univ New S Wales, Australian Ctr Nanomed, Randwick, NSW 2031, Australia	Children's Cancer Institute; University of New South Wales Sydney; Children's Cancer Institute; University of New South Wales Sydney; University of New South Wales Sydney	MacKenzie, KL (corresponding author), Univ New S Wales, Lowy Canc Res Ctr, Childrens Canc Inst Australia Med Res, Canc Cell Dev Grp, POB 81, Randwick, NSW 2031, Australia.	k.mackenzie@unsw.edu.au	Mackenzie, Karen/F-1310-2011; Pasquier, Eddy/A-8112-2018; MacKenzie, Karen/N-5849-2019; Kavallaris, Maria/J-5240-2014	Pasquier, Eddy/0000-0003-2824-5002; MacKenzie, Karen/0000-0003-2996-1617; Chang, Melissa/0000-0001-6311-3414	National Health and Medical Research Council [510378, 568611]; New South Wales Cancer Council [07-14]; Cancer Institute New South Wales [07-CDF-1/23, 07/ECF/1-21]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); New South Wales Cancer Council(Cancer Council New South Wales); Cancer Institute New South Wales	We thank Dr Galina Schevzov and Professor Peter Gunning for provision of the Tm antibody and helpful discussion. Children's Cancer Institute Australia for Medical Research is affiliated with the University of New South Wales and Sydney Children's Hospital. This research was facilitated by access to the Australian Proteome Analysis Facility established under the Australian Government's Major National Research Facilities Program. Funding: National Health and Medical Research Council (KLM Career Development Award ID no. 510378; MK Senior Research Fellowship ID no. 568611), New South Wales Cancer Council (KLM ID no. 07-14) and Cancer Institute New South Wales (KLM Career Development and Support Fellowship ID no. 07-CDF-1/23; EP Early Career Research Fellowship ID no. 07/ECF/1-21).	Alcorta DA, 1996, P NATL ACAD SCI USA, V93, P13742, DOI 10.1073/pnas.93.24.13742; Alhaja Elena, 2004, Angiogenesis, V7, P323, DOI 10.1007/s10456-005-0368-9; Baumhoer D, 2005, GYNECOL ONCOL, V97, P348, DOI 10.1016/j.ygyno.2004.12.046; Bell CD, 2003, MICROSC RES TECHNIQ, V60, P165, DOI 10.1002/jemt.10254; BHATTACHARYA B, 1990, CANCER RES, V50, P2105; CHANG E, 1995, P NATL ACAD SCI USA, V92, P11190, DOI 10.1073/pnas.92.24.11190; Chen J, 2006, AM J PHYSIOL-HEART C, V290, pH1575, DOI 10.1152/ajpheart.00364.2005; Chinnam M, 2011, CURR TOP DEV BIOL, V94, P129, DOI 10.1016/B978-0-12-380916-2.00005-X; Crawford YG, 2004, CANCER CELL, V5, P263, DOI 10.1016/S1535-6108(04)00023-6; di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118; Eckes B, 1998, J CELL SCI, V111, P1897; Eriksson JE, 2004, J CELL SCI, V117, P919, DOI 10.1242/jcs.00906; Franzen B, 1996, BRIT J CANCER, V73, P909, DOI 10.1038/bjc.1996.162; GILBENSO R, 1994, GENE CHROMOSOME CANC, V10, P210, DOI 10.1002/gcc.2870100311; Gunning PW, 2005, TRENDS CELL BIOL, V15, P333, DOI 10.1016/j.tcb.2005.04.007; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hara E, 1996, MOL CELL BIOL, V16, P859; HENDRICKS M, 1981, P NATL ACAD SCI-BIOL, V78, P5633, DOI 10.1073/pnas.78.9.5633; Hernando E, 2004, NATURE, V430, P797, DOI 10.1038/nature02820; Houle F, 2007, J CELL SCI, V120, P3666, DOI 10.1242/jcs.003251; Hsiao RS, 1997, ANTICANCER RES, V17, P827; Huang B, 2009, CARDIOVASC RES, V83, P536, DOI 10.1093/cvr/cvp154; Huang S, 1998, MOL BIOL CELL, V9, P3179, DOI 10.1091/mbc.9.11.3179; Hughes JAI, 2003, GLIA, V42, P25, DOI 10.1002/glia.10174; Ivaska J, 2007, EXP CELL RES, V313, P2050, DOI 10.1016/j.yexcr.2007.03.040; Jacobs JJL, 2004, CURR BIOL, V14, P2302, DOI 10.1016/j.cub.2004.12.025; KINDBLOM LG, 1991, VIRCHOWS ARCH A, V419, P439, DOI 10.1007/BF01605079; Koch M, 2008, J SURG ONCOL, V97, P321, DOI 10.1002/jso.20973; Kouvroukoglou S, 2000, BIOMATERIALS, V21, P1725, DOI 10.1016/S0142-9612(99)00205-7; Lamalice L, 2007, CIRC RES, V100, P782, DOI 10.1161/01.RES.0000259593.07661.1e; Ling X, 2004, BIOTECHNIQUES, V36, P450, DOI 10.2144/04363RR01; MacDonald NJ, 2001, J BIOL CHEM, V276, P25190, DOI 10.1074/jbc.M100743200; MacKenzie KL, 2002, ONCOGENE, V21, P4200, DOI 10.1038/sj.onc.1205425; MANDAHL N, 1990, GENE CHROMOSOME CANC, V1, P315, DOI 10.1002/gcc.2870010410; Milyavsky M, 2007, CANCER CELL, V11, P133, DOI 10.1016/j.ccr.2006.11.022; Minamino T, 2002, CIRCULATION, V105, P1541, DOI 10.1161/01.CIR.0000013836.85741.17; Minamino T, 2004, CURR VASC PHARMACOL, V2, P141, DOI 10.2174/1570161043476393; Nishio K, 2001, HISTOCHEM CELL BIOL, V116, P321, DOI 10.1007/s004180100325; Nylund R, 2004, PROTEOMICS, V4, P1359, DOI 10.1002/pmic.200300773; O'Hare MJ, 2001, P NATL ACAD SCI USA, V98, P646, DOI 10.1073/pnas.98.2.646; Pasquier E, 2010, MOL CANCER THER, V9, P1408, DOI 10.1158/1535-7163.MCT-09-0894; PRASAD GL, 1993, P NATL ACAD SCI USA, V90, P7039, DOI 10.1073/pnas.90.15.7039; Romanov SR, 2001, NATURE, V409, P633, DOI 10.1038/35054579; Schevzov G, 2005, J HISTOCHEM CYTOCHEM, V53, P557, DOI 10.1369/jhc.4A6505.2005; Schuborg C, 1998, CANCER GENET CYTOGEN, V100, P52, DOI 10.1016/S0165-4608(97)00012-5; SERRANO M, 1993, NATURE, V366, P704, DOI 10.1038/366704a0; Soler D, 2005, GENE CHROMOSOME CANC, V44, P339, DOI 10.1002/gcc.20244; Spike BT, 2004, EMBO J, V23, P4319, DOI 10.1038/sj.emboj.7600432; Tannapfel A, 2001, J HEPATOL, V35, P62, DOI 10.1016/S0168-8278(01)00046-0; Urashima M, 1999, BRIT J CANCER, V79, P1032, DOI 10.1038/sj.bjc.6690165; Valgeirsdottir S, 1998, J CELL SCI, V111, P1973; Venetsanakos E, 2002, EXP CELL RES, V273, P21, DOI 10.1006/excr.2001.5424; Verrills NM, 2006, PROTEOMICS, V6, P1681, DOI 10.1002/pmic.200500417; Wagner M, 2001, EXP GERONTOL, V36, P1327, DOI 10.1016/S0531-5565(01)00105-X; WANG E, 1985, J CELL BIOL, V100, P1466, DOI 10.1083/jcb.100.5.1466; Wang FL, 1996, CANCER RES, V56, P3634; Weihrauch M, 2002, HUM PATHOL, V33, P884, DOI 10.1053/hupa.2002.126880; Wen VW, 2006, CANCER RES, V66, P10691, DOI 10.1158/0008-5472.CAN-06-0979; Yang JW, 1999, J BIOL CHEM, V274, P26141, DOI 10.1074/jbc.274.37.26141; Zhang JC, 2002, P NATL ACAD SCI USA, V99, P12224, DOI 10.1073/pnas.192668299; Zheng Q, 2008, INT J CANCER, V122, P78, DOI 10.1002/ijc.23025; Zu YL, 2001, APPL IMMUNOHISTO M M, V9, P24, DOI 10.1097/00022744-200103000-00006	62	12	12	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV	2012	31	46					4815	4827		10.1038/onc.2011.645	http://dx.doi.org/10.1038/onc.2011.645			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	038YT	22310292	Green Published, hybrid			2022-12-25	WOS:000311210700002
J	Li, Y; Deng, C; Hu, X; Patel, B; Fu, X; Qiu, Y; Brand, M; Zhao, K; Huang, S				Li, Y.; Deng, C.; Hu, X.; Patel, B.; Fu, X.; Qiu, Y.; Brand, M.; Zhao, K.; Huang, S.			Dynamic interaction between TAL1 oncoprotein and LSD1 regulates TAL1 function in hematopoiesis and leukemogenesis	ONCOGENE			English	Article						TAL1/SCL; LSD1; H3K4 demethylation; serine phosphorylation; epigenetic regulation; leukemogenesis	T-CELL LEUKEMIA; CHROMOSOME-TRANSLOCATION; GENE-EXPRESSION; SCL GENE; TRANSCRIPTION; DIFFERENTIATION; PHOSPHORYLATION; PROLIFERATION; DEMETHYLASE; DISRUPTION	TAL1/SCL is a hematopoietic-specific oncogene and its activity is regulated by associated transcriptional co-activators and corepressors. Dysregulation of TAL1 activity has been associated with T-cell leukemogenesis. However, it remains unclear how the interactions between TAL1 and corepressors versus co-activators are properly regulated. Here, we reported that protein kinase A (PKA)-mediated phosphorylation regulates TAL1 interaction with the lysine-specific demethylase (LSD1) that removes methyl group from methylated Lys 4 on histone H3 tails. Phosphorylation of serine 172 in TAL1 specifically destabilizes the TAL1-LSD1 interaction leading to promoter H3K4 hypermethylation and activation of target genes that have been suppressed in normal and malignant hematopoiesis. Knockdown of TAL1 or LSD1 led to a derepression of the TAL1 target genes in T-cell acute lymphoblast leukemia (T-ALL) Jurkat cells, which is accompanied by elevating promoter H3K4 methylation. Similarly, treatment of PKA activator forskolin resulted in derepression of target genes by reducing its interaction with LSD1 while PKA inhibitor H89 represses them by suppressing H3K4 methylation levels. Consistent with the dual roles of TAL1 in transcription, TAL1-associated LSD1 is decreased while recruitment of hSET1 is increased at the TAL1 targets during erythroid differentiation. This process is accompanied by a dramatic increase in H3K4 methylation. Thus, our data revealed a novel interplay between PKA phosphorylation and TAL1-mediated epigenetic regulation that regulates hematopoietic transcription and differentiation programs during hematopoiesis and leukemogenesis. Oncogene (2012) 31, 5007-5018; doi:10.1038/onc.2012.8; published online 6 February 2012	[Li, Y.; Hu, X.; Fu, X.] Jilin Univ, Coll Life Sci, Changchun 130023, Peoples R China; [Qiu, Y.] Univ Florida, Coll Med, Dept Anat & Cell Biol, Gainesville, FL 32610 USA; [Qiu, Y.; Huang, S.] Univ Florida, Coll Med, Shands Canc Ctr, Gainesville, FL 32610 USA; [Brand, M.] Ottawa Hosp, Sprott Ctr Stem Cell Res, Res Inst, Ottawa, ON, Canada; [Zhao, K.] NHLBI, Syst Biol Ctr, NIH, Bethesda, MD 20892 USA; [Li, Y.; Deng, C.; Hu, X.; Patel, B.; Huang, S.] Univ Florida, Coll Med, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA	Jilin University; State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Ottawa; Ottawa Hospital Research Institute; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); State University System of Florida; University of Florida	Huang, S (corresponding author), Univ Florida, Coll Med, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA.	sumingh@ufl.edu	Li, Ying/L-7292-2019	, Yi/0000-0002-3282-6072	National Institute of Health [R01HL090589, R01HL091929, R01HL091929-01A1S1, R01HL095674]; NIH [5T32-CA9126-34]; Intramural Research programs, National Heart Lung Blood Institute and National Institute of Health; NATIONAL CANCER INSTITUTE [T32CA009126] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090589, ZICHL006058, ZIAHL005801, R01HL095674, ZIAHL006031, R01HL091929] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK056009] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research programs, National Heart Lung Blood Institute and National Institute of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We are grateful to members of the Huang laboratory for their suggestions and comments. This work was supported by grants from the National Institute of Health (SH, R01HL090589, R01HL091929 and R01HL091929-01A1S1-the ARRA Administrative supplement; YQ, R01HL095674). BP is supported by NIH T32 training grant (5T32-CA9126-34). KZ is supported by the Intramural Research programs, National Heart Lung Blood Institute and National Institute of Health.	APLAN PD, 1990, SCIENCE, V250, P1426, DOI 10.1126/science.2255914; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; BASH RO, 1995, BLOOD, V86, P666, DOI 10.1182/blood.V86.2.666.bloodjournal862666; Begley CG, 1999, BLOOD, V93, P2760; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Cai Y, 2009, BIOCHEM BIOPH RES CO, V390, P295, DOI 10.1016/j.bbrc.2009.09.111; Cantor AB, 2002, ONCOGENE, V21, P3368, DOI 10.1038/sj.onc.1205326; Martinez MC, 2006, BLOOD, V108, P3012, DOI 10.1182/blood-2006-04-019109; CHEN Q, 1990, EMBO J, V9, P415, DOI 10.1002/j.1460-2075.1990.tb08126.x; CHEN Q, 1990, J EXP MED, V172, P1403, DOI 10.1084/jem.172.5.1403; Condorelli GL, 1996, CANCER RES, V56, P5113; Cui KR, 2009, CELL STEM CELL, V4, P80, DOI 10.1016/j.stem.2008.11.011; de Laat W, 2003, CHROMOSOME RES, V11, P447, DOI 10.1023/A:1024922626726; Demers C, 2007, MOL CELL, V27, P573, DOI 10.1016/j.molcel.2007.06.022; Dey S, 2010, MOL CELL BIOL, V30, P2181, DOI 10.1128/MCB.01441-09; Goardon N, 2006, EMBO J, V25, P357, DOI 10.1038/sj.emboj.7600934; Grass JA, 2003, P NATL ACAD SCI USA, V100, P8811, DOI 10.1073/pnas.1432147100; Hansson A, 2003, BIOCHEM BIOPH RES CO, V312, P1073, DOI 10.1016/j.bbrc.2003.11.030; Herblot S, 2000, NAT IMMUNOL, V1, P138, DOI 10.1038/77819; Hsu PY, 2010, GENOME RES, V20, P733, DOI 10.1101/gr.101923.109; Hu Q, 2008, P NATL ACAD SCI USA, V105, P19199, DOI 10.1073/pnas.0810634105; Hu X, 2009, EPIGENETICS-US, V4, P257, DOI 10.4161/epi.4.6.9711; Hu X, 2009, P NATL ACAD SCI USA, V106, P10141, DOI 10.1073/pnas.0900437106; Huang S, 2000, MOL CELL BIOL, V20, P2248, DOI 10.1128/MCB.20.6.2248-2259.2000; Huang SM, 2000, EMBO J, V19, P6792, DOI 10.1093/emboj/19.24.6792; Huang SM, 1999, ONCOGENE, V18, P4958, DOI 10.1038/sj.onc.1202889; Izraeli S, 2004, BRIT J HAEMATOL, V126, P3, DOI 10.1111/j.1365-2141.2004.04986.x; Kassouf MT, 2010, GENOME RES, V20, P1064, DOI 10.1101/gr.104935.110; Kusy S, 2010, J EXP MED, V207, P2141, DOI 10.1084/jem.20100745; Lacombe J, 2010, BLOOD, V115, P792, DOI 10.1182/blood-2009-01-201384; Lan F, 2008, CURR OPIN CELL BIOL, V20, P316, DOI 10.1016/j.ceb.2008.03.004; Larson RC, 1996, EMBO J, V15, P1021, DOI 10.1002/j.1460-2075.1996.tb00439.x; Lee MG, 2005, NATURE, V437, P432, DOI 10.1038/nature04021; Lee MG, 2006, MOL CELL BIOL, V26, P6395, DOI 10.1128/MCB.00723-06; Li XG, 2010, BLOOD, V115, P2028, DOI 10.1182/blood-2009-07-236059; Linggi BE, 2005, J CELL BIOCHEM, V96, P938, DOI 10.1002/jcb.20604; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; O'Neil J, 2004, CANCER CELL, V5, P587, DOI 10.1016/j.ccr.2004.05.023; ORKIN SH, 1995, CURR OPIN CELL BIOL, V7, P870, DOI 10.1016/0955-0674(95)80072-7; Palamarchuk A, 2005, CANCER RES, V65, P4515, DOI 10.1158/0008-5472.CAN-05-0751; Palii CG, 2011, EMBO J, V30, P494, DOI 10.1038/emboj.2010.342; Palomero T, 2006, BLOOD, V108, P986, DOI 10.1182/blood-2005-08-3482; Porcher C, 1996, CELL, V86, P47, DOI 10.1016/S0092-8674(00)80076-8; PRASAD KSS, 1995, J BIOL CHEM, V270, P11603, DOI 10.1074/jbc.270.19.11603; Prasad KSS, 1997, J BIOL CHEM, V272, P11457; Robb L, 1997, BIOESSAYS, V19, P607, DOI 10.1002/bies.950190711; Robb L, 1996, EMBO J, V15, P4123, DOI 10.1002/j.1460-2075.1996.tb00787.x; Saleque S, 2007, MOL CELL, V27, P562, DOI 10.1016/j.molcel.2007.06.039; Sanchez MJ, 2001, DEVELOPMENT, V128, P4815; Schuh AH, 2005, MOL CELL BIOL, V25, P10235, DOI 10.1128/MCB.25.23.10235-10250.2005; Scoumanne A, 2007, J BIOL CHEM, V282, P15471, DOI 10.1074/jbc.M701023200; Shank-Calvo JA, 2006, ONCOGENE, V25, P3023, DOI 10.1038/sj.onc.1209326; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Song SH, 2007, MOL CELL, V28, P810, DOI 10.1016/j.molcel.2007.09.025; Tremblay M, 2003, J BIOL CHEM, V278, P12680, DOI 10.1074/jbc.M209870200; Tripic T, 2009, BLOOD, V113, P2191, DOI 10.1182/blood-2008-07-169417; WADMAN IA, 1994, ONCOGENE, V9, P3713; Wang J, 2009, NAT GENET, V41, P125, DOI 10.1038/ng.268; Wang Y, 2009, CELL, V138, P660, DOI 10.1016/j.cell.2009.05.050	59	51	53	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV	2012	31	48					5007	5018		10.1038/onc.2012.8	http://dx.doi.org/10.1038/onc.2012.8			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	048CU	22310283	Green Accepted			2022-12-25	WOS:000311888600005
J	Louwette, S; Labarque, V; Wittevrongel, C; Thys, C; Metz, J; Gijsbers, R; Debyser, Z; Arnout, J; Van Geet, C; Freson, K				Louwette, Sophie; Labarque, Veerle; Wittevrongel, Christine; Thys, Chantal; Metz, Juriaan; Gijsbers, Rik; Debyser, Zeger; Arnout, Jef; Van Geet, Chris; Freson, Kathleen			Regulator of G-protein signaling 18 controls megakaryopoiesis and the cilia-mediated vertebrate mechanosensory system	FASEB JOURNAL			English	Article						thrombocyte formation; zebrafish; hair cells; inner ear; neuromast migration; noncanonical Wnt	HEMATOPOIETIC STEM-CELLS; ZEBRAFISH DANIO-RERIO; NEGATIVE REGULATOR; B-LYMPHOCYTES; RGS PROTEINS; LATERAL-LINE; EXPRESSION; MATURATION; MUTATIONS; PLATELETS	RGS18 was originally identified as a R4 subfamily member of regulators of G-protein signaling (RGS) with specific expression in hematopoietic progenitors, myeloerythroid cells, and megakaryocytes, though its physiological role in hematopoiesis remained unknown. Here, we show that lentiviral RGS18 overexpression during differentiation of mouse Sca1(+) hematopoietic stem cells induced a 50% increase of megakaryocyte proliferation. RGS18 depletion in zebrafish results in thrombocytopenia, as 66 to 88% of the embryos lack thrombocytes after injection of an ATG or splice-blocking morpholino, respectively. These embryos have no defects in early hematopoiesis, erythropoiesis, or leukocyte number and migration. In addition, all RGS18 depleted embryos have curly tails and an almost absent response to acoustic stimuli. In situ hybridization in zebrafish, Xenopus, and mouse embryos shows RGS18 expression in thrombocytes and/or hematological tissues but also in brain and otic vesicles. RGS18 interferes with development of cilia in hair cells of the inner ear and neuromast cells. On the basis of literature evidence that RGS-R4 members interact with the G-protein-modulated Wnt/calcium pathway, Wnt5b-but not Wnt5a-depleted embryos phenocopy all RGS18 knockdown effects. In summary, our study is the first to show that RGS18 regulates megakaryopoiesis but also reveals its unexpected role in ciliogenesis, at least in lower vertebrates, via interference with Wnt signaling.-Louwette, S., Labarque, V., Wittevrongel, C., Thys, C., Metz, J., Gijsbers, R., Debyser, Z., Arnout, J., Van Geet, C., Freson, K. Regulator of G-protein signaling 18 controls megakaryopoiesis and the cilia-mediated vertebrate mechanosensory system. FASEB J. 26, 2125-2136 (2012). www.fasebj.org	[Labarque, Veerle; Van Geet, Chris] Univ Leuven, Dept Pediat, Louvain, Belgium; [Louwette, Sophie; Wittevrongel, Christine; Thys, Chantal; Arnout, Jef; Van Geet, Chris; Freson, Kathleen] Univ Leuven, Ctr Mol & Vasc Biol, Louvain, Belgium; [Gijsbers, Rik; Debyser, Zeger] Univ Leuven, Lab Mol Virol & Gene Therapy, Louvain, Belgium; [Metz, Juriaan] Radboud Univ Nijmegen, Dept Anim Physiol, Inst Water & Wetland Res, NL-6525 ED Nijmegen, Netherlands	KU Leuven; KU Leuven; KU Leuven; Radboud University Nijmegen	Freson, K (corresponding author), Katholieke Univ Leuven, Ctr Mol & Vasc Biol, Campus Gasthuisberg,O&N1,Herestr 49,Box 911, B-3000 Louvain, Belgium.	kathleen.freson@med.kuleuven.be	Metz, Juriaan R./A-3290-2012	Metz, Juriaan R./0000-0002-1515-1958; freson, kathleen/0000-0002-4381-2442	KU Leuven [EF/05/013]; FWO-Vlaanderen [G.0490.10N, G.0743.09]; Research Council of the University of Leuven (Onderzoeksraad KU Leuven, Leuven, Belgium) [GOA/2009/13]	KU Leuven(KU Leuven); FWO-Vlaanderen(FWO); Research Council of the University of Leuven (Onderzoeksraad KU Leuven, Leuven, Belgium)	C.V.G. is a holder of a clinical-fundamental research mandate of the Fund for Scientific Research-Flanders (FWO-Vlaanderen; Belgium) and of the Bayer and Norbert Heimburger (CSL Behring) chairs. This article was supported by the Excellentie financiering KU Leuven (EF/05/013), by research grants G.0490.10N and G.0743.09 from the FWO-Vlaanderen; and by GOA/2009/13 from the Research Council of the University of Leuven (Onderzoeksraad KU Leuven, Leuven, Belgium).	Beadling C, 1999, J IMMUNOL, V162, P2677; Berthebaud M, 2005, BLOOD, V106, P2962, DOI 10.1182/blood-2005-02-0526; Chen D, 2007, EXP HEMATOL, V35, P1344, DOI 10.1016/j.exphem.2007.06.004; De Waele L., PEDIAT RES, V67, P314; Delvaeye M, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-25; Denecke B, 1999, J BIOL CHEM, V274, P26860, DOI 10.1074/jbc.274.38.26860; Faber J., 1994, SYSTEMATICAL CHRONOL; Freisinger C. M., PLOS GENET, V6; Freson K, 2008, BLOOD, V111, P1885, DOI 10.1182/blood-2007-06-098558; Gagnon AW, 2002, CELL SIGNAL, V14, P595, DOI 10.1016/S0898-6568(02)00012-8; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; Heximer SP, 1997, DNA CELL BIOL, V16, P589, DOI 10.1089/dna.1997.16.589; Hughes I, 2004, DEV BIOL, V276, P391, DOI 10.1016/j.ydbio.2004.09.001; Ibrahimi A, 2009, HUM GENE THER, V20, P845, DOI 10.1089/hum.2008.188; Jagadeeswaran P, 1999, BLOOD CELL MOL DIS, V25, P239, DOI 10.1006/bcmd.1999.0249; Kehrl JH, 1998, IMMUNITY, V8, P1, DOI 10.1016/S1074-7613(00)80453-7; Kim SD, 2006, PLATELETS, V17, P493, DOI 10.1080/09537100600758123; KORZH V, 1993, DEVELOPMENT, V118, P417; Lele Z, 2001, GENESIS, V30, P190, DOI 10.1002/gene.1063; Lin HF, 2005, BLOOD, V106, P3803, DOI 10.1182/blood-2005-01-0179; Liu JX, 2009, J BIOL CHEM, V284, P16679, DOI 10.1074/jbc.M109.009654; Moratz C, 2000, J IMMUNOL, V164, P1829, DOI 10.4049/jimmunol.164.4.1829; Morrison SJ, 1995, ANNU REV CELL DEV BI, V11, P35, DOI 10.1146/annurev.cb.11.110195.000343; Nicolson T, 2005, ANNU REV GENET, V39, P9, DOI 10.1146/annurev.genet.39.073003.105049; Noe L, 2010, J THROMB HAEMOST, V8, P1594, DOI 10.1111/j.1538-7836.2010.03885.x; Parks IK, 2001, J BIOL CHEM, V276, P915, DOI 10.1074/jbc.M005947200; Person AD, 2010, DEV DYNAM, V239, P327, DOI 10.1002/dvdy.22156; Pizard A, 2004, CURR PROTOC MOL BIOL, V14, p14.9, DOI 10.1002/0471142727.mb1409-66; Popper AN, 2000, PHILOS T ROY SOC B, V355, P1277, DOI 10.1098/rstb.2000.0683; Reif K, 2000, J IMMUNOL, V164, P4720, DOI 10.4049/jimmunol.164.9.4720; Riley BB, 1997, DEV BIOL, V191, P191, DOI 10.1006/dbio.1997.8736; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Santos F, 2006, HEARING RES, V213, P25, DOI 10.1016/j.heares.2005.12.009; Schmid A., BIOL CELL, V103, P159; SCHULTEMERKER S, 1992, DEVELOPMENT, V116, P1021; Sercan Z., LEUK RES, V34, P946; Van Geet C, 2009, J THROMB HAEMOST, V7, P282, DOI 10.1111/j.1538-7836.2009.03399.x; Wang HY, 2003, SCIENCE, V300, P1529, DOI 10.1126/science.1085259; Westfall TA, 2003, J CELL BIOL, V162, P889, DOI 10.1083/jcb.200303107; Whitfield TT, 1996, DEVELOPMENT, V123, P241; Wu CL, 2000, DEVELOPMENT, V127, P2773	42	20	20	1	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	MAY	2012	26	5					2125	2136		10.1096/fj.11-198739	http://dx.doi.org/10.1096/fj.11-198739			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	937TD	22308195				2022-12-25	WOS:000303680800038
J	Barneda-Zahonero, B; Servitja, JM; Badiola, N; Minano-Molina, AJ; Fado, R; Saura, CA; Rodriguez-Alvarez, J				Barneda-Zahonero, Bruna; Servitja, Joan-Marc; Badiola, Nahuai; Minano-Molina, Alfredo J.; Fado, Rut; Saura, Carlos A.; Rodriguez-Alvarez, Jose			Nurr1 Protein Is Required for N-Methyl-D-aspartic Acid (NMDA) Receptor-mediated Neuronal Survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CEREBELLAR GRANULE CELLS; TRANSCRIPTION FACTOR; SIGNAL-TRANSDUCTION; GENE-EXPRESSION; NR2B SUBUNIT; BDNF GENE; IN-VIVO; RAT; DEATH; ACTIVATION	NMDA receptor(NMDAR) stimulation promotes neuronal survival during brain development. Cerebellar granule cells (CGCs) need NMDAR stimulation to survive and develop. These neurons differentiate and mature during its migration from the external granular layer to the internal granular layer, and lack of excitatory inputs triggers their apoptotic death. It is possible to mimic this process in vitro by culturing CGCs in low KCl concentrations (5 mM) in the presence or absence of NMDA. Using this experimental approach, we have obtained whole genome expression profiles after 3 and 8 h of NMDA addition to identify genes involved in NMDA-mediated survival of CGCs. One of the identified genes was Nurr1, a member of the orphan nuclear receptor subfamily Nr4a. Our results report a direct regulation of Nurr1 by CREB after NMDAR stimulation. ChIP assay confirmed CREB binding to Nurr1 promoter, whereas CREB shRNA blocked NMDA-mediated increase in Nurr1 expression. Moreover, we show that Nurr1 is important for NMDAR survival effect. We show that Nurr1 binds to Bdnf promoter IV and that silencing Nurr1 by shRNA leads to a decrease in brain-derived neurotrophic factor (BDNF) protein levels and a reduction of NMDA neuroprotective effect. Also, we report that Nurr1 and BDNF show a similar expression pattern during postnatal cerebellar development. Thus, we conclude that Nurr1 is a downstream target of CREB and that it is responsible for the NMDA-mediated increase in BDNF, which is necessary for the NMDA-mediated prosurvival effect on neurons.	[Barneda-Zahonero, Bruna; Badiola, Nahuai; Minano-Molina, Alfredo J.; Fado, Rut; Saura, Carlos A.; Rodriguez-Alvarez, Jose] Univ Autonoma Barcelona, Inst Neurociencies, E-08193 Barcelona, Spain; [Barneda-Zahonero, Bruna; Badiola, Nahuai; Minano-Molina, Alfredo J.; Fado, Rut; Saura, Carlos A.; Rodriguez-Alvarez, Jose] Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, E-08193 Barcelona, Spain; [Barneda-Zahonero, Bruna; Badiola, Nahuai; Minano-Molina, Alfredo J.; Fado, Rut; Saura, Carlos A.; Rodriguez-Alvarez, Jose] Ctr Invest Biomed Red Enfermedades Neurodegenerat, Barcelona 08193, Spain; [Servitja, Joan-Marc] Inst Invest Biomed August Pi & Sunyer IDIBAPS, Diabet & Obes Lab, Barcelona 08036, Spain; [Servitja, Joan-Marc] CIBER Diabet & Enfermedades Metab CIBERDEM, Barcelona 08036, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona; CIBERNED; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM	Rodriguez-Alvarez, J (corresponding author), Univ Autonoma Barcelona, Inst Neurociencias, Edificio M,Campus Bellaterra, E-08193 Barcelona, Spain.	jose.rodriguez@uab.es	Badiola, Nahuai/C-6526-2011; Andrés, Fadó Fadó/L-8585-2014; Saura, Carlos A/D-2727-2011; Miñano-Molina, Alfredo J/C-9863-2011; Saura, Carlos A/AFM-9239-2022; Rodriguez-Alvarez, Jose/F-8403-2011	Badiola, Nahuai/0000-0001-9488-5628; Andrés, Fadó Fadó/0000-0002-3293-2342; Saura, Carlos A/0000-0003-3692-5657; Miñano-Molina, Alfredo J/0000-0002-7761-5682; Rodriguez-Alvarez, Jose/0000-0001-8582-8082; Barneda Zahonero, Bruna/0000-0002-6557-5222; SERVITJA, JOAN-MARC/0000-0002-1241-8004	Ministerio de Ciencia e Innovacion [SAF2008-01904, SAF2011-30281, SAF2010-20925]; CIBERNED [CB06/05/0042]; Universitat Autonoma de Barcelona; Gobierno Vasco; Generalitat de Catalunya	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); CIBERNED(Instituto de Salud Carlos III); Universitat Autonoma de Barcelona; Gobierno Vasco(Basque Government); Generalitat de Catalunya(Generalitat de Catalunya)	This work was supported by grants from the Ministerio de Ciencia e Innovacion (Grants SAF2008-01904, SAF2011-30281, and RENEVAS) and CIBERNED (Grant CB06/05/0042) (to J. R. A) and the Ministerio de Ciencia e Innovacion (Grant SAF2010-20925) (to C. A. S.).; Recipient of a predoctoral fellowship from the Universitat Autonoma de Barcelona.; Recipient of a predoctoral fellowship from the Gobierno Vasco.; Recipient of a predoctoral fellowship from the Generalitat de Catalunya.	Adams SM, 2004, J NEUROSCI, V24, P9441, DOI 10.1523/JNEUROSCI.3290-04.2004; Aid T, 2007, J NEUROSCI RES, V85, P525, DOI 10.1002/jnr.21139; ALTMAN J, 1972, J COMP NEUROL, V145, P465, DOI 10.1002/cne.901450403; BALAZS R, 1988, NEUROSCIENCE, V27, P437, DOI 10.1016/0306-4522(88)90279-5; Bhave SV, 1999, J NEUROSCI, V19, P3277, DOI 10.1523/jneurosci.19-09-03277.1999; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Borghesani PR, 2002, DEVELOPMENT, V129, P1435; Braunewell KH, 2009, CELL TISSUE RES, V335, P301, DOI 10.1007/s00441-008-0716-3; Brunet A, 2001, CURR OPIN NEUROBIOL, V11, P297, DOI 10.1016/S0959-4388(00)00211-7; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; BURGOYNE RD, 1988, BRAIN RES REV, V13, P77, DOI 10.1016/0165-0173(88)90006-9; Contestabile A., 2002, CEREBELLUM, V1, P41; CULLEN BR, 1987, METHOD ENZYMOL, V152, P684; Darragh J, 2005, BIOCHEM J, V390, P749, DOI 10.1042/BJ20050196; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Enguita M, 2005, MOL PHARMACOL, V67, P1237, DOI 10.1124/mol.104.007062; ESTUS S, 1994, J CELL BIOL, V127, P1717, DOI 10.1083/jcb.127.6.1717; Farioli-Vecchioli S, 2007, FASEB J, V21, P2215, DOI 10.1096/fj.06-7548com; Fukuchi M, 2004, J NEUROSCI RES, V77, P26, DOI 10.1002/jnr.20132; GALLO V, 1987, J NEUROSCI, V7, P2203; GOULD E, 1994, J COMP NEUROL, V340, P551, DOI 10.1002/cne.903400408; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Hardingham GE, 2001, NAT NEUROSCI, V4, P261, DOI 10.1038/85109; Ikonomidou C, 1999, SCIENCE, V283, P70, DOI 10.1126/science.283.5398.70; Komuro H, 2001, J NEUROSCI, V21, P527, DOI 10.1523/JNEUROSCI.21-02-00527.2001; KUBO T, 1995, DEV BRAIN RES, V85, P249, DOI 10.1016/0165-3806(94)00220-T; Lafon-Cazal M, 2002, EUR J NEUROSCI, V16, P575, DOI 10.1046/j.1460-9568.2002.02124.x; Luo Y, 2007, EXP NEUROL, V203, P221, DOI 10.1016/j.expneurol.2006.08.005; Mancini JD, 2007, NEUROSCI LETT, V429, P87, DOI 10.1016/j.neulet.2007.09.079; Marini AM, 1998, J BIOL CHEM, V273, P29394, DOI 10.1074/jbc.273.45.29394; McEvoy AN, 2002, J IMMUNOL, V168, P2979, DOI 10.4049/jimmunol.168.6.2979; Monti B, 2000, EUR J NEUROSCI, V12, P3117, DOI 10.1046/j.1460-9568.2000.00189.x; Monti B, 2002, EUR J NEUROSCI, V16, P1490, DOI 10.1046/j.1460-9568.2002.02232.x; Monti B, 2007, J NEUROCHEM, V103, P518, DOI 10.1111/j.1471-4159.2007.04778.x; Naldini L, 1996, P NATL ACAD SCI USA, V93, P11382, DOI 10.1073/pnas.93.21.11382; Okazawa M, 2009, J NEUROSCI, V29, P2938, DOI 10.1523/JNEUROSCI.5932-08.2009; Ravnskjaer K, 2007, EMBO J, V26, P2880, DOI 10.1038/sj.emboj.7601715; Ryu H, 2003, J NEUROSCI, V23, P3597; Saucedo-Cardenas O, 1998, P NATL ACAD SCI USA, V95, P4013, DOI 10.1073/pnas.95.7.4013; Schwartz PM, 1997, NEURON, V19, P269, DOI 10.1016/S0896-6273(00)80938-1; Severini C, 2008, J NEUROCHEM, V104, P534, DOI 10.1111/j.1471-4159.2007.05068.x; Smits SM, 2003, EUR J NEUROSCI, V18, P1731, DOI 10.1046/j.1460-9568.2003.02885.x; Soriano FX, 2006, J NEUROSCI, V26, P4509, DOI 10.1523/JNEUROSCI.0455-06.2006; Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7; Tarnok K, 2008, J NEUROCHEM, V104, P818, DOI 10.1111/j.1471-4159.2007.05051.x; Tissir F, 2009, P NATL ACAD SCI USA, V106, P16871, DOI 10.1073/pnas.0903191106; TRANI E, 1995, J NEUROCHEM, V65, P2441; Volpicelli F, 2007, J NEUROCHEM, V102, P441, DOI 10.1111/j.1471-4159.2007.04494.x; Wang XM, 2005, J BIOL CHEM, V280, P16705, DOI 10.1074/jbc.M501819200; WOOD KA, 1993, NEURON, V11, P621, DOI 10.1016/0896-6273(93)90074-2; Xia ZG, 1996, J NEUROSCI, V16, P5425; Xifro X, 2005, EUR J NEUROSCI, V21, P827, DOI 10.1111/j.1460-9568.2005.03935.x; Yang YX, 2008, NEUROREPORT, V19, P867, DOI 10.1097/WNR.0b013e3282ffda48; Zhang FX, 1998, J BIOL CHEM, V273, P26596, DOI 10.1074/jbc.273.41.26596; Zhang SJ, 2007, NEURON, V53, P549, DOI 10.1016/j.neuron.2007.01.025; Zheng WH, 2002, MOL PHARMACOL, V62, P225, DOI 10.1124/mol.62.2.225; Zhou PC, 2007, NEURON, V55, P53, DOI 10.1016/j.neuron.2007.05.030; Zufferey R, 1998, J VIROL, V72, P9873, DOI 10.1128/JVI.72.12.9873-9880.1998	58	41	42	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					11351	11362		10.1074/jbc.M111.272427	http://dx.doi.org/10.1074/jbc.M111.272427			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22294685	hybrid, Green Published			2022-12-25	WOS:000302780100065
J	Morcavallo, A; Genua, M; Palummo, A; Kletvikova, E; Jiracek, J; Brzozowski, AM; Iozzo, RV; Belfiore, A; Morrione, A				Morcavallo, Alaide; Genua, Marco; Palummo, Angela; Kletvikova, Emilia; Jiracek, Jiri; Brzozowski, Andrzej M.; Iozzo, Renato V.; Belfiore, Antonino; Morrione, Andrea			Insulin and Insulin-like Growth Factor II Differentially Regulate Endocytic Sorting and Stability of Insulin Receptor Isoform A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLADDER-CANCER CELLS; HUMAN-BREAST-CANCER; DEPENDENT ENDOCYTOSIS; DOWN-REGULATION; HEPATOMA-CELLS; MESSENGER-RNA; BINDING; DEGRADATION; INTERNALIZATION; PROTEINS	The insulin receptor isoform A (IR-A) binds both insulin and insulin-like growth factor (IGF)-II, although the affinity for IGF-II is 3-10-fold lower than insulin depending on a cell and tissue context. Notably, in mouse embryonic fibroblasts lacking the IGF-IR and expressing solely the IR-A (R-/IR-A), IGF-II is a more potent mitogen than insulin. As receptor endocytosis and degradation provide spatial and temporal regulation of signaling events, we hypothesized that insulin and IGF-II could affect IR-A biological responses by differentially regulating IR-A trafficking. Using R-/IR-A cells, we discovered that insulin evoked significant IR-A internalization, a process modestly affected by IGF-II. However, the differential internalization was not due to IR-A ubiquitination. Notably, prolonged stimulation of R-/IR-A cells with insulin, but not with IGF-II, targeted the receptor to a degradative pathway. Similarly, the docking protein insulin receptor substrate 1 (IRS-1) was down-regulated after prolonged insulin but not IGF-II exposure. Similar results were also obtained in experiments using [NMeTyr(B26)]-insulin, an insulin analog with IR-A binding affinity similar to IGF-II. Finally, we discovered that IR-A was internalized through clathrin-dependent and -independent pathways, which differentially regulated the activation of downstream effectors. Collectively, our results suggest that a lower affinity of IGF-II for the IR-A promotes lower IR-A phosphorylation and activation of early downstream effectors vis a vis insulin but may protect IR-A and IRS-1 from down-regulation thereby evoking sustained and robust mitogenic stimuli.	[Morcavallo, Alaide; Genua, Marco; Morrione, Andrea] Thomas Jefferson Univ, Kimmel Canc Ctr, Dept Urol, Philadelphia, PA 19107 USA; [Morcavallo, Alaide; Genua, Marco; Morrione, Andrea] Thomas Jefferson Univ, Kimmel Canc Ctr, Endocrine Mech & Hormone Act Program, Philadelphia, PA 19107 USA; [Iozzo, Renato V.] Thomas Jefferson Univ, Kimmel Canc Ctr, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA; [Iozzo, Renato V.] Thomas Jefferson Univ, Kimmel Canc Ctr, Canc Cell Biol & Signaling Program, Philadelphia, PA 19107 USA; [Morcavallo, Alaide; Palummo, Angela; Belfiore, Antonino] Univ Catanzaro, Dept Hlth & Endocrinol, I-88100 Catanzaro, Italy; [Kletvikova, Emilia; Jiracek, Jiri] Acad Sci Czech Republic, Vvl, Inst Organ Chem & Biochem, Prague 616610, Czech Republic; [Brzozowski, Andrzej M.] Univ York, Dept Chem, York Struct Biol Lab, York YO10 5DD, N Yorkshire, England	Jefferson University; Jefferson University; Jefferson University; Jefferson University; Magna Graecia University of Catanzaro; Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences; University of York - UK	Belfiore, A (corresponding author), Univ Magna Grecia, Dept Hlth, Endocrinol Unit, Campus Univ,Viale Europa, I-88100 Catanzaro, Italy.	belfiore@unicz.it; andrea.morrione@jefferson.edu	Belfiore, Antonino/B-4652-2011; Iozzo, Renato/AAS-1980-2020; Jiracek, Jiri/Y-6703-2019; Jiracek, Jiri/A-7124-2008; Genua, Marco/J-4159-2018	Belfiore, Antonino/0000-0002-6181-4193; Jiracek, Jiri/0000-0003-3848-2773; Jiracek, Jiri/0000-0003-3848-2773; Genua, Marco/0000-0002-0764-8163; Iozzo, Renato/0000-0002-5908-5112	National Institutes of Health [RO1 DK068419]; Benjamin Perkins Bladder Cancer Fund; Martin Greitzer Fund; Associazione Italiana per la Ricerca sul Cancro (AIRC) [10625]; Fondazione Cassa di Risparmio di Calabria e Lucania, Ministero dell' Istruzione, dell' Universita e della Ricerca [2008BKRFBH_005]; Academy of Sciences of the Czech Republic [Z40550506]; NATIONAL CANCER INSTITUTE [R01CA039481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068419] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Benjamin Perkins Bladder Cancer Fund; Martin Greitzer Fund; Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Fondazione Cassa di Risparmio di Calabria e Lucania, Ministero dell' Istruzione, dell' Universita e della Ricerca; Academy of Sciences of the Czech Republic(Czech Academy of Sciences); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 DK068419 (to A. M.), the Benjamin Perkins Bladder Cancer Fund and the Martin Greitzer Fund (to A. M.), and grants from the Associazione Italiana per la Ricerca sul Cancro (AIRC Grant 10625), AIRC project Calabria 2011 and Fondazione Cassa di Risparmio di Calabria e Lucania, Programmi di Ricerca di Rilevante Interesse Nazionale-Ministero dell' Istruzione, dell' Universita e della Ricerca (PRIN-MIUR) Grant 2008BKRFBH_005 (to A. B.), and Research Project of the Academy of Sciences of the Czech Republic Grant Z40550506 (to J. J.).	Acconcia F, 2009, EXP CELL RES, V315, P1610, DOI 10.1016/j.yexcr.2008.10.014; Baldys A, 2009, BIOCHEMISTRY-US, V48, P1462, DOI 10.1021/bi801771g; Belfiore A, 2007, CURR PHARM DESIGN, V13, P671, DOI 10.2174/138161207780249173; Belfiore A, 2011, ENDOCR-RELAT CANCER, V18, pR125, DOI 10.1530/ERC-11-0074; Chen CL, 2009, J CELL SCI, V122, P1863, DOI 10.1242/jcs.038729; Di Fiore PP, 2001, CELL, V106, P1, DOI 10.1016/S0092-8674(01)00428-7; Dong LQ, 1997, J BIOL CHEM, V272, P29104, DOI 10.1074/jbc.272.46.29104; Fagerholm S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005985; FAN JY, 1982, P NATL ACAD SCI-BIOL, V79, P7788, DOI 10.1073/pnas.79.24.7788; Frasca F, 1999, MOL CELL BIOL, V19, P3278, DOI 10.1128/mcb.19.5.3278; Frasca Francesco, 2003, Breast Dis, V17, P73; Gauguin L, 2008, J BIOL CHEM, V283, P2604, DOI 10.1074/jbc.M709220200; Giudice J, 2011, J CELL SCI, V124, P801, DOI 10.1242/jcs.076869; Grant BD, 2009, NAT REV MOL CELL BIO, V10, P597, DOI 10.1038/nrm2755; Gustavsson J, 1999, FASEB J, V13, P1961, DOI 10.1096/fasebj.13.14.1961; Haglund K, 2003, NAT CELL BIOL, V5, P461, DOI 10.1038/ncb983; Hansen BF, 2011, DIABETOLOGIA, V54, P2226, DOI 10.1007/s00125-011-2203-8; Hansen BF, 1996, BIOCHEM J, V315, P271; Hansen H, 1996, J BIOL CHEM, V271, P8882, DOI 10.1074/jbc.271.15.8882; Haruta T, 2000, MOL ENDOCRINOL, V14, P783, DOI 10.1210/me.14.6.783; HWANG DL, 1985, J RECEPTOR RES, V5, P27, DOI 10.3109/10799898509041869; Jiracek J, 2010, P NATL ACAD SCI USA, V107, P1966, DOI 10.1073/pnas.0911785107; KOSAKI A, 1993, J BIOL CHEM, V268, P21990; KRYWICKI RF, 1992, BREAST CANCER RES TR, V22, P7, DOI 10.1007/BF01833329; Laviola L, 1997, J CLIN INVEST, V99, P830, DOI 10.1172/JCI119246; Le Roy C, 2005, NAT REV MOL CELL BIO, V6, P112, DOI 10.1038/nrm1571; Lee AV, 2000, MOL CELL BIOL, V20, P1489, DOI 10.1128/MCB.20.5.1489-1496.2000; LIU F, 1995, P NATL ACAD SCI USA, V92, P10287, DOI 10.1073/pnas.92.22.10287; Lovat F, 2009, CARCINOGENESIS, V30, P861, DOI 10.1093/carcin/bgp050; MCCLAIN DA, 1988, DIABETES, V37, P806, DOI 10.2337/diabetes.37.6.806; Metalli D, 2010, AM J PATHOL, V176, P2997, DOI 10.2353/ajpath.2010.090904; Milazzo G, 1997, MOL CARCINOGEN, V18, P19, DOI 10.1002/(SICI)1098-2744(199701)18:1<19::AID-MC3>3.0.CO;2-M; MIURA M, 1995, J BIOL CHEM, V270, P22639, DOI 10.1074/jbc.270.38.22639; Monami G, 2008, J CELL PHYSIOL, V216, P426, DOI 10.1002/jcp.21405; Monami G, 2006, CANCER RES, V66, P7103, DOI 10.1158/0008-5472.CAN-06-0633; Morcavallo A, 2011, MOL ENDOCRINOL, V25, P1456, DOI 10.1210/me.2010-0484; Morrione A, 1997, J BIOL CHEM, V272, P26382, DOI 10.1074/jbc.272.42.26382; Morrione A, 1997, P NATL ACAD SCI USA, V94, P3777, DOI 10.1073/pnas.94.8.3777; Morrione A, 1999, J BIOL CHEM, V274, P24094, DOI 10.1074/jbc.274.34.24094; Mosesson Y, 2003, J BIOL CHEM, V278, P21323, DOI 10.1074/jbc.C300096200; MOSTHAF L, 1990, EMBO J, V9, P2409, DOI 10.1002/j.1460-2075.1990.tb07416.x; MOUNTJOY KG, 1987, CANCER RES, V47, P6500; PACCAUD JP, 1992, J BIOL CHEM, V267, P13101; Pandini G, 2002, J BIOL CHEM, V277, P39684, DOI 10.1074/jbc.M202766200; PAPA V, 1993, CANCER RES, V53, P3736; Polo S, 2004, CURR OPIN CELL BIOL, V16, P156, DOI 10.1016/j.ceb.2004.02.003; Ramos FJ, 2006, AM J PHYSIOL-ENDOC M, V290, pE1262, DOI 10.1152/ajpendo.00609.2005; Roepstorff K, 2009, TRAFFIC, V10, P1115, DOI 10.1111/j.1600-0854.2009.00943.x; ROSE DW, 1994, P NATL ACAD SCI USA, V91, P797, DOI 10.1073/pnas.91.2.797; Sacco A, 2009, ENDOCRINOLOGY, V150, P3594, DOI 10.1210/en.2009-0377; SASAOKA T, 1994, J BIOL CHEM, V269, P13689; SEINO S, 1989, BIOCHEM BIOPH RES CO, V159, P312, DOI 10.1016/0006-291X(89)92439-X; SELL C, 1994, MOL CELL BIOL, V14, P3604, DOI 10.1128/MCB.14.6.3604; Seto ES, 2002, GENE DEV, V16, P1314, DOI 10.1101/gad.989602; Sigismund S, 2005, P NATL ACAD SCI USA, V102, P2760, DOI 10.1073/pnas.0409817102; Sigismund S, 2008, DEV CELL, V15, P209, DOI 10.1016/j.devcel.2008.06.012; Stern KA, 2008, BIOCHEM J, V410, P585, DOI 10.1042/BJ20071505; SUN XJ, 1993, MOL CELL BIOL, V13, P7418, DOI 10.1128/MCB.13.12.7418; SWILLENS S, 1995, MOL PHARMACOL, V47, P1197; Vecchione A, 2003, MOL CELL BIOL, V23, P3363, DOI 10.1128/MCB.23.9.3363-3372.2003; Webster NJG, 1997, BIOCHEM MOL MED, V62, P139, DOI 10.1006/bmme.1997.2648; White MF, 2002, AM J PHYSIOL-ENDOC M, V283, pE413, DOI 10.1152/ajpendo.00514.2001; White MF, 1998, MOL CELL BIOCHEM, V182, P3, DOI 10.1023/A:1006806722619; YAMAGUCHI Y, 1993, ENDOCRINOLOGY, V132, P1132, DOI 10.1210/en.132.3.1132; Yao DY, 2002, MOL BIOL CELL, V13, P4001, DOI 10.1091/mbc.02-07-0104; Zakova L, 2008, BIOCHEMISTRY-US, V47, P5858, DOI 10.1021/bi702086w; ZAPF A, 1994, ENDOCRINOLOGY, V134, P2445, DOI 10.1210/en.134.6.2445	67	60	63	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					11422	11436		10.1074/jbc.M111.252478	http://dx.doi.org/10.1074/jbc.M111.252478			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22318726	Green Published, hybrid			2022-12-25	WOS:000302780100071
J	Valderrama, JA; Durante-Rodriguez, G; Blazquez, B; Garcia, JL; Carmona, M; Diaz, E				Andres Valderrama, J.; Durante-Rodriguez, Gonzalo; Blazquez, Blas; Luis Garcia, Jose; Carmona, Manuel; Diaz, Eduardo			Bacterial Degradation of Benzoate CROSS-REGULATION BETWEEN AEROBIC AND ANAEROBIC PATHWAYS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-KETOADIPATE PATHWAY; BURKHOLDERIA-XENOVORANS LB400; CARBON CATABOLITE REPRESSION; GRAM-NEGATIVE BACTERIA; AROMATIC-COMPOUNDS; ESCHERICHIA-COLI; BIOCHEMICAL-CHARACTERIZATION; TRANSCRIPTIONAL REGULATION; PSEUDOMONAS-PUTIDA; PHENYLACETIC ACID	We have studied for the first time the transcriptional regulatory circuit that controls the expression of the box genes encoding the aerobic hybrid pathway used to assimilate benzoate via coenzyme A (CoA) derivatives in bacteria. The promoters responsible for the expression of the box cluster in the beta-proteobacterium Azoarcus sp., their cognate transcriptional repressor, the BoxR protein, and the inducer molecule (benzoyl-CoA) have been characterized. The BoxR protein shows a significant sequence identity to the BzdR transcriptional repressor that controls the bzd genes involved in the anaerobic degradation of benzoate. Because the boxR gene is present in all box clusters so far identified in bacteria, the BoxR/benzoyl-CoA regulatory system appears to be a widespread strategy to control this aerobic hybrid pathway. Interestingly, the paralogous BoxR and BzdR regulators act synergistically to control the expression of the box and bzd genes. This cross-regulation between anaerobic and aerobic pathways for the catabolism of aromatic compounds has never been shown before, and it may reflect a biological strategy to increase the cell fitness in organisms that survive in environments subject to changing oxygen concentrations.	[Andres Valderrama, J.; Durante-Rodriguez, Gonzalo; Blazquez, Blas; Luis Garcia, Jose; Carmona, Manuel; Diaz, Eduardo] CSIC, Ctr Invest Biol, Dept Environm Biol, Madrid 28040, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	Diaz, E (corresponding author), CSIC, Ctr Invest Biol, Dept Environm Biol, Ramiro de Maeztu 9, Madrid 28040, Spain.	ediaz@cib.csic.es	Castiñeira, Blas Blázquez/J-1353-2014; Valderrama, Jonathan Andres/AAC-1098-2021; Diaz, Eduardo/F-8605-2016; Durante-Rodríguez, Gonzalo/H-3000-2013; Garcia Lopez, Jose Luis/G-9139-2015	Diaz, Eduardo/0000-0002-9731-6524; Durante-Rodríguez, Gonzalo/0000-0003-3113-9868; Valderrama Traslavina, J. Andres/0000-0001-7440-4225; Garcia Lopez, Jose Luis/0000-0002-9238-2485; Carmona, Manuel/0000-0002-1591-7618; Blazquez, Blas/0000-0003-4099-6909	Comision Interministerial de Ciencia y Tecnologia [BIO2009-10438, CSD2007-00005]; Plan Nacional de Formacion de Personal Investigador-Ministry of Science and Innovation	Comision Interministerial de Ciencia y Tecnologia(Consejo Interinstitucional de Ciencia y Tecnologia (CICYT)); Plan Nacional de Formacion de Personal Investigador-Ministry of Science and Innovation	This work was supported by grants BIO2009-10438 and CSD2007-00005 from the Comision Interministerial de Ciencia y Tecnologia.; Recipients of predoctoral fellowships from the Plan Nacional de Formacion de Personal Investigador-Ministry of Science and Innovation.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bains J, 2008, J MOL BIOL, V379, P597, DOI 10.1016/j.jmb.2008.04.031; Bains J, 2007, J MOL BIOL, V373, P965, DOI 10.1016/j.jmb.2007.08.008; Bains J, 2009, J BIOL CHEM, V284, P16377, DOI 10.1074/jbc.M900226200; Barragan MJL, 2005, J BIOL CHEM, V280, P10683, DOI 10.1074/jbc.M412259200; Barragan MJL, 2004, J BACTERIOL, V186, P5762, DOI 10.1128/JB.186.17.5762-5774.2004; Bleichrodt FS, 2010, MICROBIOL-SGM, V156, P1313, DOI 10.1099/mic.0.037424-0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brzostowicz PC, 2003, APPL ENVIRON MICROB, V69, P1598, DOI 10.1128/AEM.69.3.1598-1606.2003; Carmona Manuel, 2008, P97; Carmona M, 2009, MICROBIOL MOL BIOL R, V73, P71, DOI 10.1128/MMBR.00021-08; CASADABAN MJ, 1976, J MOL BIOL, V104, P541, DOI 10.1016/0022-2836(76)90119-4; Cases I, 2005, NAT REV MICROBIOL, V3, P105, DOI 10.1038/nrmicro1084; Cervin MA, 1998, NUCLEIC ACIDS RES, V26, P3806, DOI 10.1093/nar/26.16.3806; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Cowles CE, 2000, J BACTERIOL, V182, P6339, DOI 10.1128/JB.182.22.6339-6346.2000; DELORENZO V, 1994, METHOD ENZYMOL, V235, P386; Denef VJ, 2006, APPL ENVIRON MICROB, V72, P585, DOI 10.1128/AEM.72.1.585-595.2006; Denef VJ, 2005, J BACTERIOL, V187, P7996, DOI 10.1128/JB.187.23.7996-8005.2005; Diaz E, 2004, INT MICROBIOL, V7, P173; Dombroski AJ, 1997, J BIOL CHEM, V272, P3487; Durante-Rodriguez G, 2006, J BACTERIOL, V188, P2343, DOI 10.1128/JB.188.7.2343-2354.2006; Durante-Rodriguez G, 2008, MICROBIOL-SGM, V154, P306, DOI 10.1099/mic.0.2007/011361-0; Durante-Rodriguez G, 2010, J BIOL CHEM, V285, P35694, DOI 10.1074/jbc.M110.143503; Ezezika OC, 2006, APPL ENVIRON MICROB, V72, P1749, DOI 10.1128/AEM.72.3.1749-1758.2006; Felsenstein J., 1993, PHYLIP PHYLOGENETIC; FERNANDEZ S, 1995, MOL MICROBIOL, V16, P205, DOI 10.1111/j.1365-2958.1995.tb02293.x; Ferrandez A, 1998, J BIOL CHEM, V273, P25974, DOI 10.1074/jbc.273.40.25974; Fuchs G, 2008, ANN NY ACAD SCI, V1125, P82, DOI 10.1196/annals.1419.010; Gescher J, 2006, J BACTERIOL, V188, P2919, DOI 10.1128/JB.188.8.2919-2927.2006; Gescher J, 2002, J BACTERIOL, V184, P6301, DOI 10.1128/JB.184.22.6301-6315.2002; Gibson J, 2002, ANNU REV MICROBIOL, V56, P345, DOI 10.1146/annurev.micro.56.012302.160749; Harwood CS, 1998, FEMS MICROBIOL REV, V22, P439, DOI 10.1016/S0168-6445(98)00026-6; Harwood CS, 1996, ANNU REV MICROBIOL, V50, P553, DOI 10.1146/annurev.micro.50.1.553; HERRERO M, 1990, J BACTERIOL, V172, P6557, DOI 10.1128/jb.172.11.6557-6567.1990; KANIGA K, 1991, GENE, V109, P137, DOI 10.1016/0378-1119(91)90599-7; Kawaguchi K, 2006, FEMS MICROBIOL LETT, V257, P208, DOI 10.1111/j.1574-6968.2006.00165.x; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Krause A, 2006, NAT BIOTECHNOL, V24, P1385, DOI 10.1038/nbt1243; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Larimer FW, 2004, NAT BIOTECHNOL, V22, P55, DOI 10.1038/nbt923; Lovley DR, 2003, NAT REV MICROBIOL, V1, P35, DOI 10.1038/nrmicro731; Maxam A M, 1980, Methods Enzymol, V65, P499; MILLER VL, 1988, J BACTERIOL, V170, P2575, DOI 10.1128/JB.170.6.2575-2583.1988; Mohamed ME, 2001, J BACTERIOL, V183, P1899, DOI 10.1128/JB.183.6.1899-1908.2001; Olivera ER, 1998, P NATL ACAD SCI USA, V95, P6419, DOI 10.1073/pnas.95.11.6419; Parales RE, 2006, PSEUDOMONAS, VOL 4: MOLECULAR BIOLOGY OF EMERGING ISSUES, P287; Puigbo P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-65; Rabus R, 2005, ARCH MICROBIOL, V183, P27, DOI 10.1007/s00203-004-0742-9; Rather LJ, 2011, J BIOL CHEM, V286, P29241, DOI 10.1074/jbc.M111.236893; Rather LJ, 2010, J BIOL CHEM, V285, P20615, DOI 10.1074/jbc.M110.124156; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sambrook J, 2001, MOL CLONING LAB MANU; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; Schuhle K, 2003, J BACTERIOL, V185, P4920, DOI 10.1128/JB.185.16.4920-4929.2003; Shingler V, 2003, ENVIRON MICROBIOL, V5, P1226, DOI 10.1111/j.1462-2920.2003.00472.x; Silva-Rocha R, 2010, ANNU REV MICROBIOL, V64, P257, DOI 10.1146/annurev.micro.091208.073229; Takeda H, 2010, J BACTERIOL, V192, P4741, DOI 10.1128/JB.00429-10; Teichmann SA, 2004, NAT GENET, V36, P492, DOI 10.1038/ng1340; Teufel R, 2010, P NATL ACAD SCI USA, V107, P14390, DOI 10.1073/pnas.1005399107; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vaillancourt FH, 2006, CRIT REV BIOCHEM MOL, V41, P241, DOI 10.1080/10409230600817422; Zaar A, 2004, MOL MICROBIOL, V54, P223, DOI 10.1111/j.1365-2958.2004.04263.x; Zaar A, 2001, J BIOL CHEM, V276, P24997, DOI 10.1074/jbc.M100291200	66	60	60	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					10494	10508		10.1074/jbc.M111.309005	http://dx.doi.org/10.1074/jbc.M111.309005			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22303008	Green Published, hybrid			2022-12-25	WOS:000302167200076
J	Chen, CH; Hsieh, TJ; Lin, KD; Lin, HY; Lee, MY; Hung, WW; Hsiao, PJ; Shin, SJ				Chen, Chao-Hung; Hsieh, Tusty-Jiuan; Lin, Kun-Der; Lin, Hsing-Yi; Lee, Mei-Yueh; Hung, Wei-Wen; Hsiao, Pi-Jung; Shin, Shyi-Jang			Increased Unbound Retinol-binding Protein 4 Concentration Induces Apoptosis through Receptor-mediated Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYPE-2 DIABETIC-PATIENTS; VITAMIN-A; INSULIN-RESISTANCE; SERUM-LEVELS; RETINOL-BINDING-PROTEIN-4; PATHWAYS; KIDNEY; PLASMA; ACID; HOMEOSTASIS	The increase of apo-/holo-retinol-binding protein 4 (RBP4) concentrations has been found in subjects with renal dysfunction and even in diabetic patients with microalbuminuria. Holo-RBP4 is recognized to possess cytoprotective function. Therefore, we supposed that the relative increase in apo-RBP4 might induce cell damage. In this study, we investigated the signal transduction that activated apoptosis in response to the increase of apo-/holo-RBP4 concentration. We found that increase of apo-/holo-RBP4 concentration ratio delayed the displacement of RBP4 with "stimulated by retinoic acid 6 '' (STRA6), enhanced Janus kinase 2 (JAK2)/STAT5 cascade, up-regulated adenylate cyclase 6 (AC6), increased cAMP, enhanced JNK1/p38 cascade, suppressed CRBP-I/RAR alpha (cellular retinol-binding protein/retinoic acid receptor alpha) expression, and led to apoptosis in HK-2 and human umbilical vein endothelial cells. Furthermore, STRA6, JAK2, STAT5, JNK1, or p38 siRNA and cAMP-PKA inhibitor reversed the repression of CRBP-I/RAR alpha and apoptosis in apo-RBP4 stimulation. In conclusion, this study indicates that the increase of apo-/holo-RBP4 concentration may influence STRA6 signaling, finally causing apoptosis.	[Lin, Kun-Der; Lin, Hsing-Yi; Lee, Mei-Yueh; Hung, Wei-Wen; Hsiao, Pi-Jung; Shin, Shyi-Jang] Kaohsiung Med Univ, Div Endocrinol & Metab, Kaohsiung Med Univ Hosp, Kaohsiung 80708, Taiwan; [Hsieh, Tusty-Jiuan; Hsiao, Pi-Jung; Shin, Shyi-Jang] Kaohsiung Med Univ, Coll Med, Kaohsiung Med Univ Hosp, Sch Med, Kaohsiung 80708, Taiwan; [Chen, Chao-Hung] Kaohsiung Med Univ, Grad Inst Med, Kaohsiung Med Univ Hosp, Kaohsiung 80708, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital	Shin, SJ (corresponding author), Kaohsiung Med Univ, Div Endocrinol & Metab, Kaohsiung Med Univ Hosp, 100 Shih Chuan 1st Rd, Kaohsiung 80708, Taiwan.	sjshin@kmu.edu.tw		Hung, Wei Wen/0000-0002-5976-6321; Hsieh, Tusty-Jiuan/0000-0001-5387-6522	National Science Council of Taiwan [NSC-95-2314-B-037-040-MY3]; Kaohsiung Medical University Hospital [KMUH98-7R21, KMUH99-8R08]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Kaohsiung Medical University Hospital	This work was supported by grants from the National Science Council of Taiwan (NSC-95-2314-B-037-040-MY3) and the Kaohsiung Medical University Hospital (KMUH98-7R21 and KMUH99-8R08).	BERNARD A, 1988, CLIN CHIM ACTA, V171, P85, DOI 10.1016/0009-8981(88)90293-8; Berry DC, 2011, P NATL ACAD SCI USA, V108, P4340, DOI 10.1073/pnas.1011115108; Blaner WS, 2007, CELL METAB, V5, P164, DOI 10.1016/j.cmet.2007.02.006; BLANER WS, 1989, ENDOCR REV, V10, P308, DOI 10.1210/edrv-10-3-308; Bouillet P, 1997, MECH DEVELOP, V63, P173, DOI 10.1016/S0925-4773(97)00039-7; Chang YH, 2008, DIABETES-METAB RES, V24, P629, DOI 10.1002/dmrr.894; Chavez AO, 2009, AM J PHYSIOL-ENDOC M, V296, pE758, DOI 10.1152/ajpendo.90737.2008; Frey SK, 2008, LIPIDS HEALTH DIS, V7, DOI 10.1186/1476-511X-7-29; Fuster G, 2011, LIPIDS, V46, P1033, DOI 10.1007/s11745-011-3594-5; Ghyselinck NB, 1999, EMBO J, V18, P4903, DOI 10.1093/emboj/18.18.4903; Graham TE, 2006, NEW ENGL J MED, V354, P2552, DOI 10.1056/NEJMoa054862; HELLER J, 1975, J BIOL CHEM, V250, P3613; Henze A, 2010, BIOCHEM BIOPH RES CO, V393, P79, DOI 10.1016/j.bbrc.2010.01.082; Henze A, 2008, DIABETES, V57, P3323, DOI 10.2337/db08-0866; Ingelsson E, 2009, ATHEROSCLEROSIS, V206, P239, DOI 10.1016/j.atherosclerosis.2009.02.029; Isken A, 2008, CELL METAB, V7, P258, DOI 10.1016/j.cmet.2008.01.009; Jaconi S, 1996, EUR J ENDOCRINOL, V134, P576, DOI 10.1530/eje.0.1340576; Kawaguchi R, 2008, BIOCHEMISTRY-US, V47, P5387, DOI 10.1021/bi8002082; Kawaguchi R, 2007, SCIENCE, V315, P820, DOI 10.1126/science.1136244; Kiernan UA, 2002, BIOCHEM BIOPH RES CO, V297, P401, DOI 10.1016/S0006-291X(02)02212-X; Kumar S, 2009, J BIOL CHEM, V284, P14760, DOI 10.1074/jbc.M900925200; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Lejeune D, 2002, J BIOL CHEM, V277, P33676, DOI 10.1074/jbc.M204204200; Molotkov A, 2004, BIOCHEM J, V383, P295, DOI 10.1042/BJ20040621; Napoli JL, 2000, NUTR REV, V58, P230, DOI 10.1111/j.1753-4887.2000.tb01870.x; Nezzar H, 2007, MOL VIS, V13, P1641; Raila J, 2007, KIDNEY INT, V72, P505, DOI 10.1038/sj.ki.5002372; SIEGENTHALER G, 1987, BIOCHEM BIOPH RES CO, V143, P418, DOI 10.1016/0006-291X(87)91370-2; Singh AB, 2012, J CELL PHYSIOL, V227, P2632, DOI 10.1002/jcp.23005; SOPRANO DR, 1986, J LIPID RES, V27, P166; Takebayashi K, 2007, J CLIN ENDOCR METAB, V92, P2712, DOI 10.1210/jc.2006-1249; Tian W, 2000, AM J PHYSIOL-RENAL, V279, pF593, DOI 10.1152/ajprenal.2000.279.4.F593; Tripathi A, 2008, INT IMMUNOL, V20, P327, DOI 10.1093/intimm/dxm145; Xu Q, 2004, KIDNEY INT, V66, P2119, DOI 10.1111/j.1523-1755.2004.66002.x; Xu QH, 2002, J BIOL CHEM, V277, P41693, DOI 10.1074/jbc.M207095200; Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711; Ziegelmeier M, 2007, DIABETES CARE, V30, P2588, DOI 10.2337/dc07-0275; Zizola CF, 2010, MOL CELL BIOL, V30, P3412, DOI 10.1128/MCB.00014-10	38	22	22	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					9694	9707		10.1074/jbc.M111.301721	http://dx.doi.org/10.1074/jbc.M111.301721			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22308028	Green Published, hybrid			2022-12-25	WOS:000302167200004
J	Seye, CI; Agca, Y; Agca, C; Derbigny, W				Seye, Cheikh I.; Agca, Yuksel; Agca, Cansu; Derbigny, Wilbert			P2Y(2) Receptor-mediated Lymphotoxin-alpha Secretion Regulates Intercellular Cell Adhesion Molecule-1 Expression in Vascular Smooth Muscle Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P2 PURINERGIC RECEPTORS; HUMAN DENDRITIC CELLS; TUMOR-NECROSIS-FACTOR; NUCLEOTIDE RECEPTORS; ENDOTHELIAL-CELLS; P2X(7) RECEPTOR; CULTURED ASTROCYTES; CYTOKINE SECRETION; P-2 PURINOCEPTORS; EXTRACELLULAR ATP	The proinflammatory cytokine lymphotoxin-alpha (LTA) is thought to contribute to the pathogenesis of atherosclerosis. However, the mechanisms that regulate its expression in vascular smooth muscle cells (VSMC) are poorly understood. The ability of exogenous nucleotides to stimulate LTA production was evaluated in VSMC by ELISA. The P2Y(2) nucleotide receptor (P2Y(2)R) agonist UTP stimulates a strong and sustained release of LTA from WT but not P2Y(2)R(-/-) SMC. Assessment of LTA gene transcription by LTA promoter-luciferase construct indicated that LTA levels are controlled at the level of transcription. We show using RNAi techniques that knockdown of the actin-binding protein filamin-A (FLNa) severely impaired nucleotide-induced Rho activation and consequent Rho-mediated LTA secretion. Reintroduction of FLNa in FLNa RNAi SMC rescued UTP-induced LTA expression. In addition, we found that UTP-stimulated LTA secretion is not sensitive to brefeldin A, which blocks the formation of vesicles involved in protein transport from the endoplasmic reticulum to the Golgi apparatus, suggesting that P2Y(2)R/filamin-mediated secretion of LTA is independent of the endoplasmic reticulum/Golgi secretory vesicle route. Furthermore, UTP selectively induces ICAM-1 expression in WT but not SMC expressing a truncated P2Y2R deficient in LTA secretion. These data suggest that P2Y2R recruits FLNa to provide a cytoskeletal scaffold necessary for Rho signaling pathway upstream of LTA release and subsequent stimulation of ICAM-1 expression on vascular smooth muscle cells.	[Seye, Cheikh I.] Indiana Univ Sch Med, Dept Cellular & Integrat Physiol, Indianapolis, IN 46202 USA; [Derbigny, Wilbert] Indiana Univ Sch Med, Dept Immunol & Microbiol, Indianapolis, IN 46202 USA; [Agca, Yuksel; Agca, Cansu] Univ Missouri, Dept Vet Pathobiol, Columbia, MO 65201 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; University of Missouri System; University of Missouri Columbia	Seye, CI (corresponding author), Indiana Univ Sch Med, Dept Cellular & Integrat Physiol, 635 Barnhill Dr,MS 332, Indianapolis, IN 46202 USA.	cseye@iupui.edu			Showalter Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K22AI072072] Funding Source: NIH RePORTER	Showalter Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a grant from the Showalter Foundation (to C. I. S.).	Abbracchio MP, 2006, PHARMACOL REV, V58, P281, DOI 10.1124/pr.58.3.3; Abdel-Latif D, 2004, BLOOD, V104, P832, DOI 10.1182/blood-2003-07-2624; Ahmed SM, 2000, J NEUROCHEM, V74, P1951, DOI 10.1046/j.1471-4159.2000.741951000000000.x; Asselbergs FW, 2007, CLIN SCI, V112, P291, DOI 10.1042/CS20060200; Baraldi PG, 2004, CURR TOP MED CHEM, V4, P1707, DOI 10.2174/1568026043387223; BERGFELD GR, 1992, CARDIOVASC RES, V26, P40, DOI 10.1093/cvr/26.1.40; BOARDER MR, 1995, TRENDS PHARMACOL SCI, V16, P133, DOI 10.1016/S0165-6147(00)89001-X; Bodin P, 2001, NEUROCHEM RES, V26, P959, DOI 10.1023/A:1012388618693; BODIN P, 1995, EXPERIENTIA, V51, P256, DOI 10.1007/BF01931108; Chaulet H, 2001, CIRC RES, V89, P772, DOI 10.1161/hh2101.098617; Ciccarelli R, 2001, INT J DEV NEUROSCI, V19, P395, DOI 10.1016/S0736-5748(00)00084-8; Ciccarelli R, 1999, GLIA, V25, P93, DOI 10.1002/(SICI)1098-1136(19990101)25:1<93::AID-GLIA9>3.0.CO;2-N; Coutinho-Silva R, 1999, AM J PHYSIOL-CELL PH, V276, pC1139, DOI 10.1152/ajpcell.1999.276.5.C1139; Di Virgilio F, 2001, BLOOD, V97, P587, DOI 10.1182/blood.V97.3.587; Erlinge D, 1998, BIOCHEM BIOPH RES CO, V248, P864, DOI 10.1006/bbrc.1998.9083; Ferrari D, 2000, FEBS LETT, V486, P217, DOI 10.1016/S0014-5793(00)02306-1; Ferrari D, 1996, J IMMUNOL, V156, P1531; Ferrari D, 2000, FASEB J, V14, P2466, DOI 10.1096/fj.00-0031com; Ferrari D, 2006, J IMMUNOL, V176, P3877, DOI 10.4049/jimmunol.176.7.3877; FUJIWARA T, 1988, J BIOL CHEM, V263, P18545; GORDON JL, 1986, BIOCHEM J, V233, P309, DOI 10.1042/bj2330309; Hobert ME, 2002, J BIOL CHEM, V277, P51025, DOI 10.1074/jbc.M210466200; HOGQUIST KA, 1991, J IMMUNOL, V147, P2181; Hong-Geller E, 2000, J CELL BIOL, V148, P481, DOI 10.1083/jcb.148.3.481; Huse M, 2006, NAT IMMUNOL, V7, P247, DOI 10.1038/ni1304; KOBAYASHI Y, 1984, J BIOCHEM-TOKYO, V95, P1775, DOI 10.1093/oxfordjournals.jbchem.a134790; Liao ZJ, 2007, J CELL SCI, V120, P1654, DOI 10.1242/jcs.03441; MacKenzie A, 2001, IMMUNITY, V15, P825, DOI 10.1016/S1074-7613(01)00229-1; Madge LA, 2008, J IMMUNOL, V180, P3467, DOI 10.4049/jimmunol.180.5.3467; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Ostrom R. S., 2001, AM J PHYSIOL, V281, P524; Ozaki K, 2004, NATURE, V429, P72, DOI 10.1038/nature02502; Pedersen S, 1999, BBA-BIOMEMBRANES, V1416, P271, DOI 10.1016/S0005-2736(98)00228-4; PERREGAUX D, 1994, J BIOL CHEM, V269, P15195; Perregaux DG, 1998, J IMMUNOL, V160, P2469; Pi M, 2002, ENDOCRINOLOGY, V143, P3830, DOI 10.1210/en.2002-220240; Pillois X, 2002, CIRC RES, V90, P678, DOI 10.1161/01.RES.0000013700.98464.8E; Pizzirani C, 2007, BLOOD, V109, P3856, DOI 10.1182/blood-2005-06-031377; Robson SC, 1997, J EXP MED, V185, P153, DOI 10.1084/jem.185.1.153; Schreyer SA, 2002, J BIOL CHEM, V277, P12364, DOI 10.1074/jbc.M111727200; Seye C. I., 2006, PURINERG SIGNAL, pC471; Seye CI, 2003, J BIOL CHEM, V278, P24960, DOI 10.1074/jbc.M301439200; Seye CI, 2002, CIRCULATION, V106, P2720, DOI 10.1161/01.CIR.0000038111.00518.35; Seye CI, 1997, ARTERIOSCL THROM VAS, V17, P3602, DOI 10.1161/01.ATV.17.12.3602; Solini A, 1999, J CELL SCI, V112, P297; Stanley AC, 2010, PHYSIOLOGY, V25, P218, DOI 10.1152/physiol.00017.2010; Ware C F, 1995, Curr Top Microbiol Immunol, V198, P175; Ware CF, 1996, J CELL BIOCHEM, V60, P47, DOI 10.1002/(SICI)1097-4644(19960101)60:1<47::AID-JCB8>3.3.CO;2-H; Warny M, 2001, J BIOL CHEM, V276, P26051, DOI 10.1074/jbc.M102568200; Weiser S, 2007, CYTOKINE, V37, P84, DOI 10.1016/j.cyto.2007.02.021; Weisman GA, 1996, J PHARMACOL EXP THER, V277, P1; Wilden PA, 1998, AM J PHYSIOL-HEART C, V275, pH1209, DOI 10.1152/ajpheart.1998.275.4.H1209; Yu N, 2008, CIRC RES, V102, P581, DOI 10.1161/CIRCRESAHA.107.162271; Zimmermann H, 1996, J AUTON PHARMACOL, V16, P397, DOI 10.1111/j.1474-8673.1996.tb00062.x	54	14	14	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					10535	10543		10.1074/jbc.M111.313189	http://dx.doi.org/10.1074/jbc.M111.313189			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22298782	Green Published, hybrid			2022-12-25	WOS:000302167200079
J	Hashimoto, K; Cho, YJ; Yang, IY; Akagi, J; Ohashi, E; Tateishi, S; de Wind, N; Hanaoka, F; Ohmori, H; Moriya, M				Hashimoto, Keiji; Cho, Youngjin; Yang, In-Young; Akagi, Jun-ichi; Ohashi, Eiji; Tateishi, Satoshi; de Wind, Niels; Hanaoka, Fumio; Ohmori, Haruo; Moriya, Masaaki			The Vital Role of Polymerase zeta and REV1 in Mutagenic, but Not Correct, DNA Synthesis across Benzo[a]pyrene-dG and Recruitment of Polymerase zeta by REV1 to Replication-stalled Site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DAMAGE-INDUCED MUTAGENESIS; TRANSLESION SYNTHESIS; Y-FAMILY; XERODERMA-PIGMENTOSUM; PROTEIN INTERACTS; DCMP TRANSFERASE; MAMMALIAN-CELLS; BRCT DOMAIN; C-TERMINUS; ERROR-FREE	The DNA synthesis across DNA lesions, termed translesion synthesis (TLS), is a complex process influenced by various factors. To investigate this process in mammalian cells, we examined TLS across a benzo[a] pyrene dihydrodiol epoxide-derived dG adduct (BPDE-dG) using a plasmid bearing a single BPDE-dG and genetically engineered mouse embryonic fibroblasts (MEFs). In wild-type MEFs, TLS was extremely miscoding (>90%) with G -> T transversions being predominant. Knockout of the Rev1 gene decreased both the TLS efficiency and the miscoding frequency. Knockout of the Rev3L gene, coding for the catalytic subunit of pol zeta, caused even greater decreases in these two TLS parameters; almost all residual TLS were error-free. Thus, REV1 and pol zeta are critical to mutagenic, but not accurate, TLS across BPDE-dG. The introduction of human REV1 cDNA into Rev1(-/-) MEFs restored the mutagenic TLS, but a REV1 mutant lacking the C terminus did not. Yeast and mammalian three-hybrid assays revealed that the REV7 subunit of pol zeta mediated the interaction between REV3 and the REV1 C terminus. These results support the hypothesis that REV1 recruits pol zeta through the interaction with REV7. Our results also predict the existence of a minor REV1-independent pol zeta recruitment pathway. Finally, although mutagenic TLS across BPDE-dG largely depends on RAD18, experiments using Polk(-/-) Polh(-/-) Poli(-/-) triple-gene knockout MEFs unexpectedly revealed that another polymerase(s) could insert a nucleotide opposite BPDE-dG. This indicates that a non-Y family polymerase(s) can insert a nucleotide opposite BPDE-dG, but the subsequent extension from miscoding termini depends on REV1-pol zeta in a RAD18-dependent manner.	[Ohashi, Eiji; Ohmori, Haruo] Kyoto Univ, Inst Virus Res, Kyoto 6068507, Japan; [Hashimoto, Keiji; Cho, Youngjin; Yang, In-Young; Moriya, Masaaki] SUNY Stony Brook, Biol Chem Lab, Dept Pharmacol Sci, Stony Brook, NY 11794 USA; [Akagi, Jun-ichi; Hanaoka, Fumio] Gakushuin Univ, Fac Sci, Tokyo 1718588, Japan; [Tateishi, Satoshi] Kumamoto Univ, Inst Mol Embryol & Genet, Kumamoto 8600811, Japan; [de Wind, Niels] Leiden Univ, Dept Toxicogenet, Med Ctr, NL-2300 RC Leiden, Netherlands	Kyoto University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Gakushuin University; Kumamoto University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Ohmori, H (corresponding author), Kyoto Univ, Inst Virus Res, Kyoto 6068507, Japan.	hohmori@virus.kyoto-u.ac.jp; maki@pharm.stonybrook.edu	Ohashi, Eiji/AAO-5794-2021	Ohashi, Eiji/0000-0002-1771-5585	National Institutes of Health [CA076163, ES018833]; NATIONAL CANCER INSTITUTE [R01CA076163, R56CA076163] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES018833] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [22131008] Funding Source: KAKEN	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA076163 and ES018833 (to M. M.).	Akagi JI, 2009, DNA REPAIR, V8, P585, DOI 10.1016/j.dnarep.2008.12.006; Andersen PL, 2011, MOL BIOL CELL, V22, P2373, DOI 10.1091/mbc.E10-12-0938; Bienko M, 2005, SCIENCE, V310, P1821, DOI 10.1126/science.1120615; Biertumpfel C, 2010, NATURE, V465, P1044, DOI 10.1038/nature09196; D'Souza S, 2008, DNA REPAIR, V7, P1455, DOI 10.1016/j.dnarep.2008.05.009; de Groote FH, 2011, DNA REPAIR, V10, P915, DOI 10.1016/j.dnarep.2011.04.033; Edmunds CE, 2008, MOL CELL, V30, P519, DOI 10.1016/j.molcel.2008.03.024; Gibbs PEM, 2000, P NATL ACAD SCI USA, V97, P4186, DOI 10.1073/pnas.97.8.4186; Guo CX, 2006, MOL CELL BIOL, V26, P8892, DOI 10.1128/MCB.01118-06; Guo CX, 2006, MOL CELL, V23, P265, DOI 10.1016/j.molcel.2006.05.038; Guo CX, 2003, EMBO J, V22, P6621, DOI 10.1093/emboj/cdg626; Hara K, 2010, J BIOL CHEM, V285, P12299, DOI 10.1074/jbc.M109.092403; HIRT B, 1967, J MOL BIOL, V26, P365, DOI 10.1016/0022-2836(67)90307-5; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Jansen JG, 2005, NUCLEIC ACIDS RES, V33, P356, DOI 10.1093/nar/gki189; Johnson RE, 1999, SCIENCE, V285, P263, DOI 10.1126/science.285.5425.263; Kannouche PL, 2004, MOL CELL, V14, P491, DOI 10.1016/S1097-2765(04)00259-X; Lange SS, 2011, NAT REV CANCER, V11, P96, DOI 10.1038/nrc2998; Lawrence CW, 2004, ADV PROTEIN CHEM, V69, P167; Lin WS, 1999, NUCLEIC ACIDS RES, V27, P4468, DOI 10.1093/nar/27.22.4468; Masuda Y, 2003, J BIOL CHEM, V278, P12356, DOI 10.1074/jbc.M211765200; Masutani C, 1999, NATURE, V399, P700, DOI 10.1038/21447; McDonald JP, 2003, J EXP MED, V198, P635, DOI 10.1084/jem.20030767; Moriya M, 1996, BIOCHEMISTRY-US, V35, P16646, DOI 10.1021/bi9608875; Murakumo Y, 2001, J BIOL CHEM, V276, P35644, DOI 10.1074/jbc.M102051200; Narita T, 2010, GENES CELLS, V15, P1228, DOI 10.1111/j.1365-2443.2010.01457.x; Nelson JR, 2000, MOL MICROBIOL, V37, P549, DOI 10.1046/j.1365-2958.2000.01997.x; Nelson JR, 1996, NATURE, V382, P729, DOI 10.1038/382729a0; Ogi T, 2002, P NATL ACAD SCI USA, V99, P15548, DOI 10.1073/pnas.222377899; Ohashi E, 2004, GENES CELLS, V9, P523, DOI 10.1111/j.1356-9597.2004.00747.x; Ohkumo T, 2006, MOL CELL BIOL, V26, P7696, DOI 10.1128/MCB.01076-06; Ohmori H, 2001, MOL CELL, V8, P7, DOI 10.1016/S1097-2765(01)00278-7; Ohmori H, 2009, ADV PROTEIN CHEM STR, V78, P99, DOI 10.1016/S1876-1623(09)78004-0; Petta TB, 2008, EMBO J, V27, P2883, DOI 10.1038/emboj.2008.210; Pollack M, 2006, CHEM RES TOXICOL, V19, P1074, DOI 10.1021/tx0600503; Rechkoblit O, 2002, J BIOL CHEM, V277, P30488, DOI 10.1074/jbc.M201167200; Ross AL, 2005, NUCLEIC ACIDS RES, V33, P1280, DOI 10.1093/nar/gki279; Shachar S, 2009, EMBO J, V28, P383, DOI 10.1038/emboj.2008.281; Sharma NM, 2011, J BIOL CHEM, V286, P33557, DOI 10.1074/jbc.M110.206680; Silverstein TD, 2010, NATURE, V465, P1039, DOI 10.1038/nature09104; Stelter P, 2003, NATURE, V425, P188, DOI 10.1038/nature01965; Suzuki N, 2002, BIOCHEMISTRY-US, V41, P6100, DOI 10.1021/bi020049c; Takata K, 2009, EMBO J, V28, P313, DOI 10.1038/emboj.2008.303; Watanabe K, 2004, EMBO J, V23, P3886, DOI 10.1038/sj.emboj.7600383; Wiltrout ME, 2011, GENETICS, V187, P21, DOI 10.1534/genetics.110.124172; Yang IY, 2009, J BIOL CHEM, V284, P191, DOI 10.1074/jbc.M806414200; Zhang YB, 2002, DNA REPAIR, V1, P559, DOI 10.1016/S1568-7864(02)00055-1; Zhou Y, 2010, NUCLEIC ACIDS RES, V38, P5036, DOI 10.1093/nar/gkq225	48	38	38	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					9613	9622		10.1074/jbc.M111.331728	http://dx.doi.org/10.1074/jbc.M111.331728			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22303021	Green Published, hybrid			2022-12-25	WOS:000301797800092
J	Hosing, AS; Valerie, NCK; Dziegielewski, J; Brautigan, DL; Larner, JM				Hosing, Amol S.; Valerie, Nicholas C. K.; Dziegielewski, Jaroslaw; Brautigan, David L.; Larner, James M.			PP6 Regulatory Subunit R1 Is Bidentate Anchor for Targeting Protein Phosphatase-6 to DNA-dependent Protein Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAK; HUMAN CANCER-CELLS; CATALYTIC SUBUNIT; IONIZING-RADIATION; SACCHAROMYCES-CEREVISIAE; IN-VIVO; AUTOPHOSPHORYLATION; REPAIR; DOMAIN; PK	DNA-dependent protein kinase (DNA-PK) becomes activated in response toDNAdouble strand breaks, initiating repair by the non-homologous end joining pathway. DNA.PK complexes with the regulatory subunit SAPSR1 (R1) of protein phosphatase-6 (PP6). Knockdown of either R1 or PP6c prevents DNA-PK activation in response to ionizing radiation-induced DNA damage and radiosensitizes glioblastoma cells. Here, we demonstrate that R1 is necessary for and bridges the interaction between DNA-PK and PP6c. Using R1 deletion mutants, DNA-PK binding was mapped to two distinct regions of R1 spanning residues 1-326 and 522-700. Either region expressed alone was sufficient to bind DNA-PK, but only deletion of residues 1-326, not 522-700, eliminated interaction of R1 with DNA-PK. We assign 1-326 as the dominant domain and 522700 as the supporting region. These results demonstrate that R1 acts as a bidentate anchor to DNA-PK and recruits PP6c. Targeting the dominant interface with small molecule or peptidomimetic inhibitors could specifically prevent activation of DNA-PK and thereby sensitize cells to ionizing radiation and other genotoxic agents.	[Hosing, Amol S.; Valerie, Nicholas C. K.; Dziegielewski, Jaroslaw; Larner, James M.] Univ Virginia Hlth Syst, Dept Radiat Oncol, Charlottesville, VA 22908 USA; [Brautigan, David L.] Univ Virginia, Sch Med, Ctr Cell Signaling, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia	Larner, JM (corresponding author), Univ Virginia Hlth Syst, Dept Radiat Oncol, POB 800383, Charlottesville, VA 22908 USA.	jml2p@virginia.edu		Valerie, Nicholas/0000-0002-9423-964X	National Institutes of Health [5R01CA142823-02]; NATIONAL CANCER INSTITUTE [R01CA142823] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health grant 5R01CA142823-02 (to J. M. L.).	ALLALUNISTURNER MJ, 1993, RADIAT RES, V134, P349, DOI 10.2307/3578196; Anbarasan S, 2010, APPL ENVIRON MICROB, V76, P356, DOI 10.1128/AEM.00357-09; ARMSTRONG KM, 1993, P NATL ACAD SCI USA, V90, P11337, DOI 10.1073/pnas.90.23.11337; Aurora R, 1998, PROTEIN SCI, V7, P21, DOI 10.1002/pro.5560070103; Bastians H, 1996, J CELL SCI, V109, P2865; Chan DW, 2002, GENE DEV, V16, P2333, DOI 10.1101/gad.1015202; Chan DW, 1996, J BIOL CHEM, V271, P8936, DOI 10.1074/jbc.271.15.8936; Chen BPC, 2007, J BIOL CHEM, V282, P6582, DOI 10.1074/jbc.M611605200; Collis SJ, 2003, CANCER RES, V63, P1550; Cui XP, 2005, MOL CELL BIOL, V25, P10842, DOI 10.1128/MCB.25.24.10842-10852.2005; Dalal SN, 1999, MOL CELL BIOL, V19, P4465; Ding Q, 2003, MOL CELL BIOL, V23, P5836, DOI 10.1128/MCB.23.16.5836-5848.2003; Douglas P, 2002, BIOCHEM J, V368, P243, DOI 10.1042/BJ20020973; Douglas P, 2001, J BIOL CHEM, V276, P18992, DOI 10.1074/jbc.M011703200; Douglas P, 2007, MOL CELL BIOL, V27, P1581, DOI 10.1128/MCB.01962-06; Douglas P, 2010, MOL CELL BIOL, V30, P1368, DOI 10.1128/MCB.00741-09; Durant S, 2003, NUCLEIC ACIDS RES, V31, P5501, DOI 10.1093/nar/gkg753; FOROOD B, 1993, P NATL ACAD SCI USA, V90, P838, DOI 10.1073/pnas.90.3.838; Guergnon J, 2009, BMC BIOCHEM, V10, DOI 10.1186/1471-2091-10-24; Ismail IH, 2004, ONCOGENE, V23, P873, DOI 10.1038/sj.onc.1207303; LeesMiller SP, 1996, BIOCHEM CELL BIOL, V74, P503, DOI 10.1139/o96-054; MANN DJ, 1993, EMBO J, V12, P4833, DOI 10.1002/j.1460-2075.1993.tb06173.x; Meek K, 2007, MOL CELL BIOL, V27, P3881, DOI 10.1128/MCB.02366-06; Merkle D, 2002, BIOCHEMISTRY-US, V41, P12706, DOI 10.1021/bi0263558; Mi J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004395; Morales-Johansson H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006331; Peng YL, 2002, CANCER RES, V62, P6400; PRESTA LG, 1988, SCIENCE, V240, P1632, DOI 10.1126/science.2837824; Prickett TD, 2004, J BIOL CHEM, V279, P38912, DOI 10.1074/jbc.M401444200; Prickett TD, 2006, J BIOL CHEM, V281, P30503, DOI 10.1074/jbc.M601054200; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Shinohara ET, 2005, CANCER RES, V65, P4987, DOI 10.1158/0008-5472.CAN-04-4250; Soubeyrand S, 2003, CANCER RES, V63, P1198; Stefansson B, 2008, BIOCHEMISTRY-US, V47, P1442, DOI 10.1021/bi7022877; Stefansson B, 2007, CELL CYCLE, V6, P1386, DOI 10.4161/cc.6.11.4276; Stefansson B, 2006, J BIOL CHEM, V281, P22624, DOI 10.1074/jbc.M601772200; Taccioli GE, 1998, IMMUNITY, V9, P355, DOI 10.1016/S1074-7613(00)80618-4; Veuger SJ, 2003, CANCER RES, V63, P6008; Virshup DM, 2009, MOL CELL, V33, P537, DOI 10.1016/j.molcel.2009.02.015; Wechsler T, 2004, P NATL ACAD SCI USA, V101, P1247, DOI 10.1073/pnas.0307765100; Zeng K, 2010, J CELL BIOL, V191, P1315, DOI 10.1083/jcb.201008106	41	33	33	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					9230	9239		10.1074/jbc.M111.333708	http://dx.doi.org/10.1074/jbc.M111.333708			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22298787	hybrid, Green Published			2022-12-25	WOS:000301797800051
J	von Maltzan, K; Tan, W; Pruett, SB				von Maltzan, Kristine; Tan, Wei; Pruett, Stephen B.			Investigation of the Role of TNF-alpha Converting Enzyme (TACE) in the Inhibition of Cell Surface and Soluble TNF-alpha Production by Acute Ethanol Exposure	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; BINGE-DRINKING MODEL; INNATE IMMUNITY; LIPID RAFTS; IN-VIVO; INFLAMMATORY RESPONSE; HUMAN MONOCYTES; POTENTIAL ROLE; DISINTEGRIN; ACTIVATION	Toll-like receptors (TLRs) play a fundamental role in the immune system by detecting pathogen associated molecular patterns (PAMPs) to sense host infection. Ethanol at doses relevant for humans inhibits the pathogen induced cytokine response mediated through TLRs. The current study was designed to investigate the mechanisms of this effect by determining whether ethanol inhibits TLR3 and TLR4 mediated TNF-alpha secretion through inhibition of transcription factor activation or post-transcriptional effects. In NF-kappa B reporter mice, activation of NF-kappa B in vivo by LPS was inhibited by ethanol (LPS alone yielded 170,000 +/- 35,300 arbitrary units of light emission; LPS plus ethanol yielded 56,120 +/- 16880, p = 0.04). Inhibition of protein synthesis by cycloheximide revealed that poly I:C- or LPS-induced secreted TNF-alpha is synthesized de novo, not released from cellular stores. Using real time RT-PCR, we found inhibition of LPS and poly I:C induced TNF-alpha gene transcription by ethanol. Using an inhibitor of tumor necrosis factor alpha converting enzyme (TACE), we found that shedding caused by TACE is a prerequisite for TNF-alpha release after pathogen challenge. Flow cytometry was used to investigate if ethanol decreases TNF-alpha secretion by inhibition of TACE. In cells treated with LPS, ethanol decreased both TNF-alpha cell surface expression and secretion. For example, 4.69 +/- 0.60% of untreated cells were positive for cell surface TNF-alpha, LPS increased this to 25.18 +/- 0.85%, which was inhibited by ethanol (86.8 mM) to 14.29 +/- 0.39% and increased by a TACE inhibitor to 57.88 +/- 0.62%. In contrast, cells treated with poly I:C had decreased secretion of TNF-alpha but not cell surface expression. There was some evidence for inhibition of TACE by ethanol in the case of LPS, but decreased TNF-alpha gene expression seems to be the major mechanism of ethanol action in this system.	[von Maltzan, Kristine] Louisiana State Univ, Hlth Sci Ctr, Dept Cellular Biol & Anat, Shreveport, LA 71105 USA; [Tan, Wei; Pruett, Stephen B.] Mississippi State Univ, Coll Vet Med, Dept Basic Sci, Mississippi State, MS 39762 USA	Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Mississippi State University	von Maltzan, K (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Cellular Biol & Anat, Shreveport, LA 71105 USA.	pruett@cvm.msstate.edu			National Institute on Alcoholism and Alcohol Abuse [R01AA009505]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA009505] Funding Source: NIH RePORTER	National Institute on Alcoholism and Alcohol Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was funded by the National Institute on Alcoholism and Alcohol Abuse, grant #R01AA009505. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Amour A, 1998, FEBS LETT, V435, P39, DOI 10.1016/S0014-5793(98)01031-X; Armstrong L, 2006, AM J RESP CELL MOL, V34, P219, DOI 10.1165/rcmb.2005-0087OC; BERMUDEZ LE, 1991, J INFECT DIS, V163, P1286, DOI 10.1093/infdis/163.6.1286; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Brennan FM, 2008, EUR J IMMUNOL, V38, P1106, DOI 10.1002/eji.200737821; Carlsen H, 2002, J IMMUNOL, V168, P1441, DOI 10.4049/jimmunol.168.3.1441; Carr RL, 2008, TOXICOL SCI, V106, P186, DOI 10.1093/toxsci/kfn164; Carson EJ, 1996, ALCOHOL CLIN EXP RES, V20, P132, DOI 10.1111/j.1530-0277.1996.tb01055.x; Cerretti DP, 1999, CYTOKINE, V11, P541, DOI 10.1006/cyto.1998.0466; Dai Q, 2005, BIOCHEM BIOPH RES CO, V332, P37, DOI 10.1016/j.bbrc.2005.04.088; Dai Q, 2006, ALCOHOL CLIN EXP RES, V30, P1436, DOI 10.1111/j.1530-0277.2006.00172.x; Diaz-Rodriguez E, 2002, MOL BIOL CELL, V13, P2031, DOI 10.1091/mbc.01-11-0561; Dolganiuc A, 2006, ALCOHOL CLIN EXP RES, V30, P76, DOI 10.1111/j.1530-0277.2006.00003.x; Doyle SE, 2002, IMMUNITY, V17, P251, DOI 10.1016/S1074-7613(02)00390-4; GERSHMAN H, 1991, Journal of Emergency Medicine, V9, P307, DOI 10.1016/0736-4679(91)90371-L; Gomez MI, 2007, EMBO J, V26, P701, DOI 10.1038/sj.emboj.7601554; Goral J, 2005, J IMMUNOL, V174, P456, DOI 10.4049/jimmunol.174.1.456; Janeway CA, 1998, SEMIN IMMUNOL, V10, P349, DOI 10.1006/smim.1998.0142; Jones AW, 2009, FORENSIC SCI INT, V188, P40, DOI 10.1016/j.forsciint.2009.03.010; Lanzke N, 2007, ADDICT BIOL, V12, P59, DOI 10.1111/j.1369-1600.2006.00042.x; Li Y, 2006, BLOOD, V108, P2275, DOI 10.1182/blood-2006-02-005827; Mandrekar P, 1999, INT IMMUNOL, V11, P1781, DOI 10.1093/intimm/11.11.1781; MOHLER KM, 1994, NATURE, V370, P218, DOI 10.1038/370218a0; Moss ML, 1997, NATURE, V385, P733, DOI 10.1038/385733a0; NELSON S, 1989, J INFECT DIS, V160, P422, DOI 10.1093/infdis/160.3.422; Pruett SB, 2004, J IMMUNOL, V173, P2715, DOI 10.4049/jimmunol.173.4.2715; Pruett SB, 2010, TOXICOL SCI, V117, P314, DOI 10.1093/toxsci/kfq215; Pruett SB, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-49; Robertshaw HJ, 2005, BRIT J ANAESTH, V94, P222, DOI 10.1093/bja/aei021; Roghani M, 1999, J BIOL CHEM, V274, P3531, DOI 10.1074/jbc.274.6.3531; Song KJ, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-123; Soond SM, 2005, J CELL SCI, V118, P2371, DOI 10.1242/jcs.02357; Stoeck A, 2006, BIOCHEM J, V393, P609, DOI 10.1042/BJ20051013; Szabo G, 2007, J IMMUNOL, V178, P1243, DOI 10.4049/jimmunol.178.3.1243; Tang P, 1996, BIOCHEMISTRY-US, V35, P8216, DOI 10.1021/bi952182t; URSO T, 1981, LIFE SCI, V28, P1053, DOI 10.1016/0024-3205(81)90752-9; Wesche H, 1997, IMMUNITY, V7, P837, DOI 10.1016/S1074-7613(00)80402-1; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Zhang ZL, 2000, J LEUKOCYTE BIOL, V67, P856, DOI 10.1002/jlb.67.6.856; Zhao XJ, 2004, ALCOHOL CLIN EXP RES, V28, P1399, DOI 10.1097/01.ALC.0000139819.46514.06; Zhao XJ, 2003, J IMMUNOL, V170, P2923, DOI 10.4049/jimmunol.170.6.2923	42	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2012	7	2							e29890	10.1371/journal.pone.0029890	http://dx.doi.org/10.1371/journal.pone.0029890			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LO	22319556	Green Published, Green Submitted, gold			2022-12-25	WOS:000302178400002
J	Sundar, IK; Chung, S; Hwang, JW; Lapek, JD; Bulger, M; Friedman, AE; Yao, HW; Davie, JR; Rahman, I				Sundar, Isaac K.; Chung, Sangwoon; Hwang, Jae-woong; Lapek, John D., Jr.; Bulger, Michael; Friedman, Alan E.; Yao, Hongwei; Davie, James R.; Rahman, Irfan			Mitogen- and Stress-Activated Kinase 1 (MSK1) Regulates Cigarette Smoke-Induced Histone Modifications on NF-kappa B-dependent Genes	PLOS ONE			English	Article							PROINFLAMMATORY CYTOKINE RELEASE; INDUCED LUNG INFLAMMATION; OXIDATIVE STRESS; PROTEIN-KINASE; INDUCED PHOSPHORYLATION; EPITHELIAL-CELLS; IKK-ALPHA; TRANSCRIPTIONAL ACTIVATION; H3 PHOSPHORYLATION; RAT LUNGS	Cigarette smoke (CS) causes sustained lung inflammation, which is an important event in the pathogenesis of chronic obstructive pulmonary disease (COPD). We have previously reported that IKK alpha (I kappaB kinase alpha) plays a key role in CS-induced pro-inflammatory gene transcription by chromatin modifications; however, the underlying role of downstream signaling kinase is not known. Mitogen-and stress-activated kinase 1 (MSK1) serves as a specific downstream NF-kappa B RelA/p65 kinase, mediating transcriptional activation of NF-kappa B-dependent pro-inflammatory genes. The role of MSK1 in nuclear signaling and chromatin modifications is not known, particularly in response to environmental stimuli. We hypothesized that MSK1 regulates chromatin modifications of pro-inflammatory gene promoters in response to CS. Here, we report that CS extract activates MSK1 in human lung epithelial (H292 and BEAS-2B) cell lines, human primary small airway epithelial cells (SAEC), and in mouse lung, resulting in phosphorylation of nuclear MSK1 (Thr581), phospho-acetylation of RelA/p65 at Ser276 and Lys310 respectively. This event was associated with phospho-acetylation of histone H3 (Ser10/Lys9) and acetylation of histone H4 (Lys12). MSK1 N- and C-terminal kinase-dead mutants, MSK1 siRNA-mediated knock-down in transiently transfected H292 cells, and MSK1 stable knock-down mouse embryonic fibroblasts significantly reduced CS extract-induced MSK1, NF-kappa B RelA/p65 activation, and posttranslational modifications of histones. CS extract/CS promotes the direct interaction of MSK1 with RelA/p65 and p300 in epithelial cells and in mouse lung. Furthermore, CS-mediated recruitment of MSK1 and its substrates to the promoters of NF-kappa B-dependent pro-inflammatory genes leads to transcriptional activation, as determined by chromatin immunoprecipitation. Thus, MSK1 is an important downstream kinase involved in CS-induced NF-kappa B activation and chromatin modifications, which have implications in pathogenesis of COPD.	[Sundar, Isaac K.; Chung, Sangwoon; Hwang, Jae-woong; Lapek, John D., Jr.; Friedman, Alan E.; Yao, Hongwei; Rahman, Irfan] Univ Rochester, Med Ctr, Dept Environm Med, Lung Biol & Dis Program, Rochester, NY 14642 USA; [Bulger, Michael] Univ Rochester, Med Ctr, Dept Pediat, Rochester, NY 14642 USA; [Davie, James R.] Univ Manitoba, Manitoba Inst Cell Biol, Winnipeg, MB, Canada	University of Rochester; University of Rochester; University of Manitoba	Sundar, IK (corresponding author), Univ Rochester, Med Ctr, Dept Environm Med, Lung Biol & Dis Program, Rochester, NY 14642 USA.	Irfan_Rahman@urmc.rochester.edu	Sundar, Isaac K/F-8764-2012; Yao, Hongwei/G-6444-2010; Friedman, Alan/Q-4858-2018	Sundar, Isaac K/0000-0001-6742-3460; Friedman, Alan/0000-0002-4764-8168; Davie, James/0000-0002-0420-6888	NIH - National Heart, Lung, and Blood Institute [R01-HL085613]; National Institute of Environmental Health Sciences [NIEHS P30-ES01247]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085613] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES001247] Funding Source: NIH RePORTER	NIH - National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported by the NIH - National Heart, Lung, and Blood Institute Grant R01-HL085613, National Institute of Environmental Health Sciences Center Grant NIEHS P30-ES01247. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ananieva O, 2008, NAT IMMUNOL, V9, P1028, DOI 10.1038/ni.1644; Anest V, 2003, NATURE, V423, P659, DOI 10.1038/nature01648; Anest V, 2004, J BIOL CHEM, V279, P31183, DOI 10.1074/jbc.M404380200; Arthur JSC, 2008, FRONT BIOSCI-LANDMRK, V13, P5866, DOI 10.2741/3122; Barnes PJ, 2003, EUR RESPIR J, V22, P672, DOI 10.1183/09031936.03.00040703; Beck IM, 2008, EMBO J, V27, P1682, DOI 10.1038/emboj.2008.95; Berger SL, 2002, CURR OPIN GENET DEV, V12, P142, DOI 10.1016/S0959-437X(02)00279-4; Caivano M, 2000, J IMMUNOL, V164, P3018, DOI 10.4049/jimmunol.164.6.3018; Carnevali S, 1998, AM J PHYSIOL-LUNG C, V274, pL591, DOI 10.1152/ajplung.1998.274.4.L591; CARP H, 1978, AM REV RESPIR DIS, V118, P617; Chadee DN, 1999, J BIOL CHEM, V274, P24914, DOI 10.1074/jbc.274.35.24914; Chen LF, 2001, SCIENCE, V293, P1653, DOI 10.1126/science.1062374; Chen LF, 2002, EMBO J, V21, P6539, DOI 10.1093/emboj/cdf660; Chen LF, 2005, MOL CELL BIOL, V25, P7966, DOI 10.1128/MCB.25.18.7966-7975.2005; Chung S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023488; Chung S, 2010, AM J PHYSIOL-LUNG C, V299, pL192, DOI 10.1152/ajplung.00426.2009; Darragh J, 2010, BIOCHEM J, V425, P595, DOI 10.1042/BJ20091062; Deak M, 1998, EMBO J, V17, P4426, DOI 10.1093/emboj/17.15.4426; Drobic B, 2010, NUCLEIC ACIDS RES, V38, P3196, DOI 10.1093/nar/gkq030; Duncan EA, 2006, J BIOL CHEM, V281, P12521, DOI 10.1074/jbc.M513333200; Dunn KL, 2005, ONCOGENE, V24, P3492, DOI 10.1038/sj.onc.1208521; Fujioka K, 2006, ENVIRON TOXICOL, V21, P47, DOI 10.1002/tox.20153; Garcia BA, 2005, BIOCHEMISTRY-US, V44, P13202, DOI 10.1021/bi050906n; Gilmour PS, 2003, AM J PHYSIOL-LUNG C, V284, pL533, DOI 10.1152/ajplung.00277.2002; Gloire G, 2007, J BIOL CHEM, V282, P21308, DOI 10.1074/jbc.M610728200; Ito K, 2007, PHARMACOL THERAPEUT, V116, P249, DOI 10.1016/j.pharmthera.2007.06.009; Jacks KA, 2010, J BIOL CHEM, V285, P1661, DOI 10.1074/jbc.M109.083808; Jamaluddin M, 2009, J VIROL, V83, P10605, DOI 10.1128/JVI.01090-09; Janknecht R, 2003, ONCOGENE, V22, P746, DOI 10.1038/sj.onc.1206185; Joo JH, 2008, J BIOL CHEM, V283, P16391, DOI 10.1074/jbc.M800945200; Kannan-Thulasiraman P, 2006, J BIOL CHEM, V281, P22446, DOI 10.1074/jbc.M603111200; Kefaloyianni E, 2006, CELL SIGNAL, V18, P2238, DOI 10.1016/j.cellsig.2006.05.004; Kim HG, 2008, CANCER RES, V68, P2538, DOI 10.1158/0008-5472.CAN-07-6597; Kim YM, 2007, CELL SIGNAL, V19, P538, DOI 10.1016/j.cellsig.2006.08.003; Kode A, 2008, AM J PHYSIOL-LUNG C, V294, pL478, DOI 10.1152/ajplung.00361.2007; Kode A, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-132; Lambert C, 2005, J ALLERGY CLIN IMMUN, V116, P916, DOI 10.1016/j.jaci.2005.05.046; Markou T, 2002, BIOCHEM J, V365, P757, DOI 10.1042/BJ20011828; Marwick JA, 2004, AM J RESP CELL MOL, V31, P633, DOI 10.1165/rcmb.2004-0006OC; Mauderly JL, 2004, TOXICOL SCI, V81, P280, DOI 10.1093/toxsci/kfh203; McCoy CE, 2005, BIOCHEM J, V387, P507, DOI 10.1042/BJ20041501; New L, 1999, J BIOL CHEM, V274, P1026, DOI 10.1074/jbc.274.2.1026; Okazaki T, 2003, BIOCHEM BIOPH RES CO, V300, P807, DOI 10.1016/S0006-291X(02)02932-7; Perez-Cadahia B, 2011, J BIOL CHEM, V286, P42, DOI 10.1074/jbc.M110.156687; Pierrat B, 1998, J BIOL CHEM, V273, P29661, DOI 10.1074/jbc.273.45.29661; Rahman I, 2006, EUR RESPIR J, V28, P219, DOI 10.1183/09031936.06.00053805; Rajendrasozhan S, 2010, AM J PHYSIOL-LUNG C, V298, pL197, DOI 10.1152/ajplung.00265.2009; Rajendrasozhan S, 2009, COPD, V6, P291, DOI 10.1080/15412550903049132; Reber L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004393; REDDEL RR, 1988, CANCER RES, V48, P1904; Smith CJ, 2000, FOOD CHEM TOXICOL, V38, P637, DOI 10.1016/S0278-6915(00)00051-X; Soloaga A, 2003, EMBO J, V22, P2788, DOI 10.1093/emboj/cdg273; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Thomson S, 1999, EMBO J, V18, P4779, DOI 10.1093/emboj/18.17.4779; Vermeulen L, 2003, EMBO J, V22, P1313, DOI 10.1093/emboj/cdg139; Vermeulen L, 2009, TRENDS BIOCHEM SCI, V34, P311, DOI 10.1016/j.tibs.2009.02.007; Wiggin GR, 2002, MOL CELL BIOL, V22, P2871, DOI 10.1128/MCB.22.8.2871-2881.2002; Yamamoto Y, 2003, NATURE, V423, P655, DOI 10.1038/nature01576; Yang SR, 2008, AM J RESP CELL MOL, V38, P689, DOI 10.1165/rcmb.2007-0379OC; Yang SR, 2007, AM J PHYSIOL-LUNG C, V292, pL567, DOI 10.1152/ajplung.00308.2006; Yang SR, 2006, AM J PHYSIOL-LUNG C, V291, pL46, DOI 10.1152/ajplung.00241.2005; Yang SR, 2009, AM J RESP CELL MOL, V40, P147, DOI 10.1165/rcmb.2008-0207OC; Yao HW, 2008, AM J PHYSIOL-LUNG C, V294, pL1174, DOI 10.1152/ajplung.00439.2007; Yao HW, 2010, J BIOL CHEM, V285, P5405, DOI 10.1074/jbc.M109.041418; Zhong HH, 1998, MOL CELL, V1, P661, DOI 10.1016/S1097-2765(00)80066-0; Zhong SP, 2001, J BIOL CHEM, V276, P33213, DOI 10.1074/jbc.M103973200	66	45	47	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2012	7	2							e31378	10.1371/journal.pone.0031378	http://dx.doi.org/10.1371/journal.pone.0031378			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UG	22312446	gold, Green Published, Green Submitted			2022-12-25	WOS:000301977500036
J	Birukova, AA; Lee, S; Starosta, V; Wu, TH; Ho, T; Kim, J; Berliner, JA; Birukov, KG				Birukova, Anna A.; Lee, Sangderk; Starosta, Vitaliy; Wu, Tinghuai; Ho, Tiffany; Kim, Jin; Berliner, Judith A.; Birukov, Konstantin G.			A Role for VEGFR2 Activation in Endothelial Responses Caused by Barrier Disruptive OxPAPC Concentrations	PLOS ONE			English	Article							ACUTE LUNG INJURY; PHOSPHOLIPID OXIDATION-PRODUCTS; OXIDIZED PHOSPHOLIPIDS; CYCLIC STRETCH; GROWTH-FACTOR; FAK PHOSPHORYLATION; PROTECTIVE RESPONSE; CELL MIGRATION; VASCULAR LEAK; BETA-CATENIN	Introduction: Oxidation products of 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphatidylcholine (OxPAPC) differentially modulate endothelial cell (EC) barrier function in a dose-dependent fashion. Vascular endothelial growth factor receptor-2 (VEGFR2) is involved in the OxPAPC-induced EC inflammatory activation. This study examined a role of VEGFR2 in barrier dysfunction caused by high concentrations of OxPAPC and evaluated downstream signaling mechanisms resulting from the effect of OxPAPC in EC from pulmonary and systemic circulation. Methods: EC monolayer permeability in human pulmonary artery endothelial cells (HPAEC) and human aortic endothelial cells (HAEC) was monitored by changes in transendothelial electrical resistance (TER) across EC monolayers. Actin cytoskeleton was examined by immunostaining with Texas Red labeled phalloidin. Phosphorylation of myosin light chains (MLC) and VE-Cadherin was examined by Western blot and immunofluorescence techniques. The role of VEGFR2 in OxPAPC-induced permeability and cytoskeletal arrangement were determined using siRNA-induced VEGFR2 knockdown. Results: Low OxPAPC concentrations (5-20 mu g/ml) induced a barrier protective response in both HPAEC and HAEC, while high OxPAPC concentrations (50-100 mu g/ml) caused a rapid increase in permeability; actin stress fiber formation and increased MLC phosphorylation were observed as early as 30 min after treatment. VEGFR2 knockdown dramatically decreased the amount of MLC phosphorylation and stress fiber formation caused by high OxPAPC concentrations with modest effects on the amount of VE-cadherin phosphorylation at Y-731. We present evidence that activation of Rho is involved in the OxPAPC/VEGFR2 mechanism of EC permeability induced by high OxPAPC concentrations. Knockdown of VEGFR2 did not rescue the early drop in TER but prevented further development of OxPAPC-induced barrier dysfunction. Conclusions: This study shows that VEGFR2 is involved in the delayed phase of EC barrier dysfunction caused by high OxPAPC concentrations and contributes to stress fiber formation and increased MLC phosphorylation.	[Birukova, Anna A.; Starosta, Vitaliy; Wu, Tinghuai; Birukov, Konstantin G.] Univ Chicago, Dept Med, Lung Injury Ctr, Sect Pulm & Crit Med, Chicago, IL 60637 USA; [Lee, Sangderk; Ho, Tiffany; Kim, Jin; Berliner, Judith A.] Univ Calif Los Angeles, Dept Pathol, Los Angeles, CA 90024 USA; [Lee, Sangderk; Ho, Tiffany; Kim, Jin; Berliner, Judith A.] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90024 USA	University of Chicago; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Birukova, AA (corresponding author), Univ Chicago, Dept Med, Lung Injury Ctr, Sect Pulm & Crit Med, 5841 S Maryland Ave, Chicago, IL 60637 USA.	kbirukov@medicine.bsd.uchicago.edu	Birukov, Konstantin/FJB-5755-2022; Ho, Tiffany/S-9875-2019		NHLBI [HL8782, HL76259, PO1 HL58064, HL89257, HL107920, PO1 HL030568, K99HL105577]; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089257, R56HL107920, K99HL105577, R01HL076259, P01HL058064, R01HL087823, R00HL105577, P01HL030568, R01HL107920] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	NHLBI HL87823, HL76259, and PO1 HL58064 for KB; HL89257, HL107920 and the American Heart Association Midwest Affiliate Grant-in-Aid for AB; NHLBI PO1 HL030568 for JB and K99HL105577 for SL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amerongen GPV, 2000, CIRC RES, V87, P335, DOI 10.1161/01.RES.87.4.335; Amerongen GPV, 2003, ARTERIOSCL THROM VAS, V23, P211, DOI 10.1161/01.ATV.0000054198.68894.88; Beckers CML, 2010, THROMB HAEMOSTASIS, V103, P40, DOI 10.1160/TH09-06-0403; Berliner JA, 2008, FREE RADICAL BIO MED, V45, P119, DOI 10.1016/j.freeradbiomed.2008.04.013; Birukov KG, 2004, CIRC RES, V95, P892, DOI 10.1161/01.RES.0000147310.18962.06; Birukov KG, 2004, MICROVASC RES, V67, P18, DOI 10.1016/j.mvr.2003.09.004; Birukova AA, 2004, MICROVASC RES, V67, P64, DOI 10.1016/j.mvr.2003.09.007; Birukova AA, 2006, AM J PATHOL, V168, P1749, DOI 10.2353/ajpath.2006.050431; Birukova AA, 2006, AM J PHYSIOL-LUNG C, V290, pL540, DOI 10.1152/ajplung.00259.2005; Birukova AA, 2004, FASEB J, V18, P1879, DOI 10.1096/fj.04-2328com; Birukova AA, 2004, J CELL PHYSIOL, V201, P55, DOI 10.1002/jcp.20055; Birukova AA, 2008, AM J PHYSIOL-LUNG C, V295, pL612, DOI 10.1152/ajplung.90236.2008; Birukova AA, 2007, AM J PHYSIOL-LUNG C, V292, pL924, DOI 10.1152/ajplung.00395.2006; Birukova AA, 2007, AM J PHYSIOL-LUNG C, V293, pL199, DOI 10.1152/ajplung.00020.2007; Birukova AA, 2007, MICROVASC RES, V73, P173, DOI 10.1016/j.mvr.2006.12.004; Birukova AA, 2007, J CELL PHYSIOL, V211, P608, DOI 10.1002/jcp.20966; Birukova AA, 2011, EXP CELL RES, V317, P859, DOI 10.1016/j.yexcr.2010.11.011; Birukova AA, 2011, J CELL PHYSIOL, V226, P2052, DOI 10.1002/jcp.22543; Bochkov VN, 2010, ANTIOXID REDOX SIGN, V12, P1009, DOI 10.1089/ars.2009.2597; Bochkov VN, 2002, NATURE, V419, P77, DOI 10.1038/nature01023; Breslin JW, 2003, AM J PHYSIOL-HEART C, V284, pH92, DOI 10.1152/ajpheart.00330.2002; Busca R, 1998, MOL BIOL CELL, V9, P1367, DOI 10.1091/mbc.9.6.1367; Chen WG, 2008, AM J PHYSIOL-LUNG C, V295, pL575, DOI 10.1152/ajplung.00428.2007; Cole AL, 2003, ARTERIOSCL THROM VAS, V23, P1384, DOI 10.1161/01.ATV.0000081215.45714.71; DeMaio L, 2006, AM J PHYSIOL-HEART C, V290, pH674, DOI 10.1152/ajpheart.00554.2005; Dudek SM, 2001, J APPL PHYSIOL, V91, P1487, DOI 10.1152/jappl.2001.91.4.1487; Essler M, 1998, J BIOL CHEM, V273, P21867, DOI 10.1074/jbc.273.34.21867; Fu PF, 2009, TRANSL RES, V153, P166, DOI 10.1016/j.trsl.2008.12.005; Gargalovic PS, 2006, ARTERIOSCL THROM VAS, V26, P2490, DOI 10.1161/01.ATV.0000242903.41158.a1; Gavard J, 2006, NAT CELL BIOL, V8, P1223, DOI 10.1038/ncb1486; Hammad LA, 2009, RAPID COMMUN MASS SP, V23, P863, DOI 10.1002/rcm.3947; Imai Y, 2008, CELL, V133, P235, DOI 10.1016/j.cell.2008.02.043; Kaner RJ, 2000, AM J RESP CELL MOL, V22, P657, DOI 10.1165/ajrcmb.22.6.3779; Lang P, 1996, EMBO J, V15, P510, DOI 10.1002/j.1460-2075.1996.tb00383.x; Lee S, 2009, FREE RADICAL BIO MED, V47, P145, DOI 10.1016/j.freeradbiomed.2009.04.013; Leitinger N, 1999, P NATL ACAD SCI USA, V96, P12010, DOI 10.1073/pnas.96.21.12010; Ma Z, 2004, AM J PHYSIOL-LUNG C, V286, pL808, DOI 10.1152/ajplung.00220.2003; Medford ARL, 2006, THORAX, V61, P621, DOI 10.1136/thx.2005.040204; Mirzapoiazova T, 2006, AM J PHYSIOL-LUNG C, V291, pL718, DOI 10.1152/ajplung.00014.2006; Nonas S, 2006, AM J RESP CRIT CARE, V173, P1130, DOI 10.1164/rccm.200511-1737OC; Nonas S, 2008, CRIT CARE, V12, DOI 10.1186/cc6805; Oskolkova OV, 2010, J IMMUNOL, V185, P7706, DOI 10.4049/jimmunol.0903594; Petrovan RJ, 2007, ARTERIOSCL THROM VAS, V27, P1095, DOI 10.1161/ATVBAHA.106.139246; Podrez EA, 2007, NAT MED, V13, P1086, DOI 10.1038/nm1626; Potter MD, 2005, J BIOL CHEM, V280, P31906, DOI 10.1074/jbc.M505568200; Qiao J, 2003, AM J PHYSIOL-LUNG C, V284, pL972, DOI 10.1152/ajplung.00429.2002; Shikata Y, 2005, EXP CELL RES, V304, P40, DOI 10.1016/j.yexcr.2004.11.001; Shikata Y, 2003, FASEB J, V17, P2240, DOI 10.1096/fj.03-0198com; Starosta V, 2011, AM J RESP CELL MOL B; Subbanagounder G, 2000, ARTERIOSCL THROM VAS, V20, P2248, DOI 10.1161/01.ATV.20.10.2248; Sun HR, 2006, MICROCIRCULATION, V13, P237, DOI 10.1080/10739680600556944; Watson AD, 1997, J BIOL CHEM, V272, P13597, DOI 10.1074/jbc.272.21.13597; Yeh M, 2001, ARTERIOSCL THROM VAS, V21, P1585, DOI 10.1161/hq1001.097027; Zeng HY, 2002, J BIOL CHEM, V277, P46791, DOI 10.1074/jbc.M206133200; Zimman A, 2007, ARTERIOSCL THROM VAS, V27, P332, DOI 10.1161/01.ATV.0000252842.57585.df; Zimman A, 2010, J PROTEOME RES, V9, P2812, DOI 10.1021/pr901194x	56	25	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2012	7	1							e30957	10.1371/journal.pone.0030957	http://dx.doi.org/10.1371/journal.pone.0030957			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	912BY	22303475	gold, Green Published, Green Submitted			2022-12-25	WOS:000301770700010
J	Nicklas, S; Otto, A; Wu, XL; Miller, P; Stelzer, S; Wen, YF; Kuang, SH; Wrogemann, K; Patel, K; Ding, H; Schwamborn, JC				Nicklas, Sarah; Otto, Anthony; Wu, Xiaoli; Miller, Pamela; Stelzer, Sandra; Wen, Yefei; Kuang, Shihuan; Wrogemann, Klaus; Patel, Ketan; Ding, Hao; Schwamborn, Jens C.			TRIM32 Regulates Skeletal Muscle Stem Cell Differentiation and Is Necessary for Normal Adult Muscle Regeneration	PLOS ONE			English	Article							SELF-RENEWAL; SATELLITE CELLS; DROSOPHILA; INHIBITION; GENE; PROLIFERATION; EXPRESSION; MICRORNAS; MYOBLAST; SWITCH	Limb girdle muscular dystrophy type 2H (LGMD2H) is an inherited autosomal recessive disease of skeletal muscle caused by a mutation in the TRIM32 gene. Currently its pathogenesis is entirely unclear. Typically the regeneration process of adult skeletal muscle during growth or following injury is controlled by a tissue specific stem cell population termed satellite cells. Given that TRIM32 regulates the fate of mammalian neural progenitor cells through controlling their differentiation, we asked whether TRIM32 could also be essential for the regulation of myogenic stem cells. Here we demonstrate for the first time that TRIM32 is expressed in the skeletal muscle stem cell lineage of adult mice, and that in the absence of TRIM32, myogenic differentiation is disrupted. Moreover, we show that the ubiquitin ligase TRIM32 controls this process through the regulation of c-Myc, a similar mechanism to that previously observed in neural progenitors. Importantly we show that loss of TRIM32 function induces a LGMD2H-like phenotype and strongly affects muscle regeneration in vivo. Our studies implicate that the loss of TRIM32 results in dysfunctional muscle stem cells which could contribute to the development of LGMD2H.	[Nicklas, Sarah; Stelzer, Sandra; Schwamborn, Jens C.] Univ Munster, Zentrum Mol Biol Entzundung, Inst Cell Biol, Stem Cell Biol & Regenerat Grp, Munster, Germany; [Wu, Xiaoli; Miller, Pamela; Wrogemann, Klaus; Ding, Hao] Univ Manitoba, Dept Biochem & Med Genet, Winnipeg, MB, Canada; [Otto, Anthony; Patel, Ketan] Univ Reading, Sch Biol Sci, Reading, Berks, England; [Wen, Yefei; Kuang, Shihuan] Purdue Univ, Dept Anim Sci, W Lafayette, IN 47907 USA	University of Munster; University of Manitoba; University of Reading; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Nicklas, S (corresponding author), Univ Munster, Zentrum Mol Biol Entzundung, Inst Cell Biol, Stem Cell Biol & Regenerat Grp, Munster, Germany.	dingh@cc.umanitoba.ca; jschwamb@uni-muenster.de	Schwamborn, Jens C/F-9395-2011	Schwamborn, Jens C/0000-0003-4496-0559; Wen, Yefei/0000-0002-2121-7538; Kuang, Shihuan/0000-0001-9180-3180	German Research Foundation (DFG) [SCHW1392/2-1, SFB629]; Kompetenznetzwerk Stammzellforschung NRW; Fonds der Chemischen Industrie; Fritz Thyssen Foundation [Az. 10.10.2.152]; German-Israeli Foundation for Scientific Research and Development [G-2226-2034.1/2009]; European Union; University of Munster Medical School [SC120901, SC411003]; Interdisciplinary Center for Clinical Research Munster [SchwJ3/001/11]; Canada Institute of Health Research; National Cancer Institute of Canada; Canada Research Chair program; Biotechnology and Biological Sciences Research Council; University of Reading; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060652] Funding Source: NIH RePORTER	German Research Foundation (DFG)(German Research Foundation (DFG)); Kompetenznetzwerk Stammzellforschung NRW; Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); Fritz Thyssen Foundation; German-Israeli Foundation for Scientific Research and Development(German-Israeli Foundation for Scientific Research and Development); European Union(European Commission); University of Munster Medical School; Interdisciplinary Center for Clinical Research Munster; Canada Institute of Health Research(Canadian Institutes of Health Research (CIHR)); National Cancer Institute of Canada(Canadian Cancer Society (CCS)); Canada Research Chair program(Canada Research Chairs); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); University of Reading; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Work in JS's lab is supported by the German Research Foundation (DFG, Emmy Noether Program, SCHW1392/2-1 and SFB629), Kompetenznetzwerk Stammzellforschung NRW, Fonds der Chemischen Industrie, Fritz Thyssen Foundation (Az. 10.10.2.152), German-Israeli Foundation for Scientific Research and Development (G-2226-2034.1/2009) and European Union FP7 network EuroSyStem. Furthermore, this work was supported by the fund "Innovative Medical Research" of the University of Munster Medical School (SC120901 and SC411003) and the Interdisciplinary Center for Clinical Research Munster (SchwJ3/001/11). Transgenic TRIM32 mouse work in HD's lab is supported by the Canada Institute of Health Research, National Cancer Institute of Canada and the Canada Research Chair program. AO and KP were supported by the Biotechnology and Biological Sciences Research Council and the University of Reading. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asakura A, 2001, DIFFERENTIATION, V68, P245, DOI 10.1046/j.1432-0436.2001.680412.x; Bello B, 2006, DEVELOPMENT, V133, P2639, DOI 10.1242/dev.02429; Betschinger J, 2006, CELL, V124, P1241, DOI 10.1016/j.cell.2006.01.038; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; Cossee M, 2009, NEUROMUSCULAR DISORD, V19, P255, DOI 10.1016/j.nmd.2009.02.003; Ding H, 2000, MECH DEVELOP, V96, P209, DOI 10.1016/S0925-4773(00)00425-1; Frosk P, 2002, AM J HUM GENET, V70, P663, DOI 10.1086/339083; Guglieri M, 2008, CURR OPIN NEUROL, V21, P576, DOI 10.1097/WCO.0b013e32830efdc2; Harris RE, 2011, DEV CELL, V20, P72, DOI 10.1016/j.devcel.2010.11.019; Hillje AL, 2011, STEM CELLS, V29, P1437, DOI 10.1002/stem.687; Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044; Kudryashova E, 2011, HUM MOL GENET; Kudryashova E, 2009, HUM MOL GENET, V18, P1353, DOI 10.1093/hmg/ddp036; Lee CY, 2006, NATURE, V439, P594, DOI 10.1038/nature04299; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V10, P177, DOI 10.1083/jcb.10.4.177; MINER JH, 1991, MOL CELL BIOL, V11, P2842, DOI 10.1128/MCB.11.5.2842; Neumuller RA, 2008, NATURE, V454, P241, DOI 10.1038/nature07014; Olguin HC, 2007, J CELL BIOL, V177, P769, DOI 10.1083/jcb.200608122; Otto A, 2008, J CELL SCI, V121, P2939, DOI 10.1242/jcs.026534; Otto A, 2006, ANAT EMBRYOL, V211, P293, DOI 10.1007/s00429-006-0083-3; Otto A, 2010, DEV BIOL, V343, P51, DOI 10.1016/j.ydbio.2010.04.014; Pan L, 2007, CELL STEM CELL, V1, P458, DOI 10.1016/j.stem.2007.09.010; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; Saccone V, 2008, HUM MUTAT, V29, P240, DOI 10.1002/humu.20633; Schwamborn JC, 2009, CELL, V136, P913, DOI 10.1016/j.cell.2008.12.024; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Wei Q, 2001, FEBS LETT, V490, P171, DOI 10.1016/S0014-5793(01)02120-2; Zammit PS, 2004, J CELL BIOL, V166, P347, DOI 10.1083/jcb.200312007	28	55	55	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2012	7	1							e30445	10.1371/journal.pone.0030445	http://dx.doi.org/10.1371/journal.pone.0030445			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911GB	22299041	Green Accepted, gold, Green Published, Green Submitted			2022-12-25	WOS:000301704200018
J	Saez, A; Sabatino, M; Aizen, MA				Saez, Agustin; Sabatino, Malena; Aizen, Marcelo A.			Interactive Effects of Large- and Small-Scale Sources of Feral Honey-Bees for Sunflower in the Argentine Pampas	PLOS ONE			English	Article							CROP POLLINATION; HABITAT FRAGMENTATION; FORAGING RANGES; FRUIT-SET; BEES; COMMUNITIES; DIVERSITY; SERVICES; FOREST; AGRICULTURE	Pollinators for animal pollinated crops can be provided by natural and semi-natural habitats, ranging from large vegetation remnants to small areas of non-crop land in an otherwise highly modified landscape. It is unknown, however, how different small-and large-scale habitat patches interact as pollinator sources. In the intensively managed Argentine Pampas, we studied the additive and interactive effects of large expanses (up to 2200 ha) of natural habitat, represented by untilled isolated "sierras", and narrow (3-7 m wide) strips of semi-natural habitat, represented by field margins, as pollinator sources for sunflower (Helianthus annus). We estimated visitation rates by feral honey-bees, Apis mellifera, and native flower visitors (as a group) at 1, 5, 25, 50 and 100 m from a field margin in 17 sunflower fields 0-10 km distant from the nearest sierra. Honey-bees dominated the pollinator assemblage accounting for >90% of all visits to sunflower inflorescences. Honey-bee visitation was strongly affected by proximity to the sierras decreasing by about 70% in the most isolated fields. There was also a decline in honey-bee visitation with distance from the field margin, which was apparent with increasing field isolation, but undetected in fields nearby large expanses of natural habitat. The probability of observing a native visitor decreased with isolation from the sierras, but in other respects visitation by flower visitors other than honey-bees was mostly unaffected by the habitat factors assessed in this study. Overall, we found strong hierarchical and interactive effects between the study large and small-scale pollinator sources. These results emphasize the importance of preserving natural habitats and managing actively field verges in the absence of large remnants of natural habitat for improving pollinator services.	[Saez, Agustin; Sabatino, Malena; Aizen, Marcelo A.] Univ Nacl Comahue, Lab Ecotono CRUB, San Carlos De Bariloche, Rio Negro, Argentina	Universidad Nacional del Comahue	Saez, A (corresponding author), Univ Nacl Comahue, Lab Ecotono CRUB, San Carlos De Bariloche, Rio Negro, Argentina.	agustinsaez@live.com.ar		Aizen, Marcelo/0000-0001-9079-9749	National Institute of Agricultural Technology (INTA) Balcarce [PNECO1302]; Argentina National Research Council for Research [PIP 01623]; National Fund for Research [PICT 01300]; National University of Comahue [B152/04]	National Institute of Agricultural Technology (INTA) Balcarce; Argentina National Research Council for Research; National Fund for Research; National University of Comahue	This work was supported by the National Institute of Agricultural Technology (INTA) Balcarce (PNECO1302), the Argentina National Research Council for Research (PIP 01623), the National Fund for Research (PICT 01300) and the National University of Comahue (B152/04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIZEN MA, 1994, ECOL APPL, V4, P378, DOI 10.2307/1941941; AIZEN MA, 1994, ECOLOGY, V75, P330, DOI 10.2307/1939538; Aizen MA, 2009, ANN BOT-LONDON, V103, P1579, DOI 10.1093/aob/mcp076; Bates D, 2009, IME4 LINEARMIXED EFF; Beekman M, 2000, FUNCT ECOL, V14, P490, DOI 10.1046/j.1365-2435.2000.00443.x; Beekman M, 2004, NATURWISSENSCHAFTEN, V91, P598, DOI 10.1007/s00114-004-0576-y; Blanche KR, 2006, J APPL ECOL, V43, P1182, DOI 10.1111/j.1365-2664.2006.01230.x; Cabrera AL, 1973, BIOGREOGRAFIA AM LAT; Chacoff NP, 2006, J APPL ECOL, V43, P18, DOI 10.1111/j.1365-2664.2005.01116.x; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Crawley M.J., 2007, J CHEM INF MODEL, DOI DOI 10.1002/9780470515075; Cresswell JE, 2004, J APPL ECOL, V41, P539, DOI 10.1111/j.0021-8901.2004.00912.x; Debinski DM, 2000, CONSERV BIOL, V14, P342, DOI 10.1046/j.1523-1739.2000.98081.x; Fernando LE, 2010, ESPACIO APICOLA, V92, P22; Frangi J L, 1996, BIODIVERSIDAD FUNCIO; Frangi JL, 1975, B SOC ARGENTINA BOT; Gathmann A, 2002, J ANIM ECOL, V71, P757, DOI 10.1046/j.1365-2656.2002.00641.x; Gelman A, 2007, DATA ANAL USING REGR, P109; Greenleaf SS, 2007, OECOLOGIA, V153, P589, DOI 10.1007/s00442-007-0752-9; Greenleaf SS, 2006, BIOL CONSERV, V133, P81, DOI 10.1016/j.biocon.2006.05.025; Greenleaf SS, 2006, P NATL ACAD SCI USA, V103, P13890, DOI 10.1073/pnas.0600929103; Hines HM, 2005, ENVIRON ENTOMOL, V34, P1477, DOI 10.1603/0046-225X-34.6.1477; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Klein AM, 2004, J ANIM ECOL, V73, P517, DOI 10.1111/j.0021-8790.2004.00826.x; Klein AM, 2003, J APPL ECOL, V40, P837, DOI 10.1046/j.1365-2664.2003.00847.x; Klein AM, 2003, P ROY SOC B-BIOL SCI, V270, P955, DOI 10.1098/rspb.2002.2306; Kremen C, 2004, ECOL LETT, V7, P1109, DOI 10.1111/j.1461-0248.2004.00662.x; Kremen C, 2002, P NATL ACAD SCI USA, V99, P16812, DOI 10.1073/pnas.262413599; LANGRIDGE D F, 1974, Australian Journal of Experimental Agriculture and Animal Husbandry, V14, P201, DOI 10.1071/EA9740201; Laterra P, 2003, J VEG SCI, V14, P43, DOI 10.1111/j.1654-1103.2003.tb02126.x; Lonsdorf E, 2009, ANN BOT-LONDON, V103, P1589, DOI 10.1093/aob/mcp069; Morales C. L., 2009, INT J PLANT REPROD B, V1, P195; MORALES CL, 2002, BIOL INVASIONS, V4, P87, DOI DOI 10.1023/A:1020513012689; *NRC, 2007, STAT POLL N AM; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; R Development Core Team, 2005, R LANG ENV STAT COMP; Ricketts TH, 2008, ECOL LETT, V11, P499, DOI 10.1111/j.1461-0248.2008.01157.x; Ricketts TH, 2004, CONSERV BIOL, V18, P1262, DOI 10.1111/j.1523-1739.2004.00227.x; Roubik DW, 2002, NATURE, V417, P708, DOI 10.1038/417708a; Sabatino M, 2010, ECOL APPL, V20, P1491, DOI 10.1890/09-1626.1; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Schneider SS, 2004, ANNU REV ENTOMOL, V49, P351, DOI 10.1146/annurev.ento.49.061802.123359; SHEPPARD WS, 1991, NATURE, V349, P782, DOI 10.1038/349782a0; Steffan-Dewenter I, 2001, P ROY SOC B-BIOL SCI, V268, P1685, DOI 10.1098/rspb.2001.1737; Steffan-Dewenter I, 1999, OECOLOGIA, V121, P432, DOI 10.1007/s004420050949; Steffan-Dewenter I, 2003, P ROY SOC B-BIOL SCI, V270, P569, DOI 10.1098/rspb.2002.2292; Steffan-Dewenter I, 2002, BIOL CONSERV, V104, P275, DOI 10.1016/S0006-3207(01)00192-6; Torretta Juan P., 2010, Rev. Soc. Entomol. Argent., V69, P17; United States Government, 1975, SOIL CONS SOIL TAX B; VISSCHER PK, 1982, ECOLOGY, V63, P1790, DOI 10.2307/1940121; Westphal C, 2003, ECOL LETT, V6, P961, DOI 10.1046/j.1461-0248.2003.00523.x; Westrich P, 1996, HABITAT REQUIREMENTS, P1; Winfree R, 2005, AM NAT, V165, P707, DOI 10.1086/430009; Winfree R, 2009, ECOLOGY, V90, P2068, DOI 10.1890/08-1245.1; Winston ML, 1992, KILLER BEES	55	17	18	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2012	7	1							e30968	10.1371/journal.pone.0030968	http://dx.doi.org/10.1371/journal.pone.0030968			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911GB	22303477	Green Published, gold, Green Submitted			2022-12-25	WOS:000301704200051
J	Schietke, RE; Hackenbeck, T; Tran, M; Gunther, R; Klanke, B; Warnecke, CL; Knaup, KX; Shukla, D; Rosenberger, C; Koesters, R; Bachmann, S; Betz, P; Schley, G; Schodel, J; Willam, C; Winkler, T; Amann, K; Eckardt, KU; Maxwell, P; Wiesener, MS				Schietke, Ruth E.; Hackenbeck, Thomas; Tran, Maxine; Guenther, Regina; Klanke, Bernd; Warnecke, Christina L.; Knaup, Karl X.; Shukla, Deepa; Rosenberger, Christian; Koesters, Robert; Bachmann, Sebastian; Betz, Peter; Schley, Gunnar; Schoedel, Johannes; Willam, Carsten; Winkler, Thomas; Amann, Kerstin; Eckardt, Kai-Uwe; Maxwell, Patrick; Wiesener, Michael S.			Renal Tubular HIF-2 alpha Expression Requires VHL Inactivation and Causes Fibrosis and Cysts	PLOS ONE			English	Article							VON-HIPPEL-LINDAU; HYPOXIA-INDUCIBLE FACTOR; GENE-EXPRESSION; E-CADHERIN; IN-VIVO; KIDNEY; ACTIVATION; HIF; INDUCTION; INJURY	The Hypoxia-inducible transcription Factor (HIF) represents an important adaptive mechanism under hypoxia, whereas sustained activation may also have deleterious effects. HIF activity is determined by the oxygen regulated alpha-subunits HIF-1 alpha or HIF-2 alpha. Both are regulated by oxygen dependent degradation, which is controlled by the tumor suppressor "von Hippel-Lindau" (VHL), the gatekeeper of renal tubular growth control. HIF appears to play a particular role for the kidney, where renal EPO production, organ preservation from ischemia-reperfusion injury and renal tumorigenesis are prominent examples. Whereas HIF-1 alpha is inducible in physiological renal mouse, rat and human tubular epithelia, HIF-2 alpha is never detected in these cells, in any species. In contrast, distinct early lesions of biallelic VHL inactivation in kidneys of the hereditary VHL syndrome show strong HIF-2 alpha expression. Furthermore, knockout of VHL in the mouse tubular apparatus enables HIF-2 alpha expression. Continuous transgenic expression of HIF-2 alpha by the Ksp-Cadherin promotor leads to renal fibrosis and insufficiency, next to multiple renal cysts. In conclusion, VHL appears to specifically repress HIF-2 alpha in renal epithelia. Unphysiological expression of HIF-2 alpha in tubular epithelia has deleterious effects. Our data are compatible with dedifferentiation of renal epithelial cells by sustained HIF-2 alpha expression. However, HIF-2 alpha overexpression alone is insufficient to induce tumors. Thus, our data bear implications for renal tumorigenesis, epithelial differentiation and renal repair mechanisms.	[Schietke, Ruth E.; Hackenbeck, Thomas; Guenther, Regina; Wiesener, Michael S.] Univ Erlangen Nurnberg, Interdisciplinary Ctr Clin Res, D-91054 Erlangen, Germany; [Klanke, Bernd; Warnecke, Christina L.; Knaup, Karl X.; Schley, Gunnar; Schoedel, Johannes; Willam, Carsten; Eckardt, Kai-Uwe; Wiesener, Michael S.] Univ Erlangen Nurnberg, Dept Hypertens & Nephrol, D-91054 Erlangen, Germany; [Tran, Maxine; Shukla, Deepa; Maxwell, Patrick] UCL, Rayne Inst, London, England; [Rosenberger, Christian] Univ Med Berlin, Dept Nephrol, Charite, Berlin, Germany; [Koesters, Robert] Univ Paris 06, INSERM, Hop Tenon, UMR S 702, Paris, France; [Bachmann, Sebastian] Univ Med Berlin, Charite, Inst Vegetat Anat, Berlin, Germany; [Betz, Peter] Univ Erlangen Nurnberg, Dept Forens Med, D-91054 Erlangen, Germany; [Winkler, Thomas] Univ Erlangen Nurnberg, Dept Genet, D-91054 Erlangen, Germany; [Amann, Kerstin] Univ Erlangen Nurnberg, Dept Pathol, D-91054 Erlangen, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of London; King's College London; University College London; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg	Schietke, RE (corresponding author), Univ Erlangen Nurnberg, Interdisciplinary Ctr Clin Res, D-91054 Erlangen, Germany.	michael.wiesener@uk-erlangen.de	Maxwell, Patrick H/C-5557-2008; Tran, Maxine/ABF-4197-2021	Maxwell, Patrick H/0000-0002-0338-2679; Tran, Maxine Gia Binh/0000-0002-6034-4433; Schley, Gunnar/0000-0001-9929-5854; Schodel, Johannes/0000-0002-3587-8839; Knaup, Karl/0000-0003-1803-4463	Interdisciplinary Centre for Clinical Research (IZKF); German Research Foundation [SFB 423]; Ulrich-Gessler Foundation; Academy of Medical Sciences (AMS) [AMS-SGCL2-Tran] Funding Source: researchfish	Interdisciplinary Centre for Clinical Research (IZKF); German Research Foundation(German Research Foundation (DFG)); Ulrich-Gessler Foundation; Academy of Medical Sciences (AMS)(Academy of Medical Sciences (AMS))	This work was supported by grants from the Interdisciplinary Centre for Clinical Research (IZKF), the German Research Foundation (SFB 423) and the Ulrich-Gessler Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asada N, 2011, J CLIN INVEST, V121, P3981, DOI 10.1172/JCI57301; Bernhardt WM, 2009, P NATL ACAD SCI USA, V106, P21276, DOI 10.1073/pnas.0903978106; Bernhardt WM, 2006, J AM SOC NEPHROL, V17, P1970, DOI 10.1681/ASN.2005121302; Bernhardt WM, 2007, AM J PATHOL, V170, P830, DOI 10.2353/ajpath.2007.060455; Eckardt Kai-Uwe, 2005, Kidney Int Suppl, pS46; Esteban MA, 2006, CANCER RES, V66, P3567, DOI 10.1158/0008-5472.CAN-05-2670; Fine LG, 2008, KIDNEY INT, V74, P867, DOI 10.1038/ki.2008.350; Franovic A, 2009, P NATL ACAD SCI USA, V106, P21306, DOI 10.1073/pnas.0906432106; Frew IJ, 2008, EMBO J, V27, P1747, DOI 10.1038/emboj.2008.96; Fu LP, 2011, CANCER RES, V71, P6848, DOI 10.1158/0008-5472.CAN-11-1745; Gordan JD, 2007, CANCER CELL, V11, P335, DOI 10.1016/j.ccr.2007.02.006; Gordan JD, 2008, CANCER CELL, V14, P435, DOI 10.1016/j.ccr.2008.10.016; Haase VH, 2001, P NATL ACAD SCI USA, V98, P1583, DOI 10.1073/pnas.98.4.1583; Haase VH, 2009, ANN NY ACAD SCI, V1177, P57, DOI 10.1111/j.1749-6632.2009.05030.x; Hackenbeck T, 2009, CELL CYCLE, V8, P1386, DOI 10.4161/cc.8.9.8306; Higgins DF, 2007, J CLIN INVEST, V117, P3810, DOI 10.1172/JCI30487; Hill P, 2008, J AM SOC NEPHROL, V19, P39, DOI 10.1681/ASN.2006090998; Iwano M, 2002, J CLIN INVEST, V110, P341, DOI 10.1172/JCI200215518; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Kaelin WG, 2008, NAT REV CANCER, V8, P865, DOI 10.1038/nrc2502; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kimura K, 2008, AM J PHYSIOL-RENAL, V295, pF1023, DOI 10.1152/ajprenal.90209.2008; Kondo K, 2002, CANCER CELL, V1, P237, DOI 10.1016/S1535-6108(02)00043-0; Krieg M, 2000, ONCOGENE, V19, P5435, DOI 10.1038/sj.onc.1203938; Lechler P, 2007, AM J PATHOL, V171, P1483, DOI 10.2353/ajpath.2007.070132; Mandriota SJ, 2002, CANCER CELL, V1, P459, DOI 10.1016/S1535-6108(02)00071-5; Maranchie JK, 2002, CANCER CELL, V1, P247, DOI 10.1016/S1535-6108(02)00044-2; Matsumoto M, 2003, J AM SOC NEPHROL, V14, P1825, DOI 10.1097/01.ASN.0000074239.22357.06; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Ohtomo S, 2008, NEPHROL DIAL TRANSPL, V23, P1166, DOI 10.1093/ndt/gfm715; Rankin EB, 2006, CANCER RES, V66, P2576, DOI 10.1158/0008-5472.CAN-05-3241; Raval RR, 2005, MOL CELL BIOL, V25, P5675, DOI 10.1128/MCB.25.13.5675-5686.2005; Rosenberger C, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000017223.49823.2A; Schietke R, 2010, J BIOL CHEM, V285, P6658, DOI 10.1074/jbc.M109.042424; Schonig K, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf134; Semenza GL, 2009, PHYSIOLOGY, V24, P97, DOI 10.1152/physiol.00045.2008; Shao XL, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000016443.50138.CD; Tanaka T, 2005, KIDNEY INT, V68, P2714, DOI 10.1111/j.1523-1755.2005.00742.x; Tanaka T, 2005, LAB INVEST, V85, P1292, DOI 10.1038/labinvest.3700328; Theilig F, 2011, AM J PATHOL, V179, P2177, DOI 10.1016/j.ajpath.2011.07.012; Tian H, 1998, GENE DEV, V12, P3320, DOI 10.1101/gad.12.21.3320; Traykova-Brauch M, 2008, NAT MED, V14, P979, DOI 10.1038/nm.1865; Turner KJ, 2002, CANCER RES, V62, P2957; Warnecke C, 2004, FASEB J, V18, P1462, DOI 10.1096/fj.04-1640fje; Warnecke C, 2003, FASEB J, V17, P1186, DOI 10.1096/fj.02-1062fje; Warnecke C, 2008, EXP CELL RES, V314, P2016, DOI 10.1016/j.yexcr.2008.03.003; Wiesener MS, 2009, J MOL MED-JMM, V87, P871, DOI 10.1007/s00109-009-0504-x; Wiesener MS, 2001, CANCER RES, V61, P5215; Wiesener MS, 2002, FASEB J, V16, P271, DOI 10.1096/fj.02-0445fje; Wiesener MS, 1998, BLOOD, V92, P2260, DOI 10.1182/blood.V92.7.2260.2260_2260_2268; Wilson PD, 2004, NEW ENGL J MED, V350, P151, DOI 10.1056/NEJMra022161; Zimmer M, 2004, MOL CANCER RES, V2, P89	52	64	69	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2012	7	1							e31034	10.1371/journal.pone.0031034	http://dx.doi.org/10.1371/journal.pone.0031034			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911GB	22299048	Green Submitted, Green Published, gold			2022-12-25	WOS:000301704200055
J	Setiawan, VW; Haessler, J; Schumacher, F; Cote, ML; Deelman, E; Fesinmeyer, MD; Henderson, BE; Jackson, RD; Vockler, JS; Wilkens, LR; Yasmeen, S; Haiman, CA; Peters, U; Le Marchand, L; Kooperberg, C				Setiawan, Veronica Wendy; Haessler, Jeffrey; Schumacher, Fredrick; Cote, Michele L.; Deelman, Ewa; Fesinmeyer, Megan D.; Henderson, Brian E.; Jackson, Rebecca D.; Voeckler, Jens-S; Wilkens, Lynne R.; Yasmeen, Shagufta; Haiman, Christopher A.; Peters, Ulrike; Le Marchand, Loic; Kooperberg, Charles			HNF1B and Endometrial Cancer Risk: Results from the PAGE study	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; PROSTATE-CANCER; MULTIETHNIC COHORT; GENE-EXPRESSION	We examined the association between HNF1B variants identified in a recent genome-wide association study and endometrial cancer in two large case-control studies nested in prospective cohorts: the Multiethnic Cohort Study (MEC) and the Women's Health Initiative (WHI) as part of the Population Architecture using Genomics and Epidemiology (PAGE) study. A total of 1,357 incident cases of invasive endometrial cancer and 7,609 controls were included in the analysis (MEC: 426 cases/3,854 controls; WHI: 931cases/3,755 controls). The majority of women in the WHI were European American, while the MEC included sizable numbers of African Americans, Japanese and Latinos. We estimated the odds ratios (ORs) per allele and 95% confidence intervals (CIs) of each SNP using unconditional logistic regression adjusting for age, body mass index, and four principal components of ancestry informative markers. The combined ORs were estimated using fixed effect models. Rs4430796 and rs7501939 were associated with endometrial cancer risk in MEC and WHI with no heterogeneity observed across racial/ethnic groups (P >= 0.21) or between studies (P >= 0.70). The ORper allele was 0.82 (95% CI: 0.75, 0.89; P = 5.63 x 10(-6)) for rs4430796 (G allele) and 0.79 (95% CI: 0.73, 0.87; P = 3.77 x 10(-7)) for rs7501939 (A allele). The associations with the risk of Type I and Type II tumors were similar (P >= 0.19). Adjustment for additional endometrial cancer risk factors such as parity, oral contraceptive use, menopausal hormone use, and smoking status had little effect on the results. In conclusion, HNF1B SNPs are associated with risk of endometrial cancer and that the associated relative risks are similar for Type I and Type II tumors.	[Setiawan, Veronica Wendy; Schumacher, Fredrick; Henderson, Brian E.; Haiman, Christopher A.] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; [Haessler, Jeffrey; Fesinmeyer, Megan D.; Peters, Ulrike; Kooperberg, Charles] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA; [Cote, Michele L.] Wayne State Univ, Sch Med & Populat Studies & Dispar Res, Karmanos Canc Inst, Dept Oncol, Detroit, MI USA; [Deelman, Ewa; Voeckler, Jens-S] Univ So Calif, Inst Informat Sci, Marina Del Rey, CA 90292 USA; [Jackson, Rebecca D.] Ohio State Univ, Ctr Clin & Translat Sci, Columbus, OH 43210 USA; [Wilkens, Lynne R.; Le Marchand, Loic] Univ Hawaii, Ctr Canc, Program Epidemiol, Honolulu, HI 96822 USA; [Yasmeen, Shagufta] Univ Calif Davis, Dept Obstet & Gynecol, Davis, CA 95616 USA	University of Southern California; Fred Hutchinson Cancer Center; Barbara Ann Karmanos Cancer Institute; Wayne State University; University of Southern California; University System of Ohio; Ohio State University; Cancer Research Center of Hawaii; University of Hawaii System; University of California System; University of California Davis	Setiawan, VW (corresponding author), Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA.	clk@fhcrc.org	Schumacher, Fredrick/R-6043-2019	Schumacher, Fredrick/0000-0002-3073-7463; Setiawan, Veronica/0000-0001-9239-5692; Fesinmeyer, Megan/0000-0003-2003-4251	National Cancer Institute (NCI) [K07 CA116543, R37CA54281, R01CA63464, P01CA33619, U01CA136792, U01CA98758, R03CA128008]; National Human Genome Research Institute (NHGRI) [U01HG004803, U01HG004798, U01HG004802, U01HG004790, U01HG004801]; NHGRI PAGE [U01HG004802, U01HG004790]; National Heart, Lung, and Blood Institute; NIH; U.S. Department of Health and Human Services [N01WH22110, 24152, 32100-2, 32105-6, 32108-9, 32111-13, 32115, 32118-32119, 32122, 42107-26, 42129-32, 44221]; NATIONAL CANCER INSTITUTE [R37CA054281, K07CA116543, R01CA063464, U01CA136792, P30CA015704, U01CA098758, P30CA071789, R03CA128008, P01CA033619] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004802, U01HG004801, U01HG004803, U01HG004798, U01HG004790] Funding Source: NIH RePORTER; WOMEN&apos;S HEALTH INITIATIVE - OFFICE OF THE DIRECTOR NIH [N01WH022110] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI PAGE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Health and Human Services; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); WOMEN&apos;S HEALTH INITIATIVE - OFFICE OF THE DIRECTOR NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Dr. Setiawan is supported in part by the National Cancer Institute (NCI) Career Development Award K07 CA116543. The Population Architecture Using Genomics and Epidemiology (PAGE) program is funded by the National Human Genome Research Institute (NHGRI), supported by U01HG004803 (CALiCo), U01HG004798 (EAGLE), U01HG004802 (MEC), U01HG004790 (WHI), and U01HG004801 (Coordinating Center). The contents of this paper are solely the responsibility of the authors and do not necessarily represent the official views of the National Institutes of Health (NIH). The complete list of PAGE members can be found at http://www.pagestudy.org. The data and materials included in this report result from a collaboration between the following studies: The Multiethnic Cohort study (MEC) characterization of epidemiological architecture is funded through the NHGRI PAGE program (U01HG004802). The MEC study is funded through the National Cancer Institute (R37CA54281, R01CA63464, P01CA33619, U01CA136792, U01CA98758, and R03CA128008). The authors thank the cohort members for their participation and Dr. Monroe for her invaluable contributions to the execution of the Multiethnic Cohort study. Funding support for the "Epidemiology of Putative Genetic Variants: The Women's Health Initiative" study is provided through the NHGRI PAGE program (U01HG004790). The WHI program is funded by the National Heart, Lung, and Blood Institute; NIH; and U.S. Department of Health and Human Services through contracts N01WH22110, 24152, 32100-2, 32105-6, 32108-9, 32111-13, 32115, 32118-32119, 32122, 42107-26, 42129-32, and 44221. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1998, CONTROLLED CLIN TRIA, V19, P61; BACH I, 1993, EMBO J, V12, P4229, DOI 10.1002/j.1460-2075.1993.tb06107.x; Cook LS, 2006, CANC EPIDEMIOLOGY PR; Curb JD, 2003, ANN EPIDEMIOL, V13, pS122, DOI 10.1016/S1047-2797(03)00048-6; Edghill EL, 2006, J MED GENET, V43, P84, DOI 10.1136/jmg.2005.032854; Elliott KS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010858; Felix AS, 2010, CANCER CAUSE CONTROL, V21, P1851, DOI 10.1007/s10552-010-9612-8; Glinsky GV, 2004, J CLIN INVEST, V113, P913, DOI 10.1172/JCI200420032; Gudmundsson J, 2007, NAT GENET, V39, P977, DOI 10.1038/ng2062; Harries LW, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-315; Horikawa Y, 1997, NAT GENET, V17, P384, DOI 10.1038/ng1297-384; Kolonel LN, 2000, AM J EPIDEMIOL, V151, P346, DOI 10.1093/oxfordjournals.aje.a010213; Matise TC, 2011, AM J EPIDEMIOL, V174, P849, DOI 10.1093/aje/kwr160; Prat J, 2004, HUM PATHOL, V35, P649, DOI 10.1016/j.humpath.2004.02.007; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Ronnett B, 2002, BLAUSTEINS PATHOLOGY, P501; Sherman ME, 2000, MODERN PATHOL, V13, P295, DOI 10.1038/modpathol.3880051; Spurdle AB, 2011, NAT GENET, V43, P451, DOI 10.1038/ng.812; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Waters KM, 2009, AM J EPIDEMIOL, V169, P937, DOI 10.1093/aje/kwp003	20	34	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2012	7	1							e30390	10.1371/journal.pone.0030390	http://dx.doi.org/10.1371/journal.pone.0030390			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911GB	22299039	Green Published, Green Submitted, gold			2022-12-25	WOS:000301704200016
J	Jgamadze, D; Bergen, J; Stone, D; Jang, JH; Schaffer, DV; Isacoff, EY; Pautot, S				Jgamadze, Dennis; Bergen, Jamie; Stone, Daniel; Jang, Jae-Hyung; Schaffer, David V.; Isacoff, Ehud Y.; Pautot, Sophie			Colloids as Mobile Substrates for the Implantation and Integration of Differentiated Neurons into the Mammalian Brain	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; IONOTROPIC GLUTAMATE-RECEPTOR; TEMPORAL-LOBE EPILEPSY; PARKINSONS-DISEASE; DOPAMINERGIC-NEURONS; HNT NEURONS; ADULT HIPPOCAMPUS; SUBSTANTIA-NIGRA; RAT MODEL; STRIATAL TRANSPLANTATION	Neuronal degeneration and the deterioration of neuronal communication lie at the origin of many neuronal disorders, and there have been major efforts to develop cell replacement therapies for treating such diseases. One challenge, however, is that differentiated cells are challenging to transplant due to their sensitivity both to being uprooted from their cell culture growth support and to shear forces inherent in the implantation process. Here, we describe an approach to address these problems. We demonstrate that rat hippocampal neurons can be grown on colloidal particles or beads, matured and even transfected in vitro, and subsequently transplanted while adhered to the beads into the young adult rat hippocampus. The transplanted cells have a 76% cell survival rate one week post-surgery. At this time, most transplanted neurons have left their beads and elaborated long processes, similar to the host neurons. Additionally, the transplanted cells distribute uniformly across the host hippocampus. Expression of a fluorescent protein and the light-gated glutamate receptor in the transplanted neurons enabled them to be driven to fire by remote optical control. At 1-2 weeks after transplantation, calcium imaging of host brain slice shows that optical excitation of the transplanted neurons elicits activity in nearby host neurons, indicating the formation of functional transplant-host synaptic connections. After 6 months, the transplanted cell survival and overall cell distribution remained unchanged, suggesting that cells are functionally integrated. This approach, which could be extended to other cell classes such as neural stem cells and other regions of the brain, offers promising prospects for neuronal circuit repair via transplantation of in vitro differentiated, genetically engineered neurons.	[Jgamadze, Dennis; Pautot, Sophie] Ctr Regenerat Therapies Dresden, Dresden, Germany; [Isacoff, Ehud Y.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Dept Mol & Cell Biol, Phys Biosci Div, Berkeley, CA 94720 USA; [Bergen, Jamie; Stone, Daniel; Jang, Jae-Hyung; Schaffer, David V.] Univ Calif Berkeley, Dept Chem Engn, Berkeley, CA 94720 USA	Technische Universitat Dresden; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Jgamadze, D (corresponding author), Ctr Regenerat Therapies Dresden, Dresden, Germany.	ehud@berkeley.edu; sophie.pautot@crt-dresden.de	Jang, Jae-Hyung/G-8030-2012; isacoff, ehud/AAP-1459-2020; Pautot, Sophie/A-1578-2011	Pautot, Sophie/0000-0002-6660-4128; Stone, Daniel/0000-0003-1619-7541; Isacoff, Ehud Y./0000-0003-4775-9359	NIH Nanomedicine Development Center in Optical Control of Biological Function [PN2 EY1018241]; Deutsche Forschungsgemeinschaft [FZ 111]	NIH Nanomedicine Development Center in Optical Control of Biological Function; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the NIH Nanomedicine Development Center in Optical Control of Biological Function (PN2 EY1018241), and by grants from the Deutsche Forschungsgemeinschaft (FZ 111). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARENDT T, 1988, BRAIN RES BULL, V21, P563, DOI 10.1016/0361-9230(88)90193-1; Baker KA, 2000, EXP NEUROL, V162, P350, DOI 10.1006/exnr.1999.7337; BANKER G, 1998, CULTURING NERVE CELL; Barberi T, 2003, NAT BIOTECHNOL, V21, P1200, DOI 10.1038/nbt870; Bibel M, 2007, NAT PROTOC, V2, P1034, DOI 10.1038/nprot.2007.147; Bjorklund LM, 2002, P NATL ACAD SCI USA, V99, P2344, DOI 10.1073/pnas.022438099; Borlongan CV, 1998, NEUROREPORT, V9, P2837, DOI 10.1097/00001756-199808240-00028; Carpentino JE, 2008, J NEUROSCI RES, V86, P512, DOI 10.1002/jnr.21514; Conti L, 2006, BRAIN PATHOL, V16, P143, DOI 10.1111/j.1750-3639.2006.00009.x; Damier P, 1999, BRAIN, V122, P1421, DOI 10.1093/brain/122.8.1421; Damier P, 1999, BRAIN, V122, P1437, DOI 10.1093/brain/122.8.1437; DUNNETT SB, 1995, BEHAV BRAIN RES, V66, P133, DOI 10.1016/0166-4328(94)00134-2; Ehninger D, 2008, CELL TISSUE RES, V331, P243, DOI 10.1007/s00441-007-0478-3; Espinosa-Jeffrey Araceli, 2009, Curr Protoc Stem Cell Biol, VChapter 2, DOI 10.1002/9780470151808.sc02d04s10; Everitt BJ, 1997, ANNU REV PSYCHOL, V48, P649, DOI 10.1146/annurev.psych.48.1.649; FEARNLEY JM, 1991, BRAIN, V114, P2283, DOI 10.1093/brain/114.5.2283; FREED CR, 1992, NEW ENGL J MED, V327, P1549, DOI 10.1056/NEJM199211263272202; Gorostiza P, 2007, MOL BIOSYST, V3, P686, DOI 10.1039/b710287a; Gorostiza P, 2007, P NATL ACAD SCI USA, V104, P10865, DOI 10.1073/pnas.0701274104; HIRSCH E, 1988, NATURE, V334, P345, DOI 10.1038/334345a0; Hurlbert MS, 1999, CELL TRANSPLANT, V8, P143, DOI 10.1177/096368979900800106; Kawasaki H, 2000, NEURON, V28, P31, DOI 10.1016/S0896-6273(00)00083-0; Kelly S, 2004, P NATL ACAD SCI USA, V101, P11839, DOI 10.1073/pnas.0404474101; Kim JH, 2002, NATURE, V418, P50, DOI 10.1038/nature00900; Kim M, 2008, NEUROPATHOLOGY, V28, P1, DOI 10.1111/j.1440-1789.2007.00858.x; Kim SU, 2009, J NEUROSCI RES, V87, P2183, DOI 10.1002/jnr.22054; LETOURNEAU PC, 1975, DEV BIOL, V44, P92, DOI 10.1016/0012-1606(75)90379-6; LETOURNEAU PC, 1975, DEV BIOL, V44, P77, DOI 10.1016/0012-1606(75)90378-4; Lindvall O, 2006, NATURE, V441, P1094, DOI 10.1038/nature04960; Lindvall O, 2000, Prog Brain Res, V127, P299; Moon SY, 2006, MOL THER, V13, P5, DOI 10.1016/j.ymthe.2005.09.008; Naegele JR, 2010, NEUROPHARMACOLOGY, V58, P855, DOI 10.1016/j.neuropharm.2010.01.019; Pautot S, 2008, NAT METHODS, V5, P735, DOI 10.1038/nmeth.1236; Redmond DE, 2008, NEUROBIOL DIS, V29, P103, DOI 10.1016/j.nbd.2007.08.008; Sanberg PR, 1997, ANN NY ACAD SCI, V831, P452; Saporta S, 1999, NEUROSCIENCE, V91, P519, DOI 10.1016/S0306-4522(98)00610-1; SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2; Shepherd G.M., 1979, SYNAPTIC ORG BRAIN; Shetty AK, 2000, NEUROSCIENCE, V99, P243, DOI 10.1016/S0306-4522(00)00178-0; SHETTY AK, 1995, NEUROSCIENCE, V67, P561, DOI 10.1016/0306-4522(95)00025-E; Shetty AK, 2007, STEM CELLS, V25, P2396, DOI 10.1634/stemcells.2007-0313; Szobota S, 2007, NEURON, V54, P535, DOI 10.1016/j.neuron.2007.05.010; Turner DA, 2003, NEUROSURGERY, V52, P632, DOI 10.1227/01.NEU.0000047825.91205.E6; Volgraf M, 2006, NAT CHEM BIOL, V2, P47, DOI 10.1038/nchembio756; Yang DL, 2008, STEM CELLS, V26, P55, DOI 10.1634/stemcells.2007-0494; Zaman V, 2001, NEUROBIOL DIS, V8, P942, DOI 10.1006/nbdi.2001.0440	46	16	18	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e30293	10.1371/journal.pone.0030293	http://dx.doi.org/10.1371/journal.pone.0030293			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910ME	22295079	gold, Green Published, Green Submitted			2022-12-25	WOS:000301640600024
J	Liu, N; He, S; Yu, X				Liu, Na; He, Shan; Yu, Xiang			Early Natural Stimulation through Environmental Enrichment Accelerates Neuronal Development in the Mouse Dentate Gyrus	PLOS ONE			English	Article							MICROTUBULE-ASSOCIATED PROTEIN; ADULT NEUROGENESIS; GRANULE CELLS; HIPPOCAMPAL-NEURONS; POTENTIAL ROLE; RHESUS-MONKEY; BRAIN; MICE; RAT; DIFFERENTIATION	The dentate gyrus is the primary afferent into the hippocampal formation, with important functions in learning and memory. Granule cells, the principle neuronal type in the dentate gyrus, are mostly formed postnatally, in a process that continues into adulthood. External stimuli, including environmental enrichment, voluntary exercise and learning, have been shown to significantly accelerate the generation and maturation of dentate granule cells in adult rodents. Whether, and to what extent, such environmental stimuli regulate the development and maturation of dentate granule cells during early postnatal development is largely unknown. Furthermore, whether natural stimuli affect the synaptic properties of granule cells had been investigated neither in newborn neurons of the adult nor during early development. To examine the effect of natural sensory stimulation on the dentate gyrus, we reared newborn mice in an enriched environment (EE). Using immunohistochemistry, we showed that dentate granule cells from EE-reared mice exhibited earlier morphological maturation, manifested as faster peaking of doublecortin expression and elevated expression of mature neuronal markers (including NeuN, calbindin and MAP2) at the end of the second postnatal week. Also at the end of the second postnatal week, we found increased density of dendritic spines across the entire dentate gyrus, together with elevated levels of postsynaptic scaffold (post-synaptic density 95) and receptor proteins (GluR2 and GABA(A)R gamma 2) of excitatory and inhibitory synapses. Furthermore, dentate granule cells of P14 EE-reared mice had lower input resistances and increased glutamatergic and GABAergic synaptic inputs. Together, our results demonstrate that EE-rearing promotes morphological and electrophysiological maturation of dentate granule cells, underscoring the importance of natural environmental stimulation on development of the dentate gyrus.	[Liu, Na; He, Shan; Yu, Xiang] Chinese Acad Sci, Inst Neurosci, Shanghai, Peoples R China; [Liu, Na; He, Shan; Yu, Xiang] Chinese Acad Sci, State Key Lab Neurosci, Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Liu, Na; He, Shan] Chinese Acad Sci, Grad Sch, Shanghai, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences	Liu, N (corresponding author), Chinese Acad Sci, Inst Neurosci, Shanghai, Peoples R China.	yuxiang@ion.ac.cn		Yu, Xiang/0000-0003-1225-7666	Ministry of Science and Technology [2011CBA00400]; National Natural Science Foundation of China [31021063]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the Ministry of Science and Technology (2011CBA00400) and the National Natural Science Foundation of China (31021063). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aimone JB, 2006, NAT NEUROSCI, V9, P723, DOI 10.1038/nn1707; ALTMAN J, 1990, J COMP NEUROL, V301, P365, DOI 10.1002/cne.903010304; ALTMAN J, 1990, J COMP NEUROL, V301, P325, DOI 10.1002/cne.903010302; ANGEVINE JAY B., 1965, EXP NEUROL SUPPL, V2, P1; BENNETT EL, 1964, SCIENCE, V146, P610, DOI 10.1126/science.146.3644.610; Brown JP, 2003, J COMP NEUROL, V467, P1, DOI 10.1002/cne.10874; CAMERON HA, 1993, NEUROSCIENCE, V56, P337, DOI 10.1016/0306-4522(93)90335-D; Cancedda L, 2004, J NEUROSCI, V24, P4840, DOI 10.1523/JNEUROSCI.0845-04.2004; Carleton A, 2003, NAT NEUROSCI, V6, P507, DOI 10.1038/nn1048; des Portes V, 1998, CELL, V92, P51; Duan X, 2008, CURR OPIN NEUROBIOL, V18, P108, DOI 10.1016/j.conb.2008.04.001; ECKENHOFF MF, 1984, J COMP NEUROL, V223, P1, DOI 10.1002/cne.902230102; Eichenbaum H, 2000, NAT REV NEUROSCI, V1, P41, DOI 10.1038/35036213; Esposito MS, 2005, J NEUROSCI, V25, P10074, DOI 10.1523/JNEUROSCI.3114-05.2005; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Flavell SW, 2008, ANNU REV NEUROSCI, V31, P563, DOI 10.1146/annurev.neuro.31.060407.125631; Francis F, 1999, NEURON, V23, P247, DOI 10.1016/S0896-6273(00)80777-1; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Gleeson JG, 1999, NEURON, V23, P257, DOI 10.1016/S0896-6273(00)80778-3; Gould E, 1999, NAT NEUROSCI, V2, P260, DOI 10.1038/6365; He S, 2010, J NEUROSCI, V30, P7910, DOI 10.1523/JNEUROSCI.6375-09.2010; Jessberger S, 2003, EUR J NEUROSCI, V18, P2707, DOI 10.1111/j.1460-9568.2003.02986.x; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kirkeby S, 2005, J IMMUNOL METHODS, V301, P102, DOI 10.1016/j.jim.2005.04.006; Levitt P, 2004, TRENDS NEUROSCI, V27, P400, DOI 10.1016/j.tins.2004.05.008; Li GN, 2005, DEV NEUROSCI-BASEL, V27, P93, DOI 10.1159/000085980; Li GN, 2007, PROG BRAIN RES, V163, P143, DOI 10.1016/S0079-6123(07)63008-8; Liu M, 2000, P NATL ACAD SCI USA, V97, P865, DOI 10.1073/pnas.97.2.865; Liu XS, 2000, BRAIN RES, V856, P202, DOI 10.1016/S0006-8993(99)02421-X; Liu YB, 1996, J NEUROPHYSIOL, V76, P1074, DOI 10.1152/jn.1996.76.2.1074; MATUS A, 1988, ANNU REV NEUROSCI, V11, P29, DOI 10.1146/annurev.neuro.11.1.29; Miyata T, 1999, GENE DEV, V13, P1647, DOI 10.1101/gad.13.13.1647; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; NOWAKOWSKI RS, 1981, J COMP NEUROL, V196, P129, DOI 10.1002/cne.901960110; Overstreet-Wadiche LS, 2006, J NEUROSCI, V26, P2326, DOI 10.1523/JNEUROSCI.4111-05.2006; Pham TM, 2002, PHARMACOL BIOCHEM BE, V73, P167, DOI 10.1016/S0091-3057(02)00783-9; Piatti VC, 2006, NEUROSCIENTIST, V12, P463, DOI 10.1177/1073858406293538; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; RAMI A, 1987, DEV BIOL, V124, P228, DOI 10.1016/0012-1606(87)90474-X; ROSENZWEIG MR, 1978, BRAIN RES, V153, P563, DOI 10.1016/0006-8993(78)90340-2; SEQUIER JM, 1988, NEUROSCI LETT, V86, P155, DOI 10.1016/0304-3940(88)90563-0; Tashiro A, 2007, J NEUROSCI, V27, P3252, DOI 10.1523/JNEUROSCI.4941-06.2007; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; WEST MJ, 1993, NEUROBIOL AGING, V14, P275, DOI 10.1016/0197-4580(93)90112-O; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zhao CJ, 2005, DEVELOPMENT, V132, P2917, DOI 10.1242/dev.01871; Zhao CM, 2006, J NEUROSCI, V26, P3, DOI 10.1523/JNEUROSCI.3648-05.2006	49	23	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e30803	10.1371/journal.pone.0030803	http://dx.doi.org/10.1371/journal.pone.0030803			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910ME	22295110	gold, Green Published, Green Submitted			2022-12-25	WOS:000301640600055
J	Martinez-Martin, D; Carrasco, C; Hernando-Perez, M; de Pablo, PJ; Gomez-Herrero, J; Perez, R; Mateu, MG; Carrascosa, JL; Kiracofe, D; Melcher, J; Raman, A				Martinez-Martin, David; Carrasco, Carolina; Hernando-Perez, Mercedes; de Pablo, Pedro J.; Gomez-Herrero, Julio; Perez, Rebeca; Mateu, Mauricio G.; Carrascosa, Jose L.; Kiracofe, Daniel; Melcher, John; Raman, Arvind			Resolving Structure and Mechanical Properties at the Nanoscale of Viruses with Frequency Modulation Atomic Force Microscopy	PLOS ONE			English	Article							MINUTE VIRUS; PARVOVIRUS; RESOLUTION	Structural Biology (SB) techniques are particularly successful in solving virus structures. Taking advantage of the symmetries, a heavy averaging on the data of a large number of specimens, results in an accurate determination of the structure of the sample. However, these techniques do not provide true single molecule information of viruses in physiological conditions. To answer many fundamental questions about the quickly expanding physical virology it is important to develop techniques with the capability to reach nanometer scale resolution on both structure and physical properties of individual molecules in physiological conditions. Atomic force microscopy (AFM) fulfills these requirements providing images of individual virus particles under physiological conditions, along with the characterization of a variety of properties including local adhesion and elasticity. Using conventional AFM modes is easy to obtain molecular resolved images on flat samples, such as the purple membrane, or large viruses as the Giant Mimivirus. On the contrary, small virus particles (25-50 nm) cannot be easily imaged. In this work we present Frequency Modulation atomic force microscopy (FM-AFM) working in physiological conditions as an accurate and powerful technique to study virus particles. Our interpretation of the so called "dissipation channel'' in terms of mechanical properties allows us to provide maps where the local stiffness of the virus particles are resolved with nanometer resolution. FM-AFM can be considered as a non invasive technique since, as we demonstrate in our experiments, we are able to sense forces down to 20 pN. The methodology reported here is of general interest since it can be applied to a large number of biological samples. In particular, the importance of mechanical interactions is a hot topic in different aspects of biotechnology ranging from protein folding to stem cells differentiation where conventional AFM modes are already being used.	[Martinez-Martin, David; Carrasco, Carolina; Hernando-Perez, Mercedes; de Pablo, Pedro J.; Gomez-Herrero, Julio] Univ Autonoma Madrid, Dept Fis Mat Condensada, E-28049 Madrid, Spain; [Carrasco, Carolina; Carrascosa, Jose L.] CSIC, Ctr Nacl Biotecnol, Madrid, Spain; [Perez, Rebeca; Mateu, Mauricio G.] CSIC, Ctr Biol Mol Severo Ochoa, Madrid, Spain; [Kiracofe, Daniel; Melcher, John; Raman, Arvind] Purdue Univ, Sch Mech Engn, W Lafayette, IN 47907 USA; [Kiracofe, Daniel; Melcher, John; Raman, Arvind] Purdue Univ, Birck Nanotechnol Ctr, W Lafayette, IN 47907 USA	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Martinez-Martin, D (corresponding author), Univ Autonoma Madrid, Dept Fis Mat Condensada, Cantoblanco, E-28049 Madrid, Spain.	Julio.gomez@uam.es	Martinez-Martin, David/P-3083-2016; Gomez-Herrero, Julio/B-6094-2013; Pérez, Rebeca/M-5235-2015; Hernando-Pérez, Mercedes/AAH-3550-2019; de Pablo, Pedro/L-9392-2014; Mateu, Mauricio/ABF-2146-2021; Melcher, John/A-1684-2015; Carrasco, Carolina/K-9142-2014	Martinez-Martin, David/0000-0002-3658-9393; Gomez-Herrero, Julio/0000-0001-8583-8061; Pérez, Rebeca/0000-0002-0445-868X; Hernando-Pérez, Mercedes/0000-0002-5875-5620; de Pablo, Pedro/0000-0003-2386-3186; Mateu, Mauricio/0000-0002-2915-1529; Melcher, John/0000-0002-9375-2708; Carrasco, Carolina/0000-0001-9322-4932; Kiracofe, Daniel/0000-0003-2804-7962	 [S2009/MAT-1467 (CAM)];  [MAT2010-20843-C02]; Direct For Mathematical & Physical Scien [1008189] Funding Source: National Science Foundation	; ; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	The authors acknowledge the financial support from projects S2009/MAT-1467 (CAM), MAT2010-20843-C02. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agbandje-McKenna M, 1998, STRUCT FOLD DES, V6, P1369, DOI 10.1016/S0969-2126(98)00137-3; Basak S, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2760175; Blum AS, 2005, SMALL, V1, P702, DOI 10.1002/smll.200500021; Calabri L, 2007, J PHYS-CONDENS MAT, V19, DOI 10.1088/0953-8984/19/39/395002; Carrasco C, 2006, P NATL ACAD SCI USA, V103, P13706, DOI 10.1073/pnas.0601881103; Carrasco C, 2009, P NATL ACAD SCI USA, V106, P5475, DOI 10.1073/pnas.0810095106; Carrasco C, 2008, P NATL ACAD SCI USA, V105, P4150, DOI 10.1073/pnas.0708017105; Cordova A, 2003, BIOPHYS J, V85, P70, DOI 10.1016/S0006-3495(03)74455-5; de Pablo PJ, 1998, APPL PHYS LETT, V73, P3300, DOI 10.1063/1.122751; Fischlechner M, 2007, ANGEW CHEM INT EDIT, V46, P3184, DOI 10.1002/anie.200603445; Flint J. S., 2004, PRINCIPLES VIROLOGY; Fukuma T, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.1999856; Giessibl FJ, 2000, PHYS REV B, V61, P9968, DOI 10.1103/PhysRevB.61.9968; Higgins MJ, 2006, BIOPHYS J, V91, P2532, DOI 10.1529/biophysj.106.085688; Horcas I, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2432410; Ivanovska IL, 2004, P NATL ACAD SCI USA, V101, P7600, DOI 10.1073/pnas.0308198101; Kontou M, 2005, J VIROL, V79, P10931, DOI 10.1128/JVI.79.17.10931-10943.2005; Melcher J, 2008, REV SCI INSTRUM, V79, DOI 10.1063/1.2938864; Moreno-Herrero F, 2002, APPL PHYS LETT, V81, P2620, DOI 10.1063/1.1509856; MULLER DJ, 1995, BIOPHYS J, V68, P1681, DOI 10.1016/S0006-3495(95)80345-0; OHNESORGE F, 1993, SCIENCE, V260, P1451, DOI 10.1126/science.260.5113.1451; Pugno NM, 2008, J PHYS CONDENSED MAT, V20; Purohit PK, 2003, P NATL ACAD SCI USA, V100, P3173, DOI 10.1073/pnas.0737893100; Roos WH, 2010, NAT PHYS, V6, P733, DOI 10.1038/NPHYS1797; Tang JH, 2008, STRUCTURE, V16, P935, DOI 10.1016/j.str.2008.02.024; VALPUESTA JM, 1994, Q REV BIOPHYS, V27, P107, DOI 10.1017/S0033583500004510; Villarrubia JS, 1997, J RES NATL INST STAN, V102, P425, DOI 10.6028/jres.102.030; Voitchovsky K, 2010, NAT NANOTECHNOL, V5, P401, DOI [10.1038/nnano.2010.67, 10.1038/NNANO.2010.67]; Xiang Y, 2006, EMBO J, V25, P5229, DOI 10.1038/sj.emboj.7601386; Xiao C, 2009, PLOS BIOL, V7, P958, DOI 10.1371/journal.pbio.1000092; Xu X, 2008, BIOPHYS J, V95, P2520, DOI 10.1529/biophysj.108.132829; Xu X, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.060801; YEAGER JG, 1979, APPL ENVIRON MICROB, V38, P694, DOI 10.1128/AEM.38.4.694-701.1979; Young M, 2008, ANNU REV PHYTOPATHOL, V46, P361, DOI 10.1146/annurev.phyto.032508.131939	34	33	34	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e30204	10.1371/journal.pone.0030204	http://dx.doi.org/10.1371/journal.pone.0030204			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910ME	22295076	Green Published, Green Submitted, gold			2022-12-25	WOS:000301640600021
J	Pearson, ML; Selby, JV; Katz, KA; Cantrell, V; Braden, CR; Parise, ME; Paddock, CD; Lewin-Smith, MR; Kalasinsky, VF; Goldstein, FC; Hightower, AW; Papier, A; Lewis, B; Motipara, S; Eberhard, ML				Pearson, Michele L.; Selby, Joseph V.; Katz, Kenneth A.; Cantrell, Virginia; Braden, Christopher R.; Parise, Monica E.; Paddock, Christopher D.; Lewin-Smith, Michael R.; Kalasinsky, Victor F.; Goldstein, Felicia C.; Hightower, Allen W.; Papier, Arthur; Lewis, Brian; Motipara, Sarita; Eberhard, Mark L.		Unexplained Dermopathy Study Team	Clinical, Epidemiologic, Histopathologic and Molecular Features of an Unexplained Dermopathy	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; MORGELLONS-DISEASE; PARASITOSIS; DELUSIONS; DIAGNOSIS; TISSUE; PCR	Background: Morgellons is a poorly characterized constellation of symptoms, with the primary manifestations involving the skin. We conducted an investigation of this unexplained dermopathy to characterize the clinical and epidemiologic features and explore potential etiologies. Methods: A descriptive study was conducted among persons at least 13 years of age and enrolled in Kaiser Permanente Northern California (KPNC) during 2006-2008. A case was defined as the self-reported emergence of fibers or materials from the skin accompanied by skin lesions and/or disturbing skin sensations. We collected detailed epidemiologic data, performed clinical evaluations and geospatial analyses and analyzed materials collected from participants' skin. Results: We identified 115 case-patients. The prevalence was 3.65 (95% CI = 2.98, 4.40) cases per 100,000 enrollees. There was no clustering of cases within the 13-county KPNC catchment area (p = .113). Case-patients had a median age of 52 years (range: 17-93) and were primarily female (77%) and Caucasian (77%). Multi-system complaints were common; 70% reported chronic fatigue and 54% rated their overall health as fair or poor with mean Physical Component Scores and Mental Component Scores of 36.63 (SD = 12.9) and 35.45 (SD = 12.89), respectively. Cognitive deficits were detected in 59% of case-patients and 63% had evidence of clinically significant somatic complaints; 50% had drugs detected in hair samples and 78% reported exposure to solvents. Solar elastosis was the most common histopathologic abnormality (51% of biopsies); skin lesions were most consistent with arthropod bites or chronic excoriations. No parasites or mycobacteria were detected. Most materials collected from participants' skin were composed of cellulose, likely of cotton origin. Conclusions: This unexplained dermopathy was rare among this population of Northern California residents, but associated with significantly reduced health-related quality of life. No common underlying medical condition or infectious source was identified, similar to more commonly recognized conditions such as delusional infestation.	[Pearson, Michele L.] Ctr Dis Control & Prevent, Div TB Eliminat, Atlanta, GA USA; [Selby, Joseph V.; Cantrell, Virginia; Motipara, Sarita] Kaiser Permanente No Calif, Div Res, Oakland, CA USA; [Katz, Kenneth A.] Hlth & Human Serv Agcy, HIV STD & Hepatitis Branch, San Diego, CA USA; [Braden, Christopher R.] Ctr Dis Control & Prevent, Div Food Waterborne & Environm Dis, Atlanta, GA USA; [Parise, Monica E.; Hightower, Allen W.; Eberhard, Mark L.] Ctr Dis Control & Prevent, Div Parasit Dis & Malaria, Atlanta, GA USA; [Paddock, Christopher D.] Ctr Dis Control & Prevent, Div High Consequence Pathogens & Pathol, Atlanta, GA USA; [Lewin-Smith, Michael R.] Joint Pathol Ctr, Silver Spring, MD USA; [Kalasinsky, Victor F.] US Dept Vet Affairs, Off Res & Dev, Washington, DC USA; [Goldstein, Felicia C.] Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30322 USA; [Papier, Arthur] Univ Rochester, Sch Med, Dept Dermatol, Rochester, NY USA; [Lewis, Brian] Agcy Tox Subst & Dis Registry, Div Hlth Studies, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Kaiser Permanente; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; US Department of Veterans Affairs; Emory University; University of Rochester; Centers for Disease Control & Prevention - USA	Pearson, ML (corresponding author), Ctr Dis Control & Prevent, Div TB Eliminat, Atlanta, GA USA.	mle1@cdc.gov			Centers for Disease Control (CDC) and Prevention	Centers for Disease Control (CDC) and Prevention	Funding for this study was provided by the Centers for Disease Control (CDC) and Prevention. Epidemiologists from the CDC participated in the study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Accordino RE, 2008, DERMATOL THER, V21, P8, DOI 10.1111/j.1529-8019.2008.00164.x; Centers for Disease Control and Prevention, 2008, BEH RISK FACT SURV S; Centers for Disease Control and Prevention (CDC), 1995, MMWR Morb Mortal Wkly Rep, V44, P590; Freudenmann RW, 2009, CLIN MICROBIOL REV, V22, P690, DOI 10.1128/CMR.00018-09; Ganesan S, 2003, MODERN PATHOL, V16, P286, DOI 10.1097/01.MP.0000062653.65441.DA; GLICKMAN L, 1978, AM J TROP MED HYG, V27, P492, DOI 10.4269/ajtmh.1978.27.492; Gordon N, 2006, KAISER PERMANENTE ME; Guarner J, 2007, AM J CLIN PATHOL, V127, P612, DOI 10.1309/J3LD0RBP788W1TM8; Guarner J, 2006, AM J CLIN PATHOL, V126, P148, DOI 10.1309/KHGVR72CBRM4FQ58; Harvey William T, 2009, J Med Case Rep, V3, P8243, DOI 10.4076/1752-1947-3-8243; Hinkle NC, 2011, CURR PSYCHIAT REP, V13, P178, DOI 10.1007/s11920-011-0188-0; Hylwa SA, 2011, ARCH DERMATOL, V147, P1041, DOI 10.1001/archdermatol.2011.114; Imrit K, 2006, J CLIN MICROBIOL, V44, P2609, DOI 10.1128/JCM.00572-06; Jones JL, 2008, AM J TROP MED HYG, V78, P35, DOI 10.4269/ajtmh.2008.78.35; Kellett C E, 1935, Ann Med Hist, V7, P467; Koblenzer CS, 1996, DERMATOL CLIN, V14, P447, DOI 10.1016/S0733-8635(05)70372-7; Lane JE, 2008, CUTIS, V81, P37; McAuliffe I, 2008, 57 ANN M AM SOC TROP; Morey L. C., 1991, PERSONALITY ASSESSME; Murakata LA, 2006, MODERN PATHOL, V19, P922, DOI 10.1038/modpathol.3800595; Murdoch DR, 2003, J CLIN MICROBIOL, V41, P63, DOI 10.1128/JCM.41.1.63-66.2003; Robles David T, 2008, Dermatol Online J, V14, P2; Savely VR, 2010, CLIN COSMET INVESTI, V3, P67; Savely VR, 2006, AM J CLIN DERMATOL, V7, P1, DOI 10.2165/00128071-200607010-00001; STEWART AL, 1989, JAMA-J AM MED ASSOC, V262, P907, DOI 10.1001/jama.262.7.907; Thomas LC, 2007, J MICROBIOL METH, V68, P296, DOI 10.1016/j.mimet.2006.09.003; TRABERT W, 1995, PSYCHOPATHOLOGY, V28, P238, DOI 10.1159/000284934; Veien NK, 2001, J AM ACAD DERMATOL, V44, P704, DOI 10.1067/mjd.2001.112912; Ware J. E., 1992, MEASURING FUNCTIONIN, P277; WELLS KB, 1989, JAMA-J AM MED ASSOC, V262, P914, DOI 10.1001/jama.262.7.914; WYKOFF RF, 1987, REV INFECT DIS, V9, P433	31	64	65	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e29908	10.1371/journal.pone.0029908	http://dx.doi.org/10.1371/journal.pone.0029908			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910ME	22295070	Green Published, gold, Green Submitted			2022-12-25	WOS:000301640600015
J	Pei, YF; Zhang, L; Yang, TL; Han, YY; Hai, R; Ran, S; Tian, Q; Shen, H; Li, J; Zhu, XZ; Luo, XG; Deng, HW				Pei, Yu-Fang; Zhang, Lei; Yang, Tie-Lin; Han, Yingying; Hai, Rong; Ran, Shu; Tian, Qing; Shen, Hui; Li, Jian; Zhu, Xue-Zhen; Luo, Xingguang; Deng, Hong-Wen			Genome-Wide Association Study of Copy Number Variants Suggests LTBP1 and FGD4 Are Important for Alcohol Drinking	PLOS ONE			English	Article							STRUCTURAL VARIANTS; GENE-EXPRESSION; MALE TWINS; DEPENDENCE; LINKAGE; SCHIZOPHRENIA; PHENOTYPE; DISEASE; RISK; SUSCEPTIBILITY	Alcohol dependence (AD) is a complex disorder characterized by psychiatric and physiological dependence on alcohol. AD is reflected by regular alcohol drinking, which is highly inheritable. In this study, to identify susceptibility genes associated with alcohol drinking, we performed a genome-wide association study of copy number variants (CNVs) in 2,286 Caucasian subjects with Affymetrix SNP6.0 genotyping array. We replicated our findings in 1,627 Chinese subjects with the same genotyping array. We identified two CNVs, CNV207 (combined p-value 1.91E-03) and CNV1836 (combined p-value 3.05E-03) that were associated with alcohol drinking. CNV207 and CNV1836 are located at the downstream of genes LTBP1 (870 kb) and FGD4 (400 kb), respectively. LTBP1, by interacting TGFB1, may down-regulate enzymes directly participating in alcohol metabolism. FGD4 plays a role in clustering and trafficking GABA(A) receptor and subsequently influence alcohol drinking through activating CDC42. Our results provide suggestive evidence that the newly identified CNV regions and relevant genes may contribute to the genetic mechanism of alcohol dependence.	[Pei, Yu-Fang; Zhang, Lei; Han, Yingying; Hai, Rong; Ran, Shu; Zhu, Xue-Zhen; Deng, Hong-Wen] Shanghai Univ Sci & Technol, Ctr Syst Biomed Sci, Shanghai 201800, Peoples R China; [Yang, Tie-Lin] Xi An Jiao Tong Univ, Sch Life Sci & Technol, Xian 710049, Peoples R China; [Hai, Rong] Inner Mongolia Med Coll Huhhot, Affiliated Hosp, Inner Mongolia, Peoples R China; [Tian, Qing; Shen, Hui; Li, Jian; Deng, Hong-Wen] Tulane Univ, Dept Biostat, New Orleans, LA 70118 USA; [Luo, Xingguang] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA; [Deng, Hong-Wen] Hunan Normal Univ, Coll Life Sci, Lab Mol & Stat Genet, Changsha, Hunan, Peoples R China; [Deng, Hong-Wen] Hunan Normal Univ, Coll Life Sci, Minist Educ, Key Lab Prot Chem & Dev Biol, Changsha, Hunan, Peoples R China	University of Shanghai for Science & Technology; Xi'an Jiaotong University; Tulane University; Yale University; Hunan Normal University; Hunan Normal University	Pei, YF (corresponding author), Shanghai Univ Sci & Technol, Ctr Syst Biomed Sci, Shanghai 201800, Peoples R China.	hdeng2@tulane.edu	Yang, Tie-Lin/G-8365-2014; Zhang, Lei/L-1016-2016; Li, Jian/G-4445-2015	Yang, Tie-Lin/0000-0001-7062-3025; Zhang, Lei/0000-0002-1007-4834; Deng, Hong-Wen/0000-0002-0387-8818	Shanghai Leading Academic Discipline Project [S30501]; University of Shanghai for Science and Technology; National Natural Science Foundation of China [31100902]; NIH [P50AR055081, R01AG026564, R01AR050496, RC2DE020756, R01AR057049, R03TW008221, K01 DA029643, R01AA016015, R21AA020319]; FOGARTY INTERNATIONAL CENTER [R03TW008221] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR057049, P50AR055081, R01AR050496] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [RC2DE020756] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG026564] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA020319, R01AA016015] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K01DA029643] Funding Source: NIH RePORTER	Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); University of Shanghai for Science and Technology; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The study was partially supported by Shanghai Leading Academic Discipline Project (S30501) and startup fund from University of Shanghai for Science and Technology. The investigators of this work were partially supported by grants from National Natural Science Foundation of China project (31100902) and grants from NIH (P50AR055081, R01AG026564, R01AR050496, RC2DE020756, R01AR057049, R03TW008221, K01 DA029643, R01AA016015 and R21AA020319). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berney A, 2002, DRUG ALCOHOL DEPEN, V65, P149, DOI 10.1016/S0376-8716(01)00156-9; Buckland PR, 2003, ANN MED, V35, P308, DOI 10.1080/07853890310001276; Cahan P, 2009, NAT GENET, V41, P430, DOI 10.1038/ng.350; Ciuclan L, J HEPATOL, V52, P407; D'Alfonso S, 1999, GENET EPIDEMIOL, V17, pS127; Dick DM, 2002, ALCOHOL CLIN EXP RES, V26, P1453, DOI 10.1097/01.ALC.0000034037.10333.FD; Economou M, 2004, AM J GASTROENTEROL, V99, P2393, DOI 10.1111/j.1572-0241.2004.40304.x; Edenberg HJ, 2004, AM J HUM GENET, V74, P705, DOI 10.1086/383283; Feuk L, 2006, HUM MOL GENET, V15, pR57, DOI 10.1093/hmg/ddl057; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Fisher KA, 2008, J ACOUST SOC AM, V123, P1862, DOI 10.1121/1.2839140; Foroud T, 1998, ALCOHOL CLIN EXP RES, V22, P2035, DOI 10.1097/00000374-199812000-00020; Freeman JL, 2006, GENOME RES, V16, P949, DOI 10.1101/gr.3677206; Gelernter J, 2006, HUM MOL GENET, V15, P3498, DOI 10.1093/hmg/ddl426; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; Grant JD, 2009, BIOL PSYCHIAT, V66, P795, DOI 10.1016/j.biopsych.2009.05.018; Grobin AC, 1998, PSYCHOPHARMACOLOGY, V139, P2, DOI 10.1007/s002130050685; Gualandris A, 2000, MOL BIOL CELL, V11, P4295, DOI 10.1091/mbc.11.12.4295; Heath AC, BIOL PSYCHIAT, V70, P513; Henrichsen CN, 2009, NAT GENET, V41, P424, DOI 10.1038/ng.345; Ibanez P, 2004, LANCET, V364, P1169, DOI 10.1016/S0140-6736(04)17104-3; Kendler KS, 1997, ARCH GEN PSYCHIAT, V54, P178; KENDLER KS, 1992, JAMA-J AM MED ASSOC, V268, P1877, DOI 10.1001/jama.268.14.1877; Kneussel M, 2000, TRENDS NEUROSCI, V23, P429, DOI 10.1016/S0166-2236(00)01627-1; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; Liu SL, PLOS ONE, V6; Luo XG, 2006, AM J HUM GENET, V78, P973, DOI 10.1086/504113; Lupski JR, 2005, PLOS GENET, V1, P627, DOI 10.1371/journal.pgen.0010049; McCarroll SA, 2006, NAT GENET, V38, P86, DOI 10.1038/ng1696; Merla G, 2006, AM J HUM GENET, V79, P332, DOI 10.1086/506371; Nguyen DQ, 2006, PLOS GENET, V2, P198, DOI 10.1371/journal.pgen.0020020; Prescott CA, 2006, MOL PSYCHIATR, V11, P603, DOI 10.1038/sj.mp.4001811; Prescott CA, 1999, AM J PSYCHIAT, V156, P34, DOI 10.1176/ajp.156.1.34; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Repping S, 2006, NAT GENET, V38, P463, DOI 10.1038/ng1754; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; Saltzman BS, 2008, CANCER RES, V68, P1236, DOI 10.1158/0008-5472.CAN-07-2144; Schumann G, P NATL ACAD SCI US, V108, P7119; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Team RDC, 2010, R LANG ENV STAT COMP; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Whitfield JB, 2004, ALCOHOL CLIN EXP RES, V28, P1153, DOI 10.1097/01.ALC.0000134221.32773.69; Xu B, 2008, NAT GENET, V40, P880, DOI 10.1038/ng.162; Zhu XF, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-S1-S128; Zuo L, NEUROPSYCHOPHARMACOL	49	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e30860	10.1371/journal.pone.0030860	http://dx.doi.org/10.1371/journal.pone.0030860			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910ME	22295116	Green Published, gold, Green Submitted			2022-12-25	WOS:000301640600061
J	Sutherland, JS; Garba, D; Fombah, AE; Mendy-Gomez, A; Mendy, FS; Antonio, M; Townend, J; Ideh, RC; Corrah, T; Ota, MOC				Sutherland, Jayne S.; Garba, Danlani; Fombah, Augustin E.; Mendy-Gomez, Awa; Mendy, Francis S.; Antonio, Martin; Townend, John; Ideh, Readon C.; Corrah, Tumani; Ota, Martin O. C.			Highly Accurate Diagnosis of Pleural Tuberculosis by Immunological Analysis of the Pleural Effusion	PLOS ONE			English	Article							INTERFERON-GAMMA; T-LYMPHOCYTES; IFN-GAMMA; IP-10; INFECTION; UTILITY; RESPONSES; CYTOKINE; PROTEIN; SITES	Pleural TB is notoriously difficult to diagnose due to its paucibacillary nature yet it is the most common cause of pleural effusions in TB endemic countries such as The Gambia. We identified both cellular and soluble biomarkers in the pleural fluid that allowed highly accurate diagnosis of pleural TB compared to peripheral blood markers. Multi-plex cytokine analysis on unstimulated pleural fluid showed that IP-10 resulted in a positive likelihood ratio (LR) of 9.6 versus 2.8 for IFN-gamma; a combination of IP-10, IL-6 and IL-10 resulted in an AUC of 0.96 and positive LR of 10. A striking finding was the significantly higher proportion of PPD-specific IFN-gamma+TNF-alpha+ cell population (PPD-IGTA) in the pleural fluid compared to peripheral blood of TB subjects. Presence of this pleural PPD-IGTA population resulted in 95% correct classification of pleural TB disease with a sensitivity of 95% and specificity of 100%. These data suggest that analysis of the site of infection provides superior diagnostic accuracy compared to peripheral blood for pleural TB, likely due to the sequestration of effector cells at this acute stage of disease.	[Sutherland, Jayne S.; Garba, Danlani; Fombah, Augustin E.; Mendy-Gomez, Awa; Mendy, Francis S.; Antonio, Martin; Townend, John; Ideh, Readon C.; Corrah, Tumani; Ota, Martin O. C.] MRC Unit, Fajara, Gambia	University of London; London School of Hygiene & Tropical Medicine	Sutherland, JS (corresponding author), MRC Unit, Atlantic Rd, Fajara, Gambia.	jsutherland@mrc.gm		Sutherland, Jayne/0000-0002-7083-4997	MRC Unit, The Gambia; Medical Research Council [MC_U190071468, MC_UP_A900_1122, MC_U190081991, MC_U190074190] Funding Source: researchfish; MRC [MC_U190081991, MC_U190071468, MC_U190074190, MC_UP_A900_1122] Funding Source: UKRI	MRC Unit, The Gambia; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was funded by the MRC Unit, The Gambia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002788; Barry SM, 2003, J INFECT DIS, V187, P243, DOI 10.1086/346112; Condos R, 1998, AM J RESP CRIT CARE, V157, P729, DOI 10.1164/ajrccm.157.3.9705044; Dheda K, 2009, EUR RESPIR J, V34, P1118, DOI 10.1183/09031936.00005309; Dheda K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004689; El Fenniri L, 2011, TUBERCULOSIS, V91, P224, DOI 10.1016/j.tube.2010.12.005; Hirsch CS, 2001, J INFECT DIS, V183, P779, DOI 10.1086/318817; Hodsdon WS, 2001, AIDS, V15, P467, DOI 10.1097/00002030-200103090-00005; John SH, 2011, BIOMARKERS      1108; Kalantri Y, 2011, INT J INFECT DIS, V15, pE226, DOI 10.1016/j.ijid.2010.11.011; Kapina MA, 2007, J IMMUNOL, V178, P976, DOI 10.4049/jimmunol.178.2.976; Krenke R, 2010, CURR OPIN PULM MED, V16, P367, DOI 10.1097/MCP.0b013e32833a7154; Nunn P, 2005, NAT REV IMMUNOL, V5, P819, DOI 10.1038/nri1704; Okamoto M, 2005, J LAB CLIN MED, V145, P88, DOI 10.1016/j.lab.2004.11.013; Porcel JM, 2011, RESPIROLOGY, V16, P44, DOI 10.1111/j.1440-1843.2010.01794.x; Porcel JM, 2010, EUR J INTERN MED, V21, P419, DOI 10.1016/j.ejim.2010.03.011; Roederer M, 2011, CYTOM PART A, V79A, P167, DOI 10.1002/cyto.a.21015; Ruhwald M, 2011, TUBERCULOSIS, V91, P260, DOI 10.1016/j.tube.2011.01.001; Supriya P, 2008, DIAGN MICR INFEC DIS, V62, P186, DOI 10.1016/j.diagmicrobio.2008.05.011; Sutherland JS, 2009, TUBERCULOSIS, V89, P398, DOI 10.1016/j.tube.2009.07.004; Toossi Z, 2011, CLIN EXP IMMUNOL, V163, P333, DOI 10.1111/j.1365-2249.2010.04269.x; Whittaker E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003901; WHO, 2010, WHO 2010 2011 TB FAC; WHO, WHO LAB BAS EV 19 CO	24	23	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e30324	10.1371/journal.pone.0030324	http://dx.doi.org/10.1371/journal.pone.0030324			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910ME	22295081	gold, Green Submitted, Green Published			2022-12-25	WOS:000301640600026
J	Zhang, S; Han, CH; Chen, XS; Zhang, M; Xu, LM; Zhang, JJ; Xia, Q				Zhang, Shun; Han, Cong-Hui; Chen, Xiao-Song; Zhang, Ming; Xu, Long-Mei; Zhang, Jian-Jun; Xia, Qiang			Transient Ureteral Obstruction Prevents against Kidney Ischemia/Reperfusion Injury via Hypoxia-Inducible Factor (HIF)-2 alpha Activation	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; DOMAIN PROTEIN-1 EPAS1; ENDOTHELIAL INJURY; HEPATIC ISCHEMIA; RETINAL ISCHEMIA; TISSUE OXYGEN; TRANSCRIPTION; EXPRESSION; DYSFUNCTION; CELLS	Although the protective effect of transient ureteral obstruction (UO) prior to ischemia on subsequent renal ischemia/reperfusion (I/R) injury has been documented, the underlying molecular mechanism remains to be understood. We showed in the current study that 24 h of UO led to renal tubular hypoxia in the ipsilateral kidney in mice, with the accumulation of hypoxia-inducible factor (HIF)-2 alpha, which lasted for a week after the release of UO. To address the functions of HIF-2 alpha in UO-mediated protection of renal IRI, we utilized the Mx-Cre/loxP recombination system to knock out target genes. Inactivation of HIF-2 alpha, but not HIF-1 alpha blunted the renal protective effects of UO, as demonstrated by much higher serum creatinine level and severer histological damage. UO failed to prevent postischemic neutrophil infiltration and apoptosis induction in HIF-2 alpha knockout mice, which also diminished the postobstructive up-regulation of the protective molecule, heat shock protein (HSP)-27. The renal protective effects of UO were associated with the improvement of the postischemic recovery of intrarenal microvascular blood flow, which was also dependent on the activation of HIF-2 alpha. Our results demonstrated that UO protected the kidney via activation of HIF-2 alpha, which reduced tubular damages via preservation of adequate renal microvascular perfusion after ischemia. Thus, preconditional HIF-2 alpha activation might serve as a novel therapeutic strategy for the treatment of ischemic acute renal failure.	[Zhang, Shun; Chen, Xiao-Song; Zhang, Ming; Xu, Long-Mei; Zhang, Jian-Jun; Xia, Qiang] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Transplantat & Hepat Surg, Shanghai 200030, Peoples R China; [Han, Cong-Hui] Xuzhou Med Univ, Sch Clin Med, Xuzhou Cent Hosp, Dept Urol, Xuzhou, Peoples R China	Shanghai Jiao Tong University; Xuzhou Medical University	Zhang, S (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Transplantat & Hepat Surg, Shanghai 200030, Peoples R China.	xiaqiang@medmail.com.cn		Zhang, Shun/0000-0002-3493-1247	Renji Hospital, Shanghai Jiaotong University School of Medicine [RJ4101301]; Science and Technology Commission of Shanghai Municipality [09410706300]	Renji Hospital, Shanghai Jiaotong University School of Medicine; Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by the Key Discipline Project of Renji Hospital, Shanghai Jiaotong University School of Medicine (RJ4101301) to QX. This study was also supported by a grant from Science and Technology Commission of Shanghai Municipality (International Science and Technology Cooperation Program, 09410706300) to JZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baranova O, 2007, J NEUROSCI, V27, P6320, DOI 10.1523/JNEUROSCI.0449-07.2007; Bernhardt WM, 2006, J AM SOC NEPHROL, V17, P1970, DOI 10.1681/ASN.2005121302; Bernhardt WM, 2006, KIDNEY INT, V69, P114, DOI 10.1038/sj.ki.5000062; Blackwell KL, 2003, CANCER RES, V63, P6162; Brodsky SV, 2002, AM J PHYSIOL-RENAL, V282, pF1140, DOI 10.1152/ajprenal.00329.2001; Bruick RK, 2003, GENE DEV, V17, P2614, DOI 10.1101/gad.1145503; Bruick RK, 2002, SCIENCE, V295, P807, DOI 10.1126/science.1069825; Chang CK, 2004, CLIN SCI, V106, P501, DOI 10.1042/CS20030263; Concannon CG, 2003, APOPTOSIS, V8, P61, DOI 10.1023/A:1021601103096; Debbabi H, 2010, AM J HYPERTENS, V23, P541, DOI 10.1038/ajh.2010.10; Donnahoo KK, 1999, AM J PHYSIOL-REG I, V277, pR922, DOI 10.1152/ajpregu.1999.277.3.R922; Dyson A, 2007, AM J PHYSIOL-HEART C, V293, pH526, DOI 10.1152/ajpheart.00052.2007; Eckle T, 2008, CIRCULATION, V118, P166, DOI 10.1161/CIRCULATIONAHA.107.758516; Ema M, 1997, P NATL ACAD SCI USA, V94, P4273, DOI 10.1073/pnas.94.9.4273; Gruber M, 2007, P NATL ACAD SCI USA, V104, P2301, DOI 10.1073/pnas.0608382104; Haase VH, 2006, AM J PHYSIOL-RENAL, V291, pF271, DOI 10.1152/ajprenal.00071.2006; Hayashi M, 2004, J CLIN INVEST, V113, P1138, DOI 10.1172/JCI200419890; Hegarty NJ, 2001, KIDNEY INT, V59, P1059, DOI 10.1046/j.1523-1755.2001.00589.x; Higgins DF, 2007, J CLIN INVEST, V117, P3810, DOI 10.1172/JCI30487; Hill P, 2008, J AM SOC NEPHROL, V19, P39, DOI 10.1681/ASN.2006090998; Hollander JM, 2004, CIRCULATION, V110, P3544, DOI 10.1161/01.CIR.0000148825.99184.50; Holmquist-Mengelbier L, 2006, CANCER CELL, V10, P413, DOI 10.1016/j.ccr.2006.08.026; Hu G, 2010, IMMUNOPHARM IMMUNOT, V32, P656, DOI 10.3109/08923971003671090; HULAND H, 1982, UROL INT, V37, P213, DOI 10.1159/000280819; Iguchi M, 2008, NEPHRON EXP NEPHROL, V110, pE82, DOI 10.1159/000166994; Kabakov AE, 2003, CELL STRESS CHAPERON, V8, P335, DOI 10.1379/1466-1268(2003)008<0335:HSPOHS>2.0.CO;2; Khan NA, 2009, NEPHROL DIAL TRANSPL, V24, P2701, DOI 10.1093/ndt/gfp369; Kim M, 2010, AM J PHYSIOL-RENAL, V299, pF347, DOI 10.1152/ajprenal.00194.2010; KINJO T, 1989, CELL TISSUE RES, V256, P27; Kojima I, 2007, J AM SOC NEPHROL, V18, P1218, DOI 10.1681/ASN.2006060639; Kostourou V, 2004, NEOPLASIA, V6, P401, DOI 10.1593/neo.04109; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Lafrance JP, 2010, J AM SOC NEPHROL, V21, P345, DOI 10.1681/ASN.2009060636; Lameire N, 2005, LANCET, V365, P417; Licht AH, 2006, BLOOD, V107, P584, DOI 10.1182/blood-2005-07-3033; Lok CN, 1999, J BIOL CHEM, V274, P24147, DOI 10.1074/jbc.274.34.24147; Ma DQ, 2009, J AM SOC NEPHROL, V20, P713, DOI 10.1681/ASN.2008070712; Milosevic J, 2007, J NEUROSCI, V27, P412, DOI 10.1523/JNEUROSCI.2482-06.2007; Molitoris BA, 2004, KIDNEY INT, V66, P496, DOI 10.1111/j.1523-1755.2004.761_5.x; Molitoris BA, 2002, CRIT CARE MED, V30, pS235, DOI 10.1097/00003246-200205001-00011; Nocito A, 2007, HEPATOLOGY, V45, P369, DOI 10.1002/hep.21516; Norregaard R, 2009, AM J PHYSIOL-REG I, V296, pR185, DOI 10.1152/ajpregu.00170.2008; O'Hara JA, 2005, PHYSIOL MEAS, V26, P203, DOI 10.1088/0967-3334/26/3/006; Park KM, 2002, J BIOL CHEM, V277, P2040, DOI 10.1074/jbc.M107525200; Park SW, 2009, AM J PHYSIOL-RENAL, V297, pF885, DOI 10.1152/ajprenal.00317.2009; Patel SA, 2008, CELL DEATH DIFFER, V15, P628, DOI 10.1038/cdd.2008.17; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Rosenberger C, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000017223.49823.2A; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Semenza GL, 1999, ANNU REV CELL DEV BI, V15, P551, DOI 10.1146/annurev.cellbio.15.1.551; Sharp Frank R, 2004, NeuroRx, V1, P26, DOI 10.1602/neurorx.1.1.26; Sutton TA, 2002, KIDNEY INT, V62, P1539, DOI 10.1046/j.1523-1755.2002.00631.x; Taie S, 2009, J CLIN NEUROSCI, V16, P1056, DOI 10.1016/j.jocn.2008.09.024; Tepper OM, 2005, BLOOD, V105, P1068, DOI 10.1182/blood-2004-03-1051; Thakar CV, 2005, J CLIN INVEST, V115, P3451, DOI 10.1172/JCI25461; Tian H, 1997, GENE DEV, V11, P72, DOI 10.1101/gad.11.1.72; Turner J, 2008, TRENDS CARDIOVAS MED, V18, P109, DOI 10.1016/j.tcm.2008.02.001; Whitehouse T, 2006, AM J PHYSIOL-RENAL, V291, pF647, DOI 10.1152/ajprenal.00475.2005; Whitlock NA, 2005, INVEST OPHTH VIS SCI, V46, P1092, DOI 10.1167/iovs.04-0043; Wiesener MS, 2002, FASEB J, V16, P271, DOI 10.1096/fj.02-0445fje; Xia GB, 2001, CANCER-AM CANCER SOC, V91, P1429, DOI 10.1002/1097-0142(20010415)91:8<1429::AID-CNCR1149>3.0.CO;2-V; ZAGER RA, 1995, KIDNEY INT, V47, P628, DOI 10.1038/ki.1995.80; Zhu YL, 2007, INVEST OPHTH VIS SCI, V48, P1735, DOI 10.1167/iovs.06-1037	63	21	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e29876	10.1371/journal.pone.0029876	http://dx.doi.org/10.1371/journal.pone.0029876			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910ME	22295069	Green Submitted, gold, Green Published			2022-12-25	WOS:000301640600014
J	Bailes, HJ; Zhuang, LY; Lucas, RJ				Bailes, Helena J.; Zhuang, Ling-Yu; Lucas, Robert J.			Reproducible and Sustained Regulation of G alpha s Signalling Using a Metazoan Opsin as an Optogenetic Tool	PLOS ONE			English	Article							PROTEIN-KINASE-A; CELLULAR CAMP; IN-VIVO; BETA(2)-ADRENERGIC RECEPTOR; ADENYLYL-CYCLASE; COUPLED RECEPTOR; CYCLIC-AMP; RHODOPSIN; CELLS; OSCILLATIONS	Originally developed to regulate neuronal excitability, optogenetics is increasingly also used to control other cellular processes with unprecedented spatiotemporal resolution. Optogenetic modulation of all major G-protein signalling pathways (Gq, Gi and Gs) has been achieved using variants of mammalian rod opsin. We show here that the light response driven by such rod opsin-based tools dissipates under repeated exposure, consistent with the known bleaching characteristics of this photopigment. We continue to show that replacing rod opsin with a bleach resistant opsin from Carybdea rastonii, the box jellyfish, (JellyOp) overcomes this limitation. Visible light induced high amplitude, reversible, and reproducible increases in cAMP in mammalian cells expressing JellyOp. While single flashes produced a brief cAMP spike, repeated stimulation could sustain elevated levels for 10s of minutes. JellyOp was more photosensitive than currently available optogenetic tools, responding to white light at irradiances >= 1 mu W/cm(2). We conclude that JellyOp is a promising new tool for mimicking the activity of Gs-coupled G protein coupled receptors with fine spatiotemporal resolution.	[Bailes, Helena J.; Zhuang, Ling-Yu; Lucas, Robert J.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England	University of Manchester	Lucas, RJ (corresponding author), Univ Manchester, Fac Life Sci, Manchester, Lancs, England.	robert.lucas@manchester.ac.uk	; Bailes, Helena/K-5413-2012	Lucas, Robert/0000-0002-1088-8029; Bailes, Helena/0000-0003-3346-0639	Medical Research Council UK [G0801731]; BBSRC; MRC [G0801731] Funding Source: UKRI; Medical Research Council [G0801731] Funding Source: researchfish	Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a Milstein Award, Medical Research Council UK to RJL and HJB (G0801731) and a BBSRC doctoral training account. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airan RD, 2009, NATURE, V458, P1025, DOI 10.1038/nature07926; Berndt A, 2011, P NATL ACAD SCI USA, V108, P7595, DOI 10.1073/pnas.1017210108; Brueggemann LI, 2002, J GEN PHYSIOL, V119, P593, DOI 10.1085/jgp.20018495; Bucher D, 2009, J NEUROGENET, V23, P220, DOI 10.1080/01677060802441356; DICKERSON CD, 1995, EXP CELL RES, V216, P46, DOI 10.1006/excr.1995.1006; DiPilato LM, 2004, P NATL ACAD SCI USA, V101, P16513, DOI 10.1073/pnas.0405973101; Dunn TA, 2006, J NEUROSCI, V26, P12807, DOI 10.1523/JNEUROSCI.3238-06.2006; Dyachok O, 2006, BIOCHEM SOC T, V34, P498, DOI 10.1042/BST0340498; Dyachok O, 2006, NATURE, V439, P349, DOI 10.1038/nature04410; Fan F, 2008, ACS CHEM BIOL, V3, P346, DOI 10.1021/cb8000414; FUNG BKK, 1981, P NATL ACAD SCI-BIOL, V78, P152, DOI 10.1073/pnas.78.1.152; Gutierrez DV, 2011, J BIOL CHEM, V286, P25848, DOI 10.1074/jbc.M111.253674; HAISENLEDER DJ, 1992, ENDOCRINOLOGY, V131, P3027, DOI 10.1210/en.131.6.3027; Hempel CM, 1996, NATURE, V384, P166, DOI 10.1038/384166a0; IMS HWR, 2000, IMS IND RANK TOP 100; Jastrzebska B, 2010, BIOCHEM J, V428, P1, DOI 10.1042/BJ20100270; Kim JM, 2005, BIOCHEMISTRY-US, V44, P2284, DOI 10.1021/bi048328i; Koyanagi M, 2008, P NATL ACAD SCI USA, V105, P15576, DOI 10.1073/pnas.0806215105; Lin JY, 2011, EXP PHYSIOL, V96, P19, DOI 10.1113/expphysiol.2009.051961; Ma JX, 1999, FEBS LETT, V452, P199, DOI 10.1016/S0014-5793(99)00606-7; Marin EP, 2000, J BIOL CHEM, V275, P1930, DOI 10.1074/jbc.275.3.1930; Mustafi D, 2009, MOL PHARMACOL, V75, P1, DOI 10.1124/mol.108.051938; Oh E, 2010, J BIOL CHEM, V285, P30825, DOI 10.1074/jbc.M110.147298; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Rich TC, 2001, P NATL ACAD SCI USA, V98, P13049, DOI 10.1073/pnas.221381398; Rogan SC, 2011, PHARMACOL REV, V63, P291, DOI 10.1124/pr.110.003020; Schoenenberger P, 2011, EXP PHYSIOL, V96, P34, DOI 10.1113/expphysiol.2009.051219; Schroder-Lang S, 2007, NAT METHODS, V4, P39, DOI 10.1038/NMETH975; Schultheis C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018766; Seibold A, 2000, MOL PHARMACOL, V58, P1162, DOI 10.1124/mol.58.5.1162; Seifert R, 1998, J BIOL CHEM, V273, P5109, DOI 10.1074/jbc.273.9.5109; Shenoy SK, 2006, J BIOL CHEM, V281, P1261, DOI 10.1074/jbc.M506576200; Stierl M, 2011, J BIOL CHEM, V286, P1181, DOI 10.1074/jbc.M110.185496; Weissenberger S, 2011, J NEUROCHEM, V116, P616, DOI 10.1111/j.1471-4159.2010.07148.x; Ye HF, 2011, SCIENCE, V332, P1565, DOI 10.1126/science.1203535; Zaccolo M, 2002, CURR OPIN CELL BIOL, V14, P160, DOI 10.1016/S0955-0674(02)00316-2; Zaccolo M, 2002, SCIENCE, V295, P1711, DOI 10.1126/science.1069982; Zemelman BV, 2002, NEURON, V33, P15, DOI 10.1016/S0896-6273(01)00574-8; Zhang F, 2007, NAT REV NEUROSCI, V8, P577, DOI 10.1038/nrn2192; Zhang J, 2005, NATURE, V437, P569, DOI 10.1038/nature04140	40	60	60	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2012	7	1							e30774	10.1371/journal.pone.0030774	http://dx.doi.org/10.1371/journal.pone.0030774			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910LV	22292038	Green Published, Green Submitted, gold			2022-12-25	WOS:000301639600055
J	Boutant, M; Ramos, OHP; Tourrel-Cuzin, C; Movassat, J; Ilias, A; Vallois, D; Planchais, J; Pegorier, JP; Schuit, F; Petit, PX; Bossard, P; Maedler, K; Grapin-Botton, A; Vasseur-Cognet, M				Boutant, Marie; Ramos, Oscar Henrique Pereira; Tourrel-Cuzin, Cecile; Movassat, Jamileh; Ilias, Anissa; Vallois, David; Planchais, Julien; Pegorier, Jean-Paul; Schuit, Frans; Petit, Patrice X.; Bossard, Pascale; Maedler, Kathrin; Grapin-Botton, Anne; Vasseur-Cognet, Mireille			COUP-TFII Controls Mouse Pancreatic beta-Cell Mass through GLP-1-beta-Catenin Signaling Pathways	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; TRANSCRIPTION FACTOR-II; GLUCOSE-HOMEOSTASIS; CHRONIC EXPOSURE; GENE-EXPRESSION; CATENIN; NEOGENESIS; APOPTOSIS; INSULIN; GROWTH	Background: The control of the functional pancreatic beta-cell mass serves the key homeostatic function of releasing the right amount of insulin to keep blood sugar in the normal range. It is not fully understood though how beta-cell mass is determined. Methodology/Principal Findings: Conditional chicken ovalbumin upstream promoter transcription factor II (COUP-TFII)deficient mice were generated and crossed with mice expressing Cre under the control of pancreatic duodenal homeobox 1 (pdx1) gene promoter. Ablation of COUP-TFII in pancreas resulted in glucose intolerance. Beta-cell number was reduced at 1 day and 3 weeks postnatal. Together with a reduced number of insulin-containing cells in the ductal epithelium and normal b-cell proliferation and apoptosis, this suggests decreased beta-cell differentiation in the neonatal period. By testing islets isolated from these mice and cultured beta-cells with loss and gain of COUP-TFII function, we found that COUP-TFII induces the expression of the beta-catenin gene and its target genes such as cyclin D1 and axin 2. Moreover, induction of these genes by glucagon-like peptide 1 (GLP-1) via beta-catenin was impaired in absence of COUP-TFII. The expression of two other target genes of GLP-1 signaling, GLP-1R and PDX-1 was significantly lower in mutant islets compared to control islets, possibly contributing to reduced b-cell mass. Finally, we demonstrated that COUP-TFII expression was activated by the Wnt signaling-associated transcription factor TCF7L2 (T-cell factor 7-like 2) in human islets and rat b-cells providing a feedback loop. Conclusions/Significance: Our findings show that COUP-TFII is a novel component of the GLP-1 signaling cascade that increases beta-cell number during the neonatal period. COUP-TFII is required for GLP-1 activation of the beta-catenin-dependent pathway and its expression is under the control of TCF7L2.	[Boutant, Marie; Ramos, Oscar Henrique Pereira; Tourrel-Cuzin, Cecile; Planchais, Julien; Pegorier, Jean-Paul; Bossard, Pascale; Vasseur-Cognet, Mireille] Cochin Inst, INSERM, Dept Endocrinol Metab & Canc, Paris, France; [Boutant, Marie; Ramos, Oscar Henrique Pereira; Tourrel-Cuzin, Cecile; Planchais, Julien; Pegorier, Jean-Paul; Bossard, Pascale; Vasseur-Cognet, Mireille] CNRS, Paris, France; [Boutant, Marie; Ramos, Oscar Henrique Pereira; Tourrel-Cuzin, Cecile; Planchais, Julien; Pegorier, Jean-Paul; Bossard, Pascale; Vasseur-Cognet, Mireille] Univ Paris 05, Paris, France; [Movassat, Jamileh; Ilias, Anissa] Paris Diderot Univ, Lab Biol & Pathol Endocrine Pancreas, Unit Funct & Adaptat Biol, Paris, France; [Vallois, David] Univ Lausanne, Ctr Integrat Genom, Lausanne, Switzerland; [Schuit, Frans] Dept Mol Cellular Biol, Louvain, Belgium; [Petit, Patrice X.] Cochin Inst, CNRS, Paris, France; [Grapin-Botton, Anne] Ecole Polytech Fed Lausanne, Lausanne, Switzerland; [Maedler, Kathrin] Univ Bremen, Ctr Biomol Interact Bremen, Bremen, Germany	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; University of Lausanne; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Bremen	Vasseur-Cognet, M (corresponding author), Cochin Inst, INSERM, Dept Endocrinol Metab & Canc, Paris, France.	mireille.vasseur@inserm.fr	Maedler, Kathrin/ABE-3022-2021; Bossard, Pascale/O-6680-2017; Ramos, Oscar HP/E-1862-2013; Petit, Patrice X./A-3692-2009; Vasseur, Mireille/L-6958-2017; Tourrel-Cuzin, Cecile/HDN-8854-2022; Petit, patrice/AAF-6774-2020	Maedler, Kathrin/0000-0002-7436-1197; Ramos, Oscar HP/0000-0002-5788-4500; Petit, Patrice X./0000-0002-5038-9101; Vasseur, Mireille/0000-0001-6963-4114; Grapin-Botton, Anne/0000-0002-1202-5235; Tourrel-Cuzin, Cecile/0000-0002-5368-4018	European Foundation for the Study of Diabetes; programme partner Merk Sharp and Dohme; Ministere de l'Enseignement Superieur et de la Recherche and Association pour la Recherche sur le Cancer; Ile-de-France CODDIM; Agence Nationale pour la Recherche [ANR-05-PCOD-088-01]; K.U.Leuven [GOA/2009/010]; German Research Foundation (DFG); European Research Council (ERC)	European Foundation for the Study of Diabetes; programme partner Merk Sharp and Dohme; Ministere de l'Enseignement Superieur et de la Recherche and Association pour la Recherche sur le Cancer; Ile-de-France CODDIM; Agence Nationale pour la Recherche(French National Research Agency (ANR)); K.U.Leuven(KU Leuven); German Research Foundation (DFG)(German Research Foundation (DFG)); European Research Council (ERC)(European Research Council (ERC)European Commission)	This work was supported by grants from the European Foundation for the Study of Diabetes and the programme partner Merk Sharp and Dohme 2010. MB is recipient of a doctoral fellowship from the Ministere de l'Enseignement Superieur et de la Recherche and Association pour la Recherche sur le Cancer, OR was recipient of a 12-month post-doctoral fellowship from Ile-de-France CODDIM 2008, CT-C was supported for 12 months by a grant from Agence Nationale pour la Recherche (ANR-05-PCOD-088-01), FS was supported by the K.U.Leuven (GOA/2009/010), KM was supported by the German Research Foundation (DFG) and the European Research Council (ERC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann AM, 2007, J MOL ENDOCRINOL, V38, P193, DOI 10.1677/JME-06-0053; Bardoux P, 2005, DIABETES, V54, P1357, DOI 10.2337/diabetes.54.5.1357; Benoit G, 2006, PHARMACOL REV, V58, P798, DOI 10.1124/pr.58.4.10; Buteau J, 1999, DIABETOLOGIA, V42, P856, DOI 10.1007/s001250051238; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Chen C, 2009, AM J PHYSIOL-GASTR L, V297, pG1126, DOI 10.1152/ajpgi.90586.2008; Cornu M, 2009, DIABETES, V58, P1816, DOI 10.2337/db09-0063; Dessimoz J, 2005, CURR BIOL, V15, P1677, DOI 10.1016/j.cub.2005.08.037; Drucker DJ, 2006, LANCET, V368, P1696, DOI 10.1016/S0140-6736(06)69705-5; Duncan S, 2010, BMC BIOINFORMATICS, V11, DOI [10.1186/1471-2105-11-100, 10.1186/1471-2105-11-S4-P10]; Farilla L, 2002, ENDOCRINOLOGY, V143, P4397, DOI 10.1210/en.2002-220405; Figeac F, 2010, AM J PHYSIOL-ENDOC M, V298, pE245, DOI 10.1152/ajpendo.00538.2009; Gomez E, 2002, J BIOL CHEM, V277, P48146, DOI 10.1074/jbc.M209165200; Gu GQ, 2002, DEVELOPMENT, V129, P2447; Heiser PW, 2006, DEVELOPMENT, V133, P2023, DOI 10.1242/dev.02366; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Hong JJ, 2009, ANAT REC, V292, P818, DOI 10.1002/ar.20897; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Inada A, 2008, P NATL ACAD SCI USA, V105, P19915, DOI 10.1073/pnas.0805803105; Jhala US, 2003, GENE DEV, V17, P1575, DOI 10.1101/gad.1097103; KAISER N, 1991, ENDOCRINOLOGY, V129, P2067, DOI 10.1210/endo-129-4-2067; Kim BJ, 2009, DEV BIOL, V326, P378, DOI 10.1016/j.ydbio.2008.11.001; Kopp JL, 2011, DEVELOPMENT, V138, P653, DOI 10.1242/dev.056499; Kwon DY, 2009, J PHARMACOL SCI, V111, P361, DOI 10.1254/jphs.09178FP; Le Bacquer O, 2011, HUM MOL GENET, V20, P1906, DOI 10.1093/hmg/ddr072; Li LP, 2009, CELL METAB, V9, P77, DOI 10.1016/j.cmet.2008.12.002; Li YZ, 2003, J BIOL CHEM, V278, P471, DOI 10.1074/jbc.M209423200; Lin FJ, 2011, ENDOCR REV, V32, P404, DOI 10.1210/er.2010-0021; Lin FJ, 2010, J CLIN INVEST, V120, P1694, DOI 10.1172/JCI40101; Liu GY, 2003, NUCLEIC ACIDS RES, V31, P82, DOI 10.1093/nar/gkg121; Liu ZY, 2008, J BIOL CHEM, V283, P8723, DOI 10.1074/jbc.M706105200; Liu ZY, 2010, ADV EXP MED BIOL, V654, P391, DOI 10.1007/978-90-481-3271-3_17; Lukowiak B, 2001, J HISTOCHEM CYTOCHEM, V49, P519, DOI 10.1177/002215540104900412; Lyssenko V, 2007, J CLIN INVEST, V117, P2155, DOI 10.1172/JCI30706; Marshak S, 1999, DIABETES, V48, P1230, DOI 10.2337/diabetes.48.6.1230; Murtaugh LC, 2005, DEVELOPMENT, V132, P4663, DOI 10.1242/dev.02063; Nauck MA, 2007, DIABETOLOGIA, V50, P2413, DOI 10.1007/s00125-007-0832-8; Oberholzer J, 2000, TRANSPLANTATION, V69, P1115, DOI 10.1097/00007890-200003270-00016; Okamura M, 2009, P NATL ACAD SCI USA, V106, P5819, DOI 10.1073/pnas.0901676106; Perfetti R, 2000, ENDOCRINOLOGY, V141, P4600, DOI 10.1210/en.141.12.4600; Perilhou A, 2008, MOL CELL BIOL, V28, P6568, DOI 10.1128/MCB.02211-07; Perilhou A, 2008, MOL CELL BIOL, V28, P4588, DOI 10.1128/MCB.01191-07; PETIT PX, 1995, J CELL BIOL, V130, P157, DOI 10.1083/jcb.130.1.157; Rulifson IC, 2007, P NATL ACAD SCI USA, V104, P6247, DOI 10.1073/pnas.0701509104; Sauter NS, 2008, ENDOCRINOLOGY, V149, P2208, DOI 10.1210/en.2007-1059; Schafer SA, 2007, DIABETOLOGIA, V50, P2443, DOI 10.1007/s00125-007-0753-6; Schulthess FT, 2009, CELL METAB, V9, P125, DOI 10.1016/j.cmet.2009.01.003; Shu L, 2008, DIABETES, V57, P645, DOI 10.2337/db07-0847; Shu LA, 2009, HUM MOL GENET, V18, P2388, DOI 10.1093/hmg/ddp178; Thorens B, 2004, HORM METAB RES, V36, P766, DOI 10.1055/s-2004-826161; Tourrel C, 2002, DIABETES, V51, P1443, DOI 10.2337/diabetes.51.5.1443; Tourrel C, 2001, DIABETES, V50, P1562, DOI 10.2337/diabetes.50.7.1562; Van Lommel L, 2006, DIABETES, V55, P3214, DOI 10.2337/db06-0774; Welters HJ, 2008, TRENDS ENDOCRIN MET, V19, P349, DOI 10.1016/j.tem.2008.08.004; Willert K, 2006, GENE DEV, V20, P1394, DOI 10.1101/gad.1424006; Xie X, 2011, P NATL ACAD SCI USA, V108, P14843, DOI 10.1073/pnas.1110236108; Xu G, 1999, DIABETES, V48, P2270, DOI 10.2337/diabetes.48.12.2270; Xu G, 2006, DIABETES RES CLIN PR, V73, P107, DOI 10.1016/j.diabres.2005.11.007; Xu Z, 2008, P NATL ACAD SCI USA, V105, P2421, DOI 10.1073/pnas.0707082105; Zhang P, 2002, MECH DEVELOP, V119, P109, DOI 10.1016/S0925-4773(02)00286-1	60	20	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2012	7	1							e30847	10.1371/journal.pone.0030847	http://dx.doi.org/10.1371/journal.pone.0030847			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910LV	22292058	gold, Green Published, Green Submitted			2022-12-25	WOS:000301639600061
J	Lamont, EA; Bannantine, JP; Armien, A; Ariyakumar, DS; Sreevatsan, S				Lamont, Elise A.; Bannantine, John P.; Armien, Anibal; Ariyakumar, Don Sanjiv; Sreevatsan, Srinand			Identification and Characterization of a Spore-Like Morphotype in Chronically Starved Mycobacterium avium Subsp Paratuberculosis Cultures	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; DIPICOLINIC ACID; CROHNS-DISEASE; TUBERCULOSIS; SPORULATION; PERSISTENCE; INFECTIONS; PRODUCTS; SURVIVAL; VECTORS	Mycobacteria are able to enter into a state of non-replication or dormancy, which may result in their chronic persistence in soil, aquatic environments, and permissive hosts. Stresses such as nutrient deprivation and hypoxia provide environmental cues to enter a persistent state; however, a clear definition of the mechanism that mycobacteria employ to achieve this remains elusive. While the concept of sporulation in mycobacteria is not novel, it continues to spark controversy and challenges our perceptions of a non-replication. We investigated the potential role of sporulation in one-year old broth cultures of Mycobacterium subsp. paratuberculosis (MAP). We show that dormant cultures of MAP contain a mix of vegetative cells and a previously unknown morphotype resembling a spore. These spore-like structures can be enriched for using sporulating media. Furthermore, purified MAP spore forms survive exposure to heat, lysozyme and proteinase K. Heat-treated spores are positive for MAP 16SrRNA and IS900. MAP spores display enhanced infectivity as well as maintain acid-fast characteristics upon germination in a well-established bovine macrophage model. This is the first study to demonstrate a new MAP morphotype possessing spore-like qualities. Data suggest that sporulation may be a viable mechanism by which MAP accomplishes persistence in the host and/or environment. Thus, our current understanding of mycobacterial persistence, pathogenesis, epidemiology and rational drug and vaccine design may need to be reevaluated.	[Lamont, Elise A.; Sreevatsan, Srinand] Univ Minnesota, Dept Vet Biomed Sci, St Paul, MN 55108 USA; [Ariyakumar, Don Sanjiv] Univ Minnesota, Vet Diagnost Lab, St Paul, MN 55108 USA; [Bannantine, John P.] ARS, Natl Anim Dis Ctr, USDA, Ames, IA USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; United States Department of Agriculture (USDA)	Lamont, EA (corresponding author), Univ Minnesota, Dept Vet Biomed Sci, St Paul, MN 55108 USA.	sreev001@umn.edu	Sreevatsan, Srinand/V-6808-2019	Sreevatsan, Srinand/0000-0002-5162-2403; Lamont, Elise/0000-0001-7085-9740; Bannantine, John/0000-0002-5692-7898	USDA-CSREES [2008-55620-18710]	USDA-CSREES(United States Department of Agriculture (USDA)National Institute of Food and Agriculture)	This work was supported by Johne's Disease Integrated Program (USDA-CSREES 2008-55620-18710) awarded to Dr. Sreevatsan. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMAHA M, 1956, J BACTERIOL, V72, P34, DOI 10.1128/JB.72.1.34-41.1956; [Anonymous], 2008, Vet Rec, V163, P171; Bentrup KHZ, 2001, TRENDS MICROBIOL, V9, P597, DOI 10.1016/S0966-842X(01)02238-7; Bloom BR, 1999, NAT MED, V5, P872, DOI 10.1038/11309; Cardona PJ, 2009, INFECTION, V37, P80, DOI 10.1007/s15010-008-8087-y; Chacon O, 2004, ANNU REV MICROBIOL, V58, P329, DOI 10.1146/annurev.micro.58.030603.123726; CHIODINI RJ, 1984, DIGEST DIS SCI, V29, P1073, DOI 10.1007/BF01317078; CHIODINI RJ, 1984, J CLIN MICROBIOL, V20, P966, DOI 10.1128/JCM.20.5.966-971.1984; Coussens PM, 2004, INFECT IMMUN, V72, P1409, DOI 10.1128/IAI.72.3.1409-1422.2004; Cunningham AF, 1998, J BACTERIOL, V180, P801, DOI 10.1128/JB.180.4.801-808.1998; DANIEL RA, 1993, J MOL BIOL, V232, P468, DOI 10.1006/jmbi.1993.1403; de Hoon MJL, 2010, CURR BIOL, V20, pR735, DOI 10.1016/j.cub.2010.06.031; Dhand NK, 2009, APPL ENVIRON MICROB, V75, P5581, DOI 10.1128/AEM.00557-09; Di Sabatino A, 2011, INFLAMM BOWEL DIS, V17, P1254, DOI 10.1002/ibd.21461; Donaghy JA, 2004, APPL ENVIRON MICROB, V70, P4899, DOI 10.1128/AEM.70.8.4899-4905.2004; Ehlers S, 2009, INFECTION, V37, P87, DOI 10.1007/s15010-009-8450-7; El-Zaatari FAK, 2001, TRENDS MOL MED, V7, P247, DOI 10.1016/S1471-4914(01)01983-9; Eltholth MM, 2009, J APPL MICROBIOL, V107, P1061, DOI 10.1111/j.1365-2672.2009.04286.x; Filippova S. N., 2005, Mikrobiologiya, V74, P204; Fischer O, 2001, MED VET ENTOMOL, V15, P208, DOI 10.1046/j.1365-2915.2001.00292.x; Fischer OA, 2004, VET MICROBIOL, V102, P247, DOI 10.1016/j.vetmic.2004.06.005; Fischer OA, 2003, VET MICROBIOL, V91, P325, DOI 10.1016/S0378-1135(02)00302-4; Fukutomi Yasuo, 2009, Nihon Hansenbyo Gakkai Zasshi, V78, P7; Garcia D, 2010, INT J FOOD MICROBIOL, V140, P146, DOI 10.1016/j.ijfoodmicro.2010.04.005; Ghosh J, 2009, P NATL ACAD SCI USA, V106, P10781, DOI 10.1073/pnas.0904104106; Greenstein RJ, 2003, LANCET INFECT DIS, V3, P507, DOI 10.1016/S1473-3099(03)00724-2; Grewal SK, 2006, APPL ENVIRON MICROB, V72, P565, DOI 10.1128/AEM.72.1.565-574.2006; Gumber S, 2009, VET MICROBIOL, V133, P344, DOI 10.1016/j.vetmic.2008.07.021; Hamilton HK, 2008, INT J DERMATOL, V47, P545, DOI 10.1111/j.1365-4632.2008.03722.x; Hesketh A, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r161; Hett EC, 2008, MICROBIOL MOL BIOL R, V72, P126, DOI 10.1128/MMBR.00028-07; JANSSEN FW, 1958, SCIENCE, V127, P26, DOI 10.1126/science.127.3288.26; KANETSUNA F, 1964, Int J Lepr, V32, P185; Lamont EA, 2010, MICROB PATHOGENESIS, V48, P143, DOI 10.1016/j.micpath.2010.02.002; Naser SA, 2004, LANCET, V364, P1039, DOI 10.1016/S0140-6736(04)17058-X; Orme IM, 2001, INT J TUBERC LUNG D, V5, P589; Orsburn BC, 2010, MOL MICROBIOL, V75, P178, DOI 10.1111/j.1365-2958.2009.06975.x; Pickup RW, 2006, APPL ENVIRON MICROB, V72, P4067, DOI 10.1128/AEM.02490-05; Pribylova R, 2011, CURR MICROBIOL, V62, P1405, DOI 10.1007/s00284-011-9875-7; Raizman EA, 2005, CAN J VET RES, V69, P32; RAMAKRISHNAN L, 1994, INFECT IMMUN, V62, P3222, DOI 10.1128/IAI.62.8.3222-3229.1994; Ratledge C, 2004, TUBERCULOSIS, V84, P110, DOI 10.1016/j.tube.2003.08.012; ROBINOW CF, 1953, J BACTERIOL, V65, P378, DOI 10.1128/JB.65.4.378-382.1953; Russell DG, 2001, NAT REV MOL CELL BIO, V2, P569, DOI 10.1038/35085034; Rustad TR, 2009, CELL MICROBIOL, V11, P1151, DOI 10.1111/j.1462-5822.2009.01325.x; Sechi LA, 2004, MICROBIOLOGICA, V27, P75; Setlow P, 2007, TRENDS MICROBIOL, V15, P172, DOI 10.1016/j.tim.2007.02.004; Shankar H, 2010, INT J INFECT DIS, V14, pE121, DOI 10.1016/j.ijid.2009.03.031; Singh SV, 2009, INT J INFECT DIS, V13, pE221, DOI 10.1016/j.ijid.2008.11.022; SOLARI AA, 1968, APPL MICROBIOL, V16, P792, DOI 10.1128/AEM.16.5.792-.1968; Stallings CL, 2009, CELL, V138, P146, DOI 10.1016/j.cell.2009.04.041; STASTNA J, 1992, FOLIA MICROBIOL, V37, P111, DOI 10.1007/BF02836614; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TANAKA K, 1991, GUT, V32, P43, DOI 10.1136/gut.32.1.43; Traag BA, 2010, P NATL ACAD SCI USA, V107, P878, DOI 10.1073/pnas.0911299107; Van Brandt L, 2011, J APPL MICROBIOL, V110, P1252, DOI 10.1111/j.1365-2672.2011.04979.x; van Schaik W, 2007, MICROBIOL-SGM, V153, P4234, DOI 10.1099/mic.0.2007/010355-0; Ventura M, 2007, MICROBIOL MOL BIOL R, V71, P495, DOI 10.1128/MMBR.00005-07; Wang MY, 2007, APPL MICROBIOL BIOT, V77, P645, DOI 10.1007/s00253-007-1196-1; Wekesa VW, 2010, J INVERTEBR PATHOL, V103, P36, DOI 10.1016/j.jip.2009.10.003; Whittington RJ, 2004, APPL ENVIRON MICROB, V70, P2989, DOI 10.1128/AEM.70.5.2989-3004.2004; Yang WW, 2009, J APPL MICROBIOL, V106, P27, DOI 10.1111/j.1365-2672.2008.03931.x	62	65	66	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2012	7	1							e30648	10.1371/journal.pone.0030648	http://dx.doi.org/10.1371/journal.pone.0030648			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910LV	22292005	Green Published, gold, Green Submitted			2022-12-25	WOS:000301639600040
J	Vijendravarma, RK; Narasimha, S; Kawecki, TJ				Vijendravarma, Roshan K.; Narasimha, Sunitha; Kawecki, Tadeusz J.			Adaptation to Abundant Low Quality Food Improves the Ability to Compete for Limited Rich Food in Drosophila melanogaster	PLOS ONE			English	Article							DEPENDENT NATURAL-SELECTION; FEEDING RATE; PARASITOID RESISTANCE; FASTER DEVELOPMENT; EVOLUTION; ACQUISITION	The rate of food consumption is a major factor affecting success in scramble competition for a limited amount of easy-to-find food. Accordingly, several studies report positive genetic correlations between larval competitive ability and feeding rate in Drosophila; both become enhanced in populations evolving under larval crowding. Here, we report the experimental evolution of enhanced competitive ability in populations of D. melanogaster previously maintained for 84 generations at low density on an extremely poor larval food. In contrast to previous studies, greater competitive ability was not associated with the evolution of higher feeding rate; if anything, the correlation between the two traits across lines tended to be negative. Thus, enhanced competitive ability may be favored by nutritional stress even when competition is not intense, and competitive ability may be decoupled from the rate of food consumption.	[Vijendravarma, Roshan K.; Narasimha, Sunitha; Kawecki, Tadeusz J.] Univ Lausanne, Dept Ecol & Evolut, CH-1015 Lausanne, Switzerland	University of Lausanne	Vijendravarma, RK (corresponding author), Univ Lausanne, Dept Ecol & Evolut, CH-1015 Lausanne, Switzerland.	roshan.vijendravarma@unil.ch	Kawecki, Tadeusz/K-5466-2015; Vijendravarma, Roshan K/E-7746-2018; Vijendravarma, Roshan/E-9985-2013	Kawecki, Tadeusz/0000-0002-9244-1991; Vijendravarma, Roshan K/0000-0002-3274-0682; Vijendravarma, Roshan Kumar/0000-0002-4930-3040	Swiss National Science Foundation (SNF) [31003A-126018]	Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF))	This study was supported by a grant from the Swiss National Science Foundation (SNF grant# 31003A-126018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATKINSON WD, 1979, J ANIM ECOL, V48, P91, DOI 10.2307/4102; Bakker K., 1961, Archives Neerlandaises de Zoologie Leiden, V14, P200; BURNET B, 1977, GENET RES, V30, P149, DOI 10.1017/S0016672300017559; Fellowes MDE, 1999, EVOLUTION, V53, P1302, DOI 10.1111/j.1558-5646.1999.tb04544.x; Joshi A, 1996, EVOL ECOL, V10, P463, DOI 10.1007/BF01237879; JOSHI A, 1988, EVOLUTION, V42, P1090, DOI 10.1111/j.1558-5646.1988.tb02527.x; Joshi A, 2001, J GENET, V80, P63, DOI 10.1007/BF02728332; Kaun KR, 2007, J EXP BIOL, V210, P3547, DOI 10.1242/jeb.006924; Kolss M, 2009, EVOLUTION, V63, P2389, DOI 10.1111/j.1558-5646.2009.00718.x; Kraaijeveld AR, 2001, P ROY SOC B-BIOL SCI, V268, P259, DOI 10.1098/rspb.2000.1354; Mery F, 2003, P ROY SOC B-BIOL SCI, V270, P2465, DOI 10.1098/rspb.2003.2548; MUELLER LD, 1988, P NATL ACAD SCI USA, V85, P4383, DOI 10.1073/pnas.85.12.4383; NUNNEY L, 1990, ECOLOGY, V71, P1904, DOI 10.2307/1937598; Prasad NG, 2001, EVOLUTION, V55, P1363, DOI 10.1111/j.0014-3820.2001.tb00658.x; Rajamani M, 2006, J GENET, V85, P209, DOI 10.1007/BF02935333; Santos M, 1997, EVOLUTION, V51, P420, DOI 10.2307/2411114; SANTOS M, 1992, HEREDITY, V69, P489, DOI 10.1038/hdy.1992.163; SEWELL DF, 1975, BEHAV BIOL, V15, P213, DOI 10.1016/S0091-6773(75)91587-4; Shakarad M, 2005, BIOL LETTERS, V1, P91, DOI 10.1098/2004.0261; Vijendravarma RK, 2011, J EVOLUTION BIOL, V24, P897, DOI 10.1111/j.1420-9101.2010.02225.x; Vijendravarma RK, J EVOLUTION IN PRESS; Vijendravarma RK, 2009, EVOLUTION, V63, P104, DOI 10.1111/j.1558-5646.2008.00516.x; Wu Q, 2005, P NATL ACAD SCI USA, V102, P13289, DOI 10.1073/pnas.0501914102	23	16	16	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2012	7	1							e30650	10.1371/journal.pone.0030650	http://dx.doi.org/10.1371/journal.pone.0030650			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910LV	22292007	Green Published, Green Submitted, gold			2022-12-25	WOS:000301639600042
J	Agundez, L; Gonzalez-Prieto, C; Machon, C; Llosa, M				Agundez, Leticia; Gonzalez-Prieto, Coral; Machon, Cristina; Llosa, Matxalen			Site-Specific Integration of Foreign DNA into Minimal Bacterial and Human Target Sequences Mediated by a Conjugative Relaxase	PLOS ONE			English	Article							PROTEIN TRWC; PLASMID; RECOMBINATION; ORIGIN; ORIT; INCW; CLEAVAGE; BINDING	Background: Bacterial conjugation is a mechanism for horizontal DNA transfer between bacteria which requires cell to cell contact, usually mediated by self-transmissible plasmids. A protein known as relaxase is responsible for the processing of DNA during bacterial conjugation. TrwC, the relaxase of conjugative plasmid R388, is also able to catalyze site-specific integration of the transferred DNA into a copy of its target, the origin of transfer (oriT), present in a recipient plasmid. This reaction confers TrwC a high biotechnological potential as a tool for genomic engineering. Methodology/Principal Findings: We have characterized this reaction by conjugal mobilization of a suicide plasmid to a recipient cell with an oriT-containing plasmid, selecting for the cointegrates. Proteins TrwA and IHF enhanced integration frequency. TrwC could also catalyze integration when it is expressed from the recipient cell. Both Y18 and Y26 catalytic tyrosil residues were essential to perform the reaction, while TrwC DNA helicase activity was dispensable. The target DNA could be reduced to 17 bp encompassing TrwC nicking and binding sites. Two human genomic sequences resembling the 17 bp segment were accepted as targets for TrwC-mediated site-specific integration. TrwC could also integrate the incoming DNA molecule into an oriT copy present in the recipient chromosome. Conclusions/Significance: The results support a model for TrwC-mediated site-specific integration. This reaction may allow R388 to integrate into the genome of non-permissive hosts upon conjugative transfer. Also, the ability to act on target sequences present in the human genome underscores the biotechnological potential of conjugative relaxase TrwC as a site-specific integrase for genomic modification of human cells.	Univ Cantabria, Dept Biol Mol, E-39005 Santander, Spain; UC CSIC SODERCAN, Inst Biomed & Biotecnol Cantabria, Santander, Spain	Universidad de Cantabria; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Cantabria; CSIC - Instituto de Biomedicina y Biotecnologia de Cantabria (IBBTEC)	Agundez, L (corresponding author), Kings Coll London, Sch Med, London WC2R 2LS, England.	llosam@unican.es	Sobrado, Cristina Machón/K-1634-2014; Gonzalez-Prieto, Coral/ABD-1690-2020; , matxalen/ABG-5541-2020	Sobrado, Cristina Machón/0000-0001-5363-2958; , matxalen/0000-0002-4826-2240	Spanish Ministry of Science and Innovation [BIO2008-00133]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by grant BIO2008-00133 from the Spanish Ministry of Science and Innovation to ML. CGP was a recipient of a predoctoral fellowship from the University of Cantabria, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agundez L, 2011, APPL ENVIRON MICROB, V77, P201, DOI 10.1128/AEM.01371-10; BUCHANANWOLLASTON V, 1987, NATURE, V328, P172, DOI 10.1038/328172a0; CAMPBELL JL, 1978, P NATL ACAD SCI USA, V75, P2276, DOI 10.1073/pnas.75.5.2276; Cesar CE, 2007, J BACTERIOL, V189, P9037, DOI 10.1128/JB.01152-07; Cesar CE, 2006, MOL MICROBIOL, V62, P984, DOI 10.1111/j.1365-2958.2006.05437.x; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DELORENZO V, 1994, METHOD ENZYMOL, V235, P386; Demarre G, 2005, RES MICROBIOL, V156, P245, DOI 10.1016/j.resmic.2004.09.007; Draper O, 2005, P NATL ACAD SCI USA, V102, P16385, DOI 10.1073/pnas.0506081102; Garcillan-Barcia MP, 2009, FEMS MICROBIOL REV, V33, P657, DOI 10.1111/j.1574-6976.2009.00168.x; Gonzalez-Perez B, 2007, EMBO J, V26, P3847, DOI 10.1038/sj.emboj.7601806; GRANDOSO G, 1994, EUR J BIOCHEM, V226, P403, DOI 10.1111/j.1432-1033.1994.tb20065.x; Grandoso G, 2000, J MOL BIOL, V295, P1163, DOI 10.1006/jmbi.1999.3425; GRANT SGN, 1990, P NATL ACAD SCI USA, V87, P4645, DOI 10.1073/pnas.87.12.4645; Guasch A, 2003, NAT STRUCT BIOL, V10, P1002, DOI 10.1038/nsb1017; HEINEMANN JA, 1989, NATURE, V340, P205, DOI 10.1038/340205a0; Kolb Andreas F., 2002, Cloning and Stem Cells, V4, P65, DOI 10.1089/153623002753632066; Llosa M, 2002, MOL MICROBIOL, V45, P1, DOI 10.1046/j.1365-2958.2002.03014.x; Llosa M, 2005, RES MICROBIOL, V156, P1, DOI 10.1016/j.resmic.2004.07.008; LLOSA M, 1994, J BACTERIOL, V176, P3210, DOI 10.1128/jb.176.11.3210-3217.1994; LLOSA M, 1991, MOL GEN GENET, V226, P473, DOI 10.1007/BF00260661; Llosa M, 1996, J MOL BIOL, V264, P56, DOI 10.1006/jmbi.1996.0623; Lucas M, 2010, J BIOL CHEM, V285, P8918, DOI 10.1074/jbc.M109.057539; Miyazaki R, 2011, MOL MICROBIOL, V79, P743, DOI 10.1111/j.1365-2958.2010.07484.x; Moncalian G, 2004, BBA-PROTEINS PROTEOM, V1701, P15, DOI 10.1016/j.bbapap.2004.05.009; Moncalian G, 1997, J MOL BIOL, V270, P188, DOI 10.1006/jmbi.1997.1082; Moncalian G, 1999, MOL MICROBIOL, V31, P1643, DOI 10.1046/j.1365-2958.1999.01288.x; Platt R, 2000, PLASMID, V43, P12, DOI 10.1006/plas.1999.1433; Sambrook J., 2001, MOL CLONING LAB MANU, V3; Waters VL, 2001, NAT GENET, V29, P375, DOI 10.1038/ng779	30	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e31047	10.1371/journal.pone.0031047	http://dx.doi.org/10.1371/journal.pone.0031047			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22292089	Green Published, gold			2022-12-25	WOS:000301570600106
J	Hoeth, M; Niederleithner, H; Hofer-Warbinek, R; Bilban, M; Mayer, H; Resch, U; Lemberger, C; Wagner, O; Hofer, E; Petzelbauer, P; de Martin, R				Hoeth, Martina; Niederleithner, Heide; Hofer-Warbinek, Renate; Bilban, Martin; Mayer, Herbert; Resch, Ulrike; Lemberger, Christof; Wagner, Oswald; Hofer, Erhard; Petzelbauer, Peter; de Martin, Rainer			The Transcription Factor SOX18 Regulates the Expression of Matrix Metalloproteinase 7 and Guidance Molecules in Human Endothelial Cells	PLOS ONE			English	Article							HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA; NF-KAPPA-B; REDUNDANT ROLES; GENE-EXPRESSION; GROWTH-FACTOR; MICE; ANGIOGENESIS; MATRILYSIN; MUTATIONS; IDENTIFICATION	Background: Mutations in the transcription factor SOX18 are responsible for specific cardiovascular defects in humans and mice. In order to gain insight into the molecular basis of its action, we identified target genes of SOX18 and analyzed one, MMP7, in detail. Methodology/Principal Findings: SOX18 was expressed in HUVEC using a recombinant adenoviral vector and the altered gene expression profile was analyzed using microarrays. Expression of several regulated candidate SOX18 target genes was verified by real-time PCR. Knock-down of SOX18 using RNA interference was then used to confirm the effect of the transcription factor on selected genes that included the guidance molecules ephrin B2 and semaphorin 3G. One gene, MMP7, was chosen for further analysis, including detailed promoter studies using reporter gene assays, electrophoretic mobility shift analysis and chromatin-immunoprecipitation, revealing that it responds directly to SOX18. Immunohistochemical analysis demonstrated the co-expression of SOX18 and MMP7 in blood vessels of human skin. Conclusions/Significance: The identification of MMP7 as a direct SOX18 target gene as well as other potential candidates including guidance molecules provides a molecular basis for the proposed function of this transcription factor in the regulation of vessel formation.	[Hoeth, Martina; Hofer-Warbinek, Renate; Mayer, Herbert; Resch, Ulrike; Lemberger, Christof; Hofer, Erhard; de Martin, Rainer] Med Univ Vienna, Dept Vasc Biol & Thrombosis Res, Vienna, Austria; [Niederleithner, Heide; Petzelbauer, Peter] Med Univ Vienna, Dept Dermatol, Vienna, Austria; [Bilban, Martin; Wagner, Oswald] Med Univ Vienna, Clin Inst Med & Chem Lab Diagnost, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna	Hoeth, M (corresponding author), Baxter Innovat GmbH, Vienna, Austria.	rainer.demartin@meduniwien.ac.at	petzelbauer, peter/GLU-3941-2022	Petzelbauer, Peter/0000-0001-7080-5259; Resch, Ulrike/0000-0002-8380-9555; Bilban, Martin/0000-0001-7043-7142	Austrian Science Foundation (FWF) within Austrian Angiogenesis Network [NFN S9405, P20940-B11]	Austrian Science Foundation (FWF) within Austrian Angiogenesis Network	This work was supported by grants from the Austrian Science Foundation (FWF; www.fwf.ac.at) within the Austrian Angiogenesis Network (NFN S9405) to RdM, and P20940-B11 (to PP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts S, 2005, NUCLEIC ACIDS RES, V33, pW393, DOI 10.1093/nar/gki354; Cermenati S, 2008, BLOOD, V111, P2657, DOI 10.1182/blood-2007-07-100412; Darby IA, 2001, LAB INVEST, V81, P937, DOI 10.1038/labinvest.3780304; DEMARTIN R, 1993, GENE, V124, P137, DOI 10.1016/0378-1119(93)90776-Y; Ding K, 2005, J CELL BIOL, V171, P729, DOI 10.1083/jcb.200508010; Downes M, 2009, HUM MOL GENET, V18, P2839, DOI 10.1093/hmg/ddp219; Fontijn RD, 2008, AM J PHYSIOL-HEART C, V294, pH891, DOI 10.1152/ajpheart.01248.2007; Francois M, 2008, NATURE, V456, P643, DOI 10.1038/nature07391; Fuller T, 2003, J CELL SCI, V116, P2461, DOI 10.1242/jcs.00426; Garcia-Ramirez M, 2005, ARTERIOSCL THROM VAS, V25, P2398, DOI 10.1161/01.ATV.0000187464.81959.23; Hashimoto G, 2002, J BIOL CHEM, V277, P36288, DOI 10.1074/jbc.M201674200; Herpers R, 2008, CIRC RES, V102, P12, DOI 10.1161/CIRCRESAHA.107.166066; Holnthoner W, 2006, BIOCHEM BIOPH RES CO, V342, P725, DOI 10.1016/j.bbrc.2006.02.011; Hosking BM, 2004, J BIOL CHEM, V279, P5314, DOI 10.1074/jbc.M308512200; Hosking BM, 2001, BIOCHEM BIOPH RES CO, V287, P493, DOI 10.1006/bbrc.2001.5589; Hosking B, 2009, DEVELOPMENT, V136, P2385, DOI 10.1242/dev.034827; Ii M, 2006, EXP BIOL MED, V231, P20; Im HJ, 2001, MOL PHARMACOL, V59, P1486, DOI 10.1124/mol.59.6.1486; Imai K, 1997, BIOCHEM J, V322, P809, DOI 10.1042/bj3220809; Irrthum A, 2003, AM J HUM GENET, V72, P1470, DOI 10.1086/375614; James K, 2003, GENESIS, V36, P1, DOI 10.1002/gene.10190; Kure T, 2003, INVEST OPHTH VIS SCI, V44, P137, DOI 10.1167/iovs.01-1058; Lioubinski O, 2003, DEV DYNAM, V227, P402, DOI 10.1002/dvdy.10311; Luo M, 2008, MED HYPOTHESES, V70, P880, DOI 10.1016/j.mehy.2007.07.024; Matsui T, 2006, J CELL SCI, V119, P3513, DOI 10.1242/jcs.03081; Mayer H, 2004, ARTERIOSCL THROM VAS, V24, P1192, DOI 10.1161/01.ATV.0000131263.06296.77; MCGRORY WJ, 1988, VIROLOGY, V163, P614, DOI 10.1016/0042-6822(88)90302-9; Neufeld G, 2007, ADV EXP MED BIOL, V600, P118; Nitta T, 2003, J CELL BIOL, V161, P653, DOI 10.1083/jcb.200302070; Nowak DE, 2005, BIOTECHNIQUES, V39, P715, DOI 10.2144/000112014; Olsson JE, 2001, GENE, V271, P151, DOI 10.1016/S0378-1119(01)00505-4; Patterson BC, 1997, J BIOL CHEM, V272, P28823, DOI 10.1074/jbc.272.46.28823; Pennisi D, 2000, NAT GENET, V24, P434, DOI 10.1038/74301; Pennisi D, 2000, MOL CELL BIOL, V20, P9331, DOI 10.1128/MCB.20.24.9331-9336.2000; Saitoh T, 2002, INT J MOL MED, V10, P339; Sakamoto Y, 2007, BIOCHEM BIOPH RES CO, V360, P539, DOI 10.1016/j.bbrc.2007.06.093; Samant GV, 2011, J BIOL CHEM, V286, P30740, DOI 10.1074/jbc.M111.220665; Sandholzer J, 2007, BIOCHEM BIOPH RES CO, V360, P370, DOI 10.1016/j.bbrc.2007.06.095; Srinivasan RS, 2010, GENE DEV, V24, P696, DOI 10.1101/gad.1859310; Stanojcic S, 2000, BBA-GENE STRUCT EXPR, V1492, P237, DOI 10.1016/S0167-4781(00)00078-6; Taniguchi M, 2005, GENES CELLS, V10, P785, DOI 10.1111/j.1365-2443.2005.00877.x; Wrighton CJ, 1996, J EXP MED, V183, P1013, DOI 10.1084/jem.183.3.1013; Young N, 2006, J NATL CANCER I, V98, P1060, DOI 10.1093/jnci/djj299; Zhang C, 2005, DEV DYNAM, V234, P878, DOI 10.1002/dvdy.20565	44	27	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30982	10.1371/journal.pone.0030982	http://dx.doi.org/10.1371/journal.pone.0030982			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22292085	gold, Green Published, Green Submitted			2022-12-25	WOS:000301570600103
J	Narayanan, A; Paul, LN; Tomar, S; Patil, DN; Kumar, P; Yernool, DA				Narayanan, Anoop; Paul, Lake N.; Tomar, Sakshi; Patil, Dipak N.; Kumar, Pravindra; Yernool, Dinesh A.			Structure-Function Studies of DNA Binding Domain of Response Regulator KdpE Reveals Equal Affinity Interactions at DNA Half-Sites	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERACTIONS; SENSOR KINASE KDPD; 2-COMPONENT SIGNAL-TRANSDUCTION; SEDIMENTATION-VELOCITY ANALYSIS; COEFFICIENT DISTRIBUTIONS C(S); ESCHERICHIA-COLI; POSITIVE REGULATOR; TRANSCRIPTION FACTOR; OPERON EXPRESSION; RECEIVER DOMAIN	Expression of KdpFABC, a K+ pump that restores osmotic balance, is controlled by binding of the response regulator KdpE to a specific DNA sequence (kdpFABC(BS)) via the winged helix-turn-helix type DNA binding domain (KdpE(DBD)). Exploration of E. coli KdpE(DBD) and kdpFABC(BS) interaction resulted in the identification of two conserved, AT-rich 6 bp direct repeats that form half-sites. Despite binding to these half-sites, KdpE(DBD) was incapable of promoting gene expression in vivo. Structure-function studies guided by our 2.5 angstrom X-ray structure of KdpE(DBD) revealed the importance of residues R193 and R200 in the alpha-8 DNA recognition helix and T215 in the wing region for DNA binding. Mutation of these residues renders KdpE incapable of inducing expression of the kdpFABC operon. Detailed biophysical analysis of interactions using analytical ultracentrifugation revealed a 2: 1 stoichiometry of protein to DNA with dissociation constants of 200 +/- 100 and 350 +/- 100 nM at half-sites. Inactivation of one half-site does not influence binding at the other, indicating that KdpE(DBD) binds independently to the half-sites with approximately equal affinity and no discernable cooperativity. To our knowledge, these data are the first to describe in quantitative terms the binding at half-sites under equilibrium conditions for a member of the ubiquitous OmpR/PhoB family of proteins.	[Narayanan, Anoop; Yernool, Dinesh A.] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [Paul, Lake N.] Purdue Univ, Bindley Biosci Ctr, W Lafayette, IN 47907 USA; [Tomar, Sakshi; Patil, Dipak N.; Kumar, Pravindra] Indian Inst Technol, Dept Biotechnol, Roorkee, Uttar Pradesh, India	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Roorkee	Narayanan, A (corresponding author), Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA.	dyernool@purdue.edu	Patil, Dipak N./X-9567-2019; KUMAR, PRAVINDRA/AAF-2859-2020; Tomar, Sakshi/AAL-6766-2020; Tomar, Sakshi/H-3283-2018	Patil, Dipak N./0000-0003-1112-5557; KUMAR, PRAVINDRA/0000-0003-2128-7736; Tomar, Sakshi/0000-0001-5994-4178; Tomar, Sakshi/0000-0001-5994-4178	Purdue University; CSIR; DST	Purdue University; CSIR(Council of Scientific & Industrial Research (CSIR) - India); DST(Department of Science & Technology (India))	This work was supported by a start-up grant from Purdue University to DAY. ST and DNP were supported by a CSIR fellowship and PK thanks DST for a BOYSCAST fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTENDORF K, 1992, ANN NY ACAD SCI, V671, P228, DOI 10.1111/j.1749-6632.1992.tb43799.x; ASHA H, 1993, J BACTERIOL, V175, P4528, DOI 10.1128/JB.175.14.4528-4537.1993; Baikalov I, 1996, BIOCHEMISTRY-US, V35, P11053, DOI 10.1021/bi960919o; Blanco AG, 2002, STRUCTURE, V10, P701, DOI 10.1016/S0969-2126(02)00761-X; Bourret RB, 2010, CURR OPIN MICROBIOL, V13, P142, DOI 10.1016/j.mib.2010.01.015; Brown PH, 2006, BIOPHYS J, V90, P4651, DOI 10.1529/biophysj.106.081372; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; CSONKA LN, 1989, MICROBIOL REV, V53, P121, DOI 10.1128/MMBR.53.1.121-147.1989; Dam J, 2005, BIOPHYS J, V89, P619, DOI 10.1529/biophysj.105.059568; Dam J, 2005, BIOPHYS J, V89, P651, DOI 10.1529/biophysj.105.059584; Das AK, 2010, J MOL BIOL, V398, P647, DOI 10.1016/j.jmb.2010.03.056; Ellison DW, 2000, J BACTERIOL, V182, P6592, DOI 10.1128/JB.182.23.6592-6597.2000; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Epstein W, 2003, PROG NUCLEIC ACID RE, V75, P293, DOI 10.1016/S0079-6603(03)75008-9; FIEDLER U, 1995, EMBO J, V14, P3696, DOI 10.1002/j.1460-2075.1995.tb00039.x; Friedland N, 2007, BIOCHEMISTRY-US, V46, P6733, DOI 10.1021/bi602546q; Galperin MY, 2006, J BACTERIOL, V188, P4169, DOI 10.1128/JB.01887-05; Galperin MY, 2010, CURR OPIN MICROBIOL, V13, P150, DOI 10.1016/j.mib.2010.01.005; Gao R, 2010, CURR OPIN MICROBIOL, V13, P160, DOI 10.1016/j.mib.2009.12.009; Garvie CW, 2001, MOL CELL, V8, P937, DOI 10.1016/S1097-2765(01)00392-6; Ghirlando R, 2011, METHODS, V54, P145, DOI 10.1016/j.ymeth.2010.12.005; Heermann R, 2003, J BIOL CHEM, V278, P51277, DOI 10.1074/jbc.M303801200; Heermann R, 2010, FEMS MICROBIOL LETT, V304, P97, DOI 10.1111/j.1574-6968.2010.01906.x; Hellman LM, 2007, NAT PROTOC, V2, P1849, DOI 10.1038/nprot.2007.249; Hizver J, 2001, P NATL ACAD SCI USA, V98, P8490, DOI 10.1073/pnas.151247298; Hoch JA, 2000, CURR OPIN MICROBIOL, V3, P165, DOI 10.1016/S1369-5274(00)00070-9; Janin J, 2007, ACTA CRYSTALLOGR D, V63, P1, DOI 10.1107/S090744490603575X; Kar SR, 2001, BIOCHEMISTRY-US, V40, P13378, DOI 10.1021/bi011289f; Karsten R., 1997, BIF FUTURA, V12, P20; KATO M, 1989, FEBS LETT, V249, P168, DOI 10.1016/0014-5793(89)80617-9; Lacal J, 2008, J MOL BIOL, V384, P1037, DOI 10.1016/j.jmb.2008.10.011; LAIMINS LA, 1981, P NATL ACAD SCI-BIOL, V78, P464, DOI 10.1073/pnas.78.1.464; Luscombe NM, 2001, NUCLEIC ACIDS RES, V29, P2860, DOI 10.1093/nar/29.13.2860; Mack TR, 2009, J MOL BIOL, V389, P349, DOI 10.1016/j.jmb.2009.04.014; Makino K, 1996, J MOL BIOL, V259, P15, DOI 10.1006/jmbi.1996.0298; MartinezHackert E, 1997, STRUCTURE, V5, P109, DOI 10.1016/S0969-2126(97)00170-6; Mascher T, 2006, MICROBIOL MOL BIOL R, V70, P910, DOI 10.1128/MMBR.00020-06; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAKASHIMA K, 1993, MOL MICROBIOL, V7, P109, DOI 10.1111/j.1365-2958.1993.tb01102.x; Naue N, 2011, NUCLEIC ACIDS RES, V39, P1398, DOI 10.1093/nar/gkq988; NIXON BT, 1986, P NATL ACAD SCI USA, V83, P7850, DOI 10.1073/pnas.83.20.7850; OHWADA T, 1987, ARCH BIOCHEM BIOPHYS, V259, P157, DOI 10.1016/0003-9861(87)90481-4; Pelton JG, 1999, J MOL BIOL, V292, P1095, DOI 10.1006/jmbi.1999.3140; Rhee JE, 2008, J BIOL CHEM, V283, P8664, DOI 10.1074/jbc.M705550200; Rohs R, 2010, ANNU REV BIOCHEM, V79, P233, DOI 10.1146/annurev-biochem-060408-091030; Rohs R, 2009, NATURE, V461, P1248, DOI 10.1038/nature08473; ROSSMANN MG, 1990, ACTA CRYSTALLOGR A, V46, P73, DOI 10.1107/S0108767389009815; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Stallkamp I, 1999, ARCH MICROBIOL, V172, P295, DOI 10.1007/s002030050783; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Straume D, 2009, BMC BIOCHEM, V10, DOI 10.1186/1471-2091-10-17; SUGIURA A, 1992, MOL MICROBIOL, V6, P1769, DOI 10.1111/j.1365-2958.1992.tb01349.x; TATE S, 1988, FEBS LETT, V242, P27, DOI 10.1016/0014-5793(88)80978-5; Toro-Roman A, 2005, PROTEIN SCI, V14, P3077, DOI 10.1110/ps.051722805; TSUZUKI M, 1994, J MOL BIOL, V242, P607, DOI 10.1006/jmbi.1994.1610; Vistica J, 2004, ANAL BIOCHEM, V326, P234, DOI 10.1016/j.ab.2003.12.014; WALDERHAUG MO, 1992, J BACTERIOL, V174, P2152, DOI 10.1128/JB.174.7.2152-2159.1992; Wood JM, 2001, COMP BIOCHEM PHYS A, V130, P437, DOI 10.1016/S1095-6433(01)00442-1; WOODWARD RS, 1980, J BIOCHEM BIOPH METH, V2, P307, DOI 10.1016/0165-022X(80)90055-X; Yoshida T, 2006, J BIOL CHEM, V281, P17114, DOI 10.1074/jbc.M602112200; ZIMMANN P, 1995, J BIOL CHEM, V270, P28282	61	15	15	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30102	10.1371/journal.pone.0030102	http://dx.doi.org/10.1371/journal.pone.0030102			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22291906	Green Submitted, Green Published, gold			2022-12-25	WOS:000301570600016
J	Ponnuswamy, P; Schrottle, A; Ostermeier, E; Gruner, S; Huang, PL; Ertl, G; Hoffmann, U; Nieswandt, B; Kuhlencordt, PJ				Ponnuswamy, Padmapriya; Schroettle, Angelika; Ostermeier, Eva; Gruener, Sabine; Huang, Paul L.; Ertl, Georg; Hoffmann, Ulrich; Nieswandt, Bernhard; Kuhlencordt, Peter J.			eNOS Protects from Atherosclerosis Despite Relevant Superoxide Production by the Enzyme in apoE(-/-) Mice	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; ENDOTHELIAL CELL-INTERACTIONS; DOUBLE-KNOCKOUT MICE; APOLIPOPROTEIN-E; DEFICIENT MICE; IN-VIVO; ACCELERATED ATHEROSCLEROSIS; LEUKOCYTE ADHESION; PLATELET-ADHESION; LESION FORMATION	Background: All three nitric oxide synthase (NOS) isoforms are expressed in atherosclerotic plaques. NOS enzymes in general catalyse NO production. However, under conditions of substrate and cofactor deficiency, the enzyme directly catalyse superoxide formation. Considering this alternative chemistry, the effects of NOS on key events in spontaneous hyperlipidemia driven atherosclerosis have not been investigated yet. Here, we evaluate how endothelial nitric oxide synthase (eNOS) modulates leukocyte/endothelial-(L/E) and platelet/endothelial-(P/E) interactions in atherosclerosis and the production of nitric oxide (NO) and superoxide by the enzyme. Principal Findings: Intravital microscopy (IVM) of carotid arteries revealed significantly increased L/E-interactions in apolipoproteinE/eNOS double knockout mice (apoE(-/-)/eNOS(-/-)), while P/E-interactions did not differ, compared to apoE(-/-). eNOS deficiency increased macrophage infiltration in carotid arteries and vascular cell adhesion molecule-1 (VCAM-1) expression, both in endothelial and smooth muscle cells. Despite the expression of other NOS isoforms (inducible NOS, iNOS and neuronal NOS, nNOS) in plaques, Electron Spin Resonance (ESR) measurements of NO showed significant contribution of eNOS to total circulating and vascular wall NO production. Pharmacological inhibition and genetic deletion of eNOS reduced vascular superoxide production, indicating uncoupling of the enzyme in apoE(-/-) vessels. Conclusion: Overt plaque formation, increased vascular inflammation and L/E-interactions are associated with significant reduction of superoxide production in apoE(-/-)/eNOS(-/-) vessels. Therefore, lack of eNOS does not cause an automatic increase in oxidative stress. Uncoupling of eNOS occurs in apoE(-/-) atherosclerosis but does not negate the enzyme's strong protective effects.	[Ponnuswamy, Padmapriya; Schroettle, Angelika; Ostermeier, Eva; Ertl, Georg; Kuhlencordt, Peter J.] Univ Wurzburg, Med Klin 1, Herz Kreislaufzentrum, Wurzburg, Germany; [Gruener, Sabine; Nieswandt, Bernhard] Univ Wurzburg, Rudolf Virchow Zentrum Expt Biomed, DFG Res Ctr Expt Biomed, Wurzburg, Germany; [Huang, Paul L.] Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA; [Huang, Paul L.] Harvard Univ, Sch Med, Boston, MA USA; [Schroettle, Angelika; Hoffmann, Ulrich; Kuhlencordt, Peter J.] Univ Munich, Med Poliklin, Div Vasc Med, D-8000 Munich, Germany	University of Wurzburg; German Research Foundation (DFG); University of Wurzburg; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Munich	Ponnuswamy, P (corresponding author), INSERM, Paris Cardiovasc Res Ctr, U970, Paris, France.	peter.kuhlencordt@med.uni-muenchen.de	Hoffmann, Ulrich/AAF-9798-2020	Huang, Paul/0000-0002-5436-8658	Deutsche-Forschungsgemeinschaft [KU-1206(1), KU1206(2)]; Interdisziplinares Zentrum fur Klinische Forschung, Wurzburg [E-30F]	Deutsche-Forschungsgemeinschaft(German Research Foundation (DFG)); Interdisziplinares Zentrum fur Klinische Forschung, Wurzburg	This work was supported by grants from the Deutsche-Forschungsgemeinschaft [KU-1206(1) and KU1206(2)] and the Interdisziplinares Zentrum fur Klinische Forschung, Wurzburg [E-30F] to PJK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht EWJA, 2003, J PATHOL, V199, P8, DOI 10.1002/path.1250; BEVILACQUA MP, 1987, P NATL ACAD SCI USA, V84, P9238, DOI 10.1073/pnas.84.24.9238; Cerwinka WH, 2002, AM J PHYSIOL-HEART C, V282, pH1111, DOI 10.1152/ajpheart.00391.2001; Chen JQ, 2001, CIRCULATION, V104, P2391, DOI 10.1161/hc4501.099729; Davignon J, 2004, CIRCULATION, V109, P27, DOI 10.1161/01.CIR.0000131515.03336.f8; DECATERINA R, 1995, J CLIN INVEST, V96, P60, DOI 10.1172/JCI118074; Detmers PA, 2000, J IMMUNOL, V165, P3430, DOI 10.4049/jimmunol.165.6.3430; Dikalov S, 2005, METHOD ENZYMOL, V396, P597, DOI 10.1016/S0076-6879(05)96052-7; Dikalova A, 2005, CIRCULATION, V112, P2668, DOI 10.1161/CIRCULATIONAHA.105.538934; Fink B, 2004, AM J PHYSIOL-CELL PH, V287, pC895, DOI 10.1152/ajpcell.00028.2004; GAUTHIER TW, 1994, AM J PHYSIOL-GASTR L, V267, pG562, DOI 10.1152/ajpgi.1994.267.4.G562; Gawaz M, 2005, J CLIN INVEST, V115, P3378, DOI 10.1172/JCI27196; Hall DM, 1996, METHOD ENZYMOL, V268, P188; HUIE RE, 1993, FREE RADICAL RES COM, V18, P195, DOI 10.3109/10715769309145868; Huo YQ, 2003, NAT MED, V9, P61, DOI 10.1038/nm810; Kleschyov AL, 2000, BIOCHEM BIOPH RES CO, V275, P672, DOI 10.1006/bbrc.2000.3361; Knowles JW, 2000, J CLIN INVEST, V105, P451, DOI 10.1172/JCI8376; KUBES P, 1991, P NATL ACAD SCI USA, V88, P4651, DOI 10.1073/pnas.88.11.4651; Kuhlencordt PJ, 2006, ARTERIOSCL THROM VAS, V26, P1539, DOI 10.1161/01.ATV.0000223143.88128.19; Kuhlencordt PJ, 2004, AM J PHYSIOL-CELL PH, V286, pC1195, DOI 10.1152/ajpcell.00546.2002; Kuhlencordt PJ, 2001, CIRCULATION, V103, P3099, DOI 10.1161/01.CIR.103.25.3099; Kuhlencordt PJ, 2001, CIRCULATION, V104, P448, DOI 10.1161/hc2901.091399; Landmesser U, 2003, J CLIN INVEST, V111, P1201, DOI 10.1172/JCI200314172; Lefer DJ, 1999, AM J PHYSIOL-HEART C, V276, pH1943, DOI 10.1152/ajpheart.1999.276.6.H1943; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Massberg S, 2002, J EXP MED, V196, P887, DOI 10.1084/jem.20012044; Massberg S, 2005, CIRCULATION, V112, P1180, DOI 10.1161/CIRCULATIONAHA.105.539221; Massberg S, 1998, RES EXP MED, V198, P23, DOI 10.1007/s004330050086; Michelson AD, 1996, AM J PHYSIOL-HEART C, V270, pH1640, DOI 10.1152/ajpheart.1996.270.5.H1640; OHARA Y, 1993, J CLIN INVEST, V91, P2546, DOI 10.1172/JCI116491; Ozaki M, 2002, J CLIN INVEST, V110, P331, DOI 10.1172/JCI200215215; Ponnuswamy P, 2009, AM J PATHOL, V174, P2400, DOI 10.2353/ajpath.2009.080730; POU S, 1992, J BIOL CHEM, V267, P24173; Rabelink TJ, 2006, ARTERIOSCL THROM VAS, V26, P267, DOI 10.1161/01.ATV.0000196554.85799.77; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Sanz MJ, 2001, BRIT J PHARMACOL, V134, P305, DOI 10.1038/sj.bjp.0704234; Schafer A, 2008, BRIT J PHARMACOL, V153, P886, DOI 10.1038/sj.bjp.0707459; Sorescu D, 2002, CIRCULATION, V105, P1429, DOI 10.1161/01.CIR.0000012917.74432.66; STAMLER J, 1989, CIRC RES, V65, P789, DOI 10.1161/01.RES.65.3.789; Theilmeier G, 2002, BLOOD, V99, P4486, DOI 10.1182/blood.V99.12.4486; Vasquez-Vivar J, 1998, P NATL ACAD SCI USA, V95, P9220, DOI 10.1073/pnas.95.16.9220; WHITE CR, 1994, P NATL ACAD SCI USA, V91, P1044, DOI 10.1073/pnas.91.3.1044; Wilcox JN, 1997, ARTERIOSCL THROM VAS, V17, P2479, DOI 10.1161/01.ATV.17.11.2479; Xia Y, 1998, J BIOL CHEM, V273, P25804, DOI 10.1074/jbc.273.40.25804; Xia Y, 1998, J BIOL CHEM, V273, P22635, DOI 10.1074/jbc.273.35.22635	45	68	74	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30193	10.1371/journal.pone.0030193	http://dx.doi.org/10.1371/journal.pone.0030193			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22291917	Green Published, Green Submitted, gold			2022-12-25	WOS:000301570600023
J	Sunarto, S; Kelly, MJ; Parakkasi, K; Klenzendorf, S; Septayuda, E; Kurniawan, H				Sunarto, Sunarto; Kelly, Marcella J.; Parakkasi, Karmila; Klenzendorf, Sybille; Septayuda, Eka; Kurniawan, Harry			Tigers Need Cover: Multi-Scale Occupancy Study of the Big Cat in Sumatran Forest and Plantation Landscapes	PLOS ONE			English	Article							ESTIMATING SITE OCCUPANCY; PANTHERA-TIGRIS; CONSERVATION; POPULATION	The critically endangered Sumatran tiger (Panthera tigris sumatrae Pocock, 1929) is generally known as a forest-dependent animal. With large-scale conversion of forests into plantations, however, it is crucial for restoration efforts to understand to what extent tigers use modified habitats. We investigated tiger-habitat relationships at 2 spatial scales: occupancy across the landscape and habitat use within the home range. Across major landcover types in central Sumatra, we conducted systematic detection, non-detection sign surveys in 47, 17x17 km grid cells. Within each cell, we surveyed 40, 1-km transects and recorded tiger detections and habitat variables in 100 m segments totaling 1,857 km surveyed. We found that tigers strongly preferred forest and used plantations of acacia and oilpalm, far less than their availability. Tiger probability of occupancy covaried positively and strongly with altitude, positively with forest area, and negatively with distance-to-forest centroids. At the fine scale, probability of habitat use by tigers across landcover types covaried positively and strongly with understory cover and altitude, and negatively and strongly with human settlement. Within forest areas, tigers strongly preferred sites that are farther from water bodies, higher in altitude, farther from edge, and closer to centroid of large forest block; and strongly preferred sites with thicker understory cover, lower level of disturbance, higher altitude, and steeper slope. These results indicate that to thrive, tigers depend on the existence of large contiguous forest blocks, and that with adjustments in plantation management, tigers could use mosaics of plantations (as additional roaming zones), riparian forests (as corridors) and smaller forest patches (as stepping stones), potentially maintaining a metapopulation structure in fragmented landscapes. This study highlights the importance of a multi-spatial scale analysis and provides crucial information relevant to restoring tigers and other wildlife in forest and plantation landscapes through improvement in habitat extent, quality, and connectivity.	[Sunarto, Sunarto; Kelly, Marcella J.] Virginia Tech, Dept Fish & Wildlife Conservat, Blacksburg, VA 24061 USA; [Sunarto, Sunarto; Parakkasi, Karmila; Septayuda, Eka; Kurniawan, Harry] Worldwide Fund Nat Indonesia, Species Program, Jakarta, Daerah Khusus I, Indonesia; [Klenzendorf, Sybille] World Wildlife Fund, Species Program, Washington, DC 20037 USA	Virginia Polytechnic Institute & State University; World Wildlife Fund	Sunarto, S (corresponding author), Virginia Tech, Dept Fish & Wildlife Conservat, Blacksburg, VA 24061 USA.	s.sunarto@yahoo.com	Kelly, Marcella/B-4891-2011	Kelly, Marcella/0000-0001-9044-3873	Hurvis Family; Critical Ecosystem Partnership Fund; National Fish and Wildlife Foundation; Save the Tiger Fund; USFWS through WWF; Indonesian Ministry of Forestry and plantation	Hurvis Family; Critical Ecosystem Partnership Fund; National Fish and Wildlife Foundation; Save the Tiger Fund; USFWS through WWF; Indonesian Ministry of Forestry and plantation	The Hurvis Family, Critical Ecosystem Partnership Fund, National Fish and Wildlife Foundation, Save the Tiger Fund, and USFWS Rhino Tiger Conservation Fund provided financial support through WWF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Indonesian Ministry of Forestry and plantation owners/managers for supporting this study. Zulfahmi, Koesdianto, A. Suprianto, F. Panjaitan, E. Tugio, L. Subali, H. Gebog, Nursamsu are some members of the field team who worked vigorously to collect data. Jim Nichols provided guidance in study design and gave many useful inputs in the analysis and during manuscript development. Rob Steinmetz, Matt Linkie, Haryo T. Wibisono provided input in study design. Jim Hines provided tremendous help in understanding, properly developing and running statistical models in the program PRESENCE. Dean Stauffer, Mike Vaughan and Steve Prisley provided input into the study design and earlier document drafts. The fieldwork for this study was fully supported by WWF Indonesia and Networks. Thanks to Riza Sukriana and team for their absolute support for this work. Thanks to A. Budiman, E. Purastuti, K. Yulianto, A. Juli, and Sunandar for the GIS support, to Abeng and team for their support and collaboration; to N. Anam, D. Rufendi, Suhandri, Tarmison, Fina, D. Rahadian, Syamsidar, Samsuardi, S. Maryati, Nursamsu, and Afdhal for their support; to Flying Squad teams, the families of Hermanto and Doni for their great hospitality in hosting the field teams; M. Lewis, B. Pandav, N. Griesshammer, C. William, M. Stuewe, Y. Uryu, B. Long, J. Vertefeuille, E. Dinerstein, and J. Seidensticker for support and advice. R. Sugiyanti, C. Tredick and two anonymous reviewers provided useful comments which improved this paper.	Anderson A., 2006, APPL NATURES DESIGN; Boomgaard P, 2001, FRONTIERS FEAR TIGER, pxii+306; BORNER M, 1978, CARNIVORE, V1, P97; Boyce MS, 1999, TRENDS ECOL EVOL, V14, P268, DOI 10.1016/S0169-5347(99)01593-1; Buckland S.T., 2001, pi; Burnham K.P., 2003, MODEL SELECTION MULT; DIAMOND JM, 2005, COLLAPSE SOC CHOOSE; DUPONT WD, 2002, STAT MODELING BIOMED; Franklin N, 1999, RIDING TIGER TIGER C, pxx; Gaston KJ, 1996, J ANIM ECOL, V65, P701, DOI 10.2307/5669; Gaveau DLA, 2009, J BIOGEOGR, V36, P2165, DOI 10.1111/j.1365-2699.2009.02147.x; Green R., 1979, SAMPLING DESIGN STAT; GRIFFITHS M, 1993, CONSERV BIOL, V7, P623, DOI 10.1046/j.1523-1739.1993.07030623.x; Griffiths M., 1994, SUMATRAN TIGER REPOR, P93; Guthery FS, 2007, J WILDLIFE MANAGE, V71, P684, DOI 10.2193/2006-285; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hines, 2006, PROGRAM PRESENCE VER; Hines, 2017, OCCUPANCY ESTIMATION; Hines JE, 2010, ECOL APPL, V20, P1456, DOI 10.1890/09-0321.1; Holmes D, 2002, TERRESTRIAL ECOREGIO, pxxix+643; Jarvis A, PRACTICAL USE SRTM D; JOHNSON DH, 1980, ECOLOGY, V61, P65, DOI 10.2307/1937156; Karanth K. Ullas, 2002, P39; Karanth KK, 2009, J APPL ECOL, V46, P1189, DOI 10.1111/j.1365-2664.2009.01710.x; Linkie M., 2008, IUCN RED LIST THREAT, V8235; Linkie M, 2008, BIOL CONSERV, V141, P2410, DOI 10.1016/j.biocon.2008.07.002; Linkie M, 2006, J APPL ECOL, V43, P576, DOI 10.1111/j.1365-2664.2006.01153.x; MacKay P, 2008, NONINVASIVE SURVEY M, pviii+385; MacKenzie Darryl I., 2004, P149; MacKenzie DI, 2005, J WILDLIFE MANAGE, V69, P849, DOI 10.2193/0022-541X(2005)069[0849:WATIWP]2.0.CO;2; MacKenzie DI, 2003, ECOLOGY, V84, P2200, DOI 10.1890/02-3090; MacKenzie DI, 2002, ECOLOGY, V83, P2387, DOI 10.2307/3071800; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Maurer BA, 2002, PREDICTING SPECIES OCCURRENCES: ISSUES OF ACCURACY AND SCALE, P125; Miquelle Dale G., 1999, P71; Morrison ML., 2006, WILDLIFE HABITAT REL; Nichols James D., 2002, P29; Nyhus PJ, 2004, ORYX, V38, P68, DOI 10.1017/S0030605304000110; O'Brien TG, 2003, ANIM CONSERV, V6, P131, DOI 10.1017/S1367943003003172; Osborne PE, 2001, J APPL ECOL, V38, P458, DOI 10.1046/j.1365-2664.2001.00604.x; POLLOCK KH, 1990, WILDLIFE MONOGR, P1; Ray JC, 2008, NONINVASIVE SURVEY M, pviii+385; Sanderson E., 2006, SETTING PRIORITIES C; Scott J.M., 2002, PREDICTING SPECIES O; Setiabudi, 2006, ANAL 1990 1995 2000; Setiabudi Budiman A, 2005, ANAL 2000 2004 LAND; Sinclair ARE, 2006, WILDLIFE ECOLOGY CON; Sunarto, 2012, ORYX IN PRESS; Sunarto, 2011, THESIS VIRGINIA TECH, P286; Sunquist ME, 1981, SOCIAL ORG TIGERS; Sunquist Mel, 1999, P5; Thomas L, 2010, USERS GUIDE DISTANCE; URYU Y., 2007, DEFORESTATION FOREST; Uryu Y., 2010, SUMATRAS FORESTS THE; Whitten T, 2000, ECOLOGY INDONESIA SE, pxxxiii+478; Wibisono HT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025931; Wibisono HT, 2010, INTEGR ZOOL, V5, P313, DOI 10.1111/j.1749-4877.2010.00219.x; Wibisono HT, 2009, ORYX, V43, P634, DOI 10.1017/S003060530999055X; Wikramanayake ED, 1998, CONSERV BIOL, V12, P865, DOI 10.1046/j.1523-1739.1998.96428.x	59	84	87	1	153	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30859	10.1371/journal.pone.0030859	http://dx.doi.org/10.1371/journal.pone.0030859			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22292063	gold, Green Published, Green Submitted			2022-12-25	WOS:000301570600089
J	Falco, A; Festa, M; Basile, A; Rosati, A; Pascale, M; Florenzano, F; Nori, SL; Nicolin, V; Di Benedetto, M; Vecchione, ML; Arra, C; Barbieri, A; De Laurenzi, V; Turco, MC				Falco, A.; Festa, M.; Basile, A.; Rosati, A.; Pascale, M.; Florenzano, F.; Nori, S. L.; Nicolin, V.; Di Benedetto, M.; Vecchione, M. L.; Arra, C.; Barbieri, A.; De Laurenzi, V.; Turco, M. C.			BAG3 controls angiogenesis through regulation of ERK phosphorylation	ONCOGENE			English	Article						BAG3; angiogenesis; tumour	HEAT-SHOCK FACTOR-1; CANCER-CELLS; NEUROBLASTOMA-CELLS; SIGNALING PATHWAY; INDUCED APOPTOSIS; GENE-EXPRESSION; PROTEIN; LEUKEMIA; STRESS; COMPLEX	BAG3 is a co-chaperone of the heat shock protein (Hsp) 70, is expressed in many cell types upon cell stress, however, its expression is constitutive in many tumours. We and others have previously shown that in neoplastic cells BAG3 exerts an antiapoptotic function thus favoring tumour progression. As a consequence we have proposed BAG3 as a target of antineoplastic therapies. Here we identify a novel role for BAG3 in regulation of neo-angiogenesis and show that its downregulation results in reduced angiogenesis therefore expanding the role of BAG3 as a therapeutical target. In brief we show that BAG3 is expressed in endothelial cells and is essential for the interaction between ERK and its phosphatase DUSP6, as a consequence its removal results in reduced binding of DUSP6 to ERK and sustained ERK phosphorylation that in turn determines increased levels of p21 and p15 and cell-cycle arrest in the G1 phase. Oncogene (2012) 31, 5153-5161; doi:10.1038/onc.2012.17; published online 6 February 2012	[Falco, A.; Festa, M.; Basile, A.; Rosati, A.; Pascale, M.; Nori, S. L.; Turco, M. C.] Univ Salerno, Dept Pharmaceut & Biomed Sci FARMABIOMED, I-84084 Fisciano, SA, Italy; [Falco, A.; Festa, M.; Basile, A.; Rosati, A.; Pascale, M.; De Laurenzi, V.; Turco, M. C.] Univ Salerno, BIOUNIVERSA Srl, I-84084 Fisciano, SA, Italy; [Florenzano, F.] IRCSS Fdn Santa Lucia, Rome, Italy; [Florenzano, F.] European Brain Res Inst Rita Levi Montalcini, Rome, Italy; [Nicolin, V.] Univ Trieste, Clin Dept Biomed, I-34127 Trieste, Italy; [Di Benedetto, M.; Vecchione, M. L.] Univ Naples Federico II, Clin & Expt Med Dept, Naples, Italy; [Arra, C.; Barbieri, A.] Pascale Tumor Inst, Anim Facil, Naples, Italy; [De Laurenzi, V.] Univ G dAnnunzio, Fdn G DAnnunzio, Dept Biomed Sci, Chieti, Italy; [De Laurenzi, V.] Ctr Studi Invecchiamento CeSI, Chieti, Italy	University of Salerno; University of Salerno; IRCCS Santa Lucia; University of Trieste; University of Naples Federico II; G d'Annunzio University of Chieti-Pescara	Turco, MC (corresponding author), Univ Salerno, Dept Pharmaceut & Biomed Sci FARMABIOMED, I-84084 Fisciano, SA, Italy.	mcturco@unisa.it	Barbieri, Antonio/AAG-8961-2019; TURCO, Maria Caterina/AAC-5282-2022; De Laurenzi, Vincenzo/K-7471-2016	Barbieri, Antonio/0000-0002-7788-6167; TURCO, Maria Caterina/0000-0002-7835-359X; Arra, Claudio/0000-0003-3162-2091; Basile, Anna/0000-0002-4523-8202; Rosati, Alessandra/0000-0001-6675-0857; Nicolin, Vanessa/0000-0002-5665-6493; De Laurenzi, Vincenzo/0000-0002-7506-1743	AIRC; Ministero Sanita' grant	AIRC(Fondazione AIRC per la ricerca sul cancro); Ministero Sanita' grant	This work was supported by AIRC and Ministero Sanita' grants to VDL.	Ammirante M, 2010, P NATL ACAD SCI USA, V107, P7497, DOI 10.1073/pnas.0907696107; Basile A, 2011, J MED CHEM, V54, P1391, DOI 10.1021/jm101435r; Baud V, 2009, NAT REV DRUG DISCOV, V8, P33, DOI 10.1038/nrd2781; Bodart JFL, 2010, J CELL BIOCHEM, V109, P850, DOI 10.1002/jcb.22477; Bonelli P, 2004, LEUKEMIA, V18, P358, DOI 10.1038/sj.leu.2403219; Cagnol S, 2010, FEBS J, V277, P2, DOI 10.1111/j.1742-4658.2009.07366.x; Canepa ET, 2007, IUBMB LIFE, V59, P419, DOI 10.1080/15216540701488358; Cesaro E, 2010, LEUKEMIA, V24, P1204, DOI 10.1038/leu.2010.68; Chiappetta G, 2007, J CLIN ENDOCR METAB, V92, P1159, DOI 10.1210/jc.2006-1712; Dai C, 2007, CELL, V130, P1005, DOI 10.1016/j.cell.2007.07.020; Doong H, 2003, J BIOL CHEM, V278, P28490, DOI 10.1074/jbc.M209682200; Doong H, 2000, ONCOGENE, V19, P4385, DOI 10.1038/sj.onc.1203797; Ezhevsky SA, 1997, P NATL ACAD SCI USA, V94, P10699, DOI 10.1073/pnas.94.20.10699; Festa M, 2011, AM J PATHOL, V178, P2504, DOI 10.1016/j.ajpath.2011.02.002; Franceschelli S, 2008, J CELL PHYSIOL, V215, P575, DOI 10.1002/jcp.21397; Gentilella A, 2008, ONCOGENE, V27, P5011, DOI 10.1038/onc.2008.142; Gil J, 2006, NAT REV MOL CELL BIO, V7, P667, DOI 10.1038/nrm1987; Guedez L, 2003, AM J PATHOL, V162, P1431, DOI 10.1016/S0002-9440(10)64276-9; Homma S, 2006, AM J PATHOL, V169, P761, DOI 10.2353/ajpath.2006.060250; Jacobs AT, 2009, J BIOL CHEM, V284, P9176, DOI 10.1074/jbc.M808656200; Jung SE, 2010, BRAIN RES, V1349, P1, DOI 10.1016/j.brainres.2010.06.043; Jurek A, 2009, J BIOL CHEM, V284, P4626, DOI 10.1074/jbc.M808490200; Katz M, 2007, BBA-MOL CELL RES, V1773, P1161, DOI 10.1016/j.bbamcr.2007.01.002; Liao Q, 2001, FEBS LETT, V503, P151, DOI 10.1016/S0014-5793(01)02728-4; Liu P, 2009, FEBS LETT, V583, P401, DOI 10.1016/j.febslet.2008.12.032; Meloche S, 2007, ONCOGENE, V26, P3227, DOI 10.1038/sj.onc.1210414; Norrby K, 2006, J CELL MOL MED, V10, P588, DOI 10.1111/j.1582-4934.2006.tb00423.x; Owens DM, 2007, ONCOGENE, V26, P3203, DOI 10.1038/sj.onc.1210412; Patterson KI, 2009, BIOCHEM J, V418, P475, DOI 10.1042/BJ20082234; Ramos JW, 2008, INT J BIOCHEM CELL B, V40, P2707, DOI 10.1016/j.biocel.2008.04.009; Romano MF, 2003, CANCER BIOL THER, V2, P508, DOI 10.4161/cbt.2.5.524; Romano MF, 2003, CELL DEATH DIFFER, V10, P383, DOI 10.1038/sj.cdd.4401167; Rosati A, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.24; Rosati A, 2009, LEUKEMIA, V23, P823, DOI 10.1038/leu.2009.23; Rosati A, 2007, INT J BIOCHEM CELL B, V39, P1337, DOI 10.1016/j.biocel.2007.03.007; Song JW, 2001, NAT CELL BIOL, V3, P276, DOI 10.1038/35060068; Tabuchi Y, 2007, CANCER LETT, V246, P149, DOI 10.1016/j.canlet.2006.02.011; Takayama S, 1999, J BIOL CHEM, V274, P781, DOI 10.1074/jbc.274.2.781; Valdez BC, 2008, LEUKEMIA RES, V32, P1684, DOI 10.1016/j.leukres.2008.01.016; Wainwright LJ, 2001, P NATL ACAD SCI USA, V98, P9396, DOI 10.1073/pnas.161288698; Wang HQ, 2009, BRIT J PHARMACOL, V158, P1405, DOI 10.1111/j.1476-5381.2009.00455.x	41	34	35	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	DEC	2012	31	50					5153	5161		10.1038/onc.2012.17	http://dx.doi.org/10.1038/onc.2012.17			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	055WY	22310281				2022-12-25	WOS:000312449800004
J	Shamri, R; Melo, RCN; Young, KM; Bivas-Benita, M; Xenakis, JJ; Spencer, LA; Weller, PF				Shamri, Revital; Melo, Rossana C. N.; Young, Kristen M.; Bivas-Benita, Maytal; Xenakis, Jason J.; Spencer, Lisa A.; Weller, Peter F.			CCL11 elicits secretion of RNases from mouse eosinophils and their cell-free granules	FASEB JOURNAL			English	Article						piecemeal degranulation; airway inflammation; cationic proteins; granulocytes	RESPIRATORY SYNCYTIAL VIRUS; MAJOR BASIC-PROTEIN; CATIONIC PROTEIN; PULMONARY INFLAMMATION; AIRWAY INFLAMMATION; ATOPIC-DERMATITIS; DEGRANULATION; MICE; RELEASE; ACTIVATION	Rapid secretion of eosinophil-associated RNases (EARs), such as the human eosinophilic cationic protein (ECP), from intracellular granules is central to the role of eosinophils in allergic diseases and host immunity. Our knowledge regarding allergic inflammation has advanced based on mouse experimental models. However, unlike human eosinophils, capacities of mouse eosinophils to secrete granule proteins have been controversial. To study mechanisms of mouse eosinophil secretion and EAR release, we combined an RNase assay of mouse EARs with ultrastructural studies. In vitro, mouse eosinophils stimulated with the chemokine eotaxin-1 (CCL11) secreted enzymatically active EARs (EC50 5 nM) by piecemeal degranulation. In vivo, in a mouse model of allergic airway inflammation, increased airway eosinophil infiltration (24-fold) correlated with secretion of active RNases (3-fold). Moreover, we found that eosinophilic inflammation in mice can involve eosinophil cytolysis and release of cell-free granules. Cell-free mouse eosinophil granules expressed functional CCR3 receptors and secreted their granule proteins, including EAR and eosinophil peroxidase in response to CCL11. Collectively, these data demonstrate chemokine-dependent secretion of EARs from both intact mouse eosinophils and their cell-free granules, findings pertinent to understanding the pathogenesis of eosinophil-associated diseases, in which EARs are key factors.-Shamri, R., Melo, R. C. N., Young, K. M., B.-B, M., Xenakis, J. J., Spencer, L. A., Weller, P. F. CCL11 elicits secretion of RNases from mouse eosinophils and their cell-free granules. FASEB J. 26, 2084-2093 (2012). www.fasebj.org	[Shamri, Revital; Melo, Rossana C. N.; Young, Kristen M.; Xenakis, Jason J.; Spencer, Lisa A.; Weller, Peter F.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Allergy & Inflammat,Dept Med, Boston, MA 02215 USA; [Bivas-Benita, Maytal] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Viral Pathogenesis,Dept Med, Boston, MA 02215 USA; [Weller, Peter F.] Univ Fed Juiz de Fora, Dept Biol, Lab Cellular Biol, Juiz De Fora, MG, Brazil	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Universidade Federal de Juiz de Fora	Weller, PF (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Allergy & Inflammat,Dept Med, Boston, MA 02215 USA.	pweller@bidmc.harvard.edu	Melo, Rossana C. N./B-8248-2013	Melo, Rossana C. N./0000-0003-1736-0806	U.S. National Institutes of Health [R01/R37 AI020241, R01 AI051645, R01 HL095699]; Conselho Nacional de Pesquisa Cinetifica e Tecnologica (CNPq); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI020241, R01AI051645, R01AI020241] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Conselho Nacional de Pesquisa Cinetifica e Tecnologica (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank Dr. James J. Lee (Mayo Clinic Arizona, Scottsdale, AZ, USA) for providing anti-mouse MBP. The authors also thank Dr. Ionita Ghiran and Dr. Roi Gazit for editorial assistance. This study was funded by grants from the U.S. National Institutes of Health to P.F.W. (R01/R37 AI020241 and R01 AI051645) and L.A.S. (R01 HL095699), and from Conselho Nacional de Pesquisa Cinetifica e Tecnologica (CNPq) and Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG) to R.C.N.M.	Adamko DJ, 2004, J IMMUNOL METHODS, V291, P101, DOI 10.1016/j.jim.2004.05.003; Alexander B, 1999, J PHARMACOL TOXICOL, V41, P55, DOI 10.1016/S1056-8719(98)00038-0; Bandeira-Melo C, 2001, AM J RESP CELL MOL, V24, P653, DOI 10.1165/ajrcmb.24.6.f209; Bivas-Benita M, 2005, EUR J PHARM BIOPHARM, V61, P214, DOI 10.1016/j.ejpb.2005.04.009; Boix E, 2001, METHOD ENZYMOL, V341, P287, DOI 10.1016/S0076-6879(01)41159-1; Bystrom J, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-10; Cheng JF, 1997, J ALLERGY CLIN IMMUN, V99, P683, DOI 10.1016/S0091-6749(97)70031-9; Clark K, 2004, J LEUKOCYTE BIOL, V75, P1001, DOI 10.1189/jlb.0803391; Cormier SA, 2001, MAMM GENOME, V12, P352, DOI 10.1007/s003350020007; De Marinis E, 2009, IUBMB LIFE, V61, P62, DOI 10.1002/iub.149; DENT LA, 1990, J EXP MED, V172, P1425, DOI 10.1084/jem.172.5.1425; Denzler KL, 2001, J IMMUNOL, V167, P1672, DOI 10.4049/jimmunol.167.3.1672; Domachowske JB, 1998, J INFECT DIS, V177, P1458, DOI 10.1086/515322; Domachowske JB, 1998, NUCLEIC ACIDS RES, V26, P3358, DOI 10.1093/nar/26.14.3358; Dvorak AM, 2000, CHEM IMMUNOL, V76, P1; El-Shazly A, 1998, INT ARCH ALLERGY IMM, V117, P55, DOI 10.1159/000053573; Erjefalt JS, 1999, AM J RESP CRIT CARE, V160, P304, DOI 10.1164/ajrccm.160.1.9809048; Garcia NV, 2011, J IMMUNOL, V187, P2268, DOI 10.4049/jimmunol.1101008; GAROFALO R, 1992, J PEDIATR-US, V120, P28, DOI 10.1016/S0022-3476(05)80592-X; Garvey TL, 2005, J IMMUNOL, V175, P4735, DOI 10.4049/jimmunol.175.7.4735; Hamelmann E, 1999, AM J RESP CELL MOL, V21, P480, DOI 10.1165/ajrcmb.21.4.3659; Hogan SP, 2008, CLIN EXP ALLERGY, V38, P709, DOI 10.1111/j.1365-2222.2008.02958.x; Kampen GT, 2000, BLOOD, V95, P1911, DOI 10.1182/blood.V95.6.1911; Kumar RK, 2002, AM J RESP CELL MOL, V27, P267, DOI 10.1165/rcmb.F248; Lee JJ, 2005, CLIN EXP ALLERGY, V35, P986, DOI 10.1111/j.1365-2222.2005.02302.x; LEIFERMAN KM, 1985, NEW ENGL J MED, V313, P282, DOI 10.1056/NEJM198508013130502; Malm-Erjefalt M, 2001, AM J RESP CELL MOL, V24, P352, DOI 10.1165/ajrcmb.24.3.4357; Melo RCN, 2005, TRAFFIC, V6, P1047, DOI 10.1111/j.1600-0854.2005.00344.x; Melo RCN, 2005, TRAFFIC, V6, P866, DOI 10.1111/j.1600-0854.2005.00322.x; Melo RCN, 2010, MICROSC MICROANAL, V16, P653, DOI 10.1017/S1431927610093864; MOLINA HA, 1988, AM J TROP MED HYG, V38, P327, DOI 10.4269/ajtmh.1988.38.327; Moqbel R, 1999, CLIN EXP ALLERGY, V29, P1017; Mould AW, 2000, J IMMUNOL, V164, P2142, DOI 10.4049/jimmunol.164.4.2142; Neves JS, 2010, J ALLERGY CLIN IMMUN, V125, P477, DOI 10.1016/j.jaci.2009.11.029; Neves JS, 2009, CURR OPIN IMMUNOL, V21, P694, DOI 10.1016/j.coi.2009.07.011; Neves JS, 2009, J IMMUNOL METHODS, V344, P64, DOI 10.1016/j.jim.2009.03.006; Neves JS, 2008, P NATL ACAD SCI USA, V105, P18478, DOI 10.1073/pnas.0804547105; NUSSE O, 1990, J EXP MED, V171, P775, DOI 10.1084/jem.171.3.775; Ochkur SI, 2007, J IMMUNOL, V178, P7879, DOI 10.4049/jimmunol.178.12.7879; Ochkur SI, 2012, J IMMUNOL METHODS, V375, P138, DOI 10.1016/j.jim.2011.10.002; Persson CGA, 1997, TRENDS PHARMACOL SCI, V18, P117, DOI 10.1016/S0165-6147(97)01042-0; Phipps S, 2007, BLOOD, V110, P1578, DOI 10.1182/blood-2007-01-071340; REIMERT CM, 1993, J IMMUNOL METHODS, V166, P183, DOI 10.1016/0022-1759(93)90359-F; Rosenberg HF, 2008, CURR PHARM BIOTECHNO, V9, P135, DOI 10.2174/138920108784567236; ROSENBERG HF, 1995, J BIOL CHEM, V270, P7876, DOI 10.1074/jbc.270.14.7876; Rosenberg HF, 2001, J LEUKOCYTE BIOL, V70, P691; Shamri R, 2011, CELL TISSUE RES, V343, P57, DOI 10.1007/s00441-010-1049-6; Spencer LA, 2009, J LEUKOCYTE BIOL, V85, P117, DOI 10.1189/jlb.0108058; Stelts D, 1998, AM J RESP CELL MOL, V18, P463, DOI 10.1165/ajrcmb.18.4.2957; Toyoda M, 1996, AM J DERMATOPATH, V18, P49, DOI 10.1097/00000372-199602000-00008; Wang HB, 2007, J IMMUNOL, V179, P7585, DOI 10.4049/jimmunol.179.11.7585; Xu X, 2000, CLIN EXP ALLERGY, V30, P794; Yang D, 2008, J EXP MED, V205, P79, DOI 10.1084/jem.20062027	53	37	37	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	MAY	2012	26	5					2084	2093		10.1096/fj.11-200246	http://dx.doi.org/10.1096/fj.11-200246			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	937TD	22294786	Green Published			2022-12-25	WOS:000303680800034
J	Shu, YL; Habchi, J; Costanzo, S; Padilla, A; Brunel, J; Gerlier, D; Oglesbee, M; Longhi, S				Shu, Yaoling; Habchi, Johnny; Costanzo, Stephanie; Padilla, Andre; Brunel, Joanna; Gerlier, Denis; Oglesbee, Michael; Longhi, Sonia			Plasticity in Structural and Functional Interactions between the Phosphoprotein and Nucleoprotein of Measles Virus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TERMINAL DOMAIN; INTRINSICALLY DISORDERED PROTEINS; MOLECULAR RECOGNITION FEATURES; SECONDARY STRUCTURE ANALYSES; VESICULAR STOMATITIS-VIRUS; STRAND RNA VIRUSES; NUCLEOCAPSID PROTEIN; CRYSTAL-STRUCTURE; MATRIX PROTEIN; UNSTRUCTURED PROTEINS	The measles virus (MeV) phosphoprotein (P) tethers the polymerase to the nucleocapsid template for transcription and genome replication. Binding of P to nucleocapsid is mediated by the X domain of P (XD) and a conserved sequence (Box-2) within the C-terminal domain of the nucleoprotein (N-TAIL). XD binding induces N-TAIL alpha-helical folding, which in turn has been proposed to stabilize the polymerase-nucleocapsid complex, with cycles of binding and release required for transcription and genome replication. The current work directly assessed the relationships among XD-induced N-TAIL folding, XD-N-TAIL binding affinity, and polymerase activity. Amino acid substitutions that abolished XD-induced N-TAIL alpha-helical folding were created within Box-2 of Edmonston MeV N-TAIL. Polymerase activity in minireplicons was maintained despite a 35-fold decrease in XD-N-TAIL binding affinity or reduction/loss of XD-induced N-TAIL alpha-helical folding. Recombinant infectious virus was recovered for all mutants, and transcriptase elongation rates remained within a 1.7-fold range of parent virus. Box-2 mutations did however impose a significant cost to infectivity, reflected in an increase in the amount of input genome required to match the infectivity of parent virus. Diminished infectivity could not be attributed to changes in virion protein composition or production of defective interfering particles, where changes from parent virus were within a 3-fold range. The results indicated that MeV polymerase activity, but not infectivity, tolerates amino acid changes in the XD-binding region of the nucleoprotein. Selectional pressure for conservation of the Box-2 sequence may thus reflect a role in assuring the fidelity of polymerase functions or the assembly of viral particles required for optimal infectivity.	[Shu, Yaoling; Oglesbee, Michael] Ohio State Univ, Dept Vet Biosci, Columbus, OH 43210 USA; [Habchi, Johnny; Costanzo, Stephanie; Longhi, Sonia] Aix Marseille Univ, Lab AFMB, CNRS, UMR 7257, F-13288 Marseille, France; [Padilla, Andre] Univ Montpellier 1, Ctr Biochim Struct, CNRS, INSERM,U554,UMR 5048, F-34090 Montpellier, France; [Padilla, Andre] Univ Montpellier 2, Ctr Biochim Struct, CNRS, INSERM,U554,UMR 5048, F-34090 Montpellier, France; [Brunel, Joanna; Gerlier, Denis] Univ Lyon 1, Ecole Normale Super Lyon, Lab Virol Humaine, INSERM,U758, F-69365 Lyon, France	University System of Ohio; Ohio State University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Oglesbee, M (corresponding author), Ohio State Univ, Dept Vet Biosci, 1925 Coffey Rd, Columbus, OH 43210 USA.	michael.oglesbee@cvm.osu.edu; Sonia.Longhi@afmb.univ-mrs.fr	BRUNEL, JOANNA/C-6322-2015; Gerlier, Denis/L-6094-2014; LONGHI, Sonia/M-5305-2014	BRUNEL, JOANNA/0000-0002-3978-9833; Gerlier, Denis/0000-0001-5539-456X; LONGHI, Sonia/0000-0002-6829-6771; PADILLA, ANDRE/0000-0001-9702-4612	National Institutes of Health from NINDS [R01 NS031693-11A2]; CNRS; Agence Nationale de la Recherche [ANR-05-MIIM-035-02, ANR-08-PCVI-0020-01]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS031693] Funding Source: NIH RePORTER	National Institutes of Health from NINDS; CNRS(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche(French National Research Agency (ANR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 NS031693-11A2 from NINDS (to M. O.). This work was also supported by the CNRS and the Agence Nationale de la Recherche programs "Microbiologie et Immunologie" (ANR-05-MIIM-035-02) and "Physico-Chimie du Vivant" (ANR-08-PCVI-0020-01) (to D. G. and S. L.).	Belle V, 2008, PROTEINS, V73, P973, DOI 10.1002/prot.22125; Bernard C, 2009, FEBS LETT, V583, P1084, DOI 10.1016/j.febslet.2009.03.004; Bischak CG, 2010, BIOPHYS J, V99, P1676, DOI 10.1016/j.bpj.2010.06.060; Blocquel D, 2012, MOL BIOSYST, V8, P392, DOI 10.1039/c1mb05401e; Bourhis JM, 2004, VIRUS RES, V99, P157, DOI 10.1016/j.virusres.2003.11.007; Bourhis JM, 2005, PROTEIN SCI, V14, P1975, DOI 10.1110/ps.051411805; BROWN HR, 1987, ARCH VIROL, V94, P163, DOI 10.1007/BF01313735; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; Cathomen T, 1998, EMBO J, V17, P3899, DOI 10.1093/emboj/17.14.3899; DahlmanWright K, 1996, BIOCHEMISTRY-US, V35, P1323, DOI 10.1021/bi952409k; Desfosses A, 2011, J VIROL, V85, P1391, DOI 10.1128/JVI.01459-10; DIALLO A, 1994, J GEN VIROL, V75, P233, DOI 10.1099/0022-1317-75-1-233; Ding HT, 2006, J VIROL, V80, P2808, DOI 10.1128/JVI.80.6.2808-2814.2006; DUBOISDALCQ M, 1973, J VIROL, V12, P909, DOI 10.1128/JVI.12.4.909-918.1973; Dunker AK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S2-S1; Dunker AK, 2008, CURR OPIN STRUC BIOL, V18, P756, DOI 10.1016/j.sbi.2008.10.002; Dunker AK, 2001, NAT BIOTECHNOL, V19, P805, DOI 10.1038/nbt0901-805; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; Freyer MW, 2008, METHOD CELL BIOL, V84, P79, DOI 10.1016/S0091-679X(07)84004-0; Fuxreiter M, 2007, BIOINFORMATICS, V23, P950, DOI 10.1093/bioinformatics/btm035; Gely S, 2010, J MOL RECOGNIT, V23, P435, DOI 10.1002/jmr.1010; Gerlier D, 2009, CURR TOP MICROBIOL, V329, P163; Gerlier D, 2011, MICROBIOL MOL BIOL R, V75, P468, DOI 10.1128/MMBR.00007-11; Habchi J, 2012, WILEY SER PROTEIN P, P47; Habchi J, 2012, MOL BIOSYST, V8, P69, DOI 10.1039/c1mb05204g; Habchi J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011684; HIRANO A, 1993, J VIROL, V67, P1848, DOI 10.1128/JVI.67.4.1848-1853.1993; Houben K, 2007, J VIROL, V81, P6807, DOI 10.1128/JVI.00338-07; Hua QX, 1998, BIOCHEMISTRY-US, V37, P5858, DOI 10.1021/bi9800808; Iakoucheva LM, 2001, PROTEIN SCI, V10, P1353, DOI 10.1110/ps.40101; Ivanov I, 2010, J VIROL, V84, P3707, DOI 10.1128/JVI.02557-09; Iwasaki M, 2009, J VIROL, V83, P10374, DOI 10.1128/JVI.01056-09; Jensen MR, 2011, P NATL ACAD SCI USA, V108, P9839, DOI 10.1073/pnas.1103270108; Johansson K, 2003, J BIOL CHEM, V278, P44567, DOI 10.1074/jbc.M308745200; Karlin D, 2003, J GEN VIROL, V84, P3239, DOI 10.1099/vir.0.19451-0; Kavalenka A, 2010, BIOPHYS J, V98, P1055, DOI 10.1016/j.bpj.2009.11.036; Kingston RL, 2004, P NATL ACAD SCI USA, V101, P8301, DOI 10.1073/pnas.0402690101; LAMB R., 2001, FIELDS VIROLOGY, V1, P1305; Liljeroos L, 2011, P NATL ACAD SCI USA, V108, P18085, DOI 10.1073/pnas.1105770108; Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002; Longhi S, 2003, J BIOL CHEM, V278, P18638, DOI 10.1074/jbc.M300518200; Longhi S, 2009, CURR TOP MICROBIOL, V329, P103; Longhi S., 2011, NEGATIVE STRAND RNA, P95; Longhi S, 2010, PROTEIN PEPTIDE LETT, V17, P961, DOI 10.2174/092986610791498894; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Mohan A, 2006, J MOL BIOL, V362, P1043, DOI 10.1016/j.jmb.2006.07.087; Morin B, 2006, J PHYS CHEM B, V110, P20596, DOI 10.1021/jp063708u; Muhlebach MD, 2011, NATURE, V480, P530, DOI 10.1038/nature10639; Oldfield CJ, 2005, BIOCHEMISTRY-US, V44, P12454, DOI 10.1021/bi050736e; Plemper RK, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002058; Plumet S, 2005, J VIROL METHODS, V128, P79, DOI 10.1016/j.jviromet.2005.03.020; Plumet S, 2005, J VIROL, V79, P6900, DOI 10.1128/JVI.79.11.6900-6908.2005; Qanungo KR, 2004, P NATL ACAD SCI USA, V101, P5952, DOI 10.1073/pnas.0401449101; RADECKE F, 1995, EMBO J, V14, P5773, DOI 10.1002/j.1460-2075.1995.tb00266.x; Radivojac P, 2007, BIOPHYS J, V92, P1439, DOI 10.1529/biophysj.106.094045; Rager M, 2002, EMBO J, V21, P2364, DOI 10.1093/emboj/21.10.2364; Riedl P, 2002, VIRUS RES, V83, P1, DOI 10.1016/S0168-1702(01)00379-3; ROBBINS SJ, 1980, J GEN VIROL, V47, P301, DOI 10.1099/0022-1317-47-2-301; Ruigrok RWH, 2011, CURR OPIN MICROBIOL, V14, P504, DOI 10.1016/j.mib.2011.07.011; SURYANARAYANA K, 1994, J VIROL, V68, P1532, DOI 10.1128/JVI.68.3.1532-1543.1994; Tarbouriech N, 2000, VIROLOGY, V266, P99, DOI 10.1006/viro.1999.0066; Tarbouriech N, 2000, NAT STRUCT BIOL, V7, P777; Tawar RG, 2009, SCIENCE, V326, P1279, DOI 10.1126/science.1177634; Tell G, 1998, BIOCHEM J, V329, P395, DOI 10.1042/bj3290395; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Turoverov KK, 2010, PROG BIOPHYS MOL BIO, V102, P73, DOI 10.1016/j.pbiomolbio.2010.01.003; Uversky VN, 2011, BBA-PROTEINS PROTEOM, V1814, P693, DOI 10.1016/j.bbapap.2011.03.010; Uversky VN, 2010, BBA-PROTEINS PROTEOM, V1804, P1231, DOI 10.1016/j.bbapap.2010.01.017; Uversky VN, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/568068; Uversky VN, 2003, CELL MOL LIFE SCI, V60, P1852, DOI 10.1007/s00018-003-3096-6; Uversky VN, 2002, PROTEIN SCI, V11, P739, DOI 10.1110/ps.4210102; Vacic V, 2007, J PROTEOME RES, V6, P2351, DOI 10.1021/pr0701411; Vincent S, 1999, VIROLOGY, V265, P185, DOI 10.1006/viro.1999.0064; Vincent S, 2000, J VIROL, V74, P9911, DOI 10.1128/JVI.74.21.9911-9915.2000; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; Yanagi Y, 2009, CURR TOP MICROBIOL, V329, P13; Yegambaram K, 2010, PROTEIN SCI, V19, P893, DOI 10.1002/pro.354; Zhang XS, 2005, VIROLOGY, V337, P162, DOI 10.1016/j.virol.2005.03.035; Zhang XS, 2002, J VIROL, V76, P8737, DOI 10.1128/JVI.76.17.8737-8746.2002	81	31	31	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					11951	11967		10.1074/jbc.M111.333088	http://dx.doi.org/10.1074/jbc.M111.333088			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22318731	Green Published, hybrid			2022-12-25	WOS:000302782200034
J	Mollan, TL; Khandros, E; Weiss, MJ; Olson, JS				Mollan, Todd L.; Khandros, Eugene; Weiss, Mitchell J.; Olson, John S.			Kinetics of alpha-Globin Binding to alpha-Hemoglobin Stabilizing Protein (AHSP) Indicate Preferential Stabilization of Hemichrome Folding Intermediate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEPARATED HUMAN ALPHA; HEMIN DISSOCIATION; BETA-THALASSEMIA; PROSTHETIC GROUPS; T-STATE; CHAINS; SUBUNITS; MECHANISM; ERYTHROPOIESIS; OXYHEMOGLOBIN	Human alpha-hemoglobin stabilizing protein (AHSP) is a conserved mammalian erythroid protein that facilitates the production of Hemoglobin A by stabilizing free alpha-globin. AHSP rapidly binds to ferrous alpha with association (k '(AHSP)) and dissociation (k(AHSP)) rate constants of approximate to 10 mu M-1 s(-1) and 0.2 s(-1), respectively, at pH 7.4 at 22 degrees C. A small slow phase was observed when AHSP binds to excess ferrous alpha CO. This slow phase appears to be due to cis to trans prolyl isomerization of the Asp(29)-Pro(30) peptide bond in wild-type AHSP because it was absent when alpha CO was mixed with P30A and P30W AHSP, which are fixed in the trans conformation. This slow phase was also absent when met(Fe3+)-alpha reacted with wild-type AHSP, suggesting that met-alpha is capable of rapidly binding to either Pro(30) conformer. Both wildtype and Pro(30)-substituted AHSPs drive the formation of a met-alpha hemichrome conformation following binding to either met-or oxy(Fe2+)-alpha. The dissociation rate of the met-alpha AHSP complex (k(AHSP) approximate to 0.002 s(-1)) is similar to 100-fold slower than that for ferrous alpha AHSPcomplexes, resulting in a much higher affinity of AHSP for met-alpha. Thus, in vivo, AHSP acts as a molecular chaperone by rapidly binding and stabilizing met-alpha hemichrome folding intermediates. The low rate of met-alpha dissociation also allows AHSP to have a quality control function by kinetically trapping ferric alpha and preventing its incorporation into less stable mixed valence Hemoglobin A tetramers. Reduction of AHSP-bound met-alpha allows more rapid release to beta subunits to form stable fully, reduced hemoglobin dimers and tetramers.	[Mollan, Todd L.; Olson, John S.] Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77251 USA; [Khandros, Eugene; Weiss, Mitchell J.] Univ Penn, Cell & Mol Biol Grp, Philadelphia, PA 19104 USA; [Khandros, Eugene; Weiss, Mitchell J.] Childrens Hosp Philadelphia, Div Hematol, Philadelphia, PA 19104 USA	Rice University; University of Pennsylvania; University of Pennsylvania; Childrens Hospital of Philadelphia	Olson, JS (corresponding author), Rice Univ, Dept Biochem & Cell Biol, POB 1892,MS-140, Houston, TX 77251 USA.	olson@rice.edu	Weiss, Mitchell J/W-9814-2018; Weiss, Mitchell J/A-1245-2013	Weiss, Mitchell J/0000-0003-2460-3036; Olson, John/0000-0002-0760-5403	National Institutes of Health [HL47020, GM35649, DK61692, HL087427, GM008362]; Welch Grant [C-0612]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087427, R01HL047020] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK061692, R01DK061692] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035649, T32GM008362] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL47020 (to J. S. O.), GM35649 (to J. S. O.), DK61692 (to M. J. W.), HL087427 (to M. J. W.), and GM008362 (to T. L. M.). This work was also supported by Welch Grant C-0612 (to J. S. O.).	ALPERT B, 1980, PHOTOCHEM PHOTOBIOL, V31, P1, DOI 10.1111/j.1751-1097.1980.tb03674.x; ANTONINI E, 1977, ANNU REV BIOPHYS BIO, V6, P239, DOI 10.1146/annurev.bb.06.060177.001323; Antonini E., 1971, HEMOGLOBIN MYOGLOBIN, P13; BANERJEE R, 1969, BIOCHEMISTRY-US, V8, P2862, DOI 10.1021/bi00835a025; Baudin-Creuza V, 2004, J BIOL CHEM, V279, P36530, DOI 10.1074/jbc.M405389200; BENZ EJ, 1974, SEMIN HEMATOL, V11, P463; Birukou I, 2010, J BIOL CHEM, V285, P8840, DOI 10.1074/jbc.M109.053934; Biswal BK, 2002, ACTA CRYSTALLOGR D, V58, P1155, DOI 10.1107/S0907444902007138; BOYER PD, 1954, J AM CHEM SOC, V76, P4331, DOI 10.1021/ja01646a025; BRANTLEY RE, 1993, J BIOL CHEM, V268, P6995; Brillet T, 2010, J BIOL CHEM, V285, P17986, DOI 10.1074/jbc.M109.098491; BRUNORI M, 1975, EUR J BIOCHEM, V53, P99, DOI 10.1111/j.1432-1033.1975.tb04046.x; BUCCI E, 1965, J BIOL CHEM, V240, pP551; BUNN HF, 1987, BLOOD, V69, P1; BUNN HF, 1966, P NATL ACAD SCI USA, V56, P974, DOI 10.1073/pnas.56.3.974; Bunn HF, 1986, HEMOGLOBIN MOL GENET; Culbertson D. S., 2010, THESIS RICE U; Culbertson DS, 2010, BIOCHEMISTRY-US, V49, P6052, DOI 10.1021/bi1006942; Feng L, 2005, NATURE, V435, P697, DOI 10.1038/nature03609; Feng L, 2004, CELL, V119, P629, DOI 10.1016/j.cell.2004.11.025; FRIEDMAN FK, 1979, ANNU REV BIOCHEM, V48, P217, DOI 10.1146/annurev.bi.48.070179.001245; Gell D, 2002, J BIOL CHEM, V277, P40602, DOI 10.1074/jbc.M206084200; Gell DA, 2009, J BIOL CHEM, V284, P29462, DOI 10.1074/jbc.M109.027045; GERACI G, 1969, J BIOL CHEM, V244, P4664; Gomes C. M., 2011, PROTEIN FOLDING META, P97; Hardison R., 2001, DISORDERS HEMOGLOBIN, P95, DOI 10.1017/CBO9780511596582; HARGROVE MS, 1994, J BIOL CHEM, V269, P4207; Hargrove MS, 1996, BIOCHEMISTRY-US, V35, P11293, DOI 10.1021/bi960371l; Hargrove MS, 1996, BIOCHEMISTRY-US, V35, P11310, DOI 10.1021/bi9603736; Hargrove MS, 1996, BIOCHEMISTRY-US, V35, P11300, DOI 10.1021/bi960372d; Hargrove MS, 1997, J BIOL CHEM, V272, P17385, DOI 10.1074/jbc.272.28.17385; KAWAMURA Y, 1983, J BIOCHEM-TOKYO, V93, P1159, DOI 10.1093/oxfordjournals.jbchem.a134241; Kemmer G, 2010, NAT PROTOC, V5, P267, DOI 10.1038/nprot.2009.182; Khandros E, 2012, J BIOL CHEM, V287, P11325, DOI 10.1074/jbc.M111.313205; Kihm AJ, 2002, NATURE, V417, P758, DOI 10.1038/nature00803; Kong Y, 2004, J CLIN INVEST, V114, P1457, DOI 10.1172/JCI200421982; Kumar KK, 2010, BIOCHEM J, V432, P275, DOI 10.1042/BJ20100642; LEUTZINGER Y, 1981, P NATL ACAD SCI-BIOL, V78, P780, DOI 10.1073/pnas.78.2.780; MANSOURI A, 1973, BIOCHEMISTRY-US, V12, P4946, DOI 10.1021/bi00748a020; MCDONALD MJ, 1987, J BIOL CHEM, V262, P5951; MCGOVERN P, 1976, J BIOL CHEM, V251, P7871; Mollan T. L., 2011, THESIS RICE U; Mollan TL, 2010, ANTIOXID REDOX SIGN, V12, P219, DOI 10.1089/ars.2009.2780; MRABET NT, 1986, J BIOL CHEM, V261, P5222; MRABET NT, 1986, J BIOL CHEM, V261, P1111; Paoli M, 1996, J MOL BIOL, V256, P775, DOI 10.1006/jmbi.1996.0124; PERUTZ MF, 1960, NATURE, V185, P416, DOI 10.1038/185416a0; RACHMILEWITZ EA, 1971, J BIOL CHEM, V246, P3356; RIFKIND JM, 1994, METHOD ENZYMOL, V231, P449; Rifkind JM, 2004, ANTIOXID REDOX SIGN, V6, P657, DOI 10.1089/152308604773934422; ROHLFS RJ, 1990, J BIOL CHEM, V265, P3168; Santiveri CM, 2004, J BIOL CHEM, V279, P34963, DOI 10.1074/jbc.M405016200; Schechter AN, 2008, BLOOD, V112, P3927, DOI 10.1182/blood-2008-04-078188; SCHMID FX, 1993, ANNU REV BIOPH BIOM, V22, P123, DOI 10.1146/annurev.bb.22.060193.001011; SHAEFFER JR, 1984, J BIOL CHEM, V259, P4544; Shen TJ, 1997, PROTEIN ENG, V10, P1085, DOI 10.1093/protein/10.9.1085; VALDES R, 1978, P NATL ACAD SCI USA, V75, P311, DOI 10.1073/pnas.75.1.311; Vergara A, 2008, METHOD ENZYMOL, V436, P425, DOI 10.1016/S0076-6879(08)36024-8; Voon HPJ, 2008, HAEMATOL-HEMATOL J, V93, P1868, DOI 10.3324/haematol.13490; WAKS M, 1973, J BIOL CHEM, V248, P6462; Weatherall DJ, 1998, BAILLIERE CLIN HAEM, V11, P127, DOI 10.1016/S0950-3536(98)80072-3; Weiss MJ, 2009, BLOOD, V113, P2136, DOI 10.1182/blood-2008-09-115238; Weiss MJ, 2005, ANN NY ACAD SCI, V1054, P103, DOI 10.1196/annals.1345.013; WIEDERMANN BL, 1975, J BIOL CHEM, V250, P5273; YIP YK, 1972, J BIOL CHEM, V247, P7237; YIP YK, 1977, P NATL ACAD SCI USA, V74, P64, DOI 10.1073/pnas.74.1.64; Yu X, 2007, J CLIN INVEST, V117, P1856, DOI 10.1172/JCI31664; Yu X, 2009, BLOOD, V113, P5961, DOI 10.1182/blood-2008-12-196030; Zhou SP, 2006, J BIOL CHEM, V281, P32611, DOI 10.1074/jbc.M607311200; Zoldak G, 2009, BIOCHEMISTRY-US, V48, P10423, DOI 10.1021/bi9014242	70	21	22	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					11338	11350		10.1074/jbc.M111.313247	http://dx.doi.org/10.1074/jbc.M111.313247			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22298770	Green Published, hybrid			2022-12-25	WOS:000302780100064
J	Arakaki, M; Ishikawa, M; Nakamura, T; Iwamoto, T; Yamada, A; Fukumoto, E; Saito, M; Otsu, K; Harada, H; Yamada, Y; Fukumoto, S				Arakaki, Makiko; Ishikawa, Masaki; Nakamura, Takashi; Iwamoto, Tsutomu; Yamada, Aya; Fukumoto, Emiko; Saito, Masahiro; Otsu, Keishi; Harada, Hidemitsu; Yamada, Yoshihiko; Fukumoto, Satoshi			Role of Epithelial-Stem Cell Interactions during Dental Cell Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR EPIPROFIN; IN-VITRO; PLURIPOTENT; EXPRESSION; INDUCTION; TEETH; IDENTIFICATION; AMELOBLASTIN; MODEL; FATE	Epithelial-mesenchymal interactions regulate the growth and morphogenesis of ectodermal organs such as teeth. Dental pulp stem cells (DPSCs) are a part of dental mesenchyme, derived from the cranial neural crest, and differentiate into dentin forming odontoblasts. However, the interactions between DPSCs and epithelium have not been clearly elucidated. In this study, we established a mouse dental pulp stem cell line (SP) comprised of enriched side population cells that displayed a multipotent capacity to differentiate into odontogenic, osteogenic, adipogenic, and neurogenic cells. We also analyzed the interactions between SP cells and cells from the rat dental epithelial SF2 line. When cultured with SF2 cells, SP cells differentiated into odontoblasts that expressed dentin sialophosphoprotein. This differentiation was regulated by BMP2 and BMP4, and inhibited by the BMP antagonist Noggin. We also found that mouse iPS cells cultured with mitomycin C-treated SF2-24 cells displayed an epithelial cell-like morphology. Those cells expressed the epithelial cell markers p63 and cytokeratin-14, and the ameloblast markers ameloblastin and enamelin, whereas they did not express the endodermal cell marker Gata6 or mesodermal cell marker brachyury. This is the first report of differentiation of iPS cells into ameloblasts via interactions with dental epithelium. Co-culturing with dental epithelial cells appears to induce stem cell differentiation that favors an odontogenic cell fate, which may be a useful approach for tooth bioengineering strategies.	[Arakaki, Makiko; Nakamura, Takashi; Iwamoto, Tsutomu; Yamada, Aya; Fukumoto, Emiko; Fukumoto, Satoshi] Tohoku Univ, Dept Oral Hlth & Dev Sci, Grad Sch Dent, Div Pediat Dent, Sendai, Miyagi 9808575, Japan; [Ishikawa, Masaki; Yamada, Yoshihiko] NIDCR, Lab Cell & Dev Biol, NIH, Bethesda, MD 20892 USA; [Saito, Masahiro] Tokyo Univ Sci, Fac Ind Sci & Technol, Chiba 2788510, Japan; [Otsu, Keishi; Harada, Hidemitsu] Iwate Med Coll, Sch Dent, Dept Oral Anat 2, Morioka, Iwate 0208505, Japan	Tohoku University; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Tokyo University of Science; Iwate Medical University	Fukumoto, S (corresponding author), Tohoku Univ, Dept Oral Hlth & Dev Sci, Grad Sch Dent, Div Pediat Dent, Sendai, Miyagi 9808575, Japan.	fukumoto@dent.tohoku.ac.jp	Nakamura, Takashi/A-8931-2012; Iwamoto, Tsutomu/AAA-6597-2019; Nakamura, Takashi/P-7796-2016; Harada, Hidemitsu/P-5692-2017; Iwamoto, Tsutomu/AAI-8952-2021	Nakamura, Takashi/0000-0001-9904-1037; Iwamoto, Tsutomu/0000-0001-8472-605X; Nakamura, Takashi/0000-0001-9904-1037; Harada, Hidemitsu/0000-0002-9724-8568; Fukumoto, Satoshi/0000-0002-5046-6891	NIDCR, National Institutes of Health; Ministry of Education, Science, and Culture of Japan [20679006, 21792054, 21792154]; NEXT program [LS010]; Takeda Science Foundation; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000483, ZIADE000485, ZIADE000720] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [23593013, 22659373, 22791774] Funding Source: KAKEN	NIDCR, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Ministry of Education, Science, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NEXT program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported, in whole or in part, by the Intramural Research Program of the NIDCR, National Institutes of Health (to Y. Y.). This work was also supported by Grants-in-aid 20679006 (to S. F.), 21792054 (to A. Y.), 21792154 (to E. F.) from the Ministry of Education, Science, and Culture of Japan, and the NEXT program (LS010, to S. F.), and by grants from the Takeda Science Foundation.	BAROFFIO A, 1991, DEVELOPMENT, V112, P301; Chang CB, 1998, J NEUROBIOL, V36, P128, DOI 10.1002/(SICI)1097-4695(199808)36:2<128::AID-NEU3>3.0.CO;2-3; Chen S, 2002, CONNECT TISSUE RES, V43, P338, DOI 10.1080/03008200290000691; Chen YP, 1996, DEVELOPMENT, V122, P3035; Cho YD, 2010, J BIOL CHEM, V285, P36369, DOI 10.1074/jbc.M110.103093; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; Fisher LW, 2003, CONNECT TISSUE RES, V44, P33, DOI 10.1080/03008200390152061; Fukumoto S, 2004, J CELL BIOL, V167, P973, DOI 10.1083/jcb.200409077; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; Hu B, 2006, J DENT RES, V85, P416, DOI 10.1177/154405910608500504; Iizuka S, 2011, MOL CELL BIOL, V31, P783, DOI 10.1128/MCB.00912-10; Klotz O, 1905, J EXP MED, V7, P633, DOI 10.1084/jem.7.6.633; Lewitzky M, 2007, CURR OPIN BIOTECH, V18, P467, DOI 10.1016/j.copbio.2007.09.007; Li LW, 2011, GENE EXPR PATTERNS, V11, P163, DOI 10.1016/j.gep.2010.11.001; Miura M, 2003, P NATL ACAD SCI USA, V100, P5807, DOI 10.1073/pnas.0937635100; Munoz-Sanjuan I, 2002, NAT REV NEUROSCI, V3, P271, DOI 10.1038/nrn786; Nakamura T, 2004, J BIOL CHEM, V279, P626, DOI 10.1074/jbc.M307502200; Nakamura T, 2008, J BIOL CHEM, V283, P4825, DOI 10.1074/jbc.M708388200; Nakamura T, 2011, J ORAL BIOSCI, V53, P22, DOI 10.2330/joralbiosci.53.22; NAKASHIMA M, 1994, J DENT RES, V73, P1515, DOI 10.1177/00220345940730090601; Nam H, 2009, BIOCHEM BIOPH RES CO, V386, P135, DOI 10.1016/j.bbrc.2009.05.141; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Plikus MV, 2005, EVOL DEV, V7, P440, DOI 10.1111/j.1525-142X.2005.05048.x; Shi S, 2005, Orthod Craniofac Res, V8, P191, DOI 10.1111/j.1601-6343.2005.00331.x; SIEBERBLUM M, 1980, DEV BIOL, V80, P96, DOI 10.1016/0012-1606(80)90501-1; So KH, 2011, INT J CARDIOL, V153, P277, DOI 10.1016/j.ijcard.2010.08.052; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Sonoda A, 2009, J BIOL CHEM, V284, P27176, DOI 10.1074/jbc.M109.033464; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Ten Cate A R, 1996, Oral Dis, V2, P55; THESLEFF I, 1981, DIFFERENTIATION, V18, P75, DOI 10.1111/j.1432-0436.1981.tb01107.x; Thesleff I, 2003, J CELL SCI, V116, P1647, DOI 10.1242/jcs.00410; VAINIO S, 1993, CELL, V75, P45, DOI 10.1016/S0092-8674(05)80083-2; Xu D, 2009, P NATL ACAD SCI USA, V106, P808, DOI 10.1073/pnas.0812090106; Yan X, 2010, STEM CELLS DEV, V19, P469, DOI 10.1089/scd.2009.0314; Yokoi T, 2007, CELL TISSUE RES, V327, P301, DOI 10.1007/s00441-006-0257-6; Yoshida Y, 2011, J MOL CELL CARDIOL, V50, P327, DOI 10.1016/j.yjmcc.2010.10.026; Yoshizaki K, 2008, J BIOL CHEM, V283, P3385, DOI 10.1074/jbc.M704913200; Yuasa K, 2004, J BIOL CHEM, V279, P10286, DOI 10.1074/jbc.M310013200; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028	42	97	100	3	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					10590	10601		10.1074/jbc.M111.285874	http://dx.doi.org/10.1074/jbc.M111.285874			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22298769	hybrid, Green Published			2022-12-25	WOS:000302167200084
J	Ramani, VC; Pruett, PS; Thompson, CA; DeLucas, LD; Sanderson, RD				Ramani, Vishnu C.; Pruett, Pamela S.; Thompson, Camilla A.; DeLucas, Lawrence D.; Sanderson, Ralph D.			Heparan Sulfate Chains of Syndecan-1 Regulate Ectodomain Shedding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMARY EPITHELIAL-CELLS; AGGRESSIVE TUMOR PHENOTYPE; GROWTH-FACTOR; TYROSINE PHOSPHORYLATION; PSEUDOMONAS-AERUGINOSA; SURFACE PROTEOGLYCAN; SOLUBLE SYNDECAN-1; MULTIPLE-MYELOMA; HELA-CELLS; CANCER	Matrix metalloproteinases release intact syndecan-1 ectodomains from the cell surface giving rise to a soluble, shed form of the proteoglycan. Although it is known that shed syndecan-1 controls diverse pathophysiological responses in cancer, wound healing, inflammation, infection, and immunity, the mechanisms regulating shedding remain unclear. We have discovered that the heparan sulfate chains present on syndecan core proteins suppress shedding of the proteoglycan. Syndecan shedding is dramatically enhanced when the heparan sulfate chains are enzymatically degraded or absent from the core protein. Exogenous heparan sulfate or heparin does not inhibit shedding, indicating that heparan sulfate must be attached to the core protein to suppress shedding. Regulation of shedding by heparan sulfate occurs in multiple cell types, for both syndecan-1 and syndecan-4 and in murine and human syndecans. Mechanistically, the loss of heparan sulfate enhances the susceptibility of the core protein to proteolytic cleavage by matrix metalloproteinases. Enhanced shedding of syndecan-1 following loss of heparan sulfate is accompanied by a dramatic increase in core protein synthesis. This suggests that in response to an increase in the rate of shedding, cells attempt to maintain a significant level of syndecan-1 on the cell surface. Together these data indicate that the amount of heparan sulfate present on syndecan core proteins regulates both the rate of syndecan shedding and core protein synthesis. These findings assign new functions to heparan sulfate chains, thereby broadening our understanding of their physiological importance and implying that therapeutic inhibition of heparan sulfate degradation could impact the progression of some diseases.	[Ramani, Vishnu C.; Thompson, Camilla A.; Sanderson, Ralph D.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Pruett, Pamela S.; DeLucas, Lawrence D.] Univ Alabama Birmingham, Ctr Biophys Sci & Engn, Birmingham, AL 35294 USA; [DeLucas, Lawrence D.; Sanderson, Ralph D.] Univ Alabama Birmingham, Ctr Comprehens Canc, Birmingham, AL 35294 USA; [Sanderson, Ralph D.] Univ Alabama Birmingham, Ctr Metab Bone Dis, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Sanderson, RD (corresponding author), Univ Alabama Birmingham, Dept Pathol, 814 SHEL,1530 3rd Ave S, Birmingham, AL 35294 USA.	sanderson@uab.edu			National Institutes of Health [CA135075, CA138340, P30 AR48311, P30 AI027767]; NATIONAL CANCER INSTITUTE [R01CA135075, R01CA138340] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027767] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048311] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095639] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA135075 and CA138340 (to R. D. S.).; We thank Enid Keyser for technical assistance in flow cytometry and sorting and the Analytical and Preparative Cytometry Facility (supported by National Institutes of Health Grant P30 AR48311) of the Comprehensive Arthritis, Musculoskeletal, and Autoimmunity Center at the University of Alabama, Birmingham. We thank the University of Alabama, Birmingham, Center for AIDS Research DNA Sequencing Core Facility (supported by National Institutes of Health Grant P30 AI027767) for DNA sequencing.	Brule S, 2006, GLYCOBIOLOGY, V16, P488, DOI 10.1093/glycob/cwj098; Busse M, 2007, J BIOL CHEM, V282, P32802, DOI 10.1074/jbc.M703560200; Charnaux N, 2005, GLYCOBIOLOGY, V15, P119, DOI 10.1093/glycob/cwh148; Couchman JR, 2010, ANNU REV CELL DEV BI, V26, P89, DOI 10.1146/annurev-cellbio-100109-104126; Ding K, 2005, J CELL BIOL, V171, P729, DOI 10.1083/jcb.200508010; Endo K, 2003, J BIOL CHEM, V278, P40764, DOI 10.1074/jbc.M306736200; Fitzgerald ML, 2000, J CELL BIOL, V148, P811, DOI 10.1083/jcb.148.4.811; Hayashida K, 2008, J BIOL CHEM, V283, P35435, DOI 10.1074/jbc.M804172200; Iozzo RV, 2011, J CELL MOL MED, V15, P1013, DOI 10.1111/j.1582-4934.2010.01236.x; JALKANEN M, 1987, J CELL BIOL, V105, P3087, DOI 10.1083/jcb.105.6.3087; JALKANEN M, 1985, J CELL BIOL, V101, P976, DOI 10.1083/jcb.101.3.976; Joensuu H, 2002, CANCER RES, V62, P5210; Kliment CR, 2009, J BIOL CHEM, V284, P3537, DOI 10.1074/jbc.M807001200; Langford JK, 1998, J BIOL CHEM, V273, P29965, DOI 10.1074/jbc.273.45.29965; Li QL, 2002, CELL, V111, P635, DOI 10.1016/S0092-8674(02)01079-6; Live DH, 1996, P NATL ACAD SCI USA, V93, P12759, DOI 10.1073/pnas.93.23.12759; Manon-Jensen T, 2010, FEBS J, V277, P3876, DOI 10.1111/j.1742-4658.2010.07798.x; Ott VL, 1998, J BIOL CHEM, V273, P35291, DOI 10.1074/jbc.273.52.35291; Park PW, 2001, NATURE, V411, P98, DOI 10.1038/35075100; Park PW, 2000, J BIOL CHEM, V275, P3057, DOI 10.1074/jbc.275.5.3057; Purushothaman A, 2008, J BIOL CHEM, V283, P32628, DOI 10.1074/jbc.M806266200; Purushothaman A, 2011, J BIOL CHEM, V286, P30377, DOI 10.1074/jbc.M111.254789; Purushothaman A, 2010, BLOOD, V115, P2449, DOI 10.1182/blood-2009-07-234757; Ra HJ, 2009, J BIOL CHEM, V284, P27924, DOI 10.1074/jbc.M109.035147; Raats CJI, 1997, J BIOL CHEM, V272, P26734, DOI 10.1074/jbc.272.42.26734; RAPRAEGER A, 1985, J BIOL CHEM, V260, P1046; Reiland J, 1996, BIOCHEM J, V319, P39, DOI 10.1042/bj3190039; SANDERSON RD, 1992, J IMMUNOL, V148, P3902; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Seidel C, 2000, BLOOD, V95, P388, DOI 10.1182/blood.V95.2.388; Shental-Bechor D, 2008, P NATL ACAD SCI USA, V105, P8256, DOI 10.1073/pnas.0801340105; Sorensen HP, 2008, J BIOL CHEM, V283, P31920, DOI 10.1074/jbc.M804113200; Su G, 2007, J BIOL CHEM, V282, P14906, DOI 10.1074/jbc.M611739200; Subramanian SV, 1997, J BIOL CHEM, V272, P14713, DOI 10.1074/jbc.272.23.14713; Teng YHF, 2012, MATRIX BIOL, V31, P3, DOI 10.1016/j.matbio.2011.10.001; Theocharis AD, 2010, FEBS J, V277, P3904, DOI 10.1111/j.1742-4658.2010.07800.x; Yang Y, 2002, BLOOD, V100, P610, DOI 10.1182/blood.V100.2.610; Yang Y, 2007, J BIOL CHEM, V282, P13326, DOI 10.1074/jbc.M611259200; Yang Y, 2010, CANCER RES, V70, P8329, DOI 10.1158/0008-5472.CAN-10-2179; Yu WH, 2000, J BIOL CHEM, V275, P4183, DOI 10.1074/jbc.275.6.4183	40	83	86	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					9952	9961		10.1074/jbc.M111.330803	http://dx.doi.org/10.1074/jbc.M111.330803			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22298773	Green Published, hybrid			2022-12-25	WOS:000302167200027
J	Iwamura, A; Fukami, T; Higuchi, R; Nakajima, M; Yokoi, T				Iwamura, Atsushi; Fukami, Tatsuki; Higuchi, Ryota; Nakajima, Miki; Yokoi, Tsuyoshi			Human alpha/beta Hydrolase Domain Containing 10 (ABHD10) Is Responsible Enzyme for Deglucuronidation of Mycophenolic Acid Acyl-glucuronide in Liver	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RENAL-TRANSPLANT RECIPIENTS; ARYLACETAMIDE DEACETYLASE; IDENTIFICATION; HYDROLYSIS; PROTEIN; CARBOXYLESTERASES; PHARMACOKINETICS; ACTIVATION; METABOLITE; MICROSOMES	Mycophenolic acid (MPA), the active metabolite of the immunosuppressant mycophenolate mofetil (MMF), is primarily metabolized by glucuronidation to a phenolic glucuronide (MPAG) and an acyl glucuronide (AcMPAG). It is known that AcMPAG, which may be an immunotoxic metabolite, is deglucuronidated in human liver. However, it has been reported that recombinant beta-glucuronidase does not catalyze this reaction. AcMPAG deglucuronidation activity was detected in both human liver cytosol (HLC) and microsomes (HLM). In this study, the enzyme responsible for AcMPAG deglucuronidation was identified by purification from HLC with column chromatographic purification steps. The purified enzyme was identified as alpha/beta hydrolase domain containing 10 (ABHD10) by amino acid sequence analysis. Recombinant ABHD10 expressed in Sf9 cells efficiently deglucuronidated AcMPAG with a K-m value of 100.7 +/- 10.2 mu M, which was similar to those in HLM, HLC, and human liver homogenates (HLH). Immunoblot analysis revealed ABHD10 protein expression in both HLC and HLM. The AcMPAG deglucuronidation by recombinant ABHD10, HLC, and HLH were potently inhibited by AgNO3, CdCl2, CuCl2, PMSF, bis-p-nitrophenylphosphate, and DTNB. The CLint value of AcMPAG formation from MPA, which was catalyzed by human UGT2B7, in HLH was increased by 1.8-fold in the presence of PMSF. Thus, human ABHD10 would affect the formation of AcMPAG, the immunotoxic metabolite.	[Iwamura, Atsushi; Fukami, Tatsuki; Higuchi, Ryota; Nakajima, Miki; Yokoi, Tsuyoshi] Kanazawa Univ, Fac Pharmaceut Sci, Dept Drug Metab & Toxicol, Kanazawa, Ishikawa 9201192, Japan	Kanazawa University	Yokoi, T (corresponding author), Kanazawa Univ, Fac Pharmaceut Sci, Dept Drug Metab & Toxicol, Kakuma Machi, Kanazawa, Ishikawa 9201192, Japan.	tyokoi@kenroku.kanazawa-u.ac.jp	yokoi, tsuyoshi/I-7115-2014; Nakajima, Miki/C-3990-2015; Fukami, Tatsuki/C-8907-2015	Yokoi, Tsuyoshi/0000-0002-3239-2817; Fukami, Tatsuki/0000-0003-2416-5988	Japan Society for the Promotion of Science [23590174]; Grants-in-Aid for Scientific Research [23590174] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grant-in-aid for Scientific Research (C) from the Japan Society for the Promotion of Science 23590174.	BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bullingham RES, 1998, CLIN PHARMACOKINET, V34, P429, DOI 10.2165/00003088-199834060-00002; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Fujiyama N, 2009, XENOBIOTICA, V39, P407, DOI 10.1080/00498250902807338; Fukami T, 2008, PHARMACOGENET GENOM, V18, P911, DOI 10.1097/FPC.0b013e32830b0c5e; Fukami T, 2010, DRUG METAB DISPOS, V38, P2173, DOI 10.1124/dmd.110.034454; HEYMANN E, 1967, H-S Z PHYSIOL CHEM, V348, P609, DOI 10.1515/bchm2.1967.348.1.609; Hosokawa M, 2008, MOLECULES, V13, P412, DOI 10.3390/molecules13020412; IWATSUBO K, 1965, JPN J PHARMACOL, V15, P244, DOI 10.1254/jjp.15.244; Johnson G, 2000, MOL IMMUNOL, V37, P707, DOI 10.1016/S0161-5890(00)00104-8; KROETZ DL, 1993, BIOCHEMISTRY-US, V32, P11606, DOI 10.1021/bi00094a018; Labar G, 2007, CHEMBIOCHEM, V8, P1293, DOI 10.1002/cbic.200700139; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Langmann T, 1997, BBA-GENE STRUCT EXPR, V1350, P65, DOI 10.1016/S0167-4781(96)00142-X; Lefevre C, 2001, AM J HUM GENET, V69, P1002, DOI 10.1086/324121; LEVVY GA, 1952, BIOCHEM J, V52, P464, DOI 10.1042/bj0520464; Li F, 2009, MOL BIOL REP, V36, P691, DOI 10.1007/s11033-008-9230-7; MINAGAWA T, 1995, BIOCHEM PHARMACOL, V49, P1361, DOI 10.1016/0006-2952(95)00071-7; Picard N, 2005, DRUG METAB DISPOS, V33, P139, DOI 10.1124/dmd.104.001651; Preuss CV, 1996, BIOCHEM PHARMACOL, V51, P1661, DOI 10.1016/0006-2952(96)00134-7; ROSENTHAL PJ, 1988, J CLIN INVEST, V82, P1560, DOI 10.1172/JCI113766; ROWE BJ, 1984, J PHARMACOL EXP THER, V230, P237; Shipkova M, 2004, PROTEOMICS, V4, P2728, DOI 10.1002/pmic.200300836; Shipkova M, 1999, BRIT J PHARMACOL, V126, P1075, DOI 10.1038/sj.bjp.0702399; Shipkova M, 2002, THER DRUG MONIT, V24, P390, DOI 10.1097/00007691-200206000-00011; Simon GM, 2006, J BIOL CHEM, V281, P26465, DOI 10.1074/jbc.M604660200; SMITH PC, 1990, J PHARMACOL EXP THER, V252, P218; SPAHNLANGGUTH H, 1992, DRUG METAB REV, V24, P5; Suzuki E, 2010, DRUG METAB DISPOS, V38, P1538, DOI 10.1124/dmd.110.032938; Tabata T, 2004, DRUG METAB DISPOS, V32, P1103, DOI 10.1124/dmd.104.000554; Takahashi S, 2009, DRUG METAB DISPOS, V37, P956, DOI 10.1124/dmd.108.024331; Watanabe A, 2009, DRUG METAB DISPOS, V37, P1513, DOI 10.1124/dmd.109.026567; Wieland E, 2000, CLIN BIOCHEM, V33, P107, DOI 10.1016/S0009-9120(99)00101-0; Xu G, 2002, CLIN CANCER RES, V8, P2605; Yamaori S, 2006, DRUG METAB PHARMACOK, V21, P147, DOI 10.2133/dmpk.21.147; Yamazaki H, 1999, DRUG METAB DISPOS, V27, P1260	36	28	29	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					9240	9249		10.1074/jbc.M111.271288	http://dx.doi.org/10.1074/jbc.M111.271288			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22294686	Green Published, hybrid			2022-12-25	WOS:000301797800052
J	Zhao, Y; He, W; Liu, WF; Liu, CC; Feng, LK; Sun, L; Yan, YB; Hang, HY				Zhao, Yun; He, Wei; Liu, Wei-Feng; Liu, Chun-Chun; Feng, Li-Kui; Sun, Lei; Yan, Yong-Bin; Hang, Hai-Ying			Two Distinct States of Escherichia coli Cells That Overexpress Recombinant Heterogeneous beta-Galactosidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL INCLUSION-BODIES; PROTEIN AGGREGATION; FLOW-CYTOMETRY; BODY FORMATION; EXPRESSION; SOLUBILITY; CHAPERONES; AGGRESOMES; STRATEGIES; QUALITY	The mechanism by which inclusion bodies form is still not well understood, partly because the dynamic processes of the inclusion body formation and its solubilization have hardly been investigated at an individual cell level, and so the important detailed information has not been acquired for the mechanism. In this study, we investigated the in vivo folding and aggregation of Aspergillus phoenicis beta-D-galactosidase fused to a red fluorescence protein in individual Escherichia coli cells. The folding status and expression level of the recombinant beta-D-galactosidase at an individual cell level was analyzed by flow cytometry in combination with transmission electron microscopy and Western blotting. We found that individual E. coli cells fell into two distinct states, one containing only inclusion bodies accompanied with low galactosidase activity and the other containing the recombinant soluble galactosidase accompanied with high galactosidase activity. The majority of the E. coli cells in the later state possessed no inclusion bodies. The two states of the cells were shifted to a cell state with high enzyme activity by culturing the cells in isopropyl 1-thio-beta-D-galactopyranoside-free medium after an initial protein expression induction in isopropyl 1-thio-beta-D-galactopyranoside-containing medium. This shift of the cell population status took place without the level change of the beta-D-galactosidase protein in individual cells, indicating that the factor(s) besides the crowdedness of the recombinant protein play a major role in the cell state transition. These results shed new light on the mechanism of inclusion body formation and will facilitate the development of new strategies in improving recombinant protein quality.	[Liu, Wei-Feng; Feng, Li-Kui; Yan, Yong-Bin] Tsinghua Univ, Sch Life Sci, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China; [Sun, Lei] Chinese Acad Sci, Inst Biophys, Ctr Biol Imaging, Beijing 100101, Peoples R China; [Zhao, Yun; He, Wei; Liu, Chun-Chun; Hang, Hai-Ying] Chinese Acad Sci, Inst Biophys, Key Lab Prot & Peptide Pharmaceut, Beijing 100101, Peoples R China; [Zhao, Yun; He, Wei; Liu, Chun-Chun] Chinese Acad Sci, Grad Sch, Beijing 100039, Peoples R China	Tsinghua University; Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Yan, YB (corresponding author), Tsinghua Univ, Sch Life Sci, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China.	ybyan@tsinghua.edu.cn; hh91@sun5.ibp.ac.cn	Yan, Yong-Bin/A-4282-2008; He, Wei/K-4776-2014; Feng, Likui/AAC-4957-2020	Yan, Yong-Bin/0000-0002-8565-3558; Feng, Likui/0000-0003-4601-4224	National Key Basic Research Program of China (973) [2011CBA00906]; Ministry of Science and Technology [2011YQ03013404]; National Natural Science Foundation of China [30970559]	National Key Basic Research Program of China (973)(National Basic Research Program of China); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Grant 2011CBA00906 (to H.-Y.H.) from the National Key Basic Research Program of China (973) and Grant 2011YQ03013404 (to H.-Y.H.) from the National Special Projects for Key Scientific Instruments and Equipment Development of Ministry of Science and Technology, and Grant 30970559 (to Y.-B.Y.) from the National Natural Science Foundation of China.	Ami D, 2005, FEBS LETT, V579, P3433, DOI 10.1016/j.febslet.2005.04.085; Baneyx F, 2004, NAT BIOTECHNOL, V22, P1399, DOI 10.1038/nbt1029; BOWDEN GA, 1991, BIO-TECHNOL, V9, P725, DOI 10.1038/nbt0891-725; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Carrio MM, 2005, J BACTERIOL, V187, P3599, DOI 10.1128/JB.187.10.3599-3601.2005; Carrio MM, 2001, FEBS LETT, V489, P29, DOI 10.1016/S0014-5793(01)02073-7; Carrio MM, 2000, FEBS LETT, V471, P7, DOI 10.1016/S0014-5793(00)01357-0; Choe WS, 2003, BIOTECHNOL BIOENG, V81, P221, DOI 10.1002/bit.10471; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Fink AL, 1998, FOLD DES, V3, pR9, DOI 10.1016/S1359-0278(98)00002-9; Garcia-Fruitos E, 2005, MICROB CELL FACT, V4, DOI 10.1186/1475-2859-4-27; Garcia-Fruitos E, 2005, BIOTECHNOL BIOENG, V90, P869, DOI 10.1002/bit.20496; Garcia-Fruitos E, 2007, J MOL BIOL, V374, P195, DOI 10.1016/j.jmb.2007.09.004; GATENBY AA, 1990, TRENDS BIOTECHNOL, V8, P354, DOI 10.1016/0167-7799(90)90224-L; Hedhammar M, 2005, J BIOTECHNOL, V119, P133, DOI 10.1016/j.jbiotec.2005.03.024; Hunt I, 2005, PROTEIN EXPRES PURIF, V40, P1, DOI 10.1016/j.pep.2004.10.018; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; LavergneMazeau F, 1996, APPL ENVIRON MICROB, V62, P3042, DOI 10.1128/AEM.62.8.3042-3046.1996; [Lei Hongxing 雷红星], 2011, [生物物理学报, Acta Biophysica Sinica], V27, P187; Lei HX, 2010, PROTEIN CELL, V1, P312, DOI 10.1007/s13238-010-0046-6; Makrides SC, 1996, MICROBIOL REV, V60, P512, DOI 10.1128/MMBR.60.3.512-538.1996; Markossian KA, 2004, BIOCHEMISTRY-MOSCOW+, V69, P971, DOI 10.1023/B:BIRY.0000043539.07961.4c; Morell M, 2008, BBA-MOL CELL RES, V1783, P1815, DOI 10.1016/j.bbamcr.2008.06.007; Patkar A, 2002, J BIOTECHNOL, V93, P217, DOI 10.1016/S0168-1656(01)00399-6; PLOVINS A, 1994, APPL ENVIRON MICROB, V60, P4638, DOI 10.1128/AEM.60.12.4638-4641.1994; Sambrook J., 2002, MOL CLONING LAB MANU; SCHEIN CH, 1989, BIO-TECHNOL, V7, P1141; Sorensen HP, 2005, MICROB CELL FACT, V4, DOI 10.1186/1475-2859-4-1; Sorensen HP, 2005, J BIOTECHNOL, V115, P113, DOI 10.1016/j.jbiotec.2004.08.004; Speed MA, 1996, NAT BIOTECHNOL, V14, P1283, DOI 10.1038/nbt1096-1283; STRANDBERG L, 1991, APPL ENVIRON MICROB, V57, P1669, DOI 10.1128/AEM.57.6.1669-1674.1991; TAYLOR G, 1986, BIO-TECHNOL, V4, P553, DOI 10.1038/nbt0686-553; Teschke Carolyn M., 1992, Current Opinion in Biotechnology, V3, P468, DOI 10.1016/0958-1669(92)90073-R; Thomas JG, 1997, APPL BIOCHEM BIOTECH, V66, P197, DOI 10.1007/BF02785589; Ventura S, 2006, TRENDS BIOTECHNOL, V24, P179, DOI 10.1016/j.tibtech.2006.02.007; WILKINSON DL, 1991, BIO-TECHNOL, V9, P443, DOI 10.1038/nbt0591-443	36	13	15	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					9259	9268		10.1074/jbc.M111.327668	http://dx.doi.org/10.1074/jbc.M111.327668			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22303013	hybrid, Green Published			2022-12-25	WOS:000301797800054
J	Budimir, N; Huckriede, A; Meijerhof, T; Boon, L; Gostick, E; Price, DA; Wilschut, J; de Haan, A				Budimir, Natalija; Huckriede, Anke; Meijerhof, Tjarko; Boon, Louis; Gostick, Emma; Price, David A.; Wilschut, Jan; de Haan, Aalzen			Induction of Heterosubtypic Cross-Protection against Influenza by a Whole Inactivated Virus Vaccine: The Role of Viral Membrane Fusion Activity	PLOS ONE			English	Article							T-CELL RESPONSES; IMMUNITY; ANTIGEN; NUCLEOPROTEIN; RECOGNITION; H5N1; MECHANISMS; INFECTION; PROSPECTS; CLONES	Background: The inability of seasonal influenza vaccines to effectively protect against infection with antigenically drifted viruses or newly emerging pandemic viruses underlines the need for development of cross-reactive influenza vaccines that induce immunity against a variety of virus subtypes. Therefore, potential cross-protective vaccines, e.g., whole inactivated virus (WIV) vaccine, that can target conserved internal antigens such as the nucleoprotein (NP) and/or matrix protein (M1) need to be explored. Methodology/Principal Findings: In the current study we show that a WIV vaccine, through induction of cross-protective cytotoxic T lymphocytes (CTLs), protects mice from heterosubtypic infection. This protection was abrogated after depletion of CD8+ cells in vaccinated mice, indicating that CTLs were the primary mediators of protection. Previously, we have shown that different procedures used for virus inactivation influence optimal activation of CTLs by WIV, most likely by affecting the membrane fusion properties of the virus. Specifically, inactivation with formalin (FA) severely compromises fusion activity of the virus, while inactivation with beta-propiolactone (BPL) preserves fusion activity. Here, we demonstrate that vaccination of mice with BPL-inactivated H5N1 WIV vaccine induces solid protection from lethal heterosubtypic H1N1 challenge. By contrast, vaccination with FA-inactivated WIV, while preventing death after lethal challenge, failed to protect against development of disease and severe body weight loss. Vaccination with BPL-inactivated WIV, compared to FA-inactivated WIV, induced higher levels of specific CD8+ T cells in blood, spleen and lungs, and a higher production of granzyme B in the lungs upon H1N1 virus challenge. Conclusion/Significance: The results underline the potential use of WIV as a cross-protective influenza vaccine candidate. However, careful choice of the virus inactivation procedure is important to retain membrane fusion activity and full immunogenicity of the vaccine.	[Budimir, Natalija; Huckriede, Anke; Meijerhof, Tjarko; Wilschut, Jan; de Haan, Aalzen] Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol, Mol Virol Sect, NL-9713 AV Groningen, Netherlands; [Boon, Louis] Bioceros, Utrecht, Netherlands; [Gostick, Emma; Price, David A.] Cardiff Univ, Sch Med, Dept Infect Immun & Biochem, Cardiff, S Glam, Wales	University of Groningen; Cardiff University	Budimir, N (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol, Mol Virol Sect, NL-9713 AV Groningen, Netherlands.	aalzen.de.haan@umcg.nl	Huckriede, Anke/P-3558-2019; Boon, Laurence/HCI-3629-2022; Price, David A/C-7876-2013	Huckriede, Anke/0000-0002-2646-5143; Price, David A/0000-0001-9416-2737; Boon, Louis/0000-0002-0937-9171	Top Institute Pharma, The Netherlands [T214-4-1]; Jan Kornelis de Cock Stichting	Top Institute Pharma, The Netherlands(Netherlands Government); Jan Kornelis de Cock Stichting	This study was partially performed in the context of project T214-4-1 financed by Top Institute Pharma, The Netherlands and by Jan Kornelis de Cock Stichting. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman AL, 2004, NAT IMMUNOL, V5, P678, DOI 10.1038/ni1082; Amigorena S, 2010, CURR OPIN IMMUNOL, V22, P109, DOI 10.1016/j.coi.2010.01.022; [Anonymous], INFL VACC SPLIT VIR; BENDER A, 1995, J EXP MED, V182, P1663, DOI 10.1084/jem.182.6.1663; BENNINK JR, 1982, NATURE, V296, P75, DOI 10.1038/296075a0; BLACKBURN NK, 1991, J VIROL METHODS, V33, P367, DOI 10.1016/0166-0934(91)90036-Y; Bodewes R, 2010, J GEN VIROL, V91, P1743, DOI 10.1099/vir.0.020784-0; Budimir N, 2010, VACCINE, V28, P8280, DOI 10.1016/j.vaccine.2010.10.007; Bungener L, 2008, VACCINE, V26, P2350, DOI 10.1016/j.vaccine.2008.02.063; Cao B, 2009, NEW ENGL J MED, V361, P2507, DOI 10.1056/NEJMoa0906612; Combadiere B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010818; Couch RB, 2011, BIRKHAUSER ADV INFEC, P359, DOI 10.1007/978-3-0346-0279-2_15; Coutsinos Z, 2005, FEMS IMMUNOL MED MIC, V43, P357, DOI 10.1016/j.femsim.2004.09.003; de Jong JC, 2000, J MED VIROL, V61, P94, DOI 10.1002/(SICI)1096-9071(200005)61:1&lt;94::AID-JMV15&gt;3.0.CO;2-C; de Jonge J, 2006, GENE THER, V13, P400, DOI 10.1038/sj.gt.3302673; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Doherty PC, 2006, NAT IMMUNOL, V7, P449, DOI 10.1038/ni1343; Doherty PC, 2008, J CLIN INVEST, V118, P3273, DOI 10.1172/JCI37232; Dormitzer PR, 2011, IMMUNOL REV, V239, P167, DOI 10.1111/j.1600-065X.2010.00974.x; Epstein Suzanne L, 2003, Expert Rev Anti Infect Ther, V1, P627, DOI 10.1586/14787210.1.4.627; Fonteneau JF, 2003, BLOOD, V101, P3520, DOI 10.1182/blood-2002-10-3063; Furuya Y, 2010, J VIROL, V84, P4212, DOI 10.1128/JVI.02508-09; Geeraedts F, 2010, AAPS J, V12, P215, DOI 10.1208/s12248-010-9179-z; Geeraedts F, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000138; Greenbaum JA, 2009, P NATL ACAD SCI USA, V106, P20365, DOI 10.1073/pnas.0911580106; Gromme M, 2002, MOL IMMUNOL, V39, P181, DOI 10.1016/S0161-5890(02)00101-3; Hanon EJ, 2008, United States patent application publication: US, Patent No. [2008/0014217, 20080014217]; Heiny AT, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001190; Hu AYC, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0014578, 10.1371/journal.pone.0029229]; Huckriede A, 2005, VACCINE, V23, pS26, DOI 10.1016/j.vaccine.2005.04.026; Kreijtz JHCM, 2008, J VIROL, V82, P5161, DOI 10.1128/JVI.02694-07; Lee LYH, 2008, J CLIN INVEST, V118, P3478, DOI 10.1172/JCI32460; MCMICHAEL AJ, 1983, NEW ENGL J MED, V309, P13, DOI 10.1056/NEJM198307073090103; MURPHY BR, 1988, J CLIN MICROBIOL, V26, P1595, DOI 10.1128/JCM.26.8.1595-1597.1988; Nabel GJ, 2010, NAT MED, V16, P1389, DOI 10.1038/nm1210-1389; Nicholson KG, 2003, LANCET, V362, P1733, DOI 10.1016/S0140-6736(03)14854-4; OXFORD JS, 1981, J BIOL STAND, V9, P483, DOI 10.1016/S0092-1157(81)80041-8; Price DA, 2005, J EXP MED, V202, P1349, DOI 10.1084/jem.20051357; Rock KL, 2005, IMMUNOL REV, V207, P166, DOI 10.1111/j.0105-2896.2005.00301.x; Sandbulte MR, 2007, PLOS MED, V4, P265, DOI 10.1371/journal.pmed.0040059; Schotsaert M, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/863985; Settembre EC, 2011, J MOL CELL BIOL, V3, P144, DOI 10.1093/jmcb/mjq046; Shen H, 2006, IMMUNOLOGY, V117, P78, DOI 10.1111/j.1365-2567.2005.02268.x; TAYLOR PM, 1986, IMMUNOLOGY, V58, P417; Teijaro JR, 2010, J VIROL, V84, P9217, DOI 10.1128/JVI.01069-10; TOWNSEND ARM, 1984, J EXP MED, V160, P552, DOI 10.1084/jem.160.2.552; TOWNSEND ARM, 1982, NATURE, V300, P655, DOI 10.1038/300655a0; Wagner H, 2004, CURR OPIN BIOTECH, V15, P538, DOI 10.1016/j.copbio.2004.09.006; Wagner H, 2009, ADV DRUG DELIVER REV, V61, P243, DOI 10.1016/j.addr.2008.12.010; Wrammert J, 2011, J EXP MED, V208, P181, DOI 10.1084/jem.20101352; YEWDELL JW, 1985, P NATL ACAD SCI USA, V82, P1785, DOI 10.1073/pnas.82.6.1785	51	60	63	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2012	7	1							e30898	10.1371/journal.pone.0030898	http://dx.doi.org/10.1371/journal.pone.0030898			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911GB	22303469	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000301704200045
J	Hirsch, A; Hahn, D; Kempna, P; Hofer, G; Mullis, PE; Nuoffer, JM; Fluck, CE				Hirsch, Andrea; Hahn, Dagmar; Kempna, Petra; Hofer, Gaby; Mullis, Primus E.; Nuoffer, Jean-Marc; Flueck, Christa E.			Role of AMP-Activated Protein Kinase on Steroid Hormone Biosynthesis in Adrenal NCI-H295R Cells	PLOS ONE			English	Article							SKELETAL-MUSCLE; GRANULOSA-CELLS; 3-BETA-HYDROXYSTEROID DEHYDROGENASE; PROGESTERONE SECRETION; 17,20-LYASE ACTIVITY; LEUKEMIA-CELLS; P450C17; APOPTOSIS; PATHWAY; AICAR	Regulation of human androgen biosynthesis is poorly understood. However, detailed knowledge is needed to eventually solve disorders with androgen dysbalance. We showed that starvation growth conditions shift steroidogenesis of human adrenal NCI-H295R cells towards androgen production attributable to decreased HSD3B2 expression and activity and increased CYP17A1 phosphorylation and 17,20-lyase activity. Generally, starvation induces stress and energy deprivation that need to be counteracted to maintain proper cell functions. AMP-activated protein kinase (AMPK) is a master energy sensor that regulates cellular energy balance. AMPK regulates steroidogenesis in the gonad. Therefore, we investigated whether AMPK is also a regulator of adrenal steroidogenesis. We hypothesized that starvation uses AMPK signaling to enhance androgen production in NCI-H295R cells. We found that AMPK subunits are expressed in NCI-H295 cells, normal adrenal tissue and human as well as pig ovary cells. Starvation growth conditions decreased phosphorylation, but not activity of AMPK in NCI-H295 cells. In contrast, the AMPK activator 5-aminoimidazole-4-carboxamide (AICAR) increased AMPK alpha phosphorylation and increased CYP17A1-17,20 lyase activity. Compound C (an AMPK inhibitor), directly inhibited CYP17A1 activities and can therefore not be used for AMPK signaling studies in steroidogenesis. HSD3B2 activity was neither altered by AICAR nor compound C. Starvation did not affect mitochondrial respiratory chain function in NCI-H295R cells suggesting that there is no indirect energy effect on AMPK through this avenue. In summary, starvation-mediated increase of androgen production in NCI-H295 cells does not seem to be mediated by AMPK signaling. But AMPK activation can enhance androgen production through a specific increase in CYP17A1-17,20 lyase activity.	[Hirsch, Andrea; Hahn, Dagmar; Kempna, Petra; Hofer, Gaby; Mullis, Primus E.; Nuoffer, Jean-Marc; Flueck, Christa E.] Univ Bern, Inselspital, Univ Hosp, Div Pediat Endocrinol Diabetol & Metab,Dept Pedia, CH-3010 Bern, Switzerland; [Hirsch, Andrea; Kempna, Petra; Hofer, Gaby; Mullis, Primus E.; Nuoffer, Jean-Marc; Flueck, Christa E.] Univ Bern, Inselspital, Univ Hosp, Dept Clin Res, CH-3010 Bern, Switzerland; [Hahn, Dagmar; Nuoffer, Jean-Marc] Univ Bern, Inselspital, Univ Hosp, Inst Clin Chem, CH-3010 Bern, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern	Hirsch, A (corresponding author), Univ Bern, Inselspital, Univ Hosp, Div Pediat Endocrinol Diabetol & Metab,Dept Pedia, CH-3010 Bern, Switzerland.	christa.flueck@dkf.unibe.ch	; Nuoffer, Jean-Marc/C-8936-2009	Flueck, Christa/0000-0002-4568-5504; Nuoffer, Jean-Marc/0000-0003-3650-6153	Swiss National Science Foundation [31003A-130710]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by a grant of the Swiss National Science Foundation (31003A-130710) to CEF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi DR, 2006, ANNU REV BIOCHEM, V75, P137, DOI 10.1146/annurev.biochem.75.103004.142702; Arlt W, 2001, J BIOL CHEM, V276, P16767, DOI 10.1074/jbc.M100040200; Auchus RJ, 1998, J BIOL CHEM, V273, P3158, DOI 10.1074/jbc.273.6.3158; Carling D, 2004, TRENDS BIOCHEM SCI, V29, P18, DOI 10.1016/j.tibs.2003.11.005; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; Eberhart K, 2011, BBA-BIOENERGETICS, V1807, P719, DOI 10.1016/j.bbabio.2010.12.010; Emerling BM, 2007, FEBS LETT, V581, P5727, DOI 10.1016/j.febslet.2007.11.038; Fluck CE, 2003, J CLIN ENDOCR METAB, V88, P3762, DOI 10.1210/jc.2003-030143; GAZDAR AF, 1990, CANCER RES, V50, P5488; Hardie DG, 2001, BIOESSAYS, V23, P1112, DOI 10.1002/bies.10009; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Kempna P, 2010, ENDOCRINOLOGY, V151, P3686, DOI 10.1210/en.2010-0093; Lage R, 2008, TRENDS MOL MED, V14, P539, DOI 10.1016/j.molmed.2008.09.007; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Mahlapuu M, 2004, AM J PHYSIOL-ENDOC M, V286, pE194, DOI 10.1152/ajpendo.00147.2003; Miller WL, 2011, ENDOCR REV, V32, P81, DOI 10.1210/er.2010-0013; Miller WL, 2009, REV ENDOCR METAB DIS, V10, P3, DOI 10.1007/s11154-008-9102-4; Nam M, 2008, ARCH BIOCHEM BIOPHYS, V479, P74, DOI 10.1016/j.abb.2008.07.029; Ramanjaneya M, 2011, BBA-MOL CELL RES, V1813, P802, DOI 10.1016/j.bbamcr.2011.02.010; Renner K, 2003, BBA-MOL CELL RES, V1642, P115, DOI 10.1016/S0167-4889(03)00105-8; Samandari E, 2007, J ENDOCRINOL, V195, P459, DOI 10.1677/JOE-07-0166; Sanders MJ, 2007, BIOCHEM J, V403, P139, DOI 10.1042/BJ20061520; Santidrian AF, 2010, BLOOD, V116, P3023, DOI 10.1182/blood-2010-05-283960; Schaller A, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-4; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Stapleton D, 1996, J BIOL CHEM, V271, P611, DOI 10.1074/jbc.271.2.611; Stapleton D, 1997, FEBS LETT, V409, P452, DOI 10.1016/S0014-5793(97)00569-3; SULLIVAN JE, 1994, FEBS LETT, V353, P33, DOI 10.1016/0014-5793(94)01006-4; Thornton C, 1998, J BIOL CHEM, V273, P12443, DOI 10.1074/jbc.273.20.12443; Tosca L, 2005, ENDOCRINOLOGY, V146, P4500, DOI 10.1210/en.2005-0301; Tosca L, 2007, BIOL REPROD, V76, P368, DOI 10.1095/biolreprod.106.055749; Tosca L, 2006, J ENDOCRINOL, V190, P85, DOI 10.1677/joe.1.06828; Waterman MR, 1996, ENDOCR RES, V22, P615, DOI 10.1080/07435809609043755; Winder WW, 2000, J APPL PHYSIOL, V88, P2219, DOI 10.1152/jappl.2000.88.6.2219; Zang Y, 2008, J BIOL CHEM, V283, P6201, DOI 10.1074/jbc.M708619200	36	16	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e30956	10.1371/journal.pone.0030956	http://dx.doi.org/10.1371/journal.pone.0030956			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910ME	22295121	Green Published, Green Submitted, gold			2022-12-25	WOS:000301640600066
J	Peng, H; Chang, BH; Lu, CL; Su, JM; Wu, YY; Lv, P; Wang, YS; Liu, J; Zhang, BW; Quan, FS; Guo, ZK; Zhang, Y				Peng, Hui; Chang, Bohao; Lu, Chenglong; Su, Jianmin; Wu, Yongyan; Lv, Pin; Wang, Yongsheng; Liu, Jun; Zhang, Bowei; Quan, Fusheng; Guo, Zekun; Zhang, Yong			Nlrp2, a Maternal Effect Gene Required for Early Embryonic Development in the Mouse	PLOS ONE			English	Article							LEUCINE-RICH REPEAT; NF-KAPPA-B; PYRIN DOMAIN; PREIMPLANTATION EMBRYOS; GENOME ACTIVATION; EXPRESSION; PROTEIN; OOCYTES; INFLAMMASOME; MUTATIONS	Maternal effect genes encode proteins that are produced during oogenesis and play an essential role during early embryogenesis. Genetic ablation of such genes in oocytes can result in female subfertility or infertility. Here we report a newly identified maternal effect gene, Nlrp2, which plays a role in early embryogenesis in the mouse. Nlrp2 mRNAs and their proteins (similar to 118 KDa) are expressed in oocytes and granulosa cells during folliculogenesis. The transcripts show a striking decline in early preimplantation embryos before zygotic genome activation, but the proteins remain present through to the blastocyst stage. Immunogold electron microscopy revealed that the NLRP2 protein is located in the cytoplasm, nucleus and close to nuclear pores in the oocytes, as well as in the surrounding granulosa cells. Using RNA interference, we knocked down Nlrp2 transcription specifically in mouse germinal vesicle oocytes. The knockdown oocytes could progress through the metaphase of meiosis I and emit the first polar body. However, the development of parthenogenetic embryos derived from Nlrp2 knockdown oocytes mainly blocked at the 2-cell stage. The maternal depletion of Nlrp2 in zygotes led to early embryonic arrest. In addition, overexpression of Nlrp2 in zygotes appears to lead to normal development, but increases blastomere apoptosis in blastocysts. These results provide the first evidence that Nlrp2 is a member of the mammalian maternal effect genes and required for early embryonic development in the mouse.	[Peng, Hui; Chang, Bohao; Lu, Chenglong; Su, Jianmin; Wu, Yongyan; Lv, Pin; Wang, Yongsheng; Liu, Jun; Zhang, Bowei; Quan, Fusheng; Zhang, Yong] NW A&F Univ, Coll Vet Med, Key Lab Anim Reprod Physiol & Embryo Technol, Yangling, Shanxi, Peoples R China; [Guo, Zekun] NW A&F Univ, Coll Life Sci, Dept Biochem & Mol Biol, Yangling, Shanxi, Peoples R China	Northwest A&F University - China; Northwest A&F University - China	Peng, H (corresponding author), NW A&F Univ, Coll Vet Med, Key Lab Anim Reprod Physiol & Embryo Technol, Yangling, Shanxi, Peoples R China.		Zhang, Yong/K-7945-2016; Wu, Yongyan/AAH-1471-2019	Zhang, Yong/0000-0001-8642-4071; Wu, Yongyan/0000-0003-1669-3860	National Key Project for Production of Transgenic Livestock, People's Republic of China [2008ZX08007-004]	National Key Project for Production of Transgenic Livestock, People's Republic of China	This work was supported by the National Key Project for Production of Transgenic Livestock, People's Republic of China (No. 2008ZX08007-004, http://www.most.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BECK F, 1995, DEV DYNAM, V204, P219, DOI 10.1002/aja.1002040302; Bertin J, 2000, CELL DEATH DIFFER, V7, P1273, DOI 10.1038/sj.cdd.4400774; Biggers JD, 2000, BIOL REPROD, V63, P281, DOI 10.1095/biolreprod63.1.281; Bortvin Alex, 2004, BMC Developmental Biology, V4; Bowerman B, 1998, CURR TOP DEV BIOL, V39, P73, DOI 10.1016/S0070-2153(08)60453-6; Boyden ED, 2006, NAT GENET, V38, P240, DOI 10.1038/ng1724; Bruey JM, 2004, J BIOL CHEM, V279, P51897, DOI 10.1074/jbc.M406741200; Bultman SJ, 2006, GENE DEV, V20, P1744, DOI 10.1101/gad.1435106; Burns KH, 2003, SCIENCE, V300, P633, DOI 10.1126/science.1081813; Christians E, 2000, NATURE, V407, P693, DOI 10.1038/35037669; Conti BJ, 2005, J BIOL CHEM, V280, P18375, DOI 10.1074/jbc.M413169200; Dade S, 2004, BIOCHEM BIOPH RES CO, V324, P547, DOI 10.1016/j.bbrc.2004.09.086; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Dumont J, 2007, DEV BIOL, V301, P254, DOI 10.1016/j.ydbio.2006.08.044; Eisenbarth SC, 2008, NATURE, V453, P1122, DOI 10.1038/nature06939; Evsikov AV, 2006, GENE DEV, V20, P2713, DOI 10.1101/gad.1471006; Fontalba A, 2007, J IMMUNOL, V179, P8519, DOI 10.4049/jimmunol.179.12.8519; Grabarek JB, 2002, GENESIS, V32, P269, DOI 10.1002/gene.10076; Gross O, 2009, NATURE, V459, P433, DOI 10.1038/nature07965; Guarda G, 2009, NATURE, V460, P269, DOI 10.1038/nature08100; Gurtu VE, 2002, GENETICS, V160, P271; Hamatani T, 2004, HUM MOL GENET, V13, P2263, DOI 10.1093/hmg/ddh241; Harton JA, 2002, J IMMUNOL, V169, P4088, DOI 10.4049/jimmunol.169.8.4088; Horikawa M, 2005, BIOL REPROD, V72, P879, DOI 10.1095/biolreprod.104.033753; Howell CY, 2001, CELL, V104, P829, DOI 10.1016/S0092-8674(01)00280-X; Kajava AV, 1998, J MOL BIOL, V277, P519, DOI 10.1006/jmbi.1998.1643; Kanneganti TD, 2006, NATURE, V440, P233, DOI 10.1038/nature04517; Kim MH, 2002, BIOCHEM BIOPH RES CO, V296, P1372, DOI 10.1016/S0006-291X(02)02070-3; KOBE B, 1995, NATURE, V374, P183, DOI 10.1038/374183a0; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Kohl A, 2004, CR BIOL, V327, P1077, DOI 10.1016/j.crvi.2004.08.006; Latham KE, 1999, INT REV CYTOL, V193, P71; LAWITTS JA, 1991, J REPROD FERTIL, V91, P543, DOI 10.1530/jrf.0.0910543; Leader B, 2002, NAT CELL BIOL, V4, P921, DOI 10.1038/ncb880; Li L, 2008, DEV CELL, V15, P416, DOI 10.1016/j.devcel.2008.07.010; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma J, 2006, DEVELOPMENT, V133, P2053, DOI 10.1242/dev.02371; Martinon F, 2001, CURR BIOL, V11, pR118, DOI 10.1016/S0960-9822(01)00056-2; McDaniel P, 2009, MOL REPROD DEV, V76, P151, DOI 10.1002/mrd.20937; Meyer E, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000423; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Moody SA, 1996, CURR TOP DEV BIOL, V32, P103, DOI 10.1016/S0070-2153(08)60426-3; Murdoch S, 2006, NAT GENET, V38, P300, DOI 10.1038/ng1740; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Nakamura T, 2007, NAT CELL BIOL, V9, P64, DOI 10.1038/ncb1519; NUSSLEINVOLHARD C, 1980, NATURE, V283, P474, DOI 10.1038/283474a0; Ohsugi M, 2008, DEVELOPMENT, V135, P259, DOI 10.1242/dev.011445; PALMIERI SL, 1994, DEV BIOL, V166, P259, DOI 10.1006/dbio.1994.1312; Payer B, 2003, CURR BIOL, V13, P2110, DOI 10.1016/j.cub.2003.11.026; Pennetier S, 2004, BIOL REPROD, V71, P1359, DOI 10.1095/biolreprod.104.030288; Pennetier S, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-26; Pisani LF, 2010, J REPROD DEVELOP, V56, P41, DOI 10.1262/jrd.09-098A; Ponsuksili S, 2006, BIOL REPROD, V74, P577, DOI 10.1095/biolreprod.105.045096; SCHUPBACH T, 1986, DEV BIOL, V113, P443, DOI 10.1016/0012-1606(86)90179-X; Strumpf D, 2005, DEVELOPMENT, V132, P2093, DOI 10.1242/dev.01801; Su JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023805; Svoboda P, 2000, DEVELOPMENT, V127, P4147; Tian X, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-202; Tong ZB, 2000, NAT GENET, V26, P267, DOI 10.1038/81547; Tong ZB, 2000, MAMM GENOME, V11, P281, DOI 10.1007/s003350010053; Tong ZB, 2004, ENDOCRINOLOGY, V145, P1427, DOI 10.1210/en.2003-1160; Tong ZB, 2002, HUM REPROD, V17, P903, DOI 10.1093/humrep/17.4.903; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Wang HH, 2008, DEV BIOL, V318, P112, DOI 10.1016/j.ydbio.2008.03.008; Westerveld GH, 2006, HUM REPROD, V21, P3178, DOI 10.1093/humrep/del293; Wianny F, 2000, NAT CELL BIOL, V2, P70, DOI 10.1038/35000016; Wu X, 2009, HUM REPROD, V24, P415, DOI 10.1093/humrep/den403; Wu XM, 2003, NAT GENET, V33, P187, DOI 10.1038/ng1079; Zhang P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002755; Zheng P, 2009, P NATL ACAD SCI USA, V106, P7473, DOI 10.1073/pnas.0900519106	70	71	77	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e30344	10.1371/journal.pone.0030344	http://dx.doi.org/10.1371/journal.pone.0030344			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910ME	22295082	Green Published, Green Submitted, gold			2022-12-25	WOS:000301640600027
J	Kravchenko, J; Akushevich, I; Sudenga, SL; Wilson, CM; Levitan, EB; Shrestha, S				Kravchenko, Julia; Akushevich, Igor; Sudenga, Staci L.; Wilson, Craig M.; Levitan, Emily B.; Shrestha, Sadeep			Transitional Probability-Based Model for HPV Clearance in HIV-1-Positive Adolescent Females	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS INFECTION; HUMAN-IMMUNODEFICIENCY-VIRUS; SQUAMOUS INTRAEPITHELIAL LESIONS; RISK HUMAN-PAPILLOMAVIRUS; CHLAMYDIA-TRACHOMATIS INFECTION; GENITAL HUMAN-PAPILLOMAVIRUS; CERVICAL-CANCER; CLINICAL MANIFESTATIONS; SEROPOSITIVE WOMEN; NATURAL-HISTORY	Background: HIV-1-positive patients clear the human papillomavirus (HPV) infection less frequently than HIV-1-negative. Datasets for estimating HPV clearance probability often have irregular measurements of HPV status and risk factors. A new transitional probability-based model for estimation of probability of HPV clearance was developed to fully incorporate information on HIV-1-related clinical data, such as CD4 counts, HIV-1 viral load (VL), highly active antiretroviral therapy (HAART), and risk factors (measured quarterly), and HPV infection status (measured at 6-month intervals). Methodology and Findings: Data from 266 HIV-1-positive and 134 at-risk HIV-1-negative adolescent females from the Reaching for Excellence in Adolescent Care and Health (REACH) cohort were used in this study. First, the associations were evaluated using the Cox proportional hazard model, and the variables that demonstrated significant effects on HPV clearance were included in transitional probability models. The new model established the efficacy of CD4 cell counts as a main clearance predictor for all type-specific HPV phylogenetic groups. The 3-month probability of HPV clearance in HIV-1-infected patients significantly increased with increasing CD4 counts for HPV16/16-like (p<0.001), HPV18/18-like (p<0.001), HPV56/56-like (p=0.05), and low-risk HPV (p<0.001) phylogenetic groups, with the lowest probability found for HPV16/16like infections (21.60 +/- 1.81% at CD4 level 200 cells/mm(3), p<0.05; and 28.03 +/- 1.47% at CD4 level 500 cells/mm(3)). HIV-1 VL was a significant predictor for clearance of low-risk HPV infections (p<0.05). HAART (with protease inhibitor) was significant predictor of probability of HPV16 clearance (p<0.05). HPV16/16-like and HPV18/18-like groups showed heterogeneity (p<0.05) in terms of how CD4 counts, HIV VL, and HAART affected probability of clearance of each HPV infection. Conclusions: This new model predicts the 3-month probability of HPV infection clearance based on CD4 cell counts and other HIV-1-related clinical measurements.	[Kravchenko, Julia] Duke Univ, Med Ctr, Duke Canc Inst, Durham, NC 27710 USA; [Akushevich, Igor] Duke Univ, Ctr Populat Hlth & Aging, Durham, NC USA; [Sudenga, Staci L.; Wilson, Craig M.; Levitan, Emily B.; Shrestha, Sadeep] Univ Alabama, Dept Epidemiol, Birmingham, AL USA	Duke University; Duke University; University of Alabama System; University of Alabama Birmingham	Kravchenko, J (corresponding author), Duke Univ, Med Ctr, Duke Canc Inst, Durham, NC 27710 USA.	julia.krauchanka@duke.edu; sshrestha@uab.edu	Sudenga, Staci/A-7726-2015; Sudenga, Staci/O-1545-2019	Sudenga, Staci/0000-0001-7305-8738; Levitan, Emily/0000-0002-5429-3852; Wilson, Craig/0000-0001-6869-1053	SPORE in Cervical Cancer [5P50CA098252-05]; Agency for Healthcare Research and Quality [K12HS019465]; Cancer Prevention and Control Training Program [5R25CA047888]; National Institute of Child Health and Human Development [U01-HD32830]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K12HS019465] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U01HD032830] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R25CA047888, P50CA098252] Funding Source: NIH RePORTER	SPORE in Cervical Cancer; Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Cancer Prevention and Control Training Program; National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by a career developmental award (SS) from the SPORE in Cervical Cancer (5P50CA098252-05). EBL was supported by the Agency for Healthcare Research and Quality (K12HS019465). SLS was supported by the Cancer Prevention and Control Training Program (5R25CA047888). The REACH study was supported by the National Institute of Child Health and Human Development (U01-HD32830). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahdieh L, 2000, AM J EPIDEMIOL, V151, P1148, DOI 10.1093/oxfordjournals.aje.a010165; Ahdieh L, 2001, J INFECT DIS, V184, P682, DOI 10.1086/323081; BONNEY GE, 1987, BIOMETRICS, V43, P951, DOI 10.2307/2531548; CLARK RA, 1993, CLIN INFECT DIS, V17, P165, DOI 10.1093/clinids/17.2.165; Crowley-Nowick PA, 2000, J INFECT DIS, V181, P939, DOI 10.1086/315311; Denny L, 2008, OBSTET GYNECOL, V111, P1380, DOI 10.1097/AOG.0b013e3181743327; FENNEMA JSA, 1995, AIDS, V9, P1071, DOI 10.1097/00002030-199509000-00014; Franco EL, 1999, J INFECT DIS, V180, P1415, DOI 10.1086/315086; Hampson L, 2006, ANTIVIR THER, V11, P813; Harris TG, 2005, JAMA-J AM MED ASSOC, V293, P1471, DOI 10.1001/jama.293.12.1471; HO GYF, 1995, JNCI-J NATL CANCER I, V87, P1365, DOI 10.1093/jnci/87.18.1365; Ho GYF, 1998, NEW ENGL J MED, V338, P423, DOI 10.1056/NEJM199802123380703; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Johansson M, 1997, SCAND J IMMUNOL, V46, P546, DOI 10.1046/j.1365-3083.1997.d01-167.x; Khanna Niharika, 2002, J Low Genit Tract Dis, V6, P111, DOI 10.1097/00128360-200204000-00007; Kjaer SK, 2016, BMJ-BRIT MED J, V353, DOI [10.1136/bmj.325.7364.572, 10.1136/bmj.i2820]; Kong XR, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-40; Koshiol JE, 2006, INT J CANCER, V119, P1623, DOI 10.1002/ijc.22015; Koskela P, 2000, INT J CANCER, V85, P35, DOI 10.1002/(SICI)1097-0215(20000101)85:1&lt;35::AID-IJC6&gt;3.0.CO;2-A; Kotloff KL, 1998, SEX TRANSM DIS, V25, P243, DOI 10.1097/00007435-199805000-00005; Kulmala SMA, 2007, CANCER EPIDEM BIOMAR, V16, P17, DOI 10.1158/1055-9965.EPI-06-0649; Lehtinen M, 2001, J CLIN VIROL, V22, P117, DOI 10.1016/S1386-6532(01)00172-X; Lillo FB, 2001, J INFECT DIS, V184, P547, DOI 10.1086/322856; Lorincz AT, 2002, LANCET, V360, P228, DOI 10.1016/S0140-6736(02)09463-1; Molano M, 2003, AM J EPIDEMIOL, V158, P486, DOI 10.1093/aje/kwg171; Moscicki AB, 2004, J INFECT DIS, V190, P37, DOI 10.1086/421467; Moscicki AB, 2004, J INFECT DIS, V190, P1413, DOI 10.1086/424466; Moscicki AB, 2000, ARCH PEDIAT ADOL MED, V154, P127, DOI 10.1001/archpedi.154.2.127; Murphy DA, 2001, AIDS CARE, V13, P27, DOI 10.1080/09540120020018161; Nakagawa M, 1997, J INFECT DIS, V175, P927, DOI 10.1086/513992; Nobbenhuis MAE, 2001, LANCET, V358, P1782, DOI 10.1016/S0140-6736(01)06809-X; Rogers AS, 1998, J ADOLESCENT HEALTH, V22, P300, DOI 10.1016/S1054-139X(97)00279-6; Rosenblatt A, 2009, HUMAN PAPILLOMAVIRUS: A PRACTICAL GUIDE FOR UROLOGISTS, P163, DOI 10.1007/978-3-540-70974-9_9; Rowhani-Rahbar A, 2007, J INFECT DIS, V196, P887, DOI 10.1086/520883; Schiffman M, 2005, VIROLOGY, V337, P76, DOI 10.1016/j.virol.2005.04.002; Schiffman Mark H, 2003, J Natl Cancer Inst, V95, pE2; Shrestha S., 2007, CANCER EPIDEM BIOMAR, V16, P1; Shrestha S, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-295; Silverberg MJ, 2006, CLIN VACCINE IMMUNOL, V13, P511, DOI 10.1128/CVI.13.4.511-519.2006; Sobhani I, 2004, AIDS, V18, P1561, DOI 10.1097/01.aids.0000131335.15301.dd; Strickler HD, 2003, JNCI-J NATL CANCER I, V95, P1062, DOI 10.1093/jnci/95.14.1062; SU H, 1995, INFECT IMMUN, V63, P3302, DOI 10.1128/IAI.63.9.3302-3308.1995; Sun XW, 1997, NEW ENGL J MED, V337, P1343, DOI 10.1056/NEJM199711063371903; SUN XW, 1995, OBSTET GYNECOL, V85, P680, DOI 10.1016/0029-7844(95)00025-M; Taubman SL, 2009, INT J EPIDEMIOL, V38, P1599, DOI 10.1093/ije/dyp192; VANRANST M, 1992, J GEN VIROL, V73, P2653, DOI 10.1099/0022-1317-73-10-2653; VERMUND SH, 1991, AM J OBSTET GYNECOL, V165, P392, DOI 10.1016/0002-9378(91)90101-V; WILLIAMS DA, 1975, BIOMETRICS, V31, P949, DOI 10.2307/2529820; Woodman CBJ, 2007, NAT REV CANCER, V7, P11, DOI 10.1038/nrc2050; Xue X, CANC EPIDEMIOL BIOMA, V19, P159; Yashin AI, 1997, STAT SCI, V12, P20; Yashin AI, 2007, MATH BIOSCI, V208, P538, DOI 10.1016/j.mbs.2006.11.006; [No title captured], DOI DOI 10.1080/08898480590932296	53	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2012	7	1							e30736	10.1371/journal.pone.0030736	http://dx.doi.org/10.1371/journal.pone.0030736			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910LV	22292027	Green Published, Green Submitted, gold			2022-12-25	WOS:000301639600051
J	Riparbelli, MG; Giordano, R; Ueyama, M; Callaini, G				Riparbelli, Maria Giovanna; Giordano, Rosanna; Ueyama, Morio; Callaini, Giuliano			Wolbachia-Mediated Male Killing Is Associated with Defective Chromatin Remodeling	PLOS ONE			English	Article							SEX-RATIO CONDITION; CYTOPLASMIC INCOMPATIBILITY; DROSOPHILA-INNUBILA; BACTERIAL DENSITY; FREE CENTROSOMES; MEIOTIC SPINDLE; HOST; EXPRESSION; INFECTION; FERTILIZATION	Male killing, induced by different bacterial taxa of maternally inherited microorganisms, resulting in highly distorted female-biased sex-ratios, is a common phenomenon among arthropods. Some strains of the endosymbiont bacteria Wolbachia have been shown to induce this phenotype in particular insect hosts. High altitude populations of Drosophila bifasciata infected with Wolbachia show selective male killing during embryonic development. However, since this was first reported, circa 60 years ago, the interaction between Wolbachia and its host has remained unclear. Herein we show that D. bifasciata male embryos display defective chromatin remodeling, improper chromatid segregation and chromosome bridging, as well as abnormal mitotic spindles and gradual loss of their centrosomes. These defects occur at different times in the early development of male embryos leading to death during early nuclear division cycles or large defective areas of the cellular blastoderm, culminating in abnormal embryos that die before eclosion. We propose that Wolbachia affects the development of male embryos by specifically targeting male chromatin remodeling and thus disturbing mitotic spindle assembly and chromosome behavior. These are the first observations that demonstrate fundamental aspects of the cytological mechanism of male killing and represent a solid base for further molecular studies of this phenomenon.	[Riparbelli, Maria Giovanna; Callaini, Giuliano] Univ Siena, Dept Evolutionary Biol, I-53100 Siena, Italy; [Giordano, Rosanna] Univ Illinois, Illinois Nat Hist Survey, Inst Nat Resource Sustainabil, Champaign, IL USA; [Ueyama, Morio] Soka Univ, Cell Biol Lab, Dept Bioinformat, Hachioji, Tokyo, Japan	University of Siena; Illinois Natural History Survey; University of Illinois System; University of Illinois Urbana-Champaign; Soka University	Riparbelli, MG (corresponding author), Univ Siena, Dept Evolutionary Biol, Via Laterina 8, I-53100 Siena, Italy.	Callaini@unisi.it	Callaini, Giuliano/T-6353-2018	Callaini, Giuliano/0000-0003-2252-0309; Giordano, Rosanna/0000-0002-6175-2981; Ueyama, Morio/0000-0002-2950-7361				Belmont AS, 2006, CURR OPIN CELL BIOL, V18, P632, DOI 10.1016/j.ceb.2006.09.007; Bentley JK, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-9; BOPP D, 1991, GENE DEV, V5, P96; Bourtzis K, 2003, CONT T ENT, P217; BOYLE L, 1993, SCIENCE, V260, P1796, DOI 10.1126/science.8511587; BREEUWER JAJ, 1993, GENETICS, V135, P565; BRESSAC C, 1993, J INVERTEBR PATHOL, V61, P226, DOI 10.1006/jipa.1993.1044; Callaini G, 1997, J CELL SCI, V110, P271; Callaini G, 1996, DEV BIOL, V176, P199, DOI 10.1006/dbio.1996.0127; CALLAINI G, 1994, J CELL SCI, V107, P673; Charlat S, 2007, BIOL LETTERS, V3, P154, DOI 10.1098/rsbl.2006.0584; Clancy DJ, 1998, ENTOMOL EXP APPL, V86, P13, DOI 10.1023/A:1003043814761; COUNCE SJ, 1962, J EXP ZOOL, V151, P17, DOI 10.1002/jez.1401510103; Debec A, 1996, J CELL BIOL, V134, P103, DOI 10.1083/jcb.134.1.103; Dyer KA, 2005, EVOLUTION, V59, P838, DOI 10.1111/j.0014-3820.2005.tb01757.x; Dyer KA, 2004, GENETICS, V168, P1443, DOI 10.1534/genetics.104.027854; Endow SA, 1998, J CELL SCI, V111, P2487; Ferree PM, 2008, CURR BIOL, V18, P1409, DOI 10.1016/j.cub.2008.07.093; Ferree PM, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000234; Fialho RF, 2000, P ROY SOC B-BIOL SCI, V267, P1469, DOI 10.1098/rspb.2000.1166; GONZALEZ C, 1990, J CELL SCI, V96, P605; Harris HL, 2003, BIOCHEM CELL BIOL, V81, P229, DOI [10.1139/o03-053, 10.1139/O03-053]; Hurst CDD, 1997, INFLUENTIAL PASSENGERS, P125; Hurst GDD, 2000, EMERG INFECT DIS, V6, P329, DOI 10.3201/eid0604.000402; Hurst GDD, 2000, GENETICS, V156, P699; IKEDA H, 1970, GENETICS, V65, P311; Ivanovska I, 2006, CELL CYCLE, V5, P2064, DOI 10.4161/cc.5.18.3253; Jaenike J, 2007, EVOLUTION, V61, P2244, DOI 10.1111/j.1558-5646.2007.00180.x; Jiggins FM, 2001, HEREDITY, V86, P161, DOI 10.1046/j.1365-2540.2001.00804.x; Kageyama D, 2009, HEREDITY, V102, P475, DOI 10.1038/hdy.2009.14; Kageyama D, 2007, NATURWISSENSCHAFTEN, V94, P333, DOI 10.1007/s00114-006-0195-x; KOSE H, 1995, MECH DEVELOP, V51, P275, DOI 10.1016/0925-4773(95)00372-X; KURODA Y, 1992, ZOOL SCI, V9, P283; Landmann F, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000343; Lassy CW, 1996, MECH DEVELOP, V57, P47, DOI 10.1016/0925-4773(96)00527-8; Luger K, 2005, CURR OPIN STRUC BIOL, V15, P188, DOI 10.1016/j.sbi.2005.03.006; MAGNI GE, 1953, NATURE, V172, P81, DOI 10.1038/172081a0; Montenegro H, 2005, INSECT MOL BIOL, V14, P281, DOI 10.1111/j.1365-2583.2005.00558.x; Oakley BR, 2000, CURR TOP DEV BIOL, V49, P27; ONeill SL, 1997, INFLUENTIAL PASSENGE; PIPERNO G, 1985, J CELL BIOL, V101, P2085, DOI 10.1083/jcb.101.6.2085; RAFF JW, 1988, J CELL BIOL, V107, P2009, DOI 10.1083/jcb.107.6.2009; Riparbelli MG, 2010, CYTOSKELETON, V67, P251, DOI 10.1002/cm.20440; Riparbelli MG, 1996, J CELL SCI, V109, P911; Riparbelli MG, 1997, MECH DEVELOP, V65, P135, DOI 10.1016/S0925-4773(97)00066-X; Riparbelli MG, 2005, J CELL SCI, V118, P2827, DOI 10.1242/jcs.02413; SAKAGUCHI B, 1963, GENETICS, V48, P841; Serbus LR, 2008, ANNU REV GENET, V42, P683, DOI 10.1146/annurev.genet.41.110306.130354; Sinkins SP, 1995, EXP PARASITOL, V81, P284, DOI 10.1006/expr.1995.1119; Stevens L, 2001, ANNU REV ECOL SYST, V32, P519, DOI 10.1146/annurev.ecolsys.32.081501.114132; Stouthamer R, 1999, ANNU REV MICROBIOL, V53, P71, DOI 10.1146/annurev.micro.53.1.71; Sugimoto TN, 2010, INSECT BIOCHEM MOLEC, V40, P847, DOI 10.1016/j.ibmb.2010.08.004; Tortosa P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009700; Tram U, 2003, MICROBES INFECT, V5, P999, DOI 10.1016/S1286-4579(03)00192-8; Tremethick DJ, 2007, CELL, V128, P651, DOI 10.1016/j.cell.2007.02.008; TSUCHIYAMA S, 1978, GENETICS, V89, P711; TSUYICHIYAOMURA S, 1985, ZOOL SCI, V5, P373; Vaizel-Ohayon D, 1999, CURR BIOL, V9, P889, DOI 10.1016/S0960-9822(99)80393-5; Veneti Z, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-52; Veneti Z, 2005, SCIENCE, V307, P1461, DOI 10.1126/science.1107182; Werren John H, 2008, Nat Rev Microbiol, V6, P741, DOI 10.1038/nrmicro1969; Wilson PG, 1998, DEV BIOL, V199, P273, DOI 10.1006/dbio.1998.8900; Woodcock CL, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000596; YASUDA GK, 1991, DEVELOPMENT, V111, P379; Zeh DW, 2005, HEREDITY, V95, P41, DOI 10.1038/sj.hdy.6800666; Zhang G, 2009, J CELL SCI, V122, P535, DOI 10.1242/jcs.040352; Zhang J, 2007, MOL BIOL CELL, V18, P4037, DOI 10.1091/mbc.E07-05-0474	67	31	37	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30045	10.1371/journal.pone.0030045	http://dx.doi.org/10.1371/journal.pone.0030045			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22291901	Green Published, Green Submitted, gold			2022-12-25	WOS:000301570600012
J	Wang, YH; Williamson, KE; Kelly, PJ; James, JA; Hamilton, PW				Wang, Yinhai; Williamson, Kate E.; Kelly, Paul J.; James, Jacqueline A.; Hamilton, Peter W.			SurfaceSlide: A Multitouch Digital Pathology Platform	PLOS ONE			English	Article							MORPHOLOGY; DIAGNOSIS; SYSTEMS; SLIDES	Background: Digital pathology provides a digital environment for the management and interpretation of pathological images and associated data. It is becoming increasing popular to use modern computer based tools and applications in pathological education, tissue based research and clinical diagnosis. Uptake of this new technology is stymied by its single user orientation and its prerequisite and cumbersome combination of mouse and keyboard for navigation and annotation. Methodology: In this study we developed SurfaceSlide, a dedicated viewing platform which enables the navigation and annotation of gigapixel digitised pathological images using fingertip touch. SurfaceSlide was developed using the Microsoft Surface, a 30 inch multitouch tabletop computing platform. SurfaceSlide users can perform direct panning and zooming operations on digitised slide images. These images are downloaded onto the Microsoft Surface platform from a remote server on-demand. Users can also draw annotations and key in texts using an on-screen virtual keyboard. We also developed a smart caching protocol which caches the surrounding regions of a field of view in multi-resolutions thus providing a smooth and vivid user experience and reducing the delay for image downloading from the internet. We compared the usability of SurfaceSlide against Aperio ImageScope and PathXL online viewer. Conclusion: SurfaceSlide is intuitive, fast and easy to use. SurfaceSlide represents the most direct, effective and intimate human-digital slide interaction experience. It is expected that SurfaceSlide will significantly enhance digital pathology tools and applications in education and clinical practice.	[Wang, Yinhai; Williamson, Kate E.; James, Jacqueline A.; Hamilton, Peter W.] Queens Univ Belfast, Ctr Canc Res & Cell Biol, Belfast, Antrim, North Ireland; [Kelly, Paul J.] Royal Victoria Hosp, Dept Pathol, Belfast, Antrim, North Ireland	Queens University Belfast	Wang, YH (corresponding author), Queens Univ Belfast, Ctr Canc Res & Cell Biol, Belfast, Antrim, North Ireland.	y.wang@qub.ac.uk			Department for Employment and Learning through its "Strengthening the all-Island Research Base" initiative; Pathological Society of Great Britain and Ireland [OS 2009 06 03]	Department for Employment and Learning through its "Strengthening the all-Island Research Base" initiative; Pathological Society of Great Britain and Ireland	This work was supported by the Department for Employment and Learning through its "Strengthening the all-Island Research Base" initiative. The purchase of Microsoft Surface was partially funded by the Pathological Society of Great Britain and Ireland under the Pathological Society Open Scheme: OS 2009 06 03. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akif Burak T, 2010, UNSUPERVISED TISSUE, P2516; [Anonymous], 2006, DIG SLID 3 PART DAT; [Anonymous], 2009, MICR SURF TRAIN COUR; Armbrust M., 2009, UCBEECS200928; Banister BA, 2002, IEEE SIGNAL PROC LET, V9, P117, DOI 10.1109/97.1001646; Burthem J, 2005, BRIT J HAEMATOL, V130, P293, DOI 10.1111/j.1365-2141.2005.05597.x; Buxton B., 2009, MULTITOUCH SYSTEMS I; Buyya R, 2009, FUTURE GENER COMP SY, V25, P599, DOI 10.1016/j.future.2008.12.001; Chen WJ, 2004, IEEE T INF TECHNOL B, V8, P89, DOI 10.1109/TITB.2004.828891; Cho Y, 2007, IEEE T IMAGE PROCESS, V16, P2005, DOI 10.1109/TIP.2007.901247; Diamond J, 2004, HUM PATHOL, V35, P1121, DOI 10.1016/j.humpath.2004.05.010; Diaz G, 2012, MICROSC RES TECHNIQ, V75, P343, DOI 10.1002/jemt.21063; Elezovic S, 2008, MULTITOUCH USER INTE, P3; Ficsor L, 2005, AUTOMATED HISTOLOGIC, P43; Fitzmaurice G.W., 1995, P SIGCHI C HUM FACT; Rojo MG, 2006, INT J SURG PATHOL, V14, P285, DOI 10.1177/1066896906292274; He L, 2011, MULTIPHASE LEVEL SET, P32; Helin H, 2005, HUM PATHOL, V36, P381, DOI 10.1016/j.humpath.2005.01.020; Jefferson YH, 2005, P 18 ANN ACM S US IN; Kumar RK, 2004, J PATHOL, V204, P613, DOI 10.1002/path.1658; Kwan-Liu M, 2000, P 2000 ACM IEEE C SU; Lee S., 1985, ACM SIGCHI B, V16, P21, DOI DOI 10.1145/317456.317461; Lundin M, 2004, J CLIN PATHOL, V57, P1288, DOI 10.1136/jcp.2004.018739; Montironi R, 2009, CANCER-AM CANCER SOC, V115, P3068, DOI 10.1002/cncr.24345; Peltonen P, 2008, CHI 2008: 26TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS VOLS 1 AND 2, CONFERENCE PROCEEDINGS, P1285; Pierre W, 1993, COMMUN ACM, V36, P87; Rooney C, 2008, NEW METHOD INTERACTI; Soenksen D, 2006, PATH VIS AP DIG PATH; Toshifumi A, 1995, INTERACTIVEDESK COMP; Treanor D, 2009, HISTOPATHOLOGY, V55, P294, DOI 10.1111/j.1365-2559.2009.03389.x; Wang YH, 2007, P ANN INT IEEE EMBS, P775, DOI 10.1109/IEMBS.2007.4352405; Wang YH, 2010, ANAL CELL PATHOL, V33, P271, DOI [10.1155/2010/918306, 10.3233/ACP-CLO-2010-0551]; Wang YH, 2009, IEEE J-STSP, V3, P112, DOI 10.1109/JSTSP.2008.2011157; Wilbur DC, 2009, ARCH PATHOL LAB MED, V133, P1949, DOI 10.1043/1543-2165-133.12.1949	34	9	10	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30783	10.1371/journal.pone.0030783	http://dx.doi.org/10.1371/journal.pone.0030783			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22292040	Green Published, gold, Green Submitted			2022-12-25	WOS:000301570600078
J	Shen, DL; Gloster, TM; Yuzwa, SA; Vocadlo, DJ				Shen, David L.; Gloster, Tracey M.; Yuzwa, Scott A.; Vocadlo, David J.			Insights into O-Linked N-Acetylglucosamine (O-GlcNAc) Processing and Dynamics through Kinetic Analysis of O-GlcNAc Transferase and O-GlcNAcase Activity on Protein Substrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURAL INSIGHTS; CYTOSOLIC PROTEINS; NUCLEAR; PHOSPHORYLATION; GLYCOSYLATION; GLCNACYLATION; MECHANISM; COMPLEX; TAU; KINASE	Cellular O-linked N-acetylglucosamine (O-GlcNAc) levels are modulated by two enzymes: uridine diphosphate-N-acetyl-D-glucosamine: polypeptidyltransferase (OGT) and O-GlcNAcase (OGA). To quantitatively address the activity of these enzymes on protein substrates, we generated five structurally diverse proteins in both unmodified and O-GlcNAc-modified states. We found a remarkably invariant upper limit for k(cat)/K-m values for human OGA (hOGA)-catalyzed processing of these modified proteins, which suggests that hOGA processing is driven by the GlcNAc moiety and is independent of the protein. Human OGT(hOGT) activity ranged more widely, by up to 15-fold, suggesting that hOGT is the senior partner in fine tuning protein O-GlcNAc levels. This was supported by the observation that Km,app values for UDP-GlcNAc varied considerably (from 1 mu M to over 20 mu M), depending on the protein substrate, suggesting that some OGT substrates will be nutrient-responsive, whereas others are constitutively modified. The ratios of kcat/Km values obtained from hOGT and hOG Akinetic studies enable a prediction of the dynamic equilibrium position of O-GlcNAc levels that can be recapitulated in vitro and suggest the relative O-GlcNAc stoichiometries of target proteins in the absence of other factors. We show that changes in the specific activities of hOGT and hOGA measured in vitro on calcium/calmodulin-dependent kinase IV (CaMKIV) and its pseudophosphorylated form can account for previously reported changes in CaMKIV O-GlcNAc levels observed in cells. These studies provide kinetic evidence for the interplay between O-GlcNAc and phosphorylation on proteins and indicate that these effects can be mediated by changes in hOGT and hOGA kinetic activity.	[Gloster, Tracey M.; Vocadlo, David J.] Simon Fraser Univ, Dept Chem, Burnaby, BC V5A 1S6, Canada; [Shen, David L.; Yuzwa, Scott A.; Vocadlo, David J.] Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada	Simon Fraser University; Simon Fraser University	Vocadlo, DJ (corresponding author), Simon Fraser Univ, Dept Chem, Burnaby, BC V5A 1S6, Canada.	dvocadlo@sfu.ca	Vocadlo, David J/E-5508-2014	Vocadlo, David J/0000-0001-6897-5558	Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada; Michael Smith Foundation for Health Research (MSFHR)	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Michael Smith Foundation for Health Research (MSFHR)(Michael Smith Foundation for Health Research)	This research was supported by grants from the Canadian Institutes of Health Research and the Natural Sciences and Engineering Research Council of Canada.; Sir Henry Wellcome postdoctoral fellow and recipient of a Michael Smith Foundation for Health Research (MSFHR) trainee award.; Recipient of a doctoral award from the Natural Sciences and Engineering Research Council of Canada.	Cetinbas N, 2006, BIOCHEMISTRY-US, V45, P3835, DOI 10.1021/bi052370b; Chen YX, 2006, CHEM BIOL, V13, P937, DOI 10.1016/j.chembiol.2006.06.017; Cheung WD, 2008, J BIOL CHEM, V283, P33935, DOI 10.1074/jbc.M806199200; Clarke AJ, 2008, EMBO J, V27, P2780, DOI 10.1038/emboj.2008.186; Comer FI, 2001, ANAL BIOCHEM, V293, P169, DOI 10.1006/abio.2001.5132; Dauphinee SM, 2005, J CELL BIOCHEM, V96, P579, DOI 10.1002/jcb.20508; Dennis RJ, 2006, NAT STRUCT MOL BIOL, V13, P365, DOI 10.1038/nsmb1079; Dias WB, 2009, J BIOL CHEM, V284, P21327, DOI 10.1074/jbc.M109.007310; DONG DLY, 1994, J BIOL CHEM, V269, P19321; Forsythe ME, 2006, P NATL ACAD SCI USA, V103, P11952, DOI 10.1073/pnas.0601931103; Fujiki R, 2009, NATURE, V459, P455, DOI 10.1038/nature07954; Gambetta MC, 2009, SCIENCE, V325, P93, DOI 10.1126/science.1169727; Gao Y, 2001, J BIOL CHEM, V276, P9838, DOI 10.1074/jbc.M010420200; Greig IR, 2009, J AM CHEM SOC, V131, P13415, DOI 10.1021/ja904506u; Hanover JA, 2003, ARCH BIOCHEM BIOPHYS, V409, P287, DOI 10.1016/S0003-9861(02)00578-7; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; HOLT GD, 1987, J CELL BIOL, V104, P1157, DOI 10.1083/jcb.104.5.1157; Iyer SPN, 2003, J BIOL CHEM, V278, P24608, DOI 10.1074/jbc.M300036200; Jinek M, 2004, NAT STRUCT MOL BIOL, V11, P1001, DOI 10.1038/nsmb833; Kamemura K, 2002, J BIOL CHEM, V277, P19229, DOI 10.1074/jbc.M201729200; Kanno T, 2010, NEUROCHEM RES, V35, P782, DOI 10.1007/s11064-010-0135-1; Kreppel LK, 1999, J BIOL CHEM, V274, P32015, DOI 10.1074/jbc.274.45.32015; Kreppel LK, 1997, J BIOL CHEM, V272, P9308; Lazarus BD, 2006, GLYCOBIOLOGY, V16, P415, DOI 10.1093/glycob/cwj078; Lazarus MB, 2011, NATURE, V469, P564, DOI 10.1038/nature09638; Leatherbarrow R.J., 2001, GRAFIT VERSION 5; Leavy TM, 2007, BIOORG MED CHEM LETT, V17, P3851, DOI 10.1016/j.bmcl.2007.05.008; Lefebvre T, 2003, BBA-GEN SUBJECTS, V1619, P167, DOI 10.1016/S0304-4165(02)00477-4; Lim KH, 2002, J MICROBIOL BIOTECHN, V12, P306; Lubas WA, 2000, J BIOL CHEM, V275, P10983, DOI 10.1074/jbc.275.15.10983; LUBAS WA, 1995, BIOCHEMISTRY-US, V34, P1686, DOI 10.1021/bi00005a025; Lubas WA, 1997, J BIOL CHEM, V272, P9316; Macauley MS, 2005, J AM CHEM SOC, V127, P17202, DOI 10.1021/ja0567687; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Marshall S, 2004, J BIOL CHEM, V279, P35313, DOI 10.1074/jbc.M404133200; Martinez-Fleites C, 2008, NAT STRUCT MOL BIOL, V15, P764, DOI 10.1038/nsmb.1443; Okafo G, 1997, ANAL CHEM, V69, P4985, DOI 10.1021/ac9707139; Rao FV, 2006, EMBO J, V25, P1569, DOI 10.1038/sj.emboj.7601026; Rexach JE, 2010, NAT CHEM BIOL, V6, P645, DOI [10.1038/NCHEMBIO.412, 10.1038/nchembio.412]; Roquemore EP, 1996, BIOCHEMISTRY-US, V35, P3578, DOI 10.1021/bi951918j; Ryu IH, 2011, BIOCHEM BIOPH RES CO, V408, P52, DOI 10.1016/j.bbrc.2011.03.115; Sack JS, 2011, BIOCHEM J, V436, P331, DOI 10.1042/BJ20102161; Schimpl M, 2010, BIOCHEM J, V432, P1, DOI 10.1042/BJ20101338; Shafi R, 2000, P NATL ACAD SCI USA, V97, P5735, DOI 10.1073/pnas.100471497; Simanek EE, 1998, CHEM REV, V98, P833, DOI 10.1021/cr940226i; Sinclair DAR, 2009, P NATL ACAD SCI USA, V106, P13427, DOI 10.1073/pnas.0904638106; Taylor RP, 2009, J BIOL CHEM, V284, P3425, DOI 10.1074/jbc.M803198200; Teo CF, 2010, NAT CHEM BIOL, V6, P338, DOI 10.1038/nchembio.338; TORRES CR, 1984, J BIOL CHEM, V259, P3308; Wang Z, 2008, P NATL ACAD SCI USA, V105, P13793, DOI 10.1073/pnas.0806216105; Wang Z, 2007, MOL CELL PROTEOMICS, V6, P1365, DOI 10.1074/mcp.M600453-MCP200; Whisenhunt TR, 2006, GLYCOBIOLOGY, V16, P551, DOI 10.1093/glycob/cwj096; Yang WH, 2006, NAT CELL BIOL, V8, P1074, DOI 10.1038/ncb1470; Yang XY, 2008, NATURE, V451, P964, DOI 10.1038/nature06668; Yuzwa SA, 2008, NAT CHEM BIOL, V4, P483, DOI 10.1038/nchembio.96; Yuzwa SA, 2011, AMINO ACIDS, V40, P857, DOI 10.1007/s00726-010-0705-1	56	82	82	0	42	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15395	15408		10.1074/jbc.M111.310664	http://dx.doi.org/10.1074/jbc.M111.310664			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22311971	hybrid, Green Published			2022-12-25	WOS:000304006300021
J	Tradtrantip, L; Zhang, H; Anderson, MO; Saadoun, S; Phuan, PW; Papadopoulos, MC; Bennett, JL; Verkman, AS				Tradtrantip, Lukmanee; Zhang, Hua; Anderson, Marc O.; Saadoun, Samira; Phuan, Puay-Wah; Papadopoulos, Marios C.; Bennett, Jeffrey L.; Verkman, A. S.			Small-molecule inhibitors of NMO-IgG binding to aquaporin-4 reduce astrocyte cytotoxicity in neuromyelitis optica	FASEB JOURNAL			English	Article						water channel; Devic's disease; drug discovery; autoantibody	ORTHOGONAL ARRAYS; IN-VITRO; IMMUNOGLOBULIN-G; WATER TRANSPORT; SINGLE; BRAIN; ANTIBODIES; QUERCETIN; DISEASE; CELLS	Neuromyelitis optica (NMO) is an inflammatory demyelinating disease of spinal cord and optic nerve caused by pathogenic autoantibodies (NMO-IgG) against astrocyte aquaporin-4 (AQP4). We developed a high-throughput screen to identify blockers of NMO-IgG binding to human AQP4 using a human recombinant monoclonal NMO-IgG and transfected Fisher rat thyroid cells stably expressing human M23-AQP4. Screening of similar to 60,000 compounds yielded the antiviral arbidol, the flavonoid tamarixetin, and several plant-derived berbamine alkaloids, each of which blocked NMO-IgG binding to AQP4 without affecting AQP4 expression, array assembly, or water permeability. The compounds inhibited NMO-IgG binding to AQP4 in NMO patient sera and blocked NMO-IgG-dependent complement-and cell-mediated cytotoxicity with IC50 down to similar to 5 mu M. Docking computations identified putative sites of blocker binding at the extracellular surface of AQP4. The blockers did not affect complement-dependent cytotoxicity caused by anti-GD3 antibody binding to ganglioside GD3. The blockers reduced by >80% the severity of NMO lesions in an ex vivo spinal cord slice culture model of NMO and in mice in vivo. Our results provide proof of concept for a small-molecule blocker strategy to reduce NMO pathology. Small-molecule blockers may also be useful for other autoimmune diseases caused by binding of pathogenic autoantibodies to defined targets.-Tradtrantip, L., Zhang, H., Anderson, M. O., Saadoun, S., Phuan, P.-W., Papadopoulos, M. C., Bennett, J. L., Verkman, A. S. Small-molecule inhibitors of NMO-IgG binding to aquaporin-4 reduce astrocyte cytotoxicity in neuromyelitis optica. FASEB J. 26, 2197-2208 (2012). www.fasebj.org	[Tradtrantip, Lukmanee; Zhang, Hua; Phuan, Puay-Wah; Verkman, A. S.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Tradtrantip, Lukmanee; Zhang, Hua; Phuan, Puay-Wah; Verkman, A. S.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; [Anderson, Marc O.] San Francisco State Univ, Dept Chem & Biochem, San Francisco, CA 94132 USA; [Saadoun, Samira; Papadopoulos, Marios C.] Univ London, Acad Neurosurg Unit, London, England; [Bennett, Jeffrey L.] Univ Colorado Denver, Dept Neurol, Aurora, CO USA; [Bennett, Jeffrey L.] Univ Colorado Denver, Dept Ophthalmol, Aurora, CO USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; California State University System; San Francisco State University; University of London; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Verkman, AS (corresponding author), Univ Calif San Francisco, Dept Med, 1246 Hlth Sci E Tower, San Francisco, CA 94143 USA.	alan.verkman@ucsf.edu		Saadoun, Samira/0000-0002-5480-5678; Papadopoulos, Marios/0000-0001-9174-4176	Guthy-Jackson Charitable Foundation; U.S. National Institutes of Health [EY13574, EB00415, DK35124, HL73856, DK86125, DK72517]; National Multiple Sclerosis Society [RG4320]; NATIONAL EYE INSTITUTE [R01EY013574] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073856] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000415, R37EB000415] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK035124, P30DK072517, RC1DK086125, R37DK035124] Funding Source: NIH RePORTER	Guthy-Jackson Charitable Foundation; U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society(National Multiple Sclerosis Society); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the Guthy-Jackson Charitable Foundation (to A.S.V., M.C.P., and J.L.B.); grants EY13574, EB00415, DK35124, HL73856, DK86125, and DK72517 from the U.S. National Institutes of Health (to A.S.V.); and grant RG4320 from the National Multiple Sclerosis Society (to J.L.B.).	Arts ICW, 2005, AM J CLIN NUTR, V81, p317S, DOI 10.1093/ajcn/81.1.317S; Auguste KI, 2007, FASEB J, V21, P108, DOI 10.1096/fj.06-6848com; Bennett JL, 2009, ANN NEUROL, V66, P617, DOI 10.1002/ana.21802; Binder DK, 2006, GLIA, V53, P631, DOI 10.1002/glia.20318; Boriskin YS, 2008, CURR MED CHEM, V15, P997, DOI 10.2174/092986708784049658; Boriskin YS, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-56; Bradl M, 2009, ANN NEUROL, V66, P630, DOI 10.1002/ana.21837; Chai HF, 2006, BIOORGAN MED CHEM, V14, P911, DOI 10.1016/j.bmc.2005.08.041; Crane JM, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.227298; Crane JM, 2009, J BIOL CHEM, V284, P35850, DOI 10.1074/jbc.M109.071670; Crane JM, 2009, J CELL SCI, V122, P813, DOI 10.1242/jcs.042341; Cree B, 2008, CURR NEUROL NEUROSCI, V8, P427, DOI 10.1007/s11910-008-0066-2; de Boer VCJ, 2005, J NUTR, V135, P1718, DOI 10.1093/jn/135.7.1718; Glushkov R. G., 1992, Drugs of the Future, V17, P1079; HERTOG MGL, 1993, LANCET, V342, P1007, DOI 10.1016/0140-6736(93)92876-U; Hinson SR, 2007, NEUROLOGY, V69, P2221, DOI 10.1212/01.WNL.0000289761.64862.ce; Ho JD, 2009, P NATL ACAD SCI USA, V106, P7437, DOI 10.1073/pnas.0902725106; Jarius S, 2008, NAT CLIN PRACT NEURO, V4, P202, DOI 10.1038/ncpneuro0764; Jarius S, 2010, NAT REV NEUROL, V6, P383, DOI 10.1038/nrneurol.2010.72; Jin BJ, 2011, BIOPHYS J, V100, P2936, DOI 10.1016/j.bpj.2011.05.012; Kinoshita M, 2009, BIOCHEM BIOPH RES CO, V386, P623, DOI 10.1016/j.bbrc.2009.06.085; Lavillette D, 2006, J BIOL CHEM, V281, P3909, DOI 10.1074/jbc.M509747200; Lennon VA, 2005, J EXP MED, V202, P473, DOI 10.1084/jem.20050304; Li LH, 2011, FASEB J, V25, P1556, DOI 10.1096/fj.10-177279; LI Q, 1981, Chinese Journal of Tuberculosis and Respiratory Diseases, V4, P321; LIU CX, 1991, PHYTOTHER RES, V5, P228, DOI 10.1002/ptr.2650050508; Liu MY, 2009, CLIN THER, V31, P784, DOI 10.1016/j.clinthera.2009.04.016; Ma TH, 1997, J CLIN INVEST, V100, P957, DOI 10.1172/JCI231; Mader S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010455; Manley GT, 2000, NAT MED, V6, P159, DOI 10.1038/72256; Marignier R, 2010, BRAIN, V133, P2578, DOI 10.1093/brain/awq177; Nielsen S, 1997, J NEUROSCI, V17, P171; Padmawar P, 2005, NAT METHODS, V2, P825, DOI 10.1038/NMETH801; Papadopoulos MC, 2004, FASEB J, V18, P1291, DOI 10.1096/fj.04-1723fje; Parratt JDE, 2010, MULT SCLER J, V16, P1156, DOI 10.1177/1352458510382324; PUKEL CS, 1982, J EXP MED, V155, P1133, DOI 10.1084/jem.155.4.1133; Ren YP, 2008, J IMMUNOL, V181, P1491, DOI 10.4049/jimmunol.181.2.1491; Saadoun S, 2005, J CELL SCI, V118, P5691, DOI 10.1242/jcs.02680; Saadoun S, 2012, ANN NEUROL, V71, P323, DOI 10.1002/ana.22686; Saadoun S, 2010, BRAIN, V133, P349, DOI 10.1093/brain/awp309; Schulz HU, 2005, ARZNEIMITTELFORSCH, V55, P561; Tajima M, 2010, J BIOL CHEM, V285, P8163, DOI 10.1074/jbc.M109.093948; Tradtrantip L, 2012, ANN NEUROL, V71, P314, DOI 10.1002/ana.22657; van der Woude H, 2004, CHEM RES TOXICOL, V17, P1520, DOI 10.1021/tx049826v; Verkman AS, 2011, ACTA PHARMACOL SIN, V32, P702, DOI 10.1038/aps.2011.27; Wei YL, 2009, ACTA PHARMACOL SIN, V30, P451, DOI 10.1038/aps.2009.19; Wingerchuk DM, 2006, NEUROLOGY, V66, P1485, DOI 10.1212/01.wnl.0000216139.44259.74; Wingerchuk DM, 2007, LANCET NEUROL, V6, P805, DOI 10.1016/S1474-4422(07)70216-8; Wolburg H, 2011, INT REV CEL MOL BIO, V287, P1, DOI 10.1016/B978-0-12-386043-9.00001-3; Xu WL, 2006, LEUKEMIA RES, V30, P407, DOI 10.1016/j.leukres.2005.08.005; Yang BX, 2008, BIOORGAN MED CHEM, V16, P7489, DOI 10.1016/j.bmc.2008.06.005; Zhang H, 2011, ANN NEUROL, V70, P943, DOI 10.1002/ana.22551	52	63	70	0	15	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2012	26	5					2197	2208		10.1096/fj.11-201608	http://dx.doi.org/10.1096/fj.11-201608			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	937TD	22319008	Green Published			2022-12-25	WOS:000303680800045
J	Nishii, T; Oikawa, Y; Ishida, Y; Kawaichi, M; Matsuda, E				Nishii, Tomonori; Oikawa, Yu; Ishida, Yasumasa; Kawaichi, Masashi; Matsuda, Eishou			CtBP-interacting BTB Zinc Finger Protein (CIBZ) Promotes Proliferation and G1/S Transition in Embryonic Stem Cells via Nanog	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SELF-RENEWAL; ES CELLS; FUNCTIONAL-ANALYSIS; MOUSE EMBRYOS; EXPRESSION; DIFFERENTIATION; PLURIPOTENCY; TERATOCARCINOMA; IDENTIFICATION; APOPTOSIS	Mouse embryonic stem cells (ESCs) require transcriptional regulation to ensure rapid proliferation that allows for self-renewal. However, the molecular mechanism by which transcriptional factors regulate this rapid proliferation remains largely unknown. Here we present data showing that CIBZ, a BTB domain zinc finger transcriptional factor, is a key transcriptional regulator for regulation of ESC proliferation. Here we show that deletion or siRNA knockdown of CIBZ inhibits ESC proliferation. Cell cycle analysis shows that loss of CIBZ delays the progression of ESCs through the G1 to S phase transition. Conversely, constitutive ectopic expression of exogenous CIBZ in ESCs promotes proliferation and accelerates G1/S transition. These findings suggest that regulation of the G1/S transition explains, in part, CIBZ-associated ESC proliferation. Our data suggest that CIBZ acts through the post-transcriptionally regulates the expression of Nanog, a positive regulator of ESC proliferation and G1/S transition, but does not affect Oct3/4 and Sox2 protein expression. Notably, constitutive overexpression of Nanog partially rescued the proliferation defect caused by CIBZ knockdown, indicating the role of CIBZ in ESC proliferation and G1/S transition at least in part depends on the Nanog protein level.	[Nishii, Tomonori; Ishida, Yasumasa; Kawaichi, Masashi; Matsuda, Eishou] Nara Inst Sci & Technol, Div Gene Funct Anim, Nara 6300192, Japan; [Oikawa, Yu] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Pathol & Appl Neurobiol, Kamigyo Ku, Kyoto 6028566, Japan	Nara Institute of Science & Technology; Kyoto Prefectural University of Medicine	Matsuda, E (corresponding author), Nara Inst Sci & Technol, Div Gene Funct Anim, 8916-5 Takayama, Nara 6300192, Japan.	ematsuda@bs.naist.jp			Global COE from Japan's Ministry of Education, Culture, Sports, Science, and Technology; Grants-in-Aid for Scientific Research [22590272] Funding Source: KAKEN	Global COE from Japan's Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant-in-aid for Scientific Research (C), and the Global COE program, from Japan's Ministry of Education, Culture, Sports, Science, and Technology.	Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Chambers I, 2004, ONCOGENE, V23, P7150, DOI 10.1038/sj.onc.1207930; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chen TJ, 2012, MOL BIOL REP, V39, P1855, DOI 10.1007/s11033-011-0928-6; Du JX, 2007, J BIOL CHEM, V282, P4782, DOI 10.1074/jbc.M603413200; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Koledova Z, 2010, STEM CELLS DEV, V19, P181, DOI 10.1089/scd.2009.0065; Liu N, 2008, J CELL BIOCHEM, V104, P2348, DOI 10.1002/jcb.21795; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Matsuda E, 2004, P NATL ACAD SCI USA, V101, P4170, DOI 10.1073/pnas.0400604101; Matsuda E, 2001, J BIOL CHEM, V276, P14222, DOI 10.1074/jbc.M010663200; Moretto-Zita M, 2010, P NATL ACAD SCI USA, V107, P13312, DOI 10.1073/pnas.1005847107; MORTENSEN RM, 1992, MOL CELL BIOL, V12, P2391, DOI 10.1128/MCB.12.5.2391; Neganova I, 2009, ONCOGENE, V28, P20, DOI 10.1038/onc.2008.358; Neganova I, 2008, J ANAT, V213, P30, DOI 10.1111/j.1469-7580.2008.00931.x; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Oikawa Y, 2008, J BIOL CHEM, V283, P14242, DOI 10.1074/jbc.M802257200; Oikawa Y, 2011, CELL RES, V21, P1578, DOI 10.1038/cr.2011.90; Paling NRD, 2004, J BIOL CHEM, V279, P48063, DOI 10.1074/jbc.M406467200; Ramakrishna S, 2011, STEM CELLS DEV, V20, P1512, DOI 10.1089/scd.2010.0410; Sasai N, 2005, GENES CELLS, V10, P871, DOI 10.1111/j.1365-2443.2005.00885.x; Storm MP, 2007, J BIOL CHEM, V282, P6265, DOI 10.1074/jbc.M610906200; Tanaka Y, 2007, BLOOD, V110, P107, DOI 10.1182/blood-2006-08-039628; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; Tay YMS, 2008, STEM CELLS, V26, P17, DOI 10.1634/stemcells.2007-0295; Tsumura A, 2006, GENES CELLS, V11, P805, DOI 10.1111/j.1365-2443.2006.00984.x; White J, 2005, STEM CELL REV, V1, P131, DOI 10.1385/SCR:1:2:131; Zeng XM, 2003, STEM CELLS, V21, P647, DOI 10.1634/stemcells.21-6-647; Zhang JY, 2005, BIOCHEM BIOPH RES CO, V338, P1098, DOI 10.1016/j.bbrc.2005.10.071; Zhang X, 2009, J CELL BIOL, V184, P67, DOI 10.1083/jcb.200801009	31	21	23	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					12417	12424		10.1074/jbc.M111.333856	http://dx.doi.org/10.1074/jbc.M111.333856			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22315219	hybrid, Green Published			2022-12-25	WOS:000302782200081
J	Fujimoto, K; Matsuura, K; Hu-Wang, E; Lu, R; Shi, YB				Fujimoto, Kenta; Matsuura, Kazuo; Hu-Wang, Eileen; Lu, Rosemary; Shi, Yun-Bo			Thyroid Hormone Activates Protein Arginine Methyltransferase 1 Expression by Directly Inducing c-Myc Transcription during Xenopus Intestinal Stem Cell Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSTEMBRYONIC DEVELOPMENT; EPITHELIAL DEVELOPMENT; RECEPTOR SUPERFAMILY; GENE REPRESSION; TR-ALPHA; METAMORPHOSIS; LAEVIS; RECRUITMENT; PROLIFERATION; MECHANISMS	Adult organ-specific stem cells are essential for organ homeostasis and tissue repair and regeneration. The formation of such stem cells during vertebrate development is poorly understood. Intestinal remodeling during thyroid hormone (T3)-dependent Xenopus metamorphosis resembles postembryonic intestinal maturation in mammals. During metamorphosis, the intestine is remodeled de novo via a yet unknown mechanism. Protein arginine methyltransferase 1 (PRMT1) is up-regulated in and required for adult intestinal stem cells during metamorphosis. PRMT1 up-regulation is the earliest known molecular event for the developing stem cells and is also conserved during zebrafish and mouse intestinal development. To analyze how PRMT1 is specifically up-regulated during the formation of the adult intestinal stem cells, wecloned the Xenopus PRMT1 promoter and characterized it in CaCo-2 cells, a human cell line with intestinal stem cell characteristics. Through a series deletion and mutational analyses, we showed that the stem cell-associated transcription factor c-Myc could bind to a conserved site in the first intron to activate the promoter. Furthermore, we demonstrated that during metamorphosis, both c-Myc and PRMT1 were highly up-regulated, specifically in the remodeling intestine but not the resorbing tail, and that c-Myc was induced by T3 prior to PRMT1 up-regulation. In addition, we showed that T3 directly activated the c-Myc gene during metamorphosis in the intestine via binding of the T3 receptor to the c-Myc promoter. These results suggest that T3 induces c-Myc transcription directly in the intestine, that c-Myc, in turn, activates PRMT1 expression, and that this is an important gene regulation cascade controlling intestinal stem cell development.	[Fujimoto, Kenta; Matsuura, Kazuo; Hu-Wang, Eileen; Lu, Rosemary; Shi, Yun-Bo] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Mol Morphogenesis, Lab Gene Regulat & Dev, PCRM,NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Shi, YB (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Mol Morphogenesis, Lab Gene Regulat & Dev, PCRM,NIH, Bethesda, MD 20892 USA.	Shi@helix.nih.gov		Shi, Yun-Bo/0000-0002-6330-0639	NICHD, National Institutes of Health; Japan Society for the Promotion of Sciences (NIH); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008858] Funding Source: NIH RePORTER	NICHD, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Japan Society for the Promotion of Sciences (NIH); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by the NICHD, National Institutes of Health intramural research program. This work was also supported by a fellowship by the Japan Society for the Promotion of Sciences (NIH) (to K. F.). This work was also supported by a Fellowship for Japanese Biochemical and Behavioral Researchers at NIH from Japan Society for the Promotion of Science (to K. F.).	Amano T, 1998, DEV GROWTH DIFFER, V40, P177; Aoki K, 2002, NUCLEIC ACIDS RES, V30, P5182, DOI 10.1093/nar/gkf638; Bagamasbad P, 2008, J BIOL CHEM, V283, P2275, DOI 10.1074/jbc.M709306200; Barrero MJ, 2006, MOL CELL, V24, P233, DOI 10.1016/j.molcel.2006.09.020; Batut J, 2005, P NATL ACAD SCI USA, V102, P15128, DOI 10.1073/pnas.0502483102; Bilesimo P, 2011, MOL ENDOCRINOL, V25, P225, DOI 10.1210/me.2010-0269; Brown DD, 2007, DEV BIOL, V306, P20, DOI 10.1016/j.ydbio.2007.03.021; Buchholz DR, 2004, GENE EXPR PATTERNS, V4, P321, DOI 10.1016/j.modgep.2003.10.005; Buchholz DR, 2003, MOL CELL BIOL, V23, P6750, DOI 10.1128/MCB.23.19.6750-6758.2003; Buchholz DR, 2006, GEN COMP ENDOCR, V145, P1, DOI 10.1016/j.ygcen.2005.07.009; Buchholz DR, 2004, MOL CELL BIOL, V24, P9026, DOI 10.1128/MCB.24.20.9026-9037.2004; Burke LJ, 2000, FASEB J, V14, P1876, DOI 10.1096/fj.99-0943rev; Chen DG, 1999, SCIENCE, V284, P2174, DOI 10.1126/science.284.5423.2174; Christen B, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-5; Das B, 2009, J BIOL CHEM, V284, P34167, DOI 10.1074/jbc.M109.066084; Denver RJ, 2009, DEV BIOL, V326, P155, DOI 10.1016/j.ydbio.2008.11.005; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Flamant F, 2002, MOL ENDOCRINOL, V16, P24, DOI 10.1210/me.16.1.24; Fujimoto K, 2006, DEV GROWTH DIFFER, V48, P223, DOI 10.1111/j.1440-169x.2006.00859.x; Gilbert L.I., 1996, METAMORPHOSIS POSTEM; Goulet I, 2007, J BIOL CHEM, V282, P33009, DOI 10.1074/jbc.M704349200; Harper J, 2011, P NATL ACAD SCI USA, V108, P10585, DOI 10.1073/pnas.1105852108; Havis E, 2003, EMBO REP, V4, P883, DOI 10.1038/sj.embor.embor908; Hu X, 2000, TRENDS ENDOCRIN MET, V11, P6, DOI 10.1016/S1043-2760(99)00215-5; Ishizuya-Oka A, 1997, DEV BIOL, V192, P149, DOI 10.1006/dbio.1997.8749; Ishizuya-Oka A, 2001, CELL TISSUE RES, V303, P187, DOI 10.1007/s004410000291; Ishizuya-Oka A, 2011, CELL BIOSCI, V1, DOI 10.1186/2045-3701-1-37; Ishizuya-Oka A, 2009, FASEB J, V23, P2568, DOI 10.1096/fj.08-128124; Ishizuya-Oka A, 2006, DEV DYNAM, V235, P3240, DOI 10.1002/dvdy.20969; ISHIZUYAOKA A, 1991, IN VITRO CELL DEV B, V27, P853; Ito M, 2001, TRENDS ENDOCRIN MET, V12, P127, DOI 10.1016/S1043-2760(00)00355-6; Jepsen K, 2002, J CELL SCI, V115, P689; Jones P. L., 2003, CURRENT TOPICS MICRO; Kress E, 2009, J BIOL CHEM, V284, P1234, DOI 10.1074/jbc.M806548200; LAZAR MA, 1993, ENDOCR REV, V14, P184, DOI 10.1210/er.14.2.184; Loots G, 2007, BIOINFORMATICS, V23, P122, DOI 10.1093/bioinformatics/btl546; MACDONALD WC, 1964, GASTROENTEROLOGY, V46, P405; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; MARSHALL JA, 1978, J EXP ZOOL, V203, P31, DOI 10.1002/jez.1402030104; Matsuda H, 2010, STEM CELLS, V28, P2073, DOI 10.1002/stem.529; Matsuda H, 2009, MOL CELL BIOL, V29, P745, DOI 10.1128/MCB.00827-08; Matsuura K, 2012, ENDOCRINOLOGY, V153, P961, DOI 10.1210/en.2011-1736; MCAVOY JW, 1977, J EXP ZOOL, V202, P129, DOI 10.1002/jez.1402020115; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Muncan V, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1463; Nakajima K, 2003, DEV DYNAM, V227, P246, DOI 10.1002/dvdy.10300; Nieuwkoop PD., 1956, DEVELOPMENT, DOI [DOI 10.1242/DEV.200356, 10.1242/dev.200356]; Paul BD, 2005, J BIOL CHEM, V280, P27165, DOI 10.1074/jbc.M503999200; Paul BD, 2005, MOL CELL BIOL, V25, P5712, DOI 10.1128/MCB.25.13.5712-5724.2005; Paul BD, 2007, J BIOL CHEM, V282, P7472, DOI 10.1074/jbc.M607589200; Pei DQ, 2009, J BIOL CHEM, V284, P3365, DOI 10.1074/jbc.R800063200; Plateroti M, 2006, MOL CELL BIOL, V26, P3204, DOI 10.1128/MCB.26.8.3204-3214.2006; Plateroti M, 2001, MOL CELL BIOL, V21, P4761, DOI 10.1128/MCB.21.14.4761-4772.2001; Plateroti M, 1999, GASTROENTEROLOGY, V116, P1367, DOI 10.1016/S0016-5085(99)70501-9; Rachez C, 2001, CURR OPIN CELL BIOL, V13, P274, DOI 10.1016/S0955-0674(00)00209-X; Rachez C, 2000, GENE, V246, P9, DOI 10.1016/S0378-1119(00)00052-4; Sachs LM, 2002, MOL CELL BIOL, V22, P8527, DOI 10.1128/MCB.22.24.8527-8538.2002; Sato Y, 2007, MECH DEVELOP, V124, P476, DOI 10.1016/j.mod.2007.03.006; Schreiber AM, 2009, DEV BIOL, V331, P89, DOI 10.1016/j.ydbio.2009.04.033; Schreiber AM, 2001, P NATL ACAD SCI USA, V98, P10739, DOI 10.1073/pnas.191361698; Schreiber AM, 2005, P NATL ACAD SCI USA, V102, P3720, DOI 10.1073/pnas.0409868102; Shi Y.-B., 1999, AMPHIBIAN METAMORPHO; SHI YB, 1992, J BIOL CHEM, V267, P733; Shi YB, 1996, CURR TOP DEV BIOL, V32, P205, DOI 10.1016/S0070-2153(08)60429-9; Shi YB, 2011, CELL BIOSCI, V1, DOI 10.1186/2045-3701-1-30; Shi YB, 2009, THYROID, V19, P987, DOI 10.1089/thy.2009.0041; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; TATA JR, 1993, BIOESSAYS, V15, P239, DOI 10.1002/bies.950150404; Tomita A, 2004, MOL CELL BIOL, V24, P3337, DOI 10.1128/MCB.24.8.3337-3346.2004; Toner P. G., 1971, DIGESTIVE SYSTEM ULT; TSAI MJ, 1994, ANNU REV BIOCHEM, V63, P451, DOI 10.1146/annurev.biochem.63.1.451; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; Wang XD, 2008, ENDOCRINOLOGY, V149, P5610, DOI 10.1210/en.2008-0751; WONG JM, 1995, J BIOL CHEM, V270, P18479, DOI 10.1074/jbc.270.31.18479; WONG JM, 1995, GENE DEV, V9, P2696, DOI 10.1101/gad.9.21.2696; Yen PM, 2001, PHYSIOL REV, V81, P1097, DOI 10.1152/physrev.2001.81.3.1097; Zhang JS, 2000, ANNU REV PHYSIOL, V62, P439, DOI 10.1146/annurev.physiol.62.1.439	77	18	20	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					10039	10050		10.1074/jbc.M111.335661	http://dx.doi.org/10.1074/jbc.M111.335661			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22315222	Green Published, hybrid			2022-12-25	WOS:000302167200036
J	Huang, XY; Hernick, M				Huang, Xinyi; Hernick, Marcy			Examination of Mechanism of N-Acetyl-1-D-myo-inosityl-2-amino-2-deoxy-alpha-D-glucopyranoside Deacetylase (MshB) Reveals Unexpected Role for Dynamic Tyrosine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-LACTAM SYNTHETASE; RATE-LIMITING STEPS; MYCOBACTERIUM-TUBERCULOSIS; MYCOTHIOL BIOSYNTHESIS; CARBAPENAM SYNTHETASE; CRYSTAL-STRUCTURE; UCSF CHIMERA; ENZYME; AMINOPEPTIDASE; INHIBITION	Actinomycetes are a group of Gram-positive bacteria that includes pathogenic mycobacterial species, such as Mycobacterium tuberculosis. These organisms do not have glutathione and instead utilize the small molecule mycothiol (MSH) as their primary reducing agent and for the detoxification of xenobiotics. Due to these important functions, enzymes involved in MSH biosynthesis and MSH-dependent detoxification are targets for drug development. The metal-dependent deacetylase N-acetyl-1-D-myo-inosityl-2-amino-2-deoxy-alpha-D-glucopyranoside deacetylase (MshB) catalyzes the hydrolysis of N-acetyl-1-D-myo-inosityl-2-amino-2-deoxy-alpha-D-glucopyranoside to form 1-D-myo-inosityl-2-amino-2-deoxy-alpha-D-glucopyranoside and acetate in MSH biosynthesis. Herein we examine the chemical mechanism of MshB. We demonstrate that the side chains of Asp-15, Tyr-142, His-144, and Asp-146 are important for catalytic activity. We show that NaF is an uncompetitive inhibitor of MshB, consistent with a metal-water/hydroxide functioning as the reactive nucleophile in the catalytic mechanism. We have previously shown that MshB activity has a bell-shaped dependence on pH with pK(a) values of similar to 7.3 and 10.5 (Huang, X., Kocabas, E. and Hernick, M. (2011) J. Biol. Chem. 286, 2027520282). Mutagenesis experiments indicate that the observed pK(a) values reflect ionization of Asp-15 and Tyr-142, respectively. Together, findings from our studies suggest that MshB functions through a general acid-base pair mechanism with the side chain of Asp-15 functioning as the general base catalyst and His-144 serving as the general acid catalyst, whereas the side chain of Tyr-142 probably assists in polarizing substrate/stabilizing the oxyanion intermediate. Additionally, our results indicate that Tyr-142 is a dynamic side chain that plays key roles in catalysis, modulating substrate binding, chemistry, and product release.	[Huang, Xinyi; Hernick, Marcy] Virginia Tech, Dept Biochem, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University	Hernick, M (corresponding author), Virginia Tech, Dept Biochem, Blacksburg, VA 24061 USA.	hernickm@vt.edu		Hernick, Marcy/0000-0002-2839-5767	Jeffress Memorial Trust [J960]; National Institutes of Health [P41 RR001081]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001081] Funding Source: NIH RePORTER	Jeffress Memorial Trust; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by Jeffress Memorial Trust Grant J960 (to M. H.).; Molecular graphics images were produced using the UCSF Chimera package from the Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco (supported by National Institutes of Health Grant P41 RR001081).	Arnett SO, 2007, BIOCHEMISTRY-US, V46, P9337, DOI 10.1021/bi0618464; Bhave Devayani P., 2007, Infectious Disorders - Drug Targets, V7, P140; Cha J, 1997, BIOCHEMISTRY-US, V36, P16019, DOI 10.1021/bi972223g; Chen GJ, 1997, BIOCHEMISTRY-US, V36, P4278, DOI 10.1021/bi9618676; Drag M, 2010, NAT REV DRUG DISCOV, V9, P690, DOI 10.1038/nrd3053; Dunbrack RL, 2002, CURR OPIN STRUC BIOL, V12, P431, DOI 10.1016/S0959-440X(02)00344-5; Fan F, 2009, CURR OPIN CHEM BIOL, V13, P451, DOI 10.1016/j.cbpa.2009.07.018; Gammon DW, 2010, BIOORGAN MED CHEM, V18, P2501, DOI 10.1016/j.bmc.2010.02.049; Gutierrez-Lugo MT, 2008, J MED CHEM, V51, P2606, DOI 10.1021/jm070719i; Gutierrez-Lugo MT, 2009, J BIOMOL SCREEN, V14, P643, DOI 10.1177/1087057109335743; Hall RS, 2007, BIOCHEMISTRY-US, V46, P7942, DOI 10.1021/bi700543x; Harris MN, 1999, FEBS LETT, V455, P321, DOI 10.1016/S0014-5793(99)00879-0; Hernick M, 2005, J BIOL CHEM, V280, P16969, DOI 10.1074/jbc.M413560200; Hernick M, 2010, COMPREHENSIVE NATURAL PRODUCTS II: CHEMISTRY AND BIOLOGY, VOL 8: ENZYMES AND ENZYME MECHANISMS, P547; Huang XY, 2011, J BIOL CHEM, V286, P20275, DOI 10.1074/jbc.M111.234229; Huang XY, 2011, ANAL BIOCHEM, V414, P278, DOI 10.1016/j.ab.2011.04.001; Javid-Majd F, 2000, BIOCHEMISTRY-US, V39, P1285, DOI 10.1021/bi992177f; Jothivasan VK, 2008, NAT PROD REP, V25, P1091, DOI 10.1039/b616489g; Li NG, 2009, CURR MED CHEM, V16, P3805, DOI 10.2174/092986709789178037; Maynes JT, 2003, J BIOL CHEM, V278, P47166, DOI 10.1074/jbc.M308914200; McCarthy AA, 2004, J MOL BIOL, V335, P1131, DOI 10.1016/j.jmb.2003.11.034; Meng EC, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-339; Metaferia BB, 2007, J MED CHEM, V50, P6326, DOI 10.1021/jm070669h; Newton GL, 2008, MICROBIOL MOL BIOL R, V72, P471, DOI 10.1128/MMBR.00008-08; Newton GL, 2006, PROTEIN EXPRES PURIF, V47, P542, DOI 10.1016/j.pep.2006.03.003; Newton GL, 2000, J BACTERIOL, V182, P6958, DOI 10.1128/JB.182.24.6958-6963.2000; Nicholas GM, 2003, BIOORGAN MED CHEM, V11, P2641, DOI 10.1016/S0968-0896(03)00154-8; Nicholas GM, 2003, BIOORGAN MED CHEM, V11, P601, DOI 10.1016/S0968-0896(02)00345-0; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Raber ML, 2009, BIOCHEMISTRY-US, V48, P4959, DOI 10.1021/bi900432n; Raber ML, 2009, J BIOL CHEM, V284, P207, DOI 10.1074/jbc.M805390200; Rawat M, 2007, FEMS MICROBIOL REV, V31, P278, DOI 10.1111/j.1574-6976.2006.00062.x; Ricci G, 1996, J BIOL CHEM, V271, P16187, DOI 10.1074/jbc.271.27.16187; Schneck JL, 2010, BIOCHEMISTRY-US, V49, P7151, DOI 10.1021/bi100824v; SCHOWEN KB, 1982, METHOD ENZYMOL, V87, P551; Supuran CT, 2010, BIOORG MED CHEM LETT, V20, P3467, DOI 10.1016/j.bmcl.2010.05.009; Todd MJ, 2000, BIOCHEMISTRY-US, V39, P5389, DOI 10.1021/bi992287m; WETTERHOLM A, 1992, P NATL ACAD SCI USA, V89, P9141, DOI 10.1073/pnas.89.19.9141; White RJ, 2003, CURR OPIN PHARMACOL, V3, P502, DOI 10.1016/S1471-4892(03)00115-2	39	14	14	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					10424	10434		10.1074/jbc.M111.320184	http://dx.doi.org/10.1074/jbc.M111.320184			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22315231	Green Published, hybrid			2022-12-25	WOS:000302167200069
J	Singh, R; Grigg, JC; Armstrong, Z; Murphy, MEP; Eltis, LD				Singh, Rahul; Grigg, Jason C.; Armstrong, Zachary; Murphy, Michael E. P.; Eltis, Lindsay D.			Distal Heme Pocket Residues of B-type Dye-decolorizing Peroxidase ARGININE BUT NOT ASPARTATE IS ESSENTIAL FOR PEROXIDASE ACTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; HORSERADISH-PEROXIDASE; BINDING; IDENTIFICATION	DypB from Rhodococcus jostii RHA1 is a bacterial dye-decolorizing peroxidase (DyP) that oxidizes lignin and Mn(II). Three residues interact with the iron-bound solvent species in ferric DypB: Asn-246 and the conserved Asp-153 and Arg-244. Substitution of either Asp-153 or Asn-246 with alanine minimally affected the second order rate constant for Compound I formation (k(1) similar to 10(5) M(-1)s(-1)) and the specificity constant (k(cat)/K-m) for H2O2. Even in the D153A/N246A double variant, these values were reduced less than 30-fold. However, these substitutions dramatically reduced the stability of Compound I (t(1/2) similar to 0.13 s) as compared with the wild-type enzyme (540 s). By contrast, substitution of Arg-244 with leucine abolished the peroxidase activity, and heme iron of the variant showed a pH-dependent transition from high spin (pH 5) to low spin (pH 8.5). Two variants were designed to mimic the plant peroxidase active site: D153H, which was more than an order of magnitude less reactive with H2O2, and N246H, which had no detectable peroxidase activity. X-ray crystallographic studies revealed that structural changes in the variants are confined to the distal heme environment. The data establish an essential role for Arg-244 in Compound I formation in DypB, possibly through charge stabilization and proton transfer. The principle roles of Asp-153 and Asn-246 appear to be in modulating the subsequent reactivity of Compound I. These results expand the range of residues known to catalyze Compound I formation in heme peroxidases.	[Singh, Rahul; Grigg, Jason C.; Armstrong, Zachary; Murphy, Michael E. P.; Eltis, Lindsay D.] Univ British Columbia, Inst Life Sci, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z3, Canada	University of British Columbia	Eltis, LD (corresponding author), Univ British Columbia, Inst Life Sci, Dept Microbiol & Immunol, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	leltis@mail.ubc.ca	Singh, Rahul/A-6891-2009; Murphy, Michael/R-6805-2017; Eltis, Lindsay D/J-8272-2015; Armstrong, Zachary/U-3635-2019	Singh, Rahul/0000-0002-1467-7915; Murphy, Michael/0000-0003-2589-0014; Eltis, Lindsay D/0000-0002-6774-8158; Armstrong, Zachary/0000-0002-4086-2946	Natural Sciences and Engineering Research Council of Canada; National Research Council of Canada; Canadian Institutes of Health Research; Province of Saskatchewan, Western Economic Diversification Canada; University of Saskatchewan	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); National Research Council of Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Province of Saskatchewan, Western Economic Diversification Canada; University of Saskatchewan	This work was supported by Natural Sciences and Engineering Research Council of Canada Discovery grants (to L. D. E. and M. E. P. M.), respectively.; Part of this work was performed at the Canadian Light Source, which is supported by Natural Sciences and Engineering Research Council of Canada, the National Research Council of Canada, the Canadian Institutes of Health Research, the Province of Saskatchewan, Western Economic Diversification Canada, and the University of Saskatchewan.	Ahmad M, 2011, BIOCHEMISTRY-US, V50, P5096, DOI 10.1021/bi101892z; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; CHILDS RE, 1975, BIOCHEM J, V145, P93, DOI 10.1042/bj1450093; Cornish-Bowden A., 1995, ANAL ENZYME KINETIC; Dailey HA, 2011, MBIO, V2, DOI 10.1128/mBio.00248-11; DeLano WL., 2020, PYMOL MOL GRAPHICS S; Efimov I, 2011, J AM CHEM SOC, V133, P15376, DOI 10.1021/ja2007017; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Falk J. E., 1964, PORPHYRINS METALLOPO, P804; FITA I, 1985, J MOL BIOL, V185, P21, DOI 10.1016/0022-2836(85)90180-9; Gajhede M, 1997, NAT STRUCT BIOL, V4, P1032, DOI 10.1038/nsb1297-1032; Goblirsch B, 2011, J MOL BIOL, V408, P379, DOI 10.1016/j.jmb.2011.02.047; Kaur A, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.50; Kong LY, 2010, ARCH MICROBIOL, V192, P585, DOI 10.1007/s00203-010-0585-5; Letoffe S, 2009, P NATL ACAD SCI USA, V106, P11719, DOI 10.1073/pnas.0903842106; Liers C, 2010, APPL MICROBIOL BIOT, V85, P1869, DOI 10.1007/s00253-009-2173-7; Liu XH, 2011, J BIOL CHEM, V286, P14922, DOI 10.1074/jbc.M110.197780; Mildvan AS, 2004, BIOCHEMISTRY-US, V43, P14517, DOI 10.1021/bi048052e; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ogola HJO, 2009, APPL ENVIRON MICROB, V75, P7509, DOI 10.1128/AEM.01121-09; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Roberts JN, 2011, BIOCHEMISTRY-US, V50, P5108, DOI 10.1021/bi200427h; RodriguezLopez JN, 1996, J BIOL CHEM, V271, P4023; Schlippe YVG, 2005, BIOCHEMISTRY-US, V44, P11700, DOI 10.1021/bi048342v; Sharp KH, 2003, NAT STRUCT BIOL, V10, P303, DOI 10.1038/nsb913; Sugano Y, 1999, J BIOSCI BIOENG, V87, P411, DOI 10.1016/S1389-1723(99)80087-5; Sugano Y, 2009, CELL MOL LIFE SCI, V66, P1387, DOI 10.1007/s00018-008-8651-8; Sugano Y, 2007, J BIOL CHEM, V282, P36652, DOI 10.1074/jbc.M706996200; Sundaramoorthy M, 1995, STRUCTURE, V3, P1367, DOI 10.1016/S0969-2126(01)00274-X; VITELLO LB, 1993, BIOCHEMISTRY-US, V32, P9807, DOI 10.1021/bi00088a036; Xiao YW, 2004, BIOCHEMISTRY-US, V43, P12809, DOI 10.1021/bi049238g; Zubieta C, 2007, PROTEINS, V69, P223, DOI 10.1002/prot.21550; Zubieta C, 2007, PROTEINS, V69, P234, DOI 10.1002/prot.21673	33	77	78	6	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					10623	10630		10.1074/jbc.M111.332171	http://dx.doi.org/10.1074/jbc.M111.332171			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22308037	Green Published, hybrid			2022-12-25	WOS:000302167200087
J	Gauthier, T; Wang, XD; Sifuentes, J; Santos, D; Fysikopoulos, A; Tadrist, S; Canlet, C; Artigot, MP; Loiseau, N; Oswald, IP; Puel, O				Gauthier, Thierry; Wang, Xiaodi; Sifuentes, Joice; Santos, Dos; Fysikopoulos, Athanasios; Tadrist, Souria; Canlet, Cecile; Artigot, Marie Pierre; Loiseau, Nicolas; Oswald, Isabelle P.; Puel, Olivier			Trypacidin, a Spore-Borne Toxin from Aspergillus fumigatus, Is Cytotoxic to Lung Cells	PLOS ONE			English	Article							PULMONARY ASPERGILLOSIS; ALKALOID BIOSYNTHESIS; EPITHELIAL-CELLS; ERGOT ALKALOIDS; GLIOTOXIN; APOPTOSIS; MYCOTOXINS; EXPOSURE; CONIDIA; FUMIQUINAZOLINE	Inhalation of Aspergillus fumigatus conidia can cause severe aspergillosis in immunosuppressed people. A. fumigatus produces a large number of secondary metabolites, some of which are airborne by conidia and whose toxicity to the respiratory tract has not been investigated. We found that spores of A. fumigatus contain five main compounds, tryptoquivaline F, fumiquinazoline C, questin, monomethylsulochrin and trypacidin. Fractionation of culture extracts using RP-HPLC and LC-MS showed that samples containing questin, monomethylsulochrin and trypacidin were toxic to the human A549 lung cell line. These compounds were purified and their structure verified using NMR in order to compare their toxicity against A549 cells. Trypacidin was the most toxic, decreasing cell viability and triggering cell lysis, both effects occurring at an IC50 close to 7 mu M. Trypacidin toxicity was also observed in the same concentration range on human bronchial epithelial cells. In the first hour of exposure, trypacidin initiates the intracellular formation of nitric oxide (NO) and hydrogen peroxide (H2O2). This oxidative stress triggers necrotic cell death in the following 24 h. The apoptosis pathway, moreover, was not involved in the cell death process as trypacidin did not induce apoptotic bodies or a decrease in mitochondrial membrane potential. This is the first time that the toxicity of trypacidin to lung cells has been reported.	[Gauthier, Thierry; Wang, Xiaodi; Sifuentes, Joice; Santos, Dos; Fysikopoulos, Athanasios; Tadrist, Souria; Canlet, Cecile; Artigot, Marie Pierre; Loiseau, Nicolas; Oswald, Isabelle P.; Puel, Olivier] UPS, INP, French Natl Inst Agr Res, TOXALIM,UMR1331, Toulouse, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); INRAE; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National Polytechnique de Toulouse	Gauthier, T (corresponding author), UPS, INP, French Natl Inst Agr Res, TOXALIM,UMR1331, Toulouse, France.	opuel@toulouse.inra.fr	dos Santos, Joice Sifuentes/J-1583-2012; LOISEAU, Nicolas/ADN-2394-2022; OSWALD, Isabelle P/A-8497-2013; OSWALD, Isabelle/GPP-1123-2022	dos Santos, Joice Sifuentes/0000-0002-1089-0620; LOISEAU, Nicolas/0000-0003-3783-0879; OSWALD, Isabelle P/0000-0001-9918-277X; OSWALD, Isabelle/0000-0001-9918-277X; Puel, Olivier/0000-0003-1946-5310; Gauthier, Thierry/0000-0003-0207-0515	Agence de l'Environnement et de la Maitrise de l'Energie [0675C0083]; Agence Francaise de Securite Sanitaire de l'Environnement et du Travail [ES-2007-063, ES-2008/1-27]	Agence de l'Environnement et de la Maitrise de l'Energie; Agence Francaise de Securite Sanitaire de l'Environnement et du Travail	This work was supported, in part, by a grant (No 0675C0083) from the Agence de l'Environnement et de la Maitrise de l'Energie and by grants (ES-2007-063 and ES-2008/1-27) from the Agence Francaise de Securite Sanitaire de l'Environnement et du Travail. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afiyatullov SS, 2004, CHEM NAT COMPD+, V40, P615, DOI 10.1007/s10600-005-0058-2; Ames BD, 2011, BIOCHEMISTRY-US, V50, P8756, DOI 10.1021/bi201302w; Ames BD, 2010, BIOCHEMISTRY-US, V49, P8564, DOI 10.1021/bi1012029; Araujo R, 2010, MED MYCOL, V48, P832, DOI 10.3109/13693780903575360; Arendrup MC, 2006, SCAND J INFECT DIS, V38, P945, DOI 10.1080/00365540600606580; BALAN J, 1965, ACTA CHEM SCAND, V19, P528, DOI 10.3891/acta.chem.scand.19-0528; BALAN J, 1963, J ANTIBIOT, V16, P157; Batard E, 2003, EUR J CLIN MICROBIOL, V22, P357, DOI 10.1007/s10096-003-0939-x; Brakhage AA, 2011, FUNGAL GENET BIOL, V48, P15, DOI 10.1016/j.fgb.2010.04.004; Chomcheon P, 2009, PHYTOCHEMISTRY, V70, P121, DOI 10.1016/j.phytochem.2008.10.007; Coyle CM, 2007, MYCOLOGIA, V99, P804, DOI 10.3852/mycologia.99.6.804; Dagenais TRT, 2009, CLIN MICROBIOL REV, V22, P447, DOI 10.1128/CMR.00055-08; Daly P, 1999, MYCOPATHOLOGIA, V146, P67, DOI 10.1023/A:1007092112873; Eduard W, 2009, CRIT REV TOXICOL, V39, P799, DOI 10.3109/10408440903307333; Femenia F, 2009, MYCOPATHOLOGIA, V167, P249, DOI 10.1007/s11046-008-9175-3; Fischer G, 1999, CHEMOSPHERE, V38, P1745, DOI 10.1016/S0045-6535(98)00391-9; Fischer G, 2000, INT J HYG ENVIR HEAL, V203, P105, DOI 10.1078/S1438-4639(04)70015-2; Flemming J, 2004, TOXICOL SCI, V78, P267, DOI 10.1093/toxsci/kfh064; Frisvad JC, 2009, MED MYCOL, V47, pS53, DOI 10.1080/13693780802307720; Geiser DM, 1998, MYCOLOGIA, V90, P831, DOI 10.2307/3761325; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Hertweck C, 2009, NAT CHEM BIOL, V5, P450, DOI 10.1038/nchembio0709-450; Hong SB, 2005, MYCOLOGIA, V97, P1316, DOI 10.3852/mycologia.97.6.1316; Karvala K, 2008, AM J RHINOL, V22, P457, DOI 10.2500/ajr.2008.22.3209; Khaldi N, 2010, FUNGAL GENET BIOL, V47, P736, DOI 10.1016/j.fgb.2010.06.003; Khoufache K, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-5; Krishnaswamy R, 2010, FREE RADICAL BIO MED, V49, P50, DOI 10.1016/j.freeradbiomed.2010.03.016; Kweon YO, 2003, J HEPATOL, V39, P38, DOI 10.1016/S0168-8278(03)00178-8; Kwon-Chung KJ, 2009, MED MYCOL, V47, pS97, DOI 10.1080/13693780802056012; Larsen TO, 2007, MED MYCOL, V45, P225, DOI 10.1080/13693780601185939; Latge JP, 1999, CLIN MICROBIOL REV, V12, P310, DOI 10.1128/CMR.12.2.310; Lewis RE, 2005, INFECT IMMUN, V73, P635, DOI 10.1128/IAI.73.1.635-637.2005; Maiya S, 2006, CHEMBIOCHEM, V7, P1062, DOI 10.1002/cbic.200600003; Matysik S, 2008, J MICROBIOL METH, V75, P182, DOI 10.1016/j.mimet.2008.05.027; Miller JD, 2010, CHEM-BIOL INTERACT, V183, P113, DOI 10.1016/j.cbi.2009.09.023; Mitchell CG, 1997, THORAX, V52, P796, DOI 10.1136/thx.52.9.796; Nierman WC, 2005, NATURE, V438, P1151, DOI 10.1038/nature04332; Panaccione DG, 2005, APPL ENVIRON MICROB, V71, P3106, DOI 10.1128/AEM.71.6.3106-3111.2005; Perrin RM, 2007, PLOS PATHOG, V3, P508, DOI 10.1371/journal.ppat.0030050; RABINOVITCH PS, 1994, METHOD CELL BIOL, V41, P263; Russell K, 2008, LANCET, V371, P2056, DOI 10.1016/S0140-6736(08)60877-6; Samson R. A., 1994, AIR QUALITY MONOGRAP, V2, P531; Shen HM, 1996, FREE RADICAL BIO MED, V21, P139, DOI 10.1016/0891-5849(96)00019-6; Tepsic K, 1997, FEMS MICROBIOL LETT, V157, P9, DOI 10.1111/j.1574-6968.1997.tb12745.x; Turner W. B., 1965, J CHEM SOC PERK T, P6658; Twumasi-Boateng K, 2009, EUKARYOT CELL, V8, P104, DOI 10.1128/EC.00265-08; Zhang L, 2009, ANTI-CANCER DRUG, V20, P416, DOI 10.1097/CAD.0b013e32832aa7b0; Zhou XM, 2000, TOXICOL SCI, V54, P194, DOI 10.1093/toxsci/54.1.194; Zielinska-Jankiewicz K, 2008, ANN AGR ENV MED, V15, P71	49	65	80	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2012	7	2							e29906	10.1371/journal.pone.0029906	http://dx.doi.org/10.1371/journal.pone.0029906			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LO	22319557	Green Published, Green Submitted, gold			2022-12-25	WOS:000302178400003
J	Yasui, Y; Mori, M; Aii, J; Abe, T; Matsumoto, D; Sato, S; Hayashi, Y; Ohnishi, O; Ota, T				Yasui, Yasuo; Mori, Masashi; Aii, Jotaro; Abe, Tomoko; Matsumoto, Daiki; Sato, Shingo; Hayashi, Yoriko; Ohnishi, Ohmi; Ota, Tatsuya			S-LOCUS EARLY FLOWERING 3 Is Exclusively Present in the Genomes of Short-Styled Buckwheat Plants that Exhibit Heteromorphic Self-Incompatibility	PLOS ONE			English	Article							S-RECEPTOR KINASE; POLLEN DETERMINANT; DNA-SEQUENCES; IDENTIFICATION; GENES; EXPRESSION; PROTEINS; CLONING; LOCUS; REJECTION	The different forms of flowers in a species have attracted the attention of many evolutionary biologists, including Charles Darwin. In Fagopyrum esculentum (common buckwheat), the occurrence of dimorphic flowers, namely short-styled and long-styled flowers, is associated with a type of self-incompatibility (SI) called heteromorphic SI. The floral morphology and intra-morph incompatibility are both determined by a single genetic locus named the S-locus. Plants with short-styled flowers are heterozygous (S/s) and plants with long-styled flowers are homozygous recessive (s/s) at the S-locus. Despite recent progress in our understanding of the molecular basis of flower development and plant SI systems, the molecular mechanisms underlying heteromorphic SI remain unresolved. By examining differentially expressed genes from the styles of the two floral morphs, we identified a gene that is expressed only in short-styled plants. The novel gene identified was completely linked to the S-locus in a linkage analysis of 1,373 plants and had homology to EARLY FLOWERING 3. We named this gene S-LOCUS EARLY FLOWERING 3 (S-ELF3). In an ion-beam-induced mutant that harbored a deletion in the genomic region spanning S-ELF3, a phenotype shift from short-styled flowers to long-styled flowers was observed. Furthermore, S-ELF3 was present in the genome of short-styled plants and absent from that of long-styled plants both in world-wide landraces of buckwheat and in two distantly related Fagopyrum species that exhibit heteromorphic SI. Moreover, independent disruptions of S-ELF3 were detected in a recently emerged self-compatible Fagopyrum species and a self-compatible line of buckwheat. The nonessential role of S-ELF3 in the survival of individuals and the prolonged evolutionary presence only in the genomes of short-styled plants exhibiting heteromorphic SI suggests that S-ELF3 is a suitable candidate gene for the control of the short-styled phenotype of buckwheat plants.	[Yasui, Yasuo; Matsumoto, Daiki; Ohnishi, Ohmi] Kyoto Univ, Grad Sch Agr, Sakyou Ku, Kyoto, Japan; [Mori, Masashi] Ishikawa Prefectural Univ, Res Inst Bioresources & Biotechnol, Nonoichi, Ishikawa, Japan; [Aii, Jotaro; Sato, Shingo] Niigata Univ Pharm & Appl Life Sci, Fac Appl Life Sci, Akiha Ku, Niigata, Japan; [Abe, Tomoko; Hayashi, Yoriko] RIKEN, Nishina Ctr Accelerator Based Sci, Wako, Saitama, Japan; [Ota, Tatsuya] Grad Univ Adv Studies, Dept Evolutionary Studies Biosyst, Hayama, Kanagawa, Japan	Kyoto University; Ishikawa Prefecture University; Niigata University; RIKEN; Graduate University for Advanced Studies - Japan	Yasui, Y (corresponding author), Kyoto Univ, Grad Sch Agr, Sakyou Ku, Kyoto, Japan.	yasyas@kais.kyoto-u.ac.jp		Ota, Tatsuya/0000-0002-1115-5169	IGARASHI Buckwheat Research Foundation; JSPS (Japan Society for Promotion of Science) [22580003]; Kyoto University; Center for the Promotion of Integrated Sciences; Hayama Center for Advanced Studies at Sokendai	IGARASHI Buckwheat Research Foundation; JSPS (Japan Society for Promotion of Science)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Kyoto University; Center for the Promotion of Integrated Sciences; Hayama Center for Advanced Studies at Sokendai	This work was supported in part by funding from the IGARASHI Buckwheat Research Foundation to YY, Grants-in-Aid for Scientific Research from JSPS (Japan Society for Promotion of Science) to YY (#22580003), Core Stage Backup Research Fund of Kyoto University to YY, and a research grant from the Center for the Promotion of Integrated Sciences and the Hayama Center for Advanced Studies at Sokendai to TO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aii J, 1999, BREEDING SCI, V48, P59; Ainsworth C, 2000, ANN BOT-LONDON, V86, P211, DOI 10.1006/anbo.2000.1201; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Barrett S.C.H., 1992, EVOLUTION FUNCTION H, DOI DOI 10.1007/978-3-642-86656-2_1; Brandbyge J., 1993, FLOWERING PLANTS DIC, P531, DOI [10.1007/978-3-662-02899-563, 10.1007/978-3-662-02899-5_63, DOI 10.1007/978-3-662-02899-5_63]; Chalesworth D, 2010, F1000 BIOL REP, V2; Chalesworth D, 1982, AM NAT, V119, P732; Cohen JI, 2010, AM J BOT, V97, P701, DOI 10.3732/ajb.0900395; Dixon LE, 2011, CURR BIOL, V21, P120, DOI 10.1016/j.cub.2010.12.013; ERNST A., 1955, Genetica, V27, P391, DOI 10.1007/BF01664170; Flint-Garcia SA, 2003, ANNU REV PLANT BIOL, V54, P357, DOI 10.1146/annurev.arplant.54.031902.134907; FOOTE HCC, 1994, P NATL ACAD SCI USA, V91, P2265, DOI 10.1073/pnas.91.6.2265; Garber RJ, 1927, J AGRIC RES, V34, P0185; GIBBS PE, 1986, PLANT SYST EVOL, V154, P285, DOI 10.1007/BF00990130; Hedges SB, 2006, BIOINFORMATICS, V22, P2971, DOI 10.1093/bioinformatics/btl505; Hicks KA, 1996, SCIENCE, V274, P790, DOI 10.1126/science.274.5288.790; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kejnovsky E, 2006, GENETICA, V128, P167, DOI 10.1007/s10709-005-5701-0; Kosugi S, 2009, P NATL ACAD SCI USA, V106, P10171, DOI 10.1073/pnas.0900604106; Labonne JDJ, 2010, HEREDITY, V105, P235, DOI 10.1038/hdy.2010.39; Labonne JDJ, 2011, MOL GENET GENOMICS, V285, P101, DOI 10.1007/s00438-010-0590-z; Labonne JJD, 2009, MOL GENET GENOMICS, V281, P673, DOI 10.1007/s00438-009-0439-5; LEE HS, 1994, NATURE, V367, P560, DOI 10.1038/367560a0; Lewis D., 1992, EVOLUTION FUNCTION H, P129, DOI DOI 10.1007/978-3-642-86656-2_5; Li JH, 2007, PLANT J, V51, P18, DOI 10.1111/j.1365-313X.2007.03125.x; Li JH, 2011, ANN BOT-LONDON, V108, P715, DOI 10.1093/aob/mcr181; Lloyd D.G, 1992, EVOLUTION FUNCTION H, P151; Manfield IW, 2005, J EXP BOT, V56, P1177, DOI 10.1093/jxb/eri110; Matsui K, 2003, NEW PHYTOL, V159, P701, DOI 10.1046/j.1469-8137.2003.00840.x; McCubbin AG, 2006, SEX PLANT REPROD, V19, P63, DOI 10.1007/s00497-006-0022-8; Miljus-Dukic J, 2004, BIOL PLANTARUM, V48, P293, DOI 10.1023/B:BIOP.0000033459.48057.8b; Ming R, 2011, ANNU REV PLANT BIOL, V62, P485, DOI 10.1146/annurev-arplant-042110-103914; MURFETT J, 1994, NATURE, V367, P563, DOI 10.1038/367563a0; Navajas-Perez R, 2005, MOL BIOL EVOL, V22, P1929, DOI 10.1093/molbev/msi186; Nishimoto Y, 2003, GENES GENET SYST, V78, P139, DOI 10.1266/ggs.78.139; Ohnishi O, 1996, GENES GENET SYST, V71, P383, DOI 10.1266/ggs.71.383; Ohnishi O, 1993, GENES GENET SYST, V68, P317; Ohsako T., 2001, Fagopyrum, V18, P9; Ono T, 1923, BOT MAG TOKYO, V37, P84; Sanchez A, 2009, INT J PLANT SCI, V170, P1044, DOI 10.1086/605121; Schopfer CR, 1999, SCIENCE, V286, P1697, DOI 10.1126/science.286.5445.1697; Sijacic P, 2004, NATURE, V429, P302, DOI 10.1038/nature02523; Silva NF, 2001, MOL GENET GENOMICS, V265, P552, DOI 10.1007/s004380100446; Smit AFA, 1996, CURR OPIN GENET DEV, V6, P743, DOI 10.1016/S0959-437X(96)80030-X; STEIN JC, 1991, P NATL ACAD SCI USA, V88, P8816, DOI 10.1073/pnas.88.19.8816; Takasaki T, 2000, NATURE, V403, P913, DOI 10.1038/35002628; Takayama S, 2000, P NATL ACAD SCI USA, V97, P1920, DOI 10.1073/pnas.040556397; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Wheeler MJ, 2009, NATURE, V459, P992, DOI 10.1038/nature08027; Yasui Y, 2004, GENOME, V47, P345, DOI [10.1139/G03-126, 10.1139/g03-126]; Yasui Y, 1998, AM J BOT, V85, P1134, DOI 10.2307/2446346; Yasui Y, 2008, GENES GENET SYST, V83, P393, DOI 10.1266/ggs.83.393; Zagotta MT, 1996, PLANT J, V10, P691, DOI 10.1046/j.1365-313X.1996.10040691.x; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	54	50	55	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2012	7	2							e31264	10.1371/journal.pone.0031264	http://dx.doi.org/10.1371/journal.pone.0031264			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UG	22312442	Green Published, gold, Green Submitted			2022-12-25	WOS:000301977500031
J	Yang, DF; Ma, PD; Liang, X; Liang, ZS; Zhang, MX; Shen, S; Liu, HY; Liu, Y				Yang, Dongfeng; Ma, Pengda; Liang, Xiao; Liang, Zongsuo; Zhang, Meixiang; Shen, Shuang; Liu, Hongyun; Liu, Yan			Metabolic Profiles and cDNA-AFLP Analysis of Salvia miltiorrhiza and Salvia castanea Diel f. tomentosa Stib	PLOS ONE			English	Article							TRANSCRIPTOME COEXPRESSION ANALYSIS; ROSMARINIC ACID ACCUMULATION; SECONDARY METABOLISM; SUSPENSION-CULTURES; PAPAVER-SOMNIFERUM; GENOMICS APPROACH; CELL-CULTURES; HAIRY ROOTS; GENE; BIOSYNTHESIS	Plants of the genus Salvia produce various types of phenolic compounds and tanshinones which are effective for treatment of coronary heart disease. Salvia miltiorrhiza and S. castanea Diels f. tomentosa Stib are two important members of the genus. In this study, metabolic profiles and cDNA-AFLP analysis of four samples were employed to identify novel genes potentially involved in phenolic compounds and tanshinones biosynthesis, including the red roots from the two species and two tanshinone-free roots from S. miltiorrhiza. The results showed that the red roots of S. castanea Diels f. tomentosa Stib produced high contents of rosmarinic acid (21.77 mg/g) and tanshinone IIA (12.60 mg/g), but low content of salvianolic acid B (1.45 mg/g). The red roots of S. miltiorrhiza produced high content of salvianolic acid B (18.69 mg/g), while tanshinones accumulation in this sample was much less than that in S. castanea Diels f. tomentosa Stib. Tanshinones were not detected in the two tanshinone-free samples, which produced high contents of phenolic compounds. A cDNA-AFLP analysis with 128 primer pairs revealed that 2300 transcript derived fragments (TDFs) were differentially expressed among the four samples. About 323 TDFs were sequenced, of which 78 TDFs were annotated with known functions through BLASTX searching the Genbank database and 14 annotated TDFs were assigned into secondary metabolic pathways through searching the KEGGPATHWAY database. The quantitative real-time PCR analysis indicated that the expression of 9 TDFs was positively correlated with accumulation of phenolic compounds and tanshinones. These TDFs additionally showed coordinated transcriptional response with 6 previously-identified genes involved in biosynthesis of tanshinones and phenolic compounds in S. miltiorrhiza hairy roots treated with yeast extract. The sequence data in the present work not only provided us candidate genes involved in phenolic compounds and tanshinones biosynthesis but also gave us further insight into secondary metabolism in Salvia.	[Yang, Dongfeng; Ma, Pengda; Liang, Xiao; Liang, Zongsuo; Zhang, Meixiang; Shen, Shuang; Liu, Hongyun] NW A&F Univ, Coll Life Sci, Yangling, Peoples R China; [Liang, Zongsuo] Zhejiang Sci Tech Univ, Coll Life Sci, Hangzhou, Zhejiang, Peoples R China; [Liu, Yan] Tianjin Tasly Modern TCM Resources Co Ltd, Tianjin, Peoples R China	Northwest A&F University - China; Zhejiang Sci-Tech University	Liang, ZS (corresponding author), NW A&F Univ, Coll Life Sci, Yangling, Peoples R China.	liangzs@ms.iswc.ac.cn			Chinese Academy of Science [KZCX2-YW-443]	Chinese Academy of Science(Chinese Academy of Sciences)	This work was supported by Knowledge Innovation Project of Chinese Academy of Science (KZCX2-YW-443). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger A, 2006, PLANTA, V224, P1503, DOI 10.1007/s00425-006-0393-y; Bezakova L, 2010, CHEM PHYS LIPIDS, V163, pS67, DOI 10.1016/j.chemphyslip.2010.05.198; Chavez-Cabrera C, 2010, APPL MICROBIOL BIOT, V85, P1953, DOI 10.1007/s00253-009-2271-6; Cui Guang-hong, 2007, Zhongguo Zhong Yao Za Zhi, V32, P1267; D'Onofrio C, 2009, FUNCT PLANT BIOL, V36, P323, DOI 10.1071/FP08280; Dai ZB, 2011, J PLANT PHYSIOL, V168, P148, DOI 10.1016/j.jplph.2010.06.008; Dong JA, 2010, J BIOTECHNOL, V148, P99, DOI 10.1016/j.jbiotec.2010.05.009; Gao W, 2009, ORG LETT, V11, P5170, DOI 10.1021/ol902051v; Ge XC, 2005, PLANT SCI, V168, P487, DOI 10.1016/j.plantsci.2004.09.012; Goossens A, 2003, P NATL ACAD SCI USA, V100, P8595, DOI 10.1073/pnas.1032967100; Guterman I, 2002, PLANT CELL, V14, P2325, DOI 10.1105/tpc.005207; HAHN MG, 1978, PLANT PHYSIOL, V62, P107, DOI 10.1104/pp.62.1.107; Hartmann T, 2007, PHYTOCHEMISTRY, V68, P2831, DOI 10.1016/j.phytochem.2007.09.017; HU ZB, 1993, PHYTOCHEMISTRY, V32, P699, DOI 10.1016/S0031-9422(00)95156-2; Hua WP, 2011, GENOMICS, V98, P272, DOI 10.1016/j.ygeno.2011.03.012; Huang BB, 2008, MOL BIOL REP, V35, P601, DOI 10.1007/s11033-007-9130-2; Inyushkina YV, 2009, BIOCHEMISTRY-MOSCOW+, V74, P917, DOI 10.1134/S0006297909080148; Kubo H, 1999, PLANT CELL, V11, P1217, DOI 10.1105/tpc.11.7.1217; Li Ying, 2010, Yaoxue Xuebao, V45, P524; Naoumkina MA, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-132; Rischer H, 2006, P NATL ACAD SCI USA, V103, P5614, DOI 10.1073/pnas.0601027103; Shalel-Levanon S, 2005, METAB ENG, V7, P364, DOI 10.1016/j.ymben.2005.07.001; Shimada S, 2004, PLANT CELL PHYSIOL, V45, P1290, DOI 10.1093/pcp/pch156; Song J, 2009, MOL BIOL REP, V36, P939, DOI 10.1007/s11033-008-9266-8; Szabo E, 1999, PLANT CELL REP, V18, P485, DOI 10.1007/s002990050608; Vuylsteke M, 2007, NAT PROTOC, V2, P1399, DOI 10.1038/nprot.2007.174; Wang QH, 2009, ACTA CHIN MED PHARM, V37, P1; Wu SJ, 2009, BIOTECHNOL APPL BIOC, V52, P89, DOI 10.1042/BA20080004; Y Xiao, 2009, PHYSL PLANT; Yan Q, 2006, PLANT SCI, V170, P853, DOI 10.1016/j.plantsci.2005.12.004; Yan XM, 2009, ACTA PHYSIOL PLANT, V31, P1015, DOI 10.1007/s11738-009-0320-5; Yang DF, 2009, FITOTERAPIA, V80, P274, DOI 10.1016/j.fitote.2009.03.004; Yonekura-Sakakibara K, 2008, PLANT CELL, V20, P2160, DOI 10.1105/tpc.108.058040; Yonekura-Sakakibara K, 2007, J BIOL CHEM, V282, P14932, DOI 10.1074/jbc.M611498200; Zhang CH, 2007, BIOTECHNOL BIOENG, V96, P506, DOI 10.1002/bit.21122; Zhang Shuncang, 2011, Zhongguo Zhong Yao Za Zhi, V36, P1269; Zhao JL, 2010, APPL MICROBIOL BIOT, V87, P137, DOI 10.1007/s00253-010-2443-4; Zhou LM, 2005, J CLIN PHARMACOL, V45, P1345, DOI 10.1177/0091270005282630; Ziegler J, 2005, PLANTA, V222, P458, DOI 10.1007/s00425-005-1550-4; Zorn H, 2003, BIOCATAL BIOTRANSFOR, V21, P341, DOI 10.1080/10242420310001630173; 廖文波, 2004, [中药材, Journal of Chinese Medicinal Materials], V27, P897	41	22	25	2	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2012	7	1							e29678	10.1371/journal.pone.0029678	http://dx.doi.org/10.1371/journal.pone.0029678			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	912BU	22303439	Green Published, gold, Green Submitted			2022-12-25	WOS:000301770300001
J	Landis, SH; Kalbe, M; Reusch, TBH; Roth, O				Landis, Susanne H.; Kalbe, Martin; Reusch, Thorsten B. H.; Roth, Olivia			Consistent Pattern of Local Adaptation during an Experimental Heat Wave in a Pipefish-Trematode Host-Parasite System	PLOS ONE			English	Article							ECOLOGICAL IMMUNOLOGY; GENETIC-VARIATION; DISEASE ECOLOGY; IMMUNE-SYSTEM; TEMPERATURE; RESISTANCE; COEVOLUTION; MARINE; DYNAMICS; SPECIFICITY	Extreme climate events such as heat waves are expected to increase in frequency under global change. As one indirect effect, they can alter magnitude and direction of species interactions, for example those between hosts and parasites. We simulated a summer heat wave to investigate how a changing environment affects the interaction between the broad-nosed pipefish (Syngnathus typhle) as a host and its digenean trematode parasite (Cryptocotyle lingua). In a fully reciprocal laboratory infection experiment, pipefish from three different coastal locations were exposed to sympatric and allopatric trematode cercariae. In order to examine whether an extreme climatic event disrupts patterns of locally adapted host-parasite combinations we measured the parasite's transmission success as well as the host's adaptive and innate immune defence under control and heat wave conditions. Independent of temperature, sympatric cercariae were always more successful than allopatric ones, indicating that parasites are locally adapted to their hosts. Hosts suffered from heat stress as suggested by fewer cells of the adaptive immune system (lymphocytes) compared to the same groups that were kept at 18 degrees C. However, the proportion of the innate immune cells (monocytes) was higher in the 18 degrees C water. Contrary to our expectations, no interaction between host immune defence, parasite infectivity and temperature stress were found, nor did the pattern of local adaptation change due to increased water temperature. Thus, in this host-parasite interaction, the sympatric parasite keeps ahead of the coevolutionary dynamics across sites, even under increasing temperatures as expected under marine global warming.	[Landis, Susanne H.; Reusch, Thorsten B. H.; Roth, Olivia] Leibniz Inst Marine Sci IFM GEOMAR, Kiel, Germany; [Kalbe, Martin] Max Planck Inst Evolutionary Biol, Dept Evolutionary Ecol, Plon, Germany	Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; Max Planck Society	Landis, SH (corresponding author), Leibniz Inst Marine Sci IFM GEOMAR, Kiel, Germany.	slandis@ifm-geomar.de	Roth, Olivia/M-3379-2016; Reusch, Thorsten B. H./B-9311-2019; Reusch, Thorsten B.H./G-4141-2011	Roth, Olivia/0000-0002-7349-7797; Reusch, Thorsten B. H./0000-0002-8961-4337	Volkswagen foundation; Kiel excellence cluster "The Future Ocean''	Volkswagen foundation(Volkswagen); Kiel excellence cluster "The Future Ocean''	SHL and OR were supported by grants from the Volkswagen foundation programme "Strengthening Evolutionary Biology''. In addition, this work was supported by a start-up grant from the Kiel excellence cluster "The Future Ocean'' to TR, OR & SHL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHNESJO I, 1995, BEHAV ECOL, V6, P229, DOI 10.1093/beheco/6.2.229; ANTONOVICS J, 1994, P ROY SOC B-BIOL SCI, V257, P105, DOI 10.1098/rspb.1994.0101; Ardia DR, 2011, FUNCT ECOL, V25, P61, DOI 10.1111/j.1365-2435.2010.01759.x; Baucom RS, 2011, FUNCT ECOL, V25, P18, DOI 10.1111/j.1365-2435.2010.01742.x; Belkin IM, 2009, PROG OCEANOGR, V81, P207, DOI 10.1016/j.pocean.2009.04.011; Belkin S., 2005, OCEANS HLTH PATHOGEN, V233; BERGLUND A, 1986, BEHAV ECOL SOCIOBIOL, V19, P301, DOI 10.1007/BF00300646; Bergmann N, 2010, MOL ECOL, V19, P2870, DOI 10.1111/j.1365-294X.2010.04731.x; Blakeslee AMH, 2008, MOL ECOL, V17, P3684, DOI 10.1111/j.1365-294X.2008.03865.x; Blanford S, 2003, ECOL LETT, V6, P2, DOI 10.1046/j.1461-0248.2003.00387.x; Braude S, 1999, BEHAV ECOL, V10, P345, DOI 10.1093/beheco/10.3.345; Carius HJ, 2001, EVOLUTION, V55, P1136, DOI 10.1111/j.0014-3820.2001.tb00633.x; Easterling DR, 2000, SCIENCE, V289, P2068, DOI 10.1126/science.289.5487.2068; Ebert D, 1996, TRENDS ECOL EVOL, V11, pA79; Ebert D, 1998, P ROY SOC B-BIOL SCI, V265, P2127, DOI 10.1098/rspb.1998.0549; Enfield DB, 1988, OCEANOGRAPHY, V1, P23; Fellowes MDE, 1999, EVOLUTION, V53, P966, DOI 10.2307/2640737; Gandon S, 2002, ECOL LETT, V5, P246, DOI 10.1046/j.1461-0248.2002.00305.x; Gandon S, 1996, P ROY SOC B-BIOL SCI, V263, P1003, DOI 10.1098/rspb.1996.0148; Gomez JM, 2009, ECOL LETT, V12, P672, DOI 10.1111/j.1461-0248.2009.01324.x; Granovitch A, 2000, OPHELIA, V53, P55, DOI 10.1080/00785326.2000.10409435; Harvell CD, 2002, SCIENCE, V296, P2158, DOI 10.1126/science.1063699; Hawley DM, 2011, FUNCT ECOL, V25, P48, DOI 10.1111/j.1365-2435.2010.01753.x; Kaltz O, 1998, HEREDITY, V81, P361, DOI 10.1046/j.1365-2540.1998.00435.x; Kirby RR, 2006, BIOL LETTERS, V2, P597, DOI 10.1098/rsbl.2006.0530; Laine AL, 2008, ECOL LETT, V11, P327, DOI 10.1111/j.1461-0248.2007.01146.x; Lazzaro BP, 2006, GENETICS, V174, P1539, DOI 10.1534/genetics.105.054593; Lazzaro BP, 2009, PHILOS T R SOC B, V364, P15, DOI 10.1098/rstb.2008.0141; LIVELY CM, 1989, EVOLUTION, V43, P1663, DOI [10.2307/2409382, 10.1111/j.1558-5646.1989.tb02616.x]; Wegner KM, 2007, EVOL ECOL, V21, P473, DOI 10.1007/s10682-006-9129-5; Matsunaga T, 1998, IMMUNOL REV, V166, P177, DOI 10.1111/j.1600-065X.1998.tb01262.x; Mazzi D, 2004, J EVOLUTION BIOL, V17, P519, DOI 10.1111/j.1420-9101.2004.00704.x; McClelland EE, 2003, INFECT IMMUN, V71, P2079, DOI 10.1128/IAI.71.4.2079-2086.2003; McCoy KD, 2001, J EVOLUTION BIOL, V14, P395, DOI 10.1046/j.1420-9101.2001.00290.x; Moret Y, 2000, SCIENCE, V290, P1166, DOI 10.1126/science.290.5494.1166; Mydlarz LD, 2006, ANNU REV ECOL EVOL S, V37, P251, DOI 10.1146/annurev.ecolsys.37.091305.110103; Palutikof JP., 2007, CLIMATE CHANGE 2007, V7-22, P8; Poulin R, 2006, PARASITOLOGY, V132, P143, DOI 10.1017/S0031182005008693; Rauch G, 2006, BIOL LETT-UK, V2, P382, DOI 10.1098/rsbl.2006.0462; Read AF, 2000, SCIENCE, V290, P1104, DOI 10.1126/science.290.5494.1104; Reusch TBH, 2005, P NATL ACAD SCI USA, V102, P2826, DOI 10.1073/pnas.0500008102; Roth O, 2011, J EVOLUTION BIOL, V24, P1410, DOI 10.1111/j.1420-9101.2011.02273.x; Roth O, 2010, MAR BIOL, V157, P1605, DOI 10.1007/s00227-010-1433-5; Schmid-Hempel P, 2003, TRENDS ECOL EVOL, V18, P27, DOI 10.1016/S0169-5347(02)00013-7; Schulte RD, 2011, P ROY SOC B-BIOL SCI, V278, P2832, DOI 10.1098/rspb.2011.0019; Seppala O, 2011, BIOL LETTERS, V7, P119, DOI 10.1098/rsbl.2010.0459; Studer A, 2010, MAR ECOL PROG SER, V415, P11, DOI 10.3354/meps08742; Stunkard HW, 1930, J MORPHOL, V50, P143, DOI 10.1002/jmor.1050500106; Thieltges DW, 2006, DIS AQUAT ORGAN, V73, P63; Thomas MB, 2003, TRENDS ECOL EVOL, V18, P344, DOI 10.1016/S0169-5347(03)00069-7; Thompson JN, 1997, ECOLOGY, V78, P1619; Thompson JN, 1994, COEVOLUTIONARY PROCE; Tort L., 2003, Inmunologia, V22, P277; Van Valen L., 1973, EVOL THEORY, V1, P1, DOI DOI 10.1038/344864A0; Wegner KM, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-124; Zander CD, 1999, PARASITOL RES, V85, P356, DOI 10.1007/s004360050562; Zander CD, 1998, NATURWISSENSCHAFTEN, V85, P426, DOI 10.1007/s001140050526	57	22	22	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2012	7	1							e30658	10.1371/journal.pone.0030658	http://dx.doi.org/10.1371/journal.pone.0030658			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911GB	22303448	gold, Green Accepted, Green Submitted, Green Published			2022-12-25	WOS:000301704200027
J	Zhang, O; Xu, W; Pillai, AB; Zhang, K				Zhang, Ou; Xu, Wei; Pillai, Agiesh Balakrishna; Zhang, Kai			Developmentally Regulated Sphingolipid Degradation in Leishmania major	PLOS ONE			English	Article							PHOSPHOSPHINGOLIPID-PHOSPHOLIPASE-C; CHRONOLOGICAL LIFE-SPAN; NIEMANN-PICK-DISEASE; SACCHAROMYCES-CEREVISIAE; NEUTRAL SPHINGOMYELINASES; ACID SPHINGOMYELINASE; INFECTIVE STAGE; STRESS-RESPONSE; PROMASTIGOTES; EXPRESSION	Leishmania parasites alternate between extracellular promastigotes in sandflies and intracellular amastigotes in mammals. These protozoans acquire sphingolipids (SLs) through de novo synthesis (to produce inositol phosphorylceramide) and salvage (to obtain sphingomyelin from the host). A single ISCL (Inositol phosphoSphingolipid phospholipase C-Like) enzyme is responsible for the degradation of both inositol phosphorylceramide (the IPC hydrolase or IPCase activity) and sphingomyelin (the SMase activity). Recent studies of a L. major ISCL-null mutant (iscl(-)) indicate that SL degradation is required for promastigote survival in stationary phase, especially under acidic pH. ISCL is also essential for L. major proliferation in mammals. To further understand the role of ISCL in Leishmania growth and virulence, we introduced a sole IPCase or a sole SMase into the iscl(-) mutant. Results showed that restoration of IPCase only complemented the acid resistance defect in iscl(-) promastigotes and improved their survival in macrophages, but failed to recover virulence in mice. In contrast, a sole SMase fully restored parasite infectivity in mice but was unable to reverse the promastigote defects in iscl(-). These findings suggest that SL degradation in Leishmania possesses separate roles in different stages: while the IPCase activity is important for promastigote survival and acid tolerance, the SMase activity is required for amastigote proliferation in mammals. Consistent with these findings, ISCL was preferentially expressed in stationary phase promastigotes and amastigotes. Together, our results indicate that SL degradation by Leishmania is critical for parasites to establish and sustain infection in the mammalian host.	[Zhang, Ou; Xu, Wei; Pillai, Agiesh Balakrishna; Zhang, Kai] Texas Tech Univ, Dept Biol Sci, Lubbock, TX 79409 USA	Texas Tech University System; Texas Tech University	Zhang, O (corresponding author), Texas Tech Univ, Dept Biol Sci, Lubbock, TX 79409 USA.	kai.zhang@ttu.edu		Zhang, Ou/0000-0001-6574-130X	Public Health Service [1R15AI076909, 1R56AI081781, 5R03AI076662]; National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI081781, R03AI076662, R15AI076909] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by Public Health Service grants 1R15AI076909 (KZ), 1R56AI081781 (KZ) and 5R03AI076662 (KZ) from the National Institute of Allergy and Infectious Diseases (http://www.niaid.nih.gov/Pages/default.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akopyants NS, 2004, MOL BIOCHEM PARASIT, V136, P71, DOI 10.1016/j.molbiopara.2004.03.002; ALMEIDA T, 2007, MOL BIOL CELL; Almeida T, 2008, MOL BIOL CELL, V19, P865, DOI 10.1091/mbc.E07-06-0604; Barbosa AD, 2011, MOL MICROBIOL, V81, P515, DOI 10.1111/j.1365-2958.2011.07714.x; Bartke N, 2009, J LIPID RES, V50, pS91, DOI 10.1194/jlr.R800080-JLR200; Bates PA, 2008, CURR OPIN MICROBIOL, V11, P340, DOI 10.1016/j.mib.2008.06.003; Bringaud F, 2006, MOL BIOCHEM PARASIT, V149, P1, DOI 10.1016/j.molbiopara.2006.03.017; Castillo E, 2010, CURR MED CHEM, V17, P4027, DOI 10.2174/092986710793205345; Clarke CJ, 2006, BIOCHEMISTRY-US, V45, P11247, DOI 10.1021/bi061307z; Clarke CJ, 2011, ADV ENZYME REGUL, V51, P51, DOI 10.1016/j.advenzreg.2010.09.016; Cowart LA, 2005, BIOCHEM SOC T, V33, P1166, DOI 10.1042/BST0331166; Croft SL, 2003, TRENDS PARASITOL, V19, P502, DOI 10.1016/j.pt.2003.09.008; de Avalos SV, 2005, J BIOL CHEM, V280, P7170, DOI 10.1074/jbc.M411058200; de Avalos SV, 2004, J BIOL CHEM, V279, P11537, DOI 10.1074/jbc.M309586200; Denny PW, 2000, J BIOL CHEM, V275, P11017, DOI 10.1074/jbc.275.15.11017; Dickson RC, 1999, BBA-GEN SUBJECTS, V1426, P347, DOI 10.1016/S0304-4165(98)00135-4; Duan RD, 2006, BBA-MOL CELL BIOL L, V1761, P281, DOI 10.1016/j.bbalip.2006.03.007; Gault CR, 2010, ADV EXP MED BIOL, V688, P1; GLASER TA, 1990, EXP PARASITOL, V71, P343, DOI 10.1016/0014-4894(90)90039-F; Goni FM, 2002, FEBS LETT, V531, P38, DOI 10.1016/S0014-5793(02)03482-8; Ha DS, 1996, MOL BIOCHEM PARASIT, V77, P57, DOI 10.1016/0166-6851(96)02580-7; Henry J, 2011, FEBS LETT, V585, P635, DOI 10.1016/j.febslet.2011.01.015; KANESHIRO ES, 1986, J LIPID RES, V27, P1294; KAPLER GM, 1990, MOL CELL BIOL, V10, P1084, DOI 10.1128/MCB.10.3.1084; Kitagaki H, 2009, J BIOL CHEM, V284, P10818, DOI 10.1074/jbc.M805029200; LEVRAN O, 1991, P NATL ACAD SCI USA, V88, P3748, DOI 10.1073/pnas.88.9.3748; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marchesini N, 2004, BIOCHEM CELL BIOL, V82, P27, DOI 10.1139/o03-091; Marchesini N, 2002, MOL BIOCHEM PARASIT, V119, P225, DOI 10.1016/S0166-6851(01)00419-4; Matmati N, 2008, J LIPID RES, V49, P922, DOI 10.1194/jlr.R800004-JLR200; Myler PJ, 2008, ADV EXP MED BIOL, V625, P133, DOI 10.1007/978-0-387-77570-8_11; Nikolova-Karakashian MN, 2010, ADV EXP MED BIOL, V688, P86; Okamoto Y, 2003, BIOCHEMISTRY-US, V42, P7855, DOI 10.1021/bi0341354; Okamoto Y, 2002, J BIOL CHEM, V277, P46470, DOI 10.1074/jbc.M207779200; Ouakad M, 2007, PARASITOL RES, V101, P473, DOI 10.1007/s00436-007-0491-1; Racoosin EL, 1997, EXP PARASITOL, V85, P283, DOI 10.1006/expr.1996.4139; Ranasinghe S, 2008, T ROY SOC TROP MED H, V102, P875, DOI 10.1016/j.trstmh.2008.04.003; SACKS DL, 1985, AM J TROP MED HYG, V34, P456, DOI 10.4269/ajtmh.1985.34.456; SACKS DL, 1984, SCIENCE, V223, P1417, DOI 10.1126/science.6701528; Saunders EC, 2010, PARASITOLOGY, V137, P1303, DOI 10.1017/S0031182010000077; Sawai H, 2000, J BIOL CHEM, V275, P39793, DOI 10.1074/jbc.M007721200; Schuchman EH, 2010, FEBS LETT, V584, P1895, DOI 10.1016/j.febslet.2009.11.083; Schulze H, 2011, COLD SPRING HARB PER, V3; Shea JM, 2006, INFECT IMMUN, V74, P5977, DOI 10.1128/IAI.00768-06; Smith EL, 2008, FASEB J, V22, P3419, DOI 10.1096/fj.08-108043; Sperling P, 2003, BBA-MOL CELL BIOL L, V1632, P1, DOI 10.1016/S1388-1981(03)00033-7; TAMURA H, 1995, BIOCHEM J, V309, P757, DOI 10.1042/bj3090757; TITUS RG, 1991, EUR J IMMUNOL, V21, P559, DOI 10.1002/eji.1830210305; TITUS RG, 1985, PARASITE IMMUNOL, V7, P545, DOI 10.1111/j.1365-3024.1985.tb00098.x; VIEIRA L, 1995, J BIOL CHEM, V270, P5299, DOI 10.1074/jbc.270.10.5299; Xu W, 2011, INFECT IMMU IN PRESS; Young SA, MOL MICROBIOL, V76, P1461; Zhang K, 2005, MOL MICROBIOL, V55, P1566, DOI 10.1111/j.1365-2958.2005.04493.x; Zhang K, 2003, EMBO J, V22, P6016, DOI 10.1093/emboj/cdg584; Zhang K, 2007, EMBO J, V26, P1094, DOI 10.1038/sj.emboj.7601565; Zhang K, 2010, MOL BIOCHEM PARASIT, V170, P55, DOI 10.1016/j.molbiopara.2009.12.004; Zhang O, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000692	57	14	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2012	7	1							e31059	10.1371/journal.pone.0031059	http://dx.doi.org/10.1371/journal.pone.0031059			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911GB	22299050	Green Published, gold, Green Submitted			2022-12-25	WOS:000301704200058
J	Frazer, LC; Darville, T; Chandra-Kuntal, K; Andrews, CW; Zurenski, M; Mintus, M; AbdelRahman, YM; Belland, RJ; Ingalls, RR; O'Connell, CM				Frazer, Lauren C.; Darville, Toni; Chandra-Kuntal, Kumar; Andrews, Charles W., Jr.; Zurenski, Matthew; Mintus, Margaret; AbdelRahman, Yasser M.; Belland, Robert J.; Ingalls, Robin R.; O'Connell, Catherine M.			Plasmid-Cured Chlamydia caviae Activates TLR2-Dependent Signaling and Retains Virulence in the Guinea Pig Model of Genital Tract Infection	PLOS ONE			English	Article							GENOME SEQUENCE; TRACHOMATIS; METABOLISM; REGULATOR; DIVERSITY; PATHOLOGY; STRAINS; BIOVAR; GENES	Loss of the conserved "cryptic" plasmid from C. trachomatis and C. muridarum is pleiotropic, resulting in reduced innate inflammatory activation via TLR2, glycogen accumulation and infectivity. The more genetically distant C. caviae GPIC is a natural pathogen of guinea pigs and induces upper genital tract pathology when inoculated intravaginally, modeling human disease. To examine the contribution of pCpGP1 to C. caviae pathogenesis, a cured derivative of GPIC, strain CC13, was derived and evaluated in vitro and in vivo. Transcriptional profiling of CC13 revealed only partial conservation of previously identified plasmid-responsive chromosomal loci (PRCL) in C. caviae. However, 2-deoxyglucose (2DG) treatment of GPIC and CC13 resulted in reduced transcription of all identified PRCL, including glgA, indicating the presence of a plasmid-independent glucose response in this species. In contrast to plasmid-cured C. muridarum and C. trachomatis, plasmid-cured C. caviae strain CC13 signaled via TLR2 in vitro and elicited cytokine production in vivo similar to wild-type C. caviae. Furthermore, inflammatory pathology induced by infection of guinea pigs with CC13 was similar to that induced by GPIC, although we observed more rapid resolution of CC13 infection in estrogen-treated guinea pigs. These data indicate that either the plasmid is not involved in expression or regulation of virulence in C. caviae or that redundant effectors prevent these phenotypic changes from being observed in C. caviae plasmid-cured strains.	[Frazer, Lauren C.; Darville, Toni; Chandra-Kuntal, Kumar; Zurenski, Matthew; Mintus, Margaret; O'Connell, Catherine M.] UPMC, Childrens Hosp Pittsburgh, Dept Pediat, Pittsburgh, PA USA; [Andrews, Charles W., Jr.] Milstead Pathol Grp, Conyers, GA USA; [AbdelRahman, Yasser M.; Belland, Robert J.] Univ Tennessee, Hlth Sci Ctr, Dept Microbiol Immunol & Biochem, Memphis, TN USA; [AbdelRahman, Yasser M.] Cairo Univ, Fac Pharm, Dept Microbiol & Immunol, Cairo, Egypt; [Ingalls, Robin R.] Boston Univ, Sch Med, Dept Med, Boston, MA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Tennessee System; University of Tennessee Health Science Center; Egyptian Knowledge Bank (EKB); Cairo University; Boston University	O'Connell, CM (corresponding author), UPMC, Childrens Hosp Pittsburgh, Dept Pediat, Pittsburgh, PA USA.	oconnellcm@upmc.edu	Andrews Jr, Charles/ABE-9558-2021	Ingalls, Robin/0000-0003-2197-7198; Frazer, Lauren/0000-0003-2366-7409; O'Connell, Catherine/0000-0002-8229-684X	Hartwell Foundation; National Institutes of Health [R21 AI083657, R01 AI070693, R01 AI064749]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064749, R21AI083657, R01AI070693] Funding Source: NIH RePORTER	Hartwell Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The Hartwell Foundation (http://www.thehartwellfoundation.org/) to TD, National Institutes of Health via grants R21 AI083657 to COC, R01 AI070693 to RB, and R01 AI064749 to RI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azuma Y, 2006, DNA RES, V13, P15, DOI 10.1093/dnares/dsi027; Batteiger BE, 1990, IMMUNIZATION GUINEA, P2650; Carlson JH, 2008, INFECT IMMUN, V76, P2273, DOI 10.1128/IAI.00102-08; COMANDUCCI M, 1988, MOL MICROBIOL, V2, P531, DOI 10.1111/j.1365-2958.1988.tb00060.x; Darville T, 2003, J IMMUNOL, V171, P6187, DOI 10.4049/jimmunol.171.11.6187; Darville T, 1997, INFECT IMMUN, V65, P3065, DOI 10.1128/IAI.65.8.3065-3073.1997; FAN VSC, 1970, J BACTERIOL, V104, P608, DOI 10.1128/JB.104.1.608-609.1970; GORDON FB, 1972, ANTIMICROB AGENTS CH, V2, P242, DOI 10.1128/AAC.2.3.242; Haggerty CL, 2010, J INFECT DIS, V201, pS134, DOI 10.1086/652395; Harley R, 2010, VET MICROBIOL, V146, P172, DOI 10.1016/j.vetmic.2010.05.005; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; INGALLS RR, 1995, INFECT IMMUN, V63, P3125, DOI 10.1128/IAI.63.8.3125-3130.1995; Jorgensen I, 2008, INFECT IMMUN, V76, P3940, DOI 10.1128/IAI.00632-08; Kelly KA, 1996, INFECT IMMUN, V64, P4976, DOI 10.1128/IAI.64.12.4976-4983.1996; Klinkert B, 2009, CELL MOL LIFE SCI, V66, P2661, DOI 10.1007/s00018-009-0041-3; Kobayashi Y, 2006, J OBSTET GYNAECOL RE, V32, P280, DOI 10.1111/j.1447-0756.2006.00399.x; Koo IC, 2006, P NATL ACAD SCI USA, V103, P750, DOI 10.1073/pnas.0509690103; Lamarche MG, 2008, FEMS MICROBIOL REV, V32, P461, DOI 10.1111/j.1574-6976.2008.00101.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Latz E, 2002, J BIOL CHEM, V277, P47834, DOI 10.1074/jbc.M207873200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lucchetti-Miganeh C, 2008, MICROBIOL-SGM, V154, P16, DOI 10.1099/mic.0.2007/012286-0; Matsumoto A, 1998, J CLIN MICROBIOL, V36, P3013, DOI 10.1128/JCM.36.10.3013-3019.1998; MCCLENAGHAN M, 1988, J GEN MICROBIOL, V134, P559; Mitchell CM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-442; O'Connell CM, 2007, J IMMUNOL, V179, P4027, DOI 10.4049/jimmunol.179.6.4027; O'Connell CM, 2006, MICROBIOL-SGM, V152, P1601, DOI 10.1099/mic.0.28658-0; O'Connell CM, 2011, INFECT IMMUN, V79, P1044, DOI 10.1128/IAI.01118-10; O'Connell CM, 2006, J BIOL CHEM, V281, P1652, DOI 10.1074/jbc.M510182200; Ojcius DM, 1998, J BIOL CHEM, V273, P7052, DOI 10.1074/jbc.273.12.7052; PASLEY JN, 1985, SEX TRANSM DIS, V12, P8, DOI 10.1097/00007435-198501000-00003; Paterson TL, 1996, SEX TRANSM DIS, V23, P145, DOI 10.1097/00007435-199603000-00010; Prantner D, 2009, INFECT IMMUN, V77, P5334, DOI 10.1128/IAI.00883-09; Rank RG, 2003, INFECT IMMUN, V71, P6148, DOI 10.1128/IAI.71.11.6148-6154.2003; RANK RG, 1992, AM J PATHOL, V140, P927; Rank RG, 1982, CHLAMYDIAL INFECTION, P391; Rank RG, 1990, ASCENDING GENITAL TR, P249; Read TD, 2003, NUCLEIC ACIDS RES, V31, P2134, DOI 10.1093/nar/gkg321; Read TD, 2000, NUCLEIC ACIDS RES, V28, P1397, DOI 10.1093/nar/28.6.1397; Rockey DD, 1996, INFECT IMMUN, V64, P4269, DOI 10.1128/IAI.64.10.4269-4278.1996; Russell M, 2011, INFECT IMMUN, V79, P98, DOI 10.1128/IAI.01105-10; Somerville GA, 2009, MICROBIOL MOL BIOL R, V73, P233, DOI 10.1128/MMBR.00005-09; Stephens RS, 2009, FEMS IMMUNOL MED MIC, V55, P115, DOI 10.1111/j.1574-695X.2008.00516.x; Sturdevant GL, 2010, INFECT IMMUN, V78, P3660, DOI 10.1128/IAI.00386-10; Thomas NS, 1997, MICROBIOL-SGM, V143, P1847, DOI 10.1099/00221287-143-6-1847; Thomson NR, 2008, GENOME RES, V18, P161, DOI 10.1101/gr.7020108	46	26	31	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2012	7	1							e30747	10.1371/journal.pone.0030747	http://dx.doi.org/10.1371/journal.pone.0030747			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910LV	22292031	Green Submitted, gold, Green Published			2022-12-25	WOS:000301639600052
J	Jahan, I; Pan, N; Kersigo, J; Calisto, LE; Morris, KA; Kopecky, B; Duncan, JS; Beisel, KW; Fritzsch, B				Jahan, Israt; Pan, Ning; Kersigo, Jennifer; Calisto, Lilian E.; Morris, Ken A.; Kopecky, Benjamin; Duncan, Jeremy S.; Beisel, Kirk W.; Fritzsch, Bernd			Expression of Neurog1 Instead of Atoh1 Can Partially Rescue Organ of Corti Cell Survival	PLOS ONE			English	Article							MAMMALIAN INNER-EAR; SPIRAL GANGLION NEURONS; GENE REGULATORY NETWORK; OUTER HAIR-CELLS; NULL MICE; SENSORY EPITHELIA; TRANSCRIPTION FACTORS; PRONEURAL GENES; MOLECULAR-BASIS; NERVOUS-SYSTEM	In the mammalian inner ear neurosensory cell fate depends on three closely related transcription factors, Atoh1 for hair cells and Neurog1 and Neurod1 for neurons. We have previously shown that neuronal cell fate can be altered towards hair cell fate by eliminating Neurod1 mediated repression of Atoh1 expression in neurons. To test whether a similar plasticity is present in hair cell fate commitment, we have generated a knockin (KI) mouse line (Atoh1(KINeurog1)) in which Atoh1 is replaced by Neurog1. Expression of Neurog1 under Atoh1 promoter control alters the cellular gene expression pattern, differentiation and survival of hair cell precursors in both heterozygous (Atoh1(+/KINeurog1)) and homozygous (Atoh1(KINeurog1/KINeurog1)) KI mice. Homozygous KI mice develop patches of organ of Corti precursor cells that express Neurog1, Neurod1, several prosensory genes and neurotrophins. In addition, these patches of cells receive afferent and efferent processes. Some cells among these patches form multiple microvilli but no stereocilia. Importantly, Neurog1 expressing mutants differ from Atoh1 null mutants, as they have intermittent formation of organ of Corti-like patches, opposed to a complete 'flat epithelium' in the absence of Atoh1. In heterozygous KI mice co-expression of Atoh1 and Neurog1 results in change in fate and patterning of some hair cells and supporting cells in addition to the abnormal hair cell polarity in the later stages of development. This differs from haploinsufficiency of Atoh1 (Pax2cre; Atoh1(f/+)), indicating the effect of Neurog1 expression in developing hair cells. Our data suggest that Atoh1(KINeurog1) can provide some degree of functional support for survival of organ of Corti cells. In contrast to the previously demonstrated fate plasticity of neurons to differentiate as hair cells, hair cell precursors can be maintained for a limited time by Neurog1 but do not transdifferentiate as neurons.	[Jahan, Israt; Pan, Ning; Kersigo, Jennifer; Kopecky, Benjamin; Duncan, Jeremy S.; Fritzsch, Bernd] Univ Iowa, Dept Biol, Iowa City, IA 52242 USA; [Calisto, Lilian E.; Morris, Ken A.; Beisel, Kirk W.] Creighton Univ, Dept Biomed Sci, Omaha, NE 68178 USA	University of Iowa; Creighton University	Fritzsch, B (corresponding author), Univ Iowa, Dept Biol, Iowa City, IA 52242 USA.	bernd-fritzsch@uiowa.edu	Duncan, Jeremy/E-8176-2013; Duncan, Jeremy/K-7230-2013	Fritzsch, Bernd/0000-0002-4882-8398; Duncan, Jeremy/0000-0002-5555-3273	National Institute on Deafness and Other Communication Disorders (NIDCD) [R01 DC 005590, R01 S1 DC 005590]; Office of the Vice President for Research (OVPR), University of Iowa College of Liberal Arts and Sciences (CLAS); P30 core grant [DC 010362]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P30DC010362, R01DC005590] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorders (NIDCD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Office of the Vice President for Research (OVPR), University of Iowa College of Liberal Arts and Sciences (CLAS); P30 core grant; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by National Institute on Deafness and Other Communication Disorders (NIDCD) (R01 DC 005590 to BF; R01 S1 DC 005590). The authors thank the Office of the Vice President for Research (OVPR), University of Iowa College of Liberal Arts and Sciences (CLAS), and the P30 core grant for support (DC 010362). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axelrod JD, 2009, SEMIN CELL DEV BIOL, V20, P964, DOI 10.1016/j.semcdb.2009.08.001; Basch ML, 2011, J NEUROSCI, V31, P8046, DOI 10.1523/JNEUROSCI.6671-10.2011; Bayly R, 2011, NAT REV GENET, V12, P385, DOI 10.1038/nrg2956; BEISEL KW, 1989, NUCLEIC ACIDS RES, V17, P10519, DOI 10.1093/nar/17.24.10519; BenArie N, 1997, NATURE, V390, P169, DOI 10.1038/36579; Bermingham NA, 1999, SCIENCE, V284, P1837, DOI 10.1126/science.284.5421.1837; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Brooker R, 2006, DEVELOPMENT, V133, P1277, DOI 10.1242/dev.02284; Cajal SR, 1919, TRAB LAB INVEST BIOL, V17, P1; Chen P, 2002, DEVELOPMENT, V129, P2495; Dabdoub A, 2008, P NATL ACAD SCI USA, V105, P18396, DOI 10.1073/pnas.0808175105; Doetzlhofer A, 2009, DEV CELL, V16, P58, DOI 10.1016/j.devcel.2008.11.008; Duncan JS, 2011, INT J DEV BIOL, V55, P297, DOI 10.1387/ijdb.103178jd; Eberl DF, 2007, INT J DEV BIOL, V51, P679, DOI 10.1387/ijdb.072364de; Farinas I, 2001, J NEUROSCI, V21, P6170, DOI 10.1523/JNEUROSCI.21-16-06170.2001; FARINAS I, 1994, NATURE, V369, P658, DOI 10.1038/369658a0; Flora A, 2007, P NATL ACAD SCI USA, V104, P15382, DOI 10.1073/pnas.0707456104; Flora A, 2009, SCIENCE, V326, P1424, DOI 10.1126/science.1181453; Fritzsch B, 2005, DEV DYNAM, V233, P570, DOI 10.1002/dvdy.20370; Fritzsch B, 2007, INT J DEV BIOL, V51, P663, DOI 10.1387/ijdb.072367bf; Fritzsch B, 2011, HEARING RES, V276, P16, DOI 10.1016/j.heares.2011.01.007; Fritzsch B, 2010, CELL MOL LIFE SCI, V67, P3089, DOI 10.1007/s00018-010-0403-x; Fritzsch B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009377; Gemel J, 1999, J BIOL CHEM, V274, P6020, DOI 10.1074/jbc.274.9.6020; Geoffroy CG, 2009, STEM CELLS, V27, P847, DOI 10.1002/stem.17; Gohlke JM, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-15; Gowan K, 2001, NEURON, V31, P219, DOI 10.1016/S0896-6273(01)00367-1; Guillemot F, 2007, DEVELOPMENT, V134, P3771, DOI 10.1242/dev.006379; Helms AW, 2000, DEVELOPMENT, V127, P1185; HOOPER M, 1987, NATURE, V326, P292, DOI 10.1038/326292a0; Izumikawa M, 2008, HEARING RES, V240, P52, DOI 10.1016/j.heares.2008.02.007; Jahan I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011661; Kele J, 2006, DEVELOPMENT, V133, P495, DOI 10.1242/dev.02223; Kiernan AE, 2005, NATURE, V434, P1031, DOI 10.1038/nature03487; Kiernan AE, 2006, PLOS GENET, V2, P27, DOI 10.1371/journal.pgen.0020004; Kim WY, 2001, DEVELOPMENT, V128, P417; Klisch TJ, 2011, P NATL ACAD SCI USA, V108, P3288, DOI 10.1073/pnas.1100230108; Kuhn S, 2011, P NATL ACAD SCI USA, V108, P2355, DOI 10.1073/pnas.1016646108; Ma QF, 2000, JARO-J ASSOC RES OTO, V1, P129, DOI 10.1007/s101620010017; Ma QF, 1998, NEURON, V20, P469, DOI 10.1016/S0896-6273(00)80988-5; Ma QF, 1996, CELL, V87, P43, DOI 10.1016/S0092-8674(00)81321-5; Ma QF, 1999, GENE DEV, V13, P1717, DOI 10.1101/gad.13.13.1717; Mao CA, 2008, DEVELOPMENT, V135, P3379, DOI 10.1242/dev.024612; Matei V, 2005, DEV DYNAM, V234, P633, DOI 10.1002/dvdy.20551; McDevitt MA, 1997, P NATL ACAD SCI USA, V94, P6781, DOI 10.1073/pnas.94.13.6781; Mcnay DEG, 2006, MOL ENDOCRINOL, V20, P1623, DOI 10.1210/me.2005-0518; Morsli H, 1998, J NEUROSCI, V18, P3327; Mu XQ, 2005, DEV BIOL, V280, P467, DOI 10.1016/j.ydbio.2005.01.028; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Nakada Y, 2004, DEVELOPMENT, V131, P1319, DOI 10.1242/dev.01008; Ohsawa R, 2008, BRAIN RES, V1192, P90, DOI 10.1016/j.brainres.2007.04.014; Ohyama T, 2010, J NEUROSCI, V30, P15044, DOI 10.1523/JNEUROSCI.3547-10.2010; Pan N, 2011, HEARING RES, V275, P66, DOI 10.1016/j.heares.2010.12.002; Pan W, 2010, P NATL ACAD SCI USA, V107, P15798, DOI 10.1073/pnas.1003089107; Parras CM, 2002, GENE DEV, V16, P324, DOI 10.1101/gad.940902; Pauley S, 2008, PANMINERVA MED, V50, P41; Pauley S, 2003, DEV DYNAM, V227, P203, DOI 10.1002/dvdy.10297; Powell LM, 2008, CURR OPIN GENET DEV, V18, P411, DOI 10.1016/j.gde.2008.07.012; Pruunsild P, 2007, GENOMICS, V90, P397, DOI 10.1016/j.ygeno.2007.05.004; Pruunsild P, 2011, J NEUROSCI, V31, P3295, DOI 10.1523/JNEUROSCI.4540-10.2011; Raft S, 2007, DEVELOPMENT, V134, P4405, DOI 10.1242/dev.009118; Seo S, 2007, EMBO J, V26, P5093, DOI 10.1038/sj.emboj.7601923; Shibata SB, 2010, EXP NEUROL, V223, P464, DOI 10.1016/j.expneurol.2010.01.011; Shroyer NF, 2007, GASTROENTEROLOGY, V132, P2478, DOI 10.1053/j.gastro.2007.03.047; Soriano P, 1997, DEVELOPMENT, V124, P2691; TURNER DL, 1994, GENE DEV, V8, P1434, DOI 10.1101/gad.8.12.1434; Wang Q, 2011, J NEUROSCI, V31, P7938, DOI 10.1523/JNEUROSCI.1434-10.2011; Wang VY, 2002, CURR BIOL, V12, P1611, DOI 10.1016/S0960-9822(02)01144-2; Weston MD, 2011, DEV DYNAM, V240, P808, DOI 10.1002/dvdy.22591; Wheeler BM, 2009, EVOL DEV, V11, P50, DOI 10.1111/j.1525-142X.2008.00302.x; Willardsen MI, 2009, DEV BIOL, V326, P471, DOI 10.1016/j.ydbio.2008.10.046; Yamamoto N, 2011, DEV BIOL, V353, P367, DOI 10.1016/j.ydbio.2011.03.016; Yang T, 2011, HEARING RES, V278, P21, DOI 10.1016/j.heares.2011.03.002; Zine A, 2001, J NEUROSCI, V21, P4712, DOI 10.1523/JNEUROSCI.21-13-04712.2001	74	29	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2012	7	1							e30853	10.1371/journal.pone.0030853	http://dx.doi.org/10.1371/journal.pone.0030853			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910LV	22292060	gold, Green Published, Green Submitted			2022-12-25	WOS:000301639600062
J	Lowry, DB; Sheng, CC; Zhu, ZR; Juenger, TE; Lahner, B; Salt, DE; Willis, JH				Lowry, David B.; Sheng, Calvin C.; Zhu, Zhirui; Juenger, Thomas E.; Lahner, Brett; Salt, David E.; Willis, John H.			Mapping of Ionomic Traits in Mimulus guttatus Reveals Mo and Cd QTLs That Colocalize with MOT1 Homologues	PLOS ONE			English	Article							AFFINITY MOLYBDATE TRANSPORTER; REPRODUCTIVE ISOLATION; ARABIDOPSIS-THALIANA; COPPER TOLERANCE; LOCAL ADAPTATION; CLIMATE-CHANGE; FOOD SECURITY; MOLYBDENUM; IRON; HYPERACCUMULATION	Natural variation in the regulation of the accumulation of mineral nutrients and trace elements in plant tissues is crucial to plant metabolism, development, and survival across different habitats. Studies of the genetic basis of natural variation in nutrient metabolism have been facilitated by the development of ionomics. Ionomics is a functional genomic approach for the identification of the genes and gene networks that regulate the elemental composition, or ionome, of an organism. In this study, we evaluated the genetic basis of divergence in elemental composition between an inland annual and a coastal perennial accession of Mimulus guttatus using a recombinant inbred line (RIL) mapping population. Out of 20 elements evaluated, Mo and Cd were the most divergent in accumulation between the two accessions and were highly genetically correlated in the RILs across two replicated experiments. We discovered two major quantitative trait loci (QTL) for Mo accumulation, the largest of which consistently colocalized with a QTL for Cd accumulation. Interestingly, both Mo QTLs also colocalized with the two M. guttatus homologues of MOT1, the only known plant transporter to be involved in natural variation in molybdate uptake.	[Lowry, David B.; Willis, John H.] Duke Univ, Med Ctr, Univ Program Genet & Genom, Durham, NC 27710 USA; [Lowry, David B.; Sheng, Calvin C.; Zhu, Zhirui; Willis, John H.] Duke Univ, Dept Biol, Durham, NC USA; [Juenger, Thomas E.] Univ Texas Austin, Sect Integrat Biol, Austin, TX 78712 USA; [Juenger, Thomas E.] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Lahner, Brett; Salt, David E.] Purdue Univ, Dept Hort & Landscape Architecture, W Lafayette, IN 47907 USA; [Salt, David E.] Univ Aberdeen, Inst Biol & Environm Sci, Aberdeen, Scotland	Duke University; Duke University; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Aberdeen	Lowry, DB (corresponding author), Duke Univ, Med Ctr, Univ Program Genet & Genom, Durham, NC 27710 USA.	davidbryantlowry@gmail.com			National Science Foundation, through a FIBR [EF-0328636]; Environmental Genomics [EF-0723814]; Doctoral Dissertation Improvement Grant [DEB-0710094]; National Institute of Health; Duke University	National Science Foundation, through a FIBR(National Science Foundation (NSF)); Environmental Genomics; Doctoral Dissertation Improvement Grant; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Duke University	Funding was provided by the National Science Foundation, through a FIBR grant (EF-0328636), an Environmental Genomics Grant (EF-0723814), and a Doctoral Dissertation Improvement Grant (DEB-0710094). Funding was also provided by a National Institute of Health Graduate Student Fellowship and a Duke University Travel Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTONOVICS J, 1970, HEREDITY, V25, P349, DOI 10.1038/hdy.1970.36; Baxter I, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000004; Baxter I, 2007, PLANT PHYSIOL, V143, P600, DOI 10.1104/pp.106.092528; Baxter I, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001193; Baxter I, 2009, CURR OPIN PLANT BIOL, V12, P381, DOI 10.1016/j.pbi.2009.05.002; Bernard DG, 2009, PLANT PHYSIOL, V151, P590, DOI 10.1104/pp.109.143651; BITTNER F, 2010, PLANT CELL MONOGR, V17, P119, DOI DOI 10.1007/978-3-642-10613-2_6; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Buescher E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011081; Chao DY, 2011, PLANT CELL, V23, P1061, DOI 10.1105/tpc.110.079095; Fitzpatrick KL, 2008, FEBS LETT, V582, P1508, DOI 10.1016/j.febslet.2008.03.045; Gardner M, 2000, BIOL J LINN SOC, V69, P443, DOI 10.1111/j.1095-8312.2000.tb01218.x; Gasber A, 2011, PLANT BIOLOGY, V13, P710, DOI 10.1111/j.1438-8677.2011.00448.x; Gupta UC, 1997, MOLYBDENUM AGR; Hall MC, 2010, MOL ECOL, V19, P2739, DOI 10.1111/j.1365-294X.2010.04680.x; Hall MC, 2006, GENETICS, V172, P1829, DOI 10.1534/genetics.105.051227; Hall MC, 2006, EVOLUTION, V60, P2466, DOI 10.1554/05-688.1; Harrison S, 2011, SERPENTINE: THE EVOLUTION AND ECOLOGY OF A MODEL SYSTEM, P1, DOI 10.1525/california/9780520268357.001.0001; HEWITT E. J., 1956, SOIL SCI, V81, P159, DOI 10.1097/00010694-195603000-00002; Ide Y, 2011, J EXP BOT, V62, P1483, DOI 10.1093/jxb/erq345; Ingram JSI, 2008, AGR ECOSYST ENVIRON, V126, P4, DOI 10.1016/j.agee.2008.01.009; Jiang RF, 2005, NEW PHYTOL, V167, P805, DOI 10.1111/j.1469-8137.2005.01452.x; Kaiser BN, 2005, ANN BOT-LONDON, V96, P745, DOI 10.1093/aob/mci226; Kay KM, 2011, SERPENTINE: THE EVOLUTION AND ECOLOGY OF A MODEL SYSTEM, P71; Kobayashi Y, 2008, PLANT PHYSIOL, V148, P969, DOI 10.1104/pp.108.119933; Lobell DB, 2008, SCIENCE, V319, P607, DOI 10.1126/science.1152339; Loudet O, 2007, NAT GENET, V39, P896, DOI 10.1038/ng2050; Lowry DB, 2008, EVOLUTION, V62, P2196, DOI 10.1111/j.1558-5646.2008.00457.x; Lowry DB, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000500; Lowry DB, 2010, BIOL LETTERS, V6, P502, DOI 10.1098/rsbl.2009.0969; Lowry DB, 2009, NEW PHYTOL, V183, P776, DOI 10.1111/j.1469-8137.2009.02901.x; MACNAIR MR, 1983, HEREDITY, V50, P295, DOI 10.1038/hdy.1983.31; Mendel RR, 2011, COORDIN CHEM REV, V255, P1145, DOI 10.1016/j.ccr.2011.01.054; Morrissey J, 2009, PLANT CELL, V21, P3326, DOI 10.1105/tpc.109.069401; Poschenrieder C, 2006, TRENDS PLANT SCI, V11, P288, DOI 10.1016/j.tplants.2006.04.007; Prinzenberg AE, 2010, PLANT PHYSIOL, V154, P1361, DOI 10.1104/pp.110.161398; Rus A, 2006, PLOS GENET, V2, P1964, DOI 10.1371/journal.pgen.0020210; Sanita di Toppi L, 1999, ENVIRON EXP BOT, V41, P105, DOI 10.1016/S0098-8472(98)00058-6; Schwarz G, 2009, NATURE, V460, P839, DOI 10.1038/nature08302; Tejada-Jimenez M, 2007, P NATL ACAD SCI USA, V104, P20126, DOI 10.1073/pnas.0704646104; Tejada-Jimenez M, 2011, P NATL ACAD SCI USA, V108, P6420, DOI 10.1073/pnas.1100700108; Tian H, 2010, PLANT CELL, V22, P3963, DOI 10.1105/tpc.110.080010; Tomatsu H, 2007, P NATL ACAD SCI USA, V104, P18807, DOI 10.1073/pnas.0706373104; Verbruggen N, 2009, NEW PHYTOL, V181, P759, DOI 10.1111/j.1469-8137.2008.02748.x; Vert G, 2002, PLANT CELL, V14, P1223, DOI 10.1105/tpc.001388; Wu CA, 2010, OECOLOGIA, V162, P23, DOI 10.1007/s00442-009-1448-0	47	15	16	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2012	7	1							e30730	10.1371/journal.pone.0030730	http://dx.doi.org/10.1371/journal.pone.0030730			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910LV	22292026	gold, Green Published, Green Submitted			2022-12-25	WOS:000301639600050
J	Tao, J; Chen, M; Zong, SX; Luo, YQ				Tao, Jing; Chen, Min; Zong, Shi-Xiang; Luo, You-Qing			Genetic Structure in the Seabuckthorn Carpenter Moth (Holcocerus hippophaecolus) in China: The Role of Outbreak Events, Geographical and Host Factors	PLOS ONE			English	Article							POPULATIONS; PATTERNS; INSECTS; SYSTEMS; DIFFERENTIATION; HETEROZYGOSITY; ORTHOPTERA; AFLP; SIZE	Understanding factors responsible for structuring genetic diversity is of fundamental importance in evolutionary biology. The seabuckthorn carpenter moth (Holcocerus hippophaecolus Hua) is a native species throughout the north of China and is considered the main threat to seabuckthorn, Hippophae rhamnoides L. We assessed the influence of outbreaks, environmental factors and host species in shaping the genetic variation and structure of H. hippophaecolus by using Amplified Fragment Length Polymorphism (AFLP) markers. We rejected the hypothesis that outbreak-associated genetic divergence exist, as evidenced by genetic clusters containing a combination of populations from historical outbreak areas, as well as non-outbreak areas. Although a small number of markers (4 of 933 loci) were identified as candidates under selection in response to population densities. H. hippophaecolus also did not follow an isolation-by-distance pattern. We rejected the hypothesis that outbreak and drought events were driving the genetic structure of H. hippophaecolus. Rather, the genetic structure appears to be influenced by various confounding bio-geographical factors. There were detectable genetic differences between H. hippophaecolus occupying different host trees from within the same geographic location. Host-associated genetic divergence should be confirmed by further investigation.	[Tao, Jing; Chen, Min; Zong, Shi-Xiang; Luo, You-Qing] Beijing Forestry Univ, Beijing, Peoples R China; [Tao, Jing; Chen, Min; Zong, Shi-Xiang; Luo, You-Qing] Beijing Forestry Univ, Silviculture & Conservat Minist Educ, Beijing, Peoples R China	Beijing Forestry University; Beijing Forestry University	Luo, YQ (corresponding author), Beijing Forestry Univ, Beijing, Peoples R China.	youqingluo@126.com			National Nature Science Fund [30730075]; Fundamental Research Funds for the Central Universities [YX2011-18]	National Nature Science Fund(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This research was supported by the National Nature Science Fund (project NO 30730075 and Fundamental Research Funds for the Central Universities (project NO YX2011-18). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antao T, 2011, BIOINFORMATICS, V27, P1717, DOI 10.1093/bioinformatics/btr253; Arnaud JF, 2003, LANDSCAPE ECOL, V18, P333, DOI 10.1023/A:1024409116214; Bailey NW, 2005, HEREDITY, V95, P166, DOI 10.1038/sj.hdy.6800704; Beaumont MA, 2004, MOL ECOL, V13, P969, DOI 10.1111/j.1365-294X.2004.02125.x; Beaumont MA, 1996, P ROY SOC B-BIOL SCI, V263, P1619, DOI 10.1098/rspb.1996.0237; Behura SK, 2006, MOL ECOL, V15, P3087, DOI 10.1111/j.1365-294X.2006.03014.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernays EA, 1994, HOST PLANT SELECTION; BERRYMAN AA, 1978, RES POPUL ECOL, V19, P181, DOI 10.1007/BF02518826; Chapuis MP, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-37; Chapuis MP, 2009, MOL ECOL, V18, P792, DOI 10.1111/j.1365-294X.2008.04072.x; Chen Min, 2008, Journal of Beijing Forestry University, V30, P116; Chitty D, 1971, NATRUAL REGULATION A; Cognato AI, 2003, ENVIRON ENTOMOL, V32, P1262, DOI 10.1603/0046-225X-32.5.1262; Dres M, 2002, PHILOS T R SOC B, V357, P471, DOI 10.1098/rstb.2002.1059; Feder JL, 2003, P NATL ACAD SCI USA, V100, P10314, DOI 10.1073/pnas.1730757100; Foll M, 2006, GENETICS, V174, P875, DOI 10.1534/genetics.106.059451; Funk DJ, 2002, GENETICA, V116, P251, DOI 10.1023/A:1021236510453; GAINES MS, 1978, EVOLUTION, V32, P723, DOI 10.1111/j.1558-5646.1978.tb04626.x; Grapputo A, 2005, MOL ECOL, V14, P4207, DOI 10.1111/j.1365-294X.2005.02740.x; Hua BZ, 1990, CHINESE COSSIDAE, P56; JAENIKE J, 1990, ANNU REV ECOL SYST, V21, P243, DOI 10.1146/annurev.ecolsys.21.1.243; Kennedy GG, 2000, ANNU REV ENTOMOL, V45, P467, DOI 10.1146/annurev.ento.45.1.467; Louy D, 2007, CONSERV GENET, V8, P671, DOI 10.1007/s10592-006-9213-y; Luo Y., 2003, FOR PEST DIS, V5, P25; Maron JL, 2001, OECOLOGIA, V126, P595, DOI 10.1007/s004420000558; Martinat P.J., 1987, P241; MATTSON WJ, 1987, BIOSCIENCE, V37, P110, DOI 10.2307/1310365; Miller MP, 1997, TOOLS POPULATION GEN; Mock KE, 2007, MOL ECOL, V16, P553, DOI 10.1111/j.1365-294X.2006.03158.x; Mopper S, 1996, TRENDS ECOL EVOL, V11, P235, DOI 10.1016/0169-5347(96)10036-7; MOTRO U, 1982, EVOLUTION, V36, P1059, DOI 10.1111/j.1558-5646.1982.tb05474.x; Myers JH, 1988, CAN GEN HYPOTHESIS E, P179; NEI M, 1974, GENETICS, V76, P379; Peterson MA, 1998, GENETIC STRUCTURE LO, P236; Price PW, 1987, INSECT OUTBREAKS, P208; Rossiter M.C., 1992, P13; Salvato P, 2002, MOL ECOL, V11, P2435, DOI 10.1046/j.1365-294X.2002.01631.x; Sander AC, 2006, BASIC APPL ECOL, V7, P555, DOI 10.1016/j.baae.2006.01.001; SCHNEIDER S., 2000, ARLEQUIN VERSION 2 0; Simchuk AP, 1999, FOREST ECOL MANAG, V113, P35, DOI 10.1016/S0378-1127(98)00340-5; SOLBRECK C, 1991, OIKOS, V60, P343, DOI 10.2307/3545077; STEWART WDP, 1967, PLANT SOIL, V26, P348, DOI 10.1007/BF01880184; Sword GA, 2005, MOL ECOL, V14, P2197, DOI 10.1111/j.1365-294X.2005.02546.x; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; WALLNER WE, 1987, ANNU REV ENTOMOL, V32, P317, DOI 10.1146/annurev.en.32.010187.001533; Walsh PJ, 1990, POPULATION DYNAMICS, P242; Wang DS, 2007, SCI TECH INFORM DEV, V17, P170; Wang Zhi-zheng, 2010, Journal of Beijing Forestry University, V32, P130; WHITE TCR, 1984, OECOLOGIA, V63, P90, DOI 10.1007/BF00379790; You Y, 2000, SHAANXI FOREST SCI T, V4, P1; Zhang De-Xing, 1998, P5; Zhivotovsky LA, 1999, MOL ECOL, V8, P907, DOI 10.1046/j.1365-294x.1999.00620.x; Zhou ZhangYi, 2007, Journal of Beijing Forestry University, V29, P50; Zhou ZY, 2002, HIPPOPHAE, V15, P7; Zong Shi-xiang, 2006, Zhongguo Senlin Bingchong, V25, P7; Zong SX, 2006, SCI SILVAE SINICAE, V41, P79	58	4	6	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2012	7	1							e30544	10.1371/journal.pone.0030544	http://dx.doi.org/10.1371/journal.pone.0030544			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910LV	22291983	Green Published, Green Submitted, gold			2022-12-25	WOS:000301639600031
J	Zhou, R; Li, XQ; Hu, GK; Gong, AY; Drescher, KM; Chen, XM				Zhou, Rui; Li, Xiaoqing; Hu, Guoku; Gong, Ai-Yu; Drescher, Kristen M.; Chen, Xian-Ming			miR-16 Targets Transcriptional Corepressor SMRT and Modulates NF-kappaB-Regulated Transactivation of Interleukin-8 Gene	PLOS ONE			English	Article							MICRORNA; EXPRESSION; COMPLEX; ALPHA; INVOLVEMENT; BIOGENESIS; ACTIVATION; MECHANISMS; PROTEIN	The signaling pathways associated with the Toll-like receptors (TLRs) and nuclear factor-kappaB (NF-kappa B) are essential to proinflammatory cytokine and chemokine expression, as well as initiating innate epithelial immune responses. The TLR/NF-kappa B signaling pathways must be stringently controlled through an intricate network of positive and negative regulatory elements. MicroRNAs (miRNAs) are non-coding small RNAs that regulate the stability and/or translation of protein-coding mRNAs. Herein we report that miR-16 promotes NF-kappa B-regulated transactivation of the IL-8 gene by suppression of the silencing mediator for retinoid and thyroid hormone receptor (SMRT). LPS stimulation activated miR-16 gene transcription in human monocytes (U937) and biliary epithelial cells (H69) through MAPK-dependent mechanisms. Transfection of cells with the miR-16 precursor promoted LPS-induced production of IL-8, IL-6, and IL-1 alpha, without a significant effect on their RNA stability. Instead, an increase in NF-kappa B-regulated transactivation of the IL-8 gene was confirmed in cells following transfection of miR-16 precursor. Importantly, miR-16 targeted the 3'-untranslated region of SMRT and caused translational suppression of SMRT. LPS decreased SMRT expression via upregulation of miR-16. Moreover, functional manipulation of SMRT altered NF-kappa B-regulated transactivation of LPS-induced IL-8 expression. These data suggest that miR-16 targets SMRT and modulates NF-kappa B-regulated transactivation of the IL-8 gene.	[Zhou, Rui; Hu, Guoku; Gong, Ai-Yu; Drescher, Kristen M.; Chen, Xian-Ming] Creighton Univ, Med Ctr, Dept Med Microbiol & Immunol, Omaha, NE 68178 USA; [Li, Xiaoqing] Huazhong Univ Sci & Technol, Union Hosp, Inst Hematol, Tongji Med Sch, Wuhan, Hubei, Peoples R China	Creighton University; Huazhong University of Science & Technology	Chen, XM (corresponding author), Creighton Univ, Med Ctr, Dept Med Microbiol & Immunol, Omaha, NE 68178 USA.	xianmingchen@creighton.edu	hu, gengkai/E-5737-2010		National Institutes of Health [AI071321, AI095532]; Nebraska Tobacco Settlement Biomedical Research Program [LB692, LB595]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI095532, R01AI071321] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nebraska Tobacco Settlement Biomedical Research Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grants AI071321, AI095532 and by the Nebraska Tobacco Settlement Biomedical Research Program (LB692 and LB595) (to XMC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Anderson P, 2008, NAT IMMUNOL, V9, P353, DOI 10.1038/ni1584; Angrisano T, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-172; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bayarsaihan D, 2011, J DENT RES, V90, P9, DOI 10.1177/0022034510378683; CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; Chen XM, 2008, IMMUNOL CELL BIOL, V86, P497, DOI 10.1038/icb.2008.37; Clark A, 2009, FRONT BIOSCI-LANDMRK, V14, P847, DOI 10.2741/3282; Fujita S, 2008, J MOL BIOL, V378, P492, DOI 10.1016/j.jmb.2008.03.015; Ghisletti S, 2009, GENE DEV, V23, P681, DOI 10.1101/gad.1773109; Gong AY, 2010, J INFECT DIS, V201, P160, DOI 10.1086/648589; Guenther MG, 2000, GENE DEV, V14, P1048; Guglielmelli P, 2011, BLOOD, V117, P6923, DOI 10.1182/blood-2010-09-306506; Hamon MA, 2008, CELL HOST MICROBE, V4, P100, DOI 10.1016/j.chom.2008.07.009; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hoberg JE, 2004, MOL CELL, V16, P245, DOI 10.1016/j.molcel.2004.10.010; HORLEIN AJ, 1995, NATURE, V377, P397, DOI 10.1038/377397a0; Hu GK, 2009, J IMMUNOL, V183, P1617, DOI 10.4049/jimmunol.0804362; Jing Q, 2005, CELL, V120, P623, DOI 10.1016/j.cell.2004.12.038; Kishore N, 2003, J BIOL CHEM, V278, P32861, DOI 10.1074/jbc.M211439200; Kobayashi KS, 2004, J LEUKOCYTE BIOL, V75, P428, DOI 10.1189/jlb.0703321; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li T, 2010, NAT IMMUNOL, V11, P799, DOI 10.1038/ni.1918; Liu J, 2009, INT REV IMMUNOL, V28, P139, DOI 10.1080/08830180902943058; O'Neill LA, 2011, NAT REV IMMUNOL, V11, P163, DOI 10.1038/nri2957; Paroo Z, 2009, CELL, V139, P112, DOI 10.1016/j.cell.2009.06.044; Perissi V, 2004, CELL, V116, P511, DOI 10.1016/S0092-8674(04)00133-3; Shin VY, 2011, CARCINOGENESIS, V32, P240, DOI 10.1093/carcin/bgq240; Stoecklin G, 2006, ADV IMMUNOL, V89, P1, DOI 10.1016/S0065-2776(05)89001-7; Tili E, 2007, J IMMUNOL, V179, P5082, DOI 10.4049/jimmunol.179.8.5082; Viswanathan VK, 2000, CURR OPIN GASTROEN, V16, P546, DOI 10.1097/00001574-200011000-00015; Wang X, 2011, J BIOL CHEM, V285, P23241; Zhou R, 2011, CELL MOL IMMUNOL, V8, P371, DOI 10.1038/cmi.2011.19; Zhou R, 2010, NUCLEIC ACIDS RES, V38, P3222, DOI 10.1093/nar/gkq056; Zhou R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000681	38	48	54	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2012	7	1							e30772	10.1371/journal.pone.0030772	http://dx.doi.org/10.1371/journal.pone.0030772			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910LV	22292036	gold, Green Submitted, Green Published			2022-12-25	WOS:000301639600053
J	Aburto, MR; Magarinos, M; Leon, Y; Varela-Nieto, I; Sanchez-Calderon, H				Aburto, Maria R.; Magarinos, Marta; Leon, Yolanda; Varela-Nieto, Isabel; Sanchez-Calderon, Hortensia			AKT Signaling Mediates IGF-I Survival Actions on Otic Neural Progenitors	PLOS ONE			English	Article							GROWTH-FACTOR-I; DEVELOPING INNER-EAR; PROGRAMMED CELL-DEATH; CHICK-EMBRYO; NEUROTROPHIC FACTOR; HEARING-LOSS; INSULIN; EXPRESSION; DIFFERENTIATION; PROLIFERATION	Background: Otic neurons and sensory cells derive from common progenitors whose transition into mature cells requires the coordination of cell survival, proliferation and differentiation programmes. Neurotrophic support and survival of postmitotic otic neurons have been intensively studied, but the bases underlying the regulation of programmed cell death in immature proliferative otic neuroblasts remains poorly understood. The protein kinase AKT acts as a node, playing a critical role in controlling cell survival and cell cycle progression. AKT is activated by trophic factors, including insulin-like growth factor I (IGF-I), through the generation of the lipidic second messenger phosphatidylinositol 3-phosphate by phosphatidylinositol 3-kinase (PI3K). Here we have investigated the role of IGF-dependent activation of the PI3K-AKT pathway in maintenance of otic neuroblasts. Methodology/Principal Findings: By using a combination of organotypic cultures of chicken (Gallus gallus) otic vesicles and acoustic-vestibular ganglia, Western blotting, immunohistochemistry and in situ hybridization, we show that IGF-I-activation of AKT protects neural progenitors from programmed cell death. IGF-I maintains otic neuroblasts in an undifferentiated and proliferative state, which is characterised by the upregulation of the forkhead box M1 (FoxM1) transcription factor. By contrast, our results indicate that post-mitotic p27(Kip)-positive neurons become IGF-I independent as they extend their neuronal processes. Neurons gradually reduce their expression of the Igf1r, while they increase that of the neurotrophin receptor, TrkC. Conclusions/Significance: Proliferative otic neuroblasts are dependent on the activation of the PI3K-AKT pathway by IGF-I for survival during the otic neuronal progenitor phase of early inner ear development.	[Aburto, Maria R.; Magarinos, Marta; Leon, Yolanda; Varela-Nieto, Isabel; Sanchez-Calderon, Hortensia] CSIC UAM, Inst Invest Biomed Alberto Sols, Madrid, Spain; [Magarinos, Marta; Leon, Yolanda] Univ Autonoma Madrid, Dept Biol, Madrid, Spain; [Aburto, Maria R.; Magarinos, Marta; Varela-Nieto, Isabel; Sanchez-Calderon, Hortensia] ISCIII, CIBERER, Unit 761, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Autonomous University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III	Aburto, MR (corresponding author), CSIC UAM, Inst Invest Biomed Alberto Sols, Madrid, Spain.	ivarela@iib.uam.es	Varela-Nieto, Isabel/G-5289-2015; SÁNCHEZ, MARTA MAGARIÑOS/ABG-7748-2020; Rodriguez Aburto, Maria/ABG-7492-2021; Leon, Yolanda/ABG-6797-2020	Varela-Nieto, Isabel/0000-0003-3077-0500; SÁNCHEZ, MARTA MAGARIÑOS/0000-0003-4592-9377; Leon Alvarez, Yolanda/0000-0002-4536-8373; de las Heras, Ana Isabel/0000-0002-4446-7417	Ministerio de Ciencia e Innovacion [SAF2008-00470]; Fundacion Mutua Madrilena	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Fundacion Mutua Madrilena(Instituto de Salud Carlos III)	This work was supported by the "Ministerio de Ciencia e Innovacion" (SAF2008-00470; http://www.micinn.es/) and the "Fundacion Mutua Madrilena" (http://www.fundacionmutua.es/) to IVN. The funders had no role in the study design, data collection and analysis, decision to publish or the preparation of the manuscript.	Aberg MAI, 2003, MOL CELL NEUROSCI, V24, P23, DOI 10.1016/S1044-7431(03)00082-4; Aberg MAI, 2000, J NEUROSCI, V20, P2896; Arsenijevic Y, 2001, J NEUROSCI, V21, P7194, DOI 10.1523/JNEUROSCI.21-18-07194.2001; AVILA MA, 1993, DEV BIOL, V159, P266, DOI 10.1006/dbio.1993.1239; Becker E, 1998, J NEUROSCI, V18, P7903; Bissonnette JP, 1996, J COMP NEUROL, V368, P620, DOI 10.1002/(SICI)1096-9861(19960513)368:4<620::AID-CNE12>3.0.CO;2-L; Camarero G, 2003, DEV BIOL, V262, P242, DOI 10.1016/S0012-1606(03)00387-7; Camarero G, 2001, J NEUROSCI, V21, P7630, DOI 10.1523/JNEUROSCI.21-19-07630.2001; Cediel R, 2006, EUR J NEUROSCI, V23, P587, DOI 10.1111/j.1460-9568.2005.04584.x; Chen WS, 2001, GENE DEV, V15, P2203, DOI 10.1101/gad.913901; Costa RH, 2005, NAT CELL BIOL, V7, P108, DOI 10.1038/ncb0205-108; Davies D, 2007, J COMP NEUROL, V502, P673, DOI 10.1002/cne.21302; De Zio D, 2005, SEMIN CELL DEV BIOL, V16, P281, DOI 10.1016/j.semcdb.2004.12.003; DICICCOBLOOM E, 1988, P NATL ACAD SCI USA, V85, P4066, DOI 10.1073/pnas.85.11.4066; ERICSON J, 1992, SCIENCE, V256, P1555, DOI 10.1126/science.1350865; Fekete DM, 2007, INT J DEV BIOL, V51, P549, DOI 10.1387/ijdb.072341df; Fero ML, 1996, CELL, V85, P733, DOI 10.1016/S0092-8674(00)81239-8; Frago LM, 2003, J CELL SCI, V116, P475, DOI 10.1242/jcs.00223; Frago LM, 1998, J CELL SCI, V111, P549; Fritzsch B, 2004, PROG BRAIN RES, V146, P265, DOI 10.1016/S0079-6123(03)46017-2; Fritzsch B, 1999, CELL TISSUE RES, V295, P369, DOI 10.1007/s004410051244; Gao DM, 2009, NAT CELL BIOL, V11, P397, DOI 10.1038/ncb1847; Hajduch E, 2001, FEBS LETT, V492, P199, DOI 10.1016/S0014-5793(01)02242-6; HAMBURGER V, 1992, DEV DYNAM, V195, P231, DOI 10.1002/dvdy.1001950404; HEMOND SG, 1991, ANAT EMBRYOL, V184, P1, DOI 10.1007/BF01744256; HERNANDEZSANCHEZ C, 1995, P NATL ACAD SCI USA, V92, P9834, DOI 10.1073/pnas.92.21.9834; Hietakangas V, 2009, ANNU REV GENET, V43, P389, DOI 10.1146/annurev-genet-102108-134815; Hodge RD, 2004, J NEUROSCI, V24, P10201, DOI 10.1523/JNEUROSCI.3246-04.2004; Husseman J, 2009, ADV OTO-RHINO-LARYNG, V66, P37, DOI 10.1159/000218206; Karis A, 2001, J COMP NEUROL, V429, P615, DOI 10.1002/1096-9861(20010122)429:4<615::AID-CNE8>3.0.CO;2-F; Kelley MW, 2006, NAT REV NEUROSCI, V7, P837, DOI 10.1038/nrn1987; Korver W, 1998, CURR BIOL, V8, P1327, DOI 10.1016/S0960-9822(07)00563-5; Lang HN, 2000, J COMP NEUROL, V417, P205, DOI 10.1002/(SICI)1096-9861(20000207)417:2<205::AID-CNE6>3.0.CO;2-Y; Lein Y, 1998, J COMP NEUROL, V398, P323, DOI 10.1002/(SICI)1096-9861(19980831)398:3<323::AID-CNE2>3.0.CO;2-1; Leon Y, 2004, APOPTOSIS, V9, P255, DOI 10.1023/B:APPT.0000025802.07676.a5; Leung TWC, 2001, FEBS LETT, V507, P59, DOI 10.1016/S0014-5793(01)02915-5; Li HW, 2004, J COMP NEUROL, V477, P1, DOI 10.1002/cne.20190; Liang J, 2002, NAT MED, V8, P1153, DOI 10.1038/nm761; Lin HK, 2009, NAT CELL BIOL, V11, P420, DOI 10.1038/ncb1849; Ma RYM, 2005, J CELL SCI, V118, P795, DOI 10.1242/jcs.01657; Magarinos M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014435; Mairet-Coello G, 2009, J NEUROSCI, V29, P775, DOI 10.1523/JNEUROSCI.1700-08.2009; Milo M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007144; Neves J, 2007, J COMP NEUROL, V503, P487, DOI 10.1002/cne.21299; Peng XD, 2003, GENE DEV, V17, P1352, DOI 10.1101/gad.1089403; Pirvola U, 1997, J NEUROBIOL, V33, P1019, DOI 10.1002/(SICI)1097-4695(199712)33:7<1019::AID-NEU11>3.0.CO;2-A; Puligilla C, 2010, J NEUROSCI, V30, P714, DOI 10.1523/JNEUROSCI.3852-09.2010; RATHJEN FG, 1987, CELL, V51, P841, DOI 10.1016/0092-8674(87)90107-3; Read DE, 2009, CELL MOL LIFE SCI, V66, P2975, DOI 10.1007/s00018-009-0057-8; Riquelme R, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00027; Rubel EW, 2002, ANNU REV NEUROSCI, V25, P51, DOI 10.1146/annurev.neuro.25.112701.142849; Russo VC, 2005, ENDOCR REV, V26, P916, DOI 10.1210/er.2004-0024; Sanchez-Calderon H, 2004, GENE EXPR PATTERNS, V4, P659, DOI 10.1016/j.modgep.2004.04.008; Sanchez-Calderon H, 2007, INT J DEV BIOL, V51, P557, DOI 10.1387/ijdb.072373hs; Sanchez-Calderon H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008699; Sinor AD, 2004, J NEUROSCI, V24, P8531, DOI 10.1523/JNEUROSCI.1470-04.2004; Vanhaesebroeck B, 2000, BIOCHEM J, V346, P561, DOI 10.1042/0264-6021:3460561; Vanhaesebroeck B, 2010, NAT REV MOL CELL BIO, V11, P329, DOI 10.1038/nrm2882; Varela-Nieto I, 2003, MOL NEUROBIOL, V28, P23, DOI 10.1385/MN:28:1:23; Varela-Nieto I, 2007, CURR PHARM DESIGN, V13, P687, DOI 10.2174/138161207780249164; Walenkamp MJE, 2007, EUR J ENDOCRINOL, V156, P155, DOI 10.1530/eje.1.02327; WIKSTROM SO, 1987, ACTA OTO-LARYNGOL, V104, P166, DOI 10.3109/00016488709109063; Ye P, 2006, J NEUROSCI RES, V83, P1, DOI 10.1002/jnr.20688	63	50	54	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30790	10.1371/journal.pone.0030790	http://dx.doi.org/10.1371/journal.pone.0030790			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22292041	gold, Green Published, Green Submitted			2022-12-25	WOS:000301570600079
J	Ito, M; Johansson, J; Stromberg, R; Nilsson, L				Ito, Mika; Johansson, Jan; Stromberg, Roger; Nilsson, Lennart			Effects of Ligands on Unfolding of the Amyloid beta-Peptide Central Helix: Mechanistic Insights from Molecular Dynamics Simulations	PLOS ONE			English	Article							FIBRIL-FORMING PROTEINS; ALZHEIMERS-DISEASE; FORCE-FIELDS; A-BETA(1-42); WATER; HYPOTHESIS; BACKBONE; PROGRAM; CHARMM; NMR	Polymerization of the amyloid beta-peptide (A beta), a process which requires that the helical structure of A beta unfolds beforehand, is suspected to cause neurodegeneration in Alzheimer's disease. According to recent experimental studies, stabilization of the A beta central helix counteracts A beta polymerization into toxic assemblies. The effects of two ligands (Dec-DETA and Pep1b), which were designed to bind to and stabilize the A beta central helix, on unfolding of the A beta central helix were investigated by molecular dynamics simulations. It was quantitatively demonstrated that the stability of the A beta central helix is increased by both ligands, and more effectively by Pep1b than by Dec-DETA. In addition, it was shown that Dec-DETA forms parallel conformations with beta-strand-like A beta, whereas Pep1b does not and instead tends to bend unwound A beta. The molecular dynamics results correlate well with previous experiments for these ligands, which suggest that the simulation method should be useful in predicting the effectiveness of novel ligands in stabilizing the A beta central helix. Detailed A beta structural changes upon loss of helicity in the presence of the ligands are also revealed, which gives further insight into which ligand may lead to which path subsequent to unwinding of the A beta central helix.	[Ito, Mika; Stromberg, Roger; Nilsson, Lennart] Karolinska Inst, Dept Biosci & Nutr, Huddinge, Sweden; [Johansson, Jan] Karolinska Inst, Dept Neurobiol Care Sci & Soc NVS, Huddinge, Sweden; [Johansson, Jan] Karolinska Inst, Alzheimer Dis Res Ctr KI ADRC, Huddinge, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet	Ito, M (corresponding author), Karolinska Inst, Dept Biosci & Nutr, Huddinge, Sweden.	Lennart.Nilsson@ki.se	Stromberg, Roger/C-2960-2013; Nilsson, Lennart/B-7208-2009	Nilsson, Lennart/0000-0002-5067-6397; Johansson, Jan/0000-0002-8719-4703	Swedish Research Council	Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by the Swedish Research Council (http://www.vr.se/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], INS 2 VERS 2000; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Cohen FE, 2003, NATURE, V426, P905, DOI 10.1038/nature02265; Coles M, 1998, BIOCHEMISTRY-US, V37, P11064, DOI 10.1021/bi972979f; DELOOF H, 1992, J AM CHEM SOC, V114, P4028, DOI 10.1021/ja00037a002; ELOFSSON A, 1993, J MOL BIOL, V233, P766, DOI 10.1006/jmbi.1993.1551; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Feng BY, 2008, NAT CHEM BIOL, V4, P197, DOI 10.1038/nchembio.65; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Hou LM, 2004, J AM CHEM SOC, V126, P1992, DOI 10.1021/ja036813f; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ito M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017587; Jarvet J, 2007, J BIOMOL NMR, V39, P63, DOI 10.1007/s10858-007-9176-4; Johansson J, 2010, BIOCHEM BIOPH RES CO, V402, P515, DOI 10.1016/j.bbrc.2010.10.062; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kallberg Y, 2001, J BIOL CHEM, V276, P12945, DOI 10.1074/jbc.M010402200; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 2004, J AM CHEM SOC, V126, P698, DOI 10.1021/ja036959e; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Mason JM, 2003, CURR OPIN STRUC BIOL, V13, P526, DOI 10.1016/S0959-440X(03)00100-3; Nerelius C, 2009, P NATL ACAD SCI USA, V106, P9191, DOI 10.1073/pnas.0810364106; Nilsson L, 2009, J COMPUT CHEM, V30, P1490, DOI 10.1002/jcc.21169; Nordling E, 2008, J COMPUT AID MOL DES, V22, P53, DOI 10.1007/s10822-007-9155-6; Paivio A, 2004, PROTEIN SCI, V13, P1251, DOI 10.1110/ps.03442404; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2; Shen L, 2008, J PHYS CHEM B, V112, P3164, DOI 10.1021/jp7108237; STEINBACH PJ, 1994, J COMPUT CHEM, V15, P667, DOI 10.1002/jcc.540150702; Tjernberg LO, 1996, J BIOL CHEM, V271, P8545, DOI 10.1074/jbc.271.15.8545; Tjernberg LO, 1997, J BIOL CHEM, V272, P12601, DOI 10.1074/jbc.272.19.12601; Triguero L, 2008, J PHYS CHEM B, V112, P7123, DOI 10.1021/jp801168v; Triguero L, 2008, J PHYS CHEM B, V112, P2159, DOI 10.1021/jp0771872; Watanabe K, 2002, BIOCHEM BIOPH RES CO, V290, P121, DOI 10.1006/bbrc.2001.6191; Watanabe K, 2001, J PEPT RES, V58, P342, DOI 10.1034/j.1399-3011.2001.00920.x; Zhang S, 2000, J STRUCT BIOL, V130, P130, DOI 10.1006/jsbi.2000.4288	40	16	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30510	10.1371/journal.pone.0030510	http://dx.doi.org/10.1371/journal.pone.0030510			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22291970	Green Published, Green Submitted, gold			2022-12-25	WOS:000301570600049
J	Popa-Lisseanu, AG; Sorgel, K; Luckner, A; Wassenaar, LI; Ibanez, C; Kramer-Schadt, S; Ciechanowski, M; Gorfol, T; Niermann, I; Beuneux, G; Myslajek, RW; Juste, J; Fonderflick, J; Kelm, DH; Voigt, CC				Popa-Lisseanu, Ana G.; Soergel, Karin; Luckner, Anja; Wassenaar, Leonard I.; Ibanez, Carlos; Kramer-Schadt, Stephanie; Ciechanowski, Mateusz; Goerfoel, Tamas; Niermann, Ivo; Beuneux, Gregory; Myslajek, Robert W.; Juste, Javier; Fonderflick, Jocelyn; Kelm, Detlev H.; Voigt, Christian C.			A Triple-Isotope Approach to Predict the Breeding Origins of European Bats	PLOS ONE			English	Article							STABLE-ISOTOPES; DELTA-D; MIGRATORY CONNECTIVITY; MONARCH BUTTERFLIES; NATAL ORIGINS; LESSER SCAUP; HYDROGEN; RATIOS; CHIROPTERA; DELINEATE	Despite a commitment by the European Union to protect its migratory bat populations, conservation efforts are hindered by a poor understanding of bat migratory strategies and connectivity between breeding and wintering grounds. Traditional methods like mark-recapture are ineffective to study broad-scale bat migratory patterns. Stable hydrogen isotopes (delta D) have been proven useful in establishing spatial migratory connectivity of animal populations. Before applying this tool, the method was calibrated using bat samples of known origin. Here we established the potential of delta D as a robust geographical tracer of breeding origins of European bats by measuring delta D in hair of five sedentary bat species from 45 locations throughout Europe. The delta D of bat hair strongly correlated with well-established spatial isotopic patterns in mean annual precipitation in Europe, and therefore was highly correlated with latitude. We calculated a linear mixed-effects model, with species as random effect, linking delta D of bat hair to precipitation delta D of the areas of hair growth. This model can be used to predict breeding origins of European migrating bats. We used delta C-13 and delta N-15 to discriminate among potential origins of bats, and found that these isotopes can be used as variables to further refine origin predictions. A triple-isotope approach could thereby pinpoint populations or subpopulations that have distinct origins. Our results further corroborated stable isotope analysis as a powerful method to delineate animal migrations in Europe.	[Popa-Lisseanu, Ana G.; Soergel, Karin; Luckner, Anja; Kramer-Schadt, Stephanie; Voigt, Christian C.] Leibniz Inst Zoo & Wildlife Res, Berlin, Germany; [Wassenaar, Leonard I.] Environm Canada, Saskatoon, SK, Canada; [Ibanez, Carlos; Juste, Javier] CSIC, Estn Biol Donana, Seville, Spain; [Ciechanowski, Mateusz] Univ Gdansk, Dept Vertebrate Ecol & Zool, PL-80952 Gdansk, Poland; [Goerfoel, Tamas] Szent Istvan Univ, Inst Biol, Fac Vet Sci, Budapest, Hungary; [Goerfoel, Tamas] Nat Conservat Fdn Tolna Cty, Szekszard, Hungary; [Niermann, Ivo] Leibniz Univ Hannover, Inst Umweltplanung, Hannover, Germany; [Beuneux, Gregory] Grp Chiropteres Corse, Corte, Corsica, France; [Myslajek, Robert W.] Assoc Nat Wolf, Lipowa, Poland; [Fonderflick, Jocelyn] Montpellier SupAgro, Dept Biol & Ecol, Montpellier, France; [Fonderflick, Jocelyn] Ctr Ecol Fonct & Evolut, Montpellier, France; [Kelm, Detlev H.] Univ Berlin, Dept Biol, Berlin, Germany	Leibniz Institut fur Zoo und Wildtierforschung; Environment & Climate Change Canada; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Fahrenheit Universities; University of Gdansk; Hungarian University of Agriculture & Life Sciences; Leibniz University Hannover; Institut Agro; Montpellier SupAgro; Universite de Montpellier; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier	Popa-Lisseanu, AG (corresponding author), Leibniz Inst Zoo & Wildlife Res, Berlin, Germany.	anapopa@izw-berlin.de	Görföl, Tamás/F-7688-2010; Wassenaar, Leonard/AAY-7081-2020; Mysłajek, Robert W./AAD-9569-2022; Juste, Javier/B-9253-2013; Ibanez, Carlos/H-7577-2015; Kramer-Schadt, Stephanie/A-8778-2013; Myslajek, Robert/K-8248-2015	Görföl, Tamás/0000-0002-1910-4024; Wassenaar, Leonard/0000-0001-5532-0771; Juste, Javier/0000-0003-1383-8462; Ibanez, Carlos/0000-0003-1181-7641; Kramer-Schadt, Stephanie/0000-0002-9269-4446; Myslajek, Robert/0000-0001-9619-2868	Alexander von Humboldt Foundation	Alexander von Humboldt Foundation(Alexander von Humboldt Foundation)	Financial support was provided by the Alexander von Humboldt Foundation with a post-doctoral fellowship for A. G. Popa-Lisseanu. Funder's website: http://www.humboldt-foundation.de. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birchall J, 2005, J ANIM ECOL, V74, P877, DOI 10.1111/j.1365-2656.2005.00979.x; Bowen GJ, 2005, OECOLOGIA, V143, P337, DOI 10.1007/s00442-004-1813-y; Bowen GJ, 2003, WATER RESOUR RES, V39, DOI 10.1029/2003WR002086; Bowen GJ, 2010, GRIDDED MAPS ISOTOPI; Britzke ER, 2009, J MAMMAL, V90, P743, DOI 10.1644/08-MAMM-A-211R2.1; Chamberlain CP, 1997, OECOLOGIA, V109, P132, DOI 10.1007/s004420050067; Chamberlain CP, 2000, P ROY SOC B-BIOL SCI, V267, P43, DOI 10.1098/rspb.2000.0964; Clark RG, 2006, CAN J ZOOL, V84, P1395, DOI 10.1139/Z06-135; CRAIG H, 1961, SCIENCE, V133, P1702, DOI 10.1126/science.133.3465.1702; Cryan PM, 2004, J MAMMAL, V85, P995, DOI 10.1644/BRG-202; Dietz C., 2007, HDB FLEDERMAUSE EURO; Dietz C, 2006, ACTA CHIROPTEROL, V8, P523, DOI 10.3161/1733-5329(2006)8[523:EOFBOH]2.0.CO;2; Ehleringer JR, 2008, P NATL ACAD SCI USA, V105, P2788, DOI 10.1073/pnas.0712228105; Eisentraut M., 1943, Zoologischer Anzeiger Leipzig, V148, P20; Ellison L., 2008, 20081363 US GEOL SUR, P1, DOI DOI 10.3996/082012-JFWM-065/SUPPLFILE/10.3996_082012-JFWM-065.S2.PDF?C0DE=UFWS-SITE; Erzberger A, ACTA CHIROP IN PRESS; Fraser KC, 2010, BIOTROPICA, V42, P512, DOI 10.1111/j.1744-7429.2009.00608.x; Gotelli NJ, 2013, ECOSIMR 1 00; Hebert CE, 2005, WILDLIFE SOC B, V33, P92, DOI 10.2193/0091-7648(2005)33[92:FSIIWN]2.0.CO;2; Hobson KA, 2005, DIVERS DISTRIB, V11, P157, DOI 10.1111/j.1366-9516.2005.00149.x; Hobson KA, 2004, OECOLOGIA, V141, P477, DOI 10.1007/s00442-004-1671-7; Hobson KA, 1999, OECOLOGIA, V120, P397, DOI 10.1007/s004420050872; Hobson KA, 1997, OECOLOGIA, V109, P142, DOI 10.1007/s004420050068; Hobson KA, 1999, OECOLOGIA, V120, P314, DOI 10.1007/s004420050865; Hobson KA, 2008, TERR ECOL SER, V2, P45, DOI 10.1016/S1936-7961(07)00003-6; Hobson KA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007915; Hobson KA, 2009, J APPL ECOL, V46, P572, DOI 10.1111/j.1365-2664.2009.01651.x; Holland RA, 2009, J MAMMAL, V90, P1324, DOI 10.1644/09-MAMM-S-086R2.1; Hutterer R., 2005, BAT MIGRATIONS EUROP; Ibanez C, 2006, ACTA CHIROPTEROL, V8, P277, DOI 10.3161/1733-5329(2006)8[277:TICTCD]2.0.CO;2; Ibanez C, 2009, J MAMMAL, V90, P235, DOI 10.1644/08-MAMM-A-037.1; Juste J, 2009, HEREDITY, V103, P178, DOI 10.1038/hdy.2009.47; Kelly JF, 2002, OECOLOGIA, V130, P216, DOI 10.1007/s004420100789; Liu XZ, 2010, RAPID COMMUN MASS SP, V24, P3063, DOI 10.1002/rcm.4735; Pain DJ, 2004, OECOLOGIA, V138, P168, DOI 10.1007/s00442-003-1416-z; Perez GE, 2007, DIVERS DISTRIB, V13, P166, DOI 10.1111/j.1472-4642.2006.00306.x; Perez-Jorda JL, 1994, THESIS U SEVILLE; Popa-Lisseanu AG, 2009, J MAMMAL, V90, P1283, DOI 10.1644/09-MAMM-S-130R2.1; R Development Core Team, 2009, R FDN STAT COMP; Reichlin TS, 2010, DIVERS DISTRIB, V16, P643, DOI 10.1111/j.1472-4642.2010.00664.x; Suits NS, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2003GB002141; Tiunov MP, 2007, ACTA CHIROPTEROL, V9, P538, DOI 10.3161/1733-5329(2007)9[538:SMIMPC]2.0.CO;2; Verbeke G., 2000, SPRINGER SERIES STAT; Wassenaar LI, 2008, TERR ECOL SER, V2, P21, DOI 10.1016/S1936-7961(07)00002-4; Wassenaar LI, 2000, ECOL APPL, V10, P911, DOI 10.1890/1051-0761(2000)010[0911:SCAHIR]2.0.CO;2; Wassenaar LI, 2003, ISOT ENVIRON HEALT S, V39, P211, DOI 10.1080/1025601031000096781; Wassenaar LI, 1998, P NATL ACAD SCI USA, V95, P15436, DOI 10.1073/pnas.95.26.15436; Wassenaar LI, 2001, ENVIRON SCI TECHNOL, V35, P1845, DOI 10.1021/es0010204; Wassenaar LI, 2000, ENVIRON SCI TECHNOL, V34, P2354, DOI 10.1021/es990804i; Webster MS, 2002, TRENDS ECOL EVOL, V17, P76, DOI 10.1016/S0169-5347(01)02380-1; Zuur Alain F., 2009, P1	51	47	47	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30388	10.1371/journal.pone.0030388	http://dx.doi.org/10.1371/journal.pone.0030388			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22291947	Green Published, gold			2022-12-25	WOS:000301570600037
J	Zedek, F; Bures, P				Zedek, Frantisek; Bures, Petr			Evidence for Centromere Drive in the Holocentric Chromosomes of Caenorhabditis	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; ALIGNMENT; ORGANIZATION; SATELLITE; SEQUENCE	In monocentric organisms with asymmetric meiosis, the kinetochore proteins, such as CENH3 and CENP-C, evolve adaptively to counterbalance the deleterious effects of centromere drive, which is caused by the expansion of centromeric satellite repeats. The selection regimes that act on CENH3 and CENP-C genes have not been analyzed in organisms with holocentric chromosomes, although holocentrism is speculated to have evolved to suppress centromere drive. We tested both CENH3 and CENP-C for positive selection in several species of the holocentric genus Caenorhabditis using the maximum likelihood approach and sliding-window analysis. Although CENP-C did not show any signs of positive selection, positive selection has been detected in the case of CENH3. These results support the hypothesis that centromere drive occurs in Nematoda, at least in the telokinetic meiosis of Caenorhabditis.	[Zedek, Frantisek; Bures, Petr] Masaryk Univ, Dept Bot & Zool, Brno, Czech Republic	Masaryk University Brno	Zedek, F (corresponding author), Masaryk Univ, Dept Bot & Zool, Brno, Czech Republic.	fzedek@gmail.com	Zedek, Frantisek/AAD-8132-2019	Zedek, Frantisek/0000-0003-1593-1775; Bures, Petr/0000-0002-0146-956X	Czech Science Foundation [GACR 206/09/1405]; Ministry of Education, Youth and Sports of the Czech Republic [LC06073, MSM0021622416]	Czech Science Foundation(Grant Agency of the Czech Republic); Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic)	This study was supported by the Czech Science Foundation (project GACR 206/09/1405) and the Ministry of Education, Youth and Sports of the Czech Republic (projects LC06073 and MSM0021622416). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertson DG., 1997, CHROMOSOME ORG MITOS; Baker RE, 2006, GENETICS, V174, P1481, DOI 10.1534/genetics.106.062794; Chan RC, 2004, J CELL BIOL, V167, P613, DOI 10.1083/jcb.200408061; Cheng ZK, 2002, PLANT CELL, V14, P1691, DOI 10.1105/tpc.003079; Comeron JM, 1999, BIOINFORMATICS, V15, P763, DOI 10.1093/bioinformatics/15.9.763; Dawe RK, 2006, TRENDS BIOCHEM SCI, V31, P662, DOI 10.1016/j.tibs.2006.10.004; Dernburg AF, 2001, J CELL BIOL, V153, pF33, DOI 10.1083/jcb.153.6.F33; Dumont J, 2010, NAT CELL BIOL, V12, P894, DOI 10.1038/ncb2093; Fishman L, 2008, SCIENCE, V322, P1559, DOI 10.1126/science.1161406; GODAY C, 1989, CHROMOSOMA, V98, P160, DOI 10.1007/BF00329679; Haizel T, 2005, CYTOGENET GENOME RES, V109, P134, DOI 10.1159/000082392; Harris TW, 2010, NUCLEIC ACIDS RES, V38, pD463, DOI 10.1093/nar/gkp952; Henikoff S, 2001, SCIENCE, V293, P1098, DOI 10.1126/science.1062939; Jiang JM, 2003, TRENDS PLANT SCI, V8, P570, DOI 10.1016/j.tplants.2003.10.011; Kiontke K, 2004, P NATL ACAD SCI USA, V101, P9003, DOI 10.1073/pnas.0403094101; Loytynoja A, 2005, P NATL ACAD SCI USA, V102, P10557, DOI 10.1073/pnas.0409137102; Loytynoja A, 2008, SCIENCE, V320, P1632, DOI 10.1126/science.1158395; Malik HS, 2009, CELL, V138, P1067, DOI 10.1016/j.cell.2009.08.036; Malik HS, 2002, P NATL ACAD SCI USA, V99, P1449, DOI 10.1073/pnas.032664299; Malik HS, 2003, NAT STRUCT BIOL, V10, P882, DOI 10.1038/nsb996; Monen J, 2005, NAT CELL BIOL, V7, P1248, DOI 10.1038/ncb1331; Niedermaier J, 2000, CHROMOSOMA, V109, P439, DOI 10.1007/s004120000104; Penn O, 2010, MOL BIOL EVOL, V27, P1759, DOI 10.1093/molbev/msq066; Penn O, 2010, NUCLEIC ACIDS RES, V38, pW23, DOI 10.1093/nar/gkq443; Rutkowska J, 2008, PHILOS T R SOC B, V363, P1675, DOI 10.1098/rstb.2007.0006; Shakes DC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000611; Stein LD, 2003, PLOS BIOL, V1, P166, DOI 10.1371/journal.pbio.0000045; Sullivan Beth A., 2009, P45, DOI 10.1007/978-0-387-69076-6_3; Surzycki SA, 2000, P NATL ACAD SCI USA, V97, P245, DOI 10.1073/pnas.97.1.245; Talbert Paul B., 2009, P193, DOI 10.1007/978-0-387-69076-6_7; TALBERT PB, 2004, J BIOL LONDON, V3, pNIL1; Tamura K, 2011, MOL BIOL EVOLUTION; Vermaak D, 2002, MOL CELL BIOL, V22, P7553, DOI 10.1128/MCB.22.21.7553-7561.2002; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	34	23	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30496	10.1371/journal.pone.0030496	http://dx.doi.org/10.1371/journal.pone.0030496			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22291967	Green Published, Green Submitted, gold			2022-12-25	WOS:000301570600047
J	Zhang, RY; Hummelgard, M; Olin, H				Zhang, Renyun; Hummelgard, Magnus; Olin, Hakan			Simple Fabrication of Gold Nanobelts and Patterns	PLOS ONE			English	Article							SURFACE; FILMS; NANOWIRES; GROWTH; MORPHOLOGY; SENSOR	Gold nanobelts are of interest in several areas; however, there are only few methods available to produce these belts. We report here on a simple evaporation induced self-assembly (EISA) method to produce porous gold nanobelts with dimensions that scale across nanometer (thickness similar to 80 nm) and micrometer (width similar to 20 mu m), to decimeter (length similar to 0.15 m). The gold nanobelts are well packed on the beaker wall and can be easily made to float on the surface of the solution for depositing onto other substrates. Microscopy showed that gold nanobelts had a different structure on the two sides of the belt; the density of gold nanowires on one side was greater than on the other side. Electrical measurements showed that these nanobelts were sensitive to compressive or tensile forces, indicating a potential use as a strain sensor. The patterned nanobelts were further used as a template to grow ZnO nanowires for potential use in applications such as piezo-electronics.	[Zhang, Renyun; Hummelgard, Magnus; Olin, Hakan] Mid Sweden Univ, Dept Nat Sci Engn & Math, Sundsvall, Sweden	Mid-Sweden University	Zhang, RY (corresponding author), Mid Sweden Univ, Dept Nat Sci Engn & Math, Sundsvall, Sweden.	renyun.zhang@miun.se	Olin, Håkan/A-8175-2008; Zhang, Renyun/C-6617-2009	Olin, Håkan/0000-0001-7329-3359; Zhang, Renyun/0000-0003-2873-7875; Hummelgard, Magnus/0000-0001-9137-3440	Sundsvall Community; European Regional Development Fund through the project Energywise [00159526]	Sundsvall Community; European Regional Development Fund through the project Energywise	The project was supported by the Sundsvall Community through a fellowship for RYZ, and also part-financed by the European Regional Development Fund through the project Energywise (00159526). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI E, 1995, LANGMUIR, V11, P1057, DOI 10.1021/la00004a003; Chen Y, 2008, NANO LETT, V8, P737, DOI 10.1021/nl0725852; Chen Y, 2009, J MATER CHEM, V19, P924, DOI 10.1039/b816897k; Deegan RD, 1997, NATURE, V389, P827, DOI 10.1038/39827; Doerk GS, 2008, J MATER CHEM, V18, P5376, DOI 10.1039/b811535d; Eustis S, 2009, J PHYS CHEM C, V113, P2277, DOI 10.1021/jp808129j; Ferralis N, 2007, J PHYS CHEM C, V111, P7508, DOI 10.1021/jp071105s; Kang IP, 2006, SMART MATER STRUCT, V15, P737, DOI 10.1088/0964-1726/15/3/009; Kondo Y, 2000, SCIENCE, V289, P606, DOI 10.1126/science.289.5479.606; Kondo Y, 1999, PHYS REV LETT, V82, P751, DOI 10.1103/PhysRevLett.82.751; Li LS, 2010, LANGMUIR, V26, P12330, DOI 10.1021/la1015737; Pan ZW, 2001, SCIENCE, V291, P1947, DOI 10.1126/science.1058120; Paulose M, 2003, J NANOSCI NANOTECHNO, V3, P341, DOI 10.1166/jnn.2003.209; Shmuylovich L, 2002, LANGMUIR, V18, P3441, DOI 10.1021/la011484v; Sun YG, 2002, SCIENCE, V298, P2176, DOI 10.1126/science.1077229; Tessier PM, 2000, J AM CHEM SOC, V122, P9554, DOI 10.1021/ja0022831; Wang XD, 2006, NANO LETT, V6, P2768, DOI 10.1021/nl061802g; Wang ZL, 2010, NANO TODAY, V5, P540, DOI 10.1016/j.nantod.2010.10.008; Zhang JH, 2007, ADV FUNCT MATER, V17, P1558, DOI 10.1002/adfm.200600727; Zhang JL, 2006, ANGEW CHEM INT EDIT, V45, P1116, DOI 10.1002/anie.200503762; Zhang RY, 2010, PHYSICA B, V405, P4517, DOI 10.1016/j.physb.2010.08.029; Zhang RY, 2009, J COLLOID INTERF SCI, V340, P58, DOI 10.1016/j.jcis.2009.08.006; Zhao N, 2008, LANGMUIR, V24, P991, DOI 10.1021/la702848x	23	6	6	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30469	10.1371/journal.pone.0030469	http://dx.doi.org/10.1371/journal.pone.0030469			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22291962	Green Published, gold, Green Submitted			2022-12-25	WOS:000301570600045
J	Zhang, XP; Qu, SG				Zhang, Xiuping; Qu, Shaogang			The Accessibility in the External Part of the TM5 of the Glutamate Transporter EAAT1 Is Conformationally Sensitive during the Transport Cycle	PLOS ONE			English	Article							AMINOBUTYRIC-ACID TRANSPORTER; RAT-BRAIN; EXTRACELLULAR GATE; REENTRANT LOOP; SUBSTRATE INTERACTIONS; ASPARTATE TRANSPORTER; INDIVIDUAL SUBUNITS; ION-BINDING; GLT-1; EXPRESSION	Background: Excitatory amino acid transporter 1 (EAAT1) is a glutamate transporter which is a key element in the termination of the synaptic actions of glutamate. It serves to keep the extracellular glutamate concentration below neurotoxic level. However the functional significance and the change of accessibility of residues in transmembrane domain (TM) 5 of the EAAT1 are not clear yet. Methodology/Principal Findings: We used cysteine mutagenesis with treatments with membrane-impermeable sulfhydryl reagent MTSET [(2-trimethylammonium) methanethiosulfonate] to investigate the change of accessibility of TM5. Cysteine mutants were introduced from position 291 to 300 of the cysteine-less version of EAAT1. We checked the activity and kinetic parameters of the mutants before and after treatments with MTSET, furthermore we analyzed the effect of the substrate and blocker on the inhibition of the cysteine mutants by MTSET. Inhibition of transport by MTSET was observed in the mutants L296C, I297C and G299C, while the activity of K300C got higher after exposure to MTSET. V-max of L296C and G299C got lower while that of K300C got higher after treated by MTSET. The L296C, G299C, K300C single cysteine mutants showed a conformationally sensitive reactivity pattern. The sensitivity of L296C to MTSET was potentiated by glutamate and TBOA, but the sensitivity of G299C to MTSET was potentiated only by TBOA. Conclusions/Significance: All these facts suggest that the accessibility of some positions of the external part of the TM5 is conformationally sensitive during the transport cycle. Our results indicate that some residues of TM5 take part in the transport pathway during the transport cycle.	[Zhang, Xiuping] Guangdong Med Coll, China Amer Canc Res Inst, Dongguan, Guangdong, Peoples R China; [Qu, Shaogang] So Med Univ, Dept Immunol, Guangzhou, Guangdong, Peoples R China	Guangdong Medical University; Southern Medical University - China	Zhang, XP (corresponding author), Guangdong Med Coll, China Amer Canc Res Inst, Dongguan, Guangdong, Peoples R China.	sgq9528@163.com			National Natural Science Foundation of China [31170734]; International Centre for Genetic Engineering and Biotechnology [CRP/CHN11-01]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Centre for Genetic Engineering and Biotechnology	This work was supported in part by the National Natural Science Foundation of China (Grant 31170734 to SQ), http://www.nsfc.gov.cn/Portal0/default106.htm, and the International Centre for Genetic Engineering and Biotechnology (Grant CRP/CHN11-01 to SQ), http://www.icgeb.org/home.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arriza JL, 1997, P NATL ACAD SCI USA, V94, P4155, DOI 10.1073/pnas.94.8.4155; Bendahan A, 2000, J BIOL CHEM, V275, P37436, DOI 10.1074/jbc.M006536200; Bennett ER, 2000, J BIOL CHEM, V275, P34106, DOI 10.1074/jbc.M004229200; Bennett ER, 1997, J BIOL CHEM, V272, P1203, DOI 10.1074/jbc.272.2.1203; Borre L, 2001, J BIOL CHEM, V276, P40396, DOI 10.1074/jbc.M104926200; Boudker O, 2007, NATURE, V445, P387, DOI 10.1038/nature05455; Brocke L, 2002, J BIOL CHEM, V277, P3985, DOI 10.1074/jbc.M107735200; Compton ELR, 2010, P NATL ACAD SCI USA, V107, P12840, DOI 10.1073/pnas.1003046107; Crisman TJ, 2009, P NATL ACAD SCI USA, V106, P20752, DOI 10.1073/pnas.0908570106; FAIRMAN WA, 1995, NATURE, V375, P599, DOI 10.1038/375599a0; FUERST TR, 1986, P NATL ACAD SCI USA, V83, P8122, DOI 10.1073/pnas.83.21.8122; Grewer C, 2005, BIOCHEMISTRY-US, V44, P11913, DOI 10.1021/bi050987n; Groeneveld M, 2007, J MOL BIOL, V372, P565, DOI 10.1016/j.jmb.2007.06.067; Grunewald M, 1998, NEURON, V21, P623, DOI 10.1016/S0896-6273(00)80572-3; Grunewald M, 2000, J BIOL CHEM, V275, P9684, DOI 10.1074/jbc.275.13.9684; Huang ZJ, 2008, BIOPHYS J, V95, P2292, DOI 10.1529/biophysj.108.133421; KANAI Y, 1992, NATURE, V360, P467, DOI 10.1038/360467a0; KANNER BI, 1978, BIOCHEMISTRY-US, V17, P3949, DOI 10.1021/bi00612a011; Kavanaugh MP, 1997, J BIOL CHEM, V272, P1703, DOI 10.1074/jbc.272.3.1703; KEYNAN S, 1992, BIOCHEMISTRY-US, V31, P1974, DOI 10.1021/bi00122a011; Koch HP, 2007, J NEUROSCI, V27, P2943, DOI 10.1523/JNEUROSCI.0118-07.2007; Koch HP, 2005, J NEUROSCI, V25, P1730, DOI 10.1523/JNEUROSCI.4138-04.2005; Leary GP, 2007, J NEUROSCI, V27, P2938, DOI 10.1523/JNEUROSCI.4851-06.2007; Levy LM, 1998, J NEUROSCI, V18, P9620, DOI 10.1523/jneurosci.18-23-09620.1998; PINES G, 1992, NATURE, V360, P464, DOI 10.1038/360464a0; Qu SG, 2008, J BIOL CHEM, V283, P26391, DOI 10.1074/jbc.M802401200; Rosental N, 2006, J BIOL CHEM, V281, P27905, DOI 10.1074/jbc.M600331200; Seal RP, 1998, NEURON, V21, P1487, DOI 10.1016/S0896-6273(00)80666-2; Shrivastava IH, 2008, J BIOL CHEM, V283, P28680, DOI 10.1074/jbc.M800889200; Slotboom DJ, 1999, MICROBIOL MOL BIOL R, V63, P293, DOI 10.1128/MMBR.63.2.293-307.1999; Slotboom DJ, 1999, P NATL ACAD SCI USA, V96, P14282, DOI 10.1073/pnas.96.25.14282; STORCK T, 1992, P NATL ACAD SCI USA, V89, P10955, DOI 10.1073/pnas.89.22.10955; TANAKA K, 1993, NEUROSCI RES, V16, P149, DOI 10.1016/0168-0102(93)90082-2; Tao Z, 2006, J BIOL CHEM, V281, P10263, DOI 10.1074/jbc.M510739200; Tao Z, 2007, J GEN PHYSIOL, V129, P331, DOI 10.1085/jgp.200609678; Teichman S, 2007, J GEN PHYSIOL, V129, P527, DOI 10.1085/jgp.200609707; Teichman S, 2009, P NATL ACAD SCI USA, V106, P14297, DOI 10.1073/pnas.0904625106; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018; Zarbiv R, 1998, J BIOL CHEM, V273, P14231, DOI 10.1074/jbc.273.23.14231; Zerangue N, 1996, NATURE, V383, P634, DOI 10.1038/383634a0; Zhang XP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021288; Zhang YM, 1999, P NATL ACAD SCI USA, V96, P1710, DOI 10.1073/pnas.96.4.1710; Zhang YM, 1998, P NATL ACAD SCI USA, V95, P751, DOI 10.1073/pnas.95.2.751	43	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30961	10.1371/journal.pone.0030961	http://dx.doi.org/10.1371/journal.pone.0030961			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22292083	Green Published, Green Submitted, gold			2022-12-25	WOS:000301570600101
J	Ferguson, J; Arozarena, I; Ehrhardt, M; Wellbrock, C				Ferguson, J.; Arozarena, I.; Ehrhardt, M.; Wellbrock, C.			Combination of MEK and SRC inhibition suppresses melanoma cell growth and invasion	ONCOGENE			English	Article						melanoma; MEK; SRC; MMP-2; invasion; combination therapy	MMP-2 EXPRESSION; FACTOR RECEPTOR; KINASE; MIGRATION; ACTIVATION; DASATINIB; ADHESION; PROTEIN; RESISTANCE; INTEGRIN	The RAS-RAF-MEK-ERK pathway is deregulated in over 90% of malignant melanomas, and targeting MEK as a central kinase of this pathway is currently tested in clinical trials. However, dose-limiting side effects are observed, and MEK inhibitors that sufficiently reduce ERK activation in patients show a low clinical response. Apart from dose limitations, a reason for the low response to MEK targeting drugs is thought to be the upregulation of counteracting signalling cascades as a direct response to MEK inhibition. Therefore, understanding the biology of melanoma cells and the effects of MEK inhibition on these cells will help to identify new combinatorial approaches that are more potent and allow for lower concentrations of the drug being used. We have discovered that in melanoma cells MEK inhibition by selumetinib (AZD6244, ARRY-142886) or PD184352, while efficiently suppressing proliferation, stimulates increased invasiveness. Inhibition of MEK suppresses actin-cortex contraction and increases integrin-mediated adhesion. Most importantly, and surprisingly, MEK inhibition results in a significant increase in matrix metalloproteases (MMP)-2 and membrane-type 1-MMP expression. All together, MEK inhibition in melanoma cells induces a 'mesenchymal' phenotype that is characterised by protease-driven invasion. This mode of invasion is dependent on integrin-mediated adhesion, and because SRC kinases are the main regulators of this process, the SRC kinase inhibitor, saracatinib (AZD0530), completely abolished the MEK inhibitor-induced invasion. Moreover, the combination of saracatinib and selumetinib effectively suppressed the growth and invasion of melanoma cells in a 3D environment, suggesting that combined inhibition of MEK and SRC is a promising approach to improve the efficacy of targeting the ERK/MAP kinase pathway in melanoma. Oncogene (2013) 32, 86-96; doi:10.1038/onc.2012.25; published online 6 February 2012	[Ferguson, J.; Arozarena, I.; Ehrhardt, M.; Wellbrock, C.] Univ Manchester, Wellcome Trust Ctr Cell Matrix Res, Manchester M13 9PT, Lancs, England	University of Manchester	Wellbrock, C (corresponding author), Univ Manchester, Wellcome Trust Ctr Cell Matrix Res, Michael Smith Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	Claudia.Wellbrock@manchester.ac.uk	Arozarena, Imanol/A-5981-2017	Arozarena, Imanol/0000-0001-6349-2442; Wellbrock, Claudia/0000-0002-3825-6381	Cancer Research UK [C11591/A10202]	Cancer Research UK(Cancer Research UK)	We thank Astra Zeneca (Macclesfield) for providing us with selumetinib and saracatinib, John Humphries (Manchester) for providing help, advice and the reagents (MB13) for the integrin analyses, Chistoph Ballestrem (Manchester) for the vinculin antibody and Stephen Taylor (Manchester) for support with microscopy. This work was funded by Cancer Research UK (grant no C11591/A10202).	AKIYAMA SK, 1989, J CELL BIOL, V109, P863, DOI 10.1083/jcb.109.2.863; Arozarena I, 2011, ONCOGENE, V30, P4531, DOI 10.1038/onc.2011.162; Arozarena I, 2011, CANCER CELL, V19, P45, DOI 10.1016/j.ccr.2010.10.029; Bass MD, 2008, J CELL BIOL, V181, P1013, DOI 10.1083/jcb.200711129; Bollag G, 2010, NATURE, V467, P596, DOI 10.1038/nature09454; Boukerche H, 2008, P NATL ACAD SCI USA, V105, P15914, DOI 10.1073/pnas.0808171105; Brunton VG, 2008, CURR OPIN PHARMACOL, V8, P427, DOI 10.1016/j.coph.2008.06.012; Buettner R, 2008, MOL CANCER RES, V6, P1766, DOI 10.1158/1541-7786.MCR-08-0169; Carragher NO, 2006, ONCOGENE, V25, P5726, DOI 10.1038/sj.onc.1209582; Carragher NO, 2003, CURR BIOL, V13, P1442, DOI 10.1016/S0960-9822(03)00544-X; Dong MY, 2010, ANTICANCER RES, V30, P4405; Dummer R, 2008, J CLIN ONCOL, V26, DOI 10.1200/jco.2008.26.15_suppl.9033; Eustace AJ, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-53; Fackler OT, 2008, J CELL BIOL, V181, P879, DOI 10.1083/jcb.200802081; Fornier MN, 2011, ANN ONCOL, V22, P2575, DOI 10.1093/annonc/mdr018; Franco S, 2004, EXP CELL RES, V299, P179, DOI 10.1016/j.yexcr.2004.05.021; Friedl P, 1998, MICROSC RES TECHNIQ, V43, P369, DOI 10.1002/(SICI)1097-0029(19981201)43:5<369::AID-JEMT3>3.0.CO;2-6; Geissinger E, 2002, CANCER RES, V62, P4820; Glading A, 2004, MOL CELL BIOL, V24, P2499, DOI 10.1128/MCB.24.6.2499-2512.2004; Gopal YNV, 2010, CANCER RES, V70, P8736, DOI 10.1158/0008-5472.CAN-10-0902; Green TP, 2009, MOL ONCOL, V3, P248, DOI 10.1016/j.molonc.2009.01.002; Heidorn SJ, 2010, CELL, V140, P209, DOI 10.1016/j.cell.2009.12.040; Hennequin LF, 2006, J MED CHEM, V49, P6465, DOI 10.1021/jm060434q; Homsi J, 2009, MELANOMA RES, V19, P167, DOI 10.1097/CMR.0b013e328304974c; Huang JH, 2003, J BIOL CHEM, V278, P48367, DOI 10.1074/jbc.M308213200; Itoh Y, 2001, EMBO J, V20, P4782, DOI 10.1093/emboj/20.17.4782; Itoh Y, 2006, IUBMB LIFE, V58, P589, DOI 10.1080/15216540600962818; Johnson ML, 2011, J THORAC ONCOL, V6, P1128, DOI 10.1097/JTO.0b013e3182161508; Klemke RL, 1997, J CELL BIOL, V137, P481, DOI 10.1083/jcb.137.2.481; Kluger HM, 2011, CANCER-AM CANCER SOC, V117, P2202, DOI 10.1002/cncr.25766; Lee JH, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-116; Lee SH, 2010, ONCOGENE, V29, P5182, DOI 10.1038/onc.2010.251; Meierjohann S, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-201; Narumiya S, 2009, CANCER METAST REV, V28, P65, DOI 10.1007/s10555-008-9170-7; Playford MP, 2004, ONCOGENE, V23, P7928, DOI 10.1038/sj.onc.1208080; Pullikuth AK, 2010, MOL CELL BIOL, V30, P3233, DOI 10.1128/MCB.01178-09; Puzanov I, 2011, MOL ONCOL, V5, P116, DOI 10.1016/j.molonc.2011.01.005; Renouf DJ, 2010, INVEST NEW DRUGS; Sabeh F, 2009, J CELL BIOL, V185, P11, DOI 10.1083/jcb.200807195; Sahai E, 2003, NAT CELL BIOL, V5, P711, DOI 10.1038/ncb1019; Sanz-Moreno V, 2008, CELL, V135, P510, DOI 10.1016/j.cell.2008.09.043; Smalley KSM, 2006, MOL CANCER THER, V5, P1136, DOI 10.1158/1535-7163.MCT-06-0084; Tower GB, 2002, BBA-MOL BASIS DIS, V1586, P265, DOI 10.1016/S0925-4439(01)00105-3; Wellbrock C, 2002, J BIOL CHEM, V277, P6443, DOI 10.1074/jbc.M110684200; Wellbrock C, 2000, EUR J BIOCHEM, V267, P3513, DOI 10.1046/j.1432-1327.2000.01378.x; Wellbrock C, 2010, BIOCHEM PHARMACOL, V80, P561, DOI 10.1016/j.bcp.2010.03.019; Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006; Yan CH, 2002, J BIOL CHEM, V277, P10804, DOI 10.1074/jbc.M112069200; Yang JY, 2010, CANCER RES, V70, P4709, DOI 10.1158/0008-5472.CAN-09-4524; Yeh TC, 2007, CLIN CANCER RES, V13, P1576, DOI 10.1158/1078-0432.CCR-06-1150; Zhang DL, 2004, J BIOL CHEM, V279, P19683, DOI 10.1074/jbc.M313145200; Zheng YH, 2009, MOL CELL, V35, P11, DOI 10.1016/j.molcel.2009.06.013	52	50	52	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2013	32	1					86	96		10.1038/onc.2012.25	http://dx.doi.org/10.1038/onc.2012.25			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	063VG	22310287	Bronze, Green Accepted			2022-12-25	WOS:000313029500009
J	Lomberk, G; Mathison, AJ; Grzenda, A; Seo, S; Demars, CJ; Rizvi, S; Bonilla-Velez, J; Calvo, E; Fernandez-Zapico, ME; Iovanna, J; Buttar, NS; Urrutia, R				Lomberk, Gwen; Mathison, Angela J.; Grzenda, Adrienne; Seo, Seungmae; Demars, Cathrine J.; Rizvi, Sumera; Bonilla-Velez, Juliana; Calvo, Ezequiel; Fernandez-Zapico, Martin E.; Iovanna, Juan; Buttar, Navtej S.; Urrutia, Raul			Sequence-specific Recruitment of Heterochromatin Protein 1 via Interaction with Kruppel-like Factor 11, a Human Transcription Factor Involved in Tumor Suppression and Metabolic Diseases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZINC-FINGER PROTEINS; DROSOPHILA-MELANOGASTER; CHROMOSOMAL-PROTEIN; SHADOW DOMAIN; BINDING-SITE; HP1 PROTEINS; FACTOR KLF11; CELL-GROWTH; HISTONE H3; LYSINE 9	Heterochromatin protein 1 (HP1) proteins are "gatekeepers" of epigenetic gene silencing that is mediated by lysine 9 of histone H3 methylation (H3K9me). Current knowledge supports a paradigm whereby HP1 proteins achieve repression by binding to H3K9me marks and interacting to H3K9 histone methyltransferases (HMTs), such as SUV39H1, which methylate this residue on adjacent nucleosomes thereby compacting chromatin and silencing gene expression. However, the mechanism underlying the recruitment of this epigenetic regulator to target gene promoters remains poorly characterized. In the current study, we reveal for the first time a mechanism whereby HP1 is recruited to promoters by a well characterized Kruppel-like transcription factor (KLF), in a sequence-specific manner, to mediate complex biological phenomena. A PXVXL HP1-interacting domain identified at position 487-491 of KLF11 mediates the binding of HP1 alpha and KLF11 in vitro and in cultured cells. KLF11 also recruits HP1 alpha and its histone methyltransferase, SUV39H1, to promoters to limit KLF11-mediated gene activation. Indeed, a KLF11 Delta HP1 mutant derepresses KLF11-regulated cancer genes, by inhibiting HP1-SUV39H1 recruitment, decreasing H3K9me3, while increasing activation-associated marks. Biologically, impairment of KLF11-mediated HP1-HMT recruitment abolishes tumor suppression, providing direct evidence that HP1-HMTs act in a sequence-specific manner to achieve this function rather than its well characterized binding to methylated chromatin without intermediary. Collectively, these studies reveal a novel role for HP1 as a cofactor in tumor suppression, expand our mechanistic understanding of a KLF associated to human disease, and outline cellular and biochemical mechanisms underlying this phenomenon, increasing the specificity of targeting HP1-HMT complexes to gene promoters.	[Lomberk, Gwen; Urrutia, Raul] Mayo Clin, GI Res Unit, Dept Biochem & Mol Biol, Lab Epigenet & Chromatin Dynam,GIH Div, Rochester, MN 55905 USA; [Fernandez-Zapico, Martin E.] Mayo Clin, Schulze Ctr Novel Therapeut, Rochester, MN 55905 USA; [Calvo, Ezequiel] CHUL Res Ctr, Mol Endocrinol & Oncol Res Ctr, Quebec City, PQ 61V 462, Canada; [Iovanna, Juan] INSERM, U624, F-13288 Marseille, France	Mayo Clinic; Mayo Clinic; Laval University; Institut National de la Sante et de la Recherche Medicale (Inserm)	Lomberk, G (corresponding author), Mayo Clin, GI Res Unit, Dept Biochem & Mol Biol, Lab Epigenet & Chromatin Dynam,GIH Div, 200 1st St SW,Guggenheim 10, Rochester, MN 55905 USA.	lomberk.gwen@mayo.edu	Iovanna, Juan/M-9805-2017; Lomberk, Gwen/AAL-8490-2020; Grzenda, Adrienne L/K-4421-2019	Iovanna, Juan/0000-0003-1822-2237; Lomberk, Gwen/0000-0001-5463-789X; Grzenda, Adrienne L/0000-0001-5952-6953; Mathison, Angela/0000-0002-6763-2710; Seo, Seungmae/0000-0003-2175-6440	National Institutes of Health [DK52913, CA110022-01, DK76845, T32-CA148073, CA102701]; Mayo Foundation; Fraternal Order of Eagles; Mayo Clinic Center for Cell Signaling in Gastroenterology [P30DK084567]; NATIONAL CANCER INSTITUTE [T32CA148073, P20CA102701, P50CA102701, R03CA110022] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK076845, R56DK052913, P30DK084567, R01DK052913] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Foundation; Fraternal Order of Eagles; Mayo Clinic Center for Cell Signaling in Gastroenterology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK52913 (to R. U.), CA110022-01 and DK76845 (to N. S. B.), T32-CA148073 (to A. G.), and CA102701 (to M. E. F. Z.), the Mayo Foundation, and the Fraternal Order of Eagles (to G. L.) and the Mayo Clinic Center for Cell Signaling in Gastroenterology (P30DK084567).	AASLAND R, 1995, NUCLEIC ACIDS RES, V23, P3168; Badugu R, 2005, CHROMOSOMA, V113, P370, DOI 10.1007/s00412-004-0324-2; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Belbin TJ, 2002, CANCER RES, V62, P1184; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Bonnefond A, 2011, J BIOL CHEM, V286, P28414, DOI 10.1074/jbc.M110.215822; Brown JL, 2010, DEVELOPMENT, V137, P2597, DOI 10.1242/dev.047761; Brown JL, 2005, NUCLEIC ACIDS RES, V33, P5181, DOI 10.1093/nar/gki827; Buck A, 2006, MOL CANCER RES, V4, P861, DOI 10.1158/1541-7786.MCR-06-0081; Buttar N, 2009, GASTROENTEROLOGY, V136, pA83; Cammas F, 2002, J CELL SCI, V115, P3439; Cao S, 2005, J BIOL CHEM, V280, P1901, DOI 10.1074/jbc.M407941200; Chin HG, 2007, NUCLEIC ACIDS RES, V35, P7313, DOI 10.1093/nar/gkm726; Collado M, 2005, CELL CYCLE, V4, P1722, DOI 10.4161/cc.4.12.2260; Cong YS, 1999, HUM MOL GENET, V8, P137, DOI 10.1093/hmg/8.1.137; Cook T, 1999, J BIOL CHEM, V274, P29500, DOI 10.1074/jbc.274.41.29500; Cook T, 1998, J BIOL CHEM, V273, P25929, DOI 10.1074/jbc.273.40.25929; Dialynas GK, 2008, MUTAT RES-FUND MOL M, V647, P13, DOI 10.1016/j.mrfmmm.2008.09.007; EISSENBERG JC, 1990, P NATL ACAD SCI USA, V87, P9923, DOI 10.1073/pnas.87.24.9923; Emery DW, 2007, J CELL BIOCHEM, V100, P1045, DOI 10.1002/jcb.21093; Fernandez-Zapico ME, 2011, BIOCHEM J, V435, P529, DOI 10.1042/BJ20100773; Fernandez-Zapico ME, 2009, J BIOL CHEM, V284, P36482, DOI 10.1074/jbc.M109.028852; Fernandez-Zapico ME, 2003, EMBO J, V22, P4748, DOI 10.1093/emboj/cdg470; Fuks F, 2003, NUCLEIC ACIDS RES, V31, P2305, DOI 10.1093/nar/gkg332; Gebelein B, 1998, J CLIN INVEST, V102, P1911, DOI 10.1172/JCI1919; Gebhard C, 2006, CANCER RES, V66, P6118, DOI 10.1158/0008-5472.CAN-06-0376; Huang Y, 2006, STRUCTURE, V14, P703, DOI 10.1016/j.str.2006.01.007; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; JAMES TC, 1986, MOL CELL BIOL, V6, P3862, DOI 10.1128/MCB.6.11.3862; Kirschmann DA, 2000, CANCER RES, V60, P3359; Koike N, 2000, FEBS LETT, V467, P17, DOI 10.1016/S0014-5793(00)01105-4; Kondo T, 2000, HUM MOL GENET, V9, P597, DOI 10.1093/hmg/9.4.597; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lee MD, 2004, J CLIN INVEST, V114, P1107, DOI 10.1172/JCI200422269; Lomberk G, 2005, BIOCHEM J, V392, P1, DOI 10.1042/BJ20051234; Lomberk G, 2006, NAT CELL BIOL, V8, P407, DOI 10.1038/ncb1383; Lomberk G, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-228; Maison C, 2004, NAT REV MOL CELL BIO, V5, P296, DOI 10.1038/nrm1355; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Neve B, 2005, P NATL ACAD SCI USA, V102, P4807, DOI 10.1073/pnas.0409177102; Nielsen AL, 1999, EMBO J, V18, P6385, DOI 10.1093/emboj/18.22.6385; Nishimura K, 2006, ANTICANCER RES, V26, P4349; Potapova A, 2010, EUR J HAEMATOL, V84, P298, DOI 10.1111/j.1600-0609.2009.01389.x; Riclet R, 2009, MOL BIOL CELL, V20, P296, DOI 10.1091/mbc.E08-05-0510; Ryan RF, 1999, MOL CELL BIOL, V19, P4366; Smothers JF, 2000, CURR BIOL, V10, P27, DOI 10.1016/S0960-9822(99)00260-2; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Stephens GE, 2005, BIOCHEMISTRY-US, V44, P13394, DOI 10.1021/bi051006+; Sun XQ, 2010, CANCER METAST REV, V29, P709, DOI 10.1007/s10555-010-9256-x; Tell R, 2011, AM J PATHOL, V178, P672, DOI 10.1016/j.ajpath.2010.10.017; Truty MJ, 2009, J BIOL CHEM, V284, P6291, DOI 10.1074/jbc.M807791200; Uchida D, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-62; Wettenhall JM, 2006, BIOINFORMATICS, V22, P897, DOI 10.1093/bioinformatics/btl025; Zhang JS, 2001, MOL CELL BIOL, V21, P5041, DOI 10.1128/MCB.21.15.5041-5049.2001; Zhang RG, 2007, MOL CELL BIOL, V27, P2343, DOI 10.1128/MCB.02019-06; Zhao T, 2001, J BIOL CHEM, V276, P9512, DOI 10.1074/jbc.M010098200	57	43	44	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					13026	13039		10.1074/jbc.M112.342634	http://dx.doi.org/10.1074/jbc.M112.342634			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22318730	Green Published, hybrid			2022-12-25	WOS:000302903700041
J	Wienk, H; Tishchenko, E; Belardinelli, R; Tomaselli, S; Dongre, R; Spurio, R; Folkers, GE; Gualerzi, CO; Boelens, R				Wienk, Hans; Tishchenko, Evgeny; Belardinelli, Riccardo; Tomaselli, Simona; Dongre, Ramachandra; Spurio, Roberto; Folkers, Gert E.; Gualerzi, Claudio O.; Boelens, Rolf			Structural Dynamics of Bacterial Translation Initiation Factor IF2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELONGATION-FACTOR-G; ESCHERICHIA-COLI; BACILLUS-STEAROTHERMOPHILUS; BINDING-SITE; SIGNAL-TRANSDUCTION; PROTEIN-SYNTHESIS; SCALAR COUPLINGS; CHEMICAL-SHIFT; HYDROGEN-BONDS; G-DOMAIN	Bacterial translation initiation factor IF2 promotes ribosomal subunit association, recruitment, and binding of fMet-tRNA to the ribosomal P-site and initiation dipeptide formation. Here, we present the solution structures of GDP-bound and apo-IF2-G2 of Bacillus stearothermophilus and provide evidence that this isolated domain binds the 50 S ribosomal subunit and hydrolyzes GTP. Differences between the free and GDP-bound structures of IF2-G2 suggest that domain reorganization within the G2-G3-C1 regions underlies the different structural requirements of IF2 during the initiation process. However, these structural signals are unlikely forwarded from IF2-G2 to the C-terminal fMet-tRNA binding domain (IF2-C2) because the connected IF2-C1 and IF2-C2 modules show completely independent mobility, indicating that the bacterial interdomain connector lacks the rigidity that was found in the archaeal IF2 homolog aIF5B.	[Belardinelli, Riccardo; Spurio, Roberto; Gualerzi, Claudio O.] Univ Camerino, Genet Lab, Dept Biosci & Biotechnol, I-62032 Camerino, Macerata, Italy; [Wienk, Hans; Tishchenko, Evgeny; Tomaselli, Simona; Dongre, Ramachandra; Folkers, Gert E.; Boelens, Rolf] Univ Utrecht, Bijvoet Ctr Biomol Res, NMR Spect, NL-3584 CH Utrecht, Netherlands	University of Camerino; Utrecht University	Gualerzi, CO (corresponding author), Univ Camerino, Genet Lab, Dept Biosci & Biotechnol, I-62032 Camerino, Macerata, Italy.	claudio.gualerzi@unicam.it; r.boelens@uu.nl	Folkers, Gert E/C-2863-2009; Wienk, Hans/P-8929-2015; Boelens, Rolf/B-4702-2009; Belardinelli, Riccardo/I-4363-2013; tomaselli, simona/A-6075-2012	Folkers, Gert E/0000-0003-1070-0505; Wienk, Hans/0000-0001-9577-0064; Boelens, Rolf/0000-0002-6939-8913; Belardinelli, Riccardo/0000-0002-3333-0466; tomaselli, simona/0000-0002-8627-6838; Spurio, Roberto/0000-0002-7611-4341	European Union [RII3-026145, 261863]; Netherlands Foundation for Scientific Research; MIUR; European Community	European Union(European Commission); Netherlands Foundation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); MIUR(Ministry of Education, Universities and Research (MIUR)); European Community(European Commission)	This work was supported in part by European Union EU-NMR Contract RII3-026145, Bio-NMR Contract 261863, the Netherlands Foundation for Scientific Research, and MIUR-PRIN 2003 Grant (to C. O. G.).; Recipient of a Mary Curie fellowship from the European Community.	AEVARSSON A, 1994, EMBO J, V13, P3669, DOI 10.1002/j.1460-2075.1994.tb06676.x; Al-Karadaghi S, 1996, STRUCTURE, V4, P555, DOI 10.1016/S0969-2126(96)00061-5; Allen GS, 2005, CELL, V121, P703, DOI 10.1016/j.cell.2005.03.023; Antoun Ayman, 2004, Biol Proced Online, V6, P35, DOI 10.1251/bpo71; Boelens R, 2002, CURR PROTEIN PEPT SC, V3, P107, DOI 10.2174/1389203023380765; Caserta E, 2006, J MOL BIOL, V362, P787, DOI 10.1016/j.jmb.2006.07.043; Caserta E, 2010, J MOL BIOL, V396, P118, DOI 10.1016/j.jmb.2009.11.026; CENATIEMPO Y, 1987, BIOCHEMISTRY-US, V26, P5070, DOI 10.1021/bi00390a028; Cole R, 2003, J BIOMOL NMR, V26, P203, DOI 10.1023/A:1023808801134; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; de la Torre JG, 2000, J MAGN RESON, V147, P138, DOI 10.1006/jmre.2000.2170; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dosset P, 2000, J BIOMOL NMR, V16, P23, DOI 10.1023/A:1008305808620; Farrar CT, 1997, STRUCTURE, V5, P1055, DOI 10.1016/S0969-2126(97)00257-8; GIESSNERPRETTRE C, 1977, NUCLEIC ACIDS RES, V4, P99, DOI 10.1093/nar/4.1.99; Grigoriadou C, 2007, J MOL BIOL, V373, P562, DOI 10.1016/j.jmb.2007.07.032; Gualerzi CO, 2010, ISR J CHEM, V50, P80, DOI 10.1002/ijch.201000006; GUALERZI CO, 1991, J BIOL CHEM, V266, P16356; Guenneugues M, 2000, EMBO J, V19, P5233, DOI 10.1093/emboj/19.19.5233; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Houben K, 2004, J MOL BIOL, V344, P513, DOI 10.1016/j.jmb.2004.09.054; Ito Y, 1997, BIOCHEMISTRY-US, V36, P9109, DOI 10.1021/bi970296u; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Julian P, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001095; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; KRAULIS PJ, 1994, BIOCHEMISTRY-US, V33, P3515, DOI 10.1021/bi00178a008; Kyrpides NC, 1998, P NATL ACAD SCI USA, V95, P3726, DOI 10.1073/pnas.95.7.3726; LAALAMI S, 1991, J MOL BIOL, V220, P335, DOI 10.1016/0022-2836(91)90017-Z; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Laursen BS, 2005, MICROBIOL MOL BIOL R, V69, P101, DOI 10.1128/MMBR.69.1.101-123.2005; Linge JP, 2001, METHOD ENZYMOL, V339, P71, DOI 10.1016/S0076-6879(01)39310-2; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; Lohr F, 2000, J AM CHEM SOC, V122, P9289, DOI 10.1021/ja001345k; Luchin S, 1999, J BIOL CHEM, V274, P6074, DOI 10.1074/jbc.274.10.6074; Marintchev A, 2004, Q REV BIOPHYS, V37, P197, DOI 10.1017/S0033583505004026; Marintchev A, 2003, P NATL ACAD SCI USA, V100, P1535, DOI 10.1073/pnas.0437845100; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Marzi S, 2003, RNA, V9, P958, DOI 10.1261/rna.2116303; Meunier S, 2000, EMBO J, V19, P1918, DOI 10.1093/emboj/19.8.1918; MILBURN MV, 1990, SCIENCE, V247, P939, DOI 10.1126/science.2406906; Milon P, 2008, MOL CELL, V30, P712, DOI 10.1016/j.molcel.2008.04.014; Milon P, 2007, METHOD ENZYMOL, V430, P1, DOI 10.1016/S0076-6879(07)30001-3; Milon P, 2006, P NATL ACAD SCI USA, V103, P13962, DOI 10.1073/pnas.0606384103; Milon P, 2010, EMBO REP, V11, P312, DOI 10.1038/embor.2010.12; Mishima M, 2000, J AM CHEM SOC, V122, P5883, DOI 10.1021/ja000005w; Misselwitz R, 1997, BIOCHEMISTRY-US, V36, P3170, DOI 10.1021/bi962613n; Moreno JMP, 1999, FEBS LETT, V455, P130, DOI 10.1016/S0014-5793(99)00858-3; Myasnikov AG, 2005, NAT STRUCT MOL BIOL, V12, P1145, DOI 10.1038/nsmb1012; PON CL, 1985, J BIOL CHEM, V260, P8918; REDFIELD AG, 1990, BIOCHEMISTRY-US, V29, P3509, DOI 10.1021/bi00466a013; Roll-Mecak A, 2000, CELL, V103, P781, DOI 10.1016/S0092-8674(00)00181-1; SEVERINI M, 1991, J BIOL CHEM, V266, P22800; Simonetti A, 2008, NATURE, V455, P416, DOI 10.1038/nature07192; Song HW, 1999, J MOL BIOL, V285, P1245, DOI 10.1006/jmbi.1998.2387; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; Spurio R, 2000, J BIOL CHEM, V275, P2447, DOI 10.1074/jbc.275.4.2447; Szkaradkiewicz K, 2000, EUR J BIOCHEM, V267, P4290, DOI 10.1046/j.1432-1327.2000.01480.x; Tomsic J, 2000, EMBO J, V19, P2127, DOI 10.1093/emboj/19.9.2127; Unbehaun A, 2007, EMBO J, V26, P3109, DOI 10.1038/sj.emboj.7601751; VACHON G, 1990, BIOCHEMISTRY-US, V29, P9728, DOI 10.1021/bi00493a031; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Wienk H, 2005, PROTEIN SCI, V14, P2461, DOI 10.1110/ps.051531305; Wijmenga SS, 1998, PROG NUCL MAG RES SP, V32, P287, DOI 10.1016/S0079-6565(97)00023-X; WISHART DS, 1994, J BIOMOL NMR, V4, P171	65	21	21	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					10922	10932		10.1074/jbc.M111.333393	http://dx.doi.org/10.1074/jbc.M111.333393			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22308033	Green Published, hybrid			2022-12-25	WOS:000302780100021
J	Pohleven, J; Renko, M; Magister, S; Smith, DF; Kunzler, M; Strukelj, B; Turk, D; Kos, J; Sabotic, J				Pohleven, Jure; Renko, Miha; Magister, Spela; Smith, David F.; Kuenzler, Markus; Strukelj, Borut; Turk, Dusan; Kos, Janko; Sabotic, Jerica			Bivalent Carbohydrate Binding Is Required for Biological Activity of Clitocybe nebularis Lectin (CNL), the N, N '-Diacetyllactosediamine (GalNAc beta 1-4GlcNAc, LacdiNAc)-specific Lectin from Basidiomycete C. nebularis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE PROTEASE INHIBITORS; SITE-DIRECTED MUTAGENESIS; CRYSTAL-STRUCTURE; MARASMIUS-OREADES; MACROMOLECULAR STRUCTURES; COPRINOPSIS-CINEREA; SECONDARY-STRUCTURE; STRUCTURAL BASIS; HIGHER FUNGI; T-CELLS	Lectins are carbohydrate-binding proteins that exert their biological activity by binding to specific cell glycoreceptors. We have expressed CNL, a ricin B-like lectin from the basidiomycete Clitocybe nebularis in Escherichia coli. The recombinant lectin, rCNL, agglutinates human blood group A erythrocytes and is specific for the unique glycan N, N'-diacetyllactosediamine (GalNAc beta 1-4GlcNAc, LacdiNAc) as demonstrated by glycan microarray analysis. We here describe the crystal structures of rCNL in complex with lactose and LacdiNAc, defining its interactions with the sugars. CNL is a homodimeric lectin, each of whose monomers consist of a single ricin B lectin domain with its beta-trefoil fold and one carbohydrate-binding site. To study the mode of CNL action, a nonsugar-binding mutant and nondimerizing monovalent CNL mutants that retain carbohydrate-binding activity were prepared. rCNL and the mutants were examined for their biological activities against Jurkat human leukemic T cells and the hypersensitive nematode Caenorhabditis elegans mutant strain pmk-1. rCNL was toxic against both, although the mutants were inactive. Thus, the bivalent carbohydrate-binding property of homodimeric CNL is essential for its activity, providing one of the rare pieces of evidence that certain activities of lectins are associated with their multivalency.	[Pohleven, Jure; Magister, Spela; Strukelj, Borut; Kos, Janko; Sabotic, Jerica] Jozef Stefan Inst, Dept Biotechnol, SI-1000 Ljubljana, Slovenia; [Renko, Miha; Turk, Dusan] Jozef Stefan Inst, Dept Biochem & Mol & Struct Biol, SI-1000 Ljubljana, Slovenia; [Renko, Miha; Turk, Dusan] Ctr Excellence CIPKeBiP, SI-1000 Ljubljana, Slovenia; [Smith, David F.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; [Kuenzler, Markus] ETH, Inst Microbiol, Dept Biol, CH-8093 Zurich, Switzerland; [Strukelj, Borut; Kos, Janko] Univ Ljubljana, Fac Pharm, SI-1000 Ljubljana, Slovenia	Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; Emory University; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Ljubljana	Pohleven, J (corresponding author), Jozef Stefan Inst, Dept Biotechnol, Jamova 39, SI-1000 Ljubljana, Slovenia.	jure.pohleven@ijs.si	Sabotič, Jerica/AAJ-5050-2021	Sabotič, Jerica/0000-0002-2404-0192; Turk, Dusan/0000-0003-0205-6609; Kunzler, Markus/0000-0003-1275-0629	Research Agency of the Republic of Slovenia [P4-0127, J4-4123, P1-0048, PR-02266]; ETH Zurich; Swiss National Science Foundation [31003A-130671]; National Institutes of Health NIGMS [GM62116]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062116] Funding Source: NIH RePORTER	Research Agency of the Republic of Slovenia(Slovenian Research Agency - Slovenia); ETH Zurich(ETH Zurich); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Institutes of Health NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Research Agency of the Republic of Slovenia Grants P4-0127 and J4-4123 (to J. K.) and Grants P1-0048 and PR-02266 (to D. T.), ETH Zurich, and Swiss National Science Foundation Grant 31003A-130671 (to M. K.).; We thank Dr. Joze Brzin (Dept. of Biotechnology, Jozef Stefan Institute, Ljubljana, Slovenia) for assistance with the work on lectins; Prof. Roger H. Pain (Dept. of Biotechnology, Jozef Stefan Institute, Ljubljana, Slovenia) for assistance with CD spectroscopy analysis and for critical review of the manuscript; Dr. Dusan Zigon (Dept. of Environmental Sciences, Jozef Stefan Institute, Ljubljana, Slovenia) for performing the mass spectrometry analysis; Silvia Bleuler-Martinez (Dept. of Biology, Institute of Microbiology, ETH, Zurich, Switzerland) for technical assistance with nematode biotoxicity assays; and Dr. Jamie Heimburg-Molinaro (Dept. of Biochemistry, Emory University School of Medicine, Atlanta, GA) for work on glycan microarrays. The glycan microarray analyses were conducted in collaboration with the Protein-Carbohydrate Interaction Core H, and the carbohydrate compound LDN was provided by the Carbohydrate Synthesis/Protein Expression Core, both of the Consortium for Functional Glycomics funded by National Institutes of Health NIGMS Grant GM62116.	Adams L, 1996, BBA-MOL CELL RES, V1312, P137, DOI 10.1016/0167-4889(96)00031-6; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; AGO H, 1991, J BIOCHEM-TOKYO, V110, P360, DOI 10.1093/oxfordjournals.jbchem.a123586; Andrejasic M, 2008, ACTA CRYSTALLOGR D, V64, P1093, DOI 10.1107/S0907444908027388; Bleuler-Martinez S, 2011, MOL ECOL, V20, P3056, DOI 10.1111/j.1365-294X.2011.05093.x; Butschi A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000717; Candy L, 2001, BIOCHEM BIOPH RES CO, V282, P655, DOI 10.1006/bbrc.2001.4626; Chavez LL, 2006, P NATL ACAD SCI USA, V103, P10254, DOI 10.1073/pnas.0510110103; Goldstein IJ, 2007, COMPREHENSIVE GLYCOS, V3, P601; Grahn E, 2007, J MOL BIOL, V369, P710, DOI 10.1016/j.jmb.2007.03.016; GRAVES BJ, 1990, BIOCHEMISTRY-US, V29, P2679, DOI 10.1021/bi00463a009; Guillot J, 1997, BIOCHEM SYST ECOL, V25, P203, DOI 10.1016/S0305-1978(96)00110-X; Hazes B, 1996, PROTEIN SCI, V5, P1490, DOI 10.1002/pro.5560050805; Hirano K., 2009, Patent No. [International PatentWO2010064683, 2010064683]; Huang J, 2007, MOL CANCER RES, V5, P543, DOI 10.1158/1541-7786.MCR-06-0431; Kadirvelraj R, 2011, GLYCOBIOLOGY, V21, P973, DOI 10.1093/glycob/cwr030; Kidric M, 2002, BIOCHEM BIOPH RES CO, V297, P962, DOI 10.1016/S0006-291X(02)02328-8; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Kunzler M, 2010, METHOD ENZYMOL, V480, P141, DOI 10.1016/S0076-6879(10)80007-2; Machado E, 2011, GLYCOBIOLOGY, V21, P376, DOI 10.1093/glycob/cwq170; Mancheno JM, 2005, J BIOL CHEM, V280, P17251, DOI 10.1074/jbc.M413933200; MONTFORT W, 1987, J BIOL CHEM, V262, P5398; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Navaza J, 1997, METHOD ENZYMOL, V276, P581, DOI 10.1016/S0076-6879(97)76079-8; Olsnes S, 2004, TOXICON, V44, P361, DOI 10.1016/j.toxicon.2004.05.003; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pace KE, 1999, J IMMUNOL, V163, P3801; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; PEUMANS WJ, 1995, PLANT PHYSIOL, V109, P347, DOI 10.1104/pp.109.2.347; Pohleven J, 2011, APPL MICROBIOL BIOT, V91, P1141, DOI 10.1007/s00253-011-3236-0; Pohleven J, 2009, BBA-GEN SUBJECTS, V1790, P173, DOI 10.1016/j.bbagen.2008.11.006; Renko M, 2010, J BIOL CHEM, V285, P308, DOI 10.1074/jbc.M109.043331; RUTENBER E, 1987, NATURE, V326, P624, DOI 10.1038/326624a0; Saarinen J, 2003, Patent No. [WO/2003/016464, 2003016464]; Sabotic J, 2007, PROTEIN EXPRES PURIF, V53, P104, DOI 10.1016/j.pep.2006.11.015; Sabotic J, 2012, J BIOL CHEM, V287, P3898, DOI 10.1074/jbc.M111.285304; Sabotic J, 2009, FEBS J, V276, P4334, DOI 10.1111/j.1742-4658.2009.07138.x; Sacchettini JC, 2001, BIOCHEMISTRY-US, V40, P3009, DOI 10.1021/bi002544j; Sasaki N, 2007, BIOCHEM BIOPH RES CO, V354, P522, DOI 10.1016/j.bbrc.2007.01.015; Smith DF, 2010, METHOD ENZYMOL, V480, P417, DOI 10.1016/S0076-6879(10)80033-3; Song HK, 1998, J MOL BIOL, V275, P347, DOI 10.1006/jmbi.1997.1469; Sulzenbacher G, 2010, J MOL BIOL, V400, P715, DOI 10.1016/j.jmb.2010.05.038; TAHIROV TH, 1995, J MOL BIOL, V250, P354, DOI 10.1006/jmbi.1995.0382; Tateno H, 2004, ARCH BIOCHEM BIOPHYS, V427, P101, DOI 10.1016/j.abb.2004.04.013; Turk D., 1992, THESIS TU MUNCHEN GE; van den Berg TK, 2004, J IMMUNOL, V173, P1902, DOI 10.4049/jimmunol.173.3.1902; VANDENEIJNDEN DH, 1995, BIOCHEM SOC T, V23, P175, DOI 10.1042/bst0230175; Varki A., 1999, ESSENTIALS GLYCOBIOL; Vas V, 2005, STEM CELLS, V23, P279, DOI 10.1634/stemcells.2004-0084; Walti MA, 2008, J MOL BIOL, V379, P146, DOI 10.1016/j.jmb.2008.03.062; WEINER MP, 1994, PCR METH APPL, V4, pS131; Wohlschlager T, 2011, J BIOL CHEM, V286, P30337, DOI 10.1074/jbc.M111.258202; WOODY RW, 1994, EUR BIOPHYS J BIOPHY, V23, P253, DOI 10.1007/BF00213575	53	46	49	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					10602	10612		10.1074/jbc.M111.317263	http://dx.doi.org/10.1074/jbc.M111.317263			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22298779	Green Published, hybrid			2022-12-25	WOS:000302167200085
J	Zhu, NL; Asahina, K; Wang, J; Ueno, A; Lazaro, R; Miyaoka, Y; Miyajima, A; Tsukamoto, H				Zhu, Nian-Ling; Asahina, Kinji; Wang, Jiaohong; Ueno, Akiko; Lazaro, Raul; Miyaoka, Yuichiro; Miyajima, Atsushi; Tsukamoto, Hidekazu			Hepatic Stellate Cell-derived Delta-like Homolog 1 (DLK1) Protein in Liver Regeneration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXPERIMENTAL MELANOMA METASTASIS; ADIPOCYTE DIFFERENTIATION; RAT HEPATOCYTES; RECEPTOR; PREF-1; ACTIVATION; ADIPOGENESIS; EXPRESSION; GENE; HETEROGENEITY	Hepatic stellate cells (HSCs) undergo myofibroblastic activation in liver fibrosis and regeneration. This phenotypic switch is mechanistically similar to dedifferentiation of adipocytes as such the necdin-Wnt pathway causes epigenetic repression of the master adipogenic gene Ppar gamma, to activate HSCs. Now we report that delta-like 1 homolog (DLK1) is expressed selectively in HSCs in the adult rodent liver and induced in liver fibrosis and regeneration. Dlk1 knockdown in activated HSCs, causes suppression of necdin and Wnt, epigenetic derepression of Ppar gamma, and morphologic and functional reversal to quiescent cells. Hepatic Dlk1 expression is induced 40-fold at 24 h after partial hepatectomy (PH) in mice. HSCs and hepatocytes (HCs) isolated from the regenerating liver show Dlk1 induction in both cell types. In HC and HSC co-culture, increased proliferation and Dlk1 expression by HCs from PH are abrogated with anti-DLK1 antibody (Ab). Dlk1 and Wnt10b expression by Sham HCs are increased by co-culture with PH HSCs, and these effects are abolished with anti-DLK Ab. A tail vein injection of anti-DLK1 Ab at 6 h after PH reduces early HC proliferation and liver growth, accompanied by decreased Wnt10b, nonphosphorylated beta-catenin, p-beta-catenin (Ser-552), cyclins (cyclin D and cyclin A), cyclin-dependent kinases (CDK4, and CDK1/2), p-ERK1/2, and p-AKT. In the mouse developing liver, HSC precursors and HSCs express high levels of Dlk1, concomitant with Dlk1 expression by hepatoblasts. These results suggest novel roles of HSC-derived DLK1 in activating HSCs via epigenetic Ppar gamma repression and participating in liver regeneration and development in a manner involving the mesenchymal-epithelial interaction.	[Zhu, Nian-Ling; Asahina, Kinji; Wang, Jiaohong; Ueno, Akiko; Lazaro, Raul; Tsukamoto, Hidekazu] Univ So Calif, Dept Pathol, Keck Sch Med, Los Angeles, CA 90033 USA; [Zhu, Nian-Ling; Asahina, Kinji; Wang, Jiaohong; Ueno, Akiko; Lazaro, Raul; Tsukamoto, Hidekazu] Univ So Calif, So Calif Res Ctr Alcohol Liver & Pancreat Dis & C, Los Angeles, CA 90033 USA; [Miyaoka, Yuichiro; Miyajima, Atsushi] Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1138656, Japan; [Tsukamoto, Hidekazu] Greater Los Angeles Healthcare Syst, Dept Vet Affairs, Los Angeles, CA 90073 USA	University of Southern California; University of Southern California; University of Tokyo	Tsukamoto, H (corresponding author), Univ So Calif, Dept Pathol, Keck Sch Med, 1333 San Pablo St,MMR-402, Los Angeles, CA 90033 USA.	htsukamo@usc.edu	Asahina, Kinji/X-8794-2019	Asahina, Kinji/0000-0003-0398-8395; Miyaoka, Yuichiro/0000-0002-8874-4738	National Institutes of Health [P50AA011999, R24AA012885, U01AA018663, RC2AA019392, R01AA020753]; Medical Research Service of the Department of Veterans Affairs; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U01AA018663, R01AA020753, R24AA012885, P50AA011999, RC2AA019392] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Service of the Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grants P50AA011999 (to H. T.), R24AA012885 (to H. T.), U01AA018663 (to H. T.), RC2AA019392 (to H. T.), and R01AA020753 (to K. A.). This work was also supported by the Medical Research Service of the Department of Veterans Affairs (to H. T.).	Abdallah BM, 2011, J BONE MINER RES, V26, P1457, DOI 10.1002/jbmr.346; Abdallah BM, 2004, J BONE MINER RES, V19, P841, DOI 10.1359/JBMR.040118; Asahina K, 2002, AM J PATHOL, V160, P2191, DOI 10.1016/S0002-9440(10)61167-4; Asahina K, 2011, HEPATOLOGY, V53, P983, DOI 10.1002/hep.24119; Asahina K, 2009, HEPATOLOGY, V49, P998, DOI 10.1002/hep.22721; Asai K, 2006, LIVER INT, V26, P595, DOI 10.1111/j.1478-3231.2006.01267.x; Bauer SR, 1998, MOL CELL BIOL, V18, P5247, DOI 10.1128/MCB.18.9.5247; Brenner David A, 2009, Trans Am Clin Climatol Assoc, V120, P361; Cheng JH, 2008, AM J PHYSIOL-GASTR L, V294, pG39, DOI 10.1152/ajpgi.00263.2007; ENZAN H, 1994, HEPATOLOGY, V19, P895, DOI 10.1016/0270-9139(94)90289-5; Floridon C, 2000, DIFFERENTIATION, V66, P49, DOI 10.1046/j.1432-0436.2000.066001049.x; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; Garces C, 1999, DIFFERENTIATION, V64, P103, DOI 10.1007/s002580050265; Hazra S, 2004, J BIOL CHEM, V279, P11392, DOI 10.1074/jbc.M310284200; Higashi N, 2005, ANAT REC PART A, V286A, P899, DOI 10.1002/ar.a.20230; Kawaguchi D, 2008, DEVELOPMENT, V135, P3849, DOI 10.1242/dev.024570; Kim Y, 2009, CANCER RES, V69, P9271, DOI 10.1158/0008-5472.CAN-09-1605; Machida K, 2009, P NATL ACAD SCI USA, V106, P1548, DOI 10.1073/pnas.0807390106; Magness ST, 2004, HEPATOLOGY, V40, P1151, DOI 10.1002/hep.20427; MAHER JJ, 1988, J CLIN INVEST, V82, P450, DOI 10.1172/JCI113618; Mann J, 2010, GASTROENTEROLOGY, V138, P705, DOI 10.1053/j.gastro.2009.10.002; Miyahara T, 2000, J BIOL CHEM, V275, P35715, DOI 10.1074/jbc.M006577200; Moon YS, 2002, MOL CELL BIOL, V22, P5585, DOI 10.1128/MCB.22.15.5585-5592.2002; Nueda ML, 2008, J MOL BIOL, V379, P428, DOI 10.1016/j.jmb.2008.03.070; Olaso E, 1997, HEPATOLOGY, V26, P634, DOI 10.1053/jhep.1997.v26.pm0009303493; Olaso E, 2003, HEPATOLOGY, V37, P674, DOI 10.1053/jhep.2003.50068; Pan RL, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.194498; Passino MA, 2007, SCIENCE, V315, P1853, DOI 10.1126/science.1137603; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Sanchez-Solana B, 2011, BBA-MOL CELL RES, V1813, P1153, DOI 10.1016/j.bbamcr.2011.03.004; She HY, 2005, J BIOL CHEM, V280, P4959, DOI 10.1074/jbc.M410078200; Smas CM, 1998, J BIOL CHEM, V273, P31751, DOI 10.1074/jbc.273.48.31751; Smas CM, 1997, MOL CELL BIOL, V17, P977, DOI 10.1128/MCB.17.2.977; SMAS CM, 1994, BIOCHEMISTRY-US, V33, P9257, DOI 10.1021/bi00197a029; SMAS CM, 1993, CELL, V73, P725, DOI 10.1016/0092-8674(93)90252-L; Sung CK, 2004, AM J PHYSIOL-GASTR L, V286, pG722, DOI 10.1152/ajpgi.00411.2003; Tanimizu N, 2003, J CELL SCI, V116, P1775, DOI 10.1242/jcs.00388; Tokairin T, 2002, J HEPATOL, V36, P725, DOI 10.1016/S0168-8278(02)00048-X; Wang YH, 2006, MOL CELL BIOL, V26, P5421, DOI 10.1128/MCB.02437-05; Wang YH, 2010, MOL CELL BIOL, V30, P3480, DOI 10.1128/MCB.00057-10; Watanabe S, 1998, BIOCHEM BIOPH RES CO, V250, P486, DOI 10.1006/bbrc.1998.9339; Xiong SG, 2003, J BIOL CHEM, V278, P17646, DOI 10.1074/jbc.M210905200; Yanai H, 2010, J BIOCHEM, V148, P85, DOI 10.1093/jb/mvq034; Yang L, 2008, J HEPATOL, V48, P98, DOI 10.1016/j.jhep.2007.07.032; Zhu NL, 2010, J BIOL CHEM, V285, P30463, DOI 10.1074/jbc.M110.156703	45	64	67	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					10355	10367		10.1074/jbc.M111.312751	http://dx.doi.org/10.1074/jbc.M111.312751			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22298767	hybrid, Green Published			2022-12-25	WOS:000302167200063
J	El-Shamy, A; Shoji, I; Kim, SR; Ide, Y; Imoto, S; Deng, L; Yoon, S; Fujisawa, T; Tani, S; Yano, Y; Seo, Y; Azuma, T; Hotta, H				El-Shamy, Ahmed; Shoji, Ikuo; Kim, Soo-Ryang; Ide, Yoshihiro; Imoto, Susumu; Deng, Lin; Yoon, Seitetsu; Fujisawa, Takashi; Tani, Satoshi; Yano, Yoshihiko; Seo, Yasushi; Azuma, Takeshi; Hotta, Hak			Sequence Heterogeneity in NS5A of Hepatitis C Virus Genotypes 2a and 2b and Clinical Outcome of Pegylated-Interferon/Ribavirin Therapy	PLOS ONE			English	Article							NONSTRUCTURAL PROTEIN 5A; SUSTAINED VIROLOGICAL RESPONSE; SENSITIVITY-DETERMINING REGION; ACID SUBSTITUTION PATTERN; VIRAL LOAD; COMBINATION THERAPY; PLUS RIBAVIRIN; MUTATIONS; 1B; ASSOCIATION	Pegylated-interferon plus ribavirin (PEG-IFN/RBV) therapy is a current standard treatment for chronic hepatitis C. We previously reported that the viral sequence heterogeneity of part of NS5A, referred to as the IFN/RBV resistance-determining region (IRRDR), and a mutation at position 70 of the core protein of hepatitis C virus genotype 1b (HCV-1b) are significantly correlated with the outcome of PEG-IFN/RBV treatment. Here, we aimed to investigate the impact of viral genetic variations within the NS5A and core regions of other genotypes, HCV-2a and HCV-2b, on PEG-IFN/RBV treatment outcome. Pretreatment sequences of NS5A and core regions were analyzed in 112 patients infected with HCV-2a or HCV-2b, who were treated with PEG-IFN/RBV for 24 weeks and followed up for another 24 weeks. The results demonstrated that HCV-2a isolates with 4 or more mutations in IRRDR (IRRDR[2a]>= 4) was significantly associated with rapid virological response at week 4 (RVR) and sustained virological response (SVR). Also, another region of NS5A that corresponds to part of the IFN sensitivity-determining region (ISDR) plus its carboxy-flanking region, which we referred to as ISDR/+C[2a], was significantly associated with SVR in patients infected with HCV-2a. Multivariate analysis revealed that IRRDR[2a]>= 4 was the only independent predictive factor for SVR. As for HCV-2b infection, an N-terminal half of IRRDR having two or more mutations (IRRDR[2b]/N >= 2) was significantly associated with RVR, but not with SVR. No significant correlation was observed between core protein polymorphism and PEG-IFN/RBV treatment outcome in HCV-2a or HCV-2b infection. Conclusion: The present results suggest that sequence heterogeneity of NS5A of HCV-2a (IRRDR[2a]>= 4 and ISDR/+C[2a]), and that of HCV-2b (IRRDR[2b]/N >= 2) to a lesser extent, is involved in determining the viral sensitivity to PEG-IFN/RBV therapy.	[El-Shamy, Ahmed; Shoji, Ikuo; Ide, Yoshihiro; Deng, Lin; Hotta, Hak] Kobe Univ, Grad Sch Med, Ctr Infect Dis, Div Microbiol, Kobe, Hyogo 657, Japan; [El-Shamy, Ahmed] Suez Canal Univ, Dept Virol, Fac Vet Med, Ismailia, Egypt; [Kim, Soo-Ryang; Imoto, Susumu] Kobe Asahi Hosp, Div Gastroenterol, Kobe, Hyogo, Japan; [Yoon, Seitetsu] Hyogo Prefectural Kakogawa Med Ctr, Dept Gastroenterol, Kakogawa, Hyogo, Japan; [Fujisawa, Takashi] Nippon Steel Hirohata Hosp, Dept Internal Med, Himeji, Hyogo, Japan; [Tani, Satoshi] Konan Hosp, Dept Internal Med, Kobe, Hyogo, Japan; [Yano, Yoshihiko; Seo, Yasushi; Azuma, Takeshi] Kobe Univ, Grad Sch Med, Dept Internal Med, Div Gastroenterol, Kobe, Hyogo 657, Japan	Kobe University; Egyptian Knowledge Bank (EKB); Suez Canal University; Kobe University	El-Shamy, A (corresponding author), Kobe Univ, Grad Sch Med, Ctr Infect Dis, Div Microbiol, Kobe, Hyogo 657, Japan.	hotta@kobe-u.ac.jp	Shoji, Ikuo/Y-7079-2019	Shoji, Ikuo/0000-0002-0730-4379; El-Shamy, Ahmed/0000-0002-6045-5889	Ministry of Health, Labour and Welfare, Japan; Ministry of Education, Culture, Sports, Science and Technology, Japan; Japan Science and Technology Agency; Japan International Cooperation Agency	Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Japan International Cooperation Agency	This study was supported in part by Health and Labour Sciences Research Grants from the Ministry of Health, Labour and Welfare, Japan, a J-GRID grant from the Ministry of Education, Culture, Sports, Science and Technology, Japan, and a SATREPS Grant from Japan Science and Technology Agency and Japan International Cooperation Agency. This study was also carried out as part of the Global Center of Excellence program of Kobe University Graduate School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akuta N, 2003, J MED VIROL, V69, P376, DOI 10.1002/jmv.10299; Akuta N, 2007, J HEPATOL, V46, P403, DOI 10.1016/j.jhep.2006.09.019; Akuta N, 2009, INTERVIROLOGY, V52, P301, DOI 10.1159/000235909; Alestig E, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-124; Chung RT, 1999, J MED VIROL, V58, P353, DOI 10.1002/(SICI)1096-9071(199908)58:4&lt;353::AID-JMV6&gt;3.0.CO;2-C; Donlin MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009032; Duverlie G, 1998, J GEN VIROL, V79, P1373, DOI 10.1099/0022-1317-79-6-1373; El-Shamy A, 2008, HEPATOLOGY, V48, P38, DOI 10.1002/hep.22339; El-Shamy A, 2007, MICROBIOL IMMUNOL, V51, P471, DOI 10.1111/j.1348-0421.2007.tb03922.x; El-Shamy A, 2012, INTERVIROLOGY, V55, P1, DOI 10.1159/000322219; ENOMOTO N, 1990, BIOCHEM BIOPH RES CO, V170, P1021, DOI 10.1016/0006-291X(90)90494-8; Enomoto N, 1996, NEW ENGL J MED, V334, P77, DOI 10.1056/NEJM199601113340203; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Hughes M, 2009, J VIROL, V83, P10788, DOI 10.1128/JVI.02406-08; Kadokura M, 2011, HEPATOL INT, V5, P789, DOI 10.1007/s12072-011-9267-x; Kau A, 2008, J HEPATOL, V49, P634, DOI 10.1016/j.jhep.2008.07.013; Limaye AR, 2011, NEW ENGL J MED, V365, P176, DOI 10.1056/NEJMc1105515; Lusida MI, 2001, J CLIN MICROBIOL, V39, P3858, DOI 10.1128/JCM.39.11.3858-3864.2001; Macdonald A, 2004, J GEN VIROL, V85, P2485, DOI 10.1099/vir.0.80204-0; Micallef JM, 2006, J VIRAL HEPATITIS, V13, P34, DOI 10.1111/j.1365-2893.2005.00651.x; Moradpour D, 2004, J VIROL, V78, P7400, DOI 10.1128/JVI.78.14.7400-7409.2004; Murakami T, 1999, HEPATOLOGY, V30, P1045, DOI 10.1002/hep.510300405; OKAMOTO H, 1992, J GEN VIROL, V73, P673, DOI 10.1099/0022-1317-73-3-673; OKAMOTO H, 1992, VIROLOGY, V188, P331, DOI 10.1016/0042-6822(92)90762-E; OKAMOTO H, 1991, J GEN VIROL, V72, P2697, DOI 10.1099/0022-1317-72-11-2697; Pascu M, 2004, GUT, V53, P1345, DOI 10.1136/gut.2003.031336; Sakamoto N, 2011, J MED VIROL, V83, P871, DOI 10.1002/jmv.22038; Sarasin-Filipowicz M, 2010, SWISS MED WKLY, V140, P3, DOI smw-12670; Sarrazin C, 2000, J INFECT DIS, V181, P432, DOI 10.1086/315263; Sherman KE, 2011, NEW ENGL J MED, V365, P1014, DOI 10.1056/NEJMoa1014463; Squadrito G, 1999, J HEPATOL, V30, P1023, DOI 10.1016/S0168-8278(99)80255-4; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Tellinghuisen TL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000032; Tsai YH, 2008, J HEPATOL, V85, P2485; Yuan HJ, 2010, J VIRAL HEPATITIS, V17, P208, DOI 10.1111/j.1365-2893.2009.01169.x; Zeuzem S, 1997, HEPATOLOGY, V25, P740, DOI 10.1002/hep.510250341	38	16	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2012	7	2							e30513	10.1371/journal.pone.0030513	http://dx.doi.org/10.1371/journal.pone.0030513			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UV	22319571	gold, Green Published, Green Submitted			2022-12-25	WOS:000301979000008
J	Salzman, J; Gawad, C; Wang, PL; Lacayo, N; Brown, PO				Salzman, Julia; Gawad, Charles; Wang, Peter Lincoln; Lacayo, Norman; Brown, Patrick O.			Circular RNAs Are the Predominant Transcript Isoform from Hundreds of Human Genes in Diverse Cell Types	PLOS ONE			English	Article							MESSENGER-RNA; MOUSE TESTIS; EXON; SRY; EXPRESSION	Most human pre-mRNAs are spliced into linear molecules that retain the exon order defined by the genomic sequence. By deep sequencing of RNA from a variety of normal and malignant human cells, we found RNA transcripts from many human genes in which the exons were arranged in a non-canonical order. Statistical estimates and biochemical assays provided strong evidence that a substantial fraction of the spliced transcripts from hundreds of genes are circular RNAs. Our results suggest that a non-canonical mode of RNA splicing, resulting in a circular RNA isoform, is a general feature of the gene expression program in human cells.	[Salzman, Julia; Gawad, Charles; Wang, Peter Lincoln; Brown, Patrick O.] Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA; [Brown, Patrick O.] Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA; [Gawad, Charles; Lacayo, Norman] Stanford Univ, Dept Pediat Hematol Oncol, Sch Med, Stanford, CA 94305 USA	Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University	Salzman, J (corresponding author), Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA.	pbrown@stanford.edu	Gawad, Charles/AAP-5448-2021; wang, peter/AAD-5851-2020; Gawad, Charles/N-8073-2018	Gawad, Charles/0000-0002-4728-8203	Canary Foundation, Howard Hughes Medical Institute; Debra; Andrew Rachleff Endowed Fellowship	Canary Foundation, Howard Hughes Medical Institute; Debra; Andrew Rachleff Endowed Fellowship	Funding provided by the Canary Foundation, Howard Hughes Medical Institute. CG's salary was paid by the Debra and Andrew Rachleff Endowed Fellowship. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Balool HH, 2011, GENOME RES; Bailleul B, 1996, NUCLEIC ACIDS RES, V24, P1015, DOI 10.1093/nar/24.6.1015; Burd CE, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001233; Caldas C, 1998, GENE, V208, P167, DOI 10.1016/S0378-1119(97)00640-9; CAO QP, 1995, MOL REPROD DEV, V40, P196, DOI 10.1002/mrd.1080400208; CAPEL B, 1993, CELL, V73, P1019, DOI 10.1016/0092-8674(93)90279-Y; CHEN CY, 1995, SCIENCE, V268, P415, DOI 10.1126/science.7536344; COCQUERELLE C, 1992, EMBO J, V11, P1095, DOI 10.1002/j.1460-2075.1992.tb05148.x; COCQUERELLE C, 1993, FASEB J, V7, P155, DOI 10.1096/fasebj.7.1.7678559; de la Mata M, 2010, RNA, V16, P904, DOI 10.1261/rna.1993510; Dixon RJ, 2005, NUCLEIC ACIDS RES, V33, P5904, DOI 10.1093/nar/gki893; HACKER A, 1995, DEVELOPMENT, V121, P1603; Hansen TB, 2011, EMBO J, V30, P4414, DOI 10.1038/emboj.2011.359; Houseley JM, 2006, J HERED, V97, P253, DOI 10.1093/jhered/esj037; HSU MT, 1979, NATURE, V280, P339, DOI 10.1038/280339a0; JESKE YWA, 1995, NAT GENET, V10, P480, DOI 10.1038/ng0895-480; Li XF, 1999, J BIOL CHEM, V274, P8153, DOI 10.1074/jbc.274.12.8153; NIGRO JM, 1991, CELL, V64, P607, DOI 10.1016/0092-8674(91)90244-S; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; Saad Fawzy, 1992, Human Molecular Genetics, V1, P345, DOI 10.1093/hmg/1.5.345; Salzman J, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001156; Schindewolf C, 1996, NUCLEIC ACIDS RES, V24, P1260, DOI 10.1093/nar/24.7.1260; Shao XA, 2006, BIOINFORMATICS, V22, P692, DOI 10.1093/bioinformatics/bti795; Surono A, 1999, HUM MOL GENET, V8, P493, DOI 10.1093/hmg/8.3.493; Suzuki H, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl151; Yang L, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r16; Zaphiropoulos PG, 1997, MOL CELL BIOL, V17, P2985, DOI 10.1128/MCB.17.6.2985; Zaphiropoulos PG, 1996, P NATL ACAD SCI USA, V93, P6536, DOI 10.1073/pnas.93.13.6536	28	1604	1762	10	227	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2012	7	2							e30733	10.1371/journal.pone.0030733	http://dx.doi.org/10.1371/journal.pone.0030733			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UG	22319583	Green Published, gold, Green Submitted			2022-12-25	WOS:000301977500016
J	Sun, L; Xing, YL; Chen, XJ; Zheng, Y; Yang, YD; Nichols, DB; Clementz, MA; Banach, BS; Li, K; Baker, SC; Chen, ZB				Sun, Li; Xing, Yaling; Chen, Xiaojuan; Zheng, Yang; Yang, Yudong; Nichols, Daniel B.; Clementz, Mark A.; Banach, Bridget S.; Li, Kui; Baker, Susan C.; Chen, Zhongbin			Coronavirus Papain-like Proteases Negatively Regulate Antiviral Innate Immune Response through Disruption of STING-Mediated Signaling	PLOS ONE			English	Article							RESPIRATORY SYNDROME CORONAVIRUS; MOUSE HEPATITIS-VIRUS; RIG-I; ADAPTER PROTEIN; INTERFERON INDUCTION; 5'-TRIPHOSPHATE RNA; TARGET GENES; RECOGNITION; UBIQUITINATION; REPLICATION	Viruses have evolved elaborate mechanisms to evade or inactivate the complex system of sensors and signaling molecules that make up the host innate immune response. Here we show that human coronavirus (HCoV) NL63 and severe acute respiratory syndrome (SARS) CoV papain-like proteases (PLP) antagonize innate immune signaling mediated by STING (stimulator of interferon genes, also known as MITA/ERIS/MYPS). STING resides in the endoplasmic reticulum and upon activation, forms dimers which assemble with MAVS, TBK-1 and IKK epsilon, leading to IRF-3 activation and subsequent induction of interferon (IFN). We found that expression of the membrane anchored PLP domain from human HCoV-NL63 (PLP2-TM) or SARS-CoV (PLpro-TM) inhibits STING-mediated activation of IRF-3 nuclear translocation and induction of IRF-3 dependent promoters. Both catalytically active and inactive forms of CoV PLPs co-immunoprecipitated with STING, and viral replicase proteins co-localize with STING in HCoV-NL63-infected cells. Ectopic expression of catalytically active PLP2-TM blocks STING dimer formation and negatively regulates assembly of STING-MAVS-TBK1/IKK epsilon complexes required for activation of IRF-3. STING dimerization was also substantially reduced in cells infected with SARS-CoV. Furthermore, the level of ubiquitinated forms of STING, RIG-I, TBK1 and IRF-3 are reduced in cells expressing wild type or catalytic mutants of PLP2-TM, likely contributing to disruption of signaling required for IFN induction. These results describe a new mechanism used by CoVs in which CoV PLPs negatively regulate antiviral defenses by disrupting the STING-mediated IFN induction.	[Sun, Li; Xing, Yaling; Chen, Xiaojuan; Zheng, Yang; Yang, Yudong; Chen, Zhongbin] Beijing Inst Radiat Med, Dept Electromagnet & Laser Biol, Div Infect & Immun, Beijing, Peoples R China; [Nichols, Daniel B.; Clementz, Mark A.; Banach, Bridget S.; Baker, Susan C.] Loyola Univ Chicago, Stritch Sch Med, Dept Microbiol & Immunol, Maywood, IL USA; [Li, Kui] Univ Tennessee, Hlth Sci Ctr, Dept Microbiol Immunol & Biochem, Memphis, TN USA	Academy of Military Medical Sciences - China; Loyola University Chicago; University of Tennessee System; University of Tennessee Health Science Center	Sun, L (corresponding author), Beijing Inst Radiat Med, Dept Electromagnet & Laser Biol, Div Infect & Immun, Beijing, Peoples R China.	sbaker1@lumc.edu; chenzb@bmi.ac.cn			National Natural Science Foundation of China [30972761, 30870536, 81172799]; Beijing Natural Science Foundation [7092075]; National ST Major Project [2008ZX10004-015]; Chinese National High-Tech R&D Program ("863" Program) [2006AA02Z412]; National Institutes of Health, USA [AI060915]; U.S. Department of Defense [W81XWH-09-01-0391]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI060915, R01AI085089] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); National ST Major Project; Chinese National High-Tech R&D Program ("863" Program)(National High Technology Research and Development Program of China); National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Defense(United States Department of Defense); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	National Natural Science Foundation of China (No. 30972761, No. 30870536, No. 81172799 to ZC), Beijing Natural Science Foundation (No. 7092075 to ZC) and National S&T Major Project (2008ZX10004-015 to ZC) and Chinese National High-Tech R&D Program ("863" Program) (2006AA02Z412 to ZC), and the National Institutes of Health, USA (AI060915 to SCB), and the U.S. Department of Defense (W81XWH-09-01-0391 to KL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen J, 2008, GENES IMMUN, V9, P168, DOI 10.1038/sj.gene.6364449; Banach BS, 2009, J VIROL METHODS, V156, P19, DOI 10.1016/j.jviromet.2008.10.022; Barral PM, 2009, PHARMACOL THERAPEUT, V124, P219, DOI 10.1016/j.pharmthera.2009.06.012; Bhoj VG, 2009, NATURE, V458, P430, DOI 10.1038/nature07959; Bibeau-Poirier A, 2008, CYTOKINE, V43, P359, DOI 10.1016/j.cyto.2008.07.012; Bowie AG, 2008, NAT REV IMMUNOL, V8, P911, DOI 10.1038/nri2436; Cervantes-Barragan L, 2007, BLOOD, V109, P1131, DOI 10.1182/blood-2006-05-023770; Chen ZB, 2007, J VIROL, V81, P6007, DOI 10.1128/JVI.02747-06; Chen ZH, 2007, J VIROL, V81, P964, DOI 10.1128/JVI.02076-06; Clementz MA, 2010, J VIROL, V84, P4619, DOI 10.1128/JVI.02406-09; Coornaert B, 2009, J BIOL CHEM, V284, P8217, DOI 10.1074/jbc.R800032200; Devaraj SG, 2007, J BIOL CHEM, V282, P32208, DOI 10.1074/jbc.M704870200; Friedman CS, 2008, EMBO REP, V9, P930, DOI 10.1038/embor.2008.136; Frieman M, 2009, J VIROL, V83, P6689, DOI 10.1128/JVI.02220-08; Gosert R, 2002, J VIROL, V76, P3697, DOI 10.1128/JVI.76.8.3697-3708.2002; Grandvaux N, 2002, J VIROL, V76, P5532, DOI 10.1128/JVI.76.11.5532-5539.2002; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Isaacson MK, 2009, CELL HOST MICROBE, V5, P559, DOI 10.1016/j.chom.2009.05.012; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Jin L, 2008, MOL CELL BIOL, V28, P5014, DOI 10.1128/MCB.00640-08; Kawai T, 2007, J BIOCHEM, V141, P137, DOI 10.1093/jb/mvm032; Kayagaki N, 2007, SCIENCE, V318, P1628, DOI 10.1126/science.1145918; Knoops K, 2008, PLOS BIOL, V6, P1957, DOI 10.1371/journal.pbio.0060226; Kopecky-Bromberg SA, 2007, J VIROL, V81, P548, DOI 10.1128/JVI.01782-06; Li JF, 2010, J VIROL, V84, P6472, DOI 10.1128/JVI.00016-10; Li XD, 2005, P NATL ACAD SCI USA, V102, P17717, DOI 10.1073/pnas.0508531102; Lin RT, 2006, J VIROL, V80, P6072, DOI 10.1128/JVI.02495-05; Lindner HA, 2005, J VIROL, V79, P15199, DOI 10.1128/JVI.79.24.15199-15208.2005; Loo YM, 2006, P NATL ACAD SCI USA, V103, P6001, DOI 10.1073/pnas.0601523103; Lu XL, 2011, VIRUS GENES, V42, P37, DOI 10.1007/s11262-010-0544-x; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Narayananj K, 2008, J VIROL, V82, P4471, DOI 10.1128/JVI.02472-07; Perlman S, 2009, NAT REV MICROBIOL, V7, P439, DOI 10.1038/nrmicro2147; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Ratia K, 2006, P NATL ACAD SCI USA, V103, P5717, DOI 10.1073/pnas.0510851103; Ratia K, 2008, P NATL ACAD SCI USA, V105, P16119, DOI 10.1073/pnas.0805240105; Rehwinkel J, 2010, CELL, V140, P397, DOI 10.1016/j.cell.2010.01.020; Rose KM, 2010, J VIROL, V84, P5656, DOI 10.1128/JVI.00211-10; Roth-Cross JK, 2008, J VIROL, V82, P9829, DOI 10.1128/JVI.01199-08; Schmidt A, 2009, P NATL ACAD SCI USA, V106, P12067, DOI 10.1073/pnas.0900971106; Seth RB, 2006, CELL RES, V16, P141, DOI 10.1038/sj.cr.7310019; Sheahan T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000240; Shembade N, 2010, SCIENCE, V327, P1135, DOI 10.1126/science.1182364; Siu KL, 2009, J BIOL CHEM, V284, P16202, DOI 10.1074/jbc.M109.008227; Spiegel M, 2005, J VIROL, V79, P2079, DOI 10.1128/JVI.79.4.2079-2086.2005; Stertz S, 2007, VIROLOGY, V361, P304, DOI 10.1016/j.virol.2006.11.027; Sun WX, 2009, P NATL ACAD SCI USA, V106, P8653, DOI 10.1073/pnas.0900850106; van der Hoek L, 2005, PLOS MED, V2, P764, DOI 10.1371/journal.pmed.0020240; Versteeg GA, 2007, VIROLOGY, V361, P18, DOI 10.1016/j.virol.2007.01.020; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Xia ZP, 2009, NATURE, V461, P114, DOI 10.1038/nature08247; Yang Y, 2007, P NATL ACAD SCI USA, V104, P7253, DOI 10.1073/pnas.0611506104; Yoneyama M, 2009, IMMUNOL REV, V227, P54, DOI 10.1111/j.1600-065X.2008.00727.x; Zeng WW, 2010, CELL, V141, P315, DOI 10.1016/j.cell.2010.03.029; Zhang MY, 2008, J BIOL CHEM, V283, P18621, DOI 10.1074/jbc.M801451200; Zhao JC, 2010, J VIROL, V84, P9318, DOI 10.1128/JVI.01049-10; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003; Zhou HX, 2007, J VIROL, V81, P568, DOI 10.1128/JVI.01512-06	59	189	207	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2012	7	2							e30802	10.1371/journal.pone.0030802	http://dx.doi.org/10.1371/journal.pone.0030802			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UG	22312431	gold, Green Published, Green Submitted			2022-12-25	WOS:000301977500018
J	Wu, CL; Wu, JC; Huang, WC; Wu, HTH; Chiou, HJ; Liu, L; Chen, YC; Chen, TJ; Cheng, H; Chang, CY				Wu, Ching-Lan; Wu, Jau-Ching; Huang, Wen-Cheng; Wu, Hung-Ta H.; Chiou, Hong-Jen; Liu, Laura; Chen, Yu-Chun; Chen, Tzeng-Ji; Cheng, Henrich; Chang, Cheng-Yen			The Risk of Stroke after Percutaneous Vertebroplasty for Osteoporosis: A Population-Based Cohort Study	PLOS ONE			English	Article							VERTEBRAL COMPRESSION FRACTURES; PULMONARY CEMENT EMBOLISM; BONE-MINERAL DENSITY; RANDOMIZED-TRIAL; ISCHEMIC-STROKE; EPIDEMIOLOGY; INCREASES; OUTCOMES; LEAKAGE; BODY	Purpose: To investigate the incidence and risk of stroke after percutaneous vertebroplasty in patients with osteoporosis. Methods: A group of 334 patients with osteoporosis, and who underwent percutaneous vertebroplasty during the study period, was compared to 1,655 age-, sex- and propensity score-matched patients who did not undergo vertebroplasty. All demographic covariates and co-morbidities were deliberately matched between the two groups to avoid selection bias. Every subject was followed-up for up to five years for stroke. Adjustments using a Cox regression model and Kaplan-Meier analyses were conducted. Results: A total of 1,989 osteoporotic patients were followed up for 3,760.13 person-years. Overall, the incidence rates of any stroke, hemorrhagic stroke and ischemic stroke were 22.6, 4.2 and 19.6 per 1,000 person-years, respectively. Patients who underwent vertebroplasty were not more likely to have any stroke (crude hazard ratio = 1.13, p = 0.693), hemorrhagic stroke (HR = 2.21, p = 0.170), or ischemic stroke (HR = 0.96, p = 0.90). After adjusting for demographics, co-morbidities and medications, the vertebroplasty group had no significant difference with the comparison group in terms of any, hemorrhagic and ischemic strokes (adjusted HR = 1.22, 3.17, and 0.96, p = 0.518, 0.055, and 0.91, respectively). Conclusions: Osteoporotic patients who undergo percutaneous vertebroplasty are not at higher risk of any stroke in the next five years after the procedure.	[Wu, Ching-Lan; Wu, Hung-Ta H.; Chiou, Hong-Jen; Chang, Cheng-Yen] Taipei Vet Gen Hosp, Dept Radiol, Taipei, Taiwan; [Wu, Jau-Ching; Huang, Wen-Cheng; Cheng, Henrich] Taipei Vet Gen Hosp, Neurol Inst, Dept Neurosurg, Taipei, Taiwan; [Wu, Jau-Ching; Huang, Wen-Cheng; Wu, Hung-Ta H.; Chiou, Hong-Jen; Cheng, Henrich; Chang, Cheng-Yen] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Wu, Jau-Ching; Cheng, Henrich] Natl Yang Ming Univ, Inst Pharmacol, Taipei 112, Taiwan; [Liu, Laura] Chang Gung Mem Hosp, Dept Ophthalmol, Tao Yuan, Taiwan; [Liu, Laura] Chang Gung Univ, Coll Med, Tao Yuan, Taiwan; [Chen, Yu-Chun] Natl Yang Ming Univ Hosp, Dept Med Res & Educ, Ilan, Taiwan; [Chen, Tzeng-Ji] Natl Yang Ming Univ, Sch Med, Inst Hosp & Hlth Care Adm, Taipei 112, Taiwan	Taipei Veterans General Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Chang Gung Memorial Hospital; Chang Gung University; National Yang Ming Chiao Tung University	Wu, CL (corresponding author), Taipei Vet Gen Hosp, Dept Radiol, Taipei, Taiwan.	yuchn.chen@googlemail.com	Wu, Jau-Ching/AAU-4009-2021; Chen, Yu-Chun/B-1227-2012; Chen, TJ/AAH-8430-2021; Chen, YuChun/L-1052-2019; Chen, Yu Chun/K-6635-2019	Wu, Jau-Ching/0000-0002-6996-3409; Chen, Yu-Chun/0000-0002-4124-1949; Chen, YuChun/0000-0002-4124-1949; Huang, Wen-Cheng/0000-0003-4249-710X				Amar AP, 2001, NEUROSURGERY, V49, P1105, DOI 10.1097/00006123-200111000-00017; Baumann A, 2006, EUR J VASC ENDOVASC, V31, P558, DOI 10.1016/j.ejvs.2005.11.008; BONITA R, 1992, LANCET, V339, P342, DOI 10.1016/0140-6736(92)91658-U; Brown DL, 2008, CEREBROVASC DIS, V25, P95, DOI 10.1159/000111997; Buchbinder R, 2010, SPINE J, V10, P241, DOI 10.1016/j.spinee.2010.01.001; Buchbinder R, 2009, NEW ENGL J MED, V361, P557, DOI 10.1056/NEJMoa0900429; Burton Allen W, 2005, Neurosurg Focus, V18, pe1; Cheng CL, 2010, PHARMACOEPIDEMIOL DR; Cortet B, 1999, J RHEUMATOL, V26, P2222; delPuente A, 1996, OSTEOPOROSIS INT, V6, P50, DOI 10.1007/BF01626538; Dennis MS, 2002, STROKE, V33, P728, DOI 10.1161/hs0302.103621; Do HM, 2005, AM J NEURORADIOL, V26, P1623; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Feigin VL, 2005, LANCET, V365, P2160, DOI 10.1016/S0140-6736(05)66755-4; Goldstein LB, 2006, STROKE, V37, P1583, DOI 10.1161/01.STR.0000223048.70103.F1; Goldstein LB, 2011, STROKE, V42, P517, DOI 10.1161/STR.0b013e3181fcb238; Halfon P, 2002, J CLIN EPIDEMIOL, V55, P573, DOI 10.1016/S0895-4356(01)00521-2; Ho JD, 2009, STROKE, V40, P2685, DOI 10.1161/STROKEAHA.109.554642; Ho JD, 2009, AM J OPHTHALMOL, V147, P283, DOI 10.1016/j.ajo.2008.08.006; Kallmes DF, 2009, NEW ENGL J MED, V361, P569, DOI 10.1056/NEJMoa0900563; Kang JH, 2011, STROKE, V42, P336, DOI 10.1161/STROKEAHA.110.595538; Kanis J, 2001, STROKE, V32, P702, DOI 10.1161/01.STR.32.3.702; Kim YJ, 2009, RADIOLOGY, V251, P250, DOI 10.1148/radiol.2511080854; Klazen CAH, 2010, LANCET, V376, P1085, DOI 10.1016/S0140-6736(10)60954-3; Lee MJ, 2009, SPINE, V34, P1228, DOI 10.1097/BRS.0b013e3181a3c742; Lim JB, 2009, J KOREAN NEUROSURG S, V45, P386, DOI 10.3340/jkns.2009.45.6.386; Lin EP, 2004, AM J NEURORADIOL, V25, P175; Lin HC, 2008, STROKE, V39, P2744, DOI 10.1161/STROKEAHA.108.519090; Lin HC, 2010, NEUROLOGY, V74, P792, DOI 10.1212/WNL.0b013e3181d31e5c; Luetmer MT, 2011, AM J NEURORADIOL, V32, P654, DOI 10.3174/ajnr.A2368; Marden FA, 2008, AM J NEURORADIOL, V29, P1986, DOI 10.3174/ajnr.A1159; Pang MYC, 2005, OSTEOPOROSIS INT, V16, P1769, DOI 10.1007/s00198-005-1925-1; Poole KES, 2002, STROKE, V33, P1432, DOI 10.1161/01.STR.0000014510.48897.7D; Ramnemark A, 1998, OSTEOPOROSIS INT, V8, P92, DOI 10.1007/s001980050053; Rollinghoff M, 2010, ACTA ORTHOP BELG, V76, P269; Sheu JJ, 2010, STROKE, V41, P244, DOI 10.1161/STROKEAHA.109.567735; Syed MI, 2006, AM J NEURORADIOL, V27, P343; Teng MMH, 2006, AM J NEURORADIOL, V27, P224; Watts NB, 2001, OSTEOPOROSIS INT, V12, P429, DOI 10.1007/s001980170086; Wen CP, 2008, ANN INTERN MED, V148, P258, DOI 10.7326/0003-4819-148-4-200802190-00004; Wu JC, 2011, NEUROSURG FOCUS, V30, DOI 10.3171/2010.12.FOCUS10268; Wu JC, 2011, J NEUROTRAUMA; Yang YW, 2011, STROKE, V42, P319, DOI 10.1161/STROKEAHA.110.596361	43	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2012	7	1							e31405	10.1371/journal.pone.0031405	http://dx.doi.org/10.1371/journal.pone.0031405			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	912BY	22303486	gold, Green Submitted, Green Published			2022-12-25	WOS:000301770700012
J	Saulnier, N; Guihard, S; Holy, X; Decembre, E; Jurdic, P; Clay, D; Feuillet, V; Pages, G; Pouyssegur, J; Porteu, F; Gaudry, M				Saulnier, Nathalie; Guihard, Soizic; Holy, Xavier; Decembre, Elodie; Jurdic, Pierre; Clay, Denis; Feuillet, Vincent; Pages, Gilles; Pouyssegur, Jacques; Porteu, Francoise; Gaudry, Murielle			ERK1 Regulates the Hematopoietic Stem Cell Niches	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; MAP KINASE; BONE; DIFFERENTIATION; ACTIVATION; RECEPTOR; KNOCKOUT; HETEROGENEITY; OSTEOPETROSIS; OSTEOCLASTS	The mitogen-activated protein kinases (MAPK) ERK1 and ERK2 are among the major signal transduction molecules but little is known about their specific functions in vivo. ERK activity is provided by two isoforms, ERK1 and ERK2, which are ubiquitously expressed and share activators and substrates. However, there are not in vivo studies which have reported a role for ERK1 or ERK2 in HSCs and the bone marrow microenvironment. The present study shows that the ERK1-deficient mice present a mild osteopetrosis phenotype. The lodging and the homing abilities of the ERK1(-/-) HSC are impaired, suggesting that the ERK1(-/-)-defective environment may affect the engrafment of HSCs. Serial transplantations demonstrate that ERK1 is involved in the maintenance of an appropriate medullar microenvironment, but that the intrinsic properties of HSCs are not altered by the ERK1(-/-) defective microenvironment. Deletion of ERK1 impaired in vitro and in vivo osteoclastogenesis while osteoblasts were unaffected. As osteoclasts derive from precursors of the monocyte/macrophage lineage, investigation of the monocytic compartment was performed. In vivo analysis of the myeloid lineage progenitors revealed that the frequency of CMPs increased by approximately 1.3-fold, while the frequency of GMPs significantly decreased by almost 2-fold, compared with the respective WT compartments. The overall mononuclear-phagocyte lineage development was compromised in these mice due to a reduced expression of the M-CSF receptor on myeloid progenitors. These results show that the cellular targets of ERK1 are M-CSFR-responsive cells, upstream to osteoclasts. While ERK1 is well known to be activated by M-CSF, the present results are the first to point out an ERK1-dependent M-CSFR regulation on hematopoietic progenitors. This study reinforces the hypothesis of an active cross-talk between HSCs, their progeny and bone cells in the maintenance of the homeostasis of these compartments.	[Saulnier, Nathalie; Guihard, Soizic; Feuillet, Vincent; Porteu, Francoise; Gaudry, Murielle] Univ Paris 05, Inst Cochin, CNRS, UMR 8104, Paris, France; [Saulnier, Nathalie; Guihard, Soizic; Feuillet, Vincent; Porteu, Francoise; Gaudry, Murielle] INSERM, U1016, Paris, France; [Holy, Xavier] IRBA IMASSA, Serv Histol & Reparat Tissulaire, Bretigny Sur Orge, France; [Decembre, Elodie; Jurdic, Pierre] Univ Lyon 1, Inst Genom Fonct Lyon, CNRS, INRA,Ecole Normale Super Lyon, F-69365 Lyon, France; [Clay, Denis] Hop Paul Brousse, Inst Andre Lwoff, INSERM, U972, Villejuif, France; [Pages, Gilles; Pouyssegur, Jacques] Univ Nice, Inst Rech Signalisat Biol Dev & Canc, F-06108 Nice 2, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur	Saulnier, N (corresponding author), Univ Paris 05, Inst Cochin, CNRS, UMR 8104, Paris, France.	murielle.gaudry@inserm.fr	PORTEU, Françoise/I-8445-2016; Gaudry, Murielle/N-5934-2018; Pages, Gilles/N-7135-2017; Feuillet, Vincent/P-4988-2017	PORTEU, Françoise/0000-0002-2403-4163; Feuillet, Vincent/0000-0003-1898-2527; Saulnier, Nathalie/0000-0003-0159-8414; Gaudry, Murielle/0000-0002-9281-2334; Decembre, Elodie/0000-0001-6891-6320	Agence Nationale pour la Recherche [ANR-08-BLAN-0332]; Ministere de l'Enseignement Superieur et de la Recherche; Institut National de la sante et de la recherche medicale (INSERM); Association pour la Recherche contre le Cancer [SFI20101201698]; Ligue Contre le Cancer, comite d'Ile de France [RS11/75-24]; Institut National du Cancer (CSHLE) [2008 INCa]	Agence Nationale pour la Recherche(French National Research Agency (ANR)); Ministere de l'Enseignement Superieur et de la Recherche(Estonian Research Council); Institut National de la sante et de la recherche medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); Ligue Contre le Cancer, comite d'Ile de France; Institut National du Cancer (CSHLE)	NS is a recipient of a fellowship from the Agence Nationale pour la Recherche (ANR-08-BLAN-0332). SG is a recipient of a fellowship from the Ministere de l'Enseignement Superieur et de la Recherche. This work was supported by Institut National de la sante et de la recherche medicale (INSERM) and grants from the Agence Nationale pour la Recherche (ANR-08-BLAN-0332), the Association pour la Recherche contre le Cancer (SFI20101201698), the Ligue Contre le Cancer, comite d'Ile de France (RS11/75-24) and the Institut National du Cancer (CSHLE 2008 INCa). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams GB, 2006, NATURE, V439, P599, DOI 10.1038/nature04247; Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557; Bost F, 2005, DIABETES, V54, P402, DOI 10.2337/diabetes.54.2.402; BOYCE BF, 1992, J CLIN INVEST, V90, P1622, DOI 10.1172/JCI116032; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Chan AS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007955; Chow A, 2011, J EXP MED, V208, P261, DOI 10.1084/jem.20101688; Dacquin R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026627; Dai XM, 2002, BLOOD, V99, P111, DOI 10.1182/blood.V99.1.111; Fichelson S, 1999, BLOOD, V94, P1601, DOI 10.1182/blood.V94.5.1601.417k19_1601_1613; Foudi A, 2006, BLOOD, V107, P2243, DOI 10.1182/blood-2005-02-0581; Glantschnig H, 2003, CELL DEATH DIFFER, V10, P1165, DOI 10.1038/sj.cdd.4401285; Glenn G, 2008, FEBS LETT, V582, P911, DOI 10.1016/j.febslet.2008.02.029; Gowen M, 1999, J BONE MINER RES, V14, P1654, DOI 10.1359/jbmr.1999.14.10.1654; GRIGORIADIS AE, 1994, SCIENCE, V266, P443, DOI 10.1126/science.7939685; Guihard S, 2010, BLOOD, V115, P3686, DOI 10.1182/blood-2009-09-242487; He YZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024780; Hodge JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021462; HOFSTETTER W, 1992, P NATL ACAD SCI USA, V89, P9637, DOI 10.1073/pnas.89.20.9637; Hsu CL, 2007, BLOOD, V110, P1420, DOI 10.1182/blood-2007-02-071761; Iwasaki H, 2007, IMMUNITY, V26, P726, DOI 10.1016/j.immuni.2007.06.004; Jones DL, 2008, NAT REV MOL CELL BIO, V9, P11, DOI 10.1038/nrm2319; KODAMA H, 1991, J EXP MED, V173, P269, DOI 10.1084/jem.173.1.269; Kohyama M, 2009, NATURE, V457, P318, DOI 10.1038/nature07472; Kollet O, 2006, NAT MED, V12, P657, DOI 10.1038/nm1417; Kong YY, 1999, NATURE, V402, P304, DOI 10.1038/35005552; Lo Celso C, 2011, J CELL SCI, V124, P3529, DOI 10.1242/jcs.074112; Matsuo K, 2008, ARCH BIOCHEM BIOPHYS, V473, P201, DOI 10.1016/j.abb.2008.03.027; Mazzucchelli C, 2002, NEURON, V34, P807, DOI 10.1016/S0896-6273(02)00716-X; Miranda MB, 2005, LEUKEMIA RES, V29, P1293, DOI 10.1016/j.leukres.2005.03.016; Nagata Y, 1998, BLOOD, V92, P1859, DOI 10.1182/blood.V92.6.1859.418k37_1859_1869; Nutt SL, 2005, J EXP MED, V201, P221, DOI 10.1084/jem.20041535; Pages G, 1999, SCIENCE, V286, P1374, DOI 10.1126/science.286.5443.1374; Ponomaryov T, 2000, J CLIN INVEST, V106, P1331, DOI 10.1172/JCI10329; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Rouyez MC, 1997, MOL CELL BIOL, V17, P4991, DOI 10.1128/MCB.17.9.4991; Saltel F, 2004, MOL BIOL CELL, V15, P5231, DOI 10.1091/mbc.E04-06-0522; Sarma U, 1996, BLOOD, V88, P2531, DOI 10.1182/blood.V88.7.2531.bloodjournal8872531; SHERR CJ, 1990, BLOOD, V75, P1; Shivtiel S, 2008, J EXP MED, V205, P2381, DOI 10.1084/jem.20080072; Stier S, 2005, J EXP MED, V201, P1781, DOI 10.1084/jem.20041992; Taylor PR, 2003, EUR J IMMUNOL, V33, P2090, DOI 10.1002/eji.200324003; Trumpp A, 2010, NAT REV IMMUNOL, V10, P201, DOI 10.1038/nri2726; Uchida M, 2001, INT J HEMATOL, V73, P78, DOI 10.1007/BF02981906; WIKTORJEDRZEJCZAK W, 1990, P NATL ACAD SCI USA, V87, P4828, DOI 10.1073/pnas.87.12.4828; Yao Y, 2003, P NATL ACAD SCI USA, V100, P12759, DOI 10.1073/pnas.2134254100; Yeung YG, 2003, MOL CELL PROTEOMICS, V2, P1143, DOI 10.1074/mcp.R300009-MCP200; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	48	18	19	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2012	7	1							e30788	10.1371/journal.pone.0030788	http://dx.doi.org/10.1371/journal.pone.0030788			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	912BU	22303456	gold, Green Published, Green Submitted			2022-12-25	WOS:000301770300005
J	Lue, N; Kang, JW; Yu, CC; Barman, I; Dingari, NC; Feld, MS; Dasari, RR; Fitzmaurice, M				Lue, Niyom; Kang, Jeon Woong; Yu, Chung-Chieh; Barman, Ishan; Dingari, Narahara Chari; Feld, Michael S.; Dasari, Ramachandra R.; Fitzmaurice, Maryann			Portable Optical Fiber Probe-Based Spectroscopic Scanner for Rapid Cancer Diagnosis: A New Tool for Intraoperative Margin Assessment	PLOS ONE			English	Article							DIFFUSE-REFLECTANCE SPECTROSCOPY	There continues to be a significant clinical need for rapid and reliable intraoperative margin assessment during cancer surgery. Here we describe a portable, quantitative, optical fiber probe-based, spectroscopic tissue scanner designed for intraoperative diagnostic imaging of surgical margins, which we tested in a proof of concept study in human tissue for breast cancer diagnosis. The tissue scanner combines both diffuse reflectance spectroscopy (DRS) and intrinsic fluorescence spectroscopy (IFS), and has hyperspectral imaging capability, acquiring full DRS and IFS spectra for each scanned image pixel. Modeling of the DRS and IFS spectra yields quantitative parameters that reflect the metabolic, biochemical and morphological state of tissue, which are translated into disease diagnosis. The tissue scanner has high spatial resolution (0.25 mm) over a wide field of view (10 cm x 10 cm), and both high spectral resolution (2 nm) and high spectral contrast, readily distinguishing tissues with widely varying optical properties (bone, skeletal muscle, fat and connective tissue). Tissue-simulating phantom experiments confirm that the tissue scanner can quantitatively measure spectral parameters, such as hemoglobin concentration, in a physiologically relevant range with a high degree of accuracy (<5% error). Finally, studies using human breast tissues showed that the tissue scanner can detect small foci of breast cancer in a background of normal breast tissue. This tissue scanner is simpler in design, images a larger field of view at higher resolution and provides a more physically meaningful tissue diagnosis than other spectroscopic imaging systems currently reported in literatures. We believe this spectroscopic tissue scanner can provide real-time, comprehensive diagnostic imaging of surgical margins in excised tissues, overcoming the sampling limitation in current histopathology margin assessment. As such it is a significant step in the development of a platform technology for intraoperative management of cancer, a clinical problem that has been inadequately addressed to date.	[Lue, Niyom; Kang, Jeon Woong; Barman, Ishan; Dingari, Narahara Chari; Feld, Michael S.; Dasari, Ramachandra R.; Fitzmaurice, Maryann] MIT, George R Harrison Spect Lab, Cambridge, MA 02139 USA; [Yu, Chung-Chieh] Canon USA Inc, Div Res & Dev, Opt Res Lab, Tucson, AZ USA; [Fitzmaurice, Maryann] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA	Massachusetts Institute of Technology (MIT); Canon Incorporated; Case Western Reserve University	Lue, N (corresponding author), MIT, George R Harrison Spect Lab, Cambridge, MA 02139 USA.	niyom@mit.edu			National Institutes of Health National Center for Research Resources [P41-RR02594, S10-RR031845]; National Cancer Institute [R01-CA97966, R01-CA140288]; Tissue Procurement, Histology and Immunohistochemistry Core Facility of the Case Comprehensive Cancer Center [P30 CA43703]; NATIONAL CANCER INSTITUTE [R01CA140288, R01CA097966, P30CA043703] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR031845, P41RR002594] Funding Source: NIH RePORTER	National Institutes of Health National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Tissue Procurement, Histology and Immunohistochemistry Core Facility of the Case Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This research was supported by the National Institutes of Health National Center for Research Resources (P41-RR02594 and S10-RR031845) and National Cancer Institute (R01-CA97966 and R01-CA140288) and by the Tissue Procurement, Histology and Immunohistochemistry Core Facility of the Case Comprehensive Cancer Center (P30 CA43703). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Backman V, 2000, NATURE, V406, P35, DOI 10.1038/35017638; Barman I, 2011, BIOMED OPT EXPRESS, V2, P592, DOI 10.1364/BOE.2.000592; Brown JQ, 2009, CURR OPIN BIOTECH, V20, P119, DOI 10.1016/j.copbio.2009.02.004; Bydlon TM, 2010, OPT EXPRESS, V18, P8058, DOI 10.1364/OE.18.008058; Cai TT, 2001, APPL SPECTROSC, V55, P1124, DOI 10.1366/0003702011953289; Chauchard F, 2005, APPL OPTICS, V44, P7091, DOI 10.1364/AO.44.007091; Georgakoudi Irene, 2004, Gastrointest Endosc Clin N Am, V14, P519, DOI 10.1016/j.giec.2004.03.008; Keller MD, 2010, LASER SURG MED, V42, P15, DOI 10.1002/lsm.20865; Kennedy S, 2011, PROC SPIE, V7890, DOI 10.1117/12.875735; Krishnaswamy V, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3065540; Lin ZJ, 2009, PROC SPIE, V7161, DOI 10.1117/12.807886; Mcgee S, 2009, ANN OTO RHINOL LARYN, V118, P817, DOI 10.1177/000348941011901112; McLaughlin SA, 2008, J AM COLL SURGEONS, V206, P76, DOI 10.1016/j.jamcollsurg.2007.07.021; Mirkovic J, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3194142; Muller MG, 2001, APPL OPTICS, V40, P4633, DOI 10.1364/AO.40.004633; Rajaram N, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2981797; Rowell NP, 2010, BREAST, V19, P14, DOI 10.1016/j.breast.2009.10.007; Scepanovic OR, 2009, REV SCI INSTRUM, V80, DOI 10.1063/1.3117832; Smith SW, SCI ENG GUIDE DIGITA, P426; Tunnell JW, 2003, TECHNOL CANCER RES T, V2, P505, DOI 10.1177/153303460300200603; Volynskaya Z, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2909672; Yu CC, 2008, OPT EXPRESS, V16, P16227, DOI 10.1364/OE.16.016227; Zhang QG, 2000, OPT LETT, V25, P1451, DOI 10.1364/OL.25.001451; Zonios G, 1999, APPL OPTICS, V38, P6628, DOI 10.1364/AO.38.006628	24	40	40	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2012	7	1							e30887	10.1371/journal.pone.0030887	http://dx.doi.org/10.1371/journal.pone.0030887			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911GB	22303465	Green Submitted, Green Published, gold			2022-12-25	WOS:000301704200041
J	Bonomini, M; Giardinelli, A; Morabito, C; Di Silvestre, S; Di Cesare, M; Di Pietro, N; Sirolli, V; Formoso, G; Amoroso, L; Mariggio, MA; Pandolfi, A				Bonomini, Mario; Giardinelli, Annalisa; Morabito, Caterina; Di Silvestre, Sara; Di Cesare, Moreno; Di Pietro, Natalia; Sirolli, Vittorio; Formoso, Gloria; Amoroso, Luigi; Mariggio, Maria Addolorata; Pandolfi, Assunta			Calcimimetic R-568 and Its Enantiomer S-568 Increase Nitric Oxide Release in Human Endothelial Cells	PLOS ONE			English	Article							CALCIUM-SENSING RECEPTOR; SMOOTH-MUSCLE-CELLS; CA2+-SENSING RECEPTOR; PARATHYROID CELLS; BLOOD-PRESSURE; SYNTHASE; RATS; HYPERPARATHYROIDISM; CLONING; CA2+	Background: Calcimimetics, such as R-568, are thought to activate G protein-linked Ca2+-sensing receptor (CaSR) by allosterically increasing the affinity of the receptor for Ca2+ allowing for efficient control of uremic hyperparathyroidism. Several recent studies suggest they possess additional vascular actions. Although it has been postulated that calcimimetics may have a direct effect on CaSR in the blood vessels, further studies are needed to elucidate their vascular CaSR-dependent versus CaSR-independent effects. Methodology/Principal Findings: Focusing on human umbilical vein endothelial cells (HUVECs), we studied the CaSR expression and distribution by Immunofluorescence and Western Blot analysis. CaSR function was evaluated by measuring the potential effect of calcimimetic R-568 and its enantiomer S-568 upon the modulation of intracellular Ca2+ levels (using a single cell approach and FURA-2AM), in the presence or absence of Calhex-231, a negative modulator of CaSR. To address their potential vascular functions, we also evaluated R-and S-568-stimulated enzymatic release of Nitric Oxide (NO) by DAF-2DA, by Nitric Oxide Synthase (NOS) radiometric assay (both in HUVECs and in Human Aortic Endothelial Cells) and by measuring eNOS-ser1177 phosphorylation levels (Immunoblotting). We show that, although the CaSR protein was expressed in HUVECs, it was mainly distributed in cytoplasm while the functional CaSR dimers, usually localized on the plasma membrane, were absent. In addition, regardless of the presence or absence of Calhex-231, both R-and S-568 significantly increased intracellular Ca2+ levels by mobilization of Ca2+ from intracellular stores, which in turn augmented NO release by a time-and Ca2+-dependent increase in eNOS-ser1177 phosphorylation levels. Conclusions/Significance: Taken together, these data indicate that in human endothelium there is no stereoselectivity in the responses to calcimimetics and that CaSR is probably not involved in the action of R-and S-568. This suggests an additional mechanism in support of the CaSR-independent role of calcimimetics as vasculotrope agents.	[Bonomini, Mario; Di Cesare, Moreno; Sirolli, Vittorio; Amoroso, Luigi] Univ G dAnnunzio, Dept Med, Inst Nephrol, Chieti, Italy; [Giardinelli, Annalisa; Di Silvestre, Sara; Di Pietro, Natalia; Pandolfi, Assunta] Univ G dAnnunzio, Dept Biomed Sci, Chieti, Italy; [Morabito, Caterina; Mariggio, Maria Addolorata] Univ G dAnnunzio, Dept Neurosci & Imaging, Chieti, Italy; [Bonomini, Mario; Di Cesare, Moreno; Sirolli, Vittorio; Formoso, Gloria; Amoroso, Luigi] Univ G dAnnunzio, Dept Med & Aging Sci, Chieti, Italy; [Giardinelli, Annalisa; Morabito, Caterina; Di Silvestre, Sara; Di Pietro, Natalia; Formoso, Gloria; Mariggio, Maria Addolorata; Pandolfi, Assunta] Univ G dAnnunzio, Ctr Sci Invecchiamento Ce SI, Aging Res Ctr, Chieti, Italy	G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara	Bonomini, M (corresponding author), Univ G dAnnunzio, Dept Med, Inst Nephrol, Chieti, Italy.	pandolfi@unich.it	Mariggiò, Maria Addolorata/T-9047-2017; Sirolli, Vittorio/AAB-2290-2019; Di Pietro, Natalia/K-1604-2016; pandolfi, assunta/K-4595-2016	Mariggiò, Maria Addolorata/0000-0001-5306-7143; Di Pietro, Natalia/0000-0001-9720-2116; pandolfi, assunta/0000-0003-4135-7631; Morabito, Caterina/0000-0002-5144-2584; Mariggio, Maria Addolorata/0000-0002-3508-8706	Amgen, Inc. [200713507]; Amgen, Inc., Thousand Oaks, California, United States of America	Amgen, Inc.(Amgen); Amgen, Inc., Thousand Oaks, California, United States of America	The funding support for the study from Amgen, Inc. (Master Agreement No:200713507, March 14, 2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Dr Bonomini received materials (R-568 and S-568) and funding support for the study from Amgen, Inc., Thousand Oaks, California, United States of America. A patent relating to this study and Calcimimetic R-568 is held by Amgen (United States PATENT NUMBER: 5,688,938; Date of Patent: Nov 18, 1997; Product Name: NPS-568). This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	AIDA K, 1995, BIOCHEM BIOPH RES CO, V214, P524, DOI 10.1006/bbrc.1995.2318; Al-Aly Z, 2009, KIDNEY INT, V75, P9, DOI 10.1038/ki.2008.563; Andrew PJ, 1999, CARDIOVASC RES, V43, P521, DOI 10.1016/S0008-6363(99)00115-7; Baylis C, 2008, AM J PHYSIOL-RENAL, V294, pF1, DOI 10.1152/ajprenal.00424.2007; Brown E. M., 2007, V45, P139; BROWN EM, 1993, NATURE, V366, P575, DOI 10.1038/366575a0; Carrasco FR, 2009, TRANSPL P, V41, P2385, DOI 10.1016/j.transproceed.2009.06.167; Di Pietro R, 2006, J CELL BIOCHEM, V97, P782, DOI 10.1002/jcb.20686; Drueke TB, 2009, CLIN J AM SOC NEPHRO, V4, P234, DOI 10.2215/CJN.04520908; Fleming I, 2003, AM J PHYSIOL-REG I, V284, pR1, DOI 10.1152/ajpregu.00323.2002; GORFIEN S, 1993, EXP CELL RES, V206, P291, DOI 10.1006/excr.1993.1149; Harno E, 2008, CELL CALCIUM, V44, P210, DOI 10.1016/j.ceca.2007.11.011; Inesi G, 2005, J BIOENERG BIOMEMBR, V37, P365, DOI 10.1007/s10863-005-9472-1; Jensen AA, 2007, CURR NEUROPHARMACOL, V5, P180, DOI 10.2174/157015907781695982; Koleganova N, 2009, KIDNEY INT, V75, P60, DOI 10.1038/ki.2008.490; Kone BC, 2003, AM J PHYSIOL-RENAL, V285, pF178, DOI 10.1152/ajprenal.00048.2003; Molostvov G, 2007, AM J PHYSIOL-RENAL, V293, pF946, DOI 10.1152/ajprenal.00474.2006; Nagano N, 2006, PHARMACOL THERAPEUT, V109, P339, DOI 10.1016/j.pharmthera.2005.06.019; Nakagawa K, 2009, PEDIATR NEPHROL, V24, P1385, DOI 10.1007/s00467-009-1153-6; Nemeth EF, 2004, J PHARMACOL EXP THER, V308, P627, DOI 10.1124/jpet.103.057273; Nemeth EF, 2004, CELL CALCIUM, V35, P283, DOI 10.1016/j.ceca.2003.10.020; Odenwald T, 2006, J AM SOC NEPHROL, V17, P655, DOI 10.1681/ASN.2005090914; Ohanian J, 2005, AM J PHYSIOL-HEART C, V288, pH1756, DOI 10.1152/ajpheart.00739.2004; Pace AJ, 1999, J BIOL CHEM, V274, P11629, DOI 10.1074/jbc.274.17.11629; Pandolfi A, 2003, J CELL PHYSIOL, V196, P378, DOI 10.1002/jcp.10325; Pi M, 2005, J BIOL CHEM, V280, P40201, DOI 10.1074/jbc.M505186200; Rybczynska A, 2005, AM J HYPERTENS, V18, P364, DOI 10.1016/j.amjhyper.2004.10.019; Rybczynska A, 2006, PHARMACOL REP, V58, P533; Shaul PW, 2002, ANNU REV PHYSIOL, V64, P749, DOI 10.1146/annurev.physiol.64.081501.155952; Smajilovic S, 2007, CARDIOVASC RES, V75, P457, DOI 10.1016/j.cardiores.2007.03.015; Strippoli GFM, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006254; Sutherland SK, 2004, AM J HYPERTENS, V17, P266, DOI 10.1016/j.amjhyper.2003.11.010; Thakore P, 2011, BRIT J PHARMACOL, V162, P749, DOI 10.1111/j.1476-5381.2010.01079.x; Villar IC, 2006, KIDNEY INT, V70, P840, DOI 10.1038/sj.ki.5001680; Wang H, 1999, FREE RADICAL BIO MED, V27, P612, DOI 10.1016/S0891-5849(99)00107-0; Wellendorph P, 2007, GENE, V396, P257, DOI 10.1016/j.gene.2007.03.008; Weston AH, 2005, CIRC RES, V97, P391, DOI 10.1161/01.RES.0000178787.59594.a0; Wonneberger K, 2000, J MEMBRANE BIOL, V175, P203, DOI 10.1007/s002320001068; Ziegelstein RC, 2006, BIOCHEM BIOPH RES CO, V342, P153, DOI 10.1016/j.bbrc.2006.01.135	39	26	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e30682	10.1371/journal.pone.0030682	http://dx.doi.org/10.1371/journal.pone.0030682			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910ME	22295103	gold, Green Submitted, Green Published			2022-12-25	WOS:000301640600048
J	Cronin, M; Akin, AR; Collins, SA; Meganck, J; Kim, JB; Baban, CK; Joyce, SA; van Dam, GM; Zhang, N; van Sinderen, D; O'Sullivan, GC; Kasahara, N; Gahan, CG; Francis, KP; Tangney, M				Cronin, Michelle; Akin, Ali R.; Collins, Sara A.; Meganck, Jeff; Kim, Jae-Beom; Baban, Chwanrow K.; Joyce, Susan A.; van Dam, Gooitzen M.; Zhang, Ning; van Sinderen, Douwe; O'Sullivan, Gerald C.; Kasahara, Noriyuki; Gahan, Cormac G.; Francis, Kevin P.; Tangney, Mark			High Resolution In Vivo Bioluminescent Imaging for the Study of Bacterial Tumour Targeting	PLOS ONE			English	Article							CANCER GENE-THERAPY; MODIFIED SALMONELLA-TYPHIMURIUM; LISTERIA-MONOCYTOGENES; DELIVERY-SYSTEM; NUDE-MICE; BIFIDOBACTERIUM-LONGUM; PROSTATE-CANCER; TOMOGRAPHY; CONSTRUCTION; METASTASIS	The ability to track microbes in real time in vivo is of enormous value for preclinical investigations in infectious disease or gene therapy research. Bacteria present an attractive class of vector for cancer therapy, possessing a natural ability to grow preferentially within tumours following systemic administration. Bioluminescent Imaging (BLI) represents a powerful tool for use with bacteria engineered to express reporter genes such as lux. BLI is traditionally used as a 2D modality resulting in images that are limited in their ability to anatomically locate cell populations. Use of 3D diffuse optical tomography can localize the signals but still need to be combined with an anatomical imaging modality like micro-Computed Tomography (mu CT) for interpretation. In this study, the non-pathogenic commensal bacteria E. coli K-12 MG1655 and Bifidobacterium breve UCC2003, or Salmonella Typhimurium SL7207 each expressing the luxABCDE operon were intravenously (IV) administered to mice bearing subcutaneous (s.c) FLuc-expressing xenograft tumours. Bacterial lux signal was detected specifically in tumours of mice post IV-administration and bioluminescence correlated with the numbers of bacteria recovered from tissue. Through whole body imaging for both lux and FLuc, bacteria and tumour cells were co-localised. 3D BLI and mu CT image analysis revealed a pattern of multiple clusters of bacteria within tumours. Investigation of spatial resolution of 3D optical imaging was supported by ex vivo histological analyses. In vivo imaging of orally-administered commensal bacteria in the gastrointestinal tract (GIT) was also achieved using 3D BLI. This study demonstrates for the first time the potential to simultaneously image multiple BLI reporter genes three dimensionally in vivo using approaches that provide unique information on spatial locations.	[Cronin, Michelle; Collins, Sara A.; Baban, Chwanrow K.; O'Sullivan, Gerald C.; Tangney, Mark] Natl Univ Ireland Univ Coll Cork, Cork Canc Res Ctr, Mercy Univ Hosp, Cork, Ireland; [Cronin, Michelle; Collins, Sara A.; Baban, Chwanrow K.; O'Sullivan, Gerald C.; Tangney, Mark] Natl Univ Ireland Univ Coll Cork, Leslie C Quick Jr Lab, Cork, Ireland; [Akin, Ali R.; Meganck, Jeff; Kim, Jae-Beom; Zhang, Ning; Francis, Kevin P.] Caliper, Alameda, CA USA; [Collins, Sara A.; Kasahara, Noriyuki; Tangney, Mark] Univ Calif Los Angeles, Sch Med, Los Angeles, CA USA; [Joyce, Susan A.; van Sinderen, Douwe; Gahan, Cormac G.] Natl Univ Ireland Univ Coll Cork, Dept Microbiol, Cork, Ireland; [Joyce, Susan A.; van Sinderen, Douwe; Gahan, Cormac G.] Natl Univ Ireland Univ Coll Cork, Alimentary Pharmabiot Ctr, Cork, Ireland; [van Dam, Gooitzen M.] Univ Groningen, Univ Med Ctr Groningen, Dept Surg, Div Surg Oncol,BioOpt Imaging Ctr, Groningen, Netherlands; [Gahan, Cormac G.] Natl Univ Ireland Univ Coll Cork, Sch Pharm, Cork, Ireland	University College Cork; University College Cork; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University College Cork; University College Cork; University of Groningen; University College Cork	Cronin, M (corresponding author), Natl Univ Ireland Univ Coll Cork, Cork Canc Res Ctr, Mercy Univ Hosp, Cork, Ireland.	m.tangney@ucc.ie	Hamblin, Mike/AAB-2511-2022; Gahan, Cormac G/AAE-9346-2019; Hamblin, Michael R/H-2758-2019; Joyce, Susan/ABE-2616-2020; Van Sinderen, Douwe/A-6778-2015	Gahan, Cormac G/0000-0003-2385-8192; Hamblin, Michael R/0000-0001-6431-4605; Joyce, Susan/0000-0003-4771-3123; Van Sinderen, Douwe/0000-0003-1823-7957; Kasahara, Noriyuki/0000-0002-6069-9082; Tangney, Mark/0000-0002-6314-1260	European Commission [PIOF-GA-2009-255466]; Irish Health Research Board [HRA_POR/2010/138]	European Commission(European CommissionEuropean Commission Joint Research Centre); Irish Health Research Board	The authors wish to acknowledge support relevant to this manuscript from the European Commission Seventh Framework Programme (PIOF-GA-2009-255466) and the Irish Health Research Board (HRA_POR/2010/138). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2011, J UROL; Ahmad S, 2011, J UROLOGY, V186, P687, DOI 10.1016/j.juro.2011.03.139; Alvarez-Martin P, 2007, APPL MICROBIOL BIOT, V76, P1395, DOI 10.1007/s00253-007-1115-5; Andreu N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010777; Baban CK, 2010, BIOENGINEERED BUGS, V1; BACHMANN BJ, 1972, BACTERIOL REV, V36, P525, DOI 10.1128/MMBR.36.4.525-557.1972; Beattie BJ, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3120495; BELAS R, 1982, SCIENCE, V218, P791, DOI 10.1126/science.10636771; Briat Arnaud, 2006, Expert Reviews in Molecular Medicine, V8, P1, DOI 10.1017/S1462399406000044; Burns-Guydish SM, 2005, PEDIATR RES, V58, P153, DOI 10.1203/01.PDR.0000157725.44213.C4; Chaudhari AJ, 2005, PHYS MED BIOL, V50, P5421, DOI 10.1088/0031-9155/50/23/001; Cheng CM, 2008, CANCER GENE THER, V15, P393, DOI 10.1038/cgt.2008.10; Clairmont C, 2000, J INFECT DIS, V181, P1996, DOI 10.1086/315497; Contag CH, 1995, MOL MICROBIOL, V18, P593, DOI 10.1111/j.1365-2958.1995.mmi_18040593.x; Critchley Rebecca J, 2004, Discov Med, V4, P194; Cronin M, 2007, APPL ENVIRON MICROB, V73, P7858, DOI 10.1128/AEM.01630-07; Cronin M, 2010, MOL THER, V18, P1397, DOI 10.1038/mt.2010.59; Cronin M, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-161; Cunningham C, 2001, Hum Gene Ther, V12, P1594; Foucault ML, 2010, APPL ENVIRON MICROB, V76, P264, DOI 10.1128/AEM.01686-09; Foucault ML, APPL ENV MICROBIOL, V76, P264; Grillot-Courvalin C, 1998, NAT BIOTECHNOL, V16, P862, DOI 10.1038/nbt0998-862; Guglielmetti S, 2008, INT J FOOD MICROBIOL, V124, P285, DOI 10.1016/j.ijfoodmicro.2008.03.033; Guo XL, 2010, IEEE T BIO-MED ENG, V57, P2876, DOI 10.1109/TBME.2010.2073468; Hayashi K, 2009, J CELL BIOCHEM, V106, P992, DOI 10.1002/jcb.22078; Hayashi K, 2009, CELL CYCLE, V8, P870, DOI 10.4161/cc.8.6.7891; HEPPNER F, 1978, ACTA NEUROCHIR, V42, P123, DOI 10.1007/BF01406639; Hoffman RM, 2011, CURR OPIN BIOTECHNOL; Hoffman RM, 2006, NAT PROTOC, V1, P2988, DOI 10.1038/nprot.2006.376; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; Iqbal U, 2010, BRIT J PHARMACOL, V160, P1016, DOI 10.1111/j.1476-5381.2010.00742.x; Kepshire D, 2009, REV SCI INSTRUM, V80, DOI 10.1063/1.3109903; Kuo C, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2717898; Lemmon MJ, 1997, GENE THER, V4, P791, DOI 10.1038/sj.gt.3300468; Min JJ, 2008, NAT PROTOC, V3, P629, DOI 10.1038/nprot.2008.32; Morrissey D, 2010, CURR GENE THER, V10, P3, DOI 10.2174/156652310790945575; Nagakura C, 2009, ANTICANCER RES, V29, P1873; Nemunaitis J, 2003, CANCER GENE THER, V10, P737, DOI 10.1038/sj.cgt.7700634; Puaux A-L, 2011, INT J MOL IMAGING; Riedel CU, 2007, APPL ENVIRON MICROB, V73, P7092, DOI 10.1128/AEM.01394-07; Riedel CU, 2007, APPL ENVIRON MICROB, V73, P3091, DOI 10.1128/AEM.02940-06; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Simpson PJ, 2003, J BACTERIOL, V185, P2571, DOI 10.1128/JB.185.8.2571-2581.2003; Sleator RD, 2009, MICROBIOL-SGM, V155, P2463, DOI 10.1099/mic.0.030205-0; Spinelli AE, 2011, OPT EXPRESS, V19, P12605, DOI 10.1364/OE.19.012605; Tangney M, 2010, DISCOV MED, V10, P195; Toso JF, 2002, J CLIN ONCOL, V20, P142, DOI 10.1200/JCO.20.1.142; van Pijkeren JP, 2010, HUM GENE THER, V21, P405, DOI 10.1089/hum.2009.022; Vassaux G, 2006, J PATHOL, V208, P290, DOI 10.1002/path.1865; Waidmann MS, BIOENG BUGS, V2, P8; Wiles S, 2006, INFECT IMMUN, V74, P5391, DOI 10.1128/IAI.00848-06; Yazawa K, 2000, CANCER GENE THER, V7, P269, DOI 10.1038/sj.cgt.7700122; Yu YA, 2004, NAT BIOTECHNOL, V22, P313, DOI 10.1038/nbt937; Yu YA, 2008, BIOTECHNOL BIOENG, V100, P567, DOI 10.1002/bit.21785; Zhao M, 2005, P NATL ACAD SCI USA, V102, P755, DOI 10.1073/pnas.0408422102; Zhao M, 2007, P NATL ACAD SCI USA, V104, P10170, DOI 10.1073/pnas.0703867104; Zhao M, 2006, CANCER RES, V66, P7647, DOI 10.1158/0008-5472.CAN-06-0716	57	104	111	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e30940	10.1371/journal.pone.0030940	http://dx.doi.org/10.1371/journal.pone.0030940			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910ME	22295120	Green Published, Green Submitted, gold			2022-12-25	WOS:000301640600065
J	Dzijak, R; Yildirim, S; Kahle, M; Novak, P; Hnilicova, J; Venit, T; Hozak, P				Dzijak, Rastislav; Yildirim, Sukriye; Kahle, Michal; Novak, Petr; Hnilicova, Jarmila; Venit, Tomas; Hozak, Pavel			Specific Nuclear Localizing Sequence Directs Two Myosin Isoforms to the Cell Nucleus in Calmodulin-Sensitive Manner	PLOS ONE			English	Article							POLYMERASE-I TRANSCRIPTION; SEX REVERSAL; ACTIN; LOCALIZATION; EXPORT; RECEPTOR; BINDING; DOMAIN; IDENTIFICATION; TRANSLOCATION	Background: Nuclear myosin I (NM1) was the first molecular motor identified in the cell nucleus. Together with nuclear actin, they participate in crucial nuclear events such as transcription, chromatin movements, and chromatin remodeling. NM1 is an isoform of myosin 1c (Myo1c) that was identified earlier and is known to act in the cytoplasm. NM1 differs from the "cytoplasmic" myosin 1c only by additional 16 amino acids at the N-terminus of the molecule. This amino acid stretch was therefore suggested to direct NM1 into the nucleus. Methodology/Principal Findings: We investigated the mechanism of nuclear import of NM1 in detail. Using over-expressed GFP chimeras encoding for truncated NM1 mutants, we identified a specific sequence that is necessary for its import to the nucleus. This novel nuclear localization sequence is placed within calmodulin-binding motif of NM1, thus it is present also in the Myo1c. We confirmed the presence of both isoforms in the nucleus by transfection of tagged NM1 and Myo1c constructs into cultured cells, and also by showing the presence of the endogenous Myo1c in purified nuclei of cells derived from knock-out mice lacking NM1. Using pull-down and co-immunoprecipitation assays we identified importin beta, importin 5 and importin 7 as nuclear transport receptors that bind NM1. Since the NLS sequence of NM1 lies within the region that also binds calmodulin we tested the influence of calmodulin on the localization of NM1. The presence of elevated levels of calmodulin interfered with nuclear localization of tagged NM1. Conclusions/Significance: We have shown that the novel specific NLS brings to the cell nucleus not only the "nuclear" isoform of myosin I (NM1 protein) but also its "cytoplasmic" isoform (Myo1c protein). This opens a new field for exploring functions of this molecular motor in nuclear processes, and for exploring the signals between cytoplasm and the nucleus.	[Dzijak, Rastislav; Yildirim, Sukriye; Kahle, Michal; Hnilicova, Jarmila; Venit, Tomas; Hozak, Pavel] ASCR, Vvi, Inst Mol Genet, Dept Biol Cell Nucleus, Prague, Czech Republic; [Novak, Petr] ASCR, Vvi, Inst Microbiol, Lab Mol Struct Characterizat, Prague, Czech Republic	Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences	Dzijak, R (corresponding author), ASCR, Vvi, Inst Mol Genet, Dept Biol Cell Nucleus, Prague, Czech Republic.	hozak@img.cas.cz	Hozak, Pavel/J-4182-2014; Dzijak, Rastislav/G-6181-2014; Venit, Tomas/G-3534-2014; Kahle, Michal/K-9936-2016; Hnilicova, Jarmila/J-5019-2014; Novak, Petr/F-9655-2014; Dzijak, Rastislav/AGI-4423-2022; Hozak, Pavel/AAB-5359-2021	Hozak, Pavel/0000-0003-1901-1394; Kahle, Michal/0000-0002-3854-0390; Hnilicova, Jarmila/0000-0002-0953-491X; Novak, Petr/0000-0001-8688-529X; Dzijak, Rastislav/0000-0003-1141-7736; Hozak, Pavel/0000-0003-1901-1394	Grant Agency of the Czech Republic [204/07/1592, 204/09/H084, P305/11/2232]; Ministry of Education, Youth and Sports of the Czech Republic [LC 545, LC06063]; Academy of Sciences of the Czech Republic [AV0Z50520514]; Boehringer Ingelheim Fonds	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Academy of Sciences of the Czech Republic(Czech Academy of Sciences); Boehringer Ingelheim Fonds(Boehringer Ingelheim)	This study was supported by Grant Agency of the Czech Republic (http://www.gacr.cz Reg. Nos. 204/07/1592, 204/09/H084 and P305/11/2232), Ministry of Education, Youth and Sports of the Czech Republic (http://www.msmt.cz/index.php?lang=2 Reg. Nos. LC 545 and LC06063). Institutional research plan Reg. No. AV0Z50520514, was funded by Academy of Sciences of the Czech Republic (http://www.isvav.cz/researchPlanDetail.do?rowId=AV0Z50520514). Dr. Dzijak was supported by the Boehringer Ingelheim Fonds travel grant (http://www.bifonds.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonsson A, 2003, MOL CELL BIOL, V23, P1418, DOI 10.1128/MCB.23.4.1418-1427.2003; Argentaro A, 2003, J BIOL CHEM, V278, P33839, DOI 10.1074/jbc.M302078200; Chen J, 2001, AM J PHYSIOL-RENAL, V280, pF619, DOI 10.1152/ajprenal.2001.280.4.F619; Chuang CH, 2006, CURR BIOL, V16, P825, DOI 10.1016/j.cub.2006.03.059; Cisterna B, 2006, FASEB J, V20, P1901, DOI 10.1096/fj.05-5278fje; Cisterna B, 2009, HISTOCHEM CELL BIOL, V131, P743, DOI 10.1007/s00418-009-0583-3; Cokol M, 2000, EMBO REP, V1, P411, DOI 10.1093/embo-reports/kvd092; Dumont RA, 2002, JARO-J ASSOC RES OTO, V3, P375, DOI 10.1007/s101620020049; Fomproix N, 2004, EXP CELL RES, V294, P140, DOI 10.1016/j.yexcr.2003.10.028; FRANGIONI JV, 1993, J CELL SCI, V105, P481; Galvez T, 2001, EMBO J, V20, P2152, DOI 10.1093/emboj/20.9.2152; Gillespie PG, 2002, BMC BIOCHEM, V3, DOI 10.1186/1471-2091-3-31; Grummt I, 2006, CURR OPIN GENET DEV, V16, P191, DOI 10.1016/j.gde.2006.02.001; Grummt I, 2003, GENE DEV, V17, P1691, DOI 10.1101/gad.1098503R; Harley VR, 1996, FEBS LETT, V391, P24, DOI 10.1016/0014-5793(96)00694-1; Hirono M, 2004, NEURON, V44, P309, DOI 10.1016/j.neuron.2004.09.020; Hofmann WA, 2004, NAT CELL BIOL, V6, P1094, DOI 10.1038/ncb1182; Hofmann WA, 2009, J CELL SCI, V122, P636, DOI 10.1242/jcs.030205; Hokanson DE, 2006, MOL BIOL CELL, V17, P4856, DOI 10.1091/mbc.e06-05-0449; Houdusse A, 2006, P NATL ACAD SCI USA, V103, P19326, DOI 10.1073/pnas.0609436103; Hu X, 2009, P NATL ACAD SCI USA, V106, P10141, DOI 10.1073/pnas.0900437106; Kahl CR, 2003, ENDOCR REV, V24, P719, DOI 10.1210/er.2003-0008; Kahle M, 2007, HISTOCHEM CELL BIOL, V127, P139, DOI 10.1007/s00418-006-0231-0; Kutay U, 1998, MOL CELL, V1, P359, DOI 10.1016/S1097-2765(00)80036-2; Kutay U, 1997, CELL, V90, P1061, DOI 10.1016/S0092-8674(00)80372-4; Kysela K, 2005, HISTOCHEM CELL BIOL, V124, P347, DOI 10.1007/s00418-005-0042-8; Laakso JM, 2008, SCIENCE, V321, P133, DOI 10.1126/science.1159419; Leneuve P, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng021; Lindsay AJ, 2009, CELL MOTIL CYTOSKEL, V66, P1057, DOI 10.1002/cm.20408; Manceva S, 2007, BIOCHEMISTRY-US, V46, P11718, DOI 10.1021/bi700894h; Mehta IS, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-r5; Mohr D, 2009, EMBO J, V28, P2541, DOI 10.1038/emboj.2009.200; Nagata T, 2010, ANAL BIOCHEM, V398, P178, DOI 10.1016/j.ab.2009.11.017; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Nowak G, 1997, J BIOL CHEM, V272, P17176, DOI 10.1074/jbc.272.27.17176; Obrdlik A, 2010, FASEB J, V24, P146, DOI 10.1096/fj.09-135863; Pemberton LF, 2005, TRAFFIC, V6, P187, DOI 10.1111/j.1600-0854.2005.00270.x; Percipalle P, 2006, CURR OPIN CELL BIOL, V18, P267, DOI 10.1016/j.ceb.2006.03.001; Pestic-Dragovich L, 2000, SCIENCE, V290, P337, DOI 10.1126/science.290.5490.337; Philimonenko VV, 2010, HISTOCHEM CELL BIOL, V134, P243, DOI 10.1007/s00418-010-0732-8; Philimonenko VV, 2004, NAT CELL BIOL, V6, P1165, DOI 10.1038/ncb1190; Sim H, 2005, MOL ENDOCRINOL, V19, P1884, DOI 10.1210/me.2004-0334; Suetsugu S, 2003, J BIOL CHEM, V278, P42515, DOI 10.1074/jbc.M302177200; Ye J, 2008, GENE DEV, V22, P322, DOI 10.1101/gad.455908; Yip MF, 2008, CELL METAB, V8, P384, DOI 10.1016/j.cmet.2008.09.011	45	34	36	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e30529	10.1371/journal.pone.0030529	http://dx.doi.org/10.1371/journal.pone.0030529			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910ME	22295092	Green Published, gold, Green Submitted			2022-12-25	WOS:000301640600037
J	Moum, SJ; Price, CC; Limotai, N; Oyama, G; Ward, H; Jacobson, C; Foote, KD; Okun, MS				Moum, Sarah J.; Price, Catherine C.; Limotai, Natlada; Oyama, Genko; Ward, Herbert; Jacobson, Charles; Foote, Kelly D.; Okun, Michael S.			Effects of STN and GPi Deep Brain Stimulation on Impulse Control Disorders and Dopamine Dysregulation Syndrome	PLOS ONE			English	Article							NONMOTOR SYMPTOMS QUESTIONNAIRE; SUBTHALAMIC NUCLEUS STIMULATION; PARKINSONS-DISEASE; DBS; PREVALENCE; VALPROATE; LEVODOPA	Objective: Impulse control disorders (ICDs) and dopamine dysregulation syndrome (DDS) are important behavioral problems that affect a subpopulation of patients with Parkinson's disease (PD) and typically result in markedly diminished quality of life for patients and their caregivers. We aimed to investigate the effects of subthalamic nucleus (STN) and internal globus pallidus (GPi) deep brain stimulation (DBS) on ICD/DDS frequency and dopaminergic medication usage. Methods: A retrospective chart review was performed on 159 individuals who underwent unilateral or bilateral PD DBS surgery in either STN or GPi. According to published criteria, pre-and post-operative records were reviewed to categorize patients both pre-and post-operatively as having ICD, DDS, both ICD and DDS, or neither ICD nor DDS. Group differences in patient demographics, clinical presentations, levodopa equivalent dose (LED), and change in diagnosis following unilateral/bilateral by brain target (STN or GPi DBS placement) were examined. Results: 28 patients met diagnostic criteria for ICD or DDS pre- or post-operatively. ICD or DDS classification did not differ by GPi or STN target stimulation. There was no change in DDS diagnosis after unilateral or bilateral stimulation. For ICD, diagnosis resolved in 2 of 7 individuals after unilateral or bilateral DBS. Post-operative development of these syndromes was significant; 17 patients developed ICD diagnoses post-operatively with 2 patients with pre-operative ICD developing DDS post-operatively. Conclusions: Unilateral or bilateral DBS did not significantly treat DDS or ICD in our sample, even though a few cases of ICD resolved post-operatively. Rather, our study provides preliminary evidence that DDS and ICD diagnoses may emerge following DBS surgery.	[Moum, Sarah J.; Limotai, Natlada; Oyama, Genko; Ward, Herbert; Jacobson, Charles; Foote, Kelly D.; Okun, Michael S.] Univ Florida, Dept Neurol, Ctr Movement Disorders & Neurorestorat, Gainesville, FL 32610 USA; [Moum, Sarah J.; Foote, Kelly D.; Okun, Michael S.] Univ Florida, Dept Neurosurg, Ctr Movement Disorders & Neurorestorat, Gainesville, FL USA; [Price, Catherine C.] Univ Florida, Dept Clin & Hlth Psychol, Ctr Movement Disorders & Neurorestorat, Gainesville, FL USA; [Limotai, Natlada] Chulalongkorn Univ Hosp, Chulalongkorn Comprehens Movement Disorders Ctr, Bangkok, Thailand; [Limotai, Natlada] Red Cross Soc, Bangkok, Thailand; [Ward, Herbert] Univ Florida, Dept Psychiat, Ctr Movement Disorders & Neurorestorat, Gainesville, FL 32611 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Chulalongkorn University; Thai Red Cross Society; State University System of Florida; University of Florida	Moum, SJ (corresponding author), Univ Florida, Dept Neurol, Ctr Movement Disorders & Neurorestorat, Gainesville, FL 32610 USA.	okun@neurology.ufl.edu		Jacobson, Charles/0000-0002-7598-5217; Okun, Michael/0000-0002-6247-9358; Price, Catherine/0000-0001-5994-0644; Foote, Kelly/0000-0002-2436-4138	National Institutes of Health [T35 07489]; National Institute of Neurological Disorders and Stroke [K23NS060660]; University of Florida (UF) National Parkinson Foundation Center of Excellence; UF Foundation; National Parkinson Foundation; National Institutes of Health (NIH); Michael J. Fox Foundation; Parkinson Alliance; University of Florida Foundation; University of South Florida CME office, PeerView; Vanderbilt University; Medtronic; ANS/St. Jude; Smallwood Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K23NS060660] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); University of Florida (UF) National Parkinson Foundation Center of Excellence(University of Florida); UF Foundation; National Parkinson Foundation; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michael J. Fox Foundation; Parkinson Alliance; University of Florida Foundation(University of Florida); University of South Florida CME office, PeerView; Vanderbilt University; Medtronic(Medtronic); ANS/St. Jude; Smallwood Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by National Institutes of Health T35 07489 (SM), National Institute of Neurological Disorders and Stroke K23NS060660 (CP); University of Florida (UF) National Parkinson Foundation Center of Excellence, UF Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; MO serves as a consultant for the National Parkinson Foundation, and has received research grants from National Institutes of Health (NIH), National Parkinson Foundation, the Michael J. Fox Foundation, the Parkinson Alliance, Smallwood Foundation, and the University of Florida Foundation. MO currently receives no support >4 months from industry. MO has received royalties for publications with Demos, Manson, and Cambridge (movement disorders books). MO has participated in CME activities on movement disorders sponsored by the University of South Florida CME office, PeerView, and by Vanderbilt University. The institution and not the PI receives grants from Medtronic and ANS/St. Jude, and the PI has no financial interest in these grants. MO has participated as a site PI and/or co-PI for several NIH, foundation, and industry sponsored trials over the years but has not received honoraria. This does not alter the authors adherence to all the PLoS ONE policies on sharing data and materials.	Ardouin C, 2006, MOVEMENT DISORD, V21, P1941, DOI 10.1002/mds.21098; Avila A, 2011, J NEUROL SC IN PRESS; Bandini F, 2007, PARKINSONISM RELAT D, V13, P369, DOI 10.1016/j.parkreldis.2006.07.011; Cabrini S, 2009, NEUROL SCI IN PRESS; Chaudhuri KR, 2006, MOVEMENT DISORD, V21, P916, DOI 10.1002/mds.20844; Demetriades P, 2011, PARKINSONS IN PRESS; Evans AH, 2004, MOVEMENT DISORD, V19, P397, DOI 10.1002/mds.20045; FRIEDMAN JH, 1994, BIOL PSYCHIAT, V36, P350, DOI 10.1016/0006-3223(94)90636-X; Giovannoni G, 2000, J NEUROL NEUROSUR PS, V68, P423, DOI 10.1136/jnnp.68.4.423; Halbig TD, 2009, EUR J NEUROL, V16, P493, DOI 10.1111/j.1468-1331.2008.02509.x; Hicks CW, 2011, PARKINSONISM RELAT D, V17, P379, DOI 10.1016/j.parkreldis.2011.03.003; Knobel D, 2008, COGN BEHAV NEUROL, V21, P187, DOI 10.1097/WNN.0b013e318185e6e2; Koran LM, 2002, J CLIN PSYCHIAT, V63, P704, DOI 10.4088/JCP.v63n0808; Martinez-Martin P, 2007, MOVEMENT DISORD, V22, P1623, DOI 10.1002/mds.21586; MCELROY SL, 1994, J CLIN PSYCHIAT, V55, P242; NAUSIEDA PA, 1985, CLIN NEUROPHARMACOL, V8, P318, DOI 10.1097/00002826-198512000-00002; Nazzaro JM, 2011, PARKINSONIS IN PRESS; Nirenberg MJ, 2006, MOVEMENT DISORD, V21, P524, DOI 10.1002/mds.20757; Oei TPS, 2010, BEHAV COGN PSYCHOTH, V38, P233, DOI 10.1017/S1352465809990701; Okun MS, 2010, EXPERT REV NEUROTHER, V10, P1847, DOI 10.1586/ERN.10.156; Pallanti S, 2002, J CLIN PSYCHIAT, V63, P559, DOI 10.4088/JCP.v63n0704; PRIEBE S, 1984, PHARMACOPSYCHIATRY, V17, P109, DOI 10.1055/s-2007-1017418; Rotondo A, 2010, MOVEMENT DISORD, V25, P1994, DOI 10.1002/mds.23177; Smeding HMM, 2007, J NEUROL NEUROSUR PS, V78, P517, DOI 10.1136/jnnp.2006.102061; Stein DJ, 2005, CNS SPECTRUMS, V10, P268, DOI 10.1017/S1092852900022574; Voon V, 2006, NEUROLOGY, V67, P1254, DOI 10.1212/01.wnl.0000238503.20816.13; Voon V, 2011, ANN NEUROL, V69, P986, DOI 10.1002/ana.22356; Voon V, 2009, LANCET NEUROL, V8, P1140, DOI 10.1016/S1474-4422(09)70287-X; Weintraub D, 2010, ARCH NEUROL-CHICAGO, V67, P589, DOI 10.1001/archneurol.2010.65; Witjas T, 2005, MOVEMENT DISORD, V20, P1052, DOI 10.1002/mds.20501	30	80	83	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e29768	10.1371/journal.pone.0029768	http://dx.doi.org/10.1371/journal.pone.0029768			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910ME	22295068	Green Published, Green Submitted, gold			2022-12-25	WOS:000301640600013
J	Reuter, KC; Loitsch, SM; Dignass, AU; Steinhilber, D; Stein, J				Reuter, Kerstin C.; Loitsch, Stefan M.; Dignass, Axel U.; Steinhilber, Dieter; Stein, Juergen			Selective Non-Steroidal Glucocorticoid Receptor Agonists Attenuate Inflammation but Do Not Impair Intestinal Epithelial Cell Restitution In Vitro	PLOS ONE			English	Article							SIGNAL-REGULATED KINASE; GROWTH-FACTOR; MOLECULAR-MECHANISMS; BOWEL-DISEASE; REPAIR MECHANISMS; MEDICAL THERAPY; PLANT-ORIGIN; WOUND REPAIR; KAPPA-B; MODULATION	Introduction: Despite the excellent anti-inflammatory and immunosuppressive action of glucocorticoids (GCs), their use for the treatment of inflammatory bowel disease (IBD) still carries significant risks in terms of frequently occurring severe side effects, such as the impairment of intestinal tissue repair. The recently-introduced selective glucocorticoid receptor (GR) agonists (SEGRAs) offer anti-inflammatory action comparable to that of common GCs, but with a reduced side effect profile. Methods: The in vitro effects of the non-steroidal SEGRAs Compound A (CpdA) and ZK216348, were investigated in intestinal epithelial cells and compared to those of Dexamethasone (Dex). GR translocation was shown by immunfluorescence and Western blot analysis. Trans-repressive effects were studied by means of NF-kappa B/p65 activity and IL-8 levels, trans-activation potency by reporter gene assay. Flow cytometry was used to assess apoptosis of cells exposed to SEGRAs. The effects on IEC-6 and HaCaT cell restitution were determined using an in vitro wound healing model, cell proliferation by BrdU assay. In addition, influences on the TGF-beta- or EGF/ERK1/2/MAPK-pathway were evaluated by reporter gene assay, Western blot and qPCR analysis. Results: Dex, CpdA and ZK216348 were found to be functional GR agonists. In terms of trans-repression, CpdA and ZK216348 effectively inhibited NF-kappa B activity and IL-8 secretion, but showed less trans-activation potency. Furthermore, unlike SEGRAs, Dex caused a dose-dependent inhibition of cell restitution with no effect on cell proliferation. These differences in epithelial restitution were TGF-beta-independent but Dex inhibited the EGF/ERK1/2/MAPK-pathway important for intestinal epithelial wound healing by induction of MKP-1 and Annexin-1 which was not affected by CpdA or ZK216348. Conclusion: Collectively, our results indicate that, while their anti-inflammatory activity is comparable to Dex, SEGRAs show fewer side effects with respect to wound healing. The fact that SEGRAs did not have a similar effect on cell restitution might be due to a different modulation of EGF/ERK1/2 MAPK signalling.	[Reuter, Kerstin C.; Loitsch, Stefan M.; Steinhilber, Dieter; Stein, Juergen] Goethe Univ Frankfurt, Inst Pharmazeut Chem, Frankfurt, Germany; [Dignass, Axel U.] Markus Hosp, Dept Med 1, Frankfurt, Germany; [Stein, Juergen] Elisabethen Hosp, Dept Internal Med, Frankfurt, Germany; [Stein, Juergen] Crohn Colitis Ctr Frankfurt, Frankfurt, Germany	Goethe University Frankfurt	Reuter, KC (corresponding author), Goethe Univ Frankfurt, Inst Pharmazeut Chem, Campus Riedberg, Frankfurt, Germany.	jstein@em.uni-frankfurt.de	Steinhilber, Dieter/J-3221-2012; Dignass, Axel/AAW-9653-2020; Dignass, Axel/V-5400-2019	Dignass, Axel/0000-0002-9724-054X; Stein, Jurgen/0000-0003-3558-3341	Deutsche Forschungsgemeinschaft (DFG) [GRK757]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by a graduate scholarship grant from the Deutsche Forschungsgemeinschaft (DFG, GRK757) to KCR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anstead G M, 1998, Adv Wound Care, V11, P277; BARNES PJ, 1993, TRENDS PHARMACOL SCI, V14, P436, DOI 10.1016/0165-6147(93)90184-L; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Beer H D, 2000, Vitam Horm, V59, P217, DOI 10.1016/S0083-6729(00)59008-6; Bladh LG, 2009, BBA-MOL CELL RES, V1793, P439, DOI 10.1016/j.bbamcr.2008.11.013; Bonner GF, 1996, SOUTHERN MED J, V89, P556, DOI 10.1097/00007611-199606000-00002; De Bosscher K, 2005, P NATL ACAD SCI USA, V102, P15827, DOI 10.1073/pnas.0505554102; De Bosscher K, 2009, MOL ENDOCRINOL, V23, P281, DOI 10.1210/me.2008-0283; de Chambrun GP, 2010, NAT REV GASTRO HEPAT, V7, P15, DOI 10.1038/nrgastro.2009.203; Dewint P, 2008, J IMMUNOL, V180, P2608, DOI 10.4049/jimmunol.180.4.2608; DIGNASS AU, 1993, GASTROENTEROLOGY, V105, P1323, DOI 10.1016/0016-5085(93)90136-Z; Durer U, 2007, CELL PHYSIOL BIOCHEM, V20, P329, DOI 10.1159/000107519; Eberhardt W, 1998, J IMMUNOL, V160, P4961; Engelbrecht Y, 2003, ENDOCRINOLOGY, V144, P412, DOI 10.1210/en.2002-220769; Goke MN, 2002, REGUL PEPTIDES, V105, P203, DOI 10.1016/S0167-0115(02)00023-X; Gossye V, 2010, ANN RHEUM DIS, V69, P291, DOI 10.1136/ard.2008.102871; Grose R, 2002, EMBO REP, V3, P575, DOI 10.1093/embo-reports/kvf119; Heitzer MD, 2007, REV ENDOCR METAB DIS, V8, P321, DOI 10.1007/s11154-007-9059-8; Herr I, 2007, APOPTOSIS, V12, P271, DOI 10.1007/s10495-006-0624-5; Jung S, 2001, SCAND J GASTROENTERO, V36, P963, DOI 10.1080/003655201750305495; Kleiman A, 2007, MOL CELL ENDOCRINOL, V275, P98, DOI 10.1016/j.mce.2007.05.009; Kozuch PL, 2008, WORLD J GASTROENTERO, V14, P354, DOI 10.3748/wjg.14.354; Okamoto R, 2005, DIGEST DIS SCI, V50, pS34, DOI 10.1007/s10620-005-2804-5; Park JE, 2004, AM J SURG, V187, p11S, DOI 10.1016/S0002-9610(03)00296-4; Piette C, 2009, J BIOL CHEM, V284, P32483, DOI 10.1074/jbc.M109.014589; Podolsky DK, 1997, J GASTROENTEROL, V32, P122, DOI 10.1007/BF01213309; REED BR, 1985, J AM ACAD DERMATOL, V13, P919, DOI 10.1016/S0190-9622(85)70242-3; Resche-Rigon M, 1998, CURR OPIN CHEM BIOL, V2, P501, DOI 10.1016/S1367-5931(98)80126-9; Rieder F, 2007, GUT, V56, P130, DOI 10.1136/gut.2006.090456; Rogler G, 2010, BEST PRACT RES CL GA, V24, P157, DOI 10.1016/j.bpg.2009.10.011; Rosen J, 2005, ENDOCR REV, V26, P452, DOI 10.1210/er.2005-0002; SATO Y, 1988, J CELL BIOL, V107, P1199, DOI 10.1083/jcb.107.3.1199; Schacke H, 2004, P NATL ACAD SCI USA, V101, P227, DOI 10.1073/pnas.0300372101; Schaecke H, 2007, MOL CELL ENDOCRINOL, V275, P109, DOI 10.1016/j.mce.2007.05.014; Stahn C, 2007, MOL CELL ENDOCRINOL, V275, P71, DOI 10.1016/j.mce.2007.05.019; Stanbury RM, 1998, BRIT J OPHTHALMOL, V82, P704, DOI 10.1136/bjo.82.6.704; Sturm A, 2008, WORLD J GASTROENTERO, V14, P348, DOI 10.3748/wjg.14.348; Suer S, 2009, CELL TISSUE RES, V336, P213, DOI 10.1007/s00441-009-0776-z; SUMMERS RW, 1979, GASTROENTEROLOGY, V77, P847; Tetreault MP, 2005, EXP CELL RES, V306, P285, DOI 10.1016/j.yexcr.2005.02.019; van Loo G, 2010, MOL ENDOCRINOL, V24, P310, DOI 10.1210/me.2009-0236; Wicke C, 2000, ARCH SURG-CHICAGO, V135, P1265, DOI 10.1001/archsurg.135.11.1265; Wilson AJ, 1997, CLIN SCI, V93, P97, DOI 10.1042/cs0930097; Wust S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008202; Yan F, 2007, OPHTHALMOLOGICA, V221, P244, DOI 10.1159/000101926; Yemelyanov A, 2008, CANCER RES, V68, P4763, DOI 10.1158/0008-5472.CAN-07-6104; Zhang ZR, 2009, J IMMUNOL, V183, P3081, DOI 10.4049/jimmunol.0901088; Znalesniak EB, 2010, CELL PHYSIOL BIOCHEM, V25, P533, DOI 10.1159/000303057	48	19	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e29756	10.1371/journal.pone.0029756	http://dx.doi.org/10.1371/journal.pone.0029756			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910ME	22295067	gold, Green Published, Green Submitted			2022-12-25	WOS:000301640600012
J	Severing, EI; van Dijk, ADJ; Morabito, G; Busscher-Lange, J; Immink, RGH; van Ham, RCHJ				Severing, Edouard I.; van Dijk, Aalt D. J.; Morabito, Giuseppa; Busscher-Lange, Jacqueline; Immink, Richard G. H.; van Ham, Roeland C. H. J.			Predicting the Impact of Alternative Splicing on Plant MADS Domain Protein Function	PLOS ONE			English	Article							FLOWERING TIME; BOX GENES; TRANSCRIPTION FACTORS; ARABIDOPSIS-THALIANA; MESSENGER-RNA; EVOLUTIONARY ANALYSIS; EXON DUPLICATION; ORGAN IDENTITY; SEQUENCE; IDENTIFICATION	Several genome-wide studies demonstrated that alternative splicing (AS) significantly increases the transcriptome complexity in plants. However, the impact of AS on the functional diversity of proteins is difficult to assess using genome-wide approaches. The availability of detailed sequence annotations for specific genes and gene families allows for a more detailed assessment of the potential effect of AS on their function. One example is the plant MADS-domain transcription factor family, members of which interact to form protein complexes that function in transcription regulation. Here, we perform an in silico analysis of the potential impact of AS on the protein-protein interaction capabilities of MIKC-type MADS-domain proteins. We first confirmed the expression of transcript isoforms resulting from predicted AS events. Expressed transcript isoforms were considered functional if they were likely to be translated and if their corresponding AS events either had an effect on predicted dimerisation motifs or occurred in regions known to be involved in multimeric complex formation, or otherwise, if their effect was conserved in different species. Nine out of twelve MIKC MADS-box genes predicted to produce multiple protein isoforms harbored putative functional AS events according to those criteria. AS events with conserved effects were only found at the borders of or within the K-box domain. We illustrate how AS can contribute to the evolution of interaction networks through an example of selective inclusion of a recently evolved interaction motif in the MADS AFFECTING FLOWERING1-3 (MAF1-3) subclade. Furthermore, we demonstrate the potential effect of an AS event in SHORT VEGETATIVE PHASE (SVP), resulting in the deletion of a short sequence stretch including a predicted interaction motif, by overexpression of the fully spliced and the alternatively spliced SVP transcripts. For most of the AS events we were able to formulate hypotheses about the potential impact on the interaction capabilities of the encoded MIKC proteins.	[Severing, Edouard I.; van Dijk, Aalt D. J.; van Ham, Roeland C. H. J.] Plant Res Int, Appl Bioinformat, Wageningen, Netherlands; [Severing, Edouard I.; van Ham, Roeland C. H. J.] Wageningen Univ, Lab Bioinformat, Wageningen, Netherlands; [Immink, Richard G. H.] Ctr BioSyst Genom, Wageningen, Netherlands; [Morabito, Giuseppa; Busscher-Lange, Jacqueline; Immink, Richard G. H.] Plant Res Int, Plant Dev Syst, Wageningen, Netherlands	Wageningen University & Research; Centre for BioSystems Genomics	Severing, EI (corresponding author), Plant Res Int, Appl Bioinformat, Wageningen, Netherlands.	aaltjan.vandijk@wur.nl	Immink, Richard G.H./A-9825-2011; Morabito, Giuseppa/AAC-2149-2020	Morabito, Giuseppa/0000-0002-9198-9349; Immink, Richard/0000-0002-0182-4138; van Dijk, Aalt-Jan/0000-0002-8872-5123	Netherlands Bioinformatics Centre [SP 3.2.1]; Netherlands Genomics Initiative; Netherlands Organization for Scientific Research (NWO) [863.08.027]; NGI [40-41009-98-8003]; Leonardo da Vinci project Unipharma-Graduates	Netherlands Bioinformatics Centre; Netherlands Genomics Initiative; Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); NGI; Leonardo da Vinci project Unipharma-Graduates	This work was supported by the BioRange program (SP 3.2.1) of the Netherlands Bioinformatics Centre, which is supported through the Netherlands Genomics Initiative, by the Netherlands Organization for Scientific Research (NWO, VENI Grant 863.08.027 to ADJvD) and by a NGI Horizon Breakthrough project (Grant 40-41009-98-8003 to RGHI). GM was supported by a scholarship of the Leonardo da Vinci project Unipharma-Graduates (www.unipharmagraduates.it) coordinated by Sapienza University of Rome. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airoldi CA, 2010, P NATL ACAD SCI USA, V107, P18898, DOI 10.1073/pnas.1009050107; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Alvarez-Buylla ER, 2000, P NATL ACAD SCI USA, V97, P5328, DOI 10.1073/pnas.97.10.5328; Amoutzias GD, 2008, TRENDS BIOCHEM SCI, V33, P220, DOI 10.1016/j.tibs.2008.02.002; Baek JM, 2008, PLANT MOL BIOL, V67, P499, DOI 10.1007/s11103-008-9334-4; Balasubramanian S, 2006, PLOS GENET, V2, P980, DOI 10.1371/journal.pgen.0020106; Balasubramanian S, 2006, PLANT SIGNAL BEHAV, V1, P227, DOI 10.4161/psb.1.5.3452; Barbazuk WB, 2008, GENOME RES, V18, P1381, DOI 10.1101/gr.053678.106; Becker A, 2003, MOL PHYLOGENET EVOL, V29, P464, DOI 10.1016/S1055-7903(03)00207-0; Caicedo AL, 2004, P NATL ACAD SCI USA, V101, P15670, DOI 10.1073/pnas.0406232101; Caicedo AL, 2009, MOL BIOL EVOL, V26, P699, DOI 10.1093/molbev/msn300; Causier B, 2005, CURR BIOL, V15, P1508, DOI 10.1016/j.cub.2005.07.063; Causier B, 2010, SEMIN CELL DEV BIOL, V21, P73, DOI 10.1016/j.semcdb.2009.10.005; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; De Bodt S, 2003, TRENDS PLANT SCI, V8, P475, DOI 10.1016/j.tplants.2003.09.006; de Folter S, 2005, PLANT CELL, V17, P1424, DOI 10.1105/tpc.105.031831; Dong QF, 2004, NUCLEIC ACIDS RES, V32, pD354, DOI 10.1093/nar/gkh046; Filichkin SA, 2010, GENOME RES, V20, P45, DOI 10.1101/gr.093302.109; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Hartmann U, 2000, PLANT J, V21, P351, DOI 10.1046/j.1365-313x.2000.00682.x; Henschel K, 2002, MOL BIOL EVOL, V19, P801, DOI 10.1093/oxfordjournals.molbev.a004137; Hill K, 2008, PLANT J, V53, P172, DOI 10.1111/j.1365-313X.2007.03336.x; Hori K, 2007, PLANT CELL PHYSIOL, V48, P1072, DOI 10.1093/pcp/pcm075; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Immink RGH, 2010, SEMIN CELL DEV BIOL, V21, P87, DOI 10.1016/j.semcdb.2009.10.004; Immink RGH, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-2-r24; Irimia M, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-188; Irimia M, 2010, MOL BIOL EVOL, V27, P1504, DOI 10.1093/molbev/msq018; Jiao YL, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.76; Katz Y, 2010, NAT METHODS, V7, P1009, DOI 10.1038/NMETH.1528; Kaufmann K, 2005, MOL GENET GENOMICS, V274, P103, DOI 10.1007/s00438-005-0010-y; Kaufmann K, 2005, GENE, V347, P183, DOI 10.1016/j.gene.2004.12.014; Keren H, 2010, NAT REV GENET, V11, P345, DOI 10.1038/nrg2776; Kim S, 2005, INT J PLANT SCI, V166, P185, DOI 10.1086/427479; Kitahara K, 2000, PLANT SCI, V151, P121, DOI 10.1016/S0168-9452(99)00206-X; Kofuji R, 2003, MOL BIOL EVOL, V20, P1963, DOI 10.1093/molbev/msg216; Kondrashov FA, 2001, HUM MOL GENET, V10, P2661, DOI 10.1093/hmg/10.23.2661; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Kyozuka J, 1997, PLANT MOL BIOL, V35, P573, DOI 10.1023/A:1005885808652; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Letunic I, 2002, HUM MOL GENET, V11, P1561, DOI 10.1093/hmg/11.13.1561; Lewis BP, 2003, P NATL ACAD SCI USA, V100, P189, DOI 10.1073/pnas.0136770100; Li D, 2008, DEV CELL, V15, P110, DOI 10.1016/j.devcel.2008.05.002; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Lightfoot DJ, 2008, MOL GENET GENOMICS, V279, P75, DOI 10.1007/s00438-007-0297-y; Liu S, 2003, NUCLEIC ACIDS RES, V31, P4828, DOI 10.1093/nar/gkg668; Masiero S, 2004, DEVELOPMENT, V131, P5981, DOI 10.1242/dev.01517; Melamud E, 2009, NUCLEIC ACIDS RES, V37, P4862, DOI 10.1093/nar/gkp444; Modrek B, 2003, NAT GENET, V34, P177, DOI 10.1038/ng1159; MONTAG K, 1995, NUCLEIC ACIDS RES, V23, P2168, DOI 10.1093/nar/23.12.2168; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Nesi N, 2002, PLANT CELL, V14, P2463, DOI 10.1105/tpc.004127; Nilsen TW, 2010, NATURE, V463, P457, DOI 10.1038/nature08909; Parenicova L, 2003, PLANT CELL, V15, P1538, DOI 10.1105/tpc.011544; Ratcliffe OJ, 2003, PLANT CELL, V15, P1159, DOI 10.1105/tpc.009506; Reeves PA, 2007, GENETICS, V176, P295, DOI 10.1534/genetics.106.069336; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Riechmann JL, 1997, BIOL CHEM, V378, P1079; Rosti S, 2007, J MOL EVOL, V65, P316, DOI 10.1007/s00239-007-9013-0; Roy SW, 2007, MOL BIOL EVOL, V24, P171, DOI 10.1093/molbev/msl159; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sayers EW, 2009, NUCLEIC ACIDS RES, V37, pD5, DOI 10.1093/nar/gkp967; Scortecci KC, 2001, PLANT J, V26, P229, DOI 10.1046/j.1365-313x.2001.01024.x; Severing EI, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-154; Shchennikova AV, 2006, PLANT J, V47, P934; Simpson CG, 2008, PLANT J, V53, P1035, DOI 10.1111/j.1365-313X.2007.03392.x; Slotte T, 2009, GENETICS, V183, P337, DOI 10.1534/genetics.109.103705; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Su ZX, 2006, GENOME RES, V16, P182, DOI 10.1101/gr.4197006; Taneri B, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r75; Tang JF, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-438; Terzi LC, 2008, REGULATION FLOWERING, P201; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tress ML, 2007, P NATL ACAD SCI USA, V104, P5495, DOI 10.1073/pnas.0700800104; van Dijk ADJ, 2008, BIOINFORMATICS, V24, P26, DOI 10.1093/bioinformatics/btm539; van Dijk ADJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001017; VERWOERD TC, 1989, NUCLEIC ACIDS RES, V17, P2362, DOI 10.1093/nar/17.6.2362; Wang BB, 2006, P NATL ACAD SCI USA, V103, P7175, DOI 10.1073/pnas.0602039103; Wang BB, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-17; Werner JD, 2005, GENETICS, V170, P1197, DOI 10.1534/genetics.104.036533; Xing Y, 2005, P NATL ACAD SCI USA, V102, P13526, DOI 10.1073/pnas.0501213102; Yang YZ, 2004, PLANT MOL BIOL, V55, P45, DOI 10.1007/s11103-004-0416-7; Yang YZ, 2003, PLANT J, V33, P47, DOI 10.1046/j.0960-7412.2003.01473.x; Yen PM, 2001, PHYSIOL REV, V81, P1097, DOI 10.1152/physrev.2001.81.3.1097; Yu WP, 2003, TRENDS GENET, V19, P180, DOI 10.1016/S0168-9525(03)00048-9; Yuan YX, 2009, J EXP BOT, V60, P1299, DOI 10.1093/jxb/erp010; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zhang JZ, 2009, PLANTA, V229, P847, DOI 10.1007/s00425-008-0885-z; Zhang PG, 2010, MOL BIOL EVOL, V27, P1686, DOI 10.1093/molbev/msq054	91	47	54	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e30524	10.1371/journal.pone.0030524	http://dx.doi.org/10.1371/journal.pone.0030524			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910ME	22295091	Green Submitted, Green Published, gold			2022-12-25	WOS:000301640600036
J	Kamiyama, H; Suzuki, K; Maeda, T; Koizumi, K; Miyaki, Y; Okada, S; Kawamura, YJ; Samuelsson, JK; Alonso, S; Konishi, F; Perucho, M				Kamiyama, H.; Suzuki, K.; Maeda, T.; Koizumi, K.; Miyaki, Y.; Okada, S.; Kawamura, Y. J.; Samuelsson, J. K.; Alonso, S.; Konishi, F.; Perucho, M.			DNA demethylation in normal colon tissue predicts predisposition to multiple cancers	ONCOGENE			English	Article						DNA demethylation; colon cancer; synchronous; metachronous; epigenetics	COLORECTAL-CANCER; MICROSATELLITE INSTABILITY; LINE-1 HYPOMETHYLATION; METHYLATION; TUMORS; FIELD; MUCOSA; AGE; GUIDELINES; MUTATIONS	Some colon cancer (CC) patients present synchronous cancers at diagnosis and others develop metachronous neoplasms, but the risk factors are unclear for non-hereditary CC. We showed previously that global DNA demethylation increased with aging and correlated with genomic damage in CC, and we show now that preferentially associates to CCs with wild-type p53. This study aimed to elucidate the extent of DNA hypomethylation in patients with single and multiple CC, its relationship with aging, and its potential as predictive tool. We compared by real-time methylation-specific PCR the relative demethylation level (RDL) of long interspersed nucleotide element-1 (LINE-1) sequences in matched cancer tissues and non-cancerous colonic mucosa (NCM) from patients with single and multiple right-sided CCs. Although no RDL difference was found in NCM from single CC patients and healthy volunteers (P = 0.5), there was more demethylation (higher RDL) in NCM from synchronous cancer patients (P = 1.1 x 10(-5)) multiple CCs also were more demethylated than single CCs (P = 0.0014). High NCM demethylation was predictive for metachronous neoplasms (P = 0.003). In multivariate logistic regression analyses RDL was the only independent predictor for metachronous (P = 0.02) and multiple (P = 4.9 x 10(-5)) tumors. The higher LINE-1 demethylation in NCM from patients with multiple (synchronous and metachronous) tumors (P = 9.6 x 10(-7)) was also very significant in patients with tumors without (P = 3.8 x 10(-6)), but not with (P = 0.16) microsatellite instability. NCM demethylation increased with aging in patients with single tumors, but decreased in those with multiple tumors. Moreover, the demethylation difference between patients with single vs multiple tumors appeared higher in younger (P = 3.6 x 10(-4)) than in older (P = 0.0016) patients. These results predict that LINE-1 hypomethylation in NCM can be used as an epigenetic predictive biomarker for multiple CC risk. The stronger association of demethylation in NCM with multiple CC risk from younger patients also suggests an inherited predisposition for the apparent field cancerization effect of somatic demethylation. Oncogene (2012) 31, 5029-5037; doi:10.1038/onc.2011.652; published online 6 February 2012	[Kamiyama, H.; Suzuki, K.; Maeda, T.; Okada, S.; Kawamura, Y. J.; Konishi, F.] Jichi Med Univ, Saitama Med Ctr, Dept Surg, Saitama, Japan; [Koizumi, K.; Miyaki, Y.] Hamamatsu Univ Sch Med, Dept Surg 1, Hamamatsu, Shizuoka 4313192, Japan; [Samuelsson, J. K.; Perucho, M.] Sanford Burnham Med Res Inst SBMRI, La Jolla, CA 92037 USA; [Samuelsson, J. K.; Alonso, S.; Perucho, M.] Inst Predict & Personalized Med Canc IMPPC, Barcelona, Spain; [Perucho, M.] Inst Catalana Recerca & Estudis Avancats ICREA, Barcelona, Spain	Jichi Medical University; Hamamatsu University School of Medicine; Sanford Burnham Prebys Medical Discovery Institute; ICREA	Suzuki, K (corresponding author), Jichi Med Univ, Saitama Med Ctr, Dept Surg, Saitama, Japan.	ksuzbnhm@omiya.jichi.ac.jp; mperucho@sanfordburnham.org	Alonso, Sergio/GVR-8346-2022; Alonso, Sergio/G-5145-2011	Alonso, Sergio/0000-0001-6497-892X; Perucho, Manuel/0000-0002-2169-2662	Ministry of Education, Culture, Science, Sports, and Technology of Japan; NIH [R37 CA63585]; Spanish Ministry of Science and Innovation [FIS PI09/02444]; ICREA Funding Source: Custom; NATIONAL CANCER INSTITUTE [R37CA063585] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [21591710] Funding Source: KAKEN	Ministry of Education, Culture, Science, Sports, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); ICREA(ICREA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants from the Ministry of Education, Culture, Science, Sports, and Technology of Japan, NIH grant R37 CA63585 and from the Spanish Ministry of Science and Innovation (FIS PI09/02444).	Ahlquist T, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-94; Belshaw NJ, 2010, CARCINOGENESIS, V31, P1158, DOI 10.1093/carcin/bgq077; Bouvier AM, 2008, EUR J CANCER, V44, P522, DOI 10.1016/j.ejca.2008.01.007; Braakhuis BJM, 2003, CANCER RES, V63, P1727; Brenner H, 2007, GUT, V56, P1585, DOI 10.1136/gut.2007.122739; Deng GR, 1996, SCIENCE, V274, P2057, DOI 10.1126/science.274.5295.2057; Eden A, 2003, SCIENCE, V300, P455, DOI 10.1126/science.1083557; Ehrlich M, 2002, ONCOGENE, V21, P5400, DOI 10.1038/sj.onc.1205651; Estecio MRH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000399; FEINBERG AP, 1983, NATURE, V301, P89, DOI 10.1038/301089a0; Feinberg AP, 2004, NAT REV CANCER, V4, P143, DOI 10.1038/nrc1279; Gaudet F, 2003, SCIENCE, V300, P489, DOI 10.1126/science.1083558; Gonzalo V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008777; Horii J, 2008, CLIN BIOCHEM, V41, P1440, DOI 10.1016/j.clinbiochem.2008.08.089; Ibrahim AEK, 2011, GUT, V60, P499, DOI 10.1136/gut.2010.223602; IONOV Y, 1993, NATURE, V363, P558, DOI 10.1038/363558a0; Kawakami K, 2011, CANCER SCI, V102, P166, DOI 10.1111/j.1349-7006.2010.01776.x; KIM HG, 1994, AM J PATHOL, V145, P148; Konishi K, 2009, CANCER PREV RES, V2, P814, DOI 10.1158/1940-6207.CAPR-09-0054; LYNCH HT, 1993, GASTROENTEROLOGY, V104, P1535, DOI 10.1016/0016-5085(93)90368-M; Menigatti M, 2009, ONCOGENE, V28, P899, DOI 10.1038/onc.2008.444; Nosho K, 2009, GASTROENTEROLOGY, V137, P1609, DOI 10.1053/j.gastro.2009.08.002; Ogino S, 2008, J NATL CANCER I, V100, P1734, DOI 10.1093/jnci/djn359; Paun BC, 2010, CANCER-AM CANCER SOC, V116, P4495, DOI 10.1002/cncr.25348; Perucho M, 1996, BIOL CHEM, V377, P675; Qu GZ, 1999, CANCER GENET CYTOGEN, V109, P34, DOI 10.1016/S0165-4608(98)00143-5; R Development Core Team, 2009, R FDN STAT COMP; Rex DK, 2006, GASTROENTEROLOGY, V130, P1865, DOI 10.1053/j.gastro.2006.03.013; SLAUGHTER DP, 1953, CANCER, V6, P963, DOI 10.1002/1097-0142(195309)6:5<963::AID-CNCR2820060515>3.0.CO;2-Q; Sunami E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018884; Suter CM, 2004, INT J COLORECTAL DIS, V19, P95, DOI 10.1007/s00384-003-0539-3; Suzuki K, 2006, CANCER CELL, V9, P199, DOI 10.1016/j.ccr.2006.02.016; Suzuki K, 2003, GASTROENTEROLOGY, V125, P1330, DOI 10.1016/j.gastro.2003.07.006; Svrcek M, 2010, GUT, V59, P1516, DOI 10.1136/gut.2009.194787; THIBODEAU SN, 1993, SCIENCE, V260, P816, DOI 10.1126/science.8484122; Tsao JL, 2000, P NATL ACAD SCI USA, V97, P1236, DOI 10.1073/pnas.97.3.1236; Umar A, 2004, NAT REV CANCER, V4, P153, DOI 10.1038/nrc1278; Ushijima T, 2007, J BIOCHEM MOL BIOL, V40, P142; Vilar E, 2010, NAT REV CLIN ONCOL, V7, P153, DOI 10.1038/nrclinonc.2009.237; Weisenberger DJ, 2005, NUCLEIC ACIDS RES, V33, P6823, DOI 10.1093/nar/gki987; Worthley DL, 2010, ONCOGENE, V29, P1653, DOI 10.1038/onc.2009.449; Xu GL, 1999, NATURE, V402, P187, DOI 10.1038/46052; Yamashita K, 2003, CANCER CELL, V4, P121, DOI 10.1016/S1535-6108(03)00190-9; Zeimet AG, 2011, GYNECOL ONCOL, V121, P24, DOI 10.1016/j.ygyno.2010.12.332	44	47	47	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV	2012	31	48					5029	5037		10.1038/onc.2011.652	http://dx.doi.org/10.1038/onc.2011.652			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	048CU	22310288	Green Accepted			2022-12-25	WOS:000311888600007
J	Rodriguez-Cuenca, S; Carobbio, S; Vidal-Puig, A				Rodriguez-Cuenca, Sergio; Carobbio, Stefania; Vidal-Puig, Antonio			Ablation of Pparg2 impairs lipolysis and reveals murine strain differences in lipolytic responses	FASEB JOURNAL			English	Article						adipose tissue; insulin resistance	ADIPOSE-TISSUE LIPOLYSIS; ACTIVATED-RECEPTOR-GAMMA; DIET-INDUCED OBESITY; LIPID DROPLETS; INSULIN SENSITIVITY; ADIPOCYTE LIPOLYSIS; TRIGLYCERIDE LIPASE; EXPRESSION; RESISTANCE; PERILIPIN	We investigate the role of PPARg2 as a regulator of lipolysis and its interaction with specific genetic backgrounds as determinants of the severity of the metabolic phenotype. This question was prompted by our previous characterization of Pparg2-knockout (KO) mice that revealed striking genetic background differences in the severity of their adipose tissue development impairment and dysfunction. Analysis is done of pharmacological lipolytic responses combined with protein and mRNA expression analysis in isolated adipocytes from the gonadal pad of Pparg2-KO mice in 2 different backgrounds (129S6/SvEv and C57BL/6). We provide evidence of the prolipolytic role of PPARg2 and how these effects are modulated by genetic background, leading to differential severity of metabolic syndrome. Specifically, ablation of Pparg2 reduced both basal and stimulated lipolysis as a result of impaired beta(3)-AR signaling, a general defect at downstream lipases, and increased insulin-mediated antilipolytic action. Of note, the C57BL/6 Pparg2-KO mice exhibited more active lipolytic response to catecholamines than 129S6/SvEv Pparg2-KO mice with respect to their wild-type controls. Pparg2-KO mice exhibit metabolic inflexibility resulting from the combined effects of impaired lipid deposition coupled with impaired lipolytic lipid mobilization. The genetic background-dependent differences in lipolysis may account for Pparg2-KO background-specific differences in the severity of their metabolic disturbances. Our findings identify the isoform Pparg2 as an integrator of the adipose lipid metabolism coordinating both anabolic and catabolic processes.-Rodriguez-Cuenca, S., Carobbio, S., Vidal-Puig, A. Ablation of Pparg2 impairs lipolysis and reveals murine strains differences in lipolytic responses. FASEB J. 26, 1835-1844 (2012). www.fasebj.org	[Rodriguez-Cuenca, Sergio; Carobbio, Stefania; Vidal-Puig, Antonio] Univ Cambridge, Addenbrookes Hosp, NIHR Cambridge Biomed Res Ctr, Dept Clin Biochem,Metab Res Labs,Inst Metab Sci, Cambridge CB2 0QQ, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Rodriguez-Cuenca, S (corresponding author), Univ Cambridge, Addenbrookes Hosp, NIHR Cambridge Biomed Res Ctr, Dept Clin Biochem,Metab Res Labs,Inst Metab Sci, Cambridge CB2 0QQ, England.	sr441@medschl.cam.ac.uk; ajv22@medschl.cam.ac.uk	carobbio, stefania/E-7095-2018	Vidal-Puig, Antonio/0000-0003-4220-9577	Hepatic and Adipose Tissue and Functions in the Metabolic Syndrome (HEPADIP) project; Wellcome Trust; UK Medical Research Council [HEALTH-F4-2008-223450]; British Heart Foundation; Medical Research Council [G0802051, G0600717B] Funding Source: researchfish; MRC [G0802051] Funding Source: UKRI	Hepatic and Adipose Tissue and Functions in the Metabolic Syndrome (HEPADIP) project; Wellcome Trust(Wellcome TrustEuropean Commission); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors thank Dr. Gema Medina-Gomez (Institute of Metabolic Sciences, University of Cambridge) for providing access to the Pparg2-KO line. The authors also thank Janice Carter, Dan Hart, Sarah Grocott, and Helen Westby for husbandry of the Pparg2-KO colony. This work was funded by the Hepatic and Adipose Tissue and Functions in the Metabolic Syndrome (HEPADIP) project, a Wellcome Trust Insulin Resistance Program grant, UK Medical Research Council Programme grants FP7-MITIN (HEALTH-F4-2008-223450) and FP7-BetaBAT, and the British Heart Foundation.	Ahmad F, 2009, BIOCHEM J, V424, P399, DOI 10.1042/BJ20090842; Almind K, 2004, DIABETES, V53, P3274, DOI 10.2337/diabetes.53.12.3274; Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200; Cohen AW, 2004, DIABETES, V53, P1261, DOI 10.2337/diabetes.53.5.1261; Cohen AW, 2003, AM J PHYSIOL-CELL PH, V285, pC222, DOI 10.1152/ajpcell.00006.2003; Dalen KT, 2004, DIABETES, V53, P1243, DOI 10.2337/diabetes.53.5.1243; Deng T, 2006, ENDOCRINOLOGY, V147, P875, DOI 10.1210/en.2005-0623; Ducharme NA, 2008, ENDOCRINOLOGY, V149, P942, DOI 10.1210/en.2007-1713; Festuccia WT, 2006, DIABETOLOGIA, V49, P2427, DOI 10.1007/s00125-006-0336-y; Granneman JG, 2009, J BIOL CHEM, V284, P34538, DOI 10.1074/jbc.M109.068478; Gray SL, 2007, NUTR REV, V65, pS7, DOI [10.1111/j.1753-4887.2007.tb00331.x, 10.1301/nr.2007.jun.S7-S12]; Harris C. A., J LIPID RES, V52, P657; Jaworski K, 2007, AM J PHYSIOL-GASTR L, V293, pG1, DOI 10.1152/ajpgi.00554.2006; Kershaw EE, 2007, AM J PHYSIOL-ENDOC M, V293, pE1736, DOI 10.1152/ajpendo.00122.2007; Kim JY, 2006, AM J PHYSIOL-ENDOC M, V291, pE115, DOI 10.1152/ajpendo.00317.2005; Langin D, 2006, CR BIOL, V329, P598, DOI 10.1016/j.crvi.2005.10.008; Medina-Gomez G, 2005, DIABETES, V54, P1706, DOI 10.2337/diabetes.54.6.1706; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Puri V, 2008, P NATL ACAD SCI USA, V105, P7833, DOI 10.1073/pnas.0802063105; RODBELL M, 1964, J BIOL CHEM, V239, P375; Snyder PB, 2005, J LIPID RES, V46, P494, DOI 10.1194/jlr.M400362-JLR200; Tansey JT, 2001, P NATL ACAD SCI USA, V98, P6494, DOI 10.1073/pnas.101042998; Thiele C, 2008, CURR OPIN CELL BIOL, V20, P378, DOI 10.1016/j.ceb.2008.05.009; VidalPuig A, 1996, J CLIN INVEST, V97, P2553, DOI 10.1172/JCI118703; Zhang JF, 2004, P NATL ACAD SCI USA, V101, P10703, DOI 10.1073/pnas.0403652101	25	11	11	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	MAY	2012	26	5					1835	1844		10.1096/fj.11-193631	http://dx.doi.org/10.1096/fj.11-193631			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	937TD	22319009				2022-12-25	WOS:000303680800012
J	Rosenzweig, R; Bronner, V; Zhang, DN; Fushman, D; Glickman, MH				Rosenzweig, Rina; Bronner, Vered; Zhang, Daoning; Fushman, David; Glickman, Michael H.			Rpn1 and Rpn2 Coordinate Ubiquitin Processing Factors at Proteasome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYUBIQUITIN-BINDING PROTEIN; DEUBIQUITINATING ENZYME; REGULATORY PARTICLE; 26S PROTEASOME; CRYSTAL-STRUCTURE; UBA DOMAINS; ATPASE SUBUNITS; HEAT; COMPLEX; DEGRADATION	Substrates tagged with (poly) ubiquitin for degradation can be targeted directly to the 26 S proteasome where they are proteolyzed. Independently, ubiquitin conjugates may also be delivered by bivalent shuttles. The majority of shuttles attach to the proteasome through a ubiquitin-like domain (UBL) while anchoring cargo at a C-terminal polyubiquitin-binding domain(s). We found that two shuttles of this class, Rad23 and Dsk2, dock at two different receptor sites embedded within a single subunit of the 19 S proteasome regulatory particle, Rpn1. Their association/dissociation constants and affinities for Rpn1 are similar. In contrast, another UBL-containing protein, the deubiquitinase Ubp6, is also anchored by Rpn1, yet it dissociates slower, thus behaving as an occasional proteasome subunit that is distinct from the transiently associated shuttles. Two neighboring subunits, Rpn10 and Rpn13, show a marked preference for polyubiquitin over UBLs. Rpn10 attaches to the central solenoid portion of Rpn1, although this association is stabilized by the presence of a third subunit, Rpn2. Rpn13 binds directly to Rpn2. These intrinsic polyubiquitin receptors may compete with substrate shuttles for their polyubiquitin-conjugate cargos, thereby aiding release of the emptied shuttles. By binding multiple ubiquitin-processing factors simultaneously, Rpn1 is uniquely suited to coordinate substrate recruitment, deubiquitination, and movement toward the catalytic core. The broad range of affinities for ubiquitin, ubiquitin-like, and non-ubiquitin signals by adjacent yet nonoverlapping sites all within the base represents a hub of activity that coordinates the intricate relay of substrates within the proteasome, and consequently it influences substrate residency time and commitment to degradation.	[Bronner, Vered; Fushman, David] Biorad Haifa Ltd, Prot Funct Div, Technion City, IL-32000 Haifa, Israel; [Rosenzweig, Rina; Glickman, Michael H.] Technion Israel Inst Technol, Dept Biol, IL-32000 Haifa, Israel; [Zhang, Daoning] Univ Maryland, Ctr Biomol Struct & Org, Dept Chem & Biochem, College Pk, MD 20910 USA	Technion Israel Institute of Technology; Technion Israel Institute of Technology; University System of Maryland; University of Maryland College Park	Fushman, D (corresponding author), Biorad Haifa Ltd, Prot Funct Div, Technion City, IL-32000 Haifa, Israel.	fushman@umd.edu; glickman@techunix.technion.ac.il		Glickman, Michael/0000-0002-1222-8104; Rosenzweig, Rina/0000-0002-4019-5135	National Institutes of Health [GM095755]; Israel Science Foundation; United States-Israel Binational Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095755] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Israel Science Foundation(Israel Science Foundation); United States-Israel Binational Science Foundation(US-Israel Binational Science Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM095755 (to D. F. and M. H. G.). This work was also supported by grants from the Israel Science Foundation (to M. H. G.) and by the United States-Israel Binational Science Foundation (to M. H. G. and D. F.).	Aksel T, 2011, STRUCTURE, V19, P349, DOI 10.1016/j.str.2010.12.018; Alag R, 2009, PROTEIN SCI, V18, P2115, DOI 10.1002/pro.226; Andersen KM, 2009, J BIOL CHEM, V284, P15246, DOI 10.1074/jbc.M900016200; Andersen KM, 2005, ESSAYS BIOCHEM, V41, P49, DOI 10.1042/EB0410049; Andrade MA, 2001, J MOL BIOL, V309, P1, DOI 10.1006/jmbi.2001.4624; Bar-Nun S., 2011, BIOCHIM BIOPHYS ACTA, V1823, P67; Bedford L, 2010, TRENDS CELL BIOL, V20, P391, DOI 10.1016/j.tcb.2010.03.007; Bertolaet BL, 2001, NAT STRUCT BIOL, V8, P417, DOI 10.1038/87575; Borodovsky A, 2001, EMBO J, V20, P5187, DOI 10.1093/emboj/20.18.5187; Chen L, 2002, MOL CELL BIOL, V22, P4902, DOI 10.1128/MCB.22.13.4902-4913.2002; Chen X, 2010, MOL CELL, V38, P404, DOI 10.1016/j.molcel.2010.04.019; Cheskis B, 1996, BIOCHEMISTRY-US, V35, P3309, DOI 10.1021/bi952283r; Conti E, 2006, CURR OPIN STRUC BIOL, V16, P237, DOI 10.1016/j.sbi.2006.03.010; Davy A, 2001, EMBO REP, V2, P821, DOI 10.1093/embo-reports/kve184; DEMARINI DJ, 1995, MOL CELL BIOL, V15, P6311; Effantin G, 2009, J MOL BIOL, V386, P1204, DOI 10.1016/j.jmb.2009.01.039; Elsasser S, 2002, NAT CELL BIOL, V4, P725, DOI 10.1038/ncb845; Elsasser S, 2004, J BIOL CHEM, V279, P26817, DOI 10.1074/jbc.M404020200; Fatimababy AS, 2010, FEBS J, V277, P796, DOI 10.1111/j.1742-4658.2009.07531.x; FINLEY D, 1987, CELL, V48, P1035, DOI 10.1016/0092-8674(87)90711-2; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Funakoshi M, 2002, P NATL ACAD SCI USA, V99, P745, DOI 10.1073/pnas.012585199; Gillette TG, 2008, J BIOL CHEM, V283, P31813, DOI 10.1074/jbc.M805935200; Glickman MH, 2004, PLOS BIOL, V2, P25, DOI 10.1371/journal.pbio.0020013; Glickman MH, 1998, CELL, V94, P615, DOI 10.1016/S0092-8674(00)81603-7; Gomez TA, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-33; Gorbea C, 2000, J BIOL CHEM, V275, P875, DOI 10.1074/jbc.275.2.875; Grinthal A, 2010, P NATL ACAD SCI USA, V107, P2467, DOI 10.1073/pnas.0914073107; Guterman A, 2004, CURR PROTEIN PEPT SC, V5, P201, DOI 10.2174/1389203043379756; Guterman A, 2004, J BIOL CHEM, V279, P1729, DOI 10.1074/jbc.M307050200; Hamazaki J, 2006, EMBO J, V25, P4524, DOI 10.1038/sj.emboj.7601338; Hanna J, 2006, CELL, V127, P99, DOI 10.1016/j.cell.2006.07.038; Harper S, 2011, BIOCHEMISTRY-US, V50, P7995, DOI 10.1021/bi200726e; Hartmann-Petersen R, 2003, TRENDS BIOCHEM SCI, V28, P26, DOI 10.1016/S0968-0004(02)00002-6; Hartmann-Petersen R, 2004, SEMIN CELL DEV BIOL, V15, P247, DOI 10.1016/j.semcdb.2003.12.006; Hartmann-Petersen R, 2003, FEBS LETT, V535, P77, DOI 10.1016/S0014-5793(02)03874-7; Hartmann-Petersen R, 2001, ARCH BIOCHEM BIOPHYS, V386, P89, DOI 10.1006/abbi.2000.2178; Heessen S, 2005, MOL CELL, V18, P225, DOI 10.1016/j.molcel.2005.03.015; Heinen C, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1179; Hendil KB, 2009, J MOL BIOL, V394, P320, DOI 10.1016/j.jmb.2009.09.038; Hetfeld BKJ, 2005, CURR BIOL, V15, P1217, DOI 10.1016/j.cub.2005.05.059; Hjerpe R, 2009, EMBO REP, V10, P1250, DOI 10.1038/embor.2009.192; Hofmann K, 1996, TRENDS BIOCHEM SCI, V21, P172, DOI 10.1016/0968-0004(96)30015-7; Hu M, 2002, CELL, V111, P1041, DOI 10.1016/S0092-8674(02)01199-6; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; Husnjak K, 2008, NATURE, V453, P481, DOI 10.1038/nature06926; Ishida T, 2007, NUCLEIC ACIDS RES, V35, pW460, DOI 10.1093/nar/gkm363; Kajava AV, 2004, J STRUCT BIOL, V146, P425, DOI 10.1016/j.jsb.2004.01.013; Kajava AV, 2002, J BIOL CHEM, V277, P49791, DOI 10.1074/jbc.M204982200; Kang Y, 2006, J MOL BIOL, V356, P1027, DOI 10.1016/j.jmb.2005.12.001; Kappel C, 2010, BIOPHYS J, V99, P1596, DOI 10.1016/j.bpj.2010.06.032; Kennedy SA, 2009, J MOL BIOL, V392, P115, DOI 10.1016/j.jmb.2009.06.062; Kippert F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007148; Knutson BA, 2010, J STRUCT BIOL, V170, P354, DOI 10.1016/j.jsb.2010.01.002; Koulich E, 2008, MOL BIOL CELL, V19, P1072, DOI 10.1091/mbc.E07-10-1040; Kraut DA, 2007, TRENDS CELL BIOL, V17, P419, DOI 10.1016/j.tcb.2007.06.008; Lee MJ, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.R110.003871; Leggett DS, 2002, MOL CELL, V10, P495, DOI 10.1016/S1097-2765(02)00638-X; Luna-Vargas MPA, 2011, EMBO REP, V12, P365, DOI 10.1038/embor.2011.33; Marques AJ, 2007, J BIOL CHEM, V282, P34869, DOI 10.1074/jbc.M705836200; Matiuhin Y, 2008, MOL CELL, V32, P415, DOI 10.1016/j.molcel.2008.10.011; Maupin-Furlow JA, 2006, CURR TOP DEV BIOL, V75, P125, DOI 10.1016/S0070-2153(06)75005-0; Peth A, 2010, MOL CELL, V40, P671, DOI 10.1016/j.molcel.2010.11.002; Peth A, 2009, MOL CELL, V36, P794, DOI 10.1016/j.molcel.2009.11.015; Raasi S, 2004, J MOL BIOL, V341, P1367, DOI 10.1016/j.jmb.2004.06.057; Raasi S, 2005, NAT STRUCT MOL BIOL, V12, P708, DOI 10.1038/nsmb962; Richmond C, 1997, J BIOL CHEM, V272, P13403, DOI 10.1074/jbc.272.20.13403; Roelofs J, 2009, NATURE, V459, P861, DOI 10.1038/nature08063; Rosenzweig R, 2008, NAT STRUCT MOL BIOL, V15, P573, DOI 10.1038/nsmb.1427; Sadre-Bazzaz K, 2010, MOL CELL, V37, P728, DOI 10.1016/j.molcel.2010.02.002; Saeki Y, 2002, BIOCHEM BIOPH RES CO, V296, P813, DOI 10.1016/S0006-291X(02)02002-8; Savulescu AF, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.R110.006890; Schauber C, 1998, NATURE, V391, P715, DOI 10.1038/35661; Schrader EK, 2009, NAT CHEM BIOL, V5, P815, DOI 10.1038/nchembio.250; Schreiner P, 2008, NATURE, V453, P548, DOI 10.1038/nature06924; Seeger M, 2003, J BIOL CHEM, V278, P16791, DOI 10.1074/jbc.M208281200; Sibanda BL, 2010, NATURE, V463, P118, DOI 10.1038/nature08648; Sirkis R, 2006, J MOL BIOL, V364, P376, DOI 10.1016/j.jmb.2006.08.086; Stadtmueller BM, 2010, J BIOL CHEM, V285, P13, DOI 10.1074/jbc.C109.070425; Tao JH, 2010, J MOL BIOL, V397, P1307, DOI 10.1016/j.jmb.2010.02.028; Tsurumi C, 1996, EUR J BIOCHEM, V239, P912, DOI 10.1111/j.1432-1033.1996.0912u.x; Tyrrell A, 2010, P NATL ACAD SCI USA, V107, P19796, DOI 10.1073/pnas.1010648107; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Verma R, 2004, CELL, V118, P99, DOI 10.1016/j.cell.2004.06.014; Walters KJ, 2008, MOL CELL, V32, P459, DOI 10.1016/j.molcel.2008.10.020; Wang SH, 2009, PLANT CELL PHYSIOL, V50, P1721, DOI 10.1093/pcp/pcp105; Wendler P, 2004, J BIOL CHEM, V279, P37751, DOI 10.1074/jbc.M403551200; Wilkinson CRM, 2001, NAT CELL BIOL, V3, P939, DOI 10.1038/ncb1001-939; Wyndham AM, 1999, PROTEIN SCI, V8, P1268, DOI 10.1110/ps.8.6.1268; Yao TT, 2002, NATURE, V419, P403, DOI 10.1038/nature01071; Zhang D, 2008, J MOL BIOL, V377, P162, DOI 10.1016/j.jmb.2007.12.029; Zhang DN, 2009, MOL CELL, V36, P1018, DOI 10.1016/j.molcel.2009.11.012; Zhang F, 2009, MOL CELL, V34, P485, DOI 10.1016/j.molcel.2009.04.022	93	85	86	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					14659	14671		10.1074/jbc.M111.316323	http://dx.doi.org/10.1074/jbc.M111.316323			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22318722	Green Published, hybrid			2022-12-25	WOS:000304003200032
J	Gurba, KN; Hernandez, CC; Hu, NN; Macdonald, RL				Gurba, Katharine N.; Hernandez, Ciria C.; Hu, Ningning; Macdonald, Robert L.			GABRB3 Mutation, G32R, Associated with Childhood Absence Epilepsy Alters alpha 1 beta 3 gamma 2L gamma-Aminobutyric Acid Type A (GABA(A)) Receptor Expression and Channel Gating	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND-BINDING DOMAIN; X-RAY-STRUCTURE; SUBUNIT COMPOSITION; CRYSTAL-STRUCTURE; GLYCOSYLATION; BIOGENESIS; ALPHA-1; SITE; IDENTIFICATION; PEPTIDES	A GABA(A) receptor beta 3 subunit mutation, G32R, has been associated with childhood absence epilepsy. We evaluated the possibility that this mutation, which is located adjacent to the most N-terminal of three beta 3 subunit N-glycosylation sites, might reduce GABAergic inhibition by increasing glycosylation of beta 3 subunits. The mutation had three major effects on GABA(A) receptors. First, coexpression of beta 3(G32R) subunits with alpha 1 or alpha 3 and gamma 2L subunits in HEK293T cells reduced surface expression of gamma 2L subunits and increased surface expression of beta 3 subunits, suggesting a partial shift from ternary alpha beta 3 gamma 2L receptors to binary alpha beta 3 and homomeric beta 3 receptors. Second, beta 3(G32R) subunits were more likely than beta 3 subunits to be N-glycosylated at Asn-33, but increases in glycosylation were not responsible for changes in subunit surface expression. Rather, both phenomena could be attributed to the presence of a basic residue at position 32. Finally, alpha 1 beta 3(G32R)gamma 2L receptors had significantly reduced macroscopic current density. This reduction could not be explained fully by changes in subunit expression levels (because gamma 2L levels decreased only slightly) or glycosylation (because reduction persisted in the absence of glycosylation at Asn-33). Single channel recording revealed that alpha 1 beta 3(G32R)gamma 2L receptors had impaired gating with shorter mean open time. Homology modeling indicated that the mutation altered salt bridges at subunit interfaces, including regions important for subunit oligomerization. Our results suggest both a mechanism for mutation-induced hyperexcitability and a novel role for the beta 3 subunit N-terminal alpha-helix in receptor assembly and gating.	[Macdonald, Robert L.] Vanderbilt Univ, Med Ctr, Dept Neurol, Nashville, TN 37232 USA; [Gurba, Katharine N.] Vanderbilt Univ, Program Neurosci, Nashville, TN 37232 USA; [Macdonald, Robert L.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; [Macdonald, Robert L.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Macdonald, RL (corresponding author), Vanderbilt Univ, Med Ctr, Dept Neurol, 6140 Med Res Bldg 3,465 21st Ave, Nashville, TN 37232 USA.	robert.macdonald@vanderbilt.edu		Hernandez, Ciria/0000-0001-9715-1734	NINDS NIH HHS [R01 NS051590] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051590] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Antenos M, 2007, MOL ENDOCRINOL, V21, P1670, DOI 10.1210/me.2007-0050; Bano-Polo M, 2011, PROTEIN SCI, V20, P179, DOI 10.1002/pro.551; Baumann SW, 2002, J BIOL CHEM, V277, P46020, DOI 10.1074/jbc.M207663200; Baumann SW, 2001, J BIOL CHEM, V276, P36275, DOI 10.1074/jbc.M105240200; BAUSE E, 1983, BIOCHEM J, V209, P331, DOI 10.1042/bj2090331; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; BULLER AL, 1994, MOL PHARMACOL, V46, P858; Castillo M, 2009, J NEUROCHEM, V108, P1399, DOI 10.1111/j.1471-4159.2009.05924.x; Chen YC, 2003, ANN NEUROL, V54, P239, DOI 10.1002/ana.10607; Cope DW, 2009, NAT MED, V15, P1392, DOI 10.1038/nm.2058; Crunelli V, 2002, NAT REV NEUROSCI, V3, P371, DOI 10.1038/nrn811; Dellisanti CD, 2007, NAT NEUROSCI, V10, P953, DOI 10.1038/nn1942; Everett K, 2007, EPILEPSY RES, V75, P145, DOI 10.1016/j.eplepsyres.2007.05.004; Everett KV, 2007, EUR J HUM GENET, V15, P463, DOI 10.1038/sj.ejhg.5201783; Fillman SG, 2010, INT J DEV NEUROSCI, V28, P513, DOI 10.1016/j.ijdevneu.2010.05.004; Fisher JL, 1997, J PHYSIOL-LONDON, V505, P283, DOI 10.1111/j.1469-7793.1997.283bb.x; Frugier G, 2007, J BIOL CHEM, V282, P3819, DOI 10.1074/jbc.M608910200; Glozman R, 2009, J CELL BIOL, V184, P847, DOI 10.1083/jcb.200808124; Hales TG, 2005, MOL CELL NEUROSCI, V29, P120, DOI 10.1016/j.mcn.2005.01.002; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; HENDSCH ZS, 1994, PROTEIN SCI, V3, P211; Hernandez CC, 2011, J PHYSIOL-LONDON, V589, P5857, DOI 10.1113/jphysiol.2011.218883; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; IMPERIALI B, 1991, BIOCHEMISTRY-US, V30, P4374, DOI 10.1021/bi00232a002; Jaeken J, 2010, ANN NY ACAD SCI, V1214, P190, DOI 10.1111/j.1749-6632.2010.05840.x; Kamei N, 2010, BIOCHEM BIOPH RES CO, V391, P557, DOI 10.1016/j.bbrc.2009.11.098; Kananura C, 2002, ARCH NEUROL-CHICAGO, V59, P1137, DOI 10.1001/archneur.59.7.1137; Kang JQ, 2009, J NEUROSCI, V29, P2845, DOI 10.1523/JNEUROSCI.4772-08.2009; KAPLAN HA, 1987, BIOCHIM BIOPHYS ACTA, V906, P161, DOI 10.1016/0304-4157(87)90010-4; Kash TL, 2004, BIOCHEM SOC T, V32, P540, DOI 10.1042/BST0320540; Klausberger T, 2000, J BIOL CHEM, V275, P8921, DOI 10.1074/jbc.275.12.8921; LAURIE DJ, 1992, J NEUROSCI, V12, P4151; Liang J, 2007, ANN HUM GENET, V71, P325, DOI 10.1111/j.1469-1809.2006.00332.x; Lo WY, 2010, J BIOL CHEM, V285, P31348, DOI 10.1074/jbc.M110.151449; Lu Jian-jun, 2005, Zhonghua Er Ke Za Zhi, V43, P133; Meeren H, 2005, ARCH NEUROL-CHICAGO, V62, P371, DOI 10.1001/archneur.62.3.371; Molinari M, 2007, NAT CHEM BIOL, V3, P313, DOI 10.1038/nchembio880; Olsen RW, 2008, PHARMACOL REV, V60, P243, DOI 10.1124/pr.108.00505; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Sieghart W., 2002, Current Topics in Medicinal Chemistry, V2, P795, DOI 10.2174/1568026023393507; Smit AB, 2003, ANN NY ACAD SCI, V998, P81, DOI 10.1196/annals.1254.010; Sutachan JJ, 2005, BRAIN RES, V1058, P30, DOI 10.1016/j.brainres.2005.07.050; Tanaka M, 2008, AM J HUM GENET, V82, P1249, DOI 10.1016/j.ajhg.2008.04.020; Taylor PM, 1999, J NEUROSCI, V19, P6360; Tretter V, 1997, J NEUROSCI, V17, P2728; TWYMAN RE, 1990, J PHYSIOL-LONDON, V423, P193, DOI 10.1113/jphysiol.1990.sp018018; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031	48	39	44	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					12083	12097		10.1074/jbc.M111.332528	http://dx.doi.org/10.1074/jbc.M111.332528			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22303015	Green Published, hybrid			2022-12-25	WOS:000302782200045
J	Madsen, KL; Thorsen, TS; Rahbek-Clemmensen, T; Eriksen, J; Gether, U				Madsen, Kenneth L.; Thorsen, Thor S.; Rahbek-Clemmensen, Troels; Eriksen, Jacob; Gether, Ulrik			Protein Interacting with C Kinase 1 (PICK1) Reduces Reinsertion Rates of Interaction Partners Sorted to Rab11-dependent Slow Recycling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMPA RECEPTOR TRAFFICKING; LONG-TERM DEPRESSION; PDZ-DOMAIN; DOPAMINE TRANSPORTER; DIFFERENTIAL REGULATION; PKC PHOSPHORYLATION; COUPLED RECEPTORS; NMDA RECEPTORS; BAR DOMAINS; IN-VIVO	The scaffolding protein PICK1 (protein interacting with C kinase 1) contains an N-terminal PSD-95/Discs large/ZO-1 (PDZ) domain and a central lipid-binding Bin/amphiphysin/Rvs (BAR) domain. PICK1 is thought to regulate trafficking of its PDZ binding partners but different and even opposing functions have been suggested. Here, we apply ELISA-based assays and confocal microscopy in HEK293 cells with inducible PICK1 expression to assess in an isolated system the ability of PICK1 to regulate trafficking of natural and engineered PDZ binding partners. The dopamine transporter (DAT), which primarily sorts to degradation upon internalization, did not form perinuclear clusters with PICK1, and PICK1 did not affect DAT internalization/recycling. However, transfer of the PICK1-binding DAT C terminus to the beta(2)-adrenergic receptor, which sorts to recycling upon internalization, led to formation of PICK1 co-clusters in Rab11-positive compartments. Furthermore, PICK1 inhibited Rab11-mediated recycling of the receptor in a BAR and PDZ domain-dependent manner. In contrast, transfer of the DAT C terminus to the delta-opioid receptor, which sorts to degradation, did not result in PICK1 co-clusters or any change in internalization/recycling. Further support for a role of PICK1 determined by its PDZ cargo was obtained for the PICK1 interaction partner prolactin-releasing peptide receptor (GPR10). GPR10 co-localized with Rab11 and clustered with PICK1 upon constitutive internalization but co-localized with the late endosomal marker Rab7 and did not cluster with PICK1 upon agonist-induced internalization. Our data suggest a selective role of PICK1 in clustering and reducing the recycling rates of PDZ domain binding partners sorted to the Rab11-dependent recycling pathway.	[Gether, Ulrik] Univ Copenhagen, Lundbeck Fdn Ctr Biomembranes Nanomed, Dept Neurosci & Pharmacol, Fac Hlth Sci,Panum Inst, DK-2200 Copenhagen N, Denmark; Univ Copenhagen, Mol Neuropharmacol Lab, Dept Neurosci & Pharmacol, Fac Hlth Sci,Panum Inst, DK-2200 Copenhagen N, Denmark	Lundbeckfonden; University of Copenhagen; University of Copenhagen	Gether, U (corresponding author), Univ Copenhagen, Lundbeck Fdn Ctr Biomembranes Nanomed, Dept Neurosci & Pharmacol, Fac Hlth Sci,Panum Inst, 18-6,Blegdamsvej 3, DK-2200 Copenhagen N, Denmark.	gether@sund.ku.dk	Madsen, Kenneth/C-7778-2012	Madsen, Kenneth/0000-0001-9274-6691; Rahbek-Clemmensen, Troels/0000-0003-2067-5411; Gether, Ulrik/0000-0002-0020-3807; Eriksen, Jacob/0000-0003-0726-9769	National Institutes of Health [P01 DA 12408]; Lundbeck Foundation; Novo Nordisk Foundation; Danish Medical Research Councils; University of Copenhagen; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA012408] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Medical Research Councils(Danish Medical Research Council); University of Copenhagen; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grant P01 DA 12408 (to U. G.). This work was also supported by the Lundbeck Foundation (to U. G.), the Novo Nordisk Foundation, the Danish Medical Research Councils (to U. G. and K. M.), and the University of Copenhagen Program of Excellence (BioScaRT) (to U. G.).	Adkins EM, 2007, BIOCHEMISTRY-US, V46, P10484, DOI 10.1021/bi700429z; Baer K, 2007, MOL CELL NEUROSCI, V35, P339, DOI 10.1016/j.mcn.2007.03.009; Bassan M, 2008, EUR J NEUROSCI, V27, P66, DOI 10.1111/j.1460-9568.2007.05986.x; Bellone C, 2006, NAT NEUROSCI, V9, P636, DOI 10.1038/nn1682; Beuming T, 2005, BIOINFORMATICS, V21, P827, DOI 10.1093/bioinformatics/bti098; Bjerggaard C, 2004, J NEUROSCI, V24, P7024, DOI 10.1523/JNEUROSCI.1863-04.2004; Boudin H, 2000, NEURON, V28, P485, DOI 10.1016/S0896-6273(00)00127-6; Cao TT, 1999, NATURE, V401, P286, DOI 10.1038/45816; Chmelar RS, 2006, J BIOL CHEM, V281, P35381, DOI 10.1074/jbc.M605954200; Citri A, 2010, J NEUROSCI, V30, P16437, DOI 10.1523/JNEUROSCI.4478-10.2010; Cong M, 2001, J BIOL CHEM, V276, P45145, DOI 10.1074/jbc.M106087200; Daniels GM, 1999, J BIOL CHEM, V274, P35794, DOI 10.1074/jbc.274.50.35794; Daw MI, 2000, NEURON, V28, P873, DOI 10.1016/S0896-6273(00)00160-4; Dev KK, 2000, J NEUROSCI, V20, P7252; Dev KK, 2007, CURR TOP MED CHEM, V7, P3, DOI 10.2174/156802607779318343; Eriksen J, 2010, J BIOL CHEM, V285, P27289, DOI 10.1074/jbc.M110.131003; Frost A, 2008, CELL, V132, P807, DOI 10.1016/j.cell.2007.12.041; Gage RM, 2001, J BIOL CHEM, V276, P44712, DOI 10.1074/jbc.M107417200; Gardner SM, 2005, NEURON, V45, P903, DOI 10.1016/j.neuron.2005.02.026; Granas C, 2003, J BIOL CHEM, V278, P4990, DOI 10.1074/jbc.M205058200; Habermann B, 2004, EMBO REP, V5, P250, DOI 10.1038/sj.embor.7400105; Hanley JG, 2006, BIOCHEM SOC T, V34, P931, DOI 10.1042/BST0340931; Hanley JG, 2005, EMBO J, V24, P3266, DOI 10.1038/sj.emboj.7600801; Hanley JG, 2008, PHARMACOL THERAPEUT, V118, P152, DOI 10.1016/j.pharmthera.2008.02.002; Hanyaloglu AC, 2005, EMBO J, V24, P2265, DOI 10.1038/sj.emboj.7600688; Hanyaloglu AC, 2007, J BIOL CHEM, V282, P3095, DOI 10.1074/jbc.M605398200; Hirbec H, 2003, NEURON, V37, P625, DOI 10.1016/S0896-6273(02)01191-1; Hoogenraad CC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000283; Hu XD, 2007, J NEUROSCI, V27, P4674, DOI 10.1523/JNEUROSCI.5365-06.2007; Iwakura Y, 2001, J BIOL CHEM, V276, P40025, DOI 10.1074/jbc.M103125200; Jeyifous O, 2009, NAT NEUROSCI, V12, P1011, DOI 10.1038/nn.2362; Jin WY, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-39; Jin WY, 2006, J NEUROSCI, V26, P2380, DOI 10.1523/JNEUROSCI.3503-05.2006; Karthikeyan S, 2001, J MOL BIOL, V308, P963, DOI 10.1006/jmbi.2001.4634; Kim CH, 2001, P NATL ACAD SCI USA, V98, P11725, DOI 10.1073/pnas.211132798; Lauffer BEL, 2010, J CELL BIOL, V190, P565, DOI 10.1083/jcb.201004060; Lauffer BEL, 2009, J BIOL CHEM, V284, P2448, DOI 10.1074/jbc.M806370200; Lavezzari G, 2004, J NEUROSCI, V24, P6383, DOI 10.1523/JNEUROSCI.1890-04.2004; Leonard AS, 2003, P NATL ACAD SCI USA, V100, P2029, DOI 10.1073/pnas.252782799; Lin DT, 2007, J NEUROSCI, V27, P13903, DOI 10.1523/JNEUROSCI.1750-07.2007; Liu SQJ, 2005, NAT NEUROSCI, V8, P768, DOI 10.1038/nn1468; Lu W, 2005, NEURON, V47, P407, DOI 10.1016/j.neuron.2005.07.006; Madsen KL, 2010, FEBS LETT, V584, P1848, DOI 10.1016/j.febslet.2010.01.053; Madsen KL, 2008, TRAFFIC, V9, P1327, DOI 10.1111/j.1600-0854.2008.00761.x; Madsen KL, 2005, J BIOL CHEM, V280, P20539, DOI 10.1074/jbc.M500577200; Mameli M, 2007, SCIENCE, V317, P530, DOI 10.1126/science.1142365; MARCHESE A, 1995, GENOMICS, V29, P335, DOI 10.1006/geno.1995.9996; Miranda M, 2005, J BIOL CHEM, V280, P35617, DOI 10.1074/jbc.M506618200; MOLLENHAUER HH, 1990, BIOCHIM BIOPHYS ACTA, V1031, P225, DOI 10.1016/0304-4157(90)90008-Z; Moore RH, 2004, J CELL SCI, V117, P3107, DOI 10.1242/jcs.01168; Pan L, 2007, EMBO J, V26, P4576, DOI 10.1038/sj.emboj.7601860; Park M, 2004, SCIENCE, V305, P1972, DOI 10.1126/science.1102026; Perez JL, 2001, J NEUROSCI, V21, P5417, DOI 10.1523/JNEUROSCI.21-15-05417.2001; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Rocca DL, 2008, NAT CELL BIOL, V10, P259, DOI 10.1038/ncb1688; Scott DB, 2001, J NEUROSCI, V21, P3063, DOI 10.1523/JNEUROSCI.21-09-03063.2001; Seachrist JL, 2000, J BIOL CHEM, V275, P27221; Sorkina T, 2005, TRAFFIC, V6, P157, DOI 10.1111/j.1600-0854.2005.00259.x; Sossa KG, 2006, MOL CELL NEUROSCI, V31, P574, DOI 10.1016/j.mcn.2005.11.011; STAUDINGER J, 1995, J CELL BIOL, V128, P263, DOI 10.1083/jcb.128.3.263; Staudinger J, 1997, J BIOL CHEM, V272, P32019, DOI 10.1074/jbc.272.51.32019; Steinberg JP, 2006, NEURON, V49, P845, DOI 10.1016/j.neuron.2006.02.025; Suh YH, 2008, NEURON, V58, P736, DOI 10.1016/j.neuron.2008.03.028; Terashima A, 2004, J NEUROSCI, V24, P5381, DOI 10.1523/JNEUROSCI.4378-03.2004; Terashima A, 2008, NEURON, V57, P872, DOI 10.1016/j.neuron.2008.01.028; Thorsen TS, 2010, P NATL ACAD SCI USA, V107, P413, DOI 10.1073/pnas.0902225107; Torres GE, 2001, NEURON, V30, P121, DOI 10.1016/S0896-6273(01)00267-7; Torres R, 1998, NEURON, V21, P1453, DOI 10.1016/S0896-6273(00)80663-7; Tsao PI, 2000, J BIOL CHEM, V275, P11130, DOI 10.1074/jbc.275.15.11130; van Weering JRT, 2010, SEMIN CELL DEV BIOL, V21, P371, DOI 10.1016/j.semcdb.2009.11.009; Volk L, 2010, P NATL ACAD SCI USA, V107, P21784, DOI 10.1073/pnas.1016103107; Wang YY, 2007, MOL PHARMACOL, V72, P429, DOI 10.1124/mol.107.037747; Xia J, 2000, NEURON, V28, P499, DOI 10.1016/S0896-6273(00)00128-8; Xia J, 1999, NEURON, V22, P179, DOI 10.1016/S0896-6273(00)80689-3; Xu JY, 2006, NEUROSIGNALS, V15, P190, DOI 10.1159/000098482; Yao YD, 2008, J NEUROSCI, V28, P7820, DOI 10.1523/JNEUROSCI.0223-08.2008	76	34	34	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					12293	12308		10.1074/jbc.M111.294702	http://dx.doi.org/10.1074/jbc.M111.294702			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22303009	Green Published, hybrid			2022-12-25	WOS:000302782200069
J	Doi, K; Li, RS; Sung, SS; Wu, HW; Liu, Y; Manieri, W; Krishnegowda, G; Awwad, A; Dewey, A; Liu, X; Amin, S; Cheng, CW; Qin, Y; Schonbrunn, E; Daughdrill, G; Loughran, TP; Sebti, S; Wang, HG				Doi, Kenichiro; Li, Rongshi; Sung, Shen-Shu; Wu, Hongwei; Liu, Yan; Manieri, Wanda; Krishnegowda, Gowdahalli; Awwad, Andy; Dewey, Alden; Liu, Xin; Amin, Shantu; Cheng, Chunwei; Qin, Yong; Schonbrunn, Ernst; Daughdrill, Gary; Loughran, Thomas P., Jr.; Sebti, Said; Wang, Hong-Gang			Discovery of Marinopyrrole A (Maritoclax) as a Selective Mcl-1 Antagonist that Overcomes ABT-737 Resistance by Binding to and Targeting Mcl-1 for Proteasomal Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BCL-2 FAMILY PROTEINS; EFFICIENTLY INDUCES APOPTOSIS; BH3 MIMETIC ABT-737; IMMUNOHISTOCHEMICAL ANALYSIS; BH3-ONLY PROTEINS; CANCER; INHIBITOR; CELLS; LEUKEMIA; THERAPY	The anti-apoptotic Bcl-2 family of proteins, including Bcl-2, Bcl-X-L and Mcl-1, are well-validated drug targets for cancer treatment. Several small molecules have been designed to interfere with Bcl-2 and its fellow pro-survival family members. While ABT-737 and its orally active analog ABT-263 are the most potent and specific inhibitors to date that bind Bcl-2 and Bcl-X-L with high affinity but have a much lower affinity for Mcl-1, they are not very effective as single agents in certain cancer types because of elevated levels of Mcl-1. Accordingly, compounds that specifically target Mcl-1 may overcome this resistance. In this study, we identified and characterized the natural product marinopyrrole A as a novel Mcl-1-specific inhibitor and named it maritoclax. We found that maritoclax binds to Mcl-1, but not Bcl-X-L, and is able to disrupt the interaction between Bim and Mcl-1. Moreover, maritoclax induces Mcl-1 degradation via the proteasome system, which is associated with the pro-apoptotic activity of maritoclax. Importantly, maritoclax selectively kills Mcl-1-dependent, but not Bcl-2- or Bcl-X-L-dependent, leukemia cells and markedly enhances the efficacy of ABT-737 against hematologic malignancies, including K562, Raji, and multidrug-resistant HL60/VCR, by similar to 60- to 2000-fold at 1-2 mu M. Taken together, these results suggest that maritoclax represents a new class of Mcl-1 inhibitors, which antagonizes Mcl-1 and overcomes ABT-737 resistance by targeting Mcl-1 for degradation.	[Doi, Kenichiro; Sung, Shen-Shu; Krishnegowda, Gowdahalli; Amin, Shantu; Wang, Hong-Gang] Penn State Univ, Coll Med, Dept Pharmacol, Hershey, PA 17033 USA; [Awwad, Andy; Dewey, Alden; Liu, Xin; Amin, Shantu; Loughran, Thomas P., Jr.; Wang, Hong-Gang] Penn State Univ, Coll Med, Penn State Hershey Canc Inst, Hershey, PA 17033 USA; [Li, Rongshi; Liu, Yan; Manieri, Wanda; Schonbrunn, Ernst; Sebti, Said] H Lee Moffitt Canc Ctr & Res Inst, Drug Discovery Dept, Tampa, FL 33612 USA; [Wu, Hongwei] Univ S Florida, Dept Cell Biol Microbiol & Mol Biol, Tampa, FL 33612 USA; [Cheng, Chunwei; Qin, Yong] Sichuan Univ, W China Sch Pharm, Chengdu 610041, Peoples R China	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; Sichuan University	Wang, HG (corresponding author), 500 Univ Dr, Hershey, PA 17033 USA.	huw11@psu.edu	Wang, Hong-Gang/A-3018-2015	Wang, Hong-Gang/0000-0003-0551-0571; Schonbrunn, Ernst/0000-0002-3589-3510; GOWDA, KRISHNE/0000-0002-6042-0520	National Institutes of Health [CA118210]; Moffitt Cancer Center; National Science Foundation [MCB0939014]; American Cancer Society [RSG-07-89-01-GMC]; NATIONAL CANCER INSTITUTE [R01CA098472, P01CA118210, P30CA076292] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Moffitt Cancer Center; National Science Foundation(National Science Foundation (NSF)); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA118210, by Moffitt Cancer Center startup funds (to R. L.), and by the National Science Foundation (Award No. MCB0939014) and the American Cancer Society (RSG-07-89-01-GMC) (to G. W. D.).	Acoca S, 2011, PROTEINS, V79, P2624, DOI 10.1002/prot.23083; Albershardt TC, 2011, J BIOL CHEM, V286, P24882, DOI 10.1074/jbc.M111.255828; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bhat UG, 2010, MOL CANCER THER, V9, P1688, DOI 10.1158/1535-7163.MCT-09-0919; Chen S, 2007, CANCER RES, V67, P782, DOI 10.1158/0008-5472.CAN-06-3964; Cheng CW, 2010, J COMB CHEM, V12, P541, DOI 10.1021/cc100052j; Czabotar PE, 2007, P NATL ACAD SCI USA, V104, P6217, DOI 10.1073/pnas.0701297104; Day CL, 2008, J MOL BIOL, V380, P958, DOI 10.1016/j.jmb.2008.05.071; Domina AM, 2004, ONCOGENE, V23, P5301, DOI 10.1038/sj.onc.1207692; Eldridge MD, 1997, J COMPUT AID MOL DES, V11, P425, DOI 10.1023/A:1007996124545; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Gomez-Bougie P, 2011, BIOCHEM BIOPH RES CO, V413, P460, DOI 10.1016/j.bbrc.2011.08.118; Haste NM, 2011, ANTIMICROB AGENTS CH, V55, P3305, DOI 10.1128/AAC.01211-10; Hikita H, 2010, HEPATOLOGY, V52, P1310, DOI 10.1002/hep.23836; Hu XD, 2008, J AM CHEM SOC, V130, P13820, DOI 10.1021/ja802683u; Hughes CC, 2008, ORG LETT, V10, P629, DOI 10.1021/ol702952n; Hughes CC, 2009, J AM CHEM SOC, V131, P12094, DOI 10.1021/ja903149u; Ji M, 2009, BRIT J HAEMATOL, V145, P648, DOI 10.1111/j.1365-2141.2009.07678.x; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; Kazi A, 2011, J BIOL CHEM, V286, P9382, DOI 10.1074/jbc.M110.203638; Konopleva M, 2006, CANCER CELL, V10, P375, DOI 10.1016/j.ccr.2006.10.006; Krajewska M, 1997, CANCER RES, V57, P1605; KRAJEWSKI S, 1994, AM J PATHOL, V145, P515; Liao AJ, 2011, BLOOD, V118, P2793, DOI 10.1182/blood-2011-01-331447; Lin X, 2007, ONCOGENE, V26, P3972, DOI 10.1038/sj.onc.1210166; Maurer U, 2006, MOL CELL, V21, P749, DOI 10.1016/j.molcel.2006.02.009; Nguyen M, 2007, P NATL ACAD SCI USA, V104, P19512, DOI 10.1073/pnas.0709443104; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Quinn BA, 2011, EXPERT OPIN INV DRUG, V20, P1397, DOI 10.1517/13543784.2011.609167; Reed J C, 1997, Adv Pharmacol, V41, P501, DOI 10.1016/S1054-3589(08)61070-4; Reed JC, 1996, J CELL BIOCHEM, V60, P23, DOI 10.1002/(SICI)1097-4644(19960101)60:1<23::AID-JCB5>3.3.CO;2-3; Sattler M, 1997, SCIENCE, V275, P983, DOI 10.1126/science.275.5302.983; Stewart ML, 2010, NAT CHEM BIOL, V6, P595, DOI [10.1038/NCHEMBIO.391, 10.1038/nchembio.391]; Tahir SK, 2007, CANCER RES, V67, P1176, DOI 10.1158/0008-5472.CAN-06-2203; Tse C, 2008, CANCER RES, V68, P3421, DOI 10.1158/0008-5472.CAN-07-5836; van Delft MF, 2006, CANCER CELL, V10, P389, DOI 10.1016/j.ccr.2006.08.027; Vogler M, 2009, CELL DEATH DIFFER, V16, P360, DOI 10.1038/cdd.2008.137; Wang GQ, 2001, J BIOL CHEM, V276, P34307, DOI 10.1074/jbc.M103526200; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Woods NT, 2007, CANCER RES, V67, P10744, DOI 10.1158/0008-5472.CAN-07-3148; Wuilleme-Toumi S, 2007, BIOCHEM BIOPH RES CO, V361, P865, DOI 10.1016/j.bbrc.2007.07.070; Yecies D, 2010, BLOOD, V115, P3304, DOI 10.1182/blood-2009-07-233304; Yip KW, 2008, ONCOGENE, V27, P6398, DOI 10.1038/onc.2008.307	43	125	132	3	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					10224	10235		10.1074/jbc.M111.334532	http://dx.doi.org/10.1074/jbc.M111.334532			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22311987	Green Published, hybrid			2022-12-25	WOS:000302167200053
J	Li, DQ; Zhang, WJ; Liu, Y; Haneline, LS; Shou, WN				Li, Deqiang; Zhang, Wenjun; Liu, Ying; Haneline, Laura S.; Shou, Weinian			Lack of Plakoglobin in Epidermis Leads to Keratoderma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIGHT-VENTRICULAR CARDIOMYOPATHY; BETA-CATENIN; PALMOPLANTAR KERATODERMAS; F9 CELLS; ROLES; DISEASE; HEART; HAIR; SKIN; KERATINOCYTES	Loss-of-function mutation of Jup has been associated with Naxos disease, which is characterized by arrhythmogenic cardiomyopathy and the cutaneous disorder palmoplantar keratoderma. Previously, we have shown that genetic ablation of Jup in cardiomyocytes in mice leads to arrhythmogenic cardiomyopathy similar to Naxos disease in humans. Currently, to determine the pathogenesis of Naxos disease-associated keratoderma, we generated Jup mutant mice by inactivating Jup restrictively in keratinocytes. Jup mutant mice largely recapitulated the clinical features of human palmoplantar keratoderma: overcornification and thickening of the epidermis. Jup mutant mice also suffered skin ulceration and inflammation. Cell apoptosis and proliferation were significantly elevated in Jup mutant epidermis. Ultrastructural analyses revealed the disruption of the assembly of desmosomes and adherens junctions in Jup mutant epidermis. We also demonstrated the compensational increase in beta-catenin at Jup mutant cell-cell junctions without altering its signaling activities. Our findings provide important insights for understanding the pathogenesis of human palmoplantar keratoderma.	[Li, Deqiang; Zhang, Wenjun; Liu, Ying; Haneline, Laura S.; Shou, Weinian] Indiana Univ Sch Med, Herman B Wells Ctr Pediat Res, Dept Pediat, Indianapolis, IN 46202 USA; [Li, Deqiang; Zhang, Wenjun; Shou, Weinian] Indiana Univ Sch Med, Riley Heart Res Ctr, Indianapolis, IN 46202 USA; [Liu, Ying; Haneline, Laura S.] Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Shou, WN (corresponding author), Indiana Univ Sch Med, Herman B Wells Ctr Pediat Res, Dept Pediat, R4-302D,1044 W Walnut, Indianapolis, IN 46202 USA.	wshou@iupui.edu			National Institutes of Health [HL81092, HL70259, HL85098]; Riley Children's Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL085098, R01HL081092, R01HL070259] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Riley Children's Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL81092, HL70259, and HL85098 (all to W. S.). This work was also supported by the Riley Children's Foundation (to W. S.).	Acehan D, 2008, J INVEST DERMATOL, V128, P2665, DOI 10.1038/jid.2008.141; Bierkamp C, 1999, DEVELOPMENT, V126, P371; Bierkamp C, 1996, DEV BIOL, V180, P780, DOI 10.1006/dbio.1996.0346; Cabral RM, 2010, J INVEST DERMATOL, V130, P1543, DOI 10.1038/jid.2010.7; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; DasGupta R, 1999, DEVELOPMENT, V126, P4557; Erken H, 2011, BRIT J DERMATOL, V165, P917, DOI 10.1111/j.1365-2133.2011.10455.x; Fukunaga Y, 2005, CELL STRUCT FUNCT, V30, P25, DOI 10.1247/csf.30.25; Garcia-Gras E, 2006, J CLIN INVEST, V116, P2012, DOI 10.1172/JCI27751; Haq S, 2003, P NATL ACAD SCI USA, V100, P4610, DOI 10.1073/pnas.0835895100; Itin PH, 2005, CLIN DERMATOL, V23, P15, DOI 10.1016/j.clindermatol.2004.09.005; Jamora C, 2002, NAT CELL BIOL, V4, pE101, DOI 10.1038/ncb0402-e101; Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747; Klymkowsky MW, 1999, MOL BIOL CELL, V10, P3151, DOI 10.1091/mbc.10.10.3151; Li DQ, 2011, HUM MOL GENET, V20, P4582, DOI 10.1093/hmg/ddr392; Li DQ, 2011, DEVELOPMENT, V138, P303, DOI 10.1242/dev.055566; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Malminen M, 2003, BRIT J DERMATOL, V149, P255, DOI 10.1046/j.1365-2133.2003.05438.x; McKoy G, 2000, LANCET, V355, P2119, DOI 10.1016/S0140-6736(00)02379-5; NIELSEN PG, 1984, DERMATOLOGICA, V168, P293, DOI 10.1159/000249727; Pigors M, 2011, HUM MOL GENET, V20, P1811, DOI 10.1093/hmg/ddr064; Pummi K, 2001, J INVEST DERMATOL, V117, P1050, DOI 10.1046/j.0022-202x.2001.01493.x; Shimizu M, 2008, MOL CELL BIOL, V28, P825, DOI 10.1128/MCB.02375-06; Tsuruta D, 2011, J DERMATOL SCI, V62, P1, DOI 10.1016/j.jdermsci.2011.01.005; van Steensel MAM, 2010, GIORN ITAL DERMAT V, V145, P763; Yost C, 1996, GENE DEV, V10, P1443, DOI 10.1101/gad.10.12.1443; Zhurinsky J, 2000, J CELL SCI, V113, P3127	27	27	28	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					10435	10443		10.1074/jbc.M111.299669	http://dx.doi.org/10.1074/jbc.M111.299669			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22315228	Green Published, hybrid			2022-12-25	WOS:000302167200070
J	Chen, CY; Samuel, TK; Krause, M; Dailey, HA; Hamza, I				Chen, Caiyong; Samuel, Tamika K.; Krause, Michael; Dailey, Harry A.; Hamza, Iqbal			Heme Utilization in the Caenorhabditis elegans Hypodermal Cells Is Facilitated by Heme-responsive Gene-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUTATHIONE-S-TRANSFERASE; BINDING PROTEIN; MOLECULAR CHARACTERIZATION; CYTOCHROME-C; IRON UPTAKE; IDENTIFICATION; TRANSPORT; REDOX; DIFFERENTIATION; RESISTANCE	The roundworm Caenorhabditis elegans is a heme auxotroph that requires the coordinated actions of HRG-1 heme permeases to transport environmental heme into the intestine and HRG-3, a secreted protein, to deliver intestinal heme to other tissues including the embryo. Here we show that heme homeostasis in the extraintestinal hypodermal tissue was facilitated by the transmembrane protein HRG-2. Systemic heme deficiency up-regulated hrg-2 mRNA expression over 200-fold in the main body hypodermal syncytium, hyp 7. HRG-2 is a type I membrane protein that binds heme and localizes to the endoplasmic reticulum and apical plasma membrane. Cytochrome heme profiles are aberrant in HRG-2-deficient worms, a phenotype that was partially suppressed by heme supplementation. A heme-deficient yeast strain, ectopically expressing worm HRG-2, revealed significantly improved growth at submicromolar concentrations of exogenous heme. Taken together, our results implicate HRG-2 as a facilitator of heme utilization in the Caenorhabditis elegans hypodermis and provide a mechanism for the regulation of heme homeostasis in an extraintestinal tissue.	[Chen, Caiyong; Samuel, Tamika K.; Hamza, Iqbal] Univ Maryland, Dept Anim & Avian Sci, College Pk, MD 20742 USA; [Chen, Caiyong; Samuel, Tamika K.; Hamza, Iqbal] Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA; [Krause, Michael] NIDDK, Mol Biol Lab, NIH, Bethesda, MD 20892 USA; [Dailey, Harry A.] Univ Georgia, Dept Microbiol, Biomed & Hlth Sci Inst, Athens, GA 30602 USA; [Dailey, Harry A.] Univ Georgia, Dept Biochem & Mol Biol, Biomed & Hlth Sci Inst, Athens, GA 30602 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Hamza, I (corresponding author), Univ Maryland, Dept Anim & Avian Sci, 2413 ANSC,Bldg 142, College Pk, MD 20742 USA.	hamza@umd.edu		Krause, Michael/0000-0001-6127-3940; Hamza, Iqbal/0000-0003-0045-0610	National Institutes of Health (NIH) [R01DK74797]; NIH from NIDDK; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074797, R56DK032303] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH from NIDDK; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health (NIH) Grant R01DK74797 (extramural funding) (to I. H.) and an NIH Intramural Research Program grant from the NIDDK (to M. K.).	Allhorn M, 2005, FREE RADICAL BIO MED, V38, P557, DOI 10.1016/j.freeradbiomed.2004.12.013; BALLA G, 1991, LAB INVEST, V64, P648; BJELLQVIST B, 1994, ELECTROPHORESIS, V15, P529, DOI 10.1002/elps.1150150171; Blumenthal T, 2002, NATURE, V417, P851, DOI 10.1038/nature00831; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Chen CY, 2011, CELL, V145, P720, DOI 10.1016/j.cell.2011.04.025; Cox EA, 2004, J CELL SCI, V117, P1885, DOI 10.1242/jcs.01176; Crisp RJ, 2003, J BIOL CHEM, V278, P45499, DOI 10.1074/jbc.M307229200; Cui YX, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r122; Dong J, 2005, BBA-GENE STRUCT EXPR, V1727, P16, DOI 10.1016/j.bbaexp.2004.11.007; Dong J, 2008, J MOL BIOL, V376, P621, DOI 10.1016/j.jmb.2007.11.094; DORFMAN BZ, 1969, GENETICS, V61, P377; Epstein HF, 1995, METHOD CELL BIOL, V48, P437; Gengyo-Ando K, 2000, BIOCHEM BIOPH RES CO, V269, P64, DOI 10.1006/bbrc.2000.2260; HARVEY JW, 1982, BLOOD, V60, P1227; Harwaldt P, 2002, BIOL CHEM, V383, P821, DOI 10.1515/BC.2002.086; HILL KK, 1995, GENETICS, V141, P595; HRKAL Z, 1974, EUR J BIOCHEM, V43, P73, DOI 10.1111/j.1432-1033.1974.tb03386.x; Hughes AL, 2007, CELL METAB, V5, P143, DOI 10.1016/j.cmet.2006.12.009; IWAHARA S, 1995, BIOCHEMISTRY-US, V34, P13398, DOI 10.1021/bi00041a017; Jeney V, 2002, BLOOD, V100, P879, DOI 10.1182/blood.V100.3.879; Keel SB, 2008, SCIENCE, V319, P825, DOI 10.1126/science.1151133; Kim BE, 2004, J BIOL CHEM, V279, P4523, DOI 10.1074/jbc.M310799200; Labouesse Michel, 2006, WormBook, P1; Liao VHC, 2002, J BIOL CHEM, V277, P42049, DOI 10.1074/jbc.M206740200; Lorenz H, 2006, NAT METHODS, V3, P205, DOI 10.1038/nmeth857; Mallory JC, 2005, MOL CELL BIOL, V25, P1669, DOI 10.1128/MCB.25.5.1669-1679.2005; McKie AT, 2000, MOL CELL, V5, P299, DOI 10.1016/S1097-2765(00)80425-6; MYERS AM, 1985, EMBO J, V4, P2087, DOI 10.1002/j.1460-2075.1985.tb03896.x; Nass R., 2007, CURRENT PROTOCOLS TO, P191; NAUSEEF WM, 1992, BLOOD, V80, P2622; Neve EPA, 2008, ANAL BIOANAL CHEM, V392, P1075, DOI 10.1007/s00216-008-2200-z; NICHOLSON DW, 1989, P NATL ACAD SCI USA, V86, P4340, DOI 10.1073/pnas.86.12.4340; Ohgami RS, 2005, NAT GENET, V37, P1264, DOI 10.1038/ng1658; Olea C, 2010, J AM CHEM SOC, V132, P12794, DOI 10.1021/ja106252b; Praitis V, 2001, GENETICS, V157, P1217; Protchenko O, 2008, EUKARYOT CELL, V7, P859, DOI 10.1128/EC.00414-07; Quigley JG, 2004, CELL, V118, P757, DOI 10.1016/j.cell.2004.08.014; Rajagopal A, 2008, NATURE, V453, P1127, DOI 10.1038/nature06934; Rao AU, 2005, P NATL ACAD SCI USA, V102, P4270, DOI 10.1073/pnas.0500877102; Richard-Fogal CL, 2009, EMBO J, V28, P2349, DOI 10.1038/emboj.2009.189; Rieske JS, 1967, METHOD ENZYMOL, V10, P488, DOI DOI 10.1016/0076-6879(67)10081-5; Rolls MM, 2002, MOL BIOL CELL, V13, P1778, DOI 10.1091/mbc.01-10-0514; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schultz IJ, 2010, J BIOL CHEM, V285, P26753, DOI 10.1074/jbc.R110.119503; Severance S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001044; Severance S, 2009, CHEM REV, V109, P4596, DOI 10.1021/cr9001116; Shadel GS, 1999, AM J HUM GENET, V65, P1230, DOI 10.1086/302630; Smith K.M., 1975, PORPHYRINS METALLOPO; Taketani S, 1998, J BIOL CHEM, V273, P31388, DOI 10.1074/jbc.273.47.31388; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TIPPING E, 1976, BIOCHEM J, V157, P461, DOI 10.1042/bj1570461; Van Rossum AJ, 2004, INFECT IMMUN, V72, P2780, DOI 10.1128/IAI.72.5.2780-2790.2004; Wu MM, 2000, CHEM BIOL, V7, P197, DOI 10.1016/S1074-5521(00)00088-0; Yang ZT, 2010, J BIOL CHEM, V285, P28874, DOI 10.1074/jbc.M110.119131; Yuan XJ, 2012, J BIOL CHEM, V287, P4914, DOI 10.1074/jbc.M111.326785; Zhan B, 2005, INFECT IMMUN, V73, P6903, DOI 10.1128/IAI.73.10.6903-6911.2005; Zhu YH, 2002, CELL GROWTH DIFFER, V13, P431	59	26	32	1	13	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					9601	9612		10.1074/jbc.M111.307694	http://dx.doi.org/10.1074/jbc.M111.307694			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22303006	Green Published, hybrid			2022-12-25	WOS:000301797800091
J	Lee, KK; Yonehara, S				Lee, Kyung-Kwon; Yonehara, Shin			Identification of Mechanism That Couples Multisite Phosphorylation of Yes-associated Protein (YAP) with Transcriptional Coactivation and Regulation of Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORGAN SIZE CONTROL; HIPPO PATHWAY; CELL-PROLIFERATION; CONTACT INHIBITION; TUMOR-SUPPRESSOR; TEAD/TEF FAMILY; GROWTH-CONTROL; DNA-DAMAGE; IN-VIVO; P73	The transcriptional coactivator Yes-associated protein (YAP) has been implicated in tumorigenesis by regulating cell proliferation and apoptosis. YAP interacts with the transcription factor TEAD and is essential in mediating TEAD-dependent gene expression. Here we show that YAP is hyperphosphorylated and activated in response to genotoxic stress such as UV irradiation and cisplatin treatment. Using high resolution mobility shift assay for phosphorylated proteins, we identified multiple sites of phosphorylation induced by UV irradiation. Pretreatment with p38 and JNK inhibitors completely suppressed the mobility retardation of phosphorylated YAP in UV-irradiated cells. Co-immunoprecipitation experiments showed that the physical interaction of YAP with TEAD was markedly enhanced by UV irradiation or CDDP treatment but suppressed by pretreatment with p38 and JNK inhibitors. Similarly, pretreatment with p38 and JNK inhibitors suppressed the expression of YAP/TEAD target genes, which were elevated on exposure to genotoxic stress. Using phosphomimetic and phosphorylation-deficient YAP mutants, we showed that the coactivator activity of YAP correlated with its state of phosphorylation and sensitivity to cisplatin-induced apoptosis. Our results demonstrate that multisite phosphorylation of YAP induces YAP/TEAD-dependent gene expression and provides a mechanism by which YAP regulates apoptosis differently depending on cellular context.	[Lee, Kyung-Kwon; Yonehara, Shin] Kyoto Univ, Lab Mol & Cellular Biol, Grad Sch Biostudies, Sakyo Ku, Kyoto 6068501, Japan	Kyoto University	Lee, KK (corresponding author), Kyoto Univ, Lab Mol & Cellular Biol, Grad Sch Biostudies, Sakyo Ku, SCRB Bldg G,Yoshida Konoe Cho, Kyoto 6068501, Japan.	kklee@lif.kyoto-u.ac.jp						Alarcon C, 2009, CELL, V139, P757, DOI 10.1016/j.cell.2009.09.035; Basu S, 2003, MOL CELL, V11, P11, DOI 10.1016/S1097-2765(02)00776-1; Beausoleil SA, 2004, P NATL ACAD SCI USA, V101, P12130, DOI 10.1073/pnas.0404720101; Blandino G, 2004, CELL CYCLE, V3, P886; Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; Cao XW, 2008, GENE DEV, V22, P3320, DOI 10.1101/gad.1726608; Conlon I, 1999, CELL, V96, P235, DOI 10.1016/S0092-8674(00)80563-2; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Heallen T, 2011, SCIENCE, V332, P458, DOI 10.1126/science.1199010; Kanai F, 2000, EMBO J, V19, P6778, DOI 10.1093/emboj/19.24.6778; Kiriyama M, 2009, MOL CELL BIOL, V29, P4729, DOI 10.1128/MCB.00289-09; Kobayashi Y, 2009, CELL DEATH DIFFER, V16, P139, DOI 10.1038/cdd.2008.136; Lapi E, 2008, MOL CELL, V32, P803, DOI 10.1016/j.molcel.2008.11.019; Lee KK, 2002, J BIOL CHEM, V277, P12351, DOI 10.1074/jbc.M108138200; Lee KK, 2001, J BIOL CHEM, V276, P19276, DOI 10.1074/jbc.M005109200; Lei QY, 2008, MOL CELL BIOL, V28, P2426, DOI 10.1128/MCB.01874-07; Levy D, 2007, CELL DEATH DIFFER, V14, P743, DOI 10.1038/sj.cdd.4402063; Levy D, 2008, MOL CELL, V29, P350, DOI 10.1016/j.molcel.2007.12.022; McClatchey AI, 2005, GENE DEV, V19, P2265, DOI 10.1101/gad.1335605; Oh H, 2009, ONCOGENE, V28, P1916, DOI 10.1038/onc.2009.43; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Ota M, 2008, DEVELOPMENT, V135, P4059, DOI 10.1242/dev.027151; Overholtzer M, 2006, P NATL ACAD SCI USA, V103, P12405, DOI 10.1073/pnas.0605579103; St John MAR, 1999, NAT GENET, V21, P182, DOI 10.1038/5965; Strano S, 2005, MOL CELL, V18, P447, DOI 10.1016/j.molcel.2005.04.008; Tomlinson V, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.7; Varelas X, 2010, DEV CELL, V19, P831, DOI 10.1016/j.devcel.2010.11.012; Varelas X, 2010, DEV CELL, V18, P579, DOI 10.1016/j.devcel.2010.03.007; Vassilev A, 2001, GENE DEV, V15, P1229, DOI 10.1101/gad.888601; Wu S, 2008, DEV CELL, V14, P388, DOI 10.1016/j.devcel.2008.01.007; Yang A, 2000, NAT REV MOL CELL BIO, V1, P199, DOI 10.1038/35043127; Yuan M, 2008, CELL DEATH DIFFER, V15, P1752, DOI 10.1038/cdd.2008.108; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Zhang L, 2008, DEV CELL, V14, P377, DOI 10.1016/j.devcel.2008.01.006; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2010, GENE DEV, V24, P862, DOI 10.1101/gad.1909210; Zhao B, 2008, CURR OPIN CELL BIOL, V20, P638, DOI 10.1016/j.ceb.2008.10.001; Zhou DW, 2009, CANCER CELL, V16, P425, DOI 10.1016/j.ccr.2009.09.026	40	28	29	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					9568	9578		10.1074/jbc.M111.296954	http://dx.doi.org/10.1074/jbc.M111.296954			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22308035	hybrid, Green Published			2022-12-25	WOS:000301797800088
J	Zou, YH; Bao, Q; Kumar, S; Hu, M; Wang, GY; Dai, GL				Zou, Yuhong; Bao, Qi; Kumar, Sudhanshu; Hu, Min; Wang, Guo-Ying; Dai, Guoli			Four Waves of Hepatocyte Proliferation Linked with Three Waves of Hepatic Fat Accumulation during Partial Hepatectomy-Induced Liver Regeneration	PLOS ONE			English	Article							RAT-LIVER; MICE; PROGRESSION; APOPTOSIS; GROWTH	Partial hepatectomy (PH) triggers hepatocyte proliferation-mediated liver repair and is widely used to study the mechanisms governing liver regeneration in mice. However, the dynamics of the hepatocyte proliferative response to PH remain unclear. We found that PH-induced mouse liver regrowth was driven by four consecutive waves of hepatocyte replication. The first wave exhibited the highest magnitude followed by two moderate waves and one minor wave. Underlying this continuous hepatocyte replication was persistent activation of cell cycle components throughout the period of liver regeneration. Hepatocyte mitotic activity in the first three proliferative cycles showed a circadian rhythm manifested by three corresponding mitosis peaks, which were always observed at Zeitgeber time 0. The Bmal1-Clock/Wee1/Cdc2 pathway has been proposed by others to govern the circadian rhythm of hepatocyte mitosis during liver regeneration. However, we did not observe the correlations in the expression or phosphorylation of these proteins in regenerating livers. Notably, Bmal1 protein displayed frequent changes in hepatic distribution and cellular localization as the liver regrowth progressed. Further, three waves of hepatic fat accumulation occurred during hepatic regeneration. The first started before and lasted through the first round of hepatocyte proliferation, whereas the second and third occurred concomitantly with the second and third mitotic peaks, respectively. Conclusion: PH-induced liver regeneration consists of four continuous waves of hepatocyte proliferation coupled with three waves of hepatic fat accumulation. Bmal1, Wee1, and Cdc2 may not form a pathway regulating the circadian rhythm of hepatocyte mitosis during liver regeneration.	[Zou, Yuhong; Bao, Qi; Kumar, Sudhanshu; Hu, Min; Wang, Guo-Ying; Dai, Guoli] Indiana Univ Purdue Univ, Dept Biol, Ctr Regenerat Biol & Med, Sch Sci, Indianapolis, IN 46205 USA	Indiana University System; Indiana University-Purdue University Indianapolis	Zou, YH (corresponding author), Indiana Univ Purdue Univ, Dept Biol, Ctr Regenerat Biol & Med, Sch Sci, Indianapolis, IN 46205 USA.	gdai@iupui.edu			National Institute of Diabetes and Digestive and Kidney Diseases [7RO1DK07596]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075968] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a grant from the National Institute of Diabetes and Digestive and Kidney Diseases (7RO1DK07596). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brasaemle DL, 2006, SCIENCE, V313, P1581, DOI 10.1126/science.1133253; BUCHER NLR, 1963, INT REV CYTOL, V15, P245, DOI 10.1016/S0074-7696(08)61119-5; Chan KM, 1996, P NATL ACAD SCI USA, V93, P13943, DOI 10.1073/pnas.93.24.13943; Dai GL, 2008, HEPATOLOGY, V47, P1277, DOI 10.1002/hep.22129; FABRIKANT JI, 1968, J CELL BIOL, V36, P551, DOI 10.1083/jcb.36.3.551; Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969; Fausto N, 2005, J HEPATO-BILIARY-PAN, V12, P181, DOI 10.1007/s00534-005-0979-y; Fernandez MA, 2006, SCIENCE, V313, P1628, DOI 10.1126/science.1130773; Greene AK, 2003, J INVEST SURG, V16, P99, DOI 10.1080/08941930390194424; Koniaris LG, 2003, J AM COLL SURGEONS, V197, P634, DOI 10.1016/S1072-7515(03)00374-0; Liao YJ, 2004, J BIOL CHEM, V279, P43107, DOI 10.1074/jbc.M407969200; Matsuo T, 2003, SCIENCE, V302, P255, DOI 10.1126/science.1086271; Michalopoulos GK, 2007, J CELL PHYSIOL, V213, P286, DOI 10.1002/jcp.21172; Michalopoulos GK, 2010, AM J PATHOL, V176, P2, DOI 10.2353/ajpath.2010.090675; Michalopoulos GK, 2005, ADV BIOCHEM ENG BIOT, V93, P101, DOI 10.1007/b99968; Mitchell C, 2008, NAT PROTOC, V3, P1167, DOI 10.1038/nprot.2008.80; Newberry EP, 2008, HEPATOLOGY, V48, P1097, DOI 10.1002/hep.22473; Picard C, 2002, J HEPATOL, V36, P645, DOI 10.1016/S0168-8278(02)00038-7; Rao MS, 2001, DIGEST DIS SCI, V46, P1821, DOI 10.1023/A:1010654908938; Sakamoto T, 1999, HEPATOLOGY, V29, P403, DOI 10.1002/hep.510290244; SCHOFIELD PS, 1987, BIOCHEM J, V241, P469, DOI 10.1042/bj2410469; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Shteyer E, 2004, HEPATOLOGY, V40, P1322, DOI 10.1002/hep.20462; TIJBURG LBM, 1991, BIOCHEM J, V277, P723, DOI 10.1042/bj2770723; Walldorf J, 2010, SCAND J GASTROENTERO, V45, P468, DOI 10.3109/00365520903583848; Zhang BH, 1999, J GASTROEN HEPATOL, V14, P133, DOI 10.1046/j.1440-1746.1999.01822.x; Zimmermann A, 2004, NEPHROL DIAL TRANSPL, V19, P6, DOI 10.1093/ndt/gfh1034	27	28	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2012	7	2							e30675	10.1371/journal.pone.0030675	http://dx.doi.org/10.1371/journal.pone.0030675			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LO	22319576	Green Submitted, Green Published, gold			2022-12-25	WOS:000302178400011
J	Danforth, CM; Orfeo, T; Everse, SJ; Mann, KG; Brummel-Ziedins, KE				Danforth, Christopher M.; Orfeo, Thomas; Everse, Stephen J.; Mann, Kenneth G.; Brummel-Ziedins, Kathleen E.			Defining the Boundaries of Normal Thrombin Generation: Investigations into Hemostasis	PLOS ONE			English	Article							BLOOD-COAGULATION; ANTITHROMBIN DEFICIENCY; MODEL; TESTS; PHARMACOLOGY; PROPAGATION; INHIBITORS; SURFACE; PLASMA	In terms of its soluble precursors, the coagulation proteome varies quantitatively among apparently healthy individuals. The significance of this variability remains obscure, in part because it is the backdrop against which the hemostatic consequences of more dramatic composition differences are studied. In this study we have defined the consequences of normal range variation of components of the coagulation proteome by using a mechanism-based computational approach that translates coagulation factor concentration data into a representation of an individual's thrombin generation potential. A novel graphical method is used to integrate standard measures that characterize thrombin generation in both empirical and computational models (e.g max rate, max level, total thrombin, time to 2 nM thrombin ("clot time'')) to visualize how normal range variation in coagulation factors results in unique thrombin generation phenotypes. Unique ensembles of the 8 coagulation factors encompassing the limits of normal range variation were used as initial conditions for the computational modeling, each ensemble representing "an individual'' in a theoretical healthy population. These "individuals'' with unremarkable proteome composition was then compared to actual normal and "abnormal'' individuals, i.e. factor ensembles measured in apparently healthy individuals, actual coagulopathic individuals or artificially constructed factor ensembles representing individuals with specific factor deficiencies. A sensitivity analysis was performed to rank either individual factors or all possible pairs of factors in terms of their contribution to the overall distribution of thrombin generation phenotypes. Key findings of these analyses include: normal range variation of coagulation factors yields thrombin generation phenotypes indistinguishable from individuals with some, but not all, coagulopathies examined; coordinate variation of certain pairs of factors within their normal ranges disproportionately results in extreme thrombin generation phenotypes, implying that measurement of a smaller set of factors may be sufficient to identify individuals with aberrant thrombin generation potential despite normal coagulation proteome composition.	[Danforth, Christopher M.] Univ Vermont, Dept Math & Stat, Ctr Complex Syst, Vermont Adv Comp Ctr, Burlington, VT 05405 USA; [Orfeo, Thomas; Everse, Stephen J.; Mann, Kenneth G.; Brummel-Ziedins, Kathleen E.] Univ Vermont, Coll Med, Dept Biochem, Burlington, VT 05405 USA	University of Vermont; University of Vermont	Danforth, CM (corresponding author), Univ Vermont, Dept Math & Stat, Ctr Complex Syst, Vermont Adv Comp Ctr, Burlington, VT 05405 USA.	kathleen.brummel@uvm.edu			National Institutes of Health (NIH) [HL46703]; Department of Biochemistry, University of Vermont (UVM); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL046703] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Biochemistry, University of Vermont (UVM); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health (NIH) HL46703 project 5 to Kathleen Brummel-Ziedins and the Department of Biochemistry, University of Vermont (UVM) to Stephen J. Everse. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams TE, 2003, J THROMB HAEMOST, V1, P1024, DOI 10.1046/j.1538-7836.2003.00127.x; Anand M, 2008, J THEOR BIOL, V253, P725, DOI 10.1016/j.jtbi.2008.04.015; Anand M, 2008, J THEOR BIOL; Ansell J, 2004, CHEST, V126, p204S, DOI 10.1378/chest.126.3_suppl.204S; Ataullakhanov FI, 2005, PATHOPHYSIOL HAEMO T, V34, P60, DOI 10.1159/000089927; Bell B, 1995, Pediatr Rev, V16, P290, DOI 10.1542/pir.16-8-290; Brummel-Ziedins K, 2005, J THROMB HAEMOST, V3, P1472, DOI 10.1111/j.1538-7836.2005.01249.x; Brummel-Ziedins K., 2004, WINTROBES CLIN HEMAT, P677; Brummel-Ziedins KE, 2009, J THROMB HAEMOST, V7, P181, DOI 10.1111/j.1538-7836.2009.03426.x; Butenas S, 2004, J BIOL CHEM, V279, P22875, DOI 10.1074/jbc.M400531200; Castoldi E, 2011, THROMB RES, V127, pS21, DOI 10.1016/S0049-3848(11)70007-X; Chatterjee MS, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000950; Crawley JTB, 2007, J THROMB HAEMOST, V5, P95, DOI 10.1111/j.1538-7836.2007.02500.x; Danforth CM, 2009, MATH MED BIOL, V26, P323, DOI 10.1093/imammb/dqp011; Fogelson AL, 2005, PATHOPHYSIOL HAEMO T, V34, P91, DOI 10.1159/000089930; Hall CL, 1998, ANN BIOMED ENG, V26, P28, DOI 10.1114/1.120; Hirsh J, 2004, CHEST, V126, p188S, DOI 10.1378/chest.126.3_suppl.188S; Hockin MF, 2002, J BIOL CHEM, V277, P18322, DOI 10.1074/jbc.M201173200; HOYER LW, 1994, NEW ENGL J MED, V330, P38, DOI 10.1056/NEJM199401063300108; Hron G, 2006, JAMA-J AM MED ASSOC, V296, P397, DOI 10.1001/jama.296.4.397; Khor B, 2010, AM J HEMATOL, V85, P947, DOI 10.1002/ajh.21893; Kuharsky AL, 2001, BIOPHYS J, V80, P1050, DOI 10.1016/S0006-3495(01)76085-7; Lancellotti S, 2009, SEMIN THROMB HEMOST, V35, P367, DOI 10.1055/s-0029-1225759; Luan D, 2007, PLOS COMPUT BIOL, V3, P1347, DOI 10.1371/journal.pcbi.0030142; Mann KG, 2009, HAMOSTASEOLOGIE, V29, P7; Mitrophanov AY, 2011, THROMB RES, V128, P381, DOI 10.1016/j.thromres.2011.05.013; Nair SC, 2010, HAEMOPHILIA, V16, P85, DOI 10.1111/j.1365-2516.2010.02304.x; Orfeo T, 2010, J THROMB HAEMOST, V8, P1745, DOI 10.1111/j.1538-7836.2010.03917.x; Orfeo T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027852; Panteleev MA, 2006, BIOPHYS J, V90, P1489, DOI 10.1529/biophysj.105.069062; Patnaik MM, 2008, HAEMOPHILIA, V14, P1229, DOI 10.1111/j.1365-2516.2008.01830.x; Regnault W, 2004, THROMB RES, V114, P539, DOI 10.1016/j.thromres.2004.06.017; Robert S, 2009, PHARMACOL RES, V59, P160, DOI 10.1016/j.phrs.2008.12.003; Rodgers GM, 2004, WINTROBES CLIN HEMAT, P1511; Runyon MK, 2008, J AM CHEM SOC, V130, P3458, DOI 10.1021/ja076301r; Shampine LF, SIAM J SCI COMPUTING, V18, P1; Ten Cate H, 2011, THROMBOSIS RES; van Veen JJ, 2008, BRIT J HAEMATOL, V142, P889, DOI 10.1111/j.1365-2141.2008.07267.x; Wajima T, 2009, CLIN PHARMACOL THER, V86, P290, DOI 10.1038/clpt.2009.87; Xu ZL, 2008, J R SOC INTERFACE, V5, P705, DOI 10.1098/rsif.2007.1202; Xu ZL, 2011, ARTERIOSCL THROM VAS, V31, P500, DOI 10.1161/ATVBAHA.110.213397	41	40	41	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2012	7	2							e30385	10.1371/journal.pone.0030385	http://dx.doi.org/10.1371/journal.pone.0030385			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UV	22319567	Green Submitted, Green Published, gold			2022-12-25	WOS:000301979000005
J	Curriu, M; Fausther-Bovendo, H; Pernas, M; Massanella, M; Carrillo, J; Cabrera, C; Lopez-Galindez, C; Clotet, B; Debre, P; Vieillard, V; Blanco, J				Curriu, Marta; Fausther-Bovendo, Hughes; Pernas, Maria; Massanella, Marta; Carrillo, Jorge; Cabrera, Cecilia; Lopez-Galindez, Cecilio; Clotet, Bonaventura; Debre, Patrice; Vieillard, Vincent; Blanco, Julia			Viremic HIV Infected Individuals with High CD4 T Cells and Functional Envelope Proteins Show Anti-gp41 Antibodies with Unique Specificity and Function	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; NKP44L EXPRESSION; NK CYTOTOXICITY; DEPLETION; GP41; MACAQUES; APOPTOSIS; DISEASE; DEATH; AIDS	Background: CD4 T-cell decay is variable among HIV-infected individuals. In exceptional cases, CD4 T-cell counts remain stable despite high plasma viremia. HIV envelope glycoprotein (Env) properties, namely tropism, fusion or the ability to induce the NK ligand NKp44L, or host factors that modulate Env cytopathic mechanisms may be modified in such situation. Methods: We identified untreated HIV-infected individuals showing non-cytopathic replication (VL>10,000 copies/mL and CD4 T-cell decay<50 cells/mu L/year, Viremic Non Progressors, VNP) or rapid progression (CD4 T-cells<350 cells/mu L within three years post-infection, RP). We isolated full-length Env clones and analyzed their functions (tropism, fusion activity and capacity to induce NKp44L expression on CD4 cells). Anti-Env humoral responses were also analyzed. Results: Env clones isolated from VNP or RP individuals showed no major phenotypic differences. The percentage of functional clones was similar in both groups. All clones tested were CCR5-tropic and showed comparable expression and fusogenic activity. Moreover, no differences were observed in their capacity to induce NKp44L expression on CD4 T cells from healthy donors through the 3S epitope of gp41. In contrast, anti-Env antibodies showed clear functional differences: plasma from VNPs had significantly higher capacity than RPs to block NKp44L induction by autologous viruses. Consistently, CD4 T-cells isolated from VNPs showed undetectable NKp44L expression and specific antibodies against a variable region flanking the highly conserved 3S epitope were identified in plasma samples from these patients. Conversely, despite continuous antigen stimulation, VNPs were unable to mount a broad neutralizing response against HIV. Conclusions: Env functions (fusion and induction of NKp44L) were similar in viremic patients with slow or rapid progression to AIDS. However, differences in humoral responses against gp41 epitopes nearby 3S sequence may contribute to the lack of CD4 T cell decay in VNPs by blocking the induction of NKp44L by gp41.	[Curriu, Marta; Massanella, Marta; Carrillo, Jorge; Cabrera, Cecilia; Clotet, Bonaventura; Blanco, Julia] Univ Autonoma Barcelona, Hosp Germans Trias, Inst Rec Ciencies Salut Germans Trias & Pujol, IrsiCaixa HIVACAT, E-08193 Barcelona, Catalonia, Spain; [Fausther-Bovendo, Hughes; Debre, Patrice; Vieillard, Vincent] Univ Paris 06, UPMC, Hop Pitie Salpetriere, INSERM UMR S 945, Paris, France; [Pernas, Maria; Lopez-Galindez, Cecilio] Inst Salud Carlos III, CNM, Madrid, Spain; [Clotet, Bonaventura] Univ Autonoma Barcelona, Hosp Germans Trias, Inst Rec Ciencies Salut Germans Trias & Pujol, Lluita SIDA Fdn, E-08193 Barcelona, Catalonia, Spain	Autonomous University of Barcelona; Hospital Germans Trias i Pujol; Institut de Recerca de la Sida - IrsiCaixa; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Microelectronica (CNM); Instituto de Salud Carlos III; Autonomous University of Barcelona; Hospital Germans Trias i Pujol	Curriu, M (corresponding author), Univ Autonoma Barcelona, Hosp Germans Trias, Inst Rec Ciencies Salut Germans Trias & Pujol, IrsiCaixa HIVACAT, E-08193 Barcelona, Catalonia, Spain.	vincent.vieillard@upmc.fr; jblanco@irsicaixa.es	Lopez-Galindez, Cecilio/A-3603-2008; Massanella, Marta/P-8619-2016; Cabrera, Cecilia/S-1113-2019; Pernas, Maria/E-3998-2018; Vieillard, Vincent/P-3001-2017; Carrillo, Jorge/AAL-9481-2021; Blanco, Julià/A-5347-2008	Lopez-Galindez, Cecilio/0000-0002-2324-9584; Massanella, Marta/0000-0002-3326-151X; Cabrera, Cecilia/0000-0002-9941-6828; Pernas, Maria/0000-0003-2966-0160; Carrillo, Jorge/0000-0003-0221-5948; Blanco, Julià/0000-0002-2225-0217	"Fundacion para la Investigacion y Prevencion del SIDA en Espana" FIPSE [08/36725, 36558/06, 36641/07, 36779/08, 360766/09]; Health Department of the Catalan Government (Generalitat de Catalunya); Instituto de Salud Carlos III [CP04/00271, CES98/3047, CD09/00150]; Spanish AIDS network 'Red Tematica Cooperativa de Investigacion en SIDA', RIS [RD06/0006]; Merck Sharp Domme;  [SAF 2007-61036];  [SAF 2010-17226]	"Fundacion para la Investigacion y Prevencion del SIDA en Espana" FIPSE; Health Department of the Catalan Government (Generalitat de Catalunya)(Generalitat de Catalunya); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Spanish AIDS network 'Red Tematica Cooperativa de Investigacion en SIDA', RIS; Merck Sharp Domme; ; 	Spanish AIDS network 'Red Tematica Cooperativa de Investigacion en SIDA', RIS, RD06/0006 (to JB, CLG, MP and MC). "Fundacion para la Investigacion y Prevencion del SIDA en Espana" FIPSE grant 08/36725 (to CC). Health Department of the Catalan Government (Generalitat de Catalunya) and Instituto de Salud Carlos III (contracts CP04/00271 and CES98/3047 to CC and JB, respectively). Instituto de Salud Carlos III (contract CD09/00150 to JC). Work in CNM is supported by grant SAF 2007-61036 and SAF 2010-17226 and by FIPSE grants 36558/06, 36641/07, 36779/08, 360766/09. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: B. C. has received research funding from Merck Sharp & Domme and has received honoraria for speaking and serving on advisory boards from Abbott, Bristol-Myers Squibb, Boehringer-Ingelheim, Gilead Sciences, GlaxoSmithKline, Roche, Janssen-Cilag, and Merck Sharp & Domme. J.B. has received honoraria as a consultant for GlaxoSmithKline. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. All other authors: no conflicts.	Badley AD, 2000, BLOOD, V96, P2951, DOI 10.1182/blood.V96.9.2951.h8002951_2951_2964; Blanco J, 2001, VIROLOGY, V285, P356, DOI 10.1006/viro.2001.0969; BLANCO J, 1992, BRIT J PHARMACOL, V107, P671, DOI 10.1111/j.1476-5381.1992.tb14505.x; Blanco J, 2003, VIROLOGY, V305, P318, DOI 10.1006/viro.2002.1764; Blanco J, 2004, J LEUKOCYTE BIOL, V76, P804, DOI 10.1189/jlb.0204100; Casado C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011079; Choudhary SK, 2007, J VIROL, V81, P8838, DOI 10.1128/JVI.02663-06; Dalmau J, 2009, CLIN INFECT DIS, V48, P229, DOI 10.1086/595704; Denizot M, 2008, AUTOPHAGY, V4, P998, DOI 10.4161/auto.6880; Doitsh G, 2010, CELL, V143, P789, DOI 10.1016/j.cell.2010.11.001; Doria-Rose NA, 2010, J VIROL, V84, P1631, DOI 10.1128/JVI.01482-09; Etemad-Moghadam B, 2001, J VIROL, V75, P5646, DOI 10.1128/JVI.75.12.5646-5655.2001; Euler Z, 2010, J INFECT DIS, V201, P1045, DOI 10.1086/651144; Fausther-Bovendo H, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000975; FREED EO, 1990, P NATL ACAD SCI USA, V87, P4650, DOI 10.1073/pnas.87.12.4650; Gandhi RT, 1998, J EXP MED, V187, P1113, DOI 10.1084/jem.187.7.1113; Garg H, 2007, J BIOL CHEM, V282, P16899, DOI 10.1074/jbc.M701701200; Gougeon ML, 2009, APOPTOSIS, V14, P501, DOI 10.1007/s10495-009-0314-1; Jensen MA, 2006, J VIROL, V80, P4698, DOI 10.1128/JVI.80.10.4698-4704.2006; Karlsson GB, 1998, J EXP MED, V188, P1159, DOI 10.1084/jem.188.6.1159; Labonte JA, 2000, J VIROL, V74, P10690, DOI 10.1128/JVI.74.22.10690-10698.2000; Lassen KG, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000377; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Li Y, 2006, J VIROL, V80, P1414, DOI 10.1128/JVI.80.3.1414-1426.2006; Lum JJ, 2003, J CLIN INVEST, V111, P1547, DOI 10.1172/JCI200316233; MALIM MH, 1988, NATURE, V335, P181, DOI 10.1038/335181a0; McCune JM, 2001, NATURE, V410, P974, DOI 10.1038/35073648; Paiardini M, 2009, ANNU REV MED, V60, P485, DOI 10.1146/annurev.med.60.041807.123753; Pietzsch J, 2010, J VIROL, V84, P5032, DOI 10.1128/JVI.00154-10; Rotger M, 2011, J CLIN INVEST; Sing T, 2007, ANTIVIR THER, V12, P1097; Sterjovski J, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-89; TERSMETTE M, 1989, LANCET, V1, P983; Vieillard V, 2005, P NATL ACAD SCI USA, V102, P10981, DOI 10.1073/pnas.0504315102; Vieillard V, 2008, P NATL ACAD SCI USA, V105, P2100, DOI 10.1073/pnas.0711629105; Vieillard V, 2008, AIDS, V22, P185, DOI 10.1097/QAD.0b013e3282f35551; Vieillard V, 2006, AIDS, V20, P1795, DOI 10.1097/01.aids.0000244198.65263.17; Vieillard V, 2010, JAIDS-J ACQ IMM DEF, V53, P564, DOI 10.1097/QAI.0b013e3181d0c5b4	38	11	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2012	7	2							e30330	10.1371/journal.pone.0030330	http://dx.doi.org/10.1371/journal.pone.0030330			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UG	22312424	Green Submitted, Green Published, gold			2022-12-25	WOS:000301977500008
J	Rigoulot, S; Pell, MD				Rigoulot, Simon; Pell, Marc D.			Seeing Emotion with Your Ears: Emotional Prosody Implicitly Guides Visual Attention to Faces	PLOS ONE			English	Article							AFFECT DECISION TASK; EVENT-RELATED FMRI; FACIAL EXPRESSIONS; HUMAN BRAIN; TIME-COURSE; ANGRY PROSODY; AUDIOVISUAL INTEGRATION; MEANINGLESS SPEECH; CROSSMODAL BINDING; FUNCTIONAL MRI	Interpersonal communication involves the processing of multimodal emotional cues, particularly facial expressions (visual modality) and emotional speech prosody (auditory modality) which can interact during information processing. Here, we investigated whether the implicit processing of emotional prosody systematically influences gaze behavior to facial expressions of emotion. We analyzed the eye movements of 31 participants as they scanned a visual array of four emotional faces portraying fear, anger, happiness, and neutrality, while listening to an emotionally-inflected pseudo-utterance (Someone migged the pazing) uttered in a congruent or incongruent tone. Participants heard the emotional utterance during the first 1250 milliseconds of a five-second visual array and then performed an immediate recall decision about the face they had just seen. The frequency and duration of first saccades and of total looks in three temporal windows ([0-1250 ms], [1250-2500 ms], [2500-5000 ms]) were analyzed according to the emotional content of faces and voices. Results showed that participants looked longer and more frequently at faces that matched the prosody in all three time windows (emotion congruency effect), although this effect was often emotion-specific (with greatest effects for fear). Effects of prosody on visual attention to faces persisted over time and could be detected long after the auditory information was no longer present. These data imply that emotional prosody is processed automatically during communication and that these cues play a critical role in how humans respond to related visual cues in the environment, such as facial expressions.	[Rigoulot, Simon; Pell, Marc D.] McGill Univ, Fac Med, Sch Commun Sci & Disorders, Montreal, PQ, Canada; [Rigoulot, Simon; Pell, Marc D.] McGill Ctr Res Brain Language & Mus, Montreal, PQ, Canada	McGill University	Rigoulot, S (corresponding author), McGill Univ, Fac Med, Sch Commun Sci & Disorders, Montreal, PQ, Canada.	simon.rigoulot@mcgill.ca	Pell, Marc D./AAL-3121-2021; Rigoulot, Simon/ABF-5776-2020	Pell, Marc D./0000-0002-9947-1552; 				Aue T, 2011, PSYCHOPHYSIOLOGY, V48, P385, DOI 10.1111/j.1469-8986.2010.01064.x; Bach DR, 2008, NEUROIMAGE, V42, P919, DOI 10.1016/j.neuroimage.2008.05.034; Batty M, 2003, COGNITIVE BRAIN RES, V17, P613, DOI 10.1016/S0926-6410(03)00174-5; Bechara A, 2000, CEREB CORTEX, V10, P295, DOI 10.1093/cercor/10.3.295; Becker MW, 2009, Q J EXP PSYCHOL, V62, P1257, DOI 10.1080/17470210902725753; Borod JC, 2000, COGNITION EMOTION, V14, P193, DOI 10.1080/026999300378932; Bostanov V, 2004, PSYCHOPHYSIOLOGY, V41, P259, DOI 10.1111/j.1469-8986.2003.00142.x; Bradley BP, 1998, COGNITION EMOTION, V12, P737, DOI 10.1080/026999398379411; Brosch T, 2008, COGNITION, V106, P1497, DOI 10.1016/j.cognition.2007.05.011; Brosch T, 2007, EMOTION, V7, P685, DOI 10.1037/1528-3542.7.3.685; Brosch T, 2009, J COGNITIVE NEUROSCI, V21, P1670, DOI 10.1162/jocn.2009.21110; Buchanan TW, 2007, PSYCHOL BULL, V133, P761, DOI 10.1037/0033-2909.133.5.761; Calder AJ, 2005, NAT REV NEUROSCI, V6, P641, DOI 10.1038/nrn1724; Calvert GA, 2000, CURR BIOL, V10, P649, DOI 10.1016/S0960-9822(00)00513-3; Calvert GA, 1998, TRENDS COGN SCI, V2, P247, DOI 10.1016/S1364-6613(98)01189-9; Calvo MG, 2006, COGNITION EMOTION, V20, P785, DOI 10.1080/02699930500465224; Calvo MG, 2009, COGN AFFECT BEHAV NE, V9, P398, DOI 10.3758/CABN.9.4.398; Calvo MG, 2005, J EXP PSYCHOL HUMAN, V31, P502, DOI 10.1037/0096-1523.31.3.502; Campanella S, 2007, TRENDS COGN SCI, V11, P535, DOI 10.1016/j.tics.2007.10.001; Collignon O, 2008, BRAIN RES, V1242, P126, DOI 10.1016/j.brainres.2008.04.023; Compton Rebecca J, 2003, Behav Cogn Neurosci Rev, V2, P115, DOI 10.1177/1534582303002002003; Dara C, 2008, BRAIN RES, V1188, P100, DOI 10.1016/j.brainres.2007.10.034; de Gelder B, 2000, COGNITION EMOTION, V14, P289, DOI 10.1080/026999300378824; de Gelder B, 1999, NEUROSCI LETT, V260, P133, DOI 10.1016/S0304-3940(98)00963-X; Dolan RJ, 2001, P NATL ACAD SCI USA, V98, P10006, DOI 10.1073/pnas.171288598; Eastwood JD, 2001, PERCEPT PSYCHOPHYS, V63, P1004, DOI 10.3758/BF03194519; EKMAN P, 1992, PSYCHOL REV, V99, P550, DOI 10.1037/0033-295X.99.3.550; Esslen M, 2004, NEUROIMAGE, V21, P1189, DOI 10.1016/j.neuroimage.2003.10.001; Ethofer T, 2006, NEUROIMAGE, V30, P580, DOI 10.1016/j.neuroimage.2005.09.059; Ethofer T, 2006, PROG BRAIN RES, V156, P345, DOI 10.1016/S0079-6123(06)56019-4; Ethofer T, 2006, HUM BRAIN MAPP, V27, P707, DOI 10.1002/hbm.20212; Ethofer T, 2009, CURR BIOL, V19, P1028, DOI 10.1016/j.cub.2009.04.054; Fox E, 2000, COGNITION EMOTION, V14, P61, DOI 10.1080/026999300378996; Fox E, 2006, EMOTION, V6, P534, DOI 10.1037/1528-3542.6.3.534; Frischen A, 2008, PSYCHOL BULL, V134, P662, DOI 10.1037/0033-2909.134.5.662; Gleitman LR, 2007, J MEM LANG, V57, P544, DOI 10.1016/j.jml.2007.01.007; Grandjean D, 2005, NAT NEUROSCI, V8, P145, DOI 10.1038/nn1392; Green MJ, 2003, COGNITION EMOTION, V17, P779, DOI 10.1080/02699930302282; Hietanen J, 2004, EUR J COGN PSYCHOL, V16, P769, DOI 10.1080/09541440340000330; Huettig F, 2005, COGNITION, V96, pB23, DOI 10.1016/j.cognition.2004.10.003; Juslin PN, 2003, PSYCHOL BULL, V129, P770, DOI 10.1037/0033-2909.129.5.770; Juth P, 2005, EMOTION, V5, P379, DOI 10.1037/1528-3542.5.4.379; Kamachi M, 2003, CURR BIOL, V13, P1709, DOI 10.1016/j.cub.2003.09.005; Kensinger EA, 2009, EMOT REV, V1, P99, DOI 10.1177/1754073908100432; Kiss M, 2008, PSYCHOPHYSIOLOGY, V45, P240, DOI 10.1111/j.1469-8986.2007.00611.x; LANG PJ, 1993, PSYCHOPHYSIOLOGY, V30, P261, DOI 10.1111/j.1469-8986.1993.tb03352.x; Leppanen JM, 2004, PSYCHOL RES-PSYCH FO, V69, P22, DOI 10.1007/s00426-003-0157-2; Massaro DW, 1996, PSYCHON B REV, V3, P215, DOI 10.3758/BF03212421; MCGURK H, 1976, NATURE, V264, P746, DOI 10.1038/264746a0; Niedenthal PM, 2007, SCIENCE, V316, P1002, DOI 10.1126/science.1136930; Niedenthal PM, 1999, PSYCHOL REV, V106, P337, DOI 10.1037/0033-295X.106.2.337; Noppeney U, 2010, J NEUROSCI, V30, P7434, DOI 10.1523/JNEUROSCI.0455-10.2010; Nygaard LC, 2008, J EXP PSYCHOL HUMAN, V34, P1017, DOI 10.1037/0096-1523.34.4.1017; Ohman A, 2001, J PERS SOC PSYCHOL, V80, P381, DOI 10.1037//0022-3514.80.3.381; P Boersma, 2010, PRAAT VERSION 5 2 03; Palermo R, 2007, NEUROPSYCHOLOGIA, V45, P75, DOI 10.1016/j.neuropsychologia.2006.04.025; Park JY, 2010, CORTEX, V46, P161, DOI 10.1016/j.cortex.2008.06.008; Paulmann S, 2008, NEUROREPORT, V19, P209, DOI 10.1097/WNR.0b013e3282f454db; Paulmann S, 2012, SPEECH COMMUN, V54, P92, DOI 10.1016/j.specom.2011.07.004; Paulmann S, 2011, MOTIV EMOTION, V35, P192, DOI 10.1007/s11031-011-9206-0; Paulmann S, 2010, COGN AFFECT BEHAV NE, V10, P230, DOI 10.3758/CABN.10.2.230; Paulmann S, 2009, NEUROREPORT, V20, P1603, DOI 10.1097/WNR.0b013e3283320e3f; Paulmann S, 2009, J PSYCHOPHYSIOL, V23, P63, DOI 10.1027/0269-8803.23.2.63; Peelen MV, 2010, J NEUROSCI, V30, P10127, DOI 10.1523/JNEUROSCI.2161-10.2010; Pell MD, 2008, SPEECH COMMUN, V50, P519, DOI 10.1016/j.specom.2008.03.006; Pell MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027256; Pell MD, 2011, COGNITION EMOTION, V25, P834, DOI 10.1080/02699931.2010.516915; Pell MD, 2009, J PHONETICS, V37, P417, DOI 10.1016/j.wocn.2009.07.005; Pell MD, 1997, BRAIN LANG, V57, P80, DOI 10.1006/brln.1997.1638; Pell MD, 2005, J NONVERBAL BEHAV, V29, P193, DOI 10.1007/s10919-005-7720-z; Pell MD, 2005, J NONVERBAL BEHAV, V29, P45, DOI 10.1007/s10919-004-0889-8; Pourtois G, 2000, NEUROREPORT, V11, P1329, DOI 10.1097/00001756-200004270-00036; Pourtois G, 2005, CORTEX, V41, P49, DOI 10.1016/S0010-9452(08)70177-1; Pourtois G, 2004, CEREB CORTEX, V14, P619, DOI 10.1093/cercor/bhh023; Pourtois G, 2002, COGNITIVE BRAIN RES, V14, P99, DOI 10.1016/S0926-6410(02)00064-2; Pourtois G, 2006, NEUROIMAGE, V31, P920, DOI 10.1016/j.neuroimage.2005.12.034; R Rosenthal, 1991, APPL SOC RES METHODS, V6, P19; Reinders AATS, 2006, NEUROIMAGE, V33, P805, DOI 10.1016/j.neuroimage.2006.06.052; Reynolds MG, 2009, VIS COGN, V17, P318, DOI 10.1080/13506280701623704; Russell JA, 2003, ANNU REV PSYCHOL, V54, P329, DOI 10.1146/annurev.psych.54.101601.145102; Sauter DA, 2010, J COGNITIVE NEUROSCI, V22, P474, DOI 10.1162/jocn.2009.21215; SCHERER KR, 1991, MOTIV EMOTION, V15, P123, DOI 10.1007/BF00995674; Schirmer A, 2006, TRENDS COGN SCI, V10, P24, DOI 10.1016/j.tics.2005.11.009; Schirmer A, 2002, COGNITIVE BRAIN RES, V14, P228, DOI 10.1016/S0926-6410(02)00108-8; Schirmer A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009080; Seubert J, 2010, NEUROIMAGE, V53, P746, DOI 10.1016/j.neuroimage.2010.07.012; Seyfarth RM, 2009, P NATL ACAD SCI USA, V106, P669, DOI 10.1073/pnas.0811894106; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Spreckelmeyer KN, 2009, BRAIN COGNITION, V69, P121, DOI 10.1016/j.bandc.2008.06.003; Spruyt A, 2007, MEM COGNITION, V35, P95, DOI 10.3758/BF03195946; SUMMERFIELD Q, 1979, PHONETICA, V36, P314, DOI 10.1159/000259969; Swerts M., 2009, INT J SPEECH LANGUAG, V11, P282; TANENHAUS MK, 1995, SCIENCE, V268, P1632, DOI 10.1126/science.7777863; Thonnessen H, 2010, NEUROIMAGE, V50, P250, DOI 10.1016/j.neuroimage.2009.11.082; Tipples J, 2002, EMOTION, V2, P288, DOI 10.1037/1528-3542.2.3.288; VASEY MW, 1987, PSYCHOPHYSIOLOGY, V24, P479, DOI 10.1111/j.1469-8986.1987.tb00324.x; Vroomen J, 2000, J EXP PSYCHOL HUMAN, V26, P1583, DOI 10.1037/0096-1523.26.5.1583; Vroomen J, 2001, COGN AFFECT BEHAV NE, V1, P382, DOI 10.3758/CABN.1.4.382; Vuilleumier P, 2007, NEUROPSYCHOLOGIA, V45, P174, DOI 10.1016/j.neuropsychologia.2006.06.003; Weymar M, 2009, PSYCHOPHYSIOLOGY, V46, P1200, DOI 10.1111/j.1469-8986.2009.00869.x; Whalen PJ, 2001, EMOTION, V1, P70, DOI 10.1037/1528-3542.1.1.70; Williams MA, 2005, VIS COGN, V12, P29, DOI 10.1080/13506280444000193; Wittfoth M, 2010, CEREB CORTEX, V20, P383, DOI 10.1093/cercor/bhp106; Zhang Q, 2010, BRAIN RES, V1329, P142, DOI 10.1016/j.brainres.2010.03.021; ZUCKERMAN M, 1975, J PERS SOC PSYCHOL, V32, P1068, DOI 10.1037/0022-3514.32.6.1068	105	35	38	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2012	7	1							e30740	10.1371/journal.pone.0030740	http://dx.doi.org/10.1371/journal.pone.0030740			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	912BU	22303454	Green Published, gold			2022-12-25	WOS:000301770300004
J	Gori, A; Cerboneschi, M; Tegli, S				Gori, Andrea; Cerboneschi, Matteo; Tegli, Stefania			High-Resolution Melting Analysis as a Powerful Tool to Discriminate and Genotype Pseudomonas savastanoi Pathovars and Strains	PLOS ONE			English	Article							SYRINGAE SUBSP SAVASTANOI; REAL-TIME PCR; PV. SAVASTANOI; CURVE ANALYSIS; RAPID IDENTIFICATION; SEMISELECTIVE MEDIUM; SECRETION SYSTEM; OLIVE LEAVES; POPULATIONS; EVOLUTION	Pseudomonas savastanoi is a serious pathogen of Olive, Oleander, Ash, and several other Oleaceae. Its epiphytic or endophytic presence in asymptomatic plants is crucial for the spread of Olive and Oleander knot disease, as already ascertained for P. savastanoi pv. savastanoi (Psv) on Olive and for pv. nerii (Psn) on Oleander, while no information is available for pv. fraxini (Psf) on Ash. Nothing is known yet about the distribution on the different host plants and the real host range of these pathovars in nature, although cross-infections were observed following artificial inoculations. A multiplex Real-Time PCR assay was recently developed to simultaneously and quantitatively discriminate in vitro and in planta these P. savastanoi pathovars, for routine culture confirmation and for epidemiological and diagnostical studies. Here an innovative High-Resolution Melting Analysis (HRMA)-based assay was set up to unequivocally discriminate Psv, Psn and Psf, according to several single nucleotide polymorphisms found in their Type Three Secretion System clusters. The genetic distances among 56 P. savastanoi strains belonging to these pathovars were also evaluated, confirming and refining data previously obtained by fAFLP. To our knowledge, this is the first time that HRMA is applied to a bacterial plant pathogen, and one of the few multiplex HRMA-based assays developed so far. This protocol provides a rapid, sensitive, specific tool to differentiate and detect Psv, Psn and Psf strains, also in vivo and against other related bacteria, with lower costs than conventional multiplex Real-Time PCR. Its application is particularly suitable for sanitary certification programs for P. savastanoi, aimed at avoiding the spreading of this phytopathogen through asymptomatic plants.	[Gori, Andrea; Cerboneschi, Matteo; Tegli, Stefania] Univ Florence, Dipartimento Biotecnol Agr, Lab Patol Vegetale & Mol, Florence, Italy	University of Florence	Gori, A (corresponding author), Univ Florence, Dipartimento Biotecnol Agr, Lab Patol Vegetale & Mol, Florence, Italy.	stefania.tegli@unifi.it	Gori, Andrea/AAC-6078-2022; Tegli, Stefania/K-7297-2014	Tegli, Stefania/0000-0003-1297-186X; Cerboneschi, Matteo/0000-0002-6448-2622	Ente Cassa di Risparmio di Firenze [2007.1005-2010.0972]	Ente Cassa di Risparmio di Firenze(Fondazione Cassa Risparmio Firenze)	The research project was funded by "Ente Cassa di Risparmio di Firenze'' with grant number 2007.1005-2010.0972. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Alvarez F, 1998, EUR J PLANT PATHOL, V104, P603, DOI 10.1023/A:1008604011154; Anonymous, 2006, Bulletin OEPP, V36, P77; AZAD HR, 1995, PHYTOPATHOLOGY, V85, P740, DOI 10.1094/Phyto-85-740; Bella P, 2008, PHYTOPATHOL MEDITERR, V47, P204; Bertolini E, 2003, PHYTOPATHOLOGY, V93, P286, DOI 10.1094/PHYTO.2003.93.3.286; Bertolini E, 2003, J MICROBIOL METH, V52, P261, DOI 10.1016/S0167-7012(02)00163-X; Bull CT, 2011, PHYTOPATHOLOGY, V101, P847, DOI 10.1094/PHYTO-11-10-0318; Bull CT, 2010, SYST APPL MICROBIOL, V33, P105, DOI 10.1016/j.syapm.2010.02.001; Caccamo D, 1999, RES MICROBIOL, V150, P221, DOI 10.1016/S0923-2508(99)80039-4; Caponero A, 1995, PLANT PATHOL, V44, P848, DOI 10.1111/j.1365-3059.1995.tb02744.x; Casano FJ, 1986, EPPO B, V17, P173; Castellanos E, 2010, CLIN MICROBIOL INFEC, V16, P1659, DOI 10.1111/j.1469-0691.2010.03198.x; Cazorla FM, 2002, PHYTOPATHOLOGY, V92, P909, DOI 10.1094/PHYTO.2002.92.8.909; De Koeyer D, 2010, MOL BREEDING, V25, P67, DOI 10.1007/s11032-009-9309-4; ERCOLANI G. L., 1971, Phytopathologia Mediterranea, V10, P130; ERCOLANI GL, 1983, J GEN MICROBIOL, V129, P901; ERCOLANI GL, 1978, J GEN MICROBIOL, V109, P245, DOI 10.1099/00221287-109-2-245; ERCOLANI GL, 1991, MICROBIAL ECOL, V21, P35, DOI 10.1007/BF02539143; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; GARDAN L, 1992, INT J SYST BACTERIOL, V42, P606, DOI 10.1099/00207713-42-4-606; Garritano S, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-5; Gundry CN, 2003, CLIN CHEM, V49, P396, DOI 10.1373/49.3.396; Hewson K, 2009, ARCH VIROL, V154, P649, DOI 10.1007/s00705-009-0357-1; Hoek KGP, 2008, J CLIN MICROBIOL, V46, P1369, DOI 10.1128/JCM.02343-07; Hofinger BJ, 2009, THEOR APPL GENET, V119, P851, DOI 10.1007/s00122-009-1094-2; Iacobellis N. S., 1995, Phytopathologia Mediterranea, V34, P15; Iacobellis NS, 1998, PLANT PATHOL, V47, P73, DOI 10.1046/j.1365-3059.1998.00202.x; Jackson RW, 2011, TRENDS GENET, V27, P32, DOI 10.1016/j.tig.2010.10.001; JANSE JD, 1982, INT J SYST BACTERIOL, V32, P166, DOI 10.1099/00207713-32-2-166; JANSE JD, 1991, SYST APPL MICROBIOL, V14, P79, DOI 10.1016/S0723-2020(11)80365-6; Jeffery N, 2007, MICROBIOL-SGM, V153, P2679, DOI 10.1099/mic.0.2006/005140-0; Jeong HJ, 2010, GENOME, V53, P1029, DOI 10.1139/G10-094; KING EO, 1954, J LAB CLIN MED, V44, P301; Krid S, 2009, J APPL MICROBIOL, V106, P886, DOI 10.1111/j.1365-2672.2008.04058.x; Krypuy M, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-168; Krypuy M, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-295; Lavermicocca P, 1987, PHYTOPATHOLMEDITERR, V26, P136; Liew M, 2006, J MOL DIAGN, V8, P97, DOI 10.2353/jmoldx.2006.050053; Mackay JF, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-8; Mao F, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-76; Marchi G, 2009, PLANT PATHOL, V58, P152, DOI 10.1111/j.1365-3059.2008.01935.x; Matas IM, 2009, APPL ENVIRON MICROB, V75, P1030, DOI 10.1128/AEM.01572-08; McCann HC, 2008, NEW PHYTOL, V177, P33, DOI 10.1111/j.1469-8137.2007.02293.x; McKinney J. T., 2010, The handbook of plant mutation screening: mining of natural and induced alleles, P149, DOI 10.1002/9783527629398.ch9; Montgomery J, 2007, NAT PROTOC, V2, P59, DOI 10.1038/nprot.2007.10; MUGNAI L, 1994, J PHYTOPATHOL, V142, P209, DOI 10.1111/j.1439-0434.1994.tb04531.x; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nasereddin A, 2010, J CLIN MICROBIOL, V48, P2240, DOI 10.1128/JCM.00553-10; Nei M., 2000, MOL EVOLUTION PHYLOG; Parkinson N, 2011, PLANT PATHOL, V60, P338, DOI 10.1111/j.1365-3059.2010.02366.x; Penyalver R, 2000, APPL ENVIRON MICROB, V66, P2673, DOI 10.1128/AEM.66.6.2673-2677.2000; Pietzka AT, 2009, J ANTIMICROB CHEMOTH, V63, P1121, DOI 10.1093/jac/dkp124; Price EP, 2007, APPL ENVIRON MICROB, V73, P3431, DOI 10.1128/AEM.02702-06; Quesada JM, 2010, PLANT PATHOL, V59, P262, DOI 10.1111/j.1365-3059.2009.02200.x; Quesada JM, 2008, RES MICROBIOL, V159, P207, DOI 10.1016/j.resmic.2007.12.010; Quesada JM, 2007, INT MICROBIOL, V10, P77, DOI 10.2436/20.1501.01.11; Renick LJ, 2008, PLANT DIS, V92, P372, DOI 10.1094/PDIS-92-3-0372; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Sarkar SF, 2006, GENETICS, V174, P1041, DOI 10.1534/genetics.106.060996; Sarkar SF, 2004, APPL ENVIRON MICROB, V70, P1999, DOI 10.1128/AEM.70.4.1999-2012.2004; Sawada H, 1999, J MOL EVOL, V49, P627, DOI 10.1007/PL00006584; SCHROTH MN, 1973, PHYTOPATHOLOGY, V63, P1064, DOI 10.1094/Phyto-63-1064; SCHROTH MN, 1968, PHYTOPATHOLOGY, V58, P524; Scortichini M, 2004, PLANT PATHOL, V53, P491, DOI 10.1111/j.1365-3059.2004.01051.x; Seipp Michael T, 2009, J Biomol Tech, V20, P160; Sheppard A, 2006, POLITIQUE SANITAIRE; Sisto A, 2007, PLANT PATHOL, V56, P366, DOI 10.1111/j.1365-3059.2007.01567.x; Sisto Angelo, 2002, Phytopathologia Mediterranea, V41, P63; Sneath P.H.A., 1963, NUMERICAL TAXONOMY; Steer PA, 2009, J CLIN MICROBIOL, V47, P311, DOI 10.1128/JCM.01567-08; SURICO G, 1985, PHYSIOL PLANT PATHOL, V26, P309, DOI 10.1016/0048-4059(85)90006-2; SURICO G, 1989, PHYTOPATHOLOGY, V79, P185, DOI 10.1094/Phyto-79-185; Surico G, 1992, MOL SIGNALS PLANT MI, P209; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tegli S, 2011, GENES-BASEL, V2, P957, DOI 10.3390/genes2040957; Tegli S, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-156; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Toi CS, 2008, J CLIN VIROL, V43, P18, DOI 10.1016/j.jcv.2008.03.027; Wang J, 2010, CAN J MICROBIOL, V56, P676, DOI [10.1139/w10-054, 10.1139/W10-054]; Wang PW, 2007, MICROBIOL-SGM, V153, P2067, DOI 10.1099/mic.0.2006/001545-0; WILSON EE, 1964, PHYTOPATHOLOGY, V54, P576; Wittwer CT, 2003, CLIN CHEM, V49, P853, DOI 10.1373/49.6.853; Wolff BJ, 2008, ANTIMICROB AGENTS CH, V52, P3542, DOI 10.1128/AAC.00582-08; Wu SB, 2008, THEOR APPL GENET, V118, P1, DOI 10.1007/s00122-008-0870-8; Wynyard S, 2011, J VIROL METHODS, V175, P95, DOI 10.1016/j.jviromet.2011.04.026; Yan SC, 2008, APPL ENVIRON MICROB, V74, P3171, DOI 10.1128/AEM.00180-08; Young J. M., 1996, Review of Plant Pathology, V75, P721; YOUNG JM, 1994, J APPL BACTERIOL, V77, P195, DOI 10.1111/j.1365-2672.1994.tb03064.x	89	27	28	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e30199	10.1371/journal.pone.0030199	http://dx.doi.org/10.1371/journal.pone.0030199			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910ME	22295075	Green Submitted, Green Published, gold			2022-12-25	WOS:000301640600020
J	Lioy, VS; Machon, C; Tabone, M; Gonzalez-Pastor, JE; Daugelavicius, R; Ayora, S; Alonso, JC				Lioy, Virginia S.; Machon, Cristina; Tabone, Mariangela; Gonzalez-Pastor, Jose E.; Daugelavicius, Rimantas; Ayora, Silvia; Alonso, Juan C.			The zeta Toxin Induces a Set of Protective Responses and Dormancy	PLOS ONE			English	Article							BACILLUS-SUBTILIS SPORULATION; PROGRAMMED CELL-DEATH; ESCHERICHIA-COLI; ANTITOXIN SYSTEMS; CRYSTAL-STRUCTURE; FUNCTIONAL-ANALYSIS; NUTRITIONAL STRESS; STREPTOCOCCUS-PNEUMONIAE; STRINGENT RESPONSE; PLASMID PSM19035	The zeta epsilon module consists of a labile antitoxin protein, e, which in dimer form (epsilon(2)) interferes with the action of the long-living monomeric zeta phosphotransferase toxin through protein complex formation. Toxin zeta, which inhibits cell wall biosynthesis and may be bactericide in nature, at or near physiological concentrations induces reversible cessation of Bacillus subtilis proliferation (protective dormancy) by targeting essential metabolic functions followed by propidium iodide (PI) staining in a fraction (20-30%) of the population and selects a subpopulation of cells that exhibit non-inheritable tolerance (1-5x10(-5)). Early after induction zeta toxin alters the expression of similar to 78 genes, with the up-regulation of relA among them. RelA contributes to enforce toxin-induced dormancy. At later times, free active zeta decreases synthesis of macromolecules and releases intracellular K+. We propose that zeta toxin induces reversible protective dormancy and permeation to PI, and expression of epsilon(2) antitoxin reverses these effects. At later times, toxin expression is followed by death of a small fraction (similar to 10%) of PI stained cells that exited earlier or did not enter into the dormant state. Recovery from stress leads to de novo synthesis of epsilon(2) antitoxin, which blocks ATP binding by zeta toxin, thereby inhibiting its phosphotransferase activity.	[Lioy, Virginia S.; Machon, Cristina; Tabone, Mariangela; Ayora, Silvia; Alonso, Juan C.] CNB CSIC, Ctr Nacl Biotecnol, Dept Microbial Biotechnol, Madrid, Spain; [Gonzalez-Pastor, Jose E.] CSIC INTA, Ctr Astrobiol, Dept Mol Evolut, Torrejon De Ardoz, Spain; [Daugelavicius, Rimantas] Vytautas Magnus Univ, Dept Biochem & Biotechnol, Kaunas, Lithuania	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Astrobiologia (INTA); Vytautas Magnus University	Lioy, VS (corresponding author), Inst Pasteur, Unite Agents Antibacteriens, F-75724 Paris, France.	sayora@cnb.csic.es; jcalonso@cnb.csic.es	Alonso, Juan Carlos/D-2595-2009; Lioy, Vicky/AAE-4039-2022; Tabone, Mariangela/ABG-3195-2020; Ayora, Silvia/D-2552-2009; González-Pastor, José/I-2118-2015; Daugelavicius, Rimantas/J-5009-2019; Lioy, Vicky S./AAL-9782-2021; Sobrado, Cristina Machón/K-1634-2014	Alonso, Juan Carlos/0000-0002-5178-7179; Lioy, Vicky/0000-0002-5366-0462; Ayora, Silvia/0000-0003-3121-1786; González-Pastor, José/0000-0002-7615-7042; Daugelavicius, Rimantas/0000-0001-9721-6200; Lioy, Vicky S./0000-0002-5366-0462; Sobrado, Cristina Machón/0000-0001-5363-2958	European Union [Health-F3-2009-223111]; Spanish Ministry of Science and Innovation [BFU2009-07167, CSD2007-00010, BFU2009-09520]; Comunidad de Madrid [CM-BIO0260-2006]	European Union(European Commission); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Comunidad de Madrid(Comunidad de Madrid)	The research was partially financed by the European Union (Grant Health-F3-2009-223111 to J.C.A.), the Spanish Ministry of Science and Innovation (Grants BFU2009-07167 and CSD2007-00010 to J.C.A. and BFU2009-09520 to S. A.) and the Comunidad de Madrid (Grant CM-BIO0260-2006 to S. A.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amitai S, 2004, J BACTERIOL, V186, P8295, DOI 10.1128/JB.186.24.8295-8300.2004; Belitskii B R, 1980, Mol Biol (Mosk), V14, P1342; Belitsky M, 2011, MOL CELL, V41, P625, DOI 10.1016/j.molcel.2011.02.023; Blower TR, 2011, CURR OPIN STRUC BIOL, V21, P109, DOI 10.1016/j.sbi.2010.10.009; Britton RA, 2002, J BACTERIOL, V184, P4881, DOI 10.1128/JB.184.17.4881-4890.2002; Camacho AG, 2002, BIOL CHEM, V383, P1701, DOI 10.1515/BC.2002.191; Cashel M., 1996, ESCHERICHIA COLI SAL, P1458; Christensen SK, 2001, P NATL ACAD SCI USA, V98, P14328, DOI 10.1073/pnas.251327898; Daugelavicius R, 2007, J MICROBIOL METH, V69, P174, DOI 10.1016/j.mimet.2006.12.023; De Jonge N, 2009, MOL CELL, V35, P154, DOI 10.1016/j.molcel.2009.05.025; de la Hoz AB, 2000, P NATL ACAD SCI USA, V97, P728, DOI 10.1073/pnas.97.2.728; Dorr T, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000317; Dorr T, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000760; Engelberg-Kulka H, 2006, PLOS GENET, V2, P1518, DOI 10.1371/journal.pgen.0020135; Eymann C, 2002, J BACTERIOL, V184, P2500, DOI 10.1128/JB.184.9.2500-2520.2002; Fu ZB, 2009, J BACTERIOL, V191, P2051, DOI 10.1128/JB.00907-08; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; Gerdes K, 2000, J BACTERIOL, V182, P561, DOI 10.1128/JB.182.3.561-572.2000; Gross M, 2006, MOL MICROBIOL, V59, P590, DOI 10.1111/j.1365-2958.2005.04956.x; Hargreaves D, 2002, STRUCTURE, V10, P1425, DOI 10.1016/S0969-2126(02)00856-0; Hayes F, 2011, CRIT REV BIOCHEM MOL, V46, P386, DOI 10.3109/10409238.2011.600437; IMLAY JA, 1988, SCIENCE, V240, P640, DOI 10.1126/science.2834821; Kamada K, 2003, MOL CELL, V11, P875, DOI 10.1016/S1097-2765(03)00097-2; Kamphuis MB, 2007, PROTEIN PEPTIDE LETT, V14, P113, DOI 10.2174/092986607779816096; Khoo SK, 2007, J BIOL CHEM, V282, P19606, DOI 10.1074/jbc.M701703200; Kolodkin-Gal I, 2007, SCIENCE, V318, P652, DOI 10.1126/science.1147248; Kolodkin-Gal I, 2008, PLOS BIOL, V6, P2774, DOI 10.1371/journal.pbio.0060319; Kostrewa D, 2001, J MOL BIOL, V305, P279, DOI 10.1006/jmbi.2000.4296; Krasny L, 2004, EMBO J, V23, P4473, DOI 10.1038/sj.emboj.7600423; Lee S, 2008, J BIOL CHEM, V283, P15232, DOI 10.1074/jbc.M800479200; Lemos JA, 2007, MOL MICROBIOL, V65, P1568, DOI 10.1111/j.1365-2958.2007.05897.x; Leplae R, 2011, NUCLEIC ACIDS RES, V39, P5513, DOI 10.1093/nar/gkr131; Lewis K, 2007, NAT REV MICROBIOL, V5, P48, DOI 10.1038/nrmicro1557; Lioy VS, 2006, MICROBIOL-SGM, V152, P2365, DOI 10.1099/mic.0.28950-0; LOPEZ JM, 1981, J BACTERIOL, V146, P605, DOI 10.1128/JB.146.2.605-613.1981; Loris R, 1999, J MOL BIOL, V285, P1667, DOI 10.1006/jmbi.1998.2395; Maisonneuve E, 2011, P NATL ACAD SCI US; Meinhart A, 2003, P NATL ACAD SCI USA, V100, P1661, DOI 10.1073/pnas.0434325100; Meinhart A, 2001, ACTA CRYSTALLOGR D, V57, P745, DOI 10.1107/S0907444901004176; Miallau L, 2009, J BIOL CHEM, V284, P276, DOI 10.1074/jbc.M805061200; Moritz EM, 2007, P NATL ACAD SCI USA, V104, P311, DOI 10.1073/pnas.0601168104; Mutschler H, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001033; Nanamiya H, 2008, MOL MICROBIOL, V67, P291, DOI 10.1111/j.1365-2958.2007.06018.x; Nariya H, 2008, CELL, V132, P55, DOI 10.1016/j.cell.2007.11.044; Nieto C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011289; Nystrom T, 2003, MOL MICROBIOL, V48, P17, DOI 10.1046/j.1365-2958.2003.03385.x; OCHI K, 1982, J BACTERIOL, V151, P1062, DOI 10.1128/JB.151.2.1062-1065.1982; Pellegrini O, 2005, MOL MICROBIOL, V56, P1139, DOI 10.1111/j.1365-2958.2005.04606.x; Potrykus K, 2008, ANNU REV MICROBIOL, V62, P35, DOI 10.1146/annurev.micro.62.081307.162903; Rosvoll TCS, 2010, FEMS IMMUNOL MED MIC, V58, P254, DOI 10.1111/j.1574-695X.2009.00633.x; Samarrai W, 2011, J BACTERIOL, V193, P723, DOI 10.1128/JB.00708-10; Schumacher MA, 2009, SCIENCE, V323, P396, DOI 10.1126/science.1163806; Srivatsan A, 2008, CURR OPIN MICROBIOL, V11, P100, DOI 10.1016/j.mib.2008.02.001; Stewart EJ, 2005, PLOS BIOL, V3, P295, DOI 10.1371/journal.pbio.0030045; Takagi H, 2005, NAT STRUCT MOL BIOL, V12, P327, DOI 10.1038/nsmb911; Tan QA, 2011, MOL MICROBIOL, V79, P109, DOI 10.1111/j.1365-2958.2010.07433.x; Tsilibaris V, 2007, J BACTERIOL, V189, P6101, DOI 10.1128/JB.00527-07; Unoson C, 2008, MOL MICROBIOL, V70, P258, DOI 10.1111/j.1365-2958.2008.06416.x; Van Melderen L, 2010, CURR OPIN MICROBIOL, V13, P781, DOI 10.1016/j.mib.2010.10.006; Van Melderen L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000437; Wang JD, 2007, CELL, V128, P865, DOI 10.1016/j.cell.2006.12.043; Wendrich TM, 1997, MOL MICROBIOL, V26, P65, DOI 10.1046/j.1365-2958.1997.5511919.x; Yamaguchi Y, 2011, NAT REV MICROBIOL, V9, P779, DOI 10.1038/nrmicro2651; Zielenkiewicz U, 2005, J BACTERIOL, V187, P6094, DOI 10.1128/JB.187.17.6094-6105.2005	64	31	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e30282	10.1371/journal.pone.0030282	http://dx.doi.org/10.1371/journal.pone.0030282			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910ME	22295078	Green Published, gold, Green Submitted			2022-12-25	WOS:000301640600023
J	Norgaard, M; Ehrenstein, V; Nielsen, RB; Bakketeig, LS; Sorensen, HT				Norgaard, Mette; Ehrenstein, Vera; Nielsen, Rikke Beck; Bakketeig, Leiv Sigmund; Sorensen, Henrik Toft			Maternal Use of Antibiotics, Hospitalisation for Infection during Pregnancy, and Risk of Childhood Epilepsy: A Population-Based Cohort Study	PLOS ONE			English	Article							PRENATAL EXPOSURE; BIRTH; SEIZURES; EPIDEMIOLOGY; SEASONALITY; REGISTER; SYSTEM	Background: Maternal infection during pregnancy may be a risk factor for epilepsy in offspring. Use of antibiotics is a valid marker of infection. Methodology/Principal Findings: To examine the relationship between maternal infection during pregnancy and risk of childhood epilepsy we conducted a historical cohort study of singletons born in northern Denmark from 1998 through 2008 who survived >= 29 days. We used population-based medical databases to ascertain maternal use of antibiotics or hospital contacts with infection during pregnancy, as well as first-time hospital contacts with a diagnosis of epilepsy among offspring. We compared incidence rates (IR) of epilepsy among children of mothers with and without infection during pregnancy. We examined the outcome according to trimester of exposure, type of antibiotic, and total number of prescriptions, using Poisson regression to estimate incidence rate ratios (IRRs) while adjusting for covariates. Among 191 383 children in the cohort, 948 (0.5%) were hospitalised or had an outpatient visit for epilepsy during follow-up, yielding an IR of 91 per 100 000 person-years (PY). The five-year cumulative incidence of epilepsy was 4.5 per 1000 children. Among children exposed prenatally to maternal infection, the IR was 117 per 100 000 PY, with an adjusted IRR of 1.40 (95% confidence interval (CI): 1.22-1.61), compared with unexposed children. The association was unaffected by trimester of exposure, antibiotic type, or prescription count. Conclusions/Significance: Prenatal exposure to maternal infection is associated with an increased risk of epilepsy in childhood. The similarity of estimates across types of antibiotics suggests that processes common to all infections underlie this outcome, rather than specific pathogens or drugs.	[Norgaard, Mette; Ehrenstein, Vera; Nielsen, Rikke Beck; Sorensen, Henrik Toft] Aarhus Univ Hosp, Inst Clin Med, Dept Clin Epidemiol, DK-8000 Aarhus, Denmark; [Bakketeig, Leiv Sigmund] Norwegian Inst Publ Hlth, Nydalen, Norway	Aarhus University; Norwegian Institute of Public Health (NIPH)	Norgaard, M (corresponding author), Aarhus Univ Hosp, Inst Clin Med, Dept Clin Epidemiol, DK-8000 Aarhus, Denmark.	mn@dce.au.dk	Sorensen, Henrik Toft/Z-6181-2019	Sorensen, Henrik Toft/0000-0003-4299-7040; Ehrenstein, Vera/0000-0002-3415-3254; Norgaard, Mette/0000-0001-6110-5891	Department of Clinical Epidemiology, Aarhus University Hospital, Denmark	Department of Clinical Epidemiology, Aarhus University Hospital, Denmark	The study was funded by a Research Grant from the Department of Clinical Epidemiology, Aarhus University Hospital, Denmark. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Andersen TF, 1999, DAN MED BULL, V46, P263; Arts WFM, 2009, EUR J PAEDIATR NEURO, V13, P93, DOI 10.1016/j.ejpn.2008.02.010; Balslev Thomas, 2004, Ugeskr Laeger, V166, P3932; Browne TR, 2001, NEW ENGL J MED, V344, P1145, DOI 10.1056/NEJM200104123441507; CAMFIELD C, 1993, J PEDIATR-US, V122, P861, DOI 10.1016/S0022-3476(09)90008-7; Chang BS, 2003, NEW ENGL J MED, V349, P1257, DOI 10.1056/NEJMra022308; Christensen J, 2007, EPILEPSY RES, V75, P162, DOI 10.1016/j.eplepsyres.2007.05.009; Cowan LD, 2002, MENT RETARD DEV D R, V8, P171, DOI 10.1002/mrdd.10035; Crider KS, 2009, ARCH PEDIAT ADOL MED, V163, P978, DOI 10.1001/archpediatrics.2009.188; Ehrenstein V, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-23; Ehrenstein V, 2007, PEDIATRICS, V119, pE554, DOI 10.1542/peds.2006-1308; Ehrenstein Vera, 2010, Clin Epidemiol, V2, P273, DOI 10.2147/CLEP.S13458; Ekman GS, 2010, BRIT J SURG, V97, P1722, DOI 10.1002/bjs.7261; Fabene PF, 2010, J NEUROIMMUNOL, V224, P22, DOI 10.1016/j.jneuroim.2010.05.016; Frank L, 2000, SCIENCE, V287, P2398, DOI 10.1126/science.287.5462.2398; FRIIS H, 1989, SCAND J INFECT DIS, V21, P551, DOI 10.3109/00365548909037884; Glass HC, 2009, J PEDIATR-US, V154, P24, DOI 10.1016/j.jpeds.2008.07.008; Greenwood R, 1998, PAEDIATR PERINAT EP, V12, P76, DOI 10.1046/j.1365-3016.1998.0120s1076.x; Guerrini R, 2006, LANCET, V367, P499, DOI 10.1016/S0140-6736(06)68182-8; HAUSER WA, 1994, EPILEPSIA, V35, pS1, DOI 10.1111/j.1528-1157.1994.tb05932.x; Jurek AM, 2005, INT J EPIDEMIOL, V34, P680, DOI 10.1093/ije/dyi060; Kannoth S, 2009, EPILEPSY BEHAV, V16, P58, DOI 10.1016/j.yebeh.2009.07.019; Knudsen LB, 1998, DAN MED BULL, V45, P320; Koepsell TD, 2003, EPIDEMIOLOGIC METHOD, Vix; Lieberman E, 2000, PEDIATRICS, V106, P983, DOI 10.1542/peds.106.5.983; Nuutinen M, 1989, Arctic Med Res, V48, P175; Olsen J, 2001, SCAND J PUBLIC HEALT, V29, P300, DOI 10.1177/14034948010290040201; Pedersen CB, 2006, DAN MED BULL, V53, P441; Procopio M, 2006, SEIZURE-EUR J EPILEP, V15, P17, DOI 10.1016/j.seizure.2005.10.001; Procopio M, 1998, ACTA NEUROL SCAND, V98, P297; Sen Wu C, 2008, PEDIATRICS, V122, P1072, DOI 10.1542/peds.2007-3666; Sun YL, 2006, EPIDEMIOLOGY, V17, P296, DOI 10.1097/01.ede.0000208478.47401.b6; Sun Y, 2008, PEDIATRICS, V121, pE1100, DOI 10.1542/peds.2007-2316; Sun Y, 2008, AM J EPIDEMIOL, V167, P262, DOI 10.1093/aje/kwm316; Sun YL, 2011, PAEDIATR PERINAT EP, V25, P53, DOI 10.1111/j.1365-3016.2010.01143.x; Vezzani A, 2005, EPILEPSIA, V46, P1724, DOI 10.1111/j.1528-1167.2005.00298.x; Whitehead E, 2006, PEDIATRICS, V117, P1298, DOI 10.1542/peds.2005-1660	37	23	24	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e30850	10.1371/journal.pone.0030850	http://dx.doi.org/10.1371/journal.pone.0030850			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910ME	22295115	Green Submitted, Green Published, gold			2022-12-25	WOS:000301640600060
J	Houot, B; Fraichard, S; Greenspan, RJ; Ferveur, JF				Houot, Benjamin; Fraichard, Stephane; Greenspan, Ralph J.; Ferveur, Jean-Francois			Genes Involved in Sex Pheromone Discrimination in Drosophila melanogaster and Their Background-Dependent Effect	PLOS ONE			English	Article							CUTICULAR HYDROCARBONS; BEHAVIOR; MALES; EXPRESSION; COURTSHIP; MUTATION; PROTEIN; TASTE; LOCI; PCR	Mate choice is based on the comparison of he sensory quality of potential mating partners, and sex pheromones play an important role in this process. In Drosophila melanogaster, contact pheromones differ between male and female in the content and in their effects on male courtship, both inhibitory and stimulatory. To investigate the genetic basis of x pheromone discrimination, we experimentally selected males showing either a higher or lower ability to discriminate sex pheromones over 20 generations. This experimental selection was carried out in parallel on two different genetic backgrounds: wild-type and desat1 mutant, in which parental males showed high and low sex pheromone discrimination ability respectively. Male perception of male and female pheromones was separately affected during the process of election. A comparison of transcriptomic activity between high and low discrimination lines revealed genes not only that varied according to the starting genetic background, but varied reciprocally. Mutants in two of these genes, Shaker and quick-to-court, were capable of producing similar effects on discrimination on their own in some instances mimicking the selected lines, in others not. This suggests that discrimination of sex pheromones depends on genes whose activity is sensitive to genetic context and provides a rare, genetically defined example of the phenomenon known as "allele flips", in which interactions have reciprocal effects on different genetic backgrounds	[Houot, Benjamin; Fraichard, Stephane; Ferveur, Jean-Francois] Univ Bourgogne, Ctr Sci Gout & Alimentat, Ctr Natl Rech Sci, UMR6265, Dijon, France; [Greenspan, Ralph J.] Univ Calif San Diego, Kavli Inst Brain & Mind, La Jolla, CA 92093 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut Agro; AgroSup Dijon; Universite de Bourgogne; University of California System; University of California San Diego	Houot, B (corresponding author), W Virginia Univ, Dept Biol, Morgantown, WV 26506 USA.	jean-francois.ferveur@u-bourgogne.fr	Fraichard, Stephane/R-1930-2019		Le Centre National de la Recherche Scientifique; Burgundy Regional Council; ANR (INSAVEL); National Science Foundation [IOS-0840717]	Le Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Burgundy Regional Council(Region Bourgogne-Franche-Comte); ANR (INSAVEL)(French National Research Agency (ANR)); National Science Foundation(National Science Foundation (NSF))	This work was supported by Le Centre National de la Recherche Scientifique, the Burgundy Regional Council, the ANR (INSAVEL) to J-FF, and a National Science Foundation grant IOS-0840717 to RJG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALAKRISHNAN R, 1991, J EXP BIOL, V157, P161; Bogart K., 2006, 200610 CGB; Boll W, 2002, DEVELOPMENT, V129, P5667, DOI 10.1242/dev.00157; Broughton SJ, 2004, CURR BIOL, V14, pR290, DOI 10.1016/j.cub.2004.03.037; Clarke GM, 2010, GENET EPIDEMIOL, V34, P266, DOI 10.1002/gepi.20458; Cowan T.M., 1984, Journal of Neurogenetics, V1, P333, DOI 10.3109/01677068409107095; Datta SR, 2008, NATURE, V452, P473, DOI 10.1038/nature06808; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Eder W, 2005, J ALLERGY CLIN IMMUN, V116, P601, DOI 10.1016/j.jaci.2005.05.003; Everaerts C, 2010, ANIM BEHAV, V79, P1135, DOI 10.1016/j.anbehav.2010.02.013; Ferveur J F, 1998, J Neurogenet, V12, P205; Ferveur JF, 2005, BEHAV GENET, V35, P279, DOI 10.1007/s10519-005-3220-5; FERVEUR JF, 1995, SCIENCE, V267, P902, DOI 10.1126/science.7846534; Ferveur JF, 1997, BIOESSAYS, V19, P353, DOI 10.1002/bies.950190413; Gaines P, 2000, GENETICS, V154, P1627; Greenspan RJ, 2009, COLD SH Q B, V74, P131, DOI 10.1101/sqb.2009.74.029; Greenspan R.J., 2004, FLY PUSHING THEORY P; Greenspan RJ, 2004, ANNU REV NEUROSCI, V27, P79, DOI 10.1146/annurev.neuro.27.070203.144323; Greenspan RJ, 2003, J NEUROGENET, V17, P241, DOI 10.1080/01677060390265648; Houot B, 2010, GENETICS, V185, P1297, DOI 10.1534/genetics.110.117226; Koganezawa M, 2010, CURR BIOL, V20, P1, DOI 10.1016/j.cub.2009.11.038; Lacaille F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000661; Lacaille F, 2009, BEHAV GENET, V39, P554, DOI 10.1007/s10519-009-9286-8; Lewontin RC, 1974, GENETIC BASIS EVOLUT; Lin PI, 2007, AM J HUM GENET, V80, P531, DOI 10.1086/512133; Mackay TFC, 2005, P NATL ACAD SCI USA, V102, P6622, DOI 10.1073/pnas.0501986102; Marcillac F, 2005, GENETICS, V171, P1617, DOI 10.1534/genetics.104.033159; Marcillac F, 2005, P ROY SOC B-BIOL SCI, V272, P303, DOI 10.1098/rspb.2004.2971; McMahon C, 2002, GENET RES, V79, P149, DOI 10.1017/S0016672301005535; Moon SJ, 2009, CURR BIOL, V19, P1623, DOI 10.1016/j.cub.2009.07.061; Park SK, 2006, CURR BIOL, V16, P1154, DOI 10.1016/j.cub.2006.04.028; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Polaczyk PJ, 1998, DEV GENES EVOL, V207, P462, DOI 10.1007/s004270050137; STERNBERG PW, 1984, ANNU REV GENET, V18, P489, DOI 10.1146/annurev.ge.18.120184.002421; Sureau G, 1999, GENET RES, V74, P129, DOI 10.1017/S0016672399003936; Svetec N, 2005, J EXP BIOL, V208, P891, DOI 10.1242/jeb.01454; van Swinderen B, 2005, GENETICS, V169, P2151, DOI 10.1534/genetics.104.032631; Vieira C, 2000, GENETICS, V154, P213; Vosshall LB, 2008, NEURON, V59, P685, DOI 10.1016/j.neuron.2008.08.014; Vosshall LB, 2007, ANNU REV NEUROSCI, V30, P505, DOI 10.1146/annurev.neuro.30.051606.094306; Wang LM, 2011, NAT NEUROSCI, V14, P757, DOI 10.1038/nn.2800	43	9	11	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30799	10.1371/journal.pone.0030799	http://dx.doi.org/10.1371/journal.pone.0030799			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22292044	Green Published, gold, Green Submitted			2022-12-25	WOS:000301570600081
J	Mathieu, M; Cotta-Grand, N; Daudelin, JF; Boulet, S; Lapointe, R; Labrecque, N				Mathieu, Melissa; Cotta-Grand, Natacha; Daudelin, Jean-Francois; Boulet, Salix; Lapointe, Rejean; Labrecque, Nathalie			CD40-Activated B Cells Can Efficiently Prime Antigen-Specific Naive CD8(+) T Cells to Generate Effector but Not Memory T cells	PLOS ONE			English	Article							IFN-GAMMA; PRESENTING CELLS; DENDRITIC CELLS; IN-VIVO; TRANSCRIPTION FACTOR; RECEPTOR EXPRESSION; TUMOR-DEVELOPMENT; INTERFERON-GAMMA; PROTEIN ANTIGENS; CUTTING EDGE	Background: The identification of the signals that should be provided by antigen-presenting cells (APCs) to induce a CD8(+) T cell response in vivo is essential to improve vaccination strategies using antigen-loaded APCs. Although dendritic cells have been extensively studied, the ability of other APC types, such as B cells, to induce a CD8(+) T cell response have not been thoroughly evaluated. Methodology/Principal Findings: In this manuscript, we have characterized the ability of CD40-activated B cells, stimulated or not with Toll-like receptor (TLR) agonists (CpG or lipopolysaccharide) to induce the response of mouse naive CD8(+) T cells in vivo. Our results show that CD40-activated B cells can directly present antigen to naive CD8(+) T cells to induce the generation of potent effectors able to secrete cytokines, kill target cells and control a Listeria monocytogenes infection. However, CD40-activated B cell immunization did not lead to the proper formation of CD8(+) memory T cells and further maturation of CD40-activated B cells with TLR agonists did not promote the development of CD8(+) memory T cells. Our results also suggest that inefficient generation of CD8(+) memory T cells with CD40-activated B cell immunization is a consequence of reduced Bcl-6 expression by effectors and enhanced contraction of the CD8(+) T cell response. Conclusions: Understanding why CD40-activated B cell immunization is defective for the generation of memory T cells and gaining new insights about signals that should be provided by APCs are key steps before translating the use of CD40-B cell for therapeutic vaccination.	[Mathieu, Melissa; Cotta-Grand, Natacha; Daudelin, Jean-Francois; Boulet, Salix; Labrecque, Nathalie] Maisonneuve Rosemont Hosp Res Ctr, Montreal, PQ, Canada; [Mathieu, Melissa; Cotta-Grand, Natacha; Boulet, Salix; Labrecque, Nathalie] Univ Montreal, Dept Microbiol & Immunol, Montreal, PQ H3C 3J7, Canada; [Lapointe, Rejean] Ctr Hosp Univ Montreal Hop Notre Dame Res Ctr CRC, Montreal, PQ, Canada; [Lapointe, Rejean; Labrecque, Nathalie] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal	Mathieu, M (corresponding author), Maisonneuve Rosemont Hosp Res Ctr, Montreal, PQ, Canada.	nathalie.labrecque@umontreal.ca			Canadian Institutes of Health Research (CIHR) [MOP-77545, MOP-115139]; Fonds de la recherche en sante du Quebec (FRSQ); Natural Sciences and Engineering Research Council of Canada	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Fonds de la recherche en sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by grants (MOP-77545 and MOP-115139) from the Canadian Institutes of Health Research (CIHR), www.cihr-irsc.gc.ca. NL holds a Senior Scholarship from the Fonds de la recherche en sante du Quebec (FRSQ). MM is supported by a studentship from the Natural Sciences and Engineering Research Council of Canada and has received a scholarship from the FRSQ to learn the Listeria infection model. SB is supported by a CIHR post-doctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadi T, 2008, IMMUNOLOGY, V124, P129, DOI 10.1111/j.1365-2567.2007.02749.x; Badovinac VP, 2005, NAT MED, V11, P748, DOI 10.1038/nm1257; Bahjat KS, 2006, INFECT IMMUN, V74, P6387, DOI 10.1128/IAI.01088-06; Banerjee A, 2010, J IMMUNOL, V185, P4988, DOI 10.4049/jimmunol.1002042; BARTH RJ, 1991, J EXP MED, V173, P647, DOI 10.1084/jem.173.3.647; BJORKMAN PJ, 1987, NATURE, V329, P512, DOI 10.1038/329512a0; Blankenstein T, 2003, CURR OPIN IMMUNOL, V15, P148, DOI 10.1016/S0952-7915(03)00007-4; Coles RM, 2002, J IMMUNOL, V168, P834, DOI 10.4049/jimmunol.168.2.834; Coughlin CM, 2004, BLOOD, V103, P2046, DOI 10.1182/blood-2003-07-2379; Dunn GP, 2004, IMMUNITY, V21, P137, DOI 10.1016/j.immuni.2004.07.017; EYNON EE, 1992, J EXP MED, V175, P131, DOI 10.1084/jem.175.1.131; FUCHS EJ, 1992, SCIENCE, V258, P1156, DOI 10.1126/science.1439825; GILBERT KM, 1994, J EXP MED, V179, P249, DOI 10.1084/jem.179.1.249; Hand TW, 2007, P NATL ACAD SCI USA, V104, P11730, DOI 10.1073/pnas.0705007104; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Ichii H, 2004, J IMMUNOL, V173, P883, DOI 10.4049/jimmunol.173.2.883; Ichii H, 2002, NAT IMMUNOL, V3, P558, DOI 10.1038/ni802; Ikeda H, 2002, CYTOKINE GROWTH F R, V13, P95, DOI 10.1016/S1359-6101(01)00038-7; Intlekofer AM, 2005, NAT IMMUNOL, V6, P1236, DOI 10.1038/ni1268; Intlekofer AM, 2007, J EXP MED, V204, P2015, DOI 10.1084/jem.20070841; Joshi NS, 2008, J IMMUNOL, V180, P1309, DOI 10.4049/jimmunol.180.3.1309; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kallies A, 2009, IMMUNITY, V31, P283, DOI 10.1016/j.immuni.2009.06.021; Kershaw MH, 2001, CANCER RES, V61, P7920; Kondo E, 2009, CLIN EXP IMMUNOL, V155, P249, DOI 10.1111/j.1365-2249.2008.03820.x; Lacombe MH, 2005, J IMMUNOL, V175, P4400, DOI 10.4049/jimmunol.175.7.4400; Lapointe R, 2003, CANCER RES, V63, P2836; LASSILA O, 1988, NATURE, V334, P253, DOI 10.1038/334253a0; Leignadier J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013740; Livingstone AM, 1999, EUR J IMMUNOL, V29, P2826, DOI 10.1002/(SICI)1521-4141(199909)29:09<2826::AID-IMMU2826>3.0.CO;2-M; Lopez JA, 2003, J IMMUNOL METHODS, V274, P47, DOI 10.1016/S0022-1759(02)00429-5; Loyer V, 1999, J IMMUNOL, V163, P6462; Mescher MF, 2006, IMMUNOL REV, V211, P81, DOI 10.1111/j.0105-2896.2006.00382.x; Meunier MC, 2005, NAT MED, V11, P1222, DOI 10.1038/nm1311; Ostiguy V, 2007, J LEUKOCYTE BIOL, V82, P645, DOI 10.1189/jlb.0806494; Parekh VV, 2003, J IMMUNOL, V170, P5897, DOI 10.4049/jimmunol.170.12.5897; Porgador A, 1997, IMMUNITY, V6, P715, DOI 10.1016/S1074-7613(00)80447-1; Prevost-Blondel A, 2000, EUR J IMMUNOL, V30, P2507, DOI 10.1002/1521-4141(200009)30:9<2507::AID-IMMU2507>3.0.CO;2-V; Qin ZH, 2000, IMMUNITY, V12, P677, DOI 10.1016/S1074-7613(00)80218-6; Qin ZH, 2003, CANCER RES, V63, P4095; Raimondi G, 2006, J IMMUNOL, V176, P4021, DOI 10.4049/jimmunol.176.7.4021; Raimondi G, 2006, J IMMUNOL, V176, P4012, DOI 10.4049/jimmunol.176.7.4012; RONCHESE F, 1993, J EXP MED, V177, P679, DOI 10.1084/jem.177.3.679; Rutishauser RL, 2009, IMMUNITY, V31, P296, DOI 10.1016/j.immuni.2009.05.014; Schultze JL, 1997, J CLIN INVEST, V100, P2757, DOI 10.1172/JCI119822; SCHULZE DH, 1983, P NATL ACAD SCI-BIOL, V80, P2007, DOI 10.1073/pnas.80.7.2007; Seki N, 2002, J IMMUNOL, V168, P3484, DOI 10.4049/jimmunol.168.7.3484; Shankaran V, 2001, NATURE, V410, P1107, DOI 10.1038/35074122; Shen S., 2007, Experimental Oncology, V29, P137; Takemoto N, 2006, J IMMUNOL, V177, P7515, DOI 10.4049/jimmunol.177.11.7515; TUTTLE TM, 1993, CANCER RES, V53, P833; Vanden Bush Tony J, 2009, J Immunol, V183, P4833, DOI 10.4049/jimmunol.0900968; von Bergwelt-Baildon M, 2006, BLOOD, V107, P2786, DOI 10.1182/blood-2004-01-0113; von Bergwelt-Baildon MS, 2002, BLOOD, V99, P3319, DOI 10.1182/blood.V99.9.3319	54	32	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30139	10.1371/journal.pone.0030139	http://dx.doi.org/10.1371/journal.pone.0030139			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22291907	Green Published, gold, Green Submitted			2022-12-25	WOS:000301570600017
J	Wu, HY; Hung, KY; Huang, TM; Hu, FC; Peng, YS; Huang, JW; Lin, SL; Chen, YM; Chu, TS; Tsai, TJ; Wu, KD				Wu, Hon-Yen; Hung, Kuan-Yu; Huang, Tao-Min; Hu, Fu-Chang; Peng, Yu-Sen; Huang, Jenq-Wen; Lin, Shuei-Liong; Chen, Yung-Ming; Chu, Tzong-Shinn; Tsai, Tun-Jun; Wu, Kwan-Dun			Safety Issues of Long-Term Glucose Load in Patients on Peritoneal Dialysis-A 7-Year Cohort Study	PLOS ONE			English	Article							STAGE RENAL-DISEASE; HEMODIALYSIS-PATIENTS; SURVIVAL; THERAPY; RISK	Background: Effects of long-term glucose load on peritoneal dialysis (PD) patient safety and outcomes have seldom been reported. This study demonstrates the influence of long-term glucose load on patient and technique survival. Methods: We surveyed 173 incident PD patients. Long-term glucose load was evaluated by calculating the average dialysate glucose concentration since initiation of PD. Risk factors were assessed by fitting Cox's models with repeatedly measured time-dependent covariates. Results: We noted that older age, higher glucose concentration, and lower residual renal function (RRF) were significantly associated with a worse patient survival. We found that female gender, absence of diabetes, lower glucose concentration, use of icodextrin, higher serum high density lipoprotein cholesterol, and higher RRF were significantly associated with a better technique survival. Conclusions: Long-term glucose load predicted mortality and technique failure in chronic PD patients. These findings emphasize the importance of minimizing glucose load in PD patients.	[Wu, Hon-Yen; Peng, Yu-Sen] Far Eastern Mem Hosp, Dept Internal Med, New Taipei City, Taiwan; [Wu, Hon-Yen; Hung, Kuan-Yu; Huang, Tao-Min; Peng, Yu-Sen; Huang, Jenq-Wen; Lin, Shuei-Liong; Chen, Yung-Ming; Chu, Tzong-Shinn; Tsai, Tun-Jun; Wu, Kwan-Dun] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Hung, Kuan-Yu] Natl Taiwan Univ Hosp, Ctr Qual Management, Taipei, Taiwan; [Hu, Fu-Chang] Natl Taiwan Univ Hosp, Natl Ctr Excellence Gen Clin Trial & Res, Taipei, Taiwan; [Wu, Hon-Yen; Huang, Tao-Min; Chen, Yung-Ming] Natl Taiwan Univ Hosp, Dept Internal Med, Yun Lin Branch, Yunlin, Taiwan; [Hu, Fu-Chang] Int Harvard Stat Consulting Co, Taipei, Taiwan	Far Eastern Memorial Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital	Wu, HY (corresponding author), Far Eastern Mem Hosp, Dept Internal Med, New Taipei City, Taiwan.	kyhung@ntu.edu.tw; 007378@ntuh.gov.tw	Lin, Shuei-Liong/AGR-2002-2022; peng, yu/GXW-2071-2022; Huang, Tao Min/C-5379-2011	Lin, Shuei-Liong/0000-0002-1041-5571; Huang, Tao Min/0000-0002-9387-0798; HUANG, JENQ-WEN/0000-0001-8011-2317; CHU, TZONG-SHINN/0000-0002-5291-2509; CHEN, YUNG-MING/0000-0002-9241-1258; TSAI, TUN-JUN/0000-0002-1666-8940; HUNG, KUAN-YU/0000-0003-3472-5512; WU, KWAN-DUN/0000-0002-3339-1509	National Science Council of Taiwan [NSC-95-2314-B-002-238-MY2]; Ta-Tung Kidney Foundation; Mrs. Hsiu-Chin Lee Kidney Research Foundation (Taipei, Taiwan); Yun-Lin Branch, National Taiwan University Hospital, Yun-Lin, Taiwan [NTUHYL.97.S007, NTUHYL.98.S010]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Ta-Tung Kidney Foundation; Mrs. Hsiu-Chin Lee Kidney Research Foundation (Taipei, Taiwan); Yun-Lin Branch, National Taiwan University Hospital, Yun-Lin, Taiwan	This work was supported by grants from the National Science Council of Taiwan (to Kuan-Yu Hung; NSC-95-2314-B-002-238-MY2), the Ta-Tung Kidney Foundation, and the Mrs. Hsiu-Chin Lee Kidney Research Foundation (Taipei, Taiwan), and grants from the Yun-Lin Branch, National Taiwan University Hospital (to Hon-Yen Wu; NTUHYL.97.S007 and NTUHYL.98.S010, Yun-Lin, Taiwan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi Y, 2006, PERITON DIALYSIS INT, V26, P405; Bergstrom J, 1998, PERITON DIALYSIS INT, V18, P467; Chaudhary K, 2008, PERITON DIALYSIS INT, V28, P113; Davies SJ, 2005, KIDNEY INT, V67, P1609, DOI 10.1111/j.1523-1755.2005.00243.x; Davies SJ, 2001, J AM SOC NEPHROL, V12, P1046, DOI 10.1681/ASN.V1251046; GRODSTEIN GP, 1981, KIDNEY INT, V19, P564, DOI 10.1038/ki.1981.53; Ho-dac-Pannekeet MM, 2006, NEPHROL DIAL TRANSPL, V21, pii60; Holmes C, 2006, KIDNEY INT, V70, pS104, DOI 10.1038/sj.ki.5001924; Laird NM, 1983, KIDNEY INT S, pS101; Li PKT, 2009, PERITON DIALYSIS INT, V29, pS149; Liu J, 2006, SEMIN DIALYSIS, V19, P32, DOI 10.1111/j.1525-139X.2006.00117.x; Lo WK, 2005, KIDNEY INT, V67, P2032, DOI 10.1111/j.1523-1755.2005.00305.x; LOWRIE EG, 1990, AM J KIDNEY DIS, V15, P458, DOI 10.1016/S0272-6386(12)70364-5; Peng YS, 2007, NEPHROL DIAL TRANSPL, V22, P857, DOI 10.1093/ndt/gfl666; *PER DIAL AD WORK, 2006, AM J KIDNEY DIS S, V48, pS98; TWARDOWSKI ZJ, 1987, PERITON DIALYSIS INT, V7, P138; Wolfe RA, 1999, NEW ENGL J MED, V341, P1725, DOI 10.1056/NEJM199912023412303; Wu HY, 2008, AM J NEPHROL, V28, P765, DOI 10.1159/000128608; Wu HY, 2010, PERITON DIALYSIS INT, V30, P448, DOI 10.3747/pdi.2009.00063	19	31	33	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30337	10.1371/journal.pone.0030337	http://dx.doi.org/10.1371/journal.pone.0030337			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22303440	gold, Green Published, Green Submitted			2022-12-25	WOS:000301570600033
J	Xu, YB; Moeller, A; Jun, SY; Le, M; Yoon, BY; Kim, JS; Lee, K; Ha, NC				Xu, Yongbin; Moeller, Arne; Jun, So-Young; Le, Minho; Yoon, Bo-Young; Kim, Jin-Sik; Lee, Kangseok; Ha, Nam-Chul			Assembly and Channel Opening of Outer Membrane Protein in Tripartite Drug Efflux Pumps of Gram-negative Bacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIDRUG EFFLUX; CRYSTAL-STRUCTURE; FUSION PROTEIN; PERIPLASMIC COMPONENT; TIP REGION; TOLC; TRANSPORTER; DOMAIN; RESISTANCE; HAIRPIN	Gram-negative bacteria are capable of expelling diverse xenobiotic substances from within the cell by use of three-component efflux pumps in which the energy-activated inner membrane transporter is connected to the outer membrane channel protein via the membrane fusion protein. In this work, we describe the crystal structure of the membrane fusion protein MexA from the Pseudomonas aeruginosa MexAB-OprM pump in the hexameric ring arrangement. Electron microscopy study on the chimeric complex of MexA and the outer membrane protein OprM reveals that MexA makes a tip-to-tip interaction with OprM, which suggests a docking model for MexA and OprM. This docking model agrees well with genetic results and depicts detailed interactions. Opening of the OprM channel is accompanied by the simultaneous exposure of a protein structure resembling a six-bladed cogwheel, which intermeshes with the complementary cogwheel structure in the MexA hexamer. Taken together, we suggest an assembly and channel opening model for the MexAB-OprM pump. This study provides a better understanding of multidrug resistance in Gram-negative bacteria.	[Le, Minho; Lee, Kangseok] Chung Ang Univ, Sch Biol Sci, Seoul 156756, South Korea; [Xu, Yongbin; Jun, So-Young; Yoon, Bo-Young; Kim, Jin-Sik; Ha, Nam-Chul] Pusan Natl Univ, Coll Pharm, Dept Mfg Pharm, Pusan 609735, South Korea; [Xu, Yongbin; Jun, So-Young; Yoon, Bo-Young; Kim, Jin-Sik; Ha, Nam-Chul] Pusan Natl Univ, Res Inst Drug Dev, Pusan 609735, South Korea; [Moeller, Arne] Scripps Res Inst, La Jolla, CA 92037 USA	Chung Ang University; Pusan National University; Pusan National University; Scripps Research Institute	Lee, K (corresponding author), Chung Ang Univ, Sch Biol Sci, Seoul 156756, South Korea.	kangseok@cau.ac.kr; hnc@pusan.ac.kr		Moeller, Arne/0000-0003-1101-5366	National Research Foundation of Korea [NRF-2009-0072268]; National Institutes of Health [P50 GM073197]; National Institutes of Health though the National Center for Research Resources [RR17573]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR017573] Funding Source: NIH RePORTER	National Research Foundation of Korea(National Research Foundation of Korea); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health though the National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by National Research Foundation of Korea Grant NRF-2009-0072268 (to N.-C. H.). This work made use of beamline NW3A at Photon Factory (Tsukuba, Japan).; Supported by National Institutes of Health Roadmap Award P50 GM073197.; We thank Pohang Accelerator Laboratory (Pohang, Korea) for help with data processing. Electron microscopy imaging was performed at the National Resource for Automated Molecular Microscopy, which was supported by the National Institutes of Health though the National Center for Research Resources P41 Program RR17573.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Akama H, 2004, J BIOL CHEM, V279, P52816, DOI 10.1074/jbc.C400445200; Akama H, 2004, J BIOL CHEM, V279, P25939, DOI 10.1074/jbc.C400164200; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bavro VN, 2008, MOL CELL, V30, P114, DOI 10.1016/j.molcel.2008.02.015; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eswaran J, 2004, CURR OPIN STRUC BIOL, V14, P741, DOI 10.1016/j.sbi.2004.10.003; Ge Q, 2009, J BACTERIOL, V191, P4365, DOI 10.1128/JB.00204-09; Goddard TD, 2007, J STRUCT BIOL, V157, P281, DOI 10.1016/j.jsb.2006.06.010; Higgins MK, 2004, P NATL ACAD SCI USA, V101, P9994, DOI 10.1073/pnas.0400375101; Husain F, 2004, J BACTERIOL, V186, P8533, DOI 10.1128/JB.186.24.8533-8536.2004; Janganan TK, 2011, J BIOL CHEM, V286, P26900, DOI 10.1074/jbc.M111.246595; Janganan TK, 2011, J BIOL CHEM, V286, P5484, DOI 10.1074/jbc.M110.187658; Kim HM, 2010, J BACTERIOL, V192, P4498, DOI 10.1128/JB.00334-10; Kim S, 2008, J MICROBIOL BIOTECHN, V18, P845; Kobayashi N, 2001, J BACTERIOL, V183, P5639, DOI 10.1128/JB.183.19.5639-5644.2001; Koronakis V, 2000, NATURE, V405, P914, DOI 10.1038/35016007; Lander GC, 2009, J STRUCT BIOL, V166, P95, DOI 10.1016/j.jsb.2009.01.002; LEDUC M, 1989, J GEN MICROBIOL, V135, P1243; Lewis K, 2000, CURR BIOL, V10, pR678, DOI 10.1016/S0960-9822(00)00682-5; Li XZ, 2009, DRUGS, V69, P1555, DOI 10.2165/11317030-000000000-00000; LI XZ, 1995, ANTIMICROB AGENTS CH, V39, P1948, DOI 10.1128/AAC.39.9.1948; Lin HT, 2009, J BIOL CHEM, V284, P1145, DOI 10.1074/jbc.M806964200; Lobedanz S, 2007, P NATL ACAD SCI USA, V104, P4612, DOI 10.1073/pnas.0610160104; Marcyjaniak M, 2004, J BIOL CHEM, V279, P43982, DOI 10.1074/jbc.M406735200; Mikolosko J, 2006, STRUCTURE, V14, P577, DOI 10.1016/j.str.2005.11.015; Modali SD, 2011, MOL MICROBIOL, V81, P937, DOI 10.1111/j.1365-2958.2011.07744.x; MORSHED SRM, 1995, BIOCHEM BIOPH RES CO, V210, P356, DOI 10.1006/bbrc.1995.1669; Murakami S, 2002, NATURE, V419, P587, DOI 10.1038/nature01050; Otwinosky Z., 1997, METHODS ENZYMOLOGY A, V276; Piao S, 2008, ACTA CRYSTALLOGR F, V64, P391, DOI 10.1107/S1744309108008701; Putman M, 2000, MICROBIOL MOL BIOL R, V64, P672, DOI 10.1128/MMBR.64.4.672-693.2000; Reffay M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005035; Roseman AM, 2003, ULTRAMICROSCOPY, V94, P225, DOI 10.1016/S0304-3991(02)00333-9; Scheres SHW, 2005, J MOL BIOL, V348, P139, DOI 10.1016/j.jmb.2005.02.031; Sorzano COS, 2004, J STRUCT BIOL, V148, P194, DOI 10.1016/j.jsb.2004.06.006; Stegmeier JF, 2006, BIOCHEMISTRY-US, V45, P10303, DOI 10.1021/bi060320g; Su CC, 2011, NATURE, V470, P558, DOI 10.1038/nature09743; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Symmons MF, 2009, P NATL ACAD SCI USA, V106, P7173, DOI 10.1073/pnas.0900693106; Tamura N, 2005, BIOCHEMISTRY-US, V44, P11115, DOI 10.1021/bi050452u; Tikhonova EB, 2011, CHEM BIOL, V18, P454, DOI 10.1016/j.chembiol.2011.02.011; Touze T, 2004, MOL MICROBIOL, V53, P697, DOI 10.1111/j.1365-2958.2004.04158.x; Trepout S, 2007, EUR BIOPHYS J BIOPHY, V36, P1029, DOI 10.1007/s00249-007-0208-5; Trepout S, 2010, BBA-BIOMEMBRANES, V1798, P1953, DOI 10.1016/j.bbamem.2010.06.019; Xu Y, 2011, J BIOL CHEM, V286, P17910, DOI 10.1074/jbc.M111.238535; Xu Y, 2011, J BIOL CHEM, V286, P13541, DOI 10.1074/jbc.M110.202598; Xu YB, 2010, BIOCHEM BIOPH RES CO, V394, P962, DOI 10.1016/j.bbrc.2010.03.097; Xu Y, 2009, BIOCHEMISTRY-US, V48, P5218, DOI 10.1021/bi900415t; Yamanaka H, 2008, J BACTERIOL, V190, P7693, DOI 10.1128/JB.00853-08; Yum SW, 2009, J MOL BIOL, V387, P1286, DOI 10.1016/j.jmb.2009.02.048; Zgurskaya HI, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00189; Zgurskaya HI, 2000, MOL MICROBIOL, V37, P219, DOI 10.1046/j.1365-2958.2000.01926.x	55	37	37	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					11740	11750		10.1074/jbc.M111.329375	http://dx.doi.org/10.1074/jbc.M111.329375			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22308040	Green Published, hybrid			2022-12-25	WOS:000302782200013
J	Nobumori, Y; Shouse, GP; Fan, L; Liu, X				Nobumori, Yumiko; Shouse, Geoffrey P.; Fan, Li; Liu, Xuan			HEAT Repeat 1 Motif Is Required for B56 gamma-containing Protein Phosphatase 2A (B56 gamma-PP2A) Holoenzyme Assembly and Tumor-suppressive Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATORY SUBUNIT; C-MYC; CANCER; ALPHA; GENE; TRANSFORMATION; MUTATIONS; COMPLEXES; P53	Background: How HEAT repeats contribute to PP2A assembly and function was unknown. Results: A tumor-associated mutation within HEAT repeat 1 disrupts PP2A function. Conclusion: HEAT repeat 1 is required for B56 gamma-PP2A assembly and tumor-suppressive function. Significance: This work provides structural insights into HEAT repeats and illuminates a mechanism to inactivate B56 gamma-PP2A.	[Nobumori, Yumiko; Shouse, Geoffrey P.; Fan, Li; Liu, Xuan] Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA	University of California System; University of California Riverside	Liu, X (corresponding author), Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA.	xuan.liu@ucr.edu		Shouse, Geoffrey/0000-0002-7917-5713	National Institutes of Health [CA0751]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grant CA0751 (to X.L.).	Arnold HK, 2006, MOL CELL BIOL, V26, P2832, DOI 10.1128/MCB.26.7.2832-2844.2006; Bennin DA, 2002, J BIOL CHEM, V277, P27449, DOI 10.1074/jbc.M111693200; Chen W, 2004, CANCER CELL, V5, P127, DOI 10.1016/S1535-6108(04)00026-1; Chen W, 2005, CANCER RES, V65, P8183, DOI 10.1158/0008-5472.CAN-05-1103; Chen Y, 2007, NAT STRUCT MOL BIOL, V14, P527, DOI 10.1038/nsmb1254; Cho US, 2007, NATURE, V445, P53, DOI 10.1038/nature05351; Csortos C, 1996, J BIOL CHEM, V271, P2578, DOI 10.1074/jbc.271.5.2578; Eichhorn PJA, 2009, BBA-REV CANCER, V1795, P1, DOI 10.1016/j.bbcan.2008.05.005; Forester CM, 2007, P NATL ACAD SCI USA, V104, P19867, DOI 10.1073/pnas.0709879104; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Letourneux C, 2006, EMBO J, V25, P727, DOI 10.1038/sj.emboj.7600980; Li HH, 2007, EMBO J, V26, P402, DOI 10.1038/sj.emboj.7601519; Margolis SS, 2006, CELL, V127, P759, DOI 10.1016/j.cell.2006.10.035; McCright B, 1996, GENOMICS, V36, P168, DOI 10.1006/geno.1996.0438; Ruediger R, 2001, ONCOGENE, V20, P10, DOI 10.1038/sj.onc.1204059; Shouse GP, 2010, ONCOGENE, V29, P3933, DOI 10.1038/onc.2010.161; Shouse GP, 2008, MOL CELL BIOL, V28, P448, DOI 10.1128/MCB.00983-07; Virshup DM, 2009, MOL CELL, V33, P537, DOI 10.1016/j.molcel.2009.02.015; Xu YH, 2006, CELL, V127, P1239, DOI 10.1016/j.cell.2006.11.033; Yeh E, 2004, NAT CELL BIOL, V6, P308, DOI 10.1038/ncb1110	20	9	9	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					11030	11036		10.1074/jbc.M111.334094	http://dx.doi.org/10.1074/jbc.M111.334094			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22315229	hybrid, Green Published			2022-12-25	WOS:000302780100031
J	Dong, Y; He, YW; de Boer, L; Stack, MS; Lumley, JW; Clements, JA; Hooper, JD				Dong, Ying; He, Yaowu; de Boer, Leonore; Stack, M. Sharon; Lumley, John W.; Clements, Judith A.; Hooper, John D.			The Cell Surface Glycoprotein CUB Domain-containing Protein 1 (CDCP1) Contributes to Epidermal Growth Factor Receptor-mediated Cell Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; EGF RECEPTOR; TYROSINE PHOSPHORYLATION; OVARIAN CARCINOMAS; TUMOR PROGRESSION; CANCER CELLS; UP-REGULATION; SRC KINASES; CROSS-TALK; E-CADHERIN	Epidermal growth factor (EGF) activation of the EGF receptor (EGFR) is an important mediator of cell migration, and aberrant signaling via this system promotes a number of malignancies including ovarian cancer. We have identified the cell surface glycoprotein CDCP1 as a key regulator of EGF/EGFR-induced cell migration. We show that signaling via EGF/EGFR induces migration of ovarian cancer Caov3 and OVCA420 cells with concomitant up-regulation of CDCP1 mRNA and protein. Consistent with a role in cell migration CDCP1 relocates from cell-cell junctions to punctate structures on filopodia after activation of EGFR. Significantly, disruption of CDCP1 either by silencing or the use of a function blocking antibody efficiently reduces EGF/EGFR-induced cell migration of Caov3 and OVCA420 cells. We also show that up-regulation of CDCP1 is inhibited by pharmacological agents blocking ERK but not Src signaling, indicating that the RAS/RAF/MEK/ERK pathway is required downstream of EGF/EGFR to induce increased expression of CDCP1. Our immunohistochemical analysis of benign, primary, and metastatic serous epithelial ovarian tumors demonstrates that CDCP1 is expressed during progression of this cancer. These data highlight a novel role for CDCP1 in EGF/EGFR-induced cell migration and indicate that targeting of CDCP1 may be a rational approach to inhibit progression of cancers driven by EGFR signaling including those resistant to anti-EGFR drugs because of activating mutations in the RAS/RAF/MEK/ERK pathway.	[He, Yaowu; Hooper, John D.] Mater Med Res Inst, Brisbane, Qld 4101, Australia; [Dong, Ying; de Boer, Leonore; Clements, Judith A.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Canc Res Program, Kelvin Grove, Qld 4059, Australia; [Stack, M. Sharon] Univ Missouri, Dept Pathol & Anat Sci, Columbia, MO 65212 USA; [Lumley, John W.] Wesley Med Ctr, Auchenflower, Qld 4066, Australia	Mater Research; Queensland University of Technology (QUT); University of Missouri System; University of Missouri Columbia; Wesley Hospital	Hooper, JD (corresponding author), Mater Med Res Inst, Brisbane, Qld 4101, Australia.	jhooper@mmri.mater.org.au	Dong, Ying/C-3511-2012; Hooper, John/C-1481-2016	Hooper, John/0000-0003-1054-8486; HE, Yaowu/0000-0002-7828-263X; Clements, Judith/0000-0001-6026-1964	Wesley Research Institute [2008/06]; Cancer Council Queensland [614205]; National Health and Medical Research Council of Australia [550523]; Principal Research Fellowship [1005717]	Wesley Research Institute; Cancer Council Queensland(Cancer Council Queensland); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Principal Research Fellowship	This work was supported by Wesley Research Institute Grant 2008/06 (to J.D.H.), Cancer Council Queensland Grant 614205 (to J.D.H.), National Health and Medical Research Council of Australia Grant 550523 (to Y.D. and J.A.C.), and Principal Research Fellowship 1005717 (to J.A.C.).	Ahmed N, 2007, J CELL PHYSIOL, V213, P581, DOI 10.1002/jcp.21240; Bendoraite A, 2010, GYNECOL ONCOL, V116, P117, DOI 10.1016/j.ygyno.2009.08.009; Benes CH, 2012, ONCOGENE, V31, P653, DOI 10.1038/onc.2011.262; Bhatt AS, 2005, ONCOGENE, V24, P5333, DOI 10.1038/sj.onc.1208582; Blake RA, 2000, MOL CELL BIOL, V20, P9018, DOI 10.1128/MCB.20.23.9018-9027.2000; Brown TA, 2004, J BIOL CHEM, V279, P14772, DOI 10.1074/jbc.M309678200; Casar B., 2011, ONCOGENE IN PRESS; Chung BM, 2009, ONCOGENE, V28, P1821, DOI 10.1038/onc.2009.31; Ciardiello F, 2008, NEW ENGL J MED, V358, P1160, DOI 10.1056/NEJMra0707704; Colomiere M, 2009, BRIT J CANCER, V100, P134, DOI 10.1038/sj.bjc.6604794; Dahl KDC, 2008, CANCER RES, V68, P4606, DOI 10.1158/0008-5472.CAN-07-5046; Deryugina EI, 2009, MOL CANCER RES, V7, P1197, DOI 10.1158/1541-7786.MCR-09-0100; Dong Y, 2001, CLIN CANCER RES, V7, P2363; Dong Y, 2010, CANCER RES, V70, P2624, DOI 10.1158/0008-5472.CAN-09-3415; DOWNWARD J, 1985, J BIOL CHEM, V260, P4538; Fischer K, 1998, FEBS LETT, V438, P101, DOI 10.1016/S0014-5793(98)01279-4; Gotoh N, 2011, INT J CLIN EXP PATHO, V4, P403; He Y, 2010, J BIOL CHEM, V285, P26162, DOI 10.1074/jbc.M109.096453; Hooper JD, 2003, ONCOGENE, V22, P1783, DOI 10.1038/sj.onc.1206220; Hudson LG, 2008, CLIN EXP METASTAS, V25, P643, DOI 10.1007/s10585-008-9171-5; Jorissen RN, 2003, EXP CELL RES, V284, P31, DOI 10.1016/S0014-4827(02)00098-8; Kim LC, 2009, NAT REV CLIN ONCOL, V6, P587, DOI 10.1038/nrclinonc.2009.129; Lee MY, 2008, CLIN CANCER RES, V14, P4743, DOI 10.1158/1078-0432.CCR-08-0234; LEVITZKI A, 1995, SCIENCE, V267, P1782, DOI 10.1126/science.7892601; Lim R, 2007, INT J CANCER, V120, P2426, DOI 10.1002/ijc.22352; Liu H, 2011, P NATL ACAD SCI USA, V108, P1379, DOI 10.1073/pnas.1017228108; Lu ZM, 2003, CANCER CELL, V4, P499, DOI 10.1016/S1535-6108(03)00304-0; MAA MC, 1995, P NATL ACAD SCI USA, V92, P6981, DOI 10.1073/pnas.92.15.6981; MacKeigan JP, 2000, J BIOL CHEM, V275, P38953, DOI 10.1074/jbc.C000684200; Mao WG, 1997, ONCOGENE, V15, P3083, DOI 10.1038/sj.onc.1201496; Miyazawa Y, 2010, CANCER RES, V70, P5136, DOI 10.1158/0008-5472.CAN-10-0220; Normanno N, 2006, GENE, V366, P2, DOI 10.1016/j.gene.2005.10.018; Oda K, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100014; Ong A, 2000, INT J CANCER, V85, P430, DOI 10.1002/(SICI)1097-0215(20000201)85:3<430::AID-IJC21>3.0.CO;2-Q; Pierce KL, 2001, J BIOL CHEM, V276, P23155, DOI 10.1074/jbc.M101303200; Poon SL, 2009, MOL ENDOCRINOL, V23, P1646, DOI 10.1210/me.2009-0147; Prenzel N, 2001, ENDOCR-RELAT CANCER, V8, P11, DOI 10.1677/erc.0.0080011; Razorenova OV, 2011, P NATL ACAD SCI USA, V108, P1931, DOI 10.1073/pnas.1011777108; Ricono JM, 2009, CANCER RES, V69, P1383, DOI 10.1158/0008-5472.CAN-08-3612; Santin AD, 2004, INT J CANCER, V112, P14, DOI 10.1002/ijc.20408; Scherl-Mostageer M, 2001, ONCOGENE, V20, P4402, DOI 10.1038/sj.onc.1204566; Schneider MR, 2009, J CELL PHYSIOL, V218, P460, DOI 10.1002/jcp.21635; Shilo BZ, 2003, EXP CELL RES, V284, P140, DOI 10.1016/S0014-4827(02)00094-0; Sibilia M, 2000, CELL, V102, P211, DOI 10.1016/S0092-8674(00)00026-X; Siva AC, 2008, CANCER RES, V68, P3759, DOI 10.1158/0008-5472.CAN-07-1657; Smith K, 2005, CANCER RES, V65, P5221, DOI 10.1158/0008-5472.CAN-05-0169; Strauss R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016186; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; TSAO SW, 1995, EXP CELL RES, V218, P499, DOI 10.1006/excr.1995.1184; Uekita T, 2008, AM J PATHOL, V172, P1729, DOI 10.2353/ajpath.2008.070981; Uekita T, 2007, MOL CELL BIOL, V27, P7649, DOI 10.1128/MCB.01246-07; Uekita T, 2011, CANCER SCI, V102, P1943, DOI 10.1111/j.1349-7006.2011.02052.x; ULLRICH A, 1984, NATURE, V309, P418, DOI 10.1038/309418a0; Wells A, 1999, INT J BIOCHEM CELL B, V31, P637, DOI 10.1016/S1357-2725(99)00015-1; Wheeler DL, 2010, NAT REV CLIN ONCOL, V7, P493, DOI 10.1038/nrclinonc.2010.97; Wortmann A, 2011, J BIOL CHEM, V286, P42303, DOI 10.1074/jbc.M111.227462; Wortmann A, 2009, IUBMB LIFE, V61, P723, DOI 10.1002/iub.198; Yamauchi T, 1997, NATURE, V390, P91, DOI 10.1038/36369; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Zeineldin R, 2010, J ONCOL, V2010, DOI 10.1155/2010/414676; Zhong H, 2000, CANCER RES, V60, P1541	61	31	32	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					9792	9803		10.1074/jbc.M111.335448	http://dx.doi.org/10.1074/jbc.M111.335448			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22315226	Green Published, hybrid			2022-12-25	WOS:000302167200012
J	Tian, G; Tepikin, AV; Tengholm, A; Gylfe, E				Tian, Geng; Tepikin, Alexei V.; Tengholm, Anders; Gylfe, Erik			cAMP Induces Stromal Interaction Molecule 1 (STIM1) Puncta but neither Orai1 Protein Clustering nor Store-operated Ca2+ Entry (SOCE) in Islet Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC BETA-CELLS; ENDOPLASMIC-RETICULUM; CYTOPLASMIC CALCIUM; INSULIN-SECRETION; PHOSPHOLIPASE-C; CRAC CHANNEL; MOUSE; GLUCOSE; ALPHA; ACTIVATION	The events leading to the activation of store-operated Ca2+ entry (SOCE) involve Ca2+ depletion of the endoplasmic reticulum (ER) resulting in translocation of the transmembrane Ca2+ sensor protein, stromal interaction molecule 1 (STIM1), to the junctions between ER and the plasma membrane where it binds to the Ca2+ channel protein Orai1 to activate Ca2+ influx. Using confocal and total internal reflection fluorescence microscopy, we studied redistribution kinetics of fluorescence-tagged STIM1 and Orai1 as well as SOCE in insulin-releasing beta-cells and glucagon-secreting alpha-cells within intact mouse and human pancreatic islets. ER Ca2+ depletion triggered accumulation of STIM1 puncta in the subplasmalemmal ER where they co-clustered with Orai1 in the plasma membrane and activated SOCE. Glucose, which promotes Ca2+ store filling and inhibits SOCE, stimulated retranslocation of STIM1 to the bulk ER. This effect was evident at much lower glucose concentrations in alpha-than in beta-cells consistent with involvement of SOCE in the regulation of glucagon secretion. Epinephrine stimulated subplasmalemmal translocation of STIM1 in beta-cells and retranslocation in beta-cells involving raising and lowering of cAMP, respectively. The cAMP effect was mediated both by protein kinase A and exchange protein directly activated by cAMP. However, the cAMP-induced STIM1 puncta did not co-cluster with Orai1, and there was no activation of SOCE. STIM1 translocation can consequently occur independently of Orai1 clustering and SOCE.	[Tian, Geng; Tengholm, Anders; Gylfe, Erik] Uppsala Univ, Dept Med Cell Biol, SE-75123 Uppsala, Sweden; [Tepikin, Alexei V.] Univ Liverpool, Dept Cellular & Mol Physiol, Physiol Lab, Liverpool L69 3BX, Merseyside, England	Uppsala University; University of Liverpool	Gylfe, E (corresponding author), Uppsala Univ, Dept Med Cell Biol, BMC Box 571, SE-75123 Uppsala, Sweden.	erik.gylfe@mcb.uu.se		Gylfe, Erik/0000-0002-8414-2107; Tepikin, Alexei/0000-0002-8172-7513	Swedish Research Council; Swedish Diabetes Association; NovoNordisk Foundation; European Foundation for the Study of Diabetes and Merck Sharp and Dohme (EFSD/MSD); Family Ernfors Foundation; Swedish National Strategic Research Initiative Exodiab (Excellence of Diabetes Research in Sweden); Juvenile Diabetes Research Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Diabetes Association; NovoNordisk Foundation(Novo Nordisk Foundation); European Foundation for the Study of Diabetes and Merck Sharp and Dohme (EFSD/MSD); Family Ernfors Foundation; Swedish National Strategic Research Initiative Exodiab (Excellence of Diabetes Research in Sweden); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation)	This work was supported by grants from the Swedish Research Council, the Swedish Diabetes Association, NovoNordisk Foundation, European Foundation for the Study of Diabetes and Merck Sharp and Dohme (EFSD/MSD), and the Family Ernfors Foundation.; We are indebted to Helene Dansk and Ing-Marie Morsare for technical assistance and to Professor Sir Michael Berridge, Babraham Institute, Cambridge, United Kingdom, for critically reading the manuscript. Human pancreatic islets were obtained from The Nordic Network for Clinical Islet Transplantation, supported by the Swedish National Strategic Research Initiative Exodiab (Excellence of Diabetes Research in Sweden) and the Juvenile Diabetes Research Foundation.	Arredouani A, 2002, DIABETES, V51, P3245, DOI 10.2337/diabetes.51.11.3245; ASHCROFT FM, 1989, PROG BIOPHYS MOL BIO, V54, P87, DOI 10.1016/0079-6107(89)90013-8; Barg S, 2000, DIABETES, V49, P1500, DOI 10.2337/diabetes.49.9.1500; Cahalan MD, 2007, CELL CALCIUM, V42, P133, DOI 10.1016/j.ceca.2007.03.002; CHOW RH, 1995, J PHYSIOL-LONDON, V485, P607, DOI 10.1113/jphysiol.1995.sp020756; Chvanov M, 2008, PFLUG ARCH EUR J PHY, V457, P505, DOI 10.1007/s00424-008-0529-y; Dyachok O, 2001, J CELL SCI, V114, P2179; Dyachok O, 2008, CELL METAB, V8, P26, DOI 10.1016/j.cmet.2008.06.003; Dzhura I, 2011, ISLETS, V3, P121, DOI 10.4161/isl.3.3.15507; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Goto M, 2004, TRANSPLANTATION, V78, P1367, DOI 10.1097/01.TP.0000140882.53773.DC; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; GYLFE E, 1991, PFLUG ARCH EUR J PHY, V419, P639, DOI 10.1007/BF00370308; GYLFE E, 1988, J BIOL CHEM, V263, P13750; GYLFE E, 1988, J BIOL CHEM, V263, P5044; HELLMAN B, 1985, BIOMED BIOCHIM ACTA, V44, P63; Hellman B., 1992, NUTR REGULATION INSU, P213; KOH G, 1987, LIFE SCI, V40, P1113, DOI 10.1016/0024-3205(87)90574-1; Korzeniowski MK, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001122; LERNMARK A, 1974, DIABETOLOGIA, V10, P431, DOI 10.1007/BF01221634; Lewis RS, 2007, NATURE, V446, P284, DOI 10.1038/nature05637; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Liu YJ, 2004, CELL CALCIUM, V35, P357, DOI 10.1016/j.ceca.2003.10.002; Liu YJ, 1996, ARCH BIOCHEM BIOPHYS, V334, P295, DOI 10.1006/abbi.1996.0458; Liu YJ, 1997, CELL CALCIUM, V22, P277, DOI 10.1016/S0143-4160(97)90066-X; Mercer JC, 2006, J BIOL CHEM, V281, P24979, DOI 10.1074/jbc.M604589200; Muik M, 2011, EMBO J, V30, P1678, DOI 10.1038/emboj.2011.79; NAKAKI T, 1980, N-S ARCH PHARMACOL, V313, P151, DOI 10.1007/BF00498572; Peinelt C, 2006, NAT CELL BIOL, V8, P771, DOI 10.1038/ncb1435; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Putney JW, 2009, IMMUNOL REV, V231, P10, DOI 10.1111/j.1600-065X.2009.00810.x; Putney JW, 2007, J CELL SCI, V120, P1959, DOI 10.1242/jcs.03462; PUTNEY JW, 1986, CELL CALCIUM, V7, P1, DOI 10.1016/0143-4160(86)90026-6; Ravier MA, 2011, DIABETES, V60, P2533, DOI 10.2337/db10-1543; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; SCHUIT FC, 1986, SCIENCE, V232, P875, DOI 10.1126/science.2871625; Shen WW, 2011, J BIOL CHEM, V286, P36448, DOI 10.1074/jbc.M111.269415; Singaravelu K, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.174029; Soboloff J, 2006, J BIOL CHEM, V281, P20661, DOI 10.1074/jbc.C600126200; Spassova MA, 2006, P NATL ACAD SCI USA, V103, P4040, DOI 10.1073/pnas.0510050103; Tamarina NA, 2008, CELL CALCIUM, V44, P533, DOI 10.1016/j.ceca.2008.03.007; Tengholm A, 2001, J PHYSIOL-LONDON, V530, P533, DOI 10.1111/j.1469-7793.2001.0533k.x; Tengholm A, 1999, J BIOL CHEM, V274, P36883, DOI 10.1074/jbc.274.52.36883; Thore S, 2005, J CELL SCI, V118, P4463, DOI 10.1242/jcs.02577; Tian G, 2011, DIABETES, V60, P1535, DOI 10.2337/db10-1087; Vieira E, 2007, DIABETOLOGIA, V50, P370, DOI 10.1007/s00125-006-0511-1; Vieira E, 2004, N-S ARCH PHARMACOL, V369, P179, DOI 10.1007/s00210-003-0858-5; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; WORLEY JF, 1994, J BIOL CHEM, V269, P14359; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Zhang SL, 2006, P NATL ACAD SCI USA, V103, P9357, DOI 10.1073/pnas.0603161103; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147; Zhou W, 2010, ATHEROSCLEROSIS, V211, P216, DOI 10.1016/j.atherosclerosis.2010.02.012	53	32	33	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					9862	9872		10.1074/jbc.M111.292854	http://dx.doi.org/10.1074/jbc.M111.292854			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22298778	Green Submitted, Green Published, hybrid			2022-12-25	WOS:000302167200019
J	Yang, YS; Murciano, B; Moubri, K; Cibrelus, P; Schetters, T; Gorenflot, A; Delbecq, S; Roumestand, C				Yang, Yin-Shan; Murciano, Brice; Moubri, Karina; Cibrelus, Prisca; Schetters, Theo; Gorenflot, Andre; Delbecq, Stephane; Roumestand, Christian			Structural and Functional Characterization of Bc28.1, Major Erythrocyte-binding Protein from Babesia canis Merozoite Surface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RED-CELL INVASION; GIBSONI INFECTION; MEMBRANE-PROTEINS; PARASITE; SEQUENCE; ANTIGEN; BOVIS; IDENTIFICATION; IMMUNIZATION; POLYMORPHISM	Babesiosis (formerly known as piroplasmosis) is a tick-borne disease caused by the intraerythrocytic development of protozoa parasites from the genus Babesia. Like Plasmodium falciparum, the agent of malaria, or Toxoplasma gondii, responsible for human toxoplasmosis, Babesia belongs to the Apicomplexa family. Babesia canis is the agent of the canine babesiosis in Europe. Clinical manifestations of this disease range from mild to severe and possibly lead to death by multiple organ failure. The identification and characterization of parasite surface proteins represent major goals, both for the understanding of the Apicomplexa invasion process and for the vaccine potential of such antigens. Indeed, we have already shown that Bd37, the major antigenic adhesion protein from Babesia divergens, the agent of bovine babesiosis, was able to induce complete protection against various parasite strains. The major merozoite surface antigens of Babesia canis have been described as a 28-kDa membrane protein family, anchored at the surface of the merozoite. Here, we demonstrate that Bc28.1, a major member of this multigenic family, is expressed at high levels at the surface of the merozoite. This protein is also found in the parasite in vitro culture supernatants, which are the basis of effective vaccines against canine babesiosis. We defined the erythrocyte binding function of Bc28.1 and determined its high resolution solution structure using NMR spectroscopy. Surprisingly, although these proteins are thought to play a similar role in the adhesion process, the structure of Bc28.1 from B. canis appears unrelated to the previously published structure of Bd37 from B. divergens. Site-directed mutagenesis experiments also suggest that the mechanism of the interaction with the erythrocyte membrane could be different for the two proteins. The resolution of the structure of Bc28 represents a milestone for the characterization of the parasite erythrocyte binding and its interaction with the host immune system.	[Yang, Yin-Shan; Murciano, Brice; Roumestand, Christian] Univ Montpellier I, Ctr Biochim Struct, CNRS, UMR 5048, F-34090 Montpellier, France; [Yang, Yin-Shan; Murciano, Brice; Roumestand, Christian] Univ Montpellier 2, Ctr Biochim Struct, CNRS, UMR 5048, F-34090 Montpellier, France; [Yang, Yin-Shan; Murciano, Brice; Roumestand, Christian] INSERM, U1054, F-34090 Montpellier, France; [Murciano, Brice; Moubri, Karina; Cibrelus, Prisca; Gorenflot, Andre; Delbecq, Stephane] Univ Montpellier I, Fac Pharm, EA4558, F-34093 Montpellier 5, France; [Schetters, Theo] Intervet Int BV, Dept Parasitol, NL-5830 AA Boxmeer, Netherlands	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; Merck & Company; Intervet International B.V.	Roumestand, C (corresponding author), Univ Montpellier I, Ctr Biochim Struct, CNRS, UMR 5048, 29 Route Navacelles, F-34090 Montpellier, France.	christian.roumestand@cbs.cnrs.fr		ROUMESTAND, Christian/0000-0002-4082-3293; Delbecq, Stephane/0000-0002-2813-1219	Intervet International B.V.; Tres Grands Equipments de Resonance Magnetique Nucleaire a Tres Haut Champs [Fr3050]; Ministere de l'Enseignement Superieur et de la Recherche	Intervet International B.V.(Merck & CompanyIntervet International B.V.); Tres Grands Equipments de Resonance Magnetique Nucleaire a Tres Haut Champs; Ministere de l'Enseignement Superieur et de la Recherche(Estonian Research CouncilEuropean Commission)	This work was supported in part by a grant from Intervet International B.V. This work (very high-field NMR at 950 MHz) was also supported by Tres Grands Equipments de Resonance Magnetique Nucleaire a Tres Haut Champs Fr3050.; Ph.D. student supported by an "Axes Prioritaires" grant from Ministere de l'Enseignement Superieur et de la Recherche.	Anantharaman V, 2007, INT REV CYTOL, V262, P1, DOI 10.1016/S0074-7696(07)62001-4; BANNISTER LH, 1990, BLOOD CELLS, V16, P257; BLACKMAN MJ, 1990, J EXP MED, V172, P379, DOI 10.1084/jem.172.1.379; BORDIER C, 1981, J BIOL CHEM, V256, P1604; Boyle MJ, 2010, BLOOD, V115, P4559, DOI 10.1182/blood-2009-09-243725; Brayton KA, 2007, PLOS PATHOG, V3, P1401, DOI 10.1371/journal.ppat.0030148; Carcy B, 2006, VET PARASITOL, V138, P33, DOI 10.1016/j.vetpar.2006.01.038; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Delbecq S, 2006, VACCINE, V24, P613, DOI 10.1016/j.vaccine.2005.08.073; Delbecq S, 2008, J MOL BIOL, V375, P409, DOI 10.1016/j.jmb.2007.08.019; Drakulovski P, 2003, INFECT IMMUN, V71, P1056, DOI 10.1128/IAI.71.3.1056-1067.2003; Drew DR, 2005, INFECT IMMUN, V73, P3912, DOI 10.1128/IAI.73.7.3912-3922.2005; Rodriguez AE, 2010, VET PARASITOL, V167, P227, DOI 10.1016/j.vetpar.2009.09.024; Ferguson MAJ, 1999, J CELL SCI, V112, P2799; Fowkes FJI, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000218; Fukumoto S, 2001, J CLIN MICROBIOL, V39, P2603, DOI 10.1128/JCM.39.7.2603-2609.2001; Fukumoto S, 2004, INFECT IMMUN, V72, P1795, DOI 10.1128/IAI.72.3.1795-1798.2004; Fukumoto S, 2007, VACCINE, V25, P1334, DOI 10.1016/j.vaccine.2006.09.083; Garcia J, 2009, VACCINE, V27, P3953, DOI 10.1016/j.vaccine.2009.04.039; Gilson PR, 2006, MOL CELL PROTEOMICS, V5, P1286, DOI 10.1074/mcp.M600035-MCP200; Guntert Peter, 2004, Methods Mol Biol, V278, P353; HINES SA, 1995, INFECT IMMUN, V63, P349, DOI 10.1128/IAI.63.1.349-352.1995; Holm L, 1999, NUCLEIC ACIDS RES, V27, P244, DOI 10.1093/nar/27.1.244; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Irwin PJ, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-S1-S4; Jackson KE, 2007, BIOCHEM J, V403, P167, DOI 10.1042/BJ20061725; Jung C, 2004, INT J PARASITOL, V34, P285, DOI 10.1016/j.ijpara.2003.12.004; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Moreau Y, 1989, Trans R Soc Trop Med Hyg, V83 Suppl, P95, DOI 10.1016/0035-9203(89)90611-1; Nederveen AJ, 2005, PROTEINS, V59, P662, DOI 10.1002/prot.20408; Orengo CA, 1997, STRUCTURE, V5, P1093, DOI 10.1016/S0969-2126(97)00260-8; Pollard AM, 2008, INFECT IMMUN, V76, P103, DOI 10.1128/IAI.01170-07; Pons JL, 1996, J BIOMOL NMR, V8, P445, DOI 10.1007/BF00228146; Precigout E, 2004, INT J PARASITOL, V34, P585, DOI 10.1016/j.ijpara.2004.01.002; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Schetters TPM, 2009, J S AFR VET ASSOC, V80, P75; Verdida RA, 2004, J VET MED SCI, V66, P1517, DOI 10.1292/jvms.66.1517; von Itzstein M, 2008, TRENDS PARASITOL, V24, P210, DOI 10.1016/j.pt.2008.02.007	40	14	15	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					9495	9508		10.1074/jbc.M111.260745	http://dx.doi.org/10.1074/jbc.M111.260745			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22294693	Green Published, hybrid			2022-12-25	WOS:000301797800078
J	Cao, LH; Silvestry, S; Zhao, N; Diehl, J; Sun, JZ				Cao, Longhui; Silvestry, Scott; Zhao, Ning; Diehl, James; Sun, Jianzhong			Effects of Preoperative Aspirin on Cardiocerebral and Renal Complications in Non-Emergent Cardiac Surgery Patients: A Sub-Group and Cohort Study	PLOS ONE			English	Article							BYPASS GRAFT-SURGERY; ANTIPLATELET THERAPY; THORACIC-SURGEONS; CORONARY; GUIDELINE; MORBIDITY; MORTALITY; SOCIETY; CLOPIDOGREL; DISEASE	Background and Objective: Postoperative cardiocerebral and renal complications are a major threat for patients undergoing cardiac surgery. This study was aimed to examine the effect of preoperative aspirin use on patients undergoing cardiac surgery. Methods: An observational cohort study was performed on consecutive patients (n = 1879) receiving cardiac surgery at this institution. The patients excluded from the study were those with preoperative anticoagulants, unknown aspirin use, or underwent emergent cardiac surgery. Outcome events included were 30-day mortality, renal failure, readmission and a composite outcome - major adverse cardiocerebral events (MACE) that include permanent or transient stroke, coma, perioperative myocardial infarction (MI), heart block and cardiac arrest. Results: Of all patients, 1145 patients met the inclusion criteria and were divided into two groups: those taking (n = 858) or not taking (n = 287) aspirin within 5 days preceding surgery. Patients with aspirin presented significantly more with history of hypertension, diabetes, peripheral arterial disease, previous MI, angina and older age. With propensity scores adjusted and multivariate logistic regression, however, this study showed that preoperative aspirin therapy (vs. no aspirin) significantly reduced the risk of MACE (8.4% vs. 12.5%, odds ratio [OR] 0.585, 95% CI 0.355-0.964, P = 0.035), postoperative renal failure (2.6% vs. 5.2%, OR 0.438, CI 0.203-0.945, P = 0.035) and dialysis required (0.8% vs. 3.1%, OR 0.230, CI 0.071-0.742, P = 0.014), but did not significantly reduce 30-day mortality (4.1% vs. 5.8%, OR 0.744, CI 0.376-1.472, P = 0.396) nor it increased readmissions in the patients undergoing cardiac surgery. Conclusions: Preoperative aspirin therapy is associated with a significant decrease in the risk of MACE and renal failure and did not increase readmissions in patients undergoing non-emergent cardiac surgery.	[Cao, Longhui; Sun, Jianzhong] Thomas Jefferson Univ, Jefferson Med Coll, Dept Anesthesiol, Philadelphia, PA 19107 USA; [Silvestry, Scott; Diehl, James] Thomas Jefferson Univ, Jefferson Med Coll, Div Cardiothorac Surg, Philadelphia, PA 19107 USA; [Cao, Longhui] Sun Yat Sen Univ, Ctr Canc, Dept Anesthesiol, Guangzhou 510275, Guangdong, Peoples R China; [Zhao, Ning] Univ Penn Hlth Syst, Dept Psychiat, Philadelphia, PA USA	Jefferson University; Jefferson University; Sun Yat Sen University; University of Pennsylvania	Cao, LH (corresponding author), Thomas Jefferson Univ, Jefferson Med Coll, Dept Anesthesiol, Philadelphia, PA 19107 USA.	jian-zhong.sun@jefferson.edu						[Anonymous], 1988, LANCET, V2, P349; Awtry EH, 2000, CIRCULATION, V101, P1206, DOI 10.1161/01.CIR.101.10.1206; Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; Barodka V, 2011, J SURG RES, V167, pE63, DOI 10.1016/j.jss.2009.11.702; Berger JS, 2008, AM J MED, V121, P43, DOI 10.1016/j.amjmed.2007.10.002; Berger JS, 2009, AM J CARDIOL, V104, p44C, DOI 10.1016/j.amjcard.2009.06.015; Brown PP, 2008, ANN THORAC SURG, V85, P1980, DOI 10.1016/j.athoracsur.2008.01.053; Bucerius J, 2003, ANN THORAC SURG, V75, P472, DOI 10.1016/S0003-4975(02)04370-9; Bybee KA, 2005, CIRCULATION, V112, pI286, DOI 10.1161/CIRCULATIONAHA.104.522805; Cao LH, 2011, ANN SURG; Chen JC, 2007, CRIT CARE MED, V35, P1296, DOI 10.1097/01.CCM.0000262403.08546.A2; CHESEBRO JH, 1982, NEW ENGL J MED, V307, P73, DOI 10.1056/NEJM198207083070201; D'Agostino RB, 2007, CIRCULATION, V115, P2340, DOI 10.1161/CIRCULATIONAHA.105.594952; Dunning J, 2008, EUR J CARDIO-THORAC, V34, P73, DOI 10.1016/j.ejcts.2008.02.024; Eagle Kim A, 2004, Circulation, V110, P1168, DOI 10.1161/01.CIR.0000138790.14877.7D; Ferguson TB, 2002, JAMA-J AM MED ASSOC, V287, P2221, DOI 10.1001/jama.287.17.2221; Ferraris VA, 2005, ANN THORAC SURG, V79, P1454, DOI 10.1016/j.athoracsur.2005.01.008; FREMES SE, 1993, EUR J CARDIO-THORAC, V7, P169, DOI 10.1016/1010-7940(93)90155-5; Gerrah R, 2004, J CARDIOVASC SURG, V45, P545; GOLDMAN S, 1989, CIRCULATION, V80, P1190, DOI 10.1161/01.CIR.80.5.1190; GOLDMAN S, 1988, CIRCULATION, V77, P1324, DOI 10.1161/01.CIR.77.6.1324; Jacob M, 2011, CIRCULATION, V123, P577, DOI 10.1161/CIRCULATIONAHA.110.957373; Kim DH, 2009, J THORAC CARDIOV SUR, V138, P1377, DOI 10.1016/j.jtcvs.2009.07.027; King SB, 2008, CIRCULATION, V117, P261, DOI 10.1161/CIRCULATIONAHA.107.188208; Kulik A, 2009, EXPERT OPIN DRUG SAF, V8, P169, DOI [10.1517/14740330902797081, 10.1517/14740330902797081 ]; Mangano DT, 2002, NEW ENGL J MED, V347, P1309, DOI 10.1056/NEJMoa020798; Sandercock P, 1997, LANCET, V349, P1569; Shahian DM, 2009, ANN THORAC SURG, V88, pS43, DOI 10.1016/j.athoracsur.2009.05.055; Shroyer ALW, 2003, ANN THORAC SURG, V75, P1856, DOI 10.1016/S0003-4975(03)00179-6; Sun JCJ, 2010, AM HEART J, V160, P1178, DOI 10.1016/j.ahj.2010.07.035; Tolpin DA, 2009, J THORAC CARDIOV SUR, V138, P873, DOI 10.1016/j.jtcvs.2009.02.019; Tran H, 2004, JAMA-J AM MED ASSOC, V292, P1867, DOI 10.1001/jama.292.15.1867; YUSUF S, 1991, JAMA-J AM MED ASSOC, V266, P93, DOI 10.1001/jama.266.1.93	33	22	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2012	7	2							e30094	10.1371/journal.pone.0030094	http://dx.doi.org/10.1371/journal.pone.0030094			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UV	22319558	Green Published, Green Submitted, gold			2022-12-25	WOS:000301979000001
J	Imielski, Y; Schwamborn, JC; Luningschror, P; Heimann, P; Holzberg, M; Werner, H; Leske, O; Puschel, AW; Memet, S; Heumann, R; Israel, A; Kaltschmidt, C; Kaltschmidt, B				Imielski, Yvonne; Schwamborn, Jens C.; Lueningschroer, Patrick; Heimann, Peter; Holzberg, Magdalena; Werner, Hendrikje; Leske, Oliver; Pueschel, Andreas W.; Memet, Sylvie; Heumann, Rolf; Israel, Alain; Kaltschmidt, Christian; Kaltschmidt, Barbara			Regrowing the Adult Brain: NF-kappa B Controls Functional Circuit Formation and Tissue Homeostasis in the Dentate Gyrus	PLOS ONE			English	Article							HIPPOCAMPAL NEUROGENESIS; PATTERN SEPARATION; PLASTICITY; SURVIVAL; NEURONS; IMPAIRMENT; DEFICITS; GROWTH; CELLS; CA3	Cognitive decline during aging is correlated with a continuous loss of cells within the brain and especially within the hippocampus, which could be regenerated by adult neurogenesis. Here we show that genetic ablation of NF-kappa B resulted in severe defects in the neurogenic region (dentate gyrus) of the hippocampus. Despite increased stem cell proliferation, axogenesis, synaptogenesis and neuroprotection were hampered, leading to disruption of the mossy fiber pathway and to atrophy of the dentate gyrus during aging. Here, NF-kappa B controls the transcription of FOXO1 and PKA, regulating axogenesis. Structural defects culminated in behavioral impairments in pattern separation. Re-activation of NF-kappa B resulted in integration of newborn neurons, finally to regeneration of the dentate gyrus, accompanied by a complete recovery of structural and behavioral defects. These data identify NF-kappa B as a crucial regulator of dentate gyrus tissue homeostasis suggesting NF-kappa B to be a therapeutic target for treating cognitive and mood disorders.	[Imielski, Yvonne; Lueningschroer, Patrick; Heimann, Peter; Holzberg, Magdalena; Kaltschmidt, Christian; Kaltschmidt, Barbara] Univ Bielefeld, Fac Biol, D-33615 Bielefeld, Germany; [Schwamborn, Jens C.] ZMBE, Inst Zellbiol, AG Stammzellbiol & Regenerat, Munster, Germany; [Werner, Hendrikje; Pueschel, Andreas W.] Univ Munster, Inst Mol Zellbiol, Munster, Germany; [Werner, Hendrikje] Immunos, Inst Med Biol, Singapore, Singapore; [Leske, Oliver; Heumann, Rolf] Ruhr Univ Bochum, Bochum, Germany; [Memet, Sylvie] Inst Pasteur, Unite Mycol Mol, CNRS URA3012, Paris, France; [Israel, Alain] Inst Pasteur, Unite Signalisat Mol & Activat Cellulair, CNRS URA 2582, Paris, France	University of Bielefeld; University of Munster; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB); Ruhr University Bochum; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Imielski, Y (corresponding author), Univ Bielefeld, Fac Biol, D-33615 Bielefeld, Germany.	barbara.kaltschmidt@uni-bielefeld.de	Heumann, Rolf/AAK-4390-2020; Heumann, Rolf/ABB-9675-2021; Schwamborn, Jens C/F-9395-2011	Heumann, Rolf/0000-0003-4364-2655; Schwamborn, Jens C/0000-0003-4496-0559; Memet, Sylvie/0000-0001-6571-4192; Luningschror, Patrick/0000-0002-3883-6554	Deutsche Forschungsgemeinschaft (DFG) [GZ: KA 1210/5-1]; Walcker Stiftung, Isny, Allgau, Germany; Bielefeld University	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Walcker Stiftung, Isny, Allgau, Germany; Bielefeld University	This study was funded in part by the Deutsche Forschungsgemeinschaft (DFG, GZ: KA 1210/5-1); the Walcker Stiftung, Isny, Allgau, Germany and Institutional Funds of Bielefeld University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Buylla A, 2001, NAT REV NEUROSCI, V2, P287, DOI 10.1038/35067582; Bakker A, 2008, SCIENCE, V319, P1640, DOI 10.1126/science.1152882; Barnes AP, 2007, CELL, V129, P549, DOI 10.1016/j.cell.2007.03.025; BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; Bhakar AL, 2002, J NEUROSCI, V22, P8466; Boersma MCH, 2011, J NEUROSCI, V31, P5414, DOI 10.1523/JNEUROSCI.2456-10.2011; Bonini SA, 2011, J NEUROSCI, V31, P11697, DOI 10.1523/JNEUROSCI.1113-11.2011; Brun VH, 2002, SCIENCE, V296, P2243, DOI 10.1126/science.1071089; Clelland CD, 2009, SCIENCE, V325, P210, DOI 10.1126/science.1173215; de la Torre-Ubieta L, 2010, GENE DEV, V24, P799, DOI 10.1101/gad.1880510; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Denis-Donini S, 2008, J NEUROSCI, V28, P3911, DOI 10.1523/JNEUROSCI.0148-08.2008; Doetsch F, 2003, NAT NEUROSCI, V6, P1127, DOI 10.1038/nn1144; FORSSMANN WG, 1977, ANAT RECORD, V188, P307, DOI 10.1002/ar.1091880304; Fridmacher V, 2003, J NEUROSCI, V23, P9403; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gavalda N, 2009, DEVELOPMENT, V136, P3405, DOI 10.1242/dev.035295; Gould E., 2007, HIPPOCAMPUS BOOK, P321; Gutierrez H, 2005, DEVELOPMENT, V132, P1713, DOI 10.1242/dev.01702; Gutierrez H, 2011, TRENDS NEUROSCI, V34, P316, DOI 10.1016/j.tins.2011.03.001; Hastings NB, 2003, NAT MED, V9, P264, DOI 10.1038/nm0303-264; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Henson PM, 2006, TRENDS IMMUNOL, V27, P244, DOI 10.1016/j.it.2006.03.005; Jagasia R, 2009, J NEUROSCI, V29, P7966, DOI 10.1523/JNEUROSCI.1054-09.2009; Jin KL, 2004, P NATL ACAD SCI USA, V101, P343, DOI 10.1073/pnas.2634794100; Kaltschmidt B, 1999, ONCOGENE, V18, P3213, DOI 10.1038/sj.onc.1202657; Kaltschmidt B, 2006, MOL CELL BIOL, V26, P2936, DOI 10.1128/MCB.26.8.2936-2946.2006; Kaltschmidt B, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001271; Khazaei MR, 2010, J NEUROCHEM; Koo JW, 2010, P NATL ACAD SCI USA, V107, P2669, DOI 10.1073/pnas.0910658107; Lafenetre P, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/neuro.08.034.2009; Leuner B, 2010, ANNU REV PSYCHOL, V61, P111, DOI 10.1146/annurev.psych.093008.100359; Leutgeb JK, 2007, SCIENCE, V315, P961, DOI 10.1126/science.1135801; Mattson MP, 2005, NEUROCHEM RES, V30, P883, DOI 10.1007/s11064-005-6961-x; Mattson MP, 2006, CELL DEATH DIFFER, V13, P852, DOI 10.1038/sj.cdd.4401837; McKay R, 1997, SCIENCE, V276, P66, DOI 10.1126/science.276.5309.66; Meffert MK, 2003, NAT NEUROSCI, V6, P1072, DOI 10.1038/nn1110; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Mu YL, 2010, CURR OPIN NEUROBIOL, V20, P416, DOI 10.1016/j.conb.2010.04.010; Nakada D, 2011, NEURON, V70, P703, DOI 10.1016/j.neuron.2011.05.011; Paik JH, 2009, CELL STEM CELL, V5, P540, DOI 10.1016/j.stem.2009.09.013; Pasparakis M, 2009, NAT REV IMMUNOL, V9, P778, DOI 10.1038/nri2655; Renault VM, 2009, CELL STEM CELL, V5, P527, DOI 10.1016/j.stem.2009.09.014; Rola R, 2004, EXP NEUROL, V188, P316, DOI 10.1016/j.expneurol.2004.05.005; Sahay A, 2011, NATURE, V472, P466, DOI 10.1038/nature09817; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; Schwamborn JC, 2004, NAT NEUROSCI, V7, P923, DOI 10.1038/nn1295; Schwamborn JC, 2009, CELL, V136, P913, DOI 10.1016/j.cell.2008.12.024; Shelly M, 2007, CELL, V129, P565, DOI 10.1016/j.cell.2007.04.012; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; SturchlerPierrat C, 1997, P NATL ACAD SCI USA, V94, P13287, DOI 10.1073/pnas.94.24.13287; Suh H, 2009, ANNU REV CELL DEV BI, V25, P253, DOI 10.1146/annurev.cellbio.042308.113256; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174	53	53	58	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2012	7	2							e30838	10.1371/journal.pone.0030838	http://dx.doi.org/10.1371/journal.pone.0030838			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UG	22312433	gold, Green Published, Green Submitted			2022-12-25	WOS:000301977500021
J	Ramazzotti, M; Monsellier, E; Kamoun, C; Degl'Innocenti, D; Melki, R				Ramazzotti, Matteo; Monsellier, Elodie; Kamoun, Choumouss; Degl'Innocenti, Donatella; Melki, Ronald			Polyglutamine Repeats Are Associated to Specific Sequence Biases That Are Conserved among Eukaryotes	PLOS ONE			English	Article							AMINO-ACID REPEATS; CAG REPEATS; TRINUCLEOTIDE REPEATS; PROTEIN SEQUENCES; HUNTINGTIN; INSTABILITY; AGGREGATION; INSIGHTS; SCA1; EXPANSION	Nine human neurodegenerative diseases, including Huntington's disease and several spinocerebellar ataxia, are associated to the aggregation of proteins comprising an extended tract of consecutive glutamine residues (polyQs) once it exceeds a certain length threshold. This event is believed to be the consequence of the expansion of polyCAG codons during the replication process. This is in apparent contradiction with the fact that many polyQs-containing proteins remain soluble and are encoded by invariant genes in a number of eukaryotes. The latter suggests that polyQs expansion and/or aggregation might be counter-selected through a genetic and/or protein context. To identify this context, we designed a software that scrutinize entire proteomes in search for imperfect polyQs. The nature of residues flanking the polyQs and that of residues other than Gln within polyQs (insertions) were assessed. We discovered strong amino acid residue biases robustly associated to polyQs in the 15 eukaryotic proteomes we examined, with an over-representation of Pro, Leu and His and an under-representation of Asp, Cys and Gly amino acid residues. These biases are conserved amongst unrelated proteins and are independent of specific functional classes. Our findings suggest that specific residues have been co-selected with polyQs during evolution. We discuss the possible selective pressures responsible of the observed biases.	[Ramazzotti, Matteo; Degl'Innocenti, Donatella] Univ Florence, Dipartimento Sci Biochim, Florence, Italy; [Monsellier, Elodie; Kamoun, Choumouss] UPR 3082 CNRS, Lab Enzymol & Biochim Struct, Gif Sur Yvette, France	University of Florence; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Ramazzotti, M (corresponding author), Univ Florence, Dipartimento Sci Biochim, Florence, Italy.	matteo.ramazzotti@unifi.it; monsellier@lebs.cnrs-gif.fr	Ramazzotti, Matteo/J-4866-2012; Degl'Innocenti, Donatella/O-8813-2014; Monsellier, Elodie/GRF-5106-2022	Ramazzotti, Matteo/0000-0002-6862-9409; Degl'Innocenti, Donatella/0000-0002-3342-5537; Monsellier, Elodie/0000-0001-7944-7531	Partenariat Hubert Curien (Franco-Italienne University) [22138SJ]; Fondi di Ateneo of the University of Florence; Agence Nationale de la Recherche [ANR-08-NEUR-001-01, ANR-09-MNPS-013-01]; Human Frontier program; EraNet Neuron (Miprotran) program; Centre National de la Recherche Scientifique; Fondation pour la Recherche Medicale [SPF20080512049]	Partenariat Hubert Curien (Franco-Italienne University); Fondi di Ateneo of the University of Florence; Agence Nationale de la Recherche(French National Research Agency (ANR)); Human Frontier program; EraNet Neuron (Miprotran) program; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	This work was supported by grants from the Partenariat Hubert Curien (Franco-Italienne University, project Galileo not equal 22138SJ), Fondi di Ateneo 2009 of the University of Florence, the Agence Nationale de la Recherche (ANR-08-NEUR-001-01, and ANR-09-MNPS-013-01), the Human Frontier and the EraNet Neuron (Miprotran) programs and the Centre National de la Recherche Scientifique, and by a fellowship from the Fondation pour la Recherche Medicale (project not equal SPF20080512049). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alba MM, 2004, GENOME RES, V14, P549, DOI 10.1101/gr.1925704; Alba MM, 2001, J MOL EVOL, V52, P249, DOI 10.1007/s002390010153; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bauer PO, 2009, J NEUROCHEM, V110, P1737, DOI 10.1111/j.1471-4159.2009.06302.x; Bhattacharyya A, 2006, J MOL BIOL, V355, P524, DOI 10.1016/j.jmb.2005.10.053; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; CHUNG MY, 1993, NAT GENET, V5, P254, DOI 10.1038/ng1193-254; Darnell G, 2007, J MOL BIOL, V374, P688, DOI 10.1016/j.jmb.2007.09.023; de Chiara C, 2005, J MOL BIOL, V354, P883, DOI 10.1016/j.jmb.2005.09.083; de Mezer M, 2011, NUCLEIC ACIDS RES, V39, P3852, DOI 10.1093/nar/gkq1323; Dehay B, 2006, J BIOL CHEM, V281, P35608, DOI 10.1074/jbc.M605558200; Dixon MJ, 2004, NUCLEIC ACIDS RES, V32, P1289, DOI 10.1093/nar/gkh292; Duennwald ML, 2006, P NATL ACAD SCI USA, V103, P11045, DOI 10.1073/pnas.0604547103; DUYAO M, 1993, NAT GENET, V4, P387, DOI 10.1038/ng0893-387; EICHLER EE, 1994, NAT GENET, V8, P88, DOI 10.1038/ng0994-88; Faux NG, 2005, GENOME RES, V15, P537, DOI 10.1101/gr.3096505; Faux NG, 2007, GENOME RES, V17, P1118, DOI 10.1101/gr.6255407; Garvie CW, 2001, MOL CELL, V8, P937, DOI 10.1016/S1097-2765(01)00392-6; Gojobori J, 2011, MOL BIOL EVOL, V28, P543, DOI 10.1093/molbev/msq225; Haerty W, 2010, GENOME RES, V20, P755, DOI 10.1101/gr.101246.109; Haider S, 2009, NUCLEIC ACIDS RES, V37, pW23, DOI 10.1093/nar/gkp265; Hands SL, 2010, ACTA NEUROPATHOL, V120, P419, DOI 10.1007/s00401-010-0703-0; Harris GM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013695; Hsu RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016417; Huang H, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-7-r47; Hubbard TJP, 2009, NUCLEIC ACIDS RES, V37, pD690, DOI 10.1093/nar/gkn828; Huntley MA, 2007, MOL BIOL EVOL, V24, P2598, DOI 10.1093/molbev/msm129; Jasinska A, 2003, NUCLEIC ACIDS RES, V31, P5463, DOI 10.1093/nar/gkg767; Jayaraman M, 2009, PROTEIN ENG DES SEL, V22, P469, DOI 10.1093/protein/gzp023; Karlin S, 2002, P NATL ACAD SCI USA, V99, P333, DOI 10.1073/pnas.012608599; KARLIN S, 1995, CURR OPIN STRUC BIOL, V5, P360, DOI 10.1016/0959-440X(95)80098-0; Katti MV, 2000, PROTEIN SCI, V9, P1203, DOI 10.1110/ps.9.6.1203; Kersey PJ, 2010, NUCLEIC ACIDS RES, V38, pD563, DOI 10.1093/nar/gkp871; Kiliszek A, 2010, NUCLEIC ACIDS RES, V38, P8370, DOI 10.1093/nar/gkq700; Kozlowski P, 2010, NUCLEIC ACIDS RES, V38, P4027, DOI 10.1093/nar/gkq127; Kumar R, 2011, LIFE SCI, V88, P565, DOI 10.1016/j.lfs.2011.01.021; Kurosaki T, 2006, GENE, V373, P23, DOI 10.1016/j.gene.2005.12.017; Lakhani VV, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000772; Langbehn DR, 2010, AM J MED GENET B, V153B, P397, DOI 10.1002/ajmg.b.30992; Lawlor KT, 2011, HUMAN MOL GENETICS P; Li LB, 2008, NATURE, V453, P1107, DOI 10.1038/nature06909; Madsen LB, 2007, NEUROGENETICS, V8, P207, DOI 10.1007/s10048-007-0088-y; Marcotte EM, 1999, J MOL BIOL, V293, P151, DOI 10.1006/jmbi.1999.3136; McKusick VA, 2007, AM J HUM GENET, V80, P588, DOI 10.1086/514346; Menon RP, 2006, CELL MOL LIFE SCI, V63, P1677, DOI 10.1007/s00018-006-6097-4; Michlewski G, 2004, J MOL BIOL, V340, P665, DOI 10.1016/j.jmb.2004.05.021; Miller M, 2009, CURR PROTEIN PEPT SC, V10, P244, DOI 10.2174/138920309788452164; Monsellier E, 2007, EMBO REP, V8, P737, DOI 10.1038/sj.embor.7401034; Mularoni L, 2007, GENOMICS, V89, P316, DOI 10.1016/j.ygeno.2006.11.011; Paulson HL, 1997, NEURON, V19, P333, DOI 10.1016/S0896-6273(00)80943-5; Pearson CE, 2005, NAT REV GENET, V6, P729, DOI 10.1038/nrg1689; Popiel HA, 2004, BIOCHEM BIOPH RES CO, V317, P1200, DOI 10.1016/j.bbrc.2004.03.161; Qin ZH, 2004, J NEUROSCI, V24, P269, DOI 10.1523/JNEUROSCI.1409-03.2004; Rebbeck TR, 2001, CANCER RES, V61, P5420; Reumers J, 2009, HUM MUTAT, V30, P431, DOI 10.1002/humu.20905; Rockabrand E, 2007, HUM MOL GENET, V16, P61, DOI 10.1093/hmg/ddl440; Rolfsmeier ML, 2000, MOL CELL BIOL, V20, P173, DOI 10.1128/MCB.20.1.173-180.2000; Ross CA, 2011, LANCET NEUROL, V10, P83, DOI 10.1016/S1474-4422(10)70245-3; Rousseau F, 2006, J MOL BIOL, V355, P1037, DOI 10.1016/j.jmb.2005.11.035; Sakamoto N, 2001, J BIOL CHEM, V276, P27178, DOI 10.1074/jbc.M101852200; Scherzinger E, 1999, P NATL ACAD SCI USA, V96, P4604, DOI 10.1073/pnas.96.8.4604; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Sen S, 2003, PROTEIN SCI, V12, P953, DOI 10.1110/ps.0224403; Sharma D, 1999, FEBS LETT, V456, P181, DOI 10.1016/S0014-5793(99)00933-3; Simon M, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r59; Siwach P, 2006, MOL BIOL EVOL, V23, P1357, DOI 10.1093/molbev/msk022; Sobczak K, 2005, J BIOL CHEM, V280, P3898, DOI 10.1074/jbc.M409984200; Sobczak K, 2004, J BIOL CHEM, V279, P41563, DOI 10.1074/jbc.M405130200; Sobczak K, 2004, HUM MUTAT, V24, P236, DOI 10.1002/humu.20075; Sobczak K, 2010, J BIOL CHEM, V285, P12755, DOI 10.1074/jbc.M109.078790; Tam S, 2009, NAT STRUCT MOL BIOL, V16, P1279, DOI 10.1038/nsmb.1700; Tartari M, 2008, MOL BIOL EVOL, V25, P330, DOI 10.1093/molbev/msm258; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Thakur AK, 2009, NAT STRUCT MOL BIOL, V16, P380, DOI 10.1038/nsmb.1570; Todd PK, 2010, ANN NEUROL, V67, P291, DOI 10.1002/ana.21948; Wang LC, 2011, CELL MOL LIFE SCI, V68, P1255, DOI 10.1007/s00018-010-0522-4; Wang Y, 2009, FASEB J, V23, P451, DOI 10.1096/fj.08-117614; Wexler NS, 2004, P NATL ACAD SCI USA, V101, P3498, DOI 10.1073/pnas.0308479101; Wong LJC, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-111; Zoghbi HY, 2009, J BIOL CHEM, V284, P7425, DOI 10.1074/jbc.R800041200	80	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2012	7	2							e30824	10.1371/journal.pone.0030824	http://dx.doi.org/10.1371/journal.pone.0030824			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UG	22312432	Green Published, Green Submitted, gold			2022-12-25	WOS:000301977500019
J	Itoh, M; Kojima, M; Nagao-Sato, S; Saijo, E; Lassmann, T; Kanamori-Katayama, M; Kaiho, A; Lizio, M; Kawaji, H; Carninci, P; Forrest, ARR; Hayashizaki, Y				Itoh, Masayoshi; Kojima, Miki; Nagao-Sato, Sayaka; Saijo, Eri; Lassmann, Timo; Kanamori-Katayama, Mutsumi; Kaiho, Ai; Lizio, Marina; Kawaji, Hideya; Carninci, Piero; Forrest, Alistair R. R.; Hayashizaki, Yoshihide			Automated Workflow for Preparation of cDNA for Cap Analysis of Gene Expression on a Single Molecule Sequencer	PLOS ONE			English	Article							TRANSCRIPTOME; CONSTRUCTION; SEQ	Background: Cap analysis of gene expression (CAGE) is a 5' sequence tag technology to globally determine transcriptional starting sites in the genome and their expression levels and has most recently been adapted to the HeliScope single molecule sequencer. Despite significant simplifications in the CAGE protocol, it has until now been a labour intensive protocol. Methodology: In this study we set out to adapt the protocol to a robotic workflow, which would increase throughput and reduce handling. The automated CAGE cDNA preparation system we present here can prepare 96 'HeliScope ready' CAGE cDNA libraries in 8 days, as opposed to 6 weeks by a manual operator. We compare the results obtained using the same RNA in manual libraries and across multiple automation batches to assess reproducibility. Conclusions: We show that the sequencing was highly reproducible and comparable to manual libraries with an 8 fold increase in productivity. The automated CAGE cDNA preparation system can prepare 96 CAGE sequencing samples simultaneously. Finally we discuss how the system could be used for CAGE on Illumina/SOLiD platforms, RNA-seq and full-length cDNA generation.	[Itoh, Masayoshi; Kojima, Miki; Lassmann, Timo; Kanamori-Katayama, Mutsumi; Kaiho, Ai; Lizio, Marina; Kawaji, Hideya; Carninci, Piero; Forrest, Alistair R. R.; Hayashizaki, Yoshihide] RIKEN Yokohama Inst, Omics Sci Ctr, Tsurumi Ku, Yokohama, Kanagawa, Japan; [Nagao-Sato, Sayaka; Saijo, Eri] KK Dnaform, Tsurumi Ku, Yokohama, Kanagawa, Japan	RIKEN	Itoh, M (corresponding author), RIKEN Yokohama Inst, Omics Sci Ctr, Tsurumi Ku, Yokohama, Kanagawa, Japan.	maitoh@riken.jp; rgscerg@gsc.riken.jp	Lassmann, Timo/A-8271-2008; Lassmann, Timo/HCH-4313-2022; Kawaji, Hideya/N-5116-2015; Itoh, Masayoshi/N-5363-2015; Carninci, Piero/K-1568-2014	Lassmann, Timo/0000-0002-0138-2691; Lassmann, Timo/0000-0002-0138-2691; Kawaji, Hideya/0000-0002-0575-0308; Itoh, Masayoshi/0000-0002-1772-318X; Carninci, Piero/0000-0001-7202-7243; Forrest, Alistair/0000-0003-4543-1675	Japanese Ministry of Education, Culture, Sports, Science and Technology	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was funded by a Research Grant from the Japanese Ministry of Education, Culture, Sports, Science and Technology through the Cell Innovation Project and for the RIKEN Omics Science Center to YH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bock C, 2010, NAT BIOTECHNOL, V28, P1106, DOI 10.1038/nbt.1681; Carninci P, 2003, GENOME RES, V13, P1273, DOI 10.1101/gr.1119703; Carninci P, 1997, DNA Res, V4, P61, DOI 10.1093/dnares/4.1.61; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Cloonan N, 2008, NAT METHODS, V5, P613, DOI 10.1038/nmeth.1223; DEANGELIS MM, 1995, NUCLEIC ACIDS RES, V23, P4742, DOI 10.1093/nar/23.22.4742; Farias-Hesson E, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/617469; Faulkner GJ, 2009, NAT GENET, V41, P563, DOI 10.1038/ng.368; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; Goren A, 2010, NAT METHODS, V7, P47, DOI [10.1038/NMETH.1404, 10.1038/nmeth.1404]; Hart C, 2010, METHOD ENZYMOL, V472, P407, DOI 10.1016/S0076-6879(10)72002-4; Haussler D, 2009, J HERED, V100, P659, DOI 10.1093/jhered/esp086; HAWKINS TL, 1994, NUCLEIC ACIDS RES, V22, P4543, DOI 10.1093/nar/22.21.4543; Hestand MS, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq602; Kaiser J, 2008, SCIENCE, V319, P395, DOI 10.1126/science.319.5862.395; Kanamori-Katayama M, 2011, GENOME RES, V21, P1150, DOI 10.1101/gr.115469.110; Lennon NJ, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r15; Maekawa M, 1999, BIOCHEM BIOPH RES CO, V262, P671, DOI 10.1006/bbrc.1999.1230; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Park PJ, 2009, NAT REV GENET, V10, P669, DOI 10.1038/nrg2641; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; SCHERER WF, 1953, J EXP MED, V97, P695, DOI 10.1084/jem.97.5.695; Shiraki T, 2003, P NATL ACAD SCI USA, V100, P15776, DOI 10.1073/pnas.2136655100; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342; Suzuki H, 2009, NAT GENET, V41, P553, DOI 10.1038/ng.375; TSUCHIYA S, 1980, INT J CANCER, V26, P171, DOI 10.1002/ijc.2910260208; Valen E, 2009, GENOME RES, V19, P255, DOI 10.1101/gr.084541.108; Vitezic M, 2010, NUCLEIC ACIDS RES, V38, P8141, DOI 10.1093/nar/gkq729; Wilhelm BT, 2008, NATURE, V453, P1239, DOI 10.1038/nature07002	34	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2012	7	1							e30809	10.1371/journal.pone.0030809	http://dx.doi.org/10.1371/journal.pone.0030809			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	912BU	22303458	gold, Green Published, Green Submitted			2022-12-25	WOS:000301770300006
J	von Knorring, N; Gafos, M; Ramokonupi, M; Jentsch, U				von Knorring, Nina; Gafos, Mitzy; Ramokonupi, Motsei; Jentsch, Ute		MDP Team	Quality Control and Performance of HIV Rapid Tests in a Microbicide Clinical Trial in Rural KwaZulu-Natal	PLOS ONE			English	Article							INFECTION; AFRICA	Background: Quality control (QC) and evaluation of HIV rapid test procedures are an important aspect of HIV prevention trials. We describe QC and performance of two rapid tests, Determine (TM) and Uni-Gold (TM) used in a microbicide clinical trial in rural KwaZulu-Natal, South Africa. Methods/Results: Internal QC of both HIV rapid tests was conducted at the trial site using a Uni-Gold control kit (UniGold (TM) Recombigen (R) HIV). Both assays produced the expected results for a total of 4637 QC tests. Study participants were tested for HIV at screening and, if enrolled, at regular time points throughout the study. Positive or discordant results were confirmed by a double HIV immunoassay testing strategy at a local laboratory. Overall, 15292 HIV rapid test were performed. Sensitivity and specificity of Determine was 98.95% (95% CI: 97.72-99.61) and 99.83% (95% CI: 99.70-99.91) respectively [positive predictive value (PPV) 97.91% (95% CI: 96.38-98.92)], for Uni-Gold it was 99.30% (95% CI: 98.21-99.81) and 99.96% (95% CI: 99.88-99.99) respectively [PPV 99.47% (95% CI: 98.46-99.89)]. Conclusions: The results suggest that a Uni-Gold control kit can be used for internal QC of both Uni-Gold and the HIV-1 component of the Determine rapid tests. Both rapid tests performed proficiently in the trial population.	[von Knorring, Nina; Gafos, Mitzy; Ramokonupi, Motsei] Univ KwaZulu Natal, Africa Ctr Hlth & Populat Studies, Mtubatuba, South Africa; [von Knorring, Nina] Wits Reprod Hlth & HIV Inst, Johannesburg, South Africa; [Jentsch, Ute] Univ Witwatersrand, Hlth Consortium, Contract Lab Serv, Johannesburg, South Africa	University of Kwazulu Natal; University of Witwatersrand	von Knorring, N (corresponding author), Univ KwaZulu Natal, Africa Ctr Hlth & Populat Studies, Mtubatuba, South Africa.	nvonknorring@wrhi.ac.za		Gafos, Mitzy/0000-0002-7894-1498	UK government through its Department for International Development; Medical Research Council; Wellcome Trust [G0100137]; Medical Research Council [G0100137] Funding Source: researchfish; MRC [G0100137] Funding Source: UKRI	UK government through its Department for International Development; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The MDP301 clinical trial was funded by the UK government through its Department for International Development and Medical Research Council. The Medical Research Council sponsored the trial. The Africa Centre for Health and Population Studies of the University of KwaZulu-Natal, South Africa, is supported through grants from the Wellcome Trust (G0100137). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	B Awazu, 2000, INT C AIDS 13; Crucitti T, 2011, CLIN VACCINE IMMUNOL, V18, P1480, DOI 10.1128/CVI.05069-11; Dessie Azene, 2008, Ethiop Med J, V46, P1; Gray RH, 2007, BRIT MED J, V335, P188, DOI 10.1136/bmj.39210.582801.BE; McCormack S, 2010, LANCET, V376, P1329, DOI 10.1016/S0140-6736(10)61086-0; Moodley D, 2008, SAMJ S AFR MED J, V98, P707; Nunn A, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-99; Phili R, 2002, SAMJ S AFR MED J, V92, P818; Piwowar-Manning Estelle M, 2010, J Int Assoc Physicians AIDS Care (Chic), V9, P170, DOI 10.1177/1545109710368151; Seed P., 2010, STAT SOFTWARE COMPON; T Barnighausen, 2009, 16 C RETR OPP INF MO; Tanser F, 2008, INT J EPIDEMIOL, V37, P956, DOI 10.1093/ije/dym211; U Jentsch, 2010, MICR 2010 PITTSB US; Welz T, 2007, AIDS, V21, P1467, DOI 10.1097/QAD.0b013e3280ef6af2; WHO, 2009, 44 WHO, V44	15	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2012	7	1							e30728	10.1371/journal.pone.0030728	http://dx.doi.org/10.1371/journal.pone.0030728			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	912BU	22303452	gold, Green Accepted, Green Published, Green Submitted			2022-12-25	WOS:000301770300003
J	Shahi, P; Park, D; Pond, AC; Seethammagari, M; Chiou, SH; Cho, K; Carstens, JL; Decker, WK; McCrea, PD; Ittmann, MM; Rosen, JM; Spencer, DM				Shahi, Payam; Park, Dongsu; Pond, Adam C.; Seethammagari, Mamatha; Chiou, Shin-Heng; Cho, Kyucheol; Carstens, Julienne L.; Decker, William K.; McCrea, Pierre D.; Ittmann, Michael M.; Rosen, Jeffrey M.; Spencer, David M.			Activation of Wnt Signaling by Chemically Induced Dimerization of LRP5 Disrupts Cellular Homeostasis	PLOS ONE			English	Article							BETA-CATENIN; PROSTATE CARCINOMA; MURINE PROSTATE; BREAST-CANCER; STEM-CELLS; RECEPTOR; TRANSDUCTION; PATHWAY; MECHANISM; DOMAINS	Wnt signaling is crucial for a variety of biological processes, including body axis formation, planar polarity, stem cell maintenance and cellular differentiation. Therefore, targeted manipulation of Wnt signaling in vivo would be extremely useful. By applying chemical inducer of dimerization (CID) technology, we were able to modify the Wnt co-receptor, low-density lipoprotein(LDL)-receptor-related protein 5 (LRP5), to generate the synthetic ligand inducible Wnt switch, iLRP5. We show that iLRP5 oligomerization results in its localization to disheveled-containing punctate structures and sequestration of scaffold protein Axin, leading to robust beta-catenin-mediated signaling. Moreover, we identify a novel LRP5 cytoplasmic domain critical for its intracellular localization and casein kinase 1-dependent beta-catenin signaling. Finally, by utilizing iLRP5 as a Wnt signaling switch, we generated the Ubiquitous Activator of beta-catenin (Ubi-Cat) transgenic mouse line. The Ubi-Cat line allows for nearly ubiquitous expression of iLRP5 under control of the H-2K(b) promoter. Activation of iLRP5 in isolated prostate basal epithelial stem cells resulted in expansion of p63(+) cells and development of hyperplasia in reconstituted murine prostate grafts. Independently, iLRP5 induction in adult prostate stroma enhanced prostate tissue regeneration. Moreover, induction of iLRP5 in male Ubi-Cat mice resulted in prostate tumor progression over several months from prostate hyperplasia to adenocarcinoma. We also investigated iLRP5 activation in Ubi-Cat-derived mammary cells, observing that prolonged activation results in mammary tumor formation. Thus, in two distinct experimental mouse models, activation of iLRP5 results in disruption of tissue homeostasis, demonstrating the utility of iLRP5 as a novel research tool for determining the outcome of Wnt activation in a precise spatially and temporally determined fashion.	[Shahi, Payam; Park, Dongsu; Seethammagari, Mamatha; Chiou, Shin-Heng; Carstens, Julienne L.; Decker, William K.; Ittmann, Michael M.; Spencer, David M.] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Pond, Adam C.; Rosen, Jeffrey M.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Cho, Kyucheol; McCrea, Pierre D.] Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center	Shahi, P (corresponding author), Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA.	dspencer@bcm.edu		Carstens, Julienne/0000-0001-9914-0430; Park, Dongsu/0000-0002-2570-3250	National Institutes of Health [U01-CA141497, R37-CA16303, T32-AI0749510]; NATIONAL CANCER INSTITUTE [U01CA141497, R01CA016303, R37CA016303] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by National Institutes of Health U01-CA141497, R37-CA16303, and T32-AI0749510. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; Brott BK, 2002, MOL CELL BIOL, V22, P6100, DOI 10.1128/MCB.22.17.6100-6110.2002; Bruxvoort KJ, 2007, CANCER RES, V67, P2490, DOI 10.1158/0008-5472.CAN-06-3028; Carron C, 2003, J CELL SCI, V116, P2541, DOI 10.1242/jcs.00451; Chen GP, 2004, CANCER-AM CANCER SOC, V101, P1345, DOI 10.1002/cncr.20518; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; Clackson T, 1998, P NATL ACAD SCI USA, V95, P10437, DOI 10.1073/pnas.95.18.10437; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cong F, 2004, DEVELOPMENT, V131, P5103, DOI 10.1242/dev.01318; CUNHA GR, 1978, J EXP ZOOL, V205, P181, DOI 10.1002/jez.1402050203; Dann CE, 2001, NATURE, V412, P86, DOI 10.1038/35083601; DAVID-WATINE B, 1990, IMMUNOL TODAY, V11, P286, DOI 10.1016/0167-5699(90)90114-O; Davidson G, 2005, NATURE, V438, P867, DOI 10.1038/nature04170; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Gounari F, 2002, ONCOGENE, V21, P4099, DOI 10.1038/sj.onc.1205562; Green JL, 2008, TRENDS CELL BIOL, V18, P536, DOI 10.1016/j.tcb.2008.08.006; Grumolato L, 2010, GENE DEV, V24, P2517, DOI 10.1101/gad.1957710; Ilyas M, 2005, J PATHOL, V205, P130, DOI 10.1002/path.1692; Krishnan V, 2006, J CLIN INVEST, V116, P1202, DOI 10.1172/JCI28551; Li B, 2002, GENE THER, V9, P233, DOI 10.1038/sj.gt.3301641; Li XF, 2005, J BIOL CHEM, V280, P19883, DOI 10.1074/jbc.M413274200; Liu GZ, 2003, MOL CELL BIOL, V23, P5825, DOI 10.1128/MCB.23.16.5825-5835.2003; Mao JH, 2001, MOL CELL, V7, P801, DOI 10.1016/S1097-2765(01)00224-6; Mi KH, 2005, J CELL BIOCHEM, V95, P328, DOI 10.1002/jcb.20400; Nusse R, 2005, CELL RES, V15, P28, DOI 10.1038/sj.cr.7290260; NUSSE R, 1982, CELL, V31, P99, DOI 10.1016/0092-8674(82)90409-3; Ontiveros CS, 2008, PROSTATE, V68, P1263, DOI 10.1002/pros.20770; Park D, 2006, NAT BIOTECHNOL, V24, P1581, DOI 10.1038/nbt1262; Polakis P, 2000, GENE DEV, V14, P1837; Robinson DR, 2008, CURR DRUG TARGETS, V9, P571; Satija NK, 2007, STEM CELLS DEV, V16, P7, DOI 10.1089/scd.2006.9998; Seto ES, 2006, J CELL BIOL, V173, P95, DOI 10.1083/jcb.200510123; Shahi P, 2011, STEM CELLS, V29, P678, DOI 10.1002/stem.606; Shibata H, 1997, SCIENCE, V278, P120, DOI 10.1126/science.278.5335.120; SPENCER DM, 1993, SCIENCE, V262, P1019, DOI 10.1126/science.7694365; Suzuki H, 2008, BRIT J CANCER, V98, P1147, DOI 10.1038/sj.bjc.6604259; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; van Amerongen R, 2006, TRENDS GENET, V22, P678, DOI 10.1016/j.tig.2006.10.001; Wang BE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002186; Xin L, 2007, STEM CELLS, V25, P2760, DOI 10.1634/stemcells.2007-0355; Yu XP, 2009, PROSTATE, V69, P249, DOI 10.1002/pros.20877; Zardawi SJ, 2009, HISTOL HISTOPATHOL, V24, P385, DOI 10.14670/HH-24.385; Zeng X, 2005, NATURE, V438, P873, DOI 10.1038/nature04185	44	14	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2012	7	1							e30814	10.1371/journal.pone.0030814	http://dx.doi.org/10.1371/journal.pone.0030814			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911GB	22303459	Green Published, gold, Green Submitted			2022-12-25	WOS:000301704200035
J	Zorc, M; Skok, DJ; Godnic, I; Calin, GA; Horvat, S; Jiang, ZH; Dovc, P; Kunej, T				Zorc, Minja; Skok, Dasa Jevsinek; Godnic, Irena; Calin, George Adrian; Horvat, Simon; Jiang, Zhihua; Dovc, Peter; Kunej, Tanja			Catalog of MicroRNA Seed Polymorphisms in Vertebrates	PLOS ONE			English	Article							MEDIATED GENE-REGULATION; PROSTATE-CANCER RISK; FUNCTIONAL POLYMORPHISM; PRE-MICRORNAS; GENOMIC VARIATIONS; MIR-146A GENE; DATABASE; ASSOCIATION; VARIANTS; REGION	MicroRNAs (miRNAs) are a class of non-coding RNA that plays an important role in posttranscriptional regulation of mRNA. Evidence has shown that miRNA gene variability might interfere with its function resulting in phenotypic variation and disease susceptibility. A major role in miRNA target recognition is ascribed to complementarity with the miRNA seed region that can be affected by polymorphisms. In the present study, we developed an online tool for the detection of miRNA polymorphisms (miRNA SNiPer) in vertebrates (http://www.integratomics-time.com/miRNA-SNiPer) and generated a catalog of miRNA seed region polymorphisms (miR-seed-SNPs) consisting of 149 SNPs in six species. Although a majority of detected polymorphisms were due to point mutations, two consecutive nucleotide substitutions (double nucleotide polymorphisms, DNPs) were also identified in nine miRNAs. We determined that miR-SNPs are frequently located within the quantitative trait loci (QTL), chromosome fragile sites, and cancer susceptibility loci, indicating their potential role in the genetic control of various complex traits. To test this further, we performed an association analysis between the mmu-miR-717 seed SNP rs30372501, which is polymorphic in a large number of standard inbred strains, and all phenotypic traits in these strains deposited in the Mouse Phenome Database. Analysis showed a significant association between the mmu-miR-717 seed SNP and a diverse array of traits including behavior, blood-clinical chemistry, body weight size and growth, and immune system suggesting that seed SNPs can indeed have major pleiotropic effects. The bioinformatics analyses, data and tools developed in the present study can serve researchers as a starting point in testing more targeted hypotheses and designing experiments using optimal species or strains for further mechanistic studies.	[Zorc, Minja; Skok, Dasa Jevsinek; Godnic, Irena; Horvat, Simon; Dovc, Peter; Kunej, Tanja] Univ Ljubljana, Biotech Fac, Dept Anim Sci, Domzale, Slovenia; [Zorc, Minja] Rothamsted Res, Ctr Math & Computat Biol, Harpenden, Herts, England; [Calin, George Adrian] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA; [Calin, George Adrian] Univ Texas MD Anderson Canc Ctr, Ctr RNA Interference & Noncoding RNAs, Houston, TX 77030 USA; [Horvat, Simon] Natl Inst Chem, Ljubljana, Slovenia; [Jiang, Zhihua] Washington State Univ, Dept Anim Sci, Pullman, WA 99164 USA	University of Ljubljana; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; National Institute of Chemistry - Slovenia; Washington State University	Zorc, M (corresponding author), Univ Ljubljana, Biotech Fac, Dept Anim Sci, Domzale, Slovenia.	tanja.kunej@bf.uni-lj.si	Calin, George/E-9390-2011; Zorc, Minja/AGD-6914-2022; Kunej, Tanja/G-5957-2017; Jiang, Zhihua/A-3378-2008	Zorc, Minja/0000-0003-3330-7909; Kunej, Tanja/0000-0002-0465-1762; Jiang, Zhihua/0000-0003-1986-088X; Calin, George/0000-0002-7427-0578; Calin, George/0000-0001-6704-5615	Slovenian Research Agency (ARRS) [P4-0220]; The University of Texas MD Anderson Research Trust; CLL Global Research Foundation; NIH/NCI [1R01CA135444]; Department of Defense; Developmental Research Awards in Breast Cancer, Ovarian Cancer, Brain Cancer, Multiple Myeloma and Leukemia SPOREs; Laura and John Arnold Foundation; RGK Foundation; NATIONAL CANCER INSTITUTE [R01CA135444] Funding Source: NIH RePORTER	Slovenian Research Agency (ARRS)(Slovenian Research Agency - Slovenia); The University of Texas MD Anderson Research Trust; CLL Global Research Foundation; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense(United States Department of Defense); Developmental Research Awards in Breast Cancer, Ovarian Cancer, Brain Cancer, Multiple Myeloma and Leukemia SPOREs; Laura and John Arnold Foundation; RGK Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Slovenian Research Agency (ARRS) through the Research programme Comparative genomics and genome biodiversity [grant number P4-0220]. G.A.C. is supported as a Fellow at The University of Texas MD Anderson Research Trust, as a University of Texas System Regents Research Scholar and by the CLL Global Research Foundation. Work in Dr. Calin's laboratory is supported in part by the NIH/NCI (1R01CA135444), a Department of Defense Breast Cancer Idea Award, Developmental Research Awards in Breast Cancer, Ovarian Cancer, Brain Cancer, Multiple Myeloma and Leukemia SPOREs, and the Laura and John Arnold Foundation and RGK Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker SJ, 2001, ONCOGENE, V20, P1015, DOI 10.1038/sj.onc.1204209; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Bhartiya D, 2011, HUM MUTAT, V32, pE2226, DOI 10.1002/humu.21482; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Chin LJ, 2008, CANCER RES, V68, P8535, DOI 10.1158/0008-5472.CAN-08-2129; Didiano D, 2006, NAT STRUCT MOL BIOL, V13, P849, DOI 10.1038/nsmb1138; Duan RH, 2007, HUM MOL GENET, V16, P1124, DOI 10.1093/hmg/ddm062; Duan SW, 2009, RNA BIOL, V6, P412, DOI 10.4161/rna.6.4.8830; Fabbri M, 2009, CARCINOGENESIS, V30, P912, DOI 10.1093/carcin/bgp063; Ferdin J, 2010, TECHNOL CANCER RES T, V9, P123, DOI 10.1177/153303461000900202; Fitch MJ, 2004, DEV DYNAM, V230, P316, DOI 10.1002/dvdy.20063; Freudenberg-Hua Y, 2003, GENOME RES, V13, P2271, DOI 10.1101/gr.1299703; George GP, 2011, MOL BIOL REP, V38, P1609, DOI 10.1007/s11033-010-0270-4; Georges M, 2007, CURR OPIN GENET DEV, V17, P166, DOI 10.1016/j.gde.2007.04.005; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Grubb SC, 2009, NUCLEIC ACIDS RES, V37, pD720, DOI 10.1093/nar/gkn778; Guo H, 2010, FAM CANCER, V9, P599, DOI 10.1007/s10689-010-9370-5; Hansen T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000873; Hiard S, 2010, NUCLEIC ACIDS RES, V38, pD640, DOI 10.1093/nar/gkp926; Hoffman AE, 2009, CANCER RES, V69, P5970, DOI 10.1158/0008-5472.CAN-09-0236; Hu ZL, 2007, MAMM GENOME, V18, P1, DOI 10.1007/s00335-006-0105-8; Hu ZB, 2009, HUM MUTAT, V30, P79, DOI 10.1002/humu.20837; Huang WF, 2011, NUCLEIC ACIDS RES, V39, P475, DOI 10.1093/nar/gkq818; Institute S, 2002, SAS SYST WIND REL 9; Iwai N, 2005, BIOCHEM BIOPH RES CO, V331, P1439, DOI 10.1016/j.bbrc.2005.04.051; Jazdzewski K, 2009, P NATL ACAD SCI; Jiang QH, 2009, NUCLEIC ACIDS RES, V37, pD98, DOI 10.1093/nar/gkn714; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Kunej T, 2011, MUTAT RES-FUND MOL M, V717, P77, DOI 10.1016/j.mrfmmm.2011.03.008; Kunej T, 2010, INT J BIOL SCI, V6, P769; Landi D, 2008, DNA CELL BIOL, V27, P35, DOI 10.1089/dna.2007.0650; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lewis MA, 2009, NAT GENET, V41, P614, DOI 10.1038/ng.369; Li SC, 2007, DNA CELL BIOL, V26, P195, DOI 10.1089/dna.2006.0558; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Mencia A, 2009, NAT GENET, V41, P609, DOI 10.1038/ng.355; Mishra PJ, 2009, PHARMACOGENOMICS, V10, P399, DOI 10.2217/14622416.10.3.399; Mittal RD, 2011, DNA CELL BIOL; Muinos-Gimeno M, 2010, EUR J HUM GENET, V18, P218, DOI 10.1038/ejhg.2009.165; Nicoloso MS, 2010, CANCER RES, V70, P2789, DOI 10.1158/0008-5472.CAN-09-3541; Okubo M, 2011, J CLIN IMMUNOL, V31, P69, DOI 10.1007/s10875-010-9461-y; Okubo M, 2010, HELICOBACTER, V15, P524, DOI 10.1111/j.1523-5378.2010.00806.x; Papadopoulos GL, 2009, NUCLEIC ACIDS RES, V37, pD155, DOI 10.1093/nar/gkn809; Rosenfeld JA, 2010, NUCL ACIDS RES; Saito Y, 2009, BIOCHEM BIOPH RES CO, V379, P726, DOI 10.1016/j.bbrc.2008.12.098; Saunders MA, 2007, P NATL ACAD SCI USA, V104, P3300, DOI 10.1073/pnas.0611347104; Sevignani C, 2007, P NATL ACAD SCI USA, V104, P8017, DOI 10.1073/pnas.0702177104; Shen J, 2008, CARCINOGENESIS, V29, P1963, DOI 10.1093/carcin/bgn172; Sun GH, 2009, RNA, V15, P1640, DOI 10.1261/rna.1560209; Tong Y, 2011, HUM MUTAT; Twigger SN, 2007, NUCLEIC ACIDS RES, V35, pD658, DOI 10.1093/nar/gkl988; Xiao FF, 2009, NUCLEIC ACIDS RES, V37, pD105, DOI 10.1093/nar/gkn851; Xu B, 2010, PROSTATE, V70, P467, DOI 10.1002/pros.21080; Xu T, 2008, CARCINOGENESIS, V29, P2126, DOI 10.1093/carcin/bgn195; Zhang C, 2010, B AUST MATH SOC, V82, P459, DOI 10.1017/S0004972710000432; Zhou B, 2011, MOL CARCINOGENESIS, pn/a; Zhou B, 2010, CLIN CHIM ACTA, V411, P1287, DOI 10.1016/j.cca.2010.05.010; Ziebarth JD, 2011, NUCL ACIDS RES	59	52	56	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2012	7	1							e30737	10.1371/journal.pone.0030737	http://dx.doi.org/10.1371/journal.pone.0030737			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911GB	22303453	gold, Green Published, Green Submitted			2022-12-25	WOS:000301704200031
J	Emir, UE; Tuite, PJ; Oz, G				Emir, Uzay E.; Tuite, Paul J.; Oez, Guelin			Elevated Pontine and Putamenal GABA Levels in Mild-Moderate Parkinson Disease Detected by 7 Tesla Proton MRS	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; VIVO H-1-NMR SPECTROSCOPY; GAMMA-AMINOBUTYRIC-ACID; MPTP-INTOXICATED MOUSE; GAD65 GENE-EXPRESSION; IN-VIVO; HUMAN BRAIN; MITOCHONDRIAL DYSFUNCTION; SUBSTANTIA-NIGRA; LOCUS-COERULEUS	Background: Parkinson disease (PD) is characterized by the degeneration of nigrostriatal dopaminergic neurons. However, postmortem evidence indicates that the pathology of lower brainstem regions, such as the pons and medulla, precedes nigral involvement. Consistently, pontomedullary damage was implicated by structural and PET imaging in early PD. Neurochemical correlates of this early pathological involvement in PD are unknown. Methodology/Principal Finding: To map biochemical alterations in the brains of individuals with mild-moderate PD we quantified neurochemical profiles of the pons, putamen and substantia nigra by 7 tesla (T) proton magnetic resonance spectroscopy. Thirteen individuals with idiopathic PD (Hoehn & Yahr stage 2) and 12 age- and gender-matched healthy volunteers participated in the study. gamma-Aminobutyric acid (GABA) concentrations in the pons and putamen were significantly higher in patients (N=11, off medications) than controls (N=11, p<0.001 for pons and p<0.05 for putamen). The GABA elevation was more pronounced in the pons (64%) than in the putamen (32%). No other neurochemical differences were observed between patients and controls. Conclusion/Significance: The GABA elevation in the putamen is consistent with prior postmortem findings in patients with PD, as well as with in vivo observations in a rodent model of PD, while the GABA finding in the pons is novel. The more significant GABA elevation in the pons relative to the putamen is consistent with earlier pathological involvement of the lower brainstem. This study provides in vivo evidence for an alteration in the GABAergic tone in the lower brainstem and striatum in early-moderate PD, which may underlie disease pathogenesis and may provide a biomarker for disease staging.	[Emir, Uzay E.; Oez, Guelin] Univ Minnesota, Dept Radiol, Ctr Magnet Resonance Res, Minneapolis, MN 55455 USA; [Tuite, Paul J.] Univ Minnesota, Dept Neurol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Emir, UE (corresponding author), Univ Minnesota, Dept Radiol, Ctr Magnet Resonance Res, Minneapolis, MN 55455 USA.	emirx001@umn.edu	Oz, Gulin/L-1306-2016; Emir, Uzay/ABB-9979-2020; Tuite, Paul/P-3164-2014	Oz, Gulin/0000-0002-5769-183X; emir, uzay/0000-0001-5376-0431; Tuite, Paul/0000-0003-1413-7924	Dana Foundation; Minnesota Medical Foundation [3444]; National Center for Research Resources (NCRR) [P41RR008079, S10 RR026783]; Neuroscience Center Core Blueprint Award [P30 NS057091]; Keck Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR008079, S10RR026783] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS057091] Funding Source: NIH RePORTER	Dana Foundation; Minnesota Medical Foundation; National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Neuroscience Center Core Blueprint Award; Keck Foundation(W.M. Keck Foundation); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Dana Foundation and the Minnesota Medical Foundation Research Fund 3444. The Center for MR Research is supported by the National Center for Research Resources (NCRR) grants P41RR008079 and S10 RR026783, the Neuroscience Center Core Blueprint Award P30 NS057091 and Keck Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriany G, 2008, MAGN RESON MED, V59, P590, DOI 10.1002/mrm.21488; Baudrexel S, 2010, NEUROIMAGE, V51, P512, DOI 10.1016/j.neuroimage.2010.03.005; BEHAR KL, 1994, MAGNET RESON MED, V32, P294, DOI 10.1002/mrm.1910320304; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Braak H, 2006, J NEUROL SCI, V248, P255, DOI 10.1016/j.jns.2006.05.011; Bruck A, 2006, MOVEMENT DISORD, V21, P958, DOI 10.1002/mds.20855; Chassain C, 2008, J NEUROCHEM, V105, P874, DOI 10.1111/j.1471-4159.2007.05185.x; Chassain C, 2010, NMR BIOMED, V23, P547, DOI 10.1002/nbm.1504; Clark JB, 1998, DEV NEUROSCI-BASEL, V20, P271, DOI 10.1159/000017321; Doder M, 2003, NEUROLOGY, V60, P601, DOI 10.1212/01.WNL.0000031424.51127.2B; Dydak U, 2011, ENVIRON HEALTH PERSP, V119, P219, DOI 10.1289/ehp.1002192; Edden RAE, 2007, MAGN RESON MED, V58, P1276, DOI 10.1002/mrm.21383; Emir UE, 2012, NMR BIOMED, V25, P152, DOI 10.1002/nbm.1727; Gelman N, 2001, MAGNET RESON MED, V45, P71, DOI 10.1002/1522-2594(200101)45:1<71::AID-MRM1011>3.0.CO;2-2; Gervasoni D, 1998, EUR J NEUROSCI, V10, P964, DOI 10.1046/j.1460-9568.1998.00106.x; Gervasoni D, 2000, J NEUROSCI, V20, P4217; Govindaraju V, 2000, NMR BIOMED, V13, P129, DOI 10.1002/1099-1492(200005)13:3<129::AID-NBM619>3.0.CO;2-V; HALLIDAY GM, 1990, ANN NEUROL, V27, P373, DOI 10.1002/ana.410270405; Hattingen E, 2009, BRAIN, V132, P3285, DOI 10.1093/brain/awp293; Henchcliffe C, 2008, ANN NY ACAD SCI, V1147, P206, DOI 10.1196/annals.1427.037; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jubault T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008247; Kaiser LG, 2008, NMR BIOMED, V21, P22, DOI 10.1002/nbm.1150; Keren NI, 2009, NEUROIMAGE, V47, P1261, DOI 10.1016/j.neuroimage.2009.06.012; Kickler N, 2007, NMR BIOMED, V20, P757, DOI 10.1002/nbm.1141; KISH SJ, 1988, NEW ENGL J MED, V318, P876, DOI 10.1056/NEJM198804073181402; KISH SJ, 1986, ANN NEUROL, V20, P26, DOI 10.1002/ana.410200106; Lancaster JL, 2007, HUM BRAIN MAPP, V28, P1194, DOI 10.1002/hbm.20345; Laprade N, 1997, MOL BRAIN RES, V48, P333, DOI 10.1016/S0169-328X(97)00112-5; Martin WRW, 2008, NEUROLOGY, V70, P1411, DOI 10.1212/01.wnl.0000286384.31050.b5; Martin WRW, 2001, ADV NEUROL, V86, P197; Moore RY, 2008, NEUROBIOL DIS, V29, P381, DOI 10.1016/j.nbd.2007.09.004; Naidich TP, 2009, INTERNAL ARCHITECTUR, P53; Naidich TP, 2009, GROSS SECTIONAL ANAT, P561; Natt O, 2005, MAGN RESON MED, V53, P3, DOI 10.1002/mrm.20337; O'Neill J, 2002, MOVEMENT DISORD, V17, P917, DOI 10.1002/mds.10214; Obeso JA, 2010, NAT MED, V16, P653, DOI 10.1038/nm.2165; Oz G, 2006, MAGN RESON MED, V55, P296, DOI 10.1002/mrm.20761; Pavese N, 2011, NEUROIMAGE, V56, P1463, DOI 10.1016/j.neuroimage.2011.03.012; Pavese N, 2010, EXP NEUROL, V222, P120, DOI 10.1016/j.expneurol.2009.12.021; PERRY TL, 1983, J NEUROCHEM, V40, P1120, DOI 10.1111/j.1471-4159.1983.tb08102.x; Provencher SW, 2001, NMR BIOMED, V14, P260, DOI 10.1002/nbm.698; PROVENCHER SW, 1993, MAGNET RESON MED, V30, P672, DOI 10.1002/mrm.1910300604; Provencher SW, 2001, LCMODEL LCMGUI USERS; Randall LO, 1938, J BIOL CHEM, V124, P0481; Sasaki M, 2006, NEUROREPORT, V17, P1215, DOI 10.1097/01.wnr.0000227984.84927.a7; Soghomonian JJ, 1997, SYNAPSE, V27, P122, DOI 10.1002/(SICI)1098-2396(199710)27:2<122::AID-SYN3>3.0.CO;2-G; TANAKA Y, 1986, EXP NEUROL, V91, P259, DOI 10.1016/0014-4886(86)90066-X; Terpstra M, 2002, MAGNET RESON MED, V47, P1009, DOI 10.1002/mrm.10146; Tkac I, 1999, MAGNET RESON MED, V41, P649, DOI 10.1002/(SICI)1522-2594(199904)41:4<649::AID-MRM2>3.0.CO;2-G; Tkac I, 2001, MAGNET RESON MED, V46, P451, DOI 10.1002/mrm.1213; Tkac I., 2008, 16 ANN M ISMRM, V16th, P1624; Tkac I, 2009, MAGN RESON MED, V62, P868, DOI 10.1002/mrm.22086; van den Bogaard SJ, 2011, J NEUROL, DOI [10.1007/s00415-00011-06099-00415, DOI 10.1007/S00415-00011-06099-00415]; Watanabe H, 2004, J NEUROL NEUROSUR PS, V75, P103; Whone AL, 2003, ANN NEUROL, V53, P206, DOI 10.1002/ana.10427; Zarow C, 2003, ARCH NEUROL-CHICAGO, V60, P337, DOI 10.1001/archneur.60.3.337	57	124	132	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e30918	10.1371/journal.pone.0030918	http://dx.doi.org/10.1371/journal.pone.0030918			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910ME	22295119	Green Published, gold, Green Submitted			2022-12-25	WOS:000301640600064
J	Kim, SD; Lee, HY; Shim, JW; Kim, HJ; Baek, SH; Zabel, BA; Bae, YS				Kim, Sang Doo; Lee, Ha Young; Shim, Jae Woong; Kim, Hak Jung; Baek, Suk-Hwan; Zabel, Brian A.; Bae, Yoe-Sik			A WKYMVm-Containing Combination Elicits Potent Anti-Tumor Activity in Heterotopic Cancer Animal Model	PLOS ONE			English	Article							FORMYL PEPTIDE RECEPTOR; VAL-D-MET; CD8(+) T-CELLS; DENDRITIC CELLS; PHOSPHOINOSITIDE HYDROLYSIS; SUPEROXIDE GENERATION; GROWTH-INHIBITION; IMMUNOTHERAPY; EXPRESSION; CHEMOATTRACTANT	The development of efficient anti-cancer therapy has been a topic of intense interest for several decades. Combined administration of certain molecules and immune cells has been shown to be an effective form of anti-cancer therapy. Here, we examined the effects of administering an immune stimulating peptide (WKYMVm), 5-fluoro-uracil (5-FU), and mature dendritic cells (mDCs) against heterotopic cancer animal model. Administration of the triple combination strongly reduced tumor volume in CT-26-inoculated heterotopic cancer animal model. The induced anti-tumor activity was well correlated with FAS expression, caspase-3 activation, and cancer cell apoptosis. The triple combination treatment caused recruitment of CD8 T lymphocytes and natural killer (NK) cells into the tumor. The production of two cytokines, IFN-gamma and IL-12, were strongly stimulated by administration of the triple combination. Depletion of CD8 T lymphocytes or NK cells by administration of anti-CD8 or anti-asialoGM1 antibody inhibited the anti-tumor activity and cytokine production of the triple combination. The triple combination strongly inhibited metastasis of colon cancer cells in a heterotopic cancer animal model as well as in a metastatic cancer animal model, and enhanced the survival rate of the mice model. Adoptive transfer of CD8 T lymphocytes and NK cells further increased the survival rate. Taken together, we suggest that the use of triple combination therapy of WKYMVm, 5-FU, and mDCs may have implications in solid tumor and metastasis treatment.	[Kim, Sang Doo; Lee, Ha Young; Shim, Jae Woong; Kim, Hak Jung; Bae, Yoe-Sik] Sungkyunkwan Univ, Dept Biol Sci, Suwon, South Korea; [Kim, Sang Doo; Lee, Ha Young; Kim, Hak Jung; Bae, Yoe-Sik] Dong A Univ, Mitochondria Hub Regulat Ctr, Pusan, South Korea; [Baek, Suk-Hwan] Yeungnam Univ, Coll Med, Dept Biochem & Mol Biol, Taegu, South Korea; [Zabel, Brian A.] Vet Affairs Hosp, Palo Alto Inst Res & Educ, Palo Alto, CA USA	Sungkyunkwan University (SKKU); Dong A University; Yeungnam University	Kim, SD (corresponding author), Sungkyunkwan Univ, Dept Biol Sci, Suwon, South Korea.	yoesik@skku.edu			Ministry for Health, Welfare and Family affairs, Republic of Korea [0920220]; National Research Foundation of Korea; Korea government [2009 0093198]; National Institutes of Health [AI-079320]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079320] Funding Source: NIH RePORTER	Ministry for Health, Welfare and Family affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); National Research Foundation of Korea(National Research Foundation of Korea); Korea government(Korean Government); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a grant from the National Research & Development Program for Cancer Control, Ministry for Health, Welfare and Family affairs, Republic of Korea (0920220) (Y-SB); National Research Foundation of Korea grant funded by the Korea government (2009 0093198) (Y-SB); and National Institutes of Health grant AI-079320 (BZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre-Ghiso JA, 2007, NAT REV CANCER, V7, P834, DOI 10.1038/nrc2256; Alymani NA, 2010, EUR J CANCER, V46, P869, DOI 10.1016/j.ejca.2010.01.001; Bae YS, 1999, J LEUKOCYTE BIOL, V66, P915, DOI 10.1002/jlb.66.6.915; Bae YS, 2000, J IMMUNOL, V164, P4089, DOI 10.4049/jimmunol.164.8.4089; Baek SH, 1996, J BIOL CHEM, V271, P8170, DOI 10.1074/jbc.271.14.8170; Charoensit P, 2010, CANCER GENE THER, V17, P512, DOI 10.1038/cgt.2010.12; Christophe T, 2001, J BIOL CHEM, V276, P21585, DOI 10.1074/jbc.M007769200; Ciavarella S, 2010, BIODRUGS, V24, P77, DOI 10.2165/11530830-000000000-00000; GERMANN T, 1995, INT ARCH ALLERGY IMM, V108, P103, DOI 10.1159/000237126; He R, 2000, J IMMUNOL, V165, P4598, DOI 10.4049/jimmunol.165.8.4598; Helms MW, 2010, CANCER IMMUNOL IMMUN, V59, P1325, DOI 10.1007/s00262-010-0860-y; Henry CJ, 2008, J IMMUNOL, V181, P8576, DOI 10.4049/jimmunol.181.12.8576; Hinrichs CS, 2009, BLOOD, V114, P596, DOI 10.1182/blood-2009-02-203935; Kadhim SA, 1997, CANCER RES, V57, P4803; Kaye SB, 1998, BRIT J CANCER, V78, P1, DOI 10.1038/bjc.1998.747; Kim SD, 2009, J IMMUNOL, V183, P5511, DOI 10.4049/jimmunol.0802986; Le YY, 1999, J IMMUNOL, V163, P6777; Lee HY, 2006, BIOCHEM PHARMACOL, V72, P860, DOI 10.1016/j.bcp.2006.06.022; Lee SJ, 2000, J IMMUNOL, V164, P1277, DOI 10.4049/jimmunol.164.3.1277; Liu HC, 2008, CURR DRUG TARGETS, V9, P878, DOI 10.2174/138945008785909257; Mayo Skye C, 2009, Expert Rev Gastroenterol Hepatol, V3, P131, DOI 10.1586/egh.09.8; Melief CJM, 2008, IMMUNITY, V29, P372, DOI 10.1016/j.immuni.2008.08.004; Melief CJM, 2008, NAT REV CANCER, V8, P351, DOI 10.1038/nrc2373; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; Mescher MF, 2006, IMMUNOL REV, V211, P81, DOI 10.1111/j.0105-2896.2006.00382.x; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Seo JK, 1998, CLIN BIOCHEM, V31, P137, DOI 10.1016/S0009-9120(97)00172-0; Seo JK, 1997, J IMMUNOL, V158, P1895; Smyth MJ, 2002, NAT REV CANCER, V2, P850, DOI 10.1038/nrc928; Steinman RM, 2006, CURR TOP MICROBIOL, V311, P17; STEINMAN RM, 1991, ANNU REV IMMUNOL, V9, P271, DOI 10.1146/annurev.iy.09.040191.001415; Talmor M, 1998, EUR J IMMUNOL, V28, P811, DOI 10.1002/(SICI)1521-4141(199803)28:03<811::AID-IMMU811>3.3.CO;2-J; Xu XL, 1998, CANCER RES, V58, P2832; YAMAKI T, 1990, NAT IMMUN CELL GROW, V9, P1; Yang D, 2002, J LEUKOCYTE BIOL, V72, P598	35	10	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e30522	10.1371/journal.pone.0030522	http://dx.doi.org/10.1371/journal.pone.0030522			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910ME	22295090	Green Submitted, Green Published, gold			2022-12-25	WOS:000301640600035
J	Naville, D; Duchampt, A; Vigier, M; Oursel, D; Lessire, R; Poirier, H; Niot, I; Begeot, M; Besnard, P; Mithieux, G				Naville, Danielle; Duchampt, Adeline; Vigier, Michele; Oursel, Delphine; Lessire, Rene; Poirier, Helene; Niot, Isabelle; Begeot, Martine; Besnard, Philippe; Mithieux, Gilles			Link between Intestinal CD36 Ligand Binding and Satiety Induced by a High Protein Diet in Mice	PLOS ONE			English	Article							CHAIN FATTY-ACIDS; BODY-WEIGHT; FOOD-INTAKE; CHOLESTEROL UPTAKE; RECEPTOR; TRANSPORT; RAT; OLEOYLETHANOLAMIDE; ABSORPTION; GLUCONEOGENESIS	CD36 is a ubiquitous membrane glycoprotein that binds long-chain fatty acids. The presence of a functional CD36 is required for the induction of satiety by a lipid load and its role as a lipid receptor driving cellular signal has recently been demonstrated. Our project aimed to further explore the role of intestinal CD36 in the regulation of food intake. Duodenal infusions of vehicle or sulfo-N-succinimidyl-oleate (SSO) was performed prior to acute infusions of saline or Intralipid (IL) in mice. Infusion of minute quantities of IL induced a decrease in food intake (FI) compared to saline. Infusion of SSO had the same effect but no additive inhibitory effect was observed in presence of IL. No IL- or SSO-mediated satiety occurred in CD36-null mice. To determine whether the CD36-mediated hypophagic effect of lipids was maintained in animals fed a satietogen diet, mice were subjected to a High-Protein diet (HPD). Concomitantly with the satiety effect, a rise in intestinal CD36 gene expression was observed. No satiety effect occurred in CD36-null mice. HPD-fed WT mice showed a diminished FI compared to control mice, after saline duodenal infusion. But there was no further decrease after lipid infusion. The lipid-induced decrease in FI observed on control mice was accompanied by a rise in jejunal oleylethanolamide (OEA). Its level was higher in HPD-fed mice than in controls after saline infusion and was not changed by lipids. Overall, we demonstrate that lipid binding to intestinal CD36 is sufficient to produce a satiety effect. Moreover, it could participate in the satiety effect induced by HPD. Intestine can modulate FI by several mechanisms including an increase in OEA production and CD36 gene expression. Furthermore, intestine of mice adapted to HPD have a diminished capacity to modulate their food intake in response to dietary lipids.	[Naville, Danielle; Duchampt, Adeline; Vigier, Michele; Begeot, Martine; Mithieux, Gilles] INSERM, U855, F-69008 Lyon, France; [Naville, Danielle; Duchampt, Adeline; Vigier, Michele; Begeot, Martine; Mithieux, Gilles] Univ Lyon 1, F-69622 Villeurbanne, France; [Naville, Danielle; Duchampt, Adeline; Vigier, Michele; Begeot, Martine; Mithieux, Gilles] Univ Lyon, Lyon, France; [Oursel, Delphine; Lessire, Rene] Univ Bordeaux Segalen, CNRS, UMR 5200, Bordeaux, France; [Poirier, Helene; Niot, Isabelle; Besnard, Philippe] Univ Bourgogne, UMR Inserm U866, AgroSup Dijon, Dijon, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Institut Agro; AgroSup Dijon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne	Naville, D (corresponding author), CarMeN, INSERM U1060, Oullins, France.	danielle.naville@inserm.fr	Naville, Danielle/N-1200-2017	Naville, Danielle/0000-0003-2615-6161; Gilles, Mithieux/0000-0003-3579-8529	Agence Nationale pour la Recherche [ANR-07-PNRA-015]; "Taste, Nutrition, Health" cluster Vitagora	Agence Nationale pour la Recherche(French National Research Agency (ANR)); "Taste, Nutrition, Health" cluster Vitagora	This research project was supported by Agence Nationale pour la Recherche (ANR-07-PNRA-015, SensoFAT project) and by the "Taste, Nutrition, Health" cluster Vitagora. AD is the recipient of subsides from ANR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABUMRAD NA, 1993, J BIOL CHEM, V268, P17665; Andersen M, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-8; Bensaid A, 2003, PHYSIOL BEHAV, V78, P311, DOI 10.1016/S0031-9384(02)00977-0; Bonen A, 2000, J BIOL CHEM, V275, P14501, DOI 10.1074/jbc.275.19.14501; Chen M, 2001, AM J PHYSIOL-ENDOC M, V281, pE916, DOI 10.1152/ajpendo.2001.281.5.E916; COLLINS S, 1991, ANNU REV PHYSIOL, V53, P497, DOI 10.1146/annurev.physiol.53.1.497; Coort SLM, 2002, MOL CELL BIOCHEM, V239, P213, DOI 10.1023/A:1020539932353; de Fonseca FR, 2001, NATURE, V414, P209, DOI 10.1038/35102582; Drover VA, 2005, J CLIN INVEST, V115, P1290, DOI 10.1172/JCI200521514; ENDEMANN G, 1993, J BIOL CHEM, V268, P11811; Febbraio M, 1999, J BIOL CHEM, V274, P19055, DOI 10.1074/jbc.274.27.19055; Fu J, 2003, NATURE, V425, P90, DOI 10.1038/nature01921; Fu J, 2007, J BIOL CHEM, V282, P1518, DOI 10.1074/jbc.M607809200; Gaetani S, 2003, NEUROPSYCHOPHARMACOL, V28, P1311, DOI 10.1038/sj.npp.1300166; Gaillard D, 2008, FASEB J, V22, P1458, DOI 10.1096/fj.07-8415com; Goudriaan JR, 2002, MOL CELL BIOCHEM, V239, P199, DOI 10.1023/A:1020575412789; GREENBERG D, 1990, AM J PHYSIOL, V259, pR110, DOI 10.1152/ajpregu.1990.259.1.R110; Halton TL, 2004, J AM COLL NUTR, V23, P373, DOI 10.1080/07315724.2004.10719381; HARMON CM, 1991, J MEMBRANE BIOL, V121, P261, DOI 10.1007/BF01951559; HARMON CM, 1993, J MEMBRANE BIOL, V133, P43; Laugerette F, 2005, J CLIN INVEST, V115, P3177, DOI 10.1172/JCI25299; Lobo MVT, 2001, J HISTOCHEM CYTOCHEM, V49, P1253, DOI 10.1177/002215540104901007; Martin C, 2011, PHYSL BEHAV IN PRESS; Mithieux G, 2004, AM J PHYSIOL-ENDOC M, V286, pE370, DOI 10.1152/ajpendo.00299.2003; Mithieux G, 2005, CELL METAB, V2, P321, DOI 10.1016/j.cmet.2005.09.010; Nassir F, 2007, J BIOL CHEM, V282, P19493, DOI 10.1074/jbc.M703330200; Nauli AM, 2006, GASTROENTEROLOGY, V131, P1197, DOI 10.1053/j.gastro.2006.08.012; Nickenig G, 1996, MOL PHARMACOL, V50, P743; Petit V, 2007, J LIPID RES, V48, P278, DOI 10.1194/jlr.M600283-JLR200; Pillot B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019107; Pillot B, 2009, ENDOCRINOLOGY, V150, P616, DOI 10.1210/en.2008-0601; Poirier H, 1996, EUR J BIOCHEM, V238, P368, DOI 10.1111/j.1432-1033.1996.0368z.x; Rac ME, 2007, MOL MED, V13, P288, DOI 10.2119/2006-00088.Rac; ROLLS BJ, 1988, PHYSIOL BEHAV, V43, P145, DOI 10.1016/0031-9384(88)90230-2; Schwartz GJ, 2008, CELL METAB, V8, P281, DOI 10.1016/j.cmet.2008.08.005; SILVERSTEIN RL, 1989, J CLIN INVEST, V84, P546, DOI 10.1172/JCI114197; TANDON NN, 1989, J BIOL CHEM, V264, P7576; Testet E, 2005, BIOCHEM J, V387, P617, DOI 10.1042/BJ20041491; Thi TTT, 2011, J BIOL CHEM, V286, P25201, DOI 10.1074/jbc.M111.233551; WELCH IM, 1988, GUT, V29, P306, DOI 10.1136/gut.29.3.306; Westerterp-Plantenga MS, 2004, INT J OBESITY, V28, P57, DOI 10.1038/sj.ijo.0802461; WOLTMAN T, 1995, AM J PHYSIOL-REG I, V269, pR7, DOI 10.1152/ajpregu.1995.269.1.R7; Yang YK, 2007, AM J PHYSIOL-REG I, V292, pR235, DOI 10.1152/ajpregu.00270.2006	43	19	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e30686	10.1371/journal.pone.0030686	http://dx.doi.org/10.1371/journal.pone.0030686			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910ME	22295104	Green Published, gold, Green Submitted			2022-12-25	WOS:000301640600049
J	Rodley, CDM; Grand, RS; Gehlen, LR; Greyling, G; Jones, MB; O'Sullivan, JM				Rodley, Chris D. M.; Grand, Ralph S.; Gehlen, Lutz R.; Greyling, Gary; Jones, M. Beatrix; O'Sullivan, Justin M.			Mitochondrial-Nuclear DNA Interactions Contribute to the Regulation of Nuclear Transcript Levels as Part of the Inter-Organelle Communication System	PLOS ONE			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; GROUP-II INTRONS; GENE-TRANSFER; ENERGY-METABOLISM; INITIATION SITES; GENOME; RNA; MOBILITY; ESCAPE; ARABIDOPSIS	Nuclear and mitochondrial organelles must maintain a communication system. Loci on the mitochondrial genome were recently reported to interact with nuclear loci. To determine whether this is part of a DNA based communication system we used genome conformation capture to map the global network of DNA-DNA interactions between the mitochondrial and nuclear genomes (Mito-nDNA) in Saccharomyces cerevisiae cells grown under three different metabolic conditions. The interactions that form between mitochondrial and nuclear loci are dependent on the metabolic state of the yeast. Moreover, the frequency of specific mitochondrial - nuclear interactions (i.e. COX1-MSY1 and Q0182-RSM7) showed significant reductions in the absence of mitochondrial encoded reverse transcriptase machinery. Furthermore, these reductions correlated with increases in the transcript levels of the nuclear loci (MSY1 and RSM7). We propose that these interactions represent an inter-organelle DNA mediated communication system and that reverse transcription of mitochondrial RNA plays a role in this process.	[Rodley, Chris D. M.; Grand, Ralph S.; Gehlen, Lutz R.; Greyling, Gary; O'Sullivan, Justin M.] Massey Univ, Inst Nat Sci, Albany, New Zealand; [Jones, M. Beatrix] Massey Univ, Ctr Math Biol, Albany, New Zealand	Massey University; Massey University	Rodley, CDM (corresponding author), Massey Univ, Inst Nat Sci, Albany, New Zealand.	J.M.OSullivan@massey.ac.nz	O'Sullivan, Justin/HDO-1639-2022	O'Sullivan, Justin/0000-0003-2927-450X; Grand, Ralph S./0000-0001-9193-5239	Marsden Fund; Auckland Medical Research Foundation; Massey University; Maurice & Phyllis Paykel Trust; HRC [08/554]	Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ)); Auckland Medical Research Foundation; Massey University; Maurice & Phyllis Paykel Trust; HRC	This work was supported by the Marsden Fund; Auckland Medical Research Foundation; Massey University Research Fund; and Maurice & Phyllis Paykel Trust. HRC Ph.D. scholarship (08/554) to CR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KL, 1999, P NATL ACAD SCI USA, V96, P13863, DOI 10.1073/pnas.96.24.13863; Adams KL, 2002, P NATL ACAD SCI USA, V99, P9905, DOI 10.1073/pnas.042694899; Arnold I, 2006, GENE, V367, P74, DOI 10.1016/j.gene.2005.09.044; Baldwin GS, 2008, J PHYS CHEM B, V112, P1060, DOI 10.1021/jp7112297; Barth C, 1999, CURR GENET, V36, P55, DOI 10.1007/s002940050472; Bassi GS, 2002, P NATL ACAD SCI USA, V99, P128, DOI 10.1073/pnas.012579299; Blank HM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000047; BRENNICKE A, 1993, FEBS LETT, V325, P140, DOI 10.1016/0014-5793(93)81430-8; Butow RA, 2004, MOL CELL, V14, P1, DOI 10.1016/S1097-2765(04)00179-0; CAMPBELL CL, 1994, MOL BIOL CELL, V5, P899, DOI 10.1091/mbc.5.8.899; Campbell CL, 1998, J CELL SCI, V111, P2455; Cheng X, 2010, AGING CELL, V9, P919, DOI 10.1111/j.1474-9726.2010.00607.x; CHRISTIANSON T, 1983, J BIOL CHEM, V258, P4025; COSTANZO MC, 1988, GENETICS, V120, P667; Danilowicz C, 2009, P NATL ACAD SCI USA, V106, P19824, DOI 10.1073/pnas.0911214106; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Duan Z, 2010, NATURE, V465, P363, DOI 10.1038/nature08973; Eskes R, 1997, CELL, V88, P865, DOI 10.1016/S0092-8674(00)81932-7; FARRELLY F, 1983, NATURE, V301, P296, DOI 10.1038/301296a0; Fekkes P, 2000, J CELL BIOL, V151, P333, DOI 10.1083/jcb.151.2.333; Foury F, 1998, FEBS LETT, V440, P325, DOI 10.1016/S0014-5793(98)01467-7; Fujita N, 2004, METHODS, V33, P81, DOI 10.1016/j.ymeth.2003.10.022; GRIFFIN EA, 1995, CHEM BIOL, V2, P761, DOI 10.1016/1074-5521(95)90104-3; Hazkani-Covo E, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000834; Holec S, 2006, MOL CELL BIOL, V26, P2869, DOI 10.1128/MCB.26.7.2869-2876.2006; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Kaiser C., 1994, METHODS YEAST GENETI; Knoop V, 1996, GENETICS, V142, P579; KOCH JL, 1992, MOL CELL BIOL, V12, P1950, DOI 10.1128/MCB.12.5.1950; Kornmann B, 2009, SCIENCE, V325, P477, DOI 10.1126/science.1175088; LAGUNAS R, 1976, BIOCHIM BIOPHYS ACTA, V440, P661, DOI 10.1016/0005-2728(76)90049-9; LAGUNAS R, 1986, YEAST, V2, P221, DOI 10.1002/yea.320020403; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Liu ZC, 1999, MOL CELL BIOL, V19, P6720; Marienfeld J, 1999, TRENDS PLANT SCI, V4, P495, DOI 10.1016/S1360-1385(99)01502-2; MONTOYA J, 1982, P NATL ACAD SCI-BIOL, V79, P7195, DOI 10.1073/pnas.79.23.7195; MORAN JV, 1995, MOL CELL BIOL, V15, P2828; Naylor K, 2006, J BIOL CHEM, V281, P2177, DOI 10.1074/jbc.M507943200; Neutzner A, 2005, J BIOL CHEM, V280, P18598, DOI 10.1074/jbc.M500807200; O'Sullivan JM, 2009, YEAST, V26, P125, DOI 10.1002/yea.1657; O'Sullivan JM, 2004, NAT GENET, V36, P1014, DOI 10.1038/ng1411; Otterstedt K, 2004, EMBO REP, V5, P532, DOI 10.1038/sj.embor.7400132; PARIKH VS, 1989, MOL CELL BIOL, V9, P1897, DOI 10.1128/MCB.9.5.1897; PARIKH VS, 1987, SCIENCE, V235, P576, DOI 10.1126/science.3027892; Ricchetti M, 1999, NATURE, V402, P96, DOI 10.1038/47076; Richly E, 2004, MOL BIOL EVOL, V21, P1081, DOI 10.1093/molbev/msh110; Rodley CDM, 2009, FUNGAL GENET BIOL, V46, P879, DOI 10.1016/j.fgb.2009.07.006; SERAPHIN B, 1992, GENE, V113, P1, DOI 10.1016/0378-1119(92)90663-A; Shafer KS, 1999, CURR GENET, V36, P183, DOI 10.1007/s002940050489; Shirafuji N, 1997, BLOOD, V90, P4567, DOI 10.1182/blood.V90.11.4567.4567_4567_4577; Spilianakis CG, 2004, NAT IMMUNOL, V5, P1017, DOI 10.1038/ni1115; Spilianakis CG, 2005, NATURE, V435, P637, DOI 10.1038/nature03574; THORSNESS PE, 1993, GENETICS, V134, P21; THORSNESS PE, 1990, NATURE, V346, P376, DOI 10.1038/346376a0; Timmis JN, 2004, NAT REV GENET, V5, P123, DOI 10.1038/nrg1271; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Toor N, 2001, RNA, V7, P1142, DOI 10.1017/S1355838201010251; Turk EM, 2010, J BIOL CHEM, V285, P8585, DOI 10.1074/jbc.M109.090761; Yang J, 1996, NATURE, V381, P332, DOI 10.1038/381332a0; ZIMMERLY S, 1995, CELL, V83, P529, DOI 10.1016/0092-8674(95)90092-6; ZIMMERLY S, 1995, CELL, V82, P545, DOI 10.1016/0092-8674(95)90027-6	61	20	20	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30943	10.1371/journal.pone.0030943	http://dx.doi.org/10.1371/journal.pone.0030943			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22292080	gold, Green Published, Green Submitted			2022-12-25	WOS:000301570600098
J	Counotte, DS; Goriounova, NA; Moretti, M; Smoluch, MT; Irth, H; Clementi, F; Schoffelmeer, ANM; Mansvelder, HD; Smit, AB; Gotti, C; Spijker, S				Counotte, Danielle S.; Goriounova, Natalia A.; Moretti, Milena; Smoluch, Marek T.; Irth, Hubertus; Clementi, Francesco; Schoffelmeer, Anton N. M.; Mansvelder, Huibert D.; Smit, August B.; Gotti, Cecilia; Spijker, Sabine			Adolescent nicotine exposure transiently increases high-affinity nicotinic receptors and modulates inhibitory synaptic transmission in rat medial prefrontal cortex	FASEB JOURNAL			English	Article						neurophysiology; membrane expression; immunoprecipitation; epibatidine binding; IPSC amplitude; pyramidal neurons	CONDITIONED PLACE PREFERENCE; ACETYLCHOLINE-RECEPTORS; CHOLINERGIC SYSTEMS; CIGARETTE-SMOKING; UP-REGULATION; ADULT RATS; GLUTAMATE RELEASE; BINDING-SITES; BRAIN; SUBTYPES	Adolescence is a critical developmental period during which most adult smokers initiate their habit. Adolescents are more vulnerable than adults to nicotine's long-term effects on addictive and cognitive behavior. We investigated whether adolescent nicotine exposure in rats modifies expression of nicotinic acetylcholine receptors (nAChRs) in medial prefrontal cortex (mPFC) in the short and/or long term, and whether this has functional consequences. Using receptor binding studies followed by immunoprecipitation of nAChR subunits, we showed that adolescent nicotine exposure, as compared with saline, caused an increase in mPFC nAChRs containing alpha 4 or beta 2 subunits (24 and 18%, respectively) 24 h after the last injection. Nicotine exposure in adulthood had no such effect. This increase was transient and was not observed 5 wk following either adolescent or adult nicotine exposure. In line with increased nAChRs expression 1 d after adolescent nicotine exposure, we observed a 34% increase in amplitude of nicotine-induced spontaneous inhibitory postsynaptic currents in layer II/III mPFC pyramidal neurons. These effects were transient and specific, and observed only acutely after adolescent nicotine exposure, but not after 5 wk, and no changes were observed in adult-exposed animals. The acute nicotine-induced increase in alpha 4 beta 2-containing receptors in adolescents interferes with the normal developmental decrease (37%) of these receptors from early adolescence (postnatal day 34) to adulthood (postnatal day 104) in the mPFC. Together, this suggests that these receptors play a role in mediating the acute rewarding effects of nicotine and may underlie the increased sensitivity of adolescents to nicotine.-Counotte, D. S., Goriounova, N. A., Moretti, M., Smoluch, M. T., Irth, H., Clementi, F., Schoffelmeer, A. N. M., Mansvelder, H. D., Smit, A. B., Gotti, C., Spijker, S. Adolescent nicotine exposure transiently increases high-affinity nicotinic receptors and modulates inhibitory synaptic transmission in rat medial prefrontal cortex. FASEB J. 26, 1810-1820 (2012). www.fasebj.org	[Counotte, Danielle S.; Smit, August B.; Spijker, Sabine] Vrije Univ Amsterdam, Med Ctr, Dept Mol & Cellular Neurobiol, Amsterdam, Netherlands; [Goriounova, Natalia A.; Mansvelder, Huibert D.] Vrije Univ Amsterdam, Med Ctr, Ctr Neurogen & Cognit Res, Dept Integrat Neurophysiol, Amsterdam, Netherlands; [Schoffelmeer, Anton N. M.] Vrije Univ Amsterdam, Med Ctr, Dept Anat & Neurosci, Amsterdam, Netherlands; [Smoluch, Marek T.; Irth, Hubertus] Vrije Univ Amsterdam, Dept Analyt Chem & Appl Spect, Amsterdam, Netherlands; [Moretti, Milena; Clementi, Francesco; Gotti, Cecilia] Univ Milan, Inst Neurosci, Dept Med Pharmacol, CNR, Milan, Italy	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Consiglio Nazionale delle Ricerche (CNR); University of Milan	Spijker, S (corresponding author), De Boelelaan 1085, NL-1081 HV Amsterdam, Netherlands.	s.spijker@vu.nl	Smoluch, Marek/AAN-8306-2021; Spijker, Sabine/F-2300-2011; Mansvelder, Huibert/N-6138-2018; Goriounova, Natalia/ABE-6759-2020; Smoluch, Marek/AGA-6079-2022	Smoluch, Marek/0000-0002-9481-988X; Mansvelder, Huibert/0000-0003-1365-5340; Spijker, Sabine/0000-0002-6814-2019; Goriounova, Natalia/0000-0002-5917-983X	Netherlands Organisation for Scientific Research (NWO-ZonMW) TOP [91206148]; European Union [HEALTH-F2-2008-202088]; Italian PRIN [2009R7WCZS]	Netherlands Organisation for Scientific Research (NWO-ZonMW) TOP; European Union(European Commission); Italian PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN))	The authors thank Martin Giera for his expertise with the extraction method to measure plasma nicotine levels. The authors also thank Rob Binnekade, Mathijs Stegeman, Dustin Schetters, and Yvar van Mourik for their excellent technical assistance in the behavioral paradigm. Funding was received from the Netherlands Organisation for Scientific Research (NWO-ZonMW) TOP project 91206148 (D. S. C., N.A.G., S. S., H. D. M., and A. B. S.), the European Union Seventh Framework Programme under grant agreement HEALTH-F2-2008-202088 (NeuroCypres project; A. B. S. and C. G.), and from the Italian PRIN 2009R7WCZS (C. G.). The authors report no conflicts of interest.	Abreu-Villaca Y, 2003, NEUROPSYCHOPHARMACOL, V28, P1935, DOI 10.1038/sj.npp.1300221; Adriani W, 2003, J NEUROSCI, V23, P4712; Barron Susan, 2005, Alcohol Clin Exp Res, V29, P1720, DOI 10.1097/01.alc.0000179220.79356.e5; Belluzzi JD, 2004, PSYCHOPHARMACOLOGY, V174, P389, DOI 10.1007/s00213-003-1758-6; BENWELL MEM, 1988, J NEUROCHEM, V50, P1243, DOI 10.1111/j.1471-4159.1988.tb10600.x; Brielmaier JM, 2007, NEUROTOXICOL TERATOL, V29, P74, DOI 10.1016/j.ntt.2006.09.023; Britton AF, 2007, J PHARMACOL EXP THER, V320, P871, DOI 10.1124/jpet.106.112730; Casey BJ, 2005, TRENDS COGN SCI, V9, P104, DOI 10.1016/j.tics.2005.01.011; Chassin L, 1996, HEALTH PSYCHOL, V15, P478, DOI 10.1037/0278-6133.15.6.478; Couey JJ, 2007, NEURON, V54, P73, DOI 10.1016/j.neuron.2007.03.006; Counotte DS, 2011, DEV COGN NEUROS-NETH, V1, P430, DOI 10.1016/j.dcn.2011.05.010; Counotte DS, 2011, NAT NEUROSCI, V14, P417, DOI 10.1038/nn.2770; Counotte DS, 2010, EUR J NEUROSCI, V32, P1452, DOI 10.1111/j.1460-9568.2010.07404.x; Counotte DS, 2009, NEUROPSYCHOPHARMACOL, V34, P299, DOI 10.1038/npp.2008.96; Doura MB, 2008, BRAIN RES, V1215, P40, DOI 10.1016/j.brainres.2008.03.056; Everitt BJ, 1997, ANNU REV PSYCHOL, V48, P649, DOI 10.1146/annurev.psych.48.1.649; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Gotti C, 2007, BIOCHEM PHARMACOL, V74, P1102, DOI 10.1016/j.bcp.2007.05.023; Gotti C, 2006, TRENDS PHARMACOL SCI, V27, P482, DOI 10.1016/j.tips.2006.07.004; Govind AP, 2009, BIOCHEM PHARMACOL, V78, P756, DOI 10.1016/j.bcp.2009.06.011; Grady SR, 2009, J NEUROSCI, V29, P2272, DOI 10.1523/JNEUROSCI.5121-08.2009; HILL P, 1983, J CHRON DIS, V36, P439, DOI 10.1016/0021-9681(83)90136-4; Iniguez SD, 2009, NEUROPSYCHOPHARMACOL, V34, P1609, DOI 10.1038/npp.2008.220; ISAAC PF, 1972, NATURE, V236, P308, DOI 10.1038/236308a0; Ji D, 2001, NEURON, V31, P131, DOI 10.1016/S0896-6273(01)00332-4; Ke L, 1998, J PHARMACOL EXP THER, V286, P825; Konradsson-Geuken A, 2009, SYNAPSE, V63, P1069, DOI 10.1002/syn.20693; Kota D, 2009, BIOCHEM PHARMACOL, V78, P873, DOI 10.1016/j.bcp.2009.06.099; Kuryatov A, 2008, MOL PHARMACOL, V74, P132, DOI 10.1124/mol.108.046789; Lambe EK, 2003, NEUROPSYCHOPHARMACOL, V28, P216, DOI 10.1038/sj.npp.1300032; Livingstone PD, 2009, EUR J NEUROSCI, V29, P539, DOI 10.1111/j.1460-9568.2009.06613.x; Marks MJ, 2006, MOL PHARMACOL, V70, P947, DOI 10.1124/mol.106.025338; MARKS MJ, 1983, J PHARMACOL EXP THER, V226, P817; MARKS MJ, 1992, J NEUROSCI, V12, P2765; Moretti M, 2010, MOL PHARMACOL, V78, P287, DOI 10.1124/mol.110.064071; Novick L F, 2000, J Public Health Manag Pract, V6, pvi; O'Dell LE, 2009, NEUROPHARMACOLOGY, V56, P263, DOI 10.1016/j.neuropharm.2008.07.039; O'Dell LE, 2006, PSYCHOPHARMACOLOGY, V186, P612, DOI 10.1007/s00213-006-0383-6; PAULY JR, 1991, J PHARMACOL EXP THER, V258, P1127; Rogers SW, 1998, J NEUROSCI, V18, P4825; RUSSELL MAH, 1980, BMJ-BRIT MED J, V280, P972, DOI 10.1136/bmj.280.6219.972; Schramm-Sapyta NL, 2009, PSYCHOPHARMACOLOGY, V206, P1, DOI 10.1007/s00213-009-1585-5; SCHWARTZ RD, 1983, SCIENCE, V220, P214, DOI 10.1126/science.6828889; Shram MJ, 2006, PSYCHOPHARMACOLOGY, V186, P201, DOI 10.1007/s00213-006-0373-8; Slotkin TA, 2004, TOXICOL APPL PHARM, V198, P132, DOI 10.1016/j.taap.2003.06.001; Slotkin TA, 2008, BRAIN RES BULL, V76, P152, DOI 10.1016/j.brainresbull.2007.12.009; Torres OV, 2008, PHARMACOL BIOCHEM BE, V90, P658, DOI 10.1016/j.pbb.2008.05.009; Trauth JA, 1999, BRAIN RES, V851, P9, DOI 10.1016/S0006-8993(99)01994-0; Tumkosit P, 2006, MOL PHARMACOL, V70, P1358, DOI 10.1124/mol.106.027326; Van den Oever MC, 2008, NAT NEUROSCI, V11, P1053, DOI 10.1038/nn.2165; Vastola BJ, 2002, PHYSIOL BEHAV, V77, P107, DOI 10.1016/S0031-9384(02)00818-1; WONNACOTT S, 1990, TRENDS PHARMACOL SCI, V11, P216, DOI 10.1016/0165-6147(90)90242-Z	52	34	34	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	MAY	2012	26	5					1810	1820		10.1096/fj.11-198994	http://dx.doi.org/10.1096/fj.11-198994			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	937TD	22308197	Green Accepted			2022-12-25	WOS:000303680800009
J	Fan, SQ; Huang, W; Wang, LX				Fan, Shu-Quan; Huang, Wei; Wang, Lai-Xi			Remarkable Transglycosylation Activity of Glycosynthase Mutants of Endo-D, an Endo-beta-N-acetylglucosaminidase from Streptococcus pneumoniae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASPARAGINE-LINKED OLIGOSACCHARIDES; CHEMOENZYMATIC SYNTHESIS; MOLECULAR-CLONING; FLAVOBACTERIUM-MENINGOSEPTICUM; SUBSTRATE-SPECIFICITY; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; PRIMARY SEQUENCE; STRUCTURAL BASIS; GLYCOPROTEINS	Endo-beta-N-acetylglucosaminidase from Streptococcus pneumoniae (Endo-D) is an endoglycosidase capable of hydrolyzing the Fc N-glycan of intact IgG antibodies after sequential removal of the sialicacid, galactose, and internal GlcNAc residues in the N-glycan. Endo-D also possesses transglycosylation activity with sugar oxazoline as the donor substrate, but the transglycosylation yield is low due to enzymatic hydrolysis of the donor substrate and the product. We report here our study on the hydrolytic and transglycosylation activity of recombinant Endo-D and its selected mutants. We found that Endo-D preferred core-fucosylated N-glycan for hydrolysis but favored nonfucosylated GlcNAc acceptor for transglycosylation. Several mutants showed significantly enhanced transglycosylation efficiency over the wild type enzyme. Two mutants (N322Q and N322A) were identified as typical glycosynthases that demonstrated remarkable transglycosylation activity with only marginal or no product hydrolysis activity. Kinetic studies revealed that the N332Q and N322A glycosynthases had much higher catalytic efficiency for glycosylating the nonfucosylated GlcNAc acceptor. In comparison, the N322Q was much more efficient than N322A for transglycosylation. However, N332Q and N332A could not take more complex N-glycan oxazoline as substrate for transglycosylation, indicating their strict substrate specificity. The usefulness of the N332Q glycosynthase was exemplified by its application for efficient glycosylation remodeling of IgG-Fc domain.	[Fan, Shu-Quan; Huang, Wei; Wang, Lai-Xi] Univ Maryland, Sch Med, Inst Human Virol, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Wang, LX (corresponding author), Univ Maryland, Sch Med, Inst Human Virol, Dept Biochem & Mol Biol, 725 W Lombard St, Baltimore, MD 21201 USA.	lwang@som.umaryland.edu	wang, xl/Y-8251-2019; Wang, Lai-Xi/E-8755-2019; Wang, Lai-Xi/E-8790-2019; Wang, Xin/AAN-8435-2021; Huang, Wei/P-9631-2017	Wang, Lai-Xi/0000-0003-4293-5819; Wang, Xin/0000-0002-4457-7376; Huang, Wei/0000-0001-6432-1848	National Institutes of Health [GM080374, GM080374-S1]; China Scholarship Council [2010622098]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080374] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China Scholarship Council(China Scholarship Council); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM080374 and GM080374-S1 (to L. X. W.).; Supported in part by a fellowship from the China Scholarship Council (2010622098).	Abbott DW, 2009, J BIOL CHEM, V284, P11676, DOI 10.1074/jbc.M809663200; Amin MN, 2011, J AM CHEM SOC, V133, P14404, DOI 10.1021/ja204831z; Collin M, 2001, EMBO J, V20, P3046, DOI 10.1093/emboj/20.12.3046; Collin M, 2001, INFECT IMMUN, V69, P7187, DOI 10.1128/IAI.69.11.7187-7189.2001; Fujita K, 2001, BIOCHEM BIOPH RES CO, V283, P680, DOI 10.1006/bbrc.2001.4836; Fujita M, 2001, BBA-GEN SUBJECTS, V1528, P9, DOI 10.1016/S0304-4165(01)00164-7; Huang W, 2011, CHEMBIOCHEM, V12, P932, DOI 10.1002/cbic.201000763; Huang W, 2009, J AM CHEM SOC, V131, P2214, DOI 10.1021/ja8074677; Jefferis R, 2009, NAT REV DRUG DISCOV, V8, P226, DOI 10.1038/nrd2804; KADOWAKI S, 1991, J BIOCHEM-TOKYO, V110, P17, DOI 10.1093/oxfordjournals.jbchem.a123536; Kato T, 2002, GLYCOBIOLOGY, V12, P581, DOI 10.1093/glycob/cwf073; Li B, 2005, J AM CHEM SOC, V127, P9692, DOI 10.1021/ja051715a; Li B, 2006, ORG LETT, V8, P3081, DOI 10.1021/ol061056m; Ling ZL, 2009, J MOL BIOL, V389, P1, DOI 10.1016/j.jmb.2009.03.050; Muramatsu H, 2001, J BIOCHEM, V129, P923, DOI 10.1093/oxfordjournals.jbchem.a002938; Nimmerjahn F, 2008, ANNU REV IMMUNOL, V26, P513, DOI 10.1146/annurev.immunol.26.021607.090232; Ochiai H, 2008, J AM CHEM SOC, V130, P13790, DOI 10.1021/ja805044x; Parsons TB, 2010, ORG BIOMOL CHEM, V8, P1861, DOI 10.1039/b926078a; Raju TS, 2006, BIOCHEM BIOPH RES CO, V341, P797, DOI 10.1016/j.bbrc.2006.01.030; Rao V, 1999, PROTEIN SCI, V8, P2338; Rising TWDF, 2006, CHEMBIOCHEM, V7, P1177, DOI 10.1002/cbic.200600183; ROBBINS PW, 1984, J BIOL CHEM, V259, P7577; Schwarz F, 2010, NAT CHEM BIOL, V6, P264, DOI [10.1038/NCHEMBIO.314, 10.1038/nchembio.314]; Takegawa K, 1997, ARCH BIOCHEM BIOPHYS, V338, P22, DOI 10.1006/abbi.1996.9803; TARENTINO AL, 1992, J BIOL CHEM, V267, P3868; TARENTINO AL, 1993, J BIOL CHEM, V268, P9702; Umekawa M, 2008, J BIOL CHEM, V283, P4469, DOI 10.1074/jbc.M707137200; Umekawa M, 2010, BBA-GEN SUBJECTS, V1800, P1203, DOI 10.1016/j.bbagen.2010.07.003; Umekawa M, 2010, J BIOL CHEM, V285, P511, DOI 10.1074/jbc.M109.059832; VANROEY P, 1994, BIOCHEMISTRY-US, V33, P13989, DOI 10.1021/bi00251a005; Waddling CA, 2000, BIOCHEMISTRY-US, V39, P7878, DOI 10.1021/bi0001731; Wang LX, 2008, CARBOHYD RES, V343, P1509, DOI 10.1016/j.carres.2008.03.025; Wang LX, 2011, TRENDS GLYCOSCI GLYC, V23, P33, DOI 10.4052/tigg.23.33; Wei YD, 2008, BIOCHEMISTRY-US, V47, P10294, DOI 10.1021/bi800874y; YAMAMOTO K, 1994, BIOSCI BIOTECH BIOCH, V58, P72, DOI 10.1271/bbb.58.72; Yamamoto S, 2005, GLYCOCONJUGATE J, V22, P35, DOI 10.1007/s10719-005-0847-7; Yin J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004658; Zou GZ, 2011, J AM CHEM SOC, V133, P18975, DOI 10.1021/ja208390n	38	63	93	0	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					11272	11281		10.1074/jbc.M112.340497	http://dx.doi.org/10.1074/jbc.M112.340497			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22318728	hybrid, Green Published			2022-12-25	WOS:000302780100055
J	Lee, KS; Kalantzis, A; Jackson, CB; O'Connor, L; Murata-Kamiya, N; Hatakeyama, M; Judd, LM; Giraud, AS; Menheniott, TR				Lee, Kai Syin; Kalantzis, Anastasia; Jackson, Cameron B.; O'Connor, Louise; Murata-Kamiya, Naoko; Hatakeyama, Masanori; Judd, Louise M.; Giraud, Andrew S.; Menheniott, Trevelyan R.			Helicobacter pylori CagA Triggers Expression of the Bactericidal Lectin REG3 gamma via Gastric STAT3 Activation	PLOS ONE			English	Article							VIRULENCE FACTOR CAGA; EPITHELIAL-CELLS; TUMOR-DEVELOPMENT; IN-VITRO; CORECEPTOR GP130; MUTANT MICE; INTERLEUKIN-8; INFECTION; PROTEIN; SIGNAL	Background: Most of what is known about the Helicobacter pylori (H. pylori) cytotoxin, CagA, pertains to a much-vaunted role as a determinant of gastric inflammation and cancer. Little attention has been devoted to potential roles of CagA in the majority of H. pylori infected individuals not showing oncogenic progression, particularly in relation to host tolerance. Regenerating islet-derived (REG)3 gamma encodes a secreted C-type lectin that exerts direct bactericidal activity against Gram-positive bacteria in the intestine. Here, we extend this paradigm of lectin-mediated innate immunity, showing that REG3 gamma expression is triggered by CagA in the H. pylori-infected stomach. Methodology/Principal Findings: In human gastric mucosal tissues, REG3 gamma expression was significantly increased in CagA-positive, compared to CagA-negative H. pylori infected individuals. Using transfected CagA-inducible gastric MKN28 cells, we recapitulated REG3 gamma induction in vitro, also showing that tyrosine phosphorylated, not unphosphorylated CagA triggers REG3 gamma transcription. In concert with induced REG3 gamma, pro-inflammatory signalling downstream of the gp130 cytokine co-receptor via the signal transducer and activator of transcription (STAT)3 and transcription of two cognate ligands, interleukin(IL)-11 and IL-6, were significantly increased. Exogenous IL-11, but not IL-6, directly stimulated STAT3 activation and REG3 gamma transcription. STAT3 siRNA knockdown or IL-11 receptor blockade respectively abrogated or subdued CagA-dependent REG3 gamma mRNA induction, thus demonstrating a requirement for uncompromised signalling via the IL-11/STAT3 pathway. Inhibition of the gp130-related SHP2-(Ras)-ERK pathway did not affect CagA-dependent REG3 gamma induction, but strengthened STAT3 activation as well as augmenting transcription of mucosal innate immune regulators, IL-6, IL-8 and interferon-response factor (IRF)1. Conclusions/Significance: Our results support a model of CagA-directed REG3 gamma expression in gastric epithelial cells via activation of the IL-11/gp130/STAT3 pathway. This response might allow Gram-negative H. pylori to manipulate host immunity to favour its own survival, by reducing the fitness of co-habiting Gram-positive bacteria with which it competes for resources in the gastric mucosal niche.	[Lee, Kai Syin; Kalantzis, Anastasia; Jackson, Cameron B.; O'Connor, Louise; Judd, Louise M.; Giraud, Andrew S.; Menheniott, Trevelyan R.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Judd, Louise M.; Giraud, Andrew S.] Univ Melbourne, Dept Paediat, Royal Childrens Hosp, Parkville, Vic 3052, Australia; [Murata-Kamiya, Naoko; Hatakeyama, Masanori] Univ Tokyo, Dept Microbiol, Grad Sch Med, Tokyo, Japan	Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; Royal Children's Hospital Melbourne; University of Melbourne; University of Tokyo	Lee, KS (corresponding author), Royal Childrens Hosp, Murdoch Childrens Res Inst, Flemington Rd, Parkville, Vic 3052, Australia.	treve.menheniott@mcri.edu.au	Menheniott, Treve/D-7964-2015	Menheniott, Treve/0000-0003-2349-8238; Judd, Louise/0000-0003-3613-4839	Victorian Government; Australian National Health and Medical Research Council; Grants-in-Aid for Scientific Research [22240085, 22114002, 22114001] Funding Source: KAKEN	Victorian Government; Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Victorian Government's Operational Infrastructure Support Program and by a project grant awarded by the Australian National Health and Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2000, ONCOGENE, V19, P2607, DOI 10.1038/sj.onc.1203478; AKIRA S, 1990, FASEB J, V4, P2860, DOI 10.1096/fasebj.4.11.2199284; ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Arnold IC, 2011, GASTROENTEROLOGY, V140, P199, DOI 10.1053/j.gastro.2010.06.047; Atherton JC, 2009, J CLIN INVEST, V119, P2475, DOI 10.1172/JCI38605; Backert S, 2008, CELL MICROBIOL, V10, P1573, DOI 10.1111/j.1462-5822.2008.01156.x; Blaser MJ, 2008, GUT, V57, P561, DOI 10.1136/gut.2007.133462; Blaser MJ, 2005, SCI AM, V292, P38, DOI 10.1038/scientificamerican0205-38; Blaser MJ, 1999, P NATL ACAD SCI USA, V96, P8359, DOI 10.1073/pnas.96.15.8359; Brandl K, 2007, J EXP MED, V204, P1891, DOI 10.1084/jem.20070563; Bronte-Tinkew DM, 2009, CANCER RES, V69, P632, DOI 10.1158/0008-5472.CAN-08-1191; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; Chen Y, 2008, J INFECT DIS, V198, P553, DOI 10.1086/590158; Churin Y, 2003, J CELL BIOL, V161, P249, DOI 10.1083/jcb.200208039; Correa P, 2008, DIGEST LIVER DIS, V40, P490, DOI 10.1016/j.dld.2008.02.035; CRABTREE JE, 1995, J CLIN PATHOL, V48, P967, DOI 10.1136/jcp.48.10.967; CRABTREE JE, 1995, J CLIN PATHOL, V48, P41, DOI 10.1136/jcp.48.1.41; CRABTREE JE, 1994, J CLIN PATHOL, V47, P945, DOI 10.1136/jcp.47.10.945; CRABTREE JE, 1991, GUT, V32, P1473, DOI 10.1136/gut.32.12.1473; Ernst M, 2008, J CLIN INVEST, V118, P1727, DOI 10.1172/JCI34944; Gharavi NM, 2007, J BIOL CHEM, V282, P31460, DOI 10.1074/jbc.M704267200; Hatakeyama M, 2008, ONCOGENE, V27, P7047, DOI 10.1038/onc.2008.353; Higashi H, 2005, J BIOL CHEM, V280, P23130, DOI 10.1074/jbc.M503583200; Higashi H, 2004, J BIOL CHEM, V279, P17205, DOI 10.1074/jbc.M309964200; Higashi H, 2002, P NATL ACAD SCI USA, V99, P14428, DOI 10.1073/pnas.222375399; Higashi H, 2002, SCIENCE, V295, P683, DOI 10.1126/science.1067147; Howlett M, 2005, GASTROENTEROLOGY, V129, P1005, DOI 10.1053/j.gastro.2005.06.068; Howlett M, 2009, BBA-MOL CELL RES, V1793, P1623, DOI 10.1016/j.bbamcr.2009.07.009; Howlett M, 2009, GASTROENTEROLOGY, V136, P967, DOI 10.1053/j.gastro.2008.12.003; Jackson CB, 2007, J PATHOL, V213, P140, DOI 10.1002/path.2218; Judd LM, 2004, GASTROENTEROLOGY, V126, P196, DOI 10.1053/j.gastro.2003.10.066; Judd LM, 2006, GASTROENTEROLOGY, V131, P1073, DOI 10.1053/j.gastro.2006.07.018; KUIPERS EJ, 1995, J NATL CANCER I, V87, P1777, DOI 10.1093/jnci/87.23.1777; Lee IO, 2010, J BIOL CHEM, V285, P16042, DOI 10.1074/jbc.M110.111054; Lehotzky RE, 2010, P NATL ACAD SCI USA, V107, P7722, DOI 10.1073/pnas.0909449107; Maldonado-Contreras A, 2011, ISME J, V5, P574, DOI 10.1038/ismej.2010.149; Menheniott TR, 2010, GASTROENTEROLOGY, V138, P1823, DOI 10.1053/j.gastro.2010.01.050; Mimuro H, 2002, MOL CELL, V10, P745, DOI 10.1016/S1097-2765(02)00681-0; MOORE AE, 1955, CANCER RES, V15, P598; Mukherjee S, 2009, J BIOL CHEM, V284, P4881, DOI 10.1074/jbc.M808077200; Murata-Kamiya N, 2007, ONCOGENE, V26, P4617, DOI 10.1038/sj.onc.1210251; Nijevitch AA, 2004, J CLIN GASTROENTEROL, V38, P14, DOI 10.1097/00004836-200401000-00005; Ohnishi N, 2008, P NATL ACAD SCI USA, V105, P1003, DOI 10.1073/pnas.0711183105; Peterson AJ, 2010, GASTROENTEROLOGY, V139, P2005, DOI 10.1053/j.gastro.2010.08.043; Poppe M, 2007, ONCOGENE, V26, P3462, DOI 10.1038/sj.onc.1210139; Reibman J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004060; Saito Y, 2010, J EXP MED, V207, P2157, DOI 10.1084/jem.20100602; Sonnenburg JL, 2006, PLOS BIOL, V4, P2213, DOI 10.1371/journal.pbio.0040413; Suzuki M, 2005, J EXP MED, V202, P1235, DOI 10.1084/jem.20051027; Tebbutt NC, 2002, NAT MED, V8, P1089, DOI 10.1038/nm763; Tsutsumi R, 2003, J BIOL CHEM, V278, P3664, DOI 10.1074/jbc.M208155200; Yamaoka Y, 2004, GASTROENTEROLOGY, V126, P1030, DOI 10.1053/j.gastro.2003.12.048; Yeh M, 2004, J BIOL CHEM, V279, P30175, DOI 10.1074/jbc.M312198200; Yoshimura A, 2006, CANCER SCI, V97, P439, DOI 10.1111/j.1349-7006.2006.00197.x; Zhu YL, 2005, ONCOGENE, V24, P3886, DOI 10.1038/sj.onc.1208551	55	47	47	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2012	7	2							e30786	10.1371/journal.pone.0030786	http://dx.doi.org/10.1371/journal.pone.0030786			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UG	22312430	Green Published, gold			2022-12-25	WOS:000301977500017
J	Hisamatsu, T; Okamoto, S; Hashimoto, M; Muramatsu, T; Andou, A; Uo, M; Kitazume, MT; Matsuoka, K; Yajima, T; Inoue, N; Kanai, T; Ogata, H; Iwao, Y; Yamakado, M; Sakai, R; Ono, N; Ando, T; Suzuki, M; Hibi, T				Hisamatsu, Tadakazu; Okamoto, Susumu; Hashimoto, Masaki; Muramatsu, Takahiko; Andou, Ayatoshi; Uo, Michihide; Kitazume, Mina T.; Matsuoka, Katsuyoshi; Yajima, Tomoharu; Inoue, Nagamu; Kanai, Takanori; Ogata, Haruhiko; Iwao, Yasushi; Yamakado, Minoru; Sakai, Ryosei; Ono, Nobukazu; Ando, Toshihiko; Suzuki, Manabu; Hibi, Toshifumi			Novel, Objective, Multivariate Biomarkers Composed of Plasma Amino Acid Profiles for the Diagnosis and Assessment of Inflammatory Bowel Disease	PLOS ONE			English	Article							HEPATIC ENCEPHALOPATHY; TRYPTOPHAN CATABOLISM; RHEUMATOID-ARTHRITIS; CROHNS-DISEASE; HISTIDINE; ANTIBODIES; IMBALANCE; COLITIS; MARKERS; INDEX	Background: Inflammatory bowel disease (IBD) is a chronic intestinal disorder that is associated with a limited number of clinical biomarkers. In order to facilitate the diagnosis of IBD and assess its disease activity, we investigated the potential of novel multivariate indexes using statistical modeling of plasma amino acid concentrations (aminogram). Methodology and Principal Findings: We measured fasting plasma aminograms in 387 IBD patients (Crohn's disease (CD), n = 165; ulcerative colitis (UC), n = 222) and 210 healthy controls. Based on Fisher linear classifiers, multivariate indexes were developed from the aminogram in discovery samples (CD, n = 102; UC, n = 102; age and sex-matched healthy controls, n = 102) and internally validated. The indexes were used to discriminate between CD or UC patients and healthy controls, as well as between patients with active disease and those in remission. We assessed index performances using the area under the curve of the receiver operating characteristic (ROC AUC). We observed significant alterations to the plasma aminogram, including histidine and tryptophan. The multivariate indexes established from plasma aminograms were able to distinguish CD or UC patients from healthy controls with ROC AUCs of 0.940 (95% confidence interval (CI): 0.898-0.983) and 0.894 (95%CI: 0.853-0.935), respectively in validation samples (CD, n = 63; UC, n = 120; healthy controls, n = 108). In addition, other indexes appeared to be a measure of disease activity. These indexes distinguished active CD or UC patients from each remission patients with ROC AUCs of 0.894 (95%CI: 0.853-0.935) and 0.849 (95%CI: 0.770-0.928), and correlated with clinical disease activity indexes for CD (r(s) = 0.592, 95%CI: 0.385-0.742, p<0.001) or UC (r(s) = 0.598, 95%CI: 0.452-0.713, p<0.001), respectively. Conclusions and Significance: In this study, we demonstrated that established multivariate indexes composed of plasma amino acid profiles can serve as novel, non-invasive, objective biomarkers for the diagnosis and monitoring of IBD, providing us with new insights into the pathophysiology of the disease.	[Hisamatsu, Tadakazu; Okamoto, Susumu; Kitazume, Mina T.; Matsuoka, Katsuyoshi; Yajima, Tomoharu; Kanai, Takanori; Hibi, Toshifumi] Keio Univ, Sch Med, Dept Internal Med, Tokyo, Japan; [Inoue, Nagamu; Ogata, Haruhiko; Iwao, Yasushi] Keio Univ, Ctr Diagnost & Therapeut Endoscopy, Tokyo, Japan; [Yamakado, Minoru] Mitsui Mem Hosp, Ctr Multiphas Hlth Testing & Serv, Tokyo 101, Japan; [Hashimoto, Masaki; Muramatsu, Takahiko; Andou, Ayatoshi; Uo, Michihide; Sakai, Ryosei; Ono, Nobukazu; Ando, Toshihiko; Suzuki, Manabu] Ajinomoto Co Inc, Inst Life Sci, Kawasaki, Kanagawa, Japan; [Hashimoto, Masaki; Muramatsu, Takahiko; Andou, Ayatoshi; Uo, Michihide; Sakai, Ryosei; Ono, Nobukazu; Ando, Toshihiko; Suzuki, Manabu] Ajinomoto Co Inc, Pharmaceut Res Labs, Kawasaki, Kanagawa, Japan	Keio University; Keio University; Mitsui Memorial Hospital; Ajinomoto Co Inc; Ajinomoto Co Inc	Hisamatsu, T (corresponding author), Keio Univ, Sch Med, Dept Internal Med, Tokyo, Japan.	hisamachi@a7.keio.jp; thibi@sc.itc.keio.ac.jp	Ogata, H/B-3964-2014; Sakai, Ryosei/AAW-4762-2021; Matsuoka, Katsuyoshi/AAB-1580-2022	Matsuoka, Katsuyoshi/0000-0002-2950-7660; Sakai, Ryosei/0000-0001-5611-0821; Uo, Michihide/0000-0003-1876-1003	Japanese Ministry of Education, Culture and Science; Japanese Ministry of Health, Labor and Welfare; Keio University; Keio Medical Foundation, Tokyo, Japan	Japanese Ministry of Education, Culture and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); Keio University; Keio Medical Foundation, Tokyo, Japan	This study was supported by grants-in-aid and "Academic Frontier" Project from the Japanese Ministry of Education, Culture and Science, the Japanese Ministry of Health, Labor and Welfare, Keio University and Keio Medical Foundation, Tokyo, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Akobeng AK, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005984; Andou A, 2009, GASTROENTEROLOGY, V136, P564, DOI 10.1053/j.gastro.2008.09.062; Brosnan JT, 2003, J NUTR, V133, p2068S, DOI 10.1093/jn/133.6.2068S; Dotan I, 2006, GASTROENTEROLOGY, V131, P366, DOI 10.1053/j.gastro.2006.04.030; FELIG P, 1975, ANNU REV BIOCHEM, V44, P933, DOI 10.1146/annurev.bi.44.070175.004441; FERENCI P, 1978, J NEURAL TRANSM, P87; Forrest CM, 2003, ADV EXP MED BIOL, V527, P395; GERBER DA, 1975, J CLIN INVEST, V55, P1164, DOI 10.1172/JCI108033; Hibi T, 2006, J GASTROENTEROL, V41, P10, DOI 10.1007/s00535-005-1744-3; Holm E, 1999, Curr Opin Clin Nutr Metab Care, V2, P47, DOI 10.1097/00075197-199901000-00009; Langhorst J, 2008, AM J GASTROENTEROL, V103, P162, DOI 10.1111/j.1572-0241.2007.01556.x; LICHTIGER S, 1994, NEW ENGL J MED, V330, P1841, DOI 10.1056/NEJM199406303302601; Maeda J, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-690; Munn DH, 1998, SCIENCE, V281, P1191, DOI 10.1126/science.281.5380.1191; Noguchi Y, 2006, AM J CLIN NUTR, V83, p513S; PINALS RS, 1977, J RHEUMATOL, V4, P414; Puccetti P, 2007, NAT REV IMMUNOL, V7, P817, DOI 10.1038/nri2163; Romani L, 2008, NATURE, V451, P211, DOI 10.1038/nature06471; SHIOTA T, 1984, BIOCHEM MED METAB B, V32, P181, DOI 10.1016/0006-2944(84)90071-1; SOETERS PB, 1976, LANCET, V2, P880; Targan SR, 2005, GASTROENTEROLOGY, V128, P2020, DOI 10.1053/j.gastro.2005.03.046; Vermeire S, 2004, INFLAMM BOWEL DIS, V10, P661, DOI 10.1097/00054725-200409000-00026; Vernier Gwenola, 2004, Curr Gastroenterol Rep, V6, P482, DOI 10.1007/s11894-004-0070-x; Wall AJ, 1975, INFLAMM BOWEL DIS, P101; Watanabe M, 2008, AM J CLIN NUTR, V87, P1860, DOI 10.1093/ajcn/87.6.1860; WINSHIP DH, 1979, GASTROENTEROLOGY, V77, P829; Wolf AM, 2004, CLIN IMMUNOL, V113, P47, DOI 10.1016/j.clim.2004.05.004; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005	28	123	130	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2012	7	1							e31131	10.1371/journal.pone.0031131	http://dx.doi.org/10.1371/journal.pone.0031131			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	912BY	22303484	gold, Green Published, Green Submitted			2022-12-25	WOS:000301770700011
J	Golzio, C; Havis, E; Daubas, P; Nuel, G; Babarit, C; Munnich, A; Vekemans, M; Zaffran, S; Lyonnet, S; Etchevers, HC				Golzio, Christelle; Havis, Emmanuelle; Daubas, Philippe; Nuel, Gregory; Babarit, Candice; Munnich, Arnold; Vekemans, Michel; Zaffran, Stephane; Lyonnet, Stanislas; Etchevers, Heather C.			ISL1 Directly Regulates FGF10 Transcription during Human Cardiac Outflow Formation	PLOS ONE			English	Article							2ND HEART FIELD; MATTHEW-WOOD-SYNDROME; GREAT-ARTERIES; FACTOR-BINDING; BETA-CATENIN; MOUSE HEART; GENE; MUTATIONS; EXPRESSION; DEFECTS	The LIM homeodomain gene Islet-1 (ISL1) encodes a transcription factor that has been associated with the multipotency of human cardiac progenitors, and in mice enables the correct deployment of second heart field (SHF) cells to become the myocardium of atria, right ventricle and outflow tract. Other markers have been identified that characterize subdomains of the SHF, such as the fibroblast growth factor Fgf10 in its anterior region. While functional evidence of its essential contribution has been demonstrated in many vertebrate species, SHF expression of Isl1 has been shown in only some models. We examined the relationship between human ISL1 and FGF10 within the embryonic time window during which the linear heart tube remodels into four chambers. ISL1 transcription demarcated an anatomical region supporting the conserved existence of a SHF in humans, and transcription factors of the GATA family were co-expressed therein. In conjunction, we identified a novel enhancer containing a highly conserved ISL1 consensus binding site within the FGF10 first intron. ChIP and EMSA demonstrated its direct occupation by ISL1. Transcription mediated by ISL1 from this FGF10 intronic element was enhanced by the presence of GATA4 and TBX20 cardiac transcription factors. Finally, transgenic mice confirmed that endogenous factors bound the human FGF10 intronic enhancer to drive reporter expression in the developing cardiac outflow tract. These findings highlight the interest of examining developmental regulatory networks directly in human tissues, when possible, to assess candidate non-coding regions that may be responsible for congenital malformations.	[Golzio, Christelle] Duke Med Ctr, Dept Cell Biol, Ctr Human Dis Modeling, Durham, NC 27705 USA; [Havis, Emmanuelle] Univ Paris 06, CNRS, UMR 7622, Paris, France; [Daubas, Philippe] Inst Pasteur, CNRS, URA 2578, Paris, France; [Nuel, Gregory] Univ Paris 05, CNRS 8145, Paris, France; [Babarit, Candice; Munnich, Arnold; Vekemans, Michel; Lyonnet, Stanislas] Univ Paris 05, INSERM, U781, Fac Med, Paris, France; [Munnich, Arnold; Vekemans, Michel; Lyonnet, Stanislas] Hop Necker Enfants Malad, Serv Genet Med, Paris, France; [Zaffran, Stephane; Etchevers, Heather C.] INSERM, U910, F-13258 Marseille, France; [Zaffran, Stephane; Etchevers, Heather C.] Aix Marseille Univ, Fac Med, UMR 910, Marseille, France	Duke University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite	Golzio, C (corresponding author), Duke Med Ctr, Dept Cell Biol, Ctr Human Dis Modeling, Durham, NC 27705 USA.	heather.etchevers@inserm.fr	Zaffran, Stéphane/S-7454-2019; Etchevers, Heather C./B-5813-2012; Lyonnet, Stanislas/H-5483-2017; Zaffran, Stéphane/I-2955-2016; Havis, Emmanuelle/K-1874-2017; daubas, philippe/P-4275-2017	Zaffran, Stéphane/0000-0002-0811-418X; Etchevers, Heather C./0000-0003-0201-3799; Lyonnet, Stanislas/0000-0001-5426-9417; Zaffran, Stéphane/0000-0002-0811-418X; Havis, Emmanuelle/0000-0001-5634-3174; Golzio, Christelle/0000-0002-4420-3921	Fondation pour la Recherche Medicale [DEQ20071210511]; Agence Nationale pour la Recherche (ANR); Association Francaise contre les Myopathies; Institut Pasteur	Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Agence Nationale pour la Recherche (ANR)(French National Research Agency (ANR)); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Institut Pasteur(European Commission)	This work was supported by the Fondation pour la Recherche Medicale (grant number DEQ20071210511 and a fellowship to C.G.); the Agence Nationale pour la Recherche (ANR2007-CRANIRARE); the Association Francaise contre les Myopathies (MNH-Decrypt-6) and the Institut Pasteur-Necker Transverse Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal P, 2003, DEVELOPMENT, V130, P623, DOI 10.1242/dev.00191; Ahlgren U, 1997, NATURE, V385, P257, DOI 10.1038/385257a0; Arauz RF, 2010, MOL SYNDROMOL, V1, P59, DOI 10.1159/000302285; Benko S, 2009, NAT GENET, V41, P359, DOI 10.1038/ng.329; Blanchette M, 2006, GENOME RES, V16, P656, DOI 10.1101/gr.4866006; Bouillet P, 1997, MECH DEVELOP, V63, P173, DOI 10.1016/S0925-4773(97)00039-7; Brade T, 2007, DEV BIOL, V311, P297, DOI 10.1016/j.ydbio.2007.08.004; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; Conlon FL, 2001, DEVELOPMENT, V128, P3749; Delous M, 2007, NAT GENET, V39, P875, DOI 10.1038/ng2039; Desai TJ, 2004, DEV BIOL, V273, P402, DOI 10.1016/j.ydbio.2004.04.039; Dodou E, 2004, DEVELOPMENT, V131, P3931, DOI 10.1242/dev.01256; Entesarian M, 2005, NAT GENET, V37, P125, DOI 10.1038/ng1507; Fairbanks TJ, 2004, J PEDIATR SURG, V39, P360, DOI 10.1016/j.jpedsurg.2003.11.034; Genead R, 2010, STEM CELL RES, V4, P69, DOI 10.1016/j.scr.2009.10.001; Goldmuntz E, 2001, CIRCULATION, V104, P2565, DOI 10.1161/hc4601.098427; Goldmuntz E, 2002, AM J HUM GENET, V70, P776, DOI 10.1086/339079; Golzio C, 2007, AM J HUM GENET, V80, P1179, DOI 10.1086/518177; Gong W, 2001, J MED GENET, V38, pE45, DOI DOI 10.1136/JMG.38.12.E45; Hadchouel J, 2003, DEVELOPMENT, V130, P3415, DOI 10.1242/dev.00552; Havis E, 2006, BIOTECHNIQUES, V40, P34, DOI 10.2144/000112098; Herzog W, 2004, DEVELOPMENT, V131, P3681, DOI 10.1242/dev.01235; Hoffman JIE, 2002, J AM COLL CARDIOL, V39, P1890, DOI 10.1016/S0735-1097(02)01886-7; Kawakami Y, 2011, DEVELOPMENT, V138, P4465, DOI 10.1242/dev.065359; Kelly RG, 2001, DEV CELL, V1, P435, DOI 10.1016/S1534-5807(01)00040-5; Kirk EP, 2007, AM J HUM GENET, V81, P280, DOI 10.1086/519530; Klar J, 2011, J MED GENET, V48, P705, DOI 10.1136/jmedgenet-2011-100166; Kostetskii I, 1999, DEV BIOL, V206, P206, DOI 10.1006/dbio.1998.9139; Lee SK, 2003, NEURON, V38, P731, DOI 10.1016/S0896-6273(03)00296-4; Lickert H, 2004, NATURE, V432, P107, DOI 10.1038/nature03071; Lillevali K, 2006, MECH DEVELOP, V123, P415, DOI 10.1016/j.mod.2006.04.007; Liu W, 2008, BIRTH DEFECTS RES B, V83, P134, DOI 10.1002/bdrb.20154; Loots GG, 2004, NUCLEIC ACIDS RES, V32, pW217, DOI 10.1093/nar/gkh383; Marguerie A, 2006, CARDIOVASC RES, V71, P50, DOI 10.1016/j.cardiores.2006.03.021; Martinovic-Bouriel J, 2007, AM J MED GENET A, V143A, P219, DOI 10.1002/ajmg.a.31599; McBride KL, 2008, HUM MOL GENET, V17, P2886, DOI 10.1093/hmg/ddn187; McCabe MJ, 2011, J CLIN ENDOCR METAB, V96, pE1709, DOI 10.1210/jc.2011-0454; Megarbane A, 2000, EUR J HUM GENET, V8, P704, DOI 10.1038/sj.ejhg.5200526; MERIKA M, 1993, MOL CELL BIOL, V13, P3999, DOI 10.1128/MCB.13.7.3999; Miller SA, 2008, GENE DEV, V22, P2980, DOI 10.1101/gad.1689708; Min HS, 1998, GENE DEV, V12, P3156, DOI 10.1101/gad.12.20.3156; Moorman A, 2003, HEART, V89, P806, DOI 10.1136/heart.89.7.806; O'Rahilly R, 1987, DEV STAGES HUMANS IN; Ohuchi H, 2000, BIOCHEM BIOPH RES CO, V277, P643, DOI 10.1006/bbrc.2000.3721; Ohuchi H, 2005, DEV DYNAM, V233, P177, DOI 10.1002/dvdy.20319; Ovcharenko I, 2004, NUCLEIC ACIDS RES, V32, pW280, DOI 10.1093/nar/gkh355; Pasutto F, 2007, AM J HUM GENET, V80, P550, DOI 10.1086/512203; Pfaff SL, 1996, CELL, V84, P309, DOI 10.1016/S0092-8674(00)80985-X; Pinson L, 2004, J MED GENET, V41, P381, DOI 10.1136/jmg.2003.014829; Posch MG, 2008, AM J MED GENET A, V146A, P251, DOI 10.1002/ajmg.a.32042; REZNIKOFF CA, 1973, CANCER RES, V33, P3231; Riazi AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005698; Riley BM, 2007, P NATL ACAD SCI USA, V104, P4512, DOI 10.1073/pnas.0607956104; Rohmann E, 2006, NAT GENET, V38, P414, DOI 10.1038/ng1757; Rojas A, 2005, DEVELOPMENT, V132, P3405, DOI 10.1242/dev.01913; Ryckebusch L, 2008, P NATL ACAD SCI USA, V105, P2913, DOI 10.1073/pnas.0712344105; SANCHEZGARCIA I, 1993, J MOL BIOL, V231, P945, DOI 10.1006/jmbi.1993.1343; Sasaki H, 2002, INT J DEV BIOL, V46, P963; Sekine K, 1999, NAT GENET, V21, P138, DOI 10.1038/5096; Sizarov A, 2011, CIRCULATION, V123, P1125, DOI 10.1161/CIRCULATIONAHA.110.980607; Snarr BS, 2007, CIRC RES, V101, P971, DOI 10.1161/CIRCRESAHA.107.162206; Stennard FA, 2003, DEV BIOL, V262, P206, DOI 10.1016/S0012-1606(03)00385-3; Stevens KN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010855; Stolfi A, 2010, SCIENCE, V329, P565, DOI 10.1126/science.1190181; Takeuchi JK, 2005, DEVELOPMENT, V132, P2463, DOI 10.1242/dev.01827; Takeuchi JK, 2009, NATURE, V459, P708, DOI 10.1038/nature08039; Thienpont B, 2010, AM J HUM GENET, V86, P839, DOI 10.1016/j.ajhg.2010.04.011; Tomita Y, 2005, J CELL BIOL, V170, P1135, DOI 10.1083/jcb.200504061; Urness LD, 2011, DEV BIOL, V356, P383, DOI 10.1016/j.ydbio.2011.05.671; VanderMeer JE, 2011, DEV DYNAM, V240, P920, DOI 10.1002/dvdy.22535; Vega-Hernandez M, 2011, DEVELOPMENT, V138, P3331, DOI 10.1242/dev.064410; VetteseDadey M, 1996, EMBO J, V15, P2508, DOI 10.1002/j.1460-2075.1996.tb00608.x; Vissers LELM, 2004, NAT GENET, V36, P955, DOI 10.1038/ng1407; Vitelli F, 2002, DEVELOPMENT, V129, P4605; Waldo KL, 2001, DEVELOPMENT, V128, P3179; Watanabe Y, 2010, CIRC RES, V106, P495, DOI 10.1161/CIRCRESAHA.109.201665; Waxman JS, 2008, DEV CELL, V15, P923, DOI 10.1016/j.devcel.2008.09.009; Xu HS, 2004, DEVELOPMENT, V131, P3217, DOI 10.1242/dev.01174; Yang L, 2006, DEVELOPMENT, V133, P1575, DOI 10.1242/dev.02322; Yuan SP, 2000, ANAT REC, V260, P204, DOI 10.1002/1097-0185(20001001)260:2<204::AID-AR90>3.0.CO;2-5; Zhou Y, 2011, NATURE, V474, P645, DOI 10.1038/nature10094	81	29	31	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2012	7	1							e30677	10.1371/journal.pone.0030677	http://dx.doi.org/10.1371/journal.pone.0030677			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911GB	22303449	Green Published, Green Submitted, gold			2022-12-25	WOS:000301704200028
J	Takami, H; Noguchi, H; Takaki, Y; Uchiyama, I; Toyoda, A; Nishi, S; Chee, GJ; Arai, W; Nunoura, T; Itoh, T; Hattori, M; Takai, K				Takami, Hideto; Noguchi, Hideki; Takaki, Yoshihiro; Uchiyama, Ikuo; Toyoda, Atsushi; Nishi, Shinro; Chee, Gab-Joo; Arai, Wataru; Nunoura, Takuro; Itoh, Takehiko; Hattori, Masahira; Takai, Ken			A Deeply Branching Thermophilic Bacterium with an Ancient Acetyl-CoA Pathway Dominates a Subsurface Ecosystem	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; MICROBIAL ECOSYSTEM; HYDROTHERMAL VENTS; RNA GENES; DIVERSITY; ORIGIN; TEMPERATURE; FERREDOXIN; ALGORITHM; EVOLUTION	A nearly complete genome sequence of Candidatus 'Acetothermum autotrophicum', a presently uncultivated bacterium in candidate division OP1, was revealed by metagenomic analysis of a subsurface thermophilic microbial mat community. Phylogenetic analysis based on the concatenated sequences of proteins common among 367 prokaryotes suggests that Ca. 'A. autotrophicum' is one of the earliest diverging bacterial lineages. It possesses a folate-dependent Wood-Ljungdahl (acetyl-CoA) pathway of CO2 fixation, is predicted to have an acetogenic lifestyle, and possesses the newly discovered archaeal-autotrophic type of bifunctional fructose 1,6-bisphosphate aldolase/phosphatase. A phylogenetic analysis of the core gene cluster of the acethyl-CoA pathway, shared by acetogens, methanogens, some sulfur-and iron-reducers and dechlorinators, supports the hypothesis that the core gene cluster of Ca. 'A. autotrophicum' is a particularly ancient bacterial pathway. The habitat, physiology and phylogenetic position of Ca. 'A. autotrophicum' support the view that the first bacterial and archaeal lineages were H-2-dependent acetogens and methanogenes living in hydrothermal environments.	[Takami, Hideto; Takaki, Yoshihiro; Nishi, Shinro; Chee, Gab-Joo; Arai, Wataru] Japan Agcy Marine Earth Sci & Technol JAMSTEC, Microbial Genome Res Grp, Yokosuka, Kanagawa, Japan; [Noguchi, Hideki; Itoh, Takehiko] Tokyo Inst Technol, Dept Biol Sci, Yokohama, Kanagawa 227, Japan; [Uchiyama, Ikuo] Natl Inst Nat Sci, Natl Inst Basic Biol, Lab Genome Informat, Aichi, Japan; [Toyoda, Atsushi] Natl Inst Genet, Mishima, Shizuoka 411, Japan; [Nunoura, Takuro; Takai, Ken] Subground Animalcule Retrieval Sugar Project, Natsushima, Japan; [Hattori, Masahira] Univ Tokyo, Ctr Omics & Bioinformat, Grad Sch Frontier Sci, Kashiwa, Chiba, Japan	Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Tokyo Institute of Technology; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; University of Tokyo	Takami, H (corresponding author), Japan Agcy Marine Earth Sci & Technol JAMSTEC, Microbial Genome Res Grp, Yokosuka, Kanagawa, Japan.	takamih@jamstec.go.jp	Itoh, Takehiko/E-8873-2014; Hattori, Masahira/AAD-3785-2019; Nunoura, Takuro/AAL-6266-2020; Hattori, Masahira/C-6958-2016; Takami, Hideto/D-4200-2012	Itoh, Takehiko/0000-0002-6113-557X; Nunoura, Takuro/0000-0003-2323-0880; Hattori, Masahira/0000-0001-9467-0344; Takami, Hideto/0000-0003-3433-7018; Uchiyama, Ikuo/0000-0002-9197-5000	Ministry of Education, Culture, Sports, Science and Technology of Japan [20310124, 18681030]; Institute for Bioinformatics Research and Development, Japan Science and Technology Agency; National Institute for Basic Biology (NIBB)	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Institute for Bioinformatics Research and Development, Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); National Institute for Basic Biology (NIBB)(National Institutes of Natural Sciences (NINS) - Japan)	This research was supported in part by Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan to HT (No. 20310124) and to TN (No. 18681030). And this research was also supported in part by Institute for Bioinformatics Research and Development, Japan Science and Technology Agency to IU and HT, and in part by Grant-in-Aid for Scientific Research on Priority Areas "Comprehensive Genomics" to MH and by collaborative research program of National Institute for Basic Biology (NIBB). Computational resources were partly provided by the Data Integration and Analysis Facility of NIBB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAROSS JA, 1985, ORIGINS LIFE EVOL B, V15, P327, DOI 10.1007/BF01808177; Biegel E, 2011, CELL MOL LIFE SCI, V68, P613, DOI 10.1007/s00018-010-0555-8; Biegel E, 2010, P NATL ACAD SCI USA, V107, P18138, DOI 10.1073/pnas.1010318107; Boussau B, 2008, NATURE, V456, P942, DOI 10.1038/nature07393; Brioukhanov AL, 2004, BIOCHEMISTRY-MOSCOW+, V69, P949, DOI 10.1023/B:BIRY.0000043537.04115.d9; Caspi R, 2008, NUCLEIC ACIDS RES, V36, pD623, DOI [10.1093/nar/gkm900, 10.1093/nar/gkt1103]; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; Corliss JB, 1981, OCEANOL ACTA, V4, P56; Costa KC, 2009, EXTREMOPHILES, V13, P447, DOI 10.1007/s00792-009-0230-x; de la Torre JR, 2008, ENVIRON MICROBIOL, V10, P810, DOI 10.1111/j.1462-2920.2007.01506.x; DELONG EF, 1992, P NATL ACAD SCI USA, V89, P5685, DOI 10.1073/pnas.89.12.5685; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hirayama H, 2005, EXTREMOPHILES, V9, P169, DOI 10.1007/s00792-005-0433-8; Hugenholtz P, 1998, J BACTERIOL, V180, P366, DOI 10.1128/JB.180.2.366-376.1998; Kaster AK, 2011, P NATL ACAD SCI USA, V108, P2981, DOI 10.1073/pnas.1016761108; Kato S, 2009, ENVIRON MICROBIOL, V11, P2094, DOI 10.1111/j.1462-2920.2009.01930.x; Kelley DS, 2005, SCIENCE, V307, P1428, DOI 10.1126/science.1102556; Kimura H, 2006, APPL ENVIRON MICROB, V72, P21, DOI 10.1128/AEM.72.1.21-27.2006; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Martin W, 2008, NAT REV MICROBIOL, V6, P805, DOI 10.1038/nrmicro1991; Martin W, 2007, PHILOS T R SOC B, V362, P1887, DOI 10.1098/rstb.2006.1881; Mulkidjanian AY, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-13; Muller V, 2003, APPL ENVIRON MICROB, V69, P6345, DOI 10.1128/AEM.69.11.6345-6353.2003; Murata T, 2005, J BIOENERG BIOMEMBR, V37, P411, DOI 10.1007/s10863-005-9481-0; Nikitin Frederic, 2004, Genome Inform, V15, P266; Nisbet EG, 2001, NATURE, V409, P1083, DOI 10.1038/35059210; Noguchi H, 2008, DNA RES, V15, P387, DOI 10.1093/dnares/dsn027; Nunoura T, 2005, ENVIRON MICROBIOL, V7, P1967, DOI 10.1111/j.1462-2920.2005.00881.x; Nunoura T, 2011, NUCLEIC ACIDS RES, V39, P3204, DOI 10.1093/nar/gkq1228; Pierce E, 2008, ENVIRON MICROBIOL, V10, P2550, DOI 10.1111/j.1462-2920.2008.01679.x; Proskurowski G, 2006, CHEM GEOL, V229, P331, DOI 10.1016/j.chemgeo.2005.11.005; Rappe MS, 2003, ANNU REV MICROBIOL, V57, P369, DOI 10.1146/annurev.micro.57.030502.090759; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sakiyama T, 2000, BIOSCI BIOTECH BIOCH, V64, P670, DOI 10.1271/bbb.64.670; Say RF, 2010, NATURE, V464, P1077, DOI 10.1038/nature08884; Shibuya T, 2010, PRECAMBRIAN RES, V182, P230, DOI 10.1016/j.precamres.2010.08.011; Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191; Takai K, 2004, EXTREMOPHILES, V8, P269, DOI 10.1007/s00792-004-0386-3; Takai K, 2002, APPL ENVIRON MICROB, V68, P3046, DOI 10.1128/AEM.68.6.3046-3054.2002; Takai Ken, 2006, Paleontological Research, V10, P269; Takami H, 1997, FEMS MICROBIOL LETT, V152, P279, DOI 10.1016/S0378-1097(97)00211-5; Takami H, 2004, NUCLEIC ACIDS RES, V32, P6292, DOI 10.1093/nar/gkh970; Takami H, 2000, NUCLEIC ACIDS RES, V28, P4317, DOI 10.1093/nar/28.21.4317; Teske A, 2002, APPL ENVIRON MICROB, V68, P1994, DOI 10.1128/AEM.68.4.1994-2007.2002; Thauer RK, 2007, SCIENCE, V318, P1732, DOI 10.1126/science.1152209; Tobler DJ, 2011, EXTREMOPHILES, V15, P473, DOI 10.1007/s00792-011-0378-z; Toei M, 2007, P NATL ACAD SCI USA, V104, P20256, DOI 10.1073/pnas.0706914105; Uchiyama I, 2006, NUCLEIC ACIDS RES, V34, P647, DOI 10.1093/nar/gkj448; Uchiyama I, 2010, NUCLEIC ACIDS RES, V38, pD361, DOI 10.1093/nar/gkp948; WACHTERSHAUSER G, 1988, MICROBIOL REV, V52, P452; Werner C, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2007JB005094; White O, 1999, SCIENCE, V286, P1571, DOI 10.1126/science.286.5444.1571; Wu DY, 2009, NATURE, V462, P1056, DOI 10.1038/nature08656; Wu M, 2005, PLOS GENET, V1, P563, DOI 10.1371/journal.pgen.0010065; Wu M, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r151	56	85	88	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2012	7	1							e30559	10.1371/journal.pone.0030559	http://dx.doi.org/10.1371/journal.pone.0030559			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911GB	22303444	gold, Green Submitted, Green Published			2022-12-25	WOS:000301704200022
J	Both, J; Wu, T; Bras, J; Schaap, GR; Baas, F; Hulsebos, TJM				Both, Joeri; Wu, Thijs; Bras, Johannes; Schaap, Gerard R.; Baas, Frank; Hulsebos, Theo J. M.			Identification of Novel Candidate Oncogenes in Chromosome Region 17p11.2-p12 in Human Osteosarcoma	PLOS ONE			English	Article							GTPASE-ACTIVATING PROTEIN; EXPRESSION ANALYSIS; GENE AMPLIFICATION; COPY NUMBER; ARRAY CGH; CANCER; PMP22; AMPLICON; PATHWAY; OVEREXPRESSION	Osteosarcoma is the most common primary malignancy of bone. The tumours are characterized by high genomic instability, including the occurrence of multiple regions of amplifications and deletions. Chromosome region 17p11.2-p12 is amplified in about 25% of cases. In previous studies, COPS3 and PMP22 have been identified as candidate oncogenes in this region. Considering the complexity and variation of the amplification profiles for this segment, the involvement of additional causative oncogenes is to be expected. The aim of the present investigation is to identify novel candidate oncogenes in 17p11.2-p12. We selected 26 of in total 85 osteosarcoma samples (31%) with amplification events in 17p11.2-p12, using quantitative PCR for 8 marker genes. These were subjected to high-resolution SNP array analysis and subsequent GISTIC analysis to identify the most significantly amplified regions. Two major amplification peaks were found in the 17p11.2-p12 region. Overexpression as a consequence of gene amplification is a major mechanism for oncogene activation in tumours. Therefore, to identify the causative oncogenes, we next determined expression levels of all genes within the two segments using expression array data that could be generated for 20 of the selected samples. We identified 11 genes that were overexpressed through amplification in at least 50% of cases. Nine of these, c17orf39, RICH2, c17orf45, TOP3A, COPS3, SHMT1, PRPSAP2, PMP22, and RASD1, demonstrated a significant association between copy number and expression level. We conclude that these genes, including COPS3 and PMP22, are candidate oncogenes in 17p11.2-p12 of importance in osteosarcoma tumourigenesis.	[Both, Joeri; Wu, Thijs; Baas, Frank; Hulsebos, Theo J. M.] Univ Amsterdam, Acad Med Ctr, Dept Genome Anal, NL-1105 AZ Amsterdam, Netherlands; [Bras, Johannes] Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands; [Schaap, Gerard R.] Univ Amsterdam, Acad Med Ctr, Dept Orthoped Surg, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Both, J (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Genome Anal, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	t.j.hulsebos@amc.uva.nl	Baas, Frank/F-9574-2010	Baas, Frank/0000-0003-3912-5428	Dutch Cancer Society [UVA 2006-3525]; Department of Orthopedic Surgery, Academic Medical Center, Amsterdam	Dutch Cancer Society(KWF Kankerbestrijding); Department of Orthopedic Surgery, Academic Medical Center, Amsterdam	This work was supported by the Dutch Cancer Society, grant no. UVA 2006-3525. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. J. Bramer (Department of Orthopedic Surgery, Academic Medical Center, Amsterdam) for osteosarcoma samples and support.	Akavia UD, 2010, CELL, V143, P1005, DOI 10.1016/j.cell.2010.11.013; Albertson DG, 2006, TRENDS GENET, V22, P447, DOI 10.1016/j.tig.2006.06.007; Atiye J, 2005, GENE CHROMOSOME CANC, V42, P158, DOI 10.1002/gcc.20120; Attiyeh EF, 2009, GENOME RES, V19, P276, DOI 10.1101/gr.075671.107; Bacci G, 2003, CANCER, V97, P3068, DOI 10.1002/cncr.11456; Benayahu D, 2002, J CELL BIOCHEM, V84, P108, DOI 10.1002/jcb.1270; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Brase JC, 2010, CLIN CANCER RES, V16, P2391, DOI 10.1158/1078-0432.CCR-09-2471; Collin SM, 2009, CANCER EPIDEM BIOMAR, V18, P2528, DOI 10.1158/1055-9965.EPI-09-0223; Evtimova V, 2003, TUMOR BIOL, V24, P189, DOI 10.1159/000074429; Fabris S, 2007, GENE CHROMOSOME CANC, V46, P1109, DOI 10.1002/gcc.20494; FORUS A, 1995, GENE CHROMOSOME CANC, V14, P15, DOI 10.1002/gcc.2870140104; Furuta B, 2002, J NEUROCHEM, V82, P1018, DOI 10.1046/j.1471-4159.2002.01021.x; Gamberi G, 1998, ONCOLOGY-BASEL, V55, P556, DOI 10.1159/000011912; Gordon N, 2010, J AEROSOL MED PULM D, V23, P189, DOI 10.1089/jamp.2009.0812; Guerin E, 2003, LEUKEMIA, V17, P532, DOI 10.1038/sj.leu.2402774; Hawkins DS, 2003, CANCER-AM CANCER SOC, V98, P2447, DOI 10.1002/cncr.11799; Henriksen J, 2003, ONCOGENE, V22, P5358, DOI 10.1038/sj.onc.1206671; Huhne K, 1999, J NEUROSCI RES, V58, P624; Hupe P, 2004, BIOINFORMATICS, V20, P3413, DOI 10.1093/bioinformatics/bth418; Jarvinen TAH, 2003, CYTOPATHOLOGY, V14, P309, DOI 10.1046/j.0956-5507.2003.00105.x; Kanta SY, 2006, HUM PATHOL, V37, P1333, DOI 10.1016/j.humpath.2006.05.008; Kaur S, 2007, CYTOGENET GENOME RES, V116, P153, DOI 10.1159/000098180; Kelemen LE, 2008, CANCER RES, V68, P2498, DOI 10.1158/0008-5472.CAN-07-5165; Kobayashi K, 2004, ONCOGENE, V23, P3089, DOI 10.1038/sj.onc.1207433; Lau CC, 2004, GENE CHROMOSOME CANC, V39, P11, DOI 10.1002/gcc.10291; Li JS, 2005, J HISTOCHEM CYTOCHEM, V53, P885, DOI 10.1369/jhc.4A6546.2005; Lietman Steven A, 2010, Cleve Clin J Med, V77 Suppl 1, pS8, DOI 10.3949/ccjm.77.s1.02; Lightfoot TJ, 2010, BLOOD, V115, P3923, DOI 10.1182/blood-2009-10-249722; Lockwood WW, 2011, J MOL DIAGN, V13, P289, DOI 10.1016/j.jmoldx.2010.11.020; Lu XY, 2008, MOL CANCER RES, V6, P937, DOI 10.1158/1541-7786.MCR-07-2115; Man TK, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-45; MANFIOLETTI G, 1990, MOL CELL BIOL, V10, P2924, DOI 10.1128/MCB.10.6.2924; Naef R, 1998, MICROSC RES TECHNIQ, V41, P359, DOI 10.1002/(SICI)1097-0029(19980601)41:5<359::AID-JEMT3>3.0.CO;2-L; Ottaviani G, 2009, CANCER TREAT RES, V152, P3, DOI 10.1007/978-1-4419-0284-9_1; Pimkin M, 2009, J BIOL CHEM, V284, P7960, DOI 10.1074/jbc.M808541200; Rao RG, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-56; Richnau N, 2001, J BIOL CHEM, V276, P35060, DOI 10.1074/jbc.M103540200; Rui LX, 2010, CANCER CELL, V18, P590, DOI 10.1016/j.ccr.2010.11.013; Sadikovic B, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-202; Sandberg AA, 2003, CANCER GENET CYTOGEN, V145, P1, DOI 10.1016/S0165-4608(03)00105-5; Schwab M, 2004, CANCER LETT, V204, P179, DOI 10.1016/S0304-3835(03)00454-3; Selvarajah S, 2008, CYTOGENET GENOME RES, V122, P5, DOI 10.1159/000151310; Simon R, 2003, INT J CANCER, V107, P764, DOI 10.1002/ijc.11477; Squire JA, 2003, GENE CHROMOSOME CANC, V38, P215, DOI 10.1002/gcc.10273; Vaidyanathan G, 2004, ONCOGENE, V23, P5858, DOI 10.1038/sj.onc.1207774; van Dartel M, 2004, CANCER GENET CYTOGEN, V152, P113, DOI 10.1016/j.cancergencyto.2003.11.003; van Dartel M, 2004, CANCER GENET CYTOGEN, V152, P8, DOI 10.1016/j.cancergencyto.2003.09.024; van Dartel M, 2002, CANCER GENET CYTOGEN, V139, P91, DOI 10.1016/S0165-4608(02)00627-1; Vijayakrishnan J, 2010, HAEMATOL-HEMATOL J, V95, P1405, DOI 10.3324/haematol.2010.022095; Yan T, 2011, CANCER GENE THER, V18, P450, DOI 10.1038/cgt.2011.16; Yan TQ, 2007, CANCER, V109, P1870, DOI 10.1002/cncr.22595; Yang ZQ, 2006, CANCER RES, V66, P11632, DOI 10.1158/0008-5472.CAN-06-2946; Yasuda T, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-26	54	28	30	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2012	7	1							e30907	10.1371/journal.pone.0030907	http://dx.doi.org/10.1371/journal.pone.0030907			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911FX	22292074	Green Submitted, gold, Green Published			2022-12-25	WOS:000301703800036
J	Kouadir, M; Yang, LF; Tan, RR; Shi, FS; Lu, Y; Zhang, SM; Yin, XM; Zhou, XM; Zhao, DM				Kouadir, Mohammed; Yang, Lifeng; Tan, Rongrong; Shi, Fushan; Lu, Yun; Zhang, Siming; Yin, Xiaomin; Zhou, Xiangmei; Zhao, Deming			CD36 Participates in PrP106-126-Induced Activation of Microglia	PLOS ONE			English	Article							NF-KAPPA-B; PRION PROTEIN-FRAGMENT; BETA-AMYLOID FIBRILS; SCAVENGER RECEPTOR; ALZHEIMERS-DISEASE; INFLAMMATION; PATHOGENESIS; PEPTIDE; MICE; QUANTIFICATION	Microglial activation is a characteristic feature of the pathogenesis of prion diseases. The molecular mechanisms that underlie prion-induced microglial activation are not very well understood. In the present study, we investigated the role of the class B scavenger receptor CD36 in microglial activation induced by neurotoxic prion protein (PrP) fragment 106-126 (PrP106-126). We first examined the time course of CD36 mRNA expression upon exposure to PrP106-126 in BV2 microglia. We then analyzed different parameters of microglial activation in PrP106-126-treated cells in the presence or not of anti-CD36 monoclonal antibody (mAb). The cells were first incubated for 1 h with CD36 monoclonal antibody to block the CD36 receptor, and were then treated with neurotoxic prion peptides PrP106-126. The results showed that PrP106-126 treatment led to a rapid yet transitory increase in the mRNA expression of CD36, upregulated mRNA and protein levels of proinflammatory cytokines (IL-1 beta, IL-6 and TNF-alpha), increased iNOS expression and nitric oxide (NO) production, stimulated the activation of NF-kappa B and caspase-1, and elevated Fyn activity. The blockade of CD36 had no effect on PrP106-126-stimulated NF-kappa B activation and TNF-alpha protein release, abrogated the PrP106-126-induced iNOS stimulation, downregulated IL-1 beta and IL-6 expression at both mRNA and protein levels as well as TNF-alpha mRNA expression, decreased NO production and Fyn phosphorylation, reduced caspase-1 cleavage induced by moderate PrP106-126-treatment, but had no effect on caspase-1 activation after treatment with a high concentration of PrP106-126. Together, these results suggest that CD36 is involved in PrP106-126-induced microglial activation and that the participation of CD36 in the interaction between PrP106-126 and microglia may be mediated by Src tyrosine kinases. Our findings provide new insights into the mechanisms underlying the activation of microglia by neurotoxic prion peptides and open perspectives for new therapeutic strategies for prion diseases by modulation of CD36 signaling.	[Kouadir, Mohammed; Yang, Lifeng; Tan, Rongrong; Shi, Fushan; Lu, Yun; Zhang, Siming; Yin, Xiaomin; Zhou, Xiangmei; Zhao, Deming] China Agr Univ, Coll Vet Med, Natl Anim Transmissible Spongiform Encephalopathy, State Key Labs Agrobiotechnol, Beijing 100094, Peoples R China	China Agricultural University	Kouadir, M (corresponding author), China Agr Univ, Coll Vet Med, Natl Anim Transmissible Spongiform Encephalopathy, State Key Labs Agrobiotechnol, Beijing 100094, Peoples R China.	zhaodm@cau.edu.cn			Ministry of Agriculture, China [2009ZX08008-010B, 2009ZX08007-008B]; Natural Science Foundation of China [31001048, 30972164, 30871854]; Beijing Natural Science Foundation [6101002]; University of China [IRT0866]	Ministry of Agriculture, China(Ministry of Agriculture & Rural Affairs); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); University of China	1 Ministry of Agriculture, Key Program, China (Project No. 2009ZX08008-010B and No. 2009ZX08007-008B). 2 Ministry of Agriculture Key Program, China (Project No. 2009ZX08007-008B). 3 The Natural Science Foundation of China (Project No. 31001048, No. 30972164, and No. 30871854). 4 Beijing Natural Science Foundation (Project No. 6101002). 5 The Program for Cheung Kong Scholars and Innovative Research Team in University of China (No. IRT0866). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguzzi A, 2006, NAT REV MICROBIOL, V4, P765, DOI 10.1038/nrmicro1492; Bacot SM, 2003, J LEUKOCYTE BIOL, V74, P118, DOI 10.1189/jlb.1102521; BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; Bamberger ME, 2003, J NEUROSCI, V23, P2665; Bate C, 2005, J NEUROIMMUNOL, V170, P62, DOI 10.1016/j.jneuroim.2005.08.021; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Cho S, 2005, J NEUROSCI, V25, P2504, DOI 10.1523/JNEUROSCI.0035-05.2005; Ciesielski-Treska J, 2004, GLIA, V46, P101, DOI 10.1002/glia.10363; Combs CK, 1999, J NEUROSCI, V19, P928; Coraci IS, 2002, AM J PATHOL, V160, P101, DOI 10.1016/S0002-9440(10)64354-4; ElKhoury J, 1996, NATURE, V382, P716; Fabrizi C, 2001, J BIOL CHEM, V276, P25692, DOI 10.1074/jbc.M100133200; Febbraio M, 2001, J CLIN INVEST, V108, P785, DOI 10.1172/JCI200114006; FORLONI G, 1993, NATURE, V362, P543, DOI 10.1038/362543a0; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; Garcao P, 2006, J NEUROSCI RES, V84, P182, DOI 10.1002/jnr.20870; Gonzalez-Scarano F, 1999, ANNU REV NEUROSCI, V22, P219, DOI 10.1146/annurev.neuro.22.1.219; Graeber MB, 2010, CHANGING FACE MICROG, V6005, P783; HUANG MM, 1991, P NATL ACAD SCI USA, V88, P7844, DOI 10.1073/pnas.88.17.7844; HUYGEN IC, 1970, ANAL CHEM, V42, P407; Ironside JW, 1998, J PATHOL, V186, P227, DOI 10.1002/(SICI)1096-9896(1998110)186:3&lt;227::AID-PATH174&gt;3.0.CO;2-3; Janabi M, 2000, ARTERIOSCL THROM VAS, V20, P1953, DOI 10.1161/01.ATV.20.8.1953; Julius C, 2008, J GEN VIROL, V89, P1545, DOI 10.1099/vir.0.83622-0; Kouadir M, 2011, DNA CELL BIOL, V30, P893, DOI 10.1089/dna.2011.1234; Kunz A, 2008, J NEUROSCI, V28, P1649, DOI 10.1523/JNEUROSCI.5205-07.2008; Latz E, 2010, CURR OPIN IMMUNOL, V22, P28, DOI 10.1016/j.coi.2009.12.004; Li W, 2010, J CLIN INVEST, V120, P3996, DOI 10.1172/JCI42823; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Means TK, 2009, J EXP MED, V206, P637, DOI 10.1084/jem.20082109; Morrison TB, 1998, BIOTECHNIQUES, V24, P954; ONeill LAJ, 1997, TRENDS NEUROSCI, V20, P252, DOI 10.1016/S0166-2236(96)01035-1; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Perry VH, 2010, NAT REV NEUROL, V6, P193, DOI 10.1038/nrneurol.2010.17; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Ransohoff RM, 2009, ANNU REV IMMUNOL, V27, P119, DOI 10.1146/annurev.immunol.021908.132528; Resh MD, 1998, INT J BIOCHEM CELL B, V30, P1159, DOI 10.1016/S1357-2725(98)00089-2; Rezaie P, 2001, BRAIN RES REV, V35, P55, DOI 10.1016/S0165-0173(01)00042-X; Ricciarelli R, 2004, FREE RADICAL BIO MED, V36, P1018, DOI 10.1016/j.freeradbiomed.2004.01.007; Silverstein RL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.272re3; Stewart CR, 2010, NAT IMMUNOL, V11, P155, DOI 10.1038/ni.1836; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Vallance P, 2002, NAT REV DRUG DISCOV, V1, P939, DOI 10.1038/nrd960; Veerhuis R, 2002, BRAIN RES, V925, P195, DOI 10.1016/S0006-8993(01)03273-5; Wechselberger C, 2002, EXP CELL RES, V281, P1, DOI 10.1006/excr.2002.5655; WILLIAMS AE, 1994, BRAIN RES, V654, P200, DOI 10.1016/0006-8993(94)90480-4; YAO JB, 1992, BRAIN RES, V591, P88, DOI 10.1016/0006-8993(92)90981-E	47	24	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2012	7	1							e30756	10.1371/journal.pone.0030756	http://dx.doi.org/10.1371/journal.pone.0030756			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911FX	22292032	Green Submitted, Green Published, gold			2022-12-25	WOS:000301703800028
J	Park, BH; Kim, DS; Won, GW; Jeon, HJ; Oh, BC; Lee, Y; Kim, EG; Lee, YH				Park, Byoung Hee; Kim, Dae Soon; Won, Gun Woo; Jeon, Hyun Jeong; Oh, Byung-Chul; Lee, YoungJoo; Kim, Eung-Gook; Lee, Yong Hee			Mammalian Ste20-Like Kinase and SAV1 Promote 3T3-L1 Adipocyte Differentiation by Activation of PPAR gamma	PLOS ONE			English	Article							CELL CONTACT INHIBITION; RECEPTOR-GAMMA; GENE-EXPRESSION; HIPPO PATHWAY; STERILE-20 KINASE; OXIDATIVE-STRESS; HISTONE H2B; APOPTOSIS; ADIPOGENESIS; PHOSPHORYLATION	The mammalian ste20 kinase (MST) signaling pathway plays an important role in the regulation of apoptosis and cell cycle control. We sought to understand the role of MST2 kinase and Salvador homolog 1 (SAV1), a scaffolding protein that functions in the MST pathway, in adipocyte differentiation. MST2 and MST1 stimulated the binding of SAV1 to peroxisome proliferator-activated receptor gamma (PPAR gamma), a transcription factor that plays a key role in adipogenesis. The interaction of endogenous SAV1 and PPAR gamma was detected in differentiating 3T3-L1 adipocytes. This binding required the kinase activity of MST2 and was mediated by the WW domains of SAV1 and the PPYY motif of PPAR gamma. Overexpression of MST2 and SAV1 increased PPAR gamma levels by stabilizing the protein, and the knockdown of SAV1 resulted in a decrease of endogenous PPAR gamma protein in 3T3-L1 adipocytes. During the differentiation of 3T3-L1 cells into adipocytes, MST2 and SAV1 expression began to increase at 2 days when PPAR gamma expression also begins to increase. MST2 and SAV1 significantly increased PPAR gamma transactivation, and SAV1 was shown to be required for the activation of PPAR gamma by rosiglitazone. Finally, differentiation of 3T3-L1 cells was augmented by MST2 and SAV1 expression and inhibited by knockdown of MST1/2 or SAV1. These results suggest that PPAR gamma activation by the MST signaling pathway may be a novel regulatory mechanism of adipogenesis.	[Park, Byoung Hee; Kim, Dae Soon; Won, Gun Woo; Kim, Eung-Gook; Lee, Yong Hee] Chungbuk Natl Univ, Coll Med, Dept Biochem, Chungbuk, South Korea; [Jeon, Hyun Jeong] Chungbuk Natl Univ, Coll Med, Dept Internal Med, Chungbuk, South Korea; [Oh, Byung-Chul] Gachon Univ Med & Sci, Lee Gil Ya Canc & Diabet Inst, Inchon, South Korea; [Lee, YoungJoo] Sejong Univ, Dept Biosci & Biotechnol, Seoul, South Korea	Chungbuk National University; Chungbuk National University; Gachon University; Sejong University	Park, BH (corresponding author), Chungbuk Natl Univ, Coll Med, Dept Biochem, Chungbuk, South Korea.	yh-lee@cbnu.ac.kr		Oh, Byung-Chul/0000-0002-4277-7083	National Research Foundation of Korea (NRF) [2011-0006216, 2011-0027507]; Korean government (MEST)	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work was supported by a research grant (2011-0006216) and a research grant (2011-0027507) to Dr. Lee from National Research Foundation of Korea (NRF) funded by the Korean government (MEST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SH, 2005, CELL, V120, P25, DOI 10.1016/j.cell.2004.11.016; Burgermeister E, 2007, MOL CELL BIOL, V27, P803, DOI 10.1128/MCB.00601-06; Burns KA, 2007, BBA-MOL CELL BIOL L, V1771, P952, DOI 10.1016/j.bbalip.2007.04.018; Chan EH, 2005, ONCOGENE, V24, P2076, DOI 10.1038/sj.onc.1208445; Cheung WL, 2003, CELL, V113, P507, DOI 10.1016/S0092-8674(03)00355-6; Choi J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008011; Ge K, 2008, MOL CELL BIOL, V28, P1081, DOI 10.1128/MCB.00967-07; Gerhold DL, 2002, ENDOCRINOLOGY, V143, P2106, DOI 10.1210/en.143.6.2106; Graves JD, 1998, EMBO J, V17, P2224, DOI 10.1093/emboj/17.8.2224; Handschin C, 2006, ENDOCR REV, V27, P728, DOI 10.1210/er.2006-0037; Hao YW, 2008, J BIOL CHEM, V283, P5496, DOI 10.1074/jbc.M709037200; Hong JH, 2005, SCIENCE, V309, P1074, DOI 10.1126/science.1110955; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Katagiri K, 2009, EMBO J, V28, P1319, DOI 10.1038/emboj.2009.82; Lee JH, 2008, EMBO J, V27, P1231, DOI 10.1038/emboj.2008.63; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Lehtinen MK, 2006, CELL, V125, P987, DOI 10.1016/j.cell.2006.03.046; Lei QY, 2008, MOL CELL BIOL, V28, P2426, DOI 10.1128/MCB.01874-07; Li Y, 2002, MOL ENDOCRINOL, V16, P1040, DOI 10.1210/me.16.5.1040; MACDOUGALD OA, 1995, ANNU REV BIOCHEM, V64, P345, DOI 10.1146/annurev.bi.64.070195.002021; Mueller E, 2002, J BIOL CHEM, V277, P41925, DOI 10.1074/jbc.M206950200; Oh S, 2009, MOL CELL BIOL, V29, P6309, DOI 10.1128/MCB.00551-09; Radu M, 2009, CURR BIOL, V19, pR421, DOI 10.1016/j.cub.2009.04.022; Tamori Y, 2002, DIABETES, V51, P2045, DOI 10.2337/diabetes.51.7.2045; Tang QQ, 2003, P NATL ACAD SCI USA, V100, P44, DOI 10.1073/pnas.0137044100; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Ura S, 2001, GENES CELLS, V6, P519, DOI 10.1046/j.1365-2443.2001.00439.x; Valverde P, 2000, BIOCHEM BIOPH RES CO, V276, P990, DOI 10.1006/bbrc.2000.3582; VidalPuig AJ, 1997, J CLIN INVEST, V99, P2416, DOI 10.1172/JCI119424; Willson TM, 2000, J MED CHEM, V43, P527, DOI 10.1021/jm990554g; Wu S, 2003, CELL, V114, P445, DOI 10.1016/S0092-8674(03)00549-X; Yin YZ, 2006, MOL ENDOCRINOL, V20, P268, DOI 10.1210/me.2005-0197; Yuan ZQ, 2010, J BIOL CHEM, V285, P3815, DOI 10.1074/jbc.M109.059675; Yuan ZQ, 2009, J BIOL CHEM, V284, P11285, DOI 10.1074/jbc.M900461200; Zeng Q, 2008, CANCER CELL, V13, P188, DOI 10.1016/j.ccr.2008.02.011; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907	36	27	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2012	7	1							e30983	10.1371/journal.pone.0030983	http://dx.doi.org/10.1371/journal.pone.0030983			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911FX	22292086	Green Submitted, Green Published, gold			2022-12-25	WOS:000301703800039
J	Ohshiro, K; Schwartz, AM; Levine, PH; Kumar, R				Ohshiro, Kazufumi; Schwartz, Arnold M.; Levine, Paul H.; Kumar, Rakesh			Alternate Estrogen Receptors Promote Invasion of Inflammatory Breast Cancer Cells via Non-Genomic Signaling	PLOS ONE			English	Article							ER-ALPHA; MOLECULAR-BIOLOGY; GENE-EXPRESSION; VARIANT; PROTEIN; GPR30; ER-ALPHA-36; CARCINOMA; 17-BETA-ESTRADIOL; IDENTIFICATION	Although Inflammatory Breast Cancer (IBC) is a rare and an aggressive type of locally advanced breast cancer with a generally worst prognosis, little work has been done in identifying the status of non-genomic signaling in the invasiveness of IBC. The present study was performed to explore the status of non-genomic signaling as affected by various estrogenic and anti-estrogenic agents in IBC cell lines SUM149 and SUM190. We have identified the presence of estrogen receptor alpha (ER alpha) variant, ER alpha 36 in SUM149 and SUM190 cells. This variant as well as ER beta was present in a substantial concentration in IBC cells. The treatment with estradiol (E2), anti-estrogenic agents 4-hydroxytamoxifen and ICI 182780, ER beta specific ligand DPN and GPR30 agonist G1 led to a rapid activation of p-ERK1/2, suggesting the involvement of ER alpha 36, ER beta and GPR30 in the non-genomic signaling pathway in these cells. We also found a substantial increase in the cell migration and invasiveness of SUM149 cells upon the treatment with these ligands. Both basal and ligand-induced migration and invasiveness of SUM149 cells were drastically reduced in the presence of MEK inhibitor U0126, implicating that the phosphorylation of ERK1/2 by MEK is involved in the observed motility and invasiveness of IBC cells. We also provide evidence for the upregulation of p-ERK1/2 through immunostaining in IBC patient samples. These findings suggest a role of non-genomic signaling through the activation of p-ERK1/2 in the hormonal dependence of IBC by a combination of estrogen receptors. These findings only explain the failure of traditional anti-estrogen therapies in ER-positive IBC which induces the non-genomic signaling, but also opens newer avenues for design of modified therapies targeting these estrogen receptors.	[Ohshiro, Kazufumi; Kumar, Rakesh] George Washington Univ, Med Ctr, Dept Biochem & Mol Biol, Washington, DC 20037 USA; [Schwartz, Arnold M.] George Washington Univ, Med Ctr, Dept Pathol, Washington, DC 20037 USA; [Levine, Paul H.] George Washington Univ, Med Ctr, Dept Epidemiol & Biostat, Washington, DC 20037 USA	George Washington University; George Washington University; George Washington University	Ohshiro, K (corresponding author), George Washington Univ, Med Ctr, Dept Biochem & Mol Biol, Washington, DC 20037 USA.	bcmrxk@gwumc.edu	Kumar, Rakesh/ABD-1065-2020	Kumar, Rakesh/0000-0001-7664-0803	National Institutes of Health [CA090970]; NATIONAL CANCER INSTITUTE [R01CA090970] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grant CA090970 (R.K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABNER AL, 1993, J CLIN ONCOL, V11, P44, DOI 10.1200/JCO.1993.11.1.44; Anderson William F, 2005, Breast Dis, V22, P9; Carmeci C, 1997, GENOMICS, V45, P607, DOI 10.1006/geno.1997.4972; Charafe-Lauffret E, 2008, SEMIN ONCOL, V35, P41, DOI 10.1053/j.seminoncol.2007.11.015; Deng H, 2010, ONCOL REP, V24, P171, DOI 10.3892/or_00000842; Dirix LY, 2006, CURR OPIN ONCOL, V18, P563, DOI 10.1097/01.cco.0000245307.29026.0a; Filardo E, 2007, ENDOCRINOLOGY, V148, P3236, DOI 10.1210/en.2006-1605; Fraser SP, 2010, J CELL PHYSIOL, V224, P527, DOI 10.1002/jcp.22154; Hance KW, 2005, JNCI-J NATL CANCER I, V97, P966, DOI 10.1093/jnci/dji172; He YY, 2009, CANCER SCI, V100, P1051, DOI 10.1111/j.1349-7006.2009.01148.x; HORTOBAGYI GN, 1988, CANCER, V62, P2507, DOI 10.1002/1097-0142(19881215)62:12<2507::AID-CNCR2820621210>3.0.CO;2-D; Huang GS, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.04.046; Ignatov A, 2010, BREAST CANCER RES TR, V123, P87, DOI 10.1007/s10549-009-0624-6; JAIYESIMI IA, 1992, J CLIN ONCOL, V10, P1014, DOI 10.1200/JCO.1992.10.6.1014; Kang LG, 2010, MOL ENDOCRINOL, V24, P709, DOI 10.1210/me.2009-0317; Kleer CG, 2004, BREAST CANCER RES, V6, pR110, DOI 10.1186/bcr755; Kleer CG, 2002, ONCOGENE, V21, P3172, DOI 10.1038/sj.onc.1205462; Kleer CG, 2000, BREAST CANCER RES, V2, P423, DOI 10.1186/bcr89; Lappano R, 2010, MOL CELL ENDOCRINOL, V320, P162, DOI 10.1016/j.mce.2010.02.006; Lee LMJ, 2008, ANTICANCER RES, V28, P479; Li Y, 2010, MOL ENDOCRINOL, V24, P969, DOI 10.1210/me.2009-0148; Lin SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009013; Lin SL, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-102; Madeo A, 2010, CANCER RES, V70, P6036, DOI 10.1158/0008-5472.CAN-10-0408; McCarthy NJ, 2002, CLIN CANCER RES, V8, P3857; Merajver SD, 1997, J CLIN ONCOL, V15, P2873, DOI 10.1200/JCO.1997.15.8.2873; Moriarty K, 2006, ENDOCRINOLOGY, V147, P5557, DOI 10.1210/en.2006-0729; Nguyen DM, 2006, CLIN CANCER RES, V12, P5047, DOI 10.1158/1078-0432.CCR-05-2248; Ohshiro K, 2006, CLIN CANCER RES, V12, P5994, DOI 10.1158/1078-0432.CCR-06-1251; PARADISO A, 1989, CANCER, V64, P1922, DOI 10.1002/1097-0142(19891101)64:9<1922::AID-CNCR2820640927>3.0.CO;2-I; Plante BJ, 2008, REPROD SCI, V15, p70A; Revankar CM, 2005, SCIENCE, V307, P1625, DOI 10.1126/science.1106943; Van den Eynden GG, 2006, BREAST CANCER RES TR, V95, P219, DOI 10.1007/s10549-005-9002-1; Van den Eynden GG, 2004, BREAST CANCER RES TR, V85, P13, DOI 10.1023/B:BREA.0000021028.33926.a8; van Golen KL, 1999, CLIN CANCER RES, V5, P2511; Vivacqua A, 2006, MOL ENDOCRINOL, V20, P631, DOI 10.1210/me.2005-0280; Vivacqua A, 2006, MOL PHARMACOL, V70, P1414, DOI 10.1124/mol.106.026344; Wang ZY, 2006, P NATL ACAD SCI USA, V103, P9063, DOI 10.1073/pnas.0603339103; Wang ZY, 2005, BIOCHEM BIOPH RES CO, V336, P1023, DOI 10.1016/j.bbrc.2005.08.226; Zhang GF, 2009, MOL ENDOCRINOL, V23, P146, DOI 10.1210/me.2008-0431; Zhang XT, 2011, ONCOGENE, V30, P770, DOI 10.1038/onc.2010.458; Zou Y, 2009, FEBS LETT, V583, P1368, DOI 10.1016/j.febslet.2009.03.047	42	39	50	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e30725	10.1371/journal.pone.0030725	http://dx.doi.org/10.1371/journal.pone.0030725			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910ME	22295107	Green Published, gold			2022-12-25	WOS:000301640600052
J	Termote, C; Meyi, MB; Djailo, BD; Huybregts, L; Lachat, C; Kolsteren, P; Van Damme, P				Termote, Celine; Meyi, Marcel Bwama; Djailo, Benoit Dhed'a; Huybregts, Lieven; Lachat, Carl; Kolsteren, Patrick; Van Damme, Patrick			A Biodiverse Rich Environment Does Not Contribute to a Better Diet: A Case Study from DR Congo	PLOS ONE			English	Article							NUTRITIONAL-VALUE; FOOD COMPOSITION; WILD VEGETABLES; WOMEN; SECURITY; CONSUMPTION; TRECULIA; EXAMPLE; HEALTH; ENERGY	The potential of biodiversity to increase and sustain nutrition security is increasingly recognized by the international research community. To date however, dietary assessment studies that have assessed how biodiversity actually contributes to human diets are virtually absent. This study measured the contribution of wild edible plants (WEP) to the dietary quality in the high biodiverse context of DR Congo. The habitual dietary intake was estimated from 2 multiple-pass 24 h dietary recalls for 363 urban and 129 rural women. All WEP were collected during previous ethnobotanical investigations and identified and deposited in the National Botanical Garden of Belgium (BR). Results showed that in a high biodiverse region with precarious food security, WEP are insufficiently consumed to increase nutrition security or dietary adequacy. The highest contribution came from Dacryodes edulis in the village sample contributing 4.8% of total energy intake. Considering the nutrient composition of the many WEP available in the region and known by the indigenous populations, the potential to increase nutrition security is vast. Additional research regarding the dietary contribution of agricultural biodiversity and the nutrient composition of WEP would allow to integrate them into appropriate dietary guidelines for the region and pave the way to domesticate the most interesting WEP.	[Termote, Celine; Van Damme, Patrick] Univ Ghent, Fac Biosci Engn, Lab Trop & Subtrop Agron & Ethnobot, B-9000 Ghent, Belgium; [Meyi, Marcel Bwama] Inst Fac Sci Agron Yangambi, Lab Dev Econ & Environm, Kisangani, DEM REP CONGO; [Djailo, Benoit Dhed'a] Univ Kisangani, Fac Sci, Lab Genet Plant Improvement & Biotechnol, Kisangani, DEM REP CONGO; [Huybregts, Lieven; Lachat, Carl; Kolsteren, Patrick] Univ Ghent, Dept Food Safety & Food Qual, Fac Biosci Engn, B-9000 Ghent, Belgium; [Lachat, Carl; Kolsteren, Patrick] Inst Trop Med, Nutr & Child Hlth Unit, B-2000 Antwerp, Belgium	Ghent University; Ghent University; Institute of Tropical Medicine (ITM)	Termote, C (corresponding author), Univ Ghent, Fac Biosci Engn, Lab Trop & Subtrop Agron & Ethnobot, B-9000 Ghent, Belgium.	celine.termote@ugent.be	Huybregts, Lieven/B-9578-2009; Van Damme, Patrick/H-6693-2018; lachat, carl/AAH-9764-2020; , Patrick/AAI-8779-2020	Huybregts, Lieven/0000-0002-3068-2853; Van Damme, Patrick/0000-0002-2548-633X; lachat, carl/0000-0002-1389-8855; Termote, Celine/0000-0003-3217-0226	VlIR-UOS (Flemish Interuniversity Council - University Cooperation) [ZEIN2004_3000, MPRDC2007_25]; Belgian 'Leopold III fund for Nature Exploration and Conservation'; Belgian 'Leopold III fund for Nature Exploration and Conservation' (http://www.naturalsciences.be/LIII/NL) and 'Stichting Roeping'	VlIR-UOS (Flemish Interuniversity Council - University Cooperation); Belgian 'Leopold III fund for Nature Exploration and Conservation'; Belgian 'Leopold III fund for Nature Exploration and Conservation' (http://www.naturalsciences.be/LIII/NL) and 'Stichting Roeping'	Financial support for this study was provided by VlIR-UOS (Flemish Interuniversity Council - University Cooperation; www.vliruos.be) projects ZEIN2004_3000; MPRDC2007_25. C.T. obtained a grant from the Belgian 'Leopold III fund for Nature Exploration and Conservation' (http://www.naturalsciences.be/LIII/NL) and 'Stichting Roeping' (http://www.vocatio.be/?lang=nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arimond M, 2010, J NUTR, V140, p2059S, DOI 10.3945/jn.110.123414; Baingana RK, 2004, J FOOD COMPOS ANAL, V17, P501, DOI 10.1016/j.jfca.2004.03.012; Bharucha Z, 2010, PHILOS T R SOC B, V365, P2913, DOI 10.1098/rstb.2010.0123; Bijttebier J, 1992, C INT AGR NOUV ZAIRC; Burlingame B, 2009, J FOOD COMPOS ANAL, V22, P361, DOI 10.1016/j.jfca.2009.05.003; CFSVA, 2008, AN GLOB SEC AL VULN; Charlier S, 2011, GRAP3A WHAT AGR POLI; Counsell S, 2006, FOREST GOVERNANCE DE; CUNNINGHAM AB, 1988, ECON BOT, V42, P301, DOI 10.1007/BF02860158; de Merode E, 2004, BIOL CONSERV, V118, P573, DOI 10.1016/j.biocon.2003.10.005; Degroote VA, 1965, TABLES COMPOSITION A; DHS-RDC, 2008, DEM HLTH SURV DEM RE; DIFE, 2018, MULT SOURC METH MSM; Dovie DBK, 2007, J ENVIRON MANAGE, V84, P146, DOI 10.1016/j.jenvman.2006.05.017; EDET EE, 1985, FOOD CHEM, V17, P41, DOI 10.1016/0308-8146(85)90091-3; Enujiugha VN, 2003, INT J FOOD SCI TECH, V38, P525, DOI 10.1046/j.1365-2621.2003.00698.x; Eyo ES, 1983, NIG J NUTR SCI, V4, P57; FAO World Health Organization, 2004, VIT MIN REQ HUM NUTR, V2nd ed; Food and Agriculture Organization/World Health Organization/United Nations University, 2001, HUM EN REQ; Gibson R.S., 1999, INTERACTIVE 24 HOUR; Grivetti LE, 2000, NUTR RES REV, V13, P31, DOI 10.1079/095442200108728990; Haubrock J, 2011, J NUTR, V141, P914, DOI 10.3945/jn.109.120394; Huybregts L, 2008, PUBLIC HEALTH NUTR, V11, P581, DOI 10.1017/S1368980007000870; Isong EU, 1999, FOOD CHEM, V64, P489, DOI 10.1016/S0308-8146(98)00139-3; Johns T, 2006, P NUTR SOC, V65, P182, DOI 10.1079/PNS2006494; Jonnalagadda SS, 2000, J AM DIET ASSOC, V100, P303, DOI 10.1016/S0002-8223(00)00095-X; Kengue J, 2002, SAFOU DACRYODES EDUL; Kennedy G, 2010, J NUTR, V140, p2070S, DOI 10.3945/jn.110.123612; Kuhnlein H. V., 2009, INDIGENOUS PEOPLES F; Lartey A, 2008, P NUTR SOC, V67, P105, DOI 10.1017/S0029665108006083; LAWAL RO, 1986, FOOD CHEM, V19, P245, DOI 10.1016/0308-8146(86)90048-8; Leonti M, 2006, ECON BOT, V60, P130, DOI 10.1663/0013-0001(2006)60[130:WGFPIT]2.0.CO;2; Leung W.-T. W., 1968, FOOD COMPOSITION TAB; Lukmanji Z., 2008, TANZANIA FOOD COMPOS; Lutaladio N, 2010, J FOOD COMPOS ANAL, V23, P481, DOI 10.1016/j.jfca.2010.08.001; Lykke AM, 2002, ECOL FOOD NUTR, V41, P119, DOI 10.1080/03670240214492; Nyambose J, 2002, J NUTR, V132, P1313, DOI 10.1093/jn/132.6.1313; Ogle BM, 2001, ECOL FOOD NUTR, V40, P159, DOI 10.1080/03670244.2001.9991646; Ogle BM, 2001, ASIA PAC J CLIN NUTR, V10, P21, DOI 10.1046/j.1440-6047.2001.00206.x; Penafiel D, 2011, ECOHEALTH, V8, P381, DOI 10.1007/s10393-011-0700-3; Rossi L, 2006, PUBLIC HEALTH NUTR, V9, P551, DOI 10.1079/PHN2005928; Shackleton C, 2004, S AFR J SCI, V100, P658; Termote C, 2011, GENET RESOUR CROP EV, V58, P585, DOI 10.1007/s10722-010-9602-4; Termote C, 2010, ECOL FOOD NUTR, V49, P173, DOI 10.1080/03670241003766030; Toledo A, 2006, J FOOD COMPOS ANAL, V19, P477, DOI 10.1016/j.jfca.2006.05.001; Torheim LE, 2010, J NUTR, V140, p2051S, DOI 10.3945/jn.110.123463; [UNDP UNOPS], 1998, MON PROV OR PROGR NA; USDA, 2007, TABL NUTR RET FACT R; Uusiku NP, 2010, J FOOD COMPOS ANAL, V23, P500; Van Damme P., 2008, AFRIKA FOCUS, V21, P45, DOI [10.1163/2031356X-02101005, DOI 10.1163/2031356X-02101005]; Venter CS, 2000, J HUM NUTR DIET, V13, P205, DOI [10.1046/j.1365-277x.2000.00228.x, 10.1046/j.1365-277X.2000.00228.x]; Voster HJ, 2007, AFRICAN J FOOD AGR N, V7; Weinberger K, 2006, ECOL FOOD NUTR, V45, P87, DOI 10.1080/03670240500530626; White F., 1983, VEGETATION AFRICA DE; Willet W, 1998, NUTR EPIDEMIOLOGY	55	53	53	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2012	7	1							e30533	10.1371/journal.pone.0030533	http://dx.doi.org/10.1371/journal.pone.0030533			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910LV	22291981	Green Published, gold, Green Submitted			2022-12-25	WOS:000301639600029
J	Heaton, PR; Santos, A; Rosas-Acosta, G; Wilson, VG				Heaton, Phillip R.; Santos, Andres; Rosas-Acosta, German; Wilson, Van G.			Analysis of Global Sumoylation Changes Occurring during Keratinocyte Differentiation	PLOS ONE			English	Article							PROTEIN SUMOYLATION; SUMO; UBIQUITIN; ASSOCIATION; FAMILY	Sumoylation is a highly dynamic process that plays a role in a multitude of processes ranging from cell cycle progression to mRNA processing and cancer. A previous study from our lab demonstrated that SUMO plays an important role in keratinocyte differentiation. Here we present a new method of tracking the sumoylation state of proteins by creating a stably transfected HaCaT keratinocyte cell line expressing an inducible SNAP-SUMO3 protein. The SNAP-tag allows covalent fluorescent labeling that is denaturation resistant. When combined with two-dimensional gel electrophoresis, the SNAP-tag technology provides direct visualization of sumoylated targets and can be used to follow temporal changes in the global cohort of sumoylated proteins during dynamic processes such as differentiation. HaCaT keratinocyte cells expressing SNAP-SUMO3 displayed normal morphological and biochemical features that are consistent with typical keratinocyte differentiation. SNAP-SUMO3 also localized normally in these cells with a predominantly nuclear signal and some minor cytoplasmic staining, consistent with previous reports for untagged SUMO2/3. During keratinocyte differentiation the total number of proteins modified by SNAP-SUMO3 was highest in basal cells, decreased abruptly after induction of differentiation, and slowly rebounded beginning between 48 and 72 hours as differentiation progressed. However, within this overall trend the pattern of change for individual sumoylated proteins was highly variable with both increases and decreases in amount over time. From these results we conclude that sumoylation of proteins during keratinocyte differentiation is a complex process which likely reflects and contributes to the biochemical changes that drive differentiation.	[Heaton, Phillip R.; Santos, Andres; Rosas-Acosta, German; Wilson, Van G.] Texas A&M Hlth Sci Ctr, Dept Microbial & Mol Pathogenesis, Coll Med, College Stn, TX USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Heaton, PR (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.	wilson@medicine.tamhsc.edu	, Van G Wilson/B-1868-2009		National Institutes of Health (NIH) [CA089298, 5G12RR008124]; T32 Life Sciences Training fellowship; NATIONAL CANCER INSTITUTE [R01CA089298] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR008124] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); T32 Life Sciences Training fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by a grant from the National Institutes of Health (NIH) (CA089298) to VGW and a T32 Life Sciences Training fellowship to PRH. The confocal microscopy conducted at the Border Biomedical Research Center (BBRC) was supported by grant 5G12RR008124 from NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azuma Y, 2003, J CELL BIOL, V163, P477, DOI 10.1083/jcb.200304088; Bayer P, 1998, J MOL BIOL, V280, P275, DOI 10.1006/jmbi.1998.1839; Binda O, 2006, MOL CELL BIOL, V26, P1917, DOI 10.1128/MCB.26.5.1917-1931.2006; Blomster HA, 2009, MOL CELL PROTEOMICS, V8, P1382, DOI 10.1074/mcp.M800551-MCP200; Campos C, 2011, DEV DYNAM, V240, P820, DOI 10.1002/dvdy.22574; Chung TL, 2004, J BIOL CHEM, V279, P39653, DOI 10.1074/jbc.M405637200; Deyrieux AF, 2007, J CELL SCI, V120, P125, DOI 10.1242/jcs.03317; Garcia-Dominguez M, 2009, BBA-GENE REGUL MECH, V1789, P451, DOI 10.1016/j.bbagrm.2009.07.001; Gautier A, 2008, CHEM BIOL, V15, P128, DOI 10.1016/j.chembiol.2008.01.007; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Heaton PR, 2011, VIRUS RES, V158, P199, DOI 10.1016/j.virusres.2011.04.001; Kamitani T, 1998, J BIOL CHEM, V273, P11349, DOI 10.1074/jbc.273.18.11349; Keppler A, 2009, ACS CHEM BIOL, V4, P127, DOI 10.1021/cb800298u; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Manza LL, 2004, CHEM RES TOXICOL, V17, P1706, DOI 10.1021/tx049767l; Melchior F, 2000, ANNU REV CELL DEV BI, V16, P591, DOI 10.1146/annurev.cellbio.16.1.591; Mukhopadhyay D, 2006, J CELL BIOL, V174, P939, DOI 10.1083/jcb.200510103; Nie MH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005905; Vivo M, 2009, CELL CYCLE, V8, P3545, DOI 10.4161/cc.8.21.9954; Yu B, 2009, EXP CELL RES, V315, P3543, DOI 10.1016/j.yexcr.2009.09.011; Zhang XD, 2008, MOL CELL, V29, P729, DOI 10.1016/j.molcel.2008.01.013; Zhou WD, 2004, J BIOL CHEM, V279, P32262, DOI 10.1074/jbc.M404173200	22	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30165	10.1371/journal.pone.0030165	http://dx.doi.org/10.1371/journal.pone.0030165			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22291911	Green Published, Green Submitted, gold			2022-12-25	WOS:000301570600020
J	Wang, SD; Rath, P; Lal, B; Richard, JP; Li, Y; Goodwin, CR; Laterra, J; Xia, S				Wang, S. D.; Rath, P.; Lal, B.; Richard, J-P; Li, Y.; Goodwin, C. R.; Laterra, J.; Xia, S.			EphB2 receptor controls proliferation/migration dichotomy of glioblastoma by interacting with focal adhesion kinase	ONCOGENE			English	Article						glioblastoma-derived stem-like neurospheres; orthotopic xenograft; EphB2; proliferation/migration dichotomy; invasion; focal adhesion kinase	CELL-MIGRATION; CANCER-CELLS; TUMOR-GROWTH; STEM-CELLS; EPHA2; PATHWAY; EXPRESSION; INVASION; INHIBITION; EPHRINS	Glioblastoma multiforme (GBM) is the most frequent and aggressive primary brain tumors in adults. Uncontrolled proliferation and abnormal cell migration are two prominent spatially and temporally disassociated characteristics of GBMs. In this study, we investigated the role of the receptor tyrosine kinase EphB2 in controlling the proliferation/migration dichotomy of GBM. We studied EphB2 gain of function and loss of function in glioblastoma-derived stem-like neurospheres, whose in vivo growth pattern closely replicates human GBM. EphB2 expression stimulated GBM neurosphere cell migration and invasion, and inhibited neurosphere cell proliferation in vitro. In parallel, EphB2 silencing increased tumor cell proliferation and decreased tumor cell migration. EphB2 was found to increase tumor cell invasion in vivo using an internally controlled dual-fluorescent xenograft model. Xenografts derived from EphB2-overexpressing GBM neurospheres also showed decreased cellular proliferation. The non-receptor tyrosine kinase focal adhesion kinase (FAK) was found to be co-associated with and highly activated by EphB2 expression, and FAK activation facilitated focal adhesion formation, cytoskeleton structure change and cell migration in EphB2-expressing GBM neurosphere cells. Taken together, our findings indicate that EphB2 has pro-invasive and anti-proliferative actions in GBM stem-like neurospheres mediated, in part, by interactions between EphB2 receptors and FAK. These novel findings suggest that tumor cell invasion can be therapeutically targeted by inhibiting EphB2 signaling, and that optimal antitumor responses to EphB2 targeting may require concurrent use of anti-proliferative agents. Oncogene (2012) 31, 5132-5143; doi:10.1038/onc.2012.16; published online 6 February 2012	[Wang, S. D.; Rath, P.; Lal, B.; Richard, J-P; Li, Y.; Laterra, J.; Xia, S.] Johns Hopkins Sch Med, Hugo W Moser Res Inst Kennedy Krieger, Baltimore, MD 21205 USA; [Rath, P.; Lal, B.; Richard, J-P; Li, Y.; Laterra, J.; Xia, S.] Johns Hopkins Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Goodwin, C. R.] Johns Hopkins Sch Med, Dept Neurosurg, Baltimore, MD 21205 USA; [Laterra, J.] Johns Hopkins Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Laterra, J.] Johns Hopkins Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Xia, S (corresponding author), Johns Hopkins Sch Med, Hugo W Moser Res Inst Kennedy Krieger, 707 N Broadway,Room 400K, Baltimore, MD 21205 USA.	xia@kennedykrieger.org		Richard, Jean-Philippe/0000-0003-2890-2316; Goodwin, C. Rory/0000-0002-6540-2751	Maryland Stem Cell Research Fund (MSCRFE) [2009-0126-00]; NIH [NS43987]; James S McDonnell Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043987] Funding Source: NIH RePORTER	Maryland Stem Cell Research Fund (MSCRFE); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); James S McDonnell Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Maryland Stem Cell Research Fund (MSCRFE) 2009-0126-00 (SX), NIH NS43987 (JL) and the James S McDonnell Foundation (JL). We thank Dr Hugo Guerrero-Cazares for technical advice and Miss Mir Shanaz Hossain for technical assistance. We also thank Mr Hao Zhang from Johns Hopkins School of Public Health for assistance with flow cytometric analysis.	Alazzouzi H, 2005, CANCER RES, V65, P10170, DOI 10.1158/0008-5472.CAN-05-2580; Arvanitis D, 2008, GENE DEV, V22, P416, DOI 10.1101/gad.1630408; Bar EE, 2007, STEM CELLS, V25, P2524, DOI 10.1634/stemcells.2007-0166; Batlle E, 2005, NATURE, V435, P1126, DOI 10.1038/nature03626; Brantley-Sieders DM, 2008, J CLIN INVEST, V118, P64, DOI 10.1172/JCI33154; Brantley-Sieders DM, 2004, J CELL SCI, V117, P2037, DOI 10.1242/jcs.01061; Candolfi M, 2007, J NEURO-ONCOL, V85, P133, DOI 10.1007/s11060-007-9400-9; Chatzizacharias NA, 2008, HISTOL HISTOPATHOL, V23, P629, DOI 10.14670/HH-23.629; Chiu ST, 2009, CARCINOGENESIS, V30, P1475, DOI 10.1093/carcin/bgp133; Conover JC, 2000, NAT NEUROSCI, V3, P1091, DOI 10.1038/80606; Cortina C, 2007, NAT GENET, V39, P1376, DOI 10.1038/ng.2007.11; Cox BD, 2006, J CELL BIOCHEM, V99, P36, DOI 10.1002/jcb.20956; Fan X, 2010, STEM CELLS, V28, P5, DOI 10.1002/stem.254; Fox BP, 2004, BIOCHEM BIOPH RES CO, V318, P882, DOI 10.1016/j.bbrc.2004.04.102; Frisch SM, 1996, J CELL BIOL, V134, P793, DOI 10.1083/jcb.134.3.793; Fukai J, 2008, MOL CANCER THER, V7, P2768, DOI 10.1158/1535-7163.MCT-07-2263; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Garber K, 2010, J NATL CANCER I, V102, P1692, DOI 10.1093/jnci/djq479; Genander M, 2009, CELL, V139, P679, DOI 10.1016/j.cell.2009.08.048; Giese A, 1996, INT J CANCER, V67, P275, DOI 10.1002/(SICI)1097-0215(19960717)67:2<275::AID-IJC20>3.0.CO;2-9; Giese A, 2003, J CLIN ONCOL, V21, P1624, DOI 10.1200/JCO.2003.05.063; Golubovskaya VM, 2008, J MED CHEM, V51, P7405, DOI 10.1021/jm800483v; Goodwin CR, 2010, CANCER RES, V70, P2932, DOI 10.1158/0008-5472.CAN-09-3570; Heese O, 2005, NEURO-ONCOLOGY, V7, P476, DOI 10.1215/S1152851704000754; Hoelzinger DB, 2005, NEOPLASIA, V7, P7, DOI 10.1593/neo.04535; Holmberg J, 2006, CELL, V125, P1151, DOI 10.1016/j.cell.2006.04.030; Huusko P, 2004, NAT GENET, V36, P979, DOI 10.1038/ng1408; Kuijper S, 2007, TRENDS CARDIOVAS MED, V17, P145, DOI 10.1016/j.tcm.2007.03.003; Kumar SR, 2009, CANCER RES, V69, P3736, DOI 10.1158/0008-5472.CAN-08-3232; Lal BC, 2005, CLIN CANCER RES, V11, P4479, DOI 10.1158/1078-0432.CCR-05-0166; Larsen AB, 2007, MOL CANCER RES, V5, P283, DOI 10.1158/1541-7786.MCR-06-0321; Lee HS, 2008, NAT CELL BIOL, V10, P979, DOI 10.1038/ncb1758; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Lugli A, 2005, CLIN CANCER RES, V11, P6450, DOI 10.1158/1078-0432.CCR-04-2458; Luo M, 2010, CANCER LETT, V289, P127, DOI 10.1016/j.canlet.2009.07.005; Madhavan S, 2009, MOL CANCER RES, V7, P157, DOI 10.1158/1541-7786.MCR-08-0435; Miao H, 2009, CANCER CELL, V16, P9, DOI 10.1016/j.ccr.2009.04.009; Nakada M, 2005, AM J PATHOL, V167, P565, DOI 10.1016/S0002-9440(10)62998-7; Nakada M, 2004, CANCER RES, V64, P3179, DOI 10.1158/0008-5472.CAN-03-3667; Nakada M, 2010, INT J CANCER, V126, P1155, DOI 10.1002/ijc.24849; Noblitt LW, 2004, CANCER GENE THER, V11, P757, DOI 10.1038/sj.cgt.7700761; Noren NK, 2007, CANCER RES, V67, P3994, DOI 10.1158/0008-5472.CAN-07-0525; Noren NK, 2006, NAT CELL BIOL, V8, P815, DOI 10.1038/ncb1438; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Pasquale EB, 2010, NAT REV CANCER, V10, P165, DOI 10.1038/nrc2806; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pollard SM, 2009, CELL STEM CELL, V4, P568, DOI 10.1016/j.stem.2009.03.014; Quick A, 2010, REV RECENT CLIN TRIA, V5, P14, DOI 10.2174/157488710790820544; Rahman R, 2010, J ONCOL, V2010, DOI 10.1155/2010/251231; Reznik TE, 2008, MOL CANCER RES, V6, P139, DOI 10.1158/1541-7786.MCR-07-0236; Sarkaria JN, 2006, CLIN CANCER RES, V12, P2264, DOI 10.1158/1078-0432.CCR-05-2510; Schwock J, 2010, EXPERT OPIN THER TAR, V14, P77, DOI 10.1517/14728220903460340; Shi Y, 2009, J NEUROSCI, V29, P8129, DOI 10.1523/JNEUROSCI.4681-08.2009; Slack-Davis JK, 2007, J BIOL CHEM, V282, P14845, DOI 10.1074/jbc.M606695200; Sun P, 2009, STEM CELLS, V27, P1473, DOI 10.1002/stem.89; Surawska H, 2004, CYTOKINE GROWTH F R, V15, P419, DOI 10.1016/j.cytogfr.2004.09.002; Taddei ML, 2009, AM J PATHOL, V174, P1492, DOI 10.2353/ajpath.2009.080473; van Nimwegen MJ, 2007, BIOCHEM PHARMACOL, V73, P597, DOI 10.1016/j.bcp.2006.08.011; Vaught D, 2009, MOL BIOL CELL, V20, P2572, DOI 10.1091/mbc.E08-04-0378; Walker EH, 2000, MOL CELL, V6, P909, DOI 10.1016/S1097-2765(05)00089-4; Ying M, 2011, ONCOGENE, V30, P3454, DOI 10.1038/onc.2011.58; Ying MY, 2011, STEM CELLS, V29, P20, DOI 10.1002/stem.561; Zhao J, 2009, CANCER METAST REV, V28, P35, DOI 10.1007/s10555-008-9165-4	63	68	70	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC	2012	31	50					5132	5143		10.1038/onc.2012.16	http://dx.doi.org/10.1038/onc.2012.16			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	055WY	22310282	Green Submitted, Green Accepted			2022-12-25	WOS:000312449800002
J	Abrahamsen, H; O'Neill, AK; Kannan, N; Kruse, N; Taylor, SS; Jennings, PA; Newton, AC				Abrahamsen, Hilde; O'Neill, Audrey K.; Kannan, Natarajan; Kruse, Nicole; Taylor, Susan S.; Jennings, Patricia A.; Newton, Alexandra C.			Peptidyl-prolyl Isomerase Pin1 Controls Down-regulation of Conventional Protein Kinase C Isozymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOINOSITIDE-DEPENDENT KINASE; TURN MOTIF PHOSPHORYLATION; BETA-II; SUBCELLULAR-LOCALIZATION; PHOSPHATASE PHLPP; CELL-CYCLE; IN-VIVO; ALPHA; CANCER; DEPHOSPHORYLATION	The down-regulation or cellular depletion of protein kinase C (PKC) attendant to prolonged activation by phorbol esters is a widely described property of this key family of signaling enzymes. However, neither the mechanism of down-regulation nor whether this mechanism occurs following stimulation by physiological agonists is known. Here we show that the peptidylprolyl isomerase Pin1 provides a timer for the lifetime of conventional PKC isozymes, converting the enzymes into a species that can be dephosphorylated and ubiquitinated following activation induced by either phorbol esters or natural agonists. The regulation by Pin1 requires both the catalytic activity of the isomerase and the presence of a Pro immediately following the phosphorylated Thr of the turn motif phosphorylation site, one of two C-terminal sites that is phosphorylated during the maturation of PKC isozymes. Furthermore, the second C-terminal phosphorylation site, the hydrophobic motif, docks Pin1 to PKC. Our data are consistent with a model in which Pin1 binds the hydrophobic motif of conventional PKC isozymes to catalyze the isomerization of the phospho-Thr-Pro peptide bond at the turn motif, thus converting these PKC isozymes into species that can be efficiently down-regulated following activation.	[Abrahamsen, Hilde; O'Neill, Audrey K.; Kannan, Natarajan; Taylor, Susan S.; Newton, Alexandra C.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Kannan, Natarajan; Kruse, Nicole; Taylor, Susan S.; Jennings, Patricia A.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [O'Neill, Audrey K.] Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Newton, AC (corresponding author), Univ Calif San Diego, Dept Pharmacol, 9500 Gilman Dr, La Jolla, CA 92093 USA.	anewton@ucsd.edu			National Institutes of Health [P01 DK54441, GM43154]; NIGMS through the University of California, San Diego [T32 GM007752]; Norwegian Research Council; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK054441] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043154, R37GM043154, T32GM007752] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS through the University of California, San Diego; Norwegian Research Council(Research Council of NorwayEuropean Commission); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants P01 DK54441 (to A. C. N. and S. S. T.) and GM43154 (to A. C. N.) and Training Grant T32 GM007752 from the NIGMS (to A. O. through the University of California, San Diego Graduate Training Program in Cellular and Molecular Pharmacology). This work was also supported by The Norwegian Research Council (to H. A.).	Amarzguioui M, 2004, BIOCHEM BIOPH RES CO, V316, P1050, DOI 10.1016/j.bbrc.2004.02.157; Ayala G, 2003, CANCER RES, V63, P6244; Bao L, 2004, AM J PATHOL, V164, P1727, DOI 10.1016/S0002-9440(10)63731-5; Behn-Krappa A, 1999, CURR BIOL, V9, P728, DOI 10.1016/S0960-9822(99)80332-7; Bornancin F, 1996, CURR BIOL, V6, P1114, DOI 10.1016/S0960-9822(02)70678-7; Cenni V, 2002, BIOCHEM J, V363, P537, DOI 10.1042/0264-6021:3630537; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; Chen D, 2004, J BIOL CHEM, V279, P4829, DOI 10.1074/jbc.M311196200; Chou MM, 1998, CURR BIOL, V8, P1069, DOI 10.1016/S0960-9822(98)70444-0; Dutil EM, 2000, J BIOL CHEM, V275, P10697, DOI 10.1074/jbc.275.14.10697; DUTIL EM, 1994, J BIOL CHEM, V269, P29359; Dutil EM, 1998, CURR BIOL, V8, P1366, DOI 10.1016/S0960-9822(98)00017-7; Edwards AS, 1997, J BIOL CHEM, V272, P18382, DOI 10.1074/jbc.272.29.18382; Edwards AS, 1999, J BIOL CHEM, V274, P6461, DOI 10.1074/jbc.274.10.6461; Facchinetti V, 2008, EMBO J, V27, P1932, DOI 10.1038/emboj.2008.120; Gao T, 2008, J BIOL CHEM, V283, P6300, DOI 10.1074/jbc.M707319200; Gao TY, 2006, J BIOL CHEM, V281, P32461, DOI 10.1074/jbc.M604076200; Gao TY, 2002, J BIOL CHEM, V277, P31585, DOI 10.1074/jbc.M204335200; Gao TY, 2001, J BIOL CHEM, V276, P19588, DOI 10.1074/jbc.M101357200; GOODE NT, 1995, J BIOL CHEM, V270, P2669, DOI 10.1074/jbc.270.6.2669; Grodsky N, 2006, BIOCHEMISTRY-US, V45, P13970, DOI 10.1021/bi061128h; Hansra G, 1996, J BIOL CHEM, V271, P32785, DOI 10.1074/jbc.271.51.32785; Hansra G, 1999, BIOCHEM J, V342, P337, DOI 10.1042/0264-6021:3420337; Hauge C, 2007, EMBO J, V26, P2251, DOI 10.1038/sj.emboj.7601682; Ikenoue T, 2008, EMBO J, V27, P1919, DOI 10.1038/emboj.2008.119; JAKEN S, 1981, CANCER RES, V41, P2175; Keranen LM, 1995, CURR BIOL, V5, P1394, DOI 10.1016/S0960-9822(95)00277-6; Kramer A, 1998, METH MOL B, V87, P25; Lahn M, 2004, ONCOLOGY-BASEL, V67, P1, DOI 10.1159/000080279; Le Good JA, 1998, SCIENCE, V281, P2042, DOI 10.1126/science.281.5385.2042; Lee HW, 1996, AM J PHYSIOL-CELL PH, V271, pC304, DOI 10.1152/ajpcell.1996.271.1.C304; Lee HW, 1997, MOL PHARMACOL, V51, P439; Leontieva OV, 2004, J BIOL CHEM, V279, P5788, DOI 10.1074/jbc.M308375200; LEVIN DE, 1990, CELL, V62, P213, DOI 10.1016/0092-8674(90)90360-Q; Liou YC, 2003, NATURE, V424, P556, DOI 10.1038/nature01832; Liou YC, 2002, P NATL ACAD SCI USA, V99, P1335, DOI 10.1073/pnas.032404099; Lu KP, 2004, TRENDS BIOCHEM SCI, V29, P200, DOI 10.1016/j.tibs.2004.02.002; Lu KP, 1996, NATURE, V380, P544; Lu KP, 2002, TRENDS CELL BIOL, V12, P164, DOI 10.1016/S0962-8924(02)02253-5; Lu ZM, 1998, MOL CELL BIOL, V18, P839, DOI 10.1128/MCB.18.2.839; Mantovani F, 2004, MOL CELL, V14, P625, DOI 10.1016/j.molcel.2004.05.007; Newton AC, 2003, BIOCHEM J, V370, P361, DOI 10.1042/BJ20021626; Newton AC, 2010, AM J PHYSIOL-ENDOC M, V298, pE395, DOI 10.1152/ajpendo.00477.2009; Oh WJ, 2010, EMBO J, V29, P3939, DOI 10.1038/emboj.2010.271; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Pinton P, 2007, SCIENCE, V315, P659, DOI 10.1126/science.1135380; Ranganathan R, 1997, CELL, V89, P875, DOI 10.1016/S0092-8674(00)80273-1; Ryo A, 2003, MOL CELL, V12, P1413, DOI 10.1016/S1097-2765(03)00490-8; Ryo A, 2001, NAT CELL BIOL, V3, P793, DOI 10.1038/ncb0901-793; Schiene-Fischer C, 2002, NAT STRUCT BIOL, V9, P419, DOI 10.1038/nsb804; Sedwick CE, 2004, MOL IMMUNOL, V41, P675, DOI 10.1016/j.molimm.2004.01.007; Shen ZJ, 2008, J CLIN INVEST, V118, P479, DOI [10.1172/JC132789, 10.1172/JCI32789]; Sonnenburg ED, 2001, J BIOL CHEM, V276, P45289, DOI 10.1074/jbc.M107416200; SZALLASI Z, 1994, J BIOL CHEM, V269, P27159; Uchida T, 2003, CHEM BIOL, V10, P15, DOI 10.1016/S1074-5521(02)00310-1; Warfel NA, 2012, J BIOL CHEM, V287, P3610, DOI 10.1074/jbc.R111.318675; Wulf G, 2005, NAT CELL BIOL, V7, P435, DOI 10.1038/ncb0505-435; Wulf GM, 2001, EMBO J, V20, P3459, DOI 10.1093/emboj/20.13.3459; Yaffe MB, 1997, SCIENCE, V278, P1957, DOI 10.1126/science.278.5345.1957; Yang CF, 2003, TRENDS PHARMACOL SCI, V24, P602, DOI 10.1016/j.tips.2003.09.003; Yeh E, 2004, NAT CELL BIOL, V6, P308, DOI 10.1038/ncb1110; Yeh ES, 2007, NAT REV CANCER, V7, P381, DOI 10.1038/nrc2107; Zacchi P, 2002, NATURE, V419, P853, DOI 10.1038/nature01120; ZHANG J, 1994, J BIOL CHEM, V269, P19578; Zheng HW, 2002, NATURE, V419, P849, DOI 10.1038/nature01116	66	30	31	3	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					13262	13278		10.1074/jbc.M112.349753	http://dx.doi.org/10.1074/jbc.M112.349753			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22318721	Green Published, hybrid			2022-12-25	WOS:000302903700063
J	Nurieva, RI; Podd, A; Chen, YH; Alekseev, AM; Yu, M; Qi, XP; Huang, H; Wen, RR; Wang, JM; Li, HYS; Watowich, SS; Qi, H; Dong, C; Wang, DM				Nurieva, Roza I.; Podd, Andrew; Chen, Yuhong; Alekseev, Andrei M.; Yu, Mei; Qi, Xiaopeng; Huang, Hua; Wen, Renren; Wang, Junmei; Li, Haiyan S.; Watowich, Stephanie S.; Qi, Hai; Dong, Chen; Wang, Demin			STAT5 Protein Negatively Regulates T Follicular Helper (Tfh) Cell Generation and Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR BATF CONTROLS; DIFFERENTIATION; AUTOIMMUNITY; ICOS; INTERLEUKIN-21; EXPRESSION; RESPONSES; BCL6	Recent work has identified a new subset of CD4(+) T cells named as Tfh cells that are localized in germinal centers and critical in germinal center formation. Tfh cell differentiation is regulated by IL-6 and IL-21, possibly via STAT3 factor, and B cell lymphoma 6 (Bcl6) is specifically expressed in Tfh cells and required for their lineage specification. In the current study, we characterized the role of STAT5 in Tfh cell development. We found that a constitutively active form of STAT5 effectively inhibited Tfh differentiation by suppressing the expression of Tfh-associated factors (CXCmotif) receptor 5 (CXCR5), musculoaponeurotic fibrosarcoma (c-Maf), Bcl6, basic leucine zipper transcription factor ATF-like (Batf), and IL-21, and STAT5 deficiency greatly enhanced Tfh gene expression. Importantly, STAT5 regulated the expression of Tfh cell suppressor factor B lymphocyte-induced maturation protein 1 (Blimp-1); STAT5 deficiency impaired Blimp-1 expression and resulted in elevated expression of Tfh-specific genes. Similarly, inhibition of IL-2 potentiated Tfh generation, associated with dampened Blimp-1 expression; Blimp-1 overexpression inhibited Tfh gene expression in Stat5-deficient T cells, suggesting that the IL-2/STAT5 axis functions to regulate Blimp-1 expression. In vivo, deletion of STAT5 in CD4(+) T cells resulted in enhanced development of Tfh cells and germinal center B cells and led to an impair-ment of B cell tolerance in a well defined mouse tolerance model. Taken together, this study demonstrates that STAT5 controls Tfh differentiation.	[Nurieva, Roza I.; Alekseev, Andrei M.; Wang, Junmei; Li, Haiyan S.; Watowich, Stephanie S.; Dong, Chen] Univ Texas Houston, MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA; [Podd, Andrew; Yu, Mei; Wen, Renren; Wang, Demin] BloodCtr Wisconsin, Blood Res Inst, Milwaukee, WI 53226 USA; [Podd, Andrew; Wang, Demin] Med Coll Wisconsin, Dept Microbiol & Mol Genet, Milwaukee, WI 53226 USA; [Qi, Xiaopeng; Huang, Hua] Natl Jewish Hlth, Dept Med, Div Allergy & Immunol, Denver, CO 80206 USA; [Huang, Hua] Univ Colorado, Sch Med, Integrated Dept Immunol, Denver, CO 80206 USA; [Qi, Hai] Tsinghua Univ, Sch Med, Tsinghua Peking Ctr Life Sci, Beijing 100084, Peoples R China	University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; Versiti Blood Center of Wisconsin; Medical College of Wisconsin; National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Tsinghua University	Dong, C (corresponding author), Univ Texas Houston, MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA.	cdong@mdanderson.org; demin.wang@bcw.edu	dong, chen/B-3181-2009; Yu, Mei/K-2206-2017; Wang, Junmei/N-2256-2014; Wang, Demin/AAX-4449-2020	dong, chen/0000-0002-0084-9130; Wang, Demin/0000-0001-5549-3795; Huang, Hua/0000-0001-7317-8983; Qi, Hai/0000-0001-5475-3989; Watowich, Stephanie/0000-0003-1969-659X	National Institutes of Health [R01 AI079087, PO1 HL44612, R56 AI071239, AI073587, AR059010]; Leukemia and Lymphoma Society; National Institutes of Health through NIAID [RO1 AI083761]; National Institutes of Health through the NIAMS [RO1 AR050772, RC2 AR059010]; M.D. Anderson Cancer Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL044612] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079087, R01AI083761, R56AI071239, R21AI073587] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050772, RC2AR059010] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); National Institutes of Health through NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health through the NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); M.D. Anderson Cancer Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AI079087 and PO1 HL44612 (to D. W.), supplement R56 AI071239 (to R. W.), and Grants AI073587 and AR059010 (to S. S. W.). This work was also supported by a Scholar Award from the Leukemia and Lymphoma Society (to D. W.).; Supported by Grant RO1 AI083761 from the National Institutes of Health through the NIAID.; Supported by grants from the National Institutes of Health through the NIAMS (Grants RO1 AR050772 and RC2 AR059010), the Leukemia and Lymphoma Society, and the M.D. Anderson Cancer Center.	Akiba H, 2005, J IMMUNOL, V175, P2340, DOI 10.4049/jimmunol.175.4.2340; Bauquet AT, 2009, NAT IMMUNOL, V10, P167, DOI 10.1038/ni.1690; Choi YS, 2011, IMMUNITY, V34, P932, DOI 10.1016/j.immuni.2011.03.023; Dai XZ, 2007, J IMMUNOL, V179, P1068, DOI 10.4049/jimmunol.179.2.1068; Fazilleau N, 2009, IMMUNITY, V30, P324, DOI 10.1016/j.immuni.2009.03.003; Fu GP, 2010, J EXP MED, V207, P309, DOI 10.1084/jem.20090880; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; Ise W, 2011, NAT IMMUNOL, V12, P536, DOI 10.1038/ni.2037; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; King C, 2008, ANNU REV IMMUNOL, V26, P741, DOI 10.1146/annurev.immunol.26.021607.090344; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Linterman MA, 2010, SEMIN IMMUNOPATHOL, V32, P183, DOI 10.1007/s00281-009-0194-z; Linterman MA, 2009, J EXP MED, V206, P561, DOI 10.1084/jem.20081886; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; Nurieva RI, 2010, CELL MOL IMMUNOL, V7, P190, DOI 10.1038/cmi.2010.24; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; Schraml BU, 2009, NATURE, V460, P405, DOI 10.1038/nature08114; Vinuesa CG, 2005, NAT REV IMMUNOL, V5, P853, DOI 10.1038/nri1714; Vinuesa CG, 2005, NATURE, V435, P452, DOI 10.1038/nature03555; Vogelzang A, 2008, IMMUNITY, V29, P127, DOI 10.1016/j.immuni.2008.06.001; Yu D, 2009, IMMUNITY, V31, P457, DOI 10.1016/j.immuni.2009.07.002	21	170	180	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					11234	11239		10.1074/jbc.M111.324046	http://dx.doi.org/10.1074/jbc.M111.324046			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22318729	hybrid, Green Published			2022-12-25	WOS:000302780100051
J	Canals, D; Roddy, P; Hannun, YA				Canals, Daniel; Roddy, Patrick; Hannun, Yusuf A.			Protein Phosphatase 1 alpha Mediates Ceramide-induced ERM Protein Dephosphorylation A NOVEL MECHANISM INDEPENDENT OF PHOSPHATIDYLINOSITOL 4, 5-BIPHOSPHATE (PIP2) AND MYOSIN/ERM PHOSPHATASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHO-ASSOCIATED KINASE; CELL-MIGRATION; PLASMA-MEMBRANE; SPHINGOSINE 1-PHOSPHATE; ACTIN CYTOSKELETON; BINDING SUBUNIT; EZRIN; PHOSPHORYLATION; DOMAIN; ACTIVATION	ERM (ezrin, radixin, and moesin) proteins are cytoskeletal interacting proteins that bind cortical actin, the plasma membrane, and membrane proteins, which are found in specialized plasma membrane structures such as microvilli and filopodia. ERM proteins are regulated by phosphatidylinositol 4, 5-biphosphate (PIP2) and by phosphorylation of a C-terminal threonine, and its inactivation involves PIP2 hydrolysis and/or myosin phosphatase (MP). Recently, we demonstrated that ERM proteins are also subject to counter regulation by the bioactive sphingolipids ceramide and sphingosine 1-phosphate. Plasma membrane ceramide induces ERM dephosphorylation whereas sphingosine 1-phosphate induces their phosphorylation. In this work, we pursue the mechanisms by which ceramide regulates dephosphorylation. We found that this dephosphorylation was independent of hydrolysis and localization of PIP2 and MP. However, the results show that ERM dephosphorylation was blocked by treatment with protein phosphatase 1 (PP1) pharmacological inhibitors and specifically by siRNA to PP1 alpha, whereas okadaic acid, a PP2A inhibitor, failed. Moreover, a catalytic inactive mutant of PP1 alpha acted as dominant negative of the endogenous PP1 alpha. Additional results showed that the ceramide mechanism of PP1 alpha activation is largely independent of PIP2 hydrolysis and MP. Taken together, these results demonstrate a novel, acute mechanism of ERM regulation dependent on PP1 alpha and plasma membrane ceramide.	[Canals, Daniel; Roddy, Patrick; Hannun, Yusuf A.] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA	Medical University of South Carolina	Hannun, YA (corresponding author), Med Univ S Carolina, Dept Biochem & Mol Biol, 173 Ashley Ave,POB 250509, Charleston, SC 29425 USA.	hannun@musc.edu	Canals, Daniel/AAJ-8176-2021; Canals, Daniel/AAW-1998-2021	Canals, Daniel/0000-0002-9293-5123	National Institutes of Health [CA87584, CA97132]; NATIONAL CANCER INSTITUTE [R01CA087584, P01CA097132] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by National Institutes of Health Grants CA87584 and CA97132.	ALESSI D, 1992, EUR J BIOCHEM, V210, P1023, DOI 10.1111/j.1432-1033.1992.tb17508.x; Arpin M, 2011, CELL ADHES MIGR, V5, P199, DOI 10.4161/cam.5.2.15081; Bae YS, 2003, MOL PHARMACOL, V63, P1043, DOI 10.1124/mol.63.5.1043; BLEASDALE JE, 1989, ADV PROSTAG THROMB L, V19, P590; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; Canals D, 2010, J BIOL CHEM, V285, P32476, DOI 10.1074/jbc.M110.141028; Cant SH, 2005, MOL BIOL CELL, V16, P3088, DOI 10.1091/mbc.E04-10-0877; Chalfant CE, 1999, J BIOL CHEM, V274, P20313, DOI 10.1074/jbc.274.29.20313; Chuan YC, 2006, J BIOL CHEM, V281, P29938, DOI 10.1074/jbc.M602237200; Denker SP, 2000, MOL CELL, V6, P1425, DOI 10.1016/S1097-2765(00)00139-8; DOBROWSKY RT, 1993, J BIOL CHEM, V268, P15523; DOBROWSKY RT, 1992, J BIOL CHEM, V267, P5048; Endo K, 2009, ONCOGENE, V28, P1725, DOI 10.1038/onc.2009.20; Eto M, 2005, CELL MOTIL CYTOSKEL, V62, P100, DOI 10.1002/cm.20088; Fukata Y, 1998, J CELL BIOL, V141, P409, DOI 10.1083/jcb.141.2.409; Galadari S, 1998, BIOCHEMISTRY-US, V37, P11232, DOI 10.1021/bi980911+; Gallego M, 2006, BIOCHEM J, V399, P169, DOI 10.1042/BJ20060678; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hannun YA, 2011, J BIOL CHEM, V286, P27855, DOI 10.1074/jbc.R111.254359; Hao JJ, 2009, J CELL BIOL, V184, P451, DOI 10.1083/jcb.200807047; Helander TS, 1996, NATURE, V382, P265, DOI 10.1038/382265a0; Hishiya A, 1999, J BIOL CHEM, V274, P26705, DOI 10.1074/jbc.274.38.26705; Hla T, 2004, PROSTAG OTH LIPID M, V73, P1, DOI 10.1016/j.prostaglandins.2003.11.001; Hutchinson JA, 2011, J BIOL CHEM, V286, P8688, DOI 10.1074/jbc.M110.141754; Jones JA, 2005, BIOCHEMISTRY-US, V44, P13235, DOI 10.1021/bi0505159; Kawano Y, 1999, J CELL BIOL, V147, P1023, DOI 10.1083/jcb.147.5.1023; Kimura K, 1998, J BIOL CHEM, V273, P5542, DOI 10.1074/jbc.273.10.5542; Kitatani K, 2006, J BIOL CHEM, V281, P36793, DOI 10.1074/jbc.M608137200; Kowluru A, 1997, FEBS LETT, V418, P179, DOI 10.1016/S0014-5793(97)01379-3; Lamb RF, 1997, CURR BIOL, V7, P682, DOI 10.1016/S0960-9822(06)00295-8; Leoni LM, 1998, BIOCHEM PHARMACOL, V55, P1105, DOI 10.1016/S0006-2952(97)00685-0; Li QZ, 2007, J MOL BIOL, V365, P1446, DOI 10.1016/j.jmb.2006.10.075; Lozupone F, 2004, J BIOL CHEM, V279, P9199, DOI 10.1074/jbc.M305561200; Luo W, 2007, EMBO J, V26, P1511, DOI 10.1038/sj.emboj.7601607; Machesky LM, 2008, FEBS LETT, V582, P2102, DOI 10.1016/j.febslet.2008.03.039; Marchesini N, 2007, BBA-MOL CELL BIOL L, V1771, P1418, DOI 10.1016/j.bbalip.2007.10.003; Matsui T, 1998, J CELL BIOL, V140, P647, DOI 10.1083/jcb.140.3.647; MeivarLevy I, 1997, J BIOL CHEM, V272, P1558, DOI 10.1074/jbc.272.3.1558; Nakamura N, 2000, GENES CELLS, V5, P571, DOI 10.1046/j.1365-2443.2000.00348.x; Oliver Carey J., 1998, Frontiers in Bioscience, V3, pD961; Prag S, 2007, MOL BIOL CELL, V18, P2935, DOI 10.1091/mbc.E06-11-1031; Scotto-Lavino E, 2010, J BIOL CHEM, V285, P6419, DOI 10.1074/jbc.M109.074773; Serrador JM, 1997, J CELL BIOL, V138, P1409, DOI 10.1083/jcb.138.6.1409; Shi YG, 2009, SCI CHINA SER C, V52, P135, DOI 10.1007/s11427-009-0018-3; Short DB, 1998, J BIOL CHEM, V273, P19797, DOI 10.1074/jbc.273.31.19797; Smith ER, 2000, METHOD ENZYMOL, V312, P361; Stauffer TP, 1998, CURR BIOL, V8, P343, DOI 10.1016/S0960-9822(98)70135-6; Tsukita S, 1997, CURR OPIN CELL BIOL, V9, P70, DOI 10.1016/S0955-0674(97)80154-8; Tsukita S, 1997, TRENDS BIOCHEM SCI, V22, P53, DOI 10.1016/S0968-0004(96)10071-2; Virshup DM, 2009, MOL CELL, V33, P537, DOI 10.1016/j.molcel.2009.02.015; Wald FA, 2008, J CELL SCI, V121, P644, DOI 10.1242/jcs.016246; Yonemura S, 1998, J CELL BIOL, V140, P885, DOI 10.1083/jcb.140.4.885; Yu H, 2009, GENES CELLS, V14, P597, DOI 10.1111/j.1365-2443.2009.01295.x; Zeidan YH, 2008, J CELL BIOL, V181, P335, DOI 10.1083/jcb.200705060; Zhang J, 1996, BIOCHEMISTRY-US, V35, P6276, DOI 10.1021/bi952954l; Zohar R, 2000, J CELL PHYSIOL, V184, P118, DOI 10.1002/(SICI)1097-4652(200007)184:1<118::AID-JCP13>3.3.CO;2-P	56	45	46	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					10145	10155		10.1074/jbc.M111.306456	http://dx.doi.org/10.1074/jbc.M111.306456			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22311981	hybrid, Green Published			2022-12-25	WOS:000302167200046
J	Kliem, C; Merling, A; Giaisi, M; Kohler, R; Krammer, PH; Li-Weber, M				Kliem, Christian; Merling, Anette; Giaisi, Marco; Koehler, Rebecca; Krammer, Peter H.; Li-Weber, Min			Curcumin Suppresses T Cell Activation by Blocking Ca2+ Mobilization and Nuclear Factor of Activated T Cells (NFAT) Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAPPA-B ACTIVATION; LYMPHOCYTE-PROLIFERATION; CHEMOPREVENTIVE AGENT; TRANSCRIPTION FACTOR; SIGNAL-TRANSDUCTION; CYTOKINE PRODUCTION; GENE-EXPRESSION; CYCLOSPORINE-A; KINASE; CHANNELS	Curcumin is the active ingredient of the spice turmeric and has been shown to have a number of pharmacologic and therapeutic activities including antioxidant, anti-microbial, anti-inflammatory, and anti-carcinogenic properties. The anti-inflammatory effects of curcumin have primarily been attributed to its inhibitory effect on NF-kappa B activity due to redox regulation. In this study, we show that curcumin is an immunosuppressive phytochemical that blocks T cell-activation-induced Ca2+ mobilization with IC50 = similar to 12.5 mu M and thereby prevents NFAT activation and NFAT-regulated cytokine expression. This finding provides a new mechanism for curcumin-mediated anti-inflammatory and immunosuppressive function. We also show that curcumin can synergize with CsA to enhance immunosuppressive activity because of different inhibitory mechanisms. Furthermore, because Ca2+ is also the secondary messenger crucial for the TCR-induced NF-kappa B signaling pathway, our finding also provides another mechanism by which curcumin suppresses NF-kappa B activation.	[Merling, Anette; Giaisi, Marco; Koehler, Rebecca; Krammer, Peter H.; Li-Weber, Min] German Canc Res Ctr, Tumor Immunol Program D030, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ)	Li-Weber, M (corresponding author), German Canc Res Ctr, Tumor Immunol Program D030, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.	m.li-weber@dkfz-heidelberg.de						Abe Y, 1999, PHARMACOL RES, V39, P41, DOI 10.1006/phrs.1998.0404; Aggarwal BB, 2003, ANTICANCER RES, V23, P363; AMMON HPT, 1991, PLANTA MED, V57, P1, DOI 10.1055/s-2006-960004; Araujo CAC, 2001, MEM I OSWALDO CRUZ, V96, P723, DOI 10.1590/S0074-02762001000500026; Badou A, 2006, P NATL ACAD SCI USA, V103, P15529, DOI 10.1073/pnas.0607262103; Baniyash M, 2004, NAT REV IMMUNOL, V4, P675, DOI 10.1038/nri1434; Cheng AL, 2001, ANTICANCER RES, V21, P2895; Cho NH, 2004, J EXP MED, V200, P681, DOI 10.1084/jem.20040924; Chueh SCJ, 2003, TRANSPLANT P, V35, P1603, DOI 10.1016/S0041-1345(03)00377-4; Cipriani B, 2001, J IMMUNOL, V167, P3454, DOI 10.4049/jimmunol.167.6.3454; del Arco PG, 2000, J BIOL CHEM, V275, P13872, DOI 10.1074/jbc.275.18.13872; DUMONT FJ, 1992, J EXP MED, V176, P751, DOI 10.1084/jem.176.3.751; Dyer JL, 2002, CELL CALCIUM, V31, P45, DOI 10.1054/ceca.2001.0259; Feske S, 2007, NAT REV IMMUNOL, V7, P690, DOI 10.1038/nri2152; Gao XH, 2004, BIOCHEM PHARMACOL, V68, P51, DOI 10.1016/j.bcp.2004.03.015; Goel A, 2008, BIOCHEM PHARMACOL, V75, P787, DOI 10.1016/j.bcp.2007.08.016; Hogan PG, 2010, ANNU REV IMMUNOL, V28, P491, DOI 10.1146/annurev.immunol.021908.132550; Im SH, 2004, MOL CELLS, V18, P1; Jang MK, 2001, PLANTA MED, V67, P550, DOI 10.1055/s-2001-16482; Jobin C, 1999, J IMMUNOL, V163, P3474; Jones EA, 2000, J UROLOGY, V163, P999, DOI 10.1016/S0022-5347(05)67871-8; Jurenka JS, 2009, ALTERN MED REV, V14, P141; Kang BY, 1999, BRIT J PHARMACOL, V128, P380, DOI 10.1038/sj.bjp.0702803; Ke HM, 2003, BIOCHEM BIOPH RES CO, V311, P1095, DOI 10.1016/S0006-291X(03)01537-7; Kotturi MF, 2003, J BIOL CHEM, V278, P46949, DOI 10.1074/jbc.M309268200; Li-Weber M, 2005, J IMMUNOL, V175, P2132, DOI 10.4049/jimmunol.175.4.2132; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Matza D, 2009, IMMUNOL REV, V231, P257, DOI 10.1111/j.1600-065X.2009.00805.x; Muller MR, 2010, NAT REV IMMUNOL, V10, P645, DOI 10.1038/nri2818; Natarajan C, 2002, J IMMUNOL, V168, P6506, DOI 10.4049/jimmunol.168.12.6506; Palkowitsch L, 2011, J BIOL CHEM, V286, P7522, DOI 10.1074/jbc.M110.155895; Parekh AB, 2010, NAT REV DRUG DISCOV, V9, P399, DOI 10.1038/nrd3136; Piwocka K, 1999, EXP CELL RES, V249, P299, DOI 10.1006/excr.1999.4480; Plummer SM, 1999, ONCOGENE, V18, P6013, DOI 10.1038/sj.onc.1202980; Porter CM, 2000, J BIOL CHEM, V275, P3543, DOI 10.1074/jbc.275.5.3543; Ranjan D, 2004, J SURG RES, V121, P171, DOI 10.1016/j.jss.2004.04.004; SERFLING E, 1995, BBA-GENE STRUCT EXPR, V1263, P181, DOI 10.1016/0167-4781(95)00112-T; Sharma RA, 2001, CLIN CANCER RES, V7, P1894; Sica A, 1997, J BIOL CHEM, V272, P30412, DOI 10.1074/jbc.272.48.30412; SIGAL NH, 1991, J EXP MED, V173, P619, DOI 10.1084/jem.173.3.619; SIGAL NH, 1992, ANNU REV IMMUNOL, V10, P519, DOI 10.1146/annurev.iy.10.040192.002511; SINGH S, 1995, J BIOL CHEM, V270, P24995, DOI 10.1074/jbc.270.42.24995; Strimpakos AS, 2008, ANTIOXID REDOX SIGN, V10, P511, DOI 10.1089/ars.2007.1769; Trushin SA, 1999, J BIOL CHEM, V274, P22923, DOI 10.1074/jbc.274.33.22923; Xu YX, 1997, EXP HEMATOL, V25, P413	45	35	37	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					10200	10209		10.1074/jbc.M111.318733	http://dx.doi.org/10.1074/jbc.M111.318733			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22303019	Green Published, hybrid			2022-12-25	WOS:000302167200051
J	Owen, CG; Nightingale, CM; Rudnicka, AR; van Sluijs, EMF; Ekelund, U; Cook, DG; Whincup, PH				Owen, Christopher G.; Nightingale, Claire M.; Rudnicka, Alicja R.; van Sluijs, Esther M. F.; Ekelund, Ulf; Cook, Derek G.; Whincup, Peter H.			Travel to School and Physical Activity Levels in 9-10 Year-Old UK Children of Different Ethnic Origin; Child Heart and Health Study in England (CHASE)	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; WALKING; YOUTH; ADOLESCENTS; INTERVENTIONS; OBESITY; TRENDS; SCHOOLCHILDREN; PERCEPTIONS; ADIPOSITY	Background: Travel to school may offer a convenient way to increase physical activity levels in childhood. We examined the association between method of travel to school and physical activity levels in urban multi-ethnic children. Methods and Findings: 2035 children (aged 9-10 years in 2006-7) provided data on their usual method of travel to school and wore an Actigraph-GT1M activity monitor during waking hours. Associations between method of travel and mean level of physical activity (counts per minute [CPM], steps, time spent in light, moderate or vigorous activity per day) were examined in models adjusted for confounding variables. 1393 children (69%) walked or cycled to school; 161 (8%) used public transport and 481 (24%) travelled by car. White European children were more likely to walk/cycle, black African Caribbeans to travel by public transport and South Asian children to travel by car. Children travelling by car spent less time in moderate to vigorous physical activity (-7 mins, 95% CI-9,-5), and had lower CPM (-32 CPM, 95% CI-44,-19) and steps per day (-813 steps, 95% CI,-1043,-582) than walkers/cyclists. Pupils travelling by public transport had similar activity levels to walkers/cyclists. Lower physical activity levels amongst car travellers' were especially marked at travelling times (school days between 8-9 am, 3-5 pm), but were also evident on weekdays at other times and at weekends; they did not differ by gender or ethnic group. Conclusion: Active travel to school is associated with higher levels of objectively measured physical activity, particularly during periods of travel but also at other times. If children travelling by car were to achieve physical activity levels (steps) similar to children using active travel, they would increase their physical activity levels by 9%. However, the population increase would be a modest 2%, because of the low proportion of car travellers in this urban population.	[Owen, Christopher G.; Nightingale, Claire M.; Rudnicka, Alicja R.; Cook, Derek G.; Whincup, Peter H.] Univ London, Div Populat Hlth Sci & Educ, London, England; [van Sluijs, Esther M. F.; Ekelund, Ulf] Addenbrookes Hosp, MRC Epidemiol Unit, Inst Metab Sci, Cambridge, England; [van Sluijs, Esther M. F.; Ekelund, Ulf] Addenbrookes Hosp, CEDAR, Inst Metab Sci, Cambridge, England	University of London; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Owen, CG (corresponding author), Univ London, Div Populat Hlth Sci & Educ, London, England.	cowen@sgul.ac.uk	Cook, Derek G/C-3271-2008; Ekelund, Ulf/AAE-8471-2019	Ekelund, Ulf/0000-0003-2115-9267; Rudnicka, Alicja R/0000-0003-0369-8574; Nightingale, Claire/0000-0002-4803-7617; Owen, Christopher/0000-0003-1135-5977; Nightingale, Claire/0000-0003-2408-757X; Whincup, Peter/0000-0002-5589-4107; van Sluijs, Esther/0000-0001-9141-9082; Cook, Derek/0000-0002-9723-5759	Wellcome Trust [068362/Z/02/Z]; British Heart Foundation [PG/06/003]; BUPA Foundation [TBF-S09-019]; National Prevention Research Initiative (NPRI); British Heart Foundation; Cancer Research UK; Department of Health; Diabetes UK; Economic and Social Research Council; Medical Research Council; Research and Development Office for the Northern Ireland Health and Social Services; Chief Scientist Office; Scottish Executive Health Department; Welsh Assembly Government; ESRC [ES/G007462/1] Funding Source: UKRI; MRC [MC_U106179473, MC_UP_1001/2, G0501295, MC_U106179474] Funding Source: UKRI; Economic and Social Research Council [ES/G007462/1] Funding Source: researchfish; Medical Research Council [MC_UP_1001/2, G0501295, MC_U106179473, MC_U106179474] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); British Heart Foundation(British Heart Foundation); BUPA Foundation; National Prevention Research Initiative (NPRI); British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Department of Health; Diabetes UK(Diabetes UK); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Research and Development Office for the Northern Ireland Health and Social Services; Chief Scientist Office; Scottish Executive Health Department; Welsh Assembly Government; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by grants from the Wellcome Trust (068362/Z/02/Z), the British Heart Foundation (PG/06/003), the BUPA Foundation (TBF-S09-019)', and by the National Prevention Research Initiative (NPRI). The Funding Partners for this NPRI award were: British Heart Foundation; Cancer Research UK; Department of Health; Diabetes UK; Economic and Social Research Council; Medical Research Council; Research and Development Office for the Northern Ireland Health and Social Services; Chief Scientist Office, Scottish Executive Health Department; and Welsh Assembly Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander LM, 2005, BRIT MED J, V331, P1061, DOI 10.1136/bmj.38567.382731.AE; [Anonymous], 2000, STANDARD OCCUPATIONA; Brown T, 2009, OBES REV, V10, P110, DOI 10.1111/j.1467-789X.2008.00515.x; Cooper AR, 2005, AM J PREV MED, V29, P179, DOI 10.1016/j.amepre.2005.05.009; Cooper AR, 2003, AM J PREV MED, V25, P273, DOI 10.1016/S0749-3797(03)00205-8; Cooper AR, 2006, MED SCI SPORT EXER, V38, P1724, DOI 10.1249/01.mss.0000229570.02037.1d; Cooper AR, 2010, AM J PREV MED, V38, P178, DOI 10.1016/j.amepre.2009.10.036; Davison K. K., 2008, Preventing Chronic Disease, V5, pA100; Department for Transport, 2009, NAT TRAV SURV 2008; Department of Education, 2011, POSTC DIST; Department of Health, 2004, LEAST 5 WEEK EV IMP; Department of Transport, 2001, ATT POT TAK ADD HOM; Dobbins M, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007651; Ekelund U, 2003, OBES RES, V11, P793, DOI 10.1038/oby.2003.110; Ekelund U, 2006, PLOS MED, V3, P2449, DOI 10.1371/journal.pmed.0030488; Faulkner GEJ, 2009, PREV MED, V48, P3, DOI 10.1016/j.ypmed.2008.10.017; Giles-Corti B, 2007, BRIT MED J, V335, P677, DOI 10.1136/bmj.39345.679514.80; Greves HM, 2007, INT J BEHAV NUTR PHY, V4, DOI 10.1186/1479-5868-4-64; Hume C, 2009, AM J PREV MED, V36, P195, DOI 10.1016/j.amepre.2008.10.011; Jago R, 2004, PREV MED, V39, P157, DOI 10.1016/j.ypmed.2004.01.014; Leary SD, 2008, HYPERTENSION, V51, P92, DOI 10.1161/HYPERTENSIONAHA.107.099051; Mattocks C, 2007, INT J PEDIAT OBES, P1; McCambridge TM, 2006, PEDIATRICS, V117, P1834, DOI 10.1542/peds.2006-0472; McDonald NC, 2007, AM J PREV MED, V32, P509, DOI 10.1016/j.amepre.2007.02.022; Mckee R, 2007, J EPIDEMIOL COMMUN H, V61, P818, DOI 10.1136/jech.2006.048181; Mendoza JA, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-122; Metcalf B, 2004, BMJ-BRIT MED J, V329, P832, DOI 10.1136/bmj.38169.688102.F71; Ness AR, 2007, PLOS MED, V4, P476, DOI 10.1371/journal.pmed.0040097; Nightingale CM, 2011, INT J EPIDEMIOL, V40, P33, DOI 10.1093/ije/dyq180; Ortega FB, 2007, INT J BEHAV NUTR PHY, V4, DOI 10.1186/1479-5868-4-61; Owen CG, 2010, DIABETOLOGIA, V53, P1620, DOI 10.1007/s00125-010-1781-1; Owen CG, 2009, INT J EPIDEMIOL, V38, P1082, DOI 10.1093/ije/dyp176; Panter JR, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-34; Puyau MR, 2002, OBES RES, V10, P150, DOI 10.1038/oby.2002.24; Riddoch CJ, 2004, MED SCI SPORT EXER, V36, P86, DOI 10.1249/01.MSS.0000106174.43932.92; Rowland D, 2003, ARCH DIS CHILD, V88, P8, DOI 10.1136/adc.88.1.8; Saksvig BI, 2007, ARCH PEDIAT ADOL MED, V161, P153, DOI 10.1001/archpedi.161.2.153; Salmon J, 2005, AUST NZ J PUBL HEAL, V29, P337, DOI 10.1111/j.1467-842X.2005.tb00204.x; Salmon J, 2007, EPIDEMIOL REV, V29, P144, DOI 10.1093/epirev/mxm010; Sardinha LB, 2008, DIABETES CARE, V31, P569, DOI 10.2337/dc07-1286; Sirard JR, 2005, MED SCI SPORT EXER, V37, P2062, DOI 10.1249/01.mss.0000179102.17183.6b; Summerbell CD, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001871.pub2, 10.1002/14651858.CD001871.pub4]; Timperio A, 2004, PREV MED, V38, P39, DOI 10.1016/j.ypmed.2003.09.026; Trost SG, 1998, MED SCI SPORT EXER, V30, P629, DOI 10.1097/00005768-199804000-00023; Tudor-Locke C, 2001, SPORTS MED, V31, P309, DOI 10.2165/00007256-200131050-00001; van der Ploeg HP, 2008, PREV MED, V46, P60, DOI 10.1016/j.ypmed.2007.06.002; van Sluijs EMF, 2007, BMJ-BRIT MED J, V335, P703, DOI 10.1136/bmj.39320.843947.BE; van Sluijs EMF, 2009, PREV MED, V48, P519, DOI 10.1016/j.ypmed.2009.03.002; Wen LM, 2008, PREV MED, V47, P612, DOI 10.1016/j.ypmed.2008.09.002; Whincup PH, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000263; Wilkin TJ, 2006, INT J OBESITY, V30, P1050, DOI 10.1038/sj.ijo.0803331	51	53	53	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2012	7	2							e30932	10.1371/journal.pone.0030932	http://dx.doi.org/10.1371/journal.pone.0030932			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LO	22319596	Green Submitted, Green Accepted, Green Published, gold			2022-12-25	WOS:000302178400021
J	Papagregoriou, G; Erguler, K; Dweep, H; Voskarides, K; Koupepidou, P; Athanasiou, Y; Pierides, A; Gretz, N; Felekkis, KN; Deltas, C				Papagregoriou, Gregory; Erguler, Kamil; Dweep, Harsh; Voskarides, Konstantinos; Koupepidou, Panayiota; Athanasiou, Yiannis; Pierides, Alkis; Gretz, Norbert; Felekkis, Kyriacos N.; Deltas, Constantinos			A miR-1207-5p Binding Site Polymorphism Abolishes Regulation of HBEGF and Is Associated with Disease Severity in CFHR5 Nephropathy	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; STAGE RENAL-DISEASE; SINGLE-NUCLEOTIDE POLYMORPHISM; VARIANT TRANSLOCATION; HB-EGF; MICRORNAS; MUTATIONS; GENE; IDENTIFICATION; PROLIFERATION	Heparin binding epidermal growth factor (HBEGF) is expressed in podocytes and was shown to play a role in glomerular physiology. MicroRNA binding sites on the 3'UTR of HBEGF were predicted using miRWalk algorithm and followed by DNA sequencing in 103 patients diagnosed with mild or severe glomerulopathy. A single nucleotide polymorphism, miRSNP C1936T (rs13385), was identified at the 3'UTR of HBEGF that corresponds to the second base of the hsa-miR-1207-5p seed region. When AB8/13 undifferentiated podocytes were transfected with miRNA mimics of hsa-miR-1207-5p, the HBEGF protein levels were reduced by about 50%. A DNA fragment containing the miRSNP allele-1936C was cloned into the pMIR-Report Luciferase vector and co-transfected with miRNA mimics of hsa-miR-1207-5p into AB8/13 podocytes. In agreement with western blot data, this resulted in reduced luciferase expression demonstrating the ability of hsa-miR-1207-5p to directly regulate HBEGF expression. On the contrary, in the presence of the miRSNP 1936T allele, this regulation was abolished. Collectively, these results demonstrate that variant 1936T of this miRSNP prevents hsa-miR-1207-5p from down-regulating HBEGF in podocytes. We hypothesized that this variant has a functional role as a genetic modifier. To this end, we showed that in a cohort of 78 patients diagnosed with CFHR5 nephropathy (also known as C3-glomerulopathy), inheritance of miRSNP 1936T allele was significantly increased in the group demonstrating progression to chronic renal failure on long follow-up. No similar association was detected in a cohort of patients with thin basement membrane nephropathy. This is the first report associating a miRSNP as genetic modifier to a monogenic renal disorder.	[Papagregoriou, Gregory; Erguler, Kamil; Voskarides, Konstantinos; Koupepidou, Panayiota; Deltas, Constantinos] Univ Cyprus, Mol Med Res Ctr, Nicosia, Cyprus; [Papagregoriou, Gregory; Erguler, Kamil; Voskarides, Konstantinos; Koupepidou, Panayiota; Deltas, Constantinos] Univ Cyprus, Dept Biol Sci, Lab Mol & Med Genet, Nicosia, Cyprus; [Dweep, Harsh; Gretz, Norbert] Heidelberg Univ, Med Res Ctr, D-6800 Mannheim, Germany; [Athanasiou, Yiannis] Nicosia Gen Hosp, Dept Nephrol, Nicosia, Cyprus; [Pierides, Alkis] Hippocrateon Hosp, Dept Nephrol, Nicosia, Cyprus; [Felekkis, Kyriacos N.] Univ Nicosia, Dept Life & Hlth Sci, Nicosia, Cyprus	University of Cyprus; University of Cyprus; Ruprecht Karls University Heidelberg; Hippocrateon Private Hospital; University of Nicosia	Papagregoriou, G (corresponding author), Univ Cyprus, Mol Med Res Ctr, Nicosia, Cyprus.	felekkis.k@unic.ac.cy; Deltas@ucy.ac.cy	Deltas, Constantinos/A-4936-2013; Erguler, Kamil/Y-5990-2019; Voskarides, Konstantinos/A-4669-2013; Erguler, Kamil/ABD-4636-2020; Deltas, Constantinos/J-9345-2013	Deltas, Constantinos/0000-0001-5549-9169; Erguler, Kamil/0000-0002-2674-592X; Voskarides, Konstantinos/0000-0002-3705-3451; Deltas, Constantinos/0000-0001-5549-9169; Papagregoriou, Gregory/0000-0002-2440-9789; Felekkis, Kyriacos/0000-0002-0919-0037	George & Maria Tyrimos endowment; Pancyprian Gymnasium, Nicosia; Cyprus Research Promotion Foundation;  [NEW INFRASTRUCTURE/STRATEGIC/0308/24]	George & Maria Tyrimos endowment; Pancyprian Gymnasium, Nicosia; Cyprus Research Promotion Foundation; 	This work was supported mainly by the George & Maria Tyrimos endowment through a grant to CD by the Pancyprian Gymnasium, Nicosia, as a scholarship to support GP and by a grant NEW INFRASTRUCTURE/STRATEGIC/0308/24 by the Cyprus Research Promotion Foundation (www.research.org.cy) to CD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelson JF, 2005, SCIENCE, V310, P317, DOI 10.1126/science.1116502; Alvarez ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018671; Athanasiou Y, 2011, CJASN IN PRESS; Bao L, 2007, NUCLEIC ACIDS RES, V35, pD51, DOI 10.1093/nar/gkl797; Barisoni L, 2007, CLIN J AM SOC NEPHRO, V2, P529, DOI 10.2215/CJN.04121206; BARNARD GA, 1947, BIOMETRIKA, V34, P123, DOI 10.2307/2332517; Beetz C, 2008, BRAIN, V131, P1078, DOI 10.1093/brain/awn026; Chen KX, 2008, CARCINOGENESIS, V29, P1306, DOI 10.1093/carcin/bgn116; Cohen RA, 2003, NEW ENGL J MED, V348, P2330, DOI 10.1056/NEJMcp012694; Deltas C, 2012, PEDIATR NEPHROL, V27, P1221, DOI 10.1007/s00467-011-1935-5; Enciso-Mora V, 2010, NAT GENET, V42, P1126, DOI 10.1038/ng.696; Farazi TA, 2008, DEVELOPMENT, V135, P1201, DOI 10.1242/dev.005629; Gale DP, 2010, LANCET, V376, P794, DOI 10.1016/S0140-6736(10)60670-8; Georges M, 2006, COLD SPRING HARB SYM, V71, P343, DOI 10.1101/sqb.2006.71.056; GRAHAM M, 1986, EMBO J, V5, P2845, DOI 10.1002/j.1460-2075.1986.tb04578.x; Guan YH, 2007, CLIN CANCER RES, V13, P5745, DOI 10.1158/1078-0432.CCR-06-2882; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Hanson RL, 2007, DIABETES, V56, P975, DOI 10.2337/db06-1072; Hariharan M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-108; Harvey SJ, 2008, J AM SOC NEPHROL, V19, P2150, DOI 10.1681/ASN.2008020233; Ho J, 2008, J AM SOC NEPHROL, V19, P2069, DOI 10.1681/ASN.2008020162; Huppi K, 2008, MOL CANCER RES, V6, P212, DOI 10.1158/1541-7786.MCR-07-0105; Iwai N, 2005, BIOCHEM BIOPH RES CO, V331, P1439, DOI 10.1016/j.bbrc.2005.04.051; Jazdzewski K, 2009, P NATL ACAD SCI USA, V106, P1502, DOI 10.1073/pnas.0812591106; Lal A, 2009, MOL CELL, V35, P610, DOI 10.1016/j.molcel.2009.08.020; Lamnissou K, 2004, GENET TEST, V8, P319, DOI 10.1089/gte.2004.8.319; Lewis MA, 2009, NAT GENET, V41, P614, DOI 10.1038/ng.369; Liu M, 2010, J AM SOC NEPHROL, V21, P1510, DOI 10.1681/ASN.2010030237; Ludbrook J, 2008, INT J EPIDEMIOL, V37, P1430, DOI 10.1093/ije/dyn162; Luo CC, 2011, NEONATOLOGY, V99, P241, DOI 10.1159/000318142; Lv K, 2008, BIOCHEM BIOPH RES CO, V374, P101, DOI 10.1016/j.bbrc.2008.06.102; Lydersen S, 2009, STAT MED, V28, P1159, DOI 10.1002/sim.3531; Martin MM, 2007, J BIOL CHEM, V282, P24262, DOI 10.1074/jbc.M701050200; Mehta CP, 1991, AM STAT, V45, P74; MEHTA CR, 1993, AM STAT, V47, P91, DOI 10.2307/2685184; Mencia A, 2009, NAT GENET, V41, P609, DOI 10.1038/ng.355; Millis MP, 2007, DIABETES, V56, P3027, DOI 10.2337/db07-0675; Mulder GM, 2010, J PATHOL, V221, P183, DOI 10.1002/path.2698; Paizis K, 1999, KIDNEY INT, V55, P2310, DOI 10.1046/j.1523-1755.1999.00469.x; Persu A, 2002, HUM MOL GENET, V11, P229, DOI 10.1093/hmg/11.3.229; Pierides A, 2009, NEPHROL DIAL TRANSPL, V24, P2721, DOI 10.1093/ndt/gfp158; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Saleem MA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133630; Saunders MA, 2007, P NATL ACAD SCI USA, V104, P3300, DOI 10.1073/pnas.0611347104; Shi SL, 2008, J AM SOC NEPHROL, V19, P2159, DOI 10.1681/ASN.2008030312; Smith JP, 2009, AM J PHYSIOL-RENAL, V296, pF957, DOI 10.1152/ajprenal.90490.2008; Song FJ, 2009, CLIN CANCER RES, V15, P6292, DOI 10.1158/1078-0432.CCR-09-0826; Sun GH, 2009, RNA, V15, P1640, DOI 10.1261/rna.1560209; Takemura T, 1999, J PATHOL, V189, P431; Tan Z, 2007, AM J HUM GENET, V81, P829, DOI 10.1086/521200; Uchiyama-Tanaka Y, 2002, KIDNEY INT, V62, P799, DOI 10.1046/j.1523-1755.2002.00537.x; Voskarides K, 2007, J AM SOC NEPHROL, V18, P3004, DOI 10.1681/ASN.2007040444; Wang G, 2008, AM J HUM GENET, V82, P283, DOI 10.1016/j.ajhg.2007.09.021; Wiggins RC, 2007, KIDNEY INT, V71, P1205, DOI 10.1038/sj.ki.5002222; Wu LG, 2006, P NATL ACAD SCI USA, V103, P4034, DOI 10.1073/pnas.0510928103; Xu J, 2009, HUM MUTAT, V30, P1231, DOI 10.1002/humu.21044; Zhuang S, 2008, AM J PHYSIOL-RENAL, V294, pF459, DOI 10.1152/ajprenal.00473.2007; Zuchner S, 2006, AM J HUM GENET, V79, P365, DOI 10.1086/505361	58	38	40	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2012	7	2							e31021	10.1371/journal.pone.0031021	http://dx.doi.org/10.1371/journal.pone.0031021			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UV	22319602	gold, Green Published, Green Submitted			2022-12-25	WOS:000301979000018
J	Shenoy, K				Shenoy, Kausalya			Environmentally Realistic Exposure to the Herbicide Atrazine Alters Some Sexually Selected Traits in Male Guppies	PLOS ONE			English	Article							MALE-MALE COMPETITION; FEMALE MATE CHOICE; POECILIA-RETICULATA; TESTOSTERONE PRODUCTION; ENDOCRINE DISRUPTION; GEOGRAPHIC-VARIATION; AGGRESSIVE-BEHAVIOR; MALE COLOR; FROGS; EXPRESSION	Male mating signals, including ornaments and courtship displays, and other sexually selected traits, like male-male aggression, are largely controlled by sex hormones. Environmental pollutants, notably endocrine disrupting compounds, can interfere with the proper functioning of hormones, thereby impacting the expression of hormonally regulated traits. Atrazine, one of the most widely used herbicides, can alter sex hormone levels in exposed animals. I tested the effects of environmentally relevant atrazine exposures on mating signals and behaviors in male guppies, a sexually dimorphic freshwater fish. Prolonged atrazine exposure reduced the expression of two honest signals: the area of orange spots (ornaments) and the number of courtship displays performed. Atrazine exposure also reduced aggression towards competing males in the context of mate competition. In the wild, exposure levels vary among individuals because of differential distribution of the pollutants across habitats; hence, differently impacted males often compete for the same mates. Disrupted mating signals can reduce reproductive success as females avoid mating with perceptibly suboptimal males. Less aggressive males are at a competitive disadvantage and lose access to females. This study highlights the effects of atrazine on ecologically relevant mating signals and behaviors in exposed wildlife. Altered reproductive traits have important implications for population dynamics, evolutionary patterns, and conservation of wildlife species.	Univ Kentucky, Dept Biol, Lexington, KY 40506 USA	University of Kentucky	Shenoy, K (corresponding author), Univ Kentucky, Dept Biol, Lexington, KY 40506 USA.	kay.yellowtoad@gmail.com	Shenoy, Kausalya/D-4085-2015		Sigma Xi; Department of Biology, University of Kentucky; University of Kentucky	Sigma Xi; Department of Biology, University of Kentucky; University of Kentucky	The study was funded by the Sigma Xi Grant-In-Aid of Research and the Ribble Mini-Grant, Department of Biology, University of Kentucky. During the course of this study, KS received support from the Kentucky Opportunity Fellowship, University of Kentucky. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarikwu SO, 2010, ARCH ENVIRON CON TOX, V58, P874, DOI 10.1007/s00244-009-9371-2; Andersson Malte, 1994; Ankley GT, 2005, TOXICOL SCI, V86, P300, DOI 10.1093/toxsci/kfi202; Ankley GT, 2002, TOXICOL SCI, V67, P121, DOI 10.1093/toxsci/67.1.121; Arellano-Aguilar O, 2008, P ROY SOC B-BIOL SCI, V275, P1343, DOI 10.1098/rspb.2008.0163; Baatrup E, 2001, ENVIRON HEALTH PERSP, V109, P1063, DOI 10.2307/3454962; BARTKE A, 1977, BIOL REPROD, V17, P645, DOI 10.1095/biolreprod17.5.645; Basrur PK, 2006, ENVIRON RES, V100, P18, DOI 10.1016/j.envres.2005.08.016; Bayley M, 2003, BIOL REPROD, V69, P1951, DOI 10.1095/biolreprod.103.017780; Bayley M, 2002, AQUAT TOXICOL, V56, P227, DOI 10.1016/S0166-445X(01)00210-7; Bell AM, 2001, ANIM BEHAV, V62, P775, DOI 10.1006/anbe.2001.1824; Bernhardt RR, 2008, BEHAVIOUR, V145, P527, DOI 10.1163/156853908792451511; Bokony V, 2008, BEHAV ECOL SOCIOBIOL, V62, P1229, DOI 10.1007/s00265-008-0551-2; Bortolotti GR, 2003, FUNCT ECOL, V17, P651, DOI 10.1046/j.1365-2435.2003.00778.x; Comber SDW, 1999, PESTIC SCI, V55, P696, DOI 10.1002/(SICI)1096-9063(199907)55:7&lt;696::AID-PS11&gt;3.0.CO;2-7; Cotton S, 2009, CONSERV BIOL, V23, P196, DOI 10.1111/j.1523-1739.2008.01053.x; Davis ES, 2002, BEHAV ECOL SOCIOBIOL, V52, P224, DOI 10.1007/s00265-002-0513-z; Devasurendra RS, 2007, P PER U RES SESS SRI; Earley RL, 2008, HORM BEHAV, V53, P442, DOI 10.1016/j.yhbeh.2007.11.017; Earley Ryan L., 2006, P84; ENDLER JA, 1993, ECOL MONOGR, V63, P1, DOI 10.2307/2937121; ENDLER JA, 1995, EVOLUTION, V49, P456, DOI [10.2307/2410270, 10.1111/j.1558-5646.1995.tb02278.x]; ENDLER JA, 1991, VISION RES, V31, P587, DOI 10.1016/0042-6989(91)90109-I; EPA, 1993, EPA821R93010A; Evans JP, 2003, BIOL J LINN SOC, V78, P605, DOI 10.1046/j.0024-4066.2002.00193.x; Evans JP, 1999, ANIM BEHAV, V58, P1001, DOI 10.1006/anbe.1999.1212; Fan WQ, 2007, ENVIRON HEALTH PERSP, V115, P720, DOI 10.1289/ehp.9758; FOLSTAD I, 1992, AM NAT, V139, P603, DOI 10.1086/285346; GODIN JGJ, 1995, OECOLOGIA, V103, P224, DOI 10.1007/BF00329084; Gordon SP, 2012, EVOLUTION, V66, P912, DOI 10.1111/j.1558-5646.2011.01495.x; Grether GF, 2000, EVOLUTION, V54, P1712, DOI 10.1111/j.0014-3820.2000.tb00715.x; Grube A, 733R11001 US EPA; Hallgren SLE, 2006, GEN COMP ENDOCR, V147, P323, DOI 10.1016/j.ygcen.2006.02.005; Haskins C. P., 1961, VERTEBRATE SPECIATIO, P320; Hayes T, 2002, NATURE, V419, P895, DOI 10.1038/419895a; Hayes T, 2003, ENVIRON HEALTH PERSP, V111, P568, DOI 10.1289/ehp.5932; Hayes TB, 2002, P NATL ACAD SCI USA, V99, P5476, DOI 10.1073/pnas.082121499; Hayes TB, 2005, INTEGR COMP BIOL, V45, P321, DOI 10.1093/icb/45.2.321; Hayes TB, 2006, ENVIRON HEALTH PERSP, V114, P134, DOI 10.1289/ehp.8067; Hayes TB, 2010, P NATL ACAD SCI USA, V107, P4612, DOI 10.1073/pnas.0909519107; Hecker M, 2005, TOXICOL SCI, V86, P273, DOI 10.1093/toxsci/kfi203; HERMAN RL, 1988, AQUACULTURE, V72, P165, DOI 10.1016/0044-8486(88)90156-1; Hillgarth Nigella, 1997, P78; Houde A.E., 1997, SEX COLOR MATE CHOIC; HOUDE AE, 1992, HEREDITY, V69, P229, DOI 10.1038/hdy.1992.120; HOUDE AE, 1988, ANIM BEHAV, V36, P888, DOI 10.1016/S0003-3472(88)80171-4; HOUDE AE, 1992, BEHAV ECOL, V3, P346, DOI 10.1093/beheco/3.4.346; HUNT GL, 1977, SCIENCE, V196, P1466, DOI 10.1126/science.196.4297.1466; Jayasooriya AP, 2002, SCIENCE, V296, P847; Jirotkul M, 1999, ANIM BEHAV, V58, P287, DOI 10.1006/anbe.1999.1149; Karino K, 2005, BEHAV ECOL SOCIOBIOL, V59, P1, DOI 10.1007/s00265-005-0001-3; Kelce WR, 1997, J MOL MED, V75, P198, DOI 10.1007/s001090050104; Kempenaers B, 1997, BEHAV ECOL, V8, P481, DOI 10.1093/beheco/8.5.481; Kidd KA, 2007, P NATL ACAD SCI USA, V104, P8897, DOI 10.1073/pnas.0609568104; Kim SK, 2007, ENVIRON TOXICOL, V22, P449, DOI 10.1002/tox.20280; Kodric-Brown A, 2001, BEHAV ECOL SOCIOBIOL, V50, P346, DOI 10.1007/s002650100374; Krisfalusi M, 1998, B ENVIRON CONTAM TOX, V61, P519, DOI 10.1007/s001289900793; Kristensen T, 2007, AQUAT TOXICOL, V81, P245, DOI 10.1016/j.aquatox.2006.12.005; Kristensen T, 2005, BIOL REPROD, V72, P150, DOI 10.1095/biolreprod.104.033001; Larsen MG, 2008, AQUAT TOXICOL, V87, P234, DOI 10.1016/j.aquatox.2008.02.003; LONG KD, 1989, ETHOLOGY, V82, P316; Lopez S, 1998, P ROY SOC B-BIOL SCI, V265, P717, DOI 10.1098/rspb.1998.0352; LUYTEN PH, 1985, BEHAVIOUR, V95, P164, DOI 10.1163/156853985X00109; MAGURRAN AE, 1990, BEHAVIOUR, V112, P194, DOI 10.1163/156853990X00194; Majewski AR, 2002, WATER QUAL RES J CAN, V37, P697, DOI 10.2166/wqrj.2002.047; Markman S, 2007, CHEMOSPHERE, V70, P119, DOI 10.1016/j.chemosphere.2007.06.045; Markman S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001674; Maynard Smith J, 2003, ANIMAL SIGNALS, P176; McGraw KJ, 2006, BEHAV ECOL SOCIOBIOL, V60, P117, DOI 10.1007/s00265-005-0135-3; Milnes MR, 2006, ENVIRON RES, V100, P3, DOI 10.1016/j.envres.2005.04.002; Mockford EJ, 2009, P ROY SOC B-BIOL SCI, V276, P2979, DOI 10.1098/rspb.2009.0586; Mougeot F, 2009, P ROY SOC B-BIOL SCI, V276, P1093, DOI 10.1098/rspb.2008.1570; Nakagawa S, 2007, BIOL REV, V82, P591, DOI 10.1111/j.1469-185X.2007.00027.x; Nakayama K, 2004, CHEMOSPHERE, V55, P1331, DOI 10.1016/j.chemosphere.2003.11.050; Palanza P, 2002, ECO ENV TOX, P377; Palanza P, 2002, NEUROTOXICOL TERATOL, V24, P55, DOI 10.1016/S0892-0362(01)00191-X; Park KJ, 2009, CHEMOSPHERE, V77, P1459, DOI 10.1016/j.chemosphere.2009.08.063; Partridge C, 2010, HORM BEHAV, V58, P800, DOI 10.1016/j.yhbeh.2010.08.002; Peters A, 2001, BEHAV ECOL SOCIOBIOL, V50, P519, DOI 10.1007/s002650100403; PORTER RD, 1969, SCIENCE, V165, P199, DOI 10.1126/science.165.3889.199; Porter WP, 1999, TOXICOL IND HEALTH, V15, P133, DOI 10.1191/074823399678846691; Quader S, 2005, CURR SCI INDIA, V89, P1220; Rasband WS, 1997, IMAGEJ VERSION 1 43U; Robinson CD, 2007, AQUAT TOXICOL, V81, P397, DOI 10.1016/j.aquatox.2006.12.020; Rodd FH, 2002, P ROY SOC B-BIOL SCI, V269, P475, DOI 10.1098/rspb.2001.1891; Rohr JR, 2010, ENVIRON HEALTH PERSP, V118, P20, DOI 10.1289/ehp.0901164; Saaristo M, 2009, HORM BEHAV, V56, P315, DOI 10.1016/j.yhbeh.2009.06.010; SAS Institute Inc, 2002, SAS VERS 9 2; Secondi J, 2009, FUNCT ECOL, V23, P800, DOI 10.1111/j.1365-2435.2009.01558.x; Seehausen O, 1997, SCIENCE, V277, P1808, DOI 10.1126/science.277.5333.1808; Seehausen O, 1998, BEHAV ECOL SOCIOBIOL, V42, P1, DOI 10.1007/s002650050405; Setchell JM, 2008, HORM BEHAV, V54, P365, DOI 10.1016/j.yhbeh.2008.05.004; Shenoy K, 2011, FUNCT ECOL, V25, P433, DOI 10.1111/j.1365-2435.2010.01787.x; Slabbekoorn H, 2008, MOL ECOL, V17, P72, DOI 10.1111/j.1365-294X.2007.03487.x; Solomon KR, 2008, CRIT REV TOXICOL, V38, P721, DOI [10.1080/10408440802116496, 10.1080/10408440802116496 ]; Solomon KR, 1996, ENVIRON TOXICOL CHEM, V15, P31, DOI [10.1002/etc.5620150105, 10.1897/1551-5028(1996)015&lt;0031:ERAOAI&gt;2.3.CO;2]; Soltis J, 2001, ANIM BEHAV, V62, P485, DOI 10.1006/anbe.2001.1774; Tillitt DE, 2010, AQUAT TOXICOL, V99, P149, DOI 10.1016/j.aquatox.2010.04.011; Toft G, 2001, ECOTOX ENVIRON SAFE, V48, P76, DOI 10.1006/eesa.2000.1985; U.S. Environmental Protection Agency, 2006, DEC DOC ATR; US EPA, 2009, PERS ORG POLL GLOB I; Walters DM, 2010, ENVIRON SCI TECHNOL, V44, P2849, DOI 10.1021/es9023139; Willingham EJ, 2005, FRONT ECOL ENVIRON, V3, P309, DOI 10.2307/3868564; ZUK M, 1995, P ROY SOC B-BIOL SCI, V260, P205, DOI 10.1098/rspb.1995.0081	104	35	39	2	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2012	7	2							e30611	10.1371/journal.pone.0030611	http://dx.doi.org/10.1371/journal.pone.0030611			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UG	22312428	Green Published, Green Submitted, gold			2022-12-25	WOS:000301977500012
J	Holliday, CM; Gardner, NM				Holliday, Casey M.; Gardner, Nicholas M.			A New Eusuchian Crocodyliform with Novel Cranial Integument and Its Significance for the Origin and Evolution of Crocodylia	PLOS ONE			English	Article							MIOCENE URUMACO FORMATION; ALLIGATOR-MISSISSIPPIENSIS; PHYLOGENETIC-RELATIONSHIPS; MORPHOLOGY; REGION; MESOEUCROCODYLIA; BIOGEOGRAPHY	Crocodyliforms were one of the most successful groups of Mesozoic tetrapods, radiating into terrestrial, semiaquatic and marine environments, while occupying numerous trophic niches, including carnivorous, insectivorous, herbivorous, and piscivorous species. Among these taxa were the enigmatic, poorly represented flat-headed crocodyliforms from the late Cretaceous of northern Africa. Here we report a new, giant crocodyliform from the early Late Cretaceous (Cenomanian) Kem Kem Formation of Morocco. Represented by a partial braincase, the taxon has an extremely long, flat skull with large jaw and craniocervical muscles. The skull roof is ridged and ornamented with a broad, rough boss surrounded by significant vascular impressions, likely forming an integumentary structure unique among crocodyliforms. Size estimates using endocranial volume indicate the specimen was very large. The taxon possesses robust laterosphenoids with laterally oriented capitate processes and isolated epipterygoids, features allying it with derived eusuchians. Phylogenetic analysis finds the taxon to be a derived eusuchian and sister taxon to Aegyptosuchus, a poorly understood, early Late Cretaceous taxon from the Bahariya formation. This clade forms the sister clade of crown-group Crocodylia, making these taxa the earliest eusuchian crocodyliforms known from Africa. These results shift phylogenetic and biogeographical hypotheses on the origin of modern crocodylians towards the circum-Tethyean region and provide important new data on eusuchian morphology and evolution.	[Holliday, Casey M.] Univ Missouri, Sch Med, Dept Pathol & Anat Sci, Columbia, MO 65211 USA; [Gardner, Nicholas M.] Marshall Univ, Dept Biol Sci, Huntington, WV USA	University of Missouri System; University of Missouri Columbia; Marshall University	Holliday, CM (corresponding author), Univ Missouri, Sch Med, Dept Pathol & Anat Sci, Columbia, MO 65211 USA.	hollidayca@missouri.edu	Gardner, Nicholas/S-3207-2019; Gardner, Nicholas/GOV-7256-2022	Gardner, Nicholas/0000-0002-5278-7541; Holliday, Casey/0000-0001-8210-8434	Department of Pathology and Anatomical Sciences and University of Missouri; University of Missouri Research Council; Marshall University	Department of Pathology and Anatomical Sciences and University of Missouri; University of Missouri Research Council; Marshall University	C. M. H. was funded by the Department of Pathology and Anatomical Sciences and University of Missouri, University of Missouri Research Council. N. M. G. was funded by Marshall University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera OA, 2006, J SYST PALAEONTOL, V4, P221, DOI 10.1017/S147720190600188X; Baumel Julian J., 1993, Publications of the Nuttall Ornithological Club, V23, P407; BREMER K, 1994, CLADISTICS, V10, P295, DOI 10.1006/clad.1994.1019; Brochu CA, 1997, SYST BIOL, V46, P479, DOI 10.2307/2413693; Brochu CA, 2003, ANNU REV EARTH PL SC, V31, P357, DOI 10.1146/annurev.earth.31.100901.141308; Brochu CA, 2001, CROCODILIAN BIOL EVO, P7; Brochu CA, 2007, ZOOL J LINN SOC-LOND, V150, P835, DOI 10.1111/j.1096-3642.2007.00315.x; BUFFETAUT E, 1977, Palaeontology (Oxford), V20, P203; Buffetaut E., 1981, GEOL RUNDSCH, V70, P611, DOI DOI 10.1007/BF01822139; CARROLL RL, 1988, VERTEBRATE PALEONTOL; Cavin L, 2010, J AFR EARTH SCI, V57, P391, DOI 10.1016/j.jafrearsci.2009.12.007; Delfino M, 2008, J VERTEBR PALEONTOL, V28, P111, DOI 10.1671/0272-4634(2008)28[111:ACSOAP]2.0.CO;2; DODSON P, 1975, J ZOOL, V175, P315; Farlow JO, 2005, J VERTEBR PALEONTOL, V25, P354, DOI 10.1671/0272-4634(2005)025[0354:FDABSO]2.0.CO;2; GARRICK LD, 1977, AM ZOOL, V17, P225; George I, 2011, J VERTEBR PALEONTOL, V31, P116; Hieronymus TL, 2009, ANAT REC, V292, P1370, DOI 10.1002/ar.20985; Holliday CM, 2009, J VERTEBR PALEONTOL, V29, P715, DOI 10.1671/039.029.0330; Ibrahim N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010875; Jenkins FA, 2008, J VERTEBR PALEONTOL, V28, P935, DOI 10.1671/0272-4634-28.4.935; Larsson HCE, 2007, ZOOL J LINN SOC-LOND, V149, P533, DOI 10.1111/j.1096-3642.2007.00271.x; Lauprasert K, 2011, PALAEONTOL Z, V85, P37, DOI 10.1007/s12542-010-0071-z; Martin JE, 2010, NATURWISSENSCHAFTEN, V97, P845, DOI 10.1007/s00114-010-0702-y; Martin JE, 2010, PALAEOGEOGR PALAEOCL, V293, P406, DOI 10.1016/j.palaeo.2009.10.021; Nopcsa F. Baron., 1926, Zentralblatt fuer Mineralogie Stuttgart B, V1926, P212; Riff D, 2008, PALAEONTOL Z, V82, P178, DOI 10.1007/BF02988408; Salisbury SW, 2006, P ROY SOC B-BIOL SCI, V273, P2439, DOI 10.1098/rspb.2006.3613; Salisbury SW, 2003, PALAEONTOGR ABT A, V270, P3; Schwimmer DR., 2002, KING CROCODYLIANS PA; Sereno PC, 2009, ZOOKEYS, P1, DOI 10.3897/zookeys.28.325; Sereno PC, 2003, J VERTEBR PALEONTOL, V23, P477, DOI 10.1671/0272-4634(2003)023[0477:ANNFTE]2.0.CO;2; Sereno PC, 1996, SCIENCE, V272, P986, DOI 10.1126/science.272.5264.986; Sereno PC, 2001, SCIENCE, V294, P1516, DOI 10.1126/science.1066521; Smith JB, 2001, SCIENCE, V292, P1704, DOI 10.1126/science.1060561; Stromer E., 1933, Abhandlungen der Bayerischen Akademie der Wissenschaften NF, V15, P1; Stromer E, 1925, ABHANDLUNGEN BAYE MN, V30, P1; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; Tsuihiji T, 2005, J MORPHOL, V263, P151, DOI 10.1002/jmor.10294; Turner AH, 2004, P ROY SOC B-BIOL SCI, V271, P2003, DOI 10.1098/rspb.2004.2840; Witmer LM, 2009, ANAT REC, V292, P1266, DOI 10.1002/ar.20983	40	56	57	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2012	7	1							e30471	10.1371/journal.pone.0030471	http://dx.doi.org/10.1371/journal.pone.0030471			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	912BY	22303441	Green Published, gold			2022-12-25	WOS:000301770700006
J	Nakamura, Y; Kitamura, N; Shinogi, D; Yoshida, M; Goda, O; Murai, R; Kamino, H; Arakawa, H				Nakamura, Yasuyuki; Kitamura, Noriaki; Shinogi, Daisuke; Yoshida, Masaki; Goda, Olga; Murai, Ryuya; Kamino, Hiroki; Arakawa, Hirofumi			BNIP3 and NIX Mediate Mieap-Induced Accumulation of Lysosomal Proteins within Mitochondria	PLOS ONE			English	Article							CELL-DEATH; PERMEABILITY TRANSITION; APOPTOSIS; DOMAIN; NIP3	Mieap, a p53-inducible protein, controls mitochondrial quality by repairing unhealthy mitochondria. During repair, Mieap induces the accumulation of intramitochondrial lysosomal proteins (designated MALM for Mieap-induced accumulation of lysosome-like organelles within mitochondria) by interacting with NIX, leading to the elimination of oxidized mitochondrial proteins. Here, we report that an additional mitochondrial outer membrane protein, BNIP3, is also involved in MALM. BNIP3 interacts with Mieap in a reactive oxygen species (ROS)-dependent manner via the BH3 domain of BNIP3 and the coiled-coil domains of Mieap. The knockdown of endogenous BNIP3 expression severely inhibited MALM. Although the overexpression of either BNIP3 or NIX did not cause a remarkable change in the mitochondrial membrane potential (MMP), the co-expression of all three exogenous proteins, Mieap, BNIP3 and NIX, caused a dramatic reduction in MMP, implying that the physical interaction of Mieap, BNIP3 and NIX at the mitochondrial outer membrane may regulate the opening of a pore in the mitochondrial double membrane. This effect was not related to cell death. These results suggest that two mitochondrial outer membrane proteins, BNIP3 and NIX, mediate MALM in order to maintain mitochondrial integrity. The physical interaction of Mieap, BNIP3 and NIX at the mitochondrial outer membrane may play a critical role in the translocation of lysosomal proteins from the cytoplasm to the mitochondrial matrix.	[Nakamura, Yasuyuki; Kitamura, Noriaki; Shinogi, Daisuke; Yoshida, Masaki; Goda, Olga; Murai, Ryuya; Kamino, Hiroki; Arakawa, Hirofumi] Natl Canc Ctr, Res Inst, Div Canc Biol, Tokyo 104, Japan	National Cancer Center - Japan	Arakawa, H (corresponding author), Natl Canc Ctr, Res Inst, Div Canc Biol, Tokyo 104, Japan.	harakawa@ncc.go.jp	Arakawa, Hirofumi/L-3459-2013	Arakawa, Hirofumi/0000-0001-6077-0638; KAMINO, HIROKI/0000-0002-2489-0453	Ministry of Education, Culture, Sports, Science, and Technology, Japan; Ministry of Health, Labor and Welfare, Japan	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan)	Grant support was provided by a grant-in-aid for Scientific Research on Priority Areas from the Ministry of Education, Culture, Sports, Science, and Technology, Japan; a grant-in-aid from the Ministry of Health, Labor and Welfare for the 3rd-Term Comprehensive 10-year Strategy for Cancer Control and for Cancer Research, Japan; and a grant-in-aid for National Cancer Center Research and Development Fund, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bocharov EV, 2007, J BIOL CHEM, V282, P16256, DOI 10.1074/jbc.M701745200; BOYD JM, 1994, CELL, V79, P341, DOI 10.1016/0092-8674(94)90202-X; Chen G, 1997, J EXP MED, V186, P1975, DOI 10.1084/jem.186.12.1975; Chen G, 1999, J BIOL CHEM, V274, P7, DOI 10.1074/jbc.274.1.7; Cizeau J, 2000, ONCOGENE, V19, P5453, DOI 10.1038/sj.onc.1203929; Dorn GW, 2010, J CARDIOVASC TRANSL, V3, P374, DOI 10.1007/s12265-010-9174-x; Kim H, 2006, NAT CELL BIOL, V8, P1348, DOI 10.1038/ncb1499; Kim JY, 2002, ARCH BIOCHEM BIOPHYS, V398, P147, DOI 10.1006/abbi.2001.2673; Kitamura N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016060; Kubasiak LA, 2002, P NATL ACAD SCI USA, V99, P12825, DOI 10.1073/pnas.202474099; Miyamoto Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016054; Ray R, 2000, J BIOL CHEM, V275, P1439, DOI 10.1074/jbc.275.2.1439; Vande Velde C, 2000, MOL CELL BIOL, V20, P5454, DOI 10.1128/MCB.20.15.5454-5468.2000; Zhang J, 2009, CELL DEATH DIFFER, V16, P939, DOI 10.1038/cdd.2009.16	14	35	41	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2012	7	1							e30767	10.1371/journal.pone.0030767	http://dx.doi.org/10.1371/journal.pone.0030767			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911FX	22292033	Green Published, gold, Green Submitted			2022-12-25	WOS:000301703800029
J	Tanae, K; Horiuchi, T; Matsuo, Y; Katayama, S; Kawamukai, M				Tanae, Katsuhiro; Horiuchi, Tomitaka; Matsuo, Yuzy; Katayama, Satoshi; Kawamukai, Makoto			Histone Chaperone Asf1 Plays an Essential Role in Maintaining Genomic Stability in Fission Yeast	PLOS ONE			English	Article							SCHIZOSACCHAROMYCES-POMBE; DNA-REPLICATION; CELL-CYCLE; S-PHASE; SACCHAROMYCES-CEREVISIAE; CHECKPOINT PATHWAYS; DAMAGE CHECKPOINTS; H3K56 ACETYLATION; IN-VIVO; CHROMATIN	The histone H3-H4 chaperone Asf1 is involved in chromatin assembly (or disassembly), histone exchange, regulation of transcription, and chromatin silencing in several organisms. To investigate the essential functions of Asf1 in Schizosaccharomyces pombe, asf1-ts mutants were constructed by random mutagenesis using PCR. One mutant (asf1-33(ts)) was mated with mutants in 77 different kinase genes to identify synthetic lethal combinations. The asf1-33 mutant required the DNA damage checkpoint factors Chk1 and Rad3 for its survival at the restrictive temperature. Chk1, but not Cds1, was phosphorylated in the asf1-33 mutant at the restrictive temperature, indicating that the DNA damage checkpoint was activated in the asf1-33 mutant. DNA damage occured in the asf1-33 mutant, with degradation of the chromosomal DNA observed through pulse-field gel electrophoresis and the formation of Rad22 foci. Sensitivity to micrococcal nuclease in the asf1-33 mutant was increased compared to the asf1(+) strain at the restrictive temperature, suggesting that asf1 mutations also caused a defect in overall chromatin structure. The Asf1-33 mutant protein was mislocalized and incapable of binding histones. Furthermore, histone H3 levels at the centromeric outer repeat region were decreased in the asf1-33 mutant and heterochromatin structure was impaired. Finally, sim3, which encodes a CenH3 histone chaperone, was identified as a strong suppressor of the asf1-33 mutant. Taken together, these results clearly indicate that Asf1 plays an essential role in maintaining genomic stability in S. pombe.	[Tanae, Katsuhiro; Horiuchi, Tomitaka; Matsuo, Yuzy; Katayama, Satoshi; Kawamukai, Makoto] Shimane Univ, Fac Life & Environm Sci, Dept Life Sci & Biotechnol, Matsue, Shimane, Japan	Shimane University	Tanae, K (corresponding author), Shimane Univ, Fac Life & Environm Sci, Dept Life Sci & Biotechnol, Matsue, Shimane, Japan.	kawamuka@life.shimane-u.ac.jp	Kawamukai, Makoto/AET-1038-2022	Kawamukai, Makoto/0000-0003-2929-8798				Adkins MW, 2004, J BIOL CHEM, V279, P52069, DOI 10.1074/jbc.M406113200; Adkins MW, 2004, MOL CELL, V14, P657, DOI 10.1016/j.molcel.2004.05.016; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; BASI G, 1993, GENE, V123, P131, DOI 10.1016/0378-1119(93)90552-E; Bimbo A, 2005, EUKARYOT CELL, V4, P799, DOI 10.1128/EC.4.4.799-813.2005; Daganzo SM, 2003, CURR BIOL, V13, P2148, DOI 10.1016/j.cub.2003.11.027; Dohke K, 2008, GENES CELLS, V13, P1027, DOI 10.1111/j.1365-2443.2008.01225.x; Dunleavy EM, 2007, MOL CELL, V28, P1029, DOI 10.1016/j.molcel.2007.10.010; Eitoku M, 2008, CELL MOL LIFE SCI, V65, P414, DOI 10.1007/s00018-007-7305-6; English CM, 2006, CELL, V127, P495, DOI 10.1016/j.cell.2006.08.047; Green EM, 2005, CURR BIOL, V15, P2044, DOI 10.1016/j.cub.2005.10.053; Greenall A, 2006, J BIOL CHEM, V281, P8732, DOI 10.1074/jbc.M512170200; Groth A, 2005, MOL CELL, V17, P301, DOI 10.1016/j.molcel.2004.12.018; Groth A, 2007, SCIENCE, V318, P1928, DOI 10.1126/science.1148992; Haldar D, 2008, EUKARYOT CELL, V7, P800, DOI 10.1128/EC.00379-07; Han JH, 2007, J BIOL CHEM, V282, P28587, DOI 10.1074/jbc.M702496200; Han JH, 2007, SCIENCE, V315, P653, DOI 10.1126/science.1133234; Hayashi M, 2007, EMBO J, V26, P1327, DOI 10.1038/sj.emboj.7601585; Hodson JA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng134; Kato H, 2008, CELL CYCLE, V7, P1085; KIM UJ, 1988, EMBO J, V7, P2211, DOI 10.1002/j.1460-2075.1988.tb03060.x; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Le SY, 1997, YEAST, V13, P1029, DOI 10.1002/(SICI)1097-0061(19970915)13:11<1029::AID-YEA160>3.0.CO;2-1; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Linger J, 2005, GENETICS, V171, P1513, DOI 10.1534/genetics.105.043000; Lopez-Girona A, 2001, P NATL ACAD SCI USA, V98, P11289, DOI 10.1073/pnas.191557598; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Malay AD, 2008, J BIOL CHEM, V283, P14022, DOI 10.1074/jbc.M800594200; Matsuo Y, 2006, BIOSCI BIOTECH BIOCH, V70, P1992, DOI 10.1271/bbb.60087; Matsuo Y, 2011, J BIOL CHEM, V286, P13775, DOI 10.1074/jbc.M110.169953; Matsuo Y, 2010, BIOSCI BIOTECH BIOCH, V74, P685, DOI 10.1271/bbb.90967; MAUNDRELL K, 1990, J BIOL CHEM, V265, P10857; Meister P, 2003, NUCLEIC ACIDS RES, V31, P5064, DOI 10.1093/nar/gkg719; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Mousson F, 2007, CHROMOSOMA, V116, P79, DOI 10.1007/s00412-006-0087-z; Murakami H, 2000, BIOCHEM J, V349, P1, DOI 10.1042/0264-6021:3490001; Nakamura T, 2001, MOL BIOL CELL, V12, P3955, DOI 10.1091/mbc.12.12.3955; Natsume R, 2007, NATURE, V446, P338, DOI 10.1038/nature05613; NURSE P, 1990, NATURE, V344, P503, DOI 10.1038/344503a0; Ozoe F, 2002, MOL CELL BIOL, V22, P7105, DOI 10.1128/MCB.22.20.7105-7119.2002; Paul SK, 2009, FEBS J, V276, P5076, DOI 10.1111/j.1742-4658.2009.07204.x; Pidoux A, 2004, METHODS, V33, P252, DOI 10.1016/j.ymeth.2003.11.021; Pidoux AL, 2004, CHROMOSOME RES, V12, P521, DOI 10.1023/B:CHRO.0000036586.81775.8b; Prado F, 2004, EMBO REP, V5, P497, DOI 10.1038/sj.embor.7400128; Ramey CJ, 2004, MOL CELL BIOL, V24, P10313, DOI 10.1128/MCB.24.23.10313-10327.2004; Ransom M, 2010, CELL, V140, P183, DOI 10.1016/j.cell.2010.01.004; Recht J, 2006, P NATL ACAD SCI USA, V103, P6988, DOI 10.1073/pnas.0601676103; Rhind N, 2000, J CELL SCI, V113, P3889; Rufiange A, 2007, MOL CELL, V27, P393, DOI 10.1016/j.molcel.2007.07.011; Sanematsu F, 2006, J BIOL CHEM, V281, P13817, DOI 10.1074/jbc.M511590200; Sato M, 2005, YEAST, V22, P583, DOI 10.1002/yea.1233; Schulz LL, 2006, FASEB J, V20, P488, DOI 10.1096/fj.05-5020fje; Schwabish MA, 2006, MOL CELL, V22, P415, DOI 10.1016/j.molcel.2006.03.014; Shandilya Jayasha, 2007, Subcell Biochem, V41, P111; Shankaranarayana GD, 2003, CURR BIOL, V13, P1240, DOI 10.1016/S0960-9822(03)00489-5; Sharp JA, 2001, CURR BIOL, V11, P463, DOI 10.1016/S0960-9822(01)00140-3; Shimada M, 2006, J MOL HISTOL, V37, P253, DOI 10.1007/s10735-006-9039-4; Tsubota T, 2007, MOL CELL, V25, P703, DOI 10.1016/j.molcel.2007.02.006; Tyler JK, 1999, NATURE, V402, P555, DOI 10.1038/990147; Umehara T, 2002, GENES CELLS, V7, P59, DOI 10.1046/j.1356-9597.2001.00493.x; Yamane K, 2011, MOL CELL, V41, P56, DOI 10.1016/j.molcel.2010.12.009; Yokoyama M, 2007, DNA REPAIR, V6, P770, DOI 10.1016/j.dnarep.2007.01.005	62	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2012	7	1							e30472	10.1371/journal.pone.0030472	http://dx.doi.org/10.1371/journal.pone.0030472			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911FX	22291963	Green Published, gold, Green Submitted			2022-12-25	WOS:000301703800016
J	Gaudieri, S; Lucas, M; Lucas, A; McKinnon, E; Albloushi, H; Rauch, A; di Iulio, J; Martino, D; Prescott, SL; Tulic, MK				Gaudieri, Silvana; Lucas, Michaela; Lucas, Andrew; McKinnon, Elizabeth; Albloushi, Hiba; Rauch, Andri; di Iulio, Julia; Martino, David; Prescott, Susan L.; Tulic, Meri K.			Genetic Variations in IL28B and Allergic Disease in Children	PLOS ONE			English	Article							LONGITUDINAL DATA-ANALYSIS; HEPATITIS-C VIRUS; INTERFERON-LAMBDA; SPONTANEOUS CLEARANCE; DENDRITIC CELLS; EXPRESSION; ASTHMA; IL-29	Environmental changes affecting the relationship between the developing immune system and microbial exposure have been implicated in the epidemic rise of allergic disease in developed countries. While early developmental differences in T cell function are well-recognised, there is now emerging evidence that this is related to developmental differences in innate immune function. In this study we sought to examine if differences associated with innate immunity contribute to the altered immune programming recognised in allergic children. Here, we describe for the first time, the association of carriage of the T allele of the tagging single nucleotide polymorphism rs12979860 3 kb upstream of IL28B, encoding the potent innate immune modulator type III interferon lambda (IFN-lambda 3), and allergy in children (p = 0.004; OR 4.56). Strikingly, the association between rs12979860 genotype and allergic disease is enhanced in girls. Furthermore, carriage of the T allele at rs12979860 correlates with differences in the pro-inflammatory profile during the first five years of life suggesting this contributes to the key differences in subsequent innate immune development in children who develop allergic disease. In the context of rising rates of disease, these immunologic differences already present at birth imply very early interaction between genetic predisposition and prenatal environmental influences.	[Gaudieri, Silvana] Univ Western Australia, Sch Anat & Human Biol, Nedlands, WA 6009, Australia; [Gaudieri, Silvana; Albloushi, Hiba] Univ Western Australia, Ctr Forens Sci, Nedlands, WA 6009, Australia; [Gaudieri, Silvana; Lucas, Michaela; Lucas, Andrew; McKinnon, Elizabeth] Murdoch Univ, Inst Immunol & Infect Dis, Murdoch, WA 6150, Australia; [Rauch, Andri] Univ Hosp Bern, Univ Clin Infect Dis, CH-3010 Bern, Switzerland; [Rauch, Andri] Univ Bern, Bern, Switzerland; [di Iulio, Julia] Univ Hosp Ctr, Inst Microbiol, Lausanne, Switzerland; [di Iulio, Julia] Univ Lausanne, Lausanne, Switzerland; [Martino, David; Prescott, Susan L.; Tulic, Meri K.] Univ Western Australia, Sch Paediat & Child Hlth, Nedlands, WA 6009, Australia	University of Western Australia; University of Western Australia; Murdoch University; University of Bern; University Hospital of Bern; University of Bern; University of Lausanne; University of Western Australia	Gaudieri, S (corresponding author), Univ Western Australia, Sch Anat & Human Biol, Nedlands, WA 6009, Australia.	silvana.gaudieri@uwa.edu.au	Prescott, Susan/H-5665-2014; Rauch, Andri/E-9948-2017; Tulic, Meri K/ABB-5138-2020; Martino, DJ/X-1753-2019; Tulic, Meri/P-6613-2016	Rauch, Andri/0000-0001-5297-6062; Tulic, Meri K/0000-0002-2661-2369; Martino, DJ/0000-0001-6823-4696; Tulic, Meri/0000-0002-2661-2369; Lucas, Andrew Douglas/0000-0003-2899-1806; DI IULIO, JULIA/0000-0001-9343-127X; , Silvana/0000-0001-6873-0198; Lucas, Michaela/0000-0001-8881-9990	NHMRC; Raine Medical Research Foundation	NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Raine Medical Research Foundation	MKT is supported by an NHMRC Career Development Award and SLP is supported by NHMRC Practitioner Fellowship. ML has been funded from a Raine Medical Research Foundation Priming Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asher MI, 2006, LANCET, V368, P733, DOI 10.1016/S0140-6736(06)69283-0; Contoli M, 2006, NAT MED, V12, P1023, DOI 10.1038/nm1462; di Iulio J, 2011, HEPATOLOGY, V53, P1446, DOI 10.1002/hep.24263; Edwards MR, 2011, EMBO MOL MED, V3, P306, DOI 10.1002/emmm.201100143; Evangelou E, 2011, AM J EPIDEMIOL, V173, P1336, DOI 10.1093/aje/kwr024; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Honda M, 2010, GASTROENTEROLOGY, V139, P499, DOI 10.1053/j.gastro.2010.04.049; Jordan WJ, 2007, GENES IMMUN, V8, P254, DOI 10.1038/sj.gene.6364382; Koltsida O, 2011, EMBO MOL MED, V3, P348, DOI 10.1002/emmm.201100142; Langhans B, 2011, J HEPATOL, V54, P859, DOI 10.1016/j.jhep.2010.08.020; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Martino D, 2011, CHEST, V139, P640, DOI 10.1378/chest.10-1800; Mennechet FJD, 2006, BLOOD, V107, P4417, DOI 10.1182/blood-2005-10-4129; Morrow MP, 2009, BLOOD, V113, P5868, DOI 10.1182/blood-2008-11-190520; Prescott SL, 2008, J ALLERGY CLIN IMMUN, V122, P391, DOI 10.1016/j.jaci.2008.04.042; Rauch A, 2010, GASTROENTEROLOGY, V138, P1338, DOI 10.1053/j.gastro.2009.12.056; Renz H, 2011, NAT IMMUNOL, V12, P273, DOI 10.1038/ni0411-273; Sheppard P, 2003, NAT IMMUNOL, V4, P63, DOI 10.1038/ni873; Srinivas S, 2008, IMMUNOLOGY, V125, P492, DOI 10.1111/j.1365-2567.2008.02862.x; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Tangye SG, 2009, J IMMUNOL, V182, P21, DOI 10.4049/jimmunol.182.1.21; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Thomas DL, 2000, JAMA-J AM MED ASSOC, V284, P450, DOI 10.1001/jama.284.4.450; Tillmann HL, 2010, GASTROENTEROLOGY, V139, P1586, DOI 10.1053/j.gastro.2010.07.005; Tulic MK, 2011, J ALLERGY CLIN IMMUN, V127, P470, DOI 10.1016/j.jaci.2010.09.020; Urban TJ, 2010, HEPATOLOGY, V52, P1888, DOI 10.1002/hep.23912; Wolk K, 2008, J LEUKOCYTE BIOL, V83, P1181, DOI 10.1189/jlb.0807525; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	28	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e30607	10.1371/journal.pone.0030607	http://dx.doi.org/10.1371/journal.pone.0030607			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910ME	22295096	gold, Green Submitted, Green Published			2022-12-25	WOS:000301640600041
J	Grandin, N; Corset, L; Charbonneau, M				Grandin, Nathalie; Corset, Laetitia; Charbonneau, Michel			Genetic and Physical Interactions between Tel2 and the Med15 Mediator Subunit in Saccharomyces cerevisiae	PLOS ONE			English	Article							TELOMERE LENGTH REGULATION; R2TP COMPLEX; CELL-GROWTH; LIFE-SPAN; YEAST; PROTEIN; DNA; TRANSCRIPTION; CHECKPOINT; STABILITY	Background: In budding yeast, the highly conserved Tel2 protein is part of several complexes and its main function is now believed to be in the biogenesis of phosphatidyl inositol 3-kinase related kinases. Principal Findings: To uncover potentially novel functions of Tel2, we set out to isolate temperature-sensitive (ts) mutant alleles of TEL2 in order to perform genetic screenings. MED15/GAL11, a subunit of Mediator, a general regulator of transcription, was isolated as a suppressor of these mutants. The isolated tel2 mutants exhibited a short telomere phenotype that was partially rescued by MED15/GAL11 overexpression. The tel2-15mutant was markedly deficient in the transcription of EST2, coding for the catalytic subunit of telomerase, potentially explaining the short telomere phenotype of this mutant. In parallel, a two-hybrid screen identified an association between Tel2 and Rvb2, a highly conserved member of the AAA+ family of ATPases further found by in vivo co-immunoprecipitation to be tight and constitutive. Transiently overproduced Tel2 and Med15/Gal11 associated together, suggesting a potential role for Tel2 in transcription. Other Mediator subunits, as well as SUA7/TFIIB, also rescued the tel2-ts mutants. Significance: Altogether, the present data suggest the existence of a novel role for Tel2, namely in transcription, possibly in cooperation with Rvb2 and involving the existence of physical interactions with the Med15/Gal11 Mediator subunit.	[Grandin, Nathalie; Charbonneau, Michel] Ecole Normale Super Lyon, BioSci Gerland IFR128, CNRS, UMR 5239, F-69364 Lyon, France; [Grandin, Nathalie; Corset, Laetitia; Charbonneau, Michel] Univ Tours, CNRS, UMR 6239, Tours, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Ecole Normale Superieure de Lyon (ENS de LYON); Universite Jean Monnet; Centre National de la Recherche Scientifique (CNRS); Universite de Tours	Grandin, N (corresponding author), Ecole Normale Super Lyon, BioSci Gerland IFR128, CNRS, UMR 5239, F-69364 Lyon, France.	Michel.Charbonneau@univ-tours.fr	Charbonneau, Michel/AGN-4817-2022	Charbonneau, Michel/0000-0002-6684-6151; Babin, Laetitia/0000-0002-9912-7321; Nathalie, Grandin/0000-0003-0393-2586	LIGUE contre le Cancer, Comite inter-regional Rhone-Alpes Auvergne	LIGUE contre le Cancer, Comite inter-regional Rhone-Alpes Auvergne	This work was supported by grants from the "LIGUE contre le Cancer, Comite inter-regional Rhone-Alpes Auvergne". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2001, CURR BIOL, V11, P1934, DOI 10.1016/S0960-9822(01)00604-2; Anderson CM, 2008, GENE DEV, V22, P854, DOI 10.1101/gad.1646208; Anderson CM, 2008, CELL CYCLE, V7, P3695, DOI 10.4161/cc.7.23.7154; Benard C, 2001, DEVELOPMENT, V128, P4045; BOTSTEIN D, 1979, GENE, V8, P17, DOI 10.1016/0378-1119(79)90004-0; Boulon S, 2008, J CELL BIOL, V180, P579, DOI 10.1083/jcb.200708110; Boulton SJ, 1998, EMBO J, V17, P1819, DOI 10.1093/emboj/17.6.1819; Bourbon HM, 2008, NUCLEIC ACIDS RES, V36, P3993, DOI 10.1093/nar/gkn349; Bourbon HM, 2004, MOL CELL, V14, P553, DOI 10.1016/j.molcel.2004.05.011; Chang M, 2008, SCIENCE, V320, P60, DOI 10.1126/science.1155132; Collis SJ, 2007, NAT CELL BIOL, V9, P391, DOI 10.1038/ncb1555; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Dahlseid JN, 2003, EUKARYOT CELL, V2, P134, DOI 10.1128/EC.2.1.134-142.2003; de Lange T, 2009, SCIENCE, V326, P948, DOI 10.1126/science.1170633; Flavin P, 2011, FEBS LETT, V585, P2537, DOI 10.1016/j.febslet.2011.07.005; Gallant P, 2007, TRENDS CELL BIOL, V17, P187, DOI 10.1016/j.tcb.2007.02.005; Grandin N, 1997, GENE DEV, V11, P512, DOI 10.1101/gad.11.4.512; GRANDIN N, 1993, MOL CELL BIOL, V13, P2113, DOI 10.1128/MCB.13.4.2113; GREENWELL PW, 1995, CELL, V82, P823, DOI 10.1016/0092-8674(95)90479-4; Hayashi T, 2007, GENES CELLS, V12, P1357, DOI 10.1111/j.1365-2443.2007.01141.x; Hector RE, 2007, MOL CELL, V27, P851, DOI 10.1016/j.molcel.2007.08.007; Horejsi Z, 2010, MOL CELL, V39, P839, DOI 10.1016/j.molcel.2010.08.037; Huen J, 2010, BIOCHEM CELL BIOL, V88, P29, DOI [10.1139/o09-122, 10.1139/O09-122]; Hurov KE, 2010, GENE DEV, V24, P1939, DOI 10.1101/gad.1934210; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Izumi N, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000468; Jha S, 2009, MOL CELL, V34, P521, DOI 10.1016/j.molcel.2009.05.016; Jiang N, 2003, J BIOL CHEM, V278, P21678, DOI 10.1074/jbc.M300286200; Jonsson ZO, 2001, J BIOL CHEM, V276, P16279, DOI 10.1074/jbc.M011523200; Kanoh J, 2007, GENES CELLS, V12, P1301, DOI 10.1111/j.1365-2443.2007.01142.x; Kota RS, 1998, NUCLEIC ACIDS RES, V26, P1528, DOI 10.1093/nar/26.6.1528; Kota RS, 1999, CHROMOSOMA, V108, P278, DOI 10.1007/s004120050379; Li WJ, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-132; Lim CS, 2001, CURR BIOL, V11, P1706, DOI 10.1016/S0960-9822(01)00526-7; Lim MK, 2007, J MOL BIOL, V374, P9, DOI 10.1016/j.jmb.2007.09.013; LUNDBLAD V, 1989, CELL, V57, P633, DOI 10.1016/0092-8674(89)90132-3; LUSTIG AJ, 1986, P NATL ACAD SCI USA, V83, P1398, DOI 10.1073/pnas.83.5.1398; Moser SC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000451; Ohdate H, 2003, J BIOL CHEM, V278, P14647, DOI 10.1074/jbc.M213220200; Ottaviani A, 2008, BIOCHIMIE, V90, P93, DOI 10.1016/j.biochi.2007.07.022; PINTO I, 1992, CELL, V68, P977, DOI 10.1016/0092-8674(92)90040-J; Porter SE, 1996, NUCLEIC ACIDS RES, V24, P582, DOI 10.1093/nar/24.4.582; ROSE MD, 1987, GENE, V60, P237, DOI 10.1016/0378-1119(87)90232-0; Runge KW, 1996, MOL CELL BIOL, V16, P3094; Sabourin M, 2008, TRENDS CELL BIOL, V18, P337, DOI 10.1016/j.tcb.2008.04.004; Sabourin M, 2007, MOL CELL, V27, P550, DOI 10.1016/j.molcel.2007.07.016; Shevchenko A, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-11-r167; Shikata M, 2007, J BIOL CHEM, V282, P5346, DOI 10.1074/jbc.M607432200; Stirling PC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002057; SUSSEL L, 1995, GENETICS, V141, P873; SUZUKI Y, 1994, MOL CELL BIOL, V14, P3791, DOI 10.1128/MCB.14.6.3791; Takai H, 2007, CELL, V131, P1248, DOI 10.1016/j.cell.2007.10.052; Takai H, 2010, GENE DEV, V24, P2019, DOI 10.1101/gad.1956410; Zhao RM, 2008, J CELL BIOL, V180, P563, DOI 10.1083/jcb.200709061; Zhu XF, 2011, MOL CELL BIOL, V31, P2413, DOI 10.1128/MCB.05242-11	55	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2012	7	1							e30451	10.1371/journal.pone.0030451	http://dx.doi.org/10.1371/journal.pone.0030451			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910LV	22291956	gold, Green Published			2022-12-25	WOS:000301639600020
J	Pan, X; Jones, M; Jiang, J; Zaprazna, K; Yu, DN; Pear, W; Maillard, I; Atchison, ML				Pan, Xuan; Jones, Morgan; Jiang, Jie; Zaprazna, Kristina; Yu, Duonan; Pear, Warren; Maillard, Ivan; Atchison, Michael L.			Increased Expression of PcG Protein YY1 Negatively Regulates B Cell Development while Allowing Accumulation of Myeloid Cells and LT-HSC Cells	PLOS ONE			English	Article							TRANSCRIPTION FACTOR YY1; HEMATOPOIETIC STEM; SELF-RENEWAL; DNA-BINDING; CYCLIN D3; TARGETED DISRUPTION; FACTOR GATA-3; IN-VIVO; C-MYC; GENE	Ying Yang 1 (YY1) is a multifunctional Polycomb Group (PcG) transcription factor that binds to multiple enhancer binding sites in the immunoglobulin (Ig) loci and plays vital roles in early B cell development. PcG proteins have important functions in hematopoietic stem cell renewal and YY1 is the only mammalian PcG protein with DNA binding specificity. Conditional knock-out of YY1 in the mouse B cell lineage results in arrest at the pro-B cell stage, and dosage effects have been observed at various YY1 expression levels. To investigate the impact of elevated YY1 expression on hematopoetic development, we utilized a mouse in vivo bone marrow reconstitution system. We found that mouse bone marrow cells expressing elevated levels of YY1 exhibited a selective disadvantage as they progressed from hematopoietic stem/progenitor cells to pro-B, pre-B, immature B and re-circulating B cell stages, but no disadvantage of YY1 over-expression was observed in myeloid lineage cells. Furthermore, mouse bone marrow cells expressing elevated levels of YY1 displayed enrichment for cells with surface markers characteristic of long-term hematopoietic stem cells (HSC). YY1 expression induced apoptosis in mouse B cell lines in vitro, and resulted in down-regulated expression of anti-apoptotic genes Bcl-xl and NF kappa B2, while no impact was observed in a mouse myeloid line. B cell apoptosis and LT-HSC enrichment induced by YY1 suggest that novel strategies to induce YY1 expression could have beneficial effects in the treatment of B lineage malignancies while preserving normal HSCs.	[Pan, Xuan; Jiang, Jie; Zaprazna, Kristina; Atchison, Michael L.] Univ Penn, Sch Vet, Dept Anim Biol, Philadelphia, PA 19104 USA; [Jones, Morgan; Maillard, Ivan] Univ Michigan, Dept Med, Inst Life Sci, Ctr Stem Cell Biol, Ann Arbor, MI 48109 USA; [Jones, Morgan; Maillard, Ivan] Univ Michigan, Dept Cell & Dev Biol, Inst Life Sci, Ctr Stem Cell Biol, Ann Arbor, MI 48109 USA; [Yu, Duonan] Childrens Hosp Philadelphia, Div Hematol, Philadelphia, PA 19104 USA; [Pear, Warren] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania	Pan, X (corresponding author), Univ Penn, Sch Vet, Dept Anim Biol, Philadelphia, PA 19104 USA.	atchison@vet.upenn.edu		Maillard, Ivan/0000-0003-1312-6748	National Institutes of Health [GM071830, AI079002]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047833, R01AI079002, R01AI091627] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071830] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM071830 and AI079002 to MA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affar E, 2006, MOL CELL BIOL, V26, P3565, DOI 10.1128/MCB.26.9.3565-3581.2006; ALT F, 1981, CELL, V27, P381, DOI 10.1016/0092-8674(81)90421-9; Anderson MK, 2002, DEV BIOL, V246, P103, DOI 10.1006/dbio.2002.0674; Atchison L, 2003, EMBO J, V22, P1347, DOI 10.1093/emboj/cdg124; Austen M, 1998, ONCOGENE, V17, P511, DOI 10.1038/sj.onc.1201968; Bain M, 2005, EUR J CELL BIOL, V84, P543, DOI 10.1016/j.ejcb.2004.12.024; Brown JL, 1998, MOL CELL, V1, P1057, DOI 10.1016/S1097-2765(00)80106-9; Busslinger M, 2004, ANNU REV IMMUNOL, V22, P55, DOI 10.1146/annurev.immunol.22.012703.104807; Calame K, 2007, GENE DEV, V21, P1145, DOI 10.1101/gad.1559007; Cato MH, 2011, MOL CELL BIOL, V31, P127, DOI 10.1128/MCB.00650-10; Chen D, 2001, EXP HEMATOL, V29, P971, DOI 10.1016/S0301-472X(01)00670-1; COLLINS LS, 1987, J IMMUNOL, V138, P1082; Cooper AB, 2006, NAT IMMUNOL, V7, P489, DOI 10.1038/ni1324; DeKoter RP, 2000, SCIENCE, V288, P1439, DOI 10.1126/science.288.5470.1439; Donohoe ME, 1999, MOL CELL BIOL, V19, P7237; Erkeland SJ, 2003, BLOOD, V101, P1111, DOI 10.1182/blood-2002-04-1207; FINDLEY HW, 1982, BLOOD, V60, P1305; Fuxa M, 2004, GENE DEV, V18, P411, DOI 10.1101/gad.291504; Gabellini D, 2002, CELL, V110, P339, DOI 10.1016/S0092-8674(02)00826-7; Galvin KM, 1997, MOL CELL BIOL, V17, P3723, DOI 10.1128/MCB.17.7.3723; Gil J, 2004, NAT CELL BIOL, V6, P67, DOI 10.1038/ncb1077; Gil J, 2005, DNA CELL BIOL, V24, P117, DOI 10.1089/dna.2005.24.117; Gordon S, 2006, ONCOGENE, V25, P1125, DOI 10.1038/sj.onc.1209080; Gordon SJ, 2003, J IMMUNOL, V170, P5549, DOI 10.4049/jimmunol.170.11.5549; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Hendriks RW, 1999, EUR J IMMUNOL, V29, P1912, DOI 10.1002/(SICI)1521-4141(199906)29:06<1912::AID-IMMU1912>3.3.CO;2-4; Hodawadekar S, 2007, EXP CELL RES, V313, P331, DOI 10.1016/j.yexcr.2006.10.015; Iwama A, 2004, IMMUNITY, V21, P843, DOI 10.1016/j.immuni.2004.11.004; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Johnson K, 2003, CURR OPIN GENET DEV, V13, P522, DOI 10.1016/j.gde.2003.08.004; Kajiume T, 2004, EXP HEMATOL, V32, P571, DOI 10.1016/j.exphem.2004.03.001; Kamminga LM, 2006, BLOOD, V107, P2170, DOI 10.1182/blood-2005-09-3585; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; LEE JS, 1995, GENE DEV, V9, P1188, DOI 10.1101/gad.9.10.1188; Lichy JH, 1996, NUCLEIC ACIDS RES, V24, P4700, DOI 10.1093/nar/24.23.4700; Liu HF, 2007, GENE DEV, V21, P1179, DOI 10.1101/gad.1529307; Matthias P, 2005, NAT REV IMMUNOL, V5, P497, DOI 10.1038/nri1633; Meccia E, 2003, BBA-GENE STRUCT EXPR, V1626, P1, DOI 10.1016/S0167-4781(03)00018-6; PANDOLFI PP, 1995, NAT GENET, V11, P40, DOI 10.1038/ng0995-40; PARK K, 1991, P NATL ACAD SCI USA, V88, P9804, DOI 10.1073/pnas.88.21.9804; Peled JU, 2010, CELL RES, V20, P631, DOI 10.1038/cr.2010.55; Petkova V, 2001, J BIOL CHEM, V276, P7932, DOI 10.1074/jbc.M007411200; RIGGS KJ, 1993, MOL CELL BIOL, V13, P7487, DOI 10.1128/MCB.13.12.7487; Schlisio S, 2002, EMBO J, V21, P5775, DOI 10.1093/emboj/cdf577; Singh H, 2005, P NATL ACAD SCI USA, V102, P4949, DOI 10.1073/pnas.0500480102; Srinivasan L, 2005, J CELL BIOCHEM, V96, P689, DOI 10.1002/jcb.20562; Srinivasan L, 2004, GENE DEV, V18, P2596, DOI 10.1101/gad.1228204; Sui GC, 2004, CELL, V117, P859, DOI 10.1016/j.cell.2004.06.004; Thomas MJ, 1999, GENE, V236, P197, DOI 10.1016/S0378-1119(99)00261-9; Ting CN, 1996, NATURE, V384, P474, DOI 10.1038/384474a0; Valk-Lingbeek ME, 2004, CELL, V118, P409, DOI 10.1016/j.cell.2004.08.005; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Walowitz JL, 1998, J BIOL CHEM, V273, P6656, DOI 10.1074/jbc.273.12.6656; Wang XL, 2008, BBA-MOL CELL RES, V1783, P1876, DOI 10.1016/j.bbamcr.2008.05.015; Wei F, 2009, MOL CELL BIOL, V29, P4612, DOI 10.1128/MCB.00234-09; Wilkinson FH, 2006, P NATL ACAD SCI USA, V103, P19296, DOI 10.1073/pnas.0603564103; Wu S, 2007, NAT STRUCT MOL BIOL, V14, P1165, DOI 10.1038/nsmb1332; Yengi L, 1996, CANCER RES, V56, P1974; Yu D, 2003, BLOOD, V101, P1950, DOI 10.1182/blood-2002-06-1797; Yu DN, 2002, ONCOGENE, V21, P1922, DOI 10.1038/sj.onc.1205244; Zweidler-McKay PA, 2005, BLOOD, V106, P3898, DOI 10.1182/blood-2005-01-0355	61	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30656	10.1371/journal.pone.0030656	http://dx.doi.org/10.1371/journal.pone.0030656			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22292011	Green Published, gold, Green Submitted			2022-12-25	WOS:000301570600068
J	Sun, YL; Huang, LQ; Pelosi, P; Wang, CZ				Sun, Ya-Lan; Huang, Ling-Qiao; Pelosi, Paolo; Wang, Chen-Zhu			Expression in Antennae and Reproductive Organs Suggests a Dual Role of an Odorant-Binding Protein in Two Sibling Helicoverpa Species	PLOS ONE			English	Article							PHEROMONE-SENSITIVE NEURONS; ARMIGERA LEPIDOPTERA; SWISS-MODEL; DROSOPHILA-MELANOGASTER; CHEMICAL-IDENTIFICATION; OVIPOSITION DETERRENTS; CHEMOSENSORY PROTEINS; SOLUBLE-PROTEINS; SEX-PHEROMONE; AEDES-AEGYPTI	Odorant-binding proteins (OBPs) mediate both perception and release of semiochemicals in insects. These proteins are the ideal targets for understanding the olfactory code of insects as well as for interfering with their communication system in order to control pest species. The two sibling Lepidopteran species Helicoverpa armigera and H. assulta are two major agricultural pests. As part of our aim to characterize the OBP repertoire of these two species, here we focus our attention on a member of this family, OBP10, particularly interesting for its expression pattern. The protein is specifically expressed in the antennae of both sexes, being absent from other sensory organs. However, it is highly abundant in seminal fluid, is transferred to females during mating and is eventually found on the surface of fertilised eggs. Among the several different volatile compounds present in reproductive organs, OBP10 binds 1-dodecene, a compound reported as an insect repellent. These results have been verified in both H. armigera and H. assulta with no apparent differences between the two species. The recombinant OBP10 binds, besides 1-dodecene, some linear alcohols and several aromatic compounds. The structural similarity of OBP10 with OBP1 of the mosquito Culex quinquefasciatus, a protein reported to bind an oviposition pheromone, and its affinity with 1-dodecene suggest that OBP10 could be a carrier for oviposition deterrents, favouring spreading of the eggs in these species where cannibalism is active among larvae.	[Sun, Ya-Lan; Huang, Ling-Qiao; Pelosi, Paolo; Wang, Chen-Zhu] Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Beijing, Peoples R China; [Pelosi, Paolo] Univ Pisa, Dept Biol Crop Plants, Pisa, Italy	Chinese Academy of Sciences; Institute of Zoology, CAS; University of Pisa	Sun, YL (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Beijing, Peoples R China.	ppelosi@agr.unipi.it; czwang@ioz.ac.cn	Rocco, Patricia/I-7460-2012	Rocco, Patricia/0000-0003-1412-7136; Sun, Ya-Lan/0000-0002-4468-1333	National Science Fund for Distinguished Young Scholars [30925026]; National Natural Science Foundation of China [30921063]; Chinese Academy of Sciences [KSCX2-EW-N5, 2009S2-32]	National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by National Science Fund for Distinguished Young Scholars (grant no. 30925026) and the Fund for Innovative Research Groups (grant no. 30921063) of the National Natural Science Foundation of China, the Chinese Academy of Sciences innovation program (grant no. KSCX2-EW-N5), and the Chinese Academy of Sciences visiting professorship for senior international scientists (grant no. 2009S2-32), that supported a nine-month visit of P. P. at the Institute of Zoology, Beijing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Calvello M, 2003, CELL MOL LIFE SCI, V60, P1933, DOI 10.1007/s00018-003-3186-5; Dani FR, 2011, CHEM SENSES, V36, P335, DOI 10.1093/chemse/bjq137; Dani FR, 2010, J PROTEOME RES, V9, P1822, DOI 10.1021/pr900969k; DONASCIMENTO RR, 1993, J CHEM ECOL, V19, P1993, DOI 10.1007/BF00983802; FITT GP, 1989, ANNU REV ENTOMOL, V34, P17, DOI 10.1146/annurev.en.34.010189.000313; Forstner Maike, 2009, Int J Biol Sci, V5, P745; Geiselhardt S, 2008, NATURWISSENSCHAFTEN, V95, P247, DOI 10.1007/s00114-007-0312-5; Gong DP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-332; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Guo L, 2009, J INSECT SCI, V9, DOI 10.1673/031.009.6701; Iovinella I, 2011, J PROTEOME RES, V10, P3439, DOI 10.1021/pr2000754; Jacquin-Joly E, 2001, CHEM SENSES, V26, P833, DOI 10.1093/chemse/26.7.833; Kruse SW, 2003, NAT STRUCT BIOL, V10, P694, DOI 10.1038/nsb960; KYHSEANDERSEN J, 1984, J BIOCHEM BIOPH METH, V10, P203, DOI 10.1016/0165-022X(84)90040-X; Lagarde A, 2011, BIOCHEM J, V437, P423, DOI 10.1042/BJ20110522; Laughlin JD, 2008, CELL, V133, P1255, DOI 10.1016/j.cell.2008.04.046; LAURENCE BR, 1982, J CHEM SOC CHEM COMM, P59, DOI 10.1039/c39820000059; Leal WS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003045; Li S, 2008, BIOCHEM BIOPH RES CO, V372, P464, DOI 10.1016/j.bbrc.2008.05.064; Liu ML, 2008, J INSECT PHYSIOL, V54, P656, DOI 10.1016/j.jinsphys.2008.01.002; LIU SH, 1989, J AGR FOOD CHEM, V37, P496, DOI 10.1021/jf00086a050; Mao Y, 2010, P NATL ACAD SCI USA, V107, P19102, DOI 10.1073/pnas.1012274107; Matsuo T, 2007, PLOS BIOL, V5, P985, DOI 10.1371/journal.pbio.0050118; Norris DM, 1991, US Patent, Patent No. 5030660; Pelletier J, 2010, J CHEM ECOL, V36, P245, DOI 10.1007/s10886-010-9762-x; Pelosi P, 2006, CELL MOL LIFE SCI, V63, P1658, DOI 10.1007/s00018-005-5607-0; Qiao HL, 2009, INSECT BIOCHEM MOLEC, V39, P414, DOI 10.1016/j.ibmb.2009.03.004; Schorkopf DLP, 2009, J EXP BIOL, V212, P1153, DOI 10.1242/jeb.021113; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Sirot LK, 2008, INSECT BIOCHEM MOLEC, V38, P176, DOI 10.1016/j.ibmb.2007.10.007; Swarup S, 2011, GENES BRAIN BEHAV, V10, P648, DOI 10.1111/j.1601-183X.2011.00704.x; Tegoni M, 2004, TRENDS BIOCHEM SCI, V29, P257, DOI 10.1016/j.tibs.2004.03.003; THIERY D, 1992, EXPERIENTIA, V48, P697, DOI 10.1007/BF02118323; TSCHINKEL WR, 1975, J INSECT PHYSIOL, V21, P753, DOI 10.1016/0022-1910(75)90008-6; VOGT RG, 1981, NATURE, V293, P161, DOI 10.1038/293161a0; VOGT RG, 2005, COMPREHENSIVE INSECT, V3, P753, DOI DOI 10.1016/B0-44-451924-6/00047-8; Wang CZ, 2001, CHINESE SCI BULL, V46, P489, DOI 10.1007/BF03187264; Xu HY, 2006, J INSECT PHYSIOL, V52, P320, DOI 10.1016/j.jinsphys.2005.11.011; Xu PX, 2005, NEURON, V45, P193, DOI 10.1016/j.neuron.2004.12.031; Zhang TT, 2011, BIOCHEM BIOPH RES CO, V407, P393, DOI 10.1016/j.bbrc.2011.03.032; Zhao XC, 2006, J COMP PHYSIOL A, V192, P1037, DOI 10.1007/s00359-006-0141-6; Zong N, 2007, PLANTA, V226, P215, DOI 10.1007/s00425-006-0459-x	44	254	272	8	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30040	10.1371/journal.pone.0030040	http://dx.doi.org/10.1371/journal.pone.0030040			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22291900	Green Published, gold, Green Submitted			2022-12-25	WOS:000301570600011
J	Amrich, CG; Davis, CP; Rogal, WP; Shirra, MK; Heroux, A; Gardner, RG; Arndt, KM; VanDemark, AP				Amrich, Christopher G.; Davis, Christopher P.; Rogal, Walter P.; Shirra, Margaret K.; Heroux, Annie; Gardner, Richard G.; Arndt, Karen M.; VanDemark, Andrew P.			Cdc73 Subunit of Paf1 Complex Contains C-terminal Ras-like Domain That Promotes Association of Paf1 Complex with Chromatin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION ELONGATION-FACTORS; RNA 3'-END FORMATION; SACCHAROMYCES-CEREVISIAE; TUMOR-SUPPRESSOR; HISTONE H2B; BINDING PROTEIN; GENE-EXPRESSION; SITE SELECTION; H3 METHYLATION; PARAFIBROMIN	The conserved Paf1 complex localizes to the coding regions of genes and facilitates multiple processes during transcription elongation, including the regulation of histone modifications. However, the mechanisms that govern Paf1 complex recruitment to active genes are undefined. Here we describe a previously unrecognized domain within the Cdc73 subunit of the Paf1 complex, the Cdc73 C-domain, and demonstrate its importance for Paf1 complex occupancy on transcribed chromatin. Deletion of the C-domain causes phenotypes associated with elongation defects without an apparent loss of complex integrity. Simultaneous mutation of the C-domain and another subunit of the Paf1 complex, Rtf1, causes enhanced mutant phenotypes and loss of histone H3 lysine 36 trimethylation. The crystal structure of the C-domain reveals unexpected similarity to the Ras family of small GTPases. Instead of a deep nucleotide-binding pocket, the C-domain contains a large but comparatively flat surface of highly conserved residues, devoid of ligand. Deletion of the C-domain results in reduced chromatin association for multiple Paf1 complex subunits. We conclude that the Cdc73 C-domain probably constitutes a protein interaction surface that functions with Rtf1 in coupling the Paf1 complex to the RNA polymerase II elongation machinery.	[Amrich, Christopher G.; Davis, Christopher P.; Rogal, Walter P.; Shirra, Margaret K.; Arndt, Karen M.; VanDemark, Andrew P.] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA; [Heroux, Annie] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA; [Gardner, Richard G.] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; United States Department of Energy (DOE); Brookhaven National Laboratory; University of Washington; University of Washington Seattle	Arndt, KM (corresponding author), Univ Pittsburgh, Dept Biol Sci, 4249 5th Ave, Pittsburgh, PA 15260 USA.	arndt@pitt.edu; andyv@pitt.edu		Davis, Christopher/0000-0003-0112-9458; Gardner, Richard/0000-0003-2162-6275; VanDemark, Andrew/0000-0003-3424-4831	National Institutes of Health [R01GM52593, R21RR025787]; Howard Hughes Medical Institute; Beckman Scholars Award; National Center for Research Resources; NATIONAL CENTER FOR RESEARCH RESOURCES [R21RR025787] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052593] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Beckman Scholars Award; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM52593 (to K. M. A.) and R21RR025787 (to R. G. G.). This work was also supported by fellowships from the Howard Hughes Medical Institute (to C. P. D. and W. P. R.) and a Beckman Scholars Award (to C. P. D.).; We are grateful to Erica McGreevy, Kristianna Ricchio, and John Hempel for technical support. We thank Brett Tomson and Alan Hinnebusch for critical reading of the manuscript and Alan Hinnebusch for communication of unpublished results. Operations at the National Synchrotron Light Source are supported by the Department of Energy, Office of Basic Energy Sciences, and the National Institutes of Health. Data collection at the National Synchrotron Light Source was funded by the National Center for Research Resources.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ausubel F., 1988, SHORT PROTOCOLS MOL; Bradley KJ, 2006, CLIN ENDOCRINOL, V64, P299, DOI 10.1111/j.1365-2265.2006.02460.x; Briggs SD, 2002, NATURE, V418, P498, DOI 10.1038/nature00970; Carpten JD, 2002, NAT GENET, V32, P676, DOI 10.1038/ng1048; Cascon A, 2011, GENE CHROMOSOME CANC, V50, P922, DOI 10.1002/gcc.20911; Chu Y, 2007, EMBO J, V26, P4646, DOI 10.1038/sj.emboj.7601887; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; de Jong RN, 2008, STRUCTURE, V16, P149, DOI 10.1016/j.str.2007.10.018; Ding L, 2009, CELL STEM CELL, V4, P403, DOI 10.1016/j.stem.2009.03.009; Dover J, 2002, J BIOL CHEM, V277, P28368, DOI 10.1074/jbc.C200348200; Eathiraj S, 2005, NATURE, V436, P415, DOI 10.1038/nature03798; EXINGER F, 1992, CURR GENET, V22, P9, DOI 10.1007/BF00351735; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Jenks MH, 2005, YEAST, V22, P1181, DOI 10.1002/yea.1300; Kaplan CD, 2005, J BIOL CHEM, V280, P913, DOI 10.1074/jbc.M411108200; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kim M, 2004, EMBO J, V23, P354, DOI 10.1038/sj.emboj.7600053; Krogan NJ, 2002, MOL CELL BIOL, V22, P6979, DOI 10.1128/MCB.22.20.6979-6992.2002; Krogan NJ, 2003, MOL CELL, V11, P721, DOI 10.1016/S1097-2765(03)00091-1; Kuehner JN, 2008, MOL CELL, V31, P201, DOI 10.1016/j.molcel.2008.05.018; Laribee RN, 2005, CURR BIOL, V15, P1487, DOI 10.1016/j.cub.2005.07.028; Liu Y, 2009, MOL CELL BIOL, V29, P4852, DOI 10.1128/MCB.00609-09; Mayer A, 2010, NAT STRUCT MOL BIOL, V17, P1272, DOI 10.1038/nsmb.1903; Mosimann C, 2006, CELL, V125, P327, DOI 10.1016/j.cell.2006.01.053; Mosimann C, 2009, MECH DEVELOP, V126, P394, DOI 10.1016/j.mod.2009.02.002; Mueller CL, 2004, MOL CELL, V14, P447, DOI 10.1016/S1097-2765(04)00257-6; Mulder KW, 2007, NUCLEIC ACIDS RES, V35, P2428, DOI 10.1093/nar/gkm175; Mutiu AI, 2007, MOL GENET GENOMICS, V277, P491, DOI 10.1007/s00438-007-0212-6; Newey PJ, 2009, J INTERN MED, V266, P84, DOI 10.1111/j.1365-2796.2009.02107.x; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; Ng HH, 2003, J BIOL CHEM, V278, P33625, DOI 10.1074/jbc.C300270200; Nordick K, 2008, EUKARYOT CELL, V7, P1158, DOI 10.1128/EC.00434-07; Oeffinger M, 2007, NAT METHODS, V4, P951, DOI 10.1038/NMETH1101; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PAI EF, 1990, EMBO J, V9, P2351, DOI 10.1002/j.1460-2075.1990.tb07409.x; Pavri R, 2006, CELL, V125, P703, DOI 10.1016/j.cell.2006.04.029; Pimenta FJ, 2006, ORAL ONCOL, V42, P735, DOI 10.1016/j.oraloncology.2005.11.019; Pruneski JA, 2011, EUKARYOT CELL, V10, P1283, DOI 10.1128/EC.05141-11; Qiu HF, 2006, MOL CELL BIOL, V26, P3135, DOI 10.1128/MCB.26.8.3135-3148.2006; RISLER JL, 1988, J MOL BIOL, V204, P1019, DOI 10.1016/0022-2836(88)90058-7; Rondon AG, 2004, EMBO REP, V5, P47, DOI 10.1038/sj.embor.7400045; ROSE MD, 1990, METHODS YEAST GENETI, P179; Rozenblatt-Rosen O, 2005, MOL CELL BIOL, V25, P612, DOI 10.1128/MCB.25.2.612-620.2005; Rozenblatt-Rosen O, 2009, P NATL ACAD SCI USA, V106, P755, DOI 10.1073/pnas.0812023106; Sheldon KE, 2005, MOL CELL, V20, P225, DOI 10.1016/j.molcel.2005.08.026; Shema E, 2008, GENE DEV, V22, P2664, DOI 10.1101/gad.1703008; Shi XM, 1996, MOL CELL BIOL, V16, P669; Shirra MK, 2005, GENETICS, V169, P1957, DOI 10.1534/genetics.104.038075; SIKORSKI RS, 1989, GENETICS, V122, P19; Sikorski TW, 2009, CURR OPIN CELL BIOL, V21, P344, DOI 10.1016/j.ceb.2009.03.006; Simic R, 2003, EMBO J, V22, P1846, DOI 10.1093/emboj/cdg179; Squazzo SL, 2002, EMBO J, V21, P1764, DOI 10.1093/emboj/21.7.1764; Stolinski LA, 1997, MOL CELL BIOL, V17, P4490, DOI 10.1128/MCB.17.8.4490; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; Tan MH, 2004, CLIN CANCER RES, V10, P6629, DOI 10.1158/1078-0432.CCR-04-0493; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tomson BN, 2011, GENETICS, V188, P273, DOI 10.1534/genetics.111.128645; Tous C, 2011, EMBO J, V30, P1953, DOI 10.1038/emboj.2011.109; TYERS M, 1992, EMBO J, V11, P1773, DOI 10.1002/j.1460-2075.1992.tb05229.x; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Wade PA, 1996, PROTEIN EXPRES PURIF, V8, P85, DOI 10.1006/prep.1996.0077; Warner MH, 2007, MOL CELL BIOL, V27, P6103, DOI 10.1128/MCB.00772-07; Wennerberg K, 2005, J CELL SCI, V118, P843, DOI 10.1242/jcs.01660; Winston F, 1998, COLD SPRING HARB SYM, V63, P553, DOI 10.1101/sqb.1998.63.553; WINSTON F, 1995, YEAST, V11, P53, DOI 10.1002/yea.320110107; Wood A, 2003, J BIOL CHEM, V278, P34739, DOI 10.1074/jbc.C300269200; Woodard GE, 2005, ONCOGENE, V24, P1272, DOI 10.1038/sj.onc.1208274; Yang YJ, 2010, NUCLEIC ACIDS RES, V38, P382, DOI 10.1093/nar/gkp991; Zhou K, 2009, P NATL ACAD SCI USA, V106, P6956, DOI 10.1073/pnas.0806302106	72	33	34	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					10863	10875		10.1074/jbc.M111.325647	http://dx.doi.org/10.1074/jbc.M111.325647			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22318720	hybrid, Green Published			2022-12-25	WOS:000302780100015
J	Iwashita, Y; Fukuchi, N; Waki, M; Hayashi, K; Tahira, T				Iwashita, Yuji; Fukuchi, Naruhiko; Waki, Mariko; Hayashi, Kenshi; Tahira, Tomoko			Genome-wide Repression of NF-kappa B Target Genes by Transcription Factor MIBP1 and Its Modulation by O-Linked beta-N-Acetylglucosamine (O-GlcNAc) Transferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENHANCER-BINDING-PROTEIN; OPEN-ACCESS DATABASE; MASS-SPECTROMETRY; EXPRESSION; GLCNACYLATION; SCHNURRI-2; SITES; IDENTIFICATION; CLONING; NUCLEAR	The transcription factor c-MYC intron binding protein 1 (MIBP1) binds to various genomic regulatory regions, including intron 1 of c-MYC. This factor is highly expressed in postmitotic neurons in the fetal brain and may be involved in various biological steps, such as neurological and immunological processes. In this study, we globally characterized the transcriptional targets of MIBP1 and proteins that interact with MIBP1. Microarray hybridization followed by gene set enrichment analysis revealed that genes involved in the pathways downstream of MYC, NF-kappa B, and TGF-beta were down-regulated when HEK293 cells stably overexpressed MIBP1. In silico transcription factor binding site analysis of the promoter regions of these down-regulated genes showed that the NF-kappa B binding site was the most overrepresented. The up-regulation of genes known to be in the NF-kappa B pathway after the knockdown of endogenous MIBP1 in HT1080 cells supports the view that MIBP1 is a down-regulator of the NF-kappa B pathway. We also confirmed the binding of the MIBP1 to the NF-kappa B site. By immunoprecipitation and mass spectrometry, we detected O-linked beta-N-acetylglucosamine (O-GlcNAc) transferase as a prominent binding partner of MIBP1. Analyses using deletion mutants revealed that a 154-amino acid region of MIBP1 was necessary for its O-GlcNAc transferase binding and O-GlcNAcylation. A luciferase reporter assay showed that NF-kappa B-responsive expression was repressed by MIBP1, and stronger repression by MIBP1 lacking the 154-amino acid region was observed. Our results indicate that the primary effect of MIBP1 expression is the down-regulation of the NF-kappa B pathway and that this effect is attenuated by O-GlcNAc signaling.	[Iwashita, Yuji; Fukuchi, Naruhiko; Waki, Mariko; Hayashi, Kenshi; Tahira, Tomoko] Kyushu Univ, Div Genome Anal, Res Ctr Genet Informat, Med Inst Bioregulat, Fukuoka 8128582, Japan; [Iwashita, Yuji; Tahira, Tomoko] Kyushu Univ, Grad Sch Syst Life Sci, Fukuoka 8128582, Japan	Kyushu University; Kyushu University	Tahira, T (corresponding author), Kyushu Univ, Div Genome Anal, Res Ctr Genet Informat, Med Inst Bioregulat, Fukuoka 8128582, Japan.	ttahira@gen.kyushu-u.ac.jp			KAKENHI [17019051, 18310131]	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by KAKENHI 17019051 (a grant-in-aid for scientific research in priority areas, "Applied Genomics") and KAKENHI 18310131 (a grant-in-aid for scientific research (B)).	Affolter M, 2007, NAT REV GENET, V8, P663, DOI 10.1038/nrg2166; Allen CE, 2005, MOL B INT U, P213; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Busino L, 2003, NATURE, V426, P87, DOI 10.1038/nature02082; Campbell DB, 2003, J COMP NEUROL, V467, P581, DOI 10.1002/cne.10958; Chalkley RJ, 2009, P NATL ACAD SCI USA, V106, P8894, DOI 10.1073/pnas.0900288106; Chen GI, 2007, METHODS, V42, P298, DOI 10.1016/j.ymeth.2007.02.018; Defrance M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-396; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dorflinger U, 1999, MOL CELL BIOL, V19, P3736; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; FAN CM, 1990, GENE DEV, V4, P29, DOI 10.1101/gad.4.1.29; Fukuda S, 2002, J BIOCHEM, V131, P349, DOI 10.1093/oxfordjournals.jbchem.a003109; Golks A, 2007, EMBO J, V26, P4368, DOI 10.1038/sj.emboj.7601845; Haider S, 2009, NUCLEIC ACIDS RES, V37, pW23, DOI 10.1093/nar/gkp265; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hulo N, 2008, NUCLEIC ACIDS RES, V36, pD245, DOI 10.1093/nar/gkm977; Hutchins JRA, 2010, SCIENCE, V328, P593, DOI 10.1126/science.1181348; Iotsova V, 1997, NAT MED, V3, P1285, DOI 10.1038/nm1197-1285; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jin WZ, 2006, DEV CELL, V10, P461, DOI 10.1016/j.devcel.2006.02.016; Johnson RS, 2005, METHODS, V35, P223, DOI 10.1016/j.ymeth.2004.08.014; Kang YB, 2003, MOL CELL, V11, P915, DOI 10.1016/S1097-2765(03)00109-6; Kawauchi K, 2009, P NATL ACAD SCI USA, V106, P3431, DOI 10.1073/pnas.0813210106; Kimura MY, 2005, J EXP MED, V201, P397, DOI 10.1084/jem.20040733; Kreppel LK, 1997, J BIOL CHEM, V272, P9308; LAMBRACHT D, 1995, IMMUNOGENETICS, V41, P375, DOI 10.1007/BF00163995; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; MAKINO R, 1994, NUCLEIC ACIDS RES, V22, P5679, DOI 10.1093/nar/22.25.5679; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; MITCHELMORE C, 1991, NUCLEIC ACIDS RES, V19, P141, DOI 10.1093/nar/19.1.141; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; NOMURA N, 1991, J BIOL CHEM, V266, P8590; Portales-Casamar E, 2010, NUCLEIC ACIDS RES, V38, pD105, DOI 10.1093/nar/gkp950; RON D, 1991, MOL CELL BIOL, V11, P2887, DOI 10.1128/MCB.11.5.2887; Rozen S, 2000, Methods Mol Biol, V132, P365; Saita Y, 2007, J BIOL CHEM, V282, P12907, DOI 10.1074/jbc.M611203200; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Shukla A, 2009, NAT CELL BIOL, V11, P777, DOI 10.1038/ncb1885; SINGH H, 1988, CELL, V52, P415, DOI 10.1016/S0092-8674(88)80034-5; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Staton TL, 2011, NATURE, V472, P105, DOI 10.1038/nature09848; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Subramanian A, 2007, BIOINFORMATICS, V23, P3251, DOI 10.1093/bioinformatics/btm369; Sui SJH, 2005, NUCLEIC ACIDS RES, V33, P3154, DOI 10.1093/nar/gki624; Suzawa M, 2003, NAT CELL BIOL, V5, P224, DOI 10.1038/ncb942; Takagi T, 2001, NAT IMMUNOL, V2, P1048, DOI 10.1038/ni728; Takagi T, 2006, BRAIN RES, V1108, P88, DOI 10.1016/j.brainres.2006.06.018; Trinkle-Mulcahy L, 2008, J CELL BIOL, V183, P223, DOI 10.1083/jcb.200805092; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; VANTVEER LJ, 1992, P NATL ACAD SCI USA, V89, P8971, DOI 10.1073/pnas.89.19.8971; Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S; Yang WH, 2008, P NATL ACAD SCI USA, V105, P17345, DOI 10.1073/pnas.0806198105; Yang XY, 2002, CELL, V110, P69, DOI 10.1016/S0092-8674(02)00810-3; Yang YC, 2003, P NATL ACAD SCI USA, V100, P10269, DOI 10.1073/pnas.1834070100; Zambelli F, 2009, NUCLEIC ACIDS RES, V37, pW247, DOI 10.1093/nar/gkp464; Zou LY, 2009, AM J PHYSIOL-HEART C, V296, pH515, DOI 10.1152/ajpheart.01025.2008	61	12	13	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					9887	9900		10.1074/jbc.M111.298521	http://dx.doi.org/10.1074/jbc.M111.298521			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22294689	Green Published, hybrid			2022-12-25	WOS:000302167200021
J	Masgras, I; Carrera, S; de Verdier, PJ; Brennan, P; Majid, A; Makhtar, W; Tulchinsky, E; Jones, GDD; Roninson, IB; Macip, S				Masgras, Ionica; Carrera, Samantha; de Verdier, Petra J.; Brennan, Paul; Majid, Aneela; Makhtar, Wan; Tulchinsky, Eugene; Jones, George D. D.; Roninson, Igor B.; Macip, Salvador			Reactive Oxygen Species and Mitochondrial Sensitivity to Oxidative Stress Determine Induction of Cancer Cell Death by p21	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN TUMOR-CELLS; DNA-DAMAGE; INDUCED APOPTOSIS; GENE-EXPRESSION; GROWTH ARREST; CYCLE ARREST; SENESCENCE; P53; FIBROBLASTS; INHIBITOR	p21(Waf1/Cip1/Sdi1) is a cyclin-dependent kinase inhibitor that mediates cell cycle arrest. Prolonged p21 up-regulation induces a senescent phenotype in normal and cancer cells, accompanied by an increase in intracellular reactive oxygen species (ROS). However, it has been shown recently that p21 expression can also lead to cell death in certain models. The mechanisms involved in this process are not fully understood. Here, we describe an induction of apoptosis by p21 in sarcoma cell lines that is p53-independent and can be ameliorated with antioxidants. Similar levels of p21 and ROS caused senescence in the absence of significant death in other cancer cell lines, suggesting a cell-specific response. We also found that cells undergoing p21-dependent cell death had higher sensitivity to oxidants and a specific pattern of mitochondrial polarization changes. Consistent with this, apoptosis could be blocked with targeted expression of catalase in the mitochondria of these cells. We propose that the balance between cancer cell death and arrest after p21 up-regulation depends on the specific effects of p21-induced ROS on the mitochondria. This suggests that selective up-regulation of p21 in cancer cells could be a successful therapeutic intervention for sarcomas and tumors with lower resistance to mitochondrial oxidative damage, regardless of p53 status.	[Masgras, Ionica; Carrera, Samantha; Macip, Salvador] Univ Leicester, Dept Biochem, Leicester LE1 9HN, Leics, England; [Majid, Aneela] Univ Leicester, MRC, Toxicol Unit, Leicester LE1 9HN, Leics, England; [Makhtar, Wan; Tulchinsky, Eugene; Jones, George D. D.] Univ Leicester, Dept Canc Studies & Mol Med, Leicester LE1 9HN, Leics, England; [de Verdier, Petra J.] Karolinska Inst, Urol Lab, Dept Mol Med & Surg, S-17176 Stockholm, Sweden; [Brennan, Paul] Cardiff Univ, Sch Med, Dept Infect Immun & Biochem, Cardiff CF14 4XN, S Glam, Wales; [Roninson, Igor B.] Univ S Carolina, S Carolina Coll Pharm, Dept Pharmaceut & Biomed Sci, Translat Canc Therapeut Program, Columbia, SC 29208 USA	University of Leicester; University of Leicester; University of Leicester; Karolinska Institutet; Cardiff University; Medical University of South Carolina; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Macip, S (corresponding author), Univ Leicester, Dept Biochem, Leicester LE1 9HN, Leics, England.	sm460@le.ac.uk	Masgras, Ionica/ABG-9245-2021; Tulchinsky, Eugene/ABD-7070-2021; Macip, Salvador/K-5985-2014; Macip, Salvador/S-6358-2019; Roninson, Igor/K-1310-2017; Macip, Salvador/P-4233-2019	Masgras, Ionica/0000-0002-9768-460X; Roninson, Igor/0000-0002-9211-1327; Macip, Salvador/0000-0003-1963-8840; Jones, George/0000-0002-9543-2206; WAN MAKHTAR, WAN RATMAAZILA/0000-0003-1630-2137	National Institutes of Health [R01 AG028687]; Medical Research Council; Consejo Nacional de Ciencia y Tecnologia; Swedish Cancer Society [2007/649]; NATIONAL INSTITUTE ON AGING [R01AG028687] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Swedish Cancer Society(Swedish Cancer Society); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AG028687 (to I. B. R.). This work was also supported by New Blood Lectureship Research Support funding from the Medical Research Council (to S. M.), Consejo Nacional de Ciencia y Tecnologia (to S. C.), and the Swedish Cancer Society Grant Cancerfonden 2007/649 (to P. J. d. V.).	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Aubry JP, 1999, CYTOMETRY, V37, P197, DOI 10.1002/(SICI)1097-0320(19991101)37:3<197::AID-CYTO6>3.0.CO;2-L; Bai JX, 2001, J BIOL CHEM, V276, P4315, DOI 10.1074/jbc.M008895200; Barzilai A, 2004, DNA REPAIR, V3, P1109, DOI 10.1016/j.dnarep.2004.03.002; Blagosklonny MV, 2002, CELL CYCLE, V1, P391, DOI 10.4161/cc.1.6.262; BOND JA, 1994, ONCOGENE, V9, P1885; Borgdorff V, 2010, ONCOGENE, V29, P2262, DOI 10.1038/onc.2009.497; Broude EV, 2007, CELL CYCLE, V6, P1468; BRUGAROLAS J, 1995, NATURE, V377, P552, DOI 10.1038/377552a0; Campisi J, 2001, EXP GERONTOL, V36, P1619, DOI 10.1016/S0531-5565(01)00160-7; Carrera S, 2010, J BIOL CHEM, V285, P13658, DOI 10.1074/jbc.M109.062562; Chang BD, 2000, ONCOGENE, V19, P2165, DOI 10.1038/sj.onc.1203573; Chang BD, 1999, ONCOGENE, V18, P4808, DOI 10.1038/sj.onc.1203078; Chang BD, 2000, P NATL ACAD SCI USA, V97, P4291, DOI 10.1073/pnas.97.8.4291; Chen XB, 1996, GENE DEV, V10, P2438, DOI 10.1101/gad.10.19.2438; Chonghaile TN, 2011, SCIENCE, V334, P1129, DOI 10.1126/science.1206727; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Duarte TL, 2009, FREE RADICAL BIO MED, V46, P78, DOI 10.1016/j.freeradbiomed.2008.09.028; Dulic V, 2000, MOL CELL BIOL, V20, P6741, DOI 10.1128/MCB.20.18.6741-6754.2000; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Fang L, 1999, ONCOGENE, V18, P2789, DOI 10.1038/sj.onc.1202615; Gartel AL, 2005, LEUKEMIA RES, V29, P1237, DOI 10.1016/j.leukres.2005.04.023; Gartel AL, 2000, ONCOGENE, V19, P961, DOI 10.1038/sj.onc.1203411; Gartel AL, 1999, EXP CELL RES, V246, P280, DOI 10.1006/excr.1998.4319; Giovannini C, 2002, FEBS LETT, V523, P200, DOI 10.1016/S0014-5793(02)02972-1; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Inoue T, 2009, CANCER SCI, V100, P1275, DOI 10.1111/j.1349-7006.2009.01166.x; Ivanov GS, 2007, MOL CELL BIOL, V27, P6756, DOI 10.1128/MCB.00460-07; Jia LJ, 2011, NEOPLASIA, V13, P561, DOI 10.1593/neo.11420; Johnson TM, 1996, P NATL ACAD SCI USA, V93, P11848, DOI 10.1073/pnas.93.21.11848; JONGKIND JF, 1982, EXP CELL RES, V138, P409, DOI 10.1016/0014-4827(82)90189-6; Ksiazek K, 2008, BIOCHEM BIOPH RES CO, V366, P793, DOI 10.1016/j.bbrc.2007.12.021; Li PF, 1999, EMBO J, V18, P6027, DOI 10.1093/emboj/18.21.6027; Macip S, 2002, EMBO J, V21, P2180, DOI 10.1093/emboj/21.9.2180; Macip S, 2003, MOL CELL BIOL, V23, P8576, DOI 10.1128/MCB.23.23.8576-8585.2003; Mai S, 2010, J CELL SCI, V123, P917, DOI 10.1242/jcs.059246; NODA A, 1994, EXP CELL RES, V211, P90, DOI 10.1006/excr.1994.1063; Paglin S, 2005, CANCER RES, V65, P11061, DOI 10.1158/0008-5472.CAN-05-1083; Passos JF, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.5; Pearce L, 2010, HAEMATOL-HEMATOL J, V95, P514, DOI 10.3324/haematol.2009.014381; Polyak K, 1997, NATURE, V389, P300, DOI 10.1038/38525; Richon VM, 2000, P NATL ACAD SCI USA, V97, P10014, DOI 10.1073/pnas.180316197; Roninson IB, 2002, CANCER LETT, V179, P1, DOI 10.1016/S0304-3835(01)00847-3; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Sugrue MM, 1999, BIOCHEM BIOPH RES CO, V261, P123, DOI 10.1006/bbrc.1999.0984; Wu S, 2010, ONCOGENE, V29, P2302, DOI 10.1038/onc.2010.34	47	64	66	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					9845	9854		10.1074/jbc.M111.250357	http://dx.doi.org/10.1074/jbc.M111.250357			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22311974	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000302167200017
J	Nagamine, S; Tamba, M; Ishimine, H; Araki, K; Shiomi, K; Okada, T; Ohto, T; Kunita, S; Takahashi, S; Wismans, RGP; van Kuppevelt, TH; Masu, M; Keino-Masu, K				Nagamine, Satoshi; Tamba, Michiko; Ishimine, Hisako; Araki, Kota; Shiomi, Kensuke; Okada, Takuya; Ohto, Tatsuyuki; Kunita, Satoshi; Takahashi, Satoru; Wismans, Ronnie G. P.; van Kuppevelt, Toin H.; Masu, Masayuki; Keino-Masu, Kazuko			Organ-specific Sulfation Patterns of Heparan Sulfate Generated by Extracellular Sulfatases Sulf1 and Sulf2 in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VIVO; 6-O-ENDOSULFATASES; PROTEOGLYCANS; EXPRESSION; BINDING; QSULF1; CANCER; GLYCOSAMINOGLYCANS; DIVERSITY; HSULF-1	Heparan sulfate endosulfatases Sulf1 and Sulf2 hydrolyze 6-O-sulfate in heparan sulfate, thereby regulating cellular signaling. Previous studies have revealed that Sulfs act predominantly on UA2S-GlcNS6S disaccharides and weakly on UA-GlcNS6S disaccharides. However, the specificity of Sulfs and their role in sulfation patterning of heparan sulfate in vivo remained unknown. Here, we performed disaccharide analysis of heparan sulfate in Sulf1 and Sulf2 knock-out mice. Significant increases in Delta UA2S-GlcNS6S were observed in the brain, small intestine, lung, spleen, testis, and skeletal muscle of adult Sulf1(-/-) mice and in the brain, liver, kidney, spleen, and testis of adult Sulf2(-/-) mice. In addition, increases in Delta UA-GlcNS6S were seen in the Sulf1(-/-) lung and small intestine. In contrast, the disaccharide compositions of chondroitin sulfate were not primarily altered, indicating specificity of Sulfs for heparan sulfate. For Sulf1, but not for Sulf2, mRNA expression levels in eight organs of wild-type mice were highly correlated with increases in Delta UA2S-GlcNS6S in the corresponding organs of knock-out mice. Moreover, overall changes in heparan sulfate compositions were greater in Sulf1(-/-) mice than in Sulf2(-/-) mice despite lower levels of Sulf1 mRNA expression, suggesting predominant roles of Sulf1 in heparan sulfate desulfation and distinct regulation of Sulf activities in vivo. Sulf1 and Sulf2 mRNAs were differentially expressed in restricted types of cells in organs, and consequently, the sulfation patterns of heparan sulfate were locally and distinctly altered in Sulf1 and Sulf2 knock-out mice. These findings indicate that Sulf1 and Sulf2 differentially contribute to the generation of organ-specific sulfation patterns of heparan sulfate.	[Nagamine, Satoshi; Tamba, Michiko; Ishimine, Hisako; Araki, Kota; Shiomi, Kensuke; Okada, Takuya; Ohto, Tatsuyuki; Masu, Masayuki; Keino-Masu, Kazuko] Univ Tsukuba, Dept Mol Neurobiol, Tsukuba, Ibaraki 3058577, Japan; [Ohto, Tatsuyuki] Univ Tsukuba, Dept Pediat, Fac Med, Tsukuba, Ibaraki 3058577, Japan; [Kunita, Satoshi; Takahashi, Satoru] Univ Tsukuba, Lab Anim Resource Ctr, Tsukuba, Ibaraki 3058577, Japan; [Wismans, Ronnie G. P.; van Kuppevelt, Toin H.] Radbout Univ Nijmegen Med Ctr, Dept Matrix Biochem, Nijmegen Ctr Mol Life Sci, NL-6500 HB Nijmegen, Netherlands	University of Tsukuba; University of Tsukuba; University of Tsukuba; Radboud University Nijmegen	Masu, M (corresponding author), Univ Tsukuba, Dept Mol Neurobiol, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058577, Japan.	mmasu@md.tsukuba.ac.jp; kazumasu@md.tsukuba.ac.jp	van Kuppevelt, A.H.M.S.M./L-4463-2015	Okada, Takuya/0000-0002-6485-9469	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Mizutani Foundation for Glycoscience; Grants-in-Aid for Scientific Research [24110502] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Mizutani Foundation for Glycoscience; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants-in-aid for Scientific Research on Priority Areas by the 21st Century COE program from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and by a research grant from the Mizutani Foundation for Glycoscience.	Ai XB, 2006, J BIOL CHEM, V281, P4969, DOI 10.1074/jbc.M511902200; Ai XB, 2003, J CELL BIOL, V162, P341, DOI 10.1083/jcb.200212083; Ai XB, 2007, DEVELOPMENT, V134, P3327, DOI 10.1242/dev.007674; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Bulow HE, 2006, ANNU REV CELL DEV BI, V22, P375, DOI 10.1146/annurev.cellbio.22.010605.093433; Danesin C, 2006, J NEUROSCI, V26, P5037, DOI 10.1523/JNEUROSCI.0715-06.2006; Dhoot GK, 2001, SCIENCE, V293, P1663, DOI 10.1126/science.293.5535.1663; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Freeman SD, 2008, DEV BIOL, V320, P436, DOI 10.1016/j.ydbio.2008.05.554; Frese MA, 2009, J BIOL CHEM, V284, P28033, DOI 10.1074/jbc.M109.035808; Gallagher JT, 2001, J CLIN INVEST, V108, P357, DOI 10.1172/JCI13713; Habuchi H, 2004, GLYCOCONJUGATE J, V21, P47, DOI 10.1023/B:GLYC.0000043747.87325.5e; Holst CR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000575; Hosono-Fukao T, 2011, J NEUROSCI RES, V89, P1840, DOI 10.1002/jnr.22690; Hossain MM, 2010, GLYCOBIOLOGY, V20, P175, DOI 10.1093/glycob/cwp159; Jenniskens GJ, 2002, DEV DYNAM, V225, P70, DOI 10.1002/dvdy.10138; Kurup S, 2007, J BIOL CHEM, V282, P21032, DOI 10.1074/jbc.M702073200; Lai JP, 2004, GASTROENTEROLOGY, V126, P231, DOI 10.1053/j.gastro.2003.09.043; Lai JP, 2003, J BIOL CHEM, V278, P23107, DOI 10.1074/jbc.M302203200; Lamanna WC, 2008, J BIOL CHEM, V283, P27724, DOI 10.1074/jbc.M802130200; Lamanna WC, 2007, J BIOTECHNOL, V129, P290, DOI 10.1016/j.jbiotec.2007.01.022; Lamanna WC, 2006, BIOCHEM J, V400, P63, DOI 10.1042/BJ20060848; Langsdorf A, 2007, DEV BIOL, V311, P464, DOI 10.1016/j.ydbio.2007.08.053; Langsdorf A, 2011, GLYCOBIOLOGY, V21, P152, DOI 10.1093/glycob/cwq133; Ledin J, 2004, J BIOL CHEM, V279, P42732, DOI 10.1074/jbc.M405382200; Lindahl U, 1998, J BIOL CHEM, V273, P24979, DOI 10.1074/jbc.273.39.24979; Lum DH, 2007, MOL CELL BIOL, V27, P678, DOI 10.1128/MCB.01279-06; Maccarana M, 1996, J BIOL CHEM, V271, P17804, DOI 10.1074/jbc.271.30.17804; Morimoto-Tomita M, 2002, J BIOL CHEM, V277, P49175, DOI 10.1074/jbc.M205131200; Nagamine S, 2005, DEV BRAIN RES, V159, P135, DOI 10.1016/j.devbrainres.2005.07.006; Nagamine S, 2010, BIOCHEM BIOPH RES CO, V391, P107, DOI 10.1016/j.bbrc.2009.11.011; Ohto T, 2002, GENES CELLS, V7, P173, DOI 10.1046/j.1356-9597.2001.00502.x; Ratelade J, 2010, HUM MOL GENET, V19, P1, DOI 10.1093/hmg/ddp462; Ratzka A, 2008, DEV DYNAM, V237, P339, DOI 10.1002/dvdy.21423; Rosen SD, 2010, EXPERT OPIN THER TAR, V14, P935, DOI 10.1517/14728222.2010.504718; Schumacher VA, 2011, J AM SOC NEPHROL, V22, P1286, DOI 10.1681/ASN.2010080860; Shi XF, 2009, J BIOL CHEM, V284, P11806, DOI 10.1074/jbc.M809637200; Tang RH, 2009, J BIOL CHEM, V284, P21505, DOI 10.1074/jbc.M109.028472; Toyoda H, 2000, J BIOL CHEM, V275, P2269, DOI 10.1074/jbc.275.4.2269; Turnbull J, 2001, TRENDS CELL BIOL, V11, P75, DOI 10.1016/S0962-8924(00)01897-3; Uchimura Kenji, 2006, BMC Biochem, V7, P2, DOI 10.1186/1471-2091-7-2; van Kuppevelt TH, 1998, J BIOL CHEM, V273, P12960, DOI 10.1074/jbc.273.21.12960; Viviano BL, 2004, J BIOL CHEM, V279, P5604, DOI 10.1074/jbc.M310691200; Wang SW, 2004, P NATL ACAD SCI USA, V101, P4833, DOI 10.1073/pnas.0401028101; Warda M, 2006, GLYCOCONJUGATE J, V23, P555, DOI 10.1007/s10719-006-7668-1	46	63	64	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					9579	9590		10.1074/jbc.M111.290262	http://dx.doi.org/10.1074/jbc.M111.290262			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22298771	Green Published, hybrid, Green Submitted			2022-12-25	WOS:000301797800089
J	Chen, V; Staub, RE; Fong, S; Tagliaferri, M; Cohen, I; Shtivelman, E				Chen, Vivian; Staub, Richard E.; Fong, Sylvia; Tagliaferri, Mary; Cohen, Isaac; Shtivelman, Emma			Bezielle Selectively Targets Mitochondria of Cancer Cells to Inhibit Glycolysis and OXPHOS	PLOS ONE			English	Article							SCUTELLARIA-BARBATA; BREAST-CANCER; ANTICANCER ACTIVITY; ROS RELEASE; DEATH; EXTRACT; APOPTOSIS; BZL101; POLY(ADP-RIBOSE); MECHANISMS	Bezielle (BZL101) is a candidate oral drug that has shown promising efficacy and excellent safety in the early phase clinical trials for advanced breast cancer. Bezielle is an aqueous extract from the herb Scutellaria barbata. We have reported previously that Bezielle was selectively cytotoxic to cancer cells while sparing non-transformed cells. In tumor, but not in non-transformed cells, Bezielle induced generation of ROS and severe DNA damage followed by hyperactivation of PARP, depletion of the cellular ATP and NAD, and inhibition of glycolysis. We show here that tumor cells' mitochondria are the primary source of reactive oxygen species induced by Bezielle. Treatment with Bezielle induces progressively higher levels of mitochondrial superoxide as well as peroxide-type ROS. Inhibition of mitochondrial respiration prevents generation of both types of ROS and protects cells from Bezielle-induced death. In addition to glycolysis, Bezielle inhibits oxidative phosphorylation in tumor cells and depletes mitochondrial reserve capacity depriving cells of the ability to produce ATP. Tumor cells lacking functional mitochondria maintain glycolytic activity in presence of Bezielle thus supporting the hypothesis that mitochondria are the primary target of Bezielle. The metabolic effects of Bezielle towards normal cells are not significant, in agreement with the low levels of oxidative damage that Bezielle inflicts on them. Bezielle is therefore a drug that selectively targets cancer cell mitochondria, and is distinguished from other such drugs by its ability to induce not only inhibition of OXPHOS but also of glycolysis. This study provides a better understanding of the mechanism of Bezielle's cytotoxicity, and the basis of its selectivity towards cancer cells.	[Chen, Vivian; Staub, Richard E.; Fong, Sylvia; Tagliaferri, Mary; Cohen, Isaac; Shtivelman, Emma] BioNovo Inc, Emeryville, CA USA		Chen, V (corresponding author), BioNovo Inc, Emeryville, CA USA.	emmas@bionovo.com		Fong, Sylvia/0000-0002-3818-4146	BioNovo, Inc.; BioNovo. Bezielle [BZL101]	BioNovo, Inc.; BioNovo. Bezielle	This research was supported entirely by BioNovo, Inc. No external funding was received for this study. The funder played a role in the decision to research Bezielle as an anti-cancer agent, but had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors acknowledge that they are paid employees and stock holders of BioNovo, Inc, and that this study, in its entirety, was supported by funds from BioNovo. Bezielle (BZL101) is Bionovo's proprietary botanical drug candidate (FDA-IND: 59,521) for the treatment of metastatic breast cancer. Bionovo's United States Patent No. 7,700,136 covers a method of treating breast cancer using an extract of Scutellaria Barbata. This patent also covers the use of Bionovo's proprietary BezielleR formulation as a monotherapy for the treatment of breast cancer. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Alano CC, 2010, J NEUROSCI, V30, P2967, DOI 10.1523/JNEUROSCI.5552-09.2010; Batandier C, 2002, J CELL MOL MED, V6, P175, DOI 10.1111/j.1582-4934.2002.tb00185.x; Cha YY, 2004, CLIN CHIM ACTA, V348, P41, DOI 10.1016/j.cccn.2004.04.013; Chen G, 2010, MITOCHONDRION, V10, P614, DOI 10.1016/j.mito.2010.08.001; Choi SW, 2009, J NEUROCHEM, V109, P1179, DOI 10.1111/j.1471-4159.2009.06055.x; Chui CH, 2005, INT J MOL MED, V16, P337; Dai Zhi-jun, 2008, Nan Fang Yi Ke Da Xue Xue Bao, V28, P1835; Desouki MM, 2005, CANCER BIOL THER, V4, P1367, DOI 10.4161/cbt.4.12.2233; Dranka BP, 2010, FREE RADICAL BIO MED, V48, P905, DOI 10.1016/j.freeradbiomed.2010.01.015; Fong S, 2008, CANCER BIOL THER, V7, P577, DOI 10.4161/cbt.7.4.5535; Goh D, 2005, J AGR FOOD CHEM, V53, P8197, DOI 10.1021/jf051506+; Graham KA, 2010, CANCER BIOL THER, V10, DOI 10.4161/cbt.10.3.12207; Hegedus C, 2008, FEBS LETT, V582, P1672, DOI 10.1016/j.febslet.2008.04.023; Kim EK, 2007, INT J MOL MED, V20, P123; Kim MY, 2005, GENE DEV, V19, P1951, DOI 10.1101/gad.1331805; Klawitter J, 2011, INT J CANCER, V129, P2945, DOI 10.1002/ijc.25965; LEBEL CP, 1992, CHEM RES TOXICOL, V5, P227, DOI 10.1021/tx00026a012; Lee SB, 2006, J BIOL CHEM, V281, P36228, DOI 10.1074/jbc.M606702200; Li YB, 1998, BIOCHEM BIOPH RES CO, V253, P295, DOI 10.1006/bbrc.1998.9729; MAJANDER A, 1994, J BIOL CHEM, V269, P21037; Marconett CN, 2010, CANCER BIOL THER, V10, P397, DOI 10.4161/cbt.10.4.12424; Neuzil J, 2007, MOL PHARMACOL, V71, P1185, DOI 10.1124/mol.106.030122; Parajuli P, 2009, PLANTA MED, V75, P41, DOI 10.1055/s-0028-1088364; Parajuli P, 2011, J NEURO-ONCOL, V101, P15, DOI 10.1007/s11060-010-0221-x; Perez AT, 2010, BREAST CANCER RES TR, V120, P111, DOI 10.1007/s10549-009-0678-5; Rouleau M, 2010, NAT REV CANCER, V10, P293, DOI 10.1038/nrc2812; Rugo H, 2007, BREAST CANCER RES TR, V105, P17, DOI 10.1007/s10549-006-9430-6; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Shoemaker M, 2005, PHYTOTHER RES, V19, P649, DOI 10.1002/ptr.1702; Sun XG, 2006, CELL CYCLE, V5, P2029, DOI 10.4161/cc.5.17.3312; von Kleist-Retzow JC, 2007, EXP CELL RES, V313, P3076, DOI 10.1016/j.yexcr.2007.04.015; Wong BYY, 2009, EUR J CANCER PREV, V18, P331, DOI 10.1097/CEJ.0b013e32832c3859; Wong BYY, 1996, CANCER BIOTHER RADIO, V11, P51, DOI 10.1089/cbr.1996.11.51; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; Yin XL, 2004, LIFE SCI, V75, P2233, DOI 10.1016/j.lfs.2004.05.015; Ying WH, 2003, BIOCHEM BIOPH RES CO, V308, P809, DOI 10.1016/S0006-291X(03)01483-9; Zong WX, 2004, GENE DEV, V18, P1272, DOI 10.1101/gad.1199904; Zorov DB, 2000, J EXP MED, V192, P1001, DOI 10.1084/jem.192.7.1001; Zorov DB, 2006, BBA-BIOENERGETICS, V1757, P509, DOI 10.1016/j.bbabio.2006.04.029	39	34	38	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2012	7	2							e30300	10.1371/journal.pone.0030300	http://dx.doi.org/10.1371/journal.pone.0030300			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LO	22319564	Green Published, Green Submitted, gold			2022-12-25	WOS:000302178400006
J	Liu, L; Drouet, V; Wu, JW; Witter, MP; Small, SA; Clelland, C; Duff, K				Liu, Li; Drouet, Valerie; Wu, Jessica W.; Witter, Menno P.; Small, Scott A.; Clelland, Catherine; Duff, Karen			Trans-Synaptic Spread of Tau Pathology In Vivo	PLOS ONE			English	Article							ENTORHINAL CORTEX; ORGANIZATION; SECTIONS; DISEASE; REGION; MEMORY; MOUSE	Tauopathy in the brain of patients with Alzheimer's disease starts in the entorhinal cortex (EC) and spreads anatomically in a defined pattern. To test whether pathology initiating in the EC spreads through the brain along synaptically connected circuits, we have generated a transgenic mouse model that differentially expresses pathological human tau in the EC and we have examined the distribution of tau pathology at different timepoints. In relatively young mice (10-11 months old), human tau was present in some cell bodies, but it was mostly observed in axons within the superficial layers of the medial and lateral EC, and at the terminal zones of the perforant pathway. In old mice (>22 months old), intense human tau immunoreactivity was readily detected not only in neurons in the superficial layers of the EC, but also in the subiculum, a substantial number of hippocampal pyramidal neurons especially in CA1, and in dentate gyrus granule cells. Scattered immunoreactive neurons were also seen in the deeper layers of the EC and in perirhinal and secondary somatosensory cortex. Immunoreactivity with the conformation-specific tau antibody MC1 correlated with the accumulation of argyrophilic material seen in old, but not young mice. In old mice, axonal human tau immunoreactivity, especially at the endzones of the perforant pathway, was greatly reduced. Relocalization of tau from axons to somatodendritic compartments and propagation of tauopathy to regions outside of the EC correlated with mature tangle formation in neurons in the EC as revealed by thioflavin-S staining. Our data demonstrate propagation of pathology from the EC and support a trans-synaptic mechanism of spread along anatomically connected networks, between connected and vulnerable neurons. In general, the mouse recapitulates the tauopathy that defines the early stages of AD and provides a model for testing mechanisms and functional outcomes associated with disease progression.	[Liu, Li; Drouet, Valerie; Wu, Jessica W.; Clelland, Catherine; Duff, Karen] Columbia Univ, Taub Inst Alzheimers Dis Res, Dept Pathol & Cell Biol, New York, NY 10027 USA; [Witter, Menno P.] Norwegian Univ Sci & Technol, Kavli Inst Syst Neurosci, N-7034 Trondheim, Norway; [Witter, Menno P.] Norwegian Univ Sci & Technol, Ctr Biol Memory, N-7034 Trondheim, Norway; [Small, Scott A.] Columbia Univ, Taub Inst Alzheimers Dis Res, Dept Neurol, New York, NY USA; [Duff, Karen] New York State Psychiat Inst & Hosp, Dept Psychiat, New York, NY 10032 USA	Columbia University; Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Columbia University; New York State Psychiatry Institute	Liu, L (corresponding author), Columbia Univ, Taub Inst Alzheimers Dis Res, Dept Pathol & Cell Biol, New York, NY 10027 USA.	ked2115@columbia.edu	Clelland, Catherine/AAZ-8551-2021	Drouet, Valerie/0000-0001-9958-8470; Duff, Karen/0000-0002-6177-868X	National Institutes of Health [NS74874, AG033790, AG025161, AG034618]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS074874] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG008702, R01AG034618, R01AG025161, R21AG033790] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health grants to KD (NS74874), CC (AG033790) and SAS (AG025161, AG034618). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bancroft J.D., 1996, THEORY PRACTICE HIST, VVolume 6; BIERNAT J, 1992, EMBO J, V11, P1593, DOI 10.1002/j.1460-2075.1992.tb05204.x; Blaizot AX, 2002, J NEUROSCI, V22, P9166; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Braak H, 2006, ACTA NEUROPATHOL, V112, P389, DOI 10.1007/s00401-006-0127-z; Braak H, 2011, ACTA NEUROPATHOL, V121, P171, DOI 10.1007/s00401-010-0789-4; Jicha GA, 1997, J NEUROSCI RES, V48, P128, DOI 10.1002/(SICI)1097-4547(19970415)48:2<128::AID-JNR5>3.0.CO;2-E; Juntti SA, 2010, NEURON, V66, P260, DOI 10.1016/j.neuron.2010.03.024; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mayford M, 1996, P NATL ACAD SCI USA, V93, P13250, DOI 10.1073/pnas.93.23.13250; Saman S., 2011, J BIOL CHEM; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Sun AY, 2002, J HISTOCHEM CYTOCHEM, V50, P463, DOI 10.1177/002215540205000403; van Groen T, 2003, HIPPOCAMPUS, V13, P133, DOI 10.1002/hipo.10037; Weaver CL, 2000, NEUROBIOL AGING, V21, P719, DOI 10.1016/S0197-4580(00)00157-3; Witter MP, 2007, PROG BRAIN RES, V163, P43, DOI 10.1016/S0079-6123(07)63003-9; Witter MP, 2000, ANN NY ACAD SCI, V911, P1; Yasuda M, 2006, NEURON, V50, P309, DOI 10.1016/j.neuron.2006.03.035	18	695	709	0	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2012	7	2							e31302	10.1371/journal.pone.0031302	http://dx.doi.org/10.1371/journal.pone.0031302			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UG	22312444	Green Published, gold			2022-12-25	WOS:000301977500034
J	Santos-Silva, R; Castro, LS; Taddei, JA; Tufik, S; Bittencourt, LRA				Santos-Silva, Rogerio; Castro, Laura Siqueira; Taddei, Jose Augusto; Tufik, Sergio; Azeredo Bittencourt, Lia Rita			Sleep Disorders and Demand for Medical Services: Evidence from a Population-Based Longitudinal Study	PLOS ONE			English	Article							HEALTH-CARE; RISK-FACTOR; INSOMNIA; APNEA; COMPLAINTS; BURDEN; COSTS; DEATH	Background: The aim of this study was to investigate whether insomnia and obstructive sleep apnea (OSA) were predictors of hospitalizations or emergency department visits during two years following the Sao Paulo Epidemiologic Sleep Study (EPISONO) sample. Methods and Findings: All participants (n = 1,101) who underwent a baseline evaluation between July and December 2007 were contacted in December 2009 and asked to fill out a questionnaire about body weight changes, number of hospitalizations and visits to the emergency department. Participants lost during the follow-up period represented 3.2% (n = 35) and 7 subjects had died. Hospitalizations were reported by 116 volunteers (10.5%) and emergency department visits were reported by 136 participants (12.4%). The average body mass index (BMI) did not vary significantly between the first and the second assessment [26.7(95% CI: 26.3-27.1) vs. 26.9(26.5-27.4) kg/m(2)]. After adjusting for confounders, a multiple logistic regression model revealed that female gender [1.4(1.0-1.9)], age >= 40 years, insomnia diagnosed according to the DSM-IV criteria [1.6(1.0-2.6)], and apnea-hypopnea index >= 15 [1.5(1.0-2.2)] were predictors of hospitalizations and/or demand for emergency services. Conclusion: Our study of a probabilistic sample of the Sao Paulo inhabitants shows that over a period of two years, insomnia and OSA were both associated with health impairment. Considering the high prevalence and public health burden of sleep disorders, the consequences of untreated disease for both the individual and society are undeniable and should be addressed.	[Santos-Silva, Rogerio; Castro, Laura Siqueira; Tufik, Sergio; Azeredo Bittencourt, Lia Rita] Univ Fed Sao Paulo UNIFESP, Dept Psicobiol, Disciplina Med & Biol Sono, Sao Paulo, Brazil; [Taddei, Jose Augusto] Univ Fed Sao Paulo UNIFESP, Dept Pediat, Disciplina Nutr & Metab, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP)	Santos-Silva, R (corresponding author), Univ Fed Sao Paulo UNIFESP, Dept Psicobiol, Disciplina Med & Biol Sono, Sao Paulo, Brazil.	lia@psicobio.epm.br	Sono, Cepid/I-5371-2013; Bittencourt, Lia/C-6551-2012; Santos-Silva, Rogerio/E-4630-2013; TADDEI, JOSE AUGUSTO A C/D-8216-2015; Tufik, Sergio/D-7606-2012; Castro, Laura/ABB-1293-2021	Bittencourt, Lia/0000-0001-7738-0927; TADDEI, JOSE AUGUSTO A C/0000-0003-3833-392X; Castro, Laura/0000-0002-0852-8235	Associacao Fundo de Incentivo a Pesquisa (AFIP); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [07/50525-1]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (CEPID) [98/14303-3]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico	Associacao Fundo de Incentivo a Pesquisa (AFIP); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (CEPID)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by the Associacao Fundo de Incentivo a Pesquisa (AFIP) and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (#07/50525-1 to RS-S, CEPID # 98/14303-3 to ST). LSC, JAT, ST and LRAB are recipients of fellowships from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Academy of Sleep Medicine, 2005, INT CLASS SLEEP DIS; American Psychiatric Association, 1994, TASK FORC D 1 DSM 4; Ban HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018455; Banno K, 2009, SLEEP, V32, P247, DOI 10.1093/sleep/32.2.247; Budhiraja R, 2010, RESP CARE, V55, P1322; Chien KL, 2010, SLEEP, V33, P177, DOI 10.1093/sleep/33.2.177; Chilcott LA, 1996, PHARMACOECONOMICS, V10, P1, DOI 10.2165/00019053-199600101-00003; Daley M, 2009, SLEEP, V32, P55; Gami AS, 2005, NEW ENGL J MED, V352, P1206, DOI 10.1056/NEJMoa041832; Holty JC, 2011, SLEEP, V34, pA334; Kapur V, 1999, SLEEP, V22, P749, DOI 10.1093/sleep/22.6.749; Kapur Vishesh, 2002, Sleep Breath, V6, P49, DOI 10.1055/s-2002-32318; Kapur VK, 2002, SLEEP, V25, P289; Kish L, 1965, SURVEY SAMPLING; Korn E. L., 1999, ANAL HLTH SURVEYS; Leger D, 2010, SLEEP MED, V11, P999, DOI 10.1016/j.sleep.2010.04.018; Marin JM, 2005, LANCET, V365, P1046, DOI 10.1016/S0140-6736(05)71141-7; Marshall NS, 2009, J CLIN SLEEP MED, V5, P15; Morrell MJ, 2010, THORAX, V65, P908, DOI 10.1136/thx.2009.126730; Ohayon MM, 1996, CAN J PSYCHIAT, V41, P457, DOI 10.1177/070674379604100711; Ohayon MM, 2002, SLEEP MED REV, V6, P97, DOI 10.1053/smrv.2002.0186; Santos-Silva R, 2009, SLEEP MED, V10, P679, DOI 10.1016/j.sleep.2008.11.001; Sassani A, 2004, SLEEP, V27, P453, DOI 10.1093/sleep/27.3.453; Simon GE, 1997, AM J PSYCHIAT, V154, P1417; Tufik S, 2010, SLEEP MED, V11, P441, DOI 10.1016/j.sleep.2009.10.005; Yaggi HK, 2005, NEW ENGL J MED, V353, P2034, DOI 10.1056/NEJMoa043104; Young T, 2008, SLEEP, V31, P1071	27	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2012	7	2							e30085	10.1371/journal.pone.0030085	http://dx.doi.org/10.1371/journal.pone.0030085			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UG	22312420	Green Published, Green Submitted, gold			2022-12-25	WOS:000301977500003
J	Nicolas-Chanoine, MH; Jarlier, V; Robert, J; Arlet, G; Drieux, L; Leflon-Guibout, V; Laouenan, C; Larroque, B; Caro, V; Mentre, F				Nicolas-Chanoine, Marie-Helene; Jarlier, Vincent; Robert, Jerome; Arlet, Guillaume; Drieux, Laurence; Leflon-Guibout, Veronique; Laouenan, Cedric; Larroque, Beatrice; Caro, Valerie; Mentre, France		Study Grp Coli	Patient's Origin and Lifestyle Associated with CTX-M-Producing Escherichia coli: A Case-Control-Control Study	PLOS ONE			English	Article							LACTAMASE-PRODUCING ENTEROBACTERIACEAE; SPECTRUM BETA-LACTAMASES; BLOOD-STREAM INFECTIONS; RISK-FACTORS; KLEBSIELLA-PNEUMONIAE; COMMUNITY-ONSET; RESISTANCE; EMERGENCE; ESBL	Background: Global dissemination of Escherichia coli producing CTX-M extended-spectrum beta-lactamases (ESBL) is a public health concern. The aim of the study was to determine factors associated with CTX-M-producing E. coli infections among patients hospitalised in the Assistance Publique-Hopitaux de Paris, the largest hospital system in France (23 000 beds), through a prospective case-control-control study. Methods/Principal Findings: From November 2008 to June 2009, 152 inpatients with a clinical sample positive for CTX-M-producing E. coli (cases), 152 inpatients with a clinical sample positive for non ESBL-producing E. coli on the day or within the three days following case detection (controls C1), and 152 inpatients with culture-negative clinical samples since the beginning of hospitalisation and until three days after case detection (controls C2) were included in ten hospitals of the Paris area. Factors studied were related to patient's origin, lifestyle and medical history as well as care during hospitalisation. Those independently associated with CTX-M-producing E. coli were determined. Three independent factors were common to the two case-control comparisons: birth outside of Europe (cases vs C1: OR1 = 2.4; 95% CI = [1.3-4.5] and cases vs C2: OR2 = 3.1; 95% CI = [1.4-7.0]), chronic infections (OR1 = 2.9; 95% CI = [1.3-6.9] and OR2 = 8.7; 95% CI = [2.0-39.7]), and antibiotic treatment between hospital admission and inclusion (OR1 = 2.0; 95% CI = [1.0-3.8] and OR2 = 3.3; 95% CI = [1.5-7.2]). Cases were also more likely to be (i) functionally dependent before hospitalisation than C2 (OR2 = 7.0; 95% CI = [2.1-23.5]) and (ii) living in collective housing before hospitalisation than C2 (OR2 = 15.2; 95% CI = [1.8-130.7]) when CTX-M-producing E. coli was present at admission. Conclusion: For the first time, patient's origin and lifestyle were demonstrated to be independently associated with isolation of CTX-M-producing E. coli, in addition to health care-related factors.	[Nicolas-Chanoine, Marie-Helene; Leflon-Guibout, Veronique] Hop Beaujon, AP HP, Microbiol Serv, Clichy, France; [Nicolas-Chanoine, Marie-Helene] Fac Med D Diderot, Paris, France; [Nicolas-Chanoine, Marie-Helene] Univ Paris, INSERM, CRB3, U773, F-75252 Paris, France; [Jarlier, Vincent; Robert, Jerome] Hop La Pitie Salpetriere, AP HP, Lab Bacteriol Hyg Hosp, Paris, France; [Jarlier, Vincent; Robert, Jerome; Drieux, Laurence] Univ Paris 06, EA 1541, Paris, France; [Arlet, Guillaume] Hop Tenon, AP HP, Serv Bacteriol, F-75970 Paris, France; [Drieux, Laurence] Hop Charles Foix, AP HP, Equipe Operat Hyg Hosp, Ivry, France; [Laouenan, Cedric; Mentre, France] Univ D Diderot, INSERM, UMR S 738, Paris, France; [Laouenan, Cedric; Mentre, France] Hop Bichat Claude Bernard, AP HP, UF Biostat, F-75877 Paris, France; [Larroque, Beatrice] Hop Beaujon, AP HP, Antenne URC Paris Nord, Unite Epidemiol & Rech Clin, Clichy, France; [Caro, Valerie] Inst Pasteur, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Charles-Foix - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Nicolas-Chanoine, MH (corresponding author), Hop Beaujon, AP HP, Microbiol Serv, Clichy, France.	mhn.chanoine@bjn.aphp.fr	Laouenan, Cedric/E-1157-2019; Arlet, Guillaume/P-2990-2017; Mentre, France/AFU-8218-2022; ROBERT, Jérôme/C-3993-2011; Arlet, Guillaume/AAW-4918-2020	Laouenan, Cedric/0000-0002-3681-6314; Mentre, France/0000-0002-7045-1275; ROBERT, Jérôme/0000-0002-9380-0570; Gallah, Salah/0000-0002-5056-079X	Programme Regional de Recherche Clinique AP-HP/Institut Pasteur, Direction de la Recherche Clinique AP-HP, Paris, France [PASo7010]	Programme Regional de Recherche Clinique AP-HP/Institut Pasteur, Direction de la Recherche Clinique AP-HP, Paris, France	This study was supported by a grant (PASu7010) from the Programme Regional de Recherche Clinique AP-HP/Institut Pasteur, Direction de la Recherche Clinique AP-HP, Paris, France (a publicly funded non profit organization). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apisarnthanarak A, 2007, AM J INFECT CONTROL, V35, P606, DOI 10.1016/j.ajic.2007.05.008; Ben-Ami R, 2009, CLIN INFECT DIS, V49, P682, DOI 10.1086/604713; Bonnet R, 2004, ANTIMICROB AGENTS CH, V48, P1, DOI 10.1128/AAC.48.1.1-14.2004; Carret G, 2003, INT J ANTIMICROB AG, V21, P364, DOI 10.1016/S0924-8579(03)00021-9; Dhanji H, 2011, J ANTIMICROB CHEMOTH, V66, P512, DOI 10.1093/jac/dkq472; Harris AD, 2001, CLIN INFECT DIS, V32, P1055, DOI 10.1086/319600; Iabadene H, 2008, J ANTIMICROB CHEMOTH, V62, P133, DOI 10.1093/jac/dkn145; JARLIER V, 1988, REV INFECT DIS, V10, P867; Kang CI, 2010, INT J ANTIMICROB AG, V36, P284, DOI 10.1016/j.ijantimicag.2010.05.009; Laupland KB, 2008, CLIN MICROBIOL INFEC, V14, P1041, DOI 10.1111/j.1469-0691.2008.02089.x; Laupland KB, 2008, J INFECTION, V57, P441, DOI 10.1016/j.jinf.2008.09.034; Lee DS, 2010, KOREAN J UROL, V51, P492, DOI 10.4111/kju.2010.51.7.492; Leflon-Guibout V, 2004, ANTIMICROB AGENTS CH, V48, P3736, DOI 10.1128/AAC.48.10.3736-3742.2004; Li B, 2011, SCAND J INFECT DIS, V43, P170, DOI 10.3109/00365548.2010.538856; Lopez-Cerero L, 2011, INT J ANTIMICROB AG, V37, P365, DOI 10.1016/j.ijantimicag.2011.01.001; Mamlouk K, 2006, J CLIN MICROBIOL, V44, P4049, DOI 10.1128/JCM.01076-06; MCCABE WR, 1962, ARCH INTERN MED, V110, P847, DOI 10.1001/archinte.1962.03620240029006; Meunier D, 2006, INT J ANTIMICROB AG, V28, P402, DOI 10.1016/j.ijantimicag.2006.08.016; Moor CT, 2008, J HOSP INFECT, V68, P355, DOI 10.1016/j.jhin.2008.02.003; Nicolas-Chanoine MH, 2008, J ANTIMICROB CHEMOTH, V61, P273, DOI 10.1093/jac/dkm464; Nicolas-Chanoine MH, 2008, CLIN MICROBIOL INFEC, V14, P111, DOI 10.1111/j.1469-0691.2007.01862.x; Overdevest I, 2011, EMERG INFECT DIS, V17, P1216, DOI 10.3201/eid1707.110209; Pitout JDD, 2008, LANCET INFECT DIS, V8, P159, DOI 10.1016/S1473-3099(08)70041-0; Pomba C, 2009, ANTIMICROB AGENTS CH, V53, P327, DOI 10.1128/AAC.00896-08; Rodriguez-Bano J, 2010, J CLIN MICROBIOL, V48, P1726, DOI 10.1128/JCM.02353-09; Rodriguez-Bano J, 2010, CLIN INFECT DIS, V50, P40, DOI 10.1086/649537; Rogers BA, 2011, J ANTIMICROB CHEMOTH, V66, P1, DOI 10.1093/jac/dkq415; Rooney PJ, 2009, J ANTIMICROB CHEMOTH, V64, P635, DOI 10.1093/jac/dkp220; Russo TA, 2003, MICROBES INFECT, V5, P449, DOI 10.1016/S1286-4579(03)00049-2; Schoevaerdts D, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-12; Serefhanoglu K, 2009, BRAZ J INFECT DIS, V13, P403, DOI 10.1590/S1413-86702009000600003; Tumbarello M, 2011, ANTIMICROB AGENTS CH, V55, P3485, DOI 10.1128/AAC.00009-11; Valverde A, 2008, J CLIN MICROBIOL, V46, P2796, DOI 10.1128/JCM.01008-08; Wu UI, 2010, J MICROBIOL IMMUNOL, V43, P310, DOI 10.1016/S1684-1182(10)60048-5; Yilmaz E, 2008, J CHEMOTHERAPY, V20, P581, DOI 10.1179/joc.2008.20.5.581	35	33	34	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2012	7	1							e30498	10.1371/journal.pone.0030498	http://dx.doi.org/10.1371/journal.pone.0030498			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911GB	22299043	Green Published, Green Submitted, gold			2022-12-25	WOS:000301704200020
J	Turcatel, G; Rubin, N; El-Hashash, A; Warburton, D				Turcatel, Gianluca; Rubin, Nicole; El-Hashash, Ahmed; Warburton, David			MIR-99a and MIR-99b Modulate TGF-beta Induced Epithelial to Mesenchymal Plasticity in Normal Murine Mammary Gland Cells	PLOS ONE			English	Article							MIR-200 FAMILY; SIGNALING PATHWAY; REPRESSORS ZEB1; SMOOTH-MUSCLE; MICRORNAS; CANCER; TRANSITION; CADHERIN; DIFFERENTIATION; BIOGENESIS	Epithelial to mesenchymal transition (EMT) is a key process during embryonic development and disease development and progression. During EMT, epithelial cells lose epithelial features and express mesenchymal cell markers, which correlate with increased cell migration and invasion. Transforming growth factor-beta (TGF-beta) is a multifunctional cytokine that induces EMT in multiple cell types. The TGF-beta pathway is regulated by microRNAs (miRNAs), which are small non-coding RNAs regulating the translation of specific messenger RNAs. Herein, we identified mir-99a and mir-99b as two novel TGF-beta target miRNA genes, the expression of which increased during TGF-beta induced EMT of NMUMG cells. Mir-99a and mir-99b inhibition decreased TGF-beta activity by inhibiting SMAD3 phosphorylation, resulting in decreased migration and increased proliferation in response to TGF-beta. However, mir-99a and mir-99b inhibition was insufficient to block TGF-beta induced EMT of NMUMG cells. Mir-99a and mir-99b over-expression in epithelial NMUMG cells resulted in increased proliferation, migration and fibronectin expression, while E-cadherin and ZO-1 expression were negatively regulated. In conclusion, we identified mir-99a and mir-99b as two novel modulators of TGF-beta pathway that alter SMAD3 phosphorylation, in turn altering cell migration and adhesion of mesenchymal NMUMG cells. The effect of mir-99a and mir-99b over-expression on NMUMUG proliferation is dependent upon the epithelial or mesenchymal status of the cells. Our study suggests that mir-99a and mir-99b may function as modulators within a complex network of factors regulating TGF-beta induced breast epithelial to mesenchymal transition, as well as proliferation and migration of breast cancer cells, providing a possible target for future translationally oriented studies in this area.	[Turcatel, Gianluca; Rubin, Nicole; El-Hashash, Ahmed; Warburton, David] Childrens Hosp Los Angeles, Saban Res Inst, Dev Biol & Regenerat Med Program, Los Angeles, CA 90027 USA	Children's Hospital Los Angeles	Turcatel, G (corresponding author), Childrens Hosp Los Angeles, Saban Res Inst, Dev Biol & Regenerat Med Program, Los Angeles, CA 90027 USA.	dwarburton@chla.usc.edu	Warburton, David/AAD-5709-2020		National Institutes of Health-NHLBI [P01 HL 60231, HL 44060, HL44977]; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL044977, P01HL060231, R01HL044060] Funding Source: NIH RePORTER	National Institutes of Health-NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was funded by National Institutes of Health-NHLBI P01 HL 60231, HL 44060 and HL44977 grants to DW as well as American Heart Association to GT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2001, CELL, V107, P823, DOI 10.1016/S0092-8674(01)00616-X; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bartels CL, 2009, CLIN CHEM, V55, P623, DOI 10.1373/clinchem.2008.112805; Bieri M, 2009, MOL IMMUNOL, V46, P866, DOI 10.1016/j.molimm.2008.09.011; Bierie B, 2006, CYTOKINE GROWTH F R, V17, P29, DOI 10.1016/j.cytogfr.2005.09.006; Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Briaud I, 2005, J BIOL CHEM, V280, P2282, DOI 10.1074/jbc.M412179200; Brodersen P, 2009, NAT REV MOL CELL BIO, V10, P141, DOI 10.1038/nrm2619; Chen CH, 2009, J HAND SURG-AM, V34A, P1777, DOI 10.1016/j.jhsa.2009.07.015; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; Duursma AM, 2008, RNA, V14, P872, DOI 10.1261/rna.972008; Gal A, 2008, ONCOGENE, V27, P1218, DOI 10.1038/sj.onc.1210741; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Harfe BD, 2005, CURR OPIN GENET DEV, V15, P410, DOI 10.1016/j.gde.2005.06.012; Jimenez RH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007373; Kato M, 2009, NAT CELL BIOL, V11, P881, DOI 10.1038/ncb1897; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Kong W, 2008, MOL CELL BIOL, V28, P6773, DOI 10.1128/MCB.00941-08; Korpal M, 2008, RNA BIOL, V5, P115, DOI 10.4161/rna.5.3.6558; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Lamouille S, 2007, J CELL BIOL, V178, P437, DOI 10.1083/jcb.200611146; Li L, 1996, CIRC RES, V78, P188, DOI 10.1161/01.RES.78.2.188; Li X, 2011, MICRORNA 223 PROMOTE; Louafi F, 2010, J BIOL CHEM; Martello G, CELL, V141, P1195; Martello G, 2007, NATURE, V449, P183, DOI 10.1038/nature06100; Martin KA, 2004, AM J PHYSIOL-CELL PH, V286, pC507, DOI 10.1152/ajpcell.00201.2003; Mongroo Perry S, 2010, Cancer Biol Ther, V10, P219; Oneyama C, 2011, ONCOGENE; Orom UA, 2008, MOL CELL, V30, P460, DOI 10.1016/j.molcel.2008.05.001; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Rai D, 2010, P NATL ACAD SCI USA, V107, P3111, DOI 10.1073/pnas.0910667107; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Song KY, 2006, EMBO J, V25, P58, DOI 10.1038/sj.emboj.7600917; Sun DD, 2011, CANCER RES, V71, P1313, DOI 10.1158/0008-5472.CAN-10-1031; WANG Y, 2010, ONCOGENE; Zhong H, 2010, INT J HEMATOL, V92, P129, DOI 10.1007/s12185-010-0626-5	38	88	100	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2012	7	1							e31032	10.1371/journal.pone.0031032	http://dx.doi.org/10.1371/journal.pone.0031032			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911GB	22299047	Green Published, Green Submitted, gold			2022-12-25	WOS:000301704200054
J	Campbell, BC; Wang, SSH				Campbell, Benjamin C.; Wang, Samuel S. -H.			Familial Linkage between Neuropsychiatric Disorders and Intellectual Interests	PLOS ONE			English	Article							NATIONAL COMORBIDITY SURVEY; MENTAL-ILLNESS; CREATIVITY; WRITERS; AUTISM; RELATIVES	From personality to neuropsychiatric disorders, individual differences in brain function are known to have a strong heritable component. Here we report that between close relatives, a variety of neuropsychiatric disorders covary strongly with intellectual interests. We surveyed an entire class of high-functioning young adults at an elite university for prospective major, familial incidence of neuropsychiatric disorders, and demographic and attitudinal questions. Students aspiring to technical majors (science/mathematics/engineering) were more likely than other students to report a sibling with an autism spectrum disorder (p = 0.037). Conversely, students interested in the humanities were more likely to report a family member with major depressive disorder (p = 8.8 x 10(-4)), bipolar disorder (p = 0.027), or substance abuse problems (p = 1.9 x 10(-6)). A combined PREdisposition for Subject MattEr (PRESUME) score based on these disorders was strongly predictive of subject matter interests (p = 9.6 x 10(-8)). Our results suggest that shared genetic (and perhaps environmental) factors may both predispose for heritable neuropsychiatric disorders and influence the development of intellectual interests.	[Campbell, Benjamin C.; Wang, Samuel S. -H.] Princeton Univ, Inst Neurosci, Princeton, NJ 08544 USA; [Campbell, Benjamin C.] Rockefeller Univ, Lab Biol Modeling, New York, NY 10021 USA; [Wang, Samuel S. -H.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Princeton University; Rockefeller University; Princeton University	Campbell, BC (corresponding author), Princeton Univ, Inst Neurosci, Princeton, NJ 08544 USA.	sswang@princeton.edu						Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346; ANDREASEN NC, 1987, AM J PSYCHIAT, V144, P1288; Aristotle, 1953, PROBLEMATA, V2; Baron-Cohen S, 2005, ANNU REV NEUROSCI, V28, P109, DOI 10.1146/annurev.neuro.27.070203.144137; Baron-Cohen S, 1998, AUTISM, V2, P296, DOI [10.1177/1362361398023008, DOI 10.1177/1362361398023008]; Baron-Cohen S, 2007, HUM NATURE-INT BIOS, V18, P125, DOI 10.1007/s12110-007-9014-0; Baron-Cohen Simon, 1997, AUTISM, V1, P101, DOI [10.1177/1362361397011010, DOI 10.1177/1362361397011010]; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BIEDERMAN J, 1992, ARCH GEN PSYCHIAT, V49, P728; Bienvenu OJ, 2011, PSYCHOL MED, V41, P33, DOI 10.1017/S003329171000084X; Cook EH, 2008, NATURE, V455, P919, DOI 10.1038/nature07458; Fombonne E, 2009, PEDIATR RES, V65, P591, DOI 10.1203/PDR.0b013e31819e7203; Hoekstra RA, 2007, ARCH PEDIAT ADOL MED, V161, P372, DOI 10.1001/archpedi.161.4.372; Jamison K.R., 1993, TOUCHED FIRE MANIC D; Kendler KS, 1997, BRIT J PSYCHIAT, V170, P541, DOI 10.1192/bjp.170.6.541; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Ludwig A. M., 1995, PRICE GREATNESS; LUDWIG AM, 1994, AM J PSYCHIAT, V151, P1650; McAdams DP, 2010, ANNU REV PSYCHOL, V61, P517, DOI 10.1146/annurev.psych.093008.100507; Mullen Anna L., 2010, DEGREES INEQUALITY C; POST F, 1994, BRIT J PSYCHIAT, V165, P22, DOI 10.1192/bjp.165.1.22; Post F, 1996, BRIT J PSYCHIAT, V168, P545, DOI 10.1192/bjp.168.5.545; REGIER D A, 1990, Journal of the American Medical Association, V264, P2511, DOI 10.1001/jama.264.19.2511; Rush Benjamin, 1812, MED INQUIRIES OBSERV; Simonton D.K., 2004, CREATIVITY SCI CHANC; Snow C., 1959, 2 CULTURES SCI REVOL; Windham GC, 2009, AUTISM RES, V2, P183, DOI 10.1002/aur.84	27	12	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2012	7	1							e30405	10.1371/journal.pone.0030405	http://dx.doi.org/10.1371/journal.pone.0030405			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911FX	22291951	Green Submitted, Green Published, gold			2022-12-25	WOS:000301703800015
J	Christie, JD; Wurfel, MM; Feng, R; O'Keefe, GE; Bradfield, J; Ware, LB; Christiani, DC; Calfee, CS; Cohen, MJ; Matthay, M; Meyer, NJ; Kim, C; Li, MY; Akey, J; Barnes, KC; Sevransky, J; Lanken, PN; May, AK; Aplenc, R; Maloney, JP; Hakonarson, H				Christie, Jason D.; Wurfel, Mark M.; Feng, Rui; O'Keefe, Grant E.; Bradfield, Jonathan; Ware, Lorraine B.; Christiani, David C.; Calfee, Carolyn S.; Cohen, Mitchell J.; Matthay, Michael; Meyer, Nuala J.; Kim, Cecilia; Li, Mingyao; Akey, Joshua; Barnes, Kathleen C.; Sevransky, Jonathan; Lanken, Paul N.; May, Addison K.; Aplenc, Richard; Maloney, James P.; Hakonarson, Hakon		Trauma ALI SNP Consortium TASC	Genome Wide Association Identifies PPFIA1 as a Candidate Gene for Acute Lung Injury Risk Following Major Trauma	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; MANNOSE-BINDING LECTIN; CHAIN-KINASE GENE; EARLY RELEASE; POLYMORPHISM; PROTEIN; SUSCEPTIBILITY; MORTALITY; ACTIVATION; EXPRESSION	Acute Lung Injury (ALI) is a syndrome with high associated mortality characterized by severe hypoxemia and pulmonary infiltrates in patients with critical illness. We conducted the first investigation to use the genome wide association (GWA) approach to identify putative risk variants for ALI. Genome wide genotyping was performed using the Illumina Human Quad 610 BeadChip. We performed a two-stage GWA study followed by a third stage of functional characterization. In the discovery phase (Phase 1), we compared 600 European American trauma-associated ALI cases with 2266 European American population-based controls. We carried forward the top 1% of single nucleotide polymorphisms (SNPs) at p<0.01 to a replication phase (Phase 2) comprised of a nested case-control design sample of 212 trauma-associated ALI cases and 283 at-risk trauma non-ALI controls from ongoing cohort studies. SNPs that replicated at the 0.05 level in Phase 2 were subject to functional validation (Phase 3) using expression quantitative trait loci (eQTL) analyses in stimulated Blymphoblastoid cell lines (B-LCL) in family trios. 159 SNPs from the discovery phase replicated in Phase 2, including loci with prior evidence for a role in ALI pathogenesis. Functional evaluation of these replicated SNPs revealed rs471931 on 11q13.3 to exert a cis-regulatory effect on mRNA expression in the PPFIA1 gene (p = 0.0021). PPFIA1 encodes liprin alpha, a protein involved in cell adhesion, integrin expression, and cell-matrix interactions. This study supports the feasibility of future multicenter GWA investigations of ALI risk, and identifies PPFIA1 as a potential functional candidate ALI risk gene for future research.	[Christie, Jason D.; Meyer, Nuala J.; Lanken, Paul N.] Univ Penn, Sch Med, Dept Med, Div Pulm Allergy & Crit Care Med, Philadelphia, PA 19104 USA; [Christie, Jason D.; Feng, Rui; Li, Mingyao] Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [O'Keefe, Grant E.] Univ Washington, Harborview Med Ctr, Dept Surg, Seattle, WA 98104 USA; [Wurfel, Mark M.] Univ Washington, Harborview Med Ctr, Dept Med, Div Pulm & Crit Care Med, Seattle, WA 98104 USA; [Bradfield, Jonathan; Kim, Cecilia; Hakonarson, Hakon] Univ Penn, Childrens Hosp Philadelphia, Sch Med, Div Human Genet,Ctr Appl Genom, Philadelphia, PA 19104 USA; [Ware, Lorraine B.] Vanderbilt Univ, Dept Med, Div Allergy Pulm & Crit Care Med, Nashville, TN USA; [Christiani, David C.] Massachusetts Gen Hosp, Dept Med, Pulm & Crit Care Unit, Boston, MA 02114 USA; [Christiani, David C.] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA; [Calfee, Carolyn S.; Matthay, Michael] Univ Calif San Francisco, Cardiovasc Res Inst, Dept Med, San Francisco, CA 94143 USA; [Calfee, Carolyn S.; Matthay, Michael] Univ Calif San Francisco, Cardiovasc Res Inst, Dept Anesthesia, San Francisco, CA 94143 USA; [Cohen, Mitchell J.] Univ Calif San Francisco, Dept Surg, San Francisco, CA USA; [Akey, Joshua] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Barnes, Kathleen C.; Sevransky, Jonathan] Johns Hopkins Univ, Sch Med, Div Pulm Allergy & Crit Care Med, Baltimore, MD USA; [May, Addison K.] Vanderbilt Univ, Dept Surg Sci, Nashville, TN USA; [Aplenc, Richard] Univ Penn, Childrens Hosp Philadelphia, Sch Med, Div Oncol, Philadelphia, PA 19104 USA; [Maloney, James P.] Univ Colorado, Hlth Sci Ctr, Div Pulm & Crit Care Med, Denver, CO USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Harborview Medical Center; University of Washington; University of Washington Seattle; Harborview Medical Center; University of Washington; University of Washington Seattle; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Vanderbilt University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard T.H. Chan School of Public Health; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Washington; University of Washington Seattle; Johns Hopkins University; Vanderbilt University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Christie, JD (corresponding author), Univ Penn, Sch Med, Dept Med, Div Pulm Allergy & Crit Care Med, Philadelphia, PA 19104 USA.	jchristi@mail.med.upenn.edu	maloney, james/K-9428-2015; Ware, Lorraine/AAJ-9307-2021; O'KEEFE, GRANT/GON-5797-2022	maloney, james/0000-0001-8348-4650; Ware, Lorraine/0000-0002-9429-4702; Christie, Jason/0000-0003-0519-218X; Akey, Joshua/0000-0002-4411-1330	NIH [P50HL60290, P01HL079063, HL081332, HL060710]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL103836, R01HL060710, P50HL060290, K23HL102254, P01HL079063] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was funded by the following NIH grants: P50HL60290, P01HL079063, HL081332, HL060710. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2000, AM J HUM GENET, V66, P279, DOI 10.1086/302698; Adamzik M, 2007, EUR RESPIR J, V29, P482, DOI 10.1183/09031936.00046106; Adamzik M, 2008, CRIT CARE MED, V36, P1776, DOI 10.1097/CCM.0b013e318174373d; Adamzik M, 2007, INTENS CARE MED, V33, P1199, DOI 10.1007/s00134-007-0649-4; Agapov E, 2009, AM J RESP CELL MOL, V41, P379, DOI [10.1165/2009-0122R, 10.1165/2009-0122RC]; Altshuler D, 2008, SCIENCE, V322, P881, DOI 10.1126/science.1156409; Arcaroli J, 2008, INTENS CARE MED, V34, P300, DOI 10.1007/s00134-007-0930-6; Arcaroli JJ, 2009, AM J RESP CRIT CARE, V179, P105, DOI 10.1164/rccm.200710-1566OC; Asperti C, 2010, EXP CELL RES, V316, P915, DOI 10.1016/j.yexcr.2010.01.017; Asperti C, 2009, J CELL SCI, V122, P3225, DOI 10.1242/jcs.054155; Barnes Kathleen C, 2005, Proc Am Thorac Soc, V2, P195, DOI 10.1513/pats.200502-013AC; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; Billerbeck E, 2010, P NATL ACAD SCI USA, V107, P3006, DOI 10.1073/pnas.0914839107; Bornstein P, 2001, J CLIN INVEST, V107, P929, DOI 10.1172/JCI12749; Calfee CS, 2007, CRIT CARE MED, V35, P2243, DOI 10.1097/01.CCM.0000280434.33451.87; Christie JD, 2008, CRIT CARE MED, V36, P2794, DOI 10.1097/CCM.0b013e318186b843; Christie JD, 2008, CRIT CARE MED; CIVIL ID, 1988, J TRAUMA, V28, P87, DOI 10.1097/00005373-198801000-00012; Cohen MJ, 2010, J TRAUMA, V68, P1273, DOI 10.1097/TA.0b013e3181db323e; Cohen MJ, 2009, CRIT CARE, V13, DOI 10.1186/cc8152; Crome SQ, 2010, J IMMUNOL, V185, P3199, DOI 10.4049/jimmunol.1000557; Crosby LM, 2010, AM J PHYSIOL-LUNG C, V298, pL715, DOI 10.1152/ajplung.00361.2009; Flores C, 2008, TRANSL RES, V152, P11, DOI 10.1016/j.trsl.2008.05.006; Flory JH, 2009, J ALLERGY CLIN IMMUN, V124, P605, DOI 10.1016/j.jaci.2009.05.047; Gao L, 2006, AM J RESP CELL MOL, V34, P487, DOI 10.1165/rcmb.2005-0404OC; Gao L, 2007, TRANSL RES, V150, P18, DOI 10.1016/j.trsl.2007.02.007; Garcia-Laorden MI, 2008, J ALLERGY CLIN IMMUN, V122, P368, DOI 10.1016/j.jaci.2008.05.037; Glavan BJ, 2010, AM J RESP CRIT CARE; Glavan BJ, 2011, AM J RESP CRIT CARE, V183, P356, DOI 10.1164/rccm.201003-0351OC; Gong MN, 2007, CRIT CARE MED, V35, P48, DOI 10.1097/01.CCM.0000251132.10689.F3; Gong MN, 2006, CLIN CHEST MED, V27, P705, DOI 10.1016/j.ccm.2006.07.001; Gong MN, 2004, CHEST, V125, P203, DOI 10.1378/chest.125.1.203; Gong MN, 2006, EUR RESPIR J, V27, P674, DOI 10.1183/09031936.06.00046405; Gong MN, 2005, EUR RESPIR J, V26, P382, DOI 10.1183/09031936.05.00000505; Gorovoy M, 2007, CIRC RES, V101, P50, DOI 10.1161/CIRCRESAHA.106.145847; Hardy J, 2009, NEW ENGL J MED, V360, P1759, DOI 10.1056/NEJMra0808700; Hoglinger GU, 2011, NAT GENET, V43, P699, DOI 10.1038/ng.859; IDELL S, 1989, CHEST, V96, P1125, DOI 10.1378/chest.96.5.1125; Ioannidis JPA, 2009, NAT REV GENET, V10, P318, DOI 10.1038/nrg2544; Ip WKE, 2005, J INFECT DIS, V191, P1697, DOI 10.1086/429631; Jerng JS, 2006, CRIT CARE MED, V34, P1001, DOI 10.1097/01.CCM.0000206107.92476.39; Lagan AL, 2008, CHEST, V133, P1302, DOI 10.1378/chest.07-1117; Lim JC, 2011, P NATL ACAD SCI USA, V108, P10472, DOI 10.1073/pnas.1101275108; Lin Z, 2000, CLIN GENET, V58, P181, DOI 10.1034/j.1399-0004.2000.580305.x; Luca D, 2008, AM J HUM GENET, V82, P453, DOI 10.1016/j.ajhg.2007.11.003; Marshall RP, 2002, AM J RESP CRIT CARE, V166, P646, DOI 10.1164/rccm.2108086; Marshall RP, 2002, CHEST, V121, p68S, DOI 10.1378/chest.121.3_suppl.68S; Marzec JM, 2007, FASEB J, V21, P2237, DOI 10.1096/fj.06-7759com; Matsuda M, 2010, EUR J CELL BIOL, V89, P807, DOI 10.1016/j.ejcb.2010.07.009; Medford ARL, 2005, THORAX, V60, P244, DOI 10.1136/thx.2004.034785; Meyer NJ, 2011, AM J RESP CRIT CARE, V183, P1344, DOI 10.1164/rccm.201005-0701OC; Min JW, 2005, J HUM GENET, V50, P118, DOI 10.1007/s10038-005-0230-3; Moreira-Teixeira L, 2011, J IMMUNOL, V186, P5758, DOI 10.4049/jimmunol.1003043; Nonas Stephanie A, 2005, Proc Am Thorac Soc, V2, P188, DOI 10.1513/pats.200501-005AC; Pino-Yanes M, 2010, AM J RESP CELL MOL B; Pope SM, 2005, J IMMUNOL, V175, P5341, DOI 10.4049/jimmunol.175.8.5341; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Quasney MW, 2004, CRIT CARE MED, V32, P1115, DOI 10.1097/01.CCM.0000124872.55243.5A; Reddy AJ, 2008, J CELL MOL MED; Reddy AJ, 2009, J CELL MOL MED, V13, P1784, DOI 10.1111/j.1582-4934.2008.00581.x; Reiner AP, 2008, ARTERIOSCL THROM VAS, V28, P1407, DOI 10.1161/ATVBAHA.108.167437; Reutershan J, 2004, CRIT CARE, V8, P453, DOI 10.1186/cc2881; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Sapru A, 2009, ANESTHESIOLOGY, V110, P1086, DOI 10.1097/ALN.0b013e3181a1081d; Satagopan JM, 2003, GENET EPIDEMIOL, V25, P149, DOI 10.1002/gepi.10260; Serra-Pages C, 1998, J BIOL CHEM, V273, P15611, DOI 10.1074/jbc.273.25.15611; Shalhub S, 2009, J TRAUMA, V66, P115, DOI 10.1097/TA.0b013e3181938d50; Sheu CC, 2009, INTENS CARE MED, V35, P1343, DOI 10.1007/s00134-009-1504-6; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Skoll AD, 2007, GENET EPIDEMIOL, V31, P776, DOI 10.1002/gepi.20240; Sleiman PMA, 2010, NEW ENGL J MED, V362, P36, DOI 10.1056/NEJMoa0901867; Sohn MH, 2010, AM J RESP CRIT CARE, V182, P918, DOI 10.1164/rccm.200912-1793OC; Storey JD, 2007, AM J HUM GENET, V80, P502, DOI 10.1086/512017; Su L, 2009, INTENS CARE MED, V35, P1024, DOI 10.1007/s00134-009-1413-8; Sutherland AM, 2005, ARCH INTERN MED, V165, P75, DOI 10.1001/archinte.165.1.75; Suzuki M, 2009, J IMMUNOL, V182, P6485, DOI 10.4049/jimmunol.0802797; Takaesu G, 2000, MOL CELL, V5, P649, DOI 10.1016/S1097-2765(00)80244-0; Tejera P, 2009, AM J RESP CELL MOL, V41, P696, DOI 10.1165/rcmb.2008-0410OC; Visscher PM, 2009, JAMA-J AM MED ASSOC, V302, P2028, DOI 10.1001/jama.2009.1643; Wurfel MM, 2008, AM J RESP CRIT CARE, V178, P710, DOI 10.1164/rccm.200803-462OC; Xia ZP, 2009, NATURE, V461, P114, DOI 10.1038/nature08247; Ye SQ, 2005, AM J RESP CRIT CARE, V171, P361, DOI 10.1164/rccm.200404-563OC; Zhai R, 2007, THORAX, V62, P718, DOI 10.1136/thx.2006.069393; Zhai RH, 2007, CRIT CARE MED, V35, P893, DOI 10.1097/01.CCM.0000256845.92640.38; Zurner M, 2009, GENOMICS, V93, P243, DOI 10.1016/j.ygeno.2008.10.007	85	56	58	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e28268	10.1371/journal.pone.0028268	http://dx.doi.org/10.1371/journal.pone.0028268			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910ME	22295056	Green Submitted, Green Published, gold			2022-12-25	WOS:000301640600001
J	Hwang, RY; Stearns, NA; Tracey, WD				Hwang, Richard Y.; Stearns, Nancy A.; Tracey, W. Daniel			The Ankyrin Repeat Domain of the TRPA Protein Painless Is Important for Thermal Nociception but Not Mechanical Nociception	PLOS ONE			English	Article							TIP-LINK; DROSOPHILA; RECEPTOR; CHANNEL; SENSITIVITY; CADHERIN-23	The Drosophila TRPA channel Painless is required for the function of polymodal nociceptors which detect noxious heat and noxious mechanical stimuli. These functions of Painless are reminiscent of mammalian TRPA channels that have also been implicated in thermal and mechanical nociception. A popular hypothesis to explain the mechanosensory functions of certain TRP channels proposes that a string of ankyrin repeats at the amino termini of these channels acts as an intracellular spring that senses force. Here, we describe the identification of two previously unknown Painless protein isoforms which have fewer ankyrin repeats than the canonical Painless protein. We show that one of these Painless isoforms, that essentially lacks ankyrin repeats, is sufficient to rescue mechanical nociception phenotypes of painless mutant animals but does not rescue thermal nociception phenotypes. In contrast, canonical Painless, which contains Ankyrin repeats, is sufficient to largely rescue thermal nociception but is not capable of rescuing mechanical nociception. Thus, we propose that in the case of Painless, ankryin repeats are important for thermal nociception but not for mechanical nociception.	[Hwang, Richard Y.; Tracey, W. Daniel] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; [Stearns, Nancy A.; Tracey, W. Daniel] Duke Univ, Med Ctr, Dept Anesthesiol, Durham, NC 27710 USA; [Tracey, W. Daniel] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA	Duke University; Duke University; Duke University	Hwang, RY (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA.	dan.tracey@duke.edu		Tracey, W. Daniel/0000-0003-4666-8199	Whitehall Foundation; Alfred P. Sloan Foundation; National Institute of Neurological Disorders and Stroke [5R01NS054899-05]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054899] Funding Source: NIH RePORTER	Whitehall Foundation; Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants to WDT from the Whitehall Foundation, the Alfred P. Sloan Foundation, and the National Institute of Neurological Disorders and Stroke (5R01NS054899-05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed ZM, 2006, J NEUROSCI, V26, P7022, DOI 10.1523/JNEUROSCI.1163-06.2006; Al-Anzi B, 2006, CURR BIOL, V16, P1034, DOI 10.1016/j.cub.2006.04.002; Brauchi S, 2006, J NEUROSCI, V26, P4835, DOI 10.1523/JNEUROSCI.5080-05.2006; Chung YD, 2001, NEURON, V29, P415, DOI 10.1016/S0896-6273(01)00215-X; Cordero-Morales JF, 2011, P NATL ACAD SCI USA, V108, pE1184, DOI 10.1073/pnas.1114124108; Corey DP, 2004, NATURE, V428, P901, DOI 10.1038/428901a; Damann N, 2008, CURR BIOL, V18, pR880, DOI 10.1016/j.cub.2008.07.063; Gopfert MC, 2006, NAT NEUROSCI, V9, P999, DOI 10.1038/nn1735; Goodman MB, 2002, NATURE, V415, P1039, DOI 10.1038/4151039a; Howard J, 2004, CURR BIOL, V14, pR224, DOI 10.1016/j.cub.2004.02.050; Hwang RY, 2007, CURR BIOL, V17, P2105, DOI 10.1016/j.cub.2007.11.029; Lee G, 2006, NATURE, V440, P246, DOI 10.1038/nature04437; Lee Y, 2005, NAT GENET, V37, P305, DOI 10.1038/ng1513; Li W, 2006, NATURE, V440, P684, DOI 10.1038/nature04538; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; O'Hagan R, 2005, INT REV NEUROBIOL, V69, P169, DOI 10.1016/S0074-7742(05)69006-X; Schumacher MA, 2000, J BIOL CHEM, V275, P2756, DOI 10.1074/jbc.275.4.2756; Sidi S, 2003, SCIENCE, V301, P96, DOI 10.1126/science.1084370; Siemens J, 2004, NATURE, V428, P950, DOI 10.1038/nature02483; Sokabe T, 2008, J NEUROSCI, V28, P9929, DOI 10.1523/JNEUROSCI.2757-08.2008; Sollner C, 2004, NATURE, V428, P955, DOI 10.1038/nature02484; Sotomayor M, 2005, STRUCTURE, V13, P669, DOI 10.1016/j.str.2005.03.001; Tracey WD, 2003, CELL, V113, P261, DOI 10.1016/S0092-8674(03)00272-1; Vlachova V, 2003, J NEUROSCI, V23, P1340, DOI 10.1523/JNEUROSCI.23-04-01340.2003; Walker RG, 2000, SCIENCE, V287, P2229, DOI 10.1126/science.287.5461.2229; Watanabe H, 2002, J BIOL CHEM, V277, P47044, DOI 10.1074/jbc.M208277200; Xiang Y, 2010, NATURE; Xu SY, 2006, GENES BRAIN BEHAV, V0, P1; Zhong LX, 2012, CELL REP, V1, P43, DOI 10.1016/j.celrep.2011.11.002; Zhong LX, 2010, CURR BIOL, V20, P429, DOI 10.1016/j.cub.2009.12.057	30	38	43	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e30090	10.1371/journal.pone.0030090	http://dx.doi.org/10.1371/journal.pone.0030090			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910ME	22295071	Green Submitted, gold, Green Published			2022-12-25	WOS:000301640600016
J	Sola, C; Paganini, H; Egea, AL; Moyano, AJ; Garnero, A; Kevric, I; Culasso, C; Vindel, A; Lopardo, H; Bocco, JL				Sola, Claudia; Paganini, Hugo; Egea, Ana L.; Moyano, Alejandro J.; Garnero, Analia; Kevric, Ines; Culasso, Catalina; Vindel, Ana; Lopardo, Horacio; Bocco, Jose L.		Study Grp CA-MRSA Children	Spread of Epidemic MRSA-ST5-IV Clone Encoding PVL as a Major Cause of Community Onset Staphylococcal Infections in Argentinean Children	PLOS ONE			English	Article							CASSETTE CHROMOSOME MEC; AUREUS CA-MRSA; METHICILLIN-RESISTANT; MOLECULAR EPIDEMIOLOGY; PCR STRATEGY; STRAINS; EMERGENCE; EVOLUTION; CORDOBA; SUSCEPTIBILITY	Background: Community-associated methicillin-resistant Staphylococcus aureus-(CA-MRSA) strains have emerged in Argentina. We investigated the clinical and molecular evolution of community-onset MRSA infections (CO-MRSA) in children of Cordoba, Argentina, 2005-2008. Additionally, data from 2007 were compared with the epidemiology of these infections in other regions of the country. Methodology/Principal Findings: Two datasets were used: i) lab-based prospective surveillance of CA-MRSA isolates from 3 Cordoba pediatric hospitals-(CBAH1-H3) in 2007-2008 (compared to previously published data of 2005) and ii) a sampling of CO-MRSA from a study involving both, healthcare-associated community-onset-(HACO) infections in children with risk-factors for healthcare-associated infections-(HRFs), and CA-MRSA infections in patients without HRFs detected in multiple centers of Argentina in 2007. Molecular typing was performed on the CA-MRSA-(n:99) isolates from the CBAH1-H3-dataset and on the HACO-MRSA-(n: 51) and CA-MRSA-(n: 213) isolates from other regions. Between 2005-2008, the annual proportion of CA-MRSA/CA-S. aureus in Cordoba hospitals increased from 25% to 49%, P<0.01. Total CA-MRSA infections increased 3.6 fold-(5.1 to 18.6 cases/100,000 annual-visits, P<0.0001), associated with an important increase of invasive CA-MRSA infections-(8.5 fold). In all regions analyzed, a single genotype prevailed in both CA-MRSA (82%) and HACO-MRSA(57%), which showed pulsed-field-gel electrophoresis-(PFGE)-type-"I", sequence-type-5-(ST5), SCCmec-type-IVa, spa-t311, and was positive for PVL. The second clone, pulsotype-N/ST30/CC30/SCCmecIVc/t019/PVL+, accounted for 11.5% of total CA-MRSA infections. Importantly, the first 4 isolates of Argentina belonging to South American-USA300 clone-(USA300/ST8/CC8/SCCmecIVc/t008/PVL+/ACME(-)) were detected. We also demonstrated that a HA-MRSA clone-(pulsotype-C/ST100/CC5) caused 2% and 10% of CA-MRSA and HACO-MRSA infections respectively and was associated with a SCCmec type closely related to SCCmecIV(2B&5). Conclusions/Significance: The dissemination of epidemic MRSA clone, ST5-IV-PVL+ was the main cause of increasing staphylococcal community-onset infections in Argentinean children (2003-2008), conversely to other countries. The predominance of this clone, which has capacity to express the h-VISA phenotype, in healthcare-associated community-onset cases suggests that it has infiltrated into hospital-settings.	[Sola, Claudia; Egea, Ana L.; Moyano, Alejandro J.; Kevric, Ines; Bocco, Jose L.] Consejo Nacl Invest Cient & Tecn, CIBICI, Dept Bioquim Clin, RA-1033 Buenos Aires, DF, Argentina; [Paganini, Hugo] Univ Nacl Cordoba, Fac Ciencias Quim, RA-5000 Cordoba, Argentina; [Paganini, Hugo; Lopardo, Horacio] Hosp Pediat Prof Dr Juan P Garrahan, Autonomous City Buenos A, Argentina; [Garnero, Analia; Culasso, Catalina] Hosp Ninos Santisima Trinidad Cordoba, Cordoba, Argentina; [Vindel, Ana] Inst Salud Carlos III, Ctr Nacl Microbiol, Lab Infecc Nosocomi, Madrid, Spain	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba; Hospital de Pediatria Doctor Juan Garrahan; Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM)	Sola, C (corresponding author), Consejo Nacl Invest Cient & Tecn, CIBICI, Dept Bioquim Clin, RA-1033 Buenos Aires, DF, Argentina.	jbocco@fcq.unc.edu.ar	Moyano, Alejandro/AAB-9092-2019	Moyano, Alejandro/0000-0002-4976-7611; Bocco, Jose Luis/0000-0002-9682-1270	National Council for Scientific Research and Technology of Argentina [CONICET-PIP-2009-2011]; Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) [PICT 07-01630]; Secretaria de Ciencia y Tecnica-Universidad Nacional de Cordoba (SECyT-UNC)	National Council for Scientific Research and Technology of Argentina; Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT)(ANPCyT); Secretaria de Ciencia y Tecnica-Universidad Nacional de Cordoba (SECyT-UNC)(Secretaria de Ciencia y Tecnologia (SECYT))	This work was supported by the National Council for Scientific Research and Technology of Argentina (CONICET-PIP-2009-2011 to CS), Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT - PICT 07-01630 to JLB) and Secretaria de Ciencia y Tecnica-Universidad Nacional de Cordoba (SECyT-UNC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benoit SR, 2008, EMERG INFECT DIS, V14, P1216, DOI 10.3201/eid1408.071183; Bhattacharya D, 2007, J CLIN MICROBIOL, V45, P1798, DOI 10.1128/JCM.01747-06; Blanco R, 2011, J CLIN MICROBIOL, V49, P433, DOI 10.1128/JCM.02201-10; Breurec S, 2011, CLIN MICROBIOL INFEC, V17, P160, DOI 10.1111/j.1469-0691.2010.03219.x; Cercenado E, 2008, DIAGN MICR INFEC DIS, V61, P143, DOI 10.1016/j.diagmicrobio.2008.01.001; Chua K, 2011, CLIN INFECT DIS, V52, P99, DOI 10.1093/cid/ciq067; Clinical and Laboratory Standards Institute, 2009, M100S19 CLSI; Corso A, 1998, MICROB DRUG RESIST, V4, P277, DOI 10.1089/mdr.1998.4.277; Dauwalder O, 2008, J CLIN MICROBIOL, V46, P3454, DOI 10.1128/JCM.01050-08; David MZ, 2008, J INFECT DIS, V197, P1235, DOI 10.1086/533502; David MZ, 2010, CLIN MICROBIOL REV, V23, P616, DOI 10.1128/CMR.00081-09; DeLeo FR, 2010, LANCET, V375, P1557, DOI 10.1016/S0140-6736(09)61999-1; Deurenberg RH, 2009, CURR MOL MED, V9, P100, DOI 10.2174/156652409787581637; Ellington MJ, 2009, EUR J CLIN MICROBIOL, V28, P1113, DOI 10.1007/s10096-009-0757-x; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Gardella N, 2008, DIAGN MICR INFEC DIS, V62, P343, DOI 10.1016/j.diagmicrobio.2008.07.008; Gerber JS, 2009, CLIN INFECT DIS, V49, P65, DOI 10.1086/599348; Goldstein Brahm, 2005, Pediatr Crit Care Med, V6, P2; Gonzalez BE, 2005, PEDIATRICS, V115, P642, DOI 10.1542/peds.2004-2300; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Heusser R, 2007, ANTIMICROB AGENTS CH, V51, P390, DOI 10.1128/AAC.00921-06; Hiramatsu K, 1997, J ANTIMICROB CHEMOTH, V40, P135, DOI 10.1093/jac/40.1.135; Howden BP, 2010, CLIN MICROBIOL REV, V23, P99, DOI 10.1128/CMR.00042-09; Kaplan SL, 2005, CLIN INFECT DIS, V40, P1785, DOI 10.1086/430312; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Klevens RM, 2006, EMERG INFECT DIS, V12, P1991; Limbago B, 2009, J CLIN MICROBIOL, V47, P1344, DOI 10.1128/JCM.02264-08; Liu C, 2011, CLIN INFECT DIS, V53, P319, DOI [10.1093/cid/cir353, 10.1093/cid/ciq146]; Ma XX, 2005, EMERG INFECT DIS, V11, P973; Maree CL, 2007, EMERG INFECT DIS, V13, P236, DOI 10.3201/eid1302.060781; Milheirico C, 2007, ANTIMICROB AGENTS CH, V51, P3374, DOI 10.1128/AAC.00275-07; Milheirico C, 2007, J ANTIMICROB CHEMOTH, V60, P42, DOI 10.1093/jac/dkm112; Monecke S, 2007, CLIN MICROBIOL INFEC, V13, P236, DOI 10.1111/j.1469-0691.2006.01635.x; Monecke S, 2009, CLIN MICROBIOL INFEC, V15, P770, DOI 10.1111/j.1469-0691.2009.02792.x; Monecke S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017936; Morrison MA, 2006, J HOSP INFECT, V62, P241, DOI 10.1016/j.jhin.2005.07.011; Niniou I, 2008, EUR J CLIN MICROBIOL, V27, P831, DOI 10.1007/s10096-008-0513-7; Nubel U, 2008, P NATL ACAD SCI USA, V105, P14130, DOI 10.1073/pnas.0804178105; Okuma K, 2002, J CLIN MICROBIOL, V40, P4289, DOI 10.1128/JCM.40.11.4289-4294.2002; Oliveira DC, 2006, ANTIMICROB AGENTS CH, V50, P3457, DOI 10.1128/AAC.00629-06; Orscheln RC, 2009, CLIN INFECT DIS, V49, P536, DOI 10.1086/600881; Paganinia H, 2008, ARCH ARGENT PEDIATR, V106, P397, DOI 10.1590/S0325-00752008000500005; Reyes J, 2009, CLIN INFECT DIS, V49, P1861, DOI 10.1086/648426; Rodriguez-Noriega E, 2010, INT J INFECT DIS, V14, pE560, DOI 10.1016/j.ijid.2009.08.018; Rossney AS, 2007, J CLIN MICROBIOL, V45, P2554, DOI 10.1128/JCM.00245-07; Satola SW, 2011, J CLIN MICROBIOL, V49, P177, DOI 10.1128/JCM.01128-10; Sola C, 2007, EUR J CLIN MICROBIOL, V26, P281, DOI 10.1007/s10096-007-0278-4; Sola C, 2006, J CLIN MICROBIOL, V44, P192, DOI 10.1128/JCM.44.1.192-200.2006; Sola C, 2002, J CLIN MICROBIOL, V40, P1427, DOI 10.1128/JCM.40.4.1427-1435.2002; Sola C, 2008, J CLIN MICROBIOL, V46, P1826, DOI 10.1128/JCM.01949-07; Sola C, 2011, ANN CLIN MICROB ANTI, V10, DOI 10.1186/1476-0711-10-15; Tokumoto MB, 2007, INT J ANTIMICROB AG, V30, P469, DOI 10.1016/j.ijantimicag.2007.06.007; Tristan A, 2007, EMERG INFECT DIS, V13, P594, DOI 10.3201/eid1304.061316; Wootton M, 2007, J CLIN MICROBIOL, V45, P329, DOI 10.1128/JCM.01508-06; Zaoutis TE, 2006, PEDIATR INFECT DIS J, V25, P343, DOI 10.1097/01.inf.0000207403.67197.cc	55	57	62	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30487	10.1371/journal.pone.0030487	http://dx.doi.org/10.1371/journal.pone.0030487			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22291965	Green Submitted, Green Published, gold			2022-12-25	WOS:000301570600046
J	Fauvet, B; Mbefo, MK; Fares, MB; Desobry, C; Michael, S; Ardah, MT; Tsika, E; Coune, P; Prudent, M; Lion, N; Eliezer, D; Moore, DJ; Schneider, B; Aebischer, P; El-Agnaf, OM; Masliah, E; Lashuel, HA				Fauvet, Bruno; Mbefo, Martial K.; Fares, Mohamed-Bilal; Desobry, Carole; Michael, Sarah; Ardah, Mustafa T.; Tsika, Elpida; Coune, Philippe; Prudent, Michel; Lion, Niels; Eliezer, David; Moore, Darren J.; Schneider, Bernard; Aebischer, Patrick; El-Agnaf, Omar M.; Masliah, Eliezer; Lashuel, Hilal A.			alpha-Synuclein in Central Nervous System and from Erythrocytes, Mammalian Cells, and Escherichia coli Exists Predominantly as Disordered Monomer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUTATHIONE-S-TRANSFERASE; FAMILIAL PARKINSONS-DISEASE; IN-VITRO; 3-DIMENSIONAL STRUCTURE; SELF-OLIGOMERIZATION; ALZHEIMERS-DISEASE; RESIDUAL STRUCTURE; TRANSGENIC MICE; EXTENDED-HELIX; CROSS-LINKING	Since the discovery and isolation of alpha-synuclein (alpha-syn) from human brains, it has been widely accepted that it exists as an intrinsically disordered monomeric protein. Two recent studies suggested that alpha-syn produced in Escherichia coli or isolated from mammalian cells and red blood cells exists predominantly as a tetramer that is rich in alpha-helical structure (Bartels, T., Choi, J. G., and Selkoe, D. J. (2011) Nature 477, 107-110; Wang, W., Perovic, I., Chittuluru, J., Kaganovich, A., Nguyen, L. T. T., Liao, J., Auclair, J. R., Johnson, D., Landeru, A., Simorellis, A. K., Ju, S., Cookson, M. R., Asturias, F. J., Agar, J. N., Webb, B. N., Kang, C., Ringe, D., Petsko, G. A., Pochapsky, T. C., and Hoang, Q. Q. (2011) Proc. Natl. Acad. Sci. 108, 17797-17802). However, it remains unknown whether or not this putative tetramer is the main physiological form of alpha-syn in the brain. In this study, we investigated the oligomeric state of alpha-syn in mouse, rat, and human brains. To assess the conformational and oligomeric state of native alpha-syn in complex mixtures, we generated alpha-syn standards of known quaternary structure and conformational properties and compared the behavior of endogenously expressed alpha-syn to these standards using native and denaturing gel electrophoresis techniques, size-exclusion chromatography, and an oligomer-specific ELISA. Our findings demonstrate that both human and rodent alpha-syn expressed in the central nervous system exist predominantly as an unfolded monomer. Similar results were observed when human alpha-syn was expressed in mouse and rat brains as well as mammalian cell lines (HEK293, HeLa, and SH-SY5Y). Furthermore, we show that alpha-syn expressed in E. coli and purified under denaturing or nondenaturing conditions, whether as a free protein or as a fusion construct with GST, is monomeric and adopts a disordered conformation after GST removal. These results do not rule out the possibility that alpha-syn becomes structured upon interaction with other proteins and/or biological membranes.	[Fauvet, Bruno; Mbefo, Martial K.; Fares, Mohamed-Bilal; Desobry, Carole; Lashuel, Hilal A.] Ecole Polytech Fed Lausanne, Lab Mol & Chem Biol Neurodegenerat, Sch Life Sci, Brain Mind Inst,Stn 19, CH-1015 Lausanne, Switzerland; [Michael, Sarah; Masliah, Eliezer] Univ Calif San Diego, Sch Med, Dept Neurosci, La Jolla, CA 92093 USA; [Ardah, Mustafa T.; El-Agnaf, Omar M.] United Arab Emirates Univ, Fac Med & Hlth Sci, Dept Biochem, Al Ain 15551, U Arab Emirates; [Tsika, Elpida; Moore, Darren J.] Ecole Polytech Fed Lausanne, Lab Mol Neurodegenerat Res, CH-1015 Lausanne, Switzerland; [Coune, Philippe; Schneider, Bernard; Aebischer, Patrick] Ecole Polytech Fed Lausanne, Neurodegenerat Dis Lab, CH-1015 Lausanne, Switzerland; [Prudent, Michel; Lion, Niels] Serv Reg Vaudois Transfus Sanguine, CH-1066 Epalinges, Switzerland; [Eliezer, David] Weill Cornell Med Coll, Dept Biochem, New York, NY 10065 USA; [Eliezer, David] Weill Cornell Med Coll, Program Struct Biol, New York, NY 10065 USA	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of California System; University of California San Diego; United Arab Emirates University; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Cornell University; Cornell University	Lashuel, HA (corresponding author), Ecole Polytech Fed Lausanne, Lab Mol & Chem Biol Neurodegenerat, Sch Life Sci, Brain Mind Inst,Stn 19, CH-1015 Lausanne, Switzerland.	hilal.lashuel@epfl.ch	Lion, Niels/B-9182-2018; Aebischer, Patrick/E-1387-2013; Lashuel, Hilal/M-3500-2017; Schneider, Bernard/H-6168-2011; , Prudent/R-7420-2016	Lion, Niels/0000-0002-1811-3236; Schneider, Bernard/0000-0001-5485-8748; , Prudent/0000-0001-9470-0179; Tsika, Elpida/0000-0003-4189-4234	National Institutes of Health from NIA [AG019391]; Michael J. Fox Foundation for Parkinson Research; Swiss National Science Foundation [31003AB_135696DE, 31003A_120653]; United Arab Emirates University; Swiss Federal Institute of Technology, Lausanne; ERC; Merck Serono; NATIONAL INSTITUTE ON AGING [R37AG018440, R37AG019391, R01AG019391] Funding Source: NIH RePORTER	National Institutes of Health from NIA; Michael J. Fox Foundation for Parkinson Research; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); United Arab Emirates University; Swiss Federal Institute of Technology, Lausanne; ERC(European Research Council (ERC)European Commission); Merck Serono(Merck & Company); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG019391 from NIA (to D. E.). This work was also supported by grants from the Michael J. Fox Foundation for Parkinson Research (to H. A. L., D. J. M., and O. M. E.), the Swiss National Science Foundation Grants 31003AB_135696DE (to P. C., B. S., and P. A.) and 31003A_120653 (to H. A. L., B. F., and M.-B. F.), the United Arab Emirates University (to M. T. A. and O. M. E.), Swiss Federal Institute of Technology, Lausanne (to H. A. L., D. J. M., P. C., B. S., and P. A.), an ERC starting grant (to B. F., C. A. D., and H. A. L.), and a Merck Serono grant (to M.-B. F., and H. A. L.). This work was partially funded by as grant from Merck Serono.	Anderson JP, 2006, J BIOL CHEM, V281, P29739, DOI 10.1074/jbc.M600933200; Anderson VL, 2010, P NATL ACAD SCI USA, V107, P18850, DOI 10.1073/pnas.1012336107; Baba M, 1998, AM J PATHOL, V152, P879; Bartels T, 2011, NATURE, V477, P107, DOI 10.1038/nature10324; Bertoncini CW, 2005, J BIOL CHEM, V280, P30649, DOI 10.1074/jbc.C500288200; Binolfi A, 2006, J AM CHEM SOC, V128, P9893, DOI 10.1021/ja0618649; Bussell R, 2001, J BIOL CHEM, V276, P45996, DOI 10.1074/jbc.M106777200; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Cole NB, 2002, J BIOL CHEM, V277, P6344, DOI 10.1074/jbc.M108414200; Conway KA, 1998, NAT MED, V4, P1318, DOI 10.1038/3311; Cookson MR, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-9; Croke RL, 2008, PROTEIN SCI, V17, P1434, DOI 10.1110/ps.033803.107; da Silveira SA, 2009, HUM MOL GENET, V18, P872, DOI 10.1093/hmg/ddn417; Dedmon MM, 2005, J AM CHEM SOC, V127, P476, DOI 10.1021/ja044834j; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Duda JE, 2000, AM J PATHOL, V157, P1439, DOI 10.1016/S0002-9440(10)64781-5; Dusonchet J, 2009, NEUROBIOL DIS, V35, P32, DOI 10.1016/j.nbd.2009.03.013; El-Agnaf OMA, 2006, FASEB J, V20, P419, DOI 10.1096/fj.03-1449com; Eliezer D, 2001, J MOL BIOL, V307, P1061, DOI 10.1006/jmbi.2001.4538; FERGUSON KA, 1964, METABOLISM, V13, P985, DOI 10.1016/S0026-0495(64)80018-4; Fernandez CO, 2004, EMBO J, V23, P2039, DOI 10.1038/sj.emboj.7600211; Georgieva ER, 2008, J AM CHEM SOC, V130, P12856, DOI 10.1021/ja804517m; Georgieva ER, 2010, J BIOL CHEM, V285, P28261, DOI 10.1074/jbc.M110.157214; Giasson BI, 2000, SCIENCE, V290, P985, DOI 10.1126/science.290.5493.985; Han V, 2010, VOX SANG, V98, P116, DOI 10.1111/j.1423-0410.2009.01249.x; JAKES R, 1994, FEBS LETT, V345, P27, DOI 10.1016/0014-5793(94)00395-5; JI XH, 1992, BIOCHEMISTRY-US, V31, P10169, DOI 10.1021/bi00157a004; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kang JH, 2003, MOL CELLS, V15, P87; Krishnan S, 2003, BIOCHEMISTRY-US, V42, P829, DOI 10.1021/bi026528t; Lee D, 2001, EUR J BIOCHEM, V268, P295, DOI 10.1046/j.1432-1033.2001.01877.x; Lee MK, 2002, P NATL ACAD SCI USA, V99, P8968, DOI 10.1073/pnas.132197599; LENNOX G, 1989, J NEUROL NEUROSUR PS, V52, P1236, DOI 10.1136/jnnp.52.11.1236; Li CG, 2009, BIOCHEMISTRY-US, V48, P8578, DOI 10.1021/bi900872p; LIM K, 1994, PROTEIN SCI, V3, P2233, DOI 10.1002/pro.5560031209; Lucking CB, 2000, CELL MOL LIFE SCI, V57, P1894, DOI 10.1007/PL00000671; Marsh JA, 2006, PROTEIN SCI, V15, P2795, DOI 10.1110/ps.062465306; Mbefo MK, 2010, J BIOL CHEM, V285, P2807, DOI 10.1074/jbc.M109.081950; McNulty BC, 2006, PROTEIN SCI, V15, P602, DOI 10.1110/ps.051867106; Munoz E, 1997, NEUROSCI LETT, V235, P57, DOI 10.1016/S0304-3940(97)00710-6; Ohrfelt A, 2011, NEUROCHEM RES, V36, P2029, DOI 10.1007/s11064-011-0527-x; Oueslati A, 2012, J NEUROSCI, V32, P1536, DOI 10.1523/JNEUROSCI.3784-11.2012; Paik SR, 1999, BIOCHEM J, V340, P821, DOI 10.1042/0264-6021:3400821; Paleologou KE, 2008, J BIOL CHEM, V283, P16895, DOI 10.1074/jbc.M800747200; Paleologou KE, 2010, J NEUROSCI, V30, P3184, DOI 10.1523/JNEUROSCI.5922-09.2010; PARKER MW, 1990, J MOL BIOL, V213, P221, DOI 10.1016/S0022-2836(05)80183-4; Perrin RJ, 2003, NEUROSCI LETT, V349, P133, DOI 10.1016/S0304-3940(03)00781-X; Pham E, 2010, FEBS J, V277, P3051, DOI 10.1111/j.1742-4658.2010.07719.x; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Rasia RM, 2005, P NATL ACAD SCI USA, V102, P4294, DOI 10.1073/pnas.0407881102; Ringrose JH, 2008, J PROTEOME RES, V7, P3060, DOI 10.1021/pr8001029; ROCKENSTEIN EM, 1995, J BIOL CHEM, V270, P28257; Rospigliosi CC, 2009, J MOL BIOL, V388, P1022, DOI 10.1016/j.jmb.2009.03.065; Santner A, 2010, METALLOMICS, V2, P378, DOI 10.1039/b926659c; Segers-Nolten IMJ, 2008, PROTEIN SCI, V17, P1395, DOI 10.1110/ps.036103.108; Selkoe D., 2011, PROTOCOL EXCHANGE; Shaikh S, 2008, J NEUROSCI RES, V86, P2071, DOI 10.1002/jnr.21644; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; Souza JM, 2000, J BIOL CHEM, V275, P18344, DOI 10.1074/jbc.M000206200; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Sung YH, 2007, J MOL BIOL, V372, P689, DOI 10.1016/j.jmb.2007.07.008; Tinsley RB, 2010, J NEUROSCI RES, V88, P2693, DOI 10.1002/jnr.22417; UEDA K, 1993, P NATL ACAD SCI USA, V90, P11282, DOI 10.1073/pnas.90.23.11282; Uversky VN, 2009, CURR PROTEIN PEPT SC, V10, P483, DOI 10.2174/138920309789351921; Walker J. M., 2002, PROTEIN PROTOCOLS 2, P57; Wang W, 2011, P NATL ACAD SCI USA, V108, P17797, DOI 10.1073/pnas.1113260108; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; Wu KP, 2008, J MOL BIOL, V378, P1104, DOI 10.1016/j.jmb.2008.03.017; Wu KP, 2009, J MOL BIOL, V391, P784, DOI 10.1016/j.jmb.2009.06.063; Yamin G, 2003, FEBS LETT, V542, P147, DOI 10.1016/S0014-5793(03)00367-3; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795	73	382	385	1	98	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15345	15364		10.1074/jbc.M111.318949	http://dx.doi.org/10.1074/jbc.M111.318949			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22315227	Green Published, hybrid			2022-12-25	WOS:000304006300017
J	Wang, Z; Collighan, RJ; Pytel, K; Rathbone, DL; Li, XL; Griffin, M				Wang, Zhuo; Collighan, Russell J.; Pytel, Kamila; Rathbone, Daniel L.; Li, Xiaoling; Griffin, Martin			Characterization of Heparin-binding Site of Tissue Transglutaminase ITS IMPORTANCE IN CELL SURFACE TARGETING, MATRIX DEPOSITION, AND CELL SIGNALING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SULFATE PROTEOGLYCANS; FIBRONECTIN; ADHESION; EXPRESSION; SYNDECAN-1; TRAFFICKING; SEQUENCE	Tissue transglutaminase (TG2) is a multifunctional Ca2+-activated protein cross-linking enzyme secreted into the extracellular matrix (ECM), where it is involved in wound healing and scarring, tissue fibrosis, celiac disease, and metastatic cancer. Extracellular TG2 can also facilitate cell adhesion important in wound healing through a nontransamidating mechanism via its association with fibronectin, heparan sulfates (HS), and integrins. Regulating the mechanism how TG2 is translocated into the ECM therefore provides a strategy for modulating these physiological and pathological functions of the enzyme. Here, through molecular modeling and mutagenesis, we have identified the HS-binding site of TG2 (202)KFLKNAGRDCSRR-SSPVYVGR(222). We demonstrate the requirement of this binding site for translocation of TG2 into the ECM through a mechanism involving cell surface shedding of HS. By synthesizing a peptide NPKFLKNAGRDCSRRSS corresponding to the HS-binding site within TG2, we also demonstrate how this mimicking peptide can in isolation compensate for the RGD-induced loss of cell adhesion on fibronectin via binding to syndecan-4, leading to activation of PKC alpha, pFAK-397, and ERK1/2 and the subsequent formation of focal adhesions and actin cytoskeleton organization. A novel regulatory mechanism for TG2 translocation into the extracellular compartment that depends upon TG2 conformation and the binding of HS is proposed.	[Wang, Zhuo; Collighan, Russell J.; Pytel, Kamila; Rathbone, Daniel L.; Li, Xiaoling; Griffin, Martin] Aston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England	Aston University	Griffin, M (corresponding author), Aston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England.	m.griffin@aston.ac.uk		WANG, ZHUO/0000-0002-2212-8318; Rathbone, Daniel L/0000-0003-4732-4662; Griffin, Martin/0000-0003-3824-306X	European Commission Marie Curie ITN [MRTN-CT-2006-036032]; European Commission Marie Curie IAPP TRANSCOM [PIA-GA-2010-251506]	European Commission Marie Curie ITN; European Commission Marie Curie IAPP TRANSCOM	This work was supported by European Commission Marie Curie ITN Project TRACKS Contract MRTN-CT-2006-036032 and by European Commission Marie Curie IAPP TRANSCOM Contract PIA-GA-2010-251506.	Akimov SS, 2000, J CELL BIOL, V148, P825, DOI 10.1083/jcb.148.4.825; Alexopoulou AN, 2007, INT J BIOCHEM CELL B, V39, P505, DOI 10.1016/j.biocel.2006.10.014; Brule S, 2006, GLYCOBIOLOGY, V16, P488, DOI 10.1093/glycob/cwj098; CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21, DOI 10.1161/01.ATV.9.1.21; Chou CY, 2011, J BIOL CHEM, V286, P27825, DOI 10.1074/jbc.M111.226340; Fitzgerald ML, 2000, J CELL BIOL, V148, P811, DOI 10.1083/jcb.148.4.811; Fuster MM, 2010, PROG MOL BIOL TRANSL, V93, P179, DOI 10.1016/S1877-1173(10)93009-3; Gaudry CA, 1999, J BIOL CHEM, V274, P30707, DOI 10.1074/jbc.274.43.30707; GENTILE V, 1991, J BIOL CHEM, V266, P478; Griffin M, 2002, BIOCHEM J, V368, P377, DOI 10.1042/BJ20021234; Griffin M, 2008, BIOORG MED CHEM LETT, V18, P5559, DOI 10.1016/j.bmcl.2008.09.006; Hang J, 2005, J BIOL CHEM, V280, P23675, DOI 10.1074/jbc.M503323200; Hileman RE, 1998, BIOESSAYS, V20, P156, DOI 10.1002/(SICI)1521-1878(199802)20:2<156::AID-BIES8>3.3.CO;2-#; Iismaa SE, 2009, PHYSIOL REV, V89, P991, DOI 10.1152/physrev.00044.2008; Johnson KA, 2005, J BIOL CHEM, V280, P15004, DOI 10.1074/jbc.M500962200; Jones RA, 1997, J CELL SCI, V110, P2461; Kotsakis P, 2011, AMINO ACIDS, V41, P909, DOI 10.1007/s00726-010-0790-1; Leblanc A, 1999, PROTEIN EXPRES PURIF, V17, P89, DOI 10.1006/prep.1999.1107; LEE KN, 1993, BIOCHIM BIOPHYS ACTA, V1202, P1, DOI 10.1016/0167-4838(93)90055-V; LEMOSY EK, 1992, J BIOL CHEM, V267, P7880; LIDHOLT K, 1992, P NATL ACAD SCI USA, V89, P2267, DOI 10.1073/pnas.89.6.2267; Liu SP, 2002, P NATL ACAD SCI USA, V99, P2743, DOI 10.1073/pnas.042454899; Mahtouk K, 2007, BLOOD, V109, P4914, DOI 10.1182/blood-2006-08-043232; Manon-Jensen T, 2010, FEBS J, V277, P3876, DOI 10.1111/j.1742-4658.2010.07798.x; MARGALIT H, 1993, J BIOL CHEM, V268, P19228; Nicholas B, 2003, BIOCHEM J, V371, P413, DOI 10.1042/BJ20021949; Okina E, 2009, SCAND J MED SCI SPOR, V19, P479, DOI 10.1111/j.1600-0838.2009.00941.x; Parsons M, 2002, MOL CELL BIOL, V22, P5897, DOI 10.1128/MCB.22.16.5897-5911.2002; Pinkas DM, 2007, PLOS BIOL, V5, P2788, DOI 10.1371/journal.pbio.0050327; Ritchie JP, 2011, CLIN CANCER RES, V17, P1382, DOI 10.1158/1078-0432.CCR-10-2476; SALO T, 1994, LAB INVEST, V70, P176; Scarpellini A, 2009, J BIOL CHEM, V284, P18411, DOI 10.1074/jbc.M109.012948; Stamnaes J, 2010, J BIOL CHEM, V285, P25402, DOI 10.1074/jbc.M109.097162; Su G, 2008, CANCER RES, V68, P9558, DOI 10.1158/0008-5472.CAN-08-1645; Telci D, 2008, J BIOL CHEM, V283, P20937, DOI 10.1074/jbc.M801763200; Telci D, 2009, J BIOL CHEM, V284, P29547, DOI 10.1074/jbc.M109.041806; Tsanou E, 2004, J EXP CLIN CANC RES, V23, P641; Verderio E, 1998, EXP CELL RES, V239, P119, DOI 10.1006/excr.1997.3874; Verderio EAM, 2009, AMINO ACIDS, V36, P671, DOI 10.1007/s00726-008-0134-6; Verderio EAM, 2004, AMINO ACIDS, V26, P387, DOI 10.1007/s00726-004-0094-4; Verderio EAM, 2003, J BIOL CHEM, V278, P42604, DOI 10.1074/jbc.M303303200; Wang Z, 2011, EXP CELL RES, V317, P367, DOI 10.1016/j.yexcr.2010.10.015; Wang Z, 2010, J BIOL CHEM, V285, P40212, DOI 10.1074/jbc.M110.123703; Zemskov EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019414	44	51	51	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					13063	13083		10.1074/jbc.M111.294819	http://dx.doi.org/10.1074/jbc.M111.294819			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22298777	hybrid, Green Accepted, Green Published			2022-12-25	WOS:000302903700047
J	Kwon, JY; Seo, SG; Heo, YS; Yue, SH; Cheng, JX; Lee, KW; Kim, KH				Kwon, Jung Yeon; Seo, Sang Gwon; Heo, Yong-Seok; Yue, Shuhua; Cheng, Ji-Xin; Lee, Ki Won; Kim, Kee-Hong			Piceatannol, Natural Polyphenolic Stilbene, Inhibits Adipogenesis via Modulation of Mitotic Clonal Expansion and Insulin Receptor-dependent Insulin Signaling in Early Phase of Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHEMOPREVENTIVE AGENT RESVERATROL; RAMAN SCATTERING MICROSCOPY; BINDING PROTEIN-BETA; KAPPA-B ACTIVATION; N-TERMINAL KINASE; ADIPOCYTE DIFFERENTIATION; TYROSINE KINASE; GENE-EXPRESSION; ADIPOSE-TISSUE; PHOSPHOINOSITIDE 3-KINASE	Piceatannol, a natural stilbene, is an analog and a metabolite of resveratrol. Despite a well documented health benefit of resveratrol in intervention of the development of obesity, the role of piceatannol in the development of adipose tissue and related diseases is unknown. Here, we sought to determine the function of piceatannol in adipogenesis and elucidate the underlying mechanism. We show that piceatannol inhibits adipogenesis of 3T3-L1 preadipocytes in a dose-dependent manner at noncytotoxic concentrations. This anti-adipogenic property of piceatannol was largely limited to the early event of adipogenesis. In the early phase of adipogenesis, piceatannol-treated preadipocytes displayed a delayed cell cycle entry into G(2)/M phase at 24 h after initiation of adipogenesis. Furthermore, the piceatannol-suppressed mitotic clonal expansion was accompanied by reduced activation of the insulin-signaling pathway. Piceatannol dose-dependently inhibited differentiation mixture-induced phosphorylation of insulin receptor (IR)/insulin receptor substrate-1 (IRS-1)/Akt pathway in the early phase of adipogenesis. Moreover, we showed that piceatannol is an inhibitor of IR kinase activity and phosphatidylinositol 3-kinase (PI3K). Our kinetics study of IR further identified a K-m value for ATP of 57.8 mu M and a K-i value for piceatannol of 28.9 mu M. We also showed that piceatannol directly binds to IR and inhibits IR kinase activity in a mixed noncompetitive manner to ATP, through which piceatannol appears to inhibit adipogenesis. Taken together, our study reveals an anti-adipogenic function of piceatannol and highlights IR and its downstream insulin signaling as novel targets for piceatannol in the early phase of adipogenesis.	[Kwon, Jung Yeon; Kim, Kee-Hong] Purdue Univ, Dept Food Sci, W Lafayette, IN 47907 USA; [Seo, Sang Gwon; Lee, Ki Won] Seoul Natl Univ, Dept Agr Biotechnol, Seoul 151921, South Korea; [Heo, Yong-Seok] Konkuk Univ, Dept Chem, Seoul 143701, South Korea; [Yue, Shuhua; Cheng, Ji-Xin] Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA; [Cheng, Ji-Xin] Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Seoul National University (SNU); Konkuk University; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Kim, KH (corresponding author), Purdue Univ, Dept Food Sci, Smith Hall, W Lafayette, IN 47907 USA.	keehong@purdue.edu	Lee, Ki Won/M-4114-2018		Purdue Research Foundation; National Research Foundation; Ministry of Education, Science, and Technology, Republic of Korea [2010-0029233, 2009-0067326]	Purdue Research Foundation; National Research Foundation; Ministry of Education, Science, and Technology, Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported in part by a Purdue Research Foundation grant (to K. H. K.) and in part by National Research Foundation and Ministry of Education, Science, and Technology, Republic of Korea, Leap Research Program Grants 2010-0029233 and 2009-0067326 (to K. W. L.).	Amri A., 2012, J CONTROLLE IN PRESS; Ashikawa K, 2002, J IMMUNOL, V169, P6490, DOI 10.4049/jimmunol.169.11.6490; Avdi NJ, 2001, J BIOL CHEM, V276, P2189, DOI 10.1074/jbc.M007527200; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Berton G, 2005, TRENDS IMMUNOL, V26, P208, DOI 10.1016/j.it.2005.02.002; Bluher M, 2004, J BIOL CHEM, V279, P31891, DOI 10.1074/jbc.M404569200; Bluher M, 2002, DEV CELL, V3, P25, DOI 10.1016/S1534-5807(02)00199-5; Bost F, 2005, DIABETES, V54, P402, DOI 10.2337/diabetes.54.2.402; Bost F, 2005, BIOCHIMIE, V87, P51, DOI 10.1016/j.biochi.2004.10.018; Brown VA, 2010, CANCER RES, V70, P9003, DOI 10.1158/0008-5472.CAN-10-2364; Choi KH, 2010, CARDIOVASC RES, V85, P836, DOI 10.1093/cvr/cvp359; Chowdhury SA, 2005, ANTICANCER RES, V25, P2055; Evans CL, 2008, ANNU REV ANAL CHEM, V1, P883, DOI 10.1146/annurev.anchem.1.031207.112754; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; FERRIGNI NR, 1984, J NAT PROD, V47, P347, DOI 10.1021/np50032a019; Gagnon A, 1999, DIABETES, V48, P691, DOI 10.2337/diabetes.48.4.691; Garofalo RS, 2003, J CLIN INVEST, V112, P197, DOI 10.1172/JCI200316885; GEAHLEN RL, 1989, BIOCHEM BIOPH RES CO, V165, P241, DOI 10.1016/0006-291X(89)91060-7; Gnoni GV, 2009, EUR J CLIN INVEST, V39, P211, DOI 10.1111/j.1365-2362.2008.02077.x; Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783; HARING H, 1986, J BIOL CHEM, V261, P3869; Heinrich T, 2010, ACS MED CHEM LETT, V1, P199, DOI 10.1021/ml100044h; Hubbard SR, 1997, EMBO J, V16, P5572, DOI 10.1093/emboj/16.18.5572; Jang YJ, 2009, ANN NY ACAD SCI, V1171, P176, DOI 10.1111/j.1749-6632.2009.04727.x; Johnson JJ, 2011, MOL NUTR FOOD RES, V55, P1169, DOI 10.1002/mnfr.201100117; Kang CH, 2011, TOXICOL IN VITRO, V25, P605, DOI 10.1016/j.tiv.2010.12.006; Kim CY, 2011, J AGR FOOD CHEM, V59, P1012, DOI 10.1021/jf103873k; Kim EJ, 2009, J MED FOOD, V12, P943, DOI 10.1089/jmf.2008.1341; Kim SW, 2001, J BIOL CHEM, V276, P10199, DOI 10.1074/jbc.M010640200; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Ku KL, 2005, J AGR FOOD CHEM, V53, P3877, DOI 10.1021/jf050242o; Kwon JY, 2009, CARCINOGENESIS, V30, P1932, DOI 10.1093/carcin/bgp216; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Larrosa M, 2004, EUR J NUTR, V43, P275, DOI 10.1007/s00394-004-0471-5; Le TT, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2795437; Lee B, 2009, TOXICOL IN VITRO, V23, P1284, DOI 10.1016/j.tiv.2009.07.023; Lee DE, 2011, CARCINOGENESIS, V32, P629, DOI 10.1093/carcin/bgr008; Lee DE, 2010, J BIOL CHEM, V285, P21458, DOI 10.1074/jbc.M109.094797; Lee KW, 2008, CANCER RES, V68, P946, DOI 10.1158/0008-5472.CAN-07-3140; Lee YM, 2009, CANCER LETT, V285, P166, DOI 10.1016/j.canlet.2009.05.011; Matsui Y, 2010, J AGR FOOD CHEM, V58, P11112, DOI 10.1021/jf102650d; Mercader J, 2011, J NUTR BIOCHEM, V22, P828, DOI 10.1016/j.jnutbio.2010.07.007; Pandey PR, 2011, BREAST CANCER RES TR, V130, P387, DOI 10.1007/s10549-010-1300-6; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Potter GA, 2002, BRIT J CANCER, V86, P774, DOI 10.1038/sj.bjc.6600197; Prusty D, 2002, J BIOL CHEM, V277, P46226, DOI 10.1074/jbc.M207776200; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Roupe KA, 2006, J PHARM PHARMACOL, V58, P1443, DOI 10.1211/jpp.58.11.0004; Sakaue H, 1998, J BIOL CHEM, V273, P28945, DOI 10.1074/jbc.273.44.28945; Son PS, 2010, CARCINOGENESIS, V31, P1442, DOI 10.1093/carcin/bgq099; Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902; Su L, 2000, J BIOL CHEM, V275, P12661, DOI 10.1074/jbc.275.17.12661; Szkudelska K, 2009, J STEROID BIOCHEM, V113, P17, DOI 10.1016/j.jsbmb.2008.11.001; Tang QQ, 2005, P NATL ACAD SCI USA, V102, P9766, DOI 10.1073/pnas.0503891102; Tang QQ, 2003, P NATL ACAD SCI USA, V100, P850, DOI 10.1073/pnas.0337434100; Tang QQ, 2003, P NATL ACAD SCI USA, V100, P44, DOI 10.1073/pnas.0137044100; Tang QQ, 1999, GENE DEV, V13, P2231, DOI 10.1101/gad.13.17.2231; THAKKAR K, 1993, J MED CHEM, V36, P2950, DOI 10.1021/jm00072a015; Valverde AM, 1999, DIABETES, V48, P2122, DOI 10.2337/diabetes.48.11.2122; Wang BH, 1998, PLANTA MED, V64, P195, DOI 10.1055/s-2006-957407; Wang HW, 2009, VIB SPECTROSC, V50, P160, DOI 10.1016/j.vibspec.2008.11.007; Wang HY, 1999, J BIOL CHEM, V274, P32159, DOI 10.1074/jbc.274.45.32159; Wieder T, 2001, LEUKEMIA, V15, P1735, DOI 10.1038/sj.leu.2402284; Wolter F, 2002, J NUTR, V132, P298; Xu JF, 2004, J BIOL CHEM, V279, P35914, DOI 10.1074/jbc.M402297200; Yu CW, 2002, PHARM RES-DORDR, V19, P1907, DOI 10.1023/A:1021414129280	66	93	99	4	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					11566	11578		10.1074/jbc.M111.259721	http://dx.doi.org/10.1074/jbc.M111.259721			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22298784	Green Published, hybrid			2022-12-25	WOS:000302780100084
J	Parker, MW; Xu, P; Li, XB; Vander Kooi, CW				Parker, Matthew W.; Xu, Ping; Li, Xiaobo; Vander Kooi, Craig W.			Structural Basis for Selective Vascular Endothelial Growth Factor-A (VEGF-A) Binding to Neuropilin-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXON 7-ENCODED DOMAIN; HEPARIN-BINDING; RECEPTOR ACTIVATION; CELL MIGRATION; TUMOR-CELLS; SEMAPHORIN; VEGF(165); COMPLEX; GROWTH-FACTOR-165; TRANSDUCTION	Background: Neuropilin is an essential cell surface receptor for VEGF-A in angiogenesis. Results: VEGF-A(164) uniquely physically engages neuropilin using two distinct regions. Conclusion: These data establish the structural basis for selective VEGF-A splice form binding to neuropilin. Significance: Understanding VEGF receptor binding will advance therapeutic targeting of pathological angiogenesis.	[Vander Kooi, Craig W.] Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA; Univ Kentucky, Struct Biol Ctr, Lexington, KY 40536 USA	University of Kentucky; University of Kentucky	Vander Kooi, CW (corresponding author), Univ Kentucky, Dept Mol & Cellular Biochem, 741 S Limestone Ave,BBSRB B263, Lexington, KY 40536 USA.	craig.vanderkooi@uky.edu	Parker, Matthew/AAW-2444-2020	Parker, Matthew/0000-0001-9845-9108	National Institutes of Health [R01GM094155, T32HL072743]; Kentucky Lung Cancer Research Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL072743] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094155] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kentucky Lung Cancer Research Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM094155 and Training Grant T32HL072743 (to M. W. P.). This work was also supported by the Kentucky Lung Cancer Research Program.	Appleton BA, 2007, EMBO J, V26, P4902, DOI 10.1038/sj.emboj.7601906; Bates DO, 2002, CANCER RES, V62, P4123; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Dosch DD, 2010, FASEB J, V24, P32, DOI 10.1096/fj.09-132670; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fairbrother WJ, 1998, STRUCT FOLD DES, V6, P637, DOI 10.1016/S0969-2126(98)00065-3; Geretti E, 2007, J BIOL CHEM, V282, P25698, DOI 10.1074/jbc.M702942200; Grunewald FS, 2010, BBA-PROTEINS PROTEOM, V1804, P567, DOI 10.1016/j.bbapap.2009.09.002; Gu CH, 2002, J BIOL CHEM, V277, P18069, DOI 10.1074/jbc.M201681200; Herzog B, 2011, MOL BIOL CELL, V22, P2766, DOI 10.1091/mbc.E09-12-1061; HOUCK KA, 1992, J BIOL CHEM, V267, P26031; Jardin BA, 2008, J BIOTECHNOL, V135, P272, DOI 10.1016/j.jbiotec.2008.04.006; Jia HY, 2006, J BIOL CHEM, V281, P13493, DOI 10.1074/jbc.M512121200; Karpanen T, 2001, CANCER RES, V61, P1786; Keyt BA, 1996, J BIOL CHEM, V271, P7788, DOI 10.1074/jbc.271.13.7788; Kitsukawa T, 1997, NEURON, V19, P995, DOI 10.1016/S0896-6273(00)80392-X; Kolodkin AL, 1997, CELL, V90, P753, DOI 10.1016/S0092-8674(00)80535-8; Krilleke D, 2007, J BIOL CHEM, V282, P28045, DOI 10.1074/jbc.M700319200; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; Liang WC, 2007, J MOL BIOL, V366, P815, DOI 10.1016/j.jmb.2006.11.021; Mamluk R, 2002, J BIOL CHEM, V277, P24818, DOI 10.1074/jbc.M200730200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pan Q, 2007, J BIOL CHEM, V282, P24049, DOI 10.1074/jbc.M703554200; Parker MW, 2010, BIOCHEMISTRY-US, V49, P4068, DOI 10.1021/bi100327r; Pellet-Many C, 2008, BIOCHEM J, V411, P211, DOI 10.1042/BJ20071639; Soker S, 1997, J BIOL CHEM, V272, P31582, DOI 10.1074/jbc.272.50.31582; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Soker S, 1996, J BIOL CHEM, V271, P5761, DOI 10.1074/jbc.271.10.5761; Starzec A, 2007, PEPTIDES, V28, P2397, DOI 10.1016/j.peptides.2007.09.013; Staton CA, 2007, J PATHOL, V212, P237, DOI 10.1002/path.2182; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Teesalu T, 2009, P NATL ACAD SCI USA, V106, P16157, DOI 10.1073/pnas.0908201106; Vander Kooi CW, 2007, P NATL ACAD SCI USA, V104, P6152, DOI 10.1073/pnas.0700043104; von Wronski MA, 2006, J BIOL CHEM, V281, P5702, DOI 10.1074/jbc.M511941200; WALTENBERGER J, 1994, J BIOL CHEM, V269, P26988; Yang Y, 2010, P NATL ACAD SCI USA, V107, P1906, DOI 10.1073/pnas.0914052107	38	125	132	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					11082	11089		10.1074/jbc.M111.331140	http://dx.doi.org/10.1074/jbc.M111.331140			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22318724	Green Published, hybrid			2022-12-25	WOS:000302780100036
J	Boehringer, D; O'Farrell, HC; Rife, JP; Ban, NN				Boehringer, Daniel; O'Farrell, Heather C.; Rife, Jason P.; Ban, Nenad			Structural Insights into Methyltransferase KsgA Function in 30S Ribosomal Subunit Biogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA ADENINE DIMETHYLTRANSFERASE; ESCHERICHIA-COLI; ELECTRON-MICROSCOPY; CRYOELECTRON MICROSCOPY; TRANSLATION INITIATION; 3' END; COMPLEX; RESOLUTION; GENE; ERA	The assembly of the ribosomal subunits is facilitated by ribosome biogenesis factors. The universally conserved methyltransferase KsgA modifies two adjacent adenosine residues in the 3'-terminal helix 45 of the 16 S ribosomal RNA (rRNA). KsgA recognizes its substrate adenosine residues only in the context of a near mature 30S subunit and is required for the efficient processing of the rRNA termini during ribosome biogenesis. Here, we present the cryo-EM structure of KsgA bound to a nonmethylated 30S ribosomal subunit. The structure reveals that KsgA binds to the 30S platform with the catalytic N-terminal domain interacting with substrate adenosine residues in helix 45 and the C-terminal domain making extensive contacts to helix 27 and helix 24. KsgA excludes the penultimate rRNA helix 44 from adopting its position in the mature 30S subunit, blocking the formation of the decoding site and subunit joining. We suggest that the activation of methyltransferase activity and subsequent dissociation of KsgA control conformational changes in helix 44 required for final rRNA processing and translation initiation.	[O'Farrell, Heather C.; Rife, Jason P.] ETH, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland; [Boehringer, Daniel; Ban, Nenad] Virginia Commonwealth Univ, Dept Physiol & Biophys, Richmond, VA 23298 USA	Swiss Federal Institutes of Technology Domain; ETH Zurich; Virginia Commonwealth University	Rife, JP (corresponding author), ETH, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland.	jason.rife@vcu.edu; ban@mol.biol.ethz.ch			Swiss National Science Foundation; National Center of Excellence in Research; European Research Council under the European Community [250071]; Max Roessler prize; Electron Microscopy ETH Zurich (EMEZ)	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Center of Excellence in Research; European Research Council under the European Community(European Research Council (ERC)); Max Roessler prize; Electron Microscopy ETH Zurich (EMEZ)	This work was supported by the Swiss National Science Foundation, the National Center of Excellence in Research, Structural Biology program of the Swiss National Science Foundation, and European Research Council Grant 250071 under the European Community's Seventh Framework Programme (to N. B.), and the Max Roessler prize (to N. B.).; We thank Sofia Arpagaus and Peter Tittmann for technical assistance. We are grateful to Gloria Culver for critically reading the manuscript. We thank the Electron Microscopy ETH Zurich (EMEZ) for support.	Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Connolly K, 2009, TRENDS BIOCHEM SCI, V34, P256, DOI 10.1016/j.tibs.2009.01.011; Connolly K, 2008, MOL MICROBIOL, V70, P1062, DOI 10.1111/j.1365-2958.2008.06485.x; Datta PP, 2007, MOL CELL, V28, P434, DOI 10.1016/j.molcel.2007.08.026; Demirci H, 2010, RNA, V16, P2319, DOI 10.1261/rna.2357210; Demirci H, 2009, J MOL BIOL, V388, P271, DOI 10.1016/j.jmb.2009.02.066; Desai PM, 2006, ARCH BIOCHEM BIOPHYS, V449, P57, DOI 10.1016/j.abb.2006.02.028; Desai PM, 2011, BIOCHEMISTRY-US, V50, P854, DOI 10.1021/bi101005r; Deutscher MP, 2009, PROG MOL BIOL TRANSL, V85, P369, DOI 10.1016/S0079-6603(08)00809-X; DUBOCHET J, 1988, Q REV BIOPHYS, V21, P129, DOI 10.1017/S0033583500004297; Fernandez JJ, 2008, J STRUCT BIOL, V164, P170, DOI 10.1016/j.jsb.2008.05.010; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Goedecke K, 2001, NAT STRUCT BIOL, V8, P121, DOI 10.1038/84104; Guo Q, 2011, P NATL ACAD SCI USA, V108, P13100, DOI 10.1073/pnas.1104645108; HELSER TL, 1972, NATURE-NEW BIOL, V235, P6, DOI 10.1038/newbio235006a0; Holmes KL, 2004, NAT STRUCT MOL BIOL, V11, P179, DOI 10.1038/nsmb719; HONIG B, 1993, J PHYS CHEM-US, V97, P1101, DOI 10.1021/j100108a002; Inoue K, 2007, J BACTERIOL, V189, P8510, DOI 10.1128/JB.01259-07; Jomaa A, 2011, RNA, V17, P2026, DOI 10.1261/rna.2922311; Jomaa A, 2011, RNA, V17, P697, DOI 10.1261/rna.2509811; Kaczanowska M, 2007, MICROBIOL MOL BIOL R, V71, P477, DOI 10.1128/MMBR.00013-07; Kohler R, 2009, MOL CELL, V34, P344, DOI 10.1016/j.molcel.2009.04.019; LAFONTAINE D, 1994, J MOL BIOL, V241, P492, DOI 10.1006/jmbi.1994.1525; Loerke J, 2010, METHOD ENZYMOL, V483, P161, DOI 10.1016/S0076-6879(10)83008-3; Lu Q, 1998, J BACTERIOL, V180, P5243, DOI 10.1128/JB.180.19.5243-5246.1998; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; MIZUSHIMA S, 1970, NATURE, V226, P1214, DOI 10.1038/2261214a0; MOAZED D, 1986, J MOL BIOL, V191, P483, DOI 10.1016/0022-2836(86)90143-9; Mulder AM, 2010, SCIENCE, V330, P673, DOI 10.1126/science.1193220; O'Farrell HC, 2006, RNA, V12, P725, DOI 10.1261/rna.2310406; O'Farrell HC, 2004, J MOL BIOL, V339, P337, DOI 10.1016/j.jmb.2004.02.068; O'Farrell HC, 2003, ACTA CRYSTALLOGR D, V59, P1490, DOI 10.1107/S0907444903011855; O'Farrell Heather C, 2008, BMC Res Notes, V1, P108, DOI 10.1186/1756-0500-1-108; Penczek PA, 2006, J STRUCT BIOL, V154, P168, DOI 10.1016/j.jsb.2006.01.003; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; POLDERMANS B, 1979, J BIOL CHEM, V254, P9094; Pulicherla N, 2009, J MOL BIOL, V391, P884, DOI 10.1016/j.jmb.2009.06.015; Schuwirth BS, 2005, SCIENCE, V310, P827, DOI 10.1126/science.1117230; Shajani Z, 2011, ANNU REV BIOCHEM, V80, P501, DOI 10.1146/annurev-biochem-062608-160432; Sharma MR, 2005, MOL CELL, V18, P319, DOI 10.1016/j.molcel.2005.03.028; Simonetti A, 2008, NATURE, V455, P416, DOI 10.1038/nature07192; Spahn CMT, 2009, CURR OPIN STRUC BIOL, V19, P623, DOI 10.1016/j.sbi.2009.08.001; Strunk BS, 2011, SCIENCE, V333, P1449, DOI 10.1126/science.1208245; Talkington MWT, 2005, NATURE, V438, P628, DOI 10.1038/nature04261; THAMMANA P, 1974, NATURE, V251, P682, DOI 10.1038/251682a0; Tu C, 2011, P NATL ACAD SCI USA, V108, P10156, DOI 10.1073/pnas.1017679108; Tu C, 2009, STRUCTURE, V17, P374, DOI 10.1016/j.str.2009.01.010; VANGEMEN B, 1989, J BACTERIOL, V171, P4002, DOI 10.1128/jb.171.7.4002-4008.1989; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Williamson JR, 2005, Q REV BIOPHYS, V38, P397, DOI 10.1017/S0033583506004264; Williamson JR, 2003, RNA, V9, P165, DOI 10.1261/rna.2164903; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; Woodson SA, 2008, CURR OPIN CHEM BIOL, V12, P667, DOI 10.1016/j.cbpa.2008.09.024; Xu Z, 2008, NAT STRUCT MOL BIOL, V15, P534, DOI 10.1038/nsmb.1408	56	54	56	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					10453	10459		10.1074/jbc.M111.318121	http://dx.doi.org/10.1074/jbc.M111.318121			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22308031	Green Published, hybrid			2022-12-25	WOS:000302167200072
J	Okuda-Ashitaka, E; Minami, T; Tsubouchi, S; Kiyonari, H; Iwamatsu, A; Noda, T; Handa, H; Ito, S				Okuda-Ashitaka, Emiko; Minami, Toshiaki; Tsubouchi, Shingo; Kiyonari, Hiroshi; Iwamatsu, Akihiro; Noda, Tetsuo; Handa, Hiroshi; Ito, Seiji			Identification of NIPSNAP1 as a Nocistatin-interacting Protein Involving Pain Transmission	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERFORMANCE AFFINITY BEADS; NOCICEPTIN/ORPHANIN FQ; ORPHANIN FQ; GENE; MICE; NUCLEUS; RATS; INVOLVEMENT; EXPRESSION; RECEPTORS	4-Nitrophenylphosphatase domain and non-neuronal SNAP25-like protein homolog 1 (NIPSNAP1) is a molecule of physiologically unknown function, although it is predominantly expressed in the brain, spinal cord, liver, and kidney. We identified NIPSNAP1 as a protein that interacts with the neuropeptide nocistatin (NST) from synaptosomal membranes of mouse spinal cord using high-performance affinity latex beads. NST, which is produced from the same precursor protein as an opioid-like neuropeptide nociceptin/orphanin FQ (N/OFQ), has opposite effects on pain transmission evoked by N/OFQ. The calculated full-length pre-protein of NIPSNAP1 was 33 kDa, whereas the N-terminal truncated form of NIPSNAP1 (29 kDa) was ubiquitously expressed in the neuronal tissues, especially in synaptic membrane and mitochondria of brain. The 29-kDa NIPSNAP1 was distributed on the cell surface, and NST interacted with the 29-kDa but not the 33-kDa NIPSNAP1. Although intrathecal injection of N/OFQ induced tactile allodynia in both wild-type and NIPSNAP1-deficient mice, the inhibition of N/OFQ-evoked tactile allodynia by NST seen in wild-type mice was completely lacking in the deficient mice. These results suggest that NIPSNAP1 is an interacting molecule of NST and plays a crucial role in pain transmission.	[Okuda-Ashitaka, Emiko] Osaka Inst Technol, Dept Biomed Engn, Asahi Ku, Osaka 5358585, Japan; [Okuda-Ashitaka, Emiko] Kansai Med Univ, Dept Med Chem, Moriguchi, Osaka 5708506, Japan; [Minami, Toshiaki] Osaka Med Coll, Dept Anesthesiol, Takatsuki, Osaka 5698686, Japan; [Tsubouchi, Shingo; Handa, Hiroshi] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Yokohama, Kanagawa 2268501, Japan; [Kiyonari, Hiroshi] RIKEN Ctr Dev Biol, Lab Anim Resources & Genet Engn, Kobe, Hyogo 6500047, Japan; [Iwamatsu, Akihiro] Prot Res Network, Yokohama, Kanagawa 2360004, Japan; [Noda, Tetsuo] Japanese Fdn Canc Res, Inst Canc, Dept Cell Biol, Tokyo 1358550, Japan	Osaka Institute of Technology; Kansai Medical University; Osaka Medical College; Tokyo Institute of Technology; RIKEN; Japanese Foundation for Cancer Research	Okuda-Ashitaka, E (corresponding author), Osaka Inst Technol, Dept Biomed Engn, Asahi Ku, 5-16-1 Omiya, Osaka 5358585, Japan.	ashitaka@bme.oit.ac.jp	Noda, Tetsuo/B-1667-2016; Kiyonari, Hiroshi/N-7936-2015		Japan Society for the Promotion of Science; Japan Science and Technology Agency	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	This work was supported in part by grants-in-aid for scientific research (S), (B), and (C) from the Japan Society for the Promotion of Science (to E. O.-A., T. M., and S. I.) and the Precursory Research for Embryonic Science and Technology (PRESTO) program from the Japan Science and Technology Agency (to E. O.-A.).	Ahmadi S, 2003, SCIENCE, V300, P2094, DOI 10.1126/science.1083970; Buechler C, 2004, GENOMICS, V83, P1116, DOI 10.1016/j.ygeno.2003.12.011; Chen YL, 2009, MOL CELL NEUROSCI, V40, P76, DOI 10.1016/j.mcn.2008.09.003; Dunah AW, 2001, J NEUROSCI, V21, P5546, DOI 10.1523/JNEUROSCI.21-15-05546.2001; Fantin M, 2007, BRIT J PHARMACOL, V152, P549, DOI 10.1038/sj.bjp.0707377; Gavioli EC, 2002, BRIT J PHARMACOL, V136, P764, DOI 10.1038/sj.bjp.0704739; Ge ZJ, 2007, NEUROSCI LETT, V413, P233, DOI 10.1016/j.neulet.2006.11.077; Hiramatsu M, 1999, EUR J PHARMACOL, V367, P151, DOI 10.1016/S0014-2999(99)00003-5; Inoue M, 2003, J PHARMACOL EXP THER, V306, P141, DOI 10.1124/jpet.103.049361; Ito S, 2000, Prog Brain Res, V129, P205; Kamei J, 2004, EUR J PHARMACOL, V489, P77, DOI 10.1016/j.ejphar.2003.12.020; Lee AH, 2002, CELL MICROBIOL, V4, P739, DOI 10.1046/j.1462-5822.2002.00225.x; Murata T, 2004, GENE EXPR PATTERNS, V5, P171, DOI 10.1016/j.modgep.2004.08.007; Nakagawa T, 1999, NEUROSCI LETT, V265, P64, DOI 10.1016/S0304-3940(99)00202-5; Nakano H, 2000, J PHARMACOL EXP THER, V292, P331; Nautiyal M, 2010, EUR J NEUROSCI, V32, P560, DOI 10.1111/j.1460-9568.2010.07326.x; Ohtsu Y, 2005, ANAL BIOCHEM, V338, P245, DOI 10.1016/j.ab.2004.10.006; Okuda-Ashitaka E, 1998, NATURE, V392, P286, DOI 10.1038/32660; Okuda-Ashitaka E, 2000, PEPTIDES, V21, P1101, DOI 10.1016/S0196-9781(00)00247-3; OkudaAshitaka E, 1996, MOL BRAIN RES, V43, P96, DOI 10.1016/S0169-328X(96)00165-9; Olszewski PK, 2000, BRAIN RES, V872, P181, DOI 10.1016/S0006-8993(00)02535-X; Satoh K, 2002, GENES CELLS, V7, P187, DOI 10.1046/j.1356-9597.2001.00505.x; Schoeber JPH, 2008, PFLUG ARCH EUR J PHY, V457, P91, DOI 10.1007/s00424-008-0494-5; Seroussi E, 1998, GENE, V212, P13, DOI 10.1016/S0378-1119(98)00098-5; Shimizu N, 2000, NAT BIOTECHNOL, V18, P877, DOI 10.1038/78496; Sun RQ, 2001, NEUROREPORT, V12, P1789, DOI 10.1097/00001756-200106130-00054; Surendran S, 2005, NEUROCHEM INT, V46, P595, DOI 10.1016/j.neuint.2005.02.010; Tummala H, 2010, EUR J NEUROSCI, V31, P1926, DOI 10.1111/j.1460-9568.2010.07248.x; UEDA T, 1979, J CELL BIOL, V83, P308, DOI 10.1083/jcb.83.2.308; Verhagen AM, 2007, CELL DEATH DIFFER, V14, P348, DOI 10.1038/sj.cdd.4402001; Wang XY, 1998, GENOMICS, V49, P448, DOI 10.1006/geno.1998.5239; YAGI T, 1993, ANAL BIOCHEM, V214, P70, DOI 10.1006/abio.1993.1458; Yamamoto T, 1999, NEUROSCI LETT, V262, P179, DOI 10.1016/S0304-3940(99)00073-7; Zeilhofer HU, 2000, J NEUROSCI, V20, P4922; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	35	20	20	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					10403	10413		10.1074/jbc.M111.271866	http://dx.doi.org/10.1074/jbc.M111.271866			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22311985	Green Published, hybrid			2022-12-25	WOS:000302167200067
J	Kode, A; Mosialou, I; Silva, BC; Joshi, S; Ferron, M; Rached, MT; Kousteni, S				Kode, Aruna; Mosialou, Ioanna; Silva, Barbara C.; Joshi, Sneha; Ferron, Mathieu; Rached, Marie Therese; Kousteni, Stavroula			FoxO1 Protein Cooperates with ATF4 Protein in Osteoblasts to Control Glucose Homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-RESISTANCE; SERUM OSTEOCALCIN; GENE-EXPRESSION; BETA-CELL; DIFFERENTIATION; CARBOXYLATION; METABOLISM; REGULATOR	The Forkhead transcription factor FoxO1 inhibits through its expression in osteoblasts beta-cell proliferation, insulin secretion, and sensitivity. At least part of the FoxO1 metabolic functions result from its ability to suppress the activity of osteocalcin, an osteoblast-derived hormone favoring glucose metabolism and energy expenditure. In searching for mechanisms mediating the metabolic actions of FoxO1, we focused on ATF4, because this transcription factor also affects glucose metabolism through its expression in osteoblasts. We show here that FoxO1 co-localizes with ATF4 in the osteoblast nucleus, and physically interacts with and promotes the transcriptional activity of ATF4. Genetic experiments demonstrate that FoxO1 and ATF4 cooperate to increase glucose levels and decrease glucose tolerance. These effects result from a synergistic effect of the two transcription factors to suppress the activity of osteocalcin through up-regulating expression of the phosphatase catalyzing osteocalcin inactivation. As a result, insulin production by beta-cells and insulin signaling in the muscle, liver and white adipose tissue are compromised and fat weight increases by the FoxO1/ATF4 interaction. Taken together these observations demonstrate that FoxO1 and ATF4 cooperate in osteoblasts to regulate glucose homeostasis.	[Kode, Aruna; Mosialou, Ioanna; Silva, Barbara C.; Joshi, Sneha; Rached, Marie Therese; Kousteni, Stavroula] Columbia Univ, Coll Phys & Surg, Dept Med, Div Endocrinol, New York, NY 10032 USA; [Ferron, Mathieu; Kousteni, Stavroula] Columbia Univ, Coll Phys & Surg, Dept Genet & Dev, New York, NY 10032 USA; [Kousteni, Stavroula] Columbia Univ, Coll Phys & Surg, Dept Physiol & Cellular Biophys, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University	Kousteni, S (corresponding author), Russ Berrie Med Sci Pavil,1150 St Nicholas Ave,Rm, New York, NY 10032 USA.	sk2836@columbia.edu	Ferron, Mathieu/M-7794-2013		NIDDK, National Institutes of Health [DK063608-07]; National Institutes of Health [R01-AR055931, 3-R01-AR055931-02S1, P01-AG032959]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR055931] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063608] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG032959] Funding Source: NIH RePORTER	NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We are grateful to Dr Timothy Townes for providing Atf4<SUP>+/-</SUP> mice. We are also thankful to Charles Duncan and Jayesh G. Shah for technical assistance. We are thankful to the histology and metabolic units facilities of the Diabetes and Endocrinology Research Center of Columbia University Medical Center (supported by NIDDK, National Institutes of Health Grant DK063608-07) for help with histological analysis.; This work was supported, in whole or in part, by National Institutes of Health Grants R01-AR055931, 3-R01-AR055931-02S1, and P01-AG032959.	Al-Masri M, 2010, DIABETOLOGIA, V53, P699, DOI 10.1007/s00125-009-1632-0; Armoni M, 2006, J BIOL CHEM, V281, P19881, DOI 10.1074/jbc.M600320200; Burgering BMT, 2003, J LEUKOCYTE BIOL, V73, P689, DOI 10.1189/jlb.1202629; Dacquin R, 2002, DEV DYNAM, V224, P245, DOI 10.1002/dvdy.10100; Ferron M, 2008, P NATL ACAD SCI USA, V105, P5266, DOI 10.1073/pnas.0711119105; Ferron M, 2010, CELL, V142, P296, DOI 10.1016/j.cell.2010.06.003; Ferron M, 2010, BIOCHEM BIOPH RES CO, V397, P691, DOI 10.1016/j.bbrc.2010.06.008; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Fulzele K, 2010, CELL, V142, P309, DOI 10.1016/j.cell.2010.06.002; Hwang Y. C., 2011, OSTEOPOROS IN PRESS; Kanazawa I, 2009, J CLIN ENDOCR METAB, V94, P45, DOI 10.1210/jc.2008-1455; Kindblom JM, 2009, J BONE MINER RES, V24, P785, DOI [10.1359/jbmr.081234, 10.1359/JBMR.081234]; Kitamura T, 2002, J CLIN INVEST, V110, P1839, DOI 10.1172/JCI200216857; Kitamura T, 2007, J CLIN INVEST, V117, P2477, DOI 10.1172/JCI32054; Lecka-Czernik B, 1999, J CELL BIOCHEM, V74, P357, DOI 10.1002/(SICI)1097-4644(19990901)74:3<357::AID-JCB5>3.0.CO;2-7; Lee NK, 2007, CELL, V130, P456, DOI 10.1016/j.cell.2007.05.047; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Pittas AG, 2009, J CLIN ENDOCR METAB, V94, P827, DOI 10.1210/jc.2008-1422; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Qiao LP, 2006, J BIOL CHEM, V281, P39915, DOI 10.1074/jbc.M607215200; Rached MT, 2010, CELL METAB, V11, P147, DOI 10.1016/j.cmet.2010.01.001; Rached MT, 2010, J CLIN INVEST, V120, P357, DOI 10.1172/JCI39901; Saleem U, 2010, ARTERIOSCL THROM VAS, V30, P1474, DOI 10.1161/ATVBAHA.110.204859; Shea MK, 2009, AM J CLIN NUTR, V90, P1230, DOI 10.3945/ajcn.2009.28151; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; Yang XG, 2004, CELL, V117, P387, DOI 10.1016/S0092-8674(04)00344-7; Yoshikawa Y, 2011, J BONE MINER RES, V26, P2012, DOI 10.1002/jbmr.417; Yoshizawa T, 2009, J CLIN INVEST, V119, P2807, DOI 10.1172/JCI39366	29	51	62	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					8757	8768		10.1074/jbc.M111.282897	http://dx.doi.org/10.1074/jbc.M111.282897			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22298775	hybrid, Green Published			2022-12-25	WOS:000301797800009
J	Han, Y; Lui, S; Kuang, WH; Lang, Q; Zou, L; Jia, JP				Han, Ying; Lui, Su; Kuang, Weihong; Lang, Qi; Zou, Ling; Jia, Jianping			Anatomical and Functional Deficits in Patients with Amnestic Mild Cognitive Impairment	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; LOW-FREQUENCY FLUCTUATION; MONKEY VISUAL-CORTEX; GRAY-MATTER LOSS; ALZHEIMERS-DISEASE; EPISODIC MEMORY; BRAIN ACTIVITY; ATROPHY; FMRI; HYPOMETABOLISM	Background Anatomical and functional deficits have been studied in patients with amnestic mild cognitive impairment (MCI). However, it is unclear whether and how the anatomical deficits are related to the functional alterations. Present study aims to characterize the association between anatomical and functional deficits in MCI patients. Methods: Seventeen amnestic MCI patients and 18 healthy aging controls were scanned using a T1 Weighted MPRAGE sequence and a gradient-echo echo-planar imaging sequence. Clinical severity of MCI patients was evaluated by using Clinical Dementia Rating, Mini Mental State Examination (MMSE), Clock Drawing Test, Auditory Verbal Learning Test and Activities of Daily Living. VBM with DARTEL was used to characterize the gray matter deficits in MCI. Regional amplitude of low-frequency (0.01-0.08 Hz) fluctuations (ALFF) was used to evaluate regional functional alteration in MCI and fractional ALFF(fALFF) in slow 4 (0.027-0.073 Hz) and slow 5 (0.01-0.027 Hz) were also calculated. Results: Significantly decreased gray matter volume (GMV) was observed in amnestic MCI group mainly in bilateral prefrontal, left temporal and posterior cingulate cortex. Significant positive correlation was observed between the GMV in left inferior frontal gyrus and MMSE scores. Interestingly, decreased ALFF/fALFF was revealed in MCI group compared to controls mainly in prefrontal, left parietal regions and right fusiform gyrus, while the increased ALFF/fALFF was found in limbic and midbrain. Furthermore, the changes of fALFF in MCI in the slow-5 band were greater than those in the slow-4. No significant correlation was found between the morphometric and functional results. Conclusions: Findings from the study document that wide spread brain volume reduction accompanied with decreased and increased regional function in MCI, while the anatomical and functional changes were independently. Therefore, the combination of structural and functional MRI methods would provide complementary information and together advance our understanding of the pathophysiology underlying the symptoms of MCI.	[Han, Ying; Jia, Jianping] Capital Med Univ, Xuanwu Hosp, Dept Neurol, Beijing, Peoples R China; [Lui, Su; Zou, Ling] Sichuan Univ, W China Hosp, Dept Radiol, Chengdu 610064, Peoples R China; [Kuang, Weihong] Sichuan Univ, W China Hosp, Dept Psychiat, Chengdu 610064, Peoples R China; [Lang, Qi] Sichuan Univ, W China Hosp, Dept Neurol, Chengdu 610064, Peoples R China	Capital Medical University; Sichuan University; Sichuan University; Sichuan University	Han, Y (corresponding author), Capital Med Univ, Xuanwu Hosp, Dept Neurol, Beijing, Peoples R China.	sophiehanying@gmail.com	Han, Ying/H-7111-2017; Lui, Su/S-9132-2019	Jia, Jianping/0000-0003-4624-0336	National Natural Science Foundation [30970823, 30830045, 30900361]; Distinguished Young Scholars of Sichuan [2011JQ0005]; Programs for New Century Excellent Talents in University [NCET-10-0596]; Research Fund for the Doctoral Program of Higher Education of China [20090181120103]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Distinguished Young Scholars of Sichuan; Programs for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This study was supported by National Natural Science Foundation (Grant Nos. 30970823, 30830045, 30900361), the Distinguished Young Scholars of Sichuan (Grant No. 2011JQ0005), the Programs for New Century Excellent Talents in University (Grant No. NCET-10-0596) and Research Fund for the Doctoral Program of Higher Education of China (Grant No. 20090181120103). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Baron JC, 2001, NEUROIMAGE, V14, P298, DOI 10.1006/nimg.2001.0848; Bell-McGinty S, 2005, ARCH NEUROL-CHICAGO, V62, P1393, DOI 10.1001/archneur.62.9.1393; Birn RM, 2006, NEUROIMAGE, V31, P1536, DOI 10.1016/j.neuroimage.2006.02.048; Borroni B, 2006, NEUROBIOL AGING, V27, P24, DOI 10.1016/j.neurobiolaging.2004.12.010; Bozzali M, 2006, NEUROLOGY, V67, P453, DOI 10.1212/01.wnl.0000228243.56665.c2; Callicott JH, 2003, AM J PSYCHIAT, V160, P2209, DOI 10.1176/appi.ajp.160.12.2209; Chetelat G, 2008, BRAIN, V131, P60, DOI 10.1093/brain/awm288; Chetelat G, 2003, BRAIN, V126, P1955, DOI 10.1093/brain/awg196; Cordes D, 2001, AM J NEURORADIOL, V22, P1326; Dickerson BC, 2004, ANN NEUROL, V56, P27, DOI 10.1002/ana.20163; Dickerson BC, 2005, NEUROLOGY, V65, P404, DOI 10.1212/01.wnl.0000171450.97464.49; Gili T, 2011, J NEUROL NEUROSUR PS, V82, P58, DOI 10.1136/jnnp.2009.199935; Goncalves SI, 2006, NEUROIMAGE, V30, P203, DOI 10.1016/j.neuroimage.2005.09.062; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Hamalainen A, 2007, NEUROBIOL AGING, V28, P1889, DOI 10.1016/j.neurobiolaging.2006.08.008; Han Y, 2011, NEUROIMAGE, V55, P287, DOI 10.1016/j.neuroimage.2010.11.059; Harrison BJ, 2008, P NATL ACAD SCI USA, V105, P9781, DOI 10.1073/pnas.0711791105; Ibanez V, 1998, NEUROLOGY, V50, P1585, DOI 10.1212/WNL.50.6.1585; Karas GB, 2004, NEUROIMAGE, V23, P708, DOI 10.1016/j.neuroimage.2004.07.006; Katura T, 2006, NEUROIMAGE, V31, P1592, DOI 10.1016/j.neuroimage.2006.02.010; Kinkingnehum S, 2008, NEUROLOGY, V70, P2201, DOI 10.1212/01.wnl.0000303960.01039.43; Klunk WE, 2004, ANN NEUROL, V55, P306, DOI 10.1002/ana.20009; Laufs H, 2003, P NATL ACAD SCI USA, V100, P11053, DOI 10.1073/pnas.1831638100; Leopold DA, 2003, CEREB CORTEX, V13, P422, DOI 10.1093/cercor/13.4.422; Lui S, 2008, J MAGN RESON IMAGING, V27, P1214, DOI 10.1002/jmri.21370; Lui S, 2009, P NATL ACAD SCI USA, V106, P15412, DOI 10.1073/pnas.0812751106; Lui S, 2009, PSYCHIAT RES-NEUROIM, V171, P71, DOI 10.1016/j.pscychresns.2008.02.004; Lui S, 2009, AM J PSYCHIAT, V166, P196, DOI 10.1176/appi.ajp.2008.08020183; Matsuda H, 2002, J NUCL MED, V43, P304; Mosconi L, 2008, J NUCL MED, V49, P390, DOI 10.2967/jnumed.107.045385; Mosconi L, 2007, J NUCL MED, V48, P1129, DOI 10.2967/jnumed.107.040675; Petersen RC, 2001, NEUROLOGY, V56, P1133, DOI 10.1212/WNL.56.9.1133; Petersen RC, 2001, ARCH NEUROL-CHICAGO, V58, P1985, DOI 10.1001/archneur.58.12.1985; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Petersen RC, 2009, ARCH NEUROL-CHICAGO, V66, P1447, DOI 10.1001/archneurol.2009.266; Petrella JR, 2011, NEUROLOGY, V76, P511, DOI 10.1212/WNL.0b013e31820af94e; Petrella JR, 2009, AM J NEURORADIOL, V30, P411, DOI 10.3174/ajnr.A1359; Pihlajamaki M, 2009, CURR ALZHEIMER RES, V6, P179, DOI 10.2174/156720509787602898; Price JL, 1999, ANN NEUROL, V45, P358, DOI 10.1002/1531-8249(199903)45:3<358::AID-ANA12>3.0.CO;2-X; Prince SE, 2005, J NEUROSCI, V25, P1203, DOI 10.1523/JNEUROSCI.2540-04.2005; Prince SE, 2007, PSYCHOL SCI, V18, P144, DOI 10.1111/j.1467-9280.2007.01864.x; Shmuel A, 2008, HUM BRAIN MAPP, V29, P751, DOI 10.1002/hbm.20580; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Sorg C, 2007, P NATL ACAD SCI USA, V104, P18760, DOI 10.1073/pnas.0708803104; Tisserand DJ, 2004, CEREB CORTEX, V14, P966, DOI 10.1093/cercor/bhh057; Villain N, 2008, J NEUROSCI, V28, P6174, DOI 10.1523/JNEUROSCI.1392-08.2008; Wagner AD, 2001, NEURON, V31, P329, DOI 10.1016/S0896-6273(01)00359-2; Yang H, 2007, NEUROIMAGE, V36, P144, DOI 10.1016/j.neuroimage.2007.01.054; Zang YF, 2004, NEUROIMAGE, V22, P394, DOI 10.1016/j.neuroimage.2003.12.030; Zang YF, 2007, BRAIN DEV-JPN, V29, P83, DOI 10.1016/j.braindev.2006.07.002; Zou QH, 2008, J NEUROSCI METH, V172, P137, DOI 10.1016/j.jneumeth.2008.04.012; Zuo XN, 2010, NEUROIMAGE, V49, P1432, DOI 10.1016/j.neuroimage.2009.09.037	54	77	83	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2012	7	2							e28664	10.1371/journal.pone.0028664	http://dx.doi.org/10.1371/journal.pone.0028664			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LO	22319555	gold, Green Submitted, Green Published			2022-12-25	WOS:000302178400001
J	Turki-Judeh, W; Courey, AJ				Turki-Judeh, Wiam; Courey, Albert J.			The Unconserved Groucho Central Region Is Essential for Viability and Modulates Target Gene Specificity	PLOS ONE			English	Article							DORSAL-MEDIATED REPRESSION; TRANSCRIPTIONAL REPRESSION; DROSOPHILA-EMBRYO; IN-VIVO; DEPENDENT REPRESSION; HISTONE DEACETYLASE; COREPRESSOR GROUCHO; SIGNALING PATHWAYS; CO-REPRESSORS; PROTEINS	Groucho (Gro) is a Drosophila corepressor required by numerous DNA-binding repressors, many of which are distributed in gradients and provide positional information during development. Gro contains well-conserved domains at its N- and C-termini, and a poorly conserved central region that includes the GP, CcN, and SP domains. All lethal point mutations in gro map to the conserved regions, leading to speculation that the unconserved central domains are dispensable. However, our sequence analysis suggests that the central domains are disordered leading us to suspect that the lack of lethal mutations in this region reflects a lack of order rather than an absence of essential functions. In support of this conclusion, genomic rescue experiments with Gro deletion variants demonstrate that the GP and CcN domains are required for viability. Misexpression assays using these same deletion variants show that the SP domain prevents unrestrained and promiscuous repression by Gro, while the GP and CcN domains are indispensable for repression. Deletion of the GP domain leads to loss of nuclear import, while deletion of the CcN domain leads to complete loss of repression. Changes in Gro activity levels reset the threshold concentrations at which graded repressors silence target gene expression. We conclude that co-regulators such as Gro are not simply permissive components of the repression machinery, but cooperate with graded DNA-binding factors in setting borders of gene expression. We suspect that disorder in the Gro central domains may provide the flexibility that allows this region to mediate multiple interactions required for repression.	[Turki-Judeh, Wiam] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Turki-Judeh, W (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 405 Hilgard Ave, Los Angeles, CA 90024 USA.	courey@chem.ucla.edu			NIH [GM44522, GM86122]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM086122] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by NIH grant GM44522 to AJC and by NIH National Research Service Award GM86122 to WTJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Shaar M, 1999, GENE DEV, V13, P935, DOI 10.1101/gad.13.8.935; Andrioli LP, 2004, DEV BIOL, V276, P541, DOI 10.1016/j.ydbio.2004.09.025; Apidianakis Y, 2001, DEVELOPMENT, V128, P4361; Brantjes H, 2001, NUCLEIC ACIDS RES, V29, P1410, DOI 10.1093/nar/29.7.1410; Burks PJ, 2009, BIOL CELL, V101, P301, DOI 10.1042/BC20080136; Buscarlet M, 2007, TRENDS CELL BIOL, V17, P353, DOI 10.1016/j.tcb.2007.07.002; Buscarlet M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008107; Cai Y, 2003, EMBO J, V22, P5522, DOI 10.1093/emboj/cdg536; Cavallo RA, 1998, NATURE, V395, P604, DOI 10.1038/26982; Chen GQ, 2000, GENE, V249, P1, DOI 10.1016/S0378-1119(00)00161-X; Chen GQ, 1998, MOL CELL BIOL, V18, P7259, DOI 10.1128/MCB.18.12.7259; Chen GQ, 1999, GENE DEV, V13, P2218, DOI 10.1101/gad.13.17.2218; Choi CY, 2005, J BIOL CHEM, V280, P21427, DOI 10.1074/jbc.M500496200; Cinnamon E, 2008, DEVELOPMENT, V135, P829, DOI 10.1242/dev.015206; Courey AJ, 2001, GENE DEV, V15, P2786; deCelis JF, 1997, DEVELOPMENT, V124, P1919; Dresch JM, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-142; Dubnicoff T, 1997, GENE DEV, V11, P2952, DOI 10.1101/gad.11.22.2952; Dunker AK, 2005, FEBS J, V272, P5129, DOI 10.1111/j.1742-4658.2005.04948.x; Fisher AL, 1996, MOL CELL BIOL, V16, P2670; Flores-Saaib RD, 2000, NUCLEIC ACIDS RES, V28, P4189, DOI 10.1093/nar/28.21.4189; Flores-Saaib RD, 2001, DEVELOPMENT, V128, P1869; Gasperowicz M, 2005, J CELL BIOCHEM, V95, P670, DOI 10.1002/jcb.20476; HARTENSTEIN V, 1990, DEV BIOL, V142, P13, DOI 10.1016/0012-1606(90)90147-B; Hasson P, 2006, BRIT J CANCER, V94, P771, DOI 10.1038/sj.bjc.6603019; Hasson P, 2005, NAT GENET, V37, P101, DOI 10.1038/ng1486; Hasson P, 2001, EMBO J, V20, P5725, DOI 10.1093/emboj/20.20.5725; HECHT A, 1995, CELL, V80, P583, DOI 10.1016/0092-8674(95)90512-X; Hong JW, 2008, P NATL ACAD SCI USA, V105, P20072, DOI 10.1073/pnas.0806476105; Jennings BH, 2008, EMBO REP, V9, P76, DOI 10.1038/sj.embor.7401122; Jennings BH, 2006, MOL CELL, V22, P645, DOI 10.1016/j.molcel.2006.04.024; Jimenez G, 1997, GENE DEV, V11, P3072, DOI 10.1101/gad.11.22.3072; Jimenez G, 2000, GENE DEV, V14, P224; Kaplan T, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001290; Kobayashi M, 2001, DEVELOPMENT, V128, P1805; Kosman D, 2004, SCIENCE, V305, P846, DOI 10.1126/science.1099247; Lee W, 2009, DEV BIOL, V325, P263, DOI 10.1016/j.ydbio.2008.10.029; Mann RS, 2009, CURR TOP DEV BIOL, V88, P63, DOI 10.1016/S0070-2153(09)88003-4; Mannervik M, 1999, P NATL ACAD SCI USA, V96, P6797, DOI 10.1073/pnas.96.12.6797; Martinez CA, 2008, MOL CELL BIOL, V28, P2792, DOI 10.1128/MCB.01203-07; Nie MH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005905; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; Nuthall HN, 2004, MOL CELL BIOL, V24, P8395, DOI 10.1128/MCB.24.19.8395-8407.2004; Nuthall HN, 2002, J BIOL CHEM, V277, P51049, DOI 10.1074/jbc.M111660200; Orian A, 2007, P NATL ACAD SCI USA, V104, P15771, DOI 10.1073/pnas.0707418104; Palaparti A, 1997, J BIOL CHEM, V272, P26604, DOI 10.1074/jbc.272.42.26604; Paroush Z, 1997, DEVELOPMENT, V124, P3827; PAROUSH Z, 1994, CELL, V79, P805, DOI 10.1016/0092-8674(94)90070-1; Payankaulam S, 2009, P NATL ACAD SCI USA, V106, P17314, DOI 10.1073/pnas.0904507106; Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537; Ratnaparkhi GS, 2006, DEVELOPMENT, V133, P4409, DOI 10.1242/dev.02643; Rorth P, 1998, MECH DEVELOP, V78, P113, DOI 10.1016/S0925-4773(98)00157-9; RUSCH J, 1994, GENE DEV, V8, P1247, DOI 10.1101/gad.8.11.1247; Sekiya T, 2007, MOL CELL, V28, P291, DOI 10.1016/j.molcel.2007.10.002; Song HY, 2004, MOL CELL BIOL, V24, P4341, DOI 10.1128/MCB.24.10.4341-4350.2004; STIFANI S, 1992, NAT GENET, V2, P119, DOI 10.1038/ng1092-119; Valentine SA, 1998, MOL CELL BIOL, V18, P6584, DOI 10.1128/MCB.18.11.6584; Venken KJT, 2006, SCIENCE, V314, P1747, DOI 10.1126/science.1134426; Winkler CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010166; Xue B, 2010, BBA-PROTEINS PROTEOM, V1804, P996, DOI 10.1016/j.bbapap.2010.01.011; Zhang HL, 2001, GENE DEV, V15, P261, DOI 10.1101/gad.861201	61	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2012	7	2							e30610	10.1371/journal.pone.0030610	http://dx.doi.org/10.1371/journal.pone.0030610			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LO	22319573	gold, Green Published, Green Submitted			2022-12-25	WOS:000302178400010
J	Hermans, RCJ; Lichtwarck-Aschoff, A; Bevelander, KE; Herman, CP; Larsen, JK; Engels, RCME				Hermans, Roel C. J.; Lichtwarck-Aschoff, Anna; Bevelander, Kirsten E.; Herman, C. Peter; Larsen, Junilla K.; Engels, Rutger C. M. E.			Mimicry of Food Intake: The Dynamic Interplay between Eating Companions	PLOS ONE			English	Article							PEER INFLUENCE; BEHAVIOR; PERCEPTION; CHILDREN; CUES	Numerous studies have shown that people adjust their intake directly to that of their eating companions; they eat more when others eat more, and less when others inhibit intake. A potential explanation for this modeling effect is that both eating companions' food intake becomes synchronized through processes of behavioral mimicry. No study, however, has tested whether behavioral mimicry can partially account for this modeling effect. To capture behavioral mimicry, real-time observations of dyads of young females having an evening meal were conducted. It was assessed whether mimicry depended on the time of the interaction and on the person who took the bite. A total of 70 young female dyads took part in the study, from which the total number of bites (N = 3,888) was used as unit of analyses. For each dyad, the total number of bites and the exact time at which each person took a bite were coded. Behavioral mimicry was operationalized as a bite taken within a fixed 5-second interval after the other person had taken a bite, whereas non-mimicked bites were defined as bites taken outside the 5-second interval. It was found that both women mimicked each other's eating behavior. They were more likely to take a bite of their meal in congruence with their eating companion rather than eating at their own pace. This behavioral mimicry was found to be more prominent at the beginning than at the end of the interaction. This study suggests that behavioral mimicry may partially account for social modeling of food intake.	[Hermans, Roel C. J.; Lichtwarck-Aschoff, Anna; Bevelander, Kirsten E.; Larsen, Junilla K.; Engels, Rutger C. M. E.] Radboud Univ Nijmegen, Dept Dev Psychopathol, Inst Behav Sci, NL-6525 ED Nijmegen, Netherlands; [Herman, C. Peter] Univ Toronto, Dept Psychol, Toronto, ON M5S 1A1, Canada	Radboud University Nijmegen; University of Toronto	Hermans, RCJ (corresponding author), Radboud Univ Nijmegen, Dept Dev Psychopathol, Inst Behav Sci, NL-6525 ED Nijmegen, Netherlands.	r.hermans@bsi.ru.nl	Hermans, Roel/D-5803-2012; Bevelander, Kirsten E/E-7878-2012	, Kirsten/0000-0003-1011-7862; Hermans, Roel/0000-0003-3560-8158; Engels, Rutger/0000-0003-1944-9126; Herman, C. Peter/0000-0001-5738-6803	Behavioural Science Institute of the Radboud University Nijmegen	Behavioural Science Institute of the Radboud University Nijmegen	The current study was financially supported by the Behavioural Science Institute of the Radboud University Nijmegen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birch LL, 1998, PEDIATRICS, V101, P539; Bot SM, 2005, ADDICTION, V100, P1270, DOI 10.1111/j.1360-0443.2005.01152.x; Brass M, 2001, ACTA PSYCHOL, V106, P3, DOI 10.1016/S0001-6918(00)00024-X; Chartrand TL, 2009, ADV EXP SOC PSYCHOL, V41, P219, DOI 10.1016/S0065-2601(08)00405-X; Chartrand TL, 1999, J PERS SOC PSYCHOL, V76, P893, DOI 10.1037/0022-3514.76.6.893; CONGER JC, 1980, J PERS, V48, P258, DOI 10.1111/j.1467-6494.1980.tb00832.x; DECASTRO JM, 1992, PHYSIOL BEHAV, V51, P121, DOI 10.1016/0031-9384(92)90212-K; Dijksterhuis A, 2001, ADV EXP SOC PSYCHOL, V33, P1, DOI 10.1016/S0065-2601(01)80003-4; Eccles JS, 1999, FUTURE CHILD, V9, P30, DOI 10.2307/1602703; GOLDMAN SJ, 1991, APPETITE, V17, P129, DOI 10.1016/0195-6663(91)90068-4; Herman CP, 2003, PSYCHOL BULL, V129, P873, DOI 10.1037/0033-2909.129.6.873; Herman CP, 2005, PHYSIOL BEHAV, V129, P873; Hermans RCJ, 2011, BRIT J NUTR IN PRESS; Hermans RCJ, 2008, APPETITE, V51, P512, DOI 10.1016/j.appet.2008.03.016; Hermans RCJ, 2009, APPETITE, V52, P801, DOI 10.1016/j.appet.2009.03.008; Iacoboni M, 1999, SCIENCE, V286, P2526, DOI 10.1126/science.286.5449.2526; Keenan T., 2009, INTRO CHILD DEV; Knoblich G, 2006, CURR DIR PSYCHOL SCI, V15, P99, DOI 10.1111/j.0963-7214.2006.00415.x; Koordeman R, 2011, ALCOHOL ALCOHOLISM, V46, P393, DOI 10.1093/alcalc/agr028; Laible D, 2007, HDB SOCIALIZATION TH; Lakin JL, 2003, J NONVERBAL BEHAV, V27, P145, DOI 10.1023/A:1025389814290; Lakin JL, 2003, PSYCHOL SCI, V14, P334, DOI 10.1111/1467-9280.14481; Larsen H, 2010, ADDICT BEHAV, V35, P49, DOI 10.1016/j.addbeh.2009.08.002; LEARY MR, 1994, J PERS SOC PSYCHOL, V67, P664, DOI 10.1037/0022-3514.67.4.664; Leone T, 2007, APPETITE, V49, P58, DOI 10.1016/j.appet.2006.11.005; Leone T, 2008, PERS SOC PSYCHOL B, V34, P1737, DOI 10.1177/0146167208325414; Lohman T.J., 1998, ANTHROPOMETRIC STAND; Muthen L.K., 2007, MPLUS STAT ANAL LATE; Patel KA, 2001, APPETITE, V36, P111, DOI 10.1006/appe.2000.0385; Pliner P, 2004, APPETITE, V42, P227, DOI 10.1016/j.appet.2003.12.001; ROCK BC, 1995, SEX ROLES, V33, P109; Roth DA, 2001, APPETITE, V36, P165, DOI 10.1006/appe.2000.0388; Salvy SJ, 2007, APPETITE, V49, P177, DOI 10.1016/j.appet.2007.01.011; Stel M, 2008, EUR J SOC PSYCHOL, V38, P965, DOI 10.1002/ejsp.472; van Baaren R, 2009, PHILOS T R SOC B, V364, P2381, DOI 10.1098/rstb.2009.0057; Vartanian LR, 2007, APPETITE, V48, P265, DOI 10.1016/j.appet.2006.10.008	36	59	60	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2012	7	2							e31027	10.1371/journal.pone.0031027	http://dx.doi.org/10.1371/journal.pone.0031027			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	914UG	22312438	gold, Green Published, Green Submitted			2022-12-25	WOS:000301977500026
J	Martel, G; Hevi, C; Wong, A; Zushida, K; Uchida, S; Shumyatsky, GP				Martel, Guillaume; Hevi, Charles; Wong, Alexandra; Zushida, Ko; Uchida, Shusaku; Shumyatsky, Gleb P.			Murine GRPR and Stathmin Control in Opposite Directions both Cued Fear Extinction and Neural Activities of the Amygdala and Prefrontal Cortex	PLOS ONE			English	Article							GLUTAMIC-ACID DECARBOXYLASE; CONDITIONED FEAR; BASOLATERAL AMYGDALA; DISSOCIABLE ROLES; NEURONAL CIRCUITS; MEMORY; EXPRESSION; MICE; ACTIVATION; BRAIN	Extinction is an integral part of normal healthy fear responses, while it is compromised in several fear-related mental conditions in humans, such as post-traumatic stress disorder (PTSD). Although much research has recently been focused on fear extinction, its molecular and cellular underpinnings are still unclear. The development of animal models for extinction will greatly enhance our approaches to studying its neural circuits and the mechanisms involved. Here, we describe two gene-knockout mouse lines, one with impaired and another with enhanced extinction of learned fear. These mutant mice are based on fear memory-related genes, stathmin and gastrin-releasing peptide receptor (GRPR). Remarkably, both mutant lines showed changes in fear extinction to the cue but not to the context. We performed indirect imaging of neuronal activity on the second day of cued extinction, using immediate-early gene c-Fos. GRPR knockout mice extinguished slower (impaired extinction) than wildtype mice, which was accompanied by an increase in c-Fos activity in the basolateral amygdala and a decrease in the prefrontal cortex. By contrast, stathmin knockout mice extinguished faster (enhanced extinction) and showed a decrease in c-Fos activity in the basolateral amygdala and an increase in the prefrontal cortex. At the same time, c-Fos activity in the dentate gyrus was increased in both mutant lines. These experiments provide genetic evidence that the balance between neuronal activities of the amygdala and prefrontal cortex defines an impairment or facilitation of extinction to the cue while the hippocampus is involved in the context-specificity of extinction.	[Martel, Guillaume; Hevi, Charles; Wong, Alexandra; Zushida, Ko; Uchida, Shusaku; Shumyatsky, Gleb P.] Rutgers State Univ, Dept Genet, Piscataway, NJ 08855 USA	Rutgers State University New Brunswick	Martel, G (corresponding author), Rutgers State Univ, Dept Genet, Piscataway, NJ 08855 USA.	gleb@biology.rutgers.edu		Uchida, Shusaku/0000-0002-1451-6222	National Science Foundation; National Institutes of Health [R01 MH080328]; Whitehall Foundation [2008-12-104]; New Jersey Governor's Council for Medical Research and Treatment of Autism, Special Child Health and Early Intervention Services, New Jersey Department of Health and Senior Services; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH080328] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Whitehall Foundation; New Jersey Governor's Council for Medical Research and Treatment of Autism, Special Child Health and Early Intervention Services, New Jersey Department of Health and Senior Services; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the National Science Foundation, National Institutes of Health (R01 MH080328), and Whitehall Foundation (#2008-12-104). Research funded in part by the New Jersey Governor's Council for Medical Research and Treatment of Autism, Special Child Health and Early Intervention Services, New Jersey Department of Health and Senior Services. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	AMAT JA, 1991, DEV BRAIN RES, V60, P205, DOI 10.1016/0165-3806(91)90049-O; Brocke B, 2010, AM J MED GENET B, V153B, P243, DOI 10.1002/ajmg.b.30989; Ehrlich I, 2009, NEURON, V62, P757, DOI 10.1016/j.neuron.2009.05.026; Frielingsdorf H, 2010, ANN NY ACAD SCI, V1208, P150, DOI 10.1111/j.1749-6632.2010.05722.x; Han JH, 2008, LEARN MEMORY, V15, P443, DOI 10.1101/lm.993608; Herry C, 2008, NATURE, V454, P600, DOI 10.1038/nature07166; Herry C, 2006, EUR J NEUROSCI, V24, P261, DOI 10.1111/j.1460-9568.2006.04893.x; Herry C, 2010, EUR J NEUROSCI, V31, P599, DOI 10.1111/j.1460-9568.2010.07101.x; Kamichi S, 2005, BRAIN RES, V1032, P162, DOI 10.1016/j.brainres.2004.10.068; Kash SF, 1999, P NATL ACAD SCI USA, V96, P1698, DOI 10.1073/pnas.96.4.1698; Knapska E, 2009, LEARN MEMORY, V16, P486, DOI 10.1101/lm.1463909; Lattal KM, 2008, BEHAV NEUROSCI, V122, P1186, DOI 10.1037/a0012993; Lee K, 1999, J PHYSIOL-LONDON, V518, P791, DOI 10.1111/j.1469-7793.1999.0791p.x; Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535; Maren S, 2011, NEURON, V70, P830, DOI 10.1016/j.neuron.2011.04.023; Martel G, 2008, P NATL ACAD SCI USA, V105, P14620, DOI 10.1073/pnas.0807507105; Myers KM, 2007, MOL PSYCHIATR, V12, P120, DOI 10.1038/sj.mp.4001939; Pape HC, 2010, PHYSIOL REV, V90, P419, DOI 10.1152/physrev.00037.2009; Paxinos G, 2001, MOUSE BRAIN STEREOTA, pxxv; Plendl W, 2010, J NEUROSCI, V30, P4990, DOI 10.1523/JNEUROSCI.6038-09.2010; Sangha S, 2009, J NEUROSCI, V29, P15713, DOI 10.1523/JNEUROSCI.2620-09.2009; Shumyatsky GP, 2005, CELL, V123, P697, DOI 10.1016/j.cell.2005.08.038; Shumyatsky GP, 2002, CELL, V111, P905, DOI 10.1016/S0092-8674(02)01116-9; Sierra-Mercado D, 2011, NEUROPSYCHOPHARMACOL, V36, P529, DOI 10.1038/npp.2010.184; Stork O, 2003, GENES BRAIN BEHAV, V2, P65, DOI 10.1034/j.1601-183X.2003.00008.x; Stork O, 2000, BRAIN RES, V865, P45, DOI 10.1016/S0006-8993(00)02206-X; Thompson BM, 2010, LEARN MEMORY, V17, P591, DOI 10.1101/lm.1920810; Uchida S, 2011, NEURON, V69, P359, DOI 10.1016/j.neuron.2010.12.023; Uchida S, 2011, P NATL ACAD SCI USA, V108, P1681, DOI 10.1073/pnas.1016424108; Uchida S, 2010, J NEUROSCI, V30, P15007, DOI 10.1523/JNEUROSCI.1436-10.2010; Yee BK, 2004, EUR J NEUROSCI, V20, P1928, DOI 10.1111/j.1460-9568.2004.03642.x	31	26	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2012	7	2							e30942	10.1371/journal.pone.0030942	http://dx.doi.org/10.1371/journal.pone.0030942			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UG	22312434	Green Submitted, gold, Green Published			2022-12-25	WOS:000301977500022
J	Pavillon, N; Kuhn, J; Moratal, C; Jourdain, P; Depeursinge, C; Magistretti, PJ; Marquet, P				Pavillon, Nicolas; Kuehn, Jonas; Moratal, Corinne; Jourdain, Pascal; Depeursinge, Christian; Magistretti, Pierre J.; Marquet, Pierre			Early Cell Death Detection with Digital Holographic Microscopy	PLOS ONE			English	Article							PHASE-CONTRAST MICROSCOPY; IONIC HOMEOSTASIS; LIVING CELLS; APOPTOSIS; VIABILITY; IDENTIFICATION; VISUALIZATION; COMPENSATION; RECOGNITION; RECEPTORS	Background: Digital holography provides a non-invasive measurement of the quantitative phase shifts induced by cells in culture, which can be related to cell volume changes. It has been shown previously that regulation of cell volume, in particular as it relates to ionic homeostasis, is crucially involved in the activation/inactivation of the cell death processes. We thus present here an application of digital holographic microscopy (DHM) dedicated to early and label-free detection of cell death. Methods and Findings: We provide quantitative measurements of phase signal obtained on mouse cortical neurons, and caused by early neuronal cell volume regulation triggered by excitotoxic concentrations of L-glutamate. We show that the efficiency of this early regulation of cell volume detected by DHM, is correlated with the occurrence of subsequent neuronal death assessed with the widely accepted trypan blue method for detection of cell viability. Conclusions: The determination of the phase signal by DHM provides a simple and rapid optical method for the early detection of cell death.	[Pavillon, Nicolas; Kuehn, Jonas; Depeursinge, Christian] Ecole Polytech Fed Lausanne, STI, Microvis & Microdiagnost Grp MVD, CH-1015 Lausanne, Switzerland; [Kuehn, Jonas; Magistretti, Pierre J.; Marquet, Pierre] Ctr Neurosci Psychiat, Dept Psychiat CHUV, Prilly, Switzerland; [Moratal, Corinne; Jourdain, Pascal; Magistretti, Pierre J.; Marquet, Pierre] Ecole Polytech Fed Lausanne, Brain Mind Inst, CH-1015 Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Pavillon, N (corresponding author), Ecole Polytech Fed Lausanne, STI, Microvis & Microdiagnost Grp MVD, CH-1015 Lausanne, Switzerland.	nicolas.pavillon@a3.epfl.ch	Kühn, Jonas G/H-2338-2011; Pavillon, Nicolas/ABF-6913-2020	Kühn, Jonas G/0000-0002-6344-4835; Pavillon, Nicolas/0000-0003-2606-2675; Magistretti, Pierre Julius/0000-0002-6678-320X	Swiss National Science Foundation (SNSF) [205320-130543, CR32I3-132993]; Commission for Technology and Innovation (CTI/KTI) [9389.1]	Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); Commission for Technology and Innovation (CTI/KTI)	This research was supported by the Swiss National Science Foundation (SNSF, http://www.snf.ch/E/Pages/default.aspx) grant #205320-130543 and #CR32I3-132993 and by the Commission for Technology and Innovation (CTI/KTI) (http://www.kti.admin.ch/index.html?lang=en) project #9389.1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN SA, 1993, BIOTECHNOL PROGR, V9, P671, DOI 10.1021/bp00024a017; ANKARCRONA M, 1995, NEURON, V15, P961, DOI 10.1016/0896-6273(95)90186-8; BANK HL, 1987, DIABETOLOGIA, V30, P812; Bortner CD, 2004, PFLUG ARCH EUR J PHY, V448, P313, DOI 10.1007/s00424-004-1266-5; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Carl D, 2004, APPL OPTICS, V43, P6536, DOI 10.1364/AO.43.006536; Chen MJ, 2008, CURR NEUROPHARMACOL, V6, P102, DOI 10.2174/157015908784533879; CHOI DW, 1994, PROG BRAIN RES, V100, P47; Colomb T, 2006, APPL OPTICS, V45, P851, DOI 10.1364/AO.45.000851; Crha I, 2011, J ASSIST REPROD GEN, V28, P725, DOI 10.1007/s10815-011-9584-y; Cuche E, 1999, APPL OPTICS, V38, P6994, DOI 10.1364/AO.38.006994; Duprez L, 2009, MICROBES INFECT, V11, P1050, DOI 10.1016/j.micinf.2009.08.013; Hoffmann EK, 2009, PHYSIOL REV, V89, P193, DOI 10.1152/physrev.00037.2007; Hudson L, 1980, PRACTICAL IMMUNOLOGY, P29; Javidi B, 2005, OPT EXPRESS, V13, P4492, DOI 10.1364/OPEX.13.004492; JONES KH, 1985, J HISTOCHEM CYTOCHEM, V33, P77, DOI 10.1177/33.1.2578146; Jourdain P, 2011, J NEUROSCI, V31, P11846, DOI 10.1523/JNEUROSCI.0286-11.2011; Kemmler M, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2804926; Kemper B, 2008, APPL OPTICS, V47, pA52, DOI 10.1364/AO.47.000A52; KORZENIEWSKI C, 1983, J IMMUNOL METHODS, V64, P313, DOI 10.1016/0022-1759(83)90438-6; Krysko DV, 2008, METHODS, V44, P205, DOI 10.1016/j.ymeth.2007.12.001; Langehanenberg P, 2008, APPL OPTICS, V47, pD176, DOI 10.1364/AO.47.00D176; Lecoeur H, 2002, EXP CELL RES, V277, P1, DOI 10.1006/excr.2002.5537; Liu R, 2011, J OPT SOC AM A, V28, P1204, DOI 10.1364/JOSAA.28.001204; Marquet P, 2005, OPT LETT, V30, P468, DOI 10.1364/OL.30.000468; Montfort F, 2006, J OPT SOC AM A, V23, P2944, DOI 10.1364/JOSAA.23.002944; Moon I, 2008, IEEE T MED IMAGING, V27, P1782, DOI 10.1109/TMI.2008.927339; Moon I, 2009, P IEEE, V97, P990, DOI 10.1109/JPROC.2009.2017563; Pache C, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3377960; Pavillon N, 2010, J BIOPHOTONICS, V3, P432, DOI 10.1002/jbio.201000018; Rappaz B, 2005, OPT EXPRESS, V13, P9361, DOI 10.1364/OPEX.13.009361; Schubert D, 2001, J NEUROSCI, V21, P7455, DOI 10.1523/JNEUROSCI.21-19-07455.2001; Stout AK, 1998, NAT NEUROSCI, V1, P366, DOI 10.1038/1577; Strober W, CURRENT PROTOCOLS IM, pA3B1; Wolbers F, 2004, APOPTOSIS, V9, P749, DOI 10.1023/B:APPT.0000045794.03359.c3; Yuan J, 2003, NEURON, V40, P401, DOI 10.1016/S0896-6273(03)00601-9; Zamai L, 1996, CYTOMETRY, V23, P303, DOI 10.1002/(SICI)1097-0320(19960401)23:4<303::AID-CYTO6>3.3.CO;2-B; Zamzami N, 1997, J BIOENERG BIOMEMBR, V29, P185, DOI 10.1023/A:1022694131572	38	144	147	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2012	7	1							e30912	10.1371/journal.pone.0030912	http://dx.doi.org/10.1371/journal.pone.0030912			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	912BY	22303471	Green Published, gold, Green Submitted			2022-12-25	WOS:000301770700009
J	An, CF; Mou, ZL				An, Chuanfu; Mou, Zhonglin			Non-Host Defense Response in a Novel Arabidopsis-Xanthomonas citri subsp citri Pathosystem	PLOS ONE			English	Article							PSEUDOMONAS-SYRINGAE; SALICYLIC-ACID; DISEASE RESISTANCE; POWDERY MILDEW; ACQUIRED-RESISTANCE; SIGNALING PATHWAYS; BASAL RESISTANCE; CALLOSE SYNTHASE; OXIDATIVE BURST; INNATE IMMUNITY	Citrus canker, caused by Xanthomonas citri subsp. citri (Xcc), is one of the most destructive diseases of citrus. Progress of breeding citrus canker-resistant varieties is modest due to limited resistant germplasm resources and lack of candidate genes for genetic manipulation. The objective of this study is to establish a novel heterologous pathosystem between Xcc and the well-established model plant Arabidopsis thaliana for defense mechanism dissection and resistance gene identification. Our results indicate that Xcc bacteria neither grow nor decline in Arabidopsis, but induce multiple defense responses including callose deposition, reactive oxygen species and salicylic aicd (SA) production, and defense gene expression, indicating that Xcc activates non-host resistance in Arabidopsis. Moreover, Xcc-induced defense gene expression is suppressed or attenuated in several well-characterized SA signaling mutants including eds1, pad4, eds5, sid2, and npr1. Interestingly, resistance to Xcc is compromised only in eds1, pad4, and eds5, but not in sid2 and npr1. However, combining sid2 and npr1 in the sid2npr1 double mutant compromises resistance to Xcc, suggesting genetic interactions likely exist between SID2 and NPR1 in the non-host resistance against Xcc in Arabidopsis. These results demonstrate that the SA signaling pathway plays a critical role in regulating non-host defense against Xcc in Arabidopsis and suggest that the SA signaling pathway genes may hold great potential for breeding citrus canker-resistant varieties through modern gene transfer technology.	[An, Chuanfu; Mou, Zhonglin] Univ Florida, Dept Microbiol & Cell Sci, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	An, CF (corresponding author), Univ Florida, Dept Microbiol & Cell Sci, Gainesville, FL 32611 USA.	zhlmou@ufl.edu			National Science Foundation [IOS-0842716]; United States Department of Agriculture National Institute of Food and Agriculture; Citrus Research and Development Foundation	National Science Foundation(National Science Foundation (NSF)); United States Department of Agriculture National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); Citrus Research and Development Foundation	This work was supported by a grant from the National Science Foundation (IOS-0842716), a special grant from United States Department of Agriculture National Institute of Food and Agriculture, and a grant from the Citrus Research and Development Foundation awarded to ZM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts N, 1998, P NATL ACAD SCI USA, V95, P10306, DOI 10.1073/pnas.95.17.10306; Adam L, 1996, PLANT J, V9, P341, DOI 10.1046/j.1365-313X.1996.09030341.x; Adams-Phillips L, 2010, PLANT PHYSIOL, V152, P267, DOI 10.1104/pp.109.148049; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Azevedo C, 2006, EMBO J, V25, P2007, DOI 10.1038/sj.emboj.7601084; Bindschedler LV, 2006, PLANT J, V47, P851, DOI 10.1111/j.1365-313X.2006.02837.x; Cao H, 1997, CELL, V88, P57, DOI 10.1016/S0092-8674(00)81858-9; CAO H, 1994, PLANT CELL, V6, P1583, DOI 10.1105/tpc.6.11.1583; Century KS, 1997, SCIENCE, V278, P1963, DOI 10.1126/science.278.5345.1963; Clarke JD, 1998, PLANT CELL, V10, P557, DOI 10.1105/tpc.10.4.557; Coemans B, 2008, MOL PLANT PATHOL, V9, P25, DOI [10.1111/J.1364-3703.2007.00440.X, 10.1111/j.1364-3703.2007.00440.x]; Collins NC, 2003, NATURE, V425, P973, DOI 10.1038/nature02076; da Silva ACR, 2002, NATURE, V417, P459, DOI 10.1038/417459a; DeFraia CT, 2010, PLANT J, V64, P511, DOI 10.1111/j.1365-313X.2010.04345.x; Fan J, 2011, SCIENCE, V331, P1185, DOI 10.1126/science.1199707; Feechan A, 2005, P NATL ACAD SCI USA, V102, P8054, DOI 10.1073/pnas.0501456102; Felix G, 2003, J BIOL CHEM, V278, P6201, DOI 10.1074/jbc.M209880200; Fliegmann J, 2004, J BIOL CHEM, V279, P1132, DOI 10.1074/jbc.M308552200; Gentile A, 2007, PLANT BREEDING, V126, P146, DOI 10.1111/j.1439-0523.2007.01297.x; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Gomez-Gomez L, 2002, TRENDS PLANT SCI, V7, P251, DOI 10.1016/S1360-1385(02)02261-6; GOTTWALD TR, 1993, PLANT DIS, V77, P1004, DOI 10.1094/PD-77-1004; Graham JH, 2004, PLANT DIS, V88, P745, DOI 10.1094/PDIS.2004.88.7.745; Grant JJ, 2000, PLANT J, V24, P569, DOI 10.1046/j.1365-313x.2000.00902.x; GUZMAN P, 1990, PLANT CELL, V2, P513, DOI 10.1105/tpc.2.6.513; Ham JH, 2007, PLANT J, V51, P604, DOI 10.1111/j.1365-313X.2007.03165.x; Hao PY, 2008, PLANT PHYSIOL, V146, P1810, DOI 10.1104/pp.107.111484; Hardham AR, 2007, CURR OPIN PLANT BIOL, V10, P342, DOI 10.1016/j.pbi.2007.05.001; Hauck P, 2003, P NATL ACAD SCI USA, V100, P8577, DOI 10.1073/pnas.1431173100; Heath MC, 2000, CURR OPIN PLANT BIOL, V3, P315, DOI 10.1016/S1369-5266(00)00087-X; Heath MC, 2001, PHYSIOL MOL PLANT P, V58, P53, DOI 10.1006/pmpp.2001.0319; Hiruma K, 2011, PLANT J, V67, P980, DOI 10.1111/j.1365-313X.2011.04651.x; Hiruma K, 2010, PLANT CELL, V22, P2429, DOI 10.1105/tpc.110.074344; Holub EB, 2004, TRENDS PLANT SCI, V9, P211, DOI 10.1016/j.tplants.2004.03.002; Huckelhoven R, 2003, PLANTA, V216, P891, DOI 10.1007/s00425-003-0973-z; Huitema E, 2003, MOL PLANT PATHOL, V4, P487, DOI [10.1046/j.1364-3703.2003.00195.x, 10.1046/J.1364-3703.2003.00195.X]; Jacobs AK, 2003, PLANT CELL, V15, P2503, DOI 10.1105/tpc.016097; Jirage D, 1999, P NATL ACAD SCI USA, V96, P13583, DOI 10.1073/pnas.96.23.13583; Kadota Y, 2010, TRENDS BIOCHEM SCI, V35, P199, DOI 10.1016/j.tibs.2009.12.005; Kamoun S, 2001, CURR OPIN PLANT BIOL, V4, P295, DOI 10.1016/S1369-5266(00)00176-X; Kang L, 2003, P NATL ACAD SCI USA, V100, P3519, DOI 10.1073/pnas.0637377100; Kanzaki H, 2003, MOL PLANT PATHOL, V4, P383, DOI [10.1046/j.1364-3703.2003.00186.x, 10.1046/J.1364-3703.2003.00186.X]; Katagiri Fumiaki, 2002, Arabidopsis Book, V1, pe0039, DOI 10.1199/tab.0039; Knoester M, 1998, P NATL ACAD SCI USA, V95, P1933, DOI 10.1073/pnas.95.4.1933; Kwon C, 2008, NATURE, V451, P835, DOI 10.1038/nature06545; Li XY, 2005, P NATL ACAD SCI USA, V102, P12990, DOI 10.1073/pnas.0502425102; Lipka V, 2005, SCIENCE, V310, P1180, DOI 10.1126/science.1119409; Loehrer M, 2008, MOL PLANT MICROBE IN, V21, P1421, DOI 10.1094/MPMI-21-11-1421; Lu M, 2001, PLANT CELL, V13, P437, DOI 10.1105/tpc.13.2.437; MATSUMURA K, 1995, PHYTOPATHOLOGY, V85, P753, DOI 10.1094/Phyto-85-753; MEHDY MC, 1994, PLANT PHYSIOL, V105, P467, DOI 10.1104/pp.105.2.467; Mellersh DG, 2003, MOL PLANT MICROBE IN, V16, P398, DOI 10.1094/MPMI.2003.16.5.398; Mishina TE, 2007, PHYSIOL PLANTARUM, V131, P448, DOI 10.1111/j.1399-3054.2007.00977.x; Mysore KS, 2004, TRENDS PLANT SCI, V9, P97, DOI 10.1016/j.tplants.2003.12.005; Narusaka Y, 2005, MOL PLANT PATHOL, V6, P615, DOI 10.1111/J.1364-3703.2005.00310.X; Navarro L, 2004, PLANT PHYSIOL, V135, P1113, DOI 10.1104/pp.103.036749; Nawrath C, 2002, PLANT CELL, V14, P275, DOI 10.1105/tpc.010376; NIKS RE, 1988, EUPHYTICA, V37, P89, DOI 10.1007/BF00037229; Nimchuk Z, 2003, ANNU REV GENET, V37, P579, DOI 10.1146/annurev.genet.37.110801.142628; Nishimura MT, 2003, SCIENCE, V301, P969, DOI 10.1126/science.1086716; Noel LD, 2007, PLANT CELL, V19, P4061, DOI 10.1105/tpc.107.051896; Nurnberger T, 2005, MOL PLANT PATHOL, V6, P335, DOI 10.1111/j.1364-3703.2005.00279.x; Nurnberger T, 2004, IMMUNOL REV, V198, P249, DOI 10.1111/j.0105-2896.2004.0119.x; Peart JR, 2002, P NATL ACAD SCI USA, V99, P10865, DOI 10.1073/pnas.152330599; Sanchez-Vallet A, 2010, PLANT J, V63, P115, DOI 10.1111/j.1365-313X.2010.04224.x; Senthil-Kumar M, 2010, PLANT SIGNAL BEHAV, V5, P586, DOI 10.4161/psb.11497; Shibata Y, 2011, PHYSIOL MOL PLANT P, V75, P120, DOI 10.1016/j.pmpp.2010.10.001; Shimizu R, 2003, MOL GENET GENOMICS, V269, P21, DOI 10.1007/s00438-003-0817-3; Shirasu K, 2009, ANNU REV PLANT BIOL, V60, P139, DOI 10.1146/annurev.arplant.59.032607.092906; Soylu S, 2005, PHYSIOL MOL PLANT P, V66, P232, DOI 10.1016/j.pmpp.2005.08.005; Staswick PE, 2002, PLANT CELL, V14, P1405, DOI 10.1105/tpc.000885; Stein M, 2006, PLANT CELL, V18, P731, DOI 10.1105/tpc.105.038372; Sun XL, 2011, NEW PHYTOL, V192, P471, DOI 10.1111/j.1469-8137.2011.03820.x; Tao Y, 2003, PLANT CELL, V15, P317, DOI 10.1105/tpc.007591; Thomma BPHJ, 1998, P NATL ACAD SCI USA, V95, P15107, DOI 10.1073/pnas.95.25.15107; Thomma BPHJ, 1999, PLANT J, V19, P163, DOI 10.1046/j.1365-313X.1999.00513.x; Thordal-Christensen H, 2003, CURR OPIN PLANT BIOL, V6, P351, DOI 10.1016/S1369-5266(03)00063-3; Torres MA, 2005, NAT GENET, V37, P1130, DOI 10.1038/ng1639; Truman W, 2006, PLANT J, V46, P14, DOI 10.1111/j.1365-313X.2006.02672.x; UKNES S, 1992, PLANT CELL, V4, P645, DOI 10.1105/tpc.4.6.645; van Baarlen P, 2007, MOL PLANT PATHOL, V8, P41, DOI 10.1111/j.1364-3703.2006.00367.x; van Wees SCM, 2003, PLANT J, V33, P733, DOI 10.1046/j.1365-313X.2003.01665.x; Verberne MC, 2002, PHYTOCHEM ANALYSIS, V13, P45, DOI 10.1002/pca.615; Viloria Z, 2004, PLANT DIS, V88, P1056, DOI 10.1094/PDIS.2004.88.10.1056; Volko SM, 1998, GENETICS, V149, P537; Wan AM, 2004, PLANT DIS, V88, P896, DOI 10.1094/PDIS.2004.88.8.896; Weigel D, 2002, ARABIDOPSIS LAB MANU, P85; Wen YQ, 2011, J EXP BOT, V62, P2117, DOI 10.1093/jxb/erq406; Wildermuth MC, 2001, NATURE, V414, P562, DOI 10.1038/35107108; Yun BW, 2003, PLANT J, V34, P768, DOI 10.1046/j.1365-313X.2003.01773.x; Zhang J, 2010, MOL PLANT MICROBE IN, V23, P940, DOI 10.1094/MPMI-23-7-0940; Zhang XD, 2010, EUR J PLANT PATHOL, V128, P91, DOI 10.1007/s10658-010-9633-x; Zhao BY, 2005, P NATL ACAD SCI USA, V102, P15383, DOI 10.1073/pnas.0503023102; Zhou N, 1999, PLANT CELL, V11, P2419, DOI 10.1105/tpc.11.12.2419; Zipfel C, 2006, CELL, V125, P749, DOI 10.1016/j.cell.2006.03.037; Zurbriggen MD, 2009, PLANT J, V60, P962, DOI 10.1111/j.1365-313X.2009.04010.x	97	23	24	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2012	7	1							e31130	10.1371/journal.pone.0031130	http://dx.doi.org/10.1371/journal.pone.0031130			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911GB	22299054	Green Published, gold, Green Submitted			2022-12-25	WOS:000301704200063
J	Ozaki, DA; Gao, HM; Todd, CA; Greene, KM; Montefiori, DC; Sarzotti-Kelsoe, M				Ozaki, Daniel A.; Gao, Hongmei; Todd, Christopher A.; Greene, Kelli M.; Montefiori, David C.; Sarzotti-Kelsoe, Marcella			International Technology Transfer of a GCLP-Compliant HIV-1 Neutralizing Antibody Assay for Human Clinical Trials	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; INFECTIONS	The Collaboration for AIDS Vaccine Discovery/Comprehensive Antibody - Vaccine Immune Monitoring Consortium (CAVD/CA-VIMC) assisted an international network of laboratories in transferring a validated assay used to judge HIV-1 vaccine immunogenicity in compliance with Good Clinical Laboratory Practice (GCLP) with the goal of adding quality to the conduct of endpoint assays for Human Immunodeficiency Virus I (HIV-1) vaccine human clinical trials. Eight Regional Laboratories in the international setting (Regional Laboratories), many located in regions where the HIV-1 epidemic is most prominent, were selected to implement the standardized, GCLP-compliant Neutralizing Antibody Assay for HIV-1 in TZM-bl Cells (TZM-bl NAb Assay). Each laboratory was required to undergo initial training and implementation of the immunologic assay on-site and then perform partial assay re-validation, competency testing, and undergo formal external audits for GCLP compliance. Furthermore, using a newly established external proficiency testing program for the TZM-bl NAb Assay has allowed the Regional Laboratories to assess the comparability of assay results at their site with the results of neutralizing antibody assays performed around the world. As a result, several of the CAVD/CA-VIMC Regional Laboratories are now in the process of conducting or planning to conduct the GCLP-compliant TZM-bl NAb Assay as an indicator of vaccine immunogenicity for ongoing human clinical trials.	[Ozaki, Daniel A.; Gao, Hongmei; Todd, Christopher A.; Greene, Kelli M.; Montefiori, David C.; Sarzotti-Kelsoe, Marcella] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; [Sarzotti-Kelsoe, Marcella] Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA	Duke University; Duke University	Ozaki, DA (corresponding author), Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA.	marcella.sarzottikelsoe@duke.edu			Bill & Melinda Gates Foundation's Collaboration for AIDS Vaccine Discovery/Comprehensive Antibody - Vaccine Immune Monitoring Consortium [38619]	Bill & Melinda Gates Foundation's Collaboration for AIDS Vaccine Discovery/Comprehensive Antibody - Vaccine Immune Monitoring Consortium	This study was supported by the Bill & Melinda Gates Foundation's Collaboration for AIDS Vaccine Discovery/Comprehensive Antibody - Vaccine Immune Monitoring Consortium, grant number 38619. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, NAT MED, V16, P981; [Anonymous], 2005, ICH TRIP GUID VAL AN, P1; Ezzelle J, 2008, J PHARMACEUT BIOMED, V46, P18, DOI 10.1016/j.jpba.2007.10.010; Fenyo EM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004505; Gilmour JW, 2007, CURR OPIN HIV AIDS, V2, P201, DOI 10.1097/COH.0b013e3280eec77a; Gotch F, 2007, NAT IMMUNOL, V8, P1273, DOI 10.1038/ni1531; Huang Y, 2009, STAT DESIGN ANAL CAV; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Montefiori D, 2007, PLOS MED, V4, P1867, DOI 10.1371/journal.pmed.0040348; Montefiori DC., 2005, CURR PROTOC IMMUNOL, VChapter 12:12.11.11-12.11.15, DOI [10.1002/0471142735.im1211s64, DOI 10.1002/0471142735.IM1211S64]; Piehler B, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-33; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; Sarzotti-Kelsoe M, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000067; Stevens W, 2003, Qual Assur, V10, P83; Stiles T, 2003, GOOD CLIN LAB PRACTI; Todd CA, 2011, J IMMUNOL METHODS; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; 2005, PLOS MED, V2, pE25	18	28	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2012	7	1							e30963	10.1371/journal.pone.0030963	http://dx.doi.org/10.1371/journal.pone.0030963			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911GB	22303476	Green Published, Green Submitted, gold			2022-12-25	WOS:000301704200050
J	Polania, R; Paulus, W; Nitsche, MA				Polania, Rafael; Paulus, Walter; Nitsche, Michael A.			Reorganizing the Intrinsic Functional Architecture of the Human Primary Motor Cortex during Rest with Non-Invasive Cortical Stimulation	PLOS ONE			English	Article							PAIRED ASSOCIATIVE STIMULATION; COMPLEX BRAIN NETWORKS; TRANSCRANIAL DIRECT; DC-STIMULATION; SMALL-WORLD; EXCITABILITY SHIFTS; CEREBRAL-CORTEX; STROKE PATIENTS; ORGANIZATION; PLASTICITY	The primary motor cortex (M1) is the main effector structure implicated in the generation of voluntary movements and is directly involved in motor learning. The intrinsic horizontal neuronal connections of M1 exhibit short-term and long-term plasticity, which is a strong substrate for learning-related map reorganization. Transcranial direct current stimulation (tDCS) applied for few minutes over M1 has been shown to induce relatively long-lasting plastic alterations and to modulate motor performance. Here we test the hypothesis that the relatively long-lasting synaptic modification induced by tDCS over M1 results in the alteration of associations among populations of M1 neurons which may be reflected in changes of its functional architecture. fMRI resting-state datasets were acquired immediately before and after 10 minutes of tDCS during rest, with the anode/cathode placed over the left M1. For each functional dataset, grey-matter voxels belonging to Brodmann area 4 (BA4) were labelled and afterwards BA4 voxel-based synchronization matrices were calculated and thresholded to construct undirected graphs. Nodal network parameters which characterize the architecture of functional networks (connectivity degree, clustering coefficient and characteristic path-length) were computed, transformed to volume maps and compared before and after stimulation. At the dorsolateral-BA4 region cathodal tDCS boosted local connectedness, while anodal-tDCS enhanced long distance functional communication within M1. Additionally, the more efficient the functional architecture of M1 was at baseline, the more efficient the tDCS-induced functional modulations were. In summary, we show here that it is possible to non-invasively reorganize the intrinsic functional architecture of M1, and to image such alterations.	[Polania, Rafael; Paulus, Walter; Nitsche, Michael A.] Univ Gottingen, Dept Clin Neurophysiol, Gottingen, Germany	University of Gottingen	Polania, R (corresponding author), Univ Gottingen, Dept Clin Neurophysiol, Gottingen, Germany.	rafael.polania@med.uni-goettingen.de	Nitsche, Michael A/B-6755-2012; Paulus, Walter/A-3544-2009	Paulus, Walter/0000-0001-5549-8377; Polania, Rafael/0000-0002-6176-6806	Rose Foundation	Rose Foundation	This study was supported by the Rose Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Amunts K, 2000, NEUROPSYCHOLOGIA, V38, P304, DOI 10.1016/S0028-3932(99)00075-5; Antal A, 2004, J COGNITIVE NEUROSCI, V16, P521, DOI 10.1162/089892904323057263; Antal A, 2011, NEUROIMAGE, V55, P590, DOI 10.1016/j.neuroimage.2010.11.085; BINDMAN LJ, 1964, J PHYSIOL-LONDON, V172, P369, DOI 10.1113/jphysiol.1964.sp007425; Birn RM, 2006, NEUROIMAGE, V31, P1536, DOI 10.1016/j.neuroimage.2006.02.048; Boggio PS, 2007, RESTOR NEUROL NEUROS, V25, P123; Boggio PS, 2006, NEUROSCI LETT, V404, P232, DOI 10.1016/j.neulet.2006.05.051; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Butefisch CM, 2000, P NATL ACAD SCI USA, V97, P3661, DOI 10.1073/pnas.050350297; Cirillo J, 2009, J PHYSIOL-LONDON, V587, P5831, DOI 10.1113/jphysiol.2009.181834; de Xivry JJO, 2011, J NEUROSCI, V31, P7102, DOI 10.1523/JNEUROSCI.0273-11.2011; DONOGHUE JP, 1992, EXP BRAIN RES, V89, P1; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fregni F, 2005, NEUROREPORT, V16, P1551, DOI 10.1097/01.wnr.0000177010.44602.5e; Fritsch B, 2010, NEURON, V66, P198, DOI 10.1016/j.neuron.2010.03.035; Gandiga PC, 2006, CLIN NEUROPHYSIOL, V117, P845, DOI 10.1016/j.clinph.2005.12.003; HESS G, 1994, J NEUROPHYSIOL, V71, P2543, DOI 10.1152/jn.1994.71.6.2543; Hummel F, 2005, BRAIN, V128, P490, DOI 10.1093/brain/awh369; Iezzi E, 2011, EUR J NEUROSCI, V33, P1908, DOI 10.1111/j.1460-9568.2011.07674.x; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Kelly C, 2009, J NEUROSCI, V29, P7364, DOI 10.1523/JNEUROSCI.0810-09.2009; Korchounov A, 2011, NEUROMODULATORY NEUR; Lang N, 2004, EXP BRAIN RES, V156, P439, DOI 10.1007/s00221-003-1800-2; Liebetanz D, 2002, BRAIN, V125, P2238, DOI 10.1093/brain/awf238; Meier JD, 2008, J NEUROPHYSIOL, V100, P1800, DOI 10.1152/jn.90531.2008; Moliadze V, 2010, CLIN NEUROPHYSIOL, V121, P2165, DOI 10.1016/j.clinph.2010.04.033; Nitsche MA, 2004, EUR J NEUROSCI, V19, P2720, DOI 10.1111/j.0953-816X.2004.03398.x; Nitsche MA, 2001, NEUROLOGY, V57, P1899, DOI 10.1212/WNL.57.10.1899; Nitsche MA, 2003, J COGNITIVE NEUROSCI, V15, P619, DOI 10.1162/089892903321662994; Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.x; Nitsche MA, 2003, J PHYSIOL-LONDON, V553, P293, DOI 10.1113/jphysiol.2003.049916; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Polania R, 2011, HUM BRAIN MAPP, DOI [10.1002/hbm.21380, DOI 10.1002/HBM.21380]; Polania R, 2011, HUM BRAIN MAPP, V32, P1236, DOI 10.1002/hbm.21104; Polania R, 2011, NEUROIMAGE, V54, P2287, DOI 10.1016/j.neuroimage.2010.09.085; PURPURA DP, 1965, J NEUROPHYSIOL, V28, P166, DOI 10.1152/jn.1965.28.1.166; RASMUSSEN T, 1947, FED PROC, V6, P184; Reis J, 2009, P NATL ACAD SCI USA, V106, P1590, DOI 10.1073/pnas.0805413106; Rioult-Pedotti MS, 2000, SCIENCE, V290, P533, DOI 10.1126/science.290.5491.533; Sanes JN, 2000, CURR BIOL, V10, pR495, DOI 10.1016/S0960-9822(00)00557-1; Sanes JN, 1997, ADV NEUROL, V73, P277; Sanes JN, 2000, NEUROIMAGE, V11, P370, DOI 10.1006/nimg.2000.0550; SANES JN, 1992, CEREB CORTEX, V2, P141, DOI 10.1093/cercor/2.2.141; Sanes JN, 2001, NEUROIMAGE, V13, P968, DOI 10.1006/nimg.2000.0733; Sanes JN, 2000, ANNU REV NEUROSCI, V23, P393, DOI 10.1146/annurev.neuro.23.1.393; Schambra HM, 2003, CLIN NEUROPHYSIOL, V114, P130, DOI 10.1016/S1388-2457(02)00342-5; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; Sporns O, 2004, NEUROINFORMATICS, V2, P145, DOI 10.1385/NI:2:2:145; Stam CJ, 2010, INT J PSYCHOPHYSIOL, V77, P186, DOI 10.1016/j.ijpsycho.2010.06.024; Stefan K, 2002, J PHYSIOL-LONDON, V543, P699, DOI 10.1113/jphysiol.2002.023317; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; van den Heuvel MP, 2008, NEUROIMAGE, V43, P528, DOI 10.1016/j.neuroimage.2008.08.010; van den Heuvel MP, 2009, J NEUROSCI, V29, P7619, DOI 10.1523/JNEUROSCI.1443-09.2009	54	72	72	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2012	7	1							e30971	10.1371/journal.pone.0030971	http://dx.doi.org/10.1371/journal.pone.0030971			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911GB	22303478	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000301704200052
J	Kumari, S; Misra, P; Tandon, R; Samant, M; Sundar, S; Dube, A				Kumari, Shraddha; Misra, Pragya; Tandon, Rati; Samant, Mukesh; Sundar, Shyam; Dube, Anuradha			Leishmania donovani: Immunostimulatory Cellular Responses of Membrane and Soluble Protein Fractions of Splenic Amastigotes in Cured Patient and Hamsters	PLOS ONE			English	Article							VISCERAL LEISHMANIASIS; T-CELL; CUTANEOUS LEISHMANIASIS; PROTECTIVE IMMUNITY; INFECTED PATIENTS; ANTIGENS; VACCINE; PROMASTIGOTES; IMMUNIZATION; INTERLEUKIN-12	Visceral leishmaniasis (VL), caused by the intracellular parasite Leishmania donovani, L. chagasi and L. infantum is characterized by defective cell-mediated immunity (CMI) and is usually fatal if not treated properly. An estimated 350 million people worldwide are at risk of acquiring infection with Leishmania parasites with approximately 500,000 cases of VL being reported each year. In the absence of an efficient and cost-effective antileishmanial drug, development of an appropriate long-lasting vaccine against VL is the need of the day. In VL, the development of a CMI, capable of mounting Th1-type of immune responses, play an important role as it correlate with recovery from and resistance to disease. Resolution of infection results in lifelong immunity against the disease which indicates towards the feasibility of a vaccine against the disease. Most of the vaccination studies in Leishmaniasis have been focused on promastigote-an infective stage of parasite with less exploration of pathogenic amastigote form, due to the cumbersome process of its purified isolation. In the present study, we have isolated and purified splenic amastigotes of L. donovani, following the traditional protocol with slight modification. These were fractionated into five membranous and soluble subfractions each i.e MAF1-5 and SAF1-5 and were subjected for evaluation of their ability to induce cellular responses. Out of five sub-fractions from each of membrane and soluble, only four viz. MAF2, MAF3, SAF2 and SAF3 were observed to stimulate remarkable lymphoproliferative, IFN-gamma, IL-12 responses and Nitric Oxide production, in Leishmania-infected cured/exposed patients and hamsters. Results suggest the presence of Th-1 type immunostimulatory molecules in these sub-fractions which may further be exploited for developing a successful subunit vaccine from the less explored pathogenic stage against VL.	[Kumari, Shraddha; Misra, Pragya; Tandon, Rati; Samant, Mukesh; Dube, Anuradha] CSIR, Cent Drug Res Inst, Div Parasitol, Lucknow, Uttar Pradesh, India; [Kumari, Shraddha] Rikshosp Radiumhosp Med Ctr, Inst Canc Res, Dept Immunol, Oslo, Norway; [Samant, Mukesh] Univ Laval, CHUL Res Ctr, Res Ctr Infect Dis, Dept Med Biol, Quebec City, PQ, Canada; [Sundar, Shyam] Banaras Hindu Univ, Inst Med Sci, Dept Med, Varanasi 221005, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); University of Oslo; Laval University; Banaras Hindu University (BHU)	Kumari, S (corresponding author), CSIR, Cent Drug Res Inst, Div Parasitol, Lucknow, Uttar Pradesh, India.	anuradha_dube@hotmail.com		Dube, Anuradha/0000-0002-5122-400X	Department of Biotechnology (DBT), New Delhi [BT/PR6048/MED/14/735/2005]; Council of Scientific and Industrial Research (CSIR), New Delhi	Department of Biotechnology (DBT), New Delhi(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research (CSIR), New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	Department of Biotechnology (DBT), New Delhi (Grant number: BT/PR6048/MED/14/735/2005) and for Senior Research Fellowship to SK, PM, RT and MS by Council of Scientific and Industrial Research (CSIR), New Delhi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AFONSO LCC, 1994, SCIENCE, V263, P235, DOI 10.1126/science.7904381; Afrin F, 2002, INFECT IMMUN, V70, P6697, DOI 10.1128/IAI.70.12.6697-6706.2002; ASSREUY J, 1994, EUR J IMMUNOL, V24, P672, DOI 10.1002/eji.1830240328; BATES PA, 1993, FEMS MICROBIOL LETT, V107, P53, DOI 10.1111/j.1574-6968.1993.tb06003.x; Bhowmick S, 2007, VACCINE, V25, P6544, DOI 10.1016/j.vaccine.2007.05.042; Bloom S, 2005, J CLIN INVEST, V115, P2300; Burchmore RJS, 2001, INT J PARASITOL, V31, P1311, DOI 10.1016/S0020-7519(01)00259-4; Cabral SM, 2008, IMMUNOLOGY, V123, P555, DOI 10.1111/j.1365-2567.2007.02725.x; CHAMPSI J, 1988, INFECT IMMUN, V56, P3272, DOI 10.1128/IAI.56.12.3272-3279.1988; CHANG KP, 1980, SCIENCE, V209, P1240, DOI 10.1126/science.7403880; Charest H, 1996, J BIOL CHEM, V271, P17081, DOI 10.1074/jbc.271.29.17081; CHOUDHRY A, 1990, T ROY SOC TROP MED H, V84, P363, DOI 10.1016/0035-9203(90)90319-A; Coler RN, 2002, INFECT IMMUN, V70, P4215, DOI 10.1128/IAI.70.8.4215-4225.2002; CONNELL ND, 1993, P NATL ACAD SCI USA, V90, P11473, DOI 10.1073/pnas.90.24.11473; Costa SR, 1999, MEM I OSWALDO CRUZ, V94, P367, DOI 10.1590/S0074-02761999000300015; Descoteaux A, 2002, MICROBES INFECT, V4, P975, DOI 10.1016/S1286-4579(02)01624-6; Desjeux P, 2004, NAT REV MICROBIOL, V2, P692, DOI 10.1038/nrmicro981; Diefenbach A, 1999, SCIENCE, V284, P951, DOI 10.1126/science.284.5416.951; DING AH, 1988, J IMMUNOL, V141, P2407; EPERON S, 1989, J PROTOZOOL, V36, P502, DOI 10.1111/j.1550-7408.1989.tb01086.x; Garg R, 2006, VACCINE, V24, P2900, DOI 10.1016/j.vaccine.2005.12.053; Garg R, 2005, CLIN EXP IMMUNOL, V140, P149, DOI 10.1111/j.1365-2249.2005.02745.x; Garg R, 2005, VACCINE, V23, P1189, DOI 10.1016/j.vaccine.2004.06.054; Garg R, 2006, INDIAN J MED RES, V123, P439; GHALIB HW, 1995, J IMMUNOL, V154, P4623; GICHERU MM, 1994, ACTA TROP, V58, P345, DOI 10.1016/0001-706X(94)90028-0; GIFAWESEN C, 1989, INFECT IMMUN, V57, P3091, DOI 10.1128/IAI.57.10.3091-3096.1989; GLASER TA, 1991, MOL BIOCHEM PARASIT, V45, P337, DOI 10.1016/0166-6851(91)90102-C; Guerin PJ, 2002, LANCET INFECT DIS, V2, P494, DOI 10.1016/S1473-3099(02)00347-X; Handman E, 2001, CLIN MICROBIOL REV, V14, P229, DOI 10.1128/CMR.14.2.229-243.2001; JAFFE CL, 1990, J IMMUNOL, V144, P699; KAHL LP, 1989, J IMMUNOL, V142, P4441; Khalil EAG, 2000, LANCET, V356, P1565, DOI 10.1016/S0140-6736(00)03128-7; Kumari S, 2008, VACCINE, V26, P4813, DOI 10.1016/j.vaccine.2008.06.102; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIEW FY, 1991, IMMUNOL LETT, V30, P193, DOI 10.1016/0165-2478(91)90024-5; McMahon-Pratt D, 1998, PARASITOL TODAY, V14, P31, DOI 10.1016/S0169-4758(97)01164-2; MELBY PC, 1991, REV INFECT DIS, V13, P1009; MELBY PC, 1989, INFECT IMMUN, V57, P2971, DOI 10.1128/IAI.57.10.2971-2976.1989; Molloy MP, 1998, ELECTROPHORESIS, V19, P837, DOI 10.1002/elps.1150190539; MOUGNEAU E, 1995, SCIENCE, V268, P563, DOI 10.1126/science.7725103; Murray HW, 1997, J EXP MED, V185, P867, DOI 10.1084/jem.185.5.867; PAN AA, 1984, EXP PARASITOL, V58, P72, DOI 10.1016/0014-4894(84)90022-5; Pham NK, 2005, INFECT IMMUN, V73, P8322, DOI 10.1128/IAI.73.12.8322-8333.2005; REED SG, 1993, CURR OPIN IMMUNOL, V5, P524, DOI 10.1016/0952-7915(93)90033-O; Rochette A, 2009, MOL BIOCHEM PARASIT, V165, P32, DOI 10.1016/j.molbiopara.2008.12.012; RODRIGUES V, 1992, PARASITE IMMUNOL, V14, P49, DOI 10.1111/j.1365-3024.1992.tb00005.x; RUSSO DM, 1993, J IMMUNOL, V150, P4713; Samant M, 2007, PARASITOLOGY, V134, P1175, DOI 10.1017/S0031182007002569; Santoni V, 2000, ELECTROPHORESIS, V21, P3329, DOI 10.1002/1522-2683(20001001)21:16<3329::AID-ELPS3329>3.0.CO;2-F; SCOTT DA, 1987, BIOCHEM PHARMACOL, V36, P2043, DOI 10.1016/0006-2952(87)90508-9; Silvestre R, 2006, IMMUNOLOGY, V119, P529, DOI 10.1111/j.1365-2567.2006.02468.x; Skeiky YAW, 1998, J IMMUNOL, V161, P6171; SYPEK JP, 1993, J EXP MED, V177, P1797, DOI 10.1084/jem.177.6.1797; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TRINCHIERI G, 1995, ANNU REV IMMUNOL, V13, P251, DOI 10.1146/annurev.immunol.13.1.251; Tripathi P, 2006, CLIN EXP IMMUNOL, V143, P380, DOI 10.1111/j.1365-2249.2005.03000.x; WHITE AC, 1990, J INFECT DIS, V161, P1313, DOI 10.1093/infdis/161.6.1313; WHITE AC, 1992, AM J TROP MED HYG, V46, P123, DOI 10.4269/ajtmh.1992.46.123	59	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2012	7	1							e30746	10.1371/journal.pone.0030746	http://dx.doi.org/10.1371/journal.pone.0030746			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911FX	22292030	Green Published, gold, Green Submitted			2022-12-25	WOS:000301703800027
J	Li, Y; O'Neill, C				Li, Yan; O'Neill, Chris			Persistence of Cytosine Methylation of DNA following Fertilisation in the Mouse	PLOS ONE			English	Article							PATERNAL GENOME; PREIMPLANTATION; EMBRYO; EXPRESSION; CULTURE; DEMETHYLATION; PATTERNS; ZYGOTES; MAINTENANCE; ACTIVATION	Normal development of the mammalian embryo requires epigenetic reprogramming of the genome. The level of cytosine methylation of CpG-rich (5meC) regions of the genome is a major epigenetic regulator and active global demethylation of 5meC throughout the genome is reported to occur within the first cell-cycle following fertilization. An enzyme or mechanism capable of catalysing such rapid global demethylation has not been identified. The mouse is a widely used model for studying developmental epigenetics. We have reassessed the evidence for this phenomenon of genome-wide demethylation following fertilisation in the mouse. We found when using conventional methods of immunolocalization that 5meC showed a progressive acid-resistant antigenic masking during zygotic maturation which gave the appearance of demethylation. Changing the unmasking strategy by also performing tryptic digestion revealed a persistence of a methylated state. Analysis of methyl binding domain 1 protein (MBD1) binding confirmed that the genome remained methylated following fertilisation. The maintenance of this methylated state over the first several cell-cycles required the actions of DNA methyltransferase activity. The study shows that any 5meC remodelling that occurs during early development is not explained by a global active loss of 5meC staining during the cleavage stage of development and global loss of methylation following fertilization is not a major component of epigenetic reprogramming in the mouse zygote.	[Li, Yan; O'Neill, Chris] Univ Sydney, Sydney Med Sch, Ctr Dev & Regenerat Med, Kolling Inst Med Res, Sydney, NSW 2006, Australia	University of Sydney; Kolling Institute of Medical Research	Li, Y (corresponding author), Univ Sydney, Sydney Med Sch, Ctr Dev & Regenerat Med, Kolling Inst Med Res, Sydney, NSW 2006, Australia.	chris.oneill@sydney.edu.au			Australian National Health and Medical Research Council	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by project grants from the Australian National Health and Medical Research Council. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adenot PG, 1997, DEVELOPMENT, V124, P4615; Barton SC, 2001, HUM MOL GENET, V10, P2983, DOI 10.1093/hmg/10.26.2983; Beaujean N, 2004, BIOL REPROD, V71, P185, DOI 10.1095/biolreprod.103.026559; Beaujean N, 2004, P NATL ACAD SCI USA, V101, P7636, DOI 10.1073/pnas.0400730101; Borgel J, 2010, NAT GENET, V42, P1093, DOI 10.1038/ng.708; Brueckner B, 2005, CANCER RES, V65, P6305, DOI 10.1158/0008-5472.CAN-04-2957; Dean W, 2001, P NATL ACAD SCI USA, V98, P13734, DOI 10.1073/pnas.241522698; Doherty AS, 2000, BIOL REPROD, V62, P1526, DOI 10.1095/biolreprod62.6.1526; Fulka H, 2004, REPRODUCTION, V128, P703, DOI 10.1530/rep.1.00217; Gu TP, 2011, NATURE, V477, P606, DOI 10.1038/nature10443; Hirasawa R, 2008, GENE DEV, V22, P1607, DOI 10.1101/gad.1667008; HOWLETT SK, 1991, DEVELOPMENT, V113, P119; Iqbal K, 2011, P NATL ACAD SCI USA, V108, P3642, DOI 10.1073/pnas.1014033108; Jeong YS, 2007, INT J DEV BIOL, V51, P707, DOI 10.1387/ijdb.072450yj; Jin XL, 2010, BIOL REPROD, V82, P459, DOI 10.1095/biolreprod.109.078758; Kim SH, 2004, BIOCHEM BIOPH RES CO, V324, P58, DOI 10.1016/j.bbrc.2004.09.023; Kurihara Y, 2008, DEV BIOL, V313, P335, DOI 10.1016/j.ydbio.2007.10.033; Lane N, 2003, GENESIS, V35, P88, DOI 10.1002/gene.10168; Li A, 2007, BIOL REPROD, V76, P362, DOI 10.1095/biolreprod.106.056838; Ma J, 2001, BIOL REPROD, V64, P1713, DOI 10.1095/biolreprod64.6.1713; Mahsoudi B, 2007, BIOL REPROD, V77, P889, DOI 10.1095/biolreprod.106.057885; Mayer W, 2000, NATURE, V403, P501, DOI 10.1038/35000656; Morgan HD, 2005, HUM MOL GENET, V14, pR47, DOI 10.1093/hmg/ddi114; Morgan HD, 2008, BIOL REPROD, V79, P618, DOI 10.1095/biolreprod.108.068213; Mu XF, 2011, BIOL REPROD, V85, P524, DOI 10.1095/biolreprod.110.089334; O'Neill C, 1998, BIOL REPROD, V58, P1303, DOI 10.1095/biolreprod58.5.1303; ONeill C, 1997, BIOL REPROD, V56, P229, DOI 10.1095/biolreprod56.1.229; Ooi SKT, 2008, CELL, V133, P1145, DOI 10.1016/j.cell.2008.06.009; Oswald J, 2000, CURR BIOL, V10, P475, DOI 10.1016/S0960-9822(00)00448-6; Polanski Z, 2008, INT J DEV BIOL, V52, P295, DOI 10.1387/ijdb.072347zp; Rougier N, 1998, GENE DEV, V12, P2108, DOI 10.1101/gad.12.14.2108; Santenard A, 2010, NAT CELL BIOL, V12, P853, DOI 10.1038/ncb2089; Santos F, 2005, DEV BIOL, V280, P225, DOI 10.1016/j.ydbio.2005.01.025; Santos F, 2002, DEV BIOL, V241, P172, DOI 10.1006/dbio.2001.0501; Shi W, 2004, BIOL REPROD, V71, P340, DOI 10.1095/biolreprod.103.024554; Smallwood SA, 2011, NAT GENET, V43, P811, DOI 10.1038/ng.864; Stojanov T, 1999, MOL HUM REPROD, V5, P116, DOI 10.1093/molehr/5.2.116; TARKOWSKI AK, 1966, CYTOGENETICS, V5, P394, DOI 10.1159/000129914; Veron N, 2011, NATURE, V473, P293, DOI 10.1038/473293a; Young LE, 2004, ANIM REPROD SCI, V82-3, P61, DOI 10.1016/j.anireprosci.2004.05.020	40	34	35	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2012	7	1							e30687	10.1371/journal.pone.0030687	http://dx.doi.org/10.1371/journal.pone.0030687			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911FX	22292019	Green Published, Green Submitted, gold			2022-12-25	WOS:000301703800024
J	von Ruesten, A; Weikert, C; Fietze, I; Boeing, H				von Ruesten, Anne; Weikert, Cornelia; Fietze, Ingo; Boeing, Heiner			Association of Sleep Duration with Chronic Diseases in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; RISK-FACTOR; BREAST-CANCER; DAYTIME SLEEPINESS; HEALTHY-ADULTS; EPIC-GERMANY; FOLLOW-UP; METABOLIC CONSEQUENCES; CARDIOVASCULAR-DISEASE; GENERAL-POPULATION	Background: In view of the reduced number of hours devoted to sleep in modern western societies the question arises what effects might result from sleep duration on occurrence of chronic diseases. Methods: Data from 23 620 middle-aged participants of the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam study, that were recruited between 1994-1998, were analyzed by using Cox proportional hazard regression to examine the association between self-reported sleep duration at baseline and incidence of chronic diseases, such as diabetes, myocardial infarction, stroke, and cancer. Results: During a mean follow-up period of 7.8 years 841 incident cases of type 2 diabetes, 197 cases of myocardial infarction, 169 incident strokes, and 846 tumor cases were observed. Compared to persons sleeping 7-<8 h/day, participants with sleep duration of <6 h had a significantly increased risk of stroke (Hazard Ratio (HR)=2.06, 95% confidence interval (CI): 1.18-3.59), cancer (HR=1.43, 95% CI: 1.09-1.87), and overall chronic diseases (HR=1.31, 95% CI: 1.10-1.55) in multivariable adjusted models. Self-reported daytime sleep at baseline was not associated with incident chronic diseases in the overall study sample. However, there had been an effect modification of daytime sleep by hypertension showing that daytime sleep was inversely related to chronic disease risk among non-hypertensive participants but directly related to chronic diseases among hypertensives. Conclusion: Sleep duration of less than 6 h is a risky behavior for the development of chronic diseases, particularly stroke and cancer, and should be therefore addressed in public health campaigns.	[von Ruesten, Anne; Weikert, Cornelia; Boeing, Heiner] German Inst Human Nutr Potsdam Rehbrucke, Dept Epidemiol, Nuthetal, Germany; [Fietze, Ingo] Charite, Dept Cardiol & Angiol, Ctr Sleep Med, CCM, D-13353 Berlin, Germany	Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	von Ruesten, A (corresponding author), German Inst Human Nutr Potsdam Rehbrucke, Dept Epidemiol, Nuthetal, Germany.	Anne.von.Ruesten@dife.de		Fietze, Ingo/0000-0001-5567-5206	Federal Ministry of Science, Germany [01 EA 9401]; European Community [SOC 95 201408 05F02, SOC 98 200769 05F02]; German Cancer Aid [70-2488-Ha I]	Federal Ministry of Science, Germany; European Community(European Commission); German Cancer Aid(Deutsche Krebshilfe)	The recruitment phase of the EPIC (European Prospective Investigation into Cancer and Nutrition)-Potsdam Study was supported by the Federal Ministry of Science, Germany (grant 01 EA 9401). Further financial support was provided by the `Europe against Cancer' program of the European Community (grant SOC 95 201408 05F02). The EPIC-Potsdam Study is now supported by the German Cancer Aid (grant 70-2488-Ha I) and the European Community (grant SOC 98 200769 05F02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amagai Y, 2010, J EPIDEMIOL, V20, P106, DOI 10.2188/jea.JE20090053; Asplund R, 1996, J INTERN MED, V239, P261, DOI 10.1046/j.1365-2796.1996.453806000.x; Asplund R, 1998, SCAND J PRIM HEALTH, V16, P112; Ayas NT, 2003, DIABETES CARE, V26, P380, DOI 10.2337/diacare.26.2.380; Ayas NT, 2003, ARCH INTERN MED, V163, P205, DOI 10.1001/archinte.163.2.205; Beihl DA, 2009, ANN EPIDEMIOL, V19, P351, DOI 10.1016/j.annepidem.2008.12.001; Bergmann MM, 1999, ANN NUTR METAB, V43, P225, DOI 10.1159/000012789; Bjorkelund C, 2005, DIABETES CARE, V28, P2739, DOI 10.2337/diacare.28.11.2739; Blask DE, 2009, SLEEP MED REV, V13, P257, DOI 10.1016/j.smrv.2008.07.007; Bliwise DL, 1996, SLEEP, V19, P462, DOI 10.1093/sleep/19.6.462; Boeing H, 1999, ANN NUTR METAB, V43, P205, DOI 10.1159/000012787; Boeing H, 1999, ANN NUTR METAB, V43, P195, DOI 10.1159/000012786; Cappuccio FP, 2011, EUR HEART J; Cappuccio FP, 2010, DIABETES CARE, V33, P414, DOI 10.2337/dc09-1124; Chandola T, 2010, SLEEP, V33, P739, DOI 10.1093/sleep/33.6.739; Chaput JP, 2009, SLEEP MED, V10, P919, DOI 10.1016/j.sleep.2008.09.016; Chatzitheochari S, 2009, WORK EMPLOY SOC, V23, P30, DOI 10.1177/0950017008099776; Chen JC, 2008, STROKE, V39, P3185, DOI 10.1161/STROKEAHA.108.521773; Dhand R, 2006, CURR OPIN PULM MED, V12, P379; Foley DJ, 2007, AM J GERIAT PSYCHIAT, V15, P344, DOI 10.1097/01.JGP.0000249385.50101.67; Gangwisch JE, 2009, OBES REV, V10, P37, DOI 10.1111/j.1467-789X.2009.00663.x; Gangwisch JE, 2007, SLEEP, V30, P1667, DOI 10.1093/sleep/30.12.1667; Gangwisch JE, 2006, HYPERTENSION, V47, P833, DOI 10.1161/01.HYP.0000217362.34748.e0; Gottlieb DJ, 2006, SLEEP, V29, P1009, DOI 10.1093/sleep/29.8.1009; Hayashino Y, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-129; Irwin M, 2002, BRAIN BEHAV IMMUN, V16, P503, DOI 10.1016/S0889-1591(02)00003-X; Kakizaki M, 2008, BRIT J CANCER, V99, P1502, DOI 10.1038/sj.bjc.6604684; Knutson KL, 2008, ANN NY ACAD SCI, V1129, P287, DOI 10.1196/annals.1417.033; Knutson KL, 2007, SLEEP MED REV, V11, P163, DOI 10.1016/j.smrv.2007.01.002; Knutson KL, 2010, SLEEP, V33, P37, DOI 10.1093/sleep/33.1.37; Kripke DF, 2002, ARCH GEN PSYCHIAT, V59, P131, DOI 10.1001/archpsyc.59.2.131; Lauderdale DS, 2008, EPIDEMIOLOGY, V19, P838, DOI 10.1097/EDE.0b013e318187a7b0; Lauderdale DS, 2006, AM J EPIDEMIOL, V164, P5, DOI 10.1093/aje/kwj199; Leproult R, 1997, SLEEP, V20, P865; Lockley SW, 1999, J SLEEP RES, V8, P175, DOI 10.1046/j.1365-2869.1999.00155.x; Mallon L, 2005, DIABETES CARE, V28, P2762, DOI 10.2337/diacare.28.11.2762; Meier-Ewert HK, 2004, J AM COLL CARDIOL, V43, P678, DOI 10.1016/j.jacc.2003.07.050; Meisinger C, 2007, SLEEP, V30, P1121, DOI 10.1093/sleep/30.9.1121; Miller MA, 2007, CURR VASC PHARMACOL, V5, P93, DOI 10.2174/157016107780368280; Milner CE, 2009, J SLEEP RES, V18, P272, DOI 10.1111/j.1365-2869.2008.00718.x; Mullington JM, 2009, PROG CARDIOVASC DIS, V51, P294, DOI 10.1016/j.pcad.2008.10.003; Naska A, 2007, ARCH INTERN MED, V167, P296, DOI 10.1001/archinte.167.3.296; Patel SR, 2006, AM J EPIDEMIOL, V164, P947, DOI 10.1093/aje/kwj280; Patel SR, 2004, SLEEP, V27, P440, DOI 10.1093/sleep/27.3.440; Pinheiro SP, 2006, CANCER RES, V66, P5521, DOI 10.1158/0008-5472.CAN-05-4652; Qureshi AI, 1997, NEUROLOGY, V48, P904, DOI 10.1212/WNL.48.4.904; Roth Thomas, 2007, J Clin Sleep Med, V3, pS7; Siegel JM, 2005, NATURE, V437, P1264, DOI 10.1038/nature04285; Signal TL, 2005, AVIAT SPACE ENVIR MD, V76, P1058; Sigurdson K, 2007, CAN J PHYSIOL PHARM, V85, P179, DOI 10.1139/Y06-095; Spiegel K, 1999, LANCET, V354, P1435, DOI 10.1016/S0140-6736(99)01376-8; Stang A, 2007, SLEEP, V30, P1111, DOI 10.1093/sleep/30.9.1111; Stranges S, 2008, AM J EPIDEMIOL, V168, P1353, DOI 10.1093/aje/kwn337; Tamakoshi A, 2004, SLEEP, V27, P51; Tanabe N, 2010, INT J EPIDEMIOL, V39, P233, DOI 10.1093/ije/dyp327; US-Sleep-Foundation, 2005, SLEEP AM POLL SUMM F; Verkasalo PK, 2005, CANCER RES, V65, P9595, DOI 10.1158/0008-5472.CAN-05-2138; Volzke H, 2011, INT J EPIDEMIOL, V40, P294, DOI 10.1093/ije/dyp394; Wu AH, 2008, CARCINOGENESIS, V29, P1244, DOI 10.1093/carcin/bgn100; Xu Q, 2010, DIABETES CARE, V33, P78, DOI 10.2337/dc09-1143; Yaggi HK, 2006, DIABETES CARE, V29, P657, DOI 10.2337/diacare.29.03.06.dc05-0879	61	150	150	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e30972	10.1371/journal.pone.0030972	http://dx.doi.org/10.1371/journal.pone.0030972			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910ME	22295122	Green Published, gold, Green Submitted			2022-12-25	WOS:000301640600067
J	Lopez-Garrido, J; Casadesus, J				Lopez-Garrido, Javier; Casadesus, Josep			Crosstalk between Virulence Loci: Regulation of Salmonella enterica Pathogenicity Island 1 (SPI-1) by Products of the std Fimbrial Operon	PLOS ONE			English	Article							DNA ADENINE METHYLATION; III SECRETION SYSTEM; SEROVAR TYPHIMURIUM INVASION; GENE-EXPRESSION; ESCHERICHIA-COLI; CELL INVASION; BACTERIAL PATHOGENESIS; PROTEIN SECRETION; CHROMOSOMAL GENES; INTESTINAL-MUCOSA	Invasion of intestinal epithelial cells is a critical step in Salmonella infection and requires the expression of genes located in Salmonella pathogenicity island 1 (SPI-1). A key factor for SPI-1 expression is DNA adenine (Dam) methylation, which activates synthesis of the SPI-1 transcriptional activator HilD. Dam-dependent regulation of hilD is postranscriptional (and therefore indirect), indicating the involvement of unknown cell functions under Dam methylation control. A genetic screen has identified the std fimbrial operon as the missing link between Dam methylation and SPI-1. We show that all genes in the std operon are part of a single transcriptional unit, and describe three previously uncharacterized ORFs (renamed stdD, stdE, and stdF). We present evidence that two such loci (stdE and stdF) are involved in Dam-dependent control of Salmonella SPI-1: in a Dam(-) background, deletion of stdE or stdF suppresses SPI-1 repression; in a Dam(+) background, constitutive expression of StdE and/or StdF represses SPI-1. Repression of SPI-1 by products of std operon explains the invasion defect of Salmonella Dam(-) mutants, which constitutively express the std operon. Dam-dependent repression of std in the ileum may be required to permit invasion, as indicated by two observations: constitutive expression of StdE and StdF reduces invasion of epithelial cells in vitro (1,000 fold) and attenuates Salmonella virulence in the mouse model (>60 fold). In turn, crosstalk between std and SPI-1 may play a role in intestinal infections by preventing expression of SPI-1 in the caecum, an intestinal compartment in which the std operon is known to be expressed.	[Lopez-Garrido, Javier; Casadesus, Josep] Univ Seville, Dept Genet, Seville, Spain	University of Sevilla	Lopez-Garrido, J (corresponding author), Univ Seville, Dept Genet, Seville, Spain.	casadesus@us.es	Casadesús, Josep/C-6222-2016	Casadesús, Josep/0000-0002-2308-293X; Lopez-Garrido, Javier/0000-0002-8907-502X	Spanish Ministry of Science and Innovation [BIO2010-15023, CSD2008-00013]; European Regional Fund	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Regional Fund	This study was supported by grant BIO2010-15023 from the Spanish Ministry of Science and Innovation and the European Regional Fund, and grant CSD2008-00013 from the Consolider-Ingenio 2010 Program of the Spanish Ministry of Science and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altier C, 2005, J MICROBIOL, V43, P85; Altier C, 2000, INFECT IMMUN, V68, P6790, DOI 10.1128/IAI.68.12.6790-6797.2000; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Baek CH, 2009, J BACTERIOL, V191, P1278, DOI 10.1128/JB.01142-08; Balbontin R, 2006, J BACTERIOL, V188, P8160, DOI 10.1128/JB.00847-06; Baxter MA, 2005, INFECT IMMUN, V73, P1377, DOI 10.1128/IAI.73.3.1377-1385.2005; Baxter MA, 2003, INFECT IMMUN, V71, P1295, DOI 10.1128/IAI.71.3.1295-1305.2003; Boddicker JD, 2004, INFECT IMMUN, V72, P2002, DOI 10.1128/IAI.72.4.2002-2013.2004; Bustamante VH, 2008, P NATL ACAD SCI USA, V105, P14591, DOI 10.1073/pnas.0801205105; CARTER PB, 1974, J EXP MED, V139, P1189, DOI 10.1084/jem.139.5.1189; CHAN RK, 1972, VIROLOGY, V50, P883, DOI 10.1016/0042-6822(72)90442-4; Chaudhuri RR, 2008, NUCLEIC ACIDS RES, V36, pD543, DOI 10.1093/nar/gkm928; Chessa D, 2009, MOL MICROBIOL, V71, P864, DOI 10.1111/j.1365-2958.2008.06566.x; Chubiz JEC, 2010, J BACTERIOL, V192, P6261, DOI 10.1128/JB.00635-10; Crump JA, 2004, B WORLD HEALTH ORGAN, V82, P346; Darwin KH, 1999, CLIN MICROBIOL REV, V12, P405, DOI 10.1128/CMR.12.3.405; Darwin KH, 2001, EMBO J, V20, P1850, DOI 10.1093/emboj/20.8.1850; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Ellermeier CD, 2005, MOL MICROBIOL, V57, P691, DOI 10.1111/j.1365-2958.2005.04737.x; Ellermeier CD, 2002, GENE, V290, P153, DOI 10.1016/S0378-1119(02)00551-6; Ellermeier CD, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 6, THIRD EDITION, P123, DOI 10.1007/0-387-30746-x_7; Ellermeier JR, 2008, J BACTERIOL, V190, P476, DOI 10.1128/JB.00926-07; Ellermeier JR, 2007, CURR OPIN MICROBIOL, V10, P24, DOI 10.1016/j.mib.2006.12.002; Fahlen TF, 2000, FEMS IMMUNOL MED MIC, V28, P25, DOI 10.1016/S0928-8244(99)00199-6; Falkow S, 1996, CELLULAR MOL BIOL, P2723; Fortune DR, 2006, INFECT IMMUN, V74, P331, DOI 10.1128/IAI.74.1.331-339.2006; FRETER R, 1981, INFECT IMMUN, V34, P241, DOI 10.1128/IAI.34.1.241-249.1981; Garcia-Del Portillo F, 1999, P NATL ACAD SCI USA, V96, P11578, DOI 10.1073/pnas.96.20.11578; GARZON A, 1995, GENETICS, V140, P427; Groisman EA, 1997, TRENDS MICROBIOL, V5, P343, DOI 10.1016/S0966-842X(97)01099-8; Groisman EA, 1996, CELL, V87, P791, DOI 10.1016/S0092-8674(00)81985-6; Hardt WD, 1998, P NATL ACAD SCI USA, V95, P2574, DOI 10.1073/pnas.95.5.2574; Heithoff DM, 1999, SCIENCE, V284, P967, DOI 10.1126/science.284.5416.967; Hensel M, 2004, INT J MED MICROBIOL, V294, P95, DOI 10.1016/j.ijmm.2004.06.025; Humphries A, 2005, INFECT IMMUN, V73, P5329, DOI 10.1128/IAI.73.9.5329-5338.2005; Humphries AD, 2003, MOL MICROBIOL, V48, P1357, DOI 10.1046/j.1365-2958.2003.03507.x; Jakomin M, 2008, J BACTERIOL, V190, P7406, DOI 10.1128/JB.01136-08; Jones BD, 2005, J MICROBIOL, V43, P110; JONES BD, 1994, J EXP MED, V180, P15, DOI 10.1084/jem.180.1.15; Kelly BG, 2009, FOOD CHEM TOXICOL, V47, P951, DOI 10.1016/j.fct.2008.02.006; Knodler LA, 2002, MOL MICROBIOL, V43, P1089, DOI 10.1046/j.1365-2958.2002.02820.x; Lawhon SD, 2002, MOL MICROBIOL, V46, P1451, DOI 10.1046/j.1365-2958.2002.03268.x; Lim S, 2007, NUCLEIC ACIDS RES, V35, P1822, DOI 10.1093/nar/gkm060; Lopez-Garrido J, 2010, GENETICS, V184, P637, DOI 10.1534/genetics.109.108985; Lostroh CP, 2001, MICROBES INFECT, V3, P1281; Lucas S, 2010, COMPLETE SEQUENCE EN; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; Majowicz SE, 2010, CLIN INFECT DIS, V50, P882, DOI 10.1086/650733; Marinus MG, 2009, FEMS MICROBIOL REV, V33, P488, DOI 10.1111/j.1574-6976.2008.00159.x; Martinez LC, 2011, MOL MICROBIOL, V80, P1637, DOI 10.1111/j.1365-2958.2011.07674.x; Miller J.H., 1972, EXPT MOL GENETICS; OCHMAN H, 1987, J MOL EVOL, V26, P74, DOI 10.1007/BF02111283; Ohl ME, 2001, ANNU REV MED, V52, P259, DOI 10.1146/annurev.med.52.1.259; Olekhnovich IN, 2006, J MOL BIOL, V357, P373, DOI 10.1016/j.jmb.2006.01.007; Pesavento C, 2008, GENE DEV, V22, P2434, DOI 10.1101/gad.475808; Porwollik S, 2003, MICROBES INFECT, V5, P977, DOI 10.1016/S1286-4579(03)00186-2; Queiroz MH, 2011, MICROBIOL-SGM, V157, P2504, DOI 10.1099/mic.0.049197-0; Saini S, 2010, J BACTERIOL, V192, P2459, DOI 10.1128/JB.00047-10; Schmidt H, 2004, CLIN MICROBIOL REV, V17, P14, DOI 10.1128/CMR.17.1.14-56.2004; SCHMIEGER H, 1972, MOL GEN GENET, V119, P75, DOI 10.1007/BF00270447; Segura I, 2004, J MICROBIOL METH, V56, P83, DOI 10.1016/j.mimet.2003.09.004; Takaya A, 2005, MOL MICROBIOL, V55, P839, DOI 10.1111/j.1365-2958.2004.04425.x; TAYLOR RK, 1987, P NATL ACAD SCI USA, V84, P2833, DOI 10.1073/pnas.84.9.2833; Teixido L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019711; Thanassi DG, 1998, CURR OPIN MICROBIOL, V1, P223, DOI 10.1016/S1369-5274(98)80015-5; Townsend SM, 2001, INFECT IMMUN, V69, P2894, DOI 10.1128/IAI.69.5.2894-2901.2001; Troxell B, 2011, J BACTERIOL, V193, P497, DOI 10.1128/JB.00942-10; Urban JH, 2007, NUCLEIC ACIDS RES, V35, P1018, DOI 10.1093/nar/gkl1040; Uzzau S, 2001, P NATL ACAD SCI USA, V98, P15264, DOI 10.1073/pnas.261348198; Weening EH, 2005, INFECT IMMUN, V73, P3358, DOI 10.1128/IAI.73.6.3358-3366.2005; Wood MW, 1998, MOL MICROBIOL, V29, P883, DOI 10.1046/j.1365-2958.1998.00984.x	72	21	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30499	10.1371/journal.pone.0030499	http://dx.doi.org/10.1371/journal.pone.0030499			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22291968	Green Published, gold, Green Submitted			2022-12-25	WOS:000301570600048
J	Nandi, P; Ghosh, S; Jana, K; Sen, PC				Nandi, Pinki; Ghosh, Swatilekha; Jana, Kuladip; Sen, Parimal C.			Elucidation of the Involvement of p14, a Sperm Protein during Maturation, Capacitation and Acrosome Reaction of Caprine Spermatozoa	PLOS ONE			English	Article							SEMINAL PLASMA; MAMMALIAN FERTILIZATION; BOVINE SPERMATOZOA; KINASE-C; LOCALIZATION; CA2+-ATPASE; CALCIUM; RAT	Mammalian sperm capacitation is an essential prerequisite to fertilization. Although progress is being made in understanding the physiology and biochemistry of capacitation, little has been yet explored about the potential role(s) of individual sperm cell protein during this process. Therefore elucidation of the role of different sperm proteins in the process of capacitation might be of great importance to understand the process of fertilization. The present work describes the partial characterization of a 14-kDa protein (p14) detected in goat spermatozoa using an antibody directed against the purified protein. Confocal microscopic analysis reveals that the protein is present in both the intracellular and extracellular regions of the acrosomal and postacrosomal portion of caudal sperm head. Though subcellular localization shows that p14 is mainly cytosolic, however it is also seen to be present in peripheral plasma membrane and soluble part of acrosome. Immuno-localization experiment shows change in the distribution pattern of this protein upon induction of capacitation in sperm cells. Increased immunolabeling in the anterior head region of live spermatozoa is also observed when these cells are incubated under capacitating conditions, whereas most sperm cells challenged with the calcium ionophore A23187 to acrosome react, lose their labeling almost completely. Intracellular distribution of p14 also changes significantly during acrosome reaction. Interestingly, on the other hand the antibody raised against this 14-kDa sperm protein enhances the forward motility of caprine sperm cells. Rose-Bengal staining method shows that this anti-p14 antibody also decreases the number of acrosome reacted cells if incubated with capacitated sperm cells before induction of acrosome reaction. All these results taken together clearly indicate that p14 is intimately involved and plays a critical role in the acrosomal membrane fusion event.	[Nandi, Pinki; Ghosh, Swatilekha; Jana, Kuladip; Sen, Parimal C.] Bose Inst, Div Mol Med, Kolkata, India	Department of Science & Technology (India); Bose Institute	Nandi, P (corresponding author), Bose Inst, Div Mol Med, Kolkata, India.	parimalsen@gmail.com	Jana, Kuladip/GXG-3481-2022	Jana, Kuladip/0000-0003-4748-253X	Council of Scientific and Industrial Research [37(1299)/07/EMR-II]; Bose Institute	Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); Bose Institute(Department of Science & Technology (India))	This work was funded by the Council of Scientific and Industrial Research [37(1299)/07/EMR-II] and by the Bose Institute. The funders has no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boue F, 1996, BIOL REPROD, V54, P1009, DOI 10.1095/biolreprod54.5.1009; Breitbart H, 2002, MOL CELL ENDOCRINOL, V187, P139, DOI 10.1016/S0303-7207(01)00704-3; Breitbart H, 1997, Rev Reprod, V2, P165, DOI 10.1530/revreprod/2.3.165; Brucker C, 1995, HUM REPROD UPDATE, V1, P51, DOI 10.1093/humupd/1.1.51; CHANG MC, 1957, NATURE, V179, P258, DOI 10.1038/179258a0; CHANG MC, 1951, NATURE, V168, P697, DOI 10.1038/168697b0; Cooper TG, 1986, EPIDIDYMIS SPERM MAT; CORNWALL GA, 1995, J ANDROL, V16, P379; Curi SM, 2003, ARCH ANDROLOGY, V49, P343, DOI 10.1080/01485010390219656; Das S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012039; DEJONGE FH, 1988, HORM BEHAV, V22, P100, DOI 10.1016/0018-506X(88)90034-7; ECCLESTON ED, 1994, MOL REPROD DEV, V37, P110, DOI 10.1002/mrd.1080370115; Florman HM, 1998, BIOL REPROD, V59, P12, DOI 10.1095/biolreprod59.1.12; Grasa P, 2009, REPRODUCTION, V137, P655, DOI 10.1530/REP-08-0280; Harlow E., 1988, ANTIBODIES LAB MANUA; HENAULT MA, 1995, BIOL REPROD, V52, P390, DOI 10.1095/biolreprod52.2.390; Kim KS, 2001, BIOL REPROD, V64, P36, DOI 10.1095/biolreprod64.1.36; Lalancette C, 2001, BIOL REPROD, V65, P628, DOI 10.1095/biolreprod65.2.628; Lax Y, 1997, BIOL REPROD, V56, P454, DOI 10.1095/biolreprod56.2.454; MACEK MB, 1988, GAMETE RES, V20, P93, DOI 10.1002/mrd.1120200109; Maiti A, 2009, J CELL PHYSIOL, V220, P394, DOI 10.1002/jcp.21778; MILLER DJ, 1990, BIOL REPROD, V42, P899, DOI 10.1095/biolreprod42.6.899; MYLES DG, 1991, ANN NY ACAD SCI, V637, P486, DOI 10.1111/j.1749-6632.1991.tb27332.x; PARRISH JJ, 1988, BIOL REPROD, V38, P1171, DOI 10.1095/biolreprod38.5.1171; ROLDAN ERS, 1988, BIOCHEM BIOPH RES CO, V155, P901, DOI 10.1016/S0006-291X(88)80581-3; Sengupta T, 2008, MOL CELL BIOCHEM, V311, P93, DOI 10.1007/s11010-007-9700-6; Sengupta T, 2007, COMP BIOCHEM PHYS B, V146, P131, DOI 10.1016/j.cbpb.2006.10.093; Tantibhedhyangkul J, 2002, BIOL REPROD, V67, P212, DOI 10.1095/biolreprod67.1.212; Therien I, 1997, BIOL REPROD, V57, P1080, DOI 10.1095/biolreprod57.5.1080; Tsai PS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011204; Visconti PE, 1998, BIOL REPROD, V59, P1, DOI 10.1095/biolreprod59.1.1; Wassarman PM, 1999, CELL, V96, P175, DOI 10.1016/S0092-8674(00)80558-9; WOLF DE, 1984, J CELL BIOL, V98, P1678, DOI 10.1083/jcb.98.5.1678; Yanagimachi R., 1994, P189	34	8	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30552	10.1371/journal.pone.0030552	http://dx.doi.org/10.1371/journal.pone.0030552			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22291985	Green Submitted, Green Published, gold			2022-12-25	WOS:000301570600056
J	Rodriguez-Ezpeleta, N; Embley, TM				Rodriguez-Ezpeleta, Naiara; Embley, T. Martin			The SAR11 Group of Alpha-Proteobacteria Is Not Related to the Origin of Mitochondria	PLOS ONE			English	Article							GENOME; PHYLOGENOMICS; EVOLUTION; SEQUENCE; ALIGNMENT; PROTEINS; PACKAGE	Although free living, members of the successful SAR11 group of marine alpha-proteobacteria contain a very small and A+T rich genome, two features that are typical of mitochondria and related obligate intracellular parasites such as the Rickettsiales. Previous phylogenetic analyses have suggested that Candidatus Pelagibacter ubique, the first cultured member of this group, is related to the Rickettsiales+mitochondria clade whereas others disagree with this conclusion. In order to determine the evolutionary position of the SAR11 group and its relationship to the origin of mitochondria, we have performed phylogenetic analyses on the concatenation of 24 proteins from 5 mitochondria and 71 proteobacteria. Our results support that SAR11 group is not the sistergroup of the Rickettsiales+mitochondria clade and confirm that the position of this group in the alpha-proteobacterial tree is strongly affected by tree reconstruction artefacts due to compositional bias. As a consequence, genome reduction and bias toward a high A+T content may have evolved independently in the SAR11 species, which points to a different direction in the quest for the closest relatives to mitochondria and Rickettsiales. In addition, our analyses raise doubts about the monophyly of the newly proposed Pelagibacteraceae family.	[Rodriguez-Ezpeleta, Naiara; Embley, T. Martin] Newcastle Univ, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK	Rodriguez-Ezpeleta, N (corresponding author), Txatxarramendi Ugartea ZG, AZTI Tecnalia, Marine Res Unit, Sukarrieta, Bizkaia, Spain.	nrodriguez@azti.es	Rodriguez-Ezpeleta, Naiara/B-7138-2014	Rodriguez-Ezpeleta, Naiara/0000-0001-6735-6755; Embley, Thomas Martin/0000-0002-1484-340X	Programa de Formacion de Investigadores del Departamento de Educacion, Universidades e Investigacion (Government of Basque Country); Royal Society	Programa de Formacion de Investigadores del Departamento de Educacion, Universidades e Investigacion (Government of Basque Country); Royal Society(Royal Society of London)	NR-E was supported by the Programa de Formacion de Investigadores del Departamento de Educacion, Universidades e Investigacion (Government of Basque Country). TME was supported by a Royal Society Wolfson Research Merit Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094; Brindefalk B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024457; Davidov Y, 2006, ENVIRON MICROBIOL, V8, P2179, DOI 10.1111/j.1462-2920.2006.01101.x; Dufresne A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-r14; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Embley TM, 2006, PHILOS T R SOC B, V361, P1055, DOI 10.1098/rstb.2006.1844; Esser C, 2004, MOL BIOL EVOL, V21, P1643, DOI 10.1093/molbev/msh160; Fitzpatrick DA, 2006, MOL BIOL EVOL, V23, P74, DOI 10.1093/molbev/msj009; Foster PG, 2004, SYST BIOL, V53, P485, DOI 10.1080/10635150490445779; Foster PG, 1997, J MOL EVOL, V44, P282, DOI 10.1007/PL00006145; Georgiades K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024857; Gillespie JJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002018; Gillespie JJ, 2010, INFECT IMMUN, V78, P1809, DOI 10.1128/IAI.01384-09; GIOVANNONI SJ, 1990, NATURE, V345, P60, DOI 10.1038/345060a0; Giovannoni SJ, 2005, SCIENCE, V309, P1242, DOI 10.1126/science.1114057; Gupta RS, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-106; Hrdy I, 2004, NATURE, V432, P618, DOI 10.1038/nature03149; Jeffroy O, 2006, TRENDS GENET, V22, P225, DOI 10.1016/j.tig.2006.02.003; Lang BF, 1999, ANNU REV GENET, V33, P351, DOI 10.1146/annurev.genet.33.1.351; Lartillot N, 2004, MOL BIOL EVOL, V21, P1095, DOI 10.1093/molbev/msh112; Lartillot N, 2006, BMC EVOL BI IN PRESS; Lartillot N, 2009, BIOINFORMATICS, V25, P2286, DOI 10.1093/bioinformatics/btp368; Meyer MM, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-268; Moran NA, 2003, CURR OPIN MICROBIOL, V6, P512, DOI 10.1016/j.mib.2003.08.001; PHILIPPE H, 1993, NUCLEIC ACIDS RES, V21, P5264, DOI 10.1093/nar/21.22.5264; Phillips MJ, 2004, MOL BIOL EVOL, V21, P1455, DOI 10.1093/molbev/msh137; Poiata E, 2009, RNA, V15, P2046, DOI 10.1261/rna.1824209; Rodriguez-Ezpeleta N, 2007, SYST BIOL, V56, P389, DOI 10.1080/10635150701397643; Roure B, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-S1-S2; Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191; Stechmann A, 2008, CURR BIOL, V18, P580, DOI 10.1016/j.cub.2008.03.037; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Thrash JC, 2011, SCI REP-UK, V1, DOI 10.1038/srep00013; Tripp HJ, 2009, ENVIRON MICROBIOL, V11, P230, DOI 10.1111/j.1462-2920.2008.01758.x; Viklund J, 2011, MOL BIOL EV IN PRESS; Vinogradov SN, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-31; Wang CX, 2007, J BACTERIOL, V189, P1954, DOI 10.1128/JB.01203-06; Wernersson R, 2003, NUCLEIC ACIDS RES, V31, P3537, DOI 10.1093/nar/gkg609; Williams KP, 2007, J BACTERIOL, V189, P4578, DOI 10.1128/JB.00269-07; WOESE CR, 1987, MICROBIOL REV, V51, P221, DOI 10.1128/MMBR.51.2.221-271.1987; WOESE CR, 1991, SYST APPL MICROBIOL, V14, P364, DOI 10.1016/S0723-2020(11)80311-5; Wu M, 2004, PLOS BIOL, V2, P327, DOI 10.1371/journal.pbio.0020069	42	59	60	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30520	10.1371/journal.pone.0030520	http://dx.doi.org/10.1371/journal.pone.0030520			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22291975	Green Submitted, Green Published, gold			2022-12-25	WOS:000301570600053
J	Serrano, I; McDonald, PC; Lock, FE; Dedhar, S				Serrano, I.; McDonald, P. C.; Lock, F. E.; Dedhar, S.			Role of the integrin-linked kinase (ILK)/Rictor complex in TGF beta-1-induced epithelial-mesenchymal transition (EMT)	ONCOGENE			English	Article						integrin-linked kinase; breast epithelial cells; ILK/Rictor complex; EMT; Rictor; cancer	GLYCOGEN-SYNTHASE KINASE-3; E-CADHERIN REPRESSOR; BREAST-CANCER CELLS; TGF-BETA; MAMMALIAN TARGET; EXPRESSION; RICTOR; SNAIL; PHOSPHORYLATION; ACTIVATION	Epithelial-to-mesenchymal transition (EMT) causes fibrosis, cancer progression and metastasis. Integrin-linked kinase (ILK) is a focal adhesion adaptor and a serine/threonine protein kinase that regulates cell proliferation, survival and EMT. Elucidating the molecular mechanisms necessary for development and progression of human malignancies is critical to predict the most appropriate targets for cancer therapy. Here, we used transforming growth factor beta-1 (TGF beta-1) to promote EMT and migration in mammary epithelial cells. We demonstrate a requirement of ILK activity for TGF beta-1-mediated EMT in mammary epithelial cells. In addition to nuclear translocation of Snail and Slug, TGF beta-1 treatment also induced expression of the mammalian target of rapamycin complex 2 component Rictor and its phosphorylation on Thr1135. Interestingly, TGF beta-1 treatment also induced an interaction between ILK and Rictor. All of these TGF beta-1-induced processes were significantly suppressed by inhibiting ILK activity or by disrupting the ILK/Rictor complex using small-interfering RNA-mediated knockdown. Furthermore, we identified ILK/Rictor complex formation in cancer but not in normal cell types, and this was accompanied by ILK-dependent phosphorylation of Rictor on residue Thr1135. Inhibition of ILK partially reversed the basal mesenchymal phenotype of MDA-MB-231 cells and prevented EMT in MCF10A cells after TGF beta-1 treatment. These data demonstrate a requirement for ILK function in TGF beta-1-induced EMT in mammary epithelial cells and identify the ILK/Rictor complex as a potential molecular target for preventing/reversing EMT. Oncogene (2013) 32, 50-60; doi:10.1038/onc.2012.30; published online 6 February 2012	[Dedhar, S.] Univ British Columbia, BC Canc Res Ctr, Inst Life Sci, Dept Biochem & Mol Biol, Vancouver, BC V5Z 1L3, Canada; [Serrano, I.; McDonald, P. C.; Lock, F. E.; Dedhar, S.] BC Canc Agcy, British Columbia Canc Res Ctr, Dept Integrat Oncol, Vancouver, BC, Canada	British Columbia Cancer Agency; University of British Columbia; British Columbia Cancer Agency	Dedhar, S (corresponding author), Univ British Columbia, BC Canc Res Ctr, Inst Life Sci, Dept Biochem & Mol Biol, 675 W 10th Ave, Vancouver, BC V5Z 1L3, Canada.	sdedhar@bccrc.ca		Dedhar, Shoukat/0000-0003-4355-1657	Canadian Cancer Society Research Institute (CCSRI); Canadian Institutes for Health Research (CIHR)	Canadian Cancer Society Research Institute (CCSRI)(Canadian Cancer Society (CCS)); Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This study was supported by grants to SD from the Canadian Cancer Society Research Institute (CCSRI) and the Canadian Institutes for Health Research (CIHR). We thank Quadra Logic Technology Inc (QLT Inc), Vancouver, BC, for supplying QLT-0267.	Bachelder RE, 2005, J CELL BIOL, V168, P29, DOI 10.1083/jcb.200409067; Bakin AV, 2000, J BIOL CHEM, V275, P36803, DOI 10.1074/jbc.M005912200; Bhowmick NA, 2001, J BIOL CHEM, V276, P46707, DOI 10.1074/jbc.M106176200; Bhowmick NA, 2001, MOL BIOL CELL, V12, P27, DOI 10.1091/mbc.12.1.27; Boulbes D, 2010, MOL CANCER RES, V8, P896, DOI 10.1158/1541-7786.MCR-09-0409; Garcia SAD, 2011, CANCER MICROENVIRON, V4, P33, DOI 10.1007/s12307-010-0059-y; Dibble CC, 2009, MOL CELL BIOL, V29, P5657, DOI 10.1128/MCB.00735-09; Doble BW, 2007, CELLS TISSUES ORGANS, V185, P73, DOI 10.1159/000101306; Dong CM, 2000, MOL CELL, V5, P27, DOI 10.1016/S1097-2765(00)80400-1; Dzwonek J, 2009, MOL CANCER RES, V7, P1342, DOI 10.1158/1541-7786.MCR-08-0558; Fielding AB, 2008, CELL CYCLE, V7, P1899, DOI 10.4161/cc.7.13.6204; Foster KG, 2010, J BIOL CHEM, V285, P14071, DOI 10.1074/jbc.R109.094003; Futterman MA, 2011, DEV DYNAM, V240, P1502, DOI 10.1002/dvdy.22607; Gao H, 2012, CELL BIOL INT, V36, P155, DOI 10.1042/CBI20100240; Garcia G, 2009, J MED CHEM, V52, P7220, DOI 10.1021/jm9003957; Gil D, 2011, ADV ENZYME REGUL, V51, P195, DOI 10.1016/j.advenzreg.2010.09.005; Gulhati P, 2011, CANCER RES, V71, P3246, DOI 10.1158/0008-5472.CAN-10-4058; Hannigan G, 2005, NAT REV CANCER, V5, P51, DOI 10.1038/nrc1524; Hong-Brown LQ, 2011, ALCOHOL CLIN EXP RES, V35, P1445, DOI 10.1111/j.1530-0277.2011.01480.x; Jing YY, 2011, CELL BIOSCI, V1, DOI 10.1186/2045-3701-1-29; Jo M, 2009, J BIOL CHEM, V284, P22825, DOI 10.1074/jbc.M109.023960; Julien LA, 2010, MOL CELL BIOL, V30, P908, DOI 10.1128/MCB.00601-09; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kavvadas P, 2010, VIRCHOWS ARCH, V457, P563, DOI 10.1007/s00428-010-0976-7; Lamb RF, 1997, MOL CELL BIOL, V17, P963, DOI 10.1128/MCB.17.2.963; Lee YI, 2004, BIOCHEM BIOPH RES CO, V316, P997, DOI 10.1016/j.bbrc.2004.02.150; Li YJ, 2009, J AM SOC NEPHROL, V20, P1907, DOI 10.1681/ASN.2008090930; Margadant C, 2010, EMBO REP, V11, P97, DOI 10.1038/embor.2009.276; Matsui Y, 2012, INT J CANCER, V130, P521, DOI 10.1002/ijc.26008; McDonald PC, 2008, J CELL SCI, V121, P3121, DOI 10.1242/jcs.017996; McDonald PC, 2008, CANCER RES, V68, P1618, DOI 10.1158/0008-5472.CAN-07-5869; McPhee TR, 2008, DEV DYNAM, V237, P2737, DOI 10.1002/dvdy.21685; Mikami S, 2011, LAB INVEST, V91, P1443, DOI 10.1038/labinvest.2011.111; Oh JS, 2002, NEOPLASIA, V4, P204, DOI 10.1038/sj.neo.7900229; Papanikolaou S, 2010, HISTOPATHOLOGY, V56, P799, DOI 10.1111/j.1365-2559.2010.03556.x; Persad S, 2001, J CELL BIOL, V153, P1161, DOI 10.1083/jcb.153.6.1161; Piek E, 1999, J CELL SCI, V112, P4557; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Savagner P, 2001, BIOESSAYS, V23, P912, DOI 10.1002/bies.1132; Shih JY, 2011, CARCINOGENESIS, V32, P1299, DOI 10.1093/carcin/bgr110; Somasiri A, 2001, J CELL SCI, V114, P1125; Tan C, 2001, ONCOGENE, V20, P133, DOI 10.1038/sj.onc.1204052; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Treins C, 2010, ONCOGENE, V29, P1003, DOI 10.1038/onc.2009.401; Troussard AA, 2006, CANCER RES, V66, P393, DOI 10.1158/0008-5472.CAN-05-2304; Valcourt U, 2005, MOL BIOL CELL, V16, P1987, DOI 10.1091/mbc.e04-08-0658; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927; Zhao JH, 2011, CANCER INVEST, V29, P377, DOI 10.3109/07357907.2010.512595; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173	49	96	110	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2013	32	1					50	60		10.1038/onc.2012.30	http://dx.doi.org/10.1038/onc.2012.30			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	063VG	22310280				2022-12-25	WOS:000313029500005
J	Leucci, E; Zriwil, A; Gregersen, LH; Jensen, KT; Obad, S; Bellan, C; Leoncini, L; Kauppinen, S; Lund, AH				Leucci, E.; Zriwil, A.; Gregersen, L. H.; Jensen, K. T.; Obad, S.; Bellan, C.; Leoncini, L.; Kauppinen, S.; Lund, A. H.			Inhibition of miR-9 de-represses HuR and DICER1 and impairs Hodgkin lymphoma tumour outgrowth in vivo	ONCOGENE			English	Article						miR-9; cytokines; Hodgkin lymphoma; HuR; DICER1	MICRORNA EXPRESSION; BINDING PROTEINS; POSTTRANSCRIPTIONAL CONTROL; STERNBERG CELLS; CANCER; INFLAMMATION; INVOLVEMENT; TRANSCRIPTION; METASTASIS; CYTOKINES	MicroRNAs are important regulators of gene expression in normal development and disease. miR-9 is overexpressed in several cancer forms, including brain tumours, hepatocellular carcinomas, breast cancer and Hodgkin lymphoma (HL). Here we demonstrated a relevance for miR-9 in HL pathogenesis and identified two new targets Dicer1 and HuR. HL is characterized by a massive infiltration of immune cells and fibroblasts in the tumour, whereas malignant cells represent only 1% of the tumour mass. These infiltrates provide important survival and growth signals to the tumour cells, and several lines of evidence indicate that they are essential for the persistence of HL. We show that inhibition of miR-9 leads to derepression of DICER and HuR, which in turn results in a decrease in cytokine production by HL cells followed by an impaired ability to attract normal inflammatory cells. Finally, inhibition of miR-9 by a systemically delivered antimiR-9 in a xenograft model of HL increases the protein levels of HuR and DICER1 and results in decreased tumour outgrowth, confirming that miR-9 actively participates in HL pathogenesis and points to miR-9 as a potential therapeutic target. Oncogene (2012) 31, 5081-5089; doi:10.1038/onc.2012.15; published online 6 February 2012	[Leucci, E.; Zriwil, A.; Gregersen, L. H.; Jensen, K. T.; Lund, A. H.] Univ Copenhagen, Copenhagen Bioctr, Biotech Res & Innovat Ctr, DK-2200 Copenhagen N, Denmark; [Obad, S.; Kauppinen, S.] Santaris Pharma, Horsholm, Denmark; [Bellan, C.; Leoncini, L.] Univ Siena, Dept Human Pathol & Oncol, I-53100 Siena, Italy; [Kauppinen, S.] Aalborg Univ, Copenhagen Inst Technol, Ballerup, Denmark	University of Copenhagen; University of Siena; Aalborg University	Lund, AH (corresponding author), Univ Copenhagen, Copenhagen Bioctr, Biotech Res & Innovat Ctr, DK-2200 Copenhagen N, Denmark.	anders.lund@bric.ku.dk	LEONCINI, Lorenzo/U-4413-2019; Lund, Anders H./F-4786-2014; BELLAN, CRISTIANA/ABG-4750-2021; Gregersen, Lea H/AAI-2386-2021; BELLAN, CRISTIANA/L-3903-2013; leoncini, lorenzo/P-8361-2018; Leucci, Eleonora/G-4938-2011	LEONCINI, Lorenzo/0000-0002-7457-300X; Lund, Anders H./0000-0002-7407-3398; BELLAN, CRISTIANA/0000-0001-6119-9007; Gregersen, Lea H/0000-0002-1205-604X; BELLAN, CRISTIANA/0000-0001-6119-9007; leoncini, lorenzo/0000-0002-7457-300X; Leucci, Eleonora/0000-0002-2898-748X; Zriwil, Alya/0000-0001-6262-7253	Danish National Advanced Technology Foundation; EC FP7 ONCOMIRS consortium [201102]; Novo Nordisk Foundation; Lundbeck Foundation; Danish Cancer Society; Danish National Research Foundation; Monte dei Paschi di Siena Foundation; Danish Medical Research Council	Danish National Advanced Technology Foundation; EC FP7 ONCOMIRS consortium; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Lundbeck Foundation(Lundbeckfonden); Danish Cancer Society(Danish Cancer Society); Danish National Research Foundation(Danmarks Grundforskningsfond); Monte dei Paschi di Siena Foundation; Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by The Danish National Advanced Technology Foundation, The EC FP7 ONCOMIRS consortium (Grant agreement number 201102: this publication reflects only authors' views; the commission is not liable for any use that may be made of the information herein), The Novo Nordisk Foundation, The Lundbeck Foundation, The Danish Cancer Society and the Danish National Research Foundation. Dr Bellan's and Professor Leoncini's work is supported by the Monte dei Paschi di Siena Foundation. Dr Leucci is supported by a grant from the Danish Medical Research Council.	Aldinucci D, 2008, INT J CANCER, V122, P769, DOI 10.1002/ijc.23119; Anderson P, 2008, NAT IMMUNOL, V9, P353, DOI 10.1038/ni1584; Bazzoni F, 2009, P NATL ACAD SCI USA, V106, P5282, DOI 10.1073/pnas.0810909106; Christoffersen NR, 2010, CELL DEATH DIFFER, V17, P236, DOI 10.1038/cdd.2009.109; de Silanes IL, 2004, P NATL ACAD SCI USA, V101, P2987, DOI 10.1073/pnas.0306453101; Dean JLE, 2004, CELL SIGNAL, V16, P1113, DOI 10.1016/j.cellsig.2004.04.006; Dewan MZ WM, 2005, CANCER SCI, V96, P7; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Gentleman R, 2005, BIOINFORMATICS COMPU, P473; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96; Katsanou V, 2005, MOL CELL, V19, P777, DOI 10.1016/j.molcel.2005.08.007; Kawai T, 2006, MOL CELL BIOL, V26, P3295, DOI 10.1128/MCB.26.8.3295-3307.2006; Khabar KSA, 2010, CELL MOL LIFE SCI, V67, P2937, DOI 10.1007/s00018-010-0383-x; Khan G, 2006, EXP HEMATOL, V34, P399, DOI 10.1016/j.exphem.2005.11.008; Kota SK, 2010, DRUG DISCOV TODAY, V15, P733, DOI 10.1016/j.drudis.2010.07.003; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Kuppers R, 2009, NAT REV CANCER, V9, P15, DOI 10.1038/nrc2542; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Kumar MS, 2009, GENE DEV, V23, P2700, DOI 10.1101/gad.1848209; Lambertz I, 2010, CELL DEATH DIFFER, V17, P633, DOI 10.1038/cdd.2009.202; Lawrie CH, 2008, LEUKEMIA, V22, P1440, DOI 10.1038/sj.leu.2405083; Lebedeva S, 2011, MOL CELL, V43, P340, DOI 10.1016/j.molcel.2011.06.008; Limma G.S., 2005, BIOINFORMATICS COMPU, P23; Linker K, 2005, NUCLEIC ACIDS RES, V33, P4813, DOI 10.1093/nar/gki797; Lopez-Rodriguez C, 2001, IMMUNITY, V15, P47, DOI 10.1016/S1074-7613(01)00165-0; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lu JY, 2004, J BIOL CHEM, V279, P12974, DOI 10.1074/jbc.M310433200; Ma L, 2010, NAT BIOTECHNOL, V28, P341, DOI 10.1038/nbt.1618; Ma L, 2010, NAT CELL BIOL, V12, P247, DOI 10.1038/ncb2024; Marstrand TT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001623; Martello G, 2010, CELL, V141, P1195, DOI 10.1016/j.cell.2010.05.017; Medzhitov R, 2009, NAT REV IMMUNOL, V9, P692, DOI 10.1038/nri2634; Mukherjee N, 2011, MOL CELL, V43, P327, DOI 10.1016/j.molcel.2011.06.007; Navarro A, 2008, BLOOD, V111, P2825, DOI 10.1182/blood-2007-06-096784; Nie K, 2008, AM J PATHOL, V173, P242, DOI 10.2353/ajpath.2008.080009; Obad S, 2011, NAT GENET, V43, P371, DOI 10.1038/ng.786; Orom UA, 2008, MOL CELL, V30, P460, DOI 10.1016/j.molcel.2008.05.001; Schetter AJ, 2009, CLIN CANCER RES, V15, P5878, DOI 10.1158/1078-0432.CCR-09-0627; Skinnider BF, 2002, BLOOD, V99, P4283, DOI 10.1182/blood-2002-01-0099; Stein CA, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp841; Van Vlierberghe P, 2009, BRIT J HAEMATOL, V147, P686, DOI 10.1111/j.1365-2141.2009.07909.x; Ventura A, 2009, CELL, V136, P586, DOI 10.1016/j.cell.2009.02.005; Wynendaele J, 2010, CANCER RES, V70, P9641, DOI 10.1158/0008-5472.CAN-10-0527	44	63	67	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC	2012	31	49					5081	5089		10.1038/onc.2012.15	http://dx.doi.org/10.1038/onc.2012.15			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	049RK	22310293				2022-12-25	WOS:000312000900004
J	Wang, A; Savas, U; Hsu, MH; Stout, CD; Johnson, EF				Wang, An; Savas, Uzen; Hsu, Mei-Hui; Stout, C. David; Johnson, Eric F.			Crystal Structure of Human Cytochrome P450 2D6 with Prinomastat Bound	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANGSTROM RESOLUTION; INHIBITION; METABOLISM; CYP2D6; PURIFICATION; EXPRESSION; MECHANISM; P4502C5; COMPLEX; PROTEIN	Human cytochrome P450 2D6 contributes to the metabolism of >15% of drugs used in clinical practice. This study determined the structure of P450 2D6 complexed with a substrate and potent inhibitor, prinomastat, to 2.85 angstrom resolution by x-ray crystallography. Prinomastat binding is well defined by electron density maps with its pyridyl nitrogen bound to the heme iron. The structure of ligand-bound P450 2D6 differs significantly from the ligand-free structure reported for the P450 2D6 Met-374 variant (Protein Data Bank code 2F9Q). Superposition of the structures reveals significant differences for beta sheet 1, helices A, F, F', G '', G, and H as well as the helix B-C loop. The structure of the ligand complex exhibits a closed active site cavity that conforms closely to the shape of prinomastat. The closure of the open cavity seen for the 2F9Q structure reflects a change in the direction and pitch of helix F and introduction of a turn at Gly-218, which is followed by a well defined helix F' that was not observed in the 2F9Q structure. These differences reflect considerable structural flexibility that is likely to contribute to the catalytic versatility of P450 2D6, and this new structure provides an alternative model for in silico studies of substrate interactions with P450 2D6.	[Stout, C. David] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Wang, An; Savas, Uzen; Hsu, Mei-Hui; Johnson, Eric F.] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Stout, CD (corresponding author), Scripps Res Inst, Dept Mol Biol, 10550 N Torrey Pines Rd,MB8, La Jolla, CA 92037 USA.	dave@scripps.edu; johnson@scripps.edu			National Institutes of Health [GM031001]; Pfizer Global Research and Development; United States Department of Energy, Office of Biological and Environmental Research; National Institutes of Health, NCRR; National Institutes of Health, NIGMS; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031001] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pfizer Global Research and Development(Pfizer); United States Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM031001 (to E. F. J.). This work was also supported by Pfizer Global Research and Development. Portions of this work were carried out at the Stanford Synchrotron Radiation Lightsource, a national user facility operated by Stanford University on behalf of the United States Department of Energy, Office of Basic Energy Sciences.; The technical support of LacThu Tonnu for the preparation and crystallization of P450 2D6 and the help provided by the support staff at Stanford Synchrotron Radiation Lightsource for data collection are greatly appreciated. We also thank Pfizer Global Research and Development for providing prinomastat for the purification and crystallization of the prinomastat P450 2D6 complex and Ben Burke, Caroline Lee, Michael Wester, and Michael Zientek for helpful discussions during the course of this work. The Stanford Synchrotron Radiation Lightsource, Structural Molecular Biology Program, is supported by the United States Department of Energy, Office of Biological and Environmental Research, and by National Institutes of Health, NCRR, Biomedical Technology Program, and NIGMS.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barnes HJ, 1996, METHOD ENZYMOL, V272, P3, DOI 10.1016/S0076-6879(96)72003-7; Berka K, 2011, J PHYS CHEM A, V115, P11248, DOI 10.1021/jp204488j; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cojocaru V, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002152; CRESPI CL, 1995, PHARMACOGENETICS, V5, P234, DOI 10.1097/00008571-199508000-00007; Dehal SS, 1997, CANCER RES, V57, P3402; Ellis SW, 1996, BIOCHEM J, V316, P647, DOI 10.1042/bj3160647; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GEGNER JA, 1991, P NATL ACAD SCI USA, V88, P750, DOI 10.1073/pnas.88.3.750; Halpert JR, 2011, DRUG METAB DISPOS, V39, P1113, DOI 10.1124/dmd.111.039719; Hande KR, 2004, CLIN CANCER RES, V10, P909, DOI 10.1158/1078-0432.CCR-0981-3; Hanna IH, 2001, ARCH BIOCHEM BIOPHYS, V393, P255, DOI 10.1006/abbi.2001.2510; Ingelman-Sundberg M, 2010, BIOCHEM BIOPH RES CO, V396, P90, DOI 10.1016/j.bbrc.2010.02.162; KLEYWEGT GJ, 1994, ACTA CRYSTALLOGR D, V50, P178, DOI 10.1107/S0907444993011333; KROEMER HK, 1995, LIFE SCI, V56, P2285, DOI 10.1016/0024-3205(95)00223-S; Kuzmic P, 2004, METHOD ENZYMOL, V383, P366; Kuzmic P, 2009, METHOD ENZYMOL, V467, P247, DOI 10.1016/S0076-6879(09)67010-5; Mast N, 2008, P NATL ACAD SCI USA, V105, P9546, DOI 10.1073/pnas.0803717105; Masuda K, 2005, CHIRALITY, V17, P37, DOI 10.1002/chir.20092; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; OMURA T, 1964, J BIOL CHEM, V239, P2379; Pearson J, 2011, ARCH BIOCHEM BIOPHYS, V511, P69, DOI 10.1016/j.abb.2011.04.008; Rowland P, 2006, J BIOL CHEM, V281, P7614, DOI 10.1074/jbc.M511232200; Sansen S, 2007, J BIOL CHEM, V282, P14348, DOI 10.1074/jbc.M611692200; Schoch GA, 2004, J BIOL CHEM, V279, P9497, DOI 10.1074/jbc.M312516200; Scott EE, 2003, P NATL ACAD SCI USA, V100, P13196, DOI 10.1073/pnas.2133986100; Shin JG, 1999, DRUG METAB DISPOS, V27, P1078; VONBAHR C, 1985, BIOCHEM PHARMACOL, V34, P2501, DOI 10.1016/0006-2952(85)90533-7; Wang A, 2011, J BIOL CHEM, V286, P5736, DOI 10.1074/jbc.M110.204420; Wang B, 2009, DRUG METAB REV, V41, P573, DOI 10.1080/03602530903118729; Wester MR, 2003, BIOCHEMISTRY-US, V42, P9335, DOI 10.1021/bi034556l; Wester MR, 2003, BIOCHEMISTRY-US, V42, P6370, DOI 10.1021/bi0273922; Wester MR, 2002, METHOD ENZYMOL, V357, P73; Yano JK, 2005, NAT STRUCT MOL BIOL, V12, P822, DOI 10.1038/nsmb971; Zanger UM, 2008, ANAL BIOANAL CHEM, V392, P1093, DOI 10.1007/s00216-008-2291-6; Zhou SF, 2009, DRUG METAB REV, V41, P89, DOI 10.1080/03602530902843483	37	77	79	0	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					10834	10843		10.1074/jbc.M111.307918	http://dx.doi.org/10.1074/jbc.M111.307918			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22308038	Green Published, hybrid			2022-12-25	WOS:000302780100012
J	Li, J; Chu, MY; Wang, SS; Chan, D; Qi, SK; Wu, M; Zhou, ZL; Li, JW; Nishi, E; Qin, J; Wong, JM				Li, Jing; Chu, Mingyue; Wang, Shanshan; Chan, Doug; Qi, Shankang; Wu, Meng; Zhou, Zhongliang; Li, Jiwen; Nishi, Eiichiro; Qin, Jun; Wong, Jiemin			Identification and Characterization of Nardilysin as a Novel Dimethyl H3K4-binding Protein Involved in Transcriptional Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARGININE DIBASIC CONVERTASE; LINKED MENTAL-RETARDATION; HISTONE H3; PHD FINGER; HETEROCHROMATIN FORMATION; CHROMATIN MODIFICATIONS; LYSINE-4 METHYLATION; COREPRESSOR COMPLEX; PLANT HOMEODOMAIN; STRUCTURAL BASIS	Histone methylation on lysine residues is believed to function primarily as docking sites to recruit specific proteins termed as histone code "readers" or "effectors." Each lysine residue can be mono-, di, and tri-methylated and different methylation states can have different effect on chromatin function. While an increasing number of proteins have been identified and characterized as specific effectors for methylated histones, very few of the proteins are known to recognize a particular state of methylation. In this study, we identified nardilysin (NRDc), a member of M16 family metalloendopeptidases, as a novel dimethyl-H3K4 (H3K4me2)-binding protein. Among three methylated states, NRDc binds preferentially H3K4me2 both in vitro and in vivo. Biochemical purification demonstrated that NRDc interacts with the NCoR/SMRT corepressor complex. We identified target genes repressed by NRDc through microarray. We showed that NRDc is physically associated with and recruits the NCoR complex to some of the repressed genes and this association correlates with binding of H3K4me2. Thus, our study has identified a novel H3K4me2-binding protein and revealed a role of NRDc in transcriptional regulation.	[Li, Jing; Chu, Mingyue; Wang, Shanshan; Qi, Shankang; Wu, Meng; Zhou, Zhongliang; Li, Jiwen; Wong, Jiemin] E China Normal Univ, Inst Biomed Sci, Shanghai Key Lab Regulatory Biol, Shanghai 200241, Peoples R China; [Li, Jing; Chu, Mingyue; Wang, Shanshan; Qi, Shankang; Wu, Meng; Zhou, Zhongliang; Li, Jiwen; Wong, Jiemin] E China Normal Univ, Sch Life Sci, Shanghai 200241, Peoples R China; [Chan, Doug; Qin, Jun] Baylor Coll Med, Ctr Mol Discovery, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Nishi, Eiichiro] Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Kyoto 6068501, Japan	East China Normal University; East China Normal University; Baylor College of Medicine; Kyoto University	Wong, JM (corresponding author), E China Normal Univ, Inst Biomed Sci, Shanghai Key Lab Regulatory Biol, 500 DongchuanRoad, Shanghai 200241, Peoples R China.	jmweng@bio.ecnu.edu.cn	Nishi, Eiichiro/A-8246-2019; Wu, Meng/N-9345-2014	Nishi, Eiichiro/0000-0002-8188-8026; Wu, Meng/0000-0001-8436-2209; Wong, Jiemin/0000-0002-5311-842X	National Natural Science Foundation of China [90919025]; Ministry of Science and Technology of China [2009CB918402, 2009CB825601, 2010CB944903]; Science and Technology Commission of Shanghai Municipality [09PJ1404200, 09DJ1400400]; ECNU [2009037]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); ECNU	This study was partially supported by grants from the National Natural Science Foundation of China (90919025), the Ministry of Science and Technology of China (2009CB918402, 2009CB825601, 2010CB944903), the Science and Technology Commission of Shanghai Municipality (09PJ1404200, 09DJ1400400), and the PhD Program Scholarship Fund of ECNU 2009 (2009037).	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Botuyan MV, 2006, CELL, V127, P1361, DOI 10.1016/j.cell.2006.10.043; Chan DW, 2009, PROTEOMICS, V9, P2343, DOI 10.1002/pmic.200800600; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Feng WJ, 2010, NAT STRUCT MOL BIOL, V17, P445, DOI 10.1038/nsmb.1778; Fumagalli P, 1998, GENOMICS, V47, P238, DOI 10.1006/geno.1997.5078; Guenther MG, 2000, GENE DEV, V14, P1048; Hughes RM, 2007, P NATL ACAD SCI USA, V104, P11184, DOI 10.1073/pnas.0610850104; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Karagianni P, 2008, MOL CELL BIOL, V28, P705, DOI 10.1128/MCB.01598-07; Kessler J. H., NAT IMMUNOL, V12, P45; Kim T, 2009, CELL, V137, P259, DOI 10.1016/j.cell.2009.02.045; Kleine-Kohlbrecher D, 2010, MOL CELL, V38, P165, DOI 10.1016/j.molcel.2010.03.002; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li H, 2007, MOL CELL, V28, P677, DOI 10.1016/j.molcel.2007.10.023; Li HT, 2006, NATURE, V442, P91, DOI 10.1038/nature04802; Li JW, 2000, EMBO J, V19, P4342, DOI 10.1093/emboj/19.16.4342; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Nair SS, 2010, EMBO REP, V11, P438, DOI 10.1038/embor.2010.62; Nishi E, 2001, EMBO J, V20, P3342, DOI 10.1093/emboj/20.13.3342; Nishi E, 2006, J BIOL CHEM, V281, P31164, DOI 10.1074/jbc.M601316200; Nishioka K, 2002, GENE DEV, V16, P479, DOI 10.1101/gad.967202; Ohno M, 2009, NAT NEUROSCI, V12, P1506, DOI 10.1038/nn.2438; Orford K, 2008, DEV CELL, V14, P798, DOI 10.1016/j.devcel.2008.04.002; Pena PV, 2006, NATURE, V442, P100, DOI 10.1038/nature04814; PIEROTTI AR, 1994, P NATL ACAD SCI USA, V91, P6078, DOI 10.1073/pnas.91.13.6078; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Qiu JH, 2010, CELL RES, V20, P908, DOI 10.1038/cr.2010.81; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Shi Y, 2007, NAT REV GENET, V8, P829, DOI 10.1038/nrg2218; Sims RJ, 2005, J BIOL CHEM, V280, P41789, DOI 10.1074/jbc.C500395200; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Upadhyay AK, 2011, PROG DRUG RES, V67, P107, DOI 10.1007/978-3-7643-8989-5_6; Vermeulen M, 2007, CELL, V131, P58, DOI 10.1016/j.cell.2007.08.016; Wen H, 2010, J BIOL CHEM, V285, P9322, DOI 10.1074/jbc.C109.097667; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Yang XJ, 1996, NATURE, V382, P319, DOI 10.1038/382319a0; Yoon HG, 2005, MOL CELL BIOL, V25, P324, DOI 10.1128/MCB.25.1.324-335.2005; Zegerman P, 2002, J BIOL CHEM, V277, P11621, DOI 10.1074/jbc.C200045200; Zhang JS, 2002, MOL CELL, V9, P611, DOI 10.1016/S1097-2765(02)00468-9	44	28	28	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					10089	10098		10.1074/jbc.M111.313965	http://dx.doi.org/10.1074/jbc.M111.313965			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22294699	Green Published, hybrid			2022-12-25	WOS:000302167200041
J	Wang, F; Olson, EM; Shyng, SL				Wang, Fang; Olson, Erik M.; Shyng, Show-Ling			Role of Derlin-1 Protein in Proteostasis Regulation of ATP-sensitive Potassium Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ER-ASSOCIATED DEGRADATION; SULFONYLUREA RECEPTOR; TRANSMEMBRANE DOMAIN; QUALITY-CONTROL; SUBUNIT STOICHIOMETRY; DEFECTIVE TRAFFICKING; MISFOLDED PROTEINS; INSULIN-SECRETION; MUTATIONS; HYPERINSULINISM	ATP-sensitive potassium (K-ATP) channels composed of sulfonylurea receptor 1 (SUR1) and Kir6.2 regulate insulin secretion by linking glucose metabolism with membrane potential. The number of K-ATP channels in the plasma membrane affects the sensitivity of beta-cells to glucose. Aberrant surface channel expression leads to insulin secretion disease. Previously, we have shown that K-ATP channel proteins undergo endoplasmic reticulum (ER)-associated degradation (ERAD) via the ubiquitin-proteasome pathway, and inhibition of proteasome function results in an increase in channel surface expression. Here, we investigated whether Derlin-1, a protein involved in retrotranslocation of misfolded or misassembled proteins across the ER membrane for degradation by cytosolic proteasomes, plays a role in ERAD and, in turn, biogenesis efficiency of K-ATP channels. We show that both SUR1 and Kir6.2 form a complex with Derlin-1 and an associated AAA-ATPase, p97. Overexpression of Derlin-1 led to a decrease in the biogenesis efficiency and surface expression of K-ATP channels. Conversely, knockdown of Derlin-1 by RNA interference resulted in increased processing of SUR1 and a corresponding increase in surface expression of K-ATP channels. Importantly, knockdown of Derlin-1 increased the abundance of disease-causing misfolded SUR1 or Kir6.2 proteins and even partially rescued surface expression in a mutant channel. We conclude that Derlin-1, by being involved in ERAD of SUR1 and Kir6.2, has a role in modulating the biogenesis efficiency and surface expression of K-ATP channels. The results suggest that physiological or pathological changes in Derlin-1 expression levels may affect glucose-stimulated insulin secretion by altering surface expression of K-ATP channels.	[Shyng, Show-Ling] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Sch Med, Portland, OR 97239 USA	Oregon Health & Science University	Shyng, SL (corresponding author), Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Sch Med, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	shyngs@ohsu.edu	Wang, Fang/GLT-2750-2022	Wang, Fang/0000-0003-1093-052X	National Institutes of Health [DK57699]; March of Dimes Research Grant Foundation [1-2001-707]; China Scholarship Council; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057699] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes Research Grant Foundation(March of Dimes); China Scholarship Council(China Scholarship Council); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK57699 (to S.-L. S.). This work was also supported by March of Dimes Research Grant Foundation Grant 1-2001-707 (to S.-L. S.) and a Scholarship from the China Scholarship Council (to F. W.).	Aguilar-Bryan L, 1999, ENDOCR REV, V20, P101, DOI 10.1210/er.20.2.101; AGUILARBRYAN L, 1995, SCIENCE, V268, P423, DOI 10.1126/science.7716547; Altier C, 2011, NAT NEUROSCI, V14, P173, DOI 10.1038/nn.2712; Ashcroft FM, 2005, J CLIN INVEST, V115, P2047, DOI 10.1172/JCI25495; Babenko AP, 2003, J BIOL CHEM, V278, P41577, DOI 10.1074/jbc.C300363200; Cartier EA, 2001, P NATL ACAD SCI USA, V98, P2882, DOI 10.1073/pnas.051499698; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; Chan KW, 2003, EMBO J, V22, P3833, DOI 10.1093/emboj/cdg376; Chen PC, 2011, AM J PHYSIOL-CELL PH, V300, pC506, DOI 10.1152/ajpcell.00429.2010; Clement JP, 1997, NEURON, V18, P827, DOI 10.1016/S0896-6273(00)80321-9; Conti LR, 2001, J BIOL CHEM, V276, P41270, DOI 10.1074/jbc.M106555200; Crawshaw SG, 2007, MOL MEMBR BIOL, V24, P113, DOI 10.1080/09687860600988727; Cui LY, 2007, J MOL BIOL, V365, P981, DOI 10.1016/j.jmb.2006.10.086; Fukuda Y, 2011, J BIOL CHEM, V286, P8481, DOI 10.1074/jbc.M110.174516; Gao YJ, 2008, J BIOL CHEM, V283, P9049, DOI 10.1074/jbc.M708022200; Hampton RY, 2002, CURR OPIN CELL BIOL, V14, P476, DOI 10.1016/S0955-0674(02)00358-7; Hegde RS, 2010, CURR OPIN CELL BIOL, V22, P437, DOI 10.1016/j.ceb.2010.05.005; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Hoseki J, 2010, J BIOCHEM, V147, P19, DOI 10.1093/jb/mvp194; Huopio H, 2002, AM J PHYSIOL-ENDOC M, V283, pE207, DOI 10.1152/ajpendo.00047.2002; Inagaki N, 1997, FEBS LETT, V409, P232, DOI 10.1016/S0014-5793(97)00488-2; INAGAKI N, 1995, SCIENCE, V270, P1166, DOI 10.1126/science.270.5239.1166; Ismail N, 2006, CELL, V126, P237, DOI 10.1016/j.cell.2006.07.001; Lilley BN, 2004, NATURE, V429, P834, DOI 10.1038/nature02592; Lin CW, 2005, DIABETES, V54, P2852, DOI 10.2337/diabetes.54.10.2852; Lin YW, 2008, J BIOL CHEM, V283, P9146, DOI 10.1074/jbc.M708798200; Matsuoka T, 2000, CIRC RES, V87, P873, DOI 10.1161/01.RES.87.10.873; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Nakatsukasa K, 2008, CELL, V132, P101, DOI 10.1016/j.cell.2007.11.023; Nestorowicz A, 1996, HUM MOL GENET, V5, P1813, DOI 10.1093/hmg/5.11.1813; Nichols CG, 2006, NATURE, V440, P470, DOI 10.1038/nature04711; Nishikawa S, 2005, J BIOCHEM, V137, P551, DOI 10.1093/jb/mvi068; Oda Y, 2006, J CELL BIOL, V172, P383, DOI 10.1083/jcb.200507057; Okuda-Shimizu Y, 2007, MOL CELL, V28, P544, DOI 10.1016/j.molcel.2007.09.012; Peroz D, 2009, J BIOL CHEM, V284, P5250, DOI 10.1074/jbc.M806459200; Sato BK, 2009, MOL CELL, V34, P212, DOI 10.1016/j.molcel.2009.03.010; Schwieger I, 2008, MOL PHARMACOL, V73, P697, DOI 10.1124/mol.107.040931; Shyng SL, 1997, J GEN PHYSIOL, V110, P655, DOI 10.1085/jgp.110.6.655; Stanley CA, 2002, J CLIN ENDOCR METAB, V87, P4857, DOI 10.1210/jc.2002-021403; Sun F, 2006, J BIOL CHEM, V281, P36856, DOI 10.1074/jbc.M607085200; Tusnady GE, 2008, BIOINFORMATICS, V24, P1469, DOI 10.1093/bioinformatics/btn202; Vashist S, 2004, J CELL BIOL, V165, P41, DOI 10.1083/jcb.200309132; Venkatachalan SP, 2007, PFLUG ARCH EUR J PHY, V454, P155, DOI 10.1007/s00424-006-0183-1; Wang J, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1849; Yan FF, 2007, DIABETES, V56, P2339, DOI 10.2337/db07-0150; Yan FF, 2010, MOL BIOL CELL, V21, P1945, DOI 10.1091/mbc.E10-02-0116; Yan FF, 2005, AM J PHYSIOL-CELL PH, V289, pC1351, DOI 10.1152/ajpcell.00240.2005; Yan FF, 2004, J BIOL CHEM, V279, P11096, DOI 10.1074/jbc.M312810200; Ye YH, 2003, J CELL BIOL, V162, P71, DOI 10.1083/jcb.200302169; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656; Younger JM, 2006, CELL, V126, P571, DOI 10.1016/j.cell.2006.06.041; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4	53	19	21	0	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					10482	10493		10.1074/jbc.M111.312223	http://dx.doi.org/10.1074/jbc.M111.312223			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22311976	Green Published, hybrid			2022-12-25	WOS:000302167200075
J	Cruchaga, C; Chakraverty, S; Mayo, K; Vallania, FLM; Mitra, RD; Faber, K; Williamson, J; Bird, T; Diaz-Arrastia, R; Foroud, TM; Boeve, BF; Graff-Radford, NR; Jean, PS; Lawson, M; Ehm, MG; Mayeux, R; Goate, AM				Cruchaga, Carlos; Chakraverty, Sumitra; Mayo, Kevin; Vallania, Francesco L. M.; Mitra, Robi D.; Faber, Kelley; Williamson, Jennifer; Bird, Tom; Diaz-Arrastia, Ramon; Foroud, Tatiana M.; Boeve, Bradley F.; Graff-Radford, Neill R.; Jean, Pamela St.; Lawson, Michael; Ehm, Margaret G.; Mayeux, Richard; Goate, Alison M.		NIA-LOAD NCRAD Family Study Consor	Rare Variants in APP, PSEN1 and PSEN2 Increase Risk for AD in Late-Onset Alzheimer's Disease Families	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; FRONTOTEMPORAL DEMENTIA; PROGRANULIN MUTATIONS; IDENTIFIES VARIANTS; PRECURSOR PROTEIN; COMMON VARIANTS; GENE MUTATION; PRESENILIN 2; PHENOTYPE; FOUNDER	Pathogenic mutations in APP, PSEN1, PSEN2, MAPT and GRN have previously been linked to familial early onset forms of dementia. Mutation screening in these genes has been performed in either very small series or in single families with late onset AD (LOAD). Similarly, studies in single families have reported mutations in MAPT and GRN associated with clinical AD but no systematic screen of a large dataset has been performed to determine how frequently this occurs. We report sequence data for 439 probands from late-onset AD families with a history of four or more affected individuals. Sixty sequenced individuals (13.7%) carried a novel or pathogenic mutation. Eight pathogenic variants, (one each in APP and MAPT, two in PSEN1 and four in GRN) three of which are novel, were found in 14 samples. Thirteen additional variants, present in 23 families, did not segregate with disease, but the frequency of these variants is higher in AD cases than controls, indicating that these variants may also modify risk for disease. The frequency of rare variants in these genes in this series is significantly higher than in the 1,000 genome project (p = 5.09 x 10(-5); OR = 2.21; 95%CI = 1.49-3.28) or an unselected population of 12,481 samples (p = 6.82 x 10(-5); OR = 2.19; 95%CI = 1.347-3.26). Rare coding variants in APP, PSEN1 and PSEN2, increase risk for or cause late onset AD. The presence of variants in these genes in LOAD and early-onset AD demonstrates that factors other than the mutation can impact the age at onset and penetrance of at least some variants associated with AD. MAPT and GRN mutations can be found in clinical series of AD most likely due to misdiagnosis. This study clearly demonstrates that rare variants in these genes could explain an important proportion of genetic heritability of AD, which is not detected by GWAS.	[Cruchaga, Carlos; Chakraverty, Sumitra; Mayo, Kevin; Goate, Alison M.] Washington Univ, Dept Psychiat, St Louis, MO 63130 USA; [Cruchaga, Carlos; Chakraverty, Sumitra; Mayo, Kevin; Goate, Alison M.] Washington Univ, Hope Ctr Program Prot Aggregat & Neurodegenerat, St Louis, MO USA; [Vallania, Francesco L. M.; Mitra, Robi D.; Goate, Alison M.] Washington Univ, Dept Genet, St Louis, MO 63110 USA; [Faber, Kelley; Foroud, Tatiana M.] Indiana Univ, Dept Med & Mol Genet, Indianapolis, IN 46204 USA; [Williamson, Jennifer; Mayeux, Richard] Columbia Univ Coll Phys & Surg, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY 10032 USA; [Bird, Tom] Univ Washington, VA Med Ctr, Seattle, WA 98195 USA; [Bird, Tom] Univ Washington, Dept Neurol, Seattle, WA 98195 USA; [Bird, Tom] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Diaz-Arrastia, Ramon] Univ Texas SW Med Ctr Dallas, Dept Neurol, Dallas, TX 75390 USA; [Boeve, Bradley F.] Mayo Clin, Dept Neurol, Rochester, MN USA; [Graff-Radford, Neill R.] Mayo Clin, Dept Neurol, Jacksonville, FL 32224 USA; [Jean, Pamela St.; Lawson, Michael; Ehm, Margaret G.] GlaxoSmithKline Inc, Genet, Res Triangle Pk, NC USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Indiana University System; Indiana University-Purdue University Indianapolis; Columbia University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Texas System; University of Texas Southwestern Medical Center Dallas; Mayo Clinic; Mayo Clinic; GlaxoSmithKline	Cruchaga, C (corresponding author), Washington Univ, Dept Psychiat, St Louis, MO 63130 USA.	cruchagc@psychiatry.wustl.edu; goatea@psychiatry.wustl.edu	Cruchaga, Carlos/ABF-4065-2020; Mayeux, Richard/E-9788-2013	Cruchaga, Carlos/0000-0002-0276-2899; Mayeux, Richard/0000-0001-6519-9696; Diaz-Arrastia, Ramon/0000-0001-6051-3594; DeKosky, Steven/0000-0003-3743-2758; Haller, Gabriel/0000-0002-3884-5776; Goate, Alison/0000-0002-0576-2472	NIA-LOAD/NCRAD Family Study Consortium [U24 AG026395]; NIH [AG16208, AG035083, P01AG03991, P50AG05681, P01AG026276, 1P30NS069329-01]; Barnes-Jewish Hospital Foundation; Department of Veterans Affairs; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060009] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS069329] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U24AG026395, R37AG015473, R01AG035083, P30AG013846, P01AG026276, P50AG008702, P50AG005681, R01AG041797, P01AG003991, U24AG021886, R01AG016208] Funding Source: NIH RePORTER	NIA-LOAD/NCRAD Family Study Consortium; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Barnes-Jewish Hospital Foundation; Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by federal grants U24 AG026395 "NIA-LOAD/NCRAD Family Study Consortium." This work was supported by grants from NIH (AG16208, AG035083, P01AG03991, P50AG05681, P01AG026276 and 1P30NS069329-01), the Barnes-Jewish Hospital Foundation, the Department of Veterans Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; [Anonymous], EXOME VARIANT SERVER; Arango D, 2001, AM J MED GENET, V103, P138, DOI 10.1002/1096-8628(20011001)103:2<138::AID-AJMG1529>3.0.CO;2-8; Athan ES, 2001, JAMA-J AM MED ASSOC, V286, P2257, DOI 10.1001/jama.286.18.2257; Azzopardi D, 2008, CANCER RES, V68, P358, DOI 10.1158/0008-5472.CAN-07-5733; Bernardi L, 2009, NEUROBIOL AGING, V30, P1825, DOI 10.1016/j.neurobiolaging.2008.01.005; Brickell KL, 2007, J NEUROL NEUROSUR PS, V78, P1050, DOI 10.1136/jnnp.2006.113803; Brouwers N, 2007, ARCH NEUROL-CHICAGO, V64, P1436, DOI 10.1001/archneur.64.10.1436; BRUNAK S, 1991, J MOL BIOL, V220, P49, DOI 10.1016/0022-2836(91)90380-O; Cortini F, 2008, EUR J NEUROL, V15, P1111, DOI 10.1111/j.1468-1331.2008.02266.x; Cruts M, 1998, HUM MOL GENET, V7, P43, DOI 10.1093/hmg/7.1.43; de Silva R, 2001, NEUROSCI LETT, V311, P145, DOI 10.1016/S0304-3940(01)02109-7; Devi G, 2000, ARCH NEUROL-CHICAGO, V57, P1454, DOI 10.1001/archneur.57.10.1454; Druley TE, 2009, NAT METHODS, V6, P263, DOI [10.1038/NMETH.1307, 10.1038/nmeth.1307]; Ertekin-Taner N, 2010, ALZHEIMERS RES THER, V2, DOI 10.1186/alzrt26; Foster NL, 2007, BRAIN, V130, P2616, DOI 10.1093/brain/awm177; Gass J, 2006, HUM MOL GENET, V15, P2988, DOI 10.1093/hmg/ddl241; Gatz M, 2006, ARCH GEN PSYCHIAT, V63, P168, DOI 10.1001/archpsyc.63.2.168; Genin E, 2011, MOL PSYCHIAT; Gerrish A, 2011, J ALZHEIMERS DIS; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; HOULDEN H, 1993, NEUROSCI LETT, V154, P161, DOI 10.1016/0304-3940(93)90196-R; Huey ED, 2006, ANN NEUROL, V60, P374, DOI 10.1002/ana.20969; Jayadev S, 2010, BRAIN, V133, P1143, DOI 10.1093/brain/awq033; Kamboh MI, 1999, NEUROSCI LETT, V263, P129, DOI 10.1016/S0304-3940(99)00129-9; KAMINO K, 1992, AM J HUM GENET, V51, P998; Kauwe JSK, 2007, ANN NEUROL, V61, P446, DOI 10.1002/ana.21099; Kelley BJ, 2010, ARCH NEUROL-CHICAGO, V67, P171, DOI 10.1001/archneurol.2010.113; Kim M, 2009, HUM MOL GENET, V18, P3987, DOI 10.1093/hmg/ddp323; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Larner AJ, 2007, J NEUROL SCI, V252, P173, DOI 10.1016/j.jns.2006.11.013; Le Ber I, 2007, HUM MUTAT, V28, P846, DOI 10.1002/humu.20520; Lindquist SG, 2008, EUR J NEUROL, V15, P377, DOI 10.1111/j.1468-1331.2008.02069.x; Llado A, 2010, EUR J NEUROL, V17, P994, DOI 10.1111/j.1468-1331.2010.02949.x; Ludolph AC, 2009, EUR J NEUROL, V16, P297, DOI 10.1111/j.1468-1331.2008.02513.x; Ma X, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001318; Marcon G, 2009, J ALZHEIMERS DIS, V16, P509, DOI 10.3233/JAD-2009-0986; Masson E, 2008, HUM GENET, V123, P83, DOI 10.1007/s00439-007-0459-3; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Mendez Mario F, 2006, Am J Alzheimers Dis Other Demen, V21, P281, DOI 10.1177/1533317506290448; Mesulam M, 2007, ARCH NEUROL-CHICAGO, V64, P43, DOI 10.1001/archneur.64.1.43; Momeni P, 2009, NEUROBIOL AGING, V30, P388, DOI 10.1016/j.neurobiolaging.2007.07.013; Naj AC, 2011, NAT GENET, V43, P436, DOI 10.1038/ng.801; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Pickering-Brown SM, 2006, BRAIN, V129, P3124, DOI 10.1093/brain/awl289; Rademakers R, 2003, HUM MUTAT, V22, P409, DOI 10.1002/humu.10269; Rademakers R, 2007, LANCET NEUROL, V6, P857, DOI 10.1016/S1474-4422(07)70221-1; Reed LA, 1997, ANN NEUROL, V42, P564, DOI 10.1002/ana.410420406; Rogaeva EA, 2001, NEUROLOGY, V57, P621, DOI 10.1212/WNL.57.4.621; Rossor MN, 1996, LANCET, V347, P1560, DOI 10.1016/S0140-6736(96)90715-1; Scacchi R, 2007, NEUROSCI LETT, V418, P282, DOI 10.1016/j.neulet.2007.03.035; Seshadri S, 2010, JAMA-J AM MED ASSOC, V303, P1832, DOI 10.1001/jama.2010.574; Silverman JM, 2005, ARCH GEN PSYCHIAT, V62, P565, DOI 10.1001/archpsyc.62.5.565; Silverman JM, 2003, ARCH GEN PSYCHIAT, V60, P190, DOI 10.1001/archpsyc.60.2.190; So HC, 2011, GENET EPIDEMIOL, V35, P310, DOI 10.1002/gepi.20579; SPINA S, 2007, NEUROLOGY; Taddei K, 2002, MOL PSYCHIATR, V7, P776, DOI 10.1038/sj.mp.4001072; TANZI RE, 1992, AM J HUM GENET, V51, P273; The AlzGene Database, ALZGENE DAT; Tomaino C, 2007, J NEUROL, V254, P391, DOI 10.1007/s00415-006-0373-y; Vallania FLM, 2010, GENOME RES, V20, P1711, DOI 10.1101/gr.109157.110; Van Deerlin VM, 2007, ARCH NEUROL-CHICAGO, V64, P1148, DOI 10.1001/archneur.64.8.1148; Wijsman EM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001308; Yu CE, 2010, ARCH NEUROL-CHICAGO, V67, P161, DOI 10.1001/archneurol.2009.328	66	208	212	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2012	7	2							e31039	10.1371/journal.pone.0031039	http://dx.doi.org/10.1371/journal.pone.0031039			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UG	22312439	Green Published, gold, Green Submitted			2022-12-25	WOS:000301977500027
J	Hosoda, Y; Sasaki, N; Kameda, Y; Torigoe, D; Agui, T				Hosoda, Yayoi; Sasaki, Nobuya; Kameda, Yayoi; Torigoe, Daisuke; Agui, Takashi			Identifying Quantitative Trait Loci Affecting Resistance to Congenital Hypothyroidism in 129(+Ter)/SvJcl Strain Mice	PLOS ONE			English	Article							TRANSCRIPTIONAL REPRESSOR DREAM; GLYCOPROTEIN HORMONE-RECEPTORS; THYROID DYSGENESIS; MISSENSE MUTATION; GENE-EXPRESSION; MOUSE; GLAND; IMPAIRMENT; RELATIVES; DWARFISM	Tyrosylprotein sulfotransferase 2 (TPST2) is one of the enzymes responsible for tyrosine O-sulfation and catalyzes the sulfation of the specific tyrosine residue of thyroid stimulating hormone receptor (TSHR). Since this modification is indispensable for the activation of TSH signaling, a non-functional TPST2 mutation (Tpst2(grt)) in DW/J-grt mice leads to congenital hypothyroidism (CH) characterized by severe thyroid hypoplasia and dwarfism related to TSH hyporesponsiveness. Previous studies indicated that the genetic background of the 129(+Ter)/SvJcl (129) mouse strain ameliorates Tpst2(grt)-induced CH. To identify loci responsible for CH resistance in 129 mice, we performed quantitative trait locus (QTL) analysis using backcross progenies from susceptible DW/J and resistant 129 mice. We used the first principal component calculated from body weights at 5, 8 and 10 weeks as an indicator of CH, and QTL analysis mapped a major QTL showing a highly significant linkage to the distal portion of chromosome (Chr) 2; between D2Mit62 and D2Mit304, particularly close to D2Mit255. In addition, two male-specific QTLs showing statistically suggestive linkage were also detected on Chrs 4 and 18, respectively. All QTL alleles derived from the 129 strain increased resistance to growth retardation. There was also a positive correlation between recovery from thyroid hypoplasia and the presence of the 129 allele at D2Mit255 in male progenies. These results suggested that the major QTL on Chr 2 is involved in thyroid development. Moreover, since DW/J congenic strain mice carrying both a Tpst2(grt) mutation and 129 alleles in the major QTL show resistance to dwarfism and thyroid hypoplasia, we confirmed the presence of the resistant gene in this region, and that it is involved in thyroid development. Further genetical analysis should lead to identification of genes for CH tolerance and, from a better understanding of thyroid organogenesis and function, the subsequent development of new treatments for thyroid disorders.	[Hosoda, Yayoi; Sasaki, Nobuya; Kameda, Yayoi; Torigoe, Daisuke; Agui, Takashi] Hokkaido Univ, Lab Lab Anim Sci & Med, Dept Dis Control, Grad Sch Vet Med, Sapporo, Hokkaido, Japan	Hokkaido University	Hosoda, Y (corresponding author), Hokkaido Univ, Lab Lab Anim Sci & Med, Dept Dis Control, Grad Sch Vet Med, Sapporo, Hokkaido, Japan.	nobsasa@vetmed.hokudai.ac.jp	Sasaki, Nobuya/F-6579-2012		Ministry of Education, Culture, Sports, Science and Technology, KAKENHI [18500323]; Japan Society for the promotion of Science, KAKENHI [09J05638]; Kurata Memorial Hitachi Science and Technology Foundation	Ministry of Education, Culture, Sports, Science and Technology, KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Society for the promotion of Science, KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Kurata Memorial Hitachi Science and Technology Foundation	This work was supported by the Ministry of Education, Culture, Sports, Science and Technology, Grant-in-Aid for Scientific Research, KAKENHI (18500323) to NS; Japan Society for the promotion of Science, KAKENHI (09J05638) to YH; and the Kurata Memorial Hitachi Science and Technology Foundation to NS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amendola E, 2005, ENDOCRINOLOGY, V146, P5038, DOI 10.1210/en.2005-0882; Amendola E, 2010, ENDOCRINOLOGY, V151, P1948, DOI 10.1210/en.2009-1240; Bonomi M, 2006, MOL ENDOCRINOL, V20, P3351, DOI 10.1210/me.2005-0521; Carrion AM, 1999, NATURE, V398, P80, DOI 10.1038/18044; Castanet M, 2005, EUR J HUM GENET, V13, P232, DOI 10.1038/sj.ejhg.5201321; Castanet M, 2010, HORM RES PAEDIAT, V73, P231, DOI 10.1159/000284386; Cheng JM, 2002, NAGOYA MED J, V45, P133; Costagliola S, 2002, EMBO J, V21, P504, DOI 10.1093/emboj/21.4.504; D'Andrea B, 2005, EXP CELL RES, V305, P166, DOI 10.1016/j.yexcr.2004.12.012; De Deken X, 2000, J BIOL CHEM, V275, P23227, DOI 10.1074/jbc.M000916200; Dentice M, 2006, J CLIN ENDOCR METAB, V91, P1428, DOI 10.1210/jc.2005-1350; Fagman H, 2011, J MOL ENDOCRINOL, V46, pR33, DOI 10.1677/JME-10-0084; Fagman H, 2010, MOL CELL ENDOCRINOL, V323, P35, DOI 10.1016/j.mce.2009.12.008; Grasberger H, 2006, J BIOL CHEM, V281, P18269, DOI 10.1074/jbc.C600095200; Grasberger H, 2010, MOL CELL ENDOCRINOL, V322, P99, DOI 10.1016/j.mce.2010.01.029; Hashemipour M, 2010, PEDIATR INT, V52, P467, DOI 10.1111/j.1442-200X.2009.03016.x; Hosoda Y, 2010, BIOMED RES-TOKYO, V31, P207, DOI 10.2220/biomedres.31.207; Johnson KR, 2007, MOL ENDOCRINOL, V21, P1593, DOI 10.1210/me.2007-0085; Kopp P, 2002, ENDOCRINOLOGY, V143, P2019, DOI 10.1210/en.143.6.2019; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Leger J, 2002, J CLIN ENDOCR METAB, V87, P575, DOI 10.1210/jc.87.2.575; Manly KF, 2001, MAMM GENOME, V12, P930, DOI 10.1007/s00335-001-1016-3; Markel P, 1997, NAT GENET, V17, P280, DOI 10.1038/ng1197-280; Persani L, 2010, MOL CELL ENDOCRINOL, V322, P72, DOI 10.1016/j.mce.2010.01.008; Postiglione MP, 2002, P NATL ACAD SCI USA, V99, P15462, DOI 10.1073/pnas.242328999; Rigutto S, 2009, J BIOL CHEM, V284, P6725, DOI 10.1074/jbc.M806893200; Rivas M, 2004, J BIOL CHEM, V279, P33114, DOI 10.1074/jbc.M403526200; Rivas M, 2009, MOL ENDOCRINOL, V23, P862, DOI 10.1210/me.2008-0466; Sasaki N, 2007, MOL ENDOCRINOL, V21, P1713, DOI 10.1210/me.2007-0040; TOMITA K, 1995, J ENDOCRINOL, V144, P209, DOI 10.1677/joe.0.1440209; Van Vliet G, 2003, CLIN GENET, V63, P445	31	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2012	7	1							e31035	10.1371/journal.pone.0031035	http://dx.doi.org/10.1371/journal.pone.0031035			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911GB	22299049	Green Published, gold			2022-12-25	WOS:000301704200056
J	Kawakami, F; Yabata, T; Ohta, E; Maekawa, T; Shimada, N; Suzuki, M; Maruyama, H; Ichikawa, T; Obata, F				Kawakami, Fumitaka; Yabata, Takatoshi; Ohta, Etsuro; Maekawa, Tatsunori; Shimada, Naoki; Suzuki, Minori; Maruyama, Hiroko; Ichikawa, Takafumi; Obata, Fumiya			LRRK2 Phosphorylates Tubulin-Associated Tau but Not the Free Molecule: LRRK2-Mediated Regulation of the Tau-Tubulin Association and Neurite Outgrowth	PLOS ONE			English	Article							PROTEIN; DISEASE; PARKINSONISM; DEGENERATION; EXPRESSION; SULFATIDE; MUTATIONS; ISOFORMS; BRAIN; CELLS	Leucine-rich repeat kinase 2 (LRRK2), a large protein kinase containing multi-functional domains, has been identified as the causal molecule for autosomal-dominant Parkinson's disease (PD). In the present study, we demonstrated for the first time that (i) LRRK2 interacts with tau in a tubulin-dependent manner; (ii) LRRK2 directly phosphorylates tubulin-associated tau, but not free tau; (iii) LRRK2 phosphorylates tau at Thr181 as one of the target sites; and (iv) The PD-associated LRRK2 mutations, G2019S and I2020T, elevated the degree of tau-phosphorylation. These results provide direct proof that tau is a physiological substrate for LRRK2. Furthermore, we revealed that LRRK2-mediated phosphorylation of tau reduces its tubulin-binding ability. Our results suggest that LRRK2 plays an important role as a physiological regulator for phosphorylation-mediated dissociation of tau from microtubules, which is an integral aspect of microtubule dynamics essential for neurite outgrowth and axonal transport.	[Kawakami, Fumitaka; Yabata, Takatoshi; Shimada, Naoki; Suzuki, Minori; Ichikawa, Takafumi] Kitasato Univ, Grad Sch Med Sci, Dept Biochem, Sagamihara, Kanagawa 228, Japan; [Ohta, Etsuro; Maekawa, Tatsunori; Obata, Fumiya] Kitasato Univ, Grad Sch Med Sci, Dept Clin Immunol, Sagamihara, Kanagawa 228, Japan; [Maruyama, Hiroko] Kitasato Univ, Grad Sch Med Sci, Lab Cytopathol, Sagamihara, Kanagawa 228, Japan; [Obata, Fumiya] Kitasato Univ, Sch Allied Hlth Sci, Inst Regenerat Med & Cell Design, Res & Dev Ctr Cell Design, Sagamihara, Kanagawa 228, Japan	Kitasato University; Kitasato University; Kitasato University; Kitasato University	Kawakami, F (corresponding author), Kitasato Univ, Grad Sch Med Sci, Dept Biochem, Sagamihara, Kanagawa 228, Japan.	kawakami@kitasato-u.ac.jp		MAEKAWA, TATSUNORI/0000-0002-1214-9959	Kitasato University School of Allied Health Science [2009-6708, 2009]	Kitasato University School of Allied Health Science	This work was supported by the Kitasato University School of Allied Health Science (Grant-in-Aid for Research Project, No. 2009-6708, 2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avila J, 2004, PHYSIOL REV, V84, P361, DOI 10.1152/physrev.00024.2003; Biskup S, 2009, BBA-MOL BASIS DIS, V1792, P625, DOI 10.1016/j.bbadis.2008.09.015; Chan D, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.234005; Cookson MR, 2007, J NEUROSCI, V27, P11865, DOI 10.1523/JNEUROSCI.3695-07.2007; Cookson MR, 2010, NAT REV NEUROSCI, V11, P791, DOI 10.1038/nrn2935; Dachsel JC, 2007, PARKINSONISM RELAT D, V13, P382, DOI 10.1016/j.parkreldis.2007.01.008; Dachsel JC, 2010, ARCH NEUROL-CHICAGO, V67, P542, DOI 10.1001/archneurol.2010.79; Deas E, 2010, J NEUROSCI, V30, P1577, DOI 10.1523/JNEUROSCI.5531-09.2010; Dickson DW, 2010, INT J CLIN EXP PATHO, V3, P1; Gillardon F, 2009, J NEUROCHEM, V110, P1514, DOI 10.1111/j.1471-4159.2009.06235.x; Gloeckner CJ, 2009, J NEUROCHEM, V109, P959, DOI 10.1111/j.1471-4159.2009.06024.x; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; Iaccarino C, 2007, HUM MOL GENET, V16, P1319, DOI 10.1093/hmg/ddm080; Imai Y, 2008, EMBO J, V27, P2432, DOI 10.1038/emboj.2008.163; Iqbal K, 2010, CURR ALZHEIMER RES, V7, P656, DOI 10.2174/156720510793611592; Iqbal K, 2009, ACTA NEUROPATHOL, V118, P53, DOI 10.1007/s00401-009-0486-3; Jaleel M, 2007, BIOCHEM J, V405, P307, DOI 10.1042/BJ20070209; Kawakami F, 2008, J BIOCHEM, V143, P359, DOI 10.1093/jb/mvm228; Kawakami F, 2008, BIOL PHARM BULL, V31, P193, DOI 10.1248/bpb.31.193; Kubo M, 2010, J NEUROIMMUNOL, V229, P123, DOI 10.1016/j.jneuroim.2010.07.021; Li YP, 2009, NAT NEUROSCI, V12, P826, DOI 10.1038/nn.2349; Lin CH, 2010, J NEUROSCI, V30, P13138, DOI 10.1523/JNEUROSCI.1737-10.2010; MacLeod D, 2006, NEURON, V52, P587, DOI 10.1016/j.neuron.2006.10.008; Maekawa T, 2010, BIOCHEM BIOPH RES CO, V392, P431, DOI 10.1016/j.bbrc.2010.01.041; Maldonado H, 2011, J NEUROSCI RES, V89, P1489, DOI 10.1002/jnr.22678; Maldonado H, 2008, BIOL RES, V41, P239, DOI [/S0716-97602008000300001, 10.4067/S0716-97602008000300001]; Meixner A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.001172; Melrose HL, 2010, NEUROBIOL DIS, V40, P503, DOI 10.1016/j.nbd.2010.07.010; Miklossy J, 2007, ACTA NEUROPATHOL, V114, P243, DOI 10.1007/s00401-007-0230-9; Miklossy J, 2006, J NEUROPATH EXP NEUR, V65, P953, DOI 10.1097/01.jnen.0000235121.98052.54; Ohta E, 2011, FEBS LETT, V585, P2165, DOI 10.1016/j.febslet.2011.05.044; Ohta E, 2010, BIOCHEM BIOPH RES CO, V391, P242, DOI 10.1016/j.bbrc.2009.11.043; Ohta E, 2009, BIOCHEM BIOPH RES CO, V390, P710, DOI 10.1016/j.bbrc.2009.10.034; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Parisiadou L, 2009, J NEUROSCI, V29, P13971, DOI 10.1523/JNEUROSCI.3799-09.2009; Plowey ED, 2008, J NEUROCHEM, V105, P1048, DOI 10.1111/j.1471-4159.2008.05217.x; Rajput A, 2006, NEUROLOGY, V67, P1506, DOI 10.1212/01.wnl.0000240220.33950.0c; Ramonet D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018568; Webber PJ, 2009, FEBS J, V276, P6436, DOI 10.1111/j.1742-4658.2009.07342.x; WEINGARTEN MD, 1975, P NATL ACAD SCI USA, V72, P1858, DOI 10.1073/pnas.72.5.1858; Zach S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013191; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	42	93	94	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2012	7	1							e30834	10.1371/journal.pone.0030834	http://dx.doi.org/10.1371/journal.pone.0030834			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911GB	22303461	Green Published, gold, Green Submitted			2022-12-25	WOS:000301704200037
J	Govero, J; Doray, B; Bai, HD; Kornfeld, S				Govero, Jennifer; Doray, Balraj; Bai, Hongdong; Kornfeld, Stuart			Analysis of Gga Null Mice Demonstrates a Non-Redundant Role for Mammalian GGA2 during Development	PLOS ONE			English	Article							TRANS-GOLGI NETWORK; UBIQUITIN-BINDING; VHS DOMAINS; PROTEINS; RECRUITMENT; MEMAPSIN-2; RECEPTORS; INTERACTS; CLATHRIN; PROMOTES	Numerous studies using cultured mammalian cells have shown that the three GGAs (Golgi-localized, gamma-ear containing, ADP-ribosylation factor-binding proteins) function in the transport of cargo proteins between the trans-Golgi network and endosomes. However, the in vivo role(s) of these adaptor proteins and their possible functional redundancy has not been analyzed. In this study, the genes encoding GGAs1-3 were disrupted in mice by insertional mutagenesis. Loss of GGA1 or GGA3 alone was well tolerated whereas the absence of GGA2 resulted in embryonic or neonatal lethality, depending on the genetic background of the mice. Thus, GGA2 mediates a vital function that cannot be compensated for by GGA1and/or GGA3. The combined loss of GGA1 and GGA3 also resulted in a high incidence of neonatal mortality but in this case the expression level of GGA2 may be inadequate to compensate for the loss of the other two GGAs. We conclude that the three mammalian GGAs are essential proteins that are not fully redundant.	[Govero, Jennifer; Doray, Balraj; Bai, Hongdong; Kornfeld, Stuart] Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA	Washington University (WUSTL)	Govero, J (corresponding author), Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA.	skornfel@dom.wustl.edu		Doray, Balraj/0000-0003-3347-5013	Washington University School of Medicine Diabetes Research Training Center (DRTC) Transgenic; DRTC [NIH P60 DK020579]; Alzheimer's Disease Research Center [NIH P50-AG05681]; National Institutes of Health [CA08759]; NATIONAL CANCER INSTITUTE [R37CA008759, R01CA008759] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020579, P60DK020579] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005681] Funding Source: NIH RePORTER	Washington University School of Medicine Diabetes Research Training Center (DRTC) Transgenic; DRTC; Alzheimer's Disease Research Center; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank the Washington University School of Medicine Diabetes Research Training Center (DRTC) Transgenic and ES Cell Core Facility (DRTC grant NIH P60 DK020579) and the Alzheimer's Disease Research Center (NIH P50-AG05681) for partly funding generation of the Gga null mice. This work was supported by the National Institutes of Health Grant CA08759 (to SK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boman AL, 2000, MOL BIOL CELL, V11, P1241, DOI 10.1091/mbc.11.4.1241; Bonifacino JS, 2004, NAT REV MOL CELL BIO, V5, P23, DOI 10.1038/nrm1279; Boucher R, 2008, HISTOCHEM CELL BIOL, V130, P315, DOI 10.1007/s00418-008-0436-5; Braulke T, 2009, BBA-MOL CELL RES, V1793, P605, DOI 10.1016/j.bbamcr.2008.10.016; Costaguta G, 2001, MOL BIOL CELL, V12, P1885, DOI 10.1091/mbc.12.6.1885; del Castillo FJ, 2010, HUM MOL GENET, V19, P262, DOI 10.1093/hmg/ddp490; Dell'Angelica EC, 2000, J CELL BIOL, V149, P81, DOI 10.1083/jcb.149.1.81; Doray B, 2002, P NATL ACAD SCI USA, V99, P8072, DOI 10.1073/pnas.082235699; Doray B, 2002, J BIOL CHEM, V277, P18477, DOI 10.1074/jbc.M201879200; Doray B, 2008, TRAFFIC, V9, P1551, DOI 10.1111/j.1600-0854.2008.00786.x; Eissenberg JC, 2011, TRAFFIC, V12, P1821, DOI 10.1111/j.1600-0854.2011.01285.x; Galy B, 2004, RNA, V10, P1019, DOI 10.1261/rna.7220704; Ghosh P, 2003, J CELL BIOL, V163, P755, DOI 10.1083/jcb.200308038; He XY, 2005, J BIOL CHEM, V280, P11696, DOI 10.1074/jbc.M411296200; He XY, 2002, FEBS LETT, V524, P183, DOI 10.1016/S0014-5793(02)03052-1; Hida T, 2007, ARCH HISTOL CYTOL, V70, P303, DOI 10.1679/aohc.70.303; Hirst J, 2011, BMC CELL BIOL, V20, P22; Hirst J, 2007, TRAFFIC, V8, P594, DOI 10.1111/j.1600-0854.2007.00556.x; Hirst J, 2009, TRAFFIC, V10, P1696, DOI 10.1111/j.1600-0854.2009.00983.x; Jacobsen L, 2002, FEBS LETT, V511, P155, DOI 10.1016/S0014-5793(01)03299-9; Kang EL, 2010, J BIOL CHEM, V285, P24108, DOI 10.1074/jbc.M109.092742; Kzhyshkowska J, 2004, J LEUKOCYTE BIOL, V76, P1151, DOI 10.1189/jlb.0504300; Mardones GA, 2007, MOL BIOL CELL, V18, P3486, DOI 10.1091/mbc.E07-02-0190; McKay MM, 2004, TRAFFIC, V5, P102, DOI 10.1111/j.1600-0854.2004.00160.x; Nielsen MS, 2001, EMBO J, V20, P2180, DOI 10.1093/emboj/20.9.2180; Osokine I, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040034; Puertollano R, 2001, SCIENCE, V292, P1712, DOI 10.1126/science.1060750; Puertollano R, 2004, NAT CELL BIOL, V6, P244, DOI 10.1038/ncb1106; Puertollano R, 2001, CELL, V105, P93, DOI 10.1016/S0092-8674(01)00299-9; Shiba Y, 2004, J BIOL CHEM, V279, P7105, DOI 10.1074/jbc.M311702200; Stauber T, 2010, J BIOL CHEM, V285, P34537, DOI 10.1074/jbc.M110.162545; Takatsu H, 2001, J BIOL CHEM, V276, P28541, DOI 10.1074/jbc.C100218200; The Jackson Laboratory, 2007, GEN BACKGR UND IMP M; Valor LM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001303; Vogel P, 2009, VET PATHOL, V46, P313, DOI 10.1354/vp.46-2-313; Voss AK, 1998, DEV DYNAM, V212, P258; Wang J, 2007, MOL BIOL CELL, V18, P2646, DOI 10.1091/mbc.E06-10-0897; Yogosawa S, 2006, BIOCHEM BIOPH RES CO, V350, P82, DOI 10.1016/j.bbrc.2006.09.013; Zhang JJ, 2009, MOL CELL BIOL, V29, P6097, DOI 10.1128/MCB.00505-09; Zhu GY, 2003, FEBS LETT, V537, P171, DOI 10.1016/S0014-5793(03)00095-4; Zhu YX, 2001, SCIENCE, V292, P1716, DOI 10.1126/science.1060896	41	23	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2012	7	1							e30184	10.1371/journal.pone.0030184	http://dx.doi.org/10.1371/journal.pone.0030184			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911FX	22291915	Green Published, gold			2022-12-25	WOS:000301703800008
J	Chang, YC; She, ZG; Sakimura, K; Roberts, A; Kucharova, K; Rowitch, DH; Stallcup, WB				Chang, Yunchao; She, Zhi-Gang; Sakimura, Kenji; Roberts, Amanda; Kucharova, Karolina; Rowitch, David H.; Stallcup, William B.			Ablation of NG2 Proteoglycan Leads to Deficits in Brown Fat Function and to Adult Onset Obesity	PLOS ONE			English	Article							PDGF ALPHA-RECEPTOR; ADIPOSE-TISSUE; TRANSCRIPTIONAL CONTROL; ADAPTIVE THERMOGENESIS; SIGNALING PATHWAYS; CELL MOTILITY; GROWTH-FACTOR; NULL MOUSE; EXPRESSION; PROTEIN	Obesity is a major health problem worldwide. We are studying the causes and effects of obesity in C57Bl/6 mice following genetic ablation of NG2, a chondroitin sulfate proteoglycan widely expressed in progenitor cells and also in adipocytes. Although global NG2 ablation delays early postnatal adipogenesis in mouse skin, adult NG2 null mice are paradoxically heavier than wild-type mice, exhibiting larger white fat deposits. This adult onset obesity is not due to NG2-dependent effects on CNS function, since specific ablation of NG2 in oligodendrocyte progenitors yields the opposite phenotype; i.e. abnormally lean mice. Metabolic analysis reveals that, while activity and food intake are unchanged in global NG2 null mice, O-2 consumption and CO2 production are decreased, suggesting a decrease in energy expenditure. Since brown fat plays important roles in regulating energy expenditure, we have investigated brown fat function via cold challenge and high fat diet feeding, both of which induce the adaptive thermogenesis that normally occurs in brown fat. In both tests, body temperatures in NG2 null mice are reduced compared to wild-type mice, indicating a deficit in brown fat function in the absence of NG2. In addition, adipogenesis in NG2 null brown pre-adipocytes is dramatically impaired compared to wild-type counterparts. Moreover, mRNA levels for PR domain containing 16 (PRDM16) and peroxisome proliferator-activated receptor gamma coactivator (PGC)1-alpha, proteins important for brown adipocyte differentiation, are decreased in NG2 null brown fat deposits in vivo and NG2 null brown pre-adipocytes in vitro. Altogether, these results indicate that brown fat dysfunction in NG2 null mice results from deficits in the recruitment and/or development of brown pre-adipocytes. As a consequence, obesity in NG2 null mice may occur due to disruptions in brown fat-dependent energy homeostasis, with resulting effects on lipid storage in white adipocytes.	[Chang, Yunchao; She, Zhi-Gang; Kucharova, Karolina; Stallcup, William B.] Sanford Burnham Med Res Inst, Ctr Canc, La Jolla, CA USA; [Sakimura, Kenji] Niigata Univ, Brain Res Inst, Dept Cellular Neurobiol, Niigata, Japan; [Roberts, Amanda] Scripps Res Inst, Mol & Integrat Neurosci Dept, La Jolla, CA 92037 USA; [Rowitch, David H.] Univ Calif San Francisco, Dept Pediat Oncol, San Francisco, CA 94143 USA	Sanford Burnham Prebys Medical Discovery Institute; Niigata University; Scripps Research Institute; University of California System; University of California San Francisco	Chang, YC (corresponding author), Sanford Burnham Med Res Inst, Ctr Canc, La Jolla, CA USA.	yunchaochang@gmail.com		Kucharova, Karolina/0000-0002-3196-748X; Rowitch, David/0000-0002-0079-0060	National Institutes of Health (NIH) [RO1 CA95287, PO1 HD25938];  [NS057096]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD025938] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA095287] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS057096] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health (NIH) grants RO1 CA95287 (Dr. Stallcup), PO1 HD25938 (Dr. Stallcup), and Blueprint NS057096 (Dr. Roberts). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alenghat FJ, 2009, J CELL BIOCHEM, V106, P529, DOI 10.1002/jcb.22001; Barraud P, 2010, EXP CELL RES, V316, P1489, DOI 10.1016/j.yexcr.2010.03.001; Bartness TJ, 2010, INT J OBESITY, V34, pS36, DOI 10.1038/ijo.2010.182; Bayatti N, 2001, J NEUROCHEM, V78, P972, DOI 10.1046/j.1471-4159.2001.00464.x; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Chekenya M, 2008, ONCOGENE, V27, P5182, DOI 10.1038/onc.2008.157; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Flier JS, 2004, CELL, V116, P337, DOI 10.1016/S0092-8674(03)01081-X; Fukushi J, 2004, MOL BIOL CELL, V15, P3580, DOI 10.1091/mbc.E04-03-0236; Fukushi J, 2003, DEV DYNAM, V228, P143, DOI 10.1002/dvdy.10359; Goretzki L, 1999, J BIOL CHEM, V274, P16831, DOI 10.1074/jbc.274.24.16831; Grako KA, 1999, J CELL SCI, V112, P905; GRAKO KA, 1995, EXP CELL RES, V221, P231, DOI 10.1006/excr.1995.1371; Hossain P, 2007, NEW ENGL J MED, V356, P213, DOI 10.1056/NEJMp068177; Huang FJ, 2010, DEV BIOL, V344, P1035, DOI 10.1016/j.ydbio.2010.06.023; Kadoya K, 2008, J HISTOCHEM CYTOCHEM, V56, P295, DOI 10.1369/jhc.7A7349.2007; Kajimura S, 2010, CELL METAB, V11, P257, DOI 10.1016/j.cmet.2010.03.005; Kucharova K, 2010, NEUROSCIENCE, V166, P185, DOI 10.1016/j.neuroscience.2009.12.014; Liang HY, 2006, ADV PHYSIOL EDUC, V30, P145, DOI 10.1152/advan.00052.2006; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; Makagiansar IT, 2007, J CELL BIOL, V178, P155, DOI 10.1083/jcb.200612084; Makagiansar IT, 2004, J BIOL CHEM, V279, P55262, DOI 10.1074/jbc.M411045200; Nasu-Tada K, 2005, GLIA, V52, P98, DOI 10.1002/glia.20224; Nedergaard J, 2007, AM J PHYSIOL-ENDOC M, V293, pE444, DOI 10.1152/ajpendo.00691.2006; NISHIYAMA A, 1991, DEVELOPMENT, V111, P933; Nishiyama A, 1996, J NEUROSCI RES, V43, P299, DOI 10.1002/(SICI)1097-4547(19960201)43:3<299::AID-JNR5>3.0.CO;2-E; Orava J, 2011, CELL METAB, V14, P272, DOI 10.1016/j.cmet.2011.06.012; Ozerdem U, 2002, MICROVASC RES, V63, P129, DOI 10.1006/mvre.2001.2376; Ozerdem U, 2001, DEV DYNAM, V222, P218, DOI 10.1002/dvdy.1200; Ozerdem Ugur, 2004, Angiogenesis, V7, P269, DOI 10.1007/s10456-004-4182-6; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Pursiheimo JP, 2000, P NATL ACAD SCI USA, V97, P168, DOI 10.1073/pnas.97.1.168; Schuller U, 2008, CANCER CELL, V14, P123, DOI 10.1016/j.ccr.2008.07.005; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Seale P, 2007, CELL METAB, V6, P38, DOI 10.1016/j.cmet.2007.06.001; Simpson D, 2000, MOL VIS, V6, P178; Soto I, 2006, J NEUROCHEM, V96, P82, DOI 10.1111/j.1471-4159.2005.03510.x; Stallcup WB, 2002, J NEUROCYTOL, V31, P423, DOI 10.1023/A:1025731428581; Stallcup WB, 2008, CELL ADHES MIGR, V2, P192, DOI 10.4161/cam.2.3.6279; Terada N, 2006, HISTOCHEM CELL BIOL, V126, P483, DOI 10.1007/s00418-006-0184-3; TEVETHIA MJ, 1984, VIROLOGY, V137, P414, DOI 10.1016/0042-6822(84)90234-4; Tseng YH, 2008, NATURE, V454, P1000, DOI 10.1038/nature07221; Vila-Bedmar Rocio, 2011, Archives of Physiology and Biochemistry, V117, P195, DOI 10.3109/13813455.2011.560951; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Wang H, 2008, MOL CELL BIOL, V28, P2187, DOI 10.1128/MCB.01479-07; Wang ZY, 2006, CELL METAB, V3, P111, DOI 10.1016/j.cmet.2006.01.002; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Westcott DJ, 2009, J EXP MED, V206, P3143, DOI 10.1084/jem.20091333; Woost PG, 1996, KIDNEY INT, V50, P125, DOI 10.1038/ki.1996.295	51	21	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e30637	10.1371/journal.pone.0030637	http://dx.doi.org/10.1371/journal.pone.0030637			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910ME	22295099	gold, Green Submitted, Green Published			2022-12-25	WOS:000301640600044
J	Audard, V; Pawlak, A; Candelier, M; Lang, P; Sahali, D				Audard, Vincent; Pawlak, Andre; Candelier, Marina; Lang, Philippe; Sahali, Djillali			Upregulation of Nuclear Factor-Related Kappa B Suggests a Disorder of Transcriptional Regulation in Minimal Change Nephrotic Syndrome	PLOS ONE			English	Article							CHROMATIN-REMODELING COMPLEX; OF-THE-LITERATURE; CELL ACTIVATION; AP-1; INDUCTION; PATHOGENESIS; NEPHROPATHY; EXPRESSION; HISTONE; IL-4	Immune mechanisms underlying the pathophysiology of idiopathic nephrotic syndrome, the most frequent glomerular disease in children, are believed to involve a systemic disorder of T cell function and cell mediated immunity. How these perturbations take place remains unclear. We report here that NFRKB, a member of the chromatin remodeling complex, is upregulated in MCNS relapse, mainly in CD4+T cells and B cells and undergo post-translational modifications including sumoylation. We showed that NFRKB was highly expressed in nuclear compartment during the relapse, while it was restricted to cytoplasm in remission. NFRKB induced the activation of AP1 signaling pathway by upregulating the expression of c-jun. We showed that NFRKB promotes hypomethylation of genomic DNA, suggesting its implication in regulation of gene expression by enhancing the binding of transcription factors through chromatin remodeling. These results suggest for the first time that NFRKB may be involved in the disorders of transcriptional regulation commonly observed in MCNS relapse.	[Audard, Vincent; Pawlak, Andre; Candelier, Marina; Lang, Philippe; Sahali, Djillali] Hop Henri Mondor, INSERM, U955, F-94010 Creteil, France; [Audard, Vincent; Pawlak, Andre; Candelier, Marina; Lang, Philippe; Sahali, Djillali] Univ Paris Est, Creteil, France; [Audard, Vincent; Lang, Philippe; Sahali, Djillali] Grp Hosp Henri Mondor Albert Chenevier, AP HP, Serv Nephrol, Creteil, France; [Audard, Vincent; Lang, Philippe; Sahali, Djillali] Hop Henri Mondor, Inst Francilien Rech Nephrol & Transplantat, F-94010 Creteil, France	Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP	Audard, V (corresponding author), Hop Henri Mondor, INSERM, U955, F-94010 Creteil, France.	vincent.audard@hmn.aphp.fr	Pawlak, André/L-9044-2018; pawlak, andré/Q-2495-2019; Sahali, Djillali/Q-5742-2018	Pawlak, André/0000-0002-5486-212X; pawlak, andré/0000-0002-5486-212X; Sahali, Djillali/0000-0003-3663-4470; AUDARD, Vincent/0000-0001-5343-2550	Programme National de Recherche sur les maladies des reins et des voies urinaires (PNRNU, INSERM); French Kidney Foundation; Association pour l'Utilisation du Rein Artificiel (AURA)	Programme National de Recherche sur les maladies des reins et des voies urinaires (PNRNU, INSERM); French Kidney Foundation; Association pour l'Utilisation du Rein Artificiel (AURA)	This work was supported in part by the Programme National de Recherche sur les maladies des reins et des voies urinaires (PNRNU, INSERM), a grant from the French Kidney Foundation and the Association pour l'Utilisation du Rein Artificiel (AURA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABATE C, 1990, SCIENCE, V249, P1157, DOI 10.1126/science.2118682; Affar E, 2006, MOL CELL BIOL, V26, P3565, DOI 10.1128/MCB.26.9.3565-3581.2006; Audard V, 2006, KIDNEY INT, V69, P2251, DOI 10.1038/sj.ki.5000341; Ballestar E, 2011, NAT REV RHEUMATOL, V7, P264, DOI 10.1038/nrrheum.2011.16; Berger SL, 1999, CURR OPIN CELL BIOL, V11, P336, DOI 10.1016/S0955-0674(99)80046-5; Conaway RC, 2009, TRENDS BIOCHEM SCI, V34, P71, DOI 10.1016/j.tibs.2008.10.010; Eddy AA, 2003, LANCET, V362, P629, DOI 10.1016/S0140-6736(03)14184-0; Elie V, 2011, PEDIAT NEPHROL; FRANCIS DA, 1995, INT IMMUNOL, V7, P151, DOI 10.1093/intimm/7.2.151; Jonsson ZO, 2004, MOL CELL, V16, P465, DOI 10.1016/j.molcel.2004.09.033; KANG SM, 1992, SCIENCE, V257, P1134, DOI 10.1126/science.257.5073.1134; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Karras A, 2005, NEPHROL DIAL TRANSPL, V20, P1075, DOI 10.1093/ndt/gfh615; KLEMSZ MJ, 1989, J IMMUNOL, V143, P1032; Krukowski K, 2011, BRAIN BEHAV IMMUN, V25, P239, DOI 10.1016/j.bbi.2010.07.244; Liu B, 2008, CURR OPIN CELL BIOL, V20, P288, DOI 10.1016/j.ceb.2008.03.014; Llort AG, 2002, NEPHRON, V92, P950, DOI 10.1159/000065576; Mathieson PW, 2007, SEMIN IMMUNOPATHOL, V29, P415, DOI 10.1007/s00281-007-0094-z; Mizuguchi G, 2004, SCIENCE, V303, P343, DOI 10.1126/science.1090701; Murr R, 2010, ADV GENET, V70, P101, DOI [10.1016/B978-0-12-380866-0.60005-8, 10.1016/S0065-2660(10)70005-5]; Nakayama M, 2002, AM J KIDNEY DIS, V39, P503, DOI 10.1053/ajkd.2002.31400; ORMAN SV, 1986, ARCH INTERN MED, V146, P1827, DOI 10.1001/archinte.146.9.1827; Rincon Mercedes, 1997, Genes and Function, V1, P51; Sahali D, 2002, J AM SOC NEPHROL, V13, P1238, DOI 10.1681/ASN.V1351238; Sahali D, 2001, J AM SOC NEPHROL, V12, P1648, DOI 10.1681/ASN.V1281648; Saito K, 2010, J BIOCHEM, V147, P833, DOI 10.1093/jb/mvq020; SHALHOUB RJ, 1974, LANCET, V2, P556; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Smith KM, 2002, IMMUNOLOGY, V106, P144, DOI 10.1046/j.1365-2567.2002.01427.x; Valanciute A, 2004, J IMMUNOL, V172, P688, DOI 10.4049/jimmunol.172.1.688; Yao T, 2008, MOL CELL, V31, P909, DOI 10.1016/j.molcel.2008.08.027; Zhang SY, 2011, CONTRIB NEPHROL, V169, P94, DOI 10.1159/000313947	32	19	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30523	10.1371/journal.pone.0030523	http://dx.doi.org/10.1371/journal.pone.0030523			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22291976	Green Published, gold, Green Submitted			2022-12-25	WOS:000301570600054
J	Fujiwara, K; Hasegawa, K; Ohkumo, T; Miyoshi, H; Tseng, YH; Yoshikawa, K				Fujiwara, Kazushiro; Hasegawa, Koichi; Ohkumo, Tsuyoshi; Miyoshi, Hiroyuki; Tseng, Yu-Hua; Yoshikawa, Kazuaki			Necdin Controls Proliferation of White Adipocyte Progenitor Cells	PLOS ONE			English	Article							PRADER-WILLI-SYNDROME; MOUSE MODEL; STEM-CELLS; PREADIPOCYTE DIFFERENTIATION; POSTMITOTIC NEURONS; GROWTH SUPPRESSOR; SKELETAL-MUSCLE; ADIPOSE-TISSUE; IN-VIVO; GENE	White adipose tissues are composed mainly of white fat cells adipocytes), which play a key role in energy storage and metabolism. White adipocytes are terminally differentiated postmitotic cells and arise from their progenitor cells (preadipocytes) or mesenchymal stem cells residing in white adipose tissues. Thus, white adipocyte number is most likely controlled by the rate of preadipocyte proliferation, which may contribute to the etiology of obesity. However, little is known about the molecular mechanisms that regulate preadipocyte proliferation during adipose tissue development. Necdin, which is expressed predominantly in postmitotic neurons, is a pleiotropic protein that possesses anti-mitotic and pro-survival activities. Here we show that necdin functions as an intrinsic regulator of white preadipocyte proliferation in developing adipose tissues. Necdin is expressed in early preadipocytes or mesenchymal stem cells residing in the stromal compartment of white adipose tissues in juvenile mice. Lentivirus-mediated knockdown of endogenous necdin expression in vivo in adipose tissues markedly increases fat mass in juvenile mice fed a high-fat diet until adulthood. Furthermore, necdin-null mutant mice exhibit a greater expansion of adipose tissues due to adipocyte hyperplasia than wild-type mice when fed the high-fat diet during the juvenile and adult periods. Adipose stromal-vascular cells prepared from necdin-null mice differentiate in vitro into a significantly larger number of adipocytes in response to adipogenic inducers than those from wild-type mice. These results suggest that necdin prevents excessive preadipocyte proliferation induced by adipogenic stimulation to control white adipocyte number during adipose tissue development.	[Fujiwara, Kazushiro; Hasegawa, Koichi; Ohkumo, Tsuyoshi; Yoshikawa, Kazuaki] Osaka Univ, Inst Prot Res, Suita, Osaka 565, Japan; [Miyoshi, Hiroyuki] RIKEN Tsukuba Inst, BioResource Ctr, Tsukuba, Ibaraki, Japan; [Tseng, Yu-Hua] Harvard Univ, Sch Med, Joslin Diabet Ctr, Div Res, Boston, MA 02115 USA	Osaka University; RIKEN; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.	Fujiwara, K (corresponding author), Osaka Univ, Inst Prot Res, Suita, Osaka 565, Japan.	yoshikaw@protein.osaka-u.ac.jp	Miyoshi, Hiroyuki/G-9808-2013; Tseng, Yu-Hua/AAE-6471-2021	Tseng, Yu-Hua/0000-0003-2053-9559	Japan Society for the Promotion of Science [21300138]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a Grant-in-Aid for Scientific Research B2 (21300138) from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Arner P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018284; Brunelli S, 2004, CIRC RES, V94, P1571, DOI 10.1161/01.RES.0000132747.12860.10; Calo E, 2010, NATURE, V466, P1110, DOI 10.1038/nature09264; CATTANACH BM, 1992, NAT GENET, V2, P270, DOI 10.1038/ng1292-270; Deponti D, 2007, J CELL BIOL, V179, P305, DOI 10.1083/jcb.200701027; Ding F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001709; Gabriel JM, 1999, P NATL ACAD SCI USA, V96, P9258, DOI 10.1073/pnas.96.16.9258; GELOEN A, 1992, AM J PHYSIOL, V263, pR1176, DOI 10.1152/ajpregu.1992.263.6.R1176; Gerard M, 1999, NAT GENET, V23, P199, DOI 10.1038/13828; Gesta S, 2007, CELL, V131, P242, DOI 10.1016/j.cell.2007.10.004; Hansen JB, 2004, P NATL ACAD SCI USA, V101, P4112, DOI 10.1073/pnas.0301964101; Haqq AM, 2011, J CLIN ENDOCR METAB, V96, pE225, DOI 10.1210/jc.2010-1733; Hasegawa K, 2008, J NEUROSCI, V28, P8772, DOI 10.1523/JNEUROSCI.3052-08.2008; HAYASHI Y, 1995, BIOCHEM BIOPH RES CO, V213, P317, DOI 10.1006/bbrc.1995.2132; Jay P, 1997, NAT GENET, V17, P357, DOI 10.1038/ng1197-357; Joe AWB, 2009, STEM CELLS, V27, P2563, DOI 10.1002/stem.190; Kobayashi M, 2002, J BIOL CHEM, V277, P42128, DOI 10.1074/jbc.M205024200; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Kubota Y, 2009, BLOOD, V114, P4383, DOI 10.1182/blood-2009-07-230292; Kurita M, 2006, J NEUROSCI, V26, P12003, DOI 10.1523/JNEUROSCI.3002-06.2006; Kuwajima T, 2004, J BIOL CHEM, V279, P40484, DOI 10.1074/jbc.M404143200; Kuwako K, 2005, J NEUROSCI, V25, P7090, DOI 10.1523/JNEUROSCI.2083-05.2005; Liu Y, 2009, CELL STEM CELL, V4, P37, DOI 10.1016/j.stem.2008.11.006; MacDonald HR, 1997, HUM MOL GENET, V6, P1873, DOI 10.1093/hmg/6.11.1873; MARUYAMA K, 1991, BIOCHEM BIOPH RES CO, V178, P291, DOI 10.1016/0006-291X(91)91812-Q; Miyoshi H, 1998, J VIROL, V72, P8150, DOI 10.1128/JVI.72.10.8150-8157.1998; Muscatelli F, 2000, HUM MOL GENET, V9, P3101, DOI 10.1093/hmg/9.20.3101; Niinobe M, 2000, DEV NEUROSCI-BASEL, V22, P310, DOI 10.1159/000017455; Rodeheffer MS, 2008, CELL, V135, P240, DOI 10.1016/j.cell.2008.09.036; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Schulz TJ, 2011, P NATL ACAD SCI USA, V108, P143, DOI 10.1073/pnas.1010929108; Scime A, 2005, CELL METAB, V2, P283, DOI 10.1016/j.cmet.2005.10.002; Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; Tang W, 2008, SCIENCE, V322, P583, DOI 10.1126/science.1156232; Taniura H, 1999, J BIOL CHEM, V274, P16242, DOI 10.1074/jbc.274.23.16242; Taniura H, 1998, J BIOL CHEM, V273, P720, DOI 10.1074/jbc.273.2.720; Tchoukalova YD, 2010, P NATL ACAD SCI USA, V107, P18226, DOI 10.1073/pnas.1005259107; Tran TT, 2010, NAT REV ENDOCRINOL, V6, P195, DOI 10.1038/nrendo.2010.20; Tseng YH, 2005, NAT CELL BIOL, V7, P601, DOI 10.1038/ncb1259; Tseng YH, 2008, NATURE, V454, P1000, DOI 10.1038/nature07221; Tseng YH, 2010, NAT REV DRUG DISCOV, V9, P465, DOI 10.1038/nrd3138; Uetsuki T, 1996, J BIOL CHEM, V271, P918, DOI 10.1074/jbc.271.2.918; van Tienen FHJ, 2011, INT J OBESITY, V35, P1154, DOI 10.1038/ijo.2010.275; Yang T, 1998, NAT GENET, V19, P25, DOI 10.1038/ng0598-25; Yoshikawa K, 2000, NEUROSCI RES, V37, P1, DOI 10.1016/S0168-0102(00)00101-2; Zhang JW, 2004, P NATL ACAD SCI USA, V101, P43, DOI 10.1073/pnas.0307229101; Zhu NL, 2010, J BIOL CHEM, V285, P30463, DOI 10.1074/jbc.M110.156703	48	39	40	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30948	10.1371/journal.pone.0030948	http://dx.doi.org/10.1371/journal.pone.0030948			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22292082	Green Published, Green Submitted, gold			2022-12-25	WOS:000301570600100
J	Renga, B; Mencarelli, A; D'Amore, C; Cipriani, S; D'Auria, MV; Sepe, V; Chini, MG; Monti, MC; Bifulco, G; Zampella, A; Fiorucci, S				Renga, Barbara; Mencarelli, Andrea; D'Amore, Claudio; Cipriani, Sabrina; D'Auria, Maria Valeria; Sepe, Valentina; Chini, Maria Giovanna; Monti, Maria Chiara; Bifulco, Giuseppe; Zampella, Angela; Fiorucci, Stefano			Discovery That Theonellasterol a Marine Sponge Sterol Is a Highly Selective FXR Antagonist That Protects against Liver Injury in Cholestasis	PLOS ONE			English	Article							CONSTITUTIVE ANDROSTANE RECEPTOR; NATURAL-PRODUCT GUGGULSTERONE; PREGNANE-X-RECEPTOR; NUCLEAR RECEPTORS; BILE-ACIDS; AGONISTS; BINDING; HEPATOPROTECTION; INHIBITION; ACTIVATION	Background: The farnesoid-x-receptor (FXR) is a bile acid sensor expressed in the liver and gastrointestinal tract. Despite FXR ligands are under investigation for treatment of cholestasis, a biochemical condition occurring in a number of liver diseases for which available therapies are poorly effective, mice harboring a disrupted FXR are protected against liver injury caused by bile acid overload in rodent models of cholestasis. Theonellasterol is a 4-methylene-24-ethylsteroid isolated from the marine sponge Theonella swinhoei. Here, we have characterized the activity of this theonellasterol on FXR-regulated genes and biological functions. Principal Findings: Interrogation of HepG2 cells, a human hepatocyte cell line, by microarray analysis and transactivation assay shows that theonellasterol is a selective FXR antagonist, devoid of any agonistic or antagonistic activity on a number of human nuclear receptors including the vitamin D receptor, PPARs, PXR, LXRs, progesterone, estrogen, glucorticoid and thyroid receptors, among others. Exposure of HepG2 cells to theonellasterol antagonizes the effect of natural and synthetic FXR agonists on FXR-regulated genes, including SHP, OST alpha, BSEP and MRP4. A proof-of-concept study carried out to investigate whether FXR antagonism rescues mice from liver injury caused by the ligation of the common bile duct, a model of obstructive cholestasis, demonstrated that theonellasterol attenuates injury caused by bile duct ligation as measured by assessing serum alanine aminostrasferase levels and extent of liver necrosis at histopathology. Analysis of genes involved in bile acid uptake and excretion by hepatocytes revealed that theonellasterol increases the liver expression of MRP4, a basolateral transporter that is negatively regulated by FXR. Administering bile duct ligated mice with an FXR agonist failed to rescue from liver injury and downregulated the expression of MRP4. Conclusions: FXR antagonism in vivo results in a positive modulation of MRP4 expression in the liver and is a feasible strategy to target obstructive cholestasis.	[Renga, Barbara; Mencarelli, Andrea; D'Amore, Claudio; Cipriani, Sabrina; Fiorucci, Stefano] Univ Perugia, Dipartimento Med Clin & Sperimentale, Nuova Fac Med & Chirurg, I-06100 Perugia, Italy; [D'Auria, Maria Valeria; Sepe, Valentina; Zampella, Angela] Univ Naples Federico II, Dipartimento Chim Sostanze Nat, Naples, Italy; [Chini, Maria Giovanna; Monti, Maria Chiara; Bifulco, Giuseppe] Univ Salerno, Dipartimento Sci Farmaceut & Biomed, I-84100 Salerno, Italy	University of Perugia; University of Naples Federico II; University of Salerno	Renga, B (corresponding author), Univ Perugia, Dipartimento Med Clin & Sperimentale, Nuova Fac Med & Chirurg, I-06100 Perugia, Italy.	fiorucci@unipg.it	Chini, Maria Giovanna/C-8066-2014; Bifulco, Giuseppe/A-5413-2011; D'Auria, Maria Valeria/K-2586-2012; Sepe, Valentina/F-5994-2010; Fiorucci, Stefano/I-1251-2012; Monti, Maria Chiara/A-4105-2011	Bifulco, Giuseppe/0000-0002-1788-5170; D'Auria, Maria Valeria/0000-0003-3450-7304; Monti, Maria Chiara/0000-0002-1337-2909; D'Amore, Claudio/0000-0001-9217-9404; Chini, Maria Giovanna/0000-0002-3943-5883; Zampella, Angela/0000-0002-6170-279X; Sepe, Valentina/0000-0002-0169-4441	MAREX: Exploring Marine Resources for Bioactive Compounds: From Discovery to Sustainable Production and Industrial Applications [245137]	MAREX: Exploring Marine Resources for Bioactive Compounds: From Discovery to Sustainable Production and Industrial Applications	This work was supported by grants from MAREX: Exploring Marine Resources for Bioactive Compounds: From Discovery to Sustainable Production and Industrial Applications (Call FP7-KBBE-2009-3, Project nr. 245137). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akwabi-Ameyaw A, 2008, BIOORG MED CHEM LETT, V18, P4339, DOI 10.1016/j.bmcl.2008.06.073; Akwabi-Ameyaw A, 2011, BIOORG MED CHEM LETT, V21, P6154, DOI 10.1016/j.bmcl.2011.08.034; Beilke LD, 2009, DRUG METAB DISPOS, V37, P1035, DOI 10.1124/dmd.108.023317; Bobeldijk I, 2008, J CHROMATOGR B, V871, P306, DOI 10.1016/j.jchromb.2008.05.008; Bridgham JT, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000497; Brobst DE, 2004, J PHARMACOL EXP THER, V310, P528, DOI 10.1124/jpet.103.064329; Burris TP, 2005, MOL PHARMACOL, V67, P948, DOI 10.1124/mol.104.007054; Carlson EE, 2010, ACS CHEM BIOL, V5, P639, DOI 10.1021/cb100105c; De Marino S, 2011, J MED CHEM, V54, P3065, DOI 10.1021/jm200169t; Downes M, 2003, MOL CELL, V11, P1079, DOI 10.1016/S1097-2765(03)00104-7; Fiorucci S, 2011, MINI-REV MED CHEM, V11, P753, DOI 10.2174/138955711796355258; Fiorucci S, 2004, GASTROENTEROLOGY, V127, P1497, DOI 10.1053/j.gastro.2004.08.001; Fiorucci S, 2009, TRENDS PHARMACOL SCI, V30, P570, DOI 10.1016/j.tips.2009.08.001; Fiorucci S, 2009, CURR OPIN GASTROEN, V25, P252, DOI 10.1097/MOG.0b013e328324f87e; Huang JG, 2011, J PHARMACEUT BIOMED, V55, P1111, DOI 10.1016/j.jpba.2011.03.035; Jonker JW, 2012, J STEROID BIOCHEM, V130, P147, DOI 10.1016/j.jsbmb.2011.06.012; KHO E, 1981, J ORG CHEM, V46, P1836, DOI 10.1021/jo00322a019; KOBAYASHI M, 1989, TETRAHEDRON LETT, V30, P2963, DOI 10.1016/S0040-4039(00)99170-6; Li JWH, 2009, SCIENCE, V325, P161, DOI 10.1126/science.1168243; Liu YP, 2003, J CLIN INVEST, V112, P1678, DOI 10.1172/JCI200318945; Mennone A, 2006, HEPATOLOGY, V43, P1013, DOI 10.1002/hep.21158; Meyer U, 2005, J MED CHEM, V48, P6948, DOI 10.1021/jm0505056; Mi LZ, 2003, MOL CELL, V11, P1093, DOI 10.1016/S1097-2765(03)00112-6; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Nishimura S, 2010, NAT CHEM BIOL, V6, P519, DOI [10.1038/nchembio.387, 10.1038/NCHEMBIO.387]; Owsley E, 2003, BIOCHEM BIOPH RES CO, V304, P191, DOI 10.1016/S0006-291X(03)00551-5; Renga B, 2011, BBA-GENE REGUL MECH, V1809, P157, DOI 10.1016/j.bbagrm.2011.01.008; Sanner MF, 1999, J MOL GRAPH MODEL, V17, P57; Sepe V, 2011, J MED CHEM      1129; Soisson SM, 2008, P NATL ACAD SCI USA, V105, P5337, DOI 10.1073/pnas.0710981105; Stedman CAM, 2005, P NATL ACAD SCI USA, V102, P2063, DOI 10.1073/pnas.0409794102; Stedman C, 2006, P NATL ACAD SCI USA, V103, P11323, DOI 10.1073/pnas.0604772103; Teng S, 2007, BRIT J PHARMACOL, V151, P367, DOI 10.1038/sj.bjp.0707235; Urizar NL, 2002, SCIENCE, V296, P1703, DOI 10.1126/science.1072891; Wu J, 2002, MOL ENDOCRINOL, V16, P1590, DOI 10.1210/me.16.7.1590; Ye L, 2007, J CHROMATOGR B, V860, P10, DOI 10.1016/j.jchromb.2007.09.031	36	53	54	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30443	10.1371/journal.pone.0030443	http://dx.doi.org/10.1371/journal.pone.0030443			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22291955	Green Published, gold, Green Submitted			2022-12-25	WOS:000301570600043
J	Toth, K; Stratil, TF; Madsen, EB; Ye, JY; Popp, C; Antolin-Llovera, M; Grossmann, C; Jensen, ON; Schussler, A; Parniske, M; Ott, T				Toth, Katalin; Stratil, Thomas F.; Madsen, Esben B.; Ye, Juanying; Popp, Claudia; Antolin-Llovera, Meritxell; Grossmann, Christina; Jensen, Ole N.; Schuessler, Arthur; Parniske, Martin; Ott, Thomas			Functional Domain Analysis of the Remorin Protein LjSYMREM1 in Lotus japonicus	PLOS ONE			English	Article							RECEPTOR-LIKE KINASE; HIGHLY SELECTIVE ENRICHMENT; PHOSPHORYLATED PEPTIDES; BACTERIAL-INFECTION; TITANIUM-DIOXIDE; MEMBRANE RAFTS; ROOT-NODULES; COILED-COIL; NODULATION; GENE	In legumes rhizobial infection during root nodule symbiosis (RNS) is controlled by a conserved set of receptor proteins and downstream components MtSYMREM1, a protein of the Remorin family in Medicago truncatula, was shown to interact with at least three receptor-like kinases (RLKs) that are essential for RNS. Remorins are comprised of a conserved C-terminal domain and a variable N-terminal region that defines the six different Remorin groups. While both N and C terminal regions of Remorins belonging to the same phylogenetic group are similar to each other throughout the plant kingdom, the N-terminal domains of legume-specific group 2 Remorins show exceptional high degrees of sequence divergence suggesting evolutionary specialization of this protein within this clade. We therefore identified and characterized the MtSYMREM1 ortholog from Lotus japonicus (LjSYMREM1), a model legume that forms determinate root nodules. Here, we resolved its spatio-temporal regulation and showed that over-expression of LjSYMREM1 increases nodulation on transgenic roots. Using a structure-function approach we show that protein interactions including Remorin oligomerization are mainly mediated and stabilized by the Remorin C-terminal region with its coiled-coil domain while the RLK kinase domains transiently interact in vivo and phosphoroylate a residue in the N-terminal region of the LjSYMREM1 protein in vitro. These data provide novel insights into the mechanism of this putative molecular scaffold protein and underline its importance during rhizobial infection.	[Toth, Katalin; Stratil, Thomas F.; Madsen, Esben B.; Popp, Claudia; Antolin-Llovera, Meritxell; Schuessler, Arthur; Parniske, Martin; Ott, Thomas] Univ Munich, Dept Genet, Martinsried, Germany; [Toth, Katalin] Eotvos Lorand Univ, Dept Genet, Budapest, Hungary; [Madsen, Esben B.; Grossmann, Christina] Aarhus Univ, Dept Mol Biol, Ctr Carbohydrate Recognit & Signalling, DK-8000 Aarhus, Denmark; [Ye, Juanying; Jensen, Ole N.] Univ So Denmark, Dept Biochem & Mol Biol, Odense, Denmark	University of Munich; Eotvos Lorand University; Aarhus University; University of Southern Denmark	Toth, K (corresponding author), Univ Munich, Dept Genet, Martinsried, Germany.	Thomas.Ott@biologie.uni-muenchen.de	Parniske, Martin/M-3781-2019; Schüßler, Arthur/F-1681-2011; Ott, Thomas/G-7056-2011; Parniske, Martin/F-2202-2011; Ott, Thomas/H-8192-2013; Jensen, Ole N/J-1763-2012	Parniske, Martin/0000-0001-8561-747X; Parniske, Martin/0000-0001-8561-747X; Ott, Thomas/0000-0002-4494-9811; Jensen, Ole N/0000-0003-1862-8528; Popp, Claudia/0000-0003-1482-7909	Deutsche Forschungsgemeinschaft (DFG) [OT423/2-1, SPP1212, Pa493/5-1]; Bayerisches Hochschulzentrum fur Mittel-, Ost- und Sudosteuropa; German Academic Exchange Service; Danish Research Council "Plant Phosphoproteomics"; Danish National Research Foundation; LMU Exzellenz-Initiative [ZUK 22/1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Bayerisches Hochschulzentrum fur Mittel-, Ost- und Sudosteuropa; German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD)); Danish Research Council "Plant Phosphoproteomics"; Danish National Research Foundation(Danmarks Grundforskningsfond); LMU Exzellenz-Initiative	This work is supported by the Deutsche Forschungsgemeinschaft (DFG) (www.dfg.de)in frame of an Emmy-Noether grant (TO, project OT423/2-1) and of the Priority Program SPP1212 PlantMicro (Pa493/5-1; MA-L and MP) of the DFG. Two consecutive research fellowships to KT provided by the Bayerisches Hochschulzentrum fur Mittel-, Ost- und Sudosteuropa and the German Academic Exchange Service. JY and OJ were supported by a grant from the Danish Research Council "Plant Phosphoproteomics" and CG was funded by the Danish National Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Jessica Folgmann and Karl-Heinz Braun for their excellent technical assistance. Entry clones were kindly provided by Jens Stougaard (University of Aarhus, Denmark). We would also like to acknowledge Riyaz A. Bhat (CEA/CNRS/Mediterranean University Aix-Marseille, Cadarache, France) for providing the vectors p35S-GW-Cerulean-nos and p35S-GW-mOrange-nos. Furthermore we would also like to thank Zsuzsanna Buzas (University of Budapest, Hungary) for providing the empty yeast split-ubiquitin vectors and for her scientific support of the project. We also thank the LMU Exzellenz-Initiative that kindly funded the FLIM-FRET equipment (grant ZUK 22/1).	Arrighi JF, 2006, PLANT PHYSIOL, V142, P265, DOI 10.1104/pp.106.084657; Bariola PA, 2004, PLANT MOL BIOL, V55, P579, DOI 10.1007/s11103-004-1520-4; Bayle V, 2008, PLANT PHYSIOL, V148, P51, DOI 10.1104/pp.108.117358; Benschop JJ, 2007, MOL CELL PROTEOMICS, V6, P1198, DOI 10.1074/mcp.M600429-MCP200; Bersoult A, 2005, MOL PLANT MICROBE IN, V18, P869, DOI 10.1094/MPMI-18-0869; Colebatch G, 2004, PLANT J, V39, P487, DOI 10.1111/j.1365-313X.2004.02150.x; FARMER EE, 1991, J BIOL CHEM, V266, P3140; Gage DJ, 2004, MICROBIOL MOL BIOL R, V68, P280, DOI 10.1128/MMBR.68.2.280-300.2004; Gage DJ, 2002, J BACTERIOL, V184, P7042, DOI 10.1128/JB.184.24.7042-7046.2002; GAMBORG OL, 1968, EXP CELL RES, V50, P151, DOI 10.1016/0014-4827(68)90403-5; Haney CH, 2010, P NATL ACAD SCI USA, V107, P478, DOI 10.1073/pnas.0910081107; Haney CH, 2011, PLANT CELL; HEIDSTRA R, 1994, PLANT PHYSIOL, V105, P787, DOI 10.1104/pp.105.3.787; Hogslund N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006556; Jarsch IK, 2011, MOL PLANT MICROBE IN, V24, P7, DOI 10.1094/MPMI-07-10-0166; Karimi M, 2005, TRENDS PLANT SCI, V10, P103, DOI 10.1016/j.tplants.2005.01.008; Kistner C, 2005, PLANT CELL, V17, P2217, DOI 10.1105/tpc.105.032714; Koushik SV, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2940367; Larsen MR, 2005, MOL CELL PROTEOMICS, V4, P873, DOI 10.1074/mcp.T500007-MCP200; Lefebvre B, 2007, PLANT PHYSIOL, V144, P402, DOI 10.1104/pp.106.094102; Lefebvre B, 2010, P NATL ACAD SCI USA, V107, P2343, DOI 10.1073/pnas.0913320107; Limpens E, 2005, P NATL ACAD SCI USA, V102, P10375, DOI 10.1073/pnas.0504284102; Limpens E, 2003, SCIENCE, V302, P630, DOI 10.1126/science.1090074; Lombari P, 2005, LOTUS JAPONICUS HDB; Madsen EB, 2003, NATURE, V425, P637, DOI 10.1038/nature02045; Madsen EB, 2011, PLANT J, V65, P404, DOI 10.1111/j.1365-313X.2010.04431.x; Madsen LH, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1009; Maekawa T, 2008, MOL PLANT MICROBE IN, V21, P375, DOI 10.1094/MPMI-21-4-0375; Mbengue M, 2010, PLANT CELL, V22, P3474, DOI 10.1105/tpc.110.075861; Oldroyd GED, 2008, ANNU REV PLANT BIOL, V59, P519, DOI 10.1146/annurev.arplant.59.032607.092839; Popp C, 2011, CURR OPIN PLANT BIOL, V14, P458, DOI 10.1016/j.pbi.2011.03.016; Radutoiu S, 2003, NATURE, V425, P585, DOI 10.1038/nature02039; Radutoiu S, 2007, EMBO J, V26, P3923, DOI 10.1038/sj.emboj.7601826; Raffaele S, 2007, PLANT PHYSIOL, V145, P593, DOI 10.1104/pp.107.108639; Raffaele S, 2009, PLANT CELL, V21, P1541, DOI 10.1105/tpc.108.064279; Rairdan GJ, 2008, PLANT CELL, V20, P739, DOI 10.1105/tpc.107.056036; Reymond P, 1996, PLANT CELL, V8, P2265, DOI 10.1105/tpc.8.12.2265; Skirpan AL, 2001, PLANT PHYSIOL, V126, P1480, DOI 10.1104/pp.126.4.1480; Smit P, 2007, PLANT PHYSIOL, V145, P183, DOI 10.1104/pp.107.100495; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; STOUGAARD J, 1987, P NATL ACAD SCI USA, V84, P5754, DOI 10.1073/pnas.84.16.5754; Stracke S, 2002, NATURE, V417, P959, DOI 10.1038/nature00841; Thingholm TE, 2006, NAT PROTOC, V1, P1929, DOI 10.1038/nprot.2006.185; Widjaja I, 2009, PROTEOMICS, V9, P138, DOI 10.1002/pmic.200800293; Ye JY, 2010, J PROTEOME RES, V9, P3561, DOI 10.1021/pr100075x	45	67	70	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30817	10.1371/journal.pone.0030817	http://dx.doi.org/10.1371/journal.pone.0030817			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22292047	gold, Green Published, Green Submitted			2022-12-25	WOS:000301570600083
J	Gao, J; Takeuchi, H; Zhang, Z; Fukuda, M; Hirata, M				Gao, Jing; Takeuchi, Hiroshi; Zhang, Zhao; Fukuda, Mitsunori; Hirata, Masato			Phospholipase C-related but Catalytically Inactive Protein (PRIP) Modulates Synaptosomal-associated Protein 25 (SNAP-25) Phosphorylation and Exocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ETHYLMALEIMIDE-SENSITIVE FACTOR; KINASE-C; DEPENDENT PHOSPHORYLATION; NEUROTRANSMITTER RELEASE; DIFFERENTIAL PHOSPHORYLATION; CRYSTAL-STRUCTURE; CALYCULIN-A; BINDING; SNARE; INHIBITION	Exocytosis is one of the most fundamental cellular events. The basic mechanism of the final step, membrane fusion, is mediated by the formation of the SNARE complex, which is modulated by the phosphorylation of proteins controlled by the concerted actions of protein kinases and phosphatases. We have previously shown that a protein phosphatase-1 (PP1) anchoring protein, phospholipase C-related but catalytically inactive protein (PRIP), has an inhibitory role in regulated exocytosis. The current study investigated the involvement of PRIP in the phospho-dependent modulation of exocytosis. Dephosphorylation of synaptosome-associated protein of 25 kDa (SNAP-25) was mainly catalyzed by PP1, and the process was modulated by wild-type PRIP but not by the mutant (F97A) lacking PP1 binding ability in in vitro studies. We then examined the role of PRIP in phospho-dependent regulation of exocytosis in cell-based studies using pheochromocytoma cell line PC12 cells, which secrete noradrenalin. Exogenous expression of PRIP accelerated the dephosphorylation process of phosphorylated SNAP-25 after forskolin or phorbol ester treatment of the cells. The phospho-states of SNAP-25 were correlated with noradrenalin secretion, which was enhanced by forskolin or phorbol ester treatment and modulated by PRIP expression in PC12 cells. Both SNAP-25 and PP1 were co-precipitated in anti-PRIP immunocomplex isolated from PC12 cells expressing PRIP. Collectively, together with our previous observation regarding the roles of PRIP in PP1 regulation, these results suggest that PRIP is involved in the regulation of the phospho-states of SNAP-25 by modulating the activity of PP1, thus regulating exocytosis.	[Gao, Jing; Takeuchi, Hiroshi; Zhang, Zhao; Hirata, Masato] Kyushu Univ, Fac Dent Sci, Lab Mol & Cellular Biochem, Fukuoka 8128582, Japan; [Fukuda, Mitsunori] Tohoku Univ, Grad Sch Life Sci, Dept Dev Biol & Neurosci, Lab Membrane Trafficking Mech, Sendai, Miyagi 9808578, Japan	Kyushu University; Tohoku University	Hirata, M (corresponding author), Kyushu Univ, Fac Dent Sci, Lab Mol & Cellular Biochem, Fukuoka 8128582, Japan.	hirata1@dent.kyushu-u.ac.jp	Fukuda, MItsunori/I-1511-2015; Takeuchi, Hiroshi/I-8849-2019	Fukuda, MItsunori/0000-0002-8620-5853; Takeuchi, Hiroshi/0000-0003-0033-2913	Ministry of Education, Culture, Science, Sports, and Technology of Japan; Shimabara Foundation; Japan China Medical Association; Japanese Government	Ministry of Education, Culture, Science, Sports, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Shimabara Foundation; Japan China Medical Association; Japanese Government	This work was supported by a grant-in-aid for scientific research from the Ministry of Education, Culture, Science, Sports, and Technology of Japan (to J. G., H. T., and M. H.), the Shimabara Foundation (to H. T.), and the Japan China Medical Association (to J. G.).; Foreign graduate student supported by the Japanese Government.	Aoyagi K, 2005, J BIOL CHEM, V280, P17346, DOI 10.1074/jbc.M413307200; Banerjee A, 1996, J BIOL CHEM, V271, P20223, DOI 10.1074/jbc.271.34.20223; CHAPMAN ER, 1995, J BIOL CHEM, V270, P23667, DOI 10.1074/jbc.270.40.23667; DAVLETOV B, 1993, J BIOL CHEM, V268, P6816; DECAMILLI P, 1991, TRENDS PHARMACOL SCI, V12, P446, DOI 10.1016/0165-6147(91)90631-2; Doira N, 2001, BIOMED RES-TOKYO, V22, P157, DOI 10.2220/biomedres.22.157; Dubois T, 2002, EUR J BIOCHEM, V269, P909, DOI 10.1046/j.0014-2956.2001.02725.x; Dulubova I, 1999, EMBO J, V18, P4372, DOI 10.1093/emboj/18.16.4372; EBERHARD DA, 1990, BIOCHEM J, V268, P15, DOI 10.1042/bj2680015; Essen LO, 1996, NATURE, V380, P595, DOI 10.1038/380595a0; Favre B, 1997, J BIOL CHEM, V272, P13856, DOI 10.1074/jbc.272.21.13856; Foletti DL, 2000, J NEUROSCI, V20, P4535, DOI 10.1523/JNEUROSCI.20-12-04535.2000; Fujii M, 2010, J BIOL CHEM, V285, P4837, DOI 10.1074/jbc.M109.070045; Fujita Y, 1996, J BIOL CHEM, V271, P7265, DOI 10.1074/jbc.271.13.7265; Gao J, 2010, ADV ENZYME REGUL, V50, P237, DOI 10.1016/j.advenzreg.2009.10.011; Gao J, 2009, CELL SIGNAL, V21, P1180, DOI 10.1016/j.cellsig.2009.03.008; Genoud S, 1999, J NEUROCHEM, V72, P1699, DOI 10.1046/j.1471-4159.1999.721699.x; Grishanin RN, 2004, NEURON, V43, P551, DOI 10.1016/j.neuron.2004.07.028; Gromada J, 2001, J PHYSIOL-LONDON, V535, P519, DOI 10.1111/j.1469-7793.2001.00519.x; GUTIERREZ LM, 1994, NEUROSCI LETT, V178, P55, DOI 10.1016/0304-3940(94)90288-7; HAY JC, 1995, NATURE, V374, P173, DOI 10.1038/374173a0; Hepp R, 2002, FEBS LETT, V532, P52, DOI 10.1016/S0014-5793(02)03629-3; Holz RW, 2000, J BIOL CHEM, V275, P17878, DOI 10.1074/jbc.M000925200; Iwasaki S, 2000, J BIOCHEM-TOKYO, V128, P407, DOI 10.1093/oxfordjournals.jbchem.a022768; Jahn R, 2003, CELL, V112, P519, DOI 10.1016/S0092-8674(03)00112-0; James DJ, 2008, J CELL BIOL, V182, P355, DOI 10.1083/jcb.200801056; Kanematsu T, 1996, BIOCHEM J, V313, P319, DOI 10.1042/bj3130319; KANEMATSU T, 1992, J BIOL CHEM, V267, P6518; Kanematsu T, 2000, EUR J BIOCHEM, V267, P2731, DOI 10.1046/j.1432-1327.2000.01291.x; Kanematsu T, 2002, EMBO J, V21, P1004, DOI 10.1093/emboj/21.5.1004; Kanematsu T, 2006, J BIOL CHEM, V281, P22180, DOI 10.1074/jbc.M603118200; Matsuda M, 2009, BIOL REPROD, V81, P681, DOI 10.1095/biolreprod.109.076760; Matveeva EA, 2001, J BIOL CHEM, V276, P12174, DOI 10.1074/jbc.M007394200; Nagy G, 2004, NEURON, V41, P417, DOI 10.1016/S0896-6273(04)00038-8; Nagy G, 2002, J NEUROSCI, V22, P9278; NICHOLS RA, 1994, J BIOL CHEM, V269, P23817; OHO C, 1995, NEUROSCI LETT, V186, P208, DOI 10.1016/0304-3940(95)11317-P; Risinger C, 1999, J NEUROCHEM, V72, P614, DOI 10.1046/j.1471-4159.1999.0720614.x; Schiavo G, 1997, P NATL ACAD SCI USA, V94, P997, DOI 10.1073/pnas.94.3.997; Shimazaki Y, 1996, J BIOL CHEM, V271, P14548, DOI 10.1074/jbc.271.24.14548; Shu YL, 2008, J NEUROSCI, V28, P21, DOI 10.1523/JNEUROSCI.2352-07.2008; Sollner TH, 2003, MOL MEMBR BIOL, V20, P209, DOI 10.1080/0968768031000104953; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Takeuchi H, 2000, BIOCHEM J, V349, P357, DOI 10.1042/0264-6021:3490357; Takeuchi H, 1997, BBA-MOL CELL RES, V1359, P275, DOI 10.1016/S0167-4889(97)00109-2; Takeuchi H, 1996, BIOCHEM J, V318, P561, DOI 10.1042/bj3180561; Terunuma M, 2004, J NEUROSCI, V24, P7074, DOI 10.1523/JNEUROSCI.1323-04.2004; Tolar LA, 1998, J NEUROSCI, V18, P10250; Uji A, 2002, LIFE SCI, V72, P443, DOI 10.1016/S0024-3205(02)02275-0; VICTOR RG, 1995, P NATL ACAD SCI USA, V92, P6269, DOI 10.1073/pnas.92.14.6269; WALENT JH, 1992, CELL, V70, P765, DOI 10.1016/0092-8674(92)90310-9; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Xu T, 1999, EMBO J, V18, P3293, DOI 10.1093/emboj/18.12.3293; YOSHIDA M, 1994, J BIOCHEM, V115, P973, DOI 10.1093/oxfordjournals.jbchem.a124447; Yoshimura K, 2001, J BIOL CHEM, V276, P17908, DOI 10.1074/jbc.M009677200	56	18	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					10565	10578		10.1074/jbc.M111.294645	http://dx.doi.org/10.1074/jbc.M111.294645			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22311984	Green Published, hybrid			2022-12-25	WOS:000302167200082
J	Gerson, KD; Shearstone, JR; Maddula, VSRK; Seligmann, BE; Mercurio, AM				Gerson, Kristin D.; Shearstone, Jeffrey R.; Maddula, V. S. R. Krishna; Seligmann, Bruce E.; Mercurio, Arthur M.			Integrin beta 4 Regulates SPARC Protein to Promote Invasion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CARCINOMA CELLS; ALPHA 6 BETA-1; NF-KAPPA-B; ALPHA-6-BETA-4 INTEGRIN; GROWTH-FACTOR; IN-VITRO; MATRICELLULAR PROTEIN; CHEMOTACTIC MIGRATION; LAMELLAE FORMATION; MDA-MB-435 CELLS	The alpha 6 beta 4 integrin (referred to as "beta 4" integrin) is a receptor for laminins that promotes carcinoma invasion through its ability to regulate key signaling pathways and cytoskeletal dynamics. An analysis of published Affymetrix GeneChip data to detect downstream effectors involved in beta 4-mediated invasion of breast carcinoma cells identified SPARC, or secreted protein acidic and rich in cysteine. This glycoprotein has been shown to play an important role in matrix remodeling and invasion. Our analysis revealed that manipulation of beta 4 integrin expression and signaling impacted SPARC expression and that SPARC facilitates beta 4-mediated invasion. Expression of beta 4 in beta 4-deficient cells reduced the expression of a specific microRNA (miR-29a) that targets SPARC and impedes invasion. In cells that express endogenous beta 4, miR-29a expression is low and beta 4 ligation facilitates the translation of SPARC through a TOR-dependent mechanism. The results obtained in this study demonstrate that beta 4 can regulate SPARC expression and that SPARC is an effector of beta 4-mediated invasion. They also highlight a potential role for specific miRNAs in executing the functions of integrins.	[Mercurio, Arthur M.] Univ Massachusetts, Sch Med, Dept Canc Biol, Worcester, MA 01605 USA; [Maddula, V. S. R. Krishna; Seligmann, Bruce E.] High Throughput Genom Inc, Tucson, AZ 85706 USA	University of Massachusetts System; University of Massachusetts Worcester	Mercurio, AM (corresponding author), Univ Massachusetts, Sch Med, Dept Canc Biol, LRB 408,364 Plantat St, Worcester, MA 01605 USA.	arthur.mercurio@umassmed.edu		Shearstone, Jeffrey/0000-0002-6875-1826	National Institutes of Health [CA80789]; Department of Defense [BC100607]; Arizona Science Foundation; NATIONAL CANCER INSTITUTE [R01CA080789] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Arizona Science Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA80789 (to A. M. M.). This work was also supported by Department of Defense Breast Cancer Fellowship BC100607 (to K. D. G.). Bruce Seligmann works in a leadership role for, and owns stock in, HTG, Inc., the company that produces and markets the qNPA assay. He has no affiliation with, nor does he consult with, the University of Massachusetts. This work was carried out using funds from the Arizona Science Foundation through a grant to the University of Arizona, David Galbraith, PI, for which HTG is the industry collaborator. Krishna Maddula works as a postdoctoral fellow for, and owns stock in, HTG, Inc., the company that produces and markets the qNPA assay. He has no affiliation with, nor does he consult with, the University of Massachusetts.	Abiatari I, 2009, INT J ONCOL, V35, P1111, DOI 10.3892/ijo_00000426; Barker HE, 2011, CANCER RES, V71, P1561, DOI 10.1158/0008-5472.CAN-10-2868; Barker TH, 2005, J BIOL CHEM, V280, P36483, DOI 10.1074/jbc.M504663200; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Borradori L, 1999, J INVEST DERMATOL, V112, P411, DOI 10.1046/j.1523-1747.1999.00546.x; Brekhman V, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-415; Chambers AF, 2009, CANCER RES, V69, P5292, DOI 10.1158/0008-5472.CAN-09-1528; Chen M, 2009, J BIOL CHEM, V284, P1484, DOI 10.1074/jbc.M803997200; Chlenski A, 2007, ONCOGENE, V26, P4513, DOI 10.1038/sj.onc.1210247; Chung J, 2002, J CELL BIOL, V158, P165, DOI 10.1083/jcb.200112015; Clark CJ, 2008, J CELL BIOCHEM, V104, P721, DOI 10.1002/jcb.21688; de Pereda JM, 2009, CELL ADHES MIGR, V3, P361, DOI 10.4161/cam.3.4.9525; Egeblad M, 2010, CURR OPIN CELL BIOL, V22, P697, DOI 10.1016/j.ceb.2010.08.015; Ellison G, 2002, J CLIN PATHOL-MOL PA, V55, P294, DOI 10.1136/mp.55.5.294; Francki A, 1999, J BIOL CHEM, V274, P32145, DOI 10.1074/jbc.274.45.32145; Francki A, 2004, J CELL BIOCHEM, V91, P915, DOI 10.1002/jcb.20008; Friedland JC, 2007, J CELL SCI, V120, P3700, DOI 10.1242/jcs.03484; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; Gilles C, 1998, CANCER RES, V58, P5529; Girotti MR, 2011, J INVEST DERMATOL, V131, P2438, DOI 10.1038/jid.2011.239; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Guo WJ, 2006, CELL, V126, P489, DOI 10.1016/j.cell.2006.05.047; HEMLER ME, 1989, J BIOL CHEM, V264, P6529; Hollestelle A, 2009, CANCER RES, V69, P7893, DOI 10.1158/0008-5472.CAN-09-2396; Hwang HW, 2007, SCIENCE, V315, P97, DOI 10.1126/science.1136235; Hynes RO, 1999, TRENDS CELL BIOL, V9, pM33, DOI 10.1016/S0962-8924(99)01667-0; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jacob K, 1999, CANCER RES, V59, P4453; Jauliac S, 2002, NAT CELL BIOL, V4, P540, DOI 10.1038/ncb816; Kapinas K, 2009, J CELL BIOCHEM, V108, P216, DOI 10.1002/jcb.22243; Kirschmann DA, 2002, CANCER RES, V62, P4478; Koblinski JE, 2005, CANCER RES, V65, P7370, DOI 10.1158/0008-5472.CAN-05-0807; Kunigal S, 2006, INT J ONCOL, V29, P1349; Kupprion C, 1998, J BIOL CHEM, V273, P29635, DOI 10.1074/jbc.273.45.29635; Ledda MF, 1997, NAT MED, V3, P171, DOI 10.1038/nm0297-171; LEE EC, 1992, J CELL BIOL, V117, P671, DOI 10.1083/jcb.117.3.671; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lipscomb EA, 2005, CANCER RES, V65, P10970, DOI 10.1158/0008-5472.CAN-05-2327; Lipscomb EA, 2005, CANCER METAST REV, V24, P413, DOI 10.1007/s10555-005-5133-4; Lu S, 2008, CLIN CANCER RES, V14, P1050, DOI 10.1158/1078-0432.CCR-07-4116; McKnight DAC, 2006, J CELL BIOCHEM, V97, P288, DOI 10.1002/jeb.20644; Montel V, 2009, DIFFERENTIATION, V78, P283, DOI 10.1016/j.diff.2009.07.007; Nie J, 2008, STEM CELLS, V26, P2735, DOI 10.1634/stemcells.2008-0212; O'Connor KL, 1998, J CELL BIOL, V143, P1749, DOI 10.1083/jcb.143.6.1749; O'Connor KL, 2000, J CELL BIOL, V148, P253, DOI 10.1083/jcb.148.2.253; Pullar CE, 2006, MOL BIOL CELL, V17, P4925, DOI 10.1091/mbc.E06-05-0433; Rabinovitz I, 1999, J CELL BIOL, V146, P1147, DOI 10.1083/jcb.146.5.1147; Rabinovitz I, 1997, J CELL BIOL, V139, P1873, DOI 10.1083/jcb.139.7.1873; Rae JM, 2007, BREAST CANCER RES TR, V104, P13, DOI 10.1007/s10549-006-9392-8; RAINES EW, 1992, P NATL ACAD SCI USA, V89, P1281, DOI 10.1073/pnas.89.4.1281; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Rivera LB, 2011, CELL MOL LIFE SCI, V68, P3165, DOI 10.1007/s00018-011-0781-8; Rivera LB, 2011, J CELL BIOL, V193, P1305, DOI 10.1083/jcb.201011143; Sano M, 2010, INT J ONCOL, V36, P321, DOI 10.3892/ijo_00000503; Santoro MM, 2003, DEV CELL, V5, P257, DOI 10.1016/S1534-5807(03)00201-6; Sarrio D, 2008, CANCER RES, V68, P989, DOI 10.1158/0008-5472.CAN-07-2017; Schiemann BJ, 2003, MOL BIOL CELL, V14, P3977, DOI 10.1091/mbc.E03-01-0001; Schietke R, 2010, J BIOL CHEM, V285, P6658, DOI 10.1074/jbc.M109.042424; Schultz C, 2002, CANCER RES, V62, P6270; Sehgal BU, 2006, J BIOL CHEM, V281, P35487, DOI 10.1074/jbc.M606317200; Sellappan S, 2004, CANCER RES, V64, P3479, DOI 10.1158/0008-5472.CAN-3299-2; SHAW LM, 1993, J BIOL CHEM, V268, P11401; Shaw LM, 1996, CANCER RES, V56, P959; Shaw LM, 1997, CELL, V91, P949, DOI 10.1016/S0092-8674(00)80486-9; Shi Q, 2007, ONCOGENE, V26, P4084, DOI 10.1038/sj.onc.1210181; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Subramanian A, 2007, BIOINFORMATICS, V23, P3251, DOI 10.1093/bioinformatics/btm369; Thomas SL, 2010, NEURO-ONCOLOGY, V12, P941, DOI 10.1093/neuonc/noq048; Tian M, 2009, FUTURE ONCOL, V5, P259, DOI 10.2217/14796694.5.2.259; Trusolino L, 2001, CELL, V107, P643, DOI 10.1016/S0092-8674(01)00567-0; van der Flier A, 2001, CELL TISSUE RES, V305, P285, DOI 10.1007/s004410100417; Weaver MS, 2008, J BIOL CHEM, V283, P22826, DOI 10.1074/jbc.M706563200; Wewer UM, 1997, AM J PATHOL, V151, P1191; Wong SY, 2008, CLIN EXP METASTAS, V25, P109, DOI 10.1007/s10585-007-9126-2; Yang XWH, 2008, CANCER RES, V68, P3204, DOI 10.1158/0008-5472.CAN-07-2949; Yang XW, 2004, J CELL BIOL, V167, P1231, DOI 10.1083/jcb.200404100; Zahir N, 2003, J CELL BIOL, V163, P1397, DOI 10.1083/jcb.200302023; Zhang QB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009712	79	31	33	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					9835	9844		10.1074/jbc.M111.317727	http://dx.doi.org/10.1074/jbc.M111.317727			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22308039	Green Published, hybrid			2022-12-25	WOS:000302167200016
J	Rajabi, H; Ahmad, R; Jin, CN; Kosugi, M; Alam, M; Joshi, MD; Kufe, D				Rajabi, Hasan; Ahmad, Rehan; Jin, Caining; Kosugi, Michio; Alam, Maroof; Joshi, Maya Datt; Kufe, Donald			MUC1-C Oncoprotein Induces TCF7L2 Transcription Factor Activation and Promotes Cyclin D1 Expression in Human Breast Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARCINOMA-ASSOCIATED ANTIGEN; BETA-CATENIN; KINASE-ACTIVITY; WNT; PROTEIN; DOMAIN; GENE; BINDING; TARGET; OVEREXPRESSION	MUC1 is a heterodimeric glycoprotein that is overexpressed in breast cancers. The present studies demonstrate that the oncogenic MUC1 C-terminal subunit (MUC1-C) associates with the TCF7L2 transcription factor. The MUC1-C cytoplasmic domain (MUC1-CD) binds directly to the TCF7L2 C-terminal region. MUC1-C blocks the interaction between TCF7L2 and the C-terminal-binding protein (CtBP), a suppressor of TCF7L2-mediated transcription. TCF7L2 and MUC1-C form a complex on the cyclin D1 gene promoter and MUC1-C promotes TCF7L2-mediated transcription by the recruitment of beta-catenin and p300. Silencing MUC1-C in human breast cancer cells down-regulated activation of the cyclin D1 promoter and decreased cyclin D1 expression. In addition, a MUC1-C inhibitor blocked the interaction with TCF7L2 and suppressed cyclin D1 levels. These findings indicate that the MUC1-C oncoprotein contributes to TCF7L2 activation and thereby promotes cyclin D1 expression in breast cancer cells.	[Rajabi, Hasan; Ahmad, Rehan; Jin, Caining; Kosugi, Michio; Alam, Maroof; Joshi, Maya Datt; Kufe, Donald] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Kufe, D (corresponding author), Dana Farber Canc Inst, 450 Brookline Ave,Dana 830, Boston, MA 02215 USA.	donald_kufe@dfci.harvard.edu	Rather, R A/J-3509-2019		National Institutes of Health [CA97098, CA42802, CA100707]; NCI; NATIONAL CANCER INSTITUTE [P50CA100707, R01CA097098, R01CA166480, R01CA042802] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA97098, CA42802, and CA100707 awarded by the NCI.	Ahmad R, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001426; Ahmad R, 2009, CANCER RES, V69, P7013, DOI 10.1158/0008-5472.CAN-09-0523; Arce L, 2006, ONCOGENE, V25, P7492, DOI 10.1038/sj.onc.1210056; Atcha FA, 2003, J BIOL CHEM, V278, P16169, DOI 10.1074/jbc.M213218200; Atcha FA, 2007, MOL CELL BIOL, V27, P8352, DOI 10.1128/MCB.02132-06; BARTKOVA J, 1994, INT J CANCER, V57, P353, DOI 10.1002/ijc.2910570311; Brannon M, 1999, DEVELOPMENT, V126, P3159; Cuilliere-Dartigues P, 2006, ONCOGENE, V25, P4441, DOI 10.1038/sj.onc.1209471; Daniels DL, 2005, NAT STRUCT MOL BIOL, V12, P364, DOI 10.1038/nsmb912; DICKSON C, 1995, CANCER LETT, V90, P43, DOI 10.1016/0304-3835(94)03676-A; Duraisamy S, 2007, INT J ONCOL, V31, P671; Duval A, 2000, CANCER RES, V60, P3872; Evans PM, 2010, MOL CELL BIOL, V30, P372, DOI 10.1128/MCB.00063-09; GILLETT C, 1994, CANCER RES, V54, P1812; Hatsell S, 2003, J MAMMARY GLAND BIOL, V8, P145, DOI 10.1023/A:1025944723047; Hecht A, 2003, J BIOL CHEM, V278, P3776, DOI 10.1074/jbc.M210081200; Hoppler S, 2007, J CELL SCI, V120, P385, DOI 10.1242/jcs.03363; Huang L, 2005, CANCER RES, V65, P10413, DOI 10.1158/0008-5472.CAN-05-2474; Huang L, 2003, CANCER BIOL THER, V2, P702; Jeselsohn R, 2010, CANCER CELL, V17, P65, DOI 10.1016/j.ccr.2009.11.024; Jirawatnotai S, 2011, NATURE, V474, P230, DOI 10.1038/nature10155; Kioussi C, 2002, CELL, V111, P673, DOI 10.1016/S0092-8674(02)01084-X; KUFE D, 1984, HYBRIDOMA, V3, P223, DOI 10.1089/hyb.1984.3.223; Kufe DW, 2009, NAT REV CANCER, V9, P874, DOI 10.1038/nrc2761; Lamb J, 2003, CELL, V114, P323, DOI 10.1016/S0092-8674(03)00570-1; Landis MW, 2006, CANCER CELL, V9, P13, DOI 10.1016/j.ccr.2005.12.019; Leng YM, 2007, J BIOL CHEM, V282, P19321, DOI 10.1074/jbc.M703222200; Li YQ, 1998, MOL CELL BIOL, V18, P7216, DOI 10.1128/MCB.18.12.7216; LOVE JJ, 1995, NATURE, V376, P791, DOI 10.1038/376791a0; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; MCINTOSH GG, 1995, ONCOGENE, V11, P885; Polakis P, 2007, CURR OPIN GENET DEV, V17, P45, DOI 10.1016/j.gde.2006.12.007; Quinlan KGR, 2006, MOL CELL BIOL, V26, P8202, DOI 10.1128/MCB.00445-06; Raina D, 2009, CANCER RES, V69, P5133, DOI 10.1158/0008-5472.CAN-09-0854; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Schroeder JA, 2003, ONCOGENE, V22, P1324, DOI 10.1038/sj.onc.1206291; Subramanian T, 2003, FEBS LETT, V540, P255, DOI 10.1016/S0014-5793(03)00275-8; Sun T, 2009, CANCER RES, V69, P3356, DOI 10.1158/0008-5472.CAN-08-4112; Takahashi-Yanaga F, 2008, CELL SIGNAL, V20, P581, DOI 10.1016/j.cellsig.2007.10.018; Valenta T, 2003, NUCLEIC ACIDS RES, V31, P2369, DOI 10.1093/nar/gkg346; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; Weise A, 2010, NUCLEIC ACIDS RES, V38, P1964, DOI 10.1093/nar/gkp1197; Yamamoto M, 1997, J BIOL CHEM, V272, P12492, DOI 10.1074/jbc.272.19.12492; Yu QY, 2001, NATURE, V411, P1017, DOI 10.1038/35082500	45	62	66	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					10703	10713		10.1074/jbc.M111.323311	http://dx.doi.org/10.1074/jbc.M111.323311			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22318732	Green Published, hybrid			2022-12-25	WOS:000302167200095
J	Wang, WY; Linsdell, P				Wang, Wuyang; Linsdell, Paul			Alternating Access to the Transmembrane Domain of the ATP-binding Cassette Protein Cystic Fibrosis Transmembrane Conductance Regulator (ABCC7)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CFTR CHLORIDE CHANNEL; CL-CHANNEL; CONFORMATIONAL-CHANGES; POSITIVE CHARGES; PORE; TRANSPORTERS; IDENTIFICATION; PERMEATION; VESTIBULE; MECHANISM	The cystic fibrosis transmembrane conductance regulator (CFTR) chloride channel is a member of the ATP-binding cassette (ABC) protein family, most members of which act as active transporters. Actively transporting ABC proteins are thought to alternate between "outwardly facing" and "inwardly facing" conformations of the transmembrane substrate pathway. In CFTR, it is assumed that the outwardly facing conformation corresponds to the channel open state, based on homology with other ABC proteins. We have used patch clamp recording to quantify the rate of access of cysteine-reactive probes to cysteines introduced into two different transmembrane regions of CFTR from both the intracellular and extracellular solutions. Two probes, the large [2-sulfonatoethyl] methanethiosulfonate (MTSES) molecule and permeant Au(CN)(2)(-) ions, were applied to either side of the membrane to modify cysteines substituted for Leu-102 (first transmembrane region) and Thr-338 (sixth transmembrane region). Channel opening and closing were altered by mutations in the nucleotide binding domains of the channel. We find that, for both MTSES and Au(CN)(2)(-), access to these two cysteines from the cytoplasmic side is faster in open channels, whereas access to these same sites from the extracellular side is faster in closed channels. These results are consistent with alternating access to the transmembrane regions, however with the open state facing inwardly and the closed state facing outwardly. Our findings therefore prompt revision of current CFTR structural and mechanistic models, as well as having broader implications for transport mechanisms in all ABC proteins. Our results also suggest possible locations of both functional and dysfunctional ("vestigial") gates within the CFTR permeation pathway.	[Wang, Wuyang; Linsdell, Paul] Dalhousie Univ, Dept Physiol & Biophys, Halifax, NS B3H 4R2, Canada	Dalhousie University	Linsdell, P (corresponding author), Dalhousie Univ, Dept Physiol & Biophys, POB 15000, Halifax, NS B3H 4R2, Canada.	paul.linsdell@dal.ca		Linsdell, Paul/0000-0001-6257-6273; Wang, Wuyang/0000-0003-1875-5463	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Institutes of Health Research.	Alexander C, 2009, BIOCHEMISTRY-US, V48, P10078, DOI 10.1021/bi901314c; Bai YH, 2011, J GEN PHYSIOL, V138, P495, DOI 10.1085/jgp.201110705; Bai YH, 2010, J GEN PHYSIOL, V136, P293, DOI 10.1085/jgp.201010480; Beck EJ, 2008, J BIOL CHEM, V283, P4957, DOI 10.1074/jbc.M702235200; Csanady L, 2010, P NATL ACAD SCI USA, V107, P1241, DOI 10.1073/pnas.0911061107; DeFelice LJ, 2007, ANNU REV PHYSIOL, V69, P87, DOI 10.1146/annurev.physiol.69.031905.164816; El Hiani Y, 2010, J BIOL CHEM, V285, P32126, DOI 10.1074/jbc.M110.113332; Fatehi M, 2007, BIOPHYS J, V92, P1241, DOI 10.1529/biophysj.106.095349; Gadsby DC, 2009, NAT REV MOL CELL BIO, V10, P344, DOI 10.1038/nrm2668; Gadsby DC, 2006, NATURE, V440, P477, DOI 10.1038/nature04712; Holstead RG, 2011, J MEMBRANE BIOL, V243, P15, DOI 10.1007/s00232-011-9388-0; Hwang TC, 1999, TRENDS PHARMACOL SCI, V20, P448, DOI 10.1016/S0165-6147(99)01386-3; Hwang TC, 2009, J PHYSIOL-LONDON, V587, P2151, DOI 10.1113/jphysiol.2009.171595; Kos V, 2009, CELL MOL LIFE SCI, V66, P3111, DOI 10.1007/s00018-009-0064-9; Li MS, 2009, BRIT J PHARMACOL, V157, P1065, DOI 10.1111/j.1476-5381.2009.00258.x; Linsdell P, 2006, EXP PHYSIOL, V91, P123, DOI 10.1113/expphysiol.2005.031757; Linsdell P, 1998, J PHYSIOL-LONDON, V512, P1, DOI 10.1111/j.1469-7793.1998.001bf.x; Locher KP, 2009, PHILOS T R SOC B, V364, P239, DOI 10.1098/rstb.2008.0125; McCarty NA, 2001, AM J PHYSIOL-LUNG C, V281, pL852, DOI 10.1152/ajplung.2001.281.4.L852; Mense M, 2006, EMBO J, V25, P4728, DOI 10.1038/sj.emboj.7601373; Miller C, 2010, P NATL ACAD SCI USA, V107, P959, DOI 10.1073/pnas.0913576107; Mio K, 2008, J BIOL CHEM, V283, P30300, DOI 10.1074/jbc.M803185200; Mornon JP, 2008, CELL MOL LIFE SCI, V65, P2594, DOI 10.1007/s00018-008-8249-1; Mornon JP, 2009, CELL MOL LIFE SCI, V66, P3469, DOI 10.1007/s00018-009-0133-0; Qian F, 2011, PFLUG ARCH EUR J PHY, V462, P559, DOI 10.1007/s00424-011-0998-2; Rees DC, 2009, NAT REV MOL CELL BIO, V10, P218, DOI 10.1038/nrm2646; Rosenberg MF, 2011, J BIOL CHEM, V286, P42647, DOI 10.1074/jbc.M111.292268; Serohijos AWR, 2008, P NATL ACAD SCI USA, V105, P3256, DOI 10.1073/pnas.0800254105; Wang WY, 2012, BBA-BIOMEMBRANES, V1818, P851, DOI 10.1016/j.bbamem.2011.12.025; Wang WY, 2011, J GEN PHYSIOL, V138, P165, DOI 10.1085/jgp.201110605; Zhang LA, 2011, BBA-BIOMEMBRANES, V1808, P399, DOI 10.1016/j.bbamem.2010.08.012; Zhang ZR, 2005, J BIOL CHEM, V280, P41997, DOI 10.1074/jbc.M510242200; Zhou JJ, 2010, J GEN PHYSIOL, V135, P229, DOI 10.1085/jgp.200910327; Zhou JJ, 2008, PFLUG ARCH EUR J PHY, V457, P351, DOI 10.1007/s00424-008-0521-6	34	26	27	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					10156	10165		10.1074/jbc.M112.342972	http://dx.doi.org/10.1074/jbc.M112.342972			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22303012	Green Published, hybrid			2022-12-25	WOS:000302167200047
J	Brown, AP; Kroon, JTM; Swarbreck, D; Febrer, M; Larson, TR; Graham, IA; Caccamo, M; Slabas, AR				Brown, Adrian P.; Kroon, Johan T. M.; Swarbreck, David; Febrer, Melanie; Larson, Tony R.; Graham, Ian A.; Caccamo, Mario; Slabas, Antoni R.			Tissue-Specific Whole Transcriptome Sequencing in Castor, Directed at Understanding Triacylglycerol Lipid Biosynthetic Pathways	PLOS ONE			English	Article							RICINOLEIC ACID BIOSYNTHESIS; UNUSUAL FATTY-ACIDS; RICINUS-COMMUNIS L; DIACYLGLYCEROL ACYLTRANSFERASE; MICROSOMAL PREPARATIONS; ENDOPLASMIC-RETICULUM; 1-ACYL-SN-GLYCEROL-3-PHOSPHATE ACYLTRANSFERASE; OLEATE 12-HYDROXYLASE; BRASSICA TAPETUM; SEED DEVELOPMENT	Background: Storage triacylglycerols in castor bean seeds are enriched in the hydroxylated fatty acid ricinoleate. Extensive tissue-specific RNA-Seq transcriptome and lipid analysis will help identify components important for its biosynthesis. Methodology/Findings: Storage triacylglycerols (TAGs) in the endosperm of developing castor (Ricinus communis) seeds are highly enriched in ricinoleic acid (18:1-OH). We have analysed neutral lipid fractions from other castor tissues using TLC, GLC and mass spectrometry. Cotyledons, like the endosperm, contain high levels of 18:1-OH in TAG. Pollen and male developing flowers accumulate TAG but do not contain 18:1-OH and leaves do not contain TAG or 18:1-OH. Analysis of acyl-CoAs in developing endosperm shows that ricinoleoyl-CoA is not the dominant acyl-CoA, indicating that either metabolic channelling or enzyme substrate selectivity are important in the synthesis of tri-ricinolein in this tissue. RNA-Seq transcriptomic analysis, using Illumina sequencing by synthesis technology, has been performed on mRNA isolated from two stages of developing seeds, germinating seeds, leaf and pollen-producing male flowers in order to identify differences in lipid-metabolic pathways and enzyme isoforms which could be important in the biosynthesis of TAG enriched in 18:1-OH. This study gives comprehensive coverage of gene expression in a variety of different castor tissues. The potential role of differentially expressed genes is discussed against a background of proteins identified in the endoplasmic reticulum, which is the site of TAG biosynthesis, and transgenic studies aimed at increasing the ricinoleic acid content of TAG. Conclusions/Significance: Several of the genes identified in this tissue-specific whole transcriptome study have been used in transgenic plant research aimed at increasing the level of ricinoleic acid in TAG. New candidate genes have been identified which might further improve the level of ricinoleic acid in transgenic crops.	[Brown, Adrian P.; Kroon, Johan T. M.; Slabas, Antoni R.] Univ Durham, Sch Biol & Biomed Sci, Durham, England; [Swarbreck, David; Febrer, Melanie; Caccamo, Mario] Genome Anal Ctr, Norwich, Norfolk, England; [Larson, Tony R.; Graham, Ian A.] Univ York, Dept Biol, Ctr Novel Agr Prod, York YO10 5DD, N Yorkshire, England	Durham University; The Genome Analysis Centre (TGAC); University of York - UK	Brown, AP (corresponding author), Univ Durham, Sch Biol & Biomed Sci, Durham, England.	a.r.slabas@durham.ac.uk	Kroon, Johan Theodorus Maria/S-8415-2019; Larson, Tony/AAI-4782-2020	Kroon, Johan Theodorus Maria/0000-0003-2086-6074; Larson, Tony/0000-0003-1337-3482; Swarbreck, David/0000-0002-5453-1013	Biotechnology and Biological Sciences Research Council [BB/F004354/1]; Linnaeus, Inc.; Arkema as industrial; BBSRC [BBS/E/T/000PR6193, BB/F004354/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/T/000PR6193] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Linnaeus, Inc.; Arkema as industrial; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the Biotechnology and Biological Sciences Research Council (http://www.bbsrc.ac.uk/), grant no. BB/F004354/1, a LINK grant with Linnaeus, Inc. and Arkema as industrial partners. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts MGM, 1995, PLANT CELL, V7, P2115, DOI 10.1105/tpc.7.12.2115; Ariizumi T, 2011, ANNU REV PLANT BIOL, V62, P437, DOI 10.1146/annurev-arplant-042809-112312; BAFOR M, 1991, BIOCHEM J, V280, P507, DOI 10.1042/bj2800507; Bates PD, 2007, J BIOL CHEM, V282, P31206, DOI 10.1074/jbc.M705447200; Bates PD, 2011, PLANT J, V68, P387, DOI 10.1111/j.1365-313X.2011.04693.x; Bates PD, 2009, PLANT PHYSIOL, V150, P55, DOI 10.1104/pp.109.137737; Baud S, 2007, PLANT J, V50, P825, DOI 10.1111/j.1365-313X.2007.03092.x; Beisson F, 2003, PLANT PHYSIOL, V132, P681, DOI 10.1104/pp.103.022988; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brough CL, 1996, MOL BREEDING, V2, P133, DOI 10.1007/BF00441428; Broun P, 1998, PLANT J, V13, P201, DOI 10.1046/j.1365-313X.1998.00023.x; Broun P, 2004, P NATL ACAD SCI USA, V101, P4706, DOI 10.1073/pnas.0305574101; Brown AP, 2011, J PROTEOME RES, V10, P3565, DOI 10.1021/pr2002066; Brown AP, 2009, ADV PHOTOSYNTH RESP, V30, P11; BROWN AP, 1995, PLANT MOL BIOL, V29, P267, DOI 10.1007/BF00043651; Burgal J, 2008, PLANT BIOTECHNOL J, V6, P819, DOI 10.1111/j.1467-7652.2008.00361.x; Chan AP, 2010, NAT BIOTECHNOL, V28, P951, DOI 10.1038/nbt.1674; Chen GQ, 2007, LIPIDS, V42, P263, DOI 10.1007/s11745-007-3022-z; Costa GGL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-462; Dahlqvist A, 2000, P NATL ACAD SCI USA, V97, P6487, DOI 10.1073/pnas.120067297; Eastmond PJ, 2010, PLANT CELL, V22, P2796, DOI 10.1105/tpc.109.071423; Eastmond PJ, 2004, J BIOL CHEM, V279, P45540, DOI 10.1074/jbc.M408686200; FOLCH J, 1957, J BIOL CHEM, V226, P497; Footitt S, 2007, PLANT PHYSIOL, V144, P1467, DOI 10.1104/pp.107.099903; Graham IA, 2008, ANNU REV PLANT BIOL, V59, P115, DOI 10.1146/annurev.arplant.59.032607.092938; GREENWOOD JS, 1982, CAN J BOT, V60, P1751, DOI 10.1139/b82-222; He XH, 2004, LIPIDS, V39, P311, DOI 10.1007/s11745-004-1234-2; Hsieh K, 2005, PLANT J, V43, P889, DOI 10.1111/j.1365-313X.2005.02502.x; Hsieh K, 2007, PLANT CELL, V19, P582, DOI 10.1105/tpc.106.049049; Hsu FF, 1999, J AM SOC MASS SPECTR, V10, P587, DOI 10.1016/S1044-0305(99)00035-5; Jessen D, 2011, PLANT J, V68, P715, DOI 10.1111/j.1365-313X.2011.04722.x; Kannangara R, 2007, PLANT CELL, V19, P1278, DOI 10.1105/tpc.106.047076; Kim HU, 2011, PLANT CELL PHYSIOL, V52, P983, DOI 10.1093/pcp/pcr051; Kroon JTM, 2006, PHYTOCHEMISTRY, V67, P2541, DOI 10.1016/j.phytochem.2006.09.020; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Larson TR, 2002, PLANT J, V32, P519, DOI 10.1046/j.1365-313X.2002.01440.x; Larson TR, 2001, PLANT J, V25, P115, DOI 10.1046/j.1365-313x.2001.00929.x; LASSNER MW, 1995, PLANT PHYSIOL, V109, P1389, DOI 10.1104/pp.109.4.1389; Li XC, 2012, MOL PLANT, V5, P131, DOI 10.1093/mp/ssr057; Li-Beisson Yonghua, 2010, Arabidopsis Book, V8, pe0133, DOI [10.1199/tab.0133, 10.1199/tab.0161]; Li-Beisson Y, 2009, P NATL ACAD SCI USA, V106, P22008, DOI 10.1073/pnas.0909090106; Lu CF, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-42; Lu CF, 2009, P NATL ACAD SCI USA, V106, P18837, DOI 10.1073/pnas.0908848106; Mancha M, 1997, PLANTA, V203, P51, DOI 10.1007/s004250050164; McConn M, 1996, PLANT CELL, V8, P403, DOI 10.1105/tpc.8.3.403; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Napier JA, 2007, ANNU REV PLANT BIOL, V58, P295, DOI 10.1146/annurev.arplant.58.032806.103811; Peng FY, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-286; Perez-Rodriquez P, 2009, NUCLEIC ACIDS RES, V38, DOI [10.1093/nar/gkp805, DOI 10.1093/NAR/GKP805]; Quettier AL, 2009, PLANT PHYSIOL BIOCH, V47, P485, DOI 10.1016/j.plaphy.2008.12.005; Saha S, 2006, PLANT PHYSIOL, V141, P1533, DOI 10.1104/pp.106.082198; Santos-Mendoza M, 2008, PLANT J, V54, P608, DOI 10.1111/j.1365-313X.2008.03461.x; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Severin AJ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-160; Shindou H, 2009, J BIOL CHEM, V284, P1, DOI 10.1074/jbc.R800046200; SLACK CR, 1983, BIOCHIM BIOPHYS ACTA, V754, P10, DOI 10.1016/0005-2760(83)90076-0; Smith MA, 2003, PLANTA, V217, P507, DOI 10.1007/s00425-003-1015-6; SMITH MA, 1992, BIOCHEM J, V287, P141, DOI 10.1042/bj2870141; Stahl U, 2008, FEBS LETT, V582, P305, DOI 10.1016/j.febslet.2007.12.020; STYMNE S, 1984, BIOCHEM J, V223, P305, DOI 10.1042/bj2230305; Testerink C, 2011, J EXP BOT, V62, P2349, DOI 10.1093/jxb/err079; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; van Erp H, 2011, PLANT PHYSIOL, V155, P683, DOI 10.1104/pp.110.167239; VANDELOO FJ, 1995, P NATL ACAD SCI USA, V92, P6743, DOI 10.1073/pnas.92.15.6743; Yang Peizhen, 2010, BMC Plant Biol, V10, P250, DOI 10.1186/1471-2229-10-250; Yang WL, 2010, P NATL ACAD SCI USA, V107, P12040, DOI 10.1073/pnas.0914149107; Yang ZL, 2009, PLANT PHYSIOL, V150, P1981, DOI 10.1104/pp.109.140491; Zhang M, 2009, PLANT CELL, V21, P3885, DOI 10.1105/tpc.109.071795; Zhao LF, 2010, PLANT J, V64, P1048, DOI 10.1111/j.1365-313X.2010.04396.x	70	94	104	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2012	7	2							e30100	10.1371/journal.pone.0030100	http://dx.doi.org/10.1371/journal.pone.0030100			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LO	22319559	Green Accepted, Green Submitted, Green Published, gold			2022-12-25	WOS:000302178400004
J	Donnem, T; Fenton, CG; Lonvik, K; Berg, T; Eklo, K; Andersen, S; Stenvold, H; Al-Shibli, K; Al-Saad, S; Bremnes, RM; Busund, LT				Donnem, Tom; Fenton, Christopher G.; Lonvik, Kenneth; Berg, Thomas; Eklo, Katrine; Andersen, Sigve; Stenvold, Helge; Al-Shibli, Khalid; Al-Saad, Samer; Bremnes, Roy M.; Busund, Lill-Tove			MicroRNA Signatures in Tumor Tissue Related to Angiogenesis in Non-Small Cell Lung Cancer	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; PROGNOSTIC IMPACT; STROMAL CELLS; EXPRESSION PROFILES; MICROARRAY DATA; POOR SURVIVAL; CARCINOMA; HYPOXIA; COEXPRESSION; HISTOLOGY	Background: Angiogenesis is regarded as a hallmark in cancer development, and anti-angiogenic treatment is presently used in non-small cell lung cancer (NSCLC) patients. MicroRNAs (miRs) are small non-coding, endogenous, single stranded RNAs that regulate gene expression. In this study we aimed to identify significantly altered miRs related to angiogenesis in NSCLC. Methods: From a large cohort of 335 NSCLC patients, paraffin-embedded samples from 10 patients with a short disease specific survival (DSS), 10 with a long DSS and 10 normal controls were analyzed. The miRs were quantified by microarray hybridization and selected miRs were validated by real-time qPCR. The impacts of different pathways, including angiogenesis, were evaluated by Gene Set Enrichment Analysis (GSEA) derived from Protein ANalysis THrough Evolutionary Relationship (PANTHER). One of the most interesting candidate markers, miR-155, was validated by in situ hybridization (ISH) in the total cohort (n = 335) and correlation analyses with several well-known angiogenic markers were done. Results: 128 miRs were significantly up-or down-regulated; normal versus long DSS (n = 68) and/or normal versus short DSS (n = 63) and/or long versus short DSS (n = 37). The pathway analysis indicates angiogenesis-related miRs to be involved in NSCLC. There were strong significant correlations between the array hybridization and qPCR validation data. The significantly altered angiogenesis-related miRs of high interest were miR-21, miR-106a, miR-126, miR-155, miR-182, miR-210 and miR-424. miR-155 correlated significantly with fibroblast growth factor 2 (FGF2) in the total cohort (r = 0.17, P = 0.002), though most prominent in the subgroup with nodal metastasis (r = 0.34, P<0.001). Conclusions: Several angiogenesis-related miRs are significantly altered in NSCLC. Further studies to understand their biological functions and explore their clinical relevance are warranted.	[Donnem, Tom; Andersen, Sigve; Stenvold, Helge; Bremnes, Roy M.] Univ Hosp N Norway, Dept Oncol, Tromso, Norway; [Donnem, Tom; Fenton, Christopher G.; Andersen, Sigve; Stenvold, Helge; Bremnes, Roy M.] Univ Tromso, Inst Clin Med, Tromso, Norway; [Lonvik, Kenneth; Berg, Thomas; Eklo, Katrine; Al-Saad, Samer; Busund, Lill-Tove] Univ Hosp N Norway, Dept Clin Pathol, Tromso, Norway; [Lonvik, Kenneth; Berg, Thomas; Eklo, Katrine; Al-Saad, Samer; Busund, Lill-Tove] Univ Tromso, Inst Med Biol, Tromso, Norway; [Al-Shibli, Khalid] Nordland Cent Hosp, Dept Pathol, Bodo, Norway	UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso	Donnem, T (corresponding author), Univ Hosp N Norway, Dept Oncol, Tromso, Norway.	tom.donnem@uit.no	Pillay, Nischalan/F-9536-2012	Al-Saad, Samer/0000-0003-3707-9667	Northern Norway Regional Health Authority (Helse Nord RHF)	Northern Norway Regional Health Authority (Helse Nord RHF)	The study was solely funded by the Northern Norway Regional Health Authority (Helse Nord RHF), which is responsible for the public hospitals in northern Norway. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Saad S, 2009, ANTICANCER RES, V29, P4175; Andersen S, 2011, LUNG CANCER, V72, P294, DOI 10.1016/j.lungcan.2010.10.006; Andersen S, 2009, J THORAC ONCOL, V4, P463, DOI 10.1097/JTO.0b013e3181991d18; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Bishop JA, 2010, CLIN CANCER RES, V16, P610, DOI 10.1158/1078-0432.CCR-09-2638; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Cho WCS, 2010, INT J BIOCHEM CELL B, V42, P1273, DOI 10.1016/j.biocel.2009.12.014; Cho WCS, 2009, EXPERT REV MOL DIAGN, V9, P773, DOI [10.1586/erm.09.57, 10.1586/ERM.09.57]; Devlin C, 2011, IUBMB LIFE, V63, P94, DOI [10.1002/iub.00427, 10.1002/iub.427]; Donnem T, 2010, ANN ONCOL, V21, P223, DOI 10.1093/annonc/mdp296; Donnem T, 2008, J THORAC ONCOL, V3, P963, DOI 10.1097/JTO.0b013e3181834f52; Donnem T, 2007, CLIN CANCER RES, V13, P6649, DOI 10.1158/1078-0432.CCR-07-0414; Donnem T, 2011, CANCER-AM CANCER SOC, V117, P3193, DOI 10.1002/cncr.25907; Donnem T, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-6; Donnem T, 2010, CANCER-AM CANCER SOC, V116, P5676, DOI 10.1002/cncr.25551; Donnem T, 2010, CANCER-AM CANCER SOC, V116, P4318, DOI 10.1002/cncr.25333; Donnem T, 2009, J THORAC ONCOL, V4, P578, DOI 10.1097/JTO.0b013e31819f2e38; Donnem T, 2009, LUNG CANCER, V63, P277, DOI 10.1016/j.lungcan.2008.05.022; Du LQ, 2010, CANCER METAST REV, V29, P109, DOI 10.1007/s10555-010-9204-9; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Faraoni I, 2009, BBA-MOL BASIS DIS, V1792, P497, DOI 10.1016/j.bbadis.2009.02.013; Ghosh G, 2010, J CLIN INVEST, V120, P4141, DOI 10.1172/JCI42980; Gidskehaug L, 2004, J CHEMOMETR, V18, P208, DOI 10.1002/cem.862; Goldstraw P, 2009, J THORAC ONCOL, V4, P671, DOI 10.1097/JTO.0b013e31819e7814; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hu ZB, 2010, J CLIN ONCOL, V28, P1721, DOI 10.1200/JCO.2009.24.9342; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jiang LL, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-318; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Kuehbacher A, 2008, TRENDS PHARMACOL SCI, V29, P12, DOI 10.1016/j.tips.2007.10.014; Kuehbacher A, 2007, CIRC RES, V101, P59, DOI 10.1161/CIRCRESAHA.107.153916; Kulshreshtha R, 2008, CELL DEATH DIFFER, V15, P667, DOI 10.1038/sj.cdd.4402310; Kulshreshtha R, 2007, MOL CELL BIOL, V27, P1859, DOI 10.1128/MCB.01395-06; Landi MT, 2010, CLIN CANCER RES, V16, P430, DOI 10.1158/1078-0432.CCR-09-1736; Lebanony D, 2009, J CLIN ONCOL, V27, P2030, DOI 10.1200/JCO.2008.19.4134; Lin PY, 2010, BRIT J CANCER, V103, P1144, DOI 10.1038/sj.bjc.6605901; Liu L.Z., 2011, PLOS ONE, V6; Meister J, 2010, THESCIENTIFICWORLDJO, V10, P2090, DOI 10.1100/tsw.2010.198; Nakashima T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014334; Nguewa PA, 2011, EXPERT OPIN INV DRUG, V20, P61, DOI 10.1517/13543784.2011.541153; Nikolic Iva, 2010, J Angiogenes Res, V2, P9, DOI 10.1186/2040-2384-2-9; Olson P, 2009, GENE DEV, V23, P2152, DOI 10.1101/gad.1820109; Patnaik SK, 2010, CANCER RES, V70, P36, DOI 10.1158/0008-5472.CAN-09-3153; Puissegur MP, 2011, CELL DEATH DIFFER, V18, P465, DOI 10.1038/cdd.2010.119; Raponi M, 2009, CANCER RES, V69, P5776, DOI 10.1158/0008-5472.CAN-09-0587; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Sandler A, 2006, NEW ENGL J MED, V355, P2542, DOI 10.1056/NEJMoa061884; Scagliotti G, 2009, ONCOLOGIST, V14, P253, DOI 10.1634/theoncologist.2008-0232; Seike M, 2009, P NATL ACAD SCI USA, V106, P12085, DOI 10.1073/pnas.0905234106; Suarez Y, 2009, CIRC RES, V104, P442, DOI 10.1161/CIRCRESAHA.108.191270; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun YQ, 2010, BIOCHEM BIOPH RES CO, V391, P1483, DOI 10.1016/j.bbrc.2009.12.098; Voortman J, 2010, CANCER RES, V70, P8288, DOI 10.1158/0008-5472.CAN-10-1348; Wang SS, 2008, DEV CELL, V15, P261, DOI 10.1016/j.devcel.2008.07.002; Wettenhall JM, 2004, BIOINFORMATICS, V20, P3705, DOI 10.1093/bioinformatics/bth449; *WHO, 1999, HLTH PROM HOSP SER, P3; Wu FS, 2009, BIOCHEM BIOPH RES CO, V386, P549, DOI 10.1016/j.bbrc.2009.06.075; Wu X, 2009, J THORAC ONCOL, V4, P1028, DOI 10.1097/JTO.0b013e3181a99c77; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Zhang CX, 2010, J CARDIOVASC TRANSL, V3, P235, DOI 10.1007/s12265-010-9164-z; Zhou WC, 2009, CELL RES, V19, P1165, DOI 10.1038/cr.2009.95	61	86	97	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e29671	10.1371/journal.pone.0029671	http://dx.doi.org/10.1371/journal.pone.0029671			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910ME	22295063	Green Published, gold, Green Submitted			2022-12-25	WOS:000301640600008
J	Linklater, WL; Gedir, JV; Law, PR; Swaisgood, RR; Adcock, K; du Preez, P; Knight, MH; Kerley, GIH				Linklater, Wayne L.; Gedir, Jay V.; Law, Peter R.; Swaisgood, Ron R.; Adcock, Keryn; du Preez, Pierre; Knight, Michael H.; Kerley, Graham I. H.			Translocations as Experiments in the Ecological Resilience of an Asocial Mega-Herbivore	PLOS ONE			English	Article							CONSERVATION; SUCCESS; POPULATION; EXPERIENCE; SELECTION; DENSITY; WILD	Species translocations are remarkable experiments in evolutionary ecology, and increasingly critical to biodiversity conservation. Elaborate socio-ecological hypotheses for translocation success, based on theoretical fitness relationships, are untested and lead to complex uncertainty rather than parsimonious solutions. We used an extraordinary 89 reintroduction and 102 restocking events releasing 682 black rhinoceros (Diceros bicornis) to 81 reserves in southern Africa (1981-2005) to test the influence of interacting socio-ecological and individual characters on post-release survival. We predicted that the socio-ecological context should feature more prominently after restocking than reintroduction because released rhinoceros interact with resident conspecifics. Instead, an interaction between release cohort size and habitat quality explained reintroduction success but only individuals' ages explained restocking outcomes. Achieving translocation success for many species may not be as complicated as theory suggests. Black rhino, and similarly asocial generalist herbivores without substantial predators, are likely to be resilient to ecological challenges and robust candidates for crisis management in a changing world.	[Linklater, Wayne L.; Gedir, Jay V.] Victoria Univ Wellington, Sch Biol Sci, Ctr Biodivers & Restorat Ecol, Wellington, New Zealand; [Linklater, Wayne L.; Knight, Michael H.; Kerley, Graham I. H.] Nelson Mandela Metropolitan Univ, Dept Zool, Ctr African Conservat Ecol, Port Elizabeth, South Africa; [Law, Peter R.] PRLDB Modeling, Monroe, LA USA; [Swaisgood, Ron R.] San Diego Zoo Global Inst Conservat Res, Escondido, CA USA; [Adcock, Keryn] IUCN African Rhino Specialist Grp, Hilton, KwaZulu Natal, South Africa; [du Preez, Pierre] Minist Environm & Tourism, Directorate Sci Serv, Windhoek, Namibia; [Knight, Michael H.] S African Natl Pk, Pk Planning & Dev, Port Elizabeth, South Africa	Victoria University Wellington; Nelson Mandela University	Linklater, WL (corresponding author), Victoria Univ Wellington, Sch Biol Sci, Ctr Biodivers & Restorat Ecol, Wellington, New Zealand.	wayne.linklater@vuw.ac.nz	Swaisgood, Ronald R/AAL-3198-2020	Swaisgood, Ronald R/0000-0001-5353-2148; Linklater, Wayne/0000-0003-2627-693X; Law, Peter/0000-0003-3382-0286	U.S. Fish and Wildlife Service [98210-2-G363, 98210-4-G920, 98210-6-G102]	U.S. Fish and Wildlife Service(US Fish & Wildlife Service)	U.S. Fish and Wildlife Service administered Rhinoceros and Tiger Conservation Act of 1994 (e. g., grant agreement numbers 98210-2-G363, 98210-4-G920, and 98210-6-G102); http://www.fws.gov/international/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adcock K, 2005, VISUAL ASSESSMENT BL; Adcock K, 2001, RHINO MANAGEMENT GRO; Adcock K, 1995, SEQUENCE REPORTS STA; [Anonymous], 1987, POS STAT TRANSL LIV; Armstrong D, 2007, TRENDS ECOLOGY EVOLU; Banks PB, 2002, BIOL CONSERV, V103, P133, DOI 10.1016/S0006-3207(01)00110-0; Beech H, 2011, TIME, P28; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Brett Rob, 1998, Pachyderm, V26, P69; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Cameron EZ, 2009, P NATL ACAD SCI USA, V106, P13850, DOI 10.1073/pnas.0900639106; Castley J. Guy, 2003, Pachyderm, V34, P33; Dawson TP, 2011, SCIENCE, V332, P53, DOI 10.1126/science.1200303; DODD CK, 1991, HERPETOLOGICA, V47, P336; Fischer J, 2000, BIOL CONSERV, V96, P1, DOI 10.1016/S0006-3207(00)00048-3; Frair JL, 2007, J WILDLIFE MANAGE, V71, P541, DOI 10.2193/2006-141; Gelman A., 2007, DATA ANAL USING REGR; GRIFFITH B, 1989, SCIENCE, V245, P477, DOI 10.1126/science.245.4917.477; HITCHINS PM, 1978, S AFR J WILDL RES, V8, P71; Hoegh-Guldberg O, 2008, SCIENCE, V321, P345, DOI 10.1126/science.1157897; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; Linklater WL, 2008, J WILDLIFE MANAGE, V72, P1059, DOI 10.2193/2007-398; Linklater WL, 2011, J APPL ECOL, V48, P493, DOI 10.1111/j.1365-2664.2011.01960.x; Matson TK, 2004, BIOL CONSERV, V116, P359, DOI 10.1016/S0006-3207(03)00229-5; Morell V, 2008, SCIENCE, V320, P742, DOI 10.1126/science.320.5877.742; Nicoll MAC, 2003, J ANIM ECOL, V72, P917, DOI 10.1046/j.1365-2656.2003.00768.x; Owen-Smith N., 2003, ANIMAL BEHAV WILDLIF; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Sarrazin F, 1996, TRENDS ECOL EVOL, V11, P474, DOI 10.1016/0169-5347(96)20092-8; Scott JM, 2010, CONSERV LETT, V3, P91, DOI 10.1111/j.1755-263X.2010.00096.x; Shrader AM, 2002, BEHAV ECOL SOCIOBIOL, V52, P255, DOI 10.1007/s00265-002-0506-y; Somers MJ, 2008, OECOLOGIA, V158, P239, DOI 10.1007/s00442-008-1134-7; Stamps JA, 2007, APPL ANIM BEHAV SCI, V102, P392, DOI 10.1016/j.applanim.2006.05.038; Whittingham MJ, 2006, J ANIM ECOL, V75, P1182, DOI 10.1111/j.1365-2656.2006.01141.x; Wolf CM, 1998, BIOL CONSERV, V86, P243	35	16	16	2	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e30664	10.1371/journal.pone.0030664	http://dx.doi.org/10.1371/journal.pone.0030664			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910ME	22295100	Green Published, gold			2022-12-25	WOS:000301640600045
J	Adetifa, IMO; Antonio, M; Okoromah, CAN; Ebruke, C; Inem, V; Nsekpong, D; Bojang, A; Adegbola, RA				Adetifa, Ifedayo M. O.; Antonio, Martin; Okoromah, Christy A. N.; Ebruke, Chinelo; Inem, Victor; Nsekpong, David; Bojang, Abdoulie; Adegbola, Richard A.			Pre-Vaccination Nasopharyngeal Pneumococcal Carriage in a Nigerian Population: Epidemiology and Population Biology	PLOS ONE			English	Article							RESISTANT STREPTOCOCCUS-PNEUMONIAE; ACUTE OTITIS-MEDIA; RISK-FACTORS; SUSCEPTIBILITY PATTERNS; HAEMOPHILUS-INFLUENZAE; INVASIVE DISEASE; ANTIBIOTIC-RESISTANCE; SEROTYPE DISTRIBUTION; CONJUGATE VACCINE; CHILDREN	Background: Introduction of pneumococcal vaccines in Nigeria is a priority as part of the Accelerated Vaccine Introduction Initiative (AVI) of the Global Alliance for Vaccines and Immunisation (GAVI). However, country data on the burden of pneumococcal disease (IPD) is limited and coverage by available conjugate vaccines is unknown. This study was carried out to describe the pre vaccination epidemiology and population biology of pneumococcal carriage in Nigeria. Methods: This was a cross sectional survey. Nasopharyngeal swabs (NPS) were obtained from a population sample in 14 contiguous peri-urban Nigerian communities. Data on demographic characteristics and risk factor for carriage were obtained from all study participants. Pneumococci isolated from NPS were characterised by serotyping, antimicrobial susceptibility and Multi Locus Sequencing Typing (MLST). Results: The prevalence of pneumococcal carriage was 52.5%. Carriage was higher in children compared to adults (67.4% vs. 26%), highest (approximate to 90%) in infants aged <9 months and reduced significantly with increasing age (P<0.001). Serotypes 19F (18.6%) and 6A (14.4%) were most predominant. Potential vaccine coverage was 43.8%, 45.0% and 62% for PCV-7, PCV-10 and PCV-13 respectively. There were 16 novel alleles, 72 different sequence types (STs) from the isolates and 3 Sequence Types (280, 310 and 5543) were associated with isolates of more than one serotype indicative of serotype switching. Antimicrobial resistance was high for cotrimoxazole (93%) and tetracycline (84%), a third of isolates had intermediate resistance to penicillin. Young age was the only risk factor significantly associated with carriage. Conclusions: Pneumococcal carriage and serotype diversity is highly prevalent in Nigeria especially in infants. Based on the coverage of serotypes in this study, PCV-13 is the obvious choice to reduce disease burden and prevalence of drug resistant pneumococci. However, its use will require careful monitoring. Our findings provide sound baseline data for impact assessment following vaccine introduction in Nigeria.	[Adetifa, Ifedayo M. O.; Antonio, Martin; Ebruke, Chinelo; Nsekpong, David; Bojang, Abdoulie; Adegbola, Richard A.] Med Res Council MRC Unit, Fajara, Gambia; [Okoromah, Christy A. N.] Univ Lagos, Coll Med, Dept Paediat & Child Hlth, Lagos, Nigeria; [Inem, Victor] Univ Lagos, Coll Med, Dept Community Hlth & Primary Care, Lagos, Nigeria	University of London; London School of Hygiene & Tropical Medicine; University of Lagos; University of Lagos	Adetifa, IMO (corresponding author), Med Res Council MRC Unit, Fajara, Gambia.	iadetifa@mrc.gm; radegbola@hotmail.com		OKOROMAH, CHRISTY/0000-0001-9623-604X	International Society for Infectious Diseases (ISID); Medical Research Council (UK); European and Developing Countries Clinical Trials Partnership Career Development Fellowship [CG_ta_2005_40203_001]; MRC [MC_U190081991, MC_U190074190] Funding Source: UKRI; Medical Research Council [MC_U190074190, MC_U190081991] Funding Source: researchfish	International Society for Infectious Diseases (ISID); Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European and Developing Countries Clinical Trials Partnership Career Development Fellowship; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by an International Society for Infectious Diseases (ISID) Small Grant to IMOA (Spring 2008), a Medical Research Council (UK) Intramural funding to RAA and MA. IMOA also received support from a European and Developing Countries Clinical Trials Partnership Career Development Fellowship (grant number CG_ta_2005_40203_001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adegbola RA, 2006, TROP MED INT HEALTH, V11, P1128, DOI 10.1111/j.1365-3156.2006.01652.x; Akanbi MO, 2009, AFR J RESPIR MED, P10; Antonio M, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-81; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; BLOCK SL, 1995, PEDIATR INFECT DIS J, V14, P751, DOI 10.1097/00006454-199509000-00005; Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; Boken DJ, 1996, PEDIATR INFECT DIS J, V15, P667, DOI 10.1097/00006454-199608000-00006; Dagan R, 2002, J INFECT DIS, V185, P927, DOI 10.1086/339525; Department of Infectious Disease Epidemiology IC, EBURSTV3; Dheda K, 2007, J INFECTION, V55, P169, DOI 10.1016/j.jinf.2007.02.005; Donkor ES, 2010, SCAND J INFECT DIS, V42, P254, DOI 10.3109/00365540903490000; Faden H, 1997, J INFECT DIS, V175, P1440, DOI 10.1086/516477; Falade AG, 2009, CLIN INFECT DIS, V48, pS190, DOI 10.1086/596500; Farrell DJ, 2007, PEDIATR INFECT DIS J, V26, P123, DOI 10.1097/01.inf.0000253059.84602.c3; Feikin DR, 2003, PEDIATR INFECT DIS J, V22, P564, DOI 10.1097/00006454-200306000-00016; Gertz RE, 2003, J CLIN MICROBIOL, V41, P4194, DOI 10.1128/JCM.41.9.4194-4216.2003; GRAY BM, 1980, J INFECT DIS, V142, P923, DOI 10.1093/infdis/142.6.923; Greenberg D, 2006, CLIN INFECT DIS, V42, P897, DOI 10.1086/500935; Guillemot D, 1998, JAMA-J AM MED ASSOC, V279, P365, DOI 10.1001/jama.279.5.365; Hausdorff WP, 2005, LANCET INFECT DIS, V5, P83, DOI 10.1016/S1473-3099(05)01280-6; Hill PC, 2008, CLIN INFECT DIS, V46, P807, DOI 10.1086/528688; Hill PC, 2006, CLIN INFECT DIS, V43, P673, DOI 10.1086/506941; Hill PC, 2010, CLIN INFECT DIS, V50, P1468, DOI 10.1086/652443; Huang SS, 2005, PEDIATRICS, V116, pE408, DOI 10.1542/peds.2004-2338; Jain A, 2005, TROP MED INT HEALTH, V10, P234, DOI 10.1111/j.1365-3156.2004.01379.x; Johnson HL, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000348; Joloba ML, 2001, INT J ANTIMICROB AG, V17, P395, DOI 10.1016/S0924-8579(00)00345-9; Kaplan SL, 2004, PEDIATRICS, V113, P443, DOI 10.1542/peds.113.3.443; Leimkugel J, 2005, J INFECT DIS, V192, P192, DOI 10.1086/431151; Lynch JP, 2010, CURR OPIN PULM MED, V16, P217, DOI 10.1097/MCP.0b013e3283385653; Marchisio P, 2002, EMERG INFECT DIS, V8, P479; Melnick N, 2010, J CLIN MICROBIOL, V48, P2311, DOI 10.1128/JCM.00410-10; Mudhune S, 2009, CLIN INFECT DIS, V48, pS147, DOI 10.1086/596494; Nwachukwu NOA, 2008, AFRICAN J RESP M SEP, V16; O'Brien KL, 2003, PEDIATR INFECT DIS J, V22, P133, DOI [10.1097/00006454-200302000-00009, 10.1097/00006454-200302000-00010]; O'Brien KL, 2001, J CLIN MICROBIOL, V39, P1021, DOI 10.1128/JCM.39.3.1021-1024.2001; ONYEMELUKWE GC, 1982, J INFECTION, V5, P157, DOI 10.1016/S0163-4453(82)91772-8; OYEDEJI G A, 1985, Nigerian Journal of Paediatrics, V12, P111; Principi N, 1999, PEDIATR INFECT DIS J, V18, P517, DOI 10.1097/00006454-199906000-00008; Rajaratnam JK, 2010, LANCET, V375, P1988, DOI 10.1016/S0140-6736(10)60703-9; Rivera-Olivero IA, 2007, CLIN INFECT DIS, V45, P1427, DOI 10.1086/522984; Roca A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001107; Rudan I, 2008, B WORLD HEALTH ORGAN, V86, P408, DOI 10.2471/BLT.07.048769; Russell FM, 2006, ANN TROP PAEDIATR, V26, P187, DOI 10.1179/146532806X120273; Saha SK, 2003, J CLIN MICROBIOL, V41, P5582, DOI 10.1128/JCM.41.12.5582-5587.2003; Sazawal S, 2003, LANCET INFECT DIS, V3, P547, DOI 10.1016/S1473-3099(03)00737-0; SILVERMAN M, 1977, ARCH DIS CHILD, V52, P925, DOI 10.1136/adc.52.12.925; Soewignjo S, 2001, CLIN INFECT DIS, V32, P1039, DOI 10.1086/319605; Syrjanen RK, 2005, PEDIATR INFECT DIS J, V24, P801, DOI 10.1097/01.inf.0000178072.83531.4f; UNICEF W. H. O, 2006, PNEUM FORG KILL CHIL; Ussery XT, 1996, PEDIATR INFECT DIS J, V15, P986, DOI 10.1097/00006454-199611000-00011; WHO, 2007, WORLD HLTH STAT; WHO, 2008, INT MAN CHILDH ILLN; Yaro S, 2006, CLIN INFECT DIS, V43, P693, DOI 10.1086/506940	54	60	61	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2012	7	1							e30548	10.1371/journal.pone.0030548	http://dx.doi.org/10.1371/journal.pone.0030548			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910LV	22291984	Green Submitted, Green Published, gold			2022-12-25	WOS:000301639600032
J	Bronmark, C; Lakowitz, T; Nilsson, PA; Ahlgren, J; Lennartsdotter, C; Hollander, J				Bronmark, Christer; Lakowitz, Thomas; Nilsson, P. Anders; Ahlgren, Johan; Lennartsdotter, Charlotte; Hollander, Johan			Costs of Inducible Defence along a Resource Gradient	PLOS ONE			English	Article							FRESH-WATER SNAIL; PHENOTYPIC PLASTICITY; LIFE-HISTORY; TRAIT COMPENSATION; SHELL MORPHOLOGY; TRADE-OFF; PREDATORS; EVOLUTION; BEHAVIOR; GROWTH	In addition to having constitutive defence traits, many organisms also respond to predation by phenotypic plasticity. In order for plasticity to be adaptive, induced defences should incur a benefit to the organism in, for example, decreased risk of predation. However, the production of defence traits may include costs in fitness components such as growth, time to reproduction, or fecundity. To test the hypothesis that the expression of phenotypic plasticity incurs costs, we performed a common garden experiment with a freshwater snail, Radix balthica, a species known to change morphology in the presence of molluscivorous fish. We measured a number of predator-induced morphological and behavioural defence traits in snails that we reared in the presence or absence of chemical cues from fish. Further, we quantified the costs of plasticity in fitness characters related to fecundity and growth. Since plastic responses may be inhibited under limited resource conditions, we reared snails in different densities and thereby levels of competition. Snails exposed to predator cues grew rounder and thicker shells, traits confirmed to be adaptive in environments with fish. Defence traits were consistently expressed independent of density, suggesting strong selection from predatory molluscivorous fish. However, the expression of defence traits resulted in reduced growth rate and fecundity, particularly with limited resources. Our results suggest full defence in predator related traits regardless of resource availability, and costs of defence consequently paid in traits related to fitness.	[Bronmark, Christer; Lakowitz, Thomas; Nilsson, P. Anders; Ahlgren, Johan; Lennartsdotter, Charlotte; Hollander, Johan] Lund Univ, Dept Biol, Lund, Sweden	Lund University	Bronmark, C (corresponding author), Lund Univ, Dept Biol, Lund, Sweden.	Johan.Hollander@biol.lu.se	Ahlgren, Johan/C-3021-2011; Nilsson, Anders/H-6836-2014	Ahlgren, Johan/0000-0002-6506-289X; Nilsson, Anders/0000-0002-3541-9835; Hollander, Johan/0000-0002-4207-2956	Swedish Research Council; Formas; Marie Curie European Reintegration Grant	Swedish Research Council(Swedish Research CouncilEuropean Commission); Formas(Swedish Research Council Formas); Marie Curie European Reintegration Grant(European Commission)	The study was supported by grants from the Swedish Research Council (to CB), Formas (to PAN) and the Marie Curie European Reintegration Grant (to JH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER JE, 1991, OECOLOGIA, V87, P435, DOI 10.1007/BF00634603; Aloi JE, 1991, VERH INTERNAT VEREIN, V24, P2936; ANHOLT BR, 1995, ECOLOGY, V76, P2230, DOI 10.2307/1941696; Arnold SJ, 1999, EVOLUTION, V53, P1516, DOI 10.1111/j.1558-5646.1999.tb05415.x; Bernot RJ, 2001, OECOLOGIA, V129, P139, DOI 10.1007/s004420100705; BRONMARK C, 1989, J MOLLUS STUD, V55, P299, DOI 10.1093/mollus/55.2.299; Bronmark C, 2011, PLOS ONE IN PRESS; Cross WF, 2002, OIKOS, V96, P251, DOI 10.1034/j.1600-0706.2002.960207.x; CROWL TA, 1990, SCIENCE, V247, P949, DOI 10.1126/science.247.4945.949; DeWitt TJ, 1999, ANIM BEHAV, V58, P397, DOI 10.1006/anbe.1999.1158; DeWitt TJ, 1998, TRENDS ECOL EVOL, V13, P77, DOI 10.1016/S0169-5347(97)01274-3; DeWitt TJ, 2000, EVOL ECOL RES, V2, P129; GOMULKIEWICZ R, 1992, EVOLUTION, V46, P390, DOI [10.2307/2409860, 10.1111/j.1558-5646.1992.tb02047.x]; HARVELL CD, 1990, Q REV BIOL, V65, P323, DOI 10.1086/416841; Hoverman JT, 2005, OECOLOGIA, V144, P481, DOI 10.1007/s00442-005-0082-8; Iwata H, 2002, J HERED, V93, P384, DOI 10.1093/jhered/93.5.384; Kats LB, 1998, ECOSCIENCE, V5, P361, DOI 10.1080/11956860.1998.11682468; Kawata M, 2005, HYDROBIOLOGIA, V533, P229, DOI 10.1007/s10750-004-2740-y; Koperski P, 1998, FRESHWATER BIOL, V39, P317, DOI 10.1046/j.1365-2427.1998.00282.x; LaFiandra EM, 2004, OECOLOGIA, V138, P350, DOI 10.1007/s00442-003-1412-3; Lakowitz T, 2008, FRESHWATER BIOL, V53, P2184, DOI 10.1111/j.1365-2427.2008.02045.x; Laurila A, 1998, OIKOS, V83, P307, DOI 10.2307/3546842; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Luttbeg B, 2003, ECOLOGY, V84, P1140, DOI 10.1890/0012-9658(2003)084[1140:PSAEDA]2.0.CO;2; MORAN NA, 1992, AM NAT, V139, P971, DOI 10.1086/285369; OSENBERG CW, 1989, ECOL MONOGR, V59, P405, DOI 10.2307/1943074; Phillips P.C., 1998, H2BOOT BOOTSTRAP EST; Quinn GP, 2003, EXPT DESIGN DATA ANA; Relyea RA, 2002, AM NAT, V159, P272, DOI 10.1086/338540; Relyea RA, 2004, ECOLOGY, V85, P172, DOI 10.1890/03-0169; Relyea RA, 2003, OECOLOGIA, V134, P596, DOI 10.1007/s00442-002-1161-8; Relyea RA, 2001, ECOLOGY, V82, P523, DOI 10.1890/0012-9658(2001)082[0523:MABPOL]2.0.CO;2; Relyea RA, 2007, OECOLOGIA, V152, P389, DOI 10.1007/s00442-007-0675-5; Roff D.A., 1997, EVOLUTIONARY QUANTIT; Rundle SD, 2001, P ROY SOC B-BIOL SCI, V268, P1463, DOI 10.1098/rspb.2001.1682; Scheiner SM, 1998, EVOLUTION, V52, P368, DOI 10.1111/j.1558-5646.1998.tb01638.x; Steiner UK, 2007, OECOLOGIA, V152, P201, DOI 10.1007/s00442-006-0645-3; Steiner UK, 2007, AM NAT, V169, P118, DOI 10.1086/509939; Teplitsky C, 2007, ECOLOGY, V88, P1641, DOI 10.1890/06-1703.1; TOLLRIAN R, 1999, ECOLOGY EVOLUTION IN; Turner AM, 2004, OIKOS, V104, P561, DOI 10.1111/j.0030-1299.2004.12615.x; Turner AM, 1996, ANIM BEHAV, V51, P747, DOI 10.1006/anbe.1996.0079; Van Buskirk J, 2000, ECOLOGY, V81, P2813, DOI 10.1890/0012-9658(2000)081[2813:TCOAID]2.0.CO;2; Van Buskirk J, 2000, J EVOLUTION BIOL, V13, P336; Van Buskirk J, 2009, J EVOLUTION BIOL, V22, P852, DOI 10.1111/j.1420-9101.2009.01685.x; Van Buskirk J, 1998, OIKOS, V82, P20; van Kleunen M, 2005, NEW PHYTOL, V166, P49, DOI 10.1111/j.1469-8137.2004.01296.x; VIA S, 1985, EVOLUTION, V39, P505, DOI [10.2307/2408649, 10.1111/j.1558-5646.1985.tb00391.x]; WERNER EE, 1993, AM NAT, V142, P242, DOI 10.1086/285537	49	17	17	1	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2012	7	1							e30467	10.1371/journal.pone.0030467	http://dx.doi.org/10.1371/journal.pone.0030467			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910LV	22291961	Green Submitted, gold, Green Published			2022-12-25	WOS:000301639600024
J	Cerone, L; Neufeld, Z				Cerone, Luca; Neufeld, Zoltan			Differential Gene Expression Regulated by Oscillatory Transcription Factors	PLOS ONE			English	Article							INCOHERENT FEEDFORWARD LOOP; FOLD-CHANGE DETECTION; NETWORK MOTIFS; DYNAMICS; TIME	Cells respond to changes in the internal and external environment by a complex regulatory system whose end-point is the activation of transcription factors controlling the expression of a pool of ad-hoc genes. Recent experiments have shown that certain stimuli may trigger oscillations in the concentration of transcription factors such as NF-kappa B and p53 influencing the final outcome of the genetic response. In this study we investigate the role of oscillations in the case of three different well known gene regulatory mechanisms using mathematical models based on ordinary differential equations and numerical simulations. We considered the cases of direct regulation, two-step regulation and feed-forward loops, and characterized their response to oscillatory input signals both analytically and numerically. We show that in the case of indirect two-step regulation the expression of genes can be turned on or off in a frequency dependent manner, and that feed-forward loops are also able to selectively respond to the temporal profile of oscillating transcription factors.	[Cerone, Luca; Neufeld, Zoltan] Univ Coll Dublin, Sch Math Sci, Dublin 2, Ireland; [Cerone, Luca; Neufeld, Zoltan] Univ Coll Dublin, Complex & Adapt Syst Lab, Dublin 2, Ireland; [Neufeld, Zoltan] Univ Queensland, Sch Math & Phys, Brisbane, Qld, Australia	University College Dublin; University College Dublin; University of Queensland	Cerone, L (corresponding author), Univ Coll Dublin, Sch Math Sci, Dublin 2, Ireland.	luca.cerone@ucd.ie	Neufeld, Zoltan/C-3008-2011	Neufeld, Zoltan/0000-0003-3236-9278; Cerone, Luca/0000-0003-2902-9416	Irish Research Council for Science, Engineering and Technology	Irish Research Council for Science, Engineering and Technology(Irish Research Council for Science, Engineering and Technology)	L.C. was supported by the Irish Research Council for Science, Engineering and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon U., 2007, INTRO SYSTEMS BIOL; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Ashall L, 2009, SCIENCE, V324, P242, DOI 10.1126/science.1164860; Aulehla A, 2008, CURR OPIN CELL BIOL, V20, P632, DOI 10.1016/j.ceb.2008.09.002; Basu S, 2004, P NATL ACAD SCI USA, V101, P6355, DOI 10.1073/pnas.0307571101; Batchelor E, 2009, NAT REV CANCER, V9, P371, DOI 10.1038/nrc2604; Cai L, 2008, NATURE, V455, P485, DOI 10.1038/nature07292; Cheong R, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.30; Cournac A, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-29; Csikasz-Nagy A, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.73; Dolmetsch R, 1994, ANNU REV GENET, V28, P373; Geva-Zatorsky N, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100068; Goentoro L, 2009, MOL CELL, V36, P894, DOI 10.1016/j.molcel.2009.11.018; Hirata H, 2002, SCIENCE, V298, P840, DOI 10.1126/science.1074560; Iqbal J, 2008, BIOCHEM BIOPH RES CO, V371, P906, DOI 10.1016/j.bbrc.2008.03.113; Isaacs FJ, 2003, P NATL ACAD SCI USA, V100, P7714, DOI 10.1073/pnas.1332628100; Kalir S, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100010; Kaplan S, 2008, MOL SYSTEMS BIOL, V4; Kruse K, 2005, CURR OPIN CELL BIOL, V17, P20, DOI 10.1016/j.ceb.2004.12.007; Locke JCW, 2009, NAT REV MICROBIOL, V7, P383, DOI 10.1038/nrmicro2056; Maeda YT, 2006, J MOL BIOL, V359, P1107, DOI 10.1016/j.jmb.2006.03.064; Mangan S, 2006, J MOL BIOL, V356, P1073, DOI 10.1016/j.jmb.2005.12.003; Mangan S, 2003, P NATL ACAD SCI USA, V100, P11980, DOI 10.1073/pnas.2133841100; Mangan S, 2003, J MOL BIOL, V334, P197, DOI 10.1016/j.jmb.2003.09.049; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Paszek P, 2010, CURRENT OPINION GENE; Prill RJ, 2005, PLOS BIOL, V3, P1881, DOI 10.1371/journal.pbio.0030343; Rosenfeld N, 2002, J MOL BIOL, V323, P785, DOI 10.1016/S0022-2836(02)00994-4; Shoval O, 2010, P NATL ACAD SCI USA, V107, P15995, DOI 10.1073/pnas.1002352107; Sun L, 2008, BIOCHEM BIOPH RES CO, V371, P912, DOI 10.1016/j.bbrc.2008.03.112; Sun L, 2008, BIOCHEM BIOPH RES CO, V371, P900, DOI 10.1016/j.bbrc.2008.03.114; Sung MH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007163; Tay S, 2010, NATURE; Tyson JJ, 2010, ANNU REV PHYS CHEM, V61, P219, DOI 10.1146/annurev.physchem.012809.103457	34	5	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2012	7	1							e30283	10.1371/journal.pone.0030283	http://dx.doi.org/10.1371/journal.pone.0030283			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910LV	22291930	Green Published, Green Submitted, gold			2022-12-25	WOS:000301639600010
J	Chun, RF; Peercy, BE; Adams, JS; Hewison, M				Chun, Rene F.; Peercy, Bradford E.; Adams, John S.; Hewison, Martin			Vitamin D Binding Protein and Monocyte Response to 25-Hydroxyvitamin D and 1,25-Dihydroxyvitamin D: Analysis by Mathematical Modeling	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; HUMAN MAMMARY CELLS; D-RECEPTOR; SERUM; METABOLISM; LIGAND; D-3; MITOCHONDRIAL; ACTIVATION; EXPRESSION	Vitamin D binding protein (DBP) plays a key role in the bioavailability of active 1,25-dihydroxyvitamin D (1,25(OH)(2)D) and its precursor 25-hydroxyvitamin D (25OHD), but accurate analysis of DBP-bound and free 25OHD and 1,25(OH)(2)D is difficult. To address this, two new mathematical models were developed to estimate: 1) serum levels of free 25OHD/1,25(OH)(2)D based on DBP concentration and genotype; 2) the impact of DBP on the biological activity of 25OHD/1,25(OH)(2)D in vivo. The initial extracellular steady state (eSS) model predicted that 50 nM 25OHD and 100 pM 1,25(OH)(2)D),<0.1% 25OHD and <1.5% 1,25(OH)(2)D are 'free' in vivo. However, for any given concentration of total 25OHD, levels of free 25OHD are higher for low affinity versus high affinity forms of DBP. The eSS model was then combined with an intracellular (iSS) model that incorporated conversion of 25OHD to 1,25(OH)(2)D via the enzyme CYP27B1, as well as binding of 1,25(OH)(2)D to the vitamin D receptor (VDR). The iSS model was optimized to 25OHD/1,25(OH)(2)D-mediated in vitro dose-responsive induction of the vitamin D target gene cathelicidin (CAMP) in human monocytes. The iSS model was then used to predict vitamin D activity in vivo (100% serum). The predicted induction of CAMP in vivo was minimal at basal settings but increased with enhanced expression of VDR (5-fold) and CYP27B1 (10-fold). Consistent with the eSS model, the iSS model predicted stronger responses to 25OHD for low affinity forms of DBP. Finally, the iSS model was used to compare the efficiency of endogenously synthesized versus exogenously added 1,25(OH)(2)D. Data strongly support the endogenous model as the most viable mode for CAMP induction by vitamin D in vivo. These novel mathematical models underline the importance of DBP as a determinant of vitamin D 'status' in vivo, with future implications for clinical studies of vitamin D status and supplementation.	[Chun, Rene F.; Adams, John S.; Hewison, Martin] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Chun, Rene F.; Adams, John S.; Hewison, Martin] Orthoped Hosp, Dept Orthoped Surg, Los Angeles, CA 90007 USA; [Chun, Rene F.; Adams, John S.; Hewison, Martin] Orthoped Hosp, Res Ctr, Los Angeles, CA USA; Univ Maryland Baltimore Cty, Dept Math & Stat, Baltimore, MD USA	University of California System; University of California Los Angeles; University System of Maryland; University of Maryland Baltimore County	Chun, RF (corresponding author), Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA.	rchun@mednet.ucla.edu	Adams, John S/I-3365-2013; Chun, Rene/A-9415-2010	Adams, John S/0000-0001-9607-5020; Chun, Rene/0000-0002-0190-0807	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR033176] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI028697] Funding Source: NIH RePORTER; NCATS NIH HHS [UL1 TR000124] Funding Source: Medline; NCRR NIH HHS [UL1 RR033176] Funding Source: Medline; NIAID NIH HHS [P30 AI028697] Funding Source: Medline	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Adams JS, 2008, NAT CLIN PRACT ENDOC, V4, P80, DOI 10.1038/ncpendmet0716; Adams JS, 2010, J CLIN ENDOCR METAB, V95, P471, DOI 10.1210/jc.2009-1773; Adams JS, 2009, J IMMUNOL, V182, P4289, DOI 10.4049/jimmunol.0803736; Ahn J, 2010, HUM MOL GENET, V19, P2739, DOI 10.1093/hmg/ddq155; ARNAUD J, 1993, HUM GENET, V92, P183; BIKLE DD, 1989, ENDOCRINOLOGY, V124, P649, DOI 10.1210/endo-124-2-649; BIKLE DD, 1985, J CLIN ENDOCR METAB, V61, P969, DOI 10.1210/jcem-61-5-969; BIKLE DD, 1986, J CLIN ENDOCR METAB, V63, P954, DOI 10.1210/jcem-63-4-954; Carlberg C, 2009, ANTICANCER RES, V29, P3485; Chlon TM, 2008, J NUTR, V138, P1323, DOI 10.1093/jn/138.7.1323; Chun RF, 2010, J CLIN ENDOCR METAB, V95, P3368, DOI 10.1210/jc.2010-0195; DUNN JF, 1988, ANN NY ACAD SCI, V538, P69; EIL C, 1981, P NATL ACAD SCI-BIOL, V78, P2562, DOI 10.1073/pnas.78.4.2562; Eto TA, 1998, ANAL BIOCHEM, V258, P53, DOI 10.1006/abio.1998.2567; FELDMAN H, 1972, ANAL BIOCHEM, V45, P530, DOI 10.1016/0003-2697(72)90216-3; Gombart AF, 2005, FASEB J, V19, P1067, DOI 10.1096/fj.04-3284com; Hammond GL, 2002, OBSTET GYN CLIN N AM, V29, P411, DOI 10.1016/S0889-8545(02)00008-6; Hewison M, 2003, J IMMUNOL, V170, P5382, DOI 10.4049/jimmunol.170.11.5382; HEWISON M, 1994, J IMMUNOL, V153, P5709; Hewison M, 2010, MOL CELL ENDOCRINOL, V321, P103, DOI 10.1016/j.mce.2010.02.013; Holick MF, 2004, AM J CLIN NUTR, V79, P362; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Holick MF, 2009, ANN EPIDEMIOL, V19, P73, DOI 10.1016/j.annepidem.2007.12.001; KAMBOH MI, 1986, HUM GENET, V72, P281, DOI 10.1007/BF00290950; Krombach F, 1997, ENVIRON HEALTH PERSP, V105, P1261, DOI 10.2307/3433544; Krutzik SR, 2008, J IMMUNOL, V181, P7115, DOI 10.4049/jimmunol.181.10.7115; Lauridsen AL, 2001, CLIN CHEM, V47, P753; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Lou YR, 2010, J STEROID BIOCHEM, V118, P162, DOI 10.1016/j.jsbmb.2009.11.011; MENDEL CM, 1989, ENDOCR REV, V10, P232, DOI 10.1210/edrv-10-3-232; Nelson CD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015469; Nykjaer A, 1999, CELL, V96, P507, DOI 10.1016/S0092-8674(00)80655-8; Nykjaer A, 2001, P NATL ACAD SCI USA, V98, P13895, DOI 10.1073/pnas.241516998; Pike JW, 2011, VITAMIN D, P97; Powe CE, 2011, J BONE MINER RES, V26, P1609, DOI 10.1002/jbmr.387; Prosser DE, 2004, TRENDS BIOCHEM SCI, V29, P664, DOI 10.1016/j.tibs.2004.10.005; Ren SY, 2005, J BIOL CHEM, V280, P20604, DOI 10.1074/jbc.M414522200; Ross AC, 2011, J AM DIET ASSOC, V111, P524, DOI 10.1016/j.jada.2011.01.004; Rowling MJ, 2006, J NUTR, V136, P2754, DOI 10.1093/jn/136.11.2754; Sakaki T, 2005, FRONT BIOSCI, V10, P119; Spina CS, 2006, ANTICANCER RES, V26, P2515; Tang EKY, 2010, J STEROID BIOCHEM, V119, P171, DOI 10.1016/j.jsbmb.2010.02.022; Toell A, 2000, BIOCHEM J, V352, P301, DOI 10.1042/0264-6021:3520301; Tsuji RF, 2003, CLIN EXP ALLERGY, V33, P249, DOI 10.1046/j.1365-2222.2003.01575.x; Urushino N, 2006, BIOCHEMISTRY-US, V45, P4405, DOI 10.1021/bi060072o; Vermeulen A, 1999, J CLIN ENDOCR METAB, V84, P3666, DOI 10.1210/jc.84.10.3666; VIETH R, 1979, J BIOL CHEM, V254, P2455; Wang TJ, 2010, LANCET, V376, P180, DOI 10.1016/S0140-6736(10)60588-0; White P, 2002, J IMMUNOL, V168, P869, DOI 10.4049/jimmunol.168.2.869; Zehnder D, 2001, J CLIN ENDOCR METAB, V86, P888, DOI 10.1210/jc.86.2.888	50	79	80	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2012	7	1							e30773	10.1371/journal.pone.0030773	http://dx.doi.org/10.1371/journal.pone.0030773			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910LV	22292037	Green Submitted, Green Published, gold			2022-12-25	WOS:000301639600054
J	Fayyad-Kazan, H; Rouas, R; Fayyad-Kazan, M; Badran, R; El Zein, N; Lewalle, P; Najar, M; Hamade, E; Jebbawi, F; Merimi, M; Romero, P; Burny, A; Badran, B; Martiat, P				Fayyad-Kazan, Hussein; Rouas, Redouane; Fayyad-Kazan, Mohammad; Badran, Rabih; El Zein, Nabil; Lewalle, Philippe; Najar, Medhi; Hamade, Eva; Jebbawi, Fadi; Merimi, Makram; Romero, Pedro; Burny, Arsene; Badran, Bassam; Martiat, Philippe			MicroRNA Profile of Circulating CD4-positive Regulatory T Cells in Human Adults and Impact of Differentially Expressed MicroRNAs on Expression of Two Genes Essential to Their Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNOLOGICAL SELF-TOLERANCE; FOXP3 EXPRESSION; NONDIVIDING CELLS; IMMUNE-SYSTEM; TGF-BETA; IN-VIVO; CTLA-4; ACTIVATION; MIRNA; INTERLEUKIN-2	Regulatory T cells (Tregs) are characterized by a high expression of IL-2 receptor alpha chain (CD25) and of forkhead box P3 (FOXP3), the latter being essential for their development and function. Another major player in the regulatory function is the cytotoxic T-lymphocyte associated molecule-4 (CTLA-4) that inhibits cytotoxic responses. However, the regulation of CTLA-4 expression remains less well explored. We therefore studied the microRNA signature of circulating CD4(+) Tregs isolated from adult healthy donors and identified a signature composed of 15 differentially expressed microRNAs. Among those, miR-24, miR-145, and miR-210 were down-regulated in Tregs compared with controls and were found to have potential target sites in the 3'-UTR of FOXP3 and CTLA-4; miR-24 and miR-210 negatively regulated FOXP3 expression by directly binding to their two target sites in its 3'-UTR. On the other hand, miR-95, which is highly expressed in adult peripheral blood Tregs, positively regulated FOXP3 expression via an indirect mechanism yet to be identified. Finally, we showed that miR-145 negatively regulated CTLA-4 expression in human CD4(+) adult peripheral blood Tregs by binding to its target site in CTLA-4 transcript 3'-UTR. To our knowledge, this is the first identification of a human adult peripheral blood CD4(+) Treg microRNA signature. Moreover, unveiling one mechanism regulating CTLA-4 expression is novel and may lead to a better understanding of the regulation of this crucial gene.	[Fayyad-Kazan, Hussein; Rouas, Redouane; Fayyad-Kazan, Mohammad; Badran, Rabih; El Zein, Nabil; Lewalle, Philippe; Najar, Medhi; Jebbawi, Fadi; Merimi, Makram; Burny, Arsene; Martiat, Philippe] Univ Libre Bruxelles, Inst Jules Bordet, Lab Expt Hematol, B-1000 Brussels, Belgium; [Hamade, Eva; Badran, Bassam] Lebanese Univ, Fac Sci, EDST PRASE, Dept Biochem,Lab Immunol, Hadath Beirut, Lebanon; [Romero, Pedro] Ludwig Inst Canc Res, Lausanne Branch, Div Clin Oncoimmunol, CH-1005 Lausanne, Switzerland	Institut Jules Bordet; Universite Libre de Bruxelles; Lebanese University; Ludwig Institute for Cancer Research	Martiat, P (corresponding author), Univ Libre Bruxelles, Inst Jules Bordet, Lab Expt Hematol, 121 Blvd Waterloo, B-1000 Brussels, Belgium.	pmartiat@ulb.ac.be	Jebbawi, Fadi/AAD-6063-2020	el zein, nabil/0000-0002-8596-5359; Fayyad-Kazan, Hussein/0000-0002-3465-4630	Belgian Fonds National de la Recherche Scientifique (FRSM, Televie); Lebanese University; MEDIC Foundation; International Brachet Stiftung, les Amis de l'Institut Bordet; Van Buuren Foundation; Lambeau Marteaux Foundation; Hoguet Foundation; European Union	Belgian Fonds National de la Recherche Scientifique (FRSM, Televie)(Fonds de la Recherche Scientifique - FNRS); Lebanese University; MEDIC Foundation; International Brachet Stiftung, les Amis de l'Institut Bordet; Van Buuren Foundation; Lambeau Marteaux Foundation; Hoguet Foundation; European Union(European Commission)	This work was supported by grants from the Belgian Fonds National de la Recherche Scientifique (FRSM, Televie), the Lebanese University, the MEDIC Foundation, the International Brachet Stiftung, les Amis de l'Institut Bordet, and the Van Buuren, Lambeau Marteaux, and Hoguet Foundations.; Supported in part by a European Union grant, "Cancer Immunotherapy."	Abbas-Terki T, 2002, HUM GENE THER, V13, P2197, DOI 10.1089/104303402320987888; Ariyan C, 2003, J IMMUNOL, V171, P5673, DOI 10.4049/jimmunol.171.11.5673; Baltimore D, 2008, NAT IMMUNOL, V9, P839, DOI 10.1038/ni.f.209; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Beyer M, 2006, BLOOD, V108, P804, DOI 10.1182/blood-2006-02-002774; Birzele F, 2011, NUCLEIC ACIDS RES, V39, P7946, DOI 10.1093/nar/gkr444; Bluestone JA, 2005, CURR OPIN IMMUNOL, V17, P638, DOI 10.1016/j.coi.2005.09.002; Brusko TM, 2008, IMMUNOL REV, V223, P371, DOI 10.1111/j.1600-065X.2008.00637.x; Cobb BS, 2006, J EXP MED, V203, P2519, DOI 10.1084/jem.20061692; Curiel TJ, 2008, CURR OPIN IMMUNOL, V20, P241, DOI 10.1016/j.coi.2008.04.008; Curiel TJ, 2007, J CLIN INVEST, V117, P1167, DOI 10.1172/JCI31202; de la Rosa M, 2004, EUR J IMMUNOL, V34, P2480, DOI 10.1002/eji.200425274; Fayyad-Kazan H, 2010, J BIOL CHEM, V285, P20481, DOI 10.1074/jbc.M110.119628; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Gambineri E, 2003, CURR OPIN RHEUMATOL, V15, P430, DOI 10.1097/00002281-200307000-00010; Gavin MA, 2006, P NATL ACAD SCI USA, V103, P6659, DOI 10.1073/pnas.0509484103; Gough SCL, 2005, IMMUNOL REV, V204, P102, DOI 10.1111/j.0105-2896.2005.00249.x; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Ha Tai-You, 2009, Immune Netw, V9, P209, DOI 10.4110/in.2009.9.6.209; Haramati S, 2010, P NATL ACAD SCI USA, V107, P13111, DOI 10.1073/pnas.1006151107; Hartigan-O'Connor DJ, 2007, J IMMUNOL METHODS, V319, P41, DOI 10.1016/j.jim.2006.10.008; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Huehn J, 2009, NAT REV IMMUNOL, V9, P83, DOI 10.1038/nri2474; Jandus C, 2008, CANCER IMMUNOL IMMUN, V57, P1795, DOI 10.1007/s00262-008-0507-4; Johnston JC, 1999, J VIROL, V73, P4991, DOI 10.1128/JVI.73.6.4991-5000.1999; Kavvoura FK, 2005, AM J EPIDEMIOL, V162, P3, DOI 10.1093/aje/kwi165; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Kremer JM, 2003, NEW ENGL J MED, V349, P1907, DOI 10.1056/NEJMoa035075; Liao GX, 2010, INT IMMUNOL, V22, P259, DOI 10.1093/intimm/dxq001; Lindsay MA, 2008, TRENDS IMMUNOL, V29, P343, DOI 10.1016/j.coph.2009.05.003; LINSLEY PS, 1992, SCIENCE, V257, P792, DOI 10.1126/science.1496399; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lodish HF, 2008, NAT REV IMMUNOL, V8, P120, DOI 10.1038/nri2252; Miller BH, 2010, BRAIN RES, V1338, P89, DOI 10.1016/j.brainres.2010.03.035; Morgan ME, 2005, HUM IMMUNOL, V66, P13, DOI 10.1016/j.humimm.2004.05.016; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Navarro F, 2010, J IMMUNOL, V184, P5939, DOI 10.4049/jimmunol.0902567; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; Pallante P, 2010, ENDOCR-RELAT CANCER, V17, pF91, DOI 10.1677/ERC-09-0217; Pandiyan P, 2007, NAT IMMUNOL, V8, P1353, DOI 10.1038/ni1536; Pfoertner S, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r54; Qin FXF, 2009, CELL MOL IMMUNOL, V6, P3, DOI 10.1038/cmi.2009.2; Raghavan S, 2005, FEMS IMMUNOL MED MIC, V44, P121, DOI 10.1016/j.femsim.2004.10.017; Ribas A, 2005, J CLIN ONCOL, V23, P8968, DOI 10.1200/JCO.2005.01.109; Rouas R, 2009, EUR J IMMUNOL, V39, P1608, DOI 10.1002/eji.200838509; Rudd CE, 2009, IMMUNOL REV, V229, P12, DOI 10.1111/j.1600-065X.2009.00770.x; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Sakaguchi S, 2010, NAT REV IMMUNOL, V10, P490, DOI 10.1038/nri2785; Schetter AJ, 2010, CARCINOGENESIS, V31, P37, DOI 10.1093/carcin/bgp272; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schramm C, 2004, INT IMMUNOL, V16, P1241, DOI 10.1093/intimm/dxh126; Seddiki N, 2006, J EXP MED, V203, P1693, DOI 10.1084/jem.20060468; Shevach EM, 2006, IMMUNITY, V25, P195, DOI 10.1016/j.immuni.2006.08.003; Slezak-Prochazka I, 2010, RNA, V16, P1087, DOI 10.1261/rna.1804410; Takahashi T, 2000, J EXP MED, V192, P303, DOI 10.1084/jem.192.2.303; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; WALUNAS TL, 1994, IMMUNITY, V1, P405, DOI 10.1016/1074-7613(94)90071-X; Wang J, 2007, EUR J IMMUNOL, V37, P129, DOI 10.1002/eji.200636435; Wang XB, 2001, SCAND J IMMUNOL, V54, P453, DOI 10.1046/j.1365-3083.2001.00985.x; Wulczyn FG, 2010, ADV EXP MED BIOL, V700, P85, DOI 10.1007/978-1-4419-7823-3_9; Xiao CC, 2009, CELL, V136, P26, DOI 10.1016/j.cell.2008.12.027; Yeung ML, 2005, CELL RES, V15, P935, DOI 10.1038/sj.cr.7290371; Zheng SG, 2004, J IMMUNOL, V172, P5213, DOI 10.4049/jimmunol.172.9.5213; Ziegler SF, 2006, ANNU REV IMMUNOL, V24, P209, DOI 10.1146/annurev.immunol.24.021605.090547; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	69	64	73	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					9910	9922		10.1074/jbc.M111.337154	http://dx.doi.org/10.1074/jbc.M111.337154			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22294691	Green Published, hybrid			2022-12-25	WOS:000302167200023
J	Kraus, D; Winter, J; Jepsen, S; Jager, A; Meyer, R; Deschner, J				Kraus, Dominik; Winter, Jochen; Jepsen, Soren; Jaeger, Andreas; Meyer, Rainer; Deschner, James			Interactions of Adiponectin and Lipopolysaccharide from Porphyromonas gingivalis on Human Oral Epithelial Cells	PLOS ONE			English	Article							KERATINOCYTE GROWTH-FACTOR; I PERIODONTAL TREATMENT; CREVICULAR FLUID LEVELS; MATRIX METALLOPROTEINASE-1; TISSUE INHIBITOR; TNF-ALPHA; EXPRESSION; MACROPHAGES; INDUCTION; RESPONSES	Background: Periodontitis is an inflammatory disease caused by pathogenic microorganisms, such as Porphyromonas gingivalis, and characterized by the destruction of the periodontium. Obese individuals have an increased risk for periodontitis and show decreased serum levels of adiponectin. This in-vitro study was established to examine whether adiponectin modulates critical effects of lipopolysaccharide (LPS) from P. gingivalis on oral epithelial cells (OECs). Methodology/Principal Findings: The presence of adiponectin and its receptors in human gingival tissue samples and OECs was analyzed by immunohistochemistry and PCR. Furthermore, OECs were treated with LPS and/or adiponectin for up to 72 h, and the gene expression and protein synthesis of pro-and anti-inflammatory mediators, matrix metalloproteinases (MMPs) and growth factors were analyzed by real-time PCR and ELISA. Additionally, cell proliferation, differentiation and invitro wound healing were studied. The nuclear translocation of NF kappa B was investigated by immunofluorescence. Gingival tissue sections showed a strong synthesis of adiponectin and its receptors in the epithelial layer. In cell cultures, LPS induced a significant up-regulation of interleukin (IL) 1 beta, IL6, IL8, MMP1 and MMP3. Adiponectin abrogated significantly the stimulatory effects of LPS on these molecules. Similarly, adiponectin inhibited significantly the LPS-induced decrease in cell viability and increase in cell proliferation and differentiation. Adiponectin led to a time-dependent induction of the anti-inflammatory mediators IL10 and heme oxygenase 1, and blocked the LPS-stimulated NF kappa B nuclear translocation. Conclusions/Significance: Adiponectin may counteract critical actions of P. gingivalis on oral epithelial cells. Low levels of adiponectin, as observed in obese individuals, may increase the risk for periodontal inflammation and destruction.	[Kraus, Dominik] Univ Bonn, Dept Prosthodont Preclin Educ & Mat Sci, Bonn, Germany; [Kraus, Dominik; Winter, Jochen; Jepsen, Soren; Jaeger, Andreas; Deschner, James] Univ Bonn, Clin Res Unit 208, Bonn, Germany; [Winter, Jochen; Jepsen, Soren] Univ Bonn, Dept Periodontol Operat & Prevent Dent, Bonn, Germany; [Jaeger, Andreas] Univ Bonn, Dept Orthodont, Bonn, Germany; [Meyer, Rainer] Univ Bonn, Inst Physiol 2, Bonn, Germany	University of Bonn; University of Bonn; University of Bonn; University of Bonn; University of Bonn	Kraus, D (corresponding author), Univ Bonn, Dept Prosthodont Preclin Educ & Mat Sci, Bonn, Germany.	james.deschner@uni-bonn.de	Meyer, Rainer/H-5871-2013; Kraus, Dominik/K-6481-2015; DESCHNER, JAMES/AAW-3998-2021	Kraus, Dominik/0000-0002-0273-5065; 	German Research Foundation [KFO 208/TP4/TP9]; University of Bonn, Germany	German Research Foundation(German Research Foundation (DFG)); University of Bonn, Germany	This study was supported by a grant from the German Research Foundation (KFO 208/TP4/TP9) and the University of Bonn, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajuwon KM, 2005, AM J PHYSIOL-REG I, V288, pR1220, DOI 10.1152/ajpregu.00397.2004; Albandar JM, 2011, J PERIODONTOL, V82, P337, DOI 10.1902/jop.2011.100638; Andrian E, 2005, J CELL PHYSIOL, V204, P178, DOI 10.1002/jcp.20287; Beikler T, 2011, PERIODONTOL 2000, V55, P87, DOI 10.1111/j.1600-0757.2010.00360.x; Brochu-Gaudreau K, 2010, ENDOCRINE, V37, P11, DOI 10.1007/s12020-009-9278-8; Cai XJ, 2010, MOL ENDOCRINOL, V24, P218, DOI 10.1210/me.2009-0128; Chaffee BW, 2010, J PERIODONTOL, V81, P1708, DOI 10.1902/jop.2010.100321; Choi HM, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2844; Dieudonne MN, 2006, BIOCHEM BIOPH RES CO, V345, P271, DOI 10.1016/j.bbrc.2006.04.076; Dos Santos E, 2008, ONCOL REP, V20, P971, DOI 10.3892/or_00000098; Eckert RL, 2004, J INVEST DERMATOL, V123, P13, DOI 10.1111/j.0022-202X.2004.22723.x; Engebretson SP, 2002, J CLIN PERIODONTOL, V29, P48, DOI 10.1034/j.1600-051x.2002.290108.x; FINCH PW, 1989, SCIENCE, V245, P752, DOI 10.1126/science.2475908; Firth JD, 2004, J INVEST DERMATOL, V122, P222, DOI 10.1046/j.0022-202X.2003.22124.x; Fitzpatrick RE, 2009, FUTURE MICROBIOL, V4, P471, DOI 10.2217/FMB.09.18; Folco EJ, 2009, J BIOL CHEM, V284, P25569, DOI 10.1074/jbc.M109.019786; Garlet GP, 2010, J DENT RES, V89, P1349, DOI 10.1177/0022034510376402; HONIG J, 1989, J PERIODONTAL RES, V24, P362, DOI 10.1111/j.1600-0765.1989.tb00883.x; [黄慧娟 HUANG Huijuan], 2008, [西北林学院学报, Journal of Northwest Forestry College], V23, P50; Inadera Hidekuni, 2008, Int J Med Sci, V5, P248; Jain S, 2010, PERIODONTOL 2000, V54, P53, DOI 10.1111/j.1600-0757.2009.00333.x; Johnson GK, 2010, J PERIODONTAL RES, V45, P583, DOI 10.1111/j.1600-0765.2009.01262.x; Jortay J, 2010, ENDOCRINOLOGY, V151, P4840, DOI 10.1210/en.2009-1462; Jotwani R, 2010, ANN NY ACAD SCI, V1192, P278, DOI 10.1111/j.1749-6632.2009.05247.x; Ka H, 2000, BIOL REPROD, V62, P1772, DOI 10.1095/biolreprod62.6.1772; Kalinin AE, 2002, BIOESSAYS, V24, P789, DOI 10.1002/bies.10144; Kamio N, 2009, FEMS IMMUNOL MED MIC, V56, P241, DOI 10.1111/j.1574-695X.2009.00573.x; Katz RW, 2002, BONE, V31, P288, DOI 10.1016/S8756-3282(02)00824-4; Kinane DF, 2008, FRONT BIOSCI-LANDMRK, V13, P966, DOI 10.2741/2736; Kocgozlu L, 2009, J DENT RES, V88, P741, DOI 10.1177/0022034509341166; Kou Y, 2008, J PERIODONTOL, V79, P174, DOI [10.1902/jop.2008.070364, 10.1902/jop.2008.070364 ]; Lackler KP, 2000, J PERIODONTOL, V71, P226, DOI 10.1902/jop.2000.71.2.226; Lago F, 2007, NAT CLIN PRACT RHEUM, V3, P716, DOI 10.1038/ncprheum0674; Li M, 2005, J PERIODONTAL RES, V40, P118, DOI 10.1111/j.1600-0765.2004.00780.x; Mandal P, 2010, HEPATOLOGY, V51, P1420, DOI 10.1002/hep.23427; Mantel PY, 2011, METHODS MOL BIOL, V677, P303, DOI 10.1007/978-1-60761-869-0_21; Neumeier M, 2006, J LEUKOCYTE BIOL, V79, P803, DOI 10.1189/jlb.0905521; O'Dowd LK, 2010, J CLIN PERIODONTOL, V37, P334, DOI 10.1111/j.1600-051X.2010.01545.x; Ogunwobi OO, 2006, REGUL PEPTIDES, V134, P105, DOI 10.1016/j.regpep.2006.02.001; Ornitz DM, 2001, GENOME BIOL, V2; Otterbein LE, 2003, TRENDS IMMUNOL, V24, P449, DOI 10.1016/S1471-4906(03)00181-9; Park PH, 2008, J BIOL CHEM, V283, P26850, DOI 10.1074/jbc.M802787200; Park PH, 2007, J BIOL CHEM, V282, P21695, DOI 10.1074/jbc.M701419200; Peake PW, 2006, BIOCHEM BIOPH RES CO, V341, P108, DOI 10.1016/j.bbrc.2005.12.162; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8; Preshaw PM, 2007, PERIODONTOL 2000, V45, P138, DOI 10.1111/j.1600-0757.2007.00221.x; Presland RB, 2000, CRIT REV ORAL BIOL M, V11, P383, DOI 10.1177/10454411000110040101; RUBIN JS, 1989, P NATL ACAD SCI USA, V86, P802, DOI 10.1073/pnas.86.3.802; Seymour GJ, 2007, CLIN MICROBIOL INFEC, V13, P3, DOI 10.1111/j.1469-0691.2007.01798.x; Skaleric U, 1997, EUR J ORAL SCI, V105, P136, DOI 10.1111/j.1600-0722.1997.tb00192.x; Soell M, 2002, J DENT RES, V81, P174, DOI 10.1177/154405910208100306; Sorsa T, 2006, ANN MED, V38, P306, DOI 10.1080/07853890600800103; Steele IA, 2001, ONCOGENE, V20, P5878, DOI 10.1038/sj.onc.1204755; Stofkova A, 2009, Endocr Regul, V43, P157; Suvan J, 2011, OBES REV, V12, pe381, DOI 10.1111/j.1467-789X.2010.00808.x; Takahashi N, 2010, J PERIODONTAL RES, V45, P512, DOI 10.1111/j.1600-0765.2009.01266.x; Taylor JJ, 2010, PERIODONTOL 2000, V54, P160, DOI 10.1111/j.1600-0757.2009.00344.x; TSAI CC, 1995, J PERIODONTOL, V66, P852, DOI 10.1902/jop.1995.66.10.852; Tsatsanis C, 2005, BIOCHEM BIOPH RES CO, V335, P1254, DOI 10.1016/j.bbrc.2005.07.197; Turner JJO, 2009, SCAND J IMMUNOL, V69, P329, DOI 10.1111/j.1365-3083.2008.02224.x; Tuter G, 2005, J CLIN PERIODONTOL, V32, P1011, DOI 10.1111/j.1600-051X.2005.00816.x; Tuter G, 2002, J PERIODONTOL, V73, P487, DOI 10.1902/jop.2002.73.5.487; Wulster-Radcliffe MC, 2004, BIOCHEM BIOPH RES CO, V316, P924, DOI 10.1016/j.bbrc.2004.02.130	64	96	96	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2012	7	2							e30716	10.1371/journal.pone.0030716	http://dx.doi.org/10.1371/journal.pone.0030716			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UV	22319581	Green Submitted, gold, Green Published			2022-12-25	WOS:000301979000012
J	Silventoinen, K; Baker, JL; Sorensen, TIA				Silventoinen, Karri; Baker, Jennifer L.; Sorensen, Thorkild I. A.			Growth in Height in Childhood and Risk of Coronary Heart Disease in Adult Men and Women	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; BIRTH-WEIGHT; BLOOD-PRESSURE; MORTALITY; CHILDREN; HEALTH; COHORT; AGE; DETERMINANTS; METAANALYSIS	Background: Adult height is inversely associated with the risk of coronary heart disease (CHD), but it is still unknown which phase of the human growth period is critical for the formation of this association. We investigated the association between growth in height from 7 to 13 years of age and the risk of CHD in adulthood. Methods and Findings: The heights of almost all children born 1930 through 1976 who attended school in the Copenhagen municipality (232,063 children) were measured annually from 7 to 13 years of age. Birth weight data were available since 1936. Fatal and non-fatal CHD events were ascertained by register linkage until 2008 (25,214 cases). Hazard ratios (HR) with 95% confidence intervals (CI) were estimated by Cox proportional hazards regression for height z-scores (standard deviation units) and change in height z-scores. Height z-scores were inversely related to the risk of CHD. The association was strongest at 7 years of age (HR = 0.91, CI 0.90-0.92 in boys and 0.88, CI 0.86-0.90 in girls) and steadily weakened thereafter, yet it still remained at 13 years of age (HR = 0.95, CI 0.94-0.97 and 0.91, CI 0.89-0.93, boys and girls respectively). The associations were not modified by birth weight. Independent of the age-specific risk, rapid growth was associated with an increased CHD risk, most pronounced between 9 and 11 years in girls (HR = 1.22, CI 1.14-1.31) and between 11 and 13 years in boys (HR = 1.28, CI 1.22-1.33) per unit increase in z-score. Adjustment for body mass index somewhat strengthened the associations of CHD risk with height and weakened the association with growth. Conclusions/Significance: Risk of CHD in adulthood is inversely related to height at ages 7 through 13 years, but strongest in the youngest, and, independently hereof, the risk increased by growth velocity.	[Silventoinen, Karri] Univ Helsinki, Dept Social Res, Populat Res Unit, Helsinki, Finland; [Silventoinen, Karri] Univ Helsinki, Dept Publ Hlth, Helsinki, Finland; [Baker, Jennifer L.; Sorensen, Thorkild I. A.] Copenhagen Univ Hosp, Inst Prevent Med, Copenhagen, Denmark	University of Helsinki; University of Helsinki; University of Copenhagen	Silventoinen, K (corresponding author), Univ Helsinki, Dept Social Res, Populat Res Unit, Helsinki, Finland.	karri.silventoinen@helsinki.fi	Baker, Jennifer L./AAH-4693-2020; Baker, Jennifer/F-1917-2010	Baker, Jennifer L./0000-0002-9649-6615; Baker, Jennifer/0000-0002-9649-6615; Silventoinen, Karri/0000-0003-1759-3079	National Institute of Diabetes and Digestive and Kidney Diseases [F32DK070491]; Lundbeck Foundation [R13-A1317]; Danish National Science Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK070491] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Lundbeck Foundation(Lundbeckfonden); Danish National Science Foundation(Danmarks Grundforskningsfond); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study is supported by grants from the National Institute of Diabetes and Digestive and Kidney Diseases (F32DK070491 to JLB), the Lundbeck Foundation (R13-A1317) and by the Danish National Science Foundation. KS works in the Academy of Finland Centre of Excellence in Complex Disease Genetics. The study is part of the activities in the Danish Obesity Research Centre, DanORC, see www.danorc.dk. The funders no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksglaede L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002728; Andersen TF, 1999, DAN MED BULL, V46, P263; Baker JL, 2007, NEW ENGL J MED, V357, P2329, DOI 10.1056/NEJMoa072515; Baker JL, 2009, INT J EPIDEMIOL, V38, P656, DOI 10.1093/ije/dyn164; Barker DJP, 2009, ANN HUM BIOL, V36, P445, DOI 10.1080/03014460902980295; Barker DJP, 2005, NEW ENGL J MED, V353, P1802, DOI 10.1056/NEJMoa044160; Eriksson JG, 2007, HYPERTENSION, V49, P1415, DOI 10.1161/HYPERTENSIONAHA.106.085597; Eveleth P. B., 2003, WORLDWIDE VARIATION; Feng Y, 2008, ATHEROSCLEROSIS, V196, P590, DOI 10.1016/j.atherosclerosis.2007.06.016; Forsen T, 1999, BRIT MED J, V319, P1403, DOI 10.1136/bmj.319.7222.1403; Frontini MG, 2003, INT J OBESITY, V27, P1398, DOI 10.1038/sj.ijo.0802422; Gamborg M, 2007, AM J EPIDEMIOL, V166, P634, DOI 10.1093/aje/kwm042; Gunnell DJ, 1998, J EPIDEMIOL COMMUN H, V52, P142, DOI 10.1136/jech.52.3.142; Hardy R, 2006, J HYPERTENS, V24, P59, DOI 10.1097/01.hjh.0000198033.14848.93; Juel K, 1999, DAN MED BULL, V46, P354; Juul A, 2006, INT J ANDROL, V29, P247, DOI 10.1111/j.1365-2605.2005.00556.x; Kindblom JM, 2006, DIABETES, V55, P3047, DOI 10.2337/db06-0192; Mackenbach JP, 2000, EUR HEART J, V21, P1141, DOI 10.1053/euhj.1999.1990; Madsen M, 2003, J CLIN EPIDEMIOL, V56, P124, DOI 10.1016/S0895-4356(02)00591-7; Nwasokwa ON, 1997, AM HEART J, V133, P147, DOI 10.1016/S0002-8703(97)70202-3; OSMOND C, 1993, BRIT MED J, V307, P1519, DOI 10.1136/bmj.307.6918.1519; Paajanen TA, 2010, EUR HEART J, V31, P1802, DOI 10.1093/eurheartj/ehq155; Risnes KR, 2011, INT J EPIDEMIOL, V40, P647, DOI 10.1093/ije/dyq267; Sandhu J, 2006, J CLIN ENDOCR METAB, V91, P3150, DOI 10.1210/jc.2005-2318; Silventoinen K, 2006, AM J EPIDEMIOL, V163, P615, DOI 10.1093/aje/kwj081; Silventoinen K, 2003, J BIOSOC SCI, V35, P263, DOI 10.1017/S0021932003002633; Silventoinen K, 2008, PEDIATRICS, V121, pE885, DOI 10.1542/peds.2007-1615; Singhal A, 2004, LANCET, V363, P1642, DOI 10.1016/S0140-6736(04)16210-7; Song YM, 2003, AM J EPIDEMIOL, V158, P479, DOI 10.1093/aje/kwg173; Sorensen HT, 1999, AM J EPIDEMIOL, V149, P726; WAALER HT, 1984, ACTA MED SCAND, P1; Wehkalampi K, 2008, AM J HUM BIOL, V20, P417, DOI 10.1002/ajhb.20748	32	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2012	7	1							e30476	10.1371/journal.pone.0030476	http://dx.doi.org/10.1371/journal.pone.0030476			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910LV	22291964	Green Published, gold, Green Submitted			2022-12-25	WOS:000301639600025
J	Allen, IC; Lich, JD; Arthur, JC; Jania, CM; Roberts, RA; Callaway, JB; Tilley, SL; Ting, JPY				Allen, Irving C.; Lich, John D.; Arthur, Janelle C.; Jania, Corey M.; Roberts, Reid A.; Callaway, Justin B.; Tilley, Stephen L.; Ting, Jenny P. -Y.			Characterization of NLRP12 during the Development of Allergic Airway Disease in Mice	PLOS ONE			English	Article							NF-KAPPA-B; CUTTING EDGE; IN-VIVO; SIGNALING PATHWAYS; PROTEIN; ACTIVATION; MONARCH-1; GENES; CELLS; CATERPILLER	Among the 22 members of the nucleotide binding-domain, leucine rich repeat-containing (NLR) family, less than half have been functionally characterized. Of those that have been well studied, most form caspase-1 activating inflammasomes. NLRP12 is a unique NLR that has been shown to attenuate inflammatory pathways in biochemical assays and mediate the lymph node homing of activated skin dendritic cells in contact hypersensitivity responses. Since the mechanism between these two important observations remains elusive, we further evaluated the contribution of NLRP12 to organ specific adaptive immune responses by focusing on the lung, which, like skin, is exposed to both exogenous and endogenous inflammatory agents. In models of allergic airway inflammation induced by either acute ovalbumin (OVA) exposure or chronic house dust mite (HDM) antigen exposure, Nlrp12(-/-) mice displayed subtle differences in eosinophil and monocyte infiltration into the airways. However, the overall development of allergic airway disease and airway function was not significantly altered by NLRP12 deficiency. Together, the combined data suggest that NLRP12 does not play a vital role in regulating Th2 driven airway inflammation using common model systems that are physiologically relevant to human disease. Thus, the allergic airway inflammation models described here should be appropriate for subsequent studies that seek to decipher the contribution of NLRP12 in mediating the host response to agents associated with asthma exacerbation.	[Allen, Irving C.; Lich, John D.; Ting, Jenny P. -Y.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Inst Inflammatory Dis, Chapel Hill, NC 27599 USA; [Allen, Irving C.; Lich, John D.; Ting, Jenny P. -Y.] Univ N Carolina, Ctr Translat Immunol, Chapel Hill, NC USA; [Allen, Irving C.; Arthur, Janelle C.; Roberts, Reid A.; Callaway, Justin B.; Ting, Jenny P. -Y.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC USA; [Jania, Corey M.; Tilley, Stephen L.] Univ N Carolina, Dept Med, Div Pulm & Crit Care Med, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Allen, IC (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Inst Inflammatory Dis, Chapel Hill, NC 27599 USA.	panyun@med.unc.edu		Arthur, Janelle/0000-0002-4796-0207; Allen, Irving/0000-0001-9573-5250	National Institutes of Health [A1063031, U19-AI067798, U19-AI077437, DK38108, DE016326, HL068141, F32-AI-082895-01, T32-AR007416, T32-CA009156]; Sandler Program; National Institutes of Health National Research Service; American Cancer Society; NATIONAL CANCER INSTITUTE [T32CA009156] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068141] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI077437, U19AI067798, F32AI082895] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007416] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE016326] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK038108, K01DK092355] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sandler Program; National Institutes of Health National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health A1063031, U19-AI067798, U19-AI077437, DK38108, DE016326 and HL068141 (J.P.Y. Ting) and F32-AI-082895-01; T32-AR007416 and T32-CA009156 (I.C. Allen). J.P.Y.T. is a Sandler Program Award Recipient. This work was also supported by a National Institutes of Health National Research Service Trainee Award (J.C.A.) and the American Cancer Society (J.D.L. and I.C.A.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen IC, 2006, AM J PHYSIOL-LUNG C, V291, pL1005, DOI 10.1152/ajplung.00174.2006; Allen IC, 2011, IMMUNITY, V34, P854, DOI 10.1016/j.immuni.2011.03.026; Allen IC, 2009, IMMUNITY, V30, P556, DOI 10.1016/j.immuni.2009.02.005; Arthur JC, 2010, J IMMUNOL, V185, P4515, DOI 10.4049/jimmunol.1002227; Conti BJ, 2005, J BIOL CHEM, V280, P18375, DOI 10.1074/jbc.M413169200; Cressman VL, 1998, AM J RESP CELL MOL, V19, P853, DOI 10.1165/ajrcmb.19.6.3194; Cui J, 2010, CELL, V141, P483, DOI 10.1016/j.cell.2010.03.040; Hisbergues M, 2007, CLIN EXP ALLERGY, V37, P1286, DOI 10.1111/j.1365-2222.2007.02792.x; Jin HL, 2009, J ALLERGY CLIN IMMUN, V123, P875, DOI 10.1016/j.jaci.2009.02.007; Lich JD, 2007, J IMMUNOL, V178, P1256, DOI 10.4049/jimmunol.178.3.1256; Lovgren AK, 2006, AM J PHYSIOL-LUNG C, V291, pL144, DOI 10.1152/ajplung.00492.2005; Macaluso F, 2007, EXP DERMATOL, V16, P692, DOI 10.1111/j.1600-0625.2007.00589.x; Matute-Bello G, 2008, AM J PHYSIOL-LUNG C, V295, pL379, DOI 10.1152/ajplung.00010.2008; Patel M, 2005, J IMMUNOL, V174, P7558, DOI 10.4049/jimmunol.174.12.7558; Rao KMK, 2006, J TOXICOL ENV HEAL A, V69, P481, DOI 10.1080/15287390500247025; Stevenson CS, 2010, PHARM THER; Ting JPY, 2005, ANNU REV IMMUNOL, V23, P387, DOI 10.1146/annurev.immunol.23.021704.115616; Wang L, 2002, J BIOL CHEM, V277, P29874, DOI 10.1074/jbc.M203915200; Williams KL, 2005, J BIOL CHEM, V280, P39914, DOI 10.1074/jbc.M502820200; Williams KL, 2003, J IMMUNOL, V170, P5354, DOI 10.4049/jimmunol.170.11.5354; Willingham SB, 2009, J IMMUNOL, V183, P2008, DOI 10.4049/jimmunol.0900138; Wu Q, 2007, AM J PHYSIOL-LUNG C, V292, pL1064, DOI 10.1152/ajplung.00301.2006; Yu M, 2006, J CLIN INVEST, V116, P1633, DOI 10.1172/JCI25702	23	24	24	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30612	10.1371/journal.pone.0030612	http://dx.doi.org/10.1371/journal.pone.0030612			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22291998	Green Published, gold, Green Submitted			2022-12-25	WOS:000301570600063
J	Yoo, DE; Park, JT; Oh, HJ; Kim, SJ; Lee, MJ; Shin, DH; Han, SH; Yoo, TH; Choi, KH; Kang, SW				Yoo, Dong Eun; Park, Jung Tak; Oh, Hyung Jung; Kim, Seung Jun; Lee, Mi Jung; Shin, Dong Ho; Han, Seung Hyeok; Yoo, Tae-Hyun; Choi, Kyu Hun; Kang, Shin-Wook			Good Glycemic Control Is Associated with Better Survival in Diabetic Patients on Peritoneal Dialysis: A Prospective Observational Study	PLOS ONE			English	Article							GLUCOSE CONTROL; MORTALITY; COMPLICATIONS; PREDICTOR; THERAPY	Background: The effect of glycemic control after starting peritoneal dialysis (PD) on the survival of diabetic PD patients has largely been unexplored, especially in Asian population. Methods: We conducted a prospective observational study, in which 140 incident PD patients with diabetes were recruited. Patients were divided into tertiles according to the means of quarterly HbA1C levels measured during the first year after starting PD. We examined the association between HbA1C and all-cause mortality using Cox proportional hazards models. Results: The mean age was 58.7 years, 59.3% were male, and the mean follow-up duration was 3.5 years (range 0.4-9.5 years). The mean HbA1C levels were 6.3%, 7.1%, and 8.5% in the 1st, 2nd, and 3rd tertiles, respectively. Compared to the 1st tertile, the all-cause mortality rates were higher in the 2nd [hazard ratio (HR), 4.16; 95% confidence interval (CI), 0.91-18.94; p = 0.065] and significantly higher in the 3rd (HR, 13.16; 95% CI, 2.67-64.92; p = 0.002) tertiles (p for trend = 0.005), after adjusting for confounding factors. Cardiovascular mortality, however, did not differ significantly among the tertiles (p for trend = 0.682). In contrast, non-cardiovascular deaths, most of which were caused by infection, were more frequent in the 2nd (HR, 7.67; 95% CI, 0.68-86.37; p = 0.099) and the 3rd (HR, 51.24; 95% CI, 3.85-681.35; p = 0.003) tertiles than the 1st tertile (p for trend = 0.007). Conclusions: Poor glycemic control is associated with high mortality rates in diabetic PD patients, suggesting that better glycemic control may improve the outcomes of these patients.	[Yoo, Dong Eun; Park, Jung Tak; Oh, Hyung Jung; Kim, Seung Jun; Lee, Mi Jung; Shin, Dong Ho; Han, Seung Hyeok; Yoo, Tae-Hyun; Choi, Kyu Hun; Kang, Shin-Wook] Yonsei Univ, Coll Med, Dept Internal Med, Severance Biomed Sci Inst, Seoul, South Korea	Yonsei University; Yonsei University Health System	Yoo, DE (corresponding author), Yonsei Univ, Coll Med, Dept Internal Med, Severance Biomed Sci Inst, Seoul, South Korea.	kswkidney@yuhs.ac	Han, Seung Hyeok/W-8825-2019; Han, Seung Hyeok/K-4559-2018; Kim, Seung Jun/N-5248-2019	Han, Seung Hyeok/0000-0001-7923-5635; Han, Seung Hyeok/0000-0001-7923-5635; Kim, Seung Jun/0000-0002-6913-6358; Yoo, Tae-Hyun/0000-0002-9183-4507; Choi, Kyu Hun/0000-0003-0095-9011; Park, Jung Tak/0000-0002-2325-8982; Lee, Mi Jung/0000-0001-8888-029X; Kang, Shin-Wook/0000-0002-5677-4756	Yonsei University; National Research Foundation of Korea; Korea government (MEST) [2011-0030711]; Ministry of Health and Welfare, Republic of Korea [A102065]	Yonsei University; National Research Foundation of Korea(National Research Foundation of Korea); Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Ministry of Health and Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This work was supported by the Brain Korea 21 Project for Medical Science, Yonsei University, by the National Research Foundation of Korea grant funded by the Korea government (MEST) (No. 2011-0030711), and by a grant of the Korea Healthcare Technology Research & Development Project, Ministry of Health and Welfare, Republic of Korea (A102065). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2011, DIABETES CARE, V34, pS11, DOI 10.2337/dc11-S011; BLAGG CR, 1991, AM J KIDNEY DIS, V17, P458, DOI 10.1016/S0272-6386(12)80641-X; Bopp C, 2008, CRIT CARE, V12, DOI 10.1186/cc6164; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chung SH, 2010, NEPHROL DIAL TRANSPL, V25, P3742, DOI 10.1093/ndt/gfq233; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; Duong U, 2011, CLIN J AM SOC NEPHRO, V6, P1041, DOI 10.2215/CJN.08921010; Genuth S, 2003, DIABETES CARE, V26, P3160; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Jin Dong Chan, 2011, Korean Journal of Internal Medicine, V26, P123, DOI 10.3904/kjim.2011.26.2.123; Kalantar-Zadeh K, 2007, DIABETES CARE, V30, P1049, DOI 10.2337/dc06-2127; KREDIET RT, 1986, NEPHRON, V42, P133, DOI 10.1159/000183652; Morioka T, 2001, DIABETES CARE, V24, P909, DOI 10.2337/diacare.24.5.909; OHKUBO Y, 1995, DIABETES RES CLIN PR, V28, P103, DOI 10.1016/0168-8227(95)01064-K; Oomichi T, 2006, DIABETES CARE, V29, P1496, DOI 10.2337/dc05-1887; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Selvin E, 2004, ANN INTERN MED, V141, P421, DOI 10.7326/0003-4819-141-6-200409210-00007; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Shurraw S, 2010, AM J KIDNEY DIS, V55, P875, DOI 10.1053/j.ajkd.2009.12.038; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; United States Renal Data System, 2010, AM J KIDNEY DIS, V52, pS212; Wade CE, 2008, CRIT CARE, V12, DOI 10.1186/cc7012; WATSON PE, 1980, AM J CLIN NUTR, V33, P27, DOI 10.1093/ajcn/33.1.27; Wei M, 1998, DIABETES CARE, V21, P1167, DOI 10.2337/diacare.21.7.1167; Williams ME, 2006, KIDNEY INT, V70, P1503, DOI 10.1038/sj.ki.5001789; Wu MS, 1999, PERITON DIALYSIS INT, V19, pS179	26	26	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30072	10.1371/journal.pone.0030072	http://dx.doi.org/10.1371/journal.pone.0030072			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22291903	Green Published, Green Submitted, gold			2022-12-25	WOS:000301570600013
J	Traves, PG; Lopez-Fontal, R; Cuadrado, I; Luque, A; Bosca, L; de las Heras, B; Hortelano, S				Traves, P. G.; Lopez-Fontal, R.; Cuadrado, I.; Luque, A.; Bosca, L.; de las Heras, B.; Hortelano, S.			Critical role of the death receptor pathway in the antitumoral effects induced by hispanolone derivatives	ONCOGENE			English	Article						hispanolone derivatives; apoptosis; death receptors; TRAIL; caspase-8	NF-KAPPA-B; INDUCED APOPTOSIS; NITRIC-OXIDE; ACTIVATION; CANCER; INHIBITION; DITERPENES; MECHANISM; THERAPY; KINASE	Labdane diterpenoids have a broad spectrum of biological activities including antibacterial, antiviral and anti-inflammatory properties. However, little is known about their possible role in the apoptotic cell death machinery. Here, we report that hispanolone derivatives, a group of labdane diterpenoids, induce apoptosis in different tumor cell lines by activating caspase-8 with subsequent participation of mitochondrial signaling. Activation of caspase-8 by hispanolone derivatives was followed by a decrease in mitochondrial membrane potential, the release of apoptotic factors from mitochondria to the cytosol, and activation of caspases-9 and 3. Hispanolone derivatives also led to a time-dependent cleavage of Bid. Inhibition of caspase-8 abrogated these processes, suggesting that the death receptor pathway has a critical role in the apoptotic events induced by hispanolone derivatives. In addition, silencing death receptors with small interfering RNA s or pretreating cells with neutralizing antibodies to Fas ligand, tumor necrosis factor receptor 1 (TNF-R1), and TNF-alpha receptor 2 (TRAIL) inhibited diterpenoid-induced apoptosis, revealing it to be dependent on these death receptors. Interestingly, hispanolone derivatives had no effect on non-tumor cells. Consistently, in vivo bioluminescence imaging corroborates this antineoplasic effect, as hispanolone derivatives significantly decrease cancer growth in tumor xenograft assays. These data demostrate the antitumoral effects of hispanolone derivatives and provide relevant preclinical validation for the use of these compounds as potent therapeutic agents in cancer treatment. Oncogene (2013) 32, 259-268; doi:10.1038/onc.2012.23; published online 6 February 2012	[Traves, P. G.; Bosca, L.] UAM, CSIC, Inst Invest Biomed Alberto Sols, Madrid, Spain; [Lopez-Fontal, R.] Ctr Nacl Invest Cardiovasc, Madrid, Spain; [Cuadrado, I.; de las Heras, B.] Univ Complutense Madrid, Fac Farm, Dept Farmacol, E-28040 Madrid, Spain; [Luque, A.] FIB Hosp Univ Nino Jesus, Madrid, Spain; [Luque, A.] IIS Hosp La Princesa, Madrid, Spain; [Hortelano, S.] Inst Salud Carlos III, Ctr Nacl Microbiol, Unidad Inflamac & Canc, Area Biol Celular & Desarrollo, Madrid 28220, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Centro Nacional de Investigaciones Cardiovasculares (CNIC); Complutense University of Madrid; Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM)	Hortelano, S (corresponding author), Inst Salud Carlos III, Ctr Nacl Microbiol, Unidad Inflamac & Canc, Area Biol Celular & Desarrollo, Ctra Majadahonda Pozuelo,Km 2,200, Madrid 28220, Spain.	lasheras@farm.ucm.es; shortelano@isciii.es	de las Heras, Beatriz/K-1811-2014; de las Heras, Beatriz/ABB-9645-2021; Cuadrado-Berrocal, Irene/K-7761-2014; Bosca, Lisardo/A-2059-2008; Cuadrado-Berrocal, Irene/P-1360-2014; Luque, Alfonso/C-5846-2018; G. Traves, Paqui/L-5693-2014; Cuadrado-Berrocal, Irene/AAZ-1917-2021; Hortelano, Sonsoles/A-7954-2010	de las Heras, Beatriz/0000-0001-5089-8988; de las Heras, Beatriz/0000-0001-5089-8988; Cuadrado-Berrocal, Irene/0000-0003-0727-9633; Bosca, Lisardo/0000-0002-0253-5469; Cuadrado-Berrocal, Irene/0000-0003-0727-9633; G. Traves, Paqui/0000-0001-5749-8426; Cuadrado-Berrocal, Irene/0000-0003-0727-9633; Hortelano, Sonsoles/0000-0003-2528-0072	FIS [PI08.0070]; ISCIII [MPY 1410/09]; Santander-Complutense grant	FIS(Instituto de Salud Carlos III); ISCIII(Instituto de Salud Carlos III); Santander-Complutense grant	This study was supported by grant PI08.0070 from the FIS and MPY 1410/09 from ISCIII to SH, and by a Santander-Complutense grant to SH and B de las H. We thank Gemma Benito for excellent technical assistance and Simon Bartlett for critical reading of the manuscript. We thank Dr S Alemany and Dr K Roby for kindly provide luc-B16F10 and ID8 cells, respectively.	Castrillo A, 2001, J BIOL CHEM, V276, P15854, DOI 10.1074/jbc.M100010200; Chinou I, 2005, CURR MED CHEM, V12, P1295, DOI 10.2174/0929867054020990; de las Heras B, 2001, LIFE SCI, V70, P269, DOI 10.1016/S0024-3205(01)01402-3; Dirsch VM, 2002, LEUKEMIA, V16, P74, DOI 10.1038/sj.leu.2402337; Enari M, 1996, NATURE, V380, P723, DOI 10.1038/380723a0; Giron N, 2008, TOXICOL APPL PHARM, V228, P179, DOI 10.1016/j.taap.2007.12.006; Hueso-Falcon I, 2011, EUR J MED CHEM, V46, P1291, DOI 10.1016/j.ejmech.2011.01.052; Hwang BY, 2001, PLANTA MED, V67, P406, DOI 10.1055/s-2001-15808; Kelley SK, 2004, CURR OPIN PHARMACOL, V4, P333, DOI 10.1016/j.coph.2004.02.006; Kuo PL, 2004, J PHARM PHARMACOL, V56, P1399, DOI 10.1211/0022357044625; Lee JH, 2006, BIOCHEM PHARMACOL, V72, P1311, DOI 10.1016/j.bcp.2006.08.014; Lee JH, 2002, J BIOL CHEM, V277, P18411, DOI 10.1074/jbc.M201368200; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Liby KT, 2007, NAT REV CANCER, V7, P357, DOI 10.1038/nrc2129; Lyss G, 1998, J BIOL CHEM, V273, P33508, DOI 10.1074/jbc.273.50.33508; Mann J, 2002, NAT REV CANCER, V2, P143, DOI 10.1038/nrc723; Nagashima F, 2003, CHEM PHARM BULL, V51, P1189, DOI 10.1248/cpb.51.1189; Nicholson DW, 1999, CELL DEATH DIFFER, V6, P1028, DOI 10.1038/sj.cdd.4400598; Peter ME, 1998, CURR OPIN IMMUNOL, V10, P545, DOI 10.1016/S0952-7915(98)80222-7; RODRIGUEZ B, 1980, PHYTOCHEMISTRY, V19, P1805, DOI 10.1016/S0031-9422(00)83817-0; SAVONA G, 1978, HETEROCYCLES, V9, P257; Slee EA, 1999, CELL DEATH DIFFER, V6, P1067, DOI 10.1038/sj.cdd.4400601; Song ZW, 1999, TRENDS CELL BIOL, V9, pM49, DOI 10.1016/S0968-0004(99)01485-1; Wajant H, 2006, CANC TREAT, V130, P141; Wang CY, 1999, NAT MED, V5, P412, DOI 10.1038/7410; Wang CY, 1996, SCIENCE, V274, P784, DOI 10.1126/science.274.5288.784; Xia YF, 2004, J IMMUNOL, V173, P4207, DOI 10.4049/jimmunol.173.6.4207; Zeini M, 2006, J IMMUNOL, V177, P3327, DOI 10.4049/jimmunol.177.5.3327; Zhou J, 2008, MOL CANCER THER, V7, P2170, DOI 10.1158/1535-7163.MCT-08-0071; Zhou J, 2006, BIOCHEM PHARMACOL, V72, P132, DOI 10.1016/j.bcp.2006.04.019	30	14	14	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 10	2013	32	2					259	268		10.1038/onc.2012.23	http://dx.doi.org/10.1038/onc.2012.23			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	078CK	22310289				2022-12-25	WOS:000314075500014
J	Forsberg, M; Holmborn, K; Kundu, S; Dagalv, A; Kjellen, L; Forsberg-Nilsson, K				Forsberg, Maud; Holmborn, Katarina; Kundu, Soumi; Dagalv, Anders; Kjellen, Lena; Forsberg-Nilsson, Karin			Undersulfation of Heparan Sulfate Restricts Differentiation Potential of Mouse Embryonic Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURAL INDUCTION; MICE DEFICIENT; TRANSCRIPTIONAL REGULATION; MOLECULAR DIVERSITY; CELLULAR UPTAKE; GENE-FUNCTION; SELF-RENEWAL; MAST-CELLS; IN-VITRO; FGF	Heparan sulfate proteoglycans, present on cell surfaces and in the extracellular matrix, interact with growth factors and morphogens to influence growth and differentiation of cells. The sulfation pattern of the heparan sulfate chains formed during biosynthesis in the Golgi compartment will determine the interaction potential of the proteoglycan. The glucosaminyl N-deacetylase/N-sulfotransferase (NDST) enzymes have a key role during biosynthesis, greatly influencing total sulfation of the heparan sulfate chains. The differentiation potential of mouse embryonic stem cells lacking both NDST1 and NDST2 was studied using in vitro differentiation protocols, expression of differentiation markers, and assessment of the ability of the cells to respond to growth factors. The results show that NDST1 and NDST2 are dispensable for mesodermal differentiation into osteoblasts but necessary for induction of adipocytes and neural cells. Gene expression analysis suggested a differentiation block at the primitive ectoderm stage. Also, GATA4, a primitive endoderm marker, was expressed by these cells. The addition of FGF4 or FGF2 together with heparin rescued the differentiation potential to neural progenitors and further to mature neurons and glia. Our results suggest that the embryonic stem cells lacking both NDST1 and NDST2, expressing a very low sulfated heparan sulfate, can take the initial step toward differentiation into all three germ layers. Except for their potential for mesodermal differentiation into osteoblasts, the cells are then arrested in a primitive ectoderm and/or endoderm stage.	[Kundu, Soumi; Forsberg-Nilsson, Karin] Uppsala Univ, Sci Life Lab, Dept Immunol Genet & Pathol, S-75185 Uppsala, Sweden; [Forsberg, Maud] Uppsala Univ, Biomed Ctr, Uppsala Univ Transgen Facil, S-75123 Uppsala, Sweden; [Forsberg, Maud; Holmborn, Katarina; Dagalv, Anders; Kjellen, Lena] Uppsala Univ, Dept Med Biochem & Microbiol, Sci Life Lab, S-75123 Uppsala, Sweden	Uppsala University; Uppsala University; Uppsala University	Forsberg-Nilsson, K (corresponding author), Uppsala Univ, Sci Life Lab, Dept Immunol Genet & Pathol, S-75185 Uppsala, Sweden.	karin.nilsson@igp.uu.se	Forsberg-Nilsson, Karin/D-9604-2019	Forsberg-Nilsson, Karin/0000-0003-0692-6245	Swedish Research Council (Medicine); Swedish Board for Agriculture; Swedish Childhood Cancer Foundation; Swedish Cancer Foundation; Polysackaridforskning AB	Swedish Research Council (Medicine)(Swedish Research Council); Swedish Board for Agriculture; Swedish Childhood Cancer Foundation(European Commission); Swedish Cancer Foundation; Polysackaridforskning AB	This work was supported by grants from the Swedish Research Council (Medicine) (to L. K. and K. F.-N.), the Swedish Board for Agriculture (K. F.-N. and M. F.), the Swedish Childhood Cancer Foundation (to K. F.-N.), the Swedish Cancer Foundation (to K. F.-N. and L. K.), and Polysackaridforskning AB (to L. K.).	Aikawa T, 2001, J BIOL CHEM, V276, P29347, DOI 10.1074/jbc.M101859200; Bachiller D, 2000, NATURE, V403, P658, DOI 10.1038/35001072; Bae KH, 2008, BIOMATERIALS, V29, P3376, DOI 10.1016/j.biomaterials.2008.04.035; Berry D, 2004, CHEM BIOL, V11, P487, DOI 10.1016/j.chembiol.2004.03.023; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Bornemann DJ, 2008, DEVELOPMENT, V135, P1039, DOI 10.1242/dev.017061; BronnerFraser M, 1997, CURR OPIN CELL BIOL, V9, P885, DOI 10.1016/S0955-0674(97)80092-0; Bulow HE, 2006, ANNU REV CELL DEV BI, V22, P375, DOI 10.1146/annurev.cellbio.22.010605.093433; De Robertis EM, 2004, ANNU REV CELL DEV BI, V20, P285, DOI 10.1146/annurev.cellbio.20.011403.154124; DOETSCHMAN TC, 1985, J EMBRYOL EXP MORPH, V87, P27; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Esko JD, 2001, J CLIN INVEST, V108, P169, DOI 10.1172/JCI200113530; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Fan GP, 2000, FEBS LETT, V467, P7, DOI 10.1016/S0014-5793(00)01111-X; Forsberg E, 1999, NATURE, V400, P773, DOI 10.1038/23488; GAO GX, 1995, EMBO J, V14, P2183, DOI 10.1002/j.1460-2075.1995.tb07212.x; Grobe K, 2005, DEVELOPMENT, V132, P3777, DOI 10.1242/dev.01935; Grobe K, 2002, BBA-GEN SUBJECTS, V1573, P209, DOI 10.1016/S0304-4165(02)00386-0; HAUB O, 1991, DEVELOPMENT, V112, P397; Hoffmann A, 2001, CRIT REV EUKAR GENE, V11, P23; Holmborn K, 2004, J BIOL CHEM, V279, P42355, DOI 10.1074/jbc.C400373200; Humphries DE, 1999, NATURE, V400, P769, DOI 10.1038/23481; Irie A, 2003, BIOCHEM BIOPH RES CO, V308, P858, DOI 10.1016/S0006-291X(03)01500-6; Jakobsson L, 2006, DEV CELL, V10, P625, DOI 10.1016/j.devcel.2006.03.009; Jasuja R, 2004, J BIOL CHEM, V279, P51289, DOI 10.1074/jbc.M408129200; Johnson CE, 2007, STEM CELLS, V25, P1913, DOI 10.1634/stemcells.2006-0445; Jordan PM, 2008, J NEUROSCI RES, V86, P35, DOI 10.1002/jnr.21460; Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605; Kraushaar DC, 2010, J BIOL CHEM, V285, P5907, DOI 10.1074/jbc.M109.066837; Kreuger J, 2004, DEV CELL, V7, P503, DOI 10.1016/j.devcel.2004.08.005; Kunath T, 2007, DEVELOPMENT, V134, P2895, DOI 10.1242/dev.02880; Kusche-Gullberg M, 1998, J BIOL CHEM, V273, P11902, DOI 10.1074/jbc.273.19.11902; Lanner F, 2010, STEM CELLS, V28, P191, DOI 10.1002/stem.265; Levine AJ, 2007, DEV BIOL, V308, P247, DOI 10.1016/j.ydbio.2007.05.036; Lin X, 2000, DEV BIOL, V224, P299, DOI 10.1006/dbio.2000.9798; LINDAHL U, 1965, J BIOL CHEM, V240, P2817; Linker C, 2004, DEVELOPMENT, V131, P5671, DOI 10.1242/dev.01445; MA YG, 1992, DEV BIOL, V154, P45, DOI 10.1016/0012-1606(92)90046-J; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Moreau M, 2004, INT J DEV BIOL, V48, P75, DOI 10.1387/ijdb.15272372; Okabe S, 1996, MECH DEVELOP, V59, P89, DOI 10.1016/0925-4773(96)00572-2; Pallerla SR, 2008, J BIOL CHEM, V283, P16885, DOI 10.1074/jbc.M709774200; PETTERSSON I, 1991, J BIOL CHEM, V266, P8044; Phillips BW, 2001, BIOCHEM BIOPH RES CO, V284, P478, DOI 10.1006/bbrc.2001.4987; Pickford CE, 2011, STEM CELLS, V29, P629, DOI 10.1002/stem.610; Ringvall M, 2000, J BIOL CHEM, V275, P25926, DOI 10.1074/jbc.C000359200; Ringvall M, 2010, PROG MOL BIOL TRANSL, V93, P35, DOI 10.1016/S1877-1173(10)93003-2; Rojas A, 2010, DEV BIOL, V346, P346, DOI 10.1016/j.ydbio.2010.07.032; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Stavridis MP, 2007, DEVELOPMENT, V134, P2889, DOI 10.1242/dev.02858; Stavridis MP, 2010, DEVELOPMENT, V137, P881, DOI 10.1242/dev.043117; Stickens D, 2005, DEVELOPMENT, V132, P5055, DOI 10.1242/dev.02088; Streit A, 2000, NATURE, V406, P74, DOI 10.1038/35017617; Taha MF, 2006, ANAT HISTOL EMBRYOL, V35, P271, DOI 10.1111/j.1439-0264.2006.00680.x; Wilsie Larissa C, 2005, Lipids Health Dis, V4, P2, DOI 10.1186/1476-511X-4-2; Wilson SI, 2000, CURR BIOL, V10, P421, DOI 10.1016/S0960-9822(00)00431-0; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780	58	49	49	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					10853	10862		10.1074/jbc.M111.337030	http://dx.doi.org/10.1074/jbc.M111.337030			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22298785	hybrid, Green Published			2022-12-25	WOS:000302780100014
J	Paar, M; Jungst, C; Steiner, NA; Magnes, C; Sinner, F; Kolb, D; Lass, A; Zimmermann, R; Zumbusch, A; Kohlwein, SD; Wolinski, H				Paar, Margret; Juengst, Christian; Steiner, Noemi A.; Magnes, Christoph; Sinner, Frank; Kolb, Dagmar; Lass, Achim; Zimmermann, Robert; Zumbusch, Andreas; Kohlwein, Sepp D.; Wolinski, Heimo			Remodeling of Lipid Droplets during Lipolysis and Growth in Adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HORMONE-SENSITIVE LIPASE; ACYL-COA SYNTHETASE; ADIPOSE TRIGLYCERIDE LIPASE; LOW-DENSITY LIPOPROTEIN; PERILIPIN-A; TRIACYLGLYCEROL; PROTEINS; PROMOTES; PHOSPHORYLATION; TRANSLOCATION	Background: Micro-lipid droplets (mLDs) appear in adipocytes upon lipolytic stimulation. LDs may grow by spontaneous, homotypic fusion. Results: Scavenging of fatty acids prevents mLD formation. LDs grow by a slow transfer of lipids between LDs. Conclusion: mLDs form due to fatty acid overflow. LD growth is a controlled process. Significance: Novel mechanistic insights into LD remodeling are provided.	[Paar, Margret; Steiner, Noemi A.; Lass, Achim; Zimmermann, Robert; Kohlwein, Sepp D.; Wolinski, Heimo] Graz Univ, Inst Mol Biosci, Lipid Res Ctr LRC Graz, A-8010 Graz, Austria; [Juengst, Christian; Zumbusch, Andreas] Univ Konstanz, Dept Chem, D-78457 Constance, Germany; [Magnes, Christoph; Sinner, Frank] Joanneum Res, Inst Biomed & Hlth Sci, HEALTH, A-8036 Graz, Austria; [Kolb, Dagmar] Med Univ Graz, Inst Cell Biol Histol & Embryol, A-8010 Graz, Austria; [Kolb, Dagmar] Med Univ Graz, ZMF, Med Res Ctr, A-8010 Graz, Austria	University of Graz; University of Konstanz; Medical University of Graz; Medical University of Graz	Wolinski, H (corresponding author), Graz Univ, Inst Mol Biosci, Lipid Res Ctr LRC Graz, Humboldtstr 50-2, A-8010 Graz, Austria.	heimo.wolinski@uni-graz.at	Lass, Achim/C-3332-2008	Lass, Achim/0000-0002-8190-7151; Magnes, Christoph/0000-0002-5153-7444; Wolinski, Heimo/0000-0002-1583-6092; Zimmermann, Robert/0000-0002-7354-870X; Kohlwein, Sepp Dieter/0000-0002-1030-0598; Jungst, Christian/0000-0002-6586-7129; Paar, Margret/0000-0001-5494-8890	Austrian Science Funds, FWF [LIPOTOX F3005-B12]; Ph.D. Program Molecular Enzymology [W901-B05]; Austrian Federal Government for Science and Research; Baden-Wurttemberg Stiftung; Konstanz Research School Chemical Biology; Austrian Science Fund (FWF) [F 3005, W 901] Funding Source: researchfish	Austrian Science Funds, FWF(Austrian Science Fund (FWF)); Ph.D. Program Molecular Enzymology; Austrian Federal Government for Science and Research; Baden-Wurttemberg Stiftung; Konstanz Research School Chemical Biology; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported in part by grants from the Austrian Science Funds, FWF, Project LIPOTOX F3005-B12 (to S. D. K.) and Ph.D. Program Molecular Enzymology, Project W901-B05, and the Austrian Federal Government for Science and Research (Project GOLD, in the framework of the Austrian Genome Program GEN-AU) (to S. D. K. and H. W.).; Supported by contract research "Methoden fur die Lebenswissenschaften" of the Baden-Wurttemberg Stiftung and a personal scholarship from the Konstanz Research School Chemical Biology.	Andersson L, 2006, J CELL SCI, V119, P2246, DOI 10.1242/jcs.02941; Bartzt R, 2007, J PROTEOME RES, V6, P3256, DOI 10.1021/pr070158j; Bezaire V, 2009, J BIOL CHEM, V284, P18282, DOI 10.1074/jbc.M109.008631; Bostrom P, 2005, ARTERIOSCL THROM VAS, V25, P1945, DOI 10.1161/01.ATV.0000179676.41064.d4; Bostrom P, 2007, NAT CELL BIOL, V9, P1286, DOI 10.1038/ncb1648; Brasaemle DL, 2012, J BIOL CHEM, V287, P2273, DOI 10.1074/jbc.R111.309088; Brasaemle DL, 2004, J BIOL CHEM, V279, P46835, DOI 10.1074/jbc.M409340200; Brasaemle DL, 2000, J BIOL CHEM, V275, P38486, DOI 10.1074/jbc.M007322200; Brasaemle DL, 2000, BBA-MOL CELL BIOL L, V1483, P251, DOI 10.1016/S1388-1981(99)00179-1; Carman GM, 2012, J BIOL CHEM, V287, P2272, DOI 10.1074/jbc.R111.323931; Cogswell Carol J., 1995, P507; EDENS NK, 1990, J LIPID RES, V31, P1423; Evans CL, 2008, ANNU REV ANAL CHEM, V1, P883, DOI 10.1146/annurev.anchem.1.031207.112754; Farese RV, 2009, CELL, V139, P855, DOI 10.1016/j.cell.2009.11.005; Gandotra S, 2011, J BIOL CHEM, V286, P34998, DOI 10.1074/jbc.M111.278853; Gauthier MS, 2008, J BIOL CHEM, V283, P16514, DOI 10.1074/jbc.M708177200; GIBBONS GF, 1995, ADV ENZYME REGUL, V35, P179, DOI 10.1016/0065-2571(94)00006-O; Girish V, 2004, Indian J Cancer, V41, P47; Gong JY, 2011, J CELL BIOL, V195, P953, DOI 10.1083/jcb.201104142; Granneman JG, 2009, J BIOL CHEM, V284, P34538, DOI 10.1074/jbc.M109.068478; Granneman JG, 2004, AM J PHYSIOL-ENDOC M, V287, pE574, DOI 10.1152/ajpendo.00567.2003; GREEN H, 1975, CELL, V5, P19, DOI 10.1016/0092-8674(75)90087-2; Jambunathan S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028614; Jungst C, 2011, J BIOPHOTONICS, V4, P435, DOI 10.1002/jbio.201000120; Kellner-Weibel G, 2001, J LIPID RES, V42, P768; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Kuerschner L, 2008, TRAFFIC, V9, P338, DOI 10.1111/j.1600-0854.2007.00689.x; Lelliott C, 2004, INT J OBESITY, V28, pS22, DOI 10.1038/sj.ijo.0802854; Lobo S, 2009, J BIOL CHEM, V284, P18347, DOI 10.1074/jbc.M109.017244; Londos C, 1999, SEMIN CELL DEV BIOL, V10, P51, DOI 10.1006/scdb.1998.0275; Magnes C, 2008, ANAL CHEM, V80, P5736, DOI 10.1021/ac800031u; Marcinkiewicz A, 2006, J BIOL CHEM, V281, P11901, DOI 10.1074/jbc.M600171200; Martin S, 2005, J BIOL CHEM, V280, P42325, DOI 10.1074/jbc.M506651200; Moore HPH, 2005, J BIOL CHEM, V280, P43109, DOI 10.1074/jbc.M506336200; Mottillo EP, 2011, AM J PHYSIOL-ENDOC M, V301, pE122, DOI 10.1152/ajpendo.00039.2011; Muller M, 2007, CHEMPHYSCHEM, V8, P2156, DOI 10.1002/cphc.200700202; Murphy S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015030; Murphy S, 2009, BBA-MOL CELL BIOL L, V1791, P441, DOI 10.1016/j.bbalip.2008.07.004; Nagayama M, 2007, J LIPID RES, V48, P9, DOI 10.1194/jlr.M600155-JLR200; Nagayama M, 2010, FEBS LETT, V584, P86, DOI 10.1016/j.febslet.2009.10.088; OMURA S, 1986, J ANTIBIOT, V39, P1211, DOI 10.7164/antibiotics.39.1211; Ozeki S, 2005, J CELL SCI, V118, P2601, DOI 10.1242/jcs.02401; Pulido MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022931; Spandl J, 2009, TRAFFIC, V10, P1579, DOI 10.1111/j.1600-0854.2009.00980.x; Stone SJ, 2009, J BIOL CHEM, V284, P5352, DOI 10.1074/jbc.M805768200; Storch J, 2010, J BIOL CHEM, V285, P32679, DOI 10.1074/jbc.R110.135210; Sztalryd C, 2003, J CELL BIOL, V161, P1093, DOI 10.1083/jcb.200210169; Tansey JT, 2004, IUBMB LIFE, V56, P379, DOI 10.1080/15216540400009968; TOMODA H, 1987, BIOCHIM BIOPHYS ACTA, V921, P595; Walther TC, 2009, BBA-MOL CELL BIOL L, V1791, P459, DOI 10.1016/j.bbalip.2008.10.009; Wang H, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.207779; Wang HJ, 2010, MOL BIOL CELL, V21, P1991, DOI 10.1091/mbc.E09-05-0364; WIGGINS D, 1992, BIOCHEM J, V284, P457, DOI 10.1042/bj2840457; Wolins NE, 2005, J BIOL CHEM, V280, P19146, DOI 10.1074/jbc.M500978200; Yamaguchi T, 2007, J LIPID RES, V48, P1078, DOI 10.1194/jlr.M600493-JLR200; Yamaguchi T, 2010, BIOL PHARM BULL, V33, P342, DOI 10.1248/bpb.33.342; Zanghellini J, 2008, FEBS J, V275, P5552, DOI 10.1111/j.1742-4658.2008.06681.x; Zehmer JK, 2009, PROTEOMICS, V9, P914, DOI 10.1002/pmic.200800584; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747; Zumbusch A, 1999, PHYS REV LETT, V82, P4142, DOI 10.1103/PhysRevLett.82.4142	60	116	121	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					11164	11173		10.1074/jbc.M111.316794	http://dx.doi.org/10.1074/jbc.M111.316794			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22311986	Green Published, hybrid, Green Submitted			2022-12-25	WOS:000302780100044
J	Reipschlager, S; Kubatzky, K; Taromi, S; Burger, M; Orth, J; Aktories, K; Schmidt, G				Reipschlaeger, Simone; Kubatzky, Katharina; Taromi, Sanaz; Burger, Meike; Orth, Joachim; Aktories, Klaus; Schmidt, Gudula			Toxin-induced RhoA Activity Mediates CCL1-triggered Signal Transducers and Activators of Transcription Protein Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOTOXIC NECROTIZING FACTOR; PASTEURELLA-MULTOCIDA TOXIN; N-TERMINAL KINASE; ESCHERICHIA-COLI; YERSINIA-PSEUDOTUBERCULOSIS; STAT3 ACTIVATION; TARGETING STAT3; GENE-EXPRESSION; C-JUN; RECEPTOR	Background: Rho GTPases are involved in STAT-dependent transcription. However, the connecting signaling pathways are unknown. Results: Activated RhoA induces STAT3 phosphorylation via ROCK, JNK, CCL1 synthesis, and secretion. Conclusion: Auto/paracrine cytokine signaling is a link between RhoA and STAT3. Significance: The knowledge about the connection between RhoA and STAT signaling is crucial for understanding several diseases, especially cancer.	[Reipschlaeger, Simone; Orth, Joachim; Aktories, Klaus; Schmidt, Gudula] Univ Freiburg, Inst Expt & Clin Pharmacol & Toxicol, D-79104 Freiburg, Germany; [Kubatzky, Katharina] Dept Infectiol Med Microbiol & Hyg, D-69120 Heidelberg, Germany; [Taromi, Sanaz; Burger, Meike] Univ Med Ctr, Dept Haematol & Oncol, D-79106 Freiburg, Germany	University of Freiburg; University of Freiburg	Schmidt, G (corresponding author), Univ Freiburg, Inst Expt & Clin Pharmacol & Toxicol, Albert Str 25, D-79104 Freiburg, Germany.	Gudula.Schmidt@pharmakol.uni-freiburg.de	Aktories, Klaus/CAJ-5682-2022; Maximilian, Burger/E-4077-2012	Aktories, Klaus/0000-0002-5397-0436; Kubatzky, Katharina F./0000-0003-3739-9329	Deutsche Forschungsgemeinschaft [Schm 1385/5-1, SFB850]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grants Schm 1385/5-1 and SFB850.	Banes-Berceli AK, 2006, AM J PHYSIOL-RENAL, V291, pF116, DOI 10.1152/ajprenal.00502.2005; Blumenthal B, 2007, INFECT IMMUN, V75, P3344, DOI 10.1128/IAI.01937-06; Bowman T, 2000, ONCOGENE, V19, P2474, DOI 10.1038/sj.onc.1203527; Bromberg JF, 1998, MOL CELL BIOL, V18, P2553, DOI 10.1128/MCB.18.5.2553; Choi YB, 2008, J VIROL, V82, P6501, DOI 10.1128/JVI.02396-07; Dalpke AH, 2003, EUR J IMMUNOL, V33, P1776, DOI 10.1002/eji.200323621; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; De Rycke J, 1999, VET RES, V30, P221; DERYCKE J, 1990, J CLIN MICROBIOL, V28, P694, DOI 10.1128/JCM.28.4.694-699.1990; Dumoutier L, 2004, J BIOL CHEM, V279, P32269, DOI 10.1074/jbc.M404789200; Emdad L, 2009, CANCER BIOL THER, V8, P402, DOI 10.4161/cbt.8.5.7581; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Flatau G, 1997, NATURE, V387, P729, DOI 10.1038/42743; Fujimoto Y, 2011, J HEPATOL, V54, P629, DOI 10.1016/j.jhep.2010.07.021; Gundogdu MS, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-225; Haque NS, 2004, BLOOD, V103, P1296, DOI 10.1182/blood-2002-05-1480; Herrmann A, 2007, J CELL SCI, V120, P3249, DOI 10.1242/jcs.03482; Hoffmann C, 2004, J BIOL CHEM, V279, P16026, DOI 10.1074/jbc.M313556200; Homey Bernhard, 2007, Chem Immunol Allergy, V93, P181, DOI 10.1159/000100895; Koch G, 1997, J PHARMACOL EXP THER, V283, P901; Kortylewski M, 2005, CANCER METAST REV, V24, P315, DOI 10.1007/s10555-005-1580-1; Kreiselmeier NE, 2003, AM J PHYSIOL-LUNG C, V285, pL1286, DOI 10.1152/ajplung.00127.2003; Lee SJ, 2007, J LEUKOCYTE BIOL, V82, P436, DOI 10.1189/jlb.1206739; Lerm M, 1999, INFECT IMMUN, V67, P496, DOI 10.1128/IAI.67.2.496-503.1999; Loucks FA, 2006, J NEUROCHEM, V97, P957, DOI 10.1111/j.1471-4159.2006.03802.x; Mackay DJG, 1998, J BIOL CHEM, V273, P20685, DOI 10.1074/jbc.273.33.20685; Marinissen MJ, 2004, MOL CELL, V14, P29, DOI 10.1016/S1097-2765(04)00153-4; Ongusaha PP, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1161938; Orth JHC, 2005, J BIOL CHEM, V280, P36701, DOI 10.1074/jbc.M507203200; Orth JHC, 2007, J BIOL CHEM, V282, P3050, DOI 10.1074/jbc.M609018200; Ouyang WJ, 2011, ANNU REV IMMUNOL, V29, P71, DOI 10.1146/annurev-immunol-031210-101312; Pfeiffer M, 2009, BRIT J CANCER, V100, P1949, DOI 10.1038/sj.bjc.6605068; Raptis L, 2011, EXP CELL RES, V317, P1787, DOI 10.1016/j.yexcr.2011.05.008; Schmidt G, 1997, NATURE, V387, P725, DOI 10.1038/42735; Sotiropoulos A, 1996, MOL ENDOCRINOL, V10, P998, DOI 10.1210/me.10.8.998; Sotiropoulos A, 1999, CELL, V98, P159, DOI 10.1016/S0092-8674(00)81011-9; Stoll T, 2009, TOXICON, V54, P745, DOI 10.1016/j.toxicon.2009.05.038; Takasaki J, 2004, J BIOL CHEM, V279, P47438, DOI 10.1074/jbc.M408846200; Tiffany HL, 1997, J EXP MED, V186, P165, DOI 10.1084/jem.186.1.165; Turkson J, 1999, MOL CELL BIOL, V19, P7519; Yue P, 2009, EXPERT OPIN INV DRUG, V18, P45, DOI 10.1517/13543780802565791 	41	11	12	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					11183	11194		10.1074/jbc.M111.313395	http://dx.doi.org/10.1074/jbc.M111.313395			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22311973	hybrid, Green Published			2022-12-25	WOS:000302780100046
J	Rothbard, JB; Kurnellas, MP; Brownell, S; Adams, CM; Su, L; Axtell, RC; Chen, R; Fathman, CG; Robinson, WH; Steinman, L				Rothbard, Jonathan B.; Kurnellas, Michael P.; Brownell, Sara; Adams, Chris M.; Su, Leon; Axtell, Robert C.; Chen, Rong; Fathman, C. Garrison; Robinson, William H.; Steinman, Lawrence			Therapeutic Effects of Systemic Administration of Chaperone alpha B-Crystallin Associated with Binding Proinflammatory Plasma Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK PROTEINS; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; MULTIPLE-SCLEROSIS; INDUCED APOPTOSIS; CELLS; TRANSLOCATION; ACTIVATION; SEQUESTER; CASPASE-3; PROTEOME	The therapeutic benefit of the small heat shock protein alpha B-crystallin (HspB5) in animal models of multiple sclerosis and ischemia is proposed to arise from its increased capacity to bind proinflammatory proteins at the elevated temperatures within inflammatory foci. By mass spectral analysis, a common set of similar to 70 ligands was precipitated by HspB5 from plasma from patients with multiple sclerosis, rheumatoid arthritis, and amyloidosis and mice with experimental allergic encephalomyelitis. These proteins were distinguished from other precipitated molecules because they were enriched in the precipitate as compared with their plasma concentrations, and they exhibited temperature-dependent binding. More than half of these ligands were acute phase proteins or members of the complement or coagulation cascades. Consistent with this proposal, plasma levels of HspB5 were increased in patients with multiple sclerosis as compared with normal individuals. The combination of the thermal sensitivity of the HspB5 combined with the high local concentration of these ligands at the site of inflammation is proposed to explain the paradox of how a protein believed to exhibit nonspecific binding can bind with some relative apparent selectivity to proinflammatory proteins and thereby modulate inflammation.	[Kurnellas, Michael P.; Brownell, Sara; Axtell, Robert C.; Steinman, Lawrence] Stanford Univ, Dept Neurol & Neurol Sci, Sch Med, Stanford, CA 94305 USA; [Rothbard, Jonathan B.; Su, Leon; Fathman, C. Garrison; Robinson, William H.] Stanford Univ, Div Rheumatol & Immunol, Sch Med, Dept Med, Stanford, CA 94305 USA; [Adams, Chris M.] Stanford Univ, Stanford Univ Mass Spectrometry, Sch Med, Stanford, CA 94305 USA; [Chen, Rong] Stanford Univ, Sch Med, Div Syst Med, Dept Pediat, Stanford, CA 94305 USA; [Robinson, William H.] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA 94304 USA	Stanford University; Stanford University; Stanford University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Steinman, L (corresponding author), Stanford Univ, Dept Neurol & Neurol Sci, Sch Med, Beckman B002,279 Campus Dr, Stanford, CA 94305 USA.	Steinman@stanford.edu	Axtell, Robert/AAJ-5053-2021	Robinson, William/0000-0003-4385-704X; Steinman, Lawrence/0000-0002-2437-2250	National Institutes of Health [R01NS55997, UO1 DK078123]; National Multiple Sclerosis Society; Endriz Fund; National Center For Research Resources, National Institutes of Health [S10RR027425]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027425] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK078123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055997] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society(National Multiple Sclerosis Society); Endriz Fund; National Center For Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01NS55997 (to L. S. and W. H. R.) and UO1 DK078123 (to C. G. F. and J.B.R.). This work was also supported by the National Multiple Sclerosis Society (to J.B.R., M. P. K., and L. S.), and the Endriz Fund (to L.S.).; The mass spectrometry was funded by Award Number S10RR027425 from the National Center For Research Resources, National Institutes of Health.	Anderson NL, 2004, MOL CELL PROTEOMICS, V3, P311, DOI 10.1074/mcp.M300127-MCP200; Arac A, 2011, P NATL ACAD SCI USA, V108, P13287, DOI 10.1073/pnas.1107368108; Axtell RC, 2010, NAT MED, V16, P406, DOI 10.1038/nm.2110; Bagneris C, 2009, J MOL BIOL, V392, P1242, DOI 10.1016/j.jmb.2009.07.069; Bergeron JJ, 2007, NAT BIOTECHNOL, V25, P61, DOI 10.1038/nbt0107-61; CASPERS GJ, 1995, J MOL EVOL, V40, P238, DOI 10.1007/BF00163229; Cazalla D, 2005, PROTEIN EXPRES PURIF, V42, P54, DOI 10.1016/j.pep.2005.03.035; Chabas D, 2001, SCIENCE, V294, P1731, DOI 10.1126/science.1062960; de Jong WW, 1998, INT J BIOL MACROMOL, V22, P151, DOI 10.1016/S0141-8130(98)00013-0; GIJBELS K, 1995, MOL MED, V1, P795, DOI 10.1007/BF03401894; Han MH, 2008, NATURE, V451, P1076, DOI 10.1038/nature06559; Haslbeck M, 2005, NAT STRUCT MOL BIOL, V12, P842, DOI 10.1038/nsmb993; Hortin GL, 2008, CLIN CHEM, V54, P1608, DOI 10.1373/clinchem.2008.108175; Horwitz J, 2003, EXP EYE RES, V76, P145, DOI 10.1016/S0014-4835(02)00278-6; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; JAKOB U, 1993, J BIOL CHEM, V268, P1517; Kamradt MC, 2005, J BIOL CHEM, V280, P11059, DOI 10.1074/jbc.M413382200; Kamradt MC, 2001, J BIOL CHEM, V276, P16059, DOI 10.1074/jbc.C100107200; Kappe G, 2003, CELL STRESS CHAPERON, V8, P53, DOI 10.1379/1466-1268(2003)8<53:THGECS>2.0.CO;2; Laganowsky A, 2010, PROTEIN SCI, V19, P1031, DOI 10.1002/pro.380; Liu S, 2007, BIOCHEM BIOPH RES CO, V354, P109, DOI 10.1016/j.bbrc.2006.12.152; Mao YW, 2004, CELL DEATH DIFFER, V11, P512, DOI 10.1038/sj.cdd.4401384; Marta M, 2009, AUTOIMMUN REV, V8, P506, DOI 10.1016/j.autrev.2009.01.006; Mchaourab HS, 2009, BIOCHEMISTRY-US, V48, P3828, DOI 10.1021/bi900212j; Murphy KM, 2010, NAT IMMUNOL, V11, P674, DOI 10.1038/ni.1899; Ousman SS, 2007, NATURE, V448, P474, DOI 10.1038/nature05935; Pangratz-Fuehrer S, 2011, EYE, V25, P809, DOI 10.1038/eye.2011.42; Rothbard JB, 2011, J IMMUNOL, V186, P4263, DOI 10.4049/jimmunol.1003934; Serada S, 2008, P NATL ACAD SCI USA, V105, P9041, DOI 10.1073/pnas.0802218105; Sreekumar PG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012578; Steinman L, 2006, ANN NEUROL, V60, P12, DOI 10.1002/ana.20913; Velotta JB, 2011, ANN THORAC SURG, V91, P1907, DOI 10.1016/j.athoracsur.2011.02.072; Zhang B, 2006, J PROTEOME RES, V5, P2909, DOI 10.1021/pr0600273	33	65	67	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					9708	9721		10.1074/jbc.M111.337691	http://dx.doi.org/10.1074/jbc.M111.337691			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22308023	hybrid, Green Published			2022-12-25	WOS:000302167200005
J	Yao, YX; Harrison, KA; Al-Hassani, M; Murphy, RC; Rezania, S; Konger, RL; Travers, JB				Yao, Yongxue; Harrison, Kathleen A.; Al-Hassani, Mohammed; Murphy, Robert C.; Rezania, Samin; Konger, Raymond L.; Travers, Jeffrey B.			Platelet-activating Factor Receptor Agonists Mediate Xeroderma Pigmentosum A Photosensitivity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCISION-REPAIR; ULTRAVIOLET-B RADIATION; INDUCED IMMUNE SUPPRESSION; FACTOR-LIKE PHOSPHOLIPIDS; TOCOPHEROL VITAMIN-E; DNA-REPAIR; GLYCEROPHOSPHOCHOLINE LIPIDS; HYPERSENSITIVITY REACTIONS; ENDOTHELIAL-CELLS; MASS-SPECTROMETRY	To date, oxidized glycerophosphocholines (Ox-GPCs) with platelet-activating factor (PAF) activity produced non-enzymatically have not been definitively demonstrated to mediate any known disease processes. Here we provide evidence that these Ox-GPCs play a pivotal role in the photosensitivity associated with the deficiency of the DNA repair protein xeroderma pigmentosum type A (XPA). It should be noted that XPA-deficient cells are known to have decreased antioxidant defenses. These studies demonstrate that treatment of human XPA-deficient fibroblasts with the pro-oxidative stressor ultraviolet B (UVB) radiation resulted in increased reactive oxygen species and PAF receptor (PAF-R) agonistic activity in comparison with gene-corrected cells. The UVB irradiation-generated PAF-R agonists were inhibited by antioxidants. UVB irradiation of XPA-deficient (Xpa(-/-)) mice also resulted in increased PAF-R agonistic activity and skin inflammation in comparison with control mice. The increased UVB irradiation-mediated skin inflammation and TNF-alpha production in Xpa(-/-) mice were blocked by systemic antioxidants and by PAF-R antagonists. Structural characterization of PAF-R-stimulating activity in UVB-irradiated XPA-deficient fibroblasts using mass spectrometry revealed increased levels of sn-2 short-chain Ox-GPCs along with native PAF. These studies support a critical role for PAF-R agonistic Ox-GPCs in the pathophysiology of XPA photosensitivity.	[Yao, Yongxue; Al-Hassani, Mohammed; Travers, Jeffrey B.] Indiana Univ, Sch Med, HB Wells Ctr Pediat Res, Indianapolis, IN 46202 USA; [Yao, Yongxue; Al-Hassani, Mohammed; Travers, Jeffrey B.] Indiana Univ, Sch Med, Dept Pediat, Indianapolis, IN 46202 USA; [Travers, Jeffrey B.] Indiana Univ, Sch Med, Richard L Roudebush Vet Affairs Med Ctr, Indianapolis, IN 46202 USA; [Yao, Yongxue; Al-Hassani, Mohammed; Konger, Raymond L.; Travers, Jeffrey B.] Indiana Univ, Sch Med, Dept Dermatol, Indianapolis, IN 46202 USA; [Travers, Jeffrey B.] Indiana Univ, Sch Med, Dept Pharmacol & Toxicol, Indianapolis, IN 46202 USA; [Rezania, Samin; Konger, Raymond L.] Indiana Univ, Sch Med, Dept Pathol, Indianapolis, IN 46202 USA; [Harrison, Kathleen A.; Murphy, Robert C.] Univ Colorado Denver, Dept Pharmacol, Aurora, CO 80045 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; US Department of Veterans Affairs; Veterans Health Administration (VHA); Richard L. Roudebush VA Medical Center; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Travers, JB (corresponding author), Indiana Univ, Sch Med, HB Wells Ctr Pediat Res, 702 Barnhill Dr, Indianapolis, IN 46202 USA.	jtravers@iupui.edu	Murphy, Robert/AAO-5349-2020; Konger, Raymond/E-4970-2012	Murphy, Robert/0000-0002-9430-6515; Travers, Jeffrey/0000-0001-7232-1039	National Institutes of Health [HL062996, HL034303]; Showalter Memorial Foundation; Riley Memorial Association; Veterans Affairs; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL034303, R01HL062996] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Showalter Memorial Foundation; Riley Memorial Association; Veterans Affairs(US Department of Veterans Affairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL062996 (to J. B. T. and R. L. K.) and HL034303 (to R. C. M.). This work was also supported by grants from the Showalter Memorial Foundation, the Riley Memorial Association, and Veterans Affairs (to J. B. T.).	Anstey AV, 2002, CLIN EXP DERMATOL, V27, P170, DOI 10.1046/j.1365-2230.2002.01040.x; Bashir MM, 2009, ARCH DERMATOL RES, V301, P87, DOI 10.1007/s00403-008-0893-7; Berg RJW, 1998, J INVEST DERMATOL, V110, P405, DOI 10.1111/j.1523-1747.1998.00173.x; BICKLEY LK, 1988, CELL BIOL INT REP, V12, P231, DOI 10.1016/0309-1651(88)90100-2; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Camenisch U, 2008, ADV EXP MED BIOL, V637, P28; CAMUSSI G, 1987, J EXP MED, V166, P1390, DOI 10.1084/jem.166.5.1390; Chen R, 2007, J BIOL CHEM, V282, P24842, DOI 10.1074/jbc.M702865200; Chen R, 2009, ARTERIOSCL THROM VAS, V29, P363, DOI 10.1161/ATVBAHA.108.178731; CLAY KL, 1990, METHOD ENZYMOL, V187, P134; DEFLORA S, 1995, J CELL BIOCHEM, P33; DEVRIES A, 1995, NATURE, V377, P169, DOI 10.1038/377169a0; Dy LC, 1999, J BIOL CHEM, V274, P26917, DOI 10.1074/jbc.274.38.26917; Eberlein-Konig B, 1998, J AM ACAD DERMATOL, V38, P45, DOI 10.1016/S0190-9622(98)70537-7; Gebicki JM, 2010, AMINO ACIDS, V39, P1131, DOI 10.1007/s00726-010-0610-7; Halliday GA, 2005, MUTAT RES-FUND MOL M, V571, P107, DOI 10.1016/j.mrfmmm.2004.09.013; Harrison KA, 2000, J MASS SPECTROM, V35, P224, DOI 10.1002/(SICI)1096-9888(200002)35:2<224::AID-JMS933>3.0.CO;2-G; Hoffschir F, 1998, FREE RADICAL BIO MED, V24, P809, DOI 10.1016/S0891-5849(97)00350-X; Horio T, 2001, J INVEST DERM SYMP P, V6, P58, DOI 10.1046/j.0022-202x.2001.00019.x; Ishii S, 2000, PROG LIPID RES, V39, P41, DOI 10.1016/S0163-7827(99)00016-8; Ishii S, 1998, J EXP MED, V187, P1779, DOI 10.1084/jem.187.11.1779; JUHLIN L, 1992, ACTA DERM-VENEREOL, V72, P197; KAYGANICHHARRISON KA, 1994, ANAL BIOCHEM, V221, P16, DOI 10.1006/abio.1994.1372; Kojo S, 2004, CURR MED CHEM, V11, P1041, DOI 10.2174/0929867043455567; Konger RL, 2008, PROSTAG OTH LIPID M, V87, P1, DOI 10.1016/j.prostaglandins.2008.04.002; Kuwamoto K, 2000, J INVEST DERMATOL, V114, P241, DOI 10.1046/j.1523-1747.2000.0883x.x; Lehmann P, 2009, AUTOIMMUN REV, V8, P456, DOI 10.1016/j.autrev.2008.12.012; Lehr HA, 1997, J CLIN INVEST, V99, P2358, DOI 10.1172/JCI119417; LEVY DD, 1995, CARCINOGENESIS, V16, P1557, DOI 10.1093/carcin/16.7.1557; Low GKM, 2008, INT J BIOCHEM CELL B, V40, P2583, DOI 10.1016/j.biocel.2008.05.009; Marathe GK, 2005, J BIOL CHEM, V280, P35448, DOI 10.1074/jbc.M503811200; Marathe GK, 1999, J BIOL CHEM, V274, P28395, DOI 10.1074/jbc.274.40.28395; MICHEL L, 1988, J IMMUNOL, V141, P948; Missura M, 2001, EMBO J, V20, P3554, DOI 10.1093/emboj/20.13.3554; Moggs JG, 1996, J BIOL CHEM, V271, P7177, DOI 10.1074/jbc.271.12.7177; Morganti P, 2009, CLIN DERMATOL, V27, P166, DOI 10.1016/j.clindermatol.2008.01.009; Moriwaki S, 2001, PHOTODERMATOL PHOTO, V17, P47, DOI 10.1034/j.1600-0781.2001.017002047.x; Murphy RC, 1996, ADV EXP MED BIOL, V416, P51; Naegeli H, 2011, DNA REPAIR, V10, P673, DOI 10.1016/j.dnarep.2011.04.019; Nakamura T, 2000, J DERMATOL SCI, V23, pS13, DOI 10.1016/S0923-1811(99)00072-9; PATEL KD, 1992, J BIOL CHEM, V267, P15168; Pei Y, 1998, J IMMUNOL, V161, P1954; Peus D, 1998, J INVEST DERMATOL, V110, P966, DOI 10.1046/j.1523-1747.1998.00210.x; Reardon JT, 2005, PROG NUCLEIC ACID RE, V79, P183, DOI 10.1016/S0079-6603(04)79004-2; Reed SH, 1996, MOL GEN GENET, V250, P515; Rybanska I, 2003, NEOPLASMA, V50, P389; Scheinfeld N, 2004, PHOTODERMATOL PHOTO, V20, P272, DOI 10.1111/j.1600-0781.2004.00094.x; Schwarz T, 2008, PHOTOCHEM PHOTOBIOL, V84, P10, DOI 10.1111/j.1751-1097.2007.00223.x; SCIBERRAS DG, 1987, BRIT J CLIN PHARMACO, V24, P753, DOI 10.1111/j.1365-2125.1987.tb03242.x; Shimizu T, 2009, ANNU REV PHARMACOL, V49, P123, DOI 10.1146/annurev.pharmtox.011008.145616; Sreevidya CS, 2008, CANCER RES, V68, P3978, DOI 10.1158/0008-5472.CAN-07-6132; Travers JB, 2010, PHOTOCHEM PHOTOBIOL, V86, P949, DOI 10.1111/j.1751-1097.2010.00743.x; Travers JB, 1996, J INVEST DERMATOL, V107, P88, DOI 10.1111/1523-1747.ep12298295; Travers JB, 2008, J INVEST DERMATOL, V128, P455, DOI 10.1038/sj.jid.5701083; Ullrich SE, 2005, MUTAT RES-FUND MOL M, V571, P185, DOI 10.1016/j.mrfmmm.2004.06.059; Vassallo MF, 2010, J ALLERGY CLIN IMMUN, V126, P217, DOI 10.1016/j.jaci.2010.06.011; VUILLAUME M, 1992, CARCINOGENESIS, V13, P321, DOI 10.1093/carcin/13.3.321; Wakasugi M, 1998, P NATL ACAD SCI USA, V95, P6669, DOI 10.1073/pnas.95.12.6669; Walterscheid JP, 2002, J EXP MED, V195, P171, DOI 10.1084/jem.20011450; Wan YS, 2000, INT J MOL MED, V6, P683; Wang HJ, 2005, FREE RADICAL BIO MED, V38, P890, DOI 10.1016/j.freeradbiomed.2004.12.005; Wolf P, 2006, AM J PATHOL, V169, P795, DOI 10.2353/ajpath.2006.060079; Wood RD, 1997, J BIOL CHEM, V272, P23465, DOI 10.1074/jbc.272.38.23465; Yang LL, 2010, J BIOL CHEM, V285, P22211, DOI 10.1074/jbc.M110.119982; Yao YX, 2009, J IMMUNOL, V182, P2842, DOI 10.4049/jimmunol.0802689; Zhang QW, 2008, J INVEST DERMATOL, V128, P1780, DOI 10.1038/sj.jid.5701251; Zhang QW, 2005, J CLIN INVEST, V115, P2855, DOI 10.1172/JCI25429	67	20	20	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					9311	9321		10.1074/jbc.M111.332395	http://dx.doi.org/10.1074/jbc.M111.332395			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22303003	Green Published, hybrid			2022-12-25	WOS:000301797800059
J	Paget, V; Lechevrel, M; Andre, R; Le Goff, J; Pottier, D; Billet, S; Garcon, G; Shirali, P; Sichel, F				Paget, Vincent; Lechevrel, Mathilde; Andre, Ronique; Le Goff, Jeremie; Pottier, Didier; Billet, Sylvain; Garcon, Guillaume; Shirali, Pirouz; Sichel, Francois			Benzo[a]pyrene, Aflatoxine B-1 and Acetaldehyde Mutational Patterns in TP53 Gene Using a Functional Assay: Relevance to Human Cancer Aetiology	PLOS ONE			English	Article							DEOXYADENOSINE N-6-AMINO GROUP; NMR SOLUTION STRUCTURE; TUMOR-SUPPRESSOR GENE; DG MISMATCH OPPOSITE; DIOL EPOXIDE; P53 MUTATIONS; NONANUCLEOTIDE DUPLEX; SEPARATED ALLELES; METHYLATED CPG; TRANS ADDITION	Mutations in the TP53 gene are the most common alterations in human tumours. TP53 mutational patterns have sometimes been linked to carcinogen exposure. In hepatocellular carcinoma, a specific G>T transversion on codon 249 is classically described as a fingerprint of aflatoxin B-1 exposure. Likewise G>T transversions in codons 157 and 158 have been related to tobacco exposure in human lung cancers. However, controversies remain about the interpretation of TP53 mutational pattern in tumours as the fingerprint of genotoxin exposure. By using a functional assay, the Functional Analysis of Separated Alleles in Yeast (FASAY), the present study depicts the mutational pattern of TP53 in normal human fibroblasts after in vitro exposure to well-known carcinogens: benzo[a]pyrene, aflatoxin B-1 and acetaldehyde. These in vitro patterns of mutations were then compared to those found in human tumours by using the IARC database of TP53 mutations. The results show that the TP53 mutational patterns found in human tumours can be only partly ascribed to genotoxin exposure. A complex interplay between the functional impact of the mutations on p53 phenotype and the cancer natural history may affect these patterns. However, our results strongly support that genotoxins exposure plays a major role in the aetiology of the considered cancers.	[Paget, Vincent; Lechevrel, Mathilde; Andre, Ronique; Le Goff, Jeremie; Pottier, Didier; Sichel, Francois] Univ Caen Basse Normandie, Grp Reg Etud Canc, EA 1772, Caen, France; [Paget, Vincent; Andre, Ronique; Le Goff, Jeremie; Pottier, Didier; Sichel, Francois] Ctr Reg Lutte Canc Francois Baclesse, Grp Reg Etud Canc, Caen, France; [Paget, Vincent; Billet, Sylvain; Garcon, Guillaume; Shirali, Pirouz] Univ Littoral Cote dOpale, EA 4492, Unite Chim Environm & Interact Vivant, Dunkerque, France; [Paget, Vincent; Billet, Sylvain; Garcon, Guillaume; Shirali, Pirouz] Univ Lille Nord France, Lille, France	Universite de Caen Normandie; UNICANCER; Centre Francois Baclesse; Universite du Littoral-Cote-d'Opale; Universite de Lille - ISITE; Universite de Lille	Paget, V (corresponding author), Univ Caen Basse Normandie, Grp Reg Etud Canc, EA 1772, Caen, France.	francois.sichel@unicaen.fr		Billet, Sylvain/0000-0003-1363-4515; GARCON, Guillaume/0000-0002-4530-7175	Agence Francaise de Securite Sanitaire de l'Environnement et du Travail (AFSSET) [EST-2007-48]; Ministere de l'Enseignement Superieur et de la Recherche [16848-2005]; Region Nord-Pas de Calais [08070005]; Ligue Nationale Contre le Cancer; Comite de l'Orne; Region Nord-Pas de Calais; Ministere de l'Enseignement Superieur et de la Recherche; European Funds (FEDER)	Agence Francaise de Securite Sanitaire de l'Environnement et du Travail (AFSSET); Ministere de l'Enseignement Superieur et de la Recherche(Estonian Research CouncilEuropean Commission); Region Nord-Pas de Calais(Region Hauts-de-FranceEuropean Commission); Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); Comite de l'Orne; Region Nord-Pas de Calais(Region Hauts-de-FranceEuropean Commission); Ministere de l'Enseignement Superieur et de la Recherche(Estonian Research CouncilEuropean Commission); European Funds (FEDER)(European Commission)	This work was supported by the Agence Francaise de Securite Sanitaire de l'Environnement et du Travail (AFSSET; Convention noEST-2007-48), the Ministere de l'Enseignement Superieur et de la Recherche (Convention no16848-2005), the Region Nord-Pas de Calais (Convention no08070005) and the Ligue Nationale Contre le Cancer, Comite de l'Orne. The Unite de Chimie Environnementale et Interactions sur le Vivant (UCEIV-EA 4492) works in partnership with the Institut de Recherches en ENvironnement Industriel (IRENI), which is financed by the Region Nord-Pas de Calais, the Ministere de l'Enseignement Superieur et de la Recherche, and European Funds (FEDER). V.P. received a post-PhD fellowship from the Region Nord-Pas de Calais. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki Y, 2007, CANCER RES, V67, P5643, DOI 10.1158/0008-5472.CAN-06-3355; Arlt VM, 2007, CARCINOGENESIS, V28, P2253, DOI 10.1093/carcin/bgm082; Baan R, 2007, LANCET ONCOL, V8, P292, DOI 10.1016/S1470-2045(07)70099-2; Balu N, 2004, CHEM RES TOXICOL, V17, P827, DOI 10.1021/tx034207s; Besaratinia A, 2010, FASEB J, V24, P2612, DOI 10.1096/fj.10-157263; Bitton A, 2005, LANCET, V365, P531; Chen JX, 1998, CANCER RES, V58, P2070; CHENG SC, 1989, CHEM RES TOXICOL, V2, P334, DOI 10.1021/tx00011a011; Culp SJ, 2000, CARCINOGENESIS, V21, P1433, DOI 10.1093/carcin/21.7.1433; Dearth LR, 2007, CARCINOGENESIS, V28, P289, DOI 10.1093/carcin/bgl132; Denissenko MF, 1996, SCIENCE, V274, P430, DOI 10.1126/science.274.5286.430; Divi RL, 2002, CARCINOGENESIS, V23, P2043, DOI 10.1093/carcin/23.12.2043; FLAMAN JM, 1995, P NATL ACAD SCI USA, V92, P3963, DOI 10.1073/pnas.92.9.3963; Hainaut P, 2000, ADV CANCER RES, V77, P81; Hakura A, 2000, MUTAT RES-FUND MOL M, V447, P239, DOI 10.1016/S0027-5107(99)00213-4; Hussain SP, 2007, ONCOGENE, V26, P2166, DOI 10.1038/sj.onc.1210279; ISHIOKA C, 1993, NAT GENET, V5, P124, DOI 10.1038/ng1093-124; Le Goff J, 2005, MUTAT RES-GEN TOX EN, V587, P90, DOI 10.1016/j.mrgentox.2005.05.013; Liu ZP, 2005, CANCER RES, V65, P2583, DOI 10.1158/0008-5472.CAN-04-3675; Luo JL, 2001, CANCER RES, V61, P8158; Olivier M, 2002, HUM MUTAT, V19, P607, DOI 10.1002/humu.10081; Paget V, 2008, MUTAT RES-GEN TOX EN, V656, P55, DOI 10.1016/j.mrgentox.2008.07.009; Paget V, 2008, MUTAT RES-GEN TOX EN, V652, P12, DOI 10.1016/j.mrgentox.2007.11.010; Penning TM, 1999, CHEM RES TOXICOL, V12, P1, DOI 10.1021/tx980143n; Petitjean A, 2007, HUM MUTAT, V28, P622, DOI 10.1002/humu.20495; Pfeifer GP, 2002, ONCOGENE, V21, P7435, DOI 10.1038/sj.onc.1205803; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; REDDY MV, 1986, CARCINOGENESIS, V7, P1543, DOI 10.1093/carcin/7.9.1543; Reinbold M, 2008, ONCOGENE, V27, P2788, DOI 10.1038/sj.onc.1210932; RUGGERI B, 1993, P NATL ACAD SCI USA, V90, P1013, DOI 10.1073/pnas.90.3.1013; SCHURTER EJ, 1995, BIOCHEMISTRY-US, V34, P1364, DOI 10.1021/bi00004a031; SCUDIERO DA, 1988, CANCER RES, V48, P4827; Shen YM, 2006, CHEM RES TOXICOL, V19, P1441, DOI 10.1021/tx0601206; SHOU M, 1993, CARCINOGENESIS, V14, P475, DOI 10.1093/carcin/14.3.475; Smela ME, 2001, CARCINOGENESIS, V22, P535, DOI 10.1093/carcin/22.4.535; Smith LE, 2000, JNCI-J NATL CANCER I, V92, P803, DOI 10.1093/jnci/92.10.803; Sohn S, 2000, MUTAT RES-DNA REPAIR, V460, P17, DOI 10.1016/S0921-8777(00)00010-0; Tang MS, 1999, CARCINOGENESIS, V20, P1085, DOI 10.1093/carcin/20.6.1085; WEI SJC, 1993, CANCER RES, V53, P3294; Xie ZW, 2003, BIOCHEMISTRY-US, V42, P11253, DOI 10.1021/bi0346704; YEH HJC, 1995, BIOCHEMISTRY-US, V34, P13570, DOI 10.1021/bi00041a037; Yoon JH, 2003, CARCINOGENESIS, V24, P113, DOI 10.1093/carcin/24.1.113; Yoon JH, 2001, CANCER RES, V61, P7110	43	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2012	7	2							e30921	10.1371/journal.pone.0030921	http://dx.doi.org/10.1371/journal.pone.0030921			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LO	22319594	Green Published, Green Submitted, gold			2022-12-25	WOS:000302178400019
J	Fielding, J; Kilpatrick, T; Millist, L; Clough, M; White, O				Fielding, Joanne; Kilpatrick, Trevor; Millist, Lynette; Clough, Meaghan; White, Owen			Longitudinal Assessment of Antisaccades in Patients with Multiple Sclerosis	PLOS ONE			English	Article							EYE-MOVEMENTS; EARLY-STAGE; COGNITION; MS; IMPAIRMENT; DISABILITY; DIAGNOSIS; ATROPHY	We have previously demonstrated that assessment of antisaccades (AS) provides not only measures of motor function in multiple sclerosis (MS), but measures of cognitive control processes in particular, attention and working memory. This study sought to demonstrate the potential for AS measures to sensitively reflect change in functional status in MS. Twenty-four patients with relapsing-remitting MS and 12 age-matched controls were evaluated longitudinally using an AS saccade task. Compared to control subjects, a number of saccade parameters changed significantly over a two year period for MS patients. These included saccade error rates, latencies, and accuracy measures. Further, for MS patients, correlations were retained between OM measures and scores on the PASAT, which is considered the reference task for the cognitive evaluation of MS patients. Notably, EDSS scores for these patients did not change significantly over this period. These results demonstrate that OM measures may reflect disease evolution in MS, in the absence of clinically evident changes as measured using conventional techniques. With replication, these markers could ultimately be developed into a cost-effective, non-invasive, and well tolerated assessment tool to assist in confirming progression early in the disease process, and in measuring and predicting response to therapy.	[Fielding, Joanne; Clough, Meaghan] Monash Univ, Sch Psychol & Psychiat, Clayton, Vic, Australia; [Fielding, Joanne; Kilpatrick, Trevor; Millist, Lynette; White, Owen] Royal Melbourne Hosp, Dept Neurol, Parkville, Vic 3050, Australia; [Kilpatrick, Trevor; White, Owen] Univ Melbourne, Ctr Neurosci, Parkville, Vic 3052, Australia	Monash University; Royal Melbourne Hospital; University of Melbourne	Fielding, J (corresponding author), Monash Univ, Sch Psychol & Psychiat, Clayton, Vic, Australia.	joanne.fielding@monash.edu		Fielding, Joanne/0000-0002-1131-0587; Kilpatrick, Trevor/0000-0003-3999-085X; White, Owen/0000-0002-2836-7344	National Health and Medical Research Council, Australia [454811]	National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported by the National Health and Medical Research Council, Australia (#454811). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achiron A, 2000, ARCH NEUROL-CHICAGO, V57, P974, DOI 10.1001/archneur.57.7.974; Audoin B, 2006, J NEUROL SCI, V245, P87, DOI 10.1016/j.jns.2005.08.026; Benedict RHB, 2004, ARCH NEUROL-CHICAGO, V61, P226, DOI 10.1001/archneur.61.2.226; Bobholz JA, 2006, NEUROLOGY, V67, P1640, DOI 10.1212/01.wnl.0000242885.71725.76; Derwenskus J, 2005, ANN NY ACAD SCI, V1039, P521, DOI 10.1196/annals.1325.058; Fielding J, 2009, CORTEX, V45, P900, DOI 10.1016/j.cortex.2009.02.016; Fielding J, 2009, NEUROPSYCHOLOGIA, V47, P1647, DOI 10.1016/j.neuropsychologia.2009.01.040; Fielding J, 2009, J NEUROL SCI, V277, P32, DOI 10.1016/j.jns.2008.10.001; Gronwall D. M. A., 1977, PACED AUDITORY SERIA; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Sahraian MA, 2010, CLIN NEUROL NEUROSUR, V112, P609, DOI 10.1016/j.clineuro.2010.03.022; Schulz D, 2006, J NEUROL, V253, P1002, DOI 10.1007/s00415-006-0145-8; Zivadinov R, 2001, J NEUROL NEUROSUR PS, V70, P773, DOI 10.1136/jnnp.70.6.773	13	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2012	7	2							e30475	10.1371/journal.pone.0030475	http://dx.doi.org/10.1371/journal.pone.0030475			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UV	22319570	Green Published, gold			2022-12-25	WOS:000301979000007
J	Looyenga, BD; Hutchings, D; Cherni, I; Kingsley, C; Weiss, GJ; MacKeigan, JP				Looyenga, Brendan D.; Hutchings, Danielle; Cherni, Irene; Kingsley, Chris; Weiss, Glen J.; MacKeigan, Jeffrey P.			STAT3 Is Activated by JAK2 Independent of Key Oncogenic Driver Mutations in Non-Small Cell Lung Carcinoma	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; CANCER; RESISTANCE; INHIBITOR; EGFR; TRANSFORMATION; AMPLIFICATION; INFLAMMATION; SENSITIVITY; INCB018424	Constitutive activation of STAT3 is a common feature in many solid tumors including non-small cell lung carcinoma (NSCLC). While activation of STAT3 is commonly achieved by somatic mutations to JAK2 in hematologic malignancies, similar mutations are not often found in solid tumors. Previous work has instead suggested that STAT3 activation in solid tumors is more commonly induced by hyperactive growth factor receptors or autocrine cytokine signaling. The interplay between STAT3 activation and other well-characterized oncogenic "driver'' mutations in NSCLC has not been fully characterized, though constitutive STAT3 activation has been proposed to play an important role in resistance to various small-molecule therapies that target these oncogenes. In this study we demonstrate that STAT3 is constitutively activated in human NSCLC samples and in a variety of NSCLC lines independent of activating KRAS or tyrosine kinase mutations. We further show that genetic or pharmacologic inhibition of the gp130/JAK2 signaling pathway disrupts activation of STAT3. Interestingly, treatment of NSCLC cells with the JAK1/2 inhibitor ruxolitinib has no effect on cell proliferation and viability in two-dimensional culture, but inhibits growth in soft agar and xenograft assays. These data demonstrate that JAK2/STAT3 signaling operates independent of known driver mutations in NSCLC and plays critical roles in tumor cell behavior that may not be effectively inhibited by drugs that selectively target these driver mutations.	[Looyenga, Brendan D.; Hutchings, Danielle; MacKeigan, Jeffrey P.] Van Andel Res Inst, Grand Rapids, MI USA; [Cherni, Irene; Weiss, Glen J.] Translat Genom Res Inst TGen, Canc & Cell Biol Div, Lung Canc Unit, Phoenix, AZ USA; [Kingsley, Chris] TGen, Diabet Cardiovasc & Metab Dis Div, Phoenix, AZ USA; [Weiss, Glen J.] Scottsdale Healthcare, Virginia G Piper Canc Ctr Clin Trials, Scottsdale, AZ USA	Van Andel Institute; Translational Genomics Research Institute; Translational Genomics Research Institute; Scottsdale Healthcare Osborn	Looyenga, BD (corresponding author), Van Andel Res Inst, Grand Rapids, MI USA.	brendan.looyenga@vai.org; jeff.mackeigan@vai.org		MacKeigan, Jeffrey/0000-0002-0198-5679; Looyenga, Brendan/0000-0002-0661-0956	VARI-TGen Integration Grant; TGen Foundation; Scottsdale-Healthcare Foundation	VARI-TGen Integration Grant; TGen Foundation; Scottsdale-Healthcare Foundation	The internal funding sources for this work include VARI-TGen Integration Grant, TGen Foundation, and Scottsdale-Healthcare Foundation. No external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez JV, 2006, CANCER RES, V66, P3162, DOI 10.1158/0008-5472.CAN-05-3757; Amann J, 2005, CANCER RES, V65, P226; Astsaturov I, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001083; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bromberg J, 2002, J CLIN INVEST, V109, P1139, DOI 10.1172/JCI200215617; Bromberg JF, 1998, MOL CELL BIOL, V18, P2553, DOI 10.1128/MCB.18.5.2553; Chen KF, 2010, CLIN CANCER RES, V16, P5189, DOI 10.1158/1078-0432.CCR-09-3389; Chiarle R, 2005, NAT MED, V11, P623, DOI 10.1038/nm1249; D'Angelo SP, 2011, J THORAC CARDIOV SUR, V141, P476, DOI 10.1016/j.jtcvs.2010.08.026; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Edge SB., 2010, AJCC CANC STAGING MA, V7th; Engelman JA, 2008, CLIN CANCER RES, V14, P2895, DOI 10.1158/1078-0432.CCR-07-2248; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Forbes S A, 2008, Curr Protoc Hum Genet, VChapter 10, DOI 10.1002/0471142905.hg1011s57; Gadina M, 2001, CURR OPIN IMMUNOL, V13, P363, DOI 10.1016/S0952-7915(00)00228-4; Gao SP, 2007, J CLIN INVEST, V117, P3846, DOI 10.1172/JCI31871; Gilbert LA, 2010, CELL, V143, P355, DOI 10.1016/j.cell.2010.09.043; Gough DJ, 2009, SCIENCE, V324, P1713, DOI 10.1126/science.1171721; Haura EB, 2005, CLIN CANCER RES, V11, P8288, DOI 10.1158/1078-0432.CCR-05-0827; He B, 2003, P NATL ACAD SCI USA, V100, P14133, DOI 10.1073/pnas.2232790100; Hedvat M, 2009, CANCER CELL, V16, P487, DOI 10.1016/j.ccr.2009.10.015; Jackman DM, 2009, CLIN CANCER RES, V15, P5267, DOI 10.1158/1078-0432.CCR-09-0888; Janne PA, 2009, NAT REV DRUG DISCOV, V8, P709, DOI 10.1038/nrd2871; Jarnicki A, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-14; Jenkins BJ, 2005, NAT MED, V11, P845, DOI 10.1038/nm1282; Jones AV, 2005, BLOOD, V106, P2162, DOI 10.1182/blood-2005-03-1320; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Leslie K, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2725; Looyenga BD, 2011, TRANSLATION IN PRESS; Lucia E, 2011, EXPERT OPIN INV DRUG, V20, P41, DOI 10.1517/13543784.2011.538382; MCCARTY KS, 1986, CANCER RES, V46, P4244; Meads MB, 2009, NAT REV CANCER, V9, P665, DOI 10.1038/nrc2714; Mukohara T, 2003, LUNG CANCER, V41, P123, DOI 10.1016/S0169-5002(03)00225-3; Pignon JP, 2008, J CLIN ONCOL, V26, P3552, DOI 10.1200/JCO.2007.13.9030; Quintas-Cardama A, 2010, BLOOD, V115, P3109, DOI 10.1182/blood-2009-04-214957; Ramos AH, 2009, CANCER BIOL THER, V8, P2042, DOI 10.4161/cbt.8.21.9764; Rosell R, 2006, CLIN CANCER RES, V12, P7222, DOI 10.1158/1078-0432.CCR-06-0627; Rumi E, 2010, CRIT REV EUKAR GENE, V20, P61, DOI 10.1615/CritRevEukarGeneExpr.v20.i1.50; Seruga B, 2010, NAT REV CLIN ONCOL; Veeriah S, 2009, P NATL ACAD SCI USA, V106, P9435, DOI 10.1073/pnas.0900571106; Verstovsek S, 2010, NEW ENGL J MED, V363, P1117, DOI 10.1056/NEJMoa1002028; Vultur A, 2005, MOL BIOL CELL, V16, P3832, DOI 10.1091/mbc.E04-12-1104; Waugh DJJ, 2008, CLIN CANCER RES, V14, P6735, DOI 10.1158/1078-0432.CCR-07-4843; Yao Z, 2010, P NATL ACAD SCI USA, V107, P15535, DOI 10.1073/pnas.1009472107; Yoon YK, 2010, MOL CARCINOGEN, V49, P353, DOI 10.1002/mc.20607; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734	47	88	90	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2012	7	2							e30820	10.1371/journal.pone.0030820	http://dx.doi.org/10.1371/journal.pone.0030820			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UV	22319590	Green Submitted, gold, Green Published			2022-12-25	WOS:000301979000016
J	Zhang, WC; Li, F; Qin, SZ; Luo, J				Zhang, Wencai; Li, Fan; Qin, Shaozheng; Luo, Jing			The Integrative Effects of Cognitive Reappraisal on Negative Affect: Associated Changes in Secretory Immunoglobulin A, Unpleasantness and ERP Activity	PLOS ONE			English	Article							EMOTION REGULATION; STRESS-MANAGEMENT; CARDIOVASCULAR REACTIONS; INDIVIDUAL-DIFFERENCES; ADRENERGIC-BLOCKADE; IMMUNE-SYSTEM; COPING STYLE; RESPONSES; PICTURES; MOOD	Although the regulatory role of cognitive reappraisal in negative emotional responses is widely recognized, this reappraisal's effect on acute saliva secretory immunoglobulin A (SIgA), as well as the relationships among affective, immunological, and event-related potential (ERP) changes, remains unclear. In this study, we selected only people with low positive coping scores (PCSs) as measured by the Trait Coping Style Questionnaire to avoid confounding by intrinsic coping styles. First, we found that the acute stress of viewing unpleasant pictures consistently decreased SIgA concentration and secretion rate, increased perceptions of unpleasantness and amplitude of late positive potentials (LPPs) between 200-300 ms and 400-1000 ms. After participants used cognitive reappraisal, their SIgA concentration and secretion rate significantly increased and their unpleasantness and LPP amplitudes significantly decreased compared with a control condition. Second, we found a significantly positive correlation between the increases in SIgA and the decreases in unpleasantness and a significantly negative correlation between the increases in SIgA and the increases in LPP across the two groups. This study is the first to demonstrate that cognitive reappraisal reverses the decrease of SIgA. In addition, it revealed strong correlations among affective, SIgA and electrophysiological changes with convergent multilevel evidence.	[Zhang, Wencai; Li, Fan; Luo, Jing] Chinese Acad Sci, Inst Psychol, Key Lab Mental Hlth, Beijing 100101, Peoples R China; [Qin, Shaozheng] Stanford Univ, Dept Psychiat & Behav Sci, Sch Med, Stanford, CA 94305 USA; [Luo, Jing] Capital Normal Univ, Dept Psychol, Beijing Key Lab Learning & Cognit, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Psychology, CAS; Stanford University; Capital Normal University	Zhang, WC (corresponding author), Chinese Acad Sci, Inst Psychol, Key Lab Mental Hlth, Beijing 100101, Peoples R China.	luoj@psych.ac.cn	Qin, Shaozheng/AAD-2107-2019	Qin, Shaozheng/0000-0002-1859-2150	National Natural Science Foundation of China [30970890, 30770708, 31100746]; Scientific Foundation of Institute of Psychology, Chinese Academy of Sciences [Y0CX451S01]; National Basic Research Program of China [2010CB833904]; Chinese Academy of Sciences [KSCX2-EW-J-8]; Key Laboratory of Mental Health, Institute of Psychology, Chinese Academy of Sciences	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Foundation of Institute of Psychology, Chinese Academy of Sciences(Chinese Academy of Sciences); National Basic Research Program of China(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences); Key Laboratory of Mental Health, Institute of Psychology, Chinese Academy of Sciences(Chinese Academy of Sciences)	This research was supported by the National Natural Science Foundation of China (Grants No. 30970890, 30770708 and 31100746), the Scientific Foundation of Institute of Psychology, Chinese Academy of Sciences (Grant No. Y0CX451S01), the National Basic Research Program of China (Grant No. 2010CB833904), the Knowledge Innovation Program of the Chinese Academy of Sciences (Grant No. KSCX2-EW-J-8) and Key Laboratory of Mental Health, Institute of Psychology, Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTONI MH, 1991, J CONSULT CLIN PSYCH, V59, P906, DOI 10.1037/0022-006X.59.6.906; [白露 BAI Lu], 2005, [中国心理卫生杂志, Chinese Mental Health Journal], V19, P719; Barling N. R., 2005, AUST J CLIN EXP HYPN, V33, P160; BLALOCK JE, 1994, IMMUNOL TODAY, V15, P504, DOI 10.1016/0167-5699(94)90205-4; Bosch JA, 2001, PSYCHOPHYSIOLOGY, V38, P836, DOI 10.1017/S0048577201000488; Bosch JA, 2002, INT REV NEUROBIOL, V52, P213; Cahill L, 2001, NEUROBIOL LEARN MEM, V75, P1, DOI 10.1006/nlme.2000.3999; Calkins SD, 2010, J PSYCHOPATHOL BEHAV, V32, P92, DOI 10.1007/s10862-009-9169-6; Canli T, 2002, P NATL ACAD SCI USA, V99, P10789, DOI 10.1073/pnas.162356599; Carroll D, 1996, INT J BEHAV MED, V3, P266, DOI 10.1207/s15327558ijbm0303_6; Cuthbert BN, 2000, BIOL PSYCHOL, V52, P95, DOI 10.1016/S0301-0511(99)00044-7; Denson TF, 2009, PSYCHOL BULL, V135, P823, DOI 10.1037/a0016909; Dien J, 2004, PSYCHOPHYSIOLOGY, V41, P665, DOI 10.1111/j.1469-8986.2004.00193.x; Dimitrov Dimiter M, 2003, Work, V20, P159; Drabant EM, 2009, BIOL PSYCHIAT, V65, P367, DOI 10.1016/j.biopsych.2008.09.007; Foti D, 2008, J COGNITIVE NEUROSCI, V20, P977, DOI 10.1162/jocn.2008.20066; Gross JJ, 2003, J PERS SOC PSYCHOL, V85, P348, DOI 10.1037/0022-3514.85.2.348; Gross JJ, 1998, J PERS SOC PSYCHOL, V74, P224, DOI 10.1037/0022-3514.74.1.224; Gross JJ, 2002, PSYCHOPHYSIOLOGY, V39, P281, DOI 10.1017/S0048577201393198; Hajcak G, 2006, COGN AFFECT BEHAV NE, V6, P291, DOI 10.3758/CABN.6.4.291; Hennig J, 1996, PERS INDIV DIFFER, V20, P589, DOI 10.1016/0191-8869(95)00218-9; HERBERT TB, 1993, PSYCHOSOM MED, V55, P364, DOI 10.1097/00006842-199307000-00004; Koh KB, 2008, BRAIN BEHAV IMMUN, V22, P1130, DOI 10.1016/j.bbi.2008.06.009; Koolhaas JM, 2008, BRAIN BEHAV IMMUN, V22, P662, DOI 10.1016/j.bbi.2007.11.006; Krompinger JW, 2008, EMOTION, V8, P132, DOI 10.1037/1528-3542.8.1.132; Kugler J, 1996, EUR J ORAL SCI, V104, P17, DOI 10.1111/j.1600-0722.1996.tb00040.x; Lang PJ, A5 U FLOR; Li F, 2008, CHINESE SCI BULL, V53, P1861, DOI 10.1007/s11434-008-0233-5; Lutgendorf SK, 1997, J CONSULT CLIN PSYCH, V65, P31, DOI 10.1037/0022-006X.65.1.31; Matsubara Y, 2010, ACUPUNCT MED, V28, P28, DOI 10.1136/aim.2009.001677; McRae K, 2010, J COGNITIVE NEUROSCI, V22, P248, DOI 10.1162/jocn.2009.21243; Miller GE, 2001, HEALTH PSYCHOL, V20, P47, DOI 10.1037/0278-6133.20.1.47; Moser JS, 2010, COGN AFFECT BEHAV NE, V10, P195, DOI 10.3758/CABN.10.2.195; Moser JS, 2009, PSYCHOPHYSIOLOGY, V46, P17, DOI 10.1111/j.1469-8986.2008.00721.x; Moser JS, 2006, PSYCHOPHYSIOLOGY, V43, P292, DOI 10.1111/j.1469-8986.2006.00402.x; Ochsner KN, 2008, CURR DIR PSYCHOL SCI, V17, P153, DOI 10.1111/j.1467-8721.2008.00566.x; Ochsner KN, 2002, J COGNITIVE NEUROSCI, V14, P1215, DOI 10.1162/089892902760807212; Ochsner KN, 2004, NEUROIMAGE, V23, P483, DOI 10.1016/j.neuroimage.2004.06.030; Ohira H, 2004, PERCEPT MOTOR SKILL, V98, P1241, DOI 10.2466/PMS.98.4.1241-1250; Olofsson JK, 2008, BIOL PSYCHOL, V77, P247, DOI 10.1016/j.biopsycho.2007.11.006; Pawlow LA, 2005, APPL PSYCHOPHYS BIOF, V30, P375, DOI 10.1007/s10484-005-8423-2; Reid MR, 2001, J PSYCHOSOM RES, V51, P721, DOI 10.1016/S0022-3999(01)00234-3; Ring C, 2000, PSYCHOPHYSIOLOGY, V37, P634, DOI 10.1017/S0048577200991030; Ring C, 1999, PSYCHOPHYSIOLOGY, V36, P602, DOI 10.1111/1469-8986.3650602; Schupp HT, 2004, PSYCHOPHYSIOLOGY, V41, P441, DOI 10.1111/j.1469-8986.2004.00174.x; Schupp HT, 2000, PSYCHOPHYSIOLOGY, V37, P257, DOI 10.1017/S0048577200001530; Segerstrom SC, 2004, PSYCHOL BULL, V130, P601, DOI 10.1037/0033-2909.130.4.601; Segerstrom SC, 1998, J PERS SOC PSYCHOL, V74, P1646, DOI 10.1037/0022-3514.74.6.1646; SEMLITSCH HV, 1986, PSYCHOPHYSIOLOGY, V23, P695, DOI 10.1111/j.1469-8986.1986.tb00696.x; Takagi S, 2004, PERCEPT MOTOR SKILL, V98, P1187, DOI 10.2466/PMS.98.4.1187-1198; Taniguchi T, 2007, ACTA MED OKAYAMA, V61, P139; Thompson R.A., 2007, HDB EMOTION REGULATI, P249, DOI DOI 10.1080/00140130600971135; Valdimarsdottir HB, 1997, CRIT REV ORAL BIOL M, V8, P461, DOI 10.1177/10454411970080040601; Willemsen G, 2002, PSYCHOPHYSIOLOGY, V39, P222, DOI 10.1017/S048577201392132; Willemsen G, 2000, BIOL PSYCHOL, V52, P127, DOI 10.1016/S0301-0511(99)00028-9; Winzer A, 1999, PSYCHOPHYSIOLOGY, V36, P591, DOI 10.1111/1469-8986.3650591; Zozulya AA, 2008, J IMMUNOTOXICOL, V5, P221, DOI 10.1080/15476910802131444	57	7	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2012	7	2							e30761	10.1371/journal.pone.0030761	http://dx.doi.org/10.1371/journal.pone.0030761			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	914UV	22319586	Green Published, Green Submitted, gold			2022-12-25	WOS:000301979000013
J	Norian, LA; Kresowik, TP; Rosevear, HM; James, BR; Rosean, TR; Lightfoot, AJ; Kucaba, TA; Schwarz, C; Weydert, CJ; Henry, MD; Griffith, TS				Norian, Lyse A.; Kresowik, Timothy P.; Rosevear, Henry M.; James, Britnie R.; Rosean, Timothy R.; Lightfoot, Andrew J.; Kucaba, Tamara A.; Schwarz, Christopher; Weydert, Christine J.; Henry, Michael D.; Griffith, Thomas S.			Eradication of Metastatic Renal Cell Carcinoma after Adenovirus-Encoded TNF-Related Apoptosis-Inducing Ligand (TRAIL)/CpG Immunotherapy	PLOS ONE			English	Article							CD8(+) T-CELLS; IN-VIVO; IMMUNE SUPPRESSION; KIDNEY CANCER; PRIMARY TUMOR; GENE-THERAPY; GROWTH; MICE; INTERLEUKIN-2; COMBINATION	Despite evidence that antitumor immunity can be protective against renal cell carcinoma (RCC), few patients respond objectively to immunotherapy and the disease is fatal once metastases develop. We asked to what extent combinatorial immunotherapy with Adenovirus-encoded murine TNF-related apoptosis-inducing ligand (Ad5mTRAIL) plus CpG oligonucleotide, given at the primary tumor site, would prove efficacious against metastatic murine RCC. To quantitate primary renal and metastatic tumor growth in mice, we developed a luciferase-expressing Renca cell line, and monitored tumor burdens via bioluminescent imaging. Orthotopic tumor challenge gave rise to aggressive primary tumors and lung metastases that were detectable by day 7. Intra-renal administration of Ad5mTRAIL+CpG on day 7 led to an influx of effector phenotype CD4 and CD8 T cells into the kidney by day 12 and regression of established primary renal tumors. Intra-renal immunotherapy also led to systemic immune responses characterized by splenomegaly, elevated serum IgG levels, increased CD4 and CD8 T cell infiltration into the lungs, and elimination of metastatic lung tumors. Tumor regression was primarily dependent upon CD8 T cells and resulted in prolonged survival of treated mice. Thus, local administration of Ad5mTRAIL+CpG at the primary tumor site can initiate CD8-dependent systemic immunity that is sufficient to cause regression of metastatic lung tumors. A similar approach may prove beneficial for patients with metastatic RCC.	[Norian, Lyse A.; Kresowik, Timothy P.; Rosevear, Henry M.; Lightfoot, Andrew J.; Schwarz, Christopher] Univ Iowa, Carver Coll Med, Dept Urol, Iowa City, IA 52242 USA; [James, Britnie R.; Griffith, Thomas S.] Univ Minnesota, Microbiol Immunol & Canc Biol Program, Minneapolis, MN USA; [Rosean, Timothy R.] Univ Iowa, Carver Coll Med, Interdisciplinary Grad Program Immunol, Iowa City, IA USA; [Kucaba, Tamara A.; Griffith, Thomas S.] Univ Minnesota, Dept Urol, Minneapolis, MN USA; [Weydert, Christine J.; Henry, Michael D.] Univ Iowa, Carver Coll Med, Dept Physiol, Iowa City, IA USA	University of Iowa; University of Minnesota System; University of Minnesota Twin Cities; University of Iowa; University of Minnesota System; University of Minnesota Twin Cities; University of Iowa	Norian, LA (corresponding author), Univ Iowa, Carver Coll Med, Dept Urol, Iowa City, IA 52242 USA.	tgriffit@umn.edu	Griffith, Thomas/ABF-8225-2020	Henry, Michael/0000-0002-7871-245X; Norian, Lyse/0000-0003-1016-313X	National Institutes of Health (NIH) [CA109446]; NATIONAL CANCER INSTITUTE [R01CA109446] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a National Institutes of Health (NIH) grant # CA109446, grants.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulghani J, 2010, EXPERT OPIN THER TAR, V14, P1091, DOI 10.1517/14728222.2010.519701; Ather MH, 2010, UROL J, V7, P1; Atzpodien J, 2004, J CLIN ONCOL, V22, P1188, DOI 10.1200/JCO.2004.06.155; Cao QH, 2008, DNA CELL BIOL, V27, P91, DOI 10.1089/dna.2007.0633; Clausen BE, 2010, IMMUNOL CELL BIOL, V88, P351, DOI 10.1038/icb.2010.40; Rocha FGD, 2010, CANCER IMMUNOL IMMUN, V59, P1357, DOI 10.1007/s00262-010-0865-6; Drake JM, 2005, CLIN EXP METASTAS, V22, P674, DOI 10.1007/s10585-006-9011-4; Elliott MR, 2010, J CELL BIOL, V189, P1059, DOI 10.1083/jcb.201004096; Elzey BD, 2003, IMMUNITY, V19, P9, DOI 10.1016/S1074-7613(03)00177-8; Flanigan Robert C, 2003, Curr Treat Options Oncol, V4, P385, DOI 10.1007/s11864-003-0039-2; Frankenberger B, 2007, SEMIN CANCER BIOL, V17, P330, DOI 10.1016/j.semcancer.2007.06.004; FYFE G, 1995, J CLIN ONCOL, V13, P688, DOI 10.1200/JCO.1995.13.3.688; Godley PA, 2001, CURR OPIN ONCOL, V13, P199, DOI 10.1097/00001622-200105000-00012; Griffith TS, 2009, CURR GENE THER, V9, P9, DOI 10.2174/156652309787354612; Gruys ME, 2001, CANCER RES, V61, P6255; Hofmann MA, 2008, J IMMUNOTHER, V31, P520, DOI 10.1097/CJI.0b013e318174a4df; Holoch PA, 2009, EUR J PHARMACOL, V625, P63, DOI 10.1016/j.ejphar.2009.06.066; Kemp TJ, 2003, APOPTOSIS, V8, P587, DOI 10.1023/A:1026286108366; Ko JS, 2010, CANCER RES, V70, P3526, DOI 10.1158/0008-5472.CAN-09-3278; Kobayashi H, 2010, ANTICANCER RES, V30, P575; KRIEG AM, 1995, NATURE, V374, P546, DOI 10.1038/374546a0; Krieg AM, 2007, J CLIN INVEST, V117, P1184, DOI 10.1172/JCI31414; Kusmartsev S, 2008, J IMMUNOL, V181, P346, DOI 10.4049/jimmunol.181.1.346; Lv S, 2005, IMMUNOL LETT, V99, P217, DOI 10.1016/j.imlet.2005.03.019; Matin SF, 2010, J UROLOGY, V183, P333, DOI 10.1016/j.juro.2009.08.110; McDermott DF, 2009, CANCER-AM CANCER SOC, V115, P2298, DOI 10.1002/cncr.24236; Norian LA, 2009, CANCER RES, V69, P3086, DOI 10.1158/0008-5472.CAN-08-2826; Ochoa AC, 2007, CLIN CANCER RES, V13, p721S, DOI 10.1158/1078-0432.CCR-06-2197; Patil S, 2010, CANCER-AM CANCER SOC, V116, P347, DOI 10.1002/cncr.24713; Pitt RM, 1996, J BIOL CHEM, V271, P12687, DOI 10.1074/jbc.271.22.12687; Quezada SA, 2010, J EXP MED, V207, P637, DOI 10.1084/jem.20091918; Rini BI, 2010, CLIN CANCER RES, V16, P1348, DOI 10.1158/1078-0432.CCR-09-2273; SALUP RR, 1986, CANCER RES, V46, P3358; SAYERS TJ, 1990, CANCER RES, V50, P5414; Seki N, 2003, CANCER RES, V63, P207; Seki N, 2002, J IMMUNOL, V168, P3484, DOI 10.4049/jimmunol.168.7.3484; Shablak A, 2009, CLIN CANCER RES, V15, P6503, DOI 10.1158/1078-0432.CCR-09-1605; Shanker A, 2008, JNCI-J NATL CANCER I, V100, P649, DOI 10.1093/jnci/djn113; Shanker A, 2009, CANCER RES, V69, P6615, DOI 10.1158/0008-5472.CAN-09-0685; Shvarts O, 2006, UROLOGY, V68, P1132, DOI 10.1016/j.urology.2006.08.1073; SPARANO JA, 1993, J CLIN ONCOL, V11, P1969, DOI 10.1200/JCO.1993.11.10.1969; Svensson RU, 2007, CANCER RES, V67, P10445, DOI 10.1158/0008-5472.CAN-07-1955; Teng MWL, 2010, CANCER RES, V70, P2665, DOI 10.1158/0008-5472.CAN-09-1574; VanOosten RL, 2007, CANCER RES, V67, P11980, DOI 10.1158/0008-5472.CAN-07-1526; Wang LX, 2010, CLIN CANCER RES, V16, P164, DOI 10.1158/1078-0432.CCR-09-1758; Webster WS, 2006, CANCER-AM CANCER SOC, V107, P46, DOI 10.1002/cncr.21951; Westwood JA, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-42; Wiley SR, 1995, IMMUNITY, V3, P673, DOI 10.1016/1074-7613(95)90057-8; Wysocki PJ, 2010, CANCER GENE THER, V17, P465, DOI 10.1038/cgt.2010.2; Xin H, 2009, CANCER RES, V69, P2506, DOI 10.1158/0008-5472.CAN-08-4323; Yockman JW, 2007, GENE THER, V14, P1399, DOI 10.1038/sj.gt.3302999; Yu P, 2007, J IMMUNOL, V179, P1960, DOI 10.4049/jimmunol.179.3.1960; Zea AH, 2005, CANCER RES, V65, P3044, DOI 10.1158/0008-5472.CAN-04-4505	53	43	44	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2012	7	2							e31085	10.1371/journal.pone.0031085	http://dx.doi.org/10.1371/journal.pone.0031085			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UG	22312440	Green Published, Green Submitted, gold			2022-12-25	WOS:000301977500028
J	Priya, NG; Ojha, A; Kajla, MK; Raj, A; Rajagopal, R				Priya, Natarajan Gayatri; Ojha, Abhishek; Kajla, Mayur K.; Raj, Anand; Rajagopal, Raman			Host Plant Induced Variation in Gut Bacteria of Helicoverpa armigera	PLOS ONE			English	Article							CULTURE-INDEPENDENT METHODS; DROSOPHILA-MELANOGASTER; MICROBIAL COMMUNITIES; COTTON BOLLWORM; BT-COTTON; DIVERSITY; RESISTANCE; MIDGUT; LEAVES; HUBNER	Helicoverpa are important polyphagous agricultural insect pests and they have a worldwide distribution. In this study, we report the bacterial community structure in the midgut of fifth instar larvae of Helicoverpa armigera, a species prevalent in the India, China, South Asia, South East Asia, Southern & Eastern Africa and Australia. Using culturable techniques, we isolated and identified members of Bacillus firmus, Bacillus niabense, Paenibacillus jamilae, Cellulomonas variformis, Acinetobacter schindleri, Micrococcus yunnanesis, Enterobacter sp., and Enterococcus cassiliflavus in insect samples collected from host plants grown in different parts of India. Besides these the presence of Sphingomonas, Ralstonia, Delftia, Paracoccus and Bacteriodetes was determined by culture independent molecular analysis. We found that Enterobacter and Enterococcus were universally present in all our Helicoverpa samples collected from different crops and in different parts of India. The bacterial diversity varied greatly among insects that were from different host plants than those from the same host plant of different locations. This result suggested that the type of host plant greatly influences the midgut bacterial diversity of H. armigera, more than the location of the host plant. On further analyzing the leaf from which the larva was collected, it was found that the H. armigera midgut bacterial community was similar to that of the leaf phyllosphere. This finding indicates that the bacterial flora of the larval midgut is influenced by the leaf surface bacterial community of the crop on which it feeds. Additionally, we found that laboratory made media or the artificial diet is a poor bacterial source for these insects compared to a natural diet of crop plant.	[Priya, Natarajan Gayatri; Rajagopal, Raman] Univ Delhi, Dept Zool, Delhi 110007, India; [Ojha, Abhishek] Int Ctr Genet Engn & Biotechnol, New Delhi, India; [Raj, Anand] Natl Dope Testing Lab, New Delhi, India; [Kajla, Mayur K.] Univ Wisconsin, Dept Entomol, Madison, WI 53706 USA	University of Delhi; Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; University of Wisconsin System; University of Wisconsin Madison	Priya, NG (corresponding author), Univ Delhi, Dept Zool, Delhi 110007, India.	zoorajagopal@gmail.com			Department of Biotechnology, Govt. of India	Department of Biotechnology, Govt. of India(Department of Biotechnology (DBT) India)	The authors thank the Department of Biotechnology, Govt. of India for funding this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Broderick NA, 2004, APPL ENVIRON MICROB, V70, P293, DOI 10.1128/AEM.70.1.293-300.2004; Cash HL, 2005, ASM NEWS, V71, P77; Cox CR, 2007, INFECT IMMUN, V75, P1565, DOI 10.1128/IAI.01496-06; Dillon RJ, 2004, ANNU REV ENTOMOL, V49, P71, DOI 10.1146/annurev.ento.49.061802.123416; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Egert M, 2005, APPL ENVIRON MICROB, V71, P4556, DOI 10.1128/AEM.71.8.4556-4566.2005; Ellis RJ, 1999, FEMS MICROBIOL ECOL, V28, P345, DOI 10.1111/j.1574-6941.1999.tb00589.x; FITT GP, 1989, ANNU REV ENTOMOL, V34, P17, DOI 10.1146/annurev.en.34.010189.000313; Gavriel S, 2011, J APPL ENTOMOL, V135, P564, DOI 10.1111/j.1439-0418.2010.01605.x; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Gunning RV, 1996, PESTIC BIOCHEM PHYS, V54, P12, DOI 10.1006/pest.1996.0004; Hao OJ, 2002, CHEMOSPHERE, V46, P797, DOI 10.1016/S0045-6535(01)00182-5; Hui XA, 2006, CAN J MICROBIOL, V52, P1085, DOI 10.1139/W06-064; Jackson CR, 2011, MICROB ECOL, V61, P113, DOI 10.1007/s00248-010-9742-2; Kapur M, 2010, CURR MICROBIOL, V61, P118, DOI 10.1007/s00284-010-9585-6; Kinkel LL, 2000, MICROBIAL ECOL, V39, P1, DOI 10.1007/s002489900182; Kranthi KR, 2004, CURR SCI INDIA, V87, P1096; Kruse JJ, 1999, ECOL ENTOMOL, V24, P37, DOI 10.1046/j.1365-2311.1999.00176.x; Lambais MR, 2006, SCIENCE, V312, P1917, DOI 10.1126/science.1124696; Lei P, 2004, J XIAN JIAOTONG U, V38, P657; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Liebhold AM, 1995, USDA GEN TECHNICA NE; Patankar AG, 2001, INSECT BIOCHEM MOLEC, V31, P453, DOI 10.1016/S0965-1748(00)00150-8; Rajendran L, 2007, J PLANT INTERACT, V2, P1, DOI 10.1080/17429140701420003; Rani A, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-96; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Scoble MJ, 1992, LEPIDOPTERA FORM FUN; Sharon G, 2010, P NATL ACAD SCI USA, V107, P20051, DOI 10.1073/pnas.1009906107; Suda W, 2008, MICROBES ENVIRON, V23, P248, DOI 10.1264/jsme2.23.248; WILSON GR, 1993, J INVERTEBR PATHOL, V62, P87, DOI 10.1006/jipa.1993.1079	33	114	126	5	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2012	7	1							e30768	10.1371/journal.pone.0030768	http://dx.doi.org/10.1371/journal.pone.0030768			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911FX	22292034	Green Published, gold, Green Submitted			2022-12-25	WOS:000301703800030
J	Melega, WP; Lacan, G; Gorgulho, AA; Behnke, EJ; De Salles, AAF				Melega, William P.; Lacan, Goran; Gorgulho, Alessandra A.; Behnke, Eric J.; De Salles, Antonio A. F.			Hypothalamic Deep Brain Stimulation Reduces Weight Gain in an Obesity-Animal Model	PLOS ONE			English	Article							HIGH-FREQUENCY STIMULATION; FEMALE GOTTINGEN MINIPIGS; VENTROMEDIAL HYPOTHALAMUS; BARIATRIC SURGERY; GASTRIC BYPASS; FOOD-INTAKE; MORBID-OBESITY; BEHAVIOR; GROWTH; MODULATION	Prior studies of appetite regulatory networks, primarily in rodents, have established that targeted electrical stimulation of ventromedial hypothalamus (VMH) can alter food intake patterns and metabolic homeostasis. Consideration of this method for weight modulation in humans with severe overeating disorders and morbid obesity can be further advanced by modeling procedures and assessing endpoints that can provide preclinical data on efficacy and safety. In this study we adapted human deep brain stimulation (DBS) stereotactic methods and instrumentation to demonstrate in a large animal model the modulation of weight gain with VMH-DBS. Female Gottingen minipigs were used because of their dietary habits, physiologic characteristics, and brain structures that resemble those of primates. Further, these animals become obese on extra-feeding regimens. DBS electrodes were first bilaterally implanted into the VMH of the animals (n = 8) which were then maintained on a restricted food regimen for 1 mo following the surgery. The daily amount of food was then doubled for the next 2 mo in all animals to produce obesity associated with extra calorie intake, with half of the animals (n = 4) concurrently receiving continuous low frequency (50 Hz) VMH-DBS. Adverse motoric or behavioral effects were not observed subsequent to the surgical procedure or during the DBS period. Throughout this 2 mo DBS period, all animals consumed the doubled amount of daily food. However, the animals that had received VMH-DBS showed a cumulative weight gain (6.1 +/- 0.4 kg; mean +/- SEM) that was lower than the nonstimulated VMH-DBS animals (9.4 +/- 1.3 kg; p<0.05), suggestive of a DBS-associated increase in metabolic rate. These results in a porcine obesity model demonstrate the efficacy and behavioral safety of a low frequency VMH-DBS application as a potential clinical strategy for modulation of body weight.	[Melega, William P.; Lacan, Goran] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Gorgulho, Alessandra A.; Behnke, Eric J.; De Salles, Antonio A. F.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Melega, WP (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA.	wmelega@mednet.ucla.edu			WPM (Neurosigma Inc.) [bio08-129970]; National Institutes of Health [1R21RR025398-01A1]; NATIONAL CENTER FOR RESEARCH RESOURCES [R21RR025398] Funding Source: NIH RePORTER	WPM (Neurosigma Inc.); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by grants to WPM from the UC Discovery Grant Program (bio08-129970 with Neurosigma Inc.) and the National Institutes of Health (1R21RR025398-01A1). The implantable pulse generators and channel extensions were kindly donated by ANS/St. Jude Medical Company, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison DB, 1999, AM J PSYCHIAT, V156, P1686; Andersen F, 2005, BRAIN RES BULL, V66, P17, DOI 10.1016/j.brainresbull.2005.02.033; ARAVICH PF, 1982, PHYSIOL BEHAV, V29, P195, DOI 10.1016/0031-9384(82)90003-8; ATRENS DM, 1987, BRAIN RES BULL, V18, P303, DOI 10.1016/0361-9230(87)90007-4; Berg EP, 2003, J ANIM SCI, V81, P167; BIELAJEW C, 1994, BEHAV BRAIN RES, V62, P143, DOI 10.1016/0166-4328(94)90021-3; Bjarkam CR, 2008, J NEUROSCI METH, V168, P151, DOI 10.1016/j.jneumeth.2007.09.008; Bjarkam CR, 2009, J NEUROSCI METH, V183, P119, DOI 10.1016/j.jneumeth.2009.06.019; Bjarkam CR, 2004, J NEUROSCI METH, V139, P293, DOI 10.1016/j.jneumeth.2004.05.004; Bollen P, 2000, COMPARATIVE MED, V50, P585; Bollen PJA, 2006, SCAND J LAB ANIM SCI, V33, P149; Bollen P, 2006, EXP TOXICOL PATHOL, V57, P347, DOI 10.1016/j.etp.2006.03.005; Bollen PJA, 2005, LAB ANIM-UK, V39, P80, DOI 10.1258/0023677052886565; Brolin RE, 2002, JAMA-J AM MED ASSOC, V288, P2793, DOI 10.1001/jama.288.22.2793; Butson CR, 2006, J NEURAL ENG, V3, P1, DOI 10.1088/1741-2560/3/1/001; Butson CR, 2006, CLIN NEUROPHYSIOL, V117, P447, DOI 10.1016/j.clinph.2005.10.007; Christou NV, 2006, ANN SURG, V244, P734, DOI 10.1097/01.sla.0000217592.04061.d5; Covalin A, 2005, P 2 INT IEEE EMBS C; Crampton NA, 1997, OBES SURG, V7, P489, DOI 10.1381/096089297765555232; DeSalles AAF, 1996, AM J NEURORADIOL, V17, P1451; Dyrby TB, 2007, NEUROIMAGE, V37, P1267, DOI 10.1016/j.neuroimage.2007.06.022; Ettrup KS, 2010, J CHEM NEUROANAT, V39, P151, DOI 10.1016/j.jchemneu.2009.12.004; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Franzini A, 2007, ACTA NEUROCHIR SUPPL, V97, P399; Franzini A, 2003, NEUROSURGERY, V52, P1095, DOI 10.1227/01.NEU.0000057698.29634.D6; Gorgulho AA, 2009, J NEUROSURG, V110, P1317, DOI 10.3171/JNS.2008.10.JNS08835; Halpern CH, 2008, J NEUROSURG, V109, P625, DOI 10.3171/JNS/2008/109/10/0625; Hamani C, 2008, ANN NEUROL, V63, P119, DOI 10.1002/ana.21295; Handforth A, 2006, EPILEPSIA, V47, P1239, DOI 10.1111/j.1528-1167.2006.00563.x; Hauptman JS, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC/2008/25/7/E3; Hernando V, 2008, STEREOT FUNCT NEUROS, V86, P219, DOI 10.1159/000131659; Higa KD, 2000, OBES SURG, V10, P509, DOI 10.1381/096089200321593706; Jensen KN, 2009, ACTA NEUROCHIR, V151, P785, DOI 10.1007/s00701-009-0334-1; Johansen T, 2001, COMPARATIVE MED, V51, P150; King BA, 2006, PHYSIOL BEHAV, V87, P221, DOI 10.1016/j.physbeh.2005.10.007; Kuhn Jens, 2008, Neurosurgery, V62, pE1182, DOI 10.1227/01.neu.0000325889.84785.69; Kuncel AM, 2004, CLIN NEUROPHYSIOL, V115, P2431, DOI 10.1016/j.clinph.2004.05.031; Lacan G, 2008, J NEUROSURG, V108, P336, DOI 10.3171/JNS/2008/108/2/0336; Larsen MO, 2004, ILAR J, V45, P303, DOI 10.1093/ilar.45.3.303; Lind NM, 2007, NEUROSCI BIOBEHAV R, V31, P728, DOI 10.1016/j.neubiorev.2007.02.003; Lonergan RP, 1998, J APPL PHYSIOL, V84, P531, DOI 10.1152/jappl.1998.84.2.531; MINOKOSHI Y, 1986, AM J PHYSIOL, V251, P1005, DOI 10.1152/ajpregu.1986.251.5.R1005; MORGANE PJ, 1961, SCIENCE, V133, P887, DOI 10.1126/science.133.3456.887; Nunoya T., 2007, J TOXICOL PATHOL, V20, P125, DOI [DOI 10.1293/T0X.20.125, 10.1293/TOX.20.125]; Pisapia JM, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.5.FOCUS10109; Raun K, 2007, OBESITY, V15, P1710, DOI 10.1038/oby.2007.204; Rocha D, 2006, DRUG DISCOV TODAY, V11, P475, DOI 10.1016/j.drudis.2006.04.009; Rosendal F, 2009, BRAIN RES BULL, V80, P403, DOI 10.1016/j.brainresbull.2009.08.012; Rosendal F, 2009, BRAIN RES BULL, V79, P41, DOI 10.1016/j.brainresbull.2009.01.002; Ruffin MP, 1999, BRAIN RES, V846, P23, DOI 10.1016/S0006-8993(99)01922-8; Salfen BE, 2004, J ANIM SCI, V82, P1957; Schernthaner G, 2008, DIABETES CARE, V31, pS297, DOI 10.2337/dc08-s270; SOLBERG TD, 1994, ACTA NEUROCHIR SUPPL, V62, P28; STENGER J, 1991, PHYSIOL BEHAV, V50, P1209, DOI 10.1016/0031-9384(91)90584-B; TAKAHASHI A, 1981, J AUTONOM NERV SYST, V4, P195, DOI 10.1016/0165-1838(81)90044-8; THORNHILL J, 1993, BRAIN RES, V615, P289, DOI 10.1016/0006-8993(93)90040-T; Torres N, 2011, ADV TECH STAND NEURO, V36, P17, DOI 10.1007/978-3-7091-0179-7_2; Vitek JL, 2002, MOVEMENT DISORD, V17, pS69, DOI 10.1002/mds.10144; Watanabe H, 2001, NEUROIMAGE, V14, P1089, DOI 10.1006/nimg.2001.0910; Wilent WB, 2010, J NEUROSURG, V112, P1295, DOI 10.3171/2009.9.JNS09577	60	33	34	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e30672	10.1371/journal.pone.0030672	http://dx.doi.org/10.1371/journal.pone.0030672			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910ME	22295102	gold, Green Published, Green Submitted			2022-12-25	WOS:000301640600047
J	Shao, L; Fan, XH; Cheng, NT; Wu, LH; Xiong, HS; Fang, H; Ding, D; Shi, LM; Cheng, YY; Tong, WD				Shao, Li; Fan, Xiaohui; Cheng, Ningtao; Wu, Leihong; Xiong, Haoshu; Fang, Hong; Ding, Don; Shi, Leming; Cheng, Yiyu; Tong, Weida			Shifting from Population-wide to Personalized Cancer Prognosis with Microarrays	PLOS ONE			English	Article							GENE-EXPRESSION PROFILES; BREAST-CANCER; CLASSIFICATION; PREDICTION; CYCLOPHOSPHAMIDE; FLUOROURACIL; CHEMOTHERAPY; DOXORUBICIN; CARCINOMAS; PACLITAXEL	The era of personalized medicine for cancer therapeutics has taken an important step forward in making accurate prognoses for individual patients with the adoption of high-throughput microarray technology. However, microarray technology in cancer diagnosis or prognosis has been primarily used for the statistical evaluation of patient populations, and thus excludes inter-individual variability and patient-specific predictions. Here we propose a metric called clinical confidence that serves as a measure of prognostic reliability to facilitate the shift from population-wide to personalized cancer prognosis using microarray-based predictive models. The performance of sample-based models predicted with different clinical confidences was evaluated and compared systematically using three large clinical datasets studying the following cancers: breast cancer, multiple myeloma, and neuroblastoma. Survival curves for patients, with different confidences, were also delineated. The results show that the clinical confidence metric separates patients with different prediction accuracies and survival times. Samples with high clinical confidence were likely to have accurate prognoses from predictive models. Moreover, patients with high clinical confidence would be expected to live for a notably longer or shorter time if their prognosis was good or grim based on the models, respectively. We conclude that clinical confidence could serve as a beneficial metric for personalized cancer prognosis prediction utilizing microarrays. Ascribing a confidence level to prognosis with the clinical confidence metric provides the clinician an objective, personalized basis for decisions, such as choosing the severity of the treatment.	[Shao, Li; Fan, Xiaohui; Wu, Leihong; Xiong, Haoshu; Cheng, Yiyu] Zhejiang Univ, Coll Pharmaceut Sci, Pharmaceut Informat Inst, Hangzhou 310003, Zhejiang, Peoples R China; [Cheng, Ningtao] Emory Univ, Atlanta, GA 30322 USA; [Cheng, Ningtao] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Fang, Hong; Ding, Don] ICF Int NCTR FDA, Jefferson, AR USA; [Shi, Leming; Tong, Weida] US FDA, Natl Ctr Toxicol Res, Jefferson, AR 72079 USA	Zhejiang University; Emory University; University System of Georgia; Georgia Institute of Technology; US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)	Shao, L (corresponding author), Zhejiang Univ, Coll Pharmaceut Sci, Pharmaceut Informat Inst, Hangzhou 310003, Zhejiang, Peoples R China.	chengyy@zju.edu.cn; weida.tong@fda.hhs.gov	Shi, Leming/B-3150-2010; Wu, Leihong/AAM-9483-2020; FAN, Xiaohui/F-6458-2010	Shi, Leming/0000-0002-7143-2033; Wu, Leihong/0000-0002-4093-3708; FAN, Xiaohui/0000-0002-6336-3007	National Science Foundation of China [30801556, 30830121]; National ST Major Project [2008ZX09312-001]; Science Foundation of Chinese University [2009QNA7031]; Zhejiang Provincial Natural Science Foundation of China [R2080693]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National ST Major Project; Science Foundation of Chinese University(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	This work was supported by the National Science Foundation of China (No. 30801556 and 30830121), National S&T Major Project (No. 2008ZX09312-001), Science Foundation of Chinese University (No. 2009QNA7031), and the Zhejiang Provincial Natural Science Foundation of China (No. R2080693). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams E., 2009, GENET ENG BIOTECHNOL, V29; Ayers M, 2004, J CLIN ONCOL, V22, P2284, DOI 10.1200/JCO.2004.05.166; Baldi P, 2000, BIOINFORMATICS, V16, P412, DOI 10.1093/bioinformatics/16.5.412; Balleine RL, 2008, CLIN CANCER RES, V14, P8244, DOI 10.1158/1078-0432.CCR-08-0939; Bertucci F, 2006, OMICS, V10, P429, DOI 10.1089/omi.2006.10.429; Cantor MN, 2009, PERS MED, V6, P589, DOI [10.2217/pme.09.35, 10.2217/PME.09.35]; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Ely S, 2009, TRANSL RES, V154, P303, DOI 10.1016/j.trsl.2009.08.001; Fan XH, 2010, CLIN CANCER RES, V16, P629, DOI 10.1158/1078-0432.CCR-09-1815; Hess KR, 2006, J CLIN ONCOL, V24, P4236, DOI 10.1200/JCO.2006.05.6861; Holmes E, 2008, CELL, V134, P714, DOI 10.1016/j.cell.2008.08.026; Iwao-Koizumi K, 2005, J CLIN ONCOL, V23, P422, DOI 10.1200/JCO.2005.09.078; Loscalzo J, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100163; MATTHEWS BW, 1975, BIOCHIM BIOPHYS ACTA, V405, P442, DOI 10.1016/0005-2795(75)90109-9; Oberthuer A, 2006, J CLIN ONCOL, V24, P5070, DOI 10.1200/JCO.2006.06.1879; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Radmacher MD, 2002, J COMPUT BIOL, V9, P505, DOI 10.1089/106652702760138592; Roepman P, 2005, NAT GENET, V37, P182, DOI 10.1038/ng1502; Shao L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011055; Shaughnessy JD, 2007, BLOOD, V109, P2276, DOI 10.1182/blood-2006-07-038430; Shi LM, 2010, NAT BIOTECHNOL, V28, P827, DOI 10.1038/nbt.1665; Slodkowska EA, 2009, EXPERT REV MOL DIAGN, V9, P417, DOI 10.1586/ERM.09.32; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sotiriou C, 2003, P NATL ACAD SCI USA, V100, P10393, DOI 10.1073/pnas.1732912100; Theodoridis S, 2006, PATTERN RECOGNITION, 3RD EDITION, P1; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Williams PD, 2009, CANCER RES, V69, P8302, DOI 10.1158/0008-5472.CAN-09-0798	30	6	6	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e29534	10.1371/journal.pone.0029534	http://dx.doi.org/10.1371/journal.pone.0029534			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910ME	22295060	Green Submitted, gold, Green Published			2022-12-25	WOS:000301640600005
J	Brentnall, TA; Lai, LA; Coleman, J; Bronner, MP; Pan, S; Chen, R				Brentnall, Teresa A.; Lai, Lisa A.; Coleman, Joshua; Bronner, Mary P.; Pan, Sheng; Chen, Ru			Arousal of Cancer-Associated Stroma: Overexpression of Palladin Activates Fibroblasts to Promote Tumor Invasion	PLOS ONE			English	Article							FAMILIAL PANCREATIC-CANCER; PROTEIN PALLADIN; CARCINOMA-CELLS; HUMAN BREAST; EXPRESSION; INVADOPODIA; PROGRESSION; GROWTH; MICE; DIFFERENTIATION	Background: Cancer-associated fibroblasts, comprised of activated fibroblasts or myofibroblasts, are found in the stroma surrounding solid tumors. These myofibroblasts promote invasion and metastasis of cancer cells. Mechanisms regulating the activation of the fibroblasts and the initiation of invasive tumorigenesis are of great interest. Upregulation of the cytoskeletal protein, palladin, has been detected in the stromal myofibroblasts surrounding many solid cancers and in expression screens for genes involved in invasion. Using a pancreatic cancer model, we investigated the functional consequence of overexpression of exogenous palladin in normal fibroblasts in vitro and its effect on the early stages of tumor invasion. Principal Findings: Palladin expression in stromal fibroblasts occurs very early in tumorigenesis. In vivo, concordant expression of palladin and the myofibroblast marker, alpha smooth muscle actin (alpha-SMA), occurs early at the dysplastic stages in peri-tumoral stroma and progressively increases in pancreatic tumorigenesis. In vitro introduction of exogenous 90 kD palladin into normal human dermal fibroblasts (HDFs) induces activation of stromal fibroblasts into myofibroblasts as marked by induction of alpha-SMA and vimentin, and through the physical change of cell morphology. Moreover, palladin expression in the fibroblasts enhances cellular migration, invasion through the extracellular matrix, and creation of tunnels through which cancer cells can follow. The fibroblast invasion and creation of tunnels results from the development of invadopodia-like cellular protrusions which express invadopodia proteins and proteolytic enzymes. Palladin expression in fibroblasts is triggered by the co-culture of normal fibroblasts with k-ras-expressing epithelial cells. Conclusions: Overall, palladin expression can impart myofibroblast properties, in turn promoting the invasive potential of these peri-tumoral cells with invadopodia-driven degradation of extracellular matrix. Palladin expression in fibroblasts can be triggered by k-ras expression in adjacent epithelial cells. This data supports a model whereby palladin-activated fibroblasts facilitate stromal-dependent metastasis and outgrowth of tumorigenic epithelium.	[Brentnall, Teresa A.; Lai, Lisa A.; Pan, Sheng; Chen, Ru] Univ Washington, Dept Med, GI Div, Seattle, WA 98195 USA; [Coleman, Joshua; Bronner, Mary P.] Cleveland Clin Fdn, Dept Anat Pathol, Cleveland, OH 44195 USA; [Bronner, Mary P.] Univ Utah, Div Anat Pathol, Salt Lake City, UT USA	University of Washington; University of Washington Seattle; Cleveland Clinic Foundation; Utah System of Higher Education; University of Utah	Brentnall, TA (corresponding author), Univ Washington, Dept Med, GI Div, Seattle, WA 98195 USA.	teribr@u.washington.edu			Gene and Mary Ann Walters Fund for Pancreatic Cancer Research; Canary Foundation; NIH NCI [5K07 CA116296]; NATIONAL CANCER INSTITUTE [K07CA116296, P30CA015704] Funding Source: NIH RePORTER	Gene and Mary Ann Walters Fund for Pancreatic Cancer Research; Canary Foundation; NIH NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Gene and Mary Ann Walters Fund for Pancreatic Cancer Research (T. A. B.), the Canary Foundation (T. A. B.), and NIH NCI 5K07 CA116296 (R. C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attanasio F, 2011, EUR J CELL BIOL, V90, P115, DOI 10.1016/j.ejcb.2010.05.004; Bartsch DK, 2010, CLIN GENET, V77, P333, DOI 10.1111/j.1399-0004.2009.01352.x; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Boukhelifa M, 2001, MOL BIOL CELL, V12, P2721, DOI 10.1091/mbc.12.9.2721; Bowden ET, 2001, METHOD CELL BIOL, V63, P613; Bradley WD, 2006, MOL BIOL CELL, V17, P4827, DOI 10.1091/mbc.E06-02-0132; Chin YR, 2010, MOL CELL, V38, P333, DOI 10.1016/j.molcel.2010.02.031; Chu GC, 2007, J CELL BIOCHEM, V101, P887, DOI 10.1002/jcb.21209; De Wever O, 2003, J PATHOL, V200, P429, DOI 10.1002/path.1398; De Wever O, 2008, INT J CANCER, V123, P2229, DOI 10.1002/ijc.23925; Denys H, 2008, CANCER LETT, V266, P263, DOI 10.1016/j.canlet.2008.02.068; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; Feldmann G, 2007, J HEPATO-BILIARY-PAN, V14, P224, DOI 10.1007/s00534-006-1166-5; Fukuda A, 2011, CANCER CELL, V19, P441, DOI 10.1016/j.ccr.2011.03.002; Gaggioli C, 2007, NAT CELL BIOL, V9, P1392, DOI 10.1038/ncb1658; Gimona M, 2008, CURR OPIN CELL BIOL, V20, P235, DOI 10.1016/j.ceb.2008.01.005; Goicoechea SM, 2008, EUR J CELL BIOL, V87, P517, DOI 10.1016/j.ejcb.2008.01.010; Goicoechea SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010347; Guerra C, 2007, CANCER CELL, V11, P291, DOI 10.1016/j.ccr.2007.01.012; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Gupta V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021494; Hayward SW, 2001, CANCER RES, V61, P8135; Hendrix MJC, 2007, NAT REV CANCER, V7, P246, DOI 10.1038/nrc2108; Ji BA, 2009, GASTROENTEROLOGY, V137, P1072, DOI 10.1053/j.gastro.2009.05.052; Jin L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012823; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Klein AP, 2009, CANCER EPIDEM BIOMAR, V18, P1328, DOI 10.1158/1055-9965.EPI-09-0056; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Kuperwasser C, 2004, P NATL ACAD SCI USA, V101, P4966, DOI 10.1073/pnas.0401064101; Laurent-Matha V, 2005, J CELL BIOL, V168, P489, DOI 10.1083/jcb.200403078; Liu XS, 2007, J CELL BIOCHEM, V100, P1288, DOI 10.1002/jcb.21126; Lochter A, 1997, J BIOL CHEM, V272, P5007, DOI 10.1074/jbc.272.8.5007; Maffini MV, 2004, J CELL SCI, V117, P1495, DOI 10.1242/jcs.01000; Malmstrom J, 2004, MOL CELL PROTEOMICS, V3, P466, DOI 10.1074/mcp.M300108-MCP200; McCullough KD, 1997, CANCER RES, V57, P1807; Ostman A, 2009, CURR OPIN GENET DEV, V19, P67, DOI 10.1016/j.gde.2009.01.003; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Olumi AF, 1999, CANCER RES, V59, P5002; Orr JW, 1972, TISSUE INTERACTIONS, P291; Parast MM, 2000, J CELL BIOL, V150, P643, DOI 10.1083/jcb.150.3.643; Pogue-Geile KL, 2006, PLOS MED, V3, P2216, DOI 10.1371/journal.pmed.0030516; Qiu W, 2008, NAT GENET, V40, P650, DOI 10.1038/ng.117; Rachlin AS, 2006, J CELL SCI, V119, P995, DOI 10.1242/jcs.02825; Rasanen K, 2010, EXP CELL RES, V316, P2713, DOI 10.1016/j.yexcr.2010.04.032; Ronty MJ, 2006, J INVEST DERMATOL, V126, P2387, DOI 10.1038/sj.jid.5700427; Ryu B, 2001, CANCER RES, V61, P1833; Sahai E, 2010, NAT REV MOL CELL BIO, V11, DOI 10.1038/nrm3000; Salaria SN, 2007, CANCER BIOL THER, V6, P324, DOI 10.4161/cbt.6.3.3904; Scott RW, 2010, J CELL BIOL, V191, P169, DOI 10.1083/jcb.201002041; Slater E, 2007, PLOS MED, V4, P774, DOI 10.1371/journal.pmed.0040164; Takkunen M, 2010, J CELL MOL MED, V14, P1569, DOI 10.1111/j.1582-4934.2009.00868.x; Tanwar PS, 2011, CANCER RES, V71, P1584, DOI 10.1158/0008-5472.CAN-10-3166; Tuxhorn JA, 2001, J UROLOGY, V166, P2472, DOI 10.1016/S0022-5347(05)65620-0; Ueda T, 2002, J CLIN PATHOL, V55, P853, DOI 10.1136/jcp.55.11.853; Wang WG, 2004, CANCER RES, V64, P8585, DOI 10.1158/0008-5472.CAN-04-1136; Wang Y, 2007, SCI STKE, V400, P1; Weaver AM, 2008, CURR BIOL, V18, pR362, DOI 10.1016/j.cub.2008.02.028; Weinger Ilene, 2005, Purinergic Signal, V1, P281, DOI 10.1007/s11302-005-8132-6; Welsch T, 2007, CURR MOL MED, V7, P504; Xu ZH, 2010, AM J PATHOL, V177, P2585, DOI 10.2353/ajpath.2010.090899; Yamamoto S, 2007, MODERN PATHOL, V20, P1278, DOI 10.1038/modpathol.3800966; Zogopoulous G, 2007, HUM GENET, V121, P635, DOI 10.1007/s00439-007-0361-z	62	68	69	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30219	10.1371/journal.pone.0030219	http://dx.doi.org/10.1371/journal.pone.0030219			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22291919	Green Published, gold, Green Submitted			2022-12-25	WOS:000301570600025
J	Neves, J; Uchikawa, M; Bigas, A; Giraldez, F				Neves, Joana; Uchikawa, Masanori; Bigas, Anna; Giraldez, Fernando			The Prosensory Function of Sox2 in the Chicken Inner Ear Relies on the Direct Regulation of Atoh1	PLOS ONE			English	Article							NEURAL PROGENITOR IDENTITY; SENSORY ORGAN DEVELOPMENT; HAIR-CELLS; MATH1 EXPRESSION; VERTEBRATE NEUROGENESIS; DEVELOPING COCHLEA; MAMMALIAN COCHLEA; OTIC PLACODE; NOTCH; DIFFERENTIATION	The proneural gene Atoh1 is crucial for the development of inner ear hair cells and it requires the function of the transcription factor Sox2 through yet unknown mechanisms In the present work, we used the chicken ernbryo and HEK293T cells to explore the regulation of Atoh1 by Sox2. The results show that hair cells derive from Sox2-positive otic progenitors and that Sox2 directly activates Atoh1 through a transcriptional activator function that requires the integrity of Sox2 DNA binding domain. Atoh1 activation depends on Sox transcription factor binding sites (SoxTFBS) present in the Atoh1 3' enhancer where Sox2 directly binds, as shown by site directed mutagenesis and chromatin immunoprecipitation (ChIP). In the inner ear, Atoh1 enhancer activity is detected in the neurosensory domain and it depends on Sox2. Dominant negative competition (Sox2HMG-Engrailed) and mutation of the SoxTFBS abolish the reporter activity in vivo. Moreover, ChIP assay in isolated otic vesicles shows that Sox2 is bound to the Atoh1 enhancer in vivo. However, besides activating Atoh1, Sox2 also promotes the expression of Atoh1 negative regulators and the temporal profile of Atoh1 activation by Sox2 is transient suggesting that Sox2 triggers an incoherent feed-forward loop. These results provide a mechanism for the prosensory function of Sox2 in the inner ear. We suggest that sensory competence is established early in otic development through the activation of Atoh1 by Sox2, however, hair cell differentiation is prevented until later stages by the parallel activation of negative regulators of Atoh1 function.	[Neves, Joana; Giraldez, Fernando] Univ Pompeu Fabra, CEXS, Barcelona, Spain; [Uchikawa, Masanori] Osaka Univ, Grad Sch Frontier Biosci, Osaka, Japan; [Bigas, Anna] IMIM Hosp Mar, Program Canc Res, Barcelona, Spain	Pompeu Fabra University; Osaka University; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar	Neves, J (corresponding author), Univ Pompeu Fabra, CEXS, Parc Rec Biomed Barcelona PRBB, Barcelona, Spain.	fernando.giraldez@upf.edu	Giraldez, Fernando/C-9821-2014; Bigas, Anna/A-7457-2014	Mendes Neves, Joana/0000-0002-1027-3489; Bigas, Anna/0000-0003-4801-6899	MICINN (Ministry of Science and Innovation) [BFU-2008-00714, PLE-2009-0098]; RTICCS/FEDER (Red Tematica de Investigacion Cooperativa en Cancer (RTICC), Spain/Spanish Federation for Rare Diseases), Spain [RD06/0020/0098, 2009SGR23]; FCT (The Foundation for Science and Technology), Portugal [SFRH/BPD/70691/2010]; National Institute of Child Health and Human Development; Grants-in-Aid for Scientific Research [23770248] Funding Source: KAKEN	MICINN (Ministry of Science and Innovation)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); RTICCS/FEDER (Red Tematica de Investigacion Cooperativa en Cancer (RTICC), Spain/Spanish Federation for Rare Diseases), Spain; FCT (The Foundation for Science and Technology), Portugal; National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The work was supported by grants MICINN (Ministry of Science and Innovation) BFU-2008-00714, PLE-2009-0098, RTICCS/FEDER (Red Tematica de Investigacion Cooperativa en Cancer (RTICC), Spain/Spanish Federation for Rare Diseases) (RD06/0020/0098) and 2009SGR23, Spain, and the fellowship SFRH/BPD/70691/2010 to Joana Neves from FCT (The Foundation for Science and Technology), Portugal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Donna Fekete and Thomas Schimmang for reading the manuscript; Pau Formosa and Marta Ibanes for inspiring comments; Marta Linares, Miguel Sas, Ivan Vachkov for excellent technical assistance; and Jordi Guiu, Maria Mulero, Lluis Espinosa, and Pura's Lab (Pura Munoz, CEXS UPF) for technical advice. Hisato Kondoh (GFSB-Osaka University) helped this project from its very initial steps. Jane Johnson (CBN, University of Texas) kindly shared reporters constructs with us. Guy Richardson (University of Sussex, Brighton, UK) kindly provided us with the HCA antibody and Islet1 and MyoVIIa monoclonal antibodies were obtained from the Developmental Studies Hybridoma Bank under the auspices of the National Institute of Child Health and Human Development and maintained by the University of Iowa, Department of Biological Sciences (Iowa City, IA).	Abello G, 2010, DEV BIOL, V339, P166, DOI 10.1016/j.ydbio.2009.12.027; Adam J, 1998, DEVELOPMENT, V125, P4645; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Alsina B, 2004, DEV BIOL, V267, P119, DOI 10.1016/j.ydbio.2003.11.012; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Bell D, 2008, DEV BIOL, V322, P109, DOI 10.1016/j.ydbio.2008.07.011; BENEZRA R, 1990, CELL, V61, P49, DOI 10.1016/0092-8674(90)90214-Y; Bermingham NA, 1999, SCIENCE, V284, P1837, DOI 10.1126/science.284.5421.1837; Bylund M, 2003, NAT NEUROSCI, V6, P1162, DOI 10.1038/nn1131; Chakravarthy H, 2008, J CELL PHYSIOL, V216, P651, DOI 10.1002/jcp.21440; Chang WI, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000050; Cimadamore F, CELL STEM CELL, V8, P538; Dabdoub A, 2008, P NATL ACAD SCI USA, V105, P18396, DOI 10.1073/pnas.0808175105; Doetzlhofer A, 2009, DEV CELL, V16, P58, DOI 10.1016/j.devcel.2008.11.008; Ebert PJ, 2003, DEVELOPMENT, V130, P1949, DOI 10.1242/dev.00419; Fischer A, 2007, NUCLEIC ACIDS RES, V35, P4583, DOI 10.1093/nar/gkm477; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; HAMBURGER V, 1992, DEV DYNAM, V195, P231, DOI 10.1002/dvdy.1001950404; Hayashi T, 2008, DEV BIOL, V316, P87, DOI 10.1016/j.ydbio.2008.01.006; Helms AW, 2000, DEVELOPMENT, V127, P1185; Hume CR, 2007, GENE EXPR PATTERNS, V7, P798, DOI 10.1016/j.modgep.2007.05.002; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Jahan I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011661; Jeon SJ, 2011, J NEUROSCI, V31, P8351, DOI 10.1523/JNEUROSCI.6366-10.2011; Jones JM, 2006, J NEUROSCI, V26, P550, DOI 10.1523/JNEUROSCI.3859-05.2006; Kamaid A, 2010, J NEUROSCI, V30, P11426, DOI 10.1523/JNEUROSCI.2570-10.2010; Kiernan AE, 2005, NATURE, V434, P1031, DOI 10.1038/nature03487; Li SD, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-20; Ma QF, 2000, JARO-J ASSOC RES OTO, V1, P129, DOI 10.1007/s101620010017; Mak ACY, 2009, GENE EXPR PATTERNS, V9, P444, DOI 10.1016/j.gep.2009.04.003; Matei V, 2005, DEV DYNAM, V234, P633, DOI 10.1002/dvdy.20551; Neves J, 2007, J COMP NEUROL, V503, P487, DOI 10.1002/cne.21299; Neves J, 2011, DEVELOPMENT, V138, P735, DOI 10.1242/dev.060657; Norton JD, 2000, J CELL SCI, V113, P3897; Nowling TK, 2000, J BIOL CHEM, V275, P3810, DOI 10.1074/jbc.275.6.3810; Pevny L, 2005, CURR OPIN NEUROBIOL, V15, P7, DOI 10.1016/j.conb.2005.01.016; Pevny LH, 1998, DEVELOPMENT, V125, P1967; Pujades C, 2006, DEV BIOL, V292, P55, DOI 10.1016/j.ydbio.2006.01.001; Puligilla C, 2010, J NEUROSCI, V30, P714, DOI 10.1523/JNEUROSCI.3852-09.2010; Raft S, 2007, DEVELOPMENT, V134, P4405, DOI 10.1242/dev.009118; Robert-Moreno A, 2008, EMBO J, V27, P1886, DOI 10.1038/emboj.2008.113; Sandberg M, 2005, NAT NEUROSCI, V8, P995, DOI 10.1038/nn1493; Satoh T, 2005, DEVELOPMENT, V132, P1687, DOI 10.1242/dev.01730; Sweet EM, DEV BIOL, V358, P113; Taranova OV, 2006, GENE DEV, V20, P1187, DOI 10.1101/gad.1407906; Tateya T, 2011, DEV BIOL, V352, P329, DOI 10.1016/j.ydbio.2011.01.038; Timmer J, 2001, GENESIS, V29, P123, DOI 10.1002/gene.1015; Uchikawa M, 1999, MECH DEVELOP, V84, P103, DOI 10.1016/S0925-4773(99)00083-0; Uchikawa M, 2003, DEV CELL, V4, P509, DOI 10.1016/S1534-5807(03)00088-1; Woods C, 2004, NAT NEUROSCI, V7, P1310, DOI 10.1038/nn1349; Zheng JL, 2000, NAT NEUROSCI, V3, P580, DOI 10.1038/75753; Zine A, 2002, HEARING RES, V170, P22, DOI 10.1016/S0378-5955(02)00449-5	52	48	51	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30871	10.1371/journal.pone.0030871	http://dx.doi.org/10.1371/journal.pone.0030871			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22292066	Green Published, gold, Green Submitted			2022-12-25	WOS:000301570600090
J	Siggens, L; Figg, N; Bennett, M; Foo, R				Siggens, Lee; Figg, Nichola; Bennett, Martin; Foo, Roger			Nutrient deprivation regulates DNA damage repair in cardiomyocytes via loss of the base-excision repair enzyme OGG1	FASEB JOURNAL			English	Article						8-oxoG; cardiomyopathy; oxidative genomic damage; heart failure	CARDIAC MYOCYTE APOPTOSIS; HEART-FAILURE; CELL-DEATH; OXIDATIVE STRESS; HEMODYNAMIC STRESS; PRESSURE-OVERLOAD; AUTOPHAGY; DISEASE; MECHANISMS; HYPERTROPHY	Oxidative stress contributes to the pathogenesis of many diseases, including heart failure, but the role and regulation of oxidative DNA damage in many cases have not been studied. Here, we set out to examine how oxidative DNA damage is regulated in cardiomyocytes. Compared to normal healthy controls, human hearts in end-stage cardiomyopathy (EsCM) showed a high degree of DNA damage by histological evidence of damage markers, including 8-oxoG and gamma H2AX (8-oxoG: 4.7 +/- 0.88 vs. 99.9 +/- 0.11%; gamma H2AX: 2.1 +/- 0.33 vs. 85.0 +/- 13.8%; P<0.01) This raised the possibility that defective DNArepair may be partly responsible. Indeed, nutrient deprivation led to impaired base-excision repair (BER) in cardiomyocytes in vitro, accompanied by loss of the BER enzyme OGG1, while BER activity was rescued by recombinant OGG1 (control vs. nutrient deprived vs. nutrient deprived + OGG1; 100 +/- 2.96 vs. 68.2 +/- 7.53 vs. 94.0 +/- 0.72%; ANOVA, P<0.01). Hearts from humans with EsCM and two murine models of myocardial stress also showed a loss of OGG1 protein. OGG1 loss was inhibited by the autophagy inhibitor bafilomycin and in autophagy-deficient Atg5(-/-) mouse embryonic fibroblasts. However, pharmacological activation of autophagy, itself, did not induce OGG1 loss, suggesting that autophagy is necessary but not sufficient for OGG1 turnover, and OGG1 loss requires concurrent nutrient deprivation. Finally, we found that the role of autophagy in nutrient starvation is complex, since it balanced the positive effects of ROS inhibition against the negative effect of OGG1 loss. Therefore, we have identified a central role for OGG1 in regulating DNA repair in cardiomyopathy. The manipulation of OGG1 may be used in future studies to examine the direct contribution of oxidative DNA damage to the progression of heart failure.-Siggens, L., Figg, N., Bennett, M., Foo, R. Nutrient deprivation regulates DNA damage repair in cardiomyocytes via loss of the base-excision repair enzyme OGG1. FASEB J. 26, 2117-2124 (2012). www.fasebj.org	[Siggens, Lee; Figg, Nichola; Bennett, Martin; Foo, Roger] Univ Cambridge, Addenbrookes Hosp, Div Cardiovasc Med, Cambridge CB2 0QQ, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Foo, R (corresponding author), Univ Cambridge, Addenbrookes Hosp, Div Cardiovasc Med, Addenbrookes Ctr Clin Invest Bldg,Level 6, Cambridge CB2 0QQ, England.	rsyf2@cam.ac.uk		Bennett, Martin/0000-0002-2565-1825; Siggens, Lee/0000-0001-7277-3633; Foo, Roger/0000-0002-8079-4618	Wellcome Trust; British Heart Foundation (BHF); UK National Institute for Health Research Cambridge Biomedical Research Centre; MRC [G1000847, G0800784] Funding Source: UKRI; British Heart Foundation [RG/08/009/25841] Funding Source: researchfish; Medical Research Council [G1000847, G0800784] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); British Heart Foundation (BHF)(British Heart Foundation); UK National Institute for Health Research Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	L.S. is supported by a Wellcome Trust Studentship in Metabolic and Cardiovascular Disease, M.R.B. is supported by a British Heart Foundation (BHF) professorship, and R.S.F. is supported by a BHF intermediate fellowship. This study is also supported by the UK National Institute for Health Research Cambridge Biomedical Research Centre.	Bialik S, 1999, CIRC RES, V85, P403, DOI 10.1161/01.RES.85.5.403; Bozkurt B, 2010, HEART FAIL REV, V15, P331, DOI 10.1007/s10741-009-9140-3; Choy MK, 2010, GENOME MED, V2, DOI 10.1186/gm158; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; Cooke MS, 2003, FASEB J, V17, P1195, DOI 10.1096/fj.02-0752rev; David SS, 2007, NATURE, V447, P941, DOI 10.1038/nature05978; Epe B, 2002, BIOL CHEM, V383, P467, DOI 10.1515/BC.2002.049; Foo RSY, 2007, J BIOL CHEM, V282, P5529, DOI 10.1074/jbc.M609046200; Foo RSY, 2006, J CELL PHYSIOL, V209, P1, DOI 10.1002/jcp.20723; Giordano FJ, 2005, J CLIN INVEST, V115, P500, DOI 10.1172/JCI200524408; Gottlieb RA, 2010, ANNU REV PHYSIOL, V72, P45, DOI 10.1146/annurev-physiol-021909-135757; Hare JM, 2001, CIRC RES, V89, P198, DOI 10.1161/res.89.3.198; Hill JW, 2008, DNA REPAIR, V7, P648, DOI 10.1016/j.dnarep.2008.01.003; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Knaapen MWM, 2001, CARDIOVASC RES, V51, P304, DOI 10.1016/S0008-6363(01)00290-5; Kubota C, 2010, J BIOL CHEM, V285, P667, DOI 10.1074/jbc.M109.053058; Lammens K, 2011, CELL, V145, P54, DOI 10.1016/j.cell.2011.02.038; Matsui Y, 2007, CIRC RES, V100, P914, DOI 10.1161/01.RES.0000261924.76669.36; Mirbahai L, 2010, DNA REPAIR, V9, P144, DOI 10.1016/j.dnarep.2009.11.009; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mizushima N, 2007, ANNU REV NUTR, V27, P19, DOI 10.1146/annurev.nutr.27.061406.093749; Molkentin JD, 2001, ANNU REV PHYSIOL, V63, P391, DOI 10.1146/annurev.physiol.63.1.391; Movassagh M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008564; Nakai A, 2007, NAT MED, V13, P619, DOI 10.1038/nm1574; Neubauer S, 2007, NEW ENGL J MED, V356, P1140, DOI 10.1056/NEJMra063052; Oka S, 2008, EMBO J, V27, P421, DOI 10.1038/sj.emboj.7601975; Osley MA, 2007, MUTAT RES-FUND MOL M, V618, P65, DOI 10.1016/j.mrfmmm.2006.07.011; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Sano M, 2007, NATURE, V446, P444, DOI 10.1038/nature05602; Saxowsky TT, 2008, P NATL ACAD SCI USA, V105, P18877, DOI 10.1073/pnas.0806464105; Suliman HB, 2004, CARDIOVASC RES, V64, P279, DOI 10.1016/j.cardiores.2004.07.005; Tachibana H, 2005, CIRCULATION, V111, P591, DOI 10.1161/01.CIR.0000142291.70954.DF; Takemura G, 2009, AUTOPHAGY, V5, P1034, DOI 10.4161/auto.5.7.9297; Tang JB, 2010, MOL CANCER RES, V8, P67, DOI 10.1158/1541-7786.MCR-09-0411; Webster KA, 2007, ANTIOXID REDOX SIGN, V9, P1303, DOI 10.1089/ars.2007.1730; Wencker D, 2003, J CLIN INVEST, V111, P1497, DOI 10.1172/JCI200317664; Whelan RS, 2010, ANNU REV PHYSIOL, V72, P19, DOI 10.1146/annurev.physiol.010908.163111; Zhu HX, 2007, J CLIN INVEST, V117, P1782, DOI 10.1172/JCI27523	38	44	46	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	MAY	2012	26	5					2117	2124		10.1096/fj.11-197525	http://dx.doi.org/10.1096/fj.11-197525			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	937TD	22302830	Green Accepted			2022-12-25	WOS:000303680800037
J	Dafik, L; Albertelli, M; Stamnaes, J; Sollid, LM; Khosla, C				Dafik, Laila; Albertelli, Megan; Stamnaes, Jorunn; Sollid, Ludvig M.; Khosla, Chaitan			Activation and Inhibition of Transglutaminase 2 in Mice	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; TISSUE TRANSGLUTAMINASE; SELECTIVE INHIBITORS; FLUOROMETRIC ASSAY; STRUCTURAL BASIS; RECOGNITION; POLY(I-C); DISEASE; ANALOGS; INJURY	Transglutaminase 2 (TG2) is an allosterically regulated enzyme with transamidating, deamidating and cell signaling activities. It is thought to catalyze sequence-specific deamidation of dietary gluten peptides in the small intestines of celiac disease patients. Because this modification has profound consequences for disease pathogenesis, there is considerable interest in the design of small molecule TG2 inhibitors. Although many classes of TG2 inhibitors have been reported, thus far an animal model for screening them to identify promising celiac drug candidates has remained elusive. Using intraperitoneal administration of the toll-like receptor 3 (TLR3) ligand, polyinosinic-polycytidylic acid (poly(I:C)), we induced rapid TG2 activation in the mouse small intestine. Dose dependence was observed in the activation of TG2 as well as the associated villous atrophy, gross clinical response, and rise in serum concentration of the IL-15/IL-15R complex. TG2 activity was most pronounced in the upper small intestine. No evidence of TG2 activation was observed in the lung mucosa, nor were TLR7/8 ligands able to elicit an analogous response. Introduction of ERW1041E, a small molecule TG2 inhibitor, in this mouse model resulted in TG2 inhibition in the small intestine. TG2 inhibition had no effect on villous atrophy, suggesting that activation of this enzyme is a consequence, rather than a cause, of poly(I:C) induced enteropathy. Consistent with this finding, administration of poly(I:C) to TG2 knockout mice also induced villous atrophy. Our findings pave the way for pharmacological evaluation of small molecule TG2 inhibitors as drug candidates for celiac disease.	[Dafik, Laila; Khosla, Chaitan] Stanford Univ, Dept Chem & Chem Engn, Stanford, CA 94305 USA; [Albertelli, Megan] Stanford Univ, Dept Comparat Med, Stanford, CA 94305 USA; [Stamnaes, Jorunn; Sollid, Ludvig M.] Univ Oslo, Dept Immunol, Oslo, Norway; [Stamnaes, Jorunn; Sollid, Ludvig M.] Univ Oslo, Ctr Immune Regulat, Oslo, Norway; [Sollid, Ludvig M.] Univ Oslo, Rikshosp, Oslo Univ Hosp, N-0027 Oslo, Norway; [Khosla, Chaitan] Stanford Univ, Dept Biochem, Stanford, CA 94305 USA	Stanford University; Stanford University; University of Oslo; University of Oslo; University of Oslo; National Hospital Norway; Stanford University	Khosla, C (corresponding author), Stanford Univ, Dept Chem & Chem Engn, Stanford, CA 94305 USA.	khosla@stanford.edu	Albertelli, Megan A/C-7650-2011; Sollid, Ludvig/N-9691-2015	Albertelli, Megan A/0000-0001-9433-229X; Sollid, Ludvig/0000-0001-8860-704X; Khosla, Chaitan/0000-0001-6529-495X; Stamnaes, Jorunn/0000-0002-0257-2112	National Institutes of Health [R01 DK063158]; Research Council of Norway; "Fonds de Recherche sur la Nature et les Technologies'' (Canada); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063158] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Council of Norway(Research Council of Norway); "Fonds de Recherche sur la Nature et les Technologies'' (Canada); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a grant from the National Institutes of Health (R01 DK063158) to CK and by the Research Council of Norway (to LMS). LD is a recipient of a postdoctoral fellowship from "Fonds de Recherche sur la Nature et les Technologies'' (Canada). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Choi K, 2005, CHEM BIOL, V12, P469, DOI 10.1016/j.chembiol.2005.02.007; Cui ZR, 2006, CANCER IMMUNOL IMMUN, V55, P1267, DOI 10.1007/s00262-005-0114-6; Dafik L, 2011, CHEM BIOL, V18, P58, DOI 10.1016/j.chembiol.2010.11.004; De Laurenzi V, 2001, MOL CELL BIOL, V21, P148, DOI 10.1128/MCB.21.1.148-155.2001; DePaolo RW, 2011, NATURE, V471, P220, DOI 10.1038/nature09849; FOLK JE, 1985, METHOD ENZYMOL, V113, P358; Gillet SMFG, 2005, ANAL BIOCHEM, V347, P221, DOI 10.1016/j.ab.2005.09.035; Griffin M, 2002, BIOCHEM J, V368, P377, DOI 10.1042/BJ20021234; Halim D, 2007, BIOORG MED CHEM LETT, V17, P305, DOI 10.1016/j.bmcl.2006.10.061; Hausch F, 2003, CHEM BIOL, V10, P225, DOI 10.1016/S1074-5521(03)00045-0; Jeitner TM, 2001, ANAL BIOCHEM, V292, P198, DOI 10.1006/abio.2001.5040; Jurk M, 2002, NAT IMMUNOL, V3, P499, DOI 10.1038/ni0602-499; Liu SP, 2002, P NATL ACAD SCI USA, V99, P2743, DOI 10.1073/pnas.042454899; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; Pardin C, 2008, J ORG CHEM, V73, P5766, DOI 10.1021/jo8004843; Pardin C, 2006, BIOORGAN MED CHEM, V14, P8379, DOI 10.1016/j.bmc.2006.09.011; Pinkas DM, 2007, PLOS BIOL, V5, P2788, DOI 10.1371/journal.pbio.0050327; Schaertl S, 2010, J BIOMOL SCREEN, V15, P478, DOI 10.1177/1087057110366035; Shan L, 2002, SCIENCE, V297, P2275, DOI 10.1126/science.1074129; Siegel M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001861; Siegel M, 2007, PHARMACOL THERAPEUT, V115, P232, DOI 10.1016/j.pharmthera.2007.05.003; Sollid LM, 2002, NAT REV IMMUNOL, V2, P647, DOI 10.1038/nri885; Stamnaes J, 2010, J BIOL CHEM, V285, P25402, DOI 10.1074/jbc.M109.097162; Verdijk RM, 1999, J IMMUNOL, V163, P57; Watts RE, 2006, J MED CHEM, V49, P7493, DOI 10.1021/jm060839a; Zhou RB, 2007, P NATL ACAD SCI USA, V104, P7512, DOI 10.1073/pnas.0700822104; Zhou RB, 2007, J IMMUNOL, V178, P4548, DOI 10.4049/jimmunol.178.7.4548	27	48	48	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2012	7	2							e30642	10.1371/journal.pone.0030642	http://dx.doi.org/10.1371/journal.pone.0030642			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UV	22319575	Green Submitted, Green Published, gold			2022-12-25	WOS:000301979000009
J	Chen, CY; Chien, TY; Lin, CK; Lin, CW; Weng, YZ; Chang, DTH				Chen, Chien-Yu; Chien, Ting-Ying; Lin, Chih-Kang; Lin, Chih-Wei; Weng, Yi-Zhong; Chang, Darby Tien-Hao			Predicting Target DNA Sequences of DNA-Binding Proteins Based on Unbound Structures	PLOS ONE			English	Article							ENERGY FUNCTION; SITES; DISCOVERY; MODEL; SPECIFICITY; PROFILES; FAMILIES	DNA-binding proteins such as transcription factors use DNA-binding domains (DBDs) to bind to specific sequences in the genome to initiate many important biological functions. Accurate prediction of such target sequences, often represented by position weight matrices (PWMs), is an important step to understand many biological processes. Recent studies have shown that knowledge-based potential functions can be applied on protein-DNA co-crystallized structures to generate PWMs that are considerably consistent with experimental data. However, this success has not been extended to DNA-binding proteins lacking co-crystallized structures. This study aims at investigating the possibility of predicting the DNA sequences bound by DNA-binding proteins from the proteins' unbound structures (structures of the unbound state). Given an unbound query protein and a template complex, the proposed method first employs structure alignment to generate synthetic protein-DNA complexes for the query protein. Once a complex is available, an atomic-level knowledge-based potential function is employed to predict PWMs characterizing the sequences to which the query protein can bind. The evaluation of the proposed method is based on seven DNA-binding proteins, which have structures of both DNA-bound and unbound forms for prediction as well as annotated PWMs for validation. Since this work is the first attempt to predict target sequences of DNA-binding proteins from their unbound structures, three types of structural variations that presumably influence the prediction accuracy were examined and discussed. Based on the analyses conducted in this study, the conformational change of proteins upon binding DNA was shown to be the key factor. This study sheds light on the challenge of predicting the target DNA sequences of a protein lacking co-crystallized structures, which encourages more efforts on the structure alignment-based approaches in addition to docking-and homology modeling-based approaches for generating synthetic complexes.	[Chen, Chien-Yu] Natl Taiwan Univ, Dept Bioind Mechatron Engn, Taipei 10764, Taiwan; [Chen, Chien-Yu; Lin, Chih-Kang] Natl Taiwan Univ, Ctr Syst Biol, Taipei 10764, Taiwan; [Chen, Chien-Yu] Natl Taiwan Univ, Ctr Biotechnol, Taipei 10764, Taiwan; [Chien, Ting-Ying; Lin, Chih-Kang; Lin, Chih-Wei; Weng, Yi-Zhong] Natl Taiwan Univ, Dept Comp Sci & Informat Engn, Taipei 10764, Taiwan; [Chang, Darby Tien-Hao] Natl Cheng Kung Univ, Dept Elect Engn, Tainan 70101, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University; National Cheng Kung University	Chen, CY (corresponding author), Natl Taiwan Univ, Dept Bioind Mechatron Engn, Taipei 10764, Taiwan.	darby@ee.ncku.edu.tw		CHEN, CHIEN-YU/0000-0002-6940-6389	National Science Council of Republic of China, Taiwan [NSC 98-2627-B-002-011]	National Science Council of Republic of China, Taiwan(Ministry of Science and Technology, Taiwan)	The authors would like to thank National Science Council of Republic of China, Taiwan, for the financial support under the contracts: NSC 98-2627-B-002-011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Apweiler R, 2010, NUCLEIC ACIDS RES, V38, pD142, DOI 10.1093/nar/gkp846; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Bulyk ML, 2004, GENOME BIOL, V5; Cheatham TE, 2001, BIOPOLYMERS, V56, P232; Dan A, 2010, PROTEINS, V78, P236, DOI 10.1002/prot.22531; Donald JE, 2007, NUCLEIC ACIDS RES, V35, P1039, DOI 10.1093/nar/gkl1103; Endres RG, 2004, PROTEINS, V57, P262, DOI 10.1002/prot.20199; Gao M, 2008, NUCLEIC ACIDS RES, V36, P3978, DOI 10.1093/nar/gkn332; Havranek JJ, 2004, J MOL BIOL, V344, P59, DOI 10.1016/j.jmb.2004.09.029; Hogg R.V., 2010, PROBABILITY STAT INF, V9th ed.; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Kirchmair J, 2008, J MED CHEM, V51, P7021, DOI 10.1021/jm8005977; Liu ZJ, 2008, PROTEINS, V72, P1114, DOI 10.1002/prot.22002; Liu ZJ, 2005, NUCLEIC ACIDS RES, V33, P546, DOI 10.1093/nar/gki204; MacIsaac KD, 2006, BIOINFORMATICS, V22, P423, DOI 10.1093/bioinformatics/bti815; Mahony S, 2005, BIOINFORMATICS, V21, pI283, DOI 10.1093/bioinformatics/bti1025; Mahony S, 2005, BIOINFORMATICS, V21, P1807, DOI 10.1093/bioinformatics/bti256; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Morozov AV, 2007, P NATL ACAD SCI USA, V104, P7068, DOI 10.1073/pnas.0701356104; Morozov AV, 2005, NUCLEIC ACIDS RES, V33, P5781, DOI 10.1093/nar/gki875; Ponder JW, 2003, ADV PROTEIN CHEM, V66, P27; Sandelin A, 2004, J MOL BIOL, V338, P207, DOI 10.1016/j.jmb.2004.02.048; Siggia ED, 2005, CURR OPIN GENET DEV, V15, P214, DOI 10.1016/j.gde.2005.02.004; Stormo GD, 2000, BIOINFORMATICS, V16, P16, DOI 10.1093/bioinformatics/16.1.16; van Dijk M, 2006, NUCLEIC ACIDS RES, V34, P3317, DOI 10.1093/nar/gkl412; Xing EP, 2004, P NATL ACAD SCI USA, V101, P10523, DOI 10.1073/pnas.0403564101; Xu BS, 2009, PROTEINS, V76, P718, DOI 10.1002/prot.22384; Zhang C, 2005, J MED CHEM, V48, P2325, DOI 10.1021/jm049314d; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524; Zhang Y, 2004, PROTEINS, V57, P702, DOI 10.1002/prot.20264	31	20	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2012	7	2							e30446	10.1371/journal.pone.0030446	http://dx.doi.org/10.1371/journal.pone.0030446			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UG	22312425	Green Published, gold, Green Submitted			2022-12-25	WOS:000301977500009
J	Costantino, CM; Spooner, E; Ploegh, HL; Hafler, DA				Costantino, Cristina Maria; Spooner, Eric; Ploegh, Hidde L.; Hafler, David A.			Class II MHC Self-Antigen Presentation in Human B and T Lymphocytes	PLOS ONE			English	Article							NATURALLY PROCESSED PEPTIDES; HLA-DR ALLELES; LYSOSOMAL CYSTEINE; INVARIANT CHAIN; FOREIGN ANTIGEN; CELLS; MOLECULES; RECOGNITION; BINDING; SPECIFICITY	Human CD4(+) T cells process and present functional class II MHC-peptide complexes, but the endogenous peptide repertoire of these non-classical antigen presenting cells remains unknown. We eluted and sequenced HLA-DR-bound self-peptides presented by CD4(+) T cells in order to compare the T cell-derived peptide repertoire to sequences derived from genetically identical B cells. We identified several novel epitopes derived from the T cell-specific proteome, including fragments of CD4 and IL-2. While these data confirm that T cells can present peptides derived from the T-cell specific proteome, the vast majority of peptides sequenced after elution from MHC were derived from the common proteome. From this pool, we identified several identical peptide epitopes in the T and B cell repertoire derived from common endogenous proteins as well as novel endogenous epitopes with promiscuous binding. These findings indicate that the endogenous HLA-DR-bound peptide repertoire, regardless of APC type and across MHC isotype, is largely derived from the same pool of self-protein.	[Costantino, Cristina Maria; Hafler, David A.] Harvard Univ, Sch Med, Program Immunol, Boston, MA 02114 USA; [Spooner, Eric; Ploegh, Hidde L.] MIT, Dept Biol, Whitehead Inst, Cambridge, MA USA; [Hafler, David A.] Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA; [Hafler, David A.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT USA	Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Whitehead Institute; Yale University; Yale University	Costantino, CM (corresponding author), Harvard Univ, Sch Med, Program Immunol, Boston, MA 02114 USA.	David.Hafler@yale.edu		Costantino, Cristina/0000-0002-3705-8519	National Institutes of Health [P01AI039671, P01AI045757]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI039671, P01AI045757] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grants P01AI039671 and P01AI045757. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKARI H, 1995, ARCH VIROL, V140, P375, DOI 10.1007/BF01309871; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Baecher-Allan C, 2006, J IMMUNOL, V176, P4622, DOI 10.4049/jimmunol.176.8.4622; BIDDISON WE, 2001, CURR PROTOC CELL BIO, pCH2; BODMER H, 1994, SCIENCE, V263, P1284, DOI 10.1126/science.7510069; CHICZ RM, 1993, J EXP MED, V178, P27, DOI 10.1084/jem.178.1.27; Cohen IR, 2004, J CLIN INVEST, V114, P1227, DOI 10.1172/JCI200422396; Costantino CM, 2008, J IMMUNOL, V180, P2876, DOI 10.4049/jimmunol.180.5.2876; Costantino CM, 2009, J IMMUNOL, V183, P945, DOI 10.4049/jimmunol.0900921; DAVENPORT MP, 1995, P NATL ACAD SCI USA, V92, P6567, DOI 10.1073/pnas.92.14.6567; DEMOTZ S, 1990, SCIENCE, V249, P1028, DOI 10.1126/science.2118680; DENZIN LK, 1995, CELL, V82, P155, DOI 10.1016/0092-8674(95)90061-6; Dongre AR, 2001, EUR J IMMUNOL, V31, P1485, DOI 10.1002/1521-4141(200105)31:5<1485::AID-IMMU1485>3.0.CO;2-A; ENGELHARD VH, 1994, ANNU REV IMMUNOL, V12, P181, DOI 10.1146/annurev.iy.12.040194.001145; Fissolo N, 2009, MOL CELL PROTEOMICS, V8, P2090, DOI 10.1074/mcp.M900001-MCP200; HARDING CV, 1990, NATURE, V346, P574, DOI 10.1038/346574a0; HEWITT CRA, 1989, J IMMUNOL, V143, P762; Honey K, 2003, NAT REV IMMUNOL, V3, P472, DOI 10.1038/nri1110; Kassiotis G, 2002, NAT IMMUNOL, V3, P244, DOI 10.1038/ni766; Kent SC, 2005, NATURE, V435, P224, DOI 10.1038/nature03625; KIRSCHMANN DA, 1995, J IMMUNOL, V155, P5655; Kropshofer H, 1996, EMBO J, V15, P6144, DOI 10.1002/j.1460-2075.1996.tb01002.x; LANZAVECCHIA A, 1988, NATURE, V334, P530, DOI 10.1038/334530a0; LASALLE JM, 1991, J IMMUNOL, V147, P774; LASALLE JM, 1992, J EXP MED, V176, P177, DOI 10.1084/jem.176.1.177; MARRACK P, 1993, J EXP MED, V178, P2173, DOI 10.1084/jem.178.6.2173; Micheletti F, 2000, J IMMUNOL, V165, P4264, DOI 10.4049/jimmunol.165.8.4264; Nielsen M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-238; Nielsen M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-296; Quintana FJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004026; Rohn TA, 2004, NAT IMMUNOL, V5, P909, DOI 10.1038/ni1108; RUDENSKY AY, 1991, NATURE, V353, P622, DOI 10.1038/353622a0; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; SHAW S, 1985, HUM IMMUNOL, V12, P191, DOI 10.1016/0198-8859(85)90336-2; Stefanova I, 2003, IMMUNOL REV, V191, P97, DOI 10.1034/j.1600-065X.2003.00006.x; Stefanova I, 2002, NATURE, V420, P429, DOI 10.1038/nature01146; VOGT AB, 1994, J IMMUNOL, V153, P1665; Vyas JM, 2008, NAT REV IMMUNOL, V8, P607, DOI 10.1038/nri2368; WUCHERPFENNIG KW, 1994, J IMMUNOL, V152, P5581; Wulfing C, 2002, NAT IMMUNOL, V3, P42, DOI 10.1038/ni741; Yi W, 2010, J CLIN INVEST, V120, P1324, DOI 10.1172/JCI40220; YU DTY, 1980, J EXP MED, V151, P91, DOI 10.1084/jem.151.1.91	42	22	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2012	7	1							e29805	10.1371/journal.pone.0029805	http://dx.doi.org/10.1371/journal.pone.0029805			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911GB	22299025	Green Published, gold, Green Submitted			2022-12-25	WOS:000301704200002
J	Zheng, YH; Fan, F; Liu, XC; Mo, L				Zheng, Yuhong; Fan, Fang; Liu, Xianchen; Mo, Lei			Life Events, Coping, and Posttraumatic Stress Symptoms among Chinese Adolescents Exposed to 2008 Wenchuan Earthquake, China	PLOS ONE			English	Article							CHILDREN; DISORDER; DISASTER; MODERATOR; SURVIVORS; ANXIETY; TAIWAN; PSYCHOPATHOLOGY; POSTDISASTER; PREDICTORS	Purpose: To examine the relationship between negative life events, coping styles, and symptoms of post-traumatic stress disorder (PTSD) among adolescent survivors exposed to 2008 Wenchuan Earthquake, China. Methods: A survey was conducted in a sample of 2250 adolescent students from two schools in Dujiangyan District, a seriously damaged area, 20 kilometers away from the epicenter, 6 months after the earthquake. Participants completed a self-administered questionnaire including demographics, negative life events, coping styles, and PTSD symptoms. Results: Academic pressure was the strongest predictor of adolescents' PTSD symptoms among all negative life events. Main effects of negative life events, positive coping and negative coping on PTSD symptoms were significant in both younger adolescents and older adolescents, while the moderator effects of two coping styles were found significant only within older adolescents. Conclusions: Coping may play a role to moderate the relationship between post-earthquake negative life events and PTSD symptom, but the function seems to depend on the age of participants. Psychosocial coping skills training may be important in the prevention and intervention of mental health problems in adolescent survivors of traumatic earthquake.	[Zheng, Yuhong; Fan, Fang; Liu, Xianchen; Mo, Lei] S China Normal Univ, Ctr Studies Psychol Applicat, Guangzhou, Guangdong, Peoples R China; [Liu, Xianchen] Indiana Univ, Dept Psychiat, Indianapolis, IN 46204 USA	South China Normal University; Indiana University System; Indiana University-Purdue University Indianapolis	Zheng, YH (corresponding author), S China Normal Univ, Ctr Studies Psychol Applicat, Guangzhou, Guangdong, Peoples R China.	fangfan@scnu.edu.cn	Fan, Fang/GRO-2696-2022; fan, fang/GQY-9173-2022		National Natural Science Foundation of China [31070920]; Chinese Ministry of Education [09YJAXLX008]; Key Laboratory of Mental Health and Cognitive Science of Guangdong Province; South China Normal University; Research Center for Crisis Intervention and Psychological Service of Guangdong Province, South China Normal University; Women's Federation of Chengdu, Sichuan Province; Research Program for Humanities and Social Science	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Education(Ministry of Education, China); Key Laboratory of Mental Health and Cognitive Science of Guangdong Province; South China Normal University; Research Center for Crisis Intervention and Psychological Service of Guangdong Province, South China Normal University; Women's Federation of Chengdu, Sichuan Province; Research Program for Humanities and Social Science	The present study was funded by National Natural Science Foundation of China (No. 31070920, http://www.nsfc.gov.cn/) and Research Program for Humanities and Social Science Granted by Chinese Ministry of Education (09YJAXLX008, http://www.sinoss.net/). This study was also supported by Key Laboratory of Mental Health and Cognitive Science of Guangdong Province, South China Normal University, and Research Center for Crisis Intervention and Psychological Service of Guangdong Province, South China Normal University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Boris Birmaher (University of Pittsburgh), who kindly assisted with the proofreading of the first draft. We also thank Dr. Elizabeth Ruiz (Governors State University) for her assistance in manuscript revision. We thank Fulei Geng and Lan Zhang in the work of data collection. We also want to express our sincere gratitude to the Women's Federation of Chengdu, Sichuan Province, for their support.	American Psychiatric Association, 1994, DIAGN STAT MAN; Asarnow J, 1999, J AM ACAD CHILD PSY, V38, P1016, DOI 10.1097/00004583-199908000-00018; Bal A, 2007, EUR CHILD ADOLES PSY, V16, P449, DOI 10.1007/s00787-007-0618-z; CARR VJ, 1995, PSYCHOL MED, V25, P539, DOI 10.1017/S0033291700033468; Chen SH, 2002, J CHIN INST ENG, V25, P597, DOI 10.1080/02533839.2002.9670734; Chengzhi Z, 2001, CHINESE MENTAL HLTH, V15, P145; Chinese Society of Psychiatry, 1995, CHIN CLASS MENT DISO; Cohen J., 2003, APPL MULTIPLE REGRES; Compas BE, 2001, PSYCHOL BULL, V127, P87, DOI 10.1037//0033-2909.127.1.87; Connor-Smith JK, 2002, COGNITIVE THER RES, V26, P39, DOI 10.1023/A:1013889504101; Edlynn ES, 2008, AM J ORTHOPSYCHIAT, V78, P249, DOI 10.1037/a0013948; Fan F, 2011, J TRAUMA STRESS, V24, P44, DOI 10.1002/jts.20599; Frazier PA, 2004, J COUNS PSYCHOL, V51, P115, DOI 10.1037/0022-0167.51.1.115; Giannopoulou I, 2006, EUR PSYCHIAT, V21, P160, DOI 10.1016/j.eurpsy.2005.09.005; Hsu CC, 2002, J AM ACAD CHILD PSY, V41, DOI 10.1097/00004583-200207000-00022; John Prashantham Baddam, 2007, Disaster Manag Response, V5, P3; Kishore Vimal, 2008, Am J Disaster Med, V3, P345; Lai TJ, 2004, J PSYCHIATR RES, V38, P313, DOI 10.1016/j.jpsychires.2003.08.005; Liu X., 1998, CHINESE J BEHAV MED, V7, P93, DOI DOI 10.1177/1524838015585313; Liu X.C., 1997, CHIN J CLIN PSYCHOL, V5, P39, DOI DOI 10.16128/J.CNKI.1005-3611.1997.01.011; Liu XC, 2005, J AFFECT DISORDERS, V86, P195, DOI 10.1016/j.jad.2005.01.016; Liu XC, 2004, PSYCHIAT RES, V126, P275, DOI 10.1016/j.psychres.2004.02.006; Liu XC, 1997, SOC PSYCH PSYCH EPID, V32, P63, DOI 10.1007/BF00788922; Liu XC, 2000, SLEEP, V23, P1053; Luthar SS, 2000, CHILD DEV, V71, P543, DOI 10.1111/1467-8624.00164; Maes M, 2001, PSYCHIAT RES, V105, P1, DOI 10.1016/S0165-1781(01)00325-0; MCFARLANE AC, 1987, J AM ACAD CHILD PSY, V26, P764, DOI 10.1097/00004583-198709000-00025; Neria Y, 2008, PSYCHIATRY, V71, P339, DOI 10.1521/psyc.2008.71.4.339; Norris FH, 2006, J TRAUMA STRESS, V19, P173, DOI 10.1002/jts.20109; Pina AA, 2008, J CLIN CHILD ADOLESC, V37, P564, DOI 10.1080/15374410802148228; Pineles SL, 2011, J ABNORM PSYCHOL, V120, P240, DOI 10.1037/a0022123; PYNOOS RS, 1993, BRIT J PSYCHIAT, V163, P239, DOI 10.1192/bjp.163.2.239; Roussos A, 2005, AM J PSYCHIAT, V162, P530, DOI 10.1176/appi.ajp.162.3.530; Schnider KR, 2007, J COUNS PSYCHOL, V54, P344, DOI 10.1037/0022-0167.54.3.344; Seiffge-Krenke I, 2005, J RES ADOLESCENCE, V15, P561, DOI 10.1111/j.1532-7795.2005.00111.x; Seiffge-Krenke I, 2004, EUR J DEV PSYCHOL, V1, P367, DOI 10.1080/17405629.2004.11453396; Stallard P, 2001, BRIT J CLIN PSYCHOL, V40, P197, DOI 10.1348/014466501163643; Thienkrua W, 2006, JAMA-J AM MED ASSOC, V296, P549, DOI 10.1001/jama.296.5.549; Udwin O, 2000, J CHILD PSYCHOL PSYC, V41, P969, DOI 10.1111/1469-7610.00685; Vernberg EM, 1996, J ABNORM PSYCHOL, V105, P237, DOI 10.1037/0021-843X.105.2.237; Weiten W., 2004, PSYCHOL THEMES VARIA, V6th; Wright M, 2010, J ABNORM CHILD PSYCH, V38, P405, DOI 10.1007/s10802-009-9375-4; Xie Y., 1998, CHINESE J CLIN PSYCH, V6, P114; [赵玉芳 ZHAO Yu-Fang], 2009, [心理科学进展, Advances in Psychological Science], V17, P511	44	30	34	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e29404	10.1371/journal.pone.0029404	http://dx.doi.org/10.1371/journal.pone.0029404			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	910ME	22295059	Green Published, gold			2022-12-25	WOS:000301640600004
J	Deng, SM; Yang, Y; Han, Y; Li, XF; Wang, XP; Li, XY; Zhang, ZP; Wang, YJ				Deng, Sanming; Yang, Ye; Han, Yong; Li, Xiaofei; Wang, Xiaoping; Li, Xueyong; Zhang, Zhipei; Wang, Yunjie			UCP2 Inhibits ROS-Mediated Apoptosis in A549 under Hypoxic Conditions	PLOS ONE			English	Article							UNCOUPLING PROTEIN-2; CANCER-CELLS; HEPG2 CELLS; MITOCHONDRIAL; EXPRESSION; PROTECTION; ACTIVATION	The Crosstalk between a tumor and its hypoxic microenvironment has become increasingly important. However, the exact role of UCP2 function in cancer cells under hypoxia remains unknown. In this study, UCP2 showed anti-apoptotic properties in A549 cells under hypoxic conditions. Over-expression of UCP2 in A549 cells inhibited reactive oxygen species (ROS) accumulation (P<0.001) and apoptosis (P<0.001) compared to the controls when the cells were exposed to hypoxia. Moreover, over-expression of UCP2 inhibited the release of cytochrome C and reduced the activation of caspase-9. Conversely, suppression of UCP2 resulted in the ROS generation (P=0.006), the induction of apoptosis (P<0.001), and the release of cytochrome C from mitochondria to the cytosolic fraction, thus activating caspase-9. These data suggest that over-expression of UCP2 has anti-apoptotic properties by inhibiting ROS-mediated apoptosis in A549 cells under hypoxic conditions.	[Deng, Sanming; Han, Yong; Li, Xiaofei; Wang, Xiaoping; Zhang, Zhipei; Wang, Yunjie] Fourth Mil Med Univ, Tangdu Hosp, Dept Thorac Surg, Xian 710032, Shaanxi Provinc, Peoples R China; [Deng, Sanming] Chinese Peoples Armed Police Force, Dept Thorac Surg, Hosp Med Coll, Tianjin, Peoples R China; [Yang, Ye] Shaanxi Prov Peoples Hosp, Dept Thorac Surg, Xian, Shaanxi Provinc, Peoples R China; [Li, Xueyong] Fourth Mil Med Univ, Tangdu Hosp, Dept Plast & Burns, Xian 710032, Shaanxi Provinc, Peoples R China	Air Force Military Medical University; Xi'an Medical University; Air Force Military Medical University	Deng, SM (corresponding author), Fourth Mil Med Univ, Tangdu Hosp, Dept Thorac Surg, Xian 710032, Shaanxi Provinc, Peoples R China.	wangyjphd@yahoo.cn	Li, xiaofei/GXF-7187-2022		Fourth Military Medical University	Fourth Military Medical University	All the financial support of this paper is from the Fourth Military Medical University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azzu V, 2010, TRENDS BIOCHEM SCI, V35, P298, DOI 10.1016/j.tibs.2009.11.001; Bae SK, 1998, CANCER LETT, V126, P97, DOI 10.1016/S0304-3835(97)00538-7; Baffy G, 2010, MITOCHONDRION, V10, P243, DOI 10.1016/j.mito.2009.12.143; Bodyak N, 2007, AM J PHYSIOL-HEART C, V293, pH829, DOI 10.1152/ajpheart.01409.2006; Chung YM, 2003, FREE RADICAL BIO MED, V34, P434, DOI 10.1016/S0891-5849(02)01301-1; Collins P, 2005, LIVER INT, V25, P880, DOI 10.1111/j.1478-3231.2005.01104.x; Derdak Z, 2008, CANCER RES, V68, P2813, DOI 10.1158/0008-5472.CAN-08-0053; Echtay KS, 2007, FREE RADICAL BIO MED, V43, P1351, DOI 10.1016/j.freeradbiomed.2007.08.011; Flachs P, 2007, FEBS LETT, V581, P1093, DOI 10.1016/j.febslet.2007.02.012; Guzy RD, 2005, CELL METAB, V1, P401, DOI 10.1016/j.cmet.2005.05.001; Hendriksen EM, 2009, MICROVASC RES, V77, P96, DOI 10.1016/j.mvr.2008.11.002; Ho PWL, 2010, NEUROTOX RES, V17, P332, DOI 10.1007/s12640-009-9109-y; Horimoto M, 2004, CLIN CANCER RES, V10, P6203, DOI 10.1158/1078-0432.CCR-04-0419; Jezek P, 1998, INT J BIOCHEM CELL B, V30, P1163, DOI 10.1016/S1357-2725(98)00076-4; Johnson  D., 1967, METHOD ENZYMOL, V10, P94, DOI DOI 10.1016/0076-6879(67)10018-9; Kim JY, 2003, FEBS LETT, V549, P94, DOI 10.1016/S0014-5793(03)00795-6; Lee SM, 2006, CANCER LETT, V242, P231, DOI 10.1016/j.canlet.2005.11.001; Liu B, 2008, FREE RADICAL BIO MED, V44, P1529, DOI 10.1016/j.freeradbiomed.2008.01.011; Liu XW, 2010, PHARMACOL RES, V62, P416, DOI 10.1016/j.phrs.2010.07.002; Mailloux RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013289; Munoz-Najar UM, 2006, ONCOGENE, V25, P2379, DOI 10.1038/sj.onc.1209273; Namgaladze D, 2010, ATHEROSCLEROSIS, V208, P142, DOI 10.1016/j.atherosclerosis.2009.07.020; Otrock ZK, 2009, CRIT REV ONCOL HEMAT, V70, P93, DOI 10.1016/j.critrevonc.2009.01.001; Pelicano H, 2004, DRUG RESIST UPDATE, V7, P97, DOI 10.1016/j.drup.2004.01.004; Piret JP, 2004, EXP CELL RES, V295, P340, DOI 10.1016/j.yexcr.2004.01.024; Plin C, 2004, EUR J PHARMACOL, V495, P111, DOI 10.1016/j.ejphar.2004.05.042; Rohwer N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012038; Santandreu FM, 2010, FREE RADICAL BIO MED, V49, P658, DOI 10.1016/j.freeradbiomed.2010.05.031; Savagner F, 2001, J CLIN ENDOCR METAB, V86, P4920, DOI 10.1210/jc.86.10.4920; Shyu KG, 2007, EXP CELL RES, V313, P1181, DOI 10.1016/j.yexcr.2007.01.013; Solaini G, 2010, BBA-BIOENERGETICS, V1797, P1171, DOI 10.1016/j.bbabio.2010.02.011; van Laarhoven HWM, 2006, INT J RADIAT ONCOL, V64, P473, DOI 10.1016/j.ijrobp.2005.07.982; Vaupel P, 2005, TRANSFUS CLIN BIOL, V12, P5, DOI 10.1016/j.tracli.2004.11.005; Yoshiba S, 2009, ORAL ONCOL, V45, P109, DOI 10.1016/j.oraloncology.2008.04.002; Zhang CY, 2001, CELL, V105, P745, DOI 10.1016/S0092-8674(01)00378-6	35	57	58	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2012	7	1							e30714	10.1371/journal.pone.0030714	http://dx.doi.org/10.1371/journal.pone.0030714			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910LV	22292025	Green Published, gold, Green Submitted			2022-12-25	WOS:000301639600049
J	Kajiho, H; Fukushima, S; Kontani, K; Katada, T				Kajiho, Hiroaki; Fukushima, Shinichi; Kontani, Kenji; Katada, Toshiaki			RINL, Guanine Nucleotide Exchange Factor Rab5-Subfamily, Is Involved in the EphA8-Degradation Pathway with Odin	PLOS ONE			English	Article							DOMAIN-CONTAINING PROTEINS; EPIDERMAL-GROWTH-FACTOR; SMALL GTPASE RAB5; MEMBRANE TRAFFICKING; ENDOCYTOSIS; BINDING; RECEPTOR; REGULATOR; TRANSPORT; DYNAMICS	The Rab family of small guanosine triphosphatases (GTPases) plays a vital role in membrane trafficking. Its active GTP-bound state is driven by guanine nucleotide-exchange factors (GEFs). Ras and Rab interactor (or Ras interaction/interference)-like (RINL), which contains a conserved VPS9 domain critical for GEF action, was recently identified as a new Rab5 subfamily GEF in vitro. However, its detailed function and interacting molecules have not yet been fully elucidated. Here we found that RINL has GEF activity for the Rab5 subfamily proteins by measuring their GTP-bound forms in cultured cells. We also found that RINL interacts with odin, a member of the ankyrin-repeat and sterile-alpha motif (SAM) domain-containing (Anks) protein family. In addition, the Eph tyrosine kinase receptor EphA8 formed a ternary complex with both RINL and odin. Interestingly, RINL expression in cultured cells reduced EphA8 levels in a manner dependent on both its GEF activity and interaction with odin. In addition, knockdown of RINL increased EphA8 level in HeLa cells. Our findings suggest that RINL, as a GEF for Rab5 subfamily, is implicated in the EphA8-degradation pathway via its interaction with odin.	[Kajiho, Hiroaki; Fukushima, Shinichi; Kontani, Kenji; Katada, Toshiaki] Univ Tokyo, Grad Sch Pharmaceut Sci, Dept Physiol Chem, Tokyo, Japan	University of Tokyo	Kajiho, H (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Dept Physiol Chem, Tokyo, Japan.	katada@mol.f.u-tokyo.ac.jp		Kajiho, Hiroaki/0000-0001-6376-7629	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; Japan Society for the Promotion of Science (JSPS)	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by research grants (to H.K., K.K. and T.K.) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan, and Japan Society for the Promotion of Science (JSPS) (URL: http://www.mext.go.jp/english/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Barbieri MA, 2000, J CELL BIOL, V151, P539, DOI 10.1083/jcb.151.3.539; Barbieri MA, 2003, J BIOL CHEM, V278, P32027, DOI 10.1074/jbc.M304324200; Carney DS, 2006, TRENDS CELL BIOL, V16, P27, DOI 10.1016/j.tcb.2005.11.001; Deininger K, 2008, P NATL ACAD SCI USA, V105, P12539, DOI 10.1073/pnas.0801174105; Delprato A, 2004, CELL, V118, P607, DOI 10.1016/j.cell.2004.08.009; Emaduddin M, 2008, CELL COMMUN SIGNAL, V6, P7; Hama H, 1999, J BIOL CHEM, V274, P15284, DOI 10.1074/jbc.274.21.15284; Horiuchi H, 1997, CELL, V90, P1149, DOI 10.1016/S0092-8674(00)80380-3; Kajiho H, 2003, J CELL SCI, V116, P4159, DOI 10.1242/jcs.00718; Kajiho H, J BIOL CHEM; Kauppi M, 2002, J CELL SCI, V115, P899; Kim J, 2010, MOL CELL BIOL, V30, P1582, DOI 10.1128/MCB.01605-09; Kimura T, 2006, J BIOL CHEM, V281, P10598, DOI 10.1074/jbc.M510531200; Mesa R, 2005, EXP CELL RES, V304, P339, DOI 10.1016/j.yexcr.2004.11.017; Otomo A, 2003, HUM MOL GENET, V12, P1671, DOI 10.1093/hmg/ddg184; Pfeffer SR, 2001, TRENDS CELL BIOL, V11, P487, DOI 10.1016/S0962-8924(01)02147-X; Saito K, 2005, METHOD ENZYMOL, V403, P276, DOI 10.1016/S0076-6879(05)03023-5; Saito K, 2002, J BIOL CHEM, V277, P3412, DOI 10.1074/jbc.M106276200; Sato M, 2005, NAT CELL BIOL, V7, P559, DOI 10.1038/ncb1261; Shin J, 2007, MOL CELL BIOL, V27, P8113, DOI 10.1128/MCB.00794-07; Simonsen A, 1998, NATURE, V394, P494, DOI 10.1038/28879; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Tall GG, 2001, DEV CELL, V1, P73, DOI 10.1016/S1534-5807(01)00008-9; Uhlik MT, 2005, J MOL BIOL, V345, P1, DOI 10.1016/j.jmb.2004.10.038; Weigert R, 2004, MOL BIOL CELL, V15, P3758, DOI 10.1091/mbc.E04-04-0342; Woller B, 2011, BBA-MOL CELL RES, V1813, P1198, DOI 10.1016/j.bbamcr.2011.03.005; Yoshikawa M, 2008, BIOCHEM BIOPH RES CO, V372, P168, DOI 10.1016/j.bbrc.2008.05.027; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhang XJ, 2006, J CELL SCI, V119, P1053, DOI 10.1242/jcs.02810	29	9	9	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30575	10.1371/journal.pone.0030575	http://dx.doi.org/10.1371/journal.pone.0030575			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22291991	Green Published, gold, Green Submitted			2022-12-25	WOS:000301570600061
J	Whitaker, N; Bageshwar, UK; Musser, SM				Whitaker, Neal; Bageshwar, Umesh K.; Musser, Siegfried M.			Kinetics of Precursor Interactions with the Bacterial Tat Translocase Detected by Real-time FRET	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TWIN-ARGININE TRANSLOCATION; SEC-INDEPENDENT PROTEIN; SIGNAL PEPTIDE BINDING; ESCHERICHIA-COLI; TRANSPORT-SYSTEM; FLUORESCENT PROTEIN; MEMBRANE-BINDING; PROTON GRADIENT; PATHWAY; STEP	The Escherichia coli twin-arginine translocation (Tat) system transports fully folded and assembled proteins across the inner membrane into the periplasmic space. Traditionally, in vitro protein translocation studies have been performed using gel-based transport assays. This technique suffers from low time resolution, and often, an inability to distinguish between different steps in a continuously occurring translocation process. To address these limitations, we have developed an in vitro FRET-based assay that reports on an early step in the Tat translocation process in real-time. The natural Tat substrate pre-SufI was labeled with Alexa532 (donor), and the fluorescent protein mCherry (acceptor) was fused to the C terminus of TatB or TatC. The colored Tat proteins were easily visible during purification, enabling identification of a highly active inverted membrane vesicle (IMV) fraction yielding transport rates with NADH almost an order of magnitude faster than previously reported. Whenpre-SufI was bound to the translocon, FRET was observed for both Tat proteins. FRET was diminished upon addition of nonfluorescent pre-SufI, indicating that the initial binding step is reversible. When the membranes were energized with NADH, the FRET signal was lost after a short delay. These data suggest a model in which a Tat cargo initially associates with the TatBC complex, and an electric field gradient is required for the cargo to proceed to the next stage of transport. This cargo migration away from the TatBC complex requires a significant fraction of the total transport time.	[Whitaker, Neal; Bageshwar, Umesh K.; Musser, Siegfried M.] Texas A&M Hlth Sci Ctr, Coll Med, Dept Mol & Cellular Med, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Musser, SM (corresponding author), Texas A&M Hlth Sci Ctr, Coll Med, Dept Mol & Cellular Med, 1114 TAMU, College Stn, TX 77843 USA.	smusser@tamu.edu			National Institutes of Health [R01 GM065534]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065534] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM065534 (to S. M. M.).	Alami M, 2003, MOL CELL, V12, P937, DOI 10.1016/S1097-2765(03)00398-8; Bageshwar UK, 2007, J CELL BIOL, V179, P87, DOI 10.1083/jcb.200702082; Bageshwar UK, 2009, MOL MICROBIOL, V74, P209, DOI 10.1111/j.1365-2958.2009.06862.x; Bendtsen JD, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-167; Berks BC, 2003, ADV MICROB PHYSIOL, V47, P187, DOI 10.1016/S0065-2911(03)47004-5; Bolhuis A, 2001, J BIOL CHEM, V276, P20213, DOI 10.1074/jbc.M100682200; Braun NA, 2007, BIOPHYS J, V93, P1993, DOI 10.1529/biophysj.106.098731; CASADABAN MJ, 1979, P NATL ACAD SCI USA, V76, P4530, DOI 10.1073/pnas.76.9.4530; Chong SR, 1998, NUCLEIC ACIDS RES, V26, P5109, DOI 10.1093/nar/26.22.5109; CLINE K, 1992, J BIOL CHEM, V267, P2688; de Leeuw E, 2002, J MOL BIOL, V322, P1135, DOI 10.1016/S0022-2836(02)00820-3; De Leeuw E, 2001, FEBS LETT, V506, P143, DOI 10.1016/S0014-5793(01)02904-0; Frielingsdorf S, 2007, J BIOL CHEM, V282, P24455, DOI 10.1074/jbc.M702630200; Frobel J, 2011, J BIOL CHEM, V286, P43679, DOI 10.1074/jbc.M111.292565; Gerard F, 2006, J BIOL CHEM, V281, P6130, DOI 10.1074/jbc.M512733200; Gerard F, 2007, J BIOL CHEM, V282, P5263, DOI 10.1074/jbc.M610337200; Gohlke U, 2005, P NATL ACAD SCI USA, V102, P10482, DOI 10.1073/pnas.0503558102; Holzapfel E, 2007, BIOCHEMISTRY-US, V46, P2892, DOI 10.1021/bi062205b; Hou B, 2006, J MOL BIOL, V355, P957, DOI 10.1016/j.jmb.2005.11.029; Jack RL, 2001, J BACTERIOL, V183, P1801, DOI 10.1128/JB.183.5.1801-1804.2001; Kreutzenbeck P, 2007, J BIOL CHEM, V282, P7903, DOI 10.1074/jbc.M610126200; Luke I, 2009, ARCH MICROBIOL, V191, P919, DOI 10.1007/s00203-009-0516-5; Maldonado B, 2011, J MOL MICROB BIOTECH, V20, P168, DOI 10.1159/000329076; Maurer C, 2010, MOL BIOL CELL, V21, P4151, DOI 10.1091/mbc.E10-07-0585; Mori H, 2002, J CELL BIOL, V157, P205, DOI 10.1083/jcb.200202048; MOULD RM, 1991, J BIOL CHEM, V266, P12189; Natale P, 2008, BBA-BIOMEMBRANES, V1778, P1735, DOI 10.1016/j.bbamem.2007.07.015; Panahandeh S, 2008, J BIOL CHEM, V283, P33267, DOI 10.1074/jbc.M804225200; Santini CL, 1998, EMBO J, V17, P101, DOI 10.1093/emboj/17.1.101; Sargent F, 2007, BIOCHEM SOC T, V35, P835, DOI 10.1042/BST0350835; Sargent F, 1998, EMBO J, V17, P3640, DOI 10.1093/emboj/17.13.3640; Sargent F, 1999, J BIOL CHEM, V274, P36073, DOI 10.1074/jbc.274.51.36073; Schlesier R, 2010, BIOL CHEM, V391, P1411, DOI 10.1515/BC.2010.138; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shanmugham A, 2006, BIOCHEMISTRY-US, V45, P2243, DOI 10.1021/bi052188a; Strauch EM, 2007, J MOL BIOL, V374, P283, DOI 10.1016/j.jmb.2007.09.050; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; Tarry MJ, 2009, P NATL ACAD SCI USA, V106, P13284, DOI 10.1073/pnas.0901566106; Thomas JD, 2001, MOL MICROBIOL, V39, P47, DOI 10.1046/j.1365-2958.2001.02253.x; Weiner JH, 1998, CELL, V93, P93, DOI 10.1016/S0092-8674(00)81149-6; Wexler M, 2000, J BIOL CHEM, V275, P16717, DOI 10.1074/jbc.M000800200; Yahr TL, 2001, EMBO J, V20, P2472, DOI 10.1093/emboj/20.10.2472; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9	43	25	25	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					11252	11260		10.1074/jbc.M111.324525	http://dx.doi.org/10.1074/jbc.M111.324525			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22315217	hybrid, Green Published			2022-12-25	WOS:000302780100053
J	Ao, ZJ; Jayappa, KD; Wang, BC; Zheng, YF; Wang, XX; Peng, JY; Yao, XJ				Ao, Zhujun; Jayappa, Kallesh Danappa; Wang, Binchen; Zheng, Yingfeng; Wang, Xiaoxia; Peng, Jinyu; Yao, Xiaojian			Contribution of Host Nucleoporin 62 in HIV-1 Integrase Chromatin Association and Viral DNA Integration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-PORE COMPLEX; IMMUNODEFICIENCY-VIRUS TYPE-1; ACUTE MYELOID-LEUKEMIA; P62 COMPLEX; PROTEASOMAL DEGRADATION; PROTEIN IMPORT; HUMAN GENOME; HUMAN-CELLS; REPLICATION; LEDGF/P75	HIV-1 integration is promoted by viral integrase (IN) and its cellular cofactors. The lens epithelium-derived growth factor (LEDGF/p75), an IN interacting cellular cofactor, has been shown to play an important role in HIV-1 chromatin targeting and integration. However, whether other cellular cofactors are also involved in viral replication steps is still elusive. Here, we show that nucleoporin 62 (Nup62) is a chromatin-bound protein and can specifically interact with HIV-1 IN in both soluble nuclear extract and chromatin-bound fractions. The knockdown of Nup62 by shRNA reduced the association of IN with host chromatin and significantly impaired viral integration and replication in HIV-1-susceptible cells. Furthermore, the expression of the IN-binding region of Nup62 in CD4(+) T cells significantly inhibited HIV-1 infection. Taken together, these results indicate that the cellular Nup62 is specifically recruited by HIV-1 IN and contribute to an efficient viral DNA integration.	[Ao, Zhujun; Jayappa, Kallesh Danappa; Wang, Binchen; Zheng, Yingfeng; Wang, Xiaoxia; Peng, Jinyu; Yao, Xiaojian] Univ Manitoba, Fac Med, Dept Med Microbiol, Lab Mol Human Retrovirol, Winnipeg, MB R3E 0J9, Canada	University of Manitoba	Yao, XJ (corresponding author), Univ Manitoba, Fac Med, Dept Med Microbiol, Lab Mol Human Retrovirol, 508 BMSB,745 William Ave, Winnipeg, MB R3E 0J9, Canada.	yao2@cc.umanitoba.ca	JAYAPPA, KALLESH DANAPPA/M-6571-2018; Zheng, Yingfeng/AAE-2983-2022	JAYAPPA, KALLESH DANAPPA/0000-0002-7239-5246; Yao, Xiaojian/0000-0002-5022-1309; Wang, Xiaoxia/0000-0002-6101-417X	Canadian Institutes of Health Research [HOP 81180, HBF 103212]; Canadian Foundation for AIDS Research [023-013]; Canadian Foundation of Innovation; Canadian Institutes of Health Research International Infectious Disease and Global Health; Manitoba Health Research Council/Manitoba Institute of Child Health; International Infectious Disease and Global Health Training Program; China Scholarship Council; Manitoba Medical Service Foundation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for AIDS Research; Canadian Foundation of Innovation(Canada Foundation for Innovation); Canadian Institutes of Health Research International Infectious Disease and Global Health(Canadian Institutes of Health Research (CIHR)); Manitoba Health Research Council/Manitoba Institute of Child Health; International Infectious Disease and Global Health Training Program; China Scholarship Council(China Scholarship Council); Manitoba Medical Service Foundation	This work was supported in part by Canadian Institutes of Health Research Grants HOP 81180 and HBF 103212, Canadian Foundation for AIDS Research Grant 023-013, and the Leaders Opportunity Fund Award from the Canadian Foundation of Innovation (to X.-J. Y.).; Recipient of a postdoctoral fellowship from the Canadian Institutes of Health Research International Infectious Disease and Global Health Training Program.; Recipient of scholarship from the Manitoba Health Research Council/Manitoba Institute of Child Health and from the International Infectious Disease and Global Health Training Program.; Recipient of a studentship from the China Scholarship Council.; Recipient of the Basic Science Career Development Research Award from the Manitoba Medical Service Foundation.	Alber F, 2007, NATURE, V450, P695, DOI 10.1038/nature06405; Ao Z, 2004, J VIROL, V78, P3170, DOI 10.1128/JVI.78.6.3170-3177.2004; Ao ZJ, 2007, J BIOL CHEM, V282, P13456, DOI 10.1074/jbc.M610546200; Ao ZJ, 2011, HUM GENE THER, V22, P1225, DOI 10.1089/hum.2010.012; Ao ZJ, 2010, J VIROL, V84, P8650, DOI 10.1128/JVI.00508-10; Ao ZJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001995; Ao ZJ, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-62; Bouyac-Bertoia M, 2001, MOL CELL, V7, P1025, DOI 10.1016/S1097-2765(01)00240-4; BUSS F, 1994, J CELL SCI, V107, P631; Capelson M, 2010, CELL, V140, P372, DOI 10.1016/j.cell.2009.12.054; CARMOFONSECA M, 1991, EUR J CELL BIOL, V55, P17; Casolari JM, 2004, CELL, V117, P427, DOI 10.1016/S0092-8674(04)00448-9; Cherepanov P, 2003, J BIOL CHEM, V278, P372, DOI 10.1074/jbc.M209278200; Christ F, 2008, CURR BIOL, V18, P1192, DOI 10.1016/j.cub.2008.07.079; Ciuffi A, 2005, NAT MED, V11, P1287, DOI 10.1038/nm1329; CORDES VC, 1993, EUR J CELL BIOL, V60, P185; Daigle N, 2001, J CELL BIOL, V154, P71, DOI 10.1083/jcb.200101089; DAVIS LI, 1987, P NATL ACAD SCI USA, V84, P7552, DOI 10.1073/pnas.84.21.7552; DAVIS LI, 1986, CELL, V45, P699, DOI 10.1016/0092-8674(86)90784-1; De Rijck J, 2006, J VIROL, V80, P11498, DOI 10.1128/JVI.00801-06; Desfarges S, 2010, VIRUSES-BASEL, V2, P111, DOI 10.3390/v2010111; Ebina H, 2004, MICROBES INFECT, V6, P715, DOI 10.1016/j.micinf.2004.04.002; Emiliani S, 2005, J BIOL CHEM, V280, P25517, DOI 10.1074/jbc.M501378200; Frey S, 2007, CELL, V130, P512, DOI 10.1016/j.cell.2007.06.024; Gallay P, 1997, P NATL ACAD SCI USA, V94, P9825, DOI 10.1073/pnas.94.18.9825; Griffis ER, 2004, MOL BIOL CELL, V15, P1991, DOI 10.1091/mbc.e03-10-0743; Griffis ER, 2002, MOL BIOL CELL, V13, P1282, DOI 10.1091/mbc.01-11-0538; GUAN TL, 1995, MOL BIOL CELL, V6, P1591, DOI 10.1091/mbc.6.11.1591; Han I, 1998, J CELL BIOCHEM, V68, P50, DOI 10.1002/(SICI)1097-4644(19980101)68:1<50::AID-JCB5>3.0.CO;2-V; Hetzer MW, 2005, ANNU REV CELL DEV BI, V21, P347, DOI 10.1146/annurev.cellbio.21.090704.151152; Hombrouck A, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030047; Hu TH, 1996, J CELL BIOL, V134, P589, DOI 10.1083/jcb.134.3.589; Ikeda T, 2004, J VIROL, V78, P11563, DOI 10.1128/JVI.78.21.11563-11573.2004; Kalverda B, 2010, CELL, V140, P360, DOI 10.1016/j.cell.2010.01.011; Kasper LH, 1999, MOL CELL BIOL, V19, P764; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; Lindsay ME, 2002, CELL, V110, P349, DOI 10.1016/S0092-8674(02)00836-X; Llano M, 2004, J BIOL CHEM, V279, P55570, DOI 10.1074/jbc.M408508200; Llano M, 2006, SCIENCE, V314, P461, DOI 10.1126/science.1132319; Maertens G, 2003, J BIOL CHEM, V278, P33528, DOI 10.1074/jbc.M303594200; Marshall WF, 2002, CURR BIOL, V12, pR185, DOI 10.1016/S0960-9822(02)00724-8; Melcak I, 2007, SCIENCE, V315, P1729, DOI 10.1126/science.1135730; Monette A, 2011, J CELL BIOL, V193, P619, DOI 10.1083/jcb.201008064; Morerio C, 2005, LEUKEMIA RES, V29, P467, DOI 10.1016/j.leukres.2004.09.002; Ocwieja KE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001313; Percipalle P, 1997, J MOL BIOL, V266, P722, DOI 10.1006/jmbi.1996.0801; Rabut G, 2004, NAT CELL BIOL, V6, P1114, DOI 10.1038/ncb1184; Romana SP, 2006, LEUKEMIA, V20, P696, DOI 10.1038/sj.leu.2404130; Schmid M, 2006, MOL CELL, V21, P379, DOI 10.1016/j.molcel.2005.12.012; Schroder ARW, 2002, CELL, V110, P521, DOI 10.1016/S0092-8674(02)00864-4; Schwarz-Herion K, 2007, J MOL BIOL, V370, P796, DOI 10.1016/j.jmb.2007.05.030; Shun MC, 2007, GENE DEV, V21, P1767, DOI 10.1101/gad.1565107; Van Impe K, 2008, TRAFFIC, V9, P695, DOI 10.1111/j.1600-0854.2008.00720.x; VONLINDERN M, 1992, MOL CELL BIOL, V12, P3346, DOI 10.1128/MCB.12.8.3346; VONLINDERN M, 1992, MOL CELL BIOL, V12, P1687, DOI 10.1128/MCB.12.4.1687; Wang GG, 2007, NAT CELL BIOL, V9, P804, DOI 10.1038/ncb1608; Woodward CL, 2009, J VIROL, V83, P6522, DOI 10.1128/JVI.02061-08; Wu XL, 2003, SCIENCE, V300, P1749, DOI 10.1126/science.1083413; Zheng YF, 2011, J BIOL CHEM, V286, P17722, DOI 10.1074/jbc.M110.184739; Zheng YF, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-68	60	26	26	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					10544	10555		10.1074/jbc.M111.317057	http://dx.doi.org/10.1074/jbc.M111.317057			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22308026	Green Published, hybrid			2022-12-25	WOS:000302167200080
J	Siddiqi, S; Mansbach, CM				Siddiqi, Shahzad; Mansbach, Charles M., II			Phosphorylation of Sar1b Protein Releases Liver Fatty Acid-binding Protein from Multiprotein Complex in Intestinal Cytosol Enabling It to Bind to Endoplasmic Reticulum (ER) and Bud the Pre-chylomicron Transport Vesicle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOLIPID-MEMBRANES; RETENTION DISEASE; LIPID ABSORPTION; APOLIPOPROTEIN-B; CARGO SELECTION; COPII VESICLES; GOLGI; COAT; IDENTIFICATION; RECEPTOR	Native cytosol requires ATP to initiate the budding of the pre-chylomicron transport vesicle from intestinal endoplasmic reticulum (ER). When FABP1 alone is used, no ATP is needed. Here, we test the hypothesis that in native cytosol FABP1 is present in a multiprotein complex that prevents FABP1 binding to the ER unless the complex is phosphorylated. We found on chromatography of native intestinal cytosol over a Sephacryl S-100 HR column that FABP1 (14 kDa) eluted in a volume suggesting a 75-kDa protein complex that contained four proteins on an anti-FABP1 antibody pulldown. The FABP1-containing column fractions were chromatographed over an anti-FABP1 antibody adsorption column. Proteins co-eluted from the column were identified as FABP1, Sar1b, Sec13, and small VCP/p97-interactive protein by immunoblot, LC-MS/MS, and MALDI-TOF. The four proteins of the complex had a total mass of 77 kDa and migrated on native PAGE at 75 kDa. When the complex was incubated with intestinal ER, there was no increase in FABP1-ER binding. However, when the complex member Sar1b was phosphorylated by PKC zeta and ATP, the complex completely disassembled into its component proteins that migrated at their monomer molecular weight on native PAGE. FABP1, freed from the complex, was now able to bind to intestinal ER and generate the pre-chylomicron transport vesicle (PCTV). No increase in ER binding or PCTV generation was observed in the absence of PKC zeta or ATP. We conclude that phosphorylation of Sar1b disrupts the FABP1-containing four-membered 75-kDa protein complex in cytosol enabling it to bind to the ER and generate PCTV.	[Siddiqi, Shahzad; Mansbach, Charles M., II] Univ Tennessee, Hlth Sci Ctr, Dept Med, Memphis, TN 38163 USA; [Mansbach, Charles M., II] Vet Affairs Med Ctr, Memphis, TN 38104 USA	University of Tennessee System; University of Tennessee Health Science Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Memphis VA Medical Center	Mansbach, CM (corresponding author), Univ Tennessee, Hlth Sci Ctr, Dept Med, Rm H210,956B Court Ave, Memphis, TN 38163 USA.	cmansbach@uthsc.edu			National Institutes of Health from NIDDK [DK074565]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074565] Funding Source: NIH RePORTER	National Institutes of Health from NIDDK; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK074565 from NIDDK (to C. M. M.).	Allen JR, 1997, J BIOL CHEM, V272, P32121, DOI 10.1074/jbc.272.51.32121; Alpers DH, 2000, BBA-MOL CELL BIOL L, V1483, P352, DOI 10.1016/S1388-1981(99)00200-0; Anandatheerthavarada HK, 1999, EMBO J, V18, P5494, DOI 10.1093/emboj/18.20.5494; Anderson C. M., 1961, MED J AUSTRALIA, V48, P617; Aridor M, 2001, J CELL BIOL, V152, P213, DOI 10.1083/jcb.152.1.213; Aridor M, 2000, J BIOL CHEM, V275, P35673, DOI 10.1074/jbc.C000449200; BARLOWE C, 1994, CELL, V77, P895, DOI 10.1016/0092-8674(94)90138-4; BASS NM, 1985, J BIOL CHEM, V260, P1432; BRESNICK EH, 1990, BIOCHEMISTRY-US, V29, P520, DOI 10.1021/bi00454a028; Cartwright IJ, 2001, J BIOL CHEM, V276, P48048, DOI 10.1074/jbc.M104229200; Ding L, 2011, J BIOL CHEM, V286, P27027, DOI 10.1074/jbc.M111.235176; Dudognon P, 2004, FEBS LETT, V561, P44, DOI 10.1016/S0014-5793(04)00109-7; Falomir-Lockhart LJ, 2011, BBA-MOL CELL BIOL L, V1811, P452, DOI 10.1016/j.bbalip.2011.04.005; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; Georges A, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-1; HIROSAWA M, 1993, COMPUT APPL BIOSCI, V9, P161; Jiang ZG, 2008, J MOL BIOL, V383, P1181, DOI 10.1016/j.jmb.2008.09.006; Jones B, 2003, NAT GENET, V34, P29, DOI 10.1038/ng1145; Kumar NS, 1997, AM J PHYSIOL-GASTR L, V273, pG18, DOI 10.1152/ajpgi.1997.273.1.G18; LUXON BA, 1993, AM J PHYSIOL, V265, pG831, DOI 10.1152/ajpgi.1993.265.5.G831; Luxon BA, 1997, AM J PHYSIOL-CELL PH, V273, pC859, DOI 10.1152/ajpcell.1997.273.3.C859; Mahan JT, 2001, AM J PHYSIOL-GASTR L, V280, pG1187, DOI 10.1152/ajpgi.2001.280.6.G1187; Mansbach CM, 1998, J LIPID RES, V39, P963; MANSBACH CM, 1982, J LIPID RES, V23, P1009; Miller E, 2002, EMBO J, V21, P6105, DOI 10.1093/emboj/cdf605; Miller EA, 2003, CELL, V114, P497, DOI 10.1016/S0092-8674(03)00609-3; Miller EA, 2010, CURR OPIN CELL BIOL, V22, P447, DOI 10.1016/j.ceb.2010.04.003; Neeli I, 2007, J BIOL CHEM, V282, P17974, DOI 10.1074/jbc.M610765200; Palmer KJ, 2005, J CELL SCI, V118, P3839, DOI 10.1242/jcs.02496; ROTHMAN JE, 1992, NATURE, V355, P409, DOI 10.1038/355409a0; ROY CC, 1987, GASTROENTEROLOGY, V92, P390, DOI 10.1016/0016-5085(87)90133-8; Sellin ME, 2011, MOL BIOL CELL, V22, P3152, DOI 10.1091/mbc.E11-03-0253; Sharpe LJ, 2011, TRAFFIC, V12, P19, DOI 10.1111/j.1600-0854.2010.01133.x; Shugrue CA, 1999, J CELL SCI, V112, P4547; Siddiqi SA, 2006, J CELL SCI, V119, P943, DOI 10.1242/jcs.02803; Siddiqi SA, 2003, J CELL SCI, V116, P415, DOI 10.1242/jcs.00215; Siddiqi SA, 2008, J CELL SCI, V121, P2327, DOI 10.1242/jcs.022780; Siddiqi SA, 2006, J BIOL CHEM, V281, P20974, DOI 10.1074/jbc.M601401200; Siddiqi S, 2010, J LIPID RES, V51, P1918, DOI 10.1194/jlr.M005611; Siddiqi S, 2010, J LIPID RES, V51, P1093, DOI 10.1194/jlr.M002758; Siddiqi S, 2010, BIOCHEM J, V429, P391, DOI 10.1042/BJ20100336; Storch J, 2008, ANNU REV NUTR, V28, P73, DOI 10.1146/annurev.nutr.27.061406.093710; STRALFORS P, 1990, FEBS LETT, V263, P153, DOI 10.1016/0014-5793(90)80726-Y; Thumser AEA, 2000, J LIPID RES, V41, P647; WALLACE BG, 1994, J CELL BIOL, V125, P661, DOI 10.1083/jcb.125.3.661; Young SG, 1995, J CLIN INVEST, V96, P2932, DOI 10.1172/JCI118365; ZILVERSMIT DB, 1967, FED PROC, V26, P1599	47	26	27	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					10178	10188		10.1074/jbc.M111.327247	http://dx.doi.org/10.1074/jbc.M111.327247			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22303004	Green Published, hybrid			2022-12-25	WOS:000302167200049
J	Svensson, H; Olofsson, V; Lundin, S; Yakkala, C; Bjorck, S; Borjesson, L; Gustavsson, B; Quiding-Jarbrink, M				Svensson, Helena; Olofsson, Veronica; Lundin, Samuel; Yakkala, Chakradhar; Bjorck, Stellan; Borjesson, Lars; Gustavsson, Bengt; Quiding-Jarbrink, Marianne			Accumulation of CCR4(+) CTLA-4(hi) FOXP3(+)CD25(hi) Regulatory T Cells in Colon Adenocarcinomas Correlate to Reduced Activation of Conventional T Cells	PLOS ONE			English	Article							COLORECTAL-CANCER; CHEMOKINE RECEPTORS; IMMUNE-RESPONSES; VASCULAR ADDRESSIN; EXPRESSION; RECRUITMENT; EFFECTOR; FOXP3; SUPPRESSION; PROGRESSION	Background: Colorectal cancer usually gives rise to a specific anti-tumor immune response, but for unknown reasons the resulting immunity is not able to clear the tumor. Recruitment of activated effector lymphocytes to the tumor is important for efficient anti-tumor responses, while the presence of regulatory T cells (Treg) down-modulate tumor-specific immunity. We therefore aimed to determine homing mechanisms and activation stage of Treg and effector T cell infiltrating colon tumors compared to cells from the unaffected mucosa in patients suffering from colon adenocarcinoma. Methodology/Principal Findings: Lymphocytes were isolated from unaffected and tumor mucosa from patients with colon adenocarcinoma, and flow cytometry, immunohistochemistry, and quantitative PCR was used to investigate the homing mechanisms and activation stage of infiltrating Treg and conventional lymphocytes. We detected significantly higher frequencies of CD25(high)FOXP3(+)CD127(low) putative Treg in tumors than unaffected mucosa, which had a complete demethylation in the FOXP3 promotor. Tumor-associated Treg had a high expression of CTLA-4, and some appeared to be antigen experienced effector/memory cells based on their expression of alpha E beta 7 (CD103). There were also significantly fewer activated T cells and more CTLA-4(+) conventional T cells susceptible to immune regulation in the tumor-associated mucosa. In contrast, CD8(+) granzyme B+ putative cytotoxic cells were efficiently recruited to the tumors. The frequencies of cells expressing alpha 4 beta 7 and the Th1 associated chemokine receptor CXCR3 were significantly decreased among CD4(+) T cells in the tumor, while frequencies of CD4(+)CCR4(+) lymphocytes were significantly increased. Conclusions/Significance: This study shows that CCR4(+)CTLA4(hi) Treg accumulate in colon tumors, while the frequencies of activated conventional Th1 type T cells are decreased. The altered lymphocyte composition in colon tumors will probably diminish the ability of the immune system to effectively attack tumor cells, and reducing the Treg activity is an important challenge for future immunotherapy protocols.	[Svensson, Helena; Olofsson, Veronica; Lundin, Samuel; Yakkala, Chakradhar; Quiding-Jarbrink, Marianne] Univ Gothenburg, Inst Biomed, Dept Microbiol & Immunol, Gothenburg, Sweden; [Bjorck, Stellan; Borjesson, Lars; Gustavsson, Bengt] Univ Gothenburg, Inst Clin Sci, Dept Surg, Gothenburg, Sweden	University of Gothenburg; University of Gothenburg	Svensson, H (corresponding author), Univ Gothenburg, Inst Biomed, Dept Microbiol & Immunol, Gothenburg, Sweden.	helena.svensson@microbio.gu.se	Quiding-JÃrbrink, Marianne/AAU-5746-2021	Quiding-JÃrbrink, Marianne/0000-0002-1978-8091; Svensson, Helena/0000-0001-6332-430X	Swedish Science Council [56X-13428]; Swedish Cancer Foundation [09 0748]; Sahlgrenska University Hospital [ALFGBG-144381]; Inga-Britt and Arne Lundberg's Foundation [354]; Professor Nanna Svartz's Foundation	Swedish Science Council; Swedish Cancer Foundation; Sahlgrenska University Hospital; Inga-Britt and Arne Lundberg's Foundation; Professor Nanna Svartz's Foundation	The work was supported by Swedish Science Council, 56X-13428 (www.vr.se); Swedish Cancer Foundation, 09 0748 (www.cancerfonden.se); Sahlgrenska University Hospital, ALFGBG-144381 (www.fou.nu/is/alfgbg); Inga-Britt and Arne Lundberg's Foundation, 354 (www.lundbergsstiftelsen.com); Professor Nanna Svartz's Foundation, (www.seb.se/pow/wcp/index). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agace WW, 2000, CURR OPIN CELL BIOL, V12, P563, DOI 10.1016/S0955-0674(00)00132-0; Anz D, 2011, INT J CANC; Bergquist C, 2000, J IMMUNOL METHODS, V234, P51, DOI 10.1016/S0022-1759(99)00213-6; BERLIN C, 1993, CELL, V74, P185, DOI 10.1016/0092-8674(93)90305-A; Bonecchi R, 1998, J EXP MED, V187, P129, DOI 10.1084/jem.187.1.129; Bonertz A, 2009, J CLIN INVEST, V119, P3311, DOI 10.1172/JCI39608; Cao XF, 2007, IMMUNITY, V27, P635, DOI 10.1016/j.immuni.2007.08.014; Christensen JE, 2006, J IMMUNOL, V176, P4235, DOI 10.4049/jimmunol.176.7.4235; Clarke SL, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000129; Correale P, 2010, J IMMUNOTHER, V33, P435, DOI 10.1097/CJI.0b013e3181d32f01; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Enarsson K, 2006, CLIN IMMUNOL, V118, P24, DOI 10.1016/j.clim.2005.08.001; Enarsson K, 2006, CLIN IMMUNOL, V121, P358, DOI 10.1016/j.clim.2006.07.002; Frey DM, 2010, INT J CANCER, V126, P2635, DOI 10.1002/ijc.24989; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Ganss R, 2004, EUR J IMMUNOL, V34, P2635, DOI 10.1002/eji.200425474; Han YM, 2009, J IMMUNOL, V182, P111, DOI 10.4049/jimmunol.182.1.111; Hiraoka N, 2006, CLIN CANCER RES, V12, P5423, DOI 10.1158/1078-0432.CCR-06-0369; Hung K, 1998, J EXP MED, V188, P2357, DOI 10.1084/jem.188.12.2357; Iellem A, 2001, J EXP MED, V194, P847, DOI 10.1084/jem.194.6.847; Janson PCJ, 2011, J IMMUNOL, V186, P92, DOI 10.4049/jimmunol.1000960; Jass JR, 2007, HISTOPATHOLOGY, V50, P113, DOI 10.1111/j.1365-2559.2006.02549.x; Kobayashi N, 2007, CLIN CANCER RES, V13, P902, DOI 10.1158/1078-0432.CCR-06-2363; Le Gouvello S, 2008, GUT, V57, P772, DOI 10.1136/gut.2007.123794; Ling Khoon Lin, 2007, Cancer Immun, V7, P7; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Lundgren A, 2005, INFECT IMMUN, V73, P523, DOI 10.1128/IAI.73.1.523-531.2005; Malmberg KJ, 2004, CANCER IMMUNOL IMMUN, V53, P879, DOI 10.1007/s00262-004-0577-x; Marelli-Berg FM, 2008, J PATHOL, V214, P179, DOI 10.1002/path.2269; Michel S, 2008, BRIT J CANCER, V99, P1867, DOI 10.1038/sj.bjc.6604756; MICHIE SA, 1993, AM J PATHOL, V143, P1688; Mohan K, 2005, EUR J IMMUNOL, V35, P1702, DOI 10.1002/eji.200425885; Nosho K, 2010, J PATHOL, V222, P350, DOI 10.1002/path.2774; Ren ZG, 2001, J GASTROEN HEPATOL, V16, P142, DOI 10.1046/j.1440-1746.2001.02385.x; Roncador G, 2005, EUR J IMMUNOL, V35, P1681, DOI 10.1002/eji.200526189; Ryschich E, 2002, INT J CANCER, V97, P719, DOI 10.1002/ijc.10074; Sakaguchi S, 2008, EUR J IMMUNOL, V38, P901, DOI 10.1002/eji.200890012; Salama P, 2009, J CLIN ONCOL, V27, P186, DOI 10.1200/JCO.2008.18.7229; Sallusto F, 2000, ANNU REV IMMUNOL, V18, P593, DOI 10.1146/annurev.immunol.18.1.593; Sansom DM, 2006, IMMUNOL REV, V212, P131, DOI 10.1111/j.0105-2896.2006.00419.x; Shen ZB, 2010, J CANCER RES CLIN, V136, P1585, DOI 10.1007/s00432-010-0816-9; Shibahara T, 2001, GASTROENTEROLOGY, V120, P60, DOI 10.1053/gast.2001.20904; Siewert C, 2008, J IMMUNOL, V180, P146, DOI 10.4049/jimmunol.180.1.146; Sinicrope FA, 2009, GASTROENTEROLOGY, V137, P1270, DOI 10.1053/j.gastro.2009.06.053; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Suzuki H, 2010, CANCER IMMUNOL IMMUN, V59, P653, DOI 10.1007/s00262-009-0781-9; Weitz J, 2005, LANCET, V365, P153, DOI 10.1016/S0140-6736(05)17706-X; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Yoon SH, 2009, EXP MOL MED, V41, P161, DOI 10.3858/emm.2009.41.3.019	49	50	53	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2012	7	2							e30695	10.1371/journal.pone.0030695	http://dx.doi.org/10.1371/journal.pone.0030695			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UG	22319577	gold, Green Submitted, Green Published			2022-12-25	WOS:000301977500015
J	Lu, YL; Zhang, K; Li, C; Yao, YL; Tao, DC; Liu, YQ; Zhang, SZ; Ma, YX				Lu, Yilu; Zhang, Kun; Li, Chao; Yao, Youlin; Tao, Dachang; Liu, Yunqiang; Zhang, Sizong; Ma, Yongxin			Piwil2 Suppresses P53 by Inducing Phosphorylation of Signal Transducer and Activator of Transcription 3 in Tumor Cells	PLOS ONE			English	Article							DNA-BINDING ACTIVITY; V-SRC; ARGONAUTE FAMILY; PROTEIN PIWIL2; GROWTH-FACTOR; HELA-CELLS; SMALL RNAS; STAT3; PATHWAY; IDENTIFICATION	Piwi proteins have been implicated in germ cell proliferation, differentiation, germline stem cell maintenance and transposon control in germline from Drosophila to mammals. The Piwi-like2 (piwil2) gene is mainly expressed in testis or embryonic cells among normal tissues but widely expressed in tumors. However, it remains to be fully determined through which mechanism piwil2 is involved in tumorigenesis. Here we report that Human piwil2, or Hili represses the tumor suppressor P53 in human cancer cells. Immunoprecipitation analysis shows that Piwil2 can directly associate with Signal Transducer and Activator of Transcription 3 (STAT3) protein via its PAZ domain and form a Piwil2/STAT3/c-Src triple protein-protein complex. Furthermore, STAT3 is phosphorylated by c-Src and translocated to nucleus, then binds to P53 promoter and represses its transcription. The present study demonstrated that Piwil2 plays a role in anti-apoptosis in tumor cells possessing P53 as a positive regulator of STAT3 signaling pathway, providing novel sights into roles of Piwil2 in tumorigenesis.	[Lu, Yilu; Zhang, Kun; Li, Chao; Yao, Youlin; Tao, Dachang; Liu, Yunqiang; Zhang, Sizong; Ma, Yongxin] Sichuan Univ, Dept Med Genet, W China Hosp, State Key Lab Biotherapy,Div Morbid Genom, Chengdu 610064, Peoples R China	Sichuan University	Lu, YL (corresponding author), Sichuan Univ, Dept Med Genet, W China Hosp, State Key Lab Biotherapy,Div Morbid Genom, Chengdu 610064, Peoples R China.	mayongxin@gmail.com			National Natural Science Foundation of China [90919006, 31070676]; Trans-Century Training Programme Foundation for the Talents by the Ministry of Education of China [NCET-07-0580]; Ministry of Education of China [Z2009-1-61003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Trans-Century Training Programme Foundation for the Talents by the Ministry of Education of China; Ministry of Education of China(Ministry of Education, China)	This work is supported by the National Natural Science Foundation of China (90919006 and 31070676), Trans-Century Training Programme Foundation for the Talents by the Ministry of Education of China (grant no. NCET-07-0580) and Spring Sunshine Programme by the Ministry of Education of China (grant no. Z2009-1-61003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravin AA, 2007, SCIENCE, V318, P761, DOI 10.1126/science.1146484; Bowman T, 2000, ONCOGENE, V19, P2474, DOI 10.1038/sj.onc.1203527; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Bromberg JF, 1998, MOL CELL BIOL, V18, P2553, DOI 10.1128/MCB.18.5.2553; Burdon T, 2002, TRENDS CELL BIOL, V12, P432, DOI 10.1016/S0962-8924(02)02352-8; Cao XM, 1996, MOL CELL BIOL, V16, P1595; Carmell MA, 2002, GENE DEV, V16, P2733, DOI 10.1101/gad.1026102; Carmell MA, 2007, DEV CELL, V12, P503, DOI 10.1016/j.devcel.2007.03.001; Chaturvedi P, 1997, MOL CELL BIOL, V17, P3295, DOI 10.1128/MCB.17.6.3295; Cox DN, 1998, GENE DEV, V12, P3715, DOI 10.1101/gad.12.23.3715; Deng W, 2002, DEV CELL, V2, P819, DOI 10.1016/S1534-5807(02)00165-X; Farazi TA, 2008, DEVELOPMENT, V135, P1201, DOI 10.1242/dev.005629; Feng DQ, 2009, ONCOL REP, V22, P1129, DOI 10.3892/or_00000545; Fridman JS, 2003, ONCOGENE, V22, P9030, DOI 10.1038/sj.onc.1207116; HAUPT Y, 1995, GENE DEV, V9, P2170, DOI 10.1101/gad.9.17.2170; HOPPESEYLER F, 1993, J VIROL, V67, P3111, DOI 10.1128/JVI.67.6.3111-3117.1993; Houwing S, 2007, CELL, V129, P69, DOI 10.1016/j.cell.2007.03.026; Kuramochi-Miyagawa S, 2004, DEVELOPMENT, V131, P839, DOI 10.1242/dev.00973; Lee JH, 2010, CANCER RES, V70, P4569, DOI 10.1158/0008-5472.CAN-09-2670; Lee JH, 2006, MOL REPROD DEV, V73, P173, DOI 10.1002/mrd.20391; Lee JH, 2006, HUM MOL GENET, V15, P201, DOI 10.1093/hmg/ddi430; Liang SF, 2010, PROTEOMICS, V10, P1474, DOI 10.1002/pmic.200900649; Lin J, 2002, ONCOGENE, V21, P3082, DOI 10.1038/sj.onc.1205426; Lu YL, 2010, BMB REP, V43, P635, DOI 10.3858/BMBRep.2010.43.9.635; Murray PJ, 2007, J IMMUNOL, V178, P2623, DOI 10.4049/jimmunol.178.5.2623; Niu GL, 2005, MOL CELL BIOL, V25, P7432, DOI 10.1128/MCB.25.17.7432-7440.2005; SADOWSKI HB, 1993, SCIENCE, V261, P1739, DOI 10.1126/science.8397445; Sasaki T, 2003, GENOMICS, V82, P323, DOI 10.1016/S0888-7543(03)00129-0; SEIDEL HM, 1995, P NATL ACAD SCI USA, V92, P3041, DOI 10.1073/pnas.92.7.3041; Seto AG, 2007, MOL CELL, V26, P603, DOI 10.1016/j.molcel.2007.05.021; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Ye Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013406; YU CL, 1995, SCIENCE, V269, P81, DOI 10.1126/science.7541555; Zamore PD, 2005, SCIENCE, V309, P1519, DOI 10.1126/science.1111444; ZHONG Z, 1994, SCIENCE, V264, P95, DOI 10.1126/science.8140422	35	67	70	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2012	7	1							e30999	10.1371/journal.pone.0030999	http://dx.doi.org/10.1371/journal.pone.0030999			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911GB	22303479	Green Published, Green Submitted, gold			2022-12-25	WOS:000301704200053
J	Johansson, AL; Collins, R; Arner, ESJ; Brzezinski, P; Hogbom, M				Johansson, Ann-Louise; Collins, Ruairi; Arner, Elias S. J.; Brzezinski, Peter; Hogbom, Martin			Biochemical Discrimination between Selenium and Sulfur 2: Mechanistic Investigation of the Selenium Specificity of Human Selenocysteine Lyase	PLOS ONE			English	Article							SYNECHOCYSTIS-SP PCC-6803; NIFS-LIKE PROTEIN; ESCHERICHIA-COLI; CYSTEINE DESULFURASE; PERSULFIDE INTERMEDIATE; DELIVERY PROTEIN; GENE CLONING; BETA-LYASE; C-DES; PURIFICATION	Selenium is an essential trace element incorporated into selenoproteins as selenocysteine. Selenocysteine (Sec) lyases (SCLs) and cysteine (Cys) desulfurases (CDs) catalyze the removal of selenium or sulfur from Sec or Cys, respectively, and generally accept both substrates. Intriguingly, human SCL (hSCL) is specific for Sec even though the only difference between Sec and Cys is a single chalcogen atom. The crystal structure of hSCL was recently determined and gain-of-function protein variants that also could accept Cys as substrate were identified. To obtain mechanistic insight into the chemical basis for its substrate discrimination, we here report time-resolved spectroscopic studies comparing the reactions of the Sec-specific wild-type hSCL and the gain-of-function D146K/H389T variant, when given Cys as a substrate. The data are interpreted in light of other studies of SCL/CD enzymes and offer mechanistic insight into the function of the wild-type enzyme. Based on these results and previously available data we propose a reaction mechanism whereby the Sec over Cys specificity is achieved using a combination of chemical and physico-mechanical control mechanisms.	[Johansson, Ann-Louise; Brzezinski, Peter; Hogbom, Martin] Stockholm Univ, Arrhenius Labs Nat Sci C4, Stockholm Ctr Biomembrane Res, Dept Biochem & Biophys, S-10691 Stockholm, Sweden; [Collins, Ruairi] Karolinska Inst, Dept Med Biochem & Biophys, Struct Genom Consortium, Stockholm, Sweden; [Arner, Elias S. J.] Karolinska Inst, Dept Med Biochem & Biophys, Div Biochem, Stockholm, Sweden	Stockholm University; Karolinska Institutet; Karolinska Institutet	Johansson, AL (corresponding author), Stockholm Univ, Arrhenius Labs Nat Sci C4, Stockholm Ctr Biomembrane Res, Dept Biochem & Biophys, S-10691 Stockholm, Sweden.	hogbom@dbb.su.se	Arnér, Elias/K-6737-2019; Arnér, Elias S.J./J-5832-2012	Arnér, Elias/0000-0002-4807-6114; Arnér, Elias S.J./0000-0002-4807-6114; Hogbom, Martin/0000-0001-5574-9383	Swedish Cancer Society; Swedish Research Council [2010-5061]; Swedish Foundation for Strategic Research; Knut and Alice Wallenberg foundation; Canadian Institutes for Health Research; Canadian Foundation for Innovation; Genome Canada through Ontario Genomics Institute; GlaxoSmithKline; Karolinska Institutet; Ontario Innovation Trust; Ontario Ministry for Research and Innovation; Merck Co., Inc.; Novartis Research Foundation; Swedish Agency for Innovation Systems; Wellcome Trust	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Knut and Alice Wallenberg foundation(Knut & Alice Wallenberg Foundation); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Genome Canada through Ontario Genomics Institute(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Karolinska Institutet(Karolinska Institutet); Ontario Innovation Trust; Ontario Ministry for Research and Innovation(Ministry of Research and Innovation, Ontario); Merck Co., Inc.(Merck & Company); Novartis Research Foundation; Swedish Agency for Innovation Systems(Vinnova); Wellcome Trust(Wellcome TrustEuropean Commission)	This study was supported by the Swedish Cancer Society to MH and ESJA, the Swedish Research Council (2010-5061), the Swedish Foundation for Strategic Research, and the Knut and Alice Wallenberg foundation to MH. The Structural Genomics Consortium is a registered charity (number 1097737) that receives funds from the Canadian Institutes for Health Research, the Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, Karolinska Institutet, the Knut and Alice Wallenberg Foundation, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, Merck & Co., Inc., the Novartis Research Foundation, the Swedish Agency for Innovation Systems, the Swedish Foundation for Strategic Research and the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allmang C, 2009, BBA-GEN SUBJECTS, V1790, P1415, DOI 10.1016/j.bbagen.2009.03.003; Angstwurm MWA, 2006, CURR OPIN CLIN NUTR, V9, P233, DOI 10.1097/01.mco.0000222105.30795.7f; Arner ESJ, 2010, EXP CELL RES, V316, P1296, DOI 10.1016/j.yexcr.2010.02.032; Behshad E, 2004, BIOCHEMISTRY-US, V43, P12220, DOI 10.1021/bi049143e; Behshad E, 2009, BIOCHEMISTRY-US, V48, P12014, DOI 10.1021/bi802161u; Campanini B, 2006, J BIOL CHEM, V281, P38769, DOI 10.1074/jbc.M607098200; Carlson BA, 2004, P NATL ACAD SCI USA, V101, P12848, DOI 10.1073/pnas.0402636101; Collins R, 2012, PLOS ONE IN PRESS; DAHER R, 1992, J TRACE ELEM ELECT H, V6, P189; ESAKI N, 1985, ARCH BIOCHEM BIOPHYS, V238, P418, DOI 10.1016/0003-9861(85)90182-1; ESAKI N, 1982, J BIOL CHEM, V257, P4386; Hondal RJ, 2011, AMINO ACIDS, V41, P73, DOI 10.1007/s00726-010-0494-6; Kaiser JT, 2000, J MOL BIOL, V297, P451, DOI 10.1006/jmbi.2000.3581; Kaiser JT, 2003, J BIOL CHEM, V278, P357, DOI 10.1074/jbc.M209862200; Lacourciere GM, 1998, J BIOL CHEM, V273, P30921, DOI 10.1074/jbc.273.47.30921; Letavayova L, 2006, TOXICOLOGY, V227, P1, DOI 10.1016/j.tox.2006.07.017; Lima CD, 2002, J MOL BIOL, V315, P1199, DOI 10.1006/jmbi.2001.5308; Mihara H, 2000, J BIOCHEM-TOKYO, V127, P559, DOI 10.1093/oxfordjournals.jbchem.a022641; Mihara H, 2000, J BIOL CHEM, V275, P6195, DOI 10.1074/jbc.275.9.6195; Mihara H, 2002, J BIOCHEM, V131, P679, DOI 10.1093/oxfordjournals.jbchem.a003151; Mihara H, 1997, J BIOL CHEM, V272, P22417, DOI 10.1074/jbc.272.36.22417; Mihara H, 1999, J BIOL CHEM, V274, P14768, DOI 10.1074/jbc.274.21.14768; Olmo M, 2002, J BIOCHEM, V132, P433, DOI 10.1093/oxfordjournals.jbchem.a003240; Omi R, 2010, J BIOL CHEM, V285, P12133, DOI 10.1074/jbc.M109.084475; Reich HJ, 2002, HELV CHIM ACTA, V85, P3748, DOI 10.1002/1522-2675(200211)85:11<3748::AID-HLCA3748>3.0.CO;2-0; Schomburg L, 2004, CELL MOL LIFE SCI, V61, P1988, DOI 10.1007/s00018-004-4114-z; Seebach D, 1977, LIEBIGS ANN CHEM, P846; Suzuki KT, 2007, BBA-GEN SUBJECTS, V1770, P1053, DOI 10.1016/j.bbagen.2007.03.007; Tirupati B, 2004, BIOCHEMISTRY-US, V43, P12210, DOI 10.1021/bi0491447; Xu XM, 2007, PLOS BIOL, V5, P96, DOI 10.1371/journal.pbio.0050004; Yoshizawa S, 2009, BBA-GEN SUBJECTS, V1790, P1404, DOI 10.1016/j.bbagen.2009.03.010; Yuan J, 2006, P NATL ACAD SCI USA, V103, P18923, DOI 10.1073/pnas.0609703104; ZHENG LM, 1993, P NATL ACAD SCI USA, V90, P2754, DOI 10.1073/pnas.90.7.2754; ZHENG LM, 1994, BIOCHEMISTRY-US, V33, P4714, DOI 10.1021/bi00181a031	34	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2012	7	1							e30528	10.1371/journal.pone.0030528	http://dx.doi.org/10.1371/journal.pone.0030528			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911FX	22291978	Green Published, gold, Green Submitted			2022-12-25	WOS:000301703800019
J	Whalan, S; Webster, NS; Negri, AP				Whalan, Steve; Webster, Nicole S.; Negri, Andrew P.			Crustose Coralline Algae and a Cnidarian Neuropeptide Trigger Larval Settlement in Two Coral Reef Sponges	PLOS ONE			English	Article							SCLERACTINIAN CORAL; BALANUS-AMPHITRITE; BROODING CORALS; METAMORPHOSIS; BEHAVIOR; RECRUITMENT; INDUCTION; BIOFILMS; QUALITY; LIGHT	In sessile marine invertebrates, larval settlement is fundamental to population maintenance and persistence. Cues contributing to the settlement choices and metamorphosis of larvae have important implications for the success of individuals and populations, but cues mediating larval settlement for many marine invertebrates are largely unknown. This study assessed larval settlement in two common Great Barrier Reef sponges, Coscinoderma matthewsi and Rhopaloeides odorabile, to cues that enhance settlement and metamorphosis in various species of scleractinian coral larvae. Methanol extracts of the crustose coralline algae (CCA), Porolithon onkodes, corresponding to a range of concentrations, were used to determine the settlement responses of sponge larvae. Cnidarian neuropeptides (GLW-amide neuropeptides) were also tested as a settlement cue. Settlement in both sponge species was approximately two-fold higher in response to live chips of CCA and optimum concentrations of CCA extract compared to 0.2 mu m filtered sea water controls. Metamorphosis also increased when larvae were exposed to GLW-amide neuropeptides; R. odorabile mean metamorphosis reached 42.0 +/- 5.8% compared to 16.0 +/- 2.4% in seawater controls and in C. matthewsi mean metamorphosis reached 68.3 +/- 5.4% compared to 36.7 +/- 3.3% in seawater controls. These results demonstrate the contributing role chemosensory communication plays in the ability of sponge larvae to identify suitable habitat for successful recruitment. It also raises the possibility that larvae from distinct phyla may share signal transduction pathways involved in metamorphosis.	[Whalan, Steve] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia; [Webster, Nicole S.; Negri, Andrew P.] Australian Inst Marine Sci, Townsville, Qld 4810, Australia	James Cook University; Australian Institute of Marine Science	Whalan, S (corresponding author), So Cross Univ, Sch Environm Sci & Management, Lismore, NSW 2480, Australia.	stephen.whalan@scu.edu.au	Webster, Nicole S/G-4980-2011; Negri, Andrew P/G-9909-2017	Webster, Nicole S/0000-0002-4753-5278; Negri, Andrew P/0000-0003-1388-7395; Whalan, Steve/0000-0001-6786-8945	Australian Research Council [LP990664]	Australian Research Council(Australian Research Council)	This work was funded through an Australian Research Council linkage grant with Reef HQ to SW (LP990664). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul Wahab MA, 2011, CORAL REEFS, V30, P451, DOI 10.1007/s00338-011-0727-5; Baird AH, 2004, MAR FRESHWATER RES, V55, P469, DOI 10.1071/MF03121; Bannister RJ, 2007, MAR FRESHWATER RES, V58, P624, DOI 10.1071/MF07011; Campbell AH, 2011, BIOFOULING, V27, P255, DOI 10.1080/08927014.2011.560384; Elbourne PD, 2010, J EXP MAR BIOL ECOL, V392, P99, DOI 10.1016/j.jembe.2010.04.013; Erwin PM, 2010, CORAL REEFS, V29, P929, DOI 10.1007/s00338-010-0634-1; Ettinger-Epstein P, 2008, MAR ECOL PROG SER, V365, P103, DOI 10.3354/meps07503; Fabricius K, 2001, CORAL REEFS, V19, P303, DOI 10.1007/s003380000120; Golbuu Y, 2007, MAR BIOL, V152, P639, DOI 10.1007/s00227-007-0717-x; Grasso LC, 2011, DEV BIOL, V353, P411, DOI 10.1016/j.ydbio.2011.02.010; Hadfield MG, 2011, ANNU REV MAR SCI, V3, P453, DOI 10.1146/annurev-marine-120709-142753; Harii S, 2002, MAR BIOL, V141, P39, DOI 10.1007/s00227-002-0812-y; Harrington L, 2004, ECOLOGY, V85, P3428, DOI 10.1890/04-0298; Hay ME, 2009, ANNU REV MAR SCI, V1, P193, DOI 10.1146/annurev.marine.010908.163708; Heyward AJ, 1999, CORAL REEFS, V18, P273, DOI 10.1007/s003380050193; Iwao K, 2002, CORAL REEFS, V21, P127, DOI 10.1007/s00338-002-0219-8; Kitamura M, 2007, J EXP MAR BIOL ECOL, V340, P96, DOI 10.1016/j.jembe.2006.08.012; Lasker HR, 1996, J EXP MAR BIOL ECOL, V207, P161, DOI 10.1016/S0022-0981(96)02625-1; MAIDA M, 1994, J EXP MAR BIOL ECOL, V180, P189, DOI 10.1016/0022-0981(94)90066-3; Maldonado M, 1998, MAR ECOL PROG SER, V174, P141, DOI 10.3354/meps174141; Maruzzo D, 2011, BIOFOULING, V27, P225, DOI 10.1080/08927014.2011.555534; Mercier A, 2009, CAN J ZOOL, V87, P967, DOI 10.1139/Z09-085; Morse ANC, 1996, BIOL BULL, V191, P149, DOI 10.2307/1542917; MORSE ANC, 1984, J EXP MAR BIOL ECOL, V75, P191, DOI 10.1016/0022-0981(84)90166-7; MORSE DE, 1988, J EXP MAR BIOL ECOL, V116, P193, DOI 10.1016/0022-0981(88)90027-5; Mundy CN, 1998, J EXP MAR BIOL ECOL, V223, P235, DOI 10.1016/S0022-0981(97)00167-6; Nelson WA, 2009, MAR FRESHWATER RES, V60, P787, DOI 10.1071/MF08335; Nozawa Y, 2011, ZOOL STUD, V50, P53; PAWLIK JR, 1992, OCEANOGR MAR BIOL, V30, P273; Raimondi PT, 2000, ECOLOGY, V81, P3193, DOI 10.1890/0012-9658(2000)081[3193:TCOCLB]2.0.CO;2; Ritson-Williams R, 2010, CORAL REEFS, V29, P71, DOI 10.1007/s00338-009-0555-z; Schmich J, 1998, DEV GENES EVOL, V208, P267, DOI 10.1007/s004270050181; Srivastava M, 2010, NATURE, V466, P720, DOI 10.1038/nature09201; Takahashi T, 1997, P NATL ACAD SCI USA, V94, P1241, DOI 10.1073/pnas.94.4.1241; Tebben J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019082; TOONEN RJ, 1994, NATURE, V370, P511, DOI 10.1038/370511a0; Webster NS, 2004, APPL ENVIRON MICROB, V70, P1213, DOI 10.1128/AEM.70.2.1213-1221.2004; Whalan S, 2008, MAR ECOL PROG SER, V368, P145, DOI 10.3354/meps07573; Whalan S, 2008, CORAL REEFS, V27, P783, DOI 10.1007/s00338-008-0400-9; Whalan S, 2007, MAR BIOL, V153, P163, DOI 10.1007/s00227-007-0792-z; Whalan S, 2007, CORAL REEFS, V26, P655, DOI 10.1007/s00338-007-0236-8	41	36	36	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e30386	10.1371/journal.pone.0030386	http://dx.doi.org/10.1371/journal.pone.0030386			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910ME	22295083	Green Published, Green Accepted, gold			2022-12-25	WOS:000301640600028
J	Ambrosone, A; Marchesano, V; Tino, A; Hobmayer, B; Tortiglione, C				Ambrosone, Alfredo; Marchesano, Valentina; Tino, Angela; Hobmayer, Bert; Tortiglione, Claudia			Hymyc1 Downregulation Promotes Stem Cell Proliferation in Hydra vulgaris	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; C-MYC; CAENORHABDITIS-ELEGANS; GENETIC INTERFERENCE; CYCLE KINETICS; IN-VIVO; EXPRESSION; DIFFERENTIATION; ATTENUATA; GROWTH	Hydra is a unique model for studying the mechanisms underlying stem cell biology. The activity of the three stem cell lineages structuring its body constantly replenishes mature cells lost due to normal tissue turnover. By a poorly understood mechanism, stem cells are maintained through self-renewal while concomitantly producing differentiated progeny. In vertebrates, one of many genes that participate in regulating stem cell homeostasis is the protooncogene c-myc, which has been recently identified also in Hydra, and found expressed in the interstitial stem cell lineage. In the present paper, by developing a novel strategy of RNA interference-mediated gene silencing (RNAi) based on an enhanced uptake of small interfering RNAi (siRNA), we provide molecular and biological evidence for an unexpected function of the Hydra myc gene (Hymyc1) in the homeostasis of the interstitial stem cell lineage. We found that Hymyc1 inhibition impairs the balance between stem cell self renewal/differentiation, as shown by the accumulation of stem cell intermediate and terminal differentiation products in genetically interfered animals. The identical phenotype induced by the 10058-F4 inhibitor, a disruptor of c-Myc/Max dimerization, demonstrates the specificity of the RNAi approach. We show the kinetic and the reversible feature of Hymyc1 RNAi, together with the effects displayed on regenerating animals. Our results show the involvement of Hymyc1 in the control of interstitial stem cell dynamics, provide new clues to decipher the molecular control of the cell and tissue plasticity in Hydra, and also provide further insights into the complex myc network in higher organisms. The ability of Hydra cells to uptake double stranded RNA and to trigger a RNAi response lays the foundations of a comprehensive analysis of the RNAi response in Hydra allowing us to track back in the evolution and the origin of this process.	[Ambrosone, Alfredo; Marchesano, Valentina; Tino, Angela; Tortiglione, Claudia] CNR, Ist Cibernet E Caianiello, Pozzuoli, Italy; [Hobmayer, Bert] Univ Innsbruck, Inst Zool, A-6020 Innsbruck, Austria; [Hobmayer, Bert] Univ Innsbruck, Ctr Mol Biosci, A-6020 Innsbruck, Austria	Consiglio Nazionale delle Ricerche (CNR); Istituto di Cibernetica "Eduardo Caianiello" (ICIB-CNR); University of Innsbruck; University of Innsbruck	Ambrosone, A (corresponding author), CNR, Ist Cibernet E Caianiello, Pozzuoli, Italy.	c.tortiglione@cib.na.cnr.it	Tortiglione, Claudia/N-3290-2019; Tino, Angela/E-8425-2014; Tortiglione, Claudia/K-5200-2014	Tortiglione, Claudia/0000-0003-1447-7611; Tino, Angela/0000-0002-9673-1064; Tortiglione, Claudia/0000-0003-1447-7611; Marchesano, Valentina/0000-0001-8140-3191; Ambrosone, Alfredo/0000-0002-1897-4028	NanoSci-ERA net project NANOTRUCK; Austrian Science Fund (FWF) [P 20734] Funding Source: researchfish	NanoSci-ERA net project NANOTRUCK; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the NanoSci-ERA net project NANOTRUCK (2009-2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMATI B, 1993, CELL, V72, P233, DOI 10.1016/0092-8674(93)90663-B; ASKEW DS, 1991, ONCOGENE, V6, P1915; Bode HR, 1996, J CELL SCI, V109, P1155; Bosch TCG, 2009, BIOESSAYS, V31, P478, DOI 10.1002/bies.200800183; CAMPBELL RD, 1974, J CELL SCI, V16, P349; Cardenas MM, 2003, DEV BIOL, V264, P495, DOI 10.1016/j.ydbio.2003.08.022; Castanotto D, 2009, NATURE, V457, P426, DOI 10.1038/nature07758; Chera S, 2006, J CELL SCI, V119, P846, DOI 10.1242/jcs.02807; Chera S, 2009, DEV CELL, V17, P279, DOI 10.1016/j.devcel.2009.07.014; DAVID CN, 1973, ROUX ARCH DEV BIOL, V171, P259, DOI 10.1007/BF00577724; DAVID CN, 1972, J CELL SCI, V11, P557; de la Cova C, 2006, SEMIN CANCER BIOL, V16, P303, DOI 10.1016/j.semcancer.2006.07.010; Demeterco C, 2002, J CLIN ENDOCR METAB, V87, P3475, DOI 10.1210/jc.87.7.3475; Duffy DJ, 2010, DEVELOPMENT, V137, P3057, DOI 10.1242/dev.046631; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; EVAN GI, 1993, CURR OPIN GENET DEV, V3, P44, DOI 10.1016/S0959-437X(05)80339-9; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Gallant P, 2009, ADV CANCER RES, V103, P111, DOI 10.1016/S0065-230X(09)03005-X; Galliot B, 2006, SEMIN CELL DEV BIOL, V17, P492, DOI 10.1016/j.semcdb.2006.05.005; Gee L, 2010, DEV BIOL, V340, P116, DOI 10.1016/j.ydbio.2009.12.036; Gheysen G, 2007, TRENDS BIOTECHNOL, V25, P89, DOI 10.1016/j.tibtech.2007.01.007; Gomez-Curet I, 2006, J PEDIATR SURG, V41, P207, DOI 10.1016/j.jpedsurg.2005.10.025; Grens A, 1996, DEV BIOL, V180, P473, DOI 10.1006/dbio.1996.0321; Hartl M, 2010, P NATL ACAD SCI US; Hobmayer B, 2000, NATURE, V407, P186, DOI 10.1038/35025063; Hobmayer B, 1990, DEVELOPMENT, V109, P897; Hobmayer B, 1990, DEVELOPMENT, V109, P887; HOLSTEIN TW, 1991, DEV BIOL, V148, P602, DOI 10.1016/0012-1606(91)90277-A; HOLSTEIN TW, 1990, DEV BIOL, V142, P392, DOI 10.1016/0012-1606(90)90360-U; Howard KA, 2009, ADV DRUG DELIVER REV, V61, P710, DOI 10.1016/j.addr.2009.04.001; Huang MJ, 2006, EXP HEMATOL, V34, P1480, DOI 10.1016/j.exphem.2006.06.019; Hunter R. J., 1988, ZETA POTENTIAL COLLO; Kim DH, 2007, NAT REV GENET, V8, P173, DOI 10.1038/nrg2006; Kim DH, 2008, BIOTECHNIQUES, V44, P613, DOI 10.2144/000112792; Laurenti E, 2009, CURR OPIN CELL BIOL, V21, P844, DOI 10.1016/j.ceb.2009.09.006; Laurenti E, 2008, CELL STEM CELL, V3, P611, DOI 10.1016/j.stem.2008.09.005; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lohmann JU, 2000, GENE DEV, V14, P2771, DOI 10.1101/gad.830100; Lohmann JU, 1999, DEV BIOL, V214, P211, DOI 10.1006/dbio.1999.9407; Miljkovic M, 2002, DEV BIOL, V246, P377, DOI 10.1006/dbio.2002.0676; Naito Y, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-392; Newmark PA, 2003, P NATL ACAD SCI USA, V100, P11861, DOI 10.1073/pnas.1834205100; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Saleh MC, 2006, NAT CELL BIOL, V8, P793, DOI 10.1038/ncb1439; Sambrook J., 2002, MOL CLONING LAB MANU; SHI YF, 1992, SCIENCE, V257, P212, DOI 10.1126/science.1378649; Smith KM, 2000, DEVELOPMENT, V127, P4743; SPROULL F, 1979, J CELL SCI, V38, P171; Timmons L, 2003, MOL BIOL CELL, V14, P2972, DOI 10.1091/mbc.E03-01-0858; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Torchilin VP, 2003, P NATL ACAD SCI USA, V100, P1972, DOI 10.1073/pnas.0435906100; Tortiglione C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007698; Watanabe H, 2009, SEMIN CELL DEV BIOL, V20, P1114, DOI 10.1016/j.semcdb.2009.09.008; Whitehead KA, 2009, NAT REV DRUG DISCOV, V8, P129, DOI 10.1038/nrd2742; Wilson A, 2009, CURR OPIN GENET DEV, V19, P461, DOI 10.1016/j.gde.2009.08.005; Wittlieb J, 2006, P NATL ACAD SCI USA, V103, P6208, DOI 10.1073/pnas.0510163103; Yin XY, 2003, ONCOGENE, V22, P6151, DOI 10.1038/sj.onc.1206641	58	26	26	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30660	10.1371/journal.pone.0030660	http://dx.doi.org/10.1371/journal.pone.0030660			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22292012	Green Published, gold, Green Submitted			2022-12-25	WOS:000301570600069
J	Wilczek, E; Szparecki, G; Lukasik, D; Koperski, L; Winiarska, M; Wilczynski, GM; Wasiutynski, A; Gornicka, B				Wilczek, Ewa; Szparecki, Grzegorz; Lukasik, Dominika; Koperski, Lukasz; Winiarska, Magdalena; Wilczynski, Grzegorz M.; Wasiutynski, Aleksander; Gornicka, Barbara			Loss of the Orphan Nuclear Receptor SHP Is More Pronounced in Fibrolamellar Carcinoma than in Typical Hepatocellular Carcinoma	PLOS ONE			English	Article							SMALL HETERODIMER PARTNER; SUPPRESSES; EXPRESSION; SURVIVAL	Hepatocellular carcinoma (HCC) remains a major problem in oncology. The molecular mechanisms which underlie its pathogenesis are poorly understood. Recently the Small Heterodimer Partner (SHP), an orphan nuclear receptor, was suggested to be involved as a tumor suppressor in hepatocellular carcinoma development. To date, there are no such studies regarding fibrolamellar carcinoma, a less common variant of HCC, which usually affects young people and displays distinct morphological features The aim of our project was to evaluate the SHP levels in typical and fibrolamellar hepatocellular carcinoma with respect to the levels of one of the cell cycle regulators, cyclin D1. We assessed the immunoreactivity levels of SHP and cyclin D1 in 48 typical hepatocellular carcinomas 9 tumors representing the fibrolamellar variant 29 non malignant liver tissues and 7 macroregenerative nodules. We detected significantly lower SHP immunoreactivity in hepatocellular carcinoma when compared to non malignant liver tissue. Moreover, we found that SHP immunoreactivity is reduced in fibrolamellar carcinoma when compared to typical hepatocellular carcinomal. We also found that SHP is more commonly lost in HCC which arises in the liver with steatosis. The comparison between the cyclin D1 and SHP expression revealed the negative correlation between these proteins in the high grade HCC Our results indicate that the impact of loss of SHP protein may be even more pronounced in fibrolamellar carcinoma than in a typical form of HCC. Further investigation of mechanisms through which the loss of SHP function may influence HCC formation may provide important information in order to design more effective HCC therapy.	[Wilczek, Ewa; Szparecki, Grzegorz; Lukasik, Dominika; Koperski, Lukasz; Wasiutynski, Aleksander; Gornicka, Barbara] Med Univ Warsaw, Dept Pathol, Warsaw, Poland; [Winiarska, Magdalena] Med Univ Warsaw, Dept Immunol, Warsaw, Poland; [Wilczynski, Grzegorz M.] M Nencki Inst Expt Biol, Lab Mol & Syst Neuromorphol, PL-02093 Warsaw, Poland	Medical University of Warsaw; Medical University of Warsaw; Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences	Wilczek, E (corresponding author), Med Univ Warsaw, Dept Pathol, Warsaw, Poland.	ewa.wilczek@wum.edu.pl	Wolinska, Ewa/AAE-4628-2021; Koperski, Lukasz/U-4594-2018	Koperski, Lukasz/0000-0001-8163-1813; Wolinska, Ewa/0000-0001-9592-1301; Wilczynski, Grzegorz/0000-0001-6667-0291; Winiarska, Magdalena/0000-0001-5605-3329; Szparecki, Grzegorz/0000-0003-3294-8229	Polish State Committee for Scientific Research [3509/B/P01/2010/38]; Foundation for Polish Science; EU; Ministry of Science and Higher Education of Poland [N N402 352938]; Iuventus Plus [0465/P01/2010/70]	Polish State Committee for Scientific Research(Polish State Committee for Scientific Research); Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission); EU(European Commission); Ministry of Science and Higher Education of Poland(Ministry of Science and Higher Education, Poland); Iuventus Plus	The presented work was supported by the grant no 3509/B/P01/2010/38 from the Polish State Committee for Scientific Research. Contributing author M.W. is a member of TEAM Programme co-financed by the Foundation for Polish Science and the EU European Regional Development Fund, and is supported by grants from the Ministry of Science and Higher Education of Poland: N N402 352938 (M.W.) and "Iuventus Plus" 0465/P01/2010/70. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aupperlee Mark, 2005, Breast Dis, V24, P37; Auwerx J, 2002, AM J PHYSIOL-GASTR L, V282, pG581, DOI 10.1152/ajpgi.00508.2001; Bavner A, 2005, TRENDS ENDOCRIN MET, V16, P478, DOI 10.1016/j.tem.2005.10.005; Dehm SM, 2006, J CELL BIOCHEM, V99, P333, DOI 10.1002/jcb.20794; Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; He N, 2008, GASTROENTEROLOGY, V134, P793, DOI 10.1053/j.gastro.2008.01.006; Inamoto T, 2010, CANCER-AM CANCER SOC, V116, P340, DOI 10.1002/cncr.24737; Kakar S, 2005, MODERN PATHOL, V18, P1417, DOI 10.1038/modpathol.3800449; Kim K, 2010, BIOCHEM J, V427, P413, DOI 10.1042/BJ20091445; Lee HK, 1998, J BIOL CHEM, V273, P14398, DOI 10.1074/jbc.273.23.14398; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Maniaci V, 2009, EJSO-EUR J SURG ONC, V35, P617, DOI 10.1016/j.ejso.2008.12.009; McKenna NJ, 2010, CELL, V142, DOI 10.1016/j.cell.2010.08.026; Nemenoff RA, 2005, EUR J CANCER, V41, P2561, DOI 10.1016/j.ejca.2005.08.015; Park YY, 2010, MOL CELLS, V30, P485, DOI 10.1007/s10059-010-0136-6; Zhang YX, 2008, HEPATOLOGY, V48, P289, DOI 10.1002/hep.22342; Zhang YX, 2010, MOL CELL BIOL, V30, P1341, DOI 10.1128/MCB.01076-09	18	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30944	10.1371/journal.pone.0030944	http://dx.doi.org/10.1371/journal.pone.0030944			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22292081	gold, Green Submitted, Green Published			2022-12-25	WOS:000301570600099
J	Satou, R; Miyata, K; Gonzalez-Villalobos, RA; Ingelfinger, JR; Navar, LG; Kobori, H				Satou, Ryousuke; Miyata, Kayoko; Gonzalez-Villalobos, Romer A.; Ingelfinger, Julie R.; Navar, L. Gabriel; Kobori, Hiroyuki			Interferon-gamma biphasically regulates angiotensinogen expression via a JAK-STAT pathway and suppressor of cytokine signaling 1 (SOCS1) in renal proximal tubular cells	FASEB JOURNAL			English	Article						kidney; inflammation; hypertension	MESSENGER-RNA; INTRARENAL ANGIOTENSINOGEN; AUGMENTS ANGIOTENSINOGEN; GENE; TRANSCRIPTION; RECEPTOR; TRANSDUCTION; INVOLVEMENT; ACTIVATION; PHYSIOLOGY	Renal inflammation modulates angiotensinogen (AGT) production in renal proximal tubular cells (RPTCs) via inflammatory cytokines, including interleukin-6, tumor necrosis factor alpha, and interferon-gamma (IFN-gamma). Among these, the effects of IFN-gamma on AGT regulation in RPTCs are incompletely delineated. This study aimed to elucidate mechanisms by which IFN-gamma regulates AGT expression in RPTCs. RPTCs were incubated with or without IFN-gamma up to 48 h. AGT expression, STAT1 and STAT3 activities, and SOCS1 expression were evaluated. RNA interference studies against STAT1, SOCS1, and STAT3 were performed to elucidate a signaling cascade. IFN-gamma decreased AGT expression at 6 h (0.61 +/- 0.05, ratio to control) and 12 h (0.47 +/- 0.03). In contrast, longer exposure for 24 and 48 h increased AGT expression (1.76 +/- 0.18, EC50 +/- 3.4 ng/ml, and 1.45 +/- 0.08, respectively). IFN-gamma treatment for 6 h strongly induced STAT1 phosphorylation and SOCS1 augmentation, and decreased STAT3 activity. However, STAT1 phosphorylation and SOCS1 augmentation waned at 24 h, while STAT3 activity increased. RNA interference studies revealed that activation of STAT1-SOCS1 axis decreased STAT3 activity. Thus, IFN-gamma biphasically regulates AGT expression in RPTCs via STAT3 activity modulated by STAT1-SOCS1 axis, suggesting the STAT1-SOCS1 axis is important in IFN-gamma-induced activation of the intrarenal renin-angiotensin system.-Satou, R., Miyata, K., Gonzalez-Villalobos, R. A., Ingelfinger, J. R., Navar, L. G., Kobori, H. Interferon-gamma biphasically regulates angiotensinogen expression via a JAK-STAT pathway and suppressor of cytokine signaling 1 (SOCS1) in renal proximal tubular cells. FASEB J. 26, 1821-1830 (2012). www.fasebj.org	[Satou, Ryousuke; Miyata, Kayoko; Navar, L. Gabriel; Kobori, Hiroyuki] Tulane Univ, Hlth Sci Ctr, Dept Physiol, New Orleans, LA 70112 USA; [Satou, Ryousuke; Miyata, Kayoko; Navar, L. Gabriel; Kobori, Hiroyuki] Tulane Univ, Hlth Sci Ctr, Hypertens & Renal Ctr Excellence, New Orleans, LA 70112 USA; [Gonzalez-Villalobos, Romer A.] Cedars Sinai Med Ctr, Dept Biomed Sci & Pathol, Los Angeles, CA 90048 USA; [Gonzalez-Villalobos, Romer A.] Cedars Sinai Med Ctr, Dept Lab Med, Los Angeles, CA 90048 USA; [Ingelfinger, Julie R.] Harvard Univ, Sch Med, Dept Pediat, Massachusetts Gen Hosp, Boston, MA 02115 USA	Tulane University; Tulane University; Cedars Sinai Medical Center; Cedars Sinai Medical Center; Harvard University; Harvard Medical School; Massachusetts General Hospital	Satou, R (corresponding author), Tulane Univ, Hlth Sci Ctr, Dept Physiol, 1430 Tulane Ave,SL39-M720, New Orleans, LA 70112 USA.	rsato@tulane.edu	Kobori, Hiroyuki/F-1994-2014	Kobori, Hiroyuki/0000-0001-5128-5059	U.S. National Institute of Diabetes and Digestive and Kidney Diseases [R01DK072408, K99DK083455]; National Center for Research Resources [P20RR017659]; National Heart, Lung, and Blood Institute [R01HL026371]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017659] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL026371] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072408, K99DK083455] Funding Source: NIH RePORTER	U.S. National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors acknowledge the valuable comments and excellent technical assistance of Dr. Maki Urushihara, Dr. Masumi Kamiyama, Dr. Daisuke Inui, Dr. Omar W. Acres, Ms. Akemi Katsurada, and Ms. Ayumi Kitano (Tulane University). This study was supported by grants from the U.S. National Institute of Diabetes and Digestive and Kidney Diseases (R01DK072408 and K99DK083455), the National Center for Research Resources (P20RR017659), and the National Heart, Lung, and Blood Institute (R01HL026371). The authors declare no conflicts of interest.	AMEZAGA MA, 1992, BLOOD, V79, P735; Cheon H, 2009, P NATL ACAD SCI USA, V106, P9373, DOI 10.1073/pnas.0903487106; Crowley SD, 2008, AM J PHYSIOL-RENAL, V295, pF515, DOI 10.1152/ajprenal.00527.2007; Decker T, 2000, ONCOGENE, V19, P2628, DOI 10.1038/sj.onc.1203481; DiGiandomenico A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.1162191; DZAU VJ, 1994, CIRCULATION, V89, P493, DOI 10.1161/01.CIR.89.1.493; Fujimoto M, 2003, TRENDS IMMUNOL, V24, P659, DOI 10.1016/j.it.2003.10.008; Fukuzawa J, 2000, HYPERTENSION, V35, P1191, DOI 10.1161/01.HYP.35.6.1191; Gonzalez-Villalobos RA, 2008, AM J PHYSIOL-RENAL, V295, pF772, DOI 10.1152/ajprenal.00019.2008; Gonzalez-Villalobos RA, 2011, J AM SOC NEPHROL, V22, P449, DOI 10.1681/ASN.2010060624; Ingelfinger JR, 1999, AM J PHYSIOL-RENAL, V276, pF218, DOI 10.1152/ajprenal.1999.276.2.F218; INGELFINGER JR, 1990, J CLIN INVEST, V85, P417, DOI 10.1172/JCI114454; Jain S, 2007, AM J PHYSIOL-CELL PH, V293, pC401, DOI 10.1152/ajpcell.00433.2006; Jain S, 2006, BBA-GENE STRUCT EXPR, V1759, P340, DOI 10.1016/j.bbaexp.2006.07.003; Katsurada A, 2007, AM J PHYSIOL-RENAL, V293, pF956, DOI 10.1152/ajprenal.00090.2007; Kile BT, 2001, CELL MOL LIFE SCI, V58, P1627, DOI 10.1007/PL00000801; Kobori H, 2005, J AM SOC NEPHROL, V16, P2073, DOI 10.1681/ASN.2004080676; Kobori H, 2001, J AM SOC NEPHROL, V12, P431, DOI 10.1681/ASN.V123431; Kobori H, 2008, AM J PHYSIOL-RENAL, V294, pF1257, DOI 10.1152/ajprenal.00588.2007; Kobori H, 2007, AM J PHYSIOL-RENAL, V293, pF938, DOI 10.1152/ajprenal.00146.2007; Kobori H, 2007, PHARMACOL REV, V59, P251, DOI 10.1124/pr.59.3.3; Kobori H, 2009, HYPERTENSION, V53, P344, DOI 10.1161/HYPERTENSIONAHA.108.123802; Krejci P, 2009, CELL SIGNAL, V21, P151, DOI 10.1016/j.cellsig.2008.10.006; Kubo M, 2003, NAT IMMUNOL, V4, P1169, DOI 10.1038/ni1012; Larsen L, 2002, APMIS, V110, P833, DOI 10.1034/j.1600-0463.2002.1101201.x; Mascareno E, 1998, P NATL ACAD SCI USA, V95, P5590, DOI 10.1073/pnas.95.10.5590; Navar LG, 2011, CURR OPIN PHARMACOL, V11, P180, DOI 10.1016/j.coph.2011.01.009; Navar LG, 2011, HYPERTENSION, V57, P355, DOI 10.1161/HYPERTENSIONAHA.110.163519; Ortiz-Munoz G, 2010, J AM SOC NEPHROL, V21, P763, DOI 10.1681/ASN.2009060625; Park YJ, 2007, BIOCHEM BIOPH RES CO, V363, P361, DOI 10.1016/j.bbrc.2007.08.195; Paul M, 2006, PHYSIOL REV, V86, P747, DOI 10.1152/physrev.00036.2005; Qing Y, 2005, J BIOL CHEM, V280, P1849, DOI 10.1074/jbc.M409863200; Ray S, 2005, GASTROENTEROLOGY, V129, P1616, DOI 10.1053/j.gastro.2005.07.055; Re RN, 2004, MED CLIN N AM, V88, P19, DOI 10.1016/S0025-7125(03)00124-X; Sachetelli S, 2006, KIDNEY INT, V69, P1016, DOI 10.1038/sj.ki.5000210; Saha B, 2010, CYTOKINE, V50, P1, DOI 10.1016/j.cyto.2009.11.021; Satou R, 2008, AM J PHYSIOL-RENAL, V295, pF283, DOI 10.1152/ajprenal.00047.2008; Satou R, 2010, AM J PHYSIOL-CELL PH, V299, pC750, DOI 10.1152/ajpcell.00078.2010; Satou R, 2009, MOL CELL ENDOCRINOL, V311, P24, DOI 10.1016/j.mce.2009.06.013; Shi YH, 2010, AM J NEPHROL, V31, P380, DOI 10.1159/000286559; Takeda K, 2000, CYTOKINE GROWTH F R, V11, P199, DOI 10.1016/S1359-6101(00)00005-8; TAMURA K, 1992, JPN HEART J, V33, P113; TERADA Y, 1993, KIDNEY INT, V43, P1251, DOI 10.1038/ki.1993.177; Tsuboi H, 2011, INT J RHEUM DIS, V14, P86, DOI 10.1111/j.1756-185X.2010.01575.x	44	49	50	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2012	26	5					1821	1830		10.1096/fj.11-195198	http://dx.doi.org/10.1096/fj.11-195198			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	937TD	22302831	Green Published			2022-12-25	WOS:000303680800010
J	Buske, PJ; Levin, PA				Buske, Paul J.; Levin, Petra Anne			Extreme C Terminus of Bacterial Cytoskeletal Protein FtsZ Plays Fundamental Role in Assembly Independent of Modulatory Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DIVISION PROTEIN; ESCHERICHIA-COLI FTSZ; BACILLUS-SUBTILIS; CRYSTAL-STRUCTURE; DYNAMICS; GTPASE; GENE; RING; POLYMERIZATION; EZRA	Bacterial cell division typically requires assembly of the cytoskeletal protein FtsZ into a ring (Z-ring) at the nascent division site that serves as a foundation for assembly of the division apparatus. High resolution imaging suggests that the Z-ring consists of short, single-stranded polymers held together by lateral interactions. Several proteins implicated in stabilizing the Z-ring enhance lateral interactions between FtsZ polymers in vitro. Here we report that residues at the C terminus of Bacillus subtilis FtsZ (C-terminal variable region (CTV)) are both necessary and sufficient for stimulating lateral interactions in vitro in the absence of modulatory proteins. Swapping the 6-residue CTV from B. subtilis FtsZ with the 4-residue CTV from Escherichia coli FtsZ completely abolished lateral interactions between chimeric B. subtilis FtsZ polymers. The E. coli FtsZ chimera readily formed higher order structures normally seen only in the presence of molecular crowding agents. CTV-mediated lateral interactions are important for the integrity of the Z-ring because B. subtilis cells expressing the B. subtilis FtsZ chimera had a low frequency of FtsZ ring formation and a high degree of filamentation relative to wild-type cells. Site-directed mutagenesis of the B. subtilis CTV suggests that electrostatic forces are an important determinant of lateral interaction potential.	[Buske, Paul J.; Levin, Petra Anne] Washington Univ, Dept Biol, St Louis, MO 63130 USA	Washington University (WUSTL)	Levin, PA (corresponding author), Washington Univ, Dept Biol, Box 1137,1 Brookings Dr, St Louis, MO 63130 USA.	plevin@wustl.edu		Levin, Petra/0000-0003-2071-0547	National Institutes of Health Public Health Service [GM64671]; Levin laboratory; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064671] Funding Source: NIH RePORTER	National Institutes of Health Public Health Service(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); Levin laboratory; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Public Health Service Grant GM64671 (to P. A. L.).; We thank Bill Margolin for the generous gift of antisera against E. coli FtsZ. We also thank Wandy Beatty for assistance with electron microscopy. We are indebted to Laura Romberg, Daniel Haeusser, and Corey Westfall for valuable comments on the manuscript and to members of the Levin laboratory for technical advice, lively discussions, and support.	Adams DW, 2009, NAT REV MICROBIOL, V7, P642, DOI 10.1038/nrmicro2198; Anderson DE, 2004, J BACTERIOL, V186, P5775, DOI 10.1128/JB.186.17.5775-5781.2004; BEALL B, 1988, J BACTERIOL, V170, P4855, DOI 10.1128/jb.170.10.4855-4864.1988; BI E, 1992, J BACTERIOL, V174, P5414, DOI 10.1128/JB.174.16.5414-5423.1992; Chen Y, 2007, J BIOL CHEM, V282, P27736, DOI 10.1074/jbc.M703788200; DAI K, 1994, J BACTERIOL, V176, P130, DOI 10.1128/JB.176.1.130-136.1994; Din N, 1998, MOL MICROBIOL, V27, P1051, DOI 10.1046/j.1365-2958.1998.00752.x; Erickson HP, 2010, MICROBIOL MOL BIOL R, V74, P504, DOI 10.1128/MMBR.00021-10; de Oliveira IFF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012048; Froschauer EM, 2004, FEMS MICROBIOL LETT, V237, P49, DOI 10.1016/j.femsle.2004.06.013; Goley ED, 2010, MOL CELL, V39, P975, DOI 10.1016/j.molcel.2010.08.027; Gueiros FJ, 2002, GENE DEV, V16, P2544, DOI 10.1101/gad.1014102; Gundogdu ME, 2011, EMBO J, V30, P617, DOI 10.1038/emboj.2010.345; Guo F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012680; Gupta P, 2010, ACTA BIOCH BIOPH SIN, V42, P58, DOI 10.1093/abbs/gmp105; Haeusser DP, 2007, J BACTERIOL, V189, P9001, DOI 10.1128/JB.01172-07; Haeusser DP, 2004, MOL MICROBIOL, V52, P801, DOI 10.1111/j.1365-2958.2004.04016.x; Haney SA, 2001, J BIOL CHEM, V276, P11980, DOI 10.1074/jbc.M009810200; Harry E, 2006, INT REV CYTOL, V253, P27, DOI [DOI 10.1016/S0074-7696(06)53002-5, 10.1016/S0074-7696(06)53002-5.]; Harwood C.R., 1990, MOL BIOL METHODS BAC; Ingerman E, 2005, METHOD ENZYMOL, V404, P611, DOI 10.1016/S0076-6879(05)04053-X; IRETON K, 1993, GENE DEV, V7, P283, DOI 10.1101/gad.7.2.283; Ishikawa S, 2006, MOL MICROBIOL, V60, P1364, DOI 10.1111/j.1365-2958.2006.05184.x; Jensen SO, 2005, J BACTERIOL, V187, P6536, DOI 10.1128/JB.187.18.6536-6544.2005; Koppelman CM, 2004, MOL MICROBIOL, V51, P645, DOI 10.1046/j.1365-2958.2003.03876.x; Lan GH, 2008, BIOPHYS J, V95, P4045, DOI 10.1529/biophysj.108.132837; LEDEAUX JR, 1995, J BACTERIOL, V177, P166, DOI 10.1128/jb.177.1.166-175.1995; Levin PA, 1996, GENE DEV, V10, P478, DOI 10.1101/gad.10.4.478; Li Z, 2007, EMBO J, V26, P4694, DOI 10.1038/sj.emboj.7601895; Low HH, 2004, J MOL BIOL, V341, P839, DOI 10.1016/j.jmb.2004.05.031; Lowe J, 1998, NATURE, V391, P203, DOI 10.1038/34472; Lu C, 2001, BMC Microbiol, V1, P7, DOI 10.1186/1471-2180-1-7; Ma XL, 1999, J BACTERIOL, V181, P7531, DOI 10.1128/JB.181.24.7531-7544.1999; Margolin W, 2005, NAT REV MOL CELL BIO, V6, P862, DOI 10.1038/nrm1745; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Monahan LG, 2009, MOL MICROBIOL, V74, P1004, DOI 10.1111/j.1365-2958.2009.06914.x; Mosyak L, 2000, EMBO J, V19, P3179, DOI 10.1093/emboj/19.13.3179; Mukherjee A, 1999, J BACTERIOL, V181, P823, DOI 10.1128/JB.181.3.823-832.1999; MUKHERJEE A, 1994, J BACTERIOL, V176, P2754, DOI 10.1128/JB.176.9.2754-2758.1994; Mukherjee A, 1998, EMBO J, V17, P462, DOI 10.1093/emboj/17.2.462; Osawa M, 2006, J BACTERIOL, V188, P7132, DOI 10.1128/JB.00647-06; Pacheco-Gomez R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019369; PEREGO M, 1988, MOL MICROBIOL, V2, P689, DOI 10.1111/j.1365-2958.1988.tb00079.x; Popp D, 2009, BIOPOLYMERS, V91, P340, DOI 10.1002/bip.21136; RayChaudhuri D, 1999, EMBO J, V18, P2372, DOI 10.1093/emboj/18.9.2372; RAYCHAUDHURI D, 1994, J BIOL CHEM, V269, P22941; Raymond A, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-37; Redick SD, 2005, J BACTERIOL, V187, P2727, DOI 10.1128/JB.187.8.2727-2736.2005; Romberg L, 2003, ANNU REV MICROBIOL, V57, P125, DOI 10.1146/annurev.micro.57.012903.074300; Romberg L, 2001, J BIOL CHEM, V276, P11743, DOI 10.1074/jbc.M009033200; Sambrook J, 2001, MOL CLONING LAB MANU; Shen B, 2009, MOL MICROBIOL, V72, P410, DOI 10.1111/j.1365-2958.2009.06651.x; Singh JK, 2007, BIOCHEMISTRY-US, V46, P11013, DOI 10.1021/bi700710j; Vaughan S, 2004, J MOL EVOL, V58, P19, DOI 10.1007/s00239-003-2523-5; WANG XD, 1993, MOL MICROBIOL, V9, P435, DOI 10.1111/j.1365-2958.1993.tb01705.x; Weart RB, 2003, J BACTERIOL, V185, P2826, DOI 10.1128/JB.185.9.2826-2834.2003; Weart RB, 2007, CELL, V130, P335, DOI 10.1016/j.cell.2007.05.043; Yan K, 2000, BIOCHEM BIOPH RES CO, V270, P387, DOI 10.1006/bbrc.2000.2439; Yu XC, 1997, EMBO J, V16, P5455, DOI 10.1093/emboj/16.17.5455	59	67	67	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					10945	10957		10.1074/jbc.M111.330324	http://dx.doi.org/10.1074/jbc.M111.330324			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22298780	Green Published, hybrid			2022-12-25	WOS:000302780100023
J	Eisenach, PA; de Sampaio, PC; Murphy, G; Roghi, C				Eisenach, Patricia A.; de Sampaio, Pedro Correa; Murphy, Gillian; Roghi, Christian			Membrane Type 1 Matrix Metalloproteinase (MT1-MMP) Ubiquitination at Lys(581) Increases Cellular Invasion through Type I Collagen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; 1-MATRIX METALLOPROTEINASE; TYROSINE PHOSPHORYLATION; EXTRACELLULAR-MATRIX; DIFFERENT PATHWAYS; OXIDATIVE STRESS; PLASMA-MEMBRANE; CANCER-THERAPY; UP-REGULATION; TUMOR-GROWTH	Membrane type 1 matrix metalloproteinase (MT1-MMP/MMP14) is a zinc-dependent type I transmembrane metalloproteinase playing pivotal roles in the regulation of pericellular proteolysis and cellular migration. Elevated expression levels of MT1-MMP have been demonstrated to correlate with a poor prognosis in cancer. MT1-MMP has a short intracellular domain (ICD) that has been shown to play important roles in cellular migration and invasion, although these ICD-mediated mechanisms remain poorly understood. In this study, we report that MT1-MMP is mono-ubiquitinated at its unique lysine residue (Lys(581)) within the ICD. Our data suggest that this post-translational modification is involved in MT1-MMP trafficking as well as in modulating cellular invasion through type I collagen matrices. By using an MT1-MMP Y573A mutant or the Src family inhibitor PP2, we observed that the previously described Src-dependent MT1-MMP phosphorylation is a prerequisite for ubiquitination. Taken together, these findings show for the first time an additional post-translational modification of MT1-MMP that regulates its trafficking and cellular invasion, which further emphasizes the key role of the MT1-MMP ICD.	[Eisenach, Patricia A.; de Sampaio, Pedro Correa; Murphy, Gillian; Roghi, Christian] Univ Cambridge, Dept Oncol, Canc Res UK Cambridge Res Inst, Li Ka Shing Ctr, Cambridge CB2 0RE, England	Cancer Research UK; CRUK Cambridge Institute; University of Cambridge	Eisenach, PA (corresponding author), Max Planck Inst Biochem, Dept Mol Biol, Klopferspitz 18, D-82152 Martinsried, Germany.	eisenach@biochem.mpg.de	Roghi, Christian/F-3228-2012	Roghi, Christian/0000-0002-4109-6382; Correa de Sampaio, Pedro/0000-0001-5597-2825	Cancer Research UK; Hutchison Whampoa Ltd.; European Union [LSHC-CT-2003-503297]; German National Academic Foundation (Studienstiftung des DeutschenVolkes); Portuguese Foundation for Science and Technology (Fundacaopara a Ciencia e Tecnologia)	Cancer Research UK(Cancer Research UK); Hutchison Whampoa Ltd.; European Union(European Commission); German National Academic Foundation (Studienstiftung des DeutschenVolkes); Portuguese Foundation for Science and Technology (Fundacaopara a Ciencia e Tecnologia)(Portuguese Foundation for Science and Technology)	This work was supported by Cancer Research UK and Hutchison Whampoa Ltd. (to P. A. E., C. R., and G. M.), European Union Framework Programme 6, LSHC-CT-2003-503297 (to G. M. and P. A. E.), the German National Academic Foundation (Studienstiftung des DeutschenVolkes) (to P. A. E.), and the Portuguese Foundation for Science and Technology (Fundacaopara a Ciencia e Tecnologia) (to P. C. d. S.).	An WG, 2000, LEUKEMIA, V14, P1276, DOI 10.1038/sj.leu.2401812; Anilkumar N, 2005, FASEB J, V19, P1326, DOI 10.1096/fj.04-3651fje; Aoh QL, 2009, MOL BIOL CELL, V20, P1816, DOI 10.1091/mbc.E08-09-0894; Atkinson SJ, 2006, BIOCHEM J, V398, P15, DOI 10.1042/BJ20060243; Bhoj VG, 2009, NATURE, V458, P430, DOI 10.1038/nature07959; Bravo-Cordero JJ, 2007, EMBO J, V26, P1499, DOI 10.1038/sj.emboj.7601606; Burrage PS, 2006, FRONT BIOSCI-LANDMRK, V11, P529, DOI 10.2741/1817; Cao C, 2005, ONCOGENE, V24, P2433, DOI 10.1038/sj.onc.1208454; Castle A, 2005, J CELL SCI, V118, P3769, DOI 10.1242/jcs.02503; Chen ZJJ, 2009, MOL CELL, V33, P275, DOI 10.1016/j.molcel.2009.01.014; d'Ortho MP, 1997, EUR J BIOCHEM, V250, P751, DOI 10.1111/j.1432-1033.1997.00751.x; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Eisenach PA, 2010, J CELL SCI, V123, P4182, DOI 10.1242/jcs.062711; Endo K, 2003, J BIOL CHEM, V278, P40764, DOI 10.1074/jbc.M306736200; Fosang AJ, 1998, FEBS LETT, V430, P186, DOI 10.1016/S0014-5793(98)00667-X; Galvez BG, 2004, MOL BIOL CELL, V15, P678, DOI 10.1091/mbc.E03-07-0516; Giasson BI, 2003, CELL, V114, P1, DOI 10.1016/S0092-8674(03)00509-9; Gingras D, 2001, FEBS LETT, V507, P231, DOI 10.1016/S0014-5793(01)02985-4; Helliwell SB, 2001, J CELL BIOL, V153, P649, DOI 10.1083/jcb.153.4.649; Hoeller D, 2009, NATURE, V458, P438, DOI 10.1038/nature07960; Holmbeck K, 1999, CELL, V99, P81, DOI 10.1016/S0092-8674(00)80064-1; Hotary K, 2000, J CELL BIOL, V149, P1309, DOI 10.1083/jcb.149.6.1309; Hunter T, 2007, MOL CELL, V28, P730, DOI 10.1016/j.molcel.2007.11.019; Janssens S, 2006, CARDIOVASC RES, V69, P585, DOI 10.1016/j.cardiores.2005.12.010; Jiang AX, 2001, P NATL ACAD SCI USA, V98, P13693, DOI 10.1073/pnas.241293698; Kajita M, 2001, J CELL BIOL, V153, P893, DOI 10.1083/jcb.153.5.893; Katz M, 2002, TRAFFIC, V3, P740, DOI 10.1034/j.1600-0854.2002.31006.x; Koshikawa N, 2000, J CELL BIOL, V148, P615, DOI 10.1083/jcb.148.3.615; Labrecque L, 2004, J BIOL CHEM, V279, P52132, DOI 10.1074/jbc.M409617200; Langlois S, 2004, BLOOD, V103, P3020, DOI 10.1182/blood-2003-08-2968; Lehti K, 2000, J BIOL CHEM, V275, P15006, DOI 10.1074/jbc.M910220199; Lehti K, 2005, GENE DEV, V19, P979, DOI 10.1101/gad.1294605; Li W, 2008, CELL MOL LIFE SCI, V65, P2397, DOI 10.1007/s00018-008-8090-6; Moss NM, 2009, CANCER RES, V69, P7121, DOI 10.1158/0008-5472.CAN-08-4151; Moss NM, 2009, J BIOL CHEM, V284, P19791, DOI 10.1074/jbc.M109.020362; Murdaca J, 2004, J BIOL CHEM, V279, P26754, DOI 10.1074/jbc.M311802200; Nakahara H, 1997, P NATL ACAD SCI USA, V94, P7959, DOI 10.1073/pnas.94.15.7959; NOMURA H, 1995, CANCER RES, V55, P3263; Nyalendo C, 2008, CARCINOGENESIS, V29, P1655, DOI 10.1093/carcin/bgn159; Nyalendo C, 2007, J BIOL CHEM, V282, P15690, DOI 10.1074/jbc.M608045200; Ohuchi E, 1997, J BIOL CHEM, V272, P2446, DOI 10.1074/jbc.272.4.2446; Onishi Y, 2005, BIOCHEM BIOPH RES CO, V336, P799, DOI 10.1016/j.bbrc.2005.08.175; Overall CM, 2006, NAT REV CANCER, V6, P227, DOI 10.1038/nrc1821; Pettet GJ, 2001, B MATH BIOL, V63, P231, DOI 10.1006/bulm.2000.0217; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Remacle A, 2003, J CELL SCI, V116, P3905, DOI 10.1242/jcs.00710; Roghi C, 2010, FEBS J, V277, P3158, DOI 10.1111/j.1742-4658.2010.07723.x; Rozanov DV, 2002, FEBS LETT, V527, P51, DOI 10.1016/S0014-5793(02)03153-8; Rozanov DV, 2001, J BIOL CHEM, V276, P25705, DOI 10.1074/jbc.M007921200; Sabeh F, 2004, J CELL BIOL, V167, P769, DOI 10.1083/jcb.200408028; Shearwin-Whyatt L, 2006, BIOESSAYS, V28, P617, DOI 10.1002/bies.20422; Sigismund S, 2004, CURR TOP MICROBIOL, V286, P149; Sithu SD, 2007, J BIOL CHEM, V282, P25010, DOI 10.1074/jbc.M611273200; Soulie P, 2005, ONCOGENE, V24, P1689, DOI 10.1038/sj.onc.1208360; Sounni NE, 2004, J BIOL CHEM, V279, P13564, DOI 10.1074/jbc.M307688200; Sounni NE, 2002, FASEB J, V16, P555, DOI 10.1096/fj.01-0790com; Stricker NL, 1997, NAT BIOTECHNOL, V15, P336, DOI 10.1038/nbt0497-336; Tam EM, 2004, P NATL ACAD SCI USA, V101, P6917, DOI 10.1073/pnas.0305862101; TOKURAKU M, 1995, INT J CANCER, V64, P355, DOI 10.1002/ijc.2910640513; Tomari T, 2009, CANCER SCI, V100, P1284, DOI 10.1111/j.1349-7006.2009.01173.x; Uekita T, 2001, J CELL BIOL, V155, P1345, DOI 10.1083/jcb.200108112; Ueno H, 1997, CANCER RES, V57, P2055; Usami Y, 2009, BIOCHEM SOC T, V37, P181, DOI 10.1042/BST0370181; van der Horst A, 2006, NAT CELL BIOL, V8, P1064, DOI 10.1038/ncb1469; Wang P, 2004, J BIOL CHEM, V279, P20461, DOI 10.1074/jbc.M400264200; Wang X, 2004, J BIOL CHEM, V279, P9331, DOI 10.1074/jbc.M312369200; Wickramasinghe RD, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-58; Wolf K, 2003, BLOOD, V102, P3262, DOI 10.1182/blood-2002-12-3791; Yoshizaki T, 1997, CANCER, V79, P139, DOI 10.1002/(SICI)1097-0142(19970101)79:1<139::AID-CNCR20>3.0.CO;2-4; Zhang WY, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-52; Zhou ZJ, 2000, P NATL ACAD SCI USA, V97, P4052, DOI 10.1073/pnas.060037197	72	21	21	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					11533	11545		10.1074/jbc.M111.306340	http://dx.doi.org/10.1074/jbc.M111.306340			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22315223	Green Published, hybrid			2022-12-25	WOS:000302780100081
J	Huynh, MB; Morin, C; Carpentier, G; Garcia-Filipe, S; Talhas-Perret, S; Barbier-Chassefiere, V; van Kuppevelt, TH; Martelly, I; Albanese, P; Papy-Garcia, D				Minh Bao Huynh; Morin, Christophe; Carpentier, Gilles; Garcia-Filipe, Stephanie; Talhas-Perret, Sofia; Barbier-Chassefiere, Veronique; van Kuppevelt, Toin H.; Martelly, Isabelle; Albanese, Patricia; Papy-Garcia, Dulce			Age-related Changes in Rat Myocardium Involve Altered Capacities of Glycosaminoglycans to Potentiate Growth Factor Functions and Heparan Sulfate-altered Sulfation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEART-FAILURE; ANTIBODY; PROTEOGLYCANS; LOCALIZATION; RECEPTOR; DOMAINS; BIOLOGY; BINDING; FAMILY; KIDNEY	Glycosaminoglycans (GAGs) are essential components of the extracellular matrix, the natural environment from which cell behavior is regulated by a number or tissue homeostasis guarantors including growth factors. Because most heparin-binding growth factor activities are regulated by GAGs, structural and functional alterations of these polysaccharides may consequently affect the integrity of tissues during critical physiological and pathological processes. Here, we investigated whether the aging process can induce changes in the myocardial GAG composition in rats and whether these changes can affect the activities of particular heparin-binding growth factors known to sustain cardiac tissue integrity. Our results showed an age-dependent increase of GAG levels in the left ventricle. Biochemical and immunohistological studies pointed out heparan sulfates (HS) as the GAG species that increased with age. ELISA-based competition assays showed altered capacities of the aged myocardial GAGs to bind FGF-1, FGF-2, and VEGF but not HB EGF. Mitogenic assays in cultured cells showed an age-dependent decrease of the elderly GAG capacities to potentiate FGF-2 whereas the potentiating effect on VEGF(165) was increased, as confirmed by augmented angiogenic cell proliferation in Matrigel plugs. Moreover, HS disaccharide analysis showed considerably altered 6-O-sulfation with modest changes in N- and 2-O-sulfations. Together, these findings suggest a physiological significance of HS structural and functional alterations during aging. This can be associated with an age-dependent decline of the extracellular matrix capacity to efficiently modulate not only the activity of resident or therapeutic growth factors but also the homing of resident or therapeutic cells.	[Minh Bao Huynh; Morin, Christophe; Carpentier, Gilles; Garcia-Filipe, Stephanie; Talhas-Perret, Sofia; Barbier-Chassefiere, Veronique; Martelly, Isabelle; Albanese, Patricia; Papy-Garcia, Dulce] Univ Paris Est Creteil, CNRS 7149, Lab Croissance Reparat & Regenerat Tissulaires EA, F-94010 Creteil, France; [van Kuppevelt, Toin H.] Radboud Univ Nijmegen, Nijmegen Ctr Mol Life Sci, Dept Matrix Biochem, NL-6500 HC Nijmegen, Netherlands	Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Radboud University Nijmegen	Papy-Garcia, D (corresponding author), 61 Ave Gen Gaulle, F-94010 Creteil, France.	papy@u-pec.fr	Morin, christophe/V-6238-2017; van Kuppevelt, A.H.M.S.M./L-4463-2015; Morin, christophe/O-8796-2019	Morin, christophe/0000-0002-2490-7585; Morin, christophe/0000-0002-2490-7585; Carpentier, Gilles/0000-0002-3730-7263	Association Francaise contre les Myopathies [12144]; French Ministry of Superior Education and Research	Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); French Ministry of Superior Education and Research	This work was supported by Association Francaise contre les Myopathies Grant 12144.; Supported by the French Ministry of Superior Education and Research.	Ashikari-Hada S, 2009, GLYCOBIOLOGY, V19, P644, DOI 10.1093/glycob/cwp031; Barbosa I, 2003, GLYCOBIOLOGY, V13, P647, DOI 10.1093/glycob/cwg082; Beenken A, 2009, NAT REV DRUG DISCOV, V8, P235, DOI 10.1038/nrd2792; Blondet B, 2005, J HISTOCHEM CYTOCHEM, V53, P971, DOI 10.1369/jhc.4A6574.2005; Blondet B, 2006, NEUROCHEM RES, V31, P907, DOI 10.1007/s11064-006-9095-x; Chu CL, 2005, BIOCHEMISTRY-US, V44, P12203, DOI 10.1021/bi050241p; Deschamps AM, 2005, CURR OPIN CARDIOL, V20, P211, DOI 10.1097/01.hco.0000162397.44843.83; Frese MA, 2009, J BIOL CHEM, V284, P28033, DOI 10.1074/jbc.M109.035808; Gaffney MM, 2007, BRIT J PHARMACOL, V152, P175, DOI 10.1038/sj.bjp.0707315; GILLIES RJ, 1986, ANAL BIOCHEM, V159, P109, DOI 10.1016/0003-2697(86)90314-3; Kardami E, 2007, HEART FAIL REV, V12, P267, DOI 10.1007/s10741-007-9027-0; Kurup S, 2007, J BIOL CHEM, V282, P21032, DOI 10.1074/jbc.M702073200; Lavu M, 2011, J MOL CELL CARDIOL, V50, P742, DOI 10.1016/j.yjmcc.2010.06.007; Lensen JFM, 2006, MATRIX BIOL, V25, P457, DOI 10.1016/j.matbio.2006.06.003; Lensen JFM, 2005, J AM SOC NEPHROL, V16, P1279, DOI 10.1681/ASN.2004050413; Marastoni S, 2008, CONNECT TISSUE RES, V49, P203, DOI 10.1080/03008200802143190; Naiki H, 2009, J BIOCHEM, V146, P751, DOI 10.1093/jb/mvp119; Najafi F, 2009, EUR J HEART FAIL, V11, P472, DOI 10.1093/eurjhf/hfp029; Najjam Saloua, 1997, Biochemical Society Transactions, V25, p3S; Narita K, 2006, CANCER RES, V66, P6025, DOI 10.1158/0008-5472.CAN-05-3582; Ori A, 2008, FRONT BIOSCI-LANDMRK, V13, P4309, DOI 10.2741/3007; ORNITZ DM, 1992, MOL CELL BIOL, V12, P240, DOI 10.1128/MCB.12.1.240; Prokopi M, 2011, CIRC RES, V108, P499, DOI 10.1161/CIRCRESAHA.110.226902; Purushothaman A, 2007, J BIOL CHEM, V282, P19442, DOI 10.1074/jbc.M700630200; Rouet V, 2005, J BIOL CHEM, V280, P32792, DOI 10.1074/jbc.M504492200; Sasisekharan R, 2000, CURR OPIN CHEM BIOL, V4, P626, DOI 10.1016/S1367-5931(00)00145-9; Smetsers TFCM, 2004, J INVEST DERMATOL, V122, P707, DOI 10.1111/j.0022-202X.2004.22316.x; Smits NC, 2004, AM J RESP CELL MOL, V30, P166, DOI 10.1165/rcmb.2003-0198OC; Smits NC, 2010, J BIOL CHEM, V285, P41143, DOI 10.1074/jbc.M110.153791; Stringer SE, 2006, BIOCHEM SOC T, V34, P451, DOI 10.1042/BST0340451; ten Dam GB, 2006, J BIOL CHEM, V281, P4654, DOI 10.1074/jbc.M506357200; ten Dam GB, 2009, HISTOCHEM CELL BIOL, V132, P117, DOI 10.1007/s00418-009-0592-2; Toyoda H, 1999, J CHROMATOGR A, V830, P197, DOI 10.1016/S0021-9673(98)00854-1; Wang XJ, 2008, J MOL CELL CARDIOL, V45, P11, DOI 10.1016/j.yjmcc.2008.03.025; Wang XJ, 2006, CIRC RES, V99, P1315, DOI 10.1161/01.RES.0000252342.61447.a2; Wijnhoven TJ, 2008, GLYCOCONJUGATE J, V25, P177, DOI 10.1007/s10719-007-9070-z; Wijnhoven TJM, 2006, AM J KIDNEY DIS, V48, P250, DOI 10.1053/j.ajkd.2006.05.003; Yung S, 2007, PERITON DIALYSIS INT, V27, pS104; Zakrzewska M, 2008, CRIT REV CL LAB SCI, V45, P91, DOI 10.1080/10408360701713120 ; Zhang XQ, 2006, J BIOL CHEM, V281, P15694, DOI 10.1074/jbc.M601252200	40	36	36	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					11363	11373		10.1074/jbc.M111.335901	http://dx.doi.org/10.1074/jbc.M111.335901			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22298772	hybrid, Green Published			2022-12-25	WOS:000302780100066
J	Lee, K; Shim, J; Bae, J; Kim, YJ; Lee, J				Lee, Kiho; Shim, Jiwon; Bae, Jaebum; Kim, Young-Joon; Lee, Junho			Stabilization of RNT-1 Protein, Runt-related Transcription Factor (RUNX) Protein Homolog of Caenorhabditis elegans, by Oxidative Stress through Mitogen-activated Protein Kinase Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-ELEGANS; DEPENDENT PHOSPHORYLATION; MEDIATED DEGRADATION; CELL-PROLIFERATION; MAPK PHOSPHATASE; OSTEOCALCIN GENE; EXPRESSION; METHYLATION; RECEPTOR; CANCER	RUNX proteins are evolutionarily conserved transcription factors known to be involved in various developmental processes. Here we report a new role for a RUNX protein: a role in stress response. We show that RNT-1, the Caenorhabditis elegans RUNX homolog, is constantly produced and degraded by the ubiquitination-proteasome pathway in the intestine of the nematode. RNT-1 was rapidly stabilized by oxidative stress, and the rnt-1-mutant animals were more sensitive to oxidative stress, indicating that rapid RNT-1 stabilization is a defense response against the oxidative stress. The MAP kinase pathway is required for RNT-1 stabilization, and RNT-1 was phosphorylated by SEK-1/PMK-1 in vitro. ChIP-sequencing analysis revealed a feedback loop mechanism of the MAP kinase pathway by the VHP-1 phosphatase in the RNT-1-mediated oxidative stress response. We propose that rnt-1 is regulated at the protein level for its role in the immediate response to environmental challenges in the intestine.	[Lee, Kiho; Shim, Jiwon; Lee, Junho] Seoul Natl Univ, Dept Biol Sci, WCU Dept Biophys & Chem Biol, Res Ctr Cellul, Seoul 151742, South Korea; [Bae, Jaebum; Kim, Young-Joon] Yonsei Univ, Dept Biochem, Coll Life Sci & Technol, Seoul 120749, South Korea	Seoul National University (SNU); Yonsei University	Lee, J (corresponding author), Seoul Natl Univ, Dept Biol Sci, WCU Dept Biophys & Chem Biol, Res Ctr Cellul, 56-1 Gwanak Gu, Seoul 151742, South Korea.	elegans@snu.ac.kr	Lee, Junho/AAO-4706-2021; Shim, Jiwon/AAQ-4501-2021	Shim, Jiwon/0000-0003-2409-1130	World Class University; Research Center for Functional Cellulomics	World Class University; Research Center for Functional Cellulomics	This work was supported by the World Class University program and Research Center for Functional Cellulomics.	Akiba H, 1998, J BIOL CHEM, V273, P13353, DOI 10.1074/jbc.273.21.13353; An JH, 2003, GENE DEV, V17, P1882, DOI 10.1101/gad.1107803; Bae SC, 2000, GENE, V241, P255, DOI 10.1016/S0378-1119(99)00488-6; BRENNER S, 1974, GENETICS, V77, P71; Bush KT, 1997, J BIOL CHEM, V272, P9086; Byon CH, 2008, J BIOL CHEM, V283, P15319, DOI 10.1074/jbc.M800021200; Chi XZ, 2009, CANCER RES, V69, P8111, DOI 10.1158/0008-5472.CAN-09-1057; Cohen MM, 2009, AM J MED GENET A, V149A, P2629, DOI 10.1002/ajmg.a.33021; Collins A, 2009, NAT REV IMMUNOL, V9, P106, DOI 10.1038/nri2489; Courbard JR, 2002, J BIOL CHEM, V277, P45267, DOI 10.1074/jbc.M206460200; Dillin A, 2002, SCIENCE, V298, P830, DOI 10.1126/science.1074240; Dornan D, 2004, NATURE, V429, P86, DOI 10.1038/nature02514; Ewbank Jonathan J, 2006, WormBook, P1; Friedrich MJ, 2006, J PATHOL, V210, P141, DOI 10.1002/path.2042; Gao M, 2004, SCIENCE, V306, P271, DOI 10.1126/science.1099414; Huang G, 2001, EMBO J, V20, P723, DOI 10.1093/emboj/20.4.723; Inoue H, 2005, GENE DEV, V19, P2278, DOI 10.1101/gad.1324805; Ito Y, 2008, ADV CANCER RES, V99, P33, DOI 10.1016/S0065-230X(07)99002-8; Jin YH, 2004, J BIOL CHEM, V279, P29409, DOI 10.1074/jbc.M313120200; Kim DH, 2004, P NATL ACAD SCI USA, V101, P10990, DOI 10.1073/pnas.0403546101; Kim DH, 2002, SCIENCE, V297, P623, DOI 10.1126/science.1073759; Kim EJ, 2008, J UROLOGY, V180, P1141, DOI 10.1016/j.juro.2008.05.002; Kim WJ, 2005, CANCER RES, V65, P9347, DOI 10.1158/0008-5472.CAN-05-1647; KRAMER JM, 1990, MOL CELL BIOL, V10, P2081, DOI 10.1128/MCB.10.5.2081; Lau QC, 2006, CANCER RES, V66, P6512, DOI 10.1158/0008-5472.CAN-06-0369; Lee YM, 2011, J CELL BIOCHEM, V112, P394, DOI 10.1002/jcb.22969; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Mizuno T, 2004, EMBO J, V23, P2226, DOI 10.1038/sj.emboj.7600226; Musti AM, 1997, SCIENCE, V275, P400, DOI 10.1126/science.275.5298.400; Nam S, 2002, MOL CELL BIOL, V22, P547, DOI 10.1128/MCB.22.2.547-554.2002; Nateri AS, 2004, SCIENCE, V303, P1374, DOI 10.1126/science.1092880; Nimmo R, 2005, DEVELOPMENT, V132, P5043, DOI 10.1242/dev.02102; Oh SW, 2006, NAT GENET, V38, P251, DOI 10.1038/ng1723; Qiao M, 2006, J BIOL CHEM, V281, P7118, DOI 10.1074/jbc.M508162200; Richardson CE, 2010, NATURE, V463, P1092, DOI 10.1038/nature08762; Rocca A, 2001, MOL BIOL CELL, V12, P1293, DOI 10.1091/mbc.12.5.1293; Rohlfing AK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009010; Seydoux G, 1995, METHOD CELL BIOL, V48, P323; Shen R, 2006, J BIOL CHEM, V281, P16347, DOI 10.1074/jbc.M603439200; Shim J, 2008, BIOCHEM BIOPH RES CO, V367, P130, DOI 10.1016/j.bbrc.2007.12.097; Shivers RP, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000892; Sierra J, 2003, MOL CELL BIOL, V23, P3339, DOI 10.1128/MCB.23.9.3339-3351.2003; Solomon A, 2004, GENETICS, V167, P161, DOI 10.1534/genetics.167.1.161; Stifani S, 2009, BLOOD CELL MOL DIS, V43, P20, DOI 10.1016/j.bcmd.2009.03.001; Sundaram Meera V, 2006, WormBook, P1; Villagra A, 2002, J CELL BIOCHEM, V85, P112, DOI 10.1002/jcb.10113; Wee HJ, 2002, EMBO REP, V3, P967, DOI 10.1093/embo-reports/kvf193; Yoshida CA, 2005, CRIT REV EUKAR GENE, V15, P243, DOI 10.1615/CritRevEukarGeneExpr.v15.i3.60	49	12	18	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					10444	10452		10.1074/jbc.M111.314146	http://dx.doi.org/10.1074/jbc.M111.314146			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22308034	Green Published, hybrid			2022-12-25	WOS:000302167200071
J	Teng, Y; Ngoka, L; Mei, Y; Lesoon, L; Cowell, JK				Teng, Yong; Ngoka, Lambert; Mei, Yun; Lesoon, Leslieann; Cowell, John K.			HSP90 and HSP70 Proteins Are Essential for Stabilization and Activation of WASF3 Metastasis-promoting Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK-PROTEIN; CANCER-CELLS; LAMELLIPODIA FORMATION; STATISTICAL-MODEL; DOWN-REGULATION; INVASION; DEGRADATION; CHAPERONES; INHIBITOR; MIGRATION	Inactivation of HSP90 and HSP70 leads to loss of invasion in a variety of cancer cell types, presumably as a result of destabilization of, as yet, undefined clients of these molecular chaperones that influence this phenotype. The WASF3 gene has been shown to be up-regulated in high-grade tumors and its down-regulation leads to loss of invasion and metastasis. WASF3 phosphorylation by ABL kinase is essential for its ability to regulate invasion. Mass spectroscopy analysis now shows that HSP90 is present in the WASF3 immunocomplex from prostate cancer cells. Inactivation of HSP90 in these and other cell types does not affect WASF3 stability but prevents its phosphoactivation as a result of destabilization of ABL. HSP70 was also found in the WASF3 immunocomplex and inactivation of HSP70 results in destabilization of WASF3 through proteasome degradation. Knockdown of WASF3, HSP90, and HSP70 individually, all lead to loss of invasion but as knockdown of WASF3 in the presence of robust expression of HSP90/70 has the same effect, it seems that the influence these chaperone proteins have on invasion is mediated, at least in part, by their control over the critical invasion promoting capacity of the WASF3 protein. Overexpression of HSP70 in WASF3 null cells does not enhance invasion. These observations suggest that targeting HSP90/70 may have efficacy in reducing cancer cell invasion.	[Teng, Yong; Ngoka, Lambert; Mei, Yun; Lesoon, Leslieann; Cowell, John K.] Georgia Hlth Sci Univ Canc Ctr, Augusta, GA 30912 USA		Cowell, JK (corresponding author), Georgia Hlth Sci Univ Canc Ctr, CN4121,1120 15th St,CN 4121A, Augusta, GA 30912 USA.	jcowell@georgiahealth.edu	Teng, Yong/AAK-4160-2020	Teng, Yong/0000-0002-1856-7289; Cowell, John/0000-0002-2079-5950	National Institutes of Health from NCI [CA120510]; NATIONAL CANCER INSTITUTE [R01CA120510] Funding Source: NIH RePORTER	National Institutes of Health from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA120510 from NCI.	An WG, 2000, CELL GROWTH DIFFER, V11, P355; BECKMANN RP, 1990, SCIENCE, V248, P850, DOI 10.1126/science.2188360; Chen JS, 2010, J BIOL CHEM, V285, P25458, DOI 10.1074/jbc.M110.139345; CHIANG HL, 1989, SCIENCE, V246, P382, DOI 10.1126/science.2799391; CHIRICO WJ, 1988, NATURE, V332, P805, DOI 10.1038/332805a0; Eden S, 2002, NATURE, V418, P790, DOI 10.1038/nature00859; Eustace BK, 2004, NAT CELL BIOL, V6, P507, DOI 10.1038/ncb1131; Gabai VL, 2009, MOL CELL BIOL, V29, P559, DOI 10.1128/MCB.01041-08; Garg M, 2010, CANCER-AM CANCER SOC, V116, P3785, DOI 10.1002/cncr.25218; Garg M, 2010, EUR J CANCER, V46, P207, DOI 10.1016/j.ejca.2009.10.020; Guo F, 2005, CANCER RES, V65, P10536, DOI 10.1158/0008-5472.CAN-05-1799; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; HIGHTOWER LE, 1991, CELL, V66, P191, DOI 10.1016/0092-8674(91)90611-2; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kim MS, 2008, MOL CANCER RES, V6, P1657, DOI 10.1158/1541-7786.MCR-08-0034; Koga F, 2009, ANTICANCER RES, V29, P797; Leng Y, 2005, P NATL ACAD SCI USA, V102, P1098, DOI 10.1073/pnas.0409120102; Leu JIJ, 2009, MOL CELL, V36, P15, DOI 10.1016/j.molcel.2009.09.023; Liu XG, 2011, ONCOL REP, V25, P1343, DOI 10.3892/or.2011.1202; Marcu MG, 2000, J BIOL CHEM, V275, P37181, DOI 10.1074/jbc.M003701200; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Saliba RS, 2002, J CELL SCI, V115, P2907; Sanderson S, 2006, MOL CANCER THER, V5, P522, DOI 10.1158/1535-7163.MCT-05-0439; Sims JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018848; Sossey-Alaoui K, 2005, J BIOL CHEM, V280, P21748, DOI 10.1074/jbc.M500503200; Sossey-Alaoui K, 2007, J BIOL CHEM, V282, P26257, DOI 10.1074/jbc.M701484200; Sossey-Alaoui K, 2007, AM J PATHOL, V170, P2112, DOI 10.2353/ajpath.2007.060975; Soti C, 2003, EUR J BIOCHEM, V270, P2421, DOI 10.1046/j.1432-1033.2003.03610.x; Steffen A, 2004, EMBO J, V23, P749, DOI 10.1038/sj.emboj.7600084; Suetsugu S, 1999, BIOCHEM BIOPH RES CO, V260, P296, DOI 10.1006/bbrc.1999.0894; Taiyab A, 2011, BBA-MOL CELL RES, V1813, P213, DOI 10.1016/j.bbamcr.2010.09.012; Teng Y, 2010, BRIT J CANCER, V103, P1066, DOI 10.1038/sj.bjc.6605850; Teng Y, 2011, INT J CANCER, V129, P2825, DOI 10.1002/ijc.25964; Walsh N, 2011, CANCER LETT, V306, P180, DOI 10.1016/j.canlet.2011.03.004; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Yokota S, 2000, CANCER RES, V60, P2942; Zaarur N, 2006, CANCER RES, V66, P1783, DOI 10.1158/0008-5472.CAN-05-3692	38	62	62	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					10051	10059		10.1074/jbc.M111.335000	http://dx.doi.org/10.1074/jbc.M111.335000			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22315230	Green Published, hybrid			2022-12-25	WOS:000302167200037
J	Yeang, HXA; Hamdam, JM; Al-Huseini, LMA; Sethu, S; Djouhri, L; Walsh, J; Kitteringham, N; Park, BK; Goldring, CE; Sathish, JG				Yeang, Han Xian Aw; Hamdam, Junnat M.; Al-Huseini, Laith M. A.; Sethu, Swaminathan; Djouhri, Laiche; Walsh, Joanne; Kitteringham, Neil; Park, B. Kevin; Goldring, Christopher E.; Sathish, Jean G.			Loss of Transcription Factor Nuclear Factor-Erythroid 2 (NF-E2) p45-related Factor-2 (Nrf2) Leads to Dysregulation of Immune Functions, Redox Homeostasis, and Intracellular Signaling in Dendritic Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; CD8(+) T-CELLS; HISTONE DEACETYLASE INHIBITORS; OXIDATIVE STRESS; IN-VIVO; ACTIVATION; MICE; MATURATION; DISEASE; TCR	Dendritic cells (DCs) are critical mediators of immunity and immune tolerance by orchestrating multiple aspects of T cell activation and function. Immature DCs (iDCs) expressing low levels of co-stimulatory receptors are highly efficient at antigen capture but are poor activators of T cells. Maturation of DCs is associated with increased expression of co-stimulatory molecules. Co-stimulatory receptor gene expression is regulated by intracellular redox, NF-kappa B, and MAPK pathways and by histone deacetylase (HDAC) activity. The transcription factor, Nrf2, is important for maintaining intracellular glutathione (GSH) levels and redox homeostasis and has been implicated in modulating DC co-stimulatory receptor expression. It is unclear whether Nrf2 mediates this effect by GSH-dependent mechanisms and whether it influences DC signaling pathways. Using bone marrow-derived iDCs from Nrf2(+/+) and Nrf2(-/-) mice, we demonstrate that Nrf2(-/-) iDCs have lower basal GSH levels, enhanced co-stimulatory receptor expression, impaired phagocytic functions, and increased antigen-specific CD8 T cell stimulation capacity. Interestingly, lowering GSH levels in Nrf2(+/+) iDCs did not recapitulate the Nrf2(-/-) iDC phenotype. Loss of Nrf2 resulted in elevated basal levels of reactive oxygen species but did not affect basal NF-kappa B activity or p38 MAPK phosphorylation. Using pharmacological inhibitors, we demonstrate that enhanced co-stimulatory receptor phenotype of Nrf2(-/-) iDC does not require ERK activity but is dependent on HDAC activity, indicating a potential interaction between Nrf2 function and HDAC. These results suggest that Nrf2 activity is required to counter rises in intracellular reactive oxygen species and to regulate pathways that control DC co-stimulatory receptor expression.	[Yeang, Han Xian Aw; Hamdam, Junnat M.; Al-Huseini, Laith M. A.; Sethu, Swaminathan; Djouhri, Laiche; Walsh, Joanne; Kitteringham, Neil; Park, B. Kevin; Goldring, Christopher E.; Sathish, Jean G.] Univ Liverpool, Dept Pharmacol, Med Res Council, Ctr Drug Safety Sci, Liverpool L69 3GE, Merseyside, England	UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Liverpool	Goldring, CE (corresponding author), Univ Liverpool, Dept Pharmacol, Med Res Council, Ctr Drug Safety Sci, Sherrington Bldg,Ashton St, Liverpool L69 3GE, Merseyside, England.	chrissy@liv.ac.uk; Jean.Sathish@liv.ac.uk	Sethu, Swaminathan/R-8577-2019; Al-Huseini, Laith M Abbas/S-6613-2019	Al-Huseini, Laith M Abbas/0000-0002-5170-1865; Walsh, Joanne/0000-0002-5109-2019; Sethu, Swaminathan/0000-0001-9210-2554; Sathish, Jean/0000-0002-5605-6957	Wellcome trust; University Of Liverpool; Biotechnology and Biological Sciences Research Council-Integrative Mammalian Biology (BBSRC-IMB); Drug Safety Centre; Medical Research Council [G0700654]; Medical Research Council [G0700420, G0700654B] Funding Source: researchfish; MRC [G0700420, G0700654] Funding Source: UKRI	Wellcome trust(Wellcome Trust); University Of Liverpool; Biotechnology and Biological Sciences Research Council-Integrative Mammalian Biology (BBSRC-IMB)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Drug Safety Centre; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Wellcome trust and grants from the University Of Liverpool (to H. X. A. Y.) and the Biotechnology and Biological Sciences Research Council-Integrative Mammalian Biology (BBSRC-IMB) award (to J. M. H.), as part of the Drug Safety Centre supported by the Medical Research Council (grant number G0700654).	Aiba S, 2003, J INVEST DERMATOL, V120, P390, DOI 10.1046/j.1523-1747.2003.12065.x; Albert ML, 1998, J EXP MED, V188, P1359, DOI 10.1084/jem.188.7.1359; Bachmann MF, 1999, EUR J IMMUNOL, V29, P2156, DOI 10.1002/(SICI)1521-4141(199907)29:07<2156::AID-IMMU2156>3.0.CO;2-P; Bindokas VP, 1996, J NEUROSCI, V16, P1324; Celluzzi CM, 1998, J IMMUNOL, V160, P3081; Chai JG, 1999, J IMMUNOL, V163, P1298; Chan KM, 2001, P NATL ACAD SCI USA, V98, P4611, DOI 10.1073/pnas.081082098; Chung KF, 2010, ANN NY ACAD SCI, V1203, P85, DOI 10.1111/j.1749-6632.2010.05600.x; Dashwood RH, 2007, SEMIN CANCER BIOL, V17, P363, DOI 10.1016/j.semcancer.2007.04.001; Delon J, 1998, J EXP MED, V188, P1473, DOI 10.1084/jem.188.8.1473; EVAVOLD BD, 1993, IMMUNOL TODAY, V14, P602, DOI 10.1016/0167-5699(93)90200-5; Faraco G, 2011, MOL MED, V17, P442, DOI 10.2119/molmed.2011.00077; Goldrath AW, 1999, NATURE, V402, P255, DOI 10.1038/35005508; GRIFFITH OW, 1979, J BIOL CHEM, V254, P7558; Hamann D, 1997, J EXP MED, V186, P1407, DOI 10.1084/jem.186.9.1407; INABA K, 1993, J EXP MED, V178, P479, DOI 10.1084/jem.178.2.479; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Johnson KG, 1999, J IMMUNOL, V162, P3802; Kantengwa S, 2003, AM J RESP CRIT CARE, V167, P431, DOI 10.1164/rccm.200205-425OC; Kemball CC, 2006, J IMMUNOL, V176, P1814, DOI 10.4049/jimmunol.176.3.1814; Kim HJ, 2008, J ALLERGY CLIN IMMUN, V121, P1255, DOI 10.1016/j.jaci.2008.01.016; Kim HJ, 2007, J ALLERGY CLIN IMMUN, V119, P1225, DOI 10.1016/j.jaci.2007.01.016; Kim HS, 2010, INT IMMUNOPHARMACOL, V10, P1284, DOI 10.1016/j.intimp.2010.07.012; Kurts C, 1997, J EXP MED, V186, P239, DOI 10.1084/jem.186.2.239; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; MAMALAKI C, 1992, P NATL ACAD SCI USA, V89, P11342, DOI 10.1073/pnas.89.23.11342; McCubrey JA, 2006, ANTIOXID REDOX SIGN, V8, P1775, DOI 10.1089/ars.2006.8.1775; Micheva I, 2006, BLOOD CELL MOL DIS, V36, P298, DOI 10.1016/j.bcmd.2005.12.029; Minucci S, 2006, NAT REV CANCER, V6, P38, DOI 10.1038/nrc1779; Monrad SU, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2517; Morgan MJ, 2011, CELL RES, V21, P103, DOI 10.1038/cr.2010.178; Nakahara T, 2006, J DERMATOL SCI, V42, P1, DOI 10.1016/j.jdermsci.2005.11.004; Nencioni A, 2007, CLIN CANCER RES, V13, P3933, DOI 10.1158/1078-0432.CCR-06-2903; Ouaaz F, 2002, IMMUNITY, V16, P257, DOI 10.1016/S1074-7613(02)00272-8; Rangasamy T, 2005, J EXP MED, V202, P47, DOI 10.1084/jem.20050538; Rangasamy T, 2010, AM J RESP CELL MOL, V43, P276, DOI 10.1165/rcmb.2008-0438OC; Reddy NM, 2007, PHYSIOL GENOMICS, V32, P74, DOI 10.1152/physiolgenomics.00126.2007; Reddy P, 2008, J CLIN INVEST, V118, P2562, DOI 10.1172/JCI34712; Reynaert NL, 2006, P NATL ACAD SCI USA, V103, P13086, DOI 10.1073/pnas.0603290103; Rigby S, 2000, EUR J IMMUNOL, V30, P98, DOI 10.1002/1521-4141(200001)30:1<98::AID-IMMU98>3.3.CO;2-R; Sheng KC, 2010, J IMMUNOL, V184, P2863, DOI 10.4049/jimmunol.0903458; Shih VFS, 2011, CELL RES, V21, P86, DOI 10.1038/cr.2010.161; Steinman RM, 2003, APMIS, V111, P675, DOI 10.1034/j.1600-0463.2003.11107802.x; Thimmulappa RK, 2006, J CLIN INVEST, V116, P984, DOI 10.1172/JCI25790; van de Laar L, 2010, J IMMUNOL, V185, P7252, DOI 10.4049/jimmunol.1000672; VANDEPUTTE C, 1994, CELL BIOL TOXICOL, V10, P415, DOI 10.1007/BF00755791; Vojinovic J, 2011, MOL MED, V17, P397, DOI 10.2119/molmed.2011.00030; Williams MA, 2008, J IMMUNOL, V181, P4545, DOI 10.4049/jimmunol.181.7.4545; Williams O, 1996, EUR J IMMUNOL, V26, P532, DOI 10.1002/eji.1830260305; Zmijewski JW, 2007, AM J PHYSIOL-CELL PH, V293, pC255, DOI 10.1152/ajpcell.00618.2006	50	50	51	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					10556	10564		10.1074/jbc.M111.322420	http://dx.doi.org/10.1074/jbc.M111.322420			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22311972	Green Published, hybrid			2022-12-25	WOS:000302167200081
J	Moyle-Heyrman, G; Viswanathan, R; Widom, J; Auble, DT				Moyle-Heyrman, Georgette; Viswanathan, Ramya; Widom, Jonathan; Auble, David T.			Two-step Mechanism for Modifier of Transcription 1 (Mot1) Enzyme-catalyzed Displacement of TATA-binding Protein (TBP) from DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYMERASE-II TRANSCRIPTION; SACCHAROMYCES-CEREVISIAE; CRYSTAL-STRUCTURE; BASAL TRANSCRIPTION; SWI2/SNF2 ATPASE; FAMILY-MEMBER; PROMOTER DNA; BOX COMPLEX; HUMAN-CELLS; DYNAMICS	The TATA box binding protein (TBP) is a central component of the transcription preinitiation complex, and its occupancy at a promoter is correlated with transcription levels. The TBP-promoter DNA complex contains sharply bent DNA and its interaction lifetime is limited by the ATP-dependent TBP displacement activity of the Snf2/Swi2 ATPase Mot1. Several mechanisms for Mot1 action have been proposed, but how it catalyzes TBP removal from DNA is unknown. To better understand the Mot1 mechanism, native gel electrophoresis and FRET were used to determine how Mot1 affects the trajectory of DNA in the TBP-DNA complex. Strikingly, in the absence of ATP, Mot1 acts to unbend DNA, whereas TBP remains closely associated with the DNA in a stable Mot1-TBP-DNA ternary complex. Interestingly, and in contrast to full-length Mot1, the isolated Mot1 ATPase domain binds DNA, and its affinity for DNA is nucleotide-dependent, suggesting parallels between the Mot1 mechanism and DNA translocation-based mechanisms of chromatin remodeling enzymes. Based on these findings, a model is presented for Mot1 that links a DNA conformational change with ATP-induced DNA translocation.	[Viswanathan, Ramya; Auble, David T.] Univ Virginia Hlth Syst, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA; [Widom, Jonathan] Northwestern Univ, Dept Chem, Evanston, IL 60208 USA; [Moyle-Heyrman, Georgette; Widom, Jonathan] Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA	University of Virginia; Northwestern University; Northwestern University	Auble, DT (corresponding author), Univ Virginia Hlth Syst, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA.	auble@virginia.edu	Viswanathan, Ramya/L-5935-2019		National Institutes of Health [GM054692, GM55763]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055763, R01GM054692] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM054692 (to J. W.) and GM55763 (to D. T. A.).	Adamkewicz JI, 2000, J BIOL CHEM, V275, P21158, DOI 10.1074/jbc.M002639200; Amitani I, 2006, MOL CELL, V23, P143, DOI 10.1016/j.molcel.2006.05.009; Auble DT, 2009, TRENDS BIOCHEM SCI, V34, P49, DOI 10.1016/j.tibs.2008.10.008; Auble DT, 1999, MOL CELL BIOL, V19, P412; AUBLE DT, 1993, GENE DEV, V7, P844, DOI 10.1101/gad.7.5.844; AUBLE DT, 1994, GENE DEV, V8, P1920, DOI 10.1101/gad.8.16.1920; Auble DT, 1997, MOL CELL BIOL, V17, P4842, DOI 10.1128/MCB.17.8.4842; Banik U, 2001, J BIOL CHEM, V276, P49100, DOI 10.1074/jbc.M109246200; Basehoar AD, 2004, CELL, V116, P699, DOI 10.1016/S0092-8674(04)00205-3; Blosser TR, 2009, NATURE, V462, P1022, DOI 10.1038/nature08627; Chen DY, 2002, MOL BIOL CELL, V13, P276, DOI 10.1091/mbc.01-10-0523; Chin J, 2004, METHOD ENZYMOL, V376, P3; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; CLEGG RM, 1992, METHOD ENZYMOL, V211, P353; Darst RP, 2001, EMBO J, V20, P2028, DOI 10.1093/emboj/20.8.2028; de Graaf P, 2010, J CELL SCI, V123, P2663, DOI 10.1242/jcs.064097; Delgadillo RF, 2009, BIOCHEMISTRY-US, V48, P1801, DOI 10.1021/bi8018724; Durr H, 2005, CELL, V121, P363, DOI 10.1016/j.cell.2005.03.026; EISEN JA, 1995, NUCLEIC ACIDS RES, V23, P2715, DOI 10.1093/nar/23.14.2715; Fitzgerald DJ, 2004, EMBO J, V23, P3836, DOI 10.1038/sj.emboj.7600364; Goodey NM, 2008, NAT CHEM BIOL, V4, P474, DOI 10.1038/nchembio.98; Gumbs OH, 2003, EMBO J, V22, P3131, DOI 10.1093/emboj/cdg304; Gupta S, 2007, BIOCHEMISTRY-US, V46, P9886, DOI 10.1021/bi7003608; Ha TJ, 1999, P NATL ACAD SCI USA, V96, P893, DOI 10.1073/pnas.96.3.893; HOOPES BC, 1992, J BIOL CHEM, V267, P11539; KIM JL, 1993, NATURE, V365, P520, DOI 10.1038/365520a0; KIM YC, 1993, NATURE, V365, P512, DOI 10.1038/365512a0; Kostrewa D, 2009, NATURE, V462, P323, DOI 10.1038/nature08548; Kuras L, 1999, NATURE, V399, P609, DOI 10.1038/21239; LAGUNAS R, 1983, EUR J BIOCHEM, V137, P479, DOI 10.1111/j.1432-1033.1983.tb07851.x; Lakowicz J.R., 1999, PRINCIPLES FLUORESCE, V2nd, DOI 10.1007/978-0-387-46312-4; LAURENT BC, 1993, GENE DEV, V7, P583, DOI 10.1101/gad.7.4.583; Lewis R, 2008, NUCLEIC ACIDS RES, V36, P1881, DOI 10.1093/nar/gkn040; Li XY, 1999, NATURE, V399, P605, DOI 10.1038/21232; Lia G, 2006, MOL CELL, V21, P417, DOI 10.1016/j.molcel.2005.12.013; Lorch Y, 2010, P NATL ACAD SCI USA, V107, P3458, DOI 10.1073/pnas.1000398107; Masters KM, 2003, J BIOL CHEM, V278, P31685, DOI 10.1074/jbc.M305201200; Motojima F, 2003, J BIOL CHEM, V278, P26648, DOI 10.1074/jbc.M300806200; Nechushtai R, 2011, P NATL ACAD SCI USA, V108, P2240, DOI 10.1073/pnas.1019502108; NIKOLOV DB, 1995, NATURE, V377, P119, DOI 10.1038/377119a0; Nimonkar AV, 2007, J BIOL CHEM, V282, P30776, DOI 10.1074/jbc.M704767200; Parkhurst KM, 1996, BIOCHEMISTRY-US, V35, P7459, DOI 10.1021/bi9530301; Parkhurst LJ, 2001, BIOPOLYMERS, V61, P180; Pazin MJ, 1997, CELL, V88, P737, DOI 10.1016/S0092-8674(00)81918-2; Pereira LA, 2003, GENE, V315, P1, DOI 10.1016/S0378-1119(03)00714-5; PEREZHOWARD GM, 1995, BIOCHEMISTRY-US, V34, P8005, DOI 10.1021/bi00025a006; PETRI V, 1995, BIOCHEMISTRY-US, V34, P9977, DOI 10.1021/bi00031a020; Poorey K, 2010, GENOME RES, V20, P1679, DOI 10.1101/gr.109504.110; Powell RM, 2002, J BIOL CHEM, V277, P7776, DOI 10.1074/jbc.M110147200; Prasad TK, 2007, J MOL BIOL, V369, P940, DOI 10.1016/j.jmb.2007.04.005; Ristic D, 2001, P NATL ACAD SCI USA, V98, P8454, DOI 10.1073/pnas.151056798; Saha A, 2002, GENE DEV, V16, P2120, DOI 10.1101/gad.995002; Schluesche P, 2007, NAT STRUCT MOL BIOL, V14, P1196, DOI 10.1038/nsmb1328; Sprouse RO, 2008, P NATL ACAD SCI USA, V105, P13304, DOI 10.1073/pnas.0801901105; Sprouse RO, 2006, EMBO J, V25, P1492, DOI 10.1038/sj.emboj.7601050; Stols L, 2007, PROTEIN EXPRES PURIF, V53, P396, DOI 10.1016/j.pep.2007.01.013; Thoma NH, 2005, NAT STRUCT MOL BIOL, V12, P350, DOI 10.1038/nsmb919; Thomas MC, 2006, CRIT REV BIOCHEM MOL, V41, P105, DOI 10.1080/10409230600648736; Tsai CJ, 2008, J MOL BIOL, V378, P1, DOI 10.1016/j.jmb.2008.02.034; Tsai FTF, 2000, EMBO J, V19, P25, DOI 10.1093/emboj/19.1.25; van Werven FJ, 2009, NAT STRUCT MOL BIOL, V16, P1043, DOI 10.1038/nsmb.1674; Viswanathan R, 2011, BBA-GENE REGUL MECH, V1809, P488, DOI 10.1016/j.bbagrm.2011.05.012; Whitehouse I, 2003, MOL CELL BIOL, V23, P1935, DOI 10.1128/MCB.23.6.1935-1945.2003; Whittington JE, 2008, BIOCHEMISTRY-US, V47, P7264, DOI 10.1021/bi800139w; Wollmann P, 2011, NATURE, V475, P403, DOI 10.1038/nature10215; Wu J, 2001, J BIOL CHEM, V276, P14614, DOI 10.1074/jbc.M004402200; Zhang YL, 2006, MOL CELL, V24, P559, DOI 10.1016/j.molcel.2006.10.025; Zhao XM, 2002, CELL, V108, P615, DOI 10.1016/S0092-8674(02)00648-7	68	9	9	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					9002	9012		10.1074/jbc.M111.333484	http://dx.doi.org/10.1074/jbc.M111.333484			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22298788	Green Published, hybrid			2022-12-25	WOS:000301797800031
J	Kumar, P; Pandit, SS; Baldwin, IT				Kumar, Pavan; Pandit, Sagar Subhash; Baldwin, Ian T.			Tobacco Rattle Virus Vector: A Rapid and Transient Means of Silencing Manduca sexta Genes by Plant Mediated RNA Interference	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; NICOTIANA-ATTENUATA PLANTS; BOMBYX-MORI; ECOLOGICAL RESEARCH; EXPRESSION; SILKWORM; DSRNASE; MIDGUT; TRANSFORMATION; ARABIDOPSIS	Background: RNAi can be achieved in insect herbivores by feeding them host plants stably transformed to express double stranded RNA (dsRNA) of selected midgut-expressed genes. However, the development of stably transformed plants is a slow and laborious process and here we developed a rapid, reliable and transient method. We used viral vectors to produce dsRNA in the host plant Nicotiana attenuata to transiently silence midgut genes of the plant's lepidopteran specialist herbivore, Manduca sexta. To compare the efficacy of longer, undiced dsRNA for insect gene silencing, we silenced N. attenuata's dicer genes (NaDCL1-4) in all combinations in a plant stably transformed to express dsRNA targeting an insect gene. Methodology/Principal Findings: Stable transgenic N. attenuata plants harboring a 312 bp fragment of MsCYP6B46 in an inverted repeat orientation (ir-CYP6B46) were generated to produce CYP6B46 dsRNA. After consuming these plants, transcripts of CYP6B46 were significantly reduced in M. sexta larval midguts. The same 312 bp cDNA was cloned in an antisense orientation into a TRV vector and Agro-infiltrated into N. attenuata plants. When larvae ingested these plants, similar reductions in CYP6B46 transcripts were observed without reducing transcripts of the most closely related MsCYP6B45. We used this transient method to rapidly silence the expression of two additional midgut-expressed MsCYPs. CYP6B46 transcripts were further reduced in midguts, when the larvae fed on ir-CYP6B46 plants transiently silenced for two combinations of NaDCLs (DCL1/3/4 and DCL2/3/4) and contained higher concentrations of longer, undiced CYP6B46 dsRNA. Conclusions: Both stable and transient expression of CYP6B46 dsRNA in host plants provides a specific and robust means of silencing this gene in M. sexta larvae, but the transient system is better suited for high throughput analyses. Transiently silencing NaDCLs in ir-CYP6B46 plants increased the silencing of MsCYP6B46, suggested that insect's RNAi machinery is more efficient with longer lengths of ingested dsRNA.	[Kumar, Pavan; Pandit, Sagar Subhash; Baldwin, Ian T.] Max Planck Inst Chem Ecol, Dept Mol Ecol, Jena, Germany	Max Planck Society	Kumar, P (corresponding author), Max Planck Inst Chem Ecol, Dept Mol Ecol, Jena, Germany.	baldwin@ice.mpg.de	Baldwin, Ian T/K-1809-2013	kumar, Pavan/0000-0003-4718-3601; Baldwin, Ian/0000-0001-5371-2974	Max Planck Society; DAAD	Max Planck Society(Max Planck SocietyFoundation CELLEX); DAAD(Deutscher Akademischer Austausch Dienst (DAAD))	This work was funded by the Max Planck Society. PK was funded by a DAAD PhD fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arimatsu Yuji, 2007, Journal of Insect Biotechnology and Sericology, V76, P57; Arimatsu Y, 2007, INSECT BIOCHEM MOLEC, V37, P176, DOI 10.1016/j.ibmb.2006.11.004; Arimatsu Yuji, 2010, Journal of Insect Biotechnology and Sericology, V79, P125; Baum JA, 2007, NAT BIOTECHNOL, V25, P1322, DOI 10.1038/nbt1359; Bautista MAM, 2009, INSECT BIOCHEM MOLEC, V39, P38, DOI 10.1016/j.ibmb.2008.09.005; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Bubner B, 2006, PLANT CELL REP, V25, P668, DOI 10.1007/s00299-005-0111-4; Dalmay T, 2000, CELL, V101, P543, DOI 10.1016/S0092-8674(00)80864-8; Dubreuil G, 2009, J EXP BOT, V60, P4041, DOI 10.1093/jxb/erp237; Dzitoyeva S, 2001, MOL PSYCHIATR, V6, P665, DOI 10.1038/sj.mp.4000955; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Gase K, 2011, MOL ECOL RESOUR, V11, P890, DOI 10.1111/j.1755-0998.2011.03017.x; Gordon KHJ, 2007, NAT BIOTECHNOL, V25, P1231, DOI 10.1038/nbt1107-1231; Govind G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008735; Halitschke R, 2003, PLANT J, V36, P794, DOI 10.1046/j.1365-313X.2003.01921.x; Henderson IR, 2006, NAT GENET, V38, P721, DOI 10.1038/ng1804; Hutvagner G, 2002, CURR OPIN GENET DEV, V12, P225, DOI 10.1016/S0959-437X(02)00290-3; Huvenne H, 2010, J INSECT PHYSIOL, V56, P227, DOI 10.1016/j.jinsphys.2009.10.004; Kim HH, 2009, GENE DEV, V23, P1743, DOI 10.1101/gad.1812509; Krugel T, 2002, CHEMOECOLOGY, V12, P177, DOI 10.1007/PL00012666; Lacomme C, 2003, PLANT J, V34, P543, DOI 10.1046/j.1365-313X.2003.01733.x; Lin HF, 2007, SCIENCE, V316, P397, DOI 10.1126/science.1137543; Lynch JA, 2006, NAT PROTOC, V1, P486, DOI 10.1038/nprot.2006.70; Mao YB, 2007, NAT BIOTECHNOL, V25, P1307, DOI 10.1038/nbt1352; Mao YB, 2011, TRANSGENIC RES, V20, P665, DOI 10.1007/s11248-010-9450-1; Meyering-Vos M, 2007, J INSECT PHYSIOL, V53, P840, DOI 10.1016/j.jinsphys.2007.04.003; Mlotshwa S, 2002, PLANT CELL, V14, pS289, DOI 10.1105/tpc.001677; Pitino M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025709; Price DRG, 2008, TRENDS BIOTECHNOL, V26, P393, DOI 10.1016/j.tibtech.2008.04.004; Rajagopal R, 2002, J BIOL CHEM, V277, P46849, DOI 10.1074/jbc.C200523200; ROGERS SO, 1985, PLANT MOL BIOL, V5, P69, DOI 10.1007/BF00020088; Rozen S, 2000, PRIMER3 WWW GEN USER; Saedler R, 2004, J EXP BOT, V55, P151, DOI 10.1093/jxb/erh004; Sambrook J, MOL CLONING LAB MANU, V1, P42; SNYDER MJ, 1995, ARCH BIOCHEM BIOPHYS, V321, P13, DOI 10.1006/abbi.1995.1362; Swevers L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020250; Terenius O, 2011, J INSECT PHYSIOL, V57, P231, DOI 10.1016/j.jinsphys.2010.11.006; Tomoyasu Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r10; Turner CT, 2006, INSECT MOL BIOL, V15, P383, DOI 10.1111/j.1365-2583.2006.00656.x; Valentine TA, 2007, PLANT BIOTECHNOL J, V5, P827, DOI 10.1111/j.1467-7652.2007.00289.x; Whyard S, 2009, INSECT BIOCHEM MOLEC, V39, P824, DOI 10.1016/j.ibmb.2009.09.007; Wink M, 2002, CHEMOECOLOGY, V12, P29, DOI 10.1007/s00049-002-8324-2; Zha WJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020504; Zhou XG, 2008, INSECT BIOCHEM MOLEC, V38, P805, DOI 10.1016/j.ibmb.2008.05.005	45	94	105	1	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2012	7	2							e31347	10.1371/journal.pone.0031347	http://dx.doi.org/10.1371/journal.pone.0031347			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UG	22312445	Green Published, gold			2022-12-25	WOS:000301977500035
J	Abou-Kandil, A; Chamias, R; Huleihel, M; Godbey, WT; Aboud, M				Abou-Kandil, Ammar; Chamias, Rachel; Huleihel, Mahmoud; Godbey, W. T.; Aboud, Mordechai			Differential Role of PKC-Induced c-Jun in HTLV-1 LTR Activation by 12-O-Tetradecanoylphorbol-13-acetate in Different Human T-cell Lines	PLOS ONE			English	Article							PROTEIN-KINASE-C; LONG TERMINAL REPEAT; VIRUS TYPE-I; NF-KAPPA-B; TYPE-1 TAX PROTEIN; DNA-DAMAGE; TRANSCRIPTION FACTORS; IMMUNE-RESPONSE; GENOMIC INSTABILITY; NUCLEAR-PROTEIN	We have previously shown that TPA activates HTLV-1 LTR in Jurkat T-cells by inducing the binding of Sp1-p53 complex to the Sp1 site residing within the Ets responsive region 1 (ERR-1) of the LTR and that this activation is inhibited by PKCalpha and PKCepsilon. However, in H9 T-cells TPA has been noted to activate the LTR in two consecutive stages. The first stage is activation is mediated by PKCetta and requires the three 21 bp TRE repeats. The second activation mode resembles that of Jurkat cells, except that it is inhibited by PKCdelta. The present study revealed that the first LTR activation in H9 cells resulted from PKCetta-induced elevation of non-phosphorylated c-Jun which bound to the AP-1 site residing within each TRE. In contrast, this TRE-dependent activation did not occur in Jurkat cells, since there was no elevation of non-phosphorylated c-Jun in these cells. However, we found that PKCalpha and PKCepsilon, in Jurkat cells, and PKCetta and PKCdelta, in H9 cells, increased the level of phosphorylated c-Jun that interacted with the Sp1-p53 complex. This interaction prevented the Sp1-p53 binding to ERR-1 and blocked, thereby, the ERR-1-mediated LTR activation. Therefore, this PKC-inhibited LTR activation started in both cell types after depletion of the relevant PKCs by their downregulation. In view of these variable activating mechanisms we assume that there might be additional undiscovered yet modes of HTLV-1 LTR activation which vary in different cell types. Moreover, in line with this presumption we speculate that in HTLV-1 carriers the LTR of the latent provirus may also be reactivated by different mechanisms that vary between its different host T-lymphocyte subclones. Since this reactivation may initiate the ATL process, understanding of these mechanisms is essential for establishing strategies to block the possibility of reactivating the latent virus as preventive means for ATL development in carriers.	[Abou-Kandil, Ammar; Chamias, Rachel; Aboud, Mordechai] Ben Gurion Univ Negev, Fac Hlth Sci, Shraga Segal Dept Microbiol & Immunol, Beer Sheva, Israel; [Huleihel, Mahmoud] Ben Gurion Univ Negev, Fac Hlth Sci, Dept Virol & Dev Genet, Beer Sheva, Israel; [Godbey, W. T.] Tulane Univ, Lab Gene Therapy & Cellular Engn, Dept Chem & Biomol Engn, New Orleans, LA 70118 USA	Ben Gurion University; Ben Gurion University; Tulane University	Abou-Kandil, A (corresponding author), Ben Gurion Univ Negev, Fac Hlth Sci, Shraga Segal Dept Microbiol & Immunol, Beer Sheva, Israel.	aboud@bgu.ac.il	HULEIHEL, MAHMOUD/F-1837-2012; Godbey, W T/H-9407-2012		Israel Science Foundation; Israel Cancer Research Fund; Directorate For Engineering [0846395] Funding Source: National Science Foundation	Israel Science Foundation(Israel Science Foundation); Israel Cancer Research Fund; Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This study was supported by grants from the Israel Science Foundation and from the Israel Cancer Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonso PV, 2010, BLOOD, V116, P3802, DOI 10.1182/blood-2010-02-270751; Ahmed AA, 2010, J PATHOL, V221, P49, DOI 10.1002/path.2696; Akimoto M, 2007, J MED VIROL, V79, P977, DOI 10.1002/jmv.20807; ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; Arima N, 2004, EXP HEMATOL, V32, P195, DOI 10.1016/j.exphem.2003.11.008; Asquith B, 2000, PHILOS T ROY SOC B, V355, P1013, DOI 10.1098/rstb.2000.0638; Avesani F, 2010, VIROLOGY, V408, P39, DOI 10.1016/j.virol.2010.08.023; Azran I, 2005, ONCOGENE, V24, P4521, DOI 10.1038/sj.onc.1208645; Azran Inbal, 2004, Retrovirology, V1, P20; Azran-Shaish I, 2008, J MOL MED, V86, P799, DOI 10.1007/s00109-008-0335-1; Bangham CRM, 2005, ONCOGENE, V24, P6035, DOI 10.1038/sj.onc.1208970; Bangham CRM, 2003, J GEN VIROL, V84, P3177, DOI 10.1099/vir.0.19334-0; Barbeau B, 2011, VIRUSES-BASEL, V3, P456, DOI 10.3390/v3050456; Bellon M, 2009, BLOOD, V113, P4914, DOI 10.1182/blood-2008-11-189845; Bogoyevitch MA, 2006, MICROBIOL MOL BIOL R, V70, P1061, DOI 10.1128/MMBR.00025-06; BOSSELUT R, 1990, EMBO J, V9, P3137, DOI 10.1002/j.1460-2075.1990.tb07511.x; Boxus M, 2009, BRIT J CANCER, V101, P1497, DOI 10.1038/sj.bjc.6605345; Brosh R, 2009, NAT REV CANCER, V9, P701, DOI 10.1038/nrc2693; Chamias R, 2010, LEUKEMIA RES, V34, P93, DOI 10.1016/j.leukres.2009.03.032; Chlichlia K, 2010, CHEM-BIOL INTERACT, V188, P359, DOI 10.1016/j.cbi.2010.06.005; CLARK NM, 1993, J VIROL, V67, P5522, DOI 10.1128/JVI.67.9.5522-5528.1993; de la Fuente C, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-43; de Souza JG, 2011, J CLIN VIROL, V50, P13, DOI 10.1016/j.jcv.2010.09.007; DITTMER D, 1993, NAT GENET, V4, P42, DOI 10.1038/ng0593-42; Dodon MD, 2010, M S-MED SCI, V26, P391, DOI 10.1051/medsci/2010264391; Durkin SS, 2008, J BIOL CHEM, V283, P36311, DOI 10.1074/jbc.M804931200; Faris M, 2008, INT REV IMMUNOL, V27, P71, DOI 10.1080/08830180701777475; Felsher DW, 1999, P NATL ACAD SCI USA, V96, P3940, DOI 10.1073/pnas.96.7.3940; Florins A, 2007, FRONT BIOSCI-LANDMRK, V12, P1520, DOI 10.2741/2165; FRENKEL K, 1989, ENVIRON HEALTH PERSP, V81, P45, DOI 10.2307/3430803; Gaudray G, 2002, J VIROL, V76, P12813, DOI 10.1128/JVI.76.24.12813-12822.2002; GEGONNE A, 1993, EMBO J, V12, P1169, DOI 10.1002/j.1460-2075.1993.tb05758.x; Giam CZ, 2007, FRONT BIOSCI, V12, P1496, DOI 10.2741/2163; GITLIN SD, 1991, J VIROL, V65, P5513, DOI 10.1128/JVI.65.10.5513-5523.1991; Gonelli A, 2009, MINI-REV MED CHEM, V9, P498, DOI 10.2174/138955709787847967; Gruhne B, 2009, P NATL ACAD SCI USA, V106, P2313, DOI 10.1073/pnas.0810619106; GUALBERTO A, 1995, J BIOL CHEM, V270, P19680, DOI 10.1074/jbc.270.34.19680; GUALBERTO A, 1995, MOL CELL BIOL, V15, P3450; Hai T, ATF TRANSCRIPTION FA, P322; HAI TW, 1989, GENE DEV, V3, P2083, DOI 10.1101/gad.3.12b.2083; Halicka HD, 2009, INT J MOL MED, V23, P695, DOI 10.3892/ijmm_00000182; Heinrich R, 1997, J CLIN ENDOCR METAB, V82, P1839, DOI 10.1210/jc.82.6.1839; Ishitsuka K, 2008, EUR J HAEMATOL, V80, P185, DOI 10.1111/j.1600-0609.2007.01016.x; JEANG KT, 1991, VIROLOGY, V181, P218, DOI 10.1016/0042-6822(91)90487-V; Jeang KT, 2010, ONCOTARGET, V1, P453; Kannagi M, 2007, INT J HEMATOL, V86, P113, DOI 10.1532/IJH97.07092; Kannagi Mari, 2004, Expert Rev Anticancer Ther, V4, P369, DOI 10.1586/14737140.4.3.369; KARIN M, 1992, TRENDS BIOCHEM SCI, V17, P418, DOI 10.1016/0968-0004(92)90012-X; Kato S, 2003, P NATL ACAD SCI USA, V100, P8424, DOI 10.1073/pnas.1431692100; Kazanietz MG, 2000, MEDICINA-BUENOS AIRE, V60, P685; Kinjo T, 2010, J VIROL, V84, P5431, DOI 10.1128/JVI.02460-09; Koivunen J, 2006, CANCER LETT, V235, P1, DOI 10.1016/j.canlet.2005.03.033; Lee AC, 1999, J BIOL CHEM, V274, P7936, DOI 10.1074/jbc.274.12.7936; Lee KH, 2010, TOXICOL LETT, V194, P42, DOI 10.1016/j.toxlet.2010.01.021; Lemasson I, 2004, MOL CELL BIOL, V24, P6117, DOI 10.1128/MCB.24.14.6117-6126.2004; Lemasson I, 2002, J BIOL CHEM, V277, P49459, DOI 10.1074/jbc.M209566200; Li MY, 2011, NULL MATH BIOL  0421, V21; Lin CW, 2010, J CELL PHYSIOL, V225, P472, DOI 10.1002/jcp.22226; Lin CT, 2006, INT J CANCER, V119, P1776, DOI 10.1002/ijc.22068; Livneh E, 1996, ONCOGENE, V12, P1545; Lu ZM, 1998, MOL CELL BIOL, V18, P839, DOI 10.1128/MCB.18.2.839; MacLachlan TK, 2002, MOL CELL BIOL, V22, P4280, DOI 10.1128/MCB.22.12.4280-4292.2002; Maor SB, 2000, MOL GENET METAB, V69, P130, DOI 10.1006/mgme.1999.2958; Marriott SJ, 2005, ONCOGENE, V24, P5986, DOI 10.1038/sj.onc.1208976; Martelli AM, 1999, J CELL BIOCHEM, V74, P499, DOI 10.1002/(SICI)1097-4644(19990915)74:4<499::AID-JCB1>3.0.CO;2-X; Matsuoka M, 2011, ONCOGENE, V30, P1379, DOI 10.1038/onc.2010.537; Matsuoka M, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-71; MONTMINY MR, 1987, NATURE, V328, P175, DOI 10.1038/328175a0; MorVaknin N, 1997, VIROLOGY, V232, P337, DOI 10.1006/viro.1997.8566; Newbound GC, 1999, J ACQ IMMUN DEF SYND, V20, P1, DOI 10.1097/00042560-199901010-00001; PAPAVASSILIOU AG, 1994, ANTICANCER RES, V14, P1801; Park SA, 2007, ANN NY ACAD SCI, V1095, P545, DOI 10.1196/annals.1397.059; Pichler K, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-100; Pise-Masison CA, 1998, J VIROL, V72, P1165, DOI 10.1128/JVI.72.2.1165-1170.1998; Raivich G, 2008, J NEUROCHEM, V107, P898, DOI 10.1111/j.1471-4159.2008.05684.x; Ratner L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004420; Reyland ME, 2009, FRONT BIOSCI-LANDMRK, V14, P2386, DOI 10.2741/3385; Ruggero K, 2010, MOL ASPECTS MED, V31, P367, DOI 10.1016/j.mam.2010.05.001; Saggioro D, 2003, ANN NY ACAD SCI, V1010, P591, DOI 10.1196/annals.1299.111; Saggioro D, 2011, VIRUSES-BASEL, V3, P1001, DOI 10.3390/v3071001; Sangfelt O, 1997, CELL GROWTH DIFFER, V8, P343; Schavinsky-Khrapunsky Y, 2003, ONCOGENE, V22, P5315, DOI 10.1038/sj.onc.1206782; Schavinsky-Khrapunsky Y, 2008, INT J CANCER, V122, P305, DOI 10.1002/ijc.23091; Shrotriya S, 2010, CANCER RES, V70, P1932, DOI 10.1158/0008-5472.CAN-09-3501; Sun SC, 2005, ONCOGENE, V24, P5952, DOI 10.1038/sj.onc.1208969; Torgeman A, 2001, VIROLOGY, V281, P10, DOI 10.1006/viro.2000.0779; Torgeman A, 2001, EXP CELL RES, V271, P169, DOI 10.1006/excr.2001.5363; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; Tsukasaki K, 2009, J CLIN ONCOL, V27, P453, DOI 10.1200/JCO.2008.18.2428; Vafa O, 2002, MOL CELL, V9, P1031, DOI 10.1016/S1097-2765(02)00520-8; Vigorito E, 1999, HEMATOL CELL THER, V41, P153, DOI 10.1007/s00282-999-0153-0; WEI HC, 1992, CANCER RES, V52, P2298; Yasunaga Jun-ichirou, 2007, Cancer Control, V14, P133; Yoshida M, 2010, P JPN ACAD B-PHYS, V86, P117, DOI 10.2183/pjab.86.117; Yu XF, 2006, BIOCHEM BIOPH RES CO, V342, P286, DOI 10.1016/j.bbrc.2006.01.147; Zhang HB, 1998, ONCOGENE, V16, P1713, DOI 10.1038/sj.onc.1201932; Zhi H, 2011, LOS PATHOG, V7	97	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2012	7	1							e29934	10.1371/journal.pone.0029934	http://dx.doi.org/10.1371/journal.pone.0029934			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911GB	22299029	gold, Green Published, Green Submitted			2022-12-25	WOS:000301704200006
J	Ferraris, L; Butel, MJ; Campeotto, F; Vodovar, M; Roze, JC; Aires, J				Ferraris, Laurent; Butel, Marie Jose; Campeotto, Florence; Vodovar, Michel; Roze, Jean Christophe; Aires, Julio			Clostridia in Premature Neonates' Gut: Incidence, Antibiotic Susceptibility, and Perinatal Determinants Influencing Colonization	PLOS ONE			English	Article							PRETERM INFANTS; NECROTIZING ENTEROCOLITIS; BACTERIAL-COLONIZATION; MICROFLORA; MICROBIOTA; DIFFICILE; FLORA; RESISTANT; BOWEL; PCR	Background: Although premature neonates (PN) gut microbiota has been studied, data about gut clostridial colonization in PN are scarce. Few studies have reported clostridia colonization in PN whereas Bacteroides and bifidobacteria have been seldom isolated. Such aberrant gut microbiota has been suggested to be a risk factor for the development of intestinal infections. Besides, PN are often treated by broad spectrum antibiotics, but little is known about how antibiotics can influence clostridial colonization based on their susceptibility patterns. The aim of this study was to report the distribution of Clostridium species isolated in feces from PN and to determine their antimicrobial susceptibility patterns. Additionally, clostridial colonization perinatal determinants were analyzed. Results: Of the 76 PN followed until hospital discharge in three French neonatal intensive care units (NICUs), 79% were colonized by clostridia. Clostridium sp. colonization, with a high diversity of species, increased throughout the hospitalization. Antibiotic courses had no effect on the clostridial colonization incidence although strains were found susceptible (except C. difficile) to anti-anaerobe molecules tested. However, levels of colonization were decreased by either antenatal or neonatal (during more than 10 days) antibiotic courses (p = 0.006 and p = 0.001, respectively). Besides, incidence of colonization was depending on the NICU (p = 0.048). Conclusion: This study shows that clostridia are part of the PN gut microbiota. It provides for the first time information on the status of clostridia antimicrobial susceptibility in PN showing that strains were susceptible to most antibiotic molecules. Thus, the high prevalence of this genus is not linked to a high degree of resistance to antimicrobial agents or to the use of antibiotics in NICUs. The main perinatal determinant influencing PN clostridia colonization appears to be the NICU environment.	[Ferraris, Laurent; Butel, Marie Jose; Campeotto, Florence; Aires, Julio] Univ Paris 05, Fac Sci Pharmaceut & Biol, EA4065, Paris, France; [Vodovar, Michel] Inst Puericulture, Paris, France; [Roze, Jean Christophe] Univ Nantes, Dept Med Neonatale, Ctr Invest Clin, CHU Nantes,INSERM,CIC004, Nantes, France	UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes	Ferraris, L (corresponding author), Univ Paris 05, Fac Sci Pharmaceut & Biol, EA4065, Paris, France.	julio.aires@parisdescartes.fr	roze, jean christophe/B-5433-2012; Rozé, Jean-Christophe/AAS-1314-2021	Roze, Jean-Christophe/0000-0003-3367-512X; Aires, Julio/0000-0002-8090-4565				Alfa MJ, 2002, CLIN INFECT DIS, V35, pS101, DOI 10.1086/341929; BENNET R, 1986, PEDIATR INFECT DIS J, V5, P533, DOI 10.1097/00006454-198609000-00009; Biasucci G, 2010, EARLY HUM DEV, V86, pS13, DOI 10.1016/j.earlhumdev.2010.01.004; Bjornvad CR, 2008, AM J PHYSIOL-GASTR L, V295, pG1092, DOI 10.1152/ajpgi.00414.2007; BLAKEY JL, 1982, J MED MICROBIOL, V15, P519, DOI 10.1099/00222615-15-4-519; BLAKEY JL, 1985, J PEDIATR GASTR NUTR, V4, P591, DOI 10.1097/00005176-198508000-00017; Blondeau JM, 2009, J ANTIMICROB CHEMOTH, V63, P238, DOI 10.1093/jac/dkn477; BROOK I, 1982, J INFECTION, V4, P253, DOI 10.1016/S0163-4453(82)92584-1; BROOK I, 1995, J MED MICROBIOL, V42, P78, DOI 10.1099/00222615-42-2-78; Brook I, 2010, ANAEROBE, V16, P183, DOI 10.1016/j.anaerobe.2009.12.001; Butel MJ, 2007, J PEDIATR GASTR NUTR, V44, P577, DOI 10.1097/MPG.0b013e3180406b20; Butel MJ, 1998, J MED MICROBIOL, V47, P391, DOI 10.1099/00222615-47-5-391; Campeotto F, 2011, BRIT J NUTR, V105, P1843, DOI 10.1017/S0007114510005702; CASHORE WJ, 1981, J PEDIATR-US, V98, P308, DOI 10.1016/S0022-3476(81)80667-1; Chang JY, 2011, J PEDIATR GASTR NUTR, V53, P512, DOI 10.1097/MPG.0b013e318227e518; Claud EC, 2001, FASEB J, V15, P1398, DOI 10.1096/fj.00-0833hyp; COLLINS MD, 1994, INT J SYST BACTERIOL, V44, P812, DOI 10.1099/00207713-44-4-812; de Man P, 2000, LANCET, V355, P973, DOI 10.1016/S0140-6736(00)90015-1; de Vos N, 1982, Eur J Clin Microbiol, V1, P267; DELACOCHETIERE MF, 2004, PEDIATR RES, V56, P1; Gewolb IH, 1999, ARCH DIS CHILD-FETAL, V80, pF167, DOI 10.1136/fn.80.3.F167; Goldstein EJC, 2003, ANTIMICROB AGENTS CH, V47, P1968, DOI 10.1128/AAC.47.6.1968-1971.2003; Goldstein EJC, 2009, DIAGN MICR INFEC DIS, V63, P447, DOI 10.1016/j.diagmicrobio.2009.01.022; Gronlund MM, 1999, J PEDIATR GASTR NUTR, V28, P19, DOI 10.1097/00005176-199901000-00007; HOWARD FM, 1977, LANCET, V2, P1099; Jacquot A, 2011, J PEDIATR-US, V158, P390, DOI 10.1016/j.jpeds.2010.09.007; Johnson EA, 2007, MANUAL OF CLINICAL MICROBIOLOGY, 9TH ED, P889; Kalia VC, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-18; KOSLOSKE AM, 1985, J PEDIATR SURG, V20, P155, DOI 10.1016/S0022-3468(85)80290-6; KOSLOSKE AM, 1978, LANCET, V2, P1014, DOI 10.1016/S0140-6736(78)92337-1; Magne F, 2006, FEMS MICROBIOL ECOL, V57, P128, DOI 10.1111/j.1574-6941.2006.00097.x; MAGOT M, 1981, J GEN MICROBIOL, V127, P113; Mai V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020647; Millar MR, 1996, J CLIN MICROBIOL, V34, P2506, DOI 10.1128/JCM.34.10.2506-2510.1996; Morowitz MJ, 2010, PEDIATRICS, V125, P777, DOI 10.1542/peds.2009-3149; Mshvildadze M, 2010, J PEDIATR-US, V156, P20, DOI 10.1016/j.jpeds.2009.06.063; Mutlu E, 2007, J MED MICROBIOL, V56, P921, DOI 10.1099/jmm.0.47176-0; Neu J, 2011, NEW ENGL J MED, V364, P255, DOI 10.1056/NEJMra1005408; Obladen M, 2009, NEONATOLOGY, V96, P203, DOI 10.1159/000215590; Penders J, 2006, PEDIATRICS, V118, P511, DOI 10.1542/peds.2005-2824; ROTIMI VO, 1985, J HYG-CAMBRIDGE, V94, P309, DOI 10.1017/S0022172400061532; Roudiere L, 2009, J MICROBIOL METH, V79, P156, DOI 10.1016/j.mimet.2009.08.005; Rouge C, 2009, AM J CLIN NUTR, V89, P1828, DOI 10.3945/ajcn.2008.26919; Schwiertz A, 2003, PEDIATR RES, V54, P393, DOI 10.1203/01.PDR.0000078274.74607.7A; Siggers RH, 2011, J NUTR BIOCHEM, V22, P511, DOI 10.1016/j.jnutbio.2010.08.002; Smith B, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-73; STARK PL, 1982, J HYG-CAMBRIDGE, V89, P59, DOI 10.1017/S0022172400070546; STURM R, 1980, PEDIATRICS, V66, P928; Waligora-Dupriet AJ, 2005, PEDIATR RES, V58, P629, DOI 10.1203/01.PDR.0000180538.13142.84; Wang YW, 2009, ISME J, V3, P944, DOI 10.1038/ismej.2009.37; Woo PCY, 2005, J CLIN PATHOL, V58, P301, DOI 10.1136/jcp.2004.022830	51	49	55	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2012	7	1							e30594	10.1371/journal.pone.0030594	http://dx.doi.org/10.1371/journal.pone.0030594			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911FX	22291996	Green Published, gold, Green Submitted			2022-12-25	WOS:000301703800021
J	Tyrka, AR; Price, LH; Marsit, C; Walters, OC; Carpenter, LL				Tyrka, Audrey R.; Price, Lawrence H.; Marsit, Carmen; Walters, Oakland C.; Carpenter, Linda L.			Childhood Adversity and Epigenetic Modulation of the Leukocyte Glucocorticoid Receptor: Preliminary Findings in Healthy Adults	PLOS ONE			English	Article							PARENTAL BONDING INSTRUMENT; CORTISOL RESPONSES; EARLY STRESS; MALTREATMENT; METHYLATION; PSYCHOPATHOLOGY; PATHOPHYSIOLOGY; CONSEQUENCES; NEUROBIOLOGY; EXPERIENCES	Background: A history of early adverse experiences is an important risk factor for adult psychopathology. Changes in stress sensitivity and functioning of the hypothalamic-pituitary-adrenal (HPA) axis may underlie the association between stress and risk for psychiatric disorders. Preclinical work in rodents has linked low levels of maternal care to increased methylation of the promoter region of the glucocorticoid receptor (GR) gene, as well as to exaggerated hormonal and behavioral responses to stress. Recent studies have begun to examine whether early-life stress leads to epigenetic modifications of the GR gene in humans. Methods: We examined the degree of methylation of a region of the promoter of the human GR gene (NR3C1) in leukocyte DNA from 99 healthy adults. Participants reported on their childhood experiences of parental behavior, parental death or desertion, and childhood maltreatment. On a separate day, participants completed the dexamethasone/corticotropinreleasing hormone (Dex/CRH) test, a standardized neuroendocrine challenge test. Results: Disruption or lack of adequate nurturing, as measured by parental loss, childhood maltreatment, and parental care, was associated with increased NR3C1 promoter methylation (p<.05). In addition, NR3C1 promoter methylation was linked to attenuated cortisol responses to the Dex/CRH test (p<.05). Conclusions: These findings suggest that childhood maltreatment or adversity may lead to epigenetic modifications of the human GR gene. Alterations in methylation of this gene could underlie the associations between childhood adversity, alterations in stress reactivity, and risk for psychopathology.	[Tyrka, Audrey R.; Price, Lawrence H.; Walters, Oakland C.; Carpenter, Linda L.] Butler Hosp, Mood Disorders Res Program, Lab Clin Neurosci, Providence, RI 02906 USA; [Tyrka, Audrey R.; Price, Lawrence H.; Carpenter, Linda L.] Brown Med Sch, Dept Psychiat & Human Behav, Providence, RI USA; [Marsit, Carmen] Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Dept Pharmacol & Toxicol,Dept Community & Family, Hanover, NH 03756 USA	Butler Hospital Rhode Island; Brown University; Dartmouth College	Tyrka, AR (corresponding author), Butler Hosp, Mood Disorders Res Program, Lab Clin Neurosci, Providence, RI 02906 USA.	Audrey_Tyrka@Brown.edu	Tyrka, Audrey/L-2504-2014	Walters, Oakland C./0000-0002-0597-8994; Marsit, Carmen/0000-0003-4566-150X	National Institute of Mental Health (NIMH) [R01 MH083704, R01 MH068767]; Centers of Biomedical Research Excellence (COBRE) [P20RR018728]; National Institutes of Mental Health; NARSAD; UCB Pharma; Sepracor; Cyberonics; Department of Defense; Medtronic; Neuronetics; NeoSync; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018728] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH091508, R01MH068767, R01MH083704] Funding Source: NIH RePORTER	National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Centers of Biomedical Research Excellence (COBRE)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NARSAD(NARSAD); UCB Pharma(UCB Pharma SA); Sepracor; Cyberonics; Department of Defense(United States Department of Defense); Medtronic(Medtronic); Neuronetics; NeoSync; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Funding for this study was provided by National Institute of Mental Health (NIMH; www.nimh.nih.gov) grants R01 MH083704 (Dr. Tyrka) and R01 MH068767 (Dr. Carpenter), and Centers of Biomedical Research Excellence (COBRE) grant P20RR018728 (Dr. Marsit). Acthrel was purchased at a discounted rate for research from Ferring Pharmaceuticals, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and report the following interests: In the last three years, Dr. Tyrka, Dr. Carpenter, and Dr. Price have received research support from the National Institutes of Mental Health, NARSAD, UCB Pharma, Sepracor, Cyberonics, the Department of Defense, Medtronic, Neuronetics, and NeoSync. Dr. Tyrka received honoraria for continuing medical education from Lundbeck and Takeda. Dr. Price received speaker honoraria from MD Conferences/Psychiatry Review Course and served as a paid consultant to Gerson Lehrman, Wiley, Springer, Qatar National Research Fund, Alberta Heritage Foundation for Medical Research, Abbott, and AstraZeneca. Dr. Carpenter served as a paid consultant to Abbott, Cyberonics, Novartis, Wyeth, AstraZenica, and Neuronetics, on the speakers bureau for Neuronetics, and received honoraria for continuing medical education from AstraZenica. Dr. Marsit and Oakland Walters report no biomedical financial interests. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Alt SR, 2010, PSYCHONEUROENDOCRINO, V35, P544, DOI 10.1016/j.psyneuen.2009.09.001; Baschant U, 2010, J STEROID BIOCHEM, V120, P69, DOI 10.1016/j.jsbmb.2010.03.058; BERNSTEIN DP, 1994, AM J PSYCHIAT, V151, P1132, DOI 10.1176/ajp.151.8.1132; Bernstein DP, 1998, CHILDHOOD TRAUMA QUE; Bjornsson HT, 2008, JAMA-J AM MED ASSOC, V299, P2877, DOI 10.1001/jama.299.24.2877; BREIER A, 1988, ARCH GEN PSYCHIAT, V45, P987; Carpenter LL, 2007, BIOL PSYCHIAT, V62, P1080, DOI 10.1016/j.biopsych.2007.05.002; Carpenter LL, 2011, PSYCHOPHARMACOLOGY, V214, P367, DOI 10.1007/s00213-010-2007-4; Carpenter LL, 2009, BIOL PSYCHIAT, V66, P69, DOI 10.1016/j.biopsych.2009.02.030; Carpenter LL, 2010, NEUROPSYCHO IN PRESS; Ceccatelli S, 2007, PHYSIOL BEHAV, V92, P87, DOI 10.1016/j.physbeh.2007.05.048; Champagne FA, 2009, NEUROSCI BIOBEHAV R, V33, P593, DOI 10.1016/j.neubiorev.2007.10.009; Cicchetti D, 2001, DEV PSYCHOPATHOL, V13, P783, DOI 10.1017/S0954579401004035; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Daniels WMU, 2009, METAB BRAIN DIS, V24, P615, DOI 10.1007/s11011-009-9163-4; Dozier M, 2006, CHILD MALTREATMENT, V11, P189, DOI 10.1177/1077559505285779; Dranovsky A, 2006, BIOL PSYCHIAT, V59, P1136, DOI 10.1016/j.biopsych.2006.03.082; Duman Ronald S, 2009, Dialogues Clin Neurosci, V11, P239; Elzinga BM, 2008, PSYCHONEUROENDOCRINO, V33, P227, DOI 10.1016/j.psyneuen.2007.11.004; Epel ES, 2009, HORM-INT J ENDOCRINO, V8, P7, DOI 10.14310/horm.2002.1217; First M. B., 1997, STRUCTURED CLIN INTE; Gunnar MR, 2007, PROG BRAIN RES, V167, P137, DOI 10.1016/S0079-6123(07)67010-1; Gunnar MR, 2006, DEV PSYCHOPATHOL, V18, P651, DOI 10.1017/S0954579406060330; Heim C, 2000, PSYCHONEUROENDOCRINO, V25, P1, DOI 10.1016/S0306-4530(99)00035-9; Kaufman J, 2001, DEV PSYCHOPATHOL, V13, P451, DOI 10.1017/S0954579401003030; Kaufman J, 1997, BIOL PSYCHIAT, V42, P669, DOI 10.1016/S0006-3223(96)00470-2; Kessler RC, 1997, PSYCHOL MED, V27, P1101, DOI 10.1017/S0033291797005588; Klaassens ER, 2009, PROG NEURO-PSYCHOPH, V33, P889, DOI 10.1016/j.pnpbp.2009.04.011; Langevin SM, 2011, EPIGENETICS, P6; Lee RS, 2010, ENDOCRINOLOGY, V151, P4332, DOI 10.1210/en.2010-0225; McEwen BS, 2007, PHYSIOL REV, V87, P873, DOI 10.1152/physrev.00041.2006; McGowan PO, 2009, NAT NEUROSCI, V12, P342, DOI 10.1038/nn.2270; Meinlschmidt G. P, 2005, LONG TERM PSYCHOBIOL; Miller AH, 2009, BIOL PSYCHIAT, V65, P732, DOI 10.1016/j.biopsych.2008.11.029; Mitra R, 2008, P NATL ACAD SCI USA, V105, P5573, DOI 10.1073/pnas.0705615105; Moser D, 2007, WORLD J BIOL PSYCHIA, V8, P262, DOI 10.1080/15622970701429862; Nelson CA, 2000, HDB INFANT MENTAL HL, P37; O'Donovan A., 2011, BIOL PSYCHIAT; Oberlander TF, 2008, EPIGENETICS-US, V3, P97, DOI 10.4161/epi.3.2.6034; Pariante CM, 2004, STRESS, V7, P209, DOI 10.1080/10253890500069650; PARKER G, 1989, PSYCHIAT DEV, V7, P317; Pryce CR, 2005, NEUROSCI BIOBEHAV R, V29, P649, DOI 10.1016/j.neubiorev.2005.03.011; Rice CJ, 2008, ENDOCRINOLOGY, V149, P4892, DOI 10.1210/en.2008-0633; Rush AJ, 1996, PSYCHOL MED, V26, P477, DOI 10.1017/S0033291700035558; Sanchez MM, 2001, DEV PSYCHOPATHOL, V13, P419, DOI 10.1017/S0954579401003029; Schilling EA, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-30; Simon NM, 2006, BIOL PSYCHIAT, V60, P432, DOI 10.1016/j.biopsych.2006.02.004; Spielberger C. D., 1989, STATE TRAIT ANXIETY; Teicher MH, 2006, ANN NY ACAD SCI, V1071, P313, DOI 10.1196/annals.1364.024; Tyrka AR, 2008, BIOL PSYCHIAT, V63, P1147, DOI 10.1016/j.biopsych.2008.01.011; Tyrka AR, 2010, BIOL PSYCHIAT, V67, P531, DOI 10.1016/j.biopsych.2009.08.014; Weaver ICG, 2007, EPIGENETICS, V2, P22, DOI 10.4161/epi.2.1.3881; Weaver ICG, 2007, J NEUROSCI, V27, P1756, DOI 10.1523/JNEUROSCI.4164-06.2007; Weaver ICG, 2005, J NEUROSCI, V25, P11045, DOI 10.1523/JNEUROSCI.3652-05.2005; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Wilhelm K, 2005, PSYCHOL MED, V35, P387, DOI 10.1017/S0033291704003538; Wolkowitz OM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017837; Yehuda R, 2009, ANN NY ACAD SCI, V1179, P56, DOI 10.1111/j.1749-6632.2009.04979.x	58	318	330	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e30148	10.1371/journal.pone.0030148	http://dx.doi.org/10.1371/journal.pone.0030148			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910ME	22295073	Green Published, gold, Green Submitted			2022-12-25	WOS:000301640600018
J	Korthagen, NM; van Moorsel, CHM; Barlo, NP; Kazemier, KM; Ruven, HJT; Grutters, JC				Korthagen, Nicoline M.; van Moorsel, Coline H. M.; Barlo, Nicole P.; Kazemier, Karin M.; Ruven, Henk J. T.; Grutters, Jan C.			Association between Variations in Cell Cycle Genes and Idiopathic Pulmonary Fibrosis	PLOS ONE			English	Article							EPITHELIAL-CELLS; INHIBITOR P21; CANCER; SURVIVAL; EXPRESSION; APOPTOSIS; DISEASES; INJURY; RISK; P53	Idiopathic pulmonary fibrosis (IPF) is a devastating and progressive lung disease. Its aetiology is thought to involve damage to the epithelium and abnormal repair. Alveolar epithelial cells near areas of remodelling show an increased expression of proapoptotic molecules. Therefore, we investigated the role of genes involved in cell cycle control in IPF. Genotypes for five single nucleotide polymorphisms (SNPs) in the tumour protein 53 (TP53) gene and four SNPs in cyclin-dependent kinase inhibitor 1A (CDKN1A), the gene encoding p21, were determined in 77 IPF patients and 353 controls. In peripheral blood mononuclear cells (PBMC) from 16 healthy controls mRNA expression of TP53 and CDKN1A was determined. Rs12951053 and rs12602273, in TP53, were significantly associated with survival in IPF patients. Carriers of a minor allele had a 4-year survival of 22% versus 57% in the non-carrier group (p = 0.006). Rs2395655 and rs733590, in CDKN1A, were associated with an increased risk of developing IPF. In addition, the rs2395655 G allele correlated with progression of the disease as it increased the risk of a rapid decline in lung function. Functional experiments showed that rs733590 correlated significantly with CDKN1A mRNA expression levels in healthy controls. This is the first study to show that genetic variations in the cell cycle genes encoding p53 and p21 are associated with IPF disease development and progression. These findings support the idea that cell cycle control plays a role in the pathology of IPF. Variations in TP53 and CDKN1A can impair the response to cell damage and increase the loss of alveolar epithelial cells.	[Korthagen, Nicoline M.; van Moorsel, Coline H. M.; Barlo, Nicole P.; Grutters, Jan C.] St Antonius Hosp, Ctr Interstitial Lung Dis, Nieuwegein, Netherlands; [Korthagen, Nicoline M.; van Moorsel, Coline H. M.; Kazemier, Karin M.; Grutters, Jan C.] Univ Med Ctr Utrecht, Div Heart & Lungs, Utrecht, Netherlands	St. Antonius Hospital Utrecht; Utrecht University; Utrecht University Medical Center	Korthagen, NM (corresponding author), St Antonius Hosp, Ctr Interstitial Lung Dis, Nieuwegein, Netherlands.	j.grutters@antoniusziekenhuis.nl	Korthagen, Nicoline M./AAA-4338-2021	Korthagen, Nicoline M./0000-0002-9277-0795				Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias, 2002, AM J RESP CRIT CARE, V165, P277, DOI [DOI 10.1164/AJRCCM.165.2.ATS01, 10.1164/ajrccm.165.2.ats01]; Baumgartner KB, 1997, AM J RESP CRIT CARE, V155, P242, DOI 10.1164/ajrccm.155.1.9001319; Bhaskaran M, 2007, J BIOL CHEM, V282, P3968, DOI 10.1074/jbc.M609060200; Bouros D, 2002, CHEST, V121, P1278, DOI 10.1378/chest.121.4.1278; Canman C E, 1997, Adv Pharmacol, V41, P429, DOI 10.1016/S1054-3589(08)61068-6; Choi YY, 2008, J HUM GENET, V53, P87, DOI 10.1007/s10038-007-0222-6; Collard HR, 2003, AM J RESP CRIT CARE, V168, P538, DOI 10.1164/rccm.200211-1311OC; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Doss CGP, 2008, FUNCT INTEGR GENOMIC, V8, P309, DOI 10.1007/s10142-008-0086-7; Egan JJ, 2005, THORAX, V60, P270, DOI 10.1136/thx.2004.035436; Gartel AL, 2002, MOL CANCER THER, V1, P639; Gribbin J, 2006, THORAX, V61, P980, DOI 10.1136/thx.2006.062836; Grutters JC, 2005, EUR RESPIR J, V25, P915, DOI 10.1183/09031936.05.00133404; HANSON D, 1995, CHEST, V108, P305, DOI 10.1378/chest.108.2.305; Heron M, 2009, CLIN IMMUNOL, V133, P117, DOI 10.1016/j.clim.2009.06.007; Inoshima I, 2004, AM J PHYSIOL-LUNG C, V286, pL727, DOI 10.1152/ajplung.00209.2003; KASTAN MB, 1993, ADV EXP MED BIOL, V339, P291; King TE, 2005, CHEST, V127, P171, DOI 10.1378/chest.127.1.171; Krtolica A, 2002, INT J BIOCHEM CELL B, V34, P1401, DOI 10.1016/S1357-2725(02)00053-5; Li J, 2005, HEREDITY, V95, P221, DOI 10.1038/sj.hdy.6800717; Liu MR, 2009, P NATL ACAD SCI USA, V106, P19035, DOI 10.1073/pnas.0910009106; Mapel DW, 1998, THORAX, V53, P469, DOI 10.1136/thx.53.6.469; Nakashima N, 2005, J CLIN PATHOL, V58, P583, DOI 10.1136/jcp.2004.022632; Navaratnam V, 2011, THORAX, V66, P462, DOI 10.1136/thx.2010.148031; Plataki M, 2005, CHEST, V127, P266, DOI 10.1378/chest.127.1.266; Raghu G, 2006, AM J RESP CRIT CARE, V174, P810, DOI 10.1164/rccm.200602-163OC; Rudd RM, 2007, THORAX, V62, P62, DOI 10.1136/thx.2005.045591; Seibold MA, 2011, NEW ENGL J MED, V364, P1503, DOI 10.1056/NEJMoa1013660; Sisson TH, 2010, AM J RESP CRIT CARE, V181, P254, DOI 10.1164/rccm.200810-1615OC; van Moorsel CHM, 2010, AM J RESP CRIT CARE, V182, P1419, DOI 10.1164/rccm.200906-0953OC; Vancheri C, 2010, EUR RESPIR J, V35, P496, DOI 10.1183/09031936.00077309; Verleden GM, 2001, EUR RESPIR J, V18, p17S; Warburton David, 2008, Proc Am Thorac Soc, V5, P703, DOI 10.1513/pats.200801-012AW	34	35	36	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30442	10.1371/journal.pone.0030442	http://dx.doi.org/10.1371/journal.pone.0030442			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22291954	Green Published, Green Submitted, gold			2022-12-25	WOS:000301570600042
J	Lakshmana, MK; Hayes, CD; Bennett, SP; Bianchi, E; Reddy, KM; Koo, EH; Kang, DE				Lakshmana, Madepalli K.; Hayes, Crystal D.; Bennett, Steven P.; Bianchi, Elisabetta; Reddy, Konda M.; Koo, Edward H.; Kang, David E.			Role of RanBP9 on amyloidogenic processing of APP and synaptic protein levels in the mouse brain	FASEB JOURNAL			English	Article						Alzheimer's disease; transgenic mice; null mice; synapses	PRECURSOR-PROTEIN; ALZHEIMERS-DISEASE; BETA-SECRETASE; BINDING PROTEIN; DENSITY; DOMAIN; BACE1; INTERACTS; RELEASE; PROMOTE	We previously reported that RanBP9 binds low-density lipoprotein receptor-related protein (LRP), amyloid precursor protein (APP), and BACE1 and robustly increased A beta generation in a variety of cell lines and primary neuronal cultures. To confirm the physiological/pathological significance of this phenotype in vivo, we successfully generated transgenic mice overexpressing RanBP9 as well as RanBP9-null mice. Here we show that RanBP9 overexpression resulted in > 2-fold increase in A beta 40 levels as early as 4 mo of age. A sustained increase in A beta 40 levels was seen at 12 mo of age in both CHAPS-soluble and formic acid (FA)-soluble brain fractions. In addition, A beta 42 levels were also significantly increased in FA-soluble fractions at 12 mo of age. More important, increased A beta levels were translated to increased deposition of amyloid plaques. In addition, RanBP9 overexpression significantly decreased the levels of synaptophysin and PSD-95 proteins. Conversely, RanBP9-null mice showed increased levels of synaptophysin, PSD-95, and drebrin A protein levels. Given that loss of synapses is the best pathological correlate of cognitive deficits in Alzheimer's disease (AD), increased A beta levels by RanBP9 observed in the present study provides compelling evidence that RanBP9 may indeed play a key role in the etiology of AD. If so, RanBP9 provides a great opportunity to develop novel therapy for AD.-Lakshmana, M. K., Hayes, C. D., Bennett, S. P., Bianchi, E., Reddy, K. M., Koo, E. H., Kang, D. E. Role of RanBP9 on amyloidogenic processing of APP and synaptic protein levels in the mouse brain. FASEB J. 26, 2072-2083 (2012). www.fasebj.org	[Lakshmana, Madepalli K.; Hayes, Crystal D.; Bennett, Steven P.] Torrey Pines Inst Mol Studies, Neurobiol Sect, Port St Lucie, FL 34987 USA; [Koo, Edward H.; Kang, David E.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Bianchi, Elisabetta] Inst Pasteur, Dept Immunol, Lab Immuneregulat, F-75724 Paris, France; [Reddy, Konda M.] Univ Cent Florida, Orlando, FL 32816 USA; [Kang, David E.] Seoul Natl Univ, Coll Med, World Class Univ Neurocyt Program, Seoul, South Korea	Torrey Pines Institute for Molecular Studies, Florida; University of California System; University of California San Diego; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; State University System of Florida; University of Central Florida; Seoul National University (SNU)	Lakshmana, MK (corresponding author), Torrey Pines Inst Mol Studies, Neurobiol Sect, 11350 SW Village Pkwy, Port St Lucie, FL 34987 USA.	mlakshmana@tpims.org; dekang@ucsd.edu	Kang, David E./E-5234-2012; Bennett, Steven/GLV-6597-2022	Kang, David E./0000-0002-7132-821X	U.S. National Institute of Aging/National Institutes of Health [1R03AG032064-01, 1R01AG036859-01, 1R01AG033055-01A1, 1K02AG031920-10A1]; National Research Foundation -World Class University -Neurocytomics (Korea); NATIONAL INSTITUTE ON AGING [K02AG031920, R01AG033055, R01AG036859, R03AG032064] Funding Source: NIH RePORTER	U.S. National Institute of Aging/National Institutes of Health; National Research Foundation -World Class University -Neurocytomics (Korea); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by U.S. National Institute of Aging/National Institutes of Health grants to M.L.K. (1R03AG032064-01 and 1R01AG036859-01) and D.E.K. (1R01AG033055-01A1 and 1K02AG031920-10A1) and by a National Research Foundation -World Class University -Neurocytomics (Korea) grant to D.E.K.	Alzheimer's Association, 2010, Alzheimers Dement, V6, P158, DOI 10.1016/j.jalz.2010.01.009; Blacker D, 1998, NAT GENET, V19, P357, DOI 10.1038/1243; Bowman AL, 2008, MOL BIOL CELL, V19, P3782, DOI 10.1091/mbc.E08-03-0237; Cheng L, 2005, J NEUROCHEM, V94, P1102, DOI 10.1111/j.1471-4159.2005.03254.x; Christensen MA, 2004, MOL CELL BIOL, V24, P865, DOI 10.1128/MCB.24.2.865-874.2004; Cole SL, 2008, J BIOL CHEM, V283, P29621, DOI 10.1074/jbc.R800015200; Counts SE, 2006, J NEUROPATH EXP NEUR, V65, P592, DOI 10.1097/00005072-200606000-00007; Cummings J, 2010, BIOL PSYCHIAT, V68, P876, DOI 10.1016/j.biopsych.2010.09.020; Dansereau DA, 2008, J CELL BIOL, V182, P963, DOI 10.1083/jcb.200711046; De Strooper B, 2000, J CELL SCI, V113, P1857; Denti S, 2004, J BIOL CHEM, V279, P13027, DOI 10.1074/jbc.M313515200; Extance A, 2010, NAT REV DRUG DISCOV, V9, P749, DOI 10.1038/nrd3288; Franklin KBJ, 2008, MOUSE BRAIN STEREOTA, V3rd; Gakhar-Koppole N, 2008, EUR J NEUROSCI, V28, P871, DOI 10.1111/j.1460-9568.2008.06398.x; Haapasalo A, 2011, J ALZHEIMERS DIS, V25, P3, DOI 10.3233/JAD-2011-101065; Harigaya Y, 1996, J NEUROSCI RES, V43, P87, DOI 10.1002/jnr.490430111; Hatanpaa K, 1999, J NEUROPATH EXP NEUR, V58, P637, DOI 10.1097/00005072-199906000-00008; Jankowsky JL, 2004, HUM MOL GENET, V13, P159, DOI 10.1093/hmg/ddh019; Kang DE, 2000, J CLIN INVEST, V106, P1159, DOI 10.1172/JCI11013; KOO EH, 1994, J BIOL CHEM, V269, P17386; Lakshmana MK, 2010, FASEB J, V24, P119, DOI 10.1096/fj.09-136457; Lakshmana MK, 2009, J BIOL CHEM, V284, P11863, DOI 10.1074/jbc.M807345200; Lakshmana MK, 2008, J CELL MOL MED, V12, P2665, DOI 10.1111/j.1582-4934.2008.00320.x; LANNFELT L, 1995, NAT MED, V1, P829, DOI 10.1038/nm0895-829; Menon RP, 2004, J MOL BIOL, V343, P43, DOI 10.1016/j.jmb.2004.08.024; Murrin LC, 2007, J NEUROIMMUNE PHARM, V2, P290, DOI 10.1007/s11481-007-9079-x; Nakayama AY, 2000, J NEUROSCI, V20, P5329, DOI 10.1523/JNEUROSCI.20-14-05329.2000; Postina R, 2004, J CLIN INVEST, V113, P1456, DOI 10.1172/JCI200420864; Quast T, 2003, FASEB J, V17, P1739, DOI 10.1096/fj.02-1059fje; REFOLO LM, 1995, J NEUROSCI RES, V40, P694, DOI 10.1002/jnr.490400515; ROCH JM, 1994, P NATL ACAD SCI USA, V91, P7450, DOI 10.1073/pnas.91.16.7450; SCHMECHEL DE, 1993, P NATL ACAD SCI USA, V90, P9649, DOI 10.1073/pnas.90.20.9649; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Sennvik K, 2000, NEUROSCI LETT, V278, P169, DOI 10.1016/S0304-3940(99)00929-5; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Togashi H, 2006, J NEUROSCI, V26, P4961, DOI 10.1523/JNEUROSCI.0704-06.2006; Valiyaveettil M, 2008, J CELL BIOL, V182, P727, DOI 10.1083/jcb.200801133; Yoon IS, 2007, FASEB J, V21, P2742, DOI 10.1096/fj.07-8114com; Yoon IS, 2005, J BIOL CHEM, V280, P20140, DOI 10.1074/jbc.M413729200	39	29	29	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2012	26	5					2072	2083		10.1096/fj.11-196709	http://dx.doi.org/10.1096/fj.11-196709			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	937TD	22294787	Green Published			2022-12-25	WOS:000303680800033
J	Dash, B; Lukas, RJ				Dash, Bhagirathi; Lukas, Ronald J.			Modulation of Gain-of-function alpha 6*-Nicotinic Acetylcholine Receptor by beta 3 Subunits	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VENTRAL TEGMENTAL AREA; NEURONAL NICOTINIC RECEPTORS; DOPAMINE RELEASE; REPORTER MUTATION; ALPHA-6 SUBUNITS; IN-VIVO; EXPRESSION; LOCOMOTION; OOCYTES; DOMAIN	We previously have shown that beta 3 subunits either eliminate (e.g. for all-human (h) or all-mouse (m) alpha 6 beta 4 beta 3-nAChR) or potentiate (e.g. for hybrid m alpha 6h beta 4h beta 3- or m alpha 6m beta 4h beta 3-nAChR containing subunits from different species) function of alpha 6*-nAChR expressed in Xenopus oocytes, and that nAChR h alpha 6 subunit residues Asn-143 and Met-145 in N-terminal domain loop E are important for dominant-negative effects of nAChR h beta 3 subunits on h alpha 6*-nAChR function. Here, we tested the hypothesis that these effects of beta 3 subunits would be preserved even if nAChR alpha 6 subunits harbored gain-of-function, leucine- or valine-to-serine mutations at 9' or 13' positions (L9'S or V13'S) in their second transmembrane domains, yielding receptors with heightened functional activity and more amenable to assessment of effects of beta 3 subunit incorporation. However, coexpression with beta 3 subunits potentiates rather than suppresses function of all-human, all-mouse, or hybrid alpha 6((L9'S or V13'S))beta 4*- or alpha 6(N143D+M145V)(L9'S)beta 2*-nAChR. This contrasts with the lack of consistent function when alpha 6((L9'S or V13'S)) and beta 2 subunits are expressed alone or in the presence of wild-type beta 3 subunits. These results provide evidence that gain-of-function h alpha 6h beta 2*-nAChR (i.e. h alpha 6(N143D+M145V)(L9'S)h beta 2h beta 3 nAChR) could be produced in vitro. These studies also indicate that nAChR beta 3 subunits can be assembly partners in functional alpha 6*-nAChR and that 9' or 13' mutations in the nAChR alpha 6 subunit second transmembrane domain can act as gain-of-function and/or reporter mutations. Moreover, our findings suggest that beta 3 subunit coexpression promotes function of alpha 6*-nAChR.	[Dash, Bhagirathi; Lukas, Ronald J.] Barrow Neurol Inst, Div Neurobiol, Phoenix, AZ 85013 USA	Barrow Neurological Institute	Lukas, RJ (corresponding author), Barrow Neurol Inst, Div Neurobiol, 350 W Thomas Rd, Phoenix, AZ 85013 USA.	rlukas@chw.edu		Dash, Bhagirathi/0000-0002-5314-5372	National Institutes of Health [DA015389]; Philip Morris USA Inc.; Philip Morris International; Men's Board of the Barrow Neurological Foundation; Women's Board of the Barrow Neurological Foundation; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015389] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Philip Morris USA Inc.; Philip Morris International; Men's Board of the Barrow Neurological Foundation; Women's Board of the Barrow Neurological Foundation; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grant DA015389 (to R. J. L.), by Philip Morris USA Inc. and Philip Morris International through their External Research Program, and by endowment and capitalization funds from the Men's and Women's Boards of the Barrow Neurological Foundation. Portions of this work have been presented in abstract form (Dash, B., Chang, Y., and Lukas, R. J. (2008) Molecular and pharmacological characterization of recombinant alpha 6 beta 4*-nAChR. Soc. Neurosci. Abst. 34, 233.13).	Booker TK, 2007, PHARMACOL BIOCHEM BE, V87, P146, DOI 10.1016/j.pbb.2007.04.011; Broadbent S, 2006, MOL PHARMACOL, V70, P1350, DOI 10.1124/mol.106.026682; Capelli AM, 2011, BRIT J PHARMACOL, V163, P313, DOI 10.1111/j.1476-5381.2011.01213.x; Chang YC, 1998, MOL PHARMACOL, V53, P511, DOI 10.1124/mol.53.3.511; Cui CH, 2003, J NEUROSCI, V23, P11045; Dash B, 2011, J BIOL CHEM, V286, P37976, DOI 10.1074/jbc.M111.263673; Dash B, 2011, J BIOL CHEM, V286, P37905, DOI 10.1074/jbc.M111.264044; Drenan RM, 2008, NEURON, V60, P123, DOI 10.1016/j.neuron.2008.09.009; Drenan RM, 2010, J NEUROSCI, V30, P9877, DOI 10.1523/JNEUROSCI.2056-10.2010; Evans NM, 2003, EUR J PHARMACOL, V466, P31, DOI 10.1016/S0014-2999(03)01540-1; Exley R, 2008, NEUROPSYCHOPHARMACOL, V33, P2158, DOI 10.1038/sj.npp.1301617; Fucile S, 1998, EUR J NEUROSCI, V10, P172, DOI 10.1046/j.1460-9568.1998.00001.x; Gerzanich V, 1997, MOL PHARMACOL, V51, P320, DOI 10.1124/mol.51.2.320; Gotti C, 2005, MOL PHARMACOL, V67, P2007, DOI 10.1124/mol.105.011940; Gotti C, 2010, J NEUROSCI, V30, P5311, DOI 10.1523/JNEUROSCI.5095-09.2010; Groot-Kormelink PJ, 2001, BRIT J PHARMACOL, V134, P789, DOI 10.1038/sj.bjp.0704313; Jackson KJ, 2008, J PHARMACOL EXP THER, V325, P302, DOI 10.1124/jpet.107.132977; Kuryatov A, 2000, NEUROPHARMACOLOGY, V39, P2570, DOI 10.1016/S0028-3908(00)00144-1; Kuryatov A, 2008, MOL PHARMACOL, V74, P132, DOI 10.1124/mol.108.046789; Kuryatov A, 2011, MOL PHARMACOL, V79, P126, DOI 10.1124/mol.110.066159; LABARCA C, 1995, NATURE, V376, P514, DOI 10.1038/376514a0; Li P, 2011, MOL PHARMACOL, V80, P818, DOI 10.1124/mol.111.073841; Lukas RJ, 1999, PHARMACOL REV, V51, P397; Meyer EL, 2008, J NEUROCHEM, V105, P1761, DOI 10.1111/j.1471-4159.2008.05266.x; Miko A, 2004, J BIOL CHEM, V279, P22833, DOI 10.1074/jbc.M402577200; Pons S, 2008, J NEUROSCI, V28, P12318, DOI 10.1523/JNEUROSCI.3918-08.2008; Salas R, 2003, MOL PHARMACOL, V63, P1059, DOI 10.1124/mol.63.5.1059; Tumkosit P, 2006, MOL PHARMACOL, V70, P1358, DOI 10.1124/mol.106.027326; Wang N, 2002, J PHYSIOL-LONDON, V542, P347, DOI 10.1113/jphysiol.2001.013456; Wang NS, 2004, J NEUROL SCI, V222, P87, DOI 10.1016/j.jns.2004.04.009; Yang KC, 2011, J NEUROSCI, V31, P2537, DOI 10.1523/JNEUROSCI.3003-10.2011	31	12	12	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					14259	14269		10.1074/jbc.M111.322610	http://dx.doi.org/10.1074/jbc.M111.322610			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22315221	Green Published, hybrid			2022-12-25	WOS:000303996300077
J	Corea, ORA; Ki, C; Cardenas, CL; Kim, SJ; Brewer, SE; Patten, AM; Davin, LB; Lewis, NG				Corea, Oliver R. A.; Ki, Chanyoung; Cardenas, Claudia L.; Kim, Sung-Jin; Brewer, Sarah E.; Patten, Ann M.; Davin, Laurence B.; Lewis, Norman G.			Arogenate Dehydratase Isoenzymes Profoundly and Differentially Modulate Carbon Flux into Lignins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THERMAL-DEGRADATION PRODUCTS; ARABIDOPSIS-THALIANA; PINUS-TAEDA; PHENYLALANINE; IDENTIFICATION; EXPRESSION; CONFIGURATION; LIGNIFICATION; BIOSYNTHESIS; DATABASE	How carbon flux differentially occurs in vascular plants following photosynthesis for protein formation, phenylpropanoid metabolism (i.e. lignins), and other metabolic processes is not well understood. Our previous discovery/deduction that a six-membered arogenate dehydratase (ADT1-6) gene family encodes the final step in Phe biosynthesis in Arabidopsis thaliana raised the fascinating question whether individual ADT isoenzymes (or combinations thereof) differentially modulated carbon flux to lignins, proteins, etc. If so, unlike all other lignin pathway manipulations that target cell wall/cytosolic processes, this would be the first example of a plastid (chloroplast)-associated metabolic process influencing cell wall formation. Homozygous T-DNA insertion lines were thus obtained for five of the six ADTs and used to generate double, triple, and quadruple knockouts (KOs) in different combinations. The various mutants so obtained gave phenotypes with profound but distinct reductions in lignin amounts, encompassing a range spanning from near wild type levels to reductions of up to similar to 68%. In the various KOs, there were also marked changes in guaiacyl: syringyl ratios ranging from similar to 3:1 to 1:1, respectively; these changes were attributed to differential carbon flux into vascular bundles versus that into fiber cells. Laser microscope dissection/pyrolysis GC/MS, histochemical staining/lignin analyses, and pADT::GUS localization indicated that ADT5 preferentially affects carbon flux into the vascular bundles, whereas the adt3456 knock-out additionally greatly reduced carbon flux into fiber cells. This plastid-localized metabolic step can thus profoundly differentially affect carbon flux into lignins in distinct anatomical regions and provides incisive new insight into different factors affecting guaiacyl: syringyl ratios and lignin primary structure.	[Corea, Oliver R. A.; Ki, Chanyoung; Cardenas, Claudia L.; Kim, Sung-Jin; Brewer, Sarah E.; Patten, Ann M.; Davin, Laurence B.; Lewis, Norman G.] Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA	Washington State University	Lewis, NG (corresponding author), Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA.	lewisn@wsu.edu		Lewis, Norman/0000-0001-5742-032X; Davin, Laurence/0000-0002-3248-6485	Chemical Sciences, Geosciences and Biosciences Division, Office of Basic Energy Sciences [DE-FG-0397ER20259]; United States Department of Agriculture-National Institute of Food and Agriculture [2011-68005-30416]; United States Department of Agriculture [683A757612]; G. Thomas and Anita Hargrove Center for Plant Genomic Research; BioEnergy Science Center; Office of Biological and Environmental Research in the Department of Energy Office of Science	Chemical Sciences, Geosciences and Biosciences Division, Office of Basic Energy Sciences(United States Department of Energy (DOE)); United States Department of Agriculture-National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); United States Department of Agriculture(United States Department of Agriculture (USDA)); G. Thomas and Anita Hargrove Center for Plant Genomic Research; BioEnergy Science Center; Office of Biological and Environmental Research in the Department of Energy Office of Science	This work was supported by a grant from the Chemical Sciences, Geosciences and Biosciences Division, Office of Basic Energy Sciences DE-FG-0397ER20259, which involved all of the lignin, laser microscope dissection, and pyrolysis GC/MS work. Complementation studies were supported by United States Department of Agriculture-National Institute of Food and Agriculture-supported Northwest Advanced Renewable Alliance Grant 2011-68005-30416. This work was also supported by United States Department of Agriculture Grant 683A757612, the G. Thomas and Anita Hargrove Center for Plant Genomic Research, and the BioEnergy Science Center, which is supported by the Office of Biological and Environmental Research in the Department of Energy Office of Science. The latter support enabled some of the mutant lines to be screened/selected for subsequent analyses.	Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Altamura MM, 2001, NEW PHYTOL, V151, P381, DOI 10.1046/j.0028-646x.2001.00188.x; Anterola AM, 2002, J BIOL CHEM, V277, P18272, DOI 10.1074/jbc.M112051200; Anterola AM, 2002, PHYTOCHEMISTRY, V61, P221, DOI 10.1016/S0031-9422(02)00211-X; Anterola AM, 1999, BIOCHEM BIOPH RES CO, V261, P652, DOI 10.1006/bbrc.1999.1097; Bernards MA, 1998, PHYTOCHEMISTRY, V47, P915, DOI 10.1016/S0031-9422(98)80052-6; Blee K, 2001, PHYTOCHEMISTRY, V57, P1159, DOI 10.1016/S0031-9422(01)00150-9; Cho MH, 2007, J BIOL CHEM, V282, P30827, DOI 10.1074/jbc.M702662200; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Corea O. R. A., 2010, PLANT BIOL 2010 MONT; Corea O.R.A., 2010, JOINT ANN M AM SOC P; Corea O. R. A., 2012, METHODS MOL IN PRESS; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Davin LB, 2008, NAT PROD REP, V25, P1015, DOI 10.1039/b510386j; Dixon R. A., 1999, COMPREHENSIVE NATURA, P773, DOI DOI 10.1016/B978-0-08-091283-7.00030-8; FAIX O, 1990, HOLZ ROH WERKST, V48, P351, DOI 10.1007/BF02639897; FAIX O, 1990, HOLZ ROH WERKST, V48, P281, DOI 10.1007/BF02626519; Franke R, 2007, CURR OPIN PLANT BIOL, V10, P252, DOI 10.1016/j.pbi.2007.04.004; IIYAMA K, 1990, J SCI FOOD AGR, V51, P145, DOI 10.1002/jsfa.2740510202; Jourdes M, 2007, PHYTOCHEMISTRY, V68, P1932, DOI 10.1016/j.phytochem.2007.03.044; JUNG E, 1986, P NATL ACAD SCI USA, V83, P7231, DOI 10.1073/pnas.83.19.7231; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Kim Kye-Won, 2006, V323, P263; Kim SJ, 2007, PHYTOCHEMISTRY, V68, P1957, DOI 10.1016/j.phytochem.2007.02.032; LAPIERRE C, 1986, HOLZFORSCHUNG, V40, P113, DOI 10.1515/hfsg.1986.40.2.113; Laskar DD, 2006, PLANT J, V48, P674, DOI 10.1111/j.1365-313X.2006.02918.x; Lewis N.G., 1989, CHEM SIGNIFICANCE CO, P23, DOI [DOI 10.1007/978-1-4684-7511-1_2, 10.1007/978-1-4684-7511-1_2]; M?ule C., 1901, BEITRAGE WISSENSCHAF, V4, P166; Maeda H, 2010, PLANT CELL, V22, P832, DOI 10.1105/tpc.109.073247; Miesak BH, 2002, PLANT PHYSIOL, V129, P650, DOI 10.1104/pp.005090; Moinuddin SGA, 2010, ORG BIOMOL CHEM, V8, P3928, DOI 10.1039/c004817h; Nakanishi K., 1999, COMPREHENSIVE NATURA, V1, P713; Patten AM, 2005, PHYTOCHEMISTRY, V66, P2092, DOI 10.1016/j.phytochem.2004.12.016; Patten AM, 2010, MOL BIOSYST, V6, P499, DOI 10.1039/b819206e; Rippert P, 2009, PLANT PHYSIOL, V149, P1251, DOI 10.1104/pp.108.130070; Rolando C., 1992, METHODS LIGNIN CHEM, P334, DOI DOI 10.1007/978-3-642-74065-7_23; Ruzin S.E., 1999, PLANT MICROTECHNIQUE; Samson F, 2002, NUCLEIC ACIDS RES, V30, P94, DOI 10.1093/nar/30.1.94; Schroder J., 1999, COMPREHENSIVE NATURA, V1, P749, DOI DOI 10.1016/b978-0-08-091283-7.00029-1; SIEHL DL, 1988, ARCH BIOCHEM BIOPHYS, V260, P822, DOI 10.1016/0003-9861(88)90513-9; Toufighi K, 2005, PLANT J, V43, P153, DOI 10.1111/j.1365-313X.2005.02437.x; vanHeerden PS, 1996, J BIOL CHEM, V271, P12350, DOI 10.1074/jbc.271.21.12350; Vassao DG, 2010, COMPREHENSIVE NATURAL PRODUCTS II: CHEMISTRY AND BIOLOGY, VOL 1: NATURAL PRODUCTS STRUCTURAL DIVERSITY-I: SECONDARY METABOLITES: ORGANIZATION AND BIOSYNTHESIS, P815; WIESNER J, 1878, SITZUNGSBERICHTE MN, V77, P60; Yamada T, 2008, PLANT CELL, V20, P1316, DOI 10.1105/tpc.107.057455	45	44	45	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					11446	11459		10.1074/jbc.M111.322164	http://dx.doi.org/10.1074/jbc.M111.322164			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22311980	Green Published, hybrid			2022-12-25	WOS:000302780100073
J	Zocher, F; Zeidel, ML; Missner, A; Sun, TT; Zhou, G; Liao, Y; von Bodungen, M; Hill, WG; Meyers, S; Pohl, P; Mathai, JC				Zocher, Florian; Zeidel, Mark L.; Missner, Andreas; Sun, Tung-Tien; Zhou, Ge; Liao, Yi; von Bodungen, Maximilian; Hill, Warren G.; Meyers, Susan; Pohl, Peter; Mathai, John C.			Uroplakins Do Not Restrict CO2 Transport through Urothelium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLADDER PERMEABILITY BARRIER; COLLECTING DUCT; CARBON-DIOXIDE; MEMBRANE; AQUAPORIN-1; EPITHELIUM; GRADIENT; ABLATION; CHANNELS; CELLS	Background: The tightness of various membrane barriers to CO2 is of unknown molecular origin. Results: The bladder tissue lacks carbonic anhydrase. The resulting low intra-epithelial CO2 concentration gives rise to the apparent CO2 impermeability. Conclusion: Uroplakins do not act to decrease transepithelial CO2 flux. Significance: Enzymatic regulation of CO2 abundance rules out that aquaporins significantly contribute to the maintenance of acid base homeostasis.	[Zocher, Florian; Missner, Andreas; Pohl, Peter] Johannes Kepler Univ Linz, Inst Biophys, A-4020 Linz, Austria; [Zeidel, Mark L.; von Bodungen, Maximilian; Hill, Warren G.; Mathai, John C.] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA; [Sun, Tung-Tien; Zhou, Ge; Liao, Yi] NYU, Dept Cell Biol, New York, NY 10016 USA; [Meyers, Susan] Univ Pittsburgh, Dept Med, Pittsburgh, PA 15260 USA	Johannes Kepler University Linz; Harvard University; Beth Israel Deaconess Medical Center; New York University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Pohl, P (corresponding author), Johannes Kepler Univ Linz, Inst Biophys, Gruberstr 40, A-4020 Linz, Austria.	peter.pohl@jku.at	Sun, Tung-Tien/J-4425-2015; Hill, Warren/AAM-1917-2020; Pohl, Peter/A-5361-2008	Sun, Tung-Tien/0000-0002-6841-1063; Hill, Warren/0000-0002-2772-7264; Pohl, Peter/0000-0002-1792-2314	National Institute of Diabetes and Digestive and Kidney Diseases [DK048217, R01DK083299]; Austrian Science Fund (FWF) [P23466]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK048217, R37DK048217, R01DK083299] Funding Source: NIH RePORTER; Austrian Science Fund (FWF) [P 23466] Funding Source: researchfish	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	The project was supported by Grant Numbers DK048217 (to M.L.Z.) and R01DK083299 (to W.G.H.) from the National Institute of Diabetes and Digestive and Kidney Diseases. This work was also supported by Austrian Science Fund (FWF) Grant P23466 (to P.P.).	Aboushwareb T, 2009, NEUROUROL URODYNAM, V28, P1028, DOI 10.1002/nau.20688; Boron WF, 2011, CHEMPHYSCHEM, V12, P1017, DOI 10.1002/cphc.201100034; CHANG A, 1994, AM J PHYSIOL-CELL PH, V267, pC1483, DOI 10.1152/ajpcell.1994.267.5.C1483; Deen PMT, 1997, PFLUG ARCH EUR J PHY, V433, P780, DOI 10.1007/s004240050345; Deng FM, 2002, J CELL BIOL, V159, P685, DOI 10.1083/jcb.200204102; DUBOSE TD, 1982, J CLIN INVEST, V69, P145, DOI 10.1172/JCI110425; Endeward V, 2006, FASEB J, V20, P1974, DOI 10.1096/fj.04-3300com; Fang XH, 2002, J PHYSIOL-LONDON, V542, P63, DOI 10.1113/jphysiol.2001.013813; GUTKNECHT J, 1977, J GEN PHYSIOL, V69, P779; Hill WG, 2008, AM J PHYSIOL-RENAL, V294, pF919, DOI 10.1152/ajprenal.00265.2007; Hodges SJ, 2008, J UROLOGY, V179, P2046, DOI 10.1016/j.juro.2007.12.039; Hu P, 2000, J CELL BIOL, V151, P961, DOI 10.1083/jcb.151.5.961; Hu P, 2002, AM J PHYSIOL-RENAL, V283, pF1200, DOI 10.1152/ajprenal.00043.2002; Hub JS, 2008, P NATL ACAD SCI USA, V105, P1198, DOI 10.1073/pnas.0707662104; Hub JS, 2006, BIOPHYS J, V91, P842, DOI 10.1529/biophysj.106.081406; Kachar B, 1999, J MOL BIOL, V285, P595, DOI 10.1006/jmbi.1998.2304; Khandelwal P, 2009, AM J PHYSIOL-RENAL, V297, pF1477, DOI 10.1152/ajprenal.00327.2009; Kong XT, 2004, J CELL BIOL, V167, P1195, DOI 10.1083/jcb.200406025; Lavelle J, 2001, Urology, V57, P113, DOI 10.1016/S0090-4295(01)01047-0; Lavelle J, 2002, AM J PHYSIOL-RENAL, V283, pF242, DOI 10.1152/ajprenal.00307.2001; Lavelle JP, 1998, AM J PHYSIOL-RENAL, V274, pF205, DOI 10.1152/ajprenal.1998.274.1.F205; Mathai JC, 2009, P NATL ACAD SCI USA, V106, P16633, DOI 10.1073/pnas.0902952106; Missner A, 2008, J BIOL CHEM, V283, P25340, DOI 10.1074/jbc.M800096200; Missner A, 2009, CHEMPHYSCHEM, V10, P1405, DOI 10.1002/cphc.200900270; Musa-Aziz R, 2009, P NATL ACAD SCI USA, V106, P5406, DOI 10.1073/pnas.0813231106; Negrete HO, 1996, AM J PHYSIOL-RENAL, V271, pF886, DOI 10.1152/ajprenal.1996.271.4.F886; POHL P, 1993, BIOCHIM BIOPHYS ACTA, V1145, P279, DOI 10.1016/0005-2736(93)90300-O; RYBERG C, 1948, ACTA PHYSIOL SCAND, V15, P123, DOI 10.1111/j.1748-1716.1948.tb00490.x; Saparov SM, 2007, J BIOL CHEM, V282, P5296, DOI 10.1074/jbc.M609343200; Wang Y, 2007, J STRUCT BIOL, V157, P534, DOI 10.1016/j.jsb.2006.11.008; Weinstein AM, 1998, AM J PHYSIOL-RENAL, V274, pF841, DOI 10.1152/ajprenal.1998.274.5.F841; WILBUR KM, 1948, J BIOL CHEM, V176, P147; ZEIDEL ML, 1992, BIOCHEMISTRY-US, V31, P7436, DOI 10.1021/bi00148a002; Zeidel ML, 1996, AM J PHYSIOL-RENAL, V271, pF243, DOI 10.1152/ajprenal.1996.271.2.F243	34	14	14	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					11011	11017		10.1074/jbc.M112.339283	http://dx.doi.org/10.1074/jbc.M112.339283			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22315218	hybrid, Green Published			2022-12-25	WOS:000302780100029
J	Boulay, G; Dubuissez, M; Van Rechem, C; Forget, A; Helin, K; Ayrault, O; Leprince, D				Boulay, Gaylor; Dubuissez, Marion; Van Rechem, Capucine; Forget, Antoine; Helin, Kristian; Ayrault, Olivier; Leprince, Dominique			Hypermethylated in Cancer 1 (HIC1) Recruits Polycomb Repressive Complex 2 (PRC2) to a Subset of Its Target Genes through Interaction with Human Polycomb-like (hPCL) Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR GENE; DNA-BINDING; TRANSCRIPTIONAL REPRESSION; MICE DEFICIENT; BREAST-CANCER; TUDOR DOMAIN; DROSOPHILA; METHYLATION; RECEPTOR; EZH2	HIC1 (hypermethylated in cancer 1) is a tumor suppressor gene epigenetically silenced or deleted in many human cancers. HIC1 is involved in regulatory loops modulating p53- and E2F1-dependent cell survival, growth control, and stress responses. HIC1 is also essential for normal development because Hic1-deficient mice die perinatally and exhibit gross developmental defects throughout the second half of development. HIC1 encodes a transcriptional repressor with five C2H2 zinc fingers mediating sequence-specific DNA binding and two repression domains: an N-terminal BTB/POZ domain and a central region recruiting CtBP and NuRD complexes. By yeast two-hybrid screening, we identified the Polycomb-like protein hPCL3 as a novel corepressor for HIC1. Using multiple biochemical strategies, we demonstrated that HIC1 interacts with hPCL3 and its paralog PHF1 to form a stable complex with the PRC2 members EZH2, EED, and Suz12. Confirming the implication of HIC1 in Polycomb recruitment, we showed that HIC1 shares some of its target genes with PRC2, including ATOH1. Depletion of HIC1 by siRNA interference leads to a partial displacement of EZH2 from the ATOH1 promoter. Furthermore, in vivo, ATOH1 repression by HIC1 is associated with Polycomb activity during mouse cerebellar development. Thus, our results identify HIC1 as the first transcription factor in mammals able to recruit PRC2 to some target promoters through its interaction with Polycomb-like proteins.	[Boulay, Gaylor; Dubuissez, Marion; Van Rechem, Capucine; Leprince, Dominique] Univ Lille Nord France, Inst Biol Lille, CNRS, UMR8161,Inst Pasteur Lille, F-59021 Lille, France; [Forget, Antoine; Ayrault, Olivier] Ctr Univ Orsay, INSERM, U1005, CNRS,UMR 3306,Inst Curie, F-91405 Orsay, France; [Helin, Kristian] Univ Copenhagen, BRIC, DK-2200 Copenhagen, Denmark	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Saclay; University of Copenhagen	Leprince, D (corresponding author), Univ Lille Nord France, Inst Biol Lille, CNRS, UMR8161,Inst Pasteur Lille, 1 Rue Prof Calmette,BP 447, F-59021 Lille, France.	dominique.leprince@ibl.fr	Forget, Antoine/AAA-4967-2020; Helin, Kristian/K-2526-2019; Helin, Kristian/HDM-8306-2022	Helin, Kristian/0000-0003-1975-6097; Van Rechem, Capucine/0000-0002-5408-6124	CNRS; Ligue Nationale contre le Cancer (Comite Interregional du Septentrion); Fondation pour la Recherche Medicale (Comite du Nord); Association pour la Recherche contre le Cancer; CNRS/Region Nord-Pas de Calais; AVENIR/INSERM/Inca	CNRS(Centre National de la Recherche Scientifique (CNRS)); Ligue Nationale contre le Cancer (Comite Interregional du Septentrion); Fondation pour la Recherche Medicale (Comite du Nord)(Fondation pour la Recherche Medicale); Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); CNRS/Region Nord-Pas de Calais(Centre National de la Recherche Scientifique (CNRS)Region Hauts-de-France); AVENIR/INSERM/Inca	This work was supported in part by grants from the CNRS, the Ligue Nationale contre le Cancer (Comite Interregional du Septentrion), the Fondation pour la Recherche Medicale (Comite du Nord), and the Association pour la Recherche contre le Cancer (to D. L.).; Supported by fellowships from the CNRS/Region Nord-Pas de Calais and the Association pour la Recherche contre le Cancer.; Supported by a AVENIR/INSERM/Inca grant.	Adams-Cioaba MA, 2009, BIOCHEM CELL BIOL, V87, P93, DOI 10.1139/O08-129; ALBAGLI O, 1995, CELL GROWTH DIFFER, V6, P1193; Ayrault O, 2010, CANCER RES, V70, P5618, DOI 10.1158/0008-5472.CAN-09-3740; Bienz M, 2006, TRENDS BIOCHEM SCI, V31, P35, DOI 10.1016/j.tibs.2005.11.001; Boldajipour B, 2008, CELL, V132, P463, DOI 10.1016/j.cell.2007.12.034; Boukarabila H, 2009, GENE DEV, V23, P1195, DOI 10.1101/gad.512009; Boulay G, 2012, J BIOL CHEM, V287, P5379, DOI 10.1074/jbc.M111.304287; Boulay G, 2011, BIOCHEM J, V434, P333, DOI 10.1042/BJ20100944; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bracken AP, 2009, NAT REV CANCER, V9, P773, DOI 10.1038/nrc2736; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Bracken AP, 2003, EMBO J, V22, P5323, DOI 10.1093/emboj/cdg542; Briggs KJ, 2008, CANCER RES, V68, P8654, DOI 10.1158/0008-5472.CAN-08-1904; Briggs KJ, 2008, GENE DEV, V22, P770, DOI 10.1101/gad.1640908; Cao R, 2008, MOL CELL BIOL, V28, P1862, DOI 10.1128/MCB.01589-07; Carter MG, 2000, HUM MOL GENET, V9, P413, DOI 10.1093/hmg/9.3.413; Casanova M, 2011, DEVELOPMENT, V138, P1471, DOI 10.1242/dev.053652; Chen WY, 2005, CELL, V123, P437, DOI 10.1016/j.cell.2005.08.011; Chen WY, 2003, NAT GENET, V33, P197, DOI 10.1038/ng1077; Chen WY, 2004, CANCER CELL, V6, P387, DOI 10.1016/j.ccr.2004.08.030; Corsini L, 2007, NAT STRUCT MOL BIOL, V14, P98, DOI 10.1038/nsmb0207-98; Coulson M, 1998, GENOMICS, V48, P381, DOI 10.1006/geno.1997.5201; Dahl JA, 2007, STEM CELLS, V25, P1037, DOI 10.1634/stemcells.2006-0430; Dehennaut V, 2009, B CANCER, V96, pE66, DOI 10.1684/bdc.2009.0959; Deltour S, 1999, P NATL ACAD SCI USA, V96, P14831, DOI 10.1073/pnas.96.26.14831; Deltour S, 2002, MOL CELL BIOL, V22, P4890, DOI 10.1128/MCB.22.13.4890-4901.2002; Dodelet VC, 2000, ONCOGENE, V19, P5614, DOI 10.1038/sj.onc.1203856; Fleuriel C, 2009, INT J BIOCHEM CELL B, V41, P26, DOI 10.1016/j.biocel.2008.05.028; Foveau B, 2012, J BIOL CHEM, V287, P5366, DOI 10.1074/jbc.M111.329466; Friberg A, 2010, PROTEIN SCI, V19, P1906, DOI 10.1002/pro.476; Grimmer MR, 2008, GENE DEV, V22, P693, DOI 10.1101/gad.1657808; Hansen KH, 2008, NAT CELL BIOL, V10, P1291, DOI 10.1038/ncb1787; Herranz N, 2008, MOL CELL BIOL, V28, P4772, DOI 10.1128/MCB.00323-08; Huang Y, 2006, SCIENCE, V312, P748, DOI 10.1126/science.1125162; Jenal M, 2009, MOL CANCER RES, V7, P916, DOI 10.1158/1541-7786.MCR-08-0359; Laible G, 1997, EMBO J, V16, P3219, DOI 10.1093/emboj/16.11.3219; Li G, 2010, GENE DEV, V24, P368, DOI 10.1101/gad.1886410; Long JY, 2004, P NATL ACAD SCI USA, V101, P99, DOI 10.1073/pnas.0307598100; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Mellor J, 2006, CELL, V126, P22, DOI 10.1016/j.cell.2006.06.028; Mohammad HP, 2011, ONCOGENE, V30, P2659, DOI 10.1038/onc.2010.633; Morey L, 2008, MOL CELL BIOL, V28, P5912, DOI 10.1128/MCB.00467-08; Morey L, 2010, TRENDS BIOCHEM SCI, V35, P323, DOI 10.1016/j.tibs.2010.02.009; Nekrasov M, 2007, EMBO J, V26, P4078, DOI 10.1038/sj.emboj.7601837; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Pasini D, 2007, MOL CELL BIOL, V27, P3769, DOI 10.1128/MCB.01432-06; Pasini D, 2010, NUCLEIC ACIDS RES, V38, P4958, DOI 10.1093/nar/gkq244; Pasini D, 2010, NATURE, V464, P306, DOI 10.1038/nature08788; Pinte S, 2004, J BIOL CHEM, V279, P38313, DOI 10.1074/jbc.M401610200; Pospichalova V, 2011, GENESIS, V49, P142, DOI 10.1002/dvg.20719; Reynolds N, 2012, EMBO J, V31, P593, DOI 10.1038/emboj.2011.431; Rood BR, 2002, CANCER RES, V62, P3794; Sarma K, 2008, MOL CELL BIOL, V28, P2718, DOI 10.1128/MCB.02017-07; Sauvageau M, 2010, CELL STEM CELL, V7, P299, DOI 10.1016/j.stem.2010.08.002; Savla U, 2008, DEVELOPMENT, V135, P813, DOI 10.1242/dev.016006; Schuettengruber B, 2009, DEVELOPMENT, V136, P3531, DOI 10.1242/dev.033902; Sierro F, 2007, P NATL ACAD SCI USA, V104, P14759, DOI 10.1073/pnas.0702229104; Sing A, 2009, CELL, V138, P885, DOI 10.1016/j.cell.2009.08.020; Srinivasan L, 2004, GENE DEV, V18, P2596, DOI 10.1101/gad.1228204; Stankovic-Valentin N, 2007, MOL CELL BIOL, V27, P2661, DOI 10.1128/MCB.01098-06; Stankovic-Valentin N, 2006, FEBS J, V273, P2879, DOI 10.1111/j.1742-4658.2006.05301.x; Stogios PJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-r82; Tie F, 2003, MOL CELL BIOL, V23, P3352, DOI 10.1128/MCB.23.9.3352-3362.2003; Van Rechem C, 2010, MOL CELL BIOL, V30, P4045, DOI 10.1128/MCB.00582-09; Van Rechem C, 2009, J BIOL CHEM, V284, P20927, DOI 10.1074/jbc.M109.022350; Van Rechem C, 2009, BIOCHEM BIOPH RES CO, V385, P586, DOI 10.1016/j.bbrc.2009.05.115; Villa R, 2007, CANCER CELL, V11, P513, DOI 10.1016/j.ccr.2007.04.009; WALES MM, 1995, NAT MED, V1, P570, DOI 10.1038/nm0695-570; Walker E, 2010, CELL STEM CELL, V6, P153, DOI 10.1016/j.stem.2009.12.014; Wang CG, 2006, NAT CELL BIOL, V8, P1025, DOI 10.1038/ncb1468; Wang SW, 2004, GENE, V343, P69, DOI 10.1016/j.gene.2004.09.006; Woo CJ, 2010, CELL, V140, P99, DOI 10.1016/j.cell.2009.12.022; Zhang W, 2010, ONCOGENE, V29, P2467, DOI 10.1038/onc.2010.12	73	36	37	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					10509	10524		10.1074/jbc.M111.320234	http://dx.doi.org/10.1074/jbc.M111.320234			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22315224	Green Published, hybrid			2022-12-25	WOS:000302167200077
J	Paatero, I; Jokilammi, A; Heikkinen, PT; Iljin, K; Kallioniemi, OP; Jones, FE; Jaakkola, PM; Elenius, K				Paatero, Ilkka; Jokilammi, Anne; Heikkinen, Pekka T.; Iljin, Kristiina; Kallioniemi, Olli-Pekka; Jones, Frank E.; Jaakkola, Panu M.; Elenius, Klaus			Interaction with ErbB4 Promotes Hypoxia-inducible Factor-1 alpha Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR TYROSINE KINASE; FACTOR 1-ALPHA; MAMMARY-GLAND; PROLYL HYDROXYLATION; NUCLEAR-LOCALIZATION; CANCER CELLS; HIF-ALPHA; GROWTH; EXPRESSION; ISOFORM	The receptor-tyrosine kinase ErbB4 was identified as a direct regulator of hypoxia-inducible factor-1 alpha (HIF-1 alpha) signaling. Cleaved intracellular domain of ErbB4 directly interacted with HIF-1 alpha in the nucleus, and stabilized HIF-1 alpha protein in both normoxic and hypoxic conditions by blocking its proteasomal degradation. The mechanism of HIF stabilization was independent of VHL and proline hydroxylation but dependent on RACK1. ErbB4 activity was necessary for efficient HRE-driven promoter activity, transcription of known HIF-1 alpha target genes, and survival of mammary carcinoma cells in vitro. In addition, mammary epithelial specific targeting of Erbb4 in the mouse significantly reduced the amount of HIF-1 alpha protein in vivo. ERBB4 expression also correlated with the expression of HIF-regulated genes in a series of 4552 human normal and cancer tissue samples. These data demonstrate that soluble ErbB4 intracellular domain promotes HIF-1 alpha stability and signaling via a novel mechanism.	[Paatero, Ilkka; Jokilammi, Anne; Elenius, Klaus] Univ Turku, Dept Med Biochem & Genet, FI-20520 Turku, Finland; [Paatero, Ilkka; Jokilammi, Anne; Elenius, Klaus] Univ Turku, MediCity Res Lab, FI-20520 Turku, Finland; [Iljin, Kristiina; Kallioniemi, Olli-Pekka] VTT Tech Res Ctr, FI-20520 Turku, Finland; [Heikkinen, Pekka T.; Iljin, Kristiina; Kallioniemi, Olli-Pekka; Jaakkola, Panu M.] Turku Ctr Biotechnol, FI-20520 Turku, Finland; [Paatero, Ilkka; Heikkinen, Pekka T.] Turku Doctoral Programme Biomed Sci, FI-20520 Turku, Finland; [Kallioniemi, Olli-Pekka] Univ Helsinki, Biomedicum, Genome Scale Biol Res Program, FI-00014 Helsinki, Finland; [Kallioniemi, Olli-Pekka] Univ Helsinki, FIMM Inst Mol Med Finland, Biomedicum, FI-00014 Helsinki, Finland; [Jones, Frank E.] Tulane Univ, Dept Cell & Mol Biol, New Orleans, LA 70118 USA; [Jaakkola, Panu M.; Elenius, Klaus] Turku Univ Hosp, Dept Oncol, FI-20520 Turku, Finland	University of Turku; University of Turku; VTT Technical Research Center Finland; University of Turku; University of Helsinki; University of Helsinki; Tulane University; University of Turku	Elenius, K (corresponding author), Univ Turku, Dept Med Biochem & Genet, Kiinamyllynkatu 10, FIN-20520 Turku, Finland.	klaus.elenius@utu.fi	Paatero, Ilkka/A-6391-2009; Kallioniemi, Olli P/H-5111-2011; Paatero, Ilkka/AAE-7542-2019; Jaakkola, Panu M/B-4355-2012; Elenius, Klaus/AAI-7594-2021	Kallioniemi, Olli P/0000-0002-3231-0332; Paatero, Ilkka/0000-0001-5926-2396; Elenius, Klaus/0000-0001-5700-0827; Iljin, Kristiina/0000-0002-5161-0584; Jaakkola, Panu/0000-0002-2365-4985; Jokilammi, Anne/0000-0002-1675-5737	Academy of Finland; Finnish Cancer Organizations; Foundation of the Finnish Cancer Institute; Marie Curie Canceromics [MEXT-CT-2003-2728]; Sigrid Juselius Foundation; Turku University Foundation; Turku University Central Hospital	Academy of Finland(Academy of Finland); Finnish Cancer Organizations; Foundation of the Finnish Cancer Institute; Marie Curie Canceromics(European Commission); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Turku University Foundation; Turku University Central Hospital	This work was supported by Academy of Finland, Finnish Cancer Organizations, Foundation of the Finnish Cancer Institute, Marie Curie Canceromics (MEXT-CT-2003-2728), Sigrid Juselius Foundation, Turku University Foundation, and Turku University Central Hospital.	Egeblad M, 2001, BIOCHEM BIOPH RES CO, V281, P25, DOI 10.1006/bbrc.2001.4302; Elenius K, 1997, J BIOL CHEM, V272, P26761, DOI 10.1074/jbc.272.42.26761; Elenius K, 1999, ONCOGENE, V18, P2607, DOI 10.1038/sj.onc.1202612; Garcia-Rivello H, 2005, AM J PHYSIOL-HEART C, V289, pH1153, DOI 10.1152/ajpheart.00048.2005; GASSMANN M, 1995, NATURE, V378, P390, DOI 10.1038/378390a0; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Hollmen M, 2010, FUTURE ONCOL, V6, P37, DOI 10.2217/fon.09.144; Hynes NE, 2009, CURR OPIN CELL BIOL, V21, P177, DOI 10.1016/j.ceb.2008.12.010; Iivanainen E, 2007, EXP CELL RES, V313, P2896, DOI 10.1016/j.yexcr.2007.03.042; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jones FE, 1999, J CELL BIOL, V147, P77, DOI 10.1083/jcb.147.1.77; Junttila TT, 2005, CANCER RES, V65, P1384, DOI 10.1158/0008-5472.CAN-04-3150; Junttila TT, 2003, CLIN CANCER RES, V9, P5346; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kainulainen V, 2000, J BIOL CHEM, V275, P8641, DOI 10.1074/jbc.275.12.8641; Kilpinen S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r139; Koh MY, 2008, MOL CELL BIOL, V28, P7081, DOI 10.1128/MCB.00773-08; Koh MY, 2008, TRENDS BIOCHEM SCI, V33, P526, DOI 10.1016/j.tibs.2008.08.002; Laughner E, 2001, MOL CELL BIOL, V21, P3995, DOI 10.1128/MCB.21.12.3995-4004.2001; Liu YV, 2007, MOL CELL, V25, P207, DOI 10.1016/j.molcel.2007.01.001; Long WW, 2003, DEVELOPMENT, V130, P5257, DOI 10.1242/dev.00715; Maatta JA, 2006, MOL BIOL CELL, V17, P67, DOI 10.1091/mbc.E05-05-0402; Masson N, 2001, EMBO J, V20, P5197, DOI 10.1093/emboj/20.18.5197; Ni CY, 2001, SCIENCE, V294, P2179, DOI 10.1126/science.1065412; PLOWMAN GD, 1993, P NATL ACAD SCI USA, V90, P1746, DOI 10.1073/pnas.90.5.1746; Pouyssegur J, 2006, NATURE, V441, P437, DOI 10.1038/nature04871; Rio C, 2000, J BIOL CHEM, V275, P10379, DOI 10.1074/jbc.275.14.10379; Ruifrok AC, 2001, ANAL QUANT CYTOL, V23, P291; Ryan HE, 1998, EMBO J, V17, P3005, DOI 10.1093/emboj/17.11.3005; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Sardi SP, 2006, CELL, V127, P185, DOI 10.1016/j.cell.2006.07.037; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Seagroves TN, 2003, DEVELOPMENT, V130, P1713, DOI 10.1242/dev.00403; SEMENZA GL, 1992, MOL CELL BIOL, V12, P5447, DOI 10.1128/MCB.12.12.5447; Semenza GL, 2001, TRENDS MOL MED, V7, P345, DOI 10.1016/S1471-4914(01)02090-1; Silberberg G, 2006, AM J MED GENET B, V141B, P142, DOI 10.1002/ajmg.b.30275; Sundvall M, 2007, ONCOGENE, V26, P6905, DOI 10.1038/sj.onc.1210501; Tidcombe H, 2003, P NATL ACAD SCI USA, V100, P8281, DOI 10.1073/pnas.1436402100; Tvorogov D, 2009, J BIOL CHEM, V284, P5582, DOI 10.1074/jbc.M805438200; Veikkolainen V, 2012, J AM SOC NEPHROL, V23, P112, DOI 10.1681/ASN.2011020160; Wang SC, 2009, CLIN CANCER RES, V15, P6484, DOI 10.1158/1078-0432.CCR-08-2813; Williams CC, 2004, J CELL BIOL, V167, P469, DOI 10.1083/jcb.200403155; Zhong H, 2000, CANCER RES, V60, P1541	45	33	34	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					9659	9671		10.1074/jbc.M111.299537	http://dx.doi.org/10.1074/jbc.M111.299537			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22308027	Green Published, hybrid			2022-12-25	WOS:000302167200001
J	Arnaud-Haond, S; Duarte, CM; Diaz-Almela, E; Marba, N; Sintes, T; Serrao, EA				Arnaud-Haond, Sophie; Duarte, Carlos M.; Diaz-Almela, Elena; Marba, Nuria; Sintes, Tomas; Serrao, Ester A.			Implications of Extreme Life Span in Clonal Organisms: Millenary Clones in Meadows of the Threatened Seagrass Posidonia oceanica	PLOS ONE			English	Article							POPULATION-DYNAMICS; GENETIC DIVERSITY; GROWTH; PATTERNS; EFFICIENCY; ECOSYSTEMS; EVOLUTION; MUTATION; DECLINE; MARKERS	The maximum size and age that clonal organisms can reach remains poorly known, although we do know that the largest natural clones can extend over hundreds or thousands of metres and potentially live for centuries. We made a review of findings to date, which reveal that the maximum clone age and size estimates reported in the literature are typically limited by the scale of sampling, and may grossly underestimate the maximum age and size of clonal organisms. A case study presented here shows the occurrence of clones of slow-growing marine angiosperm Posidonia oceanica at spatial scales ranging from metres to hundreds of kilometres, using microsatellites on 1544 sampling units from a total of 40 locations across the Mediterranean Sea. This analysis revealed the presence, with a prevalence of 3.5 to 8.9%, of very large clones spreading over one to several (up to 15) kilometres at the different locations. Using estimates from field studies and models of the clonal growth of P. oceanica, we estimated these large clones to be hundreds to thousands of years old, suggesting the evolution of general purpose genotypes with large phenotypic plasticity in this species. These results, obtained combining genetics, demography and model-based calculations, question present knowledge and understanding of the spreading capacity and life span of plant clones. These findings call for further research on these life history traits associated with clonality, considering their possible ecological and evolutionary implications.	[Arnaud-Haond, Sophie] IFREMER, DEEP Ctr Brest, Plouzane, France; [Arnaud-Haond, Sophie] Univ Algarve, Lab BEE, CCMAR, Faro, Portugal; [Duarte, Carlos M.; Diaz-Almela, Elena; Marba, Nuria] IMEDEA CSIC UIB, Dept Global Change Res, Mallorca, Spain; [Duarte, Carlos M.] Univ Western Australia, Oceans Inst, Nedlands, WA 6009, Australia; [Sintes, Tomas] IFISC CSIC UIB, Inst Fis Interdisciplinar & Sistemas Complejos, Mallorca, Spain	Ifremer; Universidade do Algarve; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Mediterraneo de Estudios Avanzados (IMEDEA); Universitat de les Illes Balears; University of Western Australia; Consejo Superior de Investigaciones Cientificas (CSIC); Universitat de les Illes Balears; CSIC-UIB - Instituto de Fisica Interdisciplinar y Sistemas Complejos (IFISC)	Arnaud-Haond, S (corresponding author), IFREMER, DEEP Ctr Brest, Plouzane, France.	sarnaud@ualg.pt	Sintes, Tomas/G-9153-2015; Serrao, Ester A/C-6686-2012; Duarte, Carlos M/A-7670-2013; Duarte Quesada, Carlos Manuel/ABD-6208-2021; Arnaud-Haond, Sophie/B-2479-2008; Marba, Nuria/H-8136-2015; Marbà, Nuria/N-8143-2019	Sintes, Tomas/0000-0003-2149-8592; Serrao, Ester A/0000-0003-1316-658X; Duarte, Carlos M/0000-0002-1213-1361; Arnaud-Haond, Sophie/0000-0001-5814-8452; Marba, Nuria/0000-0002-8048-6789; Marbà, Nuria/0000-0002-8048-6789; Diaz-Almela, Elena/0000-0002-5904-3297	Foundation BBVA (Spain); European Commission (MMS EU); European Commission (FEDER/POCI); European Commission (FCT); Spanish MEC [FIS2007-60327]	Foundation BBVA (Spain)(BBVA Foundation); European Commission (MMS EU); European Commission (FEDER/POCI); European Commission (FCT); Spanish MEC(Spanish Government)	This research was supported by the Foundation BBVA (Spain), the European Commission (M&MS EU project; FEDER/POCI 2010, FCT, project NETWORK&DIVSTAB). These funders are national (Portuguese FCT) or European (FP5) agencies funding research projects. T. Sintes acknowledges the Project FIS2007-60327, funded by the Spanish MEC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aires T, 2011, MAR ECOL PROG SER, V421, P117, DOI 10.3354/meps08879; Alberto F, 2003, MOL ECOL NOTES, V3, P253, DOI 10.1046/j.1471-8286.2003.00415.x; Alberto F, 2001, MAR ECOL PROG SER, V221, P299, DOI 10.3354/meps221299; Ally D, 2008, MOL ECOL, V17, P4897, DOI 10.1111/j.1365-294X.2008.03962.x; Arnaud-Haond S, 2007, MOL ECOL, V16, P5115, DOI 10.1111/j.1365-294X.2007.03535.x; Arnaud-Haond S, 2005, J HERED, V96, P434, DOI 10.1093/jhered/esi043; Arnaud-Haond S, 2007, J BIOGEOGR, V34, P963, DOI 10.1111/j.1365-2699.2006.01671.x; Arnaud-Haond S, 2007, MOL ECOL NOTES, V7, P15, DOI 10.1111/j.1471-8286.2006.01522.x; Arnaud-Haond S, 2010, ESTUAR COAST, V33, P878, DOI 10.1007/s12237-009-9238-9; Ayala FJ, 1998, P NATL ACAD SCI USA, V95, P3346, DOI 10.1073/pnas.95.7.3346; Balestri E, 2008, ESTUAR COAST SHELF S, V76, P634, DOI 10.1016/j.ecss.2007.07.048; Becheler R, 2010, MOL ECOL, V19, P2394, DOI 10.1111/j.1365-294X.2010.04649.x; Butlin RK, 1999, J EVOLUTION BIOL, V12, P1020; Charlesworth D, 2001, CURR OPIN GENET DEV, V11, P685, DOI 10.1016/S0959-437X(00)00254-9; COOK RE, 1983, AM SCI, V71, P244; Dehmer KJ, 2004, GENET RESOUR CROP EV, V51, P551, DOI 10.1023/B:GRES.0000024163.86762.fc; Diaz-Almela E, 2006, MAR BIOL, V148, P723, DOI 10.1007/s00227-005-0127-x; Diaz-Almela E, 2008, AQUAT BOT, V89, P497; Diaz-Almela E, 2007, CONSERV GENET, V8, P1377, DOI 10.1007/s10592-007-9288-0; Dorken ME, 2002, EVOLUTION, V56, P31, DOI 10.1111/j.0014-3820.2002.tb00847.x; Doyle J. J., 1987, PHYTOCHEMISTRY B, V19, P11, DOI DOI 10.2307/4119796; Drake JW, 1998, GENETICS, V148, P1667; HARBERD D. J., 1961, NEW PHYTOL, V60, P184, DOI 10.1111/j.1469-8137.1961.tb06251.x; HARBERD D. J., 1962, NEW PHYTOL, V61, P85, DOI 10.1111/j.1469-8137.1962.tb06277.x; HARBERD DJ, 1967, NEW PHYTOL, V66, P401, DOI 10.1111/j.1469-8137.1967.tb06019.x; Hemminga M.A., 2000, SEAGRASS ECOLOGY, DOI [10.1017/CBO9780511525551, DOI 10.1017/CBO9780511525551]; Honnay O, 2005, OIKOS, V108, P427, DOI 10.1111/j.0030-1299.2005.13569.x; Hughes AR, 2004, P NATL ACAD SCI USA, V101, P8998, DOI 10.1073/pnas.0402642101; Judson Olivia P., 1996, Trends in Ecology and Evolution, V11, P41, DOI 10.1016/0169-5347(96)81040-8; KEMPERMAN JA, 1976, CAN J BOT, V54, P2603, DOI 10.1139/b76-280; Kendrick GA, 2005, MAR ECOL PROG SER, V290, P291, DOI 10.3354/meps290291; KONDRASHOV AS, 1993, J HERED, V84, P372, DOI 10.1093/oxfordjournals.jhered.a111358; Laberge MJ, 2000, J ECOL, V88, P584, DOI 10.1046/j.1365-2745.2000.00471.x; LEGERE A, 1981, ARCTIC ALPINE RES, V13, P261, DOI 10.2307/1551033; Lynch AJJ, 1998, AUST J BOT, V46, P25, DOI 10.1071/BT96120; LYNCH M, 1984, Q REV BIOL, V59, P257, DOI 10.1086/413902; Marba N, 2005, ESTUARIES, V28, P53, DOI 10.1007/BF02732753; Marba N, 1996, MAR ECOL PROG SER, V137, P203, DOI 10.3354/meps137203; Marba N, 1998, MAR ECOL PROG SER, V174, P269, DOI 10.3354/meps174269; Marba N, 2010, GLOBAL CHANGE BIOL, V16, P2366, DOI 10.1111/j.1365-2486.2009.02130.x; Mateo MA, 1997, ESTUAR COAST SHELF S, V44, P103, DOI 10.1006/ecss.1996.0116; Nabholz B, 2008, MOL BIOL EVOL, V25, P120, DOI 10.1093/molbev/msm248; O'Connell LM, 2004, J HERED, V95, P172, DOI 10.1093/jhered/esh024; OINONEN E, 1969, Acta Forestalia Fennica, V97, P1; Oinonen E., 1967, ACTA FOR FENN, V83, P1, DOI DOI 10.14214/AFF.7180; Oinonen E, 1967, ACTA FOR FENN, V83, P76; Orth RJ, 2006, BIOSCIENCE, V56, P987, DOI 10.1641/0006-3568(2006)56[987:AGCFSE]2.0.CO;2; Otto SP, 2002, NAT REV GENET, V3, P252, DOI 10.1038/nrg761; PARKS JC, 1993, AM J BOT, V80, P537, DOI 10.2307/2445369; Reusch TBH, 1999, MAR ECOL PROG SER, V183, P301, DOI 10.3354/meps183301; Reusch TBH, 2005, P NATL ACAD SCI USA, V102, P2826, DOI 10.1073/pnas.0500008102; Schon I, 2009, LOST SEX: THE EVOLUTIONARY BIOLOGY OF PARTHENOGENESIS, P1; SHEFFIELD E, 1989, WEED RES, V29, P455, DOI 10.1111/j.1365-3180.1989.tb01318.x; Sintes T, 2005, OIKOS, V108, P165, DOI 10.1111/j.0030-1299.2005.13331.x; Sintes T, 2006, ESTUAR COAST, V29, P72, DOI 10.1007/BF02784700; SMITH ML, 1992, NATURE, V356, P428, DOI 10.1038/356428a0; Steinger T, 1996, OECOLOGIA, V105, P94, DOI 10.1007/BF00328796; STEWART CN, 1995, INT J PLANT SCI, V156, P698, DOI 10.1086/297292; TIBAYRENC M, 1990, P NATL ACAD SCI USA, V87, P2414, DOI 10.1073/pnas.87.7.2414; VASEK FC, 1980, AM J BOT, V67, P246, DOI 10.2307/2442649; VRIJENHOEK RC, 1979, AM ZOOL, V19, P787; Waycott M, 2009, P NATL ACAD SCI USA, V106, P12377, DOI 10.1073/pnas.0905620106; Wherry, 1972, CASTANEA, V37, P94; Young AG, 2002, BIOL CONSERV, V106, P71, DOI 10.1016/S0006-3207(01)00230-0	64	131	131	1	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2012	7	2							e30454	10.1371/journal.pone.0030454	http://dx.doi.org/10.1371/journal.pone.0030454			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UG	22312426	Green Published, gold			2022-12-25	WOS:000301977500010
J	Richard, A; Rossignol, G; Comet, JP; Bernot, G; Guespin-Michel, J; Merieau, A				Richard, Adrien; Rossignol, Gaelle; Comet, Jean-Paul; Bernot, Gilles; Guespin-Michel, Jannine; Merieau, Annabelle			Boolean Models of Biosurfactants Production in Pseudomonas fluorescens	PLOS ONE			English	Article							LIPOPEPTIDE PRODUCTION; PHENOTYPIC VARIATION; BIOSYNTHESIS; REGULON	Cyclolipopeptides (CLPs) are biosurfactants produced by numerous Pseudomonas fluorescens strains. CLP production is known to be regulated at least by the GacA/GacS two-component pathway, but the full regulatory network is yet largely unknown. In the clinical strain MFN1032, CLP production is abolished by a mutation in the phospholipase C gene (plcC) and not restored by plcC complementation. Their production is also subject to phenotypic variation. We used a modelling approach with Boolean networks, which takes into account all these observations concerning CLP production without any assumption on the topology of the considered network. Intensive computation yielded numerous models that satisfy these properties. All models minimizing the number of components point to a bistability in CLP production, which requires the presence of a yet unknown key self-inducible regulator. Furthermore, all suggest that a set of yet unexplained phenotypic variants might also be due to this epigenetic switch. The simplest of these Boolean networks was used to propose a biological regulatory network for CLP production. This modelling approach has allowed a possible regulation to be unravelled and an unusual behaviour of CLP production in P. fluorescens to be explained.	[Richard, Adrien; Comet, Jean-Paul; Bernot, Gilles] Univ Nice Sophia Antipolis, Lab Informat Signaux & Syst Complexes Sophia Anit, Sophia Antipolis, France; [Richard, Adrien; Comet, Jean-Paul; Bernot, Gilles] CNRS, Sophia Antipolis, France; [Rossignol, Gaelle; Guespin-Michel, Jannine; Merieau, Annabelle] Univ Rouen, Lab Microbiol Froid Signaux & Microenvironm LMDF, Evreux, France	UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); Universite de Rouen Normandie	Richard, A (corresponding author), Univ Nice Sophia Antipolis, Lab Informat Signaux & Syst Complexes Sophia Anit, Sophia Antipolis, France.	richard@i3s.unice.fr		Comet, Jean-Paul/0000-0002-6681-3501	French National Agency for Research [ANR-10-BLANC-0218]; CNRS; Universite de Nice-Sophia Antipolis	French National Agency for Research(French National Research Agency (ANR)); CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite de Nice-Sophia Antipolis	This work is partially supported by the French National Agency for Research (ANR-10-BLANC-0218 BioTempo project), the CNRS, and Universite de Nice-Sophia Antipolis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernot G, 2004, J THEOR BIOL, V229, P339, DOI 10.1016/j.jtbi.2004.04.003; Brencic A, 2009, MOL MICROBIOL, V72, P612, DOI 10.1111/j.1365-2958.2009.06670.x; Cui X, 2005, EUR J PLANT PATHOL; dAri R., 1990, BIOL FEEDBACK; de Bruijn I, 2008, J BACTERIOL, V190, P2777, DOI 10.1128/JB.01563-07; de Bruijn I, 2007, MOL MICROBIOL, V63, P417, DOI 10.1111/j.1365-2958.2006.05525.x; Filopon D, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-272; Hallet B, 2001, CURR OPIN MICROBIOL, V4, P570, DOI 10.1016/S1369-5274(00)00253-8; Hassan KA, 2010, ENVIRON MICROBIOL, V12, P899, DOI 10.1111/j.1462-2920.2009.02134.x; Khalis Z, 2009, GENES GENOMES GENOMI; Koch B, 2002, APPL ENVIRON MICROB, V68, P4509, DOI 10.1128/AEM.68.9.4509-4516.2002; Lapouge K, 2008, MOL MICROBIOL, V67, P241, DOI 10.1111/j.1365-2958.2007.06042.x; MacLean D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009101; Nielsen TH, 2002, APPL ENVIRON MICROB, V68, P3416, DOI 10.1128/AEM.68.7.3416-3423.2002; Raaijmakers JM, 2006, MOL PLANT MICROBE IN, V19, P699, DOI 10.1094/MPMI-19-0699; Raaijmakers JM, 2010, FEMS MICROBIOL REV, V34, P1037, DOI 10.1111/j.1574-6976.2010.00221.x; Remy E, 2008, ADV APPL MATH, V41, P335, DOI 10.1016/j.aam.2007.11.003; Richard A, 2007, DISCRETE APPL MATH; Rigali S, 2004, NUCLEIC ACIDS RES, V32, P3418, DOI 10.1093/nar/gkh673; Rossignol G, 2009, RES MICROBIOL, V160, P337, DOI 10.1016/j.resmic.2009.04.004; Rossignol G, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-189; Soule Christophe, 2003, ComPlexUs, V1, P123, DOI 10.1159/000076100; Thomas R, 1981, SPRINGER SERIES SYNE, V9, P180; Tran H, 2008, J APPL MICROBIOL, V104, P839, DOI 10.1111/j.1365-2672.2007.03618.x; van den Broek D, 2005, ENVIRON MICROBIOL, V7, P1686, DOI 10.1111/j.1462-2920.2005.00912.x	25	14	14	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2012	7	1							e24651	10.1371/journal.pone.0024651	http://dx.doi.org/10.1371/journal.pone.0024651			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	912BY	22303435	Green Published, Green Submitted, gold			2022-12-25	WOS:000301770700002
J	Zhang, Y; Zhang, GQ; Hendrix, LR; Tesh, VL; Samuel, JE				Zhang, Yan; Zhang, Guoquan; Hendrix, Laura R.; Tesh, Vernon L.; Samuel, James E.			Coxiella burnetii Induces Apoptosis during Early Stage Infection via a Caspase-Independent Pathway in Human Monocytic THP-1 Cells	PLOS ONE			English	Article							Q-FEVER; BACTERIAL PATHOGENS; PHASE VARIATION; DEATH; LIPOPOLYSACCHARIDE; MACROPHAGES; MODEL; MITOCHONDRIA; INTRASTRAIN; MECHANISMS	The ability of Coxiella burnetii to modulate host cell death may be a critical factor in disease development. In this study, human monocytic THP-1 cells were used to examine the ability of C. burnetii Nine Mile phase II (NMII) to modulate apoptotic signaling. Typical apoptotic cell morphological changes and DNA fragmentation were detected in NMII infected cells at an early stage of infection. FACS analysis using Annexin-V-PI double staining showed the induction of a significant number of apoptotic cells at an early stage of NMII infection. Double staining of apoptotic cell DNA and intracellular C. burnetii indicates that NMII infected cells undergoing apoptosis. Interestingly, caspase-3 was not cleaved in NMII infected cells and the caspase-inhibitor Z-VAD-fmk did not prevent NMII induced apoptosis. Surprisingly, the caspase-3 downstream substrate PARP was cleaved in NMII infected cells. These results suggest that NMII induces apoptosis during an early stage of infection through a caspase-independent pathway in THP-1 cells. In addition, NMII-infected monocytes were unable to prevent exogenous staurosporine-induced apoptotic death. Western blot analysis indicated that NMII infection induced the translocation of AIF from mitochondria into the nucleus. Cytochrome c release and cytosol-to-mitochondrial translocation of the pore-forming protein Bax in NMII infected cells occurred at 24 h post infection. These data suggest that NMII infection induced caspase-independent apoptosis through a mechanism involving cytochrome c release, cytosol-to-mitochondrial translocation of Bax and nuclear translocation of AIF in THP-1 monocytes. Furthermore, NMII infection increased TNF-alpha production and neutralization of TNF-alpha in NMII infected cells partially blocked PARP cleavage, suggesting TNF-alpha may play a role in the upstream signaling involved in NMII induced apoptosis. Antibiotic inhibition of C. burnetii RNA synthesis blocked NMII infection-induced PARP activation. These results suggest that both intracellular C. burnetii replication and secreted TNF-alpha contribute to NMII infection-triggered apoptosis during an early stage of infection.	[Zhang, Yan; Hendrix, Laura R.; Tesh, Vernon L.; Samuel, James E.] Texas A&M Hlth Sci Ctr, Coll Med, Dept Microbial & Mol Pathogenesis, Bryan, TX USA; [Zhang, Yan; Zhang, Guoquan] Univ Missouri Columbia, Coll Vet Med, Dept Vet Pathobiol, Columbia, MO USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Missouri System; University of Missouri Columbia	Zhang, Y (corresponding author), Texas A&M Hlth Sci Ctr, Coll Med, Dept Microbial & Mol Pathogenesis, Bryan, TX USA.	zhangguo@missouri.edu; jsamuel@medicine.tamhsc.edu	Zhang, Guoquan/ABA-9613-2020		United States, National Institutes of Health [AI037744]; University of Missouri; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI037744, R01AI037744, R29AI037744] Funding Source: NIH RePORTER	United States, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Missouri; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the United States, National Institutes of Health grant AI037744 to JS and University of Missouri start-up funds to GZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASSEFFA A, 1993, ONCOL RES, V5, P11; AUWERX J, 1991, EXPERIENTIA, V47, P22, DOI 10.1007/BF02041244; BACA OG, 1983, MICROBIOL REV, V47, P127, DOI 10.1128/MMBR.47.2.127-149.1983; BACA OG, 1981, INFECT IMMUN, V33, P258, DOI 10.1128/IAI.33.1.258-266.1981; Beare PA, 2006, J BACTERIOL, V188, P2309, DOI 10.1128/JB.188.7.2309-2324.2006; Brennan RE, 2003, J CLIN MICROBIOL, V41, P1869, DOI 10.1128/JCM.41.5.1869-1874.2003; Broker LE, 2005, CLIN CANCER RES, V11, P3155, DOI 10.1158/1078-0432.CCR-04-2223; Capo C, 1999, J IMMUNOL, V163, P6078; Capo C, 2003, J IMMUNOL, V170, P4217, DOI 10.4049/jimmunol.170.8.4217; Capo C, 1996, INFECT IMMUN, V64, P1638, DOI 10.1128/IAI.64.5.1638-1642.1996; Cregan SP, 2004, ONCOGENE, V23, P2785, DOI 10.1038/sj.onc.1207517; Dellacasagrande J, 1999, J IMMUNOL, V162, P2259; Fink SL, 2005, INFECT IMMUN, V73, P1907, DOI 10.1128/IAI.73.4.1907-1916.2005; Gao LY, 2000, TRENDS MICROBIOL, V8, P306, DOI 10.1016/S0966-842X(00)01784-4; Ghigo E, 2002, J IMMUNOL, V169, P4488, DOI 10.4049/jimmunol.169.8.4488; Hacker G, 2006, MED MICROBIOL IMMUN, V195, P11, DOI 10.1007/s00430-005-0239-4; HACKSTADT T, 1985, INFECT IMMUN, V48, P359, DOI 10.1128/IAI.48.2.359-365.1985; HACKSTADT T, 1990, ANN NY ACAD SCI, V590, P27, DOI 10.1111/j.1749-6632.1990.tb42203.x; Harrison LM, 2005, MICROB PATHOGENESIS, V38, P63, DOI 10.1016/j.micpath.2004.12.003; Heinzen RA, 1999, TRENDS MICROBIOL, V7, P149, DOI 10.1016/S0966-842X(99)01475-4; Hong SJ, 2004, TRENDS PHARMACOL SCI, V25, P259, DOI 10.1016/j.tips.2004.03.005; Hornef MW, 2002, NAT IMMUNOL, V3, P1033, DOI 10.1038/ni1102-1033; Howe D, 2003, CELL MICROBIOL, V5, P469, DOI 10.1046/j.1462-5822.2003.00293.x; Ismail N, 2002, FEMS MICROBIOL LETT, V207, P111, DOI 10.1111/j.1574-6968.2002.tb11038.x; Kim R, 2005, ONCOL REP, V14, P595; Kohro Takahide, 2004, J Atheroscler Thromb, V11, P88; Lai XH, 2001, INFECT IMMUN, V69, P4691, DOI 10.1128/IAI.69.7.4691-4694.2001; Lee J, 2006, J IMMUNOL, V176, P4267, DOI 10.4049/jimmunol.176.7.4267; Luhrmann A, 2007, INFECT IMMUN, V75, P5282, DOI 10.1128/IAI.00863-07; Maurin M, 1999, CLIN MICROBIOL REV, V12, P518, DOI 10.1128/CMR.12.4.518; Mege JL, 1997, FEMS MICROBIOL REV, V19, P209, DOI 10.1016/S0168-6445(96)00030-7; MOOS A, 1987, INFECT IMMUN, V55, P1144, DOI 10.1128/IAI.55.5.1144-1150.1987; Nagata S, 2000, EXP CELL RES, V256, P12, DOI 10.1006/excr.2000.4834; Neumeister B, 2002, MICROBIOL-SGM, V148, P3639, DOI 10.1099/00221287-148-11-3639; Ojcius DM, 1998, J IMMUNOL, V161, P4220; Perfettini JL, 2002, INFECT IMMUN, V70, P55, DOI 10.1128/IAI.70.1.55-61.2002; Raoult D, 2005, LANCET INFECT DIS, V5, P219, DOI 10.1016/S1473-3099(05)70052-9; Santucci MB, 2000, J INFECT DIS, V181, P1506, DOI 10.1086/315371; Shannon JG, 2005, P NATL ACAD SCI USA, V102, P8722, DOI 10.1073/pnas.0501863102; Shen HM, 2006, FASEB J, V20, P1589, DOI 10.1096/fj.05-5603rev; Sordet O, 2001, BLOOD, V97, P3931, DOI 10.1182/blood.V97.12.3931; STOKER MGP, 1956, CAN J MICROBIOL, V2, P310, DOI 10.1139/m56-036; Vega-Manriquez X, 2007, INFECT IMMUN, V75, P1223, DOI 10.1128/IAI.01047-06; VISHWANATH S, 1988, INFECT IMMUN, V56, P40, DOI 10.1128/IAI.56.1.40-44.1988; Voth DE, 2007, INFECT IMMUN, V75, P4263, DOI 10.1128/IAI.00594-07; Weinrauch Y, 1999, ANNU REV MICROBIOL, V53, P155, DOI 10.1146/annurev.micro.53.1.155; Zamboni DS, 2004, J BIOL CHEM, V279, P54405, DOI 10.1074/jbc.M410340200; Zamboni DS, 2002, MICROBES INFECT, V4, P591, DOI 10.1016/S1286-4579(02)01577-0; Zhang GQ, 2007, J IMMUNOL, V179, P8372, DOI 10.4049/jimmunol.179.12.8372	49	21	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2012	7	1							e30841	10.1371/journal.pone.0030841	http://dx.doi.org/10.1371/journal.pone.0030841			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911GB	22303462	gold, Green Published, Green Submitted			2022-12-25	WOS:000301704200038
J	Gall, JM; Wang, ZY; Liesa, M; Molina, A; Havasi, A; Schwartz, JH; Shirihai, O; Borkan, SC; Bonegio, RGB				Gall, Jonathan M.; Wang, Zhiyong; Liesa, Marc; Molina, Anthony; Havasi, Andrea; Schwartz, John H.; Shirihai, Orian; Borkan, Steven C.; Bonegio, Ramon G. B.			Role of Mitofusin 2 in the Renal Stress Response	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; NECROSIS-FACTOR-ALPHA; CYTOCHROME-C RELEASE; ACUTE KIDNEY INJURY; MITOCHONDRIAL FISSION; ATP DEPLETION; EPITHELIAL-CELLS; TUBULAR CELLS; BETA-CATENIN; EMBRYONIC-DEVELOPMENT	The role of mitofusin 2 (MFN2), a key regulator of mitochondrial morphology and function in the renal stress response is unknown. To assess its role, the MFN2 floxed gene was conditionally deleted in the kidney of mice (MFN2 cKO) by Pax2 promoter driven Cre expression (Pax2Cre). MFN2 cKO caused severe mitochondrial fragmentation in renal epithelial cells that are critical for normal kidney tubular function. However, despite a small (20%) decrease in nephron number, newborn cKO pups had organ or tubular function that did not differ from littermate Cre-negative pups. MFN2 deficiency in proximal tubule epithelial cells in primary culture induced mitochondrial fragmentation but did not significantly alter ATP turnover, maximal mitochondrial oxidative reserve capacity, or the low level of oxygen consumption during cyanide exposure. MFN2 deficiency also did not increase apoptosis of tubule epithelial cells under non-stress conditions. In contrast, metabolic stress caused by ATP depletion exacerbated mitochondrial outer membrane injury and increased apoptosis by 80% in MFN2 deficient vs. control cells. Despite similar stress-induced Bax 6A7 epitope exposure in MFN2 deficient and control cells, MFN2 deficiency significantly increased mitochondrial Bax accumulation and was associated with greater release of both apoptosis inducing factor and cytochrome c. In conclusion, MFN2 deficiency in the kidney causes mitochondrial fragmentation but does not affect kidney or tubular function during development or under non-stress conditions. However, MFN2 deficiency exacerbates renal epithelial cell injury by promoting Bax-mediated mitochondrial outer membrane injury and apoptosis.	[Gall, Jonathan M.; Wang, Zhiyong; Havasi, Andrea; Schwartz, John H.; Borkan, Steven C.; Bonegio, Ramon G. B.] Boston Med Ctr, Renal Sect, Boston, MA 02118 USA; [Liesa, Marc; Molina, Anthony; Shirihai, Orian] Boston Med Ctr, Obes Ctr, Boston, MA USA	Boston Medical Center; Boston Medical Center	Gall, JM (corresponding author), Boston Med Ctr, Renal Sect, Boston, MA 02118 USA.	ygall@bu.edu	Liesa, Marc/K-8590-2019; Schwartz, John/AAO-8158-2021	Liesa, Marc/0000-0002-5909-8570; Schwartz, John/0000-0002-1660-8681; Shirihai, Orian/0000-0002-9502-2661; Molina, Anthony/0000-0002-5786-4622; Havasi, Andrea/0000-0002-8758-0823; Borkan, Steven/0000-0003-3062-9486; Bonegio, Ramon/0000-0002-1286-141X; Wang, Zhiyon/0000-0002-6471-266X	National Institutes of Health [(RO-1) DK-52898, DK-53387]; Ruth L. Kirschstein National Research Service [DK-082150]; American Society of Nephrology; ARC from the Evans Center for Interdisciplinary Research at Boston University; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052898, R01DK035914, K08DK090143, R01DK053387, R01DK074778, F30DK082150] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirschstein National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Society of Nephrology; ARC from the Evans Center for Interdisciplinary Research at Boston University; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health research Grants (RO-1) DK-52898 (JHS), DK-53387 (SCB), a Ruth L. Kirschstein National Research Service Award DK-082150 (JMG) (www.nih.gov), a James A. Scherbenske Award from the American Society of Nephrology (SCB) (www.asn-online.org) and an ARC award from the Evans Center for Interdisciplinary Research at Boston University (www.bumc.bu.edu/evanscenteribr/the-arcs/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonsson B, 2001, J BIOL CHEM, V276, P11615, DOI 10.1074/jbc.M010810200; Arnoult D, 2005, J BIOL CHEM, V280, P35742, DOI 10.1074/jbc.M505970200; Arnoult D, 2003, EMBO J, V22, P4385, DOI 10.1093/emboj/cdg423; Ashrafian H, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001000; Autret A, 2010, CELL MOL LIFE SCI, V67, P1599, DOI 10.1007/s00018-010-0286-x; Autret A, 2009, MOL CELL, V36, P355, DOI 10.1016/j.molcel.2009.10.011; Bach D, 2005, DIABETES, V54, P2685, DOI 10.2337/diabetes.54.9.2685; Bach D, 2003, J BIOL CHEM, V278, P17190, DOI 10.1074/jbc.M212754200; Basile DP, 1997, AM J PHYSIOL-RENAL, V272, pF640, DOI 10.1152/ajprenal.1997.272.5.F640; Bonegio RGB, 2011, KIDNEY INT, V79, P1099, DOI 10.1038/ki.2010.553; Borkan SC, 1997, AM J PHYSIOL-RENAL, V272, pF347, DOI 10.1152/ajprenal.1997.272.3.F347; BREZIS M, 1995, NEW ENGL J MED, V332, P647, DOI 10.1056/NEJM199503093321006; Brooks C, 2010, AM J PHYSL CELL PHYS; Brooks C, 2007, P NATL ACAD SCI USA, V104, P11649, DOI 10.1073/pnas.0703976104; Brooks C, 2009, J CLIN INVEST, V119, P1275, DOI 10.1172/JCI37829; Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Chen HC, 2007, CELL, V130, P548, DOI 10.1016/j.cell.2007.06.026; Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026; Cullen-McEwen LA, 2003, HYPERTENSION, V41, P335, DOI 10.1161/01.HYP.0000050961.70182.56; Davies VJ, 2007, HUM MOL GENET, V16, P1307, DOI 10.1093/hmg/ddm079; DONOHOE JF, 1978, KIDNEY INT, V13, P208, DOI 10.1038/ki.1978.31; Fannjiang Y, 2004, GENE DEV, V18, P2785, DOI 10.1101/gad.1247904; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; George NM, 2010, J BIOL CHEM, V285, P1384, DOI 10.1074/jbc.M109.049924; Gobe G, 2000, J AM SOC NEPHROL, V11, P454, DOI 10.1681/ASN.V113454; Gobe G, 1999, KIDNEY INT, V56, P1299, DOI 10.1046/j.1523-1755.1999.00701.x; Goping IS, 1998, J CELL BIOL, V143, P207, DOI 10.1083/jcb.143.1.207; Goyal G, 2007, DEV CELL, V12, P807, DOI 10.1016/j.devcel.2007.02.002; Hall AM, 2008, QJM-INT J MED, V101, P755, DOI 10.1093/qjmed/hcn060; Hall AM, 2009, J AM SOC NEPHROL, V20, P1293, DOI 10.1681/ASN.2008070759; Havasi A, 2008, J BIOL CHEM, V283, P12305, DOI 10.1074/jbc.M801291200; Heyman SN, 2011, CONTRIB NEPHROL, V169, P286, DOI 10.1159/000313957; Hsu YT, 1997, P NATL ACAD SCI USA, V94, P3668, DOI 10.1073/pnas.94.8.3668; Ishihara N, 2009, NAT CELL BIOL, V11, P958, DOI 10.1038/ncb1907; Jagasia R, 2005, NATURE, V433, P754, DOI 10.1038/nature03316; Karbowski M, 2002, J CELL BIOL, V159, P931, DOI 10.1083/jcb.200209124; Karbowski M, 2006, NATURE, V443, P658, DOI 10.1038/nature05111; Li F, 2002, AM J PHYSIOL-CELL PH, V283, pC917, DOI 10.1152/ajpcell.00517.2001; Li Z, 2004, CELL, V119, P873, DOI 10.1016/j.cell.2004.11.003; Lieberthal W, 1998, AM J PHYSIOL-RENAL, V274, pF315, DOI 10.1152/ajprenal.1998.274.2.F315; Liesa M, 2009, PHYSIOL REV, V89, P799, DOI 10.1152/physrev.00030.2008; Nakada K, 2001, NAT MED, V7, P934, DOI 10.1038/90976; Ohyama T, 2004, GENESIS, V38, P195, DOI 10.1002/gene.20017; Ono T, 2001, NAT GENET, V28, P272, DOI 10.1038/90116; Pich S, 2005, HUM MOL GENET, V14, P1405, DOI 10.1093/hmg/ddi149; Price VR, 2002, J AM SOC NEPHROL, V13, P1152, DOI 10.1097/01.ASN.0000012609.22035.44; Ruchalski K, 2006, J BIOL CHEM, V281, P7873, DOI 10.1074/jbc.M513728200; Saikumar P, 1998, ONCOGENE, V17, P3401, DOI 10.1038/sj.onc.1202590; Schwartz JH, 1999, J AM SOC NEPHROL, V10, P2297; Sheridan C, 2008, MOL CELL, V31, P570, DOI 10.1016/j.molcel.2008.08.002; Su B, 2010, BBA-MOL BASIS DIS, V1802, P135, DOI 10.1016/j.bbadis.2009.09.013; Sundararajan R, 2001, J VIROL, V75, P7506, DOI 10.1128/JVI.75.16.7506-7516.2001; Taguchi N, 2007, J BIOL CHEM, V282, P11521, DOI 10.1074/jbc.M607279200; Tang WX, 2011, ENDOCRINE; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; VENKATACHALAM MA, 1978, KIDNEY INT, V14, P31, DOI 10.1038/ki.1978.87; Wang YH, 1996, AM J PHYSIOL-RENAL, V270, pF1057, DOI 10.1152/ajprenal.1996.270.6.F1057; Wang YH, 2002, CELL STRESS CHAPERON, V7, P137, DOI 10.1379/1466-1268(2002)007<0137:HEESIA>2.0.CO;2; Wang ZY, 2011, KIDNEY INT, V79, P861, DOI 10.1038/ki.2010.527; Wang ZY, 2010, J AM SOC NEPHROL, V21, P284, DOI 10.1681/ASN.2009080828; Wang ZY, 2009, J AM SOC NEPHROL, V20, P1919, DOI 10.1681/ASN.2009030253; Wasiak S, 2007, J CELL BIOL, V177, P439, DOI 10.1083/jcb.200610042; Wei Q, 2007, KIDNEY INT, V72, P53, DOI 10.1038/sj.ki.5002256; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; Zorzano A, 2009, INT J BIOCHEM CELL B, V41, P1846, DOI 10.1016/j.biocel.2009.02.004	66	42	46	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2012	7	1							e31074	10.1371/journal.pone.0031074	http://dx.doi.org/10.1371/journal.pone.0031074			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911FX	22292091	Green Published, Green Submitted, gold			2022-12-25	WOS:000301703800041
J	Reinhard, DA; Konrath, SH; Lopez, WD; Cameron, HG				Reinhard, David A.; Konrath, Sara H.; Lopez, William D.; Cameron, Heather G.			Expensive Egos: Narcissistic Males Have Higher Cortisol	PLOS ONE			English	Article							SALIVARY CORTISOL; SELF-ESTEEM; CARDIOVASCULAR REACTIVITY; PERSONALITY-INVENTORY; ORAL-CONTRACEPTIVES; SOCIAL SUPPORT; DISPLACED AGGRESSION; THREATENED EGOTISM; STRESS APPRAISAL; SEX-DIFFERENCES	Background: Narcissism is characterized by grandiosity, low empathy, and entitlement. There has been limited research regarding the hormonal correlates of narcissism, despite the potential health implications. This study examined the role of participant narcissism and sex on basal cortisol concentrations in an undergraduate population. Methods and Findings: Participants were 106 undergraduate students (79 females, 27 males, mean age 20.1 years) from one Midwestern and one Southwestern American university. Narcissism was assessed using the Narcissistic Personality Inventory, and basal cortisol concentrations were collected from saliva samples in a laboratory setting. Regression analyses examined the effect of narcissism and sex on cortisol (log). There were no sex differences in basal cortisol, F(1,97)=.20, p=.65, and narcissism scores, F(1,97)=.00, p=.99. Stepwise linear regression models of sex and narcissism and their interaction predicting cortisol concentrations showed no main effects when including covariates, but a significant interaction, beta=.27, p=.04. Narcissism was not related to cortisol in females, but significantly predicted cortisol in males. Examining the effect of unhealthy versus healthy narcissism on cortisol found that unhealthy narcissism was marginally related to cortisol in females, beta=.27, p=.06, but significantly predicted higher basal cortisol in males, beta=.72, p=.01, even when controlling for potential confounds. No relationship was found between sex, narcissism, or their interaction on self-reported stress. Conclusions: Our findings suggest that the HPA axis is chronically activated in males with unhealthy narcissism. This constant activation of the HPA axis may have important health implications.	[Reinhard, David A.] Univ Virginia, Dept Psychol, Charlottesville, VA 22903 USA; [Konrath, Sara H.; Cameron, Heather G.] Univ Michigan, Inst Social Res, Ann Arbor, MI USA; [Konrath, Sara H.] Univ Rochester, Med Ctr, Dept Psychiat, Rochester, NY 14642 USA; [Lopez, William D.] Univ Michigan, Sch Publ Hlth, Ann Arbor, MI 48109 USA	University of Virginia; University of Michigan System; University of Michigan; University of Rochester; University of Michigan System; University of Michigan	Reinhard, DA (corresponding author), Univ Virginia, Dept Psychol, Gilmer Hall, Charlottesville, VA 22903 USA.	skonrath@umich.edu		Konrath, Sara/0000-0001-9182-0095	Institute for Research on Women and Gender at the University of Michigan	Institute for Research on Women and Gender at the University of Michigan	The authors gratefully acknowledge a grant from the Institute for Research on Women and Gender at the University of Michigan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKHTAR S, 1982, AM J PSYCHIAT, V139, P12; ANSSEAU M, 1993, PSYCHONEUROENDOCRINO, V18, P37, DOI 10.1016/0306-4530(93)90053-N; ASHTON WA, 1993, SEX ROLES, V28, P461, DOI 10.1007/BF00289608; BUNTROCK CN, 1992, PERS INDIV DIFFER, V13, P1223, DOI 10.1016/0191-8869(92)90258-Q; Bushman BJ, 1998, J PERS SOC PSYCHOL, V75, P219, DOI 10.1037//0022-3514.75.1.219; Campbell WK, 2000, J RES PERS, V34, P329, DOI 10.1006/jrpe.2000.2282; Campbell WK, 1999, J PERS SOC PSYCHOL, V77, P1254, DOI 10.1037/0022-3514.77.6.1254; Campbell WK, 2002, PERS SOC PSYCHOL B, V28, P484, DOI 10.1177/0146167202287006; Campbell WK, 2002, J PERS SOC PSYCHOL, V83, P340, DOI [10.1037/0022-3514.83.2.340, 10.1037//0022-3514.83.2.340]; Edelstein RS, 2010, J RES PERS, V44, P565, DOI 10.1016/j.jrp.2010.06.008; Edwards, 2010, STANDARD, V9, P1; EMMONS RA, 1984, J PERS ASSESS, V48, P291, DOI 10.1207/s15327752jpa4803_11; EMMONS RA, 1987, J PERS SOC PSYCHOL, V52, P11, DOI 10.1037/0022-3514.52.1.11; Exline JJ, 2004, J PERS SOC PSYCHOL, V87, P894, DOI 10.1037/0022-3514.87.6.894; Farwell L, 1998, J PERS, V66, P65, DOI 10.1111/1467-6494.00003; Foster JD, 2003, J RES PERS, V37, P469, DOI 10.1016/S0092-6566(03)00026-6; FUKUNISHI I, 1995, J PSYCHOSOM RES, V39, P215, DOI 10.1016/0022-3999(94)00094-L; GABRIEL MT, 1994, J PERS, V62, P143, DOI 10.1111/j.1467-6494.1994.tb00798.x; GASPARD UJ, 1983, CONTRACEPTION, V27, P577, DOI 10.1016/0010-7824(83)90023-9; Heaney JLJ, 2010, INT J PSYCHOPHYSIOL, V78, P201, DOI 10.1016/j.ijpsycho.2010.07.009; Horvath S, 2009, J EXP SOC PSYCHOL, V45, P1252, DOI 10.1016/j.jesp.2009.07.011; JOHNSON EO, 1992, NEUROSCI BIOBEHAV R, V16, P115, DOI 10.1016/S0149-7634(05)80175-7; Kelsey RM, 2002, PSYCHOPHYSIOLOGY, V39, P322, DOI 10.1017/S004857720139306X; Kelsey RM, 2001, PSYCHOPHYSIOLOGY, V38, P292; KERNIS MH, 1994, J RES PERS, V28, P4, DOI 10.1006/jrpe.1994.1002; KING AC, 1990, J PSYCHOSOM RES, V34, P461, DOI 10.1016/0022-3999(90)90070-K; KIRSCHBAUM C, 1992, PSYCHOSOM MED, V54, P648, DOI 10.1097/00006842-199211000-00004; KIRSCHBAUM C, 1989, NEUROPSYCHOBIOLOGY, V22, P150, DOI 10.1159/000118611; Konrath S, 2006, PSYCHOL SCI, V17, P995, DOI 10.1111/j.1467-9280.2006.01818.x; Kunkel AW, 1998, SEX DIFFERENCES AND SIMILARITIES IN COMMUNICATIONS, P101; LASH SJ, 1990, BEHAV MODIF, V14, P3, DOI 10.1177/01454455900141001; LASH SJ, 1991, HEALTH PSYCHOL, V10, P392, DOI 10.1037/0278-6133.10.6.392; Latendresse G, 2008, BIOL RES NURS, V10, P54, DOI 10.1177/1099800408320970; Martinez MA, 2008, PERS INDIV DIFFER, V44, P140, DOI 10.1016/j.paid.2007.07.012; Melamed S, 1996, PSYCHOSOM MED, V58, P500, DOI 10.1097/00006842-199609000-00012; Mente A, 1999, PERS INDIV DIFFER, V27, P683, DOI 10.1016/S0191-8869(98)00268-2; MEULENBERG PMM, 1987, CLIN CHIM ACTA, V165, P379, DOI 10.1016/0009-8981(87)90183-5; Miller JD, 2008, J PERS, V76, P449, DOI 10.1111/j.1467-6494.2008.00492.x; MILLER SB, 1993, PSYCHOSOM MED, V55, P78, DOI 10.1097/00006842-199301000-00013; MORF CC, 1993, PERS SOC PSYCHOL B, V19, P668, DOI 10.1177/0146167293196001; Morf CC, 2001, PSYCHOL INQ, V12, P177, DOI 10.1207/S15327965PLI1204_1; NICKELSEN T, 1989, EXP CLIN ENDOCRINOL, V94, P275, DOI 10.1055/s-0029-1210910; Paulhus DL, 1998, J PERS SOC PSYCHOL, V74, P1197, DOI 10.1037/0022-3514.74.5.1197; Paulhus DL, 1998, J PERS, V66, P1025, DOI 10.1111/1467-6494.00041; Pruessner JC, 1997, LIFE SCI, V61, P2539, DOI 10.1016/S0024-3205(97)01008-4; Puustinen PJ, 2011, EUR ARCH PSY CLIN N, V261, P277, DOI 10.1007/s00406-010-0134-x; RASKIN R, 1988, J PERS SOC PSYCHOL, V54, P890, DOI 10.1037/0022-3514.54.5.890; RASKIN R, 1988, J PERS, V56, P393, DOI 10.1111/j.1467-6494.1988.tb00892.x; RASKIN R, 1991, J PERS, V59, P19, DOI 10.1111/j.1467-6494.1991.tb00766.x; RASKIN R, 1989, J PERS ASSESS, V53, P66, DOI 10.1207/s15327752jpa5301_8; Reevy GM, 2001, SEX ROLES, V44, P437, DOI 10.1023/A:1011930128829; RHODEWALT F, 1995, J RES PERS, V29, P1, DOI 10.1006/jrpe.1995.1001; Rhodewalt F, 2002, J RES PERS, V36, P97, DOI 10.1006/jrpe.2002.2342; Robins RW, 2001, J PERS SOC PSYCHOL, V80, P340, DOI 10.1037//0022-3514.80.2.340; Rutledge T, 2006, STRESS ITS IMPACT SO, P1; Santos J, 1999, AM J PHYSIOL-GASTR L, V277, pG391, DOI 10.1152/ajpgi.1999.277.2.G391; Scherwitz L, 1985, SELF INVOLVEMENT RIS; Scherwitz L, 1988, SELF REFERENCE CORON; Sedikides C, 2004, J PERS SOC PSYCHOL, V87, P400, DOI 10.1037/0022-3514.87.3.400; Sgoifo A, 2003, NEUROSCI BIOBEHAV R, V27, P179, DOI 10.1016/S0149-7634(03)00019-8; SHAPIRO D, 1995, PSYCHOPHYSIOLOGY, V32, P425, DOI 10.1111/j.1469-8986.1995.tb02093.x; Smith TW, 1998, HEALTH PSYCHOL, V17, P537, DOI 10.1037/0278-6133.17.6.537; Sommer KL, 2009, J APPL SOC PSYCHOL, V39, P1083, DOI 10.1111/j.1559-1816.2009.00473.x; Twenge JM, 2003, PERS SOC PSYCHOL B, V29, P261, DOI 10.1177/0146167202239051; Twenge JM, 2008, J PERS, V76, P902; VINING RF, 1983, ANN CLIN BIOCHEM, V20, P329, DOI 10.1177/000456328302000601; WARRENBURG S, 1989, J BEHAV MED, V12, P407, DOI 10.1007/BF00844875; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; WATSON PJ, 1992, J PERS DISORD, V6, P434, DOI 10.1521/pedi.1992.6.4.434; WATSON PJ, 1987, SEX ROLES, V16, P335, DOI 10.1007/BF00289546; WATSON PJ, 1984, J PERS ASSESS, V48, P301, DOI 10.1207/s15327752jpa4803_12; WATSON PJ, 1993, J PERS ASSESS, V61, P41, DOI 10.1207/s15327752jpa6101_4; WATSON PJ, 1995, J PSYCHOL, V129, P61, DOI 10.1080/00223980.1995.9914948; Whembolua GLS, 2006, HORM BEHAV, V49, P478, DOI 10.1016/j.yhbeh.2005.10.005; WINK P, 1991, J PERS SOC PSYCHOL, V61, P590	75	33	34	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30858	10.1371/journal.pone.0030858	http://dx.doi.org/10.1371/journal.pone.0030858			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	909NE	22292062	Green Submitted, Green Published, gold			2022-12-25	WOS:000301570600088
J	Kim, SI; Yoon, JI; Tommasi, S; Besaratinia, A				Kim, Sang-In; Yoon, Jae-In; Tommasi, Stella; Besaratinia, Ahmad			New experimental data linking secondhand smoke exposure to lung cancer in nonsmokers	FASEB JOURNAL			English	Article						carcinogenesis; mutagenicity; tobacco; TP53 mutations	TOBACCO-SMOKE; DNA-DAMAGE; CIGARETTE-SMOKE; TRANSVERSION MUTATIONS; LABORATORY-ANIMALS; P53 MUTATIONS; GENE; ADDUCTS; TP53; MICE	Secondhand smoke (SHS) exposure is a known risk factor for lung cancer development in lifelong nonsmokers; however, the mechanistic involvement of SHS in the genesis of this malignancy remains elusive. The present study is the first comprehensive investigation of SHS mutagenicity in vivo, in which we have established the mutagenic effects of SHS in transgenic Big Blue mice, and subsequently found correlations between our experimental findings and those obtained from our analysis of the largest database of mutations in human TP53, which is the most frequently mutated gene in human lung cancer. We demonstrate that whole-body SHS exposure of mice for 5 h/d, 5 d/wk for a duration of 2 or 4 mo elicits a significant mutagenic response in the lung, trachea, and bladder of exposed animals, as reflected by the elevation of background cII mutant frequency in the respective organs. The organ-specific mutagenicity of SHS is most pronounced in the lung and remains persistent both in the lung and bladder of SHS-exposed animals after a 1-mo recovery in clean air. The induced cII mutagenesis in the lung of SHS-exposed mice perfectly recapitulates our analysis of the TP53 mutations in human lung cancer in nonsmokers. Remarkably, the relative frequencies of all types of mutations in the TP53 gene of nonsmokers' lung tumors and in the cII transgene of lung cellular DNA from SHS-exposed mice are indistinguishable from one another. We provide the first verification of a mechanistic mode of action for SHS of relevance for carcinogenesis and the first experimental evidence linking SHS exposure to lung cancer in nonsmokers.-Kim, S.-I., Yoon, J.-I., Tommasi, S., Besaratinia, A. New experimental data linking secondhand smoke exposure to lung cancer in nonsmokers. FASEB J. 26, 1845-1854 (2012). www.fasebj.org	[Kim, Sang-In; Yoon, Jae-In; Tommasi, Stella; Besaratinia, Ahmad] City Hope Natl Med Ctr, Beckman Res Inst, Dept Canc Biol, Duarte, CA 91010 USA	City of Hope; Beckman Research Institute of City of Hope	Besaratinia, A (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Dept Canc Biol, 1500 E Duarte Rd, Duarte, CA 91010 USA.	ania@coh.org		Besaratinia, Ahmad/0000-0001-7231-228X; Tommasi, Stella/0000-0001-6897-4985	University of California [18KT-0040]	University of California(University of California System)	The authors thank Dr. Yong Jiang for technical assistance in the conduct of our experiments, Dr. Fong-Fong Chu for help with mouse breeding and colony expansion, Dr. Walter Tsark for helpful discussion on institutional animal care and use committee protocol preparation, and their department chair for general support. Special thanks to the dedicated staff and management of the City of Hope Animal Resources Center, in particular, Armando Amaya, Marie Prez, Lauren Ratcliffe, Yvonne Harper, Donna Isbell, Kenneth Golding, and Dr. Richard Ermel. This study was supported by a grant from the University of California Tobacco Related Disease Research Program (18KT-0040) to A. B. The authors declare no conflicts of interest.	ADAMS JD, 1987, CARCINOGENESIS, V8, P729, DOI 10.1093/carcin/8.5.729; Baylin SB, 2011, NAT REV CANCER, V11, P726, DOI 10.1038/nrc3130; Besaratinia A, 2008, LANCET ONCOL, V9, P657, DOI 10.1016/S1470-2045(08)70172-4; Besaratinia A, 2008, FASEB J, V22, P2379, DOI 10.1096/fj.07-105437; Besaratinia A, 2006, CARCINOGENESIS, V27, P1526, DOI 10.1093/carcin/bgi311; Coggins CRE, 2007, INT J TOXICOL, V26, P331, DOI 10.1080/10915810701490190; De Flora S, 2005, EXP LUNG RES, V31, P19, DOI 10.1080/01902140490494986; DeMarini DM, 2004, MUTAT RES-REV MUTAT, V567, P447, DOI 10.1016/j.mrrev.2004.02.001; Denissenko MF, 1996, SCIENCE, V274, P430, DOI 10.1126/science.274.5286.430; Denissenko MF, 1998, ONCOGENE, V16, P1241, DOI 10.1038/sj.onc.1201647; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Garinis GA, 2008, NAT CELL BIOL, V10, P1241, DOI 10.1038/ncb1108-1241; Guerin M.R., 1992, CHEM ENV TOBACCO SMO; Guo CX, 2009, CELL MOL LIFE SCI, V66, P2363, DOI 10.1007/s00018-009-0024-4; Hecht SS, 2003, NAT REV CANCER, V3, P733, DOI 10.1038/nrc1190; Hecht SS, 2005, CARCINOGENESIS, V26, P1488, DOI 10.1093/carcin/bgi148; Husgafvel-Pursiainen K, 2000, CANCER RES, V60, P2906; International Agency for Research on Cancer, 2004, TOB SMOK INV SMOK, V83; Kim SI, 2011, MUTAT RES-FUND MOL M, V716, P92, DOI 10.1016/j.mrfmmm.2011.08.008; Laird PW, 2010, NAT REV GENET, V11, P191, DOI 10.1038/nrg2732; Lambert LB, 2005, MUTAT RES-REV MUTAT, V590, P1, DOI 10.1016/j.mrrev.2005.04.002; Le Calvez F, 2005, CANCER RES, V65, P5076, DOI 10.1158/0008-5472.CAN-05-0551; MELLON I, 1987, CELL, V51, P241, DOI 10.1016/0092-8674(87)90151-6; [National Research Council Committee on Passive Smoking Board on Environmental Studies and Toxicology], 1986, ENV TOB SMOK MEAS EX, P25; Olivier Magali, 2004, IARC Sci Publ, P247; Olivier M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001008; Petitjean A, 2007, HUM MUTAT, V28, P622, DOI 10.1002/humu.20495; Pfeifer GP, 2009, HUM GENET, V125, P493, DOI 10.1007/s00439-009-0657-2; Pfeifer GP, 2002, ONCOGENE, V21, P7435, DOI 10.1038/sj.onc.1205803; Pfeifer GP, 1999, METHOD ENZYMOL, V304, P548; Sato M, 2007, J THORAC ONCOL, V2, P327, DOI 10.1097/01.JTO.0000263718.69320.4c; Schembri F, 2009, P NATL ACAD SCI USA, V106, P2319, DOI 10.1073/pnas.0806383106; Smith LE, 2000, JNCI-J NATL CANCER I, V92, P803, DOI 10.1093/jnci/92.10.803; Sun S, 2007, NAT REV CANCER, V7, P778, DOI 10.1038/nrc2190; Toyooka S, 2003, HUM MUTAT, V21, P229, DOI 10.1002/humu.10177; U.S. Environmental Protection Agency, 1992, EPA600690006F OFF HL; US Surgeon General, 2006, HLTH CONS INV EXP TO; Witschi Hanspeter, 2003, Methods Mol Med, V74, P441; Wogan GN, 2004, SEMIN CANCER BIOL, V14, P473, DOI 10.1016/j.semcancer.2004.06.010; World Health Organization, 2008, WHO REP GLOB TOB EP; Yoon JI, 2012, CANCER PREV RES, V5, P299, DOI 10.1158/1940-6207.CAPR-11-0309; Yoon JH, 2001, CANCER RES, V61, P7110	43	18	18	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2012	26	5					1845	1854		10.1096/fj.11-199984	http://dx.doi.org/10.1096/fj.11-199984			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	937TD	22318968	Green Submitted			2022-12-25	WOS:000303680800013
J	Caban, K; Copeland, PR				Caban, Kelvin; Copeland, Paul R.			Selenocysteine Insertion Sequence (SECIS)-binding Protein 2 Alters Conformational Dynamics of Residues Involved in tRNA Accommodation in 80 S Ribosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINOACYL-TRANSFER-RNA; SINGLE-NUCLEOTIDE RESOLUTION; ELONGATION-FACTOR SELB; EF-TU; PEPTIDYLTRANSFERASE CENTER; CRYSTAL-STRUCTURE; GTP HYDROLYSIS; L1 STALK; BINDING; TRANSLATION	Sec-tRNA(Sec) is site-specifically delivered at defined UGA codons in selenoprotein mRNAs. This recoding event is specified by the selenocysteine insertion sequence (SECIS) element and requires the selenocysteine (Sec)-specific elongation factor, eEFSec, and the SECIS binding protein, SBP2. Sec-tRNA(Sec) is delivered to the ribosome by eEFSec-GTP, but this ternary complex is not sufficient for Sec incorporation, indicating that its access to the ribosomal A-site is regulated. SBP2 stably associates with ribosomes, and mutagenic analysis indicates that this interaction is essential for Sec incorporation. However, the ribosomal function of SBP2 has not been elucidated. To shed light on the functional relevance of the SBP2-ribosome interaction, we screened the functional centers of the 28 S rRNA in translationally competent 80 S ribosomes using selective 2'-hydroxyl acylation analyzed by primer extension (SHAPE). We demonstrate that SBP2 specifically alters the reactivity of specific residues in Helix 89 (H89) and expansion segment 31 (ES31). These results are indicative of a conformational change in response to SBP2 binding. Based on the known functions of H89 during translation, we propose that SBP2 allows Sec incorporation by either promoting Sec-tRNA(Sec) accommodation into the peptidyltransferase center and/or by stimulating the ribosome-dependent GTPase activity of eEFSec.	[Caban, Kelvin; Copeland, Paul R.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Microbiol Mol Genet & Immunol, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Copeland, PR (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Microbiol Mol Genet & Immunol, 675 Hoes La, Piscataway, NJ 08854 USA.	paul.copeland@umdnj.edu		Copeland, Paul/0000-0003-3343-0587	National Institutes of Health [F31GM081920]; Public Health Service Grants [GM077073, GM094833]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077073, R01GM094833, F31GM081920] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Public Health Service Grants(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Research Service Award F31GM081920 from the National Institutes of Health (to K. C.). This work was also supported by Public Health Service Grants GM077073 and GM094833 (to P. R. C.).	Agirrezabala X, 2009, Q REV BIOPHYS, V42, P159, DOI 10.1017/S0033583509990060; Ben-Shem A, 2010, SCIENCE, V330, P1203, DOI 10.1126/science.1194294; BERRY MJ, 1991, NATURE, V353, P273, DOI 10.1038/353273a0; Budkevich TV, 2008, NUCLEIC ACIDS RES, V36, P4736, DOI 10.1093/nar/gkn424; Burakovskii D E, 2007, Mol Biol (Mosk), V41, P1031; Caban K, 2007, MOL CELL BIOL, V27, P6350, DOI 10.1128/MCB.00632-07; Cannone JJ, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-2; Chandramouli P, 2008, STRUCTURE, V16, P535, DOI 10.1016/j.str.2008.01.007; Chavatte L, 2005, NAT STRUCT MOL BIOL, V12, P408, DOI 10.1038/nsmb922; Copeland PR, 2000, EMBO J, V19, P306, DOI 10.1093/emboj/19.2.306; Copeland PR, 2001, MOL CELL BIOL, V21, P1491, DOI 10.1128/MCB.21.5.1491-1498.2001; Cornish PV, 2009, P NATL ACAD SCI USA, V106, P2571, DOI 10.1073/pnas.0813180106; DELL VA, 1990, BIOCHEMISTRY-US, V29, P1757, DOI 10.1021/bi00459a014; DIAMOND A, 1981, CELL, V25, P497, DOI 10.1016/0092-8674(81)90068-4; Donovan J, 2008, J BIOL CHEM, V283, P35129, DOI 10.1074/jbc.M806008200; Driscoll DM, 2003, ANNU REV NUTR, V23, P17, DOI 10.1146/annurev.nutr.23.011702.073318; Fagegaltier D, 2000, EMBO J, V19, P4796, DOI 10.1093/emboj/19.17.4796; Fahlman RP, 2004, MOL CELL, V16, P799, DOI 10.1016/j.molcel.2004.10.030; Fei JY, 2009, P NATL ACAD SCI USA, V106, P15702, DOI 10.1073/pnas.0908077106; Geggier P, 2010, J MOL BIOL, V399, P576, DOI 10.1016/j.jmb.2010.04.038; Huttenhofer A, 1998, BIOCHEMISTRY-US, V37, P885, DOI 10.1021/bi972298k; Jenner L, 2010, NAT STRUCT MOL BIOL, V17, P1072, DOI 10.1038/nsmb.1880; JUNG JE, 1994, J BIOL CHEM, V269, P29739; Kinzy SA, 2005, NUCLEIC ACIDS RES, V33, P5172, DOI 10.1093/nar/gki826; La Teana A, 2001, RNA, V7, P1173, DOI 10.1017/S1355838201010366; Leibundgut M, 2005, EMBO J, V24, P11, DOI 10.1038/sj.emboj.7600505; Merrick W C, 1979, Methods Enzymol, V60, P101, DOI 10.1016/S0076-6879(79)60010-1; Mortimer SA, 2009, NAT PROTOC, V4, P1413, DOI 10.1038/nprot.2009.126; Myasnikov AG, 2005, NAT STRUCT MOL BIOL, V12, P1145, DOI 10.1038/nsmb1012; Rakauskaite R, 2011, RNA, V17, P855, DOI 10.1261/rna.2593211; Roll-Mecak A, 2000, CELL, V103, P781, DOI 10.1016/S0092-8674(00)00181-1; Sanbonmatsu KY, 2005, P NATL ACAD SCI USA, V102, P15854, DOI 10.1073/pnas.0503456102; Schmeing TM, 2009, SCIENCE, V326, P688, DOI 10.1126/science.1179700; Schuette JC, 2009, EMBO J, V28, P755, DOI 10.1038/emboj.2009.26; Sergiev PV, 2005, J BIOL CHEM, V280, P31882, DOI 10.1074/jbc.M505670200; Tujebajeva RM, 2000, EMBO REP, V1, P158, DOI 10.1093/embo-reports/kvd033; Unbehaun A, 2007, EMBO J, V26, P3109, DOI 10.1038/sj.emboj.7601751; Valle M, 2003, NAT STRUCT BIOL, V10, P899, DOI 10.1038/nsb1003; Voorhees RM, 2010, SCIENCE, V330, P835, DOI 10.1126/science.1194460; Whitford PC, 2010, RNA, V16, P1196, DOI 10.1261/rna.2035410; Wilkinson KA, 2006, NAT PROTOC, V1, P1610, DOI 10.1038/nprot.2006.249; Wilson DN, 2006, CELL MOL LIFE SCI, V63, P2725, DOI 10.1007/s00018-006-6125-4; Yu HJ, 2009, J MOL BIOL, V386, P802, DOI 10.1016/j.jmb.2008.12.071; Zaher HS, 2009, CELL, V136, P746, DOI 10.1016/j.cell.2009.01.036	44	18	18	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					10664	10673		10.1074/jbc.M111.320929	http://dx.doi.org/10.1074/jbc.M111.320929			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22308032	hybrid, Green Published			2022-12-25	WOS:000302167200091
J	Jin, ZN; Leveque, V; Ma, H; Johnson, KA; Klumpp, K				Jin, Zhinan; Leveque, Vincent; Ma, Han; Johnson, Kenneth A.; Klumpp, Klaus			Assembly, Purification, and Pre-steady-state Kinetic Analysis of Active RNA-dependent RNA Polymerase Elongation Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATITIS-C VIRUS; HIV REVERSE-TRANSCRIPTASE; PROTEIN 5B POLYMERASE; DNA-POLYMERASE; DE-NOVO; NONNUCLEOSIDE INHIBITORS; CRYSTAL-STRUCTURE; NS5B POLYMERASE; MECHANISM; SPECIFICITY	NS5B is the RNA-dependent RNA polymerase responsible for replicating hepatitis C virus (HCV) genomic RNA. Despite more than a decade of work, the formation of a highly active NS5B polymerase.RNA complex suitable for mechanistic and structural studies has remained elusive. Here, we report that through a novel way of optimizing initiation conditions, we were able to generate a productive NS5B.primer.template elongation complex stalled after formation of a 9-nucleotide primer. In contrast to previous reports of very low proportions of active NS5B, we observed that under optimized conditions up to 65% of NS5B could be converted into active elongation complexes. The elongation complex was extremely stable, allowing purification away from excess nucleotide and abortive initiation products so that the purified complex was suitable for pre-steady-state kinetic analyses of polymerase activity. Single turnover kinetic studies showed that CTP is incorporated with apparent K-d and k(pol) values of 39 +/- 3 mu M and 16 +/- 1 s(-1), respectively, giving a specificity constant of k(pol)/K-d of 0.41 mu M-1 s(-1). The kinetics of multiple nucleotide incorporation during processive elongation also were determined. This work establishes a novel way to generate a highly active elongation complex of the medically important NS5B polymerase for structural and functional studies.	[Klumpp, Klaus] Hoffmann La Roche Inc, Virol Discovery, Nutley, NJ 07110 USA; [Johnson, Kenneth A.] Univ Texas Austin, Inst Cell & Mol Biol, Austin, TX 78712 USA	Roche Holding; University of Texas System; University of Texas Austin	Klumpp, K (corresponding author), Hoffmann La Roche Inc, Virol Discovery, 340 Kingsland St, Nutley, NJ 07110 USA.	klaus.klumpp@roche.com	jin, zhinan/D-4217-2013		Roche	Roche(Roche Holding)	Supported in part by the Roche Postdoc Fellowship program.	Arnold JJ, 2004, BIOCHEMISTRY-US, V43, P5126, DOI 10.1021/bi035212y; Bellon-Echeverria I, 2010, ANTIVIR RES, V87, P57, DOI 10.1016/j.antiviral.2010.04.009; Biswal BK, 2005, J BIOL CHEM, V280, P18202, DOI 10.1074/jbc.M413410200; Bressanelli S, 1999, P NATL ACAD SCI USA, V96, P13034, DOI 10.1073/pnas.96.23.13034; Carroll SS, 2000, BIOCHEMISTRY-US, V39, P8243, DOI 10.1021/bi991992s; Chinnaswamy S, 2010, J VIROL, V84, P5923, DOI 10.1128/JVI.02446-09; Chinnaswamy S, 2008, J BIOL CHEM, V283, P20535, DOI 10.1074/jbc.M801490200; Cramer J, 2006, BIOCHEMISTRY-US, V45, P3610, DOI 10.1021/bi051483s; Deval J, 2007, ANTIMICROB AGENTS CH, V51, P2920, DOI 10.1128/AAC.00186-07; Dutartre H, 2005, J BIOL CHEM, V280, P6359, DOI 10.1074/jbc.M410191200; Hong Z, 2001, VIROLOGY, V285, P6, DOI 10.1006/viro.2001.0948; Jin ZN, 2011, J BIOL CHEM, V286, P1312, DOI 10.1074/jbc.M110.156737; Jin ZN, 2011, J BIOL CHEM, V286, P2067, DOI 10.1074/jbc.M110.162685; Johnson K. A., 1992, ENZYMES, V20, P1, DOI DOI 10.1016/S1874-6047(08)60019-0; JOHNSON KA, 1993, ANNU REV BIOCHEM, V62, P685, DOI 10.1146/annurev.bi.62.070193.003345; Johnson KA, 2009, ANAL BIOCHEM, V387, P30, DOI 10.1016/j.ab.2008.12.025; Johnson KA, 2009, ANAL BIOCHEM, V387, P20, DOI 10.1016/j.ab.2008.12.024; KATI WM, 1992, J BIOL CHEM, V267, P25988; Kellinger MW, 2010, P NATL ACAD SCI USA, V107, P7734, DOI 10.1073/pnas.0913946107; Labonte P, 2002, J BIOL CHEM, V277, P38838, DOI 10.1074/jbc.M204657200; Lesburg CA, 1999, NAT STRUCT BIOL, V6, P937; Leveque VJP, 2003, J VIROL, V77, P9020, DOI 10.1128/JVI.77.16.9020-9028.2003; Liu YY, 2006, BIOCHEMISTRY-US, V45, P11312, DOI 10.1021/bi060511j; Lohmann V, 1998, VIROLOGY, V249, P108, DOI 10.1006/viro.1998.9311; Maag D, 2001, J BIOL CHEM, V276, P46094, DOI 10.1074/jbc.C100349200; MENDELMAN LV, 1989, J BIOL CHEM, V264, P14415; PATEL SS, 1991, BIOCHEMISTRY-US, V30, P511, DOI 10.1021/bi00216a029; Qin WP, 2002, J BIOL CHEM, V277, P2132, DOI 10.1074/jbc.M106880200; Qin WP, 2001, HEPATOLOGY, V33, P728, DOI 10.1053/jhep.2001.22765; Selisko B, 2006, VIROLOGY, V351, P145, DOI 10.1016/j.virol.2006.03.026; SPENCE RA, 1995, SCIENCE, V267, P988, DOI 10.1126/science.7532321; Tellinghuisen TL, 2011, HEPATITIS C: ANTIVIRAL DRUG DISCOVERY AND DEVELOPMENT, P1; Tomei L, 2000, J GEN VIROL, V81, P759, DOI 10.1099/0022-1317-81-3-759; Tsai YC, 2006, BIOCHEMISTRY-US, V45, P9675, DOI 10.1021/bi060993z; Wang QM, 2002, J VIROL, V76, P3865, DOI 10.1128/JVI.76.8.3865-3872.2002; Zhong WD, 2000, J VIROL, V74, P2017, DOI 10.1128/JVI.74.4.2017-2022.2000; Zhong WD, 2000, J VIROL, V74, P9134, DOI 10.1128/JVI.74.19.9134-9143.2000	37	44	46	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					10674	10683		10.1074/jbc.M111.325530	http://dx.doi.org/10.1074/jbc.M111.325530			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22303022	hybrid, Green Published			2022-12-25	WOS:000302167200092
J	Lorente, E; Garcia, R; Mir, C; Barriga, A; Lemonnier, FA; Ramos, M; Lopez, D				Lorente, Elena; Garcia, Ruth; Mir, Carmen; Barriga, Alejandro; Lemonnier, Francois A.; Ramos, Manuel; Lopez, Daniel			Role of Metalloproteases in Vaccinia Virus Epitope Processing for Transporter Associated with Antigen Processing (TAP)-independent Human Leukocyte Antigen (HLA)-B7 Class I Antigen Presentation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIPEPTIDYL-PEPTIDASE-II; VIRAL-ANTIGEN; MOLECULES; PROTEIN; AMINOPEPTIDASE; DEFICIENT; PATHWAY; CELLS; MICE; IDENTIFICATION	The transporter associated with antigen processing (TAP) translocates the viral proteolytic peptides generated by the proteasome and other proteases in the cytosol to the endoplasmic reticulum lumen. There, they complex with nascent human leukocyte antigen (HLA) class I molecules, which are subsequently recognized by the CD8(+) lymphocyte cellular response. However, individuals with nonfunctional TAP complexes or tumor or infected cells with blocked TAP molecules are able to present HLA class I ligands generated by TAP-independent processing pathways. Herein, using a TAP-independent polyclonal vaccinia virus-polyspecific CD8(+) T cell line, two conserved vaccinia -derived TAP-independent HLA-B*0702 epitopes were identified. The presentation of these epitopes in normal cells occurs via complex antigen-processing pathways involving the proteasome and/or different subsets of metalloproteinases (amino-, carboxy-, and endoproteases), which were blocked in infected cells with specific chemical inhibitors. These data support the hypothesis that the abundant cellular proteolytic systems contribute to the supply of peptides recognized by the antiviral cellular immune response, thereby facilitating immunosurveillance. These data may explain why TAP-deficient individuals live normal life spans without any increased susceptibility to viral infections.	[Lopez, Daniel] Inst Salud Carlos III, Ctr Nacl Microbiol, Unidad Procesamiento Antigen, Majadahonda 28220, Madrid, Spain; [Lemonnier, Francois A.] Inst Pasteur, Dept Immunol, Unite Immunite Cellulaire Antivirale, F-75724 Paris 15, France	Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Lopez, D (corresponding author), Inst Salud Carlos III, Ctr Nacl Microbiol, Unidad Procesamiento Antigen, Majadahonda 28220, Madrid, Spain.	dlopez@isciii.es	Lorente, Elena/B-1219-2019; Ramos, Manuel/F-5076-2016; López, Daniel/I-2632-2014	Lorente, Elena/0000-0002-2246-6851; Ramos, Manuel/0000-0002-0404-7936; López, Daniel/0000-0003-0268-5878; Francois, Lemonnier/0000-0002-6741-2742; Barriga, Alejandro/0000-0001-6357-1917	Foundacion para la Investigacion y Prevencion del SIDA en Espana; Ministerio de Ciencia e Innovacion	Foundacion para la Investigacion y Prevencion del SIDA en Espana; Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	This work was supported by grants provided by Foundacion para la Investigacion y Prevencion del SIDA en Espana and Ministerio de Ciencia e Innovacion.	Alzhanova D, 2009, CELL HOST MICROBE, V6, P433, DOI 10.1016/j.chom.2009.09.013; Barrett A. J., 2004, HDB PROTEOLYTIC ENZY, P231; BROYLES SS, 1986, P NATL ACAD SCI USA, V83, P3141, DOI 10.1073/pnas.83.10.3141; Cerundolo V, 2006, SEMIN IMMUNOL, V18, P330, DOI 10.1016/j.smim.2006.07.006; Del-Val M, 2002, MOL IMMUNOL, V39, P235, DOI 10.1016/S0161-5890(02)00104-9; Deng L, 1998, GENE DEV, V12, P538, DOI 10.1101/gad.12.4.538; FENTEANY G, 1995, SCIENCE, V268, P726, DOI 10.1126/science.7732382; FREED ER, 1972, AM J MED, V52, P411, DOI 10.1016/0002-9343(72)90031-9; Gil-Torregrosa BC, 2000, TRAFFIC, V1, P641, DOI 10.1034/j.1600-0854.2000.010808.x; Gil-Torregrosa BC, 1998, J EXP MED, V188, P1105, DOI 10.1084/jem.188.6.1105; Guil S, 2006, J BIOL CHEM, V281, P39925, DOI 10.1074/jbc.M608522200; HANADA K, 1978, AGR BIOL CHEM TOKYO, V42, P523, DOI 10.1080/00021369.1978.10863014; HENDERSON RA, 1992, SCIENCE, V255, P1264, DOI 10.1126/science.1546329; HOWELL S, 1993, BIOCHEM J, V290, P159, DOI 10.1042/bj2900159; Jensen PE, 2007, NAT IMMUNOL, V8, P1041, DOI 10.1038/ni1516; Jezek Z, 1988, HUMAN MONKEYPOX; Johnstone C, 2008, J GEN VIROL, V89, P2194, DOI 10.1099/vir.0.2008/002485-0; Johnstone C, 2007, TRAFFIC, V8, P1486, DOI 10.1111/j.1600-0854.2007.00635.x; KOZLOWSKI S, 1993, J IMMUNOL, V151, P4033; Larsen Mette Voldby, 2006, Current Immunology Reviews, V2, P233; Lautscham G, 2003, MICROBES INFECT, V5, P291, DOI 10.1016/S1286-4579(03)00031-5; Lautscham G, 2001, J EXP MED, V194, P1053, DOI 10.1084/jem.194.8.1053; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Lopez D, 2000, J IMMUNOL, V164, P5070, DOI 10.4049/jimmunol.164.10.5070; Lopez D, 2001, J IMMUNOL, V167, P4238, DOI 10.4049/jimmunol.167.8.4238; Lopez D, 2011, J BIOL CHEM, V286, P16910, DOI 10.1074/jbc.M111.234658; Lopez D, 2010, J IMMUNOL, V184, P5193, DOI 10.4049/jimmunol.1000050; Lorente E, 2011, J BIOL CHEM, V286, P38054, DOI 10.1074/jbc.M111.281808; MCDONALD JK, 1968, J BIOL CHEM, V243, P2028; Medina F, 2009, J IMMUNOL, V183, P4639, DOI 10.4049/jimmunol.0901356; Meyer VS, 2008, J IMMUNOL, V181, P6371, DOI 10.4049/jimmunol.181.9.6371; MORGAN JR, 1984, J VIROL, V52, P206, DOI 10.1128/JVI.52.1.206-214.1984; Neumeister C, 2001, J GEN VIROL, V82, P441, DOI 10.1099/0022-1317-82-2-441; NUCHTERN JG, 1989, NATURE, V339, P223, DOI 10.1038/339223a0; OMURA S, 1991, J ANTIBIOT, V44, P113, DOI 10.7164/antibiotics.44.113; Oseroff C, 2005, P NATL ACAD SCI USA, V102, P13980, DOI 10.1073/pnas.0506768102; Pasquetto V, 2005, J IMMUNOL, V175, P5504, DOI 10.4049/jimmunol.175.8.5504; RAWLINGS ND, 1995, METHOD ENZYMOL, V248, P183; Rawlings ND, 2010, NUCLEIC ACIDS RES, V38, pD227, DOI 10.1093/nar/gkp971; Reche Pedro A., 2007, V409, P185, DOI 10.1007/978-1-60327-118-9_13; REDFIELD RR, 1987, NEW ENGL J MED, V316, P673, DOI 10.1056/NEJM198703123161106; Rock KL, 2004, NAT IMMUNOL, V5, P670, DOI 10.1038/ni1089; Rohrlich PS, 2003, INT IMMUNOL, V15, P765, DOI 10.1093/intimm/dxg073; Samino Y, 2004, J BIOL CHEM, V279, P1151, DOI 10.1074/jbc.M305343200; Saric T, 2002, NAT IMMUNOL, V3, P1169, DOI 10.1038/ni859; Saveanu L, 2005, NAT IMMUNOL, V6, P689, DOI 10.1038/ni1208; Schomburg L, 2000, EUR J BIOCHEM, V267, P3198, DOI 10.1046/j.1432-1327.2000.01348.x; Seifert U, 2003, NAT IMMUNOL, V4, P375, DOI 10.1038/ni905; Serwold T, 2002, NATURE, V419, P480, DOI 10.1038/nature01074; SHUMAN S, 1987, J BIOL CHEM, V262, P12372; Slee EA, 1996, BIOCHEM J, V315, P21, DOI 10.1042/bj3150021; Stoltze L, 2000, NAT IMMUNOL, V1, P413, DOI 10.1038/80852; Suri A, 2006, EUR J IMMUNOL, V36, P544, DOI 10.1002/eji.200526235; THORNBERRY NA, 1994, METHOD ENZYMOL, V244, P615; Tiwari N, 2007, J IMMUNOL, V178, P7932, DOI 10.4049/jimmunol.178.12.7932; Umezawa H, 1976, Methods Enzymol, V45, P678; VANKAER L, 1992, CELL, V71, P1205, DOI 10.1016/S0092-8674(05)80068-6; WEI ML, 1992, NATURE, V356, P443, DOI 10.1038/356443a0; Weinzierl AO, 2008, EUR J IMMUNOL, V38, P1503, DOI 10.1002/eji.200838136; YEWDELL JW, 1989, SCIENCE, V244, P1072, DOI 10.1126/science.2471266; York IA, 1999, IMMUNOL REV, V172, P49, DOI 10.1111/j.1600-065X.1999.tb01355.x; York IA, 2006, J IMMUNOL, V177, P1434, DOI 10.4049/jimmunol.177.3.1434	63	13	13	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					9990	10000		10.1074/jbc.M111.314856	http://dx.doi.org/10.1074/jbc.M111.314856			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22298786	hybrid, Green Published			2022-12-25	WOS:000302167200031
J	Parameshwaran, D; Crone, NE; Thiagarajan, TC				Parameshwaran, Dhanya; Crone, Nathan E.; Thiagarajan, Tara C.			Coherence Potentials Encode Simple Human Sensorimotor Behavior	PLOS ONE			English	Article							ELECTROCORTICOGRAPHIC SPECTRAL-ANALYSIS; CATS VISUAL-CORTEX; CORTICAL ACTIVITY; NEURONAL AVALANCHES; CELL ASSEMBLIES; PREFRONTAL CORTEX; WORKING-MEMORY; BRAIN; VARIABILITY; SYNCHRONIZATION	Recent work has shown that large amplitude negative periods in the local field potential (nLFPs) are able to spread in saltatory manner across large distances in the cortex without distortion in their temporal structure forming 'coherence potentials'. Here we analysed subdural electrocorticographic (ECoG) signals recorded at 59 sites in the sensorimotor cortex in the left hemisphere of a human subject performing a simple visuomotor task (fist clenching and foot dorsiflexion) to understand how coherence potentials arising in the recordings relate to sensorimotor behavior. In all behaviors we found a particular coherence potential (i.e. a cascade of a particular nLFP wave pattern) arose consistently across all trials with temporal specificity. During contrateral fist clenching, but not the foot dorsiflexion or ipsilateral fist clenching, the coherence potential most frequently originated in the hand representation area in the somatosensory cortex during the anticipation and planning periods of the trial, moving to other regions during the actual motor behavior. While these 'expert' sites participated more consistently, other sites participated only a small fraction of the time. Furthermore, the timing of the coherence potential at the hand representation area after onset of the cue predicted the timing of motor behavior. We present the hypothesis that coherence potentials encode information relevant for behavior and are generated by the 'expert' sites that subsequently broadcast to other sites as a means of 'sharing knowledge'.	[Parameshwaran, Dhanya; Thiagarajan, Tara C.] TIFR, Natl Ctr Biol Sci, Bangalore, Karnataka, India; [Crone, Nathan E.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA	Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); Johns Hopkins University	Parameshwaran, D (corresponding author), TIFR, Natl Ctr Biol Sci, Bangalore, Karnataka, India.	tara@ncbs.res.in			National Center for Biological Sciences/Tata Institute of Fundamental Research, India; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040596] Funding Source: NIH RePORTER	National Center for Biological Sciences/Tata Institute of Fundamental Research, India; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	National Center for Biological Sciences/Tata Institute of Fundamental Research, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allman BL, 2007, J NEUROPHYSIOL, V98, P545, DOI 10.1152/jn.00173.2007; Arieli A, 1996, SCIENCE, V273, P1868, DOI 10.1126/science.273.5283.1868; Baars BJ, 2003, TRENDS NEUROSCI, V26, P671, DOI 10.1016/j.tins.2003.09.015; Beggs JM, 2003, J NEUROSCI, V23, P11167; BRUGGE JF, 1973, J NEUROPHYSIOL, V36, P1138, DOI 10.1152/jn.1973.36.6.1138; Buzsaki G, 2010, NEURON, V68, P362, DOI 10.1016/j.neuron.2010.09.023; Churchland MM, 2010, NAT NEUROSCI, V13, P369, DOI 10.1038/nn.2501; Crone NE, 1998, BRAIN, V121, P2271, DOI 10.1093/brain/121.12.2271; Crone NE, 1998, BRAIN, V121, P2301, DOI 10.1093/brain/121.12.2301; EICHENBAUM H, 1993, SCIENCE, V261, P993, DOI 10.1126/science.8351525; Eimer M, 2002, J COGNITIVE NEUROSCI, V14, P254, DOI 10.1162/089892902317236885; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Friston KJ, 2010, NAT REV NEUROSCI, V11, P127, DOI 10.1038/nrn2787; Fuster JM, 2000, NATURE, V405, P347, DOI 10.1038/35012613; Gerhard F, 2011, FRONT COMPUT NEUROSC, V5, P1, DOI [10.3389/fncom.2011.00004, 10.3389/fncom.2011.00023]; Ghazanfar AA, 2006, TRENDS COGN SCI, V10, P278, DOI 10.1016/j.tics.2006.04.008; GILBERT CD, 1979, NATURE, V280, P120, DOI 10.1038/280120a0; Gur M, 1997, J NEUROSCI, V17, P2914; Hebb DO, 1993, ORG BEHAV NEUROPSYCH; HIRSCH JA, 1991, J NEUROSCI, V11, P1800; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Izhikevich EM, 2006, NEURAL COMPUT, V18, P245, DOI 10.1162/089976606775093882; Komiyama T, 2010, NATURE, V464, P1182, DOI 10.1038/nature08897; LASHLEY KS, 1929, MECH INTELLIGENCE QU; LESSER RP, 1987, J CLIN NEUROPHYSIOL, V4, P27, DOI 10.1097/00004691-198701000-00003; McAdams CJ, 1999, NEURON, V23, P765, DOI 10.1016/S0896-6273(01)80034-9; Miller KJ, 2010, P NATL ACAD SCI USA, V107, P4430, DOI 10.1073/pnas.0913697107; Pareti G, 2004, NEUROL SCI, V25, P41, DOI 10.1007/s10072-004-0235-2; Pesaran B, 2002, NAT NEUROSCI, V5, P805, DOI 10.1038/nn890; Petermann T, 2009, P NATL ACAD SCI USA, V106, P15921, DOI 10.1073/pnas.0904089106; Pillow JW, 2008, NATURE, V454, P995, DOI 10.1038/nature07140; Plenz D, 2007, TRENDS NEUROSCI, V30, P101, DOI 10.1016/j.tins.2007.01.005; Prut Y, 1998, J NEUROPHYSIOL, V79, P2857, DOI 10.1152/jn.1998.79.6.2857; Quiroga RQ, 2005, NATURE, V435, P1102, DOI 10.1038/nature03687; Rao SC, 1997, SCIENCE, V276, P821, DOI 10.1126/science.276.5313.821; Rizzolatti G, 2001, NEURON, V31, P889, DOI 10.1016/S0896-6273(01)00423-8; Sakurai Y, 2006, J NEUROSCI, V26, P10141, DOI 10.1523/JNEUROSCI.2423-06.2006; Scaglione A, 2011, P NATL ACAD SCI USA, V108, P14956, DOI 10.1073/pnas.1103168108; Schall JD, 2001, NAT REV NEUROSCI, V2, P33, DOI 10.1038/35049054; Shadlen Michael N., 1994, Current Opinion in Neurobiology, V4, P569, DOI 10.1016/0959-4388(94)90059-0; Stein BE, 2008, NAT REV NEUROSCI, V9, P255, DOI 10.1038/nrn2331; Stettler DD, 2009, NEURON, V63, P854, DOI 10.1016/j.neuron.2009.09.005; Thiagarajan TC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000278; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Yu J, NEURON, V68, P1187; Yu S, 2011, J NEUROSCI, V31, P17514, DOI 10.1523/JNEUROSCI.3127-11.2011	46	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2012	7	2							e30514	10.1371/journal.pone.0030514	http://dx.doi.org/10.1371/journal.pone.0030514			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LO	22319572	Green Published, gold, Green Submitted			2022-12-25	WOS:000302178400009
J	Montecinos, VP; Godoy, A; Hinklin, J; Vethanayagam, RR; Smith, GJ				Montecinos, Viviana P.; Godoy, Alejandro; Hinklin, Jennifer; Vethanayagam, R. Robert; Smith, Gary J.			Primary Xenografts of Human Prostate Tissue as a Model to Study Angiogenesis Induced by Reactive Stroma	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; RAT VENTRAL PROSTATE; BLOOD-VESSELS; IN-VIVO; RADICAL PROSTATECTOMY; ANDROGEN DEPRIVATION; CANCER PROGRESSION; CELL PROLIFERATION; TUMOR ANGIOGENESIS; VEGF	Characterization of the mechanism(s) of androgen-driven human angiogenesis could have significant implications for modeling new forms of anti-angiogenic therapies for CaP and for developing targeted adjuvant therapies to improve efficacy of androgen-deprivation therapy. However, models of angiogenesis by human endothelial cells localized within an intact human prostate tissue architecture are until now extremely limited. This report characterizes the burst of angiogenesis by endogenous human blood vessels in primary xenografts of fresh surgical specimens of benign prostate or prostate cancer (CaP) tissue that occurs between Days 6-14 after transplantation into SCID mice pre-implanted with testosterone pellets. The wave of human angiogenesis was preceded by androgen-mediated up-regulation of VEGF-A expression in the stromal compartment. The neo-vessel network anastomosed to the host mouse vascular system between Days 6-10 post-transplantation, the angiogenic response ceased by Day 15, and by Day 30 the vasculature had matured and stabilized, as indicated by a lack of leakage of serum components into the interstitial tissue space and by association of nascent endothelial cells with mural cells/pericytes. The angiogenic wave was concurrent with the appearance of a reactive stroma phenotype, as determined by staining for alpha-SMA, Vimentin, Tenascin, Calponin, Desmin and Masson's trichrome, but the reactive stroma phenotype appeared to be largely independent of androgen availability. Transplantation-induced angiogenesis by endogenous human endothelial cells present in primary xenografts of benign and malignant human prostate tissue was preceded by induction of androgen-driven expression of VEGF by the prostate stroma, and was concurrent with and the appearance of a reactive stroma phenotype. Androgen-modulated expression of VEGF-A appeared to be a causal regulator of angiogenesis, and possibly of stromal activation, in human prostate xenografts.	[Montecinos, Viviana P.; Godoy, Alejandro; Hinklin, Jennifer; Vethanayagam, R. Robert; Smith, Gary J.] Roswell Pk Canc Inst, Dept Urol, Buffalo, NY 14263 USA; [Vethanayagam, R. Robert] Roswell Pk Canc Inst, Dept Med, Buffalo, NY 14263 USA; [Montecinos, Viviana P.] Pontificia Univ Catolica Chile, Fac Med, Dept Hematol Oncol, Santiago, Chile	Roswell Park Cancer Institute; Roswell Park Cancer Institute; Pontificia Universidad Catolica de Chile	Montecinos, VP (corresponding author), Roswell Pk Canc Inst, Dept Urol, Buffalo, NY 14263 USA.	gary.smith@roswellpark.org	Godoy, Alejandro/GPS-4942-2022		National Institutes of Health [PO1-CA-77739]; Department of Defense [W81XWH-08-1-0299, W81XWH-08-1-0330, W81XWH-04-1-0264]; National Cancer Institute Cancer Center [CA-016156]; NATIONAL CANCER INSTITUTE [P01CA077739] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); National Cancer Institute Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grant PO1-CA-77739 (G. J. Smith), Department of Defense Grants W81XWH-08-1-0299 (V. P. Montecinos), W81XWH-08-1-0330 (A. Godoy), and W81XWH-04-1-0264 (G. J. Smith), and, in part, by the National Cancer Institute Cancer Center Support Grant CA-016156 to the Roswell Park Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad SA, 2002, SEMIN CANCER BIOL, V12, P105, DOI 10.1006/scbi.2001.0418; Alonzi R, 2011, INT J RADIAT ONCOL, V80, P721, DOI 10.1016/j.ijrobp.2010.02.060; Asahara T, 1999, EMBO J, V18, P3964, DOI 10.1093/emboj/18.14.3964; Ayala G, 2003, CLIN CANCER RES, V9, P4792; Basanta D, 2009, CANCER RES, V69, P7111, DOI 10.1158/0008-5472.CAN-08-3957; Benjamin LE, 1997, P NATL ACAD SCI USA, V94, P8761, DOI 10.1073/pnas.94.16.8761; Benjamin LE, 1999, J CLIN INVEST, V103, P159, DOI 10.1172/JCI5028; Bergers G, 2003, J CLIN INVEST, V111, P1287, DOI 10.1172/JCI200317929; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Bettencourt MC, 1998, J UROLOGY, V160, P459, DOI 10.1016/S0022-5347(01)62925-2; Blouw B, 2003, CANCER CELL, V4, P133, DOI 10.1016/S1535-6108(03)00194-6; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Cascone T, 2011, J CLIN INVEST, V121, P1313, DOI 10.1172/JCI42405; Chang HY, 2004, PLOS BIOL, V2, P206, DOI 10.1371/journal.pbio.0020007; Dvorak HF, 2003, AM J PATHOL, V162, P1747, DOI 10.1016/S0002-9440(10)64309-X; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; Ebos JML, 2011, NAT REV CLIN ONCOL, V8, P316, DOI 10.1038/nrclinonc.2011.74; Ellis LM, 2008, NAT REV CANCER, V8, P579, DOI 10.1038/nrc2403; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Francia G, 2009, CANCER CELL, V15, P3, DOI 10.1016/j.ccr.2008.12.011; Garber K, 2009, J NATL CANCER I, V101, P6, DOI 10.1093/jnci/djn481; Godoy A, 2008, ENDOCRINOLOGY, V149, P2959, DOI 10.1210/en.2007-1078; Godoy A, 2011, AM J PHYSIOL-ENDOC M, V300, pE263, DOI 10.1152/ajpendo.00210.2010; Gray DR, 2004, CANCER RES, V64, P1712, DOI 10.1158/0008-5472.CAN-03-2700; Greenberg JI, 2008, NATURE, V456, P809, DOI 10.1038/nature07424; Grunewald M, 2006, CELL, V124, P175, DOI 10.1016/j.cell.2005.10.036; Haggstrom S, 1998, PROSTATE, V36, P71; Haggstrom S, 1999, J UROLOGY, V161, P1620, DOI 10.1016/S0022-5347(05)68994-X; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Hellstrom M, 2001, J CELL BIOL, V153, P543, DOI 10.1083/jcb.153.3.543; Inai T, 2004, AM J PATHOL, V165, P35, DOI 10.1016/S0002-9440(10)63273-7; Jain RK, 1998, P NATL ACAD SCI USA, V95, P10820, DOI 10.1073/pnas.95.18.10820; Joseph IBJK, 1997, CANCER RES, V57, P1054; Kravchick S, 2009, UROLOGY, V73, P1274, DOI 10.1016/j.urology.2008.08.461; Lee S, 2007, CELL, V130, P691, DOI 10.1016/j.cell.2007.06.054; Lissbrant IF, 2004, PROSTATE, V58, P57, DOI 10.1002/pros.10312; Lissbrant IF, 2003, BIOL REPROD, V68, P1107, DOI 10.1095/biolreprod.102.008284; Lissbrant IF, 1997, PROSTATE, V33, P38; Lissbrant IF, 2001, SCAND J UROL NEPHROL, V35, P437; Mancuso MR, 2006, J CLIN INVEST, V116, P2610, DOI 10.1172/JCI24612; Morrison C, 2009, PROSTATE, V69, P770, DOI 10.1002/pros.20925; Nicholson B, 2004, J CELL BIOCHEM, V91, P125, DOI 10.1002/jcb.10772; Nissen NN, 1998, AM J PATHOL, V152, P1445; Olumi AF, 1999, CANCER RES, V59, P5002; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Pettersson A, 2000, LAB INVEST, V80, P99, DOI 10.1038/labinvest.3780013; Phung TL, 2007, CANCER RES, V67, P5070, DOI 10.1158/0008-5472.CAN-06-3341; Pietras K, 2005, J CLIN ONCOL, V23, P939, DOI 10.1200/JCO.2005.07.093; Pinto MP, 2010, CANCER RES, V70, P2655, DOI 10.1158/0008-5472.CAN-09-4373; Presnell SC, 2001, AM J PATHOL, V159, P855, DOI 10.1016/S0002-9440(10)61761-0; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; Reinders MEJ, 2003, TRANSPLANTATION, V76, P224, DOI 10.1097/01.TP.0000071363.55007.D0; Reinders MEJ, 2003, J CLIN INVEST, V112, P1655, DOI 10.1172/JCI200317712; Shabsigh A, 1998, PROSTATE, V36, P201, DOI 10.1002/(SICI)1097-0045(19980801)36:3<201::AID-PROS9>3.0.CO;2-J; Sordello S, 1998, BIOCHEM BIOPH RES CO, V251, P287, DOI 10.1006/bbrc.1998.9328; Sun JZ, 2005, ONCOGENE, V24, P4701, DOI 10.1038/sj.onc.1208391; Sundberg C, 2001, AM J PATHOL, V158, P1145, DOI 10.1016/S0002-9440(10)64062-X; Thurston G, 1996, AM J PHYSIOL-HEART C, V271, pH2547, DOI 10.1152/ajpheart.1996.271.6.H2547; Torry RJ, 1995, TRANSPLANTATION, V60, P1451, DOI 10.1097/00007890-199560120-00014; Tuxhorn JA, 2002, CLIN CANCER RES, V8, P2912; Tuxhorn JA, 2001, J UROLOGY, V166, P2472, DOI 10.1016/S0022-5347(05)65620-0; Vartanian RK, 1995, LAB INVEST, V73, P844; WEIDNER N, 1993, AM J PATHOL, V143, P401; Weinberg RA, 2007, BIOL CANC, P527	64	24	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2012	7	1							e29623	10.1371/journal.pone.0029623	http://dx.doi.org/10.1371/journal.pone.0029623			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	912BY	22303438	Green Published, gold, Green Submitted			2022-12-25	WOS:000301770700005
J	Westin, K; Buchhave, P; Nielsen, H; Minthon, L; Janciauskiene, S; Hansson, O				Westin, Karin; Buchhave, Peder; Nielsen, Henrietta; Minthon, Lennart; Janciauskiene, Sabina; Hansson, Oskar			CCL2 Is Associated with a Faster Rate of Cognitive Decline during Early Stages of Alzheimer's Disease	PLOS ONE			English	Article							CEREBROSPINAL-FLUID; CSF BIOMARKERS; INFLAMMATION; MICROGLIA; LIPOPOLYSACCHARIDE; PROGRESSION; IMPAIRMENT; MODEL	Chemokine (C-C motif) receptor 2 (CCR2)-signaling can mediate accumulation of microglia at sites affected by neuroinflammation. CCR2 and its main ligand CCL2 (MCP-1) might also be involved in the altered metabolism of beta-amyloid (A beta) underlying Alzheimer's disease (AD). We therefore measured the levels of CCL2 and three other CCR2 ligands, i.e. CCL11 (eotaxin), CCL13 (MCP-4) and CCL26 (eotaxin-3), in the cerebrospinal fluid (CSF) and plasma of 30 controls and 119 patients with mild cognitive impairment (MCI) at baseline. During clinical follow-up 52 MCI patients were clinically stable for five years, 47 developed AD (i.e. cases with prodromal AD at baseline) and 20 developed other dementias. Only CSF CCL26 was statistically significantly elevated in patients with prodromal AD when compared to controls (p = 0.002). However, in patients with prodromal AD, the CCL2 levels in CSF at baseline correlated with a faster cognitive decline during follow-up (r(s) = 0.42, p = 0.004). Furthermore, prodromal AD patients in the highest tertile of CSF CCL2 exhibited a significantly faster cognitive decline (p<0.001) and developed AD dementia within a shorter time period (p<0.003) compared to those in the lowest tertile. Finally, in the entire MCI cohort, CSF CCL2 could be combined with CSF Tau, P-tau and A beta 42 to predict both future conversion to AD and the rate of cognitive decline. If these results are corroborated in future studies, CCL2 in CSF could be a candidate biomarker for prediction of future disease progression rate in prodromal AD. Moreover, CCR2-related signaling pathways might be new therapeutic targets for therapies aiming at slowing down the disease progression rate of AD.	[Westin, Karin; Buchhave, Peder; Nielsen, Henrietta; Minthon, Lennart; Hansson, Oskar] Lund Univ, Dept Clin Sci Malmo, Clin Memory Res Unit, Malmo, Sweden; [Westin, Karin; Buchhave, Peder; Minthon, Lennart; Hansson, Oskar] Skane Univ Hosp, Neuropsychiat Clin, Malmo, Sweden; [Nielsen, Henrietta] Lund Univ, Skane Univ Hosp, Dept Clin Sci Malmo, Mol Memory Res Unit, Malmo, Sweden; [Janciauskiene, Sabina] Hannover Med Sch, D-3000 Hannover, Germany	Lund University; Lund University; Skane University Hospital; Lund University; Skane University Hospital; Hannover Medical School	Westin, K (corresponding author), Lund Univ, Dept Clin Sci Malmo, Clin Memory Res Unit, Malmo, Sweden.	oskar.hansson@med.lu.se	Hansson, Oskar/A-7134-2013; Nielsen, Henrietta M/B-1746-2013	Hansson, Oskar/0000-0001-8467-7286; Westin, Karin/0000-0003-4497-7596; Nielsen, Henrietta M/0000-0001-9664-7068	Swedish Research Council; Swedish Brain Power; Skane County Council's Research and Development Foundation; Swedish Alzheimer Foundation; Swedish Foundations of the National Board of Health and Welfare; Torsten and Ragnar Soderberg Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Brain Power; Skane County Council's Research and Development Foundation; Swedish Alzheimer Foundation; Swedish Foundations of the National Board of Health and Welfare; Torsten and Ragnar Soderberg Foundation	This work was supported by the Swedish Research Council, the Swedish Brain Power, Skane County Council's Research and Development Foundation, The Swedish Alzheimer Foundation. The Swedish Foundations of the National Board of Health and Welfare, and the Torsten and Ragnar Soderberg Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	A Schuitemaker, 2010, NEUROBIOL AGING; Association AP, 1987, DIAGN STAT MAN MENT; Barrientos RM, 2010, AGING DIS, V1, P212; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; Blennow K, 2010, NAT REV NEUROL, V6, P131, DOI 10.1038/nrneurol.2010.4; Cameron B, 2010, NEUROBIOL DIS, V37, P503, DOI 10.1016/j.nbd.2009.10.006; El Khoury J, 2008, TRENDS PHARMACOL SCI, V29, P626, DOI 10.1016/j.tips.2008.08.004; Galimbert D, 2003, ANN NEUROL, V53, P547, DOI 10.1002/ana.10531; Hansson O, 2006, LANCET NEUROL, V5, P228, DOI 10.1016/S1474-4422(06)70355-6; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Herrup K, 2010, J NEUROSCI, V30, P16755, DOI 10.1523/JNEUROSCI.4521-10.2010; Holmes C, 2009, NEUROLOGY, V73, P768, DOI 10.1212/WNL.0b013e3181b6bb95; Kitazawa M, 2005, J NEUROSCI, V25, P8843, DOI 10.1523/JNEUROSCI.2868-05.2005; Kiyota T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006197; Maezawa I, 2011, J BIOL CHEM, V286, P3693, DOI 10.1074/jbc.M110.135244; Mattsson N, 2009, JAMA-J AM MED ASSOC, V302, P385, DOI 10.1001/jama.2009.1064; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Perry VH, 2010, NAT REV NEUROL, V6, P193, DOI 10.1038/nrneurol.2010.17; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Shaw LM, 2009, ANN NEUROL, V65, P403, DOI 10.1002/ana.21610; Sly LM, 2001, BRAIN RES BULL, V56, P581, DOI 10.1016/S0361-9230(01)00730-4; Sokolova A, 2009, BRAIN PATHOL, V19, P392, DOI 10.1111/j.1750-3639.2008.00188.x; Struthers M, 2010, CURR TOP MED CHEM, V10, P1278, DOI 10.2174/156802610791561255; Yamamoto M, 2005, AM J PATHOL, V166, P1475, DOI 10.1016/S0002-9440(10)62364-4	24	177	182	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2012	7	1							e30525	10.1371/journal.pone.0030525	http://dx.doi.org/10.1371/journal.pone.0030525			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	912BU	22303443	Green Published, Green Submitted, gold			2022-12-25	WOS:000301770300002
J	Anteau, MJ; Sherfy, MH; Wiltermuth, MT				Anteau, Michael J.; Sherfy, Mark H.; Wiltermuth, Mark T.			Selection Indicates Preference in Diverse Habitats: A Ground-Nesting Bird (Charadrius melodus) Using Reservoir Shoreline	PLOS ONE			English	Article							PIPING PLOVER; SITE SELECTION; SPRING MIGRATION; UPPER-MIDWEST; NORTH-DAKOTA; LESSER SCAUP; PREDATION; SURVIVAL; SUCCESS; TRAPS	Animals use proximate cues to select resources that maximize individual fitness. When animals have a diverse array of available habitats, those selected could give insights into true habitat preferences. Since the construction of the Garrison Dam on the Missouri River in North Dakota, Lake Sakakawea (SAK) has become an important breeding area for federally threatened piping plovers (Charadrius melodus; hereafter plovers). We used conditional logistic regression to examine nest-site selection at fine scales (1, 3, and 10 m) during summers 2006-2009 by comparing characteristics at 351 nests to those of 668 random sites within nesting territories. Plovers selected sites (1 m(2)) that were lower than unused random sites, increasing the risk of nest inundation. Plovers selected nest sites that were flat, had little silt, and at least 1 cobble; they also selected for 3-m radius nest areas that were relatively flat and devoid of vegetation and litter. Ninety percent of nests had <38% coverage of silt and <10% slope at the site, and <15% coverage of vegetation or litter and <31% slope within the 3-m radius. Gravel was selected for at nest sites (11% median), but against in the area 10-m from the nest, suggesting plovers select for patches or strips of gravel. Although elevation is rarely evaluated in studies of ground-nesting birds, our results underscore its importance in habitat-selection studies. Relative to where plovers historically nested, habitat at SAK has more diverse topography, substrate composition, vegetation communities, and greater water-level fluctuations. Accordingly, our results provide an example of how habitat-selection results can be interpreted as habitat preferences because they are not influenced by desired habitats being scarce or absent. Further, our results will be useful for directing habitat conservation for plovers and interpreting other habitat-selection studies.	[Anteau, Michael J.; Sherfy, Mark H.; Wiltermuth, Mark T.] US Geol Survey, No Prairie Wildlife Res Ctr, Jamestown, ND USA	United States Department of the Interior; United States Geological Survey	Anteau, MJ (corresponding author), US Geol Survey, No Prairie Wildlife Res Ctr, Jamestown, ND USA.	manteau@usgs.gov		Wiltermuth, Mark/0000-0002-8871-2816; Anteau, Michael/0000-0002-5173-5870	U.S. Army Corps of Engineers' Missouri River Recovery Program; Corps' Omaha District Threatened and Endangered Species Section; Garrison Project Office	U.S. Army Corps of Engineers' Missouri River Recovery Program; Corps' Omaha District Threatened and Endangered Species Section; Garrison Project Office	This study was funded by the U.S. Army Corps of Engineers' Missouri River Recovery Program through financial and logistical support from the Corps' Omaha District Threatened and Endangered Species Section and Garrison Project Office. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anteau MJ, 2008, WATERBIRDS, V31, P97, DOI 10.1675/1524-4695(2008)31[97:DOLSDS]2.0.CO;2; Anteau MJ, 2010, WETLANDS, V30, P757, DOI 10.1007/s13157-010-0066-2; Anteau MJ, 2009, WETLANDS, V29, P704, DOI 10.1672/08-157.1; Anteau MJ, 2011, NEST SURVIVAL GROUND; BURGER J, 1987, CONDOR, V89, P811, DOI 10.2307/1368529; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Callicutt JT, 2011, J FISH WILDL MANAG, V2, P29, DOI 10.3996/102010-JFWM-038; CHESSON J, 1978, ECOLOGY, V59, P211, DOI 10.2307/1936364; Clark RG, 1999, ECOLOGY, V80, P272, DOI 10.1890/0012-9658(1999)080[0272:AHSPFP]2.0.CO;2; Cohen JB, 2008, WILSON J ORNITHOL, V120, P404, DOI 10.1676/06-169.1; Elliott-Smith E., 2009, DATA SERIES S GEOLOG, V426, DOI [10.3133/ds426, DOI 10.3133/DS426]; Elliott-Smith E., 2004, BIRDS N AM ONLINE; Espie RHM, 1996, CAN J ZOOL, V74, P1069, DOI 10.1139/z96-118; FLEMMING SP, 1992, J WILDLIFE MANAGE, V56, P578, DOI 10.2307/3808875; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; GAINES EP, 1988, J WILDLIFE MANAGE, V52, P266, DOI 10.2307/3801233; Ganier A. F., 1930, Wilson Bulletin, V42, P103; HAYS H, 1971, WILSON BULL, V83, P425; Huhta E, 1996, ECOGRAPHY, V19, P85, DOI 10.1111/j.1600-0587.1996.tb00158.x; JOHNSON DH, 1980, ECOLOGY, V61, P65, DOI 10.2307/1937156; Jones J, 2001, AUK, V118, P557, DOI 10.1642/0004-8038(2001)118[0557:HSSIAE]2.0.CO;2; Jones L.K., 1997, PIPING PLOVER HABITA; Knetter JM, 2002, WILDLIFE SOC B, V30, P683; Long RA, 2009, J WILDLIFE MANAGE, V73, P294, DOI 10.2193/2008-052; Marcus JF, 2007, WATERBIRDS, V30, P251, DOI 10.1675/1524-4695(2007)30[251:DNSSOL]2.0.CO;2; Martin TE, 1998, ECOLOGY, V79, P656, DOI 10.1890/0012-9658(1998)079[0656:AMPOCS]2.0.CO;2; MELVIN SM, 1992, WILDLIFE SOC B, V20, P143; MONTEVECCHI WA, 1978, BEHAV ECOL SOCIOBIOL, V4, P143, DOI 10.1007/BF00354977; Murphy RK, 2001, WILSON BULL, V113, P331, DOI 10.1676/0043-5643(2001)113[0331:RASOPP]2.0.CO;2; National Geodetic Survey, 2010, ONL POS US SERV; Palacios E, 1996, J FIELD ORNITHOL, V67, P48; PURDUE JR, 1976, CONDOR, V78, P180, DOI 10.2307/1366853; Robertson BA, 2006, ECOLOGY, V87, P1075, DOI 10.1890/0012-9658(2006)87[1075:AFFUET]2.0.CO;2; SAS Institute, 2002, SAS STAT US GUID VER, VSixth; Shaffer TL, 2004, AUK, V121, P526, DOI 10.1642/0004-8038(2004)121[0526:AUATAN]2.0.CO;2; Sherfy MH, 2009, MISSOURI RIVER EMERG, V2008-1223, P51; Sherfy MH, 2012, J WILDLIFE IN PRESS; Sovada MA, 2000, J WILDLIFE MANAGE, V64, P820, DOI 10.2307/3802752; Thompson B.C., 1982, Colonial Waterbirds, V5, P161, DOI 10.2307/1521048; Thompson W.L., 1998, MONITORING VERTEBRAT; U.S. Army Corps of Engineers, 2010, MONTHL RES SUMM; U. S. Fish and Wildlife Service, 2003, US FISH WILDL SERV 2; U.S. Fish and Wildlife Service, 2000, US FISH WILDL SERV B; Whittingham MJ, 2002, J AVIAN BIOL, V33, P184, DOI 10.1034/j.1600-048X.2002.330210.x; Wiltermuth MT, 2009, CONDOR, V111, P550, DOI 10.1525/cond.2009.080106; [No title captured]	46	26	27	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2012	7	1							e30347	10.1371/journal.pone.0030347	http://dx.doi.org/10.1371/journal.pone.0030347			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911GB	22299037	Green Published, gold, Green Submitted			2022-12-25	WOS:000301704200014
J	Shen, L; Ciesielski, M; Ramakrishnan, S; Miles, KM; Ellis, L; Sotomayor, P; Shrikant, P; Fenstermaker, R; Pili, R				Shen, Li; Ciesielski, Michael; Ramakrishnan, Swathi; Miles, Kiersten M.; Ellis, Leigh; Sotomayor, Paula; Shrikant, Protul; Fenstermaker, Robert; Pili, Roberto			Class I Histone Deacetylase Inhibitor Entinostat Suppresses Regulatory T Cells and Enhances Immunotherapies in Renal and Prostate Cancer Models	PLOS ONE			English	Article							PERIPHERAL-BLOOD; DNA-BINDING; ANTITUMOR IMMUNITY; INTERLEUKIN-2; TUMOR; ACTIVATION; ACETYLATION; EXPRESSION; MS-275; GENE	Background: Immunosuppressive factors such as regulatory T cells (Tregs) limit the efficacy of immunotherapies. Histone deacetylase (HDAC) inhibitors have been reported to have antitumor activity in different malignancies and immunomodulatory effects. Herein, we report the Tregs-targeting and immune-promoting effect of a class I specific HDAC inhibitor, entinostat, in combination with either IL-2 in a murine renal cell carcinoma (RENCA) model or a survivin-based vaccine therapy (SurVaxM) in a castration resistant prostate cancer (CR Myc-CaP) model. Methods and Results: RENCA or CR Myc-CaP tumors were implanted orthotopically or subcutaneously, respectively. Inoculated mice were randomized into four treatment groups: vehicle, entinostat, cytokine or vaccine, and combination. Tregs in the blood were assessed by FACS analysis. Real time quantitative PCR and Western blot analysis of isolated T cell subpopulations from spleen were performed to determine Foxp3 gene and protein expression. The suppressive function of Tregs was tested by T cell proliferation assay. Low dose (5 mg/kg) entinostat reduced Foxp3 levels in Tregs and this was associated with enhanced tumor growth inhibition in combination with either IL-2 or a SurVaxM vaccine. Entinostat down-regulated Foxp3 expression transcriptionally and blocked Tregs suppressive function without affecting T effector cells (Teffs). In vitro low dose entinostat (0.5 mu M) induced STAT3 acetylation and a specific inhibitor of STAT3 partially rescued entinostat-induced down-regulation of Foxp3, suggesting that STAT3 signaling is involved in Foxp3 down-regulation by entinostat. Conclusions: These results demonstrate a novel immunomodulatory effect of class I HDAC inhibition and provide a rationale for the clinical testing of entinostat to enhance cancer immunotherapy.	[Shen, Li; Ramakrishnan, Swathi; Miles, Kiersten M.; Ellis, Leigh; Sotomayor, Paula; Pili, Roberto] Roswell Pk Canc Inst, Dept Med, Buffalo, NY 14263 USA; [Ciesielski, Michael; Fenstermaker, Robert] Roswell Pk Canc Inst, Dept Neurooncol, Buffalo, NY 14263 USA; [Shrikant, Protul] Roswell Pk Canc Inst, Dept Immunol, Buffalo, NY 14263 USA	Roswell Park Cancer Institute; Roswell Park Cancer Institute; Roswell Park Cancer Institute	Shen, L (corresponding author), Roswell Pk Canc Inst, Dept Med, Buffalo, NY 14263 USA.	Roberto.Pili@RoswellPark.org	Ramakrishnan, Swathi/O-5054-2019		National Cancer Institute [23 R21CA137649]; NATIONAL CANCER INSTITUTE [R21CA137649] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported in part by a research grant by the National Cancer Institute-23 R21CA137649. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS JS, 1990, J NATL CANCER I, V82, P1202, DOI 10.1093/jnci/82.14.1202; Ahmadzadeh M, 2006, BLOOD, V107, P2409, DOI 10.1182/blood-2005-06-2399; Antony PA, 2002, J IMMUNOTHER, V25, P202, DOI 10.1097/00002371-200205000-00002; Barnett B, 2005, AM J REPROD IMMUNOL, V54, P369, DOI 10.1111/j.1600-0897.2005.00330.x; Brogdon JL, 2007, BLOOD, V109, P1123, DOI 10.1182/blood-2006-04-019711; Cesana GC, 2006, J CLIN ONCOL, V24, P1169, DOI 10.1200/JCO.2005.03.6830; Chen LP, 2004, NAT REV IMMUNOL, V4, P336, DOI 10.1038/nri1349; Chen LW, 2005, MOL CANCER THER, V4, P1311, DOI 10.1158/1535-7163.MCT-04-0287; Chen X, 2005, J LEUKOCYTE BIOL, V78, P114, DOI 10.1189/jlb.0604341; Ciesielski MJ, 2010, CANCER IMMUNOL IMMUN, V59, P1211, DOI 10.1007/s00262-010-0845-x; Dannull J, 2005, J CLIN INVEST, V115, P3623, DOI 10.1172/JCI25947; de Zoeten EF, 2010, GASTROENTEROLOGY, V138, P583, DOI 10.1053/j.gastro.2009.10.037; Doganci A, 2005, J CLIN INVEST, V115, P313, DOI 10.1172/JCI200522433; Duong V, 2008, MOL CANCER RES, V6, P1908, DOI 10.1158/1541-7786.MCR-08-0299; Ellis L, 2011, PROSTATE; Ellwood-Yen K, 2003, CANCER CELL, V4, P223, DOI 10.1016/S1535-6108(03)00197-1; Fong L, 2009, CANCER RES, V69, P609, DOI 10.1158/0008-5472.CAN-08-3529; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Fournel M, 2008, MOL CANCER THER, V7, P759, DOI 10.1158/1535-7163.MCT-07-2026; Glozak MA, 2005, GENE, V363, P15, DOI 10.1016/j.gene.2005.09.010; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Hess-Stumpp H, 2005, P AM ASSOC CANC RES, V46, P607; Huber M, 2008, INT IMMUNOL, V20, P223, DOI 10.1093/intimm/dxm139; Jabion J, 2002, CANCER RES, V62, P6108; Johnstone RW, 2002, NAT REV DRUG DISCOV, V1, P287, DOI 10.1038/nrd772; Jonuleit H, 2001, J EXP MED, V193, P1285, DOI 10.1084/jem.193.11.1285; Kato Y, 2007, CLIN CANCER RES, V13, P4538, DOI 10.1158/1078-0432.CCR-07-0014; Kishi H, 2004, J UROLOGY, V171, P1855, DOI 10.1097/01.ju.0000120317.88372.03; Liyanage UK, 2002, J IMMUNOL, V169, P2756, DOI 10.4049/jimmunol.169.5.2756; Maeda T, 2000, BLOOD, V96, P3847, DOI 10.1182/blood.V96.12.3847.h8003847_3847_3856; Magner WJ, 2000, J IMMUNOL, V165, P7017, DOI 10.4049/jimmunol.165.12.7017; Marks PA, 2001, NAT REV CANCER, V1, P194, DOI 10.1038/35106079; Miller AM, 2006, J IMMUNOL, V177, P7398, DOI 10.4049/jimmunol.177.10.7398; Negrier S, 1998, NEW ENGL J MED, V338, P1272, DOI 10.1056/NEJM199804303381805; Onizuka S, 1999, CANCER RES, V59, P3128; Qian DZ, 2006, CLIN CANCER RES, V12, P634, DOI 10.1158/1078-0432.CCR-05-1132; Qian DZ, 2005, PROSTATE, V64, P20, DOI 10.1002/pros.20209; Read S, 2001, CURR OPIN IMMUNOL, V13, P644, DOI 10.1016/S0952-7915(01)00273-4; Reddy P, 2004, P NATL ACAD SCI USA, V101, P3921, DOI 10.1073/pnas.0400380101; Rudra D, 2009, NAT IMMUNOL, V10, P1170, DOI 10.1038/ni.1795; Saito A, 1999, P NATL ACAD SCI USA, V96, P4592, DOI 10.1073/pnas.96.8.4592; Sanderson L, 2004, DRUG METAB DISPOS, V32, P1132, DOI 10.1124/dmd.104.000638; Shariat SF, 2001, J CLIN ONCOL, V19, P2856, DOI 10.1200/JCO.2001.19.11.2856; Tao R, 2007, NAT MED, V13, P1299, DOI 10.1038/nm1652; Turkson J, 2001, J BIOL CHEM, V276, P45443, DOI 10.1074/jbc.M107527200; van Loosdregt J, 2010, BLOOD, V115, P965, DOI 10.1182/blood-2009-02-207118; Wang R, 2005, J BIOL CHEM, V280, P11528, DOI 10.1074/jbc.M413930200; Wang XF, 2005, CLIN CANCER RES, V11, P3535, DOI 10.1158/1078-0432.CCR-04-1092; Yokokawa J, 2008, CLIN CANCER RES, V14, P1032, DOI 10.1158/1078-0432.CCR-07-2056; Yuan ZL, 2005, SCIENCE, V307, P269, DOI 10.1126/science.1105166; Zhang H, 2005, NAT MED, V11, P1238, DOI 10.1038/nm1312	51	124	131	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2012	7	1							e30815	10.1371/journal.pone.0030815	http://dx.doi.org/10.1371/journal.pone.0030815			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911GB	22303460	Green Published, gold, Green Submitted			2022-12-25	WOS:000301704200036
J	Torres, JB; Doura, MB; Keita, SOY; Kittles, RA				Torres, Jada Benn; Doura, Menahem B.; Keita, Shomarka O. Y.; Kittles, Rick A.			Y Chromosome Lineages in Men of West African Descent	PLOS ONE			English	Article							ATLANTIC SLAVE-TRADE; PROSTATE-CANCER; GENETIC-STRUCTURE; MITOCHONDRIAL-DNA; HUMAN-POPULATIONS; LINKAGE DISEQUILIBRIUM; EASTERN AFRICA; MODERN HUMANS; ETHNIC-GROUPS; HAPLOTYPES	The early African experience in the Americas is marked by the transatlantic slave trade from,1619 to 1850 and the rise of the plantation system. The origins of enslaved Africans were largely dependent on European preferences as well as the availability of potential laborers within Africa. Rice production was a key industry of many colonial South Carolina low country plantations. Accordingly, rice plantations owners within South Carolina often requested enslaved Africans from the so-called "Grain Coast'' of western Africa (Senegal to Sierra Leone). Studies on the African origins of the enslaved within other regions of the Americas have been limited. To address the issue of origins of people of African descent within the Americas and understand more about the genetic heterogeneity present within Africa and the African Diaspora, we typed Y chromosome specific markers in 1,319 men consisting of 508 west and central Africans (from 12 populations), 188 Caribbeans (from 2 islands), 532 African Americans (AAs from Washington, DC and Columbia, SC), and 91 European Americans. Principal component and admixture analyses provide support for significant Grain Coast ancestry among African American men in South Carolina. AA men from DC and the Caribbean showed a closer affinity to populations from the Bight of Biafra. Furthermore, 30-40% of the paternal lineages in African descent populations in the Americas are of European ancestry. Diverse west African ancestries and sex-biased gene flow from EAs has contributed greatly to the genetic heterogeneity of African populations throughout the Americas and has significant implications for gene mapping efforts in these populations.	[Torres, Jada Benn] Univ Notre Dame, Dept Anthropol, Notre Dame, IN 46556 USA; [Doura, Menahem B.] George Washington Univ, Dept Physiol & Pharmacol, Washington, DC USA; [Keita, Shomarka O. Y.] Howard Univ, Natl Human Genome Ctr, Washington, DC 20059 USA; [Kittles, Rick A.] Univ Illinois, Dept Med, Chicago, IL USA; [Kittles, Rick A.] Univ Illinois, Div Epidemiol & Biostat, Chicago, IL USA; [Kittles, Rick A.] Univ Illinois, Inst Human Genet, Chicago, IL USA	University of Notre Dame; George Washington University; Howard University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Torres, JB (corresponding author), Univ Notre Dame, Dept Anthropol, Notre Dame, IN 46556 USA.	rkittles@uic.edu		Benn Torres, Jada/0000-0001-9678-4038; Kittles, Rick/0000-0002-5004-4437				Adeyemo AA, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-38; Agrawal S, 2005, CURR SCI INDIA, V88, P1977; Ajayi JFA, 1985, HIST W AFRICA; Alves-Silva J, 2000, AM J HUM GENET, V67, P444, DOI 10.1086/303004; Ballantyne KN, 2010, AM J HUM GENET, V87, P341, DOI 10.1016/j.ajhg.2010.08.006; Bandelt HJ, 2001, ANN HUM GENET, V65, P549, DOI [10.1046/j.1469-1809.2001.6560549.x, 10.1017/S0003480001008892]; Benn-Torres J, 2008, ANN HUM GENET, V72, P90, DOI 10.1111/j.1469-1809.2007.00398.x; Bonilla C, 2006, PROSTATE, V66, P546, DOI 10.1002/pros.20374; Carney J.A., 2001, BLACK RICE AFRICAN O; Cerny V, 2004, ANN HUM BIOL, V31, P554, DOI 10.1080/03014460412331287182; Collins-Schramm HE, 2002, HUM GENET, V111, P566, DOI 10.1007/s00439-002-0818-z; Conniff ML, 1994, AFRICANS AM HIST BLA; Cruciani F, 2002, AM J HUM GENET, V70, P1197, DOI 10.1086/340257; Curtin P., 1969, ATLANTIC SLAVE TRADE; Destro-Bisol G, 2000, AM J PHYS ANTHROPOL, V112, P319, DOI 10.1002/1096-8644(200007)112:3<319::AID-AJPA4>3.0.CO;2-F; Edelson S. M., 2006, PLANTATION ENTERPRIS; Ely B, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-34; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gomez Michael, 1998, EXCHANGING OUR COUNT; Gonzalez AM, 2006, ANN HUM GENET, V70, P631, DOI 10.1111/j.1469-1809.2006.00259.x; Hall G. M., 2005, SLAVERY AFRICAN ETHN; HAMMER MF, 1994, MOL BIOL EVOL, V11, P749; Hammer MF, 2002, ANNU REV ANTHROPOL, V31, P303, DOI 10.1146/annurev.anthro.31.040402.085413; Higman Barry W., 1984, SLAVE POPULATIONS BR; Hilton Anne, 1985, KINGDOM KONGO; Jackson BA, 2005, AM J PHYS ANTHROPOL, V128, P156, DOI 10.1002/ajpa.20040; Jackson F, 1997, Seton Hall Law Rev, V27, P951; Kayser M, 2003, GENOME RES, V13, P624, DOI 10.1101/gr.463003; Kidd LR, 2006, PROSTATE CANCER P D, V9, P284, DOI 10.1038/sj.pcan.4500884; Kittles RA, 2002, HUM GENET, V110, P553, DOI 10.1007/s00439-002-0731-5; Kittles RA, 2001, HUM GENET, V109, P253, DOI 10.1007/s004390100576; Kittles RA, 2001, CANCER EPIDEM BIOMAR, V10, P943; Klein Herbert S, 1999, ATLANTIC SLAVE TRADE; Lind JM, 2007, HUM GENET, V120, P713, DOI 10.1007/s00439-006-0261-7; Littlefield Daniel, 1981, RICE SLAVES ETHNICIT; LONG JC, 1991, GENETICS, V127, P417; LOVEJOY PE, 1989, J AFR HIST, V30, P365, DOI 10.1017/S0021853700024439; Ogot B. A., 1992, AFRICA 16 18 CENTURY; Panguluri RCK, 2004, CARCINOGENESIS, V25, P961, DOI 10.1093/carcin/bgh100; Parra EJ, 2001, AM J PHYS ANTHROPOL, V114, P18, DOI 10.1002/1096-8644(200101)114:1<18::AID-AJPA1002>3.0.CO;2-2; PHILLIPSON DW, 2005, AFRICAN ARCHAEOLOGY; Plaza S, 2004, HUM GENET, V115, P439, DOI 10.1007/s00439-004-1164-0; Pollitzer William S, 1999, GULLAH PEOPLE THEIR; POLONI ES, 1995, ANN HUM GENET, V59, P43, DOI 10.1111/j.1469-1809.1995.tb01605.x; Quinn Charlotte, 1972, MANDINGO KINGDOMS SE; Quintana-Murci L, 1999, NAT GENET, V23, P437, DOI 10.1038/70550; Reed FA, 2006, CURR OPIN GENET DEV, V16, P597, DOI 10.1016/j.gde.2006.10.008; Rodney W.A., 1970, HIST UPPER GUINEA CO; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Salas A, 2005, AM J HUM GENET, V77, P676, DOI 10.1086/491675; Salas A, 2004, AM J HUM GENET, V74, P454, DOI 10.1086/382194; Salas A, 2002, AM J HUM GENET, V71, P1082, DOI 10.1086/344348; Silva WA, 2006, HUM BIOL, V78, P29, DOI 10.1353/hub.2006.0028; Stephens JC, 2001, SCIENCE, V293, P489, DOI 10.1126/science.1059431; STRINGER CB, 1988, SCIENCE, V239, P1263, DOI 10.1126/science.3125610; Su B, 1999, AM J HUM GENET, V65, P1718, DOI 10.1086/302680; Thomas Hugh, 1997, THE SLAVE TRADE; Torres JB, 2007, ANN HUM GENET, V71, P782, DOI 10.1111/j.1469-1809.2007.00380.x; WAX DD, 1973, J NEGRO HIST, V58, P371, DOI 10.2307/2716746; Wood ET, 2005, EUR J HUM GENET, V13, P867, DOI 10.1038/sj.ejhg.5201408; Wood P. H., 1974, BLACK MAJORITY NEGRO	62	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e29687	10.1371/journal.pone.0029687	http://dx.doi.org/10.1371/journal.pone.0029687			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910ME	22295064	Green Submitted, Green Published, gold			2022-12-25	WOS:000301640600009
J	van Dijk, ADJ; van Mourik, S; van Ham, RCHJ				van Dijk, Aalt D. J.; van Mourik, Simon; van Ham, Roeland C. H. J.			Mutational Robustness of Gene Regulatory Networks	PLOS ONE			English	Article							CHIP-SEQ; TRANSCRIPTIONAL REGULATION; EVOLUTION; EVOLVABILITY; BINDING; NOISE; DIMERIZATION; MECHANISMS; STABILITY; SEQUENCE	Mutational robustness of gene regulatory networks refers to their ability to generate constant biological output upon mutations that change network structure. Such networks contain regulatory interactions (transcription factor - target gene interactions) but often also protein-protein interactions between transcription factors. Using computational modeling, we study factors that influence robustness and we infer several network properties governing it. These include the type of mutation, i.e. whether a regulatory interaction or a protein-protein interaction is mutated, and in the case of mutation of a regulatory interaction, the sign of the interaction (activating vs. repressive). In addition, we analyze the effect of combinations of mutations and we compare networks containing monomeric with those containing dimeric transcription factors. Our results are consistent with available data on biological networks, for example based on evolutionary conservation of network features. As a novel and remarkable property, we predict that networks are more robust against mutations in monomer than in dimer transcription factors, a prediction for which analysis of conservation of DNA binding residues in monomeric vs. dimeric transcription factors provides indirect evidence.	[van Dijk, Aalt D. J.; van Ham, Roeland C. H. J.] Wageningen UR, PRI, Wageningen, Netherlands; [van Dijk, Aalt D. J.; van Mourik, Simon] Wageningen UR, Plant Sci Grp, Wageningen, Netherlands; [van Dijk, Aalt D. J.] NCSB, Amsterdam, Netherlands	Wageningen University & Research; Wageningen University & Research	van Dijk, ADJ (corresponding author), Wageningen UR, PRI, Wageningen, Netherlands.	aaltjan.vandijk@wur.nl	van Mourik, Simon/D-9006-2013	van Dijk, Aalt-Jan/0000-0002-8872-5123	Netherlands Organization for Scientific Research (NWO) [863.08.027]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was carried out within the research programme of the Netherlands Consortium for Systems Biology (NCSB), which is part of the Netherlands Genomics Initiative/Netherlands Organization for Scientific Research. This work was also supported by the Netherlands Organization for Scientific Research (NWO, VENI Grant 863.08.027 to ADJvD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldana M, 2007, J THEOR BIOL, V245, P433, DOI 10.1016/j.jtbi.2006.10.027; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amoutzias GD, 2008, TRENDS BIOCHEM SCI, V33, P220, DOI 10.1016/j.tibs.2008.02.002; Balaji S, 2007, J MOL BIOL, V372, P1108, DOI 10.1016/j.jmb.2007.06.084; Becskei A, 2000, NATURE, V405, P590, DOI 10.1038/35014651; Buchler NE, 2005, P NATL ACAD SCI USA, V102, P9559, DOI 10.1073/pnas.0409553102; Buchler NE, 2008, J MOL BIOL, V384, P1106, DOI 10.1016/j.jmb.2008.09.079; Bundschuh R, 2003, J THEOR BIOL, V220, P261, DOI 10.1006/jtbi.2003.3164; Calzone L, 2006, BIOINFORMATICS, V22, P1805, DOI 10.1093/bioinformatics/btl172; Cavelier G, 2004, PROTEINS, V55, P339, DOI 10.1002/prot.20056; Chen L, 2011, BIOINFORMATICS, V27, P1447, DOI 10.1093/bioinformatics/btr156; Ciliberti S, 2007, P NATL ACAD SCI USA, V104, P13591, DOI 10.1073/pnas.0705396104; Ciliberti S, 2007, PLOS COMPUT BIOL, V3, P164, DOI 10.1371/journal.pcbi.0030015; Daniels BC, 2008, CURR OPIN BIOTECH, V19, P389, DOI 10.1016/j.copbio.2008.06.008; Doniger SW, 2007, PLOS COMPUT BIOL, V3, P932, DOI 10.1371/journal.pcbi.0030099; Geisel N, 2011, BIOPHYS J, V101, P1569, DOI 10.1016/j.bpj.2011.08.041; Grigoryan G, 2009, NATURE, V458, P859, DOI 10.1038/nature07885; Gu ZL, 2003, NATURE, V421, P63, DOI 10.1038/nature01198; Guelzim N, 2002, NAT GENET, V31, P60, DOI 10.1038/ng873; Hinman VF, 2009, BBA-GENE REGUL MECH, V1789, P326, DOI 10.1016/j.bbagrm.2009.01.004; Homann OR, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000783; Hornung G, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040008; Ihmels J, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100127; Isalan M, 2008, NATURE, V452, P840, DOI 10.1038/nature06847; Kaneko K, 2008, IET SYST BIOL, V2, P234, DOI 10.1049/iet-syb:20070078; Kauffman S, 2004, P NATL ACAD SCI USA, V101, P17102, DOI 10.1073/pnas.0407783101; Kawabata T, 2002, NUCLEIC ACIDS RES, V30, P294, DOI 10.1093/nar/30.1.294; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Kwon YK, 2007, BMC BIOINFORMATICS, V8; McManus CJ, 2010, GENOME RES, V20, P816, DOI 10.1101/gr.102491.109; Morishita Y, 2005, J THEOR BIOL, V235, P241, DOI 10.1016/j.jtbi.2005.01.007; Muino JM, 2011, NUCLEIC ACIDS RES, V39, pW524, DOI 10.1093/nar/gkr373; Munteanu A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000226; Nuzhdin SV, 2004, MOL BIOL EVOL, V21, P1308, DOI 10.1093/molbev/msh128; Pomerance A, 2009, P NATL ACAD SCI USA, V106, P8209, DOI 10.1073/pnas.0900142106; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Prill RJ, 2005, PLOS BIOL, V3, P1881, DOI 10.1371/journal.pbio.0030343; Ravasi T, 2010, CELL, V140, P744, DOI 10.1016/j.cell.2010.01.044; Rosenfeld N, 2002, J MOL BIOL, V323, P785, DOI 10.1016/S0022-2836(02)00994-4; Sakata A, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.148101; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Schmidt D, 2010, SCIENCE, V328, P1036, DOI 10.1126/science.1186176; Shou C, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001050; Smolen P, 2000, NEURON, V26, P567, DOI 10.1016/S0896-6273(00)81194-0; Tan K, 2007, P NATL ACAD SCI USA, V104, P1283, DOI 10.1073/pnas.0606914104; Tirosh I, 2009, SCIENCE, V324, P659, DOI 10.1126/science.1169766; Townsend JP, 2003, MOL BIOL EVOL, V20, P955, DOI 10.1093/molbev/msg106; Tsong AE, 2006, NATURE, V443, P415, DOI 10.1038/nature05099; Tuch BB, 2008, PLOS BIOL, V6, P352, DOI 10.1371/journal.pbio.0060038; van Dijk ADJ, 2008, BIOINFORMATICS, V24, P26, DOI 10.1093/bioinformatics/btm539; van Dijk ADJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001017; Wagner A, 2000, NAT GENET, V24, P355, DOI 10.1038/74174; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Wu YL, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000442	55	10	11	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e30591	10.1371/journal.pone.0030591	http://dx.doi.org/10.1371/journal.pone.0030591			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910ME	22295094	gold, Green Submitted, Green Published			2022-12-25	WOS:000301640600039
J	Weiner, AMJ; Scampoli, NL; Calcaterra, NB				Weiner, Andrea M. J.; Scampoli, Nadia L.; Calcaterra, Nora B.			Fishing the Molecular Bases of Treacher Collins Syndrome	PLOS ONE			English	Article							NUCLEOLAR PROTEIN TREACLE; ACID-BINDING-PROTEIN; TCOF1 GENE-PRODUCT; JAW DEVELOPMENT; NUCLEIC-ACIDS; CELL-SURVIVAL; ZEBRAFISH; MUTATIONS; PROLIFERATION; MORPHOGENESIS	Treacher Collins syndrome (TCS) is an autosomal dominant disorder of craniofacial development, and mutations in the TCOF1 gene are responsible for over 90% of TCS cases. The knowledge about the molecular mechanisms responsible for this syndrome is relatively scant, probably due to the difficulty of reproducing the pathology in experimental animals. Zebrafish is an emerging model for human disease studies, and we therefore assessed it as a model for studying TCS. We identified in silico the putative zebrafish TCOF1 ortholog and cloned the corresponding cDNA. The derived polypeptide shares the main structural domains found in mammals and amphibians. Tcof1 expression is restricted to the anterior-most regions of zebrafish developing embryos, similar to what happens in mouse embryos. Tcof1 loss-of-function resulted in fish showing phenotypes similar to those observed in TCS patients, and enabled a further characterization of the mechanisms underlying craniofacial malformation. Besides, we initiated the identification of potential molecular targets of treacle in zebrafish. We found that Tcof1 loss-of-function led to a decrease in the expression of cellular proliferation and craniofacial development. Together, results presented here strongly suggest that it is possible to achieve fish with TCS-like phenotype by knocking down the expression of the TCOF1 ortholog in zebrafish. This experimental condition may facilitate the study of the disease etiology during embryonic development.	[Weiner, Andrea M. J.; Scampoli, Nadia L.; Calcaterra, Nora B.] Univ Nacl Rosario, Inst Biol Mol & Celular Rosario IBR, Consejo Nacl Invest Cient & Tecn CONICET, Area Biol Gen,Dept Ciencias Biol,Fac Ciencias Bio, RA-2000 Rosario, Santa Fe, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Rosario	Weiner, AMJ (corresponding author), Univ Nacl Rosario, Inst Biol Mol & Celular Rosario IBR, Consejo Nacl Invest Cient & Tecn CONICET, Area Biol Gen,Dept Ciencias Biol,Fac Ciencias Bio, RA-2000 Rosario, Santa Fe, Argentina.	calcaterra@ibr.gov.ar	Calcaterra, Nora/AAP-7469-2021	, Nora/0000-0003-4259-9800	Agencia Nacional de Promocion Cientifica y Tecnica (ANPCyT)-PICT [00648]; Universidad Nacional de Rosario (UNR) [BIO19]	Agencia Nacional de Promocion Cientifica y Tecnica (ANPCyT)-PICT(ANPCyT); Universidad Nacional de Rosario (UNR)	This work was supported by Agencia Nacional de Promocion Cientifica y Tecnica (ANPCyT)-PICT 00648 and Universidad Nacional de Rosario (UNR)-BIO19. AMJW is a fellow and NBC a staff member of CONICET and UNR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angst E, 2011, SURGERY, V149, P614, DOI 10.1016/j.surg.2010.11.002; Armas P, 2004, GENE, V337, P151, DOI 10.1016/j.gene.2004.04.031; Armas P, 2008, J MOL BIOL, V382, P1043, DOI 10.1016/j.jmb.2008.07.079; Armas P, 2008, J CELL BIOCHEM, V103, P1013, DOI 10.1002/jcb.21474; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Borgognone M, 2010, BIOCHEM J, V428, P491, DOI 10.1042/BJ20100038; Calcaterra NB, 2010, IUBMB LIFE, V62, P707, DOI 10.1002/iub.379; Dixon J, 2000, HUM MOL GENET, V9, P1473, DOI 10.1093/hmg/9.10.1473; Dixon J, 2004, DEV DYNAM, V229, P907, DOI 10.1002/dvdy.20004; Dixon J, 1997, HUM MOL GENET, V6, P727, DOI 10.1093/hmg/6.5.727; Dixon J, 2006, P NATL ACAD SCI USA, V103, P13403, DOI 10.1073/pnas.0603730103; Duffy KT, 2005, NUCLEIC ACIDS RES, V33, P4914, DOI 10.1093/nar/gki799; Eberhart JK, 2006, DEVELOPMENT, V133, P1069, DOI 10.1242/dev.02281; Edwards SJ, 1997, AM J HUM GENET, V60, P515; Fong SH, 2005, DEVELOPMENT, V132, P3587, DOI 10.1242/dev.01933; Gonzales B, 2005, GENE, V359, P73, DOI 10.1016/j.gene.2005.04.042; Hayano T, 2003, J BIOL CHEM, V278, P34309, DOI 10.1074/jbc.M304304200; Hubbard T, 2002, NUCLEIC ACIDS RES, V30, P38, DOI 10.1093/nar/30.1.38; Jacobs JJL, 2000, NAT GENET, V26, P291, DOI 10.1038/81583; Jones NC, 2008, NAT MED, V14, P125, DOI 10.1038/nm1725; JOWETT T, 1994, TRENDS GENET, V10, P73, DOI 10.1016/0168-9525(94)90220-8; Kimmel CB, 2001, DEV BIOL, V233, P239, DOI 10.1006/dbio.2001.0201; Kovacevic Z, 2011, CARCINOGENESIS, V32, P732, DOI 10.1093/carcin/bgr046; Loeb-Hennard C, 2005, GENE EXPR PATTERNS, V5, P341, DOI 10.1016/j.modgep.2004.10.003; Marsh KL, 1998, HUM MOL GENET, V7, P1795, DOI 10.1093/hmg/7.11.1795; Marszalek B, 2003, AM J MED GENET A, V123A, P169, DOI 10.1002/ajmg.a.20312; Mogass M, 2004, BIOCHEM BIOPH RES CO, V325, P124, DOI 10.1016/j.bbrc.2004.10.004; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Parsons KJ, 2011, METHOD CELL BIOL, V101, P225, DOI 10.1016/B978-0-12-387036-0.00011-6; Passos-Bueno MR, 2009, AM J MED GENET A, V149A, P1853, DOI 10.1002/ajmg.a.32950; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Schilling TF, 1997, DEVELOPMENT, V124, P2945; Solomon KS, 2003, DEVELOPMENT, V130, P929, DOI 10.1242/dev.00308; Splendore A, 2000, HUM MUTAT, V16, P315, DOI 10.1002/1098-1004(200010)16:4<315::AID-HUMU4>3.0.CO;2-H; Splendore A, 2005, HUM MUTAT, V25, P429, DOI 10.1002/humu.20159; Splendore A, 2003, EUR J HUM GENET, V11, P718, DOI 10.1038/sj.ejhg.5201029; Splendore A, 2002, J MED GENET, V39, P493, DOI 10.1136/jmg.39.7.493; Steventon B, 2005, SEMIN CELL DEV BIOL, V16, P647, DOI 10.1016/j.semcdb.2005.06.001; Tang RY, 2007, ACTA BIOCH BIOPH SIN, V39, P384, DOI 10.1111/j.1745-7270.2007.00283.x; Uhlmann-Schiffler H, 2009, ONCOGENE, V28, P2065, DOI 10.1038/onc.2009.75; Valdez BC, 2004, P NATL ACAD SCI USA, V101, P10709, DOI 10.1073/pnas.0402492101; Wada N, 2005, DEVELOPMENT, V132, P3977, DOI 10.1242/dev.01943; Walker MB, 2006, CLIN GENET, V69, P471, DOI 10.1111/j.0009-9163.2006.00615.x; Weiner AMJ, 2007, J CELL BIOCHEM, V102, P1553, DOI 10.1002/jcb.21380; Weiner AM, 2011, DEV GROWTH IN PRESS; Winokur ST, 1998, HUM MOL GENET, V7, P1947, DOI 10.1093/hmg/7.12.1947; Wise CA, 1997, P NATL ACAD SCI USA, V94, P3110, DOI 10.1073/pnas.94.7.3110; Wullimann MF, 2000, ANAT EMBRYOL, V202, P385, DOI 10.1007/s004290000115; Yan YL, 2005, DEVELOPMENT, V132, P1069, DOI 10.1242/dev.01674	49	35	36	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e29574	10.1371/journal.pone.0029574	http://dx.doi.org/10.1371/journal.pone.0029574			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910ME	22295061	Green Published, gold, Green Submitted			2022-12-25	WOS:000301640600006
J	Xu, MY; Chen, XJ; Qiu, MD; Zeng, XW; Xu, J; Deng, DY; Sun, GP; Li, X; Guo, J				Xu, Meiying; Chen, Xingjuan; Qiu, Mengde; Zeng, Xiaowei; Xu, Jian; Deng, Daiyong; Sun, Guoping; Li, Xiang; Guo, Jun			Bar-Coded Pyrosequencing Reveals the Responses of PBDE-Degrading Microbial Communities to Electron Donor Amendments	PLOS ONE			English	Article							POLYBROMINATED DIPHENYL ETHERS; SP NOV.; REDUCTIVE DEBROMINATION; ANAEROBIC DEGRADATION; CONTAMINATED AQUIFER; GEN. NOV.; DIVERSITY; URANIUM; ENVIRONMENT; SEDIMENTS	Polybrominated diphenyl ethers (PBDEs) can be reductively degraded by microorganisms under anaerobic conditions. However, little is known about the effect of electron donors on microbial communities involved in PBDEs degradation. Here we employed 454 Titanium pyrosequencing to examine the phylogenetic diversity, composition, structure and dynamics of microbial communities from microcosms under the conditions of different electron donor amendments. The community structures in each of the five alternate electron donor enrichments were significantly shifted in comparison with those of the control microcosm. Commonly existing OTUs between the treatment and control consortia increased from 5 to 17 and more than 50% of OTUs increased around 13.7 to 186 times at least in one of the microcosms after 90-days enrichment. Although the microbial communities at different taxonomic levels were significantly changed by different environmental variable groups in redundancy analysis, significant correlations were observed between the microbial communities and PBDE congener profiles. The lesser-brominated PBDE congeners, tri-BDE congener (BDE-32) and hexa-BDE, were identified as the key factors shaping the microbial community structures at OTU level. Some rare populations, including the known dechlorinating bacterium, Dehalobacter, showed significant positive-correlation with the amounts of PBDE congeners in the consortia. The same results were also observed on some unclassified bacteria. These results suggest that PBDEs-degrading microbial communities can be successfully enriched, and their structures and compositions can be manipulated through adjusting the environmental parameters.	[Xu, Meiying; Chen, Xingjuan; Qiu, Mengde; Deng, Daiyong; Sun, Guoping; Guo, Jun] Guangdong Inst Microbiol, Guangdong Prov Key Lab Microbial Culture Collect, Guangzhou, Guangdong, Peoples R China; [Zeng, Xiaowei; Xu, Jian] Chinese Acad Sci, Qingdao Inst Bioenergy & Bioproc Technol, Shandong Key Lab Energy Genet, Qingdao, Shandong, Peoples R China; [Zeng, Xiaowei; Xu, Jian] Chinese Acad Sci, Bioenergy Genome Ctr, Qingdao, Shandong, Peoples R China; [Xu, Meiying; Chen, Xingjuan; Deng, Daiyong; Sun, Guoping; Guo, Jun] Minist Guangdong Prov Jointly Breeding Base, State Key Lab Appl Microbiol, Guangzhou, Guangdong, Peoples R China; [Xu, Meiying; Chen, Xingjuan; Deng, Daiyong; Sun, Guoping; Guo, Jun] Guangdong Open Lab Appl Microbiol, Guangzhou, Guangdong, Peoples R China; [Li, Xiang] Chinese Acad Sci, S China Sea Inst Oceanol, Key Lab Marine Bioresources Sustainable Utilizat, Guangzhou, Guangdong, Peoples R China	Guangdong Academy of Sciences; Institute of Microbiology, Guangdong Academy of Sciences; Chinese Academy of Sciences; Qingdao Institute of Bioenergy & Bioprocess Technology, CAS; Chinese Academy of Sciences; Chinese Academy of Sciences; South China Sea Institute of Oceanology, CAS	Xu, MY (corresponding author), Guangdong Inst Microbiol, Guangdong Prov Key Lab Microbial Culture Collect, Guangzhou, Guangdong, Peoples R China.	xumy@gdim.cn; guojun@gzb.ac.cn	Qiu, Meng/J-7264-2019; Li, Xiang/AAX-3390-2020; , dengdaiyong/ABC-2618-2020; Xu, Meiying/AAM-1646-2020; Xu, Jian/G-8430-2012	Qiu, Meng/0000-0002-0178-3479; Xu, Jian/0000-0002-0548-8477	Natural Science Foundation of Guangdong, China [9351007002000001]; Natural Science Foundation of Guangdong Province [S2011010004267]; Outstanding Scholarship Foundation of Guangdong Academy of Sciences [200902]; Guangdong-Hongkong Technology Cooperation Funding [2009A030902003]; Guangdong Province - Chinese Academy of Sciences [2009B091300023, 2010B090301048]; Science and Technology Planning Project of Foshan City [2010YS023]; Science and Technology Planning Project of Ronggui District	Natural Science Foundation of Guangdong, China(National Natural Science Foundation of Guangdong Province); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Outstanding Scholarship Foundation of Guangdong Academy of Sciences; Guangdong-Hongkong Technology Cooperation Funding; Guangdong Province - Chinese Academy of Sciences; Science and Technology Planning Project of Foshan City; Science and Technology Planning Project of Ronggui District	The authors acknowledge the Team Project of the Natural Science Foundation of Guangdong, China (9351007002000001), the Natural Science Foundation of Guangdong Province (S2011010004267), the Outstanding Scholarship Foundation of Guangdong Academy of Sciences (200902), the Guangdong-Hongkong Technology Cooperation Funding (2009A030902003), Guangdong Province - Chinese Academy of Sciences Strategic Cooperative Project (2009B091300023, 2010B090301048), Science and Technology Planning Project of Foshan City (2010YS023) and Science and Technology Planning Project of Ronggui District. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abram F, 2011, J APPL MICROBIOL, V110, P1550, DOI 10.1111/j.1365-2672.2011.05011.x; Anderson RT, 2003, APPL ENVIRON MICROB, V69, P5884, DOI 10.1128/AEM.69.10.5884-5891.2003; Behnisch PA, 2003, ENVIRON INT, V29, P861, DOI 10.1016/S0160-4120(03)00105-3; Bunge M, 2008, ENVIRON MICROBIOL, V10, P2670, DOI 10.1111/j.1462-2920.2008.01688.x; Chakraborty R, 2005, APPL ENVIRON MICROB, V71, P8649, DOI 10.1128/AEM.71.12.8649-8655.2005; Claesson MJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq873; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; de Boer J, 2000, HANDB ENVIRON CHEM, V3, P61; Deng DY, 2011, INT BIODETER BIODEGR, V65, P465, DOI 10.1016/j.ibiod.2011.01.008; Dojka MA, 1998, APPL ENVIRON MICROB, V64, P3869; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Freeborn RA, 2005, ENVIRON SCI TECHNOL, V39, P8358, DOI 10.1021/es048003p; Gerecke AC, 2005, ENVIRON SCI TECHNOL, V39, P1078, DOI 10.1021/es048634j; Godon JJ, 1997, APPL ENVIRON MICROB, V63, P2802, DOI 10.1128/AEM.63.7.2802-2813.1997; Hites RA, 2004, ENVIRON SCI TECHNOL, V38, P945, DOI 10.1021/es035082g; Horinouchi M, 2003, APPL ENVIRON MICROB, V69, P4421, DOI 10.1128/AEM.69.8.4421-4430.2003; Istok JD, 2004, ENVIRON SCI TECHNOL, V38, P468, DOI 10.1021/es034639p; Kellermann C, 2009, INT J SYST EVOL MICR, V59, P583, DOI 10.1099/ijs.0.002808-0; Krumholz LR, 1997, INT J SYST BACTERIOL, V47, P1262, DOI 10.1099/00207713-47-4-1262; Lee LK, 2010, APPL ENVIRON MICROB, V76, P794, DOI 10.1128/AEM.01872-09; Lee SH, 2007, J HAZARD MATER, V143, P65, DOI 10.1016/j.jhazmat.2006.08.059; Luo Q, 2007, SCI TOTAL ENVIRON, V383, P115, DOI 10.1016/j.scitotenv.2007.05.009; Mai BX, 2005, ENVIRON SCI TECHNOL, V39, P3521; Mazzoli R, 2007, ARCH MICROBIOL, V188, P55, DOI 10.1007/s00203-007-0223-z; Meerts IATM, 2001, ENVIRON HEALTH PERSP, V109, P399, DOI 10.1289/ehp.01109399; Niu LL, 2008, INT J SYST EVOL MICR, V58, P12, DOI 10.1099/ijs.0.65108-0; Oros DR, 2005, ENVIRON SCI TECHNOL, V39, P33, DOI 10.1021/es048905q; Qiu MD, 2012, BIODEGRADATION, V23, P351, DOI 10.1007/s10532-011-9514-9; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Tanabe S, 2008, J ENVIRON MONITOR, V10, P188, DOI 10.1039/b709928b; Teng Y, 2010, BIODEGRADATION, V21, P167, DOI 10.1007/s10532-009-9291-x; Tokarz JA, 2008, ENVIRON SCI TECHNOL, V42, P1157, DOI 10.1021/es071989t; Watanabe I, 2003, ENVIRON INT, V29, P665, DOI 10.1016/S0160-4120(03)00123-5; WOLIN EA, 1963, J BIOL CHEM, V238, P2882; Wolterink A, 2005, INT J SYST EVOL MICR, V55, P2063, DOI 10.1099/ijs.0.63404-0; Xu MY, 2010, ISME J, V4, P1060, DOI 10.1038/ismej.2010.31; Yamada T, 2006, INT J SYST EVOL MICR, V56, P1331, DOI 10.1099/ijs.0.64169-0; Yen JH, 2009, J HAZARD MATER, V165, P518, DOI 10.1016/j.jhazmat.2008.10.007	39	37	40	2	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e30439	10.1371/journal.pone.0030439	http://dx.doi.org/10.1371/journal.pone.0030439			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910ME	22295086	Green Submitted, Green Published, gold			2022-12-25	WOS:000301640600031
J	Yu, H; Compton, SG				Yu, Hui; Compton, Stephen G.			Moving Your Sons to Safety: Galls Containing Male Fig Wasps Expand into the Centre of Figs, Away From Enemies	PLOS ONE			English	Article							AGAONIDAE HYMENOPTERA CHALCIDOIDEA; SEX-RATIO ADJUSTMENT; FICUS MORACEAE; SPECIES RICHNESS; ALLOCATION; EVOLUTION; REFUGES; ECOLOGY; SIZE; EXPLOITATION	Figs are the inflorescences of fig trees (Ficus spp., Moraceae). They are shaped like a hollow ball, lined on their inner surface by numerous tiny female flowers. Pollination is carried out by host-specific fig wasps (Agaonidae). Female pollinators enter the figs through a narrow entrance gate and once inside can walk around on a platform generated by the stigmas of the flowers. They lay their eggs into the ovules, via the stigmas and styles, and also gall the flowers, causing the ovules to expand and their pedicels to elongate. A single pollinator larva develops in each galled ovule. Numerous species of non-pollinating fig wasps (NPFW, belonging to other families of Chalcidoidea) also make use of galled ovules in the figs. Some initiate galls, others make use of pollinator-generated galls, killing pollinator larvae. Most NPFW oviposit from the outside of figs, making peripherally-located pollinator larvae more prone to attack. Style length variation is high among monoecious Ficus spp. and pollinators mainly oviposit into more centrally-located ovules, with shorter styles. Style length variation is lower in male (wasp-producing) figs of dioecious Ficus spp., making ovules equally vulnerable to attack by NPFW at the time that pollinators oviposit. We recorded the spatial distributions of galled ovules in mature male figs of the dioecious Ficus hirta in Southern China. The galls contained pollinators and three NPFW that kill them. Pollinators were concentrated in galls located towards the centre of the figs, NPFW towards the periphery. Due to greater pedicel elongation by male galls, male pollinators became located in more central galls than their females, and so were less likely to be attacked. This helps ensure that sufficient males survive, despite strongly female-biased sex ratios, and may be a consequence of the pollinator females laying mostly male eggs at the start of oviposition sequences.	[Yu, Hui] Chinese Acad Sci, S China Bot Garden, Key Lab Plant Resources Conservat & Sustainable U, Guangzhou, Guangdong, Peoples R China; [Compton, Stephen G.] Univ Leeds, Fac Biol Sci, Sch Biol, Leeds, W Yorkshire, England	Chinese Academy of Sciences; South China Botanical Garden, CAS; University of Leeds	Yu, H (corresponding author), Chinese Acad Sci, S China Bot Garden, Key Lab Plant Resources Conservat & Sustainable U, Guangzhou, Guangdong, Peoples R China.	yuhui@scib.ac.cn		Compton, Stephen/0000-0002-1247-8058	National Natural Science Foundation of China [30970441, 30910103088]; Chinese Academy of Sciences [KSCX2-EW-Q-8]; National Basic Research Program of China (973 Program) [2007CB411600]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); National Basic Research Program of China (973 Program)(National Basic Research Program of China)	The work was supported by the National Natural Science Foundation of China (30970441, 30910103088), Key Project of Knowledge Innovation Program, Chinese Academy of Sciences (KSCX2-EW-Q-8) and the National Basic Research Program of China (973 Program) (2007CB411600). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ananthakrishnan T.N., 1984, BIOL GALL INSECTS; Anstett MC, 1996, J EVOLUTION BIOL, V9, P417, DOI 10.1046/j.1420-9101.1996.9040417.x; Anstett MC, 2001, OIKOS, V95, P476, DOI 10.1034/j.1600-0706.2001.950313.x; Berg C., 2005, FLORA MALESIANA 1 2, V17; Berg C.C., 1992, AFRICAN FIG TREES FI; BRONSTEIN JL, 1991, OIKOS, V61, P175, DOI 10.2307/3545335; Compton S., 1988, Antenna, V12, P102; COMPTON S G, 1990, Mitteilungen aus dem Institut fuer Allgemeine Botanik Hamburg, V23, P441; COMPTON SG, 1992, OECOLOGIA, V91, P68, DOI 10.1007/BF00317243; Compton Stephen G., 1994, P343; Cruaud A, 2010, CLADISTICS, V26, P359, DOI 10.1111/j.1096-0031.2009.00291.x; Cuevas-Reyes P, 2003, BIODIVERS CONSERV, V12, P411, DOI 10.1023/A:1022415907109; Dunn DW, 2008, PLOS BIOL, V6, P490, DOI 10.1371/journal.pbio.0060059; GALIL J, 1971, NEW PHYTOL, V70, P773, DOI 10.1111/j.1469-8137.1971.tb02578.x; GALIL J, 1968, NEW PHYTOL, V67, P745, DOI 10.1111/j.1469-8137.1968.tb05497.x; GANESHAIAH KN, 1995, J GENET, V74, P25, DOI 10.1007/BF02924244; Godfray H.C.J., 1997, P211, DOI 10.1017/CBO9780511721946.013; Greeff JM, 2011, EVOLUTION, V65, P203, DOI 10.1111/j.1558-5646.2010.01116.x; Hardy ICW, 2000, ETHOLOGY, V106, P1021, DOI 10.1046/j.1439-0310.2000.00621.x; HARDY ICW, 1995, OECOLOGIA, V103, P162, DOI 10.1007/BF00329076; Hardy NB, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-257; HEIMPEL GE, 1994, ECOL ENTOMOL, V19, P299, DOI 10.1111/j.1365-2311.1994.tb00421.x; Herre EA, 1997, P ROY SOC B-BIOL SCI, V264, P1501, DOI 10.1098/rspb.1997.0208; HERRE EA, 1985, SCIENCE, V228, P896, DOI 10.1126/science.228.4701.896; Herre EA, 1997, SOCIAL COMPETITION C, P226; HOCHBERG ME, 1992, SCIENCE, V255, P973, DOI 10.1126/science.255.5047.973; JANZEN DH, 1979, ANNU REV ECOL SYST, V10, P13, DOI 10.1146/annurev.es.10.110179.000305; JEFFRIES MJ, 1984, BIOL J LINN SOC, V23, P269, DOI 10.1111/j.1095-8312.1984.tb00145.x; Jousselin E, 2003, EVOLUTION, V57, P1255, DOI 10.1111/j.0014-3820.2003.tb00334.x; Jousselin E, 2004, INT J PLANT SCI, V165, P587, DOI 10.1086/386558; Kathuria P, 1999, OIKOS, V87, P520, DOI 10.2307/3546816; Kerdelhue C, 2000, ECOLOGY, V81, P2832, DOI 10.1890/0012-9658(2000)081[2832:CCESOO]2.0.CO;2; Kerdelhue C, 1996, OIKOS, V77, P163, DOI 10.2307/3545597; Kjellberg F, 2005, CR BIOL, V328, P471, DOI 10.1016/j.crvi.2004.11.005; Marchosky RJ, 2004, ENVIRON ENTOMOL, V33, P709, DOI 10.1603/0046-225X-33.3.709; MURRAY MG, 1990, ANIM BEHAV, V39, P434, DOI 10.1016/S0003-3472(05)80406-3; NAGELKERKE CJ, 1994, BEHAV ECOL, V5, P401, DOI 10.1093/beheco/5.4.401; NAIR PB, 1981, ORIENT INSECTS, V15, P433; Nefdt RJC, 1996, J ANIM ECOL, V65, P170, DOI 10.2307/5720; Pereira RAS, 2005, OIKOS, V110, P613, DOI 10.1111/j.0030-1299.2005.13234.x; PRICE PW, 1988, J ANIM ECOL, V57, P89, DOI 10.2307/4765; PRICE PW, 1986, ECOLOGY, V67, P1593, DOI 10.2307/1939090; PRICE PW, 1987, ENVIRON ENTOMOL, V16, P15, DOI 10.1093/ee/16.1.15; Raja S, 2008, SYMBIOSIS, V45, P25; ROMSTOCKVOLKL M, 1990, ECOL ENTOMOL, V15, P321, DOI 10.1111/j.1365-2311.1990.tb00814.x; Sun Bao-fa, 2009, Zoological Research, V30, P559, DOI 10.3724/SP.J.1141.2009.05559; Tarachai Y, 2008, SYMBIOSIS, V45, P29; VERKERKE W, 1989, EXPERIENTIA, V45, P612, DOI 10.1007/BF01975678; VERKERKE W, 1986, P K NED AKAD C BIOL, V89, P443; WALTON R, 1988, ENVIRON ENTOMOL, V17, P654, DOI 10.1093/ee/17.4.654; Weiblen GD, 2000, AM J BOT, V87, P1342, DOI 10.2307/2656726; Weiblen GD, 2002, ANNU REV ENTOMOL, V47, P299, DOI 10.1146/annurev.ento.47.091201.145213; WEIS AE, 1985, ECOLOGY, V66, P1261, DOI 10.2307/1939179; WEIS AE, 1988, ANNU REV ENTOMOL, V33, P467, DOI 10.1146/annurev.en.33.010188.002343; West SA, 1996, J BIOGEOGR, V23, P447, DOI 10.1111/j.1365-2699.1996.tb00006.x; WEST SA, 1994, P ROY SOC B-BIOL SCI, V258, P67, DOI 10.1098/rspb.1994.0143; West SA, 1997, ANIM BEHAV, V54, P437, DOI 10.1006/anbe.1996.0494; WIEBES JT, 1993, P K NED AKAD WETENSC, V96, P347; Yu DW, 2004, P ROY SOC B-BIOL SCI, V271, P1185, DOI 10.1098/rspb.2003.2630; Yu H, 2008, SYMBIOSIS, V45, P121; Yu H, 2006, BOT STUD, V47, P435; Zavodna M, 2005, ECOL ENTOMOL, V30, P210, DOI 10.1111/j.0307-6946.2005.00674.x	62	21	24	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e30833	10.1371/journal.pone.0030833	http://dx.doi.org/10.1371/journal.pone.0030833			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910ME	22295113	gold, Green Published, Green Submitted			2022-12-25	WOS:000301640600058
J	Wen, XY; Klockow, LC; Nekorchuk, M; Sharifi, HJ; de Noronha, CMC				Wen, Xiaoyun; Klockow, Laurieann Casey; Nekorchuk, Michael; Sharifi, Hamayun J.; de Noronha, Carlos M. C.			The HIV1 Protein Vpr Acts to Enhance Constitutive DCAF1-Dependent UNG2 Turnover	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; URACIL-DNA GLYCOSYLASE; CELL-CYCLE REGULATION; UBIQUITIN LIGASE; TERMINAL DOMAIN; T-CELLS; IN-VIVO; DEGRADATION; APOBEC3G; BINDING	Background: The HIV1 protein Vpr assembles with and acts through an ubiquitin ligase complex that includes DDB1 and cullin 4 (CRL4) to cause G2 cell cycle arrest and to promote degradation of both uracil DNA glycosylase 2 (UNG2) and single-strand selective mono-functional uracil DNA glycosylase 1 (SMUG1). DCAF1, an adaptor protein, is required for Vpr-mediated G2 arrest through the ubiquitin ligase complex. In work described here, we used UNG2 as a model substrate to study how Vpr acts through the ubiquitin ligase complex. We examined whether DCAF1 is essential for Vpr-mediated degradation of UNG2 and SMUG1. We further investigated whether Vpr is required for recruiting substrates to the ubiquitin ligase or acts to enhance its function and whether this parallels Vpr-mediated G2 arrest. Methodology/Principal Findings: We found that DCAF1 plays an important role in Vpr-independent UNG2 and SMUG1 depletion. UNG2 assembled with the ubiquitin ligase complex in the absence of Vpr, but Vpr enhanced this interaction. Further, Vpr-mediated enhancement of UNG2 degradation correlated with low Vpr expression levels. Vpr concentrations exceeding a threshold blocked UNG2 depletion and enhanced its accumulation in the cell nucleus. A similar dose-dependent trend was seen for Vpr-mediated cell cycle arrest. Conclusions/Significance: This work identifies UNG2 and SMUG1 as novel targets for CRL4(DCAF1)-mediated degradation. It further shows that Vpr enhances rather than enables the interaction between UNG2 and the ubiquitin ligase. Vpr augments CRL4(DCAF1)-mediated UNG2 degradation at low concentrations but antagonizes it at high concentrations, allowing nuclear accumulation of UNG2. Further, the protein that is targeted to cause G2 arrest behaves much like UNG2. Our findings provide the basis for determining whether the CRL4(DCAF1) complex is alone responsible for cell cycle-dependent UNG2 turnover and will also aid in establishing conditions necessary for the identification of additional targets of Vpr-enhanced degradation.	[Wen, Xiaoyun; Klockow, Laurieann Casey; Nekorchuk, Michael; Sharifi, Hamayun J.; de Noronha, Carlos M. C.] Albany Med Coll, Ctr Immunol & Microbial Dis, Albany, NY 12208 USA	Albany Medical College	de Noronha, CMC (corresponding author), Albany Med Coll, Ctr Immunol & Microbial Dis, Albany, NY 12208 USA.	deNoroC@mail.AMC.edu			National Institutes of Health [5R01AI073178]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073178] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grant 5R01AI073178. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn J, 2010, J BIOL CHEM, V285, P37333, DOI 10.1074/jbc.M110.133181; Belzile JP, 2007, PLOS PATHOG, V3, P882, DOI 10.1371/journal.ppat.0030085; BouHamdan M, 1998, J BIOL CHEM, V273, P8009, DOI 10.1074/jbc.273.14.8009; Bouhamdan M, 1996, J VIROL, V70, P697, DOI 10.1128/JVI.70.2.697-704.1996; DeHart JL, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-57; Fischer JA, 2004, DNA REPAIR, V3, P505, DOI 10.1016/j.dnarep.2004.01.012; Goh WC, 1998, NAT MED, V4, P65, DOI 10.1038/nm0198-065; Hagen L, 2008, EMBO J, V27, P51, DOI 10.1038/sj.emboj.7601958; Hrecka K, 2007, P NATL ACAD SCI USA, V104, P11778, DOI 10.1073/pnas.0702102104; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; Huang J, 2008, ONCOGENE, V27, P4056, DOI 10.1038/onc.2008.44; Jacquot G, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-84; Jenkins Y, 1998, J CELL BIOL, V143, P875, DOI 10.1083/jcb.143.4.875; JOWETT JBM, 1995, J VIROL, V69, P6304, DOI 10.1128/JVI.69.10.6304-6313.1995; Kaiser SM, 2006, J VIROL, V80, P875, DOI 10.1128/JVI.80.2.875-882.2006; Kewalramani VN, 1996, VIROLOGY, V218, P326, DOI 10.1006/viro.1996.0201; Laguette N, 2011, NATURE; Le Rouzic E, 2007, CELL CYCLE, V6, P182, DOI 10.4161/cc.6.2.3732; Mansky LM, 2000, J VIROL, V74, P7039, DOI 10.1128/JVI.74.15.7039-7047.2000; Mbisa JL, 2007, J VIROL, V81, P7099, DOI 10.1128/JVI.00272-07; MULLER SJ, 1993, J BIOL CHEM, V268, P1310; NAGELHUS TA, 1995, EXP CELL RES, V220, P292, DOI 10.1006/excr.1995.1318; Norman JM, 2011, NAT IMMUNOL, V12, P975, DOI 10.1038/ni.2087; Priet S, 2005, MOL CELL, V17, P479, DOI 10.1016/j.molcel.2005.01.016; Richard J, 2010, BLOOD, V115, P1354, DOI 10.1182/blood-2009-08-237370; ROGEL ME, 1995, J VIROL, V69, P882, DOI 10.1128/JVI.69.2.882-888.1995; Roshal M, 2003, J BIOL CHEM, V278, P25879, DOI 10.1074/jbc.M303948200; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Schrofelbauer B, 2007, P NATL ACAD SCI USA, V104, P4130, DOI 10.1073/pnas.0610167104; Schrofelbauer B, 2005, J VIROL, V79, P10978, DOI 10.1128/JVI.79.17.10978-10987.2005; Schuler W, 1999, J MOL BIOL, V285, P2105, DOI 10.1006/jmbi.1998.2381; Selig L, 1997, J VIROL, V71, P4842, DOI 10.1128/JVI.71.6.4842-4846.1997; Sharova N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000057; Sherman MP, 2001, J VIROL, V75, P1522, DOI 10.1128/JVI.75.3.1522-1532.2001; Singh SP, 2000, VIROLOGY, V268, P364, DOI 10.1006/viro.2000.0191; Srivastava S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000059; Tan L, 2007, J VIROL, V81, P10822, DOI 10.1128/JVI.01380-07; Ward J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000613; Wen XY, 2007, J BIOL CHEM, V282, P27046, DOI 10.1074/jbc.M703955200; Yan N, 2011, P NATL ACAD SCI U S; ZHAO LJ, 1994, J BIOL CHEM, V269, P32131	41	28	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2012	7	1							e30939	10.1371/journal.pone.0030939	http://dx.doi.org/10.1371/journal.pone.0030939			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910LV	22292079	Green Published, Green Submitted, gold			2022-12-25	WOS:000301639600067
J	Wu, YQ; Chen, DJ; He, HB; Chen, DS; Chen, LL; Chen, HC; Liu, ZF				Wu, Yi-Quan; Chen, Di-Jun; He, Hua-Bin; Chen, Dong-Sheng; Chen, Ling-Ling; Chen, Huan-Chun; Liu, Zheng-Fei			Pseudorabies Virus Infected Porcine Epithelial Cell Line Generates a Diverse Set of Host MicroRNAs and a Special Cluster of Viral MicroRNAs	PLOS ONE			English	Article							LATENCY-ASSOCIATED TRANSCRIPT; LOOP RT-PCR; GENE-EXPRESSION; MESSENGER-RNA; IDENTIFICATION; SUPPRESSION; PROMOTER; DETERMINANTS; BIOGENESIS; TARGETS	Pseudorabies virus (PRV) belongs to Alphaherpesvirinae subfamily that causes huge economic loss in pig industry worldwide. It has been recently demonstrated that many herpesviruses encode microRNAs (miRNAs), which play crucial roles in viral life cycle. However, the knowledge about PRV-encoded miRNAs is still limited. Here, we report a comprehensive analysis of both viral and host miRNA expression profiles in PRV-infected porcine epithelial cell line (PK-15). Deep sequencing data showed that the,4.6 kb intron of the large latency transcript (LLT) functions as a primary microRNA precursor (pri-miRNA) that encodes a cluster of 11 distinct miRNAs in the PRV genome, and 209 known and 39 novel porcine miRNAs were detected. Viral miRNAs were further confirmed by stem-loop RT-PCR and northern blot analysis. Intriguingly, all of these viral miRNAs exhibited terminal heterogeneity both at the 59 and 39 ends. Seven miRNA genes produced mature miRNAs from both arms and two of the viral miRNA genes showed partially overlapped in their precursor regions. Unexpectedly, a terminal loop-derived small RNA with high abundance and one special miRNA offset RNA (moRNA) were processed from a same viral miRNA precursor. The polymorphisms of viral miRNAs shed light on the complexity of host miRNA-processing machinery and viral miRNA-regulatory mechanism. The swine genes and PRV genes were collected for target prediction of the viral miRNAs, revealing a complex network formed by both host and viral genes. GO enrichment analysis of host target genes suggests that PRV miRNAs are involved in complex cellular pathways including cell death, immune system process, metabolic pathway, indicating that these miRNAs play significant roles in virus-cells interaction of PRV and its hosts. Collectively, these data suggest that PRV infected epithelial cell line generates a diverse set of host miRNAs and a special cluster of viral miRNAs, which might facilitate PRV replication in cells.	[Wu, Yi-Quan; Chen, Dong-Sheng; Chen, Huan-Chun; Liu, Zheng-Fei] Huazhong Agr Univ, Coll Vet Med, State Key Lab Agr Microbiol, Wuhan, Peoples R China; [Chen, Di-Jun; Chen, Ling-Ling] Huazhong Agr Univ, Coll Life Sci & Technol, Ctr Bioinformat, Wuhan, Peoples R China; [He, Hua-Bin] Huazhong Agr Univ, Key Lab Agr Anim Genet Breeding & Reprod, Minist Educ, Wuhan, Peoples R China; [He, Hua-Bin] Huazhong Agr Univ, Key Lab Swine Genet & Breeding, Minist Agr, Coll Anim Sci, Wuhan, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University; Huazhong Agricultural University; Huazhong Agricultural University; Ministry of Agriculture & Rural Affairs	Liu, ZF (corresponding author), Huazhong Agr Univ, Coll Vet Med, State Key Lab Agr Microbiol, Wuhan, Peoples R China.	lzf6789@mail.hzau.edu.cn	Chen, Ling-Ling/AAY-3547-2021; WU, YIQUAN/AAZ-2364-2021; Chen, Dijun/P-3877-2014	WU, YIQUAN/0000-0002-2898-3585; Chen, Dijun/0000-0002-7456-2511	Ministry of Funding for Transgenic Animals [2009ZX08006-006B-2]; Natural Science Foundation of China [31070133]; State Key Laboratory of Agricultural Microbiology, HZAU [4002-08201008]	Ministry of Funding for Transgenic Animals; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Agricultural Microbiology, HZAU	This work was supported partially by the Ministry of Funding for Transgenic Animals (2009ZX08006-006B-2) to Z-FL, partially by Natural Science Foundation of China (31070133) to Z-FL, and partially by autonomous research grant (4002-08201008) from State Key Laboratory of Agricultural Microbiology, HZAU, to H-CC and Z-FL. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anselmo A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017374; BABIC N, 1994, VIROLOGY, V204, P616, DOI 10.1006/viro.1994.1576; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Berezikov E, 2011, GENOME RES, V21, P203, DOI 10.1101/gr.116657.110; Besecker MI, 2009, J VIROL, V83, P3413, DOI 10.1128/JVI.02419-08; Betel D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r90; Boss IW, 2009, TRENDS MICROBIOL, V17, P544, DOI 10.1016/j.tim.2009.09.002; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; Cai XZ, 2005, P NATL ACAD SCI USA, V102, P5570, DOI 10.1073/pnas.0408192102; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen DJ, 2011, RNA, V17, P1012, DOI 10.1261/rna.2589011; Chen HuanChun, 1998, Acta Veterinaria et Zootechnica Sinica, V29, P156; Chen SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012745; CHEUNG AK, 1989, J VIROL, V63, P2908, DOI 10.1128/JVI.63.7.2908-2913.1989; CHEUNG AK, 1991, J VIROL, V65, P5260, DOI 10.1128/JVI.65.10.5260-5271.1991; Cui C, 2006, J VIROL, V80, P5499, DOI 10.1128/JVI.00200-06; Cullen BR, 2009, NATURE, V457, P421, DOI 10.1038/nature07757; Enquist LW, 1999, ARCH VIROL, P87; FARRELL MJ, 1991, P NATL ACAD SCI USA, V88, P790, DOI 10.1073/pnas.88.3.790; Geenen K, 2005, J GEN VIROL, V86, P1251, DOI 10.1099/vir.0.80760-0; Ghosh Z, 2009, NUCLEIC ACIDS RES, V37, P1035, DOI 10.1093/nar/gkn1004; Glazov EA, 2010, J GEN VIROL, V91, P32, DOI 10.1099/vir.0.014290-0; Gottwein E, 2008, CELL HOST MICROBE, V3, P375, DOI 10.1016/j.chom.2008.05.002; Granzow H, 2005, J VIROL, V79, P3200, DOI 10.1128/JVI.79.5.3200-3205.2005; Grey F, 2005, J VIROL, V79, P12095, DOI 10.1128/JVI.79.18.12095-12099.2005; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Grundhoff A, 2011, VIROLOGY, V411, P325, DOI 10.1016/j.virol.2011.01.002; Guo H, 2009, VIRUS GENES, V38, P269, DOI 10.1007/s11262-008-0320-3; Jin L, 2000, J VIROL, V74, P6333, DOI 10.1128/JVI.74.14.6333-6338.2000; Jurak I, 2010, J VIROL, V84, P4659, DOI 10.1128/JVI.02725-09; Klupp BG, 2004, J VIROL, V78, P424, DOI 10.1128/JVI.78.1.424-440.2004; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Kunin V, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-401; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Mukerjee R, 2004, VIROLOGY, V324, P340, DOI 10.1016/j.virol.2004.03.043; Ou CJ, 2002, VIRUS GENES, V25, P227, DOI 10.1023/A:1020959521745; Ouellet DL, 2008, NUCLEIC ACIDS RES, V36, P2353, DOI 10.1093/nar/gkn076; Perng Guey-Chuen, 2010, Interdiscip Perspect Infect Dis, V2010, P262415, DOI 10.1155/2010/262415; Pfeffer S, 2005, NAT METHODS, V2, P269, DOI 10.1038/NMETH746; Pfeffer S, 2004, SCIENCE, V304, P734, DOI 10.1126/science.1096781; Pomeranz LE, 2005, MICROBIOL MOL BIOL R, V69, P462, DOI 10.1128/MMBR.69.3.462-500.2005; Riley KJL, 2010, J VIROL, V84, P5148, DOI 10.1128/JVI.00110-10; Shi WY, 2009, NAT STRUCT MOL BIOL, V16, P183, DOI 10.1038/nsmb.1536; STEINER I, 1994, NEUROPATH APPL NEURO, V20, P253, DOI 10.1111/j.1365-2990.1994.tb00967.x; STEVENS JG, 1987, SCIENCE, V235, P1056, DOI 10.1126/science.2434993; Taharaguchi S, 2002, VET MICROBIOL, V85, P197, DOI 10.1016/S0378-1135(01)00513-2; Triboulet R, 2007, SCIENCE, V315, P1579, DOI 10.1126/science.1136319; Umbach JL, 2010, VIROLOGY, V405, P592, DOI 10.1016/j.virol.2010.06.036; Umbach JL, 2010, J VIROL, V84, P695, DOI 10.1128/JVI.02013-09; Varkonyi-Gasic E, 2011, METHODS MOL BIOL, V744, P145, DOI 10.1007/978-1-61779-123-9_10; Volk N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019391; Wang FZ, 2008, J VIROL, V82, P9065, DOI 10.1128/JVI.00961-08; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031	54	40	58	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30988	10.1371/journal.pone.0030988	http://dx.doi.org/10.1371/journal.pone.0030988			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22292087	Green Published, gold, Green Submitted			2022-12-25	WOS:000301570600104
J	Fillatre, J; Delacour, D; Van Hove, L; Bagarre, T; Houssin, N; Soulika, M; Veitia, RA; Moreau, J				Fillatre, Jonathan; Delacour, Delphine; Van Hove, Lucie; Bagarre, Thomas; Houssin, Nathalie; Soulika, Marina; Veitia, Reiner A.; Moreau, Jacques			Dynamics of the subcellular localization of RalBP1/RLIP through the cell cycle: the role of targeting signals and of protein-protein interactions	FASEB JOURNAL			English	Article						NLS; actin; centrosome	RAL-BINDING PROTEIN-1; ACTIN CYTOSKELETON; RLIP76; DOMAIN; IDENTIFICATION; RECOGNITION; INVOLVEMENT; TRANSPORT; EFFECTOR; PATHWAY	The small G protein Ras regulates many cell processes, such as gene expression, proliferation, apoptosis, and cell differentiation. Its mutations are associated with one-third of all cancers. Ras functions are mediated, at least in part, by Ral proteins and their downstream effector the Ral-binding protein 1 (RalBP1). RalBP1 is involved in endocytosis and in regulating the dynamics of the actin cytoskeleton. It also regulates early development since it is required for the completion of gastrulation in Xenopus laevis. RalBP1 has also been reported to be the main transporter of glutathione electrophiles, and it is involved in multidrug resistance. Such a variety of functions could be explained by a differential regulation of RalBP1 localization. In this study, we have detected endogenous RalBP1 in the nucleus of interphasic cells. This nuclear targeting is mediated by nuclear localization sequences that map to the N-terminal third of the protein. Moreover, in X. laevis embryos, a C-terminal coiled-coil sequence mediates RalBP1 retention in the nucleus. We have also observed RalBP1 at the level of the actin cytoskeleton, a localization that depends on interaction of the protein with active Ral. During mitosis RalBP1 also associates with the mitotic spindle and the centrosome, a localization that could be negatively regulated by active Ral. Finally, we demonstrate the presence of post-transcriptional and post-translational isoforms of RalBP1 lacking the Ral-binding domain, which opens new possibilities for the existence of Ral-independent functions.-Fillatre, J., Delacour, D., Van Hove, L., Bagarre, T., Houssin, N., Soulika, M., Veitia, R. A., Moreau, J. Dynamics of the subcellular localization of RalBP1/RLIP through the cell cycle: the role of targeting signals and of protein-protein interactions. FASEB J. 26, 2164-2174 (2012). www.fasebj.org	[Moreau, Jacques] Univ Paris Diderot, CNRS, Inst Jacques Monod, UMR 7592, F-75205 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite	Moreau, J (corresponding author), Univ Paris Diderot, CNRS, Inst Jacques Monod, UMR 7592, 15 Rue Helen Brion, F-75205 Paris, France.	moreau.jacques@ijm.univ-paris-diderot.fr	Houssin, Nathalie/AAU-7200-2020	Van Hove, Lucie/0000-0002-8499-5396; Delacour, Delphine/0000-0001-8202-4425	Centre National de la Recherche Scientifique; Association pour la Recherche sur le Cancer; Groupement des Entreprises Francaises dans la Lutte contre le Cancer	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Groupement des Entreprises Francaises dans la Lutte contre le Cancer	The authors thank Anne-Lise Haenni and Valerie Doye for critical reading of this manuscript. This work was supported by the Centre National de la Recherche Scientifique, Association pour la Recherche sur le Cancer, and Groupement des Entreprises Francaises dans la Lutte contre le Cancer.	Andreou Artemisia M., 2009, Biotechnology Journal, V4, P1740, DOI 10.1002/biot.200900219; Awasthi S, 2000, BIOCHEMISTRY-US, V39, P9327, DOI 10.1021/bi992964c; Awasthi S, 2008, CLIN CANCER RES, V14, P4372, DOI 10.1158/1078-0432.CCR-08-0145; Boissel L, 2007, DEV BIOL, V312, P331, DOI 10.1016/j.ydbio.2007.09.027; CANTOR SB, 1995, MOL CELL BIOL, V15, P4578; Cascone I, 2008, EMBO J, V27, P2375, DOI 10.1038/emboj.2008.166; Chiu VK, 2002, NAT CELL BIOL, V4, P343, DOI 10.1038/ncb783; Cocquet J, 2006, GENOMICS, V88, P127, DOI 10.1016/j.ygeno.2005.12.013; Gurdon J. B., 1967, METHODS DEV BIOL, P75; GUSSE M, 1989, MOL CELL BIOL, V9, P5395, DOI 10.1128/MCB.9.12.5395; Han K, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000187; Hicks SW, 2002, J BIOL CHEM, V277, P35833, DOI 10.1074/jbc.M206280200; Ikeda M, 1998, J BIOL CHEM, V273, P814, DOI 10.1074/jbc.273.2.814; Imasaki T, 2007, MOL CELL, V28, P57, DOI 10.1016/j.molcel.2007.08.006; Jans DA, 2000, BIOESSAYS, V22, P532, DOI 10.1002/(SICI)1521-1878(200006)22:6<532::AID-BIES6>3.0.CO;2-O; Jullien-Flores V, 2000, J CELL SCI, V113, P2837; Lebreton S, 2004, MECH DEVELOP, V121, P1481, DOI 10.1016/j.mod.2004.07.008; Lebreton S, 2003, J CELL SCI, V116, P4651, DOI 10.1242/jcs.00763; Moreau J, 1999, DEV BIOL, V209, P268, DOI 10.1006/dbio.1999.9254; Omerovic J, 2009, FEBS J, V276, P1817, DOI 10.1111/j.1742-4658.2009.06928.x; Omura T, 1998, J BIOCHEM-TOKYO, V123, P1010; Pechlivanis M, 2006, BBA-PROTEINS PROTEOM, V1764, P1914, DOI 10.1016/j.bbapap.2006.09.017; Philips MR, 2005, BIOCHEM SOC T, V33, P657, DOI 10.1042/BST0330657; Prieve MG, 1999, MOL CELL BIOL, V19, P4503; Quaroni A, 1999, J CELL SCI, V112, P707; Sato N, 2005, BIOCHEM BIOPH RES CO, V336, P617, DOI 10.1016/j.bbrc.2005.08.145; Singhal SS, 2009, BIOCHEM PHARMACOL, V77, P1074, DOI 10.1016/j.bcp.2008.11.013; Singhal SS, 2006, CANCER RES, V66, P2354, DOI 10.1158/0008-5472.CAN-05-3534	28	13	13	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	MAY	2012	26	5					2164	2174		10.1096/fj.11-196451	http://dx.doi.org/10.1096/fj.11-196451			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	937TD	22319010				2022-12-25	WOS:000303680800042
J	Kurokawa, K; Ryu, KH; Ichikawa, R; Masuda, A; Kim, MS; Lee, H; Chae, JH; Shimizu, T; Saitoh, T; Kuwano, K; Akira, S; Dohmae, N; Nakayama, H; Lee, BL				Kurokawa, Kenji; Ryu, Kyoung-Hwa; Ichikawa, Rie; Masuda, Akiko; Kim, Min-Su; Lee, Hanna; Chae, Jun-Ho; Shimizu, Takashi; Saitoh, Tatsuya; Kuwano, Koichi; Akira, Shizuo; Dohmae, Naoshi; Nakayama, Hiroshi; Lee, Bok Luel			Novel Bacterial Lipoprotein Structures Conserved in Low-GC Content Gram-positive Bacteria Are Recognized by Toll-like Receptor 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOLIPOPROTEIN N-ACYLTRANSFERASE; ESCHERICHIA-COLI; GENOME SEQUENCE; STAPHYLOCOCCUS-AUREUS; OUTER-MEMBRANE; CUTTING EDGE; IHEYA RIDGE; KAPPA-B; BACILLUS; TOLL-LIKE-RECEPTOR-1	Bacterial lipoproteins/lipopeptides inducing host innate immune responses are sensed by mammalian Toll-like receptor 2 (TLR2). These bacterial lipoproteins are structurally divided into two groups, diacylated or triacylated lipoproteins, by the absence or presence of an amide-linked fatty acid. The presence of diacylated lipoproteins has been predicted in low-GC content Gram-positive bacteria and mycoplasmas based on the absence of one modification enzyme in their genomes; however, we recently determined triacylated structures in low-GC Gram-positive Staphylococcus aureus, raising questions about the actual lipoprotein structure in other low-GC content Gram-positive bacteria. Here, through intensive MS analyses, we identified a novel and unique bacterial lipoprotein structure containing an N-acyl-S-monoacyl-glyceryl-cysteine (named the lyso structure) from low-GC Gram-positive Enterococcus faecalis, Bacillus cereus, Streptococcus sanguinis, and Lactobacillus bulgaricus. Two of the purified native lyso-form lipoproteins induced proinflammatory cytokine production from mice macrophages in a TLR2-dependent and TLR1-independent manner but with a different dependence on TLR6. Additionally, two other new lipoprotein structures were identified. One is the "N-acetyl" lipoprotein structure containing N-acetyl-S-diacylglyceryl-cysteine, which was found in five Gram-positive bacteria, including Bacillus subtilis. The N-acetyl lipoproteins induced the proinflammatory cytokines through the TLR2/6 heterodimer. The other was identified in a mycoplasma strain and is an unusual diacyl lipoprotein structure containing two amino acids before the lipid-modified cysteine residue. Taken together, our results suggest the existence of novel TLR2-stimulating lyso and N-acetyl forms of lipoproteins that are conserved in low-GC content Gram-positive bacteria and provide clear evidence for the presence of yet to be identified key enzymes involved in the bacterial lipoprotein biosynthesis.	[Ichikawa, Rie; Masuda, Akiko; Dohmae, Naoshi; Nakayama, Hiroshi] RIKEN, Biomol Characterizat Team, Adv Sci Inst, Wako, Saitama 3510198, Japan; [Kurokawa, Kenji; Ryu, Kyoung-Hwa; Kim, Min-Su; Chae, Jun-Ho; Lee, Bok Luel] Pusan Natl Univ, Coll Pharm, Global Res Lab Insect Symbiosis, Pusan 609735, South Korea; [Lee, Hanna; Saitoh, Tatsuya; Akira, Shizuo] Osaka Univ, Microbial Dis Res Inst, Dept Host Def, Suita, Osaka 5650871, Japan; [Lee, Hanna; Saitoh, Tatsuya; Akira, Shizuo] Osaka Univ, Host Def Lab, World Premier Int Immunol Frontier Res Ctr, Suita, Osaka 5650871, Japan; [Shimizu, Takashi; Kuwano, Koichi] Kurume Univ, Sch Med, Dept Bacteriol, Kurume, Fukuoka 8300011, Japan	RIKEN; Pusan National University; Osaka University; Osaka University; Kurume University	Nakayama, H (corresponding author), RIKEN, Biomol Characterizat Team, Adv Sci Inst, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	knife@riken.jp; brlee@pusan.ac.kr	Dohmae, Naoshi/C-2040-2011; Akira, Shizuo/C-3134-2009	Dohmae, Naoshi/0000-0002-5242-9410; 	Bio-Program [2008-2004086]; BK21; National Research Foundation of Korea	Bio-Program; BK21(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea); National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by Bio-Program Grant 2008-2004086 and the BK21 programs supported by the National Research Foundation of Korea (to B. L. L.).	Asanuma M, 2011, FEBS J, V278, P716, DOI 10.1111/j.1742-4658.2010.07990.x; Fukuda A, 2002, J BIOL CHEM, V277, P43512, DOI 10.1074/jbc.M206816200; Glaser P, 2001, SCIENCE, V294, P849; GUPTA SD, 1993, J BIOL CHEM, V268, P16551; Henneke P, 2008, J IMMUNOL, V180, P6149, DOI 10.4049/jimmunol.180.9.6149; HUSSAIN M, 1982, J BIOL CHEM, V257, P5177; Hutchings MI, 2009, TRENDS MICROBIOL, V17, P13, DOI 10.1016/j.tim.2008.10.001; Ivanova N, 2003, NATURE, V423, P87, DOI 10.1038/nature01582; Iwasaki A, 2010, SCIENCE, V327, P291, DOI 10.1126/science.1183021; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; KANEDA T, 1977, BACTERIOL REV, V41, P391, DOI 10.1128/MMBR.41.2.391-418.1977; Kang JY, 2009, IMMUNITY, V31, P873, DOI 10.1016/j.immuni.2009.09.018; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kovacs-Simon A, 2011, INFECT IMMUN, V79, P548, DOI 10.1128/IAI.00682-10; Kurokawa K, 2009, J BIOL CHEM, V284, P8406, DOI 10.1074/jbc.M809618200; Lu J, 2001, FEMS MICROBIOL LETT, V205, P291, DOI 10.1111/j.1574-6968.2001.tb10963.x; Machata S, 2008, J IMMUNOL, V181, P2028, DOI 10.4049/jimmunol.181.3.2028; Martin DDO, 2011, BIOCHIMIE, V93, P18, DOI 10.1016/j.biochi.2010.10.018; Masuda A, 2010, ANAL CHEM, V82, P8939, DOI 10.1021/ac101718x; Muhlradt PF, 1997, J EXP MED, V185, P1951, DOI 10.1084/jem.185.11.1951; Nakanishi H, 2010, J BIOCHEM, V147, P245, DOI 10.1093/jb/mvp171; Paulsen IT, 2003, SCIENCE, V299, P2071, DOI 10.1126/science.1080613; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Rechnitzer H, 2011, MICROBIOL-SGM, V157, P760, DOI 10.1099/mic.0.043208-0; Robichon C, 2005, J BIOL CHEM, V280, P974, DOI 10.1074/jbc.M411059200; SANKARAN K, 1994, J BIOL CHEM, V269, P19701; Serebryakova MV, 2011, J BIOL CHEM, V286, P22769, DOI 10.1074/jbc.M111.231316; Shimizu T, 2008, INFECT IMMUN, V76, P3672, DOI 10.1128/IAI.00257-08; Shimizu T, 2007, IMMUNOLOGY, V121, P473, DOI 10.1111/j.1365-2567.2007.02594.x; Takami H, 2000, EXTREMOPHILES, V4, P99, DOI 10.1007/s007920050143; Takami H, 2004, NUCLEIC ACIDS RES, V32, P6292, DOI 10.1093/nar/gkh970; Takami H, 2002, NUCLEIC ACIDS RES, V30, P3927, DOI 10.1093/nar/gkf526; Takeuchi O, 2000, J IMMUNOL, V165, P5392, DOI 10.4049/jimmunol.165.10.5392; Takeuchi O, 2002, J IMMUNOL, V169, P10, DOI 10.4049/jimmunol.169.1.10; Takeuchi O, 2001, INT IMMUNOL, V13, P933, DOI 10.1093/intimm/13.7.933; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; TOKUNAGA M, 1982, P NATL ACAD SCI-BIOL, V79, P2255, DOI 10.1073/pnas.79.7.2255; TOKUNAGA M, 1985, J BIOL CHEM, V260, P5610; Torres D, 2004, INFECT IMMUN, V72, P2131, DOI 10.1128/IAI.72.4.2131-2139.2004; Tschumi A, 2009, J BIOL CHEM, V284, P27146, DOI 10.1074/jbc.M109.022715; Veith B, 2004, J MOL MICROB BIOTECH, V7, P204, DOI 10.1159/000079829; Yakushi T, 2000, NAT CELL BIOL, V2, P212, DOI 10.1038/35008635	42	54	56	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					13170	13181		10.1074/jbc.M111.292235	http://dx.doi.org/10.1074/jbc.M111.292235			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22303020	Green Published, hybrid			2022-12-25	WOS:000302903700055
J	Evjenth, RH; Brenner, AK; Thompson, PR; Arnesen, T; Froystein, NA; Lillehaug, JR				Evjenth, Rune H.; Brenner, Annette K.; Thompson, Paul R.; Arnesen, Thomas; Froystein, Nils Age; Lillehaug, Johan R.			Human Protein N-terminal Acetyltransferase hNaa50p (hNAT5/hSAN) Follows Ordered Sequential Catalytic Mechanism COMBINED KINETIC AND NMR STUDY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HETERONUCLEAR CORRELATION SPECTRA; MAGNETIC-RESONANCE RELAXATION; MODEL-FREE APPROACH; HISTONE ACETYLTRANSFERASE; ALPHA-ACETYLTRANSFERASE; CHEMICAL-SHIFT; ARD1; YEAST; C-13; MACROMOLECULES	N-alpha-Acetylation is a common protein modification catalyzed by different N-terminal acetyltransferases (NATs). Their essential role in the biogenesis and degradation of proteins is becoming increasingly evident. TheNAThNaa50p preferentially modifies peptides starting with methionine followed by a hydrophobic amino acid. hNaa50p also possesses N-epsilon-autoacetylation activity. So far, no eukaryotic NAT has been mechanistically investigated. In this study, we used NMR spectroscopy, bisubstrate kinetic assays, and product inhibition experiments to demonstrate that hNaa50p utilizes an ordered Bi Bi reaction of the Theorell-Chance type. The NMR results, both the substrate binding study and the dynamic data, further indicate that the binding of acetyl-CoA induces a conformational change that is required for the peptide to bind to the active site. In support of an ordered Bi Bi reaction mechanism, addition of peptide in the absence of acetyl-CoA did not alter the structure of the protein. This model is further strengthened by the NMR results using a catalytically inactive hNaa50p mutant.	[Evjenth, Rune H.; Arnesen, Thomas; Lillehaug, Johan R.] Univ Bergen, Dept Mol Biol, N-5020 Bergen, Norway; [Brenner, Annette K.; Froystein, Nils Age] Univ Bergen, Dept Chem, N-5020 Bergen, Norway; [Thompson, Paul R.] Scripps Res Inst, Dept Chem, Jupiter, FL 33458 USA; [Arnesen, Thomas] Haukeland Hosp, Dept Surg, N-5021 Bergen, Norway	University of Bergen; University of Bergen; Scripps Research Institute; University of Bergen; Haukeland University Hospital	Evjenth, RH (corresponding author), Univ Bergen, Dept Mol Biol, Thormohlensgate 55, N-5020 Bergen, Norway.	rune.evjenth@mbi.uib.no; johan.lillehaug@mbi.uib.no	Arnesen, Thomas/Q-8117-2019; Arnesen, Thomas/J-7139-2017	Arnesen, Thomas/0000-0002-3005-147X; Arnesen, Thomas/0000-0002-3005-147X				Albaugh BN, 2010, BIOCHEMISTRY-US, V49, P6375, DOI 10.1021/bi100381y; Arnesen T, 2006, ONCOGENE, V25, P4350, DOI 10.1038/sj.onc.1209469; Arnesen T, 2006, GENE, V371, P291, DOI 10.1016/j.gene.2005.12.008; Arnesen T, 2009, P NATL ACAD SCI USA, V106, P8157, DOI 10.1073/pnas.0901931106; Arnesen T, 2008, CURR CANCER DRUG TAR, V8, P545, DOI 10.2174/156800908786241113; Berndsen CE, 2007, BIOCHEMISTRY-US, V46, P623, DOI 10.1021/bi602513x; Berndsen CE, 2008, CURR OPIN STRUC BIOL, V18, P682, DOI 10.1016/j.sbi.2008.11.004; Clements A, 1999, EMBO J, V18, P3521, DOI 10.1093/emboj/18.13.3521; DAVIS AL, 1992, J MAGN RESON, V98, P207, DOI 10.1016/0022-2364(92)90126-R; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dosset P, 2000, J BIOMOL NMR, V16, P23, DOI 10.1023/A:1008305808620; Evjenth Rune, 2009, BMC Proc, V3 Suppl 6, pS5, DOI 10.1186/1753-6561-3-S6-S5; Evjenth R, 2009, J BIOL CHEM, V284, P31122, DOI 10.1074/jbc.M109.001347; Fisher TS, 2005, J BIOL CHEM, V280, P17749, DOI 10.1074/jbc.M412055200; Fluge O, 2002, ONCOGENE, V21, P5056, DOI 10.1038/sj.onc.1205687; Gautschi M, 2003, MOL CELL BIOL, V23, P7403, DOI 10.1128/MCB.23.20.7403-7414.2003; Gromyko D, 2010, INT J CANCER, V127, P2777, DOI 10.1002/ijc.25275; GRZESIEK S, 1993, J AM CHEM SOC, V115, P12593, DOI 10.1021/ja00079a052; GRZESIEK S, 1993, J MAGN RESON SER B, V101, P114, DOI 10.1006/jmrb.1993.1019; Harris RK, 2001, PURE APPL CHEM, V73, P1795, DOI 10.1351/pac200173111795; Hou FJ, 2007, J CELL BIOL, V177, P587, DOI 10.1083/jcb.200701043; KAMATH U, 1989, J BIOL CHEM, V264, P5586; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; Keller R.L.J, 2005, THESIS ETH ZURICH ZU; Kuo HP, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000590; Lim JH, 2006, CANCER RES, V66, P10677, DOI 10.1158/0008-5472.CAN-06-3171; LIPARI G, 1982, J AM CHEM SOC, V104, P4559, DOI 10.1021/ja00381a010; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; Liszczak G, 2011, J BIOL CHEM, V286, P37002, DOI 10.1074/jbc.M111.282863; Liu X, 2008, NATURE, V451, P846, DOI 10.1038/nature06546; MONTELIONE GT, 1992, J AM CHEM SOC, V114, P10974, DOI 10.1021/ja00053a051; Neuwald AF, 1997, TRENDS BIOCHEM SCI, V22, P154, DOI 10.1016/S0968-0004(97)01034-7; Pimenta-Marques A, 2008, DEV BIOL, V323, P197, DOI 10.1016/j.ydbio.2008.08.021; Plasman K, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.003301; Polevoda B, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-5-reviews0006; Polevoda Bogdan, 2009, BMC Proc, V3 Suppl 6, pS2, DOI 10.1186/1753-6561-3-S6-S2; Ren TT, 2008, CANCER LETT, V264, P83, DOI 10.1016/j.canlet.2008.01.028; Rojas JR, 1999, NATURE, V401, P93, DOI 10.1038/43487; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Schanda P, 2005, J BIOMOL NMR, V33, P199, DOI 10.1007/s10858-005-4425-x; Schubert M, 1999, J MAGN RESON, V141, P34, DOI 10.1006/jmre.1999.1881; Schubert M, 2001, J MAGN RESON, V153, P186, DOI 10.1006/jmre.2001.2447; Schubert M, 2001, J BIOMOL NMR, V20, P379, DOI 10.1023/A:1011206131623; Van Damme P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002169; Vetting MW, 2005, J BIOL CHEM, V280, P22108, DOI 10.1074/jbc.M502401200; Wang L, 2008, CURR OPIN STRUC BIOL, V18, P741, DOI 10.1016/j.sbi.2008.09.004; Williams BC, 2003, CURR BIOL, V13, P2025, DOI 10.1016/j.cub.2003.11.018; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; WISHART DS, 1991, J MOL BIOL, V222, P311, DOI 10.1016/0022-2836(91)90214-Q; Yan Y, 2002, NAT STRUCT BIOL, V9, P862, DOI 10.1038/nsb849; Yi CH, 2007, J CELL BIOL, V179, P619, DOI 10.1083/jcb.200708090; Yu M, 2009, ONCOL REP, V21, P909, DOI 10.3892/or_00000303	52	16	17	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					10081	10088		10.1074/jbc.M111.326587	http://dx.doi.org/10.1074/jbc.M111.326587			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22311970	Green Published, hybrid, Green Submitted			2022-12-25	WOS:000302167200040
J	Kondo-Okamoto, N; Noda, NN; Suzuki, SW; Nakatogawa, H; Takahashi, I; Matsunami, M; Hashimoto, A; Inagaki, F; Ohsumi, Y; Okamoto, K				Kondo-Okamoto, Noriko; Noda, Nobuo N.; Suzuki, Sho W.; Nakatogawa, Hitoshi; Takahashi, Ikuko; Matsunami, Miou; Hashimoto, Ayako; Inagaki, Fuyuhiko; Ohsumi, Yoshinori; Okamoto, Koji			Autophagy-related Protein 32 Acts as Autophagic Degron and Directly Initiates Mitophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VACUOLE TARGETING PATHWAY; SELECTIVE AUTOPHAGY; SACCHAROMYCES-CEREVISIAE; MITOCHONDRIAL PROTEIN; STRUCTURAL BASIS; YEAST; MECHANISM; CARGO; CYTOPLASM; ATG32	Autophagy-related degradation selective for mitochondria (mitophagy) is an evolutionarily conserved process that is thought to be critical for mitochondrial quality and quantity control. In budding yeast, autophagy-related protein 32 (Atg32) is inserted into the outer membrane of mitochondria with its Nand C-terminal domains exposed to the cytosol and mitochondrial intermembrane space, respectively, and plays an essential role in mitophagy. Atg32 interacts with Atg8, a ubiquitin-like protein localized to the autophagosome, and Atg11, a scaffold protein required for selective autophagy-related pathways, although the significance of these interactions remains elusive. In addition, whether Atg32 is the sole protein necessary and sufficient for initiation of autophagosome formation has not been addressed. Here we show that the Atg32 IMS domain is dispensable for mitophagy. Notably, when anchored to peroxisomes, the Atg32 cytosol domain promoted autophagy-dependent peroxisome degradation, suggesting that Atg32 contains a module compatible for other organelle autophagy. X-ray crystallography reveals that the Atg32 Atg8 family-interacting motif peptide binds Atg8 in a conserved manner. Mutations in this binding interface impair association of Atg32 with the free form of Atg8 and mitophagy. Moreover, Atg32 variants, which do not stably interact with Atg11, are strongly defective in mitochondrial degradation. Finally, we demonstrate that Atg32 forms a complex with Atg8 and Atg11 prior to and independent of isolation membrane generation and subsequent autophagosome formation. Taken together, our data implicate Atg32 as a bipartite platform recruiting Atg8 and Atg11 to the mitochondrial surface and forming an initiator complex crucial for mitophagy.	[Kondo-Okamoto, Noriko; Hashimoto, Ayako; Okamoto, Koji] Osaka Univ, Grad Sch Frontier Biosci, Lab Mitochondrial Dynam, Suita, Osaka 5650871, Japan; [Noda, Nobuo N.; Inagaki, Fuyuhiko] Hokkaido Univ, Grad Sch Pharmaceut Sci, Dept Biol Struct, Sapporo, Hokkaido 0600812, Japan; [Suzuki, Sho W.; Nakatogawa, Hitoshi; Takahashi, Ikuko; Matsunami, Miou; Ohsumi, Yoshinori] Tokyo Inst Technol, Frontier Res Ctr, Yokohama, Kanagawa 2268503, Japan	Osaka University; Hokkaido University; Tokyo Institute of Technology	Okamoto, K (corresponding author), Osaka Univ, Grad Sch Frontier Biosci, Lab Mitochondrial Dynam, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	kokamoto@fbs.osaka-u.ac.jp	Ohsumi, Yoshinori/C-6449-2009; Nakatogawa, Hitoshi/D-5155-2015; Noda, Nobuo/P-1397-2015	Ohsumi, Yoshinori/0000-0003-2384-2166; Nakatogawa, Hitoshi/0000-0002-5828-0741; Noda, Nobuo/0000-0002-6940-8069; Suzuki, Sho/0000-0002-6563-5387	Ministry of Education, Culture, Science, and Technology of Japan [22770124]; Targeted Proteins Research Program; Specially Promoted Research Grant [19002015]; Scientific Research (C) Grant [20570144]; Scientific Research on Priority Areas Grants [20059034, 22020012]; Scientific Research on Innovative Areas Grant [23113717]; Challenging Exploratory Research Grant [23657090]; Osaka University; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Sumitomo Foundation; Grants-in-Aid for Scientific Research [22770124, 22020012] Funding Source: KAKEN	Ministry of Education, Culture, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Targeted Proteins Research Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Specially Promoted Research Grant; Scientific Research (C) Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Scientific Research on Priority Areas Grants(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Scientific Research on Innovative Areas Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Challenging Exploratory Research Grant; Osaka University; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Sumitomo Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grant-in-Aid 22770124 from the Ministry of Education, Culture, Science, and Technology of Japan for Young Scientists (B) (to N. K. O.), the Targeted Proteins Research Program (to F. I.), Specially Promoted Research Grant 19002015 (to Y. O.), Scientific Research (C) Grant 20570144 (to K. O.), Scientific Research on Priority Areas Grants 20059034 and 22020012 (to K. O.), Scientific Research on Innovative Areas Grant 23113717 (to K. O.), Challenging Exploratory Research Grant 23657090 (to K. O.), special coordination funds from the Osaka University Life Science Young Independent Researcher Support Program to Disseminate Tenure Tracking System (to K. O.), and by grants from the Mochida Memorial Foundation for Medical and Pharmaceutical Research (to K. O.) and the Sumitomo Foundation (to K. O.).	Aoki Y, 2011, MOL BIOL CELL, V22, P3206, DOI 10.1091/mbc.E11-02-0145; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cheong H, 2005, MOL BIOL CELL, V16, P3438, DOI 10.1091/mbc.E04-10-0894; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Farre JC, 2008, DEV CELL, V14, P365, DOI 10.1016/j.devcel.2007.12.011; Frederick RL, 2004, J CELL BIOL, V167, P87, DOI 10.1083/jcb.200405100; Halbach A, 2006, J CELL SCI, V119, P2508, DOI 10.1242/jcs.02979; Hara T, 2008, J CELL BIOL, V181, P497, DOI 10.1083/jcb.200712064; Ichimura Y, 2008, J BIOL CHEM, V283, P22847, DOI 10.1074/jbc.M802182200; Kabeya Y, 2005, MOL BIOL CELL, V16, P2544, DOI 10.1091/mbc.e04-08-0669; Kamada Y, 2000, J CELL BIOL, V150, P1507, DOI 10.1083/jcb.150.6.1507; Kanki T, 2008, J BIOL CHEM, V283, P32386, DOI 10.1074/jbc.M802403200; Kanki T, 2011, ANTIOXID REDOX SIGN, V14, P1989, DOI 10.1089/ars.2010.3762; Kanki T, 2009, MOL BIOL CELL, V20, P4730, DOI 10.1091/mbc.E09-03-0225; Kanki T, 2009, DEV CELL, V17, P98, DOI 10.1016/j.devcel.2009.06.014; Kim J, 2001, J CELL BIOL, V153, P381, DOI 10.1083/jcb.153.2.381; Kirisako T, 1999, J CELL BIOL, V147, P435, DOI 10.1083/jcb.147.2.435; Kissova I, 2004, J BIOL CHEM, V279, P39068, DOI 10.1074/jbc.M406960200; Lynch-Day MA, 2010, FEBS LETT, V584, P1359, DOI 10.1016/j.febslet.2010.02.013; Mao K, 2011, J CELL BIOL, V193, P755, DOI 10.1083/jcb.201102092; Matsuura A, 1997, GENE, V192, P245, DOI 10.1016/S0378-1119(97)00084-X; Mizushima N, 2011, ANNU REV CELL DEV BI, V27, P107, DOI 10.1146/annurev-cellbio-092910-154005; Narendra DP, 2011, ANTIOXID REDOX SIGN, V14, P1929, DOI 10.1089/ars.2010.3799; Nazarko TY, 2009, MOL BIOL CELL, V20, P3828, DOI 10.1091/mbc.E09-03-0221; Noda NN, 2010, FEBS LETT, V584, P1379, DOI 10.1016/j.febslet.2010.01.018; Noda NN, 2008, GENES CELLS, V13, P1211, DOI 10.1111/j.1365-2443.2008.01238.x; Novak I, 2010, EMBO REP, V11, P45, DOI 10.1038/embor.2009.256; Okamoto K., 2012, BIOCH BIOPH IN PRESS; Okamoto K, 2009, DEV CELL, V17, P87, DOI 10.1016/j.devcel.2009.06.013; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Satoo K, 2009, EMBO J, V28, P1341, DOI 10.1038/emboj.2009.80; Shintani T, 2002, DEV CELL, V3, P825, DOI 10.1016/S1534-5807(02)00373-8; Suzuki K, 2001, EMBO J, V20, P5971, DOI 10.1093/emboj/20.21.5971; Suzuki K, 2010, J BIOL CHEM, V285, P30019, DOI 10.1074/jbc.M110.143511; Tal R, 2007, J BIOL CHEM, V282, P5617, DOI 10.1074/jbc.M605940200; Weidberg H, 2011, ANNU REV BIOCHEM, V80, P125, DOI 10.1146/annurev-biochem-052709-094552; Yamaguchi M, 2010, J BIOL CHEM, V285, P29599, DOI 10.1074/jbc.M110.113670; Yorimitsu T, 2005, MOL BIOL CELL, V16, P1593, DOI 10.1091/mbc.E04-11-1035; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; Zhang J, 2011, ANTIOXID REDOX SIGN, V14, P1959, DOI 10.1089/ars.2010.3772	40	91	100	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					10631	10638		10.1074/jbc.M111.299917	http://dx.doi.org/10.1074/jbc.M111.299917			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22308029	hybrid, Green Published			2022-12-25	WOS:000302167200088
J	Wang, S; Li, H; Chen, YH; Wei, HT; Gao, GF; Liu, HQ; Huang, SL; Chen, JL				Wang, Song; Li, Hua; Chen, Yuhai; Wei, Haitao; Gao, George F.; Liu, Hongqiang; Huang, Shile; Chen, Ji-Long			Transport of Influenza Virus Neuraminidase (NA) to Host Cell Surface Is Regulated by ARHGAP21 and Cdc42 Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHO-GTPASES; TRANSMEMBRANE DOMAIN; VESICLE TRAFFICKING; RAFT ASSOCIATION; GOLGI MEMBRANES; ACTIN DYNAMICS; VIRAL ENTRY; COMPLEX; TRANSFORMATION; HEMAGGLUTININ	Influenza virus neuraminidase (NA) is transported to the virus assembly site at the plasma membrane and is a major viral envelope component that plays a critical role in the release of progeny virions and in determination of host range restriction. However, little is known about the host factors that are involved in regulating the intracellular and cell surface transport of NA. Here we identified the Cdc42-specific GAP, ARHGAP21 differentially expressed in host cells infected with influenza A virus using cDNA microarray analysis. Furthermore, we have investigated the involvement of Rho family GTPases in NA transport to the cell surface. We found that expression of constitutively active or inactive mutants of RhoA or Rac1 did not significantly affect the amount of NA that reached the cell surface. However, expression of constitutively active Cdc42 or depletion of ARHGAP21 promoted the transport of NA to the plasma membranes. By contrast, cells expressing shRNA targeting Cdc42 or overexpressing ARHGAP21 exhibited a significant decrease in the amount of cell surface-localized NA. Importantly, silencing Cdc42 reduced influenza A virus replication, whereas silencing ARHGAP21 increased the virus replication. Together, our results reveal that ARHGAP21- and Cdc42-based signaling regulates the NA transport and thereby impacts virus replication.	[Wang, Song; Li, Hua; Chen, Yuhai; Wei, Haitao; Gao, George F.; Liu, Hongqiang; Chen, Ji-Long] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing 100101, Peoples R China; [Huang, Shile] Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Shreveport, LA 71130 USA; [Li, Hua] Fujian Agr & Forestry Univ, Coll Anim Sci, Fuzhou 350002, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Fujian Agriculture & Forestry University	Chen, JL (corresponding author), Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, W Beichen Rd, Beijing 100101, Peoples R China.	chenjl@im.ac.cn	Chen, Ji-Long/AAJ-2134-2021; Gao, George Fu/ABD-5229-2021; Huang, Shile/I-1632-2019	Chen, Ji-Long/0000-0002-4274-0563; Huang, Shile/0000-0002-3239-1072; Wei, Haitao/0000-0001-5235-8619	National Basic Research Program (973) of China [2010CB534004]; National Key Technology RD Program [2009BA183B01-8]; Chinese Academy of Sciences [2010-Biols-CAS-0204]; National Natural Science Foundation of China Innovative Research Group [81021003]	National Basic Research Program (973) of China(National Basic Research Program of China); National Key Technology RD Program(National Key Technology R&D Program); Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China Innovative Research Group	This work was supported by National Basic Research Program (973) of China (2010CB534004), National Key Technology R&D Program (2009BA183B01-8), Intramural grant of the Chinese Academy of Sciences (2010-Biols-CAS-0204), and Hundreds of Talents Program of Chinese Academy of Sciences 2009-2014.; A leading principal investigator of the National Natural Science Foundation of China Innovative Research Group (Grant 81021003).	AKTORIES K, 1995, METHOD ENZYMOL, V256, P184; Aktories K, 2000, BIOL CHEM, V381, P421, DOI 10.1515/BC.2000.054; AKTORIES K, 1995, TRENDS CELL BIOL, V5, P441, DOI 10.1016/S0962-8924(00)89107-2; Balklava Z, 2007, NAT CELL BIOL, V9, P1066, DOI 10.1038/ncb1627; Barman S, 2000, J VIROL, V74, P6538, DOI 10.1128/JVI.74.14.6538-6545.2000; Barman S, 2004, J VIROL, V78, P5258, DOI 10.1128/JVI.78.10.5258-5269.2004; Bloom JD, 2010, SCIENCE, V328, P1272, DOI 10.1126/science.1187816; Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; Calvo F, 2011, NAT CELL BIOL, V13, P819, DOI 10.1038/ncb2271; Cerione RA, 2004, TRENDS CELL BIOL, V14, P127, DOI 10.1016/j.tcb.2004.01.008; Chen BJ, 2007, J VIROL, V81, P7111, DOI 10.1128/JVI.00361-07; Chen JL, 2005, J CELL BIOL, V169, P383, DOI 10.1083/jcb.200501157; Chen JL, 2004, FEBS LETT, V566, P281, DOI 10.1016/j.febslet.2004.04.061; Collins PJ, 2008, NATURE, V453, P1258, DOI 10.1038/nature06956; Dubois T, 2005, NAT CELL BIOL, V7, P353, DOI 10.1038/ncb1244; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fucini RV, 2002, MOL BIOL CELL, V13, P621, DOI 10.1091/mbc.01-11-0547; Gubareva LV, 2004, VIRUS RES, V103, P199, DOI 10.1016/j.virusres.2004.02.034; Guo G, 2010, ONCOGENE, V29, P3845, DOI 10.1038/onc.2010.149; Hall A, 2005, BIOCHEM SOC T, V33, P891, DOI 10.1042/BST0330891; Harris KP, 2010, TRAFFIC, V11, P1272, DOI 10.1111/j.1600-0854.2010.01102.x; Hehnly H, 2010, TRAFFIC, V11, P1067, DOI 10.1111/j.1600-0854.2010.01082.x; Hehnly H, 2009, MOL BIOL CELL, V20, P4303, DOI 10.1091/mbc.E09-02-0155; Kumari S, 2008, NAT CELL BIOL, V10, P30, DOI 10.1038/ncb1666; Lee-Kwon W, 2003, J BIOL CHEM, V278, P16494, DOI 10.1074/jbc.M300580200; Li Q, 2010, NAT STRUCT MOL BIOL, V17, P1266, DOI 10.1038/nsmb.1909; Li ZF, 2011, P NATL ACAD SCI USA, V108, P3116, DOI 10.1073/pnas.1009353108; LIU CG, 1995, J VIROL, V69, P1099, DOI 10.1128/JVI.69.2.1099-1106.1995; Liu D, 2009, SCI CHINA SER C, V52, P428, DOI 10.1007/s11427-009-0062-z; Liu SW, 2011, EUR J PHARMACOL, V660, P460, DOI 10.1016/j.ejphar.2011.04.013; Luna A, 2002, MOL BIOL CELL, V13, P866, DOI 10.1091/mbc.01-12-0579; Malyukova I, 2009, AM J PHYSIOL-GASTR L, V296, pG78, DOI 10.1152/ajpgi.90347.2008; Matas OB, 2005, EUR J CELL BIOL, V84, P699, DOI 10.1016/j.ejcb.2005.05.001; Melendez J, 2011, J BIOL CHEM, V286, P2375, DOI 10.1074/jbc.R110.200329; Menetrey J, 2007, EMBO J, V26, P1953, DOI 10.1038/sj.emboj.7601634; Nayak DP, 2009, VIRUS RES, V143, P147, DOI 10.1016/j.virusres.2009.05.010; Ohuchi M, 2006, MICROBES INFECT, V8, P1287, DOI 10.1016/j.micinf.2005.12.008; Osmani N, 2010, J CELL BIOL, V191, P1261, DOI 10.1083/jcb.201003091; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; Sabharanjak S, 2002, DEV CELL, V2, P411, DOI 10.1016/S1534-5807(02)00145-4; Slaughter BD, 2009, DEV CELL, V17, P823, DOI 10.1016/j.devcel.2009.10.022; Stamnes M, 2002, CURR OPIN CELL BIOL, V14, P428, DOI 10.1016/S0955-0674(02)00349-6; Valderrama F, 2000, P NATL ACAD SCI USA, V97, P1560, DOI 10.1073/pnas.97.4.1560; WEIS W, 1988, NATURE, V333, P426, DOI 10.1038/333426a0; Whittaker G R, 2001, Expert Rev Mol Med, V2001, P1, DOI 10.1017/S1462399401002447; WILEY DC, 1987, ANNU REV BIOCHEM, V56, P365, DOI 10.1146/annurev.bi.56.070187.002053; Wilkins TD, 1996, TRENDS MICROBIOL, V4, P49, DOI 10.1016/0966-842X(96)81508-3; Wu WJ, 2000, NATURE, V405, P800, DOI 10.1038/35015585	48	58	62	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					9804	9816		10.1074/jbc.M111.312959	http://dx.doi.org/10.1074/jbc.M111.312959			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22318733	hybrid, Green Published			2022-12-25	WOS:000302167200013
J	Nummenmaa, L; Hirvonen, J; Hannukainen, JC; Immonen, H; Lindroos, MM; Salminen, P; Nuutila, P				Nummenmaa, Lauri; Hirvonen, Jussi; Hannukainen, Jarna C.; Immonen, Heidi; Lindroos, Markus M.; Salminen, Paulina; Nuutila, Pirjo			Dorsal Striatum and Its Limbic Connectivity Mediate Abnormal Anticipatory Reward Processing in Obesity	PLOS ONE			English	Article							VISUAL FOOD STIMULI; CEREBRAL-BLOOD-FLOW; NUCLEUS-ACCUMBENS; HIGH-CALORIE; HUMAN BRAIN; INDIVIDUAL-DIFFERENCES; APPETITIVE MOTIVATION; INTRAVENOUS GLUCOSE; ACTIVATION; ADDICTION	Obesity is characterized by an imbalance in the brain circuits promoting reward seeking and those governing cognitive control. Here we show that the dorsal caudate nucleus and its connections with amygdala, insula and prefrontal cortex contribute to abnormal reward processing in obesity. We measured regional brain glucose uptake in morbidly obese (n = 19) and normal weighted (n = 16) subjects with 2-[18F]fluoro-2-deoxyglucose ([F-18]FDG) positron emission tomography (PET) during euglycemic hyperinsulinemia and with functional magnetic resonance imaging (fMRI) while anticipatory food reward was induced by repeated presentations of appetizing and bland food pictures. First, we found that glucose uptake rate in the dorsal caudate nucleus was higher in obese than in normal-weight subjects. Second, obese subjects showed increased hemodynamic responses in the caudate nucleus while viewing appetizing versus bland foods in fMRI. The caudate also showed elevated task-related functional connectivity with amygdala and insula in the obese versus normal-weight subjects. Finally, obese subjects had smaller responses to appetizing versus bland foods in the dorsolateral and orbitofrontal cortices than did normal-weight subjects, and failure to activate the dorsolateral prefrontal cortex was correlated with high glucose metabolism in the dorsal caudate nucleus. These findings suggest that enhanced sensitivity to external food cues in obesity may involve abnormal stimulus-response learning and incentive motivation subserved by the dorsal caudate nucleus, which in turn may be due to abnormally high input from the amygdala and insula and dysfunctional inhibitory control by the frontal cortical regions. These functional changes in the responsiveness and interconnectivity of the reward circuit could be a critical mechanism to explain overeating in obesity.	[Nummenmaa, Lauri] Aalto Univ, Sch Sci, Olli Viktor Lounasmaa Lab, Brain Res Unit, Espoo, Finland; [Nummenmaa, Lauri] Aalto Univ, Sch Sci, Dept Biomed Engn & Computat Sci, Espoo, Finland; [Nummenmaa, Lauri; Hirvonen, Jussi; Hannukainen, Jarna C.; Immonen, Heidi; Lindroos, Markus M.; Nuutila, Pirjo] Turku Positron Emiss Tomog PET, Turku, Finland; [Immonen, Heidi; Nuutila, Pirjo] Univ Turku, Dept Med, Turku, Finland; [Salminen, Paulina] Univ Turku, Dept Surg, Turku, Finland	Aalto University; Aalto University; University of Turku; University of Turku	Nummenmaa, L (corresponding author), Aalto Univ, Sch Sci, Olli Viktor Lounasmaa Lab, Brain Res Unit, Espoo, Finland.	nummenmaa@neuro.hut.fi	Immonen, Heidi/AAX-8893-2020; Nummenmaa, Lauri/G-6910-2012; Salminen, Paulina Taru Pipsa (T.P.)/ABB-8883-2020; Nuutila, Pirjo/J-2087-2012; Hirvonen, Jussi/AAC-1864-2020; Hirvonen, Jussi/H-2521-2012	Nummenmaa, Lauri/0000-0002-2497-9757; Salminen, Paulina Taru Pipsa (T.P.)/0000-0001-6435-9264; Nuutila, Pirjo/0000-0001-9597-338X; Hannukainen, Jarna/0000-0002-8692-4049	Academy of Finland [256147, 251125]; Aalto University (AivoAALTO); Sigrid Juselius foundation; Turku University Hospital (EVO)	Academy of Finland(Academy of Finland); Aalto University (AivoAALTO); Sigrid Juselius foundation(Sigrid Juselius Foundation); Turku University Hospital (EVO)	This work was supported by the Academy of Finland (grants #256147 and #251125 http://www.aka.fi) to LN, by the Aalto University (AivoAALTO Grant, http://www.aalto.fi) Sigrid Juselius foundation (www.sigridjuselius.fi/foundation) Turku University Hospital (EVO grant http://www.tyks.fi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaro E, 2006, BRAIN COGNITION, V60, P220, DOI 10.1016/j.bandc.2005.11.009; Ambroggi F, 2008, NEURON, V59, P648, DOI 10.1016/j.neuron.2008.07.004; Baicy K, 2007, P NATL ACAD SCI USA, V104, P18276, DOI 10.1073/pnas.0706481104; Baldo BA, 2005, BEHAV NEUROSCI, V119, P1195, DOI 10.1037/0735-7044.119.5.1195; Balleine BW, 2007, J NEUROSCI, V27, P8161, DOI 10.1523/JNEUROSCI.1554-07.2007; Beaver JD, 2006, J NEUROSCI, V26, P5160, DOI 10.1523/JNEUROSCI.0350-06.2006; Berridge KC, 1996, NEUROSCI BIOBEHAV R, V20, P1, DOI 10.1016/0149-7634(95)00033-B; Berridge KC, 2010, BRAIN RES, V1350, P43, DOI 10.1016/j.brainres.2010.04.003; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; Cornell CE, 1989, PHYSL BEHAV, V45; Cornier MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006310; Dagher A, 2009, INT J OBESITY, V33, pS30, DOI 10.1038/ijo.2009.69; DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214; Franken IHA, 2005, APPETITE, V45, P198, DOI 10.1016/j.appet.2005.04.004; Friedman DP, 2002, J COMP NEUROL, V450, P345, DOI 10.1002/cne.10336; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; Gitelman DR, 2003, NEUROIMAGE, V19, P200, DOI 10.1016/S1053-8119(03)00058-2; Graham MM, 2002, J NUCL MED, V43, P1157; Green EA, 2009, TECH REP SER, V68, P791; Haltia LT, 2007, SYNAPSE, V61, P748, DOI 10.1002/syn.20418; Haltia LT, 2010, SCAND J CLIN LAB INV, V70, P275, DOI 10.3109/00365511003792975; HAMACHER K, 1986, J NUCL MED, V27, P235; Ikemoto S, 1999, BRAIN RES REV, V31, P6, DOI 10.1016/S0165-0173(99)00023-5; Kaisti KK, 2002, ANESTHESIOLOGY, V96, P1358, DOI 10.1097/00000542-200206000-00015; Kaisti KK, 2003, ANESTHESIOLOGY, V99, P603, DOI 10.1097/00000542-200309000-00015; Kelley AE, 2004, NEUROSCI BIOBEHAV R, V27, P765, DOI 10.1016/j.neubiorev.2003.11.015; Kelley AE, 2002, J NEUROSCI, V22, P3306; Killgore WDS, 2003, NEUROIMAGE, V19, P1381, DOI 10.1016/S1053-8119(03)00191-5; Koob GF, 2010, NEUROPSYCHOPHARMACOL, V35, P217, DOI 10.1038/npp.2009.110; Kriegeskorte N, 2009, NAT NEUROSCI, V12, P535, DOI 10.1038/nn.2303; LaBar KS, 2001, BEHAV NEUROSCI, V115, P493, DOI 10.1037//0735-7044.115.2.493; Lemmens SG, PHYSL BEHAV IN PRESS; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Naqvi NH, 2009, TRENDS NEUROSCI, V32, P56, DOI 10.1016/j.tins.2008.09.009; Nathan PJ, 2009, INT J NEUROPSYCHOPH, V12, P995, DOI 10.1017/S146114570900039X; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; Passamonti L, 2009, J NEUROSCI, V29, P43, DOI 10.1523/JNEUROSCI.4966-08.2009; Passamonti L, 2008, NEUROIMAGE, V43, P562, DOI 10.1016/j.neuroimage.2008.07.045; Pelchat ML, 2004, NEUROIMAGE, V23, P1486, DOI 10.1016/j.neuroimage.2004.08.023; Rosenbaum M, 2008, J CLIN INVEST, V118, P2583, DOI 10.1172/JCI35055; Rothemund Y, 2007, NEUROIMAGE, V37, P410, DOI 10.1016/j.neuroimage.2007.05.008; RUSSCHEN FT, 1985, BRAIN RES, V329, P241, DOI 10.1016/0006-8993(85)90530-X; Small DM, 2001, BRAIN, V124, P1720, DOI 10.1093/brain/124.9.1720; Small DM, 2003, NEUROIMAGE, V19, P1709, DOI 10.1016/S1053-8119(03)00253-2; Sokoloff L, 1999, NEUROCHEM RES, V24, P321, DOI 10.1023/A:1022534709672; Stice E, 2008, J ABNORM PSYCHOL, V117, P924, DOI 10.1037/a0013600; Stoeckel LE, 2008, NEUROIMAGE, V41, P636, DOI 10.1016/j.neuroimage.2008.02.031; Stoeckel LE, 2009, BRAIN RES BULL, V79, P388, DOI 10.1016/j.brainresbull.2009.05.016; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Verdejo-Garcia A, 2009, NEUROPHARMACOLOGY, V56, P48, DOI 10.1016/j.neuropharm.2008.07.035; Volkow ND, 2004, MOL PSYCHIATR, V9, P557, DOI 10.1038/sj.mp.4001507; Volkow ND, 2005, NAT NEUROSCI, V8, P555, DOI 10.1038/nn1452; Volkow ND, 2002, SYNAPSE, V44, P175, DOI 10.1002/syn.10075; Volkow ND, 2008, PHILOS T R SOC B, V363, P3191, DOI 10.1098/rstb.2008.0107; Volkow ND, 2008, NEUROIMAGE, V42, P1537, DOI 10.1016/j.neuroimage.2008.06.002; Wang GJ, 2004, NEUROIMAGE, V21, P1790, DOI 10.1016/j.neuroimage.2003.11.026; Wang GJ, 2001, LANCET, V357, P354, DOI 10.1016/S0140-6736(00)03643-6; Will MJ, 2004, NEUROREPORT, V15, P1857, DOI 10.1097/00001756-200408260-00004	58	153	156	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2012	7	2							e31089	10.1371/journal.pone.0031089	http://dx.doi.org/10.1371/journal.pone.0031089			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LO	22319604	Green Submitted, Green Published, gold			2022-12-25	WOS:000302178400027
J	Rosenbaum, MA; Bar, HY; Beg, QK; Segre, D; Booth, J; Cotta, MA; Angenent, LT				Rosenbaum, Miriam A.; Bar, Haim Y.; Beg, Qasim K.; Segre, Daniel; Booth, James; Cotta, Michael A.; Angenent, Largus T.			Transcriptional Analysis of Shewanella oneidensis MR-1 with an Electrode Compared to Fe(III)Citrate or Oxygen as Terminal Electron Acceptor	PLOS ONE			English	Article							RHODOBACTER-SPHAEROIDES 2.4.1; TETRAHEME CYTOCHROME CYMA; MICROBIAL FUEL-CELLS; C-TYPE CYTOCHROMES; STRAIN MR-1; ANAEROBIC RESPIRATION; PUTREFACIENS MR-1; GEOBACTER-SULFURREDUCENS; MICROARRAY ANALYSIS; DIMETHYL-SULFOXIDE	Shewanella oneidensis is a target of extensive research in the fields of bioelectrochemical systems and bioremediation because of its versatile metabolic capabilities, especially with regard to respiration with extracellular electron acceptors. The physiological activity of S. oneidensis to respire at electrodes is of great interest, but the growth conditions in thin-layer biofilms make physiological analyses experimentally challenging. Here, we took a global approach to evaluate physiological activity with an electrode as terminal electron acceptor for the generation of electric current. We performed expression analysis with DNA microarrays to compare the overall gene expression with an electrode to that with soluble iron(III) or oxygen as the electron acceptor and applied new hierarchical model-based statistics for the differential expression analysis. We confirmed the differential expression of many genes that have previously been reported to be involved in electrode respiration, such as the entire mtr operon. We also formulate hypotheses on other possible gene involvements in electrode respiration, for example, a role of ScyA in inter-protein electron transfer and a regulatory role of the cbb3-type cytochrome c oxidase under anaerobic conditions. Further, we hypothesize that electrode respiration imposes a significant stress on S. oneidensis, resulting in higher energetic costs for electrode respiration than for soluble iron(III) respiration, which fosters a higher metabolic turnover to cover energy needs. Our hypotheses now require experimental verification, but this expression analysis provides a fundamental platform for further studies into the molecular mechanisms of S. oneidensis electron transfer and the physiologically special situation of growth on a poise-dpotential surface.	[Rosenbaum, Miriam A.; Angenent, Largus T.] Cornell Univ, Dept Biol & Environm Engn, Ithaca, NY USA; [Bar, Haim Y.; Booth, James] Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY USA; [Beg, Qasim K.; Segre, Daniel] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [Segre, Daniel] Boston Univ, Dept Biol, Boston, MA 02215 USA; [Segre, Daniel] Boston Univ, Bioinformat Program, Boston, MA 02215 USA; [Cotta, Michael A.] ARS, Bioenergy Res Unit, USDA, NCAUR, Peoria, IL USA	Cornell University; Cornell University; Boston University; Boston University; Boston University; United States Department of Agriculture (USDA)	Rosenbaum, MA (corresponding author), Rhein Westfal TH Aachen, Inst Appl Microbiol, Aachen, Germany.	la249@cornell.edu	Segrè, Daniel/A-1993-2009; Angenent, Largus T/A-6219-2018; Rosenbaum, Miriam A./E-5317-2011	Segrè, Daniel/0000-0003-4859-1914; Angenent, Largus T/0000-0003-0180-1865; Rosenbaum, Miriam A./0000-0002-4566-8624; Cotta, Michael/0000-0003-4565-7754	Fermentation Biotechnology Research Unit, USDA, Agricultural Research Service, Peoria, Illinois; National Science Foundation [0939882]; US Department of Energy [DE-FG02-07ER64388, DE-FG02-07ER64483]	Fermentation Biotechnology Research Unit, USDA, Agricultural Research Service, Peoria, Illinois(United States Department of Agriculture (USDA)USDA Agricultural Research Service); National Science Foundation(National Science Foundation (NSF)); US Department of Energy(United States Department of Energy (DOE))	The financial support for this work was provided through a specific collaborative agreement between Largus Angenent and the Fermentation Biotechnology Research Unit, USDA, Agricultural Research Service, Peoria, Illinois and the National Science Foundation through CAREER grant no. 0939882 to LTA, DS, and QKB are partially supported by US Department of Energy grants DE-FG02-07ER64388 and DE-FG02-07ER64483. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar H, 2010, STAT SCI, V25, P388, DOI 10.1214/10-STS339; Beliaev Alex S., 2002, OMICS A Journal of Integrative Biology, V6, P39, DOI 10.1089/15362310252780834; Beliaev AS, 2005, J BACTERIOL, V187, P7138, DOI 10.1128/JB.187.20.7138-7145.2005; Beliaev AS, 2002, J BACTERIOL, V184, P4612, DOI 10.1128/JB.184.16.4612-4616.2002; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bouhenni R, 2005, APPL ENVIRON MICROB, V71, P4935, DOI 10.1128/AEM.71.8.4935-4937.2005; Bretschger O, 2007, APPL ENVIRON MICROB, V73, P7003, DOI 10.1128/AEM.01087-07; Carpentier W, 2005, J BACTERIOL, V187, P3293, DOI 10.1128/JB.187.10.3293-3301.2005; Coursolle D, 2010, MOL MICROBIOL, V77, P995, DOI 10.1111/j.1365-2958.2010.07266.x; Coursolle D, 2010, J BACTERIOL, V192, P467, DOI 10.1128/JB.00925-09; Cury JA, 2007, ANAL BIOCHEM, V365, P208, DOI 10.1016/j.ab.2007.03.021; DiChristina TJ, 2002, J BACTERIOL, V184, P142, DOI 10.1128/JB.184.1.142-151.2002; Elias DA, 2007, J MICROBIOL METH, V68, P367, DOI 10.1016/j.mimet.2006.09.023; Faith JJ, 2007, PLOS BIOL, V5, P54, DOI 10.1371/journal.pbio.0050008; Franks AE, 2009, ENERG ENVIRON SCI, V2, P113, DOI 10.1039/b816445b; Franks AE, 2010, ISME J, V4, P509, DOI 10.1038/ismej.2009.137; Gao HC, 2010, MICROB BIOTECHNOL, V3, P455, DOI 10.1111/j.1751-7915.2010.00181.x; Gao HC, 2009, ISME J, V3, P966, DOI 10.1038/ismej.2009.40; Gescher JS, 2008, MOL MICROBIOL, V68, P706, DOI 10.1111/j.1365-2958.2008.06183.x; Gorby YA, 2006, P NATL ACAD SCI USA, V103, P11358, DOI 10.1073/pnas.0604517103; Gralnick JA, 2006, P NATL ACAD SCI USA, V103, P4669, DOI 10.1073/pnas.0505959103; Harris HW, 2010, P NATL ACAD SCI USA, V107, P326, DOI 10.1073/pnas.0907468107; Hau HH, 2008, APPL ENVIRON MICROB, V74, P6880, DOI 10.1128/AEM.00840-08; Hau HH, 2007, ANNU REV MICROBIOL, V61, P237, DOI 10.1146/annurev.micro.61.080706.093257; Holmes DE, 2006, ENVIRON MICROBIOL, V8, P1805, DOI 10.1111/j.1462-2920.2006.01065.x; Ji HK, 2010, NAT BIOTECHNOL, V28, P337, DOI 10.1038/nbt.1619; Kaplan S, 2005, BIOCHEM SOC T, V33, P51, DOI 10.1042/BST0330051; Kim BC, 2008, BIOELECTROCHEMISTRY, V73, P70, DOI 10.1016/j.bioelechem.2008.04.023; Logan BE, 2006, ENVIRON SCI TECHNOL, V40, P5181, DOI 10.1021/es0605016; Lovley DR, 2008, CURR OPIN BIOTECH, V19, P564, DOI 10.1016/j.copbio.2008.10.005; Meyer TE, 2004, OMICS, V8, P57, DOI 10.1089/153623104773547499; Murphy JN, 2007, J BACTERIOL, V189, P2283, DOI 10.1128/JB.01698-06; Myers CR, 1997, J BACTERIOL, V179, P1143, DOI 10.1128/jb.179.4.1143-1152.1997; MYERS CR, 1988, SCIENCE, V240, P1319, DOI 10.1126/science.240.4857.1319; Myers JM, 2001, APPL ENVIRON MICROB, V67, P260, DOI 10.1128/AEM.67.1.260-269.2001; Myers JM, 2000, J BACTERIOL, V182, P67, DOI 10.1128/JB.182.1.67-75.2000; Nealson KH, 2002, ANTON LEEUW INT J G, V81, P215, DOI 10.1023/A:1020518818647; Oh JI, 1999, BIOCHEMISTRY-US, V38, P2688, DOI 10.1021/bi9825100; Pinchuk GE, 2009, P NATL ACAD SCI USA, V106, P2874, DOI 10.1073/pnas.0806798106; Pitts KE, 2003, J BIOL CHEM, V278, P27758, DOI 10.1074/jbc.M302582200; Qiu XY, 2006, J BACTERIOL, V188, P1199, DOI 10.1128/JB.188.3.1199-1204.2006; Ringeisen BR, 2010, ELECTROANAL, V22, P875, DOI 10.1002/elan.200880012; Rosenbaum M, 2010, BIOTECHNOL BIOENG, V105, P880, DOI 10.1002/bit.22621; Rosenbaum MA, 2011, BIORESOURCE TECHNOL, V102, P2623, DOI 10.1016/j.biortech.2010.10.033; Ross DE, 2007, APPL ENVIRON MICROB, V73, P5797, DOI 10.1128/AEM.00146-07; Ruebush SS, 2006, APPL ENVIRON MICROB, V72, P2925, DOI 10.1128/AEM.72.4.2925-2935.2006; Sani RK, 2008, WATER RES, V42, P2993, DOI 10.1016/j.watres.2008.04.003; Saville RM, 2010, FEMS MICROBIOL LETT, V308, P76, DOI 10.1111/j.1574-6968.2010.01995.x; Schwalb C, 2003, BIOCHEMISTRY-US, V42, P9491, DOI 10.1021/bi034456f; Schwalb C, 2002, BIOCHEM SOC T, V30, P658, DOI 10.1042/bst0300658; Shi L, 2007, MOL MICROBIOL, V65, P12, DOI 10.1111/j.1365-2958.2007.05783.x; Takeno N., 2005, ATLAS EH PH DIAGRAMS; Thormann KM, 2006, J BACTERIOL, V188, P2681, DOI 10.1128/JB.188.7.2681-2691.2006; Thormann KM, 2004, J BACTERIOL, V186, P8096, DOI 10.1128/JB.186.23.8096-8104.2004; Velasquez-Orta SB, 2010, APPL MICROBIOL BIOT, V85, P1373, DOI 10.1007/s00253-009-2172-8; Viamajala S, 2002, BIOTECHNOL BIOENG, V78, P770, DOI 10.1002/bit.10261; Watanabe K, 2009, CURR OPIN BIOTECH, V20, P633, DOI 10.1016/j.copbio.2009.09.006; Weber KA, 2006, NAT REV MICROBIOL, V4, P752, DOI 10.1038/nrmicro1490	58	42	45	9	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2012	7	2							e30827	10.1371/journal.pone.0030827	http://dx.doi.org/10.1371/journal.pone.0030827			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UG	22319591	Green Submitted, Green Published, gold			2022-12-25	WOS:000301977500020
J	Zhao, Y; Yu, H; Zhu, Y; Ter-Minassian, M; Peng, ZH; Shen, HB; Diao, N; Chen, F				Zhao, Yang; Yu, Hao; Zhu, Ying; Ter-Minassian, Monica; Peng, Zhihang; Shen, Hongbing; Diao, Nancy; Chen, Feng			Genetic Association Analysis Using Sibship Data: A Multilevel Model Approach	PLOS ONE			English	Article							GENERALIZED ESTIMATING EQUATIONS; GENOME-WIDE ASSOCIATION; LINKAGE DISEQUILIBRIUM; EFFICIENCY; DESIGN; TDT	Family based association study (FBAS) has the advantages of controlling for population stratification and testing for linkage and association simultaneously. We propose a retrospective multilevel model (rMLM) approach to analyze sibship data by using genotypic information as the dependent variable. Simulated data sets were generated using the simulation of linkage and association (SIMLA) program. We compared rMLM to sib transmission/disequilibrium test (S-TDT), sibling disequilibrium test (SDT), conditional logistic regression (CLR) and generalized estimation equations (GEE) on the measures of power, type I error, estimation bias and standard error. The results indicated that rMLM was a valid test of association in the presence of linkage using sibship data. The advantages of rMLM became more evident when the data contained concordant sibships. Compared to GEE, rMLM had less underestimated odds ratio (OR). Our results support the application of rMLM to detect gene-disease associations using sibship data. However, the risk of increasing type I error rate should be cautioned when there is association without linkage between the disease locus and the genotyped marker.	[Zhao, Yang; Yu, Hao; Peng, Zhihang; Shen, Hongbing; Chen, Feng] Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanjing, Jiangsu, Peoples R China; [Zhao, Yang; Ter-Minassian, Monica; Diao, Nancy] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Environm & Occupat Med & Epidemiol Program, Boston, MA 02115 USA; [Zhu, Ying] Univ London Imperial Coll Sci Technol & Med, Imperial Coll Business Sch, London, England	Nanjing Medical University; Harvard University; Harvard T.H. Chan School of Public Health; Imperial College London	Zhao, Y (corresponding author), Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanjing, Jiangsu, Peoples R China.	fengchen@njmu.edu.cn	zhao, yang/GXF-4424-2022	Chen, Feng/0000-0002-2699-7190; Ter-Minassian, Monica/0000-0002-9497-2585	National Natural Science Foundation of China (NSFC) [30571619]; NSFC [30901232]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); NSFC(National Natural Science Foundation of China (NSFC))	This study was funded by National Natural Science Foundation of China (NSFC) grant 30571619 and NSFC grant for young scientists 30901232. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bass M P, 2004, Pac Symp Biocomput, P93; Benyamin B, 2009, PHARMACOGENOMICS, V10, P181, DOI 10.2217/14622416.10.2.181; Bull SB, 2001, GENET EPIDEMIOL, V20, P149, DOI 10.1002/1098-2272(200102)20:2<149::AID-GEPI1>3.0.CO;2-A; Burton PR, 2003, GENET EPIDEMIOL, V24, P24, DOI 10.1002/gepi.10206; Cirulli ET, 2010, NAT REV GENET, V11, P415, DOI 10.1038/nrg2779; Devlin B, 2001, THEOR POPUL BIOL, V60, P155, DOI 10.1006/tpbi.2001.1542; GOLDSTEIN H, 1986, BIOMETRIKA, V73, P43; Goldstein H, 2002, STAT MED, V21, P3291, DOI 10.1002/sim.1264; Goldstein H, MULTILEVEL STAT MODE; Goldstein H, 2009, STAT MODEL, V9, P173, DOI 10.1177/1471082X0800900301; Hancock DB, 2007, GENET EPIDEMIOL, V31, P883, DOI 10.1002/gepi.20249; Hanley JA, 2003, AM J EPIDEMIOL, V157, P364, DOI 10.1093/aje/kwf215; Hinrichs Anthony L, 2009, BMC Proc, V3 Suppl 7, pS106; Hu FB, 1998, AM J EPIDEMIOL, V147, P694; Kraft P, 2000, AM J HUM GENET, V66, P1119, DOI 10.1086/302808; Laird NM, 2006, NAT REV GENET, V7, P385, DOI 10.1038/nrg1839; Liu Y-J, 2010, OBESITY SILVER SPRIN; McGinnis R, 2002, BEHAV GENET, V32, P135, DOI 10.1023/A:1015205924326; Miller RD, 2005, GENOMICS, V86, P117, DOI 10.1016/j.ygeno.2005.04.012; NEUHAUS JM, 1991, INT STAT REV, V59, P25, DOI 10.2307/1403572; Peng G, 2010, EUR J HUM GENET, V18, P111, DOI 10.1038/ejhg.2009.115; PRENTICE R, 1976, BIOMETRICS, V32, P599, DOI 10.2307/2529748; Price AL, 2010, NAT REV GENET, V11, P459, DOI 10.1038/nrg2813; Rasbash J, 2009, MLWIN 2 1; Siegmund KD, 2000, AM J HUM GENET, V67, P244, DOI 10.1086/302973; Spielman RS, 1996, AM J HUM GENET, V59, P983; Spielman RS, 1998, AM J HUM GENET, V62, P450, DOI 10.1086/301714; Yang SH, 2010, NEW ENGL J MED, V362, P2425; ZEGER SL, 1988, BIOMETRICS, V44, P1049, DOI 10.2307/2531734; Zou GY, 2006, ANN HUM GENET, V70, P262, DOI 10.1111/j.1529-8817.2005.00213.x	30	1	1	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2012	7	2							e31134	10.1371/journal.pone.0031134	http://dx.doi.org/10.1371/journal.pone.0031134			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UG	22312441	Green Published, Green Submitted, gold			2022-12-25	WOS:000301977500029
J	Mazeiras, G; Roze, JC; Ancel, PY; Caillaux, G; Frondas-Chauty, A; Denizot, S; Flamant, C				Mazeiras, Gael; Roze, Jean-Christophe; Ancel, Pierre-Yves; Caillaux, Gaelle; Frondas-Chauty, Anne; Denizot, Sophie; Flamant, Cyril			Hyperbilirubinemia and Neurodevelopmental Outcome of Very Low Birthweight Infants: Results from the LIFT Cohort	PLOS ONE			English	Article							SERUM BILIRUBIN; FOLLOW-UP; PHOTOTHERAPY; KERNICTERUS; QUESTIONNAIRE; ASSOCIATION; JAUNDICE; CHILDREN; RISK; AGES	Background: Bilirubin-related neurotoxicity is an important clinical issue in very low birthweight (VLBW) infants, and the existing literature is inconsistent. Objective: To analyze the relationship between maximal serum unconjugated bilirubin levels (SBL) and neurodevelopmental outcome at 2-year corrected age in VLBW infants. Methods: Phototherapy was initiated in all infants born before 33 weeks of gestation, according to Maisels' recommendations. Neurodevelopmental assessment at 2-year corrected age was performed in all infants that survived. SBLs collected during the first week of life were used to define three tertiles of max-SBL. The first tertile corresponded to infants with the lowest max-SBL. Results and Conclusions: A total of 724 infants were included in the study, and among them, 631 (87%) were evaluated at two years old. The infants of the first tertile were younger and smaller than the infants of the other two tertiles, in accordance with Maisels' recommendations for very small infants. No difference in the risk of impaired functional outcome among the three groups was observed. However, among infants weighing less than 1001 g, those in the third tertile had a poorer neurodevelopmental prognosis as compared to those in the second tertile (adjusted odds ratio = 6.8, 95% CI: 1.2-36.7, p = 0.03). Considering the results obtained, we propose 196 mu mol/L (11.5 mg/dL) when birthweight varies between 1001 and 1500 g, and 170 mu mol/L (9.9 mg/dL) when birthweight is less than 1001 g, as recommended max-SBLs (defined as maximal levels of 95th percentile curves of SBLs in infants with an optimal outcome). When Maisels' recommendations were applied, max SBLs were higher in 8% of infants weighing 1001-1500 g and in 15% of infants weighing less than 1001 g. Our data seems to validate Maisels' recommendations in the overall population of infants born before 33 weeks of gestation, but not in infants weighing less than 1001 g.	[Mazeiras, Gael] St Leon Hosp, Dept Neonatal Med, Bayonne, France; [Roze, Jean-Christophe; Caillaux, Gaelle; Frondas-Chauty, Anne; Denizot, Sophie; Flamant, Cyril] Nantes Univ Hosp, Dept Neonatal Med, Nantes, France; [Roze, Jean-Christophe; Caillaux, Gaelle; Frondas-Chauty, Anne; Denizot, Sophie; Flamant, Cyril] Nantes Univ Hosp, Natl Inst Hlth & Med Res CIC004, Nantes, France; [Roze, Jean-Christophe; Caillaux, Gaelle; Frondas-Chauty, Anne; Denizot, Sophie; Flamant, Cyril] LIFT, Pays De Loire, France; [Ancel, Pierre-Yves] Tenon Univ Hosp, Natl Inst Hlth, Paris, France; [Ancel, Pierre-Yves] Tenon Univ Hosp, Med Res Mixed Res Unit S149, Fed Inst Res 69, Epidemiol Res Unit Perinatal & Womens Hlth, Paris, France; [Ancel, Pierre-Yves] Univ Paris 06, Paris, France	Nantes Universite; CHU de Nantes; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite	Mazeiras, G (corresponding author), St Leon Hosp, Dept Neonatal Med, Bayonne, France.	cyril.flamant@chu-nantes.fr	roze, jean christophe/B-5433-2012; Rozé, Jean-Christophe/AAS-1314-2021	ANCEL, pierre-yves/0000-0001-9632-7494; Roze, Jean-Christophe/0000-0003-3367-512X				Bratlid D, 2001, J Perinatol, V21 Suppl 1, pS88, DOI 10.1038/sj.jp.7210656; Cashore WJ, 2000, CLIN PERINATOL, V27, P171, DOI 10.1016/S0095-5108(05)70012-9; COCKINGTON RA, 1979, J PEDIATR-US, V95, P281; Fily A, 2006, PEDIATRICS, V117, P357, DOI 10.1542/peds.2005-0236; Flamant C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020004; GARTNER LM, 1970, PEDIATRICS, V45, P906; GOPINATHAN V, 1994, FEBS LETT, V349, P197, DOI 10.1016/0014-5793(94)00666-0; Hack M, 2000, ARCH PEDIAT ADOL MED, V154, P725, DOI 10.1001/archpedi.154.7.725; Josse D, 1997, REVISED BRUNETLEZINE; Klamer A, 2005, ACTA PAEDIATR, V94, P1327, DOI 10.1080/08035250510042825; Maisels MJ, 2004, PEDIATRICS, V114, P297; McCoy L, 1999, ARCH DIS CHILD-FETAL, V80, pF38; Moll M, 2011, NEONATOLOGY, V99, P90, DOI 10.1159/000302719; Morris BH, 2008, NEW ENGL J MED, V359, P1885, DOI 10.1056/NEJMoa0803024; Newman TB, 2000, PEDIATRICS, V105, P242; Oh W, 2003, PEDIATRICS, V112, P773, DOI 10.1542/peds.112.4.773; Oh W, 2010, ACTA PAEDIATR, V99, P673, DOI 10.1111/j.1651-2227.2010.01688.x; OSHEA TM, 1992, PEDIATRICS, V90, P888; Roze JC, 2007, ARCH PEDIATRIE, V14, pS65, DOI 10.1016/S0929-693X(07)80014-5; Skellern CY, 2001, J PAEDIATR CHILD H, V37, P125, DOI 10.1046/j.1440-1754.2001.00604.x; Squires J, 1997, J PEDIATR PSYCHOL, V22, P313, DOI 10.1093/jpepsy/22.3.313; TOZZI E, 1989, BIOL NEONATE, V56, P204; VANDEBOR M, 1989, PEDIATRICS, V83, P915; Vreman HJ, 2004, SEMIN PERINATOL, V28, P326, DOI 10.1053/j.semperi.2004.09.003	24	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2012	7	1							e30900	10.1371/journal.pone.0030900	http://dx.doi.org/10.1371/journal.pone.0030900			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911GB	22303470	gold, Green Published, Green Submitted			2022-12-25	WOS:000301704200046
J	Ricci, M; Xu, YJ; Hammond, HL; Willoughby, DA; Nathanson, L; Rodriguez, MM; Vatta, M; Lipshultz, SE; Lincoln, J				Ricci, Marco; Xu, Yanji; Hammond, Harriet L.; Willoughby, David A.; Nathanson, Lubov; Rodriguez, Maria M.; Vatta, Matteo; Lipshultz, Steven E.; Lincoln, Joy			Myocardial Alternative RNA Splicing and Gene Expression Profiling in Early Stage Hypoplastic Left Heart Syndrome	PLOS ONE			English	Article							FAILURE; VENTRICLE; SETS	Hypoplastic Left Heart Syndrome (HLHS) is a congenital defect characterized by underdevelopment of the left ventricle and pathological compensation of the right ventricle. If untreated, HLHS is invariably lethal due to the extensive increase in right ventricular workload and eventual failure. Despite the clinical significance, little is known about the molecular pathobiological state of HLHS. Splicing of mRNA transcripts is an important regulatory mechanism of gene expression. Tissue specific alterations of this process have been associated with several cardiac diseases, however, transcriptional signature profiles related to HLHS are unknown. In this study, we performed genome-wide exon array analysis to determine differentially expressed genes and alternatively spliced transcripts in the right ventricle (RV) of six neonates with HLHS, compared to the RV and left ventricle (LV) from non-diseased control subjects. In HLHS, over 180 genes were differentially expressed and 1800 were differentially spliced, leading to changes in a variety of biological processes involving cell metabolism, cytoskeleton, and cell adherence. Additional hierarchical clustering analysis revealed that differential gene expression and mRNA splicing patterns identified in HLHS are unique compared to non-diseased tissue. Our findings suggest that gene expression and mRNA splicing are broadly dysregulated in the RV myocardium of HLHS neonates. In addition, our analysis identified transcriptome profiles representative of molecular biomarkers of HLHS that could be used in the future for diagnostic and prognostic stratification to improve patient outcome.	[Ricci, Marco] Univ Miami, Miller Sch Med, Div Cardiothorac Surg, Miami, FL 33136 USA; [Ricci, Marco; Rodriguez, Maria M.; Lipshultz, Steven E.] Jackson Mem Hosp, Holtz Childrens Hosp, Miami, FL 33136 USA; [Xu, Yanji] Shaun & Lilly Int LLC, Palm City, FL USA; [Hammond, Harriet L.; Lincoln, Joy] Ohio State Univ, Dept Pediat, Nationwide Childrens Hosp, Ctr Cardiovasc & Pulm Res, Columbus, OH 43210 USA; [Willoughby, David A.] Ocean Ridge Biosci LLC, Palm Beach Gardens, FL USA; [Nathanson, Lubov] Univ Miami, Miller Sch Med, Inst Human Genom, Miami, FL 33136 USA; [Rodriguez, Maria M.] Univ Miami, Miller Sch Med, Dept Pathol, Miami, FL 33136 USA; [Vatta, Matteo] Texas Childrens Hosp, Baylor Coll Med, Div Pediat Cardiol, Houston, TX 77030 USA; [Vatta, Matteo] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA; [Lipshultz, Steven E.] Univ Miami, Miller Sch Med, Dept Pediat, Miami, FL 33136 USA	University of Miami; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University of Miami; University of Miami; Baylor College of Medicine; Baylor College of Medicine; University of Miami	Ricci, M (corresponding author), Univ Miami, Miller Sch Med, Div Cardiothorac Surg, Miami, FL 33136 USA.	mricci@med.miami.edu	HCFMUSP, Pós-Graduação DOG -/F-1162-2013; Nathanson, Lubov/ABC-2642-2021	Nathanson, Lubov/0000-0003-1038-9083; Lincoln, Joy/0000-0003-1517-6888	private University of Miami; National Heart, Lung, and Blood Institute [R01HL091878]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091878] Funding Source: NIH RePORTER	private University of Miami; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Study supported by private University of Miami research Fund (Jonathan and Eileen Otto Research Fund) and National Heart, Lung, and Blood Institute R01HL091878 (JL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann K, 2000, AM J CARDIOL, V86, P964, DOI 10.1016/S0002-9149(00)01131-0; Angelucci F, 2010, ADDICT BIOL, V15, P365, DOI 10.1111/j.1369-1600.2010.00221.x; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Bittel DC, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-1; Blencowe BJ, 2006, CELL, V126, P37, DOI 10.1016/j.cell.2006.06.023; Bracco L, 2006, PROG MOLEC, V44, P1; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Doenst T, 2010, CARDIOVASC RES, V86, P461, DOI 10.1093/cvr/cvp414; Einstein R, 2008, P NATL ACAD SCI USA, V105, P5230, DOI 10.1073/pnas.0801319105; Farina G, 2010, ARTHRITIS RHEUM-US, V62, P580, DOI 10.1002/art.27220; Gardina PJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-325; Georges R, 2008, MOL CELL BIOL, V28, P4052, DOI 10.1128/MCB.02100-07; Heidecker B, 2011, CIRCULATION, V123, P1174, DOI 10.1161/CIRCULATIONAHA.110.002857; Hinton RB, 2009, J AM COLL CARDIOL, V53, P1065, DOI 10.1016/j.jacc.2008.12.023; Hinton RB, 2007, J AM COLL CARDIOL, V50, P1590, DOI 10.1016/j.jacc.2007.07.021; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Kong SW, 2010, CIRC-CARDIOVASC GENE, V3, P138, DOI 10.1161/CIRCGENETICS.109.904698; Langer W, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-676; Margulies KB, 2009, J AM COLL CARDIOL, V53, P1752, DOI 10.1016/j.jacc.2008.12.064; Pavan M, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-113; Pizarro C, 2003, CIRCULATION, V108, P155, DOI 10.1161/01.cir.0000087390.94142.1d; Purdom E, 2008, BIOINFORMATICS, V24, P1707, DOI 10.1093/bioinformatics/btn284; Ricci M, 2006, J THORAC CARDIOV SUR, V132, P252, DOI 10.1016/j.jtcvs.2006.03.050; Ricci M, 2010, J CARD FAIL, V16, P628, DOI 10.1016/j.cardfail.2010.03.007; Rosca MG, 2008, CARDIOVASC RES, V80, P30, DOI 10.1093/cvr/cvn184; Tazi J, 2009, BBA-MOL BASIS DIS, V1792, P14, DOI 10.1016/j.bbadis.2008.09.017; Xing Y, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000088; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475	28	22	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2012	7	1							e29784	10.1371/journal.pone.0029784	http://dx.doi.org/10.1371/journal.pone.0029784			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911GB	22299024	Green Submitted, Green Published, gold			2022-12-25	WOS:000301704200001
J	Zhang, Y; Morimoto, K; Danilova, N; Zhang, B; Lin, S				Zhang, Ying; Morimoto, Kenji; Danilova, Nadia; Zhang, Bo; Lin, Shuo			Zebrafish Models for Dyskeratosis Congenita Reveal Critical Roles of p53 Activation Contributing to Hematopoietic Defects through RNA Processing	PLOS ONE			English	Article							TELOMERASE COMPONENT; GENE; MUTATIONS; PROTEIN; STRESS; CANCER; LENGTH; RIBONUCLEOPROTEINS; EXPRESSION; SNORNPS	Dyskeratosis congenita (DC) is a rare bone marrow failure syndrome in which hematopoietic defects are the main cause of mortality. The most studied gene responsible for DC pathogenesis is DKC1 while mutations in several other genes encoding components of the H/ACA RNP telomerase complex, which is involved in ribosomal RNA(rRNA) processing and telomere maintenance, have also been implicated. GAR1/nola1 is one of the four core proteins of the H/ACA RNP complex. Through comparative analysis of morpholino oligonucleotide induced knockdown of dkc1 and a retrovirus insertion induced mutation of GAR1/nola1 in zebrafish, we demonstrate that hematopoietic defects are specifically recapitulated in these models and that these defects are significantly reduced in a p53 null mutant background. We further show that changes in telomerase activity are undetectable at the early stages of DC pathogenesis but rRNA processing is clearly defective. Our data therefore support a model that deficiency in dkc1 and nola1 in the H/ACA RNP complex likely contributes to the hematopoietic phenotype through p53 activation associated with rRNA processing defects rather than telomerase deficiency during the initial stage of DC pathogenesis.	[Zhang, Ying; Lin, Shuo] Peking Univ, Lab Chem Genom, Shenzhen Grad Sch, Shenzhen, Peoples R China; [Zhang, Ying; Zhang, Bo] Peking Univ, Key Lab Cell Proliferat & Differentiat, Minist Educ, Ctr Dev Biol & Genet,Coll Life Sci, Beijing 100871, Peoples R China; [Zhang, Ying; Morimoto, Kenji; Danilova, Nadia; Lin, Shuo] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA USA	Peking University; University Town of Shenzhen; Peking University; University of California System; University of California Los Angeles	Zhang, Y (corresponding author), Peking Univ, Lab Chem Genom, Shenzhen Grad Sch, Shenzhen, Peoples R China.	shuolin@ucla.edu	Zhang, Bo/K-7162-2012		National Institutes of Health [DK54508, HL097561]; 973 program [2012CB945101]; NSFC [30730056]; China Scholarship Council, Ministry of Education; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097561] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054508, Z01DK054508] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); 973 program(National Basic Research Program of China); NSFC(National Natural Science Foundation of China (NSFC)); China Scholarship Council, Ministry of Education(China Scholarship Council); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by research grants from the National Institutes of Health to Dr. Lin (DK54508 and HL097561) and by research grants from 973 program (2012CB945101) and NSFC (30730056) to Dr. Bo Zhang. Ying Zhang was supported in part by China Scholarship Council, Ministry of Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alawi F, 2011, MOL CARCINOGEN, V50, P334, DOI 10.1002/mc.20715; Alter BP, 2009, BLOOD, V113, P6549, DOI 10.1182/blood-2008-12-192880; Armanios MY, 2007, NEW ENGL J MED, V356, P1317, DOI 10.1056/NEJMoa066157; Azuma M, 2006, J BIOL CHEM, V281, P13309, DOI 10.1074/jbc.M601892200; Berghmans S, 2005, P NATL ACAD SCI USA, V102, P407, DOI 10.1073/pnas.0406252102; BousquetAntonelli C, 1997, EMBO J, V16, P4770, DOI 10.1093/emboj/16.15.4770; Danilova N, 2011, BRIT J HAEMATOL, V152, P217, DOI 10.1111/j.1365-2141.2010.08396.x; Danilova N, 2008, BLOOD, V112, P5228, DOI 10.1182/blood-2008-01-132290; Dei Cas A, 2011, NUTR METAB CARDIOVAS; Ge JP, 2010, MOL CELL BIOL, V30, P413, DOI 10.1128/MCB.01128-09; Giordano E, 1999, J CELL BIOL, V144, P1123, DOI 10.1083/jcb.144.6.1123; GIRARD JP, 1992, EMBO J, V11, P673, DOI 10.1002/j.1460-2075.1992.tb05099.x; Heiss NS, 1998, NAT GENET, V19, P32, DOI 10.1038/ng0598-32; Henras A, 1998, EMBO J, V17, P7078, DOI 10.1093/emboj/17.23.7078; Imamura S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003364; Kirwan M, 2009, BBA-MOL BASIS DIS, V1792, P371, DOI 10.1016/j.bbadis.2009.01.010; Kishi S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000152; Kiss T, 2010, MOL CELL, V37, P597, DOI 10.1016/j.molcel.2010.01.032; Lafontaine DLJ, 1998, TRENDS BIOCHEM SCI, V23, P383, DOI 10.1016/S0968-0004(98)01260-2; Langheinrich U, 2002, CURR BIOL, V12, P2023, DOI 10.1016/S0960-9822(02)01319-2; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Meier UT, 2005, CHROMOSOMA, V114, P1, DOI 10.1007/s00412-005-0333-9; Mitchell JR, 1999, NATURE, V402, P551, DOI 10.1038/990141; Nelson ND, 2011, MUTAT RES; Nelson ND, 2011, MUTAT RES EPUB; Pereboom TC, 2011, BLOOD; Ruggero D, 2003, SCIENCE, V299, P259, DOI 10.1126/science.1079447; Salpea KD, 2010, ATHEROSCLEROSIS, V209, P42, DOI 10.1016/j.atherosclerosis.2009.09.070; Savage SA, 2008, AM J HUM GENET, V82, P501, DOI 10.1016/j.ajhg.2007.10.004; Simon NM, 2006, BIOL PSYCHIAT, V60, P432, DOI 10.1016/j.biopsych.2006.02.004; THISSE C, 1993, DEVELOPMENT, V119, P1203; Tsai SB, 2007, AGING CELL, V6, P209, DOI 10.1111/j.1474-9726.2007.00278.x; Venteicher AS, 2009, CELL CYCLE, V8, P1329, DOI 10.4161/cc.8.9.8288; Vulliamy T, 2008, P NATL ACAD SCI USA, V105, P8073, DOI 10.1073/pnas.0800042105; Vulliamy TJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024383; Walne AJ, 2010, HUM MOL GENET, V19, P4453, DOI 10.1093/hmg/ddq371; Wang DW, 2007, P NATL ACAD SCI USA, V104, P12428, DOI 10.1073/pnas.0705502104; Willeit P, 2010, JAMA-J AM MED ASSOC, V304, P69, DOI 10.1001/jama.2010.897; Zhong F, 2011, GENE DEV, V25, P11, DOI 10.1101/gad.2006411	39	32	33	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2012	7	1							e30188	10.1371/journal.pone.0030188	http://dx.doi.org/10.1371/journal.pone.0030188			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911GB	22299032	Green Submitted, Green Published, gold			2022-12-25	WOS:000301704200009
J	Tatrai, E; Simo, M; Iljicsov, A; Nemeth, J; DeBuc, DC; Somfai, GM				Tatrai, Erika; Simo, Magdolna; Iljicsov, Anna; Nemeth, Janos; DeBuc, Delia Cabrera; Somfai, Gabor Mark			In Vivo Evaluation of Retinal Neurodegeneration in Patients with Multiple Sclerosis	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; NERVE-FIBER LAYER; GANGLION-CELL COMPLEX; DIAGNOSTIC-ACCURACY; ALZHEIMERS-DISEASE; PARKINSON-DISEASE; MACULAR THICKNESS; IMPAIRMENT; NEURITIS; PATHOLOGY	Objective: To evaluate macular morphology in the eyes of patients with multiple sclerosis (MS) with or without optic neuritis (ON) in previous history. Methods: Optical coherence tomography (OCT) examination was performed in thirty-nine patients with MS and in thirty-three healthy subjects. The raw macular OCT data were processed using OCTRIMA software. The circumpapillary retinal nerve fiber layer (RNFL) thickness and the weighted mean thickness of the total retina and 6 intraretinal layers were obtained for each eye. The eyes of MS patients were divided into a group of 39 ON-affected eyes, and into a group of 34 eyes with no history of ON for the statistical analyses. Receiver operating characteristic (ROC) curves were constructed to determine which parameter can discriminate best between the non-affected group and controls. Results: The circumpapillary RNFL thickness was significantly decreased in the non-affected eyes compared to controls group only in the temporal quadrant (p = 0.001) while it was decreased in the affected eyes of the MS patients in all quadrants compared to the non-affected eyes (p < 0.05 in each comparison). The thickness of the total retina, RNFL, ganglion cell layer and inner plexiform layer complex (GCL+IPL) and ganglion cell complex (GCC, comprising the RNFL and GCL+IPL) in the macula was significantly decreased in the non-affected eyes compared to controls (p, 0.05 for each comparison) and in the ON-affected eyes compared to the non-affected eyes (p, 0.001 for each comparison). The largest area under the ROC curve (0.892) was obtained for the weighted mean thickness of the GCC. The EDSS score showed the strongest correlation with the GCL+IPL and GCC thickness (p = 0.007, r = 0.43 for both variables). Conclusions: Thinning of the inner retinal layers is present in eyes of MS patients regardless of previous ON. Macular OCT image segmentation might provide a better insight into the pathology of neuronal loss and could therefore play an important role in the diagnosis and follow-up of patients with MS.	[Tatrai, Erika; Nemeth, Janos; Somfai, Gabor Mark] Semmelweis Univ, Dept Ophthalmol, Budapest, Hungary; [Simo, Magdolna; Iljicsov, Anna] Semmelweis Univ, Dept Neurol, Budapest, Hungary; [DeBuc, Delia Cabrera] Univ Miami, Miller Sch Med, Bascom Palmer Eye Inst, Miami, FL 33136 USA	Semmelweis University; Semmelweis University; Bascom Palmer Eye Institute; University of Miami	Tatrai, E (corresponding author), Semmelweis Univ, Dept Ophthalmol, Budapest, Hungary.	tatrai.erika@gmail.com		Somfai, Gabor Mark/0000-0001-6329-442X; Nemeth, Janos/0000-0001-8575-4888; Cabrera DeBuc, Delia/0000-0002-4726-894X	Juvenile Diabetes Research Foundation; National Institutes of Health (NIH) [P30-EY014801]; Research to Prevent Blindness, Inc.; Hungarian Academy of Sciences; NATIONAL EYE INSTITUTE [P30EY014801] Funding Source: NIH RePORTER	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness, Inc.(Research to Prevent Blindness (RPB)); Hungarian Academy of Sciences(Hungarian Academy of Sciences); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This research was supported in part by a Juvenile Diabetes Research Foundation grant, a National Institutes of Health (NIH) center core grant P30-EY014801, by an unrestricted grant to the University of Miami from Research to Prevent Blindness, Inc. and by the Zsigmond Diabetes Fund of the Hungarian Academy of Sciences. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The University of Miami and Dr. DeBuc hold a pending patent used in the study and have the potential for financial benefit from its future commercialization. All other authors of the manuscript report no disclosures. The data of the patent are the following: Name: System and method for early detection of diabetic retinopathy using optical coherence tomography Pub. No.: WO/2010/080576 International Application No.: PCT/US2009/068653 This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Almarcegui C, 2010, NEUROPHYSIOL CLIN, V40, P129, DOI 10.1016/j.neucli.2009.12.001; Altintas O, 2008, DOC OPHTHALMOL, V116, P137, DOI 10.1007/s10633-007-9091-8; [Anonymous], 1991, OPHTHALMOLOGY, V98, P741; Bock M, 2010, CLIN NEUROL NEUROSUR, V112, P647, DOI 10.1016/j.clineuro.2010.04.014; Burkholder BM, 2009, ARCH NEUROL-CHICAGO, V66, P1366, DOI 10.1001/archneurol.2009.230; Costello F, 2010, CAN J OPHTHALMOL, V45, P520, DOI 10.3129/i10-063; Davies EC, 2011, J NEURO-OPHTHALMOL, V31, P260, DOI 10.1097/WNO.0b013e318221b434; Debuc DC, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3470116; Debuc DC, 2010, MED SCI MONITOR, V16, pMT15; DeBuc DC, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3268773; Fernandez DC, 2005, OPT EXPRESS, V13, P10200, DOI 10.1364/OPEX.13.010200; Fisher JB, 2006, OPHTHALMOLOGY, V113, P324, DOI 10.1016/j.ophtha.2005.10.040; Fjeldstad C, 2011, J CLIN NEUROSCI, V18, P1469, DOI 10.1016/j.jocn.2011.04.008; Garas A, 2011, EYE, V25, P57, DOI 10.1038/eye.2010.139; Green AJ, 2010, BRAIN, V133, P1591, DOI 10.1093/brain/awq080; Hajee ME, 2009, ARCH OPHTHALMOL-CHIC, V127, P737, DOI 10.1001/archophthalmol.2009.106; Henderson APD, 2008, BRAIN, V131, P277, DOI 10.1093/brain/awm285; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; Inzelberg R, 2004, VISION RES, V44, P2793, DOI 10.1016/j.visres.2004.06.009; Ishikawa H, 2005, INVEST OPHTH VIS SCI, V46, P2012, DOI 10.1167/iovs.04-0335; KERRISON JB, 1994, RETINA-J RET VIT DIS, V14, P445, DOI 10.1097/00006982-199414050-00010; Kim NR, 2010, INVEST OPHTH VIS SCI, V51, P4646, DOI 10.1167/iovs.09-5053; Kim NR, 2011, J GLAUCOMA; Klistorner A, 2009, DOC OPHTHALMOL, V118, P129, DOI 10.1007/s10633-008-9147-4; Massin P, 2001, ARCH OPHTHALMOL-CHIC, V119, P1135, DOI 10.1001/archopht.119.8.1135; Paquet C, 2007, NEUROSCI LETT, V420, P97, DOI 10.1016/j.neulet.2007.02.090; Parisi V, 1999, INVEST OPHTH VIS SCI, V40, P2520; Parisi V, 2001, CLIN NEUROPHYSIOL, V112, P1860, DOI 10.1016/S1388-2457(01)00620-4; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Pueyo V, 2008, MULT SCLER J, V14, P609, DOI 10.1177/1352458507087326; Saidha S., 2011, MULT SCLER; Saidha S, 2011, BRAIN, V134, P518, DOI 10.1093/brain/awq346; Schulze A, 2011, GRAEF ARCH CLIN EXP, V249, P1039, DOI 10.1007/s00417-010-1585-5; Sepulcre J, 2007, NEUROLOGY, V68, P1488, DOI 10.1212/01.wnl.0000260612.51849.ed; Shahidi M, 2005, AM J OPHTHALMOL, V139, P1056, DOI 10.1016/j.ajo.2005.01.012; Silber E, 1999, J NEUROL SCI, V170, P11, DOI 10.1016/S0022-510X(99)00178-1; Syc SB, 2011, BRAIN; Tan O, 2009, OPHTHALMOLOGY, V116, P2305, DOI 10.1016/j.ophtha.2009.05.025; Tatrai E, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3573817; Tegetmeyer H, 2011, NEURO-OPHTHALMOLOGY, V35, P101, DOI 10.3109/01658107.2011.580885	40	45	48	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2012	7	1							e30922	10.1371/journal.pone.0030922	http://dx.doi.org/10.1371/journal.pone.0030922			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911FX	22292076	Green Published, Green Submitted, gold			2022-12-25	WOS:000301703800037
J	Bieghs, V; Van Gorp, PJ; Wouters, K; Hendrikx, T; Gijbels, MJ; van Bilsen, M; Bakker, J; Binder, CJ; Lutjohann, D; Staels, B; Hofker, MH; Shiri-Sverdlov, R				Bieghs, Veerle; Van Gorp, Patrick J.; Wouters, Kristiaan; Hendrikx, Tim; Gijbels, Marion J.; van Bilsen, Marc; Bakker, Jaap; Binder, Christoph J.; Luetjohann, Dieter; Staels, Bart; Hofker, Marten H.; Shiri-Sverdlov, Ronit			LDL Receptor Knock-Out Mice Are a Physiological Model Particularly Vulnerable to Study the Onset of Inflammation in Non-Alcoholic Fatty Liver Disease	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; APOLIPOPROTEIN-E; SCAVENGER RECEPTOR; HEPATIC STEATOSIS; DEFICIENT MICE; ANIMAL-MODELS; MOUSE MODELS; IN-VIVO; STEATOHEPATITIS; ATHEROSCLEROSIS	Background & Aims: Non-alcoholic steatohepatitis (NASH) involves steatosis combined with inflammation, which can progress into fibrosis and cirrhosis. Exploring the molecular mechanisms of NASH is highly dependent on the availability of animal models. Currently, the most commonly used animal models for NASH imitate particularly late stages of human disease. Thus, there is a need for an animal model that can be used for investigating the factors that potentiate the inflammatory response within NASH. We have previously shown that 7-day high-fat-high-cholesterol (HFC) feeding induces steatosis and inflammation in both APOE2ki and Ldlr(-/-) mice. However, it is not known whether the early inflammatory response observed in these mice will sustain over time and lead to liver damage. We hypothesized that the inflammatory response in both models is sufficient to induce liver damage over time. Methods: APOE2ki and Ldlr(-/-) mice were fed a chow or HFC diet for 3 months. C57Bl6/J mice were used as control. Results: Surprisingly, hepatic inflammation was abolished in APOE2ki mice, while it was sustained in Ldlr(-/-) mice. In addition, increased apoptosis and hepatic fibrosis was only demonstrated in Ldlr(-/-) mice. Finally, bone-marrow-derived-macrophages of Ldlr(-/-) mice showed an increased inflammatory response after oxidized LDL (oxLDL) loading compared to APOE2ki mice. Conclusion: Ldlr(-/-) mice, but not APOE2ki mice, developed sustained hepatic inflammation and liver damage upon long term HFC feeding due to increased sensitivity for oxLDL uptake. Therefore, the Ldlr(-/-) mice are a promising physiological model particularly vulnerable for investigating the onset of hepatic inflammation in non-alcoholic steatohepatitis.	[Bieghs, Veerle; Van Gorp, Patrick J.; Hendrikx, Tim; Gijbels, Marion J.; van Bilsen, Marc; Bakker, Jaap; Shiri-Sverdlov, Ronit] Univ Maastricht, Dept Mol Genet Pathol Physiol & Clin Genet Nutr &, Maastricht, Netherlands; [Bieghs, Veerle; Van Gorp, Patrick J.; Hendrikx, Tim; Gijbels, Marion J.; van Bilsen, Marc; Bakker, Jaap; Shiri-Sverdlov, Ronit] Univ Maastricht, Cardiovasc Res CARIM Inst Maastricht, Maastricht, Netherlands; [Wouters, Kristiaan; Staels, Bart] Univ Lille Nord France, Lille, France; [Wouters, Kristiaan; Staels, Bart] INSERM, U1011, F-59045 Lille, France; [Wouters, Kristiaan; Staels, Bart] UDSL, Lille, France; [Wouters, Kristiaan; Staels, Bart] Inst Pasteur, F-59019 Lille, France; [Binder, Christoph J.] Austrian Acad Sci, Ctr Mol Med, A-1010 Vienna, Austria; [Binder, Christoph J.] Med Univ Vienna, Dept Lab Med, Vienna, Austria; [Luetjohann, Dieter] Univ Bonn, Inst Clin Chem & Clin Pharmacol, Bonn, Germany; [Hofker, Marten H.] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Lab Med, Groningen, Netherlands	Maastricht University; Maastricht University; Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Austrian Academy of Sciences; Medical University of Vienna; University of Bonn; University of Groningen	Bieghs, V (corresponding author), Univ Maastricht, Dept Mol Genet Pathol Physiol & Clin Genet Nutr &, Maastricht, Netherlands.	r.sverdlov@maastrichtuniversity.nl	van Gorp, Patrick/S-3892-2019; Staels, Bart/N-9497-2016; Hendrikx, Tim/AAI-8252-2021; Shiri-Sverdlov, Ronit/E-5571-2017; Wouters, Kristiaan/A-8536-2013; van Bilsen, Marc/E-8342-2016; Hendrikx, Tim/AAE-2329-2020; Shiri-Sverdlov, Ronit/X-2642-2019; van Gorp, Patrick/L-9580-2018; Bakker, J. A./H-7910-2019	van Gorp, Patrick/0000-0002-0355-5349; Staels, Bart/0000-0002-3784-1503; Hendrikx, Tim/0000-0002-3381-2107; Shiri-Sverdlov, Ronit/0000-0002-6736-7814; Wouters, Kristiaan/0000-0001-7127-6950; Shiri-Sverdlov, Ronit/0000-0002-6736-7814; van Gorp, Patrick/0000-0002-0355-5349; Bakker, Jaap A./0000-0002-2918-7361; Binder, Christoph J./0000-0001-8313-7050	Veni [916.76.070 (2006/00496/MW)]; Maag Lever Darm Stichting (MLDS) [WO 08-16 + WO 10-65]; Dutch Heart Foundation (NHS) [2002B18]	Veni(Netherlands Organization for Scientific Research (NWO)); Maag Lever Darm Stichting (MLDS); Dutch Heart Foundation (NHS)(Netherlands Heart Foundation)	The work was supported by the following: Veni: 916.76.070 (2006/00496/MW); Maag Lever Darm Stichting (MLDS) (WO 08-16 + WO 10-65); Dutch Heart Foundation (NHS) (2002B18). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abiru S, 2006, LIVER INT, V26, P39, DOI 10.1111/j.1478-3231.2005.01191.x; Adams LA, 2005, J HEPATOL, V42, P132, DOI 10.1016/j.jhep.2004.09.012; Anstee QM, 2006, INT J EXP PATHOL, V87, P1, DOI 10.1111/j.0959-9673.2006.00465.x; BASU SK, 1981, P NATL ACAD SCI-BIOL, V78, P7545, DOI 10.1073/pnas.78.12.7545; Bieghs V, 2010, GASTROENTEROLOGY, V138, P2477, DOI 10.1053/j.gastro.2010.02.051; Binder CJ, 2004, J CLIN INVEST, V114, P427, DOI 10.1172/jci200420479; CHOI SSY, 1991, J CLIN INVEST, V88, P1173, DOI 10.1172/JCI115419; Collins AR, 2009, CIRC RES, V104, pe42, DOI 10.1161/CIRCRESAHA.108.188771; Dam-Larsen S, 2004, GUT, V53, P750, DOI 10.1136/gut.2003.019984; Donati G, 2004, GUT, V53, P1020, DOI 10.1136/gut.2003.027086; Ekstedt M, 2006, HEPATOLOGY, V44, P865, DOI 10.1002/hep.21327; ELSHOURBAGY NA, 1985, P NATL ACAD SCI USA, V82, P203, DOI 10.1073/pnas.82.1.203; Feldstein AE, 2009, GUT, V58, P1538, DOI 10.1136/gut.2008.171280; Floreani A, 2007, DIGEST DIS, V25, P138, DOI 10.1159/000099478; Gabay C, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1917; GOLDSTEIN JL, 1979, P NATL ACAD SCI USA, V76, P333, DOI 10.1073/pnas.76.1.333; Han JH, 1997, J BIOL CHEM, V272, P21654, DOI 10.1074/jbc.272.34.21654; HENRIKSEN T, 1981, P NATL ACAD SCI-BIOL, V78, P6499, DOI 10.1073/pnas.78.10.6499; Horkko S, 1999, J CLIN INVEST, V103, P117, DOI 10.1172/JCI4533; Ikejima K, 2005, HEPATOL RES, V33, P151, DOI 10.1016/j.hepres.2005.09.024; ISHIBASHI S, 1993, J CLIN INVEST, V92, P883, DOI 10.1172/JCI116663; Kanters E, 2003, J CLIN INVEST, V112, P1176, DOI 10.1172/JCI18580; Koliwad SK, 2010, J CLIN INVEST, V120, P756, DOI 10.1172/JCI36066; Kong B, 2009, J PHARMACOL EXP THER, V328, P116, DOI 10.1124/jpet.108.144600; Larter CZ, 2008, J GASTROEN HEPATOL, V23, P1635, DOI 10.1111/j.1440-1746.2008.05543.x; LIN CT, 1986, J CLIN INVEST, V78, P947, DOI 10.1172/JCI112685; LUDWIG J, 1980, MAYO CLIN PROC, V55, P434; Ludwig J, 1997, J GASTROEN HEPATOL, V12, P398, DOI 10.1111/j.1440-1746.1997.tb00450.x; Mari M, 2006, CELL METAB, V4, P185, DOI 10.1016/j.cmet.2006.07.006; Miyata M, 1996, NAT GENET, V14, P55, DOI 10.1038/ng0996-55; PLUMP AS, 1992, CELL, V71, P343, DOI 10.1016/0092-8674(92)90362-G; Rinella ME, 2008, J LIPID RES, V49, P1068, DOI 10.1194/jlr.M800042-JLR200; Schattenberg JM, 2010, DIGEST DIS, V28, P247, DOI 10.1159/000282097; Sullivan PM, 1998, J CLIN INVEST, V102, P130, DOI 10.1172/JCI2673; Wouters K, 2005, CLIN CHEM LAB MED, V43, P470, DOI 10.1515/CCLM.2005.085; Wouters K, 2008, HEPATOLOGY, V48, P474, DOI 10.1002/hep.22363; Wouters K, 2010, FEBS LETT, V584, P1001, DOI 10.1016/j.febslet.2010.01.046; Yamaguchi K, 2007, HEPATOLOGY, V45, P1366, DOI 10.1002/hep.21655; Yoshimatsu M, 2004, INT J EXP PATHOL, V85, P335, DOI 10.1111/j.0959-9673.2004.00401.x; Zannis VI, 2001, CURR OPIN LIPIDOL, V12, P181, DOI 10.1097/00041433-200104000-00012; ZHANG SH, 1992, SCIENCE, V258, P468, DOI 10.1126/science.1411543; ZHANG SH, 1994, J CLIN INVEST, V94, P937, DOI 10.1172/JCI117460	42	113	122	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e30668	10.1371/journal.pone.0030668	http://dx.doi.org/10.1371/journal.pone.0030668			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910ME	22295101	Green Published, gold, Green Submitted			2022-12-25	WOS:000301640600046
J	Leblanc, P; Hasenkrug, K; Ward, A; Myers, L; Messer, RJ; Alais, S; Timmes, A; Priola, S				Leblanc, Pascal; Hasenkrug, Kim; Ward, Anne; Myers, Lara; Messer, Ronald J.; Alais, Sandrine; Timmes, Andrew; Priola, Sue			Co-Infection with the Friend Retrovirus and Mouse Scrapie Does Not Alter Prion Disease Pathogenesis in Susceptible Mice	PLOS ONE			English	Article							FOLLICULAR DENDRITIC CELLS; MURINE LEUKEMIA-VIRUS; IN-VITRO; INFECTION; NEUROINVASION; REPLICATION; SPLEEN; EXPRESSION; PROTEIN; RELEASE	Prion diseases are fatal, transmissible neurodegenerative diseases of the central nervous system. An abnormally protease-resistant and insoluble form (PrPSc) of the normally soluble protease-sensitive host prion protein (PrPC) is the major component of the infectious prion. During the course of prion disease, PrPSc accumulates primarily in the lymphoreticular and central nervous systems. Recent studies have shown that co-infection of prion-infected fibroblast cells with the Moloney murine leukemia virus (Mo-MuLV) strongly enhanced the release and spread of scrapie infectivity in cell culture, suggesting that retroviral coinfection might significantly influence prion spread and disease incubation times in vivo. We now show that another retrovirus, the murine leukemia virus Friend (F-MuLV), also enhanced the release and spread of scrapie infectivity in cell culture. However, peripheral co-infection of mice with both Friend virus and the mouse scrapie strain 22L did not alter scrapie disease incubation times, the levels of PrPSc in the brain or spleen, or the distribution of pathological lesions in the brain. Thus, retroviral co-infection does not necessarily alter prion disease pathogenesis in vivo, most likely because of different cell-specific sites of replication for scrapie and F-MuLV.	[Leblanc, Pascal; Alais, Sandrine] Univ Lyon, Lyon, France; [Leblanc, Pascal; Alais, Sandrine] INSERM, U758, Lab Virol Humaine, F-69008 Lyon, France; [Leblanc, Pascal] UMR5239, Lab Biol Mol Cellule, Lyon, France; [Leblanc, Pascal; Alais, Sandrine] Ecole Normale Super Lyon, F-69364 Lyon, France; [Hasenkrug, Kim; Ward, Anne; Myers, Lara; Messer, Ronald J.; Timmes, Andrew; Priola, Sue] NIAID, Rocky Mt Labs, Persistent Viral Dis Lab, NIH, Hamilton, MT 59840 USA	Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Ecole Normale Superieure de Lyon (ENS de LYON); Universite Jean Monnet; Ecole Normale Superieure de Lyon (ENS de LYON); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Leblanc, P (corresponding author), Univ Lyon, Lyon, France.	spriola@niaid.nih.gov	Leblanc, Pascal/D-4027-2019	Leblanc, Pascal/0000-0003-3214-5880; ALAIS, Sandrine/0000-0001-9588-5435	National Institutes of Health's Institute of Allergy and Infectious Diseases; CNRS; INSERM; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000753, ZIAAI000752] Funding Source: NIH RePORTER	National Institutes of Health's Institute of Allergy and Infectious Diseases; CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the Intramural Research Program of the National Institutes of Health's Institute of Allergy and Infectious Diseases (S. Priola and K. Hasenkrug) and by CNRS and INSERM (P. Leblanc). The funders had no role in study design, data collection and analysis, or preparation of the manuscript. Clearance to publish was obtained from the Intramural Research Program of the National Institutes of Health, Institute of Allergy and Infectious Diseases.	Alais S, 2008, BIOL CELL, V100, P603, DOI 10.1042/BC20080025; Brown KL, 1999, NAT MED, V5, P1308, DOI 10.1038/15264; Carp RI, 1999, J GEN VIROL, V80, P5, DOI 10.1099/0022-1317-80-1-5; Castilla J, 2005, CELL, V121, P195, DOI 10.1016/j.cell.2005.02.011; CHANDLER RL, 1965, J COMP PATHOL THERAP, V75, P323, DOI 10.1016/0021-9975(65)90037-X; Chaplin DD, 1998, CURR OPIN IMMUNOL, V10, P289, DOI 10.1016/S0952-7915(98)80167-2; CLARKE MC, 1971, RES VET SCI, V12, P195; Deleault NR, 2007, P NATL ACAD SCI USA, V104, P9741, DOI 10.1073/pnas.0702662104; Dietze KK, 2011, P NATL ACAD SCI USA, V108, P2420, DOI 10.1073/pnas.1015148108; EHRESMANN DW, 1986, INTERVIROLOGY, V25, P103, DOI 10.1159/000149663; Fraser H., 1979, Slow transmissible diseases of the nervous system. Volume 1., P387; Fraser H, 1996, J GEN VIROL, V77, P1935, DOI 10.1099/0022-1317-77-8-1935; FRASER H, 1978, J COMP PATHOL, V88, P563, DOI 10.1016/0021-9975(78)90010-5; Friedman-Levi Y, 2007, J VIROL, V81, P9942, DOI 10.1128/JVI.00780-07; Glatzel M, 2000, J GEN VIROL, V81, P2813, DOI 10.1099/0022-1317-81-11-2813; Glatzel M, 2001, NEURON, V31, P25, DOI 10.1016/S0896-6273(01)00331-2; Greenwood AD, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-44; Hasenkrug Kim J, 2003, Novartis Found Symp, V252, P194; Heikenwalder M, 2005, SCIENCE, V307, P1107, DOI 10.1126/science.1106460; KABAT D, 1989, CURR TOP MICROBIOL, V148, P1; KIMBERLIN RH, 1979, J COMP PATHOL, V89, P551, DOI 10.1016/0021-9975(79)90046-X; KIMBERLIN RH, 1989, VIRUS RES, V12, P201, DOI 10.1016/0168-1702(89)90039-7; Klein MA, 1998, NAT MED, V4, P1429, DOI 10.1038/4022; Leblanc P, 2006, EMBO J, V25, P2674, DOI 10.1038/sj.emboj.7601162; Lee KH, 2006, BIOCHEM BIOPH RES CO, V349, P122, DOI 10.1016/j.bbrc.2006.08.016; Ligios C, 2011, J VIROL, V85, P1136, DOI 10.1128/JVI.02022-10; Lotscher M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001158; Mabbott NA, 2000, NAT MED, V6, P719, DOI 10.1038/77401; Mabbott NA, 2003, J VIROL, V77, P6845, DOI 10.1128/JVI.77.12.6845-6854.2003; MOLONEY JB, 1964, ANNU REV MED, V15, P383, DOI 10.1146/annurev.me.15.020164.002123; Montrasio F, 2000, SCIENCE, V288, P1257, DOI 10.1126/science.288.5469.1257; Murakami T, 2007, BLOOD, V110, P1215, DOI 10.1182/blood-2007-01-068387; Nishida N, 2000, J VIROL, V74, P320, DOI 10.1128/JVI.74.1.320-325.2000; Priola SA, 2001, ADV PROTEIN CHEM, V57, P1; Robertson SJ, 2008, J VIROL, V82, P408, DOI 10.1128/JVI.01413-07; Seeger H, 2005, SCIENCE, V310, P324, DOI 10.1126/science.1118829; Stanton JB, 2008, J VIROL, V82, P9839, DOI 10.1128/JVI.01137-08; Stengel A, 2006, BIOCHEM BIOPH RES CO, V343, P825, DOI 10.1016/j.bbrc.2006.03.021; Vorberg I, 2004, J INFECT DIS, V189, P431, DOI 10.1086/381166; WEISSMANN C, 1994, ANN NY ACAD SCI, V724, P235, DOI 10.1111/j.1749-6632.1994.tb38913.x	40	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e30872	10.1371/journal.pone.0030872	http://dx.doi.org/10.1371/journal.pone.0030872			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910ME	22295118	Green Submitted, Green Published, gold			2022-12-25	WOS:000301640600063
J	Huang, YY; Lu, HM; Liu, S; Droz-Rosario, R; Shen, ZY				Huang, Yi-Yuan; Lu, Huimei; Liu, Stephany; Droz-Rosario, Roberto; Shen, Zhiyuan			Requirement of Mouse BCCIP for Neural Development and Progenitor Proliferation	PLOS ONE			English	Article							DNA-DAMAGE; HOMOLOGOUS RECOMBINATION; PROTEIN; REPAIR; BRAIN; BRCA2; NEUROGENESIS; INHIBITION; EXPRESSION; PREVENTION	Multiple DNA repair pathways are involved in the orderly development of neural systems at distinct stages. The homologous recombination (HR) pathway is required to resolve stalled replication forks and critical for the proliferation of progenitor cells during neural development. BCCIP is a BRCA2 and CDKN1A interacting protein implicated in HR and inhibition of DNA replication stress. In this study, we determined the role of BCCIP in neural development using a conditional BCCIP knock-down mouse model. BCCIP deficiency impaired embryonic and postnatal neural development, causing severe ataxia, cerebral and cerebellar defects, and microcephaly. These development defects are associated with spontaneous DNA damage and subsequent cell death in the proliferative cell populations of the neural system during embryogenesis. With in vitro neural spheroid cultures, BCCIP deficiency impaired neural progenitor's self-renewal capability, and spontaneously activated p53. These data suggest that BCCIP and its anti-replication stress functions are essential for normal neural development by maintaining an orderly proliferation of neural progenitors.	[Huang, Yi-Yuan; Lu, Huimei; Liu, Stephany; Droz-Rosario, Roberto; Shen, Zhiyuan] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Canc Inst New Jersey, Dept Radiat Oncol, New Brunswick, NJ USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey	Huang, YY (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Canc Inst New Jersey, Dept Radiat Oncol, New Brunswick, NJ USA.	shenzh@umdnj.edu		Shen, Zhiyuan/0000-0003-2834-0309	NIH [R01CA156706]; Cancer Institute of New Jersey [P30CA072720]; NATIONAL CANCER INSTITUTE [P30CA072720, R01CA156706] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Institute of New Jersey; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by NIH R01CA156706 to ZS, and by the Transgenic & Knockout Mouse and the Histopathology & Imaging shared resources of The Cancer Institute of New Jersey (P30CA072720). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ash SC, 2008, BIOCHEM BIOPH RES CO, V371, P333, DOI 10.1016/j.bbrc.2008.04.084; Audhya A, 2003, EMBO J, V22, P4223, DOI 10.1093/emboj/cdg397; Dehay C, 2007, NAT REV NEUROSCI, V8, P438, DOI 10.1038/nrn2097; Fan JJ, 2009, CELL CYCLE, V8, P3019; Frappart PO, 2007, EMBO J, V26, P2732, DOI 10.1038/sj.emboj.7601703; Frappart PO, 2005, NAT MED, V11, P538, DOI 10.1038/nm1228; Gao YJ, 1998, CELL, V95, P891, DOI 10.1016/S0092-8674(00)81714-6; Goldowitz D, 1998, TRENDS NEUROSCI, V21, P375, DOI 10.1016/S0166-2236(98)01313-7; Katyal S, 2008, MECH AGEING DEV, V129, P483, DOI 10.1016/j.mad.2008.03.008; Lee Y, 2009, NAT NEUROSCI, V12, P973, DOI 10.1038/nn.2375; Liu JM, 2001, ONCOGENE, V20, P336, DOI 10.1038/sj.onc.1204098; Lu HM, 2005, MOL CELL BIOL, V25, P1949, DOI 10.1128/MCB.25.5.1949-1957.2005; Lu HM, 2007, NUCLEIC ACIDS RES, V35, P7160, DOI 10.1093/nar/gkm732; Lu HM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002291; Mao NH, 2007, DNA REPAIR, V6, P1651, DOI 10.1016/j.dnarep.2007.05.012; McKinnon PJ, 2009, NAT REV NEUROSCI, V10, P100, DOI 10.1038/nrn2559; Meng X, 2007, ONCOGENE, V26, P6253, DOI 10.1038/sj.onc.1210460; Meng XB, 2004, CELL CYCLE, V3, P1457, DOI 10.4161/cc.3.11.1213; Meng XB, 2004, CELL CYCLE, V3, P343; Meng XB, 2003, GENE, V302, P139, DOI 10.1016/S0378-1119(02)01098-3; Narasimhaiah R, 2005, CEREB CORTEX, V15, P696, DOI 10.1093/cercor/bhh171; O'Driscoll M, 2008, DNA REPAIR, V7, P1039, DOI 10.1016/j.dnarep.2008.03.018; Ono T, 2000, J BIOL CHEM, V275, P31145, DOI 10.1074/jbc.M003031200; Orii KE, 2006, P NATL ACAD SCI USA, V103, P10017, DOI 10.1073/pnas.0602436103; Phillips-Mason PJ, 2008, J CELL BIOCHEM, V105, P1059, DOI 10.1002/jcb.21907; RUIZ IAA, 2002, NAT REV NEUROSCI, V3, P24, DOI DOI 10.1038/NRN704; Takahashi E, 2009, BRAIN RES, V1279, P50, DOI 10.1016/j.brainres.2009.05.016; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Wilson DM, 2008, MECH AGEING DEV, V129, P349, DOI 10.1016/j.mad.2008.02.013; Zhuo L, 2001, GENESIS, V31, P85, DOI 10.1002/gene.10008	30	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2012	7	1							e30638	10.1371/journal.pone.0030638	http://dx.doi.org/10.1371/journal.pone.0030638			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910LV	22292003	gold, Green Published, Green Submitted			2022-12-25	WOS:000301639600038
J	Lecube, A; Baena-Fustegueras, JA; Fort, JM; Pelegri, D; Hernandez, C; Simo, R				Lecube, Albert; Antonio Baena-Fustegueras, Juan; Manuel Fort, Jose; Pelegri, Dolors; Hernandez, Cristina; Simo, Rafael			Diabetes Is the Main Factor Accounting for Hypomagnesemia in Obese Subjects	PLOS ONE			English	Article							SERUM IONIZED MAGNESIUM; METABOLIC SYNDROME; DIETARY MAGNESIUM; TYPE-2; MELLITUS; INSULIN; RISK; HYPERTENSION; ASSOCIATIONS; MENOPAUSE	Objective: Type 2 diabetes (T2DM) and obesity are associated with magnesium deficiency. We aimed to determine whether the presence of type 2 diabetes and the degree of metabolic control are related to low serum magnesium levels in obese individuals. Methods: A) Case-control study: 200 obese subjects [50 with T2DM (cases) and 150 without diabetes (controls)] prospectively recruited. B) Interventional study: the effect of bariatric surgery on serum magnesium levels was examined in a subset of 120 obese subjects (40 with type 2 diabetes and 80 without diabetes). Results: Type 2 diabetic patients showed lower serum magnesium levels [0.75 +/- 0.07 vs. 0.81 +/- 0.06 mmol/L; mean difference -0.06 (95% CI -0.09 to -0.04); p<0.001] than non-diabetic patients. Forty-eight percent of diabetic subjects, but only 15% of non-diabetic subjects showed a serum magnesium concentration lower than 0.75 mmol/L. Significant negative correlations between magnesium and fasting plasma glucose, HbA1c, HOMA-IR, and BMI were detected. Multiple linear regression analysis showed that fasting plasma glucose and HbA1c independently predicted serum magnesium. After bariatric surgery serum magnesium increased only in those patients in whom diabetes was resolved, but remain unchanged in those who not, without difference in loss weight between groups. Changes in serum magnesium negatively correlated with changes in fasting plasma glucose and HbA1c. Absolute changes in HbA1c independently predicted magnesium changes in the multiple linear regression analysis. Conclusions: Our results provide evidence that the presence of diabetes and the degree of metabolic control are essential in accounting for the lower levels of magnesium that exist in obese subjects.	[Lecube, Albert; Hernandez, Cristina; Simo, Rafael] Univ Autonoma Barcelona, CIBER Diabet & Enfermedades Metab Asociadas CIBER, Inst Salud Carlos III, Diabet & Metab Res Unit,Inst Recerca, E-08193 Barcelona, Spain; [Lecube, Albert; Hernandez, Cristina; Simo, Rafael] Univ Autonoma Barcelona, Dept Endocrinol, Hosp Univ Vall dHebron VHIR, E-08193 Barcelona, Spain; [Antonio Baena-Fustegueras, Juan; Manuel Fort, Jose] Univ Autonoma Barcelona, Endocrinol Surg Unit, Hosp Univ Vall dHebron, Dept Gen Surg, E-08193 Barcelona, Spain; [Pelegri, Dolors] Univ Autonoma Barcelona, Dept Biochem, Hosp Vall dHebron, E-08193 Barcelona, Spain	Autonomous University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Instituto de Salud Carlos III; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Autonomous University of Barcelona	Lecube, A (corresponding author), Univ Autonoma Barcelona, CIBER Diabet & Enfermedades Metab Asociadas CIBER, Inst Salud Carlos III, Diabet & Metab Res Unit,Inst Recerca, E-08193 Barcelona, Spain.	alecube@vhebron.net	Lecube, Albert/H-3813-2019; Fustegueras, Juan Antonio Baena/E-2912-2012; Peinado-Onsurbe, Julia/A-4677-2016	Lecube, Albert/0000-0001-9684-0183; Fustegueras, Juan Antonio Baena/0000-0001-8543-6863; Peinado-Onsurbe, Julia/0000-0002-3880-5061; Hernandez, Cristina/0000-0002-3109-1721; Simo Canonge, Rafael/0000-0003-0475-3096	Instituto de Salud Carlos III (CIBERDEM); Generalitat de Catalunya [2009-SGR-739]	Instituto de Salud Carlos III (CIBERDEM)(Instituto de Salud Carlos III); Generalitat de Catalunya(Generalitat de Catalunya)	This study was supported by grants from the Instituto de Salud Carlos III (CIBERDEM) and the Generalitat de Catalunya (2009-SGR-739). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agus ZS, 1999, J AM SOC NEPHROL, V10, P1616; Barbagallo M, 2007, ARCH BIOCHEM BIOPHYS, V458, P40, DOI 10.1016/j.abb.2006.05.007; BRINK EJ, 1992, PROG FOOD NUTR SCI, V16, P125; Buchwald H., 2004, JAMA (Journal of the American Medical Association), V292, P1724, DOI 10.1001/jama.292.14.1724; Corica F, 2006, J AM COLL NUTR, V25, P210, DOI 10.1080/07315724.2006.10719534; Corsonello A, 2000, AM J NEPHROL, V20, P187, DOI 10.1159/000013582; EIBL NL, 1995, DIABETES CARE, V18, P188, DOI 10.2337/diacare.18.2.188; Guerrero-Romero F, 2006, DIABETES-METAB RES, V22, P471, DOI 10.1002/dmrr.644; Haglin L, 2007, ACTA DIABETOL, V44, P138, DOI 10.1007/s00592-007-0254-6; HENROTTE JG, 1988, MAGNESIUM, V7, P306; Johansson HE, 2009, OBES SURG, V19, P1250, DOI 10.1007/s11695-008-9536-5; Kao WHL, 1999, ARCH INTERN MED, V159, P2151, DOI 10.1001/archinte.159.18.2151; Larsson SC, 2007, J INTERN MED, V262, P208, DOI 10.1111/j.1365-2796.2007.01840.x; LINDSAY R, 1980, CLIN SCI, V58, P255, DOI 10.1042/cs0580255; Lopez-Ridaura R, 2004, DIABETES CARE, V27, P134, DOI 10.2337/diacare.27.1.134; MA J, 1995, J CLIN EPIDEMIOL, V48, P927, DOI 10.1016/0895-4356(94)00200-A; Maggio M, 2011, INT J ANDROL; MCNAIR P, 1982, EUR J CLIN INVEST, V12, P81, DOI 10.1111/j.1365-2362.1982.tb00942.x; Montagnana M, 2008, CLIN LAB, V54, P169; Muneyyirci-Delale O, 1999, FERTIL STERIL, V71, P869, DOI 10.1016/S0015-0282(99)00065-5; NADLER JL, 1995, ENDOCRIN METAB CLIN, V24, P623, DOI 10.1016/S0889-8529(18)30035-5; PAOLISSO G, 1986, DIABETOLOGIA, V29, P644, DOI 10.1007/BF00869264; Pham PCT, 2005, CLIN NEPHROL, V63, P429; Pham PCT, 2007, CLIN J AM SOC NEPHRO, V2, P366, DOI 10.2215/CJN.02960906; Ricos C, 1999, SCAND J CLIN LAB INV, V59, P491; Rodriguez-Moran M, 2004, MAGNESIUM RES, V17, P189; Rodriguez-Moran M, 2003, DIABETES CARE, V26, P1147, DOI 10.2337/diacare.26.4.1147; RYZEN E, 1989, J AM COLL NUTR, V8, P580; Sales CH, 2006, CLIN NUTR, V25, P554, DOI 10.1016/j.clnu.2006.03.003; Schulze MB, 2007, ARCH INTERN MED, V167, P956, DOI 10.1001/archinte.167.9.956; Shuen AY, 2009, CLIN CHIM ACTA, V409, P28, DOI 10.1016/j.cca.2009.08.007; Song CH, 2007, EUR J CLIN NUTR, V61, P682, DOI 10.1038/sj.ejcn.1602568; Takaya J, 2004, MAGNESIUM RES, V17, P126; Topf JM, 2003, REV ENDOCR METAB DIS, V4, P195, DOI 10.1023/A:1022950321817; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; WINEGRAD AI, 1987, DIABETES, V36, P396, DOI 10.2337/diab.36.3.396	36	50	51	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2012	7	1							e30599	10.1371/journal.pone.0030599	http://dx.doi.org/10.1371/journal.pone.0030599			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910LV	22291997	Green Published, Green Submitted, gold			2022-12-25	WOS:000301639600036
J	Zhang, CC; Helmsing, S; Zagrebelsky, M; Schirrmann, T; Marschall, ALJ; Schungel, M; Korte, M; Hust, M; Dubel, S				Zhang, Congcong; Helmsing, Saskia; Zagrebelsky, Marta; Schirrmann, Thomas; Marschall, Andrea L. J.; Schuengel, Manuela; Korte, Martin; Hust, Michael; Duebel, Stefan			Suppression of p75 Neurotrophin Receptor Surface Expression with Intrabodies Influences Bcl-xL mRNA Expression and Neurite Outgrowth in PC12 Cells	PLOS ONE			English	Article							NERVE-GROWTH-FACTOR; UNFOLDED PROTEIN RESPONSE; HIPPOCAMPAL-NEURONS; RECOMBINANT ANTIBODIES; ENDOPLASMIC-RETICULUM; PHAGE DISPLAY; TRKA RECEPTORS; IN-VITRO; P75(NTR); CHAIN	Background: Although p75 neurotrophin receptor (p75NTR) is the first neurotrophin receptor isolated, its diverse physiological functions and signaling have remained elusive for many years. Loss-of-function phenotypic analyses for p75NTR were mainly focused at the genetic level; however these approaches were impacted by off-target effect, insufficient stability, unspecific stress response or alternative active splicing products. In this study, p75NTR surface expression was suppressed for the first time at the protein level by endoplasmic reticulum (ER) retained intrabodies. Results: Three monoclonal recombinant antibody fragments (scFv) with affinities in the low nanomolar range to murine p75NTR were isolated by antibody phage display. To suppress p75NTR cell surface expression, the encoding genes of these scFvs extended by the ER retention peptide KDEL were transiently transfected into the neuron-like rat pheochromocytoma cell line PC12 and the mouse neuroblastoma x mouse spinal cord hybrid cell line NSC19. The ER retained intrabody construct, SH325-G7-KDEL, mediated a downregulation of p75NTR cell surface expression as shown by flow cytometry. This effect was maintained over a period of at least eight days without activating an unfolded protein response (UPR). Moreover, the ER retention of p75NTR resulted in downregulation of mRNA levels of the anti-apoptotic protein Bcl-xL as well as in strong inhibition of NGF-induced neurite outgrowth in PC12 cells. Conclusion: The ER retained intrabody SH325-G7-KDEL not only induces phenotypic knockdown of this p75NTR but also p75NTR-associated cellular responses in PC12 cells.	[Zhang, Congcong; Helmsing, Saskia; Schirrmann, Thomas; Marschall, Andrea L. J.; Hust, Michael; Duebel, Stefan] Tech Univ Carolo Wilhelmina Braunschweig, Inst Biochem & Biotechnol, Braunschweig, Germany; [Zagrebelsky, Marta; Korte, Martin] Tech Univ Carolo Wilhelmina Braunschweig, Inst Zool, Braunschweig, Germany; [Schuengel, Manuela] Hannover Med Sch, Integrated Res & Treatment Ctr Transplantat, D-3000 Hannover, Germany	Braunschweig University of Technology; Braunschweig University of Technology; Hannover Medical School	Zhang, CC (corresponding author), Tech Univ Carolo Wilhelmina Braunschweig, Inst Biochem & Biotechnol, Braunschweig, Germany.	s.duebel@tu-bs.de	Marschall, Andrea L. J./AAU-2263-2020	Marschall, Andrea L. J./0000-0002-9505-0427; Zhang, Congcong/0000-0001-9995-3079; Dubel, Stefan/0000-0001-8811-7390; Zagrebelsky, Marta/0000-0003-1083-7413; Hust, Michael/0000-0003-3418-6045	Graduate College "Molecular Complexes of Biomedical Relevance" of the Land Niedersachsen, Germany; EU [222635]; Affinity Proteome [24181]	Graduate College "Molecular Complexes of Biomedical Relevance" of the Land Niedersachsen, Germany; EU(European Commission); Affinity Proteome	This project was funded by the Graduate College "Molecular Complexes of Biomedical Relevance" of the Land Niedersachsen, Germany, and the EU consortia Affinomics (Project No. 222635) and Affinity Proteome (Project No 24181) within the FP7 (http://www.affinomics.org/ and http://www.proteomebinders.org/apframestarthome.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arevalo JC, 2006, CELL MOL LIFE SCI, V63, P1523, DOI 10.1007/s00018-006-6010-1; Bando Y, 2003, EUR J NEUROSCI, V18, P829, DOI 10.1046/j.1460-9568.2003.02818.x; Bibel M, 1999, EMBO J, V18, P616, DOI 10.1093/emboj/18.3.616; Boldicke T, 2007, J CELL MOL MED, V11, P54, DOI 10.1111/j.1582-4934.2007.00002.x; Braakman I, 2011, ANNU REV BIOCHEM, V80, P71, DOI 10.1146/annurev-biochem-062209-093836; Bradbury ARM, 2011, NAT BIOTECHNOL, V29, P245, DOI 10.1038/nbt.1791; Brann AB, 1999, J NEUROSCI, V19, P8199; Bridge AJ, 2003, NAT GENET, V34, P263, DOI 10.1038/ng1173; Bui NT, 2002, J NEUROCHEM, V81, P594, DOI 10.1046/j.1471-4159.2002.00841.x; Carter BD, 1996, SCIENCE, V272, P542, DOI 10.1126/science.272.5261.542; CASHMAN NR, 1992, DEV DYNAM, V194, P209, DOI 10.1002/aja.1001940306; Catts VS, 2008, EUR J NEUROSCI, V28, P883, DOI 10.1111/j.1460-9568.2008.06390.x; Colwill K, 2011, NAT METHODS, V8, P551, DOI [10.1038/NMETH.1607, 10.1038/nmeth.1607]; Couzin J, 2004, SCIENCE, V306, P1124, DOI 10.1126/science.306.5699.1124; Dechant G, 1997, CURR OPIN NEUROBIOL, V7, P413, DOI 10.1016/S0959-4388(97)80071-2; DUBEL S, 1992, CELL BIOPHYS, V21, P69; Dubel S, 2010, TRENDS BIOTECHNOL, V28, P333, DOI 10.1016/j.tibtech.2010.05.001; Dykxhoorn DM, 2006, GENE THER, V13, P541, DOI 10.1038/sj.gt.3302703; Epa WR, 2004, J NEUROCHEM, V89, P344, DOI 10.1111/j.1471-4159.2004.02344.x; Famulok M, 2000, ACCOUNTS CHEM RES, V33, P591, DOI 10.1021/ar960167q; Fish RJ, 2004, BMC MOL BIOL, V5, DOI 10.1186/1471-2199-5-9; Gargano N, 1997, J NEUROSCI RES, V50, P1; HEMPSTEAD BL, 1991, NATURE, V350, P678, DOI 10.1038/350678a0; Hempstead BL, 2002, CURR OPIN NEUROBIOL, V12, P260, DOI 10.1016/S0959-4388(02)00321-5; Hust Michael, 2007, V408, P243, DOI 10.1007/978-1-59745-547-3_14; Hust M, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-14; Hust M, 2011, J BIOTECHNOL, V152, P159, DOI 10.1016/j.jbiotec.2010.09.945; Hust M, 2009, NEW BIOTECHNOL, V25, P424, DOI 10.1016/j.nbt.2009.03.004; IP NY, 1993, NEURON, V10, P137, DOI 10.1016/0896-6273(93)90306-C; Ito H, 2003, J NEUROSCI RES, V72, P211, DOI 10.1002/jnr.10564; Kanning KC, 2003, J NEUROSCI, V23, P5425, DOI 10.1523/jneurosci.23-13-05425.2003; Kimpinski K, 1999, NEUROSCIENCE, V93, P253, DOI 10.1016/S0306-4522(99)00156-6; Leverrier Y, 1999, CELL DEATH DIFFER, V6, P290, DOI 10.1038/sj.cdd.4400492; Li JD, 2007, PROTEIN ENG DES SEL, V20, P491, DOI 10.1093/protein/gzm038; Liao W, 2008, BIOCHEM BIOPH RES CO, V373, P235, DOI 10.1016/j.bbrc.2008.06.020; Lu B, 2005, NAT REV NEUROSCI, V6, P603, DOI 10.1038/nrn1726; MAHONEY WC, 1979, J BIOL CHEM, V254, P6572; Majdan M, 1997, J NEUROSCI, V17, P6988; Makkerh JPS, 2005, EMBO REP, V6, P936, DOI 10.1038/sj.embor.7400503; Malhotra JD, 2007, SEMIN CELL DEV BIOL, V18, P716, DOI 10.1016/j.semcdb.2007.09.003; MARKS JD, 1992, BIO-TECHNOL, V10, P779, DOI 10.1038/nbt0792-779; Mersmann M, 2010, NEW BIOTECHNOL, V27, P118, DOI 10.1016/j.nbt.2009.10.007; Michaelsen K, 2010, EUR J NEUROSCI, V32, P1854, DOI 10.1111/j.1460-9568.2010.07460.x; Mollova S, 2010, ANTIBODY ENGINEERING, VOL 2, SECOND EDITION, P3, DOI 10.1007/978-3-642-01147-4_1; Nykjaer A, 2005, CURR OPIN NEUROBIOL, V15, P49, DOI 10.1016/j.conb.2005.01.004; OLDEN K, 1979, P NATL ACAD SCI USA, V76, P791, DOI 10.1073/pnas.76.2.791; Paul CE, 2004, J NEUROSCI, V24, P1917, DOI 10.1523/JNEUROSCI.5397-03.2004; Rondot S, 2001, NAT BIOTECHNOL, V19, P75, DOI 10.1038/83567; Rosch H, 2005, P NATL ACAD SCI USA, V102, P7362, DOI 10.1073/pnas.0502460102; Roux PP, 2001, J BIOL CHEM, V276, P23097, DOI 10.1074/jbc.M011520200; ROVELLI G, 1993, P NATL ACAD SCI USA, V90, P8717, DOI 10.1073/pnas.90.18.8717; Schofield DJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r254; Schor NF, 2005, PROG NEUROBIOL, V77, P201, DOI 10.1016/j.pneurobio.2005.10.006; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Schroder M, 2008, CELL MOL LIFE SCI, V65, P862, DOI 10.1007/s00018-007-7383-5; Sledz CA, 2003, NAT CELL BIOL, V5, P834, DOI 10.1038/ncb1038; Soltes G, 2007, J BIOTECHNOL, V127, P626, DOI 10.1016/j.jbiotec.2006.08.015; Strebe N, 2009, J IMMUNOL METHODS, V341, P30, DOI 10.1016/j.jim.2008.10.012; Taussig MJ, 2007, NAT METHODS, V4, P13, DOI 10.1038/nmeth0107-13; Tuffereau C, 1998, EMBO J, V17, P7250, DOI 10.1093/emboj/17.24.7250; von Schack D, 2001, NAT NEUROSCI, V4, P977, DOI 10.1038/nn730; Wehrman T, 2007, NEURON, V53, P25, DOI 10.1016/j.neuron.2006.09.034; Yoon SO, 1998, J NEUROSCI, V18, P3273; Zagrebelsky M, 2005, J NEUROSCI, V25, P9989, DOI 10.1523/JNEUROSCI.2492-05.2005	65	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2012	7	1							e30684	10.1371/journal.pone.0030684	http://dx.doi.org/10.1371/journal.pone.0030684			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910LV	22292018	Green Published, gold, Green Submitted			2022-12-25	WOS:000301639600047
J	Mascareno, E; Galatioto, J; Rozenberg, I; Salciccioli, L; Kamran, H; Lazar, JM; Liu, F; Pedrazzini, T; Siddiqui, MAQ				Mascareno, Eduardo; Galatioto, Josephine; Rozenberg, Inna; Salciccioli, Louis; Kamran, Haroon; Lazar, Jason M.; Liu, Fang; Pedrazzini, Thierry; Siddiqui, M. A. Q.			Cardiac Lineage Protein-1 (CLP-1) Regulates Cardiac Remodeling via Transcriptional Modulation of Diverse Hypertrophic and Fibrotic Responses and Angiotensin II-transforming Growth Factor beta (TGF-beta 1) Signaling Axis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELONGATION-FACTOR-B; PRESSURE-OVERLOAD; DOWN-REGULATION; HEART-FAILURE; ACTIVATION; SYSTEM; TRANSDUCTION; INHIBITION; MECHANISMS; RECEPTOR	It is well known that the renin-angiotensin system contributes to left ventricular hypertrophy and fibrosis, a major determinant of myocardial stiffness. TGF-beta 1 and renin-angiotensin system signaling alters the fibroblast phenotype by promoting its differentiation into morphologically distinct pathological myofibroblasts, which potentiates collagen synthesis and fibrosis and causes enhanced extracellular matrix deposition. However, the atrial natriuretic peptide, which is induced during left ventricular hypertrophy, plays an anti-fibrogenic and anti-hypertrophic role by blocking, among others, the TGF-beta-induced nuclear localization of Smads. It is not clear how the hypertrophic and fibrotic responses are transcriptionally regulated. CLP-1, the mouse homolog of human hexamethylene bis-acetamide inducible-1 (HEXIM-1), regulates the pTEFb activity via direct association with pTEFb causing inhibition of the Cdk9-mediated serine 2 phosphorylation in the carboxyl-terminal domain of RNA polymerase II. It was recently reported that the serine kinase activity of Cdk9 not only targets RNA polymerase II but also the conserved serine residues of the polylinker region in Smad3, suggesting that CLP-1-mediated changes in pTEFb activity may trigger Cdk9-dependent Smad3 signaling that can modulate collagen expression and fibrosis. In this study, we evaluated the role of CLP-1 in vivo in induction of left ventricular hypertrophy in angiotensinogen-overexpressing transgenic mice harboring CLP-1 heterozygosity. We observed that introduction of CLP-1 haplodeficiency in the transgenic alpha-myosin heavy chain-angiotensinogen mice causes prominent changes in hypertrophic and fibrotic responses accompanied by augmentation of Smad3/Stat3 signaling. Together, our findings underscore the critical role of CLP-1 in remodeling of the genetic response during hypertrophy and fibrosis.	[Mascareno, Eduardo; Galatioto, Josephine; Rozenberg, Inna; Siddiqui, M. A. Q.] Suny Downstate Med Ctr, Dept Cell Biol, Ctr Cardiovasc & Muscle Res, Brooklyn, NY 11203 USA; [Salciccioli, Louis; Kamran, Haroon; Lazar, Jason M.] Suny Downstate Med Ctr, Div Cardiol, Brooklyn, NY 11203 USA; [Liu, Fang] Rutgers State Univ, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA; [Pedrazzini, Thierry] Univ Lausanne, Sch Med, Div Hypertens & Vasc Med, CH-1011 Lausanne, Switzerland	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Rutgers State University New Brunswick; University of Lausanne	Siddiqui, MAQ (corresponding author), Suny Downstate Med Ctr, Dept Cell Biol, Ctr Cardiovasc & Muscle Res, 450 Clarkson Ave, Brooklyn, NY 11203 USA.	maq.siddiqui@downstate.edu			National Institutes of Health [HL073399]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073399] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL073399 (to M. A. Q. S.).	Alarcon C, 2009, CELL, V139, P757, DOI 10.1016/j.cell.2009.09.035; Beckles DL, 2006, VASC PHARMACOL, V45, P350, DOI 10.1016/j.vph.2006.05.006; Cucoranu I, 2005, CIRC RES, V97, P900, DOI 10.1161/01.RES.0000187457.24338.3D; Divakaran V, 2009, CIRC-HEART FAIL, V2, P633, DOI 10.1161/CIRCHEARTFAILURE.108.823070; Domenighetti AA, 2005, HYPERTENSION, V46, P426, DOI 10.1161/01.HYP.0000173069.53699.d9; Espinoza-Derout J, 2007, CARDIOVASC RES, V75, P129, DOI 10.1016/j.cardiores.2007.03.019; Espinoza-Derout J, 2009, CIRC RES, V104, P1347, DOI 10.1161/CIRCRESAHA.108.191726; Franco V, 2004, HYPERTENSION, V44, P746, DOI 10.1161/01.HYP.0000144801.09557.4c; Fukuzawa J, 2000, HYPERTENSION, V35, P1191, DOI 10.1161/01.HYP.35.6.1191; Guo YL, 2004, MOL ENDOCRINOL, V18, P1033, DOI 10.1210/me.2003-0231; Ho M K C, 2009, Curr Mol Pharmacol, V2, P19; Huang F, 2004, MECH DEVELOP, V121, P559, DOI 10.1016/j.mod.2004.04.012; Li YH, 2002, CIRCULATION, V106, P1722, DOI 10.1161/01.CIR.0000029923.57048.61; Manea A, 2010, ARTERIOSCL THROM VAS, V30, P105, DOI 10.1161/ATVBAHA.109.193896; Mascareno E, 1998, P NATL ACAD SCI USA, V95, P5590, DOI 10.1073/pnas.95.10.5590; Mazzolai L, 1998, HYPERTENSION, V31, P1324, DOI 10.1161/01.HYP.31.6.1324; Mazzolai L, 2000, HYPERTENSION, V35, P985, DOI 10.1161/01.HYP.35.4.985; McGrath MF, 2005, TRENDS ENDOCRIN MET, V16, P469, DOI 10.1016/j.tem.2005.10.007; Mitsuyama K, 2006, CYTOKINE GROWTH F R, V17, P451, DOI 10.1016/j.cytogfr.2006.09.003; Montano MM, 2008, CIRC RES, V102, P415, DOI 10.1161/CIRCRESAHA.107.157859; Mori T, 2004, CARDIOVASC RES, V61, P771, DOI 10.1016/j.cardiores.2003.12.005; Oliver PM, 1997, P NATL ACAD SCI USA, V94, P14730, DOI 10.1073/pnas.94.26.14730; Re RN, 2007, NAT CLIN PRACT CARD, V4, P549, DOI 10.1038/ncpcardio0985; Rosenkranz S, 2004, CARDIOVASC RES, V63, P423, DOI 10.1016/j.cardiores.2004.04.030; Sano M, 2004, EMBO J, V23, P3559, DOI 10.1038/sj.emboj.7600351; Sano M, 2002, NAT MED, V8, P1310, DOI 10.1038/nm778; Schmierer B, 2007, NAT REV MOL CELL BIO, V8, P970, DOI 10.1038/nrm2297; Schnee JM, 2000, CARDIOVASC RES, V46, P264, DOI 10.1016/S0008-6363(00)00044-4; Schultz JEJ, 2002, J CLIN INVEST, V109, P787, DOI 10.1172/JCI200214190; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Swaney JS, 2005, P NATL ACAD SCI USA, V102, P437, DOI 10.1073/pnas.0408704102; Wang DJ, 2003, HYPERTENSION, V42, P88, DOI 10.1161/01.HYP.0000074905.22908.A6; Wang J, 2005, CIRC RES, V97, P821, DOI 10.1161/01.RES.0000185833.42544.06; Wang J, 2012, CELL RES, V22, P516, DOI 10.1038/cr.2011.132	34	21	24	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					13084	13093		10.1074/jbc.M111.288944	http://dx.doi.org/10.1074/jbc.M111.288944			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22308025	Green Published, hybrid			2022-12-25	WOS:000302903700048
J	Holmes, I; Harris, K; Quince, C				Holmes, Ian; Harris, Keith; Quince, Christopher			Dirichlet Multinomial Mixtures: Generative Models for Microbial Metagenomics	PLOS ONE			English	Article							DIVERSITY; SEQUENCES	We introduce Dirichlet multinomial mixtures (DMM) for the probabilistic modelling of microbial metagenomics data. This data can be represented as a frequency matrix giving the number of times each taxa is observed in each sample. The samples have different size, and the matrix is sparse, as communities are diverse and skewed to rare taxa. Most methods used previously to classify or cluster samples have ignored these features. We describe each community by a vector of taxa probabilities. These vectors are generated from one of a finite number of Dirichlet mixture components each with different hyperparameters. Observed samples are generated through multinomial sampling. The mixture components cluster communities into distinct 'metacommunities', and, hence, determine envirotypes or enterotypes, groups of communities with a similar composition. The model can also deduce the impact of a treatment and be used for classification. We wrote software for the fitting of DMM models using the 'evidence framework' (http://code.google.com/p/microbedmm/). This includes the Laplace approximation of the model evidence. We applied the DMM model to human gut microbe genera frequencies from Obese and Lean twins. From the model evidence four clusters fit this data best. Two clusters were dominated by Bacteroides and were homogenous; two had a more variable community composition. We could not find a significant impact of body mass on community structure. However, Obese twins were more likely to derive from the high variance clusters. We propose that obesity is not associated with a distinct microbiota but increases the chance that an individual derives from a disturbed enterotype. This is an example of the 'Anna Karenina principle (AKP)' applied to microbial communities: disturbed states having many more configurations than undisturbed. We verify this by showing that in a study of inflammatory bowel disease (IBD) phenotypes, ileal Crohn's disease (ICD) is associated with a more variable community.	[Holmes, Ian] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Harris, Keith; Quince, Christopher] Univ Glasgow, Sch Engn, Glasgow, Lanark, Scotland	University of California System; University of California Berkeley; University of Glasgow	Holmes, I (corresponding author), Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA.	christopher.quince@glasgow.ac.uk	Harris, Keith/ABG-7349-2021	Quince, Christopher/0000-0003-1884-8440; Holmes, Ian/0000-0001-7639-5369	EPSRC [EP/H003851/1]; University of Glasgow; NIH/NIGMS [R01-GM076705]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076705] Funding Source: NIH RePORTER; Engineering and Physical Sciences Research Council [EP/H003851/1] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); University of Glasgow; NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	CQ is funded by an EPSRC Career Acceleration Fellowship EP/H003851/1. KH by a Unilever directly funded research grant to the University of Glasgow. IH was supported by NIH/NIGMS grant R01-GM076705. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; [Anonymous], 1997, GUNS GERMS STEEL; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Bishop C.M., 2006, PATTERN RECOGNITION; Bouguila N, 2011, IEEE T NEURAL NETWOR, V22, P186, DOI 10.1109/TNN.2010.2091428; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Dorigo U, 2005, WATER RES, V39, P2207, DOI 10.1016/j.watres.2005.04.007; Galassi M., 2009, GNU SCI LIB REFERENC, DOI [10.5555/1538674, DOI 10.5555/1538674]; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; Huber JA, 2007, SCIENCE, V318, P97, DOI 10.1126/science.1146689; Knights D, 2011, NAT METHODS, V8, P761, DOI 10.1038/nmeth.1650; Knights D, 2011, FEMS MICROBIOL REV, V35, P343, DOI 10.1111/j.1574-6976.2010.00251.x; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; MACKAY DJC, 1992, NEURAL COMPUT, V4, P415, DOI [10.1162/neco.1992.4.3.415, 10.1162/neco.1992.4.3.448]; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Peterson J, 2009, GENOME RES, V19, P2317, DOI 10.1101/gr.096651.109; Quince C, 2008, ISME J, V2, P997, DOI 10.1038/ismej.2008.69; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; Ramette A, 2007, FEMS MICROBIOL ECOL, V62, P142, DOI 10.1111/j.1574-6941.2007.00375.x; Schloss PD, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-34; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Sjolander K, 1996, COMPUT APPL BIOSCI, V12, P327; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Streit WR, 2004, CURR OPIN MICROBIOL, V7, P492, DOI 10.1016/j.mib.2004.08.002; Sun YJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq872; Tolstoy, 2014, A KARENINA; Turnbaugh PJ, 2010, P NATL ACAD SCI USA, V107, P7503, DOI 10.1073/pnas.1002355107; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Willing BP, 2010, GASTROENTEROLOGY, V139, P1844, DOI 10.1053/j.gastro.2010.08.049; Ye XG, 2010, J COMPUT BIOL, V17, P1607, DOI 10.1089/cmb.2010.0117	34	364	374	3	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2012	7	2							e30126	10.1371/journal.pone.0030126	http://dx.doi.org/10.1371/journal.pone.0030126			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LO	22319561	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000302178400005
J	Humphreys, DT; Hynes, CJ; Patel, HR; Wei, GH; Cannon, L; Fatkin, D; Suter, CM; Clancy, JL; Preiss, T				Humphreys, David T.; Hynes, Carly J.; Patel, Hardip R.; Wei, Grace H.; Cannon, Leah; Fatkin, Diane; Suter, Catherine M.; Clancy, Jennifer L.; Preiss, Thomas			Complexity of Murine Cardiomyocyte miRNA Biogenesis, Sequence Variant Expression and Function	PLOS ONE			English	Article							MESSENGER-RNA TRANSLATION; CARDIOVASCULAR BIOLOGY; MICRORNA TARGETS; STRUCTURAL BASIS; HEART-DISEASE; CELLS; DROSOPHILA; GENES; TRANSCRIPTOME; CONTRIBUTES	microRNAs (miRNAs) are critical to heart development and disease. Emerging research indicates that regulated precursor processing can give rise to an unexpected diversity of miRNA variants. We subjected small RNA from murine HL-1 cardiomyocyte cells to next generation sequencing to investigate the relevance of such diversity to cardiac biology. similar to 40 million tags were mapped to known miRNA hairpin sequences as deposited in miRBase version 16, calling 403 generic miRNAs as appreciably expressed. Hairpin arm bias broadly agreed with miRBase annotation, although 44 miR* were unexpectedly abundant (>20% of tags); conversely, 33 -5p/-3p annotated hairpins were asymmetrically expressed. Overall, variability was infrequent at the 5' start but common at the 3' end of miRNAs (5.2% and 52.3% of tags, respectively). Nevertheless, 105 miRNAs showed marked 5' isomiR expression (>20% of tags). Among these was miR-133a, a miRNA with important cardiac functions, and we demonstrated differential mRNA targeting by two of its prevalent 5' isomiRs. Analyses of miRNA termini and base-pairing patterns around Drosha and Dicer cleavage regions confirmed the known bias towards uridine at the 5' most position of miRNAs, as well as supporting the thermodynamic asymmetry rule for miRNA strand selection and a role for local structural distortions in fine tuning miRNA processing. We further recorded appreciable expression of 5 novel miR*, 38 extreme variants and 8 antisense miRNAs. Analysis of genome-mapped tags revealed 147 novel candidate miRNAs. In summary, we revealed pronounced sequence diversity among cardiomyocyte miRNAs, knowledge of which will underpin future research into the mechanisms involved in miRNA biogenesis and, importantly, cardiac function, disease and therapy.	[Humphreys, David T.; Hynes, Carly J.; Patel, Hardip R.; Wei, Grace H.; Suter, Catherine M.; Clancy, Jennifer L.; Preiss, Thomas] Victor Chang Cardiac Res Inst, Div Mol Genet, Sydney, NSW, Australia; [Hynes, Carly J.; Patel, Hardip R.; Clancy, Jennifer L.; Preiss, Thomas] Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT 2601, Australia; [Cannon, Leah; Fatkin, Diane] Victor Chang Cardiac Res Inst, Mol Cardiol Div, Sydney, NSW, Australia; [Fatkin, Diane; Suter, Catherine M.; Clancy, Jennifer L.; Preiss, Thomas] Univ New S Wales, St Vincents Clin Sch, Sydney, NSW, Australia; [Fatkin, Diane] St Vincents Hosp, Dept Cardiol, Sydney, NSW 2010, Australia; [Preiss, Thomas] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia	Victor Chang Cardiac Research Institute; Australian National University; John Curtin School of Medical Research; Victor Chang Cardiac Research Institute; University of New South Wales Sydney; St Vincents Hospital Sydney; University of New South Wales Sydney	Humphreys, DT (corresponding author), Victor Chang Cardiac Res Inst, Div Mol Genet, Sydney, NSW, Australia.	jennifer.clancy@anu.edu.au; thomas.preiss@anu.edu.au	Preiss, Thomas/F-7355-2010; Wei, Grace/GPX-0836-2022; Patel, Hardip R/K-6376-2012	Preiss, Thomas/0000-0001-6273-784X; Patel, Hardip/0000-0003-3169-049X; Humphreys, David/0000-0003-4140-0089	Victor Chang Cardiac Research Institute; National Health & Medical Research Council [573726, 573731, 514904]	Victor Chang Cardiac Research Institute; National Health & Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by by the Victor Chang Cardiac Research Institute and grants 573726, 573731 and 514904 from the National Health & Medical Research Council awarded to TP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Beilharz TH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006783; Burroughs AM, 2011, RNA BIOL, V8, P158, DOI 10.4161/rna.8.1.14300; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Catalucci D, 2009, CIRC-CARDIOVASC GENE, V2, P402, DOI 10.1161/CIRCGENETICS.109.857425; Cheng YH, 2010, J CARDIOVASC TRANSL, V3, P251, DOI 10.1007/s12265-010-9169-7; Chiang HR, 2010, GENE DEV, V24, P992, DOI 10.1101/gad.1884710; Cifuentes D, 2010, SCIENCE, V328, P1694, DOI 10.1126/science.1190809; Clancy JL, 2007, METHOD ENZYMOL, V431, P83, DOI 10.1016/S0076-6879(07)31006-9; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; Corsten MF, 2010, CIRC-CARDIOVASC GENE, V3, P499, DOI 10.1161/CIRCGENETICS.110.957415; Czech B, 2011, NAT REV GENET, V12, P19, DOI 10.1038/nrg2916; Davis-Dusenbery BN, 2010, J BIOCHEM, V148, P381, DOI 10.1093/jb/mvq096; Dorn GW, 2011, TRANSL RES, V157, P226, DOI 10.1016/j.trsl.2010.12.013; Duisters RF, 2009, CIRC RES, V104, P170, DOI 10.1161/CIRCRESAHA.108.182535; Ebhardt H Alexander, 2010, Silence, V1, P12, DOI 10.1186/1758-907X-1-12; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Fernandez-Valverde SL, 2010, RNA, V16, P1881, DOI 10.1261/rna.2379610; Frank F, 2010, NATURE, V465, P818, DOI 10.1038/nature09039; Ghosh G, 2010, J CLIN INVEST, V120, P4141, DOI 10.1172/JCI42980; Han BW, 2011, CURR BIOL, V21, P1878, DOI 10.1016/j.cub.2011.09.034; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; Hu HY, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-413; Hu SJ, 2010, CIRCULATION, V122, pS124, DOI 10.1161/CIRCULATIONAHA.109.928424; Huang ZP, 2010, ARTERIOSCL THROM VAS, V30, P2575, DOI 10.1161/ATVBAHA.110.213306; Hwang HW, 2009, P NATL ACAD SCI USA, V106, P7016, DOI 10.1073/pnas.0811523106; Jeffries CD, 2011, RNA, V17, P675, DOI 10.1261/rna.2006511; Kai ZS, 2010, NAT STRUCT MOL BIOL, V17, P5, DOI 10.1038/nsmb.1762; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Krol J, 2004, J BIOL CHEM, V279, P42230, DOI 10.1074/jbc.M404931200; Kuchen S, 2010, IMMUNITY, V32, P828, DOI 10.1016/j.immuni.2010.05.009; Kuchenbauer F, 2008, GENOME RES, V18, P1787, DOI 10.1101/gr.077578.108; Lee LW, 2010, RNA, V16, P2170, DOI 10.1261/rna.2225110; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liu N, 2011, CURR BIOL, V21, P1888, DOI 10.1016/j.cub.2011.10.006; Liu N, 2010, DEV CELL, V18, P510, DOI 10.1016/j.devcel.2010.03.010; Liu N, 2008, GENE DEV, V22, P3242, DOI 10.1101/gad.1738708; Matkovich SJ, 2011, CIRC RES, V108, P18, DOI 10.1161/CIRCRESAHA.110.233528; Michlewski G, 2010, ADV EXP MED BIOL, V700, P28; Miyoshi K, 2010, MOL GENET GENOMICS, V284, P95, DOI 10.1007/s00438-010-0556-1; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Newman MA, 2010, GENE DEV, V24, P1086, DOI 10.1101/gad.1919710; Okamura K, 2008, NAT STRUCT MOL BIOL, V15, P354, DOI 10.1038/nsmb.1409; Patel N, 2011, BIOCHEM J, V434, P473, DOI 10.1042/BJ20101585; Rajkowitsch L, 2007, RNA BIOL, V4, P118, DOI 10.4161/rna.4.3.5445; Rao PK, 2009, CIRC RES, V105, P585, DOI 10.1161/CIRCRESAHA.109.200451; Ro S, 2007, NUCLEIC ACIDS RES, V35, P5944, DOI 10.1093/nar/gkm641; Ryan BM, 2010, NAT REV CANCER, V10, P389, DOI 10.1038/nrc2867; Sarkar S, 2010, MOL BIOL CELL, V21, P2138, DOI 10.1091/mbc.E10-01-0062; Schroen B, 2009, HYPERTENSION, V54, P1189, DOI 10.1161/HYPERTENSIONAHA.109.133942; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Seitz Herve, 2011, Silence, V2, P4, DOI 10.1186/1758-907X-2-4; Shao NY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-409; Small EM, 2011, NATURE, V469, P336, DOI 10.1038/nature09783; Spierings DC, 2011, BLOOD, V117, P5340, DOI 10.1182/blood-2010-10-316034; Starega-Roslan J, 2011, CELL MOL LIFE SCI, V68, P2859, DOI 10.1007/s00018-011-0726-2; Starega-Roslan J, 2011, NUCLEIC ACIDS RES, V39, P257, DOI 10.1093/nar/gkq727; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; Tian G, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-64; Tyler DM, 2008, GENE DEV, V22, P26, DOI 10.1101/gad.1615208; van Rooij E, 2009, DEV CELL, V17, P662, DOI 10.1016/j.devcel.2009.10.013; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Warf MB, 2011, RNA, V17, P563, DOI 10.1261/rna.2432311; White SM, 2004, AM J PHYSIOL-HEART C, V286, pH823, DOI 10.1152/ajpheart.00986.2003; Wyman SK, 2011, GENOME RES, V21, P1450, DOI 10.1101/gr.118059.110; Xin M, 2009, GENE DEV, V23, P2166, DOI 10.1101/gad.1842409; Xu XD, 2011, J CELL PHYSL; Yang JH, 2010, NUCLEIC ACIDS RES, V38, pD123, DOI 10.1093/nar/gkp943; Yang JS, 2011, RNA, V17, P312, DOI 10.1261/rna.2537911	71	71	175	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2012	7	2							e30933	10.1371/journal.pone.0030933	http://dx.doi.org/10.1371/journal.pone.0030933			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LO	22319597	Green Published, gold			2022-12-25	WOS:000302178400022
J	Hengen, KB; Nelson, NR; Stang, KM; Johnson, SM; Crader, SM; Watters, JJ; Mitchell, GS; Behan, M				Hengen, Keith B.; Nelson, Nathan R.; Stang, Kyle M.; Johnson, Stephen M.; Crader, Stephanie M.; Watters, Jyoti J.; Mitchell, Gordon S.; Behan, Mary			Increased GABA(A) Receptor epsilon-Subunit Expression on Ventral Respiratory Column Neurons Protects Breathing during Pregnancy	PLOS ONE			English	Article							SYNAPTIC PLASTICITY; DELTA-SUBUNIT; RHYTHM; MODULATION; INSENSITIVITY; EXCITABILITY; ORGANIZATION; INHIBITION; MECHANISMS; ARC/ARG3.1	GABAergic signaling is essential for proper respiratory function. Potentiation of this signaling with allosteric modulators such as anesthetics, barbiturates, and neurosteroids can lead to respiratory arrest. Paradoxically, pregnant animals continue to breathe normally despite nearly 100-fold increases in circulating neurosteroids. epsilon subunit-containing GABA(A)Rs are insensitive to positive allosteric modulation, thus we hypothesized that pregnant rats increase e subunit-containing GABA(A)R expression on brainstem neurons of the ventral respiratory column (VRC). In vivo, pregnancy rendered respiratory motor output insensitive to otherwise lethal doses of pentobarbital, a barbiturate previously used to categorize the e subunit. Using electrode array recordings in vitro, we demonstrated that putative respiratory neurons of the preBotzinger Complex (preBotC) were also rendered insensitive to the effects of pentobarbital during pregnancy, but unit activity in the VRC was rapidly inhibited by the GABA(A)R agonist, muscimol. VRC unit activity from virgin and post-partum females was potently inhibited by both pentobarbital and muscimol. Brainstem e subunit mRNA and protein levels were increased in pregnant rats, and GABA(A)R epsilon subunit expression co-localized with a marker of rhythm generating neurons (neurokinin 1 receptors) in the preBotC. These data support the hypothesis that pregnancy renders respiratory motor output and respiratory neuron activity insensitive to barbiturates, most likely via increased epsilon subunit-containing GABA(A)R expression on respiratory rhythm-generating neurons. Increased epsilon subunit expression may be critical to preserve respiratory function (and life) despite increased neurosteroid levels during pregnancy.	[Hengen, Keith B.; Johnson, Stephen M.; Mitchell, Gordon S.; Behan, Mary] Univ Wisconsin, Neurosci Training Program, Madison, WI 53706 USA; [Nelson, Nathan R.; Stang, Kyle M.; Johnson, Stephen M.; Crader, Stephanie M.; Watters, Jyoti J.; Mitchell, Gordon S.; Behan, Mary] Univ Wisconsin, Dept Comparat Biomed Sci, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Hengen, KB (corresponding author), Univ Wisconsin, Neurosci Training Program, Madison, WI 53706 USA.	khengen@brandeis.edu		Hengen, Keith/0000-0001-5017-4090; Smith, Stephanie/0000-0002-2063-0515	National Institute on Aging [AG18760]; National Institutes of Health (PI GM) [T32 HL 7654-24]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007654] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049033] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG018760] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institutes of Health (PI GM); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The laboratory of MB is supported by a Research Project Grant from the National Institute on Aging (AG18760). At the time this work was completed, KH was supported by a training grant provided by the National Institutes of Health (PI GM; T32 HL 7654-24). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamos DA, 2008, COMPUT METH PROG BIO, V91, P232, DOI 10.1016/j.cmpb.2008.04.011; Alheid GF, 2004, RESP PHYSIOL NEUROBI, V143, P105, DOI 10.1016/j.resp.2004.06.016; Alheid GF, 2002, J NEUROCYTOL, V31, P693, DOI 10.1023/A:1025799830302; Backstrom T, 2003, ANN NY ACAD SCI, V1007, P42, DOI 10.1196/annals.1286.005; BAYLISS DA, 1987, P NATL ACAD SCI USA, V84, P7788, DOI 10.1073/pnas.84.21.7788; BAYLISS DA, 1992, J APPL PHYSIOL, V73, P393, DOI 10.1152/jappl.1992.73.2.393; BIANCHI AL, 1995, PHYSIOL REV, V75, P1, DOI 10.1152/physrev.1995.75.1.1; Bouvier J, 2010, NAT NEUROSCI, V13, P1066, DOI 10.1038/nn.2622; Davies PA, 1997, NATURE, V385, P820, DOI 10.1038/385820a0; Del Negro CA, 2002, NEURON, V34, P821, DOI 10.1016/S0896-6273(02)00712-2; Duffin J, 2004, EXP PHYSIOL, V89, P517, DOI 10.1113/expphysiol.2004.028027; Feldman JL, 2003, ANNU REV NEUROSCI, V26, P239, DOI 10.1146/annurev.neuro.26.041002.131103; FELDMAN JL, 1999, FUNDAMENTAL NEUROSCI, P1063; Feng HJ, 2010, J BIOL CHEM, V285, P23614, DOI 10.1074/jbc.M110.122564; Gao M, 2010, J NEUROSCI, V30, P7168, DOI 10.1523/JNEUROSCI.1067-10.2010; Hengen KB, 2011, AM J PHYSIOL-REG I, V300, pR272, DOI 10.1152/ajpregu.00607.2010; Hengen KB, 2009, AM J PHYSIOL-REG I, V297, pR1028, DOI 10.1152/ajpregu.00239.2009; Irnaten M, 2002, ANESTHESIOLOGY, V97, P717, DOI 10.1097/00000542-200209000-00027; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maguire J, 2008, NEURON, V59, P207, DOI 10.1016/j.neuron.2008.06.019; Maguire J, 2009, J NEUROSCI, V29, P9592, DOI 10.1523/JNEUROSCI.2162-09.2009; MANI SK, 1994, P NATL ACAD SCI USA, V91, P6468, DOI 10.1073/pnas.91.14.6468; Martyniuk CJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000894; Mortensen M, 2010, J PHYSIOL-LONDON, V588, P1251, DOI 10.1113/jphysiol.2009.182444; Paxinos G., 2004, RAT BRAIN STEREOTAXI; Pierrefiche O, 1998, J PHYSIOL-LONDON, V509, P245, DOI 10.1111/j.1469-7793.1998.245bo.x; Pintchovski SA, 2009, J NEUROSCI, V29, P1525, DOI 10.1523/JNEUROSCI.5575-08.2009; POKORSKI M, 1994, RESP PHYSIOL, V97, P33, DOI 10.1016/0034-5687(94)90010-8; Ramanan N, 2005, NAT NEUROSCI, V8, P759, DOI 10.1038/nn1462; Rekling JC, 1998, ANNU REV PHYSIOL, V60, P385, DOI 10.1146/annurev.physiol.60.1.385; Ren J, 2006, J NEUROSCI, V26, P3721, DOI 10.1523/JNEUROSCI.0026-06.2006; Ren J, 2006, J PHYSIOL-LONDON, V574, P535, DOI 10.1113/jphysiol.2006.108829; Rybak IA, 2007, PROG BRAIN RES, V165, P201, DOI 10.1016/S0079-6123(06)65013-9; Sebe JY, 2010, EUR J NEUROSCI, V32, P1310, DOI 10.1111/j.1460-9568.2010.07373.x; Smith JC, 1991, PREBOTZINGER COMPLEX; Smith JC, 2009, PHILOS T R SOC B, V364, P2577, DOI 10.1098/rstb.2009.0081; Smith SS, 2007, PHARMACOL THERAPEUT, V116, P58, DOI 10.1016/j.pharmthera.2007.03.008; Stell BM, 2003, P NATL ACAD SCI USA, V100, P14439, DOI 10.1073/pnas.2435457100; Stornetta RL, 2003, J COMP NEUROL, V455, P113, DOI 10.1002/cne.10486; Wagner DA, 2005, J NEUROSCI, V25, P10462, DOI 10.1523/JNEUROSCI.1658-05.2005; Wang H, 2001, J COMP NEUROL, V434, P128, DOI 10.1002/cne.1169; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; Zeller A, 2007, MOL PHARMACOL, V71, P852, DOI 10.1124/mol.106.030049; Zuperku EJ, 2002, RESP PHYSIOL NEUROBI, V131, P121, DOI 10.1016/S1569-9048(02)00042-3	44	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2012	7	1							e30608	10.1371/journal.pone.0030608	http://dx.doi.org/10.1371/journal.pone.0030608			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	912BY	22303446	Green Published, Green Submitted, gold			2022-12-25	WOS:000301770700008
J	Smith, KF; Stefaniak, L; Saito, Y; Gemmill, CEC; Cary, SC; Fidler, AE				Smith, Kirsty F.; Stefaniak, Lauren; Saito, Yasunori; Gemmill, Chrissen E. C.; Cary, S. Craig; Fidler, Andrew E.			Increased Inter-Colony Fusion Rates Are Associated with Reduced COI Haplotype Diversity in an Invasive Colonial Ascidian Didemnum vexillum	PLOS ONE			English	Article							GERM-CELL PARASITISM; GENETIC DIVERSITY; NATURAL CHIMERISM; EVOLUTIONARY GENETICS; MITOCHONDRIAL GENOME; POPULATION; ALLORECOGNITION; BOTRYLLUS; PATTERNS; SUCCESS	Considerable progress in our understanding of the population genetic changes associated with biological invasions has been made over the past decade. Using selectively neutral loci, it has been established that reductions in genetic diversity, reflecting founder effects, have occurred during the establishment of some invasive populations. However, some colonial organisms may actually gain an ecological advantage from reduced genetic diversity because of the associated reduction in inter-colony conflict. Here we report population genetic analyses, along with colony fusion experiments, for a highly invasive colonial ascidian, Didemnum vexillum. Analyses based on mitochondrial cytochrome oxidase I (COI) partial coding sequences revealed two distinct D. vexillum clades. One COI clade appears to be restricted to the probable native region (i.e., north-west Pacific Ocean), while the other clade is present in widely dispersed temperate coastal waters around the world. This clade structure was supported by 18S ribosomal DNA (rDNA) sequence data, which revealed a one base-pair difference between the two clades. Recently established populations of D. vexillum in New Zealand displayed greatly reduced COI genetic diversity when compared with D. vexillum in Japan. In association with this reduction in genetic diversity was a significantly higher inter-colony fusion rate between randomly paired New Zealand D. vexillum colonies (80%, standard deviation +/- 18%) when compared with colonies found in Japan (27%, standard deviation +/- 15%). The results of this study add to growing evidence that for colonial organisms reductions in population level genetic diversity may alter colony interaction dynamics and enhance the invasive potential of newly colonizing species.	[Smith, Kirsty F.; Fidler, Andrew E.] Cawthron Inst, Nelson, New Zealand; [Smith, Kirsty F.; Gemmill, Chrissen E. C.; Cary, S. Craig] Univ Waikato, Dept Biol Sci, Hamilton, New Zealand; [Stefaniak, Lauren] Univ Connecticut, Dept Marine Sci, Groton, CT 06340 USA; [Saito, Yasunori] Univ Tsukuba, Shimoda Marine Res Ctr, Shimoda, Shizuoka, Japan	Cawthron Institute; University of Waikato; University of Connecticut; University of Tsukuba	Smith, KF (corresponding author), Cawthron Inst, Nelson, New Zealand.	kirsty.smith@cawthron.org.nz	Gemmill, Chrissen E C/E-5305-2013	Gemmill, Chrissen E C/0000-0002-1704-9893; Cary, Stephen/0000-0002-2876-2387	New Zealand Ministry of Science and Innovation [CAWX0802]; Education New Zealand Postgraduate Study Abroad Award	New Zealand Ministry of Science and Innovation; Education New Zealand Postgraduate Study Abroad Award	This research was funded by the New Zealand Ministry of Science and Innovation (CAWX0802) and an Education New Zealand Postgraduate Study Abroad Award to KFS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben-Shlomo R, 2008, BIOESSAYS, V30, P1048, DOI 10.1002/bies.20848; Ben-Shlomo R, 2008, GENETICA, V132, P51, DOI 10.1007/s10709-007-9148-3; Benabentos R, 2009, CURR BIOL, V19, P567, DOI 10.1016/j.cub.2009.02.037; Bishop JDD, 1999, P ROY SOC B-BIOL SCI, V266, P241, DOI 10.1098/rspb.1999.0628; BLOSSEY B, 1995, J ECOL, V83, P887, DOI 10.2307/2261425; Bullard SG, 2007, J EXP MAR BIOL ECOL, V342, P99, DOI 10.1016/j.jembe.2006.10.020; Caputi L, 2007, P NATL ACAD SCI USA, V104, P9364, DOI 10.1073/pnas.0610158104; CHAPMAN JW, 1991, J CRUSTACEAN BIOL, V11, P386, DOI 10.2307/1548465; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Coffey B., 2001, POTENTIALLY INVASIVE; Colautti RI, 2004, ECOL LETT, V7, P721, DOI 10.1111/j.1461-0248.2004.00616.x; Corin SE, 2007, INSECT SOC, V54, P275, DOI 10.1007/s00040-007-0942-9; Cote J, 2010, P ROY SOC B-BIOL SCI, V277, P1571, DOI 10.1098/rspb.2009.2128; Coutts ADM, 2002, BIOSECURITY INVESTIG; Coutts ADM, 2007, J EXP MAR BIOL ECOL, V342, P154, DOI 10.1016/j.jembe.2006.10.042; Crawford KM, 2010, MOL ECOL, V19, P1253, DOI 10.1111/j.1365-294X.2010.04550.x; Darling JA, 2008, MOL ECOL, V17, P4992, DOI 10.1111/j.1365-294X.2008.03978.x; De Tomaso AW, 2005, NATURE, V438, P454, DOI 10.1038/nature04150; Delsuc F, 2006, NATURE, V439, P965, DOI 10.1038/nature04336; Dlugosch KM, 2008, MOL ECOL, V17, P431, DOI 10.1111/j.1365-294X.2007.03538.x; Estoup A, 2010, MOL ECOL, V19, P4113, DOI 10.1111/j.1365-294X.2010.04773.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Forslund H, 2010, OECOLOGIA, V164, P833, DOI 10.1007/s00442-010-1767-1; Geller JB, 2010, ANNU REV MAR SCI, V2, P367, DOI 10.1146/annurev.marine.010908.163745; Gittenberger A, 2007, J EXP MAR BIOL ECOL, V342, P122, DOI 10.1016/j.jembe.2006.10.022; Gotzek D, 2007, Q REV BIOL, V82, P201, DOI 10.1086/519965; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; GROSBERG RK, 1988, Q REV BIOL, V63, P377, DOI 10.1086/416026; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Helantera H, 2009, TRENDS ECOL EVOL, V24, P341, DOI 10.1016/j.tree.2009.01.013; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Iannelli F, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-155; Kelly DW, 2006, MOL ECOL, V15, P3641, DOI 10.1111/j.1365-294X.2006.03012.x; Kolbe JJ, 2004, NATURE, V431, P177, DOI 10.1038/nature02807; Kott P, 2002, J MAR BIOL ASSOC UK, V82, P625, DOI 10.1017/S0025315402005970; Lambert Gretchen, 2009, Aquatic Invasions, V4, P5, DOI 10.3391/ai.2009.4.1.2; Lee CE, 2002, TRENDS ECOL EVOL, V17, P386, DOI 10.1016/S0169-5347(02)02554-5; Lopez-Legentil S, 2005, ZOOL SCR, V34, P3, DOI 10.1111/j.1463-6409.2005.00167.x; Lopez-Legentil S, 2006, MOL ECOL, V15, P3957, DOI 10.1111/j.1365-294X.2006.03087.x; McKitrick TR, 2010, SEMIN IMMUNOL, V22, P34, DOI 10.1016/j.smim.2009.12.001; Minchin Dan, 2006, Aquatic Invasions, V1, P143, DOI 10.3391/ai.2006.1.3.8; Mooney HA, 2001, P NATL ACAD SCI USA, V98, P5446, DOI 10.1073/pnas.091093398; MUKAI H, 1974, BIOL BULL-US, V147, P411, DOI 10.2307/1540458; Nakagawa H, 1965, SCI REP TOHOKU U, V37, P31; NEI M, 1975, EVOLUTION, V29, P1, DOI 10.2307/2407137; Nentwig W, 2007, ECOLOGICAL STUDIES, V193; Nydam ML, 2011, EVOLUTION, V65, P429, DOI 10.1111/j.1558-5646.2010.01153.x; Nydam ML, 2010, MOL PHYLOGENET EVOL, V56, P718, DOI 10.1016/j.ympev.2010.03.042; Nylander J.A.A., 2004, MRMODELTEST V2 PROGR; Payne CM, 2004, ANN ZOOL FENN, V41, P843; Perez-Portela R, 2008, ZOOLOGY, V111, P163, DOI 10.1016/j.zool.2007.06.006; Phillips BL, 2010, J EVOLUTION BIOL, V23, P2595, DOI 10.1111/j.1420-9101.2010.02118.x; Pimentel D, 2000, BIOSCIENCE, V50, P53, DOI 10.1641/0006-3568(2000)050[0053:EAECON]2.3.CO;2; Price A, 2005, 200601 GSO U RHOD IS; Puillandre N, 2008, BIOL INVASIONS, V10, P319, DOI 10.1007/s10530-007-9132-y; Ramstad KM, 2007, AM FISH S S, V54, P31; Rinkevich B, 2005, J EXP MAR BIOL ECOL, V322, P93, DOI 10.1016/j.jembe.2005.02.020; Rinkevich B, 2005, CAN J ZOOL, V83, P101, DOI 10.1139/Z04-161; Rinkevich B, 2004, J EXP BIOL, V207, P3531, DOI 10.1242/jeb.01184; Roman J, 2007, TRENDS ECOL EVOL, V22, P454, DOI 10.1016/j.tree.2007.07.002; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; SAITO Y, 1994, INT J DEV BIOL, V38, P237; Sakai AK, 2001, ANNU REV ECOL SYST, V32, P305, DOI 10.1146/annurev.ecolsys.32.081501.114037; Salo P, 2007, P ROY SOC B-BIOL SCI, V274, P1237, DOI 10.1098/rspb.2006.0444; Sax DF, 2000, GLOBAL ECOL BIOGEOGR, V9, P363, DOI 10.1046/j.1365-2699.2000.00217.x; Silva N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002552; Sommerfeldt AD, 1999, MOL ECOL, V8, P885; Sommerfeldt AD, 2003, BIOL J LINN SOC, V79, P183, DOI 10.1046/j.1095-8312.2003.00179.x; Stefaniak Lauren, 2009, Aquatic Invasions, V4, P29, DOI 10.3391/ai.2009.4.1.3; Stoner DS, 1996, P NATL ACAD SCI USA, V93, P15254, DOI 10.1073/pnas.93.26.15254; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tarjuelo I, 2004, MOL ECOL, V13, P3125, DOI 10.1111/j.1365-294X.2004.02306.x; Tarjuelo I, 2001, MAR BIOL, V139, P455; Tsagkogeorga G, 2010, J MOL EVOL, V71, P153, DOI 10.1007/s00239-010-9372-9; Tsutsui ND, 2000, P NATL ACAD SCI USA, V97, P5948, DOI 10.1073/pnas.100110397; Turon X, 2003, HYDROBIOLOGIA, V503, P29, DOI 10.1023/B:HYDR.0000008481.10705.c2; Valentine PC, 2007, J EXP MAR BIOL ECOL, V342, P109, DOI 10.1016/j.jembe.2006.10.021; Van Bocxlaer I, 2010, SCIENCE, V327, P679, DOI 10.1126/science.1181707; van Wilgenburg E, 2010, EVOL APPL, V3, P136, DOI 10.1111/j.1752-4571.2009.00114.x; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Voisin M, 2005, P NATL ACAD SCI USA, V102, P5432, DOI 10.1073/pnas.0501754102; Westerman EL, 2009, MAR BIOL, V156, P2613, DOI 10.1007/s00227-009-1287-x; Williamson MH, 1996, BIOL CONSERV, V78, P163, DOI 10.1016/0006-3207(96)00025-0; Winchell CJ, 2002, MOL BIOL EVOL, V19, P762, DOI 10.1093/oxfordjournals.molbev.a004134; Winkler G, 2008, MOL ECOL, V17, P415, DOI 10.1111/j.1365-294X.2007.03480.x; Yokobori S, 2005, MOL PHYLOGENET EVOL, V34, P273, DOI 10.1016/j.ympev.2004.10.002; Zhan AB, 2010, MOL ECOL, V19, P4678, DOI 10.1111/j.1365-294X.2010.04837.x	87	22	22	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2012	7	1							e30473	10.1371/journal.pone.0030473	http://dx.doi.org/10.1371/journal.pone.0030473			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	912BY	22303442	Green Published, Green Submitted, gold			2022-12-25	WOS:000301770700007
J	Park, JES; Shao, DM; Upton, PD; deSouza, P; Adcock, IM; Davies, RJ; Morrell, NW; Griffiths, MJD; Wort, SJ				Park, John E. S.; Shao, Dongmin; Upton, Paul D.; deSouza, Patricia; Adcock, Ian M.; Davies, Rachel J.; Morrell, Nicholas W.; Griffiths, Mark J. D.; Wort, Stephen J.			BMP-9 Induced Endothelial Cell Tubule Formation and Inhibition of Migration Involves Smad1 Driven Endothelin-1 Production	PLOS ONE			English	Article							PULMONARY ARTERIAL-HYPERTENSION; MORPHOGENETIC PROTEIN BMP; GERMLINE MUTATIONS; KINASE INHIBITORS; RECEPTOR; EXPRESSION; ACTIVATION; PATHWAY; BINDING; GENE	Background: Bone morphogenetic proteins (BMPs) and their receptors, such as bone morphogenetic protein receptor (BMPR) II, have been implicated in a wide variety of disorders including pulmonary arterial hypertension (PAH). Similarly, endothelin-1 (ET-1), a mitogen and vasoconstrictor, is upregulated in PAH and endothelin receptor antagonists are used in its treatment. We sought to determine whether there is crosstalk between BMP signalling and the ET-1 axis in human pulmonary artery endothelial cells (HPAECs), possible mechanisms involved in such crosstalk and functional consequences thereof. Methodology/Principal Finding: Using western blot, real time RT-PCR, ELISA and small RNA interference methods we provide evidence that in HPAECs BMP-9, but not BMP-2, -4 and -6 significantly stimulated ET-1 release under physiological concentrations. This release is mediated by both Smad1 and p38 MAPK and is independent of the canonical Smad4 pathway. Moreover, knocking down the ALK1 receptor or BMPR II attenuates BMP-9 stimulated ET-1 release, whilst causing a significant increase in prepro ET-1 mRNA transcription and mature peptide release. Finally, BMP-9 induced ET-1 release is involved in both inhibition of endothelial cell migration and promotion of tubule formation. Conclusions/Significance: Although our data does not support an important role for BMP-9 as a source of increased endothelial ET-1 production seen in human PAH, BMP-9 stimulated ET-1 production is likely to be important in angiogenesis and vascular stability. However, increased ET-1 production by endothelial cells as a consequence of BMPR II dysfunction may be clinically relevant in the pathogenesis of PAH.	[Park, John E. S.; Shao, Dongmin; deSouza, Patricia; Griffiths, Mark J. D.; Wort, Stephen J.] Univ London Imperial Coll Sci Technol & Med, Royal Brompton Hosp, Crit Care Unit, Natl Heart & Lung Inst,Fac Med, London, England; [Upton, Paul D.; Davies, Rachel J.; Morrell, Nicholas W.] Univ Cambridge, Addenbrookes Hosp, Dept Med, Sch Clin Med, Cambridge CB2 2QQ, England; [Adcock, Ian M.] Univ London Imperial Coll Sci Technol & Med, Airways Dis Sect, Natl Heart & Lung Inst, Fac Med, London, England	Imperial College London; Royal Brompton Hospital; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Imperial College London	Park, JES (corresponding author), Univ London Imperial Coll Sci Technol & Med, Royal Brompton Hosp, Crit Care Unit, Natl Heart & Lung Inst,Fac Med, London, England.	m.griffiths@imperial.ac.uk; s.wort@imperial.ac.uk	wei, wei/HHR-8613-2022; Adcock, Ian/L-3217-2019	Morrell, Nicholas/0000-0001-5700-9792; Griffiths, Mark/0000-0002-1615-1896; Adcock, Ian/0000-0003-2101-8843	British Heart Foundation [PG/07/032/22768, RG/08/002/24718]; Medical Research Council [G0701361]; NIHR (National Institute for Health Research) Respiratory Disease BRU (Biomedical Research Unit) at the Royal Brompton; Harefield NHS Foundation Trust; Imperial College London; MRC [G0800784, G1000847, G0701361] Funding Source: UKRI; Medical Research Council [G1000847, G0800784, G1000758B, G1000758] Funding Source: researchfish; National Institute for Health Research [NF-SI-0509-10174, NF-SI-0508-10212] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIHR (National Institute for Health Research) Respiratory Disease BRU (Biomedical Research Unit) at the Royal Brompton; Harefield NHS Foundation Trust; Imperial College London(General Electric); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This study was supported by the British Heart Foundation (PG/07/032/22768 and RG/08/002/24718) and Medical Research Council (G0701361). It was also supported by the NIHR (National Institute for Health Research) Respiratory Disease BRU (Biomedical Research Unit) at the Royal Brompton and Harefield NHS Foundation Trust and Imperial College London. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson C, 2002, CIRCULATION, V105, P1672, DOI 10.1161/01.CIR.0000012754.72951.3D; Bagnall AJ, 2006, HYPERTENSION, V48, P286, DOI 10.1161/01.HYP.0000229907.58470.4c; Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Bhalla A, 2009, EUR J CLIN INVEST, V39, P74, DOI 10.1111/j.1365-2362.2009.02123.x; Cacoub P, 1997, CARDIOVASC RES, V33, P196, DOI 10.1016/S0008-6363(96)00189-7; Castanares C, 2007, J CELL SCI, V120, P1256, DOI 10.1242/jcs.03419; Daher Z, 2008, CELL SIGNAL, V20, P2256, DOI 10.1016/j.cellsig.2008.08.021; David L, 2008, CIRC RES, V102, P914, DOI 10.1161/CIRCRESAHA.107.165530; David L, 2007, BLOOD, V109, P1953, DOI 10.1182/blood-2006-07-034124; Descargues P, 2008, P NATL ACAD SCI USA, V105, P2487, DOI 10.1073/pnas.0712044105; Du Lingling, 2003, New England Journal of Medicine, V348, P500, DOI 10.1056/NEJMoa021650; Fernandez-Lopez A, 2007, HUM MOL GENET, V16, P1515, DOI 10.1093/hmg/ddm069; Hall SM, 2011, EUR RESPIR J, V38, P851, DOI 10.1183/09031936.00167010; He W, 2006, CELL, V125, P929, DOI 10.1016/j.cell.2006.03.045; Hong KH, 2008, CIRCULATION, V118, P722, DOI 10.1161/CIRCULATIONAHA.107.736801; Huang MS, 2007, J BIOL CHEM, V282, P21237, DOI 10.1074/jbc.M701341200; Humbert M, 2005, NAT CLIN PRACT RHEUM, V1, P93, DOI 10.1038/ncprheum0048; Kern JM, 2009, THROMB HAEMOSTASIS, V102, P743, DOI 10.1160/TH09-02-0128; Kimura N, 2000, J BIOL CHEM, V275, P17647, DOI 10.1074/jbc.M908622199; Lane KB, 2000, NAT GENET, V26, P81, DOI 10.1038/79226; Lee NY, 2009, FASEB J, V23, P3712, DOI 10.1096/fj.09-131607; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lux Andreas, 2006, BMC Cardiovasc Disord, V6, P13, DOI 10.1186/1471-2261-6-13; Machado RD, 2001, AM J HUM GENET, V68, P92, DOI 10.1086/316947; Mayer RJ, 2006, DRUG DISCOV TODAY, V3, p[38, 6]; Meoli DF, 2010, CAN J PHYSIOL PHARM, V88, P830, DOI 10.1139/Y10-059; Morikawa M, 2011, NUCLEIC ACIDS RES, V39, P8712, DOI 10.1093/nar/gkr572; Morrell Nicholas W, 2006, Proc Am Thorac Soc, V3, P680, DOI 10.1513/pats.200605-118SF; Mukhopadhyay A, 2009, DEVELOPMENT, V136, P2633, DOI 10.1242/dev.034439; NISHIMURA J, 1995, BRIT J PHARMACOL, V115, P1369, DOI 10.1111/j.1476-5381.1995.tb16625.x; Nohe A, 2002, J BIOL CHEM, V277, P5330, DOI 10.1074/jbc.M102750200; Park J, 2010, AM J RESP CRIT CARE, V181, pA5240; Park JK, 2007, HYPERTENSION, V49, P481, DOI 10.1161/01.HYP.0000256831.33459.ea; Price LC, 2011, EUR RESPIR J, V37, P813, DOI 10.1183/09031936.00028310; Rodriguez-Pascual F, 2004, J CARDIOVASC PHARM, V44, pS39, DOI 10.1097/01.fjc.0000166216.27544.22; Rondelet B, 2004, CIRCULATION, V110, P2220, DOI 10.1161/01.CIR.0000143836.40431.F5; Rothhammer T, 2007, ONCOGENE, V26, P4158, DOI 10.1038/sj.onc.1210182; Rubin LJ, 2002, NEW ENGL J MED, V346, P896, DOI 10.1056/NEJMoa012212; Salani D, 2000, AM J PATHOL, V157, P1537, DOI 10.1016/S0002-9440(10)64791-8; Scharpfenecker M, 2007, J CELL SCI, V120, P964, DOI 10.1242/jcs.002949; Shao DM, 2011, PHARMACOL RES, V63, P504, DOI 10.1016/j.phrs.2011.03.003; Star GP, 2010, MICROVASC RES, V80, P349, DOI 10.1016/j.mvr.2010.05.010; Su D, 2010, BIOCHEM J, V433, P333; Suzuki Y, 2010, J CELL SCI, V123, P1684, DOI 10.1242/jcs.061556; Takahashi H, 2006, AM J PHYSIOL-LUNG C, V290, pL450, DOI 10.1152/ajplung.00206.2005; Talati M, 2010, AM J PHYSIOL-LUNG C, V299, pL363, DOI 10.1152/ajplung.00295.2009; Thomson JR, 2000, J MED GENET, V37, P741, DOI 10.1136/jmg.37.10.741; Upton PD, 2008, MOL PHARMACOL, V73, P539, DOI 10.1124/mol.107.041673; Upton PD, 2009, J BIOL CHEM, V284, P15794, DOI 10.1074/jbc.M109.002881; Wang HH, 2010, J NEUROCHEM, V113, P1133, DOI 10.1111/j.1471-4159.2010.06680.x; Wendel M, 2004, HISTOCHEM CELL BIOL, V122, P507, DOI 10.1007/s00418-004-0708-7; Wort SJ, 2009, J BIOL CHEM, V284, P24297, DOI 10.1074/jbc.M109.032524; Yang XD, 2005, CIRC RES, V96, P1053, DOI 10.1161/01.RES.0000166926.54293.68; Yang XD, 2007, AM J RESP CELL MOL, V37, P598, DOI 10.1165/rcmb.2006-0360OC; YOSHIBAYASHI M, 1991, CIRCULATION, V84, P2280, DOI 10.1161/01.CIR.84.6.2280; Zeng S, 2010, CELL SIGNAL, V22, P888, DOI 10.1016/j.cellsig.2009.12.007	57	27	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2012	7	1							e30075	10.1371/journal.pone.0030075	http://dx.doi.org/10.1371/journal.pone.0030075			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911GB	22299030	Green Published, Green Submitted, gold			2022-12-25	WOS:000301704200007
J	Pascoal, S; Carvalho, G; Creer, S; Rock, J; Kawaii, K; Mendo, S; Hughes, R				Pascoal, Sonia; Carvalho, Gary; Creer, Simon; Rock, Jenny; Kawaii, Kei; Mendo, Sonia; Hughes, Roger			Plastic and Heritable Components of Phenotypic Variation in Nucella lapillus: An Assessment Using Reciprocal Transplant and Common Garden Experiments	PLOS ONE			English	Article							INTERTIDAL SNAIL; DOG-WHELK; SHELL FORM; FORAGING BEHAVIOR; LIFE-HISTORY; GROWTH-RATE; CHROMOSOMAL-POLYMORPHISM; GEOMETRIC MORPHOMETRICS; LOCAL EXTINCTION; MARINE SNAIL	Assessment of plastic and heritable components of phenotypic variation is crucial for understanding the evolution of adaptive character traits in heterogeneous environments. We assessed the above in relation to adaptive shell morphology of the rocky intertidal snail Nucella lapillus by reciprocal transplantation of snails between two shores differing in wave action and rearing snails of the same provenance in a common garden. Results were compared with those reported for similar experiments conducted elsewhere. Microsatellite variation indicated limited gene flow between the populations. Intrinsic growth rate was greater in exposed-site than sheltered-site snails, but the reverse was true of absolute growth rate, suggesting heritable compensation for reduced foraging opportunity at the exposed site. Shell morphology of reciprocal transplants partially converged through plasticity toward that of native snails. Shell morphology of F(2)s in the common garden partially retained characteristics of the P-generation, suggesting genetic control. A maternal effect was revealed by greater resemblance of F(1)s than F(2)s to the P-generation. The observed synergistic effects of plastic, maternal and genetic control of shell-shape may be expected to maximise fitness when environmental characteristics become unpredictable through dispersal.	[Pascoal, Sonia; Carvalho, Gary; Creer, Simon; Hughes, Roger] Bangor Univ, Sch Biol Sci, Environm Ctr Wales, Mol Ecol & Fisheries Genet Lab, Bangor, Gwynedd, Wales; [Pascoal, Sonia; Mendo, Sonia] Univ Aveiro, Dept Biol, Ctr Environm & Marine Studies CESAM, P-3800 Aveiro, Portugal; [Rock, Jenny] Univ Otago, Dept Zool, Ctr Sci Commun, Dunedin, New Zealand; [Kawaii, Kei] Kagoshima Univ, Res Ctr Pacific Isl, Kagoshima 890, Japan	Bangor University; Universidade de Aveiro; University of Otago; Kagoshima University	Pascoal, S (corresponding author), Bangor Univ, Sch Biol Sci, Environm Ctr Wales, Mol Ecol & Fisheries Genet Lab, Bangor, Gwynedd, Wales.	r.n.hughes@bangor.ac.uk	; Mendo, Sonia/E-1095-2011	Rock, Jenny/0000-0001-7250-6463; Mendo, Sonia/0000-0001-5057-5660	Fundacao para a Ciencia e a Tecnologia (FCT) [SFRH/BD/27711/2006]	Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by Fundacao para a Ciencia e a Tecnologia (FCT) through Ph.D. grant SFRH/BD/27711/2006 awarded to Dr. Pascoal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DC, 2004, ITAL J ZOOL, V71, P5, DOI 10.1080/11250000409356545; APPLETON RD, 1988, P NATL ACAD SCI USA, V85, P4387, DOI 10.1073/pnas.85.12.4387; BANTOCK CR, 1975, HEREDITY, V34, P231, DOI 10.1038/hdy.1975.26; BOULDING EG, 1993, EVOLUTION, V47, P576, DOI 10.1111/j.1558-5646.1993.tb02114.x; BRADSHAW A. D., 1965, ADVANCE GENET, V13, P115, DOI 10.1016/S0065-2660(08)60048-6; Bronmark C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021773; BURROWS MT, 1989, J MOLLUS STUD, V55, P285, DOI 10.1093/mollus/55.2.285; BURROWS MT, 1991, FUNCT ECOL, V5, P461, DOI 10.2307/2389628; BURROWS MT, 1990, J ANIM ECOL, V59, P723, DOI 10.2307/4891; Carvajal-Rodriguez A, 2005, J MOLLUS STUD, V71, P313, DOI 10.1093/mollus/eyi037; Carvajal-Rodriguez A, 2005, ONLINE J BIOINFORMAT, V6, P34; Cavalcanti MJ, 1999, ZOOL STUD, V38, P287; Colson I, 2004, MOL ECOL, V13, P2223, DOI 10.1111/j.1365-294X.2004.02245.x; Colson I, 2006, INTEGR ZOOL, V1, P104, DOI 10.1111/j.1749-4877.2006.00022.x; COOMBS VA, 1973, J ZOOL, V171, P57; CROTHERS J H, 1985, Field Studies, V6, P291; CURREY JD, 1982, J ANIM ECOL, V51, P47, DOI 10.2307/4309; DAY AJ, 1988, MAR BIOL, V99, P93, DOI 10.1007/BF00644981; DAY AJ, 1990, BIOL J LINN SOC, V40, P245, DOI 10.1111/j.1095-8312.1990.tb00538.x; Denny M. W., 1988, BIOL MECH WAVE SWEPT; DeWitt TJ, 1998, J EVOLUTION BIOL, V11, P465, DOI 10.1007/s000360050100; Endler J.A., 1986, Monographs in Population Biology, pviii; Etter RJ, 1996, J EXP MAR BIOL ECOL, V196, P341, DOI 10.1016/0022-0981(95)00139-5; ETTER RJ, 1988, EVOLUTION, V42, P660, DOI 10.1111/j.1558-5646.1988.tb02485.x; ETTER RJ, 1988, EVOLUTION, V42, P322, DOI 10.1111/j.1558-5646.1988.tb04136.x; GOUDET J, 1994, GENETICS AND EVOLUTION OF AQUATIC ORGANISMS, P81; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; GOULD SJ, 1966, BIOL REV, V41, P587, DOI 10.1111/j.1469-185X.1966.tb01624.x; Guerra-Varela J, 2009, EVOL ECOL, V23, P261, DOI 10.1007/s10682-007-9221-5; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Hellberg ME, 2002, B MAR SCI, V70, P273; Hollander J, 2006, J EVOLUTION BIOL, V19, P1861, DOI 10.1111/j.1420-9101.2006.01171.x; Hollander J, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-333; HUGHES RN, 1979, J ANIM ECOL, V48, P65, DOI 10.2307/4100; Hughes RN, 1997, P ROY SOC B-BIOL SCI, V264, P417, DOI 10.1098/rspb.1997.0059; HUGHES RN, 1972, OECOLOGIA, V8, P356, DOI 10.1007/BF00367538; HUGHES RN, 1992, J EXP MAR BIOL ECOL, V155, P199, DOI 10.1016/0022-0981(92)90063-G; JANSON K, 1982, MAR BIOL, V69, P73, DOI 10.1007/BF00396963; Johannesson B, 1996, J ZOOL, V240, P475, DOI 10.1111/j.1469-7998.1996.tb05299.x; Johannesson K, 1997, BIOL J LINN SOC, V61, P267; Johnson MS, 1998, MAR BIOL, V132, P295, DOI 10.1007/s002270050395; Kawai K, 2001, MOL ECOL NOTES, V1, P270, DOI 10.1046/j.1471-8278 .2001.00103.x; Kirby RR, 2004, J MOL EVOL, V58, P97, DOI 10.1007/s00239-003-2528-0; Kirby RR, 2000, MOL BIOL EVOL, V17, P1816, DOI 10.1093/oxfordjournals.molbev.a026282; KIRBY RR, 1994, BIOL J LINN SOC, V53, P255; Kirby RR, 1997, BIOL J LINN SOC, V62, P299, DOI 10.1006/bijl.1997.0164; Kirby RR, 2000, GENE, V245, P81, DOI 10.1016/S0378-1119(00)00036-6; KITCHING JA, 1977, J EXP MAR BIOL ECOL, V26, P275, DOI 10.1016/0022-0981(77)90087-9; KITCHING JA, 1966, J ANIM ECOL, V35, P113, DOI 10.2307/2693; KITCHING JA, 1976, J EXP MAR BIOL ECOL, V23, P109, DOI 10.1016/0022-0981(76)90135-0; LAM PKS, 1988, J MOLLUS STUD, V54, P197, DOI 10.1093/mollus/54.2.197; LEVINS RICHARD, 1968; Marshall DJ, 2008, OCEANOGR MAR BIOL, V46, P203, DOI 10.1201/9781420065756.ch5; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; McQuaid C.D., 1988, NATO ASI (Advanced Science Institutes) Series Series A Life Sciences, P213; MENGE BA, 1978, OECOLOGIA, V34, P1, DOI 10.1007/BF00346237; MORAN NA, 1992, AM NAT, V139, P971, DOI 10.1086/285369; PALMER AR, 1990, HYDROBIOLOGIA, V193, P155, DOI 10.1007/BF00028074; PALUMBI SR, 1994, ANNU REV ECOL SYST, V25, P547, DOI 10.1146/annurev.ecolsys.25.1.547; PALUMBI SR, 1984, SCIENCE, V225, P1478, DOI 10.1126/science.225.4669.1478; Pardo LM, 2005, MAR ECOL PROG SER, V296, P229, DOI 10.3354/meps296229; Pascoe PL, 2006, BIOL J LINN SOC, V87, P195, DOI 10.1111/j.1095-8312.2006.00567.x; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pigliucci M., 2001, SYN ECO EVO; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rock J, 1996, CYTOGENET CELL GENET, V73, P187, DOI 10.1159/000134336; Rohlf FJ, 2003, SYST BIOL, V52, P66, DOI 10.1080/10635150390132759; Rohlf FJ, 1998, SYST BIOL, V47, P147, DOI 10.1080/106351598261094; Rolan E, 2004, J MOLLUS STUD, V70, P179, DOI 10.1093/mollus/70.2.179; Sanford E, 2010, ECOLOGY, V91, P891, DOI 10.1890/09-0536.1; Schlichting CD, 1998, PHENOTYPIC EVOLUTION; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; SLATKIN M, 1987, SCIENCE, V236, P787, DOI 10.1126/science.3576198; Staiger H, 1957, ANN BIOL, V5/6; STEARNS SC, 1989, BIOSCIENCE, V39, P436, DOI 10.2307/1311135; STRUHSAKER JW, 1968, EVOLUTION, V22, P459, DOI 10.1111/j.1558-5646.1968.tb03986.x; THOMAS MLH, 1986, OPHELIA, V25, P1; Travis Joseph, 1994, P99; Trussell GC, 2000, EVOL ECOL RES, V2, P803; Trussell GC, 1997, ECOLOGY, V78, P1033, DOI 10.2307/2265856; Trussell GC, 2002, MAR ECOL PROG SER, V243, P123, DOI 10.3354/meps243123; Trussell GC, 1996, EVOLUTION, V50, P448, DOI 10.1111/j.1558-5646.1996.tb04507.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; VERMEIJ GJ, 1982, NATURE, V299, P349, DOI 10.1038/299349a0; VIA S, 1995, TRENDS ECOL EVOL, V10, P212, DOI 10.1016/S0169-5347(00)89061-8; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Wilding CS, 2001, J EVOLUTION BIOL, V14, P611, DOI 10.1046/j.1420-9101.2001.00304.x	87	18	18	2	122	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2012	7	1							e30289	10.1371/journal.pone.0030289	http://dx.doi.org/10.1371/journal.pone.0030289			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911GB	22299035	Green Published, Green Submitted, gold			2022-12-25	WOS:000301704200012
J	Yan, XC; Ding, L; Li, YC; Zhang, XF; Liang, Y; Sun, XW; Teng, CB				Yan, Xuechun; Ding, Lei; Li, Yunchao; Zhang, Xiaofeng; Liang, Yang; Sun, Xiaowen; Teng, Chun-Bo			Identification and Profiling of MicroRNAs from Skeletal Muscle of the Common Carp	PLOS ONE			English	Article							CYPRINUS-CARPIO; MYOGENIC DIFFERENTIATION; MYOBLAST DIFFERENTIATION; C-ELEGANS; EXPRESSION; MIR-206; TARGETS; PROTEIN; GROWTH; RHABDOMYOSARCOMA	The common carp is one of the most important cultivated species in the world of freshwater aquaculture. The cultivation of this species is particularly productive due to its high skeletal muscle mass; however, the molecular mechanisms of skeletal muscle development in the common carp remain unknown. It has been shown that a class of non-coding,22 nucleotide RNAs called microRNAs (miRNAs) play important roles in vertebrate development. They regulate gene expression through sequence-specific interactions with the 39 untranslated regions (UTRs) of target mRNAs and thereby cause translational repression or mRNA destabilization. Intriguingly, the role of miRNAs in the skeletal muscle development of the common carp remains unknown. In this study, a small-RNA cDNA library was constructed from the skeletal muscle of the common carp, and Solexa sequencing technology was used to perform high throughput sequencing of the library. Subsequent bioinformatics analysis identified 188 conserved miRNAs and 7 novel miRNAs in the carp skeletal muscle. The miRNA expression profiling showed that, miR-1, miR-133a-3p, and miR-206 were specifically expressed in muscle-containing organs, and that miR-1, miR-21, miR-26a, miR-27a, miR-133a-3p, miR-206, miR-214 and miR-222 were differentially expressed in the process of skeletal muscle development of the common carp. This study provides a first identification and profiling of miRNAs related to the muscle biology of the common carp. Their identification could provide clues leading towards a better understanding of the molecular mechanisms of carp skeletal muscle development.	[Yan, Xuechun; Zhang, Xiaofeng; Sun, Xiaowen] Chinese Acad Fishery Sci, Heilongjiang River Fisheries Res Inst, Key Lab Aquat Biotechnol, Harbin, Peoples R China; [Ding, Lei; Li, Yunchao; Liang, Yang; Teng, Chun-Bo] NE Forestry Univ, Coll Life Sci, Harbin, Peoples R China	Chinese Academy of Fishery Sciences; Heilongjiang River Fisheries Research Institute, CAFS; Northeast Forestry University - China	Yan, XC (corresponding author), Chinese Acad Fishery Sci, Heilongjiang River Fisheries Res Inst, Key Lab Aquat Biotechnol, Harbin, Peoples R China.	sxw2002@163.com; chunboteng@nefu.edu.cn	Sun, Xiaowen/F-1516-2014		National High Technology Research and Development Program of China (863 Program) [2009AA10Z105, 2011AA100400, 2011AA100404GRAM09]; Fundamental Research Funds for the Central Universities [DL09CA16]	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the grants from the National High Technology Research and Development Program of China (863 Program) (No. 2009AA10Z105, 2011AA100400, 2011AA100404GRAM09), and the Fundamental Research Funds for the Central Universities (No. DL09CA16). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen DL, 2011, AM J PHYSIOL-CELL PH, V300, pC124, DOI 10.1152/ajpcell.00142.2010; Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Anderson C, 2006, NUCLEIC ACIDS RES, V34, P5863, DOI 10.1093/nar/gkl743; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Berezikov E, 2005, CELL, V120, P21, DOI 10.1016/j.cell.2004.12.031; Black BL, 1998, ANNU REV CELL DEV BI, V14, P167, DOI 10.1146/annurev.cellbio.14.1.167; Blenkiron C, 2007, HUM MOL GENET, V16, pR106, DOI 10.1093/hmg/ddm056; Braun T, 2011, NAT REV MOL CELL BIO, V12, P349, DOI 10.1038/nrm3118; Buckingham M, 2001, CURR OPIN GENET DEV, V11, P440, DOI 10.1016/S0959-437X(00)00215-X; Cardinali B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007607; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Chen JF, 2010, J CELL BIOL, V190, P867, DOI 10.1083/jcb.200911036; Cheng L, 2010, ANIM GENET, V41, P191, DOI 10.1111/j.1365-2052.2009.01985.x; Chi W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023549; Crippa S, 2011, J CELL BIOL, V193, P1197, DOI 10.1083/jcb.201011099; Crist CG, 2009, P NATL ACAD SCI USA, V106, P13383, DOI 10.1073/pnas.0900210106; Drummond MJ, 2009, J NUTR, V139, P2279, DOI 10.3945/jn.109.112797; Du TT, 2005, DEVELOPMENT, V132, P4645, DOI 10.1242/dev.02070; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; *FAO, 2002, YB FISH STAT SUMM TA; Flynt AS, 2007, NAT GENET, V39, P259, DOI 10.1038/ng1953; Gagan J, 2011, J BIOL CHEM, V286, P19431, DOI 10.1074/jbc.M111.219006; Ge YJ, 2011, CELL CYCLE, V10, P441, DOI 10.4161/cc.10.3.14710; Ge YJ, 2011, J CELL BIOL, V192, P69, DOI 10.1083/jcb.201007165; Guller I, 2010, J PHYSIOL-LONDON, V588, P4075, DOI 10.1113/jphysiol.2010.194175; Haider KH, 2010, CARDIOVASC RES, V88, P168, DOI 10.1093/cvr/cvq151; Huang TH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003225; Juan AH, 2009, MOL CELL, V36, P61, DOI 10.1016/j.molcel.2009.08.008; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Kim HK, 2006, J CELL BIOL, V174, P677, DOI 10.1083/jcb.200603008; Kim J, 2010, MOL BIOL REP, V37, P3567, DOI 10.1007/s11033-010-0005-6; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Liu J, 2010, J BIOL CHEM, V285, P26599, DOI 10.1074/jbc.M110.115824; Mishima Y, 2009, GENE DEV, V23, P619, DOI 10.1101/gad.1760209; Naguibneva I, 2006, NAT CELL BIOL, V8, P278, DOI 10.1038/ncb1373; Okamura K, 2004, GENE DEV, V18, P1655, DOI 10.1101/gad.1210204; Rosenberg MI, 2006, J CELL BIOL, V175, P77, DOI 10.1083/jcb.200603039; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Seok HY, 2011, J BIOL CHEM, V286, P35339, DOI 10.1074/jbc.M111.273276; Sun Q, 2008, NUCLEIC ACIDS RES, V36, P2690, DOI 10.1093/nar/gkn032; Sun XW, 2004, AQUACULTURE, V238, P165, DOI 10.1016/S0044-8486(03)00445-9; Tanck MWT, 2001, GENOME, V44, P743, DOI 10.1139/gen-44-5-743; Taulli R, 2009, J CLIN INVEST, V119, P2366, DOI 10.1172/JCI38075; Urbich C, 2008, CARDIOVASC RES, V79, P581, DOI 10.1093/cvr/cvn156; Vandeputte M, 2003, AQUAT LIVING RESOUR, V16, P399, DOI 10.1016/S0990-7440(03)00056-1; Wang H, 2008, CANCER CELL, V14, P369, DOI 10.1016/j.ccr.2008.10.006; Wei YY, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-1-r6; Wong CF, 2008, J BIOL CHEM, V283, P9836, DOI 10.1074/jbc.M709614200; Yan D, 2009, J BIOL CHEM, V284, P29596, DOI 10.1074/jbc.M109.020511	50	59	203	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2012	7	1							e30925	10.1371/journal.pone.0030925	http://dx.doi.org/10.1371/journal.pone.0030925			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911GB	22303472	gold, Green Submitted, Green Published			2022-12-25	WOS:000301704200047
J	Huang, YJA; Grant, J; Roper, S				Huang, Yijen A.; Grant, Jeff; Roper, Stephen			Glutamate May Be an Efferent Transmitter That Elicits Inhibition in Mouse Taste Buds	PLOS ONE			English	Article							EXCITATORY AMINO-ACIDS; TO-CELL COMMUNICATION; RECEPTOR-CELLS; NERVE-FIBERS; III CELLS; RAT; SEROTONIN; EXPRESSION; ATP; HEMICHANNELS	Recent studies suggest that l-glutamate may be an efferent transmitter released from axons innervating taste buds. In this report, we determined the types of ionotropic synaptic glutamate receptors present on taste cells and that underlie this postulated efferent transmission. We also studied what effect glutamate exerts on taste bud function. We isolated mouse taste buds and taste cells, conducted functional imaging using Fura 2, and used cellular biosensors to monitor taste-evoked transmitter release. The findings show that a large fraction of Presynaptic (Type III) taste bud cells (similar to 50%) respond to 100 mM glutamate, NMDA, or kainic acid (KA) with an increase in intracellular Ca2+. In contrast, Receptor (Type II) taste cells rarely (4%) responded to 100 mM glutamate. At this concentration and with these compounds, these agonists activate glutamatergic synaptic receptors, not glutamate taste (umami) receptors. Moreover, applying glutamate, NMDA, or KA caused taste buds to secrete 5-HT, a Presynaptic taste cell transmitter, but not ATP, a Receptor cell transmitter. Indeed, glutamate-evoked 5-HT release inhibited taste-evoked ATP secretion. The findings are consistent with a role for glutamate in taste buds as an inhibitory efferent transmitter that acts via ionotropic synaptic glutamate receptors.	[Huang, Yijen A.; Grant, Jeff; Roper, Stephen] Univ Miami, Sch Med, Dept Physiol & Biophys, Miami, FL 33124 USA; [Roper, Stephen] Univ Miami, Sch Med, Program Neurosci, Miami, FL USA	University of Miami; University of Miami	Huang, YJA (corresponding author), Univ Miami, Sch Med, Dept Physiol & Biophys, Miami, FL 33124 USA.	sroper@med.miami.edu		Roper, Stephen/0000-0001-6049-8320; Tilahin, Shimelis/0000-0001-8975-8026	National Institutes of Health [2R01DC007630, 5R01DC000374]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC007630, R01DC000374] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This research was funded to SR by National Institutes of Health grants 2R01DC007630 and 5R01DC000374. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Caicedo A, 2000, J NEUROSCI, V20, P7978; Cao Y, 2009, P NATL ACAD SCI USA, V106, P4006, DOI 10.1073/pnas.0808672106; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; Chattopadhyaya B, 2004, J NEUROSCI, V24, P9598, DOI 10.1523/JNEUROSCI.1851-04.2004; Chaudhari N, 1996, J NEUROSCI, V16, P3817; Dando R, 2009, J PHYSIOL-LONDON, V587, P5899, DOI 10.1113/jphysiol.2009.180083; Dvoryanchikov G, 2007, J COMP NEUROL, V505, P302, DOI 10.1002/cne.21494; Dvoryanchikov G, 2011, J NEUROSCI, V31, P5782, DOI 10.1523/JNEUROSCI.5559-10.2011; FILIN VA, 1968, B EXP BIOL MED-USSR, V65, P9, DOI 10.1007/BF00810184; Finger TE, 2005, SCIENCE, V310, P1495, DOI 10.1126/science.1118435; FUJIMOTO S, 1970, ANAT REC, V168, P393, DOI 10.1002/ar.1091680306; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hayashi Y, 1996, BIOPHYS J, V71, P1057, DOI 10.1016/S0006-3495(96)79306-2; Heath TP, 2006, J NEUROSCI, V26, P12664, DOI 10.1523/JNEUROSCI.3459-06.2006; Herness S, 1997, NEUROREPORT, V8, P3257, DOI 10.1097/00001756-199710200-00014; Huang YJ, 2007, P NATL ACAD SCI USA, V104, P6436, DOI 10.1073/pnas.0611280104; Huang YA, 2008, J PHYSIOL-LONDON, V586, P2903, DOI 10.1113/jphysiol.2008.151233; Huang YJA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025471; Huang YJA, 2011, J NEUROSCI, V31, P13654, DOI 10.1523/JNEUROSCI.3356-11.2011; Huang YA, 2009, J NEUROSCI, V29, P13909, DOI 10.1523/JNEUROSCI.2351-09.2009; Huang YJ, 2005, J NEUROSCI, V25, P843, DOI 10.1523/JNEUROSCI.4446-04.2005; JEFTINIJA S, 1991, NEUROSCI LETT, V125, P191, DOI 10.1016/0304-3940(91)90025-O; Kaya N, 2004, AM J PHYSIOL-REG I, V286, pR649, DOI 10.1152/ajpregu.00572.2003; Kim JW, 2006, CHEM SENSES, V31, P213, DOI 10.1093/chemse/bjj021; Li XD, 2002, P NATL ACAD SCI USA, V99, P4692, DOI 10.1073/pnas.072090199; Lin WH, 1999, J NEUROPHYSIOL, V82, P2061, DOI 10.1152/jn.1999.82.5.2061; Lu SG, 2003, NEUROSCI LETT, V351, P157, DOI 10.1016/j.neulet.2003.07.016; Ma HZ, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-5; Maruyama Y, 2006, J NEUROSCI, V26, P2227, DOI 10.1523/JNEUROSCI.4329-05.2006; Mathes CM, 2011, CHEM SENSES, V36, P515, DOI 10.1093/chemse/bjr011; MILLER IJ, 1971, J GEN PHYSIOL, V57, P1, DOI 10.1085/jgp.57.1.1; MURAYAMA N, 1988, J GEN PHYSIOL, V91, P685, DOI 10.1085/jgp.91.5.685; MURRAY R G, 1969, Journal of Ultrastructure Research, V27, P444, DOI 10.1016/S0022-5320(69)80043-2; Nelson G, 2002, NATURE, V416, P199, DOI 10.1038/nature726; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; Niki M, 2011, CELL MOL NEUROBIOL, V31, P1033, DOI 10.1007/s10571-011-9702-5; NINOMIYA Y, 1991, PHYSIOL BEHAV, V49, P913, DOI 10.1016/0031-9384(91)90203-Z; Ogura T, 2002, J NEUROPHYSIOL, V87, P2643, DOI 10.1152/jn.2002.87.6.2643; Ohtubo Y, 2011, BRAIN RES, V1367, P13, DOI 10.1016/j.brainres.2010.10.060; Omote K, 1998, BRAIN RES, V787, P161, DOI 10.1016/S0006-8993(97)01568-0; RIDDLE DR, 1990, BRAIN RES, V533, P113, DOI 10.1016/0006-8993(90)91803-O; Romanov RA, 2007, EMBO J, V26, P657, DOI 10.1038/sj.emboj.7601526; ROYER SM, 1988, J COMP NEUROL, V270, P11, DOI 10.1002/cne.902700103; TAKEDA M, 1980, CELL TISSUE RES, V210, P71; Tomchik SM, 2007, J NEUROSCI, V27, P10840, DOI 10.1523/JNEUROSCI.1863-07.2007; Vandenbeuch A, 2004, NEUROSCI LETT, V358, P137, DOI 10.1016/j.neulet.2004.01.013; Vandenbeuch A, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-77; Willis WD, 1999, EXP BRAIN RES, V124, P395, DOI 10.1007/s002210050637; YAMAMOTO T, 1991, PHYSIOL BEHAV, V49, P919, DOI 10.1016/0031-9384(91)90204-2; Yee CL, 2001, J COMP NEUROL, V440, P97, DOI 10.1002/cne.1372; Zhang YF, 2003, CELL, V112, P293, DOI 10.1016/S0092-8674(03)00071-0; Zhao FL, 2005, P NATL ACAD SCI USA, V102, P11100, DOI 10.1073/pnas.0501988102	52	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2012	7	1							e30662	10.1371/journal.pone.0030662	http://dx.doi.org/10.1371/journal.pone.0030662			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911FX	22292013	Green Submitted, Green Published, gold			2022-12-25	WOS:000301703800023
J	Farallo, VR; Forstner, MRJ				Farallo, Vincent R.; Forstner, Michael R. J.			Predation and the Maintenance of Color Polymorphism in a Habitat Specialist Squamate	PLOS ONE			English	Article							MOTTLED ROCK RATTLESNAKES; CROTALUS-LEPIDUS LEPIDUS; CORRELATIONAL SELECTION; GEOGRAPHIC-VARIATION; ANTIPREDATOR BEHAVIOR; VIPERA-BERUS; PATTERN; EVOLUTION; POPULATIONS; MIMICRY	Multiple studies have addressed the mechanisms maintaining polymorphism within a population. However, several examples exist where species inhabiting diverse habitats exhibit local population-specific polymorphism. Numerous explanations have been proposed for the maintenance of geographic variation in color patterns. For example, spatial variation in patterns of selection or limited gene flow can cause entire populations to become fixed for a single morph, resulting in separate populations of the same species exhibiting separate and distinct color morphs. The mottled rock rattlesnake (Crotalus lepidus lepidus) is a montane species that exhibits among-population color polymorphism that correlates with substrate color. Habitat substrate in the eastern part of its range is composed primarily of light colored limestone and snakes have light dorsal coloration, whereas in the western region the substrate is primarily dark and snakes exhibit dark dorsal coloration. We hypothesized that predation on high contrast color and blotched patterns maintain these distinct color morphs. To test this we performed a predation experiment in the wild by deploying model snakes at 12 sites evenly distributed within each of the two regions where the different morphs are found. We employed a 262 factorial design that included two color and two blotched treatments. Our results showed that models contrasting with substrate coloration suffered significantly more avian attacks relative to models mimicking substrates. Predation attempts on blotched models were similar in each substrate type. These results support the hypothesis that color pattern is maintained by selective predation.	[Farallo, Vincent R.; Forstner, Michael R. J.] Texas State Univ San Marcos, Dept Biol, San Marcos, TX USA	Texas State University System; Texas State University San Marcos	Farallo, VR (corresponding author), Ohio Univ, Dept Biol Sci, Athens, OH 45701 USA.	vfarallo@gmail.com	Farallo, Vincent/W-3254-2019	Farallo, Vincent/0000-0001-6571-2015	Sigma Xi: The Scientific Research Society [G2009100838]; Western New York Herpetological Society	Sigma Xi: The Scientific Research Society; Western New York Herpetological Society	This research was funded by Sigma Xi: The Scientific Research Society (Grants-in-Aid of Research; http://www.sigmaxi.org/; G2009100838) and the Western New York Herpetological Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; BEAUPRE SJ, 1995, ECOLOGY, V76, P1655, DOI 10.2307/1938166; Beaupre SJ, 1996, COPEIA, P319; BEAUPRE SJ, 1995, HERPETOLOGICA, V51, P45; Bittner TD, 2003, OHIO J SCI, V103, P62; Blair WF, 1947, CONTRIBUTIONS LABORA, V37, P1; Bond AB, 2006, P NATL ACAD SCI USA, V103, P3214, DOI 10.1073/pnas.0509963103; Bond AB, 2007, ANNU REV ECOL EVOL S, V38, P489, DOI 10.1146/annurev.ecolsys.38.091206.095728; BRODIE ED, 1992, EVOLUTION, V46, P1284, DOI 10.1111/j.1558-5646.1992.tb01124.x; BRODIE ED, 1993, EVOLUTION, V47, P227, DOI 10.1111/j.1558-5646.1993.tb01212.x; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; BYERS BA, 1990, BIOL J LINN SOC, V40, P3, DOI 10.1111/j.1095-8312.1990.tb00530.x; CAIN AJ, 1950, HEREDITY, V4, P275, DOI 10.1038/hdy.1950.22; CALDWELL GS, 1986, AUK, V103, P494, DOI 10.1093/auk/103.3.494; Creer DA, 2005, ETHOLOGY, V111, P287, DOI 10.1111/j.1439-0310.2004.01062.x; Dice L, 1947, CONTRIBUTION U MICHI, V50, P1; Dice LR, 1940, AM NAT, V74, P212, DOI 10.1086/280889; Dixon JR., 2005, TEXAS SNAKES FIELD G, DOI [DOI 10.7560/320419, 10.7560/706750]; ENDLER JA, 1981, BIOL J LINN SOC, V16, P25, DOI 10.1111/j.1095-8312.1981.tb01840.x; Endler JA, 2005, BIOL J LINN SOC, V86, P405, DOI 10.1111/j.1095-8312.2005.00540.x; Forsman A, 1998, BEHAV ECOL, V9, P409, DOI 10.1093/beheco/9.4.409; FORSMAN A, 1987, OIKOS, V50, P13, DOI 10.2307/3565396; Forsman A, 2002, EVOLUTION, V56, P349, DOI 10.1111/j.0014-3820.2002.tb01345.x; FORSMAN A, 1995, BIOL J LINN SOC, V55, P273, DOI 10.1111/j.1095-8312.1995.tb01066.x; Forstner MRJ, 1997, J HERPETOL, V31, P277, DOI 10.2307/1565397; Gelbach FR, 1981, MOUNTAIN ISLANDS DES; Gomez D., 2006, AVICOL PROGRAM ANAL; GOULSON D, 1994, HEREDITY, V73, P471, DOI 10.1038/hdy.1994.145; Gray SM, 2007, TRENDS ECOL EVOL, V22, P71, DOI 10.1016/j.tree.2006.10.005; HOAGLAND KE, 1977, BIOL BULL, V152, P360, DOI 10.2307/1540424; Hoekstra HE, 2004, EVOLUTION, V58, P1329; Holycross AT, 2001, SOUTHWEST NAT, V46, P363, DOI 10.2307/3672434; JACKSON JF, 1976, AM NAT, V110, P1029, DOI 10.1086/283125; Johnston G, 1996, J ZOOL, V239, P187, DOI 10.1111/j.1469-7998.1996.tb05446.x; KAVALIERS M, 1992, J COMP PHYSIOL B, V162, P172, DOI 10.1007/BF00398344; KLAUBER L. M., 1972, RATTLESNAKES THEIR H, V2nd; Kuchta SR, 2001, AM ZOOL, V41, P1499; Lai YC, 2008, J ZOOL, V274, P270, DOI 10.1111/j.1469-7998.2007.00382.x; Maan ME, 2008, COPEIA, P621, DOI 10.1643/CE-07-114; McCullagh P, 1989, GEN LINEAR MODELS; Monney JC, 1996, REV SUISSE ZOOL, V103, P81, DOI 10.5962/bhl.part.79939; Mullen LM, 2008, EVOLUTION, V62, P1555, DOI 10.1111/j.1558-5646.2008.00425.x; Osorio D, 1999, EVOL ECOL, V13, P673, DOI 10.1023/A:1011059715610; Phifer-Rixey M, 2008, J EVOLUTION BIOL, V21, P966, DOI 10.1111/j.1420-9101.2008.01549.x; POUGH FH, 1976, COPEIA, P834, DOI 10.2307/1443481; Punzalan D, 2005, EVOL ECOL, V19, P303, DOI 10.1007/s10682-005-2777-z; Rosenblum EB, 2006, AM NAT, V167, P1, DOI 10.1086/498397; Sandoval CP, 2008, BIOL J LINN SOC, V94, P1, DOI 10.1111/j.1095-8312.2007.00941.x; Saporito RA, 2007, COPEIA, P1006, DOI 10.1643/0045-8511(2007)7[1006:EEFAIT]2.0.CO;2; Sinervo B, 2001, EVOLUTION, V55, P2040; Sinervo B, 2007, AM NAT, V170, P663, DOI 10.1086/522092; SMITH SM, 1976, BEHAVIOUR, V56, P309, DOI 10.1163/156853976X00082; SMITH SM, 1973, BEHAVIOUR, V44, P113, DOI 10.1163/156853973X00355; SWEET SS, 1985, J HERPETOL, V19, P55, DOI 10.2307/1564420; Vanderpool Robert, 2005, Herpetological Review, V36, P191; Venesky MD, 2007, HERPETOLOGICA, V63, P450, DOI 10.1655/0018-0831(2007)63[450:AAAPAB]2.0.CO;2; Vignieri SN, 2010, EVOLUTION, V64, P2153, DOI 10.1111/j.1558-5646.2010.00976.x; VINCENT JW, 1982, SOUTHWEST NAT, V27, P263, DOI 10.2307/3670874; Vorobyev M, 1998, P ROY SOC B-BIOL SCI, V265, P351, DOI 10.1098/rspb.1998.0302; Wheeler B., 2010, IMPERM PERMUTATION T; Wuster W, 2004, P ROY SOC B-BIOL SCI, V271, P2495, DOI 10.1098/rspb.2004.2894	61	47	49	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e30316	10.1371/journal.pone.0030316	http://dx.doi.org/10.1371/journal.pone.0030316			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910ME	22295080	Green Submitted, Green Published, gold			2022-12-25	WOS:000301640600025
J	Kannathasan, S; Murugananthan, A; Rajeshkannan, N; de Silva, NR				Kannathasan, Selvam; Murugananthan, Arumugam; Rajeshkannan, Nadarajah; de Silva, Nilanthy Renuka			Cutaneous Larva Migrans among Devotees of the Nallur Temple in Jaffna, Sri Lanka	PLOS ONE			English	Article								Background: Many cases of Cutaneous Larva Migrans (CLM) have been observed among devotees, during and immediately after the annual festival at the Nallur Hindu temple in Jaffna. Objective: To ascertain the risk factors associated with infestation and devotees' knowledge and practices regarding the condition. Methodology/Principal Findings: A cross-sectional study using an interviewer-administered questionnaire and observation was conducted in August 2010. Out of 200 selected devotees 194(97%) responded. Soil and dog faecal samples were collected from the temple premises and examined for the presence of nematode larva and egg respectively. Among 194 male respondents, 58.2%(95% CI: 51.2%-65.0%) had lesions of CLM. One hundred and thirty (67%) respondents performed the ritual everyday; whereas 33% did so on special days. One hundred and twelve (57.7%) participants performed the ritual before 5.00am and remaining 42.3% performed after 5.00am. Among the participants, 77(36.7%) had the similar condition in previous years. One hundred and fifty seven (80.9%) were aware about this disease and 52(27%) devotees adopted some kind of precautionary measures. Bivariate analysis showed significant association between occurrence of CLM lesions and frequency of performing the ritual (p<0.001, OR-15.1; 95% CI: 7.2-32.0), the timing of ritual performance (p = 0.022, OR-1.96; 95% CI: 1.10-3.52), similar condition in previous year (p<0.001, OR-6.83; 95% CI: 3.39-13.76) and previous awareness of the condition (p = 0.005; OR-0.59; 95% CI:0.43-0.82). Multivariate analysis showed that the frequency of ritual performance (OR-11.75; 95% CI 5.37-25.74) and similar conditions in previous years (OR-4.71; 95% CI: 2.14-10.39) were the independent risk factors. Two of the 20 soil samples were positive for the nematode larvae and three out of five dog faeces were positive for hookworm eggs. Conclusions/Significance: Deworming the stray dogs around the temple premises combined with the awareness programs among the public may be the effective and feasible precautionary measures to control similar epidemics in future.	[Kannathasan, Selvam; Murugananthan, Arumugam] Univ Jaffna, Fac Med, Dept Pathol, Div Parasitol, Jaffna, Sri Lanka; [Rajeshkannan, Nadarajah] Univ Jaffna, Fac Med, Dept Community Med, Jaffna, Sri Lanka; [de Silva, Nilanthy Renuka] Univ Kelaniya, Fac Med, Dept Parasitol, Ragama, Sri Lanka	University Jaffna; University Jaffna; University Kelaniya	Kannathasan, S (corresponding author), Univ Jaffna, Fac Med, Dept Pathol, Div Parasitol, Jaffna, Sri Lanka.	selvamkannathasan@gmail.com	Nadarajah, Rajeshkannan/AFS-0100-2022	Nadarajah, Rajeshkannan/0000-0001-9045-3369				BARDACH H, 1980, WIEN MED WOCHENSCHR, V130, P761; Chopra S, 2009, MANSONS TROPICAL DIS, P333; Heukelbach J, 2008, ANN TROP MED PARASIT, V102, P53, DOI 10.1179/136485908X252205; Heukelbach J, 2008, LANCET INFECT DIS, V8, P302, DOI 10.1016/S1473-3099(08)70098-7; Hochedez P, 2007, J TRAVEL MED, V14, P326, DOI 10.1111/j.1708-8305.2007.00148.x; Kannathasan S, 2003, P JAFFNA SCI ASS, V11, P32; Kim Tae-Heung, 2006, Korean Journal of Parasitology, V44, P145, DOI 10.3347/kjp.2006.44.2.145; Mabaso MLH, 2003, TROP MED INT HEALTH, V8, P722, DOI 10.1046/j.1365-3156.2003.01086.x; Tremblay A, 2000, TROP MED INT HEALTH, V5, P330, DOI 10.1046/j.1365-3156.2000.00557.x; World Health Organization scientific group, 1964, WHO TECH REP SER, V277, P1	10	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e30516	10.1371/journal.pone.0030516	http://dx.doi.org/10.1371/journal.pone.0030516			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910ME	22295089	gold, Green Published, Green Submitted			2022-12-25	WOS:000301640600034
J	Hu, J; Lou, DH; Carow, B; Winerdal, ME; Rottenberg, M; Wikstrom, AC; Norstedt, G; Winqvist, O				Hu, Jin; Lou, DaoHua; Carow, Berit; Winerdal, Malin E.; Rottenberg, Martin; Wikstrom, Ann-Charlotte; Norstedt, Gunnar; Winqvist, Ola			LPS Regulates SOCS2 Transcription in a Type I Interferon Dependent Autocrine-Paracrine Loop	PLOS ONE			English	Article							CYTOKINE SIGNALING 2; TOLL-LIKE RECEPTORS; DENDRITIC CELLS; NEGATIVE REGULATION; IMMUNE-RESPONSES; IRF FAMILY; SUPPRESSOR; INDUCTION; MACROPHAGES; PROTEINS	Recent studies suggest that SOCS2 is involved in the regulation of TLR signaling. In this study, we found that the expression of SOCS2 is regulated in human monocyte-derived DC by ligands stimulating TLR2, 3, 4, 5, 8 and 9 signaling. SOCS2 induction by LPS was dependent on the type I IFN regulated transcription factors IRF1 and IRF3 as shown by using silencing RNAs for IRFs. Blocking endogenous type I IFN signaling, by neutralizing antibodies to the receptor IFNAR2, abolished SOCS2 mRNA expression after TLR4 stimulation. Transcription factors STAT3, 5 and 6 displayed putative binding sites in the promoter regions of the human SOCS2 gene. Subsequent silencing experiments further supported that STAT3 and STAT5 are involved in LPS induced SOCS2 regulation. In mice we show that SOCS2 mRNA induction is 45% lower in bone marrow derived macrophages derived from MyD88(-/-) mice, and do not increase in BMMs from IRF3(-/-) mice after BCG infection. In conclusion, our results suggest that TLR4 signaling indirectly increases SOCS2 in late phase mainly via the production of endogenous type I IFN, and that subsequent IFN receptor signaling activates SOCS2 via STAT3 and STAT5.	[Hu, Jin; Lou, DaoHua; Winerdal, Malin E.; Winqvist, Ola] Karolinska Inst, Translat Immunol Unit, Dept Med, Stockholm, Sweden; [Norstedt, Gunnar] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Wikstrom, Ann-Charlotte] Karolinska Inst, Dept Biosci & Nutr, Stockholm, Sweden; [Lou, DaoHua; Rottenberg, Martin] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Hu, Jin] Guangxi Med Univ, Dept Trauma Orthoped & Hand Surg, Affiliated Hosp 1, Nanning, Peoples R China	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Guangxi Medical University	Hu, J (corresponding author), Karolinska Inst, Translat Immunol Unit, Dept Med, Stockholm, Sweden.	ola.winqvist@karolinska.se	Carow, Berit/AAE-3970-2020	Carow, Berit/0000-0002-8760-6253; Rottenberg, Martin/0000-0003-0514-7434; Norstedt, Gunnar/0000-0002-7759-3241; winqvist, Ola/0000-0003-0842-4441	Swedish Cancer Society; Wallenberg Foundation; Soderbergs Foundation, Thematic centre for immunomodulatory treatment of autoimmunity and cancer; Swedish Research Council	Swedish Cancer Society(Swedish Cancer Society); Wallenberg Foundation(European Commission); Soderbergs Foundation, Thematic centre for immunomodulatory treatment of autoimmunity and cancer; Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by the Swedish Cancer Society, the Wallenberg Foundation, the Soderbergs Foundation, Thematic centre for immunomodulatory treatment of autoimmunity and cancer, and the Swedish Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Cheng SM, 2009, BLOOD, V113, P5192, DOI 10.1182/blood-2008-10-183525; Crespo A, 2000, BIOCHEM J, V349, P99, DOI 10.1042/0264-6021:3490099; Croker BA, 2008, SEMIN CELL DEV BIOL, V19, P414, DOI 10.1016/j.semcdb.2008.07.010; Frobose H, 2006, MOL ENDOCRINOL, V20, P1587, DOI 10.1210/me.2005-0301; Gabriele L, 2007, CYTOKINE GROWTH F R, V18, P503, DOI 10.1016/j.cytogfr.2007.06.008; Gautier G, 2005, J EXP MED, V201, P1435, DOI 10.1084/jem.20041964; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Hu J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007178; Kadowaki N, 2001, J EXP MED, V194, P863, DOI 10.1084/jem.194.6.863; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; Kinjyo I, 2002, IMMUNITY, V17, P583, DOI 10.1016/S1074-7613(02)00446-6; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Machado FS, 2006, NAT MED, V12, P330, DOI 10.1038/nm1355; Mansell A, 2006, NAT IMMUNOL, V7, P148, DOI 10.1038/ni1299; Mathis D, 2011, NAT REV IMMUNOL, V11, P81, DOI 10.1038/nri2922; Medzhitov R, 2009, NAT REV IMMUNOL, V9, P692, DOI 10.1038/nri2634; Molavi O, 2008, IMMUNOL CELL BIOL, V86, P506, DOI 10.1038/icb.2008.27; Nakagawa R, 2002, IMMUNITY, V17, P677, DOI 10.1016/S1074-7613(02)00449-1; Noppert SJ, 2007, IMMUNOL CELL BIOL, V85, P446, DOI 10.1038/sj.icb.7100099; O'Neill LAJ, 2008, IMMUNITY, V29, P12, DOI 10.1016/j.immuni.2008.06.004; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Posselt G, 2011, J IMMUNOL, V187, P2875, DOI 10.4049/jimmunol.1003348; Ramsey SA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000021; Rico-Bautista E, 2006, CYTOKINE GROWTH F R, V17, P431, DOI 10.1016/j.cytogfr.2006.09.008; Rothfuchs AG, 2001, J IMMUNOL, V167, P6453, DOI 10.4049/jimmunol.167.11.6453; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Schmitz F, 2007, EUR J IMMUNOL, V37, P315, DOI 10.1002/eji.200636767; Tailor P, 2006, CELL RES, V16, P134, DOI 10.1038/sj.cr.7310018; Tailor P, 2007, IMMUNITY, V27, P228, DOI 10.1016/j.immuni.2007.06.009; Takaoka A, 2006, CELL MICROBIOL, V8, P907, DOI 10.1111/j.1462-5822.2006.00716.x; Toshchakov V, 2002, NAT IMMUNOL, V3, P392, DOI 10.1038/ni774; Uddin S, 2003, BIOCHEM BIOPH RES CO, V308, P325, DOI 10.1016/S0006-291X(03)01382-2; van Boxel-Dezaire AHH, 2006, IMMUNITY, V25, P361, DOI 10.1016/j.immuni.2006.08.014; Vidal OM, 2007, MOL ENDOCRINOL, V21, P293, DOI 10.1210/me.2006-0096; Yasukawa H, 2003, NAT IMMUNOL, V4, P551, DOI 10.1038/ni938; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093	40	16	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30166	10.1371/journal.pone.0030166	http://dx.doi.org/10.1371/journal.pone.0030166			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22291912	Green Published, Green Submitted, gold			2022-12-25	WOS:000301570600021
J	Rappl, G; Riet, T; Awerkiew, S; Schmidt, A; Hombach, AA; Pfister, H; Abken, H				Rappl, Gunter; Riet, Tobias; Awerkiew, Sabine; Schmidt, Annette; Hombach, Andreas A.; Pfister, Herbert; Abken, Hinrich			The CD3-Zeta Chimeric Antigen Receptor Overcomes TCR Hypo-Responsiveness of Human Terminal Late-Stage T Cells	PLOS ONE			English	Article							IMMUNOLOGICAL SYNAPSE; GENE-THERAPY; GALECTIN-3; LYMPHOCYTES; CANCER; ACTIVATION; TOLERANCE; EFFECTOR	Adoptive therapy of malignant diseases with tumor-specific cytotoxic T cells showed remarkable efficacy in recent trials. Repetitive T cell receptor (TCR) engagement of target antigen, however, inevitably ends up in hypo-responsive cells with terminally differentiated KLRG-1(+) CD57(+) CD7(-) phenotype limiting their therapeutic efficacy. We here revealed that hypo-responsiveness of CMV-specific late-stage CD8(+) T cells is due to reduced TCR synapse formation compared to younger cells. Membrane anchoring of TCR components contributes to T cell hypo-responsiveness since dislocation of galectin-3 from the synapse by swainsonine restored both TCR synapse formation and T cell response. Transgenic expression of a CD3-zeta signaling chimeric antigen receptor (CAR) recovered hypo-responsive T cells to full effector functions indicating that the defect is restricted to TCR membrane components while synapse formation of the transgenic CAR was not blocked. CAR engineered late-stage T cells released cytokines and mediated redirected cytotoxicity as efficiently as younger effector T cells. Our data provide a rationale for TCR independent, CAR mediated activation in the adoptive cell therapy to avoid hypo-responsiveness of late-stage T cells upon repetitive antigen encounter.	[Rappl, Gunter; Riet, Tobias; Hombach, Andreas A.; Abken, Hinrich] Univ Cologne, Dept Internal Med 1, D-50931 Cologne, Germany; [Awerkiew, Sabine; Pfister, Herbert] Univ Cologne, Inst Virol, D-50931 Cologne, Germany; [Schmidt, Annette] Bundeswehr Inst Pharmacol & Toxicol, Munich, Germany; [Rappl, Gunter; Pfister, Herbert; Abken, Hinrich] Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany	University of Cologne; University of Cologne; University of Cologne	Rappl, G (corresponding author), Univ Cologne, Dept Internal Med 1, D-50931 Cologne, Germany.	gunter.rappl@uni-koeln.de		Riet, Tobias/0000-0002-8211-7071; Hombach, Andreas/0000-0001-9328-8442	Deutsche Krebshilfe, Bonn; Faculty of Medicine, University of Cologne [45/2010]	Deutsche Krebshilfe, Bonn(Deutsche Krebshilfe); Faculty of Medicine, University of Cologne	The work in this manuscript was supported by a grant from the Deutsche Krebshilfe, Bonn, and by the Fortune Program of the Faculty of Medicine, University of Cologne (45/2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold CR, 2011, J CLIN IMMUNOL, V31, P137, DOI 10.1007/s10875-010-9499-x; Attig S, 2009, CANCER RES, V69, P8412, DOI 10.1158/0008-5472.CAN-09-0852; Bartelt RR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005430; Boding L, 2009, J IMMUNOL, V183, P4994, DOI 10.4049/jimmunol.0901539; Bour-Jordan H, 2011, IMMUNOL REV, V241, P180, DOI 10.1111/j.1600-065X.2011.01011.x; Bridgeman JS, 2010, J IMMUNOL, V184, P6938, DOI 10.4049/jimmunol.0901766; Buchholz VR, 2011, CURR OPIN IMMUNOL, V23, P549, DOI 10.1016/j.coi.2011.05.002; Chen HY, 2009, P NATL ACAD SCI USA, V106, P14496, DOI 10.1073/pnas.0903497106; Debes GF, 2005, NAT IMMUNOL, V6, P889, DOI 10.1038/ni1238; Demotte N, 2010, CANCER RES, V70, P7476, DOI 10.1158/0008-5472.CAN-10-0761; Dustin ML, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002311; Effros RB, 2011, EXP GERONTOL, V46, P135, DOI 10.1016/j.exger.2010.08.027; Fooksman DR, 2010, ANNU REV IMMUNOL, V28, P79, DOI 10.1146/annurev-immunol-030409-101308; Garber K, 2011, J NATL CANCER I, V103, P1079, DOI 10.1093/jnci/djr281; Grigorian A, 2010, METHOD ENZYMOL, V480, P245, DOI 10.1016/S0076-6879(10)80012-6; Hombach Andreas, 2003, Methods Mol Biol, V207, P365; Hsu DK, 2009, IMMUNOL REV, V230, P114, DOI 10.1111/j.1600-065X.2009.00798.x; Jorritsma A, 2011, CURR GENE THER, V11, P276, DOI 10.2174/156652311796150390; KAULEN H, 1993, YEAR IMMUN, V7, P106; Klebanoff CA, 2011, IMMUNOL REV, V239, P27, DOI 10.1111/j.1600-065X.2010.00979.x; Larbi A, 2011, AGEING RES REV, V10, P370, DOI 10.1016/j.arr.2010.09.008; Linnemann C, 2011, J INVEST DERMATOL, V131, P1806, DOI 10.1038/jid.2011.160; Ma HX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020466; Neeson P, 2010, GENE THER, V17, P1105, DOI 10.1038/gt.2010.59; Ohno-Iwashita Y, 2010, GERIATR GERONTOL INT, V10, pS41, DOI 10.1111/j.1447-0594.2010.00600.x; Park TS, 2011, TRENDS BIOTECHNOL, V29, P550, DOI 10.1016/j.tibtech.2011.04.009; Powell DJ, 2006, J IMMUNOL, V177, P6527, DOI 10.4049/jimmunol.177.9.6527; Ramos CA, 2011, EXPERT OPIN BIOL TH, V11, P855, DOI 10.1517/14712598.2011.573476; Rappl G, 2008, REJUV RES, V11, P543, DOI 10.1089/rej.2007.0612; Roszik J, 2011, EUR J IMMUNOL, V41, P1288, DOI 10.1002/eji.200940233; Simpson RJ, 2010, EXERC IMMUNOL REV, V16, P40; Stillman BN, 2006, J IMMUNOL, V176, P778, DOI 10.4049/jimmunol.176.2.778; Tavano R, 2006, NAT CELL BIOL, V8, P1270, DOI 10.1038/ncb1492; Turtle CJ, 2011, CURR OPIN IMMUNOL, V23, P299, DOI 10.1016/j.coi.2010.12.012; Vazquez-Cintron EJ, 2010, J IMMUNOL, V185, P7133, DOI 10.4049/jimmunol.1001157; Weiner HL, 2011, IMMUNOL REV, V241, P241, DOI 10.1111/j.1600-065X.2011.01017.x	36	9	10	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30713	10.1371/journal.pone.0030713	http://dx.doi.org/10.1371/journal.pone.0030713			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22292024	Green Published, Green Submitted, gold			2022-12-25	WOS:000301570600073
J	Wang, CW; Lee, JH; Kim, CH				Wang, Chuanwu; Lee, Jee H.; Kim, Chang H.			Optimal Population of FoxP3(+) T Cells in Tumors Requires an Antigen Priming-Dependent Trafficking Receptor Switch	PLOS ONE			English	Article							TRANSCRIPTION FACTOR FOXP3; FOSTERS IMMUNE PRIVILEGE; TGF-BETA; REGULATORY-CELLS; HODGKIN-LYMPHOMA; GASTRIC-CANCER; MURINE MODEL; IN-VIVO; DIFFERENTIATION; CONVERSION	FoxP3(+) T cells populate tumors and regulate anti-tumor immunity. The requirement for optimal population of FoxP3(+) regulatory T cells in tumors remains unclear. We investigated the migration requirement and stability of tumor-associated FoxP3(+) T cells. We found that only memory, but not naive, FoxP3(+) T cells are highly enriched in tumors. Almost all of the tumor-infiltrating FoxP3(+) T cells express Helios, an antigen associated either with thymus-generated FoxP3(+) T cells or activated T cells in the periphery. The tumor-infiltrating FoxP3(+) T cells largely lack CD62L and CCR7, two trafficking receptors required for T cell migration into secondary lymphoid tissues. Instead, the tumor infiltrating FoxP3(+) T cells highly express memory/tumor-associated CCR8 and CXCR4. Antigen priming is required for induction of this trafficking receptor phenotype in FoxP3(+) T cells and only antigen primed, but not antigen-inexperienced naive, FoxP3(+) T cells can efficiently migrate into tumors. While the migration of FoxP3(+) T cells into tumors was a readily detectable event, generation of induced FoxP3(+) T cells within tumors was unexpectedly inefficient. Genetic marking of current and ex-FoxP3(+) T cells revealed that tumor-infiltrating FoxP3(+) T cells are highly stable and do not readily convert back to FoxP3(-) T cells. Taken together, our results indicate that population of tumors with thymus-generated FoxP3(+) T cells requires an antigen priming-dependent trafficking receptor switch in lymphoid tissues.	[Wang, Chuanwu; Lee, Jee H.; Kim, Chang H.] Purdue Univ, Lab Immunol & Hematopoiesis, Dept Comparat Pathobiol, Purdue Canc Ctr,Bindley Biosci Ctr, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Wang, CW (corresponding author), Purdue Univ, Lab Immunol & Hematopoiesis, Dept Comparat Pathobiol, Purdue Canc Ctr,Bindley Biosci Ctr, W Lafayette, IN 47907 USA.	chkim@purdue.edu	Wang, Chuanwu/N-3186-2013; Wang, Chuanwu/E-9117-2012; Kim, Chang/ABG-8200-2020	Kim, Chang/0000-0003-4618-9139	NIH [R01AI074745, R01DK076616, R01AI080769, 1S10RR028293]; DOD [W81XWH-07-1-0555]; Sidney Kimmel Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR028293] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080769, R01AI074745] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076616] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD(United States Department of Defense); Sidney Kimmel Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work has been supported by the grants from NIH (R01AI074745, R01DK076616, R01AI080769, and 1S10RR028293), DOD (W81XWH-07-1-0555), and Sidney Kimmel Foundation to CH Kim. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimova T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024226; Alvaro T, 2005, CLIN CANCER RES, V11, P1467, DOI 10.1158/1078-0432.CCR-04-1869; Andersson J, 2008, J EXP MED, V205, P1975, DOI 10.1084/jem.20080308; AWWAD M, 1988, J EXP MED, V168, P2193, DOI 10.1084/jem.168.6.2193; Badoual C, 2006, CLIN CANCER RES, V12, P465, DOI 10.1158/1078-0432.CCR-05-1886; Baratelli F, 2005, J IMMUNOL, V175, P1483, DOI 10.4049/jimmunol.175.3.1483; Baumgartner J, 2007, J SURG RES, V141, P72, DOI 10.1016/j.jss.2007.03.053; Ben-Shoshan J, 2008, EUR J IMMUNOL, V38, P2412, DOI 10.1002/eji.200838318; Betts G, 2007, BRIT J CANCER, V96, P1849, DOI 10.1038/sj.bjc.6603824; Campbell DJ, 2007, NAT REV IMMUNOL, V7, P305, DOI 10.1038/nri2061; Carreras J, 2006, BLOOD, V108, P2957, DOI 10.1182/blood-2006-04-018218; Casares N, 2003, J IMMUNOL, V171, P5931, DOI 10.4049/jimmunol.171.11.5931; Chen ML, 2005, P NATL ACAD SCI USA, V102, P419, DOI 10.1073/pnas.0408197102; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Collison LW, 2007, NATURE, V450, P566, DOI 10.1038/nature06306; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Dang EV, 2011, CELL, V146, P772, DOI 10.1016/j.cell.2011.07.033; Elkord E, 2011, CLIN IMMUNOL, V140, P218, DOI 10.1016/j.clim.2011.04.014; Gobert M, 2009, CANCER RES, V69, P2000, DOI 10.1158/0008-5472.CAN-08-2360; Ishida T, 2006, CANCER RES, V66, P5716, DOI 10.1158/0008-5472.CAN-06-0261; Kang SG, 2007, J IMMUNOL, V179, P3724, DOI 10.4049/jimmunol.179.6.3724; Kim CH, 2006, EXP HEMATOL, V34, P1033, DOI 10.1016/j.exphem.2006.03.014; Kim Chang H, 2005, Curr Opin Hematol, V12, P298, DOI 10.1097/01.moh.0000166496.18773.e3; Kim CH, 2009, ADV EXP MED BIOL, V665, P17; Lee J, 2006, J IMMUNOL PENDING; Lee JH, 2007, J IMMUNOL, V178, P301, DOI 10.4049/jimmunol.178.1.301; Lee JH, 2011, J IMMUNOL, V187, P1778, DOI 10.4049/jimmunol.1003919; Liu VC, 2007, J IMMUNOL, V178, P2883, DOI 10.4049/jimmunol.178.5.2883; Lutsiak MEC, 2008, J IMMUNOL, V180, P5871, DOI 10.4049/jimmunol.180.9.5871; Mailloux AW, 2009, J IMMUNOL, V182, P2753, DOI 10.4049/jimmunol.0801124; Mittal S, 2008, BLOOD, V111, P5359, DOI 10.1182/blood-2007-08-105395; Miyara M, 2007, TRENDS MOL MED, V13, P108, DOI 10.1016/j.molmed.2007.01.003; Mizukami Y, 2008, BRIT J CANCER, V98, P148, DOI 10.1038/sj.bjc.6604149; Mizukami Y, 2008, INT J CANCER, V122, P2286, DOI 10.1002/ijc.23392; Moo-Young TA, 2009, J IMMUNOTHER, V32, P12, DOI 10.1097/CJI.0b013e318189f13c; MOORE MW, 1988, CELL, V54, P777, DOI 10.1016/S0092-8674(88)91043-4; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Nishikawa H, 2010, INT J CANCER, V127, P759, DOI 10.1002/ijc.25429; NORTH RJ, 1984, J EXP MED, V159, P1295, DOI 10.1084/jem.159.5.1295; NORTH RJ, 1982, J EXP MED, V155, P1063, DOI 10.1084/jem.155.4.1063; Onizuka S, 1999, CANCER RES, V59, P3128; Salama P, 2009, J CLIN ONCOL, V27, P186, DOI 10.1200/JCO.2008.18.7229; Sharma S, 2005, CANCER RES, V65, P5211, DOI 10.1158/0008-5472.CAN-05-0141; Shi LZ, 2011, J EXP MED, V208, P1367, DOI 10.1084/jem.20110278; Shimizu J, 1999, J IMMUNOL, V163, P5211; Siddiqui SA, 2007, CLIN CANCER RES, V13, P2075, DOI 10.1158/1078-0432.CCR-06-2139; Stephens GL, 2007, IMMUNITY, V27, P417, DOI 10.1016/j.immuni.2007.08.008; Tan MCB, 2009, J IMMUNOL, V182, P1746, DOI 10.4049/jimmunol.182.3.1746; Tang QZ, 2008, NAT IMMUNOL, V9, P239, DOI 10.1038/ni1572; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; Valzasina B, 2006, CANCER RES, V66, P4488, DOI 10.1158/0008-5472.CAN-05-4217; Wald O, 2006, J IMMUNOL, V177, P6983, DOI 10.4049/jimmunol.177.10.6983; Wang C, 2009, MUCOSAL IMMUNOL, V2, P173, DOI 10.1038/mi.2008.84; Wang CW, 2010, J IMMUNOL, V184, P5519, DOI 10.4049/jimmunol.0903942; Wolf D, 2005, CLIN CANCER RES, V11, P8326, DOI 10.1158/1078-0432.CCR-05-1244; Xu L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020282; Zheng Y, 2007, NAT IMMUNOL, V8, P457, DOI 10.1038/ni1455; Zhou XY, 2009, NAT IMMUNOL, V10, P1000, DOI 10.1038/ni.1774; Ziegler SF, 2006, ANNU REV IMMUNOL, V24, P209, DOI 10.1146/annurev.immunol.24.021605.090547	59	26	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30793	10.1371/journal.pone.0030793	http://dx.doi.org/10.1371/journal.pone.0030793			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22292042	gold, Green Published, Green Submitted			2022-12-25	WOS:000301570600080
J	Robinson, GL; Dinsdale, D; MacFarlane, M; Cain, K				Robinson, G. L.; Dinsdale, D.; MacFarlane, M.; Cain, K.			Switching from aerobic glycolysis to oxidative phosphorylation modulates the sensitivity of mantle cell lymphoma cells to TRAIL	ONCOGENE			English	Article						TRAIL; apoptosis; oxidative phosphorylation; aerobic glycolysis; mitochondria; 2DG	INDUCED APOPTOSIS; RECEPTOR; DEATH; GLUCOSE; INHIBITION; CANCER; RESISTANCE; LIGAND; MCL-1; ATP	TRAIL (TNF (tumour necrosis factor)-related apoptosis-inducing ligand) a putative anti-cancer cytokine induces apoptosis through DISC (death-inducing signalling complex)-mediated activation of caspase-8 and/or cleavage of Bid. TRAIL is relatively specific for tumour cells but primary chronic lymphocytic leukaemia and mantle cell lymphoma (MCL) cells are resistant. Herein, we show that cellular metabolism influences cell death and that MCL cells (Z138 cell line) can survive/proliferate in glucose-free media by switching from aerobic glycolysis to 'coupled' oxidative phosphorylation. Extracellular flux analysis and mitochondrial inhibitors reveal that in the absence of glycolysis, Z138 cells have enhanced respiratory capacity coupled to ATP synthesis, similar to 'classical' state 3 mitochondria. Conversely, 2-deoxyglucose (2DG) blocked glycolysis and partially inhibited glycolytic-dependent oxidative phosphorylation, resulting in a 50% reduction in cellular ATP levels. Also, 2DG sensitised Z138 cells to TRAIL and induced a marked decrease in caspase-8, -3, cFLIP(S), Bid and Mcl-1 expression but Bak remained unchanged, altering the Mcl-1/Bak ratio, facilitating cytochrome c release and cell death. Conversely, under glucose-free conditions, Z138 cells were less sensitive to TRAIL with reduced TRAIL-R1/R2 surface receptor expression and impaired DISC formation. Anti-apoptotic proteins Bcl-2 and XIAP were up-regulated while pro-apoptotic BAX was down-regulated. Additionally, mitochondria had higher levels of cytochrome c and ultrastucturally exhibited a condensed configuration with enhanced intracristal spaces. Thus, metabolic switching was accompanied by mitochondrial proteome and ultrastructural remodelling enabling enhanced respiration activity. Cytochrome c release was decreased in glucose-free cells, suggesting that either pore formation was inhibited or that cytochrome c was more tightly bound. Glucose-free Z138 cells were also resistant to intrinsic cell death stimuli (ABT-737 and ionising radiation). In summary, in MCL cells, the anti-glycolytic effects of 2DG and glucose restriction produced opposite effects on TRAIL-induced cell death, demonstrating that mitochondrial metabolism directly modulates sensitivity of tumour cells to apoptosis. Oncogene (2012) 31, 4996-5006; doi:10.1038/onc.2012.13; published online 6 February 2012	[Robinson, G. L.; Dinsdale, D.; MacFarlane, M.; Cain, K.] Univ Leicester, MRC Toxicol Unit, Leicester LE1 9HN, Leics, England	University of Leicester	MacFarlane, M (corresponding author), Univ Leicester, MRC Toxicol Unit, Hodgkin Bldg,Lancaster Rd, Leicester LE1 9HN, Leics, England.	mm21@le.ac.uk; kc5@le.ac.uk			UK Medical Research Council; MRC [MC_U132685863] Funding Source: UKRI; Medical Research Council [MC_U132685863] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the UK Medical Research Council.	Adrain C, 2001, TRENDS BIOCHEM SCI, V26, P390, DOI 10.1016/S0968-0004(01)01844-8; Ashkenazi A, 2002, NAT REV CANCER, V2, P420, DOI 10.1038/nrc821; Benard G, 2008, ANTIOXID REDOX SIGN, V10, P1313, DOI 10.1089/ars.2007.2000; Boyd RS, 2009, MOL CELL PROTEOMICS, V8, P1501, DOI 10.1074/mcp.M800515-MCP200; Cain K, 2002, BIOCHIMIE, V84, P203, DOI 10.1016/S0300-9084(02)01376-7; Capasso M, 2010, NAT IMMUNOL, V11, P265, DOI 10.1038/ni.1843; CHANCE B, 1956, ADV ENZYMOL REL S BI, V17, P65; Coloff JL, 2011, CANCER RES, V71, P5204, DOI 10.1158/0008-5472.CAN-10-4531; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Dyer MJS, 2007, J CLIN ONCOL, V25, P4505, DOI 10.1200/JCO.2007.13.1011; El Mjiyad N, 2011, ONCOGENE, V30, P253, DOI 10.1038/onc.2010.466; Falschlehner C, 2009, IMMUNOLOGY, V127, P145, DOI 10.1111/j.1365-2567.2009.03058.x; Ferrari D, 1998, J EXP MED, V188, P979, DOI 10.1084/jem.188.5.979; Fulda S, 2002, ONCOGENE, V21, P2283, DOI 10.1038/sj.onc.1205258; Gambhir SS, 2002, NAT REV CANCER, V2, P683, DOI 10.1038/nrc882; Gillissen B, 2010, J CELL BIOL, V188, P851, DOI 10.1083/jcb.200912070; HACKENBROCK CR, 1966, J CELL BIOL, V30, P269, DOI 10.1083/jcb.30.2.269; HALICKA HD, 1995, CANCER RES, V55, P444; Hardie DG, 2005, CURR OPIN CELL BIOL, V17, P167, DOI 10.1016/j.ceb.2005.01.006; Harper N, 2008, METHOD ENZYMOL, V446, P293, DOI 10.1016/S0076-6879(08)01618-2; Heiskanen KM, 1999, J BIOL CHEM, V274, P5654, DOI 10.1074/jbc.274.9.5654; Hughes MA, 2009, MOL CELL, V35, P265, DOI 10.1016/j.molcel.2009.06.012; LeBlanc H, 2002, NAT MED, V8, P274, DOI 10.1038/nm0302-274; Leist M, 1997, J EXP MED, V185, P1481, DOI 10.1084/jem.185.8.1481; Liu H, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-122; MacFarlane M, 2005, CANCER RES, V65, P11265, DOI 10.1158/0008-5472.CAN-05-2801; Marino K, 2010, NAT CHEM BIOL, V6, P713, DOI [10.1038/nchembio.437, 10.1038/NCHEMBIO.437]; MERINO R, 1994, EMBO J, V13, P683, DOI 10.1002/j.1460-2075.1994.tb06307.x; Munoz-Pinedo C, 2003, J BIOL CHEM, V278, P12759, DOI 10.1074/jbc.M212392200; Nam SY, 2002, ONCOGENE, V21, P337, DOI 10.1038/sj.onc.1205068; PARNIAK M, 1985, CAN J BIOCHEM CELL B, V63, P333, DOI 10.1139/o85-049; Pelicano H, 2006, ONCOGENE, V25, P4633, DOI 10.1038/sj.onc.1209597; Pitt RM, 1996, J BIOL CHEM, V271, P12687, DOI 10.1074/jbc.271.22.12687; Poukkula M, 2005, J BIOL CHEM, V280, P27345, DOI 10.1074/jbc.M504019200; Pradelli LA, 2010, ONCOGENE, V29, P1641, DOI 10.1038/onc.2009.448; Rossignol R, 2004, CANCER RES, V64, P985, DOI 10.1158/0008-5472.CAN-03-1101; Samraj AK, 2006, J BIOL CHEM, V281, P29652, DOI 10.1074/jbc.M603487200; Scaffidi C, 1999, J BIOL CHEM, V274, P22532, DOI 10.1074/jbc.274.32.22532; Tagawa H, 2005, ONCOGENE, V24, P1348, DOI 10.1038/sj.onc.1208300; THAKKAR NS, 1993, CANCER RES, V53, P2057; van Delft MF, 2006, CANCER CELL, V10, P389, DOI 10.1016/j.ccr.2006.08.027; Wagner KW, 2007, NAT MED, V13, P1070, DOI 10.1038/nm1627; Walczak H, 1999, NAT MED, V5, P157, DOI 10.1038/5517; Wallach D, 1999, ANNU REV IMMUNOL, V17, P331, DOI 10.1146/annurev.immunol.17.1.331; WARBURG O, 1956, SCIENCE, V124, P269; Wiley SR, 1995, IMMUNITY, V3, P673, DOI 10.1016/1074-7613(95)90057-8; Wood TE, 2008, MOL CANCER THER, V7, P3546, DOI 10.1158/1535-7163.MCT-08-0569; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; Yamaguchi R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024102; Zagorodna O, 2012, ONCOGENE, V31, P2738, DOI 10.1038/onc.2011.454; Zamaraeva MV, 2005, CELL DEATH DIFFER, V12, P1390, DOI 10.1038/sj.cdd.4401661	51	66	67	1	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV	2012	31	48					4996	5006		10.1038/onc.2012.13	http://dx.doi.org/10.1038/onc.2012.13			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	048CU	22310286				2022-12-25	WOS:000311888600004
J	Paschoud, S; Guillemot, L; Citi, S				Paschoud, Serge; Guillemot, Laurent; Citi, Sandra			Distinct Domains of Paracingulin Are Involved in Its Targeting to the Actin Cytoskeleton and Regulation of Apical Junction Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CELL ADHESION; TIGHT JUNCTION; ADHERENS JUNCTIONS; ALPHA-CATENIN; F-ACTIN; ZO-1; CINGULIN; PROTEIN; COMPLEX; BINDING	Paracingulin is an M-r 150-160 kDa cytoplasmic protein of vertebrate epithelial tight and adherens junctions and comprises globular head, coiled-coil rod, and globular tail domains. Unlike its homologous tight junction protein cingulin, paracingulin has been implicated in the control of junction assembly and has been localized at extrajunctional sites in association with actin filaments. Here we analyze the role of paracingulin domains, and specific regions within the head and rod domains, in the function and localization of paracingulin by inducible overexpression of exogenous proteins in epithelial Madin Darby canine kidney (MDCK) cells and by expression of mutated and chimeric constructs in Rat1 fibroblasts and MDCK cells. The overexpression of the rod + tail domains of paracingulin perturbs the development of the tight junction barrier and Rac1 activation during junction assembly by the calcium switch, indicating that regulation of junction assembly by paracingulin is mediated by these domains. Conversely, only constructs containing the head domain target to junctions in MDCK cells and Rat1 fibroblasts. Furthermore, expression of chimeric cingulin and paracingulin constructs in Rat1 fibroblasts and MDCK cells identifies specific sequences within the head and rod domains of paracingulin as critical for targeting to actin filaments and regulation of junction assembly, respectively. In summary, we characterize the functionally important domains of paracingulin that distinguish it from cingulin.	[Citi, Sandra] Univ Geneva, Dept Cell Biol, CH-1205 Geneva, Switzerland; [Paschoud, Serge; Guillemot, Laurent; Citi, Sandra] Univ Geneva, Dept Mol Biol, CH-1205 Geneva, Switzerland	University of Geneva; University of Geneva	Citi, S (corresponding author), Univ Geneva, Dept Cell Biol, 4 Blvd Yvoy, CH-1205 Geneva, Switzerland.	sandra.citi@unige.ch	Citi, Sandra/E-4514-2014	Citi, Sandra/0000-0002-6537-4818	State of Geneva; Section of Biology of the Faculty of Sciences of the University of Geneva; Swiss National Fund [31003A103637, 31003A116763]	State of Geneva; Section of Biology of the Faculty of Sciences of the University of Geneva; Swiss National Fund(Swiss National Science Foundation (SNSF))	This work was supported by the State of Geneva, the Section of Biology of the Faculty of Sciences of the University of Geneva, and by Swiss National Fund Grants 31003A103637 and 31003A116763.	Abe K, 2008, P NATL ACAD SCI USA, V105, P13, DOI 10.1073/pnas.0710504105; Anastasiadis PZ, 2001, CURR OPIN CELL BIOL, V13, P604, DOI 10.1016/S0955-0674(00)00258-1; Braga VMM, 2002, CURR OPIN CELL BIOL, V14, P546, DOI 10.1016/S0955-0674(02)00373-3; Bruewer M, 2004, AM J PHYSIOL-CELL PH, V287, pC327, DOI 10.1152/ajpcell.00087.2004; Citi S., 2012, ANN N Y ACA IN PRESS; Citi S, 2011, MOL MEMBR BIOL, V28, P427, DOI 10.3109/09687688.2011.603101; D'Atri F, 2001, FEBS LETT, V507, P21, DOI 10.1016/S0014-5793(01)02936-2; Drees F, 2005, CELL, V123, P903, DOI 10.1016/j.cell.2005.09.021; Fanning AS, 2012, MOL BIOL CELL, V23, P577, DOI 10.1091/mbc.E11-09-0791; Fanning AS, 1998, J BIOL CHEM, V273, P29745, DOI 10.1074/jbc.273.45.29745; Furuse M, 2006, TRENDS CELL BIOL, V16, P181, DOI 10.1016/j.tcb.2006.02.006; Gonzalez-Mariscal L, 2008, BBA-BIOMEMBRANES, V1778, P729, DOI 10.1016/j.bbamem.2007.08.018; Guillemot L, 2004, J CELL SCI, V117, P5245, DOI 10.1242/jcs.01399; Guillemot L, 2008, MOL BIOL CELL, V19, P4442, DOI 10.1091/mbc.E08-06-0558; Guillemot L, 2006, MOL BIOL CELL, V17, P3569, DOI 10.1091/mbc.E06-02-0122; Guillemot Laurent, 2006, P54; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; Ikenouchi J, 2007, J CELL BIOL, V176, P779, DOI 10.1083/jcb.200612080; Kitt KN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017841; Mandai K, 1997, J CELL BIOL, V139, P517, DOI 10.1083/jcb.139.2.517; Matter K, 2005, CURR OPIN CELL BIOL, V17, P453, DOI 10.1016/j.ceb.2005.08.003; McCrea P. D., 2009, COLD SPRING HARB PER, V1; Mertens AEE, 2005, J CELL BIOL, V170, P1029, DOI 10.1083/jcb.200502129; Nakagawa M, 2001, J CELL SCI, V114, P1829; Ohnishi H, 2004, J BIOL CHEM, V279, P46014, DOI 10.1074/jbc.M402616200; Otani T, 2006, J CELL BIOL, V175, P135, DOI 10.1083/jcb.200605012; Paschoud S, 2008, MOL MEMBR BIOL, V25, P1, DOI 10.1080/09687680701474009; Paschoud S, 2011, MOL MEMBR BIOL, V28, P123, DOI 10.3109/09687688.2010.538937; Pulimeno P, 2011, J BIOL CHEM, V286, P16743, DOI 10.1074/jbc.M111.230862; Samarin S, 2009, FRONT BIOSCI-LANDMRK, V14, P1129, DOI 10.2741/3298; Schlegelmilch K, 2011, CELL, V144, P782, DOI 10.1016/j.cell.2011.02.031; Shin K, 2006, ANNU REV CELL DEV BI, V22, P207, DOI 10.1146/annurev.cellbio.22.010305.104219; Van Itallie CM, 2009, MOL BIOL CELL, V20, P3930, DOI 10.1091/mbc.E09-04-0320; Van Itallie CM, 2006, ANNU REV PHYSIOL, V68, P403, DOI 10.1146/annurev.physiol.68.040104.131404; Wheelock MJ, 2003, ANNU REV CELL DEV BI, V19, P207, DOI 10.1146/annurev.cellbio.19.011102.111135; Wittchen ES, 1999, J BIOL CHEM, V274, P35179, DOI 10.1074/jbc.274.49.35179	36	7	9	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					13159	13169		10.1074/jbc.M111.315622	http://dx.doi.org/10.1074/jbc.M111.315622			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22315225	hybrid, Green Published			2022-12-25	WOS:000302903700054
J	Lee, JH; Park, AK; Do, H; Park, KS; Moh, SH; Chi, YM; Kim, HJ				Lee, Jun Hyuck; Park, Ae Kyung; Do, Hackwon; Park, Kyoung Sun; Moh, Sang Hyun; Chi, Young Min; Kim, Hak Jun			Structural Basis for Antifreeze Activity of Ice-binding Protein from Arctic Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIATOM FRAGILARIOPSIS-CYLINDRUS; CRYSTAL-STRUCTURE; DOMAIN	Arctic yeast Leucosporidium sp. produces a glycosylated ice-binding protein (LeIBP) with a molecular mass of similar to 25 kDa, which can lower the freezing point below the melting point once it binds to ice. LeIBP is a member of a large class of ice-binding proteins, the structures of which are unknown. Here, we report the crystal structures of non-glycosylated LeIBP and glycosylated LeIBP at 1.57- and 2.43-angstrom resolution, respectively. Structural analysis of the LeIBPs revealed a dimeric right-handed beta-helix fold, which is composed of three parts: a large coiled structural domain, a long helix region (residues 96-115 form a long beta-helix that packs along one face of the beta-helix), and a C-terminal hydrophobic loop region ((243)PFVPAPEVV(251)). Unexpectedly, the C-terminal hydrophobic loop region has an extended conformation pointing away from the body of the coiled structural domain and forms intertwined dimer interactions. In addition, structural analysis of glycosylated LeIBP with sugar moieties attached to Asn(185) provides a basis for interpreting previous biochemical analyses as well as the increased stability and secretion of glycosylated LeIBP. We also determined that the aligned Thr/Ser/Ala residues are critical for ice binding within the B face of LeIBP using site-directed mutagenesis. Although LeIBP has a common beta-helical fold similar to that of canonical hyperactive antifreeze proteins, the ice-binding site is more complex and does not have a simple ice-binding motif. In conclusion, we could identify the ice-binding site of LeIBP and discuss differences in the ice-binding modes compared with other known antifreeze proteins and ice-binding proteins.	[Lee, Jun Hyuck; Do, Hackwon; Park, Kyoung Sun; Kim, Hak Jun] Korea Polar Res Inst, Div Polar Life Sci, Inchon 406840, South Korea; [Lee, Jun Hyuck; Do, Hackwon; Park, Kyoung Sun; Kim, Hak Jun] Univ Sci & Technol, Dept Polar Sci, Inchon 406840, South Korea; [Park, Ae Kyung; Chi, Young Min] Korea Univ, Coll Life Sci, Div Biotechnol, Seoul 136713, South Korea; [Moh, Sang Hyun] BIO FD&C Co Ltd, Antiaging Res Inst, Inchon 405849, South Korea	Korea Institute of Ocean Science & Technology (KIOST); Korea Polar Research Institute (KOPRI); Korea University	Kim, HJ (corresponding author), Korea Polar Res Inst, Div Polar Life Sci, Inchon 406840, South Korea.	hjkim@kopri.re.kr		, Hackwon/0000-0001-7663-2010	Korea Research Council of Fundamental Science and Technology (KRCF); Korea Polar Research Institute (KOPRI) [PG11010, PE11100]	Korea Research Council of Fundamental Science and Technology (KRCF); Korea Polar Research Institute (KOPRI)	This work was supported by the National Agenda Project from the Korea Research Council of Fundamental Science and Technology (KRCF) and Korea Polar Research Institute (KOPRI) Grant PG11010 and PE11100 (to H. J. K.).	Achenbach JC, 2002, EUR J BIOCHEM, V269, P1219, DOI 10.1046/j.1432-1033.2002.02761.x; Adams PD, 2004, J SYNCHROTRON RADIAT, V11, P53, DOI 10.1107/S0909049503024130; Antson AA, 2001, J MOL BIOL, V305, P875, DOI 10.1006/jmbi.2000.4336; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bayer-Giraldi M, 2011, CRYOBIOLOGY, V63, P210, DOI 10.1016/j.cryobiol.2011.08.006; D'Amico S, 2006, EMBO REP, V7, P385, DOI 10.1038/sj.embor.7400662; Davies PL, 2002, PHILOS T R SOC B, V357, P927, DOI 10.1098/rstb.2002.1081; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano WL, 2004, PYMOL MOL GRAPHICS S; Doucet D, 2000, EUR J BIOCHEM, V267, P6082, DOI 10.1046/j.1432-1327.2000.01694.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Garnham CP, 2008, BIOCHEM J, V411, P171, DOI 10.1042/BJ20071372; Garnham CP, 2011, P NATL ACAD SCI USA, V108, P7363, DOI 10.1073/pnas.1100429108; Graether SP, 2000, NATURE, V406, P325, DOI 10.1038/35018610; Graether SP, 2004, EUR J BIOCHEM, V271, P3285, DOI 10.1111/j.1432-1033.2004.04256.x; Hoshino T, 2003, CAN J BOT, V81, P1175, DOI [10.1139/b03-116, 10.1139/B03-116]; Janech MG, 2006, J PHYCOL, V42, P410, DOI 10.1111/j.1529-8817.2006.00208.x; Jia ZC, 2002, TRENDS BIOCHEM SCI, V27, P101, DOI 10.1016/S0968-0004(01)02028-X; Krell A, 2008, EUR J PHYCOL, V43, P423, DOI 10.1080/09670260802348615; Kwan AHY, 2005, BIOCHEMISTRY-US, V44, P1980, DOI 10.1021/bi047782j; Lee JK, 2010, CRYOBIOLOGY, V60, P222, DOI 10.1016/j.cryobiol.2010.01.002; Leinala EK, 2002, STRUCTURE, V10, P619, DOI 10.1016/S0969-2126(02)00745-1; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Liou YC, 2000, NATURE, V406, P322, DOI 10.1038/35018604; Liu Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000548; Marshall CB, 2005, J BIOL CHEM, V280, P17920, DOI 10.1074/jbc.M500622200; Middleton AJ, 2009, FEBS LETT, V583, P815, DOI 10.1016/j.febslet.2009.01.035; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nishimiya Y, 2008, J MOL BIOL, V382, P734, DOI 10.1016/j.jmb.2008.07.042; Park AK, 2011, ACTA CRYSTALLOGR F, V67, P800, DOI 10.1107/S1744309111018446; Patel SN, 2010, BIOCHEM CELL BIOL, V88, P223, DOI [10.1139/o09-183, 10.1139/O09-183]; Raymond JA, 2008, EXTREMOPHILES, V12, P713, DOI 10.1007/s00792-008-0178-2; Raymond JA, 2007, FEMS MICROBIOL ECOL, V61, P214, DOI 10.1111/j.1574-6941.2007.00345.x; Raymond JA, 2009, J PHYCOL, V45, P130, DOI 10.1111/j.1529-8817.2008.00623.x; Raymond JA, 2009, CRYOBIOLOGY, V58, P151, DOI 10.1016/j.cryobiol.2008.11.009; Ritchie DW, 2000, PROTEINS, V39, P178, DOI 10.1002/(SICI)1097-0134(20000501)39:2<178::AID-PROT8>3.3.CO;2-Y; Siemer AB, 2008, J AM CHEM SOC, V130, P17394, DOI 10.1021/ja8047893; Smallwood M, 1999, BIOCHEM J, V340, P385, DOI 10.1042/0264-6021:3400385; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Venketesh S, 2008, CRIT REV BIOTECHNOL, V28, P57, DOI [10.1080/07388550801891152, 10.1080/07388550801891152 ]; Xiao N, 2010, FEBS J, V277, P394, DOI 10.1111/j.1742-4658.2009.07490.x; Yeo HJ, 2007, J BIOL CHEM, V282, P31076, DOI 10.1074/jbc.M705750200	43	78	84	2	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					11460	11468		10.1074/jbc.M111.331835	http://dx.doi.org/10.1074/jbc.M111.331835			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22303017	Green Published, hybrid			2022-12-25	WOS:000302780100074
J	Sandilos, JK; Chiu, YH; Chekeni, FB; Armstrong, AJ; Walk, SF; Ravichandran, KS; Bayliss, DA				Sandilos, Joanna K.; Chiu, Yu-Hsin; Chekeni, Faraaz B.; Armstrong, Allison J.; Walk, Scott F.; Ravichandran, Kodi S.; Bayliss, Douglas A.			Pannexin 1, an ATP Release Channel, Is Activated by Caspase Cleavage of Its Pore-associated C-terminal Autoinhibitory Region	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIND-ME SIGNAL; PH REGULATION; INACTIVATION; CONNEXIN43; INFLAMMASOME; NUCLEOTIDES; INHIBITION; CLEARANCE; APOPTOSIS; CELLS	Pannexin 1 (PANX1) channels mediate release of ATP, a "find-me" signal that recruits macrophages to apoptotic cells; PANX1 activation during apoptosis requires caspase-mediated cleavage of PANX1 at its C terminus, but how the C terminus inhibits basal channel activity is not understood. Here, we provide evidence suggesting that the C terminus interacts with the human PANX1 (hPANX1) pore and that cleavage-mediated channel activation requires disruption of this inhibitory interaction. Basally silent hPANX1 channels localized on the cell membrane could be activated directly by protease-mediated C-terminal cleavage, without additional apoptotic effectors. By serial deletion, we identified a C-terminal region just distal to the caspase cleavage site that is required for inhibition of hPANX1; point mutations within this small region resulted in partial activation of full-length hPANX1. Consistent with the C-terminal tail functioning as a pore blocker, we found that truncated and constitutively active hPANX1 channels could be inhibited, in trans, by the isolated hPANX1 C terminus either in cells or when applied directly as a purified peptide in inside-out patch recordings. Furthermore, using a cysteine cross-linking approach, we showed that relief of inhibition following cleavage requires dissociation of the C terminus from the channel pore. Collectively, these data suggest a mechanism of hPANX1 channel regulation whereby the intact, pore-associated C terminus inhibits the full-length hPANX1 channel and a remarkably well placed caspase cleavage site allows effective removal of key inhibitory C-terminal determinants to activate hPANX1.	[Sandilos, Joanna K.; Chiu, Yu-Hsin; Chekeni, Faraaz B.; Bayliss, Douglas A.] Univ Virginia, Dept Pharmacol, Charlottesville, VA 22908 USA; [Chekeni, Faraaz B.; Armstrong, Allison J.; Walk, Scott F.; Ravichandran, Kodi S.] Univ Virginia, Beirne B Carter Ctr Immunol Res, Charlottesville, VA 22908 USA; [Armstrong, Allison J.; Walk, Scott F.; Ravichandran, Kodi S.] Univ Virginia, Ctr Cell Clearance, Charlottesville, VA 22908 USA; [Ravichandran, Kodi S.] Univ Virginia, Dept Microbiol, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia; University of Virginia; University of Virginia	Bayliss, DA (corresponding author), Univ Virginia, Dept Pharmacol, 1340 Jefferson Pk Ave,5013 Jordan Hall, Charlottesville, VA 22908 USA.	bayliss@virginia.edu	Chiu, Yu-Hsin/AAT-8759-2021	Chiu, Yu-Hsin/0000-0002-4730-8104; Ravichandran, Kodi/0000-0001-9049-1410	National Institutes of Health [F30HL09640, GM064709, NS033583]; Pharmacological Sciences Training Grant [T32GM007055]; American Heart Association [PRE223005]; American Cancer Society [PF-11-024-01-CCG]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL009640] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007055, R01GM064709, T32GM007267] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033583, R29NS033583] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pharmacological Sciences Training Grant; American Heart Association(American Heart Association); American Cancer Society(American Cancer Society); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Fellowship F30HL09640 (to F. B. C.) and Grants GM064709 (to K. S. R.) and NS033583 (to D. A. B.). This work was also supported by a Pharmacological Sciences Training Grant T32GM007055 (to J. K. S. and F. B. C.), a predoctoral fellowship from the American Heart Association (PRE223005, to J. K. S.), and a postdoctoral fellowship from American Cancer Society (PF-11-024-01-CCG to A. J. A.).	ARMSTRONG CM, 1973, J GEN PHYSIOL, V62, P375, DOI 10.1085/jgp.62.4.375; Bao L, 2004, FEBS LETT, V572, P65, DOI 10.1016/j.febslet.2004.07.009; Bargiello T. A., 2011, BIOCH BIOPH IN PRESS; Billaud M, 2011, CIRC RES, V109, P80, DOI 10.1161/CIRCRESAHA.110.237594; Bunse S, 2010, J BIOL CHEM, V285, P38444, DOI 10.1074/jbc.M110.101014; Chekeni FB, 2011, J MOL MED, V89, P13, DOI 10.1007/s00109-010-0673-7; Chekeni FB, 2010, NATURE, V467, P863, DOI 10.1038/nature09413; D'hondt C, 2009, BIOESSAYS, V31, P953, DOI 10.1002/bies.200800236; Denault Jean-Bernard, 2008, V414, P191; Dubyak GR, 2009, AM J PHYSIOL-CELL PH, V296, pC235, DOI 10.1152/ajpcell.00639.2008; EkVitorin JF, 1996, BIOPHYS J, V71, P1273, DOI 10.1016/S0006-3495(96)79328-1; Elliott MR, 2009, NATURE, V461, P282, DOI 10.1038/nature08296; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; Lai CPK, 2007, CANCER RES, V67, P1545, DOI 10.1158/0008-5472.CAN-06-1396; Lei WB, 2001, J BIOL CHEM, V276, P16720, DOI 10.1074/jbc.M100207200; Li S, 2011, ENDOCRINOLOGY, V152, P2342, DOI 10.1210/en.2010-1216; Ma WH, 2009, J PHARMACOL EXP THER, V328, P409, DOI 10.1124/jpet.108.146365; MacVicar BA, 2010, TRENDS NEUROSCI, V33, P93, DOI 10.1016/j.tins.2009.11.007; Maeda S, 2009, NATURE, V458, P597, DOI 10.1038/nature07869; Moreno AP, 2002, CIRC RES, V90, P450, DOI 10.1161/hh0402.105667; Morley GE, 1996, BIOPHYS J, V70, P1294, DOI 10.1016/S0006-3495(96)79686-8; Qiu F, 2009, AM J PHYSIOL-CELL PH, V296, pC250, DOI 10.1152/ajpcell.00433.2008; Qu Y, 2011, J IMMUNOL, V186, P6553, DOI 10.4049/jimmunol.1100478; Seminario-Vidal L, 2011, J BIOL CHEM, V286, P26277, DOI 10.1074/jbc.M111.260562; Silverman WR, 2009, J BIOL CHEM, V284, P18143, DOI 10.1074/jbc.M109.004804; Sosinsky GE, 2011, CHANNELS, V5, P193, DOI 10.4161/chan.5.3.15765; Su W, 2009, MOL PHARMACOL, V75, P437, DOI 10.1124/mol.108.053298; Wang JJ, 2010, J GEN PHYSIOL, V136, P515, DOI 10.1085/jgp.201010440; Williams DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007474; ZAGOTTA WN, 1990, SCIENCE, V250, P568, DOI 10.1126/science.2122520	30	190	194	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					11303	11311		10.1074/jbc.M111.323378	http://dx.doi.org/10.1074/jbc.M111.323378			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22311983	Green Published, hybrid			2022-12-25	WOS:000302780100061
J	de la Fuente, M; Noble, DN; Verma, S; Nieman, MT				de la Fuente, Maria; Noble, Daniel N.; Verma, Sheetal; Nieman, Marvin T.			Mapping Human Protease-activated Receptor 4 (PAR4) Homodimer Interface to Transmembrane Helix 4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SWISS-MODEL WORKSPACE; COUPLED RECEPTORS; THROMBIN RECEPTOR; HUMAN PLATELETS; ERYTHROPOIETIN RECEPTOR; ENDOTHELIAL-CELLS; LEUCINE-ZIPPER; RHODOPSIN; SPECIFICITY; MEMBRANE	Thrombin activates platelets by binding and cleaving protease-activated receptors 1 and 4 (PAR1 and PAR4). Because of the importance of PAR4 activation on platelets in humans and mice and emerging roles for PAR4 in other tissues, experiments were done to characterize the interaction between PAR4 homodimers. Bimolecular fluorescence complementation and bioluminescence resonance energy transfer (BRET) were used to examine the PAR4 homodimer interface. In bimolecular fluorescence complementation experiments, PAR4 formed homodimers that were disrupted by unlabeled PAR4 in a concentration-dependent manner, but not by rhodopsin. In BRET experiments, the PAR4 homodimers showed a specific interaction as indicated by a hyperbolic BRET signal in response to increasing PAR4-GFP expression. PAR4 did not interact with rhodopsin in BRET assays. The threshold maximum BRET signal was disrupted in a concentration-dependent manner by unlabeled PAR4. In contrast, rhodopsin was unable to disrupt the BRET signal, indicating that the disruption of the PAR4 homodimer is not due to nonspecific interactions. A panel of rho-PAR4 chimeras and PAR4 point mutants has mapped the dimer interface to hydrophobic residues in transmembrane helix 4. Finally, mutations that disrupted dimer formation had reduced calcium mobilization in response to the PAR4 agonist peptide. These results link the loss of dimer formation to a loss of PAR4 signaling.	[de la Fuente, Maria; Noble, Daniel N.; Verma, Sheetal; Nieman, Marvin T.] Case Western Reserve Univ, Div Hematol Oncol, Cleveland, OH 44106 USA; [Nieman, Marvin T.] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University	Nieman, MT (corresponding author), 10900 Euclid Ave,305C Wood Bldg, Cleveland, OH 44106 USA.	nieman@case.edu			National Institutes of Health [1R01HL098217-01A1]; American Heart Association [10SDG2600021]; American Society for Hematology; Cytometry and Light Microscopy Core Facility of the Comprehensive Cancer Center of Case Western Reserve University; University Hospitals of Cleveland [P30 CA43703]; NATIONAL CANCER INSTITUTE [P30CA043703] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098217] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); American Society for Hematology; Cytometry and Light Microscopy Core Facility of the Comprehensive Cancer Center of Case Western Reserve University; University Hospitals of Cleveland; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R01HL098217-01A1 (to M. N.). This work was also supported by an American Heart Association beginning grant in aid, American Heart Association Scientist Development Grant 10SDG2600021, and an American Society for Hematology Scholar Award. This work was also supported by the Cytometry and Light Microscopy Core Facility of the Comprehensive Cancer Center of Case Western Reserve University and University Hospitals of Cleveland under Grant P30 CA43703.	ADAMUS G, 1991, VISION RES, V31, P17, DOI 10.1016/0042-6989(91)90069-H; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Arora P, 2007, J CELL SCI, V120, P921, DOI 10.1242/jcs.03409; Auge C, 2009, NEUROGASTROENT MOTIL, V21, P1189, DOI 10.1111/j.1365-2982.2009.01310.x; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Boire A, 2005, CELL, V120, P303, DOI 10.1016/j.cell.2004.12.018; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; Cherezov V, 2010, METHODS MOL BIOL, V654, P141, DOI 10.1007/978-1-60761-762-4_8; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; Covic L, 2000, BIOCHEMISTRY-US, V39, P5458, DOI 10.1021/bi9927078; Covic L, 2002, THROMB HAEMOSTASIS, V87, P722, DOI 10.1055/s-0037-1613071; Dangwal S, 2011, ARTERIOSCL THROM VAS, V31, P624, DOI 10.1161/ATVBAHA.110.219105; Falker K, 2011, BIOCHEM J, V436, P469, DOI 10.1042/BJ20101360; Fotiadis D, 2006, CURR OPIN STRUC BIOL, V16, P252, DOI 10.1016/j.sbi.2006.03.013; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Guo W, 2005, P NATL ACAD SCI USA, V102, P17495, DOI 10.1073/pnas.0508950102; Guo W, 2008, EMBO J, V27, P2293, DOI 10.1038/emboj.2008.153; Herrick-Davis K, 2004, BIOCHEMISTRY-US, V43, P13963, DOI 10.1021/bi048398p; Holinstat M, 2007, MOL PHARMACOL, V71, P686, DOI 10.1124/mol.106.029371; Holinstat M, 2006, J BIOL CHEM, V281, P26665, DOI 10.1074/jbc.M602174200; Huber O, 1999, J CELL SCI, V112, P4415; Jastrzebska B, 2011, J STRUCT BIOL, V176, P387, DOI 10.1016/j.jsb.2011.08.016; Kahn ML, 1999, J CLIN INVEST, V103, P879, DOI 10.1172/JCI6042; Kaneider NC, 2007, NAT IMMUNOL, V8, P1303, DOI 10.1038/ni1525; Kubatzky KF, 2001, CURR BIOL, V11, P110, DOI 10.1016/S0960-9822(01)00018-5; Kuliopulos A, 1999, BIOCHEMISTRY-US, V38, P4572, DOI 10.1021/bi9824792; Leger AJ, 2006, CIRCULATION, V113, P1244, DOI 10.1161/CIRCULATIONAHA.105.587758; Li DJ, 2011, J BIOL CHEM, V286, P3805, DOI 10.1074/jbc.M110.118018; Mazharian A, 2007, J BIOL CHEM, V282, P5478, DOI 10.1074/jbc.M609881200; McLaughlin JN, 2007, P NATL ACAD SCI USA, V104, P5662, DOI 10.1073/pnas.0700763104; McMillin SM, 2011, J BIOL CHEM, V286, P28584, DOI 10.1074/jbc.M111.259788; Megyeri M, 2009, J IMMUNOL, V183, P3409, DOI 10.4049/jimmunol.0900879; Mercier JF, 2002, J BIOL CHEM, V277, P44925, DOI 10.1074/jbc.M205767200; Nakanishi-Matsui M, 2000, NATURE, V404, P609, DOI 10.1038/35007085; Nieman MT, 2008, BIOCHEMISTRY-US, V47, P13279, DOI 10.1021/bi801334s; Nieman MT, 2005, FEBS LETT, V579, P25, DOI 10.1016/j.febslet.2004.11.041; Nieman MT, 2004, J PHARMACOL EXP THER, V311, P492, DOI 10.1124/jpet.104.069229; Noordeen NA, 2006, J BIOL CHEM, V281, P22744, DOI 10.1074/jbc.M603233200; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Park PSH, 2004, BIOCHEMISTRY-US, V43, P15643, DOI 10.1021/bi047907k; Pin JP, 2007, PHARMACOL REV, V59, P5, DOI 10.1124/pr.59.1.5; Poirot O, 2003, NUCLEIC ACIDS RES, V31, P3503, DOI 10.1093/nar/gkg522; Prinster SC, 2005, PHARMACOL REV, V57, P289, DOI 10.1124/pr.57.3.1; Quinton TM, 2004, J BIOL CHEM, V279, P18434, DOI 10.1074/jbc.M401431200; Riewald M, 2003, J ENDOTOXIN RES, V9, P317, DOI 10.1179/096805103225002584; Ruan WM, 2004, J BIOL CHEM, V279, P3273, DOI 10.1074/jbc.M309311200; Ruf W, 2003, J THROMB HAEMOST, V1, P1495, DOI 10.1046/j.1538-7836.2003.00300.x; Russell FA, 2010, J NEUROPHYSIOL, V103, P155, DOI 10.1152/jn.00486.2009; Sambrano GR, 2000, J BIOL CHEM, V275, P6819, DOI 10.1074/jbc.275.10.6819; Sambrano GR, 2001, NATURE, V413, P74, DOI 10.1038/35092573; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Sevigny LM, 2011, ARTERIOSCL THROM VAS, V31, pE100, DOI 10.1161/ATVBAHA.111.238261; Simon DI, 2007, J AM COLL CARDIOL, V50, P1548, DOI 10.1016/j.jacc.2007.07.023; Steinhoff M, 2005, ENDOCR REV, V26, P1, DOI 10.1210/er.2003-0025; Strande JL, 2008, J PHARMACOL EXP THER, V324, P1045, DOI 10.1124/jpet.107.133595; Swift S, 2000, J BIOL CHEM, V275, P2627, DOI 10.1074/jbc.275.4.2627; Vellani V, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-61; Voss B, 2007, MOL PHARMACOL, V71, P1399, DOI 10.1124/mol.106.033365; Wang HX, 2009, BIOCHEMISTRY-US, V48, P7132, DOI 10.1021/bi900424h; Whorton MR, 2008, J BIOL CHEM, V283, P4387, DOI 10.1074/jbc.M703346200; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104; Woulfe DS, 2005, J THROMB HAEMOST, V3, P2193, DOI 10.1111/j.1538-7836.2005.01338.x	63	24	24	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					10414	10423		10.1074/jbc.M112.341438	http://dx.doi.org/10.1074/jbc.M112.341438			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22318735	Green Published, hybrid			2022-12-25	WOS:000302167200068
J	Carrillo-de Sauvage, MA; Gomez, A; Ros, CM; Ros-Bernal, F; Martin, ED; Perez-Valles, A; Gallego-Sanchez, JM; Fernandez-Villalba, E; Barcia, C; Barcia, C; Herrero, MT				Angeles Carrillo-de Sauvage, Maria; Gomez, Aurora; Maria Ros, Carmen; Ros-Bernal, Francisco; Martin, Eduardo D.; Perez-Valles, Ana; Gallego-Sanchez, Jose M.; Fernandez-Villalba, Emiliano; Barcia, Carlos, Sr.; Barcia, Carlos, Jr.; Herrero, Maria-Trinidad			CCL2-Expressing Astrocytes Mediate the Extravasation of T Lymphocytes in the Brain. Evidence from Patients with Glioma and Experimental Models In Vivo	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; IMMUNOLOGICAL SYNAPSES; HIGH-CAPACITY; EXPRESSION; MCP-1; CHEMOKINES; IMMUNITY; VECTORS; ANIMALS	CCL2 is a chemokine involved in brain inflammation, but the way in which it contributes to the entrance of lymphocytes in the parenchyma is unclear. Imaging of the cell type responsible for this task and details on how the process takes place in vivo remain elusive. Herein, we analyze the cell type that overexpresses CCL2 in multiple scenarios of T-cell infiltration in the brain and in three different species. We observe that CCL2(+) astrocytes play a part in the infiltration of T-cells in the brain and our analysis shows that the contact of T-cells with perivascular astrocytes occurs, suggesting that may be an important event for lymphocyte extravasation.	[Angeles Carrillo-de Sauvage, Maria; Gomez, Aurora; Maria Ros, Carmen; Ros-Bernal, Francisco; Fernandez-Villalba, Emiliano; Barcia, Carlos, Jr.; Herrero, Maria-Trinidad] Univ Murcia, Sch Med, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Murcia, Spain; [Martin, Eduardo D.] Univ Castilla La Mancha, Inst Invest Discapacidades Neurol IDINE, Albacete, Spain; [Gallego-Sanchez, Jose M.; Barcia, Carlos, Sr.] Hosp Gen Univ Valencia, Dept Neurosurg, Valencia, Spain; [Perez-Valles, Ana] Hosp Gen Univ Valencia, Dept Pathol, Valencia, Spain	CIBERNED; University of Murcia; Universidad de Castilla-La Mancha; Hospital Clinic Universitari de Valencia; Hospital Clinic Universitari de Valencia	Carrillo-de Sauvage, MA (corresponding author), Univ Murcia, Sch Med, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Murcia, Spain.	mtherrer@um.es	Sánchez, José María Gallego/I-3105-2015; BERNAL, FRANCISCO ROS/H-9129-2015; Martín, Eduardo D./V-3344-2017; Villalba, Emiliano Fernández/AAP-1187-2021; Barcia, Carlos/I-8205-2014	Sánchez, José María Gallego/0000-0001-5345-2797; BERNAL, FRANCISCO ROS/0000-0001-9072-929X; Martín, Eduardo D./0000-0003-1768-3488; Barcia, Carlos/0000-0003-0976-4245; HERRERO, MARIA TRINIDAD/0000-0003-4953-1446	Spanish Ministry of Science and Innovation [FIS PI10 02827, SAF 2004 07656 C02-02, SAF 2010 21274, RYC-2010-06729]; Fundacion Seneca [FS/15329/PI/10]; CIBERNED (Centro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas)	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacion Seneca(Fundacion Seneca); CIBERNED (Centro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas)	This work was supported by grants from: the Spanish Ministry of Science and Innovation (FIS PI10 02827, SAF 2004 07656 C02-02, SAF 2010 21274, RYC-2010-06729), Fundacion Seneca (FS/15329/PI/10) and CIBERNED (Centro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barcia C, 2008, J VIROL, V82, P9978, DOI 10.1128/JVI.01326-08; Barcia C, 2007, MOL THER, V15, P2154, DOI 10.1038/sj.mt.6300305; Barcia C, 2009, AM J PATHOL, V175, P786, DOI 10.2353/ajpath.2009.081034; Conductier G, 2010, J NEUROIMMUNOL, V224, P93, DOI 10.1016/j.jneuroim.2010.05.010; delPozo MA, 1997, J CELL BIOL, V137, P493; DELPOZO MA, 1995, J CELL BIOL, V131, P495, DOI 10.1083/jcb.131.2.495; DESBAILLETS I, 1994, INT J CANCER, V58, P240, DOI 10.1002/ijc.2910580216; Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.0027; Glabinski AR, 1996, J IMMUNOL, V156, P4363; OPPENHEIM JJ, 1991, ANNU REV IMMUNOL, V9, P617, DOI 10.1146/annurev.iy.09.040191.003153; Platten M, 2003, ANN NEUROL, V54, P388, DOI 10.1002/ana.10679; Sanchez-Madrid F, 2009, NAT REV MOL CELL BIO, V10, P353, DOI 10.1038/nrm2680; Thomas CE, 2000, P NATL ACAD SCI USA, V97, P7482, DOI 10.1073/pnas.120474397; Van der Voorn P, 1999, AM J PATHOL, V154, P45, DOI 10.1016/S0002-9440(10)65249-2; Zhu X, 2010, J NEUROONCOL; Zirger JM, 2006, VIRAL IMMUNOL, V19, P508, DOI 10.1089/vim.2006.19.508	16	32	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2012	7	2							e30762	10.1371/journal.pone.0030762	http://dx.doi.org/10.1371/journal.pone.0030762			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UV	22319587	Green Published, Green Submitted, gold			2022-12-25	WOS:000301979000014
J	Ramos, D; Ades, C				Ramos, Daniela; Ades, Cesar			Two-Item Sentence Comprehension by a Dog (Canis familiaris)	PLOS ONE			English	Article							COMMUNICATION; ABILITY; SEARCH	Syntax use by non-human animals remains a controversial issue. We present here evidence that a dog may respond to verbal requests composed of two independent terms, one referring to an object and the other to an action to be performed relative to the object. A female mongrel dog, Sofia, was initially trained to respond to action (point and fetch) and object (ball, key, stick, bottle and bear) terms which were then presented as simultaneous, combinatorial requests (e. g. ball fetch, stick point). Sofia successfully responded to object-action requests presented as single sentences, and was able to flexibly generalize her performance across different contexts. These results provide empirical evidence that dogs are able to extract the information contained in complex messages and to integrate it in directed performance, an ability which is shared with other linguistically trained animals and may represent a forerunner of syntactic functioning.	[Ramos, Daniela] Univ Sao Paulo, Fac Vet Med & Anim Sci, Dept Clin Med, Sao Paulo, Brazil; [Ades, Cesar] Univ Sao Paulo, Dept Expt Psychol, Inst Psychol, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Ramos, D (corresponding author), Univ Sao Paulo, Fac Vet Med & Anim Sci, Dept Clin Med, Sao Paulo, Brazil.	daniela.ramos@usp.br			Brazilian National Council for Research and Development - CNPQ (PIBIC)	Brazilian National Council for Research and Development - CNPQ (PIBIC)	Brazilian National Council for Research and Development - CNPQ (PIBIC) funded this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnetta B., 2000, ANIMAL COGNITION, V3, P107, DOI [10.1007/s100710000070, DOI 10.1007/S100710000070, DOI 10.1177/0963721416667718]; Bloom P, 2004, SCIENCE, V304, P1605, DOI 10.1126/science.1099899; Caplan D, 1999, BEHAV BRAIN SCI, V22, P77; Eckstein G, 1949, SCIENCE, V13, P109; Ferreira F, 2002, CURR DIR PSYCHOL SCI, V11, P11, DOI 10.1111/1467-8721.00158; Fukuzawa M, 2005, APPL ANIM BEHAV SCI, V91, P129, DOI 10.1016/j.applanim.2004.08.025; Fukuzawa M, 2005, J COMP PSYCHOL, V119, P117, DOI 10.1037/0735-7036.119.1.117; Gardner RA., 1989, TEACHING SIGN LANGUA; HERMAN LM, 1984, COGNITION, V16, P129, DOI 10.1016/0010-0277(84)90003-9; Herman LM., 2010, INT J COMP PSYCHOL, V23, P310; Kaminski J, 2004, SCIENCE, V304, P1682, DOI 10.1126/science.1097859; Kaminski J, 2008, ANIM COGN, V11, P367, DOI 10.1007/s10071-007-0124-1; Kaminski J, 2009, DEVELOPMENTAL SCI, V12, P831, DOI 10.1111/j.1467-7687.2009.00815.x; Markman EM, 2004, TRENDS COGN SCI, V8, P479, DOI 10.1016/j.tics.2004.09.007; Miklosi A., 2008, DOG BEHAV EVOLUTION; Miklosi A, 2006, ANIM COGN, V9, P81, DOI 10.1007/s10071-005-0008-1; Nowak MA, 2000, NATURE, V404, P495, DOI 10.1038/35006635; Ouattara K, 2009, P NATL ACAD SCI USA, V106, P22026, DOI 10.1073/pnas.0908118106; Ouattara K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007808; Pepperberg IM, 2002, BRAIN BEHAV EVOLUT, V59, P54, DOI 10.1159/000063733; Pilley JW, 2011, BEHAV PROCESS, V86, P184, DOI 10.1016/j.beproc.2010.11.007; Pongracz P, 2003, ETHOLOGY, V109, P809, DOI 10.1046/j.0179-1613.2003.00923.x; Pongracz P, 2001, CAH PSYCHOL COGN, V20, P87; Ramos D, 2009, 31 INT ETH C RENN FR; Ramos D, 2006, UFAW C QUAL LIF HEAR; Riedel J, 2008, ANIM BEHAV, V75, P1003, DOI 10.1016/j.anbehav.2007.08.010; Rossi AP, 2008, ANIM COGN, V11, P329, DOI 10.1007/s10071-007-0122-3; Sarris E. G., 1931, SIND WIR BERECHTIGT; SAVAGERUMBAUGH ES, 1990, DEV PSYCHOBIOL, V23, P599, DOI 10.1002/dev.420230706; SCHUSTERMAN RJ, 1984, PSYCHOL REC, V34, P3, DOI 10.1007/BF03394849; Warden CJ, 1928, Q REV BIOL, V3, P1, DOI 10.1086/394292; YOUNG CA, 1991, APPL ANIM BEHAV SCI, V32, P75, DOI 10.1016/S0168-1591(05)80165-0	32	17	17	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2012	7	2							e29689	10.1371/journal.pone.0029689	http://dx.doi.org/10.1371/journal.pone.0029689			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UG	22312419	Green Published, Green Submitted, gold			2022-12-25	WOS:000301977500002
J	Fitzgerald, JP; Nayak, B; Shanmugasundaram, K; Friedrichs, W; Sudarshan, S; Eid, AA; DeNapoli, T; Parekh, DJ; Gorin, Y; Block, K				Fitzgerald, John P.; Nayak, Bijaya; Shanmugasundaram, Karthigayan; Friedrichs, William; Sudarshan, Sunil; Eid, Assaad A.; DeNapoli, Thomas; Parekh, Dipen J.; Gorin, Yves; Block, Karen			Nox4 Mediates Renal Cell Carcinoma Cell Invasion through Hypoxia-Induced Interleukin 6-and 8-Production	PLOS ONE			English	Article							NF-KAPPA-B; TUMOR-NECROSIS-FACTOR; OXIDASE SUBUNIT NOX4; INDUCIBLE FACTOR-I; ENDOTHELIAL-CELLS; OXIDATIVE STRESS; NAD(P)H OXIDASE; ACTIVATION; EXPRESSION; INFLAMMATION	Background: Inflammatory cytokines are detected in the plasma of patients with renal cell carcinoma (RCC) and are associated with poor prognosis. However, the primary cell type involved in producing inflammatory cytokines and the biological significance in RCC remain unknown. Inflammation is associated with oxidative stress, upregulation of hypoxia inducible factor 1-alpha, and production of pro-inflammatory gene products. Solid tumors are often heterogeneous in oxygen tension together suggesting that hypoxia may play a role in inflammatory processes in RCC. Epithelial cells have been implicated in cytokine release, although the stimuli to release and molecular mechanisms by which they are released remain unclear. AMP-activated protein kinase (AMPK) is a highly conserved sensor of cellular energy status and a role for AMPK in the regulation of cell inflammatory processes has recently been demonstrated. Methods and Principal Findings: We have identified for the first time that interleukin-6 and interleukin-8 (IL-6 and IL-8) are secreted solely from RCC cells exposed to hypoxia. Furthermore, we demonstrate that the NADPH oxidase isoform, Nox4, play a key role in hypoxia-induced IL-6 and IL-8 production in RCC. Finally, we have characterized that enhanced levels of IL-6 and IL-8 result in RCC cell invasion and that activation of AMPK reduces Nox4 expression, IL-6 and IL-8 production, and RCC cell invasion. Conclusions/Significance: Together, our data identify novel mechanisms by which AMPK and Nox4 may be linked to inflammation-induced RCC metastasis and that pharmacological activation of AMPK and/or antioxidants targeting Nox4 may represent a relevant therapeutic intervention to reduce IL-6- and IL-8-induced inflammation and cell invasion in RCC.	[Fitzgerald, John P.; Shanmugasundaram, Karthigayan; Sudarshan, Sunil; Parekh, Dipen J.] Univ Texas Hlth Sci Ctr San Antonio, Dept Urol, San Antonio, TX 78229 USA; [Block, Karen] Univ Texas Hlth Sci Ctr San Antonio, S Texas Vet Hlth Care Syst, Audie L Murphy Mem Hosp Div, San Antonio, TX 78229 USA; [Nayak, Bijaya; Eid, Assaad A.; Gorin, Yves; Block, Karen] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, Div Nephrol, San Antonio, TX 78229 USA; [DeNapoli, Thomas] Univ Texas Hlth Sci Ctr San Antonio, Dept Pathol, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Fitzgerald, JP (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Urol, San Antonio, TX 78229 USA.	block@uthscsa.edu		Gorin, Yves/0000-0003-4048-6925	Veterans Administration Research Service; National Institutes of Health, National Cancer Institute (NCI) [R01:CA131272, K08:CA138774]; Cancer Center Support Grant, National Cancer Institute [5 P30 CA054174-18]; NATIONAL CANCER INSTITUTE [R01CA131272, K08CA138774, P30CA054174] Funding Source: NIH RePORTER	Veterans Administration Research Service(US Department of Veterans Affairs); National Institutes of Health, National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Center Support Grant, National Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Veterans Administration Research Service, Career Scientist Award (KB) and the National Institutes of Health, National Cancer Institute (NCI) grants R01:CA131272 (KB) and K08:CA138774 (SS). This work was also supported in part by the Cancer Center Support Grant, National Cancer Institute, 5 P30 CA054174-18 (DJP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLAY JY, 1992, CANCER RES, V52, P3317; Block K, 2007, J BIOL CHEM, V282, P8019, DOI 10.1074/jbc.M611569200; Block K, 2010, AM J PATHOL, V176, P2447, DOI 10.2353/ajpath.2010.090606; Brar SS, 2002, AM J PHYSIOL-CELL PH, V282, pC1212, DOI 10.1152/ajpcell.00496.2001; Corica FA, 1999, J UROLOGY, V161, P408, DOI 10.1016/S0022-5347(01)61903-7; Csanyi G, 2009, FREE RADICAL BIO MED, V47, P1254, DOI 10.1016/j.freeradbiomed.2009.07.022; Desbaillets I, 1999, ONCOGENE, V18, P1447, DOI 10.1038/sj.onc.1202424; Diebold I, 2010, MOL BIOL CELL, V21, P2087, DOI 10.1091/mbc.E09-12-1003; DOSQUET C, 1994, EUR J CANCER, V30A, P162, DOI 10.1016/0959-8049(94)90079-5; Eid AA, 2010, J BIOL CHEM, V285, P37503, DOI 10.1074/jbc.M110.136796; Feurino LW, 2007, CANCER BIOL THER, V6, P1096, DOI 10.4161/cbt.6.7.4328; Giri DK, 1998, J BIOL CHEM, V273, P14008, DOI 10.1074/jbc.273.22.14008; Hattori Y, 2006, HYPERTENSION, V47, P1183, DOI 10.1161/01.HYP.0000221429.94591.72; Jeong HW, 2009, AM J PHYSIOL-ENDOC M, V296, pE955, DOI 10.1152/ajpendo.90599.2008; Liu J, 2011, UROL ONCOL; Lo YYC, 1996, J BIOL CHEM, V271, P15703, DOI 10.1074/jbc.271.26.15703; MAEDA Y, 1994, J EXP MED, V180, P2297, DOI 10.1084/jem.180.6.2297; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Maranchie JK, 2005, CANCER RES, V65, P9190, DOI 10.1158/0008-5472.CAN-05-2105; Maxwell PH, 1997, P NATL ACAD SCI USA, V94, P8104, DOI 10.1073/pnas.94.15.8104; McCarty MF, 2009, MED HYPOTHESES, V72, P468, DOI 10.1016/j.mehy.2008.12.024; Mittal M, 2007, CIRC RES, V101, P258, DOI 10.1161/CIRCRESAHA.107.148015; Peairs A, 2009, CLIN EXP IMMUNOL, V156, P542, DOI 10.1111/j.1365-2249.2009.03924.x; Reuter S, 2010, FREE RADICAL BIO MED, V49, P1603, DOI 10.1016/j.freeradbiomed.2010.09.006; Schulze-Osthoff K, 1998, EUR J BIOCHEM, V254, P439, DOI 10.1046/j.1432-1327.1998.2540439.x; Schulze-Osthoff K, 1997, IMMUNOBIOLOGY, V198, P35, DOI 10.1016/S0171-2985(97)80025-3; Semenza GL, 2002, TRENDS MOL MED, V8, pS62, DOI 10.1016/S1471-4914(02)02317-1; Shono T, 1996, MOL CELL BIOL, V16, P4231; Wang SX, 2010, CIRC RES, V106, P1117, DOI 10.1161/CIRCRESAHA.109.212530; Webster WS, 2006, CANCER-AM CANCER SOC, V107, P46, DOI 10.1002/cncr.21951; Woodard J, 2010, CANCER BIOL THER, V10, P1169, DOI 10.4161/cbt.10.11.13629; Xu L, 1999, CANCER RES, V59, P5822	32	76	79	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2012	7	1							e30712	10.1371/journal.pone.0030712	http://dx.doi.org/10.1371/journal.pone.0030712			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911GB	22303451	Green Published, Green Submitted, gold			2022-12-25	WOS:000301704200030
J	Huang, QL; Gong, CG; Li, JH; Zhuo, Z; Chen, Y; Wang, J; Hua, ZC				Huang, Qilai; Gong, Chenguang; Li, Jiahuang; Zhuo, Zhu; Chen, Yuan; Wang, Jin; Hua, Zi-Chun			Distance and Helical Phase Dependence of Synergistic Transcription Activation in cis-Regulatory Module	PLOS ONE			English	Article							FACTOR-BINDING-SITES; CRYSTAL-STRUCTURE; DNA RECOGNITION; STRUCTURAL BASIS; GENE; DISCOVERY; ELEMENT; PROTEIN; MECHANISM; GAL4	Deciphering of the spatial and stereospecific constraints on synergistic transcription activation mediated between activators bound to cis-regulatory elements is important for understanding gene regulation and remains largely unknown. It has been commonly believed that two activators will activate transcription most effectively when they are bound on the same face of DNA double helix and within a boundary distance from the transcription initiation complex attached to the TATA box. In this work, we studied the spatial and stereospecific constraints on activation by multiple copies of bound model activators using a series of engineered relative distances and stereospecific orientations. We observed that multiple copies of the activators GAL4-VP16 and ZEBRA bound to engineered promoters activated transcription more effectively when bound on opposite faces of the DNA double helix. This phenomenon was not affected by the spatial relationship between the proximal activator and initiation complex. To explain these results, we proposed the novel concentration field model, which posits the effective concentration of bound activators, and therefore the transcription activation potential, is affected by their stereospecific positioning. These results could be used to understand synergistic transcription activation anew and to aid the development of predictive models for the identification of cis-regulatory elements.	[Huang, Qilai; Gong, Chenguang; Li, Jiahuang; Zhuo, Zhu; Chen, Yuan; Wang, Jin; Hua, Zi-Chun] Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Nanjing, Jiangsu, Peoples R China; [Huang, Qilai; Gong, Chenguang; Li, Jiahuang; Zhuo, Zhu; Chen, Yuan; Wang, Jin; Hua, Zi-Chun] Nanjing Univ, Affiliated Stomatol Hosp, Nanjing, Jiangsu, Peoples R China; [Huang, Qilai; Hua, Zi-Chun] Macau Univ Sci & Technol, State Key Lab Qual Res Chinese Med, Macau, Peoples R China; [Huang, Qilai; Hua, Zi-Chun] Macau Univ Sci & Technol, Macau Inst Appl Res Med, Macau, Peoples R China; [Huang, Qilai; Hua, Zi-Chun] Nanjing Univ, Changzhou High Tech Res Inst, Changzhou, Peoples R China; [Huang, Qilai; Hua, Zi-Chun] Jiangsu TargetPharma Labs Inc, Changzhou, Peoples R China	Nanjing University; Nanjing University; Macau University of Science & Technology; Macau University of Science & Technology; Nanjing University	Huang, QL (corresponding author), Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Nanjing, Jiangsu, Peoples R China.	jwang@nju.edu.cn; huazc@nju.edu.cn	z, z/HHN-3970-2022; Huang, Qilai/B-4725-2015; z, z/GXZ-4805-2022; Gong, Chenguang/F-5791-2014; Z, Z/AEN-2153-2022	Huang, Qilai/0000-0002-4252-3980; 	National Natural Science Foundation of China [90208021, 39970184, 79970116]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (90208021, 39970184, 79970116 to JW; http://www.nsfc.gov.cn/e_nsfc/desktop/zn/0101.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts B, 2002, MOL BIOL CELL; Beer MA, 2004, CELL, V117, P185, DOI 10.1016/S0092-8674(04)00304-6; Benfante R, 2005, BIOCHEM J, V386, P63, DOI 10.1042/BJ20041294; Blais A, 2005, GENE DEV, V19, P1499, DOI 10.1101/gad.1325605; Brown BL, 2011, J BIOL CHEM, V286, P2285, DOI 10.1074/jbc.M110.172643; Brutinel ED, 2009, J BACTERIOL, V191, P3811, DOI 10.1128/JB.00002-09; Bussemaker HJ, 2001, NAT GENET, V27, P167, DOI 10.1038/84792; CAREY M, 1992, J VIROL, V66, P4803, DOI 10.1128/JVI.66.8.4803-4813.1992; Carey M, 1998, CELL, V92, P5, DOI 10.1016/S0092-8674(00)80893-4; CAREY M, 1990, NATURE, V345, P361, DOI 10.1038/345361a0; CHI TH, 1993, MOL CELL BIOL, V13, P7045, DOI 10.1128/MCB.13.11.7045; Cliften P, 2003, SCIENCE, V301, P71, DOI 10.1126/science.1084337; Collins T, 2001, MOL CELL BIOL, V21, P3609, DOI 10.1128/MCB.21.11.3609-3615.2001; Cooper GM, 2003, CURR OPIN GENET DEV, V13, P604, DOI 10.1016/j.gde.2003.10.001; CRESS WD, 1991, SCIENCE, V251, P87, DOI 10.1126/science.1846049; Dong W, 2006, ACTA BIOCH BIOPH SIN, V38, P780, DOI 10.1111/j.1745-7270.2006.00220.x; Elemento O, 2007, MOL CELL, V28, P337, DOI 10.1016/j.molcel.2007.09.027; FLEMINGTON EK, 1992, J VIROL, V66, P922, DOI 10.1128/JVI.66.2.922-929.1992; Gertz J, 2009, NATURE, V457, P215, DOI 10.1038/nature07521; GINIGER E, 1988, P NATL ACAD SCI USA, V85, P382, DOI 10.1073/pnas.85.2.382; GROGAN E, 1987, P NATL ACAD SCI USA, V84, P1332, DOI 10.1073/pnas.84.5.1332; GuhaThakurta D, 2001, BIOINFORMATICS, V17, P608, DOI 10.1093/bioinformatics/17.7.608; Gupta M, 2005, P NATL ACAD SCI USA, V102, P7079, DOI 10.1073/pnas.0408743102; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Harley VR, 2003, P NATL ACAD SCI USA, V100, P7045, DOI 10.1073/pnas.1137864100; Hong MQ, 2008, STRUCTURE, V16, P1019, DOI 10.1016/j.str.2008.03.015; Huang QL, 2006, J IMMUNOL METHODS, V309, P130, DOI 10.1016/j.jim.2005.11.009; JANSON L, 1990, P NATL ACAD SCI USA, V87, P4732, DOI 10.1073/pnas.87.12.4732; Johnson KM, 2002, GENE DEV, V16, P1852, DOI 10.1101/gad.995702; Kadonaga JT, 2004, CELL, V116, P247, DOI 10.1016/S0092-8674(03)01078-X; Lewin, 2000, GENES-BASEL; Li T, 1998, NUCLEIC ACIDS RES, V26, P5707, DOI 10.1093/nar/26.24.5707; Liberati C, 1999, J MOL BIOL, V285, P1441, DOI 10.1006/jmbi.1998.2384; LIN YS, 1990, NATURE, V345, P359, DOI 10.1038/345359a0; MARMORSTEIN R, 1992, NATURE, V356, P408, DOI 10.1038/356408a0; MARMORSTEIN R, 1994, GENE DEV, V8, P2504, DOI 10.1101/gad.8.20.2504; MARTINEZ E, 1987, EMBO J, V6, P3719, DOI 10.1002/j.1460-2075.1987.tb02706.x; Mo Y, 2001, J MOL BIOL, V314, P495, DOI 10.1006/jmbi.2001.5138; MOSSING MC, 1986, SCIENCE, V233, P889, DOI 10.1126/science.3090685; Murphy KF, 2007, P NATL ACAD SCI USA, V104, P12726, DOI 10.1073/pnas.0608451104; Newberry KJ, 2004, J BIOL CHEM, V279, P20356, DOI 10.1074/jbc.M400960200; Pearce D, 1998, J BIOL CHEM, V273, P30081, DOI 10.1074/jbc.273.46.30081; Petosa C, 2006, MOL CELL, V21, P565, DOI 10.1016/j.molcel.2006.01.006; Pilpel Y, 2001, NAT GENET, V29, P153, DOI 10.1038/ng724; Ptashne M, 1997, NATURE, V386, P569, DOI 10.1038/386569a0; Roberts SGE, 2000, CELL MOL LIFE SCI, V57, P1149, DOI 10.1007/PL00000755; RUDEN DM, 1988, P NATL ACAD SCI USA, V85, P4262, DOI 10.1073/pnas.85.12.4262; SADOWSKI I, 1988, NATURE, V335, P563, DOI 10.1038/335563a0; Sayle RA, 1995, TRENDS BIOCH SCI, P20; SCHUMACHER MA, 1994, SCIENCE, V266, P763, DOI 10.1126/science.7973627; SEGAL R, 1991, J BIOL CHEM, V266, P20406; SMITH KP, 1995, J BIOL CHEM, V270, P4484, DOI 10.1074/jbc.270.9.4484; TAYLOR ICA, 1991, GENE DEV, V5, P1285, DOI 10.1101/gad.5.7.1285; THOMPSON JF, 1988, NUCLEIC ACIDS RES, V16, P9687, DOI 10.1093/nar/16.20.9687; Tompa M, 2005, NAT BIOTECHNOL, V23, P137, DOI 10.1038/nbt1053; USHIDA C, 1990, NUCLEIC ACIDS RES, V18, P6325, DOI 10.1093/nar/18.21.6325; Vallania F, 2009, P NATL ACAD SCI USA, V106, P5117, DOI 10.1073/pnas.0900473106; Vandenbon A, 2010, NUCLEIC ACIDS RES, V38, P17, DOI 10.1093/nar/gkp866; Vardhanabhuti S, 2007, NUCLEIC ACIDS RES, V35, P3203, DOI 10.1093/nar/gkm201; Wasserman WW, 2004, NAT REV GENET, V5, P276, DOI 10.1038/nrg1315; Wasserman WW, 2000, NAT GENET, V26, P225, DOI 10.1038/79965; WING HJ, 1995, J BACTERIOL, V177, P6704, DOI 10.1128/jb.177.23.6704-6710.1995; Wray GA, 2003, MOL BIOL EVOL, V20, P1377, DOI 10.1093/molbev/msg140; WU L, 1988, GENE DEV, V2, P403, DOI 10.1101/gad.2.4.403; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Yokoyama KD, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp423; Yu XP, 2006, NUCLEIC ACIDS RES, V34, P4925, DOI 10.1093/nar/gkl595	67	10	10	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2012	7	1							e31198	10.1371/journal.pone.0031198	http://dx.doi.org/10.1371/journal.pone.0031198			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KO	22299056	Green Published, gold, Green Submitted			2022-12-25	WOS:000305693600002
J	Wikan, N; Sakoonwatanyoo, P; Ubol, S; Yoksan, S; Smith, DR				Wikan, Nitwara; Sakoonwatanyoo, Prirayapak; Ubol, Sukathida; Yoksan, Sutee; Smith, Duncan R.			Chikungunya Virus Infection of Cell Lines: Analysis of the East, Central and South African Lineage	PLOS ONE			English	Article							AEDES-ALBOPICTUS; REUNION ISLAND; OUTBREAK; EPIDEMIC; FEVER; DISEASE; GLOBALIZATION; ESTABLISHMENT; REEMERGENCE; EMERGENCE	Chikungunya virus (CHIKV) is a re-emerging mosquito borne alphavirus that has caused large scale epidemics in the countries around the Indian Ocean, as well as leading to autochthonous transmission in some European countries. The transmission of the disease has been driven by the emergence of an African lineage of CHIKV with enhanced transmission and dissemination in Aedes mosquito hosts. Two main genotypes of this lineage have been circulating, characterized by the presence of a substitution of a valine for an alanine at position 226 of the E1 protein. The outbreak, numbering in millions of cases in the infected areas, has been associated with increasing numbers of cases with non-classical presentation including encephalitis and meningitis. This study sought to compare the original Ross strain with two isolates from the recent outbreak of chikungunya fever in respect of infectivity and the induction of apoptosis in eight mammalian cell lines and two insect cell lines, in addition to generating a comprehensive virus production profile for one of the newer isolates. Results showed that in mammalian cells there were few differences in either tropism or pathogenicity as assessed by induction of apoptosis with the exception of Hela cells were the recent valine isolate showed less infectivity. The Aedes albopictus C6/36 cell line was however significantly more permissive for both of the more recent isolates than the Ross strain. The results suggest that the increased infectivity seen in insect cells derives from an evolution of the CHIKV genome not solely associated with the E1:226 substitution.	[Wikan, Nitwara; Yoksan, Sutee; Smith, Duncan R.] Mahidol Univ, Inst Mol Biosci, Bangkok 10700, Thailand; [Sakoonwatanyoo, Prirayapak] Navamindradhiraj Univ, Fac Med, Vajira Hosp, Dept Clin Pathol, Bangkok, Thailand; [Ubol, Sukathida] Mahidol Univ, Fac Sci, Dept Microbiol, Bangkok 10400, Thailand; [Ubol, Sukathida; Yoksan, Sutee; Smith, Duncan R.] Mahidol Univ, Ctr Emerging & Neglected Infect Dis, Bangkok 10700, Thailand	Mahidol University; Mahidol University; Mahidol University	Wikan, N (corresponding author), Mahidol Univ, Inst Mol Biosci, Bangkok 10700, Thailand.	duncan_r_smith@hotmail.com	Wikan, Nitwara/V-9296-2017; Smith, Duncan R/C-6891-2011; Wikan, Nitwara/GSN-6014-2022	Wikan, Nitwara/0000-0002-0708-0328; Smith, Duncan R/0000-0002-6592-9852; Wikan, Nitwara/0000-0002-0708-0328	Office of the Higher Education Commission; Mahidol University under the National Research Universities Initiative; Mahidol University; TRF	Office of the Higher Education Commission; Mahidol University under the National Research Universities Initiative; Mahidol University; TRF(Thailand Research Fund (TRF))	This work was supported by grants from the Office of the Higher Education Commission and Mahidol University under the National Research Universities Initiative and Mahidol University. N.W. is supported by a TRF and Mahidol University (Thai Royal Golden Jubilee) Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIKAT BK, 1964, INDIAN J MED RES, V52, P660; Arankalle VA, 2007, J GEN VIROL, V88, P1967, DOI 10.1099/vir.0.82714-0; Beesoon S, 2008, EMERG INFECT DIS, V14, P337, DOI 10.3201/eid1402.071024; Bhavana K, 2008, INT J PEDIATR OTORHI, V72, P257, DOI 10.1016/j.ijporl.2007.09.022; Blair CD, 2011, FUTURE MICROBIOL, V6, P265, DOI [10.2217/FMB.11.11, 10.2217/fmb.11.11]; Bordi L, 2008, CLIN INFECT DIS, V47, P428, DOI 10.1086/589925; Borgherini G, 2007, CLIN INFECT DIS, V44, P1401, DOI 10.1086/517537; Brackney DE, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000856; Charrel RN, 2007, NEW ENGL J MED, V356, P769, DOI 10.1056/NEJMp078013; Chen LH, 2010, CURR OPIN INFECT DIS, V23, P438, DOI 10.1097/QCO.0b013e32833c1d16; Cherian SS, 2009, INFECT GENET EVOL, V9, P16, DOI 10.1016/j.meegid.2008.09.004; Chow A, 2011, J INFECT DIS, V203, P149, DOI 10.1093/infdis/jiq042; Chua H H, 2010, Med J Malaysia, V65, P83; Chusri S, 2011, AM J TROP MED HYG, V85, P386, DOI 10.4269/ajtmh.2011.10-0725; Das S, 2007, J Commun Dis, V39, P37; Das T, 2010, PROG NEUROBIOL, V91, P121, DOI 10.1016/j.pneurobio.2009.12.006; de Lamballerie X, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-33; Gerardin P, 2008, PLOS MED, V5, P413, DOI 10.1371/journal.pmed.0050060; Grandadam M, 2011, EMERG INFECT DIS, V17, P910, DOI 10.3201/eid1705.101873; Hapuarachchi HC, 2010, J GEN VIROL, V91, P1067, DOI 10.1099/vir.0.015743-0; Her ZS, 2010, J IMMUNOL, V184, P5903, DOI 10.4049/jimmunol.0904181; Her Z, 2009, MICROBES INFECT, V11, P1165, DOI 10.1016/j.micinf.2009.09.004; JACOBS JP, 1970, NATURE, V227, P168, DOI 10.1038/227168a0; Jaffar-Bandjee MC, 2010, EXPERT REV ANTI-INFE, V8, P987, DOI [10.1586/eri.10.92, 10.1586/ERI.10.92]; JANABI N, 1995, NEUROSCI LETT, V195, P105, DOI 10.1016/0304-3940(94)11792-H; Josseran L, 2006, EMERG INFECT DIS, V12, P1994; KANAMITSU M, 1979, AM J TROP MED HYG, V28, P351, DOI 10.4269/ajtmh.1979.28.351; Ketting RF, 2011, DEV CELL, V20, P148, DOI 10.1016/j.devcel.2011.01.012; Khan AH, 2002, J GEN VIROL, V83, P3075, DOI 10.1099/0022-1317-83-12-3075; Krejbich-Trotot P, 2011, FASEB J, V25, P314, DOI 10.1096/fj.10-164178; Labadie K, 2010, J CLIN INVEST, V120, P894, DOI 10.1172/JCI40104; Lalitha P, 2007, AM J OPHTHALMOL, V144, P552, DOI 10.1016/j.ajo.2007.06.002; Manimunda SP, 2007, EMERG INFECT DIS, V13, P1259, DOI 10.3201/eid1308.070193; MARCHETTE N J, 1980, Southeast Asian Journal of Tropical Medicine and Public Health, V11, P14; Mittal A, 2007, ARCH OPHTHALMOL-CHIC, V125, P1381, DOI 10.1001/archopht.125.10.1381; Mittal A, 2007, OPHTHALMOLOGY, V114, P1798, DOI 10.1016/j.ophtha.2007.03.045; Nandha B, 2009, Indian J Public Health, V53, P209; Ng LC, 2010, INFECT GENET EVOL, V10, P876, DOI 10.1016/j.meegid.2010.07.012; Paupy C, 2009, MICROBES INFECT, V11, P1177, DOI 10.1016/j.micinf.2009.05.005; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Pialoux G, 2007, LANCET INFECT DIS, V7, P319, DOI 10.1016/S1473-3099(07)70107-X; Powers AM, 2000, J GEN VIROL, V81, P471, DOI 10.1099/0022-1317-81-2-471; Pulmanausahakul R, 2011, INT J INFECT DIS, V15, pE671, DOI 10.1016/j.ijid.2011.06.002; Rampal, 2007, J Assoc Physicians India, V55, P765; Rampal, 2007, J Assoc Physicians India, V55, P598; Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6; ROBINSON M C, 1955, Trans R Soc Trop Med Hyg, V49, P28, DOI [10.1016/0035-9203(57)90022-6, 10.1016/0035-9203(55)90080-8]; ROSS R. W., 1956, JOUR HYG, V54, P177; Sam IC, 2010, TROP BIOMED, V27, P343; Santhosh SR, 2008, VIRUS RES, V135, P36, DOI 10.1016/j.virusres.2008.02.004; SARKAR JK, 1964, INDIAN J MED RES, V52, P684; Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263; Schwartz O, 2010, NAT REV MICROBIOL, V8, P491, DOI 10.1038/nrmicro2368; Simon F, 2008, MED CLIN N AM, V92, P1323, DOI 10.1016/j.mcna.2008.07.008; SINGH KRP, 1967, CURR SCI INDIA, V36, P506; Sissoko D, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000389; Solignat M, 2009, VIROLOGY, V393, P183, DOI 10.1016/j.virol.2009.07.024; Soumahoro MK, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001197; Soumahoro MK, 2009, PLOS ONE, V4, pA221, DOI 10.1371/journal.pone.0007800; Sourisseau M, 2007, PLOS PATHOG, V3, P804, DOI 10.1371/journal.ppat.0030089; Staples JE, 2009, CLIN INFECT DIS, V49, P942, DOI 10.1086/605496; Sudeep AB, 2008, J BIOSCIENCES, V33, P443, DOI 10.1007/s12038-008-0063-2; SUNDSTROM C, 1976, INT J CANCER, V17, P565, DOI 10.1002/ijc.2910170504; Theamboonlers A, 2009, JPN J INFECT DIS, V62, P303; Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201; Tsetsarkin KA, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-376; Tsetsarkin KA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006835	67	67	68	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2012	7	1							e31102	10.1371/journal.pone.0031102	http://dx.doi.org/10.1371/journal.pone.0031102			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911GB	22299053	gold, Green Published, Green Submitted			2022-12-25	WOS:000301704200061
J	Lev, A; Simon, AJ; Bareket, M; Bielorai, B; Hutt, D; Amariglio, N; Rechavi, G; Somech, R				Lev, Atar; Simon, Amos J.; Bareket, Mor; Bielorai, Bella; Hutt, Daphna; Amariglio, Ninette; Rechavi, Gideon; Somech, Raz			The Kinetics of Early T and B Cell Immune Recovery after Bone Marrow Transplantation in RAG-2-Deficient SCID Patients	PLOS ONE			English	Article							VERSUS-HOST-DISEASE; SEVERE COMBINED IMMUNODEFICIENCY; ALLOGENEIC TRANSPLANTATION; REPERTOIRE DIVERSITY; NEGATIVE SELECTION; LEUKEMIA PATIENTS; THYMIC OUTPUT; RECONSTITUTION; LYMPHOCYTES; DEFICIENCY	The kinetics of T and B cell immune recovery after bone marrow transplantation (BMT) is affected by many pre- and post-transplant factors. Because of the profoundly depleted baseline T and B cell immunity in recombination activating gene 2 (RAG-2)-deficient severe combined immunodeficiency (SCID) patients, some of these factors are eliminated, and the immune recovery after BMT can then be clearly assessed. This process was followed in ten SCID patients in parallel to their associated transplant-related complications. Early peripheral presence of T and B cells was observed in 8 and 4 patients, respectively. The latter correlated with pre-transplant conditioning therapy. Cells from these patients carried mainly signal joint DNA episomes, indicative of newly derived B and T cells. They were present before the normalization of the T cell receptor (TCR) and the B cell receptor (BCR) repertoire. Early presentation of the ordered TCR gene rearrangements after BMT occurred simultaneously, but this pattern was heterogeneous over time, suggesting different and individual thymic recovery processes. Our findings early after transplant could suggest the long-term patients' clinical outcome. Early peripheral presence of newly produced B and T lymphocytes from their production and maturation sites after BMT suggests donor stem cell origin rather than peripheral expansion, and is indicative of successful outcome. Peripheral detection of TCR excision circles and kappa-deleting recombination excision circles in RAG-2-deficient SCID post-BMT are early markers of T and B cell reconstitution, and can be used to monitor outcome and tailor specific therapy for patients undergoing BMT.	[Lev, Atar; Simon, Amos J.; Amariglio, Ninette; Rechavi, Gideon; Somech, Raz] Canc Res Ctr, Tel Hashomer, Israel; [Lev, Atar; Simon, Amos J.; Bareket, Mor; Bielorai, Bella; Hutt, Daphna; Amariglio, Ninette; Rechavi, Gideon; Somech, Raz] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel; [Lev, Atar; Simon, Amos J.; Bareket, Mor; Somech, Raz] Jeffery Modell Fdn JMF Ctr, Pediat Immunol Serv, Tel Hashomer, Israel; [Bielorai, Bella; Hutt, Daphna] Safra Childrens Hosp, Sheba Med Ctr, Div Pediat Hematol Oncol, Tel Hashomer, Israel; [Bielorai, Bella; Hutt, Daphna] Safra Childrens Hosp, Sheba Med Ctr, Bone Marrow Transplantat Unit, Tel Hashomer, Israel; [Amariglio, Ninette] Sheba Med Ctr, Hematol Lab, Tel Hashomer, Israel	Tel Aviv University; Sackler Faculty of Medicine; Chaim Sheba Medical Center; Chaim Sheba Medical Center; Chaim Sheba Medical Center	Lev, A (corresponding author), Canc Res Ctr, Tel Hashomer, Israel.	rsomech@hotmail.com		Hutt, Daphna/0000-0003-4354-5193				Amariglio N, 2010, PEDIATR RES, V67, P211, DOI 10.1203/PDR.0b013e3181c6e554; [Anonymous], 2011, EBMT ESID GUID HEM S; Bains I, 2009, J IMMUNOL, V183, P4329, DOI 10.4049/jimmunol.0900743; Brown L, 2011, BLOOD, V117, P3243, DOI 10.1182/blood-2010-08-300384; Buckley RH, 1999, NEW ENGL J MED, V340, P508, DOI 10.1056/NEJM199902183400703; Cavadini P, 2005, J CLIN INVEST, V115, P728, DOI 10.1172/JCI200523087; Champlin RE, 2000, BLOOD, V95, P3702; Clave E, 2009, BLOOD, V113, P6477, DOI 10.1182/blood-2008-09-176594; Cuvelier GDE, 2009, CLIN IMMUNOL, V131, P179, DOI 10.1016/j.clim.2009.01.003; Dik WA, 2005, J EXP MED, V201, P1715, DOI 10.1084/jem.20042524; Farge D, 2005, ARTHRITIS RHEUM, V52, P1555, DOI 10.1002/art.21036; FRY AM, 1989, SCIENCE, V246, P1044, DOI 10.1126/science.2511630; Giver CR, 2004, IMMUNOL RES, V29, P269, DOI 10.1385/IR:29:1-3:269; Godthelp BC, 1999, BLOOD, V94, P4358, DOI 10.1182/blood.V94.12.4358.424k02_4358_4369; Griffith LM, 2009, J ALLERGY CLIN IMMUN, V124, P1152, DOI 10.1016/j.jaci.2009.10.022; Hazenberg MD, 2003, NAT IMMUNOL, V4, P97, DOI 10.1038/ni0203-97; Heitger A, 2000, TRANSPLANTATION, V69, P2366, DOI 10.1097/00007890-200006150-00026; Hochberg EP, 2001, BLOOD, V98, P1116, DOI 10.1182/blood.V98.4.1116; HODES RJ, 1989, SCIENCE, V246, P1041, DOI 10.1126/science.2587987; Lamb LS, 1998, BONE MARROW TRANSPL, V21, P461; Lev A, 2010, BONE MARROW TRANSPL, V45, P1084, DOI 10.1038/bmt.2009.314; Lewin SR, 2002, BLOOD, V100, P2235, DOI 10.1182/blood.V100.6.2235.h81802002235_2235_2242; Motta M, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-111; NOSSAL GJV, 1994, CELL, V76, P229, DOI 10.1016/0092-8674(94)90331-X; Olkinuora H, 2007, BONE MARROW TRANSPL, V39, P149, DOI 10.1038/sj.bmt.1705557; Peterson P, 2008, NAT REV IMMUNOL, V8, P948, DOI 10.1038/nri2450; Puck JM, 2007, J ALLERGY CLIN IMMUN, V120, P760, DOI 10.1016/j.jaci.2007.08.043; Roifman CM, 2008, BONE MARROW TRANSPL, V41, P947, DOI 10.1038/bmt.2008.11; Sarantopoulos S, 2007, CLIN CANCER RES, V13, P6107, DOI 10.1158/1078-0432.CCR-07-1290; Sarantopoulos S, 2009, BLOOD, V113, P3865, DOI 10.1182/blood-2008-09-177840; Sarzotti M, 2003, J IMMUNOL, V170, P2711, DOI 10.4049/jimmunol.170.5.2711; Serana F, 2010, J IMMUNOL, V185, P7713, DOI 10.4049/jimmunol.1001770; Somech R, 2009, J ALLERGY CLIN IMMUN, V124, P793, DOI 10.1016/j.jaci.2009.06.048; Sottini A, 2010, CLIN IMMUNOL, V136, P217, DOI 10.1016/j.clim.2010.04.005; Storek J, 2002, TRANSPLANTATION, V73, P1154, DOI 10.1097/00007890-200204150-00026; Storek J, 2001, BLOOD, V98, P3505, DOI 10.1182/blood.V98.13.3505; Talvensarri K, 2002, BLOOD, V99, P1458, DOI 10.1182/blood.V99.4.1458; van Dongen JJM, 2003, LEUKEMIA, V17, P2257, DOI 10.1038/sj.leu.2403202; van Zelm MC, 2007, J EXP MED, V204, P645, DOI 10.1084/jem.20060964; Wu CJ, 2000, BLOOD, V95, P352; Ye P, 2002, CRIT REV IMMUNOL, V22, P483	41	44	44	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e30494	10.1371/journal.pone.0030494	http://dx.doi.org/10.1371/journal.pone.0030494			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910ME	22295088	Green Published, Green Submitted, gold			2022-12-25	WOS:000301640600033
J	Maatouk, I; Wild, B; Wesche, D; Herzog, W; Raum, E; Muller, H; Rothenbacher, D; Stegmaier, C; Schellberg, D; Brenner, H				Maatouk, Imad; Wild, Beate; Wesche, Daniela; Herzog, Wolfgang; Raum, Elke; Mueller, Heiko; Rothenbacher, Dietrich; Stegmaier, Christa; Schellberg, Dieter; Brenner, Hermann			Elderly People with Diabetes: Results of a German Cohort Study	PLOS ONE			English	Article							QUALITY-OF-LIFE; HEALTH SURVEY; ASSOCIATION; POPULATION; DEPRESSION; ADULTS; COMPLICATIONS; VARIABLES; REDUCE; RISK	Background: The aim of the study was to determine predictors that influence health-related quality of life (HRQOL) in a large cohort of elderly diabetes patients from primary care over a follow-up period of five years. Methods and Results: At the baseline measurement of the ESTHER cohort study (2000-2002), 1375 out of 9953 participants suffered from diabetes (13.8%). 1057 of these diabetes patients responded to the second-follow up (2005-2007). HRQOL at baseline and follow-up was measured using the SF-12; mental component scores (MCS) and physical component scores (PCS) were calculated; multiple linear regression models were used to determine predictors of HRQOL at follow-up. As possible predictors for HRQOL, the following baseline variables were examined: treatment with insulin, glycated hemoglobin (HbA1c), number of diabetes related complications, number of comorbid diseases, Body-Mass-Index (BMI), depression and HRQOL. Regression analyses were adjusted for sociodemographic variables and smoking status. 1034 patients (97.8%) responded to the SF-12 both at baseline and after five years and were therefore included in the study. Regression analyses indicated that significant predictors of decreased MCS were a lower HRQOL, a higher number of diabetes related complications and a reported history of depression at baseline. Complications, BMI, smoking and HRQOL at baseline significantly predicted PCS at the five year follow-up. Conclusions: Our findings expand evidence from previous cross-sectional data indicating that in elderly diabetes patients, depression, diabetes related complications, smoking and BMI are temporally predictive for HRQOL.	[Maatouk, Imad; Wild, Beate; Wesche, Daniela; Herzog, Wolfgang; Schellberg, Dieter] Med Univ Hosp Heidelberg, Dept Gen Internal Med & Psychosomat, Heidelberg, Germany; [Raum, Elke; Mueller, Heiko; Rothenbacher, Dietrich; Brenner, Hermann] German Canc Res Ctr, Div Clin Epidemiol & Aging Res, D-6900 Heidelberg, Germany; [Rothenbacher, Dietrich] Univ Ulm, Inst Epidemiol & Med Biometry, Ulm, Germany; [Stegmaier, Christa] Saarland Minist Publ Hlth, Saarland Canc Registry, Saarbrucken, Germany	Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ulm University	Maatouk, I (corresponding author), Med Univ Hosp Heidelberg, Dept Gen Internal Med & Psychosomat, Heidelberg, Germany.	imad.maatouk@med.uni-heidelberg.de	Brenner, Hermann/ABE-6383-2020; Brenner, Hermann/B-4627-2017	Brenner, Hermann/0000-0002-6129-1572; Brenner, Hermann/0000-0002-6129-1572	Baden Wurttemberg Ministry of Science, Research and Arts; German Federal Ministry of Education and Research; German Federal Ministry of Family, Senior Citizens, Women and Youth; German Ministry of Research and Education [01ET0718]	Baden Wurttemberg Ministry of Science, Research and Arts; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); German Federal Ministry of Family, Senior Citizens, Women and Youth; German Ministry of Research and Education(Federal Ministry of Education & Research (BMBF))	The ESTHER study was funded by grants from the Baden Wurttemberg Ministry of Science, Research and Arts, the German Federal Ministry of Education and Research and the German Federal Ministry of Family, Senior Citizens, Women and Youth. This analysis was done as part of the consortium "Multimorbidity and frailty at old age: epidemiology, biology, psychiatric comorbidity, medical care and costs" funded by the German Ministry of Research and Education (grant number 01ET0718). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahola AJ, 2010, NEPHROL DIAL TRANSPL, V25, P1903, DOI 10.1093/ndt/gfp709; Ali S, 2010, DIABETES-METAB RES, V26, P75, DOI 10.1002/dmrr.1065; BENDEL RB, 1977, J AM STAT ASSOC, V72, P46, DOI 10.2307/2286904; Damush TM, 2002, J AGING HEALTH, V14, P195, DOI 10.1177/089826430201400202; Glasgow RE, 1997, DIABETES CARE, V20, P562, DOI 10.2337/diacare.20.4.562; Haley WE, 2011, QUAL LIFE RES, V20, P799, DOI 10.1007/s11136-010-9810-6; Hopman WM, 2006, QUAL LIFE RES, V15, P527, DOI 10.1007/s11136-005-2096-4; HOSMER DW, 1989, APPL LOGISTIC REGRES; Jimenez-Garcia R, 2008, DIABETES CARE, V31, P90, DOI 10.2337/dc07-1382; Jorm AF, 2000, PSYCHOL MED, V30, P11, DOI 10.1017/S0033291799001452; Landman GWD, 2010, DIABETES CARE, V33, P2378, DOI 10.2337/dc10-0979; Low M, 2004, DEUT MED WOCHENSCHR, V129, P2643, DOI 10.1055/s-2004-836089; Nelson JC, 2008, AM J GERIAT PSYCHIAT, V16, P558, DOI 10.1097/JGP.0b013e3181693288; Peyrot M, 2010, DIABETES CARE, V33, P240, DOI 10.2337/dc09-1348; Richards JB, 2007, ARCH INTERN MED, V167, P188, DOI 10.1001/archinte.167.2.188; Rose M, 2002, DIABETES CARE, V25, P35, DOI 10.2337/diacare.25.1.35; Rubin RR, 1999, DIABETES-METAB RES, V15, P205, DOI 10.1002/(SICI)1520-7560(199905/06)15:3<205::AID-DMRR29>3.0.CO;2-O; Selim A, 2009, QUAL LIFE RES, V18, P43, DOI 10.1007/s11136-008-9418-2; Simson U, 2008, DIABETIC MED, V25, P206, DOI 10.1111/j.1464-5491.2007.02370.x; Spiro, 2004, IMPUTING PHYS MENTAL; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; Testa MA, 1996, NEW ENGL J MED, V334, P835, DOI 10.1056/NEJM199603283341306; Tokuda Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003985; UK Prospective Diabetes Study Grp, 1999, DIABETES CARE, V22, P1125; *UN, 2005, POP CHALL DEV GOALS; Vitry AI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014024; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; WEINBERGER M, 1994, MED CARE, V32, P1173, DOI 10.1097/00005650-199412000-00002; Wikman A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018952; Wild B, 2012, INT J GERIATR PSYCH, V27, P375, DOI 10.1002/gps.2728; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Williamson DA, 2009, ARCH INTERN MED, V169, P163, DOI 10.1001/archinternmed.2008.544; WILSON IB, 1995, JAMA-J AM MED ASSOC, V273, P59, DOI 10.1001/jama.273.1.59	33	36	37	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2012	7	1							e31088	10.1371/journal.pone.0031088	http://dx.doi.org/10.1371/journal.pone.0031088			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	910LV	22292092	gold, Green Published, Green Submitted			2022-12-25	WOS:000301639600068
J	Liu, H; Ning, H; Men, HC; Hou, R; Fu, MG; Zhang, HL; Liu, JG				Liu, Huan; Ning, Huan; Men, Hongchao; Hou, Rong; Fu, Mingui; Zhang, Hailin; Liu, Jianguo			Regulation of CCL5 Expression in Smooth Muscle Cells Following Arterial Injury	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; INTERFERON-INDUCIBLE PROTEIN-10; CARDIOVASCULAR RISK MARKERS; NATURAL-KILLER-CELLS; FACTOR-KAPPA-B; TRANSCRIPTION FACTOR; IN-VIVO; NEOINTIMA FORMATION; GENE-TRANSCRIPTION; IMMUNE-RESPONSES	Chemokines play a crucial role in inflammation and in the pathophysiology of atherosclerosis by recruiting inflammatory immune cells to the endothelium. Chemokine CCL5 has been shown to be involved in atherosclerosis progression. However, little is known about how CCL5 is regulated in vascular smooth muscle cells. In this study we report that CCL5 mRNA expression was induced and peaked in aorta at day 7 and then declined after balloon artery injury, whereas IP-10 and MCP-1 mRNA expression were induced and peaked at day 3 and then rapidly declined. The expression of CCL5 receptors (CCR1, 3 & 5) were also rapidly induced and then declined except CCR5 which expression was still relatively high at day 14 after balloon injury. In rat smooth muscle cells (SMCs), similar as in aorta CCL5 mRNA expression was induced and kept increasing after LPS plus IFN-gamma stimulation, whereas IP-10 mRNA expression was rapidly induced and then declined. Our data further indicate that induction of CCL5 expression in SMCs was mediated by IRF-1 via binding to the IRF-1 response element in CCL5 promoter. Moreover, p38 MAPK was involved in suppression of CCL5 and IP-10 expression in SMCs through common upstream molecule MKK3. The downstream molecule MK2 was required for p38-mediated CCL5 but not IP-10 inhibition. Our findings indicate that CCL5 induction in aorta and SMCs is mediated by IRF-1 while activation of p38 MAPK signaling inhibits CCL5 and IP-10 expression. Methods targeting MK2 expression could be used to selectively regulate CCL5 but not IP-10 expression in SMCs.	[Liu, Huan; Men, Hongchao; Zhang, Hailin] Hebei Med Univ, Dept Pharmacol, Shijiazhuang, Peoples R China; [Liu, Huan] Heibei N Univ, Coll Med, Zhangjiakou, Peoples R China; [Ning, Huan; Hou, Rong; Liu, Jianguo] St Louis Univ, Sch Med, Dept Internal Med, Div Infect Dis Allergy & Immunol, St Louis, MO USA; [Fu, Mingui] Univ Missouri Kansas City, Sch Med, Dept Basic Med Sci, Kansas City, MO USA; [Fu, Mingui] Univ Missouri Kansas City, Shock Trauma Res Ctr, Kansas City, MO USA	Hebei Medical University; Saint Louis University; University of Missouri System; University of Missouri Kansas City; University of Missouri System; University of Missouri Kansas City	Liu, H (corresponding author), Hebei Med Univ, Dept Pharmacol, Shijiazhuang, Peoples R China.	zhanghl@hebmu.edu.cn; jliu9@slu.edu	NING, HUAN/R-4786-2018		National Natural Science Foundation of China [30730031]; 973 Program [2007CB512100]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 Program(National Basic Research Program of China)	Start-up fund to JL; National Natural Science Foundation of China (30730031) and the 973 Program (2007CB512100) to HZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appay V, 2001, TRENDS IMMUNOL, V22, P83, DOI 10.1016/S1471-4906(00)01812-3; Baggiolini M, 1998, NATURE, V392, P565, DOI 10.1038/33340; Beyaert R, 1996, EMBO J, V15, P1914, DOI 10.1002/j.1460-2075.1996.tb00542.x; Bjorkbacka H, 2006, CURR OPIN LIPIDOL, V17, P527; Braunersreuther V, 2008, ARTERIOSCL THROM VAS, V28, P1090, DOI 10.1161/ATVBAHA.108.165423; Braunersreuther V, 2007, ARTERIOSCL THROM VAS, V27, P373, DOI 10.1161/01.ATV.0000253886.44609.ae; CLOWES AW, 1983, LAB INVEST, V49, P208; Duncan GS, 1996, J EXP MED, V184, P2043, DOI 10.1084/jem.184.5.2043; Erickson L, 2004, TRANSPL IMMUNOL, V13, P169, DOI 10.1016/j.trim.2004.06.003; Erridge C, 2010, J LEUKOCYTE BIOL, V87, P989, DOI 10.1189/jlb.1209775; Giese NA, 1997, J EXP MED, V186, P1535, DOI 10.1084/jem.186.9.1535; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; GUNTHER S, 1982, J CELL BIOL, V92, P289, DOI 10.1083/jcb.92.2.289; Hansson GK, 2006, NAT REV IMMUNOL, V6, P508, DOI 10.1038/nri1882; Hertzog PJ, 2003, TRENDS IMMUNOL, V24, P534, DOI 10.1016/j.it.2003.08.006; Hou R, 2006, J CELL BIOL, V173, P417, DOI 10.1083/jcb.200508121; Hou R, 2009, J BIOL CHEM, V284, P6955, DOI 10.1074/jbc.M809333200; Koh SJ, 2009, INT J CARDIOL, V132, P102, DOI 10.1016/j.ijcard.2007.10.038; Kovacic JC, 2010, J CLIN INVEST, V120, P303, DOI 10.1172/JCI40364; Krohn R, 2007, CIRCULATION, V116, P1812, DOI 10.1161/CIRCULATIONAHA.107.708016; Lee AH, 2000, BIOCHEM J, V350, P131, DOI 10.1042/0264-6021:3500131; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; Levy JA, 2009, J IMMUNOL, V182, P3945, DOI 10.4049/jimmunol.0990015; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Liu JG, 2005, J BIOL CHEM, V280, P24347, DOI 10.1074/jbc.M500973200; Liu JG, 2003, J EXP MED, V198, P1265, DOI 10.1084/jem.20030026; Liu JG, 2006, J BIOL CHEM, V281, P19188, DOI 10.1074/jbc.M602059200; Lohoff M, 2000, J EXP MED, V192, P325, DOI 10.1084/jem.192.3.325; Luster AD, 1998, NEW ENGL J MED, V338, P436, DOI 10.1056/NEJM199802123380706; MATSUYAMA T, 1993, CELL, V75, P83, DOI 10.1016/S0092-8674(05)80086-8; Ogasawara K, 1998, NATURE, V391, P700, DOI 10.1038/35636; Ohmori Y, 1997, J BIOL CHEM, V272, P14899, DOI 10.1074/jbc.272.23.14899; Ohteki T, 1998, J EXP MED, V187, P967, DOI 10.1084/jem.187.6.967; Raines EW, 2005, J LIPID RES, V46, P1081, DOI 10.1194/jlr.R500004-JLR200; Rollins BJ, 1997, BLOOD, V90, P909, DOI 10.1182/blood.V90.3.909.909_909_928; Rothenbacher D, 2006, ARTERIOSCL THROM VAS, V26, P194, DOI 10.1161/01.ATV.0000191633.52585.14; SCHALL TJ, 1988, J IMMUNOL, V141, P1018; Schober A, 2002, CIRCULATION, V106, P1523, DOI 10.1161/01.CIR.0000028590.02477.6F; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Sikorski K, 2011, AM J PHYSL CELL PHYS; Taki S, 1997, IMMUNITY, V6, P673, DOI 10.1016/S1074-7613(00)80443-4; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; TAUB DD, 1993, J EXP MED, V177, P1809, DOI 10.1084/jem.177.6.1809; Tedgui A, 2006, PHYSIOL REV, V86, P515, DOI 10.1152/physrev.00024.2005; Torella D, 2007, AM J PHYSIOL-HEART C, V292, pH2935, DOI 10.1152/ajpheart.00887.2006; Veillard NR, 2004, CIRC RES, V94, P253, DOI 10.1161/01.RES.0000109793.17591.4E; von Hundelshausen P, 2001, CIRCULATION, V103, P1772, DOI 10.1161/01.CIR.103.13.1772; Wang XK, 1996, J BIOL CHEM, V271, P24286, DOI 10.1074/jbc.271.39.24286; Weber KSC, 1999, EUR J IMMUNOL, V29, P700, DOI 10.1002/(SICI)1521-4141(199902)29:02<700::AID-IMMU700>3.0.CO;2-1; Zhang JD, 2010, J BIOL CHEM, V285, P21269, DOI 10.1074/jbc.M110.100818	51	15	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30873	10.1371/journal.pone.0030873	http://dx.doi.org/10.1371/journal.pone.0030873			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22292067	Green Submitted, gold, Green Published			2022-12-25	WOS:000301570600091
J	Okamoto, S; Sato, M; Toda, T; Yamamoto, M				Okamoto, Shin-ya; Sato, Masamitsu; Toda, Takashi; Yamamoto, Masayuki			SCF Ensures Meiotic Chromosome Segregation Through a Resolution of Meiotic Recombination Intermediates	PLOS ONE			English	Article							FISSION YEAST SKP1; BOX DNA HELICASE; F-BOX; SCHIZOSACCHAROMYCES-POMBE; RHP51-DEPENDENT RECOMBINATION; UBIQUITIN LIGASE; DISTINCT ROLES; PROTEIN; MEIOSIS; CENTROMERE	The SCF (Skp1-Cul1-F-box) complex contributes to a variety of cellular events including meiotic cell cycle control, but its function during meiosis is not understood well. Here we describe a novel function of SCF/Skp1 in meiotic recombination and subsequent chromosome segregation. The skp1 temperature-sensitive mutant exhibited abnormal distribution of spindle microtubules in meiosis II, which turned out to originate from abnormal bending of the spindle in meiosis I. Bent spindles were reported in mitosis of this mutant, but it remained unknown how SCF could affect spindle morphology. We found that the meiotic bent spindle in skp1 cells was due to a hypertension generated by chromosome entanglement. The spindle bending was suppressed by inhibiting double strand break (DSB) formation, indicating that the entanglement was generated by the meiotic recombination machinery. Consistently, Rhp51/Rad51-Rad22/Rad52 foci persisted until meiosis I in skp1 cells, proving accumulation of recombination intermediates. Intriguingly bent spindles were also observed in the mutant of Fbh1, an F-box protein containing the DNA helicase domain, which is involved in meiotic recombination. Genetic evidence suggested its cooperation with SCF/Skp1. Thus, SCF/Skp1 together with Fbh1 is likely to function in the resolution of meiotic recombination intermediates, thereby ensuring proper chromosome segregation.	[Okamoto, Shin-ya; Sato, Masamitsu; Yamamoto, Masayuki] Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Tokyo 113, Japan; [Sato, Masamitsu] Japan Sci & Technol Agcy, PRESTO, Honcho Kawaguchi, Saitama, Japan; [Toda, Takashi] Lincolns Inn Fields Labs, Canc Res UK, Lab Cell Regulat, London Res Inst, London, England; [Yamamoto, Masayuki] Kazusa DNA Res Inst, Kisarazu, Chiba, Japan	University of Tokyo; Japan Science & Technology Agency (JST); Cancer Research UK; Kazusa DNA Research Institute	Okamoto, S (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Tokyo 113, Japan.	masasato@biochem.s.u-tokyo.ac.jp	Okamoto, Shin-ya/C-8175-2017		Japan Society for the Promotion of Science (JSPS); PRESTO of JST; Global COE; Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; Cancer Research UK; Grants-in-Aid for Scientific Research [21227007] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); PRESTO of JST; Global COE(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Cancer Research UK(Cancer Research UK); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	MS and MY are supported by Grants-in-Aid from Japan Society for the Promotion of Science (JSPS) and also by a PRESTO program of JST (MS) and a Global COE program (MY) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan. TT is supported by Cancer Research UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akamatsu Y, 2007, EMBO J, V26, P1352, DOI 10.1038/sj.emboj.7601582; Bachrati CZ, 2003, BIOCHEM J, V374, P577, DOI 10.1042/BJ20030491; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Barbour L, 2003, MUTAT RES-FUND MOL M, V532, P137, DOI 10.1016/j.mrfmmm.2003.08.014; Branzei D, 2008, NAT REV MOL CELL BIO, V9, P297, DOI 10.1038/nrm2351; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Cooper JP, 1997, NATURE, V385, P744, DOI 10.1038/385744a0; Cromie GA, 2008, GENETICS, V179, P1157, DOI 10.1534/genetics.108.088955; Du LL, 2003, MOL CELL BIOL, V23, P6150, DOI 10.1128/MCB.23.17.6150-6158.2003; Harrison C, 2005, EMBO J, V24, P599, DOI 10.1038/sj.emboj.7600536; Hermand D, 2003, J BIOL CHEM, V278, P9671, DOI 10.1074/jbc.M211358200; Jallepalli PV, 1998, P NATL ACAD SCI USA, V95, P8159, DOI 10.1073/pnas.95.14.8159; Jourdain I, 2009, BIOCHEM J, V420, P169, DOI 10.1042/BJ20081659; Katayama S, 2002, MOL BIOL CELL, V13, P211, DOI 10.1091/mbc.01-07-0333; Kominami K, 1998, GENES CELLS, V3, P721, DOI 10.1046/j.1365-2443.1998.00225.x; Kominami K, 1997, GENE DEV, V11, P1548, DOI 10.1101/gad.11.12.1548; Kurokawa Y, 2008, PLOS BIOL, V6, P836, DOI 10.1371/journal.pbio.0060088; Lehmann A, 2004, GENES CELLS, V9, P367, DOI 10.1111/j.1356-9597.2004.00730.x; Lehmann A, 2004, FEBS LETT, V566, P77, DOI 10.1016/j.febslet.2004.04.022; LIN YK, 1994, GENETICS, V136, P769; Mamnun YM, 2006, BIOCHEM BIOPH RES CO, V350, P125, DOI 10.1016/j.bbrc.2006.09.024; MAUNDRELL K, 1993, GENE, V123, P127, DOI 10.1016/0378-1119(93)90551-D; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Morishita T, 2005, MOL CELL BIOL, V25, P8074, DOI 10.1128/MCB.25.18.8074-8083.2005; MURIS DFR, 1993, NUCLEIC ACIDS RES, V21, P4586, DOI 10.1093/nar/21.19.4586; Octobre G, 2008, GENETICS, V178, P2399, DOI 10.1534/genetics.107.085696; Osman F, 2005, MOL CELL BIOL, V25, P8084, DOI 10.1128/MCB.25.18.8084-8096.2005; Petronczki M, 2003, CELL, V112, P423, DOI 10.1016/S0092-8674(03)00083-7; Saitoh S, 1997, CELL, V90, P131, DOI 10.1016/S0092-8674(00)80320-7; Sakaguchi C, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-27; Sakuno T, 2009, CHROMOSOME RES, V17, P239, DOI 10.1007/s10577-008-9013-y; Sato M, 2009, METHODS MOL BIOL, V545, P185, DOI 10.1007/978-1-60327-993-2_11; Sharif WD, 2002, CELL CHROMOSOME, V1, P1; Sun W, 2011, NUCLEIC ACIDS RES, V39, P1718, DOI 10.1093/nar/gkq977; Sunnerhagen P, 2007, MOL GENET GENOMICS, V277, P341, DOI 10.1007/s00438-007-0221-5; Takayama Y, 2010, DEV CELL, V18, P385, DOI 10.1016/j.devcel.2009.12.024; Watanabe Y, 1999, NATURE, V400, P461, DOI 10.1038/22774; Wolf DA, 1999, CURR BIOL, V9, P373, DOI 10.1016/S0960-9822(99)80165-1; Yokobayashi S, 2005, CELL, V123, P803, DOI 10.1016/j.cell.2005.09.013; Young JA, 2004, GENETICS, V167, P593, DOI 10.1534/genetics.103.023762	40	11	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30622	10.1371/journal.pone.0030622	http://dx.doi.org/10.1371/journal.pone.0030622			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22292001	gold, Green Published, Green Submitted			2022-12-25	WOS:000301570600065
J	Wu, J; Lee, SW; Zhang, X; Han, F; Kwan, SY; Yuan, X; Yang, WL; Jeong, YS; Rezaeian, AH; Gao, Y; Zeng, YX; Lin, HK				Wu, J.; Lee, S-W; Zhang, X.; Han, F.; Kwan, S-Y; Yuan, X.; Yang, W-L; Jeong, Y. S.; Rezaeian, A. H.; Gao, Y.; Zeng, Y-X; Lin, H-K			Foxo3a transcription factor is a negative regulator of Skp2 and Skp2 SCF complex	ONCOGENE			English	Article						Foxo3a; Skp2 SCF complex; ubiquitination	CDK INHIBITOR P27; CELL-CYCLE; UBIQUITIN LIGASE; PROMOTES TUMORIGENESIS; DEPENDENT REGULATION; CANCER PROGRESSION; DEGRADATION; P27(KIP1); SENESCENCE; EXPRESSION	Skp2 (S-phase kinase-associated protein-2) SCF complex displays E3 ligase activity and oncogenic activity by regulating protein ubiquitination and degradation, in turn regulating cell cycle entry, senescence and tumorigenesis. The maintenance of the integrity of Skp2 SCF complex is critical for its E3 ligase activity. The Skp2 F-box protein is a rate-limiting step and key factor in this complex, which binds to its protein substrates and triggers ubiquitination and degradation of its substrates. Skp2 is found to be overexpressed in numerous human cancers, which has an important role in tumorigenesis. The molecular mechanism by which the function of Skp2 and Skp2 SCF complex is regulated remains largely unknown. Here we show that Foxo3a transcription factor is a novel and negative regulator of Skp2 SCF complex. Foxo3a is found to be a transcriptional repressor of Skp2 gene expression by directly binding to the Skp2 promoter, thereby inhibiting Skp2 protein expression. Surprisingly, we found for the first time that Foxo3a also displays a transcription-independent activity by directly interacting with Skp2 and disrupting Skp2 SCF complex formation, in turn inhibiting Skp2 SCF E3 ligase activity and promoting p27 stability. Finally, we show that the oncogenic activity of Skp2 is repressed by Foxo3a overexpression. Our results not only reveal novel insights into how Skp2 SCF complex is regulated, but also establish a new role for Foxo3a in tumor suppression through a transcription-dependent and independent manner. Oncogene (2013) 32, 78-85; doi:10.1038/onc.2012.26; published online 6 February 2012	[Wu, J.; Lee, S-W; Zhang, X.; Han, F.; Kwan, S-Y; Yuan, X.; Yang, W-L; Jeong, Y. S.; Rezaeian, A. H.; Gao, Y.; Lin, H-K] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Wu, J.; Zeng, Y-X] Sun Yat Sen Univ Canc Ctr, Dept Expt Res, Guangzhou, Guangdong, Peoples R China; [Wu, J.; Zeng, Y-X] Sun Yat Sen Univ Canc Ctr, State Key Lab Oncol S China, Guangzhou, Guangdong, Peoples R China; [Lee, S-W; Zhang, X.; Han, F.; Kwan, S-Y; Yang, W-L; Jeong, Y. S.; Gao, Y.; Lin, H-K] Univ Texas Grad Sch Biomed Sci Houston, Houston, TX USA; [Wu, J.] Guangzhou Med Univ, Canc Hosp, Canc Ctr, Guangzhou, Guangdong, Peoples R China	University of Texas System; UTMD Anderson Cancer Center; Sun Yat Sen University; Sun Yat Sen University; Guangzhou Medical University	Lin, HK (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA.	hklin@mdanderson.org	kwan, suet yan/AAH-3974-2020; Rezaeian, Abdol-Hossein/AAV-6900-2021; Yang, Wei-Lei/E-2598-2012	Zhang, Xian/0000-0001-9674-7886	MD Anderson Trust Scholar Fund; National Cancer Institute's Prostate Cancer Specialized Program of Research Excellence (SPORE) development grant at the MD Anderson Cancer Center; NIH; CPRIT; DOD; NATIONAL CANCER INSTITUTE [R01CA136787, R01CA149321, P50CA140388] Funding Source: NIH RePORTER	MD Anderson Trust Scholar Fund; National Cancer Institute's Prostate Cancer Specialized Program of Research Excellence (SPORE) development grant at the MD Anderson Cancer Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CPRIT; DOD(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Drs ME Greenberg, WR Sellers, VA Boussiotis and D Bohmann for providing the reagents. We are grateful to Dr Lin's lab members for their insightful comments and suggestions. We extend our special thanks to S Zhang and Dr Z Han for their technical support. This work was supported by the MD Anderson Trust Scholar Fund, the National Cancer Institute's Prostate Cancer Specialized Program of Research Excellence (SPORE) development grant at the MD Anderson Cancer Center, NIH RO1 grants, CPRIT grant, and DOD New Investigator Award to HKL.	Appleman LJ, 2006, CELL CYCLE, V5, P2123, DOI 10.4161/cc.5.18.3139; Barre B, 2007, EMBO J, V26, P4841, DOI 10.1038/sj.emboj.7601899; Bashir T, 2004, NATURE, V428, P190, DOI 10.1038/nature02330; Bloom J, 2003, SEMIN CANCER BIOL, V13, P41, DOI 10.1016/S1044-579X(02)00098-6; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Chan CH, 2011, J MOL MED, V89, P857, DOI 10.1007/s00109-011-0766-y; Chan CH, 2010, THESCIENTIFICWORLDJO, V10, P1001, DOI 10.1100/tsw.2010.89; Chan CH, 2010, NAT CELL BIOL, V12, P457, DOI 10.1038/ncb2047; Chu IM, 2008, NAT REV CANCER, V8, P253, DOI 10.1038/nrc2347; Dansen TB, 2008, TRENDS CELL BIOL, V18, P421, DOI 10.1016/j.tcb.2008.07.004; Gao DM, 2009, NAT CELL BIOL, V11, P397, DOI 10.1038/ncb1847; Hershko DD, 2008, CANCER-AM CANCER SOC, V112, P1415, DOI 10.1002/cncr.23317; Hu MCT, 2004, CELL, V117, P225, DOI 10.1016/S0092-8674(04)00302-2; Huang H, 2005, P NATL ACAD SCI USA, V102, P1649, DOI 10.1073/pnas.0406789102; Imaki H, 2003, CANCER RES, V63, P4607; Jonason JH, 2007, CELL CYCLE, V6, P951, DOI 10.4161/cc.6.8.4104; Lin HK, 2004, NATURE, V431, P205, DOI 10.1038/nature02783; Lin HK, 2010, NATURE, V464, P374, DOI 10.1038/nature08815; Lin HK, 2009, NAT CELL BIOL, V11, P420, DOI 10.1038/ncb1849; Liu JD, 2002, MOL CELL, V10, P1511, DOI 10.1016/S1097-2765(02)00783-9; Majumder PK, 2008, CANCER CELL, V14, P146, DOI 10.1016/j.ccr.2008.06.002; Mamillapalli R, 2001, CURR BIOL, V11, P263, DOI 10.1016/S0960-9822(01)00065-3; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Nakayama K, 2000, EMBO J, V19, P2069, DOI 10.1093/emboj/19.9.2069; Nakayama K, 2004, DEV CELL, V6, P661, DOI 10.1016/S1534-5807(04)00131-5; Nakayama KI, 2005, SEMIN CELL DEV BIOL, V16, P323, DOI 10.1016/j.semcdb.2005.02.010; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Reichert M, 2007, CANCER RES, V67, P4149, DOI 10.1158/0008-5472.CAN-06-4484; Sarmento LM, 2005, J EXP MED, V202, P157, DOI 10.1084/jem.20050559; Schneider G, 2006, EMBO J, V25, P3801, DOI 10.1038/sj.emboj.7601259; Sicinski P, 2007, GENE DEV, V21, P1703, DOI 10.1101/gad.1583207; Tran H, 2002, SCIENCE, V296, P530, DOI 10.1126/science.1068712; van Duijn PW, 2006, PROSTATE, V66, P749, DOI 10.1002/pros.20398; Wang F, 2012, ONCOGENE, V31, P1546, DOI 10.1038/onc.2011.347; Wang HB, 2010, NAT GENET, V42, P83, DOI 10.1038/ng.498; Wang IC, 2005, MOL CELL BIOL, V25, P10875, DOI 10.1128/MCB.25.24.10875-10894.2005; Wei W, 2004, NATURE, V428, P194, DOI 10.1038/nature02381; Yang JY, 2008, NAT CELL BIOL, V10, P138, DOI 10.1038/ncb1676; Yang JY, 2009, CLIN CANCER RES, V15, P752, DOI 10.1158/1078-0432.CCR-08-0124; Yang WL, 2009, SCIENCE, V325, P1134, DOI 10.1126/science.1175065; Young AP, 2008, NAT CELL BIOL, V10, P361, DOI 10.1038/ncb1699; Zhang L, 2006, ONCOGENE, V25, P2615, DOI 10.1038/sj.onc.1209286; Zheng JY, 2002, MOL CELL, V10, P1519, DOI 10.1016/S1097-2765(02)00784-0; Zuo T, 2007, J CLIN INVEST, V117, P3765, DOI 10.1172/JCI32538	44	31	33	1	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JAN	2013	32	1					78	85		10.1038/onc.2012.26	http://dx.doi.org/10.1038/onc.2012.26			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	063VG	22310285	Green Accepted			2022-12-25	WOS:000313029500008
J	Liu, SL; Premont, RT; Rockey, DC				Liu, Songling; Premont, Richard T.; Rockey, Don C.			G-protein-coupled Receptor Kinase Interactor-1 (GIT1) Is a New Endothelial Nitric-oxide Synthase (eNOS) Interactor with Functional Effects on Vascular Homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE-ACTIVATING PROTEINS; EPIDERMAL-GROWTH-FACTOR; PLASMALEMMAL CAVEOLAE; PHOSPHORYLATION SITES; PORTAL-HYPERTENSION; ANGIOTENSIN-II; IN-VIVO; TRANSLOCATION; CELLS; FAMILY	Endothelial cell nitric-oxide (NO) synthase (eNOS), the enzyme responsible for synthesis of NO in the vasculature, undergoes extensive post-translational modifications that modulate its activity. Here we have identified a novel eNOS interactor, G-protein-coupled receptor (GPCR) kinase interactor-1 (GIT1), which plays an unexpected role in GPCR stimulated NO signaling. GIT1 interacted with eNOS in the endothelial cell cytoplasm, and this robust association was associated with stimulatory eNOS phosphorylation (Ser(1177)), enzyme activation, and NO synthesis. GIT1 knockdown had the opposite effect. Additionally, GIT1 expression was reduced in sinusoidal endothelial cells after liver injury, consistent with previously described endothelial dysfunction in this disease. Re-expression of GIT1 after liver injury rescued the endothelial phenotype. These data emphasize the role of GPCR signaling partners in eNOS function and have fundamental implications for vascular disorders involving dysregulated eNOS.	[Liu, Songling; Rockey, Don C.] Univ Texas SW Med Ctr Dallas, Div Digest & Liver Dis, Dallas, TX 75390 USA; [Premont, Richard T.] Duke Univ, Med Ctr, Div Gastroenterol, Durham, NC 27710 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Duke University	Rockey, DC (corresponding author), 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	don.rockey@utsouthwestern.edu		Premont, Richard/0000-0002-8053-5026	National Institutes of Health [R01 DK 57830]; American Liver Fund Liver Scholar Award; Burroughs Welcome Fund Translational Scientist Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057830] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Liver Fund Liver Scholar Award; Burroughs Welcome Fund Translational Scientist Award(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DK 57830 (to D. C. R.).; Recipient of a American Liver Fund Liver Scholar Award.; Recipient of a Burroughs Welcome Fund Translational Scientist Award.	Bakir S, 2000, CIRCULATION, V101, P2342, DOI 10.1161/01.CIR.101.20.2342; BUSCONI L, 1993, J BIOL CHEM, V268, P8410; BUSSE R, 1990, FEBS LETT, V265, P133, DOI 10.1016/0014-5793(90)80902-U; Cao S, 2001, J BIOL CHEM, V276, P14249, DOI 10.1074/jbc.M006258200; Connelly L, 2005, J BIOL CHEM, V280, P10040, DOI 10.1074/jbc.M411991200; Dedio J, 2001, FASEB J, V15, P79, DOI 10.1096/fj.00-0078com; Dessy C, 2000, EMBO J, V19, P4272, DOI 10.1093/emboj/19.16.4272; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Dudzinski DM, 2007, CARDIOVASC RES, V75, P247, DOI 10.1016/j.cardiores.2007.03.023; Dudzinski DM, 2006, ANNU REV PHARMACOL, V46, P235, DOI 10.1146/annurev.pharmtox.44.101802.121844; Dulin NO, 1999, MOL CELL BIOL, V19, P714; Fernandez-Hernando C, 2006, J CELL BIOL, V174, P369, DOI 10.1083/jcb.200601051; Figueroa XF, 2002, J PHYSIOL-LONDON, V544, P883, DOI 10.1113/jphysiol.2002.021972; Fleming I, 2001, CIRC RES, V88, pE68, DOI 10.1161/hh1101.092677; Freedman NJ, 1997, J BIOL CHEM, V272, P17734, DOI 10.1074/jbc.272.28.17734; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Fulton D, 2002, J BIOL CHEM, V277, P4277, DOI 10.1074/jbc.M106302200; Gallis B, 1999, J BIOL CHEM, V274, P30101, DOI 10.1074/jbc.274.42.30101; Garcia-Cardena G, 1998, NATURE, V392, P821, DOI 10.1038/33934; GarciaCardena G, 1996, J BIOL CHEM, V271, P27237, DOI 10.1074/jbc.271.44.27237; Goetz RM, 1999, P NATL ACAD SCI USA, V96, P2788, DOI 10.1073/pnas.96.6.2788; Govers R, 2002, J HISTOCHEM CYTOCHEM, V50, P779, DOI 10.1177/002215540205000604; Haendeler J, 2003, J BIOL CHEM, V278, P49936, DOI 10.1074/jbc.M307317200; Hoefen RJ, 2006, J CELL SCI, V119, P1469, DOI 10.1242/jcs.02925; Isshiki M, 1998, P NATL ACAD SCI USA, V95, P5009, DOI 10.1073/pnas.95.9.5009; Jones CA, 2009, NAT CELL BIOL, V11, P1325, DOI 10.1038/ncb1976; Ju H, 1997, J BIOL CHEM, V272, P18522, DOI 10.1074/jbc.272.30.18522; Kim S, 2003, J BIOL CHEM, V278, P6291, DOI 10.1074/jbc.M212287200; Ko J, 2003, J NEUROSCI, V23, P1667; Lieu AS, 2006, J NEUROSURG, V105, P103, DOI 10.3171/jns.2006.105.1.103; Liu SL, 2005, NAT MED, V11, P952, DOI 10.1038/nm1289; Liu SL, 2003, J BIOL CHEM, V278, P49929, DOI 10.1074/jbc.M306930200; LOSCALZO J, 1995, PROG CARDIOVASC DIS, V38, P87, DOI 10.1016/S0033-0620(05)80001-5; Manabe R, 2002, J CELL SCI, V115, P1497; Meyer MZ, 2006, J BIOL CHEM, V281, P7919, DOI 10.1074/jbc.M600081200; Michel JB, 1997, J BIOL CHEM, V272, P15583, DOI 10.1074/jbc.272.25.15583; Nambi P, 1997, MOL CELL BIOCHEM, V175, P29, DOI 10.1023/A:1006827007251; Nayal A, 2004, CURR OPIN CELL BIOL, V16, P94, DOI 10.1016/j.ceb.2003.11.007; Nishida CR, 1998, J BIOL CHEM, V273, P5566, DOI 10.1074/jbc.273.10.5566; Pang JJ, 2011, J MOL CELL CARDIOL, V51, P769, DOI 10.1016/j.yjmcc.2011.06.020; Pang JJ, 2009, CIRCULATION, V119, P1524, DOI 10.1161/CIRCULATIONAHA.108.823997; Pott C, 2006, AM J PHYSIOL-CELL PH, V290, pC1437, DOI 10.1152/ajpcell.00005.2005; Prabhakar P, 2000, J BIOL CHEM, V275, P19416, DOI 10.1074/jbc.M001952200; Prabhakar P, 1998, J BIOL CHEM, V273, P27383, DOI 10.1074/jbc.273.42.27383; Prasad SVN, 2001, J BIOL CHEM, V276, P18953, DOI 10.1074/jbc.M102376200; Premont RT, 2004, CELL SIGNAL, V16, P1001, DOI 10.1016/j.cellsig.2004.02.002; Premont RT, 1998, P NATL ACAD SCI USA, V95, P14082, DOI 10.1073/pnas.95.24.14082; Rockey DC, 1998, GASTROENTEROLOGY, V114, P344, DOI 10.1016/S0016-5085(98)70487-1; Saji M, 2005, BIOCHEM BIOPH RES CO, V332, P167, DOI 10.1016/j.bbrc.2005.04.109; Schmalzigaug R, 2007, CELL SIGNAL, V19, P1733, DOI 10.1016/j.cellsig.2007.03.010; Shah V, 1999, GASTROENTEROLOGY, V117, P1222, DOI 10.1016/S0016-5085(99)70408-7; Shaul PW, 2002, ANNU REV PHYSIOL, V64, P749, DOI 10.1146/annurev.physiol.64.081501.155952; Shaul PW, 1996, J BIOL CHEM, V271, P6518, DOI 10.1074/jbc.271.11.6518; Shikata Y, 2003, FASEB J, V17, P2240, DOI 10.1096/fj.03-0198com; Shikata Y, 2003, J APPL PHYSIOL, V94, P1193, DOI 10.1152/japplphysiol.00690.2002; Vitale N, 2000, J BIOL CHEM, V275, P13901, DOI 10.1074/jbc.275.18.13901; Webb DJ, 2006, J CELL SCI, V119, P2847, DOI 10.1242/jcs03044; Whalen EJ, 2007, CELL, V129, P511, DOI 10.1016/j.cell.2007.02.046; XUE C, 1995, NEW ENGL J MED, V333, P1642; Yin GY, 2004, MOL CELL BIOL, V24, P875, DOI 10.1128/MCB.24.2.875-885.2004; Yu Q, 2002, AM J PHYSIOL-GASTR L, V282, pG565, DOI 10.1152/ajpgi.00512.2000; Zhang HY, 2005, J NEUROSCI, V25, P3379, DOI 10.1523/JNEUROSCI.3553-04.2005; Zhao ZS, 2000, MOL CELL BIOL, V20, P6354, DOI 10.1128/MCB.20.17.6354-6363.2000	63	29	30	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					12309	12320		10.1074/jbc.M111.320465	http://dx.doi.org/10.1074/jbc.M111.320465			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22294688	Green Published, hybrid			2022-12-25	WOS:000302782200070
J	Shilling, D; Mak, DOD; Kang, DE; Foskett, JK				Shilling, Dustin; Mak, Don-On Daniel; Kang, David E.; Foskett, J. Kevin			Lack of Evidence for Presenilins as Endoplasmic Reticulum Ca2+ Leak Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDIATED CALCIUM-RELEASE; ALZHEIMERS-DISEASE; FIBROBLASTS; HOMEOSTASIS; MUTATIONS; RESPONSES; ACCUMULATION; HIPPOCAMPAL; TURNOVER; TOPOLOGY	Familial Alzheimer disease (FAD) is linked to mutations in the presenilin (PS) homologs. FAD mutant PS expression has several cellular consequences, including exaggerated intracellular Ca2+ ([Ca2+](i)) signaling due to enhanced agonist sensitivity and increased magnitude of [Ca2+](i) signals. The mechanisms underlying these phenomena remain controversial. It has been proposed that PSs are constitutively active, passive endoplasmic reticulum (ER) Ca2+ leak channels and that FAD PS mutations disrupt this function resulting in ER store overfilling that increases the driving force for release upon ER Ca2+ release channel opening. To investigate this hypothesis, we employed multiple Ca2+ imaging protocols and indicators to directly measure ER Ca2+ dynamics in several cell systems. However, we did not observe consistent evidence that PSs act as ER Ca2+ leak channels. Nevertheless, we confirmed observations made using indirect measurements employed in previous reports that proposed this hypothesis. Specifically, cells lacking PS or expressing a FAD-linked PS mutation displayed increased area under the ionomycin-induced [Ca2+](i) versus time curve (AI) compared with cells expressing WT PS. However, an ER-targeted Ca2+ indicator revealed that this did not reflect overloaded ER stores. Monensin pretreatment selectively attenuated the AI in cells lacking PS or expressing a FAD PS allele. These findings contradict the hypothesis that PSs form ER Ca2+ leak channels and highlight the need to use ER-targeted Ca2+ indicators when studying ER Ca2+ dynamics.	[Shilling, Dustin; Mak, Don-On Daniel; Foskett, J. Kevin] Univ Penn, Dept Physiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Foskett, J. Kevin] Univ Penn, Dept Cell & Dev Biol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Kang, David E.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of California System; University of California San Diego	Foskett, JK (corresponding author), Univ Penn, Dept Physiol, Perelman Sch Med, B39 Anat Chem Bldg, Philadelphia, PA 19104 USA.	foskett@mail.med.upenn.edu	Foskett, Kevin/R-2549-2019; Kang, David E./E-5234-2012	Foskett, J. Kevin/0000-0002-8854-0268; Kang, David E./0000-0002-7132-821X	National Institutes of Health [R01 MH059937, R01 GM056328]; NIA, National Institutes of Health [F31 AG038240]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059937] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIA, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 MH059937 and R01 GM056328 (to J. K. F.).; Supported by a NIA, National Institutes of Health Ruth L. Kirschstein National Research Service Award for Individual Predoctoral Fellows Grant F31 AG038240.	Berridge MJ, 2010, PFLUG ARCH EUR J PHY, V459, P441, DOI 10.1007/s00424-009-0736-1; Bezprozvanny I, 2008, TRENDS NEUROSCI, V31, P454, DOI 10.1016/j.tins.2008.06.005; Brunello L, 2009, J CELL MOL MED, V13, P3358, DOI 10.1111/j.1582-4934.2009.00755.x; Chakroborty S, 2009, J NEUROSCI, V29, P9458, DOI 10.1523/JNEUROSCI.2047-09.2009; Cheung KH, 2008, NEURON, V58, P871, DOI 10.1016/j.neuron.2008.04.015; Cheung KH, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000818; Dries DR, 2008, CURR ALZHEIMER RES, V5, P132, DOI 10.2174/156720508783954695; Etcheberrigaray R, 1998, NEUROBIOL DIS, V5, P37, DOI 10.1006/nbdi.1998.0176; FASOLATO C, 1991, J BIOL CHEM, V266, P20159; Fassler M, 2010, TRAFFIC, V11, P250, DOI 10.1111/j.1600-0854.2009.01014.x; Gandy S, 2006, NAT MED, V12, P1121, DOI 10.1038/nm1006-1121; Giacomello M, 2005, NEUROBIOL DIS, V18, P638, DOI 10.1016/j.nbd.2004.10.016; Green KN, 2008, J CELL BIOL, V181, P1107, DOI 10.1083/jcb.200706171; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Guo Q, 1999, NAT MED, V5, P101, DOI 10.1038/4789; Herreman A, 2000, NAT CELL BIOL, V2, P461, DOI 10.1038/35017105; Hirashima N, 1996, NEUROBIOL AGING, V17, P549; ITO E, 1994, P NATL ACAD SCI USA, V91, P534, DOI 10.1073/pnas.91.2.534; Kasri NN, 2006, CELL CALCIUM, V40, P41, DOI 10.1016/j.ceca.2006.03.005; Laudon H, 2005, J BIOL CHEM, V280, P35352, DOI 10.1074/jbc.M507217200; Lissandron V, 2010, P NATL ACAD SCI USA, V107, P9198, DOI 10.1073/pnas.1004702107; LIU CM, 1978, J BIOL CHEM, V253, P5892; Marx J, 2007, SCIENCE, V318, P384, DOI 10.1126/science.318.5849.384; Mattson MP, 2007, AGING CELL, V6, P337, DOI 10.1111/j.1474-9726.2007.00275.x; Mattson MP, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3114pe10; McCombs JE, 2010, MOL BIOSYST, V6, P1640, DOI 10.1039/c001975e; Meberg PJ, 2003, METHOD CELL BIOL, V71, P111, DOI 10.1016/S0091-679X(03)01007-0; Nelson O, 2007, J CLIN INVEST, V117, P1230, DOI 10.1172/JCI30447; Nelson O, 2011, J BIOL CHEM, V286, P22339, DOI 10.1074/jbc.M111.243063; Nelson O, 2010, J ALZHEIMERS DIS, V21, P781, DOI 10.3233/JAD-2010-100159; Palmer AE, 2004, P NATL ACAD SCI USA, V101, P17404, DOI 10.1073/pnas.0408030101; Palmer AE, 2006, NAT PROTOC, V1, P1057, DOI 10.1038/nprot.2006.172; Repetto E, 2007, J BIOL CHEM, V282, P31504, DOI 10.1074/jbc.M704273200; RICKERT RC, 1995, NATURE, V376, P352, DOI 10.1038/376352a0; Smith IF, 2005, J NEUROCHEM, V94, P1711, DOI 10.1111/j.1471-4159.2005.03332.x; Spasic D, 2006, J BIOL CHEM, V281, P26569, DOI 10.1074/jbc.M600592200; Stutzmann GE, 2005, NEUROSCIENTIST, V11, P110, DOI 10.1177/1073858404270899; Stutzmann GE, 2004, J NEUROSCI, V24, P508, DOI 10.1523/JNEUROSCI.4386-03.2004; Stutzmann GE, 2007, ANN NY ACAD SCI, V1097, P265, DOI 10.1196/annals.1379.025; Stutzmann GE, 2006, J NEUROSCI, V26, P5180, DOI 10.1523/JNEUROSCI.0739-06.2006; Thinakaran G, 1996, NEURON, V17, P181, DOI 10.1016/S0896-6273(00)80291-3; Thinakaran G, 2006, NAT NEUROSCI, V9, P1354, DOI 10.1038/nn1106-1354; Tu HP, 2006, CELL, V126, P981, DOI 10.1016/j.cell.2006.06.059; Zatti G, 2004, NEUROBIOL DIS, V15, P269, DOI 10.1016/j.nbd.2003.11.002; Zatti G, 2006, CELL CALCIUM, V39, P539, DOI 10.1016/j.ceca.2006.03.002; Zhang H, 2010, J NEUROSCI, V30, P8566, DOI 10.1523/JNEUROSCI.1554-10.2010	46	72	75	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					10933	10944		10.1074/jbc.M111.300491	http://dx.doi.org/10.1074/jbc.M111.300491			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22311977	Green Published, hybrid			2022-12-25	WOS:000302780100022
J	Xu, XQ; Francischetti, IMB; Lai, R; Ribeiro, JMC; Andersen, JF				Xu, Xueqing; Francischetti, Ivo M. B.; Lai, Ren; Ribeiro, Jose M. C.; Andersen, John F.			Structure of Protein Having Inhibitory Disintegrin and Leukotriene Scavenging Functions Contained in Single Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINE-BINDING PROTEIN; CRYSTAL-STRUCTURE; EXTRACELLULAR SEGMENT; IIB-IIIA; VENOM; RECOGNITION; FIBRINOGEN; INTEGRINS; SALIVA; ALPHA-V-BETA-3	The antihemostatic/antiangiogenic protein tablysin-15 is a member of the CAP (cysteine-rich secretory, antigen 5, and pathogenesis-related 1 protein) superfamily and has been shown to bind the integrins alpha(IIb)beta(3) and alpha(V)beta(3) by means of an Arg-Gly-Asp (RGD) tripeptide sequence. Here we describe the x-ray crystal structure of tablysin-15 and show that the RGD motif is located in a novel structural context. The motif itself is contained in a type II beta-turn structure that is similar in its conformation to the RGD sequence of the cyclic pentapeptide cilengitide when bound to integrin alpha V beta 3. The CAP domain also contains a hydrophobic channel that appears to bind a fatty acid molecule in the crystal structure after purification from Escherichia coli. After delipidation of the protein, tablysin-15 was found to bind proinflammatory cysteinyl leukotrienes with sub-micromolar affinities. The structure of the leukotriene E-4-tablysin-15 complex shows that the ligand binds with the nonfunctionalized end of the fatty acid chain buried in the hydrophobic pocket, whereas the carboxylate end of the ligand binds forms hydrogen bond/salt bridge interactions with polar side chains at the channel entrance. Therefore, tablysin-15 functions as an inhibitor of integrin function and as an anti-inflammatory scavenger of eicosanoids.	[Lai, Ren] Chinese Acad Sci, Kunming Inst Zool, Key Lab Anim Models & Human Dis Mech, Kunming 650223, Yunnan, Peoples R China; [Xu, Xueqing; Francischetti, Ivo M. B.; Ribeiro, Jose M. C.; Andersen, John F.] NIAID, Lab Malaria & Vector Res, NIH, Bethesda, MD 20892 USA	Chinese Academy of Sciences; Kunming Institute of Zoology; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Lai, R (corresponding author), Chinese Acad Sci, Kunming Inst Zool, Key Lab Anim Models & Human Dis Mech, Kunming 6550223, Yunnan, Peoples R China.	lairen72@yahoo.com.cn; jandersen@niaid.nih.gov	Ribeiro, Jose/J-7011-2015	Ribeiro, Jose/0000-0002-9107-0818	National Institutes of Health of NIAID; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000810, ZIAAI001012] Funding Source: NIH RePORTER	National Institutes of Health of NIAID; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by the National Institutes of Health intramural research program of NIAID. This work was also supported in part by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences under Contract W-31-109-Eng-38.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alvarenga PH, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000547; Andersen JF, 2003, J BIOL CHEM, V278, P4611, DOI 10.1074/jbc.M211438200; Asojo OA, 2005, J MOL BIOL, V346, P801, DOI 10.1016/j.jmb.2004.12.023; Asojo OA, 2011, ACTA CRYSTALLOGR D, V67, P847, DOI [10.1107/S0907444911028198, 10.1107/S0907444911028198847]; Boyce JA, 2005, CHEM IMMUNOL ALLERGY, V87, P59, DOI 10.1159/000087571; Calvete JJ, 2005, TOXICON, V45, P1063, DOI 10.1016/j.toxicon.2005.02.024; Calvo E, 2009, P NATL ACAD SCI USA, V106, P3728, DOI 10.1073/pnas.0813190106; CHERESH DA, 1989, CELL, V58, P945, DOI 10.1016/0092-8674(89)90946-X; Chou KC, 2000, ANAL BIOCHEM, V286, P1, DOI 10.1006/abio.2000.4757; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Francischetti IMB, 1997, TOXICON, V35, P1217, DOI 10.1016/S0041-0101(97)00021-4; Fujii Y, 2003, J MOL BIOL, V332, P1115, DOI 10.1016/S0022-2836(03)00991-4; Gibbs GM, 2008, ENDOCR REV, V29, P865, DOI 10.1210/er.2008-0032; Henriksen A, 2001, PROTEINS, V45, P438, DOI 10.1002/prot.1160; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Ma DY, 2011, THROMB HAEMOSTASIS, V105, P1032, DOI 10.1160/TH11-01-0029; Mans BJ, 2008, INSECT BIOCHEM MOLEC, V38, P862, DOI 10.1016/j.ibmb.2008.06.002; Mans BJ, 2008, INSECT BIOCHEM MOLEC, V38, P841, DOI 10.1016/j.ibmb.2008.06.007; Mans BJ, 2007, J BIOL CHEM, V282, P36626, DOI 10.1074/jbc.M706410200; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Padavattan S, 2008, J MOL BIOL, V383, P178, DOI 10.1016/j.jmb.2008.08.023; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; RIBEIRO JMC, 1994, J EXP MED, V180, P2251, DOI 10.1084/jem.180.6.2251; Ribeiro JMC, 2004, INSECT BIOCHEM MOLEC, V34, P61, DOI 10.1016/j.ibmb.2003.09.004; Ribeiro JMC, 2003, ANNU REV ENTOMOL, V48, P73, DOI 10.1146/annurev.ento.48.060402.102812; RIBEIRO JMC, 1995, INFECT AGENT DIS, V4, P143; Ribeiro JMC, 2010, INSECT BIOCHEM MOLEC, V40, P767, DOI 10.1016/j.ibmb.2010.08.002; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; SENN H, 1993, J MOL BIOL, V232, P907, DOI 10.1006/jmbi.1993.1439; Shikamoto Y, 2005, J MOL BIOL, V350, P735, DOI 10.1016/j.jmb.2005.05.020; SMITH JW, 1990, J BIOL CHEM, V265, P12267; SOTER NA, 1983, J INVEST DERMATOL, V80, P115, DOI 10.1111/1523-1747.ep12531738; Springer TA, 2008, J CELL BIOL, V182, P791, DOI 10.1083/jcb.200801146; Wang YL, 2010, J BIOL CHEM, V285, P37872, DOI 10.1074/jbc.M110.146290; Wermelinger LS, 2009, ARCH BIOCHEM BIOPHYS, V482, P25, DOI 10.1016/j.abb.2008.11.023; Xiao T, 2004, NATURE, V432, P59, DOI 10.1038/nature02976; Xiong JP, 2001, SCIENCE, V294, P339, DOI 10.1126/science.1064535; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; Xu XQ, 2011, J BIOL CHEM, V286, P32383, DOI 10.1074/jbc.M111.268904	42	42	44	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					10967	10976		10.1074/jbc.M112.340471	http://dx.doi.org/10.1074/jbc.M112.340471			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22311975	hybrid, Green Published			2022-12-25	WOS:000302780100025
J	Yin, HQ; Hu, M; Zhang, R; Shen, Z; Flatow, L; You, M				Yin, Huquan; Hu, Ming; Zhang, Ray; Shen, Zheng; Flatow, Laura; You, Min			MicroRNA-217 Promotes Ethanol-induced Fat Accumulation in Hepatocytes by Down-regulating SIRT1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALCOHOLIC LIVER-DISEASE; ACTIVATED PROTEIN-KINASE; SUBCELLULAR-LOCALIZATION; MAMMALIAN SIRTUIN-1; PROTECTIVE ACTION; LIPID-METABOLISM; EXPRESSION; MICE; INVOLVEMENT; MACROPHAGES	Ethanol-mediated inhibition of hepatic sirtuin 1 (SIRT1) plays a crucial role in the pathogenesis of alcoholic fatty liver disease. Here, we investigated the underlying mechanisms of this inhibition by identifying a new hepatic target of ethanol action, microRNA-217 (miR-217). The role of miR-217 in the regulation of the effects of ethanol was investigated in cultured mouse AML-12 hepatocytes and in the livers of chronically ethanol-fed mice. In AML-12 hepatocytes and in mouse livers, chronic ethanol exposure drastically and specifically induced miR-217 levels and caused excess fat accumulation. Further studies revealed that overexpression of miR-217 in AML-12 cells promoted ethanol-mediated impairments of SIRT1 and SIRT1-regulated genes encoding lipogenic or fatty acid oxidation enzymes. More importantly, miR-217 impairs functions of lipin-1, a vital lipid regulator, in hepatocytes. Taken together, our novel findings suggest that miR-217 is a specific target of ethanol action in the liver and may present as a potential therapeutic target for treating human alcoholic fatty liver disease.	Univ S Florida, Hlth Sci Ctr, Dept Mol Pharmacol, Tampa, FL 33612 USA; Univ S Florida, Hlth Sci Ctr, Dept Physiol, Tampa, FL 33612 USA	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	You, M (corresponding author), Univ S Florida, Coll Med, Sch Basic Biomed Sci, Dept Mol Pharmacol & Physiol, Box 8,12901 Bruce B Downs Blvd, Tampa, FL 33612 USA.	myou@health.usf.edu	You, Min/I-4973-2012	You, Min/0000-0003-1977-3479	National Institutes of Health, National Institute on Alcoholism and Alcohol Abuse [AA-015951, AA-013623]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA015951, R01AA013623] Funding Source: NIH RePORTER	National Institutes of Health, National Institute on Alcoholism and Alcohol Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health, National Institute on Alcoholism and Alcohol Abuse, Grants AA-015951 and AA-013623 (to M.Y.).	Abdelmohsen K, 2007, MOL CELL, V25, P543, DOI 10.1016/j.molcel.2007.01.011; Ajmo JM, 2008, AM J PHYSIOL-GASTR L, V295, pG833, DOI 10.1152/ajpgi.90358.2008; Bala S, 2011, J BIOL CHEM, V286, P1436, DOI 10.1074/jbc.M110.145870; Beckman JD, 2011, J BIOL CHEM, V286, P3194, DOI 10.1074/jbc.M110.148726; Derdak Z, 2011, J HEPATOL, V54, P164, DOI 10.1016/j.jhep.2010.08.007; Dolganiuc A, 2009, ALCOHOL CLIN EXP RES, V33, P1704, DOI 10.1111/j.1530-0277.2009.01007.x; Gao B, 2011, GASTROENTEROLOGY, V141, P1572, DOI 10.1053/j.gastro.2011.09.002; Haller JF, 2011, BBA-MOL BASIS DIS, V1812, P1393, DOI 10.1016/j.bbadis.2011.07.007; Han GS, 2010, J BIOL CHEM, V285, P14628, DOI 10.1074/jbc.M110.117747; Harris TE, 2011, TRENDS ENDOCRIN MET, V22, P226, DOI 10.1016/j.tem.2011.02.006; Hou XY, 2008, J BIOL CHEM, V283, P20015, DOI 10.1074/jbc.M802187200; Hu M, 2012, HEPATOLOGY, V55, P437, DOI 10.1002/hep.24708; Kato M, 2009, NAT CELL BIOL, V11, P881, DOI 10.1038/ncb1897; Khalil MB, 2009, J LIPID RES, V50, P47, DOI 10.1194/jlr.M800204-JLR200; Liang XM, 2011, ANTIOXID REDOX SIGN, V15, P425, DOI 10.1089/ars.2010.3780; Lieber CS, 2008, BIOCHEM BIOPH RES CO, V370, P44, DOI 10.1016/j.bbrc.2008.03.005; Liu GH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007031; McMullen MR, 2003, J BIOL CHEM, V278, P38333, DOI 10.1074/jbc.M304566200; Menghini R, 2009, CIRCULATION, V120, P1524, DOI 10.1161/CIRCULATIONAHA.109.864629; Miranda RC, 2010, ALCOHOL CLIN EXP RES, V34, P575, DOI 10.1111/j.1530-0277.2009.01126.x; Nemoto S, 2004, SCIENCE, V306, P2105, DOI 10.1126/science.1101731; Park PH, 2005, AM J PHYSIOL-GASTR L, V289, pG1124, DOI 10.1152/ajpgi.00091.2005; Peterfy M, 2005, J BIOL CHEM, V280, P32883, DOI 10.1074/jbc.M503885200; Peterson TR, 2011, CELL, V146, P408, DOI 10.1016/j.cell.2011.06.034; Pihlajamaki J, 2011, CELL METAB, V14, P208, DOI 10.1016/j.cmet.2011.06.007; Ponugoti B, 2010, J BIOL CHEM, V285, P33959, DOI 10.1074/jbc.M110.122978; Sayed D, 2011, PHYSIOL REV, V91, P827, DOI 10.1152/physrev.00006.2010; Shen Z, 2010, AM J PHYSIOL-GASTR L, V298, pG364, DOI 10.1152/ajpgi.00456.2009; Shen Z, 2009, AM J PHYSIOL-GASTR L, V296, pG1047, DOI 10.1152/ajpgi.00016.2009; Sugden MC, 2010, J ENDOCRINOL, V204, P93, DOI 10.1677/JOE-09-0359; Tang YM, 2008, ALCOHOL CLIN EXP RES, V32, P355, DOI 10.1111/j.1530-0277.2007.00584.x; Valdearcos M, 2011, J IMMUNOL, V186, P6004, DOI 10.4049/jimmunol.1003279; Walker AK, 2010, GENE DEV, V24, P1403, DOI 10.1101/gad.1901210; Yamakuchi M, 2008, P NATL ACAD SCI USA, V105, P13421, DOI 10.1073/pnas.0801613105; Yeligar S, 2009, J IMMUNOL, V183, P5232, DOI 10.4049/jimmunol.0901084; You M, 2004, GASTROENTEROLOGY, V127, P1798, DOI 10.1053/j.gastro.2004.09.049; You M, 2008, AM J PHYSIOL-GASTR L, V294, pG892, DOI 10.1152/ajpgi.00575.2007; You M, 2008, J NUTR, V138, P497, DOI 10.1093/jn/138.3.497; Zhang Y, 2010, CLIN CHEM, V56, P1830, DOI 10.1373/clinchem.2010.147850	39	118	127	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					9817	9826		10.1074/jbc.M111.333534	http://dx.doi.org/10.1074/jbc.M111.333534			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22308024	Green Published, hybrid			2022-12-25	WOS:000302167200014
J	Barba, M; Sobolev, AP; Zobnina, V; di Patti, MCB; Cervoni, L; Spiezia, MC; Schinina, ME; Pietraforte, D; Mannina, L; Musci, G; Polticelli, F				Barba, Marco; Sobolev, Anatoli P.; Zobnina, Veranika; di Patti, Maria Carmela Bonaccorsi; Cervoni, Laura; Spiezia, Maria Carolina; Schinina, M. Eugenia; Pietraforte, Donatella; Mannina, Luisa; Musci, Giovanni; Polticelli, Fabio			Cupricyclins, Novel Redox-Active Metallopeptides Based on Conotoxins Scaffold	PLOS ONE			English	Article							CU,ZN SUPEROXIDE-DISMUTASE; METAL-BINDING; CONTRYPHAN-VN; COPPER; PROTEIN; PEPTIDE; MODEL; SITE; DENATURATION; PLASTOCYANIN	Highly stable natural scaffolds which tolerate multiple amino acid substitutions represent the ideal starting point for the application of rational redesign strategies to develop new catalysts of potential biomedical and biotechnological interest. The knottins family of disulphide-constrained peptides display the desired characteristics, being highly stable and characterized by hypervariability of the inter-cysteine loops. The potential of knottins as scaffolds for the design of novel copper-based biocatalysts has been tested by engineering a metal binding site on two different variants of an v-conotoxin, a neurotoxic peptide belonging to the knottins family. The binding site has been designed by computational modelling and the redesigned peptides have been synthesized and characterized by optical, fluorescence, electron spin resonance and nuclear magnetic resonance spectroscopy. The novel peptides, named Cupricyclin-1 and -2, bind one Cu2+ ion per molecule with nanomolar affinity. Cupricyclins display redox activity and catalyze the dismutation of superoxide anions with an activity comparable to that of non-peptidic superoxide dismutase mimics. We thus propose knottins as a novel scaffold for the design of catalytically-active mini metalloproteins.	[Barba, Marco; Zobnina, Veranika; Spiezia, Maria Carolina; Musci, Giovanni; Polticelli, Fabio] Univ Roma Tre, Dept Biol, Rome, Italy; [Sobolev, Anatoli P.; Mannina, Luisa] CNR, Inst Chem Methodol, Monterotondo Stn, I-00185 Rome, Italy; [di Patti, Maria Carmela Bonaccorsi; Cervoni, Laura; Schinina, M. Eugenia] Univ Roma La Sapienza, Dept Biochem Sci, I-00185 Rome, Italy; [Pietraforte, Donatella] Ist Super Sanita, Dept Cell Biol & Neurosci, I-00161 Rome, Italy; [Mannina, Luisa] Univ Roma La Sapienza, Dept Drug Sci & Technol, Rome, Italy; [Musci, Giovanni] Univ Molise, STAAM Dept, Campobasso, Italy; [Polticelli, Fabio] Natl Inst Nucl Phys, Roma Tre Sect, Rome, Italy	Roma Tre University; Consiglio Nazionale delle Ricerche (CNR); Istituto di Metodologie Chimiche (IMC-CNR); Sapienza University Rome; Istituto Superiore di Sanita (ISS); Sapienza University Rome; University of Molise; Istituto Nazionale di Fisica Nucleare (INFN)	Barba, M (corresponding author), Univ Roma Tre, Dept Biol, Rome, Italy.	polticel@uniroma3.it	Mannina, Luisa/AGY-1694-2022; Bonaccorsi di Patti, Maria Carmela/F-1198-2011; Pietraforte, Donatella/G-1816-2011; Polticelli, Fabio/A-4573-2009; Sobolev, Anatoly/AAX-1170-2020; Musci, Giovanni/H-2862-2012	Bonaccorsi di Patti, Maria Carmela/0000-0002-4794-7037; Polticelli, Fabio/0000-0002-7657-2019; Sobolev, Anatoly/0000-0001-8709-7666; Musci, Giovanni/0000-0002-5196-709X; Pietraforte, Donatella/0000-0001-6370-912X; Mannina, Luisa/0000-0001-8659-5890	italian Ministry of Education University [RBAU01YMY5]	italian Ministry of Education University(Ministry of Education, Universities and Research (MIUR))	This work was supported by the italian Ministry of Education University and Research, Fund for Investments in Basic Research (http://firb.miur.it) grant no. RBAU01YMY5 to FP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babu CS, 2006, J PHYS CHEM A, V110, P691, DOI 10.1021/jp054177x; Barba M, 2009, PROTEIN SCI, V18, P559, DOI 10.1002/pro.58; BEEM KM, 1974, J BIOL CHEM, V249, P7298; BERENDSEN HJC, 1987, J PHYS CHEM-US, V91, P6269, DOI 10.1021/j100308a038; Berry SM, 2011, ENCY LIFE SCI ELS, P1; BRYCE GF, 1966, J BIOL CHEM, V241, P122; Buczek O, 2004, BIOCHEMISTRY-US, V43, P1093, DOI 10.1021/bi0354233; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Case D.A., 2006, AMBER, V9; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; CUPANE A, 1994, BIOCHEMISTRY-US, V33, P15103, DOI 10.1021/bi00254a020; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DESIDERI A, 1992, J MOL BIOL, V223, P337, DOI 10.1016/0022-2836(92)90734-2; Eliseo T, 2004, BIOPOLYMERS, V74, P189, DOI 10.1002/bip.20025; ENGESETH HR, 1986, BIOCHEMISTRY-US, V25, P2448, DOI 10.1021/bi00357a023; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Gracy J, 2008, NUCLEIC ACIDS RES, V36, pD314, DOI 10.1093/nar/gkm939; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Han TS, 2008, CURR PHARM DESIGN, V14, P2462, DOI 10.2174/138161208785777469; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Jackel C, 2008, ANNU REV BIOPHYS, V37, P153, DOI 10.1146/annurev.biophys.37.032807.125832; Jitsukawa K, 2001, INORG CHIM ACTA, V324, P108, DOI 10.1016/S0020-1693(01)00567-9; Kolmar H, 2009, CURR OPIN PHARMACOL, V9, P608, DOI 10.1016/j.coph.2009.05.004; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lu Y, 2009, NATURE, V460, P855, DOI 10.1038/nature08304; MARKLUND S, 1974, EUR J BIOCHEM, V47, P469; Massilia GR, 2003, BIOCHEM BIOPH RES CO, V303, P238, DOI 10.1016/S0006-291X(03)00331-0; Massilia GR, 2001, BIOCHEM BIOPH RES CO, V288, P908, DOI 10.1006/bbrc.2001.5833; Mejare M, 2001, TRENDS BIOTECHNOL, V19, P67, DOI 10.1016/S0167-7799(00)01534-1; Miller AF, 2004, CURR OPIN CHEM BIOL, V8, P162, DOI 10.1016/j.cbpa.2004.02.011; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Mobley DL, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2221683; Olivera BM, 2007, MOL INTERV, V7, P251, DOI 10.1124/mi.7.5.7; Pallaghy PK, 1999, J PEPT RES, V53, P343, DOI 10.1034/j.1399-3011.1999.00040.x; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; PEISACH J, 1974, ARCH BIOCHEM BIOPHYS, V165, P691, DOI 10.1016/0003-9861(74)90298-7; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Podtetenieff J, 2010, ANGEW CHEM INT EDIT, V49, P5151, DOI 10.1002/anie.201002106; Pogni R, 1999, J INORG BIOCHEM, V73, P157, DOI 10.1016/S0162-0134(99)00012-4; Polticelli F, 1998, PROTEIN SCI, V7, P2354, DOI 10.1002/pro.5560071112; Polticelli F, 1999, BIOL CHEM, V380, P1247, DOI 10.1515/BC.1999.159; Riley DP, 1999, CHEM REV, V99, P2573, DOI 10.1021/cr980432g; Roberts BR, 2007, J MOL BIOL, V373, P877, DOI 10.1016/j.jmb.2007.07.043; ROTILIO G, 1972, BIOCHIM BIOPHYS ACTA, V268, P605, DOI 10.1016/0005-2744(72)90359-2; SAKAGUCHI U, 1979, J CHEM SOC DALTON, P600, DOI 10.1039/dt9790000600; Sandberg A, 2003, BIOCHEMISTRY-US, V42, P10301, DOI 10.1021/bi034371e; Schaffer AA, 2001, NUCLEIC ACIDS RES, V29, P2994, DOI 10.1093/nar/29.14.2994; Shosheva A, 2005, BBA-PROTEINS PROTEOM, V1748, P116, DOI 10.1016/j.bbapap.2004.12.012; TAINER JA, 1982, J MOL BIOL, V160, P181, DOI 10.1016/0022-2836(82)90174-7; Valentine JS, 2005, ANNU REV BIOCHEM, V74, P563, DOI 10.1146/annurev.biochem.72.121801.161647; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; VITA C, 1995, P NATL ACAD SCI USA, V92, P6404, DOI 10.1073/pnas.92.14.6404; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F	53	6	6	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2012	7	2							e30739	10.1371/journal.pone.0030739	http://dx.doi.org/10.1371/journal.pone.0030739			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LO	22319584	gold, Green Published, Green Submitted			2022-12-25	WOS:000302178400014
J	Eissens, DN; Spanholtz, J; van der Meer, A; van Cranenbroek, B; Dolstra, H; Kwekkeboom, J; Preijers, FWMB; Joosten, I				Eissens, Diana N.; Spanholtz, Jan; van der Meer, Arnold; van Cranenbroek, Bram; Dolstra, Harry; Kwekkeboom, Jaap; Preijers, Frank W. M. B.; Joosten, Irma			Defining Early Human NK Cell Developmental Stages in Primary and Secondary Lymphoid Tissues	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; UMBILICAL-CORD BLOOD; HLA-E; TRANSPLANTATION; RECEPTORS; BIOLOGY; RECONSTITUTION; EXPRESSION; SUBSET; NKG2A	A better understanding of human NK cell development in vivo is crucial to exploit NK cells for immunotherapy. Here, we identified seven distinctive NK cell developmental stages in bone marrow of single donors using 10-color flow cytometry and found that NK cell development is accompanied by early expression of stimulatory co-receptor CD244 in vivo. Further analysis of cord blood (CB), peripheral blood (PB), inguinal lymph node (inLN), liver lymph node (liLN) and spleen (SPL) samples showed diverse distributions of the NK cell developmental stages. In addition, distinctive expression profiles of early development marker CD33 and C-type lectin receptor NKG2A between the tissues, suggest that differential NK cell differentiation may take place at different anatomical locations. Differential expression of NKG2A and stimulatory receptors (e.g. NCR, NKG2D) within the different subsets of committed NK cells demonstrated the heterogeneity of the CD56(bright)CD16(+/-) and CD56(dim)CD16(+) subsets within the different compartments and suggests that microenvironment may play a role in differential in situ development of the NK cell receptor repertoire of committed NK cells. Overall, differential in situ NK cell development and trafficking towards multiple tissues may give rise to a broad spectrum of mature NK cell subsets found within the human body.	[Eissens, Diana N.; van der Meer, Arnold; van Cranenbroek, Bram; Joosten, Irma] Radboud Univ Nijmegen, Med Ctr, Lab Med Immunol, Dept Lab Med, NL-6525 ED Nijmegen, Netherlands; [Spanholtz, Jan; Dolstra, Harry; Preijers, Frank W. M. B.] Radboud Univ Nijmegen, Med Ctr, Hematol Lab, Dept Lab Med, NL-6525 ED Nijmegen, Netherlands; [Kwekkeboom, Jaap] Erasmus MC, Lab Gastroenterol & Hepatol, Rotterdam, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Erasmus University Rotterdam; Erasmus MC	Eissens, DN (corresponding author), Radboud Univ Nijmegen, Med Ctr, Lab Med Immunol, Dept Lab Med, NL-6525 ED Nijmegen, Netherlands.	I.Joosten@labgk.umcn.nl	van der Meer, Arnold/E-8793-2018; van der Meer, Arnold/M-1693-2016; Preijers, Frank/L-4586-2015; Dolstra, H./L-4276-2015; Joosten, Irma/N-4418-2013; van Cranenbroek, Bram/K-1549-2016	van der Meer, Arnold/0000-0001-8274-414X; Dolstra, H./0000-0002-3998-687X; Joosten, Irma/0000-0003-2950-4977; van Cranenbroek, Bram/0000-0001-5135-1183; Spanholtz, Jan/0000-0001-7152-6956	Radboud University Nijmegen Medical Centre	Radboud University Nijmegen Medical Centre	This work was financially supported by the Radboud University Nijmegen Medical Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Braud VM, 1998, NATURE, V391, P795, DOI 10.1038/35869; Colucci F, 2003, NAT REV IMMUNOL, V3, P413, DOI 10.1038/nri1088; Cooley S, 2007, BLOOD, V110, P578, DOI 10.1182/blood-2006-07-036228; Cooper MA, 2001, TRENDS IMMUNOL, V22, P633, DOI 10.1016/S1471-4906(01)02060-9; Crellin NK, 2010, J EXP MED, V207, P281, DOI 10.1084/jem.20091509; Dalle JH, 2005, PEDIATR RES, V57, P649, DOI 10.1203/01.PDR.0000156501.55431.20; Di Santo JP, 2006, ANNU REV IMMUNOL, V24, P257, DOI 10.1146/annurev.immunol.24.021605.090700; Dulphy N, 2008, J IMMUNOL, V181, P2227, DOI 10.4049/jimmunol.181.3.2227; Eissens DN, 2010, LEUKEMIA, V24, P583, DOI 10.1038/leu.2009.269; Farag SS, 2006, BLOOD REV, V20, P123, DOI 10.1016/j.blre.2005.10.001; Fathman JW, 2011, BLOOD, V118, P5439, DOI 10.1182/blood-2011-04-348912; Fehniger TA, 2003, BLOOD, V101, P3052, DOI 10.1182/blood-2002-09-2876; Ferlazzo G, 2004, J IMMUNOL, V172, P1455, DOI 10.4049/jimmunol.172.3.1455; Freud AG, 2006, J EXP MED, V203, P1033, DOI 10.1084/jem.20052507; Freud AG, 2005, IMMUNITY, V22, P295, DOI 10.1016/j.immuni.2005.01.013; Freud AG, 2006, IMMUNOL REV, V214, P56, DOI 10.1111/j.1600-065X.2006.00451.x; Kaiser BK, 2008, P NATL ACAD SCI USA, V105, P6696, DOI 10.1073/pnas.0802736105; Kobari L, 2001, J HEMATOTH STEM CELL, V10, P273, DOI 10.1089/15258160151134980; Ljunggren HG, 2007, NAT REV IMMUNOL, V7, P329, DOI 10.1038/nri2073; Male V, 2010, J IMMUNOL, V185, P3913, DOI 10.4049/jimmunol.1001637; Moroso V, 2010, LIVER TRANSPLANT, V16, P895, DOI 10.1002/lt.22080; Nguyen S, 2005, BLOOD, V105, P4135, DOI 10.1182/blood-2004-10-4113; Papamichail M, 2004, CANCER IMMUNOL IMMUN, V53, P176, DOI 10.1007/s00262-003-0478-4; Peruzzi G, 2009, IMMUNOL RES, V43, P210, DOI 10.1007/s12026-008-8072-7; Raulet DH, 1999, CURR OPIN IMMUNOL, V11, P129, DOI 10.1016/S0952-7915(99)80023-5; ROBERTSON MJ, 1990, BLOOD, V76, P2421; Shilling HG, 2003, BLOOD, V101, P3730, DOI 10.1182/blood-2002-08-2568; Sivori S, 2000, EUR J IMMUNOL, V30, P787, DOI 10.1002/1521-4141(200003)30:3<787::AID-IMMU787>3.0.CO;2-I; Sivori S, 2002, P NATL ACAD SCI USA, V99, P4526, DOI 10.1073/pnas.072065999; Spanholtz J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009221; SPITS H, 1995, BLOOD, V85, P2654, DOI 10.1182/blood.V85.10.2654.bloodjournal85102654; Tanaka H, 2003, EUR J HAEMATOL, V71, P29, DOI 10.1034/j.1600-0609.2003.00081.x; Thomson AW, 2010, NAT REV IMMUNOL, V10, P753, DOI 10.1038/nri2858; Wang YY, 2007, CELL MOL IMMUNOL, V4, P377; Yokoyama WM, 2004, ANNU REV IMMUNOL, V22, P405, DOI 10.1146/annurev.immunol.22.012703.104711; Yu J, 2009, BLOOD BLOOD 2009; Zhao XY, 2007, BIOL BLOOD MARROW TR, V13, P734, DOI 10.1016/j.bbmt.2007.02.010	37	41	43	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2012	7	2							e30930	10.1371/journal.pone.0030930	http://dx.doi.org/10.1371/journal.pone.0030930			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LO	22319595	Green Published, Green Submitted, gold			2022-12-25	WOS:000302178400020
J	Maiga, M; Agarwal, N; Ammerman, NC; Gupta, R; Guo, HD; Maiga, MC; Lun, SC; Bishai, WR				Maiga, Mamoudou; Agarwal, Nisheeth; Ammerman, Nicole C.; Gupta, Radhika; Guo, Haidan; Maiga, Marama C.; Lun, Shichun; Bishai, William R.			Successful Shortening of Tuberculosis Treatment Using Adjuvant Host-Directed Therapy with FDA-Approved Phosphodiesterase Inhibitors in the Mouse Model	PLOS ONE			English	Article							CYCLIC-AMP; MYCOBACTERIUM-TUBERCULOSIS; IMMUNOTHERAPY; CHEMOTHERAPY; ACTIVATION; IMMUNITY; RABBITS; CELLS; MICE; CAMP	Global control of tuberculosis (TB), an infectious disease that claims nearly 2 million lives annually, is hindered by the long duration of chemotherapy required for curative treatment. Lack of adherence to this intense treatment regimen leads to poor patient outcomes, development of new or additional drug resistance, and continued spread of M.tb. within communities. Hence, shortening the duration of TB therapy could increase drug adherence and cure in TB patients. Here, we report that addition of the United Stated Food and Drug Administration-approved phosphodiesterase inhibitors (PDE-Is) cilostazol and sildenafil to the standard TB treatment regimen reduces tissue pathology, leads to faster bacterial clearance and shortens the time to lung sterilization by one month, compared to standard treatment alone, in a murine model of TB. Our data suggest that these PDE-Is could be repurposed for use as adjunctive drugs to shorten TB treatment in humans.	[Maiga, Mamoudou; Agarwal, Nisheeth; Ammerman, Nicole C.; Gupta, Radhika; Guo, Haidan; Maiga, Marama C.; Lun, Shichun; Bishai, William R.] Johns Hopkins Univ, Sch Med, Ctr TB Res, Baltimore, MD 21218 USA; [Agarwal, Nisheeth] Translat Hlth Sci & Technol Inst, Vaccine & Infect Dis Res Ctr, Gurgaon, India; [Bishai, William R.] KwaZulu Natal Res Inst TB & HIV K RITH, Durban, South Africa; [Bishai, William R.] Howard Hughes Med Inst, Chevy Chase, MD USA	Johns Hopkins University; Department of Biotechnology (DBT) India; Translational Health Science & Technology Institute (THSTI); Howard Hughes Medical Institute	Maiga, M (corresponding author), Johns Hopkins Univ, Sch Med, Ctr TB Res, Baltimore, MD 21218 USA.	wbishai1@jhmi.edu		Ammerman, Nicole C./0000-0001-9359-9144; Gupta, Radhika/0000-0002-0445-0194	National Institute of Allergy and Infectious Diseases [AI30036, AI37856, AI36973]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI036973, R01AI030036, R29AI036973, R01AI037856] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The project described in this communication was supported by awards AI30036, AI37856 and AI36973 from the National Institute of Allergy and Infectious Diseases and by the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal N, 2009, NATURE, V460, P98, DOI 10.1038/nature08123; Agarwal N, 2009, INDIAN J EXP BIOL, V47, P393; Aizawa T, 2003, CIRC RES, V93, P406, DOI 10.1161/01.RES.0000091074.33584.F0; Bender AT, 2006, PHARMACOL REV, V58, P488, DOI 10.1124/pr.58.3.5; Churchyard GJ, 2009, CLIN CHEST MED, V30, P769, DOI 10.1016/j.ccm.2009.08.009; COURTADE ET, 1975, AM J PATHOL, V78, P243; Dhillon J, 1996, ANTIMICROB AGENTS CH, V40, P552, DOI 10.1128/AAC.40.3.552; Gao L, 2006, J PHARMACOL EXP THER, V318, P53, DOI 10.1124/jpet.106.101444; Harris J, 2010, CLIN EXP IMMUNOL, V161, P1, DOI 10.1111/j.1365-2249.2010.04146.x; Hattori Y, 2009, CARDIOVASC RES, V81, P133, DOI 10.1093/cvr/cvn226; Jassal MS, 2010, CLIN INFECT DIS, V50, pS156, DOI 10.1086/651486; Koo MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017091; Lienhardt C, 2010, CURR OPIN PULM MED, V16, P186, DOI 10.1097/MCP.0b013e328337580c; LOWRIE DB, 1975, NATURE, V254, P600, DOI 10.1038/254600a0; Mayanja-Kizza H, 2005, J INFECT DIS, V191, P856, DOI 10.1086/427995; Mendes JB, 2009, LIFE SCI, V84, P537, DOI 10.1016/j.lfs.2009.01.023; Moens MJU, 2007, FRONT BIOSCI-LANDMRK, V12, P1814; Nuermberger EL, 2010, RESPIROLOGY, V15, P764, DOI 10.1111/j.1440-1843.2010.01775.x; Omori K, 2007, CIRC RES, V100, P309, DOI 10.1161/01.RES.0000256354.95791.f1; Paige C, 2010, CELL MICROBIOL, V12, P301, DOI 10.1111/j.1462-5822.2009.01424.x; Pan H, 2005, NATURE, V434, P767, DOI 10.1038/nature03419; Quesniaux VFJ, 2010, CURR DIR AUTOIMMUN, V11, P157, DOI 10.1159/000289204; Russell DG, 2007, NAT REV MICROBIOL, V5, P39, DOI 10.1038/nrmicro1538; Serezani CH, 2008, AM J RESP CELL MOL, V39, P127, DOI 10.1165/rcmb.2008-0091TR; Shenoy AR, 2006, TRENDS MICROBIOL, V14, P543, DOI 10.1016/j.tim.2006.10.005; Spina D, 2008, BRIT J PHARMACOL, V155, P308, DOI 10.1038/bjp.2008.307; Subbian S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002262; Subbian S, 2011, AM J PATHOL, V179, P289, DOI 10.1016/j.ajpath.2011.03.039; Szczypka M, 2010, PHARMACOL REP, V62, P1148, DOI 10.1016/S1734-1140(10)70377-7; Wallis RS, 2005, CLIN INFECT DIS, V41, P201, DOI 10.1086/430914; WHO, 2010, GLOB TUB CONTR 2010; Word Health Organization, 2007, REP EXP CONS IMM INT, P29	32	42	42	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2012	7	2							e30749	10.1371/journal.pone.0030749	http://dx.doi.org/10.1371/journal.pone.0030749			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LO	22319585	Green Published, gold, Green Submitted			2022-12-25	WOS:000302178400015
J	Leisher, C; Hess, S; Boucher, TM; van Beukering, P; Sanjayan, M				Leisher, Craig; Hess, Sebastiaan; Boucher, Timothy M.; van Beukering, Pieter; Sanjayan, M.			Measuring the Impacts of Community-based Grasslands Management in Mongolia's Gobi	PLOS ONE			English	Article							DRIVEN DEVELOPMENT; CONSERVATION; PRODUCTIVITY; SUSTAINABILITY; DIVERSITY; FRAMEWORK; BIOMASS; NDVI	We assessed a donor-funded grassland management project designed to create both conservation and livelihood benefits in the rangelands of Mongolia's Gobi desert. The project ran from 1995 to 2006, and we used remote sensing Normalized Differential Vegetation Index data from 1982 to 2009 to compare project grazing sites to matched control sites before and after the project's implementation. We found that the productivity of project grazing sites was on average within 1% of control sites for the 20 years before the project but generated 11% more biomass on average than the control areas from 2000 to 2009. To better understand the benefits of the improved grasslands to local people, we conducted 280 household interviews, 8 focus group discussions, and 31 key informant interviews across 6 districts. We found a 12% greater median annual income as well as a range of other socioeconomic benefits for project households compared to control households in the same areas. Overall, the project generated measurable benefits to both nature and people. The key factors underlying project achievements that may be replicable by other conservation projects include the community-driven approach of the project, knowledge exchanges within and between communities inside and outside the country, a project-supported local community organizer in each district, and strong community leadership.	[Leisher, Craig; Boucher, Timothy M.; Sanjayan, M.] Nature Conservancy, Cent Sci, Arlington, VA USA; [Hess, Sebastiaan] Hess Environm Econ Analyst, Haarlem, Netherlands; [van Beukering, Pieter] Vrije Univ Amsterdam, Inst Environm Studies, Dept Environm Econ, Amsterdam, Netherlands	Nature Conservancy; Vrije Universiteit Amsterdam	Leisher, C (corresponding author), Nature Conservancy, Cent Sci, 1815 N Lynn St, Arlington, VA USA.	cleisher@tnc.org	van Beukering, Pieter/L-3509-2013	van Beukering, Pieter/0000-0001-7146-4409	Schooner Foundation; HRH Foundation; Nature Conservancy	Schooner Foundation; HRH Foundation; Nature Conservancy	The Schooner Foundation, along with Harry and Shirley Hagey of the HRH Foundation, and The Nature Conservancy provided the funding to make this study possible. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler RF, 2003, J HYDROMETEOROL, V4, P1147, DOI 10.1175/1525-7541(2003)004<1147:TVGPCP>2.0.CO;2; Angerer J., 2008, RANGELANDS, V30, P46, DOI [DOI 10.2111/1551-501X(2008)30[46:CCAEOA]2.0.CO;2, 10.2111/1551-501X(2008)30]; Barthel H, 1983, STUDIA GEOGRAPHICA, V34, P1; Bullock JM, 2007, J APPL ECOL, V44, P6, DOI 10.1111/j.1365-2664.2006.01252.x; Cardinale BJ, 2007, P NATL ACAD SCI USA, V104, P18123, DOI 10.1073/pnas.0709069104; Dasgupta A, 2007, DEV CHANGE, V38, P229, DOI 10.1111/j.1467-7660.2007.00410.x; GEORGIADIS NJ, 1989, OECOLOGIA, V81, P316, DOI 10.1007/BF00377077; Guo QF, 2007, BASIC APPL ECOL, V8, P199, DOI 10.1016/j.baae.2006.02.005; Gutierrez NL, 2011, NATURE, V470, P386, DOI 10.1038/nature09689; Henwood William D., 2010, Great Plains Research, V20, P121; Jacobs SM, 2008, J ARID ENVIRON, V72, P891, DOI 10.1016/j.jaridenv.2007.11.015; Kawamura Kensuke, 2005, Grassland Science, V51, P33, DOI 10.1111/j.1744-697X.2005.00006.x; Knight AT, 2006, CONSERV BIOL, V20, P408, DOI 10.1111/j.1523-1739.2006.00305.x; Mansuri G, 2004, WORLD BANK RES OBSER, V19, P1, DOI 10.1093/wbro/lkh012; MCNAUGHTON SJ, 1979, AM NAT, V113, P691, DOI 10.1086/283426; Morton DC, 2005, EARTH INTERACT, V9; Murray S., 2000, PILOT ANAL GLOBAL EC; National Statistical Office of Mongolia, 2022, GEN STAT DAT; NSOM, 2009, MONTHLY B STAT   DEC; Ostrom E, 2009, SCIENCE, V325, P419, DOI 10.1126/science.1172133; Peters AJ, 2002, PHOTOGRAMM ENG REM S, V68, P71; Pollnac RB, 2001, OCEAN COAST MANAGE, V44, P683, DOI 10.1016/S0964-5691(01)00075-8; Reading RP, 1999, BIODIVERS CONSERV, V8, P1115, DOI 10.1023/A:1008900427566; Salafsky N, 2002, CONSERV BIOL, V16, P1469, DOI 10.1046/j.1523-1739.2002.01232.x; Singh A., 2005, ONE PLANET MANY PEOP; Sullivan S, 2002, J BIOGEOGR, V29, P1595, DOI 10.1046/j.1365-2699.2002.00799.x; Tilman D, 1996, NATURE, V379, P718, DOI 10.1038/379718a0; Tilman D, 2001, SCIENCE, V294, P843, DOI 10.1126/science.1060391; UNDERWOOD AJ, 1994, ECOL APPL, V4, P3, DOI 10.2307/1942110; Wang J., 2005, GEOCARTO INT, V20, P5, DOI DOI 10.1080/10106040508542350; Wang Q, 2003, ENVIRON MONIT ASSESS, V82, P119, DOI 10.1023/A:1021898531229; World Bank, 2001, ATT POV WORLD DEV RE; Yang LM, 1998, REMOTE SENS ENVIRON, V65, P25, DOI 10.1016/S0034-4257(98)00012-1; Zhou L, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002510	34	28	32	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2012	7	2							e30991	10.1371/journal.pone.0030991	http://dx.doi.org/10.1371/journal.pone.0030991			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UG	22312436	Green Submitted, Green Published, gold			2022-12-25	WOS:000301977500024
J	Martinez-Canto, A; Castillejo, A; Mata-Balaguer, T; Castillejo, MI; Hernandez-Illan, E; Irles, E; Barbera, VM; Egoavil, C; Guarinos, C; Alenda, C; Ochoa, E; Lazaro, R; Fajardo, S; Lacueva, J; Calpena, R; Soto, JL				Martinez-Canto, Ana; Castillejo, Adela; Mata-Balaguer, Trinidad; Castillejo, Maria-Isabel; Hernandez-Illan, Eva; Irles, Esperanza; Manuel Barbera, Victor; Egoavil, Cecilia; Guarinos, Carla; Alenda, Cristina; Ochoa, Enrique; Lazaro, Rafael; Fajardo, Silvia; Lacueva, Javier; Calpena, Rafael; Luis Soto, Jose			TGFBR1 Intralocus Epistatic Interaction as a Risk Factor for Colorectal Cancer	PLOS ONE			English	Article							ALLELE-SPECIFIC EXPRESSION; GENETIC PREDISPOSITION; TGFBR1-ASTERISK-6A; SUSCEPTIBILITY; METAANALYSIS; POPULATION; GENOMICS; LOCUS	In colorectal cancer (CRC), an inherited susceptibility risk affects about 35% of patients, whereas high-penetrance germline mutations account for <6% of cases. A considerable proportion of sporadic tumors could be explained by the coinheritance of multiple low-penetrance variants, some of which are common. We assessed the susceptibility to CRC conferred by genetic variants at the TGFBR1 locus. We analyzed 14 polymorphisms and the allele-specific expression (ASE) of TGFBR1 in 1025 individuals from the Spanish population. A case-control study was undertaken with 504 controls and 521 patients with sporadic CRC. Fourteen polymorphisms located at the TGFBR1 locus were genotyped with the ipLEx Gold (MassARRAY-Sequenom) technology. Descriptive analyses of the polymorphisms and haplotypes and association studies were performed with the SNPator workpackage. No relevant associations were detected between individual polymorphisms or haplotypes and the risk of CRC. The TGFBR1*9A/6A polymorphism was used for the ASE analysis. Heterozygous individuals were analyzed for ASE by fragment analysis using cDNA from normal tissue. The relative level of allelic expression was extrapolated from a standard curve. The cutoff value was calculated with Youden's index. ASE was found in 25.4% of patients and 16.4% of controls. Considering both bimodal and continuous types of distribution, no significant differences between the ASE values of patients and controls were identified. Interestingly, a combined analysis of the polymorphisms and ASE for the association with CRC occurrence revealed that ASE-positive individuals carrying one of the most common haplotypes (H2: 20.7%) showed remarkable susceptibility to CRC (RR: 5.25; 95% CI: 2.547-5.250; p<0.001) with a synergy factor of 3.7. In our study, 54.1% of sporadic CRC cases were attributable to the coinheritance of the H2 haplotype and TGFBR1 ASE. These results support the hypothesis that the allelic architecture of cancer genes, rather than individual polymorphisms, more accurately defines the CRC risk.	[Martinez-Canto, Ana; Castillejo, Adela; Mata-Balaguer, Trinidad; Castillejo, Maria-Isabel; Hernandez-Illan, Eva; Irles, Esperanza; Manuel Barbera, Victor; Egoavil, Cecilia; Guarinos, Carla; Fajardo, Silvia; Luis Soto, Jose] Elche Univ Hosp, Mol Genet Lab, Elche, Spain; [Alenda, Cristina] Alicante Univ Hosp, Dept Pathol, Alicante, Spain; [Ochoa, Enrique] Castellon Prov Hosp, Castellon de La Plana, Spain; [Lazaro, Rafael] La Plana Hosp, Dept Pathol, Villareal, Spain; [Lacueva, Javier; Calpena, Rafael] Elche Univ Hosp, Dept Surg, Elche, Spain	General University Hospital of Alicante	Martinez-Canto, A (corresponding author), Elche Univ Hosp, Mol Genet Lab, Elche, Spain.	soto_jos@gva.es	Egoavil, Cecilia/X-5134-2018; Castillo, Adela Castillejo/AAD-3477-2020; Alenda, Cristina/AAR-3433-2020; Cantó, Ana Martínez/AAL-1354-2020; Egoavil, Cecilia/ABG-8531-2020; Soto, José Luis/AAC-6520-2020	Egoavil, Cecilia/0000-0003-0166-4901; Castillo, Adela Castillejo/0000-0002-9581-6285; Egoavil, Cecilia/0000-0003-0166-4901; Soto, Jose Luis/0000-0003-0234-9188; Castillejo Castillo, Maria Isabel/0000-0002-4545-6429; Barbera, Victor-Manuel/0000-0002-4012-6973; Irles, Esperanza/0000-0002-9184-9549; Alenda, Cristina/0000-0002-0560-1759; Fajardo Sebastian, Silvia Maria/0000-0003-4359-1202	Generalitat Valenciana in Spain [AP140/08]; Biomedical Research Foundation from the Hospital of Elche, Spain [FIBEIx0902]; Fundacion Juan Peran-Pikolinos; Fundacion Carolina-BBVA; Conselleria de Educacion (Generalitat Valenciana)	Generalitat Valenciana in Spain; Biomedical Research Foundation from the Hospital of Elche, Spain; Fundacion Juan Peran-Pikolinos; Fundacion Carolina-BBVA; Conselleria de Educacion (Generalitat Valenciana)(Center for Forestry Research & Experimentation (CIEF))	This action has been supported in part by grants from the Generalitat Valenciana in Spain (AP140/08) and the Biomedical Research Foundation from the Hospital of Elche, Spain (FIBEIx0902). AM-C, CE, and CG are recipients of fellowships from the Fundacion Juan Peran-Pikolinos; Fundacion Carolina-BBVA and Conselleria de Educacion (Generalitat Valenciana), respectivelly. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadie C, 2011, BRIT J CANCER, V104, P1517, DOI 10.1038/bjc.2011.124; Bian Yansong, 2003, Cancer Treat Res, V115, P73; Carvajal-Carmona LG, 2010, P NATL ACAD SCI USA, V107, P7858, DOI 10.1073/pnas.1002816107; Castellsague E, 2010, GASTROENTEROLOGY, V139, P439, DOI 10.1053/j.gastro.2010.04.047; Castillejo A, 2009, INT J CANCER, V124, P608, DOI 10.1002/ijc.24013; Castillejo A, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-193; de la Chapelle A, 2009, ONCOGENE, V28, P3345, DOI 10.1038/onc.2009.194; Fletcher O, 2010, NAT REV CANCER, V10, P353, DOI 10.1038/nrc2840; Forsti A, 2010, GENE CHROMOSOME CANC, V49, P270, DOI 10.1002/gcc.20738; Goldstein DB, 2001, CURR BIOL, V11, pR576, DOI 10.1016/S0960-9822(01)00348-7; Guda K, 2009, CANCER RES, V69, P4959, DOI 10.1158/0008-5472.CAN-09-0225; Hsieh AR, 2011, GENOMICS, V97, P77, DOI 10.1016/j.ygeno.2010.11.003; Knight JC, 2004, TRENDS GENET, V20, P113, DOI 10.1016/j.tig.2004.01.001; Liao RY, 2010, MOL BIOL REP, V37, P3227, DOI 10.1007/s11033-009-9906-7; Lynch HT, 2009, CLIN GENET, V76, P1, DOI 10.1111/j.1399-0004.2009.01230.x; Morcillo-Suarez C, 2008, BIOINFORMATICS, V24, P1643, DOI 10.1093/bioinformatics/btn241; Pasche B, 2004, J CLIN ONCOL, V22, P756, DOI 10.1200/JCO.2004.99.271; Pasche B, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-57; Segui N, 2011, BRIT J CANCER, V104, P735, DOI 10.1038/sj.bjc.6606079; Serre D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000006; Skelly DA, 2009, ANNU REV GENOM HUM G, V10, P313, DOI 10.1146/annurev-genom-082908-150121; Suriano G, 2007, HUM MOL GENET, V16, P2209, DOI 10.1093/hmg/ddm172; Tomlinson IPM, 2010, BRIT J CANCER, V102, P447, DOI 10.1038/sj.bjc.6605338; Tomsic J, 2010, CARCINOGENESIS, V31, P1800, DOI 10.1093/carcin/bgq165; Valle L, 2008, SCIENCE, V321, P1361, DOI 10.1126/science.1159397; Yan H, 2002, NAT GENET, V30, P25, DOI 10.1038/ng799	26	4	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30812	10.1371/journal.pone.0030812	http://dx.doi.org/10.1371/journal.pone.0030812			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22292045	Green Published, gold			2022-12-25	WOS:000301570600082
J	Rhee, J; Ryu, JH; Kim, JH; Chun, CH; Chun, JS				Rhee, Jinseol; Ryu, Je-Hwang; Kim, Jin-Hong; Chun, Churl-Hong; Chun, Jang-Soo			alpha-Catenin Inhibits beta-Catenin-T-cellFactor/Lymphoid Enhancing Factor Transcriptional Activity and Collagen Type II Expression in Articular Chondrocytes through Formation of Gli3R.alpha-Catenin.beta-Catenin Ternary Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIFFERENTIATED PHENOTYPE; OSTEOARTHRITIS; MAINTENANCE; PATHWAY; DOMAIN; ROLES	Chondrocytes, a unique cell type in cartilage tissue, are responsible for the regulation of anabolic and catabolic homeostasis in cartilage-specific extracellular matrix synthesis. Activation of Wnt/beta-catenin signaling induces dedifferentiation of articular chondrocytes, resulting in suppression of type II collagen expression. Wehave shown previously that beta-catenin inhibits beta-catenin-Tcf/Lef (T-cell factor/lymphoid-enhancing factor) transcriptional activity in articular chondrocytes with a concomitant recovery of type II collagen expression. In the current study, we elucidated the mechanism underlying this inhibition of beta-catenin-Tcf/Lef transcriptional activity by beta-catenin, showing that it requires direct interaction between beta-catenin and beta-catenin. We further showed that it involves recruitment of Gli3R, the short transcription-repressing form of the transcription factor Gli3, to beta-catenin by beta-catenin. The resulting inhibition of beta-catenin transcriptional activity leads to increased expression of type II collagen. Gli3R and beta-catenin actions are co-dependent: both are necessary for the observed inhibitory effects on beta-catenin transcriptional activity. Reducing Gli3R expression levels through activation of Indian Hedgehog (Ihh) signaling also is sufficient to activate beta-catenin transcriptional activity, suggesting that the ternary complex, Gli3R.beta-catenin.beta-catenin, mediates Ihh-dependent activation of Wnt/beta-catenin signaling in articular chondrocytes. Collectively, this study shows that beta-catenin functions as a nuclear factor that recruits the transcriptional repressor Gli3R to beta-catenin to inhibit beta-catenin transcriptional activity and dedifferentiation of articular chondrocytes. Finally, osteoarthritic cartilage showed elevated levels of beta-catenin and decreased levels of beta-catenin and Gli3R, suggesting that decreased levels of -catenin and Gli3R levels contribute to increased beta-catenin transcriptional activity during osteoarthritic cartilage destruction.	[Rhee, Jinseol; Ryu, Je-Hwang; Kim, Jin-Hong; Chun, Jang-Soo] Gwangju Inst Sci & Technol, Sch Life Sci, Kwangju 500712, South Korea; [Rhee, Jinseol; Ryu, Je-Hwang; Kim, Jin-Hong; Chun, Jang-Soo] Gwangju Inst Sci & Technol, Cell Dynam Res Ctr, Kwangju 500712, South Korea; [Chun, Churl-Hong] Wonkwang Univ, Sch Med, Dept Orthoped Surg, Iksan 570711, South Korea	Gwangju Institute of Science & Technology (GIST); Gwangju Institute of Science & Technology (GIST); Wonkwang University	Chun, JS (corresponding author), Gwangju Inst Sci & Technol, Sch Life Sci, Kwangju 500712, South Korea.	jschun@gist.ac.kr		Kim, Jin-Hong/0000-0002-6480-1929	National Research Foundation of Korea [2009-0074544, 2010-0012410, 2011-0001158, 2010-0026293]	National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by National Research Foundation of Korea Grants 2009-0074544 and 2010-0012410 (to J. R.) and 2011-0001158 and 2010-0026293 (to J.-S. C.).	Alvarez-Medina R, 2008, DEVELOPMENT, V135, P237, DOI 10.1242/dev.012054; Benjamin JM, 2008, SEMIN CANCER BIOL, V18, P53, DOI 10.1016/j.semcancer.2007.08.003; Dai P, 2002, GENE DEV, V16, P2843, DOI 10.1101/gad.1017302; Daniel JM, 1999, MOL CELL BIOL, V19, P3614; Daniels DL, 2005, NAT STRUCT MOL BIOL, V12, P364, DOI 10.1038/nsmb912; Davis MA, 2003, J CELL BIOL, V163, P525, DOI 10.1083/jcb.200307111; Drees F, 2005, CELL, V123, P903, DOI 10.1016/j.cell.2005.09.021; El-Bahrawy M, 2002, LAB INVEST, V82, P1167, DOI 10.1097/01.LAB.0000028821.41246.6A; Giannini AL, 2000, J BIOL CHEM, V275, P21883, DOI 10.1074/jbc.M001929200; Glasson SS, 2007, OSTEOARTHR CARTILAGE, V15, P1061, DOI 10.1016/j.joca.2007.03.006; Hecht A, 2000, EMBO J, V19, P1839, DOI 10.1093/emboj/19.8.1839; Heuberger J, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002915; Huber O, 1997, J CELL SCI, V110, P1759; Hwang SG, 2005, J BIOL CHEM, V280, P12758, DOI 10.1074/jbc.M413367200; Hwang SG, 2004, J BIOL CHEM, V279, P26597, DOI 10.1074/jbc.M401401200; Kim JS, 2007, J BIOL CHEM, V282, P29359, DOI 10.1074/jbc.M700965200; Lien WH, 2006, SCIENCE, V311, P1609, DOI 10.1126/science.1121449; Lin AC, 2009, NAT MED, V15, P1421, DOI 10.1038/nm.2055; Mak KK, 2008, DEVELOPMENT, V135, P1947, DOI 10.1242/dev.018044; Park JI, 2005, DEV CELL, V8, P843, DOI 10.1016/j.devcel.2005.04.010; Ribes V, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002014; Ruiz i Altaba A, 2007, TRENDS CELL BIOL, V17, P438, DOI 10.1016/j.tcb.2007.06.007; Ryu JH, 2006, J BIOL CHEM, V281, P22039, DOI 10.1074/jbc.M601804200; Ryu JH, 2011, ARTHRITIS RHEUM-US, V63, P2732, DOI 10.1002/art.30451; Ryu JH, 2002, DEVELOPMENT, V129, P5541, DOI 10.1242/dev.00110; Schulze-Tanzil G, 2009, ANN ANAT, V191, P325, DOI 10.1016/j.aanat.2009.05.003; Scott JA, 2006, J CELL SCI, V119, P4599, DOI 10.1242/jcs.03267; Sehgal RNM, 1997, J CELL BIOL, V139, P1033, DOI 10.1083/jcb.139.4.1033; Ulloa F, 2007, CURR BIOL, V17, P545, DOI 10.1016/j.cub.2007.01.062; Xiao KY, 2003, J CELL BIOL, V163, P535, DOI 10.1083/jcb.200306001; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020; Yang S, 2010, NAT MED, V16, P687, DOI 10.1038/nm.2153; Yoon YM, 2002, J BIOL CHEM, V277, P8412, DOI 10.1074/jbc.M110608200; Zhu M, 2009, J BONE MINER RES, V24, P12, DOI 10.1359/JBMR.080901	34	10	13	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					11751	11760		10.1074/jbc.M111.281014	http://dx.doi.org/10.1074/jbc.M111.281014			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22298781	Green Published, hybrid			2022-12-25	WOS:000302782200014
J	Chaparro-Riggers, J; Liang, H; Devay, RM; Bai, LF; Sutton, JE; Chen, W; Geng, T; Lindquist, K; Casas, MG; Boustany, LM; Brown, CL; Chabot, J; Gomes, B; Garzone, P; Rossi, A; Strop, P; Shelton, D; Pons, J; Rajpal, A				Chaparro-Riggers, Javier; Liang, Hong; DeVay, Rachel M.; Bai, Lanfang; Sutton, Janette E.; Chen, Wei; Geng, Tao; Lindquist, Kevin; Casas, Meritxell Galindo; Boustany, Leila M.; Brown, Colleen L.; Chabot, Jeffrey; Gomes, Bruce; Garzone, Pamela; Rossi, Andrea; Strop, Pavel; Shelton, Dave; Pons, Jaume; Rajpal, Arvind			Increasing Serum Half-life and Extending Cholesterol Lowering in Vivo by Engineering Antibody with pH-sensitive Binding to PCSK9	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THERAPEUTIC MONOCLONAL-ANTIBODIES; DENSITY-LIPOPROTEIN CHOLESTEROL; POPULATION PHARMACOKINETICS; NONHUMAN-PRIMATES; LDL-CHOLESTEROL; RECEPTOR; HYPERCHOLESTEROLEMIA; PHARMACODYNAMICS; MECHANISMS; DEPENDENCE	Background: An antagonistic anti-PCSK9 antibody exhibits target- mediated clearance, resulting in a dose-dependent PK. Results: Engineering of an antibody with pH-sensitive binding to PCSK9 decreases target-mediated clearance, resulting in increased PK and efficacy in vivo. Conclusion: pH-sensitive anti-PCSK9 antibodies are excellent candidates for therapeutic development. Significance: pH-sensitive antibodies may enable less frequent or lower dosing of antibodies hampered by target-mediated clearance and high antigen load.	[Chaparro-Riggers, Javier; Liang, Hong; DeVay, Rachel M.; Bai, Lanfang; Sutton, Janette E.; Chen, Wei; Geng, Tao; Lindquist, Kevin; Casas, Meritxell Galindo; Boustany, Leila M.; Brown, Colleen L.; Chabot, Jeffrey; Garzone, Pamela; Rossi, Andrea; Strop, Pavel; Shelton, Dave; Pons, Jaume; Rajpal, Arvind] Rinat Pfizer Inc, San Francisco, CA 94080 USA; [Gomes, Bruce] Novartis Inst BioMed Res Inc, Cambridge, MA 02139 USA	Pfizer; Novartis	Pons, J (corresponding author), Rinat Pfizer Inc, 230 E Grand Ave, San Francisco, CA 94080 USA.	jaume.pons@pfizer.com; arvind.rajpal@pfizer.com		Lindquist, Kevin/0000-0001-6059-7425; Galindo Casas, Meritxell/0000-0002-5034-1722				Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Abifadel M, 2010, EXPERT OPIN THER PAT, V20, P1547, DOI 10.1517/13543776.2010.518615; Bottomley MJ, 2009, J BIOL CHEM, V284, P1313, DOI 10.1074/jbc.M808363200; Chan JCY, 2009, P NATL ACAD SCI USA, V106, P9820, DOI 10.1073/pnas.0903849106; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Dirks NL, 2010, CLIN PHARMACOKINET, V49, P633, DOI 10.2165/11535960-000000000-00000; Hayashi N, 2007, BRIT J CLIN PHARMACO, V63, P548, DOI 10.1111/j.1365-2125.2006.02803.x; Hooper AJ, 2007, ATHEROSCLEROSIS, V193, P445, DOI 10.1016/j.atherosclerosis.2006.08.039; Horton JD, 2009, J LIPID RES, V50, pS172, DOI 10.1194/jlr.R800091-JLR200; Igawa T, 2010, NAT BIOTECHNOL, V28, P1203, DOI 10.1038/nbt.1691; Jonathan C, 2005, NAT GENET, V37, P161, DOI 10.1038/ng1509; Kotowski IK, 2006, AM J HUM GENET, V78, P410, DOI 10.1086/500615; Lambert G, 2009, ATHEROSCLEROSIS, V203, P1, DOI 10.1016/j.atherosclerosis.2008.06.010; Lazar GA, 2006, P NATL ACAD SCI USA, V103, P4005, DOI 10.1073/pnas.0508123103; Liang H, 2012, J PHARMACOL EXP THER, V340, P228, DOI 10.1124/jpet.111.187419; Maeda K, 2002, J CONTROL RELEASE, V82, P71, DOI 10.1016/S0168-3659(02)00126-8; Murtaugh ML, 2011, PROTEIN SCI, V20, P1619, DOI 10.1002/pro.696; Nassoury N, 2007, TRAFFIC, V8, P718, DOI 10.1111/j.1600-0854.2007.00562.x; Nelson AL, 2010, NAT REV DRUG DISCOV, V9, P767, DOI 10.1038/nrd3229; Ni YG, 2011, J LIPID RES, V52, P78, DOI 10.1194/jlr.M011445; Ni YG, 2010, J BIOL CHEM, V285, P12882, DOI 10.1074/jbc.M110.113035; Piper DE, 2007, STRUCTURE, V15, P545, DOI 10.1016/j.str.2007.04.004; RAGHAVAN M, 1995, BIOCHEMISTRY-US, V34, P14649, DOI 10.1021/bi00045a005; Rehlaender BN, 1998, PHARMACEUT RES, V15, P1652, DOI 10.1023/A:1011936007457; Roopenian DC, 2003, J IMMUNOL, V170, P3528, DOI 10.4049/jimmunol.170.7.3528; Sarkar CA, 2002, NAT BIOTECHNOL, V20, P908, DOI 10.1038/nbt725; Tabrizi MA, 2006, DRUG DISCOV TODAY, V11, P81, DOI 10.1016/S1359-6446(05)03638-X; Tabrizi M, 2010, AAPS J, V12, P33, DOI 10.1208/s12248-009-9157-5; Wang W, 2008, CLIN PHARMACOL THER, V84, P548, DOI 10.1038/clpt.2008.170; Yeung YA, 2009, J IMMUNOL, V182, P7663, DOI 10.4049/jimmunol.0804182; Zalevsky J, 2010, NAT BIOTECHNOL, V28, P157, DOI 10.1038/nbt.1601; Zhang DW, 2008, P NATL ACAD SCI USA, V105, P13045, DOI 10.1073/pnas.0806312105; Zhao ZZ, 2006, AM J HUM GENET, V79, P514, DOI 10.1086/507488	33	125	173	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					11090	11097		10.1074/jbc.M111.319764	http://dx.doi.org/10.1074/jbc.M111.319764			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22294692	Green Published, hybrid			2022-12-25	WOS:000302780100037
J	Rombouts, Y; Brust, B; Ojha, AK; Maes, E; Coddeville, B; Elass-Rochard, E; Kremer, L; Guerardel, Y				Rombouts, Yoann; Brust, Belinda; Ojha, Anil K.; Maes, Emmanuel; Coddeville, Bernadette; Elass-Rochard, Elisabeth; Kremer, Laurent; Guerardel, Yann			Exposure of Mycobacteria to Cell Wall-inhibitory Drugs Decreases Production of Arabinoglycerolipid Related to Mycolyl-arabinogalactan-peptidoglycan Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OUTER-MEMBRANE; TUBERCULOSIS; BIOSYNTHESIS; THIACETAZONE; ACIDS; IDENTIFICATION; ENVELOPE; AVIUM; ARABINOFURANOSYLTRANSFERASE; LIPOOLIGOSACCHARIDES	Background: Mycolyl-arabinogalactan-peptidoglycan (mAGP) represents the hallmark of the mycobacterial cell envelope and the target of several antitubercular drugs. Results: Loss of a glycolipid structurally analogous to the terminal portion of mAGP correlates with drug treatment in mycobacteria. Conclusion: This work establishes the versatility of arabinoglycerolipids in M. tuberculosis. Significance: Further work will define the importance of the metabolic relationship between the two components in cell wall remodeling and/or pathogenesis.	[Rombouts, Yoann; Maes, Emmanuel; Coddeville, Bernadette; Elass-Rochard, Elisabeth; Guerardel, Yann] Univ Lille 1, Univ Lille Nord France, Unite Glycobiol Struct & Fonct UGSF, F-59650 Villeneuve Dascq, France; [Rombouts, Yoann; Maes, Emmanuel; Coddeville, Bernadette; Elass-Rochard, Elisabeth; Guerardel, Yann] CNRS, UMR 8576, F-59650 Villeneuve Dascq, France; [Brust, Belinda; Kremer, Laurent] Univ Montpellier 2, Lab Dynam Interact Membranaires Normales & Pathol, F-34095 Montpellier 05, France; [Brust, Belinda; Kremer, Laurent] Univ Montpellier I, CNRS, UMR 5235, F-34095 Montpellier 05, France; [Kremer, Laurent] INSERM, F-34095 Montpellier 05, France; [Ojha, Anil K.] Univ Pittsburgh, Dept Infect Dis & Microbiol, Pittsburgh, PA 15260 USA; [Brust, Belinda] Biorad Labs, Div Clin Microbiol, F-59114 Steenvoorde, France	Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Guerardel, Y (corresponding author), Univ Lille 1, Univ Lille Nord France, Unite Glycobiol Struct & Fonct UGSF, F-59650 Villeneuve Dascq, France.	yann.guerardel@univ-lille1.fr	Kremer, Laurent/M-4935-2017	Kremer, Laurent/0000-0002-6604-4458; Rombouts, Yoann/0000-0003-4482-2199; Guerardel, Yann/0000-0003-4967-9512; elass, elisabeth/0000-0002-2573-2959	French National Research Agency [ANR-05-MIIM-025]; Ministere de l'Enseignement Superieur; Tres Grand Equipment de Resonance Magnetique Nucleaire a Tres Hauts Champs Grant [Fr3050]; Association Nationale de la Recherche et de la Technologie and Bio-Rad Laboratories; Region Nord-Pas de Calais; European Union; Ministere Francais de la Recherche; Universite Lille1-Sciences et Technologies; CNRS; Institut Pasteur de Lille	French National Research Agency(French National Research Agency (ANR)); Ministere de l'Enseignement Superieur; Tres Grand Equipment de Resonance Magnetique Nucleaire a Tres Hauts Champs Grant; Association Nationale de la Recherche et de la Technologie and Bio-Rad Laboratories; Region Nord-Pas de Calais(Region Hauts-de-FranceEuropean Commission); European Union(European Commission); Ministere Francais de la Recherche(Ministry of Research, France); Universite Lille1-Sciences et Technologies; CNRS(Centre National de la Recherche Scientifique (CNRS)); Institut Pasteur de Lille	This study was supported by French National Research Agency Grant ANR-05-MIIM-025 (to Y. G. and L. K.), a grant from the Ministere de l'Enseignement Superieur (to Y. R.), Tres Grand Equipment de Resonance Magnetique Nucleaire a Tres Hauts Champs Grant Fr3050 (for conducting the research on the 800 and 900 MHz spectrometers), and the Association Nationale de la Recherche et de la Technologie and Bio-Rad Laboratories (to B. B.).; The 800 and 900 MHz spectrometers were funded by Region Nord-Pas de Calais, European Union (Fonds Europeen de Developpement Regional), Ministere Francais de la Recherche, Universite Lille1-Sciences et Technologies, and CNRS. The 600 MHz facility used in this study was funded by the European Union, Region Nord-Pas de Calais, CNRS, and Institut Pasteur de Lille.	Alahari A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001343; Alahari A, 2009, MOL MICROBIOL, V71, P1263, DOI 10.1111/j.1365-2958.2009.06604.x; Bermudez LE, 2003, ANTIMICROB AGENTS CH, V47, P2685, DOI 10.1128/AAC.47.8.2685-2687.2003; Birch HL, 2008, MOL MICROBIOL, V69, P1191, DOI 10.1111/j.1365-2958.2008.06354.x; BOCK K, 1973, TETRAHEDRON LETT, P1037; BRENNAN PJ, 1995, ANNU REV BIOCHEM, V64, P29, DOI 10.1146/annurev.bi.64.070195.000333; BRUCKNER J, 1955, BIOCHEM J, V60, P200; Burguiere A, 2005, J BIOL CHEM, V280, P42124, DOI 10.1074/jbc.M507500200; Caminero JA, 2010, LANCET INFECT DIS, V10, P621, DOI 10.1016/S1473-3099(10)70139-0; Candela T, 2011, J BIOL CHEM, V286, P31250, DOI 10.1074/jbc.M111.249821; Daffe M, 1998, ADV MICROB PHYSIOL, V39, P131; Dao DN, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000081; DAVIDSON PT, 1992, DRUGS, V43, P651, DOI 10.2165/00003495-199243050-00003; DENG LY, 1995, ANTIMICROB AGENTS CH, V39, P694, DOI 10.1128/AAC.39.3.694; Dover LG, 2007, ANTIMICROB AGENTS CH, V51, P1055, DOI 10.1128/AAC.01063-06; Dubnau E, 1997, MOL MICROBIOL, V23, P313, DOI 10.1046/j.1365-2958.1997.2301589.x; Dubnau E, 2000, MOL MICROBIOL, V36, P630, DOI 10.1046/j.1365-2958.2000.01882.x; Fujita Y, 2005, MICROBIOL-SGM, V151, P3403, DOI 10.1099/mic.0.28158-0; Haites RE, 2005, J BIOL CHEM, V280, P10981, DOI 10.1074/jbc.M413443200; Hoffmann C, 2008, P NATL ACAD SCI USA, V105, P3963, DOI 10.1073/pnas.0709530105; HONDA I, 1993, RES MICROBIOL, V144, P229, DOI 10.1016/0923-2508(93)90048-7; HOUSTON S, 1994, DRUGS, V48, P689, DOI 10.2165/00003495-199448050-00004; Karakousis PC, 2004, CELL MICROBIOL, V6, P105, DOI 10.1046/j.1462-5822.2003.00351.x; Kremer L, 2002, MICROBIOL-SGM, V148, P3145, DOI 10.1099/00221287-148-10-3145; Kremer L, 2000, MOLECULAR GENETICS OF MYCOBACTERIA, P173; Lee A, 2006, BIOCHEMISTRY-US, V45, P15817, DOI 10.1021/bi060688d; Matsunaga I, 2008, J BIOL CHEM, V283, P28835, DOI 10.1074/jbc.M805776200; MIKUSOVA K, 1995, ANTIMICROB AGENTS CH, V39, P2484, DOI 10.1128/AAC.39.11.2484; Minnikin DE, 2002, CHEM BIOL, V9, P545, DOI 10.1016/S1074-5521(02)00142-4; Mizutani K., 1983, CARBOHYD RES, V185, P27; Neyrolles O, 2011, TUBERCULOSIS, V91, P187, DOI 10.1016/j.tube.2011.01.002; NUNN P, 1993, T ROY SOC TROP MED H, V87, P578, DOI 10.1016/0035-9203(93)90096-9; Ojha AK, 2010, J BIOL CHEM, V285, P17380, DOI 10.1074/jbc.M110.112813; Rombouts Y, 2009, J BIOL CHEM, V284, P20975, DOI 10.1074/jbc.M109.011429; Sakamoto T, 2004, BBA-GEN SUBJECTS, V1674, P85, DOI 10.1016/j.bbagen.2004.06.001; Sambandamurthy VK, 2006, VACCINE, V24, P6309, DOI 10.1016/j.vaccine.2006.05.097; Seidel M, 2007, J BIOL CHEM, V282, P14729, DOI 10.1074/jbc.M700271200; Skovierova H, 2009, GLYCOBIOLOGY, V19, P1235, DOI 10.1093/glycob/cwp116; Stinear TP, 2008, GENOME RES, V18, P729, DOI 10.1101/gr.075069.107; Takayama K, 2005, CLIN MICROBIOL REV, V18, P81, DOI 10.1128/CMR.18.1.81-101.2005; Telenti A, 1997, NAT MED, V3, P567, DOI 10.1038/nm0597-567; Vilcheze C, 2007, ANNU REV MICROBIOL, V61, P35, DOI 10.1146/annurev.micro.61.111606.122346; Watanabe M, 1997, EUR J BIOCHEM, V248, P93, DOI 10.1111/j.1432-1033.1997.00093.x; WATANABE M, 1992, BIOCHIM BIOPHYS ACTA, V1165, P53, DOI 10.1016/0005-2760(92)90075-7; WINDER F G, 1970, Journal of General Microbiology, V63, P41; Xin Y, 1999, BBA-GEN SUBJECTS, V1473, P267, DOI 10.1016/S0304-4165(99)00204-4; Zanetta JP, 1999, GLYCOCONJUGATE J, V16, P617, DOI 10.1023/A:1007076900562; Zuber B, 2008, J BACTERIOL, V190, P5672, DOI 10.1128/JB.01919-07	48	20	22	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					11060	11069		10.1074/jbc.M111.327387	http://dx.doi.org/10.1074/jbc.M111.327387			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22315220	Green Published, hybrid			2022-12-25	WOS:000302780100034
J	Declercq, J; Meulemans, S; Plets, E; Creemers, JWM				Declercq, Jeroen; Meulemans, Sandra; Plets, Evelyn; Creemers, John W. M.			Internalization of Proprotein Convertase PC7 from Plasma Membrane Is Mediated by a Novel Motif	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANS-GOLGI NETWORK; TAIL SORTING SIGNALS; CYTOPLASMIC TAIL; INTRACELLULAR TRAFFICKING; CELL-SURFACE; GENE FAMILY; FURIN; LOCALIZATION; PROTEINS; COMPARTMENTS	Proprotein convertase 7 (PC7) is a member of the subtilisin-like proprotein convertase family, which is involved in the endoproteolysis of a variety of precursor proteins. Under steady state conditions, PC7 is mainly localized in the trans-Golgi network, but a small fraction is found at the cell surface. So far, no sorting signals for membrane trafficking have been identified in PC7. In this study, we have examined the internalization of PC7 from the plasma membrane. Our results show that internalization of PC7 is mediated by clathrin-coated vesicles. After inhibition of clathrin-mediated endocytosis using hypertonic conditions or the small molecule inhibitor, Pitstop 2, PC7 accumulated at the plasma membrane. Furthermore, PC7 was present in isolated clathrin-coated vesicles. To determine the internalization motif, constructs were generated in which parts of the N and C terminus of the cytoplasmic tail of PC7 were deleted, and chimeric proteins were constructed consisting of the luminal and transmembrane domains of Tac (CD25) and parts of the cytoplasmic domain of PC7. Antibody uptake experiments as well as surface biotinylation experiments demonstrated that the region between Ala(713) and Cys(726) in the cytoplasmic domain of PC7 is essential and sufficient for the internalization of PC7 but not for trans-Golgi network localization. Individual amino acids in this region were substituted with alanine, which identified Pro, Leu, and Cys as the essential amino acids. In conclusion, internalization of PC7 depends on a short transferable sequence in the cytoplasmic tail, which contains the three crucial amino acids PLC.	[Declercq, Jeroen; Meulemans, Sandra; Plets, Evelyn; Creemers, John W. M.] Univ Louvain, Dept Human Genet, Lab Biochem Neuroendocrinol, B-3000 Louvain, Belgium		Creemers, JWM (corresponding author), Univ Louvain, Dept Human Genet, Lab Biochem Neuroendocrinol, O&N1,Herestr 49 Bus 602, B-3000 Louvain, Belgium.	john.creemers@med.kuleuven.be		Plets, Evelyn/0000-0001-7312-8804	"Fonds voor Wetenschappelijk Onderzoek Vlaanderen" (FWO); Geconcerteerde Onderzoeksacties (GOA) [2008/16, GOA/12/016]	"Fonds voor Wetenschappelijk Onderzoek Vlaanderen" (FWO)(FWO); Geconcerteerde Onderzoeksacties (GOA)	This work was supported in part by grants from the "Fonds voor Wetenschappelijk Onderzoek Vlaanderen" (FWO) and "Geconcerteerde Onderzoeksacties" (GOA 2008/16 and GOA/12/016).	Blagoveshchenskaya AD, 1998, J BIOL CHEM, V273, P2729, DOI 10.1074/jbc.273.5.2729; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Bruzzaniti A, 1996, BIOCHEM J, V314, P727, DOI 10.1042/bj3140727; Constam DB, 1996, J CELL BIOL, V134, P181, DOI 10.1083/jcb.134.1.181; Constam DB, 1999, J CELL BIOL, V144, P139, DOI 10.1083/jcb.144.1.139; Creemers JWM, 2008, FRONT BIOSCI-LANDMRK, V13, P4960, DOI 10.2741/3055; Creemers JWM, 2000, J BIOL CHEM, V275, P38842, DOI 10.1074/jbc.M006758200; CREEMERS JWM, 1993, J BIOL CHEM, V268, P21826; DeBie I, 1996, J CELL BIOL, V135, P1261, DOI 10.1083/jcb.135.5.1261; Essalmani R, 2006, MOL CELL BIOL, V26, P354, DOI 10.1128/MCB.26.1.354-361.2006; FRANZUSOFF A, 1991, J CELL BIOL, V112, P27, DOI 10.1083/jcb.112.1.27; HEUSER JE, 1989, J CELL BIOL, V108, P389, DOI 10.1083/jcb.108.2.389; JONES BG, 1995, EMBO J, V14, P5869, DOI 10.1002/j.1460-2075.1995.tb00275.x; Leonhardt RM, 2010, J IMMUNOL, V184, P2985, DOI 10.4049/jimmunol.0900308; Meerabux J, 1996, CANCER RES, V56, P448; MOLLOY SS, 1994, EMBO J, V13, P18, DOI 10.1002/j.1460-2075.1994.tb06231.x; Rappoport JZ, 2006, AM J PHYSIOL-CELL PH, V291, pC1072, DOI 10.1152/ajpcell.00160.2006; Roebroek AJM, 1998, DEVELOPMENT, V125, P4863; Rousselet E, 2011, J BIOL CHEM, V286, P9185, DOI 10.1074/jbc.M110.189936; Rousselet E, 2011, J BIOL CHEM, V286, P2728, DOI 10.1074/jbc.M110.192344; Seidah NG, 2011, ANN NY ACAD SCI, V1220, P149, DOI 10.1111/j.1749-6632.2010.05883.x; Seidah NG, 1996, P NATL ACAD SCI USA, V93, P3388, DOI 10.1073/pnas.93.8.3388; Siegfried G, 2005, ONCOGENE, V24, P6925, DOI 10.1038/sj.onc.1208838; Siegfried G, 2003, J CLIN INVEST, V111, P1723, DOI 10.1172/JCI200317220; Siegfried G, 2003, CANCER RES, V63, P1458; Taylor NA, 2003, FASEB J, V17, P1215, DOI 10.1096/fj.02-0831rev; Teuchert M, 1999, J BIOL CHEM, V274, P8199, DOI 10.1074/jbc.274.12.8199; Teuchert M, 1999, J BIOL CHEM, V274, P36781, DOI 10.1074/jbc.274.51.36781; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; van de Loo JWHP, 2000, BIOCHEM J, V352, P827, DOI 10.1042/0264-6021:3520827; vandeLoo JWHP, 1997, J BIOL CHEM, V272, P27116, DOI 10.1074/jbc.272.43.27116; Villeneuve P, 2002, J NEUROCHEM, V82, P783, DOI 10.1046/j.1471-4159.2002.00988.x; von Kleist L, 2011, CELL, V146, P471, DOI 10.1016/j.cell.2011.06.025; VOORHEES P, 1995, EMBO J, V14, P4961, DOI 10.1002/j.1460-2075.1995.tb00179.x; Wan L, 1998, CELL, V94, P205, DOI 10.1016/S0092-8674(00)81420-8; Wouters S, 1998, BIOCHEM J, V336, P311, DOI 10.1042/bj3360311; Xiang Y, 2000, MOL BIOL CELL, V11, P1257, DOI 10.1091/mbc.11.4.1257	37	17	17	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					9052	9060		10.1074/jbc.M111.306407	http://dx.doi.org/10.1074/jbc.M111.306407			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22294700	Green Published, hybrid			2022-12-25	WOS:000301797800035
J	Foeger, NC; Norris, AJ; Wren, LM; Nerbonne, JM				Foeger, Nicholas C.; Norris, Aaron J.; Wren, Lisa M.; Nerbonne, Jeanne M.			Augmentation of Kv4.2-encoded Currents by Accessory Dipeptidyl Peptidase 6 and 10 Subunits Reflects Selective Cell Surface Kv4.2 Protein Stabilization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORTICAL PYRAMIDAL NEURONS; GATED POTASSIUM CHANNELS; ADULT-MOUSE VENTRICLES; K+ CURRENTS; ALPHA-SUBUNITS; I-A; HIPPOCAMPAL-NEURONS; EXPRESSION; COMPLEXES; DPPX	Rapidly activating and inactivating somatodendritic voltage-gated K+ (Kv) currents, I-A, play critical roles in the regulation of neuronal excitability. Considerable evidence suggests that native neuronal I-A channels function in macromolecular protein complexes comprising pore-forming (alpha) subunits of the Kv4 subfamily together with cytosolic, K+ channel interacting proteins (KChIPs) and transmembrane, dipeptidyl peptidase 6 and 10 (DPP6/10) accessory subunits, as well as other accessory and regulatory proteins. Several recent studies have demonstrated a critical role for the KChIP subunits in the generation of native Kv4.2-encoded channels and that Kv4.2-KChIP complex formation results in mutual (Kv4.2-KChIP) protein stabilization. The results of the experiments here, however, demonstrate that expression of DPP6 in the mouse cortex is unaffected by the targeted deletion of Kv4.2 and/or Kv4.3. Further experiments revealed that heterologously expressed DPP6 and DPP10 localize to the cell surface in the absence of Kv4.2, and that co-expression with Kv4.2 does not affect total or cell surface DPP6 or DPP10 protein levels. In the presence of DPP6 or DPP10, however, cell surface Kv4.2 protein expression is selectively increased. Further addition of KChIP3 in the presence of DPP10 markedly increases total and cell surface Kv4.2 protein levels, compared with cells expressing only Kv4.2 and DPP10. Taken together, the results presented here demonstrate that the expression and localization of the DPP accessory subunits are independent of Kv4 alpha subunits and further that the DPP6/10 and KChIP accessory subunits independently stabilize the surface expression of Kv4.2.	[Foeger, Nicholas C.; Norris, Aaron J.; Wren, Lisa M.; Nerbonne, Jeanne M.] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA	Washington University (WUSTL)	Nerbonne, JM (corresponding author), Washington Univ, Sch Med, Dept Dev Biol, Campus Box 8103,660 S Euclid Ave, St Louis, MO 63110 USA.	jnerbonne@wustl.edu		Norris, Aaron/0000-0001-7825-1756	National Institutes of Health [HL034161]; NHLBI, National Institutes of Health [T32-HL007275]; National Eye Institute [T32-EY013360]; NATIONAL EYE INSTITUTE [T32EY013360] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007275] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL034161 (to J. M. N.).; Supported by Grant T32-HL007275 from the NHLBI, National Institutes of Health.; Supported by Grant T32-EY013360 from the National Eye Institute.	Amarillo Y, 2008, J PHYSIOL-LONDON, V586, P2093, DOI 10.1113/jphysiol.2007.150540; An WF, 2000, NATURE, V403, P553, DOI 10.1038/35000592; Anderson D, 2010, CHANNELS, V4, P163, DOI 10.4161/chan.4.3.11955; Anderson D, 2010, NAT NEUROSCI, V13, P333, DOI 10.1038/nn.2493; Bahring R, 2001, J BIOL CHEM, V276, P23888, DOI 10.1074/jbc.M101320200; Bekkers JM, 2000, J PHYSIOL-LONDON, V525, P611, DOI 10.1111/j.1469-7793.2000.t01-2-00611.x; Birnbaum SG, 2004, PHYSIOL REV, V84, P803, DOI 10.1152/physrev.00039.2003; Brunet S, 2004, J PHYSIOL-LONDON, V559, P103, DOI 10.1113/jphysiol.2004.063347; Burgoyne RD, 2004, TRENDS NEUROSCI, V27, P203, DOI 10.1016/j.tins.2004.01.010; Burgoyne RD, 2001, BIOCHEM J, V353, P1; Cai X, 2004, NEURON, V44, P351, DOI 10.1016/j.neuron.2004.09.026; Chen XX, 2006, J NEUROSCI, V26, P12143, DOI 10.1523/JNEUROSCI.2667-06.2006; Clark B. D., 2008, FRONT MOL NEUROSCI, V1, DOI [10.3389/neuro.3302.3008.2008, DOI 10.3389/NEURO.3302.3008.2008]; CONNOR JA, 1971, J PHYSIOL-LONDON, V213, P21, DOI 10.1113/jphysiol.1971.sp009365; Cronin S, 2008, HUM MOL GENET, V17, P768, DOI 10.1093/hmg/ddm361; Foeger NC, 2010, J BIOL CHEM, V285, P33413, DOI 10.1074/jbc.M110.145185; Gardoni F, 2007, J BIOL CHEM, V282, P28691, DOI 10.1074/jbc.M701899200; Guo WN, 2005, CIRC RES, V97, P1342, DOI 10.1161/01.RES.0000196559.63223.aa; Hausser M, 2000, SCIENCE, V290, P739, DOI 10.1126/science.290.5492.739; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; Jerng HH, 2005, J PHYSIOL-LONDON, V568, P767, DOI 10.1113/jphysiol.2005.087858; Jerng HH, 2004, BIOPHYS J, V87, P2380, DOI 10.1529/biophysj.104.042358; Johns DC, 1999, J NEUROSCI, V19, P1691; Kang J, 2000, J NEUROPHYSIOL, V83, P70, DOI 10.1152/jn.2000.83.1.70; Kaulin YA, 2009, J NEUROSCI, V29, P3242, DOI 10.1523/JNEUROSCI.4767-08.2009; Kim J, 2005, J PHYSIOL-LONDON, V569, P41, DOI 10.1113/jphysiol.2005.095042; Kin Y, 2001, J BIOCHEM-TOKYO, V129, P289, DOI 10.1093/oxfordjournals.jbchem.a002856; Kunjilwar K, 2004, J BIOL CHEM, V279, P54542, DOI 10.1074/jbc.M409721200; Maffie J, 2009, NEUROSCI LETT, V449, P189, DOI 10.1016/j.neulet.2008.10.098; Maffie J, 2008, J PHYSIOL-LONDON, V586, P5609, DOI 10.1113/jphysiol.2008.161620; Marionneau C, 2008, CIRC RES, V102, P1406, DOI 10.1161/CIRCRESAHA.107.170050; Marionneau C, 2009, CHANNELS, V3, P284; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; Menegola M, 2006, J NEUROSCI, V26, P12137, DOI 10.1523/JNEUROSCI.2783-06.2006; Nadal MS, 2003, NEURON, V37, P449, DOI 10.1016/S0896-6273(02)01185-6; Nerbonne JM, 2008, J PHYSIOL-LONDON, V586, P1565, DOI 10.1113/jphysiol.2007.146597; Niwa N, 2008, J MOL CELL CARDIOL, V44, P95, DOI 10.1016/j.yjmcc.2007.10.007; Norris AJ, 2010, J NEUROSCI, V30, P13644, DOI 10.1523/JNEUROSCI.2487-10.2010; Norris AJ, 2010, J NEUROSCI, V30, P5092, DOI 10.1523/JNEUROSCI.5890-09.2010; Petrecca K, 2000, J NEUROSCI, V20, P8736; Phelan Mary C, 2007, Curr Protoc Cell Biol, VChapter 1, DOI 10.1002/0471143030.cb0101s36; Ren XM, 2005, MOL CELL NEUROSCI, V29, P320, DOI 10.1016/j.mcn.2005.02.003; ROGAWSKI MA, 1985, TRENDS NEUROSCI, V8, P214, DOI 10.1016/0166-2236(85)90082-7; SEGAL M, 1984, J NEUROSCI, V4, P604; Seikel E, 2009, BIOCHEMISTRY-US, V48, P5721, DOI 10.1021/bi802316m; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shibata R, 2003, J BIOL CHEM, V278, P36445, DOI 10.1074/jbc.M306142200; Strop P, 2004, J MOL BIOL, V343, P1055, DOI 10.1016/j.jmb.2004.09.003; Stuart G, 1997, TRENDS NEUROSCI, V20, P125, DOI 10.1016/S0166-2236(96)10075-8; Sun W, 2011, NEURON, V71, P1102, DOI 10.1016/j.neuron.2011.08.008; van Es MA, 2008, NAT GENET, V40, P29, DOI 10.1038/ng.2007.52; Wu MN, 2010, NAT NEUROSCI, V13, P69, DOI 10.1038/nn.2454; Yuan WL, 2005, J NEUROSCI, V25, P9185, DOI 10.1523/JNEUROSCI.2858-05.2005; Zagha E, 2005, J BIOL CHEM, V280, P18853, DOI 10.1074/jbc.M410613200; Zhu XR, 1999, RECEPTOR CHANNEL, V6, P387	55	27	31	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					9640	9650		10.1074/jbc.M111.324574	http://dx.doi.org/10.1074/jbc.M111.324574			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22311982	Green Published, hybrid			2022-12-25	WOS:000301797800095
J	Ikenouchi, J; Suzuki, M; Umeda, K; Ikeda, K; Taguchi, R; Kobayashi, T; Sato, SB; Kobayashi, T; Stolz, DB; Umeda, M				Ikenouchi, Junichi; Suzuki, Mayu; Umeda, Kazuaki; Ikeda, Kazutaka; Taguchi, Ryo; Kobayashi, Tetsuyuki; Sato, Satoshi B.; Kobayashi, Toshihide; Stolz, Donna B.; Umeda, Masato			Lipid Polarity Is Maintained in Absence of Tight Junctions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASOLATERAL PLASMA-MEMBRANE; SEPTIN DIFFUSION BARRIER; BELT-LIKE ADHERENS; EPITHELIAL-CELLS; MDCK CELLS; SPHINGOMYELIN; PROTEIN; CHOLESTEROL; LYSENIN; DOMAIN	The role of tight junctions (TJs) in the establishment and maintenance of lipid polarity in epithelial cells has long been a subject of controversy. We have addressed this issue using lysenin, a toxin derived from earthworms, and an influenza virus labeled with a fluorescent lipid, octadecylrhodamine B (R18). When epithelial cells are stained with lysenin, lysenin selectively binds to their apical membranes. Using an artificial liposome, we demonstrated that lysenin recognizes the membrane domains where sphingomyelins are clustered. Interestingly, lysenin selectively stained the apical membranes of epithelial cells depleted of zonula occludens proteins (ZO-deficient cells), which completely lack TJs. Furthermore, the fluorescent lipid inserted into the apical membrane by fusion with the influenza virus did not diffuse to the lateral membrane in ZO-deficient epithelial cells. This study revealed that sphingomyelin-cluster formation occurs only in the apical membrane and that lipid polarity is maintained even in the absence of TJs.	[Ikenouchi, Junichi] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Umeda, Masato] Kyoto Univ, Dept Synthet Chem & Biol Chem, Grad Sch Engn, Kyoto 6158510, Japan; [Umeda, Kazuaki] Kumamoto Univ, Dept Mol Pharmacol, Grad Sch Med Sci, Kumamoto 8608556, Japan; [Ikeda, Kazutaka; Taguchi, Ryo] Univ Tokyo, Dept Metabolome, Grad Sch Med, Bunkyo Ku, Tokyo 1130033, Japan; [Ikeda, Kazutaka; Taguchi, Ryo; Kobayashi, Tetsuyuki] Japan Sci & Technol Agcy JST, CREST, Kawaguchi, Saitama 3320012, Japan; Ochanomizu Univ, Dept Biol, Fac Sci, Tokyo 1128610, Japan; [Sato, Satoshi B.] Kyoto Univ, Res Ctr Low Temp & Mat Sci, Kyoto 6068501, Japan; [Kobayashi, Toshihide] RIKEN, Wako, Saitama 3510198, Japan; [Stolz, Donna B.] Univ Pittsburgh, Sch Med, Dept Cell Biol & Physiol, Pittsburgh, PA 15261 USA	Japan Science & Technology Agency (JST); Kyoto University; Kumamoto University; University of Tokyo; Japan Science & Technology Agency (JST); Ochanomizu University; Kyoto University; RIKEN; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Ikenouchi, J (corresponding author), Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan.	ikenouchi@sbchem.kyoto-u.ac.jp	Kobayashi, Toshihide/B-6298-2015; Ikenouchi, Junichi/X-2871-2019; Kobayashi, Tetsuyuki/AAH-2985-2020; KOBAYASHI, TOSHIHIDE/S-8313-2019	Kobayashi, Toshihide/0000-0002-4811-7270; Ikenouchi, Junichi/0000-0002-2936-3548; Kobayashi, Tetsuyuki/0000-0002-9285-0859; KOBAYASHI, TOSHIHIDE/0000-0002-4811-7270	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Precursory Research for Embryonic Science and Technology, Japan Science and Technology Agency	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Precursory Research for Embryonic Science and Technology, Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	This work was supported by grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to M. U. and J. I.) and from the Precursory Research for Embryonic Science and Technology, Japan Science and Technology Agency (to J. I.).	Adachi M, 2009, MOL CELL BIOL, V29, P2372, DOI 10.1128/MCB.01505-08; Baas AF, 2004, CELL, V116, P457, DOI 10.1016/S0092-8674(04)00114-X; Balda MS, 1996, J CELL BIOL, V134, P1031, DOI 10.1083/jcb.134.4.1031; Carvalho K, 2008, BIOPHYS J, V95, P4348, DOI 10.1529/biophysj.107.126912; Caudron F, 2009, DEV CELL, V16, P493, DOI 10.1016/j.devcel.2009.04.003; Furuse M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002907; Gassama-Diagne A, 2006, NAT CELL BIOL, V8, P963, DOI 10.1038/ncb1461; Horger KS, 2009, J AM CHEM SOC, V131, P1810, DOI 10.1021/ja805625u; Hu QC, 2010, SCIENCE, V329, P436, DOI 10.1126/science.1191054; Ikenouchi J, 2005, J CELL BIOL, V171, P939, DOI 10.1083/jcb.200510043; Ikenouchi J, 2007, J CELL BIOL, V176, P779, DOI 10.1083/jcb.200612080; Ikenouchi J, 2010, P NATL ACAD SCI USA, V107, P748, DOI 10.1073/pnas.0908423107; Ishitsuka R, 2004, BIOPHYS J, V86, P296, DOI 10.1016/S0006-3495(04)74105-3; Ishitsuka R, 2007, BIOCHEMISTRY-US, V46, P1495, DOI 10.1021/bi061290k; Jou TS, 1998, J CELL BIOL, V142, P101, DOI 10.1083/jcb.142.1.101; Kiyokawa E, 2004, BIOCHEMISTRY-US, V43, P9766, DOI 10.1021/bi049561j; LOWY RJ, 1995, EXP CELL RES, V216, P411, DOI 10.1006/excr.1995.1052; Martin-Belmonte F, 2007, CELL, V128, P383, DOI 10.1016/j.cell.2006.11.051; Nelson WJ, 2003, NATURE, V422, P766, DOI 10.1038/nature01602; Pandit SA, 2004, BIOPHYS J, V87, P3312, DOI 10.1529/biophysj.104.046078; Rojas R, 2001, MOL BIOL CELL, V12, P2257, DOI 10.1091/mbc.12.8.2257; STOLZ DB, 1992, J CELL SCI, V103, P53; Taguchi R, 2005, J CHROMATOGR B, V823, P26, DOI 10.1016/j.jchromb.2005.06.005; Takizawa PA, 2000, SCIENCE, V290, P341, DOI 10.1126/science.290.5490.341; Tsukita S, 2001, NAT REV MOL CELL BIO, V2, P285, DOI 10.1038/35067088; Tsukita S, 2009, ANN NY ACAD SCI, V1165, P44, DOI 10.1111/j.1749-6632.2009.04056.x; Umeda K, 2006, CELL, V126, P741, DOI 10.1016/j.cell.2006.06.043; VAN MEER G, 1986, EMBO J, V5, P1455, DOI 10.1002/j.1460-2075.1986.tb04382.x; VAN MEER G, 1982, EMBO J, V1, P847, DOI 10.1002/j.1460-2075.1982.tb01258.x; Veatch SL, 2003, BIOPHYS J, V85, P3074, DOI 10.1016/S0006-3495(03)74726-2; Versele M, 2005, TRENDS CELL BIOL, V15, P414, DOI 10.1016/j.tcb.2005.06.007; Yamaji A, 1998, J BIOL CHEM, V273, P5300, DOI 10.1074/jbc.273.9.5300; Yamazaki Y, 2008, MOL BIOL CELL, V19, P3801, DOI 10.1091/mbc.E08-04-0352; Yu ASL, 2005, AM J PHYSIOL-CELL PH, V288, pC1231, DOI 10.1152/ajpcell.00581.2004	34	34	34	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					9525	9533		10.1074/jbc.M111.327064	http://dx.doi.org/10.1074/jbc.M111.327064			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22294698	Green Published, hybrid			2022-12-25	WOS:000301797800083
J	Romero-Ruiz, A; Bautista, L; Navarro, V; Heras-Garvin, A; March-Diaz, R; Castellano, A; Gomez-Diaz, R; Castro, MJ; Berra, E; Lopez-Barneo, J; Pascual, A				Romero-Ruiz, Antonio; Bautista, Lucia; Navarro, Virginia; Heras-Garvin, Antonio; March-Diaz, Rosana; Castellano, Antonio; Gomez-Diaz, Raquel; Castro, Maria J.; Berra, Edurne; Lopez-Barneo, Jose; Pascual, Alberto			Prolyl Hydroxylase-dependent Modulation of Eukaryotic Elongation Factor 2 Activity and Protein Translation under Acute Hypoxia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA TRANSLATION; FACTOR-II; CELL-PROLIFERATION; ENERGY STRESS; KINASE LEADS; HIF-ALPHA; PHOSPHORYLATION; SITE; IDENTIFICATION; ACTIVATION	Early adaptive responses to hypoxia are essential for cell survival, but their nature and underlying mechanisms are poorly known. We have studied the post-transcriptional changes in the proteome of mammalian cells elicited by acute hypoxia and found that phosphorylation of eukaryotic elongation factor 2 (eEF2), a ribosomal translocase whose phosphorylation inhibits protein synthesis, is under the precise and reversible control of O-2 tension. Upon exposure to hypoxia, phosphorylation of eEF2 at Thr(56) occurred rapidly (<15 min) and resulted in modest translational arrest, a fundamental homeostatic response to hypoxia that spares ATP and thus facilitates cell survival. Acute inhibitory eEF2 phosphorylation occurred without ATP depletion or AMP kinase activation. Furthermore, eEF2 phosphorylation was mimicked by prolyl hydroxylase (PHD) inhibition with dimethyloxalylglycine or by selective PHD2 siRNA silencing but was independent of hypoxia-inducible factor alpha stabilization. Moreover, overexpression of PHD2 blocked hypoxic accumulation of phosphorylated eEF2. Therefore, our findings suggest that eEF2 phosphorylation status (and, as a consequence, translation rate) is controlled by PHD2 activity. They unravel a novel pathway for cell adaptation to hypoxia that could have pathophysiologic relevance in tissue ischemia and cancer.	[Romero-Ruiz, Antonio; Bautista, Lucia; Heras-Garvin, Antonio; March-Diaz, Rosana; Castellano, Antonio; Gomez-Diaz, Raquel; Castro, Maria J.; Lopez-Barneo, Jose; Pascual, Alberto] Univ Seville, Hosp Univ Virgen del Rocio, Inst Biomed Sevilla, CSIC, Seville 41013, Spain; [Navarro, Virginia; Berra, Edurne] CIC BioGUNE, Ctr Invest Cooperat Biociencias, Derio 48160, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; CIC bioGUNE	Lopez-Barneo, J (corresponding author), Univ Seville, Hosp Univ Virgen del Rocio, Inst Biomed Sevilla, CSIC, Av Manuel Siurot S-N, Seville 41013, Spain.	lbarneo@us.es; apascual-ibis@us.es	IBIS, NEURONAL/O-9910-2015; Gómez-Díaz, Raquel/D-9886-2013; IBIS, NEUROBIOLOGIA/O-9922-2015; Pascual, Alberto/L-2014-2019; Castellano, Antonio/AAH-8829-2021; cancer, biogune/H-7276-2012; Romero-Ruiz, Antonio/ABF-2083-2020; Navarro, Virginia/Q-2213-2015; IBIS, VASCULAR/P-3934-2015; Berra, Edurne/F-9692-2011; Pascual, Alberto P/E-9609-2015; Castellano, Antonio/E-6285-2010; Romero Ruiz, Antonio/K-3902-2014	Gómez-Díaz, Raquel/0000-0002-1423-1315; Pascual, Alberto/0000-0001-5459-6207; Castellano, Antonio/0000-0003-3955-5137; Navarro, Virginia/0000-0003-0108-7171; Berra, Edurne/0000-0002-3820-5744; Pascual, Alberto P/0000-0001-5459-6207; Castellano, Antonio/0000-0003-3955-5137; Castro Perez, Maria Jose/0000-0001-5221-0032; Romero Ruiz, Antonio/0000-0002-7651-9402; HERAS-GARVIN, ANTONIO/0000-0003-2231-2681	Spanish Ministry of Science and Health; Marcelino Botin Foundation; Andalusian Government	Spanish Ministry of Science and Health; Marcelino Botin Foundation; Andalusian Government	This work was supported by the Spanish Ministry of Science and Health, the Marcelino Botin Foundation, and the Andalusian Government.	Akao M, 2001, CIRC RES, V88, P1267, DOI 10.1161/hh1201.092094; Arsham AM, 2003, J BIOL CHEM, V278, P29655, DOI 10.1074/jbc.M212770200; Avila MA, 1998, GASTROENTEROLOGY, V114, P364, DOI 10.1016/S0016-5085(98)70489-5; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Bristow RG, 2008, NAT REV CANCER, V8, P180, DOI 10.1038/nrc2344; Browne GJ, 2004, MOL CELL BIOL, V24, P2986, DOI 10.1128/MCB.24.7.2986-2997.2004; Browne GJ, 2004, J BIOL CHEM, V279, P12220, DOI 10.1074/jbc.M309773200; Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; Connolly E, 2006, MOL CELL BIOL, V26, P3955, DOI 10.1128/MCB.26.10.3955-3965.2006; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Ginouves A, 2008, P NATL ACAD SCI USA, V105, P4745, DOI 10.1073/pnas.0705680105; Hardie DG, 2003, FEBS LETT, V546, P113, DOI 10.1016/S0014-5793(03)00560-X; Hawley SA, 1996, J BIOL CHEM, V271, P27879, DOI 10.1074/jbc.271.44.27879; Hochachka PW, 1996, P NATL ACAD SCI USA, V93, P9493, DOI 10.1073/pnas.93.18.9493; Hockel M, 2001, JNCI-J NATL CANCER I, V93, P266, DOI 10.1093/jnci/93.4.266; Horman S, 2002, CURR BIOL, V12, P1419, DOI 10.1016/S0960-9822(02)01077-1; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Koritzinsky M, 2007, RADIOTHER ONCOL, V83, P353, DOI 10.1016/j.radonc.2007.04.031; Koritzinsky M, 2007, METHOD ENZYMOL, V435, P247, DOI 10.1016/S0076-6879(07)35013-1; Koumenis C, 2002, MOL CELL BIOL, V22, P7405, DOI 10.1128/MCB.22.21.7405-7416.2002; Lang KJD, 2002, MOL BIOL CELL, V13, P1792, DOI 10.1091/mbc.02-02-0017; LEFEBVRE VHL, 1993, ARCH BIOCHEM BIOPHYS, V304, P322, DOI 10.1006/abbi.1993.1357; Liu LP, 2006, MOL CELL, V21, P521, DOI 10.1016/j.molcel.2006.01.010; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Lopez-Barneo J, 2001, ANNU REV PHYSIOL, V63, P259, DOI 10.1146/annurev.physiol.63.1.259; Masson N, 2001, EMBO J, V20, P5197, DOI 10.1093/emboj/20.18.5197; NAIRN AC, 1987, J BIOL CHEM, V262, P17299; Pascual A, 2009, PROTEOMICS, V9, P2946, DOI 10.1002/pmic.200800748; Proud CG, 2007, BIOCHEM J, V403, P217, DOI 10.1042/BJ20070024; REDPATH NT, 1990, BIOCHEM J, V272, P175, DOI 10.1042/bj2720175; REDPATH NT, 1991, BIOCHIM BIOPHYS ACTA, V1093, P36, DOI 10.1016/0167-4889(91)90135-K; REDPATH NT, 1993, EUR J BIOCHEM, V213, P689, DOI 10.1111/j.1432-1033.1993.tb17809.x; RYAZANOV AG, 1988, NATURE, V334, P170, DOI 10.1038/334170a0; Semenza GL, 2009, PHYSIOLOGY, V24, P97, DOI 10.1152/physiol.00045.2008; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Takeda K, 2007, HYPERTENSION, V49, P178, DOI 10.1161/01.HYP.0000251360.40838.0f; Thomas JD, 2007, RNA, V13, P1116, DOI 10.1261/rna.534807; Weir EK, 2005, NEW ENGL J MED, V353, P2042, DOI 10.1056/NEJMra050002; Wouters BG, 2005, SEMIN CELL DEV BIOL, V16, P487, DOI 10.1016/j.semcdb.2005.03.009	41	25	27	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					9651	9658		10.1074/jbc.M111.299180	http://dx.doi.org/10.1074/jbc.M111.299180			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22308030	Green Published, hybrid, Green Submitted			2022-12-25	WOS:000301797800096
J	De Palma, G; Capilla, A; Nova, E; Castillejo, G; Varea, V; Pozo, T; Garrote, JA; Polanco, I; Lopez, A; Ribes-Koninckx, C; Marcos, A; Garcia-Novo, MD; Calvo, C; Ortigosa, L; Pena-Quintana, L; Palau, F; Sanz, Y				De Palma, Giada; Capilla, Amalia; Nova, Esther; Castillejo, Gemma; Varea, Vicente; Pozo, Tamara; Antonio Garrote, Jose; Polanco, Isabel; Lopez, Ana; Ribes-Koninckx, Carmen; Marcos, Ascension; Dolores Garcia-Novo, Maria; Calvo, Carmen; Ortigosa, Luis; Pena-Quintana, Luis; Palau, Francesc; Sanz, Yolanda			Influence of Milk-Feeding Type and Genetic Risk of Developing Coeliac Disease on Intestinal Microbiota of Infants: The PROFICEL Study	PLOS ONE			English	Article							MICROFLORA; CHILDREN; BACTERIA; GUT; COLONIZATION; PRIMERS; CELLS; PCR	Interactions between environmental factors and predisposing genes could be involved in the development of coeliac disease (CD). This study has assessed whether milk-feeding type and HLA-genotype influence the intestinal microbiota composition of infants with a family history of CD. The study included 164 healthy newborns, with at least one first-degree relative with CD, classified according to their HLA-DQ genotype by PCR-SSP DQB1 and DQA1 typing. Faecal microbiota was analysed by quantitative PCR at 7 days, and at 1 and 4 months of age. Significant interactions between milk-feeding type and HLA-DQ genotype on bacterial numbers were not detected by applying a linear mixed-model analysis for repeated measures. In the whole population, breast-feeding promoted colonization of C. leptum group, B. longum and B. breve, while formula-feeding promoted that of Bacteroides fragilis group, C. coccoides-E. rectale group, E. coli and B. lactis. Moreover, increased numbers of B. fragilis group and Staphylococcus spp., and reduced numbers of Bifidobacterium spp. and B. longum were detected in infants with increased genetic risk of developing CD. Analyses within subgroups of either breast-fed or formula-fed infants indicated that in both cases increased risk of CD was associated with lower numbers of B. longum and/or Bifidobacterium spp. In addition, in breast-fed infants the increased genetic risk of developing CD was associated with increased C. leptum group numbers, while in formula-fed infants it was associated with increased Staphylococcus and B. fragilis group numbers. Overall, milk-feeding type in conjunction with HLA-DQ genotype play a role in establishing infants' gut microbiota; moreover, breast-feeding reduced the genotype-related differences in microbiota composition, which could partly explain the protective role attributed to breast milk in this disorder.	[De Palma, Giada; Sanz, Yolanda] CSIC, Inst Agroquim & Tecnol Alimentos, E-46010 Valencia, Spain; [Capilla, Amalia; Palau, Francesc] CIBER Enfermedades Raras CIBERER, CSIC, Inst Biomed Valencia, Valencia, Spain; [Nova, Esther; Pozo, Tamara; Marcos, Ascension] CSIC, ICTAN, Dept Metab & Nutr, Madrid, Spain; [Castillejo, Gemma] Hosp Univ St Joan de Reus, Unidad Gastroenterol Pediat, Tarragona, Spain; [Varea, Vicente] Hosp Univ St Joan de Deu, Barcelona, Spain; [Varea, Vicente] Inst Dexeus, Unidad Gastroenterol Pediat, Barcelona, Spain; [Antonio Garrote, Jose; Calvo, Carmen] Hosp Clin Univ Valladolid, Unidad Gastroenterol Pediat, Valladolid, Spain; [Polanco, Isabel] Hosp Univ La Paz, Serv Gastroenterol & Nutr Pediat, Madrid, Spain; [Lopez, Ana; Ribes-Koninckx, Carmen] Hosp Univ La Fe, Unidad Gastroenterol Pediat, Valencia, Spain; [Dolores Garcia-Novo, Maria] Hosp Univ Infantil Nino Jesus, Unidad Gastroenterol, Madrid, Spain; [Ortigosa, Luis] Hosp Univ Nuestra Senora Candelaria, Unidad Gastroenterol Hepatol & Nutr Pediat, Santa Cruz De Tenerife, Canarias, Spain; [Pena-Quintana, Luis] Univ Las Palmas Gran Canaria, Hosp Univ Maternoinfantil Canarias, Unidad Gastroenterol Hepatol & Nutr Pediat, Las Palmas Gran Canaria, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Instituto de Agroquimica y Tecnologia de los Alimentos (IATA); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biomedicina de Valencia (IBV); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencia y Tecnologia de Alimentos y Nutricion (ICTAN); Hospital Universitario La Paz; Hospital Universitari i Politecnic La Fe; Universidad de Las Palmas de Gran Canaria	De Palma, G (corresponding author), CSIC, Inst Agroquim & Tecnol Alimentos, Jaime Roig 11, E-46010 Valencia, Spain.	yolsanz@iata.csic.es	Sanz, Yolanda/H-5498-2012; Rebato, Esther Nova/AAA-8744-2020; Ribes-Koninckx, Maria Carmen/ABH-5577-2020; Sanchez, Ascension Marcos/K-4965-2014; Peña-Quintana, Luis/AAR-3421-2020; De Palma, Giada/AAP-8806-2020; Capilla, Amalia/AAW-5955-2021; Palau, Francesc/A-9391-2014; Garrote, Jose A/B-1257-2013	Sanz, Yolanda/0000-0002-1615-1976; Rebato, Esther Nova/0000-0002-1995-2955; Sanchez, Ascension Marcos/0000-0002-8022-9563; Peña-Quintana, Luis/0000-0001-6052-5894; De Palma, Giada/0000-0002-2063-7741; Capilla, Amalia/0000-0002-9546-9818; Palau, Francesc/0000-0002-8635-5421; Garrote, Jose A/0000-0003-1797-6520	Spanish Ministry of Science and Innovation [AGL2007-66126-C03-01-03/ALI, CSD2007-00063]; Consejo Superior de Investigaciones Cientificas (CSIC), Spain	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Consejo Superior de Investigaciones Cientificas (CSIC), Spain	This study was supported by public grants AGL2007-66126-C03-01-03/ALI and Consolider Fun-C-Food CSD2007-00063 from the Spanish Ministry of Science and Innovation. GDP was recipient of I3P scholarship from Consejo Superior de Investigaciones Cientificas (CSIC), Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEZIRTZOGLOU E, 1990, J PERINAT MED, V18, P139; Bezirtzoglou E, 1997, ANAEROBE, V3, P173, DOI 10.1006/anae.1997.0102; Bezirtzoglou E, 2011, ANAEROBE, V17, P478, DOI 10.1016/j.anaerobe.2011.03.009; Bourgey M, 2007, GUT, V56, P1054, DOI 10.1136/gut.2006.108530; Collado MC, 2009, J CLIN PATHOL, V62, P264, DOI 10.1136/jcp.2008.061366; De Palma G, 2010, CURR ISSUES MOL BIOL, V12, P1; Donat E, 2009, TISSUE ANTIGENS, V73, P255, DOI 10.1111/j.1399-0039.2008.01191.x; Dubois PC, 2008, CLIN EXP IMMUNOL, V153, P162, DOI 10.1111/j.1365-2249.2008.03704.x; Fasano A, 2005, BEST PRACT RES CL GA, V19, P467, DOI 10.1016/j.bpg.2005.01.008; Frank DN, 2011, INFLAMM BOWEL DIS, V17, P179, DOI 10.1002/ibd.21339; Hapfelmeier S, 2008, J EXP MED, V205, P437, DOI 10.1084/jem.20070633; Ivarsson A, 2002, AM J CLIN NUTR, V75, P914, DOI 10.1093/ajcn/75.5.914; Kagnoff MF, 2007, J CLIN INVEST, V117, P41, DOI 10.1172/JCI30253; KAISERLIAN D, 1993, IMMUNOL TODAY, V14, P144, DOI 10.1016/0167-5699(93)90222-7; Kalliomaki M, 2001, J ALLERGY CLIN IMMUN, V107, P129, DOI 10.1067/mai.2001.111237; Malinen E, 2003, MICROBIOL-SGM, V149, P269, DOI 10.1099/mic.0.25975-0; Martin R, 2003, J PEDIATR-US, V143, P754, DOI 10.1016/j.jpeds.2003.09.028; Martin R, 2009, APPL ENVIRON MICROB, V75, P965, DOI 10.1128/AEM.02063-08; Matsuki T, 2002, APPL ENVIRON MICROB, V68, P5445, DOI 10.1128/AEM.68.11.5445-5451.2002; Nadal I, 2007, J MED MICROBIOL, V56, P1669, DOI 10.1099/jmm.0.47410-0; Newburg DS, 2005, J NUTR, V135, P1308, DOI 10.1093/jn/135.5.1308; OLERUP O, 1993, TISSUE ANTIGENS, V41, P119, DOI 10.1111/j.1399-0039.1993.tb01991.x; Penders J, 2006, PEDIATRICS, V118, P511, DOI 10.1542/peds.2005-2824; Plot L, 2009, INFECTIONS MAY HAVE, P670; Plot L, 2009, AUTOIMMUN REV, V8, P316, DOI 10.1016/j.autrev.2008.10.001; Rajagopalan G, 2008, TISSUE ANTIGENS, V71, P135, DOI 10.1111/j.1399-0039.2007.00986.x; Reviriego C, 2005, J HUM LACT, V21, P131, DOI 10.1177/0890334405275394; Salminen S, 2006, J PEDIATR-US, V149, pS115, DOI 10.1016/j.jpeds.2006.06.062; Sanz Y, 2008, CHILD NUTR PHYSL, P210; Sanz Yolanda, 2007, Recent Pat Antiinfect Drug Discov, V2, P148, DOI 10.2174/157489107780832596; Sanz Y, 2009, MINI-REV MED CHEM, V9, P359, DOI 10.2174/1389557510909030359; Sollid LM, 2002, NAT REV IMMUNOL, V2, P647, DOI 10.1038/nri885; Stewart JA, 2005, J MED MICROBIOL, V54, P1239, DOI 10.1099/jmm.0.46189-0; Zoetendal Erwin G., 2001, Microbial Ecology in Health and Disease, V13, P129, DOI 10.1080/089106001750462669	34	95	96	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2012	7	2							e30791	10.1371/journal.pone.0030791	http://dx.doi.org/10.1371/journal.pone.0030791			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LO	22319588	Green Submitted, Green Published, gold			2022-12-25	WOS:000302178400016
J	Yan, TT; Li, Q; Zhou, HT; Zhao, YT; Yu, SQ; Xu, GL; Yin, ZM; Li, ZJ; Zhao, ZH				Yan, TingTing; Li, Qing; Zhou, HuiTing; Zhao, YueTao; Yu, ShuQin; Xu, GuangLin; Yin, ZhiMin; Li, ZhongJun; Zhao, ZhiHui			Gu-4 Suppresses Affinity and Avidity Modulation of CD11b and Improves the Outcome of Mice with Endotoxemia and Sepsis	PLOS ONE			English	Article							EARLY LACTATE CLEARANCE; MOLECULAR-MECHANISMS; CECAL LIGATION; LEUKOCYTE; SHOCK; INFLAMMATION; ACTIVATION; MORTALITY; INTEGRIN; ADHESION	Background: Systemic leukocyte activation and disseminated leukocyte adhesion will impair the microcirculation and cause severe decrements in tissue perfusion and organ function in the process of severe sepsis. Gu-4, a lactosyl derivative, could selectively target CD11b to exert therapeutic effect in a rat model of severe burn shock. Here, we addressed whether Gu-4 could render protective effects on septic animals. Methodology/Principal Findings: On a murine model of endotoxemia induced by lipopolysaccharide (LPS), we found that the median effective dose (ED50) of Gu-4 was 0.929 mg/kg. In vivo treatment of Gu-4 after LPS challenge prominently attenuated LPS-induced lung injury and decreased lactic acid level in lung tissue. Using the ED50 of Gu-4, we also demonstrated that Gu-4 treatment significantly improved the survival rate of animals underwent sepsis induced by cecal ligation and puncture. By adhesion and transwell migration assays, we found that Gu-4 treatment inhibited the adhesion and transendothelial migration of LPS-stimulated THP-1 cells. By flow cytometry and microscopy, we demonstrated that Gu-4 treatment inhibited the exposure of active I-domain and the cluster formation of CD11b on the LPS-stimulated polymorphonuclear leukocytes. Western blot analyses further revealed that Gu-4 treatment markedly inhibited the activation of spleen tyrosine kinase in LPS-stimulated THP-1 cells. Conclusions/Significance: Gu-4 improves the survival of mice underwent endotoxemia and sepsis, our in vitro investigations indicate that the possible underlying mechanism might involve the modulations of the affinity and avidity of CD11b on the leukocyte. Our findings shed light on the potential use of Gu-4, an interacting compound to CD11b, in the treatment of sepsis and septic shock.	[Yan, TingTing; Zhou, HuiTing; Yu, ShuQin; Xu, GuangLin; Yin, ZhiMin; Zhao, ZhiHui] Nanjing Normal Univ, Coll Life Sci, Jiangsu Prov Key Lab Mol & Med Biotechnol, Nanjing, Jiangsu, Peoples R China; [Li, Qing; Zhao, YueTao; Li, ZhongJun] Peking Univ, Sch Pharmaceut Sci, State Key Lab Nat & Biomimet Drugs, Beijing 100871, Peoples R China	Nanjing Normal University; Peking University	Yan, TT (corresponding author), Nanjing Normal Univ, Coll Life Sci, Jiangsu Prov Key Lab Mol & Med Biotechnol, Nanjing, Jiangsu, Peoples R China.	zjli@bjmu.edu.cn; zhaozhihui_1964@yahoo.com.cn	Yu, Shu-Qin/K-5982-2012	Yu, Shu-Qin/0000-0002-2824-4651	Natural Science Foundation of China [2008104GZ40166]; State New Drug Innovation Plan [2009ZX09103-044]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State New Drug Innovation Plan; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was financially supported by the Natural Science Foundation of China (Grant No. 2008104GZ40166), the State New Drug Innovation Plan (Grant No. 2009ZX09103-044), and a project from the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler V, 1999, ONCOGENE, V18, P6104, DOI 10.1038/sj.onc.1203128; Alencar NMN, 2010, INFLAMM RES, V59, P245, DOI 10.1007/s00011-009-0092-9; BAKER CC, 1983, SURGERY, V94, P331; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chandra Abhijit, 2006, Clinics, V61, P71, DOI 10.1590/S1807-59322006000100012; Chishti AD, 2004, INTENS CARE MED, V30, P605, DOI 10.1007/s00134-004-2175-y; De Petrocellis L, 2010, J NEUROIMMUNE PHARM, V5, P103, DOI 10.1007/s11481-009-9177-z; Decking J, 2001, INFLAMM RES, V50, P609, DOI 10.1007/PL00000242; Ellis CG, 2005, CRIT CARE, V9, pS3, DOI 10.1186/cc3751; Engel C, 2007, INTENS CARE MED, V33, P606, DOI 10.1007/s00134-006-0517-7; Ghezzi Pietro, 2004, Methods Mol Med, V98, P1; Gutierrez G, 1996, INTENS CARE MED, V22, P6, DOI 10.1007/BF01728325; Haji-Michael PG, 1999, METABOLISM, V48, P779, DOI 10.1016/S0026-0495(99)90179-8; Hirahashi J, 2006, IMMUNITY, V25, P271, DOI 10.1016/j.immuni.2006.05.014; Hodgson JC, 2006, J COMP PATHOL, V135, P157, DOI 10.1016/j.jcpa.2006.09.001; Hollenberg SM, 2007, CRIT CARE, V11, DOI 10.1186/cc6190; Hu G, 2008, CIRC RES, V102, pE120, DOI 10.1161/CIRCRESAHA.107.167486; Hubbard WJ, 2005, SHOCK, V24, P52, DOI 10.1097/01.shk.0000191414.94461.7e; Ince C, 2005, CRIT CARE, V9, pS13, DOI 10.1186/cc3753; Joshi A, 2006, J CLIN PHARMACOL, V46, P10, DOI 10.1177/0091270005283282; Karima R, 1999, MOL MED TODAY, V5, P123, DOI 10.1016/S1357-4310(98)01430-0; Kim M, 2004, J CELL BIOL, V167, P1241, DOI 10.1083/jcb.200404160; LEE JO, 1995, CELL, V80, P631, DOI 10.1016/0092-8674(95)90517-0; Lefort CT, 2009, J IMMUNOL, V183, P6460, DOI 10.4049/jimmunol.0900983; Lehmann C, 2001, INTENS CARE MED, V27, P258, DOI 10.1007/s001340000782; Levy MM, 2010, INTENS CARE MED, V36, P222, DOI 10.1007/s00134-009-1738-3; Liu LX, 2003, THROMB HAEMOSTASIS, V89, P213; Liu ZW, 2008, FEBS LETT, V582, P1643, DOI 10.1016/j.febslet.2008.04.016; Luster AD, 2005, NAT IMMUNOL, V6, P1182, DOI 10.1038/ni1275; McCuskey RS, 1996, CARDIOVASC RES, V32, P752, DOI 10.1016/S0008-6363(96)00113-7; Mogensen TH, 2009, CLIN MICROBIOL REV, V22, P240, DOI 10.1128/CMR.00046-08; Murakami K, 2002, CRIT CARE MED, V30, P2083, DOI 10.1097/00003246-200209000-00022; Nguyen HB, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-6; Nguyen HB, 2004, CRIT CARE MED, V32, P1637, DOI 10.1097/01.CCM.0000132904.35713.A7; Ploppa A, 2010, CRIT CARE, V14, DOI 10.1186/cc9322; Pruitt JH, 1996, BLOOD, V87, P3282; Rittirsch D, 2008, NAT REV IMMUNOL, V8, P776, DOI 10.1038/nri2402; Schnare M, 2001, NAT IMMUNOL, V2, P947, DOI 10.1038/ni712; Soriano FG, 2011, SHOCK, V35, P560, DOI 10.1097/SHK.0b013e31820fe5d5; van Kooyk Y, 2000, CURR OPIN CELL BIOL, V12, P542, DOI 10.1016/S0955-0674(00)00129-0; Winters BD, 2010, CRIT CARE MED, V38, P1276, DOI 10.1097/CCM.0b013e3181d8cc1d; Zhao ZH, 2009, GLYCOCONJUGATE J, V26, P173, DOI 10.1007/s10719-008-9174-0	42	13	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2012	7	2							e30110	10.1371/journal.pone.0030110	http://dx.doi.org/10.1371/journal.pone.0030110			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UV	22319560	Green Published, gold, Green Submitted			2022-12-25	WOS:000301979000002
J	Maggini, I; Bairlein, F				Maggini, Ivan; Bairlein, Franz			Innate Sex Differences in the Timing of Spring Migration in a Songbird	PLOS ONE			English	Article							CHIFFCHAFFS PHYLLOSCOPUS-COLLYBITA; WHEATEAR OENANTHE-OENANTHE; NORTHERN WHEATEAR; CIRCANNUAL CLOCKS; PROXIMATE CONTROL; WINTER; AGE; SETTLEMENT; FEMALES; AFRICA	In migrating animals protandry is the phenomenon whereby males of a species arrive at the breeding grounds earlier than females. In the present study we investigated the proximate causes of protandry in a migratory songbird, the northern wheatear Oenanthe oenanthe. Previous experiments with caged birds revealed that males and females show differentiated photoperiod-induced migratory habits. However, it remained open whether protandry would still occur without photoperiodic cues. In this study we kept captive first-year birds under constant photoperiod and environmental conditions in a "common garden" experiment. Male northern wheatears started their spring migratory activity earlier than females, even in the absence of environmental cues. This indicates that protandry in the northern wheatear has an endogenous basis with an innate earlier spring departure of males than females.	[Maggini, Ivan; Bairlein, Franz] Inst Avian Res Vogelwarte Helgoland, Wilhelmshaven, Germany		Maggini, I (corresponding author), Inst Avian Res Vogelwarte Helgoland, Wilhelmshaven, Germany.	ivan.maggini@ifv-vogelwarte.de	Maggini, Ivan/I-1744-2014	Maggini, Ivan/0000-0002-1528-2288	Deutsche Forschungsgemeinschaft DFG [Ba 815/16]	Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG))	The study has been funded by the Deutsche Forschungsgemeinschaft DFG (Ba 815/16). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAIRLEIN F, 1986, J ORNITHOL, V127, P338, DOI 10.1007/BF01640417; Catry P, 2005, J AVIAN BIOL, V36, P184, DOI 10.1111/j.0908-8857.2005.03445.x; Catry P, 2004, J AVIAN BIOL, V35, P204, DOI 10.1111/j.0908-8857.2004.03266.x; Catry P, 2007, J ORNITHOL, V148, P241, DOI 10.1007/s10336-007-0130-8; Coppack T, 2008, BIOL LETTERS, V4, P619, DOI 10.1098/rsbl.2008.0388; Coppack T, 2009, INTEGR COMP BIOL, V49, P493, DOI 10.1093/icb/icp029; Cramp S., 1988, BIRDS W PALEARCTIC, V5; Currie D, 2000, IBIS, V142, P389, DOI 10.1111/j.1474-919X.2000.tb04435.x; Dierschke V, 2005, BEHAV ECOL SOCIOBIOL, V57, P470, DOI 10.1007/s00265-004-0872-8; Gordo O, 2007, CLIM RES, V35, P37, DOI 10.3354/cr00713; Gwinner E, 1996, IBIS, V138, P47, DOI 10.1111/j.1474-919X.1996.tb04312.x; Gwinner E, 1990, BIRD MIGRATION PHYSL; GWINNER EBERHARD, 1968, J ORNITHOL, V109, P70, DOI 10.1007/BF01678108; HEDENSTROM A, 1986, ORNIS SCAND, V17, P182, DOI 10.2307/3676868; Maggini I, 2010, J BIOL RHYTHM, V25, P268, DOI 10.1177/0748730410373442; Marra PP, 1998, SCIENCE, V282, P1884, DOI 10.1126/science.282.5395.1884; Morbey YE, 2001, ECOL LETT, V4, P663, DOI 10.1046/j.1461-0248.2001.00265.x; Newton I, 2008, MIGRATION ECOLOGY OF BIRDS, P1; Part T, 2001, ANIM BEHAV, V62, P379, DOI 10.1006/anbe.2001.1754; Pulido F, 2004, ADV ECOL RES, V35, P151, DOI 10.1016/S0065-2504(04)35008-7; SPINA F, 1994, OSTRICH, V65, P137, DOI 10.1080/00306525.1994.9639676; Stouffer PC, 2003, AUK, V120, P836, DOI 10.1642/0004-8038(2003)120[0836:SWDATO]2.0.CO;2; TERRILL SB, 1990, OECOLOGIA, V85, P266, DOI 10.1007/BF00319412; Widmer M., 1999, THESIS U ZURICH SWIT; Wikelski M, 2008, PHILOS T R SOC B, V363, P411, DOI 10.1098/rstb.2007.2147	25	45	47	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2012	7	2							e31271	10.1371/journal.pone.0031271	http://dx.doi.org/10.1371/journal.pone.0031271			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UG	22312443	gold, Green Submitted, Green Published			2022-12-25	WOS:000301977500032
J	Sucupira, MCA; Sanabani, S; Cortes, RM; Giret, MTM; Tomiyama, H; Sauer, MM; Sabino, EC; Janini, LM; Kallas, EG; Diaz, RS				Araripe Sucupira, Maria Cecilia; Sanabani, Sabri; Cortes, Rodrigo M.; Giret, Maria Teresa M.; Tomiyama, Helena; Sauer, Mariana M.; Sabino, Ester Cerdeira; Janini, Luiz Mario; Kallas, Esper Georges; Diaz, Ricardo Sobhie			Faster HIV-1 Disease Progression among Brazilian Individuals Recently Infected with CXCR4-Utilizing Strains	PLOS ONE			English	Article							VIRUS TYPE-1 SUBTYPES; T-CELL-ACTIVATION; HEPATITIS-G VIRUS; ANTIRETROVIRAL THERAPY; GENETIC RESTRICTION; ENZYME-IMMUNOASSAY; CORECEPTOR USAGE; PROGNOSTIC VALUE; AIDS; VARIANTS	Introduction: Primary HIV infection is usually caused by R5 viruses, and there is an association between the emergence of CCXR4-utilizing strains and faster disease progression. We characterized HIV-1 from a cohort of recently infected individuals in Brazil, predicted the virus's co-receptor use based on the env genotype and attempted to correlate virus profiles with disease progression. Methods: A total of 72 recently infected HIV patients were recruited based on the Serologic Testing Algorithm for Recent HIV Seroconversion and were followed every three to four months for up to 78 weeks. The HIV-1 V3 region was characterized by sequencing nine to twelve weeks after enrollment. Disease progression was characterized by CD4+ T-cell count decline to levels consistently below 350 cells/mu L. Results: Twelve out of 72 individuals (17%) were predicted to harbor CXCR4-utilizing strains; a baseline CD4,350 was more frequent among these individuals (p = 0.03). Fifty-seven individuals that were predicted to have CCR5-utilizing viruses and 10 individuals having CXCR4-utilizing strains presented with baseline CD4.350; after 78 weeks, 33 individuals with CCR5 strains and one individual with CXCR4 strains had CD4.350 (p = 0.001). There was no association between CD4 decline and demographic characteristics or HIV-1 subtype. Conclusions: Our findings confirm the presence of strains with higher in vitro pathogenicity during early HIV infection, suggesting that even among recently infected individuals, rapid progression may be a consequence of the early emergence of CXCR4-utilizing strains. Characterizing the HIV-1 V3 region by sequencing may be useful in predicting disease progression and guiding treatment initiation decisions.	[Araripe Sucupira, Maria Cecilia; Cortes, Rodrigo M.; Tomiyama, Helena; Sauer, Mariana M.; Diaz, Ricardo Sobhie] Univ Fed Sao Paulo, Div Infect Dis, Sao Paulo, Brazil; [Sanabani, Sabri] Fundacao Pro Sangue, Sao Paulo Blood Bank, Sao Paulo, Brazil; [Giret, Maria Teresa M.; Kallas, Esper Georges] Univ Sao Paulo, Div Clin Immunol & Allergy, Sao Paulo, Brazil; [Sabino, Ester Cerdeira] Univ Sao Paulo, Div Infect Dis, Sao Paulo, Brazil; [Janini, Luiz Mario] Univ Fed Sao Paulo, Div Microbiol, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP)	Sucupira, MCA (corresponding author), Univ Fed Sao Paulo, Div Infect Dis, Sao Paulo, Brazil.	rsdiaz@catg.com.br	Sabino, Ester C/F-7750-2010; Kallas, Esper G/C-9539-2012; Diaz, Ricardo/K-3978-2012; Sanabani, Sabri Saeed/F-5600-2012; Araripe Sucupira, Maria Cecilia/K-1931-2012; Janini, Luiz Mario R/E-9700-2012	Sabino, Ester C/0000-0003-2623-5126; Sanabani, Sabri Saeed/0000-0002-8876-8262; Araripe Sucupira, Maria Cecilia/0000-0002-1114-5382; Kallas, Esper/0000-0003-2026-6925; Janini, Luiz Mario/0000-0002-6186-6284	Brazilian Program for STD and AIDS; Ministry of Health [914/BRA/3014-UNESCO/Kallas]; Sao Paulo City Health Department [2004-0.168.922-7/Kallas]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [04/15856-9/Diaz]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Brazilian Ministry of Education	Brazilian Program for STD and AIDS; Ministry of Health; Sao Paulo City Health Department; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Brazilian Ministry of Education	This study was supported with funding from the Brazilian Program for STD and AIDS, Ministry of Health (914/BRA/3014-UNESCO/Kallas), the Sao Paulo City Health Department (2004-0.168.922-7/Kallas), and the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (04/15856-9/Diaz, Sabino, Janini & Kallas; M. C. A. S. was supported by the Programa Nacional de Pos Doutorado (PNPD) of the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) T. M. G. was supported by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Brazilian Ministry of Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accetturi CA, 2000, J ACQ IMMUN DEF SYND, V24, P399, DOI 10.1097/00126334-200008010-00016; Sucupira MCA, 2007, AIDS PATIENT CARE ST, V21, P116, DOI 10.1089/apc.2006.0079; Bennett DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004724; Brenner BG, 2008, AIDS, V22, P2509, DOI 10.1097/QAD.0b013e3283121c90; Busch MP, 2010, AIDS, V24, P2763, DOI 10.1097/QAD.0b013e32833f1142; Casseb J, 2002, INT J INFECT DIS, V6, P164; Cavaleiro R, 2007, EUR J IMMUNOL, V37, P3435, DOI 10.1002/eji.200737511; Cecilia D, 2000, VIROLOGY, V271, P253, DOI 10.1006/viro.2000.0297; Cimerman S, 2007, AIDS PATIENT CARE ST, V21, P100, DOI 10.1089/apc.2006.0035; de Mendoza C, 2008, JAIDS-J ACQ IMM DEF, V48, P241, DOI 10.1097/QAI.0b013e3181734f0e; Dean M, 1996, SCIENCE, V273, P1856, DOI 10.1126/science.273.5283.1856; Diaz RS, 1996, AIDS RES HUM RETROV, V12, P1291, DOI 10.1089/aid.1996.12.1291; Diaz RS, 1997, AIDS, V11, P415, DOI 10.1097/00002030-199704000-00003; Diaz RS, 2008, SELECTIVE R IN PRESS; Easterbrook PJ, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-4; Frange P, 2009, J ANTIMICROB CHEMOTH, V64, P135, DOI 10.1093/jac/dkp151; Fusuma EE, 2005, AIDS RES HUM RETROV, V21, P965, DOI 10.1089/aid.2005.21.965; Hendel H, 1999, J IMMUNOL, V162, P6942; Huang W, 2009, AIDS RES HUM RETROV, V25, P795, DOI 10.1089/aid.2008.0252; Hunt PW, 2008, J INFECT DIS, V197, P126, DOI 10.1086/524143; Ioannidis JPA, 2001, ANN INTERN MED, V135, P782, DOI 10.7326/0003-4819-135-9-200111060-00008; Janssen RS, 1998, JAMA-J AM MED ASSOC, V280, P42, DOI 10.1001/jama.280.1.42; Jarvis LM, 1996, LANCET, V348, P1352, DOI 10.1016/S0140-6736(96)04041-X; Kallas Esper Georges, 2004, Braz J Infect Dis, V8, P399, DOI 10.1590/S1413-86702004000600003; Kanki PJ, 1999, J INFECT DIS, V179, P68, DOI 10.1086/314557; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; KOOT M, 1993, ANN INTERN MED, V118, P681, DOI 10.7326/0003-4819-118-9-199305010-00004; Kothe D, 2003, JAIDS-J ACQ IMM DEF, V33, P625, DOI 10.1097/00126334-200308150-00012; Leal E, 2008, RETROVIROLOGY RES TR, V1, P1; Maidana-Giret MT, 2009, AIDS, V23, P2277, DOI 10.1097/QAD.0b013e32832d7a11; Markowitz M, 2005, LANCET, V365, P1031, DOI 10.1016/S0140-6736(05)74227-6; McGovern RA, 2010, AIDS, V24, P2512, DOI 10.1097/QAD.0b013e32833e6cfb; Mellors JW, 2007, JAMA-J AM MED ASSOC, V297, P2349, DOI 10.1001/jama.297.21.2349; Montano MA, 1997, J VIROL, V71, P8657, DOI 10.1128/JVI.71.11.8657-8665.1997; Munerato Patrícia, 2003, Braz J Infect Dis, V7, P236, DOI 10.1590/S1413-86702003000400002; Ping LH, 1999, J VIROL, V73, P6271, DOI 10.1128/JVI.73.8.6271-6281.1999; Raymond S, 2010, AIDS, V24, P2305, DOI 10.1097/QAD.0b013e32833e50bb; Sanabani S, 2006, AIDS RES HUM RETROV, V22, P171, DOI 10.1089/aid.2006.22.171; Santoro-Lopes G, 2000, AIDS RES HUM RETROV, V16, P953, DOI 10.1089/08892220050058362; Schlueter V, 1996, J CLIN MICROBIOL, V34, P2660, DOI 10.1128/JCM.34.11.2660-2664.1996; Sing T, 2007, ANTIVIR THER, V12, P1097; Souza IE, 2006, HIV MED, V7, P25, DOI 10.1111/j.1468-1293.2005.00339.x; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tscherning C, 1998, VIROLOGY, V241, P181, DOI 10.1006/viro.1997.8980; Tucker TJ, 1999, J MED VIROL, V59, P52, DOI 10.1002/(SICI)1096-9071(199909)59:1&lt;52::AID-JMV9&gt;3.0.CO;2-D; Verhofstede C, 2009, JAIDS-J ACQ IMM DEF, V50, P126, DOI 10.1097/QAI.0b013e31819118fa; Westby M, 2007, J VIROL, V81, P2359, DOI 10.1128/JVI.02006-06; Winkler C, 1998, SCIENCE, V279, P389, DOI 10.1126/science.279.5349.389; Xiang JH, 2001, NEW ENGL J MED, V345, P707, DOI 10.1056/NEJMoa003364	49	26	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2012	7	1							e30292	10.1371/journal.pone.0030292	http://dx.doi.org/10.1371/journal.pone.0030292			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911FX	22291931	Green Published, Green Submitted, gold			2022-12-25	WOS:000301703800012
J	Hochmann, S; Kaslin, J; Hans, S; Weber, A; Machate, A; Geffarth, M; Funk, RHW; Brand, M				Hochmann, Sarah; Kaslin, Jan; Hans, Stefan; Weber, Anke; Machate, Anja; Geffarth, Michaela; Funk, Richard H. W.; Brand, Michael			Fgf Signaling is Required for Photoreceptor Maintenance in the Adult Zebrafish Retina	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; MIDBRAIN-HINDBRAIN BOUNDARY; MULLER GLIA; FIN REGENERATION; STEM-CELLS; TRANSGENIC MICE; NEURONAL PROGENITORS; INDUCED ANTAGONIST; PATTERN-FORMATION; ALBINO ZEBRAFISH	Fibroblast growth factors (Fgf) are secreted signaling molecules that have mitogenic, patterning, neurotrophic and angiogenic properties. Their importance during embryonic development in patterning and morphogenesis of the vertebrate eye is well known, but less is known about the role of Fgfs in the adult vertebrate retina. To address Fgf function in adult retina, we determined the spatial distribution of components of the Fgf signaling pathway in the adult zebrafish retina. We detected differential expression of Fgf receptors, ligands and downstream Fgf targets within specific retinal layers. Furthermore, we blocked Fgf signaling in the retina, by expressing a dominant negative variant of Fgf receptor 1 conditionally in transgenic animals. After blocking Fgf signaling we observe a fast and progressive photoreceptor degeneration and disorganization of retinal tissue, coupled with cell death in the outer nuclear layer. Following the degeneration of photoreceptors, a profound regeneration response is triggered that starts with proliferation in the inner nuclear layer. Ultimately, rod and cone photoreceptors are regenerated completely. Our study reveals the requirement of Fgf signaling to maintain photoreceptors and for proliferation during regeneration in the adult zebrafish retina.	[Hochmann, Sarah; Kaslin, Jan; Hans, Stefan; Weber, Anke; Machate, Anja; Geffarth, Michaela; Brand, Michael] Tech Univ Dresden, DFG Ctr Regenerat Therapies Dresden, Cluster Excellence CRTD, Ctr Biotechnol, D-01062 Dresden, Germany; [Funk, Richard H. W.] Tech Univ Dresden, Med Fac Carl Gustav Carus, D-01062 Dresden, Germany	German Research Foundation (DFG); Technische Universitat Dresden; Technische Universitat Dresden; Carl Gustav Carus University Hospital	Hochmann, S (corresponding author), Tech Univ Dresden, DFG Ctr Regenerat Therapies Dresden, Cluster Excellence CRTD, Ctr Biotechnol, D-01062 Dresden, Germany.	michael.brand@biotec.tu-dresden.de	Brand, Michael/A-5509-2010; Funk, Richard HW/I-1780-2013	Brand, Michael/0000-0001-5711-6512; Weber, Anke/0000-0003-2220-658X; Kaslin, Jan/0000-0002-6207-1889; Hochmann, Sarah/0000-0002-6766-4093	Deutsche Forschungsgemeinschaft [SFB 655]; European Union (ZF Health)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Union (ZF Health)(European Commission)	This work was supported by the Deutsche Forschungsgemeinschaft (SFB 655 and CRTD seed grant), and the European Union (ZF Health). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey TJ, 2010, EXP EYE RES, V91, P601, DOI 10.1016/j.exer.2010.07.017; Becker CG, 2008, RESTOR NEUROL NEUROS, V26, P71; Bernardos RL, 2007, J NEUROSCI, V27, P7028, DOI 10.1523/JNEUROSCI.1624-07.2007; BRAISTED JE, 1992, DEVELOPMENT, V114, P913; Brand M., 2002, ZEBRAFISH PRACTICAL; CAMERON DA, 1995, J NEUROSCI, V15, P2255, DOI 10.1523/JNEUROSCI.15-03-02255.1995; Campochiaro PA, 1996, J NEUROSCI, V16, P1679; Cornish E, 2004, MOL VIS, V10, P1; Diep CQ, 2011, NATURE, V470, P95, DOI 10.1038/nature09669; Draper BW, 2003, DEVELOPMENT, V130, P4639, DOI 10.1242/dev.00671; Eckenstein FP, 2006, EXP NEUROL, V198, P338, DOI 10.1016/j.expneurol.2005.12.020; FAKTOROVICH EG, 1990, NATURE, V347, P83, DOI 10.1038/347083a0; Fausett BV, 2006, J NEUROSCI, V26, P6303, DOI 10.1523/JNEUROSCI.0332-06.2006; Fimbel SM, 2007, J NEUROSCI, V27, P1712, DOI 10.1523/JNEUROSCI.5317-06.2007; Fleisch VC, 2011, BBA-MOL BASIS DIS, V1812, P364, DOI 10.1016/j.bbadis.2010.10.012; Fontaine V, 1998, J NEUROSCI, V18, P9662; Furthauer M, 2002, NAT CELL BIOL, V4, P170, DOI 10.1038/ncb750; Furthauer M, 2001, DEVELOPMENT, V128, P2175; Ganz J, 2010, GLIA, V58, P1345, DOI 10.1002/glia.21012; Gestri G., 2011, DEV NEUROBIOL; Grandel H, 2006, DEV BIOL, V295, P263, DOI 10.1016/j.ydbio.2006.03.040; Hamaoka T, 2002, GENESIS, V34, P215, DOI 10.1002/gene.10155; Hans S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004640; HITCHCOCK PF, 1994, VISUAL NEUROSCI, V11, P209, DOI 10.1017/S0952523800001577; Joly S, 2007, INVEST OPHTH VIS SCI, V48, P2311, DOI 10.1167/iovs.06-1205; Karl MO, 2010, TRENDS MOL MED, V16, P193, DOI 10.1016/j.molmed.2010.02.003; Kaslin J, 2008, PHILOS T R SOC B, V363, P101, DOI 10.1098/rstb.2006.2015; Kassen SC, 2007, DEV NEUROBIOL, V67, P1009, DOI 10.1002/dneu.20362; Kawakami Y, 2003, NAT CELL BIOL, V5, P513, DOI 10.1038/ncb989; Kinkl N, 2002, MOL VIS, V8, P149; Kizil C, 2011, DEV NEUROBIOL; Kroehne V, 2011, DEVELOPMENT, V138, P4831, DOI 10.1242/dev.072587; Lee Y, 2005, DEVELOPMENT, V132, P5173, DOI 10.1242/dev.02101; Martinez-Morales JR, 2005, DEV CELL, V8, P565, DOI 10.1016/j.devcel.2005.01.022; Mason I, 2007, NAT REV NEUROSCI, V8, P583, DOI 10.1038/nrn2189; Molina GA, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-62; Picker A, 2005, DEVELOPMENT, V132, P4951, DOI 10.1242/dev.02071; Picker A, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000214; Poss FD, 2000, DEV BIOL, V222, P347, DOI 10.1006/dbio.2000.9722; Poss KD, 2003, DEV DYNAM, V226, P202, DOI 10.1002/dvdy.10220; Poss KD, 2007, SEMIN CELL DEV BIOL, V18, P36, DOI 10.1016/j.semcdb.2006.11.009; Qin Z, 2011, EXP EYE RES; Qin Z, 2009, P NATL ACAD SCI USA, V106, P9310, DOI 10.1073/pnas.0811186106; Raible F, 2001, MECH DEVELOP, V107, P105, DOI 10.1016/S0925-4773(01)00456-7; Raible F, 2004, TRENDS NEUROSCI, V27, P727, DOI 10.1016/j.tins.2004.10.003; Raymond PA, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-36; Reifers F, 1998, DEVELOPMENT, V125, P2381; Rousseau B, 2000, EXP EYE RES, V71, P395, DOI 10.1006/exer.2000.0892; Scholpp S, 2004, DEV GENES EVOL, V214, P285, DOI 10.1007/s00427-004-0409-1; STREISINGER G, 1981, NATURE, V291, P293, DOI 10.1038/291293a0; Takechi M, 2003, FEBS LETT, V553, P90, DOI 10.1016/S0014-5793(03)00977-3; Tawk M, 2002, GENESIS, V32, P27, DOI 10.1002/gene.10025; Thummel R, 2006, DEV DYNAM, V235, P336, DOI 10.1002/dvdy.20630; Thummel R, 2008, EXP EYE RES, V87, P433, DOI 10.1016/j.exer.2008.07.009; Tonou-Fujimori Noriko, 2002, Gene Expression Patterns, V2, P183, DOI 10.1016/S0925-4773(02)00422-7; Vihtelic TS, 2000, J NEUROBIOL, V44, P289, DOI 10.1002/1097-4695(20000905)44:3<289::AID-NEU1>3.0.CO;2-H; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Whitehead GG, 2005, SCIENCE, V310, P1957, DOI 10.1126/science.1117637; Wu DM, 2001, INVEST OPHTH VIS SCI, V42, P2115; Yang XH, 2004, SEMIN CELL DEV BIOL, V15, P91, DOI 10.1016/j.semcdb.2003.09.004; Yurco P, 2005, VISION RES, V45, P991, DOI 10.1016/j.visres.2004.10.022	61	51	52	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2012	7	1							e30365	10.1371/journal.pone.0030365	http://dx.doi.org/10.1371/journal.pone.0030365			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911FX	22291943	Green Submitted, Green Published, gold			2022-12-25	WOS:000301703800013
J	Kam, WWY; Meikle, SR; Dunstan, CR; Banati, RB				Kam, Winnie Wai-Ying; Meikle, Steven R.; Dunstan, Colin R.; Banati, Richard B.			The 18 kDa Translocator Protein (Peripheral Benzodiazepine Receptor) Expression in the Bone of Normal, Osteoprotegerin or Low Calcium Diet Treated Mice	PLOS ONE			English	Article							BINDING-SITES; AFFINITY BINDING; BRAIN; CELLS; INVOLVEMENT; ACTIVATION; RESORPTION; MICROGLIA; PK-11195; PET	The presence of the translocator protein (TSPO), previously named as the mitochondrial or peripheral benzodiazepine receptor, in bone cells was studied in vitro and in situ using RT-qPCR, and receptor autoradiography using the selective TSPO ligand PK11195. In vitro, the TSPO is highly expressed in osteoblastic and osteoclastic cells. In situ, constitutive expression of TSPO is found in bone marrow and trabecular bone, e. g., spongiosa. Mice with a reduction of bone turnover induced by a 4-day treatment of osteoprotegerin reduces [H-3]PK11195 binding in the spongiosa (320 +/- 128 Bq.mg(-1), 499 +/- 106 Bq.mg(-1) in saline-treated controls). In contrast, mice with an increase in bone turnover caused by a 4-day low calcium diet increases [H-3]PK11195 binding in the spongiosa (615 +/- 90 Bq.mg(-1)). Further, our study includes technical feasibility data on [F-18]fluoride microPET imaging of rodent bone with altered turnover. Despite [F-18]fluoride having high uptake, the in vivo signal differences were small. Using a phantom model, we describe the spillover effect and partial volume loss that affect the quantitative microPET imaging of the small bone structures in experimental mouse models. In summary, we demonstrate the expression of TSPO in small rodent bone tissues, including osteoblasts and osteoclasts. A trend increase in TSPO expression was observed in the spongiosa from low to high bone turnover conditions. However, despite the potential utility of TSPO expression as an in vivo biomarker of bone turnover in experimental rodent models, our small animal PET imaging data using [F-18]fluoride show that even under the condition of a good biological signal-to-noise ratio and high tracer uptake, the currently achievable instrument sensitivity and spatial resolution is unlikely to be sufficient to detect subtle differences in small structures, such as mouse bone.	[Kam, Winnie Wai-Ying; Meikle, Steven R.; Banati, Richard B.] Univ Sydney, Fac Hlth Sci, Discipline Med Radiat Sci, Cumberland, MD USA; [Kam, Winnie Wai-Ying; Meikle, Steven R.; Banati, Richard B.] Univ Sydney, Ramaciotti Imaging Ctr, Brain & Mind Res Inst, Camperdown, NSW, Australia; [Dunstan, Colin R.] Univ Sydney, Anzac Res Inst, Bone Res Program, Concord, NSW, Australia; [Kam, Winnie Wai-Ying; Banati, Richard B.] Australian Nucl Sci & Technol Org, Lucas Heights, NSW, Australia; [Dunstan, Colin R.] Univ Sydney, Sch Aerosp Mech & Mechatron Engn, Camperdown, NSW, Australia	University of Sydney; University of Sydney; University of Sydney; ANZAC Research Institute; Australian Nuclear Science & Technology Organisation; University of Sydney	Kam, WWY (corresponding author), Univ Sydney, Fac Hlth Sci, Discipline Med Radiat Sci, Cumberland, MD USA.	wik@ansto.gov.au	Meikle, Steven R/A-5470-2009; Dunstan, Colin/G-6214-2013; Meikle, Steven/AAH-4973-2020; Kam, Winnie/AAI-8622-2021; Ekanayake, Kanchana/P-8817-2016; Research Institute, ANZAC/CAE-9030-2022; Kam, Winnie WY/B-7407-2013	Meikle, Steven R/0000-0001-7397-0364; Dunstan, Colin/0000-0001-7586-4071; Meikle, Steven/0000-0001-7397-0364; Kam, Winnie WY/0000-0002-5508-2432; Zheng, Yu/0000-0002-6324-8148; Seibel, Markus J/0000-0002-2701-378X				Banati RB, 2002, J PHYSIOLOGY-PARIS, V96, P289, DOI 10.1016/S0928-4257(02)00018-9; Banati RB, 1997, J NEUROCYTOL, V26, P77, DOI 10.1023/A:1018567510105; Banati RB, 2000, BRAIN, V123, P2321, DOI 10.1093/brain/123.11.2321; BENAVIDES J, 1984, BIOCHEM PHARMACOL, V33, P2467, DOI 10.1016/0006-2952(84)90719-6; BERKOVICH A, 1993, LIFE SCI, V52, P1265, DOI 10.1016/0024-3205(93)90087-J; Bianco P, 2000, J CLIN INVEST, V105, P1663, DOI 10.1172/JCI10413; BRAESTRUP C, 1977, P NATL ACAD SCI USA, V74, P3805, DOI 10.1073/pnas.74.9.3805; Brenner W, 2004, J NUCL MED, V45, P1493; Cagnin A, 2001, BRAIN, V124, P2014, DOI 10.1093/brain/124.10.2014; CANAT X, 1993, LIFE SCI, V52, P107, DOI 10.1016/0024-3205(93)90293-C; Carayon P, 1996, BLOOD, V87, P3170, DOI 10.1182/blood.V87.8.3170.bloodjournal8783170; Casellas P, 2002, NEUROCHEM INT, V40, P475, DOI 10.1016/S0197-0186(01)00118-8; DESOUZA EB, 1985, ENDOCRINOLOGY, V116, P567, DOI 10.1210/endo-116-2-567; Duan Y, 1997, BONE, V21, P447, DOI 10.1016/S8756-3282(97)00177-4; Dveksler G S, 1992, PCR Methods Appl, V1, P283; Gavish M, 1999, PHARMACOL REV, V51, P629; Gerhard A, 2004, MOVEMENT DISORD, V19, P1221, DOI 10.1002/mds.20162; Giatzakis C, 2004, ENDOCRINOLOGY, V145, P1113, DOI 10.1210/en.2003-1330; Granholm S, 2007, J ENDOCRINOL, V195, P415, DOI 10.1677/JOE-07-0338; HOFFMAN EJ, 1979, J COMPUT ASSIST TOMO, V3, P299, DOI 10.1097/00004728-197906000-00001; Kim YJ, 2004, J BIOL CHEM, V279, P50773, DOI 10.1074/jbc.M404145200; LEFUR G, 1983, LIFE SCI, V33, P449, DOI 10.1016/0024-3205(83)90794-4; LEFUR G, 1983, LIFE SCI, V32, P1839, DOI 10.1016/0024-3205(83)90062-0; LIN KP, 1995, PHYS MED BIOL, V40, P629, DOI 10.1088/0031-9155/40/4/009; Miltyk W, 2006, Adv Med Sci, V51, P156; Morony S, 1999, J BONE MINER RES, V14, P1478, DOI 10.1359/jbmr.1999.14.9.1478; MYERS R, 1991, J CEREBR BLOOD F MET, V11, P314, DOI 10.1038/jcbfm.1991.64; Nothdurfter C, 2012, J NEUROENDOCRINOL, V24, P82, DOI 10.1111/j.1365-2826.2011.02166.x; OLSON JMM, 1988, EUR J PHARMACOL, V152, P47, DOI 10.1016/0014-2999(88)90834-5; Owen DRJ, 2011, J NUCL MED, V52, P24, DOI 10.2967/jnumed.110.079459; Papadopoulos V, 2006, TRENDS PHARMACOL SCI, V27, P402, DOI 10.1016/j.tips.2006.06.005; PENNEY JB, 1981, EUR J PHARMACOL, V72, P421, DOI 10.1016/0014-2999(81)90591-4; Qi JY, 1998, PHYS MED BIOL, V43, P1001, DOI 10.1088/0031-9155/43/4/027; Rosenberg N, 2006, J BONE JOINT SURG BR, V88-B, P342; RUFF MR, 1985, SCIENCE, V229, P1281, DOI 10.1126/science.2994216; Schule C, 2011, NEUROSCIENCE, V191, P55, DOI 10.1016/j.neuroscience.2011.03.025; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Wilms H, 2003, NEUROBIOL DIS, V14, P417, DOI 10.1016/j.nbd.2003.07.002; WOODARD HQ, 1975, J NUCL MED, V16, P958; Zheng Y, 2007, CANCER RES, V67, P9542, DOI 10.1158/0008-5472.CAN-07-1046	40	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e30623	10.1371/journal.pone.0030623	http://dx.doi.org/10.1371/journal.pone.0030623			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910ME	22295097	Green Published, Green Submitted, gold			2022-12-25	WOS:000301640600042
J	Rao, HL; Chen, JW; Li, M; Xiao, YB; Fu, J; Zeng, YX; Cai, MY; Xie, D				Rao, Hui-Lan; Chen, Jie-Wei; Li, Mei; Xiao, Yong-Bo; Fu, Jia; Zeng, Yi-Xin; Cai, Mu-Yan; Xie, Dan			Increased Intratumoral Neutrophil in Colorectal Carcinomas Correlates Closely with Malignant Phenotype and Predicts Patients' Adverse Prognosis	PLOS ONE			English	Article							CANCER PROGRESSION; EXPRESSION; CELLS; METASTASIS; INVASION; MODEL	Background: Substantial evidence suggests that the presence of inflammatory cells plays a critical role in the development and/or progression of human tumors. Neutrophils are the common inflammatory cells in tumors; however, the infiltration of intratumoral neutrophils in colorectal carcinoma (CRC) and its effect on CRC patients' prognosis are poorly understood. Methodology/Principal Findings: In this study, the methods of tissue microarray and immunohistochemistry (IHC) were used to investigate the prognostic significance of intratumoral CD66b+ neutrophil in CRC. According to receiver operating characteristic curve analysis, the cutoff score for high intratumoral CD66b+ neutrophil in CRC was defined when the mean counts were more than 60 per TMA spot. In our study, high intratumoral CD66b+ neutrophil was observed in 104/229 (45.4%) of CRCs and in 29/229 (12.7%) of adjacent mucosal tissues. Further correlation analysis showed that high intratumoral neutrophil was positively correlated with pT status, pM status and clinical stage (P<0.05). In univariate survival analysis, a significant association between high intratumoral neutrophil and shortened patients' survival was found (P<0.0001). In different subsets of CRC patients, intratumoral neutrophil was also a prognostic indicator in patients with stage II, stage III, grade 2, grade 3, pT1, pT2, pN0 and pN1 (P<0.05). Importantly, high intratumoral neutrophil was evaluated as an independent prognostic factor in multivariate analysis (P<0.05). Conclusions/Significance: Our results provide evidence that increased intratumoral neutrophil in CRC may be important in the acquisition of a malignant phenotype, indicating that the presence of intratumoral neutrophil is an independent factor for poor prognosis of patients with CRC.	[Rao, Hui-Lan; Chen, Jie-Wei; Li, Mei; Xiao, Yong-Bo; Fu, Jia; Zeng, Yi-Xin; Cai, Mu-Yan; Xie, Dan] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol S China, Guangzhou 510275, Guangdong, Peoples R China; [Rao, Hui-Lan; Chen, Jie-Wei; Li, Mei; Xiao, Yong-Bo; Fu, Jia; Cai, Mu-Yan; Xie, Dan] Sun Yat Sen Univ, Ctr Canc, Dept Pathol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Rao, HL (corresponding author), Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol S China, Guangzhou 510275, Guangdong, Peoples R China.	caimuyan@hotmail.com; xied@mail.sysu.edu.cn			Medical Science Technology Research Foundation of Guangdong [303041012001]; Nature Science Foundation of China [30972884]	Medical Science Technology Research Foundation of Guangdong; Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the Medical Science Technology Research Foundation of Guangdong (No. 303041012001) and the Nature Science Foundation of China (No. 30972884). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cai MY, 2011, GUT, V60, P967, DOI 10.1136/gut.2010.231993; Cai MY, 2010, CANCER SCI, V101, P1543, DOI 10.1111/j.1349-7006.2010.01560.x; Campregher C, 2008, GUT, V57, P780, DOI 10.1136/gut.2007.141556; Chua W, 2011, BRIT J CANCER, V104, P1288, DOI 10.1038/bjc.2011.100; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; Coussens LM, 2000, CELL, V103, P481, DOI 10.1016/S0092-8674(00)00139-2; Eck M, 2003, CLIN EXP IMMUNOL, V134, P508, DOI 10.1111/j.1365-2249.2003.02305.x; Fridlender ZG, 2009, CANCER CELL, V16, P183, DOI 10.1016/j.ccr.2009.06.017; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; GRISHAM MB, 1992, GASTROENTEROLOGY, V103, P1260, DOI 10.1016/0016-5085(92)91513-4; Hu LM, 2009, LAB INVEST, V89, P531, DOI 10.1038/labinvest.2009.17; Ilie M, 2011, CANCER IN PRESS; Jensen HK, 2009, J CLIN ONCOL, V27, P4709, DOI 10.1200/JCO.2008.18.9498; Jensen TO, 2011, CANCER IN PRESS; Kuang DM, 2011, J HEPATOL, V54, P948, DOI 10.1016/j.jhep.2010.08.041; Li YW, 2011, J HEPATOL, V54, P497, DOI 10.1016/j.jhep.2010.07.044; Mantovani A, 2009, CANCER CELL, V16, P173, DOI 10.1016/j.ccr.2009.08.014; Mantovani A, 2009, NATURE, V457, P36, DOI 10.1038/457036b; McLean MH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015366; Mookerjee RP, 2007, HEPATOLOGY, V46, P831, DOI 10.1002/hep.21737; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Nielsen HJ, 1999, J PATHOL, V189, P487, DOI 10.1002/(SICI)1096-9896(199912)189:4<487::AID-PATH484>3.0.CO;2-I; O'Connell JB, 2004, JNCI-J NATL CANCER I, V96, P1420, DOI 10.1093/jnci/djh275; Obrand DI, 1997, DIS COLON RECTUM, V40, P15, DOI 10.1007/BF02055676; Shojaei F, 2008, P NATL ACAD SCI USA, V105, P2640, DOI 10.1073/pnas.0712185105; Sun Y, 2011, CLIN CANCER RES, V17, P4331, DOI 10.1158/1078-0432.CCR-11-0226; Sun ZF, 2004, LANCET ONCOL, V5, P182, DOI 10.1016/S1470-2045(04)01414-7; Vermeer ITM, 2004, TOXICOL LETT, V154, P175, DOI 10.1016/j.toxlet.2004.07.013; You Wei-Cheng, 2002, J Cancer Epidemiol Prev, V7, P143; Zafirellis K, 2008, J SURG RES, V147, P99, DOI 10.1016/j.jss.2007.05.041; Zhu W, 2011, GUT IN PRESS	31	150	162	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e30806	10.1371/journal.pone.0030806	http://dx.doi.org/10.1371/journal.pone.0030806			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910ME	22295111	Green Published, Green Submitted, gold			2022-12-25	WOS:000301640600056
J	Mielecki, D; Zugaj, DL; Muszewska, A; Piwowarski, J; Chojnacka, A; Mielecki, M; Nieminuszczy, J; Grynberg, M; Grzesiuk, E				Mielecki, Damian; Zugaj, Dorota L.; Muszewska, Anna; Piwowarski, Jan; Chojnacka, Aleksandra; Mielecki, Marcin; Nieminuszczy, Jadwiga; Grynberg, Marcin; Grzesiuk, Elzbieta			Novel AlkB Dioxygenases-Alternative Models for In Silico and In Vivo Studies	PLOS ONE			English	Article							ESCHERICHIA-COLI; INDUCED MUTAGENESIS; REPAIR; DNA; PROTEIN; RNA; BACTERIAL; DAMAGE; GENES; 1-METHYLGUANINE	Background: ALKBH proteins, the homologs of Escherichia coli AlkB dioxygenase, constitute a direct, single-protein repair system, protecting cellular DNA and RNA against the cytotoxic and mutagenic activity of alkylating agents, chemicals significantly contributing to tumor formation and used in cancer therapy. In silico analysis and in vivo studies have shown the existence of AlkB homologs in almost all organisms. Nine AlkB homologs (ALKBH1-8 and FTO) have been identified in humans. High ALKBH levels have been found to encourage tumor development, questioning the use of alkylating agents in chemotherapy. The aim of this work was to assign biological significance to multiple AlkB homologs by characterizing their activity in the repair of nucleic acids in prokaryotes and their subcellular localization in eukaryotes. Methodology and Findings: Bioinformatic analysis of protein sequence databases identified 1943 AlkB sequences with eight new AlkB subfamilies. Since Cyanobacteria and Arabidopsis thaliana contain multiple AlkB homologs, they were selected as model organisms for in vivo research. Using E. coli alkB 2 mutant and plasmids expressing cyanobacterial AlkBs, we studied the repair of methyl methanesulfonate (MMS) and chloroacetaldehyde (CAA) induced lesions in ssDNA, ssRNA, and genomic DNA. On the basis of GFP fusions, we investigated the subcellular localization of ALKBHs in A. thaliana and established its mostly nucleo-cytoplasmic distribution. Some of the ALKBH proteins were found to change their localization upon MMS treatment. Conclusions: Our in vivo studies showed highly specific activity of cyanobacterial AlkB proteins towards lesions and nucleic acid type. Subcellular localization and translocation of ALKBHs in A. thaliana indicates a possible role for these proteins in the repair of alkyl lesions. We hypothesize that the multiplicity of ALKBHs is due to their involvement in the metabolism of nucleo-protein complexes; we find their repair by ALKBH proteins to be economical and effective alternative to degradation and de novo synthesis.	[Mielecki, Damian; Zugaj, Dorota L.; Muszewska, Anna; Piwowarski, Jan; Chojnacka, Aleksandra; Mielecki, Marcin; Nieminuszczy, Jadwiga; Grynberg, Marcin; Grzesiuk, Elzbieta] Polish Acad Sci, Inst Biochem & Biophys, Warsaw, Poland	Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences	Mielecki, D (corresponding author), Polish Acad Sci, Inst Biochem & Biophys, Warsaw, Poland.	greenb@ibb.waw.pl; elag@ibb.waw.pl	Chojnacka, Aleksandra/HGA-7394-2022; Muszewska, Anna/S-9406-2019	Muszewska, Anna/0000-0002-4578-844X; Chojnacka, Aleksandra/0000-0001-7802-1678; Grzesiuk, Elzbieta/0000-0002-7833-7602; Grynberg, Marcin/0000-0003-1887-7209; Mielecki, Damian/0000-0003-2929-4500	Polish State Committee for Scientific Research [N301 165835]; Polish-Norwegian Research Fund [PNRF-143-Al-1/079]	Polish State Committee for Scientific Research(Polish State Committee for Scientific Research); Polish-Norwegian Research Fund	This work was supported by a grant from Polish State Committee for Scientific Research N301 165835 and Polish-Norwegian Research Fund (Grant PNRF-143-Al-1/079). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas PA, 2003, NATURE, V421, P859, DOI 10.1038/nature01363; Ba ANN, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-202; Bjornstad LG, 2011, BIOCHEM J, V434, P391, DOI 10.1042/BJ20101667; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Delaney JC, 2004, P NATL ACAD SCI USA, V101, P14051, DOI 10.1073/pnas.0403489101; Dinglay S, 2000, GENE DEV, V14, P2097; Drablos F, 2004, DNA REPAIR, V3, P1389, DOI 10.1016/j.dnarep.2004.05.004; Falnes PO, 2002, NATURE, V419, P178, DOI 10.1038/nature01048; Falnes PO, 2004, NUCLEIC ACIDS RES, V32, P6260, DOI 10.1093/nar/gkh964; Falnes PO, 2004, NUCLEIC ACIDS RES, V32, P3456, DOI 10.1093/nar/gkh655; Frickey T, 2004, BIOINFORMATICS, V20, P3702, DOI 10.1093/bioinformatics/bth444; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Haasen D, 1999, PLANT J, V20, P695, DOI 10.1046/j.1365-313X.1999.00644.x; He Ping, 2007, Methods Mol Biol, V354, P1; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Iyer LM, 2001, GENOME BIOL, V2; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; Kilpelainen TO, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001116; Korvald H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025188; Kosugi S, 2009, P NATL ACAD SCI USA, V106, P10171, DOI 10.1073/pnas.0900604106; Kuchta K, 2011, NUCL ACIDS RES; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Kurowski MA, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-48; Lafontaine DLJ, 2010, TRENDS BIOCHEM SCI, V35, P267, DOI 10.1016/j.tibs.2009.12.006; Leihne V, 2011, NUCLEIC ACIDS RES, V39, P7688, DOI 10.1093/nar/gkr406; Lin ZG, 2006, P NATL ACAD SCI USA, V103, P10328, DOI 10.1073/pnas.0604232103; LINDAHL T, 1988, ANNU REV BIOCHEM, V57, P133, DOI 10.1146/annurev.bi.57.070188.001025; Maciejewska AM, 2011, MUTAGENESIS, V26, P401, DOI 10.1093/mutage/geq107; Maciejewska AM, 2010, MUTAT RES-FUND MOL M, V684, P24, DOI 10.1016/j.mrfmmm.2009.11.005; Muller TA, 2010, DNA REPAIR, V9, P58, DOI 10.1016/j.dnarep.2009.10.011; Nieminuszczy J, 2006, DNA REPAIR, V5, P181, DOI 10.1016/j.dnarep.2005.09.007; Nieminuszczy J, 2007, ACTA BIOCHIM POL, V54, P459, DOI 10.18388/abp.2007_3221; Nieminuszczy J, 2009, ENVIRON MOL MUTAGEN, V50, P791, DOI 10.1002/em.20497; Nordstrand LM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013827; Ougland R, 2004, MOL CELL, V16, P107, DOI 10.1016/j.molcel.2004.09.002; Pan ZS, 2008, DEV DYNAM, V237, P316, DOI 10.1002/dvdy.21418; Pierleoni A, 2006, BIOINFORMATICS, V22, pE408, DOI 10.1093/bioinformatics/btl222; Sambrook J, 2001, MOL CLONING LAB MANU; Sedgwick B, 2002, ONCOGENE, V21, P8886, DOI 10.1038/sj.onc.1205998; Stratigopoulos G, 2010, NAT GENET, V42, P1038, DOI 10.1038/ng1210-1038; Tasaki M, 2011, BRIT J CANCER, V104, P700, DOI 10.1038/sj.bjc.6606012; Thalhammer A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016210; Trewick SC, 2002, NATURE, V419, P174, DOI 10.1038/nature00908; Tzfira T, 2005, PLANT MOL BIOL, V57, P503, DOI 10.1007/s11103-005-0340-5; van den Born E, 2008, NUCLEIC ACIDS RES, V36, P5451, DOI 10.1093/nar/gkn519; van den Born E, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1173; van den Born E, 2009, NUCLEIC ACIDS RES, V37, P7124, DOI 10.1093/nar/gkp774; VOGEL HJ, 1956, J BIOL CHEM, V218, P97; Westbye MP, 2008, J BIOL CHEM, V283, P25046, DOI 10.1074/jbc.M803776200; Wu SS, 2011, ACTA PHARMACOL SIN, V32, P393, DOI 10.1038/aps.2010.216	50	45	48	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2012	7	1							e30588	10.1371/journal.pone.0030588	http://dx.doi.org/10.1371/journal.pone.0030588			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910LV	22291995	Green Submitted, gold, Green Published			2022-12-25	WOS:000301639600035
J	Dommerich, S; Frickmann, H; Ostwald, J; Lindner, T; Zautner, AE; Arndt, K; Pau, HW; Podbielski, A				Dommerich, Steffen; Frickmann, Hagen; Ostwald, Juergen; Lindner, Tobias; Zautner, Andreas Erich; Arndt, Kathleen; Pau, Hans Wilhelm; Podbielski, Andreas			Effects of High Hydrostatic Pressure on Bacterial Growth on Human Ossicles Explanted from Cholesteatoma Patients	PLOS ONE			English	Article							LISTERIA-MONOCYTOGENES; STAPHYLOCOCCUS-AUREUS; OSSICULAR CHAIN; CAMPYLOBACTER-JEJUNI; ESCHERICHIA-COLI; INACTIVATION; RESISTANCE; BIOFILMS; MACROMOLECULES; RECONSTRUCTION	Background: High hydrostatic pressure (HHP) treatment can eliminate cholesteatoma cells from explanted human ossicles prior to re-insertion. We analyzed the effects of HHP treatment on the microbial flora on ossicles and on the planktonic and biofilm states of selected isolates. Methodology: Twenty-six ossicles were explanted from cholesteatoma patients. Five ossicles were directly analyzed for microbial growth without further treatment. Fifteen ossicles were cut into two pieces. One piece was exposed to HHP of 350 MPa for 10 minutes. Both the treated and untreated (control) pieces were then assessed semi-quantitatively. Three ossicles were cut into two pieces and exposed to identical pressure conditions with or without the addition of one of two different combinations of antibiotics to the medium. Differential effects of 10-minute in vitro exposure of planktonic and biofilm bacteria to pressures of 100 MPa, 250 MPa, 400 MPa and 540 MPa in isotonic and hypotonic media were analyzed using two patient isolates of Staphylococcus epidermidis and Neisseria subflava. Bacterial cell inactivation and biofilm destruction were assessed by colony counting and electron microscopy. Principal Findings: A variety of microorganisms were isolated from the ossicles. Irrespective of the medium, HHP treatment at 350 MPa for 10 minutes led to satisfying but incomplete inactivation especially of Gram-negative bacteria. The addition of antibiotics increased the efficacy of elimination. A comparison of HHP treatment of planktonic and biofilm cells showed that the effects of HPP were reduced by about one decadic logarithmic unit when HPP was applied to biofilms. High hydrostatic pressure conditions that are suitable to inactivate cholesteatoma cells fail to completely sterilize ossicles even if antibiotics are added. As a result of the reduced microbial load and the viability loss of surviving bacteria, however, there is a lower risk of re-infection after re-insertion.	[Dommerich, Steffen; Ostwald, Juergen; Pau, Hans Wilhelm] Univ Rostock Hosp, Dept Otorhinolaryngol Head & Neck Surg, Rostock, Germany; [Frickmann, Hagen; Zautner, Andreas Erich; Arndt, Kathleen; Podbielski, Andreas] Univ Rostock Hosp, Inst Med Microbiol Virol & Hyg, Rostock, Germany; [Lindner, Tobias] Univ Rostock Hosp, Dept Orthoped, Biomech & Implant Technol Res Lab, Rostock, Germany	University of Rostock; University of Rostock; University of Rostock	Dommerich, S (corresponding author), Univ Rostock Hosp, Dept Otorhinolaryngol Head & Neck Surg, Rostock, Germany.	Frickmann@bni-hamburg.de	Lindner, Tobias/B-6952-2014; Zautner, Andreas Erich/ABA-9655-2020; Zautner, Andreas Erich/AAE-7425-2019	Lindner, Tobias/0000-0001-7826-3132; Zautner, Andreas Erich/0000-0003-0984-013X; Zautner, Andreas Erich/0000-0003-0984-013X				Alpas H, 1999, APPL ENVIRON MICROB, V65, P4248; Balny C, 2002, BBA-PROTEIN STRUCT M, V1595, P3, DOI 10.1016/S0167-4838(01)00331-4; Baumann I, 1997, HNO, V45, P990, DOI 10.1007/s001060050184; Bieche C, 2009, LETT APPL MICROBIOL, V48, P198, DOI 10.1111/j.1472-765X.2008.02511.x; Brouillet M, 2009, J BIOMED MATER RES B, V91B, P348, DOI 10.1002/jbm.b.31408; Cebrian G, 2010, APPL ENVIRON MICROB, V76, P6982, DOI 10.1128/AEM.00900-10; Cheftel JC, 1995, FOOD SCI TECHNOL INT, V1, P75, DOI 10.1177/108201329500100203; Chole RA, 2002, ARCH OTOLARYNGOL, V128, P1129, DOI 10.1001/archotol.128.10.1129; Crenshaw HC, 1996, EXP CELL RES, V227, P285, DOI 10.1006/excr.1996.0278; Diehl P, 2005, INT J MOL MED, V16, P285; Diehl P, 2003, ONCOL REP, V10, P1851; Diehl P, 2006, J ORTHOP SCI, V11, P380, DOI 10.1007/s00776-006-1031-z; Dommerich S, 2010, LARYNGO RHINO OTOL, V89, P284, DOI 10.1055/s-0030-1248306; Dost P, 2000, LARYNGO RHINO OTOL, V79, P193; Eloe EA, 2008, APPL ENVIRON MICROB, V74, P6298, DOI 10.1128/AEM.01316-08; Geyer G, 2002, LARYNGO RHINO OTOL, V81, P164, DOI 10.1055/s-2002-25031; GLASSCOCK ME, 1988, ARCH OTOLARYNGOL, V114, P1252; Gollwitzer Hans, 2009, Open Orthop J, V3, P1, DOI 10.2174/1874325000903010001; GROSS M, 1994, EUR J BIOCHEM, V221, P617, DOI 10.1111/j.1432-1033.1994.tb18774.x; Hall-Stoodley L, 2006, JAMA-J AM MED ASSOC, V296, P202, DOI 10.1001/jama.296.2.202; Hauben KJA, 1997, APPL ENVIRON MICROB, V63, P945, DOI 10.1128/AEM.63.3.945-950.1997; HILDMANN H, 1992, LARYNGO RHINO OTOL, V71, P5, DOI 10.1055/s-2007-997235; Hildmann H, 2000, LARYNGO RHINO OTOL, V79, pS73; Hormann S, 2006, PROTEOMICS, V6, P1878, DOI 10.1002/pmic.200402086; Igura N, 2003, APPL ENVIRON MICROB, V69, P6307, DOI 10.1128/AEM.69.10.6307-6310.2003; Jaryszak EM, 2009, OTOL NEUROTOL, V30, P1191, DOI 10.1097/MAO.0b013e3181be64b3; Jaryszak EM, 2009, AM J OTOLARYNG, V30, P367, DOI 10.1016/j.amjoto.2008.07.007; Jofre A, 2010, INT MICROBIOL, V13, P105, DOI 10.2436/20.1501.01.115; Juhn SK, 2008, CLIN EXP OTORHINOLAR, V1, P117, DOI 10.3342/ceo.2008.1.3.117; Kingsley DH, 2006, J FOOD PROTECT, V69, P2454, DOI 10.4315/0362-028X-69.10.2454; Koseki S, 2006, INT J FOOD MICROBIOL, V111, P175, DOI 10.1016/j.ijfoodmicro.2006.05.008; Lembke C, 2006, APPL ENVIRON MICROB, V72, P2864, DOI 10.1128/AEM.72.4.2864-2875.2006; Magdolen U, 2006, INT J MOL MED, V17, P1017; Masson Patrick, 2001, Journal of Biomedicine and Biotechnology, V1, P85, DOI 10.1155/S1110724301000158; Mentre P, 2001, INT REV CYTOL, V201, P1, DOI 10.1016/S0074-7696(01)01001-4; Nelson RRS, 1999, J HOSP INFECT, V42, P275, DOI 10.1053/jhin.1998.0605; Pavlovic M, 2005, ARCH MICROBIOL, V184, P11, DOI 10.1007/s00203-005-0021-4; Post J Christopher, 2004, Curr Opin Otolaryngol Head Neck Surg, V12, P185, DOI 10.1097/01.moo.0000124936.46948.6a; Ricciardiello F, 2009, ACTA OTORHINOLARYNGO, V29, P197; SADE J, 1993, EUR ARCH OTO-RHINO-L, V250, P193; Sagarzazu N, 2010, J APPL MICROBIOL, V109, P146, DOI 10.1111/j.1365-2672.2009.04639.x; Standar K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013135; Steinhauser E, 2006, J BIOMED MATER RES B, V76B, P130, DOI 10.1002/jbm.b.30343; THORNLEY MJ, 1968, J CELL SCI, V3, P273; Van Boeijen IKH, 2008, J FOOD PROTECT, V71, P2007, DOI 10.4315/0362-028X-71.10.2007; Van Boeijen IKH, 2010, APPL ENVIRON MICROB, V76, P2225, DOI 10.1128/AEM.02434-09; Van Opstal I, 2003, INT J FOOD MICROBIOL, V88, P1, DOI 10.1016/S0168-1605(03)00070-9; Vercammen A, 2011, INT J FOOD MICR 0319, V19; VOGEL RF, 2008, HIGH PRESSURE MICROB, P117; Weber P, 2008, BIOMED TECH, V53, P190, DOI 10.1515/BMT.2008.027; Welkoborsky HJ, 2011, LARYNGO RHINO OTOL, V90, P38, DOI 10.1055/s-0030-1268464; Wen J, 2009, APPL ENVIRON MICROB, V75, P1581, DOI 10.1128/AEM.01942-08; Zahnert T, 2005, HNO, V53, P89, DOI 10.1007/s00106-004-1168-z	53	8	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30150	10.1371/journal.pone.0030150	http://dx.doi.org/10.1371/journal.pone.0030150			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22291908	Green Submitted, Green Published, gold			2022-12-25	WOS:000301570600018
J	Nem, D; Baranyai, D; Qiu, H; Godtel-Armbrust, U; Nestler, S; Wojnowski, L				Nem, Dieudonne; Baranyai, Dorothea; Qiu, Huan; Goedtel-Armbrust, Ute; Nestler, Sebastian; Wojnowski, Leszek			Pregnane X Receptor and Yin Yang 1 Contribute to the Differential Tissue Expression and Induction of CYP3A5 and CYP3A4	PLOS ONE			English	Article							TRANSCRIPTION FACTOR-BINDING; NUCLEAR RECEPTOR; CYTOCHROME-P450 3A; IN-VITRO; INDUCED OSTEOMALACIA; SIGNALING PATHWAY; BLOOD-PRESSURE; HUMAN PROSTATE; MESSENGER-RNA; HUMAN LIVER	The hepato-intestinal induction of the detoxifying enzymes CYP3A4 and CYP3A5 by the xenosensing pregnane X receptor (PXR) constitutes a key adaptive response to oral drugs and dietary xenobiotics. In contrast to CYP3A4, CYP3A5 is additionally expressed in several, mostly steroidogentc organs, which creates potential for induction-driven disturbances of the steroid homeostasis. Using cell lines and mice transgenic for a CYP3A5 promoter we demonstrate that the CYP3A5 expression in these organs is non-inducible and independent from PXR. Instead, it is enabled by the loss of a suppressing yin yang 1 (YY1)-binding site from the CYP3A5 promoter which occurred in haplorrhine primates. This YY1 site is conserved in CYP3A4, but its inhibitory effect can be offset by PXR acting on response elements such as XREM. Taken together, the loss of YY1 binding site from promoters of the CYP3A5 gene lineage during primate evolution may have enabled the utilization of CYP3A5 both in the adaptive hepato-intestinal response to xenobiotics and as a constitutively expressed gene in other organs. Our results thus constitute a first description of uncoupling induction from constitutive expression for a major detoxifying enzyme. They also suggest an explanation for he considerable tissue expression differences between CYP3A5 and CYP3A4.	[Nem, Dieudonne; Baranyai, Dorothea; Qiu, Huan; Goedtel-Armbrust, Ute; Nestler, Sebastian; Wojnowski, Leszek] Johannes Gutenberg Univ Mainz, Dept Pharmacol, Univ Med Ctr, D-6500 Mainz, Germany	Johannes Gutenberg University of Mainz	Wojnowski, L (corresponding author), Johannes Gutenberg Univ Mainz, Dept Pharmacol, Univ Med Ctr, D-6500 Mainz, Germany.	wojnowski@uni-mainz.de	Qiu, Huan/C-2671-2016		DFG (German Research Foundation) [WO505/2-2]; DAAD (German Academic Exchange Office)	DFG (German Research Foundation)(German Research Foundation (DFG)); DAAD (German Academic Exchange Office)(Deutscher Akademischer Austausch Dienst (DAAD))	This work was supported by the DFG (German Research Foundation) grant WO505/2-2 and by a doctoral stipend of the DAAD (German Academic Exchange Office) to DN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleksa K, 2005, PEDIATR NEPHROL, V20, P872, DOI 10.1007/s00467-004-1807-3; Arthur JM, 2000, TISSUE CELL, V32, P446, DOI 10.1054/tice.2000.0135; Bertilsson G, 1998, P NATL ACAD SCI USA, V95, P12208, DOI 10.1073/pnas.95.21.12208; Biggs JS, 2007, MOL PHARMACOL, V72, P514, DOI 10.1124/mol.106.033795; Blumberg B, 1998, GENE DEV, V12, P3195, DOI 10.1101/gad.12.20.3195; BRODIE MJ, 1980, CLIN PHARMACOL THER, V27, P810, DOI 10.1038/clpt.1980.115; Brudno M, 2003, GENOME RES, V13, P721, DOI 10.1101/gr.926603; Burk O, 2004, J BIOL CHEM, V279, P38379, DOI 10.1074/jbc.M404949200; Cedrone E, 2009, ATCC CONNECTION, V29, P4; Cedrone E, 2009, ATCC CONNECTION, V29, P15; Chekmenev DS, 2005, NUCLEIC ACIDS RES, V33, pW432, DOI 10.1093/nar/gki441; Cheng XG, 2006, DRUG METAB DISPOS, V34, P1863, DOI 10.1124/dmd.106.010520; CLORE J, 1992, KIDNEY INT, V42, P1297, DOI 10.1038/ki.1992.421; Dai Y, 2006, DRUG METAB DISPOS, V34, P836, DOI 10.1124/dmd.105.008680; Dai Y, 2004, BIOCHEM PHARMACOL, V68, P1889, DOI 10.1016/j.bcp.2004.07.012; Geick A, 2001, J BIOL CHEM, V276, P14581, DOI 10.1074/jbc.M010173200; Gellner K, 2001, PHARMACOGENETICS, V11, P111, DOI 10.1097/00008571-200103000-00002; Godtel-Armbrust U, 2007, N-S ARCH PHARMACOL, V375, P377, DOI 10.1007/s00210-007-0172-8; Gordon S, 2006, ONCOGENE, V25, P1125, DOI 10.1038/sj.onc.1209080; Greiner B, 1999, J CLIN INVEST, V104, P147, DOI 10.1172/JCI6663; Gupta RP, 2005, J CLIN ENDOCR METAB, V90, P1210, DOI 10.1210/jc.2004-0966; Gupta RP, 2004, J BONE MINER RES, V19, P680, DOI 10.1359/JBMR.0301257; Haehner BD, 1996, MOL PHARMACOL, V50, P52; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; HARIHARAN N, 1991, P NATL ACAD SCI USA, V88, P9799, DOI 10.1073/pnas.88.21.9799; HASHIMOTO H, 1993, EUR J BIOCHEM, V218, P585, DOI 10.1111/j.1432-1033.1993.tb18412.x; Heikamp Stephanie, 2008, THESIS J GUTENBERG U; Henshall J, 2008, DRUG METAB DISPOS, V36, P1332, DOI 10.1124/dmd.108.021279; Ho H, 2005, HYPERTENSION, V45, P294, DOI 10.1161/01.HYP.0000151361.31736.96; Hustert E, 2001, PHARMACOGENETICS, V11, P773, DOI 10.1097/00008571-200112000-00005; Hustert E, 2001, DRUG METAB DISPOS, V29, P1454; HYDEDERUYSCHER RP, 1995, NUCLEIC ACIDS RES, V23, P4457, DOI 10.1093/nar/23.21.4457; Ihunnah CA, 2011, BBA-MOL BASIS DIS, V1812, P956, DOI 10.1016/j.bbadis.2011.01.014; Iwano S, 2001, BIOCHEM BIOPH RES CO, V286, P55, DOI 10.1006/bbrc.2001.5352; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; Joy MS, 2007, NEPHROL DIAL TRANSPL, V22, P1963, DOI 10.1093/ndt/gfm133; Kliewer SA, 1998, CELL, V92, P73, DOI 10.1016/S0092-8674(00)80900-9; Koch I, 2002, DRUG METAB DISPOS, V30, P1108, DOI 10.1124/dmd.30.10.1108; Kreutz R, 2005, PHARMACOGENET GENOM, V15, P831, DOI 10.1097/01213011-200512000-00001; Kuehl P, 2001, NAT GENET, V27, P383, DOI 10.1038/86882; Lamba V, 2004, TOXICOL APPL PHARM, V199, P251, DOI 10.1016/j.taap.2003.12.027; Lash LH, 2008, TOXICOLOGY, V244, P56, DOI 10.1016/j.tox.2007.10.022; Lehmann JM, 1998, J CLIN INVEST, V102, P1016, DOI 10.1172/JCI3703; LI HC, 1995, J BIOCHEM TOXICOL, V10, P51; Lin YS, 2002, MOL PHARMACOL, V62, P162, DOI 10.1124/mol.62.1.162; Luke MPS, 2006, J BIOL CHEM, V281, P33226, DOI 10.1074/jbc.M606584200; Masuyama H, 2001, MOL CELL ENDOCRINOL, V172, P47, DOI 10.1016/S0303-7207(00)00395-6; MATSUZAKI K, 1995, STEROIDS, V60, P457, DOI 10.1016/0039-128X(95)00038-R; McCune JS, 2005, DRUG METAB DISPOS, V33, P1074, DOI 10.1124/dmd.104.002279; Moilanen AM, 2007, CARCINOGENESIS, V28, P916, DOI 10.1093/carcin/bgl222; Morris DJ, 1998, AM J PHYSIOL-CELL PH, V274, pC1245, DOI 10.1152/ajpcell.1998.274.5.C1245; Murray GI, 1999, BRIT J CANCER, V79, P1836, DOI 10.1038/sj.bjc.6690292; Nishimura Masuhiro, 2004, Drug Metab Pharmacokinet, V19, P135, DOI 10.2133/dmpk.19.135; Novotna A, 2010, EUR J PHARM SCI, V41, P276, DOI 10.1016/j.ejps.2010.06.019; Qiu H, 2008, PHARMACOGENET GENOM, V18, P53, DOI 10.1097/FPC.0b013e3282f313f8; Qiu H, 2010, PHARMACOGENET GENOM, V20, P167, DOI 10.1097/FPC.0b013e328336bbeb; Saito T, 2001, J BIOL CHEM, V276, P38010; SHAH SC, 1981, TUBERCLE, V62, P207, DOI 10.1016/0041-3879(81)90008-8; Shi Y, 1997, BBA-REV CANCER, V1332, pF49, DOI 10.1016/S0304-419X(96)00044-3; SHIMADA T, 1994, J PHARMACOL EXP THER, V270, P414; Singer GAC, 2005, MOL BIOL EVOL, V22, P767, DOI 10.1093/molbev/msi062; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Tegude H, 2007, DRUG METAB DISPOS, V35, P946, DOI 10.1124/dmd.106.013565; Thompson EE, 2004, AM J HUM GENET, V75, P1059, DOI 10.1086/426406; TOM BH, 1976, IN VITRO CELL DEV B, V12, P180; Verkoelen CF, 1999, KIDNEY INT, V55, P1426, DOI 10.1046/j.1523-1755.1999.00383.x; Weill L, 2003, J VIROL, V77, P2903, DOI 10.1128/JVI.77.5.2903-2914.2003; Xu Y, 2006, MOL PHARMACOL, V69, P56, DOI 10.1124/mol.105.017392; Yamakoshi Y, 1999, BIOCHEM BIOPH RES CO, V260, P676, DOI 10.1006/bbrc.1999.0960	69	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30895	10.1371/journal.pone.0030895	http://dx.doi.org/10.1371/journal.pone.0030895			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22292071	Green Published, gold, Green Submitted			2022-12-25	WOS:000301570600095
J	Wei, H; Hu, CX; Wang, M; van den Hoek, AM; Reijmers, TH; Wopereis, S; Bouwman, J; Ramaker, R; Korthout, HAAJ; Vennik, M; Hankemeier, T; Havekes, LM; Witkamp, RF; Verheij, ER; Xu, GW; van der Greef, J				Wei, Heng; Hu, Chunxiu; Wang, Mei; van den Hoek, Anita M.; Reijmers, Theo H.; Wopereis, Suzan; Bouwman, Jildau; Ramaker, Raymond; Korthout, Henrie A. A. J.; Vennik, Marco; Hankemeier, Thomas; Havekes, Louis M.; Witkamp, Renger F.; Verheij, Elwin R.; Xu, Guowang; van der Greef, Jan			Lipidomics Reveals Multiple Pathway Effects of a Multi-Components Preparation on Lipid Biochemistry in ApoE*3Leiden.CETP Mice	PLOS ONE			English	Article							CHOLESTERYL ESTER TRANSFER; SYSTEMS BIOLOGY; AGGRAVATES ATHEROSCLEROSIS; OVERWEIGHT PATIENTS; CHINESE MEDICINE; WEIGHT-REDUCTION; TRANSFER PROTEIN; HDL-CHOLESTEROL; INCREASES HDL; RISK-FACTORS	Background: Causes and consequences of the complex changes in lipids occurring in the metabolic syndrome are only partly understood. Several interconnected processes are deteriorating, which implies that multi-target approaches might be more successful than strategies based on a limited number of surrogate markers. Preparations from Chinese Medicine (CM) systems have been handed down with documented clinical features similar as metabolic syndrome, which might help developing new intervention for metabolic syndrome. The progress in systems biology and specific animal models created possibilities to assess the effects of such preparations. Here we report the plasma and liver lipidomics results of the intervention effects of a preparation SUB885C in apolipoprotein E3 Leiden cholesteryl ester transfer protein (ApoE*3Leiden.CETP) mice. SUB885C was developed according to the principles of CM for treatment of metabolic syndrome. The cannabinoid receptor type 1 blocker rimonabant was included as a general control for the evaluation of weight and metabolic responses. Methodology/Principal Findings: ApoE*3Leiden.CETP mice with mild hypercholesterolemia were divided into SUB885C-, rimonabant- and non-treated control groups. SUB885C caused no weight loss, but significantly reduced plasma cholesterol (-49%, p < 0.001), CETP levels (-31%, p<0.001), CETP activity (-74%, p<0.001) and increased HDL-C (39%, p<0.05). It influenced lipidomics classes of cholesterol esters and triglycerides the most. Rimonabant induced a weight loss (-9%, p<0.05), but only a moderate improvement of lipid profiles. In vitro, SUB885C extract caused adipolysis stimulation and adipogenesis inhibition in 3T3-L1 cells. Conclusions: SUB885C, a multi-components preparation, is able to produce anti-atherogenic changes in lipids of the ApoE*3Leiden.CETP mice, which are comparable to those obtained with compounds belonging to known drugs (e. g. rimonabant, atorvastatin, niacin). This study successfully illustrated the power of lipidomics in unraveling intervention effects and to help finding new targets or ingredients for lifestyle-related metabolic abnormality.	[Wei, Heng; Wopereis, Suzan; Bouwman, Jildau; Ramaker, Raymond; Verheij, Elwin R.; van der Greef, Jan] TNO, Dept Earth Environm & Life Sci, NL-3700 AJ Zeist, Netherlands; [Wei, Heng; Wang, Mei; Xu, Guowang; van der Greef, Jan] Sino Dutch Ctr Prevent & Personalized Med, Zeist, Netherlands; [Hu, Chunxiu; Reijmers, Theo H.; Hankemeier, Thomas; van der Greef, Jan] Leiden Univ, Leiden Amsterdam Ctr Drug Res, Div Analyt Biosci, Leiden, Netherlands; [Hu, Chunxiu; Xu, Guowang] Chinese Acad Sci, Dalian Inst Chem Phys, CAS Key Lab Separat Sci Analyt Chem, Dalian, Peoples R China; [Wang, Mei; van der Greef, Jan] SU BioMed, Zeist, Netherlands; [Korthout, Henrie A. A. J.; Vennik, Marco] Fytagoras BV, Leiden, Netherlands; [Reijmers, Theo H.; Bouwman, Jildau; Hankemeier, Thomas] Leiden Univ, Netherlands Metabol Ctr, Leiden, Netherlands; [Havekes, Louis M.] Leiden Univ, Med Ctr, Dept Endocrinol & Cardiol, Leiden, Netherlands; [Witkamp, Renger F.] Wageningen Univ, Div Human Nutr, Wageningen, Netherlands	Netherlands Organization Applied Science Research; Leiden University; Leiden University - Excl LUMC; Chinese Academy of Sciences; Dalian Institute of Chemical Physics, CAS; Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Wageningen University & Research	Wei, H (corresponding author), TNO, Dept Earth Environm & Life Sci, NL-3700 AJ Zeist, Netherlands.	xugw@dicp.ac.cn; jan.vandergreef@tno.nl	Witkamp, Renger/I-7622-2012; Hankemeier, Thomas/V-5407-2019; Xu, Guowang/L-6910-2014	Witkamp, Renger/0000-0002-7935-8261; Hankemeier, Thomas/0000-0001-7871-2073; Xu, Guowang/0000-0003-4298-3554	Netherlands Genomics Initiative; Netherlands Metabolomics Centre; Sino-Dutch Centre for Preventive and Personalized Medicine; SU Biomedicine (SUB) [031.13097]	Netherlands Genomics Initiative; Netherlands Metabolomics Centre; Sino-Dutch Centre for Preventive and Personalized Medicine; SU Biomedicine (SUB)	This work was sponsored by the Netherlands Genomics Initiative, the Netherlands Metabolomics Centre, and the Sino-Dutch Centre for Preventive and Personalized Medicine. In addition, the work presented is part of a larger project with Project No. 031.13097 financially supported by SU Biomedicine (SUB). Authors employed by SUB (Mei Wang and Jan van der Greef) contributed to experimental conceiving and design, guidance and discussion of the project. All the other funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand SS, 2011, LANCET, V377, P529, DOI 10.1016/S0140-6736(10)62346-X; Anthonsen MW, 1998, J BIOL CHEM, V273, P215, DOI 10.1074/jbc.273.1.215; Balakumar P, 2007, PHARMACOL RES, V56, P91, DOI 10.1016/j.phrs.2007.03.002; Barker M, 2003, J CHEMOMETR, V17, P166, DOI 10.1002/cem.785; Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628; Bernatoniene J, 2009, PHYTOTHER RES, V23, P1701, DOI 10.1002/ptr.2815; Bijlsma S, 2006, ANAL CHEM, V78, P567, DOI 10.1021/ac051495j; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Cannon CP, 2009, LANCET, V373, P1313, DOI 10.1016/S0140-6736(09)60652-8; Chau CF, 2006, TRENDS FOOD SCI TECH, V17, P313, DOI 10.1016/j.tifs.2005.12.005; Chui SH, 2008, J COMPLEMENTARY INTE, V5, P17; de Haan W, 2008, CIRCULATION, V117, P2515, DOI 10.1161/CIRCULATIONAHA.107.761965; de Haan W, 2008, ATHEROSCLEROSIS, V197, P57, DOI 10.1016/j.atherosclerosis.2007.08.001; de Haan W, 2009, BBA-MOL CELL BIOL L, V1791, P191, DOI 10.1016/j.bbalip.2008.12.008; de Vries-van der Weij J, 2009, ATHEROSCLEROSIS, V206, P153, DOI 10.1016/j.atherosclerosis.2009.02.038; Despres JP, 2005, NEW ENGL J MED, V353, P2121, DOI 10.1056/NEJMoa044537; Dullaart RPF, 1999, EUR J CLIN INVEST, V29, P663; Feng Y, 2010, BRIT J PHARMACOL, V161, P113, DOI 10.1111/j.1476-5381.2010.00826.x; Franco OH, 2004, BMJ-BRIT MED J, V329, P1447, DOI 10.1136/bmj.329.7480.1447; Gary-Bobo M, 2006, MOL PHARMACOL, V69, P471, DOI 10.1124/mol.105.015040; German JB, 2007, CURR OPIN LIPIDOL, V18, P66; Grover JK, 2002, J ETHNOPHARMACOL, V81, P81, DOI 10.1016/S0378-8741(02)00059-4; Hu CX, 2008, J PROTEOME RES, V7, P4982, DOI 10.1021/pr800373m; Hu CX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019423; James WPT, 2008, J INTERN MED, V263, P336, DOI 10.1111/j.1365-2796.2008.01922.x; Jones D, 2008, NAT REV DRUG DISCOV, V7, P961, DOI 10.1038/nrd2775; Liu J.P., 2002, COCHRANE DB SYST REV, VRev0, DOI [10.1002/14651858.cd003642.pub2, DOI 10.1002/14651858.CD003642.PUB2]; Lonn E, 2009, CURR OPIN LIPIDOL, V20, P453, DOI 10.1097/MOL.0b013e32833305a3; Mitchell PB, 2007, LANCET, V370, P1671, DOI 10.1016/S0140-6736(07)61705-X; Ng TB, 2005, BIOCHEM CELL BIOL, V83, P78, DOI [10.1139/o04-100, 10.1139/O04-100]; NISHINA PM, 1990, J LIPID RES, V31, P859; Nissen SE, 2008, JAMA-J AM MED ASSOC, V299, P1547, DOI 10.1001/jama.299.13.1547; Niwano Y, 2009, PLANT FOOD HUM NUTR, V64, P6, DOI 10.1007/s11130-008-0102-z; RAMIREZZACARIAS JL, 1992, HISTOCHEMISTRY, V97, P493, DOI 10.1007/BF00316069; Smeyers-Verbeke J, 1998, HDB CHEMOMETRICS QUA; Smit S, 2007, ANAL CHIM ACTA, V592, P210, DOI 10.1016/j.aca.2007.04.043; Tadic VM, 2008, J AGR FOOD CHEM, V56, P7700, DOI 10.1021/jf801668c; Tian WX, 2004, LIFE SCI, V74, P2389, DOI 10.1016/j.lfs.2003.09.064; van der Greef J, 2007, J PROTEOME RES, V6, P1540, DOI 10.1021/pr0606530; van der Hoorn JWA, 2009, BRIT J PHARMACOL, V156, P1067, DOI 10.1111/j.1476-5381.2008.00109.x; van der Hoorn JWA, 2008, ARTERIOSCL THROM VAS, V28, P2016, DOI 10.1161/ATVBAHA.108.171363; van der Kloet FM, 2009, J PROTEOME RES, V8, P5132, DOI 10.1021/pr900499r; Van Gaal LF, 2005, LANCET, V365, P1389, DOI 10.1016/S0140-6736(05)66374-X; van Wietmarschen H, 2009, JCR-J CLIN RHEUMATOL, V15, P330, DOI 10.1097/RHU.0b013e3181ba3926; VANVLIJMEN BJM, 1994, J CLIN INVEST, V93, P1403, DOI 10.1172/JCI117117; Verpoorte R, 2009, J ETHNOPHARMACOL, V121, P479, DOI 10.1016/j.jep.2008.11.005; Wang M, 2005, PHYTOTHER RES, V19, P173, DOI 10.1002/ptr.1624; Westerterp M, 2006, ARTERIOSCL THROM VAS, V26, P2552, DOI 10.1161/01.ATV.0000243925.65265.3c; Witkamp RF, 2011, PHARM RES-DORDR, V28, P1792, DOI 10.1007/s11095-010-0341-1; Witkamp RF, 2010, BIOL ACTIVE COMPOUND; Wopereis S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004525; Yuliana ND, 2011, FOOD CHEM, V126, P1724, DOI 10.1016/j.foodchem.2010.12.066; Zadelaar S, 2007, ARTERIOSCL THROM VAS, V27, P1706, DOI 10.1161/ATVBAHA.107.142570	53	10	11	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30332	10.1371/journal.pone.0030332	http://dx.doi.org/10.1371/journal.pone.0030332			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22291936	Green Published, Green Submitted, gold			2022-12-25	WOS:000301570600031
J	Paget, C; Ivanov, S; Fontaine, J; Renneson, J; Blanc, F; Pichavant, M; Dumoutier, L; Ryffel, B; Renauld, JC; Gosset, P; Gosset, P; Si-Tahar, M; Faveeuw, C; Trottein, F				Paget, Christophe; Ivanov, Stoyan; Fontaine, Josette; Renneson, Joelle; Blanc, Fany; Pichavant, Muriel; Dumoutier, Laure; Ryffel, Bernhard; Renauld, Jean Christophe; Gosset, Philippe; Gosset, Pierre; Si-Tahar, Mustapha; Faveeuw, Christelle; Trottein, Francois			Interleukin-22 Is Produced by Invariant Natural Killer T Lymphocytes during Influenza A Virus Infection POTENTIAL ROLE IN PROTECTION AGAINST LUNG EPITHELIAL DAMAGES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INNATE IMMUNE-RESPONSE; HERPES-SIMPLEX-VIRUS; DOUBLE-STRANDED-RNA; NKT CELLS; VIRAL-INFECTION; RIG-I; ANTIVIRAL RESPONSES; MUCOSAL IMMUNITY; CUTTING EDGE; MICROBIAL INFECTION	Invariant natural killer T (iNKT) cells are non-conventional lipid-reactive alpha beta T lymphocytes that play a key role in host responses during viral infections, in particular through the swift production of cytokines. Their beneficial role during experimental influenza A virus (IAV) infection has recently been proposed, although the mechanisms involved remain elusive. Here we show that during in vivo IAV infection, mouse pulmonary iNKT cells produce IFN-gamma and IL-22, a Th17-related cytokine critical in mucosal immunity. Although permissive to viral replication, IL-22 production by iNKT cells is not due to IAV infection per se of these cells but is indirectly mediated by IAV-infected dendritic cells (DCs). We show that activation of the viral RNA sensors TLR7 and RIG-I in DCs is important for triggering IL-22 secretion by iNKT cells, whereas the NOD-like receptors NOD2 and NLRP3 are dispensable. Invariant NKT cells respond to IL-1 beta and IL-23 provided by infected DCs independently of the CD1d molecule to release IL-22. In vitro, IL-22 protects IAV-infected airway epithelial cells against mortality but has no role on viral replication. Finally, during early IAV infection, IL-22 plays a positive role in the control of lung epithelial damages. Overall, IAV infection of DCs activates iNKT cells, providing a rapid source of IL-22 that might be beneficial to preserve the lung epithelium integrity.	[Trottein, Francois] Inst Pasteur, CNRS, INSERM, Ctr Infect & Immun Lille,UMR 8204,U1019, F-59019 Lille, France; [Paget, Christophe; Ivanov, Stoyan; Fontaine, Josette; Renneson, Joelle; Pichavant, Muriel; Gosset, Philippe; Faveeuw, Christelle; Trottein, Francois] Univ Lille Nord France, F-59000 Lille, France; [Paget, Christophe; Ivanov, Stoyan; Fontaine, Josette; Renneson, Joelle; Pichavant, Muriel; Gosset, Philippe; Faveeuw, Christelle; Trottein, Francois] CNRS, UMR 8204, F-59021 Lille, France; [Paget, Christophe; Ivanov, Stoyan; Fontaine, Josette; Renneson, Joelle; Pichavant, Muriel; Gosset, Philippe; Faveeuw, Christelle; Trottein, Francois] Inst Federatif Rech, F-59019 Lille, France; [Blanc, Fany; Si-Tahar, Mustapha] Inst Pasteur, F-75015 Paris, France; [Blanc, Fany; Si-Tahar, Mustapha] INSERM, U874, F-75015 Paris, France; [Dumoutier, Laure; Renauld, Jean Christophe] Catholic Univ Louvain, Ludwig Inst Canc Res, B-1200 Brussels, Belgium; [Ryffel, Bernhard] Univ Orleans, CNRS, UMR 6218, F-45071 Orleans, France; [Gosset, Pierre] Univ Catholique Lille, Inst Catholique Lille, Grp Hosp, Hop St Vincent, F-59020 Lille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Ludwig Institute for Cancer Research; Universite Catholique Louvain; Centre National de la Recherche Scientifique (CNRS); Universite de Orleans; Universite Catholique de Lille	Trottein, F (corresponding author), Inst Pasteur, CNRS, INSERM, Ctr Infect & Immun Lille,UMR 8204,U1019, 1 Rue Prof Calmette,BP 245, F-59019 Lille, France.	francois.trottein@pasteur-lille.fr	Paget, Christophe/P-5165-2014; Faveeuw, Christelle/N-6303-2017; TROTTEIN, Francois/C-2405-2018; SI-TAHAR, Mustapha/L-4149-2014; Pichavant, Muriel/B-9036-2018; Gosset, Philippe/C-6174-2018; Si-Tahar, Mustapha/W-8034-2019; Renauld, Jean-Christophe/B-7268-2012	Paget, Christophe/0000-0002-5374-5407; Faveeuw, Christelle/0000-0002-8373-3992; TROTTEIN, Francois/0000-0003-3373-1814; SI-TAHAR, Mustapha/0000-0002-5792-7742; Pichavant, Muriel/0000-0002-1315-4397; Gosset, Philippe/0000-0002-4043-6429; Si-Tahar, Mustapha/0000-0002-5792-7742; Renauld, Jean-Christophe/0000-0003-1736-2131; Ivanov, Stoyan/0000-0002-0527-2297; Dumoutier, Laure/0000-0002-6645-684X	Institut National de la Sante et de la Recherche Medicale; CNRS; University of Lille Nord de France; Pasteur Institute of Lille; French National Research Agency (ANR) [ANR-08-MIEN-021-01]; Conseil Regional Nord Pas de Calais/INSERM; Ministere de l'Education Nationale de la Recherche et Technique; French National Research Agency [08-MIEN-R08066ES/RPV08036ESA]; "Fondation pour la Recherche Medicale" (FRM allergy DAL) [2007 0822007]; "Fond Europeen de Developpement Regional" (FEDER Asthme) [1575-32168]; European project Eumodic	Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); CNRS(Centre National de la Recherche Scientifique (CNRS)); University of Lille Nord de France; Pasteur Institute of Lille; French National Research Agency (ANR)(French National Research Agency (ANR)); Conseil Regional Nord Pas de Calais/INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)Region Hauts-de-France); Ministere de l'Education Nationale de la Recherche et Technique; French National Research Agency(French National Research Agency (ANR)); "Fondation pour la Recherche Medicale" (FRM allergy DAL); "Fond Europeen de Developpement Regional" (FEDER Asthme); European project Eumodic	This work was supported by the Institut National de la Sante et de la Recherche Medicale, the CNRS, the University of Lille Nord de France, the Pasteur Institute of Lille, and the French National Research Agency (ANR) under reference ANR-08-MIEN-021-01 (to F. T.).; Recipient of a doctoral fellowship from the Conseil Regional Nord Pas de Calais/INSERM.; Recipient of a doctoral fellowship from the Ministere de l'Education Nationale de la Recherche et Technique.; Supported by a postdoctoral fellowship from the French National Research Agency-08-MIEN-R08066ES/RPV08036ESA.; Supported by the "Fondation pour la Recherche Medicale" (FRM allergy DAL 2007 0822007), the "Fond Europeen de Developpement Regional" (FEDER Asthme 1575-32168) and the European project Eumodic.	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Allen IC, 2009, IMMUNITY, V30, P556, DOI 10.1016/j.immuni.2009.02.005; Ashkar AA, 2003, J VIROL, V77, P10168, DOI 10.1128/JVI.77.18.10168-10171.2003; Aujla SJ, 2008, NAT MED, V14, P275, DOI 10.1038/nm1710; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Bender A, 1998, IMMUNOBIOLOGY, V198, P552, DOI 10.1016/S0171-2985(98)80078-8; Brigl M, 2003, NAT IMMUNOL, V4, P1230, DOI 10.1038/ni1002; Brigl M, 2011, J EXP MED, V208, P1163, DOI 10.1084/jem.20102555; Brigl M, 2010, SEMIN IMMUNOL, V22, P79, DOI 10.1016/j.smim.2009.10.006; Colonna M, 2009, IMMUNITY, V31, P15, DOI 10.1016/j.immuni.2009.06.008; Coquet JM, 2008, P NATL ACAD SCI USA, V105, P11287, DOI 10.1073/pnas.0801631105; Dambacher J, 2008, CYTOKINE, V41, P209, DOI 10.1016/j.cyto.2007.11.016; De Santo C, 2008, J CLIN INVEST, V118, P4036, DOI 10.1172/JCI36264; Diana J, 2009, EUR J IMMUNOL, V39, P3283, DOI 10.1002/eji.200939800; Diana J, 2009, IMMUNITY, V30, P289, DOI 10.1016/j.immuni.2008.12.017; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Doisne JM, 2011, J IMMUNOL, V186, P662, DOI 10.4049/jimmunol.1002725; Doisne JM, 2009, J IMMUNOL, V183, P2142, DOI 10.4049/jimmunol.0901059; Doss M, 2009, J IMMUNOL, V182, P7878, DOI 10.4049/jimmunol.0804049; Exley MA, 2003, IMMUNOLOGY, V110, P519, DOI 10.1111/j.1365-2567.2003.01779.x; Eyerich S, 2010, TRENDS IMMUNOL, V31, P354, DOI 10.1016/j.it.2010.06.004; Gad HH, 2009, J BIOL CHEM, V284, P20869, DOI 10.1074/jbc.M109.002923; Godfrey DI, 2004, J CLIN INVEST, V114, P1379, DOI 10.1172/JCI200423594; Graf R, 2006, J SURG RES, V133, P113, DOI 10.1016/j.jss.2005.09.030; Grubor-Bauk B, 2003, J IMMUNOL, V170, P1430, DOI 10.4049/jimmunol.170.3.1430; Grubor-Bauk B, 2008, J VIROL, V82, P11073, DOI 10.1128/JVI.00205-08; Guillot L, 2005, J BIOL CHEM, V280, P5571, DOI 10.1074/jbc.M410592200; Guo HL, 2010, J VIROL, V84, P7750, DOI 10.1128/JVI.00187-10; Hao XL, 2008, J VIROL, V82, P4908, DOI 10.1128/JVI.02367-07; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Hobbs JA, 2001, J VIROL, V75, P10746, DOI 10.1128/JVI.75.22.10746-10754.2001; Hoegl S, 2011, AM J RESP CELL MOL, V44, P369, DOI 10.1165/rcmb.2009-0440OC; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Ichinohe T, 2010, NAT IMMUNOL, V11, P404, DOI 10.1038/ni.1861; Ilyinskii PO, 2006, J VIROL, V80, P7146, DOI 10.1128/JVI.02745-05; Ishikawa H, 2010, VIROLOGY, V407, P325, DOI 10.1016/j.virol.2010.08.030; Johnson TR, 2002, J VIROL, V76, P4294, DOI 10.1128/JVI.76.9.4294-4303.2002; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; Kim EY, 2008, NAT MED, V14, P633, DOI 10.1038/nm1770; Klotman ME, 2006, NAT REV IMMUNOL, V6, P447, DOI 10.1038/nri1860; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Kok WL, 2012, J LEUKOCYTE BIOL, V91, P357, DOI 10.1189/jlb.0411184; Kolls JK, 2010, CYTOKINE GROWTH F R, V21, P443, DOI 10.1016/j.cytogfr.2010.11.002; Koyama S, 2007, J IMMUNOL, V179, P4711, DOI 10.4049/jimmunol.179.7.4711; Kreymborg K, 2007, J IMMUNOL, V179, P8098, DOI 10.4049/jimmunol.179.12.8098; Kronenberg M, 2005, ANNU REV IMMUNOL, V23, P877, DOI 10.1146/annurev.immunol.23.021704.115742; Kulkarni RR, 2010, J LEUKOCYTE BIOL, V88, P635, DOI 10.1189/jlb.0410191; Kumar H, 2006, J EXP MED, V203, P1795, DOI 10.1084/jem.20060792; Le Goffic R, 2006, PLOS PATHOG, V2, P526, DOI 10.1371/journal.ppat.0020053; Leikina E, 2005, NAT IMMUNOL, V6, P995, DOI 10.1038/ni1248; Leite-De-Moraes MC, 1999, J IMMUNOL, V163, P5871; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Manicassamy B, 2010, P NATL ACAD SCI USA, V107, P11531, DOI 10.1073/pnas.0914994107; Martin B, 2009, IMMUNITY, V31, P321, DOI 10.1016/j.immuni.2009.06.020; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Mattner J, 2005, NATURE, V434, P525, DOI 10.1038/nature03408; Mendiratta SK, 1997, IMMUNITY, V6, P469, DOI 10.1016/S1074-7613(00)80290-3; Michel ML, 2007, J EXP MED, V204, P995, DOI 10.1084/jem.20061551; Motsinger A, 2002, J EXP MED, V195, P869, DOI 10.1084/jem.20011712; Nagarajan NA, 2007, J IMMUNOL, V178, P2706, DOI 10.4049/jimmunol.178.5.2706; Nieuwenhuis EES, 2009, J CLIN INVEST, V119, P1241, DOI 10.1172/JCI36509; Ouyang WJ, 2008, IMMUNITY, V28, P454, DOI 10.1016/j.immuni.2008.03.004; Paget C, 2007, IMMUNITY, V27, P597, DOI 10.1016/j.immuni.2007.08.017; Paget C, 2011, J IMMUNOL, V186, P5590, DOI 10.4049/jimmunol.1002348; Pagliaccetti NE, 2010, VIROLOGY, V401, P197, DOI 10.1016/j.virol.2010.02.022; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Pickert G, 2009, J EXP MED, V206, P1465, DOI 10.1084/jem.20082683; Poeck H, 2010, NAT IMMUNOL, V11, P63, DOI 10.1038/ni.1824; Rachitskaya AV, 2008, J IMMUNOL, V180, P5167, DOI 10.4049/jimmunol.180.8.5167; Renneson J, 2011, AM J PATHOL, V179, P1872, DOI 10.1016/j.ajpath.2011.06.023; Sabbah A, 2009, NAT IMMUNOL, V10, P1073, DOI 10.1038/ni.1782; Salio M, 2007, P NATL ACAD SCI USA, V104, P20490, DOI 10.1073/pnas.0710145104; Simonian PL, 2010, J EXP MED, V207, P2239, DOI 10.1084/jem.20100061; Skold M, 2003, INFECT IMMUN, V71, P5447, DOI 10.1128/IAI.71.10.5447-5455.2003; Sonnenberg GF, 2011, NAT IMMUNOL, V12, P383, DOI 10.1038/ni.2025; Sonnenberg GF, 2010, J EXP MED, V207, P1293, DOI 10.1084/jem.20092054; Spits H, 2011, NAT IMMUNOL, V12, P21, DOI 10.1038/ni.1962; Stout-Delgado HW, 2009, CELL HOST MICROBE, V6, P446, DOI 10.1016/j.chom.2009.09.011; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; Tessmer MS, 2009, EXPERT OPIN THER TAR, V13, P153, DOI [10.1517/14712590802653601 , 10.1517/14712590802653601]; Thomas PG, 2009, IMMUNITY, V30, P566, DOI 10.1016/j.immuni.2009.02.006; Tupin E, 2007, NAT REV MICROBIOL, V5, P405, DOI 10.1038/nrmicro1657; Tyznik AJ, 2008, J IMMUNOL, V181, P4452, DOI 10.4049/jimmunol.181.7.4452; Van Kaer L, 2005, CURR BIOL, V15, pR429, DOI 10.1016/j.cub.2005.05.032; Venkataswamy MM, 2010, SEMIN IMMUNOL, V22, P68, DOI 10.1016/j.smim.2009.10.003; Vivier E, 2009, NAT REV IMMUNOL, V9, P229, DOI 10.1038/nri2522; Wahl C, 2009, J IMMUNOL, V182, P4521, DOI 10.4049/jimmunol.0802810; Wesley JD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000106; Wilson MT, 2002, TRENDS MOL MED, V8, P225, DOI 10.1016/S1471-4914(02)02325-0; Wingender G, 2008, AM J PHYSIOL-GASTR L, V294, pG1, DOI 10.1152/ajpgi.00437.2007; Wolk K, 2004, IMMUNITY, V21, P241, DOI 10.1016/j.immuni.2004.07.007; Wolk K, 2010, SEMIN IMMUNOPATHOL, V32, P17, DOI 10.1007/s00281-009-0188-x; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zenewicz LA, 2008, EUR J IMMUNOL, V38, P3265, DOI 10.1002/eji.200838655; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720	96	130	136	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					8816	8829		10.1074/jbc.M111.304758	http://dx.doi.org/10.1074/jbc.M111.304758			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22294696	hybrid, Green Published			2022-12-25	WOS:000301797800014
J	Kim, J; Yip, MLR; Shen, XM; Li, H; Hsin, LYC; Labarge, S; Heinrich, EL; Lee, W; Lu, JM; Vaidehi, N				Kim, Joseph; Yip, M. L. Richard; Shen, Xiaoming; Li, Hubert; Hsin, Li-Yu Charlie; Labarge, Samuel; Heinrich, Eileen L.; Lee, Wendy; Lu, Jianming; Vaidehi, Nagarajan			Identification of Anti-Malarial Compounds as Novel Antagonists to Chemokine Receptor CXCR4 in Pancreatic Cancer Cells	PLOS ONE			English	Article							SMALL-MOLECULE; PLASMODIUM-FALCIPARUM; BETA-ARRESTIN; EXPRESSION; GEMCITABINE; CHLOROQUINE; AUTOPHAGY; BICYCLAM; SCREEN; PROLIFERATION	Despite recent advances in targeted therapies, patients with pancreatic adenocarcinoma continue to have poor survival highlighting the urgency to identify novel therapeutic targets. Our previous investigations have implicated chemokine receptor CXCR4 and its selective ligand CXCL12 in the pathogenesis and progression of pancreatic intraepithelial neoplasia and invasive pancreatic cancer; hence, CXCR4 is a promising target for suppression of pancreatic cancer growth. Here, we combined in silico structural modeling of CXCR4 to screen for candidate anti-CXCR4 compounds with in vitro cell line assays and identified NSC56612 from the National Cancer Institute's (NCI) Open Chemical Repository Collection as an inhibitor of activated CXCR4. Next, we identified that NSC56612 is structurally similar to the established anti-malarial drugs chloroquine and hydroxychloroquine. We evaluated these compounds in pancreatic cancer cells in vitro and observed specific antagonism of CXCR4-mediated signaling and cell proliferation. Recent in vivo therapeutic applications of chloroquine in pancreatic cancer mouse models have demonstrated decreased tumor growth and improved survival. Our results thus provide a molecular target and basis for further evaluation of chloroquine and hydroxychloroquine in pancreatic cancer. Historically safe in humans, chloroquine and hydroxychloroquine appear to be promising agents to safely and effectively target CXCR4 in patients with pancreatic cancer.	[Kim, Joseph; Shen, Xiaoming; Heinrich, Eileen L.; Lee, Wendy; Lu, Jianming] City Hope Natl Med Ctr, Dept Surg, Duarte, CA USA; [Yip, M. L. Richard; Hsin, Li-Yu Charlie; Labarge, Samuel] City Hope Natl Med Ctr, Dept Mol Med, Duarte, CA USA; [Li, Hubert; Vaidehi, Nagarajan] City Hope Natl Med Ctr, Dept Immunol, Duarte, CA USA	City of Hope; City of Hope; City of Hope	Kim, J (corresponding author), City Hope Natl Med Ctr, Dept Surg, Duarte, CA USA.	jokim@coh.org	Yip, Richard/J-5289-2012		National Cancer Institute [P30 CA33572]; National Institutes of Health (NIH) [NIH CA134637]; American Cancer Society (ACS) [RSG-11-070-01-TBE]; NATIONAL CANCER INSTITUTE [K22CA134637, P30CA033572] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society (ACS)(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by grants from the National Cancer Institute [P30 CA33572 to JK, MLRY, and NV]; the National Institutes of Health (NIH) [NIH CA134637 to JK]; and the American Cancer Society (ACS) [RSG-11-070-01-TBE to JK]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The contents are solely the responsibility of the authors and do not represent the official views of the National Cancer Institute, NIH or ACS.	Ben-Zvi I, 2011, CLIN REV ALLERGY IMM; Bhattacharya S, 2010, J AM CHEM SOC, V132, P5205, DOI 10.1021/ja910700y; COATNEY GR, 1963, AM J TROP MED HYG, V12, P121, DOI 10.4269/ajtmh.1963.12.121; De Clercq E, 2005, MINI-REV MED CHEM, V5, P805, DOI 10.2174/1389557054867075; Denizot M, 2008, AUTOPHAGY, V4, P998, DOI 10.4161/auto.6880; Di Marco M, 2010, ONCOL REP, V23, P1183, DOI 10.3892/or_00000749; Doucette C, 2009, J BIOMOL SCREEN, V14, P381, DOI 10.1177/1087057109333974; Endres MJ, 1996, CELL, V87, P745, DOI 10.1016/S0092-8674(00)81393-8; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Ghosh A, 1998, J PHYS CHEM B, V102, P10983, DOI 10.1021/jp982533o; Gravel S, 2010, J BIOL CHEM, V285, P37939, DOI 10.1074/jbc.C110.147470; Hanson BJ, 2009, J BIOMOL SCREEN, V14, P798, DOI 10.1177/1087057109335260; Hatse S, 2002, FEBS LETT, V527, P255, DOI 10.1016/S0014-5793(02)03143-5; Hempelmann E, 2007, PARASITOL RES, V100, P671, DOI 10.1007/s00436-006-0313-x; Hendrix CW, 2004, JAIDS-J ACQ IMM DEF, V37, P1253, DOI 10.1097/01.qai.0000137371.80695.ef; Heo J, 2007, CHEMBIOCHEM, V8, P1527, DOI 10.1002/cbic.200700188; Ihlenfeldt WD, 2002, J CHEM INF COMP SCI, V42, P46, DOI 10.1021/ci010056s; Kalatskaya I, 2009, MOL PHARMACOL, V75, P1240, DOI 10.1124/mol.108.053389; Kilts JD, 2002, J PHARMACOL EXP THER, V301, P1179, DOI 10.1124/jpet.301.3.1179; Kim J, 2005, J CLIN ONCOL, V23, P2744, DOI 10.1200/JCO.2005.07.078; Kim J, 2006, ANN SURG, V244, P113, DOI 10.1097/01.sla.0000217690.65909.9c; Koshiba T, 2000, CLIN CANCER RES, V6, P3530; Kufareva I, 2011, STATUS GPCR IN PRESS; Lam AR, 2011, J CHEM INF MODEL, V51, P139, DOI 10.1021/ci1003027; Leyris JP, 2011, ANAL BIOCHEM, V408, P253, DOI 10.1016/j.ab.2010.09.030; Li J, 2004, J MOL BIOL, V343, P1409, DOI 10.1016/j.jmb.2004.08.090; Lipinski MM, 2010, DEV CELL, V18, P1041, DOI 10.1016/j.devcel.2010.05.005; Maclean KH, 2008, J CLIN INVEST, V118, P79, DOI 10.1172/JCI33700; Marchesi F, 2004, CANCER RES, V64, P8420, DOI 10.1158/0008-5472.CAN-04-1343; McCormick PJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008102; Moore MJ, 2007, J CLIN ONCOL, V25, P1960, DOI 10.1200/JCO.2006.07.9525; Moss RA, 2009, AUTOPHAGY ANTIANGIOG; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Philip PA, 2007, J CLIN ONCOL, V25, P1145, DOI 10.1200/JCO.2006.09.6040; Ratajczak MZ, 2006, LEUKEMIA, V20, P1915, DOI 10.1038/sj.leu.2404357; Rosenkilde MM, 2007, J BIOL CHEM, V282, P27354, DOI 10.1074/jbc.M704739200; Rubin JB, 2003, P NATL ACAD SCI USA, V100, P13513, DOI 10.1073/pnas.2235846100; Sasaki K, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-370; Saur D, 2005, GASTROENTEROLOGY, V129, P1237, DOI 10.1053/j.gastro.2005.06.056; Schertler GFX, 1998, EYE, V12, P504, DOI 10.1038/eye.1998.138; Shen XM, 2010, PANCREAS, V39, P81, DOI 10.1097/MPA.0b013e3181bb2ab7; Singh S, 2010, BRIT J CANCER, V103, P1671, DOI 10.1038/sj.bjc.6605968; Sotelo J, 2006, ANN INTERN MED, V144, P337, DOI 10.7326/0003-4819-144-5-200603070-00008; Trabanino RJ, 2004, BIOPHYS J, V86, P1904, DOI 10.1016/S0006-3495(04)74256-3; Wang Zi-xuan, 2006, V332, P115; Warhurst DC, 2003, J ANTIMICROB CHEMOTH, V52, P188, DOI 10.1093/jac/dkg319; Whalen EJ, 2011, TRENDS MOL MED, V17, P126, DOI 10.1016/j.molmed.2010.11.004; Wong RSY, 2008, MOL PHARMACOL, V74, P1485, DOI 10.1124/mol.108.049775; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Yang SH, 2011, GENE DEV, V25, P717, DOI 10.1101/gad.2016111; Zeelenberg IS, 2003, CANCER RES, V63, P3833; Zwier JM, 2010, J BIOMOL SCREEN, V15, P1248, DOI 10.1177/1087057110384611	52	50	52	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2012	7	2							e31004	10.1371/journal.pone.0031004	http://dx.doi.org/10.1371/journal.pone.0031004			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LO	22319600	gold, Green Published, Green Submitted			2022-12-25	WOS:000302178400025
J	Luykx, JJ; Bakker, SC; Lentjes, E; Boks, MPM; van Geloven, N; Eijkemans, MJC; Janson, E; Strengman, E; de Lepper, AM; Westenberg, H; Klopper, KE; Hoorn, HJ; Gelissen, HPMM; Jordan, J; Tolenaar, NM; van Dongen, EPA; Michel, B; Abramovic, L; Horvath, S; Kappen, T; Bruins, P; Keijzers, P; Borgdorff, P; Ophoff, RA; Kahn, RS				Luykx, Jurjen J.; Bakker, Steven C.; Lentjes, Eef; Boks, Marco P. M.; van Geloven, Nan; Eijkemans, Marinus J. C.; Janson, Esther; Strengman, Eric; de Lepper, Anne M.; Westenberg, Herman; Klopper, Kai E.; Hoorn, Hendrik J.; Gelissen, Harry P. M. M.; Jordan, Julian; Tolenaar, Noortje M.; van Dongen, Eric P. A.; Michel, Bregt; Abramovic, Lucija; Horvath, Steve; Kappen, Teus; Bruins, Peter; Keijzers, Peter; Borgdorff, Paul; Ophoff, Roel A.; Kahn, Rene S.			Season of Sampling and Season of Birth Influence Serotonin Metabolite Levels in Human Cerebrospinal Fluid	PLOS ONE			English	Article							MALE RHESUS MACAQUES; CSF MONOAMINE METABOLITES; GENERAL-POPULATION; NORTHERN FINLAND; SCHIZOPHRENIA; HIBERNATION; BEHAVIORS; MELATONIN; SUICIDES; SUMMER	Background: Animal studies have revealed seasonal patterns in cerebrospinal fluid (CSF) monoamine (MA) turnover. In humans, no study had systematically assessed seasonal patterns in CSF MA turnover in a large set of healthy adults. Methodology/Principal Findings: Standardized amounts of CSF were prospectively collected from 223 healthy individuals undergoing spinal anesthesia for minor surgical procedures. The metabolites of serotonin (5-hydroxyindoleacetic acid, 5-HIAA), dopamine (homovanillic acid, HVA) and norepinephrine (3-methoxy-4-hydroxyphenylglycol, MPHG) were measured using high performance liquid chromatography (HPLC). Concentration measurements by sampling and birth dates were modeled using a non-linear quantile cosine function and locally weighted scatterplot smoothing (LOESS, span = 0.75). The cosine model showed a unimodal season of sampling 5-HIAA zenith in April and a nadir in October (p-value of the amplitude of the cosine = 0.00050), with predicted maximum (PCmax) and minimum (PCmin) concentrations of 173 and 108 nmol/L, respectively, implying a 60% increase from trough to peak. Season of birth showed a unimodal 5-HIAA zenith in May and a nadir in November (p = 0.00339; PCmax = 172 and PCmin = 126). The non-parametric LOESS showed a similar pattern to the cosine in both season of sampling and season of birth models, validating the cosine model. A final model including both sampling and birth months demonstrated that both sampling and birth seasons were independent predictors of 5-HIAA concentrations. Conclusion: In subjects without mental illness, 5-HT turnover shows circannual variation by season of sampling as well as season of birth, with peaks in spring and troughs in fall.	[Luykx, Jurjen J.; Bakker, Steven C.; Boks, Marco P. M.; de Lepper, Anne M.; Westenberg, Herman; Abramovic, Lucija; Ophoff, Roel A.; Kahn, Rene S.] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Psychiat, Utrecht, Netherlands; [Luykx, Jurjen J.] ZNA Hosp, Dept Psychiat, Antwerp, Belgium; [Lentjes, Eef] Univ Med Ctr Utrecht, Dept Clin Chem & Hematol, Utrecht, Netherlands; [Eijkemans, Marinus J. C.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Dept Biostat, Utrecht, Netherlands; [van Geloven, Nan] Univ Amsterdam, Acad Med Ctr, Clin Res Unit, NL-1105 AZ Amsterdam, Netherlands; [Janson, Esther; Strengman, Eric] Univ Med Ctr Utrecht, Dept Med Genet, Utrecht, Netherlands; [Strengman, Eric; Ophoff, Roel A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Klopper, Kai E.; Hoorn, Hendrik J.; Borgdorff, Paul] Diakonessen Hosp, Dept Anesthesiol Intens Care & Pain Management, Utrecht, Netherlands; [Gelissen, Harry P. M. M.; Jordan, Julian; Keijzers, Peter] Cent Mil Hosp, Utrecht, Netherlands; [Gelissen, Harry P. M. M.] Vrije Univ Amsterdam, Med Ctr, Intens Care Unit, Amsterdam, Netherlands; [Tolenaar, Noortje M.; van Dongen, Eric P. A.; Bruins, Peter] St Antonius Hosp, Dept Anesthesiol Intens Care & Pain Management, Nieuwegein, Netherlands; [Michel, Bregt; Kappen, Teus] Univ Med Ctr Utrecht, Div Anesthesiol Intens Care & Emergency Med, Utrecht, Netherlands; [Horvath, Steve] Univ Calif Los Angeles, Biostat Sch Publ Hlth, Los Angeles, CA USA; [Ophoff, Roel A.] Univ Calif Los Angeles, Ctr Neurobehav Genet, Semel Inst Neurosci & Human Behav, Los Angeles, CA USA	Utrecht University; Utrecht University Medical Center; ZNA Middelheim Hospital; ZNA Stuivenberg; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Amsterdam; Academic Medical Center Amsterdam; Utrecht University; Utrecht University Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Diakonessenhuis; Vrije Universiteit Amsterdam; St. Antonius Hospital Utrecht; Utrecht University; Utrecht University Medical Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Luykx, JJ (corresponding author), Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Psychiat, Utrecht, Netherlands.	rophoff@mednet.ucla.edu	Kappen, Teus H/J-8733-2015	Kappen, Teus H/0000-0003-1895-0998; Luykx, Jurjen/0000-0002-6439-2774; Boks, Marco/0000-0001-6163-7484				Arendt J, PINEAL GLAND PINEAL; Bjorksten KS, 2005, PSYCHIAT RES, V133, P205, DOI 10.1016/j.psychres.2004.12.002; BREWERTON TD, 1988, PSYCHIAT RES, V23, P257, DOI 10.1016/0165-1781(88)90016-9; CHEW KSY, 1995, SOC SCI MED, V40, P223, DOI 10.1016/0277-9536(94)E0070-9; Chotai J, 2004, NORD J PSYCHIAT, V58, P429, DOI 10.1080/08039480410006052; Chotai J, 1999, NEUROPSYCHOBIOLOGY, V39, P57, DOI 10.1159/000026561; Chotai J, 2001, NEUROPSYCHOBIOLOGY, V44, P19, DOI 10.1159/000054909; Chotai J, 2006, PSYCHIAT RES, V145, P189, DOI 10.1016/j.psychres.2005.11.008; Chotai J, 2009, COMPR PSYCHIAT, V50, P562, DOI 10.1016/j.comppsych.2008.11.010; Davies G, 2003, SCHIZOPHRENIA BULL, V29, P587, DOI 10.1093/oxfordjournals.schbul.a007030; Dome P, 2010, BIOL PSYCHIAT, V68, P148, DOI 10.1016/j.biopsych.2010.03.005; Eisenberg DTA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001216; Eisenberg DP, 2010, J NEUROSCI, V30, P14691, DOI 10.1523/JNEUROSCI.1953-10.2010; Fellman J, 2009, BIODEMOGR SOC BIOL, V55, P103, DOI 10.1080/19485560903054788; Fowler JS, 2007, BIOL PSYCHIAT, V62, P355, DOI 10.1016/j.biopsych.2006.08.038; Friedman E, 2006, ACTA PSYCHIAT SCAND, V113, P510, DOI 10.1111/j.1600-0447.2005.00701.x; Garidou ML, 2003, AM J PHYSIOL-REG I, V284, pR1043, DOI 10.1152/ajpregu.00457.2002; HARRIS S, 1993, PSYCHIAT RES, V49, P77, DOI 10.1016/0165-1781(93)90031-B; Heerlein A, 2006, PSYCHOPATHOLOGY, V39, P75, DOI 10.1159/000090596; Hetsroni I, 2011, J BONE JOINT SURG BR, V93B, P47, DOI 10.1302/0301-620X.93B1.25498; Higley JD, 1996, ARCH GEN PSYCHIAT, V53, P537; Howell S, 2007, AM J PRIMATOL, V69, P851, DOI 10.1002/ajp.20369; Juul S, 1999, HUM REPROD, V14, P1250, DOI 10.1093/humrep/14.5.1250; LEWY AJ, 1987, SCIENCE, V235, P352, DOI 10.1126/science.3798117; Macchi MM, 2004, FRONT NEUROENDOCRIN, V25, P177, DOI 10.1016/j.yfrne.2004.08.001; MACCHI MM, 2002, SOC RES BIOL RHYTHMS, V9, P157; MANICKAM P, 1989, GEN COMP ENDOCR, V75, P437, DOI 10.1016/0016-6480(89)90179-2; Mehlman PT, 1997, PSYCHIAT RES, V72, P89, DOI 10.1016/S0165-1781(97)00084-X; Messias E, 2004, ARCH GEN PSYCHIAT, V61, P985, DOI 10.1001/archpsyc.61.10.985; Murakami N, 2000, J VET MED SCI, V62, P763, DOI 10.1292/jvms.62.763; Nagayama H, 1998, PSYCHOPHARMACOLOGY, V135, P279, DOI 10.1007/s002130050510; Partonen T, 2004, J AFFECT DISORDERS, V78, P11, DOI 10.1016/S0165-0327(02)00236-7; POPOVA NK, 1981, PHARMACOL BIOCHEM BE, V14, P773, DOI 10.1016/0091-3057(81)90360-9; Riala K, 2009, CHRONOBIOL INT, V26, P1660, DOI 10.3109/07420520903534484; Rocchi Marco B L, 2002, Crisis, V23, P161, DOI 10.1027//0227-5910.23.4.161; ROENNEBERG T, 1990, J BIOL RHYTHM, V5, P195, DOI 10.1177/074873049000500303; ROY A, 1991, ACTA PSYCHIAT SCAND, V84, P579, DOI 10.1111/j.1600-0447.1991.tb03199.x; SACK RL, 1990, ARCH GEN PSYCHIAT, V47, P343; SWEDO SE, 1989, ACTA PSYCHIAT SCAND, V80, P644, DOI 10.1111/j.1600-0447.1989.tb03038.x; Zajicek KB, 2000, NEUROPSYCHOPHARMACOL, V22, P240, DOI 10.1016/S0893-133X(99)00097-4	40	17	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2012	7	2							e30497	10.1371/journal.pone.0030497	http://dx.doi.org/10.1371/journal.pone.0030497			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UG	22312427	Green Submitted, Green Published, gold			2022-12-25	WOS:000301977500011
J	Casaca, VI; Illi, S; Suttner, K; Schleich, I; Ballenberger, N; Klucker, E; Turan, E; von Mutius, E; Kabesch, M; Schaub, B				Casaca, Vera Isabel; Illi, Sabina; Suttner, Kathrin; Schleich, Isolde; Ballenberger, Nikolaus; Klucker, Elizabeth; Turan, Elif; von Mutius, Erika; Kabesch, Michael; Schaub, Bianca			TBX21 and HLX1 Polymorphisms Influence Cytokine Secretion at Birth	PLOS ONE			English	Article							T-BET; TRANSCRIPTION FACTOR; CORD BLOOD; LINEAGE COMMITMENT; ASTHMA; CELLS; ATOPY; ASSOCIATION; HAPLOTYPE; EXPOSURE	Background: TBX21 (T cell specific T-box transcription factor) and HLX1 (H.20-like homeobox 1) are crucial transcription factors of T(H)1-cells, inducing their differentiation and suppressing T(H)2 commitment, particularly important for early life immune development. This study investigated the influence of TBX21 and HLX1 single nucleotide polymorphisms (SNPs), which have previously been shown to be associated with asthma, on T(H)1/T(H)2 lineage cytokines at birth. Methods and Findings: Cord blood mononuclear cells (CBMCs) of 200 neonates were genotyped for two TBX21 and three HLX1 SNPs. CBMCs were stimulated with innate (Lipid A, LpA; Peptidoglycan, Ppg), adaptive stimuli (house dust mite Dermatophagoides pteronyssinus 1, Derp1) or mitogen (phytohemagglutinin, PHA). Cytokines, T-cells and mRNA expression of T(H)1/T(H)2-related genes were assessed. Atopic diseases during the first 3 years of life were assessed by questionnaire answered by the parents. Carriers of TBX21 promoter SNP rs17250932 and HLX1 promoter SNP rs2738751 showed reduced or trendwise reduced (p <= 0.07) IL-5, IL-13 and TNF-alpha secretion after LpA-stimulation. Carriers of HLX1 SNP rs2738751 had lower IL-13 levels following Ppg-stimulation (p = 0.08). Carriers of HLX1 exon 1 SNP rs12141189 showed increased IL-5 (LpA, p = 0.007; Ppg, p = 0.10), trendwise increased IL-13 (LpA), higher GM-CSF (LpA/Ppg, p <= 0.05) and trendwise decreased IFN-c secretion (Derp1+LpA-stimulation, p = 0.1). Homozygous carriers of HLX1 promoter SNP rs3806325 showed increased IL-13 and IL-6 (unstimulated, p <= 0.03). In carriers of TBX21 intron 3 SNP rs11079788 no differences in cytokine secretion were observed. mRNA expression of T(H)1/T(H)2-related genes partly correlated with cytokines at protein level. TBX21 SNP rs11079788 carriers developed less symptoms of atopic dermatitis at 3 years of age (p = 0.03). Conclusions: Polymorphisms in TBX21 and HLX1 influenced primarily IL-5 and IL-13 secretion after LpA-stimulation in cord blood suggesting that genetic variations in the transcription factors essential for the T(H)1-pathway may contribute to modified T(H)2-immune responses already early in life. Further follow-up of the cohort is required to study the polymorphisms' relevance for immune-mediated diseases such as childhood asthma.	[Casaca, Vera Isabel; Illi, Sabina; Schleich, Isolde; Ballenberger, Nikolaus; Klucker, Elizabeth; Turan, Elif; von Mutius, Erika; Schaub, Bianca] Univ Childrens Hosp Munich, Dept Pulm & Allergy, Munich, Germany; [Suttner, Kathrin; Kabesch, Michael] Hannover Med Sch, Dept Paediat Pneumol Allergy & Neonatol, D-3000 Hannover, Germany	University of Munich; Hannover Medical School	Casaca, VI (corresponding author), Univ Childrens Hosp Munich, Dept Pulm & Allergy, Munich, Germany.	Bianca.Schaub@med.uni-muenchen.de	Schaub, Bianca/B-9935-2019; Kabesch, Michael/AAB-5701-2020; Kabesch, Michael/GZM-1583-2022	Schaub, Bianca/0000-0003-1652-8873; von Mutius, Erika/0000-0002-8893-4515	Bayerische Forschungsstiftung [DOK-111-09]; Comprehensive Pneumology Centre (CPC); German Ministry of Education and Research (BMBF) as part of the National Genome Research Network (NGFN); NGFN [01GS0810]	Bayerische Forschungsstiftung; Comprehensive Pneumology Centre (CPC); German Ministry of Education and Research (BMBF) as part of the National Genome Research Network (NGFN)(Federal Ministry of Education & Research (BMBF)); NGFN	This work was funded by Bayerische Forschungsstiftung (DOK-111-09)(VC), Comprehensive Pneumology Centre (CPC)(Dr. Schaub), and the German Ministry of Education and Research (BMBF) as part of the National Genome Research Network (NGFN), with grant NGFN 01GS0810 (Dr. Kabesch, Dr. Sutter). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akahoshi M, 2005, HUM GENET, V117, P16, DOI 10.1007/s00439-005-1285-0; B Schaub, 2009, J ALLERGY CLIN IMMUN, V123, p[774, e775]; Braun-Fahrlander C, 2002, NEW ENGL J MED, V347, P869, DOI 10.1056/NEJMoa020057; Chung Hun Taek, 2003, Hum Mutat, V22, P257, DOI 10.1002/humu.9169; Finkelman FD, 2007, J ALLERGY CLIN IMMUN, V120, P544, DOI 10.1016/j.jaci.2007.05.025; Fusaro AE, 2009, IMMUNOLOGY, V128, pe541, DOI 10.1111/j.1365-2567.2008.03028.x; J Liu, 2011, ALLERGY; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kormann MSD, 2009, ALLERGY, V64, P636, DOI 10.1111/j.1398-9995.2008.01891.x; Lakos G, 2006, PATHOBIOLOGY, V73, P224, DOI 10.1159/000098208; Macaubas C, 2003, LANCET, V362, P1192, DOI 10.1016/S0140-6736(03)14542-4; Mullen AC, 2002, NAT IMMUNOL, V3, P652, DOI 10.1038/ni807; Munthe-Kaas MC, 2008, J ALLERGY CLIN IMMUN, V121, P51, DOI 10.1016/j.jaci.2007.07.068; Pfefferle PI, 2010, J ALLERGY CLIN IMMUN, V125, P108, DOI 10.1016/j.jaci.2009.09.019; Pinto LA, 2008, J PEDIAT, V84, pS68, DOI [10.1590/S0021-75572008000500010, 10.2223/JPED.1781]; PRENTICE RL, 1978, BIOMETRIKA, V65, P167, DOI 10.1093/biomet/65.1.167; Raby BA, 2006, AM J RESP CRIT CARE, V173, P64, DOI 10.1164/rccm.200503-505OC; Sandberg M, 2009, PEDIAT ALLERG IMM-UK, V20, P519, DOI 10.1111/j.1399-3038.2008.00794.x; Schaub B, 2008, J ALLERGY CLIN IMMUN, V121, P1491, DOI 10.1016/j.jaci.2008.04.010; Schedel M, 2004, J ALLERGY CLIN IMMUN, V114, P1100, DOI 10.1016/j.jaci.2004.07.048; Schedel M, 2008, AM J RESP CRIT CARE, V177, P613, DOI 10.1164/rccm.200703-373OC; Schedel M, 2009, J ALLERGY CLIN IMMUN, V124, P583, DOI 10.1016/j.jaci.2009.06.024; Suttner K, 2009, J ALLERGY CLIN IMMUN, V123, P82, DOI 10.1016/j.jaci.2008.09.047; Suttner K, 2009, J ALLERGY CLIN IMMUN, V123, P1062, DOI 10.1016/j.jaci.2009.02.025; Suzuki K, 2008, INT ARCH ALLERGY IMM, V146, P33, DOI 10.1159/000126058; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Szabo SJ, 2002, SCIENCE, V295, P338, DOI 10.1126/science.1065543; Tadaki H, 2009, PEDIAT ALLERG IMM-UK, V20, P227, DOI 10.1111/j.1399-3038.2008.00783.x; von Mutius E, 2009, J ALLERGY CLIN IMMUN, V123, P3, DOI 10.1016/j.jaci.2008.10.046; Williams TJ, 2000, J ALLERGY CLIN IMMUN, V105, P951, DOI 10.1067/mai.2000.106211; Wilson CB, 2009, NAT REV IMMUNOL, V9, P91, DOI 10.1038/nri2487; Woodruff PG, 2009, AM J RESP CRIT CARE, V180, P388, DOI 10.1164/rccm.200903-0392OC	32	11	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2012	7	1							e31069	10.1371/journal.pone.0031069	http://dx.doi.org/10.1371/journal.pone.0031069			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	912BU	22303482	Green Published, Green Submitted, gold			2022-12-25	WOS:000301770300008
J	He, WM; Li, JJ; Peng, PH				He, Wei-Ming; Li, Jing-Ji; Peng, Pei-Hao			Simulated Warming Differentially Affects the Growth and Competitive Ability of Centaurea maculosa Populations from Home and Introduced Ranges	PLOS ONE			English	Article							INVASION; PLANTS; KNAPWEED; AMERICA; CLIMATE; STOEBE	Climate warming may drive invasions by exotic plants, thereby raising concerns over the risks of invasive plants. However, little is known about how climate warming influences the growth and competitive ability of exotic plants from their home and introduced ranges. We conducted a common garden experiment with an invasive plant Centaurea maculosa and a native plant Poa pratensis, in which a mixture of sand and vermiculite was used as a neutral medium, and contrasted the total biomass, competitive effects, and competitive responses of C. maculosa populations from Europe (home range) and North America (introduced range) under two different temperatures. The warming-induced inhibitory effects on the growth of C. maculosa alone were stronger in Europe than in North America. The competitive ability of C. maculosa plants from North America was greater than that of plants from Europe under the ambient condition whereas this competitive ability followed the opposite direction under the warming condition, suggesting that warming may enable European C. maculosa to be more invasive. Across two continents, warming treatment increased the competitive advantage instead of the growth advantage of C. maculosa, suggesting that climate warming may facilitate C. maculosa invasions through altering competitive outcomes between C. maculosa and its neighbors. Additionally, the growth response of C. maculosa to warming could predict its ability to avoid being suppressed by its neighbors.	[He, Wei-Ming] Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China; [Li, Jing-Ji; Peng, Pei-Hao] Chengdu Univ Technol, Dept Landscape Architecture, Chengdu, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Chengdu University of Technology	He, WM (corresponding author), Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China.	weiminghe@ibcas.ac.cn		jingji, li/0000-0002-0611-1364	National Natural Science Foundation of China [31170507]; State Key Laboratory of Vegetation and Environmental Change [2011zyts02]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Vegetation and Environmental Change	Funding was provided by the National Natural Science Foundation of China (31170507; www.nsfc.gov.cn) and the State Key Laboratory of Vegetation and Environmental Change (2011zyts02; www.plantcenter.inbcas.ac.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alward RD, 1999, SCIENCE, V283, P229, DOI 10.1126/science.283.5399.229; Armas C, 2004, ECOLOGY, V85, P2682, DOI 10.1890/03-0650; BLOSSEY B, 1995, J ECOL, V83, P887, DOI 10.2307/2261425; Bradley BA, 2010, TRENDS ECOL EVOL, V25, P310, DOI 10.1016/j.tree.2009.12.003; Bradley BA, 2010, BIOL INVASIONS, V12, P1855, DOI 10.1007/s10530-009-9597-y; Broennimann O, 2008, BIOL LETTERS, V4, P585, DOI 10.1098/rsbl.2008.0254; Callaway RM, 2000, SCIENCE, V290, P521, DOI 10.1126/science.290.5491.521; Callaway RM, 2004, ECOLOGY, V85, P1062, DOI 10.1890/02-0775; Callaway RM, 2004, NATURE, V427, P731, DOI 10.1038/nature02322; Dukes JS, 1999, TRENDS ECOL EVOL, V14, P135, DOI 10.1016/S0169-5347(98)01554-7; He WM, 2010, BIOL INVASIONS, V12, P3591, DOI 10.1007/s10530-010-9753-4; He WM, 2009, OECOLOGIA, V159, P803, DOI 10.1007/s00442-008-1234-4; Henery ML, 2010, J ECOL, V98, P800, DOI 10.1111/j.1365-2745.2010.01672.x; IPCC, 2007, CLIM CHANG 2007 PHYS; Maron JL, 2007, EVOLUTION, V61, P1912, DOI 10.1111/j.1558-5646.2007.00153.x; Marrs RA, 2008, MOL ECOL, V17, P4197, DOI 10.1111/j.1365-294X.2008.03903.x; McCormick AJ, 2006, NEW PHYTOL, V171, P759, DOI 10.1111/j.1469-8137.2006.01785.x; Morrien E, 2010, ANN BOT-LONDON, V105, P843, DOI 10.1093/aob/mcq064; Ridenour WM, 2008, ECOL MONOGR, V78, P369, DOI 10.1890/06-1926.1; Roche BF, 1988, NW SCI, V62, P242; Seabloom EW, 2003, P NATL ACAD SCI USA, V100, P13384, DOI 10.1073/pnas.1835728100; Treier UA, 2009, ECOLOGY, V90, P1366, DOI 10.1890/08-0420.1; Turnbull MH, 2002, PLANT CELL ENVIRON, V25, P1729, DOI 10.1046/j.1365-3040.2002.00947.x; Verlinden M, 2010, BIOL INVASIONS, V12, P2777, DOI 10.1007/s10530-009-9683-1; Walther GR, 2009, TRENDS ECOL EVOL, V24, P686, DOI 10.1016/j.tree.2009.06.008; Weigelt A, 2003, J ECOL, V91, P707, DOI 10.1046/j.1365-2745.2003.00805.x; Williams AL, 2007, NEW PHYTOL, V176, P365, DOI 10.1111/j.1469-8137.2007.02170.x; Woodward F.I., 1987, CLIMATE PLANT DISTRI	28	6	8	3	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2012	7	1							e31170	10.1371/journal.pone.0031170	http://dx.doi.org/10.1371/journal.pone.0031170			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	912BU	22303485	Green Published, gold, Green Submitted			2022-12-25	WOS:000301770300009
J	Ioannidou, K; Anderson, KI; Strachan, D; Edgar, JM; Barnett, SC				Ioannidou, Kalliopi; Anderson, Kurt I.; Strachan, David; Edgar, Julia M.; Barnett, Susan C.			Time-Lapse Imaging of the Dynamics of CNS Glial-Axonal Interactions In Vitro and Ex Vivo	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; MYELIN-BASIC-PROTEIN; MURINE SPINAL-CORD; MAJOR DENSE LINE; MUTANT MOUSE; SHIVERER; OLIGODENDROCYTE; GROWTH; MICE; CELL	Background: Myelination is an exquisite and dynamic example of heterologous cell-cell interaction, which consists of the concentric wrapping of multiple layers of oligodendrocyte membrane around neuronal axons. Understanding the mechanism by which oligodendrocytes ensheath axons may bring us closer to designing strategies to promote remyelination in demyelinating diseases. The main aim of this study was to follow glial-axonal interactions over time both in vitro and ex vivo to visualize the various stages of myelination. Methodology/Principal Findings: We took two approaches to follow myelination over time: i) time-lapse imaging of mixed CNS myelinating cultures generated from mouse spinal cord to which exogenous GFP-labelled murine cells were added, and ii) ex vivo imaging of the spinal cord of shiverer (Mbp mutant) mice, transplanted with GFP-labelled murine neurospheres. We demonstrate that oligodendrocyte-axonal interactions are dynamic events with continuous retraction and extension of oligodendroglial processes. Using cytoplasmic and membrane-GFP labelled cells to examine different components of the myelin-like sheath, we provide evidence from time-lapse fluorescence microscopy and confocal microscopy that the oligodendrocytes' cytoplasm-filled processes initially spiral around the axon in a corkscrew-like manner. This is followed subsequently by focal expansion of the corkscrew process to form short cuffs, which then extend longitudinally along the axons. We predict from this model that these spiral cuffs must extend over each other first before extending to form internodes of myelin. Conclusion: These experiments show the feasibility of visualizing the dynamics of glial-axonal interaction during myelination over time. Moreover, these approaches complement each other with the in vitro approach allowing visualization of an entire internodal length of myelin and the ex vivo approach validating the in vitro data.	[Ioannidou, Kalliopi; Edgar, Julia M.; Barnett, Susan C.] Univ Glasgow, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland; [Anderson, Kurt I.; Strachan, David] Beatson Inst Canc Res, Inst Canc Sci, Glasgow G61 1BD, Lanark, Scotland	University of Glasgow; Beatson Institute; University of Glasgow	Ioannidou, K (corresponding author), Univ Glasgow, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland.	Susan.Barnett@glasgow.ac.uk	Edgar, Julia M/U-8456-2019; Edgar, Julia M/G-3275-2012	Edgar, Julia M/0000-0002-3869-0962; Anderson, Kurt/0000-0002-9324-9598; Strachan, David/0000-0003-0553-8670; Gilbey, Thomas/0000-0001-5677-3318	MRC; Cancer Research UK [15565] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK)	The work was funded by a MRC Capacity Build Studentship (http://www.mrc.ac.uk/Fundingopportunities/Studentships/index.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARBARESE E, 1983, J NEUROCHEM, V40, P1680, DOI 10.1111/j.1471-4159.1983.tb08142.x; Bauer NG, 2009, GLIA, V57, P1691, DOI 10.1002/glia.20885; BOTTENSTEIN JE, 1979, P NATL ACAD SCI USA, V76, P514, DOI 10.1073/pnas.76.1.514; BUNGE MB, 1962, J CELL BIOL, V12, P448, DOI 10.1083/jcb.12.2.448; BUNGE MB, 1961, J BIOPHYS BIOCHEM CY, V10, P67, DOI 10.1083/jcb.10.1.67; CHERNOFF GF, 1981, J HERED, V72, P128, DOI 10.1093/oxfordjournals.jhered.a109442; COLMAN DR, 1982, J CELL BIOL, V95, P598, DOI 10.1083/jcb.95.2.598; Czopka T, 2011, METHOD CELL BIOL, P10525; DUPOUEY P, 1979, NEUROSCI LETT, V12, P113, DOI 10.1016/0304-3940(79)91490-3; Edgar JM, 2004, J CELL BIOL, V166, P121, DOI 10.1083/jcb.200312012; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Franklin RJM, 2008, NAT REV NEUROSCI, V9, P839, DOI 10.1038/nrn2480; HIRANO A, 1967, J CELL BIOL, V34, P555, DOI 10.1083/jcb.34.2.555; Kerschensteiner M, 2008, NAT PROTOC, V3, P1645, DOI 10.1038/nprot.2008.160; KIMURA M, 1985, J NEUROCHEM, V44, P692, DOI 10.1111/j.1471-4159.1985.tb12870.x; Kirby BB, 2006, NAT NEUROSCI, V9, P1506, DOI 10.1038/nn1803; KNOBLER RL, 1976, J ULTRA MOL STRUCT R, V55, P417, DOI 10.1016/S0022-5320(76)80097-4; Laursen LS, 2009, J NEUROSCI, V29, P9174, DOI 10.1523/JNEUROSCI.5942-08.2009; Li HL, 2007, J NEUROSCI, V27, P14375, DOI 10.1523/JNEUROSCI.4456-07.2007; LUSE SA, 1956, J BIOPHYS BIOCHEM CY, V2, P777, DOI 10.1083/jcb.2.6.777; MATTHEWS MA, 1971, J COMP NEUROL, V142, P1, DOI 10.1002/cne.901420102; MOLINEAUX SM, 1986, P NATL ACAD SCI USA, V83, P7542, DOI 10.1073/pnas.83.19.7542; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Pedraza L, 2009, J NEUROSCI RES, V87, P3480, DOI 10.1002/jnr.22004; PETERS A, 1960, J BIOPHYS BIOCHEM CY, V8, P431, DOI 10.1083/jcb.8.2.431; Pfeiffer Steve E., 1993, Trends in Cell Biology, V3, P191, DOI 10.1016/0962-8924(93)90213-K; PRIVAT A, 1979, NEUROSCI LETT, V12, P107, DOI 10.1016/0304-3940(79)91489-7; RAFF MC, 1983, NATURE, V303, P390, DOI 10.1038/303390a0; REMAHL S, 1990, J NEUROCYTOL, V19, P883, DOI 10.1007/BF01186817; Ridley AJ, 2011, CELL, V145, P1012, DOI 10.1016/j.cell.2011.06.010; Sherman DL, 2005, NAT REV NEUROSCI, V6, P683, DOI 10.1038/nrn1743; Sobottka B, 2011, GLIA, V59, P1841, DOI 10.1002/glia.21228; SOMMER I, 1981, DEV BIOL, V83, P311, DOI 10.1016/0012-1606(81)90477-2; Sorensen A, 2008, GLIA, V56, P750, DOI 10.1002/glia.20650; Thomson CE, 2008, EUR J NEUROSCI, V28, P1518, DOI 10.1111/j.1460-9568.2008.06415.x; Thomson CE, 2006, J NEUROSCI RES, V84, P1703, DOI 10.1002/jnr.21084; Trajkovic K, 2006, J CELL BIOL, V172, P937, DOI 10.1083/jcb.200509022; UZMAN BG, 1964, J ULTRA MOL STRUCT R, V11, P208, DOI 10.1016/S0022-5320(64)80104-0; Watkins TA, 2008, NEURON, V60, P555, DOI 10.1016/j.neuron.2008.09.011; WEBSTER HD, 1971, J CELL BIOL, V48, P348, DOI 10.1083/jcb.48.2.348; Werner HB, 2010, EXPERT REV PROTEOMIC, V7, P159, DOI 10.1586/EPR.09.105; Yamada M, 1999, J NEUROSCI, V19, P2143	42	28	30	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2012	7	1							e30775	10.1371/journal.pone.0030775	http://dx.doi.org/10.1371/journal.pone.0030775			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911GB	22303455	Green Accepted, gold, Green Published, Green Submitted			2022-12-25	WOS:000301704200032
J	Stachowiak, B; Weingartl, HM				Stachowiak, Beata; Weingartl, Hana M.			Nipah Virus Infects Specific Subsets of Porcine Peripheral Blood Mononuclear Cells	PLOS ONE			English	Article							EMERGENT DEADLY PARAMYXOVIRUS; CENTRAL-NERVOUS-SYSTEM; ENDOTHELIAL-CELLS; PIGS; HOST; PROTECTION; CHALLENGE; PATHOLOGY; RESPONSES; RECEPTOR	Nipah virus (NiV), a zoonotic paramyxovirus, is highly contagious in swine, and can cause fatal infections in humans following transmission from the swine host. The main viral targets in both species are the respiratory and central nervous systems, with viremia implicated as a mode of dissemination of NiV throughout the host. The presented work focused on the role of peripheral blood mononuclear cells (PBMC) in the viremic spread of the virus in the swine host. B lymphocytes, CD4-CD8-, as well as CD4+CD8- T lymphocytes were not permissive to NiV, and expansion of the CD4+CD8- cells early post infection was consistent with functional humoral response to NiV infection observed in swine. In contrast, significant drop in the CD4+CD8- T cell frequency was observed in piglets which succumbed to the experimental infection, supporting the hypothesis that antibody development is the critical component of the protective immune response. Productive viral replication was detected in monocytes, CD6+CD8+ T lymphocytes and NK cells by recovery of infectious virus in the cell supernatants. Virus replication was supported by detection of the structural N and the non-structural C proteins or by detection of genomic RNA increase in the infected cells. Infection of T cells carrying CD6 marker, a strong ligand for the activated leukocyte cell adhesion molecule ALCAM (CD166) highly expressed on the microvascular endothelial cell of the blood-air and the blood-brain barrier may explain NiV preferential tropism for small blood vessels of the lung and brain.	[Stachowiak, Beata; Weingartl, Hana M.] Univ Manitoba, Dept Med Microbiol, Fac Med, Winnipeg, MB, Canada; [Weingartl, Hana M.] Canadian Food Inspect Agcy, Natl Ctr Anim Dis NCFAD, Winnipeg, MB, Canada	University of Manitoba; Canadian Food Inspection Agency	Stachowiak, B (corresponding author), Univ Manitoba, Dept Med Microbiol, Fac Med, Winnipeg, MB, Canada.	hana.weingartl@inspection.gc.ca			National Science and Engineering Research Council [327187-06]; internal Canadian Food Inspection Agency [W1001]	National Science and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); internal Canadian Food Inspection Agency	The funding for the project was provided by National Science and Engineering Research Council grant #327187-06 and from the internal Canadian Food Inspection Agency Research partnership strategy project W1001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berhane Y, 2008, TRANSBOUND EMERG DIS, V55, P165, DOI 10.1111/j.1865-1682.2008.01021.x; Cayrol R, 2008, NAT IMMUNOL, V9, P137, DOI 10.1038/ni1551; Chua KB, 2000, SCIENCE, V288, P1432, DOI 10.1126/science.288.5470.1432; Chua KB, 2003, J CLIN VIROL, V26, P265, DOI 10.1016/S1386-6532(02)00268-8; Dawson HD, 2005, INFECT IMMUN, V73, P1116, DOI 10.1128/IAI.73.2.1116-1128.2005; Erbar S, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-305; Garcia-Briones MM, 2000, VACCINE, V19, P1167, DOI 10.1016/S0264-410X(00)00313-3; Gerner W, 2009, DEV COMP IMMUNOL, V33, P310, DOI 10.1016/j.dci.2008.06.003; GRIFFIN DE, 1995, CURR TOP MICROBIOL, V191, P117; Guillaume V, 2004, J VIROL METHODS, V120, P229, DOI 10.1016/j.jviromet.2004.05.018; Guillaume V, 2004, J VIROL, V78, P834, DOI 10.1128/JVI.78.2.834-840.2004; Hooper P, 2001, MICROBES INFECT, V3, P315, DOI 10.1016/S1286-4579(01)01385-5; Hossain MJ, 2008, CLIN INFECT DIS, V46, P977, DOI 10.1086/529147; Lee BPL, 2008, NAT IMMUNOL, V9, P117, DOI 10.1038/ni0208-117; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lo MK, 2010, VIROLOGY, V404, P78, DOI 10.1016/j.virol.2010.05.005; Lo MK, 2009, J GEN VIROL, V90, P398, DOI 10.1099/vir.0.007294-0; Luby SP, 2009, CLIN INFECT DIS, V49, P1743, DOI 10.1086/647951; Maisner A, 2009, THROMB HAEMOSTASIS, V102, P1014, DOI 10.1160/TH09-05-0310; Mathieu C, 2011, J VIROL, V85, P7863, DOI 10.1128/JVI.00549-11; Middleton DJ, 2002, J COMP PATHOL, V126, P124, DOI 10.1053/jcpa.2001.0532; Mungall BA, 2007, J INFECT DIS, V196, P812, DOI 10.1086/520818; Negrete OA, 2005, NATURE, V436, P401, DOI 10.1038/nature03838; Negrete Oscar A, 2006, PLoS Pathog, V2, pe7; Nor MNM, 2000, REV SCI TECH OIE, V19, P160; Ofori-Acquah SF, 2008, MICROVASC RES, V75, P391, DOI 10.1016/j.mvr.2007.10.006; Seo YJ, 2010, ADV APPL MICROBIOL, V73, P83, DOI 10.1016/S0065-2164(10)73004-5; van Reeth K, 2000, VET RES, V31, P187, DOI 10.1051/vetres:2000113; Virtue ER, 2011, J VIROL, V85, P4031, DOI 10.1128/JVI.02412-10; Volf J, 2007, ZOONOSES PUBLIC HLTH, V54, P286, DOI 10.1111/j.1863-2378.2007.01064.x; Wang LF, 2001, MICROBES INFECT, V3, P279, DOI 10.1016/S1286-4579(01)01381-8; Weingartl H, 2005, J VIROL, V79, P7528, DOI 10.1128/JVI.79.12.7528-7534.2005; Weingartl HM, 2006, J VIROL, V80, P7929, DOI 10.1128/JVI.00263-06; Weingartl HM, 2010, J VIROL, V84, P2245, DOI 10.1128/JVI.02118-09; Weingartl HM, 2002, J VIROL METHODS, V104, P203, DOI 10.1016/S0166-0934(02)00085-X; Wong KT, 2002, AM J PATHOL, V161, P2153, DOI 10.1016/S0002-9440(10)64493-8; Yu G, 2003, J IMMUNOL, V171, P106, DOI 10.4049/jimmunol.171.1.106; ZACHARY JF, 2007, PATHOLOGIC BASIS VET, P833	38	25	26	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2012	7	1							e30855	10.1371/journal.pone.0030855	http://dx.doi.org/10.1371/journal.pone.0030855			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911GB	22303463	gold, Green Submitted, Green Published			2022-12-25	WOS:000301704200039
J	Ventura, BA; Siewerdt, F; Estevez, I				Ventura, Beth A.; Siewerdt, Frank; Estevez, Inma			Access to Barrier Perches Improves Behavior Repertoire in Broilers	PLOS ONE			English	Article							DOMESTIC-FOWL; STOCKING DENSITY; LEG WEAKNESS; GROUP-SIZE; ENVIRONMENTAL ENRICHMENT; VERTICAL PANELS; ENCLOSURE SIZE; CHICKENS; SPACE; WELFARE	Restriction of behavioral opportunities and uneven use of space are considerable welfare concerns in modern broiler production, particularly when birds are kept at high densities. We hypothesized that increased environmental complexity by provision of barrier perches would help address these issues by encouraging perching and enhancing use of the pen space across a range of stocking densities. 2,088 day-old broiler chicks were randomly assigned to one of the following barrier and density treatment combinations over four replications: simple barrier, complex barrier, or control (no barrier) and low (8 birds/m(2)), moderate (13 birds/m(2)), or high (18 birds/m(2)) density. Data were collected on focal birds via instantaneous scan sampling from 2 to 6 weeks of age. Mean estimates per pen for percent of observations seen performing each behavior, as well as percent of observations in the pen periphery vs. center, were quantified and submitted to an analysis of variance with week as the repeated measure. Barrier perches, density and age affected the behavioral time budget of broilers. Both simple and complex barrier perches effectively stimulated high perching rates. Aggression and disturbances were lower in both barrier treatments compared to controls (P<0.05). Increasing density to 18 birds/m(2) compared to the lower densities suppressed activity levels, with lower foraging (P<0.005), decreased perching (P<0.0001) and increased sitting (P = 0.001) earlier in the rearing period. Disturbances also increased at higher densities (P<0.05). Use of the central pen area was higher in simple barrier pens compared to controls (P<0.001), while increasing density above 8 birds/m(2) suppressed use of the central space (P<0.05). This work confirms some negative effects of increasing density and suggests that barrier perches have the potential to improve broiler welfare by encouraging activity (notably by providing accessible opportunities to perch), decreasing aggression and disturbances, and promoting more even distribution of birds throughout the pen space.	[Ventura, Beth A.; Siewerdt, Frank; Estevez, Inma] Univ Maryland, Dept Anim & Avian Sci, College Pk, MD 20742 USA; [Estevez, Inma] Basque Fdn Sci, IKERBASQUE, Alameda Urquijo, Spain; [Estevez, Inma] Neiker Tecnalia, Vitoria, Spain	University System of Maryland; University of Maryland College Park; Basque Foundation for Science	Ventura, BA (corresponding author), Univ British Columbia, Anim Welf Program, Vancouver, BC V5Z 1M9, Canada.	iestevez@neiker.net	Ventura, Beth/H-7085-2019	Ventura, Beth/0000-0001-9476-6901; Estevez, Inma/0000-0002-9054-9528	University of Maryland; Department of Animal and Avian Sciences, University of Maryland, College Park	University of Maryland; Department of Animal and Avian Sciences, University of Maryland, College Park	This work was funded by the University of Maryland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank the staff and most especially Mark Spicknall at the University of Maryland Applied Poultry Research facility (Upper Marlboro, MD) for their assistance during the research phase of this study. We are also indebted to Erin Leone, Kathleen Baczynski, Taylor Callicrate, Avanti Mallapur and W. Ray Stricklin (Department of Animal and Avian Sciences, University of Maryland, College Park) for their support during various stages of this project.	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Arnould C, 2004, APPL ANIM BEHAV SCI, V87, P153, DOI 10.1016/j.applanim.2003.11.001; Berg CC, 1998, VETERINARIA, V36; Bizeray D, 2002, APPL ANIM BEHAV SCI, V79, P27, DOI 10.1016/S0168-1591(02)00083-7; Cornetto T, 2002, APPL ANIM BEHAV SCI, V75, P325, DOI 10.1016/S0168-1591(01)00195-2; Cornetto T, 2001, APPL ANIM BEHAV SCI, V71, P141, DOI 10.1016/S0168-1591(00)00171-4; Cornetto T, 2001, POULTRY SCI, V80, P1455, DOI 10.1093/ps/80.10.1455; Deeming DC, 2011, BRIT POULTRY SCI, V52, P403, DOI 10.1080/00071668.2011.590796; Dozier WA, 2005, POULTRY SCI, V84, P1328, DOI 10.1093/ps/84.8.1328; Estevez I, 2007, POULTRY SCI, V86, P1265, DOI 10.1093/ps/86.6.1265; Estevez I, 2006, APPL ANIM BEHAV SCI, V97, P221, DOI 10.1016/j.applanim.2005.01.013; Estevez I, 1999, POULTRY PERSPECTIVES, V1, P4; evez I. R. C., 1997, ETOLOGIA, V5, P19; FAURE JM, 1982, APPL ANIM ETHOL, V8, P281, DOI 10.1016/0304-3762(82)90211-5; FRANKENHUIS MT, 1991, BRIT POULTRY SCI, V32, P227, DOI 10.1080/00071669108417344; Hall AL, 2001, ANIM WELFARE, V10, P23; KESTIN SC, 1992, VET REC, V131, P190, DOI 10.1136/vr.131.9.190; Leone EH, 2008, POULTRY SCI, V87, P14, DOI 10.3382/ps.2007-00154; Leone EH, 2008, ANIM BEHAV, V76, P1673, DOI 10.1016/j.anbehav.2008.08.004; LeVan NF, 2000, APPL ANIM BEHAV SCI, V65, P349, DOI 10.1016/S0168-1591(99)00059-3; LEWIS NJ, 1990, POULTRY SCI, V69, P1087, DOI 10.3382/ps.0691087; Mallapur A, 2009, APPL ANIM BEHAV SCI, V117, P28, DOI 10.1016/j.applanim.2008.11.005; MANKOVICH NJ, 1982, APPL ANIM ETHOL, V9, P177, DOI 10.1016/0304-3762(82)90193-6; National Agricultural Statistics Service (NASS) Agricultural Statistics Board US Department of Agriculture, 2002, US BROIL IND STRUCT; NEWBERRY RC, 1995, APPL ANIM BEHAV SCI, V44, P229, DOI 10.1016/0168-1591(95)00616-Z; NEWBERRY RC, 1990, APPL ANIM BEHAV SCI, V25, P125, DOI 10.1016/0168-1591(90)90075-O; Pettit-Riley R, 2002, APPL ANIM BEHAV SCI, V79, P11, DOI 10.1016/S0168-1591(02)00116-8; Pettit-Riley R, 2001, APPL ANIM BEHAV SCI, V71, P127, DOI 10.1016/S0168-1591(00)00174-X; Reiter K, 2000, ARCH GEFLUGELKD, V64, P93; Reiter K, 2001, ARCH GEFLUGELKD, V65, P137; *SAS I INC, 2003, SAS VERS 9 1 3; *SCAHAW, 2000, SANCOB3AHR152000 SCA; Steel R., 1997, PRINCIPLES PROCEDURE; Su G, 2000, POULTRY SCI, V79, P1259, DOI 10.1093/ps/79.9.1259; Ventura BA, 2010, POULTRY SCI, V89, P1574, DOI 10.3382/ps.2009-00576	35	65	67	0	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2012	7	1							e29826	10.1371/journal.pone.0029826	http://dx.doi.org/10.1371/journal.pone.0029826			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911GB	22299026	gold, Green Accepted, Green Published, Green Submitted			2022-12-25	WOS:000301704200003
J	Verove, J; Bernarde, C; Bohn, YST; Boulay, F; Rabiet, MJ; Attree, I; Cretin, F				Verove, Julien; Bernarde, Cedric; Bohn, Yu-Sing Tammy; Boulay, Francois; Rabiet, Marie-Josephe; Attree, Ina; Cretin, Francois			Injection of Pseudomonas aeruginosa Exo Toxins into Host Cells Can Be Modulated by Host Factors at the Level of Translocon Assembly and/or Activity	PLOS ONE			English	Article							III SECRETION SYSTEM; YERSINIA-PSEUDOTUBERCULOSIS; PLASMA-MEMBRANE; PORE FORMATION; LEADING-EDGE; BACTERIAL INVASION; EPITHELIAL-CELLS; EXOENZYME-S; TIP COMPLEX; PROTEIN	Pseudomonas aeruginosa type III secretion apparatus exports and translocates four exotoxins into the cytoplasm of the host cell. The translocation requires two hydrophobic bacterial proteins, PopB and PopD, that are found associated with host cell membranes following infection. In this work we examined the influence of host cell elements on exotoxin translocation efficiency. We developed a quantitative flow cytometry based assay of translocation that used protein fusions between either ExoS or ExoY and the beta-lactamase reporter enzyme. In parallel, association of translocon proteins with host plasma membranes was evaluated by immunodetection of PopB/D following sucrose gradient fractionation of membranes. A promyelocytic cell line (HL-60) and a pro-monocytic cell line (U937) were found resistant to toxin injection even though PopB/D associated with host cell plasma membranes. Differentiation of these cells to either macrophage-or neutrophil-like cell lines resulted in injection-sensitive phenotype without significantly changing the level of membrane-inserted translocon proteins. As previous in vitro studies have indicated that the lysis of liposomes by PopB and PopD requires both cholesterol and phosphatidyl-serine, we first examined the role of cholesterol in translocation efficiency. Treatment of sensitive HL-60 cells with methyl-beta-cyclodextrine, a cholesterol-depleting agent, resulted in a diminished injection of ExoS-Bla. Moreover, the PopB translocator was found in the membrane fraction, obtained from sucrose-gradient purifications, containing the lipid-raft marker flotillin. Examination of components of signalling pathways influencing the toxin injection was further assayed through a pharmacological approach. A systematic detection of translocon proteins within host membranes showed that, in addition to membrane composition, some general signalling pathways involved in actin polymerization may be critical for the formation of a functional pore. In conclusion, we provide new insights in regulation of translocation process and suggest possible cross-talks between eukaryotic cell and the pathogen at the level of exotoxin translocation.	[Verove, Julien; Bernarde, Cedric; Bohn, Yu-Sing Tammy; Boulay, Francois; Rabiet, Marie-Josephe; Attree, Ina; Cretin, Francois] INSERM, U1036, Grenoble, France; [Verove, Julien; Bernarde, Cedric; Bohn, Yu-Sing Tammy; Boulay, Francois; Rabiet, Marie-Josephe; Attree, Ina; Cretin, Francois] CNRS, ERL 5261, Grenoble, France; [Verove, Julien; Bernarde, Cedric; Bohn, Yu-Sing Tammy; Boulay, Francois; Rabiet, Marie-Josephe; Attree, Ina; Cretin, Francois] Univ Grenoble 1, Grenoble, France; [Verove, Julien; Bernarde, Cedric; Bohn, Yu-Sing Tammy; Boulay, Francois; Rabiet, Marie-Josephe; Attree, Ina; Cretin, Francois] CEA, DSV iRTSV, Grenoble, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA	Verove, J (corresponding author), INSERM, U1036, Grenoble, France.	francois.cretin@cea.fr		Cretin, Francois/0000-0001-9939-0931; Attree, Ina/0000-0002-2580-764X	CEA DSV; Rhone Alpes region; cluster 10 "Infectiology"; ANR [ANR-08-MIEN-020-01]	CEA DSV(French Atomic Energy Commission); Rhone Alpes region(Region Auvergne-Rhone-Alpes); cluster 10 "Infectiology"(Region Auvergne-Rhone-Alpes); ANR(French National Research Agency (ANR))	Y.-S.T. Bohn received a fellowship from the CEA DSV program "Membrane proteins". J. Verove was a PhD fellow from the Rhone Alpes region and was supported by cluster 10 "Infectiology". The project was in part financed by ANR grant ANR-08-MIEN-020-01 to M.-J. Rabiet and I. Attree. C. Bernarde was a postdoctoral fellow financed by ANR. CEA: French Alternative Energies and Atomic Energy Commission (Commissariat a l'Energie Atomique et aux Energies Alternatives). DSV: Life Sciences Division (Departement des Sciences du Vivant). ANR: National Research Agency (Agence Nationale de la Recherche). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akopyan K, 2011, P NATL ACAD SCI USA, V108, P1639, DOI 10.1073/pnas.1013888108; Aktories K, 2005, NAT REV MICROBIOL, V3, P397, DOI 10.1038/nrmicro1150; Alli M, 2008, INT J MED MICROBIOL, V298, P183, DOI 10.1016/j.ijmm.2007.04.007; Allmond LR, 2003, INFECT IMMUN, V71, P2230, DOI 10.1128/IAI.71.4.2230-2233.2003; Auerbuch V, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000686; Bleves S, 2010, INT J MED MICROBIOL, V300, P534, DOI 10.1016/j.ijmm.2010.08.005; Bridge DR, 2010, MICROBIOL-SGM, V156, P356, DOI 10.1099/mic.0.033241-0; Broz P, 2007, MOL MICROBIOL, V65, P1311, DOI 10.1111/j.1365-2958.2007.05871.x; Caroline G, 2008, J BIOL CHEM, V283, P23940, DOI 10.1074/jbc.M803146200; Charpentier X, 2004, J BACTERIOL, V186, P5486, DOI 10.1128/JB.186.16.5486-5495.2004; Charpentier X, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000501; Christophe T, 2001, J BIOL CHEM, V276, P21585, DOI 10.1074/jbc.M007769200; Chuanchuen R, 2002, BIOTECHNIQUES, V33, P760, DOI 10.2144/02334bm08; Cisz M, 2008, J BACTERIOL, V190, P2726, DOI 10.1128/JB.01553-07; Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526; Dewoody R, 2011, MOL MICROBIOL, V79, P1445, DOI 10.1111/j.1365-2958.2011.07534.x; Diaz MH, 2010, INFECT IMMUN, V78, P1447, DOI 10.1128/IAI.01134-09; Eitel J, 2005, CELL MICROBIOL, V7, P63, DOI 10.1111/j.1462-5822.2004.00434.x; Engel J, 2009, CURR OPIN MICROBIOL, V12, P61, DOI 10.1016/j.mib.2008.12.007; Faudry E, 2007, FEBS J, V274, P3601, DOI 10.1111/j.1742-4658.2007.05893.x; Faudry E, 2006, BIOCHEMISTRY-US, V45, P8117, DOI 10.1021/bi060452+; Fenteany G, 2003, CURR TOP MED CHEM, V3, P593, DOI 10.2174/1568026033452348; Franchi L, 2007, EUR J IMMUNOL, V37, P3030, DOI 10.1002/eji.200737532; Gomez-Mouton C, 2001, P NATL ACAD SCI USA, V98, P9642, DOI 10.1073/pnas.171160298; Goure J, 2005, J INFECT DIS, V192, P218, DOI 10.1086/430932; Goure J, 2004, INFECT IMMUN, V72, P4741, DOI 10.1128/IAI.72.8.4741-4750.2004; Grassme H, 2003, NAT MED, V9, P322, DOI 10.1038/nm823; HAKANSSON S, 1993, INFECT IMMUN, V61, P71; Hakansson S, 1996, EMBO J, V15, P5812, DOI 10.1002/j.1460-2075.1996.tb00968.x; Hauser AR, 2009, NAT REV MICROBIOL, V7, P654, DOI 10.1038/nrmicro2199; Hayward RD, 2005, MOL MICROBIOL, V56, P590, DOI 10.1111/j.1365-2958.2005.04568.x; Hudson KJ, 2005, CELL MICROBIOL, V7, P1474, DOI 10.1111/j.1462-5822.2005.00571.x; Ireton K, 1996, SCIENCE, V274, P780, DOI 10.1126/science.274.5288.780; Job V, 2010, J BIOL CHEM, V285, P23222, DOI 10.1074/jbc.M110.111278; Kierbel A, 2005, MOL BIOL CELL, V16, P2577, DOI 10.1091/mbc.E04-08-0717; Lafont F, 2002, EMBO J, V21, P4449, DOI 10.1093/emboj/cdf457; Manes S, 2004, TRENDS CELL BIOL, V14, P275, DOI 10.1016/j.tcb.2004.04.008; Marketon MM, 2005, SCIENCE, V309, P1739, DOI 10.1126/science.1114580; Mattei PJ, 2011, FEBS J, V278, P414, DOI 10.1111/j.1742-4658.2010.07974.x; McGhie EJ, 2002, MOL MICROBIOL, V44, P1309, DOI 10.1046/j.1365-2958.2002.02958.x; McGuffie EM, 1999, INFECT IMMUN, V67, P3494, DOI 10.1128/IAI.67.7.3494-3503.1999; Mejia E, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040003; Miao EA, 2008, P NATL ACAD SCI USA, V105, P2562, DOI 10.1073/pnas.0712183105; Mueller CA, 2008, MOL MICROBIOL, V68, P1085, DOI 10.1111/j.1365-2958.2008.06237.x; Nanao M, 2003, BMC MICROBIOL, V3, DOI 10.1186/1471-2180-3-21; Neyt C, 1999, MOL MICROBIOL, V33, P971, DOI 10.1046/j.1365-2958.1999.01537.x; Pastor A, 2005, FEMS MICROBIOL LETT, V253, P95, DOI 10.1016/j.femsle.2005.09.028; Peterson LR, 2009, CLIN INFECT DIS, V49, P992, DOI 10.1086/605539; Roehrich AD, 2010, INFECT IMMUN, V78, P1682, DOI 10.1128/IAI.00645-09; Rucks EA, 2005, INFECT IMMUN, V73, P638, DOI 10.1128/IAI.73.1.638-643.2005; Schoehn G, 2003, EMBO J, V22, P4957, DOI 10.1093/emboj/cdg499; SCHWEIZER HP, 1992, MOL MICROBIOL, V6, P1195, DOI 10.1111/j.1365-2958.1992.tb01558.x; SCHWEIZER HP, 1991, GENE, V97, P109, DOI 10.1016/0378-1119(91)90016-5; Seveau S, 2001, MOL BIOL CELL, V12, P3550, DOI 10.1091/mbc.12.11.3550; Shin H, 2007, CELL MICROBIOL, V9, P2893, DOI 10.1111/j.1462-5822.2007.01004.x; Skoudy A, 2000, CELL MICROBIOL, V2, P19, DOI 10.1046/j.1462-5822.2000.00028.x; Sutterwala FS, 2007, J EXP MED, V204, P3235, DOI 10.1084/jem.20071239; Uliczka F, 2009, CELL MICROBIOL, V11, P1782, DOI 10.1111/j.1462-5822.2009.01371.x; Vance RE, 2005, INFECT IMMUN, V73, P1706, DOI 10.1128/IAI.73.3.1706-1713.2005; Vasanji A, 2004, DEV CELL, V6, P29, DOI 10.1016/S1534-5807(03)00397-6; Yu XJ, 2010, SCIENCE, V328, P1040, DOI 10.1126/science.1189000	61	25	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2012	7	1							e30488	10.1371/journal.pone.0030488	http://dx.doi.org/10.1371/journal.pone.0030488			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911GB	22299042	Green Published, Green Submitted, gold			2022-12-25	WOS:000301704200019
J	Carew, JS; Esquivel, JA; Espitia, CM; Schultes, CM; Mulbaier, M; Lewis, JD; Janssen, B; Giles, FJ; Nawrocki, ST				Carew, Jennifer S.; Esquivel, Juan A., II; Espitia, Claudia M.; Schultes, Christoph M.; Muelbaier, Marcel; Lewis, Joe D.; Janssen, Bernd; Giles, Francis J.; Nawrocki, Steffan T.			ELR510444 Inhibits Tumor Growth and Angiogenesis by Abrogating HIF Activity and Disrupting Microtubules in Renal Cell Carcinoma	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; HIPPEL-LINDAU PROTEIN; SUPPRESSOR PROTEIN; FACTOR 1-ALPHA; ORAL 2-METHOXYESTRADIOL; UNFAVORABLE PROGNOSIS; FACTORS HIF-1-ALPHA; COLCHICINE-BINDING; BREAST-CANCER; GENE	Background: Hypoxia-inducible factor (HIF) is an attractive therapeutic target for renal cell carcinoma (RCC) as its high expression due to the loss of von Hippel-Lindau (VHL) promotes RCC progression. Considering this, we hypothesized that ELR510444, a novel orally available small molecule inhibitor of HIF activity, would reduce angiogenesis and possess significant activity in RCC. The mechanism of action and therapeutic efficacy of ELR510444 were investigated in in vitro and in vivo models of RCC. Principal Findings: ELR510444 decreased HIF-1 alpha and HIF-2 alpha levels, reduced RCC cell viability and clonogenic survival, and induced apoptosis. VHL-deficient RCC cells were more sensitive to ELR510444-mediated apoptosis and restoration of VHL promoted drug resistance. Higher concentrations of ELR51044 promoted apoptosis independently of VHL status, possibly due to the microtubule destabilizing properties of this agent. ELR510444 significantly reduced tumor burden in the 786-O and A498 RCC xenograft models. These effects were associated with increased necrosis and apoptosis and inhibition of angiogenesis. Conclusions: ELR510444 is a promising new HIF inhibitor that reduced RCC cell viability, induced apoptosis, and diminished tumor burden in RCC xenograft models. ELR510444 also destabilized microtubules suggesting that it possesses vascular disrupting and anti-angiogenic properties. Further investigation of ELR510444 for the therapy of RCC is warranted.	[Carew, Jennifer S.; Esquivel, Juan A., II; Espitia, Claudia M.; Giles, Francis J.; Nawrocki, Steffan T.] Univ Texas Hlth Sci Ctr San Antonio, Canc Therapy & Res Ctr, Dept Med, San Antonio, TX 78229 USA; [Carew, Jennifer S.; Esquivel, Juan A., II; Espitia, Claudia M.; Giles, Francis J.; Nawrocki, Steffan T.] Univ Texas Hlth Sci Ctr San Antonio, Canc Therapy & Res Ctr, Inst Drug Dev, San Antonio, TX 78229 USA; [Schultes, Christoph M.; Muelbaier, Marcel; Lewis, Joe D.; Janssen, Bernd] Elara Pharmaceut GmbH, Heidelberg, Germany	Cancer Therapy & Research Center; University of Texas System; University of Texas Health San Antonio; Cancer Therapy & Research Center; University of Texas System; University of Texas Health San Antonio	Carew, JS (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Canc Therapy & Res Ctr, Dept Med, San Antonio, TX 78229 USA.	Nawrocki@uthscsa.edu		Lewis, Joe/0000-0002-9926-1328	Congressionally directed Medical Research Programs (CDMRP) [W81XWH-07-2-0025]; National Cancer Institute P30 Cancer Center [CA054174]; Institute for Drug Development, Cancer Therapy and Research Center at University of Texas Health Science Center at San Antonio; Bundesministerium fur Bildung und Forschung, Germany [0315418]; NATIONAL CANCER INSTITUTE [P30CA054174] Funding Source: NIH RePORTER	Congressionally directed Medical Research Programs (CDMRP)(United States Department of Defense); National Cancer Institute P30 Cancer Center; Institute for Drug Development, Cancer Therapy and Research Center at University of Texas Health Science Center at San Antonio; Bundesministerium fur Bildung und Forschung, Germany(Federal Ministry of Education & Research (BMBF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Congressionally directed Medical Research Programs (CDMRP) Grant #W81XWH-07-2-0025, National Cancer Institute P30 Cancer Center Support Grant #CA054174, and funds provided by The Institute for Drug Development, Cancer Therapy and Research Center at University of Texas Health Science Center at San Antonio. CMS and MM were supported by the Bundesministerium fur Bildung und Forschung, Germany (Grant 0315418). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of this manuscript.	Beasley NJP, 2002, CANCER RES, V62, P2493; Birner P, 2000, CANCER RES, V60, P4693; Blancher C, 2000, CANCER RES, V60, P7106; Bos R, 2001, JNCI-J NATL CANCER I, V93, P309, DOI 10.1093/jnci/93.4.309; Burkitt K, 2009, MOL CANCER THER, V8, P1148, DOI 10.1158/1535-7163.MCT-08-0944; Carew JS, 2011, J BIOL CHEM, V286, P6602, DOI 10.1074/jbc.M110.151324; Dahut WL, 2006, CANCER BIOL THER, V5, P22, DOI 10.4161/cbt.5.1.2349; Fortin S, 2010, BIOL PROCED ONLINE, V12, P113, DOI 10.1007/s12575-010-9029-5; Giatromanolaki A, 2001, BRIT J CANCER, V85, P881, DOI 10.1054/bjoc.2001.2018; Gnarra JR, 1996, P NATL ACAD SCI USA, V93, P10589, DOI 10.1073/pnas.93.20.10589; Heng DYC, 2008, CURR CANCER DRUG TAR, V8, P676, DOI 10.2174/156800908786733450; Hergovich A, 2003, NAT CELL BIOL, V5, P64, DOI 10.1038/ncb899; Iliopoulos O, 1996, P NATL ACAD SCI USA, V93, P10595, DOI 10.1073/pnas.93.20.10595; ILIOPOULOS O, 1995, NAT MED, V1, P822, DOI 10.1038/nm0895-822; Kaelin WG, 2007, CLIN CANCER RES, V13, p680S, DOI 10.1158/1078-0432.CCR-06-1865; Kelly KR, 2011, REOVIRUS TH IN PRESS; Kondo K, 2002, CANCER CELL, V1, P237, DOI 10.1016/S1535-6108(02)00043-0; Krieg M, 2000, ONCOGENE, V19, P5435, DOI 10.1038/sj.onc.1203938; Kurokawa T, 2003, BRIT J CANCER, V89, P1042, DOI 10.1038/sj.bjc.6601186; LITTLE M, 1985, EMBO J, V4, P51, DOI 10.1002/j.1460-2075.1985.tb02316.x; Mabjeesh NJ, 2003, CANCER CELL, V3, P363, DOI 10.1016/S1535-6108(03)00077-1; Mahalingam D, 2010, CLIN CANCER RES, V16, P141, DOI 10.1158/1078-0432.CCR-09-1385; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Pasquier E, 2010, MOL CANCER THER, V9, P1408, DOI 10.1158/1535-7163.MCT-09-0894; Patel PH, 2006, CLIN CANCER RES, V12, P7215, DOI 10.1158/1078-0432.CCR-06-2254; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Powis G, 2004, MOL CANCER THER, V3, P647; Rajkumar SV, 2007, CLIN CANCER RES, V13, P6162, DOI 10.1158/1078-0432.CCR-07-0807; Risinger AL, 2011, J PHARMACOL EXP THER, V336, P652, DOI 10.1124/jpet.110.175331; Schindl M, 2002, CLIN CANCER RES, V8, P1831; Siemann DW, 2008, ANTICANCER RES, V28, P2027; Sosman JA, 2007, CLIN CANCER RES, V13, p764S, DOI 10.1158/1078-0432.CCR-06-1975; Staller P, 2003, NATURE, V425, P307, DOI 10.1038/nature01874; Sweeney C, 2005, CLIN CANCER RES, V11, P6625, DOI 10.1158/1078-0432.CCR-05-0440; Thoma CR, 2010, J CELL BIOL, V190, P991, DOI 10.1083/jcb.201006059; Thomas GV, 2006, NAT MED, V12, P122, DOI 10.1038/nm1337; Turner KJ, 2002, CANCER RES, V62, P2957; Verheul HMW, 2008, CLIN CANCER RES, V14, P3589, DOI 10.1158/1078-0432.CCR-07-4306; Welsh S, 2004, MOL CANCER THER, V3, P233; Welsh SJ, 2003, MOL CANCER THER, V2, P235; Yeo EJ, 2003, J NATL CANCER I, V95, P516, DOI 10.1093/jnci/95.7.516	41	19	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e31120	10.1371/journal.pone.0031120	http://dx.doi.org/10.1371/journal.pone.0031120			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910ME	22295124	Green Submitted, Green Published, gold			2022-12-25	WOS:000301640600069
J	Harmel, N; Cokic, B; Zolles, G; Berkefeld, H; Mauric, V; Fakler, B; Stein, V; Klocker, N				Harmel, Nadine; Cokic, Barbara; Zolles, Gerd; Berkefeld, Henrike; Mauric, Veronika; Fakler, Bernd; Stein, Valentin; Kloecker, Nikolaj			AMPA Receptors Commandeer an Ancient Cargo Exporter for Use as an Auxiliary Subunit for Signaling	PLOS ONE			English	Article							LONG-TERM POTENTIATION; ENDOPLASMIC-RETICULUM; ER EXPORT; SYNAPTIC PLASTICITY; KINETIC-PROPERTIES; GLUTAMATE RECEPTORS; CORNICHON PROTEINS; LENTIVIRAL VECTORS; TRAFFICKING; CHANNELS	Fast excitatory neurotransmission in the mammalian central nervous system is mainly mediated by ionotropic glutamate receptors of the AMPA subtype (AMPARs). AMPARs are protein complexes of the pore-lining alpha-subunits GluA1-4 and auxiliary beta-subunits modulating their trafficking and gating. By a proteomic approach, two homologues of the cargo exporter cornichon, CNIH-2 and CNIH-3, have recently been identified as constituents of native AMPARs in mammalian brain. In heterologous reconstitution experiments, CNIH-2 promotes surface expression of GluAs and modulates their biophysical properties. However, its relevance in native AMPAR physiology remains controversial. Here, we have studied the role of CNIH-2 in GluA processing both in heterologous cells and primary rat neurons. Our data demonstrate that CNIH-2 serves an evolutionarily conserved role as a cargo exporter from the endoplasmic reticulum (ER). CNIH-2 cycles continuously between ER and Golgi complex to pick up cargo protein in the ER and then to mediate its preferential export in a coat protein complex (COP) II dependent manner. Interaction with GluA subunits breaks with this ancestral role of CNIH-2 confined to the early secretory pathway. While still taking advantage of being exported preferentially from the ER, GluAs recruit CNIH-2 to the cell surface. Thus, mammalian AMPARs commandeer CNIH-2 for use as a bona fide auxiliary subunit that is able to modify receptor signaling.	[Harmel, Nadine; Mauric, Veronika; Kloecker, Nikolaj] Univ Dusseldorf, Fac Med, Inst Neuro & Sensory Physiol, D-40225 Dusseldorf, Germany; [Cokic, Barbara] Max Planck Inst Neurobiol, Dept Synapt Receptor Trafficking, Martinsried, Germany; [Zolles, Gerd; Berkefeld, Henrike; Fakler, Bernd] Univ Freiburg, Inst Physiol, Freiburg, Germany; [Fakler, Bernd] Ctr Biol Signaling Studies BIOSS, Freiburg, Germany; [Stein, Valentin] Univ Bonn, Dept Physiol, Bonn, Germany	Heinrich Heine University Dusseldorf; Max Planck Society; University of Freiburg; University of Bonn	Harmel, N (corresponding author), Univ Dusseldorf, Fac Med, Inst Neuro & Sensory Physiol, D-40225 Dusseldorf, Germany.	nikolaj.kloecker@uni-duesseldorf.de	Stein, Valentin/A-8025-2008	Stein, Valentin/0000-0003-1222-4928	Deutsche Forschungs gemeinschaft (DFG) [SFB780 TP B04]	Deutsche Forschungs gemeinschaft (DFG)(German Research Foundation (DFG))	The work was funded by a grant of the Deutsche Forschungs gemeinschaft (DFG) to N.K. (SFB780 TP B04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aridor M, 2004, J NEUROSCI, V24, P3770, DOI 10.1523/JNEUROSCI.4775-03.2004; Aridor M, 2001, J CELL BIOL, V152, P213, DOI 10.1083/jcb.152.1.213; Aridor M, 1998, J CELL BIOL, V141, P61, DOI 10.1083/jcb.141.1.61; Bats C, 2007, NEURON, V53, P719, DOI 10.1016/j.neuron.2007.01.030; Bear Mark F., 1994, Current Opinion in Neurobiology, V4, P389, DOI 10.1016/0959-4388(94)90101-5; Bokel C, 2006, DEVELOPMENT, V133, P459, DOI 10.1242/dev.02219; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Cole NB, 1996, SCIENCE, V273, P797, DOI 10.1126/science.273.5276.797; Coleman SK, 2006, J NEUROSCI, V26, P11220, DOI 10.1523/JNEUROSCI.2301-06.2006; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; DiCiommo DP, 1998, J BIOL CHEM, V273, P18060, DOI 10.1074/jbc.273.29.18060; Everts I, 1997, MOL PHARMACOL, V52, P861, DOI 10.1124/mol.52.5.861; GALLO V, 1992, J NEUROSCI, V12, P1010; Gill MB, 2011, J NEUROSCI, V31, P6928, DOI 10.1523/JNEUROSCI.6271-10.2011; Greger IH, 2002, NEURON, V34, P759, DOI 10.1016/S0896-6273(02)00693-1; Grosskreutz J, 2003, EUR J NEUROSCI, V17, P1173, DOI 10.1046/j.1460-9568.2003.02531.x; Hoshino H, 2007, MOL BIOL CELL, V18, P1143, DOI 10.1091/mbc.E06-08-0733; HUME RI, 1991, SCIENCE, V253, P1028, DOI 10.1126/science.1653450; Kato AS, 2010, NEURON, V68, P1082, DOI 10.1016/j.neuron.2010.11.026; KOHLER M, 1994, J BIOL CHEM, V269, P17367; Koike M, 2000, J NEUROSCI, V20, P2166; LOMELI H, 1994, SCIENCE, V266, P1709, DOI 10.1126/science.7992055; Ma D, 2002, NEURON, V33, P715, DOI 10.1016/S0896-6273(02)00614-1; Ma DK, 2001, SCIENCE, V291, P316, DOI 10.1126/science.291.5502.316; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; MALEY F, 1989, ANAL BIOCHEM, V180, P195, DOI 10.1016/0003-2697(89)90115-2; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Milstein AD, 2008, TRENDS PHARMACOL SCI, V29, P333, DOI 10.1016/j.tips.2008.04.004; Nicoll RA, 2006, SCIENCE, V311, P1253, DOI 10.1126/science.1123339; Penn AC, 2008, EMBO J, V27, P3056, DOI 10.1038/emboj.2008.222; Perez Castro C, 2007, J CELL SCI, V120, P2454, DOI 10.1242/jcs.004200; Pfeifer A, 2001, MOL THER, V3, P319, DOI 10.1006/mthe.2001.0276; Pfeifer A, 2002, P NATL ACAD SCI USA, V99, P2140, DOI 10.1073/pnas.251682798; Powers J, 1998, J CELL BIOL, V142, P1209, DOI 10.1083/jcb.142.5.1209; Powers J, 2002, MOL BIOL CELL, V13, P880, DOI 10.1091/mbc.01-10-0499; ROTH S, 1995, CELL, V81, P967, DOI 10.1016/0092-8674(95)90016-0; Schwenk J, 2009, SCIENCE, V323, P1313, DOI 10.1126/science.1167852; Shi Y, 2010, P NATL ACAD SCI USA, V107, P16315, DOI 10.1073/pnas.1011706107; SOMMER B, 1990, SCIENCE, V249, P1580, DOI 10.1126/science.1699275; Soto D, 2007, NAT NEUROSCI, V10, P1260, DOI 10.1038/nn1966; Standley S, 1998, J NEUROCHEM, V70, P2434; Stein V, 2003, J NEUROSCI, V23, P5503; Stockklausner C, 2001, FEBS LETT, V493, P129, DOI 10.1016/S0014-5793(01)02286-4; Storrie B, 1998, J CELL BIOL, V143, P1505, DOI 10.1083/jcb.143.6.1505; Tomita S, 2005, NATURE, V435, P1052, DOI 10.1038/nature03624; Tomita S, 2003, J CELL BIOL, V161, P805, DOI 10.1083/jcb.200212116; Vandenberghe W, 2005, J NEUROSCI, V25, P1095, DOI 10.1523/JNEUROSCI.3568-04.2005; VERDOORN TA, 1991, SCIENCE, V252, P1715, DOI 10.1126/science.1710829; von Engelhardt J, 2010, SCIENCE, V327, P1518, DOI 10.1126/science.1184178; Ward TH, 2001, J CELL BIOL, V155, P557, DOI 10.1083/jcb.200107045; Wiseman RL, 2007, CELL, V131, P809, DOI 10.1016/j.cell.2007.10.025	51	29	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2012	7	1							e30681	10.1371/journal.pone.0030681	http://dx.doi.org/10.1371/journal.pone.0030681			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910LV	22292017	Green Submitted, gold, Green Published			2022-12-25	WOS:000301639600046
J	Hong, SL; Barton, SJ; Rebec, GV				Hong, S. Lee; Barton, Scott J.; Rebec, George V.			Altered Neural and Behavioral Dynamics in Huntington's Disease: An Entropy Conservation Approach	PLOS ONE			English	Article							MOUSE MODEL; DOPAMINE; PHENOTYPE; NEURONS	Background: Huntington's disease (HD) is an inherited condition that results in neurodegeneration of the striatum, the forebrain structure that processes cortical information for behavioral output. In the R6/2 transgenic mouse model of HD, striatal neurons exhibit aberrant firing patterns that are coupled with reduced flexibility in the motor system. The aim of this study was to test the patterns of unpredictability in brain and behavior in wild-type (WT) and R6/2 mice. Methodology/Principal Findings: Striatal local field potentials (LFP) were recorded from 18 WT and 17 R6/2 mice (aged 8 11 weeks) while the mice were exploring a plus-shaped maze. We targeted LFP activity for up to 2 s before and 2 s after each choice-point entry. Approximate Entropy (ApEn) was calculated for LFPs and Shannon Entropy was used to measure the probability of arm choice, as well as the likelihood of making consecutive 90-degree turns in the maze. We found that although the total number of choice-point crossings and entropy of arm-choice probability was similar in both groups, R6/2 mice had more predictable behavioral responses (i.e., were less likely to make 90-degree turns and perform them in alternation with running straight down the same arm), while exhibiting more unpredictable striatal activity, as indicated by higher ApEn values. In both WT and R6/2 mice, however, behavioral unpredictability was negatively correlated with LFP ApEn. Conclusions/Significance: HD results in a perseverative exploration of the environment, occurring in concert with more unpredictable brain activity. Our results support the entropy conservation hypothesis in which unpredictable behavioral patterns are coupled with more predictable brain activation patterns, suggesting that this may be a fundamental process unaffected by HD.	[Hong, S. Lee] Indiana Univ, Dept Kinesiol, Bloomington, IN 47405 USA; [Barton, Scott J.; Rebec, George V.] Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN 47405 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Hong, SL (corresponding author), Indiana Univ, Dept Kinesiol, Bloomington, IN 47405 USA.	rebec@indiana.edu	Hong, S./B-2390-2008	Hong, S./0000-0001-6044-2482	National Institute on Aging [R21 AG 039818, R21 AG 035158]; National Institute of Neurological Diseases and Stroke [R01 NS 35663]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035663] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG039818, R21AG035158] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Neurological Diseases and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding was provided by National Institute on Aging R21 AG 039818 and R21 AG 035158 and National Institute of Neurological Diseases and Stroke R01 NS 35663. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed., DOI DOI 10.4324/9780203771587; Daffertshofer A, 2004, CLIN BIOMECH, V19, P415, DOI 10.1016/j.clinbiomech.2004.01.005; Fiorillo CD, 2003, SCIENCE, V299, P1898, DOI 10.1126/science.1077349; Fowler SC, 2009, BEHAV BRAIN RES, V202, P130, DOI 10.1016/j.bbr.2009.03.022; Hickey MA, 2002, J NEUROCHEM, V81, P46, DOI 10.1046/j.1471-4159.2002.00804.x; Hong S Lee, 2008, Nonlinear Dynamics Psychol Life Sci, V12, P163; Hong SL, 2010, NONLIN DYNAM PSYCHOL, V14, P291; Hong SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011461; Kelso J. A. S., 2006, COMPLEMENTARY NATURE; Kern DS, 2007, NEUROLOGIST, V13, P237, DOI 10.1097/NRL.0b013e3181492c48; Mandell AJ, 1997, CHAOS, V7, P67, DOI 10.1063/1.166241; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Miller BR, 2008, J NEUROPHYSIOL, V100, P2205, DOI 10.1152/jn.90606.2008; PINCUS SM, 1991, P NATL ACAD SCI USA, V88, P2297, DOI 10.1073/pnas.88.6.2297; Rebec GV, 2003, NEUROREPORT, V14, P1263, DOI 10.1097/00001756-200307010-00015; Schultz W, 1997, CURR OPIN NEUROBIOL, V7, P191, DOI 10.1016/S0959-4388(97)80007-4; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI DOI 10.1002/J.1538-7305.1948.TB01338.X; Smotherman WP, 1996, PSYCHONEUROENDOCRINO, V21, P173, DOI 10.1016/0306-4530(95)00040-2	18	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30879	10.1371/journal.pone.0030879	http://dx.doi.org/10.1371/journal.pone.0030879			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22292068	gold, Green Published, Green Submitted			2022-12-25	WOS:000301570600092
J	Collins, RA; Armstrong, KF; Meier, R; Yi, YG; Brown, SDJ; Cruickshank, RH; Keeling, S; Johnston, C				Collins, Rupert A.; Armstrong, Karen F.; Meier, Rudolf; Yi, Youguang; Brown, Samuel D. J.; Cruickshank, Robert H.; Keeling, Suzanne; Johnston, Colin			Barcoding and Border Biosecurity: Identifying Cyprinid Fishes in the Aquarium Trade	PLOS ONE			English	Article							FRESH-WATER FISHES; DNA BARCODES; MITOCHONDRIAL-DNA; ORNAMENTAL FISH; TUNA SUSHI; IDENTIFICATION; BIODIVERSITY; TELEOSTEI; HOMOGENIZATION; CONSEQUENCES	Background: Poorly regulated international trade in ornamental fishes poses risks to both biodiversity and economic activity via invasive alien species and exotic pathogens. Border security officials need robust tools to confirm identifications, often requiring hard-to-obtain taxonomic literature and expertise. DNA barcoding offers a potentially attractive tool for quarantine inspection, but has yet to be scrutinised for aquarium fishes. Here, we present a barcoding approach for ornamental cyprinid fishes by: (1) expanding current barcode reference libraries; (2) assessing barcode congruence with morphological identifications under numerous scenarios (e. g. inclusion of GenBank data, presence of singleton species, choice of analytical method); and (3) providing supplementary information to identify difficult species. Methodology/Principal Findings: We sampled 172 ornamental cyprinid fish species from the international trade, and provide data for 91 species currently unrepresented in reference libraries (GenBank/Bold). DNA barcodes were found to be highly congruent with our morphological assignments, achieving success rates of 90-99%, depending on the method used (neighbour-joining monophyly, bootstrap, nearest neighbour, GMYC, percent threshold). Inclusion of data from GenBank (additional 157 spp.) resulted in a more comprehensive library, but at a cost to success rate due to the increased number of singleton species. In addition to DNA barcodes, our study also provides supporting data in the form of specimen images, morphological characters, taxonomic bibliography, preserved vouchers, and nuclear rhodopsin sequences. Using this nuclear rhodopsin data we also uncovered evidence of interspecific hybridisation, and highlighted unrecognised diversity within popular aquarium species, including the endangered Indian barb Puntius denisonii. Conclusions/Significance: We demonstrate that DNA barcoding provides a highly effective biosecurity tool for rapidly identifying ornamental fishes. In cases where DNA barcodes are unable to offer an identification, we improve on previous studies by consolidating supplementary information from multiple data sources, and empower biosecurity agencies to confidently identify high-risk fishes in the aquarium trade.	[Collins, Rupert A.; Armstrong, Karen F.] Lincoln Univ, Bioprotect Res Ctr, Canterbury, New Zealand; [Meier, Rudolf; Yi, Youguang] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Meier, Rudolf; Yi, Youguang] Natl Univ Singapore, Univ Scholars Programme, Singapore 117548, Singapore; [Brown, Samuel D. J.; Cruickshank, Robert H.] Lincoln Univ, Dept Ecol, Fac Agr & Life Sci, Canterbury, New Zealand; [Keeling, Suzanne; Johnston, Colin] Minist Agr & Forestry, Hlth Anim Lab, Invest & Diagnost Ctr, Upper Hutt, New Zealand	Lincoln University - New Zealand; National University of Singapore; National University of Singapore; Lincoln University - New Zealand	Collins, RA (corresponding author), Lincoln Univ, Bioprotect Res Ctr, Canterbury, New Zealand.	rupertcollins@gmail.com	Armstrong, Karen F/J-3460-2013; Meier, Rudolf/AAB-3848-2021; Meier, Rudolf/A-7099-2011; Brown, Samuel/P-8847-2017; Schuler, Herwig/E-5751-2011; Arner, Elias/J-5832-2012	Armstrong, Karen F/0000-0003-4973-2651; Meier, Rudolf/0000-0002-4452-2885; Meier, Rudolf/0000-0002-4452-2885; Brown, Samuel/0000-0001-7112-421X; Schuler, Herwig/0000-0003-4059-3501; Collins, Rupert A./0000-0002-9135-1169; Arner, Elias/0000-0002-4807-6114; Hogbom, Martin/0000-0001-5574-9383	Ministry of Agriculture and Forestry Biosecurity New Zealand; Ministry of Education (Singapore) [R377-000-040-112]	Ministry of Agriculture and Forestry Biosecurity New Zealand; Ministry of Education (Singapore)(Ministry of Education, Singapore)	This work was supported by a Ministry of Agriculture and Forestry Biosecurity New Zealand scholarship for RAC; grant R377-000-040-112 by the Ministry of Education (Singapore) for RM and YY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali A, 2010, IUCN 2011 IUCN RED L; Armstrong KF, 2005, PHILOS T R SOC B, V360, P1813, DOI 10.1098/rstb.2005.1713; Austerlitz F, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S14-S10; Baensch HA, 2007, AQUARIUM ATLAS PHOTO; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Broughton RE, 2001, GENOME RES, V11, P1958, DOI 10.1101/gr.156801; Brown SDJ, 2012, MOL ECOL RESOUR, V12, P562, DOI 10.1111/j.1755-0998.2011.03108.x; Buhay JE, 2009, J CRUSTACEAN BIOL, V29, P96, DOI 10.1651/08-3020.1; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Chen WJ, 2008, GENE, V423, P125, DOI 10.1016/j.gene.2008.07.016; Chen WJ, 2003, MOL PHYLOGENET EVOL, V26, P262, DOI 10.1016/S1055-7903(02)00371-8; Cohen NJ, 2009, J FOOD PROTECT, V72, P810, DOI 10.4315/0362-028X-72.4.810; Collins RA, 2012, METHODS ECOL EVOL, V3, P457, DOI 10.1111/j.2041-210X.2011.00176.x; Copp GH, 2010, AQUAT CONSERV, V20, P595, DOI 10.1002/aqc.1129; Darling JA, 2007, BIOL INVASIONS, V9, P751, DOI 10.1007/s10530-006-9079-4; Dasmahapatra KK, 2006, HEREDITY, V97, P254, DOI 10.1038/sj.hdy.6800858; Dasmahapatra KK, 2010, MOL ECOL RESOUR, V10, P264, DOI 10.1111/j.1755-0998.2009.02763.x; deWaard JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014280; Dinca V, 2011, P ROY SOC B-BIOL SCI, V278, P347, DOI 10.1098/rspb.2010.1089; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950; Elias M, 2007, P ROY SOC B-BIOL SCI, V274, P2881, DOI 10.1098/rspb.2007.1035; Eschmeyer WN, 2010, CATALOG FISHES ELECT; Fang Fang, 2000, Ichthyological Exploration of Freshwaters, V11, P149; Fang F, 2009, ZOOL SCR, V38, P237, DOI 10.1111/j.1463-6409.2008.00373.x; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Frezal L, 2008, INFECT GENET EVOL, V8, P727, DOI 10.1016/j.meegid.2008.05.005; Funk DJ, 2003, ANNU REV ECOL EVOL S, V34, P397, DOI 10.1146/annurev.ecolsys.34.011802.132421; Galtier N, 2009, MOL ECOL, V18, P4541, DOI 10.1111/j.1365-294X.2009.04380.x; Gerson H, 2008, CONSERV BIOL, V22, P4, DOI 10.1111/j.1523-1739.2007.00857.x; Gerstner CL, 2006, J FISH BIOL, V68, P862, DOI 10.1111/j.1095.8649.2006.00978.x; Glez-Pena D, 2010, NUCLEIC ACIDS RES, V38, pW14, DOI 10.1093/nar/gkq321; Go J, 2006, AQUACULTURE, V258, P140, DOI 10.1016/j.aquaculture.2006.04.033; Gozlan RE, 2005, NATURE, V435, P1046, DOI 10.1038/4351046a; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Han MV, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-356; Harris DJ, 2003, TRENDS ECOL EVOL, V18, P317, DOI 10.1016/S0169-5347(03)00150-2; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hensen RR, 2010, STANDARD NAMES FRESH; Hickerson MJ, 2006, SYST BIOL, V55, P729, DOI 10.1080/10635150600969898; HILLIS DM, 1993, SYST BIOL, V42, P182, DOI 10.2307/2992540; Holmes BH, 2009, FISH RES, V95, P280, DOI 10.1016/j.fishres.2008.09.036; Hubert N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002490; Hui TH, 2008, RAFFLES B ZOOL, V56, P423; Hulme PE, 2009, J APPL ECOL, V46, P10, DOI 10.1111/j.1365-2664.2008.01600.x; Kottelat M, 2007, HDB EUROPEAN FRESHWA; Liao TY, 2011, RAFFLES B ZOOL, V59, P77; Lim GS, 2012, SYST BIOL, V61, P165, DOI 10.1093/sysbio/syr030; Linthoingambi I., 2007, Zootaxa, V1450, P45; Lowenstein JH, 2010, BIOL LETTERS, V6, P692, DOI 10.1098/rsbl.2010.0156; Lowenstein JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007866; MAF Biosecurity New Zealand, 2011, IMP HLTH STAND ORN F; McDowall RM, 2004, NEW ZEAL J MAR FRESH, V38, P503, DOI 10.1080/00288330.2004.9517256; Meier R, 2008, SYST BIOL, V57, P809, DOI 10.1080/10635150802406343; Meier R, 2008, SYST ASSOC SPEC VOL, V76, P95; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Monaghan MT, 2009, SYST BIOL, V58, P298, DOI 10.1093/sysbio/syp027; Nelson J. S., 2006, FISHES WORLD; NG PKL, 1993, BIOL CONSERV, V64, P19, DOI 10.1016/0006-3207(93)90379-F; Padial JM, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-16; Padilla DK, 2004, FRONT ECOL ENVIRON, V2, P131, DOI 10.1890/1540-9295(2004)002[0131:BBWAAO]2.0.CO;2; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Ploeg A, 2008, OFI J, V58, P21; Ploeg A, 2009, BIOSECURITY ORNAMENT; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; R Core Team, 2021, R LANG ENV STAT COMP; Raghavan R, 2007, CURR SCI INDIA, V92, P1671; Rahel FJ, 2002, ANNU REV ECOL SYST, V33, P291, DOI 10.1146/annurev.ecolsys.33.010802.150429; Rahel FJ, 2007, FRESHWATER BIOL, V52, P696, DOI 10.1111/j.1365-2427.2006.01708.x; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Rosenberg NA, 2007, EVOLUTION, V61, P317, DOI 10.1111/j.1558-5646.2007.00023.x; Ross HA, 2003, J HERED, V94, P111, DOI 10.1093/jhered/esg027; Ross HA, 2008, SYST BIOL, V57, P216, DOI 10.1080/10635150802032990; Rubinoff D, 2006, J HERED, V97, P581, DOI 10.1093/jhered/esl036; Rubinoff D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016361; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sarkar IN, 2008, MOL ECOL RESOUR, V8, P1256, DOI 10.1111/j.1755-0998.2008.02235.x; Sevilla RG, 2007, MOL ECOL NOTES, V7, P730, DOI 10.1111/j.1471-8286.2007.01863.x; Silva A, 2010, ICHTHYOL EXPLOR FRES, V21, P27; Smits SA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012267; Song H, 2008, P NATL ACAD SCI USA, V105, P13486, DOI 10.1073/pnas.0803076105; Srivathsan A, 2012, CLADISTICS, V28, P190, DOI 10.1111/j.1096-0031.2011.00370.x; Steinke D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006300; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tang KL, 2010, MOL PHYLOGENET EVOL, V57, P189, DOI 10.1016/j.ympev.2010.05.021; Valdez-Moreno M, 2009, J FISH BIOL, V74, P377, DOI 10.1111/j.1095-8649.2008.02077.x; Vogler AP, 2007, J ZOOL SYST EVOL RES, V45, P1, DOI 10.1111/j.1439-0469.2006.00384.x; Ward RD, 2009, J FISH BIOL, V74, P329, DOI 10.1111/j.1095-8649.2008.02080.x; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Whittington RJ, 2007, PREV VET MED, V81, P92, DOI 10.1016/j.prevetmed.2007.04.007; Will KW, 2004, CLADISTICS, V20, P47, DOI 10.1111/j.1096-0031.2003.00008.x; Wong EHK, 2009, MOL ECOL RESOUR, V9, P243, DOI 10.1111/j.1755-0998.2009.02653.x; Wong YT, 2011, BIOL INVASIONS, V13, P341, DOI 10.1007/s10530-010-9825-5; YOKOYAMA R, 1995, INVEST OPHTH VIS SCI, V36, P939; Zemlak TS, 2009, MOL ECOL RESOUR, V9, P237, DOI 10.1111/j.1755-0998.2009.02649.x	99	110	115	2	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e28381	10.1371/journal.pone.0028381	http://dx.doi.org/10.1371/journal.pone.0028381			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909MH	22295093	Green Submitted, gold, Green Published			2022-12-25	WOS:000301568100003
J	Jin, Y; Liu, Z; Cao, W; Ma, XY; Fan, YH; Yu, Y; Bai, J; Chen, F; Rosales, J; Lee, KY; Fu, SB				Jin, Yan; Liu, Zheng; Cao, Wei; Ma, Xinying; Fan, Yihui; Yu, Yang; Bai, Jing; Chen, Feng; Rosales, Jesusa; Lee, Ki-Young; Fu, Songbin			Novel Functional MAR Elements of Double Minute Chromosomes in Human Ovarian Cells Capable of Enhancing Gene Expression	PLOS ONE			English	Article							MATRIX ATTACHMENT REGIONS; DNA; AMPLIFICATION; ONCOGENE; CARCINOMA; SCAFFOLD; SITES; ORGANIZATION; SEQUENCES; LOOP	Double minute chromosomes or double minutes (DMs) are cytogenetic hallmarks of extrachromosomal genomic amplification and play a critical role in tumorigenesis. Amplified copies of oncogenes in DMs have been associated with increased growth and survival of cancer cells but DNA sequences in DMs which are mostly non-coding remain to be characterized. Following sequencing and bioinformatics analyses, we have found 5 novel matrix attachment regions (MARs) in a 682 kb DM in the human ovarian cancer cell line, UACC-1598. By electrophoretic mobility shift assay (EMSA), we determined that all 5 MARs interact with the nuclear matrix in vitro. Furthermore, qPCR analysis revealed that these MARs associate with the nuclear matrix in vivo, indicating that they are functional. Transfection of MARs constructs into human embryonic kidney 293T cells showed significant enhancement of gene expression as measured by luciferase assay, suggesting that the identified MARS, particularly MARs 1 to 4, regulate their target genes in vivo and are potentially involved in DM-mediated oncogene activation.	[Jin, Yan; Liu, Zheng; Cao, Wei; Ma, Xinying; Fan, Yihui; Yu, Yang; Bai, Jing; Chen, Feng; Fu, Songbin] Harbin Med Univ, Med Genet Lab, Harbin, Peoples R China; [Rosales, Jesusa] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB, Canada; [Lee, Ki-Young] Univ Calgary, Dept Cell Biol & Anat, Calgary, AB, Canada	Harbin Medical University; University of Calgary; University of Calgary	Jin, Y (corresponding author), Harbin Med Univ, Med Genet Lab, Harbin, Peoples R China.	fusb@ems.hrbmu.edu.cn	; Jin, Guangze/F-5271-2017	Liu, Zhili/0000-0001-7704-5133; Jin, Guangze/0000-0002-9852-0965; Rosales, Jesusa/0000-0002-2543-3801	National Basic Research Program of China [2010CB534901]; National Natural Science Foundation of China [30971583, 30800268, 81000906]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Basic Research Program of China (No. 2010CB534901) and the National Natural Science Foundation of China (No. 30971583, No. 30800268, and No. 81000906). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI Y, 1989, EMBO J, V8, P3997, DOI 10.1002/j.1460-2075.1989.tb08582.x; ALITALO K, 1983, P NATL ACAD SCI-BIOL, V80, P1707, DOI 10.1073/pnas.80.6.1707; Allen GC, 2000, PLANT MOL BIOL, V43, P361, DOI 10.1023/A:1006424621037; Bode J, 2000, CRIT REV EUKAR GENE, V10, P73; Bode J, 2000, J CELL BIOCH SUPPL S, P353; COCKERILL PN, 1986, FEBS LETT, V204, P5, DOI 10.1016/0014-5793(86)81377-1; FAKHARZADEH SS, 1993, GENOMICS, V15, P283, DOI 10.1006/geno.1993.1058; Fan YH, 2011, J APPL GENET, V52, P53, DOI 10.1007/s13353-010-0007-z; Fukuda Y, 1999, PLANT MOL BIOL, V39, P1051, DOI 10.1023/A:1006133003283; GEBHART E, 1984, INT J CANCER, V34, P369, DOI 10.1002/ijc.2910340313; Gebhart Erich, 2005, Clin Transl Oncol, V7, P477, DOI 10.1007/BF02717000; Girod PA, 2005, BIOTECHNOL BIOENG, V91, P1, DOI 10.1002/bit.20563; Guan XY, 2001, CANCER RES, V61, P3806; HAHN PJ, 1993, BIOESSAYS, V15, P477, DOI 10.1002/bies.950150707; Kim JM, 2004, J BIOTECHNOL, V107, P95, DOI 10.1016/j.jbiotec.2003.09.015; Kuttler F, 2007, SEMIN CANCER BIOL, V17, P56, DOI 10.1016/j.semcancer.2006.10.007; Kwaks THJ, 2006, TRENDS BIOTECHNOL, V24, P137, DOI 10.1016/j.tibtech.2006.01.007; Lestou VS, 2003, BRIT J HAEMATOL, V122, P745, DOI 10.1046/j.1365-2141.2003.04502.x; Martins RP, 2004, J BIOL CHEM, V279, P51862, DOI 10.1074/jbc.M409415200; MCGILL JR, 1993, CANCER GENET CYTOGEN, V71, P125, DOI 10.1016/0165-4608(93)90017-G; MIRKOVITCH J, 1984, CELL, V39, P223, DOI 10.1016/0092-8674(84)90208-3; Morales C, 2009, MOL CANCER THER, V8, P424, DOI 10.1158/1535-7163.MCT-08-0759; MULERIS M, 1994, ONCOGENE, V9, P2717; Neznanov N, 1996, MOL BIOL CELL, V7, P541, DOI 10.1091/mbc.7.4.541; PEACH C, 1991, PLANT MOL BIOL, V17, P49, DOI 10.1007/BF00036805; Singer MJ, 2000, P NATL ACAD SCI USA, V97, P7921, DOI 10.1073/pnas.130194897; SLOVAK ML, 1994, GENE CHROMOSOME CANC, V9, P62, DOI 10.1002/gcc.2870090111; SPRIGGS AI, 1962, BRIT MED J, P1431, DOI 10.1136/bmj.2.5317.1431; SREEKANTAIAH C, 1992, CANCER GENET CYTOGEN, V58, P134, DOI 10.1016/0165-4608(92)90099-T; Tetko IV, 2006, PLOS COMPUT BIOL, V2, P136, DOI 10.1371/journal.pcbi.0020021; van Leeuwen W, 2001, PLANT MOL BIOL, V47, P543, DOI 10.1023/A:1011840310436; VANDEVANTER DR, 1990, J NATL CANCER I, V82, P1815, DOI 10.1093/jnci/82.23.1815; WAHL GM, 1989, CANCER RES, V49, P1333; Yoshimoto M, 1999, AM J PATHOL, V155, P1439, DOI 10.1016/S0002-9440(10)65457-0	34	55	60	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2012	7	2							e30419	10.1371/journal.pone.0030419	http://dx.doi.org/10.1371/journal.pone.0030419			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LO	22427822	gold, Green Published, Green Submitted			2022-12-25	WOS:000302178400008
J	Li, LQ; Zhang, Y; Zou, LY; Li, CQ; Yu, B; Zheng, XQ; Zhou, Y				Li, Liqi; Zhang, Yuan; Zou, Lingyun; Li, Changqing; Yu, Bo; Zheng, Xiaoqi; Zhou, Yue			An Ensemble Classifier for Eukaryotic Protein Subcellular Location Prediction Using Gene Ontology Categories and Amino Acid Hydrophobicity	PLOS ONE			English	Article							SUPPORT VECTOR MACHINE; LOCALIZATION PREDICTION; MULTIPLE SITES; WEB SERVER; EUK-MPLOC; PSI-BLAST; SEQUENCE; FEATURES; PLOC; COMPLEXITY	With the rapid increase of protein sequences in the post-genomic age, it is challenging to develop accurate and automated methods for reliably and quickly predicting their subcellular localizations. Till now, many efforts have been tried, but most of which used only a single algorithm. In this paper, we proposed an ensemble classifier of KNN (k-nearest neighbor) and SVM (support vector machine) algorithms to predict the subcellular localization of eukaryotic proteins based on a voting system. The overall prediction accuracies by the one-versus-one strategy are 78.17%, 89.94% and 75.55% for three benchmark datasets of eukaryotic proteins. The improved prediction accuracies reveal that GO annotations and hydrophobicity of amino acids help to predict subcellular locations of eukaryotic proteins.	[Li, Liqi; Zhang, Yuan; Li, Changqing; Zhou, Yue] Third Mil Med Univ, Xinqiao Hosp, Dept Orthoped, Chongqing, Peoples R China; [Zou, Lingyun] Third Mil Med Univ, Coll Basic Med Sci, Dept Microbiol, Chongqing, Peoples R China; [Yu, Bo] Yichun Peoples Hosp, Dept Orthoped, Yichun, Peoples R China; [Zheng, Xiaoqi] Shanghai Normal Univ, Dept Math, Shanghai, Peoples R China; [Zheng, Xiaoqi] Sci Comp Key Lab Shanghai Univ, Shanghai, Peoples R China	Army Medical University; Army Medical University; Shanghai Normal University; Shanghai Key Laboratory of Scalable Computing & System	Li, LQ (corresponding author), Third Mil Med Univ, Xinqiao Hosp, Dept Orthoped, Chongqing, Peoples R China.	xqzheng@shnu.edu.cn; zhouyxq@163.com			National Natural Science Foundation of China [30901512, 31100953]; Shanghai Leading Academic Discipline Project [S30405]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project)	This work was supported by grants from the National Natural Science Foundation of China (No. 30901512 and No. 31100953) and the Shanghai Leading Academic Discipline Project (No. S30405). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansari HR, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-160; B Panwar, 2011, AMINO ACIDS; Bhasin M, 2004, NUCLEIC ACIDS RES, V32, pW414, DOI 10.1093/nar/gkh350; Bulashevska A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-298; Cai YD, 2005, J THEOR BIOL, V234, P145, DOI 10.1016/j.jtbi.2004.11.017; Cai Yu-Dong, 2000, Molecular Cell Biology Research Communications, V4, P172, DOI 10.1006/mcbr.2001.0269; Chou KC, 2008, NAT PROTOC, V3, P153, DOI 10.1038/nprot.2007.494; Chou KC, 2007, J PROTEOME RES, V6, P1728, DOI 10.1021/pr060635i; Chou KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018258; Chou KC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011335; Chou KC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009931; Cuo Jian, 2006, Journal of Bioinformatics and Computational Biology, V4, P1181; Currie RA, 2005, REPROD TOXICOL, V20, P433, DOI 10.1016/j.reprotox.2005.03.014; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Gu Q, 2010, AMINO ACIDS, V38, P975, DOI 10.1007/s00726-008-0209-4; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Huang T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016036; Huang T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025297; Huang WL, 2009, BIOSYSTEMS, V98, P73, DOI 10.1016/j.biosystems.2009.06.007; Jia PL, 2007, BIOCHEM BIOPH RES CO, V357, P366, DOI 10.1016/j.bbrc.2007.03.139; Khan A, 2011, COMPUT BIOL CHEM, V35, P218, DOI 10.1016/j.compbiolchem.2011.05.003; Khan A, 2010, AMINO ACIDS, V38, P347, DOI 10.1007/s00726-009-0238-7; Kim JK, 2006, PATTERN RECOGN LETT, V27, P996, DOI 10.1016/j.patrec.2005.11.014; Laurila K, 2011, AMINO ACIDS, V40, P975, DOI 10.1007/s00726-010-0724-y; Lei ZD, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-491; Liao B, 2011, PROTEIN PEPTIDE LETT, V18, P1086, DOI 10.2174/092986611797200931; Lin TH, 2011, IEEE ACM T COMPUT BI, V8, P441, DOI 10.1109/TCBB.2009.82; Liqi L., 2011, J COMPUT BIOL BIOINF, V3, P15; Marinov M, 2001, HUM HERED, V51, P169, DOI 10.1159/000053338; Mei SY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-44; Mount D.W., 2009, COLD SPRING HARB PRO; NAKASHIMA H, 1994, J MOL BIOL, V238, P54, DOI 10.1006/jmbi.1994.1267; Park KJ, 2003, BIOINFORMATICS, V19, P1656, DOI 10.1093/bioinformatics/btg222; Pierleoni A, 2011, BIOINFORMATICS, V27, P1224, DOI 10.1093/bioinformatics/btr108; Qian ZL, 2006, BIOCHEM BIOPH RES CO, V348, P1034, DOI 10.1016/j.bbrc.2006.07.149; Qiu JD, 2010, AMINO ACIDS, V38, P1201, DOI 10.1007/s00726-009-0331-y; Rao HB, 2011, NUCLEIC ACIDS RES, V39, pW385, DOI 10.1093/nar/gkr284; Rashid M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-337; Sahu SS, 2010, COMPUT BIOL CHEM, V34, P320, DOI 10.1016/j.compbiolchem.2010.09.002; Seo MJ, 2005, GYNECOL ONCOL, V96, P621, DOI 10.1016/j.ygyno.2004.11.032; Shen HB, 2007, AMINO ACIDS, V33, P57, DOI 10.1007/s00726-006-0478-8; Shen HB, 2009, ANAL BIOCHEM, V394, P269, DOI 10.1016/j.ab.2009.07.046; Shen YQ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-563; Shi RJ, 2011, PROTEIN PEPTIDE LETT, V18, P625, DOI 10.2174/092986611795222768; Shi SP, 2011, BBA-MOL CELL RES, V1813, P424, DOI 10.1016/j.bbamcr.2011.01.011; SMITH TF, 1980, NATURE, V285, P620, DOI 10.1038/285620a0; Wang J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024498; Wang P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018476; Wang T, 2010, PROTEIN PEPTIDE LETT, V17, P32, DOI 10.2174/092986610789909494; Wang W, 2011, PROTEIN PEPTIDE LETT, V18, P480, DOI 10.2174/092986611794927947; Xie D, 2005, NUCLEIC ACIDS RES, V33, pW105, DOI 10.1093/nar/gki359; Xu QA, 2011, IEEE ACM T COMPUT BI, V8, P748, DOI 10.1109/TCBB.2010.22; Yu NY, 2011, NUCLEIC ACIDS RES, V39, pD241, DOI 10.1093/nar/gkq1093; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249; Yu X., 2011, AMINO ACIDS; Yuan Z, 1999, FEBS LETT, V451, P23, DOI 10.1016/S0014-5793(99)00506-2; Zhang Y, 2010, ACTA BIOMATER, V6, P776, DOI 10.1016/j.actbio.2009.08.025; Zhang Y, 2009, BIOSCI BIOTECH BIOCH, V73, P1999, DOI 10.1271/bbb.90187; Zheng XQ, 2009, AMINO ACIDS, V37, P427, DOI 10.1007/s00726-008-0172-0; Zhou XB, 2008, AMINO ACIDS, V35, P383, DOI 10.1007/s00726-007-0608-y; Zou Lingyun, 2007, Journal of Genetics and Genomics, V34, P1080, DOI 10.1016/S1673-8527(07)60123-4	62	93	98	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2012	7	1							e31057	10.1371/journal.pone.0031057	http://dx.doi.org/10.1371/journal.pone.0031057			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	912BU	22303481	Green Submitted, gold, Green Published			2022-12-25	WOS:000301770300007
J	Shi, XD; Pan, Y; Wang, ML; Wang, DS; Li, WY; Jiang, T; Zhang, P; Chi, XM; Jiang, YF; Gao, YH; Zhong, J; Sun, B; Xu, DM; Jiang, J; Niu, JQ				Shi, Xiaodong; Pan, Yu; Wang, Moli; Wang, Dongsheng; Li, Wanyu; Jiang, Tao; Zhang, Peng; Chi, Xiumei; Jiang, Yanfang; Gao, Yanhang; Zhong, Jin; Sun, Bing; Xu, Damo; Jiang, Jing; Niu, Junqi			IL28B Genetic Variation Is Associated with Spontaneous Clearance of Hepatitis C Virus, Treatment Response, Serum IL-28B Levels in Chinese Population	PLOS ONE			English	Article							ALPHA-2B PLUS RIBAVIRIN; VIROLOGICAL RESPONSE; IFN-LAMBDA; INFECTION; THERAPY	Background: The interleukin-28B gene (IL28B) locus has been associated with host resistance to hepatitis C virus (HCV) infection and response to PEG-IFN/RBV treatment in western populations. This study was to determine whether this gene variant is also associated with spontaneous clearance of HCV infection, treatment response and IL-28B protein production in Chinese patients. Methods: We genotyped IL28B genetic variations (rs12980275, rs8103142, rs8099917 and rs12979860) by pyrosequencing DNA samples from cohorts consisting of 529 subjects with persistent HCV infection, 196 subjects who cleared the infection, 171 healthy individuals and 235 chronic HCV patients underwent IFN/RBV treatment. The expression of IL-28B were measured by ELISA and RT-PCR. Results: We found that the four IL28B variants were in complete linkage disequilibrium (r2 = 0.97-0.98). The rs12979860 CC genotype was strongly associated with spontaneously HCV clearance and successful IFN/RBV treatment compared to the CT/TT. IL-28B levels in persistent HCV patients were significantly lower than subjects who spontaneously resolved HCV and healthy controls and were also associated with high levels of ALT (alanine aminotransferase) and AST (aspartate aminotransferase). IL-28B levels were also significantly lower in individuals carrying T alleles than CC homozygous. Conclusions: Thus, the rs12979860-CC variant upstream of IL28B gene is associated with spontaneous clearance of HCV, susceptible to IFN/RBV treatment and increased IL-28B levels in this Chinese population.	[Shi, Xiaodong; Pan, Yu; Li, Wanyu; Zhang, Peng; Chi, Xiumei; Jiang, Yanfang; Gao, Yanhang; Niu, Junqi] Jilin Univ, Dept Hepatol, Hosp 1, Changchun 130023, Peoples R China; [Jiang, Jing] Jilin Univ, Dept Clin Epidemiol, Hosp 1, Changchun 130023, Peoples R China; [Zhong, Jin; Sun, Bing] Chinese Acad Sci, Inst Pasteur Shanghai, Shanghai, Peoples R China; [Wang, Dongsheng; Jiang, Tao] Hosp HepatologyBiliary Jilin Prov, Changchun, Peoples R China; [Xu, Damo] Univ Glasgow, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland; [Wang, Moli] Jilin Univ, Hosp 4, Changchun 130023, Peoples R China	Jilin University; Jilin University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP); University of Glasgow; Jilin University	Shi, XD (corresponding author), Jilin Univ, Dept Hepatol, Hosp 1, Changchun 130023, Peoples R China.	jiangjing19702000@yahoo.cn; junqiniu@yahoo.cn	Zhong, Jin/J-4613-2019; Wang, Mengqiang/A-1215-2010; zhi, zhouzhi/J-8063-2013; Yue, Feng/S-6565-2017; Zhong, Jin/M-6859-2018	Wang, Mengqiang/0000-0003-4702-3309; Zhong, Jin/0000-0002-3554-1275	Shanghai Pasteur Health Research Foundation [SPHRF2009001]; Eleventh 5-year National Key Programs on Infectious Disease [2008ZX10002-014]; National Natural Science Foundation of China [81001312/H1005, 81072347/H2609]; Jilin University [20101036]	Shanghai Pasteur Health Research Foundation; Eleventh 5-year National Key Programs on Infectious Disease; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jilin University(Jilin University)	This study was supported by grants from the Shanghai Pasteur Health Research Foundation (SPHRF2009001), the Eleventh 5-year National Key Programs on Infectious Disease (2008ZX10002-014), the National Natural Science Foundation of China under grants No 81001312/H1005 and 81072347/H2609 and the Graduate Innovation Fund of Jilin University (No. 20101036). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ank N, 2006, J VIROL, V80, P4501, DOI 10.1128/JVI.80.9.4501-4509.2006; Ank N, 2008, J IMMUNOL, V180, P2474, DOI 10.4049/jimmunol.180.4.2474; [Anonymous], 2002, NIH Consens State Sci Statements, V19, P1; Aparicio E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013771; Armstrong GL, 2006, ANN INTERN MED, V144, P705, DOI 10.7326/0003-4819-144-10-200605160-00004; Benvegnu L, 2004, GUT, V53, P744, DOI 10.1136/gut.2003.020263; Bruno S, 2008, ANN HEPATOL, V7, P114, DOI 10.1016/S1665-2681(19)31865-4; Davis GL, 2003, HEPATOLOGY, V38, P645, DOI 10.1053/jhep.2003.50364; Dolganiuc A, 2006, J IMMUNOL, V177, P6758, DOI 10.4049/jimmunol.177.10.6758; Doyle SE, 2006, HEPATOLOGY, V44, P896, DOI 10.1002/hep.21312; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Hadziyannis SJ, 2004, ANN INTERN MED, V140, P346, DOI 10.7326/0003-4819-140-5-200403020-00010; Hepburn MJ, 2004, AM J MED, V117, P163, DOI 10.1016/j.amjmed.2004.02.043; Huang CF, 2010, J GASTROEN HEPATOL, V25, P758, DOI 10.1111/j.1440-1746.2009.06148.x; Hwang SJ, 2001, J MED VIROL, V65, P505, DOI 10.1002/jmv.2064; Kenny-Walsh E, 1999, NEW ENGL J MED, V340, P1228, DOI 10.1056/NEJM199904223401602; Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875; Langhans B, 2011, J HEPATOL, V54, P859, DOI 10.1016/j.jhep.2010.08.020; Lavanchy D, 2009, LIVER INT, V29, P74, DOI 10.1111/j.1478-3231.2008.01934.x; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Marukian S, 2008, HEPATOLOGY, V48, P1843, DOI 10.1002/hep.22550; Missiha SB, 2008, GASTROENTEROLOGY, V134, P1699, DOI 10.1053/j.gastro.2008.02.069; Rauch A, 2010, EUR J CLIN INVEST, V40, P950, DOI 10.1111/j.1365-2362.2010.02337.x; Rauch A, 2010, GASTROENTEROLOGY, V138, P1338, DOI 10.1053/j.gastro.2009.12.056; Rauch A, 2009, PHARMACOGENOMICS, V10, P1819, DOI 10.2217/PGS.09.121; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Sarasin-Filipowicz M, 2008, P NATL ACAD SCI USA, V105, P7034, DOI 10.1073/pnas.0707882105; Sheppard P, 2003, NAT IMMUNOL, V4, P63, DOI 10.1038/ni873; Shiina M, 2008, HEPATOLOGY, V47, P385, DOI 10.1002/hep.21996; Sommereyns C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000017; Spann KM, 2005, J VIROL, V79, P5353, DOI 10.1128/JVI.79.9.5353-5362.2005; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Thio CL, 2000, HEPATOLOGY, V31, P819, DOI 10.1053/he.2000.4316; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Yu ML, 2009, J GASTROEN HEPATOL, V24, P336, DOI 10.1111/j.1440-1746.2009.05789.x; Zechini B, 2004, EUR J GASTROEN HEPAT, V16, P891, DOI 10.1097/00042737-200409000-00013	40	101	108	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e37054	10.1371/journal.pone.0037054	http://dx.doi.org/10.1371/journal.pone.0037054			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22649509	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000305335800027
J	Shi, XW; Zhou, Z; Wang, LL; Yue, F; Wang, MQ; Yang, CY; Song, LS				Shi, Xiaowei; Zhou, Zhi; Wang, Lingling; Yue, Feng; Wang, Mengqiang; Yang, Chuanyan; Song, Linsheng			The Immunomodulation of Acetylcholinesterase in Zhikong Scallop Chlamys farreri	PLOS ONE			English	Article							PERIPHERAL ANIONIC SITE; MOLECULAR CHARACTERIZATION; MUSCLE REGENERATION; INNATE IMMUNITY; NERVOUS-SYSTEM; RAT-BRAIN; EXPRESSION; INHIBITION; HEMOCYTES; RECEPTOR	Background: Acetycholinesterase (AChE; EC 3.1.1.7) is an essential hydrolytic enzyme in the cholinergic nervous system, which plays an important role during immunomodulation in vertebrates. Though AChEs have been identified in most invertebrates, the knowledge about immunomodulation function of AChE is still quite meagre in invertebrates. Methodology: A scallop AChE gene was identified from Chlamys farreri (designed as CfAChE), and its open reading frame encoded a polypeptide of 522 amino acids. A signal peptide, an active site triad, the choline binding site and the peripheral anionic sites (PAS) were identified in CfAChE. The recombinant mature polypeptide of CfAChE (rCfAChE) was expressed in Pichia pastoris GS115, and its activity was 71.3 +/- 1.3 U mg(-1) to catalyze the hydrolysis of acetylthiocholine iodide. The mRNA transcripts of CfAChE were detected in haemocytes, hepatopancreas, adductor muscle, mantle, gill, kidney and gonad, with the highest expression level in hepatopancreas. The relative expression level of CfAChE mRNA in haemocytes was both up-regulated after LPS (0.5 mg mL(-1)) and human TNF-alpha (50 ng mL(-1)) stimulations, and it reached the highest level at 12 h (10.4-fold, P<0.05) and 1 h (3.2-fold, P<0.05), respectively. After Dichlorvos (DDVP) (50 mg L-1) stimulation, the CfAChE activity in the supernatant of haemolymph decreased significantly from 0.16 U mg(-1) at 0 h to 0.03 U mg(-1) at 3 h, while the expression level of lysozyme in the haemocytes was up-regulated and reached the highest level at 6 h, which was 3.0-fold (P<0.05) of that in the blank group. Conclusions:The results collectively indicated that CfAChE had the acetylcholine-hydrolyzing activity, which was in line with the potential roles of AChE in the neuroimmune system of vertebrates which may help to re-balance the immune system after immune response.	[Shi, Xiaowei; Zhou, Zhi; Wang, Lingling; Yue, Feng; Wang, Mengqiang; Yang, Chuanyan; Song, Linsheng] Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao, Peoples R China; [Shi, Xiaowei; Zhou, Zhi; Yue, Feng; Wang, Mengqiang; Yang, Chuanyan] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Shi, XW (corresponding author), Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao, Peoples R China.	wanglingling@ms.qdio.ac.cn; lshsong@ms.qdio.ac.cn	Zhong, Jin/J-4613-2019; Wang, Mengqiang/A-1215-2010; zhi, zhouzhi/J-8063-2013; Yue, Feng/S-6565-2017; Zhong, Jin/M-6859-2018	Wang, Mengqiang/0000-0003-4702-3309; Zhong, Jin/0000-0002-3554-1275	Chinese Ministry of Science and Technology [2010CB126404]; National Natural Science Foundation of China [30925028, 30730070, 31072192]	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by National Basic Research Program of China (973 program, no. 2010CB126404) from Chinese Ministry of Science and Technology, and grants (No. 30925028 and 30730070 to LS, and 31072192 to LW) from National Natural Science Foundation of China, http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelini C, 2004, EUR J HISTOCHEM, V48, P235; Anguiano GA, 2010, ENVIRON TOXICOL, V25, P327, DOI 10.1002/tox.20491; Arpagaus M, 1998, J PHYSIOLOGY-PARIS, V92, P363, DOI 10.1016/S0928-4257(99)80006-0; Askar KA, 2011, APPL BIOCH BIOTECHNO; Azevedo-Pereira HMVS, 2011, ECOTOX ENVIRON SAFE, V74, P1210, DOI 10.1016/j.ecoenv.2011.03.018; Baxter GD, 1999, INT J PARASITOL, V29, P1765, DOI 10.1016/S0020-7519(99)00136-8; BERGMANN F, 1950, BIOCHIM BIOPHYS ACTA, V6, P217, DOI 10.1016/0006-3002(50)90094-1; Beutler B, 2003, NAT REV IMMUNOL, V3, P169, DOI 10.1038/nri1004; Beutler B, 2004, MOL IMMUNOL, V40, P845, DOI 10.1016/j.molimm.2003.10.005; Boudinot E, 2009, RESP PHYSIOL NEUROBI, V165, P40, DOI 10.1016/j.resp.2008.10.003; Bourne Y, 2003, EMBO J, V22, P1, DOI 10.1093/emboj/cdg005; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Branduardi D, 2005, J AM CHEM SOC, V127, P9147, DOI 10.1021/ja0512780; BULBRING E, 1953, PROC R SOC SER B-BIO, V141, P445, DOI 10.1098/rspb.1953.0053; Cao A, 2007, INT IMMUNOPHARMACOL, V7, P1395, DOI 10.1016/j.intimp.2007.07.008; Cheng T.C., 1981, INVERTEBRATE BLOOD C, V1, P223; Cheng Thomas C., 1996, P299; Costa MM, 2009, FISH SHELLFISH IMMUN, V26, P515, DOI 10.1016/j.fsi.2009.02.001; CYMBOROWSKI B, 1970, COMP BIOCHEM PHYSIOL, V32, P367, DOI 10.1016/0010-406X(70)90950-3; Das UN, 2007, MED SCI MONITOR, V13, pRA214; De Zoysa M, 2009, FISH SHELLFISH IMMUN, V26, P625, DOI 10.1016/j.fsi.2008.10.004; DEWHURST SA, 1975, COMP BIOCHEM PHYS C, V50, P53; DOUGHERTY DA, 1990, SCIENCE, V250, P1558, DOI 10.1126/science.2274786; Dvir H, 2010, CHEM-BIOL INTERACT, V187, P10, DOI 10.1016/j.cbi.2010.01.042; ELBERMANI AWI, 1978, J EMBRYOL EXP MORPH, V48, P177; HORNSTEIN EP, 1994, VISUAL NEUROSCI, V11, P989, DOI 10.1017/S0952523800003928; Johnson G, 2006, CURR PHARM DESIGN, V12, P217, DOI 10.2174/138161206775193127; Johnson JL, 2003, BIOCHEMISTRY-US, V42, P5438, DOI 10.1021/bi027065u; Jones AK, 2002, FASEB J, V16, P441, DOI 10.1096/fj.01-0683fje; Kang JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019063; Karczmar AG, 2010, CHEM-BIOL INTERACT, V187, P34, DOI 10.1016/j.cbi.2010.03.009; Kawli T, 2010, DIS MODEL MECH, V3, P721, DOI 10.1242/dmm.003871; KEYHANI E, 1981, J CELL SCI, V52, P327; KUSSATHE.E, 1967, HISTOCHEMISTRY, V8, P237, DOI 10.1007/BF00306086; Leone P, 2010, CHEM-BIOL INTERACT, V187, P49, DOI 10.1016/j.cbi.2010.01.030; Lin G, 2005, J BIOCHEM MOL TOXIC, V19, P234, DOI 10.1002/jbt.20087; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo CY, 2010, BIOCHEM PHARMACOL, V80, P1427, DOI 10.1016/j.bcp.2010.07.020; MCKENNA OC, 1968, CIRC RES, V23, P645, DOI 10.1161/01.RES.23.5.645; Monnet-Tschudi F, 2000, TOXICOL APPL PHARM, V165, P175, DOI 10.1006/taap.2000.8934; Nizri E, 2006, NEUROPHARMACOLOGY, V50, P540, DOI 10.1016/j.neuropharm.2005.10.013; ORON U, 1984, CELL MOL BIOL, V30, P411; Pegan K, 2010, CHEM-BIOL INTERACT, V187, P96, DOI 10.1016/j.cbi.2010.03.034; PITZURRA L, 1989, INFECT IMMUN, V57, P2452, DOI 10.1128/IAI.57.8.2452-2456.1989; QUAN N, 1994, J NEUROIMMUNOL, V49, P125, DOI 10.1016/0165-5728(94)90188-0; QUINN DM, 1987, CHEM REV, V87, P955, DOI 10.1021/cr00081a005; Rand James B, 2007, WormBook, P1; Rosas-Ballina M, 2009, J INTERN MED, V265, P663, DOI 10.1111/j.1365-2796.2009.02098.x; ROSENBERRY TL, 1975, ADV ENZYMOL RAMB, V43, P103; RYBICKA K, 1967, EXP PARASITOL, V20, P263, DOI 10.1016/0014-4894(67)90048-3; Salzet M, 2001, TRENDS IMMUNOL, V22, P285, DOI 10.1016/S1471-4906(01)01895-6; SCHWARTZ JH, 1975, J GEN PHYSIOL, V65, P255, DOI 10.1085/jgp.65.3.255; SERAVIN LN, 1965, DOKL AKAD NAUK SSSR+, V160, P486; STEITZ TA, 1982, ANNU REV BIOPHYS BIO, V11, P419, DOI 10.1146/annurev.bb.11.060182.002223; Szegletes T, 1998, BIOCHEMISTRY-US, V37, P4206, DOI 10.1021/bi972158a; Talesa V, 1999, J NEUROCHEM, V72, P1250, DOI 10.1046/j.1471-4159.1999.0721250.x; THIEDEMANN KU, 1986, CELL TISSUE RES, V244, P153; Travers MA, 2008, FISH SHELLFISH IMMUN, V24, P400, DOI 10.1016/j.fsi.2007.10.001; Tyagi E, 2010, EUR J PHARMACOL, V640, P206, DOI 10.1016/j.ejphar.2010.04.041; Tyagi E, 2008, J NEUROIMMUNOL, V205, P51, DOI 10.1016/j.jneuroim.2008.08.015; van Nierop P, 2006, J BIOL CHEM, V281, P1680, DOI 10.1074/jbc.M508571200; von Wachtendonk D., 1979, Comparative Biochemistry and Physiology C Comparative Pharmacology, V63, P279, DOI 10.1016/0306-4492(79)90074-1; Wang LL, 2009, FISH SHELLFISH IMMUN, V26, P744, DOI 10.1016/j.fsi.2009.03.002; WATSON JE, 1976, PFLUG ARCH EUR J PHY, V363, P161, DOI 10.1007/BF01062285; WHITTAKER JR, 1980, J EMBRYOL EXP MORPH, V55, P343; Wootton EC, 2003, FISH SHELLFISH IMMUN, V15, P195, DOI 10.1016/S1050-4648(02)00161-4; Xuereb B, 2009, AQUAT TOXICOL, V94, P114, DOI 10.1016/j.aquatox.2009.06.010; Yang JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017089; Zaitseva O V, 2008, Morfologiia, V133, P55; Zhang HA, 2010, FISH SHELLFISH IMMUN, V29, P149, DOI 10.1016/j.fsi.2010.02.024; Zhao PC, 2010, J BIOCHEM MOL TOXIC, V24, P51, DOI 10.1002/jbt.20311; Zhou XX, 2011, PROTEIN EXPRES PURIF, V77, P62, DOI 10.1016/j.pep.2010.11.017	72	101	108	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30828	10.1371/journal.pone.0030828	http://dx.doi.org/10.1371/journal.pone.0030828			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22649509	gold, Green Published, Green Submitted			2022-12-25	WOS:000301570600085
J	Sanchez-Vidal, A; Canals, M; Calafat, AM; Lastras, G; Pedrosa-Pamies, R; Menendez, M; Medina, R; Company, JB; Hereu, B; Romero, J; Alcoverro, T				Sanchez-Vidal, Anna; Canals, Miquel; Calafat, Antoni M.; Lastras, Galderic; Pedrosa-Pamies, Rut; Menendez, Melisa; Medina, Raul; Company, Joan B.; Hereu, Bernat; Romero, Javier; Alcoverro, Teresa			Impacts on the Deep-Sea Ecosystem by a Severe Coastal Storm	PLOS ONE			English	Article							MARINE-SEDIMENTS; ORGANIC-MATTER; INNER-SHELF; DYNAMICS; MODEL; PRESERVATION; OCEAN; GULF; SIZE	Major coastal storms, associated with strong winds, high waves and intensified currents, and occasionally with heavy rains and flash floods, are mostly known because of the serious damage they can cause along the shoreline and the threats they pose to navigation. However, there is a profound lack of knowledge on the deep-sea impacts of severe coastal storms. Concurrent measurements of key parameters along the coast and in the deep-sea are extremely rare. Here we present a unique data set showing how one of the most extreme coastal storms of the last decades lashing the Western Mediterranean Sea rapidly impacted the deep-sea ecosystem. The storm peaked the 26th of December 2008 leading to the remobilization of a shallow-water reservoir of marine organic carbon associated with fine particles and resulting in its redistribution across the deep basin. The storm also initiated the movement of large amounts of coarse shelf sediment, which abraded and buried benthic communities. Our findings demonstrate, first, that severe coastal storms are highly efficient in transporting organic carbon from shallow water to deep water, thus contributing to its sequestration and, second, that natural, intermittent atmospheric drivers sensitive to global climate change have the potential to tremendously impact the largest and least known ecosystem on Earth, the deep-sea ecosystem.	[Sanchez-Vidal, Anna; Canals, Miquel; Calafat, Antoni M.; Lastras, Galderic; Pedrosa-Pamies, Rut] Univ Barcelona, Grp Recerca Consilidat GRC Geociencies Marines, Dept Estratig Paleontol & Geociencies Marines, Barcelona, Spain; [Menendez, Melisa; Medina, Raul] Univ Cantabria, Inst Hidraul Ambiental IH Cantabria, E-39005 Santander, Spain; [Company, Joan B.] CSIC, Inst Ciencies Mar, Barcelona, Spain; [Hereu, Bernat; Romero, Javier] Univ Barcelona, Dept Ecol, E-08028 Barcelona, Spain; [Alcoverro, Teresa] CSIC, Ctr Estudis Avancats Blanes, Blanes, Spain	University of Barcelona; Universidad de Cantabria; IHCantabria - Instituto de Hidraulica Ambiental de la Universidad de Cantabria; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centre d'Estudis Avancats de Blanes (CEAB)	Sanchez-Vidal, A (corresponding author), Univ Barcelona, Grp Recerca Consilidat GRC Geociencies Marines, Dept Estratig Paleontol & Geociencies Marines, Barcelona, Spain.	anna.sanchez@ub.edu	Romero, Javier/A-8905-2013; Sanchez-Vidal, Anna/B-6919-2016; Menendez, Melisa/L-4600-2014; Pamies, Rut Pedrosa/I-1119-2015; Hereu, Bernat/K-9150-2015; Company, Joan B./K-7274-2014; Lastras, Galderic/A-6487-2013; Alcoverro, Teresa/J-9258-2012; Medina, Raul/L-2456-2014; Calafat, Antoni/J-5848-2017; Canals, Miquel/F-4922-2013; Etter, Andres/E-1860-2011	Romero, Javier/0000-0002-2772-8486; Sanchez-Vidal, Anna/0000-0002-8209-1959; Menendez, Melisa/0000-0002-5168-257X; Pamies, Rut Pedrosa/0000-0003-3504-4727; Hereu, Bernat/0000-0001-6247-7638; Company, Joan B./0000-0002-5878-7155; Lastras, Galderic/0000-0002-8756-3855; Alcoverro, Teresa/0000-0002-3910-9594; Medina, Raul/0000-0002-0126-2710; Calafat, Antoni/0000-0001-7927-3105; Canals, Miquel/0000-0001-5267-7601; Etter, Andres/0000-0003-0665-9300	European Community [226354, PERG04-GA-2008-239175]; Spanish project ROV-CANONES [CTM2009-06778]; Spanish project GRACCIE-CONSOLIDER [CSD2007-00067]; Spanish project DOS MARES [CTM2010-21810-C03]; Spanish project REDECO [CTM2008-04973-E]; Spanish project PIE-CSIC [200430E599]; Catalan Government Grups de Recerca Consolidats [2009 SGR 1305]	European Community(European Commission); Spanish project ROV-CANONES; Spanish project GRACCIE-CONSOLIDER; Spanish project DOS MARES; Spanish project REDECO; Spanish project PIE-CSIC; Catalan Government Grups de Recerca Consolidats	This work was supported by the European Community's Seventh Framework Programme projects HERMIONE (226354) and ARISTEUS (PERG04-GA-2008-239175), the Spanish projects ROV-CANONES (CTM2009-06778), GRACCIE-CONSOLIDER (CSD2007-00067), DOS MARES (CTM2010-21810-C03), REDECO (CTM2008-04973-E) and PIE-CSIC (200430E599) and a Catalan Government Grups de Recerca Consolidats grant (2009 SGR 1305). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnarson TS, 2007, GEOCHIM COSMOCHIM AC, V71, P3545, DOI 10.1016/j.gca.2007.04.027; Bolanos R, 2009, J MARINE SYST, V77, P237, DOI 10.1016/j.jmarsys.2007.12.018; Canals M, 2004, MAR GEOL, V213, P9, DOI 10.1016/j.margeo.2004.10.001; Canals M, 2006, NATURE, V444, P354, DOI 10.1038/nature05271; Company JB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001431; Dee DP, 2009, Q J ROY METEOR SOC, V135, P1830, DOI 10.1002/qj.493; Dickens AF, 2006, GEOCHIM COSMOCHIM AC, V70, P666, DOI 10.1016/j.gca.2005.10.024; Ferre B, 2005, CONT SHELF RES, V25, P2410, DOI 10.1016/j.csr.2005.08.017; FRY B, 1984, CONTRIB MAR SCI, V27, P13; Galy V, 2007, NATURE, V450, P407, DOI 10.1038/nature06273; Garcia-Rubies A, 2009, PLIN C; Guillen J, 2006, MAR GEOL, V234, P129, DOI 10.1016/j.margeo.2006.09.018; Guillen J, 2000, SCI MAR, V64, P427, DOI 10.3989/scimar.2000.64n4427; HEDGES JI, 1995, MAR CHEM, V49, P81, DOI 10.1016/0304-4203(95)00008-F; Hedges JI, 1997, ORG GEOCHEM, V27, P195, DOI 10.1016/S0146-6380(97)00066-1; HEUSSNER S, 1990, CONT SHELF RES, V10, P943, DOI 10.1016/0278-4343(90)90069-X; Hilton RG, 2008, NAT GEOSCI, V1, P759, DOI 10.1038/ngeo333; Keil RG, 1998, GEOCHIM COSMOCHIM AC, V62, P1347, DOI 10.1016/S0016-7037(98)00080-5; Kennedy H, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2010GB003848; Lastras G, 2011, MAR GEOL, V280, P20, DOI 10.1016/j.margeo.2010.11.005; Li MZ, 2001, COMPUT GEOSCI-UK, V27, P619, DOI 10.1016/S0098-3004(00)00120-5; Lionello P, 2006, DEV EARTH ENV SCI, V4, P5463; Marcos M, 2011, GLOBAL PLANET CHANGE, V77, P116, DOI 10.1016/j.gloplacha.2011.04.002; MAYER LM, 1994, GEOCHIM COSMOCHIM AC, V58, P1271, DOI 10.1016/0016-7037(94)90381-6; Mendoza ET, 2009, P I CIVIL ENG-MAR EN, V162, P127, DOI 10.1680/maen.2009.162.3.127; Navarro L, 2011, ESTUAR COAST SHELF S, V95, P52, DOI 10.1016/j.ecss.2011.08.002; Skamarock W.C., 2008, NCARTN475STR, DOI [10.5065/D68S4MVH, DOI 10.5065/D68S4MVH]; Somot S, 2006, CLIM DYNAM, V27, P851, DOI 10.1007/s00382-006-0167-z; Tolman HL, 2002, 222 NOAA NWS NCEP MM, P133; Ulbrich U, 2009, THEOR APPL CLIMATOL, V96, P117, DOI 10.1007/s00704-008-0083-8; Young IR, 2011, SCIENCE, V332, P451, DOI 10.1126/science.1197219	31	158	166	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e30395	10.1371/journal.pone.0030395	http://dx.doi.org/10.1371/journal.pone.0030395			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910ME	22952816	Green Published, gold			2022-12-25	WOS:000301640600029
J	Johnson, RM; Mao, WF; Pollock, HS; Niu, GD; Schuler, MA; Berenbaum, MR				Johnson, Reed M.; Mao, Wenfu; Pollock, Henry S.; Niu, Guodong; Schuler, Mary A.; Berenbaum, May R.			Ecologically Appropriate Xenobiotics Induce Cytochrome P450s in Apis mellifera	PLOS ONE			English	Article							HELICOVERPA-ARMIGERA HUBNER; DRUG-METABOLIZING-ENZYMES; FALL ARMYWORM LARVAE; HONEY-BEE; DROSOPHILA-MELANOGASTER; PYRETHROID INSECTICIDE; MOLECULAR-CLONING; DETOXIFYING ENZYMES; RESISTANT STRAINS; MICROARRAY DATA	Background: Honey bees are exposed to phytochemicals through the nectar, pollen and propolis consumed to sustain the colony. They may also encounter mycotoxins produced by Aspergillus fungi infesting pollen in beebread. Moreover, bees are exposed to agricultural pesticides, particularly in-hive acaricides used against the parasite Varroa destructor. They cope with these and other xenobiotics primarily through enzymatic detoxificative processes, but the regulation of detoxificative enzymes in honey bees remains largely unexplored. Methodology/Principal Findings: We used several approaches to ascertain effects of dietary toxins on bee susceptibility to synthetic and natural xenobiotics, including the acaricide tau-fluvalinate, the agricultural pesticide imidacloprid, and the naturally occurring mycotoxin aflatoxin. We administered potential inducers of cytochrome P450 enzymes, the principal biochemical system for Phase 1 detoxification in insects, to investigate how detoxification is regulated. The drug phenobarbital induces P450s in many insects, yet feeding bees with phenobarbital had no effect on the toxicity of taufluvalinate, a pesticide known to be detoxified by bee P450s. Similarly, no P450 induction, as measured by tau-fluvalinate tolerance, occurred in bees fed xanthotoxin, salicylic acid, or indole-3-carbinol, all of which induce P450s in other insects. Only quercetin, a common pollen and honey constituent, reduced tau-fluvalinate toxicity. In microarray comparisons no change in detoxificative gene expression was detected in phenobarbital-treated bees. However, northern blot analyses of guts of bees fed extracts of honey, pollen and propolis showed elevated expression of three CYP6AS P450 genes. Diet did not influence tau-fluvalinate or imidacloprid toxicity in bioassays; however, aflatoxin toxicity was higher in bees consuming sucrose or high-fructose corn syrup than in bees consuming honey. Conclusions/Significance: These results suggest that regulation of honey bee P450s is tuned to chemicals occurring naturally in the hive environment and that, in terms of toxicological capacity, a diet of sugar is not equivalent to a diet of honey.	[Johnson, Reed M.; Mao, Wenfu; Pollock, Henry S.; Niu, Guodong; Berenbaum, May R.] Univ Illinois, Dept Entomol, Urbana, IL USA; [Schuler, Mary A.] Univ Illinois, Dept Cell & Dev Biol, Urbana, IL USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Johnson, RM (corresponding author), Ohio State Univ, Ohio Agr Res & Dev Ctr, Dept Entomol, Wooster, OH 44691 USA.	johnson.5005@osu.edu	Johnson, Reed M./H-3742-2011; Niu, Guodong/E-5846-2012	Johnson, Reed M./0000-0002-2431-0180; Niu, Guodong/0000-0002-1406-6698; Johnson, Rebecca/0000-0003-2249-2643	United States Department of Agriculture, Agriculture and Food Research Initiative (USDA-AFRI)	United States Department of Agriculture, Agriculture and Food Research Initiative (USDA-AFRI)(United States Department of Agriculture (USDA))	United States Department of Agriculture, Agriculture and Food Research Initiative (USDA-AFRI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGOSIN M, 1976, MOL CELL BIOCHEM, V12, P33, DOI 10.1007/BF01731901; Amichot M, 1998, COMP BIOCHEM PHYS C, V121, P311, DOI 10.1016/S0742-8413(98)10052-X; Anspaugh DD, 2005, J INSECT PHYSIOL, V51, P523, DOI 10.1016/j.jinsphys.2004.12.008; Berenbaum M.R., 1990, P257; BRATTSTEN LB, 1975, BIOCHEM J, V150, P97, DOI 10.1042/bj1500097; Brodschneider R, 2010, APIDOLOGIE, V41, P278, DOI 10.1051/apido/2010012; Brown D, 2003, ARCH INSECT BIOCHEM, V53, P119, DOI 10.1002/arch.10089; Brun A, 1996, INSECT BIOCHEM MOLEC, V26, P697, DOI 10.1016/S0965-1748(96)00036-7; BULL DL, 1986, J CHEM ECOL, V12, P885, DOI 10.1007/BF01020258; Calderone, 2000, BEE CULT, V128, P1, DOI DOI 10.3896/IBRA.1.49.1.01; Campos M, 1997, PHYTOCHEM ANALYSIS, V8, P181, DOI 10.1002/(SICI)1099-1565(199707)8:4&lt;181::AID-PCA359&gt;3.0.CO;2-A; CARINO FA, 1994, INSECT BIOCHEM MOLEC, V24, P411, DOI 10.1016/0965-1748(94)90034-5; Claudianos C, 2006, INSECT MOL BIOL, V15, P615, DOI 10.1111/j.1365-2583.2006.00672.x; COHEN MB, 1992, P NATL ACAD SCI USA, V89, P10920, DOI 10.1073/pnas.89.22.10920; Cresswell JE, 2011, ECOTOXICOLOGY, V20, P149, DOI 10.1007/s10646-010-0566-0; Danielson PB, 1997, P NATL ACAD SCI USA, V94, P10797, DOI 10.1073/pnas.94.20.10797; DENISON MS, 1995, J BIOL CHEM, V270, P18175, DOI 10.1074/jbc.270.31.18175; Dunkov BC, 1997, DNA CELL BIOL, V16, P1345, DOI 10.1089/dna.1997.16.1345; Felsenstein J, PHYLIP PHYLOGENY INF; Feyereisen R., 2005, P1; ffrench-Constant RH, 2004, TRENDS GENET, V20, P163, DOI 10.1016/j.tig.2004.01.003; Finney D.J., 1971, PROBIT ANAL; Fisher T, 2003, ECOTOX ENVIRON SAFE, V54, P1, DOI 10.1016/S0147-6513(02)00031-3; Furgala B., 1992, HIVE HONEY BEE, P829; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gonzalez G, 2005, INT J FOOD MICROBIOL, V105, P1, DOI 10.1016/j.ijfoodmicro.2005.05.001; GUIRGUIS GN, 1976, ENVIRON ENTOMOL, V5, P590, DOI 10.1093/ee/5.3.590; Hardstone MC, 2010, PEST MANAG SCI, V66, P1171, DOI 10.1002/ps.2001; Johansen C.A., 1990, POLLINATOR PROTECTIO; Johnson RM, 2006, J ECON ENTOMOL, V99, P1046, DOI 10.1603/0022-0493-99.4.1046; Johnson RM, 2010, APIDOLOGIE, V41, P312, DOI 10.1051/apido/2010018; Johnson RM, 2009, J ECON ENTOMOL, V102, P474, DOI 10.1603/029.102.0202; Kasai S, 2001, INSECT BIOCHEM MOLEC, V32, P1, DOI 10.1016/S0965-1748(01)00073-X; Kenjeric D, 2007, FOOD CHEM, V102, P683, DOI 10.1016/j.foodchem.2006.05.055; KEZIC N, 1992, APIDOLOGIE, V23, P217, DOI 10.1051/apido:19920304; King-Jones K, 2005, NAT REV GENET, V6, P311, DOI 10.1038/nrg1581; Le Goff G, 2006, INSECT BIOCHEM MOLEC, V36, P674, DOI 10.1016/j.ibmb.2006.05.009; LeBlanc BW, 2009, J AGR FOOD CHEM, V57, P7369, DOI 10.1021/jf9014526; Lewis DFV, 2002, J CHEM TECHNOL BIOT, V77, P1095, DOI 10.1002/jctb.648; Li XC, 2002, NATURE, V419, P712, DOI 10.1038/nature01003; Li XC, 2000, INSECT BIOCHEM MOLEC, V30, P75, DOI 10.1016/S0965-1748(99)00102-2; Li XC, 2007, ANNU REV ENTOMOL, V52, P231, DOI 10.1146/annurev.ento.51.110104.151104; Liu FL, 2006, BEHAV ECOL SOCIOBIOL, V59, P582, DOI 10.1007/s00265-005-0084-x; Liu XN, 2006, PESTIC BIOCHEM PHYS, V84, P127, DOI 10.1016/j.pestbp.2005.06.002; Mao WF, 2006, J CHEM ECOL, V32, P523, DOI 10.1007/s10886-005-9018-3; Mao WF, 2011, P NATL ACAD SCI USA, V108, P12657, DOI 10.1073/pnas.1109535108; Mao WF, 2009, COMP BIOCHEM PHYS B, V154, P427, DOI 10.1016/j.cbpb.2009.08.008; Medina A, 2004, SYST APPL MICROBIOL, V27, P261, DOI 10.1078/072320204322881880; Mullin CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009754; Natsuhara K, 2004, PESTIC BIOCHEM PHYS, V79, P33, DOI 10.1016/j.pestbp.2004.04.002; NEBERT DW, 1987, ANNU REV BIOCHEM, V56, P945, DOI 10.1146/annurev.biochem.56.1.945; Niu GD, 2011, APIDOLOGIE, V42, P79, DOI 10.1051/apido/2010039; Oakeshott JG, 2010, INSECT MOL BIOL, V19, P147, DOI 10.1111/j.1365-2583.2009.00961.x; Oshlack A, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r2; PILLING ED, 1995, PESTIC BIOCHEM PHYS, V51, P1, DOI 10.1006/pest.1995.1001; PILLING ED, 1993, PESTIC SCI, V39, P293, DOI 10.1002/ps.2780390407; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ranasinghe C, 1999, INSECT MOL BIOL, V8, P443, DOI 10.1046/j.1365-2583.1999.00135.x; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; REMMER H, 1963, SCIENCE, V142, P1657, DOI 10.1126/science.142.3600.1657; RISKALLAH MR, 1986, PESTIC BIOCHEM PHYS, V25, P233, DOI 10.1016/0048-3575(86)90050-7; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Schell R, 2005, AM BEE J, V145, P392; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; SCOTT JG, 1993, INSECT BIOCHEM MOLEC, V23, P729, DOI 10.1016/0965-1748(93)90047-V; Sen Zeng R, 2007, J CHEM ECOL, V33, P449, DOI 10.1007/s10886-006-9238-1; Simone-Finstrom M, 2010, APIDOLOGIE, V41, P295, DOI 10.1051/apido/2010016; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; SNYDER MJ, 1995, ARCH BIOCHEM BIOPHYS, V321, P13, DOI 10.1006/abbi.1995.1362; Stevens JL, 2000, INSECT BIOCHEM MOLEC, V30, P559, DOI 10.1016/S0965-1748(00)00024-2; Suchail S, 2000, ENVIRON TOXICOL CHEM, V19, P1901, DOI [10.1897/1551-5028(2000)019&lt;1901:COITIT&gt;2.3.CO;2, 10.1002/etc.5620190726]; Suchail S, 2004, PEST MANAG SCI, V60, P291, DOI 10.1002/ps.772; Sun W, 2006, INSECT MOL BIOL, V15, P455, DOI 10.1111/j.1365-2583.2006.00662.x; Tanaka E, 1999, J CLIN PHARM THER, V24, P87, DOI 10.1046/j.1365-2710.1999.00201.x; TERRIERE LC, 1974, J AGR FOOD CHEM, V22, P366, DOI 10.1021/jf60193a057; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Treutter D, 2005, PLANT BIOLOGY, V7, P581, DOI 10.1055/s-2005-873009; Tushar T, 2007, BASIC CLIN PHARMACOL, V100, P269, DOI 10.1111/j.1742-7843.2006.00039.x; VanEngelsdorp D, 2007, AM BEE J, V147, P603; Venables W.N., 2002, MODERN APPL STAT S, V4th ed, DOI DOI 10.1007/978-0-387-21706-2; Wanner KW, 2007, P NATL ACAD SCI USA, V104, P14383, DOI 10.1073/pnas.0705459104; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; WIERMANN R, 1968, BER DEUT BOT GES, V81, P3; WILKINSON CF, 1972, DRUG METAB REV, V1, P153, DOI 10.3109/03602537208993912; Willoughby L, 2006, INSECT BIOCHEM MOLEC, V36, P934, DOI 10.1016/j.ibmb.2006.09.004; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; YU SJ, 1983, PESTIC BIOCHEM PHYS, V19, P330, DOI 10.1016/0048-3575(83)90061-5; YU SJ, 1984, PESTIC BIOCHEM PHYS, V22, P360, DOI 10.1016/0048-3575(84)90029-4; YU SJ, 1984, COMP BIOCHEM PHYS C, V78, P145, DOI 10.1016/0742-8413(84)90062-8; YU SJ, 1995, ARCH INSECT BIOCHEM, V28, P365, DOI 10.1002/arch.940280406	90	153	158	2	126	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2012	7	2							e31051	10.1371/journal.pone.0031051	http://dx.doi.org/10.1371/journal.pone.0031051			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LO	22319603	Green Published, gold, Green Submitted			2022-12-25	WOS:000302178400026
J	Wang, YS; Chou, WW; Chen, KC; Cheng, HY; Lin, RT; Juo, SHH				Wang, Yung-Song; Chou, Wen-Wen; Chen, Ku-Chung; Cheng, Hsin-Yun; Lin, Ruey-Tay; Juo, Suh-Hang Hank			microRNA-152 Mediates DNMT1-Regulated DNA Methylation in the Estrogen Receptor alpha Gene	PLOS ONE			English	Article							MUSCLE-CELL-PROLIFERATION; ATHEROSCLEROSIS; EXPRESSION; HYPOMETHYLATION; INHIBITION; DISEASE; INFLAMMATION; MECHANISMS; MIGRATION; DNMT3B	Background: Estrogen receptor alpha (ER alpha) has been shown to protect against atherosclerosis. Methylation of the ER alpha gene can reduce ER alpha expression leading to a higher risk for cardiovascular disease. Recently, microRNAs have been found to regulate DNA methyltransferases (DNMTs) and thus control methylation status in several genes. We first searched for microRNAs involved in DNMT-associated DNA methylation in the ER alpha gene. We also tested whether statin and a traditional Chinese medicine (San-Huang-Xie-Xin-Tang, SHXXT) could exert a therapeutic effect on microRNA, DNMT and ER alpha methylation. Methodology/Principal Findings: The ER alpha expression was decreased and ER alpha methylation was increased in LPS-treated human aortic smooth muscle cells (HASMCs) and the aorta from rats under a high-fat diet. microRNA-152 was found to be down regulated in the LPS-treated HASMCs. We validated that microRNA-152 can knock down DNMT1 in HASMCs leading to hypermethylation of the ER alpha gene. Statin had no effect on microRNA-152, DNMT1 or ER alpha expression. On the contrary, SHXXT could restore microRNA-152, decrease DNMT1 and increase ER alpha expression in both cellular and animal studies. Conclusions/Significance: The present study showed that microRNA-152 decreases under the pro-atherosclerotic conditions. The reduced microRNA-152 can lose an inhibitory effect on DNA methyltransferase, which leads to hypermethylation of the ER alpha gene and a decrease of ER alpha level. Although statin can not reverse these cascade proatherosclerotic changes, the SHXXT shows a promising effect to inhibit this unwanted signaling pathway.	[Wang, Yung-Song; Chou, Wen-Wen; Chen, Ku-Chung; Cheng, Hsin-Yun; Juo, Suh-Hang Hank] Kaohsiung Med Univ, Dept Med Genet, Kaohsiung, Taiwan; [Lin, Ruey-Tay] Kaohsiung Med Univ, Dept Neurol, Kaohsiung, Taiwan; [Lin, Ruey-Tay] Kaohsiung Med Univ Hosp, Dept Neurol, Kaohsiung, Taiwan; [Juo, Suh-Hang Hank] Kaohsiung Med Univ Hosp, Dept Med Res, Kaohsiung, Taiwan; [Juo, Suh-Hang Hank] Kaohsiung Med Univ Hosp, Ctr Canc, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital	Wang, YS (corresponding author), Kaohsiung Med Univ, Dept Med Genet, Kaohsiung, Taiwan.	tay@kmu.edu.tw; hjuo@kmu.edu.tw	Juo, Suh-Hang/C-9545-2009; Liu, Xingyue/A-3019-2013	Gao, Yanzheng/0000-0002-3814-3555; Liu, Xingyue/0000-0002-9168-0659	Ministry of Economic Affairs (Taiwan, R.O.C.) [98-EC-17-A-20-S1-134]; National Science Council (Taiwan, R.O.C.) [NSC 99-2628-B-037-037-MY3]; National Health Research Institutes (Taiwan, R.O.C.) [NHRI-Ex96-9607PI]; Department of Health, Executive Yuan (Taiwan, R.O.C.) [DOH99-TD-C-111-002]; Kaohsiung Medical University Hospital [KMUH98-8I11, KMUH99-9M19]	Ministry of Economic Affairs (Taiwan, R.O.C.)(Ministry of Economic Affairs, Taiwan); National Science Council (Taiwan, R.O.C.)(Ministry of Science and Technology, Taiwan); National Health Research Institutes (Taiwan, R.O.C.)(National Health Research Institutes - Taiwan); Department of Health, Executive Yuan (Taiwan, R.O.C.); Kaohsiung Medical University Hospital	This work was supported by the following grants: No. 98-EC-17-A-20-S1-134 from the Ministry of Economic Affairs (Taiwan, R.O.C., Website: www.moea.gov.tw), NSC 99-2628-B-037-037-MY3 from the National Science Council (Taiwan, R.O.C., Website: web1.nsc.gov.tw), NHRI-Ex96-9607PI from the National Health Research Institutes (Taiwan, R.O.C., Website: www.nhri.org.tw), Excellence for Cancer Research Center Grant (DOH99-TD-C-111-002) from the Department of Health, Executive Yuan (Taiwan, R.O.C., Website: www.doh.gov.tw), and Kaohsiung Medical University Hospital intramural grants (KMUH98-8I11 and KMUH99-9M19; Website: www.kmuh.org.tw). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham ST, 1997, CIRC RES, V81, P575, DOI 10.1161/01.RES.81.4.575; Ashton AW, 1999, J BIOL CHEM, V274, P35562, DOI 10.1074/jbc.274.50.35562; Braconi C, 2010, HEPATOLOGY, V51, P881, DOI 10.1002/hep.23381; Chen KC, 2011, FASEB J; Christian RC, 2006, J CLIN ENDOCR METAB, V91, P2713, DOI 10.1210/jc.2005-2672; Diomede L, 2001, ARTERIOSCL THROM VAS, V21, P1327, DOI 10.1161/hq0801.094222; Dong CM, 2002, J NUTR, V132, p2406S, DOI 10.1093/jn/132.8.2406S; Duursma AM, 2008, RNA, V14, P872, DOI 10.1261/rna.972008; Fabbri M, 2007, P NATL ACAD SCI USA, V104, P15805, DOI 10.1073/pnas.0707628104; Farmer J A, 2000, Curr Atheroscler Rep, V2, P208, DOI 10.1007/s11883-000-0022-3; Gitan RS, 2002, GENOME RES, V12, P158, DOI 10.1101/gr.202801; Hiltunen M, 2002, VASC MED, V7, P5, DOI 10.1191/1358863x02vm418oa; Hiltunen MO, 2003, ARTERIOSCL THROM VAS, V23, P1750, DOI 10.1161/01.ATV.0000092871.30563.41; Huang JF, 2010, HEPATOLOGY, V52, P60, DOI 10.1002/hep.23660; Jiang YD, 2007, DNA CELL BIOL, V26, P603, DOI 10.1089/dna.2007.0584; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Laukkanen MO, 1999, ARTERIOSCL THROM VAS, V19, P2171, DOI 10.1161/01.ATV.19.9.2171; Lee ME, 1999, TRENDS CARDIOVAS MED, V9, P49, DOI 10.1016/S1050-1738(99)00002-X; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Libby P, 2002, NAT MED, V8, P1257, DOI 10.1038/nm1102-1257; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261; Lund G, 2004, J BIOL CHEM, V279, P29147, DOI 10.1074/jbc.M403618200; Matouk CC, 2008, CIRC RES, V102, P873, DOI 10.1161/CIRCRESAHA.107.171025; Millette E, 2005, CIRC RES, V96, P172, DOI 10.1161/01.RES.0000154595.87608.db; Nakamura Y, 2004, MOL CELL ENDOCRINOL, V219, P17, DOI 10.1016/j.mce.2004.02.013; Newman PE, 1999, MED HYPOTHESES, V53, P421, DOI 10.1054/mehy.1998.0794; Nishimura T, 2003, CIRCULATION, V108, P1640, DOI 10.1161/01.CIR.0000087592.47401.37; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Okubo T, 2000, ENDOCR J, V47, P205, DOI 10.1507/endocrj.47.205; Porter KE, 2002, J VASC SURG, V36, P150, DOI 10.1067/mva.2002.122029; Post WS, 1999, CARDIOVASC RES, V43, P985, DOI 10.1016/S0008-6363(99)00153-4; Pussinen PJ, 2007, ARTERIOSCL THROM VAS, V27, P1433, DOI 10.1161/ATVBAHA.106.138743; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Rubanyi GM, 2002, VASC PHARMACOL, V38, P81, DOI 10.1016/S0306-3623(02)00130-1; Schwartz SM, 1997, J CLIN INVEST, V100, pS87; Seeger H, 2001, MENOPAUSE, V8, P5, DOI 10.1097/00042192-200101000-00003; Sharma P, 2008, DNA CELL BIOL, V27, P357, DOI 10.1089/dna.2007.0694; Turunen MP, 2009, BBA-GEN SUBJECTS, V1790, P886, DOI 10.1016/j.bbagen.2009.02.008; Wang YS, 2011, J ETHNOPHARMACOL, V133, P442, DOI 10.1016/j.jep.2010.10.018; Yang AS, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh032; Ying AK, 2000, CARDIOVASC RES, V46, P172, DOI 10.1016/S0008-6363(00)00004-3	42	139	154	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e30635	10.1371/journal.pone.0030635	http://dx.doi.org/10.1371/journal.pone.0030635			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910ME	23139811	Green Submitted, Green Published, gold			2022-12-25	WOS:000301640600043
J	Chen, L; Huang, LZ; Min, DH; Phillips, A; Wang, SQ; Madgwick, PJ; Parry, MAJ; Hu, YG				Chen, Liang; Huang, Linzhou; Min, Donghong; Phillips, Andy; Wang, Shiqiang; Madgwick, Pippa J.; Parry, Martin A. J.; Hu, Yin-Gang			Development and Characterization of a New TILLING Population of Common Bread Wheat (Triticum aestivum L.)	PLOS ONE			English	Article							CHEMICALLY-INDUCED MUTATIONS; DETECT INDUCED MUTATIONS; GENE-FUNCTION; INSERTIONAL MUTAGENESIS; FUNCTIONAL GENOMICS; POINT MUTATIONS; INDUCED MUTANTS; DISCOVERY; RESOURCE; RICE	Mutagenesis is an important tool in crop improvement. However, the hexaploid genome of wheat (Triticum aestivum L.) presents problems in identifying desirable genetic changes based on phenotypic screening due to gene redundancy. TILLING (Targeting Induced Local Lesions IN Genomes), a powerful reverse genetic strategy that allows the detection of induced point mutations in individuals of the mutagenized populations, can address the major challenge of linking sequence information to the biological function of genes and can also identify novel variation for crop breeding. Wheat is especially well-suited for TILLING due to the high mutation densities tolerated by polyploids. However, only a few wheat TILLING populations are currently available in the world, which is far from satisfying the requirement of researchers and breeders in different growing environments. In addition, current TILLING screening protocols require costly fluorescence detection systems, limiting their use, especially in developing countries. We developed a new TILLING resource comprising 2610 M-2 mutants in a common wheat cultivar 'Jinmai 47'. Numerous phenotypes with altered morphological and agronomic traits were observed from the M-2 and M-3 lines in the field. To simplify the procedure and decrease costs, we use unlabeled primers and either non-denaturing polyacrylamide gels or agarose gels for mutation detection. The value of this new resource was tested using PCR with RAPD and Intron-spliced junction (ISJ) primers, and also TILLING in three selected candidate genes, in 300 and 512 mutant lines, revealing high mutation densities of 1/34 kb by RAPD/ISJ analysis and 1/47 kb by TILLING. In total, 31 novel alleles were identified in the 3 targeted genes and confirmed by sequencing. The results indicate that this mutant population represents a useful resource for the wheat research community. We hope that the use of this reverse genetics resource will provide novel allelic diversity for wheat improvement and functional genomics.	[Chen, Liang; Huang, Linzhou; Min, Donghong; Wang, Shiqiang; Hu, Yin-Gang] NW A&F Univ, Coll Agron, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China; [Phillips, Andy; Madgwick, Pippa J.; Parry, Martin A. J.] Rothamsted Res, Dept Plant Sci, Ctr Crop Genet Improvement, Harpenden, Herts, England; NW A&F Univ, Inst Water Saving Agr Arid Reg China, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; Northwest A&F University - China	Hu, YG (corresponding author), NW A&F Univ, Coll Agron, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China.	huyingang@nwsuaf.edu.cn	Chen, Lei/A-2275-2011	Chen, Lei/0000-0003-3068-1583; Parry, Martin/0000-0002-4477-672X; cai, yudong/0000-0001-5664-7979	Ministry of Science and Technology [2006AA100201, 2006AA100223, 2006CB708208]; 111 Program of Introducing Talents of Discipline to Universities P. R. China [111-2-16]; ACIAR Project of Australia [CIM/2005/111]; Biotechnology and Biological Sciences Research Council [BBS/E/C/00004820, BBS/E/C/00005202, BBS/E/C/00004952, BB/E025161/1, BB/I000607/1] Funding Source: researchfish	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); 111 Program of Introducing Talents of Discipline to Universities P. R. China; ACIAR Project of Australia(Australian Ctr Intl Agr Res); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the sub-project of the 863 Program (2006AA100201, 2006AA100223), the pre-phase project of the 973 Program (2006CB708208) of the Ministry of Science and Technology, and the 111 Program of Introducing Talents of Discipline to Universities (111-2-16), P. R. China, as well as the ACIAR Project (CIM/2005/111) of Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldrich C, 1993, PLANT MOL BIOL REP, V11, P128, DOI DOI 10.1007/BF02670471; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; BASSAM BJ, 1991, ANAL BIOCHEM, V196, P80, DOI 10.1016/0003-2697(91)90120-I; Bentley A, 2000, GENETICS, V156, P1169; Bibi S, 2009, PAK J BOT, V41, P1022; Caldwell DG, 2004, PLANT J, V40, P143, DOI 10.1111/j.1365-313X.2004.02190.x; Chawade A, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-86; Chen LA, 2011, AUST J CROP SCI, V5, P318; Chua NH, 2006, CURR OPIN BIOTECH, V17, P103, DOI 10.1016/j.copbio.2006.03.002; Cooper JL, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-9; Dahmani-Mardas F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015776; Dong CM, 2009, PLANT GENOME-US, V2, P39, DOI 10.3835/plantgenome2008.10.0012; Eversole K, 2009, ANN WHEAT N IN PRESS, P55; Fox JL, 2004, NAT BIOTECHNOL, V22, P1062, DOI 10.1038/nbt0904-1062; Fu DL, 2007, TRANSGENIC RES, V16, P689, DOI 10.1007/s11248-007-9150-7; Gonzalez FG, 2005, EUPHYTICA, V146, P253, DOI 10.1007/s10681-005-9021-3; Gottwald Sven, 2009, BMC Res Notes, V2, P258, DOI 10.1186/1756-0500-2-258; Greene EA, 2003, GENETICS, V164, P731; HALLORAN GM, 1982, ANN BOT-LONDON, V49, P115, DOI 10.1093/oxfordjournals.aob.a086220; Henikoff S, 2004, PLANT PHYSIOL, V135, P630, DOI 10.1104/pp.104.041061; Hirochika H, 2001, CURR OPIN PLANT BIOL, V4, P118, DOI 10.1016/S1369-5266(00)00146-1; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Jeon JS, 2000, PLANT J, V22, P561, DOI 10.1046/j.1365-313x.2000.00767.x; Knoll JE, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-81; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; McCallum CM, 2000, PLANT PHYSIOL, V123, P439, DOI 10.1104/pp.123.2.439; MERRIL CR, 1984, ELECTROPHORESIS, V5, P289, DOI 10.1002/elps.1150050509; Minoia Silvia, 2010, BMC Res Notes, V3, P69, DOI 10.1186/1756-0500-3-69; Muth J, 2008, PLANT BIOTECHNOL J, V6, P576, DOI 10.1111/j.1467-7652.2008.00340.x; Naghavi Mohammad Reza, 2004, Iranian Journal of Biotechnology, V2, P195; Nomura T, 2005, P NATL ACAD SCI USA, V102, P16490, DOI 10.1073/pnas.0505156102; Oleykowski CA, 1998, NUCLEIC ACIDS RES, V26, P4597, DOI 10.1093/nar/26.20.4597; Parry MAJ, 2009, J EXP BOT, V60, P2817, DOI 10.1093/jxb/erp189; Piron F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011313; Przetakiewicz J, 2002, CELL MOL BIOL LETT, V7, P671; Raghavan C, 2007, MOL BREEDING, V19, P87, DOI 10.1007/s11032-006-9046-x; Rothe N, 2010, THESIS KANSASS STATE; Sabetta W, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-20; Slade AJ, 2005, NAT BIOTECHNOL, V23, P75, DOI 10.1038/nbt1043; Slafer GA, 1996, FIELD CROP RES, V46, P1, DOI 10.1016/0378-4290(95)00081-X; SONG WN, 1995, GENET RESOUR CROP EV, V42, P273, DOI 10.1007/BF02431262; Stephenson P, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-62; Suzuki T, 2008, MOL GENET GENOMICS, V279, P213, DOI 10.1007/s00438-007-0293-2; Talame V, 2008, PLANT BIOTECHNOL J, V6, P477, DOI 10.1111/j.1467-7652.2008.00341.x; Till B. J., 2007, GENOMICS ASSISTED CR, P333; Till BJ, 2003, METH MOL B, V236, P205; Till BJ, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-19; Till Bradley J., 2004, BMC Plant Biology, V4, P12, DOI 10.1186/1471-2229-4-12; Uauy C, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-115; Wang N, 2008, NEW PHYTOL, V180, P751, DOI 10.1111/j.1469-8137.2008.02619.x; Weigel D, 2000, PLANT PHYSIOL, V122, P1003, DOI 10.1104/pp.122.4.1003; Wu JL, 2005, PLANT MOL BIOL, V59, P85, DOI 10.1007/s11103-004-5112-0; Xin ZG, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-103	53	254	259	6	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41570	10.1371/journal.pone.0041570	http://dx.doi.org/10.1371/journal.pone.0041570			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844501	Green Published, gold, Green Submitted			2022-12-25	WOS:000306687700113
J	Chen, L; Ma, YL; Kim, EY; Yu, W; Schwartz, RJ; Qian, L; Wang, J				Chen, Li; Ma, Yanlin; Kim, Eun Young; Yu, Wei; Schwartz, Robert J.; Qian, Ling; Wang, Jun			Conditional Ablation of Ezh2 in Murine Hearts Reveals Its Essential Roles in Endocardial Cushion Formation, Cardiomyocyte Proliferation and Survival	PLOS ONE			English	Article							HISTONE METHYLTRANSFERASE ACTIVITY; CARDIAC DEVELOPMENT; TRANSCRIPTION FACTOR; MOUSE DEVELOPMENT; NOTCH ACTIVATION; GENE-EXPRESSION; OUTFLOW-TRACT; BHLH FACTORS; CELL FATE; METHYLATION	Ezh2 is a histone trimethyltransferase that silences genes mainly via catalyzing trimethylation of histone 3 lysine 27 (H3K27Me3). The role of Ezh2 as a regulator of gene silencing and cell proliferation in cancer development has been extensively investigated; however, its function in heart development during embryonic cardiogenesis has not been well studied. In the present study, we used a genetically modified mouse system in which Ezh2 was specifically ablated in the mouse heart. We identified a wide spectrum of cardiovascular malformations in the Ezh2 mutant mice, which collectively led to perinatal death. In the Ezh2 mutant heart, the endocardial cushions (ECs) were hypoplastic and the endothelial-to-mesenchymal transition (EMT) process was impaired. The hearts of Ezh2 mutant mice also exhibited decreased cardiomyocyte proliferation and increased apoptosis. We further identified that the Hey2 gene, which is important for cardiomyocyte proliferation and cardiac morphogenesis, is a downstream target of Ezh2. The regulation of Hey2 expression by Ezh2 may be independent of Notch signaling activity. Our work defines an indispensible role of the chromatin remodeling factor Ezh2 in normal cardiovascular development.	[Chen, Li; Kim, Eun Young; Qian, Ling; Wang, Jun] Texas Heart Inst, Basic Res Labs, Dept Stem Cell Engn, Houston, TX 77025 USA; [Ma, Yanlin] Texas A&M Hlth Sci Ctr, Inst Biosci & Technol, Houston, TX USA; [Kim, Eun Young] Univ Texas Hlth Sci Ctr Houston, Program Genes & Dev, Houston, TX USA; [Yu, Wei; Schwartz, Robert J.] Univ Houston, Dept Biochem & Mol Biol, Houston, TX USA	Texas Heart Institute; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Health Science Center Houston; University of Houston System; University of Houston	Chen, L (corresponding author), Texas Heart Inst, Basic Res Labs, Dept Stem Cell Engn, Houston, TX 77025 USA.	junwang@heart.thi.tmc.edu	Chen, Lei/A-2275-2011	Chen, Lei/0000-0003-3068-1583; Parry, Martin/0000-0002-4477-672X; cai, yudong/0000-0001-5664-7979	American Heart Association; National Health Institute; American Heart Association Southern Central Affiliate; Biotechnology and Biological Sciences Research Council [BBS/E/C/00004820, BBS/E/C/00005202, BBS/E/C/00004952, BB/E025161/1, BB/I000607/1] Funding Source: researchfish	American Heart Association(American Heart Association); National Health Institute; American Heart Association Southern Central Affiliate; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported in part by grants from the American Heart Association to JW. JW is also supported by a P30 grant from the National Health Institute as a Newly Independent Investigator (NII). LC is supported by a Postdoctoral Fellowship from the American Heart Association Southern Central Affiliate. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama H, 2004, P NATL ACAD SCI USA, V101, P6502, DOI 10.1073/pnas.0401711101; Bracken AP, 2003, EMBO J, V22, P5323, DOI 10.1093/emboj/cdg542; Brutsaert DL, 2003, PHYSIOL REV, V83, P59, DOI 10.1152/physrev.00017.2002; Cao R, 2004, MOL CELL, V15, P57, DOI 10.1016/j.molcel.2004.06.020; Caretti G, 2004, GENE DEV, V18, P2627, DOI 10.1101/gad.1241904; Cha TL, 2005, SCIENCE, V310, P306, DOI 10.1126/science.1118947; Chase A, 2011, CLIN CANCER RES, V17, P2613, DOI 10.1158/1078-0432.CCR-10-2156; Conerly ML, 2011, GENE DEV, V25, P997, DOI 10.1101/gad.2054311; Curry CL, 2005, ONCOGENE, V24, P6333, DOI 10.1038/sj.onc.1208783; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; de la Pompa JL, 1998, NATURE, V392, P182, DOI 10.1038/32419; Diez H, 2007, EXP CELL RES, V313, P1, DOI 10.1016/j.yexcr.2006.09.009; Doetzlhofer A, 2009, DEV CELL, V16, P58, DOI 10.1016/j.devcel.2008.11.008; Donovan J, 2002, CURR BIOL, V12, P1605, DOI 10.1016/S0960-9822(02)01149-1; Esteller M, 2007, HUM MOL GENET, V16, pR50, DOI 10.1093/hmg/ddm018; Ezhkova E, 2011, GENE DEV, V25, P485, DOI 10.1101/gad.2019811; Fischer A, 2007, NUCLEIC ACIDS RES, V35, P4583, DOI 10.1093/nar/gkm477; Fouse SD, 2008, CELL STEM CELL, V2, P160, DOI 10.1016/j.stem.2007.12.011; Fussbroich B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021651; Gessler M, 2002, CURR BIOL, V12, P1601, DOI 10.1016/S0960-9822(02)01150-8; Gordadze AV, 2001, J VIROL, V75, P5899, DOI 10.1128/JVI.75.13.5899-5912.2001; Han P, 2011, CIRC RES, V108, P378, DOI 10.1161/CIRCRESAHA.110.224287; Harrelson Z, 2004, DEVELOPMENT, V131, P5041, DOI 10.1242/dev.01378; High FA, 2008, NAT REV GENET, V9, P49, DOI 10.1038/nrg2279; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Jiang XB, 2000, DEVELOPMENT, V127, P1607; Kim EY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020803; Lee ST, 2011, MOL CELL, V43, P798, DOI 10.1016/j.molcel.2011.08.011; Leimeister C, 2000, DEV BIOL, V227, P91, DOI 10.1006/dbio.2000.9884; Leimeister C, 1999, MECH DEVELOP, V85, P173, DOI 10.1016/S0925-4773(99)00080-5; Li X, 2009, AM J PATHOL, V175, P1246, DOI 10.2353/ajpath.2009.090042; Liu W, 2004, P NATL ACAD SCI USA, V101, P4489, DOI 10.1073/pnas.0308466101; Liu YG, 2010, AM J PHYSIOL-HEART C, V298, pH2082, DOI 10.1152/ajpheart.00747.2009; Ma Q, 2008, DEV BIOL, V323, P98, DOI 10.1016/j.ydbio.2008.08.013; Moses Kelvin A., 2001, Genesis The Journal of Genetics and Development, V31, P176, DOI 10.1002/gene.10022; Niessen K, 2008, CIRC RES, V102, P1169, DOI 10.1161/CIRCRESAHA.108.174318; Niessen K, 2008, J CELL BIOL, V182, P315, DOI 10.1083/jcb.200710067; Noseda M, 2004, CIRC RES, V94, P910, DOI 10.1161/01.RES.0000124300.76171.C9; O'Carroll D, 2001, MOL CELL BIOL, V21, P4330, DOI 10.1128/MCB.21.13.4330-4336.2001; Olson EN, 2004, NAT MED, V10, P467, DOI 10.1038/nm0504-467; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Person AD, 2005, INT REV CYTOL, V243, P287, DOI 10.1016/S0074-7696(05)43005-3; Riising EM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002704; Rutenberg JB, 2006, DEVELOPMENT, V133, P4381, DOI 10.1242/dev.02607; Sakata Y, 2006, J MOL CELL CARDIOL, V40, P267, DOI 10.1016/j.yjmcc.2005.09.006; Shen XH, 2008, MOL CELL, V32, P491, DOI 10.1016/j.molcel.2008.10.016; Shi B, 2007, MOL CELL BIOL, V27, P5105, DOI 10.1128/MCB.00162-07; Shirai M, 2009, P NATL ACAD SCI USA, V106, P18604, DOI 10.1073/pnas.0900635106; Su IH, 2003, NAT IMMUNOL, V4, P124, DOI 10.1038/ni876; Tanay A, 2007, P NATL ACAD SCI USA, V104, P5521, DOI 10.1073/pnas.0609746104; Timmerman LA, 2004, GENE DEV, V18, P99, DOI 10.1101/gad.276304; van Weerd JH, 2011, CARDIOVASC RES, V91, P203, DOI 10.1093/cvr/cvr138; Wang J, 2008, J BIOL CHEM, V283, P23235, DOI 10.1074/jbc.M709748200; Wang J, 2007, MOL CELL BIOL, V27, P622, DOI 10.1128/MCB.01160-06; Wang J, 2011, WIRES SYST BIOL MED, V3, P446, DOI 10.1002/wsbm.130; Wang J, 2011, BIRTH DEFECTS RES A, V91, P468, DOI 10.1002/bdra.20816; Wilkinson FH, 2006, P NATL ACAD SCI USA, V103, P19296, DOI 10.1073/pnas.0603564103; Wu JC, 2004, CURR PROB CARDIOLOGY, V29, P641, DOI 10.1016/j.cpcardiol.2004.04.003; Wu SC, 2011, J BIOL CHEM, V286, P28511, DOI 10.1074/jbc.M111.240515; Wu ZL, 2010, CELL DEATH DIFFER, V17, P801, DOI 10.1038/cdd.2009.162; Wyngaarden LA, 2011, DEVELOPMENT, V138, P3759, DOI 10.1242/dev.063180	61	254	259	6	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2012	7	2							e31005	10.1371/journal.pone.0031005	http://dx.doi.org/10.1371/journal.pone.0031005			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UG	22844501	Green Published, Green Submitted, gold			2022-12-25	WOS:000301977500025
J	Chen, LC; Hsu, C; Chiueh, CC; Lee, WS				Chen, Li-Ching; Hsu, Chin; Chiueh, Chuang Chin; Lee, Wen-Sen			Ferrous Citrate Up-Regulates the NOS2 through Nuclear Translocation of NF kappa B Induced by Free Radicals Generation in Mouse Cerebral Endothelial Cells	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; TRANSIENT FOREBRAIN ISCHEMIA; SUBARACHNOID HEMORRHAGE; OXIDATIVE STRESS; BRAIN-INJURY; PUTATIVE ROLE; IRON; ACTIVATION; EXPRESSION; FERRITIN	Previous studies indicate that the inducible nitric oxide synthase 2 (NOS2) of the brain vascular tissue in experimental subarachnoid hemorrhage (SAH) rats is a critical factor for inducing cerebral vasospasm. However, the underlying molecular mechanisms remain to be elucidated. Here, we applied ferrous citrate (FC) complexes to the primary cultured mouse cerebral endothelial cell (CEC) to mimic the SAH conditions and to address the issue how SAH-induced NOS2 up-regulation. Using immunocytochemical staining technique, we demonstrated that NOS2 was expressed in the cultured CEC. Treatment of the CEC with FC induced increases of the intracellular level of ROS, nuclear factor kappa-light-chain-enhancer of activated B cells (NF kappa B) nuclear translocation as well as NF kappa B binding onto the NOS promoter, and the levels of NOS2 mRNA and protein. These effects were abolished by pre-treatment of the cell with N-Acetyl-Cysteine (NAC), a reactive oxygen species (ROS) scavenger. In the present study, two previously predicted NFkB binding sites were confirmed in the NOS2 promoter within the range of -1529 bp to -1516 bp and -1224 bp to -1210 bp. Interestingly, both NF kappa B binding sites are involved in the FC-activated NOS2 transcriptional activity; the binding site located at -1529 bp to -1516 bp played a greater role than the other binding site located at -1224 bp to -1210 bp in the mouse CEC. These findings highlight the molecular mechanism underlying FC-induced up-regulation of NOS2 in the mouse CEC.	[Chen, Li-Ching; Lee, Wen-Sen] Taipei Med Univ, Grad Inst Med Sci, Sch Med, Taipei, Taiwan; [Hsu, Chin] Kaohsiung Med Univ, Dept Physiol, Kaohsiung, Taiwan; [Chiueh, Chuang Chin] Taipei Med Univ, Shuang Ho Hosp, Taipei, Taiwan; [Lee, Wen-Sen] Taipei Med Univ, Dept Physiol, Sch Med, Taipei, Taiwan; [Lee, Wen-Sen] Taipei Med Univ Hosp, Canc Res Ctr, Taipei, Taiwan	Taipei Medical University; Kaohsiung Medical University; Taipei Medical University; Shuang Ho Hospital; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital	Lee, WS (corresponding author), Taipei Med Univ, Grad Inst Med Sci, Sch Med, Taipei, Taiwan.	wslee@tmu.edu.tw	Chen, Lei/A-2275-2011	Chen, Lei/0000-0003-3068-1583; Parry, Martin/0000-0002-4477-672X; cai, yudong/0000-0001-5664-7979	National Science Council of Taiwan [NSC-101-2320-B-038-005, NSC-101-2629-B-037-001, NSC-95-2320-B-037-032-MY2, NSC97-2314-B-037-039-MY2, NSC-95-2320-B-038-027-MY2]; Biotechnology and Biological Sciences Research Council [BBS/E/C/00004820, BBS/E/C/00005202, BBS/E/C/00004952, BB/E025161/1, BB/I000607/1] Funding Source: researchfish	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by research grants from the National Science Council of Taiwan (NSC-101-2320-B-038-005 and NSC-101-2629-B-037-001 to W. S. L.; NSC-95-2320-B-037-032-MY2 and NSC97-2314-B-037-039-MY2 to C. H.; NSC-95-2320-B-038-027-MY2 to C. C. C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aladag MA, 2009, NEUROCHEM RES, V34, P1935, DOI 10.1007/s11064-009-9979-7; ALLEN DR, 1994, ARCH BIOCHEM BIOPHYS, V315, P235, DOI 10.1006/abbi.1994.1495; Amberg GC, 2010, CIRC RES, V107, P1002, DOI 10.1161/CIRCRESAHA.110.217018; Asehnoune K, 2004, J IMMUNOL, V172, P2522, DOI 10.4049/jimmunol.172.4.2522; Ayer RE, 2008, ACTA NEUROCHIR SUPPL, V104, P33; Berra L V, 2007, J Neurosurg Sci, V51, P1; BIEMOND P, 1988, FREE RADICAL BIO MED, V4, P185, DOI 10.1016/0891-5849(88)90026-3; Bishop GM, 2001, BRAIN RES, V907, P175, DOI 10.1016/S0006-8993(01)02303-4; Chen LC, 2009, J AGR FOOD CHEM, V57, P7331, DOI 10.1021/jf901477g; Chen TY, 2010, STROKE, V41, P160, DOI 10.1161/STROKEAHA.109.562850; Chiueh CC, 2001, PEDIATR NEUROL, V25, P138, DOI 10.1016/S0887-8994(01)00266-1; Chiueh CC, 2000, NEUROTOX RES, V2, P293, DOI 10.1007/BF03033799; Defrere S, 2008, MOL HUM REPROD, V14, P377, DOI 10.1093/molehr/gan033; del Zoppo G, 2000, BRAIN PATHOL, V10, P95; Du WL, 2005, CHEST, V128, p556S, DOI 10.1378/chest.128.6_suppl.556S; Dumont AS, 2003, NEUROSURGERY, V53, P123, DOI 10.1227/01.NEU.0000068863.37133.9E; Gaasch JA, 2007, NEUROCHEM RES, V32, P1196, DOI 10.1007/s11064-007-9290-4; Hanggi D, 2006, ACTA NEUROCHIR, V148, P605, DOI 10.1007/s00701-005-0721-1; Ho PY, 2006, MOL CANCER THER, V5, P3130, DOI 10.1158/1535-7163.MCT-06-0457; Horky LL, 1998, J NEUROSURG, V88, P298, DOI 10.3171/jns.1998.88.2.0298; Hua Y, 2007, STROKE, V38, P759, DOI 10.1161/01.STR.0000247868.97078.10; Ishimaru H, 1996, BRAIN RES, V726, P23, DOI 10.1016/0006-8993(96)00294-6; Janjua Nazli, 2003, Curr Opin Crit Care, V9, P113, DOI 10.1097/00075198-200304000-00006; Jaramillo M, 2003, J IMMUNOL, V171, P4243, DOI 10.4049/jimmunol.171.8.4243; KONDO Y, 1995, J CEREBR BLOOD F MET, V15, P216, DOI 10.1038/jcbfm.1995.27; Lin CL, 2006, J NEUROSURG, V104, P298, DOI 10.3171/jns.2006.104.2.298; Lopez-Ongil S, 1998, BRIT J PHARMACOL, V124, P447, DOI 10.1038/sj.bjp.0701847; Mills E, 2010, FUTURE MED CHEM, V2, P51, DOI 10.4155/FMC.09.140; MOHANAKUMAR KP, 1994, ANN NY ACAD SCI, V738, P392; MORRIS SM, 1994, AM J PHYSIOL, V266, pE829, DOI 10.1152/ajpendo.1994.266.6.E829; Ong WY, 2005, REPROD NUTR DEV, V45, P647, DOI 10.1051/rnd:2005051; Ortego M, 2005, J CARDIOVASC PHARM, V45, P468, DOI 10.1097/01.fjc.0000159042.50488.e5; Osuka K, 2009, J NEUROTRAUM, V26, P1157, DOI 10.1089/neu.2008-0836; Otani H, 2009, ANTIOXID REDOX SIGN, V11, P1913, DOI [10.1089/ars.2009.2453, 10.1089/ARS.2009.2453]; Palmer C, 1999, J NEUROSCI RES, V56, P60, DOI 10.1002/(SICI)1097-4547(19990401)56:1<60::AID-JNR8>3.0.CO;2-A; Ql WN, 2004, MICROSURG, V24, P316, DOI 10.1002/micr.20030; Rauhala P, 1998, FREE RADICAL BIO MED, V24, P1065, DOI 10.1016/S0891-5849(97)00386-9; Regunathan S, 2003, ANN NY ACAD SCI, V1009, P20, DOI 10.1196/annals.1304.002; Shih HC, 2006, STROKE, V37, P3025, DOI 10.1161/01.STR.0000249008.18669.5a; Sorond FA, 2000, ANTIOXID REDOX SIGN, V2, P421, DOI 10.1089/15230860050192206; Taylor BS, 2001, PROG INFLAM RES, P1; Taylor BS, 2000, SHOCK, V13, P413, DOI 10.1097/00024382-200006000-00001; Van Bergen P, 1999, FREE RADICAL RES, V31, P631, DOI 10.1080/10715769900301201; Vijay A, 2006, NEUROL RES, V28, P759, DOI 10.1179/016164106X152034; West KA, 2003, J CLIN INVEST, V111, P81, DOI 10.1172/JCI200316147; Wilkinson DS, 2005, MOL CELL BIOL, V25, P1200, DOI 10.1128/MCB.25.3.1200-1212.2005; Won SM, 2011, EXP MOL MED, V43, P121, DOI 10.3858/emm.2011.43.2.020; Wong J M, 1995, Adv Pharmacol, V34, P155; Xu J, 2000, STROKE, V31, P1744, DOI 10.1161/01.STR.31.7.1744; Young HM, 1997, HISTOCHEM CELL BIOL, V107, P19, DOI 10.1007/s004180050085; Zhen JH, 2008, AM J HYPERTENS, V21, P28, DOI 10.1038/ajh.2007.14	51	254	259	6	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46239	10.1371/journal.pone.0046239	http://dx.doi.org/10.1371/journal.pone.0046239			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	22844501	Green Submitted, gold, Green Published			2022-12-25	WOS:000309973900115
J	Li, Y; Farooq, M; Sheng, DL; Chandramouli, C; Lan, T; Mahajan, NK; Kini, RM; Hong, YH; Lisowsky, T; Ge, RW				Li, Yan; Farooq, Muhammad; Sheng, Donglai; Chandramouli, Chanchal; Lan, Tian; Mahajan, Nilesh K.; Kini, R. Manjunatha; Hong, Yunhan; Lisowsky, Thomas; Ge, Ruowen			Augmenter of Liver Regeneration (alr) Promotes Liver Outgrowth during Zebrafish Hepatogenesis	PLOS ONE			English	Article							HEPATIC STIMULATOR SUBSTANCE; DISULFIDE RELAY SYSTEM; MITOCHONDRIAL SULFHYDRYL OXIDASE; INTERMEMBRANE SPACE; RESPIRATORY-CHAIN; PROTEIN IMPORT; CYTOCHROME-C; GENE; HEPATOPOIETIN; YEAST	Augmenter of Liver Regeneration (ALR) is a sulfhydryl oxidase carrying out fundamental functions facilitating protein disulfide bond formation. In mammals, it also functions as a hepatotrophic growth factor that specifically stimulates hepatocyte proliferation and promotes liver regeneration after liver damage or partial hepatectomy. Whether ALR also plays a role during vertebrate hepatogenesis is unknown. In this work, we investigated the function of alr in liver organogenesis in zebrafish model. We showed that alr is expressed in liver throughout hepatogenesis. Knockdown of alr through morpholino antisense oligonucleotide (MO) leads to suppression of liver outgrowth while overexpression of alr promotes liver growth. The small-liver phenotype in alr morphants results from a reduction of hepatocyte proliferation without affecting apoptosis. When expressed in cultured cells, zebrafish Alr exists as dimer and is localized in mitochondria as well as cytosol but not in nucleus or secreted outside of the cell. Similar to mammalian ALR, zebrafish Alr is a flavin-linked sulfhydryl oxidase and mutation of the conserved cysteine in the CxxC motif abolishes its enzymatic activity. Interestingly, overexpression of either wild type Alr or enzyme-inactive Alr(C131S) mutant promoted liver growth and rescued the liver growth defect of alr morphants. Nevertheless, alr(C131S) is less efficacious in both functions. Meantime, high doses of alr MOs lead to widespread developmental defects and early embryonic death in an alr sequence-dependent manner. These results suggest that alr promotes zebrafish liver outgrowth using mechanisms that are dependent as well as independent of its sulfhydryl oxidase activity. This is the first demonstration of a developmental role of alr in vertebrate. It exemplifies that a low-level sulfhydryl oxidase activity of Alr is essential for embryonic development and cellular survival. The dose-dependent and partial suppression of alr expression through MO-mediated knockdown allows the identification of its late developmental role in vertebrate liver organogenesis.	[Li, Yan; Farooq, Muhammad; Sheng, Donglai; Chandramouli, Chanchal; Lan, Tian; Mahajan, Nilesh K.; Kini, R. Manjunatha; Hong, Yunhan; Ge, Ruowen] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Farooq, Muhammad] King Saud Univ, Coll Sci, Dept Zool, Riyadh 11451, Saudi Arabia; [Kini, R. Manjunatha] Virginia Commonwealth Univ, Med Coll Virginia, Dept Biochem & Mol Biol, Richmond, VA 23298 USA; [Lisowsky, Thomas] MultiBIND Biotec GmbH, Cologne, Germany	National University of Singapore; King Saud University; Virginia Commonwealth University	Li, Y (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore.	dbsgerw@nus.edu.sg	He, Zheng-Guo/P-3647-2014; Ge, Ruowen/D-8352-2012; Kini, Manjunatha/H-8029-2012; Chandramouli, Chanchal/AAF-2848-2020; Hong, Yunhan/D-4197-2009; Farooq, Muhammad/G-9838-2013; Li, Zhi-Yong/G-9701-2011; Li, Zhi-Yong/G-9701-2011	Ge, Ruowen/0000-0002-0750-7336; Farooq, Muhammad/0000-0001-9891-2443; Kini, Manjunatha/0000-0002-6100-3251; Zhang, Yuesheng/0000-0002-0976-2875; Li, Zhi-Yong/0000-0003-3039-8833; Li, Zhi-Yong/0000-0002-6814-9165	Singapore Biomedical Research Council [BMRC/01/1/21/18/068]; Ministry of Education [R-154-000-475-112]; NCI NIH HHS [CA120533, R01 CA124627, R01 CA120533, P30 CA016056] Funding Source: Medline	Singapore Biomedical Research Council(Agency for Science Technology & Research (A*STAR)); Ministry of Education; NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported by the Singapore Biomedical Research Council grant BMRC/01/1/21/18/068 and Ministry of Education grant R-154-000-475-112 to Dr. Ge. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen S, 2005, J MOL BIOL, V353, P937, DOI 10.1016/j.jmb.2005.08.049; Bihlmaier K, 2007, J CELL BIOL, V179, P389, DOI 10.1083/jcb.200707123; Cao Y, 2009, FREE RADICAL BIO MED, V47, P1057, DOI 10.1016/j.freeradbiomed.2009.07.017; Chen J, 2005, GENE DEV, V19, P2900, DOI 10.1101/gad.1366405; Chen XX, 2003, J BIOL CHEM, V278, P49022, DOI 10.1074/jbc.M304057200; Chu J, 2009, HEPATOLOGY, V50, P1656, DOI 10.1002/hep.23157; Daithankar VN, 2010, BIOCHEMISTRY-US, V49, P6737, DOI 10.1021/bi100912m; Daithankar VN, 2009, BIOCHEMISTRY-US, V48, P4828, DOI 10.1021/bi900347v; Di Fonzo A, 2009, AM J HUM GENET, V84, P594, DOI 10.1016/j.ajhg.2009.04.004; Farooq M, 2008, DEV BIOL, V317, P336, DOI 10.1016/j.ydbio.2008.02.034; Farrell SR, 2005, BIOCHEMISTRY-US, V44, P1532, DOI 10.1021/bi0479555; Field HA, 2003, DEV BIOL, V253, P279, DOI 10.1016/S0012-1606(02)00017-9; Gandhi CR, 1999, HEPATOLOGY, V29, P1435, DOI 10.1002/hep.510290522; Gandhi CR, 2009, J CELL PHYSL; Gatzidou E, 2006, WORLD J GASTROENTERO, V12, P4951, DOI 10.3748/wjg.v12.i31.4951; GHOSH C, 1994, CELL BIOL TOXICOL, V10, P167, DOI 10.1007/BF00757560; HAGIYA M, 1994, P NATL ACAD SCI USA, V91, P8142, DOI 10.1073/pnas.91.17.8142; HE FH, 1993, HEPATOLOGY, V17, P225, DOI 10.1016/0270-9139(93)90081-W; Hofhaus G, 1999, EUR J CELL BIOL, V78, P349, DOI 10.1016/S0171-9335(99)80069-7; Ilowski M, 2011, BIOCHEM BIOPH RES CO, V404, P148, DOI 10.1016/j.bbrc.2010.11.083; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kondili VG, 2005, DIGEST DIS SCI, V50, P297, DOI 10.1007/s10620-005-1598-9; Korzh S, 2001, MECH DEVELOP, V103, P137, DOI 10.1016/S0925-4773(01)00330-6; LABRECQUE DR, 1975, J PHYSIOL-LONDON, V248, P273, DOI 10.1113/jphysiol.1975.sp010973; Lange H, 2001, EMBO REP, V2, P715, DOI 10.1093/embo-reports/kve161; Lee JE, 2000, FEBS LETT, V477, P62, DOI 10.1016/S0014-5793(00)01767-1; Levitan A, 2004, J BIOL CHEM, V279, P20002, DOI 10.1074/jbc.M312877200; Li Y, 2002, EUR J BIOCHEM, V269, P3888, DOI 10.1046/j.1432-1033.2002.03054.x; Li Y, 2000, J BIOL CHEM, V275, P37443, DOI 10.1074/jbc.M004373200; Liatsos GD, 2003, DIGEST DIS SCI, V48, P1929, DOI 10.1023/A:1026157901805; LISOWSKY T, 1995, GENOMICS, V29, P690, DOI 10.1006/geno.1995.9950; LISOWSKY T, 1992, MOL GEN GENET, V232, P58, DOI 10.1007/BF00299137; Lisowsky T, 2001, DIGEST LIVER DIS, V33, P173, DOI 10.1016/S1590-8658(01)80074-8; Lu CR, 2002, FASEB J, V16, P90, DOI 10.1096/fj.01-0506fje; Lu J, 2002, WORLD J GASTROENTERO, V8, P353; McClure KD, 2008, DEV BIOL, V319, P68, DOI 10.1016/j.ydbio.2008.04.004; Mesecke N, 2005, CELL, V121, P1059, DOI 10.1016/j.cell.2005.04.011; Ober EA, 2006, NATURE, V442, P688, DOI 10.1038/nature04888; Passeri MJ, 2009, HEPATOLOGY, V49, P443, DOI 10.1002/hep.22667; Sadler KC, 2007, P NATL ACAD SCI USA, V104, P1570, DOI 10.1073/pnas.0610774104; Shin D, 2007, DEVELOPMENT, V134, P2041, DOI 10.1242/dev.000281; Tanigawa K, 2000, J GASTROENTEROL, V35, P112, DOI 10.1007/s005350050023; Thasler WE, 2005, HISTOPATHOLOGY, V47, P57, DOI 10.1111/j.1365-2559.2005.02172.x; Thirunavukkarasu C, 2008, J HEPATOL, V48, P578, DOI 10.1016/j.jhep.2007.12.010; Tokatlidis K, 2005, CELL, V121, P965, DOI 10.1016/j.cell.2005.06.019; Wang CP, 2006, WORLD J GASTROENTERO, V12, P4859; Wang G, 1999, J BIOL CHEM, V274, P11469, DOI 10.1074/jbc.274.17.11469; Wang WZ, 2007, BIOCHEMISTRY-US, V46, P3246, DOI 10.1021/bi602499t; WESTERFIELD M, 1995, ZEBRAFISH BOOK; Wiedenmann J, 2009, IUBMB LIFE, V61, P1029, DOI 10.1002/iub.256; Yabu T, 2001, FISHERIES SCI, V67, P333, DOI 10.1046/j.1444-2906.2001.00233.x; Yang XM, 1997, SCI CHINA SER C, V40, P642, DOI 10.1007/BF02882695	52	150	169	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2012	7	1							e30835	10.1371/journal.pone.0030835	http://dx.doi.org/10.1371/journal.pone.0030835			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911FX	22905149	gold, Green Published			2022-12-25	WOS:000301703800034
J	Li, YY; Zhu, RN; Qian, Y; Deng, J				Li, Yuyun; Zhu, Runan; Qian, Yuan; Deng, Jie			The Characteristics of Blood Glucose and WBC Counts in Peripheral Blood of Cases of Hand Foot and Mouth Disease in China: A Systematic Review	PLOS ONE			English	Review							ENTEROVIRUS 71; OUTBREAK; INFECTIONS; MALAYSIA; TAIWAN; MANIFESTATIONS	Background: Outbreaks of Hand Foot and Mouth Disease (HFMD) have occurred in many parts of the world especially in China. We aimed to summarize the characteristics of the levels of blood glucose and white blood cell (WBC) counts in cases of HFMD in Mainland China and Taiwan, using meta-analysis based on systematic review of published articles. Methods: We systematically reviewed published studies, from the MEDLINE and WANFANG Data, about the levels of blood glucose and WBC counts in cases of HFMD until 15(th) June 2011, and quantitatively summarized the characteristics of them using meta-analysis. Results: In total, 37 studies were included in this review. In Mainland China and Taiwan, generally, the average level of blood glucose, the prevalence of hyperglycemia, WBC counts and the prevalence of leukocytosis increased with the severity of the illness. There was no significant difference in the prevalence of leukocytosis between ANS (autonomic nervous system dysregulation)/PE (pulmonary edema) group and CNS (central nervous system) group, and in the average level of blood glucose between healthy controls and mild cases of HFMD. WBC counts in cases infected by EV71 were less than those in cases infected by CA16. Conclusions: our analyses indicated that blood glucose and WBC counts increased with the severity of HFMD disease, which would help doctors to manage patients efficiently.	[Li, Yuyun; Zhu, Runan; Qian, Yuan; Deng, Jie] Capital Inst Pediat, Virol Lab, Beijing, Peoples R China	Capital Institute of Pediatrics (CIP)	Li, YY (corresponding author), Capital Inst Pediat, Virol Lab, Beijing, Peoples R China.	qybds1129@163.com	He, Zheng-Guo/P-3647-2014; Ge, Ruowen/D-8352-2012; Kini, Manjunatha/H-8029-2012; Chandramouli, Chanchal/AAF-2848-2020; Hong, Yunhan/D-4197-2009; Farooq, Muhammad/G-9838-2013; Li, Zhi-Yong/G-9701-2011; Li, Zhi-Yong/G-9701-2011	Ge, Ruowen/0000-0002-0750-7336; Farooq, Muhammad/0000-0001-9891-2443; Kini, Manjunatha/0000-0002-6100-3251; Zhang, Yuesheng/0000-0002-0976-2875; Li, Zhi-Yong/0000-0003-3039-8833; Li, Zhi-Yong/0000-0002-6814-9165	NCI NIH HHS [CA120533, R01 CA124627, R01 CA120533, P30 CA016056] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abubakar S, 1999, SCAND J INFECT DIS, V31, P331, DOI 10.1080/00365549950163734; AbuBakar S, 2009, EMERG INFECT DIS, V15, P79, DOI 10.3201/eid1501.080264; Ahmad K, 2000, LANCET, V356, P1338, DOI 10.1016/S0140-6736(05)74253-7; ALEXANDER JP, 1994, J INFECT DIS, V169, P905, DOI 10.1093/infdis/169.4.905; Chang LY, 1999, LANCET, V354, P1682, DOI 10.1016/S0140-6736(99)04434-7; Chen JH, 2010, ACTA ACAD MEDICINAE, V32, P363; Chen WB, 2000, 5 DIAGNOSTICS; Chu PY, 2001, ARCH VIROL, V146, P589, DOI 10.1007/s007050170164; Cui LD, 2011, CHINA PRAC MED, V6, P50; Dai W, 2011, CHINESE COMMUNITY DO, V13, P88; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Ding NZ, 2009, VIRUS RES, V145, P157, DOI 10.1016/j.virusres.2009.06.006; Fan XC, 2009, ANHUI MED J, V30, P253; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Hsia SH, 2005, PEDIATR INFECT DIS J, V24, P331, DOI 10.1097/01.inf.0000157219.19674.98; Huang S, 2008, ANHUI MED J, V29, P361; Huang YF, 2003, J INFECTION, V46, P238, DOI 10.1053/jinf.2002.1117; Jiang J, 2010, J QILU NURSING, V16, P119; Kehle J, 2003, J NEUROVIROL, V9, P126, DOI 10.1080/13550280390173364; Li CC, 2002, SCAND J INFECT DIS, V34, P104, DOI 10.1080/00365540110077119; Li JM, 2009, CHIN PEDIAT EMERG ME, V16, P142; Li LL, 2005, J CLIN MICROBIOL, V43, P3835, DOI 10.1128/JCM.43.8.3835-3839.2005; Li Q., 2010, ANHUI MED J, V31, P1410; Li SH, 2010, CHIN PECIATR EMERG M, V17, P49; Li SH, 2010, CHIN J CLIN INFECT D, V3, P337; [李玉芬 Li Yufen], 2010, [临床儿科杂志, Journal of Chinical Pediatrics], V28, P1011; Liao Y, 2010, JILIN MED J, P4075; Lin TY, 2003, EMERG INFECT DIS, V9, P291, DOI 10.3201/eid0903.020285; Lin TY, 2003, CLIN INFECT DIS, V36, P269, DOI 10.1086/345905; Lin TY, 2002, ACTA PAEDIATR, V91, P632, DOI 10.1080/080352502760069016; Liu J, 2009, ANHUI MED J, V30, P261; Liu X, 2010, CHIN J MED ULTRASOUN, V7, P1844; Liu Ying-xia, 2008, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V22, P475; Lu CY, 2002, J MED VIROL, V67, P217, DOI 10.1002/jmv.2210; Luo LP, 2010, J N CHINA COAL MED U, V12, P356; Mai LL, 2011, CHINESE J NEW CLIN M, V4, P356; MANTEL N, 1959, J NATL CANCER I, V22, P719; [毛国顺 MAO Guoshun], 2008, [中华传染病杂志, Chinese Journal of Infections Diseases], V26, P387; [毛月燕 MAO Yue-yan], 2009, [中华传染病杂志, Chinese Journal of Infections Diseases], V27, P35; McMinn P, 2001, CLIN INFECT DIS, V32, P236, DOI 10.1086/318454; Podin Y, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-180; Qian N, 2010, THESIS QINGDAO U, P17; Shen Q, 2011, J MED RES, V40, P93; Shimizu H, 1999, JPN J INFECT DIS, V52, P12; Tang LP, 2009, CHIN J M ISDIAGN, V9, P6840; Verbruggen SCAT, 2007, CLIN NUTR, V26, P677, DOI 10.1016/j.clnu.2007.08.012; Wang HC, 2010, CHINA CLIN PRAC MED, V4, P155; Wang JR, 2002, J CLIN MICROBIOL, V40, P10, DOI 10.1128/JCM.40.1.10-15.2002; Wang SM, 2003, J INFECT DIS, V188, P564, DOI 10.1086/376998; Wei XL, 2010, SHANDONG MED J, V50, P70; World Health Organization, 2017, GUID DRINK WAT QUAL, VFourth, DOI 10.1016/S1462-0758(00)00006-6; Yan ZW, 2011, CHIN J GEN PRACT, V10, P343; Yang T, 2010, ACTA MEDCINAE SINICA, V23, P68; Yu LX, 2011, CHIN PEDIAT EMERG ME, V18, P57; [岳保珠 Yue Baozhu], 2010, [中国全科医学, Chinese General Practice], V13, P2239; Zhang GH, 2010, CHINA CLIN PRAC MED, V4, P132; Zhang JH, 2010, CHINESE FOREIGN MED, V8, P12; Zhang Shou-Bin, 2008, Zhongguo Dang Dai Er Ke Za Zhi, V10, P38; Zhao H., 2008, J CLIN PEDIAT, V26, P467; Zheng NH, 2011, CHINA MODERN DOCTOR, V49, P126; Zhou AR, 2000, 5 BIOCH; [周大明 Zhou Daming], 2010, [重庆医科大学学报, Acta Universitatis Scientiae Medicinae Chongqing], V35, P1724	63	150	169	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29003	10.1371/journal.pone.0029003	http://dx.doi.org/10.1371/journal.pone.0029003			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22905149	Green Published, Green Submitted, gold			2022-12-25	WOS:000301123400018
J	Li, YQ; He, ZG				Li, Yuqing; He, Zheng-Guo			The Mycobacterial LysR-Type Regulator OxyS Responds to Oxidative Stress and Negatively Regulates Expression of the Catalase-Peroxidase Gene	PLOS ONE			English	Article							TRANSCRIPTIONAL REGULATOR; PATHOGENIC MYCOBACTERIA; TUBERCULOSIS; KATG; FURA; SENSITIVITY; SMEGMATIS; MACROPHAGES; RESISTANCE; PROTEINS	Protection against oxidative stress is one of the primary defense mechanisms contributing to the survival of Mycobacterium tuberculosis in the host. In this study, we provide evidence that OxyS, a LysR-type transcriptional regulator functions as an oxidative stress response regulator in mycobacteria. Overexpression of OxyS lowers expression of the catalase-peroxidase (KatG) gene in M. smegmatis. OxyS binds directly with the katG promoter region and a conserved, GC-rich T-N-11-A motif for OxyS binding was successfully characterized in the core binding site. Interestingly, the DNA-binding activity of OxyS was inhibited by H2O2, but not by dithiothreitol. Cys25, which is situated at the DNA-binding domain of OxyS, was found to have a regulatory role for the DNA-binding ability of OxyS in response to oxidative stress. In contrast, the other three cysteine residues in OxyS do not appear to have this function. Furthermore, the mycobacterial strain over-expressing OxyS had a higher sensitivity to H2O2. Thus, OxyS responds to oxidative stress through a unique cysteine residue situated in its DNA-binding domain and negatively regulates expression of the katG gene. These findings uncover a specific regulatory mechanism for mycobacterial adaptation to oxidative stress.	[Li, Yuqing; He, Zheng-Guo] Huazhong Agr Univ, Natl Key Lab Agr Microbiol, Ctr Prote Res, Coll Life Sci & Technol, Wuhan, Hubei, Peoples R China	Huazhong Agricultural University	He, ZG (corresponding author), Huazhong Agr Univ, Natl Key Lab Agr Microbiol, Ctr Prote Res, Coll Life Sci & Technol, Wuhan, Hubei, Peoples R China.	hezhengguo@mail.hzau.edu.cn	He, Zheng-Guo/P-3647-2014; Ge, Ruowen/D-8352-2012; Kini, Manjunatha/H-8029-2012; Chandramouli, Chanchal/AAF-2848-2020; Hong, Yunhan/D-4197-2009; Farooq, Muhammad/G-9838-2013; Li, Zhi-Yong/G-9701-2011; Li, Zhi-Yong/G-9701-2011	Ge, Ruowen/0000-0002-0750-7336; Farooq, Muhammad/0000-0001-9891-2443; Kini, Manjunatha/0000-0002-6100-3251; Zhang, Yuesheng/0000-0002-0976-2875; Li, Zhi-Yong/0000-0003-3039-8833; Li, Zhi-Yong/0000-0002-6814-9165	National Natural Science Foundation of China [31025002, 30930003]; Fundamental Research Funds for the Central Universities [2011PY140]; Hubei Chutian Scholar Program; NCI NIH HHS [CA120533, R01 CA124627, R01 CA120533, P30 CA016056] Funding Source: Medline	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Hubei Chutian Scholar Program; NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Natural Science Foundation of China (31025002, 30930003), the Fundamental Research Funds for the Central Universities (2011PY140) and Hubei Chutian Scholar Program (to Z-GH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Chen H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001602; CHRISTMAN MF, 1989, P NATL ACAD SCI USA, V86, P3484, DOI 10.1073/pnas.86.10.3484; DERETIC V, 1995, MOL MICROBIOL, V17, P889, DOI 10.1111/j.1365-2958.1995.mmi_17050889.x; Dhandayuthapani S, 1996, J BACTERIOL, V178, P3641, DOI 10.1128/jb.178.12.3641-3649.1996; Domenech P, 2001, MICROBES INFECT, V3, P713, DOI 10.1016/S1286-4579(01)01422-8; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Green J, 2004, NAT REV MICROBIOL, V2, P954, DOI 10.1038/nrmicro1022; Guo MM, 2009, GENOME RES, V19, P1301, DOI 10.1101/gr.086595.108; He ZG, 2003, J BIOL CHEM, V278, P29538, DOI 10.1074/jbc.M304318200; Italiani VCS, 2011, J BACTERIOL, V193, P1734, DOI 10.1128/JB.01339-10; Jittawuttipoka T, 2009, J BACTERIOL, V191, P7372, DOI 10.1128/JB.00788-09; Kim SO, 2002, CELL, V109, P383, DOI 10.1016/S0092-8674(02)00723-7; Lee HI, 2010, J BIOCHEM, V147, P511, DOI 10.1093/jb/mvp197; Li YQ, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-242; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maddocks SE, 2008, MICROBIOL-SGM, V154, P3609, DOI 10.1099/mic.0.2008/022772-0; Manca C, 1999, INFECT IMMUN, V67, P74, DOI 10.1128/IAI.67.1.74-79.1999; Master S, 2001, J BACTERIOL, V183, P4033, DOI 10.1128/JB.183.13.4033-4039.2001; Milano A, 2001, J BACTERIOL, V183, P6801, DOI 10.1128/JB.183.23.6801-6806.2001; Muraoka S, 2003, J MOL BIOL, V328, P555, DOI 10.1016/S0022-2836(03)00312-7; Nguyen L, 2005, TRENDS CELL BIOL, V15, P269, DOI 10.1016/j.tcb.2005.03.009; Pagan-Ramos E, 1998, J BACTERIOL, V180, P4856; Pym AS, 2001, MOL MICROBIOL, V40, P879, DOI 10.1046/j.1365-2958.2001.02427.x; Sala C, 2003, J BACTERIOL, V185, P5357, DOI 10.1128/JB.185.18.5357-5362.2003; Sala C, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-33; SHERMAN DR, 1995, P NATL ACAD SCI USA, V92, P6625, DOI 10.1073/pnas.92.14.6625; Singh A, 2007, P NATL ACAD SCI USA, V104, P11562, DOI 10.1073/pnas.0700490104; Sreevatsan S, 1996, J CLIN MICROBIOL, V34, P2007, DOI 10.1128/JCM.34.8.2007-2010.1996; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; Yu K., 1999, Tubercle and Lung Disease, V79, P191, DOI 10.1054/tuld.1998.0203; Zahrt TC, 2001, MOL MICROBIOL, V39, P1174, DOI 10.1046/j.1365-2958.2001.02321.x; Zhang H, 2008, FEBS J, V275, P753, DOI 10.1111/j.1742-4658.2007.06241.x; ZHANG Y, 1992, NATURE, V358, P591, DOI 10.1038/358591a0; Zheng M, 1998, SCIENCE, V279, P1718, DOI 10.1126/science.279.5357.1718	36	150	169	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30186	10.1371/journal.pone.0030186	http://dx.doi.org/10.1371/journal.pone.0030186			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22905149	Green Published, gold, Green Submitted			2022-12-25	WOS:000301454400077
